id	antibody	specie	treatment	control_id	cell_id	experiment_type	tf_uniprot_id	title	input
EXP000489	sc-345	Homo sapiens	IFN gamma	EXP000490	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	PEAKS033050
EXP000389	STAT5A	Mus musculus	IL-2	NULL	44	unspecified	P42230	T-cells	PEAKS035184
EXP000480	custom made against Tcfcp2l1	Mus musculus	NULL	EXP000488	2	unspecified	Q3UNW5	mESCs (mouse embryonic stem cells)	PEAKS035185
EXP000481	07-729 (Upstate)	Mus musculus	NULL	EXP000488	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS035186
EXP000482	custom made against Zfx	Mus musculus	NULL	EXP000488	2	unspecified	P17012	mESCs (mouse embryonic stem cells)	PEAKS035187
EXP000483	sc-482 (Upstate)	Mus musculus	NULL	EXP000488	2	unspecified	P42227	mESCs (mouse embryonic stem cells)	PEAKS035188
EXP000484	custom made against Klf4	Mus musculus	NULL	EXP000488	2	unspecified	Q60793	mESCs (mouse embryonic stem cells)	PEAKS035189
EXP000485	custom made against Esrrb	Mus musculus	NULL	EXP000488	2	unspecified	Q61539	mESCs (mouse embryonic stem cells)	PEAKS035190
EXP000486	custom made against c-Myc	Mus musculus	NULL	EXP000488	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	PEAKS035191
EXP000487	custom made against n-Myc	Mus musculus	NULL	EXP000488	2	unspecified	P03966	mESCs (mouse embryonic stem cells)	PEAKS035192
EXP000372	NCoR	Mus musculus	ZT22	EXP000376	5	unspecified	Q60974	liver	PEAKS035193
EXP000373	Rev-erba	Mus musculus	ZT10	EXP000375	5	unspecified	Q3UV55	liver	PEAKS035194
EXP000370	EOMES	Homo sapiens	NULL	EXP000369	396	unspecified	O95936	WA09 (embryonic stem cells)	PEAKS033051
EXP000278	Combined anti-DUX4 C-terminus rabbit polyclonal antibodies MO488 and MO489	Homo sapiens	myoblasts transduced with lentivirus carrying DUX4	EXP000279	467	unspecified	Q9UBX2	myoblasts	PEAKS033052
EXP000277	anti-CTCF	Mus musculus	NULL	NULL	41	unspecified	Q61164	B-cells	PEAKS035195
EXP000276		Homo sapiens	NULL	EXP000275	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033053
EXP000274	Jarid1b-DAIN	Mus musculus	NULL	NULL	230	unspecified	Q80Y84	ES-E14 (E14, embryonic stem cells)	PEAKS035196
EXP000273	TCF7L1 (M-20)	Mus musculus	24 hours of adipogenic stimuli	NULL	18	unspecified	Q9Z1J1	3T3-L1 (embryonic fibroblasts)	PEAKS035197
EXP000271	yy1	Mus musculus	NULL	EXP000272	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS035198
EXP000379	NFYA (Santa Cruz H-209 sc-10779, Lot D2408)	Homo sapiens	NULL	EXP000377	514	unspecified	P23511	K562 (myelogenous leukemia)	PEAKS033054
EXP000653	sc-15022	Homo sapiens	DHT	EXP030990	70	unspecified	Q99801	LNCaP (prostate carcinoma)	PEAKS033055
EXP000623	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	E2	NULL	111	unspecified	P55317	T47D (invasive ductal carcinoma)	PEAKS033056
EXP000578	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	430	unspecified	P49116	HepG2 (hepatoblastoma)	PEAKS033057
EXP000579	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	356	unspecified	P49116	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033058
EXP000574	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	423	unspecified	Q96GC6	HeLa S3 (cervical adenocarcinoma)	PEAKS033059
EXP000575	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	356	unspecified	Q96GC6	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033060
EXP000576	Epitomics monoclonal rabbit anti ELK1	Homo sapiens	NULL	NULL	423	unspecified	P19419	HeLa S3 (cervical adenocarcinoma)	PEAKS033061
EXP000577	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	514	unspecified	P49116	K562 (myelogenous leukemia)	PEAKS033062
EXP000570	anti-BAF155 (H-76), Santa Cruz Biotechnology, sc-10756	Homo sapiens	NULL	NULL	423	unspecified	Q92922	HeLa S3 (cervical adenocarcinoma)	PEAKS033063
EXP000571	anti-BAF170 (H-116), Santa Cruz Biotechnology, sc-10757	Homo sapiens	NULL	NULL	423	unspecified	Q8TAQ2	HeLa S3 (cervical adenocarcinoma)	PEAKS033064
EXP000572	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	514	unspecified	Q96GC6	K562 (myelogenous leukemia)	PEAKS033065
EXP000573	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	430	unspecified	Q96GC6	HepG2 (hepatoblastoma)	PEAKS033066
EXP000475	REC-RCAB0002PF (Cosmo Bio)	Mus musculus	NULL	EXP000488	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS035199
EXP000474	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	E2 for 24hr	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033067
EXP000477	sc-17320	Mus musculus	NULL	EXP000488	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS035200
EXP000476	sc-8628	Mus musculus	NULL	EXP000488	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS035201
EXP000471	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	DMSO	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033068
EXP000473	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	E2 for 4hr	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033069
EXP000472	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	E2 for 1hr	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033070
EXP000772	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000773	356	unspecified	Q04206	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033071
EXP000770	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000771	363	unspecified	Q04206	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	PEAKS033072
EXP000479	05-379 (Upstate)	Mus musculus	NULL	EXP000488	2	unspecified	Q61501	mESCs (mouse embryonic stem cells)	PEAKS035202
EXP000478	sc-7965	Mus musculus	NULL	EXP000488	2	unspecified	P70340	mESCs (mouse embryonic stem cells)	PEAKS035203
EXP000774	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000775	357	unspecified	Q04206	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033073
EXP000371	NCoR	Mus musculus	ZT10	EXP000375	5	unspecified	Q60974	liver	PEAKS035204
EXP000509	p73 beta isoform	Homo sapiens	NULL	EXP000507	783	unspecified	O15350	SaOS2 (osteosarcoma)	PEAKS033074
EXP000508	p73 alpha isoform	Homo sapiens	NULL	EXP000507	783	unspecified	O15350	SaOS2 (osteosarcoma)	PEAKS033075
EXP000501	RXR	Mus musculus	Day 4 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	PEAKS035205
EXP000500	RXR	Mus musculus	Day 3 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	PEAKS035206
EXP000503	Flag M2	Mus musculus	NULL	EXP000504	2	unspecified	P43241	mESCs (mouse embryonic stem cells)	PEAKS036831
EXP000502	RXR	Mus musculus	Day 6 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	PEAKS035207
EXP000505	STAT1	Homo sapiens	IFNgamma	NULL	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	PEAKS033076
EXP000506	STAT1	Homo sapiens		NULL	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	PEAKS033077
EXP000835	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 6h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	PEAKS036832
EXP000834	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 1h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	PEAKS036833
EXP000837	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 48h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	PEAKS036834
EXP000836	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 24h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	PEAKS036835
EXP000831	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 48h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	PEAKS036836
EXP000830	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 24h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	PEAKS036837
EXP000116	Taf1 (L-20)	Mus musculus	NULL	NULL	44	unspecified	Q80UV9	T-cells	PEAKS035208
EXP000114	Ets1 (C-20) sc-350x	Mus musculus	NULL	NULL	44	unspecified	P27577	T-cells	PEAKS035209
EXP000838	Biotin-tagged LXRb bound to NanoLink Streptavidin Magnetic Microspheres (Vendor: SoluLink, cat# M1002-010, lot# LM041609)	Mus musculus	GW3965, 1h	EXP000839	91	unspecified	Q60644	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS035210
EXP000057	ERa(HC20 Santa Cruz)	Homo sapiens	NULL	NULL	2301	unspecified	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS036838
EXP000055	STAT6<SantaCruz#sc981>	Mus musculus	STAT6 KO	EXP000056	499	unspecified	P52633	Th2-cells	PEAKS035211
EXP000054	STAT6<SantaCruz#sc981>	Mus musculus	NULL	EXP000056	499	unspecified	P52633	Th2-cells	PEAKS035212
EXP051004	STAT4<SantaCruz#sc486>	Mus musculus	STAT4 KO	NULL	76	unspecified	P42228	Th1-cells	PEAKS049004
EXP051003	STAT4<SantaCruz#sc486>	Mus musculus	NULL	NULL	76	unspecified	P42228	Th1-cells	PEAKS049003
EXP000865	CTCF (07-729), DAM1421463	Mus musculus	RAG1 KO	NULL	105	unspecified	Q61164	pro-B cells	PEAKS035215
EXP000058	ERa(HC20 Santa Cruz)	Homo sapiens	NULL	NULL	2301	unspecified	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS036839
EXP000204	ER beta	Homo sapiens	NULL	EXP000206	848	unspecified	Q92731	U2OS (osteosarcoma)	PEAKS033078
EXP000205	ER beta	Homo sapiens	E2	EXP000207	848	unspecified	Q92731	U2OS (osteosarcoma)	PEAKS033079
EXP000202	E2F4	Homo sapiens	NULL	EXP000203	335	unspecified	Q16254	GM06990 (female B-cells)	PEAKS033080
EXP000949	TCF7L2	Homo sapiens	bio	EXP000960	65	unspecified	Q9NQB0	U937 (adult acute monocytic leukemia)	PEAKS033081
EXP000238	REST	Mus musculus	NULL	NULL	252	unspecified	Q8VIG1	V6.5 (embryonic stem cells)	PEAKS035216
EXP000200	ap2	Homo sapiens	NULL	EXP000201	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS033082
EXP000629	Tet1 rabbit polyclonal antibodies	Mus musculus	Tet1 KD	EXP000628	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035217
EXP000233	sc-858	Homo sapiens	NULL	EXP000234	512	unspecified	P41182	JURL-MK1 (chronic myelogenous leukemia)	PEAKS033083
EXP000232	sc-8005	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033084
EXP000231	sc-8005	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033085
EXP000944	SMAD1	Homo sapiens	dorso	EXP000959	514	unspecified	Q15797	K562 (myelogenous leukemia)	PEAKS033086
EXP000345	sc-1008	Homo sapiens	calcitriol	EXP000342	340	unspecified	P11473	GM10855 (female B-cells)	PEAKS033087
EXP000602	HNF4	Homo sapiens	NULL	NULL	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS036840
EXP000603	GABP	Homo sapiens	NULL	NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	PEAKS036841
EXP000600	07-079	Homo sapiens	NULL	NULL	673	unspecified	P49711	normal epidermal keratinocytes	PEAKS033088
EXP000601	FOXA2	Homo sapiens	NULL	NULL	430	unspecified	Q9Y261	HepG2 (hepatoblastoma)	PEAKS036842
EXP000609	IMG-124A	Homo sapiens	NULL	NULL	93	unspecified	P62380	BJ (fibroblasts)	PEAKS033089
EXP000650	sc-816	Homo sapiens	ethanol	EXP030990	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS033090
EXP000785	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	1058	unspecified	P23772	CD4+ T-cells	PEAKS035218
EXP000784	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	140	unspecified	P23772	CD4- CD8- T cells	PEAKS035219
EXP000620	cFos - Cat# sc-7202, Santa Cruz	Homo sapiens	NULL	NULL	113	unspecified	P01100	MCF7 (Invasive ductal breast carcinoma)	PEAKS033091
EXP000939	GATA1	Homo sapiens	bio	EXP000959	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS033092
EXP000288	ERalpha	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033093
EXP000289	ERalpha	Homo sapiens	Tamoxifen	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033094
EXP000287	ERalpha	Homo sapiens	NULL	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033095
EXP000284	FoxO1	Mus musculus	NULL	EXP000286	503	unspecified	Q9R1E0	pre-B cells	PEAKS036843
EXP000285	Pax5	Mus musculus	NULL	EXP000286	503	unspecified	Q02650	pre-B cells	PEAKS036844
EXP000283	LRH-1	Mus musculus	NULL	EXP000282	713	unspecified	P45448	pancreas	PEAKS035220
EXP000280	Runx2 Flag tagged	Homo sapiens	NULL	EXP000281	129	unspecified	Q13950	LNCaP C4-2B (prostate carcinoma)	PEAKS033096
EXP000788	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	498	unspecified	P23772	Th17-cells	PEAKS035221
EXP000624	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	NULL	NULL	111	unspecified	P55317	T47D (invasive ductal carcinoma)	PEAKS033097
EXP000518	stat6	Homo sapiens	Act+IL-4 for 4hr	NULL	881	unspecified	P42226	CD4+ T-cells	PEAKS033098
EXP000625	Tet1 rabbit polyclonal antibodies	Mus musculus	wild-type	EXP000627	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035222
EXP000519	tcf4	Homo sapiens	NULL	EXP000522	188	unspecified	Q9NQB0	LS174T (colon adenocarcinoma)	PEAKS033099
EXP000626	Tet1 rabbit polyclonal antibodies	Mus musculus	control KD	EXP000628	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035223
EXP000309	Jun	Homo sapiens	NULL	NULL	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS033100
EXP000308	HNF4g	Homo sapiens	NULL	NULL	430	unspecified	Q14541	HepG2 (hepatoblastoma)	PEAKS033101
EXP000307	HNF4a AB domain	Homo sapiens	NULL	NULL	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS033102
EXP000306	HNF4a F domain	Homo sapiens	NULL	NULL	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS033103
EXP000304	KDM2A	Mus musculus	NULL	EXP000305	252	unspecified	P59997	V6.5 (embryonic stem cells)	PEAKS035224
EXP000303	CFP1 (Sc-25391 â€“ Santa Cruz)	Mus musculus	NULL	NULL	143	unspecified	Q9CWW7	brain	PEAKS035225
EXP000300	RUNX monoclonal from Nancy Speck	Homo sapiens	NULL	EXP000302	510	unspecified	Q01196	Jurkat E6.1 (T-cells)	PEAKS033104
EXP000736	anti-ERG	Homo sapiens	Treatment: none	NULL	66	normal	P11308	prostate cancer	PEAKS033105
EXP000737	anti-ERG	Homo sapiens	Treatment: none	NULL	66	normal	P11308	prostate cancer	PEAKS033106
EXP000734	anti-ERG	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS033107
EXP000735	anti-ERG	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P11308	LNCaP (prostate carcinoma)	PEAKS033108
EXP000732	anti-AR	Homo sapiens	Treatment: ethanol; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS033109
EXP000733	anti-AR	Homo sapiens	Treatment: R1881; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS033110
EXP000730	anti-AR	Homo sapiens	Treatment: ethanol; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS033111
EXP000731	anti-AR	Homo sapiens	Treatment: R1881; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS033112
EXP000738	anti-AR	Homo sapiens	Treatment: none	NULL	604	normal	P10275	metastatic prostate cancer tissue	PEAKS033113
EXP000739	anti-ERG	Homo sapiens	Treatment: none	NULL	604	normal	P11308	metastatic prostate cancer tissue	PEAKS033114
EXP000172	Jarid2	Mus musculus	NULL	EXP000176	543	unspecified	Q62315	LF2 (embryonic stem cells)	PEAKS035226
EXP000673	gata2	Homo sapiens	NULL	EXP000671	472	unspecified	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033115
EXP000672	cfos	Homo sapiens	NULL	EXP000671	472	unspecified	P01100	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033116
EXP000517	stat6	Homo sapiens	Act for 4hr	NULL	881	unspecified	P42226	CD4+ T-cells	PEAKS033117
EXP000670	GATA3	Homo sapiens		NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS033118
EXP001014	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	PEAKS033119
EXP001015	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	PEAKS033120
EXP001016	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	PEAKS033121
EXP001010	in-house polyclonal Ab against RXRa and RAR	Mus musculus	NULL	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035227
EXP001011	in-house polyclonal Ab against RXRa	Mus musculus	NULL	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035228
EXP001012	in-house polyclonal Ab against RXRa	Mus musculus	NULL	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035229
EXP001013	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	PEAKS033122
EXP000545	ab16509	Mus musculus	25ng/ml Activin	EXP000548	233	unspecified	Q62432	E14TG2A (embryonic stem cells)	PEAKS035230
EXP000859	anti-V5 (Abcam, ab15828)	Mus musculus	NULL	EXP000860	60	unspecified	P09633	Ainv15 (embryonic stem cells)	PEAKS035231
EXP000542	Oct4	Mus musculus	NULL	EXP000543	151	unspecified	P20263	CCE (embryonic stem cells)	PEAKS035232
EXP000422	Smad1	Mus musculus	NULL	EXP000420	265	unspecified	P70340	G1E (embryonic stem cells)	PEAKS035233
EXP000423	Rabbit anti RBPJ	Homo sapiens	NULL	EXP000424	474	unspecified	Q06330	IB4 (lymphocytes)	PEAKS033123
EXP000674	ZNF143	Homo sapiens	NULL	EXP000675	199	unspecified	P52747	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS033124
EXP000170	scl	Mus musculus	NULL	EXP000171	300	unspecified	P22091	fetal liver erythroblasts	PEAKS035234
EXP000855	SC-352	Mus musculus	NULL	EXP000847	15	unspecified	P17433	38B9 (A-MuLV pre-B-cells)	PEAKS035235
EXP000012	CTCF	Mus musculus	NULL	EXP000011	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS035236
EXP000854	MyoD	Mus musculus	day 5	NULL	580	unspecified	P10085	MC1R(20):tetMyod1(14) (embryonic stem cells)	PEAKS035237
EXP000017	Sox11 (M. Wegner)	Mus musculus	NULL	EXP000013	285	unspecified	Q7M6Y2	embryonic stem cell-drived neurons	PEAKS035238
EXP051002	Sox2 (Millipore)	Mus musculus	NULL	NULL	280	unspecified	P48432	embryonic stem cell-derived neural progenitors	PEAKS049002
EXP051001	Sox3 (T. Edlund)	Mus musculus	NULL	NULL	280	unspecified	P53784	embryonic stem cell-derived neural progenitors	PEAKS049001
EXP051000	Sox3 (T. Edlund)	Mus musculus	NULL	NULL	1153	unspecified	P53784	C2C12 (myoblasts)	PEAKS049000
EXP000018	sc-8628	Mus musculus	NULL	EXP000019	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS035242
EXP000547	ab16509	Mus musculus	10uM SB	EXP000550	233	unspecified	Q62432	E14TG2A (embryonic stem cells)	PEAKS035243
EXP000175	Jarid1a	Mus musculus	NULL	EXP000176	543	unspecified	Q3UXZ9	LF2 (embryonic stem cells)	PEAKS035244
EXP000295	MYC	Homo sapiens	NULL	NULL	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	PEAKS033125
EXP000546	ab16509	Mus musculus	1/5000 DMSO	EXP000549	233	unspecified	Q62432	E14TG2A (embryonic stem cells)	PEAKS035245
EXP000294	KLF4	Homo sapiens	NULL	NULL	376	unspecified	O43474	WA01 (H1, human embryonic stem cells)	PEAKS033126
EXP000793	Fli1 (santa cruz, cat#sc356X, Lot#L0407)	Mus musculus	NULL	NULL	2479	unspecified	P26323	CD8+ T-cells	PEAKS035246
EXP000177	Estrogen Receptor (ER)	Homo sapiens	hormone starved for 3 days, treated with 1% ethanol for 45 minutes	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033127
EXP000297	OCT4	Homo sapiens	NULL	NULL	376	unspecified	Q01860	WA01 (H1, human embryonic stem cells)	PEAKS033128
EXP000884	sc-543	Homo sapiens	ETOH (ethanol)	EXP000892	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS033129
EXP000885	sc-543	Homo sapiens	E2	EXP000890	504	unspecified	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS033130
EXP000886	sc-543	Homo sapiens	E2	EXP000890	504	unspecified	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS033131
EXP000887	ER?	Homo sapiens	ETOH (ethanol)	EXP000891	239	unspecified	P03372	ECC-1 (endometrial adenocarcinoma)	PEAKS033132
EXP000880	TBP (Santa Cruz sc-204, LOT H0508)	Mus musculus		NULL	91	unspecified	P29037	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS035247
EXP000881	sc-543	Homo sapiens	ETOH (ethanol)	EXP000889	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033133
EXP000882	sc-543	Homo sapiens	E2	EXP000889	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033134
EXP000883	sc-543	Homo sapiens	ETOH (ethanol)	EXP000892	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS033135
EXP000291	GATA-1	Mus musculus	NULL	NULL	600	unspecified	P17679	SK-MEL-86 (melanoma)	PEAKS035248
EXP000888	sc-543	Homo sapiens	E2	EXP000891	239	unspecified	P03372	ECC-1 (endometrial adenocarcinoma)	PEAKS033136
EXP000290	ERalpha	Homo sapiens	Fulvestrant	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033137
EXP000293	4A4 against p63	Homo sapiens	NULL	NULL	215	unspecified	Q9H3D4	keratinocytes	PEAKS033138
EXP000292	H129 against p63	Homo sapiens	NULL	NULL	215	unspecified	Q9H3D4	keratinocytes	PEAKS033139
EXP000074	anti p65	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033140
EXP000905	FOXA2	Mus musculus	NULL	EXP000906	5	unspecified	P35583	liver	PEAKS035249
EXP000826	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	PU.1 KO	NULL	190	unspecified	P17433	myeloid cells	PEAKS036845
EXP000868	E2A.E12(V-18) (sc-349)	Mus musculus	NULL	NULL	171	unspecified	P15806	CD4+ CD8+ T cells	PEAKS035250
EXP000869	ATRX H300 (Santa Cruz Biotechnology, batch G0105)	Homo sapiens	NULL	EXP000870	460	unspecified	P46100	primary erythroblasts	PEAKS033141
EXP000900	anti-NFYA	Mus musculus	NULL	NULL	828	unspecified	P23708	terminally differentiated neurons	PEAKS035251
EXP000122	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	PEAKS035252
EXP000426	ETV4(Aviva Systems Biology, cat# ARP32263, lot# QC1723)	Homo sapiens	NULL	EXP000425	725	unspecified	P43268	PC3(bone mets prostate adenocarcinoma)	PEAKS033142
EXP000642	PPARgamma	Mus musculus	day 2 of differentiation	EXP000644	19	unspecified	P37238	3T3-L1-derived preadipocytes	PEAKS035253
EXP000643	PPARgamma	Mus musculus	day 6 of differentiation	EXP000644	19	unspecified	P37238	3T3-L1-derived preadipocytes	PEAKS035254
EXP000864	FKHR (H-128) (sc-11350)	Mus musculus	RAG1 KO	NULL	105	unspecified	Q9R1E0	pro-B cells	PEAKS035255
EXP000427	JUND(Santa Cruz Biotechnology, cat# sc-74, lot# C0310)	Homo sapiens	NULL	NULL	725	unspecified	P17535	PC3(bone mets prostate adenocarcinoma)	PEAKS033143
EXP000166	ctcf	Mus musculus	NULL	EXP000167	252	unspecified	Q61164	V6.5 (embryonic stem cells)	PEAKS035256
EXP000164	GATA1	Mus musculus	NULL	EXP000165	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035257
EXP000088	CTCF (Millipore 07-729)	Mus musculus	NULL	EXP000090	105	unspecified	Q61164	pro-B cells	PEAKS035258
EXP000085	anti-Scl/Tal1	Mus musculus	NULL	EXP000087	549	unspecified	P22091	Lin- bone marrow hematopoietic progenitor cells	PEAKS035259
EXP000086	anti-Gata2	Mus musculus	NULL	EXP000087	549	unspecified	O09100	Lin- bone marrow hematopoietic progenitor cells	PEAKS035260
EXP000080	rabbit anti-YY1 polyclonal	Homo sapiens	NULL	EXP000081	881	unspecified	P25490	CD4+ T-cells	PEAKS033144
EXP000082	goat-anti-eGFP, raised against His-tagged full-length eGFP and affinity-purified with GST-tagged full-length eGFP	Mus musculus	NULL	EXP000083	763	unspecified	Q61164	R1/E (embryonic stem cells)	PEAKS035261
EXP000677	anti-CTCF (SantaCruz #15914)	Mus musculus	Dnmt1/3a/3b KO	EXP000676	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS035262
EXP000125	Bcl6 antibody N-3	Mus musculus	NULL	EXP000119	5	unspecified	P41183	liver	PEAKS035263
EXP000178	Estrogen Receptor (ER)	Homo sapiens	hormone starved for 3 days, treated with 10 nM Î²-estradiol for 45 minutes	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033145
EXP000124	Bcl6 antibody N-3	Mus musculus	NULL	EXP000119	5	unspecified	P41183	liver	PEAKS035264
EXP000159	nrsf	Homo sapiens	NULL	EXP000160	509	unspecified	Q13127	Jurkat (T-cells)	PEAKS036846
EXP000349	E2F4	Mus musculus	NULL	EXP000350	12	unspecified	Q8R0K9	MEF (mouse embryonic fibroblasts)	PEAKS035265
EXP000348	phospho-Stat3 (14-6727, ebiosciences, CA)	Mus musculus	IL-6, IL-23	NULL	1058	unspecified	P42227	CD4+ T-cells	PEAKS035266
EXP000179	anti-HA	Mus musculus	NULL	EXP000180	2	unspecified	P45448	mESCs (mouse embryonic stem cells)	PEAKS035267
EXP000341	scl	Mus musculus	NULL	EXP000335	236	unspecified	P22091	embryonic stem cell-derived haematopoietic cells	PEAKS035268
EXP000340	runx1	Mus musculus	NULL	EXP000335	236	unspecified	Q03347	embryonic stem cell-derived haematopoietic cells	PEAKS035269
EXP000778	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	PEAKS033146
EXP000344	sc-1008	Homo sapiens		EXP000342	340	unspecified	P11473	GM10855 (female B-cells)	PEAKS033147
EXP000262	anti-SMAD1/5	Homo sapiens	50 ng/ml BMP-4	NULL	470	unspecified	Q99717	pulmonary arterial smooth muscle cells	PEAKS033148
EXP000264	ERalpha	Homo sapiens	NULL	EXP000265	848	unspecified	P03372	U2OS (osteosarcoma)	PEAKS036847
EXP000266	Goat anti-GFP (kindly provided by Kevin P White, University of Chicago)	Mus musculus	NULL	EXP000267	53	unspecified	Q9ES03	heart	PEAKS035270
EXP000268	HA tagged ZFP57	Mus musculus	NULL	NULL	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS035271
EXP000269	HA tagged ZFP57	Mus musculus	NULL	NULL	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS035272
EXP000533	PPARgamma	Mus musculus	NULL	NULL	732	unspecified	P37238	peritoneal macrophages	PEAKS035273
EXP000047	GR (Santa Cruz Biotechnologies, sc-1004; and Affinity BioReagents, PA1-511A)	Mus musculus	NULL	NULL	19	unspecified	P06537	3T3-L1-derived preadipocytes	PEAKS035274
EXP000858	Smad3	Mus musculus	TGFÎ² 5 ng/ml for 2 hour	EXP000847	15	unspecified	Q8BUN5	38B9 (A-MuLV pre-B-cells)	PEAKS035275
EXP000776	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	PEAKS033149
EXP000777	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	PEAKS033150
EXP000581	sc-13030X	Homo sapiens	NULL	NULL	423	unspecified	P28324	HeLa S3 (cervical adenocarcinoma)	PEAKS033151
EXP000580	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	423	unspecified	P49116	HeLa S3 (cervical adenocarcinoma)	PEAKS033152
EXP000583	RUNX1	Homo sapiens		EXP000582	183	unspecified	Q01196	CMK (acute megakaryoblastic leukemia)	PEAKS033153
EXP000585	RUNX1	Homo sapiens		EXP000584	514	unspecified	Q01196	K562 (myelogenous leukemia)	PEAKS033154
EXP000587	RUNX1	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	Q01196	K562 (myelogenous leukemia)	PEAKS033155
EXP000333	gata2	Mus musculus	NULL	EXP000335	236	unspecified	O09100	embryonic stem cell-derived haematopoietic cells	PEAKS035276
EXP000589	FOS	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	P01100	K562 (myelogenous leukemia)	PEAKS033156
EXP000588	GATA1	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS033157
EXP000467	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ³ for 6 hour	EXP000468	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS035277
EXP000465	anti-STAT1? (santa cruz: sc-417)	Mus musculus		EXP000466	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS035278
EXP000463	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ² for 6 hour	EXP000464	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS035279
EXP000461	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ³ for 6 hour	EXP000462	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS035280
EXP000747	RAR	Homo sapiens		NULL	851	unspecified	P10276	UPR9 (hematopoietic stem cells)	PEAKS033158
EXP000746	RXR	Homo sapiens		NULL	69	unspecified	P19793	acute promyelocytic leukemia blasts	PEAKS033159
EXP000745	RAR	Homo sapiens	24 hours ATRA	EXP000751	648	unspecified	P10276	NB4 (acute promyelocytic leukemia )	PEAKS033160
EXP000744	RXR	Homo sapiens	24 hours ATRA	EXP000751	648	unspecified	P19793	NB4 (acute promyelocytic leukemia )	PEAKS033161
EXP000743	RXR	Homo sapiens		NULL	69	unspecified	P19793	acute promyelocytic leukemia blasts	PEAKS033162
EXP000742	RAR	Homo sapiens		EXP000751	648	unspecified	P10276	NB4 (acute promyelocytic leukemia )	PEAKS033163
EXP000469	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ² for 6 hour	EXP000470	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS035281
EXP000334	gfi1b	Mus musculus	NULL	EXP000335	236	unspecified	O70237	embryonic stem cell-derived haematopoietic cells	PEAKS035282
EXP000725	anti-AR	Homo sapiens	Treatment: siRNA against ERG; Conditions: cells were hormone starved for 48 hours; Genotype: ERG knokdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS033164
EXP000688	polyclonal anti-RARg	Mus musculus	24hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	PEAKS035283
EXP000726	anti-ERG	Homo sapiens	Treatment: siRNA against ERG; Conditions: cells were hormone starved for 48 hours; Genotype: ERG knokdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS033165
EXP001025	CTCF	Homo sapiens	NULL	EXP001019	296	unspecified	P49711	FB0167P (progeria fibroblasts)	PEAKS033166
EXP001024	cMYC	Homo sapiens	NULL	EXP001018	297	unspecified	P01106	FB8470 (fibroblasts)	PEAKS033167
EXP001027	CTCF	Homo sapiens	NULL	EXP001020	391	unspecified	P49711	D54 (H54, Human glioblastoma)	PEAKS033168
EXP001026	cMYC	Homo sapiens	NULL	EXP001019	296	unspecified	P01106	FB0167P (progeria fibroblasts)	PEAKS033169
EXP001021	CTCF	Homo sapiens	NULL	EXP001017	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033170
EXP001023	CTCF	Homo sapiens	NULL	EXP001018	297	unspecified	P49711	FB8470 (fibroblasts)	PEAKS033171
EXP001022	cMYC	Homo sapiens	NULL	EXP001017	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	PEAKS033172
EXP000512	NFI (H300): sc-5567, SantaCruz Biotechnology	Mus musculus	NFI-C KO	EXP000513	12	unspecified	P70255	MEF (mouse embryonic fibroblasts)	PEAKS035284
EXP000510	DO1 against p53	Homo sapiens	NULL	EXP000507	783	unspecified	P04637	SaOS2 (osteosarcoma)	PEAKS033173
EXP000511	NFI (H300): sc-5567, SantaCruz Biotechnology	Mus musculus	NULL	EXP000513	12	unspecified	P70255	MEF (mouse embryonic fibroblasts)	PEAKS035285
EXP000516	stat6	Homo sapiens	Act+IL-4 for 1hr	NULL	881	unspecified	P42226	CD4+ T-cells	PEAKS033174
EXP001028	cMYC	Homo sapiens	NULL	EXP001020	391	unspecified	P01106	D54 (H54, Human glioblastoma)	PEAKS033175
EXP000514	stat6	Homo sapiens	NULL	NULL	881	unspecified	P42226	CD4+ T-cells	PEAKS033176
EXP000515	stat6	Homo sapiens	Act for 1hr	NULL	881	unspecified	P42226	CD4+ T-cells	PEAKS033177
EXP000494	PPARg	Mus musculus	Day 3 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035286
EXP000719	sc-835	Mus musculus	Stat5 overexpression	EXP000713	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	PEAKS035287
EXP000123	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	PEAKS035288
EXP000827	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	PEAKS036848
EXP000824	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	The cells were spin-infected with a retrovirus expressing truncated E2A (lacking both activation domains) fused to the estrogen receptor ligand binding domain, as well as hCD25 from a second cistron. After 16 h in culture, cells were treated with tamoxifen (1 ÂµM final concentration) for 6 h. Cells expressing hCD25 were then enriched magnetically (Miltenyi).	NULL	198	unspecified	P17433	pre-pro-B-cells	PEAKS036849
EXP000825	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	The cells were spin-infected with a retrovirus expressing full length E2A fused to the estrogen receptor ligand binding domain, as well as hCD25 from a second cistron. After 16 h in culture, cells were treated with tamoxifen (1 ÂµM final concentration) for 6 h. Cells expressing hCD25 were then enriched magnetically (Miltenyi).	NULL	198	unspecified	P17433	pre-pro-B-cells	PEAKS036850
EXP000822	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	EBF KO	NULL	198	unspecified	P17433	pre-pro-B-cells	PEAKS036851
EXP000823	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	RAG1 KO	NULL	105	unspecified	P17433	pro-B cells	PEAKS036852
EXP000821	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	E2A KO	NULL	198	unspecified	P17433	pre-pro-B-cells	PEAKS036853
EXP000041	SCBT, Cat# SC-7196X, Lot# A0380	Mus musculus	NULL	EXP000040	20	unspecified	P37238	3T3-L1-derived adipocytes	PEAKS035289
EXP000042	Call Signaling Technologies, Cat# 2443, Lot# 5/29/2007	Mus musculus	NULL	EXP000040	20	unspecified	P37238	3T3-L1-derived adipocytes	PEAKS035290
EXP000043	Upstate, Cat# 07-729, Lot# 1350637	Mus musculus	NULL	EXP000040	19	unspecified	Q61164	3T3-L1-derived preadipocytes	PEAKS035291
EXP000044	Upstate, Cat# 07-729, Lot# 1350637	Mus musculus	NULL	EXP000040	20	unspecified	Q61164	3T3-L1-derived adipocytes	PEAKS035292
EXP000045	CEBP? (Santa Cruz Biotechnologies, sc-150)	Mus musculus	NULL	EXP000048	18	unspecified	P28033	3T3-L1 (embryonic fibroblasts)	PEAKS035293
EXP000046	CEBP? (Santa Cruz Biotechnologies, sc-150)	Mus musculus	NULL	EXP000051	19	unspecified	P28033	3T3-L1-derived preadipocytes	PEAKS035294
EXP000829	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 6h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	PEAKS036854
EXP000495	PPARg	Mus musculus	Day 4 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035295
EXP000242	VDR	Homo sapiens	1Î±,25(OH)2D3	EXP000240	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS033178
EXP000121	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	PEAKS035296
EXP000241	VDR	Homo sapiens		EXP000240	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS033179
EXP000710	T-bet	Mus musculus	NULL	NULL	76	unspecified	Q9JKD8	Th1-cells	PEAKS035297
EXP000965	R&D Systems AF4248	Homo sapiens	NULL	EXP000966	396	unspecified	O75593	WA09 (embryonic stem cells)	PEAKS033180
EXP000120	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	PEAKS035298
EXP000387	STAT5B	Mus musculus	2 rounds priming	EXP000384	76	unspecified	P42232	Th1-cells	PEAKS035299
EXP000386	STAT5A	Mus musculus	2 rounds priming	EXP000384	76	unspecified	P42230	Th1-cells	PEAKS035300
EXP000385	STAT4	Mus musculus	2 rounds priming	EXP000384	76	unspecified	P42228	Th1-cells	PEAKS035301
EXP000380	NFYB (Diagenode pAb-007-100, Lot TF-0010)	Homo sapiens	NULL	EXP000377	514	unspecified	P25208	K562 (myelogenous leukemia)	PEAKS033181
EXP000224	anti-GABP-alpha (sc-22810)	Homo sapiens	NULL	EXP000225	165	unspecified	Q06546	CD34+CD133+ hematopoietic progenitors	PEAKS033182
EXP000226	anti-TAL1 Ab (Santa Cruz sc-12984)	Homo sapiens	NULL	EXP000228	509	unspecified	P17542	Jurkat (T-cells)	PEAKS033183
EXP000227	anti-TAL1 Ab (Santa Cruz sc-12984)	Homo sapiens	NULL	NULL	743	unspecified	P17542	proerythroblasts	PEAKS033184
EXP000220	anti-ETV1 (Abcam Ab81086, lot#787879)	Homo sapiens	NULL	EXP000219	331	unspecified	P50549	GIST48 (gastrointestinal stromal tumor)	PEAKS033185
EXP000637	C/EBPdelta	Mus musculus	day 0 of differentiation	EXP000644	19	unspecified	Q00322	3T3-L1-derived preadipocytes	PEAKS035302
EXP000636	C/EBPbeta	Mus musculus	day 2 of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	PEAKS035303
EXP000635	C/EBPbeta	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	PEAKS035304
EXP000634	C/EBPbeta	Mus musculus	2 hours of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	PEAKS035305
EXP000633	C/EBPbeta	Mus musculus	day 0 of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	PEAKS035306
EXP000632	CTCF	Mus musculus	NULL	NULL	578	unspecified	Q61164	mature B-cells	PEAKS035307
EXP000347	sc-1008	Homo sapiens	calcitriol	EXP000343	341	unspecified	P11473	GM10861 (female B-cells)	PEAKS033186
EXP000630	CTCF	Mus musculus	NULL	NULL	171	unspecified	Q61164	CD4+ CD8+ T cells	PEAKS035308
EXP000638	C/EBPdelta	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	Q00322	3T3-L1-derived preadipocytes	PEAKS035309
EXP000958	TCF7L2	Homo sapiens	bio	EXP000959	514	unspecified	Q9NQB0	K562 (myelogenous leukemia)	PEAKS033187
EXP000315	Crx	Mus musculus	NULL	EXP000314	141	unspecified	O54751	retina	PEAKS035310
EXP000316	Crx	Mus musculus	Nrl KO	EXP000317	141	unspecified	O54751	retina	PEAKS035311
EXP000318	rabbit polyclonal to KLF1	Mus musculus	NULL	EXP000319	267	unspecified	P46099	erythroid cells	PEAKS035312
EXP000250	HIF-2 alpha	Homo sapiens	NULL	EXP000251	113	unspecified	Q99814	MCF7 (Invasive ductal breast carcinoma)	PEAKS036856
EXP000252	HIF-1 beta	Homo sapiens	NULL	EXP000253	113	unspecified	P27540	MCF7 (Invasive ductal breast carcinoma)	PEAKS036857
EXP000952	CEBP	Homo sapiens	bmp	EXP000954	514	unspecified	P49715	K562 (myelogenous leukemia)	PEAKS033188
EXP000953	SMAD1	Homo sapiens	bmp	EXP000954	514	unspecified	Q15797	K562 (myelogenous leukemia)	PEAKS033189
EXP000956	GATA2	Homo sapiens	NULL	EXP000959	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033190
EXP000222	Sox2 antibody (Abcam cat#ab59776)	Homo sapiens	NULL	EXP000223	552	unspecified	P48431	LN229 (glioblastoma)	PEAKS033191
EXP000388	STAT5A	Mus musculus		NULL	44	unspecified	P42230	T-cells	PEAKS035313
EXP000659	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	PEAKS033192
EXP000421	Gata1	Mus musculus	NULL	EXP000420	265	unspecified	P17679	G1E (embryonic stem cells)	PEAKS035314
EXP000556	sc-8977 (H-77)	Homo sapiens	estradiol	NULL	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS033193
EXP000557	ab5089	Homo sapiens	ethanol	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS033194
EXP000555	sc-8977 (H-77)	Homo sapiens	ethanol	NULL	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS033195
EXP000552	07-729  (Millipore)	Homo sapiens	NULL	EXP000554	402	unspecified	P49711	pancreatic islets	PEAKS033196
EXP000551	ab70303	Homo sapiens	NULL	EXP000554	402	unspecified	P49711	pancreatic islets	PEAKS033197
EXP000415	SRC1	Homo sapiens	tamoxifen	EXP000416	563	unspecified	Q15788	LY-2 (invasive ductal carcinoma)	PEAKS033198
EXP000414	sc-8995	Homo sapiens		EXP000416	563	unspecified	Q15788	LY-2 (invasive ductal carcinoma)	PEAKS033199
EXP000005	anti-GFP(ab290-050) GATAD1 tagged	Homo sapiens	NULL	EXP000004	422	unspecified	Q8WUU5	HeLa Kyoto (cervical adenocarcinoma)	PEAKS033200
EXP000828	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 1h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	PEAKS036858
EXP000631	CTCF	Mus musculus	NULL	NULL	105	unspecified	Q61164	pro-B cells	PEAKS035315
EXP000002	Oct1	Homo sapiens	H2O2 1hr	EXP000001	78	unspecified	P14859	HeLa (cervical adenocarcinoma)	PEAKS033201
EXP000907	sc-7196X	Homo sapiens	NULL	EXP000901	792	unspecified	P37231	Simpson Golabi Behmel Syndrome adipocytes	PEAKS033202
EXP000929	GATA2	Homo sapiens	NULL	EXP000930	459	unspecified	P23769	hematopoietic stem cells and progenitors	PEAKS033203
EXP000779	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	PEAKS033204
EXP000903	FOXA2	Homo sapiens	NULL	EXP000904	879	unspecified	Q9Y261	liver	PEAKS033205
EXP000128	HA	Homo sapiens	NULL	EXP000129	290	unspecified	Q01543	EWS502 (Ewing sarcoma)	PEAKS033206
EXP000649	CTCF (Upstate, 07-729, Lot #DAM1421463)	Mus musculus	NULL	EXP000648	230	unspecified	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS035316
EXP000862	E2A.E12(V-18) (sc-349)	Mus musculus	RAG1 KO	NULL	105	unspecified	P15806	pro-B cells	PEAKS036859
EXP000639	GR	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P06537	3T3-L1-derived preadipocytes	PEAKS035317
EXP000647	CTCF (Upstate, 07-729, Lot #DAM1421463)	Mus musculus	NULL	EXP000648	230	unspecified	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS035318
EXP000914	ab-11852	Homo sapiens	BRG1 KD shLuc control	EXP000916	168	unspecified	P15976	CD36+ erythroid cells	PEAKS033207
EXP000912	sc-12984	Homo sapiens	BRG1 KD shLuc control	EXP000916	168	unspecified	P17542	CD36+ erythroid cells	PEAKS033208
EXP000913	ab-11852	Homo sapiens	BRG1 RNAi KD	EXP000917	168	unspecified	P15976	CD36+ erythroid cells	PEAKS033209
EXP000910	07-729	Homo sapiens	BRG1 RNAi KD	EXP000917	168	unspecified	P49711	CD36+ erythroid cells	PEAKS033210
EXP000911	sc-12984	Homo sapiens	BRG1 RNAi KD	EXP000917	168	unspecified	P17542	CD36+ erythroid cells	PEAKS033211
EXP000857	Smad3	Mus musculus	TGFÎ² 2.5 ng/ml for 2 hour	EXP000848	1153	unspecified	Q8BUN5	C2C12 (myoblasts)	PEAKS035319
EXP000856	MyoD	Mus musculus	NULL	EXP000848	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS035320
EXP000679	polyclonal anti-RXRa	Mus musculus	48hr ethanol	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035321
EXP000678	anti-CTCF (SantaCruz #15914)	Mus musculus	NULL	EXP000676	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS035322
EXP000853	Smad3	Mus musculus	+Myod1, day 5	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	PEAKS035323
EXP000852	Smad3	Mus musculus	-Myod1, day 5	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	PEAKS035324
EXP000851	Smad3	Mus musculus	Activin, +Myod1, day 2	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	PEAKS035325
EXP000850	Smad3	Mus musculus	Activin, -Myod1, day 2	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	PEAKS035326
EXP000071	anti p65	Homo sapiens	DMSO	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033212
EXP000070	anti p65	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033213
EXP000073	anti p65	Homo sapiens	TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033214
EXP000072	anti p65	Homo sapiens	TA	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033215
EXP000075	anti p65	Homo sapiens	DMSO	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033216
EXP000640	Stat5a	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P42230	3T3-L1-derived preadipocytes	PEAKS035327
EXP000077	anti GR	Homo sapiens	DMSO	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033217
EXP000076	anti p65	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033218
EXP000078	anti GR	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033219
EXP000641	RXR	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P28700	3T3-L1-derived preadipocytes	PEAKS035328
EXP000535	PU.1	Mus musculus	NULL	NULL	732	unspecified	P17433	peritoneal macrophages	PEAKS035329
EXP000989	sc-764X	Homo sapiens	NULL	NULL	673	unspecified	P01106	normal epidermal keratinocytes	PEAKS033220
EXP000986	sc-764X	Homo sapiens	NULL	EXP000987	472	unspecified	P01106	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033221
EXP000981	TAL1	Mus musculus	NULL	EXP000975	266	unspecified	P22091	erythroblasts	PEAKS035330
EXP000980	GATA1	Mus musculus	NULL	EXP000975	266	unspecified	P17679	erythroblasts	PEAKS035331
EXP000983	sc-764X	Homo sapiens	NULL	NULL	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	PEAKS033222
EXP000431	GABPA(Santa Cruz Biotechnology, cat# sc-22810, lot# B2009)	Homo sapiens	NULL	NULL	781	unspecified	Q06546	RWPE1 (prostate epithelial cells)	PEAKS033223
EXP000658	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	PEAKS033224
EXP000430	ETS1(Santa Cruz Biotechnology, cat# sc-350, lot# E1010)	Homo sapiens	NULL	EXP000428	781	unspecified	P14921	RWPE1 (prostate epithelial cells)	PEAKS033225
EXP000433	FLAG(Sigma, cat# F1804, lot# 080M6035)	Homo sapiens	NULL	EXP000429	781	unspecified	P50549	RWPE1 (prostate epithelial cells)	PEAKS033226
EXP000432	FLAG(Sigma, cat# F1804, lot# 080M6035)	Homo sapiens	NULL	EXP000429	781	unspecified	P11308	RWPE1 (prostate epithelial cells)	PEAKS033227
EXP000358	YY1	Mus musculus	NULL	NULL	280	unspecified	Q00899	embryonic stem cell-derived neural progenitors	PEAKS035332
EXP000359	FLAG and HA	Mus musculus	NULL	EXP000360	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	PEAKS035333
EXP000354	FLI1	Homo sapiens	NULL	EXP000356	598	unspecified	Q01543	megakaryocytes	PEAKS033228
EXP000355	SCL	Homo sapiens	NULL	EXP000356	598	unspecified	P17542	megakaryocytes	PEAKS033229
EXP000357	YY1	Mus musculus	NULL	NULL	252	unspecified	Q00899	V6.5 (embryonic stem cells)	PEAKS035334
EXP000351	GATA1	Homo sapiens	NULL	EXP000356	598	unspecified	P15976	megakaryocytes	PEAKS033230
EXP000352	GATA2	Homo sapiens	NULL	EXP000356	598	unspecified	P23769	megakaryocytes	PEAKS033231
EXP000353	RUNX1	Homo sapiens	NULL	EXP000356	598	unspecified	Q01196	megakaryocytes	PEAKS033232
EXP000217	ER Ab-10	Mus musculus	activated MYB	EXP000214	190	unspecified	P06876	myeloid cells	PEAKS035335
EXP000216	ER Ab-10	Mus musculus	inactivated MYB	EXP000215	190	unspecified	P06876	myeloid cells	PEAKS035336
EXP000211	anti-PU.1 (T-21) (sc-352)	Mus musculus	NULL	EXP000210	602	unspecified	P17433	erythroleukemic cells	PEAKS035337
EXP000212	anti-PU.1 (T-21) (sc-352)	Mus musculus	NULL	NULL	271	unspecified	P17433	embryonic stem cell-derived erythroid progenitors	PEAKS035338
EXP000436	Jun-D	Homo sapiens	NULL	NULL	356	unspecified	P17535	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033233
EXP000218	TBP 	Mus musculus	NULL	NULL	252	unspecified	P29037	V6.5 (embryonic stem cells)	PEAKS035339
EXP000383	FoxA2	Mus musculus	NULL	NULL	5	unspecified	P35583	liver	PEAKS035340
EXP000185	Jarid2	Mus musculus	Jarid2 depletion	NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS035341
EXP000184	Jarid2	Mus musculus	NULL	NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS035342
EXP000955	GATA1	Homo sapiens	NULL	EXP000959	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS033234
EXP000181	Srf	Mus musculus	NULL	NULL	437	unspecified	Q9JM73	HL-1 (cardiac muscle cells)	PEAKS035343
EXP000182	tbx3	Mus musculus	NULL	EXP000183	2	unspecified	P70324	mESCs (mouse embryonic stem cells)	PEAKS035344
EXP000832	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	PU.1 KO	NULL	190	unspecified	P28033	myeloid cells	PEAKS036860
EXP000188	anti-EBF1b	Mus musculus	NULL	EXP000189	15	unspecified	Q07802	38B9 (A-MuLV pre-B-cells)	PEAKS035345
EXP000168	scl	Mus musculus	NULL	EXP000169	300	unspecified	P22091	fetal liver erythroblasts	PEAKS035346
EXP000329	?-p53-pS15 (Cell Signaling)	Homo sapiens	Etoposide	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS033235
EXP000328	?-p53-pS15 (Cell Signaling)	Homo sapiens	Actinomycin D	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS033236
EXP000459	anti-STAT1? (santa cruz: sc-417)	Mus musculus		EXP000460	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS035347
EXP000596	07-079	Homo sapiens	NULL	NULL	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	PEAKS033237
EXP000597	07-079	Homo sapiens	NULL	NULL	423	unspecified	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS033238
EXP000321	sc-126, sc-372	Homo sapiens	NULL	NULL	884	unspecified	P04637	heart	PEAKS036861
EXP000320	sc-126, sc-372	Homo sapiens	NULL	NULL	884	unspecified	P04637	heart	PEAKS036862
EXP000323	Phospho-STAT3(Ser727)	Mus musculus	NULL	NULL	498	unspecified	P42227	Th17-cells	PEAKS035348
EXP000322	anti-EGR1 antibody (H-588, Santa Cruz Biotechnology)	Homo sapiens	PMA 10 ng/ml for 2 hr	NULL	514	unspecified	P18146	K562 (myelogenous leukemia)	PEAKS033239
EXP000325	DO1 (BD PharMingen)	Homo sapiens	Etoposide	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS033240
EXP000324	DO1 (BD PharMingen)	Homo sapiens	Actinomycin D	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS033241
EXP000327	?-p53-pS15 (Cell Signaling)	Homo sapiens	Etoposide	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS033242
EXP000326	?-p53-pS15 (Cell Signaling)	Homo sapiens	Actinomycin D	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS033243
EXP000750	RXR	Homo sapiens	5 hours zinc	NULL	851	unspecified	P19793	UPR9 (hematopoietic stem cells)	PEAKS033244
EXP000592	Tet1-C	Mus musculus	Tet1 KO	EXP000595	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035349
EXP000752	RAR sc-773	Mus musculus		EXP000754	406	unspecified	P11416	HBG3 (embryonic stem cells)	PEAKS035350
EXP000753	RAR sc-773	Mus musculus	retinoic acid	EXP000755	406	unspecified	P11416	HBG3 (embryonic stem cells)	PEAKS035351
EXP000756	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000757	366	unspecified	Q04206	GM19193 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033245
EXP000593	Tet1-N	Mus musculus	NULL	EXP000595	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035352
EXP000691	GR	Homo sapiens	NULL	EXP030492	70	unspecified	P04150	LNCaP (prostate carcinoma)	PEAKS033246
EXP000692	GR	Homo sapiens	siFoxA1	EXP030492	70	unspecified	P04150	LNCaP (prostate carcinoma)	PEAKS033247
EXP000695	AR	Homo sapiens	siFoxA1	EXP030492	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS033248
EXP000590	FOS	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	P53539	K562 (myelogenous leukemia)	PEAKS033249
EXP000697	FoxA1	Homo sapiens	siFoxA1	EXP030492	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS033250
EXP000696	FoxA1	Homo sapiens	NULL	EXP030492	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS033251
EXP000408	AR	Homo sapiens	Treatment: vehicle; Time point: 4 hours	EXP000411	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS033252
EXP000591	Tet1-C	Mus musculus	NULL	EXP000595	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035353
EXP000409	AR	Homo sapiens	Treatment: AR stimulated with 1nM R1881 for 4 hours; Time point: 4 hours	EXP000411	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS033253
EXP000909	07-729	Homo sapiens	BRG1 KD shLuc control	EXP000916	168	unspecified	P49711	CD36+ erythroid cells	PEAKS033254
EXP000439	c-Myc	Homo sapiens	NULL	NULL	356	unspecified	P01106	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033255
EXP000741	RXR	Homo sapiens		EXP000751	648	unspecified	P19793	NB4 (acute promyelocytic leukemia )	PEAKS033256
EXP000453	CTCF	Homo sapiens	NULL	EXP000454	94	unspecified	P49711	BL41(Burkitt lymphoma)	PEAKS033257
EXP000908	07-729	Homo sapiens		EXP000915	166	unspecified	P49711	CD34+ hematopoietic stem cells	PEAKS033258
EXP000451	CTCF	Homo sapiens	NULL	EXP000452	92	unspecified	P49711	BJAB (Burkitt lymphoma)	PEAKS033259
EXP000438	Max	Homo sapiens	NULL	NULL	356	unspecified	P61244	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033260
EXP000919	sc-12984	Homo sapiens	CD34 WT	EXP000915	166	unspecified	P17542	CD34+ hematopoietic stem cells	PEAKS033261
EXP000863	EBF (H00001879-M01), 08344-1C2	Mus musculus	RAG1 KO	NULL	105	unspecified	Q07802	pro-B cells	PEAKS035354
EXP000529	SC-8332	Homo sapiens	D3	EXP000527	397	unspecified	Q15796	H9-derived endodermal progenitors	PEAKS033262
EXP000528	SC-8332	Homo sapiens	D0	EXP000527	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS033263
EXP000457	sc-66870	Homo sapiens	NULL	EXP000458	78	unspecified	Q96AV8	HeLa (cervical adenocarcinoma)	PEAKS033264
EXP000524	GATA2	Homo sapiens	NULL	EXP000105	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033265
EXP000523	GATA1	Homo sapiens	NULL	EXP000105	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS033266
EXP000521	tcf4	Homo sapiens	NULL	EXP000522	188	unspecified	Q9NQB0	LS174T (colon adenocarcinoma)	PEAKS033267
EXP000520	tcf4	Homo sapiens	NULL	EXP000522	188	unspecified	Q9NQB0	LS174T (colon adenocarcinoma)	PEAKS033268
EXP000026	anti-Tip60 Ab	Homo sapiens		EXP000028	881	unspecified	Q92993	CD4+ T-cells	PEAKS033269
EXP000455	sc126X [200mg/0.1ml]	Homo sapiens	NULL	EXP000456	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS033270
EXP000598	07-079	Homo sapiens	NULL	NULL	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033271
EXP000134	VDR	Homo sapiens	vehicle control	EXP000146	557	unspecified	P11473	LS180 (colon cancer)	PEAKS033272
EXP000699	ERa	Homo sapiens	ethanol	EXP000700	386	unspecified	P03372	H3396 (breast carcinoma)	PEAKS033273
EXP000136	RXR	Homo sapiens	vehicle control	EXP000146	557	unspecified	P19793	LS180 (colon cancer)	PEAKS033274
EXP000137	RXR	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	P19793	LS180 (colon cancer)	PEAKS033275
EXP000039	NANOG	Homo sapiens	NULL	NULL	376	unspecified	Q9H9S0	WA01 (H1, human embryonic stem cells)	PEAKS033276
EXP000038	SOX2 	Homo sapiens	NULL	NULL	376	unspecified	P48431	WA01 (H1, human embryonic stem cells)	PEAKS033277
EXP000132	HA	Homo sapiens	NULL	EXP000133	472	unspecified	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033278
EXP000035	BCL6	Mus musculus		EXP000032	81	unspecified	P41183	BMDM (bone marrow-derived macrophages)	PEAKS035355
EXP000034	p65	Mus musculus		EXP000032	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS035356
EXP000037	BCL6	Mus musculus	3 hr LPS stimulated macrophages	EXP000032	81	unspecified	P41183	BMDM (bone marrow-derived macrophages)	PEAKS035357
EXP000036	p65	Mus musculus	3 hr LPS stimulated macrophages	EXP000032	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS035358
EXP000031	scl	Mus musculus	NULL	NULL	236	unspecified	P22091	embryonic stem cell-derived haematopoietic cells	PEAKS035359
EXP000537	E2F1 	Homo sapiens	NULL	NULL	78	unspecified	Q01094	HeLa (cervical adenocarcinoma)	PEAKS033279
EXP000902	sc-7196X	Mus musculus	NULL	NULL	197	unspecified	P37238	adipocytes	PEAKS035360
EXP000599	07-079	Homo sapiens	NULL	NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS033280
EXP000861	E2A.E12(V-18) (sc-349)	Mus musculus	EBF KO	NULL	198	unspecified	P15806	pre-pro-B-cells	PEAKS036863
EXP000310	Fos	Homo sapiens	NULL	NULL	514	unspecified	P01100	K562 (myelogenous leukemia)	PEAKS033281
EXP000311	Myc	Homo sapiens	NULL	NULL	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033282
EXP000758	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000759	362	unspecified	Q04206	GM18505 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033283
EXP000313	Jarid2	Mus musculus	NULL	NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS035361
EXP000866	E2A.E12(V-18) (sc-349)	Mus musculus	E2A KO, 1h	NULL	198	unspecified	P15806	pre-pro-B-cells	PEAKS035362
EXP000782	ASH2	Mus musculus	dextran	EXP000783	41	unspecified	O35885	B-cells	PEAKS035363
EXP000781	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	PEAKS033284
EXP000780	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	PEAKS033285
EXP000787	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	76	unspecified	P23772	Th1-cells	PEAKS035364
EXP000786	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	2479	unspecified	P23772	CD8+ T-cells	PEAKS035365
EXP000969	ab28379	Homo sapiens	NULL	EXP000972	396	unspecified	P84022	WA09 (embryonic stem cells)	PEAKS033286
EXP000968	R&D Systems AF3797	Homo sapiens	NULL	EXP000972	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS033287
EXP000967	sc-8332	Homo sapiens	NULL	EXP000972	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS033288
EXP000789	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	44	unspecified	P23772	T-cells	PEAKS035366
EXP000964	R&D Systems AF2097	Homo sapiens	NULL	EXP000966	396	unspecified	Q13485	WA09 (embryonic stem cells)	PEAKS033289
EXP000963	ab28379	Homo sapiens	NULL	EXP000966	396	unspecified	P84022	WA09 (embryonic stem cells)	PEAKS033290
EXP000962	R&D Systems AF3797	Homo sapiens	NULL	EXP000966	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS033291
EXP000961	sc-8332	Homo sapiens	NULL	EXP000966	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS033292
EXP000141	TCF4	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	Q9NQB0	LS180 (colon cancer)	PEAKS033293
EXP000140	TCF4	Homo sapiens	vehicle control	EXP000146	557	unspecified	Q9NQB0	LS180 (colon cancer)	PEAKS033294
EXP000143	CEBPb	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	P17676	LS180 (colon cancer)	PEAKS033295
EXP000142	CEBPb	Homo sapiens	vehicle control	EXP000146	557	unspecified	P17676	LS180 (colon cancer)	PEAKS033296
EXP000145	CDX2	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	Q99626	LS180 (colon cancer)	PEAKS033297
EXP000144	CDX2	Homo sapiens	vehicle control	EXP000146	557	unspecified	Q99626	LS180 (colon cancer)	PEAKS033298
EXP000149	SP1	Homo sapiens	NULL	NULL	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS033299
EXP000148	Sox6	Mus musculus	NULL	EXP000147	645	unspecified	P40645	myotubes	PEAKS035367
EXP000867	E2A.E12(V-18) (sc-349)	Mus musculus	E2A KO, 6h	NULL	198	unspecified	P15806	pre-pro-B-cells	PEAKS035368
EXP000701	GATA1 made in-house	Homo sapiens	NULL	EXP000702	460	unspecified	P15976	primary erythroblasts	PEAKS033300
EXP000707	E2F3	Mus musculus	E2F3 KO	EXP000709	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	PEAKS035369
EXP000706	E2F3	Mus musculus	NULL	EXP000708	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	PEAKS035370
EXP000819	Oct2 (Vendor: Santa Cruz, cat# sc-233)	Mus musculus		EXP000820	41	unspecified	Q00196	B-cells	PEAKS036864
EXP000818	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		EXP000820	41	unspecified	P17433	B-cells	PEAKS036865
EXP000813	Cell Signaling Technologies, Cat# 2443, Lot# 5/29/2007	Homo sapiens	time point 4	EXP000807	404	unspecified	P37231	hASC (preadipocytes)	PEAKS033301
EXP000812	SCBT, Cat# SC-7196X, Lot# A0380	Homo sapiens	time point 4	EXP000807	404	unspecified	P37231	hASC (preadipocytes)	PEAKS033302
EXP000811	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 4	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	PEAKS033303
EXP000810	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 3	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	PEAKS033304
EXP000816	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus		EXP000817	732	unspecified	P28033	peritoneal macrophages	PEAKS036866
EXP000815	C/EBPa (Vendor: Santa Cruz, cat# sc-61, lot# D0108)	Mus musculus		EXP000817	732	unspecified	P53566	peritoneal macrophages	PEAKS036867
EXP000814	PU.1	Mus musculus		EXP000817	732	unspecified	P17433	peritoneal macrophages	PEAKS036868
EXP000497	RXR	Mus musculus	Day 0 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	PEAKS035371
EXP000496	PPARg	Mus musculus	Day 6 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035372
EXP000493	PPARg	Mus musculus	Day 2 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035373
EXP000492	PPARg	Mus musculus	Day 1 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035374
EXP000491	PPARg	Mus musculus	Day 0 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035375
EXP000715	sc-835	Mus musculus	Stat5 KO, Growth hormone	EXP000716	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	PEAKS035376
EXP000717	sc-835	Mus musculus	Stat5 KO empty vector, Growth hormone	EXP000718	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	PEAKS035377
EXP000711	sc-835	Mus musculus	Growth hormone	EXP000712	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	PEAKS035378
EXP000499	RXR	Mus musculus	Day 2 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	PEAKS035379
EXP000498	RXR	Mus musculus	Day 1 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	PEAKS035380
EXP000895	CDX2	Mus musculus	NULL	EXP000896	496	unspecified	P43241	intestinal villus	PEAKS035381
EXP000398	STAT5B	Homo sapiens		NULL	882	unspecified	P51692	T-cells	PEAKS033305
EXP000399	STAT5B	Homo sapiens	IL-2	NULL	882	unspecified	P51692	T-cells	PEAKS033306
EXP000390	STAT5B	Mus musculus		NULL	44	unspecified	P42232	T-cells	PEAKS035382
EXP000391	STAT5B	Mus musculus	IL-2	NULL	44	unspecified	P42232	T-cells	PEAKS035383
EXP000392	STAT1	Homo sapiens		NULL	882	unspecified	P42224	T-cells	PEAKS033307
EXP000393	STAT1	Homo sapiens	IFNg	NULL	882	unspecified	P42224	T-cells	PEAKS033308
EXP000394	STAT4	Homo sapiens		NULL	882	unspecified	Q14765	T-cells	PEAKS033309
EXP000395	STAT4	Homo sapiens	IL-12	NULL	882	unspecified	Q14765	T-cells	PEAKS033310
EXP000396	STAT5A	Homo sapiens		NULL	882	unspecified	P42229	T-cells	PEAKS033311
EXP000397	STAT5A	Homo sapiens	IL-2	NULL	882	unspecified	P42229	T-cells	PEAKS033312
EXP000794	Fli1 (santa cruz, cat#sc356X, Lot#L0407)	Mus musculus	NULL	NULL	499	unspecified	P26323	Th2-cells	PEAKS035384
EXP000948	SMAD1	Homo sapiens	bmp	EXP000950	65	unspecified	Q15797	U937 (adult acute monocytic leukemia)	PEAKS033313
EXP000560	ER	Homo sapiens		EXP000563	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033314
EXP000566	sc-9144X	Homo sapiens	NULL	EXP000567	603	unspecified	Q00613	mesenchymal stem cells-derived adipocytes	PEAKS033315
EXP000565	sc-9314X	Homo sapiens	NULL	EXP000567	603	unspecified	P49715	mesenchymal stem cells-derived adipocytes	PEAKS033316
EXP000564	sc-1082X	Homo sapiens	NULL	EXP000567	603	unspecified	Q16254	mesenchymal stem cells-derived adipocytes	PEAKS033317
EXP000768	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000769	364	unspecified	Q04206	GM18951 (B-cells Lymphoblastoid Cell Lines)	PEAKS033318
EXP000406	AR	Homo sapiens	Treatment: vehicle; Time point: 4 hours	EXP000410	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS033319
EXP000407	AR	Homo sapiens	Treatment: AR stimulated with 1nM R1881 for 4 hours; Time point: 4 hours	EXP000410	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS033320
EXP000760	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000761	365	unspecified	Q04206	GM19099 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033321
EXP000762	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000763	361	unspecified	Q04206	GM15510 (B-cells)	PEAKS033322
EXP000764	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000765	358	unspecified	Q04206	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS033323
EXP000766	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000767	339	unspecified	Q04206	GM10847 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033324
EXP000941	GATA2	Homo sapiens	bio	EXP000959	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033325
EXP000940	GATA1	Homo sapiens	bmp	EXP000945	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS033326
EXP000943	SMAD1	Homo sapiens	bmp	EXP000945	514	unspecified	Q15797	K562 (myelogenous leukemia)	PEAKS033327
EXP000796	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	2479	unspecified	P23772	CD8+ T-cells	PEAKS035385
EXP000942	GATA2	Homo sapiens	bmp	EXP000945	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033328
EXP000681	polyclonal anti-RXRa	Mus musculus	6hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035386
EXP000947	CEBPA	Homo sapiens	dmso	EXP000951	65	unspecified	P49715	U937 (adult acute monocytic leukemia)	PEAKS033329
EXP000795	Ets1 (santa cruz, cat#sc111X, Lot#G1905)	Mus musculus	NULL	NULL	499	unspecified	P27577	Th2-cells	PEAKS035387
EXP000946	CEBPA	Homo sapiens	bio	EXP000960	65	unspecified	P49715	U937 (adult acute monocytic leukemia)	PEAKS033330
EXP000797	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	171	unspecified	P23772	CD4+ CD8+ T cells	PEAKS035388
EXP000686	polyclonal anti-RARg	Mus musculus	2hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	PEAKS035389
EXP000664	tet1	Mus musculus		EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035390
EXP000970	R&D Systems AF2097	Homo sapiens	NULL	EXP000972	396	unspecified	Q13485	WA09 (embryonic stem cells)	PEAKS033331
EXP000666	tet1	Mus musculus	tet1_mut2	EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035391
EXP000667	rabbit polyclonal antibody against mouse Tet1 (made in-house)	Mus musculus		EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035392
EXP000844	Oct4	Homo sapiens	NULL	EXP000849	89	unspecified	Q01860	BGO3 (embryonic stem cells)	PEAKS033332
EXP000845	Smad3	Homo sapiens	NULL	EXP000849	89	unspecified	P84022	BGO3 (embryonic stem cells)	PEAKS033333
EXP000107	rabbit anti-E2F6 (Santa Cruz Biotechnology, catalog# sc-22823x)	Homo sapiens	NULL	EXP000105	514	unspecified	O75461	K562 (myelogenous leukemia)	PEAKS033334
EXP000101	SMAD1/5	Homo sapiens	BMP-6	EXP001029	472	unspecified	Q15797	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033335
EXP000100	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	PEAKS035393
EXP000103	rabbit anti-ELK4 (SantaCruz, catalog # sc13030-X)	Homo sapiens	NULL	EXP000104	421	unspecified	P28324	HEK293 (embryonic kidney)	PEAKS033336
EXP000102	SMAD1/5	Homo sapiens	BMP-9	EXP001029	472	unspecified	Q15797	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033337
EXP000063	anti GR	Homo sapiens	DMSO	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033338
EXP000061	custom made PRDM14	Homo sapiens	NULL	EXP000062	878	unspecified	Q9GZV8	embryonic stem cells	PEAKS033339
EXP000066	anti GR	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033340
EXP000067	anti GR	Homo sapiens	DMSO	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033341
EXP000064	anti GR	Homo sapiens	TA	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033342
EXP000065	anti GR	Homo sapiens	TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033343
EXP000790	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	44	unspecified	P23772	T-cells	PEAKS035394
EXP000068	anti GR	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	PEAKS033344
EXP000069	anti p65	Homo sapiens	DMSO	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	PEAKS033345
EXP000791	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	647	unspecified	P23772	natural killer T cells	PEAKS035395
EXP000833	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus		NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	PEAKS036869
EXP000878	HNF4A (Santa Cruz 8987 and Santa Cruz 6547)	Homo sapiens	differentiated cells	EXP000879	145	unspecified	P41235	Caco-2 (colon adenocarcinoma)	PEAKS033346
EXP000792	Fli1 (santa cruz, cat#sc356X, Lot#L0407)	Mus musculus	NULL	NULL	2479	unspecified	P26323	CD8+ T-cells	PEAKS035396
EXP000998	sc-764	Homo sapiens	NULL	EXP001003	94	unspecified	P01106	BL41(Burkitt lymphoma)	PEAKS033347
EXP000999	sc-764	Homo sapiens	NULL	EXP001004	768	unspecified	P01106	Ramos (Burkitt lymphoma)	PEAKS033348
EXP000996	sc-764	Homo sapiens	NULL	EXP001001	144	unspecified	P01106	CA-46 (Burkitt lymphoma)	PEAKS033349
EXP000997	sc-764	Homo sapiens	NULL	EXP001002	100	unspecified	P01106	Blue1 (sporadic Burkitt lymphoma)	PEAKS033350
EXP000994	sc-764X	Homo sapiens	NULL	EXP000988	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033351
EXP000995	sc-764	Homo sapiens	NULL	EXP001000	767	unspecified	P01106	Raji (Burkitt lymphoma)	PEAKS033352
EXP000992	07-729	Homo sapiens	NULL	EXP000985	430	unspecified	P49711	HepG2 (hepatoblastoma)	PEAKS033353
EXP000993	sc-764X	Homo sapiens	NULL	EXP000985	430	unspecified	P01106	HepG2 (hepatoblastoma)	PEAKS033354
EXP000990	sc-764X	Homo sapiens	NULL	EXP000982	356	unspecified	P01106	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033355
EXP000991	sc-764X	Homo sapiens	NULL	EXP000984	423	unspecified	P01106	HeLa S3 (cervical adenocarcinoma)	PEAKS033356
EXP000871	ATRX H300 (Santa Cruz Biotechnology, batch G0105)	Mus musculus	NULL	EXP000872	230	unspecified	Q61687	ES-E14 (E14, embryonic stem cells)	PEAKS035397
EXP000703	ab9110	Mus musculus	NULL	EXP000705	642	unspecified	P25425	myeloblasts	PEAKS035398
EXP000654	ab5089	Homo sapiens	ethanol	EXP030990	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS033357
EXP000657	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000661	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	PEAKS033358
EXP000651	sc-816	Homo sapiens	DHT	EXP030990	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS033359
EXP000799	npas4	Mus musculus		EXP000805	159	unspecified	Q8BGD7	cortical neurons	PEAKS035399
EXP000610	IMG-148A	Homo sapiens	NULL	EXP000611	93	unspecified	P62380	BJ (fibroblasts)	PEAKS033360
EXP000613	TAL1	Homo sapiens	NULL	EXP000612	154	unspecified	P17542	CD133+ umbilical cord blood cells	PEAKS033361
EXP000615	IKZF1	Homo sapiens	NULL	EXP000612	154	unspecified	Q13422	CD133+ umbilical cord blood cells	PEAKS033362
EXP000614	Pu.1	Homo sapiens	NULL	EXP000612	154	unspecified	P17947	CD133+ umbilical cord blood cells	PEAKS033363
EXP000617	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	E2	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS033364
EXP000616	MEIS1	Homo sapiens	NULL	EXP000612	154	unspecified	O00470	CD133+ umbilical cord blood cells	PEAKS033365
EXP000619	cFos - Cat# sc-7202, Santa Cruz	Homo sapiens	E2	NULL	113	unspecified	P01100	MCF7 (Invasive ductal breast carcinoma)	PEAKS033366
EXP000618	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	NULL	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS033367
EXP000652	sc-15022	Homo sapiens	ethanol	EXP030990	70	unspecified	Q99801	LNCaP (prostate carcinoma)	PEAKS033368
EXP000209	Oct4	Homo sapiens	NULL	EXP000208	396	unspecified	Q01860	WA09 (embryonic stem cells)	PEAKS033369
EXP000196	anti-ZNF711	Homo sapiens	NULL	NULL	664	unspecified	Q9Y462	SH-SY5Y (neuroblastoma)	PEAKS033370
EXP000346	sc-1008	Homo sapiens	NULL	EXP000343	341	unspecified	P11473	GM10861 (female B-cells)	PEAKS033371
EXP000192	CTCF	Homo sapiens	NULL	EXP000194	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	PEAKS033372
EXP000190	OCT4	Homo sapiens	NULL	EXP000193	376	unspecified	Q01860	WA01 (H1, human embryonic stem cells)	PEAKS033373
EXP000191	NANOG	Homo sapiens	NULL	EXP000194	376	unspecified	Q9H9S0	WA01 (H1, human embryonic stem cells)	PEAKS033374
EXP000364	anti-PU.1	Homo sapiens	NULL	EXP000365	2334	unspecified	P17947	THP-1 (acute monocytic leukemia)	PEAKS033375
EXP000928	AB32631	Mus musculus	NULL	NULL	252	unspecified	Q8C796	V6.5 (embryonic stem cells)	PEAKS035400
EXP000299	ETS1 sc355 from Santa Cruz Biotechnology	Homo sapiens	NULL	EXP000302	510	unspecified	P14921	Jurkat E6.1 (T-cells)	PEAKS033376
EXP000298	TAFII	Homo sapiens	NULL	NULL	376	unspecified	P21675	WA01 (H1, human embryonic stem cells)	PEAKS033377
EXP000382	anti-Flag	Mus musculus	NULL	EXP000381	1153	unspecified	P13297	C2C12 (myoblasts)	PEAKS035401
EXP000526	ZNF263	Homo sapiens	NULL	NULL	514	unspecified	O14978	K562 (myelogenous leukemia)	PEAKS033378
EXP000923	Santa Cruz N-20	Homo sapiens	DHT, siFoxA1	EXP000926	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS036870
EXP000921	Santa Cruz N-20	Homo sapiens	DHT	EXP000926	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS036871
EXP000927	Upstate 07-574	Mus musculus	NULL	NULL	252	unspecified	Q8VIG1	V6.5 (embryonic stem cells)	PEAKS035402
EXP000925	ab5089	Homo sapiens	DHT	EXP000926	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS036872
EXP000924	ab5089	Homo sapiens	vehicle	EXP000926	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS036873
EXP000840	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035403
EXP000665	tet1	Mus musculus	tet1_mut1	EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS035404
EXP000842	Smad3	Mus musculus	NULL	NULL	252	unspecified	Q8BUN5	V6.5 (embryonic stem cells)	PEAKS035405
EXP000332	Fli1	Mus musculus	NULL	EXP000335	236	unspecified	P26323	embryonic stem cell-derived haematopoietic cells	PEAKS035406
EXP000338	meis1	Mus musculus	NULL	EXP000335	236	unspecified	P25425	embryonic stem cell-derived haematopoietic cells	PEAKS035407
EXP000339	pu.1	Mus musculus	NULL	EXP000335	236	unspecified	P17433	embryonic stem cell-derived haematopoietic cells	PEAKS035408
EXP000449	ab62126	Mus musculus	NULL	EXP000450	2	unspecified	P29037	mESCs (mouse embryonic stem cells)	PEAKS035409
EXP000444	FOXP1	Homo sapiens	NULL	EXP000443	396	unspecified	Q9H334	WA09 (embryonic stem cells)	PEAKS033379
EXP010000	2899	Homo sapiens		EXP010929	430	unspecified	P49711	HepG2 (hepatoblastoma)	PEAKS033380
EXP000447	anti-TAF1	Mus musculus	NULL	EXP000448	2	unspecified	Q80UV9	mESCs (mouse embryonic stem cells)	PEAKS036874
EXP000440	sc-349x	Mus musculus		EXP000442	44	unspecified	P15806	T-cells	PEAKS035410
EXP000441	sc-349x	Mus musculus	anti-CD3e Ab injection	EXP000442	44	unspecified	P15806	T-cells	PEAKS035411
EXP000621	cJun - Cat# sc-45, Santa Cruz	Homo sapiens	E2	NULL	113	unspecified	P05412	MCF7 (Invasive ductal breast carcinoma)	PEAKS033381
EXP000724	anti-ERG	Homo sapiens	Treatment: non-silencing control siRNA; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS033382
EXP000727	anti-AR	Homo sapiens	Treatment: None	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS033383
EXP000689	polyclonal anti-RARg	Mus musculus	48hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	PEAKS035412
EXP000721	anti-FoxA1	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS033384
EXP000720	sc-835	Mus musculus	Stat5 overexpression, Growth hormone	EXP000714	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	PEAKS035413
EXP000723	anti-AR	Homo sapiens	Treatment: non-silencing control siRNA; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS033385
EXP000722	anti-FoxA1	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS033386
EXP000682	polyclonal anti-RXRa	Mus musculus	24hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035414
EXP000683	polyclonal anti-RXRa	Mus musculus	48hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035415
EXP000680	polyclonal anti-RXRa	Mus musculus	2hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035416
EXP000663	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	PEAKS033387
EXP000729	anti-AR	Homo sapiens	Treatment: 1nm R1881; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS033388
EXP000728	anti-AR	Homo sapiens	Treatment: 10nm R1881; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS033389
EXP000684	polyclonal anti-RXRa	Mus musculus	48hr ATRA, RXRa KO	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS035417
EXP000685	polyclonal anti-RARg	Mus musculus	48hr ethanol	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	PEAKS035418
EXP000669	GATA3	Homo sapiens	estradiol (E2)	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS033390
EXP000934	SMAD1	Homo sapiens	NULL	EXP000930	459	unspecified	Q15797	hematopoietic stem cells and progenitors	PEAKS033391
EXP001008	anti-Flag (Sigma, F1804-200UG)	Mus musculus	+Dox	EXP001009	60	unspecified	P09633	Ainv15 (embryonic stem cells)	PEAKS035419
EXP000029	anti Tip60 Ab	Homo sapiens		EXP000027	881	unspecified	Q92993	CD4+ T-cells	PEAKS033392
EXP000935	TCF7L2	Homo sapiens	NULL	EXP000938	459	unspecified	Q9NQB0	hematopoietic stem cells and progenitors	PEAKS033393
EXP000841	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	LXRD KO	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035420
EXP001007	anti-V5 (Abcam, ab15828)	Mus musculus	+Dox	EXP001009	60	unspecified	P09633	Ainv15 (embryonic stem cells)	PEAKS035421
EXP001006	anti-V5 (Abcam, ab15828)	Mus musculus	+Dox	EXP001009	60	unspecified	Q9EQW6	Ainv15 (embryonic stem cells)	PEAKS035422
EXP001005	Olig2 (Millipore, ab9610)	Mus musculus		EXP001009	60	unspecified	Q9EQW6	Ainv15 (embryonic stem cells)	PEAKS035423
EXP000534	PPARgamma	Mus musculus	NULL	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035424
EXP000419	Smad1	Mus musculus	NULL	EXP000417	265	unspecified	P70340	G1E (embryonic stem cells)	PEAKS035425
EXP000536	C/EBPbeta	Mus musculus	NULL	NULL	732	unspecified	P28033	peritoneal macrophages	PEAKS035426
EXP000331	Sigma F9291	Mus musculus	NULL	EXP000330	25	unspecified	P48985	cerebellum	PEAKS035427
EXP000418	Gata2	Mus musculus	NULL	EXP000417	265	unspecified	O09100	G1E (embryonic stem cells)	PEAKS035428
EXP000435	MafA (Abcam ab17976 lot 950583)	Mus musculus	NULL	NULL	898	unspecified	Q8CF90	pancreatic islets	PEAKS035429
EXP000434	NeuroD1 (Santa Cruz sc-1084 X lot H1709)	Mus musculus	NULL	NULL	898	unspecified	Q60867	pancreatic islets	PEAKS035430
EXP000437	c-Fos	Homo sapiens	NULL	NULL	356	unspecified	P01100	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033394
EXP000931	GATA1	Homo sapiens	NULL	EXP000936	743	unspecified	P15976	proerythroblasts	PEAKS033395
EXP000655	ab5089	Homo sapiens	DHT	EXP030990	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS033396
EXP000932	GATA1	Homo sapiens	NULL	EXP000937	743	unspecified	P15976	proerythroblasts	PEAKS033397
EXP000933	SMAD1	Homo sapiens	NULL	EXP000937	743	unspecified	Q15797	proerythroblasts	PEAKS033398
EXP000704	ab9110	Mus musculus	NULL	EXP000705	642	unspecified	P09631	myeloblasts	PEAKS035431
EXP000135	VDR	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	P11473	LS180 (colon cancer)	PEAKS033399
EXP000363	anti-pan-RXR	Homo sapiens	NULL	EXP000365	2334	unspecified	P19793	THP-1 (acute monocytic leukemia)	PEAKS033400
EXP000698	Santa Cruz HC20	Homo sapiens	estrogen	EXP000700	386	unspecified	P03372	H3396 (breast carcinoma)	PEAKS033401
EXP000022	sc-8635	Mus musculus	NULL	EXP000019	2	unspecified	Q9Z1J1	mESCs (mouse embryonic stem cells)	PEAKS035432
EXP000020	AF2018	Mus musculus	NULL	EXP000019	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS035433
EXP000021	bl1662	Mus musculus	NULL	EXP000019	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS035434
EXP000687	polyclonal anti-RARg	Mus musculus	6hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	PEAKS035435
EXP000843	Smad3	Mus musculus	Activin	NULL	252	unspecified	Q8BUN5	V6.5 (embryonic stem cells)	PEAKS035436
EXP000558	anti-FoxA1	Homo sapiens	estradiol	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS033402
EXP000559	ER	Homo sapiens	Estrogen	EXP000563	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS033403
EXP000893	Rfx1	Mus musculus	NULL	NULL	138	unspecified	P48377	neural progenitors	PEAKS035437
EXP000337	lyl1	Mus musculus	NULL	EXP000335	236	unspecified	P27792	embryonic stem cell-derived haematopoietic cells	PEAKS035438
EXP000362	anti-PPARg	Homo sapiens	NULL	EXP000365	2334	unspecified	P37231	THP-1 (acute monocytic leukemia)	PEAKS033404
EXP000899	anti-NFYA	Mus musculus	NULL	NULL	138	unspecified	P23708	neural progenitors	PEAKS035439
EXP000898	anti-NFYA	Mus musculus	NULL	EXP000897	2	unspecified	P23708	mESCs (mouse embryonic stem cells)	PEAKS035440
EXP000249	HIF-1 alpha	Homo sapiens	NULL	EXP000251	113	unspecified	Q16665	MCF7 (Invasive ductal breast carcinoma)	PEAKS036875
EXP000660	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	PEAKS033405
EXP000622	cJun - Cat# sc-45, Santa Cruz	Homo sapiens	NULL	NULL	113	unspecified	P05412	MCF7 (Invasive ductal breast carcinoma)	PEAKS033406
EXP000971	R&D Systems AF4248	Homo sapiens	NULL	EXP000972	396	unspecified	O75593	WA09 (embryonic stem cells)	PEAKS033407
EXP000974	GATA1	Mus musculus	E2	NULL	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035441
EXP000976	TAL1	Mus musculus	NULL	EXP000973	265	unspecified	P22091	G1E (embryonic stem cells)	PEAKS035442
EXP000977	GATA2	Mus musculus	NULL	EXP000973	265	unspecified	O09100	G1E (embryonic stem cells)	PEAKS035443
EXP000978	GATA2	Mus musculus	E2	NULL	319	unspecified	O09100	G1E-ER4 (embryonic stem cells)	PEAKS035444
EXP000979	TAL1	Mus musculus	E2	NULL	319	unspecified	P22091	G1E-ER4 (embryonic stem cells)	PEAKS035445
EXP000873	CDX2 (Bethyl Labs BL3194)	Homo sapiens	proliferating cells	EXP000879	145	unspecified	Q99626	Caco-2 (colon adenocarcinoma)	PEAKS033408
EXP000798	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	499	unspecified	P23772	Th2-cells	PEAKS035446
EXP000874	CDX2 (Bethyl Labs BL3194)	Homo sapiens	differentiated cells	EXP000879	145	unspecified	Q99626	Caco-2 (colon adenocarcinoma)	PEAKS033409
EXP000877	HNF4A (Santa Cruz 8987 and Santa Cruz 6547)	Homo sapiens	proliferating cells	EXP000879	145	unspecified	P41235	Caco-2 (colon adenocarcinoma)	PEAKS033410
EXP000876	GATA6 (Santa Cruz 7244 and Santa Cruz 9055)	Homo sapiens	differentiated cells	EXP000879	145	unspecified	Q92908	Caco-2 (colon adenocarcinoma)	PEAKS033411
EXP000099	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	PEAKS035447
EXP000098	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	PEAKS035448
EXP000092	mixture of STAT5a (PA-ST5A: R&D) and STAT5b (PA-ST5B: R&D) antibodies, 2 ul each per IP	Mus musculus	NULL	NULL	498	unspecified	P42230	Th17-cells	PEAKS035449
EXP000091	5 ug of STAT3 (14-6727: eBioScience) per IP	Mus musculus	NULL	NULL	498	unspecified	P42227	Th17-cells	PEAKS035450
EXP000097	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	PEAKS035451
EXP000096	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	PEAKS035452
EXP000095	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	PEAKS035453
EXP000749	RXR	Homo sapiens		NULL	851	unspecified	P19793	UPR9 (hematopoietic stem cells)	PEAKS033412
EXP000748	RAR	Homo sapiens	5 hours zinc	NULL	851	unspecified	P10276	UPR9 (hematopoietic stem cells)	PEAKS033414
EXP000875	GATA6 (Santa Cruz 7244 and Santa Cruz 9055)	Homo sapiens	proliferating cells	EXP000879	145	unspecified	Q92908	Caco-2 (colon adenocarcinoma)	PEAKS033415
EXP000846	Smad2/3	Mus musculus	Activin	NULL	252	unspecified	Q62432	V6.5 (embryonic stem cells)	PEAKS035454
EXP000808	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 1	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	PEAKS033416
EXP000809	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 2	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	PEAKS033417
EXP000804	H300 (Sc-13029)	Mus musculus	KCL	EXP000806	159	unspecified	Q9JM73	cortical neurons	PEAKS035455
EXP000800	npas4	Mus musculus	KCL	EXP000806	159	unspecified	Q8BGD7	cortical neurons	PEAKS035456
EXP000801	Santa Cruz (Sc-186)	Mus musculus		EXP000806	159	unspecified	Q01147	cortical neurons	PEAKS035457
EXP000802	Santa Cruz (Sc-186)	Mus musculus	KCL	EXP000806	159	unspecified	Q01147	cortical neurons	PEAKS035458
EXP000803	H300 (Sc-13029)	Mus musculus		EXP000805	159	unspecified	Q9JM73	cortical neurons	PEAKS035459
EXP010001	sc-33759	Homo sapiens		EXP010428	376	unspecified	Q9H9S0	WA01 (H1, human embryonic stem cells)	PEAKS033418
EXP010002	NRSF	Homo sapiens		EXP010120	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS033419
EXP010003	sc-7874	Mus musculus		EXP010644	1174	unspecified	P06876	MEL cell line	PEAKS035460
EXP010004	2899	Homo sapiens		EXP010053	353	unspecified	P49711	GM12873 (female B-cells)	PEAKS033420
EXP010008	H00010127-A01	Homo sapiens		EXP010287	421	unspecified	O14978	HEK293 (embryonic kidney)	PEAKS033421
EXP010009	NB100-1800	Mus musculus		EXP010613	1144	unspecified	O35185	CH12.LX (Mouse lymphoma)	PEAKS036671
EXP010010	sc-357	Homo sapiens		EXP010538	430	unspecified	Q99081	HepG2 (hepatoblastoma)	PEAKS033422
EXP010011	sc-357	Homo sapiens		EXP010539	430	unspecified	Q99081	HepG2 (hepatoblastoma)	PEAKS033423
EXP010012	sc-268	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	unspecified	P23771	T47D (invasive ductal carcinoma)	PEAKS033424
EXP010013	sc-229	Homo sapiens		EXP010726	430	unspecified	P22415	HepG2 (hepatoblastoma)	PEAKS033425
EXP010014	sc-12984	Mus musculus		EXP010710	265	unspecified	P22091	G1E (embryonic stem cells)	PEAKS035461
EXP010018	sc-8983	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	unspecified	P22415	SK-N-SH (neuroblastoma)	PEAKS033426
EXP010019	sc-866	Mus musculus		EXP010644	1174	unspecified	Q8R0K9	MEL cell line	PEAKS035462
EXP010020	H00010127-A01	Homo sapiens		EXP010823	514	unspecified	O14978	K562 (myelogenous leukemia)	PEAKS033427
EXP010021	sc-188	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P18847	A549 (lung carcinoma)	PEAKS033428
EXP010022	sc-28312	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q06546	A549 (lung carcinoma)	PEAKS033429
EXP010024	sc-183	Homo sapiens		EXP010428	376	unspecified	P15407	WA01 (H1, human embryonic stem cells)	PEAKS033430
EXP010025	sc-735	Homo sapiens		EXP010318	376	unspecified	P21675	WA01 (H1, human embryonic stem cells)	PEAKS033431
EXP010026	2899	Homo sapiens		EXP010827	408	unspecified	P49711	HBMEC (human brain microvascular endothelial cells)	PEAKS033432
EXP010028	sc-17824	Homo sapiens		EXP010375	356	unspecified	P08047	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033433
EXP010029	sc-1694	Homo sapiens		EXP010255	430	unspecified	P05412	HepG2 (hepatoblastoma)	PEAKS033434
EXP010031	ab60931	Mus musculus		EXP010265	1174	unspecified	Q64705	MEL cell line	PEAKS035463
EXP010032	sc-477	Homo sapiens		EXP010255	430	unspecified	O60675	HepG2 (hepatoblastoma)	PEAKS033435
EXP010033	sc-553	Homo sapiens		EXP010726	430	unspecified	P19793	HepG2 (hepatoblastoma)	PEAKS033436
EXP010035	sc-764	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033437
EXP010036	sc-22805	Homo sapiens		EXP010141	357	unspecified	P17947	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033438
EXP010037	sc-185	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P20749	A549 (lung carcinoma)	PEAKS033439
EXP010038	ab50322	Homo sapiens		EXP010530	514	unspecified	O60675	K562 (myelogenous leukemia)	PEAKS033440
EXP010040	sc-1694	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS033441
EXP010041	sc-6556	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS033442
EXP010042	sc-269	Homo sapiens		EXP010619	664	unspecified	P23771	SH-SY5Y (neuroblastoma)	PEAKS036672
EXP010043	2899	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010815	665	unspecified	P49711	SK-N-SH (neuroblastoma)	PEAKS033443
EXP010044	sc-12732	Mus musculus		EXP010882	1153	unspecified	P12979	C2C12 (myoblasts)	PEAKS036673
EXP010045	M8194	Homo sapiens		EXP010530	514	unspecified	Q9ULX9	K562 (myelogenous leukemia)	PEAKS036674
EXP010046	2899	Homo sapiens		EXP010744	354	unspecified	P49711	GM12874 (male B-cells)	PEAKS033444
EXP010047	GATA-1	Homo sapiens		EXP010823	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS033445
EXP010049	sc-28312	Homo sapiens		EXP010671	514	unspecified	Q06546	K562 (myelogenous leukemia)	PEAKS033446
EXP010056	sc-150	Homo sapiens		EXP010530	514	unspecified	P17676	K562 (myelogenous leukemia)	PEAKS033447
EXP010057	AF4185	Homo sapiens		EXP010530	514	unspecified	P50539	K562 (myelogenous leukemia)	PEAKS033448
EXP010058	sc-7202	Homo sapiens	(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	PEAKS036675
EXP010063	sc-631	Homo sapiens		EXP010489	430	unspecified	P32519	HepG2 (hepatoblastoma)	PEAKS033449
EXP010064	sc-197	Homo sapiens		EXP010027	423	unspecified	P61244	HeLa S3 (cervical adenocarcinoma)	PEAKS033450
EXP010065	HPA006672	Homo sapiens		EXP010054	423	unspecified	P17029	HeLa S3 (cervical adenocarcinoma)	PEAKS036676
EXP010067	ab55744	Homo sapiens		EXP010714	376	unspecified	Q16656	WA01 (H1, human embryonic stem cells)	PEAKS033451
EXP010068	sc-6553	Homo sapiens		EXP010489	430	unspecified	P55317	HepG2 (hepatoblastoma)	PEAKS033452
EXP010069	sc-482	Homo sapiens	(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	EXP010052	583	unspecified	P40763	MCF10A (breast epithelial cells)	PEAKS033453
EXP010070	sc-497	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P10914	K562 (myelogenous leukemia)	PEAKS036677
EXP010071	sc-1703	Homo sapiens		EXP010048	244	unspecified	P25490	NT2-D1 (embryonic carcinoma)	PEAKS033454
EXP010072	2569	Homo sapiens		EXP010476	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	PEAKS036678
EXP010073	16618-1-AP	Homo sapiens		EXP010714	376	unspecified	P52747	WA01 (H1, human embryonic stem cells)	PEAKS036679
EXP010074	sc-17824	Homo sapiens		EXP010428	376	unspecified	P08047	WA01 (H1, human embryonic stem cells)	PEAKS033455
EXP010075	AF4185	Homo sapiens		EXP010054	423	unspecified	P50539	HeLa S3 (cervical adenocarcinoma)	PEAKS033456
EXP010077	sc-643	Homo sapiens		EXP010023	430	unspecified	Q02086	HepG2 (hepatoblastoma)	PEAKS033457
EXP010078	sc-281	Homo sapiens		EXP010137	356	unspecified	P25490	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033458
EXP010079	sc-1694	Mus musculus		EXP010613	1144	unspecified	P05627	CH12.LX (Mouse lymphoma)	PEAKS035464
EXP010080	sc-17824	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P08047	A549 (lung carcinoma)	PEAKS033459
EXP010081	sc-12984	Homo sapiens		EXP010630	514	unspecified	P17542	K562 (myelogenous leukemia)	PEAKS033460
EXP010082	sc-345	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P42224	K562 (myelogenous leukemia)	PEAKS033461
EXP010083	sc-764	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033462
EXP010084	2899	Homo sapiens		EXP010814	1146	unspecified	P49711	epithelial cell of proximal tubule	PEAKS033463
EXP010085	sc-14700	Homo sapiens		EXP010530	514	unspecified	O14867	K562 (myelogenous leukemia)	PEAKS036680
EXP010086	sc-268	Homo sapiens		EXP010876	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS036681
EXP010087	sc-764	Homo sapiens		EXP010530	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS036682
EXP010088	sc-357	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q99081	A549 (lung carcinoma)	PEAKS033464
EXP010089	sc-5916	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010555	504	unspecified	P49711	Ishikawa (endometrial adenocarcinoma)	PEAKS033465
EXP010091	CTCF	Mus musculus		EXP010910	53	unspecified	Q61164	heart	PEAKS035465
EXP010092	sc-13030	Homo sapiens		EXP010669	423	unspecified	P28324	HeLa S3 (cervical adenocarcinoma)	PEAKS033466
EXP054853	Med1/TRAP220 (Bethyl, A300-793A-2)	Homo sapiens		EXP054852	2608	normal	O95243	HSMM (skeletal muscle myoblasts)	PEAKS051544
EXP010095	sc-645	Homo sapiens		EXP010513	376	unspecified	Q02446	WA01 (H1, human embryonic stem cells)	PEAKS033467
EXP010096	2569	Homo sapiens		EXP010876	113	unspecified	Q9NQB0	MCF7 (Invasive ductal breast carcinoma)	PEAKS036683
EXP010097	sc-233	Homo sapiens		EXP010060	356	unspecified	P09086	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033468
EXP010098	ab19489	Homo sapiens		EXP010581	356	unspecified	Q9H165	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033469
EXP010100	sc-476	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P52630	K562 (myelogenous leukemia)	PEAKS033470
EXP010102	sc-764	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033471
EXP010104	ab19489	Homo sapiens		EXP010580	356	unspecified	Q9H165	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033472
EXP010105	TR4	Homo sapiens		EXP010673	430	unspecified	P49116	HepG2 (hepatoblastoma)	PEAKS033473
EXP054036	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	440	normal	P49711	HMEC (human mammary epithelial cells)	PEAKS050967
EXP054033	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054025	2606	normal	P49711	NHLF (lung fibroblasts)	PEAKS050964
EXP010108	2899	Homo sapiens		EXP010786	38	unspecified	P49711	A549 (lung carcinoma)	PEAKS033476
EXP010109	sc-229	Homo sapiens		EXP010428	376	unspecified	P22415	WA01 (H1, human embryonic stem cells)	PEAKS033477
EXP010110	ab60931	Homo sapiens		EXP010255	430	unspecified	Q15853	HepG2 (hepatoblastoma)	PEAKS033478
EXP010111	sc-13125	Homo sapiens		EXP010630	514	unspecified	P17480	K562 (myelogenous leukemia)	PEAKS036684
EXP010112	sc-8987	Homo sapiens		EXP010539	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS033479
EXP010114	sc-5916	Homo sapiens		EXP010489	430	unspecified	P49711	HepG2 (hepatoblastoma)	PEAKS033480
EXP010115	sc-482	Homo sapiens		EXP010054	423	unspecified	P40763	HeLa S3 (cervical adenocarcinoma)	PEAKS033481
EXP010116	2899	Homo sapiens		EXP010397	863	unspecified	P49711	WERI-Rb-1 (retinoblastoma)	PEAKS033482
EXP010117	07-729	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	Q61164	G1E-ER4 (embryonic stem cells)	PEAKS035466
EXP010118	sc-22827	Homo sapiens		EXP010122	356	unspecified	Q16621	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033483
EXP010119	sc-188	Homo sapiens		EXP010597	514	unspecified	P18847	K562 (myelogenous leukemia)	PEAKS033484
EXP010127	sc-28312	Homo sapiens		EXP010093	356	unspecified	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033485
EXP010128	sc-101184	Homo sapiens		EXP010546	514	unspecified	Q15561	K562 (myelogenous leukemia)	PEAKS033486
EXP010129	sc-28312	Homo sapiens		EXP010094	356	unspecified	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033487
EXP010132	sc-137065	Homo sapiens		EXP010122	356	unspecified	Q9UH73	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033488
EXP010133	sc-197	Mus musculus		EXP010883	644	unspecified	P28574	myocytes	PEAKS035467
EXP010134	07-729	Mus musculus		EXP010059	1174	unspecified	Q61164	MEL cell line	PEAKS035468
EXP010135	sc-150	Homo sapiens		EXP010255	430	unspecified	P17676	HepG2 (hepatoblastoma)	PEAKS033489
EXP010138	sc-150	Homo sapiens		EXP010066	489	unspecified	P17676	IMR90 (lung fibroblasts)	PEAKS036685
EXP010139	sc-98174	Homo sapiens		EXP010671	514	unspecified	Q9NVV9	K562 (myelogenous leukemia)	PEAKS033490
EXP010140	sc-197	Homo sapiens		EXP010587	376	unspecified	P61244	WA01 (H1, human embryonic stem cells)	PEAKS033491
EXP010142	sc-357	Mus musculus		EXP010883	644	unspecified	Q61286	myocytes	PEAKS035469
EXP010143	sc-197	Homo sapiens		EXP010255	430	unspecified	P61244	HepG2 (hepatoblastoma)	PEAKS036686
EXP010144	07-729	Homo sapiens	45 min with 100 nM Estradiol (Crawford)	EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033492
EXP010145	sc-631	Homo sapiens		EXP010130	514	unspecified	P32519	K562 (myelogenous leukemia)	PEAKS033493
EXP010146	sc-1694	Homo sapiens		EXP010054	423	unspecified	P05412	HeLa S3 (cervical adenocarcinoma)	PEAKS033494
EXP010149	sc-1694	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS036687
EXP010150	sc-197	Homo sapiens		EXP010745	356	unspecified	P61244	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036688
EXP010151	sc-23871	Homo sapiens		EXP010403	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	PEAKS033495
EXP010152	sc-265	Mus musculus		EXP010710	265	unspecified	P17679	G1E (embryonic stem cells)	PEAKS035470
EXP010153	sc-313	Homo sapiens		EXP010671	514	unspecified	Q02078	K562 (myelogenous leukemia)	PEAKS033496
EXP010154	2899	Homo sapiens		EXP010801	648	unspecified	P49711	NB4 (acute promyelocytic leukemia )	PEAKS033497
EXP010155	sc-6553	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	unspecified	P55317	T47D (invasive ductal carcinoma)	PEAKS033498
EXP010156	sc-110	Homo sapiens		EXP010094	356	unspecified	P18146	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033499
EXP010160	sc-553	Homo sapiens		EXP010428	376	unspecified	P19793	WA01 (H1, human embryonic stem cells)	PEAKS033500
EXP010161	sc-23871	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q86T24	A549 (lung carcinoma)	PEAKS033501
EXP010162	sc-335	Homo sapiens		EXP010489	430	unspecified	P11831	HepG2 (hepatoblastoma)	PEAKS033502
EXP010164	sc-233	Homo sapiens		EXP010141	357	unspecified	P09086	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033503
EXP010165	sc-100974	Homo sapiens		EXP010580	356	unspecified	Q16520	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033504
EXP010166	ab85725	Homo sapiens		EXP010530	514	unspecified	P56270	K562 (myelogenous leukemia)	PEAKS036689
EXP010167	sc-98982	Homo sapiens		EXP010671	514	unspecified	Q8NI51	K562 (myelogenous leukemia)	PEAKS033505
EXP010169	sc-100974	Homo sapiens		EXP010581	356	unspecified	Q16520	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033506
EXP010174	2899	Homo sapiens		EXP010802	420	unspecified	P49711	esophageal epithelial cells	PEAKS033507
EXP010175	200-401-194	Homo sapiens		EXP010714	376	unspecified	P48382	WA01 (H1, human embryonic stem cells)	PEAKS033508
EXP010177	ab50322	Homo sapiens		EXP010066	489	unspecified	O60675	IMR90 (lung fibroblasts)	PEAKS036690
EXP010178	sc-22823	Homo sapiens		EXP010823	514	unspecified	O75461	K562 (myelogenous leukemia)	PEAKS033509
EXP010179	sc-1975	Homo sapiens		EXP010375	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033510
EXP010180	ab55744	Homo sapiens		EXP010255	430	unspecified	Q16656	HepG2 (hepatoblastoma)	PEAKS033511
EXP010181	CTCF	Mus musculus		EXP010923	5	unspecified	Q61164	liver	PEAKS035471
EXP010182	sc-350	Homo sapiens		EXP010137	356	unspecified	P14921	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033512
EXP010183	sc-74	Homo sapiens		EXP010122	356	unspecified	P17535	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033513
EXP010185	sc-81188	Homo sapiens		EXP010513	376	unspecified	P15336	WA01 (H1, human embryonic stem cells)	PEAKS033514
EXP010187	sc-188	Homo sapiens		EXP010489	430	unspecified	P18847	HepG2 (hepatoblastoma)	PEAKS033515
EXP010188	sc-74442	Homo sapiens		EXP010546	514	unspecified	P42229	K562 (myelogenous leukemia)	PEAKS033516
EXP010189	sc-482	Homo sapiens	36 h with 0.01% Ethanol	EXP010052	583	unspecified	P40763	MCF10A (breast epithelial cells)	PEAKS033517
EXP010190	200-401-194	Homo sapiens		EXP010255	430	unspecified	P48382	HepG2 (hepatoblastoma)	PEAKS033518
EXP010191	sc-55706	Homo sapiens		EXP010379	514	unspecified	Q8N196	K562 (myelogenous leukemia)	PEAKS033519
EXP010192	sc-197	Homo sapiens		EXP010030	648	unspecified	P61244	NB4 (acute promyelocytic leukemia )	PEAKS033520
EXP010193	sc-15914	Homo sapiens		EXP010066	489	unspecified	P49711	IMR90 (lung fibroblasts)	PEAKS036691
EXP010194	ab60931	Homo sapiens		EXP010745	356	unspecified	Q15853	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033521
EXP010195	2899	Homo sapiens		EXP010925	114	unspecified	P49711	bronchial epithelial cells	PEAKS033522
EXP010196	sc-267	Homo sapiens		EXP010671	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033523
EXP010197	2899	Homo sapiens		EXP010790	441	unspecified	P49711	HMF (human mammary fibroblasts)	PEAKS033524
EXP010198	sc-101023	Homo sapiens		EXP010403	430	unspecified	O14503	HepG2 (hepatoblastoma)	PEAKS033525
EXP010199	sc-110	Homo sapiens		EXP010137	356	unspecified	P18146	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033526
EXP010200	ab85725	Homo sapiens		EXP010255	430	unspecified	P56270	HepG2 (hepatoblastoma)	PEAKS036692
EXP010201	sc-735	Homo sapiens		EXP010158	430	unspecified	P21675	HepG2 (hepatoblastoma)	PEAKS033527
EXP010202	NRSF	Homo sapiens		EXP010171	733	unspecified	Q13127	PFSK1 (primitive neuroectodermal tumor)	PEAKS033528
EXP010203	2899	Homo sapiens		EXP010877	414	unspecified	P49711	HCFaa (cardiac fibroblasts - adult atrial)	PEAKS033529
EXP010204	sc-6553	Homo sapiens		EXP010539	430	unspecified	P55317	HepG2 (hepatoblastoma)	PEAKS033530
EXP010205	sc-735	Homo sapiens		EXP010157	430	unspecified	P21675	HepG2 (hepatoblastoma)	PEAKS033531
EXP010206	2899	Homo sapiens		EXP010830	1141	unspecified	P49711	BE2C	PEAKS033532
EXP010207	9115	Homo sapiens		EXP010054	423	unspecified	O75626	HeLa S3 (cervical adenocarcinoma)	PEAKS033533
EXP010211	sc-1002	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P04150	HepG2 (hepatoblastoma)	PEAKS033534
EXP010212	NB100-279	Homo sapiens		EXP010255	430	unspecified	Q99856	HepG2 (hepatoblastoma)	PEAKS036693
EXP010213	sc-281	Homo sapiens		EXP010062	356	unspecified	P25490	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033535
EXP010214	2899	Homo sapiens		EXP010898	55	unspecified	P49711	AG04450 (fibroblasts)	PEAKS033536
EXP010217	sc-604	Homo sapiens		EXP010726	430	unspecified	P15408	HepG2 (hepatoblastoma)	PEAKS033537
EXP010218	ab62126	Homo sapiens		EXP010745	356	unspecified	P20226	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033538
EXP010219	CTCF	Mus musculus		EXP010930	81	unspecified	Q61164	BMDM (bone marrow-derived macrophages)	PEAKS035472
EXP010220	eGFP	Homo sapiens		EXP010847	514	unspecified	P17275	K562 (myelogenous leukemia)	PEAKS033539
EXP010222	05-379	Homo sapiens		EXP010027	423	unspecified	Q01094	HeLa S3 (cervical adenocarcinoma)	PEAKS033540
EXP010223	2899	Homo sapiens		EXP010851	423	unspecified	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS033541
EXP010224	06-325	Homo sapiens		EXP010597	514	unspecified	P18846	K562 (myelogenous leukemia)	PEAKS036694
EXP010225	sc-150	Homo sapiens		EXP010769	38	unspecified	P17676	A549 (lung carcinoma)	PEAKS036695
EXP010229	sc-866	Homo sapiens	(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	EXP010486	583	unspecified	Q16254	MCF10A (breast epithelial cells)	PEAKS036696
EXP010230	H00010782-A01	Homo sapiens		EXP010823	514	unspecified	Q96GC6	K562 (myelogenous leukemia)	PEAKS033542
EXP010231	ab24166	Homo sapiens		EXP010530	514	unspecified	Q9UKL0	K562 (myelogenous leukemia)	PEAKS036697
EXP010232	sc-9082	Homo sapiens		EXP010054	423	unspecified	Q14653	HeLa S3 (cervical adenocarcinoma)	PEAKS033543
EXP010234	MMS-101P	Homo sapiens		EXP010027	423	unspecified	Q01094	HeLa S3 (cervical adenocarcinoma)	PEAKS033544
EXP010235	sc-23871	Homo sapiens		EXP010278	417	unspecified	Q86T24	HCT-116 (colon carcinoma)	PEAKS033545
EXP010236	sc-101058	Homo sapiens		EXP010489	430	unspecified	P55317	HepG2 (hepatoblastoma)	PEAKS033546
EXP010237	sc-12984	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	P22091	G1E-ER4 (embryonic stem cells)	PEAKS035473
EXP010240	sc-764	Homo sapiens		EXP010113	472	unspecified	P01106	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033547
EXP010241	2569	Homo sapiens		EXP010669	423	unspecified	Q9NQB0	HeLa S3 (cervical adenocarcinoma)	PEAKS036698
EXP010243	sc-150	Homo sapiens		EXP010054	423	unspecified	P17676	HeLa S3 (cervical adenocarcinoma)	PEAKS033548
EXP010245	sc-197	Homo sapiens		EXP010054	423	unspecified	P61244	HeLa S3 (cervical adenocarcinoma)	PEAKS036699
EXP010246	2899	Homo sapiens		EXP010686	344	unspecified	P49711	GM12864 (male B-cells)	PEAKS033549
EXP010247	sc-74	Homo sapiens		EXP010714	376	unspecified	P17535	WA01 (H1, human embryonic stem cells)	PEAKS036700
EXP010248	ab50322	Mus musculus		EXP010613	1144	unspecified	Q61827	CH12.LX (Mouse lymphoma)	PEAKS036701
EXP010249	sc-1703	Homo sapiens		EXP010704	358	unspecified	P25490	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS033550
EXP010250	2899	Homo sapiens		EXP010922	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033551
EXP010251	sc-1974	Homo sapiens		EXP010704	358	unspecified	Q02548	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS033552
EXP010252	07-729	Homo sapiens		EXP010061	391	unspecified	P49711	D54 (H54, Human glioblastoma)	PEAKS033553
EXP010253	sc-98982	Homo sapiens		EXP010379	514	unspecified	Q8NI51	K562 (myelogenous leukemia)	PEAKS033554
EXP010254	ab12000	Mus musculus		EXP010677	1144	unspecified	Q02650	CH12.LX (Mouse lymphoma)	PEAKS035474
EXP010256	sc-281	Homo sapiens		EXP010489	430	unspecified	P25490	HepG2 (hepatoblastoma)	PEAKS033555
EXP010257	sc-22805	Homo sapiens		EXP010581	356	unspecified	P17947	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033556
EXP010258	sc-55706	Homo sapiens		EXP010419	514	unspecified	Q8N196	K562 (myelogenous leukemia)	PEAKS033557
EXP010259	sc-55706	Homo sapiens		EXP010415	514	unspecified	Q8N196	K562 (myelogenous leukemia)	PEAKS033558
EXP010260	sc-7202	Homo sapiens		EXP010597	514	unspecified	P01100	K562 (myelogenous leukemia)	PEAKS033559
EXP010261	sc-15914	Mus musculus		EXP010644	1174	unspecified	Q61164	MEL cell line	PEAKS035475
EXP010262	sc-866	Homo sapiens		EXP010745	356	unspecified	Q16254	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036702
EXP010263	sc-197	Mus musculus		EXP010613	1144	unspecified	P28574	CH12.LX (Mouse lymphoma)	PEAKS035476
EXP010264	NRSF	Homo sapiens		EXP010645	665	unspecified	Q13127	SK-N-SH (neuroblastoma)	PEAKS033560
EXP010266	NRSF	Homo sapiens		EXP010039	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033561
EXP054039	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2608	normal	P49711	HSMM (skeletal muscle myoblasts)	PEAKS050970
EXP010269	2899	Homo sapiens		EXP010784	434	unspecified	P49711	HFF-Myc (fetal fibroblasts)	PEAKS033563
EXP010271	sc-6553	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010555	504	unspecified	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS033564
EXP010272	2899	Homo sapiens		EXP010819	56	unspecified	P49711	AG09309 (fibroblasts)	PEAKS033565
EXP010273	sc-281	Homo sapiens		EXP010428	376	unspecified	P25490	WA01 (H1, human embryonic stem cells)	PEAKS033566
EXP010274	1277-1	Homo sapiens		EXP010745	356	unspecified	P19419	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036703
EXP010275	sc-350	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P14921	A549 (lung carcinoma)	PEAKS033567
EXP010276	sc-15914	Homo sapiens		EXP010530	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS036704
EXP010277	sc-30189	Homo sapiens		EXP010054	423	unspecified	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	PEAKS036705
EXP010279	ab16046	Homo sapiens		EXP010124	289	unspecified	O15409	SK-N-MC (Askin tumor)	PEAKS033568
EXP010280	sc-335	Homo sapiens		EXP010137	356	unspecified	P11831	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033569
EXP010282	sc-1974	Homo sapiens		EXP010580	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033570
EXP010283	sc-197	Homo sapiens		EXP010732	472	unspecified	P61244	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033571
EXP010284	CTCF	Mus musculus		EXP010888	523	unspecified	Q61164	kidney	PEAKS035477
EXP010285	2569	Homo sapiens		EXP010221	712	unspecified	Q9NQB0	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS036706
EXP010286	eGFP	Homo sapiens		EXP010184	514	unspecified	P22736	K562 (myelogenous leukemia)	PEAKS033572
EXP010290	sc-9008	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	O09100	G1E-ER4 (embryonic stem cells)	PEAKS035478
EXP010295	2899	Homo sapiens		EXP010778	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033573
EXP010296	NRSF	Homo sapiens	None	EXP010737	849	unspecified	Q13127	U87 (glioblastoma)	PEAKS033574
EXP010297	sc-15914	Homo sapiens		EXP010122	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033575
EXP010298	sc-281	Homo sapiens		EXP010700	357	unspecified	P25490	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033576
EXP010299	sc-9081	Homo sapiens		EXP010428	376	unspecified	Q01860	WA01 (H1, human embryonic stem cells)	PEAKS033577
EXP010300	sc-350	Homo sapiens		EXP010671	514	unspecified	P14921	K562 (myelogenous leukemia)	PEAKS033578
EXP010301	CTCF	Mus musculus		EXP010817	1165	unspecified	Q61164	cortical plate	PEAKS035479
EXP010302	sc-5916	Homo sapiens		EXP010130	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS033579
EXP010304	sc-5916	Homo sapiens		EXP010131	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS033580
EXP010305	2899	Homo sapiens		EXP010881	54	unspecified	P49711	AG04449 (fibroblasts)	PEAKS033581
EXP010306	ab55744	Homo sapiens		EXP010725	423	unspecified	Q16656	HeLa S3 (cervical adenocarcinoma)	PEAKS033582
EXP010307	sc-110	Homo sapiens		EXP010428	376	unspecified	P18146	WA01 (H1, human embryonic stem cells)	PEAKS033583
EXP010308	sc-7202	Homo sapiens	36 h with 0.01% Ethanol	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	PEAKS036707
EXP010309	CTCF	Mus musculus		EXP010885	103	unspecified	Q61164	bone marrow	PEAKS035480
EXP010310	sc-335	Homo sapiens		EXP010428	376	unspecified	P11831	WA01 (H1, human embryonic stem cells)	PEAKS033584
EXP010312	sc-23871	Homo sapiens		EXP010489	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	PEAKS033585
EXP010313	sc-1703	Homo sapiens		EXP010122	356	unspecified	P25490	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033586
EXP010314	NRSF	Homo sapiens		EXP010318	376	unspecified	Q13127	WA01 (H1, human embryonic stem cells)	PEAKS033587
EXP010315	sc-22823	Homo sapiens		EXP010131	514	unspecified	O75461	K562 (myelogenous leukemia)	PEAKS033588
EXP010316	sc-497	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P10914	K562 (myelogenous leukemia)	PEAKS033589
EXP010317	sc-22823	Homo sapiens		EXP010130	514	unspecified	O75461	K562 (myelogenous leukemia)	PEAKS033590
EXP010319	sc-735	Homo sapiens		EXP010101	733	unspecified	P21675	PFSK1 (primitive neuroectodermal tumor)	PEAKS033591
EXP010320	sc-735	Homo sapiens		EXP010671	514	unspecified	P21675	K562 (myelogenous leukemia)	PEAKS033592
EXP010322	2899	Homo sapiens		EXP010838	93	unspecified	P49711	BJ (fibroblasts)	PEAKS033593
EXP010323	NRSF	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q13127	A549 (lung carcinoma)	PEAKS033594
EXP010324	2899	Homo sapiens		EXP010783	57	unspecified	P49711	AG09319 (fibroblasts)	PEAKS033595
EXP010325	sc-28312	Homo sapiens		EXP010157	430	unspecified	Q06546	HepG2 (hepatoblastoma)	PEAKS033596
EXP010327	sc-28312	Homo sapiens		EXP010158	430	unspecified	Q06546	HepG2 (hepatoblastoma)	PEAKS033597
EXP010329	sc-265	Mus musculus		EXP010281	266	unspecified	P17679	erythroblasts	PEAKS035481
EXP010330	sc-281	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P25490	A549 (lung carcinoma)	PEAKS033598
EXP010332	sc-764	Homo sapiens		EXP010027	423	unspecified	P01106	HeLa S3 (cervical adenocarcinoma)	PEAKS033599
EXP010333	sc-291	Homo sapiens		EXP010597	514	unspecified	Q16621	K562 (myelogenous leukemia)	PEAKS033600
EXP010334	sc-23871	Homo sapiens		EXP010726	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	PEAKS033601
EXP054042	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	149	normal	P49711	osteoblasts	PEAKS050973
EXP010336	sc-229	Homo sapiens		EXP010093	356	unspecified	P22415	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033603
EXP010337	sc-229	Homo sapiens		EXP010094	356	unspecified	P22415	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033604
EXP010339	sc-764	Homo sapiens		EXP010597	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033605
EXP010340	sc-1694	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS033606
EXP010342	sc-764	Mus musculus		EXP010644	1174	unspecified	P01108	MEL cell line	PEAKS035482
EXP054034	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054024	472	normal	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS050965
EXP010344	ab19489	Homo sapiens		EXP010428	376	unspecified	Q9H165	WA01 (H1, human embryonic stem cells)	PEAKS033608
EXP010345	2899	Homo sapiens		EXP010706	345	unspecified	P49711	GM12865 (female B-cells)	PEAKS033609
EXP010347	sc-497	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P10914	K562 (myelogenous leukemia)	PEAKS036708
EXP010348	sc-74	Mus musculus		EXP010613	1144	unspecified	P15066	CH12.LX (Mouse lymphoma)	PEAKS035483
EXP010349	NB100-1800	Homo sapiens		EXP010530	514	unspecified	O14503	K562 (myelogenous leukemia)	PEAKS033610
EXP010350	H00010782-A01	Homo sapiens		EXP010673	430	unspecified	Q96GC6	HepG2 (hepatoblastoma)	PEAKS033611
EXP010351	sc-735	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P21675	A549 (lung carcinoma)	PEAKS033612
EXP010352	2899	Homo sapiens		EXP010913	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS033613
EXP010353	NF-YA	Homo sapiens		EXP010745	356	unspecified	P23511	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036709
EXP010354	sc-74442	Homo sapiens		EXP010159	514	unspecified	P42229	K562 (myelogenous leukemia)	PEAKS033614
EXP010355	ab62126	Mus musculus		EXP010265	1174	unspecified	P29037	MEL cell line	PEAKS035484
EXP010357	sc-8987	Homo sapiens		EXP010489	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS033615
EXP010360	sc-1694	Homo sapiens		EXP010732	472	unspecified	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033616
EXP010361	1277-1	Homo sapiens		EXP010054	423	unspecified	P19419	HeLa S3 (cervical adenocarcinoma)	PEAKS036710
EXP010362	sc-335	Homo sapiens		EXP010094	356	unspecified	P11831	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033617
EXP010363	sc-335	Homo sapiens		EXP010093	356	unspecified	P11831	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033618
EXP010364	sc-1694	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS033619
EXP054087	PLU1 (YangShi lab)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9UGL1	K562 (myelogenous leukemia)	PEAKS051018
EXP054054	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	220	normal	P49711	DND41 (acute lymphoblastic leukemia)	PEAKS050985
EXP010369	sc-197	Homo sapiens		EXP010131	514	unspecified	P61244	K562 (myelogenous leukemia)	PEAKS033622
EXP010370	sc-197	Homo sapiens		EXP010130	514	unspecified	P61244	K562 (myelogenous leukemia)	PEAKS033623
EXP010371	2565	Homo sapiens		EXP010669	423	unspecified	Q9NQB0	HeLa S3 (cervical adenocarcinoma)	PEAKS036711
EXP010372	ab62126	Homo sapiens		EXP010630	514	unspecified	P20226	K562 (myelogenous leukemia)	PEAKS033624
EXP010373	GATA-1	Homo sapiens		EXP010090	893	unspecified	P15976	erythroblasts	PEAKS033625
EXP054037	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2607	normal	P49711	NHDF-Ad (adult dermal fibroblasts)	PEAKS050968
EXP010376	ab85725	Homo sapiens		EXP010745	356	unspecified	P56270	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036712
EXP010377	NRSF	Homo sapiens		EXP010381	423	unspecified	Q13127	HeLa S3 (cervical adenocarcinoma)	PEAKS033627
EXP010378	sc-30189	Homo sapiens		EXP010745	356	unspecified	Q9UKL0	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036713
EXP010380	sc-866	Mus musculus		EXP010613	1144	unspecified	Q8R0K9	CH12.LX (Mouse lymphoma)	PEAKS035485
EXP010382	sc-32758	Mus musculus		EXP010816	644	unspecified	P10085	myocytes	PEAKS036714
EXP010383	2899	Homo sapiens		EXP010798	58	unspecified	P49711	AG10803 (fibroblasts)	PEAKS033628
EXP010384	H00010782-A01	Homo sapiens		EXP010389	336	unspecified	Q96GC6	GM08714 (female B-cells)	PEAKS036715
EXP010385	sc-764	Homo sapiens		EXP010599	423	unspecified	P01106	HeLa S3 (cervical adenocarcinoma)	PEAKS033629
EXP010387	07-729	Mus musculus		EXP010677	1144	unspecified	Q61164	CH12.LX (Mouse lymphoma)	PEAKS035486
EXP010388	sc-764	Homo sapiens	4 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P01106	MCF10A (breast epithelial cells)	PEAKS036716
EXP010391	sc-735	Homo sapiens		EXP010505	665	unspecified	P21675	SK-N-SH (neuroblastoma)	PEAKS033630
EXP010392	sc-6059	Homo sapiens		EXP010581	356	unspecified	Q15306	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033631
EXP010393	sc-6059	Homo sapiens		EXP010580	356	unspecified	Q15306	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033632
EXP010394	sc-188	Homo sapiens		EXP010671	514	unspecified	P18847	K562 (myelogenous leukemia)	PEAKS033633
EXP010395	2899	Homo sapiens		EXP010629	352	unspecified	P49711	GM12872 (male B-cells)	PEAKS033634
EXP010396	sc-9144	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	Q00613	HepG2 (hepatoblastoma)	PEAKS033635
EXP054094	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054090	521	normal	Q3UKU1	KH2 (embryonic stem cells)	PEAKS051021
EXP010398	H00010782-A01	Homo sapiens		EXP010048	244	unspecified	Q96GC6	NT2-D1 (embryonic carcinoma)	PEAKS033636
EXP010399	sc-6554	Homo sapiens		EXP010489	430	unspecified	Q9Y261	HepG2 (hepatoblastoma)	PEAKS033637
EXP010400	16618-1-AP	Homo sapiens		EXP010054	423	unspecified	P52747	HeLa S3 (cervical adenocarcinoma)	PEAKS036717
EXP010401	sc-631	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P32519	A549 (lung carcinoma)	PEAKS033638
EXP010402	IKZF1_(IkN)	Homo sapiens		EXP010122	356	unspecified	Q13422	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036718
EXP010405	NRSF	Mus musculus		EXP010816	644	unspecified	Q8VIG1	myocytes	PEAKS036719
EXP010406	ab55744	Homo sapiens		EXP010745	356	unspecified	Q16656	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033639
EXP010407	SAB1404509	Homo sapiens		EXP010630	514	unspecified	P17480	K562 (myelogenous leukemia)	PEAKS036720
EXP010408	sc-23871	Homo sapiens		EXP010228	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	PEAKS033640
EXP010409	CTCF	Mus musculus		EXP010894	162	unspecified	Q61164	olfactory bulb	PEAKS035487
EXP010410	sc-5916	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	unspecified	P49711	T47D (invasive ductal carcinoma)	PEAKS033641
EXP010411	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033642
EXP010412	sc-866	Mus musculus		EXP010883	644	unspecified	Q8R0K9	myocytes	PEAKS035488
EXP010413	07-729	Mus musculus		EXP010710	265	unspecified	Q61164	G1E (embryonic stem cells)	PEAKS035489
EXP010416	sc-74	Homo sapiens		EXP010530	514	unspecified	P17535	K562 (myelogenous leukemia)	PEAKS036721
EXP054032	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	376	normal	P49711	WA01 (H1, human embryonic stem cells)	PEAKS050963
EXP010421	sc-28312	Homo sapiens		EXP010428	376	unspecified	Q06546	WA01 (H1, human embryonic stem cells)	PEAKS033644
EXP010422	2569	Homo sapiens		EXP010673	430	unspecified	Q9NQB0	HepG2 (hepatoblastoma)	PEAKS036722
EXP010423	sc-5916	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010638	38	unspecified	P49711	A549 (lung carcinoma)	PEAKS033645
EXP010425	GATA-1	Mus musculus		EXP010424	1174	unspecified	P17679	MEL cell line	PEAKS035490
EXP054030	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054027	2605	normal	P49711	HNEK (epidermal keratinocytes)	PEAKS050961
EXP010429	07-729	Homo sapiens		EXP010599	423	unspecified	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS033647
EXP010430	ab62126	Homo sapiens		EXP010714	376	unspecified	P20226	WA01 (H1, human embryonic stem cells)	PEAKS033648
EXP010431	sc-553	Homo sapiens		EXP010062	356	unspecified	P19793	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033649
EXP010432	sc-553	Homo sapiens		EXP010060	356	unspecified	P19793	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033650
EXP010433	2899	Homo sapiens		EXP010889	955	unspecified	P49711	primary foreskin fibroblasts	PEAKS033651
EXP010434	ab50322	Homo sapiens		EXP010054	423	unspecified	O60675	HeLa S3 (cervical adenocarcinoma)	PEAKS036723
EXP010435	sc-764	Homo sapiens		EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	PEAKS033652
EXP010437	sc-81192	Homo sapiens		EXP010023	430	unspecified	P10244	HepG2 (hepatoblastoma)	PEAKS033653
EXP010438	2899	Homo sapiens		EXP010867	215	unspecified	P49711	keratinocytes	PEAKS033654
EXP010439	sc-22805	Homo sapiens		EXP010415	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS033655
EXP010440	NRSF	Homo sapiens		EXP010101	733	unspecified	Q13127	PFSK1 (primitive neuroectodermal tumor)	PEAKS033656
EXP010441	eGFP	Homo sapiens		EXP010795	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033657
EXP010442	sc-22805	Homo sapiens		EXP010419	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS033658
EXP010443	TR4	Homo sapiens		EXP010027	423	unspecified	P49116	HeLa S3 (cervical adenocarcinoma)	PEAKS033659
EXP010444	AF4185	Mus musculus		EXP010613	1144	unspecified	P50540	CH12.LX (Mouse lymphoma)	PEAKS035491
EXP010446	sc-891	Homo sapiens		EXP010375	356	unspecified	P40426	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033660
EXP010447	ab60931	Homo sapiens		EXP010714	376	unspecified	Q15853	WA01 (H1, human embryonic stem cells)	PEAKS033661
EXP010448	sc-8984	Homo sapiens	For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	EXP010545	430	unspecified	P36956	HepG2 (hepatoblastoma)	PEAKS033662
EXP010449	sc-764	Homo sapiens	45 min with 100 nM Estradiol (Crawford)	EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	PEAKS033663
EXP010450	sc-15914	Mus musculus		EXP010613	1144	unspecified	Q61164	CH12.LX (Mouse lymphoma)	PEAKS036724
EXP054043	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS050974
EXP010452	sc-1694	Homo sapiens		EXP010597	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS033665
EXP010453	ab62126	Homo sapiens		EXP010054	423	unspecified	P20226	HeLa S3 (cervical adenocarcinoma)	PEAKS033666
EXP010454	sc-866	Homo sapiens		EXP010027	423	unspecified	Q16254	HeLa S3 (cervical adenocarcinoma)	PEAKS033667
EXP010455	sc-150	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P17676	HepG2 (hepatoblastoma)	PEAKS033668
EXP010456	sc-137065	Homo sapiens		EXP010580	356	unspecified	Q9UH73	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033669
EXP010457	2899	Homo sapiens		EXP010829	1160	unspecified	P49711	HRE (Human Renal Epithelial cells)	PEAKS033670
EXP010458	sc-150	Homo sapiens		EXP010714	376	unspecified	P17676	WA01 (H1, human embryonic stem cells)	PEAKS036725
EXP010459	sc-137065	Homo sapiens		EXP010581	356	unspecified	Q9UH73	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033671
EXP010460	NF-YA	Homo sapiens		EXP010054	423	unspecified	P23511	HeLa S3 (cervical adenocarcinoma)	PEAKS036726
EXP010461	sc-1703	Homo sapiens		EXP010131	514	unspecified	P25490	K562 (myelogenous leukemia)	PEAKS033672
EXP010462	NRSF	Homo sapiens		EXP010210	733	unspecified	Q13127	PFSK1 (primitive neuroectodermal tumor)	PEAKS033673
EXP010463	sc-1703	Homo sapiens		EXP010130	514	unspecified	P25490	K562 (myelogenous leukemia)	PEAKS033674
EXP010464	2899	Homo sapiens		EXP010916	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS033675
EXP010465	sc-55706	Homo sapiens		EXP010428	376	unspecified	Q8N196	WA01 (H1, human embryonic stem cells)	PEAKS033676
EXP010467	sc-5916	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	unspecified	P49711	A549 (lung carcinoma)	PEAKS033677
EXP010468	CTCF	Mus musculus		EXP010920	561	unspecified	Q61164	lung	PEAKS035492
EXP010469	sc-13268	Homo sapiens		EXP010137	356	unspecified	Q06413	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033678
EXP010470	NB100-1800	Homo sapiens		EXP010745	356	unspecified	O14503	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036727
EXP010471	200-401-194	Homo sapiens		EXP010745	356	unspecified	P48382	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033679
EXP010472	2899	Homo sapiens		EXP010854	421	unspecified	P49711	HEK293 (embryonic kidney)	PEAKS033680
EXP010473	NB100-1800	Homo sapiens		EXP010255	430	unspecified	O14503	HepG2 (hepatoblastoma)	PEAKS036728
EXP010477	sc-185	Homo sapiens		EXP010137	356	unspecified	P20749	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033681
EXP010478	2899	Homo sapiens		EXP010908	473	unspecified	P49711	human villous mesenchymal fibroblast cells	PEAKS033682
EXP010479	sc-197	Mus musculus		EXP010644	1174	unspecified	P28574	MEL cell line	PEAKS035493
EXP010480	sc-32758	Mus musculus		EXP010859	644	unspecified	P10085	myocytes	PEAKS036729
EXP010481	sc-34508	Homo sapiens		EXP010671	514	unspecified	O95365	K562 (myelogenous leukemia)	PEAKS033683
EXP010482	sc-229	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010638	38	unspecified	P22415	A549 (lung carcinoma)	PEAKS033684
EXP010483	sc-764	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033685
EXP010485	sc-764	Homo sapiens		EXP010030	648	unspecified	P01106	NB4 (acute promyelocytic leukemia )	PEAKS033686
EXP010488	sc-1975	Homo sapiens		EXP010581	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033687
EXP010490	2899	Homo sapiens		EXP010812	1152	unspecified	P49711	fibroblast of pulmonary artery	PEAKS033688
EXP010491	sc-55706	Homo sapiens		EXP010671	514	unspecified	Q8N196	K562 (myelogenous leukemia)	PEAKS033689
EXP010493	sc-74	Homo sapiens		EXP010428	376	unspecified	P17535	WA01 (H1, human embryonic stem cells)	PEAKS033690
EXP010494	sc-764	Homo sapiens		EXP010714	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	PEAKS036730
EXP010495	sc-281	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	unspecified	P25490	SK-N-SH (neuroblastoma)	PEAKS033691
EXP010496	sc-55706	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q8N196	A549 (lung carcinoma)	PEAKS033692
EXP010497	sc-345	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P42224	K562 (myelogenous leukemia)	PEAKS033693
EXP010498	sc-10757	Homo sapiens		EXP010725	423	unspecified	Q8TAQ2	HeLa S3 (cervical adenocarcinoma)	PEAKS033694
EXP010499	NRSF	Homo sapiens		EXP010094	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033695
EXP010500	2899	Homo sapiens		EXP010921	67	unspecified	P49711	aortic adventitial fibroblasts	PEAKS033696
EXP010501	NRSF	Homo sapiens		EXP010093	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033697
EXP010502	2899	Homo sapiens		EXP010805	416	unspecified	P49711	HCPEpiC (choroid plexus epithelial cells)	PEAKS033698
EXP010503	AP-2alpha	Homo sapiens	None	EXP010027	423	unspecified	P05549	HeLa S3 (cervical adenocarcinoma)	PEAKS033699
EXP010504	sc-764	Homo sapiens	36 h with 0.01% Ethanol	EXP010486	583	unspecified	P01106	MCF10A (breast epithelial cells)	PEAKS036731
EXP010506	ab55744	Homo sapiens		EXP010530	514	unspecified	Q16656	K562 (myelogenous leukemia)	PEAKS033700
EXP010508	NF-YB	Homo sapiens		EXP010054	423	unspecified	P25208	HeLa S3 (cervical adenocarcinoma)	PEAKS036732
EXP010509	sc-281	Homo sapiens		EXP010278	417	unspecified	P25490	HCT-116 (colon carcinoma)	PEAKS033701
EXP010510	CTCF	Mus musculus		EXP010835	1174	unspecified	Q61164	MEL cell line	PEAKS035494
EXP010511	sc-7202	Homo sapiens	4 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	PEAKS036733
EXP010514	07-729	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	unspecified	P49711	SK-N-SH (neuroblastoma)	PEAKS033702
EXP010515	sc-476	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P52630	K562 (myelogenous leukemia)	PEAKS033703
EXP010516	ZNF217	Homo sapiens		EXP010876	113	unspecified	O75362	MCF7 (Invasive ductal breast carcinoma)	PEAKS036734
EXP010518	sc-8821	Homo sapiens		EXP010530	514	unspecified	Q99856	K562 (myelogenous leukemia)	PEAKS036735
EXP010519	NF-YA	Homo sapiens		EXP010597	514	unspecified	P23511	K562 (myelogenous leukemia)	PEAKS036736
EXP010520	NF-YB	Homo sapiens		EXP010597	514	unspecified	P25208	K562 (myelogenous leukemia)	PEAKS036737
EXP010521	sc-1703	Homo sapiens		EXP010823	514	unspecified	P25490	K562 (myelogenous leukemia)	PEAKS033704
EXP010522	sc-32758	Mus musculus		EXP010662	644	unspecified	P10085	myocytes	PEAKS035495
EXP010523	sc-81335	Homo sapiens		EXP010023	430	unspecified	P08651	HepG2 (hepatoblastoma)	PEAKS033705
EXP010524	ab85725	Homo sapiens		EXP010054	423	unspecified	P56270	HeLa S3 (cervical adenocarcinoma)	PEAKS036738
EXP010527	sc-265	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035496
EXP010528	sc-643	Homo sapiens		EXP010130	514	unspecified	Q02086	K562 (myelogenous leukemia)	PEAKS033706
EXP010529	sc-197	Homo sapiens		EXP010530	514	unspecified	P61244	K562 (myelogenous leukemia)	PEAKS036739
EXP010531	TR4	Homo sapiens		EXP010122	356	unspecified	P49116	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033707
EXP010532	sc-482	Homo sapiens		EXP010745	356	unspecified	P40763	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033708
EXP010535	sc-229	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P22415	A549 (lung carcinoma)	PEAKS033709
EXP010536	sc-357	Homo sapiens		EXP010581	356	unspecified	Q99081	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033710
EXP010537	sc-357	Homo sapiens		EXP010580	356	unspecified	Q99081	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033711
EXP010540	sc-271940	Homo sapiens		EXP010546	514	unspecified	P24468	K562 (myelogenous leukemia)	PEAKS033712
EXP054040	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2609	normal	P49711	NA-A (astrocytes)	PEAKS050971
EXP010544	M8194	Homo sapiens		EXP010255	430	unspecified	Q9ULX9	HepG2 (hepatoblastoma)	PEAKS033714
EXP010547	sc-482	Homo sapiens	12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P40763	MCF10A (breast epithelial cells)	PEAKS036740
EXP010548	sc-631	Homo sapiens		EXP010228	430	unspecified	P32519	HepG2 (hepatoblastoma)	PEAKS033715
EXP010549	16618-1-AP	Homo sapiens		EXP010530	514	unspecified	P52747	K562 (myelogenous leukemia)	PEAKS036741
EXP010550	TR4	Homo sapiens		EXP010823	514	unspecified	P49116	K562 (myelogenous leukemia)	PEAKS033716
EXP010551	sc-604	Homo sapiens		EXP010403	430	unspecified	P15408	HepG2 (hepatoblastoma)	PEAKS033717
EXP010552	GATA-2	Homo sapiens		EXP010007	472	unspecified	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033718
EXP010553	sc-9082	Homo sapiens		EXP010745	356	unspecified	Q14653	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033719
EXP010554	sc-335	Mus musculus		EXP010859	644	unspecified	Q9JM73	myocytes	PEAKS036742
EXP010557	sc-32758	Mus musculus		EXP010882	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS036743
EXP010559	AP-2gamma	Homo sapiens	None	EXP010027	423	unspecified	Q92754	HeLa S3 (cervical adenocarcinoma)	PEAKS033720
EXP010561	sc-74	Mus musculus		EXP010644	1174	unspecified	P15066	MEL cell line	PEAKS035497
EXP010562	sc-7202	Homo sapiens		EXP010027	423	unspecified	P01100	HeLa S3 (cervical adenocarcinoma)	PEAKS033721
EXP010563	sc-23871	Homo sapiens		EXP010671	514	unspecified	Q86T24	K562 (myelogenous leukemia)	PEAKS033722
EXP010564	sc-188	Homo sapiens		EXP010539	430	unspecified	P18847	HepG2 (hepatoblastoma)	PEAKS033723
EXP010565	CTCF	Mus musculus		EXP010875	139	unspecified	Q61164	thymus	PEAKS035498
EXP010566	sc-345	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010289	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	PEAKS033724
EXP010567	sc-6558	Homo sapiens		EXP010489	430	unspecified	Q14541	HepG2 (hepatoblastoma)	PEAKS033725
EXP010568	sc-335	Homo sapiens		EXP010671	514	unspecified	P11831	K562 (myelogenous leukemia)	PEAKS033726
EXP010569	NRSF	Homo sapiens		EXP010158	430	unspecified	Q13127	HepG2 (hepatoblastoma)	PEAKS033727
EXP010570	NRSF	Homo sapiens		EXP010157	430	unspecified	Q13127	HepG2 (hepatoblastoma)	PEAKS033728
EXP010571	2569	Homo sapiens		EXP010651	421	unspecified	Q9NQB0	HEK293 (embryonic kidney)	PEAKS036744
EXP010572	sc-150	Homo sapiens		EXP010228	430	unspecified	P17676	HepG2 (hepatoblastoma)	PEAKS033729
EXP010574	sc-349	Mus musculus		EXP010816	644	unspecified	P15806	myocytes	PEAKS036745
EXP010576	sc-12732	Mus musculus		EXP010859	644	unspecified	P12979	myocytes	PEAKS036746
EXP010577	sc-188	Homo sapiens		EXP010428	376	unspecified	P18847	WA01 (H1, human embryonic stem cells)	PEAKS033730
EXP010578	sc-229	Homo sapiens		EXP010671	514	unspecified	P22415	K562 (myelogenous leukemia)	PEAKS033731
EXP010584	eGFP	Homo sapiens		EXP010788	514	unspecified	P17535	K562 (myelogenous leukemia)	PEAKS033732
EXP010585	NRSF	Homo sapiens	None	EXP010541	849	unspecified	Q13127	U87 (glioblastoma)	PEAKS033733
EXP010586	sc-735	Homo sapiens		EXP010386	358	unspecified	P21675	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS033734
EXP010588	eGFP	Homo sapiens		EXP010865	514	unspecified	P01100	K562 (myelogenous leukemia)	PEAKS033735
EXP010590	2899	Homo sapiens		EXP010779	399	unspecified	P49711	astrocytes of cerebellum	PEAKS033736
EXP010591	sc-5916	Homo sapiens		EXP010428	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	PEAKS033737
EXP010593	sc-7202	Homo sapiens		EXP010007	472	unspecified	P01100	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033738
EXP010594	sc-604	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P15408	A549 (lung carcinoma)	PEAKS033739
EXP010595	16618-1-AP	Homo sapiens		EXP010122	356	unspecified	P52747	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033740
EXP010596	sc-14700	Homo sapiens		EXP010714	376	unspecified	O14867	WA01 (H1, human embryonic stem cells)	PEAKS036747
EXP010598	sc-12984	Mus musculus		EXP010281	266	unspecified	P22091	erythroblasts	PEAKS035499
EXP010600	sc-25388	Homo sapiens		EXP010062	356	unspecified	P37275	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033741
EXP010602	NF-YB	Homo sapiens		EXP010745	356	unspecified	P25208	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036748
EXP010606	ab16046	Homo sapiens		EXP010697	733	unspecified	O15409	PFSK1 (primitive neuroectodermal tumor)	PEAKS033742
EXP010607	sc-1974	Homo sapiens		EXP010700	357	unspecified	Q02548	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033743
EXP010608	sc-17824	Homo sapiens		EXP010539	430	unspecified	P08047	HepG2 (hepatoblastoma)	PEAKS033744
EXP010609	2899	Homo sapiens		EXP010741	355	unspecified	P49711	GM12875 (female B-cells)	PEAKS033745
EXP010610	sc-17824	Homo sapiens		EXP010538	430	unspecified	P08047	HepG2 (hepatoblastoma)	PEAKS033746
EXP010611	sc-74	Homo sapiens		EXP010255	430	unspecified	P17535	HepG2 (hepatoblastoma)	PEAKS033747
EXP010612	CTCF	Mus musculus		EXP010896	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS035500
EXP010614	sc-55706	Homo sapiens		EXP010060	356	unspecified	Q8N196	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033748
EXP010615	sc-55706	Homo sapiens		EXP010062	356	unspecified	Q8N196	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033749
EXP010616	ab50322	Mus musculus		EXP010644	1174	unspecified	Q61827	MEL cell line	PEAKS036749
EXP010617	sc-229	Homo sapiens		EXP010403	430	unspecified	P22415	HepG2 (hepatoblastoma)	PEAKS033750
EXP010618	sc-636	Homo sapiens		EXP010228	430	unspecified	P49716	HepG2 (hepatoblastoma)	PEAKS033751
EXP010620	sc-357	Homo sapiens		EXP010428	376	unspecified	Q99081	WA01 (H1, human embryonic stem cells)	PEAKS033752
EXP010621	200-401-194	Homo sapiens		EXP010054	423	unspecified	P48382	HeLa S3 (cervical adenocarcinoma)	PEAKS033753
EXP010622	07-729	Homo sapiens		EXP010328	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS033754
EXP010623	2899	Homo sapiens		EXP010811	446	unspecified	P49711	HPF (pulmonary fibroblasts isolated from lung tissue)	PEAKS033755
EXP010624	2899	Homo sapiens		EXP010902	440	unspecified	P49711	HMEC (human mammary epithelial cells)	PEAKS033756
EXP010625	ab19489	Homo sapiens		EXP010428	376	unspecified	Q9H165	WA01 (H1, human embryonic stem cells)	PEAKS033757
EXP010626	sc-643	Homo sapiens		EXP010513	376	unspecified	Q02086	WA01 (H1, human embryonic stem cells)	PEAKS033758
EXP010627	sc-28312	Homo sapiens		EXP010381	423	unspecified	Q06546	HeLa S3 (cervical adenocarcinoma)	PEAKS033759
EXP010628	ab50322	Homo sapiens		EXP010255	430	unspecified	O60675	HepG2 (hepatoblastoma)	PEAKS033760
EXP010631	sc-197	Homo sapiens		EXP010597	514	unspecified	P61244	K562 (myelogenous leukemia)	PEAKS033761
EXP010632	sc-101023	Homo sapiens		EXP010769	38	unspecified	O14503	A549 (lung carcinoma)	PEAKS036750
EXP010634	ab50322	Homo sapiens		EXP010714	376	unspecified	O60675	WA01 (H1, human embryonic stem cells)	PEAKS036751
EXP010635	sc-12984	Mus musculus		EXP010059	1174	unspecified	P22091	MEL cell line	PEAKS035501
EXP010637	sc-74	Homo sapiens		EXP010054	423	unspecified	P17535	HeLa S3 (cervical adenocarcinoma)	PEAKS033762
EXP010640	sc-101023	Homo sapiens		EXP010489	430	unspecified	O14503	HepG2 (hepatoblastoma)	PEAKS033763
EXP010641	sc-9082	Homo sapiens		EXP010255	430	unspecified	Q14653	HepG2 (hepatoblastoma)	PEAKS033764
EXP010642	sc-13030	Homo sapiens		EXP010651	421	unspecified	P28324	HEK293 (embryonic kidney)	PEAKS033765
EXP010643	H00010782-A01	Homo sapiens		EXP010122	356	unspecified	Q96GC6	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033766
EXP010646	sc-8984	Homo sapiens	DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder)	EXP010227	430	unspecified	P36956	HepG2 (hepatoblastoma)	PEAKS033767
EXP010647	sc-345	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P42224	K562 (myelogenous leukemia)	PEAKS033768
EXP010648	sc-17824	Homo sapiens		EXP010671	514	unspecified	P08047	K562 (myelogenous leukemia)	PEAKS033769
EXP010650	H00010782-A01	Homo sapiens		EXP010669	423	unspecified	Q96GC6	HeLa S3 (cervical adenocarcinoma)	PEAKS033770
EXP010653	NRSF	Homo sapiens		EXP010228	430	unspecified	Q13127	HepG2 (hepatoblastoma)	PEAKS033771
EXP010654	sc-349	Homo sapiens		EXP010062	356	unspecified	P15923	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033772
EXP010655	sc-349	Homo sapiens		EXP010060	356	unspecified	P15923	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033773
EXP010658	ab60931	Mus musculus		EXP010703	1144	unspecified	Q64705	CH12.LX (Mouse lymphoma)	PEAKS035502
EXP010659	sc-9008	Mus musculus		EXP010710	265	unspecified	O09100	G1E (embryonic stem cells)	PEAKS035503
EXP010660	NRSF	Homo sapiens		EXP010173	665	unspecified	Q13127	SK-N-SH (neuroblastoma)	PEAKS033774
EXP010661	2899	Homo sapiens		EXP010912	415	unspecified	P49711	HCM (cardiac myocytes)	PEAKS033775
EXP010663	2899	Homo sapiens		EXP010794	448	unspecified	P49711	retinal pigment epithelial cells	PEAKS033776
EXP010664	2899	Homo sapiens		EXP010601	343	unspecified	P49711	GM12801 (male B-cells)	PEAKS033777
EXP010666	sc-7202	Homo sapiens		EXP010122	356	unspecified	P01100	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033778
EXP010667	sc-101184	Homo sapiens		EXP010023	430	unspecified	Q15561	HepG2 (hepatoblastoma)	PEAKS033779
EXP010668	GATA-2	Homo sapiens		EXP010823	514	unspecified	P23769	K562 (myelogenous leukemia)	PEAKS033780
EXP010672	sc-23871	Homo sapiens		EXP010580	356	unspecified	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033781
EXP010674	sc-23871	Homo sapiens		EXP010581	356	unspecified	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033782
EXP010675	AF4185	Homo sapiens		EXP010745	356	unspecified	P50539	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036752
EXP010678	sc-30189	Homo sapiens		EXP010530	514	unspecified	Q9UKL0	K562 (myelogenous leukemia)	PEAKS036753
EXP010679	2899	Homo sapiens		EXP010808	438	unspecified	P49711	HL-60 (acute myeloid leukemia)	PEAKS033783
EXP010680	CTCF	Mus musculus		EXP010839	25	unspecified	Q61164	cerebellum	PEAKS035504
EXP010681	sc-66882	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P11474	HepG2 (hepatoblastoma)	PEAKS033784
EXP010682	sc-735	Homo sapiens		EXP010141	357	unspecified	P21675	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033785
EXP010683	sc-313	Homo sapiens		EXP010137	356	unspecified	Q02078	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033786
EXP010684	sc-150	Mus musculus		EXP010883	644	unspecified	P28033	myocytes	PEAKS035505
EXP010685	sc-30189	Homo sapiens		EXP010255	430	unspecified	Q9UKL0	HepG2 (hepatoblastoma)	PEAKS036754
EXP010687	200-401-194	Homo sapiens		EXP010530	514	unspecified	P48382	K562 (myelogenous leukemia)	PEAKS036755
EXP010688	AF4185	Mus musculus		EXP010644	1174	unspecified	P50540	MEL cell line	PEAKS035506
EXP010689	sc-233	Homo sapiens		EXP010581	356	unspecified	P09086	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033787
EXP010690	sc-269	Homo sapiens		EXP010876	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS036756
EXP010692	07-729	Homo sapiens		EXP010113	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033788
EXP010693	H00010782-M01	Homo sapiens		EXP010823	514	unspecified	Q96GC6	K562 (myelogenous leukemia)	PEAKS036757
EXP010694	sc-150	Homo sapiens		EXP010546	514	unspecified	P17676	K562 (myelogenous leukemia)	PEAKS033789
EXP010695	GATA-1	Homo sapiens		EXP010147	893	unspecified	P15976	erythroblasts	PEAKS036758
EXP010696	2899	Homo sapiens		EXP010904	405	unspecified	P49711	human astrocytes from spinal cord	PEAKS033790
EXP010698	sc-74	Homo sapiens		EXP010403	430	unspecified	P17535	HepG2 (hepatoblastoma)	PEAKS033791
EXP010699	MMS-101P	Homo sapiens		EXP010876	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	PEAKS033792
EXP010701	sc-101058	Homo sapiens		EXP010539	430	unspecified	P55317	HepG2 (hepatoblastoma)	PEAKS033793
EXP010705	sc-10756	Homo sapiens		EXP010725	423	unspecified	Q92922	HeLa S3 (cervical adenocarcinoma)	PEAKS033794
EXP010707	sc-12732	Mus musculus		EXP010816	644	unspecified	P12979	myocytes	PEAKS036759
EXP010708	2899	Homo sapiens		EXP010928	145	unspecified	P49711	Caco-2 (colon adenocarcinoma)	PEAKS033795
EXP010709	07-729	Mus musculus		EXP010882	1153	unspecified	Q61164	C2C12 (myoblasts)	PEAKS036760
EXP010711	sc-1694	Homo sapiens		EXP010714	376	unspecified	P05412	WA01 (H1, human embryonic stem cells)	PEAKS033796
EXP010713	sc-553	Homo sapiens		EXP010403	430	unspecified	P19793	HepG2 (hepatoblastoma)	PEAKS033797
EXP010715	AF4185	Homo sapiens		EXP010714	376	unspecified	P50539	WA01 (H1, human embryonic stem cells)	PEAKS036761
EXP010716	NRSF	Homo sapiens		EXP010051	665	unspecified	Q13127	SK-N-SH (neuroblastoma)	PEAKS033798
EXP010717	sc-631	Homo sapiens		EXP010137	356	unspecified	P32519	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033799
EXP010719	sc-345	Homo sapiens		EXP010122	356	unspecified	P42224	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033800
EXP010720	sc-22805	Homo sapiens		EXP010062	356	unspecified	P17947	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033801
EXP010721	sc-34508	Homo sapiens		EXP010228	430	unspecified	O95365	HepG2 (hepatoblastoma)	PEAKS033802
EXP010722	ab60931	Homo sapiens		EXP010530	514	unspecified	Q15853	K562 (myelogenous leukemia)	PEAKS033803
EXP010723	ab60931	Homo sapiens		EXP010725	423	unspecified	Q15853	HeLa S3 (cervical adenocarcinoma)	PEAKS033804
EXP010724	sc-497	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P10914	K562 (myelogenous leukemia)	PEAKS033805
EXP010728	NRSF	Homo sapiens		EXP010062	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033806
EXP010729	NRSF	Homo sapiens		EXP010558	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS033807
EXP010733	sc-891	Homo sapiens		EXP010581	356	unspecified	P40426	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033808
EXP010734	2899	Homo sapiens		EXP010924	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS033809
EXP010735	CTCF	Mus musculus		EXP010836	32	unspecified	Q61164	testis	PEAKS035507
EXP010736	sc-866	Homo sapiens		EXP010823	514	unspecified	Q16254	K562 (myelogenous leukemia)	PEAKS033810
EXP010738	sc-735	Homo sapiens		EXP010381	423	unspecified	P21675	HeLa S3 (cervical adenocarcinoma)	PEAKS033811
EXP010739	NRSF	Homo sapiens		EXP010507	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS033812
EXP054041	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2610	normal	P49711	HSMM dirived skeletal muscle myotubes	PEAKS050972
EXP010742	sc-17824	Homo sapiens		EXP010580	356	unspecified	P08047	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033814
EXP010743	sc-345	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P42224	K562 (myelogenous leukemia)	PEAKS033815
EXP054096	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: treated with 0.3 uM of all-trans retinoic acid for 6 hours; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054091	521	normal	Q3UKU1	KH2 (embryonic stem cells)	PEAKS051023
EXP010746	sc-110	Homo sapiens		EXP010671	514	unspecified	P18146	K562 (myelogenous leukemia)	PEAKS033816
EXP010748	sc-229	Mus musculus		EXP010883	644	unspecified	Q61069	myocytes	PEAKS035508
EXP010749	ab62126	Homo sapiens		EXP010255	430	unspecified	P20226	HepG2 (hepatoblastoma)	PEAKS033817
EXP010750	sc-183	Homo sapiens		EXP010671	514	unspecified	P15407	K562 (myelogenous leukemia)	PEAKS033818
EXP010751	sc-22823	Homo sapiens		EXP010027	423	unspecified	O75461	HeLa S3 (cervical adenocarcinoma)	PEAKS033819
EXP010752	GATA-2	Homo sapiens		EXP010619	664	unspecified	P23769	SH-SY5Y (neuroblastoma)	PEAKS033820
EXP010753	sc-12732	Mus musculus		EXP010662	644	unspecified	P12979	myocytes	PEAKS035509
EXP010754	sc-229	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	unspecified	P22415	A549 (lung carcinoma)	PEAKS033821
EXP010756	sc-764	Homo sapiens		EXP010328	514	unspecified	P01106	K562 (myelogenous leukemia)	PEAKS033822
EXP010757	sc-735	Homo sapiens		EXP010581	356	unspecified	P21675	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033823
EXP010759	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033824
EXP010760	ab62126	Mus musculus		EXP010703	1144	unspecified	P29037	CH12.LX (Mouse lymphoma)	PEAKS035510
EXP010761	NRSF	Homo sapiens		EXP010671	514	unspecified	Q13127	K562 (myelogenous leukemia)	PEAKS033825
EXP010762	sc-1974	Homo sapiens		EXP010375	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033826
EXP010763	10007663	Homo sapiens	For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	EXP010545	430	unspecified	Q12772	HepG2 (hepatoblastoma)	PEAKS033827
EXP010764	sc-764	Mus musculus		EXP010613	1144	unspecified	P01108	CH12.LX (Mouse lymphoma)	PEAKS035511
EXP010766	2899	Homo sapiens		EXP010901	335	unspecified	P49711	GM06990 (female B-cells)	PEAKS033828
EXP010768	2899	Homo sapiens		EXP010787	867	unspecified	P49711	WI-38 (lung fibroblasts)	PEAKS033829
EXP010770	sc-7202	Homo sapiens	12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	PEAKS036762
EXP010772	sc-188	Homo sapiens		EXP010137	356	unspecified	P18847	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033830
EXP010773	sc-150	Mus musculus		EXP010662	644	unspecified	P28033	myocytes	PEAKS035512
EXP010774	sc-197	Homo sapiens		EXP010769	38	unspecified	P61244	A549 (lung carcinoma)	PEAKS036763
EXP054098	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: starved by washing cells 2x in PBS; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054092	521	normal	O00472	KH2 (embryonic stem cells)	PEAKS051025
EXP054097	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: treated with 0.3 uM of all-trans retinoic acid for 6 hours; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054091	521	normal	Q9ESC8	KH2 (embryonic stem cells)	PEAKS051024
EXP054126	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: 500nM JQ1 treated for 24hr; Source: Freshly isolated human cells;	NULL	881	normal	O60885	CD4+ T-cells	PEAKS051044
EXP054127	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: untreated; Source: Freshly isolated human cells;	NULL	878	normal	O60885	embryonic stem cells	PEAKS051045
EXP054125	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: untreated; Source: Freshly isolated human cells;	NULL	881	normal	O60885	CD4+ T-cells	PEAKS051043
EXP056002	anti-CTCF (Millipore, 07-729)	Mus musculus	Developmental stage: Embryonic day 14.5;	EXP010880	2736	normal	Q61164	whole brain	PEAKS052297
EXP054058	Control	Homo sapiens	Treatment: None;	NULL	164	normal	A0AVK6	CD20+ B-cells	PEAKS050989
EXP054095	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054090	521	normal	Q9ESC8	KH2 (embryonic stem cells)	PEAKS051022
EXP010933	2899	Homo sapiens		NULL	346	unspecified	P49711	GM12866 (male B-cells)	PEAKS033831
EXP010934	sc-101184	Homo sapiens		EXP010796	113	unspecified	Q15561	MCF7 (Invasive ductal breast carcinoma)	PEAKS033832
EXP010935	sc-1694	Homo sapiens		EXP010530	514	unspecified	P05412	K562 (myelogenous leukemia)	PEAKS036764
EXP010936	sc-110	Homo sapiens		EXP010799	113	unspecified	P18146	MCF7 (Invasive ductal breast carcinoma)	PEAKS033833
EXP010938	200-401-194	Homo sapiens		EXP010066	489	unspecified	P48382	IMR90 (lung fibroblasts)	PEAKS036765
EXP010939	sc-17834	Homo sapiens		EXP010843	356	unspecified	O95644	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033835
EXP010941	sc-268	Homo sapiens		EXP010832	665	unspecified	P23771	SK-N-SH (neuroblastoma)	PEAKS033837
EXP010942	sc-12984	Mus musculus		EXP010006	912	unspecified	P22091	megakaryocytes	PEAKS035513
EXP010945	sc-604	Homo sapiens		EXP010895	113	unspecified	P15408	MCF7 (Invasive ductal breast carcinoma)	PEAKS033840
EXP010946	2899	Homo sapiens		NULL	348	unspecified	P49711	GM12868 (female B-cells)	PEAKS033841
EXP010947	sc-229	Mus musculus		EXP010828	1153	unspecified	Q61069	C2C12 (myoblasts)	PEAKS035514
EXP010948	07-729	Homo sapiens		EXP010813	910	unspecified	P49711	lung	PEAKS033842
EXP010949	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010841	364	unspecified	Q04206	GM18951 (B-cells Lymphoblastoid Cell Lines)	PEAKS033843
EXP010950	sc-356	Mus musculus		EXP010006	912	unspecified	P26323	megakaryocytes	PEAKS035515
EXP010951	sc-271940	Homo sapiens		EXP010895	113	unspecified	P24468	MCF7 (Invasive ductal breast carcinoma)	PEAKS033844
EXP054031	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054026	430	normal	P49711	HepG2 (hepatoblastoma)	PEAKS050962
EXP054072	NCoR (Bethyl Laboratories, A301-145A)	Homo sapiens	Treatment: None;	NULL	514	normal	O75376	K562 (myelogenous leukemia)	PEAKS051003
EXP010954	sc-240	Homo sapiens		EXP010864	430	unspecified	P16220	HepG2 (hepatoblastoma)	PEAKS033847
EXP054083	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: 1 h with 0.02% Ethanol;	NULL	38	normal	P49711	A549 (lung carcinoma)	PEAKS051014
EXP010956	MafK_(ab50322)	Mus musculus	None	EXP010793	230	unspecified	Q61827	ES-E14 (E14, embryonic stem cells)	PEAKS036766
EXP010957	NB100-1800	Mus musculus		EXP010644	1174	unspecified	O35185	MEL cell line	PEAKS036767
EXP010958	sc-281	Homo sapiens		EXP010671	514	unspecified	P25490	K562 (myelogenous leukemia)	PEAKS033849
EXP010959	sc-240	Homo sapiens		EXP010822	514	unspecified	P16220	K562 (myelogenous leukemia)	PEAKS033850
EXP010960	sc-636	Homo sapiens		EXP010822	514	unspecified	P49716	K562 (myelogenous leukemia)	PEAKS033851
EXP010961	sc-281	Homo sapiens		EXP010874	665	unspecified	P25490	SK-N-SH (neuroblastoma)	PEAKS033852
EXP010962	sc-150	Mus musculus		EXP010828	1153	unspecified	P28033	C2C12 (myoblasts)	PEAKS035516
EXP010963	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033853
EXP010964	200-401-194	Homo sapiens		EXP010911	665	unspecified	P48382	SK-N-SH (neuroblastoma)	PEAKS036768
EXP010965	07-729	Homo sapiens		EXP010914	909	unspecified	P49711	kidney	PEAKS033854
EXP054053	PLU1 (YangShi lab)	Homo sapiens	Treatment: None;	NULL	376	normal	Q9UGL1	WA01 (H1, human embryonic stem cells)	PEAKS050984
EXP054063	REST (Millipore, 17-641 )	Homo sapiens	Treatment: None;	NULL	514	normal	Q13127	K562 (myelogenous leukemia)	PEAKS050994
EXP010968	sc-28312	Homo sapiens		EXP010832	665	unspecified	Q06546	SK-N-SH (neuroblastoma)	PEAKS033857
EXP010969	sc-101184	Homo sapiens		EXP010899	417	unspecified	Q15561	HCT-116 (colon carcinoma)	PEAKS033858
EXP010970	sc-101184	Homo sapiens		EXP010900	417	unspecified	Q15561	HCT-116 (colon carcinoma)	PEAKS033859
EXP010971	07-729	Homo sapiens		EXP010810	360	unspecified	P49711	GM13977 (female B-cells)	PEAKS033860
EXP010972	sc-229	Homo sapiens		EXP010871	665	unspecified	P22415	SK-N-SH (neuroblastoma)	PEAKS033861
EXP010973	NRSF	Homo sapiens		EXP010856	504	unspecified	Q13127	Ishikawa (endometrial adenocarcinoma)	PEAKS033862
EXP010974	sc-265	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010807	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035517
EXP010975	sc-150	Homo sapiens		EXP010856	504	unspecified	P17676	Ishikawa (endometrial adenocarcinoma)	PEAKS033863
EXP010977	ab50322	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010931	1174	unspecified	Q61827	MEL cell line	PEAKS036769
EXP010978	sc-13125	Mus musculus		EXP010265	1174	unspecified	P25976	MEL cell line	PEAKS036770
EXP010979	sc-28312	Homo sapiens		EXP010799	113	unspecified	Q06546	MCF7 (Invasive ductal breast carcinoma)	PEAKS033865
EXP010980	sc-22823	Homo sapiens		EXP010860	376	unspecified	O75461	WA01 (H1, human embryonic stem cells)	PEAKS033866
EXP010983	sc-313	Homo sapiens		EXP010872	665	unspecified	Q02078	SK-N-SH (neuroblastoma)	PEAKS033869
EXP010984	sc-265	Mus musculus		EXP010006	912	unspecified	P17679	megakaryocytes	PEAKS035518
EXP010985	sc-764	Homo sapiens		EXP010852	430	unspecified	P01106	HepG2 (hepatoblastoma)	PEAKS033870
EXP010986	sc-240	Homo sapiens		EXP010860	376	unspecified	P16220	WA01 (H1, human embryonic stem cells)	PEAKS033871
EXP010987	2899	Homo sapiens		NULL	350	unspecified	P49711	GM12870 (male B-cells)	PEAKS033872
EXP010988	HPA004051	Mus musculus		EXP010613	1144	unspecified	E9Q1A5	CH12.LX (Mouse lymphoma)	PEAKS036771
EXP010989	sc-74	Homo sapiens		EXP010900	417	unspecified	P17535	HCT-116 (colon carcinoma)	PEAKS033873
EXP010990	CTCF	Mus musculus		EXP010880	143	unspecified	Q61164	brain	PEAKS035519
EXP010991	sc-74	Homo sapiens		EXP010899	417	unspecified	P17535	HCT-116 (colon carcinoma)	PEAKS033874
EXP010992	sc-101184	Homo sapiens		EXP010868	38	unspecified	Q15561	A549 (lung carcinoma)	PEAKS033875
EXP010993	NRSF	Homo sapiens		EXP010870	1180	unspecified	Q13127	neural cell	PEAKS033876
EXP010994	sc-197	Homo sapiens		EXP010832	665	unspecified	P61244	SK-N-SH (neuroblastoma)	PEAKS033877
EXP010995	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010927	365	unspecified	Q04206	GM19099 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033878
EXP010996	07-729	Homo sapiens		EXP010873	337	unspecified	P49711	GM10248 (male B-cells)	PEAKS033879
EXP010997	sc-81188	Homo sapiens		EXP010843	356	unspecified	P15336	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033880
EXP010999	sc-17824	Homo sapiens		EXP010899	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS033882
EXP011000	sc-17824	Homo sapiens		EXP010900	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS033883
EXP011001	sc-357	Homo sapiens		EXP010874	665	unspecified	Q99081	SK-N-SH (neuroblastoma)	PEAKS033884
EXP011002	H00010782-M01	Homo sapiens		EXP010587	376	unspecified	Q96GC6	WA01 (H1, human embryonic stem cells)	PEAKS036772
EXP011004	sc-101184	Homo sapiens		EXP010797	113	unspecified	Q15561	MCF7 (Invasive ductal breast carcinoma)	PEAKS033886
EXP011005	sc-266	Homo sapiens		EXP010630	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS036773
EXP011006	2899	Homo sapiens		EXP010926	955	unspecified	P49711	primary foreskin fibroblasts	PEAKS033887
EXP011007	sc-30189	Mus musculus		EXP010613	1144	unspecified	Q8CFE3	CH12.LX (Mouse lymphoma)	PEAKS036774
EXP011008	sc-631	Homo sapiens		EXP010895	113	unspecified	P32519	MCF7 (Invasive ductal breast carcinoma)	PEAKS033888
EXP011009	sc-66882	Homo sapiens		EXP010834	356	unspecified	P11474	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036775
EXP011010	07-729	Homo sapiens		EXP010852	430	unspecified	P49711	HepG2 (hepatoblastoma)	PEAKS033889
EXP011011	GATA-1	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010931	1174	unspecified	P17679	MEL cell line	PEAKS036776
EXP011012	sc-22810	Mus musculus		EXP010644	1174	unspecified	Q00422	MEL cell line	PEAKS036777
EXP011013	sc-265	Mus musculus	14 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010897	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035520
EXP011014	sc-74	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	P17535	A549 (lung carcinoma)	PEAKS033890
EXP011015	sc-553	Homo sapiens		EXP010872	665	unspecified	P19793	SK-N-SH (neuroblastoma)	PEAKS033891
EXP011016	sc-631	Homo sapiens		EXP010832	665	unspecified	P32519	SK-N-SH (neuroblastoma)	PEAKS033892
EXP011017	HPA004051	Mus musculus		EXP010793	230	unspecified	E9Q1A5	ES-E14 (E14, embryonic stem cells)	PEAKS036778
EXP011018	sc-271940	Homo sapiens		EXP010799	113	unspecified	P24468	MCF7 (Invasive ductal breast carcinoma)	PEAKS033893
EXP011019	NRSF	Homo sapiens		EXP010895	113	unspecified	Q13127	MCF7 (Invasive ductal breast carcinoma)	PEAKS033894
EXP011020	sc-150	Homo sapiens		EXP010782	38	unspecified	P17676	A549 (lung carcinoma)	PEAKS033895
EXP011021	sc-13125	Mus musculus		EXP010613	1144	unspecified	P25976	CH12.LX (Mouse lymphoma)	PEAKS036779
EXP011022	07-729	Homo sapiens		EXP010848	38	unspecified	P49711	A549 (lung carcinoma)	PEAKS033896
EXP011023	sc-81335	Homo sapiens		EXP010832	665	unspecified	P08651	SK-N-SH (neuroblastoma)	PEAKS033897
EXP011024	07-729	Homo sapiens		EXP010915	1177	unspecified	P49711	LNCaP clone FGC	PEAKS033898
EXP011025	sc-74	Homo sapiens		EXP010832	665	unspecified	P17535	SK-N-SH (neuroblastoma)	PEAKS033899
EXP011026	sc-197	Mus musculus		EXP010828	1153	unspecified	P28574	C2C12 (myoblasts)	PEAKS035521
EXP011027	sc-636	Homo sapiens		EXP010861	514	unspecified	P49716	K562 (myelogenous leukemia)	PEAKS033900
EXP011028	AF4185	Homo sapiens		EXP010673	430	unspecified	P50539	HepG2 (hepatoblastoma)	PEAKS036780
EXP011029	sc-150	Homo sapiens		EXP010868	38	unspecified	P17676	A549 (lung carcinoma)	PEAKS033901
EXP011030	sc-265	Mus musculus	30 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010887	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035522
EXP011031	sc-6554	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	Q9Y261	A549 (lung carcinoma)	PEAKS033902
EXP011032	HPA006672	Mus musculus		EXP010613	1144	unspecified	Q8BGS3	CH12.LX (Mouse lymphoma)	PEAKS036781
EXP011033	sc-335	Homo sapiens		EXP010900	417	unspecified	P11831	HCT-116 (colon carcinoma)	PEAKS033903
EXP011034	sc-335	Homo sapiens		EXP010899	417	unspecified	P11831	HCT-116 (colon carcinoma)	PEAKS033904
EXP011037	sc-5916	Homo sapiens		EXP010899	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS033907
EXP011038	sc-5916	Homo sapiens		EXP010900	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS033908
EXP011039	sc-764	Homo sapiens		EXP010866	356	unspecified	P01106	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033909
EXP011040	sc-604	Homo sapiens		EXP010872	665	unspecified	P15408	SK-N-SH (neuroblastoma)	PEAKS033910
EXP054035	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS050966
EXP011042	sc-357	Homo sapiens		EXP010824	504	unspecified	Q99081	Ishikawa (endometrial adenocarcinoma)	PEAKS033912
EXP011043	sc-268	Homo sapiens		EXP010895	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS033913
EXP011044	sc-150	Homo sapiens		EXP010899	417	unspecified	P17676	HCT-116 (colon carcinoma)	PEAKS033914
EXP011045	07-729	Homo sapiens		EXP010878	370	unspecified	P49711	GM20000 (B-cells)	PEAKS033915
EXP011046	sc-150	Homo sapiens		EXP010900	417	unspecified	P17676	HCT-116 (colon carcinoma)	PEAKS033916
EXP011047	sc-81325	Homo sapiens		EXP010843	356	unspecified	Q9BTC8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033917
EXP011048	sc-502	Homo sapiens		EXP010832	665	unspecified	Q08050	SK-N-SH (neuroblastoma)	PEAKS033918
EXP011049	sc-764	Homo sapiens		EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	PEAKS033919
EXP011050	sc-101184	Homo sapiens		EXP010782	38	unspecified	Q15561	A549 (lung carcinoma)	PEAKS033920
EXP011051	07-729	Homo sapiens		NULL	368	unspecified	P49711	GM19239 (male B-cells lymphoblastoid cell line)	PEAKS033921
EXP011053	CTCF	Mus musculus		EXP010820	799	unspecified	Q61164	small intestine	PEAKS035523
EXP011054	sc-268	Homo sapiens		EXP010782	38	unspecified	P23771	A549 (lung carcinoma)	PEAKS033922
EXP011055	sc-281	Homo sapiens		EXP010856	504	unspecified	P25490	Ishikawa (endometrial adenocarcinoma)	PEAKS033923
EXP011056	sc-240	Homo sapiens		EXP010918	356	unspecified	P16220	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033924
EXP011057	sc-764	Homo sapiens		NULL	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	PEAKS033925
EXP011058	sc-74	Homo sapiens		EXP010834	356	unspecified	P17535	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036783
EXP011059	sc-150	Homo sapiens		EXP010824	504	unspecified	P17676	Ishikawa (endometrial adenocarcinoma)	PEAKS033926
EXP011061	CTCF	Mus musculus		EXP010858	917	unspecified	Q61164	spleen	PEAKS035524
EXP011064	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010837	362	unspecified	Q04206	GM18505 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033930
EXP011065	sc-553	Homo sapiens		EXP010832	665	unspecified	P19793	SK-N-SH (neuroblastoma)	PEAKS033931
EXP011066	sc-22810	Mus musculus		EXP010613	1144	unspecified	Q00422	CH12.LX (Mouse lymphoma)	PEAKS036784
EXP011067	sc-313	Homo sapiens		EXP010832	665	unspecified	Q02078	SK-N-SH (neuroblastoma)	PEAKS033932
EXP011069	sc-265	Mus musculus	7 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010849	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035525
EXP011070	sc-604	Homo sapiens		EXP010799	113	unspecified	P15408	MCF7 (Invasive ductal breast carcinoma)	PEAKS033934
EXP011072	sc-15914	Homo sapiens		EXP010769	38	unspecified	P49711	A549 (lung carcinoma)	PEAKS036785
EXP011073	sc-6554	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	Q9Y261	A549 (lung carcinoma)	PEAKS033936
EXP011074	sc-74	Homo sapiens		EXP010895	113	unspecified	P17535	MCF7 (Invasive ductal breast carcinoma)	PEAKS033937
EXP011075	sc-110	Homo sapiens		EXP010856	504	unspecified	P18146	Ishikawa (endometrial adenocarcinoma)	PEAKS033938
EXP011077	sc-268	Homo sapiens		EXP010874	665	unspecified	P23771	SK-N-SH (neuroblastoma)	PEAKS033940
EXP011078	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010850	357	unspecified	Q04206	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS033941
EXP011079	sc-271940	Homo sapiens		EXP010780	430	unspecified	P24468	HepG2 (hepatoblastoma)	PEAKS033942
EXP011080	sc-101184	Homo sapiens		EXP010872	665	unspecified	Q15561	SK-N-SH (neuroblastoma)	PEAKS033943
EXP011081	sc-502	Homo sapiens		EXP010843	356	unspecified	Q08050	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033944
EXP011082	NRSF	Homo sapiens		EXP010824	504	unspecified	Q13127	Ishikawa (endometrial adenocarcinoma)	PEAKS033945
EXP011083	sc-335	Homo sapiens		EXP010856	504	unspecified	P11831	Ishikawa (endometrial adenocarcinoma)	PEAKS033946
EXP011084	sc-268	Homo sapiens		EXP010917	38	unspecified	P23771	A549 (lung carcinoma)	PEAKS033947
EXP011085	CTCF	Mus musculus		EXP010869	547	unspecified	Q61164	limb	PEAKS035526
EXP011087	ab85725	Mus musculus		EXP010644	1174	unspecified	P56671	MEL cell line	PEAKS036786
EXP011088	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010777	358	unspecified	Q04206	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS033949
EXP054064	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2612	normal	P49711	RO01746 (CD14+ monocytes)	PEAKS050995
EXP054084	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: 1 h with 100 nM Dexamethasone;	NULL	38	normal	P49711	A549 (lung carcinoma)	PEAKS051015
EXP011092	ab55744	Homo sapiens		EXP010911	665	unspecified	Q16656	SK-N-SH (neuroblastoma)	PEAKS036787
EXP011093	sc-30189	Mus musculus		EXP010644	1174	unspecified	Q8CFE3	MEL cell line	PEAKS036788
EXP011094	sc-502	Homo sapiens		EXP010856	504	unspecified	Q08050	Ishikawa (endometrial adenocarcinoma)	PEAKS033953
EXP011095	07-729	Homo sapiens		NULL	215	unspecified	P49711	keratinocytes	PEAKS033954
EXP011096	sc-5916	Homo sapiens		EXP010796	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS033955
EXP011097	sc-25388	Homo sapiens		EXP010780	430	unspecified	P37275	HepG2 (hepatoblastoma)	PEAKS033956
EXP011098	sc-605	Mus musculus		EXP010828	1153	unspecified	P48755	C2C12 (myoblasts)	PEAKS035527
EXP011099	sc-240	Homo sapiens		EXP010780	430	unspecified	P16220	HepG2 (hepatoblastoma)	PEAKS033957
EXP011100	sc-631	Homo sapiens		EXP010874	665	unspecified	P32519	SK-N-SH (neuroblastoma)	PEAKS033958
EXP011101	sc-197	Homo sapiens		EXP010895	113	unspecified	P61244	MCF7 (Invasive ductal breast carcinoma)	PEAKS033959
EXP011102	sc-240	Homo sapiens		EXP010824	504	unspecified	P16220	Ishikawa (endometrial adenocarcinoma)	PEAKS033960
EXP011103	sc-764	Homo sapiens		EXP010769	38	unspecified	P01106	A549 (lung carcinoma)	PEAKS036789
EXP011104	sc-891	Homo sapiens		EXP010832	665	unspecified	P40426	SK-N-SH (neuroblastoma)	PEAKS033961
EXP011107	sc-735	Homo sapiens		EXP010856	504	unspecified	P21675	Ishikawa (endometrial adenocarcinoma)	PEAKS033964
EXP054046	JARID1A (abcam, ab26049)	Homo sapiens	Treatment: None;	NULL	376	normal	P29375	WA01 (H1, human embryonic stem cells)	PEAKS050977
EXP011109	sc-197	Homo sapiens		EXP010872	665	unspecified	P61244	SK-N-SH (neuroblastoma)	PEAKS033966
EXP011110	sc-502	Homo sapiens		EXP010799	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS033967
EXP011111	sc-764	Homo sapiens		EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	PEAKS033968
EXP011112	sc-350	Mus musculus		EXP010613	1144	unspecified	P27577	CH12.LX (Mouse lymphoma)	PEAKS036790
EXP011113	sc-15914	Homo sapiens		EXP010911	665	unspecified	P49711	SK-N-SH (neuroblastoma)	PEAKS036791
EXP011114	ab85725	Mus musculus		EXP010613	1144	unspecified	P56671	CH12.LX (Mouse lymphoma)	PEAKS036792
EXP011115	sc-891	Homo sapiens		EXP010872	665	unspecified	P40426	SK-N-SH (neuroblastoma)	PEAKS033969
EXP011116	07-729	Homo sapiens		NULL	358	unspecified	P49711	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS033970
EXP011117	sc-357	Homo sapiens		EXP010856	504	unspecified	Q99081	Ishikawa (endometrial adenocarcinoma)	PEAKS033971
EXP011118	sc-74	Homo sapiens		EXP010874	665	unspecified	P17535	SK-N-SH (neuroblastoma)	PEAKS033972
EXP011119	HPA004051	Homo sapiens		EXP010530	514	unspecified	Q8TF68	K562 (myelogenous leukemia)	PEAKS036793
EXP011120	sc-22805	Homo sapiens		EXP010892	438	unspecified	P17947	HL-60 (acute myeloid leukemia)	PEAKS033973
EXP011121	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010806	363	unspecified	Q04206	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	PEAKS033974
EXP011122	sc-25388	Homo sapiens		EXP010864	430	unspecified	P37275	HepG2 (hepatoblastoma)	PEAKS033975
EXP011124	HPA004051	Homo sapiens		EXP010745	356	unspecified	Q8TF68	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036794
EXP011125	07-729	Homo sapiens		EXP010886	338	unspecified	P49711	GM10266 (male B-cells)	PEAKS033977
EXP011126	sc-197	Homo sapiens		EXP010856	504	unspecified	P61244	Ishikawa (endometrial adenocarcinoma)	PEAKS033978
EXP011127	07-729	Homo sapiens		EXP010846	633	unspecified	P49711	spleen	PEAKS033979
EXP011128	sc-74	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	P17535	A549 (lung carcinoma)	PEAKS033980
EXP011129	sc-101184	Homo sapiens		EXP010513	376	unspecified	Q15561	WA01 (H1, human embryonic stem cells)	PEAKS033981
EXP011130	sc-101184	Homo sapiens		EXP010832	665	unspecified	Q15561	SK-N-SH (neuroblastoma)	PEAKS033982
EXP011131	sc-28312	Homo sapiens		EXP010895	113	unspecified	Q06546	MCF7 (Invasive ductal breast carcinoma)	PEAKS033983
EXP011132	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010855	361	unspecified	Q04206	GM15510 (B-cells)	PEAKS033984
EXP011133	sc-197	Homo sapiens		EXP010780	430	unspecified	P61244	HepG2 (hepatoblastoma)	PEAKS033985
EXP011134	sc-81335	Homo sapiens		EXP010843	356	unspecified	P08651	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033986
EXP011135	sc-265	Mus musculus	3 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010879	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035528
EXP011136	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010825	366	unspecified	Q04206	GM19193 (female B-cells Lymphoblastoid Cell Lines)	PEAKS033987
EXP011137	sc-735	Homo sapiens		EXP010870	1180	unspecified	P21675	neural cell	PEAKS033988
EXP011138	sc-891	Homo sapiens		EXP010782	38	unspecified	P40426	A549 (lung carcinoma)	PEAKS033989
EXP011139	sc-81335	Homo sapiens		EXP010874	665	unspecified	P08651	SK-N-SH (neuroblastoma)	PEAKS033990
EXP011140	10007663	Homo sapiens		EXP010834	356	unspecified	Q12772	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036795
EXP011141	07-729	Homo sapiens	12 hrs with 1 nM Methyltrienolone (R1881) (Crawford)	EXP010915	1177	unspecified	P49711	LNCaP clone FGC	PEAKS033991
EXP011142	sc-229	Homo sapiens		EXP010856	504	unspecified	P22415	Ishikawa (endometrial adenocarcinoma)	PEAKS033992
EXP011143	sc-150	Homo sapiens		EXP010843	356	unspecified	P17676	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS033993
EXP011144	AF4185	Homo sapiens		EXP010066	489	unspecified	P50539	IMR90 (lung fibroblasts)	PEAKS036796
EXP011145	sc-197	Homo sapiens		EXP010860	376	unspecified	P61244	WA01 (H1, human embryonic stem cells)	PEAKS033994
EXP011146	sc-183	Homo sapiens		EXP010900	417	unspecified	P15407	HCT-116 (colon carcinoma)	PEAKS033995
EXP011147	sc-183	Homo sapiens		EXP010899	417	unspecified	P15407	HCT-116 (colon carcinoma)	PEAKS033996
EXP011148	sc-197	Homo sapiens		EXP010899	417	unspecified	P61244	HCT-116 (colon carcinoma)	PEAKS033997
EXP011149	sc-197	Homo sapiens		EXP010900	417	unspecified	P61244	HCT-116 (colon carcinoma)	PEAKS033998
EXP011150	sc-502	Homo sapiens		EXP010824	504	unspecified	Q08050	Ishikawa (endometrial adenocarcinoma)	PEAKS033999
EXP011151	sc-110	Homo sapiens		EXP010899	417	unspecified	P18146	HCT-116 (colon carcinoma)	PEAKS034000
EXP011152	sc-110	Homo sapiens		EXP010900	417	unspecified	P18146	HCT-116 (colon carcinoma)	PEAKS034001
EXP054061	NSD2 (abcam, ab75359)	Homo sapiens	Treatment: None;	NULL	514	normal	O96028	K562 (myelogenous leukemia)	PEAKS050992
EXP011154	sc-74442	Homo sapiens		EXP010843	356	unspecified	P42229	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS034003
EXP011155	sc-22805	Homo sapiens		EXP010905	438	unspecified	P17947	HL-60 (acute myeloid leukemia)	PEAKS034004
EXP011156	sc-8984	Homo sapiens		EXP010834	356	unspecified	P36956	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036797
EXP011157	NRSF	Homo sapiens		EXP010791	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS034005
EXP011158	sc-188	Homo sapiens		EXP010899	417	unspecified	P18847	HCT-116 (colon carcinoma)	PEAKS034006
EXP011159	sc-229	Homo sapiens		EXP010900	417	unspecified	P22415	HCT-116 (colon carcinoma)	PEAKS034007
EXP011160	sc-229	Homo sapiens		EXP010899	417	unspecified	P22415	HCT-116 (colon carcinoma)	PEAKS034008
EXP011162	sc-188	Homo sapiens		EXP010900	417	unspecified	P18847	HCT-116 (colon carcinoma)	PEAKS034010
EXP011163	2899	Homo sapiens		NULL	347	unspecified	P49711	GM12867 (female B-cells)	PEAKS034011
EXP011164	sc-350	Mus musculus		EXP010644	1174	unspecified	P27577	MEL cell line	PEAKS036798
EXP011165	sc-101184	Homo sapiens		EXP010856	504	unspecified	Q15561	Ishikawa (endometrial adenocarcinoma)	PEAKS034012
EXP011166	sc-28312	Homo sapiens		EXP010874	665	unspecified	Q06546	SK-N-SH (neuroblastoma)	PEAKS034013
EXP011167	sc-81335	Homo sapiens		EXP010824	504	unspecified	P08651	Ishikawa (endometrial adenocarcinoma)	PEAKS034014
EXP051006	2899	Homo sapiens		EXP039117	446	unspecified	P49711	HPF (pulmonary fibroblasts isolated from lung tissue)	PEAKS049006
EXP011169	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS034016
EXP011170	NRSF	Homo sapiens		EXP010899	417	unspecified	Q13127	HCT-116 (colon carcinoma)	PEAKS034017
EXP011171	NRSF	Homo sapiens		EXP010900	417	unspecified	Q13127	HCT-116 (colon carcinoma)	PEAKS034018
EXP011172	ab85725	Homo sapiens		EXP010066	489	unspecified	P56270	IMR90 (lung fibroblasts)	PEAKS036799
EXP011173	07-729	Homo sapiens		EXP010866	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS034019
EXP011174	2899	Homo sapiens		NULL	349	unspecified	P49711	GM12869 (female B-cells)	PEAKS034020
EXP011175	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010803	356	unspecified	Q04206	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS034021
EXP011176	sc-197	Homo sapiens		EXP010782	38	unspecified	P61244	A549 (lung carcinoma)	PEAKS034022
EXP011177	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010821	339	unspecified	Q04206	GM10847 (female B-cells Lymphoblastoid Cell Lines)	PEAKS034023
EXP011178	sc-502	Homo sapiens		EXP010874	665	unspecified	Q08050	SK-N-SH (neuroblastoma)	PEAKS034024
EXP011179	sc-271940	Homo sapiens		EXP010864	430	unspecified	P24468	HepG2 (hepatoblastoma)	PEAKS034025
EXP011180	ab60931	Mus musculus		EXP010644	1174	unspecified	Q64705	MEL cell line	PEAKS036800
EXP011181	1277-1	Homo sapiens		EXP010530	514	unspecified	P19419	K562 (myelogenous leukemia)	PEAKS036801
EXP011182	AF4185	Homo sapiens		EXP010911	665	unspecified	P50539	SK-N-SH (neuroblastoma)	PEAKS036802
EXP011183	sc-604	Homo sapiens		EXP010832	665	unspecified	P15408	SK-N-SH (neuroblastoma)	PEAKS034026
EXP011184	sc-34508	Homo sapiens		EXP010856	504	unspecified	O95365	Ishikawa (endometrial adenocarcinoma)	PEAKS034027
EXP011185	sc-197	Homo sapiens		EXP010799	113	unspecified	P61244	MCF7 (Invasive ductal breast carcinoma)	PEAKS034028
EXP011186	07-729	Homo sapiens		NULL	367	unspecified	P49711	GM19238 (female B-cells lymphoblastoid cell lines)	PEAKS034029
EXP011187	sc-101553	Homo sapiens		EXP010843	356	unspecified	Q13761	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS034030
EXP011188	sc-5916	Homo sapiens		EXP010895	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS034031
EXP011189	2899	Homo sapiens		NULL	351	unspecified	P49711	GM12871 (male B-cells)	PEAKS034032
EXP011190	HPA006672	Mus musculus		EXP010644	1174	unspecified	Q8BGS3	MEL cell line	PEAKS036803
EXP011191	sc-265	Mus musculus		EXP010840	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035529
EXP011192	sc-74	Homo sapiens		EXP010911	665	unspecified	P17535	SK-N-SH (neuroblastoma)	PEAKS036804
EXP011193	07-729	Homo sapiens		NULL	369	unspecified	P49711	GM19240 (B cells Lymphoblastoid Cell Lines)	PEAKS034033
EXP011194	sc-23871	Homo sapiens		EXP010832	665	unspecified	Q86T24	SK-N-SH (neuroblastoma)	PEAKS034034
EXP011195	sc-240	Homo sapiens		EXP010856	504	unspecified	P16220	Ishikawa (endometrial adenocarcinoma)	PEAKS034035
EXP054057	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2611	normal	P49711	CD20+	PEAKS050988
EXP011197	NRSF	Homo sapiens		EXP010905	438	unspecified	Q13127	HL-60 (acute myeloid leukemia)	PEAKS034037
EXP011198	07-729	Homo sapiens		EXP010932	920	unspecified	P49711	pancreas	PEAKS034038
EXP011199	07-729	Homo sapiens		EXP010890	1159	unspecified	P49711	medulloblastoma	PEAKS034039
EXP011200	sc-81335	Homo sapiens		EXP010856	504	unspecified	P08651	Ishikawa (endometrial adenocarcinoma)	PEAKS034040
EXP011201	07-729	Homo sapiens		NULL	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	PEAKS034041
EXP011202	sc-335	Homo sapiens		EXP010797	113	unspecified	P11831	MCF7 (Invasive ductal breast carcinoma)	PEAKS034042
EXP011203	sc-335	Homo sapiens		EXP010796	113	unspecified	P11831	MCF7 (Invasive ductal breast carcinoma)	PEAKS034043
EXP011204	sc-28312	Homo sapiens		EXP010905	438	unspecified	Q06546	HL-60 (acute myeloid leukemia)	PEAKS034044
EXP011205	sc-197	Homo sapiens		EXP010824	504	unspecified	P61244	Ishikawa (endometrial adenocarcinoma)	PEAKS034045
EXP011207	sc-22823	Homo sapiens		EXP010782	38	unspecified	O75461	A549 (lung carcinoma)	PEAKS034047
EXP011208	sc-15914	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010931	1174	unspecified	Q61164	MEL cell line	PEAKS036805
EXP011209	sc-735	Homo sapiens		EXP010919	1180	unspecified	P21675	neural cell	PEAKS034048
EXP011210	NRSF	Homo sapiens		EXP010919	1180	unspecified	Q13127	neural cell	PEAKS034049
EXP011211	sc-502	Homo sapiens		EXP010895	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS034050
EXP011212	sc-240	Homo sapiens		EXP010844	356	unspecified	P16220	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS034051
EXP011213	CTCF	Mus musculus		EXP010789	117	unspecified	Q61164	Bruce4 (embryonic stem cells)	PEAKS036806
EXP011214	07-729	Homo sapiens		EXP010884	359	unspecified	P49711	GM13976 (female B-cells)	PEAKS034052
EXP011215	sc-197	Homo sapiens		EXP010864	430	unspecified	P61244	HepG2 (hepatoblastoma)	PEAKS034053
EXP011216	sc-735	Homo sapiens		EXP010796	113	unspecified	P21675	MCF7 (Invasive ductal breast carcinoma)	PEAKS034054
EXP011217	sc-735	Homo sapiens		EXP010797	113	unspecified	P21675	MCF7 (Invasive ductal breast carcinoma)	PEAKS034055
EXP011218	sc-110	Homo sapiens		EXP010895	113	unspecified	P18146	MCF7 (Invasive ductal breast carcinoma)	PEAKS034056
EXP011219	sc-357	Homo sapiens		EXP010832	665	unspecified	Q99081	SK-N-SH (neuroblastoma)	PEAKS034057
EXP011220	sc-30189	Homo sapiens		EXP010066	489	unspecified	Q9UKL0	IMR90 (lung fibroblasts)	PEAKS036807
EXP011221	sc-357	Homo sapiens		EXP010797	113	unspecified	Q99081	MCF7 (Invasive ductal breast carcinoma)	PEAKS034058
EXP011222	sc-281	Homo sapiens		EXP010832	665	unspecified	P25490	SK-N-SH (neuroblastoma)	PEAKS034059
EXP011223	sc-150	Homo sapiens		EXP010895	113	unspecified	P17676	MCF7 (Invasive ductal breast carcinoma)	PEAKS034060
EXP011224	sc-229	Homo sapiens		EXP010832	665	unspecified	P22415	SK-N-SH (neuroblastoma)	PEAKS034061
EXP054038	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	356	normal	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050969
EXP011226	sc-357	Homo sapiens		EXP010796	113	unspecified	Q99081	MCF7 (Invasive ductal breast carcinoma)	PEAKS034063
EXP011227	sc-6327	Homo sapiens		EXP010745	356	unspecified	P39880	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036808
EXP011228	sc-6327	Homo sapiens		EXP010530	514	unspecified	P39880	K562 (myelogenous leukemia)	PEAKS036809
EXP011230	sc-74	Homo sapiens		EXP010857	111	unspecified	P17535	T47D (invasive ductal carcinoma)	PEAKS034065
EXP011231	07-729	Homo sapiens		NULL	357	unspecified	P49711	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS034066
EXP011232	ab50322	Homo sapiens		EXP010745	356	unspecified	O60675	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS036810
EXP011233	sc-631	Homo sapiens		EXP010899	417	unspecified	P32519	HCT-116 (colon carcinoma)	PEAKS034067
EXP011234	sc-631	Homo sapiens		EXP010900	417	unspecified	P32519	HCT-116 (colon carcinoma)	PEAKS034068
EXP011235	HPA004051	Mus musculus		EXP010644	1174	unspecified	E9Q1A5	MEL cell line	PEAKS036811
EXP030002	MEF2C	Homo sapiens		EXP030000	553	unspecified	Q06413	LoVo (colorectal adenocarcinoma)	PEAKS034069
EXP030003	MEF2A	Homo sapiens		EXP030000	553	unspecified	Q02078	LoVo (colorectal adenocarcinoma)	PEAKS034070
EXP030004	ZNF639	Homo sapiens		EXP030000	553	unspecified	Q9UID6	LoVo (colorectal adenocarcinoma)	PEAKS034071
EXP030005	ZNF250	Homo sapiens		EXP030000	553	unspecified	P15622	LoVo (colorectal adenocarcinoma)	PEAKS034072
EXP030006	HOXD13	Homo sapiens		EXP030000	553	unspecified	P35453	LoVo (colorectal adenocarcinoma)	PEAKS034073
EXP030007	RORA	Homo sapiens		EXP030000	553	unspecified	P35398	LoVo (colorectal adenocarcinoma)	PEAKS034074
EXP030008	REST	Homo sapiens		EXP030000	553	unspecified	Q13127	LoVo (colorectal adenocarcinoma)	PEAKS034075
EXP030009	MXI1	Homo sapiens		EXP030000	553	unspecified	P50539	LoVo (colorectal adenocarcinoma)	PEAKS034076
EXP030010	HOXD11	Homo sapiens		EXP030000	553	unspecified	P31277	LoVo (colorectal adenocarcinoma)	PEAKS034077
EXP030011	FOXF1	Homo sapiens		EXP030000	553	unspecified	Q12946	LoVo (colorectal adenocarcinoma)	PEAKS034078
EXP030012	FOXF2	Homo sapiens		EXP030000	553	unspecified	Q12947	LoVo (colorectal adenocarcinoma)	PEAKS034079
EXP030013	PATZ1	Homo sapiens		EXP030000	553	unspecified	Q9HBE1	LoVo (colorectal adenocarcinoma)	PEAKS034080
EXP030014	BHLHB3	Homo sapiens		EXP030000	553	unspecified	Q9C0J9	LoVo (colorectal adenocarcinoma)	PEAKS034081
EXP030015	RCOR1	Homo sapiens		EXP030000	553	unspecified	Q9UKL0	LoVo (colorectal adenocarcinoma)	PEAKS034082
EXP030016	BARHL1	Homo sapiens		EXP030000	553	unspecified	Q9BZE3	LoVo (colorectal adenocarcinoma)	PEAKS034083
EXP030017	RXRA	Homo sapiens		EXP030000	553	unspecified	P19793	LoVo (colorectal adenocarcinoma)	PEAKS034084
EXP030018	EOMES	Homo sapiens		EXP030000	553	unspecified	O95936	LoVo (colorectal adenocarcinoma)	PEAKS034085
EXP030019	HNF4G	Homo sapiens		EXP030000	553	unspecified	Q14541	LoVo (colorectal adenocarcinoma)	PEAKS034086
EXP030020	TOX4	Homo sapiens		EXP030000	553	unspecified	O94842	LoVo (colorectal adenocarcinoma)	PEAKS034087
EXP030021	ZNF236	Homo sapiens		EXP030000	553	unspecified	Q9UL36	LoVo (colorectal adenocarcinoma)	PEAKS034088
EXP030022	MSX1	Homo sapiens		EXP030000	553	unspecified	P28360	LoVo (colorectal adenocarcinoma)	PEAKS034089
EXP030023	HNF4A	Homo sapiens		EXP030000	553	unspecified	P41235	LoVo (colorectal adenocarcinoma)	PEAKS034090
EXP030024	JUN	Homo sapiens		EXP030000	553	unspecified	P05412	LoVo (colorectal adenocarcinoma)	PEAKS034091
EXP030025	FOXG1	Homo sapiens		EXP030000	553	unspecified	P55316	LoVo (colorectal adenocarcinoma)	PEAKS034092
EXP030026	TGIF1	Homo sapiens		EXP030000	553	unspecified	Q15583	LoVo (colorectal adenocarcinoma)	PEAKS034093
EXP030027	MYBL1	Homo sapiens		EXP030000	553	unspecified	P10243	LoVo (colorectal adenocarcinoma)	PEAKS034094
EXP030028	MYBL2	Homo sapiens		EXP030000	553	unspecified	P10244	LoVo (colorectal adenocarcinoma)	PEAKS034095
EXP030029	HESX1	Homo sapiens		EXP030000	553	unspecified	Q9UBX0	LoVo (colorectal adenocarcinoma)	PEAKS034096
EXP030030	T	Homo sapiens		EXP030000	553	unspecified	O15178	LoVo (colorectal adenocarcinoma)	PEAKS034097
EXP030031	LYL1	Homo sapiens		EXP030000	553	unspecified	P12980	LoVo (colorectal adenocarcinoma)	PEAKS034098
EXP030032	CASZ1	Homo sapiens		EXP030000	553	unspecified	Q86V15	LoVo (colorectal adenocarcinoma)	PEAKS034099
EXP030033	ARNTL2	Homo sapiens		EXP030000	553	unspecified	Q8WYA1	LoVo (colorectal adenocarcinoma)	PEAKS034100
EXP030034	VEZF1	Homo sapiens		EXP030000	553	unspecified	Q14119	LoVo (colorectal adenocarcinoma)	PEAKS034101
EXP030035	ESRRA	Homo sapiens		EXP030000	553	unspecified	P11474	LoVo (colorectal adenocarcinoma)	PEAKS034102
EXP030036	KLF13	Homo sapiens		EXP030000	553	unspecified	Q9Y2Y9	LoVo (colorectal adenocarcinoma)	PEAKS034103
EXP030037	KLF10	Homo sapiens		EXP030000	553	unspecified	Q13118	LoVo (colorectal adenocarcinoma)	PEAKS034104
EXP030038	KLF11	Homo sapiens		EXP030000	553	unspecified	O14901	LoVo (colorectal adenocarcinoma)	PEAKS034105
EXP030039	TFCP2	Homo sapiens		EXP030000	553	unspecified	Q12800	LoVo (colorectal adenocarcinoma)	PEAKS034106
EXP030040	KLF15	Homo sapiens		EXP030000	553	unspecified	Q9UIH9	LoVo (colorectal adenocarcinoma)	PEAKS034107
EXP030041	USF2	Homo sapiens		EXP030000	553	unspecified	Q15853	LoVo (colorectal adenocarcinoma)	PEAKS034108
EXP030042	ZNF217	Homo sapiens		EXP030000	553	unspecified	O75362	LoVo (colorectal adenocarcinoma)	PEAKS034109
EXP030043	MZF1	Homo sapiens		EXP030000	553	unspecified	P28698	LoVo (colorectal adenocarcinoma)	PEAKS034110
EXP030044	BACH1	Homo sapiens		EXP030000	553	unspecified	O14867	LoVo (colorectal adenocarcinoma)	PEAKS034111
EXP030045	ELF1	Homo sapiens		EXP030000	553	unspecified	P32519	LoVo (colorectal adenocarcinoma)	PEAKS034112
EXP030046	HNF1B	Homo sapiens		EXP030000	553	unspecified	P35680	LoVo (colorectal adenocarcinoma)	PEAKS034113
EXP030047	ELF2	Homo sapiens		EXP030000	553	unspecified	Q15723	LoVo (colorectal adenocarcinoma)	PEAKS034114
EXP030048	HNF1A	Homo sapiens		EXP030000	553	unspecified	P20823	LoVo (colorectal adenocarcinoma)	PEAKS034115
EXP030049	ELF3	Homo sapiens		EXP030000	553	unspecified	P78545	LoVo (colorectal adenocarcinoma)	PEAKS034116
EXP030050	FOXA2	Homo sapiens		EXP030000	553	unspecified	Q9Y261	LoVo (colorectal adenocarcinoma)	PEAKS034117
EXP030051	ELF4	Homo sapiens		EXP030000	553	unspecified	Q99607	LoVo (colorectal adenocarcinoma)	PEAKS034118
EXP030052	YBX1	Homo sapiens		EXP030000	553	unspecified	P67809	LoVo (colorectal adenocarcinoma)	PEAKS034119
EXP030053	EVI1	Homo sapiens		EXP030000	553	unspecified	Q03112	LoVo (colorectal adenocarcinoma)	PEAKS034120
EXP030054	HSF1	Homo sapiens		EXP030000	553	unspecified	Q00613	LoVo (colorectal adenocarcinoma)	PEAKS034121
EXP030055	HSF2	Homo sapiens		EXP030000	553	unspecified	Q03933	LoVo (colorectal adenocarcinoma)	PEAKS034122
EXP030056	SPIB	Homo sapiens		EXP030000	553	unspecified	Q01892	LoVo (colorectal adenocarcinoma)	PEAKS034123
EXP030057	HSF4	Homo sapiens		EXP030000	553	unspecified	Q9ULV5	LoVo (colorectal adenocarcinoma)	PEAKS034124
EXP030058	GATAD1	Homo sapiens		EXP030000	553	unspecified	Q8WUU5	LoVo (colorectal adenocarcinoma)	PEAKS034125
EXP030059	MYB	Homo sapiens		EXP030000	553	unspecified	P10242	LoVo (colorectal adenocarcinoma)	PEAKS034126
EXP030060	MYC	Homo sapiens		EXP030000	553	unspecified	P01106	LoVo (colorectal adenocarcinoma)	PEAKS034127
EXP030061	ZNF281	Homo sapiens		EXP030000	553	unspecified	Q9Y2X9	LoVo (colorectal adenocarcinoma)	PEAKS034128
EXP030062	BATF3	Homo sapiens		EXP030000	553	unspecified	Q9NR55	LoVo (colorectal adenocarcinoma)	PEAKS034129
EXP030063	AR	Homo sapiens		EXP030000	553	unspecified	P10275	LoVo (colorectal adenocarcinoma)	PEAKS034130
EXP030064	GMEB2	Homo sapiens		EXP030000	553	unspecified	Q9UKD1	LoVo (colorectal adenocarcinoma)	PEAKS034131
EXP030065	GMEB1	Homo sapiens		EXP030000	553	unspecified	Q9Y692	LoVo (colorectal adenocarcinoma)	PEAKS034132
EXP030066	TP53	Homo sapiens		EXP030000	553	unspecified	P04637	LoVo (colorectal adenocarcinoma)	PEAKS034133
EXP030067	ZNF143	Homo sapiens		EXP030000	553	unspecified	P52747	LoVo (colorectal adenocarcinoma)	PEAKS034134
EXP030068	FOSB	Homo sapiens		EXP030000	553	unspecified	P53539	LoVo (colorectal adenocarcinoma)	PEAKS034135
EXP030069	MXD1	Homo sapiens		EXP030000	553	unspecified	Q05195	LoVo (colorectal adenocarcinoma)	PEAKS034136
EXP030070	MXD3	Homo sapiens		EXP030000	553	unspecified	Q9BW11	LoVo (colorectal adenocarcinoma)	PEAKS034137
EXP030071	FOXC1	Homo sapiens		EXP030000	553	unspecified	Q12948	LoVo (colorectal adenocarcinoma)	PEAKS034138
EXP030072	CLOCK	Homo sapiens		EXP030000	553	unspecified	O15516	LoVo (colorectal adenocarcinoma)	PEAKS034139
EXP030073	CREM	Homo sapiens		EXP030000	553	unspecified	Q03060	LoVo (colorectal adenocarcinoma)	PEAKS034140
EXP030074	FOXD2	Homo sapiens		EXP030000	553	unspecified	O60548	LoVo (colorectal adenocarcinoma)	PEAKS034141
EXP030075	ZNF266	Homo sapiens		EXP030000	553	unspecified	Q14584	LoVo (colorectal adenocarcinoma)	PEAKS034142
EXP030076	ZNF263	Homo sapiens		EXP030000	553	unspecified	O14978	LoVo (colorectal adenocarcinoma)	PEAKS034143
EXP030077	MYF6	Homo sapiens		EXP030000	553	unspecified	P23409	LoVo (colorectal adenocarcinoma)	PEAKS034144
EXP030078	LMX1B	Homo sapiens		EXP030000	553	unspecified	O60663	LoVo (colorectal adenocarcinoma)	PEAKS034145
EXP030079	TP73	Homo sapiens		EXP030000	553	unspecified	O15350	LoVo (colorectal adenocarcinoma)	PEAKS034146
EXP030080	RLF	Homo sapiens		EXP030000	553	unspecified	Q13129	LoVo (colorectal adenocarcinoma)	PEAKS034147
EXP030081	MEF2D	Homo sapiens		EXP030000	553	unspecified	Q14814	LoVo (colorectal adenocarcinoma)	PEAKS034148
EXP030082	ZBTB4	Homo sapiens		EXP030000	553	unspecified	Q9P1Z0	LoVo (colorectal adenocarcinoma)	PEAKS034149
EXP030083	ZBTB2	Homo sapiens		EXP030000	553	unspecified	Q8N680	LoVo (colorectal adenocarcinoma)	PEAKS034150
EXP030084	NR5A2	Homo sapiens		EXP030000	553	unspecified	O00482	LoVo (colorectal adenocarcinoma)	PEAKS034151
EXP030085	ZNF581	Homo sapiens		EXP030000	553	unspecified	Q9P0T4	LoVo (colorectal adenocarcinoma)	PEAKS034152
EXP030086	JDP2	Homo sapiens		EXP030000	553	unspecified	Q8WYK2	LoVo (colorectal adenocarcinoma)	PEAKS034153
EXP030087	PDX1	Homo sapiens		EXP030000	553	unspecified	P52945	LoVo (colorectal adenocarcinoma)	PEAKS034154
EXP030088	NR2E3	Homo sapiens		EXP030000	553	unspecified	Q9Y5X4	LoVo (colorectal adenocarcinoma)	PEAKS034155
EXP030089	ZIC2	Homo sapiens		EXP030000	553	unspecified	O95409	LoVo (colorectal adenocarcinoma)	PEAKS034156
EXP030090	RELA	Homo sapiens		EXP030000	553	unspecified	Q04206	LoVo (colorectal adenocarcinoma)	PEAKS034157
EXP030091	RELB	Homo sapiens		EXP030000	553	unspecified	Q01201	LoVo (colorectal adenocarcinoma)	PEAKS034158
EXP030092	HES7	Homo sapiens		EXP030000	553	unspecified	Q9BYE0	LoVo (colorectal adenocarcinoma)	PEAKS034159
EXP030093	GRHL1	Homo sapiens		EXP030000	553	unspecified	Q9NZI5	LoVo (colorectal adenocarcinoma)	PEAKS034160
EXP030094	CSDA	Homo sapiens		EXP030000	553	unspecified	P16989	LoVo (colorectal adenocarcinoma)	PEAKS034161
EXP030095	GRHL2	Homo sapiens		EXP030000	553	unspecified	Q6ISB3	LoVo (colorectal adenocarcinoma)	PEAKS034162
EXP030096	DDIT3	Homo sapiens		EXP030000	553	unspecified	P35638	LoVo (colorectal adenocarcinoma)	PEAKS034163
EXP030097	JUNB	Homo sapiens		EXP030000	553	unspecified	P17275	LoVo (colorectal adenocarcinoma)	PEAKS034164
EXP030098	ZNF3	Homo sapiens		EXP030000	553	unspecified	P17036	LoVo (colorectal adenocarcinoma)	PEAKS034165
EXP030099	ASCL2	Homo sapiens		EXP030000	553	unspecified	Q99929	LoVo (colorectal adenocarcinoma)	PEAKS034166
EXP030100	HHEX	Homo sapiens		EXP030000	553	unspecified	Q03014	LoVo (colorectal adenocarcinoma)	PEAKS034167
EXP030101	HIF1A	Homo sapiens		EXP030000	553	unspecified	Q16665	LoVo (colorectal adenocarcinoma)	PEAKS034168
EXP030102	TCFL5	Homo sapiens		EXP030000	553	unspecified	Q9UL49	LoVo (colorectal adenocarcinoma)	PEAKS034169
EXP030103	MNX1	Homo sapiens		EXP030000	553	unspecified	P50219	LoVo (colorectal adenocarcinoma)	PEAKS034170
EXP030104	TFAP2A	Homo sapiens		EXP030000	553	unspecified	P05549	LoVo (colorectal adenocarcinoma)	PEAKS034171
EXP030105	NFE2L1	Homo sapiens		EXP030000	553	unspecified	Q14494	LoVo (colorectal adenocarcinoma)	PEAKS034172
EXP030106	NFE2L2	Homo sapiens		EXP030000	553	unspecified	Q16236	LoVo (colorectal adenocarcinoma)	PEAKS034173
EXP030107	NFE2L3	Homo sapiens		EXP030000	553	unspecified	Q9Y4A8	LoVo (colorectal adenocarcinoma)	PEAKS034174
EXP030108	TFE3	Homo sapiens		EXP030000	553	unspecified	P19532	LoVo (colorectal adenocarcinoma)	PEAKS034175
EXP030109	TFEB	Homo sapiens		EXP030000	553	unspecified	P19484	LoVo (colorectal adenocarcinoma)	PEAKS034176
EXP030110	ATF1	Homo sapiens		EXP030000	553	unspecified	P18846	LoVo (colorectal adenocarcinoma)	PEAKS034177
EXP030111	ATF2	Homo sapiens		EXP030000	553	unspecified	P15336	LoVo (colorectal adenocarcinoma)	PEAKS034178
EXP030112	ARNT	Homo sapiens		EXP030000	553	unspecified	P27540	LoVo (colorectal adenocarcinoma)	PEAKS034179
EXP030113	MEIS2	Homo sapiens		EXP030000	553	unspecified	O14770	LoVo (colorectal adenocarcinoma)	PEAKS034180
EXP030114	OVOL2	Homo sapiens		EXP030000	553	unspecified	Q9BRP0	LoVo (colorectal adenocarcinoma)	PEAKS034181
EXP030115	TEL	Homo sapiens		EXP030000	553	unspecified	P41212	LoVo (colorectal adenocarcinoma)	PEAKS034182
EXP030116	TEAD4	Homo sapiens		EXP030000	553	unspecified	Q15561	LoVo (colorectal adenocarcinoma)	PEAKS034183
EXP030117	JUND	Homo sapiens		EXP030000	553	unspecified	P17535	LoVo (colorectal adenocarcinoma)	PEAKS034184
EXP030118	TFDP2	Homo sapiens		EXP030000	553	unspecified	Q14188	LoVo (colorectal adenocarcinoma)	PEAKS034185
EXP030119	TFDP1	Homo sapiens		EXP030000	553	unspecified	Q14186	LoVo (colorectal adenocarcinoma)	PEAKS034186
EXP030120	EPAS1	Homo sapiens		EXP030000	553	unspecified	Q99814	LoVo (colorectal adenocarcinoma)	PEAKS034187
EXP030121	FOXA1	Homo sapiens		EXP030000	553	unspecified	P55317	LoVo (colorectal adenocarcinoma)	PEAKS034188
EXP030122	NR4A2	Homo sapiens		EXP030000	553	unspecified	P43354	LoVo (colorectal adenocarcinoma)	PEAKS034189
EXP030123	NR4A1	Homo sapiens		EXP030000	553	unspecified	P22736	LoVo (colorectal adenocarcinoma)	PEAKS034190
EXP030124	WHSC1	Homo sapiens		EXP030000	553	unspecified	O96028	LoVo (colorectal adenocarcinoma)	PEAKS034191
EXP030125	TEAD2	Homo sapiens		EXP030000	553	unspecified	Q15562	LoVo (colorectal adenocarcinoma)	PEAKS034192
EXP030126	NEUROG3	Homo sapiens		EXP030000	553	unspecified	Q9Y4Z2	LoVo (colorectal adenocarcinoma)	PEAKS034193
EXP030127	ATF6	Homo sapiens		EXP030000	553	unspecified	P18850	LoVo (colorectal adenocarcinoma)	PEAKS034194
EXP030128	ATF5	Homo sapiens		EXP030000	553	unspecified	Q9Y2D1	LoVo (colorectal adenocarcinoma)	PEAKS034195
EXP030129	ATF7	Homo sapiens		EXP030000	553	unspecified	P17544	LoVo (colorectal adenocarcinoma)	PEAKS034196
EXP030130	HIVEP3	Homo sapiens		EXP030000	553	unspecified	Q5T1R4	LoVo (colorectal adenocarcinoma)	PEAKS034197
EXP030131	HIVEP1	Homo sapiens		EXP030000	553	unspecified	P15822	LoVo (colorectal adenocarcinoma)	PEAKS034198
EXP030132	E2F1	Homo sapiens		EXP030000	553	unspecified	Q01094	LoVo (colorectal adenocarcinoma)	PEAKS034199
EXP030133	E2F2	Homo sapiens		EXP030000	553	unspecified	Q14209	LoVo (colorectal adenocarcinoma)	PEAKS034200
EXP030134	E2F3	Homo sapiens		EXP030000	553	unspecified	O00716	LoVo (colorectal adenocarcinoma)	PEAKS034201
EXP030135	E2F4	Homo sapiens		EXP030000	553	unspecified	Q16254	LoVo (colorectal adenocarcinoma)	PEAKS034202
EXP030136	E2F7	Homo sapiens		EXP030000	553	unspecified	Q96AV8	LoVo (colorectal adenocarcinoma)	PEAKS034203
EXP030137	E2F8	Homo sapiens		EXP030000	553	unspecified	A0AVK6	LoVo (colorectal adenocarcinoma)	PEAKS034204
EXP030138	CTCF	Homo sapiens		EXP030000	553	unspecified	P49711	LoVo (colorectal adenocarcinoma)	PEAKS034205
EXP030139	PAX2	Homo sapiens		EXP030000	553	unspecified	Q02962	LoVo (colorectal adenocarcinoma)	PEAKS034206
EXP030140	FEV	Homo sapiens		EXP030000	553	unspecified	Q99581	LoVo (colorectal adenocarcinoma)	PEAKS034207
EXP030141	MAX	Homo sapiens		EXP030000	553	unspecified	P61244	LoVo (colorectal adenocarcinoma)	PEAKS034208
EXP030142	BARX1	Homo sapiens		EXP030000	553	unspecified	Q9HBU1	LoVo (colorectal adenocarcinoma)	PEAKS034209
EXP030143	MAZ	Homo sapiens		EXP030000	553	unspecified	P56270	LoVo (colorectal adenocarcinoma)	PEAKS034210
EXP030144	BARX2	Homo sapiens		EXP030000	553	unspecified	Q9UMQ3	LoVo (colorectal adenocarcinoma)	PEAKS034211
EXP030145	HEY1	Homo sapiens		EXP030000	553	unspecified	Q9Y5J3	LoVo (colorectal adenocarcinoma)	PEAKS034212
EXP030146	ZNF407	Homo sapiens		EXP030000	553	unspecified	Q9C0G0	LoVo (colorectal adenocarcinoma)	PEAKS034213
EXP030147	NFIL3	Homo sapiens		EXP030000	553	unspecified	Q16649	LoVo (colorectal adenocarcinoma)	PEAKS034214
EXP030148	FOSL1	Homo sapiens		EXP030000	553	unspecified	P15407	LoVo (colorectal adenocarcinoma)	PEAKS034215
EXP030149	ZNF280D	Homo sapiens		EXP030000	553	unspecified	Q6N043	LoVo (colorectal adenocarcinoma)	PEAKS034216
EXP030150	OTX1	Homo sapiens		EXP030000	553	unspecified	P32242	LoVo (colorectal adenocarcinoma)	PEAKS034217
EXP030151	ESR1	Homo sapiens		EXP030000	553	unspecified	P03372	LoVo (colorectal adenocarcinoma)	PEAKS034218
EXP030152	CDC5L	Homo sapiens		EXP030000	553	unspecified	Q99459	LoVo (colorectal adenocarcinoma)	PEAKS034219
EXP030153	HMGA1	Homo sapiens		EXP030000	553	unspecified	P17096	LoVo (colorectal adenocarcinoma)	PEAKS034220
EXP030154	NCOA1	Homo sapiens		EXP030000	553	unspecified	Q15788	LoVo (colorectal adenocarcinoma)	PEAKS034221
EXP030155	HOXC11	Homo sapiens		EXP030000	553	unspecified	O43248	LoVo (colorectal adenocarcinoma)	PEAKS034222
EXP030156	NCOA3	Homo sapiens		EXP030000	553	unspecified	Q9Y6Q9	LoVo (colorectal adenocarcinoma)	PEAKS034223
EXP030157	HOXC13	Homo sapiens		EXP030000	553	unspecified	P31276	LoVo (colorectal adenocarcinoma)	PEAKS034224
EXP030158	IRX3	Homo sapiens		EXP030000	553	unspecified	P78415	LoVo (colorectal adenocarcinoma)	PEAKS034225
EXP030159	IRX5	Homo sapiens		EXP030000	553	unspecified	P78411	LoVo (colorectal adenocarcinoma)	PEAKS034226
EXP030160	IRX2	Homo sapiens		EXP030000	553	unspecified	Q9BZI1	LoVo (colorectal adenocarcinoma)	PEAKS034227
EXP030161	NR3C2	Homo sapiens		EXP030000	553	unspecified	P08235	LoVo (colorectal adenocarcinoma)	PEAKS034228
EXP030162	NFYC	Homo sapiens		EXP030000	553	unspecified	Q13952	LoVo (colorectal adenocarcinoma)	PEAKS034229
EXP030163	NFYB	Homo sapiens		EXP030000	553	unspecified	P25208	LoVo (colorectal adenocarcinoma)	PEAKS034230
EXP030164	NFYA	Homo sapiens		EXP030000	553	unspecified	P23511	LoVo (colorectal adenocarcinoma)	PEAKS034231
EXP030165	NR3C1	Homo sapiens		EXP030000	553	unspecified	P04150	LoVo (colorectal adenocarcinoma)	PEAKS034232
EXP030166	MSX2	Homo sapiens		EXP030000	553	unspecified	P35548	LoVo (colorectal adenocarcinoma)	PEAKS034233
EXP030167	TFAM	Homo sapiens		EXP030000	553	unspecified	Q00059	LoVo (colorectal adenocarcinoma)	PEAKS034234
EXP030168	HIC2	Homo sapiens		EXP030000	553	unspecified	Q96JB3	LoVo (colorectal adenocarcinoma)	PEAKS034235
EXP030169	CEBPZ	Homo sapiens		EXP030000	553	unspecified	P35638	LoVo (colorectal adenocarcinoma)	PEAKS034236
EXP030170	NFATC4	Homo sapiens		EXP030000	553	unspecified	Q14934	LoVo (colorectal adenocarcinoma)	PEAKS034237
EXP030171	NFATC3	Homo sapiens		EXP030000	553	unspecified	Q12968	LoVo (colorectal adenocarcinoma)	PEAKS034238
EXP030172	NFATC1	Homo sapiens		EXP030000	553	unspecified	O95644	LoVo (colorectal adenocarcinoma)	PEAKS034239
EXP030173	CEBPB	Homo sapiens		EXP030000	553	unspecified	P17676	LoVo (colorectal adenocarcinoma)	PEAKS034240
EXP030174	CEBPE	Homo sapiens		EXP030000	553	unspecified	Q15744	LoVo (colorectal adenocarcinoma)	PEAKS034241
EXP030175	CREB1	Homo sapiens		EXP030000	553	unspecified	P16220	LoVo (colorectal adenocarcinoma)	PEAKS034242
EXP030176	CEBPG	Homo sapiens		EXP030000	553	unspecified	P53567	LoVo (colorectal adenocarcinoma)	PEAKS034243
EXP030177	ISL1	Homo sapiens		EXP030000	553	unspecified	P61371	LoVo (colorectal adenocarcinoma)	PEAKS034244
EXP030178	ISL2	Homo sapiens		EXP030000	553	unspecified	Q96A47	LoVo (colorectal adenocarcinoma)	PEAKS034245
EXP030179	ID2	Homo sapiens		EXP030000	553	unspecified	Q02363	LoVo (colorectal adenocarcinoma)	PEAKS034246
EXP030180	ID1	Homo sapiens		EXP030000	553	unspecified	P41134	LoVo (colorectal adenocarcinoma)	PEAKS034247
EXP030181	DBP	Homo sapiens		EXP030000	553	unspecified	Q10586	LoVo (colorectal adenocarcinoma)	PEAKS034248
EXP030182	ZBED4	Homo sapiens		EXP030000	553	unspecified	O75132	LoVo (colorectal adenocarcinoma)	PEAKS034249
EXP030183	HEYL	Homo sapiens		EXP030000	553	unspecified	Q9NQ87	LoVo (colorectal adenocarcinoma)	PEAKS034250
EXP030184	ID4	Homo sapiens		EXP030000	553	unspecified	P47928	LoVo (colorectal adenocarcinoma)	PEAKS034251
EXP030185	ID3	Homo sapiens		EXP030000	553	unspecified	Q02535	LoVo (colorectal adenocarcinoma)	PEAKS034252
EXP030186	CDX1	Homo sapiens		EXP030000	553	unspecified	P47902	LoVo (colorectal adenocarcinoma)	PEAKS034253
EXP030187	CDX2	Homo sapiens		EXP030000	553	unspecified	Q99626	LoVo (colorectal adenocarcinoma)	PEAKS034254
EXP030188	STAT5A	Homo sapiens		EXP030000	553	unspecified	P42229	LoVo (colorectal adenocarcinoma)	PEAKS034255
EXP030189	BBX	Homo sapiens		EXP030000	553	unspecified	Q8WY36	LoVo (colorectal adenocarcinoma)	PEAKS034256
EXP030190	CREB3L2	Homo sapiens		EXP030000	553	unspecified	Q70SY1	LoVo (colorectal adenocarcinoma)	PEAKS034257
EXP030191	CREB3L1	Homo sapiens		EXP030000	553	unspecified	Q96BA8	LoVo (colorectal adenocarcinoma)	PEAKS034258
EXP030192	CREB3L4	Homo sapiens		EXP030000	553	unspecified	Q8TEY5	LoVo (colorectal adenocarcinoma)	PEAKS034259
EXP030193	RARA	Homo sapiens		EXP030000	553	unspecified	P10276	LoVo (colorectal adenocarcinoma)	PEAKS034260
EXP030194	PITX3	Homo sapiens		EXP030000	553	unspecified	O75364	LoVo (colorectal adenocarcinoma)	PEAKS034261
EXP030195	PITX1	Homo sapiens		EXP030000	553	unspecified	P78337	LoVo (colorectal adenocarcinoma)	PEAKS034262
EXP030196	RARG	Homo sapiens		EXP030000	553	unspecified	P13631	LoVo (colorectal adenocarcinoma)	PEAKS034263
EXP030197	EMX1	Homo sapiens		EXP030000	553	unspecified	Q04741	LoVo (colorectal adenocarcinoma)	PEAKS034264
EXP030198	YY1	Homo sapiens		EXP030000	553	unspecified	P25490	LoVo (colorectal adenocarcinoma)	PEAKS034265
EXP030199	NKX2-8	Homo sapiens		EXP030000	553	unspecified	O15522	LoVo (colorectal adenocarcinoma)	PEAKS034266
EXP030200	HES1	Homo sapiens		EXP030000	553	unspecified	Q14469	LoVo (colorectal adenocarcinoma)	PEAKS034267
EXP030201	PRDM4	Homo sapiens		EXP030000	553	unspecified	Q9UKN5	LoVo (colorectal adenocarcinoma)	PEAKS034268
EXP030202	HES5	Homo sapiens		EXP030000	553	unspecified	Q5TA89	LoVo (colorectal adenocarcinoma)	PEAKS034269
EXP030203	HES4	Homo sapiens		EXP030000	553	unspecified	Q9HCC6	LoVo (colorectal adenocarcinoma)	PEAKS034270
EXP030204	HES2	Homo sapiens		EXP030000	553	unspecified	Q9Y543	LoVo (colorectal adenocarcinoma)	PEAKS034271
EXP030205	MNT	Homo sapiens		EXP030000	553	unspecified	Q99583	LoVo (colorectal adenocarcinoma)	PEAKS034272
EXP030206	PRDM1	Homo sapiens		EXP030000	553	unspecified	O75626	LoVo (colorectal adenocarcinoma)	PEAKS034273
EXP030207	NKX2.2	Homo sapiens		EXP030000	553	unspecified	O95096	LoVo (colorectal adenocarcinoma)	PEAKS034274
EXP030208	HOXA13	Homo sapiens		EXP030000	553	unspecified	P31271	LoVo (colorectal adenocarcinoma)	PEAKS034275
EXP030209	HOXA11	Homo sapiens		EXP030000	553	unspecified	P31270	LoVo (colorectal adenocarcinoma)	PEAKS034276
EXP030210	HOXB13	Homo sapiens		EXP030000	553	unspecified	Q92826	LoVo (colorectal adenocarcinoma)	PEAKS034277
EXP030211	NR1H2	Homo sapiens		EXP030000	553	unspecified	P55055	LoVo (colorectal adenocarcinoma)	PEAKS034278
EXP030212	TAL1	Homo sapiens		EXP030000	553	unspecified	P17542	LoVo (colorectal adenocarcinoma)	PEAKS034279
EXP030213	LHX1	Homo sapiens		EXP030000	553	unspecified	P48742	LoVo (colorectal adenocarcinoma)	PEAKS034280
EXP030214	LHX2	Homo sapiens		EXP030000	553	unspecified	P50458	LoVo (colorectal adenocarcinoma)	PEAKS034281
EXP030215	LHX3	Homo sapiens		EXP030000	553	unspecified	Q9UBR4	LoVo (colorectal adenocarcinoma)	PEAKS034282
EXP030216	HOXA10	Homo sapiens		EXP030000	553	unspecified	P31260	LoVo (colorectal adenocarcinoma)	PEAKS034283
EXP030217	LHX4	Homo sapiens		EXP030000	553	unspecified	Q969G2	LoVo (colorectal adenocarcinoma)	PEAKS034284
EXP030218	NKX2-1	Homo sapiens		EXP030000	553	unspecified	P43699	LoVo (colorectal adenocarcinoma)	PEAKS034285
EXP030219	LHX5	Homo sapiens		EXP030000	553	unspecified	Q9H2C1	LoVo (colorectal adenocarcinoma)	PEAKS034286
EXP030220	LHX6	Homo sapiens		EXP030000	553	unspecified	Q9UPM6	LoVo (colorectal adenocarcinoma)	PEAKS034287
EXP030221	NKX2-5	Homo sapiens		EXP030000	553	unspecified	P52952	LoVo (colorectal adenocarcinoma)	PEAKS034288
EXP030222	NKX2-3	Homo sapiens		EXP030000	553	unspecified	Q8TAU0	LoVo (colorectal adenocarcinoma)	PEAKS034289
EXP030223	NR1H3	Homo sapiens		EXP030000	553	unspecified	Q13133	LoVo (colorectal adenocarcinoma)	PEAKS034290
EXP030224	PLAG1	Homo sapiens		EXP030000	553	unspecified	Q6DJT9	LoVo (colorectal adenocarcinoma)	PEAKS034291
EXP030225	KLF5	Homo sapiens		EXP030000	553	unspecified	Q13887	LoVo (colorectal adenocarcinoma)	PEAKS034292
EXP030226	IKZF5	Homo sapiens		EXP030000	553	unspecified	Q9H5V7	LoVo (colorectal adenocarcinoma)	PEAKS034293
EXP030227	AEBP2	Homo sapiens		EXP030000	553	unspecified	Q6ZN18	LoVo (colorectal adenocarcinoma)	PEAKS034294
EXP030228	KLF6	Homo sapiens		EXP030000	553	unspecified	Q99612	LoVo (colorectal adenocarcinoma)	PEAKS034295
EXP030229	SMAD5	Homo sapiens		EXP030000	553	unspecified	Q99717	LoVo (colorectal adenocarcinoma)	PEAKS034296
EXP030230	SMAD4	Homo sapiens		EXP030000	553	unspecified	Q13485	LoVo (colorectal adenocarcinoma)	PEAKS034297
EXP030231	SMAD3	Homo sapiens		EXP030000	553	unspecified	P84022	LoVo (colorectal adenocarcinoma)	PEAKS034298
EXP030232	SMAD2	Homo sapiens		EXP030000	553	unspecified	Q15796	LoVo (colorectal adenocarcinoma)	PEAKS034299
EXP030233	SMAD1	Homo sapiens		EXP030000	553	unspecified	Q15797	LoVo (colorectal adenocarcinoma)	PEAKS034300
EXP030234	ZBTB44	Homo sapiens		EXP030000	553	unspecified	Q8NCP5	LoVo (colorectal adenocarcinoma)	PEAKS034301
EXP030235	UBP1	Homo sapiens		EXP030000	553	unspecified	Q9NZI7	LoVo (colorectal adenocarcinoma)	PEAKS034302
EXP030236	NKX6-1	Homo sapiens		EXP030000	553	unspecified	P78426	LoVo (colorectal adenocarcinoma)	PEAKS034303
EXP030237	DLX2	Homo sapiens		EXP030000	553	unspecified	Q07687	LoVo (colorectal adenocarcinoma)	PEAKS034304
EXP030238	DLX1	Homo sapiens		EXP030000	553	unspecified	P56177	LoVo (colorectal adenocarcinoma)	PEAKS034305
EXP030239	NR1I2	Homo sapiens		EXP030000	553	unspecified	O75469	LoVo (colorectal adenocarcinoma)	PEAKS034306
EXP030240	DLX6	Homo sapiens		EXP030000	553	unspecified	P56179	LoVo (colorectal adenocarcinoma)	PEAKS034307
EXP030241	DLX4	Homo sapiens		EXP030000	553	unspecified	Q92988	LoVo (colorectal adenocarcinoma)	PEAKS034308
EXP030242	RBPJ	Homo sapiens		EXP030000	553	unspecified	Q06330	LoVo (colorectal adenocarcinoma)	PEAKS034309
EXP030243	ZFHX3	Homo sapiens		EXP030000	553	unspecified	Q15911	LoVo (colorectal adenocarcinoma)	PEAKS034310
EXP030244	TCF12	Homo sapiens		EXP030000	553	unspecified	Q99081	LoVo (colorectal adenocarcinoma)	PEAKS034311
EXP030245	KLF3	Homo sapiens		EXP030000	553	unspecified	P57682	LoVo (colorectal adenocarcinoma)	PEAKS034312
EXP030246	PPARA	Homo sapiens		EXP030000	553	unspecified	Q07869	LoVo (colorectal adenocarcinoma)	PEAKS034313
EXP030247	ZBTB33	Homo sapiens		EXP030000	553	unspecified	Q86T24	LoVo (colorectal adenocarcinoma)	PEAKS034314
EXP030248	EVX1	Homo sapiens		EXP030000	553	unspecified	P49640	LoVo (colorectal adenocarcinoma)	PEAKS034315
EXP030249	MITF	Homo sapiens		EXP030000	553	unspecified	O75030	LoVo (colorectal adenocarcinoma)	PEAKS034316
EXP030250	PPARG	Homo sapiens		EXP030000	553	unspecified	P37231	LoVo (colorectal adenocarcinoma)	PEAKS034317
EXP030251	ZBTB39	Homo sapiens		EXP030000	553	unspecified	O15060	LoVo (colorectal adenocarcinoma)	PEAKS034318
EXP030252	NFKB1	Homo sapiens		EXP030000	553	unspecified	P19838	LoVo (colorectal adenocarcinoma)	PEAKS034319
EXP030253	NFKB2	Homo sapiens		EXP030000	553	unspecified	Q00653	LoVo (colorectal adenocarcinoma)	PEAKS034320
EXP030254	GLI2	Homo sapiens		EXP030000	553	unspecified	P10070	LoVo (colorectal adenocarcinoma)	PEAKS034321
EXP030255	GLI3	Homo sapiens		EXP030000	553	unspecified	P10071	LoVo (colorectal adenocarcinoma)	PEAKS034322
EXP030256	GLI1	Homo sapiens		EXP030000	553	unspecified	P08151	LoVo (colorectal adenocarcinoma)	PEAKS034323
EXP030257	FERD3L	Homo sapiens		EXP030000	553	unspecified	Q96RJ6	LoVo (colorectal adenocarcinoma)	PEAKS034324
EXP030258	NR2F6	Homo sapiens		EXP030000	553	unspecified	P10588	LoVo (colorectal adenocarcinoma)	PEAKS034325
EXP030259	ZFAT	Homo sapiens		EXP030000	553	unspecified	Q9P243	LoVo (colorectal adenocarcinoma)	PEAKS034326
EXP030260	SNAPC4	Homo sapiens		EXP030000	553	unspecified	Q5SXM2	LoVo (colorectal adenocarcinoma)	PEAKS034327
EXP030261	ZBTB24	Homo sapiens		EXP030000	553	unspecified	O43167	LoVo (colorectal adenocarcinoma)	PEAKS034328
EXP030262	ETV7	Homo sapiens		EXP030000	553	unspecified	Q9Y603	LoVo (colorectal adenocarcinoma)	PEAKS034329
EXP030263	MLLT7	Homo sapiens		EXP030000	553	unspecified	P98177	LoVo (colorectal adenocarcinoma)	PEAKS034330
EXP030264	THAP4	Homo sapiens		EXP030000	553	unspecified	Q8WY91	LoVo (colorectal adenocarcinoma)	PEAKS034331
EXP030265	EHF	Homo sapiens		EXP030000	553	unspecified	Q9NZC4	LoVo (colorectal adenocarcinoma)	PEAKS034332
EXP030266	CIC	Homo sapiens		EXP030000	553	unspecified	Q96RK0	LoVo (colorectal adenocarcinoma)	PEAKS034333
EXP030267	ZBTB17	Homo sapiens		EXP030000	553	unspecified	Q13105	LoVo (colorectal adenocarcinoma)	PEAKS034334
EXP030268	STAT6	Homo sapiens		EXP030000	553	unspecified	P42226	LoVo (colorectal adenocarcinoma)	PEAKS034335
EXP030269	STAT4	Homo sapiens		EXP030000	553	unspecified	Q14765	LoVo (colorectal adenocarcinoma)	PEAKS034336
EXP030270	NR1D1	Homo sapiens		EXP030000	553	unspecified	P20393	LoVo (colorectal adenocarcinoma)	PEAKS034337
EXP030271	XBP1	Homo sapiens		EXP030000	553	unspecified	P17861	LoVo (colorectal adenocarcinoma)	PEAKS034338
EXP030272	BCL11A	Homo sapiens		EXP030000	553	unspecified	Q9H165	LoVo (colorectal adenocarcinoma)	PEAKS034339
EXP030273	BCL6	Homo sapiens		EXP030000	553	unspecified	P41182	LoVo (colorectal adenocarcinoma)	PEAKS034340
EXP030274	HBP1	Homo sapiens		EXP030000	553	unspecified	O60381	LoVo (colorectal adenocarcinoma)	PEAKS034341
EXP030275	TLX1	Homo sapiens		EXP030000	553	unspecified	P31314	LoVo (colorectal adenocarcinoma)	PEAKS034342
EXP030276	ETV4	Homo sapiens		EXP030000	553	unspecified	P43268	LoVo (colorectal adenocarcinoma)	PEAKS034343
EXP030277	TBX3	Homo sapiens		EXP030000	553	unspecified	O15119	LoVo (colorectal adenocarcinoma)	PEAKS034344
EXP030278	STAT1	Homo sapiens		EXP030000	553	unspecified	P42224	LoVo (colorectal adenocarcinoma)	PEAKS034345
EXP030279	SNAI1	Homo sapiens		EXP030000	553	unspecified	O95863	LoVo (colorectal adenocarcinoma)	PEAKS034346
EXP030280	STAT3	Homo sapiens		EXP030000	553	unspecified	P40763	LoVo (colorectal adenocarcinoma)	PEAKS034347
EXP030281	STAT2	Homo sapiens		EXP030000	553	unspecified	P52630	LoVo (colorectal adenocarcinoma)	PEAKS034348
EXP030282	UBTF	Homo sapiens		EXP030000	553	unspecified	P17480	LoVo (colorectal adenocarcinoma)	PEAKS034349
EXP030283	MEOX2	Homo sapiens		EXP030000	553	unspecified	P50222	LoVo (colorectal adenocarcinoma)	PEAKS034350
EXP030284	NEUROD2	Homo sapiens		EXP030000	553	unspecified	Q15784	LoVo (colorectal adenocarcinoma)	PEAKS034351
EXP030285	PBX1	Homo sapiens		EXP030000	553	unspecified	P40424	LoVo (colorectal adenocarcinoma)	PEAKS034352
EXP030286	PBX3	Homo sapiens		EXP030000	553	unspecified	P40426	LoVo (colorectal adenocarcinoma)	PEAKS034353
EXP030287	PBX2	Homo sapiens		EXP030000	553	unspecified	P40425	LoVo (colorectal adenocarcinoma)	PEAKS034354
EXP030288	NHLH1	Homo sapiens		EXP030000	553	unspecified	Q02575	LoVo (colorectal adenocarcinoma)	PEAKS034355
EXP030289	MYOD1	Homo sapiens		EXP030000	553	unspecified	P15172	LoVo (colorectal adenocarcinoma)	PEAKS034356
EXP030290	ARNT2	Homo sapiens		EXP030000	553	unspecified	Q9HBZ2	LoVo (colorectal adenocarcinoma)	PEAKS034357
EXP030291	FOXO1	Homo sapiens		EXP030000	553	unspecified	Q12778	LoVo (colorectal adenocarcinoma)	PEAKS034358
EXP030292	FOXO3	Homo sapiens		EXP030000	553	unspecified	O43524	LoVo (colorectal adenocarcinoma)	PEAKS034359
EXP030293	HOXD1	Homo sapiens		EXP030000	553	unspecified	Q9GZZ0	LoVo (colorectal adenocarcinoma)	PEAKS034360
EXP030294	FOXO4	Homo sapiens		EXP030000	553	unspecified	P98177	LoVo (colorectal adenocarcinoma)	PEAKS034361
EXP030295	HOXC6	Homo sapiens		EXP030000	553	unspecified	P09630	LoVo (colorectal adenocarcinoma)	PEAKS034362
EXP030296	GATA1	Homo sapiens		EXP030000	553	unspecified	P15976	LoVo (colorectal adenocarcinoma)	PEAKS034363
EXP030297	GATA2	Homo sapiens		EXP030000	553	unspecified	P23769	LoVo (colorectal adenocarcinoma)	PEAKS034364
EXP030298	HOXC8	Homo sapiens		EXP030000	553	unspecified	P31273	LoVo (colorectal adenocarcinoma)	PEAKS034365
EXP030299	ATOH1	Homo sapiens		EXP030000	553	unspecified	Q92858	LoVo (colorectal adenocarcinoma)	PEAKS034366
EXP030300	GATA6	Homo sapiens		EXP030000	553	unspecified	Q92908	LoVo (colorectal adenocarcinoma)	PEAKS034367
EXP030301	GATA4	Homo sapiens		EXP030000	553	unspecified	P43694	LoVo (colorectal adenocarcinoma)	PEAKS034368
EXP030302	SATB1	Homo sapiens		EXP030000	553	unspecified	Q01826	LoVo (colorectal adenocarcinoma)	PEAKS034369
EXP030303	ARNTL	Homo sapiens		EXP030000	553	unspecified	O00327	LoVo (colorectal adenocarcinoma)	PEAKS034370
EXP030304	HOXD9	Homo sapiens		EXP030000	553	unspecified	P28356	LoVo (colorectal adenocarcinoma)	PEAKS034371
EXP030305	HOXD4	Homo sapiens		EXP030000	553	unspecified	P09016	LoVo (colorectal adenocarcinoma)	PEAKS034372
EXP030306	MYNN	Homo sapiens		EXP030000	553	unspecified	Q9NPC7	LoVo (colorectal adenocarcinoma)	PEAKS034373
EXP030307	TSHZ1	Homo sapiens		EXP030000	553	unspecified	Q6ZSZ6	LoVo (colorectal adenocarcinoma)	PEAKS034374
EXP030308	SOX3	Homo sapiens		EXP030000	553	unspecified	P41225	LoVo (colorectal adenocarcinoma)	PEAKS034375
EXP030309	TFAP2	Homo sapiens		EXP030000	553	unspecified	P05549	LoVo (colorectal adenocarcinoma)	PEAKS034376
EXP030310	SOX2	Homo sapiens		EXP030000	553	unspecified	P48431	LoVo (colorectal adenocarcinoma)	PEAKS034377
EXP030311	SOX4	Homo sapiens		EXP030000	553	unspecified	Q06945	LoVo (colorectal adenocarcinoma)	PEAKS034378
EXP030312	SOX9	Homo sapiens		EXP030000	553	unspecified	P48436	LoVo (colorectal adenocarcinoma)	PEAKS034379
EXP030313	SRF	Homo sapiens		EXP030000	553	unspecified	P11831	LoVo (colorectal adenocarcinoma)	PEAKS034380
EXP030314	HOXA1	Homo sapiens		EXP030000	553	unspecified	P49639	LoVo (colorectal adenocarcinoma)	PEAKS034381
EXP030315	HOXA2	Homo sapiens		EXP030000	553	unspecified	O43364	LoVo (colorectal adenocarcinoma)	PEAKS034382
EXP030316	FOXQ1	Homo sapiens		EXP030000	553	unspecified	Q9C009	LoVo (colorectal adenocarcinoma)	PEAKS034383
EXP030317	HOXA4	Homo sapiens		EXP030000	553	unspecified	Q00056	LoVo (colorectal adenocarcinoma)	PEAKS034384
EXP030318	HOXA5	Homo sapiens		EXP030000	553	unspecified	P20719	LoVo (colorectal adenocarcinoma)	PEAKS034385
EXP030319	HOXA6	Homo sapiens		EXP030000	553	unspecified	P31267	LoVo (colorectal adenocarcinoma)	PEAKS034386
EXP030320	HOXA7	Homo sapiens		EXP030000	553	unspecified	P31268	LoVo (colorectal adenocarcinoma)	PEAKS034387
EXP030321	HOXA9	Homo sapiens		EXP030000	553	unspecified	P31269	LoVo (colorectal adenocarcinoma)	PEAKS034388
EXP030322	NKX3-1	Homo sapiens		EXP030000	553	unspecified	Q99801	LoVo (colorectal adenocarcinoma)	PEAKS034389
EXP030323	BHLHE40	Homo sapiens		EXP030000	553	unspecified	O14503	LoVo (colorectal adenocarcinoma)	PEAKS034390
EXP030324	RUNX1	Homo sapiens		EXP030000	553	unspecified	Q01196	LoVo (colorectal adenocarcinoma)	PEAKS034391
EXP030325	CREBL2	Homo sapiens		EXP030000	553	unspecified	O60519	LoVo (colorectal adenocarcinoma)	PEAKS034392
EXP030326	SREBF1	Homo sapiens		EXP030000	553	unspecified	P36956	LoVo (colorectal adenocarcinoma)	PEAKS034393
EXP030327	MAFG	Homo sapiens		EXP030000	553	unspecified	O15525	LoVo (colorectal adenocarcinoma)	PEAKS034394
EXP030328	MAFF	Homo sapiens		EXP030000	553	unspecified	Q9ULX9	LoVo (colorectal adenocarcinoma)	PEAKS034395
EXP030329	RFX5	Homo sapiens		EXP030000	553	unspecified	P48382	LoVo (colorectal adenocarcinoma)	PEAKS034396
EXP030330	MAFB	Homo sapiens		EXP030000	553	unspecified	Q9Y5Q3	LoVo (colorectal adenocarcinoma)	PEAKS034397
EXP030331	RFX7	Homo sapiens		EXP030000	553	unspecified	Q2KHR2	LoVo (colorectal adenocarcinoma)	PEAKS034398
EXP030332	MAFK	Homo sapiens		EXP030000	553	unspecified	O60675	LoVo (colorectal adenocarcinoma)	PEAKS034399
EXP030333	FOXP3	Homo sapiens		EXP030000	553	unspecified	Q9BZS1	LoVo (colorectal adenocarcinoma)	PEAKS034400
EXP030334	FOXP1	Homo sapiens		EXP030000	553	unspecified	Q9H334	LoVo (colorectal adenocarcinoma)	PEAKS034401
EXP030335	SREBF2	Homo sapiens		EXP030000	553	unspecified	Q12772	LoVo (colorectal adenocarcinoma)	PEAKS034402
EXP030336	FOXP2	Homo sapiens		EXP030000	553	unspecified	O15409	LoVo (colorectal adenocarcinoma)	PEAKS034403
EXP030337	HOXB4	Homo sapiens		EXP030000	553	unspecified	P17483	LoVo (colorectal adenocarcinoma)	PEAKS034404
EXP030338	HOXB1	Homo sapiens		EXP030000	553	unspecified	P14653	LoVo (colorectal adenocarcinoma)	PEAKS034405
EXP030339	SALL4	Homo sapiens		EXP030000	553	unspecified	Q9UJQ4	LoVo (colorectal adenocarcinoma)	PEAKS034406
EXP030340	HOXB2	Homo sapiens		EXP030000	553	unspecified	P14652	LoVo (colorectal adenocarcinoma)	PEAKS034407
EXP030341	HOXB7	Homo sapiens		EXP030000	553	unspecified	P09629	LoVo (colorectal adenocarcinoma)	PEAKS034408
EXP030342	HOXB8	Homo sapiens		EXP030000	553	unspecified	P17481	LoVo (colorectal adenocarcinoma)	PEAKS034409
EXP030343	HOXB5	Homo sapiens		EXP030000	553	unspecified	P09067	LoVo (colorectal adenocarcinoma)	PEAKS034410
EXP030344	HOXB6	Homo sapiens		EXP030000	553	unspecified	P17509	LoVo (colorectal adenocarcinoma)	PEAKS034411
EXP030345	RFX1	Homo sapiens		EXP030000	553	unspecified	P22670	LoVo (colorectal adenocarcinoma)	PEAKS034412
EXP030346	RFX2	Homo sapiens		EXP030000	553	unspecified	P48378	LoVo (colorectal adenocarcinoma)	PEAKS034413
EXP030347	ZNF84	Homo sapiens		EXP030000	553	unspecified	P51523	LoVo (colorectal adenocarcinoma)	PEAKS034414
EXP030348	ZNF83	Homo sapiens		EXP030000	553	unspecified	P51522	LoVo (colorectal adenocarcinoma)	PEAKS034415
EXP030349	FOXK1	Homo sapiens		EXP030000	553	unspecified	P85037	LoVo (colorectal adenocarcinoma)	PEAKS034416
EXP030350	FOXK2	Homo sapiens		EXP030000	553	unspecified	Q01167	LoVo (colorectal adenocarcinoma)	PEAKS034417
EXP030351	FOS	Homo sapiens		EXP030000	553	unspecified	P01100	LoVo (colorectal adenocarcinoma)	PEAKS034418
EXP030352	ALX4	Homo sapiens		EXP030000	553	unspecified	Q9H161	LoVo (colorectal adenocarcinoma)	PEAKS034419
EXP030353	ERM	Homo sapiens		EXP030000	553	unspecified	P41161	LoVo (colorectal adenocarcinoma)	PEAKS034420
EXP030354	EGR1	Homo sapiens		EXP030000	553	unspecified	P18146	LoVo (colorectal adenocarcinoma)	PEAKS034421
EXP030355	EGR2	Homo sapiens		EXP030000	553	unspecified	P11161	LoVo (colorectal adenocarcinoma)	PEAKS034422
EXP030356	FOXJ2	Homo sapiens		EXP030000	553	unspecified	Q9P0K8	LoVo (colorectal adenocarcinoma)	PEAKS034423
EXP030357	EGR4	Homo sapiens		EXP030000	553	unspecified	Q05215	LoVo (colorectal adenocarcinoma)	PEAKS034424
EXP030358	DMRT1	Homo sapiens		EXP030000	553	unspecified	Q9Y5R6	LoVo (colorectal adenocarcinoma)	PEAKS034425
EXP030359	DMRT2	Homo sapiens		EXP030000	553	unspecified	Q9Y5R5	LoVo (colorectal adenocarcinoma)	PEAKS034426
EXP030360	LEF1	Homo sapiens		EXP030000	553	unspecified	Q9UJU2	LoVo (colorectal adenocarcinoma)	PEAKS034427
EXP030361	MSC	Homo sapiens		EXP030000	553	unspecified	O60682	LoVo (colorectal adenocarcinoma)	PEAKS034428
EXP030362	MIXL1	Homo sapiens		EXP030000	553	unspecified	Q9H2W2	LoVo (colorectal adenocarcinoma)	PEAKS034429
EXP030363	GZF1	Homo sapiens		EXP030000	553	unspecified	Q9H116	LoVo (colorectal adenocarcinoma)	PEAKS034430
EXP030364	CUX1	Homo sapiens		EXP030000	553	unspecified	P39880	LoVo (colorectal adenocarcinoma)	PEAKS034431
EXP030365	GLIS3	Homo sapiens		EXP030000	553	unspecified	Q8NEA6	LoVo (colorectal adenocarcinoma)	PEAKS034432
EXP030366	GLIS2	Homo sapiens		EXP030000	553	unspecified	Q9BZE0	LoVo (colorectal adenocarcinoma)	PEAKS034433
EXP030367	FOXM1	Homo sapiens		EXP030000	553	unspecified	Q08050	LoVo (colorectal adenocarcinoma)	PEAKS034434
EXP030368	GLIS1	Homo sapiens		EXP030000	553	unspecified	Q8NBF1	LoVo (colorectal adenocarcinoma)	PEAKS034435
EXP030369	CTCFL	Homo sapiens		EXP030000	553	unspecified	Q8NI51	LoVo (colorectal adenocarcinoma)	PEAKS034436
EXP030370	TCF7L2	Homo sapiens		EXP030000	553	unspecified	Q9NQB0	LoVo (colorectal adenocarcinoma)	PEAKS034437
EXP030371	TCF7L1	Homo sapiens		EXP030000	553	unspecified	Q9HCS4	LoVo (colorectal adenocarcinoma)	PEAKS034438
EXP030372	RAX2	Homo sapiens		EXP030000	553	unspecified	Q96IS3	LoVo (colorectal adenocarcinoma)	PEAKS034439
EXP030373	HAND1	Homo sapiens		EXP030000	553	unspecified	O96004	LoVo (colorectal adenocarcinoma)	PEAKS034440
EXP030374	NFAT5	Homo sapiens		EXP030000	553	unspecified	O94916	LoVo (colorectal adenocarcinoma)	PEAKS034441
EXP030375	HINFP	Homo sapiens		EXP030000	553	unspecified	Q9BQA5	LoVo (colorectal adenocarcinoma)	PEAKS034442
EXP030376	ZBTB7B	Homo sapiens		EXP030000	553	unspecified	O15156	LoVo (colorectal adenocarcinoma)	PEAKS034443
EXP030377	ERF	Homo sapiens		EXP030000	553	unspecified	P50548	LoVo (colorectal adenocarcinoma)	PEAKS034444
EXP030378	ERG	Homo sapiens		EXP030000	553	unspecified	P11308	LoVo (colorectal adenocarcinoma)	PEAKS034445
EXP030379	IRF9	Homo sapiens		EXP030000	553	unspecified	Q00978	LoVo (colorectal adenocarcinoma)	PEAKS034446
EXP030380	SP1	Homo sapiens		EXP030000	553	unspecified	P08047	LoVo (colorectal adenocarcinoma)	PEAKS034447
EXP030381	SP2	Homo sapiens		EXP030000	553	unspecified	Q02086	LoVo (colorectal adenocarcinoma)	PEAKS034448
EXP030382	SP3	Homo sapiens		EXP030000	553	unspecified	Q02447	LoVo (colorectal adenocarcinoma)	PEAKS034449
EXP030383	IRF8	Homo sapiens		EXP030000	553	unspecified	Q02556	LoVo (colorectal adenocarcinoma)	PEAKS034450
EXP030384	IRF1	Homo sapiens		EXP030000	553	unspecified	P10914	LoVo (colorectal adenocarcinoma)	PEAKS034451
EXP030385	IRF2	Homo sapiens		EXP030000	553	unspecified	P14316	LoVo (colorectal adenocarcinoma)	PEAKS034452
EXP030386	IRF3	Homo sapiens		EXP030000	553	unspecified	Q14653	LoVo (colorectal adenocarcinoma)	PEAKS034453
EXP030387	IRF4	Homo sapiens		EXP030000	553	unspecified	Q15306	LoVo (colorectal adenocarcinoma)	PEAKS034454
EXP030388	NFIB	Homo sapiens		EXP030000	553	unspecified	O00712	LoVo (colorectal adenocarcinoma)	PEAKS034455
EXP030398	CTCF	Homo sapiens		EXP030389	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS034456
EXP030399	CTCF	Homo sapiens		EXP030390	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	PEAKS034457
EXP030400	CTCF	Homo sapiens		EXP030391	430	unspecified	P49711	HepG2 (hepatoblastoma)	PEAKS034458
EXP030401	CTCF	Homo sapiens		EXP030392	440	unspecified	P49711	HMEC (human mammary epithelial cells)	PEAKS034459
EXP030402	CTCF	Homo sapiens		EXP030393	450	unspecified	P49711	skeletal muscles and myoblasts	PEAKS034460
EXP030403	CTCF	Homo sapiens		EXP030394	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034461
EXP030404	CTCF	Homo sapiens		EXP030395	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS034462
EXP030405	CTCF	Homo sapiens		EXP030396	673	unspecified	P49711	normal epidermal keratinocytes	PEAKS034463
EXP030406	CTCF	Homo sapiens		EXP030397	446	unspecified	P49711	HPF (pulmonary fibroblasts isolated from lung tissue)	PEAKS034464
EXP030408	kdm5a	Mus musculus		EXP030407	2	unspecified	Q3UXZ9	mESCs (mouse embryonic stem cells)	PEAKS035530
EXP030409	rbp2	Mus musculus		EXP030407	2	unspecified	Q3UXZ9	mESCs (mouse embryonic stem cells)	PEAKS035531
EXP030410	rbp2	Mus musculus	kdm5a KO	EXP030407	2	unspecified	Q3UXZ9	mESCs (mouse embryonic stem cells)	PEAKS035532
EXP030412	TCF12/HEB	Homo sapiens		EXP030411	510	unspecified	Q99081	Jurkat E6.1 (T-cells)	PEAKS034465
EXP030413	TCF3/E2A	Homo sapiens		EXP030411	510	unspecified	P15923	Jurkat E6.1 (T-cells)	PEAKS034466
EXP030414	GATA3	Homo sapiens		EXP030411	510	unspecified	P23771	Jurkat E6.1 (T-cells)	PEAKS034467
EXP030415	TAL1	Homo sapiens		EXP030411	510	unspecified	P17542	Jurkat E6.1 (T-cells)	PEAKS034468
EXP030416	RUNX1	Homo sapiens		EXP030411	510	unspecified	Q01196	Jurkat E6.1 (T-cells)	PEAKS034469
EXP030418	ab23980 (lot number728911)	Homo sapiens		EXP030417	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034470
EXP030421		Homo sapiens		EXP030419	39	unspecified	P06401	AB32 (normal breast cells)	PEAKS034471
EXP030422		Homo sapiens		EXP030420	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS034472
EXP030423	Glucocorticoid Receptor	Mus musculus	Dexamethasone treated, unstimulated	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	PEAKS035533
EXP030424	Glucocorticoid Receptor	Mus musculus	Dexamethasone treated, LPS-stimulated	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	PEAKS035534
EXP030425	p65	Mus musculus	Dexamethasone treated, LPS-stimulated	NULL	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS035535
EXP030426	cJun	Mus musculus	LPS-stimulated	NULL	81	unspecified	P05627	BMDM (bone marrow-derived macrophages)	PEAKS035536
EXP030427	cJun	Mus musculus	Dexamethasone treated, LPS-stimulated	NULL	81	unspecified	P05627	BMDM (bone marrow-derived macrophages)	PEAKS035537
EXP030428	GRIP1	Mus musculus	LPS-stimulated macrophages	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	PEAKS035538
EXP030429	GRIP1	Mus musculus	Dexamethasone treated, LPS-stimulated macrophages	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	PEAKS035539
EXP030430	IRF3	Mus musculus	LPS-stimulated macrophages	NULL	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS035540
EXP030431	IRF3	Mus musculus	Dexamethasone treated, LPS-stimulated macrophages	NULL	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS035541
EXP030433	anti-p63 4A4	Homo sapiens	progenitor	EXP030432	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS034473
EXP030434	anti-p63 4A4	Homo sapiens	differentiated	EXP030432	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS034474
EXP030438	Spi-1	Mus musculus		EXP030435	805	unspecified	P17433	spleen-derived erythroleukemic cells	PEAKS035542
EXP030439	Spi-1	Mus musculus		EXP030437	805	unspecified	P17433	spleen-derived erythroleukemic cells	PEAKS035543
EXP051005	anti-EGR2 (Krox-20)	Mus musculus		NULL	44	unspecified	P08152	T-cells	PEAKS049005
EXP030443	anti-EGR2 (Krox-20)	Mus musculus		EXP030440	647	unspecified	P08152	natural killer T cells	PEAKS035545
EXP030445	hoxc9	Homo sapiens		EXP030444	82	unspecified	P31274	SK-N-BE(2)-C (neuroblastoma)	PEAKS034475
EXP030447	ERa	Homo sapiens	estradiol	EXP030446	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034476
EXP030448	anti-RAR	Mus musculus	all trans retinoic acid	NULL	2	unspecified	P11416	mESCs (mouse embryonic stem cells)	PEAKS035546
EXP030449	anti-RAR	Mus musculus	all trans retinoic acid	NULL	2	unspecified	P11416	mESCs (mouse embryonic stem cells)	PEAKS035547
EXP030451	abcam 7970, lot number GR51446-1	Mus musculus	differentiated TNF	EXP030450	18	unspecified	Q04207	3T3-L1 (embryonic fibroblasts)	PEAKS035548
EXP030453	Ebf1 (custom-made against murine Ebf1b)	Mus musculus		EXP030452	41	unspecified	Q07802	B-cells	PEAKS035549
EXP030454	anti-Foxo3a (FKHRL1 (H-144))	Mus musculus		NULL	81	unspecified	Q9WVH4	BMDM (bone marrow-derived macrophages)	PEAKS035550
EXP030456	anti-CLK (Novus Biological; #NB100-126; lot B1)	Mus musculus		EXP030455	5	unspecified	O08785	liver	PEAKS035551
EXP030457	anti-BMAL1 (Abcam; #ab3350-200; lot 805009)	Mus musculus		EXP030455	5	unspecified	Q9WTL8	liver	PEAKS035552
EXP030459	NcoA3	Mus musculus		EXP030458	230	unspecified	O09000	ES-E14 (E14, embryonic stem cells)	PEAKS035553
EXP030461	anti-SNAPC 190 (SNAAD17A) mouse monoclonal (Santa Cruz, sc-81379)	Homo sapiens		EXP030460	583	unspecified	Q5SXM2	MCF10A (breast epithelial cells)	PEAKS034477
EXP051033	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		NULL	105	unspecified	Q02650	pro-B cells	PEAKS049033
EXP051034	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		NULL	105	unspecified	Q02650	pro-B cells	PEAKS049034
EXP030465	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		EXP030462	578	unspecified	Q02650	mature B-cells	PEAKS035556
EXP030466	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		EXP030462	578	unspecified	Q02650	mature B-cells	PEAKS035557
EXP030467	(G22) sc-133592, lot A2109	Homo sapiens		NULL	78	unspecified	P85037	HeLa (cervical adenocarcinoma)	PEAKS034478
EXP030468	(H-140) sc-134550, lot A1110	Homo sapiens		NULL	78	unspecified	P85037	HeLa (cervical adenocarcinoma)	PEAKS034479
EXP030470	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Homo sapiens		NULL	514	unspecified	P52747	K562 (myelogenous leukemia)	PEAKS034480
EXP030471	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Homo sapiens		NULL	11	unspecified	P52747	HEK293-T-Rex (embryonic kidney)	PEAKS034481
EXP030472	ZNF143	Homo sapiens		EXP030469	444	unspecified	P52747	HPB-ALL (T acute lymphoblastic leukemia)	PEAKS034482
EXP030473	HA, 12CA5 antibody, (Roche Applied Science)	Homo sapiens	0h Induction with 1Âµg/mL ofdoxycycline	NULL	307	unspecified	P52747	FLP143HA (embryonic kidney)	PEAKS034483
EXP030474	HA, 12CA5 antibody, (Roche Applied Science)	Homo sapiens	4h Induction with 1Âµg/mL ofdoxycycline	NULL	307	unspecified	P52747	FLP143HA (embryonic kidney)	PEAKS034484
EXP030475	ZNF76, mouse monoclonal (Santa Cruz Biotechnology, cat. #sc-81147)	Homo sapiens	4h Induction with 1Âµg/mL ofdoxycycline	NULL	308	unspecified	Q9NYW8	FLP76 (embryonic kidney)	PEAKS034485
EXP030476	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Mus musculus		NULL	675	unspecified	O70230	NIH 3T3 (embryonic fibroblasts)	PEAKS035558
EXP030477	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Mus musculus		NULL	506	unspecified	O70230	J1 (embryonic stem cells)	PEAKS035559
EXP030478	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Mus musculus		NULL	12	unspecified	O70230	MEF (mouse embryonic fibroblasts)	PEAKS035560
EXP030479	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Homo sapiens		NULL	423	unspecified	P52747	HeLa S3 (cervical adenocarcinoma)	PEAKS034486
EXP030480	SRC-1 (Santa Cruz, M-341, sc-8495)	Homo sapiens	ethanol	NULL	557	unspecified	Q15788	LS180 (colon cancer)	PEAKS034487
EXP030481	SRC-1 (Santa Cruz, M-341, sc-8495)	Homo sapiens	10-7M 1,25-dihydroxyvitamin D3	NULL	557	unspecified	Q15788	LS180 (colon cancer)	PEAKS034488
EXP030482	NCoR (Santa Cruz, C-20, sc-1609)	Homo sapiens	ethanol	NULL	557	unspecified	O75376	LS180 (colon cancer)	PEAKS034489
EXP030483	NCoR (Santa Cruz, C-20, sc-1609)	Homo sapiens	10-7M 1,25-dihydroxyvitamin D3	NULL	557	unspecified	O75376	LS180 (colon cancer)	PEAKS034490
EXP030484	SMRT (Affinity Bioreagents, PA1-843)	Homo sapiens	ethanol	NULL	557	unspecified	Q9Y618	LS180 (colon cancer)	PEAKS034491
EXP030485	SMRT (Affinity Bioreagents, PA1-843)	Homo sapiens	10-7M 1,25-dihydroxyvitamin D3	NULL	557	unspecified	Q9Y618	LS180 (colon cancer)	PEAKS034492
EXP030489	Meis1/2 (K830, K844)	Mus musculus		EXP030486	134	unspecified	Q60954	embryo trunk (day 11.5)	PEAKS035561
EXP030490	Prep1/2 (N15 Santa Cruz)	Mus musculus		EXP030487	134	unspecified	O70477	embryo trunk (day 11.5)	PEAKS035562
EXP030491	Pbx1 (4342 CST)	Mus musculus		EXP030488	134	unspecified	P41778	embryo trunk (day 11.5)	PEAKS035563
EXP030496	anti-AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: Vehicle; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034493
EXP030497	anti-AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 1000 nM Bica; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034494
EXP030498	anti-GR (Widen et al. 2000)	Homo sapiens	Treatment: 2 hours of 100 nM DEX; Time point: 2 hours	EXP030493	70	normal	P04150	LNCaP (prostate carcinoma)	PEAKS034495
EXP030499	anti-GR (BuGr2, Millipore and Mab-010-050, Diagenode)	Homo sapiens	Treatment: 2 hours of 100 nM DEX; Time point: 2 hours	EXP030494	71	normal	P04150	VCaP (prostate carcinoma)	PEAKS034496
EXP030500	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 100 nM DHT; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034497
EXP030501	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 100 nM DHT+Dex; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034498
EXP030502	anti-GR (BuGr2, Millipore and Mab-010-050, Diagenode)	Homo sapiens	Treatment: 2 hours of 100 nM Dex; Time point: 2 hours	EXP030493	70	normal	P04150	LNCaP (prostate carcinoma)	PEAKS034499
EXP030503	anti-GR (BuGr2, Millipore and Mab-010-050, Diagenode)	Homo sapiens	Treatment: 2 hours of 100 nM DHT+Dex; Time point: 2 hours	EXP030493	70	normal	P04150	LNCaP (prostate carcinoma)	PEAKS034500
EXP030504	non-commercial (Kang et al, 2004)	Homo sapiens	Treatment: 2 hours of 100nm DHT or 100nm DEX, siRNA against FoxA1; Time point: 2 hours; Genotype: FoxA1 depletion	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034501
EXP030505	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 1000 nM CPA; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034502
EXP030506	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 1000 nM RU486; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS034503
EXP030507	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 100 nM DHT; Time point: 2 hours	EXP030494	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034504
EXP030509	p53	Homo sapiens		EXP030508	396	unspecified	P04637	WA09 (embryonic stem cells)	PEAKS034505
EXP030510	p53	Homo sapiens	DOX	EXP030508	396	unspecified	P04637	WA09 (embryonic stem cells)	PEAKS034506
EXP030511	p53	Homo sapiens	Retinoic Acid	EXP030508	396	unspecified	P04637	WA09 (embryonic stem cells)	PEAKS034507
EXP030513	NKX3.1 Santa Cruz (sc-15022)	Homo sapiens		EXP030512	70	unspecified	Q99801	LNCaP (prostate carcinoma)	PEAKS034508
EXP030514	sc-6554	Mus musculus		NULL	177	unspecified	P35583	embryonic stem cell-derived endodermal cells	PEAKS035564
EXP030516	sc-592, Santa Cruz Biotechnology	Mus musculus		EXP030515	1058	unspecified	P42225	CD4+ T-cells	PEAKS035565
EXP030518	KDM2A	Mus musculus		EXP030517	252	unspecified	P59997	V6.5 (embryonic stem cells)	PEAKS035566
EXP030520	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034509
EXP030521	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034510
EXP030522	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034511
EXP030523	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034512
EXP030524	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034513
EXP030525	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034514
EXP030526	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034515
EXP030527	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034516
EXP030528	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034517
EXP030529	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034518
EXP030530	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034519
EXP030531	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	PEAKS034520
EXP030533	Millipore 07-729	Mus musculus		EXP030532	140	unspecified	Q61164	CD4- CD8- T cells	PEAKS035567
EXP030535	c-Myc	Homo sapiens	24 hr	EXP030534	880	unspecified	P01106	B-cells	PEAKS034521
EXP030536	Max	Homo sapiens	24 hr	EXP030534	880	unspecified	P61244	B-cells	PEAKS034522
EXP030538	Grhl3 (Andersen Lab)	Homo sapiens		EXP030537	215	unspecified	Q8TE85	keratinocytes	PEAKS034523
EXP030540	Flag M2, Sigma	Homo sapiens		EXP030539	798	unspecified	Q03112	SK-OV-3 (ovarian serous cystadenocarcinoma)	PEAKS034524
EXP030541	Gata2	Mus musculus		NULL	576	unspecified	O09100	mast cells	PEAKS035568
EXP030542	Gfi1	Mus musculus		NULL	576	unspecified	P70338	mast cells	PEAKS035569
EXP030544	Cebpa, Santa Cruz 14-AA	Mus musculus		EXP030543	425	unspecified	P53566	hematopoietic stem cells	PEAKS035570
EXP030545	Cebpa: Santa Cruz 14-AA	Mus musculus		NULL	400	unspecified	P53566	hematopoietic progenitors	PEAKS035571
EXP030546	Cebpa: Santa Cruz 14-AA	Mus musculus		NULL	643	unspecified	P28033	Tot2 (myeloid progenitor cell line)	PEAKS035572
EXP030548	BCL6	Homo sapiens		EXP030547	327	unspecified	P41182	germinal center B-cells	PEAKS034525
EXP030549	SMRT	Homo sapiens		EXP030547	327	unspecified	Q9Y618	germinal center B-cells	PEAKS034526
EXP030552	CTCF (Millipore ref: 07-729 lot: DAM1772428)	Mus musculus	stimulated	EXP030550	41	unspecified	Q61164	B-cells	PEAKS035573
EXP030553	CTCF (Millipore ref: 07-729 lot: DAM1772428)	Mus musculus		NULL	41	unspecified	Q61164	B-cells	PEAKS035574
EXP030555	Upstate 07-729	Homo sapiens		EXP030554	618	unspecified	P49711	MM1.S (plasma cell myeloma)	PEAKS034527
EXP030565	Ascl1 (ab74065)	Mus musculus		EXP030556	12	unspecified	Q02067	MEF (mouse embryonic fibroblasts)	PEAKS035575
EXP030566	Ascl1 (ab74065)	Mus musculus	Ascl1	EXP030557	138	unspecified	Q02067	neural progenitors	PEAKS035576
EXP030567	Ascl1 (ab74065)	Homo sapiens		EXP030558	2360	unspecified	P50553	fibroblasts	PEAKS034528
EXP030568	Ascl1 (ab74065)	Homo sapiens		EXP030559	463	unspecified	P50553	epidermal keratinocytes	PEAKS034529
EXP030569	Brn2 (ab15828)	Mus musculus		EXP030560	12	unspecified	P31360	MEF (mouse embryonic fibroblasts)	PEAKS035577
EXP030570	Brn2 (ab15828)	Mus musculus	BAM factors	EXP030561	12	unspecified	P31360	MEF (mouse embryonic fibroblasts)	PEAKS035578
EXP030571	Santa Cruz Biotechnology SC-6029	Mus musculus		EXP030562	138	unspecified	P31360	neural progenitors	PEAKS035579
EXP030572	Myt1l (ab15828)	Mus musculus	BAM factors	EXP030563	12	unspecified	P97500	MEF (mouse embryonic fibroblasts)	PEAKS035580
EXP030573	Ascl1 (ab74065)	Mus musculus	BAM factors	EXP030564	12	unspecified	Q02067	MEF (mouse embryonic fibroblasts)	PEAKS035581
EXP030574	anti-HA (Roche 11867423001)	Mus musculus		NULL	213	unspecified	Q64249	mesenchymal stem cells	PEAKS035582
EXP030575	NR6A1	Mus musculus		NULL	213	unspecified	Q64249	mesenchymal stem cells	PEAKS035583
EXP030578	anti-A-MYB	Mus musculus		EXP030576	32	unspecified	P51960	testis	PEAKS035584
EXP030581	ESE-3A (E-15) antibody [Santa Cruz Biotechnology, Catalog# sc-15450, Lot# I1704]	Mus musculus		EXP030580	133	unspecified	O70273	corneal epithelium	PEAKS035585
EXP030586	Rabbit Anti-AR (Epitomics Clone ER179)	Mus musculus		EXP030582	632	unspecified	P19091	prostate	PEAKS035586
EXP030587	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030582	632	unspecified	P81270	prostate	PEAKS035587
EXP030588	Rabbit Anti-AR (Epitomics Clone ER179)	Mus musculus		EXP030583	632	unspecified	P19091	prostate	PEAKS035588
EXP030589	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030583	632	unspecified	P81270	prostate	PEAKS035589
EXP030590	androgen	Mus musculus		EXP030584	632	unspecified	P19091	prostate	PEAKS035590
EXP030591	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030584	632	unspecified	P81270	prostate	PEAKS035591
EXP030592	Rabbit Anti-AR (Epitomics Clone ER179)	Mus musculus		EXP030585	632	unspecified	P19091	prostate	PEAKS035592
EXP030593	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030585	632	unspecified	P81270	prostate	PEAKS035593
EXP030596	ptf1a	Mus musculus		NULL	827	unspecified	Q9QX98	telencephalon	PEAKS035594
EXP030597	Lab generated rabbit anti-Ptf1a (AN255/256)	Mus musculus		EXP030594	476	unspecified	Q9QX98	neural tube	PEAKS035595
EXP030598	Lab generated rabbit anti-Ptf1a (AN255/256)	Mus musculus		EXP030595	713	unspecified	Q9QX98	pancreas	PEAKS035596
EXP030599	Lab generated rabbit anti-Rbpj(Tx857)	Mus musculus		EXP030594	476	unspecified	P31266	neural tube	PEAKS035597
EXP030600	Lab generated rabbit anti-Rbpjl (AN2165/2166)	Mus musculus		EXP030595	713	unspecified	O08674	pancreas	PEAKS035598
EXP030601	Goat anti-Foxa2 (Santa cruz;Hnf3b M-20 #6554)	Mus musculus		EXP030595	713	unspecified	P35583	pancreas	PEAKS035599
EXP030603	Anti-FLAG M2 Affinity Gel (Sigma)	Mus musculus		EXP030602	53	unspecified	P97474	heart	PEAKS035600
EXP030604	FOXA2	Mus musculus		NULL	132	unspecified	P35583	uterus	PEAKS035601
EXP030605	FOXA2	Mus musculus		NULL	132	unspecified	P35583	uterus	PEAKS035602
EXP030608	AR	Homo sapiens		EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034530
EXP030609	AR	Homo sapiens	1 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034531
EXP030610	AR	Homo sapiens	100 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034532
EXP030611	AR	Homo sapiens		EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034533
EXP030612	AR	Homo sapiens	1 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034534
EXP030613	AR	Homo sapiens	100 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034535
EXP030614	AR	Homo sapiens		EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034536
EXP030615	AR	Homo sapiens	1 nM  DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034537
EXP030616	AR	Homo sapiens	100 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034538
EXP030617	AR	Homo sapiens		EXP030607	560	unspecified	P10275	LuCaP73 (prostate carcinoma)	PEAKS034539
EXP030618	AR	Homo sapiens		EXP030607	559	unspecified	P10275	LuCaP69 (prostate carcinoma)	PEAKS034540
EXP030621	ESR1	Mus musculus		EXP030619	5	unspecified	P19785	liver	PEAKS035603
EXP030622	ESR1	Mus musculus		EXP030620	132	unspecified	P19785	uterus	PEAKS035604
EXP030632	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030623	683	unspecified	P40763	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS034541
EXP030633	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030624	684	unspecified	P40763	OCI-LY19 (diffuse large B-cell lymphoma)	PEAKS034542
EXP030634	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030625	686	unspecified	P40763	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS034543
EXP030635	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030626	687	unspecified	P40763	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS034544
EXP030636	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030627	812	unspecified	P40763	SU-DHL-10 (diffuse large B-cell lymphoma)	PEAKS034545
EXP030637	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030628	813	unspecified	P40763	SU-DHL-2 (anaplastic large cell lymphoma)	PEAKS034546
EXP030638	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030629	815	unspecified	P40763	SU-DHL-4 (diffuse large B-cell lymphoma)	PEAKS034547
EXP030639	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030630	816	unspecified	P40763	SU-DHL-6 (diffuse large B-cell lymphoma)	PEAKS034548
EXP030640	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030631	847	unspecified	P40763	U2932 (diffuse large B-cell lymphoma)	PEAKS034549
EXP030643	sc-372	Mus musculus		EXP030642	570	unspecified	Q04207	macrophages	PEAKS035605
EXP030644	sc-372	Mus musculus		EXP030642	570	unspecified	Q04207	macrophages	PEAKS035606
EXP030645	sc-372	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP030642	570	unspecified	Q04207	macrophages	PEAKS035607
EXP030646	sc-372	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP030642	570	unspecified	Q04207	macrophages	PEAKS035608
EXP030654	Santa Cruz Biotechnology, Inc. : sc-15914 X	Homo sapiens		EXP030648	371	unspecified	P49711	GP5d (colon adenocarcinoma)	PEAKS034550
EXP030655	Santa Cruz Biotechnology, Inc. : sc-8987	Homo sapiens		EXP030650	371	unspecified	P41235	GP5d (colon adenocarcinoma)	PEAKS034551
EXP030656	Abcam : ab28837	Homo sapiens		EXP030650	371	unspecified	P17535	GP5d (colon adenocarcinoma)	PEAKS034552
EXP030657	Santa Cruz Biotechnology, Inc. : sc-22797	Homo sapiens		EXP030650	371	unspecified	Q13887	GP5d (colon adenocarcinoma)	PEAKS034553
EXP030658	Abcam : ab32	Homo sapiens		EXP030650	371	unspecified	P01106	GP5d (colon adenocarcinoma)	PEAKS034554
EXP030659	Abcam : ab21635	Homo sapiens		EXP030650	371	unspecified	Q13127	GP5d (colon adenocarcinoma)	PEAKS034555
EXP030660	Santa Cruz Biotechnology, Inc. : sc-10659 X	Homo sapiens		EXP030648	371	unspecified	P48378	GP5d (colon adenocarcinoma)	PEAKS034556
EXP030661	Santa Cruz Biotechnology, Inc. : sc-15914 X	Homo sapiens	siRAD21	EXP030651	371	unspecified	P49711	GP5d (colon adenocarcinoma)	PEAKS034557
EXP030662	Santa Cruz Biotechnology, Inc. : sc-8987	Homo sapiens	siRAD21	EXP030653	371	unspecified	P41235	GP5d (colon adenocarcinoma)	PEAKS034558
EXP030663	Abcam : ab28837	Homo sapiens	siRAD21	EXP030653	371	unspecified	P17535	GP5d (colon adenocarcinoma)	PEAKS034559
EXP030664	Santa Cruz Biotechnology, Inc. : sc-22797	Homo sapiens	siRAD21	EXP030653	371	unspecified	Q13887	GP5d (colon adenocarcinoma)	PEAKS034560
EXP030665	Abcam : ab32	Homo sapiens	siRAD21	EXP030653	371	unspecified	P01106	GP5d (colon adenocarcinoma)	PEAKS034561
EXP030666	Abcam : ab21635	Homo sapiens	siRAD21	EXP030653	371	unspecified	Q13127	GP5d (colon adenocarcinoma)	PEAKS034562
EXP030667	Santa Cruz Biotechnology, Inc. : sc-10659 X	Homo sapiens	siRAD21	EXP030651	371	unspecified	P48378	GP5d (colon adenocarcinoma)	PEAKS034563
EXP030670	GT	Homo sapiens	DEX 100nM	EXP030668	555	unspecified	P04150	LREX' (prostate cancer)	PEAKS034564
EXP030671	AR	Homo sapiens	DHT 1nM	EXP030669	555	unspecified	P10275	LREX' (prostate cancer)	PEAKS034565
EXP030672	anti-Cebpa (Santa Cruz, catalog: sc-61, lot: k1009)	Mus musculus		NULL	41	unspecified	P53566	B-cells	PEAKS035609
EXP030673	anti-Cebpa (Santa Cruz, catalog: sc-61, lot: k1009)	Mus musculus	Estradiol for 18h	NULL	41	unspecified	P53566	B-cells	PEAKS035610
EXP030674	Anti-KDM5B antibody (Abcam; ab50958)	Mus musculus		NULL	765	unspecified	Q80Y84	R1 (embryonic stem cells)	PEAKS035611
EXP030675	SC-543	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034566
EXP030676	SC-543	Homo sapiens		NULL	409	unspecified	P03372	HCC-1428 (breast adenocarcinoma)	PEAKS034567
EXP030678	Monoclonal ANTI-FLAG M2 antibody	Mus musculus		EXP030677	247	unspecified	Q61602	embryonic heart	PEAKS035612
EXP030681	C/EBPbeta	Mus musculus		EXP030679	483	unspecified	P28033	brown preadipocytes	PEAKS035613
EXP030682	C/EBPbeta	Mus musculus		EXP030679	483	unspecified	P28033	brown preadipocytes	PEAKS035614
EXP030683	C/EBPbeta	Mus musculus		EXP030680	483	unspecified	P28033	brown preadipocytes	PEAKS035615
EXP030684	C/EBPbeta	Mus musculus		EXP030680	483	unspecified	P28033	brown preadipocytes	PEAKS035616
EXP030685	MLL4	Mus musculus		EXP030679	483	unspecified	O08550	brown preadipocytes	PEAKS035617
EXP030686	MLL4	Mus musculus		EXP030680	483	unspecified	O08550	brown preadipocytes	PEAKS035618
EXP030688	Utf1 (Abcam, ab24273)	Mus musculus	Standard Serum	EXP030687	2	unspecified	Q6J1H4	mESCs (mouse embryonic stem cells)	PEAKS035619
EXP030689	Utf1 (Abcam, ab24273)	Mus musculus	Standard Serum	EXP030687	2	unspecified	Q6J1H4	mESCs (mouse embryonic stem cells)	PEAKS035620
EXP030694	PAX8	Rattus norvegicus		EXP030693	727	unspecified	P51974	PCCL3 (thyroid cells)	PEAKS036812
EXP030696	ZNF143; Polyclonal anti-ZNF143 (ZNF143, {Cold Spring Harbor, 19164 #4})	Homo sapiens		EXP030695	78	unspecified	P52747	HeLa (cervical adenocarcinoma)	PEAKS034568
EXP030697	THAP11; polyclonal anti-THAP11 (G4275, {Dejosez, 2008 #99})	Homo sapiens		EXP030695	78	unspecified	Q96EK4	HeLa (cervical adenocarcinoma)	PEAKS034569
EXP030698	GABP; polyclonal anti-GABPa (sc-22810)	Homo sapiens		EXP030695	78	unspecified	Q06546	HeLa (cervical adenocarcinoma)	PEAKS034570
EXP030699	YY1; polyclonal anti-YY1 (sc-1703)	Homo sapiens		EXP030695	78	unspecified	P25490	HeLa (cervical adenocarcinoma)	PEAKS034571
EXP030701	PU.1	Homo sapiens		EXP030700	98	unspecified	P17947	blood monocytes	PEAKS034572
EXP030702	ebp	Homo sapiens		EXP030700	98	unspecified	P17676	blood monocytes	PEAKS034573
EXP030703	PU.1	Homo sapiens		EXP030700	466	unspecified	P17947	MDM(monocyte derived macrophages)	PEAKS034574
EXP030704	C/EBPbeta	Homo sapiens		EXP030700	466	unspecified	P17676	MDM(monocyte derived macrophages)	PEAKS034575
EXP030705	EGR2	Homo sapiens		EXP030700	466	unspecified	P11161	MDM(monocyte derived macrophages)	PEAKS034576
EXP030706	anti-MLL1	Mus musculus		NULL	614	unspecified	P55200	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS035621
EXP030708	CDX2 Ab	Homo sapiens		EXP030707	185	unspecified	Q99626	COLO-320 (colon adenocarcinoma)	PEAKS034577
EXP030709	CDX2 Ab (clone CDX2-88)	Homo sapiens		EXP030707	185	unspecified	Q99626	COLO-320 (colon adenocarcinoma)	PEAKS034578
EXP030711	ab70183	Homo sapiens		EXP030710	774	unspecified	O95251	RKO (colon carcinoma cell)	PEAKS034579
EXP030713	M2 (Sigma Aldrich)	Mus musculus		EXP030712	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS035622
EXP030714	M2 (Sigma Aldrich)	Mus musculus		EXP030712	18	unspecified	P05627	3T3-L1 (embryonic fibroblasts)	PEAKS035623
EXP030715	17-600 (Millipore)	Mus musculus	DMSO	EXP030712	18	unspecified	Q01147	3T3-L1 (embryonic fibroblasts)	PEAKS035624
EXP030716	17-600 (Millipore)	Mus musculus	lactacystin	EXP030712	18	unspecified	Q01147	3T3-L1 (embryonic fibroblasts)	PEAKS035625
EXP030717	CTCF	Mus musculus		NULL	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS035626
EXP030718	V5	Mus musculus		NULL	2	unspecified	A2APF3	mESCs (mouse embryonic stem cells)	PEAKS035627
EXP030719	CTCFL	Mus musculus		NULL	2	unspecified	A2APF3	mESCs (mouse embryonic stem cells)	PEAKS035628
EXP030721	A300-797A	Mus musculus		EXP030720	536	unspecified	A2A5K6	lateral telencephalon	PEAKS035629
EXP030722	A300-798A	Mus musculus		EXP030720	536	unspecified	A2A5K6	lateral telencephalon	PEAKS035630
EXP030724	anti-Flag antibody	Mus musculus		EXP030723	871	unspecified	P20263	ZHBTc4 F-Oct4 (embryonic stem cells)	PEAKS035631
EXP030726	Smad3	Mus musculus	TGFb	EXP030725	2775	unspecified	Q8BUN5	neural stem cells	PEAKS035632
EXP030728	A300-086A	Homo sapiens		EXP030727	779	unspecified	Q03164	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS034580
EXP030730	anti-AR (Santa Cruz (N-20))	Homo sapiens		EXP030729	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034581
EXP030734	AR	Homo sapiens	EtOH vehicle treated	EXP030732	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034582
EXP030735	AR	Homo sapiens	EtOH vehicle treated	EXP030733	7	unspecified	P10275	22RV1 (prostate carcinoma)	PEAKS034583
EXP030736	AR	Homo sapiens	DHT treated (4h)	EXP030733	7	unspecified	P10275	22RV1 (prostate carcinoma)	PEAKS034584
EXP030737	FOXA1	Homo sapiens	EtOH vehicle treated	EXP030731	129	unspecified	P55317	LNCaP C4-2B (prostate carcinoma)	PEAKS034585
EXP030738	FOXA1	Homo sapiens	DHT treated (4h)	EXP030731	129	unspecified	P55317	LNCaP C4-2B (prostate carcinoma)	PEAKS034586
EXP030739	AR	Homo sapiens	EtOH vehicle treated	EXP030731	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS034587
EXP030740	AR	Homo sapiens	DHT treated (16h)	EXP030731	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS034588
EXP030741	androgen	Homo sapiens	DHT treated (4h)	EXP030732	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034589
EXP030744	ab5089	Homo sapiens	siNT	EXP030742	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS034590
EXP030745	ab5089	Homo sapiens	siGATA	EXP030742	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS034591
EXP030746	sc-543	Homo sapiens	siNT, E2 100nM for 3h	EXP030743	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	PEAKS034592
EXP030747	sc-543	Homo sapiens	siGATA, E2 100nM for 3h	EXP030743	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	PEAKS034593
EXP030748	sc-248	Homo sapiens	E2 100nM for 3h	EXP030742	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS034594
EXP030749	sc-248	Homo sapiens		EXP030742	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS034595
EXP030750	sc-543	Homo sapiens	siNT, E2 100nM for 3h	EXP030742	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034596
EXP030751	sc-543	Homo sapiens	siGATA, E2 100nM for 3h	EXP030742	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034597
EXP030752	CTCF (Pugacheva et. al. 2005 Hum Mol Genet 14, 953-965)	Mus musculus		NULL	96	unspecified	Q61164	trophoblast stem cells	PEAKS035633
EXP030753	sc-7208	Homo sapiens	RU486	NULL	538	unspecified	P06401	uterine leiomyoma smooth muscle cells	PEAKS034598
EXP030754	sc-7208	Homo sapiens	RU486	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS034599
EXP030759	sc-6059	Mus musculus		EXP030755	498	unspecified	Q64287	Th17-cells	PEAKS035634
EXP030760	BATF	Mus musculus		EXP030755	498	unspecified	O35284	Th17-cells	PEAKS035635
EXP030761	sc-6059	Mus musculus		EXP030758	499	unspecified	Q64287	Th2-cells	PEAKS035636
EXP030762	sc-6059	Mus musculus		EXP030756	830	unspecified	Q64287	Th0-cells	PEAKS035637
EXP030763	sc-6059	Mus musculus	stimulated with LPS for 6hrs	EXP030757	104	unspecified	Q64287	dendritic cells	PEAKS035638
EXP030766	Santa Cruz, sc-1081	Mus musculus		EXP030764	573	unspecified	P42230	mammary tissue	PEAKS035639
EXP030767	Santa Cruz, sc-835	Mus musculus		EXP030764	573	unspecified	P42232	mammary tissue	PEAKS035640
EXP030768	Santa Cruz, sc-1081	Mus musculus	stat5a-null	EXP030765	573	unspecified	P42230	mammary tissue	PEAKS035641
EXP030769	Santa Cruz, sc-835	Mus musculus	stat5a-null	EXP030765	573	unspecified	P42232	mammary tissue	PEAKS035642
EXP030770	TFAP2C monoclonal antibody SC-12762X (Santa Cruz Biotechnology, Santa Cruz, CA)	Homo sapiens		NULL	36	unspecified	Q92754	A375 (malignant melanoma)	PEAKS034600
EXP030772	sc-8563	Homo sapiens		EXP030771	511	unspecified	Q01196	T-REx-Jurkat (T-cells)	PEAKS034601
EXP030774	GFP (Abcam, ab290)	Mus musculus		EXP030773	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	PEAKS035643
EXP030777	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF (10ng/ml)	EXP030775	157	unspecified	P42224	CD14+ monocytes	PEAKS034602
EXP030778	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF (10ng/ml) and stimulated with LPS (50ng/ml) for 3 hours	EXP030775	157	unspecified	P42224	CD14+ monocytes	PEAKS034603
EXP030779	IRF1 (Santa Cruz sc-497)	Homo sapiens	MCSF (10ng/ml)	EXP030776	157	unspecified	P10914	CD14+ monocytes	PEAKS034604
EXP030780	IRF1 (Santa Cruz sc-497)	Homo sapiens	MCSF (10ng/ml) and IFN-gamma (100U/ml) for 24 hours	EXP030776	157	unspecified	P10914	CD14+ monocytes	PEAKS034605
EXP030781	IRF1 (Santa Cruz sc-497)	Homo sapiens	MCSF (10ng/ml) and stimulated with LPS (50ng/ml) for 6 hours	EXP030776	157	unspecified	P10914	CD14+ monocytes	PEAKS034606
EXP030782	IRF1 (Santa Cruz sc-497)	Homo sapiens	Cultured with MCSF (10ng/ml) and IFN-gamma (100U/ml) for 24 hours, stimulated with LPS (50ng/ml) for 6 hours	EXP030776	157	unspecified	P10914	CD14+ monocytes	PEAKS034607
EXP030783	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF 10ng/ml and IFN-gamma 100U/ml for 24 hours	EXP030775	157	unspecified	P42224	CD14+ monocytes	PEAKS034608
EXP030784	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF (10ng/ml) and IFN-gamma (100U/ml) for 24 hours, stimulated with LPS (50ng/ml) for 3 hours	EXP030775	157	unspecified	P42224	CD14+ monocytes	PEAKS034609
EXP030787	ZFX	Homo sapiens		EXP030785	677	unspecified	P17010	NOMO-1 (acute monocytic leukemia)	PEAKS034610
EXP030788	ZFX	Homo sapiens		EXP030786	777	unspecified	P17010	RPMI-8402 (T acute lymphoblastic leukemia)	PEAKS034611
EXP030789	Mash1	Mus musculus		NULL	804	unspecified	Q02067	spinal cord	PEAKS035644
EXP030796	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	no treatment	EXP030790	514	unspecified	Q00613	K562 (myelogenous leukemia)	PEAKS034612
EXP030797	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	no treatment	EXP030790	514	unspecified	Q03933	K562 (myelogenous leukemia)	PEAKS034613
EXP030798	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	30 min at 42C	EXP030791	514	unspecified	Q00613	K562 (myelogenous leukemia)	PEAKS034614
EXP030799	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	30 min at 42C	EXP030791	514	unspecified	Q03933	K562 (myelogenous leukemia)	PEAKS034615
EXP030800	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	no treatment	EXP030793	514	unspecified	Q00613	K562 (myelogenous leukemia)	PEAKS034616
EXP030801	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	no treatment	EXP030793	514	unspecified	Q03933	K562 (myelogenous leukemia)	PEAKS034617
EXP030802	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	30 min at 42C	EXP030794	514	unspecified	Q00613	K562 (myelogenous leukemia)	PEAKS034618
EXP030803	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	30 min at 42C	EXP030794	514	unspecified	Q03933	K562 (myelogenous leukemia)	PEAKS034619
EXP030805	GATA1	Homo sapiens		EXP030804	766	unspecified	P15976	R3/R4 erythroid cells	PEAKS034620
EXP030806	KLF1	Homo sapiens		EXP030804	766	unspecified	Q13351	R3/R4 erythroid cells	PEAKS034621
EXP030807	NFE2	Homo sapiens		EXP030804	766	unspecified	Q16621	R3/R4 erythroid cells	PEAKS034622
EXP030809	sc-7196	Mus musculus		NULL	115	unspecified	P37238	brown adipose tissue	PEAKS035645
EXP030810	sc-7196	Mus musculus		NULL	3	unspecified	P37238	epididymal white adipose tissue	PEAKS035646
EXP030812	Santa Cruz SC-8628X	Mus musculus		EXP030811	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS035647
EXP030813	R&D Systems MAB2018	Mus musculus		EXP030811	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS035648
EXP030814	Bethyl A300-397A	Mus musculus		EXP030811	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS035649
EXP030817	USF1	Mus musculus		EXP030815	5	unspecified	Q61069	liver	PEAKS035650
EXP030818	USF1	Mus musculus		EXP030816	5	unspecified	Q61069	liver	PEAKS035651
EXP030819	USF1	Mus musculus		EXP030815	5	unspecified	Q61069	liver	PEAKS035652
EXP030820	USF1	Mus musculus		EXP030815	5	unspecified	Q61069	liver	PEAKS035653
EXP030821	CLOCK (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	O08785	liver	PEAKS035654
EXP030822	CLOCK (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030816	5	unspecified	O08785	liver	PEAKS035655
EXP030823	CLOCK (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	O08785	liver	PEAKS035656
EXP030824	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	Q9WTL8	liver	PEAKS035657
EXP030825	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus	C57BL/6J, liver, Clock delta 19	EXP030816	5	unspecified	Q9WTL8	liver	PEAKS035658
EXP030826	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	Q9WTL8	liver	PEAKS035659
EXP030827	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	Q9WTL8	liver	PEAKS035660
EXP030829	IRF3 (Abcam, ab76367)	Homo sapiens		EXP030828	1521	unspecified	Q14653	Namalwa (Burkitt lymphoma)	PEAKS034623
EXP030830	IRF3 (Abcam, ab76367)	Homo sapiens	sendai virus	EXP030828	1521	unspecified	Q14653	Namalwa (Burkitt lymphoma)	PEAKS034624
EXP030831	NF?B p65 (Abcam, ab7970)	Homo sapiens		EXP030828	1521	unspecified	Q04206	Namalwa (Burkitt lymphoma)	PEAKS034625
EXP030832	NF?B p65 (Abcam, ab7970)	Homo sapiens	sendai virus	EXP030828	1521	unspecified	Q04206	Namalwa (Burkitt lymphoma)	PEAKS034626
EXP030835	anti-RUNX1 (c-terminus) [Yoram Groner lab, Weizmann Institute]	Homo sapiens		EXP030833	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034627
EXP030836	anti-RUNX1 (n-terminus) [Yoram Groner lab, Weizmann Institute]	Homo sapiens		EXP030833	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034628
EXP030837	anti-AP4 [Takeshi Egawa]	Homo sapiens		EXP030834	516	unspecified	Q01664	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034629
EXP030841	GRHL2	Homo sapiens		EXP030838	114	unspecified	Q6ISB3	bronchial epithelial cells	PEAKS034630
EXP030842	GRHL2	Homo sapiens		EXP030839	114	unspecified	Q6ISB3	bronchial epithelial cells	PEAKS034631
EXP030843	GRHL2	Homo sapiens		EXP030840	114	unspecified	Q6ISB3	bronchial epithelial cells	PEAKS034632
EXP030846	ERG-1/2/3 (clone C-17, Sc354X, Santa Cruz)	Mus musculus		EXP030844	917	unspecified	P81270	spleen	PEAKS035661
EXP030847	ERG-1/2/3 (clone C-17, Sc354X, Santa Cruz)	Mus musculus		EXP030845	917	unspecified	P81270	spleen	PEAKS035662
EXP030850	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	Doxo	EXP030848	566	unspecified	P04637	lymphoblastoid cells	PEAKS034633
EXP030851	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	vehicle	EXP030849	566	unspecified	P04637	lymphoblastoid cells	PEAKS034634
EXP030853	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	nutlin-3	EXP030852	566	unspecified	P04637	lymphoblastoid cells	PEAKS034635
EXP030855	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	ionizing radiation	EXP030854	566	unspecified	P04637	lymphoblastoid cells	PEAKS034636
EXP030857	Cebpa: Santa Cruz 14-AA	Mus musculus		EXP030856	400	unspecified	P53566	hematopoietic progenitors	PEAKS035663
EXP030858	07-729 from Millipore	Mus musculus		NULL	266	unspecified	Q61164	erythroblasts	PEAKS035664
EXP030859	ab11852 from Abcam	Mus musculus		NULL	266	unspecified	P17679	erythroblasts	PEAKS035665
EXP030860	SC-477 from Santa Crus	Mus musculus		NULL	266	unspecified	Q07279	erythroblasts	PEAKS035666
EXP030864	LHX2	Mus musculus		EXP030861	160	unspecified	Q9Z0S2	hair follicle stem cells	PEAKS035667
EXP030865	LHX2	Mus musculus		EXP030862	160	unspecified	Q9Z0S2	hair follicle stem cells	PEAKS035668
EXP030866	LHX2	Mus musculus		EXP030863	160	unspecified	Q9Z0S2	hair follicle stem cells	PEAKS035669
EXP030868	TCF3	Mus musculus		EXP030867	160	unspecified	Q9Z1J1	hair follicle stem cells	PEAKS035670
EXP030869	sc-8631	Mus musculus		EXP030867	160	unspecified	Q924A0	hair follicle stem cells	PEAKS035671
EXP030872	anti-C/EBP? (sc-61; Santa Cruz)	Mus musculus	0.1% DMSO (Vehicle) for 1 hour	EXP030870	20	unspecified	P53566	3T3-L1-derived adipocytes	PEAKS035672
EXP030873	anti-C/EBP? (sc-61; Santa Cruz)	Mus musculus	1 Î¼M rosiglitazone / 0.1% DMSO for 1 hour	EXP030871	20	unspecified	P53566	3T3-L1-derived adipocytes	PEAKS035673
EXP030874	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	0.1% DMSO (Vehicle) for 1 hour	EXP030870	20	unspecified	P37238	3T3-L1-derived adipocytes	PEAKS035674
EXP030875	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	1 Î¼M rosiglitazone / 0.1% DMSO for 1 hour	EXP030871	20	unspecified	P37238	3T3-L1-derived adipocytes	PEAKS035675
EXP030876	NFATc1 (generated by our laboratories)	Homo sapiens		NULL	472	unspecified	O95644	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034637
EXP030877	NFATc1 (generated by our laboratories)	Homo sapiens	VEGF for 1h	NULL	472	unspecified	O95644	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034638
EXP030879	anti-p53 antibody (Santa Cruz Biotech; catalog# sc-6243; lot# C1609)	Mus musculus		EXP030878	234	unspecified	P02340	E15.5 embryonic kidney	PEAKS035676
EXP030880	CTCF  cell type: CD4+ T cells	Homo sapiens		NULL	881	unspecified	P49711	CD4+ T-cells	PEAKS034639
EXP030881	CTCF  cell type: HeLa cells	Homo sapiens		NULL	78	unspecified	P49711	HeLa (cervical adenocarcinoma)	PEAKS034640
EXP030882	CTCF  cell type: Jurkat cells	Homo sapiens		NULL	509	unspecified	P49711	Jurkat (T-cells)	PEAKS034641
EXP030885	C/EBPalpha	Mus musculus		EXP030883	429	unspecified	P53566	hepatocytes	PEAKS035677
EXP030886	FOXA2	Mus musculus		EXP030883	429	unspecified	P35583	hepatocytes	PEAKS035678
EXP030887	FOXA1	Mus musculus		EXP030883	429	unspecified	P35582	hepatocytes	PEAKS035679
EXP030888	E2F4	Mus musculus		EXP030883	429	unspecified	Q8R0K9	hepatocytes	PEAKS035680
EXP030889	C/EBPalpha	Mus musculus		EXP030884	20	unspecified	P53566	3T3-L1-derived adipocytes	PEAKS035681
EXP030890	E2F4	Mus musculus		EXP030884	20	unspecified	Q8R0K9	3T3-L1-derived adipocytes	PEAKS035682
EXP030891	anti-p53	Homo sapiens		NULL	93	unspecified	P04637	BJ (fibroblasts)	PEAKS034642
EXP030892	anti-p53	Homo sapiens	p53 KO	NULL	93	unspecified	P04637	BJ (fibroblasts)	PEAKS034643
EXP030894	gata4	Mus musculus		EXP030893	437	unspecified	Q08369	HL-1 (cardiac muscle cells)	PEAKS035683
EXP030895	mef2a	Mus musculus		EXP030893	437	unspecified	Q60929	HL-1 (cardiac muscle cells)	PEAKS035684
EXP030896	nkx2-5	Mus musculus		EXP030893	437	unspecified	P42582	HL-1 (cardiac muscle cells)	PEAKS035685
EXP030897	srf	Mus musculus		EXP030893	437	unspecified	Q9JM73	HL-1 (cardiac muscle cells)	PEAKS035686
EXP030898	tbx5	Mus musculus		EXP030893	437	unspecified	P70326	HL-1 (cardiac muscle cells)	PEAKS035687
EXP030899	sc357	Homo sapiens		NULL	516	unspecified	Q99081	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034644
EXP030900	sc353	Homo sapiens		NULL	796	unspecified	P11308	SKNO-1 (acute myeloid leukemia)	PEAKS034645
EXP030901	sc356	Homo sapiens		NULL	796	unspecified	Q01543	SKNO-1 (acute myeloid leukemia)	PEAKS034646
EXP030902	ERG	Homo sapiens		NULL	65	unspecified	P11308	U937 (adult acute monocytic leukemia)	PEAKS034647
EXP030903	ERG	Homo sapiens		NULL	65	unspecified	P11308	U937 (adult acute monocytic leukemia)	PEAKS034648
EXP030904	ERG	Homo sapiens		NULL	69	unspecified	P11308	acute promyelocytic leukemia blasts	PEAKS034649
EXP030905	RUNX1	Homo sapiens		NULL	796	unspecified	Q01196	SKNO-1 (acute myeloid leukemia)	PEAKS034650
EXP030906	ERG	Homo sapiens		NULL	113	unspecified	P11308	MCF7 (Invasive ductal breast carcinoma)	PEAKS034651
EXP030907	ERG	Homo sapiens		NULL	514	unspecified	P11308	K562 (myelogenous leukemia)	PEAKS034652
EXP030908	ERG	Homo sapiens	72 hrs dox	NULL	514	unspecified	P11308	K562 (myelogenous leukemia)	PEAKS034653
EXP030909	antibody FLI1 (Abcam, Ab15289)	Homo sapiens		NULL	648	unspecified	Q01543	NB4 (acute promyelocytic leukemia )	PEAKS034654
EXP030910	antibody FLI1 (Abcam, Ab15289)	Homo sapiens		NULL	850	unspecified	Q01543	acute leukemia	PEAKS034655
EXP030911	antibody FLI1 (Abcam, Ab15289)	Homo sapiens	5 hrs zinc	NULL	850	unspecified	Q01543	acute leukemia	PEAKS034656
EXP030917	myf5	Mus musculus		EXP030912	904	unspecified	P24699	myoblasts	PEAKS035688
EXP030918	myod	Mus musculus		EXP030912	904	unspecified	P10085	myoblasts	PEAKS035689
EXP030919	myod	Mus musculus	10 hours in differentiating medium	EXP030913	644	unspecified	P10085	myocytes	PEAKS035690
EXP030920	myod	Mus musculus	48 hours in differentiating medium	EXP030914	645	unspecified	P10085	myotubes	PEAKS035691
EXP030921	myod	Mus musculus		EXP030915	897	unspecified	P10085	fibroblasts	PEAKS035692
EXP030922	snai1	Mus musculus		EXP030916	904	unspecified	Q02085	myoblasts	PEAKS035693
EXP030928	santa cruz, sc-543	Homo sapiens	oestrogen	EXP030924	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034657
EXP030929	santa cruz, sc-543	Homo sapiens	vehicle	EXP030923	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034658
EXP030930	HNF4a	Homo sapiens	none	EXP030927	430	unspecified	P41235	HepG2 (hepatoblastoma)	PEAKS034659
EXP030931	CTCF	Homo sapiens	oestrogen, CTCF siRNA	EXP030925	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS034660
EXP030932	CTCF	Homo sapiens	oestrogen	EXP030926	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS034661
EXP030933	Millipore, 07-729	Homo sapiens	oestrogen	EXP030924	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS034662
EXP030934	Millipore, 07-729	Homo sapiens	none	EXP030927	430	unspecified	P49711	HepG2 (hepatoblastoma)	PEAKS034663
EXP030935	santa cruz, sc-9314	Homo sapiens	none	EXP030927	430	unspecified	P49715	HepG2 (hepatoblastoma)	PEAKS034664
EXP030937	Pax7	Mus musculus		EXP030936	904	unspecified	P47239	myoblasts	PEAKS035694
EXP030938	Pax3	Mus musculus		EXP030936	904	unspecified	P24610	myoblasts	PEAKS035695
EXP030949	sc-1312	Mus musculus	untreated	EXP030947	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	PEAKS035696
EXP030950	sc-1312	Mus musculus	adriamycin	EXP030948	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	PEAKS035697
EXP030951	anti-p53S18P	Mus musculus	untreated	EXP030947	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	PEAKS035698
EXP030952	anti-p53S18P	Mus musculus	adriamycin	EXP030948	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	PEAKS035699
EXP030954	B-Myb	Homo sapiens		EXP030953	78	unspecified	P10244	HeLa (cervical adenocarcinoma)	PEAKS034665
EXP030955	anti-SMRT	Mus musculus		NULL	81	unspecified	Q9WU42	BMDM (bone marrow-derived macrophages)	PEAKS035700
EXP030956	anti-NCoR	Mus musculus		NULL	81	unspecified	Q60974	BMDM (bone marrow-derived macrophages)	PEAKS035701
EXP030957	anti-SMRT	Mus musculus		NULL	81	unspecified	Q9WU42	BMDM (bone marrow-derived macrophages)	PEAKS035702
EXP030958	anti-NCoR	Mus musculus		NULL	81	unspecified	Q60974	BMDM (bone marrow-derived macrophages)	PEAKS035703
EXP030960	anti-REST (Santa Cruz, #H-290)	Mus musculus		EXP030959	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS035704
EXP030961	anti-REST (Santa Cruz, #H-290)	Mus musculus		EXP030959	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS035705
EXP030962	anti-REST (Santa Cruz, #H-290)	Mus musculus		EXP030959	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS035706
EXP030963	anti-REST (Santa Cruz, #H-290)	Mus musculus		NULL	138	unspecified	Q8VIG1	neural progenitors	PEAKS035707
EXP030964	anti-REST (Santa Cruz, #H-290)	Mus musculus		NULL	138	unspecified	Q8VIG1	neural progenitors	PEAKS035708
EXP030965	anti-REST (Santa Cruz, #H-290)	Mus musculus		NULL	138	unspecified	Q8VIG1	neural progenitors	PEAKS035709
EXP030966	Invtrogen, monoclonal antibody ST3-5G7	Mus musculus		NULL	104	unspecified	P42227	dendritic cells	PEAKS035710
EXP030967	Invtrogen, monoclonal antibody ST3-5G7	Mus musculus	IL21	NULL	104	unspecified	P42227	dendritic cells	PEAKS035711
EXP030968	Invtrogen, monoclonal antibody ST3-5G7	Mus musculus	IL-21 and GM-CSF	NULL	104	unspecified	P42227	dendritic cells	PEAKS035712
EXP030969	R&D systems, anti-stat 5B serum PA-ST5B	Mus musculus		NULL	104	unspecified	P42232	dendritic cells	PEAKS035713
EXP030970	R&D systems, anti-stat 5B serum PA-ST5B	Mus musculus	IL21	NULL	104	unspecified	P42232	dendritic cells	PEAKS035714
EXP030971	R&D systems, anti-stat 5B serum PA-ST5B	Mus musculus	IL-21 and GM-CSF	NULL	104	unspecified	P42232	dendritic cells	PEAKS035715
EXP030973	Ptf1a  (Beta Cell Biology Consortium)	Mus musculus		EXP030972	8	unspecified	Q9QX98	266-6 (pancreatic acinar tumor)	PEAKS035716
EXP030975	SMAD4 (20% Cell Signaling Technology, 80% Santa Cruz Biotechnology)	Homo sapiens	none	EXP030974	33	unspecified	Q13485	A2780 (ovarian carcinoma)	PEAKS036813
EXP030976	SMAD4 (20% Cell Signaling Technology, 80% Santa Cruz Biotechnology)	Homo sapiens	TGF-beta	EXP030974	33	unspecified	Q13485	A2780 (ovarian carcinoma)	PEAKS036814
EXP030979	GATA3	Mus musculus	Th1	EXP030977	1058	unspecified	P23772	CD4+ T-cells	PEAKS035717
EXP030980	GATA3	Mus musculus	Th2	EXP030978	1058	unspecified	P23772	CD4+ T-cells	PEAKS035718
EXP030982	anti LXR alpha and beta	Homo sapiens	vehicle	EXP030981	2334	unspecified	Q13133	THP-1 (acute monocytic leukemia)	PEAKS034666
EXP030983	anti LXR alpha and beta	Homo sapiens	T09	EXP030981	2334	unspecified	Q13133	THP-1 (acute monocytic leukemia)	PEAKS034667
EXP030984	Sox2 produced in-house	Mus musculus	control	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	PEAKS035719
EXP030985	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	PEAKS035720
EXP030986	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	PEAKS035721
EXP030987	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	PEAKS035722
EXP030988	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	PEAKS035723
EXP030989	Sox2 produced in-house	Mus musculus	Tet	NULL	13	unspecified	P48432	2TS22C (embryonic stem cells)	PEAKS035724
EXP030991	anti-AP4 (sc-18593 (N-17), lot D2903)	Homo sapiens	Treatment: 2 hours of 100nM DHT; Growth: cells were maintained in RPMI Medium 1640 (Gibco) supplemented with 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, 100 units/ml penicillin, 100 ug/ml streptomycin, and 30 ug/ml gentamycin in a 37C incubator with 5% CO2. Prior to vehicle/drug stimulation, ~4 millions cells were seeded into 150 mm dish and starved with phenol red-free RPMI Medium 1640 containing 5% charcoal-dextran treated FBS (Hyclone) and the same amount of sodium pyruvate, penicillin, streptomycin and gentamycin as mentioned earlier for at least 72 hrs to ~80% confluence.	EXP030990	70	normal	Q01664	LNCaP (prostate carcinoma)	PEAKS034668
EXP030994	NR2F1 (PP-H8132-00, Perseus Proteomics)	Homo sapiens		EXP030993	661	unspecified	P10589	H9-derived neural crest cells	PEAKS034669
EXP030995	NR2F2 (PP-H7147-00, Perseus Proteomics)	Homo sapiens		EXP030993	661	unspecified	P24468	H9-derived neural crest cells	PEAKS034670
EXP030996	ap2	Homo sapiens		EXP030992	661	unspecified	P05549	H9-derived neural crest cells	PEAKS034671
EXP030998	anti-AR (Santa Cruz, sc-815x, D1709)	Homo sapiens	Treatment: none; Time point: 0 hours	EXP030997	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034672
EXP030999	anti-AR (Santa Cruz, sc-815x, D1709)	Homo sapiens	Treatment: 2 hours of DHT; Time point: 2 hours	EXP030997	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034673
EXP031000	anti-AR (Santa Cruz, sc-815x, D1709)	Homo sapiens	Treatment: 18 hours of DHT; Time point: 18 hours	EXP030997	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034674
EXP031001	anti-ERG (Santa Cruz, sc-353, lot l2509)	Homo sapiens	Treatment: none; Time point: 0 hours	EXP030997	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS034675
EXP031002	anti-ERG (Santa Cruz, sc-353, lot l2509)	Homo sapiens	Treatment: 2 hours of DHT; Time point: 2 hours	EXP030997	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS034676
EXP031003	anti-ERG (Santa Cruz, sc-353, lot l2509)	Homo sapiens	Treatment: 18 hours of DHT; Time point: 18 hours	EXP030997	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS034677
EXP031023	CTCF	Mus musculus		EXP031004	193	unspecified	Q61164	cortex	PEAKS035725
EXP031024	CTCF	Mus musculus		EXP031005	103	unspecified	Q61164	bone marrow	PEAKS035726
EXP031025	CTCF	Mus musculus		EXP031006	25	unspecified	Q61164	cerebellum	PEAKS035727
EXP031026	CTCF	Mus musculus		EXP031007	53	unspecified	Q61164	heart	PEAKS035728
EXP031027	CTCF	Mus musculus		EXP031008	523	unspecified	Q61164	kidney	PEAKS035729
EXP031028	CTCF	Mus musculus		EXP031009	5	unspecified	Q61164	liver	PEAKS035730
EXP031029	CTCF	Mus musculus		EXP031010	561	unspecified	Q61164	lung	PEAKS035731
EXP031030	CTCF	Mus musculus		EXP031022	917	unspecified	Q61164	spleen	PEAKS035732
EXP031031	CTCF	Mus musculus		EXP031011	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS035733
EXP031032	CTCF	Mus musculus		EXP031012	117	unspecified	Q61164	Bruce4 (embryonic stem cells)	PEAKS035734
EXP031033	CTCF	Mus musculus		EXP031013	622	unspecified	Q61164	E14.5 brain	PEAKS035735
EXP031034	CTCF	Mus musculus		EXP031014	623	unspecified	Q61164	E14.5 heart	PEAKS035736
EXP031035	CTCF	Mus musculus		EXP031015	624	unspecified	Q61164	E14.5 limb	PEAKS035737
EXP031036	CTCF	Mus musculus		EXP031016	5	unspecified	Q61164	liver	PEAKS035738
EXP031037	CTCF	Mus musculus		EXP031017	142	unspecified	Q61164	intestine	PEAKS035739
EXP031038	CTCF	Mus musculus		EXP031018	162	unspecified	Q61164	olfactory bulb	PEAKS035740
EXP031039	CTCF	Mus musculus		EXP031019	631	unspecified	Q61164	placenta	PEAKS035741
EXP031040	CTCF	Mus musculus		EXP031020	32	unspecified	Q61164	testis	PEAKS035742
EXP031041	CTCF	Mus musculus		EXP031021	139	unspecified	Q61164	thymus	PEAKS035743
EXP031049	BCL6 (N3-antibody)	Homo sapiens		EXP031043	685	unspecified	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS034678
EXP031051	SMRT	Homo sapiens		EXP031045	685	unspecified	Q9Y618	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS034679
EXP031052	NCOR	Homo sapiens		EXP031046	685	unspecified	O75376	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS034680
EXP031053	BCL6 N-3	Homo sapiens		EXP031047	327	unspecified	P41182	germinal center B-cells	PEAKS034681
EXP031055	ab23980-100	Mus musculus	Runx1+/VE-cadherin+/CD41+	EXP031054	216	unspecified	Q03347	differentiated embryonic stem cells	PEAKS035744
EXP031056	ab23980-100	Mus musculus	Runx1+/VE-cadherin+/CD41-	EXP031054	216	unspecified	Q03347	differentiated embryonic stem cells	PEAKS035745
EXP031057	ab23980-100	Mus musculus	Runx1+/VE-cadherin-/CD41+	EXP031054	216	unspecified	Q03347	differentiated embryonic stem cells	PEAKS035746
EXP031060	elf5	Homo sapiens	doxycycline 24 hours	EXP031058	111	unspecified	Q9UKW6	T47D (invasive ductal carcinoma)	PEAKS034682
EXP031061	elf5	Homo sapiens	doxycycline 48 hours	EXP031059	111	unspecified	Q9UKW6	T47D (invasive ductal carcinoma)	PEAKS034683
EXP031064	SC8589	Mus musculus		EXP031062	550	unspecified	Q00417	Lin- SCA+ CD34+ hematopoietic stem cells	PEAKS035747
EXP031065	anti-AML(RUNX1) rabbit polyclonal antibody	Mus musculus		EXP031063	550	unspecified	Q03347	Lin- SCA+ CD34+ hematopoietic stem cells	PEAKS035748
EXP031071	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031066	301	unspecified	P17433	fetal liver precursors	PEAKS035749
EXP031072	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031067	301	unspecified	P17433	fetal liver precursors	PEAKS035750
EXP031073	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031068	301	unspecified	P17433	fetal liver precursors	PEAKS035751
EXP031074	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031070	44	unspecified	P17433	T-cells	PEAKS035752
EXP031075	GATA3 (Santa cruz sc-268)	Mus musculus		EXP031066	301	unspecified	P23772	fetal liver precursors	PEAKS035753
EXP031076	GATA3 (Santa cruz sc-268)	Mus musculus		EXP031068	301	unspecified	P23772	fetal liver precursors	PEAKS035754
EXP031077	GATA3 (Santa cruz sc-268)	Mus musculus		EXP031070	44	unspecified	P23772	T-cells	PEAKS035755
EXP031078	Anti-Androgen Receptor (AR)	Homo sapiens		NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034684
EXP031079	Anti-Androgen Receptor (AR)	Homo sapiens		NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS034685
EXP031082	T-bet; Antibody vendor: Lab produced (Szabo et al., Nature 2000).	Homo sapiens		EXP031080	886	unspecified	Q9UL17	Th1-cells	PEAKS034686
EXP031083	GATA-3; Antibody vendor: Santa Cruz; Antibody catalog number:sc-22206; Antibody lot number: F1306	Homo sapiens		EXP031080	886	unspecified	P23771	Th1-cells	PEAKS034687
EXP031084	GATA-3; Antibody vendor: Santa Cruz; Antibody catalog number:sc-22206; Antibody lot number: F1306	Homo sapiens		EXP031081	907	unspecified	P23771	Th2-cells	PEAKS034688
EXP031086	sc-9008	Mus musculus		EXP031085	320	unspecified	O09100	G1ME (megakaryocyte progenitor cell line)	PEAKS035756
EXP031087	sc-7392	Mus musculus		EXP031085	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS035757
EXP031088	sc-350	Mus musculus		EXP031085	320	unspecified	P27577	G1ME (megakaryocyte progenitor cell line)	PEAKS035758
EXP031090	anti-V5 (Abcam, ab15828, Lot: 103968)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P50481	Ainv15 (embryonic stem cells)	PEAKS035759
EXP031091	anti-Isl1/2 (gift from Dr. T. Jessell)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P61372	Ainv15 (embryonic stem cells)	PEAKS035760
EXP031092	anti-V5 (Abcam, ab15828)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	Q62066	Ainv15 (embryonic stem cells)	PEAKS035761
EXP031093	anti-Isl1/2 (gift from Dr. T. Jessell)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P61372	Ainv15 (embryonic stem cells)	PEAKS035762
EXP031094	anti-Isl1/2 (gift from Dr. T. Jessell)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P61372	Ainv15 (embryonic stem cells)	PEAKS035763
EXP031097	anti-STAT3 (Santa Cruz sc-482)	Mus musculus		EXP031095	48	unspecified	P42227	adherent peritoneal exudate macrophages	PEAKS035764
EXP031098	anti-STAT3 (Santa Cruz sc-482)	Mus musculus	Il10	EXP031096	48	unspecified	P42227	adherent peritoneal exudate macrophages	PEAKS035765
EXP031099	ab21061	Mus musculus		NULL	615	unspecified	P70338	bone marrow progenitors	PEAKS035766
EXP031101	p63 (4A4)	Homo sapiens		EXP031100	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS034689
EXP031104	homemade Aiolos	Mus musculus		EXP031102	171	unspecified	O08900	CD4+ CD8+ T cells	PEAKS035767
EXP031105	homemade Ikaros (Ikzf1)	Mus musculus		EXP031103	171	unspecified	Q03267	CD4+ CD8+ T cells	PEAKS035768
EXP031106	anti-AR (Santa Cruz, sc-816)	Homo sapiens	Treatment: 4 hours of 10nM DHT; Growth: Cells were incubated in DMEM supplemented with 5% charcoal/dextran-treated FBS for 3 days; Time point: 4 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034690
EXP031107	anti-AR (Santa Cruz, sc-816)	Homo sapiens	Treatment: 4 hours of 10nM DHT; Growth: Cells were incubated in DMEM supplemented with 5% charcoal/dextran-treated FBS for 3 days; Time point: 4 hours	NULL	859	normal	P10275	VCS2 (prostate carcinoma)	PEAKS034691
EXP031110	Bethyl,A301.034A	Homo sapiens		EXP031108	514	unspecified	P41229	K562 (myelogenous leukemia)	PEAKS034692
EXP031111	Bethyl,A301-145A	Homo sapiens		EXP031108	514	unspecified	O75376	K562 (myelogenous leukemia)	PEAKS034693
EXP031112	Abcam,ab73539	Homo sapiens		EXP031108	514	unspecified	O96028	K562 (myelogenous leukemia)	PEAKS034694
EXP031113	Millipore,17-641	Homo sapiens		EXP031108	514	unspecified	Q13127	K562 (myelogenous leukemia)	PEAKS034695
EXP031114	Abcam,ab26049	Homo sapiens		EXP031109	376	unspecified	P29375	WA01 (H1, human embryonic stem cells)	PEAKS034696
EXP031115	Abcam,ab26049	Homo sapiens		EXP031109	376	unspecified	P29375	WA01 (H1, human embryonic stem cells)	PEAKS034697
EXP031116	Bethyl,A301.813A	Homo sapiens		EXP031109	376	unspecified	Q9UGL1	WA01 (H1, human embryonic stem cells)	PEAKS034698
EXP031117	Bethyl,A301.034A	Homo sapiens		EXP031109	376	unspecified	P41229	WA01 (H1, human embryonic stem cells)	PEAKS034699
EXP031118	A custom antibody	Homo sapiens		EXP031108	514	unspecified	Q9UGL1	K562 (myelogenous leukemia)	PEAKS034700
EXP031120	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034701
EXP031121	AR	Homo sapiens	Treatment: 30 mins of 0.1% DMSO (Vehicle ); Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034702
EXP031122	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 0.1uM Compound 30; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034703
EXP031123	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 1uM Compound 30; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034704
EXP031124	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 10uM Compound 30; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034705
EXP031125	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 0.1uM Compound 26; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034706
EXP031126	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 1uM Compound 26; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034707
EXP031127	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 10uM Compound 26; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS034708
EXP031130	ab19867	Mus musculus	all-trans retinoic acid (RA)	EXP031129	704	unspecified	Q60954	P19C6 (embryonic carcinoma)	PEAKS035769
EXP031131	Anti-Tet1	Mus musculus		EXP031128	704	unspecified	Q3URK3	P19C6 (embryonic carcinoma)	PEAKS035770
EXP031132	Anti-Tet1	Mus musculus	all-trans retinoic acid (RA)	EXP031129	704	unspecified	Q3URK3	P19C6 (embryonic carcinoma)	PEAKS035771
EXP031137	Runx1	Mus musculus	50nM TPA	EXP031133	533	unspecified	Q03347	L8057 (megakaryoblastic leukemia)	PEAKS035772
EXP031138	Runx1	Mus musculus		EXP031134	533	unspecified	Q03347	L8057 (megakaryoblastic leukemia)	PEAKS035773
EXP031139	Runx1	Mus musculus		EXP031135	44	unspecified	Q03347	T-cells	PEAKS035774
EXP031140	Runx1	Mus musculus	Runx1KO	EXP031136	44	unspecified	Q03347	T-cells	PEAKS035775
EXP031141	Foxa1	Mus musculus		NULL	5	unspecified	P35582	liver	PEAKS035776
EXP031143	Ikaros-N terminal Ab (IkN)	Mus musculus		EXP031142	139	bio_control	Q03267	thymus	PEAKS035777
EXP031144	Ikaros-N terminal Ab (IkN)	Mus musculus		EXP031142	139	bio_control	Q03267	thymus	PEAKS035778
EXP031145	Ikaros-N terminal Ab (IkN)	Mus musculus		EXP031142	139	unspecified	Q03267	thymus	PEAKS035779
EXP031149	Santa Cruz SC-349	Homo sapiens		EXP031146	153	unspecified	P15923	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS034709
EXP031150	Santa Cruz SC-22206	Homo sapiens		EXP031146	153	unspecified	P23771	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS034710
EXP031151	Santa Cruz SC-357	Homo sapiens		EXP031146	153	unspecified	Q99081	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS034711
EXP031152	Santa Cruz SC-8563	Homo sapiens		EXP031146	153	unspecified	Q01196	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS034712
EXP031153	Santa Cruz SC-12984	Homo sapiens		EXP031146	153	unspecified	P17542	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS034713
EXP031154	Santa Cruz SC-12984	Homo sapiens		EXP031147	825	unspecified	P17542	T-cell acute lymphoblastic leukemia	PEAKS034714
EXP031155	Santa Cruz SC-12984	Homo sapiens		EXP031148	825	unspecified	P17542	T-cell acute lymphoblastic leukemia	PEAKS034715
EXP031157	sc-188	Homo sapiens	Dox + Arvanil + BMP7	EXP031156	332	unspecified	P18847	glioblastoma cells	PEAKS034716
EXP031161	anti-HoxB4	Mus musculus		EXP031158	208	unspecified	P10284	embryoid body (day 6)	PEAKS035780
EXP031162	anti-HoxB4	Mus musculus		EXP031159	237	unspecified	P10284	embryoid body	PEAKS035781
EXP031163	HoxB4	Mus musculus		EXP031160	237	unspecified	P10284	embryoid body	PEAKS035782
EXP031165	REV-ERB alpha	Mus musculus		EXP031164	5	unspecified	Q3UV55	liver	PEAKS035783
EXP031166	REV-ERB beta	Mus musculus		EXP031164	5	unspecified	Q60674	liver	PEAKS035784
EXP031167	sc-551	Mus musculus		NULL	184	unspecified	P11416	CMTi-1 (embryonic stem cells)	PEAKS035785
EXP031168	sc-551	Mus musculus	shH2A.Z	NULL	184	unspecified	P11416	CMTi-1 (embryonic stem cells)	PEAKS035786
EXP031169	Abcam: Ab19857	Mus musculus		NULL	184	unspecified	P20263	CMTi-1 (embryonic stem cells)	PEAKS035787
EXP031170	Abcam: Ab19857	Mus musculus	shH2A.Z	NULL	184	unspecified	P20263	CMTi-1 (embryonic stem cells)	PEAKS035788
EXP031171	ab7970	Homo sapiens		NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034717
EXP031172	ab7970	Homo sapiens	TNF 10ng/ml for 30 min	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034718
EXP031175	ETO(C20)sc ( lot number F1809)	Homo sapiens		NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034719
EXP031176	ETO(C20)sc ( lot number F1809)	Homo sapiens		NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034720
EXP031177	ETO (E/S19)	Homo sapiens		EXP031173	45	unspecified	Q01196	acute myeloblastic leukemia	PEAKS034721
EXP031178	ETO (E/S19)	Homo sapiens		EXP031174	45	unspecified	Q01196	acute myeloblastic leukemia	PEAKS034722
EXP031180	Bethyl BL3194, lotA300-691A-1	Mus musculus		EXP031179	634	unspecified	P43241	villus	PEAKS035789
EXP031181	HNF4? c-19 (Santa Cruz 6547, lot c1810)	Mus musculus		EXP031179	634	unspecified	P49698	villus	PEAKS035790
EXP031182	HNF4? c-19 (Santa Cruz 6547, lot c1810)	Mus musculus		EXP031179	634	unspecified	P49698	villus	PEAKS035791
EXP031183	Bethyl BL3194, lotA300-691A-1	Mus musculus		EXP031179	634	unspecified	P43241	villus	PEAKS035792
EXP031185	Anti-FLAG M2	Homo sapiens		EXP031184	423	unspecified	Q14119	HeLa S3 (cervical adenocarcinoma)	PEAKS034723
EXP031187	HIF-2alpha (PM9)	Homo sapiens		EXP031186	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	PEAKS034724
EXP031188	HIF-1beta (Novus Biologicals, NB100-110)	Homo sapiens		EXP031186	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	PEAKS034725
EXP031190	two MyoD antibody raised in rabbits by our lab (6196 and 6975) and previously described (Tapscott et al., 1988)	Mus musculus		EXP031189	705	unspecified	P10085	P19 (embryonic carcinoma)	PEAKS035793
EXP031191	two MyoD antibody raised in rabbits by our lab (6196 and 6975) and previously described (Tapscott et al., 1988)	Mus musculus		NULL	12	unspecified	P10085	MEF (mouse embryonic fibroblasts)	PEAKS035794
EXP031193	PR	Mus musculus	oil	EXP031192	132	unspecified	Q00175	uterus	PEAKS035795
EXP031194	PR	Mus musculus	P4	EXP031192	132	unspecified	Q00175	uterus	PEAKS035796
EXP031195	PR	Mus musculus	P4	EXP031192	132	unspecified	Q00175	uterus	PEAKS035797
EXP031198	streptavidin	Mus musculus		EXP031196	1	unspecified	P41230	IB10 (embryonic stem cells)	PEAKS035798
EXP031199	streptavidin	Mus musculus		EXP031197	280	unspecified	P41230	embryonic stem cell-derived neural progenitors	PEAKS035799
EXP031201	EGR2 (Abcam)	Rattus norvegicus		EXP031200	784	unspecified	P51774	Schwann cells	PEAKS036815
EXP031202	SOX10 (Santa Cruz Biotechnology, sc-17342x)	Rattus norvegicus		EXP031200	784	unspecified	O55170	Schwann cells	PEAKS036816
EXP031205	CTCF	Mus musculus		EXP031203	143	unspecified	Q61164	brain	PEAKS035800
EXP031206	CTCF	Mus musculus		EXP031204	143	unspecified	Q61164	brain	PEAKS035801
EXP031208	Tbx3 (A-20)	Mus musculus		EXP031207	53	unspecified	P70324	heart	PEAKS035802
EXP031209	Gata4 (C-20)	Mus musculus		EXP031207	53	unspecified	Q08369	heart	PEAKS035803
EXP031210	Nkx2-5 (N-19)	Mus musculus		EXP031207	53	unspecified	Q8CB76	heart	PEAKS035804
EXP031211	anti-N-CoR	Homo sapiens	siCTL	NULL	10	unspecified	O75376	HEK293T (embryonic kidney)	PEAKS034726
EXP031212	anti-N-CoR	Homo sapiens	siGPS2	NULL	10	unspecified	O75376	HEK293T (embryonic kidney)	PEAKS034727
EXP031214	Tcf4 (mouse monoclonal, clone 6H5-3)	Mus musculus		EXP031213	429	unspecified	Q924A0	hepatocytes	PEAKS035805
EXP031215	anti-LXR alpha and beta	Mus musculus	Bexarotene	NULL	5	unspecified	Q9Z0Y9	liver	PEAKS035806
EXP031216	anti-LXR alpha and beta	Mus musculus	Control	NULL	5	unspecified	Q9Z0Y9	liver	PEAKS035807
EXP031217	anti-LXR alpha and beta	Mus musculus	T0901317	NULL	5	unspecified	Q9Z0Y9	liver	PEAKS035808
EXP031218	SC-9000	Mus musculus	Control	NULL	5	unspecified	P23204	liver	PEAKS035809
EXP031219	SC-9000	Mus musculus	Control	NULL	5	unspecified	P23204	liver	PEAKS035810
EXP031220	SC-553	Mus musculus	Bexarotene	NULL	5	unspecified	P28700	liver	PEAKS035811
EXP031221	SC-553	Mus musculus	Control	NULL	5	unspecified	P28700	liver	PEAKS035812
EXP031222	SC-553	Mus musculus	T0901317	NULL	5	unspecified	P28700	liver	PEAKS035813
EXP031223	SC-553	Mus musculus	Bexarotene	NULL	5	unspecified	P28700	liver	PEAKS035814
EXP031224	SC-553	Mus musculus	Control	NULL	5	unspecified	P28700	liver	PEAKS035815
EXP031225	SC-553	Mus musculus	T0901317	NULL	5	unspecified	P28700	liver	PEAKS035816
EXP031227	anti-YY1	Mus musculus		EXP031226	272	unspecified	Q00899	cardiac progenitors	PEAKS035817
EXP031229	polyclonal rabbit a-GATA-1 produced in-house (H Im et al. PNAS 2005)	Mus musculus	Proliferating	NULL	271	unspecified	P17679	embryonic stem cell-derived erythroid progenitors	PEAKS035818
EXP031230	polyclonal rabbit a-GATA-1 produced in-house (H Im et al. PNAS 2005)	Mus musculus	Differentiating	EXP031228	271	unspecified	P17679	embryonic stem cell-derived erythroid progenitors	PEAKS035819
EXP031232	aFOXO3 (H144)	Homo sapiens		EXP031231	219	unspecified	O43524	DLD-1 (colon adenocarcinoma)	PEAKS034728
EXP031239	Sox2	Mus musculus		EXP031238	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS035820
EXP031240	Santa Cruz, SC-6029	Mus musculus		EXP031234	2	unspecified	P31360	mESCs (mouse embryonic stem cells)	PEAKS035821
EXP031241	R & D Systems (R&D), AF2018	Mus musculus		EXP031234	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS035822
EXP031242	Santa Cruz, SC-6029	Mus musculus		EXP031235	138	unspecified	P31360	neural progenitors	PEAKS035823
EXP031243	R & D Systems (R&D), AF2018	Mus musculus		EXP031235	138	unspecified	P48432	neural progenitors	PEAKS035824
EXP031244	Santa Cruz, SC-6029	Mus musculus		EXP031236	2	unspecified	P31360	mESCs (mouse embryonic stem cells)	PEAKS035825
EXP031245	R & D Systems (R&D), AF2018	Mus musculus		EXP031236	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS035826
EXP031246	Santa Cruz, SC-6029	Mus musculus		EXP031237	138	unspecified	P31360	neural progenitors	PEAKS035827
EXP031247	R & D Systems (R&D), AF2018	Mus musculus		EXP031237	138	unspecified	P48432	neural progenitors	PEAKS035828
EXP031248	R & D Systems (R&D), AF2018	Mus musculus		EXP031233	280	unspecified	P48432	embryonic stem cell-derived neural progenitors	PEAKS035829
EXP031249	Santa Cruz, SC-6029	Mus musculus		EXP031233	280	unspecified	P31360	embryonic stem cell-derived neural progenitors	PEAKS035830
EXP031251	HA-tag antibody (Santa Crruz Biotechnology, sc-7392)	Mus musculus		EXP031250	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS035831
EXP031252	anti-CHOP	Mus musculus	Tunicamycin	NULL	12	unspecified	P35639	MEF (mouse embryonic fibroblasts)	PEAKS035832
EXP031253	anti-CHOP	Mus musculus	Tunicamycin	NULL	12	bio_control	P35639	MEF (mouse embryonic fibroblasts)	PEAKS035833
EXP031254	anti-ATF4	Mus musculus	Tunicamycin	NULL	12	unspecified	Q06507	MEF (mouse embryonic fibroblasts)	PEAKS035834
EXP031255	anti-ATF4	Mus musculus	Tunicamycin	NULL	12	bio_control	Q06507	MEF (mouse embryonic fibroblasts)	PEAKS035835
EXP031258	anti EBF1 #0647 homemade	Mus musculus		EXP031256	105	unspecified	Q07802	pro-B cells	PEAKS035836
EXP031259	anti EBF1 #0647 homemade	Mus musculus		EXP031257	564	unspecified	Q07802	lymph nodes	PEAKS035837
EXP031260	anti-Nkx3.1 (Santa Cruz Biotechnology, sc-15022)	Mus musculus		NULL	632	bio_control	P97436	prostate	PEAKS035838
EXP031261	anti-Nkx3.1 (Santa Cruz Biotechnology, sc-15022)	Mus musculus		NULL	632	unspecified	P97436	prostate	PEAKS035839
EXP031262	anti-Nkx3.1 (Santa Cruz Biotechnology, sc-15022)	Mus musculus		NULL	632	unspecified	P97436	prostate	PEAKS035840
EXP031263	Cux2	Mus musculus		NULL	5	unspecified	P70298	liver	PEAKS035841
EXP031264	Cux2	Mus musculus		NULL	5	unspecified	P70298	liver	PEAKS035842
EXP031266	CTCF	Mus musculus		EXP031265	675	unspecified	Q61164	NIH 3T3 (embryonic fibroblasts)	PEAKS035843
EXP031271	ab81937	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P30561	dendritic cells	PEAKS035844
EXP031272	ab81937	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P30561	dendritic cells	PEAKS035845
EXP031273	ab81937	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P30561	dendritic cells	PEAKS035846
EXP031274	ab81937	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P30561	dendritic cells	PEAKS035847
EXP031275	Upstate 07-729	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q61164	dendritic cells	PEAKS035848
EXP031276	Upstate 07-729	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q61164	dendritic cells	PEAKS035849
EXP031277	Upstate 07-729	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q61164	dendritic cells	PEAKS035850
EXP031278	Upstate 07-729	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q61164	dendritic cells	PEAKS035851
EXP031279	sc-193	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q61501	dendritic cells	PEAKS035852
EXP031280	sc-193	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q61501	dendritic cells	PEAKS035853
EXP031281	sc-193	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q61501	dendritic cells	PEAKS035854
EXP031282	sc-193	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q61501	dendritic cells	PEAKS035855
EXP031283	sc-512	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q8R0K9	dendritic cells	PEAKS035856
EXP031284	sc-512	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q8R0K9	dendritic cells	PEAKS035857
EXP031285	sc-512	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q8R0K9	dendritic cells	PEAKS035858
EXP031286	sc-512	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q8R0K9	dendritic cells	PEAKS035859
EXP031287	sc-351	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q99K36	dendritic cells	PEAKS035860
EXP031288	sc-351	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q99K36	dendritic cells	PEAKS035861
EXP031289	sc-351	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q99K36	dendritic cells	PEAKS035862
EXP031290	sc-351	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q99K36	dendritic cells	PEAKS035863
EXP031291	Bethyl NB100-134	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q61221	dendritic cells	PEAKS035864
EXP031292	Bethyl NB100-134	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q61221	dendritic cells	PEAKS035865
EXP031293	Bethyl NB100-134	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q61221	dendritic cells	PEAKS035866
EXP031294	Bethyl NB100-134	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q61221	dendritic cells	PEAKS035867
EXP031295	sc-640, ab52520	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P15314	dendritic cells	PEAKS035868
EXP031296	sc-640, ab52520	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P15314	dendritic cells	PEAKS035869
EXP031297	sc-640, ab52520	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P15314	dendritic cells	PEAKS035870
EXP031298	sc-640, ab52520	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P15314	dendritic cells	PEAKS035871
EXP031299	sc-46, ab28838	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P09450	dendritic cells	PEAKS035872
EXP031300	sc-46, ab28838	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P09450	dendritic cells	PEAKS035873
EXP031301	sc-46, ab28838	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P09450	dendritic cells	PEAKS035874
EXP031302	sc-46, ab28838	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P09450	dendritic cells	PEAKS035875
EXP031303	sc-20690	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P08152	dendritic cells	PEAKS035876
EXP031304	sc-20690	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P08152	dendritic cells	PEAKS035877
EXP031305	sc-20690	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P08152	dendritic cells	PEAKS035878
EXP031306	sc-20690	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P08152	dendritic cells	PEAKS035879
EXP031307	Maff	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	O54791	dendritic cells	PEAKS035880
EXP031308	Maff	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	O54791	dendritic cells	PEAKS035881
EXP031309	Maff	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	O54791	dendritic cells	PEAKS035882
EXP031310	Maff	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	O54791	dendritic cells	PEAKS035883
EXP031311	sc-352	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P17433	dendritic cells	PEAKS035884
EXP031312	sc-352	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P17433	dendritic cells	PEAKS035885
EXP031313	sc-352	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P17433	dendritic cells	PEAKS035886
EXP031314	PU.1	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P17433	dendritic cells	PEAKS035887
EXP031315	sc-226, Bethyl A302-183A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q04863	dendritic cells	PEAKS035888
EXP031316	sc-226, Bethyl A302-183A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q04863	dendritic cells	PEAKS035889
EXP031317	sc-226, Bethyl A302-183A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q04863	dendritic cells	PEAKS035890
EXP031318	sc-226, Bethyl A302-183A	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q04863	dendritic cells	PEAKS035891
EXP031319	sc-372, Bethyl A301-824A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q04207	dendritic cells	PEAKS035892
EXP031320	sc-372, Bethyl A301-824A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q04207	dendritic cells	PEAKS035893
EXP031321	sc-372, Bethyl A301-824A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q04207	dendritic cells	PEAKS035894
EXP031322	p65	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q04207	dendritic cells	PEAKS035895
EXP031323	sc-8564, ab61753	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q03347	dendritic cells	PEAKS035896
EXP031324	sc-8564, ab61753	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q03347	dendritic cells	PEAKS035897
EXP031325	sc-8564, ab61753	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q03347	dendritic cells	PEAKS035898
EXP031326	Bethyl A302-406A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P42227	dendritic cells	PEAKS035899
EXP031327	Bethyl A302-406A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P42227	dendritic cells	PEAKS035900
EXP031328	Bethyl A302-406A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P42227	dendritic cells	PEAKS035901
EXP031329	Bethyl A302-406A	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P42227	dendritic cells	PEAKS035902
EXP031330	sc-188, ab70005-100	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q60765	dendritic cells	PEAKS035903
EXP031331	sc-188, ab70005-100	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q60765	dendritic cells	PEAKS035904
EXP031332	sc-188, ab70005-100	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q60765	dendritic cells	PEAKS035905
EXP031333	sc-188, ab70005-100	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q60765	dendritic cells	PEAKS035906
EXP031334	sc-200, ab28830-100	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q06507	dendritic cells	PEAKS035907
EXP031335	sc-70, sc-71	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P15307	dendritic cells	PEAKS035908
EXP031336	sc-70, sc-71	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P15307	dendritic cells	PEAKS035909
EXP031337	sc-70, sc-71	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P15307	dendritic cells	PEAKS035910
EXP031338	sc-70, sc-71	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P15307	dendritic cells	PEAKS035911
EXP031339	sc-150	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P28033	dendritic cells	PEAKS035912
EXP031340	sc-150	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P28033	dendritic cells	PEAKS035913
EXP031341	sc-150	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P28033	dendritic cells	PEAKS035914
EXP031342	sc-150	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P28033	dendritic cells	PEAKS035915
EXP031343	sc-110, ab54966-100	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P08046	dendritic cells	PEAKS035916
EXP031344	sc-110, ab54966-100	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P08046	dendritic cells	PEAKS035917
EXP031345	sc-110, ab54966-100	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P08046	dendritic cells	PEAKS035918
EXP031346	sc-110, ab54966-100	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P08046	dendritic cells	PEAKS035919
EXP031347	sc-498, ab65048	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P23906	dendritic cells	PEAKS035920
EXP031348	sc-498, ab65048	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P23906	dendritic cells	PEAKS035921
EXP031349	sc-498, ab65048	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P23906	dendritic cells	PEAKS035922
EXP031350	sc-498, ab65048	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P23906	dendritic cells	PEAKS035923
EXP031351	sc-6059	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q64287	dendritic cells	PEAKS035924
EXP031352	sc-6059	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q64287	dendritic cells	PEAKS035925
EXP031353	sc-6059	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q64287	dendritic cells	PEAKS035926
EXP031354	sc-6059	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q64287	dendritic cells	PEAKS035927
EXP031355	sc-114	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P25799	dendritic cells	PEAKS035928
EXP031356	sc-114	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P25799	dendritic cells	PEAKS035929
EXP031357	sc-114	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P25799	dendritic cells	PEAKS035930
EXP031358	sc-114	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P25799	dendritic cells	PEAKS035931
EXP031359	sc-346, Bethyl A302-753A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P42225	dendritic cells	PEAKS035932
EXP031360	sc-346, Bethyl A302-753A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P42225	dendritic cells	PEAKS035933
EXP031361	sc-346, Bethyl A302-753A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P42225	dendritic cells	PEAKS035934
EXP031362	sc-346, Bethyl A302-753A	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P42225	dendritic cells	PEAKS035935
EXP031363	sc-839, ab53149	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q9WVL2	dendritic cells	PEAKS035936
EXP031364	sc-839, ab53149	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q9WVL2	dendritic cells	PEAKS035937
EXP031365	sc-839, ab53149	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q9WVL2	dendritic cells	PEAKS035938
EXP031366	sc-839, ab53149	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q9WVL2	dendritic cells	PEAKS035939
EXP031367	Rel	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P15307	dendritic cells	PEAKS035940
EXP031368	Relb	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q04863	dendritic cells	PEAKS035941
EXP031370	taf1	Mus musculus		EXP031369	230	unspecified	Q80UV9	ES-E14 (E14, embryonic stem cells)	PEAKS035942
EXP031372	ab19857	Homo sapiens		NULL	245	unspecified	Q01860	NCCIT (testicular embryonic carcinoma)	PEAKS034729
EXP031373	ab19857	Homo sapiens	SNF5 overexpression	EXP031371	245	unspecified	Q01860	NCCIT (testicular embryonic carcinoma)	PEAKS034730
EXP031375	CTCF (Millipore;  07-729 DAM1772428)	Mus musculus		EXP031374	280	unspecified	Q61164	embryonic stem cell-derived neural progenitors	PEAKS035943
EXP031376	sc-12762	Homo sapiens		NULL	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS034731
EXP031377	sc-12762	Homo sapiens		NULL	119	unspecified	Q92754	BT-474 (breast invasive ductal carcinoma)	PEAKS034732
EXP031378	sc-12762	Homo sapiens		NULL	590	unspecified	Q92754	MDA-MB-453 (breast adenocarcinoma)	PEAKS034733
EXP031379	sc-12762	Homo sapiens		NULL	758	unspecified	Q92754	SK-BR-3 (breast adenocarcinoma)	PEAKS034734
EXP031387	Santa Cruz SC-764	Homo sapiens	cMyc expression released for 24 hours	EXP031382	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS034735
EXP031388	Santa Cruz SC-764	Homo sapiens	cMyc expression released for 0 hours	EXP031380	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS034736
EXP031389	Santa Cruz SC-764	Homo sapiens	cMyc expression released for 1 hours	EXP031381	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS034737
EXP031390	c-Myc	Homo sapiens		EXP031384	849	unspecified	P01106	U87 (glioblastoma)	PEAKS034738
EXP031391	Santa Cruz SC-197	Homo sapiens	cMyc expression released for 0 hours	EXP031380	708	unspecified	P61244	P493-6 (B-cell lymphoma)	PEAKS034739
EXP031392	Santa Cruz SC-197	Homo sapiens	cMyc expression released for 1 hours	EXP031381	708	unspecified	P61244	P493-6 (B-cell lymphoma)	PEAKS034740
EXP031393	Santa Cruz SC-197	Homo sapiens	cMyc expression released for 24 hours	EXP031382	708	unspecified	P61244	P493-6 (B-cell lymphoma)	PEAKS034741
EXP031394	Santa Cruz SC-197	Homo sapiens		EXP031384	849	unspecified	P61244	U87 (glioblastoma)	PEAKS034742
EXP031395	Santa Cruz SC-197	Homo sapiens	DMSO	EXP031386	880	unspecified	P61244	B-cells	PEAKS034743
EXP031396	Santa Cruz SC-764	Homo sapiens		EXP031383	374	unspecified	P01106	NCI-H128 (small cell lung carcinoma)	PEAKS034744
EXP031397	Santa Cruz SC-197	Homo sapiens		EXP031383	374	unspecified	P61244	NCI-H128 (small cell lung carcinoma)	PEAKS034745
EXP031398	Santa Cruz SC-764	Homo sapiens		EXP031385	384	unspecified	P01106	NCI-H2171 (small cell lung carcinoma)	PEAKS034746
EXP031399	Santa Cruz SC-197	Homo sapiens		EXP031385	384	unspecified	P61244	NCI-H2171 (small cell lung carcinoma)	PEAKS034747
EXP031400	Santa Cruz SC-764	Homo sapiens	DMSO	EXP031386	880	unspecified	P01106	B-cells	PEAKS034748
EXP031401	Rev-erb(beta)	Mus musculus	time 5pm/ZT10	NULL	5	unspecified	Q60674	liver	PEAKS035944
EXP031402	Rev-erb(beta)	Mus musculus	time 5am/ZT22	NULL	5	unspecified	Q60674	liver	PEAKS035945
EXP031403	Rev-erb(alpha)	Mus musculus	Rev-erb alpha KO	NULL	5	unspecified	Q3UV55	liver	PEAKS035946
EXP031405	Anti-V5 Agarose Affinity Gel antibody produced in mouse purified    immunoglobulin, clone V5-10	Mus musculus		EXP031404	2	unspecified	P22227	mESCs (mouse embryonic stem cells)	PEAKS035947
EXP031407	ER alpha (sc-542, lot# D1310, Santa Cruz)	Mus musculus	vehicle	EXP031406	132	unspecified	P19785	uterus	PEAKS035948
EXP031408	ER alpha (sc-542, lot# D1310, Santa Cruz)	Mus musculus	estradiol	EXP031406	132	unspecified	P19785	uterus	PEAKS035949
EXP031410	ab19857	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	Q01860	BJ (fibroblasts)	PEAKS034749
EXP031411	AF2018	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	P48431	BJ (fibroblasts)	PEAKS034750
EXP031412	AF3640	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	O43474	BJ (fibroblasts)	PEAKS034751
EXP031413	AF3696	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	P01106	BJ (fibroblasts)	PEAKS034752
EXP031414	ab19857	Homo sapiens	1 ug/ml dox for 48 hours	NULL	93	unspecified	Q01860	BJ (fibroblasts)	PEAKS034753
EXP031415	c-Myc	Homo sapiens	1 ug/ml dox for 48 hours	NULL	93	unspecified	P01106	BJ (fibroblasts)	PEAKS034754
EXP031417	Abcam AB28379	Homo sapiens	Activin A 48 hours	EXP031416	89	unspecified	P84022	BGO3 (embryonic stem cells)	PEAKS034755
EXP031418	Abcam AB28379	Homo sapiens	Activin A 2 hours	EXP031416	89	unspecified	P84022	BGO3 (embryonic stem cells)	PEAKS034756
EXP031419	Abcam AB28379	Homo sapiens	Activin A 0 hours	EXP031416	89	unspecified	P84022	BGO3 (embryonic stem cells)	PEAKS034757
EXP031422	GATA1 (Santacruz,clone N6, sc-265)	Mus musculus		EXP031420	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	PEAKS035950
EXP031423	GATA1 (Santacruz,clone N6, sc-265)	Mus musculus		EXP031421	73	unspecified	P17679	G1E-derived erythroid cells	PEAKS035951
EXP031425	p53 (FL-393; Santa Cruz; sc-6243)	Homo sapiens		EXP031424	2360	unspecified	P04637	fibroblasts	PEAKS034758
EXP031430	Anti-Stat5A	Mus musculus		EXP031426	44	unspecified	P42230	T-cells	PEAKS035952
EXP031431	Anti-Stat5B	Mus musculus		EXP031426	44	unspecified	P42232	T-cells	PEAKS035953
EXP031432	Anti-Stat5A	Mus musculus	IL-2 for 1 hr	EXP031427	44	unspecified	P42230	T-cells	PEAKS035954
EXP031433	Anti-Stat5B	Mus musculus	IL-2 for 1 hr	EXP031427	44	unspecified	P42232	T-cells	PEAKS035955
EXP031434	Anti-Stat5A	Mus musculus	mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031428	44	unspecified	P42230	T-cells	PEAKS035956
EXP031435	Anti-Stat5B	Mus musculus	mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031428	44	unspecified	P42232	T-cells	PEAKS035957
EXP031436	Anti-Stat5A	Mus musculus	IL-2 for 1 hr, mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031429	44	unspecified	P42230	T-cells	PEAKS035958
EXP031437	Anti-Stat5B	Mus musculus	IL-2 for 1 hr, mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031429	44	unspecified	P42232	T-cells	PEAKS035959
EXP031441	sc-12984	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034759
EXP031442	sc-12984	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034760
EXP031443	sc-291	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	Q16621	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034761
EXP031444	sc-291	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	Q16621	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034762
EXP031445	Millipore 07-729	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	P49711	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034763
EXP031446	Millipore 07-729	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	P49711	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034764
EXP031447	ab11852	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	P15976	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034765
EXP031448	ab11852	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	P15976	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034766
EXP031449	ab55331 and ABE115	Homo sapiens	adult bone marrow	EXP031440	167	unspecified	P14316	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS034767
EXP031455	Clontech, 632460	Mus musculus	conconavalin for 4 hours	EXP031450	44	unspecified	P01108	T-cells	PEAKS035960
EXP031456	Clontech, 632460	Mus musculus	conconavalin for 14 hours	EXP031451	44	unspecified	P01108	T-cells	PEAKS035961
EXP031457	Clontech, 632460	Mus musculus		EXP031452	41	unspecified	P01108	B-cells	PEAKS035962
EXP031458	Clontech, 632460	Mus musculus	LPS and 10058-F4 for 4 hours	EXP031453	41	unspecified	P01108	B-cells	PEAKS035963
EXP031459	Clontech, 632460	Mus musculus	LPS for 4 hours	EXP031454	41	unspecified	P01108	B-cells	PEAKS035964
EXP031461	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	Mus musculus	LIF	EXP031460	75	unspecified	P42227	AtT-20 (pituitary tumor)	PEAKS035965
EXP031462	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	Mus musculus	Dex+LIF	EXP031460	75	unspecified	P42227	AtT-20 (pituitary tumor)	PEAKS035966
EXP031463	GR (sc-1004) from SantaCruz	Mus musculus	Dex+LIF	EXP031460	75	unspecified	P06537	AtT-20 (pituitary tumor)	PEAKS035967
EXP031464	GR (sc-1004) from SantaCruz	Mus musculus	Dex	EXP031460	75	unspecified	P06537	AtT-20 (pituitary tumor)	PEAKS035968
EXP031466	PBX1 monoclonal antibody (M01)	Homo sapiens		EXP031465	113	unspecified	P40424	MCF7 (Invasive ductal breast carcinoma)	PEAKS034768
EXP031469	TEAD4 (Abcam, Cat. No. ab58310, Lot #GR33778-1)	Mus musculus		EXP031467	96	unspecified	Q62296	trophoblast stem cells	PEAKS035969
EXP031471	c-Jun, SantaCruz: sc-1694x	Mus musculus		EXP031470	1153	unspecified	P05627	C2C12 (myoblasts)	PEAKS035970
EXP031474	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens	 10 uM D,L-sulforaphane for 5 hours	EXP031472	566	unspecified	Q16236	lymphoblastoid cells	PEAKS034769
EXP031475	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens		EXP031473	566	unspecified	Q16236	lymphoblastoid cells	PEAKS034770
EXP031477	ERG	Homo sapiens		EXP031476	781	unspecified	P11308	RWPE1 (prostate epithelial cells)	PEAKS034771
EXP031480	sc-9144	Mus musculus		EXP031478	809	unspecified	P38532	STHdhQ7 (striatal cells)	PEAKS035971
EXP031481	sc-9144	Mus musculus		EXP031479	808	unspecified	P38532	STHdhQ111 (striatal cells)	PEAKS035972
EXP031482	sc-9144	Mus musculus	cells were heat-shocked at 42Â°C for six hours	EXP031478	809	unspecified	P38532	STHdhQ7 (striatal cells)	PEAKS035973
EXP031483	sc-9144	Mus musculus	cells were heat-shocked at 42Â°C for six hours	EXP031479	808	unspecified	P38532	STHdhQ111 (striatal cells)	PEAKS035974
EXP031485	Sc-1008x	Homo sapiens		EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	PEAKS034772
EXP031486	Sc-1008x	Homo sapiens	100nM calcipotriol	EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	PEAKS034773
EXP031487	ab28379	Homo sapiens	100nM calcipotriol + 1ng/ml TGFb	EXP031484	562	unspecified	P84022	LX-2 (hepatic stellate cells)	PEAKS034774
EXP031488	ab28379	Homo sapiens	1ng/ml TGFb	EXP031484	562	unspecified	P84022	LX-2 (hepatic stellate cells)	PEAKS034775
EXP031489	Sc-1008x	Homo sapiens	100nM calcipotriol + 1ng/ml TGFb	EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	PEAKS034776
EXP031490	Sc-1008x	Homo sapiens	1ng/ml TGFb	EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	PEAKS034777
EXP031492	Rabbit anti-C-terminal Ikaros	Mus musculus		EXP031491	503	unspecified	Q03267	pre-B cells	PEAKS035975
EXP031493	Anti-haemagglutinin (HA) (Covance).	Mus musculus		EXP031491	503	unspecified	Q03267	pre-B cells	PEAKS035976
EXP031495	sc-502	Homo sapiens		EXP031494	848	unspecified	Q08050	U2OS (osteosarcoma)	PEAKS034778
EXP031496	snapc4	Homo sapiens		NULL	489	unspecified	Q5SXM2	IMR90 (lung fibroblasts)	PEAKS034779
EXP031497	mix of monoclonal antibodies YL8 and YL15	Homo sapiens		NULL	78	unspecified	Q01860	HeLa (cervical adenocarcinoma)	PEAKS034780
EXP031498	HOXA9	Homo sapiens		NULL	541	unspecified	P31269	SEM (childhood B acute lymphoblastic leukemia)	PEAKS034781
EXP031499	MEIS1	Homo sapiens		NULL	541	unspecified	O00470	SEM (childhood B acute lymphoblastic leukemia)	PEAKS034782
EXP031500		Mus musculus		NULL	124	unspecified	P63058	C17.2a (neural progenitors)	PEAKS035977
EXP031501		Mus musculus		NULL	124	unspecified	P37242	C17.2a (neural progenitors)	PEAKS035978
EXP031502	RXR	Mus musculus		NULL	124	unspecified	P28700	C17.2a (neural progenitors)	PEAKS035979
EXP031503	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	LPS (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035980
EXP031504	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	LPS (10 ng/ml) for 24hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035981
EXP031505	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035982
EXP031506	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035983
EXP031507	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	TNFa (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035984
EXP031508	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	TGFb1 (1 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035985
EXP031509	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	IL1b (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035986
EXP031510	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	MALP2 (1 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035987
EXP031511	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	CpG (100 nM) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035988
EXP031512	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6ko ctrl	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035989
EXP031513	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6ko ctrl, IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035990
EXP031514	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6ko	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035991
EXP031515	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6 ko, IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035992
EXP031516	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko ctrl	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035993
EXP031517	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko ctrl, IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035994
EXP031518	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035995
EXP031519	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko, IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS035996
EXP031520	Santa Cruz Biotechnology, sc-981	Mus musculus		NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	PEAKS035997
EXP031521	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 15min	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	PEAKS035998
EXP031522	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 30min	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	PEAKS035999
EXP031523	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 1hrs	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	PEAKS036000
EXP031524	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 2hrs	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	PEAKS036001
EXP031525	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	PEAKS036002
EXP031526	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036003
EXP031527	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 30min	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036004
EXP031528	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 1hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036005
EXP031529	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 2hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036006
EXP031530	Santa Cruz Biotechnology, sc-592	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS036007
EXP031531	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 30min	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS036008
EXP031532	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 1hrs	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS036009
EXP031533	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 2hrs	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS036010
EXP031534	Santa Cruz Biotechnology, sc-46	Mus musculus		NULL	81	unspecified	P09450	BMDM (bone marrow-derived macrophages)	PEAKS036011
EXP031535	Santa Cruz Biotechnology, sc-46	Mus musculus	LPS (10 ng/ml) for 4hrs	NULL	81	unspecified	P09450	BMDM (bone marrow-derived macrophages)	PEAKS036012
EXP031536	Santa Cruz Biotechnology, sc-592	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS036013
EXP031537	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS036014
EXP031538	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036015
EXP031540	rabbit anti-CTCF	Homo sapiens		EXP031539	79	unspecified	P49711	BCBL-1 (B-cell lymphoma)	PEAKS034783
EXP031542	ab21689	Homo sapiens	patient1	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	PEAKS034784
EXP031543	ab21689	Homo sapiens	patient3	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	PEAKS034785
EXP031544	ab21689	Homo sapiens	patient4, immune complexes	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	PEAKS034786
EXP031545	ab21689	Homo sapiens	patient6, immune complexes	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	PEAKS034787
EXP031546	sc-486	Homo sapiens	patient1	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034788
EXP031547	sc-486	Homo sapiens	patient2	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034789
EXP031548	sc-486	Homo sapiens	patient3	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034790
EXP031549	sc-486	Homo sapiens	patient4, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034791
EXP031550	sc-486	Homo sapiens	patient5, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034792
EXP031551	sc-486	Homo sapiens	patient5, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034793
EXP031552	sc-486	Homo sapiens	patient6, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	PEAKS034794
EXP031553	ab21689	Homo sapiens	patient2	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	PEAKS034795
EXP031554	ab21689	Homo sapiens	patient5, immune complexes	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	PEAKS034796
EXP031555	CTCF	Homo sapiens		NULL	738	unspecified	P49711	PrEC (prostate cells)	PEAKS034797
EXP031556	CTCF	Homo sapiens		NULL	70	unspecified	P49711	LNCaP (prostate carcinoma)	PEAKS034798
EXP031557	anti-T-bet antibody (sc-21749, Santa Cruz)	Mus musculus		NULL	76	unspecified	Q9JKD8	Th1-cells	PEAKS036016
EXP031559	goat anti-IRF8 antibody (C-19; Santa Cruz Biotechnology)	Mus musculus	MSCV-IRF8 transduced	EXP031558	643	unspecified	P23611	Tot2 (myeloid progenitor cell line)	PEAKS036017
EXP031560	rabbit anti-PU.1 antibody (sc-352, Santa Cruz)	Mus musculus	MSCV-IRF8 transduced	EXP031558	643	unspecified	P17433	Tot2 (myeloid progenitor cell line)	PEAKS036018
EXP031583	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031561	440	unspecified	Q00613	HMEC (human mammary epithelial cells)	PEAKS034799
EXP031584	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031562	106	unspecified	Q00613	BPE (mammary epithelial cells)	PEAKS034800
EXP031585	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031565	440	unspecified	Q00613	HMEC (human mammary epithelial cells)	PEAKS034801
EXP031586	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031566	107	unspecified	Q00613	BPLER (mammary epithelial cells)	PEAKS034802
EXP031587	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031567	583	unspecified	Q00613	MCF10A (breast epithelial cells)	PEAKS034803
EXP031588	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	heat shock	EXP031568	583	unspecified	Q00613	MCF10A (breast epithelial cells)	PEAKS034804
EXP031589	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031569	650	unspecified	Q00613	NCI-H1703 (squamous cell lung carcinoma )	PEAKS034805
EXP031590	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031570	874	unspecified	Q00613	ZR-75-1 (invasive ductal carcinoma)	PEAKS034806
EXP031591	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031571	822	unspecified	Q00613	SW620 (colon adenocarcinoma)	PEAKS034807
EXP031592	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031572	418	unspecified	Q00613	HCT-15 (colon carcinoma)	PEAKS034808
EXP031593	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031573	452	unspecified	Q00613	HT29 (colon adenocarcinoma)	PEAKS034809
EXP031594	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031574	113	unspecified	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS034810
EXP031595	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031575	388	unspecified	Q00613	NCI-H441 (squamous cell lung carcinoma )	PEAKS034811
EXP031596	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031576	758	unspecified	Q00613	SK-BR-3 (breast adenocarcinoma)	PEAKS034812
EXP031597	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031577	657	unspecified	Q00613	NCI-H838 (lung adenocarcinoma)	PEAKS034813
EXP031598	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031578	118	unspecified	Q00613	BT-20 (breast invasive ductal carcinoma)	PEAKS034814
EXP031599	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	heat shock	EXP031564	106	unspecified	Q00613	BPE (mammary epithelial cells)	PEAKS034815
EXP031600	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	heat shock	EXP031563	440	unspecified	Q00613	HMEC (human mammary epithelial cells)	PEAKS034816
EXP031601	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031579	1123	unspecified	Q00613	breast tumor	PEAKS034817
EXP031602	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031580	1123	unspecified	Q00613	breast tumor	PEAKS034818
EXP031603	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031581	718	unspecified	Q00613	colon cancer	PEAKS034819
EXP031604	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031582	718	unspecified	Q00613	colon cancer	PEAKS034820
EXP031607	HIF1? [Novus Biologicals NB100-134 lot.K2]	Homo sapiens		EXP031605	472	unspecified	Q16665	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034821
EXP031608	HIF1? [Novus Biologicals NB100-134 lot.K2]	Homo sapiens	hypoxia	EXP031606	472	unspecified	Q16665	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034822
EXP031609	YY1 (Santa Cruz Biotechnology, sc-1703X)	Homo sapiens		NULL	376	unspecified	P25490	WA01 (H1, human embryonic stem cells)	PEAKS034823
EXP031611	TCF3/E2A	Homo sapiens		EXP031610	777	unspecified	P15923	RPMI-8402 (T acute lymphoblastic leukemia)	PEAKS036817
EXP031612	GATA3	Homo sapiens		EXP031610	777	unspecified	P23771	RPMI-8402 (T acute lymphoblastic leukemia)	PEAKS036818
EXP031613	TCF12/HEB	Homo sapiens		EXP031610	777	unspecified	Q99081	RPMI-8402 (T acute lymphoblastic leukemia)	PEAKS036819
EXP031614	TAL1	Homo sapiens		EXP031610	777	unspecified	P17542	RPMI-8402 (T acute lymphoblastic leukemia)	PEAKS036820
EXP031617	FoxA1	Homo sapiens	mitotic block and release	EXP031616	1474	unspecified	P55317	HuH7 (hepatocellular carcinoma)	PEAKS034824
EXP031618	FoxA1	Homo sapiens	asynchronously cycling	EXP031615	1474	unspecified	P55317	HuH7 (hepatocellular carcinoma)	PEAKS034825
EXP031619	SP1 (Santa Cruz sc-17824)	Mus musculus		NULL	96	unspecified	O89090	trophoblast stem cells	PEAKS036019
EXP031620	TBP (Abcam ab818)	Mus musculus		NULL	96	unspecified	P29037	trophoblast stem cells	PEAKS036020
EXP031621	CTCF (Pugacheva et. al. 2005 Hum Mol Genet 14, 953-965)	Mus musculus		NULL	96	unspecified	Q61164	trophoblast stem cells	PEAKS036021
EXP031623	anti-V5 (Abcam, ab15828)	Mus musculus	+RA +Hh +Dox +FGF	EXP031622	60	unspecified	P43241	Ainv15 (embryonic stem cells)	PEAKS036022
EXP031624	anti-V5 (Abcam, ab15828)	Mus musculus	+RA +Hh +Dox	EXP031622	60	unspecified	P43241	Ainv15 (embryonic stem cells)	PEAKS036023
EXP031628	CTCF (Millipore, 07-729, lot DAM1682158)	Mus musculus		EXP031625	216	unspecified	Q61164	differentiated embryonic stem cells	PEAKS036024
EXP031629	CTCF (Millipore, 07-729, lot DAM1682158)	Mus musculus		EXP031627	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS036025
EXP031631	streptavidin beads	Mus musculus		EXP031630	2	unspecified	Q6J1H4	mESCs (mouse embryonic stem cells)	PEAKS036026
EXP031635	IRF4 (Santa Cruz, sc-6059)	Mus musculus		EXP031632	41	unspecified	Q64287	B-cells	PEAKS036027
EXP031636	IRF4 (Santa Cruz, sc-6059)	Mus musculus	IL21	EXP031632	41	unspecified	Q64287	B-cells	PEAKS036028
EXP031637	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus		EXP031633	1058	unspecified	Q64287	CD4+ T-cells	PEAKS036029
EXP031638	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	IL21	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	PEAKS036030
EXP031639	IRF8 (from Keiko Ozato, not commercial available)	Mus musculus		EXP031633	1058	unspecified	P23611	CD4+ T-cells	PEAKS036031
EXP031640	IRF8 (from Keiko Ozato, not commercial available)	Mus musculus	IL21	NULL	1058	unspecified	P23611	CD4+ T-cells	PEAKS036032
EXP031641	cJUN (Abcam, ab31419, GR30-33)	Mus musculus		EXP031633	1058	unspecified	P05627	CD4+ T-cells	PEAKS036033
EXP031642	cJUN (Abcam, ab31419, GR30-33)	Mus musculus	IL21	EXP031633	1058	unspecified	P05627	CD4+ T-cells	PEAKS036034
EXP031643	STAT3 (Invitrogen, 13-7000)	Mus musculus		EXP031633	1058	unspecified	P42227	CD4+ T-cells	PEAKS036035
EXP031644	STAT3 (Invitrogen, 13-7000)	Mus musculus	IL21	EXP031633	1058	unspecified	P42227	CD4+ T-cells	PEAKS036036
EXP031645	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus		EXP031633	1058	unspecified	O35284	CD4+ T-cells	PEAKS036037
EXP031646	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	IL21, IRF4KO	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	PEAKS036038
EXP031647	cJUN (Abcam, ab31419, GR30-33)	Mus musculus	IL21, IRF4KO	EXP031633	1058	unspecified	P05627	CD4+ T-cells	PEAKS036039
EXP031648	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus	IRF4KO	EXP031633	1058	unspecified	O35284	CD4+ T-cells	PEAKS036040
EXP031649	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus	IL21, IRF4KO	EXP031633	1058	unspecified	O35284	CD4+ T-cells	PEAKS036041
EXP031650	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus	BATFKO, IL21	EXP031633	1058	unspecified	O35284	CD4+ T-cells	PEAKS036042
EXP031651	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	BATFKO	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	PEAKS036043
EXP031652	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	BATFKO, IL21	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	PEAKS036044
EXP031653	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus		EXP031634	498	unspecified	O35284	Th17-cells	PEAKS036045
EXP031654	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus		EXP031634	498	unspecified	Q64287	Th17-cells	PEAKS036046
EXP031655	JunB (Santa Cruz, sc-73, k0311)	Mus musculus		EXP031634	498	unspecified	P09450	Th17-cells	PEAKS036047
EXP031656	cJUN (Abcam, ab31419, GR30-33)	Mus musculus		EXP031634	498	unspecified	P05627	Th17-cells	PEAKS036048
EXP031657	JunD (Santa Cruz, sc-74, J-1411)	Mus musculus		EXP031634	498	unspecified	P15066	Th17-cells	PEAKS036049
EXP031658	STAT3 (Invitrogen, 13-7000)	Mus musculus		EXP031634	498	unspecified	P42227	Th17-cells	PEAKS036050
EXP031660	Tfe3 (Santa Cruz, sc-5958)	Mus musculus		EXP031659	2	unspecified	Q64092	mESCs (mouse embryonic stem cells)	PEAKS036051
EXP031661	Tfe3 (Santa Cruz, sc-5958)	Mus musculus	shFlcn	EXP031659	2	unspecified	Q64092	mESCs (mouse embryonic stem cells)	PEAKS036052
EXP031662	Tfe3 (Santa Cruz, sc-5958)	Mus musculus	shTfe3	EXP031659	2	unspecified	Q64092	mESCs (mouse embryonic stem cells)	PEAKS036053
EXP031665	six2	Mus musculus		EXP031663	660	unspecified	Q62232	nephron progenitors	PEAKS036054
EXP031666	six2	Mus musculus		EXP031664	660	unspecified	Q62232	nephron progenitors	PEAKS036055
EXP031671	BMAL1	Mus musculus		EXP031667	5	unspecified	Q9WTL8	liver	PEAKS036056
EXP031672	BMAL1	Mus musculus		EXP031670	5	unspecified	Q9WTL8	liver	PEAKS036057
EXP031673	CLOCK	Mus musculus		EXP031668	5	unspecified	O08785	liver	PEAKS036058
EXP031674	NPAS2	Mus musculus		NULL	5	unspecified	P97460	liver	PEAKS036059
EXP031678	NKX2-1 [Bethyl Laboratories, BL4000]	Homo sapiens		EXP031675	651	unspecified	P43699	NCI-H1819 (lung adenocarcinoma)	PEAKS034826
EXP031679	NKX2-1 [Bethyl Laboratories, BL4000]	Homo sapiens		EXP031676	653	unspecified	P43699	NCI-H2087 (non-small cell lung adenocarcinoma)	PEAKS034827
EXP031680	FOXA1 [Abcam, ab23738 (lot 947435)]	Homo sapiens		EXP031677	655	unspecified	P55317	NCI-H3122 (lung adenocarcinoma)	PEAKS034828
EXP031681	NKX2-1 [Bethyl Laboratories, BL4000]	Homo sapiens		EXP031677	655	unspecified	P43699	NCI-H3122 (lung adenocarcinoma)	PEAKS034829
EXP031684	CTCF (07-729, Millipore), lot# DAM1772428	Mus musculus		EXP031682	198	unspecified	Q61164	pre-pro-B-cells	PEAKS036060
EXP031685	CTCF (07-729, Millipore), lot# DAM1772428	Mus musculus		EXP031683	105	unspecified	Q61164	pro-B cells	PEAKS036061
EXP031686	c-Myc (sc764x, Santa Cruz), lot# H0107	Mus musculus		EXP031683	105	unspecified	P01108	pro-B cells	PEAKS036062
EXP031688	Anti-HA	Mus musculus		EXP031687	217	unspecified	Q03347	hematopoietic cells	PEAKS036063
EXP031689	Anti-HA	Mus musculus	dox	EXP031687	217	unspecified	Q03347	hematopoietic cells	PEAKS036064
EXP031690	sc-356	Mus musculus		EXP031687	217	unspecified	P26323	hematopoietic cells	PEAKS036065
EXP031691	sc-356	Mus musculus	dox	EXP031687	868	unspecified	P26323	hemogenic endothelium	PEAKS036066
EXP031692	sc-150	Mus musculus		EXP031687	217	unspecified	P28033	hematopoietic cells	PEAKS036067
EXP031693	sc-12984	Mus musculus		EXP031687	217	unspecified	P22091	hematopoietic cells	PEAKS036068
EXP031694	sc-12984	Mus musculus	dox	EXP031687	217	unspecified	P22091	hematopoietic cells	PEAKS036069
EXP031695	sc-356	Mus musculus		NULL	400	unspecified	P26323	hematopoietic progenitors	PEAKS036070
EXP031696	sc-12984	Mus musculus		EXP031687	217	unspecified	P22091	hematopoietic cells	PEAKS036071
EXP031698	anti-FLAG, clone M2	Mus musculus		EXP031697	1058	unspecified	Q99JB6	CD4+ T-cells	PEAKS036072
EXP031701	E2F7 antibody	Homo sapiens	growing	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	PEAKS034830
EXP031702	E2F7 antibody	Homo sapiens	quiescent	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	PEAKS034831
EXP031703	E2F7 antibody	Homo sapiens	infected with Ras	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	PEAKS034832
EXP031704	E2F7 antibody	Homo sapiens	infected with Ras and RB hairpin	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	PEAKS034833
EXP031705	E2F7 antibody	Homo sapiens	infected with Ras and E2F7 hairpin	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	PEAKS034834
EXP031707	ab136253	Rattus norvegicus		EXP031706	218	unspecified	G3V612	oligodendrocytes	PEAKS036821
EXP031709	T-bet (Lab produced (Szabo et al., Nature 2000))	Mus musculus		EXP031708	76	unspecified	Q9JKD8	Th1-cells	PEAKS036073
EXP031710	T-bet (Lab produced (Szabo et al., Nature 2000))	Mus musculus	TbetKO	EXP031708	76	unspecified	Q9JKD8	Th1-cells	PEAKS036074
EXP031713	Foxo1 antibody (Abcam, Ab39670, lot#GR16346-7)	Mus musculus		EXP031711	44	unspecified	Q9R1E0	T-cells	PEAKS036075
EXP031714	Strepdavidin	Mus musculus	endogenously biotinylated foxo1	EXP031712	44	unspecified	Q9R1E0	T-cells	PEAKS036076
EXP031715	GATA2	Mus musculus	P4	NULL	132	unspecified	O09100	uterus	PEAKS036077
EXP031717	Elf1	Mus musculus		EXP031716	1058	unspecified	Q60775	CD4+ T-cells	PEAKS036078
EXP031718	Elf1	Mus musculus		EXP031716	1058	unspecified	Q60775	CD4+ T-cells	PEAKS036079
EXP031719	ets1	Mus musculus		EXP031716	1058	unspecified	P27577	CD4+ T-cells	PEAKS036080
EXP031720	Ets1	Mus musculus		EXP031716	1058	unspecified	P27577	CD4+ T-cells	PEAKS036081
EXP031721	cbfb	Mus musculus		EXP031716	1058	unspecified	P23708	CD4+ T-cells	PEAKS036082
EXP031722	cbfb	Mus musculus		EXP031716	1058	unspecified	P23708	CD4+ T-cells	PEAKS036083
EXP031723	foxp3	Mus musculus		EXP031716	1058	unspecified	Q99JB6	CD4+ T-cells	PEAKS036084
EXP031724	foxm1	Homo sapiens	DMSO	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS034835
EXP031725	foxm1	Homo sapiens	thiostrepton	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS034836
EXP031726	foxm1	Homo sapiens	DMSO	NULL	2301	unspecified	Q08050	MDA-MB-231 (breast adenocarcinoma)	PEAKS034837
EXP031727	foxm1	Homo sapiens	thiostrepton	NULL	2301	unspecified	Q08050	MDA-MB-231 (breast adenocarcinoma)	PEAKS034838
EXP031729	ab12132	Mus musculus		EXP031728	105	unspecified	Q00899	pro-B cells	PEAKS036085
EXP031731	Nkx-6.1	Mus musculus		EXP031730	898	unspecified	Q99MA9	pancreatic islets	PEAKS036086
EXP031734	CTCF	Homo sapiens		EXP031732	867	unspecified	P49711	WI-38 (lung fibroblasts)	PEAKS034839
EXP031735	CTCF	Homo sapiens		EXP031733	867	unspecified	P49711	WI-38 (lung fibroblasts)	PEAKS034840
EXP031737	p65 (Santa Cruz, C-20, Cat no. SC372)	Homo sapiens	DMSO	EXP031736	175	unspecified	Q04206	cervical carcinoma	PEAKS034841
EXP031738	p65 (Santa Cruz, C-20, Cat no. SC372)	Homo sapiens	TNF	EXP031736	175	unspecified	Q04206	cervical carcinoma	PEAKS034842
EXP031739	p65 (Santa Cruz, C-20, Cat no. SC372)	Homo sapiens	TNF-MST	EXP031736	175	unspecified	Q04206	cervical carcinoma	PEAKS034843
EXP031742	Max	Homo sapiens		EXP031740	384	unspecified	P61244	NCI-H2171 (small cell lung carcinoma)	PEAKS034844
EXP031743	Max	Homo sapiens		EXP031741	374	unspecified	P61244	NCI-H128 (small cell lung carcinoma)	PEAKS034845
EXP031744	cMyc	Homo sapiens		EXP031741	374	unspecified	P01106	NCI-H128 (small cell lung carcinoma)	PEAKS034846
EXP031745	cMyc	Homo sapiens		EXP031740	384	unspecified	P01106	NCI-H2171 (small cell lung carcinoma)	PEAKS034847
EXP031747	sc350x	Homo sapiens	VEGF, 0 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034848
EXP031748	sc350x	Homo sapiens	VEGF, 1 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034849
EXP031749	sc350x	Homo sapiens	VEGF, 4 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034850
EXP031750	sc350x	Homo sapiens	VEGF, 12 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034851
EXP031752	Monoclonal ANTI-FLAG M2, Clone M2 (SIGMA, F1804)	Mus musculus		EXP031751	282	unspecified	P63015	embryonic stem cell-derived neural progenitor-like cells	PEAKS036087
EXP031753	Monoclonal ANTI-FLAG M2, Clone M2 (SIGMA, F1804)	Mus musculus		EXP031751	282	unspecified	P97360	embryonic stem cell-derived neural progenitor-like cells	PEAKS036088
EXP031756	STAT5B	Mus musculus		EXP031755	831	unspecified	P42232	Th9-cells	PEAKS036090
EXP031757	STAT6 (Santa Cruz, M-20, sc-981)	Mus musculus		EXP031755	831	unspecified	P52633	Th9-cells	PEAKS036091
EXP031758	STAT5B	Mus musculus	Th9 conditions 0 hours	NULL	831	unspecified	P42232	Th9-cells	PEAKS036092
EXP031759	STAT5B	Mus musculus	Th9 conditions 16 hours	NULL	831	unspecified	P42232	Th9-cells	PEAKS036093
EXP031760	STAT5B	Mus musculus	Th9 conditions 72 hours	NULL	831	unspecified	P42232	Th9-cells	PEAKS036094
EXP031761	STAT5B	Mus musculus	Th9 conditions 72 hours, antiIL2 antibody	NULL	831	unspecified	P42232	Th9-cells	PEAKS036095
EXP031762	STAT6	Mus musculus	Th9 conditions 72 hours	NULL	831	unspecified	P52633	Th9-cells	PEAKS036096
EXP031763	STAT6	Mus musculus	Th9 conditions 72 hours, antiIL2 antibody	NULL	831	unspecified	P52633	Th9-cells	PEAKS036097
EXP031764	GATA4	Mus musculus		NULL	2	unspecified	Q08369	mESCs (mouse embryonic stem cells)	PEAKS036098
EXP031765	GATA4	Mus musculus		NULL	2	unspecified	Q08369	mESCs (mouse embryonic stem cells)	PEAKS036099
EXP031766	GATA4	Mus musculus	Dexamethasone	NULL	305	unspecified	Q08369	Flk1+ embryonic stem cell-derived mesodermal progenitors	PEAKS036100
EXP031767	GATA4	Mus musculus	Dexamethasone	NULL	305	unspecified	Q08369	Flk1+ embryonic stem cell-derived mesodermal progenitors	PEAKS036101
EXP031769	anti-Progesterone receptor	Homo sapiens	progestin R5020 5 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS034852
EXP031770	anti-Progesterone receptor	Homo sapiens	progestin R5020 30 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS034853
EXP031771	anti-Progesterone receptor	Homo sapiens	progestin R5020 60 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS034854
EXP031772	anti-Progesterone receptor	Homo sapiens	progestin R5020 360 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS034855
EXP031774	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	none	EXP031773	262	unspecified	P37238	white adipocytes	PEAKS036102
EXP031775	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	none	EXP031773	491	unspecified	P37238	inguinal white adipous tissue-derived adipocytes	PEAKS036103
EXP031776	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	none	EXP031773	116	unspecified	P37238	brown adipocytes	PEAKS036104
EXP031778	Pitx1	Mus musculus		EXP031777	475	unspecified	P70314	embryonic hindlimb	PEAKS036105
EXP031780	anti-PPAR-gamma	Homo sapiens		EXP031779	49	unspecified	P37231	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	PEAKS034856
EXP031781	anti-CEBP-alpha	Homo sapiens		EXP031779	49	unspecified	P49715	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	PEAKS034857
EXP031782	anti-LXR	Homo sapiens		EXP031779	49	unspecified	Q13133	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	PEAKS034858
EXP031784	Anti-CTCF	Mus musculus		EXP031783	171	unspecified	Q61164	CD4+ CD8+ T cells	PEAKS036106
EXP031786	Anti-CTCF	Mus musculus		EXP031785	105	unspecified	Q61164	pro-B cells	PEAKS036107
EXP031788	anti-Stat5a	Mus musculus	cognate P1A antigen	EXP031787	2479	unspecified	P42230	CD8+ T-cells	PEAKS036108
EXP031790	sc-5579	Homo sapiens		EXP031789	113	unspecified	P35869	MCF7 (Invasive ductal breast carcinoma)	PEAKS034859
EXP031791	sc-5580	Homo sapiens		EXP031789	113	unspecified	P27540	MCF7 (Invasive ductal breast carcinoma)	PEAKS034860
EXP031794	PPAR? (sc-7196)	Mus musculus		EXP031792	50	unspecified	P37238	C3H10T1/2-derived adipocytes	PEAKS036109
EXP031795	PPAR? (sc-7196)	Mus musculus		EXP031793	127	unspecified	P37238	C3H10T1/2 (embryonic fibroblasts)	PEAKS036110
EXP031796	anti-TBP (abcam 62126)	Mus musculus		EXP031792	50	unspecified	P29037	C3H10T1/2-derived adipocytes	PEAKS036111
EXP031797	anti-TBP (abcam 62126)	Mus musculus		EXP031793	127	unspecified	P29037	C3H10T1/2 (embryonic fibroblasts)	PEAKS036112
EXP031799	REST	Homo sapiens		EXP031798	69	unspecified	Q13127	acute promyelocytic leukemia blasts	PEAKS034861
EXP031801	Runx1	Homo sapiens		EXP031800	541	unspecified	Q01196	SEM (childhood B acute lymphoblastic leukemia)	PEAKS034862
EXP031803	GliFLAG	Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	EXP031802	662	unspecified	P47806	neuralized embryoid body	PEAKS036113
EXP031804	Sox2	Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	EXP031802	662	unspecified	P48432	neuralized embryoid body	PEAKS036114
EXP031805	Foxa2	Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	EXP031802	662	unspecified	P35583	neuralized embryoid body	PEAKS036115
EXP031808	Eomes (Abcam, ab23345-100, lot 798757)	Mus musculus		EXP031806	96	unspecified	O54839	trophoblast stem cells	PEAKS036116
EXP031809	Eomes (Abcam, ab23345-100, lot 798757)	Mus musculus		EXP031807	96	unspecified	O54839	trophoblast stem cells	PEAKS036117
EXP031810	Elf5 (Santa Cruz, sc-9645x, lot D2109)	Mus musculus		EXP031806	96	unspecified	Q8VDK3	trophoblast stem cells	PEAKS036118
EXP031811	Elf5 (Santa Cruz, sc-9645x, lot D2109)	Mus musculus		EXP031807	96	unspecified	Q8VDK3	trophoblast stem cells	PEAKS036119
EXP031812	Cdx2 (Bethyl Labs, A300-691-A, lot A300-691-A1)	Mus musculus		EXP031806	96	unspecified	P43241	trophoblast stem cells	PEAKS036120
EXP031814	CTCF (Millipore, Cat. No. 07-729, Lot No. JCB1881349)	Mus musculus		EXP031813	546	unspecified	Q61164	limb bud	PEAKS036121
EXP031815	CTCF (Millipore, Cat. No. 07-729, Lot No. DAM1745366)	Mus musculus		EXP031813	314	unspecified	Q61164	forelimb bud	PEAKS036122
EXP031816	CTCF (Millipore, Cat. No. 07-729, Lot No. DAM1745366)	Mus musculus		EXP031813	436	unspecified	Q61164	hind limb bud	PEAKS036123
EXP031818	anti-p45 antibody by Bresnick EH	Mus musculus		EXP031817	912	unspecified	Q07279	megakaryocytes	PEAKS036124
EXP031820	c-Myc	Homo sapiens		EXP031819	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS034863
EXP031821	Max	Homo sapiens		EXP031819	708	unspecified	P61244	P493-6 (B-cell lymphoma)	PEAKS034864
EXP031823	Sc-61	Mus musculus	0 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036125
EXP031824	Sc-61	Mus musculus	3 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036126
EXP031825	Sc-61	Mus musculus	8 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036127
EXP031826	Sc-61	Mus musculus	16 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036128
EXP031827	Sc-61	Mus musculus	24 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036129
EXP031828	Sc-61	Mus musculus	36 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036130
EXP031829	Sc-61	Mus musculus	48 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036131
EXP031830	Sc-61	Mus musculus	168 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	PEAKS036132
EXP031831	Sc-150	Mus musculus	0 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036133
EXP031832	Sc-150	Mus musculus	3 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036134
EXP031833	Sc-150	Mus musculus	8 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036135
EXP031834	Sc-150	Mus musculus	16 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036136
EXP031835	Sc-150	Mus musculus	24 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036137
EXP031836	Sc-150	Mus musculus	36 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036138
EXP031837	Sc-150	Mus musculus	48 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036139
EXP031838	Sc-150	Mus musculus	168 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	PEAKS036140
EXP031839	Sc-110x	Mus musculus	36 hours after partial hepatectomy	EXP031822	5	unspecified	P08046	liver	PEAKS036141
EXP031840	Olig2 (Millipore, Ab9610)	Rattus norvegicus	mitogen treatment	NULL	752	unspecified	G3V612	oligodendrocyte precursors	PEAKS036822
EXP031841	Olig2 (Millipore, Ab9610)	Rattus norvegicus	T3 treatment	NULL	482	unspecified	G3V612	immature oligodendrocytes	PEAKS036823
EXP031842	Olig2 (Millipore, Ab9610)	Rattus norvegicus	T3 treatment	NULL	749	unspecified	G3V612	mature oligodendrocytes	PEAKS036824
EXP031844	Rabbit anti-C-terminal Ikaros [from Stephen Smale Lab]	Mus musculus		EXP031843	503	unspecified	Q03267	pre-B cells	PEAKS036142
EXP031846	p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909]	Homo sapiens		NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS034865
EXP031847	p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909]	Homo sapiens	senescent	NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS034866
EXP031848	p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909]	Homo sapiens	senescent, p53 KO	NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS034867
EXP031850	Scl/Tal1	Mus musculus		EXP031849	103	unspecified	P22091	bone marrow	PEAKS036143
EXP031851	Gata1	Mus musculus		EXP031849	103	unspecified	P17679	bone marrow	PEAKS036144
EXP031853	sc-7208	Mus musculus	17Î²-estradiol for 24 hours and then 17Î²-estradiol plus progesterone for 6 hrs	EXP031852	572	unspecified	Q00175	mammary gland	PEAKS036145
EXP031855	NF1B	Mus musculus		EXP031854	160	unspecified	P97863	hair follicle stem cells	PEAKS036146
EXP031856	S17S anti-Erf rabbit polyclonal antibody	Mus musculus	starved	NULL	12	unspecified	P70459	MEF (mouse embryonic fibroblasts)	PEAKS036147
EXP031857	S17S anti-Erf rabbit polyclonal antibody	Mus musculus	exponential	NULL	12	unspecified	P70459	MEF (mouse embryonic fibroblasts)	PEAKS036148
EXP031861	NF-?B p65 (Santa Cruz sc-372)	Homo sapiens	no treat	EXP031858	302	unspecified	Q04206	fetal lung fibroblasts	PEAKS034868
EXP031862	NF-?B p65 (Santa Cruz sc-372)	Homo sapiens	TNF-Î± (10ng/mL) 1hr	EXP031859	302	unspecified	Q04206	fetal lung fibroblasts	PEAKS034869
EXP031863	CTCF (Millipore 07-729)	Homo sapiens	no treat	EXP031858	302	unspecified	P49711	fetal lung fibroblasts	PEAKS034870
EXP031864	NF-?B p65 (Santa Cruz sc-372)	Homo sapiens	TNF-Î± (10ng/mL) 1hr	EXP031860	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS034871
EXP031865	CTCF	Homo sapiens		NULL	98	unspecified	P49711	blood monocytes	PEAKS034872
EXP031866	CTCF	Homo sapiens		NULL	466	unspecified	P49711	MDM(monocyte derived macrophages)	PEAKS034873
EXP031868	anti-p63	Homo sapiens		EXP031867	259	unspecified	Q9H3D4	EP156T (primary prostate cells)	PEAKS034874
EXP031871	Mef2Da1	Mus musculus		EXP031869	1153	unspecified	Q63943	C2C12 (myoblasts)	PEAKS036149
EXP031872	Mef2Da2	Mus musculus		EXP031870	1153	unspecified	Q63943	C2C12 (myoblasts)	PEAKS036150
EXP031873	anti-Myc (Santa Cruz sc-764)	Homo sapiens		NULL	78	unspecified	P01106	HeLa (cervical adenocarcinoma)	PEAKS034875
EXP031874	anti-Max (Santa Cruz sc-197)	Homo sapiens		NULL	78	unspecified	P61244	HeLa (cervical adenocarcinoma)	PEAKS034876
EXP031876	cMyc (9402), Cell signaling	Mus musculus		EXP031875	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	PEAKS036151
EXP031877	Nanog (A300-397A), Bethyl Laboratories	Mus musculus		EXP031875	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS036152
EXP031878	Oct4(N-19)(sc-8628), Santa Cruz Biotechnology	Mus musculus		EXP031875	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS036153
EXP031879	cMyc (9402), Cell signaling	Mus musculus	jmjd2b KD	EXP031875	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	PEAKS036154
EXP031880	Oct4(N-19)(sc-8628), Santa Cruz Biotechnology	Mus musculus	jmjd2b KD	EXP031875	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS036155
EXP031881	cMyc (9402), Cell signaling	Mus musculus	jmjd2c KD	EXP031875	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	PEAKS036156
EXP031882	Nanog (A300-397A), Bethyl Laboratories	Mus musculus	jmjd2c KD	EXP031875	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS036157
EXP031883	Oct4(N-19)(sc-8628), Santa Cruz Biotechnology	Mus musculus	jmjd2c KD	EXP031875	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS036158
EXP031884	Nanog (A300-397A), Bethyl Laboratories	Mus musculus	jmjd2b KD	EXP031875	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS036159
EXP031891	BL4000	Mus musculus		EXP031885	609	unspecified	P50220	lung adenocarcinoma	PEAKS036160
EXP031892	BL4000	Mus musculus		EXP031886	609	unspecified	P50220	lung adenocarcinoma	PEAKS036161
EXP031893	sc-6553	Mus musculus		EXP031887	609	unspecified	P35582	lung adenocarcinoma	PEAKS036162
EXP031894	sc-6553	Mus musculus		EXP031888	609	unspecified	P35582	lung adenocarcinoma	PEAKS036163
EXP031895	sc-6553	Mus musculus	Nkx2-1 negative	EXP031889	609	unspecified	P35582	lung adenocarcinoma	PEAKS036164
EXP031896	sc-6553	Mus musculus	Nkx2-1 negative	EXP031890	609	unspecified	P35582	lung adenocarcinoma	PEAKS036165
EXP031898	sc-543	Mus musculus		EXP031897	572	unspecified	P19785	mammary gland	PEAKS036166
EXP031901	Fra-2 (Santa Cruz, sc-604x, lot I0210)	Mus musculus		EXP031899	809	unspecified	P47930	STHdhQ7 (striatal cells)	PEAKS036167
EXP031902	Fra-2 (Santa Cruz, sc-604x, lot I0210)	Mus musculus		EXP031900	808	unspecified	P47930	STHdhQ111 (striatal cells)	PEAKS036168
EXP031903	Jund (Santa Cruz, sc-74x, lot B0111)	Mus musculus		EXP031899	809	unspecified	P15066	STHdhQ7 (striatal cells)	PEAKS036169
EXP031904	Jund (Santa Cruz, sc-74x, lot B0111)	Mus musculus		EXP031900	808	unspecified	P15066	STHdhQ111 (striatal cells)	PEAKS036170
EXP031905	Sox2 (R&D, MAB2018, lot KGQ0311111)	Mus musculus		EXP031899	809	unspecified	P48432	STHdhQ7 (striatal cells)	PEAKS036171
EXP031907	Epitomics ERR? (2131-1)	Mus musculus		EXP031906	5	unspecified	O08580	liver	PEAKS036172
EXP031913		Homo sapiens	PR infected	EXP031909	258	unspecified	P06401	endothelial cells	PEAKS034877
EXP031914		Homo sapiens	PR infected + Progesterone	EXP031910	258	unspecified	P06401	endothelial cells	PEAKS034878
EXP031915		Homo sapiens		EXP031912	258	unspecified	P06401	endothelial cells	PEAKS034879
EXP031918	anti-ETO (home made, antigen-purified)	Homo sapiens		EXP031916	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034880
EXP031919	anti-HEB (Santa Cruz; sc-357)	Homo sapiens		EXP031917	516	unspecified	Q99081	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034881
EXP031920	anti-E2A (Santa Cruz; sc-763)	Homo sapiens		EXP031917	516	unspecified	P15923	Kasumi-1 (acute myeloblastic leukemia)	PEAKS034882
EXP031922	TSC22D3	Mus musculus		EXP031921	498	unspecified	Q9Z2S7	Th17-cells	PEAKS036173
EXP031924	SF-1 (Millipore, catalog# 07-618, lot# JBC1355794)	Homo sapiens		EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	PEAKS034883
EXP031925	SF-1 (Millipore, catalog# 07-618, lot# JBC1355794)	Homo sapiens	overexpressed SF-1	EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	PEAKS034884
EXP031926	SF-1 (Perseus Proteomics, catalog# PP-N1665-00, lot# A-2)	Homo sapiens		EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	PEAKS034885
EXP031927	SF-1 (Perseus Proteomics, catalog# PP-N1665-00, lot# A-2)	Homo sapiens	overexpressed SF-1	EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	PEAKS034886
EXP031930	TEAD4 (Abnova, H00007004-M01, 11105-5H3)	Homo sapiens		EXP031928	613	unspecified	Q15561	MKN28 (gastric tubular adenocarcinoma)	PEAKS034887
EXP031931	TEAD4 (Abnova, H00007004-M01, 11105-5H3)	Homo sapiens		EXP031929	802	unspecified	Q15561	SNU216 (gastric tubular adenocarcinoma)	PEAKS034888
EXP031933	BACH2	Homo sapiens		EXP031932	687	unspecified	Q9BYV9	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS034889
EXP031934	Bcl-6 Antibody (N-3)	Homo sapiens		EXP031932	687	unspecified	P41182	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS034890
EXP031938	Pax-5 antibody (C-20)	Homo sapiens	none	EXP031935	767	unspecified	Q02548	Raji (Burkitt lymphoma)	PEAKS034891
EXP031939	Pax-5 antibody (C-20)	Homo sapiens	none	EXP031936	1521	unspecified	Q02548	Namalwa (Burkitt lymphoma)	PEAKS034892
EXP031940	Pax-5 antibody (C-20)	Homo sapiens	Mifepristone	EXP031937	532	unspecified	Q02548	L428 (Hodgkin lymphoma)	PEAKS034893
EXP031943	CTCF	Mus musculus		EXP031941	41	unspecified	Q61164	B-cells	PEAKS036174
EXP031944	CTCF	Mus musculus		EXP031942	723	unspecified	Q61164	plasmablasts	PEAKS036175
EXP031948	anti-V5 antibody (Cat# R960-CUS, Life Technologies, Carlsbad, CA)	Mus musculus		EXP031945	12	unspecified	Q60980	MEF (mouse embryonic fibroblasts)	PEAKS036176
EXP031949	klf3	Mus musculus		EXP031946	12	bio_control	Q60980	MEF (mouse embryonic fibroblasts)	PEAKS036177
EXP031950	anti-V5 antibody (Cat# R960-CUS, Life Technologies, Carlsbad, CA)	Mus musculus		EXP031947	12	bio_control	Q60980	MEF (mouse embryonic fibroblasts)	PEAKS036178
EXP031951	Tbx3 (Santa Cruz)	Mus musculus		NULL	2	unspecified	P70324	mESCs (mouse embryonic stem cells)	PEAKS036179
EXP031952	Tbx3 (Santa Cruz)	Mus musculus		NULL	237	unspecified	P70324	embryoid body	PEAKS036180
EXP031953	Nanog (Santa Cruz)	Mus musculus		NULL	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS036181
EXP031954	Nanog (Santa Cruz)	Mus musculus		NULL	237	unspecified	Q80Z64	embryoid body	PEAKS036182
EXP031955	Tbx3 (A-20)	Mus musculus		NULL	53	unspecified	P70324	heart	PEAKS036183
EXP031957	Santa Cruz; sc-32758	Mus musculus		EXP031956	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS036184
EXP031958	Santa Cruz; sc-12732	Mus musculus		EXP031956	1153	unspecified	P12979	C2C12 (myoblasts)	PEAKS036185
EXP031959	CEBPb [CEBP B:(C-19): sc-150, lot:#I1010]	Mus musculus	No treatment	NULL	212	unspecified	P28033	dermal fibroblasts	PEAKS036186
EXP031960	CEBPb [CEBP B:(C-19): sc-150, lot:#I1010]	Mus musculus	Thapsigargin treatment for 3 hrs	NULL	212	unspecified	P28033	dermal fibroblasts	PEAKS036187
EXP031961	ATF4 [CREB-2 (C-20): sc-200, Lot#J2011]	Mus musculus	Thapsigargin treatment for 3 hrs	NULL	212	unspecified	Q06507	dermal fibroblasts	PEAKS036188
EXP031963	anti-Runx1	Mus musculus		EXP031962	171	unspecified	Q03347	CD4+ CD8+ T cells	PEAKS036189
EXP031966	PSF	Homo sapiens	ethanol (Vehicle) treatment	EXP031964	70	unspecified	P23246	LNCaP (prostate carcinoma)	PEAKS034894
EXP031967	PSF	Homo sapiens	R1881 10 nM treatment	EXP031965	70	unspecified	P23246	LNCaP (prostate carcinoma)	PEAKS034895
EXP031969	anti-ZNF322 antibody (sc-102205, Santa Cruz)	Mus musculus		EXP031968	230	unspecified	Q8BZ89	ES-E14 (E14, embryonic stem cells)	PEAKS036190
EXP031971	ERG (Santa Cruz, sc-354X), A2510 & H1612	Homo sapiens		EXP031970	166	unspecified	P11308	CD34+ hematopoietic stem cells	PEAKS034896
EXP031972	FLI1 (Abcam ab15289), GR46872-1	Homo sapiens		EXP031970	166	unspecified	Q01543	CD34+ hematopoietic stem cells	PEAKS034897
EXP031973	SCL (Santa Cruz, sc-12984X), B2312	Homo sapiens		EXP031970	166	unspecified	P17542	CD34+ hematopoietic stem cells	PEAKS034898
EXP031974	LYL1 (Abcam, ab30334-200), 383134	Homo sapiens		EXP031970	166	unspecified	P12980	CD34+ hematopoietic stem cells	PEAKS034899
EXP031975	GATA2 (Santa Cruz, sc-9008x) I0109	Homo sapiens		EXP031970	166	unspecified	P23769	CD34+ hematopoietic stem cells	PEAKS034900
EXP031976	RUNX1 (Abcam, ab23980-100), 700492	Homo sapiens		EXP031970	166	unspecified	Q01196	CD34+ hematopoietic stem cells	PEAKS034901
EXP031978	sc-764 Santa Cruz	Homo sapiens	6h DHT	EXP031977	590	unspecified	P01106	MDA-MB-453 (breast adenocarcinoma)	PEAKS034902
EXP031979	sc-816 Santa Cruz	Homo sapiens	16h DHT	EXP031977	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	PEAKS034903
EXP031980	ab23738 Abcam	Homo sapiens	16h DHT	EXP031977	590	unspecified	P55317	MDA-MB-453 (breast adenocarcinoma)	PEAKS034904
EXP031981	sc-8631 Santa Cruz	Homo sapiens	16h DHT	EXP031977	590	unspecified	Q9NQB0	MDA-MB-453 (breast adenocarcinoma)	PEAKS034905
EXP031982	tcf7l2	Homo sapiens		EXP031977	590	unspecified	Q9NQB0	MDA-MB-453 (breast adenocarcinoma)	PEAKS034906
EXP031984	anti-Runx1	Mus musculus		EXP031983	912	unspecified	Q03347	megakaryocytes	PEAKS036191
EXP031986	rabbit anti-Runx1 [generated against a C-terminal peptide (kindly provided by Y. Groner and D. Levanon (Weizmann Institute, Rehovot))]	Mus musculus		EXP031985	102	unspecified	Q03347	BMiFLT3(15-3) (murine acute lymphoblastic leukemia)	PEAKS036192
EXP031987	sc-E20	Homo sapiens	1 micromolar dexamethasone	NULL	537	unspecified	P04150	pooled Yoruba and Tuscan lymphoblastoid cell lines	PEAKS034907
EXP031988	sc-E20	Homo sapiens	EtOH	NULL	537	unspecified	P04150	pooled Yoruba and Tuscan lymphoblastoid cell lines	PEAKS034908
EXP031989	sc-372X	Homo sapiens	1 micromolar dexamethasone	NULL	537	unspecified	P19838	pooled Yoruba and Tuscan lymphoblastoid cell lines	PEAKS034909
EXP031990	sc-372X	Homo sapiens	EtOH	NULL	537	unspecified	P19838	pooled Yoruba and Tuscan lymphoblastoid cell lines	PEAKS034910
EXP031991	Mix of GR Antibody (Santa Cruz Biotech, catalog# sc-1004) and Glucocorticoid Receptor Antibody (Thermo Scientific, catalog# PA1-511A)	Mus musculus	Ad-lib fed	NULL	5	unspecified	P06537	liver	PEAKS036193
EXP031992	C/EBP ? Antibody (Santa Cruz Biotech, catalog# sc-150)	Mus musculus	Ad-lib fed	NULL	5	unspecified	P28033	liver	PEAKS036194
EXP031993	CREB-1 Antibody (Santa Cruz Biotech, catalog# sc-186)	Mus musculus	Fasted 24h	NULL	5	unspecified	Q01147	liver	PEAKS036195
EXP031994	CREB	Mus musculus	Fasted 24h, Re-fed 2h	NULL	5	unspecified	Q01147	liver	PEAKS036196
EXP031995	sc-543	Homo sapiens	1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034911
EXP032002	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	DMSO	EXP031998	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	PEAKS034912
EXP032003	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	DMSO	EXP031996	113	unspecified	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS034913
EXP032004	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	Cycloheximide (10 ÂµM)	EXP031997	113	unspecified	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS034914
EXP032005	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	27A (20 nM)	EXP031999	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	PEAKS034915
EXP032006	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	27A (100 nM)	EXP032000	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	PEAKS034916
EXP032007	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	Cycloheximide (10 ÂµM)	EXP032001	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	PEAKS034917
EXP032010	SC-1703	Mus musculus		EXP032008	1153	unspecified	Q00899	C2C12 (myoblasts)	PEAKS036197
EXP032011	AB58066	Mus musculus		EXP032008	1153	unspecified	Q00899	C2C12 (myoblasts)	PEAKS036198
EXP032012	SC-1703	Mus musculus		EXP032009	126	unspecified	Q00899	C2C12 (myotubes)	PEAKS036199
EXP032014	Streptavidin T1 dynabeads (Invitrogen)	Mus musculus		EXP032013	91	unspecified	Q3UV55	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS036200
EXP032015	Streptavidin T1 dynabeads (Invitrogen)	Mus musculus		EXP032013	91	unspecified	Q60674	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS036201
EXP032016	anti-PU.1 (Santa Cruz, SC-352)	Mus musculus		EXP032013	91	unspecified	P17433	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS036202
EXP032017	anti-PU.1 (Santa Cruz, SC-352)	Mus musculus		EXP032013	91	unspecified	P17433	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS036203
EXP032019	anti-Bach2 - rabbit antibody (generated in-house, Tohoku University)	Mus musculus		EXP032018	1058	unspecified	P97303	CD4+ T-cells	PEAKS036204
EXP032020	sc-20693	Homo sapiens	none	NULL	592	unspecified	P23511	ME-1 (acute myeloid leukemia )	PEAKS034918
EXP032021	A1329	Homo sapiens	none	NULL	592	unspecified	P23511	ME-1 (acute myeloid leukemia )	PEAKS034919
EXP032022	ab23980	Homo sapiens	none	NULL	592	unspecified	Q01196	ME-1 (acute myeloid leukemia )	PEAKS034920
EXP032023	MAb-002-100	Homo sapiens	none	NULL	592	unspecified	P20226	ME-1 (acute myeloid leukemia )	PEAKS034921
EXP032024	sc-357	Homo sapiens	none	NULL	592	unspecified	Q99081	ME-1 (acute myeloid leukemia )	PEAKS034922
EXP032025	sc-9008	Homo sapiens	none	NULL	592	unspecified	P23769	ME-1 (acute myeloid leukemia )	PEAKS034923
EXP032026	sc-12984	Homo sapiens	none	NULL	592	unspecified	P17542	ME-1 (acute myeloid leukemia )	PEAKS034924
EXP032027	sc-356	Homo sapiens	none	NULL	592	unspecified	Q01543	ME-1 (acute myeloid leukemia )	PEAKS034925
EXP032028	sc-631	Homo sapiens	none	NULL	592	unspecified	P32519	ME-1 (acute myeloid leukemia )	PEAKS034926
EXP032029	sc-354	Homo sapiens	none	NULL	592	unspecified	P11308	ME-1 (acute myeloid leukemia )	PEAKS034927
EXP032030	sc-22805	Homo sapiens	none	NULL	592	unspecified	P17947	ME-1 (acute myeloid leukemia )	PEAKS034928
EXP032031	CBFB	Homo sapiens	none	NULL	45	unspecified	P23511	acute myeloblastic leukemia	PEAKS034929
EXP032032	A1329	Homo sapiens	3 days Tet free medium	NULL	65	unspecified	P23511	U937 (adult acute monocytic leukemia)	PEAKS034930
EXP032033	A1329	Homo sapiens	Tet (1 mM) containing medium	NULL	65	unspecified	P23511	U937 (adult acute monocytic leukemia)	PEAKS034931
EXP032036	C/EBPbeta sc-150, santa cruz	Mus musculus	dex adGFP	EXP032035	5	unspecified	P28033	liver	PEAKS036205
EXP032037	C/EBPbeta sc-150, santa cruz	Mus musculus	dex adDN-C/EBP	EXP032035	5	unspecified	P28033	liver	PEAKS036206
EXP032038	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	veh	EXP032034	5	unspecified	P06537	liver	PEAKS036207
EXP032039	C/EBPbeta sc-150, santa cruz	Mus musculus	veh	EXP032034	5	unspecified	P28033	liver	PEAKS036208
EXP032040	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	dex	EXP032035	5	unspecified	P06537	liver	PEAKS036209
EXP032041	C/EBPbeta sc-150, santa cruz	Mus musculus	dex	EXP032035	5	unspecified	P28033	liver	PEAKS036210
EXP032042	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	dex adGFP	EXP032035	5	unspecified	P06537	liver	PEAKS036211
EXP032043	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	dex adDN-C/EBP	EXP032035	5	unspecified	P06537	liver	PEAKS036212
EXP032046	GR	Mus musculus	untreated	EXP032045	629	unspecified	P06537	mammary cells	PEAKS036213
EXP032047	GR	Mus musculus	Dexamethasone for 30 minutes	EXP032045	629	unspecified	P06537	mammary cells	PEAKS036214
EXP032048	GR	Mus musculus	Estradiol for 30 minutes	EXP032045	629	unspecified	P06537	mammary cells	PEAKS036215
EXP032049	GR	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032045	629	unspecified	P06537	mammary cells	PEAKS036216
EXP032050	ER	Mus musculus	untreated	EXP032045	629	unspecified	P19785	mammary cells	PEAKS036217
EXP032051	ER	Mus musculus	Dexamethasone for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	PEAKS036218
EXP032052	ER	Mus musculus	Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	PEAKS036219
EXP032053	ER	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	PEAKS036220
EXP032054	ER	Mus musculus	Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	PEAKS036221
EXP032055	estrogen	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	PEAKS036222
EXP032056	GR	Mus musculus	untreated	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	PEAKS036223
EXP032057	GR	Mus musculus	Dexamethasone for 30 minutes	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	PEAKS036224
EXP032058	GR	Mus musculus	Estradiol for 30 minutes	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	PEAKS036225
EXP032059	GR	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	PEAKS036226
EXP032060	ER	Mus musculus	untreated	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	PEAKS036227
EXP032061	ER	Mus musculus	Dexamethasone for 30 minutes	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	PEAKS036228
EXP032062	ER	Mus musculus	Estradiol for 30 minutes	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	PEAKS036229
EXP032063	ER	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	PEAKS036230
EXP032064	anti-Oct4 (Abcam, ab19857, GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	PEAKS034932
EXP032065	anti-FOXA2 (R&D, AF2400, ULB 0311101)	Homo sapiens		NULL	456	unspecified	Q9Y261	HUES64-derived endodermal cells	PEAKS034933
EXP032066	anti-SOX2 (SC, sc-17320 X, 3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	PEAKS034934
EXP032067	anti-Nanog (R&D, AF1997, KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	PEAKS034935
EXP032070	anti-p53	Mus musculus	0.2ug/ml doxorubicin for 6h	EXP032068	12	unspecified	P02340	MEF (mouse embryonic fibroblasts)	PEAKS036231
EXP032071	anti-p53	Mus musculus	0.2ug/ml doxorubicin for 6h	EXP032069	12	unspecified	P02340	MEF (mouse embryonic fibroblasts)	PEAKS036232
EXP032073	anti-EGR2 (PRB-236P,Covance)	Mus musculus	immobilized anti-CD3 mAb	EXP032072	1058	unspecified	P08152	CD4+ T-cells	PEAKS036233
EXP032074	anti-EGR2 (PRB-236P,Covance)	Mus musculus	immobilized anti-CD3 mAb	EXP032072	1058	unspecified	P08152	CD4+ T-cells	PEAKS036234
EXP032076	NR2F2	Mus musculus		EXP032075	141	unspecified	P43135	retina	PEAKS036235
EXP032079	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	PEAKS036236
EXP032080	anti-PU.1	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032077	732	unspecified	P17433	peritoneal macrophages	PEAKS036237
EXP032081	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	PEAKS036238
EXP032082	anti-PU.1	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032078	732	unspecified	P17433	peritoneal macrophages	PEAKS036239
EXP032083	anti-C/EBPa	Mus musculus	no treatment	NULL	732	unspecified	P53566	peritoneal macrophages	PEAKS036240
EXP032084	anti-C/EBPa	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032077	732	unspecified	P53566	peritoneal macrophages	PEAKS036241
EXP032085	anti-C/EBPa	Mus musculus	no treatment	NULL	732	unspecified	P53566	peritoneal macrophages	PEAKS036242
EXP032086	anti-C/EBPa	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032078	732	unspecified	P53566	peritoneal macrophages	PEAKS036243
EXP032087	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	PEAKS036244
EXP032088	anti-C/EBPa	Mus musculus	no treatment	NULL	732	unspecified	P53566	peritoneal macrophages	PEAKS036245
EXP032089	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	PEAKS036246
EXP032090	anti-p65	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032077	732	unspecified	Q04207	peritoneal macrophages	PEAKS036247
EXP032091	anti-p65	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032078	732	unspecified	Q04207	peritoneal macrophages	PEAKS036248
EXP032093	anti-Irf4 (Santa Cruz; sc-6059)	Mus musculus	stimulated for 1 day	EXP032092	41	unspecified	Q64287	B-cells	PEAKS036249
EXP032094	anti-Irf4 (Santa Cruz; sc-6059)	Mus musculus	stimulated for 3 days	EXP032092	41	unspecified	Q64287	B-cells	PEAKS036250
EXP032095	anti-PU.1 (Santa Cruz; sc-352)	Mus musculus	stimulated for 1 day	EXP032092	41	unspecified	P17433	B-cells	PEAKS036251
EXP032096	anti-PU.1 (Santa Cruz; sc-352)	Mus musculus	stimulated for 3 days	EXP032092	41	unspecified	P17433	B-cells	PEAKS036252
EXP032099	Tcf1	Mus musculus		EXP032097	139	unspecified	Q00417	thymus	PEAKS036253
EXP032100	Tcf1	Mus musculus	stabilized form of beta-catenin	EXP032098	139	unspecified	Q00417	thymus	PEAKS036254
EXP032102	E2F1	Homo sapiens	DMSO	EXP032101	685	unspecified	Q01094	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS034936
EXP032103	BCL6	Homo sapiens	DMSO	EXP032101	685	unspecified	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS034937
EXP032105	RXRalpha	Mus musculus		EXP032104	5	unspecified	P28700	liver	PEAKS036255
EXP032106	RAR? antibody	Mus musculus		EXP032104	5	unspecified	P11416	liver	PEAKS036256
EXP032107	ctcf	Homo sapiens		NULL	97	unspecified	P49711	blood lymphocytes	PEAKS034938
EXP032108	TFAP4, HPA001912, Sigma	Homo sapiens		NULL	219	unspecified	Q01664	DLD-1 (colon adenocarcinoma)	PEAKS034939
EXP032111	Foxo1 antibody (Abcam, Ab39670)	Mus musculus		EXP032109	2479	unspecified	Q9R1E0	CD8+ T-cells	PEAKS036257
EXP032112	Streptavidin	Mus musculus		EXP032110	2479	unspecified	Q9R1E0	CD8+ T-cells	PEAKS036258
EXP032114	anti-ETV1 (Rabbit, Abcam 81086, Lot 787879)	Homo sapiens	Treatment: None	EXP032113	66	normal	P50549	prostate cancer	PEAKS034940
EXP032115	anti-AR (Rabbit, Epitomics Clone ER179)	Homo sapiens	Treatment: 3 days of crambled shRNA infection; Time point: 3 days; Conditions: MOI 5	EXP032113	66	normal	P10275	prostate cancer	PEAKS034941
EXP032116	anti-AR (Rabbit, Epitomics Clone ER179)	Homo sapiens	Treatment: 3 days of ETV1sh2 infection; Time point: 3 days; Conditions: MOI 5	EXP032113	66	normal	P10275	prostate cancer	PEAKS034942
EXP032117	anti-p53	Homo sapiens	0.1% DMSO for 24 hr	EXP032118	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS034943
EXP032119	anti-p53	Homo sapiens		EXP032120	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS034944
EXP032121	anti-p53	Homo sapiens	0.6 ug/ml Doxorubicin for 24 hr	EXP032122	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS034945
EXP032123	anti-p53	Homo sapiens	10 uM Nutlin-3 for 24 hr	EXP032124	848	unspecified	P04637	U2OS (osteosarcoma)	PEAKS034946
EXP032126	anti-HA ChIP-grade (ab9110), Abcam	Homo sapiens		EXP032125	421	unspecified	P67809	HEK293 (embryonic kidney)	PEAKS034947
EXP032133	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036259
EXP032134	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036260
EXP032135	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036261
EXP032136	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036262
EXP032137	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036263
EXP032138	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036264
EXP032139	anti-CLK	Mus musculus		EXP032127	5	unspecified	O08785	liver	PEAKS036265
EXP032140	anti-CLK	Mus musculus		EXP032128	5	unspecified	O08785	liver	PEAKS036266
EXP032141	anti-CLK	Mus musculus		EXP032129	5	unspecified	O08785	liver	PEAKS036267
EXP032142	anti-CLK	Mus musculus		EXP032130	5	unspecified	O08785	liver	PEAKS036268
EXP032143	anti-CLK	Mus musculus		EXP032131	5	unspecified	O08785	liver	PEAKS036269
EXP032144	anti-CLK	Mus musculus		EXP032132	5	unspecified	O08785	liver	PEAKS036270
EXP032149	anti-CTCF	Mus musculus		EXP032148	105	unspecified	Q61164	pro-B cells	PEAKS036271
EXP032150	anti-MAFK	Homo sapiens		NULL	687	unspecified	O60675	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS034950
EXP032153	anti-EKLF	Mus musculus		EXP032151	268	unspecified	P46099	erythroid progenitors	PEAKS036272
EXP032154	anti-EKLF	Mus musculus		EXP032152	266	unspecified	P46099	erythroblasts	PEAKS036273
EXP032156	anti-Flag M2 (ERbeta)	Homo sapiens	10nM E2	EXP032155	128	unspecified	Q92731	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS034951
EXP032157		Homo sapiens	Vehicle	EXP032155	128	unspecified	Q92731	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS034952
EXP032165	FOXA1 (ab23738, Abcam)	Mus musculus	castrated+vehicle	EXP032158	632	unspecified	P35582	prostate	PEAKS036274
EXP032166	HNF4a (ab41898, Abcam)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P49698	prostate	PEAKS036275
EXP032167	AP2a (ab52222, Abcam)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P34056	prostate	PEAKS036276
EXP032168	AR (Sahu et al. 2011)	Mus musculus	castrated+vehicle	EXP032161	523	unspecified	P19091	kidney	PEAKS036277
EXP032169	HNF4	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P49698	kidney	PEAKS036278
EXP032170	FOXA1 (ab23738, Abcam)	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P35582	kidney	PEAKS036279
EXP032171	AP2a (ab52222, Abcam)	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P34056	kidney	PEAKS036280
EXP032172	AR (Sahu et al. 2011)	Mus musculus	castrated+vehicle	EXP032163	150	unspecified	P19091	caput epididymis	PEAKS036281
EXP032173	FOXA1 (ab23738, Abcam)	Mus musculus	intact	EXP032163	150	unspecified	P35582	caput epididymis	PEAKS036282
EXP032174	HNF4a (ab41898, Abcam)	Mus musculus	intact	EXP032163	150	unspecified	P49698	caput epididymis	PEAKS036283
EXP032175	AR (Sahu et al. 2011)	Mus musculus	castrated+vehicle	EXP032158	632	unspecified	P19091	prostate	PEAKS036284
EXP032176	AR (Sahu et al. 2011)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P19091	prostate	PEAKS036285
EXP032177	FOXA1 (ab23738, Abcam)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P35582	prostate	PEAKS036286
EXP032178	AR (Sahu et al. 2011)	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P19091	kidney	PEAKS036287
EXP032179	HNF4a (ab41898, Abcam)	Mus musculus	castrated+vehicle	EXP032161	523	unspecified	P49698	kidney	PEAKS036288
EXP032180	AR (Sahu et al. 2011)	Mus musculus	intact	EXP032163	150	unspecified	P19091	caput epididymis	PEAKS036289
EXP032181	AP2a (ab52222, Abcam)	Mus musculus	castrated+vehicle	EXP032163	150	unspecified	P34056	caput epididymis	PEAKS036290
EXP032182	AP2a (ab52222, Abcam)	Mus musculus	intact	EXP032163	150	unspecified	P34056	caput epididymis	PEAKS036291
EXP032184	custom antibody	Homo sapiens		EXP032183	78	unspecified	Q00059	HeLa (cervical adenocarcinoma)	PEAKS034953
EXP032187	Ascl1: Abcam ab74065, lot# 830280	Mus musculus		EXP032185	742	unspecified	Q02067	primary adult neural progenitors	PEAKS036292
EXP032188	Foxo3-NFL: Brunet Lab (Greer et al., 2007 PMID 17900900)	Mus musculus	LY	EXP032186	742	unspecified	Q9WVH4	primary adult neural progenitors	PEAKS036293
EXP032193	anti-Jarid2	Mus musculus		EXP032189	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS036294
EXP032194	anti-Jarid2 (Novus Biologicals)	Mus musculus		EXP032192	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS036295
EXP032195	anti-REST	Mus musculus		EXP032189	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS036296
EXP032198	anti-REST	Mus musculus		EXP032192	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS036297
EXP032201	anti-Blimp1	Mus musculus		EXP032199	44	unspecified	Q60636	T-cells	PEAKS036298
EXP032204	PPARg H-100 (Santa Cruz, sc-7196x)	Mus musculus	adeno-LACZ	EXP032202	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS036299
EXP032205	PPARg H-100 (Santa Cruz, sc-7196x)	Mus musculus	adeno-PU1	EXP032203	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS036300
EXP032206	PU.1 T-21 (Santa Cruz, sc-352x)	Mus musculus	adeno-PU1	EXP032203	18	unspecified	P17433	3T3-L1 (embryonic fibroblasts)	PEAKS036301
EXP032209	GR (Santa Cruz, sc-1003, lot # D1812)	Homo sapiens	dexamethasone	EXP032208	461	unspecified	P04150	embryonic kidney	PEAKS034954
EXP032210	GR (Santa Cruz, sc-1003, lot # D1812)	Homo sapiens	dexamethasone, stably expressing wt GR	EXP032208	461	unspecified	P04150	embryonic kidney	PEAKS034955
EXP032211	GR (Santa Cruz, sc-1003, lot # D1812)	Homo sapiens	dexamethasone, stably expressing SUMOylation-defective GR	EXP032208	461	unspecified	P04150	embryonic kidney	PEAKS034956
EXP032214	JARID2	Homo sapiens		EXP032212	635	unspecified	Q92833	MRC-iPS-25 (induced pluripotent stem cells)	PEAKS034957
EXP032215	JARID2	Homo sapiens	MEG3 IncRNA overexpression	EXP032213	635	unspecified	Q92833	MRC-iPS-25 (induced pluripotent stem cells)	PEAKS034958
EXP032224	JARID2	Homo sapiens		EXP032216	63	unspecified	Q92833	AM-iPS-6 (induced pluripotent cells)	PEAKS034959
EXP032225	JARID2	Homo sapiens		EXP032217	64	unspecified	Q92833	AM-iPS-8 (induced pluripotent cells)	PEAKS034960
EXP032226	JARID2	Homo sapiens		EXP032219	635	unspecified	Q92833	MRC-iPS-25 (induced pluripotent stem cells)	PEAKS034961
EXP032227	JARID2	Homo sapiens		EXP032220	853	unspecified	Q92833	UtE-iPS-11 (induced pluripotent stem cells)	PEAKS034962
EXP032228	JARID2	Homo sapiens		EXP032221	854	unspecified	Q92833	UtE-iPS-4 (induced pluripotent stem cells)	PEAKS034963
EXP032229	JARID2	Homo sapiens		EXP032222	855	unspecified	Q92833	UtE-iPS-6 (induced pluripotent stem cells)	PEAKS034964
EXP032230	JARID2	Homo sapiens		EXP032223	856	unspecified	Q92833	UtE-iPS-7 (induced pluripotent stem cells)	PEAKS034965
EXP032231	JARID2	Homo sapiens		EXP032218	240	unspecified	Q92833	Edom-iPS-2 (induced pluripotent stem cells)	PEAKS034966
EXP032233	G18 (Santa Cruz, sc-5986)	Homo sapiens		EXP032232	2301	unspecified	Q13105	MDA-MB-231 (breast adenocarcinoma)	PEAKS034967
EXP032237	STAT5A (Santa Cruz, sc-1081)	Mus musculus	day 6 of pregnancy	EXP032234	572	unspecified	P42230	mammary gland	PEAKS036302
EXP032238	STAT5A (Santa Cruz, sc-1081, lot# J3007)	Mus musculus	L1	EXP032235	572	unspecified	P42230	mammary gland	PEAKS036303
EXP032239	STAT5A (Santa Cruz, sc-1081, lot# J3007)	Mus musculus		EXP032236	572	unspecified	P42230	mammary gland	PEAKS036304
EXP032242	PU.1 (Santa Cruz sc-352)	Mus musculus	none	EXP032240	570	unspecified	P17433	macrophages	PEAKS036305
EXP032243	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	P17433	macrophages	PEAKS036306
EXP032244	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036307
EXP032245	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 12h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036308
EXP032246	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 24h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036309
EXP032247	p65 (Santa Cruz sc-372)	Mus musculus	none	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036310
EXP032248	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	Q04207	macrophages	PEAKS036311
EXP032249	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036312
EXP032250	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 24h	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036313
EXP032251	p65 (Santa Cruz sc-372)	Mus musculus	none	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036314
EXP032252	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	Q04207	macrophages	PEAKS036315
EXP032253	C/EBPa (Santa Cruz sc-61)	Mus musculus	none	EXP032240	570	unspecified	P53566	macrophages	PEAKS036316
EXP032254	C/EBPa (Santa Cruz sc-61)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	P53566	macrophages	PEAKS036317
EXP032255	PU.1 (Santa Cruz sc-352)	Mus musculus	DMSO 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036318
EXP032256	PU.1 (Santa Cruz sc-352)	Mus musculus	Flavopiridol 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036319
EXP032257	p65 (Santa Cruz sc-372)	Mus musculus	DMSO 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036320
EXP032258	p65 (Santa Cruz sc-372)	Mus musculus	Flavopiridol 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036321
EXP032259	PU.1 (Santa Cruz sc-352)	Mus musculus	DMSO 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036322
EXP032260	PU.1 (Santa Cruz sc-352)	Mus musculus	IBET 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	P17433	macrophages	PEAKS036323
EXP032261	p65 (Santa Cruz sc-372)	Mus musculus	DMSO 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036324
EXP032262	p65 (Santa Cruz sc-372)	Mus musculus	IBET 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	Q04207	macrophages	PEAKS036325
EXP032264	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	PEAKS036326
EXP032265	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	PEAKS036327
EXP032266	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	PEAKS036328
EXP032267	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	PEAKS036329
EXP032268	anti-ER-alpha	Homo sapiens	10nM E2, 45 minutes	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034968
EXP032269	anti-SPDEF	Homo sapiens	Full media	NULL	113	unspecified	O95238	MCF7 (Invasive ductal breast carcinoma)	PEAKS034969
EXP032271	anti-NRSF/REST	Homo sapiens		EXP032270	385	unspecified	Q13127	H295R (adrenal cortex carcinoma)	PEAKS034970
EXP032272	NRSF/REST Millipore #07-579	Homo sapiens	doxycycline 1mg/mL for 3 days	EXP032270	385	unspecified	Q13127	H295R (adrenal cortex carcinoma)	PEAKS034971
EXP032274	anti-GATA4	Mus musculus		EXP032273	5	unspecified	Q08369	liver	PEAKS036330
EXP032275	MyoD (C-20, Santa Cruz)	Mus musculus		NULL	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS036331
EXP032276	MyoD (C-20, Santa Cruz)	Mus musculus		NULL	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS036332
EXP032277	MyoG (M-225, Santa Cruz)	Mus musculus		NULL	1153	unspecified	P12979	C2C12 (myoblasts)	PEAKS036333
EXP032279	anti-EGR2	Mus musculus	TCR	EXP032278	44	unspecified	P08152	T-cells	PEAKS036825
EXP032280	anti-EGR2	Mus musculus	TCR	EXP032278	44	unspecified	P08152	T-cells	PEAKS036826
EXP032281	anti-EGR2	Mus musculus	TCR	EXP032278	44	unspecified	P08152	T-cells	PEAKS036827
EXP032283	anti-HA	Homo sapiens		NULL	113	unspecified	O00482	MCF7 (Invasive ductal breast carcinoma)	PEAKS034973
EXP032284	anti-ER-alpha	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034974
EXP032285	anti-ER-alpha	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS034975
EXP032287	Santa Cruz SOX2 (sc-17320)	Homo sapiens	non-targeting siRNA	EXP032286	915	unspecified	P48431	hNSC (neural stem cells)	PEAKS034976
EXP032288	Santa Cruz SOX2 (sc-17320)	Homo sapiens	RMST siRNA	EXP032286	915	unspecified	P48431	hNSC (neural stem cells)	PEAKS034977
EXP032289	Klf4 (SC-20691, Santa Cruz)	Mus musculus		NULL	902	unspecified	Q60793	mammary epithelial cells	PEAKS036334
EXP032291	anti-IRF4	Mus musculus	anti-CD3, anti-CD28 and recombinant hIL-2	EXP032290	2479	unspecified	Q64287	CD8+ T-cells	PEAKS036335
EXP032295	XBP1 (Biolegend, 619502)	Homo sapiens	hypoxia and glucose deprivation	NULL	2301	unspecified	P17861	MDA-MB-231 (breast adenocarcinoma)	PEAKS034978
EXP032296	XBP1 (Biolegend, 619502)	Homo sapiens	hypoxia and glucose deprivation	EXP032293	111	unspecified	P17861	T47D (invasive ductal carcinoma)	PEAKS034979
EXP032297	XBP1 (Biolegend, 619502)	Homo sapiens	hypoxia and glucose deprivation	EXP032294	449	unspecified	P17861	HS578T (invasive ductal breast carcinoma)	PEAKS034980
EXP032298	XBP1 (Biolegend, 619502)	Homo sapiens		NULL	2301	unspecified	P17861	MDA-MB-231 (breast adenocarcinoma)	PEAKS034981
EXP032300	Runx3 poly clonal home made	Mus musculus		EXP032299	806	unspecified	Q64131	natural killer cells	PEAKS036336
EXP032303	Runx3 poly clonal home made	Mus musculus		EXP032301	2479	unspecified	Q64131	CD8+ T-cells	PEAKS036337
EXP032304	Runx3 poly clonal home made	Mus musculus		EXP032302	2479	unspecified	Q64131	CD8+ T-cells	PEAKS036338
EXP032307	Runx3 poly clonal home made	Mus musculus		EXP032305	806	unspecified	Q64131	natural killer cells	PEAKS036339
EXP032308	Runx3 poly clonal home made	Mus musculus		EXP032306	806	unspecified	Q64131	natural killer cells	PEAKS036340
EXP032311	Runx3 poly clonal home made	Mus musculus		EXP032310	2479	unspecified	Q64131	CD8+ T-cells	PEAKS036341
EXP032312	Runx3 poly clonal home made	Mus musculus		EXP032309	2479	unspecified	Q64131	CD8+ T-cells	PEAKS036342
EXP032315	MLL4	Mus musculus	D0 of adipogenesis	EXP032313	483	unspecified	O08550	brown preadipocytes	PEAKS036343
EXP032316	MLL4	Mus musculus	D2 of adipogenesis	EXP032313	483	unspecified	O08550	brown preadipocytes	PEAKS036344
EXP032317	MLL4	Mus musculus	D7 of adipogenesis	EXP032313	483	unspecified	O08550	brown preadipocytes	PEAKS036345
EXP032318	MLL4	Mus musculus	D0 of adipogenesis, MLL4 KO	EXP032314	483	unspecified	O08550	brown preadipocytes	PEAKS036346
EXP032319	MLL4	Mus musculus	D2 of adipogenesis, MLL4 KO	EXP032314	483	unspecified	O08550	brown preadipocytes	PEAKS036347
EXP032320	MLL4	Mus musculus	D7 of adipogenesis, MLL4 KO	EXP032314	483	unspecified	O08550	brown preadipocytes	PEAKS036348
EXP032322	anti-Runx3	Mus musculus		EXP032321	806	unspecified	Q64131	natural killer cells	PEAKS036349
EXP032324	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036350
EXP032325	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	PEAKS036351
EXP032326	anti-Pu.1	Mus musculus		EXP032323	299	unspecified	P17433	FDCP-Mix (multipotent stem cells)	PEAKS036352
EXP032327	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036353
EXP032328	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	PEAKS036354
EXP032329	anti-Pu.1	Mus musculus		EXP032323	299	unspecified	P17433	FDCP-Mix (multipotent stem cells)	PEAKS036355
EXP032330	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036356
EXP032331	Pu.1	Mus musculus		EXP032323	299	unspecified	P17433	FDCP-Mix (multipotent stem cells)	PEAKS036357
EXP032332	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	PEAKS036358
EXP032333	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	PEAKS036359
EXP032334	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036360
EXP032335	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036361
EXP032336	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	PEAKS036362
EXP032337	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	PEAKS036363
EXP032338	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036364
EXP032339	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	PEAKS036365
EXP051007	anti-MyoD	Homo sapiens		NULL	467	unspecified	P15172	myoblasts	PEAKS049007
EXP032342	anti-MyoD	Homo sapiens		EXP032340	918	unspecified	P15172	myotube	PEAKS034983
EXP051008	anti-MyoD	Homo sapiens		NULL	773	unspecified	P15172	rhabdomyosarcoma	PEAKS049008
EXP032344	anti-C/EBPalpha	Mus musculus		NULL	483	unspecified	P53566	brown preadipocytes	PEAKS036366
EXP032345	anti-C/EBPalpha	Mus musculus		NULL	483	unspecified	P53566	brown preadipocytes	PEAKS036367
EXP032346	anti-C/EBPbeta	Mus musculus		NULL	483	unspecified	P28033	brown preadipocytes	PEAKS036368
EXP032347	anti-C/EBPbeta	Mus musculus		NULL	483	unspecified	P28033	brown preadipocytes	PEAKS036369
EXP032348	anti-PPARgamma	Mus musculus		NULL	483	unspecified	P37238	brown preadipocytes	PEAKS036370
EXP032349	anti-PPARgamma	Mus musculus		NULL	483	unspecified	P37238	brown preadipocytes	PEAKS036371
EXP032354	anti-MyoD	Mus musculus		EXP032350	483	unspecified	P10085	brown preadipocytes	PEAKS036372
EXP032355	anti-MyoD	Mus musculus		EXP032351	483	unspecified	P10085	brown preadipocytes	PEAKS036373
EXP032356	anti-MyoD	Mus musculus		EXP032352	483	unspecified	P10085	brown preadipocytes	PEAKS036374
EXP032357	anti-MyoD	Mus musculus		EXP032353	483	unspecified	P10085	brown preadipocytes	PEAKS036375
EXP032358	anti-MLL4	Mus musculus		EXP032350	483	unspecified	O08550	brown preadipocytes	PEAKS036376
EXP032359	anti-MLL4	Mus musculus		EXP032351	483	unspecified	O08550	brown preadipocytes	PEAKS036377
EXP032360	anti-MLL4	Mus musculus		EXP032352	483	unspecified	O08550	brown preadipocytes	PEAKS036378
EXP032361	anti-MLL4	Mus musculus		EXP032353	483	unspecified	O08550	brown preadipocytes	PEAKS036379
EXP032362	anti-C/EBPalpha	Mus musculus		NULL	81	unspecified	P53566	BMDM (bone marrow-derived macrophages)	PEAKS036380
EXP032365	SMAD1(BMR00479)	Mus musculus	12h, Blimp1-mVenus reporter	EXP032364	206	unspecified	P70340	epiblast-like cells	PEAKS036381
EXP032366	SMAD1(BMR00479)	Mus musculus	24h, Blimp1-mVenus reporter	EXP032364	206	unspecified	P70340	epiblast-like cells	PEAKS036382
EXP032367	SMAD1(BMR00479)	Mus musculus	36h, Blimp1-mVenus reporter	EXP032364	206	unspecified	P70340	epiblast-like cells	PEAKS036383
EXP032368	SMAD1(BMR00479)	Mus musculus	36h, Prdm14-mVenus reporter	EXP032363	206	unspecified	P70340	epiblast-like cells	PEAKS036384
EXP032369	T (sc-17743)	Mus musculus	Prdm14-mVenus reporter	EXP032363	206	unspecified	P20293	epiblast-like cells	PEAKS036385
EXP032370	TCF1 (CST#2203)	Mus musculus	Blimp1-mVenus reporter	EXP032364	206	unspecified	Q00417	epiblast-like cells	PEAKS036386
EXP032372	anti-Gfi1 (a custom rabbit polyclonal antibody raised against N- and C-terminal peptides)	Mus musculus		EXP032371	492	unspecified	P70338	group 2 innate lymphoid cells (ILC2s)	PEAKS036387
EXP032373	anti-MITF	Homo sapiens		NULL	601	unspecified	O75030	melanocytes	PEAKS034985
EXP032374	anti-MITF	Homo sapiens		NULL	601	unspecified	O75030	melanocytes	PEAKS034986
EXP032375	anti-MITF	Homo sapiens	DMSO (control)	NULL	1549	unspecified	O75030	COLO-829 (melanoma)	PEAKS034987
EXP032376	anti-MITF	Homo sapiens	BRAF inhibitor PLX4032 (Vemurafenib)	NULL	1549	unspecified	O75030	COLO-829 (melanoma)	PEAKS034988
EXP032380	Hnf4a (Santa Cruz, sc-8987)	Rattus norvegicus	E20	EXP032377	908	unspecified	P22449	kidney	PEAKS036828
EXP032381	Hnf4a (Santa Cruz, sc-8987)	Rattus norvegicus	P13	EXP032378	908	unspecified	P22449	kidney	PEAKS036829
EXP032382	Hnf4a (Santa Cruz, sc-8987)	Rattus norvegicus	Adult	EXP032379	908	unspecified	P22449	kidney	PEAKS036830
EXP032385	ER? (Santa Cruz, HC-20)	Homo sapiens	estrogen	EXP032383	587	unspecified	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS034989
EXP032386	ER? (Santa Cruz, HC-20)	Homo sapiens	EtOH	EXP032384	587	unspecified	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS034990
EXP032387	SMRT	Mus musculus	ZT10	NULL	5	unspecified	Q9WU42	liver	PEAKS036388
EXP032388	SMRT	Mus musculus	ZT22	NULL	5	unspecified	Q9WU42	liver	PEAKS036389
EXP032391	(rb) ?-MLL4 (#403; Ali  Shilatifard)	Homo sapiens		EXP032389	417	unspecified	Q9UMN6	HCT-116 (colon carcinoma)	PEAKS034991
EXP032392	(rb) ?-MLL4 (#403; Ali  Shilatifard)	Mus musculus		EXP032390	521	unspecified	O08550	KH2 (embryonic stem cells)	PEAKS036390
EXP032395	Sox2 raised by ourselves	Mus musculus		EXP032393	872	unspecified	P48432	ZHBTc4-TS (trophoblast stem cells)	PEAKS036391
EXP032396	Tfap2c (sc-8977, Santa Cruz)	Mus musculus		EXP032393	872	unspecified	Q61312	ZHBTc4-TS (trophoblast stem cells)	PEAKS036392
EXP032397	Cdx2 (CDX2-88, BioGenex)	Mus musculus		EXP032393	872	unspecified	P43241	ZHBTc4-TS (trophoblast stem cells)	PEAKS036393
EXP032398	Sox2 raised by ourselves	Mus musculus		EXP032394	241	unspecified	P48432	EGFP-TS3.5 TS (trophoblast stem cells)	PEAKS036394
EXP032399	STAT1(sc-592, SantaCruz)	Mus musculus		NULL	1058	unspecified	P42225	CD4+ T-cells	PEAKS036395
EXP032401	TCF7L2 (Cell Signaling Technology  C48H11, 2569)	Homo sapiens		EXP032400	70	unspecified	Q9NQB0	LNCaP (prostate carcinoma)	PEAKS034992
EXP032404	ETS1 (santa cruz sc-350)	Homo sapiens	vehicle	NULL	199	unspecified	P14921	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS034993
EXP032405	GABPA (santa cruz sc-22810)	Homo sapiens	vehicle	NULL	199	unspecified	Q06546	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS034994
EXP032406	RUNX1 (Abcam ab23980	Homo sapiens	vehicle	NULL	199	unspecified	Q01196	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS034995
EXP032407	Rabbit anti RBPJ	Homo sapiens	GSI 72 hrs	EXP032402	199	unspecified	Q06330	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS034996
EXP032408	Rabbit anti RBPJ	Homo sapiens	GSI 72 hrs, wash out 4 hrs	EXP032403	199	unspecified	Q06330	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS034997
EXP032409	prdm5 ab1	Mus musculus		NULL	12	unspecified	Q9CXE0	MEF (mouse embryonic fibroblasts)	PEAKS036396
EXP032410	prdm5 ab2	Mus musculus		NULL	12	unspecified	Q9CXE0	MEF (mouse embryonic fibroblasts)	PEAKS036397
EXP032413	GATA6	Homo sapiens		EXP032411	59	unspecified	Q92908	AGS (gastric adenocarcinoma)	PEAKS034998
EXP032414	GATA6	Homo sapiens		EXP032412	457	unspecified	Q92908	HuG-1 (gastric tubular adenocarcinoma)	PEAKS034999
EXP032416	NR2F2 (Active Motif, Cat#61213)	Homo sapiens		EXP032415	256	unspecified	P24468	endometrial stromal cells	PEAKS035000
EXP032418	Stat5	Mus musculus	Ezh2 KO	EXP032417	573	unspecified	P42230	mammary tissue	PEAKS036398
EXP032419	Stat5	Mus musculus	none	EXP032417	573	unspecified	P42230	mammary tissue	PEAKS036399
EXP032424	JARID2	Mus musculus	no	EXP032422	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS036400
EXP032425	JARID2	Mus musculus	Doxycycline 1 ug/mL	EXP032422	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS036401
EXP032426	JARID2	Mus musculus	no	EXP032423	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS036402
EXP032427	JARID2	Mus musculus	Doxycycline 1 ug/mL	EXP032423	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS036403
EXP032428	JARID2	Mus musculus	no	EXP032420	844	unspecified	Q62315	TX1072 (embryonic stem cells)	PEAKS036404
EXP032429	JARID2	Mus musculus	Doxycycline 1 ug/mL	EXP032421	844	unspecified	Q62315	TX1072 (embryonic stem cells)	PEAKS036405
EXP032430	anti-FOXM1	Homo sapiens		NULL	423	unspecified	Q08050	HeLa S3 (cervical adenocarcinoma)	PEAKS035001
EXP032431	anti-NFATc1	Mus musculus		NULL	160	unspecified	O88942	hair follicle stem cells	PEAKS036406
EXP032434	anti-ZFHX4	Homo sapiens		EXP032432	332	unspecified	Q86UP3	glioblastoma cells	PEAKS035002
EXP032435	anti-ZFHX4	Homo sapiens		EXP032433	332	unspecified	Q86UP3	glioblastoma cells	PEAKS035003
EXP032440	anti-TEAD4	Homo sapiens	4h DMSO	EXP032436	396	unspecified	Q15561	WA09 (embryonic stem cells)	PEAKS035004
EXP032441	anti-TEAD4	Homo sapiens	4h SB431542	EXP032437	396	unspecified	Q15561	WA09 (embryonic stem cells)	PEAKS035005
EXP032442	anti-SMAD2	Homo sapiens	4h DMSO	EXP032436	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS035006
EXP032443	anti-SMAD2	Homo sapiens	4h SB431542	EXP032439	396	unspecified	Q15796	WA09 (embryonic stem cells)	PEAKS035007
EXP032444	anti-p65	Homo sapiens	none	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS035008
EXP032445	anti-p65	Homo sapiens	10ng/ml IL-1alpha for 1 h	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS035009
EXP032446	anti-AR	Homo sapiens	siControl	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035010
EXP032447	anti-AR	Homo sapiens	siGATA2	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035011
EXP032448	anti-FoxA1	Homo sapiens		NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS035012
EXP032449	anti-PU.1	Mus musculus	LPS	NULL	104	unspecified	P17433	dendritic cells	PEAKS036407
EXP032450	anti-BATF	Mus musculus	LPS	NULL	104	unspecified	O35284	dendritic cells	PEAKS036408
EXP032451	anti-JunB	Mus musculus	LPS	NULL	104	unspecified	P09450	dendritic cells	PEAKS036409
EXP032452	anti-Ascl2	Mus musculus	Empty vector transfected	NULL	1058	unspecified	O35885	CD4+ T-cells	PEAKS036410
EXP032453	anti-Ascl2	Mus musculus	Ascl2 vector transfected	NULL	1058	unspecified	O35885	CD4+ T-cells	PEAKS036411
EXP032455	anti-GATA1	Homo sapiens		EXP032454	167	unspecified	P15976	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS035013
EXP032456	anti-TAL1	Homo sapiens		EXP032454	167	unspecified	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS035014
EXP032457	anti-GFI1B	Homo sapiens		EXP032454	167	unspecified	Q5VTD9	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS035015
EXP032458	anti-ICSBP	Mus musculus		NULL	104	unspecified	P23611	dendritic cells	PEAKS036412
EXP032459	anti-ICSBP	Mus musculus		NULL	104	unspecified	P23611	dendritic cells	PEAKS036413
EXP032460	anti-ICSBP	Mus musculus		NULL	104	unspecified	P23611	dendritic cells	PEAKS036414
EXP032463	Custom GFP antibody	Mus musculus		EXP032461	2	unspecified	Q9CWW7	mESCs (mouse embryonic stem cells)	PEAKS036415
EXP032464	Custom GFP antibody	Mus musculus		EXP032461	2	unspecified	O35885	mESCs (mouse embryonic stem cells)	PEAKS036416
EXP032465	Custom GFP antibody	Mus musculus		EXP032461	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	PEAKS036417
EXP032466	Custom GFP antibody from MPI-CBG "anti-GFP 2007" (Vermeulen et al., 2010)	Mus musculus		EXP032462	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	PEAKS036418
EXP032467	Custom GFP antibody from MPI-CBG "anti-GFP 2007" (Vermeulen et al., 2010)	Mus musculus		EXP032462	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	PEAKS036419
EXP032469	Zrf1 Ab generated in Di CroceÂ´s lab	Mus musculus		EXP032468	233	unspecified	P54103	E14TG2A (embryonic stem cells)	PEAKS036420
EXP032472	Snf2h	Mus musculus	untreated	EXP032470	14	unspecified	Q91ZW3	3134 (mammary adenocarcinoma)	PEAKS036421
EXP032473	Snf2h	Mus musculus	untreated	EXP032471	14	unspecified	Q91ZW3	3134 (mammary adenocarcinoma)	PEAKS036422
EXP032475	anti V5 (clone V5-10)-agarose, Sigma A7345	Mus musculus		EXP032474	105	unspecified	Q07802	pro-B cells	PEAKS036423
EXP032476	pu.1	Mus musculus		EXP032474	105	unspecified	P17433	pro-B cells	PEAKS036424
EXP032477	anti IRF4 (M-17), Santa Cruz sc-6059x, lot:E0608	Mus musculus		EXP032474	105	unspecified	Q64287	pro-B cells	PEAKS036425
EXP032478	ikaros	Mus musculus		EXP032474	105	unspecified	Q03267	pro-B cells	PEAKS036426
EXP032479	ikaros	Mus musculus		NULL	171	unspecified	Q03267	CD4+ CD8+ T cells	PEAKS036427
EXP032480	ikaros	Mus musculus		NULL	198	unspecified	Q03267	pre-pro-B-cells	PEAKS036428
EXP032482	RARa	Mus musculus		EXP032481	5	unspecified	P11416	liver	PEAKS036429
EXP032483	RARb	Mus musculus		EXP032481	5	unspecified	P22605	liver	PEAKS036430
EXP032484	RXRa	Mus musculus		EXP032481	5	unspecified	P28700	liver	PEAKS036431
EXP032485	RARa	Mus musculus	RA-treatment	EXP032481	5	unspecified	P11416	liver	PEAKS036432
EXP032486	RARb	Mus musculus	RA-treatment	EXP032481	5	unspecified	P22605	liver	PEAKS036433
EXP032487	RXRa	Mus musculus	RA-treatment	EXP032481	5	unspecified	P28700	liver	PEAKS036434
EXP032488	CLOCK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036435
EXP032489	CLOCK	Mus musculus		NULL	5	unspecified	O08785	liver	PEAKS036436
EXP032490	BMAL1	Mus musculus		NULL	5	unspecified	Q9WTL8	liver	PEAKS036437
EXP032491	BMAL1	Mus musculus		NULL	5	unspecified	Q9WTL8	liver	PEAKS036438
EXP032493	hoxc11	Homo sapiens	Tamoxifen	EXP032492	563	unspecified	O43248	LY-2 (invasive ductal carcinoma)	PEAKS035016
EXP032494	hoxc11	Homo sapiens	Untreated	EXP032492	563	unspecified	O43248	LY-2 (invasive ductal carcinoma)	PEAKS035017
EXP032495	OTX2	Mus musculus		NULL	776	unspecified	P80206	retinal pigmented epithelium	PEAKS036439
EXP032496	GFP (Abcam, Cambridge, UK)	Mus musculus		NULL	776	unspecified	P80206	retinal pigmented epithelium	PEAKS036440
EXP032497	OTX2 (R&D systems, Minneapolis, MN, USA)	Mus musculus		NULL	663	unspecified	P80206	neural retina	PEAKS036441
EXP032498	GFP (Abcam, Cambridge, UK)	Mus musculus		NULL	663	unspecified	P80206	neural retina	PEAKS036442
EXP032500	SRF (Santa Cruz Biotechnology, sc-335, Lot# I2712)	Mus musculus	Dstn1-corn mutant	EXP032499	865	unspecified	Q9JM73	cornea	PEAKS036443
EXP032501	SRF (Santa Cruz Biotechnology, sc-335, Lot# I2712)	Mus musculus		EXP032499	865	unspecified	Q9JM73	cornea	PEAKS036444
EXP032505	AB5535	Mus musculus		EXP032502	160	unspecified	Q04887	hair follicle stem cells	PEAKS036445
EXP032506	AB5535	Mus musculus		EXP032503	160	unspecified	Q04887	hair follicle stem cells	PEAKS036446
EXP032507	AB5535	Mus musculus		EXP032504	494	unspecified	Q04887	interfollicular epidermal cells	PEAKS036447
EXP032509	oct6	Mus musculus	oct6 overexpressed ESC	EXP032508	2	unspecified	P21952	mESCs (mouse embryonic stem cells)	PEAKS036448
EXP032511	anti-FoxA1	Homo sapiens		EXP032510	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS035018
EXP032512	anti-FoxA1	Homo sapiens		EXP032510	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS035019
EXP032513	anti-AR	Homo sapiens	hormone-deprived	EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035020
EXP032514	anti-AR	Homo sapiens	hormone-deprived	EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035021
EXP032515	anti-AR	Homo sapiens		EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035022
EXP032516	anti-AR	Homo sapiens		EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035023
EXP032518	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036449
EXP032519	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036450
EXP032520	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036451
EXP032521	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036452
EXP032522	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036453
EXP032523	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036454
EXP032524	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036455
EXP032525	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	PEAKS036456
EXP032530	sc-335	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	PEAKS036457
EXP032531	sc-335	Mus musculus	U0126 10uM	EXP032529	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	PEAKS036458
EXP032532	ab32106	Mus musculus		EXP032526	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	PEAKS036459
EXP032533	ab32106	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	PEAKS036460
EXP032534	ab32106	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	PEAKS036461
EXP032535	ab32106	Mus musculus	U0126 10uM	EXP032529	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	PEAKS036462
EXP032536	sc-13030	Mus musculus		EXP032526	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	PEAKS036463
EXP032537	sc-13030	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	PEAKS036464
EXP032538	sc-13030	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	PEAKS036465
EXP032539	sc-13030	Mus musculus	U0126 10uM	EXP032529	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	PEAKS036466
EXP032540	anti-Net 1996	Mus musculus		EXP032526	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	PEAKS036467
EXP032541	anti-Net 1996	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	PEAKS036468
EXP032542	anti-Net 1996	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	PEAKS036469
EXP032543	anti-Net 1996	Mus musculus	U0126 10uM	EXP032529	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	PEAKS036470
EXP032544	sc-335	Mus musculus		EXP032526	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	PEAKS036471
EXP032545	sc-335	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	PEAKS036472
EXP032547	anti-Cdx2 (anti-V5)	Mus musculus	+Dox +FGF	NULL	60	unspecified	P43241	Ainv15 (embryonic stem cells)	PEAKS036473
EXP032548	anti-Cdx2 truncated (anti-Flag)	Mus musculus	+Dox +FGF	NULL	60	unspecified	P43241	Ainv15 (embryonic stem cells)	PEAKS036474
EXP032549	anti-Cdx2 (anti-V5)	Mus musculus	none	NULL	756	bio_control	P43241	motor neuron progenitors	PEAKS036475
EXP032550	anti-Cdx2 (anti-V5)	Mus musculus		EXP032546	254	unspecified	P43241	endodermal cells	PEAKS036476
EXP032552	anti-NFATc1	Mus musculus		EXP032551	676	unspecified	O88942	NKC (pancreatic cancer cells)	PEAKS036477
EXP032553	anti-NFATc1	Mus musculus		EXP032551	676	unspecified	O88942	NKC (pancreatic cancer cells)	PEAKS036478
EXP032561	anti-STAT5	Homo sapiens		EXP032554	169	unspecified	P42229	CD4+ CD25+ CD45RA+ T-cells	PEAKS035024
EXP032562	anti-STAT5	Homo sapiens		EXP032555	169	unspecified	P42229	CD4+ CD25+ CD45RA+ T-cells	PEAKS035025
EXP032563	anti-STAT5	Homo sapiens		EXP032554	170	unspecified	P42229	CD4+ CD25- T-cells	PEAKS035026
EXP032564	anti-STAT5	Homo sapiens		EXP032556	170	unspecified	P42229	CD4+ CD25- T-cells	PEAKS035027
EXP032565	anti-ETS1	Homo sapiens		EXP032555	169	unspecified	P14921	CD4+ CD25+ CD45RA+ T-cells	PEAKS035028
EXP032566	anti-ETS1	Homo sapiens		EXP032554	169	unspecified	P14921	CD4+ CD25+ CD45RA+ T-cells	PEAKS035029
EXP032567	anti-ETS1	Homo sapiens		EXP032560	169	unspecified	P14921	CD4+ CD25+ CD45RA+ T-cells	PEAKS035030
EXP032568	anti-ETS1	Homo sapiens		EXP032554	170	unspecified	P14921	CD4+ CD25- T-cells	PEAKS035031
EXP032569	anti-ETS1	Homo sapiens		EXP032560	170	unspecified	P14921	CD4+ CD25- T-cells	PEAKS035032
EXP032570	anti-RUNX1	Homo sapiens		EXP032554	169	unspecified	Q01196	CD4+ CD25+ CD45RA+ T-cells	PEAKS035033
EXP032571	anti-RUNX1	Homo sapiens		EXP032554	170	unspecified	Q01196	CD4+ CD25- T-cells	PEAKS035034
EXP032572	anti-RUNX1	Homo sapiens		EXP032560	170	unspecified	Q01196	CD4+ CD25- T-cells	PEAKS035035
EXP032573	anti-FOXP3	Homo sapiens		EXP032554	169	unspecified	Q9BZS1	CD4+ CD25+ CD45RA+ T-cells	PEAKS035036
EXP032574	anti-FOXP3	Homo sapiens		EXP032555	169	unspecified	Q9BZS1	CD4+ CD25+ CD45RA+ T-cells	PEAKS035037
EXP032575	anti-FOXP3	Homo sapiens		EXP032554	170	unspecified	Q9BZS1	CD4+ CD25- T-cells	PEAKS035038
EXP032576	anti-FOXP3	Homo sapiens		EXP032559	170	unspecified	Q9BZS1	CD4+ CD25- T-cells	PEAKS035039
EXP032577	anti-AP-2?	Homo sapiens		NULL	113	unspecified	P05549	MCF7 (Invasive ductal breast carcinoma)	PEAKS035040
EXP032579	anti-TAL1	Homo sapiens		EXP032578	469	unspecified	P17542	primary endothelial colony-forming cells	PEAKS035041
EXP032584	ncoa1	Mus musculus		EXP032580	627	unspecified	P70365	E11.5 embryonic hindbrain	PEAKS036479
EXP032585	ncoa2	Mus musculus		EXP032581	627	unspecified	Q61026	E11.5 embryonic hindbrain	PEAKS036480
EXP032586	smarcc2	Mus musculus		EXP032582	627	unspecified	Q6PDG5	E11.5 embryonic hindbrain	PEAKS036481
EXP032587	smarcc2	Mus musculus		EXP032583	626	unspecified	Q6PDG5	E11.5 embryonic face	PEAKS036482
EXP032590	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	ethanol vehicle	EXP032588	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	PEAKS036483
EXP032591	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	ethanol vehicle	EXP032588	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	PEAKS036484
EXP032592	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	ethanol vehicle	EXP032589	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	PEAKS036485
EXP032593	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	ethanol vehicle	EXP032589	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	PEAKS036486
EXP032595	E2-2 Ab is a rabbit monoclonal Ab generated in Dr. Louis Staudt's lab	Homo sapiens		EXP032594	147	unspecified	P15884	CAL-1 (plasmacytoid dendritic neoplasm)	PEAKS035042
EXP032606	c-Myc antibody (N262) [Santa Cruz,  catalog# sc764]	Homo sapiens		EXP032596	78	unspecified	P01106	HeLa (cervical adenocarcinoma)	PEAKS035043
EXP032607	anti-Miz (residues 637-803) antibody [non-commercial; lab-prepared]	Homo sapiens		EXP032596	78	unspecified	Q13105	HeLa (cervical adenocarcinoma)	PEAKS035044
EXP032608	anti-c-Myc (N262) [Santa Cruz, catalog# sc764]	Homo sapiens	Doxycycline 1ug/ml for 30 hours	EXP032597	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS035045
EXP032609	anti-c-Myc (N262) [Santa Cruz, catalog# sc764]	Homo sapiens		EXP032598	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS035046
EXP032610	anti-Miz (10E2)	Homo sapiens	Doxycycline 1ug/ml for 30 hours	EXP032597	848	unspecified	Q13105	U2OS (osteosarcoma)	PEAKS035047
EXP032611	anti-Miz (10E2)	Homo sapiens		EXP032598	848	unspecified	Q13105	U2OS (osteosarcoma)	PEAKS035048
EXP032612	N262 (Santa Cruz, sc764)	Mus musculus	Doxycycline 1ug/ml for 30 hours	EXP032600	44	unspecified	P01108	T-cells	PEAKS036487
EXP032613	N262 (Santa Cruz, sc764)	Mus musculus		EXP032601	44	unspecified	P01108	T-cells	PEAKS036488
EXP032614	10E2	Mus musculus	Doxycycline 1ug/ml for 30 hours	EXP032600	44	unspecified	Q60821	T-cells	PEAKS036489
EXP032615	10E2	Mus musculus		EXP032601	44	unspecified	Q60821	T-cells	PEAKS036490
EXP032616	N262 (Santa Cruz, sc764)	Mus musculus		EXP032604	715	unspecified	P01108	pancreatic carcinoma	PEAKS036491
EXP032617	10E2	Mus musculus		EXP032604	715	unspecified	Q60821	pancreatic carcinoma	PEAKS036492
EXP032618	N262 (Santa Cruz, sc764)	Mus musculus		NULL	12	unspecified	P01108	MEF (mouse embryonic fibroblasts)	PEAKS036493
EXP032619	10E2	Mus musculus		EXP032605	12	unspecified	Q60821	MEF (mouse embryonic fibroblasts)	PEAKS036494
EXP032626	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032620	113	unspecified	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	PEAKS035049
EXP032627	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siJARID1B	EXP032620	113	unspecified	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	PEAKS035050
EXP032628	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siCTCF	EXP032620	113	unspecified	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	PEAKS035051
EXP032629	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032621	111	unspecified	Q9UGL1	T47D (invasive ductal carcinoma)	PEAKS035052
EXP032630	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032622	818	unspecified	Q9UGL1	SUM185PE (ductal breast carcinoma)	PEAKS035053
EXP032631	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siCTCF	EXP032622	818	unspecified	Q9UGL1	SUM185PE (ductal breast carcinoma)	PEAKS035054
EXP032632	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032623	817	unspecified	Q9UGL1	SUM159PT (Triple negative breast cancer)	PEAKS035055
EXP032633	CTCF (Millipore, 07-729)	Homo sapiens	siControl	EXP032623	817	unspecified	P49711	SUM159PT (Triple negative breast cancer)	PEAKS035056
EXP032634	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032624	2301	unspecified	Q9UGL1	MDA-MB-231 (breast adenocarcinoma)	PEAKS035057
EXP032635	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032625	411	unspecified	Q9UGL1	HCC2157 (ductal breast carcinoma)	PEAKS035058
EXP032639	T6719; Institute of Immunology, Kyoto ; lot: 901119	Mus musculus		EXP032636	823	unspecified	P31266	T29 (T-cell leukemia)	PEAKS036495
EXP032640	T6719; Institute of Immunology, Kyoto ; lot: 901119	Mus musculus		EXP032637	823	unspecified	P31266	T29 (T-cell leukemia)	PEAKS036496
EXP032641	in house anti-Ikaros rabbit polyclonal antibody ; lot: A3	Mus musculus		EXP032638	823	unspecified	Q03267	T29 (T-cell leukemia)	PEAKS036497
EXP032644	Fra-1 (R-20, Santa Cruz)	Homo sapiens		EXP032642	120	unspecified	P15407	BT-549 (breast invasive ductal carcinoma)	PEAKS035059
EXP032645	c-Jun (H-79, Santa Cruz)	Homo sapiens		EXP032642	120	unspecified	P05412	BT-549 (breast invasive ductal carcinoma)	PEAKS035060
EXP032650	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Infection with 3XFlagFezf2IRESZsGFP	EXP032646	161	unspecified	Q9ESP5	neurosphere cells	PEAKS036498
EXP032651	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Infection with 3XFlagFezf2IRESZsGFP	EXP032647	161	unspecified	Q61079	neurosphere cells	PEAKS036499
EXP032656	SOX2	Homo sapiens		EXP032652	530	unspecified	P48431	KYSE70 (esophageal squamous carcinoma)	PEAKS035061
EXP032657	p63	Homo sapiens		EXP032652	530	unspecified	Q9H3D4	KYSE70 (esophageal squamous carcinoma)	PEAKS035062
EXP032658	SOX2	Homo sapiens		EXP032653	840	unspecified	P48431	TT (hereditary thyroid gland medullary carcinoma)	PEAKS035063
EXP032659	p63	Homo sapiens		EXP032653	840	unspecified	Q9H3D4	TT (hereditary thyroid gland medullary carcinoma)	PEAKS035064
EXP032660	SOX2	Homo sapiens		EXP032654	413	unspecified	P48431	HCC95 (squamous cell lung carcinoma)	PEAKS035065
EXP032661	p63	Homo sapiens		EXP032654	413	unspecified	Q9H3D4	HCC95 (squamous cell lung carcinoma)	PEAKS035066
EXP032662	SOX2	Homo sapiens		EXP032655	396	unspecified	P48431	WA09 (embryonic stem cells)	PEAKS035067
EXP032663	LRH-1	Homo sapiens		NULL	113	unspecified	O00482	MCF7 (Invasive ductal breast carcinoma)	PEAKS035068
EXP032665	p53 Antibody (DO-1)	Homo sapiens	5Î¼M Nutlin-3a for 24hr	EXP032664	113	unspecified	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS035069
EXP032668	anti PU.1 (Santa Cruz Biotechnology, sc-352X, lot D2011)	Homo sapiens		EXP032666	466	unspecified	P17947	MDM(monocyte derived macrophages)	PEAKS035070
EXP032669	anti PU.1 (Santa Cruz Biotechnology, sc-352X, lot D2011)	Homo sapiens		EXP032667	466	unspecified	P17947	MDM(monocyte derived macrophages)	PEAKS035071
EXP032672	Jarid2 (Abcam, ab48137)	Mus musculus		EXP032670	43	unspecified	Q62315	CD4+ Th17+ T-cells	PEAKS036500
EXP032673	Jarid2 (Abcam, ab48137)	Mus musculus	mir155 KO	EXP032671	43	unspecified	Q62315	CD4+ Th17+ T-cells	PEAKS036501
EXP032674	c-Maf  (Santa Cruz, M-153)	Mus musculus		EXP032670	43	unspecified	P54843	CD4+ Th17+ T-cells	PEAKS036502
EXP032675	c-Maf  (Santa Cruz, M-153)	Mus musculus	mir155 KO	EXP032671	43	unspecified	P54843	CD4+ Th17+ T-cells	PEAKS036503
EXP032677	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens		EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035072
EXP032678	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035073
EXP032679	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	+FoxA1 high	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035074
EXP032680	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens		EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	PEAKS035075
EXP032681	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	+FoxA1	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	PEAKS035076
EXP032682	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	+FoxA1 high	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	PEAKS035077
EXP032683	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	C562S+FoxA1	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	PEAKS035078
EXP032684	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	Q640X+FoxA1	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	PEAKS035079
EXP032685	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	C562S	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035080
EXP032686	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	C562S+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035081
EXP032687	androgen	Homo sapiens	Q640X	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035082
EXP032688	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	Q640X+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035083
EXP032689	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	G568W	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035084
EXP032690	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	G568W+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS035085
EXP032691	ctcf	Mus musculus		NULL	445	unspecified	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS036504
EXP032692	E2A	Mus musculus		NULL	445	unspecified	P15806	HPC7 (haematopoietic multipotent progenitors)	PEAKS036505
EXP032693	ctcf	Mus musculus		NULL	576	unspecified	Q61164	mast cells	PEAKS036506
EXP032694	e2a	Mus musculus		NULL	576	unspecified	P15806	mast cells	PEAKS036507
EXP032695	erg	Mus musculus		NULL	576	unspecified	P81270	mast cells	PEAKS036508
EXP032696	fli1	Mus musculus		NULL	576	unspecified	P26323	mast cells	PEAKS036509
EXP032697	gata2	Mus musculus		NULL	576	unspecified	O09100	mast cells	PEAKS036510
EXP032698	Meis1	Mus musculus		NULL	576	unspecified	Q60954	mast cells	PEAKS036511
EXP032699	pu.1	Mus musculus		NULL	576	unspecified	P17433	mast cells	PEAKS036512
EXP032700	runx1	Mus musculus		NULL	576	unspecified	Q03347	mast cells	PEAKS036513
EXP032701	scl	Mus musculus		NULL	576	unspecified	P22091	mast cells	PEAKS036514
EXP032702	mitf	Mus musculus		NULL	576	unspecified	Q08874	mast cells	PEAKS036515
EXP032703	cfos	Mus musculus		NULL	576	unspecified	P01101	mast cells	PEAKS036516
EXP032706	Dynabeads  MyOneTM Streptavidin T1	Mus musculus		EXP032704	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	PEAKS036517
EXP032707	anti-Max	Mus musculus		EXP032705	2	unspecified	P28574	mESCs (mouse embryonic stem cells)	PEAKS036518
EXP032714	SREBP1	Mus musculus	ZT02	EXP032708	5	unspecified	Q9WTN3	liver	PEAKS036519
EXP032715	SREBP1	Mus musculus	ZT06	EXP032709	5	unspecified	Q9WTN3	liver	PEAKS036520
EXP032716	SREBP1	Mus musculus	ZT10	EXP032710	5	unspecified	Q9WTN3	liver	PEAKS036521
EXP032717	SREBP1	Mus musculus	ZT14	EXP032711	5	unspecified	Q9WTN3	liver	PEAKS036522
EXP032718	SREBP1	Mus musculus	ZT18	EXP032712	5	unspecified	Q9WTN3	liver	PEAKS036523
EXP032719	SREBP1	Mus musculus	ZT22	EXP032713	5	unspecified	Q9WTN3	liver	PEAKS036524
EXP032722	Runx3poly clonal home made	Mus musculus		EXP032720	104	unspecified	Q64131	dendritic cells	PEAKS036525
EXP032723	Runx3poly clonal home made	Mus musculus		EXP032721	104	unspecified	Q64131	dendritic cells	PEAKS036526
EXP032726	anti-Oct4	Mus musculus		EXP032724	506	unspecified	P20263	J1 (embryonic stem cells)	PEAKS036527
EXP032727	anti-Klf4	Mus musculus		EXP032724	506	unspecified	Q60793	J1 (embryonic stem cells)	PEAKS036528
EXP032728	anti-Oct4	Mus musculus		EXP032725	506	unspecified	P20263	J1 (embryonic stem cells)	PEAKS036529
EXP032729	anti-Klf4	Mus musculus		EXP032725	506	unspecified	Q60793	J1 (embryonic stem cells)	PEAKS036530
EXP032731	anti-GATA6	Homo sapiens		EXP032730	188	unspecified	Q92908	LS174T (colon adenocarcinoma)	PEAKS035086
EXP032738	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: time 0; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032732	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS035087
EXP032739	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: vehicle; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032733	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS035088
EXP032740	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: 1 nM methyltrienolone (R1881); Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032733	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS035089
EXP032741	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: time 0; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032734	71	normal	Q06546	VCaP (prostate carcinoma)	PEAKS035090
EXP032742	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: vehicle; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032735	71	normal	Q06546	VCaP (prostate carcinoma)	PEAKS035091
EXP032743	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: 1 nM methyltrienolone (R1881); Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032735	71	normal	Q06546	VCaP (prostate carcinoma)	PEAKS035092
EXP032744	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032736	509	normal	Q06546	Jurkat (T-cells)	PEAKS035093
EXP032745	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032737	509	normal	P11308	Jurkat (T-cells)	PEAKS035094
EXP032747	Klf4	Mus musculus		EXP032746	176	unspecified	Q60793	CGR8 (embryonic stem cells)	PEAKS036531
EXP032748	Klf5	Mus musculus		EXP032746	176	unspecified	Q9Z0Z7	CGR8 (embryonic stem cells)	PEAKS036532
EXP032749	Klf4	Mus musculus	KLF4 overexpression	EXP032746	176	unspecified	Q60793	CGR8 (embryonic stem cells)	PEAKS036533
EXP032750	Klf5	Mus musculus	KLF5 overexpression	EXP032746	176	unspecified	Q9Z0Z7	CGR8 (embryonic stem cells)	PEAKS036534
EXP032752	SOX4	Mus musculus		EXP032751	105	unspecified	Q06831	pro-B cells	PEAKS036535
EXP032753	PPAR?/?	Homo sapiens	DMSO, normoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS035095
EXP032754	PPAR?/?	Homo sapiens	PPARbeta/delta agonist, normoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS035096
EXP032755	PPAR?/?	Homo sapiens	DMSO, hypoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS035097
EXP032756	PPAR?/?	Homo sapiens	PPARbeta/delta agonist, hypoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS035098
EXP032758	MLL1	Mus musculus		EXP032757	1153	unspecified	P55200	C2C12 (myoblasts)	PEAKS036536
EXP032759	CTCF	Homo sapiens	DNMT1KO	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS035099
EXP032760	CTCF	Homo sapiens	DNMT3BKO	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS035100
EXP032761	CTCF	Homo sapiens	No special treatment	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS035101
EXP032762	CTCF	Homo sapiens	 DNMT1KO, DNMT3BKO	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	PEAKS035102
EXP032763	CTCF	Homo sapiens		NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS035103
EXP032764	CTCF	Homo sapiens	5-aza-2â€™-deoxycytidine (decitabine; Sigma, A3656) dissolved in DMSO to 10mM. Drug was administered at 1uM daily for 3 days. Control K562 cells were mock treated with DMSO.	NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS035104
EXP032765	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036537
EXP032766	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS036538
EXP032769	Nrf1 (ab55744, Abcam)	Mus musculus		EXP032767	18	unspecified	Q9WU00	3T3-L1 (embryonic fibroblasts)	PEAKS036539
EXP032770	Nrf1 (ab55744, Abcam)	Mus musculus		EXP032768	18	unspecified	Q9WU00	3T3-L1 (embryonic fibroblasts)	PEAKS036540
EXP032774	AR (Sahu et al. 2011)	Mus musculus		EXP032771	150	unspecified	P19091	caput epididymis	PEAKS036541
EXP032775	AR (Sahu et al. 2011)	Mus musculus		EXP032771	150	unspecified	P19091	caput epididymis	PEAKS036542
EXP032776	AR (Sahu et al. 2011)	Mus musculus	specificity affecting androgen receptor knock-in	EXP032772	150	unspecified	P19091	caput epididymis	PEAKS036543
EXP032777	AR (Sahu et al. 2011)	Mus musculus	specificity affecting androgen receptor knock-in	EXP032772	150	unspecified	P19091	caput epididymis	PEAKS036544
EXP032778	AR (Sahu et al. 2011)	Mus musculus		EXP032773	860	unspecified	P19091	ventral prostate	PEAKS036545
EXP032779	AR (Sahu et al. 2011)	Mus musculus	specificity affecting androgen receptor knock-in	NULL	860	unspecified	P19091	ventral prostate	PEAKS036546
EXP032780	p65	Homo sapiens	vehicle	NULL	40	unspecified	Q04206	AC16 (normal cardiomyocytes)	PEAKS035105
EXP032781	p65	Homo sapiens	TNFÎ±	NULL	40	unspecified	Q04206	AC16 (normal cardiomyocytes)	PEAKS035106
EXP032782	monoclonal anti-p53 (Santa Cruz Biotechnology)	Homo sapiens		NULL	783	unspecified	P04637	SaOS2 (osteosarcoma)	PEAKS035107
EXP032787	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032783	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS035108
EXP032788	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032784	111	unspecified	P23771	T47D (invasive ductal carcinoma)	PEAKS035109
EXP032789	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032785	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS035110
EXP032790	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032786	111	unspecified	P23771	T47D (invasive ductal carcinoma)	PEAKS035111
EXP032792	sc-7208	Homo sapiens		EXP032791	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS035112
EXP032793	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	PEAKS036547
EXP032794	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	PEAKS036548
EXP032795	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	PEAKS036549
EXP032796	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	PEAKS036550
EXP032797	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	PEAKS036551
EXP032798	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	PEAKS036552
EXP032799	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	PEAKS036553
EXP032800	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	PEAKS036554
EXP032801	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	PEAKS036555
EXP032802	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	PEAKS036556
EXP032803	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	PEAKS036557
EXP032804	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	PEAKS036558
EXP032809	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032805	2	unspecified	Q9D1P2	mESCs (mouse embryonic stem cells)	PEAKS036559
EXP032810	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032806	2	unspecified	Q9D1P2	mESCs (mouse embryonic stem cells)	PEAKS036560
EXP032811	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032807	138	unspecified	Q9D1P2	neural progenitors	PEAKS036561
EXP032812	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032808	138	unspecified	Q9D1P2	neural progenitors	PEAKS036562
EXP032814	custom made antiserum for Tcf1	Mus musculus		EXP032813	2479	unspecified	Q00417	CD8+ T-cells	PEAKS036563
EXP032819	anti mouse ER-alpha	Mus musculus	10 nM beta-estradiol (E2)	EXP032815	68	unspecified	P19785	aortic cells	PEAKS036564
EXP032820	estrogen	Mus musculus	10 nM beta-estradiol (E2)	EXP032816	68	unspecified	O08537	aortic cells	PEAKS036565
EXP032821	anti mouse ER-alpha	Mus musculus	10 nM beta-estradiol (E2)	EXP032817	5	unspecified	P19785	liver	PEAKS036566
EXP032822	estrogen	Mus musculus	10 nM beta-estradiol (E2)	EXP032818	5	unspecified	P19785	liver	PEAKS036567
EXP032823	HNF4A (ab41898, Abcam, lot # GR4841-13)	Mus musculus	water only	NULL	187	unspecified	P49698	colon epithelium	PEAKS036568
EXP032824	HNF4A (ab41898, Abcam, lot # GR4841-13)	Mus musculus	3% DSS	NULL	187	unspecified	P49698	colon epithelium	PEAKS036569
EXP032825	anti-Sp1 antibody (Santa Cruz sc-17824X)	Mus musculus		NULL	230	unspecified	O89090	ES-E14 (E14, embryonic stem cells)	PEAKS036570
EXP032826	anti-Sp1 antibody (Santa Cruz sc-17824X)	Mus musculus		NULL	306	unspecified	O89090	Flk+ cKit+ progenitors	PEAKS036571
EXP032828	FLAG-M2 monoclonal (Sigma, F3165)	Mus musculus		EXP032827	546	unspecified	Q61602	limb bud	PEAKS036572
EXP032831	BAF155	Homo sapiens	CARM1 KO	EXP032829	113	unspecified	Q92922	MCF7 (Invasive ductal breast carcinoma)	PEAKS035113
EXP032832	BAF155	Homo sapiens		EXP032830	113	unspecified	Q92922	MCF7 (Invasive ductal breast carcinoma)	PEAKS035114
EXP032835	anti-TAL1 (C-21, Santa-Cruz)	Homo sapiens	none	EXP032833	469	unspecified	P17542	primary endothelial colony-forming cells	PEAKS035115
EXP032836	anti-TAL1 (C-21, Santa-Cruz)	Homo sapiens	100 ng/ml final TSA	EXP032834	469	unspecified	P17542	primary endothelial colony-forming cells	PEAKS035116
EXP032837	anti-YY1 (Santa Cruz, catalog# SC-1703, lot# E0511)	Mus musculus		NULL	196	unspecified	Q00899	jejunal crypt intestinal epithelial cells	PEAKS036573
EXP032839	ER? (Santa Cruz Biotechnology; sc-534X, sc-7207X)	Homo sapiens	siCtrl	EXP032838	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS035117
EXP032840	ER? (Santa Cruz Biotechnology; sc-534X, sc-7207X)	Homo sapiens	siERalpha	EXP032838	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS035118
EXP032842	antibody against Ovol2	Mus musculus		EXP032841	902	unspecified	Q8CIV7	mammary epithelial cells	PEAKS036574
EXP051009	Runx2 antibody (M70, Santa Cruz Biotechnologies, Inc.)	Mus musculus		NULL	739	unspecified	Q08775	MC3T3-E1 subclone 4 (preosteoblasts)	PEAKS049009
EXP032845	Runx2 antibody (M70, Santa Cruz Biotechnologies, Inc.)	Mus musculus		EXP032843	577	unspecified	Q08775	matrix-depositing osteoblasts	PEAKS036576
EXP032846	Runx2 antibody (M70, Santa Cruz Biotechnologies, Inc.)	Mus musculus		NULL	607	unspecified	Q08775	mineralizing osteoblasts	PEAKS036577
EXP032853	anti-AR	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035119
EXP032854	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035120
EXP032855	anti-AR	Homo sapiens	BICALUTAMIDE	EXP032852	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035121
EXP032856	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035122
EXP032857	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035123
EXP032858	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035124
EXP032859	anti-AR	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035125
EXP032860	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035126
EXP032861	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035127
EXP032862	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035128
EXP032863	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035129
EXP032864	anti-AR	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035130
EXP032865	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035131
EXP032866	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035132
EXP032867	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS035133
EXP032868	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS035134
EXP032869	anti-AR	Homo sapiens	Ethanol	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	PEAKS035135
EXP032870	anti-AR	Homo sapiens	Ethanol	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	PEAKS035136
EXP032871	anti-AR	Homo sapiens	10 nM R1881	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	PEAKS035137
EXP032872	anti-AR	Homo sapiens	10 nM R1881	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	PEAKS035138
EXP032875	anti-AR	Homo sapiens	Ethanol	EXP032873	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	PEAKS035139
EXP032876	anti-AR	Homo sapiens	Ethanol	EXP032874	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	PEAKS035140
EXP032877	anti-AR	Homo sapiens	10 nM R1881	EXP032873	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	PEAKS035141
EXP032878	anti-AR	Homo sapiens	10 nM R1881	EXP032874	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	PEAKS035142
EXP032880	anti-cJun	Mus musculus		EXP032879	2479	unspecified	P05627	CD8+ T-cells	PEAKS036578
EXP032881	anti-JunB	Mus musculus		NULL	2479	unspecified	P09450	CD8+ T-cells	PEAKS036579
EXP032882	anti-JunD	Mus musculus		NULL	2479	unspecified	P15066	CD8+ T-cells	PEAKS036580
EXP032884	anti-BATF	Mus musculus		EXP032879	2479	unspecified	O35284	CD8+ T-cells	PEAKS036582
EXP032885	anti-IRF4	Mus musculus		EXP032879	2479	unspecified	Q64287	CD8+ T-cells	PEAKS036583
EXP032889	anti-Meis1/2	Mus musculus		EXP032886	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	PEAKS036584
EXP032890	anti-Meis1/2	Mus musculus		EXP032887	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	PEAKS036585
EXP032891	anti-Meis1/2	Mus musculus		EXP032888	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	PEAKS036586
EXP032892	anti-Prep1	Mus musculus		EXP032888	12	unspecified	O70477	MEF (mouse embryonic fibroblasts)	PEAKS036587
EXP032893	anti-HIF1a	Homo sapiens		NULL	771	unspecified	Q16665	Caki-2 (renal carcinoma)	PEAKS035143
EXP032894	sox2	Mus musculus		NULL	204	unspecified	P48432	D3 (embryonic stem cells)	PEAKS036588
EXP032895	PU.1 (sc-352)	Mus musculus		NULL	123	unspecified	P17433	BV-2 (brain microglial cells)	PEAKS036589
EXP032896	PU.1 (sc-352)	Mus musculus	wt human Htt overexpression	NULL	123	unspecified	P17433	BV-2 (brain microglial cells)	PEAKS036590
EXP032897	PU.1 (sc-352)	Mus musculus	mutant human Htt overexpression	NULL	123	unspecified	P17433	BV-2 (brain microglial cells)	PEAKS036591
EXP032898	CEBPa (sc-61)	Mus musculus		NULL	123	unspecified	P53566	BV-2 (brain microglial cells)	PEAKS036592
EXP032899	CEBPa (sc-61)	Mus musculus	wt human Htt overexpression	NULL	123	unspecified	P53566	BV-2 (brain microglial cells)	PEAKS036593
EXP032900	CEBPa (sc-61)	Mus musculus	mutant human Htt overexpression	NULL	123	unspecified	P53566	BV-2 (brain microglial cells)	PEAKS036594
EXP032901	CEBPb (sc-150)	Mus musculus		NULL	123	unspecified	P28033	BV-2 (brain microglial cells)	PEAKS036595
EXP032902	CEBPb (sc-150)	Mus musculus	wt human Htt overexpression	NULL	123	unspecified	P28033	BV-2 (brain microglial cells)	PEAKS036596
EXP032903	CEBPb (sc-150)	Mus musculus	mutant human Htt overexpression	NULL	123	unspecified	P28033	BV-2 (brain microglial cells)	PEAKS036597
EXP032905	SRC-2 (A300-346A, Bethyl Lab., Inc.)	Mus musculus		EXP032904	632	unspecified	Q61026	prostate	PEAKS036598
EXP032907	sc-1008	Mus musculus		EXP032906	477	unspecified	P48281	IDG-SW3 (bone cells)	PEAKS036599
EXP032908	sc-1008	Mus musculus	100nM 1,25(OH)2D3 for 3 hours	EXP032906	477	unspecified	P48281	IDG-SW3 (bone cells)	PEAKS036600
EXP032909	sc-774	Mus musculus		EXP032906	477	unspecified	P28700	IDG-SW3 (bone cells)	PEAKS036601
EXP032910	sc-774	Mus musculus	100nM 1,25(OH)2D3 for 3 hours	EXP032906	477	unspecified	P28700	IDG-SW3 (bone cells)	PEAKS036602
EXP032912	custom-made EBF1 antibody (rabbit)	Homo sapiens		EXP032911	51	unspecified	Q9UH73	adipose stromal cell adipocytes	PEAKS035144
EXP032913	Anti-Brachyury antibody, Custom-made, rabbits were immunized with Brachyury residues 249-436 GST fusion proteins	Mus musculus		NULL	204	unspecified	P20293	D3 (embryonic stem cells)	PEAKS036603
EXP032914	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	PEAKS036604
EXP032915	anti-p50	Mus musculus		NULL	141	unspecified	P25799	retina	PEAKS036605
EXP032916	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	PEAKS036606
EXP032917	anti-p50	Mus musculus		NULL	141	unspecified	P25799	retina	PEAKS036607
EXP032918	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	PEAKS036608
EXP032919	anti-p50	Mus musculus		NULL	141	unspecified	P25799	retina	PEAKS036609
EXP032920	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	PEAKS036610
EXP032921	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	PEAKS036611
EXP032922	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	PEAKS036612
EXP032923	anti-ATF3	Mus musculus	LPS	NULL	141	unspecified	Q60765	retina	PEAKS036613
EXP032924	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	PEAKS036614
EXP032925	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	PEAKS036615
EXP032926	anti-p65	Mus musculus		NULL	141	unspecified	Q04207	retina	PEAKS036616
EXP032927	anti-ATF3	Mus musculus	LPS	NULL	141	unspecified	Q60765	retina	PEAKS036617
EXP032929	Anti-Brachyury antibody Rabbit #1, Custom-made, rabbits were immunized with Brachyury residues 249-436 GST fusion protein	Mus musculus		EXP032928	204	unspecified	P20293	D3 (embryonic stem cells)	PEAKS036618
EXP032930	Anti-Brachyury antibody Rabbit #2, Custom-made, rabbits were immunized with Brachyury residues 249-436 GST fusion protein	Mus musculus		EXP032928	204	unspecified	P20293	D3 (embryonic stem cells)	PEAKS036619
EXP032932	Anti-BCL11a	Homo sapiens		EXP032931	147	unspecified	Q9H165	CAL-1 (plasmacytoid dendritic neoplasm)	PEAKS035145
EXP032934	CTCF : 07-729 Millipore Lot. DAM1745366	Homo sapiens		EXP032933	2334	unspecified	P49711	THP-1 (acute monocytic leukemia)	PEAKS035146
EXP032936	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: Vehicle	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS035147
EXP032937	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 12 hours of DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS035148
EXP032938	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 12 hours of 500nM JQ1 and then 12 hours of DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS035149
EXP032939	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 6 hours of MDV3100 and then 12 hours of DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS035150
EXP032940	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 6 hours of 25ÂµM Bicalutamide and then 12 hours of 10nM DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS035151
EXP032941	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: DMSO for 12 hours; Time point: 12 hours	EXP032935	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS035152
EXP032942	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: 12 hours of 500nM JQ1; Time point: 12 hours	EXP032935	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS035153
EXP032944	anti-Tead2	Mus musculus		EXP032943	760	unspecified	P48301	Py2T (breast cancer)	PEAKS036620
EXP032946	Foxp3	Mus musculus		EXP032945	44	unspecified	Q99JB6	T-cells	PEAKS036621
EXP032949	anti-Ascl1	Mus musculus		EXP032947	476	unspecified	Q02067	neural tube	PEAKS036622
EXP032950	anti-Ptf1a	Mus musculus		NULL	476	unspecified	Q9QX98	neural tube	PEAKS036623
EXP032951	anti-Ptf1a	Mus musculus		NULL	476	unspecified	Q9QX98	neural tube	PEAKS036624
EXP032953	anti-p53	Homo sapiens	none	EXP032952	93	unspecified	P04637	BJ (fibroblasts)	PEAKS035154
EXP032954	anti-p53	Homo sapiens	ionizing radiation	EXP032952	93	unspecified	P04637	BJ (fibroblasts)	PEAKS035155
EXP032957	ER? HC-20 (sc543 from Santa Cruz, 1 Âµg used)	Homo sapiens	JQ1+E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS035156
EXP032958	ER? HC-20 (sc543 from Santa Cruz, 1 Âµg used)	Homo sapiens	E2	EXP032956	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS035157
EXP032961	anti-Foxp3	Mus musculus		NULL	243	unspecified	Q99JB6	EL4 (lymphoma)	PEAKS036625
EXP032962	anti-RORgamma	Mus musculus		EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036626
EXP032963	anti-RORgamma	Mus musculus	Th17 polarizing conditions	EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036627
EXP032964	anti-RORgamma	Mus musculus	DMSO	EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036628
EXP032965	anti-RORgamma	Mus musculus	TMP778 (2.5uM)	EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036629
EXP032966	anti-RORgamma	Mus musculus	Digoxin (10uM)	EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036630
EXP032967	anti-RORgamma	Mus musculus	TMP920 (10uM)	EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036631
EXP032968	anti-RORgamma	Mus musculus	DMSO and Th17 polarizing conditions	EXP032959	498	unspecified	P51450	Th17-cells	PEAKS036632
EXP032969	Anti-Flag	Mus musculus		EXP032960	243	unspecified	P51450	EL4 (lymphoma)	PEAKS036633
EXP032970	anti-Foxp3	Mus musculus		NULL	498	unspecified	Q99JB6	Th17-cells	PEAKS036634
EXP032976	anti-Oct4	Mus musculus	Activin A	EXP032971	206	unspecified	P20263	epiblast-like cells	PEAKS036635
EXP032977	anti-Oct4	Mus musculus		EXP032972	206	unspecified	P20263	epiblast-like cells	PEAKS036636
EXP032978	anti-Otx2	Mus musculus	Activin A	EXP032971	206	unspecified	P80206	epiblast-like cells	PEAKS036637
EXP032979	anti-Otx2	Mus musculus		EXP032972	206	unspecified	P80206	epiblast-like cells	PEAKS036638
EXP032980	anti-Oct4	Mus musculus		EXP032973	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS036639
EXP032981	anti-Otx2	Mus musculus		EXP032973	2	unspecified	P80206	mESCs (mouse embryonic stem cells)	PEAKS036640
EXP032982	anti-Oct4	Mus musculus	Dox	EXP032974	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS036641
EXP032983	anti-Otx2	Mus musculus	Dox	EXP032974	2	unspecified	P80206	mESCs (mouse embryonic stem cells)	PEAKS036642
EXP032985	anti-Oct4	Mus musculus		EXP032975	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS036644
EXP032986	anti-Otx2	Mus musculus		EXP032975	2	unspecified	P80206	mESCs (mouse embryonic stem cells)	PEAKS036645
EXP032988	anti-Runx1	Mus musculus		EXP032987	44	unspecified	Q03347	T-cells	PEAKS036646
EXP032989	E47	Mus musculus		NULL	171	unspecified	P15806	CD4+ CD8+ T cells	PEAKS036647
EXP032990	anti-Ets1	Mus musculus		EXP032987	44	unspecified	P27577	T-cells	PEAKS036648
EXP032992	anti-ERalpha	Mus musculus	saline vehicle	NULL	852	unspecified	P19785	uterine cells	PEAKS036649
EXP032993	anti-ERalpha	Mus musculus	estradiol (250 ng/mouse)	NULL	852	unspecified	O08537	uterine cells	PEAKS036650
EXP032995	anti-p63	Homo sapiens	none	EXP032994	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS035158
EXP032996	anti-p63	Homo sapiens	350nM Adrimycin	EXP032994	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS035159
EXP032997	anti-p63	Homo sapiens	25uM Cisplatin	EXP032994	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS035160
EXP032998	anti-p53	Homo sapiens	none	EXP032994	468	unspecified	P04637	neonatal keratinocytes	PEAKS035161
EXP032999	anti-p53	Homo sapiens	350nM Adrimycin	EXP032994	468	unspecified	P04637	neonatal keratinocytes	PEAKS035162
EXP033000	anti-p53	Homo sapiens	25uM Cisplatin	EXP032994	468	unspecified	P04637	neonatal keratinocytes	PEAKS035163
EXP033002	anti-C/EBPalpha	Mus musculus	none	EXP033001	20	unspecified	P53566	3T3-L1-derived adipocytes	PEAKS036651
EXP033003	anti-C/EBPbeta	Mus musculus		EXP033001	20	unspecified	P28033	3T3-L1-derived adipocytes	PEAKS036652
EXP033004	anti-ATF2	Mus musculus		EXP033001	20	unspecified	P16951	3T3-L1-derived adipocytes	PEAKS036653
EXP033005	anti-JunD	Mus musculus		EXP033001	20	unspecified	P15066	3T3-L1-derived adipocytes	PEAKS036654
EXP033011	anti-B-ATF	Homo sapiens		EXP033006	686	unspecified	Q16520	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035164
EXP033012	anti-IRF4	Homo sapiens		EXP033006	686	unspecified	Q15306	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035165
EXP033013	anti-PU.1	Homo sapiens		EXP033006	686	unspecified	P17947	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035166
EXP033014	anti-SPI-B	Homo sapiens		EXP033006	686	unspecified	Q01892	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035167
EXP033015	anti-B-ATF	Homo sapiens		EXP033007	683	unspecified	Q16520	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS035168
EXP033016	anti-IRF4	Homo sapiens		EXP033007	683	unspecified	Q15306	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS035169
EXP033017	anti-PU.1	Homo sapiens		EXP033007	683	unspecified	P17947	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS035170
EXP033018	anti-SPI-B	Homo sapiens		EXP033007	683	unspecified	Q01892	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS035171
EXP033019	anti-IRF4	Homo sapiens		EXP033008	394	unspecified	Q15306	H929 (plasma cell myeloma)	PEAKS035172
EXP033020	anti-PU.1	Homo sapiens		EXP033008	394	unspecified	P17947	H929 (plasma cell myeloma)	PEAKS035173
EXP033021	anti-SPI-B	Homo sapiens		EXP033008	394	unspecified	Q01892	H929 (plasma cell myeloma)	PEAKS035174
EXP033022	anti-IRF4	Homo sapiens		EXP033009	686	unspecified	Q15306	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035175
EXP033023	anti-PU.1	Homo sapiens		EXP033009	686	unspecified	P17947	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035176
EXP033024	anti-SPI-B	Homo sapiens		EXP033009	686	unspecified	Q01892	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035177
EXP033025	anti-IRF4	Homo sapiens		EXP033010	686	unspecified	Q15306	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035178
EXP033026	anti-PU.1	Homo sapiens		EXP033010	686	unspecified	P17947	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035179
EXP033027	anti-SPI-B	Homo sapiens		EXP033010	686	unspecified	Q01892	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS035180
EXP033028	anti-ATF2	Mus musculus		NULL	18	unspecified	P16951	3T3-L1 (embryonic fibroblasts)	PEAKS036655
EXP033029	anti-ATF7	Mus musculus		NULL	18	unspecified	Q8R0S1	3T3-L1 (embryonic fibroblasts)	PEAKS036656
EXP033030	anti-cJun	Mus musculus		NULL	18	unspecified	P05627	3T3-L1 (embryonic fibroblasts)	PEAKS036657
EXP033031	anti-JunB	Mus musculus		NULL	18	unspecified	P09450	3T3-L1 (embryonic fibroblasts)	PEAKS036658
EXP033032	anti-KLF4	Mus musculus		NULL	18	unspecified	Q60793	3T3-L1 (embryonic fibroblasts)	PEAKS036659
EXP033033	anti-KLF5	Mus musculus		NULL	18	unspecified	Q9Z0Z7	3T3-L1 (embryonic fibroblasts)	PEAKS036660
EXP033034	anti-PBX1	Mus musculus		NULL	18	unspecified	P41778	3T3-L1 (embryonic fibroblasts)	PEAKS036661
EXP033035	anti-STAT1	Mus musculus		NULL	18	unspecified	P42225	3T3-L1 (embryonic fibroblasts)	PEAKS036662
EXP033036	anti-VDR	Mus musculus		NULL	18	unspecified	P48281	3T3-L1 (embryonic fibroblasts)	PEAKS036663
EXP033037	anti-RXR	Mus musculus		NULL	18	unspecified	O54915	3T3-L1 (embryonic fibroblasts)	PEAKS036664
EXP033039	anti-CTCF	Homo sapiens		EXP033038	725	unspecified	P49711	PC3(bone mets prostate adenocarcinoma)	PEAKS035181
EXP033041	Anti-AP4	Mus musculus		EXP033040	2479	unspecified	Q9JIZ5	CD8+ T-cells	PEAKS036665
EXP033042	Anti-Myc	Mus musculus		EXP033040	2479	unspecified	P01108	CD8+ T-cells	PEAKS036666
EXP033044	anti-WT1 (C-19) [Santa Cruz, sc-192]	Mus musculus		EXP033043	523	unspecified	P22561	kidney	PEAKS036667
EXP033046	anti-Ebf1 (Abnova H00001879-M01)	Mus musculus		EXP033045	18	unspecified	Q07802	3T3-L1 (embryonic fibroblasts)	PEAKS036668
EXP033048	anti-HA	Mus musculus		EXP033047	400	unspecified	P09631	hematopoietic progenitors	PEAKS036669
EXP033049	anti-C/EBPalpha	Mus musculus		EXP033047	400	unspecified	P53566	hematopoietic progenitors	PEAKS036670
EXP033051	anti-PDX1	Homo sapiens		EXP033050	431	unspecified	P52945	embryonic stem cell-derived pancreatic cells	PEAKS035182
EXP033052	Twist1 (Sigma, T6451, 5 ?g)	Mus musculus	none	NULL	227	unspecified	P26687	E12.5 embryonic endocardial cushion cells	PEAKS039522
EXP033053	Twist1 (Sigma, T6451, 5 ?g)	Mus musculus	none	NULL	226	unspecified	P26687	E10.5 embryonic limb bud cells	PEAKS039523
EXP033054	Twist1 (Sigma, T6451, 5 ?g)	Mus musculus	none	NULL	731	unspecified	P26687	peripheral nerve sheath tumor	PEAKS039524
EXP033055	anti-CTCF	Homo sapiens	none	NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS039444
EXP033057	c-Jun	Mus musculus	KSM; Doxycycline	EXP033056	693	unspecified	P05627	OG2 transgenetic mouse embryonic stem cells	PEAKS039525
EXP033058	c-Jun	Mus musculus	KSM; Doxycycline; c-Jun (dominant negative)	EXP033056	694	unspecified	P05627	OG2 transgenetic mouse embryonic fibroblasts	PEAKS039526
EXP033082	anti-AR (N20) from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	Bicalutamide	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039450
EXP033083	anti-AR (N20) from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	Enzalutamide	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039451
EXP033086	anti-HNF4a (Santa Cruz Biotechnology, Inc.: sc-8987)	Homo sapiens	double thymidine block	EXP033084	553	unspecified	P41235	LoVo (colorectal adenocarcinoma)	PEAKS039452
EXP033087	anti-KLF5 (Santa Cruz Biotechnology, Inc. : sc-22797)	Homo sapiens	double thymidine block	EXP033084	553	unspecified	Q13887	LoVo (colorectal adenocarcinoma)	PEAKS039453
EXP033088	anti-MYC (MILLIPORE: 06-340)	Homo sapiens	double thymidine block	EXP033084	553	unspecified	P01106	LoVo (colorectal adenocarcinoma)	PEAKS039454
EXP033089	anti-HNF4a (Santa Cruz Biotechnology, Inc.: sc-8987)	Homo sapiens	double thymidine block + nocodazole	EXP033085	553	unspecified	P41235	LoVo (colorectal adenocarcinoma)	PEAKS039455
EXP033090	anti-KLF5 (Santa Cruz Biotechnology, Inc. : sc-22797)	Homo sapiens	double thymidine block + nocodazole	EXP033085	553	unspecified	Q13887	LoVo (colorectal adenocarcinoma)	PEAKS039456
EXP033091	anti-MYC (MILLIPORE: 06-340)	Homo sapiens	double thymidine block + nocodazole	EXP033085	553	unspecified	P01106	LoVo (colorectal adenocarcinoma)	PEAKS039457
EXP033095	sc-22797	Homo sapiens	none	EXP033092	870	unspecified	Q13887	YCC3 (gastric adenocarcinoma)	PEAKS039458
EXP033096	sc-9053	Homo sapiens	none	EXP033092	870	unspecified	P43694	YCC3 (gastric adenocarcinoma)	PEAKS039459
EXP033097	sc-9055	Homo sapiens	none	EXP033092	870	unspecified	Q92908	YCC3 (gastric adenocarcinoma)	PEAKS039460
EXP033098	sc-22797	Homo sapiens	none	EXP033093	59	unspecified	Q13887	AGS (gastric adenocarcinoma)	PEAKS039461
EXP033099	sc-9053	Homo sapiens	none	EXP033093	59	unspecified	P43694	AGS (gastric adenocarcinoma)	PEAKS039462
EXP033100	sc-9055	Homo sapiens	none	EXP033093	59	unspecified	Q92908	AGS (gastric adenocarcinoma)	PEAKS039463
EXP033101	sc-22797	Homo sapiens	none	EXP033094	518	unspecified	Q13887	KATOIII (signet ring cell gastric adenocarcinoma)	PEAKS039464
EXP033102	sc-9053	Homo sapiens	none	EXP033094	518	unspecified	P43694	KATOIII (signet ring cell gastric adenocarcinoma)	PEAKS039465
EXP033103	sc-9055	Homo sapiens	none	EXP033094	518	unspecified	Q92908	KATOIII (signet ring cell gastric adenocarcinoma)	PEAKS039466
EXP033106	sc-1237x, Santa Cruz	Mus musculus	none	EXP033104	53	unspecified	Q08369	heart	PEAKS039539
EXP033107	none (streptavidin-coated beads used to pulldown biotinylated Gata4; 11205D, M-280 Streptavidin Invitrogen)	Mus musculus	none	EXP033104	53	unspecified	Q08369	heart	PEAKS039540
EXP033108	sc-1237x, Santa Cruz	Mus musculus	none	EXP033105	53	unspecified	Q08369	heart	PEAKS039541
EXP033109	none (streptavidin-coated beads used to pulldown biotinylated Gata4; 11205D, M-280 Streptavidin Invitrogen)	Mus musculus	none	EXP033105	53	unspecified	Q08369	heart	PEAKS039542
EXP033111	Anti-SOX11 (Sigma, HPA000536. Lot: B33103)	Homo sapiens	none	EXP033110	372	unspecified	P35716	Granta-519 (mantle cell lymphoma)	PEAKS039467
EXP033112	anti-CTCF	Homo sapiens	none	NULL	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	PEAKS039468
EXP033113	anti-CTCF	Homo sapiens	none	NULL	379	unspecified	P49711	H1-derived mesendodermal cells	PEAKS039469
EXP033114	anti-CTCF	Homo sapiens	none	NULL	378	unspecified	P49711	H1-derived mesenchymal stem cells	PEAKS039470
EXP033115	anti-CTCF	Homo sapiens	none	NULL	380	unspecified	P49711	H1-derived neuronal progenitors	PEAKS039471
EXP033116	anti-CTCF	Homo sapiens	none	NULL	382	unspecified	P49711	H1-derived trophectodermal cells	PEAKS039472
EXP033119	anti-CTCF	Homo sapiens	none	EXP033118	895	unspecified	P49711	erythroid progenitors	PEAKS039473
EXP033122	Flag (anti-Flag-M2, Sigma)	Homo sapiens	none	EXP033121	65	unspecified	Q9H2W2	U937 (adult acute monocytic leukemia)	PEAKS039474
EXP033123	Flag (anti-Flag-M2, Sigma)	Homo sapiens	none	EXP033121	65	unspecified	Q9H2W2	U937 (adult acute monocytic leukemia)	PEAKS039475
EXP033124	MAF (Santa Cruz, cat.# SC-10022, lot# B1513)_wrong antibody ID (for Maf-B)	Homo sapiens	differentiation induction	NULL	463	unspecified	O75444	epidermal keratinocytes	PEAKS039476
EXP033125	MAFB (Santa Cruz, cat.# SC-7866, lot# G0312)_wrong antibody ID (for c-Maf)	Homo sapiens	differentiation induction	NULL	463	unspecified	Q9Y5Q3	epidermal keratinocytes	PEAKS039477
EXP033127	SRC-2  antibody (Bethyl Laboratories, catalog number A300-346, lot number A-1)	Mus musculus	none	EXP033126	5	unspecified	Q61026	liver	PEAKS039543
EXP033128	SRC-2  antibody (Bethyl Laboratories, catalog number A300-346, lot number A-1)	Mus musculus	none	EXP033126	5	unspecified	Q61026	liver	PEAKS039544
EXP033129	SRC-2  antibody (Bethyl Laboratories, catalog number A300-346, lot number A-1)	Mus musculus	none	EXP033126	5	unspecified	Q61026	liver	PEAKS039545
EXP033131	anti-NRF1 [in house antibody]	Homo sapiens		EXP033130	1521	unspecified	Q16656	Namalwa (Burkitt lymphoma)	PEAKS039478
EXP033136	SMAD2/3 (R&D Systems, AF3797, lot XHY01)	Mus musculus	none	EXP033132	176	unspecified	Q62432	CGR8 (embryonic stem cells)	PEAKS039546
EXP033137	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	none	EXP033132	176	unspecified	Q61286	CGR8 (embryonic stem cells)	PEAKS039547
EXP033138	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	10 uM SB431542 inhibitor of TGF-beta pathway	EXP033133	176	unspecified	Q61286	CGR8 (embryonic stem cells)	PEAKS039548
EXP033139	SMAD2/3 (R&D Systems, AF3797, lot XHY01)	Mus musculus	none	EXP033134	177	unspecified	Q62432	embryonic stem cell-derived endodermal cells	PEAKS039549
EXP033140	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	none	EXP033134	177	unspecified	Q61286	embryonic stem cell-derived endodermal cells	PEAKS039550
EXP033141	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	10 uM SB431542 inhibitor of TGF-beta pathway	EXP033135	177	unspecified	Q61286	embryonic stem cell-derived endodermal cells	PEAKS039551
EXP033142	C/EBPa (sc-61, Santa Cruz)	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039552
EXP033143	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039553
EXP033144	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039554
EXP033145	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039555
EXP033146	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039556
EXP033147	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039557
EXP033148	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039558
EXP033149	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	PEAKS039559
EXP033150	C/EBPb (sc-150, Santa Cruz)	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	P28033	C10 (pre-B-cells)	PEAKS039560
EXP033151	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	PEAKS039561
EXP033152	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	PEAKS039562
EXP033153	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	PEAKS039563
EXP033154	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	PEAKS039564
EXP033155	PU.1 (sc-352, Santa Cruz)	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	P17433	C10 (pre-B-cells)	PEAKS039565
EXP033156	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	PEAKS039566
EXP033157	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	PEAKS039567
EXP033158	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	PEAKS039568
EXP033159	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	PEAKS039569
EXP033160	abnova 1879-mol clone 1c12	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	PEAKS039570
EXP033161	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	PEAKS039571
EXP033162	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	PEAKS039572
EXP033163	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	PEAKS039573
EXP033164	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	PEAKS039574
EXP033165	anti-CTCF (catalog# 07-729, Millipore)	Homo sapiens	unstimulated	NULL	111	unspecified	P49711	T47D (invasive ductal carcinoma)	PEAKS039479
EXP033166	anti-CTCF (catalog# 07-729, Millipore)	Homo sapiens	progestin R5020-stimulated	NULL	111	unspecified	P49711	T47D (invasive ductal carcinoma)	PEAKS039480
EXP033171	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	none (growing)	EXP033168	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS039481
EXP033172	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	DNA damage response	NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS039482
EXP033173	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	Ras-induced senescence	EXP033169	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS039483
EXP033174	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	DNA damage response	EXP033167	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS039484
EXP033175	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	proapoptotic condition (sustained 53 activation; pAPO)	EXP033170	489	unspecified	P04637	IMR90 (lung fibroblasts)	PEAKS039485
EXP033178	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	none	EXP033176	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	PEAKS039486
EXP033179	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033176	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	PEAKS039487
EXP033180	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033176	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	PEAKS039488
EXP033181	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	none	EXP033177	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	PEAKS039489
EXP033182	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033177	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	PEAKS039490
EXP033183	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033177	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	PEAKS039491
EXP033184	p65	Homo sapiens	None	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039492
EXP033185	p65	Homo sapiens	TNF alpha	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039493
EXP033186	p65	Homo sapiens	TNF alpha and JQ1	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039494
EXP033188	Insm1 (Welcker et al , 2013)	Mus musculus	none	EXP033187	286	unspecified	Q63ZV0	pancreatic beta-cells	PEAKS039575
EXP033189	Neurod1 (#4373, Cell Signaling Technology, Danvers, MA)	Mus musculus	none	EXP033187	286	unspecified	Q60867	pancreatic beta-cells	PEAKS039576
EXP033190	Foxa2 (sc-6554, Santa Cruz Biotechnology)	Mus musculus	none	EXP033187	286	unspecified	P35583	pancreatic beta-cells	PEAKS039577
EXP033192	HNF4a SantaCruz H191 sc-8987 lot #J1003	Mus musculus	none	EXP033191	571	unspecified	P49698	DLK1+ hepatoblasts	PEAKS039578
EXP033193	FOXA2 Santa Cruz sc-6554	Mus musculus	none	EXP033191	571	unspecified	P35583	DLK1+ hepatoblasts	PEAKS039579
EXP033197	rabbit anti-TR4 antibody	Homo sapiens	none	EXP033194	894	unspecified	P49116	erythroid cells	PEAKS039495
EXP033198	rabbit anti-TR4 antibody	Homo sapiens	none	EXP033196	894	unspecified	P49116	erythroid cells	PEAKS039496
EXP033199	rabbit anti-TR4 antibody	Homo sapiens	none	EXP033196	894	unspecified	P49116	erythroid cells	PEAKS039497
EXP033205	anti-PDX1, BCBC goat	Homo sapiens	none	EXP033200	202	unspecified	P52945	CyT49-derived endodermal cells	PEAKS039498
EXP033206	anti-FOXA1	Homo sapiens	none	EXP033201	202	unspecified	P55317	CyT49-derived endodermal cells	PEAKS039499
EXP033207	FOXA1	Homo sapiens	none	EXP033202	202	unspecified	P55317	CyT49-derived endodermal cells	PEAKS039500
EXP033208	FOXA1	Homo sapiens	none	EXP033203	202	unspecified	P55317	CyT49-derived endodermal cells	PEAKS039501
EXP033209	FOXA1	Homo sapiens	none	EXP033204	202	unspecified	P55317	CyT49-derived endodermal cells	PEAKS039502
EXP033210	FOXA2	Homo sapiens	none	EXP033201	202	unspecified	Q9Y261	CyT49-derived endodermal cells	PEAKS039503
EXP033211	FOXA2	Homo sapiens	none	EXP033202	202	unspecified	Q9Y261	CyT49-derived endodermal cells	PEAKS039504
EXP033212	FOXA2	Homo sapiens	none	EXP033203	202	unspecified	Q9Y261	CyT49-derived endodermal cells	PEAKS039505
EXP033213	FOXA2	Homo sapiens	none	EXP033204	202	unspecified	Q9Y261	CyT49-derived endodermal cells	PEAKS039506
EXP033215	anti-Flag M2 (Sigma, Cat#F3165)	Mus musculus		EXP033214	35	unspecified	Q9JK54	A2lox FMsgn1 (embryonic stem cells)	PEAKS039580
EXP033217	anti-TGIF-1 (H-172) (Santa Cruz Biotechnology, catalog# sc-9084, lot# K2608)	Mus musculus	EtOH	EXP033216	614	unspecified	P70284	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS039581
EXP033218	anti-TGIF-1 (H-172) (Santa Cruz Biotechnology, catalog# sc-9084, lot# K2608)	Mus musculus	4-OHT	EXP033216	614	unspecified	P70284	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS039582
EXP033219	anti-Meis-1 (Abcam, catalog# ab19867, lot# GR76623-1)	Mus musculus	EtOH	EXP033216	614	unspecified	Q60954	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS039583
EXP033220	anti-Meis-1 (Abcam, catalog# ab19867, lot# GR76623-1)	Mus musculus	4-OHT	EXP033216	614	unspecified	Q60954	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS039584
EXP033221	anti-TBP rabbit polyclonal, Santa Cruz Technology, catalog # sc-204X (ChIP-grade), lot # C-0513	Homo sapiens	none	NULL	514	unspecified	P20226	K562 (myelogenous leukemia)	PEAKS039507
EXP033223	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 0 min	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039508
EXP033224	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 2 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039509
EXP033225	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 5 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039510
EXP033226	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 10 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039511
EXP033227	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 40 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039512
EXP033228	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol1 60 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039513
EXP033231	Anti-Zfp57, Abcam ab45341	Mus musculus	none	EXP033229	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS039585
EXP033232	Anti-Zfp57, Abcam ab45341	Mus musculus	none	EXP033230	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS039586
EXP033239	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	none	EXP033233	215	unspecified	O43623	keratinocytes	PEAKS039514
EXP033240	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	SNAI2 knockdown	EXP033234	215	unspecified	O43623	keratinocytes	PEAKS039515
EXP033241	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	LACZ overexpressing	EXP033235	215	unspecified	O43623	keratinocytes	PEAKS039516
EXP033242	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	SNAI2 overexpressing	EXP033236	215	unspecified	O43623	keratinocytes	PEAKS039517
EXP033243	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	LACZ overexpressing + Differentiation medium	EXP033237	215	unspecified	O43623	keratinocytes	PEAKS039518
EXP033244	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	SNAI2 overexpressing + Differentiation medium	EXP033238	215	unspecified	O43623	keratinocytes	PEAKS039519
EXP033246	anti-Jarid2 IP (Li et al. Gene & development 2010)	Mus musculus	LIF	EXP033245	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS039587
EXP033247	anti-Jarid2 K116me2 IP (this study, Sanulli et al.)	Mus musculus	LIF	EXP033245	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS039588
EXP033251	anti-p53	Homo sapiens	0.2 ug/ml Doxorubicin 12 hours	EXP033248	334	unspecified	P04637	GM06170 (fetal skin fibroblasts)	PEAKS039520
EXP033252	anti-p53	Homo sapiens	0.2 ug/ml Doxorubicin 12 hours	EXP033249	333	unspecified	P04637	GM00011 (fetal skin fibroblasts)	PEAKS039521
EXP033253	anti-p53	Mus musculus	0.2 ug/ml Doxorubicin 12 hours	EXP033250	595	unspecified	P02340	MEF-1 (mouse embryonic fibroblasts)	PEAKS039589
EXP033255	anti-TCF7L2 (CST, Cat #2569, lot 2, ref: 07/2010)	Rattus norvegicus		EXP033254	389	unspecified	D4A8X6	H4-II-E (hepatocellular carcinoma)	PEAKS036876
EXP033257	2469(non-commercial, unpublished)	Homo sapiens	differentiated with TPA for 96 hours	EXP033256	65	unspecified	P29375	U937 (adult acute monocytic leukemia)	PEAKS036877
EXP033258	2471(Klose et al.,Cell 128:889-900)	Homo sapiens	differentiated with TPA for 96 hours	EXP033256	65	unspecified	P29375	U937 (adult acute monocytic leukemia)	PEAKS036878
EXP033262	S-peptide tagged Bapx1 [S-Pepetide - Bethyl laboratories (A-190-134A)]	Mus musculus		EXP033259	246	unspecified	P97503	E12.5 embryonic vertebral column	PEAKS036879
EXP033263	Sox9 [R&D system (AF3075)]	Mus musculus		EXP033260	246	unspecified	Q04887	E12.5 embryonic vertebral column	PEAKS036880
EXP033264	V5, ab15828	Mus musculus		EXP033261	17	unspecified	P97503	3T3 (embryonic fibroblasts)	PEAKS036881
EXP033266	Zic3	Mus musculus		EXP033265	230	unspecified	Q62521	ES-E14 (E14, embryonic stem cells)	PEAKS036882
EXP033267	GATA2	Homo sapiens		NULL	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS036883
EXP033269	FLAG	Mus musculus		EXP033268	757	unspecified	P19091	proximal caput epididymus	PEAKS036884
EXP033270	FLAG	Mus musculus		NULL	679	unspecified	P19091	non-proliferating proximal caput epididymus	PEAKS036885
EXP033272	Fli-1, antibody vendor, cat#, lot #: Abcam, ab15289, gr1478-2	Mus musculus		EXP033271	579	unspecified	P26323	mature megakaryocytes	PEAKS036886
EXP033273	Runx1, antibody vendor, cat#, lot #: Abcam, ab23980, gr25538-1	Mus musculus		EXP033271	579	unspecified	Q03347	mature megakaryocytes	PEAKS036887
EXP033278	NF-E2 TB16+TB17, home made	Mus musculus		EXP033274	481	unspecified	Q07279	immature megakaryocytes	PEAKS036888
EXP033279	NF-E2 TB16+TB17, home made	Mus musculus		EXP033275	579	unspecified	Q07279	mature megakaryocytes	PEAKS036889
EXP033280	NF-E2 TB16+TB17, home made	Mus musculus		EXP033276	479	unspecified	Q07279	immature erythroid cells	PEAKS036890
EXP033281	PU.1, antibody vendor, cat #, lot #: Santa Cruz, sc-352, D2011	Mus musculus		EXP033277	480	unspecified	P17433	immature granulocytes	PEAKS036891
EXP033282	Scl/TAL1 (gifted by C. Porcher).	Homo sapiens		NULL	894	unspecified	P17542	erythroid cells	PEAKS036892
EXP033283	Scl/TAL1 (gifted by C. Porcher).	Homo sapiens		NULL	894	unspecified	P17542	erythroid cells	PEAKS036893
EXP033284	HIF1a	Homo sapiens	normoxy	NULL	911	unspecified	Q16665	macrophages	PEAKS036894
EXP033285	HIF1a	Homo sapiens	normoxy	NULL	911	unspecified	Q16665	macrophages	PEAKS036895
EXP033286	HIF1a	Homo sapiens	hypoxy	NULL	911	unspecified	Q16665	macrophages	PEAKS036896
EXP033287	HIF1a	Homo sapiens	hypoxy	NULL	911	unspecified	Q16665	macrophages	PEAKS036897
EXP033288	HIF2a	Homo sapiens	normoxy	NULL	911	unspecified	Q99814	macrophages	PEAKS036898
EXP033289	HIF2a	Homo sapiens	normoxy	NULL	911	unspecified	Q99814	macrophages	PEAKS036899
EXP033290	HIF2a	Homo sapiens	hypoxy	NULL	911	unspecified	Q99814	macrophages	PEAKS036900
EXP033291	HIF2a	Homo sapiens	hypoxy	NULL	911	unspecified	Q99814	macrophages	PEAKS036901
EXP033292	HIF1a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	PEAKS036902
EXP033293	HIF1a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	PEAKS036903
EXP033294	HIF1a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	PEAKS036904
EXP033295	HIF1a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	PEAKS036905
EXP033296	HIF2a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	PEAKS036906
EXP033297	HIF2a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	PEAKS036907
EXP033298	HIF2a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	PEAKS036908
EXP033299	HIF2a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	PEAKS036909
EXP033300	anti-FoxA1 from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	vehicle, control	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS036910
EXP033301	anti-FoxA1 from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	10 nm DHT	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS036911
EXP033303	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	EXP033302	71	normal	P03372	VCaP (prostate carcinoma)	PEAKS036912
EXP033304	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	NULL	71	normal	P03372	VCaP (prostate carcinoma)	PEAKS036913
EXP033305	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	NULL	71	normal	P03372	VCaP (prostate carcinoma)	PEAKS036914
EXP033306	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	NULL	656	normal	P03372	NCI-H660 (prostate carcinoma)	PEAKS036915
EXP033308	Affinity-purified anti-Ikaros antibody	Homo sapiens		EXP033307	735	unspecified	Q13422	pre-B acute lymphoblastic leukemia	PEAKS036916
EXP033309	BMAL1	Homo sapiens		NULL	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS036917
EXP033310	CLOCK	Homo sapiens		NULL	848	unspecified	O15516	U2OS (osteosarcoma)	PEAKS036918
EXP033311	CRY1	Homo sapiens		NULL	848	unspecified	Q16526	U2OS (osteosarcoma)	PEAKS036919
EXP033313	sc-8697	Mus musculus		EXP033312	53	unspecified	P42582	heart	PEAKS036920
EXP033315	ZFX	Homo sapiens		EXP033314	205	unspecified	P17010	DAOY (medulloblastoma)	PEAKS036921
EXP033318	anti-TRF2 / Rabbit polyclonal IgG (Santa Cruz sc-9143)	Homo sapiens		EXP033316	867	unspecified	P62380	WI-38 (lung fibroblasts)	PEAKS036922
EXP033319	anti-NR2F2 / Rabbit polyclonal IgG (Abcam ab50487)	Homo sapiens		EXP033316	867	unspecified	P24468	WI-38 (lung fibroblasts)	PEAKS036923
EXP033320	anti-NR2C2 / Mouse monoclonal IgG (PPMX PP-H0107B-00)	Homo sapiens		EXP033316	867	unspecified	P49116	WI-38 (lung fibroblasts)	PEAKS036924
EXP033321	anti-HMBOX1 / Rabbit polyclonal IgG (Abcam ab97643)	Homo sapiens		EXP033316	867	unspecified	Q6NT76	WI-38 (lung fibroblasts)	PEAKS036925
EXP033322	anti-TRF2 / Rabbit polyclonal IgG (Santa Cruz sc-9143)	Homo sapiens		EXP033317	78	unspecified	P62380	HeLa (cervical adenocarcinoma)	PEAKS036926
EXP033323	anti-NR2F2 / Rabbit polyclonal IgG (Abcam ab50487)	Homo sapiens		EXP033317	78	unspecified	P24468	HeLa (cervical adenocarcinoma)	PEAKS036927
EXP033324	anti-NR2C2 / Mouse monoclonal IgG (PPMX PP-H0107B-00)	Homo sapiens		EXP033317	78	unspecified	P49116	HeLa (cervical adenocarcinoma)	PEAKS036928
EXP033325	anti-HMBOX1 / Rabbit polyclonal IgG (Abcam ab97643)	Homo sapiens		EXP033317	78	unspecified	Q6NT76	HeLa (cervical adenocarcinoma)	PEAKS036929
EXP033327	FKHR (H-128)X sc-11350X lot# F0310	Mus musculus		EXP033326	1058	unspecified	Q9R1E0	CD4+ T-cells	PEAKS036930
EXP033329	ERR? (Dufour et al. Cell Metab 5, 345-356 (2007))	Mus musculus	none	EXP033328	668	unspecified	P62509	ES-D3 embryonic stem cell-derived neurons	PEAKS036931
EXP033334	Scl/Tal1	Mus musculus		NULL	602	unspecified	P22091	erythroleukemic cells	PEAKS036932
EXP033335	Scl/Tal1	Mus musculus	EB formation, 48h 1ug/ml doxycycline from day2 of EB formation, enrichment for Flk1+ cells at day 4	NULL	2	unspecified	P22091	mESCs (mouse embryonic stem cells)	PEAKS036933
EXP033336	sc-9413X	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	EXP033333	506	unspecified	Q64279	J1 (embryonic stem cells)	PEAKS036934
EXP033337	sc-12984X	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	EXP033333	506	unspecified	P22091	J1 (embryonic stem cells)	PEAKS036935
EXP033338	sc-12984X	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	EXP033331	2	unspecified	P22091	mESCs (mouse embryonic stem cells)	PEAKS036936
EXP033339	sc-12984X	Mus musculus	48h 1ug/ml doxycycline	EXP033332	2	unspecified	P22091	mESCs (mouse embryonic stem cells)	PEAKS036937
EXP033341	HOXB7 (H0291, Sigma-Aldrich)	Homo sapiens		EXP033340	120	unspecified	P09629	BT-549 (breast invasive ductal carcinoma)	PEAKS036938
EXP033343	anti hGATA6 R&D AF1700	Homo sapiens		EXP033342	720	unspecified	Q92908	PaTu8988S (pancreatic adenocarcinoma)	PEAKS036939
EXP033344	anti-Stat3	Mus musculus	PBS	NULL	323	unspecified	P42227	gastric tumors	PEAKS036940
EXP033345	anti-Stat3	Mus musculus	IL6	NULL	323	unspecified	P42227	gastric tumors	PEAKS036941
EXP033346	anti-Stat3	Mus musculus	IL11	NULL	323	unspecified	P42227	gastric tumors	PEAKS036942
EXP033348	anti-REST (Nurit Ballas et al. Cell 2005)	Mus musculus		EXP033347	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS036943
EXP033350	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q9JI44	J1 (embryonic stem cells)	PEAKS036944
EXP033351	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q8R0K9	J1 (embryonic stem cells)	PEAKS036945
EXP033352	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q9D1P2	J1 (embryonic stem cells)	PEAKS036946
EXP033353	antiFLAG	Mus musculus		EXP033349	506	unspecified	P28574	J1 (embryonic stem cells)	PEAKS036947
EXP033354	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q80Z64	J1 (embryonic stem cells)	PEAKS036948
EXP033355	antiFLAG	Mus musculus		EXP033349	506	unspecified	P01108	J1 (embryonic stem cells)	PEAKS036949
EXP033356	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q61066	J1 (embryonic stem cells)	PEAKS036950
EXP033358	Meis1 (Abcam, ab19867, lot 676286)	Mus musculus		EXP033357	1493	unspecified	Q60954	acute myeloid leukemia	PEAKS036951
EXP033359	FLAG (Sigma, F7425, lot 011M4789)	Mus musculus		EXP033357	1493	unspecified	P09631	acute myeloid leukemia	PEAKS036952
EXP033360	FLAG (Sigma, F7425, lot 011M4789)	Mus musculus		NULL	1493	unspecified	P09631	acute myeloid leukemia	PEAKS036953
EXP033361	Pbx1/2/3 (Santa Cruz, sc-888, lot J157)	Mus musculus		EXP033357	1493	unspecified	P41778	acute myeloid leukemia	PEAKS036954
EXP033362	Pbx1/2/3 (Santa Cruz, sc-888, lot J157)	Mus musculus		NULL	1493	unspecified	P41778	acute myeloid leukemia	PEAKS036955
EXP033364	anti-REST Ab (Millipore 07-579)	Homo sapiens		EXP033363	881	unspecified	Q13127	CD4+ T-cells	PEAKS036956
EXP033369	MLL4	Mus musculus		EXP033365	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	PEAKS036957
EXP033370	MLL4	Mus musculus		EXP033366	2	bio_control	O08550	mESCs (mouse embryonic stem cells)	PEAKS036958
EXP033371	MLL4	Mus musculus		EXP033367	214	unspecified	O08550	embryoid body (day 4)	PEAKS036959
EXP033372	MLL4	Mus musculus		EXP033368	214	bio_control	O08550	embryoid body (day 4)	PEAKS036960
EXP033374	VDR	Homo sapiens		EXP033373	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS036961
EXP033375	VDR	Homo sapiens	1,25D for 1h	EXP033373	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS036962
EXP033376	VDR	Homo sapiens	1,25D for 2h	EXP033373	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS036963
EXP033378	STAT3 antibody (Cell Signaling Technology, Cat# 9132)	Mus musculus		EXP033377	885	unspecified	P42227	astrocytes	PEAKS036964
EXP033381	SMAD3 [Abcam, Catalog#: ab4085, Lot#: GR27326-2]	Homo sapiens	siControl	EXP033380	388	unspecified	P84022	NCI-H441 (squamous cell lung carcinoma )	PEAKS036965
EXP033382	SMAD3 [Abcam, Catalog#: ab4085, Lot#: GR27326-2]	Homo sapiens	siTTF-1	EXP033380	388	unspecified	P84022	NCI-H441 (squamous cell lung carcinoma )	PEAKS036966
EXP033383	TTF-1 [Thermo Scientific, Catalog#: MS-699-P clone 8G7G3/1]	Homo sapiens		EXP033380	388	unspecified	P43699	NCI-H441 (squamous cell lung carcinoma )	PEAKS036967
EXP033384	TTF-1 [Thermo Scientific, Catalog#: MS-699-P clone 8G7G3/1]	Homo sapiens	1.5h	EXP033380	388	unspecified	P43699	NCI-H441 (squamous cell lung carcinoma )	PEAKS036968
EXP033385	SMAD4 [R&D, Catalog#: AF2097]	Homo sapiens	siControl	EXP033380	388	unspecified	Q13485	NCI-H441 (squamous cell lung carcinoma )	PEAKS036969
EXP033386	SMAD4 [R&D, Catalog#: AF2097]	Homo sapiens	siTTF-1	EXP033380	388	unspecified	Q13485	NCI-H441 (squamous cell lung carcinoma )	PEAKS036970
EXP033387	SMAD3 [Abcam, Catalog#: ab4085, Lot#: GR27326-2]	Homo sapiens		EXP033379	38	unspecified	P84022	A549 (lung carcinoma)	PEAKS036971
EXP033388	CTCF (Pugacheva et. al. 2005 Hum Mol Genet 14, 953-965; PMID: 15731119)	Mus musculus		NULL	96	unspecified	Q61164	trophoblast stem cells	PEAKS036972
EXP033390	anti-Flag (Sigma, Catalog# F3165)	Homo sapiens		EXP033389	552	unspecified	Q06945	LN229 (glioblastoma)	PEAKS036973
EXP033392	Anti-FOXK1 (ab18196),  Abcam	Homo sapiens		EXP033391	309	unspecified	P85037	Flp-In-T-REx-293 (embryonic kidney)	PEAKS036974
EXP033393	VDR	Homo sapiens	unstimulated	NULL	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS036975
EXP033394	VDR	Homo sapiens	1Î±,25(OH)2D3	NULL	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	PEAKS036976
EXP033397	Monoclonal ANTI-FLAG M2, Clone M2, F1804	Homo sapiens		EXP033395	824	unspecified	Q99607	T3M-1 Cl-10 (oral cavity squamous cell carcinoma)	PEAKS036977
EXP033398	Monoclonal ANTI-FLAG M2, Clone M2, F1804	Homo sapiens	L211M mutation of ELF4	EXP033396	824	unspecified	Q99607	T3M-1 Cl-10 (oral cavity squamous cell carcinoma)	PEAKS036978
EXP033400	HNF4A (Lot A-2, clone H1415, cat # PP-H1415-00, R&D Systems, Minneapolis, MN, USA)	Rattus norvegicus	siRNA - Scrambled	EXP033399	389	unspecified	P22449	H4-II-E (hepatocellular carcinoma)	PEAKS036979
EXP033401	HNF4A (Lot A-2, clone H1415, cat # PP-H1415-00, R&D Systems, Minneapolis, MN, USA)	Rattus norvegicus	siRNA - Tcf7l2	EXP033399	389	unspecified	P22449	H4-II-E (hepatocellular carcinoma)	PEAKS036980
EXP033402	TCF7L2 (Lot 2, clone C48H11, cat # 2569, Cell Signaling Technology, Danvers, MA, USA)	Rattus norvegicus	siRNA - Scrambled	EXP033399	389	unspecified	D4A8X6	H4-II-E (hepatocellular carcinoma)	PEAKS036981
EXP033403	TCF7L2 (Lot 2, clone C48H11, cat # 2569, Cell Signaling Technology, Danvers, MA, USA)	Rattus norvegicus	siRNA -Tcf7l2	EXP033399	389	unspecified	D4A8X6	H4-II-E (hepatocellular carcinoma)	PEAKS036982
EXP033405	Anti-Meis Millipore 05-779	Mus musculus		EXP033404	819	unspecified	Q60954	superior cervical ganglion	PEAKS036983
EXP033409	ab3749	Mus musculus		EXP033406	682	unspecified	Q91ZW3	nucleus accumbens cells	PEAKS036984
EXP033410	ab3749	Mus musculus	resilient	EXP033407	682	unspecified	Q91ZW3	nucleus accumbens cells	PEAKS036985
EXP033411	ab3749	Mus musculus	susceptible	EXP033408	682	unspecified	Q91ZW3	nucleus accumbens cells	PEAKS036986
EXP033413	V5-KLF6	Mus musculus		EXP033412	428	unspecified	O08584	hepatocellular carcinoma	PEAKS036987
EXP033416	Santa Cruz, N-20	Homo sapiens	ethanol	EXP033414	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS036988
EXP033417	Santa Cruz, N-20	Homo sapiens	10 nmol/l of mibolerone	EXP033414	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS036989
EXP033418	Santa Cruz, N-20	Homo sapiens	ethanol	EXP033415	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS036990
EXP033419	Santa Cruz, N-20	Homo sapiens	10 nmol/l of mibolerone	EXP033415	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS036991
EXP033422	sc-543	Homo sapiens	androstendione for 45min	EXP033420	540	unspecified	P03372	MCF-7aro Let-R (invasive ductal carcinoma)	PEAKS036992
EXP033423	sc-543	Homo sapiens		EXP033420	540	unspecified	P03372	MCF-7aro Let-R (invasive ductal carcinoma)	PEAKS036993
EXP033424	ER	Homo sapiens		EXP033421	563	unspecified	P03372	LY-2 (invasive ductal carcinoma)	PEAKS036994
EXP033425	rabbit polyclonal anti-Atf3 antibody	Mus musculus		NULL	81	unspecified	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS036995
EXP033426	rabbit polyclonal anti-Atf3 antibody	Mus musculus	2mg/ml HDL for 6h	NULL	81	unspecified	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS036996
EXP033427	rabbit polyclonal anti-Atf3 antibody	Mus musculus	2mg/ml HDL for 6h + 100nM CpG for 4h	NULL	81	unspecified	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS036997
EXP033429	Tgif1 (Santa Cruz, SC9084X)	Mus musculus		EXP033428	2	unspecified	P70284	mESCs (mouse embryonic stem cells)	PEAKS036998
EXP033430	Smad3 (Abcam, ab28379)	Mus musculus		EXP033428	2	unspecified	Q8BUN5	mESCs (mouse embryonic stem cells)	PEAKS036999
EXP033431	streptavidin-conjugated beads	Mus musculus		EXP033428	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS037000
EXP033432	streptavidin-conjugated beads (life technology, 64601).	Mus musculus		EXP033428	2	unspecified	Q8C0Y1	mESCs (mouse embryonic stem cells)	PEAKS037001
EXP033433	anti-CEBPA	Mus musculus		NULL	829	unspecified	P53566	leukemic bone marrow	PEAKS037002
EXP033434	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus	RbKO	NULL	495	unspecified	O35261	intestinal crypt cells	PEAKS037003
EXP033435	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus	RbKO	NULL	495	unspecified	P01108	intestinal crypt cells	PEAKS037004
EXP033436	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus	RbKO	NULL	496	unspecified	O35261	intestinal villus	PEAKS037005
EXP033437	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus	RbKO	NULL	496	unspecified	P01108	intestinal villus	PEAKS037006
EXP033438	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus		NULL	495	unspecified	O35261	intestinal crypt cells	PEAKS037007
EXP033439	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus		NULL	495	unspecified	P01108	intestinal crypt cells	PEAKS037008
EXP033440	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus		NULL	496	unspecified	O35261	intestinal villus	PEAKS037009
EXP033441	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus		NULL	496	unspecified	P01108	intestinal villus	PEAKS037010
EXP033442	c-Jun Antibody (H-79) from Santa Cruz Biotechnology	Homo sapiens		NULL	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	PEAKS037011
EXP033443	c-Jun Antibody (H-79) from Santa Cruz Biotechnology	Homo sapiens	dexametasone	NULL	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	PEAKS037012
EXP033444	c-Jun Antibody (H-79) from Santa Cruz Biotechnology	Homo sapiens	compaund A	NULL	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	PEAKS037013
EXP033445	NF?B p65 Antibody (C-20) from Santa Cruz Biotechnology	Homo sapiens		NULL	2301	unspecified	Q04206	MDA-MB-231 (breast adenocarcinoma)	PEAKS037014
EXP033446	NF?B p65 Antibody (C-20) from Santa Cruz Biotechnology	Homo sapiens	dexametasone	NULL	2301	unspecified	Q04206	MDA-MB-231 (breast adenocarcinoma)	PEAKS037015
EXP033447	NF?B p65 Antibody (C-20) from Santa Cruz Biotechnology	Homo sapiens	compaund A	NULL	2301	unspecified	Q04206	MDA-MB-231 (breast adenocarcinoma)	PEAKS037016
EXP033448	Glucocorticoid Receptor (D8H2) XPÂ® Rabbit mAb #3660 from CST	Homo sapiens		NULL	2301	unspecified	P04150	MDA-MB-231 (breast adenocarcinoma)	PEAKS037017
EXP033449	Glucocorticoid Receptor (D8H2) XPÂ® Rabbit mAb #3660 from CST	Homo sapiens	dexametasone	NULL	2301	unspecified	P04150	MDA-MB-231 (breast adenocarcinoma)	PEAKS037018
EXP033450	Glucocorticoid Receptor (D8H2) XPÂ® Rabbit mAb #3660 from CST	Homo sapiens	compaund A	NULL	2301	unspecified	P04150	MDA-MB-231 (breast adenocarcinoma)	PEAKS037019
EXP033453	CTCF (Active Motif, 61311)	Homo sapiens		EXP033451	87	unspecified	P49711	BEAS-2B (bronchial epithelium)	PEAKS037020
EXP033454	CTCF (Active Motif, 61311)	Homo sapiens	NiCl2	EXP033452	87	unspecified	P49711	BEAS-2B (bronchial epithelium)	PEAKS037021
EXP033457	Rabbit anti c-Jun (sc-1694, Santa Cruz Biotechnology)	Mus musculus		EXP033455	904	unspecified	P05627	myoblasts	PEAKS037022
EXP033458	Runx1 (in house)	Mus musculus		EXP033456	904	unspecified	Q03347	myoblasts	PEAKS037023
EXP033459	Mouse anti MyoD (sc-32758, Santa Cruz Biotechnology)	Mus musculus		EXP033456	904	unspecified	P10085	myoblasts	PEAKS037024
EXP033460	Mouse anti MyoG (sc-12732, Santa Cruz Biotechnology)	Mus musculus		EXP033456	645	unspecified	P12979	myotubes	PEAKS037025
EXP033462	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037026
EXP033463	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: 2 hours of EtOH; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS037027
EXP033464	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS037028
EXP033465	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: siPIAS1 transefection and 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037029
EXP033466	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: siNON transefection and 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS037030
EXP033467	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: siPIAS1 transefection and 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS037031
EXP033468	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus		NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS037032
EXP033469	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS037033
EXP033470	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS037034
EXP033471	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus		NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS037035
EXP033472	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS037036
EXP033473	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS037037
EXP033474	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS037038
EXP033475	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS037039
EXP033476	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS037040
EXP033477	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS037041
EXP033478	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS037042
EXP033479	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS037043
EXP033480	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037044
EXP033481	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 30 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037045
EXP033482	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 60 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037046
EXP033483	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037047
EXP033484	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 30 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037048
EXP033485	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 60 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037049
EXP033486	STAT1 (santa cruz, sc-592)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037050
EXP033487	STAT2 (santa crus, sc-950)	Mus musculus		NULL	81	unspecified	Q9WVL2	BMDM (bone marrow-derived macrophages)	PEAKS037051
EXP033488	STAT2 (santa crus, sc-950)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	Q9WVL2	BMDM (bone marrow-derived macrophages)	PEAKS037052
EXP033489	STAT2 (santa crus, sc-950)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	Q9WVL2	BMDM (bone marrow-derived macrophages)	PEAKS037053
EXP033490	IRF1 (santa cruz, sc-640)	Mus musculus		NULL	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	PEAKS037054
EXP033491	IRF1 (santa cruz, sc-640)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	PEAKS037055
EXP033492	IRF1 (santa cruz, sc-640)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	PEAKS037056
EXP033493	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037057
EXP033494	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037058
EXP033495	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037059
EXP033496	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037060
EXP033497	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037061
EXP033498	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037062
EXP033499	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037063
EXP033500	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037064
EXP033501	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037065
EXP033502	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037066
EXP033503	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037067
EXP033504	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037068
EXP033505	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037069
EXP033506	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037070
EXP033507	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037071
EXP033508	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	PEAKS037072
EXP033509	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037073
EXP033510	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037074
EXP033511	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037075
EXP033512	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037076
EXP033513	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037077
EXP033514	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037078
EXP033515	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037079
EXP033516	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037080
EXP033517	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037081
EXP033518	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037082
EXP033519	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037083
EXP033520	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037084
EXP033521	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037085
EXP033522	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037086
EXP033523	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	PEAKS037087
EXP033524	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037088
EXP033525	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037089
EXP033526	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037090
EXP033527	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037091
EXP033528	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	PEAKS037092
EXP033529	foxa1	Homo sapiens		NULL	435	unspecified	P55317	prostate tumor	PEAKS037093
EXP033530	hoxb13	Homo sapiens		NULL	435	unspecified	Q92826	prostate tumor	PEAKS037094
EXP033531	hoxb13	Homo sapiens		NULL	70	unspecified	Q92826	LNCaP (prostate carcinoma)	PEAKS037095
EXP033532	AR	Homo sapiens	FOXA1 overexpression	NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	PEAKS037096
EXP033533	AR	Homo sapiens	HOXB13 overexpression	NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	PEAKS037097
EXP033534	AR	Homo sapiens	HOXB13 and FOXA1 overexpression	NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	PEAKS037098
EXP033535	AR	Homo sapiens		NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	PEAKS037099
EXP033536	anti OCT3 antibody	Homo sapiens		NULL	1143	unspecified	Q01860	iPSC (induced pluripotent stem cells)	PEAKS037100
EXP033537	anti SOX2 antibody	Homo sapiens		NULL	1143	unspecified	P48431	iPSC (induced pluripotent stem cells)	PEAKS037101
EXP033538	anti KLF4 antibody	Homo sapiens		NULL	1143	unspecified	O43474	iPSC (induced pluripotent stem cells)	PEAKS037102
EXP033542	anti-HSF1 (cat. no SPA-901, Enzo)	Mus musculus		EXP033539	803	unspecified	P38532	spermatocytes	PEAKS037103
EXP033543	anti-HSF1 (cat. no SPA-901, Enzo)	Mus musculus	heatshock_38C	EXP033540	803	unspecified	P38532	spermatocytes	PEAKS037104
EXP033544	anti-HSF1 (cat. no SPA-901, Enzo)	Mus musculus	heatshock_43C	EXP033541	803	unspecified	P38532	spermatocytes	PEAKS037105
EXP033545	anti-HSF2 (cat. no AF5227, R&D Systems)	Mus musculus		EXP033539	803	unspecified	P38533	spermatocytes	PEAKS037106
EXP033546	anti-HSF2 (cat. no AF5227, R&D Systems)	Mus musculus	heatshock_38C	EXP033540	803	unspecified	P38533	spermatocytes	PEAKS037107
EXP033547	anti-HSF2 (cat. no AF5227, R&D Systems)	Mus musculus	heatshock_43C	EXP033541	803	unspecified	P38533	spermatocytes	PEAKS037108
EXP033549	NFYA: Santa-cruz, NF-YA (G-2)X, sc-17753X, Mouse monoclonal IgG2a	Mus musculus		EXP033548	2	unspecified	P23708	mESCs (mouse embryonic stem cells)	PEAKS037109
EXP033550	NFYB: Santa-cruz, NF-YB (FL-207)X, sc-13045X, Rabbit polyclonal	Mus musculus		EXP033548	2	unspecified	P63139	mESCs (mouse embryonic stem cells)	PEAKS037110
EXP033551	NFYC: Santa-cruz, NF-YC (N-19)X, sc-7715X, Rabbit polyclonal	Mus musculus		EXP033548	2	unspecified	P70353	mESCs (mouse embryonic stem cells)	PEAKS037111
EXP033553	Arid3a Streptavidin-conjugated beads	Mus musculus	Arid3a overexpression high	EXP033552	506	unspecified	Q62431	J1 (embryonic stem cells)	PEAKS037112
EXP033554	Arid3a Streptavidin-conjugated beads	Mus musculus	Arid3a overexpression moderate	EXP033552	506	unspecified	Q62431	J1 (embryonic stem cells)	PEAKS037113
EXP033556	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus		EXP033555	292	unspecified	P11416	F9 (embryonal carcinoma)	PEAKS037114
EXP033557	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus		EXP033555	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS037115
EXP033558	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus	all-trans retinoic acid 2h	NULL	292	unspecified	P11416	F9 (embryonal carcinoma)	PEAKS037116
EXP033559	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus	all-trans retinoic acid 2h	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS037117
EXP033560	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus	all-trans retinoic acid 24h	NULL	292	unspecified	P11416	F9 (embryonal carcinoma)	PEAKS037118
EXP033561	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus	all-trans retinoic acid 24h	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS037119
EXP033562	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus	all-trans retinoic acid 48h	NULL	292	unspecified	P11416	F9 (embryonal carcinoma)	PEAKS037120
EXP033563	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus	all-trans retinoic acid 48h	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS037121
EXP033565	Santa Cruz sc-13450, Lot D1911	Mus musculus		EXP033564	1153	unspecified	P42128	C2C12 (myoblasts)	PEAKS037122
EXP033567	sc-8628 X (Pou5f1)	Mus musculus	Standard Serum	EXP033566	521	unspecified	P20263	KH2 (embryonic stem cells)	PEAKS037123
EXP033568	sc-8628 X (Pou5f1)	Mus musculus	2i for 24 hours	EXP033566	521	unspecified	P20263	KH2 (embryonic stem cells)	PEAKS037124
EXP033569	REC-RCAB0002P-F (Nanog)	Mus musculus	GFP_high_Serum	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	PEAKS037125
EXP033570	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 24 hours_v3	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	PEAKS037126
EXP033571	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 24 hours	EXP033566	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS037127
EXP033572	REC-RCAB0002P-F (Nanog)	Mus musculus	Standard Serum	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	PEAKS037128
EXP033573	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 3 passages	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	PEAKS037129
EXP033574	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 24 hours_v1	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	PEAKS037130
EXP033579	ATRX	Mus musculus		EXP033575	12	unspecified	Q61687	MEF (mouse embryonic fibroblasts)	PEAKS037131
EXP033580	ATRX	Mus musculus		EXP033576	2	unspecified	Q61687	mESCs (mouse embryonic stem cells)	PEAKS037132
EXP033581	ATRX	Mus musculus		EXP033577	216	unspecified	Q61687	differentiated embryonic stem cells	PEAKS037133
EXP033582	ATRX	Mus musculus		EXP033578	12	unspecified	Q61687	MEF (mouse embryonic fibroblasts)	PEAKS037134
EXP033584	Smad4 R&D Systems, cat.# AF2097, Lot# KUH0311081	Mus musculus		EXP033583	561	unspecified	P97471	lung	PEAKS037135
EXP033586	R&D hSOX3 (AF2569)	Mus musculus		EXP033585	764	unspecified	P53784	R1 embryonic stem cell-derived neural progenitors	PEAKS037136
EXP033588	rabbit polyclonal anti-E4F1	Mus musculus		EXP033587	2	unspecified	Q8CCE9	mESCs (mouse embryonic stem cells)	PEAKS037137
EXP033591	FXR (1:1 mixture of sc-1204x and sc-13063x, ChIP grade, Santa Cruz)	Homo sapiens	0.1% DMSO for 1h	EXP033589	900	unspecified	Q96RI1	hepatocytes	PEAKS037138
EXP033592	FXR (1:1 mixture of sc-1204x and sc-13063x, ChIP grade, Santa Cruz)	Homo sapiens	0.1% DMSO + 5uM GW4064 for 1h	EXP033590	900	unspecified	Q96RI1	hepatocytes	PEAKS037139
EXP033594	GATA6	Mus musculus	none	EXP033593	713	unspecified	Q61169	pancreas	PEAKS037140
EXP033597	rabbit polyclonal anti-E4F1	Mus musculus		EXP033595	12	unspecified	Q8CCE9	MEF (mouse embryonic fibroblasts)	PEAKS037141
EXP033598	rabbit polyclonal anti-E4F1	Mus musculus		EXP033596	12	unspecified	Q8CCE9	MEF (mouse embryonic fibroblasts)	PEAKS037142
EXP033600	Upstate 07-633	Mus musculus		EXP033599	5	unspecified	P35583	liver	PEAKS037143
EXP033601	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	638	unspecified	P17433	multipotent hematopoietic progenitors	PEAKS037144
EXP033602	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	189	unspecified	P17433	common dendritic cell progenitors	PEAKS037145
EXP033603	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	104	unspecified	P17433	dendritic cells	PEAKS037146
EXP033604	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	312	unspecified	P17433	plasmacytoid dendritic cells	PEAKS037147
EXP033607	rabbit anti-Miz-1 H-190	Mus musculus		EXP033605	711	unspecified	Q60821	P6D4 (thymic lymphoma)	PEAKS037148
EXP033608	rabbit anti-Miz-1 H-190	Mus musculus		EXP033606	28	unspecified	Q60821	70Z/3 (leukemia)	PEAKS037149
EXP033614	SALL1 (Abcam, ab41974)	Mus musculus		EXP033609	839	unspecified	Q9ER74	TT2 (embryonic stem cells)	PEAKS037150
EXP033615	Polyclonal antibody against TET1 was raised in a rabbit.(PMID:21514197)	Mus musculus		EXP033609	839	unspecified	Q3URK3	TT2 (embryonic stem cells)	PEAKS037151
EXP033616	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	Sall4 flox/-	EXP033610	2	unspecified	Q8BX22	mESCs (mouse embryonic stem cells)	PEAKS037152
EXP033617	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	Sall4 KO	EXP033611	2	unspecified	Q8BX22	mESCs (mouse embryonic stem cells)	PEAKS037153
EXP033618	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	scrambled shRNA	EXP033612	839	unspecified	Q8BX22	TT2 (embryonic stem cells)	PEAKS037154
EXP033619	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	shRNA of Tet1	EXP033613	839	unspecified	Q8BX22	TT2 (embryonic stem cells)	PEAKS037155
EXP033620	R&D AF3640 Lot # XVH0311061	Homo sapiens		NULL	463	unspecified	O43474	epidermal keratinocytes	PEAKS037156
EXP033621	Santa Cruz SC-30189 Lot # C2511	Homo sapiens		NULL	463	unspecified	Q9UKL0	epidermal keratinocytes	PEAKS037157
EXP033623	TBP (Abcam ab28175)	Mus musculus		EXP033622	5	unspecified	P29037	liver	PEAKS037158
EXP033624	TBP (Abcam ab28175)	Mus musculus	Taf4-/-	EXP033622	5	unspecified	P29037	liver	PEAKS037159
EXP033625	HNF4A (Santa Cruz sc-8987 X)	Mus musculus		EXP033622	5	unspecified	P49698	liver	PEAKS037160
EXP033626	HNF4A (Santa Cruz sc-8987 X)	Mus musculus	Taf4-/-	EXP033622	5	unspecified	P49698	liver	PEAKS037161
EXP033627	CTCF ((Millipore 07-729)	Mus musculus		EXP033622	5	unspecified	Q61164	liver	PEAKS037162
EXP033628	CTCF ((Millipore 07-729)	Mus musculus	Taf4-/-	EXP033622	5	unspecified	Q61164	liver	PEAKS037163
EXP033629	HNF4A (Santa Cruz sc-8987 X)	Mus musculus		NULL	5	unspecified	P49698	liver	PEAKS037164
EXP033634	HSF1: Cell Signaling, 4356	Homo sapiens	none	EXP033631	417	unspecified	Q00613	HCT-116 (colon carcinoma)	PEAKS037165
EXP033635	HSF1: Cell Signaling, 4356	Homo sapiens	none	EXP033633	417	unspecified	Q00613	HCT-116 (colon carcinoma)	PEAKS037166
EXP033636	HSF1: Cell Signaling, 4356	Homo sapiens	heat shock	EXP033632	417	unspecified	Q00613	HCT-116 (colon carcinoma)	PEAKS037167
EXP033637	HSF1: Cell Signaling, 4356	Homo sapiens	heat shock	EXP033630	417	unspecified	Q00613	HCT-116 (colon carcinoma)	PEAKS037168
EXP033640	GATA4 (R&D system, AF2606, lot VAZ0312091)	Mus musculus		EXP033638	12	unspecified	Q08369	MEF (mouse embryonic fibroblasts)	PEAKS037169
EXP033641	GATA6 (R&D system, AF1700, lot KWT0112101)	Mus musculus		EXP033639	12	unspecified	Q61169	MEF (mouse embryonic fibroblasts)	PEAKS037170
EXP033644	Monoclonal ANTI-FLAG M2 (F3165 SIGMA)	Mus musculus		EXP033642	862	unspecified	P17433	WEHI-279 (lymphoma)	PEAKS037171
EXP033645	Monoclonal ANTI-FLAG M2 (F3165 SIGMA)	Mus musculus		EXP033643	862	unspecified	O35906	WEHI-279 (lymphoma)	PEAKS037172
EXP033648	CTCF (Cell Signaling 2899)	Mus musculus		EXP033646	216	unspecified	Q61164	differentiated embryonic stem cells	PEAKS037173
EXP033649	CTCF (Cell Signaling 2899)	Mus musculus		EXP033647	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS037174
EXP033652	Cell Signaling 3660S	Homo sapiens		EXP033650	45	unspecified	P04150	acute myeloblastic leukemia	PEAKS037175
EXP033653	Cell Signaling 3660S	Homo sapiens	dexametasone	EXP033651	45	unspecified	P04150	acute myeloblastic leukemia	PEAKS037176
EXP033656	Zfp335/NIF1 (A300-797A, Bethyl Laboratories, lot no. A300-797A-1)	Mus musculus		EXP033654	44	unspecified	A2A5K6	T-cells	PEAKS037177
EXP033657	Zfp335/NIF1 (A300-797A, Bethyl Laboratories, lot no. A300-797A-1)	Mus musculus	blt/blt	EXP033655	44	unspecified	A2A5K6	T-cells	PEAKS037178
EXP033658	Zfp335/NIF1 (A300-798A, Bethyl Laboratories, lot no. A300-798A-1)	Mus musculus		EXP033654	44	unspecified	A2A5K6	T-cells	PEAKS037179
EXP033659	Zfp335/NIF1 (A300-798A, Bethyl Laboratories, lot no. A300-798A-1)	Mus musculus	blt/blt	EXP033655	44	unspecified	A2A5K6	T-cells	PEAKS037180
EXP033662	Polyclonal (goat) against full length His-EGFP	Homo sapiens		EXP033660	652	unspecified	P37231	NCI-H1993 (lung adenocarcinoma)	PEAKS037181
EXP033663	Polyclonal (goat) against full length His-EGFP	Homo sapiens		EXP033661	654	unspecified	P37231	NCI-H2347 (lung adenocarcinoma)	PEAKS037182
EXP033667	sc-9081X	Mus musculus	Lif 2i	EXP033664	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS037183
EXP033668	sc-9081X	Mus musculus	-Lif -2i day 1	EXP033665	216	unspecified	P20263	differentiated embryonic stem cells	PEAKS037184
EXP033669	sc-9081X	Mus musculus	-Lif -2i day 3	EXP033666	206	unspecified	P20263	epiblast-like cells	PEAKS037185
EXP033670	M2 anti-Flag	Mus musculus	Lif 2i	EXP033664	2	unspecified	Q61060	mESCs (mouse embryonic stem cells)	PEAKS037186
EXP033671	M2 anti-Flag	Mus musculus	Lif 2i	EXP033666	206	unspecified	Q61060	epiblast-like cells	PEAKS037187
EXP033672	anti-SATB1	Rattus norvegicus		NULL	770	unspecified	Q5U2Y2	GC pituitary cells	PEAKS037188
EXP033674	anti-HA-tagged-Pit1wild	Rattus norvegicus	none	NULL	770	unspecified	P10037	GC pituitary cells	PEAKS037190
EXP033675	anti-HA-tagged-Pit1R27W1 mutant	Rattus norvegicus	none	NULL	770	unspecified	P10037	GC pituitary cells	PEAKS037191
EXP033677	anti-Oct4 (Abcam, catalog# ab19857)	Homo sapiens	none	EXP033676	38	unspecified	Q01860	A549 (lung carcinoma)	PEAKS037192
EXP033679	anti-AR (N20, Santa Cruz)	Homo sapiens	non-target siRNA	EXP033678	7	unspecified	P10275	22RV1 (prostate carcinoma)	PEAKS037193
EXP033680	anti-AR (N20, Santa Cruz)	Homo sapiens	siRNA targeting AR exon 7 to knock-down AR-FL	EXP033678	7	unspecified	P10275	22RV1 (prostate carcinoma)	PEAKS037194
EXP033681	anti-AR (N20, Santa Cruz)	Homo sapiens	siRNA targeting all AR isoforms	EXP033678	7	unspecified	P10275	22RV1 (prostate carcinoma)	PEAKS037195
EXP033685	anti-FOXP1 (home-made)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	Q9H334	VCaP (prostate carcinoma)	PEAKS037196
EXP033686	anti-RUNX1 (Abcam, catalog ab23980)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	Q01196	VCaP (prostate carcinoma)	PEAKS037197
EXP033687	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against FOXA1; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037198
EXP033688	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against FOXP1; Time point: 24 hours; Genotype: FOXP1 knockdown	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037199
EXP033689	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against RUNX1; Time point: 24 hours; Genotype: RUNX1 knockdown	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037200
EXP033690	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS037201
EXP033691	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033683	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS037202
EXP033692	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033683	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037203
EXP033693	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033684	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS037204
EXP033694	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS037205
EXP033695	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against FOXA1; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033684	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS037206
EXP033696	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037207
EXP033697	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours	EXP033684	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS037208
EXP033699	anti-p53 (FL636 from SC-6243)	Homo sapiens	5FU for 0h	NULL	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS037209
EXP033701	p53-specific DO1	Homo sapiens	5FU for 6 hrs	EXP033700	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS037210
EXP033702	HA	Homo sapiens		NULL	753	unspecified	P10275	ovarian granulosa cells	PEAKS037211
EXP033703	HA	Homo sapiens	Insertion	NULL	753	unspecified	P10275	ovarian granulosa cells	PEAKS037212
EXP033704	androgen	Homo sapiens	Deletion	NULL	753	unspecified	P10275	ovarian granulosa cells	PEAKS037213
EXP033706	PU.1 SC-352 from SantaCruz	Homo sapiens		EXP033705	620	unspecified	P17947	monocyte-derived dendritic cells	PEAKS037214
EXP033707	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: 12 hours of 50 ÂµM mutational form of ERG inhibitory peptidomimetics; Time point: 12 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS037215
EXP033708	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: 12 hours of 50 ÂµM functional form of ERG inhibitory peptidomimetics; Time point: 12 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS037216
EXP033710	anti-ER-alpha (HC20)	Homo sapiens		EXP033709	583	unspecified	P03372	MCF10A (breast epithelial cells)	PEAKS037217
EXP033713	anti-Meis1/2 (Santa Cruz Biotechnology, sc-10599X, lot# C2912)	Mus musculus	none	EXP033711	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	PEAKS037218
EXP033714	anti-Prep1(N-15X) (Santa Cruz Biotechnology, sc-6245X, lot# F2003)	Mus musculus	none	EXP033711	12	unspecified	O70477	MEF (mouse embryonic fibroblasts)	PEAKS037219
EXP033715	anti-Meis1/2 (Santa Cruz Biotechnology, sc-10599X, lot# C2912)	Mus musculus	none	EXP033712	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	PEAKS037220
EXP033716	Prep1(N-15X) (Santa Cruz Biotechnology, sc-6245X, lot# F2003)	Mus musculus	none	EXP033712	12	unspecified	O70477	MEF (mouse embryonic fibroblasts)	PEAKS037221
EXP033719	ETS1 (Santa Cruz, sc-350, lot #F2811)	Homo sapiens		EXP033717	223	unspecified	P14921	DU145 (prostate carcinoma)	PEAKS037222
EXP033720	ELF1 (Santa Cruz, sc-631, lot #L2702)	Homo sapiens		EXP033717	223	unspecified	P32519	DU145 (prostate carcinoma)	PEAKS037223
EXP033721	ELK4 (Santa Cruz, sc-1426, lot #G2711)	Homo sapiens		EXP033717	223	unspecified	P28324	DU145 (prostate carcinoma)	PEAKS037224
EXP033722	GABPA (Santa Cruz, sc-13442, lot #B2009)	Homo sapiens		EXP033717	223	unspecified	Q06546	DU145 (prostate carcinoma)	PEAKS037225
EXP033723	JUND (Santa Cruz, sc-74, lot #K1111)	Homo sapiens		EXP033717	223	unspecified	P17535	DU145 (prostate carcinoma)	PEAKS037226
EXP033724	ETS1 (Santa Cruz, sc-350, lot #F1312)	Homo sapiens		EXP033718	712	unspecified	P14921	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS037227
EXP033725	Anti-p53, clone DO-1	Homo sapiens		NULL	113	unspecified	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS037228
EXP033726	Anti-p53, clone DO-1	Homo sapiens		NULL	588	unspecified	P04637	MDA-MB-175VII (invasive ductal carcinoma)	PEAKS037229
EXP033727	Anti-p53, clone DO-1	Homo sapiens		NULL	591	unspecified	P04637	MDA-MB-468 (breast adenocarcinoma)	PEAKS037230
EXP033728	Anti-p53, clone DO-1	Homo sapiens		NULL	412	unspecified	P04637	HCC70 (ductal breast carcinoma)	PEAKS037231
EXP033729	Anti-p53, clone DO-1	Homo sapiens		NULL	120	unspecified	P04637	BT-549 (breast invasive ductal carcinoma)	PEAKS037232
EXP033732	10E2	Homo sapiens	BI8622	EXP033730	188	unspecified	Q13105	LS174T (colon adenocarcinoma)	PEAKS037233
EXP033733	sc764	Homo sapiens	BI8622	EXP033730	188	unspecified	P01106	LS174T (colon adenocarcinoma)	PEAKS037234
EXP033734	10E2	Homo sapiens	DMSO	EXP033731	188	unspecified	Q13105	LS174T (colon adenocarcinoma)	PEAKS037235
EXP033735	sc764	Homo sapiens	DMSO	EXP033731	188	unspecified	P01106	LS174T (colon adenocarcinoma)	PEAKS037236
EXP033738	pAb	Mus musculus	doxycycline	EXP033736	2	unspecified	P41163	mESCs (mouse embryonic stem cells)	PEAKS037237
EXP033739	V5	Mus musculus		EXP033737	2	unspecified	P41163	mESCs (mouse embryonic stem cells)	PEAKS037238
EXP033740	sc-9550 and sc-9549	Mus musculus		NULL	5	unspecified	O08750	liver	PEAKS037239
EXP033741	sc-6062	Mus musculus		NULL	5	unspecified	P51448	liver	PEAKS037240
EXP033749	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033742	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	PEAKS037241
EXP033750	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033743	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	PEAKS037242
EXP033751	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033744	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	PEAKS037243
EXP033752	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033745	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	PEAKS037244
EXP033753	anti-Oct3/4 (N-19) (Santa Cruz #sc-8628)	Mus musculus	none	EXP033746	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS037245
EXP033754	anti-Nanog (D2A3) XPÂ® (Cell Signaling #8822)	Mus musculus	none	EXP033746	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS037246
EXP033755	anti-Sox2 (Santa Cruz #sc-17320)	Mus musculus	none	EXP033747	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS037247
EXP033756	anti-Med1 (CRSP1/TRAP220) (Bethyl #A300-793A)	Mus musculus	none	EXP033748	2	unspecified	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS037248
EXP033757	anti-Med12 (Bethyl #A300-774A)	Mus musculus	none	EXP033748	2	unspecified	A2AGH6	mESCs (mouse embryonic stem cells)	PEAKS037249
EXP033760	anti-BCL6 (rabbit 4242, Cell Signalling)	Homo sapiens	none	EXP033758	754	unspecified	P41182	ICN12 (primary pre-B acute lymphomablastic leukemia)	PEAKS037250
EXP033761	anti-E2A (rabbit sc-888, Santa Cruz)	Homo sapiens	none	EXP033758	754	unspecified	P15923	ICN12 (primary pre-B acute lymphomablastic leukemia)	PEAKS037251
EXP033762	anti-PBX1 (rabbit, Roeder Lab)	Homo sapiens	none	EXP033759	754	unspecified	P40424	ICN12 (primary pre-B acute lymphomablastic leukemia)	PEAKS037252
EXP033768	anti-MYB (Millipore 05-175)	Homo sapiens	none	EXP033763	509	unspecified	P10242	Jurkat (T-cells)	PEAKS037253
EXP033769	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033763	509	unspecified	P10242	Jurkat (T-cells)	PEAKS037254
EXP033770	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033765	509	unspecified	P10242	Jurkat (T-cells)	PEAKS037255
EXP033771	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033764	509	unspecified	P10242	Jurkat (T-cells)	PEAKS037256
EXP033772	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033766	509	unspecified	P10242	Jurkat (T-cells)	PEAKS037257
EXP033773	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033767	621	unspecified	P10242	MOLT3 (adult T acute lymphoblastic leukemia)	PEAKS037258
EXP033774	anti-Tal-1 (Santa Cruz SC-12984)	Homo sapiens	none	EXP033767	621	unspecified	P17542	MOLT3 (adult T acute lymphoblastic leukemia)	PEAKS037259
EXP033775	anti-Tal-1 (Santa Cruz SC-12984)	Homo sapiens	none	NULL	154	unspecified	P17542	CD133+ umbilical cord blood cells	PEAKS037260
EXP033778	anti-KLF11 (10D8; Novus Biologicals)	Homo sapiens	differentiaiton inductors	EXP033776	439	unspecified	O14901	hMADS-3 (adipose-derived stem cells)	PEAKS037261
EXP033779	anti-KLF11 (10D8; Novus Biologicals)	Homo sapiens	differentiaiton inductors	EXP033777	439	unspecified	O14901	hMADS-3 (adipose-derived stem cells)	PEAKS037262
EXP033780	anti-PPAR? (H-100, sc-7196; Santa Cruz)	Homo sapiens	differentiaiton inductors	EXP033776	439	unspecified	P37231	hMADS-3 (adipose-derived stem cells)	PEAKS037263
EXP033781	anti-PPAR? (H-100, sc-7196; Santa Cruz)	Homo sapiens	differentiaiton inductors	EXP033777	439	unspecified	P37231	hMADS-3 (adipose-derived stem cells)	PEAKS037264
EXP033788	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033783	5	unspecified	P06537	liver	PEAKS037265
EXP033789	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033784	5	unspecified	P06537	liver	PEAKS037266
EXP033790	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	prednisolone	EXP033785	5	unspecified	P06537	liver	PEAKS037267
EXP033791	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033782	5	unspecified	P06537	liver	PEAKS037268
EXP033792	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033786	5	unspecified	P06537	liver	PEAKS037269
EXP033793	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	prednisolone	EXP033787	5	unspecified	P06537	liver	PEAKS037270
EXP033794	anti-C/EBPb, sc-150, Santa Cruz	Mus musculus	none	EXP033786	5	unspecified	P28033	liver	PEAKS037271
EXP033795	anti-C/EBPb, sc-150, Santa Cruz	Mus musculus	none	EXP033782	5	unspecified	P28033	liver	PEAKS037272
EXP033796	anti-C/EBPb, sc-150, Santa Cruz	Mus musculus	prednisolone	EXP033787	5	unspecified	P28033	liver	PEAKS037273
EXP033798	anti-GR, sc-1004, Santa Cruz	Mus musculus	dexamethasone and (or) lipopolysaccharide	EXP033797	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	PEAKS037274
EXP033799	anti-GR, sc-1004, Santa Cruz	Mus musculus	dexamethasone and (or) lipopolysaccharide	EXP033797	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	PEAKS037275
EXP033801	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	PEAKS037276
EXP033802	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	PEAKS037277
EXP033803	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	PEAKS037278
EXP033804	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	PEAKS037279
EXP033806	anti-Gfi-1B Antibody (D-19)	Mus musculus	none	EXP033805	602	unspecified	O70237	erythroleukemic cells	PEAKS037280
EXP033808	anti-BCL6 (Santa Cruz, sc-858)	Homo sapiens	none	EXP033807	881	unspecified	P41182	CD4+ T-cells	PEAKS037281
EXP033810	anti-HIF-1a(Ab-2185, Abcam)	Homo sapiens	hypoxia and DMOG for 16 hrs	EXP033809	111	unspecified	Q16665	T47D (invasive ductal carcinoma)	PEAKS037282
EXP033811	anti-HIF-1b(Ab-2, Abcam)	Homo sapiens	hypoxia and DMOG for 16 hrs	EXP033809	111	unspecified	Q9Y2N7	T47D (invasive ductal carcinoma)	PEAKS037283
EXP033812	anti-NRF1 (AB55744, Abcam)	Homo sapiens	hypoxia and DMOG for 16 hrs	EXP033809	111	unspecified	Q16656	T47D (invasive ductal carcinoma)	PEAKS037284
EXP033814	anti-V5 antibody	Mus musculus	10 ug/ml curdlan for 30 min	EXP033813	104	unspecified	Q60591	dendritic cells	PEAKS037285
EXP033815	anti-FLAG M2 antibody (anti-HES-1; F1804, SIGMA)	Homo sapiens	none	NULL	820	unspecified	Q14469	SW1353 (chondrosarcoma)	PEAKS037286
EXP033816	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037287
EXP033817	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037288
EXP033818	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037289
EXP033819	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037290
EXP033820	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037291
EXP033821	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037292
EXP033822	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037293
EXP033823	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	PEAKS037294
EXP033824	anti-RUNX1, Ab23980	Homo sapiens		NULL	45	unspecified	Q01196	acute myeloblastic leukemia	PEAKS037295
EXP033825	anti-C/EBPA, sc-61X lot C1510	Homo sapiens		NULL	516	unspecified	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037296
EXP033826	anti-C/EBPA, sc-61X lot C1510	Homo sapiens	RUNX1/ETO knockdown	NULL	516	unspecified	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037297
EXP033827	anti-PU.1 (Santa Cruz, sc-352x)	Homo sapiens		NULL	516	unspecified	P17947	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037298
EXP033828	anti-PU.1 (Santa Cruz, sc-352x)	Homo sapiens	RUNX1/ETO knockdown	NULL	516	unspecified	P17947	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037299
EXP033830	anti-GFP, RbIgG, Abcam ab290	Mus musculus		EXP033829	734	unspecified	Q60636	primordial germ cell-like cells	PEAKS037300
EXP033831	anti-GFP, RbIgG, Abcam ab290	Mus musculus		EXP033829	734	unspecified	Q60636	primordial germ cell-like cells	PEAKS037301
EXP033835	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Homo sapiens	shControl	EXP033832	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS037302
EXP033836	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Homo sapiens	shTerc	EXP033832	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS037303
EXP033837	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Homo sapiens	shTert	EXP033832	708	unspecified	P01106	P493-6 (B-cell lymphoma)	PEAKS037304
EXP033838	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Mus musculus	none	EXP033833	748	unspecified	P01108	lymphoma	PEAKS037305
EXP033839	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Mus musculus	none	EXP033834	748	unspecified	P01108	lymphoma	PEAKS037306
EXP033840	CTCF, Millipore #07-729	Mus musculus		NULL	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS037307
EXP033841	CTCF, Millipore #07-729	Mus musculus		NULL	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	PEAKS037308
EXP033842	CTCF, Millipore #07-729	Mus musculus		NULL	180	unspecified	Q61164	motor neurons	PEAKS037309
EXP033843	CTCF, Millipore #07-729	Mus musculus		NULL	180	unspecified	Q61164	motor neurons	PEAKS037310
EXP033845	Anti-ATF3 (cat#sc-188 Santa Cruz)	Mus musculus	4 hours after the initiation of CIP	EXP033844	716	unspecified	Q60765	pancreatic tissue	PEAKS037311
EXP033847	Anti-p53 AB7 (Calbiochem)	Homo sapiens		EXP033846	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS037312
EXP033848	Anti-p53 AB7 (Calbiochem)	Homo sapiens		EXP033846	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS037313
EXP033857	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	1hr treatment with 100nM E2	EXP033849	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037314
EXP033858	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	no treatment with doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	PEAKS037315
EXP033859	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	PEAKS037316
EXP033860	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	PEAKS037317
EXP033861	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	PEAKS037318
EXP033862	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	PEAKS037319
EXP033863	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	PEAKS037320
EXP033864	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	PEAKS037321
EXP033865	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	EXP033850	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	PEAKS037322
EXP033866	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	EXP033851	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	PEAKS037323
EXP033867	GATA3, Santa Cruz Biotech, SC-268	Homo sapiens	1hr treatment with 100nM E2	EXP033852	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS037324
EXP033868	Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS037325
EXP033869	GATA3, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS037326
EXP033870	GATA3, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS037327
EXP033871	AP2g, Santa Cruz Biotech, SC-8977	Homo sapiens	1hr treatment with 100nM E2	EXP033853	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS037328
EXP033872	ERa, Santa Cruz Biotech, SC-12915-R	Homo sapiens	shCTL, 1hr treatment with 100nM E2	EXP033854	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037329
EXP033873	ERa, Santa Cruz Biotech, SC-12915-R	Homo sapiens	shRARs, 1hr treatment with 100nM E2	EXP033855	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037330
EXP033874	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	shCTL, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037331
EXP033875	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	shRARs, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037332
EXP033876	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siCTL, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037333
EXP033877	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siGATA3, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037334
EXP033878	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siCTL, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037335
EXP033879	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siFoxA1, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037336
EXP033880	FOXA1, Abcam, ab5089	Homo sapiens	1hr treatment with 100nM E2	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS037337
EXP033881	anti-RARa (Diagenode C15310155)	Mus musculus		NULL	76	unspecified	P11416	Th1-cells	PEAKS037338
EXP033883	anti-PROX1 goat antibody (R&D Systems)	Homo sapiens		EXP033882	821	unspecified	Q92786	SW480 (colon adenocarcinoma)	PEAKS037339
EXP033884	Foxa2-specific rabbit antiserum, WRAB-1200	Mus musculus		NULL	5	unspecified	P35583	liver	PEAKS037340
EXP033885	Foxa2-specific rabbit antiserum, WRAB-1200	Mus musculus		NULL	5	unspecified	P35583	liver	PEAKS037341
EXP033887	Jarid2 (Abcam, ab48137)	Mus musculus		EXP033886	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS037342
EXP033888	Jarid2 (Abcam, ab48137)	Mus musculus		NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	PEAKS037343
EXP033890	Rabbit polyclonal antibodies to DMRT6(DMRTB1)	Mus musculus		EXP033889	32	unspecified	A2A9I7	testis	PEAKS037344
EXP033893	Foxo1 antibody (Abcam, Ab39670)	Mus musculus		EXP033891	1058	unspecified	Q9R1E0	CD4+ T-cells	PEAKS037345
EXP033894	Strepdavidin	Mus musculus		EXP033892	1058	unspecified	Q9R1E0	CD4+ T-cells	PEAKS037346
EXP033895	ERG, sc-353x	Homo sapiens	none	NULL	838	unspecified	P11308	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037347
EXP033896	ERG	Homo sapiens	1 um ATRA for 24 hrs	NULL	838	unspecified	P11308	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037348
EXP033897	RARa, A704, Diagenode	Homo sapiens	none	NULL	838	unspecified	P10276	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037349
EXP033898	Fli-1, sc-356	Homo sapiens	none	NULL	838	unspecified	Q01543	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037350
EXP033899	RXR, sc-774x	Homo sapiens	none	NULL	838	unspecified	P19793	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037351
EXP033900	RUNX1, ab23980	Homo sapiens	none	NULL	838	unspecified	Q01196	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037352
EXP033901	GATA2, sc-9008	Homo sapiens	none	NULL	838	unspecified	P23769	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037353
EXP033902	LYL1, sc-374164x	Homo sapiens	none	NULL	838	unspecified	P12980	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037354
EXP033903	TAL1, sc-12984x	Homo sapiens	none	NULL	838	unspecified	P17542	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037355
EXP033904	SPI1/PU.1, sc-352x	Homo sapiens	none	NULL	838	unspecified	P17947	TSU-1621-MT (adult acute myeloid leukemia)	PEAKS037356
EXP033905	chip antibody: anti-CTCF	Mus musculus	FACS sorted naive CD4+T cells cultured in vitro for 7 days under Th1 condition	NULL	76	unspecified	Q61164	Th1-cells	PEAKS037357
EXP033906	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037358
EXP033907	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037359
EXP033908	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	558	unspecified	P03372	LTED (breast cancer)	PEAKS037360
EXP033909	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	558	unspecified	P03372	LTED (breast cancer)	PEAKS037361
EXP033912	BRACHYURY (R&D systems, AF2085)	Homo sapiens	none	EXP033910	397	unspecified	O15178	H9-derived endodermal progenitors	PEAKS037362
EXP033913	BRACHYURY (R&D systems, AF2085)	Homo sapiens	none	EXP033911	398	unspecified	O15178	H9-derived mesodermal progenitors	PEAKS037363
EXP033914	BRACHYURY (Santa Cruz, sc-20109)	Homo sapiens	none	EXP033910	397	unspecified	O15178	H9-derived endodermal progenitors	PEAKS037364
EXP033915	BRACHYURY (Santa Cruz, sc-20109)	Homo sapiens	none	EXP033911	398	unspecified	O15178	H9-derived mesodermal progenitors	PEAKS037365
EXP033916	anti-MITF (ab12039, abcam)	Homo sapiens	none	NULL	601	unspecified	O75030	melanocytes	PEAKS037366
EXP033917	anti-MITF (ab12039, abcam)	Homo sapiens	none	NULL	601	unspecified	O75030	melanocytes	PEAKS037367
EXP033918	Hey-1	Mus musculus	none	NULL	639	unspecified	Q9WV93	CM7/1 (embryonic stem cells)	PEAKS037368
EXP033919	Hey-1	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	639	unspecified	Q9WV93	CM7/1 (embryonic stem cells)	PEAKS037369
EXP033920	Hey-2	Mus musculus	none	NULL	639	unspecified	Q9QUS4	CM7/1 (embryonic stem cells)	PEAKS037370
EXP033921	Hey-2	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	639	unspecified	Q9QUS4	CM7/1 (embryonic stem cells)	PEAKS037371
EXP033922	Hey-1	Mus musculus	none	NULL	497	unspecified	Q9WV93	CM7/1-derived cardiomyocytes	PEAKS037372
EXP033923	Hey-1	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	497	unspecified	Q9WV93	CM7/1-derived cardiomyocytes	PEAKS037373
EXP033924	Hey-2	Mus musculus	none	NULL	497	unspecified	Q9QUS4	CM7/1-derived cardiomyocytes	PEAKS037374
EXP033925	Hey-2	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	497	unspecified	Q9QUS4	CM7/1-derived cardiomyocytes	PEAKS037375
EXP033930	anti-Zic 1/2 C-terminus	Mus musculus	none	EXP033926	25	unspecified	P46684	cerebellum	PEAKS037378
EXP033931	anti-Zic 1/2 C-terminus	Mus musculus	none	EXP033927	25	unspecified	P46684	cerebellum	PEAKS037379
EXP033933	anti-Gata2	Homo sapiens	none (vehicle)	EXP033932	269	unspecified	P23769	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS037380
EXP033934	anti-Gata2, sc-9008	Homo sapiens	ACY-957 (HDAC1/2 selective inhibitor)	EXP033932	269	unspecified	P23769	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS037381
EXP033936	p63, H-129, Santa Cruz	Homo sapiens	Ad-LacZ	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	PEAKS037382
EXP033937	p63, H-129, Santa Cruz	Homo sapiens	Ad-LacZ and 3 ng/ml of TGF-beta3 for 1.5 hrs	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	PEAKS037383
EXP033938	p63, H-129, Santa Cruz	Homo sapiens	Ad-caRAS and 3 ng/ml of TGF-beta3 for 1.5 hrs	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	PEAKS037384
EXP033939	p63, H-129, Santa Cruz	Homo sapiens	Ad-dnRAS and 3 ng/ml of TGF-beta3 for 1.5 hrs	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	PEAKS037385
EXP033940	anti-ASH2 (Bethyl Laboratories, A300-489A)	Homo sapiens	Treatment: vehicle; Time point: 12 hours; Conditions: cells were grown in 5% charcoal-stripped serum containing media for 48 hours	NULL	71	normal	Q99929	VCaP (prostate carcinoma)	PEAKS037386
EXP033941	anti-ASH2 (Bethyl Laboratories, A300-489A)	Homo sapiens	Treatment: 12 hours of 100nM R1881; Time point: 12 hours; Conditions: cells were grown in 5% charcoal-stripped serum containing media for 48 hours	NULL	71	normal	Q99929	VCaP (prostate carcinoma)	PEAKS037387
EXP033943	anti-FOXL2 C-terminal antibody (from lab)	Mus musculus	none	EXP033942	173	unspecified	O88470	preantral follicles	PEAKS037388
EXP033950	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	Vehicle	EXP033944	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037389
EXP033951	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2	EXP033945	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037390
EXP033952	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	TNFa	EXP033946	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037391
EXP033953	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa	EXP033947	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037392
EXP033954	p65  (Abcam ab7970)	Homo sapiens	Vehicle	EXP033944	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS037393
EXP033955	p65  (Abcam ab7970)	Homo sapiens	E2	EXP033945	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS037394
EXP033956	p65  (Abcam ab7970)	Homo sapiens	TNFa	EXP033946	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS037395
EXP033957	p65  (Abcam ab7970)	Homo sapiens	E2+TNFa	EXP033947	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS037396
EXP033958	FoxA1 (Abcam ab23738)	Homo sapiens	Vehicle	EXP033944	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS037397
EXP033959	FoxA1 (Abcam ab23738)	Homo sapiens	E2	EXP033945	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS037398
EXP033960	FoxA1 (Abcam ab23738)	Homo sapiens	TNFa	EXP033946	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS037399
EXP033961	FoxA1 (Abcam ab23738)	Homo sapiens	E2+TNFa	EXP033947	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS037400
EXP033962	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa, siCTRL	EXP033948	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037401
EXP033963	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa, siFOXA1	EXP033949	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037402
EXP033964	CTCF Millipore #07-729	Mus musculus	TFII-I KD	NULL	861	unspecified	Q61164	WEHI-231 (lymphoma )	PEAKS037403
EXP033965	CTCF Millipore #07-729	Mus musculus		NULL	861	unspecified	Q61164	WEHI-231 (lymphoma )	PEAKS037404
EXP033967	anti-HSF1	Homo sapiens	heat shock at 43C for 10 minutes	EXP033966	848	unspecified	Q00613	U2OS (osteosarcoma)	PEAKS037405
EXP033968	anti-HSF1	Homo sapiens	heat shock at 43C for 20 minutes	EXP033966	848	unspecified	Q00613	U2OS (osteosarcoma)	PEAKS037406
EXP033973	Ikaros	Mus musculus		EXP033969	171	unspecified	Q03267	CD4+ CD8+ T cells	PEAKS037407
EXP033974	Ikaros	Mus musculus		EXP033971	294	unspecified	Q03267	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25+, CD44- thymocytes	PEAKS037408
EXP033975	Ikaros	Mus musculus		EXP033972	293	unspecified	Q03267	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25-, CD44- thymocytes	PEAKS037409
EXP033976	Ikaros	Mus musculus		EXP033970	295	unspecified	Q03267	CD4+, CD8+, CD3low thymocytes	PEAKS037410
EXP033977	anti-Mta2 (ab8106, Abcam)	Mus musculus		EXP033971	294	unspecified	Q9R190	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25+, CD44- thymocytes	PEAKS037411
EXP033979	Zic3 (Abcam, ab80966)	Mus musculus		EXP033978	2	unspecified	Q62521	mESCs (mouse embryonic stem cells)	PEAKS037412
EXP033980	Zic2 (Abcam, ab150404)	Mus musculus		EXP033978	2	unspecified	Q62520	mESCs (mouse embryonic stem cells)	PEAKS037413
EXP033982	anti-HA	Mus musculus		EXP033981	23	unspecified	P17433	416B (hematopoietic precursor cells)	PEAKS037414
EXP033983	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	PEAKS037415
EXP033984	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	PEAKS037416
EXP033985	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	842	unspecified	P50553	non-small cell lung carcinoma	PEAKS037417
EXP033986	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	PEAKS037418
EXP033987	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	PEAKS037419
EXP033988	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	842	unspecified	P50553	non-small cell lung carcinoma	PEAKS037420
EXP033989	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	PEAKS037421
EXP033992	Slug (C19G7) Rabbit mAb	Mus musculus	high slug expression	EXP033990	619	unspecified	P97469	MMTV-PyMT breast cancer cells	PEAKS037422
EXP033993	Anti-SNAIL + SLUG antibody	Mus musculus	high snail expression	EXP033991	619	unspecified	Q02085	MMTV-PyMT breast cancer cells	PEAKS037423
EXP033998	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus		EXP033994	14	unspecified	P06537	3134 (mammary adenocarcinoma)	PEAKS037424
EXP033999	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus	cort for 20min	EXP033995	14	unspecified	P06537	3134 (mammary adenocarcinoma)	PEAKS037425
EXP034000	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus	cort pulsed 60min	EXP033996	14	unspecified	P06537	3134 (mammary adenocarcinoma)	PEAKS037426
EXP034001	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus	cort constant 60min	EXP033997	14	unspecified	P06537	3134 (mammary adenocarcinoma)	PEAKS037427
EXP034002	Millipore 07-729	Mus musculus		EXP033994	14	unspecified	Q61164	3134 (mammary adenocarcinoma)	PEAKS037428
EXP034004	anti-HIF1a	Mus musculus		EXP034003	95	unspecified	Q61221	E12.5 embryonic heart	PEAKS037429
EXP034006	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control Ethl	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037430
EXP034007	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control R1881	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037431
EXP034008	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR Ethl	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037432
EXP034009	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR R1881	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037433
EXP034010	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control knockdown Ethl	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS037434
EXP034011	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control knockdown R1881	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS037435
EXP034012	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR knockdown Ethl	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS037436
EXP034013	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR knockdown R1881	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS037437
EXP034015	Santa Cruz sc-1694	Homo sapiens		EXP034014	192	unspecified	P05412	HCASMC (Human coronary artery smooth muscle cells)	PEAKS037438
EXP034016	Santa Cruz sc-74	Homo sapiens		EXP034014	192	unspecified	P17535	HCASMC (Human coronary artery smooth muscle cells)	PEAKS037439
EXP034017	Sigma HPA013189	Homo sapiens		EXP034014	192	unspecified	O43680	HCASMC (Human coronary artery smooth muscle cells)	PEAKS037440
EXP034018	Abcam #ab49475, Lot No. 153899	Homo sapiens		EXP034014	192	unspecified	O43680	HCASMC (Human coronary artery smooth muscle cells)	PEAKS037441
EXP034024	anti-MEF2D (Flavell et al., 2008)	Mus musculus	Mef2d KO	EXP034019	141	unspecified	Q63943	retina	PEAKS037442
EXP034025	anti-MEF2D (Flavell et al., 2008)	Mus musculus	unstim Ctx1	EXP034020	141	unspecified	Q63943	retina	PEAKS037443
EXP034026	anti-MEF2D (Flavell et al., 2008)	Mus musculus	stim Ctx1	EXP034021	141	unspecified	Q63943	retina	PEAKS037444
EXP034027	anti-MEF2D (Flavell et al., 2008)	Mus musculus	unstim Ctx2	NULL	141	unspecified	Q63943	retina	PEAKS037445
EXP034028	anti-MEF2D (Flavell et al., 2008)	Mus musculus	stim Ctx2	NULL	141	unspecified	Q63943	retina	PEAKS037446
EXP034029	anti-MEF2D (Flavell et al., 2008)	Mus musculus	Crx KO	EXP034022	141	unspecified	Q63943	retina	PEAKS037447
EXP034030	anti-MEF2D (Flavell et al., 2008)	Mus musculus		EXP034023	141	unspecified	Q63943	retina	PEAKS037448
EXP034031	Millipore 05-909 TFAP2C	Mus musculus		NULL	574	unspecified	Q61312	mammary tumor	PEAKS037449
EXP034033	anti-PU.1	Mus musculus	LPS and IL-4	EXP034032	41	unspecified	P17433	B-cells	PEAKS037450
EXP034034	anti-PU.1	Mus musculus	LPS and IL-4	EXP034032	41	unspecified	P17433	B-cells	PEAKS037451
EXP034035	anti-PU.1	Mus musculus	LPS and IL-4	EXP034032	41	unspecified	P17433	B-cells	PEAKS037452
EXP034037	anti-phospho-HLXB9	Mus musculus	none	EXP034036	606	unspecified	Q9QZW9	MIN6-4N (insulinoma)	PEAKS037453
EXP034039	Prdm9	Mus musculus		EXP034038	803	unspecified	Q96EQ9	spermatocytes	PEAKS037454
EXP034046	Anti-NKX2-2	Mus musculus		EXP034040	284	unspecified	P42586	ventral neural progenitors	PEAKS037455
EXP034047	anti-NKX6.1	Mus musculus		EXP034041	284	unspecified	Q99MA9	ventral neural progenitors	PEAKS037456
EXP034048	Millipore AB9610	Mus musculus		EXP034042	284	unspecified	Q9EQW6	ventral neural progenitors	PEAKS037457
EXP034049	anti-FLAG M2 clone	Mus musculus		EXP034043	283	unspecified	Q61602	dorsal neural progenitors	PEAKS037458
EXP034050	Cocktail of DSHB (74.5A5), Sigma (HPA003468), and custom (from T. Jessell)	Mus musculus		EXP034044	138	unspecified	P42586	neural progenitors	PEAKS037459
EXP034051	Cocktail of DSHB (F55A10, F55A12, F64A6B4, and F65A2), RD Systems  (AF5857) and custom (from T. Jessell)	Mus musculus		EXP034045	138	unspecified	Q99MA9	neural progenitors	PEAKS037460
EXP034052	Millipore (AB9610)	Mus musculus		EXP034045	138	unspecified	Q9EQW6	neural progenitors	PEAKS037461
EXP034053	anti-PPARalpha	Mus musculus		NULL	5	unspecified	P23204	liver	PEAKS037462
EXP034054	anti-PPARalpha	Mus musculus	GW7647	NULL	5	unspecified	P23204	liver	PEAKS037463
EXP034055	anti-PPARalpha	Mus musculus	PPARalpha KO	NULL	5	unspecified	P23204	liver	PEAKS037464
EXP034056	anti-PPARalpha	Mus musculus	GW7647, PPARalpha KO	NULL	5	unspecified	P23204	liver	PEAKS037465
EXP034059	AR -N20 (Santa Cruz, SC-816 lot B1012)	Homo sapiens	Ethanol (vehicle control)	EXP034057	761	unspecified	P10275	R1-AD1 (prostate cancer)	PEAKS037466
EXP034060	AR -N20 (Santa Cruz, SC-816 lot B1012)	Homo sapiens	dihydrotestosterone, 1nM	EXP034057	761	unspecified	P10275	R1-AD1 (prostate cancer)	PEAKS037467
EXP034061	AR -N20 (Santa Cruz, SC-816 lot B1012)	Homo sapiens	Ethanol (vehicle control)	EXP034058	762	unspecified	P10275	R1-D567 (prostate cancer)	PEAKS037468
EXP034063	BD Transduction Laboratories 610922	Homo sapiens		EXP034062	788	unspecified	P28347	SF268 (astrocytoma )	PEAKS037469
EXP034066	BuGR2, monoclonal (Pierce/ThermoFisher)	Mus musculus	dex	EXP034064	141	unspecified	P06537	retina	PEAKS037470
EXP034067	BuGR2, monoclonal (Pierce/ThermoFisher)	Mus musculus		EXP034065	141	unspecified	P06537	retina	PEAKS037471
EXP034069	Sigma Imprint anti-GR, monoclonal	Homo sapiens		EXP034068	466	unspecified	P04150	MDM(monocyte derived macrophages)	PEAKS037472
EXP034070	zfhx3	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	PEAKS037473
EXP034071	zfhx3	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	PEAKS037474
EXP034072	klf6	Homo sapiens		NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	PEAKS037475
EXP034073	klf6	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	PEAKS037476
EXP034074	klf6	Homo sapiens		NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	PEAKS037477
EXP034075	klf6	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	PEAKS037478
EXP034076	zbtb16	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q05516	HeLa (cervical adenocarcinoma)	PEAKS037479
EXP034077	zbtb16	Homo sapiens		NULL	78	unspecified	Q05516	HeLa (cervical adenocarcinoma)	PEAKS037480
EXP034078	zfhx3	Homo sapiens		NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	PEAKS037481
EXP034079	zfhx3	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	PEAKS037482
EXP034084	anti-HA	Mus musculus	HA-tagged full-length GATA1	EXP034080	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS037483
EXP034085	anti-HA	Mus musculus	HA-tagged full-length GATA1	EXP034081	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS037484
EXP034086	anti-HA	Mus musculus	GATA1s	EXP034082	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS037485
EXP034087	anti-HA	Mus musculus	GATA1s	EXP034083	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS037486
EXP034090	FLI1 (Santa Cruz, sc-356)	Homo sapiens		EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	PEAKS037487
EXP034091	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shGFP for 48h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	PEAKS037488
EXP034092	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shGFP for 96h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	PEAKS037489
EXP034093	GABPA (Santa Cruz, sc-22810)	Homo sapiens	shGFP for 96h	EXP034088	289	unspecified	Q06546	SK-N-MC (Askin tumor)	PEAKS037490
EXP034094	ELF1 (Santa Cruz, sc-631)	Homo sapiens	shGFP for 96h	EXP034088	289	unspecified	P32519	SK-N-MC (Askin tumor)	PEAKS037491
EXP034095	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shFLI1 for 48h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	PEAKS037492
EXP034096	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shFLI1 for 96h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	PEAKS037493
EXP034097	GABPA (Santa Cruz, sc-22810)	Homo sapiens	shFLI1 for 96h	EXP034088	289	unspecified	Q06546	SK-N-MC (Askin tumor)	PEAKS037494
EXP034098	ELF1 (Santa Cruz, sc-631)	Homo sapiens	shFLI1 for 96h	EXP034088	289	unspecified	P32519	SK-N-MC (Askin tumor)	PEAKS037495
EXP034099	FLI1 (Santa Cruz, sc-356)	Homo sapiens		EXP034089	288	unspecified	Q01543	A673 (Ewing sarcoma)	PEAKS037496
EXP034100	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shGFP for 48h	EXP034089	288	unspecified	Q01543	A673 (Ewing sarcoma)	PEAKS037497
EXP034101	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shFLI1 for 48h	EXP034089	288	unspecified	Q01543	A673 (Ewing sarcoma)	PEAKS037498
EXP034103	Millipore AB5535	Homo sapiens		EXP034102	201	unspecified	P48436	CyT49 (embryonic stem cells)	PEAKS037499
EXP034106	HA : IGBMC (12CA5)	Homo sapiens		EXP034104	27	unspecified	O75030	501Mel-Cl8 (melanoma)	PEAKS037500
EXP034107	SOX10 : Abcam (ab155270)	Homo sapiens		EXP034105	26	unspecified	P56693	501Mel (melanoma)	PEAKS037501
EXP034110	Abcam,Ab21990,GR139309-4Â 	Homo sapiens		EXP034108	896	unspecified	P32243	embryonic stem cell-derived neural progenitors	PEAKS037502
EXP034111	Abcam,Ab21990,GR139309-4Â 	Homo sapiens		EXP034109	281	unspecified	P32243	embryonic stem cell- derived mid radial glial neural progenitors	PEAKS037503
EXP034114	klf9	Homo sapiens		EXP034112	324	unspecified	Q13886	HSR-GBM1A (glioblastoma)	PEAKS037504
EXP034115	klf9	Homo sapiens		EXP034113	325	unspecified	Q13886	HSR-GBM1B (glioblastoma)	PEAKS037505
EXP034118	SC-543, Santa Cruz Biotech	Homo sapiens	1hr with ethanol, crosslinked with 1% formaldehyde	EXP034116	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037506
EXP034119	SC-543, Santa Cruz Biotech	Homo sapiens	1hr with 100nM E2, crosslinked with 1% formaldehyde	EXP034117	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037507
EXP034120	SC-543, Santa Cruz Biotech	Homo sapiens	cells transfected with siNCAPG, and 1hr with 100nM E2, double crosslinked	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037508
EXP034121	SC-543, Santa Cruz Biotech	Homo sapiens	cells transfected with siNCAPD3 and H2 together, and 1hr with 100nM E2, double crosslinked	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037509
EXP034122	SC-543, Santa Cruz Biotech	Homo sapiens	cells transfected with siCTL, and 1hr with 100nM E2, double crosslinked	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS037510
EXP034124	anti-TLX1 (C-18 rabbit polyclonal antibody (sc-880), Santa Cruz Biotechnology)	Homo sapiens		EXP034123	61	unspecified	P31314	ALL-SIL (acute lymphoblastic leukemia)	PEAKS037511
EXP034126	Prdm5 ab1	Mus musculus		EXP034125	582	unspecified	Q9CXE0	MC3T3 (osteogenic cell line)	PEAKS037512
EXP034127	Prdm5 ab2	Mus musculus		EXP034125	582	unspecified	Q9CXE0	MC3T3 (osteogenic cell line)	PEAKS037513
EXP034130	TEAD	Homo sapiens		EXP034128	152	unspecified	P28347	CC-LP-1 (intrahepatic cholangiocarcinoma)	PEAKS037514
EXP034132	FOXM1	Homo sapiens		EXP034131	440	unspecified	Q08050	HMEC (human mammary epithelial cells)	PEAKS037515
EXP034133	MYBL2	Homo sapiens		EXP034131	440	unspecified	P10244	HMEC (human mammary epithelial cells)	PEAKS037516
EXP034134	E2F1	Homo sapiens		EXP034131	440	unspecified	Q01094	HMEC (human mammary epithelial cells)	PEAKS037517
EXP034138	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of vehicle; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS037518
EXP034139	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM R1881; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS037519
EXP034140	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM R1881 and 10uM Bicalutamide; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS037520
EXP034141	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM R1881 and 10uM MDV3100; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS037521
EXP034142	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of vehicle; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037522
EXP034143	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037523
EXP034144	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM Bicalutamide; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037524
EXP034145	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM MDV3100; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS037525
EXP034146	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of vehicle; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	PEAKS037526
EXP034147	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	PEAKS037527
EXP034148	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM Bicalutamide; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	PEAKS037528
EXP034149	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM MDV3100; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	PEAKS037529
EXP034151	anti-flag M2 affinity gel (Sigma, A2220)	Homo sapiens	PGR-A isoform	EXP034150	256	unspecified	P06401	endometrial stromal cells	PEAKS037530
EXP034152	anti-flag M2 affinity gel (Sigma, A2220)	Homo sapiens	PGR-B isoform	EXP034150	256	unspecified	P06401	endometrial stromal cells	PEAKS037531
EXP034159	SY4530 (custom)	Homo sapiens	PMA/ionomycin	EXP034153	886	unspecified	Q9UL17	Th1-cells	PEAKS037532
EXP034160	Sigma M2	Mus musculus	PMA/ionomycin	NULL	243	unspecified	Q9JKD8	EL4 (lymphoma)	PEAKS037533
EXP034161	Sigma M2	Mus musculus	PMA/ionomycin	NULL	243	unspecified	Q9JKD8	EL4 (lymphoma)	PEAKS037534
EXP034162	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin	EXP034156	243	unspecified	Q04207	EL4 (lymphoma)	PEAKS037535
EXP034163	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin	EXP034157	243	unspecified	Q04207	EL4 (lymphoma)	PEAKS037536
EXP034164	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin	EXP034154	76	unspecified	Q04207	Th1-cells	PEAKS037537
EXP034165	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin, T-bet KO	EXP034155	76	unspecified	Q04207	Th1-cells	PEAKS037538
EXP034166	Santa Cruz C-20 (sc-372)	Homo sapiens	PMA/ionomycin, DMSO	EXP034158	886	unspecified	Q04206	Th1-cells	PEAKS037539
EXP034167	p65	Homo sapiens	PMA/ionomycin, BAY 11-7082	NULL	886	unspecified	Q04206	Th1-cells	PEAKS037540
EXP034169	AR	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037541
EXP034170	AR	Homo sapiens	R1881 10 nM	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037542
EXP034171	AR	Homo sapiens	DHT 10 nM treatment, siControl	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037543
EXP034172	AR	Homo sapiens	DHT 10 nM treatment, siFOXP1	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037544
EXP034173	FOXP1	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	unspecified	Q9H334	LNCaP (prostate carcinoma)	PEAKS037545
EXP034174	FOXP1	Homo sapiens	DHT 10 nM treatment	EXP034168	70	unspecified	Q9H334	LNCaP (prostate carcinoma)	PEAKS037546
EXP034175	RUNX1	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	unspecified	Q01196	LNCaP (prostate carcinoma)	PEAKS037547
EXP034176	RUNX1	Homo sapiens	DHT 10 nM treatment	EXP034168	70	unspecified	Q01196	LNCaP (prostate carcinoma)	PEAKS037548
EXP034177	AR	Homo sapiens	DHT 10 nM treatment, siControl	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037549
EXP034178	AR	Homo sapiens	DHT 10 nM treatment, siRUNX1	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037550
EXP034180	c-Myc (N-262) Santa Cruz Cat# sc-764	Mus musculus		EXP034179	487	unspecified	P01108	multipotent otic progenitors	PEAKS037551
EXP034181	Sox2 clone 6F1.2 EMD Millipore Cat# 17-656	Mus musculus		EXP034179	487	unspecified	P48432	multipotent otic progenitors	PEAKS037552
EXP034183	anti-FOXL2 C-terminal antibody (from lab)	Mus musculus		EXP034182	173	unspecified	O88470	preantral follicles	PEAKS037553
EXP034184	anti-ESR1 C-terminal antibody (Santa Cruz sc543)	Mus musculus		EXP034182	173	unspecified	P19785	preantral follicles	PEAKS037554
EXP034186	Rabbit polyclonal  anti-RUNX1 (non-commercial antibody)	Mus musculus		EXP034185	253	unspecified	Q03347	EML -C1(EML, clone 1)	PEAKS037555
EXP034188	ZNF644	Homo sapiens		EXP034187	10	unspecified	Q9H582	HEK293T (embryonic kidney)	PEAKS037556
EXP034189	WIZ	Homo sapiens		EXP034187	10	unspecified	O95785	HEK293T (embryonic kidney)	PEAKS037557
EXP034191	AR IP (Epitomics clone ER179(2))	Mus musculus		EXP034190	901	unspecified	P19091	prostate tumor	PEAKS037558
EXP034192	AR IP (Epitomics clone ER179(2))	Mus musculus	castrate	EXP034190	901	unspecified	P19091	prostate tumor	PEAKS037559
EXP034193	AR IP (Epitomics clone ER179(2))	Mus musculus	bicalutamide	EXP034190	901	unspecified	P19091	prostate tumor	PEAKS037560
EXP034194	AR IP (Epitomics clone ER179(2))	Mus musculus	enzalutamide	EXP034190	901	unspecified	P19091	prostate tumor	PEAKS037561
EXP034196	aebp2	Mus musculus		EXP034195	139	unspecified	Q9Z248	thymus	PEAKS037562
EXP034197	Irf7	Mus musculus	t0	NULL	190	unspecified	P70434	myeloid cells	PEAKS037563
EXP034198	Irf7	Mus musculus	t1	NULL	190	unspecified	P70434	myeloid cells	PEAKS037564
EXP034199	Irf7	Mus musculus	t2	NULL	190	unspecified	P70434	myeloid cells	PEAKS037565
EXP034200	Irf7	Mus musculus	t4	NULL	190	unspecified	P70434	myeloid cells	PEAKS037566
EXP034201	Pu.1	Mus musculus		NULL	914	unspecified	P17433	monocyte-derived dendritic cells	PEAKS037567
EXP034202	Pu.1	Mus musculus		NULL	312	unspecified	P17433	plasmacytoid dendritic cells	PEAKS037568
EXP034203	Irf8	Mus musculus		NULL	914	unspecified	P23611	monocyte-derived dendritic cells	PEAKS037569
EXP034204	Irf8	Mus musculus		NULL	312	unspecified	P23611	plasmacytoid dendritic cells	PEAKS037570
EXP034205	Cebpb	Mus musculus		NULL	914	unspecified	P28033	monocyte-derived dendritic cells	PEAKS037571
EXP034206	Cebpb	Mus musculus		NULL	312	unspecified	P28033	plasmacytoid dendritic cells	PEAKS037572
EXP034208	mouse monoclonal anti-FLAG M2 Sigma-Aldrich F1804	Homo sapiens		EXP034207	692	unspecified	Q9H334	OF4155 (neural progenitors)	PEAKS037573
EXP034209	GATA-1 Antibody (N6) sc-265	Mus musculus		NULL	265	unspecified	P17679	G1E (embryonic stem cells)	PEAKS037574
EXP034210	GATA-1 Antibody (N6) sc-265	Mus musculus	250nM JQ1 for 24 hours	NULL	265	unspecified	P17679	G1E (embryonic stem cells)	PEAKS037575
EXP034211	Meis1/2 (K830, K844)	Mus musculus		NULL	131	unspecified	Q60954	E10.5 embryonic optic cups	PEAKS037576
EXP034213	GR (Santa Cruz: H300, sc-8992)	Mus musculus		NULL	122	unspecified	P06537	burst-forming unit erythroid	PEAKS037577
EXP034214	PPAR alpha (Santa Cruz: H-98, sc-9000)	Mus musculus		NULL	122	unspecified	P23204	burst-forming unit erythroid	PEAKS037578
EXP034215	GR (Santa Cruz: H300, sc-8992)	Mus musculus	Dexamethasone 4 hrs	NULL	122	unspecified	P06537	burst-forming unit erythroid	PEAKS037579
EXP034216	PPAR alpha (Santa Cruz: H-98, sc-9000)	Mus musculus	Dexamethasone 4 hrs	NULL	122	unspecified	P23204	burst-forming unit erythroid	PEAKS037580
EXP034217	GR (Santa Cruz: H300, sc-8992)	Mus musculus	Dexamethasone and GW7647 4 hrs	EXP034212	122	unspecified	P06537	burst-forming unit erythroid	PEAKS037581
EXP034218	PPAR alpha (Santa Cruz: H-98, sc-9000)	Mus musculus	Dexamethasone and GW7647 4 hrs	EXP034212	122	unspecified	P23204	burst-forming unit erythroid	PEAKS037582
EXP034230	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034219	535	unspecified	P17433	large peritoneal macrophages	PEAKS037583
EXP034231	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034220	800	unspecified	P17433	small peritoneal macrophages	PEAKS037584
EXP034232	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034221	605	unspecified	P17433	microglia	PEAKS037585
EXP034233	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		EXP034222	732	unspecified	P17433	peritoneal macrophages	PEAKS037586
EXP034234	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034223	535	unspecified	P17433	large peritoneal macrophages	PEAKS037587
EXP034235	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034224	535	unspecified	P17433	large peritoneal macrophages	PEAKS037588
EXP034236	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		NULL	605	unspecified	P17433	microglia	PEAKS037589
EXP034237	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034225	605	unspecified	P17433	microglia	PEAKS037590
EXP034238	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 2um DMSO 7d	EXP034226	535	unspecified	P17433	large peritoneal macrophages	PEAKS037591
EXP034239	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 2um ATRA 7d	EXP034227	535	unspecified	P17433	large peritoneal macrophages	PEAKS037592
EXP034240	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 1ng/ml TGFB1 7d	EXP034228	535	unspecified	P17433	large peritoneal macrophages	PEAKS037593
EXP034241	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 1ng/ml VehTGFB1 7d	EXP034229	535	unspecified	P17433	large peritoneal macrophages	PEAKS037594
EXP034243	HA 12CA5	Mus musculus		EXP034242	16	unspecified	Q8C7R7	MIN6-B1 (insulinoma)	PEAKS037595
EXP034245	AML1	Homo sapiens		EXP034244	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037596
EXP034246	SC-1609	Homo sapiens		EXP034244	516	unspecified	O75376	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037597
EXP034249	affinity-purified anti-HNF4? (?445)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a2 expression	EXP034247	417	unspecified	P41235	HCT-116 (colon carcinoma)	PEAKS037598
EXP034250	affinity-purified anti-HNF4? (?445)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a8 expression	EXP034248	417	unspecified	P41235	HCT-116 (colon carcinoma)	PEAKS037599
EXP034251	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.0 Î¼g/mL DOX, HNF4a2 expression	NULL	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	PEAKS037600
EXP034252	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a2 expression	EXP034247	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	PEAKS037601
EXP034253	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.0 Î¼g/mL DOX, HNF4a8 expression	NULL	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	PEAKS037602
EXP034254	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a8 expression	EXP034248	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	PEAKS037603
EXP034256	sox15	Homo sapiens		EXP034255	77	unspecified	O60248	CP-A(Barrett esophagus epithelium)	PEAKS037604
EXP034262	sox2	Homo sapiens		EXP034258	244	unspecified	P48431	NT2-D1 (embryonic carcinoma)	PEAKS037608
EXP034263	nanog	Homo sapiens		EXP034258	244	unspecified	Q9H9S0	NT2-D1 (embryonic carcinoma)	PEAKS037609
EXP034264	oct4	Homo sapiens		EXP034258	244	unspecified	Q01860	NT2-D1 (embryonic carcinoma)	PEAKS037610
EXP034265	CREB1	Homo sapiens		NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	PEAKS037611
EXP034266	FOXA1	Homo sapiens		NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS037612
EXP034267	CREB1	Homo sapiens		NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	PEAKS037613
EXP034268	FoxA1 (Abcam ab23738)	Homo sapiens	siControl	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS037614
EXP034269	CREB1 (Abcam ab31387)	Homo sapiens	siControl	NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	PEAKS037615
EXP034270	FoxA1 (Abcam ab23738)	Homo sapiens	siCREB1	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS037616
EXP034271	CREB1 (Abcam ab31387)	Homo sapiens	siFOXA1	NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	PEAKS037617
EXP034273	JunB (Cell signaling 3753S)	Homo sapiens		EXP034272	468	unspecified	P17275	neonatal keratinocytes	PEAKS037618
EXP034275	AR (Santa Cruz; sc-816)	Homo sapiens		EXP034274	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037619
EXP034276	STAT3 (Invitrogen, 13-7000)	Mus musculus		NULL	1058	unspecified	P42227	CD4+ T-cells	PEAKS037620
EXP034277	STAT3 (Invitrogen, 13-7000)	Mus musculus	IL21	NULL	1058	unspecified	P42227	CD4+ T-cells	PEAKS037621
EXP034278	STAT3 (Invitrogen, 13-7000)	Mus musculus	Stat1 KO	NULL	1058	unspecified	P42227	CD4+ T-cells	PEAKS037622
EXP034279	STAT3 (Invitrogen, 13-7000)	Mus musculus	Stat1 KO, IL21	NULL	1058	unspecified	P42227	CD4+ T-cells	PEAKS037623
EXP034280	STAT1 (Santa Cruz, sc-346)	Mus musculus		NULL	1058	unspecified	P42225	CD4+ T-cells	PEAKS037624
EXP034281	STAT1 (Santa Cruz, sc-346)	Mus musculus	IL21	NULL	1058	unspecified	P42225	CD4+ T-cells	PEAKS037625
EXP034282	STAT1 (Santa Cruz, sc-346)	Mus musculus	Stat3 KO	NULL	1058	unspecified	P42225	CD4+ T-cells	PEAKS037626
EXP034283	STAT1 (Santa Cruz, sc-346)	Mus musculus	Stat3 KO, IL21	NULL	1058	unspecified	P42225	CD4+ T-cells	PEAKS037627
EXP034292	GR	Homo sapiens		EXP034284	618	unspecified	P04150	MM1.S (plasma cell myeloma)	PEAKS037628
EXP034293	GR	Homo sapiens	Dex 1uM	EXP034285	618	unspecified	P04150	MM1.S (plasma cell myeloma)	PEAKS037629
EXP034294	GR	Homo sapiens		EXP034286	617	unspecified	P04150	MM1.RL (plasma cell myeloma)	PEAKS037630
EXP034295	GR	Homo sapiens	Dex 1uM	EXP034287	617	unspecified	P04150	MM1.RL (plasma cell myeloma)	PEAKS037631
EXP034296	anti-UBF1/2 rabbit polyclonal	Mus musculus		NULL	675	unspecified	P25976	NIH 3T3 (embryonic fibroblasts)	PEAKS037632
EXP034297	anti-UBF1/2 rabbit polyclonal	Homo sapiens		NULL	440	unspecified	P17480	HMEC (human mammary epithelial cells)	PEAKS037633
EXP034298	anti-UBF1/2 rabbit polyclonal	Homo sapiens		NULL	442	unspecified	P17480	HMLER (mammary epithelial cells)	PEAKS037634
EXP034306	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034299	92	unspecified	Q9H334	BJAB (Burkitt lymphoma)	PEAKS037635
EXP034307	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034300	407	unspecified	Q9H334	HBL1 (diffuse large B-cell lymphoma)	PEAKS037636
EXP034308	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034301	453	unspecified	Q9H334	HT (diffuse large B-cell lymphoma)	PEAKS037637
EXP034309	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034302	689	unspecified	Q9H334	OCI-LY8 (diffuse large B-cell lymphoma)	PEAKS037638
EXP034310	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034303	683	unspecified	Q9H334	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS037639
EXP034311	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034304	684	unspecified	Q9H334	OCI-LY19 (diffuse large B-cell lymphoma)	PEAKS037640
EXP034312	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034305	835	unspecified	Q9H334	TMD8 (diffuse large B-cell lymphoma)	PEAKS037641
EXP034314	PREP-1 N-15 (Santa Cruz Biotechnology, sc-6245)	Mus musculus		EXP034313	2	unspecified	O70477	mESCs (mouse embryonic stem cells)	PEAKS037642
EXP034317	Pu.1 (Santa Cruz sc352x)	Mus musculus	PuER	EXP034315	869	unspecified	P17433	X18.1.1 (acute myeloid leukemia)	PEAKS037643
EXP034318	Pu.1 (Santa Cruz sc352x)	Mus musculus		EXP034316	869	unspecified	P17433	X18.1.1 (acute myeloid leukemia)	PEAKS037644
EXP034319	CEBPA (Santa Cruz sc61x)	Mus musculus	PuER	EXP034315	869	unspecified	P53566	X18.1.1 (acute myeloid leukemia)	PEAKS037645
EXP034320	CEBPA (Santa Cruz sc61x)	Mus musculus		EXP034316	869	unspecified	P53566	X18.1.1 (acute myeloid leukemia)	PEAKS037646
EXP034322	EHF (Clone 5A.5), Pierce	Homo sapiens		EXP034321	148	unspecified	Q9NZC4	Calu-3 (lung adenocarcinoma)	PEAKS037647
EXP034326	anti-LYL1	Homo sapiens		EXP034323	516	unspecified	P12980	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037648
EXP034327	anti-LYL1	Homo sapiens		EXP034324	438	unspecified	P12980	HL-60 (acute myeloid leukemia)	PEAKS037649
EXP034328	anti-LYL1	Homo sapiens		EXP034325	648	unspecified	P12980	NB4 (acute promyelocytic leukemia )	PEAKS037650
EXP034329	anti-LYL1	Homo sapiens		NULL	2334	unspecified	P12980	THP-1 (acute monocytic leukemia)	PEAKS037651
EXP034331	HSF1 (Cell Signaling, catalog# 4356, lot# 2)	Homo sapiens		EXP034330	24	unspecified	Q00613	451Lu (WM-451Lu, Melanoma)	PEAKS037652
EXP034333	anti-Tbr2, Chemicon cat.no AB9618	Mus musculus		EXP034332	228	unspecified	O54839	E14.5 embryonic cerebral cortices	PEAKS037653
EXP034334	anti-Neurog2, non-commercial: a gift of Prof. Yongchao Ma, Chicago	Mus musculus		EXP034332	228	unspecified	P70447	E14.5 embryonic cerebral cortices	PEAKS037654
EXP034336	SOX9  (Millipore, AB5535)	Homo sapiens		EXP034335	452	unspecified	P48436	HT29 (colon adenocarcinoma)	PEAKS037655
EXP034337	sc-553, sc-774	Mus musculus		NULL	732	unspecified	P28700	peritoneal macrophages	PEAKS037656
EXP034338	sc-7196, sc-1984	Mus musculus		NULL	732	unspecified	P37238	peritoneal macrophages	PEAKS037657
EXP034339	sc-13551, sc-8984, sc-367	Mus musculus	GW3965 6h	NULL	732	unspecified	Q9WTN3	peritoneal macrophages	PEAKS037658
EXP034340	HEB	Mus musculus		NULL	171	unspecified	Q61286	CD4+ CD8+ T cells	PEAKS037659
EXP034341	TCF1	Mus musculus		NULL	171	unspecified	Q00417	CD4+ CD8+ T cells	PEAKS037660
EXP034343	NFkB p65 (C-20) #sc-372, rabbit pkAb	Homo sapiens		EXP034342	531	unspecified	Q04206	L1236 (Hodgkin lymphoma)	PEAKS037661
EXP034344	RelB (C-19) #sc-226, rabbit pkAb	Homo sapiens		EXP034342	531	unspecified	Q01201	L1236 (Hodgkin lymphoma)	PEAKS037662
EXP034345	NFkB p50 (C-19) #sc-1190, goat pkAb	Homo sapiens		EXP034342	531	unspecified	P19838	L1236 (Hodgkin lymphoma)	PEAKS037663
EXP034346	NFkB p52 Millipore #05-361, mouse mk Ab	Homo sapiens		EXP034342	531	unspecified	Q00653	L1236 (Hodgkin lymphoma)	PEAKS037664
EXP034349	HMGA2 (Santa cruz, cat. sc-30223, lot: F1407 )	Mus musculus		EXP034347	12	unspecified	P52927	MEF (mouse embryonic fibroblasts)	PEAKS037665
EXP034350	HMGA2 (Santa cruz, cat. sc-30223, lot: F1407 )	Mus musculus	Hmga2 KO	EXP034348	12	unspecified	P52927	MEF (mouse embryonic fibroblasts)	PEAKS037666
EXP034351	smad	Homo sapiens		NULL	786	unspecified	Q15796	NCI-H345 (small cell lung carcinoma)	PEAKS037667
EXP034353	Made in Lab (Harms et al. 2014. Cell Metab.)	Mus musculus		EXP034352	115	unspecified	A2A935	brown adipose tissue	PEAKS037668
EXP034354	Made in Lab (Harms et al. 2014. Cell Metab.)	Mus musculus	Prdm16 KO	EXP034352	115	unspecified	A2A935	brown adipose tissue	PEAKS037669
EXP034356	sc-5279, Santa Cruz	Mus musculus	shCtrl	EXP034355	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS037670
EXP034357	sc-5279, Santa Cruz	Mus musculus	shNup153-2	EXP034355	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS037671
EXP034359	Santa Cruz (sc-15408)	Mus musculus	Non-stimulated control	EXP034358	159	unspecified	Q61687	cortical neurons	PEAKS037672
EXP034360	Santa Cruz (sc-15408)	Mus musculus	KCl stimulated (Isotonic KCl, 55 mM)	EXP034358	159	unspecified	Q61687	cortical neurons	PEAKS037673
EXP034362	WT1 (Santa Cruz, sc-192, Lot F1711)	Mus musculus		EXP034361	522	unspecified	P22561	kidney cortex	PEAKS037674
EXP034364	HA : IGBMC (12CA5)	Homo sapiens		EXP034363	26	unspecified	O75030	501Mel (melanoma)	PEAKS037675
EXP034367	Anti-Flag antibody	Homo sapiens	Dexamethasone (24h)	NULL	10	unspecified	P04150	HEK293T (embryonic kidney)	PEAKS037676
EXP034368	Anti-Flag antibody	Homo sapiens		EXP034366	10	unspecified	O00327	HEK293T (embryonic kidney)	PEAKS037677
EXP034373	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens		EXP034370	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS037678
EXP034374	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	IL1	EXP034369	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS037679
EXP034375	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	5ÂµM PHA-408	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS037680
EXP034376	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	5ÂµM PHA-408 + IL1	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS037681
EXP034377	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	1ÂµM 5Z-7-oxozeaenol for 1 h	EXP034371	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS037682
EXP034378	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	1ÂµM 5Z-7-oxozeaenol for 1 h + IL1	EXP034372	519	unspecified	Q04206	KB (cervical adenocarcinoma)	PEAKS037683
EXP034381	RELA (C-20, sc-372, Santa Cruz)	Homo sapiens	TNF	EXP034380	789	unspecified	Q04206	SGBS (Simpson Golabi Behmel syndrome type 1 adipocytes)	PEAKS037684
EXP034382	RELA (C-20, sc-372, Santa Cruz)	Homo sapiens		EXP034379	789	unspecified	Q04206	SGBS (Simpson Golabi Behmel syndrome type 1 adipocytes)	PEAKS037685
EXP034384	sc-8431	Homo sapiens		EXP034383	215	unspecified	Q9H3D4	keratinocytes	PEAKS037686
EXP034386	anti-HA	Mus musculus		EXP034385	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS037687
EXP034387	anti-HA	Mus musculus	GATA1 short isoform	EXP034385	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	PEAKS037688
EXP034394	anti-mouse NFAT1 (67.1)	Mus musculus		EXP034388	2479	unspecified	Q60591	CD8+ T-cells	PEAKS037689
EXP034395	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO Mock	EXP034389	2479	unspecified	Q60591	CD8+ T-cells	PEAKS037690
EXP034396	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO CA-RIT-RV	EXP034390	2479	unspecified	Q60591	CD8+ T-cells	PEAKS037691
EXP034397	anti-mouse NFAT1 (67.1)	Mus musculus	P+I 1h	EXP034391	2479	unspecified	Q60591	CD8+ T-cells	PEAKS037692
EXP034398	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO P+I 1h	EXP034392	2479	unspecified	Q60591	CD8+ T-cells	PEAKS037693
EXP034399	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO CA-RIT-RV P+I 1h	EXP034393	2479	unspecified	Q60591	CD8+ T-cells	PEAKS037694
EXP034403	10E2	Mus musculus		EXP034400	321	unspecified	Q60821	medulloblastoma, type G3	PEAKS037695
EXP034404	N262 (sc-764)	Mus musculus		EXP034400	321	unspecified	P01108	medulloblastoma, type G3	PEAKS037696
EXP034405	10E2	Mus musculus		EXP034401	321	unspecified	Q60821	medulloblastoma, type G3	PEAKS037697
EXP034406	B8.4.B (sc-53993, Lot#D0214)	Mus musculus		EXP034401	321	unspecified	P03966	medulloblastoma, type G3	PEAKS037698
EXP034407	10E2	Mus musculus		EXP034402	791	unspecified	Q60821	Sonic Hedgehog medulloblastoma	PEAKS037699
EXP034408	B8.4.B (sc-53993, Lot#D0214)	Mus musculus		EXP034402	791	unspecified	P03966	Sonic Hedgehog medulloblastoma	PEAKS037700
EXP034412	sc-7196	Mus musculus	standard rodent chow diet	EXP034409	136	unspecified	P37238	white adipose tissue	PEAKS037701
EXP034413	sc-7196	Mus musculus	standard rodent chow diet	EXP034410	4	unspecified	P37238	inguinal white adipose tissue	PEAKS037702
EXP034414	anti-PPAR? antibody	Mus musculus	standard rodent chow diet	EXP034411	4	unspecified	P37238	inguinal white adipose tissue	PEAKS037703
EXP034415	sc-7196	Mus musculus		NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS037704
EXP034416	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus	standard rodent chow diet	EXP034409	136	unspecified	P06537	white adipose tissue	PEAKS037705
EXP034417	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus	standard rodent chow diet	EXP034410	4	unspecified	P06537	inguinal white adipose tissue	PEAKS037706
EXP034418	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus		NULL	136	unspecified	P06537	white adipose tissue	PEAKS037707
EXP034419	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus		NULL	3	unspecified	P06537	epididymal white adipose tissue	PEAKS037708
EXP034420	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037709
EXP034421	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037710
EXP034422	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037711
EXP034423	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037712
EXP034424	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037713
EXP034425	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037714
EXP034426	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037715
EXP034427	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037716
EXP034428	sc-7196	Mus musculus	low fat diet	NULL	136	unspecified	P37238	white adipose tissue	PEAKS037717
EXP034429	sc-7196	Mus musculus	low fat diet	NULL	3	unspecified	P37238	epididymal white adipose tissue	PEAKS037718
EXP034430	sc-7196	Mus musculus	standard rodent chow diet	NULL	136	unspecified	P37238	white adipose tissue	PEAKS037719
EXP034431	sc-7196	Mus musculus	standard rodent chow diet	NULL	3	unspecified	P37238	epididymal white adipose tissue	PEAKS037720
EXP034432	sc-7196	Mus musculus	standard rodent chow diet	NULL	3	unspecified	P37238	epididymal white adipose tissue	PEAKS037721
EXP034433	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037722
EXP034434	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037723
EXP034435	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037724
EXP034436	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	PEAKS037725
EXP034437	ascl1	Mus musculus		NULL	75	unspecified	Q02067	AtT-20 (pituitary tumor)	PEAKS037726
EXP034438	anti-TBX19 (HPA005800, Sigma-Aldrich)	Mus musculus		NULL	75	unspecified	Q99ME7	AtT-20 (pituitary tumor)	PEAKS037727
EXP034439	Sigma HPA003479	Homo sapiens		NULL	697	unspecified	P78545	pancreatic ductal adenocarcinoma	PEAKS037728
EXP034440	Abcam 23738	Homo sapiens		NULL	697	unspecified	P55317	pancreatic ductal adenocarcinoma	PEAKS037729
EXP034441	Sigma HPA002083	Homo sapiens		NULL	697	unspecified	P35680	pancreatic ductal adenocarcinoma	PEAKS037730
EXP034442	SC-640	Homo sapiens		NULL	697	unspecified	P10914	pancreatic ductal adenocarcinoma	PEAKS037731
EXP034443	Millipore 07-1580	Homo sapiens		NULL	697	unspecified	Q13887	pancreatic ductal adenocarcinoma	PEAKS037732
EXP034444	SC-25388	Homo sapiens		NULL	697	unspecified	P37275	pancreatic ductal adenocarcinoma	PEAKS037733
EXP034445	RnD AF3640	Homo sapiens		NULL	697	unspecified	O43474	pancreatic ductal adenocarcinoma	PEAKS037734
EXP034446	Anti-KLF6 (SCBT # SC-7158)	Homo sapiens		NULL	697	unspecified	Q99612	pancreatic ductal adenocarcinoma	PEAKS037735
EXP034447	Anti-ELF3 (Sigma # HPA003479)	Homo sapiens	KLF5 KO	NULL	697	unspecified	P78545	pancreatic ductal adenocarcinoma	PEAKS037736
EXP034448	Anti-FOXA1 (Abcam # 23738)	Homo sapiens	KLF5 KO	NULL	697	unspecified	P55317	pancreatic ductal adenocarcinoma	PEAKS037737
EXP034449	Anti-ELF3 (Sigma # HPA003479)	Homo sapiens		NULL	697	unspecified	P78545	pancreatic ductal adenocarcinoma	PEAKS037738
EXP034450	Anti-FOXA1 (Abcam # 23738)	Homo sapiens		NULL	697	unspecified	P55317	pancreatic ductal adenocarcinoma	PEAKS037739
EXP034451	RUNX1	Mus musculus		NULL	278	unspecified	Q03347	embryonic stem cell-derived myeloid progenitors	PEAKS037740
EXP034452	RUNX1	Mus musculus	induced	NULL	278	unspecified	Q03347	embryonic stem cell-derived myeloid progenitors	PEAKS037741
EXP034453	MyoD antibody 6196	Mus musculus	MyoD transduction	NULL	705	unspecified	P10085	P19 (embryonic carcinoma)	PEAKS037742
EXP034454	MyoD antibody 6975	Mus musculus	MyoD transduction	NULL	705	unspecified	P10085	P19 (embryonic carcinoma)	PEAKS037743
EXP034455	NeuroD2 antibody 1165	Mus musculus	NeuroD2 transduction	NULL	705	unspecified	Q62414	P19 (embryonic carcinoma)	PEAKS037744
EXP034456	NeuroD2 antibody 1240	Mus musculus	NeuroD2 transduction	NULL	705	unspecified	Q62414	P19 (embryonic carcinoma)	PEAKS037745
EXP034457	NeuroD2 antibody 1240	Mus musculus		NULL	705	unspecified	Q62414	P19 (embryonic carcinoma)	PEAKS037746
EXP034458	MyoD antibody 6975	Mus musculus		NULL	705	unspecified	P10085	P19 (embryonic carcinoma)	PEAKS037747
EXP034462	Santa cruz N21	Homo sapiens		EXP034459	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037748
EXP034463	homemade	Homo sapiens		EXP034460	70	unspecified	P11473	LNCaP (prostate carcinoma)	PEAKS037749
EXP034464	Abcam, ab5090	Homo sapiens		EXP034461	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS037750
EXP034467	Sox-10; Santa Cruz Biotechnology, sc-17342x	Rattus norvegicus		EXP034465	921	unspecified	O55170	spinal cord	PEAKS037751
EXP034468	Sox-10; Santa Cruz Biotechnology, sc-17342x	Rattus norvegicus		EXP034466	785	unspecified	O55170	sciatic nerve	PEAKS037752
EXP034469	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens		NULL	890	unspecified	P51692	CD8+ T-cells	PEAKS037753
EXP034470	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	IL2	NULL	890	unspecified	P51692	CD8+ T-cells	PEAKS037754
EXP034471	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	H9	NULL	890	unspecified	P51692	CD8+ T-cells	PEAKS037755
EXP034472	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	H9RET	NULL	890	unspecified	P51692	CD8+ T-cells	PEAKS037756
EXP034473	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	H9RETR	NULL	890	unspecified	P51692	CD8+ T-cells	PEAKS037757
EXP034478	anti-STAT6 (Cell Signalling, catalog# sc9362, lot# 4)	Mus musculus		EXP034474	1058	unspecified	P52633	CD4+ T-cells	PEAKS037758
EXP034479	anti-IRF4 (Santa Cruz, catalog# sc6059, lot# B2614)	Mus musculus		EXP034474	1058	unspecified	Q64287	CD4+ T-cells	PEAKS037759
EXP034480	anti-BATF (Cell Signalling, catalog# sc8638, lot# 1)	Mus musculus		EXP034474	1058	unspecified	O35284	CD4+ T-cells	PEAKS037760
EXP034481	anti-STAT6 (Cell Signalling, catalog# sc9362, lot# 4)	Mus musculus	NLRP3KO	EXP034476	1058	unspecified	P52633	CD4+ T-cells	PEAKS037761
EXP034482	anti-IRF4 (Santa Cruz, catalog# sc6059, lot# B2614)	Mus musculus	NLRP3KO	EXP034476	1058	unspecified	Q64287	CD4+ T-cells	PEAKS037762
EXP034483	anti-BATF (Cell Signalling, catalog# sc8638, lot# 1)	Mus musculus	NLRP3KO	EXP034476	1058	unspecified	O35284	CD4+ T-cells	PEAKS037763
EXP034485	LEF-1 (homemade)	Homo sapiens		EXP034484	878	unspecified	Q9UJU2	embryonic stem cells	PEAKS037764
EXP034486	LEF-1 (homemade)	Homo sapiens	Wnt3a 4h	EXP034484	878	unspecified	Q9UJU2	embryonic stem cells	PEAKS037765
EXP034488	CREB (clone: 48H2)	Mus musculus		EXP034487	81	unspecified	Q01147	BMDM (bone marrow-derived macrophages)	PEAKS037766
EXP034489	Runx1, ab23980	Homo sapiens		NULL	45	unspecified	Q01196	acute myeloblastic leukemia	PEAKS037767
EXP034490	Santa Cruz Biotechnology; sc-253	Homo sapiens	siMM	NULL	641	unspecified	P01100	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS037768
EXP034491	Santa Cruz Biotechnology; sc-253	Homo sapiens	siFLT3	NULL	641	unspecified	P01100	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS037769
EXP034492	Santa Cruz Biotechnology; sc-835	Homo sapiens		NULL	641	unspecified	P42229	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS037770
EXP034493	Abcam; ab23980	Homo sapiens		NULL	45	unspecified	Q01196	acute myeloblastic leukemia	PEAKS037771
EXP034494	Abcam; ab23980	Homo sapiens		NULL	724	unspecified	Q01196	stem cells from periferal blood	PEAKS037772
EXP034495	sc-6243	Homo sapiens		NULL	430	unspecified	P04637	HepG2 (hepatoblastoma)	PEAKS037773
EXP034496	sc-6243	Homo sapiens	HBV HBx protein expressing	NULL	430	unspecified	P04637	HepG2 (hepatoblastoma)	PEAKS037774
EXP034500	dmrt1 Antibody (PMID: 11040213)	Mus musculus		EXP034498	32	unspecified	Q9QZ59	testis	PEAKS037776
EXP034501	sc-816	Homo sapiens	ethanol	NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS037777
EXP034502	sc-816	Homo sapiens	10 nmol/l of mibolerone	NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS037778
EXP034503	sc-816	Homo sapiens	ethanol	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037779
EXP034504	sc-816	Homo sapiens	10 nmol/l of mibolerone	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037780
EXP034506	neurod1	Mus musculus		EXP034505	222	unspecified	Q60867	A2lox (embryonic stem cells)	PEAKS037781
EXP034507	Abcam ab19857	Mus musculus		NULL	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS037782
EXP034508	Tcf4 (Santa Cruz, Cat# SC-8631, Lot# J0709)	Rattus norvegicus	proliferation medium	NULL	696	unspecified	D4A8X6	oligodendrocyte progenitors	PEAKS037783
EXP034509	Tcf4 (Santa Cruz, Cat# SC-8631, Lot# J0709)	Rattus norvegicus	T3 treated for 1 day	NULL	696	unspecified	D4A8X6	oligodendrocyte progenitors	PEAKS037784
EXP034510	Tcf4 (Santa Cruz, Cat# SC-8631, Lot# J0709)	Rattus norvegicus	T3 treated for 3 days	NULL	696	unspecified	D4A8X6	oligodendrocyte progenitors	PEAKS037785
EXP034513	V5 (Abcam ab15828)	Mus musculus		EXP034511	429	unspecified	A2BH40	hepatocytes	PEAKS037786
EXP034514	C/ebp? (Santa Cruz, sc-61)	Mus musculus		EXP034511	429	unspecified	P53566	hepatocytes	PEAKS037787
EXP034515	C/ebp? (Santa Cruz, sc-61)	Mus musculus	cebpa KO	EXP034512	429	unspecified	P53566	hepatocytes	PEAKS037788
EXP034517	RUNX1	Homo sapiens		EXP034516	113	unspecified	Q01196	MCF7 (Invasive ductal breast carcinoma)	PEAKS037789
EXP034519	anti-Tcf4 (Cell signaling, catalog 2569S and lot2)	Mus musculus	Ring KO	EXP034518	195	unspecified	Q924A0	crypt cells	PEAKS037790
EXP034520	anti-Tcf4 (Cell signaling, catalog 2569S and lot2)	Mus musculus		EXP034518	195	unspecified	Q924A0	crypt cells	PEAKS037791
EXP034523	anti-AML1 (C19) (ab23980; Abcam)	Homo sapiens		EXP034521	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037792
EXP034524	anti-AML1 (N20) (sc-8563 X; Santa Cruz Biotechnology)	Homo sapiens		EXP034521	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS037793
EXP034525	anti-AML1 (C19) (ab23980; Abcam)	Homo sapiens		EXP034522	65	unspecified	Q01196	U937 (adult acute monocytic leukemia)	PEAKS037794
EXP034527	anti-MYC N262 (Santa Cruz Biotechnology, catalog number sc-764)	Homo sapiens	transduced with MycER and BPTF-targeting shRNA, treated with 4-hydroxytamoxifen (4-OHT)	EXP034526	659	unspecified	P01106	neonatal foreskin fibroblasts	PEAKS037795
EXP034528	anti-MYC N262 (Santa Cruz Biotechnology, catalog number sc-764)	Homo sapiens	transduced with MycER and control shRNA, treated with 4-hydroxytamoxifen (4-OHT)	EXP034526	659	unspecified	P01106	neonatal foreskin fibroblasts	PEAKS037796
EXP034538	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0	EXP034529	1058	unspecified	P42225	CD4+ T-cells	PEAKS037797
EXP034539	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0	EXP034529	1058	unspecified	P42227	CD4+ T-cells	PEAKS037798
EXP034540	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6)	EXP034530	1058	unspecified	P42225	CD4+ T-cells	PEAKS037799
EXP034541	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6)	EXP034530	1058	unspecified	P42227	CD4+ T-cells	PEAKS037800
EXP034542	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27)	EXP034531	1058	unspecified	P42225	CD4+ T-cells	PEAKS037801
EXP034543	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27)	EXP034531	1058	unspecified	P42227	CD4+ T-cells	PEAKS037802
EXP034544	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, STAT1 KO	EXP034532	1058	unspecified	P42227	CD4+ T-cells	PEAKS037803
EXP034545	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6), STAT1 KO	EXP034533	1058	unspecified	P42227	CD4+ T-cells	PEAKS037804
EXP034546	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27), STAT1 KO	EXP034534	1058	unspecified	P42227	CD4+ T-cells	PEAKS037805
EXP034547	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, STAT3 KO	EXP034535	1058	unspecified	P42225	CD4+ T-cells	PEAKS037806
EXP034548	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6), STAT3 KO	EXP034536	1058	unspecified	P42225	CD4+ T-cells	PEAKS037807
EXP034549	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27), STAT3 KO	EXP034537	1058	unspecified	P42225	CD4+ T-cells	PEAKS037808
EXP034555	GATA3	Homo sapiens		NULL	520	unspecified	P23771	Kelly (neuroblastoma)	PEAKS037809
EXP034556	GATA3	Homo sapiens		EXP034550	664	unspecified	P23771	SH-SY5Y (neuroblastoma)	PEAKS037810
EXP034557	GATA3	Homo sapiens		EXP034554	82	unspecified	P23771	SK-N-BE(2)-C (neuroblastoma)	PEAKS037811
EXP034558	GATA3	Homo sapiens		EXP034552	82	unspecified	P23771	SK-N-BE(2)-C (neuroblastoma)	PEAKS037812
EXP034559	GATA3	Homo sapiens		EXP034553	669	unspecified	P23771	NGP (neuroblastoma)	PEAKS037813
EXP034560	RXR (Santa Cruz, SC-774)	Mus musculus		NULL	233	unspecified	P28700	E14TG2A (embryonic stem cells)	PEAKS037814
EXP034561	Nur77 (Santa Cruz, SC-5569)	Mus musculus		NULL	233	unspecified	P12813	E14TG2A (embryonic stem cells)	PEAKS037815
EXP034562	RXR (Santa Cruz, SC-774)	Mus musculus	1um Retinoic Acid (RA) for 48hrs	NULL	233	unspecified	P28700	E14TG2A (embryonic stem cells)	PEAKS037816
EXP034563	Nur77 (Santa Cruz, SC-5569)	Mus musculus	1um Retinoic Acid (RA) for 48hrs	NULL	233	unspecified	P12813	E14TG2A (embryonic stem cells)	PEAKS037817
EXP034565	SC-55351x	Mus musculus		EXP034564	151	unspecified	Q3U0X6	CCE (embryonic stem cells)	PEAKS037818
EXP034568	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	Ctcf.6 shRNA	EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	PEAKS037819
EXP034569	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	Ctcf.7 shRNA	EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	PEAKS037820
EXP034570	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	Smchd1 null	EXP034567	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	PEAKS037821
EXP034571	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	non-silencing shRNA	EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	PEAKS037822
EXP034572	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus		EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	PEAKS037823
EXP034573	GKLF, Santa Cruz Biotechnology, sc-20691, Lot# J1212	Mus musculus		NULL	612	unspecified	Q60793	mixture of cell types	PEAKS037824
EXP034574	GKLF, Santa Cruz Biotechnology, sc-20691, Lot# J1212	Mus musculus	KLF4 KO	NULL	612	unspecified	Q60793	mixture of cell types	PEAKS037825
EXP034579	Dnmt3a (SantaCruz H-295	Homo sapiens		EXP034576	215	unspecified	Q9Y6K1	keratinocytes	PEAKS037826
EXP034580	Dnmt3b (Novus Biotechnology. Cat: NB100-266)	Homo sapiens		NULL	215	unspecified	Q9UBC3	keratinocytes	PEAKS037827
EXP034581	DNMT3A SantaCruz (H-295)	Homo sapiens	shDNMT3A	EXP034577	261	unspecified	Q9Y6K1	epidermal stem cells	PEAKS037828
EXP034582	DNMT3B Novus (NB300-516)	Homo sapiens	shDNMT3B	EXP034578	315	unspecified	Q9UBC3	foreskin	PEAKS037829
EXP034583	DNMT3A SantaCruz (H-295)	Homo sapiens	shSETD2	EXP034575	261	unspecified	Q9Y6K1	epidermal stem cells	PEAKS037830
EXP034584	DNMT3B Novus (NB300-516)	Homo sapiens	shSETD2	EXP034575	261	unspecified	Q9UBC3	epidermal stem cells	PEAKS037831
EXP034585	Dnmt3a (SantaCruz H-295	Homo sapiens		EXP034575	261	unspecified	Q9Y6K1	epidermal stem cells	PEAKS037832
EXP034586	Dnmt3b (Novus Biotechnology. Cat: NB100-266)	Homo sapiens		EXP034575	261	unspecified	Q9UBC3	epidermal stem cells	PEAKS037833
EXP034589	GR (Santa Cruz)	Homo sapiens	siNS	EXP034587	848	unspecified	P04150	U2OS (osteosarcoma)	PEAKS037834
EXP034590	GR (Santa Cruz)	Homo sapiens	siHic5	EXP034588	848	unspecified	P04150	U2OS (osteosarcoma)	PEAKS037835
EXP034593	SantaCruz, catalog# sc-232X	Mus musculus	rest	EXP034591	1058	unspecified	P25425	CD4+ T-cells	PEAKS037836
EXP034594	SantaCruz, catalog# sc-232X	Mus musculus	restimulated	EXP034592	1058	unspecified	P25425	CD4+ T-cells	PEAKS037837
EXP034596	Polyclonal V5 Antibody (Abcam, catalog# 9116)	Homo sapiens		EXP034595	864	unspecified	P49910	WHIM12 (breast cancer)	PEAKS037838
EXP034598	anti-Grhl2 (Sigma Aldrich, catalog# HPA004820, lot# A35809)	Mus musculus		EXP034597	631	unspecified	Q8K5C0	placenta	PEAKS037839
EXP034603	AR (santacruz H-280)	Homo sapiens	Bicalutamide 1 Î¼M	EXP034599	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS037840
EXP034604	AR (santacruz H-280)	Homo sapiens	DHT 10 nM	EXP034602	90	unspecified	P10275	BicR (prostate cancer)	PEAKS037841
EXP034605	AR (santacruz H-280)	Homo sapiens	Bicalutamide 1 Î¼M	EXP034600	90	unspecified	P10275	BicR (prostate cancer)	PEAKS037842
EXP034606	AR (santacruz H-280)	Homo sapiens	ethanol	EXP034601	90	unspecified	P10275	BicR (prostate cancer)	PEAKS037843
EXP034610	GFP Tag Antibody (3E6)	Mus musculus	expressing Blimp-1-eGFP fusion protein	EXP034607	799	unspecified	Q60636	small intestine	PEAKS037844
EXP034611	polyclonal rabbit anti-Irf1 antibody (M-20)	Mus musculus		EXP034608	799	unspecified	P15314	small intestine	PEAKS037845
EXP034612	polyclonal rabbit anti-Irf1 antibody (M-20)	Mus musculus	Prdm1/Blimp-1 mutant	EXP034609	799	unspecified	P15314	small intestine	PEAKS037846
EXP034614	TEF-3 (N-G2) (SCBT, sc-101184, lot C2812)	Homo sapiens		EXP034613	2301	unspecified	Q15561	MDA-MB-231 (breast adenocarcinoma)	PEAKS037847
EXP034615	JUN (BD Bioscience, 610326, lot 3263734)	Homo sapiens		EXP034613	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	PEAKS037848
EXP034617	Pu.1 (sc-352; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P17433	acute myeloid leukemia	PEAKS037849
EXP034618	Fli1 (ab15289; Abcam)	Mus musculus		EXP034616	1493	unspecified	P26323	acute myeloid leukemia	PEAKS037850
EXP034619	Erg (sc-354; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P81270	acute myeloid leukemia	PEAKS037851
EXP034620	C/EBP? (sc-61; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P53566	acute myeloid leukemia	PEAKS037852
EXP034621	C/EBP? (sc-150; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P28033	acute myeloid leukemia	PEAKS037853
EXP034622	Myb (sc-7874; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P06876	acute myeloid leukemia	PEAKS037854
EXP034624	Rbpj (Cell Signaling Technology, 5313)	Mus musculus		EXP034623	31	unspecified	P31266	8946 cells - Flag-Zmiz1/ L1601PDP (T lymphoblastic leukemia)	PEAKS037855
EXP034625	C/EBP beta antibody (Santa Cruz, catalog# sc-150, lot# co513)	Homo sapiens		NULL	911	unspecified	P17676	macrophages	PEAKS037856
EXP034626	C/EBP beta antibody (Santa Cruz, catalog# sc-150, lot# co513)	Homo sapiens	oxLDL (50mcg/ml)	NULL	911	unspecified	P17676	macrophages	PEAKS037857
EXP034628	FOXA2 (Santa-Cruz sc-6554)	Homo sapiens		EXP034627	145	unspecified	Q9Y261	Caco-2 (colon adenocarcinoma)	PEAKS037858
EXP034630	Pu.1 (#2266, Cell Signaling)	Mus musculus		EXP034629	80	unspecified	P17433	B lymphoblastic leukemia	PEAKS037859
EXP034632	Satb1 (AbCam ab109122)	Mus musculus		EXP034631	44	unspecified	Q60611	T-cells	PEAKS037860
EXP034634	HA (Abcam ab 9110)	Homo sapiens		EXP034633	440	unspecified	P01106	HMEC (human mammary epithelial cells)	PEAKS037861
EXP034635	NCOR2  (PA1-843) (Thermo Scientific)	Mus musculus		NULL	81	unspecified	Q9WU42	BMDM (bone marrow-derived macrophages)	PEAKS037862
EXP034638	sc-126, Santa Cruz	Homo sapiens		EXP034637	2301	unspecified	P04637	MDA-MB-231 (breast adenocarcinoma)	PEAKS037863
EXP034643	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF (72h)	EXP034639	729	unspecified	P17947	macrophages form periferal blood	PEAKS037864
EXP034644	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + IFN-y	EXP034640	729	unspecified	P17947	macrophages form periferal blood	PEAKS037865
EXP034645	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + IL4	EXP034641	729	unspecified	P17947	macrophages form periferal blood	PEAKS037866
EXP034646	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + TNF-a + PGE2 + Pam3CSK4	EXP034642	729	unspecified	P17947	macrophages form periferal blood	PEAKS037867
EXP034647	BETHYL A302-564A	Homo sapiens		NULL	691	unspecified	Q8IVW6	OECM1 (oral cavity squamous cell carcinoma)	PEAKS037868
EXP034648	BETHYL A302-564A	Homo sapiens	ARID3B KD	NULL	691	unspecified	Q8IVW6	OECM1 (oral cavity squamous cell carcinoma)	PEAKS037869
EXP034650	Abcam ab79436	Mus musculus	minus	EXP034649	159	unspecified	Q8CFN5	cortical neurons	PEAKS037870
EXP034651	Abcam ab79436	Mus musculus	plus	EXP034649	159	unspecified	Q8CFN5	cortical neurons	PEAKS037871
EXP034652	Santa Cruz Biotechnologies sc-313	Mus musculus	minus	EXP034649	159	unspecified	Q60929	cortical neurons	PEAKS037872
EXP034653	Santa Cruz Biotechnologies sc-313	Mus musculus	plus	EXP034649	159	unspecified	Q60929	cortical neurons	PEAKS037873
EXP034654	Rosenfeld Lab	Mus musculus	minus	EXP034649	159	unspecified	Q60974	cortical neurons	PEAKS037874
EXP034655	Rosenfeld lab	Mus musculus	plus	EXP034649	159	unspecified	Q60974	cortical neurons	PEAKS037875
EXP034657	anti-Batf3	Mus musculus		EXP034656	311	unspecified	Q9D275	CD24+ dendritic cells	PEAKS037876
EXP034658	anti-Irf8	Mus musculus		EXP034656	311	unspecified	P23611	CD24+ dendritic cells	PEAKS037877
EXP034659	anti-Batf3	Mus musculus		EXP034656	310	unspecified	Q9D275	CD172+ dendritic cells	PEAKS037878
EXP034660	anti-Irf8	Mus musculus		EXP034656	312	unspecified	P23611	plasmacytoid dendritic cells	PEAKS037879
EXP034664	anti-Flag	Mus musculus	Flag-Six4	EXP034661	1153	unspecified	Q61321	C2C12 (myoblasts)	PEAKS037880
EXP034665	anti-Six4	Mus musculus	shNS	EXP034663	1153	unspecified	Q61321	C2C12 (myoblasts)	PEAKS037881
EXP034666	anti-Six4	Mus musculus	shSix4	EXP034662	1153	unspecified	Q61321	C2C12 (myoblasts)	PEAKS037882
EXP034667	HIF1? (ab2185, Abcam)	Homo sapiens	hypoxia	NULL	78	unspecified	Q16665	HeLa (cervical adenocarcinoma)	PEAKS037883
EXP034668	E2F7 (sc-66870, Santa Cruz Biotechnology)	Homo sapiens	normoxia	NULL	78	unspecified	Q96AV8	HeLa (cervical adenocarcinoma)	PEAKS037884
EXP034669	E2F7 (sc-66870, Santa Cruz Biotechnology)	Homo sapiens	hypoxia	NULL	78	unspecified	Q96AV8	HeLa (cervical adenocarcinoma)	PEAKS037885
EXP034672	Pax6 (Millipore, ab2237, lot# NG1731333)	Mus musculus		EXP034671	539	unspecified	P63015	lens	PEAKS037886
EXP034673	Pax6 (Millipore, ab2237, lot# NG1731333)	Mus musculus		EXP034670	313	unspecified	P63015	forebrain	PEAKS037887
EXP034675	Ikaros (Ik-C, rabbit antibody (kind gift of S.Smale))	Mus musculus		EXP034674	105	unspecified	Q03267	pro-B cells	PEAKS037888
EXP034676	Ikaros (Ik-C, rabbit antibody (kind gift of S.Smale))	Mus musculus		NULL	198	unspecified	Q03267	pre-pro-B-cells	PEAKS037889
EXP034679	sc-1003	Homo sapiens	CASP1	EXP034678	646	unspecified	P04150	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS037890
EXP034680	sc-1003	Homo sapiens		EXP034677	646	unspecified	P04150	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS037891
EXP034682	p53	Homo sapiens	16 hours doxycyclin, p53-VSV	EXP034681	821	unspecified	P04637	SW480 (colon adenocarcinoma)	PEAKS037892
EXP034684	GATA3 (sigma)	Homo sapiens		EXP034683	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS037893
EXP034685	MTA3 (upstate)	Homo sapiens		EXP034683	113	unspecified	Q9BTC8	MCF7 (Invasive ductal breast carcinoma)	PEAKS037894
EXP034689	Novus Biological, NB100-110	Homo sapiens		EXP034686	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	PEAKS037895
EXP034690	HIF-2alpha Antibody (PM9)	Homo sapiens		EXP034686	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	PEAKS037896
EXP034691	HIF-1alpha Antibody (PM14)	Homo sapiens	HIF-1a re-expression	EXP034687	30	unspecified	Q16665	RCC 7860 (Renal cell carcinoma)	PEAKS037897
EXP034692	Novus Biological, NB100-110	Homo sapiens	HIF-1a re-expression	EXP034687	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	PEAKS037898
EXP034693	HIF-2alpha Antibody (PM9)	Homo sapiens	HIF-1a re-expression	EXP034687	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	PEAKS037899
EXP034694	Novus Biological, NB100-110	Homo sapiens	HIF-2a over expression	EXP034688	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	PEAKS037900
EXP034695	HIF-2alpha Antibody (PM9)	Homo sapiens	HIF-2a over expression	EXP034688	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	PEAKS037901
EXP034698	Flag, Sigma M2	Mus musculus	-EGS	EXP034696	247	unspecified	Q8R1H0	embryonic heart	PEAKS037902
EXP034699	Flag, Sigma M2	Mus musculus	+EGS	EXP034697	247	unspecified	Q8R1H0	embryonic heart	PEAKS037903
EXP034701	Sigma F1804	Homo sapiens		EXP034700	78	unspecified	Q8N1L9	HeLa (cervical adenocarcinoma)	PEAKS037904
EXP034702	Sox2	Homo sapiens		NULL	505	unspecified	P48431	IVF-derived glioma stem cells	PEAKS037905
EXP034703	Sox2	Homo sapiens		NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	PEAKS037906
EXP034704	Sox2	Homo sapiens	inhibition of the PI3K and MAPK signaling pathways	NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	PEAKS037907
EXP034705	Sox2	Homo sapiens	Inhibition of P53	NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	PEAKS037908
EXP034706	Sox2	Homo sapiens	Inhibition of P53 and PI3K and MAPK signaling pathways	NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	PEAKS037909
EXP034708	KMT2D antibody	Homo sapiens		EXP034707	687	unspecified	Q9UMN6	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS037910
EXP034713	SRF	Mus musculus	Lipid A stimulation for 0 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	PEAKS037911
EXP034714	SRF	Mus musculus	Lipid A stimulation for 15 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	PEAKS037912
EXP034715	SRF	Mus musculus	Lipid A stimulation for 30 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	PEAKS037913
EXP034716	SRF	Mus musculus	Lipid A stimulation for 60 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	PEAKS037914
EXP034717	SRF	Mus musculus	Lipid A stimulation for 120 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	PEAKS037915
EXP034718	IRF3	Mus musculus	Lipid A stimulation for 0 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037916
EXP034719	IRF3	Mus musculus	Lipid A stimulation for 15 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037917
EXP034720	IRF3	Mus musculus	Lipid A stimulation for 30 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037918
EXP034721	IRF3	Mus musculus	Lipid A stimulation for 60 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037919
EXP034722	IRF3	Mus musculus	Lipid A stimulation for 120 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037920
EXP034723	IRF3	Mus musculus	Lipid A stimulation for 0 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037921
EXP034724	IRF3	Mus musculus	Lipid A stimulation for 15 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037922
EXP034725	IRF3	Mus musculus	Lipid A stimulation for 30 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037923
EXP034726	IRF3	Mus musculus	Lipid A stimulation for 60 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037924
EXP034727	IRF3	Mus musculus	Lipid A stimulation for 120 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	PEAKS037925
EXP034728	RelA	Mus musculus	Lipid A stimulation for 0 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS037926
EXP034729	RelA	Mus musculus	Lipid A stimulation for 15 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS037927
EXP034730	RelA	Mus musculus	Lipid A stimulation for 30 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS037928
EXP034731	RelA	Mus musculus	Lipid A stimulation for 60 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS037929
EXP034732	RelA	Mus musculus	Lipid A stimulation for 120 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS037930
EXP034734	H137 (Santa Cruz, cat#sc-8343, lot#A0614)	Homo sapiens	Brg1/Brm	EXP034733	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS037931
EXP034735	H137 (Santa Cruz, cat#sc-8343, lot#A0614)	Homo sapiens		EXP034733	468	unspecified	Q9H3D4	neonatal keratinocytes	PEAKS037932
EXP034736	sc-111	Mus musculus		NULL	1058	unspecified	P27577	CD4+ T-cells	PEAKS037933
EXP034737	sc-111	Mus musculus		NULL	1058	unspecified	P27577	CD4+ T-cells	PEAKS037934
EXP034738	ab23980	Mus musculus		NULL	1058	unspecified	Q03347	CD4+ T-cells	PEAKS037935
EXP034739	ab23980	Mus musculus		NULL	1058	unspecified	Q03347	CD4+ T-cells	PEAKS037936
EXP034740	ab23980	Mus musculus	PMA 120 min	NULL	1058	unspecified	Q03347	CD4+ T-cells	PEAKS037937
EXP034741	sc-46	Mus musculus		NULL	1058	unspecified	P09450	CD4+ T-cells	PEAKS037938
EXP034742	sc-46	Mus musculus	120 min PMA	NULL	1058	unspecified	P09450	CD4+ T-cells	PEAKS037939
EXP034744	ICSBP/IRF8 (Santa Cruz, sc-6058, Lot C2713)	Mus musculus		EXP034743	322	unspecified	P23611	gastric epithelial cells	PEAKS037940
EXP034745	ICSBP/IRF8 (Santa Cruz, sc-6058, Lot C2713)	Mus musculus	10ng/ml IFNg for 2 days	EXP034743	322	unspecified	P23611	gastric epithelial cells	PEAKS037941
EXP034748	anti-MLL2 (Sigma, catalog# HPA035977, lot# A69497)	Homo sapiens		EXP034746	327	unspecified	Q9UMN6	germinal center B-cells	PEAKS037942
EXP034749	anti-MLL2 (Sigma, catalog# HPA035977, lot# A69497)	Homo sapiens		EXP034747	327	unspecified	Q9UMN6	germinal center B-cells	PEAKS037943
EXP034752	Millipore 07-729	Mus musculus		EXP034750	897	unspecified	Q61164	fibroblasts	PEAKS037944
EXP034753	Millipore 07-729	Mus musculus	Xist deletion	EXP034751	212	unspecified	Q61164	dermal fibroblasts	PEAKS037945
EXP034763	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034754	750	unspecified	P20263	E13.5 embryonic fibroblasts	PEAKS037946
EXP034764	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034755	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037947
EXP034765	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034756	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037948
EXP034766	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034757	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037949
EXP034767	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034758	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037950
EXP034768	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034759	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037951
EXP034769	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034760	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037952
EXP034770	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034761	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037953
EXP034771	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034754	750	unspecified	P20263	E13.5 embryonic fibroblasts	PEAKS037954
EXP034772	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034755	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037955
EXP034773	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034756	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037956
EXP034774	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034757	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037957
EXP034775	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034758	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037958
EXP034776	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034759	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037959
EXP034777	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034760	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037960
EXP034778	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034761	906	unspecified	P20263	induced pluripotent stem cells	PEAKS037961
EXP034779	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034762	287	unspecified	P20263	induced embryonic stem cells	PEAKS037962
EXP034781	NeuroD2 antibody, vendor:Abcam, cat#:ab168932, lot#:GR161014-2	Mus musculus		EXP034780	174	unspecified	Q62414	cerebral cortex	PEAKS037963
EXP034782	NeuroD2 antibody, vendor:Abcam, cat#:ab104430, lot#:GR94291-1	Mus musculus		EXP034780	174	unspecified	Q62414	cerebral cortex	PEAKS037964
EXP034783	NeuroD2 antibody, Abcam, cat#:ab109406, lot#:YK010204CS	Mus musculus		EXP034780	174	unspecified	Q62414	cerebral cortex	PEAKS037965
EXP034786	c-Myc antibody (sc-764, Santa Cruz)	Mus musculus		EXP034784	12	unspecified	P01108	MEF (mouse embryonic fibroblasts)	PEAKS037966
EXP034787	c-Myc antibody (sc-764, Santa Cruz)	Mus musculus	day 2	EXP034785	12	unspecified	P01108	MEF (mouse embryonic fibroblasts)	PEAKS037967
EXP034789	Anti-GATA4 (Santa Cruz, C-20; Santa Cruz, H-112; eBioscience, eBioevan)	Mus musculus		EXP034788	904	unspecified	Q08369	myoblasts	PEAKS037968
EXP034791	sc-8986x	Homo sapiens		EXP034790	145	unspecified	P20823	Caco-2 (colon adenocarcinoma)	PEAKS037969
EXP034794	CTCF	Homo sapiens		EXP034792	471	unspecified	P49711	stem and progenitor cells	PEAKS037970
EXP034795	CTCF	Homo sapiens		EXP034793	894	unspecified	P49711	erythroid cells	PEAKS037971
EXP034797	sc-193	Homo sapiens		EXP034796	70	unspecified	Q01094	LNCaP (prostate carcinoma)	PEAKS037972
EXP034799	anti-RARbeta (sc-552, Santa Cruz)	Mus musculus		EXP034798	108	unspecified	P22605	brain caudate putamen	PEAKS037973
EXP034801	BAF180 (Bethyl A301-591A)	Mus musculus	CT10	EXP034800	5	unspecified	Q8BSQ9	liver	PEAKS037974
EXP034802	BAF180 (Bethyl A301-591A)	Mus musculus	CT22	EXP034800	5	unspecified	Q8BSQ9	liver	PEAKS037975
EXP034803	BAF180 (Active Motif 61381)	Mus musculus	CT22	EXP034800	5	unspecified	Q8BSQ9	liver	PEAKS037976
EXP034804	REV-ERB? (Cell signaling 2124)	Mus musculus		EXP034800	5	unspecified	Q3UV55	liver	PEAKS037977
EXP034805	REV-ERB? (Cell signaling 2124)	Mus musculus	src-2 -/-	EXP034800	5	unspecified	Q3UV55	liver	PEAKS037978
EXP034814	NRF1 (Abcam, ab55744)	Mus musculus	adaptation to 2i (> 3 weeks)	EXP034806	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS037979
EXP034815	NRF1 (Abcam, ab55744)	Mus musculus	adaptation from 2i back to serum (3 weeks)	EXP034807	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS037980
EXP034816	NRF1 (Abcam, ab55744)	Mus musculus	serum, NRF1 overexpression	EXP034808	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS037981
EXP034817	NRF1 (Abcam, ab55744)	Mus musculus	serum	EXP034809	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS037982
EXP034818	NRF1 (Abcam, ab55744)	Mus musculus	serum, DNMT TKO	EXP034810	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS037983
EXP034819	NRF1 (Abcam, ab55744)	Mus musculus		EXP034813	138	unspecified	Q9WU00	neural progenitors	PEAKS037984
EXP034820	NRF1 (Abcam, ab55744)	Homo sapiens		EXP034811	440	unspecified	Q16656	HMEC (human mammary epithelial cells)	PEAKS037985
EXP034821	NRF1 (Abcam, ab55744)	Homo sapiens		EXP034812	410	unspecified	Q16656	HCC1954 (ductal breast carcinoma)	PEAKS037986
EXP034824	Rev-erbalpha	Mus musculus		EXP034823	110	unspecified	Q3UV55	brain (ventral tegmental area)	PEAKS037987
EXP034825	RORalpha	Mus musculus		NULL	5	unspecified	P51448	liver	PEAKS037988
EXP034826	RORgamma	Mus musculus	ZT10	NULL	5	unspecified	P51450	liver	PEAKS037989
EXP034827	RORgamma	Mus musculus	ZT22	NULL	5	unspecified	P51450	liver	PEAKS037990
EXP034828	Rev-erbalpha	Mus musculus		EXP034822	3	unspecified	Q3UV55	epididymal white adipose tissue	PEAKS037991
EXP034829	Rev-erbalpha	Mus musculus		NULL	5	unspecified	Q3UV55	liver	PEAKS037992
EXP034830	Rev-erbalpha	Mus musculus		NULL	5	unspecified	Q3UV55	liver	PEAKS037993
EXP034831	Rev-erbalpha	Mus musculus	DBD mutant	NULL	5	unspecified	Q3UV55	liver	PEAKS037994
EXP034836	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 3+4=7; Source: initial PSA 15.65	EXP034834	2538	normal	P10275	primary prostate cancer	PEAKS037995
EXP034837	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 3+4=7; Source: initial PSA 16.28	EXP034835	2538	normal	P10275	primary prostate cancer	PEAKS037996
EXP034838	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 4+5=9; Source: initial PSA 8.5	EXP034834	2538	normal	P10275	primary prostate cancer	PEAKS037997
EXP034839	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 5+5=10; Source: initial PSA 6.5	EXP034832	435	normal	P10275	prostate tumor	PEAKS037998
EXP034840	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 5+5=10; Source: initial PSA 511	EXP034832	435	normal	P10275	prostate tumor	PEAKS037999
EXP034841	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 5+5=10; Source: initial PSA 35	EXP034832	435	normal	P10275	prostate tumor	PEAKS038000
EXP034842	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 4+5=9; Source: initial PSA 38	EXP034835	2538	normal	P10275	primary prostate cancer	PEAKS038001
EXP034848	Bio-yy1	Mus musculus		EXP034843	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038002
EXP034849	Bio-yy1	Mus musculus	100 uM DRB under ES culture conditions for 30min	EXP034843	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038003
EXP034850	Bio-yy1	Mus musculus	1uM DMSO under ES culture conditions for 6hr	EXP034844	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038004
EXP034851	Bio-yy1	Mus musculus	1 uM ACTD treated 6 hrs	EXP034844	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038005
EXP034852	Bio-yy1	Mus musculus	1 uM DMSO for 6 hrs	EXP034845	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038006
EXP034853	Bio-yy1	Mus musculus	CDK7 inhibitor (10 uMTHZ1 for 6 hrs)	EXP034845	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038007
EXP034854	Bio-yy1	Mus musculus	1 uM Triptolide under ES culture condiction	EXP034845	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038008
EXP034855	Bio-YY1	Mus musculus	100 uM DRB under ES culture conditions for 30min	EXP034843	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038009
EXP034856	Bio-YY1	Mus musculus	shLuciferase	EXP034846	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038010
EXP034857	Bio-YY1	Mus musculus	shExosc3	EXP034847	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	PEAKS038011
EXP034859	E2F-1 Antibody (C-20)	Homo sapiens		EXP034858	794	unspecified	Q01094	SK-MEL-147 (melanoma)	PEAKS038012
EXP034862	Nanog, Abcam ab21624	Mus musculus		EXP034860	156	unspecified	Q80Z64	CD133(+) tumor inititating stem cells	PEAKS038013
EXP034863	Nanog, Abcam ab21624	Mus musculus		EXP034861	155	unspecified	Q80Z64	CD133(-) tumor inititating stem cells	PEAKS038014
EXP034866	sc-10657	Mus musculus		EXP034864	210	unspecified	P48379	decapsulated testis	PEAKS038015
EXP034867	sc-10657	Mus musculus		EXP034865	210	unspecified	P48379	decapsulated testis	PEAKS038016
EXP034869	Anti-Smad3 (ab28379)	Homo sapiens	BJ fibroblasts 5 days post induced viral expression of OSKM	EXP034868	93	unspecified	P84022	BJ (fibroblasts)	PEAKS038017
EXP034872	TEAD1	Homo sapiens		EXP034871	454	unspecified	P28347	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS038018
EXP034873	TEAD4	Homo sapiens		EXP034871	454	unspecified	Q15561	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS038019
EXP034876	anti-FOXO1 (Abcam, ab39670)	Homo sapiens		EXP034874	327	unspecified	Q12778	germinal center B-cells	PEAKS038020
EXP034877	anti-FOXO1 (Abcam, ab39670)	Homo sapiens		EXP034875	327	unspecified	Q12778	germinal center B-cells	PEAKS038021
EXP034878	anti-BCL6, N3 (Santa Cruz)	Homo sapiens		EXP034874	327	unspecified	P41182	germinal center B-cells	PEAKS038022
EXP034879	bcl6	Homo sapiens		EXP034875	327	unspecified	P41182	germinal center B-cells	PEAKS038023
EXP034880	sc-543	Homo sapiens	Vehicle	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038024
EXP034881	sc-543	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038025
EXP034882	sc-543	Homo sapiens	PG	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038026
EXP034883	sc-543	Homo sapiens	E2+PG	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038027
EXP034884	sc-543	Homo sapiens	Vehicle	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038028
EXP034885	sc-543	Homo sapiens	E2	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038029
EXP034886	sc-543	Homo sapiens	PG	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038030
EXP034887	sc-543	Homo sapiens	E2+PG	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038031
EXP034888	sc-7208	Homo sapiens	Vehicle	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038032
EXP034889	sc-7208	Homo sapiens	E2	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038033
EXP034890	sc-7208	Homo sapiens	PG	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038034
EXP034891	sc-7208	Homo sapiens	E2+PG	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038035
EXP034892	sc-7208	Homo sapiens	Vehicle	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038036
EXP034893	sc-7208	Homo sapiens	E2	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038037
EXP034894	sc-7208	Homo sapiens	PG	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038038
EXP034895	sc-7208	Homo sapiens	E2+PG	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038039
EXP034899	sc-543	Homo sapiens	Vehicle	EXP034896	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038040
EXP034900	sc-7208	Homo sapiens	Vehicle	EXP034896	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038041
EXP034901	sc-543	Homo sapiens	E2	EXP034897	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038042
EXP034902	sc-7208	Homo sapiens	E2	EXP034897	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038043
EXP034903	sc-543	Homo sapiens	E2+PG	EXP034898	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038044
EXP034904	progest	Homo sapiens	E2+PG	EXP034898	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038045
EXP034908	Klf4 (kind gift from Dr. Ng from the Genome Institute of Singapore)	Mus musculus	EGFP KD	EXP034905	230	unspecified	Q60793	ES-E14 (E14, embryonic stem cells)	PEAKS038046
EXP034909	Klf4 (kind gift from Dr. Ng from the Genome Institute of Singapore)	Mus musculus	MBD3 KO	EXP034906	230	unspecified	Q60793	ES-E14 (E14, embryonic stem cells)	PEAKS038047
EXP034910	Klf4 (kind gift from Dr. Ng from the Genome Institute of Singapore)	Mus musculus	Smarca4 KD	EXP034907	230	unspecified	Q60793	ES-E14 (E14, embryonic stem cells)	PEAKS038048
EXP034913	In house	Mus musculus	EtOH	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS038049
EXP034914	In house	Mus musculus	ATRA 2h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS038050
EXP034915	In house	Mus musculus	ATRA 6h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS038051
EXP034916	In house	Mus musculus	ATRA 24h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS038052
EXP034917	In house	Mus musculus	ATRA 48h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	PEAKS038053
EXP034918	In house	Mus musculus	EtOH	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	PEAKS038054
EXP034919	In house	Mus musculus	ATRA 2h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	PEAKS038055
EXP034920	In house	Mus musculus	ATRA 6h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	PEAKS038056
EXP034921	In house	Mus musculus	ATRA 24h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	PEAKS038057
EXP034922	In house	Mus musculus	ATRA 48h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	PEAKS038058
EXP034924	Sox9 (Millipore, AB5535)	Mus musculus		EXP034923	513	unspecified	Q04887	K14CreER SmoM2 (basal cell carcinoma)	PEAKS038059
EXP034927	PR Antibody (H-190)	Homo sapiens	R5020	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038060
EXP034928	ER? Antibody (HC-20)	Homo sapiens	Full_Media	EXP034925	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038061
EXP034929	ER? Antibody (HC-20)	Homo sapiens	Progesterone	EXP034925	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038062
EXP034930	ER? Antibody (HC-20)	Homo sapiens	R5020	EXP034925	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038063
EXP034931	PR Antibody (H-190)	Homo sapiens	Full_Media	EXP034925	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038064
EXP034932	PR Antibody (H-190)	Homo sapiens	Progesterone	EXP034925	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038065
EXP034933	PR Antibody (H-190)	Homo sapiens	R5020	EXP034925	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS038066
EXP034934	ER? Antibody (HC-20)	Homo sapiens	Full_Media	EXP034926	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038067
EXP034935	ER? Antibody (HC-20)	Homo sapiens	Progesterone	EXP034926	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038068
EXP034936	ER? Antibody (HC-20)	Homo sapiens	R5020	EXP034926	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038069
EXP034937	PR Antibody (H-190)	Homo sapiens	Full_Media	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038070
EXP034938	PR Antibody (H-190)	Homo sapiens	Progesterone	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038071
EXP034939	PR Antibody (H-190)	Homo sapiens	R5020	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	PEAKS038072
EXP034942	MLL (anti-rabbit antibody made by our lab)	Mus musculus	DMSO	EXP034940	614	unspecified	P55200	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS038073
EXP034943	MLL (anti-rabbit antibody made by our lab)	Mus musculus	MM-401	EXP034941	614	unspecified	P55200	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS038074
EXP034945	SATB2 antibody	Mus musculus		EXP034944	163	unspecified	Q8VI24	embryo cerebral cortex (day 15)	PEAKS038075
EXP034947	gata4	Mus musculus		EXP034946	507	unspecified	Q08369	jejunal epithelial cells	PEAKS038076
EXP034949	ISL1	Mus musculus		EXP034948	793	unspecified	P61372	sinoatrial node cells	PEAKS038077
EXP034954	CTCF	Homo sapiens		EXP034950	509	unspecified	P49711	Jurkat (T-cells)	PEAKS038078
EXP034955	RUNX1	Homo sapiens		EXP034951	509	unspecified	Q01196	Jurkat (T-cells)	PEAKS038079
EXP034956	GATA3	Homo sapiens		EXP034951	509	unspecified	P23771	Jurkat (T-cells)	PEAKS038080
EXP034957	CTCF	Homo sapiens	mutated	EXP034953	10	unspecified	P49711	HEK293T (embryonic kidney)	PEAKS038081
EXP034958	CTCF	Homo sapiens		EXP034952	10	unspecified	P49711	HEK293T (embryonic kidney)	PEAKS038082
EXP034960	anti-FOXP1	Homo sapiens		NULL	685	unspecified	Q9H334	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS038083
EXP034961	anti-FOXP1	Homo sapiens		NULL	686	unspecified	Q9H334	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS038084
EXP034962	anti-FOXP1	Homo sapiens		NULL	687	unspecified	Q9H334	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS038085
EXP034963	anti-FOXP1	Homo sapiens		EXP034959	683	unspecified	Q9H334	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS038086
EXP034964	anti-FOXP1	Homo sapiens		NULL	747	unspecified	Q9H334	memory B-cells	PEAKS038087
EXP034967	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034966	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038088
EXP034968	C/EBPb, sc-150, Santa Cruz	Homo sapiens	DMI for 6 hrs	EXP034966	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038089
EXP034969	CEBPb, sc-150, Santa Cruz	Homo sapiens	DMI for 6 hrs	EXP034966	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038090
EXP034970	GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Homo sapiens	DMI for 6 hrs	EXP034966	892	unspecified	P04150	MSC (mesenchymal stem cells)	PEAKS038091
EXP034971	ATF4, sc-200, Santa Cruz	Homo sapiens	none	EXP034966	892	unspecified	P18848	MSC (mesenchymal stem cells)	PEAKS038092
EXP034972	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038093
EXP034973	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038094
EXP034974	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038095
EXP034975	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	PEAKS038096
EXP034976	ATF4, sc-200, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P18848	MSC (mesenchymal stem cells)	PEAKS038097
EXP034977	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	273	unspecified	P28033	embryonic stem cell-derived hemangioblasts	PEAKS038098
EXP034978	Gata2 Santa Cruz sc267	Mus musculus	none	NULL	273	unspecified	O09100	embryonic stem cell-derived hemangioblasts	PEAKS038099
EXP034979	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	273	unspecified	P22091	embryonic stem cell-derived hemangioblasts	PEAKS038100
EXP034980	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	275	unspecified	P28033	embryonic stem cell-derived hemogenic endothelium	PEAKS038101
EXP034981	Fli1 Santa Cruz sc356	Mus musculus	none	NULL	275	unspecified	P26323	embryonic stem cell-derived hemogenic endothelium	PEAKS038102
EXP034982	Meis1 Santa Cruz sc10599	Mus musculus	none	NULL	275	unspecified	Q60954	embryonic stem cell-derived hemogenic endothelium	PEAKS038103
EXP034983	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	275	unspecified	P22091	embryonic stem cell-derived hemogenic endothelium	PEAKS038104
EXP034984	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	274	unspecified	P28033	embryonic stem cell-derived hematopoietic progenitors	PEAKS038105
EXP034985	Fli1 Santa Cruz sc356	Mus musculus	none	NULL	274	unspecified	P26323	embryonic stem cell-derived hematopoietic progenitors	PEAKS038106
EXP034986	Gata1 AbCam ab11963	Mus musculus	none	NULL	274	unspecified	P17679	embryonic stem cell-derived hematopoietic progenitors	PEAKS038107
EXP034987	Gata2 Santa Cruz sc267	Mus musculus	none	NULL	274	unspecified	O09100	embryonic stem cell-derived hematopoietic progenitors	PEAKS038108
EXP034988	Gfi1 AbCam ab21061	Mus musculus	none	NULL	274	unspecified	P70338	embryonic stem cell-derived hematopoietic progenitors	PEAKS038109
EXP034989	Gfi1b Santa Cruz sc8559	Mus musculus	none	NULL	274	unspecified	O70237	embryonic stem cell-derived hematopoietic progenitors	PEAKS038110
EXP034990	Runx1 AbCam ab23980	Mus musculus	none	NULL	274	unspecified	Q03347	embryonic stem cell-derived hematopoietic progenitors	PEAKS038111
EXP034991	Spi1 Santa Cruz sc352	Mus musculus	none	NULL	274	unspecified	P17433	embryonic stem cell-derived hematopoietic progenitors	PEAKS038112
EXP034992	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	274	unspecified	P22091	embryonic stem cell-derived hematopoietic progenitors	PEAKS038113
EXP034993	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	276	unspecified	P28033	embryonic stem cell-derived macrophages	PEAKS038114
EXP034994	Fli1 Santa Cruz sc356	Mus musculus	none	NULL	276	unspecified	P26323	embryonic stem cell-derived macrophages	PEAKS038115
EXP034995	Runx1 AbCam ab23980	Mus musculus	none	NULL	276	unspecified	Q03347	embryonic stem cell-derived macrophages	PEAKS038116
EXP034996	Spi1 Santa Cruz sc352	Mus musculus	none	NULL	276	unspecified	P17433	embryonic stem cell-derived macrophages	PEAKS038117
EXP034997	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	276	unspecified	P22091	embryonic stem cell-derived macrophages	PEAKS038118
EXP034998	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	277	unspecified	P28033	embryonic stem cell-derived mesoderm	PEAKS038119
EXP034999	Elk4 Santa Cruz sc13030	Mus musculus	none	NULL	277	unspecified	P41158	embryonic stem cell-derived mesoderm	PEAKS038120
EXP035000	Pou5F1 Santa Cruz sc8628	Mus musculus	none	NULL	277	unspecified	P20263	embryonic stem cell-derived mesoderm	PEAKS038121
EXP035001	Tead-4 (Abcam ab58310)	Mus musculus	none	NULL	273	unspecified	Q62296	embryonic stem cell-derived hemangioblasts	PEAKS038122
EXP035003	BMAL1 bethyl A302-616A	Homo sapiens		EXP035002	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS038123
EXP035004	HIF1A active motif (cat # 39665).	Homo sapiens		EXP035002	848	unspecified	Q16665	U2OS (osteosarcoma)	PEAKS038124
EXP035007	Sox9	Mus musculus	none	EXP035005	707	unspecified	Q04887	rib chondrocytes	PEAKS038125
EXP035009	Sox9	Mus musculus	none	EXP035006	235	unspecified	Q04887	E17.5 embryonic nasal chondrocytes	PEAKS038127
EXP035012	RARa (C-20), Santa Cruz,Cat No. Sc551	Homo sapiens	untreated	EXP035010	665	unspecified	P10276	SK-N-SH (neuroblastoma)	PEAKS038128
EXP035013	RARa (C-20), Santa Cruz,Cat No. Sc551	Homo sapiens	RA treated	EXP035011	665	unspecified	P10276	SK-N-SH (neuroblastoma)	PEAKS038129
EXP035016	anti-Pou5f1, Santa Cruz, Cat# sc-8629	Mus musculus	antisense oligonucleotide	EXP035014	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS038130
EXP035017	anti-Baf155	Mus musculus	antisense oligonucleotide	EXP035014	2	unspecified	P97496	mESCs (mouse embryonic stem cells)	PEAKS038131
EXP035018	anti-Pou5f1, Santa Cruz, Cat# sc-8629	Mus musculus	7SK antisense oligonucleotide	EXP035015	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	PEAKS038132
EXP035019	anti-Baf155, Gift from Crabtree Lab	Mus musculus	7SK antisense oligonucleotide	EXP035015	2	unspecified	P97496	mESCs (mouse embryonic stem cells)	PEAKS038133
EXP035023	anti-VDR (Santa Cruz Biotechnology; sc-1008)	Mus musculus	vehicle control	EXP035022	225	unspecified	P48281	duodenum and jejunum	PEAKS038136
EXP035024	anti-VDR (Santa Cruz Biotechnology; sc-1008)	Mus musculus	1,25(OH)2D3 (10 ng/g bw)	EXP035022	225	unspecified	P48281	duodenum and jejunum	PEAKS038137
EXP035029	anti-Ebf1	Mus musculus	none	EXP035025	105	unspecified	Q07802	pro-B cells	PEAKS038138
EXP035030	anti-Ebf1	Mus musculus	none	EXP035026	105	unspecified	Q07802	pro-B cells	PEAKS038139
EXP035031	anti-Ebf1	Mus musculus	none	EXP035027	105	unspecified	Q07802	pro-B cells	PEAKS038140
EXP035032	anti-Ebf1	Mus musculus	none	EXP035028	105	unspecified	Q07802	pro-B cells	PEAKS038141
EXP035034	ATF4 (Santa Cruz Biotechnology sc-200, Lot No. C0513)	Homo sapiens	2 mM histidinol, 24 hours	EXP035033	1507	unspecified	P18848	HAP1 (chronic myelogenous leukemia)	PEAKS038142
EXP035035	ATF4 (Cell Signaling Technology, D4B8, Cat. No. 11815, Lot No. 2)	Homo sapiens	2 mM histidinol, 24 hours	EXP035033	1507	unspecified	P18848	HAP1 (chronic myelogenous leukemia)	PEAKS038143
EXP035036	ATF4 (Millipore, ABE387)	Homo sapiens	2 mM histidinol, 24 hours	EXP035033	1507	unspecified	P18848	HAP1 (chronic myelogenous leukemia)	PEAKS038144
EXP035041	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	ChIP for FLAG-tagged Gata6 in embryonic stem cell line1 36h following Gata6 induction	EXP035037	2	unspecified	Q61169	mESCs (mouse embryonic stem cells)	PEAKS038145
EXP035042	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	ChIP for FLAG-tagged Gata6 in embryonic stem cell line2 36h following Gata6 induction	EXP035038	2	unspecified	Q61169	mESCs (mouse embryonic stem cells)	PEAKS038146
EXP035043	anti-Gata-6 (R&D, catalog number AF1700)	Mus musculus		EXP035039	291	unspecified	Q61169	endodermal stem cells	PEAKS038147
EXP035044	Gata6 (R&D, catalog number AF1700)	Mus musculus		EXP035040	291	unspecified	Q61169	endodermal stem cells	PEAKS038148
EXP035046	TEAD1	Homo sapiens		EXP035045	637	unspecified	P28347	MSTO-211H (pleural mesothelioma)	PEAKS038149
EXP035047	Santa Cruz Cat#: H-86x	Homo sapiens		NULL	766	unspecified	P22415	R3/R4 erythroid cells	PEAKS038150
EXP035048	Santa Cruz Cat#: C-20x	Homo sapiens		NULL	766	unspecified	Q15853	R3/R4 erythroid cells	PEAKS038151
EXP035052	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Homo sapiens		NULL	374	unspecified	P50553	NCI-H128 (small cell lung carcinoma)	PEAKS038152
EXP035053	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Homo sapiens		NULL	383	unspecified	P50553	NCI-H2107 (small cell lung carcinoma)	PEAKS038153
EXP035054	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Homo sapiens		EXP035050	393	unspecified	P50553	NCI-H889 (small cell lung carcinoma)	PEAKS038154
EXP035055	goat anti-NEUROD1 (Santa Cruz, N-19)	Homo sapiens		NULL	392	unspecified	Q13562	NCI-H82 (small cell lung carcinoma)	PEAKS038155
EXP035056	goat anti-NEUROD1 (Santa Cruz, N-19)	Homo sapiens		EXP035049	390	unspecified	Q13562	NCI-H524 (small cell lung carcinoma)	PEAKS038156
EXP035057	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Mus musculus		EXP035051	666	unspecified	Q02067	neuroendocrine lung tumor	PEAKS038157
EXP035060	SOX2 (R&D 2018)	Homo sapiens		EXP035058	878	unspecified	P48431	embryonic stem cells	PEAKS038158
EXP035061	SOX2 (R&D 2018)	Homo sapiens		EXP035059	395	unspecified	P48431	H9-derived neural progenitors	PEAKS038159
EXP035063	Flag M2 Antibody Sigma	Mus musculus		EXP035062	484	unspecified	Q9ER42	E13.5 stomach mesenchymal cells	PEAKS038160
EXP035065	H-190/sc-7208	Homo sapiens		EXP035064	256	unspecified	P06401	endometrial stromal cells	PEAKS038161
EXP035066	Q-20/sc-604	Homo sapiens		EXP035064	256	unspecified	P15408	endometrial stromal cells	PEAKS038162
EXP035068	H-128/sc-11350	Homo sapiens		EXP035067	256	unspecified	Q12778	endometrial stromal cells	PEAKS038163
EXP035070	Millipore, cat # 07-618	Mus musculus		EXP035069	132	unspecified	P33242	uterus	PEAKS038164
EXP035076	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035071	209	unspecified	Q02080	DB (diffuse large B-cell lymphoma)	PEAKS038165
EXP035077	MEF2B_HPA004734 (Atlas, catalog# HPA004734, lot# R57933)	Homo sapiens		EXP035071	209	unspecified	Q02080	DB (diffuse large B-cell lymphoma)	PEAKS038166
EXP035078	Bach2 (ARP39513, AVIVA)	Homo sapiens		EXP035072	221	unspecified	Q9BYV9	DOHH2 (diffuse large B-cell lymphoma)	PEAKS038167
EXP035079	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035072	221	unspecified	Q02080	DOHH2 (diffuse large B-cell lymphoma)	PEAKS038168
EXP035080	PAX5 (Santa Cruz, catalog# sc-1975x, lot# I1511)	Homo sapiens		EXP035072	221	unspecified	Q02548	DOHH2 (diffuse large B-cell lymphoma)	PEAKS038169
EXP035081	Pu.1 (Santa Cruz, catalog# sc-22805, lot# D0609)	Homo sapiens		EXP035072	221	unspecified	P17947	DOHH2 (diffuse large B-cell lymphoma)	PEAKS038170
EXP035082	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035073	1138	unspecified	Q02080	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS038171
EXP035083	Bach2 (ARP39513, AVIVA)	Homo sapiens		EXP035074	687	unspecified	Q9BYV9	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS038172
EXP035084	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035074	687	unspecified	Q02080	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS038173
EXP035085	PAX5 (Santa Cruz, catalog# sc-1975x, lot# I1511)	Homo sapiens		EXP035074	687	unspecified	Q02548	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS038174
EXP035086	Pu.1 (Santa Cruz, catalog# sc-22805, lot# D0609)	Homo sapiens		EXP035074	687	unspecified	P17947	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS038175
EXP035087	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035075	815	unspecified	Q02080	SU-DHL-4 (diffuse large B-cell lymphoma)	PEAKS038176
EXP035088	MEF2B_HPA004734 (Atlas, catalog# HPA004734, lot# R57933)	Homo sapiens		EXP035075	815	unspecified	Q02080	SU-DHL-4 (diffuse large B-cell lymphoma)	PEAKS038177
EXP035090	Santa Cruz -  sc-32761X	Homo sapiens		EXP035089	430	unspecified	O14497	HepG2 (hepatoblastoma)	PEAKS038178
EXP035091	Santa Cruz - sc-32762X	Homo sapiens		EXP035089	430	unspecified	Q8NFD5	HepG2 (hepatoblastoma)	PEAKS038179
EXP035092	Bethyl - A302-230A	Homo sapiens		EXP035089	430	unspecified	Q68CP9	HepG2 (hepatoblastoma)	PEAKS038180
EXP035095	FLAG M2 (Sigma F1805)	Mus musculus	O-GlcNAc-deficient SOX2, long fragments	EXP035094	13	unspecified	P48432	2TS22C (embryonic stem cells)	PEAKS038181
EXP035096	FLAG M2 (Sigma F1805)	Mus musculus	O-GlcNAc-deficient SOX2, short fragments	EXP035094	13	unspecified	P48432	2TS22C (embryonic stem cells)	PEAKS038182
EXP035097	FLAG M2 (Sigma F1805)	Mus musculus	long fragments	EXP035093	13	unspecified	P48432	2TS22C (embryonic stem cells)	PEAKS038183
EXP035098	FLAG M2 (Sigma F1805)	Mus musculus	short fragments	EXP035093	13	unspecified	P48432	2TS22C (embryonic stem cells)	PEAKS038184
EXP035101	Millipore 07-729	Homo sapiens		EXP035099	878	unspecified	P49711	embryonic stem cells	PEAKS038185
EXP035102	sc8628	Homo sapiens		EXP035099	878	unspecified	Q01860	embryonic stem cells	PEAKS038186
EXP035103	Upstate/Millipore 07-729	Homo sapiens		EXP035100	878	unspecified	P49711	embryonic stem cells	PEAKS038187
EXP035104	sc8628	Homo sapiens		EXP035100	878	unspecified	Q01860	embryonic stem cells	PEAKS038188
EXP035105	anti-Tip60	Mus musculus		NULL	2	unspecified	Q8CHK4	mESCs (mouse embryonic stem cells)	PEAKS038189
EXP035106	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 3	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038190
EXP035107	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 4	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038191
EXP035108	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 11	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038192
EXP035109	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 12	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038193
EXP035110	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 5	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038194
EXP035111	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 9	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038195
EXP035112	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Male 1	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038196
EXP035113	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Male 2	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038197
EXP035114	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Male 3	NULL	593	unspecified	P08154	medial prefrontal cortex	PEAKS038198
EXP035116	sc-354x	Mus musculus		EXP035115	23	unspecified	P81270	416B (hematopoietic precursor cells)	PEAKS038199
EXP035117	ab15289-500	Mus musculus		EXP035115	23	unspecified	P26323	416B (hematopoietic precursor cells)	PEAKS038200
EXP035118	sc-9008x	Mus musculus		EXP035115	23	unspecified	O09100	416B (hematopoietic precursor cells)	PEAKS038201
EXP035119	sc-8559x	Mus musculus		EXP035115	23	unspecified	O70237	416B (hematopoietic precursor cells)	PEAKS038202
EXP035120	ab30334-200	Mus musculus		EXP035115	23	unspecified	P27792	416B (hematopoietic precursor cells)	PEAKS038203
EXP035121	sc-10599x	Mus musculus		EXP035115	23	unspecified	Q60954	416B (hematopoietic precursor cells)	PEAKS038204
EXP035122	sc-352x	Mus musculus		EXP035115	23	unspecified	P17433	416B (hematopoietic precursor cells)	PEAKS038205
EXP035123	ab23890	Mus musculus		EXP035115	23	unspecified	Q03347	416B (hematopoietic precursor cells)	PEAKS038206
EXP035124	sc-12984x	Mus musculus		EXP035115	23	unspecified	P22091	416B (hematopoietic precursor cells)	PEAKS038207
EXP035126	Pou3f1 antibody (Santa Cruz, sc-11661, Lot# C2012)	Mus musculus		EXP035125	2	unspecified	P21952	mESCs (mouse embryonic stem cells)	PEAKS038208
EXP035127	CTCF	Mus musculus		NULL	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS038209
EXP035128	CTCF1	Mus musculus	AKT1 KO	NULL	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS038210
EXP035130	anti-FLAG (Sigma F3165)	Mus musculus		EXP035129	528	unspecified	Q8BW74	Lin-Sca-1+ c-Kit+ hematopietic multipotent stem cells	PEAKS038211
EXP035134	Sox-2 Antibody (Y-17); goat polyclonal	Mus musculus		EXP035131	2775	unspecified	P48432	neural stem cells	PEAKS038212
EXP035135	rabbit polyclonals	Mus musculus		EXP035132	2775	unspecified	P21952	neural stem cells	PEAKS038213
EXP035136	rabbit polyclonals	Mus musculus		EXP035132	2775	unspecified	P31361	neural stem cells	PEAKS038214
EXP035137	Brn-2 Antibody (C-20); goat polyclonal	Mus musculus		EXP035133	2775	unspecified	P31360	neural stem cells	PEAKS038215
EXP035138	in-house GR antibody	Mus musculus		NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	PEAKS038216
EXP035139	in-house GR antibody	Mus musculus	dexametasone	NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	PEAKS038217
EXP035140	in-house GR antibody	Mus musculus	Klf15 -/-	NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	PEAKS038218
EXP035141	in-house GR antibody	Mus musculus	dexametasone, Klf15 -/-	NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	PEAKS038219
EXP035143	SOX10 (sc-17342X; Santa Cruz Biotechnology)	Mus musculus		EXP035142	913	unspecified	Q04888	melanocytes	PEAKS038220
EXP035145	HA	Homo sapiens		EXP035144	440	unspecified	P01106	HMEC (human mammary epithelial cells)	PEAKS038221
EXP035146	HA	Homo sapiens		EXP035144	440	unspecified	P01106	HMEC (human mammary epithelial cells)	PEAKS038222
EXP035149	SOX9 (AB5535, Millipore)	Rattus norvegicus		EXP035147	769	unspecified	F1LYL9	chondrosarcoma	PEAKS038223
EXP035150	SOX6 (ab30455, Abcam)	Rattus norvegicus		EXP035148	769	unspecified	Q4V8G3	chondrosarcoma	PEAKS038224
EXP035152	rabbit antiserum against AR	Homo sapiens	10 nM R1881 for 2hrs, siPIAS1	EXP035151	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	PEAKS038225
EXP035153	rabbit antiserum against AR	Homo sapiens	10 nM R1881 for 2hrs	EXP035151	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	PEAKS038226
EXP035155	Gfi1 antibody http://www.ncbi.nlm.nih.gov/pubmed/24141388	Mus musculus		EXP035154	373	unspecified	P70338	granulocyte macrophage progenitors	PEAKS038227
EXP035156	Irf8 antibody Santa Cruz sc-6058	Mus musculus		EXP035154	373	unspecified	P23611	granulocyte macrophage progenitors	PEAKS038228
EXP035158	bcl3	Mus musculus		EXP035157	176	unspecified	Q9Z2F6	CGR8 (embryonic stem cells)	PEAKS038229
EXP035160	anti-HA	Mus musculus		EXP035159	95	unspecified	P70390	E12.5 embryonic heart	PEAKS038230
EXP035161	SC-8697	Mus musculus		EXP035159	95	unspecified	P42582	E12.5 embryonic heart	PEAKS038231
EXP035165	Antibody Mix: MC20 (SantaCruz) + ab10 (TE111-SD1) (Abcam)	Mus musculus	Placebo	EXP035162	5	unspecified	P19785	liver	PEAKS038232
EXP035166	Antibody Mix: MC20 (SantaCruz) + ab10 (TE111-SD1) (Abcam)	Mus musculus	E2	EXP035163	5	unspecified	P19785	liver	PEAKS038233
EXP035167	Antibody Mix: clone 3C10 (Millipore) + ab23630 (Abcam)	Mus musculus	E2	EXP035163	5	unspecified	P35583	liver	PEAKS038234
EXP035168	Antibody Mix: MC20 (SantaCruz) + ab10 (TE111-SD1) (Abcam)	Mus musculus	E2, ER KO	EXP035164	5	unspecified	P19785	liver	PEAKS038235
EXP035169	Antibody Mix: clone 3C10 (Millipore) + ab23630 (Abcam)	Mus musculus	E2, ER KO	NULL	5	unspecified	P35583	liver	PEAKS038236
EXP035170	anti-NR4A1 antibody, clone H1648 (Perseus Proteomics, catalog# PP-H1648-00, lot# A-1)	Mus musculus		NULL	44	unspecified	P12813	T-cells	PEAKS038237
EXP035172	STAT5A (Santa Cruz, sc-1081)	Mus musculus	Ezh2 KO	EXP035171	572	unspecified	P42230	mammary gland	PEAKS038238
EXP035173	STAT5A (Santa Cruz, sc-1081)	Mus musculus		EXP035171	572	unspecified	P42230	mammary gland	PEAKS038239
EXP035175	ctcf	Homo sapiens		EXP035174	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS038240
EXP035176	gata1	Homo sapiens		EXP035174	514	unspecified	P15976	K562 (myelogenous leukemia)	PEAKS038241
EXP035177	pu.1	Homo sapiens		EXP035174	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS038242
EXP035178	rest	Homo sapiens		EXP035174	514	unspecified	Q13127	K562 (myelogenous leukemia)	PEAKS038243
EXP035180	anti-HA (H3663, Sigma)	Mus musculus		EXP035179	303	unspecified	Q61060	FH-Foxd3 (embryonic stem cells)	PEAKS038244
EXP035181	anti-Flag (F3165, Sigma)	Mus musculus		EXP035179	303	unspecified	Q61060	FH-Foxd3 (embryonic stem cells)	PEAKS038245
EXP035184	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus		EXP035182	230	unspecified	P70340	ES-E14 (E14, embryonic stem cells)	PEAKS038246
EXP035185	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus	BMP-4	EXP035182	230	unspecified	P70340	ES-E14 (E14, embryonic stem cells)	PEAKS038247
EXP035186	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus	BMP4 for 1.5h	EXP035183	260	unspecified	P70340	epiblast stem cells	PEAKS038248
EXP035187	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus	BMP4 for 24h	EXP035183	260	unspecified	P70340	epiblast stem cells	PEAKS038249
EXP035190	ab11852	Homo sapiens		EXP035188	745	unspecified	P15976	fetal CD34+ hematopoietic stem progenitor cells	PEAKS038250
EXP035191	ab11852	Homo sapiens		EXP035189	741	unspecified	P15976	CD34+ hematopoietic stem progenitor cells	PEAKS038251
EXP035192	sc-12984	Homo sapiens		EXP035188	745	unspecified	P17542	fetal CD34+ hematopoietic stem progenitor cells	PEAKS038252
EXP035193	sc-12984	Homo sapiens		NULL	746	unspecified	P17542	fetal proerythroblasts	PEAKS038253
EXP035194	sc-12984	Homo sapiens		EXP035189	741	unspecified	P17542	CD34+ hematopoietic stem progenitor cells	PEAKS038254
EXP035195	sc-291	Homo sapiens		EXP035188	745	unspecified	Q16621	fetal CD34+ hematopoietic stem progenitor cells	PEAKS038255
EXP035196	sc-291	Homo sapiens		NULL	746	unspecified	Q16621	fetal proerythroblasts	PEAKS038256
EXP035197	sc-291	Homo sapiens		EXP035189	741	unspecified	Q16621	CD34+ hematopoietic stem progenitor cells	PEAKS038257
EXP035198	ab55331	Homo sapiens		EXP035189	741	unspecified	P14316	CD34+ hematopoietic stem progenitor cells	PEAKS038258
EXP035199	sc-22805	Homo sapiens		EXP035188	745	unspecified	P17947	fetal CD34+ hematopoietic stem progenitor cells	PEAKS038259
EXP035200	sc-22805	Homo sapiens		EXP035189	741	unspecified	P17947	CD34+ hematopoietic stem progenitor cells	PEAKS038260
EXP035201	ab23980	Homo sapiens		EXP035188	745	unspecified	Q01196	fetal CD34+ hematopoietic stem progenitor cells	PEAKS038261
EXP035202	ab23980	Homo sapiens		EXP035189	741	unspecified	Q01196	CD34+ hematopoietic stem progenitor cells	PEAKS038262
EXP035203	ab22849	Homo sapiens		NULL	743	unspecified	P23769	proerythroblasts	PEAKS038263
EXP035204	TBP (ab28175, Abcam)	Mus musculus		NULL	2	unspecified	P29037	mESCs (mouse embryonic stem cells)	PEAKS038264
EXP035205	TBP (ab28175, Abcam)	Mus musculus	TAF4 KO	NULL	2	unspecified	P29037	mESCs (mouse embryonic stem cells)	PEAKS038265
EXP035206	TBP (ab28175, Abcam)	Mus musculus		NULL	237	unspecified	P29037	embryoid body	PEAKS038266
EXP035207	TBP (ab28175, Abcam)	Mus musculus	TAF4 KO	NULL	237	unspecified	P29037	embryoid body	PEAKS038267
EXP035210		Homo sapiens		EXP035208	224	unspecified	P10275	DUCaP (prostate carcinoma)	PEAKS038268
EXP035211		Homo sapiens	androgen	EXP035209	224	unspecified	P10275	DUCaP (prostate carcinoma)	PEAKS038269
EXP035220	anti-Bmal1 (Abcam, ab93806, lot GR8441-9, 1mg/ml)	Homo sapiens		EXP035219	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	PEAKS038270
EXP035221	anti-Bmal1 (Abcam, ab93806, lot GR8441-9, 1mg/ml)	Homo sapiens		EXP035213	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	PEAKS038271
EXP035222	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035213	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	PEAKS038272
EXP035223	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035213	677	unspecified	O15516	NOMO-1 (acute monocytic leukemia)	PEAKS038273
EXP035224	hoxa9	Homo sapiens		EXP035215	677	unspecified	P31269	NOMO-1 (acute monocytic leukemia)	PEAKS038274
EXP035225	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035216	2334	unspecified	O00327	THP-1 (acute monocytic leukemia)	PEAKS038275
EXP035226	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035216	2334	unspecified	O15516	THP-1 (acute monocytic leukemia)	PEAKS038276
EXP035227	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035217	2334	unspecified	O00327	THP-1 (acute monocytic leukemia)	PEAKS038277
EXP035228	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035217	2334	unspecified	O15516	THP-1 (acute monocytic leukemia)	PEAKS038278
EXP035229	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035219	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	PEAKS038279
EXP035230	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035219	677	unspecified	O15516	NOMO-1 (acute monocytic leukemia)	PEAKS038280
EXP035231	STAT5	Mus musculus	TPO	NULL	445	unspecified	P42230	HPC7 (haematopoietic multipotent progenitors)	PEAKS038281
EXP035232	STAT5	Mus musculus		NULL	445	unspecified	P42230	HPC7 (haematopoietic multipotent progenitors)	PEAKS038282
EXP035233	anti-IRF4 (Santa Curz, M-17)	Mus musculus	culture time 72h	NULL	41	unspecified	Q64287	B-cells	PEAKS038283
EXP035234	anti-IRF4 (Santa Curz, M-17)	Mus musculus	culture time 48h	NULL	41	unspecified	Q64287	B-cells	PEAKS038284
EXP035235	anti-IRF8 (Santa Cruz, C-19)	Mus musculus	culture time 72h	NULL	41	unspecified	P23611	B-cells	PEAKS038285
EXP035236	anti-IRF8 (Santa Cruz, C-19)	Mus musculus	culture time 48h	NULL	41	unspecified	P23611	B-cells	PEAKS038286
EXP035237	anti-IRF8 (Santa Cruz, C-19)	Mus musculus		NULL	41	unspecified	P23611	B-cells	PEAKS038287
EXP035238	C/EBPa, sc-61, Santa Cruz	Mus musculus		NULL	5	unspecified	P53566	liver	PEAKS038288
EXP035239	C/EBPa, sc-61, Santa Cruz	Mus musculus	Trib1_LSKO	NULL	5	unspecified	P53566	liver	PEAKS038289
EXP035240	C/EBPa, sc-61, Santa Cruz	Mus musculus	AAV_Null	NULL	5	unspecified	P53566	liver	PEAKS038290
EXP035241	C/EBPa, sc-61, Santa Cruz	Mus musculus	AAV_Cebpa	NULL	5	unspecified	P53566	liver	PEAKS038291
EXP035243	anti-NR2F1 (Perseus Proteomics, catalog# PP-H8132-00, lot# A-2)	Homo sapiens		EXP035242	194	unspecified	P10589	cranial neural crest cells	PEAKS038292
EXP035244	anti-TFAP2A (Santa Cruz Biotechnology, catalog# sc-184, lot# H0911)	Homo sapiens		EXP035242	194	unspecified	P05549	cranial neural crest cells	PEAKS038293
EXP035251	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		EXP035245	514	unspecified	P49711	K562 (myelogenous leukemia)	PEAKS038294
EXP035252	boris	Homo sapiens		EXP035245	514	unspecified	Q8NI51	K562 (myelogenous leukemia)	PEAKS038295
EXP035253	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		EXP035246	211	unspecified	P49711	Delta47 (plasma cell myeloma)	PEAKS038296
EXP035254	custom mouse monoclonal BORIS  (characterized in PMID: 21659515)	Homo sapiens		EXP035246	211	unspecified	Q8NI51	Delta47 (plasma cell myeloma)	PEAKS038297
EXP035255	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		EXP035247	701	unspecified	P49711	OVCAR8 (high grade ovarian serous adenocarcinoma)	PEAKS038298
EXP035256	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens		EXP035247	701	unspecified	Q8NI51	OVCAR8 (high grade ovarian serous adenocarcinoma)	PEAKS038299
EXP035257	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		NULL	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS038300
EXP035258	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens	Clone1, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS038301
EXP035259	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens	Clone2, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS038302
EXP035260	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens	Clone1, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	Q8NI51	MCF7 (Invasive ductal breast carcinoma)	PEAKS038303
EXP035261	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens	Clone2, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	Q8NI51	MCF7 (Invasive ductal breast carcinoma)	PEAKS038304
EXP035262	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens		EXP035249	672	unspecified	Q8NI51	normal dermal fibroblasts	PEAKS038305
EXP035263	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Mus musculus		EXP035250	636	unspecified	Q61164	round spermatids	PEAKS038306
EXP035264	custom rabbit polyclonal BORIS (characterized in PMID:20231363)	Mus musculus		EXP035250	636	unspecified	A2APF3	round spermatids	PEAKS038307
EXP035266	CDX2	Mus musculus		EXP035265	52	unspecified	P43241	intestinal stem cells	PEAKS038308
EXP035269	ATRX antibody (SC-15408)	Mus musculus		EXP035267	506	unspecified	Q61687	J1 (embryonic stem cells)	PEAKS038309
EXP035270	ATRX antibody (SC-15408)	Mus musculus		EXP035268	2	unspecified	Q61687	mESCs (mouse embryonic stem cells)	PEAKS038310
EXP035271	Santa Cruz M19 H1908	Mus musculus		NULL	1058	unspecified	P70338	CD4+ T-cells	PEAKS038311
EXP035272	Santa Cruz M19 H1908	Mus musculus	Gfi1 KO	NULL	1058	unspecified	P70338	CD4+ T-cells	PEAKS038312
EXP035275	ATRX (Santa Cruz, sc-15408 H300, 10ug)	Homo sapiens		EXP035273	514	unspecified	P46100	K562 (myelogenous leukemia)	PEAKS038313
EXP035276	ATRX (Abcam, ab97508, 10ug)	Homo sapiens		EXP035273	514	unspecified	P46100	K562 (myelogenous leukemia)	PEAKS038314
EXP035277	ATRX (Abcam, ab97508, 6ug)	Homo sapiens		EXP035274	534	unspecified	P46100	LAN6 (neuroblastoma)	PEAKS038315
EXP035281	Anti-Lhx1 (Santa Cruz sc-19341,goat IgG)	Mus musculus	clone1	EXP035278	705	unspecified	P63006	P19 (embryonic carcinoma)	PEAKS038316
EXP035282	Anti-Lhx1 (Santa Cruz sc-19341,goat IgG)	Mus musculus	clone 2	EXP035279	705	unspecified	P63006	P19 (embryonic carcinoma)	PEAKS038317
EXP035283	Anti-Lhx1 (Santa Cruz sc-19341,goat IgG)	Mus musculus	parental	EXP035280	705	unspecified	P63006	P19 (embryonic carcinoma)	PEAKS038318
EXP035286	bmal1	Mus musculus		EXP035285	88	unspecified	Q9WTL8	Beta-TC-6 (insulinoma)	PEAKS038319
EXP035287	clock	Mus musculus		EXP035285	88	unspecified	O08785	Beta-TC-6 (insulinoma)	PEAKS038320
EXP035288	pdx1	Mus musculus		EXP035284	88	unspecified	P52946	Beta-TC-6 (insulinoma)	PEAKS038321
EXP035291	Jarid2 (AbCam, ab48137)	Mus musculus		EXP035289	230	unspecified	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS038322
EXP035292	Jarid2 (AbCam, ab48137)	Mus musculus	shTip5	EXP035290	230	unspecified	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS038323
EXP035296	GRHL2	Homo sapiens		EXP035293	699	unspecified	Q6ISB3	OVCAR3 (high grade ovarian serous adenocarcinoma)	PEAKS038324
EXP035297	GRHL2	Homo sapiens		EXP035294	698	unspecified	Q6ISB3	OVCA429 (ovarian cystadenocarcinoma)	PEAKS038325
EXP035298	GRHL2	Homo sapiens		EXP035295	700	unspecified	Q6ISB3	PEO1 (ovarian cystadenocarcinoma)	PEAKS038326
EXP035299	anti-CTCF (Millipore #07-729)	Mus musculus		NULL	230	unspecified	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS038327
EXP035300	anti-CTCF (Millipore #07-729)	Mus musculus		NULL	232	unspecified	Q61164	E14-derived embryonic neural progenitor cells	PEAKS038328
EXP035302	p53	Mus musculus	mock	EXP035301	41	unspecified	P02340	B-cells	PEAKS038329
EXP035303	p53	Mus musculus	4h 7Gy	EXP035301	41	unspecified	P02340	B-cells	PEAKS038330
EXP035304	p53	Mus musculus	mock	NULL	678	unspecified	P02340	spleen non-B-cells	PEAKS038331
EXP035305	p53	Mus musculus	4h 7Gy	NULL	678	unspecified	P02340	spleen non-B-cells	PEAKS038332
EXP035306	p53	Mus musculus	4h 7Gy	NULL	917	unspecified	P02340	spleen	PEAKS038333
EXP035308	anti-GATA3 (L50-823)	Mus musculus		EXP035307	846	unspecified	P23772	ILC3 (type 3 Innate lympoid cells)	PEAKS038334
EXP035309	anti-GATA3 (L50-823)	Mus musculus		NULL	845	unspecified	P23772	ILC2 (type 2 Innate lympoid cells)	PEAKS038335
EXP035310	anti-GATA3 (L50-823)	Mus musculus		NULL	499	unspecified	P23772	Th2-cells	PEAKS038336
EXP035313	Gli2 (R&D Systems, AF3635)	Mus musculus		NULL	419	unspecified	Q0VGT2	head	PEAKS038337
EXP035314	Gli2 (R&D Systems, AF3635)	Mus musculus		EXP035311	546	unspecified	Q0VGT2	limb bud	PEAKS038338
EXP035315	Gli2 (R&D Systems, AF3635)	Mus musculus		NULL	837	unspecified	Q0VGT2	trunk	PEAKS038339
EXP035316	Gli2 (R&D Systems, AF3635)	Mus musculus		EXP035312	25	unspecified	Q0VGT2	cerebellum	PEAKS038340
EXP035321	R&D, AF3158	Mus musculus		EXP035317	41	unspecified	Q60793	B-cells	PEAKS038341
EXP035322	R&D, AF3158	Mus musculus	Cebpa18h	EXP035318	41	unspecified	Q60793	B-cells	PEAKS038342
EXP035323	R&D, AF3158	Mus musculus	Cebpa18h, OSKM1d	EXP035319	41	unspecified	Q60793	B-cells	PEAKS038343
EXP035324	R&D, AF3158	Mus musculus	Cebpa18h, OSKM2d	EXP035320	41	unspecified	Q60793	B-cells	PEAKS038344
EXP035325	Santa Cruz, SC-61	Mus musculus	Cebpa18h	EXP035318	41	unspecified	P53566	B-cells	PEAKS038345
EXP035326	Santa Cruz, SC-61	Mus musculus		EXP035317	41	unspecified	P53566	B-cells	PEAKS038346
EXP035327	sc-352, Santa Cruz	Mus musculus		EXP035317	41	unspecified	P17433	B-cells	PEAKS038347
EXP035328	sc-352, Santa Cruz	Mus musculus	Cebpa18h	EXP035318	41	unspecified	P17433	B-cells	PEAKS038348
EXP035331	Sc22840	Mus musculus		EXP035329	478	unspecified	P27889	IMCD3 inner medullary collecting duct)	PEAKS038349
EXP035332	Sc22840	Mus musculus		EXP035330	478	unspecified	P27889	IMCD3 inner medullary collecting duct)	PEAKS038350
EXP035333	PBX3 (Abcam ab109173, lot/batch number GR-46727-7)	Homo sapiens		NULL	801	unspecified	P40426	SMMC-7721 (hepatocellular carcinoma)	PEAKS038351
EXP035334	ER	Homo sapiens	EtOH	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038352
EXP035335	ER	Homo sapiens	EtOH, HOTAIR transgene	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038353
EXP035336	ER	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038354
EXP035337	ER	Homo sapiens	E2, HOTAIR transgene	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038355
EXP035340	Bethyl, A301-034A	Homo sapiens		EXP035338	875	unspecified	P41229	ZR-75-30 (invasive ductal carcinoma)	PEAKS038356
EXP035341	Bethyl, A301-034A	Homo sapiens	RACK7 KO	EXP035339	875	unspecified	P41229	ZR-75-30 (invasive ductal carcinoma)	PEAKS038357
EXP035342	anti-E2F1 (Santa Cruz, catalog# sc-193x, lot# B0615)	Mus musculus		NULL	12	unspecified	Q61501	MEF (mouse embryonic fibroblasts)	PEAKS038358
EXP035343	anti-E2F3 (Santa Cruz, catalog# sc-878x, lot# E1712)	Mus musculus	E2F3A overexpression	NULL	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	PEAKS038359
EXP035344	anti-E2F3 (Santa Cruz, catalog# sc-878x, lot# E1712)	Mus musculus	E2F3B overexpression	NULL	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	PEAKS038360
EXP035345	anti-E2F1 (Santa Cruz, catalog# sc-193x, lot# B0615)	Mus musculus	E2F1 KO	NULL	12	unspecified	Q61501	MEF (mouse embryonic fibroblasts)	PEAKS038361
EXP035346	anti-E2F3 (Santa Cruz, catalog# sc-878x, lot# E1712)	Mus musculus	E2F3 KO	NULL	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	PEAKS038362
EXP035348	Rabbit anti TBR1 (Abcam) antibody	Mus musculus		EXP035347	866	unspecified	Q64336	E15.5 embryonic cortex	PEAKS038363
EXP035353	GR (Novus, NB300-731; Cell Signaling, D8H2; Abcam ab3579)	Homo sapiens	none (no stimulation control)	EXP035349	779	unspecified	P04150	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS038364
EXP035354	PU.1 (Pierce, E.388.3; Cell Signaling, 2266; Santa Cruz Biotechnology, SC-352X)	Homo sapiens	none (no stimulation control)	EXP035350	779	unspecified	P17947	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS038365
EXP035355	GR (Novus, NB300-731; Cell Signaling, D8H2; Abcam ab3579)	Homo sapiens	10 nM dexamethasone for 1 hour	EXP035351	779	unspecified	P04150	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS038366
EXP035356	PU.1 (Pierce, E.388.3; Cell Signaling, 2266; Santa Cruz Biotechnology, SC-352X)	Homo sapiens	10 nM dexamethasone for 1 hour	EXP035352	779	unspecified	P17947	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS038367
EXP035359	POU5F1 (Santa Cruz, catalog# sc-5279)	Mus musculus		EXP035357	521	unspecified	P20263	KH2 (embryonic stem cells)	PEAKS038368
EXP035360	PRDM14 (Homemade)	Mus musculus		EXP035357	521	unspecified	E9Q3T6	KH2 (embryonic stem cells)	PEAKS038369
EXP035361	PRDM14 (Homemade)	Homo sapiens		EXP035358	245	unspecified	Q9GZV8	NCCIT (testicular embryonic carcinoma)	PEAKS038370
EXP035362	Streptavidin	Mus musculus		NULL	723	unspecified	P17433	plasmablasts	PEAKS038371
EXP035363	Irf4 Ab, SantaCruz SC6059X, lot: E0608	Mus musculus		NULL	41	unspecified	Q64287	B-cells	PEAKS038372
EXP035364	Irf4 Ab, SantaCruz SC6059X, lot: E0608	Mus musculus		NULL	723	unspecified	Q64287	plasmablasts	PEAKS038373
EXP035365	Irf4 Ab, SantaCruz SC6059X, lot: E0608	Mus musculus		NULL	740	unspecified	Q64287	preplasmablasts	PEAKS038374
EXP035366	Streptavidin	Mus musculus		NULL	723	unspecified	Q60636	plasmablasts	PEAKS038375
EXP035367	AR	Homo sapiens	siPSA-eRNA	NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS038376
EXP035368	AR	Homo sapiens		NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS038377
EXP035375	Cell Signaling (CS) #4356	Mus musculus		EXP035369	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038378
EXP035376	gift from Morimoto lab (MM)	Mus musculus		EXP035369	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038379
EXP035377	Cell Signaling (CS) #4356	Mus musculus	after 12 min heat shock	EXP035371	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038380
EXP035378	gift from Morimoto lab (MM)	Mus musculus	after 12 min heat shock	EXP035371	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038381
EXP035379	Cell Signaling (CS) #4356	Mus musculus	after 60 min heat shock	EXP035373	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038382
EXP035380	gift from Morimoto lab (MM)	Mus musculus	after 60 min heat shock	EXP035373	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038383
EXP035381	Cell Signaling (CS) #4356	Mus musculus	HSF1KO	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038384
EXP035382	gift from Morimoto lab (MM)	Mus musculus	HSF1KO	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038385
EXP035383	Cell Signaling (CS) #4356	Mus musculus	HSF1KO, after 12 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038386
EXP035384	gift from Morimoto lab (MM)	Mus musculus	HSF1KO, after 12 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038387
EXP035385	Cell Signaling (CS) #4356	Mus musculus	HSF1KO, after 60 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038388
EXP035386	gift from Morimoto lab (MM)	Mus musculus	HSF1KO, after 60 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	PEAKS038389
EXP035387	SRF (D71A9) from Cell Signaling (#5147)	Mus musculus		NULL	12	unspecified	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS038390
EXP035388	SRF (D71A9) from Cell Signaling (#5147)	Mus musculus	after 12 min heat shock	NULL	12	unspecified	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS038391
EXP035389	SRF (D71A9) from Cell Signaling (#5147)	Mus musculus	after 60 min heat shock	NULL	12	unspecified	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS038392
EXP035391	gata3	Homo sapiens		EXP035390	888	unspecified	P23771	thymus	PEAKS038393
EXP035392	KMT2D (Sigma, HPA035977)	Homo sapiens		NULL	719	unspecified	Q9UMN6	cutaneous melanoma	PEAKS038394
EXP035393	KMT2D (Sigma, HPA035977)	Homo sapiens	shKMT2D	NULL	719	unspecified	Q9UMN6	cutaneous melanoma	PEAKS038395
EXP035394	KMT2D (Sigma, HPA035977)	Homo sapiens	shLuc	NULL	719	unspecified	Q9UMN6	cutaneous melanoma	PEAKS038396
EXP035395	KMT2D (Sigma, HPA035977)	Homo sapiens	shLuc	NULL	719	unspecified	Q9UMN6	cutaneous melanoma	PEAKS038397
EXP035399	NANOG (RCAB0001P)	Mus musculus		EXP035396	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS038398
EXP035400	NANOG (RCAB0001P)	Mus musculus		EXP035397	206	unspecified	Q80Z64	epiblast-like cells	PEAKS038399
EXP035401	NANOG (RCAB0001P)	Mus musculus		EXP035398	206	unspecified	Q80Z64	epiblast-like cells	PEAKS038400
EXP035403	Tcf4 (C48H11) (Cell signaling, catalog# 2569S, lot# 2)	Mus musculus		EXP035402	799	unspecified	Q924A0	small intestine	PEAKS038401
EXP035406	c-Jun (H-79, Santa Cruz)	Homo sapiens		NULL	120	unspecified	P05412	BT-549 (breast invasive ductal carcinoma)	PEAKS038402
EXP035407	c-Jun (H-79, Santa Cruz)	Homo sapiens	TNFÎ± for 6 h	EXP035404	120	unspecified	P05412	BT-549 (breast invasive ductal carcinoma)	PEAKS038403
EXP035410	p63 antibody (Santa Cruz, H129)	Homo sapiens		EXP035408	2301	unspecified	Q9H3D4	MDA-MB-231 (breast adenocarcinoma)	PEAKS038404
EXP035411	p63 antibody (Santa Cruz, H129)	Homo sapiens		EXP035409	586	unspecified	Q9H3D4	MCFDCIS (breast cancer)	PEAKS038405
EXP035412	GATA3	Mus musculus		NULL	1058	unspecified	P23772	CD4+ T-cells	PEAKS038406
EXP035413	GATA3	Mus musculus	TGF-Î² +IL-4	NULL	1058	unspecified	P23772	CD4+ T-cells	PEAKS038407
EXP035415	ab137676	Mus musculus		EXP035414	527	unspecified	Q9Z0Z7	KSIC_c806 (pancreatic cancer)	PEAKS038408
EXP035416	Diagenode C1531012A	Mus musculus		EXP035414	527	unspecified	Q06831	KSIC_c806 (pancreatic cancer)	PEAKS038409
EXP035417	Cell Signaling #8685	Mus musculus	Smad4	EXP035414	527	unspecified	Q62432	KSIC_c806 (pancreatic cancer)	PEAKS038410
EXP035418	Cell Signaling #8685	Mus musculus		EXP035414	527	unspecified	Q62432	KSIC_c806 (pancreatic cancer)	PEAKS038411
EXP035419	GABPA, Santa Cruz Biotechnology, sc-28312	Homo sapiens	modified	NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	PEAKS038412
EXP035420	CREB1 Santa Cruz Biotechnology, sc-240	Homo sapiens	modified	NULL	430	unspecified	P16220	HepG2 (hepatoblastoma)	PEAKS038413
EXP035421	FLAG M2 Sigma F1804	Mus musculus		NULL	252	unspecified	Q00422	V6.5 (embryonic stem cells)	PEAKS038414
EXP035422	GABPA, Santa Cruz Biotechnology, sc-28312	Homo sapiens		NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	PEAKS038415
EXP035423	FLAG M2 Sigma F1804	Homo sapiens	modified	NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	PEAKS038416
EXP035424	CREB1	Homo sapiens		NULL	430	unspecified	P16220	HepG2 (hepatoblastoma)	PEAKS038417
EXP035425	FLAG M2 Sigma F1804	Homo sapiens		NULL	430	unspecified	P16220	HepG2 (hepatoblastoma)	PEAKS038418
EXP035426	FLAG M2 Sigma F1804	Homo sapiens		NULL	430	unspecified	P18846	HepG2 (hepatoblastoma)	PEAKS038419
EXP035438	Bcl6	Mus musculus		EXP035437	501	unspecified	P41183	T follicular helpers	PEAKS038427
EXP035434	GATA3 serum (Adomas et al, 2014)	Homo sapiens		EXP035427	2301	unspecified	P23771	MDA-MB-231 (breast adenocarcinoma)	PEAKS038424
EXP035435	GATA3 serum (Adomas et al, 2014)	Homo sapiens		EXP035428	2301	unspecified	P23771	MDA-MB-231 (breast adenocarcinoma)	PEAKS038425
EXP035436	GATA3	Homo sapiens		EXP035429	2301	unspecified	P23771	MDA-MB-231 (breast adenocarcinoma)	PEAKS038426
EXP035439	Bcl6	Mus musculus		NULL	500	unspecified	P41183	non-T follicular helpers	PEAKS038428
EXP035443	GR E-20X sc-1003 Santa Cruz	Homo sapiens		EXP035440	113	unspecified	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS038429
EXP035444	GR E-20X sc-1003 Santa Cruz	Homo sapiens	Dexamethasone	EXP035440	113	unspecified	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS038430
EXP035445	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens		EXP035440	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038431
EXP035446	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens	17Î²-estradiol	EXP035440	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038432
EXP035447	FoxA1 ab23738 Abcam	Homo sapiens		EXP035440	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS038433
EXP035448	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone	EXP035440	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS038434
EXP035449	FoxA1 ab23738 Abcam	Homo sapiens	17Î²-estradiol	EXP035440	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS038435
EXP035450	GR E-20X sc-1003 Santa Cruz	Homo sapiens		EXP035441	874	unspecified	P04150	ZR-75-1 (invasive ductal carcinoma)	PEAKS038436
EXP035451	GR E-20X sc-1003 Santa Cruz	Homo sapiens	Dexamethasone	EXP035441	874	unspecified	P04150	ZR-75-1 (invasive ductal carcinoma)	PEAKS038437
EXP035452	estrogen	Homo sapiens		EXP035441	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	PEAKS038438
EXP035453	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens	17Î²-estradiol	EXP035441	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	PEAKS038439
EXP035454	FoxA1 ab23738 Abcam	Homo sapiens		EXP035441	874	unspecified	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS038440
EXP035455	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone	EXP035441	874	unspecified	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS038441
EXP035456	FoxA1 ab23738 Abcam	Homo sapiens	17Î²-estradiol	EXP035441	874	unspecified	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS038442
EXP035457	GR E-20X sc-1003 Santa Cruz	Homo sapiens		EXP035442	111	unspecified	P04150	T47D (invasive ductal carcinoma)	PEAKS038443
EXP035458	GR E-20X sc-1003 Santa Cruz	Homo sapiens	Dexamethasone	EXP035442	111	unspecified	P04150	T47D (invasive ductal carcinoma)	PEAKS038444
EXP035459	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens		EXP035442	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038445
EXP035460	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens	17Î²-estradiol	EXP035442	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038446
EXP035461	FoxA1 ab23738 Abcam	Homo sapiens		EXP035442	111	unspecified	P55317	T47D (invasive ductal carcinoma)	PEAKS038447
EXP035462	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone	EXP035442	111	unspecified	P55317	T47D (invasive ductal carcinoma)	PEAKS038448
EXP035463	FoxA1 ab23738 Abcam	Homo sapiens	17Î²-estradiol	EXP035442	111	unspecified	P55317	T47D (invasive ductal carcinoma)	PEAKS038449
EXP035466	myb	Homo sapiens		EXP035464	907	unspecified	P10242	Th2-cells	PEAKS038450
EXP035467	maf	Homo sapiens		EXP035464	907	unspecified	O75444	Th2-cells	PEAKS038451
EXP035468	gata3	Homo sapiens		EXP035465	886	unspecified	P23771	Th1-cells	PEAKS038452
EXP035469	gata3	Homo sapiens		EXP035464	907	unspecified	P23771	Th2-cells	PEAKS038453
EXP035470	myb	Homo sapiens		EXP035465	886	unspecified	P10242	Th1-cells	PEAKS038454
EXP035471	maf	Homo sapiens		EXP035465	886	unspecified	O75444	Th1-cells	PEAKS038455
EXP035472	RFX1	Mus musculus		NULL	286	unspecified	P48377	pancreatic beta-cells	PEAKS038456
EXP035473	RFX3	Mus musculus		NULL	286	unspecified	P48381	pancreatic beta-cells	PEAKS038457
EXP035474	FOXA1	Homo sapiens		NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS038458
EXP035475	anti-STAT5/R & D Systems, #PA-ST5A, lot #RU07	Mus musculus		NULL	2479	unspecified	P42230	CD8+ T-cells	PEAKS038459
EXP035476	anti-STAT5/R & D Systems, #PA-ST5A, lot #RU07	Mus musculus	0.5 ug/ml IL-2 for 1 hour	NULL	2479	unspecified	P42230	CD8+ T-cells	PEAKS038460
EXP035478	Antibody:  ANTI-FLAGÂ® M2 Affinity Gel A2220 (Sigma-Aldrich)	Mus musculus		EXP035477	714	unspecified	Q6XP49	alphaTC1 Clone 9 (pancreatic alpha cells)	PEAKS038461
EXP035480	MYCN (Abcam ab16898)	Homo sapiens		EXP035479	82	unspecified	P04198	SK-N-BE(2)-C (neuroblastoma)	PEAKS038462
EXP035482	sc-85804	Homo sapiens		EXP035481	191	unspecified	Q9BRP0	corneal epithelium	PEAKS038463
EXP035483	sc-85804	Homo sapiens		NULL	191	unspecified	Q9BRP0	corneal epithelium	PEAKS038464
EXP035484	SNF2H (Abcam, ab72499)	Homo sapiens		NULL	70	unspecified	O60264	LNCaP (prostate carcinoma)	PEAKS038465
EXP035485	SMARCA1 (Abcam, ab37003)	Homo sapiens		NULL	70	unspecified	P28370	LNCaP (prostate carcinoma)	PEAKS038466
EXP035488	AR (Santa Cruz; sc-815)	Homo sapiens	vehicle for 24hrs	EXP035486	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS038467
EXP035489	AR (Santa Cruz; sc-815)	Homo sapiens	5 ÂµM SR2211 for 24hrs	EXP035487	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	PEAKS038468
EXP035490	Sox10 (Abcam ab27655)	Rattus norvegicus		NULL	218	unspecified	O55170	oligodendrocytes	PEAKS038469
EXP035494	goat polyclonal Anti-Sox2 (R&D, catalog# AF2018, lot# KOY0213101)	Mus musculus	Chaf1a KO	EXP035491	695	unspecified	P48432	OKSM reprogrammed embryonic fibroblasts	PEAKS038470
EXP035495	goat polyclonal Anti-Sox2 (R&D, catalog# AF2018, lot# KOY0213101)	Mus musculus		EXP035492	695	unspecified	P48432	OKSM reprogrammed embryonic fibroblasts	PEAKS038471
EXP035496	goat polyclonal Anti-Sox2 (AF2018, R&D); lot#: KOY0213101	Mus musculus		EXP035493	12	unspecified	P48432	MEF (mouse embryonic fibroblasts)	PEAKS038472
EXP035497	anti-E2A (sc-349; Santa Cruz Technologies)	Homo sapiens		NULL	768	unspecified	P15923	Ramos (Burkitt lymphoma)	PEAKS038473
EXP035499	fli1	Mus musculus		EXP035498	787	unspecified	P26323	subcutaneous osteosarcoma	PEAKS038474
EXP035500	LEF1	Homo sapiens	EGF for 0h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	PEAKS038475
EXP035501	LEF1	Homo sapiens	EGF for 12h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	PEAKS038476
EXP035502	LEF1	Homo sapiens	EGF for 24h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	PEAKS038477
EXP035503	LEF1	Homo sapiens	EGF for 48h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	PEAKS038478
EXP035519	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1214)	Mus musculus	vehicle 6h	EXP035504	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS038479
EXP035520	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1214)	Mus musculus	tissuehomogenate 6h	EXP035505	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS038480
EXP035521	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	vehicle 6h	EXP035506	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	PEAKS038481
EXP035522	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	tissuehomogenate 6h	EXP035507	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	PEAKS038482
EXP035523	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	no treatment	EXP035508	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	PEAKS038483
EXP035524	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	KLA 6h	EXP035509	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	PEAKS038484
EXP035525	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	vehicle 6h	EXP035510	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS038485
EXP035526	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	tissuehomogenate 6h	EXP035511	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS038486
EXP035527	Smad3 (Vendor: Abcam, cat# ab28379, lot# GR188908-1)	Mus musculus	vehicle 6h	EXP035510	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	PEAKS038487
EXP035528	Smad3 (Vendor: Abcam, cat# ab28379, lot# GR188908-1)	Mus musculus	tissuehomogenate 6h	EXP035511	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	PEAKS038488
EXP035529	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	KLA 6h	EXP035512	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS038489
EXP035530	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	TGFb 6h	EXP035513	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS038490
EXP035531	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	no treatment	EXP035514	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS038491
EXP035532	Smad3 (Vendor: Abcam, cat# ab28379)	Mus musculus	no treatment	EXP035515	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	PEAKS038492
EXP035533	Smad3 (Vendor: Abcam, cat# ab28379)	Mus musculus	TGFb 4h	EXP035516	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	PEAKS038493
EXP035534	Nrf2  (Vendor: Santa Cruz, cat# sc-13032X, lot# I1311)	Mus musculus	vehicle 6h	EXP035517	81	unspecified	Q60795	BMDM (bone marrow-derived macrophages)	PEAKS038494
EXP035535	Nrf2  (Vendor: Santa Cruz, cat# sc-13032X, lot# I1311)	Mus musculus	tissuehomogenate 6h	EXP035518	81	unspecified	Q60795	BMDM (bone marrow-derived macrophages)	PEAKS038495
EXP035537	foxm1	Homo sapiens	Proliferating	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS038496
EXP035538	foxm1	Homo sapiens	Confluent	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS038497
EXP035539	foxm1	Homo sapiens	mi63	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS038498
EXP035540	foxm1	Homo sapiens		EXP035536	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	PEAKS038499
EXP035542	M2 (Sigma, catalog# F3165, lot# SLBF1225). Used 4ug of antibody per ChIP	Mus musculus	plus Dox to induce Flag-Sp5 expression	EXP035541	34	unspecified	Q9JHX2	A2Lox.cre (embryonic stem cells)	PEAKS038500
EXP035545	Helios (Santa Cruz, G-20, sc-9866)	Mus musculus		EXP035544	1058	unspecified	P81183	CD4+ T-cells	PEAKS038501
EXP035546	Helios (Santa Cruz, G-20, sc-9866)	Mus musculus		EXP035543	2479	unspecified	P81183	CD8+ T-cells	PEAKS038502
EXP035548	SOX9 (Millipore, catalog# AB5535, lot# LV 1478872)	Mus musculus		EXP035547	858	unspecified	Q04887	valve mesenchyme	PEAKS038503
EXP035549	SOX9 (Millipore, catalog# AB5535, lot# LV 1478872)	Mus musculus		EXP035547	548	unspecified	Q04887	limb mesenchyme	PEAKS038504
EXP035550	Tcf1	Mus musculus		NULL	44	unspecified	Q00417	T-cells	PEAKS038505
EXP035551	Tcf1	Mus musculus	Tcf1-deficient	NULL	44	unspecified	Q00417	T-cells	PEAKS038506
EXP035553	ab72152	Homo sapiens		EXP035552	146	unspecified	P41229	Caki-1 (renal carcinoma)	PEAKS038507
EXP035554	Bethyl A301-034	Homo sapiens		EXP035552	146	unspecified	P41229	Caki-1 (renal carcinoma)	PEAKS038508
EXP035556	ERalpha (H-20, Santa Cruz)	Homo sapiens		EXP035555	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038509
EXP035557	FOXA1 (Abcam, Cat. # ab23738, Lot # GR44102-1)	Homo sapiens	shCtrl	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS038510
EXP035558	FOXA1 (Abcam, Cat. # ab23738, Lot # GR44102-1)	Homo sapiens	shTET1	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS038511
EXP035560	Jun(Abcam Cat#ab31419)	Mus musculus		EXP035559	179	unspecified	P05627	chondrocytes	PEAKS038512
EXP035564	PLZF	Mus musculus		EXP035561	833	unspecified	Q3UQ17	THY1+ spermatogonia	PEAKS038513
EXP035565	PLZF	Mus musculus		EXP035562	833	unspecified	Q3UQ17	THY1+ spermatogonia	PEAKS038514
EXP035566	PLZF	Mus musculus		EXP035563	833	unspecified	Q3UQ17	THY1+ spermatogonia	PEAKS038515
EXP035567	SALL4	Mus musculus		EXP035561	833	unspecified	Q8BX22	THY1+ spermatogonia	PEAKS038516
EXP035568	SALL4	Mus musculus		EXP035562	833	unspecified	Q8BX22	THY1+ spermatogonia	PEAKS038517
EXP035569	SALL4	Mus musculus		EXP035563	833	unspecified	Q8BX22	THY1+ spermatogonia	PEAKS038518
EXP035570	HA-antibody (Abcam, ab9110)	Mus musculus	doxycycline treatment	NULL	2	unspecified	P83870	mESCs (mouse embryonic stem cells)	PEAKS038519
EXP035571	HA-antibody (Abcam, ab9110)	Mus musculus		NULL	2	unspecified	P83870	mESCs (mouse embryonic stem cells)	PEAKS038520
EXP035573	anti-Mef2c (Santa Cruz; catalog# sc-13266X; lot# C2309)	Mus musculus		EXP035572	102	unspecified	Q8CFN5	BMiFLT3(15-3) (murine acute lymphoblastic leukemia)	PEAKS038521
EXP035575	MLLc (Millipore 05-765)	Homo sapiens		EXP035574	641	unspecified	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS038522
EXP035576	MLLn (Bethyl Laboratories A300-086A)	Homo sapiens		EXP035574	641	unspecified	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS038523
EXP035581	YY1	Mus musculus		EXP035577	105	unspecified	Q00899	pro-B cells	PEAKS038524
EXP035582	YY1	Mus musculus		EXP035578	503	unspecified	Q00899	pre-B cells	PEAKS038525
EXP035583	YY1	Mus musculus		EXP035579	41	unspecified	Q00899	B-cells	PEAKS038526
EXP035584	YY1	Mus musculus		EXP035580	41	unspecified	Q00899	B-cells	PEAKS038527
EXP035587	anti-SATB1 (sc-5990)	Homo sapiens	vehicle (Ham's F-12 media)	EXP035585	664	unspecified	Q01826	SH-SY5Y (neuroblastoma)	PEAKS038528
EXP035588	anti-SATB1 (sc-5990)	Homo sapiens	100 nM amyloid-beta1-42 oligomers for 4 h	EXP035586	664	unspecified	Q01826	SH-SY5Y (neuroblastoma)	PEAKS038529
EXP035593	FXR (SantaCruz, sc-13063)	Mus musculus	OCA (10mg/kg/day)	EXP035589	5	unspecified	Q60641	liver	PEAKS038530
EXP035594	FXR (SantaCruz, sc-13063)	Mus musculus	OCA (10mg/kg/day)	EXP035590	5	unspecified	Q60641	liver	PEAKS038531
EXP035595	FXR (SantaCruz, sc-13063)	Mus musculus	vehicle (1% methyl cellulose)	EXP035591	5	unspecified	Q60641	liver	PEAKS038532
EXP035596	FXR (SantaCruz, sc-13063)	Mus musculus	vehicle (1% methyl cellulose)	EXP035592	5	unspecified	Q60641	liver	PEAKS038533
EXP035597	Gata2 (Santa Cruz, cat# sc9008x, lot# I0109)	Mus musculus	TGFb	NULL	545	unspecified	O09100	Lhx2 (hematopoietic stem cells)	PEAKS038534
EXP035599	Anti-Nanog antibody (R&D AF1997)	Homo sapiens		EXP035598	396	unspecified	Q9H9S0	WA09 (embryonic stem cells)	PEAKS038535
EXP035603	REV-ERBa (Cell Signaling, E1Y6D, #13418)	Mus musculus		EXP035600	53	unspecified	Q3UV55	heart	PEAKS038536
EXP035604	REV-ERBa (Cell Signaling, E1Y6D, #13418)	Mus musculus	KLF15 knockout	EXP035601	53	unspecified	Q3UV55	heart	PEAKS038537
EXP035605	FLAG (Sigma, F3165)	Mus musculus		EXP035602	53	unspecified	Q9EPW2	heart	PEAKS038538
EXP035608	SIX2 antibody (MyBiosource, MBS610128)	Homo sapiens		EXP035606	462	unspecified	Q9NPC8	embryonic kidney cortex	PEAKS038539
EXP035609	Six2 antibody (Proteintech,11562-1-AP)	Mus musculus		EXP035607	903	unspecified	Q62232	embryonic kidney	PEAKS038540
EXP035610	SIX2 antibody (MyBiosource, MBS610128)	Mus musculus		EXP035607	903	unspecified	Q62232	embryonic kidney	PEAKS038541
EXP035611	anti-Flag M2	Homo sapiens		NULL	421	unspecified	Q9NZL3	HEK293 (embryonic kidney)	PEAKS038542
EXP035614	MLL1	Mus musculus		EXP035612	260	unspecified	P55200	epiblast stem cells	PEAKS038543
EXP035615	MLL1	Mus musculus	MM401	EXP035613	260	unspecified	P55200	epiblast stem cells	PEAKS038544
EXP035617	E2F1 c20 ( santa cruz sc193)	Mus musculus		EXP035616	429	unspecified	Q61501	hepatocytes	PEAKS038545
EXP035619	M2 Flag	Mus musculus		EXP035618	616	unspecified	P43120	MLL-ENL leukemia	PEAKS038546
EXP035621	ERalpha (H-20, Santa Cruz)	Homo sapiens		EXP035620	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038547
EXP035622	Santa Cruz (sc-350x)	Mus musculus		NULL	710	unspecified	P27577	P5424 (thymic cells)	PEAKS038548
EXP035624	YY1 (Santa Cruz)	Mus musculus		EXP035623	1153	unspecified	Q00899	C2C12 (myoblasts)	PEAKS038549
EXP035626	AR (Santa Cruz Biotech, N-20, sc-816)	Homo sapiens		EXP035625	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	PEAKS038550
EXP035627	AR (Santa Cruz Biotech, N-20, sc-816)	Homo sapiens	DHT 10nM	NULL	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	PEAKS038551
EXP035628	AR (Santa Cruz Biotech, N-20, sc-816)	Homo sapiens	medroxyprogesterone acetate 10nM	NULL	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	PEAKS038552
EXP035630	STAT3 (Cat. 9132, Cell Signaling)	Mus musculus		EXP035629	104	unspecified	P42227	dendritic cells	PEAKS038553
EXP035631	STAT3 (Cat. 9132, Cell Signaling)	Mus musculus	SAHA (500nm)	EXP035629	104	unspecified	P42227	dendritic cells	PEAKS038554
EXP035634	HA (Covance, MMS-101P)	Mus musculus		EXP035632	2	unspecified	E9QAG8	mESCs (mouse embryonic stem cells)	PEAKS038555
EXP035635	HA (Covance, MMS-101P)	Mus musculus		EXP035633	1153	unspecified	E9QAG8	C2C12 (myoblasts)	PEAKS038556
EXP035637	mycPet-1	Mus musculus		EXP035636	137	unspecified	Q8QZW2	hindbrain	PEAKS038557
EXP035638	ATF3	Homo sapiens	camptothecin	NULL	417	unspecified	P18847	HCT-116 (colon carcinoma)	PEAKS038558
EXP035639	ATF3	Homo sapiens	ATF3 KO	NULL	417	unspecified	P18847	HCT-116 (colon carcinoma)	PEAKS038559
EXP035640	p53	Homo sapiens	camptothecin	NULL	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS038560
EXP035641	p53	Homo sapiens	p53 KO	NULL	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS038561
EXP035642	ATF3	Homo sapiens	DMSO	NULL	417	unspecified	P18847	HCT-116 (colon carcinoma)	PEAKS038562
EXP035645	anti-BMAL1 (ab3350; Abcam)	Homo sapiens	DMSO	EXP035643	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS038563
EXP035646	anti-BMAL1 (ab3350; Abcam)	Homo sapiens	6AN	EXP035644	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS038564
EXP035647	anti-CLOCK (NB100-126; Novus Biologicals)	Homo sapiens	DMSO	EXP035643	848	unspecified	O15516	U2OS (osteosarcoma)	PEAKS038565
EXP035648	anti-CLOCK (NB100-126; Novus Biologicals)	Homo sapiens	6AN	EXP035644	848	unspecified	O15516	U2OS (osteosarcoma)	PEAKS038566
EXP035650	HA (ab9110)	Mus musculus		EXP035649	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	PEAKS038567
EXP035651	HA (ab9110)	Mus musculus		EXP035649	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	PEAKS038568
EXP035653	sc-17320	Mus musculus		EXP035652	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	PEAKS038569
EXP035655	olig2	Mus musculus		EXP035654	2775	unspecified	Q9EQW6	neural stem cells	PEAKS038570
EXP035658	ZFP57 (Abcam, ab45341)	Mus musculus		EXP035656	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS038571
EXP035659	ZFP57 (Abcam, ab45341)	Mus musculus		EXP035657	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS038572
EXP035662	MLL (Bethyl, A300-086A)	Homo sapiens		EXP035660	541	unspecified	Q03164	SEM (childhood B acute lymphoblastic leukemia)	PEAKS038573
EXP035663	CFP1 (Bethyl, A303-161A/1)	Homo sapiens		EXP035661	541	unspecified	Q9P0U4	SEM (childhood B acute lymphoblastic leukemia)	PEAKS038574
EXP035664	sc-6029	Homo sapiens		NULL	887	unspecified	P20265	neural progenitors	PEAKS038575
EXP035665	sc-393324	Homo sapiens		NULL	887	unspecified	P20265	neural progenitors	PEAKS038576
EXP035666	sc-6029	Homo sapiens	after 2 weeks of differentiation	NULL	887	unspecified	P20265	neural progenitors	PEAKS038577
EXP035667	sc-393324	Homo sapiens	after 2 weeks of differentiation	NULL	887	unspecified	P20265	neural progenitors	PEAKS038578
EXP035669	custom-made antibodies against Ronin G4275	Mus musculus		EXP035668	141	unspecified	Q9JJD0	retina	PEAKS038579
EXP035670	ELF5 (Santa Cruz, sc-9645)	Mus musculus	pregnancy day 13	NULL	572	unspecified	Q8VDK3	mammary gland	PEAKS038580
EXP035671	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE1a	NULL	572	unspecified	P06537	mammary gland	PEAKS038581
EXP035672	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE1b	NULL	572	unspecified	P06537	mammary gland	PEAKS038582
EXP035673	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE1c	NULL	572	unspecified	P06537	mammary gland	PEAKS038583
EXP035674	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE2	NULL	572	unspecified	P06537	mammary gland	PEAKS038584
EXP035675	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE3	NULL	572	unspecified	P06537	mammary gland	PEAKS038585
EXP035676	ELF5 (Santa Cruz, sc-9645)	Mus musculus	lactation day 1, Wap-delE1b	NULL	572	unspecified	Q8VDK3	mammary gland	PEAKS038586
EXP035677	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1	NULL	572	unspecified	P42230	mammary gland	PEAKS038587
EXP035678	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1	NULL	572	unspecified	P06537	mammary gland	PEAKS038588
EXP035679	ELF5 (Santa Cruz, sc-9645)	Mus musculus	lactation day 1	NULL	572	unspecified	Q8VDK3	mammary gland	PEAKS038589
EXP035680	STAT5A (Santa Cruz, sc-1081)	Mus musculus	pregnancy day 13	NULL	572	unspecified	P42230	mammary gland	PEAKS038590
EXP035681	GR (Thermo Scientific, PA1-511A)	Mus musculus	pregnancy day 13	NULL	572	unspecified	P06537	mammary gland	PEAKS038591
EXP035682	ELF5 (Santa Cruz, sc-9645)	Mus musculus	pregnancy day 13	NULL	572	unspecified	Q8VDK3	mammary gland	PEAKS038592
EXP035683	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE1a	NULL	572	unspecified	P42230	mammary gland	PEAKS038593
EXP035684	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE1b	NULL	572	unspecified	P42230	mammary gland	PEAKS038594
EXP035685	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE1c	NULL	572	unspecified	P42230	mammary gland	PEAKS038595
EXP035686	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE2	NULL	572	unspecified	P42230	mammary gland	PEAKS038596
EXP035687	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE3	NULL	572	unspecified	P42230	mammary gland	PEAKS038597
EXP035688	ELF5 (Santa Cruz, sc-9645)	Mus musculus	lactation day 1, Wap-delE1c	NULL	572	unspecified	Q8VDK3	mammary gland	PEAKS038598
EXP035691	anti-CTCF [D31H2] (Cell signaling) Lot #1	Homo sapiens		EXP035689	882	unspecified	P49711	T-cells	PEAKS038599
EXP035692	anti-CTCF [D31H2] (Cell signaling) Lot #1	Homo sapiens		EXP035690	882	unspecified	P49711	T-cells	PEAKS038600
EXP035695	SHP (sc-30169)	Mus musculus	FGF19	EXP035693	5	unspecified	Q62227	liver	PEAKS038601
EXP035696	SHP (sc-30169)	Mus musculus	vehicle	EXP035694	5	unspecified	Q62227	liver	PEAKS038602
EXP035699	CREB (Millipore, 17-600)	Homo sapiens	DMSO (0.1%, 6h)	EXP035697	47	unspecified	P16220	KG1 (acute myeloid leukemia)	PEAKS038603
EXP035700	CREB (Millipore, 17-600)	Homo sapiens	XX-650-23 (5 mM, 6hrs)	EXP035698	47	unspecified	P16220	KG1 (acute myeloid leukemia)	PEAKS038604
EXP035701	anti-CTCF polyclonal antibody (ab070303, Abcam)	Homo sapiens		NULL	878	unspecified	P49711	embryonic stem cells	PEAKS038605
EXP035704	zbtb7a	Homo sapiens	SFEM doxycycline+ (Day0)	EXP035702	893	unspecified	O95365	erythroblasts	PEAKS038606
EXP035705	zbtb7a	Homo sapiens	EDM-II (Day8)	EXP035703	326	unspecified	O95365	CD34+ stem cells-derived erythroblasts	PEAKS038607
EXP035707	cJUN Polyclonal Rabbit antibody (Santa Cruz sc-44)	Mus musculus		EXP035706	142	unspecified	P05627	intestine	PEAKS038608
EXP035709	rabbit anti-Gata1, Abcam ab11963, lot I0303	Mus musculus		EXP035708	780	unspecified	P17679	embryonic blood cell progenitors	PEAKS038609
EXP035712	sc-22805	Homo sapiens	0.5% 1xPBS vehicle	EXP035710	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS038610
EXP035713	sc-22805	Homo sapiens	0.5 mM NaBut	EXP035711	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS038611
EXP035714	sc-22805	Homo sapiens	0.01% DMSO vehicle	NULL	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS038612
EXP035715	sc-22805	Homo sapiens	1 Î¼M SAHA	NULL	514	unspecified	P17947	K562 (myelogenous leukemia)	PEAKS038613
EXP035717	Rcor2	Mus musculus		EXP035716	135	unspecified	Q8C796	embryonic brain	PEAKS038614
EXP035718	Nr3b2	Mus musculus	DOX, asynchronous	NULL	233	unspecified	Q61539	E14TG2A (embryonic stem cells)	PEAKS038615
EXP035719	Nr3b2	Mus musculus	DOX, mitosis	NULL	233	unspecified	Q61539	E14TG2A (embryonic stem cells)	PEAKS038616
EXP035720	Nr3b2	Mus musculus	DOX, asynchronous	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	PEAKS038617
EXP035721	Nr3b2	Mus musculus	48h DOX withdrawal, asynchronous	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	PEAKS038618
EXP035722	Nr3b2	Mus musculus	DOX, mitosis	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	PEAKS038619
EXP035723	Nr3b2	Mus musculus	48h DOX withdrawal, mitosis	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	PEAKS038620
EXP035726	Cell Signaling #4334	Homo sapiens		EXP035724	113	unspecified	Q01196	MCF7 (Invasive ductal breast carcinoma)	PEAKS038621
EXP035727	Cell Signaling #4334	Homo sapiens		EXP035725	113	unspecified	Q01196	MCF7 (Invasive ductal breast carcinoma)	PEAKS038622
EXP035729	sc-11146	Homo sapiens		EXP035728	432	unspecified	Q05516	primary stromal cells	PEAKS038623
EXP035731	CEBPG C-terminal antiserum (our lab)	Mus musculus		EXP035730	12	unspecified	P53568	MEF (mouse embryonic fibroblasts)	PEAKS038624
EXP035732	ATF4 (Santa Cruz; C-20)	Mus musculus		EXP035730	12	unspecified	Q06507	MEF (mouse embryonic fibroblasts)	PEAKS038625
EXP035739	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus	Nrf2(AY/AY) mutant	EXP035733	732	unspecified	Q60795	peritoneal macrophages	PEAKS038626
EXP035740	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus	Nrf2(AY/AY) mutant	EXP035734	732	unspecified	Q60795	peritoneal macrophages	PEAKS038627
EXP035741	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus		EXP035735	732	unspecified	Q60795	peritoneal macrophages	PEAKS038628
EXP035742	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus		EXP035736	732	unspecified	Q60795	peritoneal macrophages	PEAKS038629
EXP035743	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus		EXP035737	732	unspecified	Q60795	peritoneal macrophages	PEAKS038630
EXP035744	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus	Nrf2(AY/AY) mutant	EXP035738	732	unspecified	Q60795	peritoneal macrophages	PEAKS038631
EXP035746	M2 anti-FLAG antibody (F1804; Sigma)	Mus musculus		EXP035745	834	unspecified	Q61575	thymic epithelial cells	PEAKS038632
EXP035747	Stat2 (EMD Millipore, #07-140)	Mus musculus		NULL	41	unspecified	Q9WVL2	B-cells	PEAKS038633
EXP035748	Stat2 (EMD Millipore, #07-140)	Mus musculus	10,000U IFNa	NULL	41	unspecified	Q9WVL2	B-cells	PEAKS038634
EXP035749	Stat1 (Santa Cruz Biotechnology, sc-592)	Mus musculus		NULL	41	unspecified	P42225	B-cells	PEAKS038635
EXP035750	Stat1 (Santa Cruz Biotechnology, sc-592)	Mus musculus	10,000U IFNa	NULL	41	unspecified	P42225	B-cells	PEAKS038636
EXP035755	SMAD3, Abcam, AB28379	Homo sapiens		EXP035751	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	PEAKS038637
EXP035756	SMAD3, Abcam, AB28379	Homo sapiens	differentiated at day 0	EXP035752	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	PEAKS038638
EXP035757	SMAD3, Abcam, AB28379	Homo sapiens	differentiated at day 1	EXP035753	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	PEAKS038639
EXP035758	SMAD3, Abcam, AB28379	Homo sapiens	differentiated at 48 hours	EXP035754	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	PEAKS038640
EXP035761	myod	Mus musculus		EXP035759	12	unspecified	P10085	MEF (mouse embryonic fibroblasts)	PEAKS038641
EXP035762	myf5	Mus musculus		EXP035760	12	unspecified	P24699	MEF (mouse embryonic fibroblasts)	PEAKS038642
EXP035765	EMD Millipore AB10523	Homo sapiens		EXP035763	640	unspecified	Q9UH73	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS038643
EXP035766	EMD Millipore AB10523	Homo sapiens		EXP035764	537	unspecified	Q9UH73	pooled Yoruba and Tuscan lymphoblastoid cell lines	PEAKS038644
EXP035767	Abcam AB25949	Homo sapiens		EXP035763	640	unspecified	Q06330	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS038645
EXP035768	Abcam AB25949	Homo sapiens		EXP035764	537	unspecified	Q06330	pooled Yoruba and Tuscan lymphoblastoid cell lines	PEAKS038646
EXP035770	p53 Antibody (FL-393R)	Homo sapiens		EXP035769	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS038647
EXP035771	p53 Antibody (FL-393R)	Homo sapiens	5 Î¼M Camptothecin (Sigma) for 8 hrs	EXP035769	417	unspecified	P04637	HCT-116 (colon carcinoma)	PEAKS038648
EXP035775	PU.1 (Santa Cruz Biotechnology, sc-352)	Mus musculus	Maf-DKO	EXP035772	570	unspecified	P17433	macrophages	PEAKS038649
EXP035776	PU.1 (Santa Cruz Biotechnology, sc-352)	Mus musculus		EXP035773	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS038650
EXP035777	PU.1 (Santa Cruz Biotechnology, sc-352)	Mus musculus		EXP035774	62	unspecified	P17433	alveolar macrophages	PEAKS038651
EXP035778	Flag M2 antibody (Sigma)	Mus musculus	Maf-DKO	EXP035772	570	unspecified	P54841	macrophages	PEAKS038652
EXP035779	MafB (Bethyl IHC-101)	Mus musculus		EXP035773	81	unspecified	P54841	BMDM (bone marrow-derived macrophages)	PEAKS038653
EXP035782	Blimp1 (Cell Signaling #9115)	Mus musculus	9 day in vitro culture for Th17 cells, growth protocol1	EXP035780	498	unspecified	Q60636	Th17-cells	PEAKS038654
EXP035783	Blimp1 (Cell Signaling #9115)	Mus musculus	3 day in vitro culture for Treg, growth protocol 2	EXP035781	1058	unspecified	Q60636	CD4+ T-cells	PEAKS038655
EXP035785	TFE3 (Sigma, Catalog# HPA023881, Lot# E96562)	Mus musculus		EXP035784	12	unspecified	Q64092	MEF (mouse embryonic fibroblasts)	PEAKS038656
EXP035786	TFE3 (Sigma, Catalog# HPA023881, Lot# E96562)	Mus musculus	starvation	EXP035784	12	unspecified	Q64092	MEF (mouse embryonic fibroblasts)	PEAKS038657
EXP035787	TFE3 (Sigma, Catalog# HPA023881, Lot# E96562)	Mus musculus	tunicamycin	EXP035784	12	unspecified	Q64092	MEF (mouse embryonic fibroblasts)	PEAKS038658
EXP035788	anti-ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038659
EXP035789	anti-ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038660
EXP035790	anti-ERa (SC-543; Santa Cruz)	Homo sapiens	sgRNA_enh588	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038661
EXP035791	anti-ERa (SC-543; Santa Cruz)	Homo sapiens	sgRNA_enh588	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS038662
EXP035793	V5-tag (Abcam ab15828)	Homo sapiens		EXP035792	467	unspecified	Q9UBX2	myoblasts	PEAKS038663
EXP035795	TFE3: Sigma, Catalog: HPA023881-100ul, Lot: E96562	Mus musculus		EXP035794	91	unspecified	Q64092	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS038664
EXP035796	TFE3: Sigma, Catalog: HPA023881-100ul, Lot: E96562	Mus musculus	starvation	EXP035794	91	unspecified	Q64092	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS038665
EXP035797	TFE3: Sigma, Catalog: HPA023881-100ul, Lot: E96562	Mus musculus	LPS	EXP035794	91	unspecified	Q64092	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS038666
EXP035800	KDM5c 333	Mus musculus		EXP035798	625	unspecified	P41230	embryonic cortex	PEAKS038667
EXP035801	KDM5c 333	Mus musculus	SMCX KO	EXP035798	625	unspecified	P41230	embryonic cortex	PEAKS038668
EXP035802	KDM5c 333	Mus musculus		EXP035799	625	unspecified	P41230	embryonic cortex	PEAKS038669
EXP035803	KDM5c 333	Mus musculus	SMCX KO	EXP035799	625	unspecified	P41230	embryonic cortex	PEAKS038670
EXP035805	ERRa	Homo sapiens		EXP035804	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	PEAKS038671
EXP035806	ERRa	Homo sapiens	AICAR	EXP035804	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	PEAKS038672
EXP035810	six1	Homo sapiens	16 weeks 2 days	EXP035807	772	unspecified	Q15475	renal cortex	PEAKS038673
EXP035811	six1	Homo sapiens	17 weeks 3 days	EXP035808	772	unspecified	Q15475	renal cortex	PEAKS038674
EXP035812	six1	Homo sapiens	17 weeks 2 days	EXP035809	772	unspecified	Q15475	renal cortex	PEAKS038675
EXP035813	six2	Homo sapiens	16 weeks 2 days	EXP035807	772	unspecified	Q9NPC8	renal cortex	PEAKS038676
EXP035814	six2	Homo sapiens	17 weeks 3 days	EXP035808	772	unspecified	Q9NPC8	renal cortex	PEAKS038677
EXP035815	six2	Homo sapiens	17 weeks 2 days	EXP035809	772	unspecified	Q9NPC8	renal cortex	PEAKS038678
EXP035816	six2	Homo sapiens	17 weeks 2 days	EXP035809	772	unspecified	Q9NPC8	renal cortex	PEAKS038679
EXP035818	CS2443 (lot#2)	Mus musculus		EXP035817	127	unspecified	P37238	C3H10T1/2 (embryonic fibroblasts)	PEAKS038680
EXP035821	anti-Pbx1 (Abnova, Cat# H00005087, Lot# E5141-4A2)	Mus musculus	CTLi	EXP035820	1153	unspecified	P41778	C2C12 (myoblasts)	PEAKS038681
EXP035822	anti-Pbx1 (Abnova, Cat# H00005087, Lot# E5141-4A2)	Mus musculus	mH2A1i	EXP035820	1153	unspecified	P41778	C2C12 (myoblasts)	PEAKS038682
EXP035823	anti-Pbx1 (Abnova, Cat# H00005087,  Lot# E5141-4A2)	Mus musculus	Myoblast	EXP035819	1153	unspecified	P41778	C2C12 (myoblasts)	PEAKS038683
EXP035824	anti-Pbx1 (Abnova, Cat# H00005087, Lot# E5141-4A2)	Mus musculus	Myotubes	EXP035820	1153	unspecified	P41778	C2C12 (myoblasts)	PEAKS038684
EXP035825	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc (tet-Myc expression off)	NULL	5	unspecified	P01108	liver	PEAKS038685
EXP035826	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	LAPtTA	NULL	5	unspecified	P01108	liver	PEAKS038686
EXP035827	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus		NULL	5	unspecified	P01108	liver	PEAKS038687
EXP035828	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus		NULL	5	unspecified	P01108	liver	PEAKS038688
EXP035829	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	PEAKS038689
EXP035830	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	PEAKS038690
EXP035831	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	PEAKS038691
EXP035832	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	PEAKS038692
EXP035833	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	PEAKS038693
EXP035834	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	PEAKS038694
EXP035835	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression off)	NULL	551	unspecified	P01108	liver tumor	PEAKS038695
EXP035836	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression off)	NULL	551	unspecified	P01108	liver tumor	PEAKS038696
EXP035837	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression off)	NULL	551	unspecified	P01108	liver tumor	PEAKS038697
EXP035838	ab23980	Homo sapiens		NULL	509	unspecified	Q01196	Jurkat (T-cells)	PEAKS038698
EXP035839	sc-22206X	Homo sapiens		NULL	509	unspecified	P23771	Jurkat (T-cells)	PEAKS038699
EXP035842	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035840	889	unspecified	Q8VI67	osteoblasts	PEAKS038700
EXP035843	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035841	581	unspecified	Q8VI67	MC3T3-E1 (preosteoblasts)	PEAKS038701
EXP035844	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035841	581	unspecified	P70396	MC3T3-E1 (preosteoblasts)	PEAKS038702
EXP035845	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035841	581	unspecified	O89090	MC3T3-E1 (preosteoblasts)	PEAKS038703
EXP035848	c-Myc (Santa Cruz Biotech., sc-764)	Homo sapiens		EXP035846	767	unspecified	P01106	Raji (Burkitt lymphoma)	PEAKS038704
EXP035849	E2F-1 (Santa Cruz Biotech., sc-193)	Homo sapiens		EXP035846	767	unspecified	Q01094	Raji (Burkitt lymphoma)	PEAKS038705
EXP035850	c-Myc (Santa Cruz Biotech., sc-764)	Homo sapiens	100 nM of JQ1	EXP035847	767	unspecified	P01106	Raji (Burkitt lymphoma)	PEAKS038706
EXP035851	E2F-1 (Santa Cruz Biotech., sc-193)	Homo sapiens	100 nM of JQ1	EXP035847	767	unspecified	Q01094	Raji (Burkitt lymphoma)	PEAKS038707
EXP035852	ZNF143 (Novus Biologicals H00007702-M01)	Homo sapiens	vehicle	NULL	113	unspecified	P52747	MCF7 (Invasive ductal breast carcinoma)	PEAKS038708
EXP035853	ZNF143 (Novus Biologicals H00007702-M01)	Homo sapiens	10 uM 17-beta oestradiol (E2)	NULL	113	unspecified	P52747	MCF7 (Invasive ductal breast carcinoma)	PEAKS038709
EXP035856	CTCF	Mus musculus		EXP035855	568	unspecified	Q61164	macrophage-derived p20 iPS	PEAKS038710
EXP035857	CTCF	Mus musculus		EXP035854	569	unspecified	Q61164	macrophage-derived p3 iPS	PEAKS038711
EXP035858	CTCF	Mus musculus		NULL	596	unspecified	Q61164	embryonic fibroblast-derived p20 iPSC	PEAKS038712
EXP035859	CTCF	Mus musculus		NULL	597	unspecified	Q61164	embryonic fibroblast-derived p3 iPSC	PEAKS038713
EXP035860	CTCF	Mus musculus		NULL	680	unspecified	Q61164	neural stem cell-derived p20 iPSC	PEAKS038714
EXP035861	CTCF	Mus musculus		NULL	681	unspecified	Q61164	neural stem cell-derived p3 iPSC	PEAKS038715
EXP035862	CTCF	Mus musculus		NULL	736	unspecified	Q61164	preB-derived p20 induced pluripotent stem cells	PEAKS038716
EXP035863	CTCF	Mus musculus		NULL	737	unspecified	Q61164	preB-derived p3 induced pluripotent stem cells	PEAKS038717
EXP035864	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	A0PJY2	HEK293 (embryonic kidney)	PEAKS038718
EXP035865	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	B2RXF5	HEK293 (embryonic kidney)	PEAKS038719
EXP035866	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O14978	HEK293 (embryonic kidney)	PEAKS038720
EXP035867	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O43296	HEK293 (embryonic kidney)	PEAKS038721
EXP035868	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O43829	HEK293 (embryonic kidney)	PEAKS038722
EXP035869	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O60765	HEK293 (embryonic kidney)	PEAKS038723
EXP035870	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O75467	HEK293 (embryonic kidney)	PEAKS038724
EXP035871	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O75626	HEK293 (embryonic kidney)	PEAKS038725
EXP035872	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O75840	HEK293 (embryonic kidney)	PEAKS038726
EXP035873	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P08047	HEK293 (embryonic kidney)	PEAKS038727
EXP035874	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P10074	HEK293 (embryonic kidney)	PEAKS038728
EXP035875	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P10075	HEK293 (embryonic kidney)	PEAKS038729
EXP035876	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P13682	HEK293 (embryonic kidney)	PEAKS038730
EXP035877	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P15622	HEK293 (embryonic kidney)	PEAKS038731
EXP035878	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17019	HEK293 (embryonic kidney)	PEAKS038732
EXP035879	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17022	HEK293 (embryonic kidney)	PEAKS038733
EXP035880	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17032	HEK293 (embryonic kidney)	PEAKS038734
EXP035881	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17098	HEK293 (embryonic kidney)	PEAKS038735
EXP035882	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P28698	HEK293 (embryonic kidney)	PEAKS038736
EXP035883	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P36508	HEK293 (embryonic kidney)	PEAKS038737
EXP035884	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P52737	HEK293 (embryonic kidney)	PEAKS038738
EXP035885	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P52738	HEK293 (embryonic kidney)	PEAKS038739
EXP035886	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P52741	HEK293 (embryonic kidney)	PEAKS038740
EXP035887	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P56270	HEK293 (embryonic kidney)	PEAKS038741
EXP035888	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P59817	HEK293 (embryonic kidney)	PEAKS038742
EXP035889	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q02086	HEK293 (embryonic kidney)	PEAKS038743
EXP035890	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q03923	HEK293 (embryonic kidney)	PEAKS038744
EXP035891	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q06730	HEK293 (embryonic kidney)	PEAKS038745
EXP035892	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q06889	HEK293 (embryonic kidney)	PEAKS038746
EXP035893	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q0VGE8	HEK293 (embryonic kidney)	PEAKS038747
EXP035894	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q13351	HEK293 (embryonic kidney)	PEAKS038748
EXP035895	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q15072	HEK293 (embryonic kidney)	PEAKS038749
EXP035896	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q3ZCT1	HEK293 (embryonic kidney)	PEAKS038750
EXP035897	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q53GI3	HEK293 (embryonic kidney)	PEAKS038751
EXP035898	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q5HYK9	HEK293 (embryonic kidney)	PEAKS038752
EXP035899	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6IQ21	HEK293 (embryonic kidney)	PEAKS038753
EXP035900	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6NX45	HEK293 (embryonic kidney)	PEAKS038754
EXP035901	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6P9A3	HEK293 (embryonic kidney)	PEAKS038755
EXP035902	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6P9G9	HEK293 (embryonic kidney)	PEAKS038756
EXP035903	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6U7Q0	HEK293 (embryonic kidney)	PEAKS038757
EXP035904	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6ZN55	HEK293 (embryonic kidney)	PEAKS038758
EXP035905	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q7Z7K2	HEK293 (embryonic kidney)	PEAKS038759
EXP035906	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q86TJ5	HEK293 (embryonic kidney)	PEAKS038760
EXP035907	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q86UD4	HEK293 (embryonic kidney)	PEAKS038761
EXP035908	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IVP9	HEK293 (embryonic kidney)	PEAKS038762
EXP035909	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IWY8	HEK293 (embryonic kidney)	PEAKS038763
EXP035910	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IYB9	HEK293 (embryonic kidney)	PEAKS038764
EXP035911	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IZ26	HEK293 (embryonic kidney)	PEAKS038765
EXP035912	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N141	HEK293 (embryonic kidney)	PEAKS038766
EXP035913	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N2R0	HEK293 (embryonic kidney)	PEAKS038767
EXP035914	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N8E2	HEK293 (embryonic kidney)	PEAKS038768
EXP035915	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N9F8	HEK293 (embryonic kidney)	PEAKS038769
EXP035916	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NBF1	HEK293 (embryonic kidney)	PEAKS038770
EXP035917	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NCA9	HEK293 (embryonic kidney)	PEAKS038771
EXP035918	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TA94	HEK293 (embryonic kidney)	PEAKS038772
EXP035919	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TC21	HEK293 (embryonic kidney)	PEAKS038773
EXP035920	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TF45	HEK293 (embryonic kidney)	PEAKS038774
EXP035921	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TF68	HEK293 (embryonic kidney)	PEAKS038775
EXP035922	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q92664	HEK293 (embryonic kidney)	PEAKS038776
EXP035923	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96BR6	HEK293 (embryonic kidney)	PEAKS038777
EXP035924	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96HQ0	HEK293 (embryonic kidney)	PEAKS038778
EXP035925	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96LW9	HEK293 (embryonic kidney)	PEAKS038779
EXP035926	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96MU6	HEK293 (embryonic kidney)	PEAKS038780
EXP035927	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96PE6	HEK293 (embryonic kidney)	PEAKS038781
EXP035928	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q99592	HEK293 (embryonic kidney)	PEAKS038782
EXP035929	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q99676	HEK293 (embryonic kidney)	PEAKS038783
EXP035930	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9BWW7	HEK293 (embryonic kidney)	PEAKS038784
EXP035931	znf341	Homo sapiens		NULL	421	unspecified	Q9BYN7	HEK293 (embryonic kidney)	PEAKS038785
EXP035932	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9C0F3	HEK293 (embryonic kidney)	PEAKS038786
EXP035933	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9H5H4	HEK293 (embryonic kidney)	PEAKS038787
EXP035934	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9HBE1	HEK293 (embryonic kidney)	PEAKS038788
EXP035935	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NPC7	HEK293 (embryonic kidney)	PEAKS038789
EXP035936	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NQX0	HEK293 (embryonic kidney)	PEAKS038790
EXP035937	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NXT0	HEK293 (embryonic kidney)	PEAKS038791
EXP035938	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NZL3	HEK293 (embryonic kidney)	PEAKS038792
EXP035939	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9UL59	HEK293 (embryonic kidney)	PEAKS038793
EXP035940	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9ULM2	HEK293 (embryonic kidney)	PEAKS038794
EXP035941	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y2X9	HEK293 (embryonic kidney)	PEAKS038795
EXP035942	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y473	HEK293 (embryonic kidney)	PEAKS038796
EXP035943	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y4X4	HEK293 (embryonic kidney)	PEAKS038797
EXP035944	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	A2RRD8	HEK293 (embryonic kidney)	PEAKS038798
EXP035945	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O95863	HEK293 (embryonic kidney)	PEAKS038799
EXP035946	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P10073	HEK293 (embryonic kidney)	PEAKS038800
EXP035947	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P11161	HEK293 (embryonic kidney)	PEAKS038801
EXP035948	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17026	HEK293 (embryonic kidney)	PEAKS038802
EXP035949	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17039	HEK293 (embryonic kidney)	PEAKS038803
EXP035950	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P25490	HEK293 (embryonic kidney)	PEAKS038804
EXP035951	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P49711	HEK293 (embryonic kidney)	PEAKS038805
EXP035952	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P51814	HEK293 (embryonic kidney)	PEAKS038806
EXP035953	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P58317	HEK293 (embryonic kidney)	PEAKS038807
EXP035954	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q02446	HEK293 (embryonic kidney)	PEAKS038808
EXP035955	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q15916	HEK293 (embryonic kidney)	PEAKS038809
EXP035956	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q3MIS6	HEK293 (embryonic kidney)	PEAKS038810
EXP035957	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NEM1	HEK293 (embryonic kidney)	PEAKS038811
EXP035958	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NHY6	HEK293 (embryonic kidney)	PEAKS038812
EXP035959	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TBZ5	HEK293 (embryonic kidney)	PEAKS038813
EXP035960	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96MM3	HEK293 (embryonic kidney)	PEAKS038814
EXP035961	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96NG8	HEK293 (embryonic kidney)	PEAKS038815
EXP035962	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96PQ6	HEK293 (embryonic kidney)	PEAKS038816
EXP035963	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96SR6	HEK293 (embryonic kidney)	PEAKS038817
EXP035964	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9GZX5	HEK293 (embryonic kidney)	PEAKS038818
EXP035965	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9H4T2	HEK293 (embryonic kidney)	PEAKS038819
EXP035966	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9HCK0	HEK293 (embryonic kidney)	PEAKS038820
EXP035967	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NPA5	HEK293 (embryonic kidney)	PEAKS038821
EXP035968	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NQX6	HEK293 (embryonic kidney)	PEAKS038822
EXP035969	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9UIH9	HEK293 (embryonic kidney)	PEAKS038823
EXP035970	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y2Q1	HEK293 (embryonic kidney)	PEAKS038824
EXP035971	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y330	HEK293 (embryonic kidney)	PEAKS038825
EXP035974	smad2	Mus musculus		EXP035972	279	unspecified	Q62432	embryonic stem cell-drived neuroepithelial cells	PEAKS038826
EXP035975	smad3	Mus musculus		EXP035973	279	unspecified	Q8BUN5	embryonic stem cell-drived neuroepithelial cells	PEAKS038827
EXP035978	anti-UBTF (Millipore # MABE195)	Homo sapiens		EXP035976	396	unspecified	P17480	WA09 (embryonic stem cells)	PEAKS038828
EXP035979	anti-UBTF (Millipore # MABE195)	Homo sapiens	50 ng/mL Activin A for 6 hours	EXP035976	396	unspecified	P17480	WA09 (embryonic stem cells)	PEAKS038829
EXP035981	HIF-1alpha	Homo sapiens		EXP035980	375	unspecified	Q16665	NCI-H1299 (large cell lung carcinoma)	PEAKS038830
EXP035982	CTCF (Millipore, catalog# 07-729)	Homo sapiens		NULL	665	unspecified	P49711	SK-N-SH (neuroblastoma)	PEAKS038831
EXP035984	sc543x	Homo sapiens	100nM E2, 120min	EXP035983	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038832
EXP035986	Anti-Wiz NBP180586, Novus Biologicals, USA	Mus musculus		EXP035985	25	unspecified	O88286	cerebellum	PEAKS038833
EXP035989	E2f4 (Santa Cruz, sc-866x)	Mus musculus		EXP035987	5	unspecified	Q8R0K9	liver	PEAKS038834
EXP035990	E2f4 (Santa Cruz, sc-866x)	Mus musculus	Arid1a KO	EXP035988	5	unspecified	Q8R0K9	liver	PEAKS038835
EXP035998	anti-NR1H2 (Active Motif, 61178)	Homo sapiens	GW3965 2h	EXP035991	452	unspecified	P55055	HT29 (colon adenocarcinoma)	PEAKS038836
EXP035999	anti-NR1H2 (Active Motif, 61178)	Homo sapiens	GW3965 48h	EXP035992	452	unspecified	P55055	HT29 (colon adenocarcinoma)	PEAKS038837
EXP036000	anti-FLAG (Sigma, F1804)	Homo sapiens	GW3965 2h	EXP035993	452	unspecified	Q13133	HT29 (colon adenocarcinoma)	PEAKS038838
EXP036001	anti-FLAG (Sigma, F1804)	Homo sapiens	GW3965 48h	EXP035994	452	unspecified	Q13133	HT29 (colon adenocarcinoma)	PEAKS038839
EXP036002	anti-PPARG (Santa Cruz, sc-7273)	Homo sapiens	Rosiglitazone 2h	EXP035995	452	unspecified	P37231	HT29 (colon adenocarcinoma)	PEAKS038840
EXP036003	anti-PPARG (Santa Cruz, sc-7273)	Homo sapiens	Rosiglitazone 48h	EXP035996	452	unspecified	P37231	HT29 (colon adenocarcinoma)	PEAKS038841
EXP036004	anti-JunD (Santa Cruz, sc-74)	Homo sapiens	DMSO	EXP035997	452	unspecified	P17535	HT29 (colon adenocarcinoma)	PEAKS038842
EXP036006	Bmal1 (Santa Cruz, catalog# sc-8550, lot# J1211 )	Mus musculus		EXP036005	12	unspecified	Q9WTL8	MEF (mouse embryonic fibroblasts)	PEAKS038843
EXP036008		Mus musculus	unstimulated	EXP036007	159	unspecified	P48377	cortical neurons	PEAKS038844
EXP036009		Mus musculus	KCl Depolarized 1 hour	EXP036007	159	unspecified	P48377	cortical neurons	PEAKS038845
EXP036010		Mus musculus		EXP036007	159	unspecified	P48377	cortical neurons	PEAKS038846
EXP036013	p53-DO1 (Santa Cruz, catalog# sc126, lot#K2613)	Homo sapiens	DMSO	EXP036011	891	unspecified	P04637	dermal fibroblasts	PEAKS038847
EXP036014	p53-DO1 (Santa Cruz, catalog# sc126, lot#K2613)	Homo sapiens	Nutlin-3a 10 Î¼M	EXP036012	891	unspecified	P04637	dermal fibroblasts	PEAKS038848
EXP036021	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036015	892	unspecified	Q01094	MSC (mesenchymal stem cells)	PEAKS038849
EXP036022	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036016	892	unspecified	Q01094	MSC (mesenchymal stem cells)	PEAKS038850
EXP036023	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036017	892	unspecified	Q01094	MSC (mesenchymal stem cells)	PEAKS038851
EXP036024	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036018	892	unspecified	Q01094	MSC (mesenchymal stem cells)	PEAKS038852
EXP036025	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036019	892	unspecified	Q01094	MSC (mesenchymal stem cells)	PEAKS038853
EXP036026	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036020	892	unspecified	Q01094	MSC (mesenchymal stem cells)	PEAKS038854
EXP036028	prop1	Mus musculus		EXP036027	330	unspecified	P97458	GHFT1 (pituitary cell line)	PEAKS038855
EXP036030	HA (ab9110 , Abcam)	Homo sapiens	HA-OmoMYCwt, Doxycycline	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038856
EXP036031	c-MYC (N262, Santa Cruz)	Homo sapiens	empty vector	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038857
EXP036032	c-MYC (N262, Santa Cruz)	Homo sapiens	empty vector, Doxycycline	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038858
EXP036033	c-MYC (N262, Santa Cruz)	Homo sapiens	HA-OmoMYCwt	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038859
EXP036034	c-MYC (N262, Santa Cruz)	Homo sapiens	HA-OmoMYCwt, Doxycycline	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038860
EXP036035	HES1 (H-140), Santa CruzÃ¯Â¼? Cat # sc-25392, Lot # : I2413	Mus musculus		NULL	81	unspecified	P35428	BMDM (bone marrow-derived macrophages)	PEAKS038861
EXP036036	HES1 (H-140), Santa CruzÃ¯Â¼? Cat # sc-25392, Lot # : I2413	Mus musculus	LPS for 1 hour	NULL	81	unspecified	P35428	BMDM (bone marrow-derived macrophages)	PEAKS038862
EXP036039	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens	Dox	EXP036037	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038863
EXP036040	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens		EXP036037	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038864
EXP036041	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens	siCTR	EXP036038	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038865
EXP036042	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens	siMYC	EXP036038	848	unspecified	P01106	U2OS (osteosarcoma)	PEAKS038866
EXP036046	ZFP57 (Abcam, ab45341)	Mus musculus		EXP036043	37	unspecified	Q8C6P8	A3 (embryonic stem cells)	PEAKS038867
EXP036047	ZFP57 (Abcam, ab45341)	Mus musculus	Zfp57 -/-	EXP036044	37	unspecified	Q8C6P8	A3 (embryonic stem cells)	PEAKS038868
EXP036048	ZFP57 (Abcam, ab45341)	Mus musculus		EXP036045	230	unspecified	Q8C6P8	ES-E14 (E14, embryonic stem cells)	PEAKS038869
EXP036051	Avi-tag (Vendor: Genescript,  cat# A01738)	Mus musculus		EXP036049	5	unspecified	O54790	liver	PEAKS038870
EXP036052	Avi-tag (Vendor: Genescript,  cat# A01738)	Mus musculus		EXP036050	5	unspecified	O54790	liver	PEAKS038871
EXP036054	sc-543X	Mus musculus		EXP036053	572	unspecified	P19785	mammary gland	PEAKS038872
EXP036055	sc-7208X	Mus musculus		EXP036053	572	unspecified	Q00175	mammary gland	PEAKS038873
EXP036063	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1)	EXP036056	1058	unspecified	P42230	CD4+ T-cells	PEAKS038874
EXP036064	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A DKO	EXP036057	1058	unspecified	P42230	CD4+ T-cells	PEAKS038875
EXP036065	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5B DKO	NULL	1058	unspecified	P42230	CD4+ T-cells	PEAKS038876
EXP036066	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A+/- STAT5B+/-	EXP036058	1058	unspecified	P42230	CD4+ T-cells	PEAKS038877
EXP036067	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1)	EXP036059	1058	unspecified	P42230	CD4+ T-cells	PEAKS038878
EXP036068	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5B DKO	EXP036060	1058	unspecified	P42230	CD4+ T-cells	PEAKS038879
EXP036069	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A DKO	EXP036061	1058	unspecified	P42230	CD4+ T-cells	PEAKS038880
EXP036070	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A+/- STAT5B+/-	EXP036062	1058	unspecified	P42230	CD4+ T-cells	PEAKS038881
EXP036073	Santa Cruz, sc-5361	Mus musculus		EXP036071	5	unspecified	P35584	liver	PEAKS038882
EXP036074	Santa Cruz, sc-5361	Mus musculus	FoxA1 and FoxA2 KO	EXP036072	5	unspecified	P35584	liver	PEAKS038883
EXP036075	Santa Cruz, sc-150	Mus musculus		EXP036071	5	unspecified	P28033	liver	PEAKS038884
EXP036076	Santa Cruz, sc-150	Mus musculus	FoxA1 and FoxA2 KO	EXP036072	5	unspecified	P28033	liver	PEAKS038885
EXP036077	Abcam, ab42898	Mus musculus		EXP036071	5	unspecified	P49698	liver	PEAKS038886
EXP036078	Abcam, ab42898	Mus musculus	FoxA1 and FoxA2 KO	EXP036072	5	unspecified	P49698	liver	PEAKS038887
EXP036080	Tcf3	Mus musculus	DSG, 2-day LPS stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	PEAKS038888
EXP036081	Tcf3	Mus musculus	2-day LPS stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	PEAKS038889
EXP036082	Tcf3	Mus musculus	DSG, 2-day anti-CD40 rIL-4 stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	PEAKS038890
EXP036083	Tcf3	Mus musculus	2-day anti-CD40 rIL-4 stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	PEAKS038891
EXP036084	Tcf3	Mus musculus	DSG, CD138- MACS-sorted	EXP036079	740	unspecified	P15806	preplasmablasts	PEAKS038892
EXP036085	Tcf3	Mus musculus	CD138- MACS-sorted	EXP036079	740	unspecified	P15806	preplasmablasts	PEAKS038893
EXP036086	Tcf3	Mus musculus	DSG, CD138+ MACS-sorted	EXP036079	723	unspecified	P15806	plasmablasts	PEAKS038894
EXP036087	Tcf3	Mus musculus	CD138+ MACS-sorted	EXP036079	723	unspecified	P15806	plasmablasts	PEAKS038895
EXP036088	Tcf3	Mus musculus	DSG, CD43â€“ and CD23+ MACS-sorted	EXP036079	41	unspecified	P15806	B-cells	PEAKS038896
EXP036089	Tcf3	Mus musculus	CD43â€“ and CD23+ MACS-sorted	EXP036079	41	unspecified	P15806	B-cells	PEAKS038897
EXP036095	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036090	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038898
EXP036096	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA against OCT1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036090	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038899
EXP036097	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036091	70	normal	P14859	LNCaP (prostate carcinoma)	PEAKS038900
EXP036098	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036091	70	normal	P14859	LNCaP (prostate carcinoma)	PEAKS038901
EXP036099	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: siRNA against FOXA1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P14859	LNCaP (prostate carcinoma)	PEAKS038902
EXP036100	anti-FOXA1 (Abcam, catalog ab94580)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS038903
EXP036101	anti-FOXA1 (Abcam, catalog ab94580)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS038904
EXP036102	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P14859	VCaP (prostate carcinoma)	PEAKS038905
EXP036103	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P14859	VCaP (prostate carcinoma)	PEAKS038906
EXP036104	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: siRNA against FOXA1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036090	71	normal	P14859	VCaP (prostate carcinoma)	PEAKS038907
EXP051010	anti-FOXA1 (Abcam, catalog ab94580)	Homo sapiens	Treatment: siRNA against OCT1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS049010
EXP036106	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS038909
EXP036107	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA against OCT1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS038910
EXP036108	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: vehicle control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036094	70	normal	P14859	LNCaP (prostate carcinoma)	PEAKS038911
EXP036109	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: PI polyamide Oct1-1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036094	70	normal	P14859	LNCaP (prostate carcinoma)	PEAKS038912
EXP036110	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: PI polyamide Oct1-3 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036094	70	normal	P14859	LNCaP (prostate carcinoma)	PEAKS038913
EXP036111	anti Myc-tag antibody (CST, 9B11, mouse mAb)	Mus musculus		NULL	2	unspecified	P13864	mESCs (mouse embryonic stem cells)	PEAKS038914
EXP036113	anti-IRF8 (SantaCruz, sc-6058x)	Mus musculus	no treatment	EXP036112	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS038915
EXP036114	anti-IRF8 (SantaCruz, sc-6058x)	Mus musculus	IFNg (400U/ml) 0.5h	EXP036112	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS038916
EXP036115	anti-IRF8 (SantaCruz, sc-6058x)	Mus musculus	IFNg (400U/ml) 3h	EXP036112	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	PEAKS038917
EXP036116	anti-IRF1 (SantaCruz, sc-640x)	Mus musculus	no treatment	EXP036112	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	PEAKS038918
EXP036117	anti-IRF1 (SantaCruz, sc-640x)	Mus musculus	IFNg (400U/ml) 0.5h	EXP036112	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	PEAKS038919
EXP036118	anti-IRF1 (SantaCruz, sc-640x)	Mus musculus	IFNg (400U/ml) 3h	EXP036112	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	PEAKS038920
EXP036119	anti-PU.1 (SantaCruz, sc-352x)	Mus musculus	no treatment	EXP036112	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS038921
EXP036120	anti-PU.1 (SantaCruz, sc-352x)	Mus musculus	IFNg (400U/ml) 0.5h	EXP036112	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS038922
EXP036121	anti-PU.1 (SantaCruz, sc-352x)	Mus musculus	IFNg (400U/ml) 3h	EXP036112	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	PEAKS038923
EXP036123	FOXF1, R&D Biosystems, AF4798, Lot#B1508	Mus musculus		EXP036122	561	unspecified	Q61080	lung	PEAKS038924
EXP036139	sp1	Homo sapiens		EXP036124	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS038925
EXP036140	sp1	Homo sapiens		EXP036125	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS038926
EXP036141	sp1	Homo sapiens		EXP036126	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS038927
EXP036142	sp1	Homo sapiens		EXP036127	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS038928
EXP036143	sp1	Homo sapiens		EXP036128	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS038929
EXP036144	sp1	Homo sapiens		EXP036129	417	unspecified	P08047	HCT-116 (colon carcinoma)	PEAKS038930
EXP036145	myc	Homo sapiens		EXP036130	417	unspecified	P01106	HCT-116 (colon carcinoma)	PEAKS038931
EXP036146	myc	Homo sapiens		EXP036131	417	unspecified	P01106	HCT-116 (colon carcinoma)	PEAKS038932
EXP036147	myc	Homo sapiens		EXP036132	417	unspecified	P01106	HCT-116 (colon carcinoma)	PEAKS038933
EXP036148	myc	Homo sapiens		EXP036133	417	unspecified	P01106	HCT-116 (colon carcinoma)	PEAKS038934
EXP036149	myc	Homo sapiens		EXP036134	417	unspecified	P01106	HCT-116 (colon carcinoma)	PEAKS038935
EXP036150	myc	Homo sapiens		EXP036135	417	unspecified	P01106	HCT-116 (colon carcinoma)	PEAKS038936
EXP036151	tcf7l1	Homo sapiens		EXP036136	417	unspecified	Q9HCS4	HCT-116 (colon carcinoma)	PEAKS038937
EXP036152	tcf7l1	Homo sapiens		EXP036137	417	unspecified	Q9HCS4	HCT-116 (colon carcinoma)	PEAKS038938
EXP036153	tcf7l1	Homo sapiens		EXP036138	417	unspecified	Q9HCS4	HCT-116 (colon carcinoma)	PEAKS038939
EXP036155	Oct4 (Santa Cruz, sc-5279)	Mus musculus	G1	EXP036154	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS038940
EXP036156	Oct4 (Santa Cruz, sc-5279)	Mus musculus	G2/M	EXP036154	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS038941
EXP036160	CTCF (#07-729, Millipore)	Homo sapiens	Normoxia	EXP036157	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS038942
EXP036161	CTCF (#07-729, Millipore)	Homo sapiens	Hypoxia	EXP036158	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS038943
EXP036162	CTCF (#07-729, Millipore)	Homo sapiens	Normoxia	EXP036159	30	unspecified	P49711	RCC 7860 (Renal cell carcinoma)	PEAKS038944
EXP036164	Flag (Sigma, F1804)	Homo sapiens	250 ng/ml doxycycline 6hrs	EXP036163	486	unspecified	Q9UBX2	LHCN-M2 (myoblasts)	PEAKS038945
EXP036167	HC-20, santacruz	Homo sapiens	Vehicle treatment	EXP036165	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038946
EXP036168	HC-20, santacruz	Homo sapiens	E2 treatment	EXP036165	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038947
EXP036169	HC-20, santacruz	Homo sapiens	Vehicle treatment	EXP036166	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038948
EXP036170	HC-20, santacruz	Homo sapiens	E2 treatment	EXP036166	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS038949
EXP036172	Pbx1/2/3 (Santa Cruz, sc-888)	Mus musculus		EXP036171	174	unspecified	P41778	cerebral cortex	PEAKS038950
EXP036173	Pbx1/2/3 (Santa Cruz, sc-888)	Mus musculus	PBX blocking peptide (Santa Cruz, sc-888P)	EXP036171	174	unspecified	P41778	cerebral cortex	PEAKS038951
EXP036175	Cell Signaling Technology D1Z9C	Mus musculus	100 nmol/L CDDO-Im for 3 h	EXP036174	1153	unspecified	Q60795	C2C12 (myoblasts)	PEAKS038952
EXP036178	Myc (D84C12) (CST, catalog# 5605, lot# 0004)	Rattus norvegicus	adenovirus encoding Myc	EXP036176	658	unspecified	P09416	neonatal cardiomyocytes	PEAKS038953
EXP036179	Myc (D84C12) (CST, catalog# 5605, lot# 0004)	Rattus norvegicus	adenovirus encoding LacZ control	EXP036177	658	unspecified	P09416	neonatal cardiomyocytes	PEAKS038954
EXP036180	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	826	unspecified	P41969	differentiated embryonic fibroblasts	PEAKS038955
EXP036181	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	826	unspecified	P41969	differentiated embryonic fibroblasts	PEAKS038956
EXP036182	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	826	unspecified	P41969	differentiated embryonic fibroblasts	PEAKS038957
EXP036183	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	181	unspecified	P41969	induced neural stem cell-like cells	PEAKS038958
EXP036184	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	138	unspecified	P41969	neural progenitors	PEAKS038959
EXP036185	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	826	unspecified	Q0VGT2	differentiated embryonic fibroblasts	PEAKS038960
EXP036186	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	826	unspecified	Q0VGT2	differentiated embryonic fibroblasts	PEAKS038961
EXP036187	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	826	unspecified	Q0VGT2	differentiated embryonic fibroblasts	PEAKS038962
EXP036188	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	181	unspecified	Q0VGT2	induced neural stem cell-like cells	PEAKS038963
EXP036189	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	138	unspecified	Q0VGT2	neural progenitors	PEAKS038964
EXP036190	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against NTC (non targeting control); Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: none	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038965
EXP036191	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh1; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038966
EXP036192	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh2; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038967
EXP036193	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh3; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038968
EXP036194	anti-AR	Homo sapiens	Treatment: 24 hours of R1881 and shRNA against NTC (non targeting control); Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: none	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038969
EXP036195	anti-AR	Homo sapiens	Treatment: 24 hours of R1881 and shRNA against PRMT5 sh1; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038970
EXP036196	anti-AR	Homo sapiens	Treatment: 24 hours of R1881 and shRNA against PRMT5 sh2; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS038971
EXP036197	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against NTC (non targeting control); Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: none	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS038972
EXP036198	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh1; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS038973
EXP036199	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh2; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS038974
EXP036200	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh3; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS038975
EXP036202	EBF1	Mus musculus		EXP036201	105	unspecified	Q07802	pro-B cells	PEAKS038976
EXP036207	EBF1	Mus musculus	ebf1 delta C	EXP036206	2392	unspecified	Q07802	fetal liver	PEAKS038979
EXP036209	Pbx1/2/3 (Santa Cruz, sc-888)	Mus musculus		EXP036208	174	unspecified	P41778	cerebral cortex	PEAKS038980
EXP036210	Pbx1/2/3 (Santa Cruz, sc-888) mixed with the PBX blocking peptide (Santa Cruz, sc-888P) at 1:400 molar ratio	Mus musculus	PBX blocking peptide (Santa Cruz, sc-888P)	EXP036208	174	unspecified	P41778	cerebral cortex	PEAKS038981
EXP036212	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus		EXP036211	3	unspecified	Q3UV55	epididymal white adipose tissue	PEAKS038982
EXP036217	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036213	919	unspecified	O08584	oligodendrocyte progenitors	PEAKS038983
EXP036218	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036214	919	unspecified	O08584	oligodendrocyte progenitors	PEAKS038984
EXP036219	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036215	905	unspecified	O08584	immature oligodendrocytes	PEAKS038985
EXP036220	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036216	905	unspecified	O08584	immature oligodendrocytes	PEAKS038986
EXP036221	c-Fos (Santa Cruz Biotechnology, catalog# sc-253-X)	Mus musculus	0d	NULL	203	unspecified	P01101	Flk1+ hemangioblasts	PEAKS038987
EXP036222	c-Jun (Santa Cruz Biotechnology, catalog# sc-1694-X)	Mus musculus	0d	NULL	203	unspecified	P05627	Flk1+ hemangioblasts	PEAKS038988
EXP036223	TEAD4 (Abcam, catalog# ab58310)	Mus musculus	0d	NULL	203	unspecified	Q62296	Flk1+ hemangioblasts	PEAKS038989
EXP036224	TEAD4 (Abcam, catalog# ab58310)	Mus musculus	1d	NULL	203	unspecified	Q62296	Flk1+ hemangioblasts	PEAKS038990
EXP036225	TEAD4 (Abcam, catalog# ab58310)	Mus musculus	0d	NULL	868	unspecified	Q62296	hemogenic endothelium	PEAKS038991
EXP036226	sc-253-X	Mus musculus	0d	NULL	203	unspecified	P05627	Flk1+ hemangioblasts	PEAKS038992
EXP036227	jun	Mus musculus	1d	NULL	203	unspecified	P05627	Flk1+ hemangioblasts	PEAKS038993
EXP036228	blimp1	Mus musculus		NULL	2479	unspecified	Q60636	CD8+ T-cells	PEAKS038994
EXP036229	anti-GR (Santa Cruz Biotechnology, sc-1003)	Homo sapiens	dex	NULL	38	unspecified	P04150	A549 (lung carcinoma)	PEAKS038995
EXP036230	anti-GR (Santa Cruz Biotechnology, sc-1003)	Homo sapiens	etoh	NULL	38	unspecified	P04150	A549 (lung carcinoma)	PEAKS038996
EXP036234	oct2	Homo sapiens		EXP036231	407	unspecified	P09086	HBL1 (diffuse large B-cell lymphoma)	PEAKS038997
EXP036235	oct2	Homo sapiens		EXP036232	407	unspecified	P09086	HBL1 (diffuse large B-cell lymphoma)	PEAKS038998
EXP036236	oct2	Homo sapiens		EXP036233	92	unspecified	P09086	BJAB (Burkitt lymphoma)	PEAKS038999
EXP036239	anti-NR4A1 (Santa Cruz, sc-990)	Homo sapiens	NR4A1 mRNA electroporation	EXP036237	516	unspecified	P22736	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039000
EXP036240	anti-NR4A1 (Santa Cruz, sc-990)	Homo sapiens	NR4A1 mRNA electroporation	EXP036238	516	unspecified	P22736	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039001
EXP036242	rabbit monoclonal anti-NRF2 (Abcam, Clone ID EP1808Y)	Homo sapiens		EXP036241	342	unspecified	Q16236	GM12763 (female B-cells)	PEAKS039002
EXP036243	Flag (M2 affinity gel, Sigma), TRF2 (in house)	Mus musculus		NULL	32	unspecified	P62340	testis	PEAKS039003
EXP036244	Flag (M2 affinity gel, Sigma), TRF2 (in house)	Mus musculus	TRF2 -/-	NULL	32	unspecified	P62340	testis	PEAKS039004
EXP036245	TBP (ab28175, Abcam), TBP (ab51841, Abcam)	Mus musculus		NULL	32	unspecified	P29037	testis	PEAKS039005
EXP036246	TBP (ab28175, Abcam), TBP (ab51841, Abcam)	Mus musculus	TRF2 -/-	NULL	32	unspecified	P29037	testis	PEAKS039006
EXP036248	Santa Cruz FOXM1-C20 (sc-502)	Homo sapiens		EXP036247	857	unspecified	Q08050	VAL-3 (embryonic stem cells)	PEAKS039007
EXP036250	ISL1 Abcam ab109517	Mus musculus		EXP036249	231	unspecified	P61372	E14-derived embryonic cardiac progenitor cells	PEAKS039008
EXP036253	Abcam ab25949	Homo sapiens		EXP036251	332	unspecified	Q06330	glioblastoma cells	PEAKS039009
EXP036254	Abcam ab25949	Homo sapiens		EXP036252	332	unspecified	Q06330	glioblastoma cells	PEAKS039010
EXP036256	p65	Homo sapiens	TNF	EXP036255	87	unspecified	Q04206	BEAS-2B (bronchial epithelium)	PEAKS039011
EXP036257	GR	Homo sapiens	dexamethasone	EXP036255	87	unspecified	P04150	BEAS-2B (bronchial epithelium)	PEAKS039012
EXP036258	GR	Homo sapiens	dexamethasone + TNF	EXP036255	87	unspecified	P04150	BEAS-2B (bronchial epithelium)	PEAKS039013
EXP036259	p65	Homo sapiens	dexamethasone + TNF	EXP036255	87	unspecified	Q04206	BEAS-2B (bronchial epithelium)	PEAKS039014
EXP036260	GR	Homo sapiens	vehicle	EXP036255	87	unspecified	P04150	BEAS-2B (bronchial epithelium)	PEAKS039015
EXP036261	p65	Homo sapiens	vehicle	EXP036255	87	unspecified	Q04206	BEAS-2B (bronchial epithelium)	PEAKS039016
EXP036266	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus		EXP036262	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039017
EXP036267	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3	EXP036262	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039018
EXP036268	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus		EXP036262	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039019
EXP036269	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3	EXP036262	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039020
EXP036270	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus		EXP036262	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	PEAKS039021
EXP036271	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus		EXP036262	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	PEAKS039022
EXP036272	C/EBP? (14AA, sc-61, lot# J1811)	Mus musculus		EXP036262	575	unspecified	P53566	bone marrow-derived mesenchymal stem cells	PEAKS039023
EXP036273	PPAR? (81B8, 2443s, lot# 2)	Mus musculus		EXP036262	575	unspecified	P37238	bone marrow-derived mesenchymal stem cells	PEAKS039024
EXP036274	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039025
EXP036275	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3 + osteogenic media day 7	EXP036263	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039026
EXP036276	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039027
EXP036277	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3 + osteogenic media day 7	EXP036263	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039028
EXP036278	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	PEAKS039029
EXP036279	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	PEAKS039030
EXP036280	C/EBP? (14AA, sc-61, lot# J1811)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P53566	bone marrow-derived mesenchymal stem cells	PEAKS039031
EXP036281	PPAR? (81B8, 2443s, lot# 2)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P37238	bone marrow-derived mesenchymal stem cells	PEAKS039032
EXP036282	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039033
EXP036283	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3 + osteogenic media day 15	EXP036264	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039034
EXP036284	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039035
EXP036285	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3 + osteogenic media day 15	EXP036264	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039036
EXP036286	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	PEAKS039037
EXP036287	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	PEAKS039038
EXP036288	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039039
EXP036289	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3 + adipose media day 7	EXP036265	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	PEAKS039040
EXP036290	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039041
EXP036291	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3 + adipose media day 7	EXP036265	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	PEAKS039042
EXP036292	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	PEAKS039043
EXP036293	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	PEAKS039044
EXP036294	C/EBP? (14AA, sc-61, lot# J1811)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P53566	bone marrow-derived mesenchymal stem cells	PEAKS039045
EXP036295	PPAR? (81B8, 2443s, lot# 2)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P37238	bone marrow-derived mesenchymal stem cells	PEAKS039046
EXP036297	GFP (Abcam, ab290)	Homo sapiens	GFP-GATAD2A	EXP036296	422	unspecified	Q86YP4	HeLa Kyoto (cervical adenocarcinoma)	PEAKS039047
EXP036298	GFP (Abcam, ab290)	Homo sapiens	GFP-GATAD2B	EXP036296	422	unspecified	Q8WXI9	HeLa Kyoto (cervical adenocarcinoma)	PEAKS039048
EXP036305	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036299	318	unspecified	Q06710	FT33 (fallopian tube secretory cells)	PEAKS039049
EXP036306	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036300	316	unspecified	Q06710	FT194 (fallopian tube secretory cells)	PEAKS039050
EXP036307	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036301	317	unspecified	Q06710	FT246 (fallopian tube secretory cells)	PEAKS039051
EXP036308	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036302	529	unspecified	Q06710	KURAMOCHI (high grade ovarian serous adenocarcinoma)	PEAKS039052
EXP036309	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036303	702	unspecified	Q06710	OVSAHO (high grade ovarian serous adenocarcinoma)	PEAKS039053
EXP036310	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036304	508	unspecified	Q06710	JHOS4 (high grade ovarian serous adenocarcinoma)	PEAKS039054
EXP036312	Tbx1	Mus musculus		EXP036311	706	unspecified	P70323	P19CL6 (embryonic carcinoma)	PEAKS039055
EXP036314	Cxxc1	Mus musculus	Cxxc1 +/-	NULL	171	unspecified	Q9CWW7	CD4+ CD8+ T cells	PEAKS039056
EXP036315	Cxxc1	Mus musculus		EXP036313	171	unspecified	Q9CWW7	CD4+ CD8+ T cells	PEAKS039057
EXP036316	znf618	Homo sapiens		NULL	10	unspecified	Q5T7W0	HEK293T (embryonic kidney)	PEAKS039058
EXP036317	Olig2 (Millipore, cat# AB9610)	Mus musculus		NULL	109	unspecified	Q9EQW6	glioma	PEAKS039059
EXP036318	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus		NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS039060
EXP036319	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus	dox	NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS039061
EXP036320	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus	sr3	NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS039062
EXP036321	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus	sr8	NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	PEAKS039063
EXP036325	ab16898	Homo sapiens	None	EXP036322	790	unspecified	P04198	Tet21N (neuroblastoma)	PEAKS039064
EXP036326	ab16898	Homo sapiens	0.2 ug/mL DOX for 24HR	EXP036323	790	unspecified	P04198	Tet21N (neuroblastoma)	PEAKS039065
EXP036327	ab16898	Homo sapiens	0.2 ug/mL DOX for 2HR	EXP036324	790	unspecified	P04198	Tet21N (neuroblastoma)	PEAKS039066
EXP036334	ab16898	Homo sapiens		EXP036328	82	unspecified	P04198	SK-N-BE(2)-C (neuroblastoma)	PEAKS039067
EXP036335	ab50887	Homo sapiens		EXP036328	82	unspecified	Q15672	SK-N-BE(2)-C (neuroblastoma)	PEAKS039068
EXP036336	ab16898	Homo sapiens		EXP036329	520	unspecified	P04198	Kelly (neuroblastoma)	PEAKS039069
EXP036337	ab16898	Homo sapiens		EXP036330	669	unspecified	P04198	NGP (neuroblastoma)	PEAKS039070
EXP036338	ab16898	Homo sapiens		EXP036331	790	unspecified	P04198	Tet21N (neuroblastoma)	PEAKS039071
EXP036339	TWIST	Homo sapiens		NULL	790	unspecified	Q15672	Tet21N (neuroblastoma)	PEAKS039072
EXP036340	TWIST	Homo sapiens	0.2 ug/mL DOX for 24HR	EXP036332	790	unspecified	Q15672	Tet21N (neuroblastoma)	PEAKS039073
EXP036341	ab16898	Homo sapiens	0.2 ug/mL DOX for 24HR	EXP036332	790	unspecified	P04198	Tet21N (neuroblastoma)	PEAKS039074
EXP036342	ab16898	Homo sapiens	0.2 ug/mL DOX for 2HR	EXP036333	790	unspecified	P04198	Tet21N (neuroblastoma)	PEAKS039075
EXP036343	ab50887	Homo sapiens	0.2 ug/mL DOX for 2HR	EXP036333	790	unspecified	Q15672	Tet21N (neuroblastoma)	PEAKS039076
EXP036346	FLAG M2 antibody (Sigma, catalog# F1804, lot# SLBK1346V)	Mus musculus		EXP036344	581	unspecified	Q8VI67	MC3T3-E1 (preosteoblasts)	PEAKS039077
EXP036347	FLAG M2 antibody (Sigma, catalog# F1804, lot# SLBK1346V)	Mus musculus		EXP036344	581	unspecified	Q8VI67	MC3T3-E1 (preosteoblasts)	PEAKS039078
EXP036348	Sp7 antibody (Abcam, catalog #ab22552, lot# GR193738-1)	Mus musculus		EXP036345	889	unspecified	Q8VI67	osteoblasts	PEAKS039079
EXP036357	PR	Homo sapiens	Vehicle	EXP036349	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS039080
EXP036358	ER	Homo sapiens	Vehicle	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039081
EXP036359	PR	Homo sapiens	10 nM Estradiol	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS039082
EXP036360	ER	Homo sapiens	10 nM Estradiol	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039083
EXP036361	PR	Homo sapiens	10 nM R5020	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS039084
EXP036362	ER	Homo sapiens	10 nM R5020	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039085
EXP036363	PR	Homo sapiens	10nM Estradiol + 10 nM R5020	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	PEAKS039086
EXP036364	ER	Homo sapiens	10nM Estradiol + 10 nM R5020	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039087
EXP036365	ER	Homo sapiens	Vehicle	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039088
EXP036366	ER	Homo sapiens	10 nM Estradiol	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039089
EXP036367	ER	Homo sapiens	10 nM R5020	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039090
EXP036368	ER	Homo sapiens	10nM Estradiol + 10 nM R5020	EXP036356	111	unspecified	P03372	T47D (invasive ductal carcinoma)	PEAKS039091
EXP036370	ERRa	Mus musculus		EXP036369	126	unspecified	O08580	C2C12 (myotubes)	PEAKS039092
EXP036371	KDM5A #1416 (gift Kaelin Lab DFCI)	Homo sapiens	DMSO	NULL	111	unspecified	P29375	T47D (invasive ductal carcinoma)	PEAKS039093
EXP036372	KDM5A #1416 (gift Kaelin Lab DFCI)	Homo sapiens	MK2206	NULL	111	unspecified	P29375	T47D (invasive ductal carcinoma)	PEAKS039094
EXP036376	anti-AP4 (in house)	Mus musculus		EXP036373	328	unspecified	Q9JIZ5	germinal center dark zone cells	PEAKS039095
EXP036377	anti-AP4 (in house)	Mus musculus		EXP036374	329	unspecified	Q9JIZ5	germinal center light zone cells	PEAKS039096
EXP036378	Anti-c-MYC (Santa cruz sc-764)	Mus musculus		EXP036375	41	unspecified	P01108	B-cells	PEAKS039097
EXP036381	Abcam ab15289	Mus musculus	DNMT3A overexpression	EXP036379	542	unspecified	P26323	leukemic cells	PEAKS039098
EXP036382	Abcam ab15289	Mus musculus		EXP036380	542	unspecified	P26323	leukemic cells	PEAKS039099
EXP036387	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	DMSO	EXP036383	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039100
EXP036388	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	E2	EXP036384	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039101
EXP036389	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	DMSO	EXP036385	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039102
EXP036390	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	E2	EXP036386	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039103
EXP036392	foxa1	Homo sapiens		EXP036391	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS039104
EXP036394	klf5	Mus musculus	day0 of differentiation	EXP036393	1153	unspecified	Q9Z0Z7	C2C12 (myoblasts)	PEAKS039105
EXP036395	klf5	Mus musculus	day2 of differentiation	EXP036393	1153	unspecified	Q9Z0Z7	C2C12 (myoblasts)	PEAKS039106
EXP036396	klf5	Mus musculus	day5 of differentiation	EXP036393	1153	unspecified	Q9Z0Z7	C2C12 (myoblasts)	PEAKS039107
EXP036397	MyoD	Mus musculus	day3 of differentiation	EXP036393	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS039108
EXP036398	MyoD	Mus musculus	day3 of differentiation, KLF5 KO	EXP036393	1153	unspecified	P10085	C2C12 (myoblasts)	PEAKS039109
EXP036399	In house aYY2 polyclonal rabbit serum	Mus musculus		NULL	836	unspecified	Q3TTC2	trophoblast precursors	PEAKS039110
EXP036400	Described in Garcia-TuÃ±on I et al. Stem Cell Res.(2011)7(1), 1-16. and in PÃ©rez-Palacios et al., 2016.	Mus musculus		NULL	836	unspecified	Q3TTC2	trophoblast precursors	PEAKS039111
EXP036402	Zfp281 (Abcam #ab101318)	Mus musculus		EXP036401	182	unspecified	Q99LI5	CJ7 (embryonic stem cells)	PEAKS039112
EXP036405	Runx1, rabbit (Aziz-Aloya R, 1998)	Mus musculus	RUNX-ERt2	EXP036403	298	unspecified	Q03347	FDC-P1 (lymphoblasts)	PEAKS039113
EXP036406	Runx1, rabbit (Aziz-Aloya R, 1998)	Mus musculus		EXP036404	298	unspecified	Q03347	FDC-P1 (lymphoblasts)	PEAKS039114
EXP036408	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor A	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	PEAKS039115
EXP036409	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor A	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	PEAKS039116
EXP036410	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor C	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	PEAKS039117
EXP036411	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor C	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	PEAKS039118
EXP036412	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor D	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	PEAKS039119
EXP036413	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor E	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	PEAKS039120
EXP036414	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor E	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	PEAKS039121
EXP036415	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor B	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	PEAKS039122
EXP036416	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor B	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	PEAKS039123
EXP036420	Nfib antibody (Sigma, #HPA003956)	Mus musculus		EXP036417	6	unspecified	P97863	16T (small cell lung carcinoma)	PEAKS039124
EXP036421	Nfib antibody (Sigma, #HPA003956)	Mus musculus		EXP036418	524	unspecified	P97863	KP1 (small cell lung carcinoma)	PEAKS039125
EXP036422	Nfib antibody (Sigma, #HPA003956)	Mus musculus		EXP036419	525	unspecified	P97863	KP22 (small cell lung carcinoma)	PEAKS039126
EXP036423	AML1-ETO (Diagenode, Cat. C15310197; Lot A706-001)	Homo sapiens		NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039127
EXP036424	AML1-ETO (Diagenode, Cat. C15310197; Lot A706-001)	Homo sapiens	MEIS2 KD	NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039128
EXP036428	anti-ChREBP (NB400-135, Novus Biologicals)	Rattus norvegicus		EXP036425	493	unspecified	Q8VIP2	INS-1E (pancreatic beta-cells)	PEAKS039129
EXP036429	anti-ChREBP (NB400-135, Novus Biologicals)	Rattus norvegicus	2h glucose	EXP036426	493	unspecified	Q8VIP2	INS-1E (pancreatic beta-cells)	PEAKS039130
EXP036430	anti-ChREBP (NB400-135, Novus Biologicals)	Rattus norvegicus	12h glucose	EXP036427	493	unspecified	Q8VIP2	INS-1E (pancreatic beta-cells)	PEAKS039131
EXP036432	HIF-2? (Novus, NB100-122)	Homo sapiens		EXP036431	87	unspecified	Q99814	BEAS-2B (bronchial epithelium)	PEAKS039132
EXP036439	err1	Homo sapiens	starved, PBS	EXP036436	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	PEAKS039133
EXP036440	err1	Homo sapiens	starved, 100uM EGF 90min	NULL	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	PEAKS039134
EXP036441	err1	Homo sapiens	starved, 100uM HRG 90min	NULL	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	PEAKS039135
EXP036442	err1	Homo sapiens	starved, PBS	EXP036433	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	PEAKS039136
EXP036443	err1	Homo sapiens	starved, 100uM EGF 90min	EXP036434	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	PEAKS039137
EXP036444	err1	Homo sapiens	starved, 100uM HRG 90min	EXP036435	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	PEAKS039138
EXP036445	err1	Homo sapiens	untreated	EXP036437	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	PEAKS039139
EXP036446	err1	Homo sapiens	lapatinib 2uM	EXP036438	556	unspecified	P11474	LR-SK-BR-3 (lapatinib-resistant breast adenocarcinoma)	PEAKS039140
EXP036448	Hox11	Mus musculus		EXP036447	485	unspecified	P43345	embryonic spleen mesenchymal cells	PEAKS039141
EXP036451	Streptavidin beads (Invitrogen; 14204)	Mus musculus	PLZF tg/BirA tg mice	EXP036449	44	unspecified	Q3UQ17	T-cells	PEAKS039142
EXP036452	plzf	Mus musculus	PLZF tg/BirA tg/Valpha14 tg mice	EXP036450	44	unspecified	Q3UQ17	T-cells	PEAKS039143
EXP036454	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		EXP036453	248	unspecified	P70390	E12.5 embryonic limb	PEAKS039144
EXP036455	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		NULL	249	unspecified	P70390	E13.5 embryonic limb	PEAKS039145
EXP036456	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		NULL	251	unspecified	P70390	E12.5 embryonic palate	PEAKS039146
EXP036457	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		NULL	250	unspecified	P70390	embryonic limb and palate mix	PEAKS039147
EXP036458	pbx	Mus musculus		EXP036453	248	unspecified	P41778	E12.5 embryonic limb	PEAKS039148
EXP036465	AR N-20 (SC-816)	Homo sapiens	72 hour CDT + 3 hour EtOH	EXP036459	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039149
EXP036466	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 0.5Î¼M PD-0332991 +3 hour 10nm DHT	EXP036460	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039150
EXP036467	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 5Î¼g/mL roscovitine + 3 hour DHT	EXP036461	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039151
EXP036468	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 2Î¼g/mL aphidicolin +3 hour 10nm DHT	EXP036462	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039152
EXP036469	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 1mM hydroxyurea +3 hour 10nm DHT	EXP036463	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039153
EXP036470	AR N-20 (SC-816)	Homo sapiens	2Î¼g/mL aphidicolin for 15 hours, followed by washout and treatment with 50ng/mL nocodozole for 9 hours +3 hour 10nm DHT	EXP036464	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039154
EXP036473	JARID1D (Bethyl, A301-750A, A310-624A)	Homo sapiens	None	EXP036471	223	unspecified	Q9BY66	DU145 (prostate carcinoma)	PEAKS039155
EXP036474	JARID1D (Bethyl, A301-750A, A310-624A)	Homo sapiens	None	EXP036472	223	unspecified	Q9BY66	DU145 (prostate carcinoma)	PEAKS039156
EXP036478	Santa Cruz, sc-150, C-19	Homo sapiens		EXP036477	464	unspecified	P17676	fetal osteoblasts	PEAKS039158
EXP036479	fra2	Homo sapiens		EXP036477	464	unspecified	P15408	fetal osteoblasts	PEAKS039159
EXP036480	Santa Cruz, sc-74,329	Homo sapiens		EXP036477	464	unspecified	P17535	fetal osteoblasts	PEAKS039160
EXP036481	BD Biosciences,  610922, 31/TEF-1	Homo sapiens		EXP036477	464	unspecified	P28347	fetal osteoblasts	PEAKS039161
EXP036482	Santa Cruz, sc-482, C-20	Homo sapiens		EXP036477	464	unspecified	P40763	fetal osteoblasts	PEAKS039162
EXP036485	anti-FS2 (Gift from Prof.Rob Klose; reference: Elife. 2012 Dec 18;1:e00205. doi: 10.7554/eLife.00205)	Mus musculus		EXP036483	2	unspecified	Q9Z248	mESCs (mouse embryonic stem cells)	PEAKS039163
EXP036486	anti-AEBP2 (generated in this study)	Mus musculus		EXP036484	2	unspecified	Q9Z248	mESCs (mouse embryonic stem cells)	PEAKS039164
EXP036489	anti-FLAG M2 mouse monoclonal (Sigma)	Homo sapiens	3xFLAG WT ZNF335	EXP036487	511	unspecified	Q9H4Z2	T-REx-Jurkat (T-cells)	PEAKS039165
EXP036490	anti-FLAG M2 mouse monoclonal (Sigma)	Homo sapiens	3xFLAG bloto (R1092W) ZNF335	EXP036488	511	unspecified	Q9H4Z2	T-REx-Jurkat (T-cells)	PEAKS039166
EXP036493	zfat	Mus musculus		EXP036492	139	unspecified	Q7TS63	thymus	PEAKS039167
EXP036494	zfat	Mus musculus		EXP036491	139	unspecified	Q7TS63	thymus	PEAKS039168
EXP036496	c-Myc	Homo sapiens		EXP036495	509	unspecified	P01106	Jurkat (T-cells)	PEAKS039169
EXP036497	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus		NULL	5	unspecified	Q3UV55	liver	PEAKS039170
EXP036498	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus		NULL	5	unspecified	Q3UV55	liver	PEAKS039171
EXP036499	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus		NULL	5	unspecified	Q3UV55	liver	PEAKS039172
EXP036500	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus	HNF6 KO	NULL	5	unspecified	Q3UV55	liver	PEAKS039173
EXP036501	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus	HNF6 KO	NULL	5	unspecified	Q3UV55	liver	PEAKS039174
EXP036502	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus	HNF6 KO	NULL	5	unspecified	Q3UV55	liver	PEAKS039175
EXP036504	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	TNF-alpha (1000 U/ml, 2h) + siFOXA1	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	PEAKS039176
EXP036505	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	PEAKS039177
EXP036506	anti-AR (Karvonen et al., 1997)	Homo sapiens	DHT (100nM, 2h) + TNF-alpha (1000U/ml, 2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039178
EXP036507	anti-AR (Karvonen et al., 1997)	Homo sapiens	DHT (100nM, 2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039179
EXP036508	anti-AR (Karvonen et al., 1997)	Homo sapiens	DMSO (2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039180
EXP036509	anti-AR (Karvonen et al., 1997)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039181
EXP036510	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	DHT (100nM, 2h) + TNF-alpha (1000U/ml, 2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039182
EXP036511	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	DHT (100nM, 2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039183
EXP036512	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	DMSO (2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039184
EXP036513	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039185
EXP036514	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	DHT (100nM, 2h) + TNF-alpha (1000U/ml, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	PEAKS039186
EXP036515	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	DHT (100nM, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	PEAKS039187
EXP036516	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	DMSO (2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	PEAKS039188
EXP036517	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	PEAKS039189
EXP036519	rabbit anti-Chx10	Mus musculus		EXP036518	180	unspecified	Q61412	motor neurons	PEAKS039190
EXP036521	goat anti-SOX2 (AF2018, R&D).	Mus musculus		EXP036520	810	unspecified	P48432	stomach	PEAKS039191
EXP036522	goat anti-SOX2 (AF2018, R&D).	Mus musculus	SOX2 KO	EXP036520	810	unspecified	P48432	stomach	PEAKS039192
EXP036523	oligo2	Rattus norvegicus		NULL	218	unspecified	G3V612	oligodendrocytes	PEAKS039193
EXP036524	oligo2	Rattus norvegicus	LPC (12.5 mM) for 6h	NULL	218	unspecified	G3V612	oligodendrocytes	PEAKS039194
EXP036525	STAT3 (Santa Cruz, sc-482)	Mus musculus	lactation day one	NULL	572	unspecified	P42227	mammary gland	PEAKS039195
EXP036526	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	heterozygous for Stat5, lactation day one	NULL	572	unspecified	P42230	mammary gland	PEAKS039196
EXP036527	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	one Stat5-null allele and one mutant allele, lactation day one	NULL	572	unspecified	P42230	mammary gland	PEAKS039197
EXP036528	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	lactation day one	NULL	572	unspecified	P42230	mammary gland	PEAKS039198
EXP036529	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	involution 12 hours	NULL	572	unspecified	P42230	mammary gland	PEAKS039199
EXP036530	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	involution 24 hours	NULL	572	unspecified	P42230	mammary gland	PEAKS039200
EXP036531	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day one	NULL	572	unspecified	P06537	mammary gland	PEAKS039201
EXP036532	GR (Thermo Scientific, PA1-511A)	Mus musculus	involution 12 hours	NULL	572	unspecified	P06537	mammary gland	PEAKS039202
EXP036533	GR (Thermo Scientific, PA1-511A)	Mus musculus	involution 24 hours	NULL	572	unspecified	P06537	mammary gland	PEAKS039203
EXP036534	STAT3 (Santa Cruz, sc-482)	Mus musculus	involution 12 hours	NULL	572	unspecified	P42227	mammary gland	PEAKS039204
EXP036535	STAT3 (Santa Cruz, sc-482)	Mus musculus	involution 24 hours	NULL	572	unspecified	P42227	mammary gland	PEAKS039205
EXP036536	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	homozygous for the Stat5 enhancer mutation, lactation day one	NULL	572	unspecified	P42230	mammary gland	PEAKS039206
EXP036537	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	homozygous for the Stat5 enhancer mutation, involution 12 hours	NULL	572	unspecified	P42230	mammary gland	PEAKS039207
EXP036538	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	homozygous for the Stat5 enhancer mutation, involution 24 hours	NULL	572	unspecified	P42230	mammary gland	PEAKS039208
EXP036540	anti-TEAD4 (ab58310; abcam)	Homo sapiens		EXP036539	795	unspecified	Q15561	SK-N-BE2 (neuroblastoma)	PEAKS039209
EXP036542	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 30 min of 10nM R1881; Time point: 30 min; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS039210
EXP036543	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 4 hours of 10nM R1881; Time point: 4 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS039211
EXP036544	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: 2 hours of Ethanol; Time point: 2 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P49711	VCaP (prostate carcinoma)	PEAKS039212
EXP036545	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: 2 hours of 10nM R1881; Time point: 2 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P49711	VCaP (prostate carcinoma)	PEAKS039213
EXP036547	gata2	Homo sapiens		EXP036546	517	unspecified	P23769	Kasumi-3 (adult acute myeloid leukemia with minimal differentiation)	PEAKS039214
EXP036549	anti-FLAG M2 (Sigma-Aldrich, Catalog no. F3165)	Homo sapiens		EXP036548	166	unspecified	Q9C0K0	CD34+ hematopoietic stem cells	PEAKS039215
EXP036550	BCL11B	Homo sapiens	mutant BCL11B	EXP036548	166	unspecified	Q9C0K0	CD34+ hematopoietic stem cells	PEAKS039216
EXP036551	Streptavidin (BioChIP using a Streptavidin pulldown; PMID:21552207)	Mus musculus		NULL	44	unspecified	P15806	T-cells	PEAKS039217
EXP036553	abcam ab3350	Homo sapiens	peak DMOG	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS039218
EXP036554	abcam ab3350	Homo sapiens	trough DMOG	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS039219
EXP036555	abcam ab3350	Homo sapiens	peak DMSO	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS039220
EXP036556	abcam ab3350	Homo sapiens	through DMSO	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	PEAKS039221
EXP036557	active motif (cat # 39665).	Homo sapiens	peak DMOG	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	PEAKS039222
EXP036558	active motif (cat # 39666).	Homo sapiens	trough DMOG	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	PEAKS039223
EXP036559	active motif (cat # 39667).	Homo sapiens	peak DMSO	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	PEAKS039224
EXP036560	active motif (cat # 39668).	Homo sapiens	through DMSO	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	PEAKS039225
EXP036562	Anti-CTCF antibody - ChIP Grade,ab70303	Homo sapiens		EXP036561	798	unspecified	P49711	SK-OV-3 (ovarian serous cystadenocarcinoma)	PEAKS039226
EXP036564	sc-53993	Homo sapiens		EXP036563	459	unspecified	P04198	hematopoietic stem cells and progenitors	PEAKS039227
EXP036569	NKX2-1 polyclonal (Santa Cruz Biotechnology #sc-13040 RRID:AB_10015210)	Mus musculus		EXP036566	158	unspecified	P50220	basal ganglia	PEAKS039228
EXP036570	LHX6 polyclonal (Genscript)	Mus musculus		EXP036568	158	unspecified	Q9R1R0	basal ganglia	PEAKS039229
EXP036573	Cell Signaling Technology #9743	Mus musculus	DMSO	EXP036571	214	unspecified	P70340	embryoid body (day 4)	PEAKS039230
EXP036574	Cell Signaling Technology #9743	Mus musculus	IWR1	EXP036572	214	unspecified	P70340	embryoid body (day 4)	PEAKS039231
EXP036576	PTF1A antiboby from RJ MacDonald	Mus musculus		EXP036575	713	unspecified	Q9QX98	pancreas	PEAKS039232
EXP036577	PTF1A antiboby from JE Johnson	Mus musculus		EXP036575	713	unspecified	Q9QX98	pancreas	PEAKS039233
EXP036579	rabbit antibody against human MIST1 provided by Mills JC. (Am J Pathol. 2010 Sep;177(3):1514-33.)	Mus musculus		EXP036578	713	unspecified	Q9QYC3	pancreas	PEAKS039234
EXP036580	rabbit antibody against rat MIST1 provided by Konieczny SF. (Dev Biol. 1997 Feb 1;182(1):101-13.)	Mus musculus		EXP036578	713	unspecified	Q9QYC3	pancreas	PEAKS039235
EXP036583	EMD Millipore/MABE911	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	O08900	pre-pro-B-cells	PEAKS039236
EXP036584	EMD Millipore/MABE911	Mus musculus		EXP036582	198	unspecified	O08900	pre-pro-B-cells	PEAKS039237
EXP036585	Santa Cruz Biotech/sc-6059x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	P15806	pre-pro-B-cells	PEAKS039238
EXP036586	Santa Cruz Biotech/sc-349x	Mus musculus		EXP036582	198	unspecified	P15806	pre-pro-B-cells	PEAKS039239
EXP036587	Abnova/H00001879-M01	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q07802	pre-pro-B-cells	PEAKS039240
EXP036588	Abnova/H00001879-M01	Mus musculus		EXP036582	198	unspecified	Q07802	pre-pro-B-cells	PEAKS039241
EXP036589	Santa Cruz Biotech/sc-349x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	P27577	pre-pro-B-cells	PEAKS039242
EXP036590	Santa Cruz Biotech/sc-350x	Mus musculus		EXP036582	198	unspecified	P27577	pre-pro-B-cells	PEAKS039243
EXP036591	EMD Millipore/MABE912 & MABE913	Mus musculus		EXP036582	198	unspecified	Q03267	pre-pro-B-cells	PEAKS039244
EXP036592	Santa Cruz Biotech/sc-6059x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q64287	pre-pro-B-cells	PEAKS039245
EXP036593	Santa Cruz Biotech/sc-6059x	Mus musculus		EXP036582	198	unspecified	Q64287	pre-pro-B-cells	PEAKS039246
EXP036594	Santa Cruz Biotech/sc-349x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q9Z0S2	pre-pro-B-cells	PEAKS039247
EXP036595	Santa Cruz Biotech/sc-6059x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q02650	pre-pro-B-cells	PEAKS039248
EXP036596	Santa Cruz Biotech/sc-6059x	Mus musculus		EXP036582	198	unspecified	Q02650	pre-pro-B-cells	PEAKS039249
EXP036597	BD Transduction Laboratories/610923	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	P30051	pre-pro-B-cells	PEAKS039250
EXP036598	BD Transduction Laboratories/610923	Mus musculus		EXP036582	198	unspecified	P30051	pre-pro-B-cells	PEAKS039251
EXP036600	rabbit-anti-Nrf2 monoclonal	Mus musculus		EXP036599	12	unspecified	Q60795	MEF (mouse embryonic fibroblasts)	PEAKS039252
EXP036601	rabbit-anti-Nrf2 polyclonal	Mus musculus		EXP036599	12	unspecified	Q60795	MEF (mouse embryonic fibroblasts)	PEAKS039253
EXP036603	Sp9 (homemade antibody)	Mus musculus		EXP036602	162	unspecified	Q64HY3	olfactory bulb	PEAKS039254
EXP036604	sc-13063	Mus musculus	No treatment (Chow)	NULL	5	unspecified	Q60641	liver	PEAKS039255
EXP036605	sc-13063	Mus musculus	TCA	NULL	5	unspecified	Q60641	liver	PEAKS039256
EXP036606	sc-13063	Mus musculus	Metformin	NULL	5	unspecified	Q60641	liver	PEAKS039257
EXP036607	sc-13063	Mus musculus	TCA+Metformin	NULL	5	unspecified	Q60641	liver	PEAKS039258
EXP036609	B2D and AFKJS-9 from eBioscience	Mus musculus		EXP036608	44	unspecified	P51450	T-cells	PEAKS039259
EXP036610	B2D and AFKJS-9 from eBioscience	Mus musculus	MRL-871	EXP036608	44	unspecified	P51450	T-cells	PEAKS039260
EXP036611	B2D and AFKJS-9 from eBioscience	Mus musculus	MRL-248	EXP036608	44	unspecified	P51450	T-cells	PEAKS039261
EXP036612	B2D and AFKJS-9 from eBioscience	Mus musculus	RORC -/-	EXP036608	44	unspecified	P51450	T-cells	PEAKS039262
EXP036615	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ RPMI+10%FBS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039263
EXP036616	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shFOXA1 RPMI+10%FBS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039264
EXP036617	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ phenolfree RPMI+5%FCS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039265
EXP036618	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shFOXA1 phenolfree RPMI+5%FCS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039266
EXP036619	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ phenolfree RPMI+5%FCS	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039267
EXP036620	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ csFCS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039268
EXP036621	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shFOXA1 csFCS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039269
EXP036622	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ FBS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039270
EXP036623	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shFOXA1 FBS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039271
EXP036624	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ R1881 (10nM,16h)	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039272
EXP036625	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ R1881 (10nM,16h)	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039273
EXP036626	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ R1881 (10nM,16h)	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039274
EXP036627	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shGATA2 R1881 (10nM,16h)	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039275
EXP036628	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	shGATA2 R1881 (10nM,16h)	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039276
EXP036629	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shGATA2 R1881 (10nM,16h)	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039277
EXP036630	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ EtOH	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039278
EXP036631	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ EtOH	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039279
EXP036632	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ EtOH	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039280
EXP036633	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shGATA2 EtOH	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	PEAKS039281
EXP036634	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	shGATA2 EtOH	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039282
EXP036635	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shGATA2 EtOH	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	PEAKS039283
EXP036636	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	Ad LacZ	EXP036613	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS039284
EXP036637	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	Ad GATA2	EXP036613	223	unspecified	P10275	DU145 (prostate carcinoma)	PEAKS039285
EXP036638	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ Normal	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039286
EXP036639	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	shFOXA1 Normal	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	PEAKS039287
EXP036643	Upstate 07-729	Homo sapiens		EXP036642	448	unspecified	P49711	retinal pigment epithelial cells	PEAKS039288
EXP036644	Santa Cruz SC-1082	Homo sapiens		EXP036642	448	unspecified	Q16254	retinal pigment epithelial cells	PEAKS039289
EXP036645	Abgent AP4646A	Homo sapiens		EXP036642	448	unspecified	Q03936	retinal pigment epithelial cells	PEAKS039290
EXP036646	AB21990	Homo sapiens		EXP036640	448	unspecified	P32243	retinal pigment epithelial cells	PEAKS039291
EXP036647	Active motif 39789	Homo sapiens		EXP036641	448	unspecified	O75030	retinal pigment epithelial cells	PEAKS039292
EXP036648	AB5790	Homo sapiens		EXP036640	448	unspecified	P26367	retinal pigment epithelial cells	PEAKS039293
EXP036649	SC-19342X	Homo sapiens		EXP036640	448	unspecified	P50458	retinal pigment epithelial cells	PEAKS039294
EXP036652	anti-FOXM1 (GTX-1000276 and GTX102170)	Homo sapiens		EXP036650	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	PEAKS039295
EXP036653	anti-GFP (ab290)	Homo sapiens	GFP-foxm1	EXP036651	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	PEAKS039296
EXP036654	anti-GFP (ab290)	Homo sapiens	GFP-foxm1 HA mut	EXP036651	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	PEAKS039297
EXP036655	anti-GFP (ab290)	Homo sapiens	GFP-foxm1 RA mut	EXP036651	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	PEAKS039298
EXP036666	sc52	Mus musculus		EXP036656	159	unspecified	P01101	cortical neurons	PEAKS039299
EXP036667	sc7202	Mus musculus		EXP036656	159	unspecified	P01101	cortical neurons	PEAKS039300
EXP036668	sc48	Mus musculus		EXP036656	159	unspecified	P13346	cortical neurons	PEAKS039301
EXP036669	sc52	Mus musculus	KCl stimulated	EXP036657	159	unspecified	P01101	cortical neurons	PEAKS039302
EXP036670	sc7202	Mus musculus	KCl stimulated	EXP036657	159	unspecified	P01101	cortical neurons	PEAKS039303
EXP036671	sc48	Mus musculus	KCl stimulated	EXP036657	159	unspecified	P13346	cortical neurons	PEAKS039304
EXP036672	sc52	Mus musculus		EXP036658	159	unspecified	P01101	cortical neurons	PEAKS039305
EXP036673	sc7202	Mus musculus		EXP036658	159	unspecified	P01101	cortical neurons	PEAKS039306
EXP036674	sc48	Mus musculus		EXP036658	159	unspecified	P13346	cortical neurons	PEAKS039307
EXP036675	sc46	Mus musculus		EXP036658	159	unspecified	P09450	cortical neurons	PEAKS039308
EXP036676	sc52	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P01101	cortical neurons	PEAKS039309
EXP036677	sc7202	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P01101	cortical neurons	PEAKS039310
EXP036678	sc48	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P13346	cortical neurons	PEAKS039311
EXP036679	sc46	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P09450	cortical neurons	PEAKS039312
EXP036680	sc52	Mus musculus	KCl stimulated, control shRNA	EXP036660	159	unspecified	P01101	cortical neurons	PEAKS039313
EXP036681	sc48	Mus musculus	KCl stimulated, control shRNA	EXP036660	159	unspecified	P13346	cortical neurons	PEAKS039314
EXP036682	sc52	Mus musculus	KCl stimulated, c-Fos shRNA	EXP036661	159	unspecified	P01101	cortical neurons	PEAKS039315
EXP036683	sc48	Mus musculus	KCl stimulated, FosB shRNA	EXP036662	159	unspecified	P13346	cortical neurons	PEAKS039316
EXP036684	sc52	Mus musculus	KCl stimulated, control shRNA	EXP036663	159	unspecified	P01101	cortical neurons	PEAKS039317
EXP036685	sc48	Mus musculus	KCl stimulated, control shRNA	EXP036663	159	unspecified	P13346	cortical neurons	PEAKS039318
EXP036686	sc52	Mus musculus	KCl stimulated, c-Fos shRNA	EXP036664	159	unspecified	P01101	cortical neurons	PEAKS039319
EXP036687	sc48	Mus musculus	KCl stimulated, FosB shRNA	EXP036665	159	unspecified	P13346	cortical neurons	PEAKS039320
EXP036689	M2 agarose (Sigma; F1804)	Homo sapiens	no exogenious myc expression	NULL	421	unspecified	P01106	HEK293 (embryonic kidney)	PEAKS039321
EXP036690	M2 agarose (Sigma; F1804)	Homo sapiens	WT-MYC expression	EXP036688	421	unspecified	P01106	HEK293 (embryonic kidney)	PEAKS039322
EXP036691	M2 agarose (Sigma; F1804)	Homo sapiens	WBM-MYC expressing	EXP036688	421	unspecified	P01106	HEK293 (embryonic kidney)	PEAKS039323
EXP036693	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens		NULL	455	unspecified	O75626	HUES64 (embryonic stem cells)	PEAKS039324
EXP036694	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens		NULL	455	unspecified	O75626	HUES64 (embryonic stem cells)	PEAKS039325
EXP036695	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens		EXP036692	455	unspecified	O75626	HUES64 (embryonic stem cells)	PEAKS039326
EXP036696	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens	HUES64 dEN	NULL	455	unspecified	O75626	HUES64 (embryonic stem cells)	PEAKS039327
EXP036697	CDX2(Novus,NB100-2136,A1)	Homo sapiens		NULL	455	unspecified	Q99626	HUES64 (embryonic stem cells)	PEAKS039328
EXP036698	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	PEAKS039329
EXP036699	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	PEAKS039330
EXP036700	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	PEAKS039331
EXP036701	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	PEAKS039332
EXP036702	EOMES(Abcam,ab23345,GR50189-1)	Homo sapiens		EXP036692	455	unspecified	O95936	HUES64 (embryonic stem cells)	PEAKS039333
EXP036703	FOXA1(Santa Cruz,sc-101058,H1111)	Homo sapiens		EXP036692	455	unspecified	P55317	HUES64 (embryonic stem cells)	PEAKS039334
EXP036704	FOXA1(Santa Cruz,sc-101058,H1111)	Homo sapiens		EXP036692	455	unspecified	P55317	HUES64 (embryonic stem cells)	PEAKS039335
EXP036705	FOXA2(Santa Cruz,sc-6554 X,C1810)	Homo sapiens		NULL	455	unspecified	Q9Y261	HUES64 (embryonic stem cells)	PEAKS039336
EXP036706	FOXA2	Homo sapiens		EXP036692	455	unspecified	Q9Y261	HUES64 (embryonic stem cells)	PEAKS039337
EXP036707	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens		EXP036692	455	unspecified	P43694	HUES64 (embryonic stem cells)	PEAKS039338
EXP036708	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens		NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	PEAKS039339
EXP036709	GATA6	Homo sapiens		EXP036692	455	unspecified	Q92908	HUES64 (embryonic stem cells)	PEAKS039340
EXP036710	GATA6	Homo sapiens		NULL	455	unspecified	Q92908	HUES64 (embryonic stem cells)	PEAKS039341
EXP036711	HEY1(Santa Cruz,sc-16424 X,F2411)	Homo sapiens		NULL	455	unspecified	Q9Y5J3	HUES64 (embryonic stem cells)	PEAKS039342
EXP036712	HNF1B(Santa Cruz,sc-22840 X,E2108)	Homo sapiens		EXP036692	455	unspecified	P35680	HUES64 (embryonic stem cells)	PEAKS039343
EXP036713	HNF1B(Santa Cruz,sc-22840 X,E2108)	Homo sapiens		NULL	455	unspecified	P35680	HUES64 (embryonic stem cells)	PEAKS039344
EXP036714	HNF4A(Santa Cruz,sc-8987 X,L1709)	Homo sapiens		NULL	455	unspecified	P41235	HUES64 (embryonic stem cells)	PEAKS039345
EXP036715	HNF4A(Santa Cruz,sc-8987 X,L1709)	Homo sapiens		EXP036692	455	unspecified	P41235	HUES64 (embryonic stem cells)	PEAKS039346
EXP036716	KLF5(Santa Cruz,sc-22797 X,I2804)	Homo sapiens		NULL	455	unspecified	Q13887	HUES64 (embryonic stem cells)	PEAKS039347
EXP036717	KLF5(Santa Cruz,sc-22797 X,I2804)	Homo sapiens		NULL	455	unspecified	Q13887	HUES64 (embryonic stem cells)	PEAKS039348
EXP036718	KLF5(Santa Cruz,sc-22797 X,I2804)	Homo sapiens		EXP036692	455	unspecified	Q13887	HUES64 (embryonic stem cells)	PEAKS039349
EXP036719	LEF1(Santa Cruz,sc-8591 X,J0510)	Homo sapiens		NULL	455	unspecified	Q9UJU2	HUES64 (embryonic stem cells)	PEAKS039350
EXP036720	LEF1(Santa Cruz,sc-8591 X,J0510)	Homo sapiens		NULL	455	unspecified	Q9UJU2	HUES64 (embryonic stem cells)	PEAKS039351
EXP036721	NR5A2(Abcam,ab18293,GR34910-1)	Homo sapiens		EXP036692	455	unspecified	O00482	HUES64 (embryonic stem cells)	PEAKS039352
EXP036722	NR5A2(Abcam,ab18293,GR34910-1)	Homo sapiens		NULL	455	unspecified	O00482	HUES64 (embryonic stem cells)	PEAKS039353
EXP036723	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	PEAKS039354
EXP036724	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	PEAKS039355
EXP036725	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	PEAKS039356
EXP036726	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	PEAKS039357
EXP036727	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	PEAKS039358
EXP036728	PAX6(Abcam,ab5790,GR23677-3)	Homo sapiens		NULL	455	unspecified	P26367	HUES64 (embryonic stem cells)	PEAKS039359
EXP036729	PAX6(Abcam,ab5790,GR23677-3)	Homo sapiens		NULL	455	unspecified	P26367	HUES64 (embryonic stem cells)	PEAKS039360
EXP036730	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	PEAKS039361
EXP036731	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	PEAKS039362
EXP036732	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	PEAKS039363
EXP036733	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	PEAKS039364
EXP036734	REX1(Abcam,ab28141,GR43152-1)	Homo sapiens		NULL	455	unspecified	Q96MM3	HUES64 (embryonic stem cells)	PEAKS039365
EXP036735	REX1(Abcam,ab28141,GR43152-1)	Homo sapiens		NULL	455	unspecified	Q96MM3	HUES64 (embryonic stem cells)	PEAKS039366
EXP036736	REX1(Abcam,ab28141,GR43152-1)	Homo sapiens		EXP036692	455	unspecified	Q96MM3	HUES64 (embryonic stem cells)	PEAKS039367
EXP036737	SALL4(Santa Cruz,sc-101147,G1811)	Homo sapiens		EXP036692	455	unspecified	Q9UJQ4	HUES64 (embryonic stem cells)	PEAKS039368
EXP036738	SALL4(Santa Cruz,sc-101147,G1811)	Homo sapiens		NULL	455	unspecified	Q9UJQ4	HUES64 (embryonic stem cells)	PEAKS039369
EXP036739	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039370
EXP036740	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		EXP036692	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039371
EXP036741	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039372
EXP036742	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	PEAKS039373
EXP036743	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	PEAKS039374
EXP036744	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	PEAKS039375
EXP036745	SNAI2	Homo sapiens		EXP036692	455	unspecified	O43623	HUES64 (embryonic stem cells)	PEAKS039376
EXP036746	SNAI2(Santa Cruz,sc-15391 X,I2409)	Homo sapiens		NULL	455	unspecified	O43623	HUES64 (embryonic stem cells)	PEAKS039377
EXP036747	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		EXP036692	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	PEAKS039378
EXP036748	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		NULL	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	PEAKS039379
EXP036749	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		NULL	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	PEAKS039380
EXP036750	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		NULL	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	PEAKS039381
EXP036751	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	PEAKS039382
EXP036752	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	PEAKS039383
EXP036753	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	PEAKS039384
EXP036754	SP1(Cell Signaling,9389BF,2)	Homo sapiens		NULL	455	unspecified	P08047	HUES64 (embryonic stem cells)	PEAKS039385
EXP036755	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	PEAKS039386
EXP036756	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	PEAKS039387
EXP036757	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	PEAKS039388
EXP036758	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	PEAKS039389
EXP036759	STAT3(Cell Signaling,4904BF,4)	Homo sapiens		NULL	455	unspecified	P40763	HUES64 (embryonic stem cells)	PEAKS039390
EXP036760	STAT3(Cell Signaling,4904BF,4)	Homo sapiens		NULL	455	unspecified	P40763	HUES64 (embryonic stem cells)	PEAKS039391
EXP036761	STAT3	Homo sapiens		EXP036692	455	unspecified	P40763	HUES64 (embryonic stem cells)	PEAKS039392
EXP036762	T(R&D Systems,AF2085,KQP0212061)	Homo sapiens		EXP036692	455	unspecified	O15178	HUES64 (embryonic stem cells)	PEAKS039393
EXP036763	TAL1(Abcam,ab75738,GR33312-8)	Homo sapiens		EXP036692	455	unspecified	P17542	HUES64 (embryonic stem cells)	PEAKS039394
EXP036764	TAL1(Abcam,ab75738,GR33312-8)	Homo sapiens		NULL	455	unspecified	P17542	HUES64 (embryonic stem cells)	PEAKS039395
EXP036765	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	PEAKS039396
EXP036766	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	PEAKS039397
EXP036767	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	PEAKS039398
EXP036768	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	PEAKS039399
EXP036769	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		EXP036692	455	unspecified	P15884	HUES64 (embryonic stem cells)	PEAKS039400
EXP036770	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	PEAKS039401
EXP036771	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	PEAKS039402
EXP036772	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	PEAKS039403
EXP036773	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	PEAKS039404
EXP036774	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		EXP036692	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	PEAKS039405
EXP036775	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	PEAKS039406
EXP036776	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	PEAKS039407
EXP036777	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	PEAKS039408
EXP036778	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		EXP036692	455	unspecified	P01106	HUES64 (embryonic stem cells)	PEAKS039409
EXP036779	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	PEAKS039410
EXP036780	HAND2(Santa Cruz,sc-22818 X,I2804)	Homo sapiens		NULL	455	unspecified	P61296	HUES64 (embryonic stem cells)	PEAKS039411
EXP036781	HAND1(Santa Cruz,sc-22817 X,F2304)	Homo sapiens		NULL	455	unspecified	O96004	HUES64 (embryonic stem cells)	PEAKS039412
EXP036782	HAND1(Santa Cruz,sc-22817 X,F2304)	Homo sapiens		EXP036692	455	unspecified	O96004	HUES64 (embryonic stem cells)	PEAKS039413
EXP036783	HAND1(Santa Cruz,sc-22817 X,F2304)	Homo sapiens		NULL	455	unspecified	O96004	HUES64 (embryonic stem cells)	PEAKS039414
EXP036784	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		EXP036692	455	unspecified	P49711	HUES64 (embryonic stem cells)	PEAKS039415
EXP036785	EOMES(Abcam,ab23345,GR50189-1)	Homo sapiens		NULL	455	unspecified	O95936	HUES64 (embryonic stem cells)	PEAKS039416
EXP036786	EOMES(Abcam,ab23345,GR50189-1)	Homo sapiens		NULL	455	unspecified	O95936	HUES64 (embryonic stem cells)	PEAKS039417
EXP036787	FOXA1(Santa Cruz,sc-101058,H1111)	Homo sapiens		NULL	455	unspecified	P55317	HUES64 (embryonic stem cells)	PEAKS039418
EXP036788	FOXA2(Santa Cruz,sc-6554 X,C1810)	Homo sapiens		NULL	455	unspecified	Q9Y261	HUES64 (embryonic stem cells)	PEAKS039419
EXP036789	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens		NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	PEAKS039420
EXP036790	GATA4	Homo sapiens		NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	PEAKS039421
EXP036791	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens	shGATA4	NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	PEAKS039422
EXP036792	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens	shGATA4	NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	PEAKS039423
EXP036793	GATA6(Santa Cruz,sc-7244 X,H0911)	Homo sapiens		NULL	455	unspecified	Q92908	HUES64 (embryonic stem cells)	PEAKS039424
EXP036794	GATA6(Santa Cruz,sc-7244 X,H0911)	Homo sapiens		NULL	455	unspecified	Q92908	HUES64 (embryonic stem cells)	PEAKS039425
EXP036795	HNF1B(Santa Cruz,sc-22840 X,E2108)	Homo sapiens		NULL	455	unspecified	P35680	HUES64 (embryonic stem cells)	PEAKS039426
EXP036796	HNF4A(Santa Cruz,sc-8987 X,L1709)	Homo sapiens		NULL	455	unspecified	P41235	HUES64 (embryonic stem cells)	PEAKS039427
EXP036797	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		EXP036692	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	PEAKS039428
EXP036798	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	PEAKS039429
EXP036799	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		EXP036692	455	unspecified	P32243	HUES64 (embryonic stem cells)	PEAKS039430
EXP036800	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	PEAKS039431
EXP036801	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	PEAKS039432
EXP036802	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		EXP036692	455	unspecified	Q01860	HUES64 (embryonic stem cells)	PEAKS039433
EXP036803	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039434
EXP036804	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039435
EXP036805	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens	shGATA4	NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039436
EXP036806	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens	shGATA4	NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	PEAKS039437
EXP036807	SMAD4	Homo sapiens		EXP036692	455	unspecified	Q13485	HUES64 (embryonic stem cells)	PEAKS039438
EXP036808	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	PEAKS039439
EXP036809	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		EXP036692	455	unspecified	P48431	HUES64 (embryonic stem cells)	PEAKS039440
EXP036810	SP1(Cell Signaling,9389BF,2)	Homo sapiens		EXP036692	455	unspecified	P08047	HUES64 (embryonic stem cells)	PEAKS039441
EXP036811	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		EXP036692	455	unspecified	P11831	HUES64 (embryonic stem cells)	PEAKS039442
EXP036812	T(R&D Systems,AF2085,KQP0212061)	Homo sapiens		NULL	455	unspecified	O15178	HUES64 (embryonic stem cells)	PEAKS039443
EXP036813	sc-542	Mus musculus	IGF1	NULL	132	normal	P19785	uterus	PEAKS039590
EXP036814	sc-542	Mus musculus	ICI 182,780	NULL	132	normal	P19785	uterus	PEAKS039591
EXP036816	MEF2	Mus musculus	WT3	EXP036815	53	normal	Q60929	heart	PEAKS039592
EXP036817	MEF2	Mus musculus	WT70	EXP036815	53	normal	Q60929	heart	PEAKS039593
EXP036818	MEF2	Mus musculus	Med12 KO58	EXP036815	53	normal	Q60929	heart	PEAKS039594
EXP036819	MEF2	Mus musculus	Med12 KO60	EXP036815	53	normal	Q60929	heart	PEAKS039595
EXP036824	sc-126 X	Homo sapiens	irradiation 0h	EXP036820	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039596
EXP036825	sc-126 X	Homo sapiens	irradiation 1h	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039597
EXP036826	sc-126 X	Homo sapiens	irradiation 2.5h	EXP036821	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039598
EXP036827	sc-126 X	Homo sapiens	irradiation 4h	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039599
EXP036828	sc-126 X	Homo sapiens	irradiation 5h	EXP036822	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039600
EXP036829	sc-126 X	Homo sapiens	irradiation 7.5h	EXP036823	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039601
EXP036830	sc-126 X	Homo sapiens	irradiation 7.5h + Nutlin	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039602
EXP036831	p65	Homo sapiens		NULL	466	normal	Q04206	MDM(monocyte derived macrophages)	PEAKS039603
EXP036832	p65	Homo sapiens	TNF (10ng/ml) for 24 hours	NULL	466	normal	Q04206	MDM(monocyte derived macrophages)	PEAKS039604
EXP036833	irf1	Homo sapiens		NULL	466	normal	P10914	MDM(monocyte derived macrophages)	PEAKS039605
EXP036834	irf1	Homo sapiens	FNA (25ng/ml) for 24 hours	NULL	466	normal	P10914	MDM(monocyte derived macrophages)	PEAKS039606
EXP036835	PU.1 (sc-352) lot#B0513	Homo sapiens	untreated	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS039607
EXP036836	PU.1 (sc-352) lot#B0513	Homo sapiens	IL-4	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS039608
EXP036837	RXR (sc-774) lot#E0213	Homo sapiens	untreated	NULL	466	normal	P19793	MDM(monocyte derived macrophages)	PEAKS039609
EXP036838	RXR (sc-774) lot#E0213	Homo sapiens	IL-4	NULL	466	normal	P19793	MDM(monocyte derived macrophages)	PEAKS039610
EXP036839	STAT6 (sc-981) lot#I1812	Homo sapiens	untreated	NULL	466	normal	P42226	MDM(monocyte derived macrophages)	PEAKS039611
EXP036840	STAT6 (sc-981) lot#I1812	Homo sapiens	IL-4	NULL	466	normal	P42226	MDM(monocyte derived macrophages)	PEAKS039612
EXP036841	CTCF	Homo sapiens		NULL	687	normal	P49711	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS039613
EXP036842	CTCF	Homo sapiens		NULL	687	normal	P49711	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS039614
EXP036843	CTCF	Homo sapiens		NULL	926	normal	P49711	IPSC-derived bipolar neuron	PEAKS039615
EXP036844	CTCF	Homo sapiens		NULL	926	normal	P49711	IPSC-derived bipolar neuron	PEAKS039616
EXP036845	CTCF	Homo sapiens		NULL	221	normal	P49711	DOHH2 (diffuse large B-cell lymphoma)	PEAKS039617
EXP036846	CTCF	Homo sapiens		NULL	221	normal	P49711	DOHH2 (diffuse large B-cell lymphoma)	PEAKS039618
EXP036847	KDM5B	Homo sapiens		NULL	376	normal	Q9UGL1	WA01 (H1, human embryonic stem cells)	PEAKS039619
EXP036848	KDM5B	Homo sapiens		NULL	199	normal	Q9UGL1	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS039620
EXP036849	CTCF	Homo sapiens		NULL	927	normal	P49711	PC9 (lung adenocarcinoma)	PEAKS039621
EXP036850	CTCF	Homo sapiens		NULL	927	normal	P49711	PC9 (lung adenocarcinoma)	PEAKS039622
EXP036851	Cayman HIF-1a (Cay10006421)	Homo sapiens	1 mM dimethyloxalylglycine	NULL	928	normal	Q16665	renal tubular cells	PEAKS039623
EXP036852	Novus HIF-1b (NB100-110)	Homo sapiens	1 mM dimethyloxalylglycine	NULL	928	normal	P27540	renal tubular cells	PEAKS039624
EXP036853	CTCF	Homo sapiens		NULL	618	normal	P49711	MM1.S (plasma cell myeloma)	PEAKS039625
EXP036854	CTCF	Homo sapiens		NULL	618	normal	P49711	MM1.S (plasma cell myeloma)	PEAKS039626
EXP036855	CTCF	Homo sapiens		NULL	900	normal	P49711	hepatocytes	PEAKS039627
EXP036856	CTCF	Homo sapiens		NULL	900	normal	P49711	hepatocytes	PEAKS039628
EXP036857	CTCF	Homo sapiens		NULL	900	normal	P49711	hepatocytes	PEAKS039629
EXP036858	WHSC1	Homo sapiens		NULL	356	normal	O96028	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS039630
EXP036859	WHSC1	Homo sapiens		NULL	356	normal	O96028	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS039631
EXP036860	REST	Homo sapiens		NULL	376	normal	Q13127	WA01 (H1, human embryonic stem cells)	PEAKS039632
EXP036861	REST	Homo sapiens		NULL	376	normal	Q13127	WA01 (H1, human embryonic stem cells)	PEAKS039633
EXP036862	CTCF	Homo sapiens		NULL	929	normal	P49711	neutrophils	PEAKS039634
EXP036863	CTCF	Homo sapiens		NULL	929	normal	P49711	neutrophils	PEAKS039635
EXP036864	REST	Homo sapiens		NULL	38	normal	Q13127	A549 (lung carcinoma)	PEAKS039636
EXP036865	REST	Homo sapiens		NULL	38	normal	Q13127	A549 (lung carcinoma)	PEAKS039637
EXP036866	KDM5A	Homo sapiens		NULL	38	normal	P29375	A549 (lung carcinoma)	PEAKS039638
EXP036867	KDM5A	Homo sapiens		NULL	38	normal	P29375	A549 (lung carcinoma)	PEAKS039639
EXP036868	KDM5A	Homo sapiens		NULL	356	normal	P29375	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS039640
EXP036869	KDM5A	Homo sapiens		NULL	356	normal	P29375	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS039641
EXP036872	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	400 ng/mL neocarzinostatin for 3 h	EXP036870	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039642
EXP036873	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	untreated	EXP036870	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039643
EXP036874	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	400 ng/mL neocarzinostatin for 3 h	NULL	128	normal	P04637	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS039644
EXP036875	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	untreated	EXP036871	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS039645
EXP036877	RXR	Mus musculus	GW3965 for 24 h	EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	PEAKS039646
EXP036878	RXR	Mus musculus	LG268 for 24 h	EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	PEAKS039647
EXP036879	RXR	Mus musculus	RA for 24 h	EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	PEAKS039648
EXP036880	RXR	Mus musculus		EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	PEAKS039649
EXP036881	RXR	Mus musculus		EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	PEAKS039650
EXP036883	anti-GABPalpha (sc-22810X, Santa Cruz).	Mus musculus		EXP036882	1058	normal	Q00422	CD4+ T-cells	PEAKS039651
EXP036886	Androgen Receptor (SCBT, sc-816)	Homo sapiens	radiation	EXP036884	762	normal	P10275	R1-D567 (prostate cancer)	PEAKS039652
EXP036887	Androgen Receptor (SCBT, sc-816)	Homo sapiens		EXP036885	762	normal	P10275	R1-D567 (prostate cancer)	PEAKS039653
EXP036890	anti-CTCF antibody (Millipore, 07-729)	Homo sapiens	untreated	EXP036888	930	normal	P49711	226LDM (normal breast luminal cells)	PEAKS039654
EXP036891	anti-CTCF antibody (Millipore, 07-729)	Homo sapiens	hydroxyurea and nocodazole	EXP036889	930	normal	P49711	226LDM (normal breast luminal cells)	PEAKS039655
EXP036893	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	wild type FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	PEAKS039656
EXP036894	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus		NULL	1058	bio_control	Q99JB6	CD4+ T-cells	PEAKS039657
EXP036895	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	mutated FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	PEAKS039658
EXP036896	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	mutated FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	PEAKS039659
EXP036897	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	mutated FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	PEAKS039660
EXP036900	anti-p53 (FL393, sc6243)	Homo sapiens	TNF-alpha 0 h	EXP036898	821	normal	P04637	SW480 (colon adenocarcinoma)	PEAKS039661
EXP036901	anti-p53 (FL393, sc6243)	Homo sapiens	TNF-alpha 16 h	EXP036899	821	normal	P04637	SW480 (colon adenocarcinoma)	PEAKS039662
EXP036902	anti-p65 (sc372x)	Homo sapiens	TNF-alpha 0 h	EXP036898	821	normal	Q04206	SW480 (colon adenocarcinoma)	PEAKS039663
EXP036903	anti-p65 (sc372x)	Homo sapiens	TNF-alpha 16 h	EXP036899	821	normal	Q04206	SW480 (colon adenocarcinoma)	PEAKS039664
EXP036907	anti-ERalpha HC20	Homo sapiens	E2	EXP036904	848	normal	P03372	U2OS (osteosarcoma)	PEAKS039665
EXP036908	anti-SRC1 M341	Homo sapiens	E2	EXP036906	848	normal	Q15788	U2OS (osteosarcoma)	PEAKS039666
EXP036912	anti-Sox9	Mus musculus		EXP036909	932	normal	Q04887	E13.5 limbs and tails	PEAKS039667
EXP036913	anti-HA	Mus musculus		EXP036910	932	normal	P35710	E13.5 limbs and tails	PEAKS039668
EXP036914	anti-Sox6	Mus musculus		EXP036911	932	normal	P40645	E13.5 limbs and tails	PEAKS039669
EXP036919	RXR?	Mus musculus	calorie restricted diet	EXP036915	5	normal	P28700	liver	PEAKS039670
EXP036920	PPAR?	Mus musculus	calorie restricted diet	EXP036916	5	normal	P23204	liver	PEAKS039671
EXP036921	RXR?	Mus musculus	high-fat diet	EXP036917	5	normal	P28700	liver	PEAKS039672
EXP036922	PPAR?	Mus musculus	high-fat diet	EXP036918	5	normal	P23204	liver	PEAKS039673
EXP036923	RXR?	Mus musculus	calorie restricted diet	EXP036915	5	normal	P28700	liver	PEAKS039674
EXP036924	PPAR?	Mus musculus	calorie restricted diet	EXP036916	5	normal	P23204	liver	PEAKS039675
EXP036925	RXR?	Mus musculus	high-fat diet	EXP036917	5	normal	P28700	liver	PEAKS039676
EXP036926	PPAR?	Mus musculus	high-fat diet	EXP036918	5	normal	P23204	liver	PEAKS039677
EXP036928	MAZ	Homo sapiens		EXP036927	933	normal	P56270	T778 (well differentiated liposarcoma)	PEAKS039678
EXP036930	Monoclonal (rabbit) against SOX2	Homo sapiens		EXP036929	934	normal	P48431	HOT1 tumor derived from a human glioblastoma	PEAKS039679
EXP036933	Ik-C, Smale lab	Homo sapiens		EXP036931	735	normal	Q13422	pre-B acute lymphoblastic leukemia	PEAKS039680
EXP036934	Ik-C, Smale lab	Homo sapiens		EXP036932	735	normal	Q13422	pre-B acute lymphoblastic leukemia	PEAKS039681
EXP036935	H-100, Santa Cruz, sc-13039 X	Homo sapiens		EXP036931	735	normal	Q13422	pre-B acute lymphoblastic leukemia	PEAKS039682
EXP036936	H-100, Santa Cruz, sc-13039 X	Homo sapiens		EXP036932	735	normal	Q13422	pre-B acute lymphoblastic leukemia	PEAKS039683
EXP036939	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036937	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039684
EXP036940	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036937	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039685
EXP036941	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039686
EXP036942	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039687
EXP036943	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039688
EXP036944	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039689
EXP036945	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	PEAKS039690
EXP036946	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	PEAKS039691
EXP036947	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	PEAKS039692
EXP036948	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	PEAKS039693
EXP036949	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	PEAKS039694
EXP036950	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	PEAKS039695
EXP036951	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	PEAKS039696
EXP036952	anti-CLOCK	Mus musculus		NULL	5	normal	O08785	liver	PEAKS039697
EXP036954	Monoclonal ANTI-FLAGÂ®Â M2 (SIGMA ALDRICH, F3165, lot-SLBG5311 )	Homo sapiens	NUP98-HOXA9-FLAG expression	EXP036953	935	normal	P31269	HEK293-FT (human embryonic kidney, female transformed)	PEAKS039698
EXP036955	Monoclonal ANTI-FLAGÂ®Â M2 (SIGMA ALDRICH, F3165, lot-SLBG5311 )	Homo sapiens	HOXA9-FLAG expression	EXP036953	935	normal	P31269	HEK293-FT (human embryonic kidney, female transformed)	PEAKS039699
EXP036957	Gata6 (AF1700, R&D Systems)	Mus musculus	GATA6 overexpression	EXP036956	936	normal	Q61169	primary keratinocytes	PEAKS039700
EXP036958	Gata6 (D61E4, Cell Signaling)	Mus musculus	GATA6 overexpression	EXP036956	936	normal	Q61169	primary keratinocytes	PEAKS039701
EXP036959	Flag	Mus musculus		NULL	936	bio_control	Q61169	primary keratinocytes	PEAKS039702
EXP036960	Bach2 (SIGMA, cat#: SAB2001201, lot#: QC10599	Mus musculus		NULL	1058	normal	P97303	CD4+ T-cells	PEAKS039703
EXP036961	Bach2 (SIGMA, cat#: SAB2001201, lot#: QC10599	Mus musculus	Bach2 knockout	NULL	1058	bio_control	P97303	CD4+ T-cells	PEAKS039704
EXP036964	MyoD (Santa Cruz, sc-760)	Mus musculus		NULL	1153	normal	P10085	C2C12 (myoblasts)	PEAKS039705
EXP036965	MyoD (Santa Cruz, sc-760)	Mus musculus	differentiated	EXP036963	1153	normal	P10085	C2C12 (myoblasts)	PEAKS039706
EXP036966	Flag-HES5	Mus musculus		NULL	277	bio_control	P70120	embryonic stem cell-derived mesoderm	PEAKS039707
EXP036967	Flag-HES5	Mus musculus	doxycycline for 48 h	NULL	277	normal	P70120	embryonic stem cell-derived mesoderm	PEAKS039708
EXP036969	ZNF143 antibodies	Homo sapiens		EXP036968	65	normal	P52747	U937 (adult acute monocytic leukemia)	PEAKS039709
EXP036970	anti-FOXO3	Mus musculus		NULL	2775	normal	Q9WVH4	neural stem cells	PEAKS039710
EXP036971	anti-FOXO3	Mus musculus	Tet2 knockout	NULL	2775	normal	Q9WVH4	neural stem cells	PEAKS039711
EXP036973	anti-STAT3	Homo sapiens		EXP036972	938	normal	P40763	Th17-cells	PEAKS039712
EXP036974	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IKK7	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039713
EXP036975	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IL1b+IKK7	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039714
EXP036976	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	E2+ICI	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039715
EXP036977	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IL1b+ICI	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039716
EXP036978	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	E2+ICI	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS039717
EXP036979	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	IL1b+ICI	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS039718
EXP036980	ER (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens		NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039719
EXP036981	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	E2 for 45m	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039720
EXP036982	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IL1b for 45m	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039721
EXP036983	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	TNFa for 45m	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS039722
EXP036984	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	vehicle	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS039723
EXP036985	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	E2 for 45m	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS039724
EXP036986	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	IL1b for 45m	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS039725
EXP036987	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	TNFa for 45m	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	PEAKS039726
EXP036989	anti-TFAP2A (3B5, Santa Cruz Biotechnology, Inc.	Homo sapiens		EXP036988	939	normal	P05549	neonatal primary melanocytes	PEAKS039727
EXP036992	SP1 (Abcam) antibody	Homo sapiens	DMSO	EXP036990	36	normal	P08047	A375 (malignant melanoma)	PEAKS039728
EXP036993	SP1 (Abcam) antibody	Homo sapiens	25 Î¼M A771726	EXP036991	36	normal	P08047	A375 (malignant melanoma)	PEAKS039729
EXP036995	MLL4 (PMCID: PMC3869375)	Mus musculus		EXP036994	1058	normal	O08550	CD4+ T-cells	PEAKS039730
EXP036996	YY1 antibody sc-7341(Santa Cruz Biotechnology)	Homo sapiens		NULL	78	normal	P25490	HeLa (cervical adenocarcinoma)	PEAKS039731
EXP036998	anti-MYC antibody (Santacruz Biotechnology, N262X)	Homo sapiens		NULL	940	normal	P01106	GEN2.2 (blastic plasmacytoid dendritic cell neoplasm)	PEAKS039733
EXP037001	anti-REST (Millipore, 17-641)	Rattus norvegicus	quiescence	EXP036999	941	normal	O54963	hippocampal neural stem cells	PEAKS039734
EXP037002	anti-REST (Hsieh lab homemade antibody)	Rattus norvegicus	quiescence	EXP036999	941	normal	O54963	hippocampal neural stem cells	PEAKS039735
EXP037003	anti-REST (Millipore, 17-641)	Rattus norvegicus	proliferation	EXP037000	941	normal	O54963	hippocampal neural stem cells	PEAKS039736
EXP037004	anti-REST (Hsieh lab homemade antibody)	Rattus norvegicus	proliferation	EXP037000	941	normal	O54963	hippocampal neural stem cells	PEAKS039737
EXP037008	Rabbit Anti-Npas3 (Sigma: HPA002892)	Mus musculus		EXP037005	942	normal	Q9QZQ0	NS5 (neural stem cells)	PEAKS039738
EXP037009	Rabbit Anti-Olig2 (Milipore: AB9610)	Mus musculus		EXP037006	942	normal	Q9EQW6	NS5 (neural stem cells)	PEAKS039739
EXP037010	Smad4 antibody (R&D Systems: AF2097)	Mus musculus		EXP037007	942	normal	P97471	NS5 (neural stem cells)	PEAKS039740
EXP037017	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037011	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039741
EXP037018	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037012	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039742
EXP037019	rabbit anti-Prox1 (ProteinTech)	Homo sapiens	none	EXP037013	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039743
EXP037020	rabbit anti-Prox1 (ProteinTech)	Homo sapiens	none	EXP037014	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039744
EXP037021	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037015	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039745
EXP037022	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037016	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS039746
EXP037025	KLF1 Antibody	Mus musculus	(Z)-4-Hydroxytamoxifen at a final concentration of 200 nM for 3 h; K1-ER construct	EXP037023	943	normal	P46099	KLF1 erythroblasts	PEAKS039747
EXP037026	KLF1 Antibody	Mus musculus	(Z)-4-Hydroxytamoxifen at a final concentration of 200 nM for 3 h; K1-NanER construct	EXP037024	943	normal	P46099	KLF1 erythroblasts	PEAKS039748
EXP037028	Anti-Lhx6	Mus musculus		EXP037027	944	normal	Q9R1R0	E11.5 maxillary arch	PEAKS039749
EXP037029	CREB (48H2) Rabbit mAb #9197	Mus musculus		NULL	429	normal	Q01147	hepatocytes	PEAKS039750
EXP037030	C/EBP ?  (C-19), sc-150	Mus musculus	fed 10 h	NULL	429	normal	P28033	hepatocytes	PEAKS039751
EXP037031	C/EBP ?  (C-19), sc-150	Mus musculus	fasted 24 h	NULL	429	normal	P28033	hepatocytes	PEAKS039752
EXP037032	Phospho-CREB (Ser133) (87G3) Rabbit mAb #9198	Mus musculus	fed 24 h	NULL	429	normal	Q01147	hepatocytes	PEAKS039753
EXP037033	Phospho-CREB (Ser133) (87G3) Rabbit mAb #9198	Mus musculus	fasted 24 h	NULL	429	normal	Q01147	hepatocytes	PEAKS039754
EXP037034	cocktail of GR Abs (3.3ul of each Ab): PA1-511A (ThermoScientific),  MA1-510 (ThermoScientific), M-20 (sc-1004, Santa Cruz)	Mus musculus	fed 10 h	NULL	429	normal	P06537	hepatocytes	PEAKS039755
EXP037035	cocktail of GR Abs (3.3ul of each Ab): PA1-511A (ThermoScientific),  MA1-510 (ThermoScientific), M-20 (sc-1004, Santa Cruz)	Mus musculus	fasted 24 h	NULL	429	normal	P06537	hepatocytes	PEAKS039756
EXP037036	CREB (48H2) Rabbit mAb #9197	Mus musculus	glucagon (10nM) for 1hr	NULL	429	normal	Q01147	hepatocytes	PEAKS039757
EXP037037	CREB (48H2) Rabbit mAb #9197	Mus musculus	glucagon (10nM) + corticosterone (1.7uM) for 1 hr	NULL	429	normal	Q01147	hepatocytes	PEAKS039758
EXP037038	cocktail of GR Abs (3.3ul of each Ab): PA1-511A (ThermoScientific),  MA1-510 (ThermoScientific), M-20 (sc-1004, Santa Cruz)	Mus musculus	glucagon (10nM) + corticosterone (1.7uM) for 1hr	NULL	429	normal	P06537	hepatocytes	PEAKS039759
EXP037042	anti-AhR HA (abcam, ab9110)	Mus musculus		EXP037041	936	normal	P30561	primary keratinocytes	PEAKS039762
EXP037046	anti-Pu.1 (SantaCruz Sc-352X, lot B0314)	Mus musculus	6 days of wash 	EXP037043	401	normal	P17433	C10 (pre-B-cells)	PEAKS039763
EXP037047	anti-Pu.1 (SantaCruz Sc-352X, lot B0314)	Mus musculus		EXP037045	401	normal	P17433	C10 (pre-B-cells)	PEAKS039764
EXP037048	anti-Pu.1 (SantaCruz Sc-352X, lot B0314)	Mus musculus	induction Cebpa for 6 h	EXP037044	401	normal	P17433	C10 (pre-B-cells)	PEAKS039765
EXP037050	AP-2alpha (3B5):sc12726	Mus musculus		EXP037049	945	normal	P34056	Melan-a (immortalized melanocytes)	PEAKS039766
EXP037052	mouse monoclonal anti-FLAG , M2 (Sigma, Cat.-No.: F1804)	Mus musculus		EXP037051	946	normal	Q61039	E10.5 embryonic heart	PEAKS039767
EXP037055	anti-ERG (Clone 9FY Biocare CM421 C)	Homo sapiens	Treatment: None; Growth: cells were grown in DMEM media (Mediatech-cellgro) with 10%FBS and 1% penicillin/streptomycin	EXP037054	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS039768
EXP037056	anti-ERG (Clone 9FY Biocare CM421 C)	Homo sapiens	Treatment: mutated ERG; Growth: cells were grown in Keratinocyte SFM media supplemented with bovine pitutiary extract, human recombinant epidermal growth factor, penicillin/streptomycin, and selection agents (puromycin/hygromycin)	EXP037053	781	normal	P11308	RWPE1 (prostate epithelial cells)	PEAKS039769
EXP037057	anti-ERG (Clone 9FY Biocare CM421 C)	Homo sapiens	Treatment: none; Growth: cells were grown in Keratinocyte SFM media supplemented with bovine pitutiary extract, human recombinant epidermal growth factor, penicillin/streptomycin, and selection agents (puromycin/hygromycin)	EXP037053	781	normal	P11308	RWPE1 (prostate epithelial cells)	PEAKS039770
EXP037060	CEBPe GTX109155 (GeneTex)	Mus musculus		EXP037058	947	normal	Q6PZD9	primary whole bone marrow cells	PEAKS039771
EXP037061	CEBPe GTX109155 (GeneTex)	Mus musculus	CEBPE knockout	EXP037059	947	bio_control	Q6PZD9	primary whole bone marrow cells	PEAKS039772
EXP037062	CEBPe SC-158 (Santa Cruz Biotechnology)	Mus musculus		EXP037058	947	normal	Q6PZD9	primary whole bone marrow cells	PEAKS039773
EXP037063	CEBPe SC-158 (Santa Cruz Biotechnology)	Mus musculus	CEBPE knockout	EXP037059	947	bio_control	Q6PZD9	primary whole bone marrow cells	PEAKS039774
EXP037066	anti-AR, santa cruz (scbt-816X)	Homo sapiens	R1881	EXP037064	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS039775
EXP037067	anti-AR, santa cruz (scbt-816X)	Homo sapiens	R1881+Doxycycline	EXP037065	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS039776
EXP037068	anti-MYC, RnD (AF3696)	Homo sapiens	R1881	EXP037064	70	normal	P01106	LNCaP (prostate carcinoma)	PEAKS039777
EXP037069	anti-MYC, RnD (AF3696)	Homo sapiens	R1881+Doxycycline	EXP037064	70	normal	P01106	LNCaP (prostate carcinoma)	PEAKS039778
EXP037072	Oct4 (Santa Cruz; sc-8628)	Mus musculus	PARP-1 KO	EXP037070	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS039779
EXP037073	Sox2 (Santa Cruz; sc-17320)	Mus musculus	PARP-1 KO	EXP037070	2	normal	P48432	mESCs (mouse embryonic stem cells)	PEAKS039780
EXP037074	Sox2 (Santa Cruz; sc-17320)	Mus musculus		EXP037071	2	normal	P48432	mESCs (mouse embryonic stem cells)	PEAKS039781
EXP037075	Oct4 (Santa Cruz; sc-8628)	Mus musculus		EXP037071	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS039782
EXP037083	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	P53566	brown preadipocytes	PEAKS039783
EXP037084	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	P53566	brown preadipocytes	PEAKS039784
EXP037085	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	P53566	brown preadipocytes	PEAKS039785
EXP037086	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	P53566	brown adipocytes	PEAKS039786
EXP037087	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	P28033	brown preadipocytes	PEAKS039787
EXP037088	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	NULL	483	normal	P28033	brown preadipocytes	PEAKS039788
EXP037089	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	P28033	brown preadipocytes	PEAKS039789
EXP037090	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	P28033	brown adipocytes	PEAKS039790
EXP037091	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	O08792	brown preadipocytes	PEAKS039791
EXP037092	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	O08792	brown preadipocytes	PEAKS039792
EXP037093	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	O08792	brown preadipocytes	PEAKS039793
EXP037094	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	O08792	brown adipocytes	PEAKS039794
EXP037095	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	P37238	brown preadipocytes	PEAKS039795
EXP037096	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	P37238	brown preadipocytes	PEAKS039796
EXP037097	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	P37238	brown preadipocytes	PEAKS039797
EXP037098	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	P37238	brown adipocytes	PEAKS039798
EXP037099	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	Q61164	brown preadipocytes	PEAKS039799
EXP037100	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	Q61164	brown preadipocytes	PEAKS039800
EXP037101	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	Q61164	brown preadipocytes	PEAKS039801
EXP037102	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	Q61164	brown adipocytes	PEAKS039802
EXP037103	Anti-MLL4 #3	Mus musculus	MLL3 -/-; MLL4 flox/flox	EXP037080	483	normal	O08550	brown preadipocytes	PEAKS039803
EXP037104	Anti-MLL4 #3	Mus musculus	MLL3 -/-; MLL4 -/-	EXP037081	483	normal	O08550	brown preadipocytes	PEAKS039804
EXP037105	Anti-MLL4 #3 (Home-made)	Mus musculus		EXP037082	20	normal	O08550	3T3-L1-derived adipocytes	PEAKS039805
EXP037107	anti-ZIC2	Mus musculus		EXP037106	260	normal	Q62520	epiblast stem cells	PEAKS039806
EXP037108	anti-OTX2	Mus musculus		EXP037106	260	normal	P80206	epiblast stem cells	PEAKS039807
EXP037109	anti-SOX2	Mus musculus		EXP037106	260	normal	P48432	epiblast stem cells	PEAKS039808
EXP037110	anti-POU5F1	Mus musculus		EXP037106	260	normal	P20263	epiblast stem cells	PEAKS039809
EXP037111	anti-POU3F1	Mus musculus		EXP037106	260	normal	P21952	epiblast stem cells	PEAKS039810
EXP037112	anti-ZIC2	Mus musculus	feeder free	EXP037106	260	normal	Q62520	epiblast stem cells	PEAKS039811
EXP037113	anti-OTX2	Mus musculus	feeder free	EXP037106	260	normal	P80206	epiblast stem cells	PEAKS039812
EXP037114	anti-SOX2	Mus musculus	feeder free	EXP037106	260	normal	P48432	epiblast stem cells	PEAKS039813
EXP037115	anti-POU5F1	Mus musculus	feeder free	EXP037106	260	normal	P20263	epiblast stem cells	PEAKS039814
EXP037116	anti-POU3F1	Mus musculus	feeder free	EXP037106	260	normal	P21952	epiblast stem cells	PEAKS039815
EXP037119	NANOG IgG	Homo sapiens		EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	PEAKS039816
EXP037120	NANOG IgG	Homo sapiens	doxycycline for 4 days	EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	PEAKS039817
EXP037121	NANOGP8 IgG	Homo sapiens		EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	PEAKS039818
EXP037122	NANOGP8 IgG	Homo sapiens	doxycycline for 4 days	EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	PEAKS039819
EXP037125	FOXA1	Homo sapiens	tamoxifen	EXP037123	948	normal	P55317	MCF-7L (invasive ductal carcinoma)	PEAKS039820
EXP037126	FOXA1	Homo sapiens	tamoxifen	EXP037124	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS039821
EXP037127	ELK-1 in house antibody	Mus musculus	TKO recon pMY Empty; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039822
EXP037128	ELK-1 in house antibody	Mus musculus	TKO recon pMY Empty; 12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039823
EXP037129	ELK1 in house antibody	Mus musculus	TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039824
EXP037130	ELK1 in house antibody	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039825
EXP037131	ELK1 in house antibody	Mus musculus	TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039826
EXP037132	ELK1 in house antibody	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039827
EXP037133	ELK1 in house antibody	Mus musculus	TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039828
EXP037134	ELK1 in house antibody	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	PEAKS039829
EXP037135	SRF (sc-335) (Lot: D3013)	Mus musculus		NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS039830
EXP037136	SRF (sc-335) (Lot: D3013)	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes	NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS039831
EXP037137	SRF (sc-335) (Lot: D3013)	Mus musculus	TCF KO	NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS039832
EXP037138	SRF (sc-335) (Lot: D3013)	Mus musculus	TCF KO; 12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes	NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	PEAKS039833
EXP037146	NEUROG2 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037139	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039834
EXP037147	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037139	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039835
EXP037148	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037140	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039836
EXP037149	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037140	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039837
EXP037150	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037141	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039838
EXP037151	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037141	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039839
EXP037152	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037142	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039840
EXP037153	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037142	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039841
EXP037154	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037143	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039842
EXP037155	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037143	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039843
EXP037156	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037144	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039844
EXP037157	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037144	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	PEAKS039845
EXP037158	Sox4 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037145	950	normal	Q06945	MRC-5 (fetal lung fibroblasts)	PEAKS039846
EXP037159	Sox4 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037145	950	normal	Q06945	MRC-5 (fetal lung fibroblasts)	PEAKS039847
EXP037160	Sox4 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037145	950	normal	Q06945	MRC-5 (fetal lung fibroblasts)	PEAKS039848
EXP037162	anti-MLL1 (BETHYL, A300-086A, lot 4)	Mus musculus		EXP037161	528	normal	P55200	Lin-Sca-1+ c-Kit+ hematopietic multipotent stem cells	PEAKS039849
EXP037167	CTCF	Mus musculus		EXP037163	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	PEAKS039850
EXP037168	Runx2	Mus musculus		EXP037163	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	PEAKS039851
EXP037169	CTCF	Mus musculus		EXP037164	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	PEAKS039852
EXP037170	Runx2	Mus musculus		EXP037164	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	PEAKS039853
EXP037171	CTCF	Mus musculus		EXP037165	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	PEAKS039854
EXP037172	Runx2	Mus musculus		EXP037165	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	PEAKS039855
EXP037173	CTCF	Mus musculus		EXP037166	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	PEAKS039856
EXP037174	Runx2	Mus musculus		EXP037166	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	PEAKS039857
EXP037175	Sox2	Homo sapiens		NULL	396	normal	P48431	WA09 (embryonic stem cells)	PEAKS039858
EXP037176	Sox2	Homo sapiens		NULL	953	normal	P48431	H9-derived neuroectoderm cells	PEAKS039859
EXP037177	anti-ASH1 (made in-house)	Homo sapiens		NULL	514	normal	P50553	K562 (myelogenous leukemia)	PEAKS039860
EXP037180	TCF4	Homo sapiens		EXP037178	147	normal	P15884	CAL-1 (plasmacytoid dendritic neoplasm)	PEAKS039861
EXP037181	TCF4	Homo sapiens		EXP037179	940	normal	P15884	GEN2.2 (blastic plasmacytoid dendritic cell neoplasm)	PEAKS039862
EXP037182	CTCF (Upstate 07-729)	Mus musculus	WT; 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039863
EXP037183	CTCF (Upstate 07-729)	Mus musculus	WT; 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039864
EXP037184	CTCF (Upstate 07-729)	Mus musculus	Ctcf(fl/fl); 4h Adeno-Cre and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039865
EXP037185	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Smc3(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039866
EXP037186	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Smc3(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039867
EXP037187	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Wapl(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039868
EXP037188	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Wapl(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	PEAKS039869
EXP037190	anti-SOX9 (Millipore AB5535)	Homo sapiens	Treatment: None	EXP037189	71	normal	P48436	VCaP (prostate carcinoma)	PEAKS039870
EXP037191	FLI1	Homo sapiens		NULL	516	normal	Q01543	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039871
EXP037192	ERG	Homo sapiens		NULL	516	normal	P11308	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039872
EXP037193	GATA2	Homo sapiens		NULL	516	normal	P23769	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039873
EXP037194	TAL1	Homo sapiens		NULL	516	normal	P17542	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039874
EXP037195	LYL	Homo sapiens		NULL	516	normal	P12980	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039875
EXP037196	RUNX1	Homo sapiens		NULL	516	normal	Q01196	Kasumi-1 (acute myeloblastic leukemia)	PEAKS039876
EXP037198	KLF4	Mus musculus		EXP037197	171	normal	Q60793	CD4+ CD8+ T cells	PEAKS039877
EXP037201	anti-VDR	Homo sapiens	vehicle treated control	EXP037199	955	normal	P11473	primary foreskin fibroblasts	PEAKS039878
EXP037202	anti-VDR	Homo sapiens	vitamin D treated	EXP037200	955	normal	P11473	primary foreskin fibroblasts	PEAKS039879
EXP037204	Custom made RUNX2 antibody	Homo sapiens		EXP037203	783	normal	Q13950	SaOS2 (osteosarcoma)	PEAKS039880
EXP037206	Satb1 (AbCam ab109122)	Mus musculus		EXP037205	44	normal	Q60611	T-cells	PEAKS039881
EXP037208	Anti-V5 (Abcam, catalog# 15828, lot# GR195596-1)	Mus musculus	transduced with AAV8-hSyn-Satb2-V5 at DIV4	EXP037207	956	normal	Q8VI24	primary hippocampal neuron	PEAKS039882
EXP037210	Znf281	Mus musculus		EXP037209	252	normal	Q99LI5	V6.5 (embryonic stem cells)	PEAKS039883
EXP037212	Zic1	Mus musculus		EXP037211	280	normal	P46684	embryonic stem cell-derived neural progenitors	PEAKS039884
EXP037214	Avi-tagged hGATA6	Homo sapiens		EXP037213	376	normal	Q92908	WA01 (H1, human embryonic stem cells)	PEAKS039885
EXP037216	rabbit anti-Hnf1?  (Santa Cruz, H-85, SC-22840)	Mus musculus		EXP037215	957	normal	P27889	mpkDCT4a (immortalized murine DCT cell line)	PEAKS039886
EXP037218	Santa Cruz, C-20, lot SC-193	Homo sapiens		EXP037217	725	normal	Q01094	PC3(bone mets prostate adenocarcinoma)	PEAKS039887
EXP037220	Flag (Sigma, Cat. F1804)	Mus musculus	tet1e isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039888
EXP037221	Flag (Sigma, Cat. F1804)	Mus musculus	tet1s isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039889
EXP037222	Flag (Sigma, Cat. F1804)	Mus musculus	tet1e delta cxxc isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039890
EXP037223	Flag (Sigma, Cat. F1804)	Mus musculus	Tet1n isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039891
EXP037224	Flag (Sigma, Cat. F1804)	Mus musculus	tet1delta delta cxxc isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039892
EXP037225	Tet1 (home-made; same as the one used for ChIP-seq in PMID 21514197)	Mus musculus		EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039893
EXP037226	Tet1 (home-made; same as the one used for ChIP-seq in PMID 21514197)	Mus musculus	tet1cs isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS039894
EXP037237	Mll2 (Homemade, #9173)	Mus musculus	mCXXC/mCXXC genotype	EXP037227	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039895
EXP037238	Mll2 (Homemade, #9173)	Mus musculus	mCXXC/mCXXC genotype	EXP037228	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039896
EXP037239	Mll2 (Homemade, #9173)	Mus musculus	Y2602A/Y2602A genotype	EXP037229	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039897
EXP037240	Mll2 (Homemade, #9173)	Mus musculus	Y2602A/Y2602A genotype	EXP037230	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039898
EXP037241	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo-MLL2(deltaCXXC)	EXP037231	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039899
EXP037242	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo-MLL2(Y2604A)	EXP037231	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039900
EXP037243	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo-MLL2(WT)	EXP037231	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039901
EXP037244	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo	EXP037231	252	bio_control	O08550	V6.5 (embryonic stem cells)	PEAKS039902
EXP037245	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO	EXP037231	252	bio_control	O08550	V6.5 (embryonic stem cells)	PEAKS039903
EXP037246	Mll2 (Homemade, #9173)	Mus musculus	Halo	EXP037233	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039904
EXP037247	Mll2 (Homemade, #9173)	Mus musculus		EXP037233	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039905
EXP037248	Mll2 (Homemade, #9173)	Mus musculus	shMenin	EXP037232	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039906
EXP037249	Mll2 (Homemade, #9173)	Mus musculus	shMll2	EXP037236	252	bio_control	O08550	V6.5 (embryonic stem cells)	PEAKS039907
EXP037250	Mll2 (Homemade, #9175)	Mus musculus		EXP037234	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039908
EXP037251	Mll2 (Homemade, #9173)	Mus musculus	shGFP	EXP037235	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS039909
EXP037252	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus	4Â°C	NULL	80	normal	Q3UV55	B lymphoblastic leukemia	PEAKS039910
EXP037253	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus	30Â°C	NULL	80	normal	Q3UV55	B lymphoblastic leukemia	PEAKS039911
EXP037254	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus	30Â°C, Rev-erb alpha KO	NULL	80	bio_control	Q3UV55	B lymphoblastic leukemia	PEAKS039912
EXP037257	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus		EXP037256	958	normal	P17433	BN cells (granulocyte-macrophage progenitor)	PEAKS039913
EXP037258	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus	1000 ng/ml doxycycline	EXP037255	958	normal	P17433	BN cells (granulocyte-macrophage progenitor)	PEAKS039914
EXP037260	07-729, Millipore	Mus musculus		EXP037259	803	normal	Q61164	spermatocytes	PEAKS039915
EXP037262	AR (santa cruz, sc-815X, lot K0713)	Homo sapiens		NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS039916
EXP037263	AR (santa cruz, sc-815X, lot K0713)	Homo sapiens	NOV induced	EXP037261	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS039917
EXP037276	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	none (control)	EXP037266	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	PEAKS039918
EXP037277	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	Desmosterol (20uM) for 18 hours	EXP037266	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	PEAKS039919
EXP037278	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	GW3965 (1uM) for 18 hours	EXP037266	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	PEAKS039920
EXP037279	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	KLA for 24 hours	EXP037267	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	PEAKS039921
EXP037280	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	none (control)	EXP037265	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	PEAKS039922
EXP037281	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	none (control)	EXP037264	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	PEAKS039923
EXP037282	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	none (control)	EXP037265	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	PEAKS039924
EXP037283	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	KLA for 6 hours	EXP037265	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	PEAKS039925
EXP037284	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	KLA for 24 hours	EXP037264	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	PEAKS039926
EXP037285	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	none (control)	EXP037269	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039927
EXP037286	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 1 hours	EXP037271	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039928
EXP037287	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 6 hours	EXP037273	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039929
EXP037288	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 24 hours	EXP037275	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039930
EXP037289	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	Srebp1 -/-	EXP037268	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039931
EXP037290	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 1 hours, Srebp1 -/-	EXP037270	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039932
EXP037291	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 6 hours, Srebp1 -/-	EXP037272	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039933
EXP037292	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 24 hours, Srebp1 -/-	EXP037274	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS039934
EXP037294	STAT5a (Santa Cruz, sc1081X)	Mus musculus	IL3 deprivation for 6h	EXP037293	105	normal	P42230	pro-B cells	PEAKS039935
EXP037295	STAT5a (Santa Cruz, sc1081X)	Mus musculus	IL3 deprivation for 6h and IL3 stimulation for 30min	EXP037293	105	normal	P42230	pro-B cells	PEAKS039936
EXP037297	anti JARID2 rabbit Novus NB100-2214	Mus musculus		EXP037296	233	normal	Q62315	E14TG2A (embryonic stem cells)	PEAKS039937
EXP037298	anti JARID2 rabbit Novus NB100-2214	Mus musculus	c17orf96 knock-down	EXP037296	233	normal	Q62315	E14TG2A (embryonic stem cells)	PEAKS039938
EXP037300	Nkx2.2 (Sigma-Hpa003468)	Mus musculus		EXP037299	16	normal	P42586	MIN6-B1 (insulinoma)	PEAKS039939
EXP037301	MLL	Homo sapiens		NULL	641	normal	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS039940
EXP037302	RUNX1	Homo sapiens		NULL	641	normal	Q01196	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS039941
EXP037303	MLL	Homo sapiens		NULL	2334	normal	Q03164	THP-1 (acute monocytic leukemia)	PEAKS039942
EXP037304	RUNX1	Homo sapiens		NULL	2334	normal	Q01196	THP-1 (acute monocytic leukemia)	PEAKS039943
EXP037306	3ug Santa Cruz sc-352x/IP	Mus musculus		EXP037305	960	normal	P17433	Ly6Chi monocytes	PEAKS039944
EXP037307	3ug Santa Cruz sc-352x/IP	Mus musculus		EXP037305	961	normal	P17433	Ly6Clo monocytes	PEAKS039945
EXP037308	3ug Santa Cruz sc-150x/IP	Mus musculus		EXP037305	961	normal	P28033	Ly6Clo monocytes	PEAKS039946
EXP037316	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037309	41	normal	P02340	B-cells	PEAKS039947
EXP037317	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037310	41	normal	P02340	B-cells	PEAKS039948
EXP037318	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037311	41	normal	P02340	B-cells	PEAKS039949
EXP037319	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037312	41	normal	P02340	B-cells	PEAKS039950
EXP037320	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037309	41	normal	P02340	B-cells	PEAKS039951
EXP037321	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037310	41	normal	P02340	B-cells	PEAKS039952
EXP037322	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037311	41	normal	P02340	B-cells	PEAKS039953
EXP037323	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037312	41	normal	P02340	B-cells	PEAKS039954
EXP037324	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	EXP037313	41	normal	P02340	B-cells	PEAKS039955
EXP037325	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	EXP037314	41	normal	P02340	B-cells	PEAKS039956
EXP037326	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	EXP037315	41	normal	P02340	B-cells	PEAKS039957
EXP037327	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O	EXP037313	41	normal	P02340	B-cells	PEAKS039958
EXP037328	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O	EXP037314	41	normal	P02340	B-cells	PEAKS039959
EXP037329	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O	EXP037315	41	normal	P02340	B-cells	PEAKS039960
EXP037330	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO	EXP037313	41	normal	P02340	B-cells	PEAKS039961
EXP037331	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO	EXP037314	41	normal	P02340	B-cells	PEAKS039962
EXP037332	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO	EXP037315	41	normal	P02340	B-cells	PEAKS039963
EXP037333	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (+)-Nutlin	EXP037313	41	normal	P02340	B-cells	PEAKS039964
EXP037334	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (+)-Nutlin	EXP037314	41	normal	P02340	B-cells	PEAKS039965
EXP037335	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (+)-Nutlin	EXP037315	41	normal	P02340	B-cells	PEAKS039966
EXP037336	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1ÂµM doxorubicin	EXP037313	41	normal	P02340	B-cells	PEAKS039967
EXP037337	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1ÂµM doxorubicin	EXP037314	41	normal	P02340	B-cells	PEAKS039968
EXP037338	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1ÂµM doxorubicin	EXP037315	41	normal	P02340	B-cells	PEAKS039969
EXP037339	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (-)-Nutlin	EXP037313	41	normal	P02340	B-cells	PEAKS039970
EXP037340	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (-)-Nutlin	EXP037314	41	normal	P02340	B-cells	PEAKS039971
EXP037341	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (-)-Nutlin	EXP037315	41	normal	P02340	B-cells	PEAKS039972
EXP037342	Sigma HPA004820	Homo sapiens		NULL	70	normal	Q6ISB3	LNCaP (prostate carcinoma)	PEAKS039973
EXP037343	Santa Cruz sc-816 X	Homo sapiens		NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS039974
EXP037346	antibody: millipore (07-729)	Mus musculus		EXP037344	962	normal	Q61164	haploid mESCs derived from strain 129/Ola	PEAKS039975
EXP037347	antidoby: calbiochem (SC1000)	Mus musculus		EXP037344	962	normal	Q80Z64	haploid mESCs derived from strain 129/Ola	PEAKS039976
EXP037348	antibody: calbiochem (SC1000)	Mus musculus		EXP037345	963	normal	Q80Z64	embryonic stem cells from stran 129	PEAKS039977
EXP037361	anti-Oct4 (Santa Cruz sc-5279)	Mus musculus	+12hrDox(iFlag.Ngn2)	EXP037349	237	normal	P20263	embryoid body	PEAKS039978
EXP037362	anti-Oct4 (Santa Cruz sc-5279)	Mus musculus	(iNgn2.Isl1.Lhx3.V5)	EXP037352	237	normal	P20263	embryoid body	PEAKS039979
EXP037363	anti-Oct4 (Santa Cruz sc-5279)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P20263	embryoid body	PEAKS039980
EXP037364	anti-V5 (Abcam ab15828)	Mus musculus	+36hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	EXP037360	237	normal	P50481	embryoid body	PEAKS039981
EXP037365	anti-V5 (Abcam ab15828)	Mus musculus	+48hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	normal	P50481	embryoid body	PEAKS039982
EXP037366	anti-Ngn2 (Santa Cruz sc-19233)	Mus musculus	+12hrDox(iFlag.Ngn2)	EXP037349	237	normal	P70447	embryoid body	PEAKS039983
EXP037367	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iIsl1.Lhx3.V5)	EXP037350	237	normal	P50481	embryoid body	PEAKS039984
EXP037368	anti-V5 (Abcam ab15828)	Mus musculus	+48hrDox(iIsl1.Lhx3.V5)	EXP037351	237	normal	P50481	embryoid body	PEAKS039985
EXP037369	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+8hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	normal	P61372	embryoid body	PEAKS039986
EXP037370	anti-V5 (Abcam ab15828)	Mus musculus	+8hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	normal	P50481	embryoid body	PEAKS039987
EXP037371	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P61372	embryoid body	PEAKS039988
EXP037372	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P50481	embryoid body	PEAKS039989
EXP037373	anti-Ngn2 (Santa Cruz sc-19233)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P70447	embryoid body	PEAKS039990
EXP037374	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037354	237	normal	P61372	embryoid body	PEAKS039991
EXP037375	anti-V5 (Abcam ab15828)	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037354	237	normal	P50481	embryoid body	PEAKS039992
EXP037376	anti-Ebf2 (Abcam ab156999)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	O08792	embryoid body	PEAKS039993
EXP037377	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	P61372	embryoid body	PEAKS039994
EXP037378	anti-V5 (Abcam ab15828)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	P50481	embryoid body	PEAKS039995
EXP037379	anti-Onecut2 (R&D Systems AF294)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	Q6XBJ3	embryoid body	PEAKS039996
EXP037380	anti-V5 (Abcam ab15828)	Mus musculus	+24hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	EXP037358	237	normal	P50481	embryoid body	PEAKS039997
EXP037381	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5.Ebf2.Onecut2)	EXP037357	237	normal	P50481	embryoid body	PEAKS039998
EXP037382	anti-V5 (Abcam ab15828)	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5.Ebf2.Onecut2)	EXP037359	237	normal	P50481	embryoid body	PEAKS039999
EXP037383	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	EXP037356	237	normal	P50481	embryoid body	PEAKS040000
EXP037387	CTCF (Millipore, 07-729, lot 2517762)	Mus musculus		EXP037384	73	normal	Q61164	G1E-derived erythroid cells	PEAKS040001
EXP037388	CTCF (Millipore, 07-729, lot 2517762)	Mus musculus	D_Brd2KO	EXP037385	73	normal	Q61164	G1E-derived erythroid cells	PEAKS040002
EXP037389	CTCF (Millipore, 07-729, lot 2517762)	Mus musculus	C8_Brd2KO	EXP037386	73	normal	Q61164	G1E-derived erythroid cells	PEAKS040003
EXP037392	anti DP1	Homo sapiens	none	EXP037390	618	normal	Q14186	MM1.S (plasma cell myeloma)	PEAKS040004
EXP037393	anti E2F1	Homo sapiens	none	EXP037390	618	normal	Q01094	MM1.S (plasma cell myeloma)	PEAKS040005
EXP037394	anti DP1	Homo sapiens	none	EXP037391	964	normal	Q14186	U266 (plasma cell myeloma)	PEAKS040006
EXP037395	anti E2F1	Homo sapiens	none	EXP037391	964	normal	Q01094	U266 (plasma cell myeloma)	PEAKS040007
EXP037398	WT1	Homo sapiens		EXP037396	514	normal	P19544	K562 (myelogenous leukemia)	PEAKS040008
EXP037399	WT1	Homo sapiens	WT1 plusKTS splice isoform	EXP037397	514	normal	P19544	K562 (myelogenous leukemia)	PEAKS040009
EXP037401	SC-66882, Santa Cruz Biotechnology	Mus musculus		EXP037400	965	normal	O08580	frontal cortex	PEAKS040010
EXP037404	anti-HoxA13 (in-house, affinity purified)	Mus musculus		EXP037402	314	normal	Q62424	forelimb bud	PEAKS040011
EXP037405	anti-HoxD13 (in-house, affinity purified)	Mus musculus		EXP037403	314	normal	P70217	forelimb bud	PEAKS040012
EXP037411	GR Antibody	Mus musculus		EXP037406	483	normal	P06537	brown preadipocytes	PEAKS040013
EXP037412	GR Antibody	Mus musculus	GR KO	EXP037407	483	normal	P06537	brown preadipocytes	PEAKS040014
EXP037413	GR Antibody	Mus musculus		EXP037408	483	normal	P06537	brown preadipocytes	PEAKS040015
EXP037414	GR Antibody	Mus musculus		EXP037409	483	normal	P06537	brown preadipocytes	PEAKS040016
EXP037415	C/EBP ? Antibody (C-19)	Mus musculus		EXP037408	483	normal	P53566	brown preadipocytes	PEAKS040017
EXP037416	C/EBP ? Antibody (C-19)	Mus musculus		EXP037409	483	normal	P53566	brown preadipocytes	PEAKS040018
EXP037417	C/EBP ? Antibody (C-19)	Mus musculus	GR KO	EXP037410	483	normal	P53566	brown preadipocytes	PEAKS040019
EXP037418	p-CREB Antibody	Mus musculus		EXP037408	483	normal	Q01147	brown preadipocytes	PEAKS040020
EXP037419	p-CREB Antibody	Mus musculus		EXP037409	483	normal	Q01147	brown preadipocytes	PEAKS040021
EXP037420	p-CREB Antibody	Mus musculus	GR KO	EXP037410	483	normal	Q01147	brown preadipocytes	PEAKS040022
EXP037421	anti-FOXR2 (Rabbit polyclonal antibody against human FOXR2 (residues 1311) was generated and affinity purified in house)	Homo sapiens		NULL	591	normal	Q6PJQ5	MDA-MB-468 (breast adenocarcinoma)	PEAKS040023
EXP037422	anti-MAX(S20) (Cell signaling, catalog# 4739)	Homo sapiens		NULL	591	normal	P61244	MDA-MB-468 (breast adenocarcinoma)	PEAKS040024
EXP037423	anti-MYC(D84C12) (Cell signaling, catalog# 5605S, lot# 6)	Homo sapiens		NULL	591	normal	P01106	MDA-MB-468 (breast adenocarcinoma)	PEAKS040025
EXP037425	ATF3 (Santa Cruz Cat.No. 188 C-19)	Homo sapiens		EXP037424	891	normal	P18847	dermal fibroblasts	PEAKS040026
EXP037426	ATF3 (SantaCruz Cat.No.188 C-19)	Homo sapiens	overexpressed ATF3	EXP037424	891	normal	P18847	dermal fibroblasts	PEAKS040027
EXP037428	Rabbit anti-A-MYB (Sigma-Aldrich, HPA008791)	Mus musculus		EXP037427	32	normal	P51960	testis	PEAKS040028
EXP037430	rabbit anti SOX9 homemade (ref Gasca et al, PNAS 2002, vol 99, 11199-11204)	Mus musculus		EXP037429	966	normal	Q04887	E13.5 fetal testis	PEAKS040029
EXP037433	anti-FOXA1 (ab5089) Abcam	Homo sapiens	No treatment	EXP037431	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040030
EXP037434	anti-FOXA1 (ab5089) Abcam	Homo sapiens	Nonspecific siRNA	EXP037432	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040031
EXP037435	anti-GRHL2 (HPA004820)  Sigma Aldrich	Homo sapiens	No treatment	EXP037431	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS040032
EXP037437	Stat1a p91 sc-345	Homo sapiens		EXP037436	113	normal	P42224	MCF7 (Invasive ductal breast carcinoma)	PEAKS040033
EXP037440	anti-T-bet SY4530FB	Homo sapiens	anti-CD3/CD28	EXP037438	886	normal	Q9UL17	Th1-cells	PEAKS040034
EXP037441	anti-T-bet SY4530FB	Homo sapiens	anti-CD3/CD28	EXP037439	886	normal	Q9UL17	Th1-cells	PEAKS040035
EXP037443	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	ICI	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040036
EXP037444	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	ICI, DEX	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040037
EXP037445	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	E2	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040038
EXP037446	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	E2, DEX	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040039
EXP037447	streptavidin beads	Homo sapiens	ICI	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040040
EXP037448	streptavidin beads	Homo sapiens	ICI, DEX	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040041
EXP037449	streptavidin beads	Homo sapiens	E2	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040042
EXP037450	streptavidin beads	Homo sapiens	E2, DEX	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040043
EXP037451	streptavidin beads	Homo sapiens	ICI, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040044
EXP037452	streptavidin beads	Homo sapiens	ICI, DEX, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040045
EXP037453	streptavidin beads	Homo sapiens	E2, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040046
EXP037454	streptavidin beads	Homo sapiens	E2, DEX, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	PEAKS040047
EXP037455	streptavidin beads	Homo sapiens	ICI	EXP037442	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS040048
EXP037456	streptavidin beads	Homo sapiens	E2	EXP037442	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS040049
EXP037457	streptavidin beads	Homo sapiens	E2, DEX	EXP037442	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS040050
EXP037459	CTCF (Millipore 07-729)	Homo sapiens		EXP037458	1549	normal	P49711	COLO-829 (melanoma)	PEAKS040051
EXP037460	antibody RUNX1 (Abcam ab23980)	Homo sapiens		NULL	648	normal	Q01196	NB4 (acute promyelocytic leukemia )	PEAKS040052
EXP037463	CBF?	Mus musculus		EXP037461	967	normal	P23708	naive CD8+ T-cells	PEAKS040053
EXP037464	CBF?	Mus musculus	CBF-B KO	EXP037461	967	bio_control	P23708	naive CD8+ T-cells	PEAKS040054
EXP037465	CBF?	Mus musculus		EXP037461	2479	normal	P23708	CD8+ T-cells	PEAKS040055
EXP037468	GFP	Mus musculus		EXP037466	968	normal	P48985	colon	PEAKS040056
EXP037469	GFP	Mus musculus		EXP037467	969	normal	P48985	distal small intestine	PEAKS040057
EXP037470	Bethy Laboratories, A300-086A	Mus musculus	activated	NULL	970	normal	P55200	spleen B-cells	PEAKS040058
EXP037471	Bethy Laboratories, A300-086A	Mus musculus	resting	NULL	970	normal	P55200	spleen B-cells	PEAKS040059
EXP037472	abcam, ab70303	Mus musculus	activated	NULL	970	normal	Q61164	spleen B-cells	PEAKS040060
EXP037473	abcam, ab70303	Mus musculus	resting	NULL	970	normal	Q61164	spleen B-cells	PEAKS040061
EXP037474		Mus musculus		NULL	971	normal	P01108	blastocyst B-cells	PEAKS040062
EXP037475	anti-STAT5A (Santa Cruz, sc-1081)	Mus musculus	Socs2 mut, lactation day1	NULL	572	normal	P42230	mammary gland	PEAKS040063
EXP037476	anti-STAT5A (Santa Cruz, sc-1081)	Mus musculus	Socs2 mut, pregnancy day13	NULL	572	normal	P42230	mammary gland	PEAKS040064
EXP037477	anti-GR (ThermoFisher, PA1-511A)	Mus musculus	Socs2 mut, pregnancy day13	NULL	572	normal	P06537	mammary gland	PEAKS040065
EXP037484	anti-FoxA1, Abcam, ab5089	Mus musculus		EXP037478	292	normal	P35582	F9 (embryonal carcinoma)	PEAKS040066
EXP037485	anti-FoxA1, Abcam, ab5089	Mus musculus	treated 48 hrs with RA	EXP037483	292	normal	P35582	F9 (embryonal carcinoma)	PEAKS040067
EXP037486	anti-Meis1, Abcam, ab19867	Mus musculus		EXP037478	292	normal	Q60954	F9 (embryonal carcinoma)	PEAKS040068
EXP037487	anti-Meis1, Abcam, ab19867	Mus musculus	treated 6 hrs with RA	EXP037479	292	normal	Q60954	F9 (embryonal carcinoma)	PEAKS040069
EXP037488	anti-Meis1, Abcam, ab19867	Mus musculus	treated 12 hrs with RA	EXP037480	292	normal	Q60954	F9 (embryonal carcinoma)	PEAKS040070
EXP037489	anti-Meis1, Abcam, ab19867	Mus musculus	treated 18 hrs with RA	EXP037481	292	normal	Q60954	F9 (embryonal carcinoma)	PEAKS040071
EXP037490	anti-Meis1, Abcam, ab19867	Mus musculus	treated 24 hrs with RA	EXP037482	292	normal	Q60954	F9 (embryonal carcinoma)	PEAKS040072
EXP037491	anti-Meis1, Abcam, ab19867	Mus musculus	treated 48 hrs with RA	EXP037483	292	normal	Q60954	F9 (embryonal carcinoma)	PEAKS040073
EXP037492	anti-Pbx1, Abnova, H00005087-M01	Mus musculus	treated 48 hrs with RA	EXP037483	292	normal	P41778	F9 (embryonal carcinoma)	PEAKS040074
EXP037498	TEAD4 Aviva	Mus musculus		EXP037493	1153	normal	Q62296	C2C12 (myoblasts)	PEAKS040075
EXP037499	TEAD4 Aviva	Mus musculus		EXP037494	126	normal	Q62296	C2C12 (myotubes)	PEAKS040076
EXP037500	TEAD1 BD Biosciences	Mus musculus		EXP037493	1153	normal	P30051	C2C12 (myoblasts)	PEAKS040077
EXP037501	TEAD1 BD Biosciences	Mus musculus		EXP037494	126	normal	P30051	C2C12 (myotubes)	PEAKS040078
EXP037502	TEAD4 Aviva	Mus musculus		EXP037495	972	normal	Q62296	hindlimb muscles	PEAKS040079
EXP037503	TEAD4	Mus musculus	Tead4 KO	EXP037497	972	bio_control	Q62296	hindlimb muscles	PEAKS040080
EXP037505	anti-MLL1 (MO453, provide by James Hsieh lab)	Mus musculus		EXP037504	973	normal	P55200	bone marrow derived immortalised LSK cells	PEAKS040081
EXP037517	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037506	974	normal	Q03164	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS040082
EXP037518	MLL1	Homo sapiens		EXP037507	2334	normal	Q03164	THP-1 (acute monocytic leukemia)	PEAKS040083
EXP037519	MLL1	Homo sapiens		EXP037508	975	normal	Q03164	KOPN8 (childhood B acute lymphoblastic leukemia)	PEAKS040084
EXP037520	MLL1	Homo sapiens		EXP037509	641	normal	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS040085
EXP037521	MLL1	Homo sapiens		EXP037510	153	normal	Q03164	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS040086
EXP037522	MLL1	Homo sapiens		EXP037511	976	normal	Q03164	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS040087
EXP037523	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037512	541	normal	Q03164	SEM (childhood B acute lymphoblastic leukemia)	PEAKS040088
EXP037524	MLL1 (Bethyl, A300-086A)	Homo sapiens	control siRNA	EXP037513	541	normal	Q03164	SEM (childhood B acute lymphoblastic leukemia)	PEAKS040089
EXP037525	MLL1 (Bethyl, A300-086A)	Homo sapiens	fused MLL1-AF4	EXP037514	541	normal	Q03164	SEM (childhood B acute lymphoblastic leukemia)	PEAKS040090
EXP037526	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037515	978	normal	Q03164	cord blood-derived mononuclear cells	PEAKS040091
EXP037527	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037516	979	normal	Q03164	fetal bone marrow-derived mononuclear cells	PEAKS040092
EXP037529	MYCN, Santa Cruz (catsc-53993 lot mAb)	Homo sapiens		EXP037528	980	normal	P04198	RH4 (alveolar rhabdomyosarcoma)	PEAKS040093
EXP037530	MYOD1 (Santa Cruz, sc-706)	Homo sapiens		EXP037528	980	normal	P15172	RH4 (alveolar rhabdomyosarcoma)	PEAKS040094
EXP037531	Myogenin (Santa Cruz, cat. #sc-576)	Homo sapiens		EXP037528	980	normal	P15173	RH4 (alveolar rhabdomyosarcoma)	PEAKS040095
EXP037532	CTCF, EMD Millipore (cat07-729 lot2628833 pAb)	Homo sapiens		EXP037528	980	normal	P49711	RH4 (alveolar rhabdomyosarcoma)	PEAKS040096
EXP037534	Ets1 (Santa Cruz, Sc-350X)	Mus musculus		EXP037533	981	normal	P27577	primary splenic B-cells	PEAKS040097
EXP037535	NFI	Mus musculus	day0	NULL	116	normal	Q02780	brown adipocytes	PEAKS040098
EXP037536	NFI	Mus musculus	day6	NULL	116	normal	Q02780	brown adipocytes	PEAKS040099
EXP037537	FLAG M2	Mus musculus	day0	NULL	1153	normal	Q02780	C2C12 (myoblasts)	PEAKS040100
EXP037538	FLAG M2	Mus musculus	day7	NULL	1153	normal	Q02780	C2C12 (myoblasts)	PEAKS040101
EXP037539	CEBPalpha	Mus musculus	day0	NULL	116	normal	P53566	brown adipocytes	PEAKS040102
EXP037540	CEBPbeta	Mus musculus	day0	NULL	116	normal	P28033	brown adipocytes	PEAKS040103
EXP037541	CEBPalpha	Mus musculus	day6	NULL	116	normal	P53566	brown adipocytes	PEAKS040104
EXP037542	CEBPbeta	Mus musculus	day6	NULL	116	normal	P28033	brown adipocytes	PEAKS040105
EXP037543	NFI	Mus musculus	day7	NULL	982	normal	Q02780	3T3F442A (white adipocytes)	PEAKS040106
EXP037544	PPARg	Mus musculus	day7	NULL	982	normal	P37238	3T3F442A (white adipocytes)	PEAKS040107
EXP037545	EBF2	Mus musculus	day0	NULL	116	normal	O08792	brown adipocytes	PEAKS040108
EXP037546	EBF2	Mus musculus	day6	NULL	116	normal	O08792	brown adipocytes	PEAKS040109
EXP037547	PPARg	Mus musculus	day0	NULL	116	normal	P37238	brown adipocytes	PEAKS040110
EXP037548	PPARg	Mus musculus	day6	NULL	116	normal	P37238	brown adipocytes	PEAKS040111
EXP037550	Anti-ERRalpha [ABCAM, Cat# 16363, Lot# GR263385-1]	Mus musculus	29C, HDAC3 floxed	EXP037549	115	normal	O08580	brown adipose tissue	PEAKS040112
EXP037551	Anti-ERRalpha [ABCAM, Cat# 16363, Lot# GR263385-1]	Mus musculus	29C, Adiponectin-Cre, HDAC3 floxed	EXP037549	115	normal	O08580	brown adipose tissue	PEAKS040113
EXP037552	anti-TFAP4 (Santa Cruz Biotechnology, sc-18593X)	Homo sapiens		NULL	983	normal	Q01664	SNU175 (adenocarcinoma)	PEAKS040114
EXP037553	anti-TFAP4 (Santa Cruz Biotechnology, sc-18593X)	Homo sapiens		NULL	185	normal	Q01664	COLO-320 (colon adenocarcinoma)	PEAKS040115
EXP037554	anti-ELF1 (Santa Cruz Biotechnology, sc-631X)	Homo sapiens		NULL	983	normal	P32519	SNU175 (adenocarcinoma)	PEAKS040116
EXP037555	anti-ELF1 (Santa Cruz Biotechnology, sc-631X)	Homo sapiens		NULL	185	normal	P32519	COLO-320 (colon adenocarcinoma)	PEAKS040117
EXP037557	Lmx1b polyclonal (BM08), Suleiman et al., 2007	Mus musculus		EXP037556	546	normal	O88609	limb bud	PEAKS040118
EXP037559	DLX-5	Mus musculus		EXP037558	984	normal	P70396	T-cell lymphoma	PEAKS040119
EXP037563	STAT5A (sc-1081)	Homo sapiens	Untreated	EXP037560	985	normal	P42229	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS040120
EXP037564	STAT5A (sc-1081)	Homo sapiens	3 h IL-2	EXP037561	985	normal	P42229	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS040121
EXP037565	STAT5A (sc-1081)	Homo sapiens	3 h IL-2 + 100 micromolar HODHBt	EXP037562	985	normal	P42229	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS040122
EXP037567	FOXK2	Homo sapiens		EXP037566	113	normal	Q01167	MCF7 (Invasive ductal breast carcinoma)	PEAKS040123
EXP037569	Cebpa (Santa Cruz, cat no. sc-61x, lot F2811)	Mus musculus		EXP037568	986	normal	P53566	Hoxb8-FL	PEAKS040124
EXP037570	Cebpb (Santa Cruz, cat no. sc-150x, lot F0711)	Mus musculus		EXP037568	986	normal	P28033	Hoxb8-FL	PEAKS040125
EXP037571	Erg (Santa Cruz, cat no. sc-354x, lot A2510)	Mus musculus		EXP037568	986	normal	P81270	Hoxb8-FL	PEAKS040126
EXP037572	Fli1 (Abcam, cat no. ab15289-500, lot 775077)	Mus musculus		EXP037568	986	normal	P26323	Hoxb8-FL	PEAKS040127
EXP037573	Gata2 (Santa Cruz, cat no. sc-9008x, lot I0109)	Mus musculus		EXP037568	986	normal	O09100	Hoxb8-FL	PEAKS040128
EXP037574	Gfi1 (Abcam, cat no. ab21061, lot 151880)	Mus musculus		EXP037568	986	normal	P70338	Hoxb8-FL	PEAKS040129
EXP037575	Gfi1b (Santa Cruz, cat no. sc8559x, lot E1409)	Mus musculus		EXP037568	986	normal	O70237	Hoxb8-FL	PEAKS040130
EXP037576	Lyl1 (Abcam, cat no. ab30334-200, lot 383134)	Mus musculus		EXP037568	986	normal	P27792	Hoxb8-FL	PEAKS040131
EXP037577	Meis1 (Santa Cruz, cat no. sc-10599x, lot D2310)	Mus musculus		EXP037568	986	normal	Q60954	Hoxb8-FL	PEAKS040132
EXP037578	Runx1 (Abcam, cat no. ab23980, lot GR37372-1)	Mus musculus		EXP037568	986	normal	Q03347	Hoxb8-FL	PEAKS040133
EXP037579	Spi1 (Santa Cruz, cat no. sc-352x, lot B0314)	Mus musculus		EXP037568	986	normal	P17433	Hoxb8-FL	PEAKS040134
EXP037580	Tal1 (Santa Cruz, cat no. sc-12984x, lot B2511)	Mus musculus		EXP037568	986	normal	P22091	Hoxb8-FL	PEAKS040135
EXP037582	KDM5A antibody (ab70892; Abcam)	Mus musculus	day0	EXP037581	18	normal	Q3UXZ9	3T3-L1 (embryonic fibroblasts)	PEAKS040136
EXP037583	KDM5A antibody (ab70892; Abcam)	Mus musculus	4hour	EXP037581	18	normal	Q3UXZ9	3T3-L1 (embryonic fibroblasts)	PEAKS040137
EXP037584	KDM5A antibody (ab70892; Abcam)	Mus musculus	day2	EXP037581	18	normal	Q3UXZ9	3T3-L1 (embryonic fibroblasts)	PEAKS040138
EXP037585	JARID1C/Kdm5C Antibody (A301-034A; Bethyl lab)	Mus musculus	day2	EXP037581	18	normal	P41230	3T3-L1 (embryonic fibroblasts)	PEAKS040139
EXP037587	CTCF millipore antibody (07-729)	Mus musculus		EXP037586	987	normal	Q61164	hippocampus	PEAKS040140
EXP037590	ER alpha (sc543) Santa Cruz	Homo sapiens	DMSO	EXP037589	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS040141
EXP037591	FOXA1 (ab5089) Abcam	Homo sapiens	DMSO	EXP037589	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS040142
EXP037592	ER alpha (sc543) Santa Cruz	Homo sapiens	BYL719	EXP037588	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS040143
EXP037593	FOXA1 (ab5089) Abcam	Homo sapiens	BYL719	EXP037588	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS040144
EXP037595	Myf-5, Santa Cruz (C-20) cat# sc-302	Homo sapiens		EXP037594	988	normal	P13349	RH18 (alveolar rhabdomyosarcoma)	PEAKS040145
EXP037596	CTCF (Millipore, catalog#  07-729, lot# JBC1881349)	Homo sapiens	undifferentiated	NULL	463	normal	P49711	epidermal keratinocytes	PEAKS040146
EXP037597	CTCF (Millipore, catalog#  07-729, lot# JBC1881349)	Homo sapiens	day3 of differentiation	NULL	463	normal	P49711	epidermal keratinocytes	PEAKS040147
EXP037598	CTCF (Millipore, catalog#  07-729, lot# JBC1881349)	Homo sapiens	day6 of differentiation	NULL	463	normal	P49711	epidermal keratinocytes	PEAKS040148
EXP037599	EHF (Santa Cruz, catalog#  sc-166653, lot# C0910)	Homo sapiens	day3 of differentiation	NULL	463	normal	Q9NZC4	epidermal keratinocytes	PEAKS040149
EXP037600	BCL11B	Homo sapiens		NULL	989	normal	Q9C0K0	thymus-derived CD34+ cells	PEAKS040150
EXP037601	BCL11B	Homo sapiens		NULL	990	normal	Q9C0K0	thymus-derived CD34- cells	PEAKS040151
EXP037603	Anti-Islet 1 antibody [EP4182] (Abcam, ab109517)	Mus musculus		EXP037602	286	normal	P61372	pancreatic beta-cells	PEAKS040152
EXP037605	Gfi1 Abcam cat #: ab21061	Mus musculus	p53-/-; p18-/-	EXP037604	161	normal	P70338	neurosphere cells	PEAKS040153
EXP037606	Gfi1 Abcam cat #: ab21061	Mus musculus	p53-/-; p18-/-	EXP037604	161	normal	P70338	neurosphere cells	PEAKS040154
EXP037607	CTCF (Active motif: 613111)	Mus musculus		NULL	991	normal	Q61164	E10.5 forelimb	PEAKS040155
EXP037608	CTCF (Active motif: 613111)	Mus musculus		NULL	992	normal	Q61164	E11.5 forelimb	PEAKS040156
EXP037609	CTCF (Active motif: 613111)	Mus musculus		NULL	993	normal	Q61164	E13.5 forelimb	PEAKS040157
EXP037610	CTCF (Active motif: 613111)	Mus musculus		NULL	994	normal	Q61164	E10.5 hindlimb	PEAKS040158
EXP037611	CTCF (Active motif: 613111)	Mus musculus		NULL	995	normal	Q61164	E11.5 hindlimb	PEAKS040159
EXP037612	CTCF (Active motif: 613111)	Mus musculus		NULL	996	normal	Q61164	E13.5 hindlimb	PEAKS040160
EXP037613	CTCF (Active motif: 613111)	Mus musculus		NULL	997	normal	Q61164	E10.5 midbrain	PEAKS040161
EXP037615	anti-ARID4B antibody (CAT#: A302-233A, LOT#: A302-233A-1,Bethyl Laboratories)	Mus musculus		EXP037614	32	normal	A2CG63	testis	PEAKS040162
EXP037618	PPARG (Cell Signaling Technologies SC-7196X)	Mus musculus		EXP037616	18	normal	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS040163
EXP037619	PPARG (Cell Signaling Technologies SC-7196X)	Mus musculus		EXP037617	18	normal	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS040164
EXP037620	NeuroD2 antibody (Abcam, ab168932, GR161014-2)	Mus musculus		NULL	998	normal	Q62414	cortex of postnatal dorsal telencephalon	PEAKS040165
EXP037621	NeuroD2 antibody (Abcam, ab104430, GR94291-1)	Mus musculus		NULL	998	normal	Q62414	cortex of postnatal dorsal telencephalon	PEAKS040166
EXP037622	NeuroD2 antibody (Abcam, ab109406, YK010204CS)	Mus musculus		NULL	998	normal	Q62414	cortex of postnatal dorsal telencephalon	PEAKS040167
EXP037624	Biogenex, MU392A-UC (CDX2-88)	Mus musculus	24h CHIR99021 + Fgf8	NULL	260	normal	P43241	epiblast stem cells	PEAKS040169
EXP037625	brachyury	Mus musculus	24h CHIR99021 + Fgf8	NULL	260	normal	P20293	epiblast stem cells	PEAKS040170
EXP037628	ZSCAN5B (Santa Cruz)	Homo sapiens	treatment	EXP037626	421	normal	A6NJL1	HEK293 (embryonic kidney)	PEAKS040171
EXP037629	ZSCAN5A	Homo sapiens	treatment	EXP037627	999	normal	Q9BUG6	BeWo (gestational choriocarcinoma)	PEAKS040172
EXP037630	ZSCAN5D	Homo sapiens	treatment	EXP037627	999	normal	P0CG00	BeWo (gestational choriocarcinoma)	PEAKS040173
EXP037631	ZSCAN5B (Santa Cruz)	Homo sapiens	treatment	EXP037627	999	normal	A6NJL1	BeWo (gestational choriocarcinoma)	PEAKS040174
EXP037633	Oct1	Mus musculus		EXP037632	2	normal	P25425	mESCs (mouse embryonic stem cells)	PEAKS040175
EXP037634	Oct4	Mus musculus		EXP037632	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS040176
EXP037640	CEBPB	Mus musculus	Vehicle	EXP037635	19	normal	P28033	3T3-L1-derived preadipocytes	PEAKS040177
EXP037641		Mus musculus	CEBPB mutated; Vehicle	EXP037636	19	normal	P28033	3T3-L1-derived preadipocytes	PEAKS040178
EXP037642		Mus musculus	Doxycycline	EXP037637	19	normal	P28033	3T3-L1-derived preadipocytes	PEAKS040179
EXP037643		Mus musculus	CEBPB mutated;Doxycycline	EXP037638	19	normal	P28033	3T3-L1-derived preadipocytes	PEAKS040180
EXP037644		Mus musculus	Doxycycline + BYK204165	EXP037639	19	normal	P28033	3T3-L1-derived preadipocytes	PEAKS040181
EXP037646	CTCF: Millipore 07-729 (lot #2453497)	Homo sapiens	control; 100 nM 17-beta-estradiol for 0h	EXP037645	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS040182
EXP037647	CTCF: Millipore 07-729 (lot #2453497)	Homo sapiens	100 nM 17-beta-estradiol for 45 min	EXP037645	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS040183
EXP037648	CTCF: Millipore 07-729 (lot #2453497)	Homo sapiens	100 nM 17-beta-estradiol for 3h	EXP037645	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS040184
EXP037649	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	control; 100 nM 17-beta-estradiol for 0h	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040185
EXP037650	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	100 nM 17-beta-estradiol for 45 min	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040186
EXP037651	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	100 nM 17-beta-estradiol for 3h	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040187
EXP037652	FOXA1 AbCam ab5089 (lot #GK122110-17) and ab23738 (lot #GK176970-1)	Homo sapiens	control; 100 nM 17-beta-estradiol for 0h	EXP037645	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040188
EXP037653	FOXA1 AbCam ab5089 (lot #GK122110-17) and ab23738 (lot #GK176970-1)	Homo sapiens	100 nM 17-beta-estradiol for 45 min	EXP037645	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040189
EXP037654	FOXA1 AbCam ab5089 (lot #GK122110-17) and ab23738 (lot #GK176970-1)	Homo sapiens	100 nM 17-beta-estradiol for 3h	EXP037645	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040190
EXP037655	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	siCTCF	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040191
EXP037656	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	siNT	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040192
EXP037659	anti-BATF	Mus musculus		EXP037657	499	normal	O35284	Th2-cells	PEAKS040193
EXP037660	anti-IRF4	Mus musculus		EXP037657	499	normal	Q64287	Th2-cells	PEAKS040194
EXP037661	anti-IRF4	Mus musculus	BATF1/3 DKO; overexpressing Batf-HKE	EXP037658	499	normal	Q64287	Th2-cells	PEAKS040195
EXP037662	anti-IRF4	Mus musculus	Batf1/3 DKO	EXP037658	499	normal	Q64287	Th2-cells	PEAKS040196
EXP037663	anti-IRF4	Mus musculus	day 4, 10 ng	EXP037657	499	normal	Q64287	Th2-cells	PEAKS040197
EXP037664	anti-IRF4	Mus musculus	day 4, 2.2 ng	EXP037657	499	normal	Q64287	Th2-cells	PEAKS040198
EXP037665	anti-IRF4	Mus musculus	day 2, 10 ng	EXP037657	499	normal	Q64287	Th2-cells	PEAKS040199
EXP037666	anti-IRF4	Mus musculus		EXP037657	499	normal	Q64287	Th2-cells	PEAKS040200
EXP037667	anti-IRF4	Mus musculus	B-ATF KO	NULL	499	normal	Q64287	Th2-cells	PEAKS040201
EXP037668	anti-BATF3	Mus musculus	B-ATF KO	NULL	499	normal	Q9D275	Th2-cells	PEAKS040202
EXP037672	anti-CTCF (Millipore #07-729)	Mus musculus	2i/LIF conditions	EXP037669	252	normal	Q61164	V6.5 (embryonic stem cells)	PEAKS040203
EXP037673	anti-CTCF (Millipore #07-729)	Mus musculus	standard serum/LIF conditions	EXP037670	252	normal	Q61164	V6.5 (embryonic stem cells)	PEAKS040204
EXP037674	anti-CTCF (Millipore #07-729)	Mus musculus		EXP037671	1000	normal	Q61164	P1 (neural progenitor cells)	PEAKS040205
EXP037676	anti-MLL1 (A300-086A, Bethyl)	Homo sapiens	vehicle	EXP037675	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	PEAKS040206
EXP037677	anti-MLL2/TRX2 (A300-113A, Bethyl)	Homo sapiens	vehicle	EXP037675	113	normal	Q9UMN6	MCF7 (Invasive ductal breast carcinoma)	PEAKS040207
EXP037679	anti-GR antibody (Santa Cruz, sc-8992; lot #H1314)	Homo sapiens		NULL	430	normal	P04150	HepG2 (hepatoblastoma)	PEAKS040208
EXP037682	EHF	Homo sapiens		EXP037680	114	normal	Q9NZC4	bronchial epithelial cells	PEAKS040209
EXP037683	c-Jun (sc-1694)	Homo sapiens		EXP037681	148	normal	P05412	Calu-3 (lung adenocarcinoma)	PEAKS040210
EXP037684	JunD (sc-74)	Homo sapiens		EXP037681	148	normal	P17535	Calu-3 (lung adenocarcinoma)	PEAKS040211
EXP037688	RUNX1 antibody (Abcam, cat.no ab23980)	Homo sapiens		EXP037685	509	normal	Q01196	Jurkat (T-cells)	PEAKS040212
EXP037689	RUNX1 antibody (Abcam, cat.no ab23980)	Homo sapiens		EXP037686	10	normal	Q01196	HEK293T (embryonic kidney)	PEAKS040213
EXP037690	RUNX1 antibody (Abcam, cat.no ab23980)	Homo sapiens		EXP037687	730	normal	Q01196	mononuclear cells from periferal blood	PEAKS040214
EXP037698	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	N/A	EXP037691	1003	normal	P40763	A139 ER-, PR-, HER2- breast cancer cells	PEAKS040215
EXP037699	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	N/A	EXP037692	1004	normal	P40763	A137 ER-, PR-, HER2- breast cancer cells	PEAKS040216
EXP037700	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037693	1001	normal	P40763	MDA-MB-157 (triple negative breast carcinoma)	PEAKS040217
EXP037701	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037694	2301	normal	P40763	MDA-MB-231 (breast adenocarcinoma)	PEAKS040218
EXP037702	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037695	1002	normal	P40763	HCC1143 (ductal breast carcinoma)	PEAKS040219
EXP037703	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037696	412	normal	P40763	HCC70 (ductal breast carcinoma)	PEAKS040220
EXP037704	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037697	591	normal	P40763	MDA-MB-468 (breast adenocarcinoma)	PEAKS040221
EXP037712	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037705	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040222
EXP037713	TBX5 (sc17866)	Homo sapiens		EXP037705	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040223
EXP037714	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037706	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040224
EXP037715	TBX5 (sc17866)	Homo sapiens		EXP037706	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040225
EXP037716	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037707	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040226
EXP037717	TBX5 (sc17866)	Homo sapiens		EXP037707	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040227
EXP037718	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037708	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040228
EXP037719	TBX5 (sc17866)	Homo sapiens		EXP037708	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040229
EXP037720	GATA4 (sc1237, lot:E0912)	Homo sapiens	G296S mutant	EXP037709	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040230
EXP037721	TBX5 (sc17866)	Homo sapiens	G296S mutant	EXP037709	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040231
EXP037722	GATA4 (sc1237, lot:E0912)	Homo sapiens	G296S mutant	EXP037710	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040232
EXP037723	TBX5 (sc17866)	Homo sapiens	G296S mutant	EXP037710	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040233
EXP037724	GATA4 (sc1237, lot:E0912)	Homo sapiens	G296S mutant	EXP037711	1005	normal	P43694	iPSC-derived cardiomyocytes	PEAKS040234
EXP037725	TBX5 (sc17866)	Homo sapiens	G296S mutant	EXP037711	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS040235
EXP037727	anti-Myc tag antibody 9B11 (Cell Signaling Technology #2276, lot #24)	Mus musculus	pioglitazone at a concentration of 200 parts per million in irradiated Purina rodent diet 5001	EXP037726	1006	normal	P01108	thyroid gland	PEAKS040236
EXP037729	SREBP1c Anti-HA, A2095, Sigma-Aldrich	Mus musculus		EXP037728	5	normal	Q9WTN3	liver	PEAKS040237
EXP037731	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus		EXP037730	5	normal	O35426	liver	PEAKS040238
EXP037732	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	shXBP1 (7 days)	EXP037730	5	bio_control	O35426	liver	PEAKS040239
EXP037733	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	6h after partial hepatectomy	EXP037730	5	normal	O35426	liver	PEAKS040240
EXP037734	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	7d after XBP1 silencing and 6h after partial hepatectomy	EXP037730	5	bio_control	O35426	liver	PEAKS040241
EXP037735	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	48h after partial hepatectomy	EXP037730	5	normal	O35426	liver	PEAKS040242
EXP037736	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	7d after XBP1 silencing and 48h after partial hepatectomy	EXP037730	5	bio_control	O35426	liver	PEAKS040243
EXP037737	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	6h after sham operation	EXP037730	5	normal	O35426	liver	PEAKS040244
EXP037738	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	48h after sham operation	EXP037730	5	normal	O35426	liver	PEAKS040245
EXP037740	ETS1 (sc-350)	Homo sapiens		EXP037739	30	normal	P14921	RCC 7860 (Renal cell carcinoma)	PEAKS040246
EXP037741	p65 (sc-372, Santa Cruz)	Homo sapiens		EXP037739	30	normal	Q04206	RCC 7860 (Renal cell carcinoma)	PEAKS040247
EXP037742	c-Jun (sc-1694, Santa Cruz)	Homo sapiens		EXP037739	30	normal	P05412	RCC 7860 (Renal cell carcinoma)	PEAKS040248
EXP037746	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	DMSO	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS040249
EXP037747	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	Nutlin	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS040250
EXP037748	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	DMSO	EXP037744	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS040251
EXP037749	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	Nutlin	EXP037744	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS040252
EXP037750	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	DMSO	EXP037745	1518	normal	P04637	SJSA-1(osteosarcoma)	PEAKS040253
EXP037751	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	Nutlin	EXP037745	1518	normal	P04637	SJSA-1(osteosarcoma)	PEAKS040254
EXP037753	STAT3 (Cell Signaling 12640)	Mus musculus		EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	PEAKS040255
EXP037754	STAT3 (Cell Signaling 12640)	Mus musculus	30min IL-10	EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	PEAKS040256
EXP037755	STAT3 (Cell Signaling 12640)	Mus musculus	195min LPS	EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	PEAKS040257
EXP037756	STAT3 (Cell Signaling 12640)	Mus musculus	195min LPS + 30min IL-10	EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	PEAKS040258
EXP037757	ETS2	Homo sapiens	ETS1 KO	NULL	223	normal	P15036	DU145 (prostate carcinoma)	PEAKS040259
EXP037759	Myc antibody (Cell Signaling Technology, 9402S)	Homo sapiens		EXP037758	1008	normal	P01106	HT1080 (fibrosarcoma)	PEAKS040260
EXP037763	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Untreated with Dox	EXP037760	1009	normal	P01106	U87MG(glioblastoma)	PEAKS040261
EXP037764	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Dox treated	EXP037761	1009	normal	P01106	U87MG(glioblastoma)	PEAKS040262
EXP037765	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Untreated with Dox	EXP037762	1010	normal	P01106	BT168 (glioblastoma stem cells)	PEAKS040263
EXP037766	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Dox treated	EXP037762	1010	normal	P01106	BT168 (glioblastoma stem cells)	PEAKS040264
EXP037769	JUNB	Mus musculus		EXP037767	1011	normal	P09450	Th17(beta)-cells	PEAKS040265
EXP037770	JUNB	Mus musculus		EXP037768	1012	normal	P09450	Th17(23)-cells	PEAKS040266
EXP037771	IRF4	Mus musculus		EXP037767	1011	normal	Q64287	Th17(beta)-cells	PEAKS040267
EXP037772	IRF4	Mus musculus		EXP037768	1012	normal	Q64287	Th17(23)-cells	PEAKS040268
EXP037773	BATF	Mus musculus		EXP037767	1011	normal	O35284	Th17(beta)-cells	PEAKS040269
EXP037774	BATF	Mus musculus		EXP037768	1012	normal	O35284	Th17(23)-cells	PEAKS040270
EXP037775	er	Homo sapiens	White Medium + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040271
EXP037776	er	Homo sapiens	White Medium	NULL	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS040272
EXP037777	er	Homo sapiens	White Medium + E2	NULL	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS040273
EXP037778	er	Homo sapiens	White Medium	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040274
EXP037779	er	Homo sapiens	White Medium + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040275
EXP037780	er	Homo sapiens	N/A	NULL	1013	normal	P03372	patient-derived pleaural effusion	PEAKS040276
EXP037781	Runx2	Homo sapiens	Full Medium + Doxycycline	NULL	113	normal	Q13950	MCF7 (Invasive ductal breast carcinoma)	PEAKS040277
EXP037783	HIF1A (#AF1935)	Mus musculus		EXP037782	1015	normal	Q61221	melan-Ink4a-Arf- melanocytes	PEAKS040278
EXP037785	MYC N262 (sc-764, Santa Cruz)	Homo sapiens	na	NULL	417	normal	P01106	HCT-116 (colon carcinoma)	PEAKS040280
EXP037787	anti-STAT5 antibody (Santa Cruz, sc-835 (C-17))	Mus musculus		EXP037786	80	normal	P42230	B lymphoblastic leukemia	PEAKS040281
EXP037788	THAP1	Mus musculus		NULL	2	normal	Q8CHW1	mESCs (mouse embryonic stem cells)	PEAKS040282
EXP037789		Mus musculus		NULL	2	normal	Q8CHW1	mESCs (mouse embryonic stem cells)	PEAKS040283
EXP037792	NKX2-1 (TTF-1) antibody	Homo sapiens		EXP037790	38	normal	P43699	A549 (lung carcinoma)	PEAKS040284
EXP037793	SPDEF antibody	Homo sapiens		EXP037791	38	normal	O95238	A549 (lung carcinoma)	PEAKS040285
EXP037799	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037794	1017	normal	P49711	E14 retina	PEAKS040286
EXP037800	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037795	1018	normal	P49711	E16 retina	PEAKS040287
EXP037801	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037796	1019	normal	P49711	E18 retina	PEAKS040288
EXP037802	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037797	1020	normal	P49711	E23 retina	PEAKS040289
EXP037803	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037798	1016	normal	P49711	retinoblastoma xenograft	PEAKS040290
EXP037807	c-MYC (D3N8F, Cell Signaling Technology)	Mus musculus		EXP037804	1021	normal	P01108	PB115 (lung cancer)	PEAKS040291
EXP037808	c-MYC (D3N8F, Cell Signaling Technology)	Mus musculus		EXP037805	1022	normal	P01108	PB119 (lung cancer)	PEAKS040292
EXP037809	c-MYC (D3N8F, Cell Signaling Technology)	Mus musculus		EXP037806	1023	normal	P01108	PB120 (lung cancer)	PEAKS040293
EXP037811		Mus musculus	IFNg 2h	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	PEAKS040294
EXP037812		Mus musculus	IFNg IL4 2h	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	PEAKS040295
EXP037813		Mus musculus	IL4 2h	EXP037810	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS040296
EXP037814		Mus musculus	IFNg IL4 2h	EXP037810	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS040297
EXP037815	Anti-STAT1 (Santa Cruz sc-592)	Mus musculus		EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	PEAKS040298
EXP037816	Anti-STAT1 (Santa Cruz sc-592)	Mus musculus	IFNg (100 ng/ml) for 2hrs	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	PEAKS040299
EXP037817	Anti-STAT1 (Santa Cruz sc-592)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	PEAKS040300
EXP037818	Anti-IRF1 (Santa Cruz sc-640)	Mus musculus		EXP037810	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS040301
EXP037819	Anti-IRF1 (Santa Cruz sc-640)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS040302
EXP037820	Anti-IRF1 (Santa Cruz sc-640)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS040303
EXP037821	Anti-JunB (Santa Cruz sc-46x)	Mus musculus		EXP037810	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040304
EXP037822	Anti-JunB (Santa Cruz sc-46x)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040305
EXP037823	Anti-JunB (Santa Cruz sc-46x)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040306
EXP037824	Anti-CEBPb (Santa Cruz sc-150X)	Mus musculus		EXP037810	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040307
EXP037825	Anti-CEBPb (Santa Cruz sc-150X)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040308
EXP037826	Anti-CEBPb (Santa Cruz sc-150X)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040309
EXP037827	Anti-Myc (Santa-Cruz sc-764)	Mus musculus		EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	PEAKS040310
EXP037828	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IL4 (10ng/ml) for 2hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	PEAKS040311
EXP037829	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	PEAKS040312
EXP037830	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 2hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	PEAKS040313
EXP037831	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	PEAKS040314
EXP037832		Homo sapiens		NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040315
EXP037833		Homo sapiens		NULL	1024	normal	Q01196	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040316
EXP037834		Homo sapiens		NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040317
EXP037835		Homo sapiens	RUNX1-EVI1 KD after 10 days	NULL	1024	bio_control	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040318
EXP037836		Homo sapiens		NULL	1024	normal	Q01196	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040319
EXP037837		Homo sapiens	RUNX1-EVI1 KD after 10 days	NULL	1024	bio_control	Q01196	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040320
EXP037838		Homo sapiens		NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040321
EXP037839		Homo sapiens	RUNX1-EVI1 KD after 10 days	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040322
EXP037840	AF2046	Homo sapiens		NULL	1024	normal	P23769	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040323
EXP037841	AF2046	Homo sapiens	RUNX1-EVI1 KD	NULL	1024	normal	P23769	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS040324
EXP037860	CTCF(ActiveMotif,61311)	Mus musculus	p107 minus minus MDMXTg	EXP037843	141	normal	Q61164	retina	PEAKS040325
EXP037861	CTCF(ActiveMotif,61311)	Mus musculus		EXP037844	1033	normal	Q61164	fibroblast-derived iPSCs fG140.03	PEAKS040326
EXP037862	CTCF(ActiveMotif,61311)	Mus musculus		EXP037845	1034	normal	Q61164	fibroblast-derived iPSCs fG140.04	PEAKS040327
EXP037863	CTCF(ActiveMotif,61311)	Mus musculus		EXP037846	1036	normal	Q61164	fibroblast-derived iPSCs fMG02	PEAKS040328
EXP037864	CTCF(ActiveMotif,61311)	Mus musculus		EXP037847	1037	normal	Q61164	fibroblast-derived iPSCs fMG03	PEAKS040329
EXP037865	CTCF(ActiveMotif,61311)	Mus musculus		EXP037848	1038	normal	Q61164	Eb5 embryonic stem cells	PEAKS040330
EXP037866	CTCF(ActiveMotif,61311)	Mus musculus		EXP037849	1039	normal	Q61164	immature retinal-derived iPSCs 8601	PEAKS040331
EXP037867	CTCF(ActiveMotif,61311)	Mus musculus		EXP037850	1040	normal	Q61164	mature retinal-derived iPSCs 3302	PEAKS040332
EXP037868	CTCF(ActiveMotif,61311)	Mus musculus		NULL	1041	normal	Q61164	mature retinal-derived iPSCs 7602	PEAKS040333
EXP037869	CTCF(ActiveMotif,61311)	Mus musculus		EXP037852	1025	normal	Q61164	E14.5 retina	PEAKS040334
EXP037870	CTCF(ActiveMotif,61311)	Mus musculus		EXP037842	1026	normal	Q61164	E17.5 retina	PEAKS040335
EXP037871	CTCF(ActiveMotif,61311)	Mus musculus		EXP037853	1027	normal	Q61164	P0 retina	PEAKS040336
EXP037872	CTCF(ActiveMotif,61311)	Mus musculus		EXP037854	1028	normal	Q61164	P3 retina	PEAKS040337
EXP037873	CTCF(ActiveMotif,61311)	Mus musculus		EXP037855	1029	normal	Q61164	P7 retina	PEAKS040338
EXP037874	CTCF(ActiveMotif,61311)	Mus musculus		EXP037856	1030	normal	Q61164	P10 retina	PEAKS040339
EXP037875	CTCF(ActiveMotif,61311)	Mus musculus		EXP037857	1031	normal	Q61164	P14 retina	PEAKS040340
EXP037876	CTCF(ActiveMotif,61311)	Mus musculus		EXP037858	1032	normal	Q61164	P21 retina	PEAKS040341
EXP037877	CTCF(ActiveMotif,61311)	Mus musculus		EXP037859	141	normal	Q61164	retina	PEAKS040342
EXP037879	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	DMSO	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	PEAKS040343
EXP037880	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	100nM trametinib	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	PEAKS040344
EXP037881	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	300nM JQ1	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	PEAKS040345
EXP037882	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	100nM trametinib, 300nM JQ1	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	PEAKS040346
EXP037885	Bach1 (A1-6)	Mus musculus		EXP037884	198	normal	P97302	pre-pro-B-cells	PEAKS040347
EXP037886	MafK	Mus musculus		EXP037884	198	normal	Q61827	pre-pro-B-cells	PEAKS040348
EXP037887	Bach2 (Bach2N2)	Mus musculus		EXP037883	198	normal	P97303	pre-pro-B-cells	PEAKS040349
EXP037889	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus	induced	EXP037888	105	normal	P17433	pro-B cells	PEAKS040350
EXP037890	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus	induced	EXP037888	105	normal	P17433	pro-B cells	PEAKS040351
EXP037892	rabbit polyclonal anti-mouse Sox9 antibody (Abcam, UK)	Mus musculus	db/+	EXP037891	52	normal	Q04887	intestinal stem cells	PEAKS040352
EXP037893	rabbit polyclonal anti-mouse Sox9 antibody (Abcam, UK)	Mus musculus	db/db	EXP037891	52	normal	Q04887	intestinal stem cells	PEAKS040353
EXP037896	Rabbit anti-Pax6 (Biolegend,  901301)	Homo sapiens		EXP037894	1042	normal	P26367	EndoC-betaH2 (immortalized pancreatic beta cells)	PEAKS040354
EXP037897	Rabbit anti-Pax6 (Biolegend,  901301)	Mus musculus		EXP037895	1043	normal	P63015	MIN6 (insulinoma)	PEAKS040355
EXP037900		Homo sapiens	knockout ASCL1	EXP037898	1044	bio_control	P50553	G523NS (glioblastoma)	PEAKS040356
EXP037901		Homo sapiens		EXP037899	1044	normal	P50553	G523NS (glioblastoma)	PEAKS040357
EXP037904		Mus musculus		EXP037902	105	normal	Q07802	pro-B cells	PEAKS040358
EXP037905		Mus musculus	EBF1-H240	EXP037903	105	normal	Q07802	pro-B cells	PEAKS040359
EXP037908	NRSF (Santa Cruz, sc25398x)	Rattus norvegicus		EXP037906	1045	normal	O54963	paraventricular nucleus	PEAKS040360
EXP037909	NRSF (Santa Cruz, sc25398x)	Rattus norvegicus	CNQX/MK-801 (50 uM) for 52 h	EXP037907	1045	normal	O54963	paraventricular nucleus	PEAKS040361
EXP037911	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	P17325	liver	PEAKS040362
EXP037912	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	P17325	liver	PEAKS040363
EXP037913	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	P17325	liver	PEAKS040364
EXP037914	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	P17325	liver	PEAKS040365
EXP037915	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	P17325	liver	PEAKS040366
EXP037916	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	P17325	liver	PEAKS040367
EXP037917	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	Q01714	liver	PEAKS040368
EXP037918	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	Q01714	liver	PEAKS040369
EXP037919	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	Q01714	liver	PEAKS040370
EXP037920	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	Q01714	liver	PEAKS040371
EXP037921	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	Q01714	liver	PEAKS040372
EXP037922	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	Q01714	liver	PEAKS040373
EXP037923	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	P22449	liver	PEAKS040374
EXP037924	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	P22449	liver	PEAKS040375
EXP037925	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	P22449	liver	PEAKS040376
EXP037926	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	P22449	liver	PEAKS040377
EXP037927	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	P22449	liver	PEAKS040378
EXP037928	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	P22449	liver	PEAKS040379
EXP037929	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	Q62735	liver	PEAKS040380
EXP037930	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	Q62735	liver	PEAKS040381
EXP037931	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	Q62735	liver	PEAKS040382
EXP037932	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	Q62735	liver	PEAKS040383
EXP037933	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	Q62735	liver	PEAKS040384
EXP037934	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	Q62735	liver	PEAKS040385
EXP037936	Tfcp2l1 (RnD, AF5726)	Mus musculus		EXP037935	523	normal	Q3UNW5	kidney	PEAKS040386
EXP037939	Cell Signalling (#5677)	Mus musculus	untreated control	EXP037937	873	normal	P20263	ZHBTc4 (embryonic stem cells)	PEAKS040387
EXP037940	Cell Signalling (#5677)	Mus musculus	doxycycline-treated	EXP037937	873	bio_control	P20263	ZHBTc4 (embryonic stem cells)	PEAKS040388
EXP037941	Cell Signalling (#23064)	Mus musculus	untreated control	EXP037937	873	normal	P48432	ZHBTc4 (embryonic stem cells)	PEAKS040389
EXP037942	Cell Signalling (#23064)	Mus musculus	doxycycline-treated	EXP037937	873	normal	P48432	ZHBTc4 (embryonic stem cells)	PEAKS040390
EXP037943	Cell Signalling (#8822)	Mus musculus	untreated control	EXP037937	873	normal	Q80Z64	ZHBTc4 (embryonic stem cells)	PEAKS040391
EXP037944	Cell Signalling (#8822)	Mus musculus	doxycycline-treated	EXP037937	873	normal	Q80Z64	ZHBTc4 (embryonic stem cells)	PEAKS040392
EXP037945	Cell Signalling (#5677)	Mus musculus	untreated control	EXP037938	1047	normal	P20263	Brg1fl/fl (embryonic stem cells)	PEAKS040393
EXP037946	Cell Signalling (#5677)	Mus musculus	tamoxifen-treated	EXP037938	1047	normal	P20263	Brg1fl/fl (embryonic stem cells)	PEAKS040394
EXP037947	Cell Signalling (#23064)	Mus musculus	untreated control	EXP037938	1047	normal	P48432	Brg1fl/fl (embryonic stem cells)	PEAKS040395
EXP037948	Cell Signalling (#23064)	Mus musculus	tamoxifen-treated	EXP037938	1047	normal	P48432	Brg1fl/fl (embryonic stem cells)	PEAKS040396
EXP037949	Cell Signalling (#8822)	Mus musculus		EXP037938	1047	normal	Q80Z64	Brg1fl/fl (embryonic stem cells)	PEAKS040397
EXP037950	Cell Signalling (#8822)	Mus musculus	tamoxifen-treated	EXP037938	1047	normal	Q80Z64	Brg1fl/fl (embryonic stem cells)	PEAKS040398
EXP037952	CTCF (ActiveMotif: #61311, lot# 16712001)	Homo sapiens		EXP037951	848	normal	P49711	U2OS (osteosarcoma)	PEAKS040399
EXP037954	Fli1 antibody from Santa Cruz (sc-356X)	Mus musculus	No treatment	EXP037953	81	normal	P26323	BMDM (bone marrow-derived macrophages)	PEAKS040400
EXP037955	Elf1 antibody from Santa Cruz (sc-631X)	Mus musculus	No treatment	EXP037953	81	normal	Q60775	BMDM (bone marrow-derived macrophages)	PEAKS040401
EXP037956	Elf4 home made antibody	Mus musculus	No treatment	EXP037953	81	normal	Q9Z2U4	BMDM (bone marrow-derived macrophages)	PEAKS040402
EXP037957	Elf4 home made antibody	Mus musculus	alpha amanitin 10Î¼g/ml for 5 hours (SIGMA)	EXP037953	81	normal	Q9Z2U4	BMDM (bone marrow-derived macrophages)	PEAKS040403
EXP037958	Elf4 home made antibody	Mus musculus	4h LPS treatment (10ng/ml)	EXP037953	81	normal	Q9Z2U4	BMDM (bone marrow-derived macrophages)	PEAKS040404
EXP037959	GABP-? antibody from Santa Cruz (sc-22810)	Mus musculus	No treatment	EXP037953	81	normal	Q00422	BMDM (bone marrow-derived macrophages)	PEAKS040405
EXP037960	GABP-? antibody from Santa Cruz (sc-22810)	Mus musculus	No treatment	EXP037953	81	normal	Q00422	BMDM (bone marrow-derived macrophages)	PEAKS040406
EXP037961	GABP-? antibody from Santa Cruz (sc-22810)	Mus musculus	alpha amanitin 10Î¼g/ml for 5 hours (SIGMA)	EXP037953	81	normal	Q00422	BMDM (bone marrow-derived macrophages)	PEAKS040407
EXP037962	PU.1 home made antibody	Mus musculus	No treatment	EXP037953	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS040408
EXP037963	PU.1 home made antibody	Mus musculus	alpha amanitin 10Î¼g/ml for 5 hours (SIGMA)	EXP037953	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS040409
EXP037965	anti-C/EBP? (EP709Y, Abcam)	Homo sapiens		EXP037964	641	normal	P49715	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS040410
EXP037966	anti-C/EBP? (E299, Abcam)	Homo sapiens		EXP037964	641	normal	P17676	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS040411
EXP037970	CTCF	Mus musculus	high IL-2	EXP037967	1048	normal	Q61164	CD4+ Th1	PEAKS040412
EXP037971	CTCF	Mus musculus	low IL-2	EXP037968	1048	normal	Q61164	CD4+ Th1	PEAKS040413
EXP037972	CTCF	Mus musculus	low IL-2 + aKG	EXP037969	1048	normal	Q61164	CD4+ Th1	PEAKS040414
EXP037974	p63 (H129, Santacruz)	Homo sapiens		EXP037973	1049	normal	Q9H3D4	JHU-029 (laryngeal squamous cell carcinoma)	PEAKS040415
EXP037976	anti-cFos antibody (Santa Cruz, Cat:sc-253)	Mus musculus		EXP037975	213	normal	P01101	mesenchymal stem cells	PEAKS040416
EXP037979	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Esrrb-FLAG	EXP037977	12	normal	Q61539	MEF (mouse embryonic fibroblasts)	PEAKS040417
EXP037980	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Zic3-FLAG	EXP037977	12	normal	Q62521	MEF (mouse embryonic fibroblasts)	PEAKS040418
EXP037981	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Esrrb-FLAG	EXP037978	12	normal	Q61539	MEF (mouse embryonic fibroblasts)	PEAKS040419
EXP037982	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Zic3-FLAG	EXP037978	12	normal	Q62521	MEF (mouse embryonic fibroblasts)	PEAKS040420
EXP037983	zeb1	Homo sapiens	1 ng/ml of TGF-beta3 for 1.5 h	NULL	1051	normal	P37275	MDA-231-D (breast adenocarcinoma)	PEAKS040421
EXP037984	zeb1	Homo sapiens	1 ng/ml of TGF-beta3 for 1.5 h	NULL	449	normal	P37275	HS578T (invasive ductal breast carcinoma)	PEAKS040422
EXP037987	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	none	EXP037985	1474	normal	Q04206	HuH7 (hepatocellular carcinoma)	PEAKS040423
EXP037988	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	DMEM containing CoV-229E at MOI = 1	EXP037985	1474	normal	Q04206	HuH7 (hepatocellular carcinoma)	PEAKS040424
EXP037989	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	10ng/ml IL-1alpha for 1 h	EXP037986	1474	normal	Q04206	HuH7 (hepatocellular carcinoma)	PEAKS040425
EXP037991	Cell Signaling Technology, anti-TCF11 (D5B10)	Mus musculus		EXP037990	12	normal	Q61985	MEF (mouse embryonic fibroblasts)	PEAKS040426
EXP037992	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	EtOH for 2h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	PEAKS040427
EXP037993	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	100 nM 1,25(OH)2D3 for 2h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	PEAKS040428
EXP037994	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	EtOH for 24h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	PEAKS040429
EXP037995	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	100 nM 1,25(OH)2D3 for 24h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	PEAKS040430
EXP038000	MLL NT86	Mus musculus		EXP037996	12	normal	P55200	MEF (mouse embryonic fibroblasts)	PEAKS040431
EXP038001	MLL D2M7U	Mus musculus		EXP037996	12	normal	P55200	MEF (mouse embryonic fibroblasts)	PEAKS040432
EXP038002	MLL D2M7U	Mus musculus	MLL knockout	EXP037997	12	bio_control	P55200	MEF (mouse embryonic fibroblasts)	PEAKS040433
EXP038003	MLL D2N1D	Mus musculus		EXP037996	12	normal	P55200	MEF (mouse embryonic fibroblasts)	PEAKS040434
EXP038004	MLL D2N1D	Mus musculus	MLL knockout	EXP037997	12	bio_control	P55200	MEF (mouse embryonic fibroblasts)	PEAKS040435
EXP038005	MLL NT86	Homo sapiens	DMSO	EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	PEAKS040436
EXP038006	MLL NT86	Homo sapiens	IRAK1/4 inhibitor	EXP037999	421	normal	Q03164	HEK293 (embryonic kidney)	PEAKS040437
EXP038007	MLL D2M7U	Homo sapiens	DMSO	EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	PEAKS040438
EXP038008	MLL D2M7U	Homo sapiens	IRAK1/4 inhibitor	EXP037999	421	normal	Q03164	HEK293 (embryonic kidney)	PEAKS040439
EXP038009	MLL D2M7U	Homo sapiens		EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	PEAKS040440
EXP038010	MLL D2N1D	Homo sapiens		EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	PEAKS040441
EXP038017	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038011	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS040442
EXP038018	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038012	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS040443
EXP038019	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038013	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS040444
EXP038020	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038014	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS040445
EXP038021	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038015	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS040446
EXP038022	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038016	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS040447
EXP038023	etv4	Mus musculus		NULL	1052	normal	P28322	EpRas (mammary gland epithelial cells)	PEAKS040448
EXP038024	etv5	Mus musculus		NULL	1052	normal	Q9CXC9	EpRas (mammary gland epithelial cells)	PEAKS040449
EXP038027	FoxP3 (affinity purified rabbit polyclonal antibody, generated in house)	Mus musculus		EXP038025	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	PEAKS040450
EXP038028	FoxP3 (affinity purified rabbit polyclonal antibody, generated in house)	Mus musculus	FoxP3 A384T mutant	EXP038026	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	PEAKS040451
EXP038030	abcam ab178428	Mus musculus		EXP038029	1054	normal	Q64205	suprabasal keratinocytes	PEAKS040452
EXP038038	IRF1, Santa Cruz #sc-497x	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	P10914	HAEC (human aortic endothelial cells)	PEAKS040455
EXP038037	CEBPD, Santa Cruz #sc-636X	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	P49716	HAEC (human aortic endothelial cells)	PEAKS040454
EXP038032	pu.1	Mus musculus		EXP038031	605	normal	P17433	microglia	PEAKS040453
EXP038039	IRF1, Santa Cruz #sc-497x	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	P10914	HAEC (human aortic endothelial cells)	PEAKS040456
EXP038040	JUNB, Santa Cruz #sc-73	Homo sapiens	control, 4h	EXP038033	1055	normal	P17275	HAEC (human aortic endothelial cells)	PEAKS040457
EXP038041	Santa Cruz #sc354	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	P11308	HAEC (human aortic endothelial cells)	PEAKS040458
EXP038042	Santa Cruz #sc-13032X	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	P05412	HAEC (human aortic endothelial cells)	PEAKS040459
EXP038043	Santa Cruz #sc-13032X	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	P05412	HAEC (human aortic endothelial cells)	PEAKS040460
EXP038044	Santa Cruz #sc-13032X	Homo sapiens	oxpapc, 4h	EXP038035	1055	normal	P05412	HAEC (human aortic endothelial cells)	PEAKS040461
EXP038045	ERG, Santa Cruz #sc354	Homo sapiens	control, 4h	EXP038033	1055	normal	P11308	HAEC (human aortic endothelial cells)	PEAKS040462
EXP038046	JUN, Santa Cruz #sc-13032X	Homo sapiens	control, 4h	EXP038033	1055	normal	P05412	HAEC (human aortic endothelial cells)	PEAKS040463
EXP038047	NRF2, Santa Cruz #sc-1694X	Homo sapiens	oxpapc, 4h	EXP038035	1055	normal	Q16236	HAEC (human aortic endothelial cells)	PEAKS040464
EXP038048	p65, Santa Cruz #sc-372X	Homo sapiens	control, 4h	EXP038033	1055	normal	Q04206	HAEC (human aortic endothelial cells)	PEAKS040465
EXP038049	p65, Santa Cruz #sc-372X	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	Q04206	HAEC (human aortic endothelial cells)	PEAKS040466
EXP038050	p65, Santa Cruz #sc-372X	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	Q04206	HAEC (human aortic endothelial cells)	PEAKS040467
EXP038053	Pax7 (DSHB, 3 ug for ChIP)	Mus musculus	0.75ug/ml dox in iPax7 media	EXP038051	1056	normal	P47239	myogenic progenitors	PEAKS040468
EXP038054	Pax7 (DSHB, 3 ug for ChIP)	Mus musculus	minusdox 3d iPax7 media	EXP038052	1056	normal	P47239	myogenic progenitors	PEAKS040469
EXP038055	Irf8 (Bethyl A303-BL12058)	Mus musculus	mature	NULL	1057	normal	P23611	medullary thymic epithelial cells	PEAKS040470
EXP038056	Irf8 (Bethyl A303-BL12058)	Mus musculus	immature	NULL	1057	normal	P23611	medullary thymic epithelial cells	PEAKS040471
EXP038059	SP140	Homo sapiens	no LPS treatment	EXP038057	911	normal	Q13342	macrophages	PEAKS040472
EXP038060	SP140	Homo sapiens	LPS treated, 100ng/mL, 4h	EXP038058	911	normal	Q13342	macrophages	PEAKS040473
EXP038063	Hnf4a (Abcam ab41898)	Mus musculus	GF	EXP038061	196	normal	P49698	jejunal crypt intestinal epithelial cells	PEAKS040474
EXP038064	Hnf4a (Abcam ab41898)	Mus musculus	CV	EXP038062	196	normal	P49698	jejunal crypt intestinal epithelial cells	PEAKS040475
EXP038065	Hnf4g (Santa Cruz sc-6558X)	Mus musculus	GF	EXP038061	196	normal	Q9WUU6	jejunal crypt intestinal epithelial cells	PEAKS040476
EXP038066	Hnf4g (Santa Cruz sc-6558X)	Mus musculus	CV	EXP038062	196	normal	Q9WUU6	jejunal crypt intestinal epithelial cells	PEAKS040477
EXP038069	Anti-PU.1; SCBT; sc-22805	Mus musculus	Untreated	EXP038067	103	normal	P17433	bone marrow	PEAKS040478
EXP038070	Anti-PU.1; SCBT; sc-22805	Mus musculus	Vitamin C	EXP038068	103	normal	P17433	bone marrow	PEAKS040479
EXP038071	Anti-Runx1; Abcam; ab23980	Mus musculus	Untreated	EXP038067	103	normal	Q03347	bone marrow	PEAKS040480
EXP038072	Anti-Runx1; Abcam; ab23980	Mus musculus	Vitamin C	EXP038068	103	normal	Q03347	bone marrow	PEAKS040481
EXP038073	anti-AHR (Santa Cruz, H-211)	Homo sapiens	DMSO for 24h	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	PEAKS040482
EXP038074	anti-AHR (Santa Cruz, H-211)	Homo sapiens	2,3,7,8-tetrachlorodibenzo-Ï-dioxin (TCDD) for 24 h	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	PEAKS040483
EXP038075	anti-AHRR (Sigma, HPA019614)	Homo sapiens	DMSO for 24h	NULL	113	normal	A9YTQ3	MCF7 (Invasive ductal breast carcinoma)	PEAKS040484
EXP038076	anti-AHRR (Sigma, HPA019614)	Homo sapiens	2,3,7,8-tetrachlorodibenzo-Ï-dioxin (TCDD) for 24 h	NULL	113	normal	A9YTQ3	MCF7 (Invasive ductal breast carcinoma)	PEAKS040485
EXP038077	anti-AHR (Santa Cruz, H-211)	Homo sapiens	DMSO for 45 min	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	PEAKS040486
EXP038078	anti-AHR (Santa Cruz, H-211)	Homo sapiens	2,3,7,8-tetrachlorodibenzo-Ï-dioxin (TCDD) for 45 min	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	PEAKS040487
EXP038082	KLF10 Abcam, ab184182	Homo sapiens		EXP038079	38	normal	Q13118	A549 (lung carcinoma)	PEAKS040488
EXP038083	KLF10 Abcam, ab184182	Homo sapiens		EXP038080	38	normal	Q13118	A549 (lung carcinoma)	PEAKS040489
EXP038084	KLF10 Abcam, ab184182	Homo sapiens		EXP038081	38	normal	Q13118	A549 (lung carcinoma)	PEAKS040490
EXP038086	SATB1	Mus musculus		EXP038085	171	normal	Q60611	CD4+ CD8+ T cells	PEAKS040491
EXP038087	SATB1	Mus musculus		EXP038085	1058	normal	Q60611	CD4+ T-cells	PEAKS040492
EXP038088	SATB1	Mus musculus		EXP038085	1058	normal	Q60611	CD4+ T-cells	PEAKS040493
EXP038089	SATB1	Mus musculus		EXP038085	44	normal	Q60611	T-cells	PEAKS040494
EXP038090	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens		NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	PEAKS040495
EXP038091	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens		NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	PEAKS040496
EXP038092	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens		NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	PEAKS040497
EXP038093	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens	mutant EBF3	NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	PEAKS040498
EXP038098	NFATc2	Mus musculus		EXP038094	967	normal	Q60591	naive CD8+ T-cells	PEAKS040499
EXP038099	NFATc2	Mus musculus		EXP038095	967	normal	Q60591	naive CD8+ T-cells	PEAKS040500
EXP038100	NFATc2	Mus musculus	Restimulation with PMA/Ionomycin in the presence of CsA (Calcineurin inhibitor) 	EXP038096	967	normal	Q60591	naive CD8+ T-cells	PEAKS040501
EXP038101	NFATc2	Mus musculus	Restimulation with PMA/Ionomycin in the presence of DRB (pTEFb inhibitor)	EXP038097	967	normal	Q60591	naive CD8+ T-cells	PEAKS040502
EXP038102	Arid3a	Mus musculus		NULL	506	normal	Q62431	J1 (embryonic stem cells)	PEAKS040503
EXP038103	Arid3a	Mus musculus		NULL	1059	normal	Q62431	trophoblast stem-like cells	PEAKS040504
EXP038106	anti-AR (Santa Cruz, H280, sc-13062, Lot D0414)	Homo sapiens	Treatment: none	EXP038104	1061	normal	P10275	fetal prostate fibroblasts	PEAKS040505
EXP038107	anti-AR (Santa Cruz, H280, sc-13062, Lot D0414)	Homo sapiens	Treatment: none	EXP038105	1060	normal	P10275	prostate cancer-associated fibroblasts	PEAKS040506
EXP038108	anti-AR (Santa Cruz, H280, sc-13062, Lot D0414)	Homo sapiens	Treatment: none	NULL	1062	normal	P10275	myofibroblasts	PEAKS040507
EXP038110	PROX1	Mus musculus		EXP038109	5	normal	P48437	liver	PEAKS040508
EXP038111	PROX1	Mus musculus	HNF4A floxed	EXP038109	5	normal	P48437	liver	PEAKS040509
EXP038112	PROX1	Mus musculus	HNF4A floxed, liver KO	EXP038109	5	normal	P48437	liver	PEAKS040510
EXP038113	HNF4A	Mus musculus	HNF4A floxed	EXP038109	5	normal	P49698	liver	PEAKS040511
EXP038114	HNF4A	Mus musculus	HNF4A floxed, liver KO	EXP038109	5	normal	P49698	liver	PEAKS040512
EXP038117	Johnson lab generated rabbit polyclonal antibodies (PRDM13-Ab1 (ZF) PA6659, rabbit anti-mouse PRDM13)	Mus musculus		EXP038115	476	normal	E9PZZ1	neural tube	PEAKS040513
EXP038118	Johnson lab generated rabbit polyclonal antibodies (PRDM13-Ab2 (FL) TX970, rabbit anti-mouse PRDM13)	Mus musculus		EXP038115	476	normal	E9PZZ1	neural tube	PEAKS040514
EXP038119	Johnson lab generated rabbit polyclonal antibodies (PRDM13-Ab2 (FL) TX970, rabbit anti-mouse PRDM13)	Mus musculus		NULL	827	normal	E9PZZ1	telencephalon	PEAKS040515
EXP038120	Life Technologies (A6455, rabbit anti-GFP)	Mus musculus	GFP-PRDM13 fusion	EXP038116	476	normal	E9PZZ1	neural tube	PEAKS040516
EXP038121	anti-Bcl11b antibody (Bethyl Laboratories, A300383A)	Mus musculus	Thpok gfp genotype	NULL	44	normal	Q99PV8	T-cells	PEAKS040517
EXP038122	anti-Bcl11b antibody (Bethyl Laboratories, A300383A)	Mus musculus	Thpok gfp:dTESPE genotype	NULL	44	normal	Q99PV8	T-cells	PEAKS040518
EXP038127	CTCF (Abcam ab128873)	Mus musculus		EXP038124	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	PEAKS040519
EXP038128	CTCF (Abcam ab128873)	Mus musculus	Rad21-SNAPf-V5	EXP038126	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	PEAKS040520
EXP038131	FLAG (Sigma F1804)	Mus musculus		EXP038130	1065	normal	Q80Z64	neural stem cell (NSC)-derived pre-iPSCs	PEAKS040521
EXP038135	KLF4	Mus musculus		EXP038132	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	PEAKS040522
EXP038136	cMyc	Mus musculus		EXP038132	12	normal	P01108	MEF (mouse embryonic fibroblasts)	PEAKS040523
EXP038137	Oct4	Mus musculus		EXP038132	1066	normal	P20263	embryonic fibroblasts expressing OSKM for 48h	PEAKS040524
EXP038138	Sox2	Mus musculus		EXP038132	1066	normal	P48432	embryonic fibroblasts expressing OSKM for 48h	PEAKS040525
EXP038139	KLF4	Mus musculus		EXP038132	1066	normal	Q60793	embryonic fibroblasts expressing OSKM for 48h	PEAKS040526
EXP038140	cMyc	Mus musculus		EXP038132	1066	normal	P01108	embryonic fibroblasts expressing OSKM for 48h	PEAKS040527
EXP038141	Oct4	Mus musculus		EXP038134	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS040528
EXP038142	Sox2	Mus musculus		EXP038134	2	normal	P48432	mESCs (mouse embryonic stem cells)	PEAKS040529
EXP038143	KLF4	Mus musculus		EXP038134	2	normal	Q60793	mESCs (mouse embryonic stem cells)	PEAKS040530
EXP038144	cMyc	Mus musculus		EXP038134	2	normal	P01108	mESCs (mouse embryonic stem cells)	PEAKS040531
EXP038145	KLF4	Mus musculus		EXP038132	1070	normal	Q60793	embryonic fibroblasts expressing Klf4 from pMX vector for 48h	PEAKS040532
EXP038146	KLF4	Mus musculus		EXP038132	1071	normal	Q60793	embryonic fibroblasts expressing Klf4 from inducible system for 48h	PEAKS040533
EXP038147	Oct4	Mus musculus		NULL	1072	normal	P20263	embryonic fibroblasts expressing Oct4 from pMX vector for 48h	PEAKS040534
EXP038148	Oct4	Mus musculus		EXP038132	1073	normal	P20263	embryonic fibroblasts expressing Oct4 from inducible system for 48h	PEAKS040535
EXP038149	Sox2	Mus musculus		EXP038132	1074	normal	P48432	embryonic fibroblasts expressing Sox2 from pMX vector for 48h	PEAKS040536
EXP038150	Sox2	Mus musculus		EXP038132	1075	normal	P48432	embryonic fibroblasts expressing Sox2 from inducible system for 48h	PEAKS040537
EXP038151	Oct4	Mus musculus		EXP038132	1076	normal	P20263	embryonic fibroblasts expressing Oct4,Klf4 from pMX vector for 48h	PEAKS040538
EXP038152	KLF4	Mus musculus		EXP038132	1076	normal	Q60793	embryonic fibroblasts expressing Oct4,Klf4 from pMX vector for 48h	PEAKS040539
EXP038153	Sox2	Mus musculus		EXP038132	1078	normal	P48432	embryonic fibroblasts expressing Sox2,Klf4 from pMX vector for 48h	PEAKS040540
EXP038154	KLF4	Mus musculus		EXP038132	1078	normal	Q60793	embryonic fibroblasts expressing Sox2,Klf4 from pMX vector for 48h	PEAKS040541
EXP038155	Oct4	Mus musculus		EXP038132	1080	normal	P20263	embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h	PEAKS040542
EXP038156	Sox2	Mus musculus		EXP038132	1080	normal	P48432	embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h	PEAKS040543
EXP038157	KLF4	Mus musculus		EXP038132	1080	normal	Q60793	embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h	PEAKS040544
EXP038158	Oct4	Mus musculus		EXP038132	1082	normal	P20263	embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h	PEAKS040545
EXP038159	Sox2	Mus musculus		EXP038132	1082	normal	P48432	embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h	PEAKS040546
EXP038160	KLF4	Mus musculus		EXP038132	1082	normal	Q60793	embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h	PEAKS040547
EXP038161	Fra1	Mus musculus		EXP038132	12	normal	P48755	MEF (mouse embryonic fibroblasts)	PEAKS040548
EXP038162	Fra1	Mus musculus		EXP038132	1066	normal	P48755	embryonic fibroblasts expressing OSKM for 48h	PEAKS040549
EXP038163	Runx1	Mus musculus		EXP038132	12	normal	Q03347	MEF (mouse embryonic fibroblasts)	PEAKS040550
EXP038164	Runx1	Mus musculus		EXP038132	1066	normal	Q03347	embryonic fibroblasts expressing OSKM for 48h	PEAKS040551
EXP038165	CEBPA	Mus musculus		EXP038132	12	normal	P53566	MEF (mouse embryonic fibroblasts)	PEAKS040552
EXP038166	CEBPA	Mus musculus		EXP038132	1066	normal	P53566	embryonic fibroblasts expressing OSKM for 48h	PEAKS040553
EXP038167	CEBPB	Mus musculus		EXP038132	12	normal	P28033	MEF (mouse embryonic fibroblasts)	PEAKS040554
EXP038168	CEBPB	Mus musculus		EXP038132	1066	normal	P28033	embryonic fibroblasts expressing OSKM for 48h	PEAKS040555
EXP038169	CEBPB	Mus musculus		EXP038133	1067	normal	P28033	pre-induced pluripotent stem cells	PEAKS040556
EXP038170	Nanog	Mus musculus		EXP038134	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS040557
EXP038171	ERR2	Mus musculus		EXP038134	2	normal	Q61539	mESCs (mouse embryonic stem cells)	PEAKS040558
EXP038172	Fra1	Mus musculus		EXP038132	1069	normal	P48755	embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h	PEAKS040559
EXP038173	Oct4	Mus musculus		EXP038132	1069	normal	P20263	embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h	PEAKS040560
EXP038174	KLF4	Mus musculus		EXP038132	1069	normal	Q60793	embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h	PEAKS040561
EXP038175	ERR2	Mus musculus		EXP038132	1068	normal	Q61539	embryonic fibroblasts expressing OSKM and Esrrb for 48h	PEAKS040562
EXP038176	Oct4	Mus musculus		EXP038132	1068	normal	P20263	embryonic fibroblasts expressing OSKM and Esrrb for 48h	PEAKS040563
EXP038177	KLF4	Mus musculus		EXP038132	1068	normal	Q60793	embryonic fibroblasts expressing OSKM and Esrrb for 48h	PEAKS040564
EXP038178	Oct4	Mus musculus		EXP038133	1067	normal	P20263	pre-induced pluripotent stem cells	PEAKS040565
EXP038179	Sox2	Mus musculus		EXP038133	1067	normal	P48432	pre-induced pluripotent stem cells	PEAKS040566
EXP038180	Klf4	Mus musculus		EXP038133	1067	normal	Q60793	pre-induced pluripotent stem cells	PEAKS040567
EXP038181	cMyc	Mus musculus		EXP038133	1067	normal	P01108	pre-induced pluripotent stem cells	PEAKS040568
EXP038183	anti-GATA2	Mus musculus		EXP038182	96	normal	O09100	trophoblast stem cells	PEAKS040569
EXP038184	anti-GATA3	Mus musculus		EXP038182	96	normal	P23772	trophoblast stem cells	PEAKS040570
EXP038188	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of 10nM DHT; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038185	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS040571
EXP038189	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of vehicle; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038185	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS040572
EXP038190	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of 10nM DHT; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: Expression of Src-527F	EXP038186	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS040573
EXP038191	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of vehicle; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: Expression of Src-527F	EXP038186	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS040574
EXP038192	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of 10nM DHT; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038187	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS040575
EXP038193	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of vehicle; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038187	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS040576
EXP038196	OTX2	Homo sapiens		EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	PEAKS040577
EXP038197	OTX2.abcam	Homo sapiens		EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	PEAKS040578
EXP038198	NEUROD1	Homo sapiens		EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	PEAKS040579
EXP038199	OTX2	Homo sapiens		EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040580
EXP038200	OTX2.abcam	Homo sapiens		EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040581
EXP038201	NEUROD1	Homo sapiens		EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	PEAKS040582
EXP038202	OTX2	Homo sapiens	CRISPR.GFP1	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040583
EXP038203	OTX2	Homo sapiens	CRISPR.GFP2	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040584
EXP038204	OTX2	Homo sapiens	CRISPR.OTX2.2	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040585
EXP038205	OTX2	Homo sapiens	CRISPR.OTX2.4	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040586
EXP038206	NEUROD1	Homo sapiens	shGFP	EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	PEAKS040587
EXP038207	NEUROD1	Homo sapiens	shNEUROD1.1154	EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	PEAKS040588
EXP038208	NEUROD1	Homo sapiens	shNEUROD1.1579	EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	PEAKS040589
EXP038209	OTX2	Homo sapiens	shGFP	EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	PEAKS040590
EXP038210	OTX2	Homo sapiens	shOTX2.1393	EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	PEAKS040591
EXP038211	NEUROD1	Homo sapiens	shGFP	EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	PEAKS040592
EXP038212	NEUROD1	Homo sapiens	shNEUROD1.1154	EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	PEAKS040593
EXP038213	NEUROD1	Homo sapiens	shNEUROD1.1579	EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	PEAKS040594
EXP038214	OTX2	Homo sapiens	shGFP	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040595
EXP038215	OTX2	Homo sapiens	shOTX2.1393	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	PEAKS040596
EXP038216	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delAB mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040597
EXP038217	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delC mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040598
EXP038218	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delE mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040599
EXP038219	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus		NULL	572	normal	Q61164	mammary gland	PEAKS040600
EXP038220	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delCDE mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040601
EXP038221	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delD mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040602
EXP038223	PPARG (Santa Cruz, sc-7196X)	Mus musculus		EXP038222	115	normal	P37238	brown adipose tissue	PEAKS040603
EXP038224	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delA mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040604
EXP038225	GR (Thermo Scientific, PA1-511A)	Mus musculus	delA mutant	NULL	572	normal	P06537	mammary gland	PEAKS040605
EXP038226	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	delA mutant	NULL	572	normal	P42230	mammary gland	PEAKS040606
EXP038227	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delC mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040607
EXP038228	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delB mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040608
EXP038229	GR (Thermo Scientific, PA1-511A)	Mus musculus	delC mutant	NULL	572	normal	P06537	mammary gland	PEAKS040609
EXP038230	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	delC mutant	NULL	572	normal	P42230	mammary gland	PEAKS040610
EXP038231	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delD mutant	NULL	572	normal	Q61164	mammary gland	PEAKS040611
EXP038233	Aire	Mus musculus		EXP038232	1057	normal	Q9Z0E3	medullary thymic epithelial cells	PEAKS040612
EXP038235	PPARG	Mus musculus		NULL	18	normal	P37238	3T3-L1 (embryonic fibroblasts)	PEAKS040613
EXP038236	PPARG	Mus musculus		NULL	732	normal	P37238	peritoneal macrophages	PEAKS040614
EXP038237	PPARG	Mus musculus	high fat diet, 12 weeks	EXP038234	4	normal	P37238	inguinal white adipose tissue	PEAKS040615
EXP038238	PPARG	Mus musculus	low fat diet, 12 weeks	NULL	4	normal	P37238	inguinal white adipose tissue	PEAKS040616
EXP038239	PPARG	Mus musculus	low fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040617
EXP038240	PPARG	Mus musculus	high fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040618
EXP038241	PPARG	Mus musculus	low fat diet, 4 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040619
EXP038242	PPARG	Mus musculus	high fat diet, 4 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040620
EXP038243	PPARG	Mus musculus	high fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040621
EXP038244	PPARG	Mus musculus	low fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040622
EXP038245	PPARG	Mus musculus	rosiglitazone, high fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	PEAKS040623
EXP038247	KLF1 Antibody	Mus musculus	induced with tamoxifen, tamoxifen-inducible KLF1-ER	EXP038246	1085	normal	P46099	J2E (erythroid cells)	PEAKS040624
EXP038248	Fli	Homo sapiens	no doxycycline, serum-induction	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS040625
EXP038249	SRF	Homo sapiens	no doxycycline, serum-induction	NULL	1086	normal	P11831	A-673 clone Asp114 (Ewing sarcoma)	PEAKS040626
EXP038256	Klf4 (R&D AF3158)	Mus musculus	asynchronous cell cycle	EXP038251	1088	normal	Q60793	E3.5 embryonic stem cells	PEAKS040627
EXP038257	Klf4 (R&D AF3158)	Mus musculus	asynchronous cell cycle	EXP038250	1088	normal	Q60793	E3.5 embryonic stem cells	PEAKS040628
EXP038258	Klf4 (R&D AF3158)	Mus musculus	asynchronous cell cycle	EXP038253	1088	normal	Q60793	E3.5 embryonic stem cells	PEAKS040629
EXP038259	Klf4 (R&D AF3158)	Mus musculus		EXP038254	1088	normal	Q60793	E3.5 embryonic stem cells	PEAKS040630
EXP038260	Klf4 (R&D AF3158)	Mus musculus		EXP038255	1087	normal	Q60793	embryonic stem and neural progenitor cells	PEAKS040631
EXP038261	Oct4 (Santa Cruz SC-8628)	Mus musculus	asynchronous cell cycle	EXP038253	1088	normal	P20263	E3.5 embryonic stem cells	PEAKS040632
EXP038262	Sox2  (R&D AF2018)	Mus musculus	asynchronous cell cycle	EXP038253	1088	normal	P48432	E3.5 embryonic stem cells	PEAKS040633
EXP038263	Klf4 (R&D AF3158)	Mus musculus		EXP038252	1088	normal	Q60793	E3.5 embryonic stem cells	PEAKS040634
EXP038264	Oct4 (Santa Cruz SC-8628)	Mus musculus		EXP038254	1088	normal	P20263	E3.5 embryonic stem cells	PEAKS040635
EXP038265	Sox2 (R&D AF2018)	Mus musculus		EXP038254	1088	normal	P48432	E3.5 embryonic stem cells	PEAKS040636
EXP038267	CTCF	Homo sapiens		EXP038266	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS040637
EXP038268	CTCF	Homo sapiens	+DOX 3 days, mutant CTCF	EXP038266	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS040638
EXP038269	CTCF	Homo sapiens		NULL	417	normal	P49711	HCT-116 (colon carcinoma)	PEAKS040639
EXP038271	CUX1 sc-6327 Santa Cruz	Homo sapiens		EXP038270	514	normal	P39880	K562 (myelogenous leukemia)	PEAKS040640
EXP038272	CUX1 sc-6327 Santa Cruz	Homo sapiens		EXP038270	514	normal	P39880	K562 (myelogenous leukemia)	PEAKS040641
EXP038273	CUX1 sc-6327 Santa Cruz	Homo sapiens		EXP038270	514	normal	P39880	K562 (myelogenous leukemia)	PEAKS040642
EXP038274	ETS1, Santa-Cruz sc-111X	Homo sapiens		NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040643
EXP038275	ETS1, Santa-Cruz sc-111X	Homo sapiens	VEGF stimulation for 1hour	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040644
EXP038276	ETS1, Santa-Cruz sc-111X	Homo sapiens	VEGF stimulation for 4hours	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040645
EXP038277	ETS1, Santa-Cruz sc-111X	Homo sapiens	VEGF stimulation for 12hours	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040646
EXP038278	ETS1, Santa-Cruz sc-111X	Homo sapiens		NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040647
EXP038279	ETS1, Santa-Cruz sc-111X	Homo sapiens		NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040648
EXP038280	myc, Santa Cruz sc-764 X	Homo sapiens		NULL	472	normal	P01106	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS040649
EXP038284	ER (sc-543X, Santa Cruz Biotechnology), lot# F1215	Homo sapiens	estrogen	EXP038281	1089	normal	P03372	breast tumor xenograft	PEAKS040651
EXP038285	PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415	Homo sapiens	estrogen	EXP038281	1089	normal	P06401	breast tumor xenograft	PEAKS040652
EXP038286	ER (sc-543X, Santa Cruz Biotechnology), lot# F1215	Homo sapiens	estrogen plus progesterone	EXP038282	1089	normal	P03372	breast tumor xenograft	PEAKS040653
EXP038287	PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415	Homo sapiens	estrogen plus progesterone	EXP038282	1089	normal	P06401	breast tumor xenograft	PEAKS040654
EXP038291	CTCF 07-729 Millipore	Mus musculus		EXP038289	1091	normal	Q61164	ECOMG-derived differentiated neutrophils	PEAKS040656
EXP038292	CTCF 07-729 Millipore	Mus musculus		EXP038290	1092	normal	Q61164	ECOMG (myeloid progenitor cell line)	PEAKS040657
EXP038294	MO488, MO489 (anti-hDUX4)	Mus musculus	DOXYCYCLINE	EXP038293	1153	normal	A1JVI8	C2C12 (myoblasts)	PEAKS040658
EXP038296	MyoD	Homo sapiens		EXP038295	891	normal	P15172	dermal fibroblasts	PEAKS040659
EXP038298	Pitx	Homo sapiens		EXP038297	664	normal	O75364	SH-SY5Y (neuroblastoma)	PEAKS040660
EXP038301	BMAL1 (Bethyl, A302-616A)	Mus musculus	EtOH	EXP038299	12	normal	Q9WTL8	MEF (mouse embryonic fibroblasts)	PEAKS040661
EXP038302	BMAL1 (Bethyl, A302-616A)	Mus musculus	4-OHT	EXP038300	12	normal	Q9WTL8	MEF (mouse embryonic fibroblasts)	PEAKS040662
EXP038304	FOXD3	Homo sapiens		EXP038303	38	normal	Q9UJU5	A549 (lung carcinoma)	PEAKS040663
EXP038306	GATA1 (Abcam, ab11852)	Homo sapiens		EXP038305	269	normal	P15976	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS040664
EXP038307	TAL1 (Santa Cruz, sc-12984)	Homo sapiens		EXP038305	269	normal	P17542	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS040665
EXP038310	CTCF (Millipore 07-729)	Mus musculus	tamoxifen	EXP038308	5	normal	Q61164	liver	PEAKS040666
EXP038311	CTCF (Millipore 07-729)	Mus musculus	tamoxifen	EXP038309	5	normal	Q61164	liver	PEAKS040667
EXP038313	Bcl11b  Abs, a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST)	Mus musculus		EXP038312	1093	normal	Q99PV8	Lin- bone marrow-derived CD44- CD25+ thymocytes	PEAKS040668
EXP038315	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	0h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040669
EXP038316	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	3h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040670
EXP038317	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	8h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040671
EXP038318	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex 3h pre, 0h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040672
EXP038319	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex 3h pre, 3h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040673
EXP038320	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex 3h pre, 8h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040674
EXP038321	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex late, 8h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040675
EXP038322	GR (MA1-510, Thermo Fisher Scientific) and anti-IgG paramagnetic beads	Mus musculus	Dex/DSG+FA	NULL	81	normal	P06537	BMDM (bone marrow-derived macrophages)	PEAKS040676
EXP038323	GR (MA1-510, Thermo Fisher Scientific) and anti-IgG paramagnetic beads	Mus musculus	LPS+Dex/DSG+FA	NULL	81	normal	P06537	BMDM (bone marrow-derived macrophages)	PEAKS040677
EXP038325	anti-V5 antibody (clone V5-10)	Mus musculus		EXP038324	1094	normal	Q99PV5	splenic B-1a-cells	PEAKS040678
EXP038326	anti-V5 antibody (clone V5-10)	Mus musculus		EXP038324	1094	normal	Q99PV5	splenic B-1a-cells	PEAKS040679
EXP038328	FOXN3	Homo sapiens		EXP038327	113	normal	O00409	MCF7 (Invasive ductal breast carcinoma)	PEAKS040680
EXP038330	MYB	Homo sapiens		EXP038329	1095	normal	P10242	Loucy (adult T acute lymphoblastic leukemia)	PEAKS040681
EXP038331	MYB	Homo sapiens		NULL	1097	normal	P10242	PF-382 (childhood T acute lymphoblastic leukemia)	PEAKS040682
EXP038332	MYB	Homo sapiens		NULL	1096	normal	P10242	DU-528 (childhood T acute lymphoblastic leukemia)	PEAKS040683
EXP038333	FOXA1 antibodies mixed ab5089, ab23738	Homo sapiens		NULL	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040684
EXP038334	FOXA1 antibodies mixed ab5089, ab23738	Homo sapiens	ShMEN1	NULL	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS040685
EXP038335	 F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	NoTreat	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040686
EXP038336	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	5min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040687
EXP038337	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	10min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040688
EXP038338	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	20min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040689
EXP038339	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	40min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040690
EXP038340	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	80min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040691
EXP038341	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	160min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040692
EXP038342	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	320min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040693
EXP038343	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	640min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040694
EXP038344	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	1280min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040695
EXP038345	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040696
EXP038346	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040697
EXP038347	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040698
EXP038348	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040699
EXP038349	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040700
EXP038350	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040701
EXP038351	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040702
EXP038352	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040703
EXP038353	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040704
EXP038354	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040705
EXP038355	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040706
EXP038356	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	PEAKS040707
EXP038359	anti-MYC (ab32072, Abcam)	Mus musculus	DMSO vehicle	EXP038357	1099	normal	P01108	E??-Myc lymphoma	PEAKS040708
EXP038360	anti-MYC (ab32072, Abcam)	Mus musculus	1000nM JQ1	EXP038357	1099	normal	P01108	E??-Myc lymphoma	PEAKS040709
EXP038361	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	DMSO vehicle	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	PEAKS040710
EXP038362	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	1000nM JQ1	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	PEAKS040711
EXP038363	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	1ng/mL IFN-Î³	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	PEAKS040712
EXP038364	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	1000nM JQ1+ 1ng/mL IFN-Î³	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	PEAKS040713
EXP038365	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	DMSO vehicle	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	PEAKS040714
EXP038366	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	1000nM JQ1	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	PEAKS040715
EXP038367	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	1ng/mL IFN-Î³	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	PEAKS040716
EXP038368	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	1000nM JQ1+ 1ng/mL IFN-Î³	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	PEAKS040717
EXP038369	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040718
EXP038370	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040719
EXP038371	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040720
EXP038372	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040721
EXP038373	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040722
EXP038374	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040723
EXP038375	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040724
EXP038376	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040725
EXP038377	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040726
EXP038378	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040727
EXP038379	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040728
EXP038380	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040729
EXP038381	ER	Homo sapiens	E2	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS040730
EXP038382	ER	Homo sapiens	Doxycycline	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS040731
EXP038383	ER	Homo sapiens	Doxycycline + E2	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS040732
EXP038384	ER	Homo sapiens	none	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040733
EXP038385	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040734
EXP038386	ER	Homo sapiens	none	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040735
EXP038387	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040736
EXP038388	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040737
EXP038389	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040738
EXP038390	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS040739
EXP038392	Eralpha, Santa Cruz sc-542	Mus musculus	saline (Vehicle, V); mutant ERa	EXP038391	132	normal	P19785	uterus	PEAKS040740
EXP038393	Eralpha, Santa Cruz sc-542	Mus musculus	250 ng of estradiol (E2); mutant ERa	EXP038391	132	normal	P19785	uterus	PEAKS040741
EXP038397	N-MYC B8.4b (Santa Cruz, Catalog# sc-53993, Lot# K1315)	Homo sapiens		EXP038394	669	normal	P04198	NGP (neuroblastoma)	PEAKS040742
EXP038398	N-MYC B8.4b (Santa Cruz, Catalog# sc-53993, Lot# K1315)	Homo sapiens		EXP038395	520	normal	P04198	Kelly (neuroblastoma)	PEAKS040743
EXP038399	N-MYC B8.4b (Santa Cruz, Catalog# sc-53993, Lot# K1315)	Homo sapiens		EXP038396	1101	normal	P04198	NB-1643 (neuroblastoma)	PEAKS040744
EXP038401	Taz	Rattus norvegicus		EXP038400	784	normal	Q9JKY3	Schwann cells	PEAKS040745
EXP038402	Grhl3	Homo sapiens		NULL	468	normal	Q8TE85	neonatal keratinocytes	PEAKS040746
EXP038404	Fra-1 (or FOSL1) (Santa Cruz; sc-183)	Homo sapiens		EXP038403	1102	normal	P15407	MDA231-LM2-4175 (breast adenocarcinoma)	PEAKS040747
EXP038405	c-Myc (Santa Cruz; sc-764)	Homo sapiens		EXP038403	1102	normal	P01106	MDA231-LM2-4175 (breast adenocarcinoma)	PEAKS040748
EXP038406	E2F1 (Millipore; 05-379)	Homo sapiens		EXP038403	1102	normal	Q01094	MDA231-LM2-4175 (breast adenocarcinoma)	PEAKS040749
EXP038407	p53 (BD-Pharmingen; 554294)	Homo sapiens		EXP038403	1102	normal	P04637	MDA231-LM2-4175 (breast adenocarcinoma)	PEAKS040750
EXP038408	DUX4	Homo sapiens	18hr dox-induction	NULL	1143	normal	Q9UBX2	iPSC (induced pluripotent stem cells)	PEAKS040751
EXP038410	DUX	Mus musculus	12hr dox-induction	EXP038409	2	normal	A1JVI8	mESCs (mouse embryonic stem cells)	PEAKS040752
EXP038411	DUX	Mus musculus	18hr dox-induction	EXP038409	2	normal	A1JVI8	mESCs (mouse embryonic stem cells)	PEAKS040753
EXP038412	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040754
EXP038413	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040755
EXP038414	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040756
EXP038415	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040757
EXP038416	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040758
EXP038417	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040759
EXP038418	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040760
EXP038419	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040761
EXP038420	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040762
EXP038421	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	PEAKS040763
EXP038422	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	PEAKS040764
EXP038423	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	PEAKS040765
EXP038424	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	PEAKS040766
EXP038425	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	PEAKS040767
EXP038428	C-Jun Santa Cruz catalog# SC-1694X	Homo sapiens		EXP038426	1103	normal	P05412	HCC827 (lung adenocarcinoma)	PEAKS040768
EXP038429	C-Jun Santa Cruz catalog# SC-1694X	Homo sapiens		EXP038427	1104	normal	P05412	HCC827 ZDR3 (lung adenocarcinoma)	PEAKS040769
EXP038430	CTCF (Active motif REF# 61311)	Mus musculus		NULL	1105	normal	Q61164	E12.5 embryonic distal forelimb	PEAKS040770
EXP038431	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS040771
EXP038432	anti-AR (Santa Cruz Biotechnology cat. sc-816)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS040772
EXP038433	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	7	normal	Q92826	22RV1 (prostate carcinoma)	PEAKS040773
EXP038434	anti-FOXA1 (EMD Millipore cat. 17-10267)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS040774
EXP038435	anti-FOXA1 (EMD Millipore cat. 17-10267)	Homo sapiens	Treatment: siRNA against control; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep	NULL	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS040775
EXP038436	anti-FOXA1 (EMD Millipore cat. 17-10267)	Homo sapiens	Treatment: siRNA against ERG; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep; Genotype: ERG knockdown	NULL	71	normal	P55317	VCaP (prostate carcinoma)	PEAKS040776
EXP038437	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: siRNA against control; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep	NULL	71	normal	Q92826	VCaP (prostate carcinoma)	PEAKS040777
EXP038438	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: siRNA against ERG; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep; Genotype: ERG knockdown	NULL	71	normal	Q92826	VCaP (prostate carcinoma)	PEAKS040778
EXP038440	IRF1 abcam, ab186384	Mus musculus	IFN-g	EXP038439	831	normal	P15314	Th9-cells	PEAKS040779
EXP038441	IRF1	Mus musculus	IFN-g	NULL	831	normal	P15314	Th9-cells	PEAKS040780
EXP038442	IRF4 abcam,  ab101168	Mus musculus		EXP038439	831	normal	Q64287	Th9-cells	PEAKS040781
EXP038443	IRF4 abcam,  ab101168	Mus musculus	IFN-g	EXP038439	831	normal	Q64287	Th9-cells	PEAKS040782
EXP038450	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038444	1058	normal	P42225	CD4+ T-cells	PEAKS040783
EXP038451	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038445	1058	normal	P42225	CD4+ T-cells	PEAKS040784
EXP038452	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038446	1058	normal	P42225	CD4+ T-cells	PEAKS040785
EXP038453	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038444	1058	normal	Q9WVL2	CD4+ T-cells	PEAKS040786
EXP038454	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038445	1058	normal	Q9WVL2	CD4+ T-cells	PEAKS040787
EXP038455	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038446	1058	normal	Q9WVL2	CD4+ T-cells	PEAKS040788
EXP038456	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038447	1058	normal	P42225	CD4+ T-cells	PEAKS040789
EXP038457	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038448	1058	normal	P42225	CD4+ T-cells	PEAKS040790
EXP038458	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038449	1058	normal	P42225	CD4+ T-cells	PEAKS040791
EXP038459	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038447	1058	normal	Q9WVL2	CD4+ T-cells	PEAKS040792
EXP038460	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038448	1058	normal	Q9WVL2	CD4+ T-cells	PEAKS040793
EXP038461	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038449	1058	normal	Q9WVL2	CD4+ T-cells	PEAKS040794
EXP038462	anti-T-bet, sc-21003, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038447	1058	normal	Q9JKD8	CD4+ T-cells	PEAKS040795
EXP038463	anti-T-bet, sc-21003, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038448	1058	normal	Q9JKD8	CD4+ T-cells	PEAKS040796
EXP038464	anti-T-bet, sc-21003, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038449	1058	normal	Q9JKD8	CD4+ T-cells	PEAKS040797
EXP038466	ZNF532 (anti-ZNF532, 10ul  Bethyl Laboratories, cat. no. A305-442A	Homo sapiens	none	EXP038465	1106	normal	Q9HCE3	ZNF532-NUT 24335 (NUT-midline carcinoma)	PEAKS040798
EXP038469	SMARCC1 (Santa Cruz, sc-9746)	Homo sapiens		EXP038467	1108	normal	Q92922	HMLE-Twist-ER (breast cancer)	PEAKS040799
EXP038470	SMARCE1 (Abcam, ab70540)	Homo sapiens		EXP038467	1108	normal	Q969G3	HMLE-Twist-ER (breast cancer)	PEAKS040800
EXP038471	SMARCC1 (Santa Cruz, sc-9746)	Homo sapiens	125 nM 4-OHT for 14 days	EXP038468	1108	normal	Q92922	HMLE-Twist-ER (breast cancer)	PEAKS040801
EXP038472	SMARCE1 (Abcam, ab70540)	Homo sapiens	125 nM 4-OHT for 14 days	EXP038468	1108	normal	Q969G3	HMLE-Twist-ER (breast cancer)	PEAKS040802
EXP038473	PPARy H100 (sc-7196X)	Mus musculus		NULL	115	normal	P37238	brown adipose tissue	PEAKS040803
EXP038474	PPARy H100 (sc-7196X)	Mus musculus	EBF2 KO	NULL	115	normal	P37238	brown adipose tissue	PEAKS040804
EXP038475	EBF2 (R+D AF 7006)	Mus musculus		NULL	115	normal	O08792	brown adipose tissue	PEAKS040805
EXP038476	CDX-2, Clone CDX2-88; cat.no. AM392-10M; Biogenex	Homo sapiens		NULL	188	normal	Q99626	LS174T (colon adenocarcinoma)	PEAKS040806
EXP038479	KLF4	Homo sapiens	R458A mutation	EXP038478	849	normal	O43474	U87 (glioblastoma)	PEAKS040808
EXP038480	KLF4	Homo sapiens		EXP038478	849	normal	O43474	U87 (glioblastoma)	PEAKS040809
EXP038486	AhR SA-210	Mus musculus	TCDD	EXP038481	5	normal	P30561	liver	PEAKS040810
EXP038487	AhR SA-210	Mus musculus	TCDD	EXP038482	5	normal	P30561	liver	PEAKS040811
EXP038488	AhR SA-210	Mus musculus	TCDD	EXP038483	5	normal	P30561	liver	PEAKS040812
EXP038489	AhR SA-210	Mus musculus	TCDD	EXP038484	5	normal	P30561	liver	PEAKS040813
EXP038490	AhR SA-210	Mus musculus	TCDD	EXP038485	5	normal	P30561	liver	PEAKS040814
EXP038496	AhR SA-210	Mus musculus	TCDD	EXP038491	5	normal	P30561	liver	PEAKS040815
EXP038497	AhR SA-210	Mus musculus	TCDD	EXP038492	5	normal	P30561	liver	PEAKS040816
EXP038498	AhR SA-210	Mus musculus	TCDD	EXP038493	5	normal	P30561	liver	PEAKS040817
EXP038499	AhR SA-210	Mus musculus	TCDD	EXP038494	5	normal	P30561	liver	PEAKS040818
EXP038500	AhR SA-210	Mus musculus	TCDD	EXP038495	5	normal	P30561	liver	PEAKS040819
EXP051011	KLF10 R846.1.1D3	Homo sapiens		EXP038501	430	normal	Q13118	HepG2 (hepatoblastoma)	PEAKS049011
EXP038522	NFIL3 R1053.1.2B5	Homo sapiens		EXP038510	430	normal	Q16649	HepG2 (hepatoblastoma)	PEAKS040821
EXP038523	ZBTB2	Homo sapiens		EXP038514	356	normal	Q8N680	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040822
EXP051012	FOXO3 R5.2.1B7	Homo sapiens		EXP038501	430	normal	O43524	HepG2 (hepatoblastoma)	PEAKS049012
EXP038525	SMAD4 13.2.1A5	Homo sapiens		EXP038506	430	normal	Q13485	HepG2 (hepatoblastoma)	PEAKS040824
EXP038526	FOXO3  R5.2.1B7	Homo sapiens		EXP038505	514	normal	O43524	K562 (myelogenous leukemia)	PEAKS040825
EXP038527	TSC22D4 R154.1.3E10	Homo sapiens		EXP038513	356	normal	Q9Y3Q8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040826
EXP038528	STAT2 R16.1.2H10	Homo sapiens		EXP038513	356	normal	P52630	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040827
EXP038529	L3MBTL4	Homo sapiens		EXP038509	430	normal	Q8NA19	HepG2 (hepatoblastoma)	PEAKS040828
EXP038530	SMAD4 R516.1.1G12	Homo sapiens		EXP038512	430	normal	Q13485	HepG2 (hepatoblastoma)	PEAKS040829
EXP038531	SMAD4 R516.2.1D12	Homo sapiens		EXP038512	430	normal	Q13485	HepG2 (hepatoblastoma)	PEAKS040830
EXP038532	ZNF639 R270.2.1E7	Homo sapiens		EXP038519	514	normal	Q9UID6	K562 (myelogenous leukemia)	PEAKS040831
EXP038533	ZNF639	Homo sapiens		EXP038519	514	normal	Q9UID6	K562 (myelogenous leukemia)	PEAKS040832
EXP038534	BATF R451.2.1E10	Homo sapiens		EXP038503	356	normal	Q16520	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040833
EXP038535	ZNF410 R585.2.2C9	Homo sapiens		EXP038518	514	normal	Q86VK4	K562 (myelogenous leukemia)	PEAKS040834
EXP038536	NRF1	Homo sapiens		EXP038511	514	normal	Q16656	K562 (myelogenous leukemia)	PEAKS040835
EXP038537	NRF1 R157.1.3H1	Homo sapiens		EXP038511	514	normal	Q16656	K562 (myelogenous leukemia)	PEAKS040836
EXP038538	NRF1 R157.1.3H3	Homo sapiens		EXP038511	514	normal	Q16656	K562 (myelogenous leukemia)	PEAKS040837
EXP038539	ZNF18	Homo sapiens		EXP038511	514	normal	P17022	K562 (myelogenous leukemia)	PEAKS040838
EXP038540	ZNF410 R585.2.2C9	Homo sapiens		EXP038511	514	normal	Q86VK4	K562 (myelogenous leukemia)	PEAKS040839
EXP038541	HMG20A R1617.1.2H9	Homo sapiens		EXP038516	356	normal	Q9NP66	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040840
EXP051013	ZBTB2 R6.1.3.46F2	Homo sapiens		EXP038501	430	normal	Q8N680	HepG2 (hepatoblastoma)	PEAKS049013
EXP038543	NF-1A R1356.1.2C6	Homo sapiens		EXP038515	430	normal	Q12857	HepG2 (hepatoblastoma)	PEAKS040842
EXP038544	NRF1  R157.1.3H3	Homo sapiens		EXP038515	430	normal	Q16656	HepG2 (hepatoblastoma)	PEAKS040843
EXP038545	ARID3A R21.1.1E9	Homo sapiens		EXP038501	430	normal	Q99856	HepG2 (hepatoblastoma)	PEAKS040844
EXP038546	ZSCAN2 R767.1.1F8	Homo sapiens		EXP038501	430	normal	Q7Z7L9	HepG2 (hepatoblastoma)	PEAKS040845
EXP038547	USF2 R1156.1.1A7	Homo sapiens		EXP038501	430	normal	Q15853	HepG2 (hepatoblastoma)	PEAKS040846
EXP038548	ZNF75A R1014.1.1B6	Homo sapiens		EXP038520	514	normal	Q96N20	K562 (myelogenous leukemia)	PEAKS040847
EXP038549	NF-1A R1356.1.2C6	Homo sapiens		EXP038520	514	normal	Q12857	K562 (myelogenous leukemia)	PEAKS040848
EXP038550	ZNF18 R177.1.2D2	Homo sapiens		EXP038517	356	normal	P17022	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040849
EXP038551	BATF3 R1066.1.1H3	Homo sapiens		EXP038517	356	normal	Q9NR55	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040850
EXP038552	HMG20A R1617.1.2H9	Homo sapiens		EXP038517	356	normal	Q9NP66	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040851
EXP038553	P73 YP322.1.1A8	Homo sapiens		EXP038517	356	normal	O15350	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040852
EXP038554	ETV6 R1092.1.1A7	Homo sapiens		EXP038504	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040853
EXP038555	ETV6 R1092.1.1A9	Homo sapiens		EXP038504	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040854
EXP038556	ZNF597 R917.1.1C12	Homo sapiens		EXP038504	356	normal	Q96LX8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040855
EXP038557	TSC22D4 R154.1.3E10	Homo sapiens		EXP038504	356	normal	Q9Y3Q8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040856
EXP038558	USF2 R1156.1.1A7	Homo sapiens		EXP038504	356	normal	Q15853	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS040857
EXP038559	HES1	Homo sapiens		EXP038507	430	normal	Q14469	HepG2 (hepatoblastoma)	PEAKS040858
EXP038560	NFATC3 R1106.1.2A12	Homo sapiens		EXP038507	430	normal	Q12968	HepG2 (hepatoblastoma)	PEAKS040859
EXP038561	TSC22D4 R160.2.2A2	Homo sapiens		EXP038507	430	normal	Q9Y3Q8	HepG2 (hepatoblastoma)	PEAKS040860
EXP038562	SMAD4 R516.2.1D12	Homo sapiens		EXP038507	430	normal	Q13485	HepG2 (hepatoblastoma)	PEAKS040861
EXP038563	ATF2 YP185.1.1B4	Homo sapiens		EXP038507	430	normal	P15336	HepG2 (hepatoblastoma)	PEAKS040862
EXP038564	KLF10  R846.1.1D3	Homo sapiens		EXP038508	113	normal	Q13118	MCF7 (Invasive ductal breast carcinoma)	PEAKS040863
EXP038565	ZNF701 R1015.1.1C5	Homo sapiens		EXP038508	113	normal	Q9NV72	MCF7 (Invasive ductal breast carcinoma)	PEAKS040864
EXP038566	ZNF75A R1014.1.1B6	Homo sapiens		EXP038508	113	normal	Q96N20	MCF7 (Invasive ductal breast carcinoma)	PEAKS040865
EXP038567	ZXDC JH98.1.2B5	Homo sapiens		EXP038508	113	normal	Q2QGD7	MCF7 (Invasive ductal breast carcinoma)	PEAKS040866
EXP038568	NRF1 R157.1.3D4	Homo sapiens		EXP038508	113	normal	Q16656	MCF7 (Invasive ductal breast carcinoma)	PEAKS040867
EXP038569	NRF1 R157.1.3H1	Homo sapiens		EXP038508	113	normal	Q16656	MCF7 (Invasive ductal breast carcinoma)	PEAKS040868
EXP038570	ZSCAN2	Homo sapiens		EXP038508	113	normal	Q7Z7L9	MCF7 (Invasive ductal breast carcinoma)	PEAKS040869
EXP038571	anti-CTCF, Millipore 07-729	Mus musculus	Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	PEAKS040870
EXP038572	anti-CTCF, Millipore 07-729	Mus musculus	D29 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	PEAKS040871
EXP038573	anti-CTCF, Millipore 07-729	Mus musculus	D38_D39 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	PEAKS040872
EXP038574	anti-CTCF, Millipore 07-729	Mus musculus	D38 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	PEAKS040873
EXP038575	anti-CTCF, Millipore 07-729	Mus musculus	D39 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	PEAKS040874
EXP038577	ZNF516	Homo sapiens		EXP038576	113	normal	Q92618	MCF7 (Invasive ductal breast carcinoma)	PEAKS040875
EXP038580	Myc	Mus musculus	DMSO	EXP038578	1110	normal	P01108	Eph4 (mammary epithelial cells)	PEAKS040876
EXP038581	Myc	Mus musculus	AU-1 (5uM)	EXP038579	1110	normal	P01108	Eph4 (mammary epithelial cells)	PEAKS040877
EXP038582	ZEB1	Homo sapiens		NULL	113	normal	P37275	MCF7 (Invasive ductal breast carcinoma)	PEAKS040878
EXP038583	anti-HA antibody (ab9110, abcam)	Mus musculus	Spinal metastatic tumor	NULL	791	normal	P48985	Sonic Hedgehog medulloblastoma	PEAKS040879
EXP038584	anti-HA antibody (ab9110, abcam)	Mus musculus	Primary tumor	NULL	791	normal	P48985	Sonic Hedgehog medulloblastoma	PEAKS040880
EXP038586	anti-MAF (Santa Cruz sc-7866)	Homo sapiens	IFN-gamma	NULL	466	normal	O75444	MDM(monocyte derived macrophages)	PEAKS040882
EXP038587	anti-MAF (Santa Cruz sc-7866)	Homo sapiens	none	NULL	466	normal	O75444	MDM(monocyte derived macrophages)	PEAKS040883
EXP038588	anti-C/EBPB (Santa Cruz sc-150)	Homo sapiens	IFN-gamma	NULL	466	normal	P17676	MDM(monocyte derived macrophages)	PEAKS040884
EXP038589	anti-C/EBPB (Santa Cruz sc-150)	Homo sapiens	none	NULL	466	normal	P17676	MDM(monocyte derived macrophages)	PEAKS040885
EXP038590	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	IFN-gamma	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS040886
EXP038591	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	none	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS040887
EXP038596	JunB (N-17; sc-46x)	Mus musculus		EXP038592	498	normal	P09450	Th17-cells	PEAKS040888
EXP038597	JunB (C-11; sc-8051x)	Mus musculus		EXP038593	498	normal	P09450	Th17-cells	PEAKS040889
EXP038598	JunD (329; sc-74x)	Mus musculus		EXP038594	1111	normal	P15066	Junb+/+ CD4cre Th17-cells	PEAKS040890
EXP038599	JunD (329; sc-74x)	Mus musculus		EXP038595	1112	normal	P15066	Junb fl/fl CD4cre Th17-cells	PEAKS040891
EXP038602	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040892
EXP038603	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040893
EXP038604	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040894
EXP038605	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040895
EXP038606	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040896
EXP038607	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Asp380Tyr)	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040897
EXP038608	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Lys179*)	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040898
EXP038609	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1 hemizygous deletion	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040899
EXP038610	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Leu366Pro)	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040900
EXP038611	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040901
EXP038612	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040902
EXP038613	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040903
EXP038614	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040904
EXP038615	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	PEAKS040905
EXP038616	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Asp380Tyr)	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040906
EXP038617	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Lys179*)	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040907
EXP038618	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1 hemizygous deletion	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040908
EXP038619	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Leu366Pro)	EXP038601	566	normal	P25490	lymphoblastoid cells	PEAKS040909
EXP038623	CTCF	Homo sapiens		EXP038620	583	normal	P49711	MCF10A (breast epithelial cells)	PEAKS040910
EXP038624	CTCF	Homo sapiens		EXP038621	1113	normal	P49711	MCF10AT1 (breast premetastatic epithelial cells)	PEAKS040911
EXP038625	CTCF	Homo sapiens		EXP038622	1114	normal	P49711	MCF10CA1a (breast metastatic epithelial cells)	PEAKS040912
EXP038627	Runx1 Abcam; ab23980	Mus musculus		EXP038626	647	normal	Q03347	natural killer T cells	PEAKS040913
EXP038630	CTCF (Active Motif 61311) + Spike in antibody (Active Motif 61686)	Mus musculus		EXP038628	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS040914
EXP038631	CTCF (Active Motif 61311) + Spike in antibody (Active Motif 61686)	Mus musculus		EXP038629	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS040915
EXP038632	CTCF (Active Motif 61311) + Spike in antibody (Active Motif 61686)	Mus musculus	washoff2days	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS040916
EXP038636	anti-AR (ab108341)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	EXP038633	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS040917
EXP038637	anti-ERG (ab92513)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	EXP038633	71	normal	P11308	VCaP (prostate carcinoma)	PEAKS040918
EXP038638	anti-ERF (PA5-30237)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	EXP038634	71	normal	P50548	VCaP (prostate carcinoma)	PEAKS040919
EXP038639	anti-ERF (PA5-30237)	Homo sapiens	Treatment: shRNA against ERG and then 100ng/mL doxycycline	EXP038635	71	normal	P50548	VCaP (prostate carcinoma)	PEAKS040920
EXP038641	PAX7 (Developmental Studies Hybridoma Bank)	Homo sapiens	dox-treated from (day 10 to 23)	EXP038640	396	normal	P23759	WA09 (embryonic stem cells)	PEAKS040921
EXP038644	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	10 ng/mL of TNFÎ±	NULL	430	normal	Q04206	HepG2 (hepatoblastoma)	PEAKS040924
EXP038645	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens		NULL	430	normal	Q04206	HepG2 (hepatoblastoma)	PEAKS040925
EXP038646	CTCF	Mus musculus		NULL	1115	normal	Q61164	activated primary B-cells	PEAKS040926
EXP038647	CTCF	Mus musculus		NULL	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS040927
EXP038648	CTCF	Mus musculus		NULL	1116	normal	Q61164	resting primary B-cells	PEAKS040928
EXP038649	CTCF	Mus musculus		NULL	1117	normal	Q61164	primary T-cells	PEAKS040929
EXP038660	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038650	1118	normal	P35582	pancreatic ductal adenocarcinoma	PEAKS040930
EXP038661	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038651	1118	normal	P35582	pancreatic ductal adenocarcinoma	PEAKS040931
EXP038662	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038652	1118	normal	P35582	pancreatic ductal adenocarcinoma	PEAKS040932
EXP038663	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038653	1119	normal	P35582	pancreatic ductal adenocarcinoma, liver metastasis	PEAKS040933
EXP038664	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038654	1120	normal	P35582	pancreatic ductal adenocarcinoma, peritoneum metastasis	PEAKS040934
EXP038665	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038655	1120	normal	P35582	pancreatic ductal adenocarcinoma, peritoneum metastasis	PEAKS040935
EXP038666	FOXA1 (ab23738; Abcam)	Mus musculus	Transduced with miR-E/shRen retrovirus	EXP038658	1119	normal	P35582	pancreatic ductal adenocarcinoma, liver metastasis	PEAKS040936
EXP038667	FOXA1 (ab23738; Abcam)	Mus musculus	Transduced with miR-E/shFoxa1.2959 retrovirus	EXP038659	1119	normal	P35582	pancreatic ductal adenocarcinoma, liver metastasis	PEAKS040937
EXP038668	FOXA1 (ab23738; Abcam)	Mus musculus	Transduced with MSCV/emp retrovirus	EXP038656	1121	normal	P35582	cultured pancreatic ductal adenocarcinoma cells	PEAKS040938
EXP038669	FOXA1 (ab23738; Abcam)	Mus musculus	transduced with MSCV/FOXA1 retrovirus	EXP038657	1121	normal	P35582	cultured pancreatic ductal adenocarcinoma cells	PEAKS040939
EXP038672	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	PEAKS040940
EXP038673	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	PEAKS040941
EXP038674	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	PEAKS040942
EXP038675	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	PEAKS040943
EXP038676	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	PEAKS040944
EXP038677	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	PEAKS040945
EXP038678	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	PEAKS040946
EXP038679	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	PEAKS040947
EXP038684	HA (ab9110)	Homo sapiens	ChimpPRDM9(W11a)_HA	EXP038683	10	normal	Q9NQV7	HEK293T (embryonic kidney)	PEAKS040948
EXP038685	V5 (ab9116)	Homo sapiens	ChimpPRDM9(W11a)_V5	NULL	10	normal	Q9NQV7	HEK293T (embryonic kidney)	PEAKS040949
EXP038686	HA (ab9110)	Homo sapiens	HumanPRDM9(B)_HA	EXP038683	10	normal	Q9NQV7	HEK293T (embryonic kidney)	PEAKS040950
EXP038687	V5 (ab9116)	Homo sapiens	HumanPRDM9(B)_V5	EXP038683	10	normal	Q9NQV7	HEK293T (embryonic kidney)	PEAKS040951
EXP038688	GFP (Abcam ab290)	Homo sapiens	YFP_HumanPRDM9(B)	EXP038681	10	normal	Q9NQV7	HEK293T (embryonic kidney)	PEAKS040952
EXP038691	NANOG	Homo sapiens		EXP038689	396	normal	Q9H9S0	WA09 (embryonic stem cells)	PEAKS040953
EXP038692	NANOG	Homo sapiens		EXP038690	396	normal	Q9H9S0	WA09 (embryonic stem cells)	PEAKS040954
EXP038693	OCT4	Homo sapiens		EXP038689	396	normal	Q01860	WA09 (embryonic stem cells)	PEAKS040955
EXP038694	OCT4	Homo sapiens		EXP038690	396	normal	Q01860	WA09 (embryonic stem cells)	PEAKS040956
EXP038696	p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	Mus musculus	100ng/ml of CNTF (Peprotech) for 15 m	EXP038695	1122	normal	P42227	primary cortical oligodendrocyte progenitors	PEAKS040957
EXP038700	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040958
EXP038701	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040959
EXP038702	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040960
EXP038703	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040961
EXP038704	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS040962
EXP038705	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 0 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	PEAKS040963
EXP038706	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 15 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	PEAKS040964
EXP038707	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 30 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	PEAKS040965
EXP038708	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 60 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	PEAKS040966
EXP038709	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 120 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	PEAKS040967
EXP038710	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS040968
EXP038711	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS040969
EXP038712	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS040970
EXP038713	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS040971
EXP038714	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS040972
EXP038715	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040973
EXP038716	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040974
EXP038717	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040975
EXP038718	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040976
EXP038719	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS040977
EXP038720	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS040978
EXP038721	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS040979
EXP038722	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS040980
EXP038723	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS040981
EXP038724	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS040982
EXP038725	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 0 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS040983
EXP038726	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 15 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS040984
EXP038727	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 30 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS040985
EXP038728	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 60 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS040986
EXP038729	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 120 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS040987
EXP038730	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 0 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040988
EXP038731	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 15 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040989
EXP038732	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 30 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040990
EXP038733	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 60 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040991
EXP038734	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 120 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040992
EXP038735	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 0 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040993
EXP038736	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 15 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040994
EXP038737	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 30 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040995
EXP038738	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 60 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040996
EXP038739	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 120 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS040997
EXP038740	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 0 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	PEAKS040998
EXP038741	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 15 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	PEAKS040999
EXP038742	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 30 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	PEAKS041000
EXP038743	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 60 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	PEAKS041001
EXP038744	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 120 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	PEAKS041002
EXP038746	IRF4	Mus musculus	IRF4 KO; pre IL21	NULL	1058	normal	Q64287	CD4+ T-cells	PEAKS041003
EXP038747	IRF4	Mus musculus	IRF4 KO; post IL21	NULL	1058	normal	Q64287	CD4+ T-cells	PEAKS041004
EXP038748	IRF4	Mus musculus	pre IL21	NULL	1058	normal	Q64287	CD4+ T-cells	PEAKS041005
EXP038749	IRF4	Mus musculus	post IL21	EXP038745	1058	normal	Q64287	CD4+ T-cells	PEAKS041006
EXP038750	STAT3	Mus musculus		NULL	1058	normal	P42227	CD4+ T-cells	PEAKS041007
EXP038751	STAT3	Mus musculus		NULL	1058	normal	P42227	CD4+ T-cells	PEAKS041008
EXP038752	STAT3	Mus musculus	IRF4 KO; pre IL21	NULL	1058	normal	P42227	CD4+ T-cells	PEAKS041009
EXP038753	STAT3	Mus musculus	IRF4 KO; post IL21	NULL	1058	normal	P42227	CD4+ T-cells	PEAKS041010
EXP038755	CEBPA sc9314	Mus musculus		EXP038754	5	normal	P53566	liver	PEAKS041011
EXP038760	ER	Homo sapiens		EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041012
EXP038761	ER	Homo sapiens	vehicle	EXP038756	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS041013
EXP038762	ER	Homo sapiens	Tam	EXP038756	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS041014
EXP038763	FoxA1	Homo sapiens		EXP038757	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS041015
EXP038764	FoxA1	Homo sapiens		EXP038759	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS041016
EXP038765	FoxA1	Homo sapiens		EXP038758	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS041017
EXP038766	FoxA1	Homo sapiens		EXP038756	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS041018
EXP038767	CTCF	Homo sapiens		EXP038757	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS041019
EXP038768	ER	Homo sapiens	E2	EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041020
EXP038769	ER	Homo sapiens		EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041021
EXP038770	ER	Homo sapiens	siNT	EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041022
EXP038771	ER	Homo sapiens	siFOXA1	EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041023
EXP038772	FoxA1	Homo sapiens		EXP038757	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS041024
EXP038773	CTCF	Homo sapiens		EXP038757	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS041025
EXP038774	CTCF	Homo sapiens		EXP038757	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS041026
EXP038775	ER	Homo sapiens		EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041027
EXP038776	ER	Homo sapiens		EXP038759	874	normal	P03372	ZR-75-1 (invasive ductal carcinoma)	PEAKS041028
EXP038777	ER	Homo sapiens		EXP038758	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS041029
EXP038787	anti-FOXA1 (AB5089, Abcam)	Homo sapiens	Veh_90	EXP038778	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS041030
EXP038788	anti-FOXA1 (AB5089, Abcam)	Homo sapiens	Cocktail_90	EXP038778	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS041031
EXP038789	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Cocktail_90	EXP038778	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041032
EXP038790	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Resist	EXP038782	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS041033
EXP038791	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Resist	EXP038781	119	normal	P03372	BT-474 (breast invasive ductal carcinoma)	PEAKS041034
EXP038792	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Responsive	EXP038780	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS041035
EXP038793	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Responsive	EXP038779	874	normal	P03372	ZR-75-1 (invasive ductal carcinoma)	PEAKS041036
EXP038794	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Responsive	EXP038778	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS041037
EXP038795	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	ER-	EXP038783	1123	normal	P03372	breast tumor	PEAKS041038
EXP038796	ER	Homo sapiens	Metastasis	EXP038784	1124	normal	P03372	breast tumour metastasis	PEAKS041039
EXP038797	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Non-responder	NULL	1123	normal	P03372	breast tumor	PEAKS041040
EXP038798	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Responder	EXP038786	1123	normal	P03372	breast tumor	PEAKS041041
EXP038863	B-ATF	Mus musculus		EXP038811	830	normal	O35284	Th0-cells	PEAKS041042
EXP038864	B-ATF	Mus musculus		EXP038812	830	normal	O35284	Th0-cells	PEAKS041043
EXP038865	B-ATF	Mus musculus		EXP038850	498	normal	O35284	Th17-cells	PEAKS041044
EXP038866	B-ATF	Mus musculus		EXP038850	498	normal	O35284	Th17-cells	PEAKS041045
EXP038867	B-ATF	Mus musculus	B-ATF ko	EXP038854	498	bio_control	O35284	Th17-cells	PEAKS041046
EXP038868	Batf	Mus musculus	IRF4 wt	EXP038799	830	normal	O35284	Th0-cells	PEAKS041047
EXP038869	Batf	Mus musculus	IRF4 ko	EXP038800	830	normal	O35284	Th0-cells	PEAKS041048
EXP038870	Batf	Mus musculus	IRF4 wt	EXP038801	830	normal	O35284	Th0-cells	PEAKS041049
EXP038871	Batf	Mus musculus	IRF4 ko	EXP038802	830	normal	O35284	Th0-cells	PEAKS041050
EXP038872	BATF	Mus musculus	16h	EXP038818	498	normal	O35284	Th17-cells	PEAKS041051
EXP038873	Batf	Mus musculus	IRF4 wt	EXP038823	498	normal	O35284	Th17-cells	PEAKS041052
EXP038874	Batf	Mus musculus	IRF4 ko	NULL	498	normal	O35284	Th17-cells	PEAKS041053
EXP038875	Batf	Mus musculus	IRF4 wt	EXP038824	498	normal	O35284	Th17-cells	PEAKS041054
EXP038876	Batf	Mus musculus	IRF4 ko	EXP038825	498	normal	O35284	Th17-cells	PEAKS041055
EXP038877	c-Maf	Mus musculus		EXP038808	830	normal	P54843	Th0-cells	PEAKS041056
EXP038878	c-Maf	Mus musculus		EXP038846	498	normal	P54843	Th17-cells	PEAKS041057
EXP038879	c-Maf	Mus musculus		EXP038846	498	normal	P54843	Th17-cells	PEAKS041058
EXP038880	c-Maf	Mus musculus	c-Maf ko	EXP038853	498	bio_control	P54843	Th17-cells	PEAKS041059
EXP038881	CTCF	Mus musculus		EXP038812	830	normal	Q61164	Th0-cells	PEAKS041060
EXP038882	CTCF	Mus musculus		EXP038813	830	normal	Q61164	Th0-cells	PEAKS041061
EXP038883	CTCF	Mus musculus		EXP038849	498	normal	Q61164	Th17-cells	PEAKS041062
EXP038884	CTCF	Mus musculus		EXP038857	498	normal	Q61164	Th17-cells	PEAKS041063
EXP038885	Etv6	Mus musculus		EXP038827	498	normal	P97360	Th17-cells	PEAKS041064
EXP038886	Etv6	Mus musculus	48h	EXP038830	498	normal	P97360	Th17-cells	PEAKS041065
EXP038887	Fra	Mus musculus		EXP038809	830	normal	P47930	Th0-cells	PEAKS041066
EXP038888	Fra2	Mus musculus		EXP038845	498	normal	P47930	Th17-cells	PEAKS041067
EXP038889	Fra2	Mus musculus		EXP038860	498	normal	P47930	Th17-cells	PEAKS041068
EXP038890	Hif1a	Mus musculus	48h	EXP038826	498	normal	Q61221	Th17-cells	PEAKS041069
EXP038891	Hif1a	Mus musculus	48h	EXP038828	498	normal	Q61221	Th17-cells	PEAKS041070
EXP038892	IRF4	Mus musculus	Batf +/+; 48h	EXP038803	830	normal	Q64287	Th0-cells	PEAKS041071
EXP038893	IRF4	Mus musculus	Batf -/-; 48h	EXP038804	830	normal	Q64287	Th0-cells	PEAKS041072
EXP038894	IRF4	Mus musculus		EXP038805	830	normal	Q64287	Th0-cells	PEAKS041073
EXP038895	IRF4	Mus musculus		EXP038807	830	normal	Q64287	Th0-cells	PEAKS041074
EXP038896	IRF4	Mus musculus	Batf wt	EXP038814	830	normal	Q64287	Th0-cells	PEAKS041075
EXP038897	IRF4	Mus musculus	Batf ko	EXP038815	830	normal	Q64287	Th0-cells	PEAKS041076
EXP038898	IRF4	Mus musculus	16h	EXP038817	498	normal	Q64287	Th17-cells	PEAKS041077
EXP038899	IRF4	Mus musculus	3h	EXP038820	498	normal	Q64287	Th17-cells	PEAKS041078
EXP038900	IRF4	Mus musculus	Batf +/+; 48h	EXP038821	498	normal	Q64287	Th17-cells	PEAKS041079
EXP038901	IRF4	Mus musculus	Batf -/-; 48h	EXP038822	498	normal	Q64287	Th17-cells	PEAKS041080
EXP038902	IRF4	Mus musculus		EXP038837	498	normal	Q64287	Th17-cells	PEAKS041081
EXP038903	IRF4	Mus musculus	IRF4 ko	EXP038839	498	bio_control	Q64287	Th17-cells	PEAKS041082
EXP038904	IRF4	Mus musculus	RORg wt	EXP038847	498	normal	Q64287	Th17-cells	PEAKS041083
EXP038905	IRF4	Mus musculus	RORg ko	EXP038848	498	normal	Q64287	Th17-cells	PEAKS041084
EXP038906	IRF4	Mus musculus	RORg wt	EXP038855	498	normal	Q64287	Th17-cells	PEAKS041085
EXP038907	IRF4	Mus musculus	RORg ko	EXP038856	498	normal	Q64287	Th17-cells	PEAKS041086
EXP038908	IRF4	Mus musculus	Batf wt	EXP038861	498	normal	Q64287	Th17-cells	PEAKS041087
EXP038909	IRF4	Mus musculus	Batf ko	EXP038862	498	normal	Q64287	Th17-cells	PEAKS041088
EXP038910	RORg	Mus musculus		EXP038813	830	normal	P51450	Th0-cells	PEAKS041089
EXP038911	RORg	Mus musculus	RORg ko	EXP038840	498	bio_control	P51450	Th17-cells	PEAKS041090
EXP038912	RORg	Mus musculus		EXP038842	498	normal	P51450	Th17-cells	PEAKS041091
EXP038913	RORg	Mus musculus		EXP038846	498	normal	P51450	Th17-cells	PEAKS041092
EXP038914	STAT3	Mus musculus		EXP038813	830	normal	P42227	Th0-cells	PEAKS041093
EXP038915	Stat3	Mus musculus	16h	EXP038816	498	normal	P42227	Th17-cells	PEAKS041094
EXP038916	Stat3	Mus musculus	3h	EXP038819	498	normal	P42227	Th17-cells	PEAKS041095
EXP038917	STAT3	Mus musculus		EXP038838	498	normal	P42227	Th17-cells	PEAKS041096
EXP038918	STAT3	Mus musculus		EXP038838	498	normal	P42227	Th17-cells	PEAKS041097
EXP038919	STAT3	Mus musculus	STAT3 ko	EXP038841	498	bio_control	P42227	Th17-cells	PEAKS041098
EXP038920	STAT3	Mus musculus	RORg wt	EXP038847	498	normal	P42227	Th17-cells	PEAKS041099
EXP038921	STAT3	Mus musculus	RORg ko	EXP038848	498	normal	P42227	Th17-cells	PEAKS041100
EXP038922	STAT3	Mus musculus	RORg wt	EXP038855	498	normal	P42227	Th17-cells	PEAKS041101
EXP038923	STAT3	Mus musculus	RORg ko	EXP038856	498	normal	P42227	Th17-cells	PEAKS041102
EXP038926	Pou5f1/Oct4 SC8628	Mus musculus		NULL	292	normal	P20263	F9 (embryonal carcinoma)	PEAKS041104
EXP038927	Pou5f1/Oct4 SC8628	Mus musculus	Treated with retinoic acid; Differentiated into primitive endoderm-like cells	NULL	292	normal	P20263	F9 (embryonal carcinoma)	PEAKS041105
EXP038928	Sox17 AF1924	Mus musculus	Treated with retinoic acid; Differentiated into primitive endoderm-like cells	NULL	292	normal	Q61473	F9 (embryonal carcinoma)	PEAKS041106
EXP038929	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox17-V5 tagged	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	PEAKS041107
EXP038930	V5 R96025	Mus musculus	Overexpress Sox2-V5 tagged	EXP038925	521	normal	P48432	KH2 (embryonic stem cells)	PEAKS041108
EXP038931	Sox17 AF1924, V5 R96025	Mus musculus	Overexpress Sox17-V5 tagged	EXP038925	521	normal	Q61473	KH2 (embryonic stem cells)	PEAKS041109
EXP038932	V5 R96025	Mus musculus	Overexpress Sox2KE-V5 tagged; Sox2KE variant	EXP038925	521	normal	P48432	KH2 (embryonic stem cells)	PEAKS041110
EXP038933	V5 R96025	Mus musculus	Overexpress Sox17EK-V5 tagged; Sox17EK variant	EXP038925	521	normal	Q61473	KH2 (embryonic stem cells)	PEAKS041111
EXP038934	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox2-V5 tagged	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	PEAKS041112
EXP038935	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox2KE-V5 tagged; Sox2KE	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	PEAKS041113
EXP038936	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox17EK-V5 tagged; Sox17EK	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	PEAKS041114
EXP038938	ZC3H8	Homo sapiens		EXP038937	417	normal	Q8N5P1	HCT-116 (colon carcinoma)	PEAKS041115
EXP038945	c-Myc N262 (Santa Cruz, catalog# sc764, lot#G0111)	Mus musculus		EXP038943	970	normal	P01108	spleen B-cells	PEAKS041116
EXP038946	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Homo sapiens	0.2 Âµg/mL Tetracycline (Myc transgene repressed)	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS041117
EXP038947	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Homo sapiens	200 nM OHT (endogenous Myc activated) and 0.2 Âµg/mL Tetracyclin (Myc transgene repressed)	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS041118
EXP038948	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Homo sapiens	none (Myc transgene expressed)	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS041119
EXP038949	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Mus musculus	c-mycflox/flox; in vitro infected with MycER; EtOH	EXP038940	22	normal	P01108	3T9 fibroblasts	PEAKS041120
EXP038950	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Mus musculus	c-mycflox/flox; in vitro infected with MycER; 400 nM 4-hydroxytamoxifen	EXP038940	22	normal	P01108	3T9 fibroblasts	PEAKS041121
EXP038951	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Homo sapiens	0.2 Âµg/mL Tetracycline (Myc transgene repressed) for 72h and then released in fresh medium without Tetracycline for 1h	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS041122
EXP038952	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Homo sapiens	0.2 Âµg/mL Tetracycline (Myc transgene repressed) for 72h and then released in fresh medium without Tetracycline for 24h	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS041123
EXP038953	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Mus musculus		EXP038942	22	normal	P01108	3T9 fibroblasts	PEAKS041124
EXP038954	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Mus musculus	serum starved (0% FBS for 48h), then serum stimulated (10% FBS for 1h)	EXP038940	22	normal	P01108	3T9 fibroblasts	PEAKS041125
EXP038955	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Mus musculus	serum starved (0% FBS for 48h), then serum stimulated (10% FBS for 2h)	EXP038942	22	normal	P01108	3T9 fibroblasts	PEAKS041126
EXP038956	c-Myc N262 (Santa Cruz, catalog# sc764, lot#G0111)	Mus musculus		NULL	970	normal	P01108	spleen B-cells	PEAKS041127
EXP038957	c-Myc N262 (Santa Cruz, catalog# sc764, lot#G0111)	Mus musculus		NULL	1125	normal	P01108	B-cells, lymphnode-derived	PEAKS041128
EXP038958	ERa HC20 sc-543	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with 100nM 4-OHT for 24h.	NULL	583	normal	P03372	MCF10A (breast epithelial cells)	PEAKS041129
EXP038959	ERa HC20 sc-543	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with solvent control for 24h.	NULL	583	normal	P03372	MCF10A (breast epithelial cells)	PEAKS041130
EXP038960	ERa HC20 sc-543	Homo sapiens	Cells were lentivirally transduced with MYC-ER and stable pools were treated with solvent control for 24h.	NULL	583	normal	P03372	MCF10A (breast epithelial cells)	PEAKS041131
EXP038961	10E2 (anti-MIZ1)	Homo sapiens		NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	PEAKS041132
EXP038962	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with 100nM 4-OHT for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	PEAKS041133
EXP038963	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with solvent control for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	PEAKS041134
EXP038964	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ER and stable pools were treated with 100nM 4-OHT for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	PEAKS041135
EXP038965	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ER and stable pools were treated with solvent control for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	PEAKS041136
EXP038971	anti-Smad2/3	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	EXP038966	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	PEAKS041137
EXP038972	anti-Smad2/3	Mus musculus	SB431542 (Tocris, #1614) were used at 10Î¼M	NULL	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	PEAKS041138
EXP038973	anti-Tcf3	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	EXP038966	1126	normal	P15806	E14TG2a.4 (embryonic stem cells)	PEAKS041139
EXP038974	anti-Smad2/3	Mus musculus		EXP038967	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	PEAKS041140
EXP038975	anti-Tcf3	Mus musculus		EXP038967	1126	normal	P15806	E14TG2a.4 (embryonic stem cells)	PEAKS041141
EXP038976	anti-p53(FL-393) and anti-p53(M19)	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. 	EXP038968	1126	normal	P02340	E14TG2a.4 (embryonic stem cells)	PEAKS041142
EXP038977	anti-p53(FL-393) and anti-p53(M19)	Mus musculus	SB431542 (Tocris, #1614) were used at 10Î¼M	NULL	1126	normal	P02340	E14TG2a.4 (embryonic stem cells)	PEAKS041143
EXP038978	anti-Smad2/3	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	EXP038969	237	normal	Q62432	embryoid body	PEAKS041144
EXP038979	anti-Smad2/3	Mus musculus	SB431542 (Tocris, #1614) were used at 10Î¼M	NULL	237	normal	Q62432	embryoid body	PEAKS041145
EXP038980	anti-Smad2/3	Mus musculus	Trp53-/-, p73shRNA; Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. 	EXP038970	237	normal	Q62432	embryoid body	PEAKS041146
EXP038981	anti-Smad2/3	Mus musculus	Trp53-/-, p73shRNA; SB431542 (Tocris, #1614) were used at 10Î¼M	EXP038970	237	normal	Q62432	embryoid body	PEAKS041147
EXP038987	Myt1la (rabbit)	Mus musculus		EXP038983	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041148
EXP038988	Myt1la (rabbit)	Mus musculus		EXP038984	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041149
EXP038989	Myt1lab	Mus musculus		EXP038982	1127	normal	P97500	E13.5 brain	PEAKS041150
EXP038990	Myt1lb (rabbit)	Mus musculus		EXP038983	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041151
EXP038991	Myt1lb (rabbit)	Mus musculus		EXP038984	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041152
EXP038992	Myt1lb (rabbit)	Mus musculus		EXP038985	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041153
EXP038993	Myt1lb (rabbit)	Mus musculus	truncated Myt1l(200-623)	EXP038986	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041154
EXP038994	Myt1lb (rabbit)	Mus musculus		NULL	12	normal	P97500	MEF (mouse embryonic fibroblasts)	PEAKS041155
EXP038999	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif)	EXP038995	2	normal	E9Q8T2	mESCs (mouse embryonic stem cells)	PEAKS041156
EXP039000	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif) and 2i; Prdm15KO	EXP038997	2	bio_control	E9Q8T2	mESCs (mouse embryonic stem cells)	PEAKS041157
EXP039001	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif) and 2i; Differentiation by culture in KOSR medium without Lif for 3 or 6 days; Prdm15KO	EXP038998	2	bio_control	E9Q8T2	mESCs (mouse embryonic stem cells)	PEAKS041158
EXP039002	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif) and 2i; Differentiation by culture in KOSR medium without Lif for 3 or 6 days	EXP038996	2	normal	E9Q8T2	mESCs (mouse embryonic stem cells)	PEAKS041159
EXP039004	phox2b sc-376997X (mouse monoclonal)	Homo sapiens	none	EXP039003	1128	normal	Q99453	CLB-Ga (neuroblastoma)	PEAKS041160
EXP039005	GATA3 sc-22206X (goat polyclonal)	Homo sapiens	none	EXP039003	1128	normal	P23771	CLB-Ga (neuroblastoma)	PEAKS041161
EXP039006	hand2 sc-9409 (goat polyclonal)	Homo sapiens	none	EXP039003	1128	normal	P61296	CLB-Ga (neuroblastoma)	PEAKS041162
EXP039011	ZBTB48 (ab1)	Homo sapiens	ZBTB48 KO	EXP039010	78	bio_control	P10074	HeLa (cervical adenocarcinoma)	PEAKS041163
EXP039012	ZBTB48 (ab2)	Homo sapiens	ZBTB48 KO	EXP039010	78	bio_control	P10074	HeLa (cervical adenocarcinoma)	PEAKS041164
EXP039013	ZBTB48 (ab1)	Homo sapiens		EXP039007	78	normal	P10074	HeLa (cervical adenocarcinoma)	PEAKS041165
EXP039014	ZBTB48 (ab2)	Homo sapiens		EXP039007	78	normal	P10074	HeLa (cervical adenocarcinoma)	PEAKS041166
EXP039015	ZBTB48 (ab1)	Homo sapiens	ZBTB48 KO	EXP039008	848	bio_control	P10074	U2OS (osteosarcoma)	PEAKS041167
EXP039016	ZBTB48 (ab2)	Homo sapiens	ZBTB48 KO	EXP039008	848	bio_control	P10074	U2OS (osteosarcoma)	PEAKS041168
EXP039017	ZBTB48 (ab1)	Homo sapiens		EXP039009	848	normal	P10074	U2OS (osteosarcoma)	PEAKS041169
EXP039018	ZBTB48 (ab2)	Homo sapiens		EXP039009	848	normal	P10074	U2OS (osteosarcoma)	PEAKS041170
EXP039310	07-729	Homo sapiens		EXP039296	1169	normal	P49711	sigmoid colon	PEAKS041171
EXP039311	ab290	Homo sapiens		EXP039092	421	normal	Q13398	HEK293 (embryonic kidney)	PEAKS041172
EXP039312	sc-9144	Homo sapiens		EXP039220	356	normal	Q00613	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041173
EXP039313	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039257	38	normal	P04150	A549 (lung carcinoma)	PEAKS041174
EXP039314	A300-754A	Homo sapiens		EXP039188	356	normal	Q99081	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041175
EXP039315	F1804	Homo sapiens		EXP039140	430	normal	P10828	HepG2 (hepatoblastoma)	PEAKS041176
EXP039316	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q3SY52	HEK293 (embryonic kidney)	PEAKS041177
EXP039317	A300-348A	Homo sapiens		EXP039074	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	PEAKS041178
EXP039318	ab290	Homo sapiens		EXP039092	421	normal	Q02447	HEK293 (embryonic kidney)	PEAKS041179
EXP039319	goat-anti-GFP-UC	Homo sapiens		EXP039145	514	normal	Q9Y473	K562 (myelogenous leukemia)	PEAKS041180
EXP039320	A302-473A	Homo sapiens		EXP039034	514	normal	O60315	K562 (myelogenous leukemia)	PEAKS041181
EXP039321	07-729	Homo sapiens		EXP039097	633	normal	P49711	spleen	PEAKS041182
EXP039322	ab290	Homo sapiens		EXP039092	421	normal	Q9BU19	HEK293 (embryonic kidney)	PEAKS041183
EXP039323	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q96K83	HEK293 (embryonic kidney)	PEAKS041184
EXP039324	sc-1003	Homo sapiens	1 h with 5 nM Dexamethasone (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	PEAKS041185
EXP039325	sc-1003	Homo sapiens	1 h with 500 pM Dexamethasone (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	PEAKS041186
EXP039326	sc-1003	Homo sapiens	1 h with 50 nM Dexamethasone (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	PEAKS041187
EXP039327	A302-765A	Homo sapiens		EXP039020	430	normal	P27540	HepG2 (hepatoblastoma)	PEAKS041188
EXP039328	07-729	Homo sapiens		EXP039194	1170	normal	P49711	lower leg skin	PEAKS041189
EXP039329	GTX114991	Homo sapiens		EXP039076	356	normal	P55347	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041190
EXP039330	ab290	Homo sapiens		EXP039092	421	normal	Q96MX3	HEK293 (embryonic kidney)	PEAKS041191
EXP039331	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	P17275	A549 (lung carcinoma)	PEAKS041192
EXP039332	ab55744	Homo sapiens		EXP039046	113	normal	Q16656	MCF7 (Invasive ductal breast carcinoma)	PEAKS041193
EXP039333	sc-8984	Homo sapiens		EXP039046	113	normal	P36956	MCF7 (Invasive ductal breast carcinoma)	PEAKS041194
EXP039334	07-729	Homo sapiens		EXP039207	1167	normal	P49711	esophagus muscularis mucosa	PEAKS041195
EXP039335	HPA030062	Homo sapiens		EXP039240	113	normal	Q06710	MCF7 (Invasive ductal breast carcinoma)	PEAKS041196
EXP039336	F1804	Homo sapiens		EXP039140	430	normal	Q9NP66	HepG2 (hepatoblastoma)	PEAKS041197
EXP039337	61311	Mus musculus		EXP039093	810	normal	Q61164	stomach	PEAKS041198
EXP039338	ab290	Homo sapiens		EXP039092	421	normal	Q9BWM5	HEK293 (embryonic kidney)	PEAKS041199
EXP039339	goat-anti-GFP-UC	Homo sapiens		EXP039228	514	normal	Q15329	K562 (myelogenous leukemia)	PEAKS041200
EXP039340	ab290	Homo sapiens		EXP039092	421	normal	Q8NBF1	HEK293 (embryonic kidney)	PEAKS041201
EXP039341	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	P17275	A549 (lung carcinoma)	PEAKS041202
EXP039342	GTX114991	Homo sapiens		EXP039232	10	normal	P55347	HEK293T (embryonic kidney)	PEAKS041203
EXP039343	ab290	Homo sapiens		EXP039092	421	normal	Q2M1K9	HEK293 (embryonic kidney)	PEAKS041204
EXP039344	sc-543	Homo sapiens	1 h with 10 nM Estradiol (Myers)	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS041205
EXP039345	sc-74	Homo sapiens		EXP039193	879	normal	P17535	liver	PEAKS041206
EXP039346	sc-543	Homo sapiens	1 h with 100 nM Genistein (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS041207
EXP039347	WH0002120M1	Homo sapiens		EXP039105	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041208
EXP039348	sc-1003	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010555	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	PEAKS041209
EXP039349	sc-543	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS041210
EXP039350	goat-anti-GFP-UC	Homo sapiens		EXP039165	514	normal	O43889	K562 (myelogenous leukemia)	PEAKS041211
EXP039351	sc-1003	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	PEAKS041212
EXP039352	ab290	Homo sapiens		EXP039092	421	normal	A8K8V0	HEK293 (embryonic kidney)	PEAKS041213
EXP039353	sc-543	Homo sapiens	1 h with 10 nM Estradiol (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS041214
EXP039354	sc-543	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS041215
EXP039355	sc-1003	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039026	38	normal	P04150	A549 (lung carcinoma)	PEAKS041216
EXP039356	sc-543	Homo sapiens	1 h with 100 nM Genistein (Myers)	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS041217
EXP039357	sc-1003	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP039026	38	normal	P04150	A549 (lung carcinoma)	PEAKS041218
EXP039358	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q6ZS27	HEK293 (embryonic kidney)	PEAKS041219
EXP039359	F1804	Homo sapiens		EXP039140	430	normal	P48380	HepG2 (hepatoblastoma)	PEAKS041220
EXP039360	sc-1003	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010555	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	PEAKS041221
EXP039361	goat-anti-GFP-UC	Homo sapiens		EXP039111	514	normal	P18847	K562 (myelogenous leukemia)	PEAKS041222
EXP039362	F1804	Homo sapiens		EXP039140	430	normal	Q8IX15	HepG2 (hepatoblastoma)	PEAKS041223
EXP039363	A301-729A	Homo sapiens		EXP039114	430	normal	Q01167	HepG2 (hepatoblastoma)	PEAKS041224
EXP039364	sc-101058	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039033	38	normal	P55317	A549 (lung carcinoma)	PEAKS041225
EXP039365	F1804	Homo sapiens		EXP039140	430	normal	P28702	HepG2 (hepatoblastoma)	PEAKS041226
EXP039366	A303-047A	Homo sapiens		EXP039216	514	normal	P13056	K562 (myelogenous leukemia)	PEAKS041227
EXP039367	sc-543	Homo sapiens	100nM bisphenol A (CHEBI:33216) for 30 minute	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS041228
EXP039368	R157.1.3D4	Homo sapiens		EXP039034	514	normal	Q16656	K562 (myelogenous leukemia)	PEAKS041229
EXP039369	HPA005732	Homo sapiens		EXP039074	113	normal	Q86T24	MCF7 (Invasive ductal breast carcinoma)	PEAKS041230
EXP039370	07-729	Homo sapiens		EXP039241	1132	normal	P49711	heart left ventricle	PEAKS041231
EXP039371	ab290	Homo sapiens		EXP039092	421	normal	Q9UID6	HEK293 (embryonic kidney)	PEAKS041232
EXP039372	ab60931	Homo sapiens		EXP039199	665	normal	Q15853	SK-N-SH (neuroblastoma)	PEAKS041233
EXP039373	600-401-A59	Homo sapiens		EXP039106	514	normal	Q15796	K562 (myelogenous leukemia)	PEAKS041234
EXP039374	GTX116020	Homo sapiens		EXP039034	514	normal	P17542	K562 (myelogenous leukemia)	PEAKS041235
EXP039375	ab290	Homo sapiens		EXP039092	421	normal	Q9H4T2	HEK293 (embryonic kidney)	PEAKS041236
EXP039376	A301-531A	Homo sapiens		EXP039046	113	normal	Q92610	MCF7 (Invasive ductal breast carcinoma)	PEAKS041237
EXP039377	ab85725	Homo sapiens		EXP039081	38	normal	P56270	A549 (lung carcinoma)	PEAKS041238
EXP039378	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041239
EXP039379	07-729	Homo sapiens		EXP039300	1167	normal	P49711	esophagus muscularis mucosa	PEAKS041240
EXP039380	S9809	Homo sapiens		EXP039034	514	normal	P08047	K562 (myelogenous leukemia)	PEAKS041241
EXP039381	ab290	Homo sapiens		EXP039092	421	normal	P17023	HEK293 (embryonic kidney)	PEAKS041242
EXP039382	61311	Mus musculus		EXP039308	523	normal	Q61164	kidney	PEAKS041243
EXP039383	sc-1003	Homo sapiens		EXP039246	38	normal	P04150	A549 (lung carcinoma)	PEAKS041244
EXP039384	S9809	Homo sapiens		EXP039020	430	normal	P08047	HepG2 (hepatoblastoma)	PEAKS041245
EXP039385	A301-145A	Homo sapiens		EXP039034	514	normal	O75376	K562 (myelogenous leukemia)	PEAKS041246
EXP039386	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	P49711	A549 (lung carcinoma)	PEAKS041247
EXP039387	A302-659A	Homo sapiens		EXP039232	10	normal	Q99607	HEK293T (embryonic kidney)	PEAKS041248
EXP039388	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	P49711	A549 (lung carcinoma)	PEAKS041249
EXP039389	F1804	Homo sapiens		EXP039185	430	normal	Q08945	HepG2 (hepatoblastoma)	PEAKS041250
EXP039390	goat-anti-GFP-UC	Homo sapiens		EXP039119	514	normal	Q15853	K562 (myelogenous leukemia)	PEAKS041251
EXP039391	sc-769	Homo sapiens		EXP039034	514	normal	Q99583	K562 (myelogenous leukemia)	PEAKS041252
EXP039392	HPA003256	Homo sapiens		EXP039034	514	normal	O14770	K562 (myelogenous leukemia)	PEAKS041253
EXP039393	ab290	Homo sapiens		EXP039092	421	normal	Q3KP31	HEK293 (embryonic kidney)	PEAKS041254
EXP039394	sc-166835	Homo sapiens		EXP039076	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041255
EXP039395	F1804	Homo sapiens		EXP039140	430	normal	Q8IZ40	HepG2 (hepatoblastoma)	PEAKS041256
EXP039396	sc-240	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	normal	P16220	A549 (lung carcinoma)	PEAKS041257
EXP039397	sc-240	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010017	38	normal	P16220	A549 (lung carcinoma)	PEAKS041258
EXP039398	07-729	Homo sapiens		EXP039292	1172	normal	P49711	adrenal gland	PEAKS041259
EXP039399	sc-240	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	normal	P16220	A549 (lung carcinoma)	PEAKS041260
EXP039400	A303-230A	Homo sapiens		EXP039034	514	normal	P67809	K562 (myelogenous leukemia)	PEAKS041261
EXP039401	sc-101058	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP039033	38	normal	P55317	A549 (lung carcinoma)	PEAKS041262
EXP039402	07-729	Homo sapiens		EXP039222	1172	normal	P49711	adrenal gland	PEAKS041263
EXP039403	sc-543	Homo sapiens	1 h with 100 nM Bisphenol A (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS041264
EXP039404	F1804	Homo sapiens		EXP039140	430	normal	Q9H582	HepG2 (hepatoblastoma)	PEAKS041265
EXP039405	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P10070	HEK293 (embryonic kidney)	PEAKS041266
EXP039406	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	P49711	A549 (lung carcinoma)	PEAKS041267
EXP039407	61311	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	P49711	A549 (lung carcinoma)	PEAKS041268
EXP039408	goat-anti-GFP-UC	Homo sapiens		EXP039279	514	normal	Q13351	K562 (myelogenous leukemia)	PEAKS041269
EXP039409	ab290	Homo sapiens		EXP039092	421	normal	Q52M93	HEK293 (embryonic kidney)	PEAKS041270
EXP039410	F1804	Homo sapiens		EXP039140	430	normal	P17097	HepG2 (hepatoblastoma)	PEAKS041271
EXP039411	ab290	Homo sapiens		EXP039092	421	normal	Q494X3	HEK293 (embryonic kidney)	PEAKS041272
EXP039412	goat-anti-GFP-UC	Homo sapiens		EXP039229	113	normal	P53567	MCF7 (Invasive ductal breast carcinoma)	PEAKS041273
EXP039413	07-729	Homo sapiens		EXP039053	1095	normal	P49711	Loucy (adult T acute lymphoblastic leukemia)	PEAKS041274
EXP039414	NRSF	Homo sapiens		EXP039274	879	normal	Q13127	liver	PEAKS041275
EXP039415	ab290	Homo sapiens		EXP039092	421	normal	Q9UKN5	HEK293 (embryonic kidney)	PEAKS041276
EXP039416	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	P05412	A549 (lung carcinoma)	PEAKS041277
EXP039417	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q8TD17	HEK293 (embryonic kidney)	PEAKS041278
EXP039418	ab290	Homo sapiens		EXP039092	421	normal	Q6ZNG1	HEK293 (embryonic kidney)	PEAKS041279
EXP039419	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	P15408	A549 (lung carcinoma)	PEAKS041280
EXP039420	A301-932A	Homo sapiens		EXP039114	430	normal	Q9NUA8	HepG2 (hepatoblastoma)	PEAKS041281
EXP039421	ab290	Homo sapiens		EXP039092	421	normal	O95365	HEK293 (embryonic kidney)	PEAKS041282
EXP039422	NRSF	Homo sapiens		EXP039193	879	normal	Q13127	liver	PEAKS041283
EXP039423	17-641	Homo sapiens		EXP010775	376	normal	Q13127	WA01 (H1, human embryonic stem cells)	PEAKS041284
EXP039424	A301-932A	Homo sapiens		EXP039188	356	normal	Q9NUA8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041285
EXP039425	ab290	Homo sapiens		EXP039092	421	normal	Q96T92	HEK293 (embryonic kidney)	PEAKS041286
EXP039426	F1804	Homo sapiens		EXP039140	430	normal	P35711	HepG2 (hepatoblastoma)	PEAKS041287
EXP039427	F1804	Homo sapiens		EXP039140	430	normal	P53567	HepG2 (hepatoblastoma)	PEAKS041288
EXP039428	A303-279A	Homo sapiens		EXP039074	113	normal	Q8N1G0	MCF7 (Invasive ductal breast carcinoma)	PEAKS041289
EXP039429	goat-anti-GFP-UC	Homo sapiens		EXP039235	514	normal	Q8NDX6	K562 (myelogenous leukemia)	PEAKS041290
EXP039430	A301-669A	Homo sapiens		EXP039074	113	normal	P16220	MCF7 (Invasive ductal breast carcinoma)	PEAKS041291
EXP039431	ab290	Homo sapiens		EXP039092	421	normal	Q8IZC7	HEK293 (embryonic kidney)	PEAKS041292
EXP039432	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	P20749	A549 (lung carcinoma)	PEAKS041293
EXP039433	A303-266A	Homo sapiens		EXP039240	113	normal	O75362	MCF7 (Invasive ductal breast carcinoma)	PEAKS041294
EXP039434	61311	Homo sapiens		EXP039112	38	normal	P49711	A549 (lung carcinoma)	PEAKS041295
EXP039435	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q9Y467	HEK293 (embryonic kidney)	PEAKS041296
EXP039436	A303-285A	Homo sapiens		EXP039034	514	normal	Q8IWY8	K562 (myelogenous leukemia)	PEAKS041297
EXP039437	goat-anti-GFP-UC	Homo sapiens		EXP039149	514	normal	P40425	K562 (myelogenous leukemia)	PEAKS041298
EXP039438	07-729	Homo sapiens		EXP039280	1148	normal	P49711	esophagus squamous epithelium	PEAKS041299
EXP039439	39550	Homo sapiens		EXP039177	356	normal	P17275	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041300
EXP039440	goat-anti-GFP-UC	Homo sapiens		EXP039122	514	normal	Q9H582	K562 (myelogenous leukemia)	PEAKS041301
EXP039441	ab290	Homo sapiens		EXP039092	421	normal	P52744	HEK293 (embryonic kidney)	PEAKS041302
EXP039442	HPA003384	Homo sapiens		EXP039076	356	normal	P17544	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041303
EXP039443	A303-390A	Homo sapiens		EXP039034	514	normal	P18146	K562 (myelogenous leukemia)	PEAKS041304
EXP039444	sc-1694	Homo sapiens		EXP039046	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	PEAKS041305
EXP039445	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q9UJU3	HEK293 (embryonic kidney)	PEAKS041306
EXP039446	sc-357	Mus musculus		EXP010613	1144	normal	Q61286	CH12.LX (Mouse lymphoma)	PEAKS041307
EXP039447	A300-754A	Homo sapiens		EXP039034	514	normal	Q99081	K562 (myelogenous leukemia)	PEAKS041308
EXP039448	A303-230A	Homo sapiens		EXP039020	430	normal	P67809	HepG2 (hepatoblastoma)	PEAKS041309
EXP039449	F1804	Homo sapiens		EXP039140	430	normal	Q96EK4	HepG2 (hepatoblastoma)	PEAKS041310
EXP039450	ab290	Homo sapiens		EXP039092	421	normal	Q9UEG4	HEK293 (embryonic kidney)	PEAKS041311
EXP039451	ab290	Homo sapiens		EXP039092	421	normal	Q5TYW1	HEK293 (embryonic kidney)	PEAKS041312
EXP039452	goat-anti-GFP-UC	Homo sapiens		EXP039128	514	normal	Q96ME7	K562 (myelogenous leukemia)	PEAKS041313
EXP039453	07-729	Homo sapiens		EXP039035	1148	normal	P49711	esophagus squamous epithelium	PEAKS041314
EXP039454	07-729	Homo sapiens		EXP039272	1148	normal	P49711	esophagus squamous epithelium	PEAKS041315
EXP039455	A301-729A	Homo sapiens		EXP039034	514	normal	Q01167	K562 (myelogenous leukemia)	PEAKS041316
EXP039456	07-729	Homo sapiens		EXP039154	1140	normal	P49711	subcutaneous adipose tissue	PEAKS041317
EXP039457	07-729	Homo sapiens		EXP039283	440	normal	P49711	HMEC (human mammary epithelial cells)	PEAKS041318
EXP039458	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P21506	HEK293 (embryonic kidney)	PEAKS041319
EXP039459	GTX104189	Homo sapiens		EXP039120	514	normal	Q6NT76	K562 (myelogenous leukemia)	PEAKS041320
EXP039460	sc-7874	Homo sapiens		EXP039220	356	normal	P10242	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041321
EXP039461	GTX114835	Homo sapiens		EXP039034	514	normal	P10589	K562 (myelogenous leukemia)	PEAKS041322
EXP039462	A300-343A	Homo sapiens		EXP039034	514	normal	Q15788	K562 (myelogenous leukemia)	PEAKS041323
EXP039463	07-729	Homo sapiens		EXP039162	1179	normal	P49711	tibial nerve	PEAKS041324
EXP039464	A303-486A	Homo sapiens		EXP039161	10	normal	Q9UJU2	HEK293T (embryonic kidney)	PEAKS041325
EXP039465	ab290	Homo sapiens		EXP039092	421	normal	A0PJY2	HEK293 (embryonic kidney)	PEAKS041326
EXP039466	HPA039433	Homo sapiens		EXP039034	514	normal	Q9BTC8	K562 (myelogenous leukemia)	PEAKS041327
EXP039467	200-401-194	Homo sapiens		EXP039118	38	normal	P48382	A549 (lung carcinoma)	PEAKS041328
EXP039468	3418	Homo sapiens	10 nM 17Î²-hydroxy-5Î±-androstan-3-one (CHEBI:16330) for 4 hour	EXP039244	70	normal	P49711	LNCaP (prostate carcinoma)	PEAKS041329
EXP039469	07-729	Homo sapiens		EXP039065	633	normal	P49711	spleen	PEAKS041330
EXP039470	ab290	Homo sapiens		EXP039092	421	normal	P17028	HEK293 (embryonic kidney)	PEAKS041331
EXP039471	A303-626A	Homo sapiens		EXP039216	514	normal	Q99583	K562 (myelogenous leukemia)	PEAKS041332
EXP039472	07-729	Homo sapiens		EXP039187	1163	normal	P49711	transverse colon	PEAKS041333
EXP039473	ab290	Homo sapiens		EXP039092	421	normal	Q96NG5	HEK293 (embryonic kidney)	PEAKS041334
EXP039474	07-729	Homo sapiens		EXP039102	1156	normal	P49711	gastroesophageal sphincter	PEAKS041335
EXP039475	07-729	Homo sapiens		EXP039299	1142	normal	P49711	Peyer's patch	PEAKS041336
EXP039476	ab290	Homo sapiens		EXP039092	421	normal	Q6ZR52	HEK293 (embryonic kidney)	PEAKS041337
EXP039477	WH0055892M1	Homo sapiens		EXP039049	514	normal	Q9NPC7	K562 (myelogenous leukemia)	PEAKS041338
EXP039478	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	P20749	A549 (lung carcinoma)	PEAKS041339
EXP039479	F1804	Homo sapiens		EXP039140	430	normal	P10276	HepG2 (hepatoblastoma)	PEAKS041340
EXP039480	WH0006932M1	Homo sapiens		EXP039049	514	normal	P36402	K562 (myelogenous leukemia)	PEAKS041341
EXP039481	sc-8984	Homo sapiens		EXP039118	38	normal	P36956	A549 (lung carcinoma)	PEAKS041342
EXP039482	sc-13125	Homo sapiens		EXP039030	423	normal	P17480	HeLa S3 (cervical adenocarcinoma)	PEAKS041343
EXP039483	A303-091A	Homo sapiens		EXP039188	356	normal	P17028	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041344
EXP039484	ab290	Homo sapiens		EXP039092	421	normal	Q13351	HEK293 (embryonic kidney)	PEAKS041345
EXP039485	R157.1.3H3	Homo sapiens		EXP039034	514	normal	Q16656	K562 (myelogenous leukemia)	PEAKS041346
EXP039486	A301-017A	Homo sapiens		EXP039240	113	normal	O60264	MCF7 (Invasive ductal breast carcinoma)	PEAKS041347
EXP039487	3418	Homo sapiens		EXP039189	1166	normal	P49711	epithelial cell of prostate	PEAKS041348
EXP039488	sc-1694	Homo sapiens		EXP039081	38	normal	P05412	A549 (lung carcinoma)	PEAKS041349
EXP039489	A301-649A	Homo sapiens		EXP039188	356	normal	P15336	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041350
EXP039490	F1804	Homo sapiens		EXP039185	430	normal	Q9GZN2	HepG2 (hepatoblastoma)	PEAKS041351
EXP039491	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	P17676	A549 (lung carcinoma)	PEAKS041352
EXP039492	goat-anti-GFP-UC	Homo sapiens		EXP039223	514	normal	Q15776	K562 (myelogenous leukemia)	PEAKS041353
EXP039493	A301-146A	Homo sapiens		EXP039216	514	normal	O75376	K562 (myelogenous leukemia)	PEAKS041354
EXP039494	16618-1-AP	Homo sapiens		EXP039076	356	normal	P52747	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041355
EXP039495	sc-166705	Homo sapiens		EXP039181	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041356
EXP039496	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	P05412	A549 (lung carcinoma)	PEAKS041357
EXP039497	A303-391A	Homo sapiens		EXP039077	514	normal	P18146	K562 (myelogenous leukemia)	PEAKS041358
EXP039498	3418	Homo sapiens		EXP039291	1182	normal	P49711	RWPE2	PEAKS041359
EXP039499	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	P17676	A549 (lung carcinoma)	PEAKS041360
EXP039500	ab290	Homo sapiens		EXP039084	421	normal	Q9BUY5	HEK293 (embryonic kidney)	PEAKS041361
EXP039501	A303-275A	Homo sapiens		EXP039240	113	normal	Q8NAF0	MCF7 (Invasive ductal breast carcinoma)	PEAKS041362
EXP039502	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	P15408	A549 (lung carcinoma)	PEAKS041363
EXP039503	ab290	Homo sapiens		EXP039092	421	normal	P10074	HEK293 (embryonic kidney)	PEAKS041364
EXP039504	sc-166702	Homo sapiens		EXP039290	430	normal	Q15233	HepG2 (hepatoblastoma)	PEAKS041365
EXP039505	SAB2102741	Homo sapiens		EXP039151	113	normal	O95625	MCF7 (Invasive ductal breast carcinoma)	PEAKS041366
EXP039506	A302-474A	Homo sapiens		EXP039034	514	normal	O60315	K562 (myelogenous leukemia)	PEAKS041367
EXP039507	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	P05412	A549 (lung carcinoma)	PEAKS041368
EXP039508	sc-229	Mus musculus		EXP010644	1174	normal	Q61069	MEL cell line	PEAKS041369
EXP039509	CST_5419S	Homo sapiens		EXP039068	129	normal	P17010	LNCaP C4-2B (prostate carcinoma)	PEAKS041370
EXP039510	F1804	Homo sapiens		EXP039140	430	normal	Q86YP4	HepG2 (hepatoblastoma)	PEAKS041371
EXP039511	ab290	Homo sapiens		EXP039092	421	normal	P11161	HEK293 (embryonic kidney)	PEAKS041372
EXP039512	goat-anti-GFP-UC	Homo sapiens		EXP039137	514	normal	P49116	K562 (myelogenous leukemia)	PEAKS041373
EXP039513	HPA001923	Homo sapiens		EXP039034	514	normal	P35712	K562 (myelogenous leukemia)	PEAKS041374
EXP039514	R157.1.3H3	Homo sapiens		EXP039123	430	normal	Q16656	HepG2 (hepatoblastoma)	PEAKS041375
EXP039515	ab290	Homo sapiens		EXP039092	421	normal	O95409	HEK293 (embryonic kidney)	PEAKS041376
EXP039516	F1804	Homo sapiens		EXP039140	430	normal	Q9UK33	HepG2 (hepatoblastoma)	PEAKS041377
EXP039517	ab290	Homo sapiens		EXP039092	421	normal	Q6ZSB9	HEK293 (embryonic kidney)	PEAKS041378
EXP039518	61311	Mus musculus		EXP039048	561	normal	Q61164	lung	PEAKS041379
EXP039519	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	P05412	A549 (lung carcinoma)	PEAKS041380
EXP039520	A301-730A	Homo sapiens		EXP039161	10	normal	Q01167	HEK293T (embryonic kidney)	PEAKS041381
EXP039521	M8194	Homo sapiens		EXP039167	423	normal	Q9ULX9	HeLa S3 (cervical adenocarcinoma)	PEAKS041382
EXP039522	A303-570A	Homo sapiens		EXP039034	514	normal	Q12968	K562 (myelogenous leukemia)	PEAKS041383
EXP039523	3418	Homo sapiens		EXP039139	71	normal	P49711	VCaP (prostate carcinoma)	PEAKS041384
EXP039524	CST_5419S	Homo sapiens		EXP039019	417	normal	P17010	HCT-116 (colon carcinoma)	PEAKS041385
EXP039525	07-729	Homo sapiens		EXP039213	1156	normal	P49711	gastroesophageal sphincter	PEAKS041386
EXP039526	ab290	Homo sapiens		EXP039092	421	normal	Q8TDD2	HEK293 (embryonic kidney)	PEAKS041387
EXP039527	A302-357A	Homo sapiens		EXP039077	514	normal	Q86YP4	K562 (myelogenous leukemia)	PEAKS041388
EXP039528	61311	Mus musculus		EXP039085	142	normal	Q61164	intestine	PEAKS041389
EXP039529	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q9P2J8	HEK293 (embryonic kidney)	PEAKS041390
EXP039530	ab34682	Mus musculus		EXP010613	1144	normal	Q9WU00	CH12.LX (Mouse lymphoma)	PEAKS041391
EXP039531	ab290	Homo sapiens		EXP039031	421	normal	Q9HCK0	HEK293 (embryonic kidney)	PEAKS041392
EXP039532	HPA006672	Homo sapiens		EXP039036	430	normal	P17029	HepG2 (hepatoblastoma)	PEAKS041393
EXP039533	ab290	Homo sapiens		EXP039092	421	normal	Q9C0K0	HEK293 (embryonic kidney)	PEAKS041394
EXP039534	07-729	Homo sapiens		EXP039219	1157	normal	P49711	stomach	PEAKS041395
EXP039535	goat-anti-GFP-UC	Homo sapiens		EXP039069	514	normal	P17676	K562 (myelogenous leukemia)	PEAKS041396
EXP039536	07-729	Homo sapiens		EXP039127	1149	normal	P49711	testis	PEAKS041397
EXP039537	07-729	Homo sapiens		EXP039190	1170	normal	P49711	lower leg skin	PEAKS041398
EXP039538	goat-anti-GFP-UC	Homo sapiens		EXP039143	113	normal	P32519	MCF7 (Invasive ductal breast carcinoma)	PEAKS041399
EXP039539	sc-66882	Homo sapiens		EXP039046	113	normal	P11474	MCF7 (Invasive ductal breast carcinoma)	PEAKS041400
EXP039540	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	P17275	A549 (lung carcinoma)	PEAKS041401
EXP039541	A300-810A	Homo sapiens		EXP039034	514	normal	Q969G3	K562 (myelogenous leukemia)	PEAKS041402
EXP039542	3742S	Homo sapiens		EXP039034	514	normal	Q01094	K562 (myelogenous leukemia)	PEAKS041403
EXP039543	ab290	Homo sapiens		EXP039092	421	normal	Q9NV72	HEK293 (embryonic kidney)	PEAKS041404
EXP039544	07-729	Homo sapiens		EXP039221	929	normal	P49711	neutrophils	PEAKS041405
EXP039545	558036	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	P05412	A549 (lung carcinoma)	PEAKS041406
EXP039546	GTX108356	Homo sapiens		EXP039074	113	normal	Q14469	MCF7 (Invasive ductal breast carcinoma)	PEAKS041407
EXP039547	07-729	Homo sapiens		EXP039184	1142	normal	P49711	Peyer's patch	PEAKS041408
EXP039548	07-729	Homo sapiens		EXP039298	1163	normal	P49711	transverse colon	PEAKS041409
EXP039549	sc-30189	Homo sapiens		EXP039081	38	normal	Q9UKL0	A549 (lung carcinoma)	PEAKS041410
EXP039550	07-729	Homo sapiens		EXP039129	1181	normal	P49711	upper lobe of left lung	PEAKS041411
EXP039551	ab26049,ab70892	Homo sapiens		EXP010775	376	normal	P29375	WA01 (H1, human embryonic stem cells)	PEAKS041412
EXP039552	goat-anti-GFP-UC	Homo sapiens		EXP039075	514	normal	O95625	K562 (myelogenous leukemia)	PEAKS041413
EXP039553	goat-anti-GFP-UC	Homo sapiens		EXP039079	514	normal	Q9H2P0	K562 (myelogenous leukemia)	PEAKS041414
EXP039554	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	P15408	A549 (lung carcinoma)	PEAKS041415
EXP039555	ab290	Homo sapiens		EXP039092	421	normal	Q5JT82	HEK293 (embryonic kidney)	PEAKS041416
EXP039556	ab70892	Homo sapiens		EXP039242	356	normal	P29375	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041417
EXP039557	sc-13032	Homo sapiens		EXP039036	430	normal	Q16236	HepG2 (hepatoblastoma)	PEAKS041418
EXP039558	ab290	Homo sapiens		EXP039092	421	normal	O15391	HEK293 (embryonic kidney)	PEAKS041419
EXP039559	ab290	Homo sapiens		EXP039092	421	normal	Q9NQV6	HEK293 (embryonic kidney)	PEAKS041420
EXP039560	goat-anti-GFP-UC	Homo sapiens		EXP039237	514	normal	P10914	K562 (myelogenous leukemia)	PEAKS041421
EXP039561	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	P17676	A549 (lung carcinoma)	PEAKS041422
EXP039562	NB100-1800	Homo sapiens		EXP039188	356	normal	O14503	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041423
EXP039563	1277-1	Homo sapiens		EXP039046	113	normal	P19419	MCF7 (Invasive ductal breast carcinoma)	PEAKS041424
EXP039564	ab290	Homo sapiens		EXP039092	421	normal	Q9BS34	HEK293 (embryonic kidney)	PEAKS041425
EXP039565	ab290	Homo sapiens		EXP039092	421	normal	Q8ND82	HEK293 (embryonic kidney)	PEAKS041426
EXP039566	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q9UQR1	HEK293 (embryonic kidney)	PEAKS041427
EXP039567	CST_5419S	Homo sapiens		EXP039192	10	normal	P17010	HEK293T (embryonic kidney)	PEAKS041428
EXP039568	goat-anti-GFP-UC	Homo sapiens		EXP039148	514	normal	Q96LW1	K562 (myelogenous leukemia)	PEAKS041429
EXP039569	07-729	Homo sapiens		EXP039101	1149	normal	P49711	testis	PEAKS041430
EXP039570	ab290	Homo sapiens		EXP039092	421	normal	Q96C55	HEK293 (embryonic kidney)	PEAKS041431
EXP039571	F1804	Homo sapiens		EXP039140	430	normal	Q8WUU5	HepG2 (hepatoblastoma)	PEAKS041432
EXP039572	07-729	Homo sapiens		EXP039141	1157	normal	P49711	stomach	PEAKS041433
EXP039573	B0933	Homo sapiens		EXP039240	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS041434
EXP039574	07-729	Homo sapiens		EXP039297	1170	normal	P49711	lower leg skin	PEAKS041435
EXP039575	A301-281A	Homo sapiens		EXP039240	113	normal	Q8WXI9	MCF7 (Invasive ductal breast carcinoma)	PEAKS041436
EXP039576	07-729	Homo sapiens		EXP039109	1176	normal	P49711	ascending aorta	PEAKS041437
EXP039577	ab50322	Homo sapiens		EXP039046	113	normal	O60675	MCF7 (Invasive ductal breast carcinoma)	PEAKS041438
EXP039578	F1804	Homo sapiens		EXP039140	430	normal	Q13886	HepG2 (hepatoblastoma)	PEAKS041439
EXP039579	07-729	Homo sapiens		EXP039301	1175	normal	P49711	prostate gland	PEAKS041440
EXP039580	ab19857	Mus musculus		EXP039261	233	normal	P20263	E14TG2A (embryonic stem cells)	PEAKS041441
EXP039581	07-729	Homo sapiens		EXP039130	633	normal	P49711	spleen	PEAKS041442
EXP039582	A303-242A	Homo sapiens		EXP039074	113	normal	Q9Y2K1	MCF7 (Invasive ductal breast carcinoma)	PEAKS041443
EXP039583	goat-anti-GFP-UC	Homo sapiens		EXP039273	113	normal	Q13886	MCF7 (Invasive ductal breast carcinoma)	PEAKS041444
EXP039584	sc-166705	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041445
EXP039585	HPA006672	Homo sapiens		EXP039046	113	normal	P17029	MCF7 (Invasive ductal breast carcinoma)	PEAKS041446
EXP039586	07-729	Homo sapiens		EXP039204	920	normal	P49711	pancreas	PEAKS041447
EXP039587	F1804	Homo sapiens		EXP039140	430	normal	Q9P2R6	HepG2 (hepatoblastoma)	PEAKS041448
EXP039588	goat-anti-GFP-UC	Homo sapiens		EXP039067	514	normal	Q04206	K562 (myelogenous leukemia)	PEAKS041449
EXP039589	1277-1	Homo sapiens		EXP039081	38	normal	P19419	A549 (lung carcinoma)	PEAKS041450
EXP039590	sc-150	Homo sapiens		EXP039181	38	normal	P17676	A549 (lung carcinoma)	PEAKS041451
EXP039591	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	P17676	A549 (lung carcinoma)	PEAKS041452
EXP039592	F1804	Homo sapiens		EXP039140	430	normal	Q7Z3K6	HepG2 (hepatoblastoma)	PEAKS041453
EXP039593	13232S	Homo sapiens		EXP039076	356	normal	Q9UL17	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041454
EXP039594	sc-9081	Homo sapiens		EXP039131	1184	normal	Q01860	GM23338	PEAKS041455
EXP039595	GTX108356	Homo sapiens		EXP039034	514	normal	Q14469	K562 (myelogenous leukemia)	PEAKS041456
EXP039596	ab290	Homo sapiens		EXP039092	421	normal	Q9BYN7	HEK293 (embryonic kidney)	PEAKS041457
EXP039597	61311	Mus musculus		EXP039304	137	normal	Q61164	hindbrain	PEAKS041458
EXP039598	goat-anti-GFP-UC	Homo sapiens		EXP039038	514	normal	P50549	K562 (myelogenous leukemia)	PEAKS041459
EXP039599	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	P20749	A549 (lung carcinoma)	PEAKS041460
EXP039600	A301-017A	Homo sapiens		EXP039034	514	normal	O60264	K562 (myelogenous leukemia)	PEAKS041461
EXP039601	HPA006672	Homo sapiens		EXP039106	514	normal	P17029	K562 (myelogenous leukemia)	PEAKS041462
EXP039602	goat-anti-GFP-UC	Homo sapiens		EXP039155	514	normal	Q9P0K8	K562 (myelogenous leukemia)	PEAKS041463
EXP039603	F1804	Homo sapiens		EXP039140	430	normal	Q8N344	HepG2 (hepatoblastoma)	PEAKS041464
EXP039604	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039176	38	normal	P04150	A549 (lung carcinoma)	PEAKS041465
EXP039605	GTX129438	Homo sapiens		EXP039188	356	normal	Q13422	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041466
EXP039606	1277-1	Homo sapiens		EXP039044	489	normal	P19419	IMR90 (lung fibroblasts)	PEAKS041467
EXP039607	A303-047A	Homo sapiens		EXP039188	356	normal	P13056	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041468
EXP039608	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039303	38	normal	P04150	A549 (lung carcinoma)	PEAKS041469
EXP039609	07-729	Homo sapiens		EXP039107	221	normal	P49711	DOHH2 (diffuse large B-cell lymphoma)	PEAKS041470
EXP039610	07-729	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039252	1145	normal	P49711	bipolar neuron	PEAKS041471
EXP039611	ab290	Homo sapiens		EXP039092	421	normal	P17020	HEK293 (embryonic kidney)	PEAKS041472
EXP039612	07-729	Homo sapiens		EXP039045	1142	normal	P49711	Peyer's patch	PEAKS041473
EXP039613	ab290	Homo sapiens		EXP039092	421	normal	Q96MR9	HEK293 (embryonic kidney)	PEAKS041474
EXP039614	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	P17275	A549 (lung carcinoma)	PEAKS041475
EXP039615	F1804	Homo sapiens		EXP039140	430	normal	P37231	HepG2 (hepatoblastoma)	PEAKS041476
EXP039616	A303-197A	Homo sapiens		EXP039034	514	normal	Q6ZNB6	K562 (myelogenous leukemia)	PEAKS041477
EXP039617	sc-6327	Homo sapiens		EXP039074	113	normal	P39880	MCF7 (Invasive ductal breast carcinoma)	PEAKS041478
EXP039618	07-729	Homo sapiens		EXP039186	1169	normal	P49711	sigmoid colon	PEAKS041479
EXP039619	F1804	Homo sapiens		EXP039198	514	normal	P40425	K562 (myelogenous leukemia)	PEAKS041480
EXP039620	07-729	Homo sapiens		EXP039142	1148	normal	P49711	esophagus squamous epithelium	PEAKS041481
EXP039621	ab290	Homo sapiens		EXP039092	421	normal	Q9BWW7	HEK293 (embryonic kidney)	PEAKS041482
EXP039622	sc-281	Homo sapiens		EXP039302	879	normal	P25490	liver	PEAKS041483
EXP039623	goat-anti-GFP-UC	Homo sapiens		EXP039264	514	normal	P15407	K562 (myelogenous leukemia)	PEAKS041484
EXP039624	ab290	Homo sapiens		EXP039031	421	normal	P58317	HEK293 (embryonic kidney)	PEAKS041485
EXP039625	ab290	Homo sapiens		EXP039031	421	normal	Q96CX3	HEK293 (embryonic kidney)	PEAKS041486
EXP039626	ab290	Homo sapiens		EXP039092	421	normal	Q9C0A1	HEK293 (embryonic kidney)	PEAKS041487
EXP039627	goat-anti-GFP-UC	Homo sapiens		EXP039200	514	normal	Q14494	K562 (myelogenous leukemia)	PEAKS041488
EXP039628	A301-039A	Homo sapiens		EXP039061	430	normal	Q8TAQ2	HepG2 (hepatoblastoma)	PEAKS041489
EXP039629	07-729	Mus musculus		EXP039261	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS041490
EXP039630	goat-anti-GFP-UC	Homo sapiens		EXP039150	514	normal	P51522	K562 (myelogenous leukemia)	PEAKS041491
EXP039631	A301-729A	Homo sapiens		EXP039074	113	normal	Q01167	MCF7 (Invasive ductal breast carcinoma)	PEAKS041492
EXP039632	WH0001390M2	Homo sapiens		EXP039105	356	normal	Q03060	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041493
EXP039633	A300-396A	Homo sapiens		EXP039074	113	normal	O94776	MCF7 (Invasive ductal breast carcinoma)	PEAKS041494
EXP039634	sc-6059	Mus musculus		EXP010613	1144	normal	Q64287	CH12.LX (Mouse lymphoma)	PEAKS041495
EXP039635	39550	Homo sapiens		EXP039086	514	normal	P17275	K562 (myelogenous leukemia)	PEAKS041496
EXP039636	GTX80982	Homo sapiens		EXP039086	514	normal	Q9BXK1	K562 (myelogenous leukemia)	PEAKS041497
EXP039637	558036	Homo sapiens		EXP039112	38	normal	P05412	A549 (lung carcinoma)	PEAKS041498
EXP039638	07-729	Homo sapiens		EXP039248	900	normal	P49711	hepatocytes	PEAKS041499
EXP039639	07-729	Homo sapiens		EXP039125	440	normal	P49711	HMEC (human mammary epithelial cells)	PEAKS041500
EXP039640	sc-185	Homo sapiens		EXP039181	38	normal	P20749	A549 (lung carcinoma)	PEAKS041501
EXP039641	CST_5419S	Homo sapiens		EXP039056	113	normal	P17010	MCF7 (Invasive ductal breast carcinoma)	PEAKS041502
EXP039642	A301-932A	Homo sapiens		EXP039240	113	normal	Q9NUA8	MCF7 (Invasive ductal breast carcinoma)	PEAKS041503
EXP039643	A300-810A	Homo sapiens		EXP039240	113	normal	Q969G3	MCF7 (Invasive ductal breast carcinoma)	PEAKS041504
EXP039644	HPA005732	Homo sapiens		EXP039034	514	normal	Q86T24	K562 (myelogenous leukemia)	PEAKS041505
EXP039645	07-729	Homo sapiens		EXP039090	1168	normal	P49711	thyroid gland	PEAKS041506
EXP039646	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q16670	HEK293 (embryonic kidney)	PEAKS041507
EXP039647	sc-345	Homo sapiens		EXP039134	1184	normal	P42224	GM23338	PEAKS041508
EXP039648	goat-anti-GFP-UC	Homo sapiens		EXP039153	514	normal	P19419	K562 (myelogenous leukemia)	PEAKS041509
EXP039649	F1804	Homo sapiens		EXP039185	430	normal	Q03014	HepG2 (hepatoblastoma)	PEAKS041510
EXP039650	sc-160	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	P15408	A549 (lung carcinoma)	PEAKS041511
EXP039651	ab290	Homo sapiens		EXP039092	421	normal	O00110	HEK293 (embryonic kidney)	PEAKS041512
EXP039652	goat-anti-GFP-UC	Homo sapiens		EXP039160	514	normal	Q86UQ0	K562 (myelogenous leukemia)	PEAKS041513
EXP039653	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q9ULD5	HEK293 (embryonic kidney)	PEAKS041514
EXP039654	ab85725	Homo sapiens		EXP039046	113	normal	P56270	MCF7 (Invasive ductal breast carcinoma)	PEAKS041515
EXP039655	GTX113275	Homo sapiens		EXP039049	514	normal	Q14186	K562 (myelogenous leukemia)	PEAKS041516
EXP039656	A300-993A	Homo sapiens		EXP039034	514	normal	Q9H7Z6	K562 (myelogenous leukemia)	PEAKS041517
EXP039657	sc-8987	Homo sapiens		EXP039302	879	normal	P41235	liver	PEAKS041518
EXP039658	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	P15408	A549 (lung carcinoma)	PEAKS041519
EXP039659	A303-516A	Homo sapiens		EXP039188	356	normal	Q13422	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041520
EXP039660	sc-9081	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039289	1145	normal	Q01860	bipolar neuron	PEAKS041521
EXP039661	SAB1404509	Homo sapiens		EXP039220	356	normal	P17480	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041522
EXP039662	2569S	Homo sapiens		EXP039106	514	normal	Q9NQB0	K562 (myelogenous leukemia)	PEAKS041523
EXP039663	07-729	Homo sapiens		EXP039126	1129	normal	P49711	suprapubic skin	PEAKS041524
EXP039664	ab290	Homo sapiens		EXP039031	421	normal	Q5T0B9	HEK293 (embryonic kidney)	PEAKS041525
EXP039665	A303-619A	Homo sapiens		EXP039188	356	normal	Q9UKS7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041526
EXP039666	goat-anti-GFP-UC	Homo sapiens		EXP039039	113	normal	Q06546	MCF7 (Invasive ductal breast carcinoma)	PEAKS041527
EXP039667	07-729	Homo sapiens		EXP039121	1162	normal	P49711	thoracic aorta	PEAKS041528
EXP039668	sc-10813	Homo sapiens		EXP039046	113	normal	Q13330	MCF7 (Invasive ductal breast carcinoma)	PEAKS041529
EXP039669	sc-197	Homo sapiens		EXP039302	879	normal	P61244	liver	PEAKS041530
EXP039670	sc-350	Homo sapiens		EXP039131	1184	normal	P14921	GM23338	PEAKS041531
EXP039671	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	A6NGD5	HEK293 (embryonic kidney)	PEAKS041532
EXP039672	N8664	Homo sapiens		EXP039216	514	normal	Q15233	K562 (myelogenous leukemia)	PEAKS041533
EXP039673	ab290	Homo sapiens		EXP039092	421	normal	Q13127	HEK293 (embryonic kidney)	PEAKS041534
EXP039674	4373S	Homo sapiens		EXP039106	514	normal	Q13562	K562 (myelogenous leukemia)	PEAKS041535
EXP039675	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q7Z3V5	HEK293 (embryonic kidney)	PEAKS041536
EXP039676	GTX100308	Homo sapiens		EXP039077	514	normal	P55317	K562 (myelogenous leukemia)	PEAKS041537
EXP039677	07-729	Homo sapiens		EXP039041	1163	normal	P49711	transverse colon	PEAKS041538
EXP039678	07-729	Homo sapiens		EXP039226	1157	normal	P49711	stomach	PEAKS041539
EXP039679	ab290	Homo sapiens		EXP039092	421	normal	Q6ZSZ6	HEK293 (embryonic kidney)	PEAKS041540
EXP039680	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	P15408	A549 (lung carcinoma)	PEAKS041541
EXP039681	ab290	Homo sapiens		EXP039092	421	normal	Q13886	HEK293 (embryonic kidney)	PEAKS041542
EXP039682	sc-14700	Homo sapiens		EXP039188	356	normal	O14867	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041543
EXP039683	07-729	Homo sapiens		EXP039024	927	normal	P49711	PC9 (lung adenocarcinoma)	PEAKS041544
EXP039684	F1804	Homo sapiens		EXP039140	430	normal	P28347	HepG2 (hepatoblastoma)	PEAKS041545
EXP039685	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039179	38	normal	P04150	A549 (lung carcinoma)	PEAKS041546
EXP039686	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041547
EXP039687	39204	Homo sapiens		EXP039034	514	normal	P26358	K562 (myelogenous leukemia)	PEAKS041548
EXP039688	ab290	Homo sapiens		EXP039092	421	normal	Q9Y5A6	HEK293 (embryonic kidney)	PEAKS041549
EXP039689	61311	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039209	1145	normal	P49711	bipolar neuron	PEAKS041550
EXP039690	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9NQX0	HEK293 (embryonic kidney)	PEAKS041551
EXP039691	HPA024069	Homo sapiens		EXP039034	514	normal	Q96BA8	K562 (myelogenous leukemia)	PEAKS041552
EXP039692	2750S	Homo sapiens		EXP039106	514	normal	Q01860	K562 (myelogenous leukemia)	PEAKS041553
EXP039693	sc-9144	Homo sapiens		EXP039046	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS041554
EXP039694	ab290	Homo sapiens		EXP039092	421	normal	Q96EG3	HEK293 (embryonic kidney)	PEAKS041555
EXP039695	07-729	Homo sapiens		EXP039210	1154	normal	P49711	omental fat pad	PEAKS041556
EXP039696	07-729	Homo sapiens		EXP039175	1163	normal	P49711	transverse colon	PEAKS041557
EXP039697	ab290	Homo sapiens		EXP039092	421	normal	O95125	HEK293 (embryonic kidney)	PEAKS041558
EXP039698	sc-188	Homo sapiens		EXP039214	879	normal	P18847	liver	PEAKS041559
EXP039699	07-729	Homo sapiens		EXP039082	1163	normal	P49711	transverse colon	PEAKS041560
EXP039700	07-729	Homo sapiens		EXP039051	1181	normal	P49711	upper lobe of left lung	PEAKS041561
EXP039701	A301-530A	Homo sapiens		EXP039216	514	normal	Q92610	K562 (myelogenous leukemia)	PEAKS041562
EXP039702	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039064	38	normal	P04150	A549 (lung carcinoma)	PEAKS041563
EXP039703	A303-626A	Homo sapiens		EXP039240	113	normal	Q99583	MCF7 (Invasive ductal breast carcinoma)	PEAKS041564
EXP039704	07-729	Homo sapiens		EXP039088	1136	normal	P49711	gastrocnemius medialis	PEAKS041565
EXP039705	61311,3418	Homo sapiens		EXP039147	712	normal	P49711	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS041566
EXP039706	WH0009580M1	Homo sapiens		EXP039234	430	normal	Q9UN79	HepG2 (hepatoblastoma)	PEAKS041567
EXP039707	07-729	Homo sapiens		EXP039218	1170	normal	P49711	lower leg skin	PEAKS041568
EXP039708	NB600-244	Homo sapiens		EXP039167	423	normal	Q9UKY1	HeLa S3 (cervical adenocarcinoma)	PEAKS041569
EXP039709	A303-627A	Homo sapiens		EXP039216	514	normal	Q99583	K562 (myelogenous leukemia)	PEAKS041570
EXP039710	N8664	Homo sapiens		EXP039020	430	normal	Q15233	HepG2 (hepatoblastoma)	PEAKS041571
EXP039711	ab34682	Mus musculus		EXP010644	1174	normal	Q9WU00	MEL cell line	PEAKS041572
EXP039712	GTX100255	Homo sapiens		EXP039123	430	normal	P10588	HepG2 (hepatoblastoma)	PEAKS041573
EXP039713	61311	Mus musculus		EXP039164	313	normal	Q61164	forebrain	PEAKS041574
EXP039714	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q6NX49	HEK293 (embryonic kidney)	PEAKS041575
EXP039715	ab290	Homo sapiens		EXP039092	421	normal	O75626	HEK293 (embryonic kidney)	PEAKS041576
EXP039716	61311	Mus musculus		EXP039294	5	normal	Q61164	liver	PEAKS041577
EXP039717	ab290	Homo sapiens		EXP039092	421	normal	Q9NSC2	HEK293 (embryonic kidney)	PEAKS041578
EXP039718	goat-anti-GFP-UC	Homo sapiens		EXP039215	514	normal	Q8IVC4	K562 (myelogenous leukemia)	PEAKS041579
EXP039719	ab290	Homo sapiens		EXP039092	421	normal	P52738	HEK293 (embryonic kidney)	PEAKS041580
EXP039720	HPA024062	Homo sapiens		EXP039034	514	normal	P17028	K562 (myelogenous leukemia)	PEAKS041581
EXP039721	sc-23871	Homo sapiens		EXP039095	879	normal	Q86T24	liver	PEAKS041582
EXP039722	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039057	38	normal	P04150	A549 (lung carcinoma)	PEAKS041583
EXP039723	07-729	Homo sapiens		EXP039250	1131	normal	P49711	tibial artery	PEAKS041584
EXP039724	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039059	38	normal	P04150	A549 (lung carcinoma)	PEAKS041585
EXP039725	goat-anti-GFP-UC	Homo sapiens		EXP039087	514	normal	P13056	K562 (myelogenous leukemia)	PEAKS041586
EXP039726	GTX102170	Homo sapiens		EXP039034	514	normal	Q08050	K562 (myelogenous leukemia)	PEAKS041587
EXP039727	A302-765A	Homo sapiens		EXP039161	10	normal	P27540	HEK293T (embryonic kidney)	PEAKS041588
EXP039728	A303-091A	Homo sapiens		EXP039240	113	normal	P17028	MCF7 (Invasive ductal breast carcinoma)	PEAKS041589
EXP039729	ab290	Homo sapiens		EXP039092	421	normal	Q8IVP9	HEK293 (embryonic kidney)	PEAKS041590
EXP039730	ab290	Homo sapiens		EXP039092	421	normal	P19544	HEK293 (embryonic kidney)	PEAKS041591
EXP039731	F1804	Homo sapiens		EXP039140	430	normal	Q9H2W2	HepG2 (hepatoblastoma)	PEAKS041592
EXP039732	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	P15408	A549 (lung carcinoma)	PEAKS041593
EXP039733	ab290	Homo sapiens		EXP039092	421	normal	Q9Y473	HEK293 (embryonic kidney)	PEAKS041594
EXP039734	sc-9082	Homo sapiens		EXP039076	356	normal	Q14653	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041595
EXP039735	sc-313	Mus musculus		EXP010613	1144	normal	Q60929	CH12.LX (Mouse lymphoma)	PEAKS041596
EXP039736	ab290	Homo sapiens		EXP039092	421	normal	Q9UJL9	HEK293 (embryonic kidney)	PEAKS041597
EXP039737	sc-10650	Homo sapiens		EXP039074	113	normal	P22670	MCF7 (Invasive ductal breast carcinoma)	PEAKS041598
EXP039738	F1804	Homo sapiens		EXP039185	430	normal	Q9UIS9	HepG2 (hepatoblastoma)	PEAKS041599
EXP039739	ab290	Homo sapiens		EXP039092	421	normal	P56270	HEK293 (embryonic kidney)	PEAKS041600
EXP039740	07-729	Homo sapiens		EXP039172	618	normal	P49711	MM1.S (plasma cell myeloma)	PEAKS041601
EXP039741	F1804	Homo sapiens		EXP039140	430	normal	Q9HCK0	HepG2 (hepatoblastoma)	PEAKS041602
EXP039742	sc-66882	Homo sapiens		EXP039081	38	normal	P11474	A549 (lung carcinoma)	PEAKS041603
EXP039743	sc-8984	Homo sapiens		EXP039106	514	normal	P36956	K562 (myelogenous leukemia)	PEAKS041604
EXP039744	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	P17275	A549 (lung carcinoma)	PEAKS041605
EXP039745	07-729	Homo sapiens		EXP039094	1150	normal	P49711	ovary	PEAKS041606
EXP039746	sc-6558	Homo sapiens		EXP039274	879	normal	Q14541	liver	PEAKS041607
EXP039747	ab290	Homo sapiens		EXP039092	421	normal	Q8N9Z0	HEK293 (embryonic kidney)	PEAKS041608
EXP039748	A301-017A	Homo sapiens		EXP039188	356	normal	O60264	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041609
EXP039749	ab290	Homo sapiens		EXP039092	421	normal	P98169	HEK293 (embryonic kidney)	PEAKS041610
EXP039750	goat-anti-GFP-UC	Homo sapiens		EXP039043	514	normal	P15036	K562 (myelogenous leukemia)	PEAKS041611
EXP039751	A301-530A	Homo sapiens		EXP039074	113	normal	Q92610	MCF7 (Invasive ductal breast carcinoma)	PEAKS041612
EXP039752	A301-146A	Homo sapiens		EXP039034	514	normal	O75376	K562 (myelogenous leukemia)	PEAKS041613
EXP039753	HPA006079	Homo sapiens		EXP039034	514	normal	Q13127	K562 (myelogenous leukemia)	PEAKS041614
EXP039754	ab290	Homo sapiens		EXP039092	421	normal	Q16600	HEK293 (embryonic kidney)	PEAKS041615
EXP039755	A301-654A	Homo sapiens		EXP039216	514	normal	P10244	K562 (myelogenous leukemia)	PEAKS041616
EXP039756	A303-701A	Homo sapiens		EXP039046	113	normal	O15156	MCF7 (Invasive ductal breast carcinoma)	PEAKS041617
EXP039757	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	P15408	A549 (lung carcinoma)	PEAKS041618
EXP039758	sc-166702	Homo sapiens		EXP039309	514	normal	Q15233	K562 (myelogenous leukemia)	PEAKS041619
EXP039759	07-729	Homo sapiens		EXP039070	1129	normal	P49711	suprapubic skin	PEAKS041620
EXP039760	A301-813A	Homo sapiens		EXP010775	376	normal	Q9UGL1	WA01 (H1, human embryonic stem cells)	PEAKS041621
EXP039761	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041622
EXP039762	61311	Homo sapiens		EXP039263	7	normal	P49711	22RV1 (prostate carcinoma)	PEAKS041623
EXP039763	sc-188	Homo sapiens		EXP039095	879	normal	P18847	liver	PEAKS041624
EXP039764	ab290	Homo sapiens		EXP039092	421	normal	Q8NEK5	HEK293 (embryonic kidney)	PEAKS041625
EXP039765	ab290	Homo sapiens		EXP039092	421	normal	Q96NJ6	HEK293 (embryonic kidney)	PEAKS041626
EXP039766	ab290	Homo sapiens		EXP039092	421	normal	Q9BUG6	HEK293 (embryonic kidney)	PEAKS041627
EXP039767	07-729	Homo sapiens		EXP039113	1138	normal	P49711	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS041628
EXP039768	A303-220A	Homo sapiens		EXP039240	113	normal	Q9UIU6	MCF7 (Invasive ductal breast carcinoma)	PEAKS041629
EXP039769	61311	Mus musculus		EXP039166	1147	normal	Q61164	midbrain	PEAKS041630
EXP039770	ab290	Homo sapiens		EXP039084	421	normal	Q8IZ26	HEK293 (embryonic kidney)	PEAKS041631
EXP039771	sc-13032	Homo sapiens		EXP039044	489	normal	Q16236	IMR90 (lung fibroblasts)	PEAKS041632
EXP039772	07-729	Homo sapiens		EXP039286	1163	normal	P49711	transverse colon	PEAKS041633
EXP039773	ab290	Homo sapiens		EXP039092	421	normal	Q6P9A1	HEK293 (embryonic kidney)	PEAKS041634
EXP039774	sc-345	Homo sapiens		EXP039076	356	normal	P42224	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041635
EXP039775	sc-10652	Homo sapiens		EXP039074	113	normal	P22670	MCF7 (Invasive ductal breast carcinoma)	PEAKS041636
EXP039776	F1804	Homo sapiens		EXP039185	430	normal	Q16534	HepG2 (hepatoblastoma)	PEAKS041637
EXP039777	sc-6553	Homo sapiens		EXP039274	879	normal	P55317	liver	PEAKS041638
EXP039778	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	O14628	HEK293 (embryonic kidney)	PEAKS041639
EXP039779	sc-8051x	Homo sapiens		EXP039112	38	normal	P17275	A549 (lung carcinoma)	PEAKS041640
EXP039780	HPA003876	Homo sapiens		EXP039020	430	normal	Q9H334	HepG2 (hepatoblastoma)	PEAKS041641
EXP039781	07-729	Homo sapiens		EXP039089	1164	normal	P49711	uterus	PEAKS041642
EXP039782	07-729	Homo sapiens		EXP039243	1151	normal	P49711	right lobe of liver	PEAKS041643
EXP039783	sc-271940	Homo sapiens		EXP039302	879	normal	P24468	liver	PEAKS041644
EXP039784	ab290	Homo sapiens		EXP039092	421	normal	Q9H165	HEK293 (embryonic kidney)	PEAKS041645
EXP039785	sc-23871	Homo sapiens		EXP039302	879	normal	Q86T24	liver	PEAKS041646
EXP039786	ab290	Homo sapiens		EXP039092	421	normal	Q9BSG1	HEK293 (embryonic kidney)	PEAKS041647
EXP039787	F1804	Homo sapiens		EXP039140	430	normal	Q99612	HepG2 (hepatoblastoma)	PEAKS041648
EXP039788	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041649
EXP039789	GTX113850	Homo sapiens		EXP039138	430	normal	P20823	HepG2 (hepatoblastoma)	PEAKS041650
EXP039790	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039078	38	normal	P04150	A549 (lung carcinoma)	PEAKS041651
EXP039791	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039281	421	normal	Q9GZX5	HEK293 (embryonic kidney)	PEAKS041652
EXP039792	ab290	Homo sapiens		EXP039092	421	normal	Q14584	HEK293 (embryonic kidney)	PEAKS041653
EXP039793	sc-769	Homo sapiens		EXP039046	113	normal	Q99583	MCF7 (Invasive ductal breast carcinoma)	PEAKS041654
EXP039794	CST_5419S	Homo sapiens		EXP039263	7	normal	P17010	22RV1 (prostate carcinoma)	PEAKS041655
EXP039795	ab290	Homo sapiens		EXP039092	421	normal	Q9NPC7	HEK293 (embryonic kidney)	PEAKS041656
EXP039796	sc-229	Mus musculus		EXP010613	1144	normal	Q61069	CH12.LX (Mouse lymphoma)	PEAKS041657
EXP039797	sc-1003	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039208	38	normal	P04150	A549 (lung carcinoma)	PEAKS041658
EXP039798	ab60931	Homo sapiens		EXP039044	489	normal	Q15853	IMR90 (lung fibroblasts)	PEAKS041659
EXP039799	A300-396A	Homo sapiens		EXP039034	514	normal	O94776	K562 (myelogenous leukemia)	PEAKS041660
EXP039800	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	P15408	A549 (lung carcinoma)	PEAKS041661
EXP039801	GTX100308	Homo sapiens		EXP039020	430	normal	P55317	HepG2 (hepatoblastoma)	PEAKS041662
EXP039802	07-729	Homo sapiens		EXP039071	1178	normal	P49711	coronary artery	PEAKS041663
EXP039803	ab290	Homo sapiens		EXP039084	421	normal	Q8NEP9	HEK293 (embryonic kidney)	PEAKS041664
EXP039804	sc-10652	Homo sapiens		EXP039216	514	normal	P22670	K562 (myelogenous leukemia)	PEAKS041665
EXP039805	07-729	Homo sapiens		EXP039225	920	normal	P49711	pancreas	PEAKS041666
EXP039806	07-729	Homo sapiens		EXP039055	1158	normal	P49711	vagina	PEAKS041667
EXP039807	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	P20749	A549 (lung carcinoma)	PEAKS041668
EXP039808	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	P49711	A549 (lung carcinoma)	PEAKS041669
EXP039809	HPA039433	Homo sapiens		EXP039046	113	normal	Q9BTC8	MCF7 (Invasive ductal breast carcinoma)	PEAKS041670
EXP039810	ab290	Homo sapiens		EXP039031	421	normal	Q13029	HEK293 (embryonic kidney)	PEAKS041671
EXP039811	ab290	Homo sapiens		EXP039092	421	normal	Q9BXK1	HEK293 (embryonic kidney)	PEAKS041672
EXP039812	F1804	Homo sapiens		EXP039140	430	normal	P10588	HepG2 (hepatoblastoma)	PEAKS041673
EXP039813	600-401-B29	Homo sapiens		EXP039106	514	normal	Q15797	K562 (myelogenous leukemia)	PEAKS041674
EXP039814	F1804	Homo sapiens		EXP039140	430	normal	Q9UKD1	HepG2 (hepatoblastoma)	PEAKS041675
EXP039815	ab290	Homo sapiens		EXP039092	421	normal	Q9UK33	HEK293 (embryonic kidney)	PEAKS041676
EXP039816	HPA001923	Homo sapiens		EXP039020	430	normal	P35712	HepG2 (hepatoblastoma)	PEAKS041677
EXP039817	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039281	421	normal	Q15697	HEK293 (embryonic kidney)	PEAKS041678
EXP039818	A301-932A	Homo sapiens		EXP039034	514	normal	Q9NUA8	K562 (myelogenous leukemia)	PEAKS041679
EXP039819	sc-10652	Homo sapiens		EXP039034	514	normal	P22670	K562 (myelogenous leukemia)	PEAKS041680
EXP039820	F1804	Homo sapiens		EXP039140	430	normal	Q6P2D0	HepG2 (hepatoblastoma)	PEAKS041681
EXP039821	ab290	Homo sapiens		EXP039092	421	normal	Q9NR11	HEK293 (embryonic kidney)	PEAKS041682
EXP039822	goat-anti-GFP-UC	Homo sapiens		EXP039285	514	normal	P22736	K562 (myelogenous leukemia)	PEAKS041683
EXP039823	F1804	Homo sapiens		EXP039140	430	normal	Q14582	HepG2 (hepatoblastoma)	PEAKS041684
EXP039824	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q96RE9	HEK293 (embryonic kidney)	PEAKS041685
EXP039825	sc-197	Homo sapiens		EXP039095	879	normal	P61244	liver	PEAKS041686
EXP039826	F1804	Homo sapiens		EXP039140	430	normal	Q9UMN6	HepG2 (hepatoblastoma)	PEAKS041687
EXP039827	ab290	Homo sapiens		EXP039092	421	normal	Q8N3J9	HEK293 (embryonic kidney)	PEAKS041688
EXP039828	ab290	Homo sapiens		EXP039092	421	normal	P52736	HEK293 (embryonic kidney)	PEAKS041689
EXP039829	ab290	Homo sapiens		EXP039092	421	normal	Q9UJN7	HEK293 (embryonic kidney)	PEAKS041690
EXP039830	F1804	Homo sapiens		EXP039100	430	normal	P18846	HepG2 (hepatoblastoma)	PEAKS041691
EXP039831	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	P17275	A549 (lung carcinoma)	PEAKS041692
EXP039832	07-729	Homo sapiens		EXP039037	1181	normal	P49711	upper lobe of left lung	PEAKS041693
EXP039833	goat-anti-GFP-UC	Homo sapiens		EXP039201	514	normal	Q14814	K562 (myelogenous leukemia)	PEAKS041694
EXP039834	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	P17676	A549 (lung carcinoma)	PEAKS041695
EXP039835	A301-649A	Homo sapiens		EXP039114	430	normal	P15336	HepG2 (hepatoblastoma)	PEAKS041696
EXP039836	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039157	38	normal	P04150	A549 (lung carcinoma)	PEAKS041697
EXP039837	sc-313	Mus musculus		EXP010644	1174	normal	Q60929	MEL cell line	PEAKS041698
EXP039838	ab290	Homo sapiens		EXP039092	421	normal	Q13105	HEK293 (embryonic kidney)	PEAKS041699
EXP039839	NB100-279	Homo sapiens		EXP039188	356	normal	Q99856	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041700
EXP039840	3418	Homo sapiens		EXP039244	70	normal	P49711	LNCaP (prostate carcinoma)	PEAKS041701
EXP039841	A303-284A	Homo sapiens		EXP039188	356	normal	Q8IWY8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041702
EXP039842	A301-046A	Homo sapiens		EXP039034	514	normal	Q8NFD5	K562 (myelogenous leukemia)	PEAKS041703
EXP039843	WH0000861M6	Homo sapiens		EXP039049	514	normal	Q01196	K562 (myelogenous leukemia)	PEAKS041704
EXP039844	ab290	Homo sapiens		EXP039092	421	normal	Q12901	HEK293 (embryonic kidney)	PEAKS041705
EXP039845	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	P49711	A549 (lung carcinoma)	PEAKS041706
EXP039846	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	P20749	A549 (lung carcinoma)	PEAKS041707
EXP039847	sc-6554	Homo sapiens		EXP039274	879	normal	Q9Y261	liver	PEAKS041708
EXP039848	WH0004090M1	Homo sapiens		EXP039052	514	normal	Q99717	K562 (myelogenous leukemia)	PEAKS041709
EXP039849	A303-037A	Homo sapiens		EXP039077	514	normal	Q96AV8	K562 (myelogenous leukemia)	PEAKS041710
EXP039850	WH0002120M1	Homo sapiens		EXP039022	514	normal	P41212	K562 (myelogenous leukemia)	PEAKS041711
EXP039851	H00010782-A01	Homo sapiens		EXP010651	421	normal	Q96GC6	HEK293 (embryonic kidney)	PEAKS041712
EXP039852	A303-279A	Homo sapiens		EXP039188	356	normal	Q8N1G0	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041713
EXP039853	ab290	Homo sapiens		EXP039092	421	normal	Q15072	HEK293 (embryonic kidney)	PEAKS041714
EXP039854	07-729	Homo sapiens		EXP039108	1180	normal	P49711	neural cell	PEAKS041715
EXP039855	F1804	Homo sapiens		EXP039140	430	normal	Q9Y2D9	HepG2 (hepatoblastoma)	PEAKS041716
EXP039856	39789	Homo sapiens		EXP039096	514	normal	O75030	K562 (myelogenous leukemia)	PEAKS041717
EXP039857	GTX102698	Homo sapiens		EXP039096	514	normal	Q16621	K562 (myelogenous leukemia)	PEAKS041718
EXP039858	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q8NDW4	HEK293 (embryonic kidney)	PEAKS041719
EXP039859	sc-631	Mus musculus		EXP010613	1144	normal	Q60775	CH12.LX (Mouse lymphoma)	PEAKS041720
EXP039860	F1804	Homo sapiens		EXP039140	430	normal	Q9UH92	HepG2 (hepatoblastoma)	PEAKS041721
EXP039861	07-729	Homo sapiens		EXP039255	1168	normal	P49711	thyroid gland	PEAKS041722
EXP039862	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	P15408	A549 (lung carcinoma)	PEAKS041723
EXP039863	61311	Mus musculus		EXP039288	53	normal	Q61164	heart	PEAKS041724
EXP039864	07-729	Homo sapiens		EXP039271	920	normal	P49711	pancreas	PEAKS041725
EXP039865	sc-6553	Homo sapiens		EXP039193	879	normal	P55317	liver	PEAKS041726
EXP039866	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	P49711	A549 (lung carcinoma)	PEAKS041727
EXP039867	ab290	Homo sapiens		EXP039092	421	normal	Q9HC78	HEK293 (embryonic kidney)	PEAKS041728
EXP039868	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	P17275	A549 (lung carcinoma)	PEAKS041729
EXP039869	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	P05412	A549 (lung carcinoma)	PEAKS041730
EXP039870	WH0006932M1	Homo sapiens		EXP039183	356	normal	P36402	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041731
EXP039871	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	P17676	A549 (lung carcinoma)	PEAKS041732
EXP039872	A300-395A	Homo sapiens		EXP039034	514	normal	O94776	K562 (myelogenous leukemia)	PEAKS041733
EXP039873	WH0009189M1	Homo sapiens		EXP039163	356	normal	O96006	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041734
EXP039874	A303-098A	Homo sapiens		EXP039061	430	normal	O15119	HepG2 (hepatoblastoma)	PEAKS041735
EXP039875	WH0006932M1	Homo sapiens		EXP039234	430	normal	P36402	HepG2 (hepatoblastoma)	PEAKS041736
EXP039876	ab290	Homo sapiens		EXP039092	421	normal	Q02086	HEK293 (embryonic kidney)	PEAKS041737
EXP039877	ab290	Homo sapiens		EXP039092	421	normal	Q86Y25	HEK293 (embryonic kidney)	PEAKS041738
EXP039878	F1804	Homo sapiens		EXP039140	430	normal	O15535	HepG2 (hepatoblastoma)	PEAKS041739
EXP039879	ab290	Homo sapiens		EXP039092	421	normal	Q8IZM8	HEK293 (embryonic kidney)	PEAKS041740
EXP039880	07-729	Homo sapiens		EXP039284	1172	normal	P49711	adrenal gland	PEAKS041741
EXP039881	A303-386A	Homo sapiens		EXP039076	356	normal	Q13568	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041742
EXP039882	ab290	Homo sapiens		EXP039092	421	normal	P10075	HEK293 (embryonic kidney)	PEAKS041743
EXP039883	F1804	Homo sapiens		EXP039140	430	normal	Q12857	HepG2 (hepatoblastoma)	PEAKS041744
EXP039884	F1804	Homo sapiens		EXP039146	430	normal	P18848	HepG2 (hepatoblastoma)	PEAKS041745
EXP039885	goat-anti-GFP-UC	Homo sapiens		EXP039260	113	normal	O43474	MCF7 (Invasive ductal breast carcinoma)	PEAKS041746
EXP039886	goat-anti-GFP-UC	Homo sapiens		EXP039072	514	normal	Q8NDX6	K562 (myelogenous leukemia)	PEAKS041747
EXP039887	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041748
EXP039888	sc-7202	Homo sapiens		EXP039044	489	normal	P01100	IMR90 (lung fibroblasts)	PEAKS041749
EXP039889	F1804	Homo sapiens		EXP039185	430	normal	Q9UIS9	HepG2 (hepatoblastoma)	PEAKS041750
EXP039890	A303-248A	Homo sapiens		EXP039034	514	normal	A6NFI3	K562 (myelogenous leukemia)	PEAKS041751
EXP039891	F1804	Homo sapiens		EXP039140	430	normal	P55318	HepG2 (hepatoblastoma)	PEAKS041752
EXP039892	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041753
EXP039893	200-401-194	Homo sapiens		EXP039046	113	normal	P48382	MCF7 (Invasive ductal breast carcinoma)	PEAKS041754
EXP039894	ab290	Homo sapiens		EXP039092	421	normal	P15336	HEK293 (embryonic kidney)	PEAKS041755
EXP039895	goat-anti-GFP-UC	Homo sapiens		EXP039239	514	normal	Q06546	K562 (myelogenous leukemia)	PEAKS041756
EXP039896	F1804	Homo sapiens		EXP039140	430	normal	Q8N5A5	HepG2 (hepatoblastoma)	PEAKS041757
EXP039897	F1804	Homo sapiens		EXP039185	430	normal	P40425	HepG2 (hepatoblastoma)	PEAKS041758
EXP039898	07-729	Homo sapiens		EXP039212	879	normal	P49711	liver	PEAKS041759
EXP039899	F1804	Homo sapiens		EXP039185	430	normal	Q9UBC3	HepG2 (hepatoblastoma)	PEAKS041760
EXP039900	NB600-244	Homo sapiens		EXP039106	514	normal	Q9UKY1	K562 (myelogenous leukemia)	PEAKS041761
EXP039901	ab290	Homo sapiens		EXP039092	421	normal	Q8N2R0	HEK293 (embryonic kidney)	PEAKS041762
EXP039902	A301-730A	Homo sapiens		EXP039034	514	normal	Q01167	K562 (myelogenous leukemia)	PEAKS041763
EXP039903	F1804	Homo sapiens		EXP039140	430	normal	Q13952	HepG2 (hepatoblastoma)	PEAKS041764
EXP039904	sc-28312	Homo sapiens		EXP039302	879	normal	Q06546	liver	PEAKS041765
EXP039905	ab290	Homo sapiens		EXP039092	421	normal	Q9NYW8	HEK293 (embryonic kidney)	PEAKS041766
EXP039906	HPA040398	Homo sapiens		EXP039076	356	normal	Q13887	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041767
EXP039907	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	P20749	A549 (lung carcinoma)	PEAKS041768
EXP039908	F1804	Homo sapiens		EXP039140	430	normal	Q4LE39	HepG2 (hepatoblastoma)	PEAKS041769
EXP039909	A303-486A	Homo sapiens		EXP039034	514	normal	Q9UJU2	K562 (myelogenous leukemia)	PEAKS041770
EXP039910	GTX100308	Homo sapiens		EXP039232	10	normal	P55317	HEK293T (embryonic kidney)	PEAKS041771
EXP039911	HPA003384	Homo sapiens		EXP039034	514	normal	P17544	K562 (myelogenous leukemia)	PEAKS041772
EXP039912	ab290	Homo sapiens		EXP039092	421	normal	Q5TEC3	HEK293 (embryonic kidney)	PEAKS041773
EXP039913	goat-anti-GFP-UC	Homo sapiens		EXP039080	514	normal	O14867	K562 (myelogenous leukemia)	PEAKS041774
EXP039914	AF4185	Homo sapiens		EXP039108	1180	normal	P50539	neural cell	PEAKS041775
EXP039915	ab50322	Homo sapiens		EXP039118	38	normal	O60675	A549 (lung carcinoma)	PEAKS041776
EXP039916	ab290	Homo sapiens		EXP039092	421	normal	O75123	HEK293 (embryonic kidney)	PEAKS041777
EXP039917	S9809	Homo sapiens		EXP039074	113	normal	P08047	MCF7 (Invasive ductal breast carcinoma)	PEAKS041778
EXP039918	ab290	Homo sapiens		EXP039031	421	normal	Q9Y6Q3	HEK293 (embryonic kidney)	PEAKS041779
EXP039919	F1804	Homo sapiens		EXP039140	430	normal	P10589	HepG2 (hepatoblastoma)	PEAKS041780
EXP039920	ab290	Homo sapiens		EXP039092	421	normal	Q9Y2K1	HEK293 (embryonic kidney)	PEAKS041781
EXP039921	ab290	Homo sapiens		EXP039092	421	normal	P36508	HEK293 (embryonic kidney)	PEAKS041782
EXP039922	ab50322	Mus musculus		EXP010793	230	normal	Q61827	ES-E14 (E14, embryonic stem cells)	PEAKS041783
EXP039923	07-729	Homo sapiens		EXP039110	687	normal	P49711	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS041784
EXP039924	goat-anti-GFP-UC	Homo sapiens		EXP039158	514	normal	P17028	K562 (myelogenous leukemia)	PEAKS041785
EXP039925	goat-anti-GFP-UC	Homo sapiens		EXP039293	514	normal	P39880	K562 (myelogenous leukemia)	PEAKS041786
EXP039926	ab290	Homo sapiens		EXP039092	421	normal	Q5VTD9	HEK293 (embryonic kidney)	PEAKS041787
EXP039927	HPA004051	Homo sapiens		EXP039232	10	normal	Q8TF68	HEK293T (embryonic kidney)	PEAKS041788
EXP039928	sc-6554	Homo sapiens		EXP039193	879	normal	Q9Y261	liver	PEAKS041789
EXP039929	07-729	Homo sapiens		EXP039103	1175	normal	P49711	prostate gland	PEAKS041790
EXP039930	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041791
EXP039931	sc-30189	Homo sapiens		EXP039046	113	normal	Q9UKL0	MCF7 (Invasive ductal breast carcinoma)	PEAKS041792
EXP039932	F1804	Homo sapiens		EXP039140	430	normal	P41182	HepG2 (hepatoblastoma)	PEAKS041793
EXP039933	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q5JNZ3	HEK293 (embryonic kidney)	PEAKS041794
EXP039934	A302-765A	Homo sapiens		EXP039034	514	normal	P27540	K562 (myelogenous leukemia)	PEAKS041795
EXP039935	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	P17676	A549 (lung carcinoma)	PEAKS041796
EXP039936	A301-281A	Homo sapiens		EXP039188	356	normal	Q8WXI9	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041797
EXP039937	A303-262A	Homo sapiens		EXP039034	514	normal	Q8N680	K562 (myelogenous leukemia)	PEAKS041798
EXP039938	A300-810A	Homo sapiens		EXP039061	430	normal	Q969G3	HepG2 (hepatoblastoma)	PEAKS041799
EXP039939	NB100-1800	Homo sapiens		EXP039044	489	normal	O14503	IMR90 (lung fibroblasts)	PEAKS041800
EXP039940	WH0004090M1	Homo sapiens		EXP039105	356	normal	Q99717	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041801
EXP039941	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	P05412	A549 (lung carcinoma)	PEAKS041802
EXP039942	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	P17275	A549 (lung carcinoma)	PEAKS041803
EXP039943	61311	Homo sapiens	10 nM 17Î²-hydroxy-5Î±-androstan-3-one (CHEBI:16330) for 4 hour	EXP039263	7	normal	P49711	22RV1 (prostate carcinoma)	PEAKS041804
EXP039944	A301-443A	Homo sapiens		EXP039188	356	normal	P32519	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041805
EXP039945	goat-anti-GFP-UC	Homo sapiens		EXP039227	514	normal	P53567	K562 (myelogenous leukemia)	PEAKS041806
EXP039946	A303-249A	Homo sapiens		EXP039034	514	normal	A6NFI3	K562 (myelogenous leukemia)	PEAKS041807
EXP039947	A303-626A	Homo sapiens		EXP039061	430	normal	Q99583	HepG2 (hepatoblastoma)	PEAKS041808
EXP039948	A303-565A	Homo sapiens		EXP039074	113	normal	O00712	MCF7 (Invasive ductal breast carcinoma)	PEAKS041809
EXP039949	07-729	Homo sapiens		EXP039091	686	normal	P49711	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS041810
EXP039950	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	P05412	A549 (lung carcinoma)	PEAKS041811
EXP039951	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8N8L2	HEK293 (embryonic kidney)	PEAKS041812
EXP039952	07-729	Homo sapiens		EXP039099	440	normal	P49711	HMEC (human mammary epithelial cells)	PEAKS041813
EXP039953	sc-13032	Homo sapiens		EXP039081	38	normal	Q16236	A549 (lung carcinoma)	PEAKS041814
EXP039954	07-729	Homo sapiens		EXP039259	1136	normal	P49711	gastrocnemius medialis	PEAKS041815
EXP039955	A303-123A	Homo sapiens		EXP039034	514	normal	P08651	K562 (myelogenous leukemia)	PEAKS041816
EXP039956	ab290	Homo sapiens		EXP039031	421	normal	Q14526	HEK293 (embryonic kidney)	PEAKS041817
EXP039957	8186S	Homo sapiens		EXP039114	430	normal	Q9Y261	HepG2 (hepatoblastoma)	PEAKS041818
EXP039958	F1804	Homo sapiens		EXP039140	430	normal	O14901	HepG2 (hepatoblastoma)	PEAKS041819
EXP039959	sc-735	Homo sapiens		EXP039274	879	normal	P21675	liver	PEAKS041820
EXP039960	10007663	Homo sapiens		EXP039118	38	normal	Q12772	A549 (lung carcinoma)	PEAKS041821
EXP039961	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	P17676	A549 (lung carcinoma)	PEAKS041822
EXP039962	9197S	Homo sapiens		EXP039074	113	normal	P16220	MCF7 (Invasive ductal breast carcinoma)	PEAKS041823
EXP039963	A303-091A	Homo sapiens		EXP039034	514	normal	P17028	K562 (myelogenous leukemia)	PEAKS041824
EXP039964	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q68DI1	HEK293 (embryonic kidney)	PEAKS041825
EXP039965	ab290	Homo sapiens		EXP039092	421	normal	Q8NAM6	HEK293 (embryonic kidney)	PEAKS041826
EXP039966	F1804	Homo sapiens		EXP039140	430	normal	Q15776	HepG2 (hepatoblastoma)	PEAKS041827
EXP039967	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	P05412	A549 (lung carcinoma)	PEAKS041828
EXP039968	07-729	Homo sapiens		EXP039173	1140	normal	P49711	subcutaneous adipose tissue	PEAKS041829
EXP039969	R1283.1.2C6	Homo sapiens		EXP039034	514	normal	Q99459	K562 (myelogenous leukemia)	PEAKS041830
EXP039970	A300-113A	Homo sapiens		EXP010582	514	normal	Q9UMN6	K562 (myelogenous leukemia)	PEAKS041831
EXP039971	07-729	Homo sapiens		EXP039115	1169	normal	P49711	sigmoid colon	PEAKS041832
EXP039972	sc-1237	Mus musculus		EXP039253	5	normal	Q08369	liver	PEAKS041833
EXP039973	ab290	Homo sapiens		EXP039092	421	normal	Q8N8C0	HEK293 (embryonic kidney)	PEAKS041834
EXP039974	F1804	Homo sapiens		EXP039140	430	normal	Q96MX3	HepG2 (hepatoblastoma)	PEAKS041835
EXP039975	ab290	Homo sapiens		EXP039092	421	normal	Q96K75	HEK293 (embryonic kidney)	PEAKS041836
EXP039976	A303-091A	Homo sapiens		EXP039061	430	normal	P17028	HepG2 (hepatoblastoma)	PEAKS041837
EXP039977	A302-182A	Homo sapiens		EXP039076	356	normal	Q01201	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041838
EXP039978	A300-755A	Homo sapiens		EXP039034	514	normal	Q99081	K562 (myelogenous leukemia)	PEAKS041839
EXP039979	A303-197A	Homo sapiens		EXP039188	356	normal	Q6ZNB6	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041840
EXP039980	07-729	Homo sapiens		EXP039073	633	normal	P49711	spleen	PEAKS041841
EXP039981	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	P05412	A549 (lung carcinoma)	PEAKS041842
EXP039982	A303-487A	Homo sapiens		EXP039077	514	normal	Q9UJU2	K562 (myelogenous leukemia)	PEAKS041843
EXP039983	07-729	Homo sapiens		EXP039116	1156	normal	P49711	gastroesophageal sphincter	PEAKS041844
EXP039984	sc-13032	Homo sapiens		EXP039167	423	normal	Q16236	HeLa S3 (cervical adenocarcinoma)	PEAKS041845
EXP039985	F1804	Homo sapiens		EXP039140	430	normal	Q13485	HepG2 (hepatoblastoma)	PEAKS041846
EXP039986	A303-618A	Homo sapiens		EXP039188	356	normal	Q9UKS7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041847
EXP039987	sc-8987	Homo sapiens		EXP039275	879	normal	P41235	liver	PEAKS041848
EXP039988	ab290	Homo sapiens		EXP039092	421	normal	Q9NPA5	HEK293 (embryonic kidney)	PEAKS041849
EXP039989	ab290	Homo sapiens		EXP039092	421	normal	O95625	HEK293 (embryonic kidney)	PEAKS041850
EXP039990	HPA003384	Homo sapiens		EXP039046	113	normal	P17544	MCF7 (Invasive ductal breast carcinoma)	PEAKS041851
EXP039991	goat-anti-GFP-UC	Homo sapiens		EXP039306	514	normal	Q02535	K562 (myelogenous leukemia)	PEAKS041852
EXP039992	61311	Mus musculus		EXP039282	5	normal	Q61164	liver	PEAKS041853
EXP039993	61311	Mus musculus		EXP039270	561	normal	Q61164	lung	PEAKS041854
EXP039994	07-729	Homo sapiens		EXP039021	1179	normal	P49711	tibial nerve	PEAKS041855
EXP039995	A301-649A	Homo sapiens		EXP039034	514	normal	P15336	K562 (myelogenous leukemia)	PEAKS041856
EXP039996	A303-566A	Homo sapiens		EXP039074	113	normal	O00712	MCF7 (Invasive ductal breast carcinoma)	PEAKS041857
EXP039997	ab290	Homo sapiens		EXP039092	421	normal	O75840	HEK293 (embryonic kidney)	PEAKS041858
EXP039998	NB100-1800	Homo sapiens		EXP039161	10	normal	O14503	HEK293T (embryonic kidney)	PEAKS041859
EXP039999	A301-729A	Homo sapiens		EXP039188	356	normal	Q01167	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041860
EXP040000	07-729	Homo sapiens		EXP039266	1158	normal	P49711	vagina	PEAKS041861
EXP040001	A303-230A	Homo sapiens		EXP039240	113	normal	P67809	MCF7 (Invasive ductal breast carcinoma)	PEAKS041862
EXP040002	ab290	Homo sapiens		EXP039092	421	normal	Q9H4Z2	HEK293 (embryonic kidney)	PEAKS041863
EXP040003	sc-271940	Homo sapiens		EXP039275	879	normal	P24468	liver	PEAKS041864
EXP040004	goat-anti-GFP-UC	Homo sapiens		EXP039032	514	normal	O14709	K562 (myelogenous leukemia)	PEAKS041865
EXP040005	A304-063A	Homo sapiens		EXP039034	514	normal	O15062	K562 (myelogenous leukemia)	PEAKS041866
EXP040006	A303-235A	Homo sapiens		EXP039074	113	normal	Q96KM6	MCF7 (Invasive ductal breast carcinoma)	PEAKS041867
EXP040007	sc-357	Mus musculus		EXP010644	1174	normal	Q61286	MEL cell line	PEAKS041868
EXP040008	HPA005799	Homo sapiens		EXP039020	430	normal	O15119	HepG2 (hepatoblastoma)	PEAKS041869
EXP040009	ab290	Homo sapiens		EXP039092	421	normal	O75467	HEK293 (embryonic kidney)	PEAKS041870
EXP040010	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	P20749	A549 (lung carcinoma)	PEAKS041871
EXP040011	GTX114991	Homo sapiens		EXP039074	113	normal	P55347	MCF7 (Invasive ductal breast carcinoma)	PEAKS041872
EXP040012	07-729	Homo sapiens		EXP039191	920	normal	P49711	pancreas	PEAKS041873
EXP040013	ab290	Homo sapiens		EXP039092	421	normal	Q96GC6	HEK293 (embryonic kidney)	PEAKS041874
EXP040014	goat-anti-GFP-UC	Homo sapiens		EXP039182	514	normal	Q14186	K562 (myelogenous leukemia)	PEAKS041875
EXP040015	ab290	Homo sapiens		EXP039092	421	normal	P17022	HEK293 (embryonic kidney)	PEAKS041876
EXP040016	F1804	Homo sapiens		EXP039140	430	normal	Q9H7Z6	HepG2 (hepatoblastoma)	PEAKS041877
EXP040017	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	P05412	A549 (lung carcinoma)	PEAKS041878
EXP040018	goat-anti-GFP-UC	Homo sapiens		EXP039268	514	normal	Q16621	K562 (myelogenous leukemia)	PEAKS041879
EXP040019	ab290	Homo sapiens		EXP039092	421	normal	Q14929	HEK293 (embryonic kidney)	PEAKS041880
EXP040020	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	P20749	A549 (lung carcinoma)	PEAKS041881
EXP040021	GTX100255	Homo sapiens		EXP039086	514	normal	P10588	K562 (myelogenous leukemia)	PEAKS041882
EXP040022	HPA003384	Homo sapiens		EXP039020	430	normal	P17544	HepG2 (hepatoblastoma)	PEAKS041883
EXP040023	WH0001390M2	Homo sapiens		EXP039123	430	normal	Q03060	HepG2 (hepatoblastoma)	PEAKS041884
EXP040024	GTX114835	Homo sapiens		EXP039188	356	normal	P10589	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041885
EXP040025	ab290	Homo sapiens		EXP039092	421	normal	P17027	HEK293 (embryonic kidney)	PEAKS041886
EXP040026	07-729	Homo sapiens		EXP039133	1129	normal	P49711	suprapubic skin	PEAKS041887
EXP040027	07-729	Homo sapiens		EXP039025	1179	normal	P49711	tibial nerve	PEAKS041888
EXP040028	07-729	Homo sapiens		EXP039168	1135	normal	P49711	right atrium auricular region	PEAKS041889
EXP040029	ab290	Homo sapiens		EXP039092	421	normal	Q8N8Y5	HEK293 (embryonic kidney)	PEAKS041890
EXP040030	sc-150	Homo sapiens		EXP039220	356	normal	P17676	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041891
EXP040031	07-729	Homo sapiens		EXP039197	1142	normal	P49711	Peyer's patch	PEAKS041892
EXP040032	goat-anti-GFP-UC	Homo sapiens		EXP039144	514	normal	P32519	K562 (myelogenous leukemia)	PEAKS041893
EXP040033	ab290	Homo sapiens		EXP039092	421	normal	Q8NEM1	HEK293 (embryonic kidney)	PEAKS041894
EXP040034	goat-anti-GFP-UC	Homo sapiens		EXP039063	514	normal	Q9Y3Q8	K562 (myelogenous leukemia)	PEAKS041895
EXP040035	ab290	Homo sapiens		EXP039092	421	normal	Q96C28	HEK293 (embryonic kidney)	PEAKS041896
EXP040036	sc-8051x	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	P17275	A549 (lung carcinoma)	PEAKS041897
EXP040037	R157.1.3H3	Homo sapiens		EXP039049	514	normal	Q16656	K562 (myelogenous leukemia)	PEAKS041898
EXP040038	sc-769	Homo sapiens		EXP039114	430	normal	Q99583	HepG2 (hepatoblastoma)	PEAKS041899
EXP040039	GTX129438	Homo sapiens		EXP039034	514	normal	Q13422	K562 (myelogenous leukemia)	PEAKS041900
EXP040040	sc-10813	Homo sapiens		EXP039034	514	normal	Q13330	K562 (myelogenous leukemia)	PEAKS041901
EXP040041	GTX112232	Homo sapiens		EXP039234	430	normal	Q9Y6X8	HepG2 (hepatoblastoma)	PEAKS041902
EXP040042	A303-516A	Homo sapiens		EXP039034	514	normal	Q13422	K562 (myelogenous leukemia)	PEAKS041903
EXP040043	F1804	Homo sapiens		EXP039140	430	normal	P19532	HepG2 (hepatoblastoma)	PEAKS041904
EXP040044	F1804	Homo sapiens		EXP039224	430	normal	Q06546	HepG2 (hepatoblastoma)	PEAKS041905
EXP040045	ab290	Homo sapiens		EXP039092	421	normal	Q9BZE0	HEK293 (embryonic kidney)	PEAKS041906
EXP040046	goat-anti-GFP-UC	Homo sapiens		EXP039156	514	normal	Q15562	K562 (myelogenous leukemia)	PEAKS041907
EXP040047	goat-anti-GFP-UC	Homo sapiens		EXP039258	514	normal	O15525	K562 (myelogenous leukemia)	PEAKS041908
EXP040048	F1804	Homo sapiens		EXP039140	430	normal	Q99594	HepG2 (hepatoblastoma)	PEAKS041909
EXP040049	goat-anti-GFP-UC	Homo sapiens		EXP039152	514	normal	Q9UID6	K562 (myelogenous leukemia)	PEAKS041910
EXP040050	07-729	Homo sapiens		EXP039203	1168	normal	P49711	thyroid gland	PEAKS041911
EXP040051	sc-365644	Homo sapiens		EXP039034	514	normal	Q01196	K562 (myelogenous leukemia)	PEAKS041912
EXP040052	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	P20749	A549 (lung carcinoma)	PEAKS041913
EXP040053	16618-1-AP	Homo sapiens		EXP039036	430	normal	P52747	HepG2 (hepatoblastoma)	PEAKS041914
EXP040054	07-729	Homo sapiens		EXP039276	1167	normal	P49711	esophagus muscularis mucosa	PEAKS041915
EXP040055	ab290	Homo sapiens		EXP039031	421	normal	Q9NQ03	HEK293 (embryonic kidney)	PEAKS041916
EXP040056	H00010782-A01	Homo sapiens		EXP010476	417	normal	Q96GC6	HCT-116 (colon carcinoma)	PEAKS041917
EXP040057	HPA004051	Homo sapiens		EXP039036	430	normal	Q8TF68	HepG2 (hepatoblastoma)	PEAKS041918
EXP040058	07-729	Homo sapiens		EXP039287	1164	normal	P49711	uterus	PEAKS041919
EXP040059	sc-631	Mus musculus		EXP010644	1174	normal	Q60775	MEL cell line	PEAKS041920
EXP040060	F1804	Homo sapiens		EXP039185	430	normal	O60381	HepG2 (hepatoblastoma)	PEAKS041921
EXP040061	ab290	Homo sapiens		EXP039092	421	normal	P49711	HEK293 (embryonic kidney)	PEAKS041922
EXP040062	A300-347A	Homo sapiens		EXP039074	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	PEAKS041923
EXP040063	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	P49711	A549 (lung carcinoma)	PEAKS041924
EXP040064	A303-738A	Homo sapiens		EXP039034	514	normal	Q99676	K562 (myelogenous leukemia)	PEAKS041925
EXP040065	A301-281A	Homo sapiens		EXP039216	514	normal	Q8WXI9	K562 (myelogenous leukemia)	PEAKS041926
EXP040066	goat-anti-GFP-UC	Homo sapiens		EXP039124	514	normal	Q9BQA5	K562 (myelogenous leukemia)	PEAKS041927
EXP040067	A302-659A	Homo sapiens		EXP039034	514	normal	Q99607	K562 (myelogenous leukemia)	PEAKS041928
EXP040068	07-729	Homo sapiens		EXP039178	1150	normal	P49711	ovary	PEAKS041929
EXP040069	A303-092A	Homo sapiens		EXP039034	514	normal	P17028	K562 (myelogenous leukemia)	PEAKS041930
EXP040070	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041931
EXP040071	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	P49711	A549 (lung carcinoma)	PEAKS041932
EXP040072	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	P49711	A549 (lung carcinoma)	PEAKS041933
EXP040073	39879	Homo sapiens		EXP039242	356	normal	O96028	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041934
EXP040074	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q8N143	HEK293 (embryonic kidney)	PEAKS041935
EXP040075	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	P52740	HEK293 (embryonic kidney)	PEAKS041936
EXP040076	ab290	Homo sapiens		EXP039031	421	normal	Q8N895	HEK293 (embryonic kidney)	PEAKS041937
EXP040077	07-729	Homo sapiens		EXP039050	1132	normal	P49711	heart left ventricle	PEAKS041938
EXP040078	sc-74	Homo sapiens		EXP039302	879	normal	P17535	liver	PEAKS041939
EXP040079	A302-865A	Homo sapiens		EXP039216	514	normal	Q8IWI9	K562 (myelogenous leukemia)	PEAKS041940
EXP040080	goat-anti-GFP-UC	Homo sapiens		EXP039278	113	normal	Q16254	MCF7 (Invasive ductal breast carcinoma)	PEAKS041941
EXP040081	F1804	Homo sapiens		EXP039140	430	normal	Q9BW11	HepG2 (hepatoblastoma)	PEAKS041942
EXP040082	61311	Homo sapiens		EXP039131	1184	normal	P49711	GM23338	PEAKS041943
EXP040083	A303-197A	Homo sapiens		EXP039240	113	normal	Q6ZNB6	MCF7 (Invasive ductal breast carcinoma)	PEAKS041944
EXP040084	WH0009189M1	Homo sapiens		EXP039096	514	normal	O96006	K562 (myelogenous leukemia)	PEAKS041945
EXP040085	A303-230A	Homo sapiens		EXP039076	356	normal	P67809	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041946
EXP040086	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	P20749	A549 (lung carcinoma)	PEAKS041947
EXP040087	07-729	Homo sapiens		EXP039262	1181	normal	P49711	upper lobe of left lung	PEAKS041948
EXP040088	A301-531A	Homo sapiens		EXP039188	356	normal	Q92610	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041949
EXP040089	07-729	Homo sapiens		EXP039245	1154	normal	P49711	omental fat pad	PEAKS041950
EXP040090	07-729	Homo sapiens		EXP039023	1154	normal	P49711	omental fat pad	PEAKS041951
EXP040091	goat-anti-GFP-UC	Homo sapiens		EXP039265	514	normal	P18846	K562 (myelogenous leukemia)	PEAKS041952
EXP040092	17-641	Homo sapiens		EXP039132	38	normal	Q13127	A549 (lung carcinoma)	PEAKS041953
EXP040093	ab290	Homo sapiens		EXP039031	421	normal	Q53GI3	HEK293 (embryonic kidney)	PEAKS041954
EXP040094	F1804	Homo sapiens		EXP039198	514	normal	P18846	K562 (myelogenous leukemia)	PEAKS041955
EXP040095	N8664	Homo sapiens		EXP039046	113	normal	Q15233	MCF7 (Invasive ductal breast carcinoma)	PEAKS041956
EXP040096	GTX129438	Homo sapiens		EXP039020	430	normal	Q13422	HepG2 (hepatoblastoma)	PEAKS041957
EXP040097	A301-443A	Homo sapiens		EXP039034	514	normal	P32519	K562 (myelogenous leukemia)	PEAKS041958
EXP040098	HPA001759	Homo sapiens		EXP039034	514	normal	P27540	K562 (myelogenous leukemia)	PEAKS041959
EXP040099	ab290	Homo sapiens		EXP039092	421	normal	Q3MJ62	HEK293 (embryonic kidney)	PEAKS041960
EXP040100	F1804	Homo sapiens		EXP039140	430	normal	Q9UN79	HepG2 (hepatoblastoma)	PEAKS041961
EXP040101	3418	Homo sapiens		EXP039170	781	normal	P49711	RWPE1 (prostate epithelial cells)	PEAKS041962
EXP040102	goat-anti-GFP-UC	Homo sapiens		EXP039066	514	normal	Q8TCN5	K562 (myelogenous leukemia)	PEAKS041963
EXP040103	sc-66882	Homo sapiens		EXP039034	514	normal	P11474	K562 (myelogenous leukemia)	PEAKS041964
EXP040104	sc-9082	Homo sapiens		EXP039199	665	normal	Q14653	SK-N-SH (neuroblastoma)	PEAKS041965
EXP040105	ab290	Homo sapiens		EXP039092	421	normal	O95600	HEK293 (embryonic kidney)	PEAKS041966
EXP040106	sc-281	Homo sapiens		EXP039095	879	normal	P25490	liver	PEAKS041967
EXP040107	07-729	Homo sapiens		EXP039174	920	normal	P49711	pancreas	PEAKS041968
EXP040108	GTX114991	Homo sapiens		EXP039034	514	normal	P55347	K562 (myelogenous leukemia)	PEAKS041969
EXP040109	ab290	Homo sapiens		EXP039092	421	normal	Q6ZN18	HEK293 (embryonic kidney)	PEAKS041970
EXP040110	goat-anti-GFP-UC	Homo sapiens		EXP039171	514	normal	P53567	K562 (myelogenous leukemia)	PEAKS041971
EXP040111	ab290	Homo sapiens		EXP039092	421	normal	Q9HBE1	HEK293 (embryonic kidney)	PEAKS041972
EXP040112	F1804	Homo sapiens		EXP039140	430	normal	Q6BEB4	HepG2 (hepatoblastoma)	PEAKS041973
EXP040113	ab70892	Homo sapiens		EXP039132	38	normal	P29375	A549 (lung carcinoma)	PEAKS041974
EXP040114	F1804	Homo sapiens		EXP039140	430	normal	Q3KQV3	HepG2 (hepatoblastoma)	PEAKS041975
EXP040115	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041976
EXP040116	goat-anti-GFP-UC	Homo sapiens		EXP039060	514	normal	Q00978	K562 (myelogenous leukemia)	PEAKS041977
EXP040117	goat-anti-GFP-UC	Homo sapiens		EXP039238	514	normal	P17010	K562 (myelogenous leukemia)	PEAKS041978
EXP040118	07-729	Homo sapiens		EXP039254	1157	normal	P49711	stomach	PEAKS041979
EXP040119	F1804	Homo sapiens		EXP039140	430	normal	P17036	HepG2 (hepatoblastoma)	PEAKS041980
EXP040120	GTX102170	Homo sapiens		EXP039161	10	normal	Q08050	HEK293T (embryonic kidney)	PEAKS041981
EXP040121	F1804	Homo sapiens		EXP039140	430	normal	Q9P0W2	HepG2 (hepatoblastoma)	PEAKS041982
EXP040122	sc-28312	Homo sapiens		EXP039275	879	normal	Q06546	liver	PEAKS041983
EXP040123	ab290	Homo sapiens		EXP039092	421	normal	Q6N043	HEK293 (embryonic kidney)	PEAKS041984
EXP040124	ab290	Homo sapiens		EXP039092	421	normal	Q9ULJ3	HEK293 (embryonic kidney)	PEAKS041985
EXP040125	goat-anti-GFP-UC	Homo sapiens		EXP039267	514	normal	Q9Y2Y9	K562 (myelogenous leukemia)	PEAKS041986
EXP040126	F1804	Homo sapiens		EXP039140	430	normal	Q9NPA5	HepG2 (hepatoblastoma)	PEAKS041987
EXP040127	A303-265A	Homo sapiens		EXP039188	356	normal	O75362	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041988
EXP040128	07-729	Homo sapiens		EXP039042	1172	normal	P49711	adrenal gland	PEAKS041989
EXP040129	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	Q9Y543	A549 (lung carcinoma)	PEAKS041990
EXP040130	goat-anti-GFP-UC	Homo sapiens		EXP039305	113	normal	P15408	MCF7 (Invasive ductal breast carcinoma)	PEAKS041991
EXP040131	A303-070A	Homo sapiens		EXP039034	514	normal	P16989	K562 (myelogenous leukemia)	PEAKS041992
EXP040132	A300-396A	Homo sapiens		EXP039188	356	normal	O94776	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS041993
EXP040133	ab290	Homo sapiens		EXP039092	421	normal	P17031	HEK293 (embryonic kidney)	PEAKS041994
EXP040134	07-729	Homo sapiens		EXP039180	1136	normal	P49711	gastrocnemius medialis	PEAKS041995
EXP040135	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	P17275	A549 (lung carcinoma)	PEAKS041996
EXP040136	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	P17275	A549 (lung carcinoma)	PEAKS041997
EXP040137	sc-7202	Homo sapiens		EXP039046	113	normal	P01100	MCF7 (Invasive ductal breast carcinoma)	PEAKS041998
EXP040138	TA805187	Homo sapiens		EXP039216	514	normal	P10827	K562 (myelogenous leukemia)	PEAKS041999
EXP040139	GTX114393	Homo sapiens		EXP039138	430	normal	P43268	HepG2 (hepatoblastoma)	PEAKS042000
EXP040140	A301-282A	Homo sapiens		EXP039074	113	normal	Q8WXI9	MCF7 (Invasive ductal breast carcinoma)	PEAKS042001
EXP040141	GTX100308	Homo sapiens		EXP039046	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS042002
EXP040142	goat-anti-GFP-UC	Homo sapiens		EXP039135	514	normal	Q5HY98	K562 (myelogenous leukemia)	PEAKS042003
EXP040143	ab290	Homo sapiens		EXP039092	421	normal	Q6AHZ1	HEK293 (embryonic kidney)	PEAKS042004
EXP040144	A304-181A	Homo sapiens		EXP039034	514	normal	Q9C0G0	K562 (myelogenous leukemia)	PEAKS042005
EXP040145	3418	Homo sapiens		EXP039068	129	normal	P49711	LNCaP C4-2B (prostate carcinoma)	PEAKS042006
EXP040146	WH0007023M3	Homo sapiens		EXP039231	430	normal	Q01664	HepG2 (hepatoblastoma)	PEAKS042007
EXP040147	RCAB0002P-F	Mus musculus		EXP039261	233	normal	Q80Z64	E14TG2A (embryonic stem cells)	PEAKS042008
EXP040148	HPA019589	Homo sapiens		EXP039034	514	normal	Q8N108	K562 (myelogenous leukemia)	PEAKS042009
EXP040149	F1804	Homo sapiens		EXP039140	430	normal	Q9BXK1	HepG2 (hepatoblastoma)	PEAKS042010
EXP040150	A300-755A	Homo sapiens		EXP039061	430	normal	Q99081	HepG2 (hepatoblastoma)	PEAKS042011
EXP040151	ab290	Homo sapiens		EXP039092	421	normal	Q8N7K0	HEK293 (embryonic kidney)	PEAKS042012
EXP040152	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q6ZSS3	HEK293 (embryonic kidney)	PEAKS042013
EXP040153	F1804	Homo sapiens		EXP039140	430	normal	Q8NB15	HepG2 (hepatoblastoma)	PEAKS042014
EXP040154	A301-443A	Homo sapiens		EXP039240	113	normal	P32519	MCF7 (Invasive ductal breast carcinoma)	PEAKS042015
EXP040155	sc-13042	Homo sapiens		EXP039106	514	normal	P14316	K562 (myelogenous leukemia)	PEAKS042016
EXP040156	F1804	Homo sapiens		EXP039249	430	normal	P16220	HepG2 (hepatoblastoma)	PEAKS042017
EXP040157	07-729	Homo sapiens		EXP039211	1148	normal	P49711	esophagus squamous epithelium	PEAKS042018
EXP040158	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	P17676	A549 (lung carcinoma)	PEAKS042019
EXP040159	sc-160	Homo sapiens		EXP039181	38	normal	P15408	A549 (lung carcinoma)	PEAKS042020
EXP040160	F1804	Homo sapiens		EXP039140	430	normal	P78545	HepG2 (hepatoblastoma)	PEAKS042021
EXP040161	A302-229A	Homo sapiens		EXP039034	514	normal	Q68CP9	K562 (myelogenous leukemia)	PEAKS042022
EXP040162	ab60931	Homo sapiens		EXP039118	38	normal	Q15853	A549 (lung carcinoma)	PEAKS042023
EXP040163	ab290	Homo sapiens		EXP039092	421	normal	O60315	HEK293 (embryonic kidney)	PEAKS042024
EXP040164	39894	Homo sapiens		EXP039159	430	normal	P43694	HepG2 (hepatoblastoma)	PEAKS042025
EXP040165	SAB2102741	Homo sapiens		EXP039029	514	normal	O95625	K562 (myelogenous leukemia)	PEAKS042026
EXP040166	F1804	Homo sapiens		EXP039140	430	normal	Q9NPF5	HepG2 (hepatoblastoma)	PEAKS042027
EXP040167	F1804	Homo sapiens		EXP039140	430	normal	Q16649	HepG2 (hepatoblastoma)	PEAKS042028
EXP040168	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039205	38	normal	P04150	A549 (lung carcinoma)	PEAKS042029
EXP040169	07-729	Homo sapiens		EXP039202	1156	normal	P49711	gastroesophageal sphincter	PEAKS042030
EXP040170	GTX115430	Homo sapiens		EXP039086	514	normal	O75398	K562 (myelogenous leukemia)	PEAKS042031
EXP040171	39550	Homo sapiens		EXP039134	1184	normal	P17275	GM23338	PEAKS042032
EXP040172	ab290	Homo sapiens		EXP039092	421	normal	P37275	HEK293 (embryonic kidney)	PEAKS042033
EXP040173	ab290	Homo sapiens		EXP039092	421	normal	P51786	HEK293 (embryonic kidney)	PEAKS042034
EXP040174	F1804	Homo sapiens		EXP039140	430	normal	O14593	HepG2 (hepatoblastoma)	PEAKS042035
EXP040175	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q8NC26	HEK293 (embryonic kidney)	PEAKS042036
EXP040176	NB100-279	Homo sapiens		EXP039074	113	normal	Q99856	MCF7 (Invasive ductal breast carcinoma)	PEAKS042037
EXP040177	sc-150	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	P17676	A549 (lung carcinoma)	PEAKS042038
EXP040178	sc-185	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	P20749	A549 (lung carcinoma)	PEAKS042039
EXP040179	ab290	Homo sapiens		EXP039092	421	normal	Q9UK11	HEK293 (embryonic kidney)	PEAKS042040
EXP040180	10007663	Homo sapiens		EXP039030	423	normal	Q12772	HeLa S3 (cervical adenocarcinoma)	PEAKS042041
EXP040181	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	P15408	A549 (lung carcinoma)	PEAKS042042
EXP040182	ab290	Homo sapiens		EXP039092	421	normal	Q3KQV3	HEK293 (embryonic kidney)	PEAKS042043
EXP040183	F1804	Homo sapiens		EXP039140	430	normal	P49715	HepG2 (hepatoblastoma)	PEAKS042044
EXP040184	ab290	Homo sapiens		EXP039092	421	normal	O60281	HEK293 (embryonic kidney)	PEAKS042045
EXP040185	WH0001390M2	Homo sapiens		EXP039049	514	normal	Q03060	K562 (myelogenous leukemia)	PEAKS042046
EXP040186	A301-145A	Homo sapiens		EXP010781	430	normal	O75376	HepG2 (hepatoblastoma)	PEAKS042047
EXP040187	GTX112232	Homo sapiens		EXP039151	113	normal	Q9Y6X8	MCF7 (Invasive ductal breast carcinoma)	PEAKS042048
EXP040188	S9809	Homo sapiens		EXP039232	10	normal	P08047	HEK293T (embryonic kidney)	PEAKS042049
EXP040189	sc-30189	Homo sapiens		EXP039199	665	normal	Q9UKL0	SK-N-SH (neuroblastoma)	PEAKS042050
EXP040190	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	P17676	A549 (lung carcinoma)	PEAKS042051
EXP040191	sc-166835	Homo sapiens		EXP039106	514	normal	P41212	K562 (myelogenous leukemia)	PEAKS042052
EXP040192	07-729	Homo sapiens		EXP039230	1163	normal	P49711	transverse colon	PEAKS042053
EXP040193	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	P49711	A549 (lung carcinoma)	PEAKS042054
EXP040221	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 20 minute	EXP040219	38	normal	P04150	A549 (lung carcinoma)	PEAKS042055
EXP040222	A300-346A	Homo sapiens		EXP039216	514	normal	Q15596	K562 (myelogenous leukemia)	PEAKS042056
EXP040223	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 minute	EXP040216	38	normal	P04150	A549 (lung carcinoma)	PEAKS042057
EXP040224	goat-anti-GFP-UC	Homo sapiens		EXP040208	514	normal	Q14119	K562 (myelogenous leukemia)	PEAKS042058
EXP040225	A300-832A	Homo sapiens		EXP039034	514	normal	Q66K89	K562 (myelogenous leukemia)	PEAKS042059
EXP040226	A300-832A	Homo sapiens		EXP039074	113	normal	Q66K89	MCF7 (Invasive ductal breast carcinoma)	PEAKS042060
EXP040227	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P28698	HEK293 (embryonic kidney)	PEAKS042061
EXP040228	07-729	Homo sapiens		EXP040197	417	normal	P49711	HCT-116 (colon carcinoma)	PEAKS042062
EXP040229	A303-284A	Homo sapiens		EXP039034	514	normal	Q8IWY8	K562 (myelogenous leukemia)	PEAKS042063
EXP040230	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9Y2Y9	HEK293 (embryonic kidney)	PEAKS042064
EXP040231	sc-553	Homo sapiens		EXP039302	879	normal	P19793	liver	PEAKS042065
EXP040232	A301-817A	Homo sapiens		EXP039240	113	normal	Q6ZN55	MCF7 (Invasive ductal breast carcinoma)	PEAKS042066
EXP040233	A302-618A	Homo sapiens		EXP039240	113	normal	O15516	MCF7 (Invasive ductal breast carcinoma)	PEAKS042067
EXP040234	07-729	Homo sapiens		EXP040200	1187	normal	P49711	Parathyroid adenoma	PEAKS042068
EXP040235	A303-571A	Homo sapiens		EXP039188	356	normal	Q12968	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042069
EXP040236	A302-766A	Homo sapiens		EXP039216	514	normal	Q9Y692	K562 (myelogenous leukemia)	PEAKS042070
EXP040237	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9UL59	HEK293 (embryonic kidney)	PEAKS042071
EXP040238	goat-anti-GFP-UC	Homo sapiens		EXP040198	514	normal	Q9UQR1	K562 (myelogenous leukemia)	PEAKS042072
EXP040239	A303-207A	Homo sapiens		EXP039077	514	normal	Q13129	K562 (myelogenous leukemia)	PEAKS042073
EXP040240	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039031	421	normal	O75820	HEK293 (embryonic kidney)	PEAKS042074
EXP040241	07-729	Homo sapiens		EXP040205	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS042075
EXP040242	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	O14771	HEK293 (embryonic kidney)	PEAKS042076
EXP040243	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 25 minute	EXP040199	38	normal	P05412	A549 (lung carcinoma)	PEAKS042077
EXP040244	07-729	Homo sapiens	1mM calcium (CHEBI:86158) for 5 day	EXP040206	1185	normal	P49711	foreskin keratinocyte	PEAKS042078
EXP040245	11815S	Homo sapiens		EXP039034	514	normal	P18848	K562 (myelogenous leukemia)	PEAKS042079
EXP040246	07-729	Homo sapiens		EXP040203	665	normal	P49711	SK-N-SH (neuroblastoma)	PEAKS042080
EXP040247	R303.2.1B10	Homo sapiens		EXP039074	113	normal	P11474	MCF7 (Invasive ductal breast carcinoma)	PEAKS042081
EXP040248	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 minute	EXP040216	38	normal	P05412	A549 (lung carcinoma)	PEAKS042082
EXP040249	F1804	Homo sapiens		EXP039140	430	normal	Q49AG3	HepG2 (hepatoblastoma)	PEAKS042083
EXP040250	sc-33759	Homo sapiens		EXP039131	1184	normal	Q9H9S0	GM23338	PEAKS042084
EXP040251	A303-039A	Homo sapiens		EXP039034	514	normal	A0AVK6	K562 (myelogenous leukemia)	PEAKS042085
EXP040252	A303-172A	Homo sapiens		EXP039188	356	normal	P11831	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042086
EXP040253	07-729	Homo sapiens		EXP040211	415	normal	P49711	HCM (cardiac myocytes)	PEAKS042087
EXP040254	07-729	Homo sapiens		EXP040220	1183	normal	P49711	KMS-11 (Plasma cell myeloma)	PEAKS042088
EXP040255	A302-764A	Homo sapiens		EXP039034	514	normal	P27540	K562 (myelogenous leukemia)	PEAKS042089
EXP040256	07-729	Homo sapiens	1mM calcium (CHEBI:86158) for 2 day	EXP040202	1185	normal	P49711	foreskin keratinocyte	PEAKS042090
EXP040257	07-729	Homo sapiens		EXP040204	288	normal	P49711	A673 (Ewing sarcoma)	PEAKS042091
EXP040258	A303-274A	Homo sapiens		EXP039240	113	normal	Q8TCN5	MCF7 (Invasive ductal breast carcinoma)	PEAKS042092
EXP040259	07-729	Homo sapiens		EXP040196	1184	normal	P49711	GM23338	PEAKS042093
EXP040260	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q68DY1	HEK293 (embryonic kidney)	PEAKS042094
EXP040261	TA805006	Homo sapiens		EXP039216	514	normal	P51843	K562 (myelogenous leukemia)	PEAKS042095
EXP040262	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9Y2H8	HEK293 (embryonic kidney)	PEAKS042096
EXP040263	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 15 minute	EXP040194	38	normal	P05412	A549 (lung carcinoma)	PEAKS042097
EXP040264	4373S	Homo sapiens		EXP039046	113	normal	Q13562	MCF7 (Invasive ductal breast carcinoma)	PEAKS042098
EXP040265	558036	Homo sapiens		EXP040210	38	normal	P05412	A549 (lung carcinoma)	PEAKS042099
EXP040266	A303-265A	Homo sapiens		EXP039074	113	normal	O75362	MCF7 (Invasive ductal breast carcinoma)	PEAKS042100
EXP040267	GTX101120	Homo sapiens		EXP039034	514	normal	P04150	K562 (myelogenous leukemia)	PEAKS042101
EXP040268	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9Y330	HEK293 (embryonic kidney)	PEAKS042102
EXP040269	A303-204A	Homo sapiens		EXP039077	514	normal	Q9NQV6	K562 (myelogenous leukemia)	PEAKS042103
EXP040270	A301-039A	Homo sapiens		EXP039034	514	normal	Q8TAQ2	K562 (myelogenous leukemia)	PEAKS042104
EXP040271	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 25 minute	EXP040199	38	normal	P04150	A549 (lung carcinoma)	PEAKS042105
EXP040272	A300-344A	Homo sapiens		EXP039034	514	normal	Q15788	K562 (myelogenous leukemia)	PEAKS042106
EXP040273	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 15 minute	EXP040194	38	normal	P04150	A549 (lung carcinoma)	PEAKS042107
EXP040274	A304-064A	Homo sapiens		EXP039034	514	normal	O15062	K562 (myelogenous leukemia)	PEAKS042108
EXP040275	07-729	Homo sapiens		EXP040195	394	normal	P49711	H929 (plasma cell myeloma)	PEAKS042109
EXP040276	600-401-B29	Homo sapiens		EXP039076	356	normal	Q15797	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042110
EXP040277	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 minute	EXP040212	38	normal	P04150	A549 (lung carcinoma)	PEAKS042111
EXP040278	07-729	Homo sapiens		EXP040215	1187	normal	P49711	Parathyroid adenoma	PEAKS042112
EXP040279	07-729	Homo sapiens		EXP040201	816	normal	P49711	SU-DHL-6 (diffuse large B-cell lymphoma)	PEAKS042113
EXP040280	A303-234A	Homo sapiens		EXP039074	113	normal	Q96KM6	MCF7 (Invasive ductal breast carcinoma)	PEAKS042114
EXP040281	GTX70250	Homo sapiens		EXP039034	514	normal	Q15788	K562 (myelogenous leukemia)	PEAKS042115
EXP040282	07-729	Homo sapiens		EXP040207	1185	normal	P49711	foreskin keratinocyte	PEAKS042116
EXP040283	A302-400A	Homo sapiens		EXP039034	514	normal	Q9UID6	K562 (myelogenous leukemia)	PEAKS042117
EXP040284	A303-039A	Homo sapiens		EXP039074	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	PEAKS042118
EXP040285	goat-anti-GFP-UC	Homo sapiens		EXP040218	514	normal	Q9NUA8	K562 (myelogenous leukemia)	PEAKS042119
EXP040286	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q6P9G9	HEK293 (embryonic kidney)	PEAKS042120
EXP040287	HPA024374	Homo sapiens		EXP039020	430	normal	Q9UDV7	HepG2 (hepatoblastoma)	PEAKS042121
EXP040288	HPA024374	Homo sapiens		EXP039034	514	normal	Q9UDV7	K562 (myelogenous leukemia)	PEAKS042122
EXP040289	HPA030062	Homo sapiens		EXP039188	356	normal	Q06710	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042123
EXP040290	07-729	Homo sapiens		EXP040214	887	normal	P49711	neural progenitors	PEAKS042124
EXP040291	07-729	Homo sapiens		EXP040217	725	normal	P49711	PC3(bone mets prostate adenocarcinoma)	PEAKS042125
EXP040292	NB100-92169	Homo sapiens		EXP039036	430	normal	P14921	HepG2 (hepatoblastoma)	PEAKS042126
EXP040293	A302-401A	Homo sapiens		EXP039034	514	normal	Q9UID6	K562 (myelogenous leukemia)	PEAKS042127
EXP040294	HPA005732	Homo sapiens		EXP039076	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042128
EXP040295	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9BSK1	HEK293 (embryonic kidney)	PEAKS042129
EXP040296	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q6P280	HEK293 (embryonic kidney)	PEAKS042130
EXP040297	sc-1003	Homo sapiens		EXP040210	38	normal	P04150	A549 (lung carcinoma)	PEAKS042131
EXP040298	07-729	Homo sapiens		EXP040209	1186	normal	P49711	smooth muscle cell	PEAKS042132
EXP040299	A303-039A	Homo sapiens		EXP039076	356	normal	A0AVK6	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042133
EXP040300	2/61715	Homo sapiens		EXP039216	514	normal	P18847	K562 (myelogenous leukemia)	PEAKS042134
EXP040301	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q8TD94	HEK293 (embryonic kidney)	PEAKS042135
EXP040302	A302-765A	Homo sapiens		EXP039188	356	normal	P27540	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042136
EXP040303	A302-390A	Homo sapiens		EXP039074	113	normal	P17098	MCF7 (Invasive ductal breast carcinoma)	PEAKS042137
EXP040304	A300-832A	Homo sapiens		EXP039076	356	normal	Q66K89	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS042138
EXP040305	A302-617A	Homo sapiens		EXP039240	113	normal	O15516	MCF7 (Invasive ductal breast carcinoma)	PEAKS042139
EXP040306	TA800173	Homo sapiens		EXP039034	514	normal	P59817	K562 (myelogenous leukemia)	PEAKS042140
EXP040307	GTX70165	Homo sapiens		EXP039216	514	normal	Q01094	K562 (myelogenous leukemia)	PEAKS042141
EXP040308	A303-739A	Homo sapiens		EXP039034	514	normal	Q99676	K562 (myelogenous leukemia)	PEAKS042142
EXP040309	A304-180A	Homo sapiens		EXP039034	514	normal	Q9C0G0	K562 (myelogenous leukemia)	PEAKS042143
EXP040310	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9UK13	HEK293 (embryonic kidney)	PEAKS042144
EXP040311	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q15916	HEK293 (embryonic kidney)	PEAKS042145
EXP040312	TA806187	Homo sapiens		EXP039034	514	normal	P04150	K562 (myelogenous leukemia)	PEAKS042146
EXP040313	A303-269A	Homo sapiens		EXP039074	113	normal	Q8N0Y2	MCF7 (Invasive ductal breast carcinoma)	PEAKS042147
EXP040314	9197S	Homo sapiens		EXP039020	430	normal	P16220	HepG2 (hepatoblastoma)	PEAKS042148
EXP040315	HPA024062	Homo sapiens		EXP039061	430	normal	P17028	HepG2 (hepatoblastoma)	PEAKS042149
EXP040316	A303-571A	Homo sapiens		EXP039034	514	normal	Q12968	K562 (myelogenous leukemia)	PEAKS042150
EXP040317	39789	Homo sapiens		EXP039034	514	normal	O75030	K562 (myelogenous leukemia)	PEAKS042151
EXP040318	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9NQX6	HEK293 (embryonic kidney)	PEAKS042152
EXP040319	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9H5H4	HEK293 (embryonic kidney)	PEAKS042153
EXP040320	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 20 minute	EXP040219	38	normal	P05412	A549 (lung carcinoma)	PEAKS042154
EXP040321	07-729	Homo sapiens		EXP040213	685	normal	P49711	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS042155
EXP040322	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 minute	EXP040212	38	normal	P05412	A549 (lung carcinoma)	PEAKS042156
EXP040323	sc-10652	Homo sapiens		EXP039020	430	normal	P22670	HepG2 (hepatoblastoma)	PEAKS042157
EXP040324	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P25490	HEK293 (embryonic kidney)	PEAKS042158
EXP040325	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q6IQ21	HEK293 (embryonic kidney)	PEAKS042159
EXP040326	A300-345A	Homo sapiens		EXP039216	514	normal	Q15596	K562 (myelogenous leukemia)	PEAKS042160
EXP044373	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 34Â°C to desired stage	EXP044370	1202	normal	G5EFT5	whole worms (developmental stage: L2)	PEAKS044524
EXP040332	RBPSUH(D10A4) (Cell Signaling, Catalog# 5313s, lot# 3)	Homo sapiens		EXP040331	2301	normal	Q06330	MDA-MB-231 (breast adenocarcinoma)	PEAKS042163
EXP040335	IRF2	Mus musculus	Hcfc2 KO	EXP040334	12	normal	P23906	MEF (mouse embryonic fibroblasts)	PEAKS042164
EXP040336	IRF2	Mus musculus		EXP040333	12	normal	P23906	MEF (mouse embryonic fibroblasts)	PEAKS042165
EXP040340	ATRX H300 antibody (Santa Cruz)	Mus musculus	ATRX -/-	EXP040337	1189	bio_control	Q61687	neuroepithelial progenitor cells	PEAKS042166
EXP040341	ATRX H300 antibody (Santa Cruz)	Mus musculus		EXP040338	1189	normal	Q61687	neuroepithelial progenitor cells	PEAKS042167
EXP040342	ATRX H300 antibody (Santa Cruz)	Mus musculus	p53 -/-	EXP040339	1189	normal	Q61687	neuroepithelial progenitor cells	PEAKS042168
EXP040346	MYCN	Mus musculus	None	EXP040343	1190	normal	P03966	neuroblastoma (Th-MYCN)	PEAKS042169
EXP040347	MYCN	Mus musculus	None	EXP040344	1190	normal	P03966	neuroblastoma (Th-MYCN)	PEAKS042170
EXP040348	MYCN	Mus musculus	None	EXP040345	1190	normal	P03966	neuroblastoma (Th-MYCN)	PEAKS042171
EXP040351	anti-pSMAD1	Homo sapiens	BSA (control)	EXP040349	1191	normal	Q15797	tracheobronchial epithelial cells	PEAKS042172
EXP040352	anti-pSMAD1	Homo sapiens	GDF15	EXP040350	1191	normal	Q15797	tracheobronchial epithelial cells	PEAKS042173
EXP040355	STAT1 (Cell Signaling, 9172)	Mus musculus	serum-starved	EXP040353	445	normal	P42225	HPC7 (haematopoietic multipotent progenitors)	PEAKS042174
EXP040356	STAT1 (Cell Signaling, 9172)	Mus musculus	thrombopoietin 30 minutes	EXP040354	445	normal	P42225	HPC7 (haematopoietic multipotent progenitors)	PEAKS042175
EXP040357	CTCF (Millipore, 07-729)	Mus musculus	thrombopoietin 30 minutes	EXP040354	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS042176
EXP040358	CTCF (Millipore, 07-729)	Mus musculus	serum-starved	EXP040353	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS042177
EXP040360	LEF1	Mus musculus		EXP040359	1193	normal	P27782	suprabasal transient amplifying cells	PEAKS042178
EXP040363	IRF1	Mus musculus	irradiated with 6Gy IR for 0h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS042179
EXP040364	IRF1	Mus musculus	irradiated with 6Gy IR for 1h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS042180
EXP040365	IRF1	Mus musculus	irradiated with 6Gy IR for 2h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS042181
EXP040366	IRF1	Mus musculus	irradiated with 6Gy IR for 6h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	PEAKS042182
EXP040367	IRF3	Mus musculus	irradiated with 6Gy IR for 0h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	PEAKS042183
EXP040368	IRF3	Mus musculus	irradiated with 6Gy IR for 1h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	PEAKS042184
EXP040369	IRF3	Mus musculus	irradiated with 6Gy IR for 2h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	PEAKS042185
EXP040370	IRF3	Mus musculus	irradiated with 6Gy IR for 6h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	PEAKS042186
EXP040371	p-p53	Mus musculus	irradiated with 6Gy IR for 0h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	PEAKS042187
EXP040372	p-p53	Mus musculus	irradiated with 6Gy IR for 0.5h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	PEAKS042188
EXP040373	p-p53	Mus musculus	irradiated with 6Gy IR for 1h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	PEAKS042189
EXP040374	p-p53	Mus musculus	irradiated with 6Gy IR for 2h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	PEAKS042190
EXP040375	p-p53	Mus musculus	irradiated with 6Gy IR for 6h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	PEAKS042191
EXP040378	RORa	Mus musculus	ROR LDKO	EXP040376	5	normal	P51448	liver	PEAKS042192
EXP040379	RORg	Mus musculus	ROR LDKO	EXP040377	5	normal	P51450	liver	PEAKS042193
EXP040383	CTCF	Homo sapiens	Treatment: none	EXP040380	664	normal	P49711	SH-SY5Y (neuroblastoma)	PEAKS042194
EXP040384	CTCF	Homo sapiens	Treatment: none	EXP040381	1194	normal	P49711	SK-N-AS (neuroblastoma)	PEAKS042195
EXP040385	CTCF	Homo sapiens	Treatment: none	EXP040382	1195	normal	P49711	NB69 (neuroblastoma)	PEAKS042196
EXP040387	anti-STAT5B (R&D systems)	Mus musculus		EXP040386	1192	normal	P42232	primary splenic NK cells	PEAKS042197
EXP040388	anti-STAT5B (R&D systems)	Mus musculus	40 ng/ml of IL-15 for 1 hr	EXP040386	1192	normal	P42232	primary splenic NK cells	PEAKS042198
EXP040389	anti-STAT5B (R&D systems)	Mus musculus	double knockin (DKI) mice	EXP040386	1192	normal	P42232	primary splenic NK cells	PEAKS042199
EXP040390	anti-STAT5B (R&D systems)	Mus musculus	double knockin (DKI) mice; 40 ng/ml of IL-15 for 1 hr	EXP040386	1192	bio_control	P42232	primary splenic NK cells	PEAKS042200
EXP040392	isl1 Cell Signaling Technology # 3724	Homo sapiens	DOX added to induce ISL1 expression	EXP040391	1196	normal	P61371	HuES6-derived cardiomyocyte progenitors	PEAKS042201
EXP040393	isl1 Cell Signaling Technology # 3724	Homo sapiens	no DOX	NULL	1196	bio_control	P61371	HuES6-derived cardiomyocyte progenitors	PEAKS042202
EXP040395	HA (AbCam ab9110)	Drosophila melanogaster	10 microMolar Cu2SO4; HA-Ubx transfection	EXP040394	1197	normal	P83949	S2-DRSC (embryonic stem cells)	PEAKS042203
EXP040398	Smad4	Mus musculus	IL6+TGFbR inhibitor	EXP040396	1058	normal	P97471	CD4+ T-cells	PEAKS042204
EXP040399	Smad4	Mus musculus	IL6+TGFbR inhibitor; SMAD4 KO	EXP040397	1058	normal	P97471	CD4+ T-cells	PEAKS042205
EXP040400	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	CD1 strain	NULL	1105	normal	Q61164	E12.5 embryonic distal forelimb	PEAKS042206
EXP040401	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	CD1 strain	NULL	1198	normal	Q61164	E12.5 embryonic proximal forelimbs	PEAKS042207
EXP040402	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	PEAKS042208
EXP040403	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(8-13)d11lac	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	PEAKS042209
EXP040404	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(8-13)rXII	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	PEAKS042210
EXP040405	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(1-13)d9lac	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	PEAKS042211
EXP040406	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(attP-rel5)d9lac	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	PEAKS042212
EXP040410	GFP (Abcam, ab290)	Mus musculus	Serum/LIF; ZBTB2-GFP BAC	EXP040407	1	normal	Q3V3W4	IB10 (embryonic stem cells)	PEAKS042213
EXP040411	GFP (Abcam, ab290)	Mus musculus	Serum/LIF	NULL	1	bio_control	P47856	IB10 (embryonic stem cells)	PEAKS042214
EXP040412	GFP (Abcam, ab290)	Mus musculus	Serum/LIF + 2i; ZBTB2-GFP BAC	EXP040408	1	normal	Q3V3W4	IB10 (embryonic stem cells)	PEAKS042215
EXP040413	GFP (Abcam, ab290)	Mus musculus	NPC medium; ZBTB2-GFP BAC	EXP040409	765	normal	Q3V3W4	R1 (embryonic stem cells)	PEAKS042216
EXP040414	GFP (Abcam, ab290)	Mus musculus	NPC medium	NULL	764	bio_control	P47856	R1 embryonic stem cell-derived neural progenitors	PEAKS042217
EXP040419	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	Control drug (C37)	EXP040415	1200	normal	P29052	S2-DGRC (embryonic stem cells)	PEAKS042218
EXP040420	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	Control drug (C37)	EXP040416	1200	normal	P29052	S2-DGRC (embryonic stem cells)	PEAKS042219
EXP040421	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	CBP inhibitor (C646)	EXP040417	1200	normal	P29052	S2-DGRC (embryonic stem cells)	PEAKS042220
EXP040422	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	CBP inhibitor (C646)	EXP040418	1200	normal	P29052	S2-DGRC (embryonic stem cells)	PEAKS042221
EXP040425	CTCF (Millipore, 07-729, lot 2757161)	Homo sapiens	Fetal	EXP040423	326	normal	P49711	CD34+ stem cells-derived erythroblasts	PEAKS042222
EXP040426	CTCF (Millipore, 07-729, lot 2757161)	Homo sapiens	Adult	EXP040424	326	normal	P49711	CD34+ stem cells-derived erythroblasts	PEAKS042223
EXP040429	GFP beads(ChromoTek, Gat-20)	Caenorhabditis elegans		EXP040427	1202	normal	P52906	whole worms (developmental stage: L2)	PEAKS042224
EXP040430	GFP beads(ChromoTek, Gat-20)	Caenorhabditis elegans		EXP040428	1202	normal	G5ECR9	whole worms (developmental stage: L2)	PEAKS042225
EXP040432	anti-STAT5B (R&D systems)	Mus musculus	CD4	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042226
EXP040433	anti-STAT3 (Invitrogen)	Mus musculus	CD4	EXP040431	1203	normal	P42227	spleen T cells	PEAKS042227
EXP040434	anti-STAT3 (Invitrogen)	Mus musculus	IL-21 (100 ng/ml) for 1h, CD4	EXP040431	1203	normal	P42227	spleen T cells	PEAKS042228
EXP040435	anti-STAT5B (R&D systems)	Mus musculus	CD8	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042229
EXP040436	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, CD8	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042230
EXP040437	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, UP deletion, CD4	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042231
EXP040438	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, IN1 deletion, CD4	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042232
EXP040439	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, IN2 deletion, CD4	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042233
EXP040440	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, CD4	EXP040431	1203	normal	P42232	spleen T cells	PEAKS042234
EXP044372	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 20Â°C to desired stage	EXP044370	1202	normal	G5EFT5	whole worms (developmental stage: L2)	PEAKS044523
EXP044369	anti-LEM-2 (Novus Biologicals, catalog #48540002, lot# T01872A01)	Caenorhabditis elegans	GW828 strain	EXP044366	1405	normal	Q9XTB5	whole organism (development stage: early embryonic)	PEAKS044522
EXP040447	PRDM1 (C14A4) rabbit mAb (Cell Signaling Tecnology)	Homo sapiens		EXP040446	964	normal	O75626	U266 (plasma cell myeloma)	PEAKS042240
EXP040449	BACH2 (D3T3G)	Homo sapiens		EXP040448	880	normal	Q9BYV9	B-cells	PEAKS042241
EXP040450	BACH2 (D3T3G)	Homo sapiens	siBACH2	EXP040448	880	bio_control	Q9BYV9	B-cells	PEAKS042242
EXP040453	ZIC2 (Abcam, ab150404)	Homo sapiens	TREx-F3H3-K-Rta; latent cells	EXP040451	79	normal	O95409	BCBL-1 (B-cell lymphoma)	PEAKS042243
EXP040454	ZIC2 (Abcam, ab150404)	Homo sapiens	TREx-F3H3-K-Rta; lytic cells	EXP040452	79	normal	O95409	BCBL-1 (B-cell lymphoma)	PEAKS042244
EXP040456	rabbit anti-Grh antibody	Drosophila melanogaster		EXP040455	1204	normal	P13002	13-16 h embryo	PEAKS042245
EXP040457	rabbit polyclonal Naa10p (made in-house)	Mus musculus	The mES cells were cultured without feeders for 5 passages for depleting feeder cells; Naa10+/Y	NULL	204	normal	Q9QY36	D3 (embryonic stem cells)	PEAKS042246
EXP040458	rabbit polyclonal Naa10p (made in-house)	Mus musculus	The mES cells were cultured without feeders for 5 passages for depleting feeder cells; Naa10-/Y	NULL	204	bio_control	Q9QY36	D3 (embryonic stem cells)	PEAKS042247
EXP040460	Santa Cruz, sc-373739	Homo sapiens	Treatment: untreated	NULL	326	normal	Q13772	CD34+ stem cells-derived erythroblasts	PEAKS042248
EXP040461	Santa Cruz, sc-373739	Homo sapiens	Treatment: GC1	EXP040459	326	normal	Q13772	CD34+ stem cells-derived erythroblasts	PEAKS042249
EXP040466	MYC (Santa Cruz, sc-764x)	Mus musculus	LAP-tta-Arid1afl/fl;Alb-cre;TRE-MYC	EXP040463	551	normal	P01108	liver tumor	PEAKS042251
EXP040467	MYC (Santa Cruz, sc-764x)	Mus musculus	LAP-tta-Arid1afl/+;Alb-cre;TRE-MYC	EXP040464	551	normal	P01108	liver tumor	PEAKS042252
EXP040468	MYC (Santa Cruz, sc-764x)	Mus musculus	LAP-tta-Arid1aflfl;TRE-MYC (WT)	EXP040465	551	normal	P01108	liver tumor	PEAKS042253
EXP040477	ZFX	Homo sapiens	Treatment: none	EXP040469	128	normal	P17010	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS042254
EXP040478	ZFX	Homo sapiens	Treatment: none	EXP040470	128	normal	P17010	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS042255
EXP040479	ZNF711	Homo sapiens	Treatment: none	EXP040469	128	normal	Q9Y462	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS042256
EXP040480	ZNF711	Homo sapiens	Treatment: none	EXP040470	128	normal	Q9Y462	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS042257
EXP040481	ZFX	Homo sapiens	Treatment: none	EXP040471	129	normal	P17010	LNCaP C4-2B (prostate carcinoma)	PEAKS042258
EXP040482	ZFX	Homo sapiens	Treatment: none	EXP040472	129	normal	P17010	LNCaP C4-2B (prostate carcinoma)	PEAKS042259
EXP040483	ZFX	Homo sapiens	Treatment: none	EXP040473	417	normal	P17010	HCT-116 (colon carcinoma)	PEAKS042260
EXP040484	ZFX	Homo sapiens	Treatment: none	EXP040474	417	normal	P17010	HCT-116 (colon carcinoma)	PEAKS042261
EXP040485	ZFX	Homo sapiens	Treatment: none	EXP040475	10	normal	P17010	HEK293T (embryonic kidney)	PEAKS042262
EXP040486	ZFX	Homo sapiens	Treatment: none	EXP040476	10	normal	P17010	HEK293T (embryonic kidney)	PEAKS042263
EXP040487	ZFX	Homo sapiens	Treatment: none	NULL	738	normal	P17010	PrEC (prostate cells)	PEAKS042264
EXP040490	CSL antibody	Homo sapiens		EXP040489	215	normal	Q14406	keratinocytes	PEAKS042266
EXP040491	anti-Smad4	Mus musculus	Abcam (Ab40759)	NULL	1126	normal	P97471	E14TG2a.4 (embryonic stem cells)	PEAKS042267
EXP040492	anti-Smad4	Mus musculus	Santa Cruz (SC-7966X)	NULL	1126	normal	P97471	E14TG2a.4 (embryonic stem cells)	PEAKS042268
EXP040493	Anti-HA magnetic beads (Thermo Fisher Scientific)	Homo sapiens	Positive IP/test condition	NULL	1205	normal	P41212	Reh (ATCC CRL-8286)	PEAKS042269
EXP040494	Anti-HA magnetic beads (Thermo Fisher Scientific)	Homo sapiens	Negative IP/background	NULL	1205	bio_control	P41212	Reh (ATCC CRL-8286)	PEAKS042270
EXP040495	SMC3	Homo sapiens	Wild type	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042271
EXP040496	SMC3	Homo sapiens	Wild type	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042272
EXP040497	SMC3	Homo sapiens	WAPL-depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042273
EXP040498	SMC3	Homo sapiens	WAPL-depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042274
EXP040499	SMC3	Homo sapiens	Pds5SA/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042275
EXP040500	SMC3	Homo sapiens	Pds5SA/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042276
EXP040501	SMC3	Homo sapiens	Wapl/Pds5A/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042277
EXP040502	SMC3	Homo sapiens	Wapl/Pds5A/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042278
EXP040503	CTCF	Homo sapiens	Wild type	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042279
EXP040504	CTCF	Homo sapiens	Wapl-depletion	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042280
EXP040505	CTCF	Homo sapiens	Pds5SA/B depletion	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042281
EXP040506	CTCF	Homo sapiens	Wapl/Pds5A/B depletion	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	PEAKS042282
EXP040508	BRD4	Mus musculus	Control	EXP040507	1058	normal	Q9ESU6	CD4+ T-cells	PEAKS042283
EXP040509	BRD4	Mus musculus	OX40L treated	EXP040507	1058	normal	Q9ESU6	CD4+ T-cells	PEAKS042284
EXP040510	EED(Active Motif,61203 )	Mus musculus	Wild type	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS042285
EXP040511	EED (Active Motif, Cat.61203 )	Mus musculus	Dnmt 3a-/- Dnmt 3b-/-	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS042286
EXP040512	SP5	Homo sapiens	0 h; Wnt3a, 1nM concentration	NULL	376	normal	Q6BEB4	WA01 (H1, human embryonic stem cells)	PEAKS042287
EXP040513	SP5	Homo sapiens	24 h; Wnt3a, 1nM concentration	NULL	376	normal	Q6BEB4	WA01 (H1, human embryonic stem cells)	PEAKS042288
EXP040516	SIN3A (Abcam, catalog# ab3479, lot# 2497679 GR220251-4)	Homo sapiens	Normoxia	EXP040514	472	normal	Q96ST3	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS042289
EXP040517	SIN3A (Abcam, catalog# ab3479, lot# 2497679 GR220251-4)	Homo sapiens	Hypoxia	EXP040515	472	normal	Q96ST3	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS042290
EXP040519	Olig2 (Millipore #A9610)	Mus musculus		EXP040518	804	normal	Q9EQW6	spinal cord	PEAKS042291
EXP040524	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 days (acute exposure)	EXP040520	1210	normal	P26358	HBEC3-KT	PEAKS042292
EXP040525	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 days (acute exposure)	EXP040520	1210	normal	Q15910	HBEC3-KT	PEAKS042293
EXP040526	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 days (acute exposure)	EXP040521	1210	normal	P26358	HBEC3-KT	PEAKS042294
EXP040527	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 days (acute exposure)	EXP040521	1210	normal	Q15910	HBEC3-KT	PEAKS042295
EXP040528	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 months (chronic exposure)	EXP040522	1210	normal	P26358	HBEC3-KT	PEAKS042296
EXP040529	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 months (chronic exposure)	EXP040522	1210	normal	Q15910	HBEC3-KT	PEAKS042297
EXP040530	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 months (chronic exposure)	EXP040523	1210	normal	P26358	HBEC3-KT	PEAKS042298
EXP040531	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 months (chronic exposure)	EXP040523	1210	normal	Q15910	HBEC3-KT	PEAKS042299
EXP040533	anti-BRD4 antibody (Bethyl Laboratories)	Homo sapiens		EXP040532	1211	normal	O60885	TREx-(F3H3)-K-Rta BCBL-1 cells	PEAKS042300
EXP040535	anti-dBigH1 (Perez-Montero et al., 2013)	Drosophila melanogaster		EXP040534	1212	normal	Q8MSC4	early embryos (0-2 hours after fertilization)	PEAKS042301
EXP040540	HDAC5 (Cell Signaling Technology, cat#2082, lot#2)	Mus musculus	Control	EXP040536	1214	normal	Q9Z2V6	mouse embryonic striatal neuron (day 15-160)	PEAKS042302
EXP040541	HDAC5 (Cell Signaling Technology, cat#2082, lot#2)	Mus musculus	10uM forskilin for 3 hours	EXP040538	1214	normal	Q9Z2V6	mouse embryonic striatal neuron (day 15-160)	PEAKS042303
EXP040554	V5-tag (R960CUS, Life Technologies)	Homo sapiens		EXP040546	1215	normal	Q9H165	HUDEP-2 (Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells-2)	PEAKS042306
EXP040555	V5-tag (R960CUS, Life Technologies)	Homo sapiens	Induction of the BCL11A-ER-V5 system was achieved with the addition of 4-hydroxytamoxifen (dissolved in 100% ethanol) at a final concentration of 10-7 M (0.1 nmol). Cells were harvested after 24 hours of induction for downstream experimentation.	EXP040547	1215	normal	Q9H165	HUDEP-2 (Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells-2)	PEAKS042307
EXP040556	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040548	514	normal	O95365	K562 (myelogenous leukemia)	PEAKS042308
EXP040557	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040549	514	normal	O95365	K562 (myelogenous leukemia)	PEAKS042309
EXP040558	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040550	514	normal	O95365	K562 (myelogenous leukemia)	PEAKS042310
EXP040559	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040551	514	normal	O95365	K562 (myelogenous leukemia)	PEAKS042311
EXP040560	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens	Wild type (Î”GÎ³)	EXP040552	930	normal	O95365	226LDM (normal breast luminal cells)	PEAKS042312
EXP040561	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens	195C>G (Î”GÎ³)	EXP040553	930	normal	O95365	226LDM (normal breast luminal cells)	PEAKS042313
EXP040562	Sigma HPA015055	Homo sapiens	Treatment: Untreated	NULL	1216	normal	O60885	AR-dependent LNCaP/AR (LNAR)	PEAKS042314
EXP040563	Sigma HPA015055	Homo sapiens	Treatment: Enzalutamide (Enz)	NULL	1216	normal	O60885	AR-dependent LNCaP/AR (LNAR)	PEAKS042315
EXP040564	Sigma HPA015055	Homo sapiens	Treatment: Untreated	NULL	555	normal	O60885	LREX' (prostate cancer)	PEAKS042316
EXP040565	Sigma HPA015055	Homo sapiens	Treatment: Enzalutamide (Enz)	NULL	555	normal	O60885	LREX' (prostate cancer)	PEAKS042317
EXP040566	rabbit anti-BMAL1 	Mus musculus		NULL	1217	normal	Q9WTL8	P20 retina	PEAKS042318
EXP040567	rabbit anti-BMAL1 	Mus musculus		NULL	1217	bio_control	Q9WTL8	P20 retina	PEAKS042319
EXP040569	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Wild type (strain: C57BL/6)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042320
EXP040570	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Ezh1/Ezh2 dKO (strain: C57BL/6)	EXP040568	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042321
EXP040571	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Eed KO (strain: C57BL/6)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042322
EXP040572	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Suz12 KO (strain: C57BL/6)	NULL	2	bio_control	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042323
EXP040573	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Wild type (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042324
EXP040574	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Suz12 KO (strain: 129B6F1)	NULL	2	bio_control	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042325
EXP040575	Ezh2 (Cell Signaling, Rabbit mAb, D2C9)	Mus musculus	Wild type (strain: 129B6F1)	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS042326
EXP040576	Ezh2 (Cell Signaling, Rabbit mAb, D2C9)	Mus musculus	Suz12 KO (strain: 129B6F1)	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS042327
EXP040577	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	SUZ12 rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042328
EXP040578	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	SUZ12-VEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042329
EXP040579	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	SUZ12-DeltaVEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042330
EXP040580	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	SUZ12-VEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042331
EXP040581	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	SUZ12-DeltaVEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS042332
EXP040583	House-made Bicoid antibody (Paris et al 2013)	Drosophila melanogaster		EXP040582	1218	normal	P09081	Stage 5 embryos	PEAKS042333
EXP040586	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		EXP040584	1219	normal	P53061	SK1 meiotic cells (4 hours)	PEAKS042334
EXP040587	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		EXP040584	1219	normal	Q06032	SK1 meiotic cells (4 hours)	PEAKS042335
EXP040588	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		EXP040584	1219	normal	P40511	SK1 meiotic cells (4 hours)	PEAKS042336
EXP040589	c-Myc monoclonal antibody (9E10, Santa Cruz)	Saccharomyces cerevisiae		EXP040585	1219	normal	P17122	SK1 meiotic cells (4 hours)	PEAKS042337
EXP040594	Bcl-6 (N-3), sc-858, Lot# A3013	Homo sapiens	none	NULL	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS042338
EXP040595	Bcl-6 (N-3), sc-858, Lot# A3013	Homo sapiens		EXP040592	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS042339
EXP040596	Bcl-6 (N-3), sc-858, Lot# A3013	Homo sapiens	UV	EXP040590	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS042340
EXP040597	anti-FLAG antibody (Wako)	Saccharomyces cerevisiae	3h after meiotic induction	NULL	1220	normal	P14291	SK1	PEAKS042341
EXP040602	Biotin	Mus musculus		EXP040600	1221	normal	Q8VEK3	AML12	PEAKS042342
EXP040603	Biotin	Mus musculus		EXP040601	1221	normal	Q8VEK3	AML12	PEAKS042343
EXP040604	Millipore (07-729)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q61164	liver	PEAKS042344
EXP040605	Millipore (07-729)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q61164	liver	PEAKS042345
EXP040606	Bethyl (A300-793A)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q925J9	liver	PEAKS042346
EXP040607	Bethyl (A300-793A)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q925J9	liver	PEAKS042347
EXP040608	Bethyl (A300-793A)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	normal	Q925J9	liver	PEAKS042348
EXP040609	Abcam (ab992)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q61550	liver	PEAKS042349
EXP040610	Abcam (ab992)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q61550	liver	PEAKS042350
EXP040611	Abcam (ab992)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q61550	liver	PEAKS042351
EXP040612	Abcam (ab992)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q61550	liver	PEAKS042352
EXP040613	Bethyl (A301-985A100)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q9ESU6	liver	PEAKS042353
EXP040614	Bethyl (A301-985A100)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q9ESU6	liver	PEAKS042354
EXP040615	Bethyl (A301-985A100)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	normal	Q9ESU6	liver	PEAKS042355
EXP040616	Cell Signaling (2124)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q3UV55	liver	PEAKS042356
EXP040617	Cell Signaling (2124)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q3UV55	liver	PEAKS042357
EXP040618	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q3UV55	liver	PEAKS042358
EXP040619	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q3UV55	liver	PEAKS042359
EXP040620	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	bio_control	Q3UV55	liver	PEAKS042360
EXP040621	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	bio_control	Q3UV55	liver	PEAKS042361
EXP040625	BRD4	Mus musculus	mice without tumor cell inoculation, treated with vehicle	EXP040622	1223	normal	Q9ESU6	adult skeletal muscle	PEAKS042362
EXP040626	BRD4	Mus musculus	C26-bearing mice, 20 mg/kg body weight of the inactive JQ1 enantiomer	EXP040623	1223	normal	Q9ESU6	adult skeletal muscle	PEAKS042363
EXP040627	BRD4	Mus musculus	C26-bearing mice, 20 mg/kg body weight of the active JQ1 enantiomer	EXP040624	1223	normal	Q9ESU6	adult skeletal muscle	PEAKS042364
EXP040628	anti-NOTCH3 antibody (Cell Signaling, #2889)	Homo sapiens	Treatment: vehicle (DMSO) for 1 day	NULL	1224	normal	Q9UM47	TALL1 (T-Acute Lymphoblastic Leukemia)	PEAKS042365
EXP040629	anti-NOTCH3 antibody (Cell Signaling, #2889)	Homo sapiens	Treatment: GSI (compound E 1?M) for 1 day	NULL	1224	normal	Q9UM47	TALL1 (T-Acute Lymphoblastic Leukemia)	PEAKS042366
EXP040631	anti-APC (a polyclonal antibody recognizing the C-terminal 50 amino acids of APC, catalog #A300-981A, Bethyl Laboratories, Inc.)	Homo sapiens		EXP040630	417	normal	P25054	HCT-116 (colon carcinoma)	PEAKS042367
EXP040636	F1804, Sigma/Aldrich	Mus musculus	wild type cells	EXP040632	1225	normal	Q8VE65	MLL-AF9/NrasG12D AML	PEAKS042368
EXP040637	ab138774, Abcam	Mus musculus	wild type cells	EXP040633	1225	normal	Q8K0H5	MLL-AF9/NrasG12D AML	PEAKS042369
EXP040638	A302-131, Behtyl	Mus musculus	wild type cells	EXP040633	1225	normal	Q8C176	MLL-AF9/NrasG12D AML	PEAKS042370
EXP040639	F1804, Sigma/Aldrich	Mus musculus	dox regulated shREN	EXP040634	1225	normal	Q8VE65	MLL-AF9/NrasG12D AML	PEAKS042371
EXP040640	F1804, Sigma/Aldrich	Mus musculus	dox regulated shMYB.2652	EXP040635	1225	normal	Q8VE65	MLL-AF9/NrasG12D AML	PEAKS042372
EXP040642	anti-LXR anti-FLAG M2 (SIGMA #F3165)	Mus musculus	GW3965 1uM agonist 24 hours	NULL	81	bio_control	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	PEAKS042373
EXP040643	lxra anti-FLAG M2 (SIGMA #F3165)	Mus musculus	GW3965 1uM agonist 24 hours	EXP040641	81	normal	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	PEAKS042374
EXP040644	LXRb anti-FLAG M2 (SIGMA #F3165)	Mus musculus	GW3965 1uM agonist 24 hours	EXP040641	81	normal	Q60644	BMDM (bone marrow-derived macrophages)	PEAKS042375
EXP040648	CTCF (Millipore Sigma #07-729)	Mus musculus		EXP040645	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS042376
EXP040649	CTCF (Millipore Sigma #07-729)	Mus musculus	Firre KO	EXP040646	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS042377
EXP040650	CTCF (Millipore Sigma #07-729)	Mus musculus	Firre transgene	EXP040647	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS042378
EXP040651	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	LPS	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS042379
EXP040652	anti-C/EBPB (Santa Cruz sc-150)	Homo sapiens		NULL	466	normal	P17676	MDM(monocyte derived macrophages)	PEAKS042380
EXP040655	CEBPB (sc-7962, H-7, Lot#: E1916, Santa Cruz Biotechnology)	Homo sapiens	Control No Treatment	EXP040653	1226	normal	P17676	OCI-AML3	PEAKS042381
EXP040656	CEBPB (sc-7962, H-7, Lot #: E1916, Santa Cruz Biotechnology)	Homo sapiens	JQ1, 500 nM for 24 h	EXP040654	1226	normal	P17676	OCI-AML3	PEAKS042382
EXP040660	AR	Homo sapiens	Treatment: Treatment: Female	EXP040657	1123	normal	P10275	breast tumor	PEAKS042383
EXP040661	AR	Homo sapiens	Treatment: Treatment: Female	EXP040658	128	normal	P10275	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS042384
EXP040662	GR	Homo sapiens	Treatment: Treatment: Female	EXP040658	128	normal	P04150	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS042385
EXP040663	ER	Homo sapiens	Treatment: Treatment: Female	EXP040657	1123	normal	P03372	breast tumor	PEAKS042386
EXP040664	FOXA1	Homo sapiens	Treatment: Treatment: Female	EXP040657	1123	normal	P55317	breast tumor	PEAKS042387
EXP040665	AR	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P10275	breast tumor	PEAKS042388
EXP040666	FOXA1	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P55317	breast tumor	PEAKS042389
EXP040667	GATA3	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P23771	breast tumor	PEAKS042390
EXP040668	PR	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P06401	breast tumor	PEAKS042391
EXP040669	GR	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P04150	breast tumor	PEAKS042392
EXP040670	ER	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P03372	breast tumor	PEAKS042393
EXP040671	RAD21	Homo sapiens	Treatment: N/A	NULL	1228	normal	O60216	HCT-116-RAD21-mAC	PEAKS042394
EXP040672	RAD21	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	O60216	HCT-116-RAD21-mAC	PEAKS042395
EXP040673	smc1	Homo sapiens	Treatment: N/A	NULL	1228	normal	Q14683	HCT-116-RAD21-mAC	PEAKS042396
EXP040674	smc1	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	Q14683	HCT-116-RAD21-mAC	PEAKS042397
EXP040675	h2az	Homo sapiens	Treatment: N/A	NULL	1228	normal	P0C0S5	HCT-116-RAD21-mAC	PEAKS042398
EXP040676	h2az	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	P0C0S5	HCT-116-RAD21-mAC	PEAKS042399
EXP040677	NIPBL	Homo sapiens	Treatment: N/A	NULL	1228	normal	Q6KC79	HCT-116-RAD21-mAC	PEAKS042400
EXP040678	NIPBL	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	Q6KC79	HCT-116-RAD21-mAC	PEAKS042401
EXP040679	CTCF	Homo sapiens	Treatment: N/A	NULL	1228	normal	P49711	HCT-116-RAD21-mAC	PEAKS042402
EXP040680	CTCF	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	P49711	HCT-116-RAD21-mAC	PEAKS042403
EXP040682	SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2 WT; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042404
EXP040683	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2 WT; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042405
EXP040684	SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2 WT; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042406
EXP040685	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2 WT; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042407
EXP040686	Anti-SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2-deltaPBMA; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042408
EXP040687	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2-deltaPBMA; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042409
EXP040688	Anti-SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2-deltaPBMA; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042410
EXP040689	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2-deltaPBMA; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	PEAKS042411
EXP040692	rabbit-anti-ada2b	Drosophila melanogaster	Treatment: none	EXP040690	1229	normal	Q8I8V0	1-3 h embryo	PEAKS042412
EXP040693	rabbit-anti-ada2b	Drosophila melanogaster	Treatment: none	EXP040691	1229	normal	Q8I8V0	1-3 h embryo	PEAKS042413
EXP040695	HN1L	Homo sapiens		EXP040694	817	normal	Q96RY5	SUM159PT (Triple negative breast cancer)	PEAKS042414
EXP040702	anti-GATA3 (#CM405A, Biocare Medical)	Homo sapiens	BMP4 for 3 day	EXP040701	396	normal	P23771	WA09 (embryonic stem cells)	PEAKS042415
EXP040703	anti-GATA3 (#CM405A, Biocare Medical)	Homo sapiens	BMP4 for 3 day	EXP040698	396	normal	P23771	WA09 (embryonic stem cells)	PEAKS042416
EXP040704	anti-GATA3 (#CM405A, Biocare Medical)	Homo sapiens	BMP4 for 3 day	EXP040698	396	normal	P23771	WA09 (embryonic stem cells)	PEAKS042417
EXP040705	anti-GATA2 (H116, sc-9008, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040701	396	normal	P23769	WA09 (embryonic stem cells)	PEAKS042418
EXP040706	anti-GATA2 (H116, sc-9008, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040698	396	normal	P23769	WA09 (embryonic stem cells)	PEAKS042419
EXP040707	anti-GATA2 (H116, sc-9008, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040700	396	normal	P23769	WA09 (embryonic stem cells)	PEAKS042420
EXP040708	anti-TFAP2A (#sc-184, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040696	396	normal	P05549	WA09 (embryonic stem cells)	PEAKS042421
EXP040709	anti-TFAP2A (#sc-184, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040697	396	normal	P05549	WA09 (embryonic stem cells)	PEAKS042422
EXP040710	anti-TFAP2A (#sc-184, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040701	396	normal	P05549	WA09 (embryonic stem cells)	PEAKS042423
EXP040711	anti-TFAP2C (#sc-12762, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040696	396	normal	Q92754	WA09 (embryonic stem cells)	PEAKS042424
EXP040712	anti-TFAP2C (#sc-12762, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040699	396	normal	Q92754	WA09 (embryonic stem cells)	PEAKS042425
EXP040713	anti-TFAP2C (#sc-12762, Santa Cruz)	Homo sapiens	BMP4 for 3 day	NULL	396	normal	Q92754	WA09 (embryonic stem cells)	PEAKS042426
EXP040721	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18	EXP040714	1192	normal	P42228	primary splenic NK cells	PEAKS042427
EXP040722	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18	EXP040715	1192	normal	P42228	primary splenic NK cells	PEAKS042428
EXP040723	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18	EXP040716	1192	normal	P42228	primary splenic NK cells	PEAKS042429
EXP040724	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	unstim	EXP040717	1192	normal	P42228	primary splenic NK cells	PEAKS042430
EXP040725	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18; Stat4KO	EXP040718	1192	normal	P42228	primary splenic NK cells	PEAKS042431
EXP040726	anti-STAT1 (Santa Cruz, sc-592, clone M-22, lot# F1312)	Mus musculus	IFNa	EXP040719	1192	normal	P42225	primary splenic NK cells	PEAKS042432
EXP040727	anti-STAT1 (Santa Cruz, sc-592, clone M-22, lot# F1312)	Mus musculus	IFNa, IL2	EXP040720	1192	normal	P42225	primary splenic NK cells	PEAKS042433
EXP040728	Anti-Myc Tag, clone 4A6 (Millipore, Cat. #05-724, Lot #2324563)	Arabidopsis thaliana	mock	NULL	1231	normal	Q6NQK2	whole plants	PEAKS042434
EXP040729	Anti-Myc Tag, clone 4A6 (Millipore, Cat. #05-724, Lot #2324563)	Arabidopsis thaliana	15 ÂµM zeocin	NULL	1231	normal	Q6NQK2	whole plants	PEAKS042435
EXP040732	SMC4	Saccharomyces cerevisiae		EXP040730	1232	normal	Q12267	S. cerevisiae cells	PEAKS042436
EXP040733	SMC4	Saccharomyces cerevisiae		EXP040731	1232	normal	Q12267	S. cerevisiae cells	PEAKS042437
EXP040734	CEBPa (sc-61X)	Mus musculus	cells differentiated in the presence of MCSF	NULL	81	normal	P53566	BMDM (bone marrow-derived macrophages)	PEAKS042438
EXP040735	IRF8 (sc-32528x)	Mus musculus	cells differentiated in the presence of MCSF	NULL	81	normal	P23611	BMDM (bone marrow-derived macrophages)	PEAKS042439
EXP040736	JUNB (sc-46x)	Mus musculus	cells differentiated in the presence of MCSF	NULL	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS042440
EXP040737	CEBPa (sc-61X)	Mus musculus	cells differentiated in the presence of MCSF (1h IL4)	NULL	81	normal	P53566	BMDM (bone marrow-derived macrophages)	PEAKS042441
EXP040738	IRF8 (sc-32528x)	Mus musculus	cells differentiated in the presence of MCSF (1h IL4)	NULL	81	normal	P23611	BMDM (bone marrow-derived macrophages)	PEAKS042442
EXP040739	JUNB (sc-46x)	Mus musculus	cells differentiated in the presence of MCSF (1h IL4)	NULL	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS042443
EXP040740	STAT3	Homo sapiens	DMSO	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	PEAKS042444
EXP040741	STAT3	Homo sapiens	AZD1480(JAK inhibitor) for 4hrs	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	PEAKS042445
EXP040742	STAT3	Homo sapiens	DMSO	NULL	683	normal	P40763	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS042446
EXP040743	STAT3	Homo sapiens	AZD1480(JAK inhibitor) for 4hrs	NULL	683	normal	P40763	OCI-LY10 (diffuse large B-cell lymphoma)	PEAKS042447
EXP040744	HDAC1 (ab7028)	Mus musculus	control	NULL	81	normal	O09106	BMDM (bone marrow-derived macrophages)	PEAKS042448
EXP040745	HDAC1 (ab7028)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	O09106	BMDM (bone marrow-derived macrophages)	PEAKS042449
EXP040746	HDAC2 (ab7029)	Mus musculus	control	NULL	81	normal	P70288	BMDM (bone marrow-derived macrophages)	PEAKS042450
EXP040747	HDAC2 (ab7029)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	P70288	BMDM (bone marrow-derived macrophages)	PEAKS042451
EXP040748	HDAC3 (ab4729)	Mus musculus	control	NULL	81	normal	O88895	BMDM (bone marrow-derived macrophages)	PEAKS042452
EXP040749	HDAC3 (ab4729)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	O88895	BMDM (bone marrow-derived macrophages)	PEAKS042453
EXP040750	PU1 (sc-352)	Mus musculus	control	NULL	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS042454
EXP040751	PU.1 (sc-352)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS042455
EXP040752	p300 (sc-585)	Mus musculus	control	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS042456
EXP040753	p300 (sc-585)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS042457
EXP040754	p65 (sc-372)	Mus musculus	control	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS042458
EXP040755	p65 (sc-372)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 24 hours).	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS042459
EXP040756	p65 (sc-372)	Mus musculus	cells differentiated in the presence of MCSF (ctrl_1hLPS)	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS042460
EXP040757	p65 (sc-372)	Mus musculus	cells differentiated in the presence of MCSF (24h IL4_1h LPS)	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS042461
EXP040758	STAT6 (sc-981)	Mus musculus	control	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042462
EXP040759	STAT6 (sc-981)	Mus musculus	cells differentiated in the presence of MCSF (1hIL4)	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042463
EXP040760	STAT6 (sc-981)	Mus musculus	cells differentiated in the presence of MCSF (6hIL4)	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042464
EXP040761	STAT6 (sc-981)	Mus musculus	cells differentiated in the presence of MCSF (24hIL4)	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042465
EXP040762	anti-ZEB1	Homo sapiens	H1975 R2 (ZEB1 resistant)	NULL	1233	normal	P37275	Lung adenocarcinoma (H1975)	PEAKS042466
EXP040763	anti-ZEB1	Homo sapiens	H1975	NULL	1233	normal	P37275	Lung adenocarcinoma (H1975)	PEAKS042467
EXP040765	STF1	Mus musculus	vehicle	EXP040764	1234	normal	P35175	Leydig cells	PEAKS042468
EXP040766	STF1	Mus musculus	cAMP	EXP040764	1234	normal	P35175	Leydig cells	PEAKS042469
EXP040768	CTCF	Homo sapiens	Treatment: none	EXP040767	166	normal	P49711	CD34+ hematopoietic stem cells	PEAKS042470
EXP040770	oef-1	Caenorhabditis elegans		EXP040769	1235	normal	G4SGI5	whole worms (developmental stage: young adults)	PEAKS042471
EXP040771	CTCF (Millipore, 07-729)	Mus musculus	C57BL/6; 3 months; male	NULL	81	normal	Q61164	BMDM (bone marrow-derived macrophages)	PEAKS042472
EXP040772	RAD21 (ab992)	Mus musculus	C57BL/6; 3 months; male	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS042473
EXP040774	P300 (sc-585)	Mus musculus		EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS042474
EXP040775	P300 (sc-585)	Mus musculus	1h IL4	EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS042475
EXP040776	P300 (sc-585)	Mus musculus	6h IL4	EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS042476
EXP040777	P300 (sc-585)	Mus musculus	24h IL4	EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS042477
EXP040778	PU.1 (sc-352)	Mus musculus		EXP040773	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS042478
EXP040779	PU.1 (sc-352)	Mus musculus	1h IL4	EXP040773	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS042479
EXP040780	RAD21 (ab992)	Mus musculus		EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS042480
EXP040781	RAD21 (ab992)	Mus musculus	1h IL4	EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS042481
EXP040782	RAD21 (ab992)	Mus musculus	6h IL4	EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS042482
EXP040783	RAD21 (ab992)	Mus musculus	24h IL4	EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS042483
EXP040784	RXR (sc-774)	Mus musculus		EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042484
EXP040785	RXR (sc-774)	Mus musculus	1h IL4	EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042485
EXP040786	RXR (sc-774)	Mus musculus	6h IL4	EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042486
EXP040787	STAT6 (sc-981)	Mus musculus	1h IL4	EXP040773	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042487
EXP040788	STAT6 (sc-981)	Mus musculus	6h IL4	EXP040773	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042488
EXP040789	STAT6 (sc-981)	Mus musculus	24h IL4	EXP040773	81	normal	P52633	BMDM (bone marrow-derived macrophages)	PEAKS042489
EXP040790	PPARg (Perseus #PP-A3409A)	Mus musculus		EXP040773	81	normal	P37238	BMDM (bone marrow-derived macrophages)	PEAKS042490
EXP040791	PPARg (Perseus #PP-A3409A)	Mus musculus		EXP040773	81	normal	P37238	BMDM (bone marrow-derived macrophages)	PEAKS042491
EXP040792	RXR (sc-774)	Mus musculus	STAT6_KO	NULL	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042492
EXP040793	RXR (sc-774)	Mus musculus	PPARG_KO	NULL	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042493
EXP040794	RXR (sc-774)	Mus musculus		EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042494
EXP040795	RXR (sc-774)	Mus musculus		EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS042495
EXP040799	anti-SKI (sc-9140, Santa Cruz)	Homo sapiens	Treatment: none	EXP040797	438	normal	P12755	HL-60 (acute myeloid leukemia)	PEAKS042496
EXP040800	anti-RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: none	EXP040796	438	normal	Q01196	HL-60 (acute myeloid leukemia)	PEAKS042497
EXP040801	anti-CEBPbeta (sc-150, Santa Cruz)	Homo sapiens	Treatment: none	EXP040796	438	normal	P17676	HL-60 (acute myeloid leukemia)	PEAKS042498
EXP040802	anti-SKI (sc-9140, Santa Cruz)	Homo sapiens	Treatment: none	EXP040796	438	normal	P12755	HL-60 (acute myeloid leukemia)	PEAKS042499
EXP040803	anti-SKI (sc-9140, Santa Cruz)	Homo sapiens	Treatment: none	EXP040798	438	bio_control	P12755	HL-60 (acute myeloid leukemia)	PEAKS042500
EXP040807	GATA1 Abcam, ab11852, 772403	Homo sapiens	Treatment: none	EXP040804	514	normal	P15976	K562 (myelogenous leukemia)	PEAKS042501
EXP040808	TAL1 Santa Cruz Biotechnology,sc-12984,C1315	Homo sapiens	Treatment: none	EXP040804	514	normal	P17542	K562 (myelogenous leukemia)	PEAKS042502
EXP040809	GATA1 Abcam, ab11852, 772403	Homo sapiens	Treatment: MYO1D Non-hub KO	EXP040805	514	normal	P15976	K562 (myelogenous leukemia)	PEAKS042503
EXP040810	TAL1 Santa Cruz Biotechnology,sc-12984,C1315	Homo sapiens	Treatment: MYO1D Non-hub KO	EXP040805	514	normal	P17542	K562 (myelogenous leukemia)	PEAKS042504
EXP040811	GATA1 Abcam, ab11852, 772403	Homo sapiens	Treatment: MYO1D Hub KO	EXP040806	514	normal	P15976	K562 (myelogenous leukemia)	PEAKS042505
EXP040812	TAL1 Santa Cruz Biotechnology,sc-12984,C1315	Homo sapiens	Treatment: MYO1D Hub KO	EXP040806	514	normal	P17542	K562 (myelogenous leukemia)	PEAKS042506
EXP040815	RXRA (Perseus Proteomics, K8508, lot A2)	Homo sapiens	Treatment: genotype: RXRA WT	EXP040813	1236	normal	P19793	JMSU-1 (Bladder carcinoma)	PEAKS042507
EXP040816	RXRA (Perseus Proteomics, K8508, lot A2)	Homo sapiens	Treatment: genotype: RXRA S427F	EXP040814	1236	normal	P19793	JMSU-1 (Bladder carcinoma)	PEAKS042508
EXP040818	INO80 ab105451	Homo sapiens	None	EXP040817	430	normal	Q9ULG1	HepG2 (hepatoblastoma)	PEAKS042509
EXP040819	MCRS1	Homo sapiens	None	EXP040817	430	normal	Q96EZ8	HepG2 (hepatoblastoma)	PEAKS042510
EXP040820	RUVBL1	Homo sapiens	None	EXP040817	430	normal	Q9Y265	HepG2 (hepatoblastoma)	PEAKS042511
EXP040821	RUVBL2	Homo sapiens	None	EXP040817	430	normal	Q9Y230	HepG2 (hepatoblastoma)	PEAKS042512
EXP040824	input	Mus musculus	LPS 1hr	EXP040822	81	normal	A1A546	BMDM (bone marrow-derived macrophages)	PEAKS042513
EXP040825	input	Mus musculus	LPS 1hr	EXP040823	81	normal	A1A546	BMDM (bone marrow-derived macrophages)	PEAKS042514
EXP040826	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	control	EXP040822	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	PEAKS042515
EXP040827	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	control	EXP040823	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	PEAKS042516
EXP040828	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	LPS 1hr	EXP040822	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	PEAKS042517
EXP040829	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	LPS 1hr	EXP040823	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	PEAKS042518
EXP040830	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	control	EXP040822	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS042519
EXP040831	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	control	EXP040823	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS042520
EXP040832	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	LPS 1hr	EXP040822	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS042521
EXP040833	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	LPS 1hr	EXP040823	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS042522
EXP040835	GATA2 (Santa Cruz Biotechnologies, sc-9008)	Homo sapiens		EXP040834	256	normal	P23769	endometrial stromal cells	PEAKS042523
EXP040841	SMRC1	Homo sapiens		EXP040840	430	normal	Q92922	HepG2 (hepatoblastoma)	PEAKS042526
EXP040842	SATB1	Homo sapiens		EXP040840	430	normal	Q01826	HepG2 (hepatoblastoma)	PEAKS042527
EXP040843	NFIC	Homo sapiens		EXP040840	430	normal	P08651	HepG2 (hepatoblastoma)	PEAKS042528
EXP040844	anti-hsf1	Saccharomyces cerevisiae	control	NULL	1232	normal	P10961	S. cerevisiae cells	PEAKS042529
EXP040845	anti-hsf1	Saccharomyces cerevisiae	heat shock	NULL	1232	normal	P10961	S. cerevisiae cells	PEAKS042530
EXP040847	Suz12	Mus musculus		EXP040846	233	normal	Q80U70	E14TG2A (embryonic stem cells)	PEAKS042531
EXP040848	KDM6A	Mus musculus		EXP040846	233	normal	O70546	E14TG2A (embryonic stem cells)	PEAKS042532
EXP040849	Ezh2	Mus musculus		EXP040846	233	normal	Q61188	E14TG2A (embryonic stem cells)	PEAKS042533
EXP040850	Spt6	Mus musculus		EXP040846	233	normal	Q62383	E14TG2A (embryonic stem cells)	PEAKS042534
EXP040853	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 1.5h	EXP040851	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	PEAKS042535
EXP040854	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 16h	EXP040851	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	PEAKS042536
EXP040855	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 1.5h	EXP040852	120	normal	Q15796	BT-549 (breast invasive ductal carcinoma)	PEAKS042537
EXP040856	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 16h	EXP040852	120	normal	Q15796	BT-549 (breast invasive ductal carcinoma)	PEAKS042538
EXP040858	Hoxb5	Mus musculus		EXP040857	198	normal	P09079	pre-pro-B-cells	PEAKS042539
EXP040864	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	mock-infected cells	EXP040859	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	PEAKS054000
EXP040865	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	ela wild type	EXP040860	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	PEAKS054001
EXP040866	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	FOXKb-	EXP040861	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	PEAKS054002
EXP040867	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	DCAF7b-	EXP040862	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	PEAKS054003
EXP040868	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	CtBPb-	EXP040863	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	PEAKS054004
EXP040875	CID-GFP	Drosophila melanogaster		EXP040869	1239	normal	Q9V6Q2	0-24 h embryo	PEAKS042545
EXP040876	anti-CidH epitope	Drosophila melanogaster		EXP040870	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	PEAKS042546
EXP040877	anti-CidM epitope	Drosophila melanogaster		EXP040871	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	PEAKS042547
EXP040878	anti-CidM	Drosophila melanogaster		EXP040872	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	PEAKS042548
EXP040879	anti-CidM	Drosophila melanogaster		EXP040873	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	PEAKS042549
EXP040880	anti-GFP	Drosophila melanogaster	OregonR	EXP040874	1239	normal	Q9V6Q2	0-24 h embryo	PEAKS042550
EXP040881	JMJD1A	Mus musculus		NULL	1241	normal	Q6PCM1	inguinal subcutaneous white adipose tissue-derived preadipocytes	PEAKS042551
EXP040882	PPAR?	Mus musculus		NULL	1241	normal	P37238	inguinal subcutaneous white adipose tissue-derived preadipocytes	PEAKS042552
EXP040885	FUL	Arabidopsis thaliana		EXP040883	1237	normal	Q38876	inflorescence meristems	PEAKS042553
EXP040886	FUL	Arabidopsis thaliana		EXP040884	1238	normal	Q38876	pistils	PEAKS042554
EXP040889	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	100 nM ICI for 30 min	EXP040887	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054005
EXP040890	SUMO2/3 (Cedarlane M114-3)	Homo sapiens		EXP040887	113	normal	P61956	MCF7 (Invasive ductal breast carcinoma)	PEAKS054006
EXP040892	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	5 nM E2 for 30 min	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054008
EXP040893	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	vehicle for 3h	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054009
EXP040894	ESR? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	ICI for 3h	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054010
EXP040895	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	E2 for 3h	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054011
EXP040896	SUMO2/3 (Cedarlane M114-3)	Homo sapiens	vehicle for 30 min	EXP040888	113	normal	P61956	MCF7 (Invasive ductal breast carcinoma)	PEAKS054012
EXP040897	SUMO2/3 (Cedarlane M114-3)	Homo sapiens	ICI for 3h	EXP040888	113	normal	P61956	MCF7 (Invasive ductal breast carcinoma)	PEAKS054013
EXP040898	Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #D2215	Mus musculus		NULL	32	normal	Q61880	testis	PEAKS042564
EXP040899	DMC1 Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #D2215	Mus musculus		NULL	32	normal	Q61880	testis	PEAKS042565
EXP040900	Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #J1215	Mus musculus		NULL	32	normal	Q61880	testis	PEAKS042566
EXP040901	Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #D2215	Mus musculus		NULL	32	normal	Q61880	testis	PEAKS042567
EXP040904	BAF155 (R-18) (Santa Cruz Biotechnology, Cat. sc-9746, Lot B1513)	Homo sapiens	Treatment: none	EXP040902	730	normal	Q92922	mononuclear cells from periferal blood	PEAKS042568
EXP040905	BAF155 (R-18) (Santa Cruz Biotechnology, Cat. sc-9746, Lot B1513)	Homo sapiens	Treatment: AML patient	EXP040903	1243	normal	Q92922	bone marrow-derived nuclear cells (adult)	PEAKS042569
EXP040909	rabbit anti-CLAMP	Drosophila melanogaster	CLAMP RNAi	NULL	1242	bio_control	Q961A1	S2 cells	PEAKS042570
EXP040910	rabbit anti-GAF	Drosophila melanogaster	CLAMP RNAi	EXP040906	1242	normal	Q08605	S2 cells	PEAKS042571
EXP040911	goat anti-MSL3	Drosophila melanogaster	CLAMP RNAi	EXP040906	1242	normal	P50536	S2 cells	PEAKS042572
EXP040912	rabbit anti-CLAMP	Drosophila melanogaster	GFP RNAi	EXP040907	1242	normal	Q961A1	S2 cells	PEAKS042573
EXP040913	rabbit anti-GAF	Drosophila melanogaster	GFP RNAi	EXP040907	1242	normal	Q08605	S2 cells	PEAKS042574
EXP040914	goat anti-MSL3	Drosophila melanogaster	GFP RNAi	EXP040907	1242	normal	P50536	S2 cells	PEAKS042575
EXP040915	rabbit anti-CLAMP	Drosophila melanogaster	GAF RNAi	EXP040908	1242	normal	Q961A1	S2 cells	PEAKS042576
EXP040916	rabbit anti-GAF	Drosophila melanogaster	GAF RNAi	EXP040908	1242	normal	Q08605	S2 cells	PEAKS042577
EXP040917	goat anti-MSL3	Drosophila melanogaster	GAF RNAi	EXP040908	1242	normal	P50536	S2 cells	PEAKS042578
EXP040920	EZH2	Homo sapiens	Treatment: none	EXP040918	47	normal	Q15910	KG1 (acute myeloid leukemia)	PEAKS042579
EXP040921	EZH2	Homo sapiens	Treatment: none	EXP040919	47	normal	Q15910	KG1 (acute myeloid leukemia)	PEAKS042580
EXP040922	PLZF	Homo sapiens	Treatment: none	EXP040918	47	normal	Q05516	KG1 (acute myeloid leukemia)	PEAKS042581
EXP040923	PLZF	Homo sapiens	Treatment: none	NULL	47	normal	Q05516	KG1 (acute myeloid leukemia)	PEAKS042582
EXP040924	Suz12	Homo sapiens	Treatment: none	NULL	47	normal	Q15022	KG1 (acute myeloid leukemia)	PEAKS042583
EXP040927	STAT5 Cell Signaling Cat#8363 Lot9	Mus musculus	Treatment: T-ALL- JAK3 active	EXP040925	917	normal	P42230	spleen	PEAKS042584
EXP040928	Cell Signaling Cat#8363 Lot9	Mus musculus	Treatment: T-ALL-JAK3+HOXA9 active	EXP040926	917	normal	P24270	spleen	PEAKS042585
EXP040929	HOXA9 Sigma Atlas Antibodies Cat#HPA061982 Lot#86503	Mus musculus	Treatment: T-ALL-JAK3+HOXA9 active	EXP040926	917	normal	P09631	spleen	PEAKS042586
EXP040930	p53 antibody (Santa Cruz, sc-126)	Homo sapiens		NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS042587
EXP040931	p53 antibody (Santa Cruz, sc-126)	Homo sapiens	MDMX C463A mutation	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS042588
EXP040950	SC-543	Homo sapiens	control	EXP040932	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054014
EXP040951	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040933	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054015
EXP040952	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040934	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054016
EXP040953	SC-543	Homo sapiens	control	EXP040935	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054017
EXP040954	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040936	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054018
EXP040955	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040937	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054019
EXP040956	SC-543	Homo sapiens	control	EXP040938	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054020
EXP040957	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040939	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054021
EXP040958	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040940	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054022
EXP040959	SC-543	Homo sapiens	control	EXP040941	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054023
EXP040960	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040942	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054024
EXP040961	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040943	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054025
EXP040962	HPA004820	Homo sapiens	control	EXP040944	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS054026
EXP040963	HPA004820	Homo sapiens	control	EXP040945	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS042602
EXP040964	HPA004820	Homo sapiens	control	EXP040946	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS042603
EXP040965	HPA004820	Homo sapiens	100nm E2 (45 min)	EXP040947	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS042604
EXP040966	HPA004820	Homo sapiens	100nm E2 (45 min)	EXP040948	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS042605
EXP040967	HPA004820	Homo sapiens	100nm E2 (45 min)	EXP040949	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS042606
EXP040970	anti-KAP1 (ab10483, Abcam)	Mus musculus		EXP040968	1245	normal	Q62318	Neuro-2A cells	PEAKS042607
EXP040971	anti-KAP1 (ab10483, Abcam)	Mus musculus		EXP040969	1245	normal	Q62318	Neuro-2A cells	PEAKS042608
EXP040973	Hdac3 (Santa Cruz Biotechnology, sc-13914)	Rattus norvegicus	Treatment: none	EXP040972	784	normal	Q6P6W3	Schwann cells	PEAKS042609
EXP040974	Hdac3 (Santa Cruz Biotechnology, sc-13914)	Rattus norvegicus	Treatment: none	EXP040972	784	normal	Q6P6W3	Schwann cells	PEAKS042610
EXP040975	p300	Rattus norvegicus	Treatment: none	EXP040972	784	normal	Q91XT0	Schwann cells	PEAKS042611
EXP040979	Myc	Danio rerio		EXP040976	1248	normal	A5JNG8	3.5 hpf embryo	PEAKS042612
EXP040980	Myc	Danio rerio		EXP040977	1247	normal	A5JNG8	4.5 hpf embryo	PEAKS042613
EXP040981	Myc	Danio rerio		EXP040978	1247	normal	Q9I944	4.5 hpf embryo	PEAKS042614
EXP040983	gata1	Danio rerio	Treatment: none	EXP040982	1249	normal	Q05AJ3	red blood cells, adult	PEAKS042615
EXP040985	Sox2	Danio rerio		EXP040984	1251	normal	Q6P0E1	embryos, late blastula	PEAKS042616
EXP040986	anti-FLAGÂ® M2	Danio rerio		EXP040984	1251	normal	Q90270	embryos, late blastula	PEAKS042617
EXP040987	anti-FLAGÂ® M2	Danio rerio		EXP040984	1252	normal	Q90270	embryos, 512 cell stage	PEAKS042618
EXP040990	Zic3	Danio rerio	wild type	EXP040988	1253	normal	Q6PV84	8 hpf embryo	PEAKS042619
EXP040991	Zic3	Danio rerio	sqet33 transgenic	EXP040989	1254	normal	Q6PV84	24 hpf embryo	PEAKS042620
EXP040993	Smad2	Danio rerio		EXP040992	1255	normal	Q9I9P9	embryos, high sphere stage	PEAKS042621
EXP040994	Eomesa	Danio rerio		EXP040992	1255	normal	Q98TU2	embryos, high sphere stage	PEAKS042622
EXP041000	Tbx6	Danio rerio		EXP040998	1256	normal	Q8JIS6	10S embryo	PEAKS042625
EXP041001	myc	Danio rerio		EXP040999	1256	normal	P52160	10S embryo	PEAKS042626
EXP041002	Smad2	Danio rerio	none	NULL	1247	normal	Q9I9P9	4.5 hpf embryo	PEAKS042627
EXP041003	Smad2	Danio rerio	Squint injection	NULL	1247	normal	Q9I9P9	4.5 hpf embryo	PEAKS042628
EXP041004	Smad2	Danio rerio	SB505124	NULL	1247	normal	Q9I9P9	4.5 hpf embryo	PEAKS042629
EXP041005	FoxH1	Danio rerio	none	NULL	1247	normal	Q9I9E1	4.5 hpf embryo	PEAKS042630
EXP041006	FoxH1	Danio rerio	Squint injection	NULL	1247	normal	Q9I9E1	4.5 hpf embryo	PEAKS042631
EXP041007	FoxH1	Danio rerio	SB505124	NULL	1247	normal	Q9I9E1	4.5 hpf embryo	PEAKS042632
EXP041012	Hif-1a custom antibody	Danio rerio	Wild type	EXP041010	1259	normal	Q6EHI4	4 dpf embryo	PEAKS042636
EXP041009	SOX10	Danio rerio	Treatment: Treatment: none	EXP041008	1258	normal	Q90XD1	melanoma tumor cell line	PEAKS042635
EXP041013	Hif-1a custom antibody	Danio rerio	von Hippel Lindau mutant (VHL)	EXP041011	1259	normal	Q6EHI4	4 dpf embryo	PEAKS042637
EXP041017	Rad21	Danio rerio		EXP041014	1260	normal	Q6TEL1	2.5 hpf embryo	PEAKS042638
EXP041018	Rad21 (custom made by GenScript Corporation, USA)	Danio rerio		EXP041015	1247	normal	Q6TEL1	4.5 hpf embryo	PEAKS042639
EXP041019	Rad21 (custom made by GenScript Corporation, USA)	Danio rerio		EXP041016	1257	normal	Q6TEL1	10 hpf embryo (bud stage)	PEAKS042640
EXP041020	CTCF (custom made by GenScript Corporation, USA)	Danio rerio		EXP041016	1257	normal	Q6JAA4	10 hpf embryo (bud stage)	PEAKS042641
EXP041024	Mixl1	Danio rerio		EXP041022	1262	normal	Q9PTQ9	epiboly, 30-50%	PEAKS042642
EXP041025	Ta	Danio rerio		EXP041021	1261	normal	Q07998	epiboly, 75-85%	PEAKS042643
EXP041026	Tbx16	Danio rerio		EXP041023	1261	normal	Q504I8	epiboly, 75-85%	PEAKS042644
EXP041028	Mediator subunit Med7 antibody [conjugated with beads (IgG Sepharose 6 Fast Flow from GE healthcare, 17-0969-01, Lot# 10026538)]	Schizosaccharomyces pombe		EXP041027	1263	normal	O60104	whole cells	PEAKS042645
EXP041038	Ctr9-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041030	1263	normal	O42668	whole cells	PEAKS042646
EXP041039	Swd1-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041031	1263	normal	O42858	whole cells	PEAKS042647
EXP041040	Set2-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041032	1263	normal	O14026	whole cells	PEAKS042648
EXP041041	Spt6	Schizosaccharomyces pombe	Treatment: none	EXP041029	1263	normal	Q09915	whole cells	PEAKS042649
EXP041042	Ctr9-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041033	1264	normal	O42668	spt6-1 strain	PEAKS042650
EXP041043	Set2-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041034	1264	normal	O14026	spt6-1 strain	PEAKS042651
EXP041044	Swd1-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041035	1264	normal	O42858	spt6-1 strain	PEAKS042652
EXP041046	Rabbit Polyclonal anti-TBP (Huang et al (2000) JBC 275:31480)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	P17871	KLP694 strain	PEAKS042653
EXP041047	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: G2/M	EXP041045	1265	normal	Q9HGP4	KLP694 strain	PEAKS042654
EXP041048	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: metaphase	EXP041045	1265	normal	Q9HGP4	KLP694 strain	PEAKS042655
EXP041049	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: anaphase	EXP041045	1265	normal	Q9HGP4	KLP694 strain	PEAKS042656
EXP041050	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: G1/S	EXP041045	1265	normal	Q9HGP4	KLP694 strain	PEAKS042657
EXP041051	Mouse Monoclonal anti-FLAG M2	Schizosaccharomyces pombe	Treatment: G2/M	EXP041045	1265	normal	P41004	KLP694 strain	PEAKS042658
EXP041052	Cut3	Schizosaccharomyces pombe	Treatment: metaphase	EXP041045	1265	normal	P41004	KLP694 strain	PEAKS042659
EXP041053	Cut3	Schizosaccharomyces pombe	Treatment: anaphase	EXP041045	1265	normal	P41004	KLP694 strain	PEAKS042660
EXP041054	Cut3	Schizosaccharomyces pombe	Treatment: G1/S	EXP041045	1265	normal	P41004	KLP694 strain	PEAKS042661
EXP041055	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	Q9HGP4	KLP694 strain	PEAKS042662
EXP041056	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	P40231	KLP694 strain	PEAKS042663
EXP041057	Rabbit Polyclonal anti-ptr6 (RTK7-8) (Mitsuzawa et al (2001) JBC 276:17117)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	O13701	KLP694 strain	PEAKS042664
EXP041062	GFP	Schizosaccharomyces pombe		EXP041058	1266	normal	O42995	A7988 strain	PEAKS042665
EXP041063	GFP	Schizosaccharomyces pombe		EXP041059	1267	normal	O94682	A7984 strain	PEAKS042666
EXP041064	GFP	Schizosaccharomyces pombe		EXP041060	1268	normal	Q9P802	A94 strain	PEAKS042667
EXP041065	GFP	Schizosaccharomyces pombe		EXP041061	1269	normal	Q9HDY7	5929 strain	PEAKS042668
EXP041068	anti-Myc; Clontech Cat. nr 631206	Schizosaccharomyces pombe	Treatment: Treatment: none	EXP041066	1270	normal	Q9UUA2	NS29 strain	PEAKS042669
EXP041069	anti-HA; Santa Cruz Cat nr. sc.7392x	Schizosaccharomyces pombe	Treatment: Treatment: none	EXP041067	1271	normal	P87154	NS119 strain	PEAKS042670
EXP041070	anti-HA; Santa Cruz Cat nr. sc.7392x	Schizosaccharomyces pombe	Treatment: Treatment: Pfh1-depleted	EXP041067	1271	normal	P87154	NS119 strain	PEAKS042671
EXP041072	Anti-Myc (Abcam ab9132)	Danio rerio	Treatment: none	EXP041071	1257	normal	F1QWA0	10 hpf embryo (bud stage)	PEAKS042672
EXP041073	Anti-Myc (Abcam ab9132)	Danio rerio	Treatment: none	EXP041071	1257	normal	F1QDF2	10 hpf embryo (bud stage)	PEAKS042673
EXP041074	IgG Sepharose 6 Fast Flow (GE, catalog #17-0969-01, lot #10035322, 10160338)	Schizosaccharomyces pombe	untagged	NULL	1277	normal	O43047	F108 Strain	PEAKS042674
EXP041075	IgG Sepharose 6 Fast Flow (GE, catalog #17-0969-01, lot #10035322, 10160338)	Schizosaccharomyces pombe		NULL	1276	normal	O60129	JLP1586 Strain	PEAKS042675
EXP041076	IgG Sepharose 6 Fast Flow (GE, catalog #17-0969-01, lot #10035322, 10160338)	Schizosaccharomyces pombe		NULL	1275	normal	P48383	JLP1792 Strain	PEAKS042676
EXP041077	sep1	Schizosaccharomyces pombe	1mM bortezomib (45 min.)	NULL	1274	normal	O43058	JLP1670 Strain	PEAKS042677
EXP041082	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041078	1282	normal	O14126	SPO195 Strain	PEAKS042678
EXP044368	anti-LEM-2 (Novus Biologicals, catalog #48540002, lot# T01872A01)	Caenorhabditis elegans	GW638 strain	EXP044365	1405	normal	Q9XTB5	whole organism (development stage: early embryonic)	PEAKS044521
EXP041084	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041079	1284	normal	Q9P6R0	SPK971 Strain	PEAKS042680
EXP041085	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041080	1285	normal	P41003	SPO16 Strain	PEAKS042681
EXP041086	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041080	1286	normal	O60174	SPK886 Strain	PEAKS042682
EXP041087	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041080	1287	normal	Q9UTL5	SPK1072 Strain	PEAKS042683
EXP041088	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures	EXP041081	1289	normal	Q9Y7R3	SPO572 Strain	PEAKS042684
EXP041089	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures; Cnd2 F701R	EXP041081	1290	normal	Q9Y7R3	SPO568 Strain	PEAKS042685
EXP041090	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures; Cnd2 C703R	EXP041081	1291	normal	Q9Y7R3	SPO569 Strain	PEAKS042686
EXP041095	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe		EXP041091	1295	bio_control	G2TRJ8	KYP123 Strain	PEAKS042687
EXP041096	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe		EXP041092	1292	normal	Q96UP3	KYP1265 Strain	PEAKS042688
EXP041097	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe	rap1delta	EXP041093	1293	normal	Q96UP3	KYP1308 Strain	PEAKS042689
EXP041098	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe	taz1delta	EXP041094	1294	normal	Q96UP3	KYP1306 Strain	PEAKS042690
EXP041099	none	Schizosaccharomyces pombe		NULL	1269	normal	A0ZWU1	5929 strain	PEAKS042691
EXP041100	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe		NULL	1269	normal	G2TRJ8	5929 strain	PEAKS042692
EXP041110	anti-Flag M2 antibody	Schizosaccharomyces pombe	mitiotically arrested	EXP041101	1296	normal	P41003	nda3-KM311 Cut14-3FLAG	PEAKS042693
EXP041111	anti-Flag M2 antibody	Schizosaccharomyces pombe	mitiotically arrested	EXP041102	1297	normal	P30776	nda3-KM311 Rad21-3FLAG	PEAKS042694
EXP041112	anti-Flag M2 antibody	Schizosaccharomyces pombe	mitiotically arrested	EXP041103	1298	normal	P08096	nda3-KM311 Top2-3FLAG	PEAKS042695
EXP041113	anti-Flag M2 antibody	Schizosaccharomyces pombe	Asynchronous cells	EXP041104	1299	normal	P41003	Cut14-3FLAG	PEAKS042696
EXP041114	Rad21	Schizosaccharomyces pombe	Asynchronous cells	EXP041105	1300	normal	P30776	Rad21-3FLAG	PEAKS042697
EXP041115	anti-Flag M2 antibody	Schizosaccharomyces pombe	Asynchronous cells	EXP041106	1301	normal	P08096	Top2-3FLAG	PEAKS042698
EXP041116	Cut14	Schizosaccharomyces pombe	heat shock	EXP041107	1299	normal	P41003	Cut14-3FLAG	PEAKS042699
EXP041117	anti-Flag M2 antibody	Schizosaccharomyces pombe	heat shock	EXP041108	1300	normal	P30776	Rad21-3FLAG	PEAKS042700
EXP041118	anti-Flag M2 antibody	Schizosaccharomyces pombe	heat shock	EXP041109	1301	normal	P08096	Top2-3FLAG	PEAKS042701
EXP041121	GFP-Trap beads	Schizosaccharomyces pombe	High Phosphate	EXP041119	1304	normal	Q9Y7Z8	Myo1-GFP	PEAKS042702
EXP041122	GFP-Trap beads	Schizosaccharomyces pombe	Low Phosphate	EXP041120	1304	normal	Q9Y7Z8	Myo1-GFP	PEAKS042703
EXP041124	mouse monoclonal anti-V5/Pk1	Schizosaccharomyces pombe		EXP041123	1305	normal	O13861	Y4250 Strain	PEAKS042704
EXP041125	mouse monoclonal anti-V5/Pk1	Schizosaccharomyces pombe	SWI1 deletion	EXP041123	1306	normal	O13861	Y4256 Strain	PEAKS042705
EXP041127	HA tag antibody [12CA5] (abcam16918)	Schizosaccharomyces pombe		EXP041126	1303	normal	P49777	wild-type	PEAKS042706
EXP041129	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	NULL	1308	normal	Q10103	SPY137 Strain	PEAKS042707
EXP041130	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	NULL	1309	normal	Q10103	SPY815 Strain	PEAKS042708
EXP041131	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	NULL	1310	normal	Q10103	SPY4642 Strain	PEAKS042709
EXP041132	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4I418P	NULL	1311	normal	Q10103	SPY6537 Strain	PEAKS042710
EXP041133	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: chp1_delta	NULL	1312	normal	Q10103	SPY2421 Strain	PEAKS042711
EXP041134	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	NULL	1308	normal	P40381	SPY137 Strain	PEAKS042712
EXP041135	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	NULL	1309	normal	P40381	SPY815 Strain	PEAKS042713
EXP041136	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	NULL	1310	normal	P40381	SPY4642 Strain	PEAKS042714
EXP041137	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: swi6_delta	NULL	1313	normal	P40381	SPY1098 Strain	PEAKS042715
EXP041138	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	EXP041128	1314	normal	O42934	SPY5378 Strain	PEAKS042716
EXP041139	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	EXP041128	1315	normal	O42934	SPY5380 Strain	PEAKS042717
EXP041140	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	EXP041128	1316	normal	O42934	SPY5382 Strain	PEAKS042718
EXP041141	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	EXP041128	1317	normal	P56523	SPY5593 Strain	PEAKS042719
EXP041142	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	EXP041128	1318	normal	P56523	SPY5595 Strain	PEAKS042720
EXP041143	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	EXP041128	1319	normal	P56523	SPY5597 Strain	PEAKS042721
EXP041144	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: flag-clr4	EXP041128	1320	normal	O60016	SPY4636 Strain	PEAKS042722
EXP041145	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: flag-clr4F449Y	EXP041128	1310	normal	O60016	SPY4642 Strain	PEAKS042723
EXP041146	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: flag-clr4W31G	EXP041128	1321	normal	O60016	SPY5562 Strain	PEAKS042724
EXP041150	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: mock_WT	NULL	1303	normal	G2TRJ8	wild-type	PEAKS042725
EXP041151	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: mock_WT	EXP041149	1303	normal	G2TRJ8	wild-type	PEAKS042726
EXP041152	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1322	normal	O74842	Fft2-5xFLAG	PEAKS042727
EXP041153	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1322	normal	O74842	Fft2-5xFLAG	PEAKS042728
EXP041154	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1323	normal	O42861	Fft3-5xFLAG	PEAKS042729
EXP041155	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1323	normal	O42861	Fft3-5xFLAG	PEAKS042730
EXP041156	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1324	normal	O14148	Ino80-5xFLAG	PEAKS042731
EXP041157	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1269	normal	O14148	5929 strain	PEAKS042732
EXP041158	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1269	normal	Q9UTN6	5929 strain	PEAKS042733
EXP041159	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1269	normal	Q9UTN6	5929 strain	PEAKS042734
EXP041160	sc-9996; Santa Cruz Biotech.	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1325	normal	O94267	GFP_Spt16	PEAKS042735
EXP041161	sc-9996; Santa Cruz Biotech.	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1325	normal	O94267	GFP_Spt16	PEAKS042736
EXP041162	ccp1	Schizosaccharomyces pombe	wt (h- ade6+::cnp1-GFP leu1-32 ura4-D18)	NULL	1326	normal	Q9Y812	FL571 Strain	PEAKS042737
EXP041163	GFP (Abcam, ab290)	Schizosaccharomyces pombe	ccp1 mutant (h? ccp1{delta}::ura4+ ade6+::cnp1-GFP leu1-32 ura4-D18)	NULL	1327	normal	A0ZWU1	FL656 Strain	PEAKS042738
EXP041164	GFP (Abcam, ab290)	Schizosaccharomyces pombe	ccp1 mutant (h? ccp1{delta}::kanMX6 ade6+::cnp1-GFP leu1-32 ura4-D18)	NULL	1328	normal	A0ZWU1	FL657 Strain	PEAKS042739
EXP041169		Schizosaccharomyces pombe	h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1, pcf11::pcf11-TAP::KanMX	NULL	1263	normal	Q10237	whole cells	PEAKS042740
EXP041170		Schizosaccharomyces pombe	h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1, pcf11::pcf11-TAP::KanMX	NULL	1263	normal	Q10237	whole cells	PEAKS042741
EXP041171		Schizosaccharomyces pombe	untagged; h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1	NULL	1263	bio_control	A0A075WJH4	whole cells	PEAKS042742
EXP041172		Schizosaccharomyces pombe	untagged; h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1	NULL	1263	bio_control	A0A075WJH4	whole cells	PEAKS042743
EXP041177		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+	EXP041173	1303	normal	A0A075WJH4	wild-type	PEAKS042744
EXP041178		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+	EXP041174	1303	normal	A0A075WJH4	wild-type	PEAKS042745
EXP041179		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+, seb1-3HA-TAP::kan MX	EXP041175	1329	normal	Q9UTE3	seb1-3HA-TAP	PEAKS042746
EXP041180		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+, seb1-3HA-TAP::kan MX	EXP041176	1329	normal	Q9UTE3	seb1-3HA-TAP	PEAKS042747
EXP041181	anti-FLAG M2-Magnetic Beads (Sigma-Aldrich)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: wild type	NULL	1330	normal	O74856	773 Strain	PEAKS042748
EXP041182	anti-FLAG M2-Magnetic Beads (Sigma-Aldrich)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Clr4?	NULL	1331	normal	O74856	848 Strain	PEAKS042749
EXP041184	Cnd2	Schizosaccharomyces pombe	5 Âµg/mL thiamine	EXP041183	1332	normal	Q9Y7R3	YUK421 Cnd2-HA	PEAKS042750
EXP041186	anti-FLAG	Schizosaccharomyces pombe	Treatment: ura4-D18 leu1-32	EXP041185	1263	normal	P87048	whole cells	PEAKS042751
EXP041187	anti-FLAG	Schizosaccharomyces pombe	Treatment: ura4-D18 leu1-32	EXP041185	1263	normal	Q09720	whole cells	PEAKS042752
EXP041196	anti-V5	Schizosaccharomyces pombe	DMSO	EXP041188	1333	normal	O13936	FWP486 (Spt5-degron) Strain	PEAKS042753
EXP041197	anti-V5	Schizosaccharomyces pombe	thiamine + 1-Napthaleneacetic acid (NAA)	EXP041189	1333	normal	O13936	FWP486 (Spt5-degron) Strain	PEAKS042754
EXP041198	anti-V5	Schizosaccharomyces pombe	no treatment	EXP041191	1334	normal	O13936	FWP485 (Spt5-V5-IAA17) Strain	PEAKS042755
EXP041199	anti-V5	Schizosaccharomyces pombe	DMSO	EXP041192	1333	normal	O13936	FWP486 (Spt5-degron) Strain	PEAKS042756
EXP041200	anti-V5	Schizosaccharomyces pombe	thiamine + 1-Napthaleneacetic acid (NAA)	EXP041193	1333	normal	O13936	FWP486 (Spt5-degron) Strain	PEAKS042757
EXP041201	anti-V5	Schizosaccharomyces pombe	no treatment	EXP041195	1334	normal	O13936	FWP485 (Spt5-V5-IAA17) Strain	PEAKS042758
EXP041202	anti-SEP3	Arabidopsis thaliana	wild type	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	PEAKS042759
EXP041203	anti-SEP3	Arabidopsis thaliana	wild type	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	PEAKS042760
EXP041204	anti-SEP3	Arabidopsis thaliana	sep3 mutant (sep3-1)	NULL	1336	bio_control	O22456	inflorescence meristems and floral buds (5-7 weeks)	PEAKS042761
EXP041205	anti-SEP3	Arabidopsis thaliana	wild type	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	PEAKS042762
EXP041206	anti-SEP3	Arabidopsis thaliana	agamous mutant (ag-1)	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	PEAKS042763
EXP041207	AMS	Arabidopsis thaliana		NULL	1337	normal	Q9ZVX2	buds	PEAKS042764
EXP041209	AP2 custom antibody 	Arabidopsis thaliana		EXP041208	1337	normal	P47927	buds	PEAKS042765
EXP041210	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	single treatment of 1 uM DEX to the shoot apex (2 hours)	NULL	1338	normal	P35631	apical meristems	PEAKS042766
EXP041211	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	single treatment of 1 uM DEX to the shoot apex (2 hours)	NULL	1338	normal	P35631	apical meristems	PEAKS042767
EXP041212	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	control	NULL	1338	normal	P35631	apical meristems	PEAKS042768
EXP041213	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	control	NULL	1338	normal	P35631	apical meristems	PEAKS042769
EXP041216	F3165 Sigma Monoclonal ANTI-FLAG M2	Arabidopsis thaliana	Col-0 transgene	EXP041214	1340	normal	Q9SE43	complete seedlings	PEAKS042770
EXP041217	F3165 Sigma Monoclonal ANTI-FLAG M2	Arabidopsis thaliana	35S::FLAG-GR-REVd	EXP041215	1341	normal	Q9SE43	10 day old seedlings	PEAKS042771
EXP041218	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	wild type (Col-0)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042772
EXP041219	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	wild type (Col-0)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042773
EXP041220	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	plants that overexpressed LFY (35S:LFY)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042774
EXP041221	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	plants that overexpressed LFY (35S:LFY)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042775
EXP041222	FLAG (Sigma-Aldrich)	Arabidopsis thaliana	Dark (35S:3FLAG-FHY3-3HA fhy3-4 transgenic line)	NULL	1343	normal	Q9LIE5	4 day old seedlings	PEAKS042776
EXP041223	FLAG (Sigma-Aldrich)	Arabidopsis thaliana	Far-Red (35S:3FLAG-FHY3-3HA fhy3-4 transgenic line)	NULL	1343	normal	Q9LIE5	4 day old seedlings	PEAKS042777
EXP041225	anti-FlagM2	Arabidopsis thaliana	low R/FR light (PIF5-HA overexpressor Flag tagged)	EXP041224	1344	normal	Q84LH8	14 day old seedling	PEAKS042778
EXP041226	anti-myc antibody	Arabidopsis thaliana	genotype: pPIF4::PIF4-myc (grown in the dark for 5 days)	EXP041227	1340	normal	Q8W2F3	complete seedlings	PEAKS042779
EXP041228	GFP:Living Colors_ full-length A.v. polyclonal antibody Clontech	Arabidopsis thaliana	wild type Col	NULL	1346	normal	Q9FVC1	inflorescence meristem and flower from stages 1 to 11	PEAKS042781
EXP041229	GFP:Living Colors_ full-length A.v. polyclonal antibody Clontech	Arabidopsis thaliana	pSVP::SVP-GFP svp-41	NULL	1346	normal	Q9FVC1	inflorescence meristem and flower from stages 1 to 11	PEAKS042782
EXP041230	GFP:Living Colors_ full-length A.v. polyclonal antibody Clontech	Arabidopsis thaliana	pSVP::SVP-GFP svp-41	NULL	1348	normal	Q9FVC1	seedlings 2 weeks old	PEAKS042783
EXP041234	AGO4 antibody	Arabidopsis thaliana	Wild type (Col-0)	EXP041231	1347	normal	Q9ZVD5	2-3 week old seedling	PEAKS042784
EXP041235	AGO4 antibody	Arabidopsis thaliana	ago4 mutant (ago4-1)	EXP041232	1347	normal	Q9ZVD5	2-3 week old seedling	PEAKS042785
EXP041236	AGO4 antibody	Arabidopsis thaliana	nrpe1 mutant (nrpd1b-11)	EXP041233	1347	normal	Q9ZVD5	2-3 week old seedling	PEAKS042786
EXP041238	anti-GFP	Arabidopsis thaliana	TMG-YFP/toc1-2	EXP041237	1340	normal	Q9LKL2	complete seedlings	PEAKS042787
EXP041239	Anti-GFP	Arabidopsis thaliana	PI-GFP AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1188	normal	P48007	floral tissue	PEAKS042788
EXP041240	ap3	Arabidopsis thaliana	AP3-GFP AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1188	normal	P35632	floral tissue	PEAKS042789
EXP041241	Anti-GFP AB290	Arabidopsis thaliana	AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1188	bio_control	F4IIH6	floral tissue	PEAKS042790
EXP041242	anti-FLAG catalog #: M8823-5ml, Lot #: 041M6135	Arabidopsis thaliana	Transgenic plants expressing CMT3-FLAG	NULL	1188	normal	Q94F88	floral tissue	PEAKS042791
EXP041243	anti-FLAG catalog #: M8823-5ml, Lot #: 041M6135	Arabidopsis thaliana	Wild-type plants not expressing CMT3-FLAG	NULL	1188	bio_control	Q4V3D6	floral tissue	PEAKS042792
EXP041245	anti-GFP	Arabidopsis thaliana	PRR5pro:FLAG-PRR5-GFP/prr5 (12 h light/12 h dark conditions for 18 d; 10 hr after light on)	EXP041244	1231	normal	Q6LA42	whole plants	PEAKS042793
EXP041246	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	true dark; WT genotype	NULL	1349	normal	O80536	2 day old seedlings	PEAKS042794
EXP041247	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	true dark; pif3-3 genotype	NULL	1349	normal	O80536	2 day old seedlings	PEAKS042795
EXP041251	anti-HA (Abcam ab9110)	Arabidopsis thaliana	eds1 wt; 35S:RPS4-HS	EXP041248	1350	normal	Q9XGM3	leaves	PEAKS042796
EXP041252	anti-HA (Abcam ab9110)	Arabidopsis thaliana	eds 1-2 mutant; 35S:RPS4-HS eds1-2	EXP041249	1350	normal	Q9XGM3	leaves	PEAKS042797
EXP041253	anti-HA (Abcam ab9110)	Arabidopsis thaliana		EXP041250	1350	normal	Q9XGM3	leaves	PEAKS042798
EXP044367	anti-LEM-2 (Novus Biologicals, catalog #48540002, lot# T01872A01)	Caenorhabditis elegans	GW1 strain	EXP044364	1405	normal	Q9XTB5	whole organism (development stage: early embryonic)	PEAKS044520
EXP041262	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF1 (P1M)	EXP041259	1351	normal	Q8GZM7	3 day old seedlings	PEAKS042804
EXP041263	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF1 (P1M)	EXP041260	1351	normal	Q8GZM7	3 day old seedlings	PEAKS042805
EXP041264	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF1 (P1M)	EXP041261	1351	normal	Q8GZM7	3 day old seedlings	PEAKS042806
EXP041268	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF4 (P1M)	EXP041265	1351	normal	Q8W2F3	3 day old seedlings	PEAKS042807
EXP041269	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF4 (P1M)	EXP041266	1351	normal	Q8W2F3	3 day old seedlings	PEAKS042808
EXP041270	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF4 (P1M)	EXP041267	1351	normal	Q8W2F3	3 day old seedlings	PEAKS042809
EXP041271	FLAG antibody	Arabidopsis thaliana	35S:FLAG-SPL7 transgene	NULL	1352	normal	Q8S9G8	7 days old seedlings	PEAKS042810
EXP041272		Arabidopsis thaliana	spl7 mutant	NULL	1352	bio_control	A0A023T4L8	7 days old seedlings	PEAKS042811
EXP041274	anti-HA antibodies (H6908, Sigma-Aldrich)	Arabidopsis thaliana	genotype: 35S:ATAF1-HA	EXP041273	1353	normal	Q39013	rosette stage (5 weeks, short day)	PEAKS042812
EXP041275	Anti-GFP AB290 (Abcam)	Arabidopsis thaliana	AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1345	bio_control	P17839	inflorescence	PEAKS042813
EXP041276	Anti-GFP AB290 (Abcam)	Arabidopsis thaliana	AG-GFP AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1345	normal	P17839	inflorescence	PEAKS042814
EXP041280	anti-SEP3 antibody (Eurogentec, custom-made, peptide antibody)	Arabidopsis thaliana	4 days after DEX	EXP041278	1345	normal	O22456	inflorescence	PEAKS042815
EXP041281	anti-SEP3 antibody (Eurogentec, custom-made, peptide antibody)	Arabidopsis thaliana	8 days after DEX	EXP041279	1345	normal	O22456	inflorescence	PEAKS042816
EXP041282	anti-GR antibody (Glucocorticoid Receptor alpha Polyclonal antibody (Thermo Scientific, cat# PA1-516, lot# MD153967; to precipitate AP1-GR)	Arabidopsis thaliana	4 days after DEX	EXP041278	1345	normal	P35631	inflorescence	PEAKS042817
EXP041283	anti-GR antibody (Glucocorticoid Receptor alpha Polyclonal antibody (Thermo Scientific, cat# PA1-516, lot# MD153967; to precipitate AP1-GR)	Arabidopsis thaliana	8 days after DEX	EXP041279	1345	normal	P35631	inflorescence	PEAKS042818
EXP041284	anti-GR antibody (Glucocorticoid Receptor alpha Polyclonal antibody (Thermo Scientific, cat# PA1-516, lot# MD153967; to precipitate AP1-GR)	Arabidopsis thaliana	2 days after DEX	EXP041277	1345	normal	P35631	inflorescence	PEAKS042819
EXP041285	SEP3 antibody	Arabidopsis thaliana	2 days after DEX	EXP041277	1345	normal	O22456	inflorescence	PEAKS042820
EXP041287	Sigma anti-FLAG magnetic beads (Product No. A2220)	Arabidopsis thaliana	45 minutes DEX treatment	EXP041286	1341	normal	Q93WJ9	10 day old seedlings	PEAKS042821
EXP041291	anti-GFP	Arabidopsis thaliana		EXP041288	1339	normal	Q9AT76	seedling	PEAKS042822
EXP041292	anti-GFP Ab (Abcam #ab290)	Arabidopsis thaliana	iFLM-beta splicing variant	EXP041289	1339	normal	Q9AT76	seedling	PEAKS042823
EXP041293	anti-GFP Ab (Abcam #ab290)	Arabidopsis thaliana	iFLM-delta splicing variant	EXP041290	1339	normal	Q9AT76	seedling	PEAKS042824
EXP041295	anti-GFP 632592	Arabidopsis thaliana		EXP041294	1343	normal	P14712	4 day old seedlings	PEAKS042825
EXP041297	ERF115	Arabidopsis thaliana	35S::ERF115-HBH genotype	EXP041296	1354	normal	Q9LY29	PSB-d dark growing suspension cells	PEAKS042826
EXP041300	anti-HA	Arabidopsis thaliana	prr7-3 genotype	EXP041298	1342	normal	Q93WK5	complete 15 day-old seedlings	PEAKS042827
EXP041301	anti-HA	Arabidopsis thaliana	prr7-3 PRR7::HA-PRR7 genotype	EXP041299	1342	normal	Q93WK5	complete 15 day-old seedlings	PEAKS042828
EXP041303	GFP ab290	Arabidopsis thaliana	p35S::IBH1-GFP (IBH1OE) genotype	EXP041302	1341	normal	Q9M0B9	10 day old seedlings	PEAKS042829
EXP041305	anti-GFP	Arabidopsis thaliana	 JAG:JAG-GFP genotype	EXP041304	1355	normal	Q6S591	unopened buds	PEAKS042830
EXP041307	anti-myc antibody	Arabidopsis thaliana	ARF6p::ARF6-Myc in arf6;arf8 seedlings	EXP041306	1339	normal	Q9ZTX8	seedling	PEAKS042831
EXP041309	antiserum against the full-length LHY protein	Arabidopsis thaliana		EXP041308	1348	normal	Q6R0H1	seedlings 2 weeks old	PEAKS042832
EXP041312	anti-GFP microbeads (Miltenyi ÂµMACS GFP Isolation Kit)	Arabidopsis thaliana		EXP041310	1356	normal	Q6PQQ4	somatic embryos	PEAKS042833
EXP041313	anti-GFP microbeads (Miltenyi ÂµMACS GFP Isolation Kit)	Arabidopsis thaliana		EXP041311	1358	normal	Q6PQQ4	whole embryogenic seedlings	PEAKS042834
EXP041315	YFP antibody (Homemade)	Arabidopsis thaliana		EXP041314	1359	normal	Q9ZPW3	4 week old seedlings	PEAKS042835
EXP041317	E2Fa	Arabidopsis thaliana		EXP041316	1354	normal	Q9FNY0	PSB-d dark growing suspension cells	PEAKS042836
EXP041321	DEK3	Arabidopsis thaliana	OE3-1	EXP041318	1344	normal	Q9SUA1	14 day old seedling	PEAKS042837
EXP041322	GFP antibdoy (abcam #290)	Arabidopsis thaliana	OE9-1	EXP041319	1344	normal	Q9SUA1	14 day old seedling	PEAKS042838
EXP041323	GFP antibdoy (abcam #290)	Arabidopsis thaliana	OE17-4	EXP041320	1344	normal	Q9SUA1	14 day old seedling	PEAKS042839
EXP041325	Polyclonal antibody of AL5 protein	Arabidopsis thaliana	AL5 overexpression	EXP041324	1359	normal	Q5XEM9	4 week old seedlings	PEAKS042840
EXP041327	Anti-Myc (Cell Signaling Technology, catalog# 71D10, lot# 5)	Arabidopsis thaliana	SPCHp:SPCH2-4A-MYC in spch3	EXP041326	1343	normal	Q700C7	4 day old seedlings	PEAKS042841
EXP041329	FHY1	Arabidopsis thaliana	35S: GFP-FHY1, fhy1-1	EXP041328	1343	normal	Q8S4Q6	4 day old seedlings	PEAKS042842
EXP041332	c-Myc Mouse Monoclonal Antibody	Arabidopsis thaliana	proMBD7::gMBD7:4xMYC transgenic	EXP041330	1340	normal	Q9FJF4	complete seedlings	PEAKS042843
EXP041333	c-Myc Mouse Monoclonal Antibody	Arabidopsis thaliana	wt; 35S-SUC2-Myc-ChIP	EXP041331	1340	normal	Q39231	complete seedlings	PEAKS042844
EXP041335	GFP-Trap_A (ChromoTek)	Arabidopsis thaliana	18 h 10 ÂµM PAC, 6 h 5 ÂµM BA; RGA::RGA-GFP	EXP041334	1341	normal	Q9SLH3	10 day old seedlings	PEAKS042845
EXP041337	AbCam290	Arabidopsis thaliana		EXP041336	1360	normal	Q700D2	ground tissue and stem cell organizer (QC)	PEAKS042846
EXP041338	AT1G14580.1	Arabidopsis thaliana		EXP041336	1361	normal	Q8RWX7	Ground tissue	PEAKS042847
EXP041340	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	EXP041339	1363	normal	Q9SQX9	12 day old seedlings	PEAKS042848
EXP041341	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	EXP041339	1363	normal	Q9SQY0	12 day old seedlings	PEAKS042849
EXP041342	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: jmj14-1 mutant	EXP041339	1363	bio_control	A0A1I9LN22	12 day old seedlings	PEAKS042850
EXP041343	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	EXP041339	1363	normal	Q8GUI6	12 day old seedlings	PEAKS042851
EXP041344	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: JMJ14-FYR-HA genotype	EXP041339	1363	normal	Q8GUI6	12 day old seedlings	PEAKS042852
EXP041346	anti-GFP	Arabidopsis thaliana		EXP041345	1364	normal	Q8H1P9	9 day old seedlings	PEAKS042853
EXP044363	a-ELT-2 (455-2A4)	Caenorhabditis elegans	Treatment: N2 strain	EXP044361	1390	normal	Q10655	whole worms (developmental stage: L3)	PEAKS044519
EXP044360	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: N2 strain	EXP044353	1235	normal	P48996	whole worms (developmental stage: young adults)	PEAKS044518
EXP041353	rabbit (#4028) against the LFY C-terminal amino acids 223-424	Arabidopsis thaliana		NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042860
EXP041354	rabbit (#4028) against the LFY C-terminal amino acids 223-424	Arabidopsis thaliana	p35S:LFY; CA26-15 strain	NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042861
EXP041355	rabbit (#4028) against the LFY C-terminal amino acids 223-424	Arabidopsis thaliana	p35S:LFYTERE; CA29-17 strain	NULL	1342	normal	Q00958	complete 15 day-old seedlings	PEAKS042862
EXP041357	HA (Sigma, Catalog: H6908)	Arabidopsis thaliana	Treatment: REF6p::REF6-HA ref6-1	EXP041356	1363	normal	Q9STM3	12 day old seedlings	PEAKS042863
EXP041358	HA (Sigma, Catalog: H6908)	Arabidopsis thaliana	Treatment: REF6p::REF6-ZnF-HA ref6-1	EXP041356	1363	normal	Q9STM3	12 day old seedlings	PEAKS042864
EXP041360	anti-FLAG M2 magnetic beads (Sigma, catalog# A2220)	Arabidopsis thaliana		EXP041359	1341	normal	P46602	10 day old seedlings	PEAKS042865
EXP041363	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour mock treated; wt	NULL	1365	bio_control	A0A178V8T3	4 week old mature leaves	PEAKS042866
EXP041364	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour post inoculation with spores of Botrytis cinerea 2100; wt	NULL	1365	bio_control	A0A178V8T3	4 week old mature leaves	PEAKS042867
EXP041365	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour mock treated; WRKY33-HA	EXP041361	1365	normal	Q8S8P5	4 week old mature leaves	PEAKS042868
EXP041366	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour post inoculation with spores of Botrytis cinerea 2100	EXP041362	1365	normal	Q8S8P5	4 week old mature leaves	PEAKS042869
EXP041367	anti-FLAG antibody	Arabidopsis thaliana	CCA1pro:CCA1-FLAG cca1 lhy	NULL	1344	normal	P92973	14 day old seedling	PEAKS042870
EXP041368	anti-FLAG antibody	Arabidopsis thaliana	CCA1pro:CCA1-FLAG cca1 lhy	NULL	1344	normal	P92973	14 day old seedling	PEAKS042871
EXP041372	anti-FLAG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	EXP041369	1366	normal	Q96524	5 day old seedlings	PEAKS042872
EXP041373	anti-FLAG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	EXP041370	1366	normal	Q8W2F3	5 day old seedlings	PEAKS042873
EXP041374	anti-FLAG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	EXP041371	1366	normal	Q84LH8	5 day old seedlings	PEAKS042874
EXP041376	Sigma-Aldrich, A2220	Arabidopsis thaliana		EXP041375	1367	normal	Q9LIE5	Inflorescence containing stage 8 and younger flowers	PEAKS042875
EXP041379	GFP-Trap A matrix	Arabidopsis thaliana	TRB1pro:TRB1-GFP/TRB1pro:TRB1-GFP	EXP041377	1344	normal	Q8VWK4	14 day old seedling	PEAKS042876
EXP041380	anti-TRB1 (5.2)	Arabidopsis thaliana		EXP041378	1344	normal	Q8VWK4	14 day old seedling	PEAKS042877
EXP041382	Chromotek, GFP-Trap	Arabidopsis thaliana		EXP041381	1345	normal	Q9T0G7	inflorescence	PEAKS042878
EXP041383	Chromotek, GFP-Trap	Arabidopsis thaliana	WT; SUVH9-VENUS	EXP041381	1345	normal	Q9T0G7	inflorescence	PEAKS042879
EXP041385	anti-GFP	Arabidopsis thaliana	Constant Light after entrainment in 12h:12h Light: Dark; ZT14	EXP041384	1344	normal	P92973	14 day old seedling	PEAKS042880
EXP041386	anti-GFP	Arabidopsis thaliana	Constant Light after entrainment in 12h:12h Light: Dark; ZT2	EXP041384	1344	normal	P92973	14 day old seedling	PEAKS042881
EXP041387	anti-GFP	Arabidopsis thaliana	Diel 12h:12h Light:Dark; ZT2	EXP041384	1344	normal	P92973	14 day old seedling	PEAKS042882
EXP041391	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1-GFP;soc1-2; 15 days SD + 3 days LD	EXP041388	1368	normal	O64645	transition apices	PEAKS042883
EXP041392	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1-GFP;soc1-2; 15 days SD + 3 days LD	EXP041389	1368	normal	O64645	transition apices	PEAKS042884
EXP041393	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1-GFP;soc1-2; 15 days SD + 3 days LD	EXP041390	1368	normal	O64645	transition apices	PEAKS042885
EXP041396	APRR9	Arabidopsis thaliana	Cycling 12 h light/12 h dark; ZT4	EXP041394	1344	normal	Q8L500	14 day old seedling	PEAKS042886
EXP041397	APRR9	Arabidopsis thaliana	Cycling 12 h light/12 h dark; ZT4	EXP041395	1344	normal	Q8L500	14 day old seedling	PEAKS042887
EXP041398	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana	rpl-1 mutant transformed with genomic contruct expressing a fusion between RPL and GFP (pRPL:RPL-GFP)	NULL	1369	normal	Q9LZM8	inflorescence apices	PEAKS042888
EXP041399	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana	wild-type	NULL	1369	normal	Q9LZM8	inflorescence apices	PEAKS042889
EXP041401	Anti-FLAGÂ® M2 Magnetic Beads (M8823 SIGMA)	Arabidopsis thaliana	Treatment: Temp 17C	EXP041400	1363	normal	P41151	12 day old seedlings	PEAKS042890
EXP041402	Anti-FLAGÂ® M2 Magnetic Beads (M8823 SIGMA)	Arabidopsis thaliana	Treatment: Temp 27C	EXP041400	1363	normal	P41151	12 day old seedlings	PEAKS042891
EXP041403	Anti-FLAGÂ® M2 Magnetic Beads (M8823 SIGMA)	Arabidopsis thaliana	Treatment: Temp 37C	EXP041400	1363	normal	P41151	12 day old seedlings	PEAKS042892
EXP041404	anti-GFP	Arabidopsis thaliana	none (untreated; NHS); 35S::FRG1-YFP	NULL	1370	normal	Q9LHE4	6 day old seedlings	PEAKS042893
EXP041405	anti-GFP	Arabidopsis thaliana	acclimatizing (ACC) heat stress; 35S::FRG1-YFP	NULL	1370	normal	Q9LHE4	6 day old seedlings	PEAKS042894
EXP041406	anti-GFP	Arabidopsis thaliana	acclimatizing (ACC) heat stress; WT	NULL	1370	normal	Q9LHE4	6 day old seedlings	PEAKS042895
EXP041407	anti-GFP	Arabidopsis thaliana	none (untreated; NHS); WT	NULL	1370	normal	Q9LHE4	6 day old seedlings	PEAKS042896
EXP041409	anti-GFP	Arabidopsis thaliana		EXP041408	1371	normal	Q38876	pistil/silique stage 12-16	PEAKS042897
EXP041411	anti-GFP	Arabidopsis thaliana		EXP041410	1362	normal	Q5YGP7	roots	PEAKS042898
EXP041413	anti-FLAG	Arabidopsis thaliana	Treatment: none	EXP041412	1350	normal	Q8H0W2	leaves	PEAKS042899
EXP041415	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9M7Q3	3 day old seedlings	PEAKS042900
EXP041416	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9M7Q3	3 day old seedlings	PEAKS042901
EXP041417	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9M7Q2	3 day old seedlings	PEAKS042902
EXP041418	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9M7Q2	3 day old seedlings	PEAKS042903
EXP041419	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46897	3 day old seedlings	PEAKS042904
EXP041420	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46897	3 day old seedlings	PEAKS042905
EXP041421	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	A0A178US99	3 day old seedlings	PEAKS042906
EXP041422	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	A0A178US99	3 day old seedlings	PEAKS042907
EXP041423	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	O22533	3 day old seedlings	PEAKS042908
EXP041424	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	O22533	3 day old seedlings	PEAKS042909
EXP041425	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46668	3 day old seedlings	PEAKS042910
EXP041426	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46668	3 day old seedlings	PEAKS042911
EXP041427	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46667	3 day old seedlings	PEAKS042912
EXP041428	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46667	3 day old seedlings	PEAKS042913
EXP041429	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9FDW1	3 day old seedlings	PEAKS042914
EXP041430	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9FDW1	3 day old seedlings	PEAKS042915
EXP041431	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q1PDN3	3 day old seedlings	PEAKS042916
EXP041432	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q1PDN3	3 day old seedlings	PEAKS042917
EXP041433	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q93VY3	3 day old seedlings	PEAKS042918
EXP041434	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q93VY3	3 day old seedlings	PEAKS042919
EXP041435	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours	EXP041414	1351	normal	O82132	3 day old seedlings	PEAKS042920
EXP041436	GFP (ThermoFisher #A11122)AT5G05410	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	O82132	3 day old seedlings	PEAKS042921
EXP041437	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9S9K9	3 day old seedlings	PEAKS042922
EXP041438	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9S9K9	3 day old seedlings	PEAKS042923
EXP041439	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9C690	3 day old seedlings	PEAKS042924
EXP041440	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9C690	3 day old seedlings	PEAKS042925
EXP041441	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46604	3 day old seedlings	PEAKS042926
EXP041442	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46604	3 day old seedlings	PEAKS042927
EXP041443	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P42775	3 day old seedlings	PEAKS042928
EXP041444	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P42775	3 day old seedlings	PEAKS042929
EXP041445	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q8LCG7	3 day old seedlings	PEAKS042930
EXP041446	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q8LCG7	3 day old seedlings	PEAKS042931
EXP041447	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9CAR0	3 day old seedlings	PEAKS042932
EXP041448	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9CAR0	3 day old seedlings	PEAKS042933
EXP041449	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q8H115	3 day old seedlings	PEAKS042934
EXP041450	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q8H115	3 day old seedlings	PEAKS042935
EXP041451	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P42776	3 day old seedlings	PEAKS042936
EXP041452	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P42776	3 day old seedlings	PEAKS042937
EXP041453	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9M7Q5	3 day old seedlings	PEAKS042938
EXP041454	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9M7Q5	3 day old seedlings	PEAKS042939
EXP041455	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9FGJ3	3 day old seedlings	PEAKS042940
EXP041456	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9FGJ3	3 day old seedlings	PEAKS042941
EXP041458	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM dexamethasone, 6 hours; dark	EXP041457	1343	normal	Q9LZU9	4 day old seedlings	PEAKS042942
EXP041459	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM dexamethasone, 6 hours; dark	EXP041457	1343	normal	Q9FK36	4 day old seedlings	PEAKS042943
EXP041462	anti-HA	Arabidopsis thaliana	Treatment: none	EXP041460	1372	normal	Q9LT47	30 hrs old seedlings	PEAKS042944
EXP041463	anti-Myc	Arabidopsis thaliana	Treatment: none	EXP041461	1372	normal	Q9SSW1	30 hrs old seedlings	PEAKS042945
EXP041464	anti-Myc	Arabidopsis thaliana	Treatment: none	EXP041461	1372	normal	Q9SKD0	30 hrs old seedlings	PEAKS042946
EXP041469	anti-HA	Arabidopsis thaliana	untreated	EXP041465	1363	normal	Q8S8P5	12 day old seedlings	PEAKS042947
EXP041470	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041466	1363	normal	Q8S8P5	12 day old seedlings	PEAKS042948
EXP041471	anti-HA	Arabidopsis thaliana	untreated	EXP041465	1363	normal	Q9C5T4	12 day old seedlings	PEAKS042949
EXP041472	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041466	1363	normal	Q9C5T4	12 day old seedlings	PEAKS042950
EXP041473	anti-HA	Arabidopsis thaliana	untreated	EXP041465	1363	normal	Q9SAH7	12 day old seedlings	PEAKS042951
EXP041474	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041466	1363	normal	Q9SAH7	12 day old seedlings	PEAKS042952
EXP041475	anti-HA	Arabidopsis thaliana	untreated	EXP041467	1363	normal	Q8S8P5	12 day old seedlings	PEAKS042953
EXP041476	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041468	1363	normal	Q8S8P5	12 day old seedlings	PEAKS042954
EXP041477	anti-HA	Arabidopsis thaliana	untreated	EXP041467	1363	normal	Q9C5T4	12 day old seedlings	PEAKS042955
EXP041478	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041468	1363	normal	Q9C5T4	12 day old seedlings	PEAKS042956
EXP041479	anti-HA	Arabidopsis thaliana	untreated	EXP041467	1363	normal	Q9SAH7	12 day old seedlings	PEAKS042957
EXP041480	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041468	1363	normal	Q9SAH7	12 day old seedlings	PEAKS042958
EXP041482	anti-GFP (Clontech 632592)	Arabidopsis thaliana	Treatment: none	EXP041481	1344	normal	Q9FMT4	14 day old seedling	PEAKS042959
EXP041484	anti-FLC	Arabidopsis thaliana	Col FRI genotype	EXP041483	1373	normal	Q9S7Q7	above-ground tissue	PEAKS042960
EXP041486	anti-Myc	Arabidopsis thaliana	control	EXP041485	1374	normal	Q9SG86	13 day old seedlings	PEAKS042961
EXP041487	anti-Myc	Arabidopsis thaliana	treated at 42C for 1h	EXP041485	1374	normal	Q9SG86	13 day old seedlings	PEAKS042962
EXP041489	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana		EXP041488	1369	normal	Q9SLH3	inflorescence apices	PEAKS042963
EXP041504	AGO1	Arabidopsis thaliana	none	EXP041490	1341	normal	O04379	10 day old seedlings	PEAKS042964
EXP041505	AGO1	Arabidopsis thaliana	Swi3b genotype	EXP041490	1341	normal	O04379	10 day old seedlings	PEAKS042965
EXP041506	AGO1	Arabidopsis thaliana	brm-4 genotype	EXP041490	1341	normal	O04379	10 day old seedlings	PEAKS042966
EXP041507	AGO1	Arabidopsis thaliana	ago1-36; untreated	EXP041492	1341	normal	O04379	10 day old seedlings	PEAKS042967
EXP041508	AGO1	Arabidopsis thaliana	BTH control; wt	EXP041493	1341	normal	O04379	10 day old seedlings	PEAKS042968
EXP041509	AGO1	Arabidopsis thaliana	BTH; wt	EXP041494	1341	normal	O04379	10 day old seedlings	PEAKS042969
EXP041510	AGO1	Arabidopsis thaliana	Cold control	EXP041495	1341	normal	O04379	10 day old seedlings	PEAKS042970
EXP041511	AGO1	Arabidopsis thaliana	Cold	EXP041496	1341	normal	O04379	10 day old seedlings	PEAKS042971
EXP041512	AGO1	Arabidopsis thaliana	Flg22 control	EXP041497	1341	normal	O04379	10 day old seedlings	PEAKS042972
EXP041513	AGO1	Arabidopsis thaliana	Flg22	EXP041498	1341	normal	O04379	10 day old seedlings	PEAKS042973
EXP041514	AGO1	Arabidopsis thaliana	IAA control	EXP041499	1341	normal	O04379	10 day old seedlings	PEAKS042974
EXP041515	AGO1	Arabidopsis thaliana	IAA	EXP041500	1341	normal	O04379	10 day old seedlings	PEAKS042975
EXP041516	AGO1	Arabidopsis thaliana	MeJA control	EXP041501	1341	normal	O04379	10 day old seedlings	PEAKS042976
EXP041517	AGO1	Arabidopsis thaliana	MeJA	EXP041502	1341	normal	O04379	10 day old seedlings	PEAKS042977
EXP041518	AGO1	Arabidopsis thaliana	none	EXP041503	1341	normal	O04379	10 day old seedlings	PEAKS042978
EXP041520	anti-FIE	Arabidopsis thaliana		EXP041519	1372	normal	Q9LT47	30 hrs old seedlings	PEAKS042979
EXP041521	anti-FIE	Arabidopsis thaliana	pRNAi-BPC; pRNAi-ZnF	EXP041519	1372	normal	Q9LT47	30 hrs old seedlings	PEAKS042980
EXP041523	Rabbit polyclonal whole serum raised against LFY	Arabidopsis thaliana	treatment with a solution containing 10 Î¼M dexamethasone (Sigma-Aldrich), 0.01% (v/v) ethanol, and 0.015% (v/v) Silwet L-77 (De Sangosse).	EXP041522	1345	normal	Q00958	inflorescence	PEAKS042981
EXP041526	Anti-myc antibody	Arabidopsis thaliana		EXP041524	1375	normal	Q5HZ36	3 week old seedlings	PEAKS042982
EXP041527	At4g26150	Arabidopsis thaliana		EXP041525	1375	normal	Q9SZI6	3 week old seedlings	PEAKS042983
EXP041529	anti-GFP (Neuromab, catalog# 75-131, lot# 455-1JD-56)	Arabidopsis thaliana		EXP041528	1376	normal	Q9SFD8	bent cotyledon stage seeds	PEAKS042984
EXP041532	anti-GFP (abcam ab290)	Arabidopsis thaliana	Treatment: none	EXP041530	1344	normal	Q56WH4	14 day old seedling	PEAKS042985
EXP041533	HD2B	Arabidopsis thaliana	Treatment: 30min of flg22	EXP041531	1344	normal	Q56WH4	14 day old seedling	PEAKS042986
EXP041540	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041534	1344	normal	Q6EVK6	14 day old seedling	PEAKS042987
EXP041541	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041535	1344	normal	Q9STM3	14 day old seedling	PEAKS042988
EXP041542	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041538	1344	normal	Q6EVK6	14 day old seedling	PEAKS042989
EXP041543	GFP (ab290, abcam)	Arabidopsis thaliana	ref6-1; Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041539	1344	normal	Q6EVK6	14 day old seedling	PEAKS042990
EXP041544	GFP (ab290, abcam)	Arabidopsis thaliana	brm-1; Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041537	1344	normal	Q9STM3	14 day old seedling	PEAKS042991
EXP041545	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041536	1344	normal	Q9STM3	14 day old seedling	PEAKS042992
EXP041547	monoclonal anti-Myc antibody 9E10	Saccharomyces cerevisiae	W303-1A TBF1-13xMyc::HIS3	EXP041546	1232	normal	Q02457	S. cerevisiae cells	PEAKS042993
EXP041550	Flag M2 [200472-21 (Agilent)]	Saccharomyces cerevisiae	Treatment: YMC OX phase cells; CEN.PK a SPT7-FLAG::Nat	EXP041548	1232	normal	P35177	S. cerevisiae cells	PEAKS042994
EXP041551	Flag M2 [200472-21 (Agilent)]	Saccharomyces cerevisiae	Treatment: YMC RC phase cells; CEN.PK a SPT7-FLAG::Nat	EXP041549	1232	normal	P35177	S. cerevisiae cells	PEAKS042995
EXP041557	Pho4	Saccharomyces cerevisiae	NoPi; W303 strain	EXP041552	1232	normal	P07270	S. cerevisiae cells	PEAKS042996
EXP041558	Pho4	Saccharomyces cerevisiae	HighPi; W303 strain	EXP041553	1232	normal	P07270	S. cerevisiae cells	PEAKS042997
EXP041559	Pho2	Saccharomyces cerevisiae	NoPi; W303 strain	EXP041554	1232	normal	P07269	S. cerevisiae cells	PEAKS042998
EXP041560	Pho2	Saccharomyces cerevisiae	HighPi; W303 strain	EXP041555	1232	normal	P07269	S. cerevisiae cells	PEAKS042999
EXP041561	Cbf1	Saccharomyces cerevisiae	NoPi; W303 strain	EXP041556	1232	normal	P17106	S. cerevisiae cells	PEAKS043000
EXP041562	Cbf1	Saccharomyces cerevisiae	HighPi; W303 strain	EXP041556	1232	normal	P17106	S. cerevisiae cells	PEAKS043001
EXP041563		Saccharomyces cerevisiae	dPHO80; W303 strain	NULL	1232	normal	A0A023IRJ6	S. cerevisiae cells	PEAKS043002
EXP041564		Saccharomyces cerevisiae	dPHO80; dCBF1; W303 strain	NULL	1232	normal	A0A023IRJ6	S. cerevisiae cells	PEAKS043003
EXP041565		Saccharomyces cerevisiae	dPHO2; W303 strain	EXP041552	1232	normal	A0A023IRJ6	S. cerevisiae cells	PEAKS043004
EXP041569	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Mif2-9xMyc-KanMX4	EXP041566	1232	normal	P35201	S. cerevisiae cells	PEAKS043005
EXP041570	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc10-9xMyc-KanMX4	EXP041566	1232	normal	P32504	S. cerevisiae cells	PEAKS043006
EXP041571	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc80-9xMyc-KanMX4	EXP041566	1232	normal	P40460	S. cerevisiae cells	PEAKS043007
EXP041572	anti-HA EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Pgal1-Cse4-3xHA-KanMX4 (internal tag)	EXP041568	1232	normal	P36012	S. cerevisiae cells	PEAKS043008
EXP041573	Mif2	Saccharomyces cerevisiae	W303 strain; Mif2-9xMyc-KanMX4 Pgal1-Cse4	EXP041567	1232	normal	P35201	S. cerevisiae cells	PEAKS043009
EXP041574	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc10-9xMyc-KanMX4 Pgal1-Cse4	EXP041567	1232	normal	P32504	S. cerevisiae cells	PEAKS043010
EXP041575	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc80-9xMyc-KanMX4 Pgal1-Cse4	EXP041567	1232	normal	P40460	S. cerevisiae cells	PEAKS043011
EXP041576	anti-HA EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; scm3 deletion; Pgal1-Cse4-3xHA-KanMX4 (internal tag) scm3::HphMX4	EXP041568	1232	normal	P36012	S. cerevisiae cells	PEAKS043012
EXP041579	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	(mock-treated by addition of YEPD)	EXP041577	1232	normal	P32485	S. cerevisiae cells	PEAKS043013
EXP041580	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	YEPD + 0.4 M KCl for 5 minutes	EXP041578	1232	normal	P32485	S. cerevisiae cells	PEAKS043014
EXP041581	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	Dsko1Dhot1 (mock-treated by addition of YEPD)	EXP041577	1232	normal	P32485	S. cerevisiae cells	PEAKS043015
EXP041582	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	Dsko1Dhot1 (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	normal	P32485	S. cerevisiae cells	PEAKS043016
EXP041583	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	EXP041577	1232	normal	Q02100	S. cerevisiae cells	PEAKS043017
EXP041584	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	normal	Q02100	S. cerevisiae cells	PEAKS043018
EXP041585	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	EXP041577	1232	normal	Q03213	S. cerevisiae cells	PEAKS043019
EXP041586	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	normal	Q03213	S. cerevisiae cells	PEAKS043020
EXP041587	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	EXP041577	1232	bio_control	A0A023PXA5	S. cerevisiae cells	PEAKS043021
EXP041588	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	bio_control	A0A023PXA5	S. cerevisiae cells	PEAKS043022
EXP041591	FLAG	Saccharomyces cerevisiae	strain: CEN.PK a IFH1-FLAG::Nat	EXP041589	1379	normal	P39520	YMC OX phase S. cerevisiae cells	PEAKS043023
EXP041592	FLAG	Saccharomyces cerevisiae	strain: CEN.PK a IFH1-FLAG::Nat	EXP041590	1380	normal	P39520	YMC RC phase S. cerevisiae cells	PEAKS043024
EXP041594	anti-Myc tag antibody, clone A46	Saccharomyces cerevisiae	Cells were fixed with formaldehyde (final conc. 1%) for six hours and quenched with glycine (final conc. 0.125M) for 10 minutes; mid-log phase (OD 600=0.7) ASF1-18myc cells	EXP041593	1232	normal	P32447	S. cerevisiae cells	PEAKS043025
EXP041595	anti-HA 12CA5	Saccharomyces cerevisiae	background strain: BY4741; Hog1-6HA::HIS3;exposed to osmostress (0.4M NaCl) 	NULL	1232	normal	P32485	S. cerevisiae cells	PEAKS043026
EXP041596	anti-HA 12CA5	Saccharomyces cerevisiae	background strain: BY4741; Hog1-6HA::HIS3; not exposed to osmostress 	NULL	1232	normal	P32485	S. cerevisiae cells	PEAKS043027
EXP041598	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Sir2	EXP041597	1232	normal	P06700	S. cerevisiae cells	PEAKS043028
EXP041599	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Sum1	EXP041597	1232	normal	P46676	S. cerevisiae cells	PEAKS043029
EXP041600	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst1	EXP041597	1232	normal	P53685	S. cerevisiae cells	PEAKS043030
EXP041601	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst2	EXP041597	1232	normal	P53686	S. cerevisiae cells	PEAKS043031
EXP041602	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst3	EXP041597	1232	normal	P53687	S. cerevisiae cells	PEAKS043032
EXP041603	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst4	EXP041597	1232	normal	P53688	S. cerevisiae cells	PEAKS043033
EXP041608	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, + broken cells (beadbeater and sonication), WT; c. cycle: G2 (benomyl) 	EXP041604	1232	normal	P13586	S. cerevisiae cells	PEAKS043034
EXP041609	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, - broken cells (beadbeater and sonication), WT; c. cycle: G2 (benomyl) 	EXP041605	1232	normal	P13586	S. cerevisiae cells	PEAKS043035
EXP041610	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, + broken cells (beadbeater and sonication), Rad30 deletion; c. cycle: G2 (benomyl) 	EXP041606	1232	normal	P13586	S. cerevisiae cells	PEAKS043036
EXP041611	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, - broken cells (beadbeater and sonication), Rad30 deletion; c. cycle: G2 (benomyl) 	EXP041607	1232	normal	P13586	S. cerevisiae cells	PEAKS043037
EXP041621	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; Snt2-13Myc strain;	EXP041612	1232	normal	P53127	S. cerevisiae cells	PEAKS043038
EXP041622	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; Snt2-13Myc strain;	EXP041613	1232	normal	P53127	S. cerevisiae cells	PEAKS043039
EXP041623	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; Snt2-13Myc strain;	EXP041614	1232	normal	P53127	S. cerevisiae cells	PEAKS043040
EXP041624	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; Ecm5-13Myc strain;	EXP041615	1232	normal	Q03214	S. cerevisiae cells	PEAKS043041
EXP041625	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; Ecm5-13Myc strain;	EXP041616	1232	normal	Q03214	S. cerevisiae cells	PEAKS043042
EXP041626	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; Ecm5-13Myc strain;	EXP041617	1232	normal	Q03214	S. cerevisiae cells	PEAKS043043
EXP041627	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	EXP041618	1232	bio_control	P53127	S. cerevisiae cells	PEAKS043044
EXP041628	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	EXP041619	1232	bio_control	P53127	S. cerevisiae cells	PEAKS043045
EXP041629	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	EXP041620	1232	bio_control	P53127	S. cerevisiae cells	PEAKS043046
EXP041645	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	untreated (0 hour time-point); Snt2-13Myc strain	EXP041630	1232	normal	P53127	S. cerevisiae cells	PEAKS043047
EXP041646	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Snt2-13Myc strain	EXP041631	1232	normal	P53127	S. cerevisiae cells	PEAKS043048
EXP041647	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; Snt2-13Myc strain	EXP041632	1232	normal	P53127	S. cerevisiae cells	PEAKS043049
EXP041648	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Snt2-13Myc strain	EXP041633	1232	normal	P53127	S. cerevisiae cells	PEAKS043050
EXP041649	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; Snt2-13Myc strain	EXP041634	1232	normal	P53127	S. cerevisiae cells	PEAKS043051
EXP041650	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	untreated (0 hour time-point); Ecm5-13Myc strain	EXP041635	1232	normal	Q03214	S. cerevisiae cells	PEAKS043052
EXP041651	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Ecm5-13Myc strain	EXP041636	1232	normal	Q03214	S. cerevisiae cells	PEAKS043053
EXP041652	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; Ecm5-13Myc strain	EXP041637	1232	normal	Q03214	S. cerevisiae cells	PEAKS043054
EXP041653	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Ecm5-13Myc strain	EXP041638	1232	normal	Q03214	S. cerevisiae cells	PEAKS043055
EXP041654	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; Ecm5-13Myc strain	EXP041639	1232	normal	Q03214	S. cerevisiae cells	PEAKS043056
EXP041655	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	untreated (0 hour time-point); untagged strain (BY4741)	EXP041640	1232	bio_control	Q03214	S. cerevisiae cells	PEAKS043057
EXP041656	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; untagged strain (BY4741)	EXP041641	1232	bio_control	Q03214	S. cerevisiae cells	PEAKS043058
EXP041657	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; untagged strain (BY4741)	EXP041642	1232	bio_control	Q03214	S. cerevisiae cells	PEAKS043059
EXP041658	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with DMSO; untagged strain (BY4741)	EXP041643	1232	bio_control	Q03214	S. cerevisiae cells	PEAKS043060
EXP041659	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; untagged strain (BY4741)	EXP041644	1232	bio_control	Q03214	S. cerevisiae cells	PEAKS043061
EXP041661	Arp5 antibody from Abcam (ab12099).	Saccharomyces cerevisiae	Treatment: CY1838 strain	EXP041660	1232	normal	P53946	S. cerevisiae cells	PEAKS043062
EXP041662	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t1	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043063
EXP041663	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t2	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043064
EXP041664	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t3	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043065
EXP041665	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t4	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043066
EXP041666	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t5	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043067
EXP041667	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t6	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043068
EXP041668	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t7	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043069
EXP041669	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t8	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043070
EXP041670	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t9	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043071
EXP041671	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t10	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043072
EXP041672	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t11	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043073
EXP041673	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t12	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043074
EXP041674	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t13	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043075
EXP041675	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t14	NULL	1381	normal	Q03330	YMC cycling cells	PEAKS043076
EXP041676	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t1	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043077
EXP041677	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t2	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043078
EXP041678	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t3	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043079
EXP041679	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t4	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043080
EXP041680	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t5	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043081
EXP041681	Set1	Saccharomyces cerevisiae	t6	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043082
EXP041682	Set1	Saccharomyces cerevisiae	t7	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043083
EXP041683	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t8	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043084
EXP041684	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t9	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043085
EXP041685	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t10	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043086
EXP041686	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t11	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043087
EXP041687	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t12	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043088
EXP041688	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t13	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043089
EXP041689	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t14	NULL	1381	normal	P38827	YMC cycling cells	PEAKS043090
EXP041690	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t1	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043091
EXP041691	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t2	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043092
EXP041692	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t3	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043093
EXP041693	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t4	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043094
EXP041694	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t5	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043095
EXP041695	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t6	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043096
EXP041696	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t7	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043097
EXP041697	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t8	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043098
EXP041698	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t9	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043099
EXP041699	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t10	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043100
EXP041700	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t11	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043101
EXP041701	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t12	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043102
EXP041702	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t13	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043103
EXP041703	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t14	NULL	1381	normal	Q08649	YMC cycling cells	PEAKS043104
EXP041712	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	G1 phase	EXP041704	1232	normal	P30665	S. cerevisiae cells	PEAKS043105
EXP041713	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	G1 phase	EXP041705	1232	normal	P53091	S. cerevisiae cells	PEAKS043106
EXP041714	Anti-HA (abcam,ab16918)	Saccharomyces cerevisiae	S phase	EXP041706	1379	normal	Q08032	YMC OX phase S. cerevisiae cells	PEAKS043107
EXP041715	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase	NULL	1379	normal	P30665	YMC OX phase S. cerevisiae cells	PEAKS043108
EXP041716	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase	EXP041708	1379	normal	P53091	YMC OX phase S. cerevisiae cells	PEAKS043109
EXP041717	Anti-HA (abcam,ab16918)	Saccharomyces cerevisiae	S phase	EXP041709	1379	normal	P32354	YMC OX phase S. cerevisiae cells	PEAKS043110
EXP041718	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase; 72 min	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	PEAKS043111
EXP041719	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase; 84 min	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	PEAKS043112
EXP041720	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase; 96 min	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	PEAKS043113
EXP041721	PCNA (804)	Saccharomyces cerevisiae	S phase	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	PEAKS043114
EXP041722	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase	EXP041710	1379	normal	P38630	YMC OX phase S. cerevisiae cells	PEAKS043115
EXP041727	anti-FLAG	Saccharomyces cerevisiae	YSD3 strain; 4h after transfer to sporulation medium (SPM)	EXP041724	1232	normal	Q12188	S. cerevisiae cells	PEAKS043116
EXP041728	anti-Rec8	Saccharomyces cerevisiae	GAL4BD-SPO11; YSD7 strain; 4h after transfer to sporulation medium (SPM)	EXP041724	1232	normal	Q12188	S. cerevisiae cells	PEAKS043117
EXP041729	anti-FLAG	Saccharomyces cerevisiae	RKD1311 strain; 3h after transfer to sporulation medium (SPM)	EXP041723	1232	normal	P23179	S. cerevisiae cells	PEAKS043118
EXP041730	anti-FLAG	Saccharomyces cerevisiae	RKD1311 strain; 4h after transfer to sporulation medium (SPM)	EXP041724	1232	normal	P23179	S. cerevisiae cells	PEAKS043119
EXP041731	anti-FLAG	Saccharomyces cerevisiae	RKD1311 strain; 5h after transfer to sporulation medium (SPM)	EXP041725	1232	normal	P23179	S. cerevisiae cells	PEAKS043120
EXP041732		Saccharomyces cerevisiae	GAL4BD-SPO11; YMD97 strain; 0h after transfer to sporulation medium (SPM)	EXP041726	1232	normal	A0A023IRJ6	S. cerevisiae cells	PEAKS043121
EXP041737	IgG	Saccharomyces cerevisiae	BY4741; DMSO; temperature: 30 C	EXP041733	1232	bio_control	A0A023PXA5	S. cerevisiae cells	PEAKS043122
EXP041738	IgG	Saccharomyces cerevisiae	MNN10 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041734	1232	normal	P50108	S. cerevisiae cells	PEAKS043123
EXP041739	IgG	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041733	1232	normal	P09959	S. cerevisiae cells	PEAKS043124
EXP041740	IgG	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; none; temperature: 30 C	EXP041735	1232	normal	P09959	S. cerevisiae cells	PEAKS043125
EXP041741	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041734	1232	normal	P16649	S. cerevisiae cells	PEAKS043126
EXP041742	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041733	1232	normal	P16649	S. cerevisiae cells	PEAKS043127
EXP041743	IgG	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; none; temperature: 39 C	EXP041736	1232	normal	P09959	S. cerevisiae cells	PEAKS043128
EXP041744	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; rapamycin; temperature: 30 C	EXP041734	1232	normal	P16649	S. cerevisiae cells	PEAKS043129
EXP041745	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; rapamycin; temperature: 30 C	EXP041733	1232	normal	P16649	S. cerevisiae cells	PEAKS043130
EXP041746	IgG	Saccharomyces cerevisiae	HSF1 TAP-tagged yeast cells; none; temperature: 30 C	EXP041735	1232	normal	P10961	S. cerevisiae cells	PEAKS043131
EXP041747	IgG	Saccharomyces cerevisiae	HSF1 TAP-tagged yeast cells; none; temperature: 39 C	EXP041736	1232	normal	P10961	S. cerevisiae cells	PEAKS043132
EXP041748	IgG	Saccharomyces cerevisiae	RSC2 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041733	1232	normal	Q06488	S. cerevisiae cells	PEAKS043133
EXP041749	IgG	Saccharomyces cerevisiae	RSC2 TAP-tagged yeast cells; rapamycin; temperature: 30 C	EXP041733	1232	normal	Q06488	S. cerevisiae cells	PEAKS043134
EXP041751	Monoclonal ANTI-Flag M2 antibody (Sigma, catalog# F3165, lot# 103K6043)	Saccharomyces cerevisiae	strain: W303	EXP041750	1232	normal	P47156	S. cerevisiae cells	PEAKS043135
EXP041754	anti-V5 tag antibody (AbD Serotec, mouse IgG2a, MCA 1360, batch 1009A)	Saccharomyces cerevisiae	Strain: W303 (C3857); Condensin mutant; Brn1 (M1 M2 M4)-PK6 mutant	EXP041753	1232	normal	P38170	S. cerevisiae cells	PEAKS043136
EXP041755	anti-V5 tag antibody (AbD Serotec, mouse IgG2a, MCA 1360, batch 1009A)	Saccharomyces cerevisiae	Strain: W303 (C3632); Wild type; Brn1-PK6	EXP041752	1232	normal	P38170	S. cerevisiae cells	PEAKS043137
EXP041757	PK, clone SV5-Pk1 Serotec MCA1360 #0407	Saccharomyces cerevisiae	strain: Y2422; MATa, Scc2-Pk9::TRP1	NULL	1232	normal	Q04002	S. cerevisiae cells	PEAKS043138
EXP041758	PK, clone SV5-Pk1 Serotec MCA1360 #0407	Saccharomyces cerevisiae	strain: Y4373; MATa, Scc4-Pk9::TRP1	NULL	1232	normal	P40090	S. cerevisiae cells	PEAKS043139
EXP041759	PK, clone SV5-Pk1 Serotec MCA1360 #0407	Saccharomyces cerevisiae	strain: Y4262; MATa, Sth1-Pk9::TRP1	NULL	1232	normal	P32597	S. cerevisiae cells	PEAKS043140
EXP041762	Santa Cruz Biotechnology (sc-33626)	Saccharomyces cerevisiae	4hrs sporulation yeast; H4K44->R mutant yeast	EXP041761	1220	normal	P25454	SK1	PEAKS043141
EXP041763	Santa Cruz Biotechnology (sc-33626)	Saccharomyces cerevisiae	4hrs sporulation yeast; wild type	EXP041760	1220	normal	P25454	SK1	PEAKS043142
EXP041769		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ INO80-3FLAG-kanMX4	EXP041766	1232	normal	P53115	S. cerevisiae cells	PEAKS043143
EXP041770		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ STH1-3FLAG-kanMX4	EXP041767	1232	normal	P32597	S. cerevisiae cells	PEAKS043144
EXP041771		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ SWR1-3FLAG-kanMX4	EXP041768	1232	normal	Q05471	S. cerevisiae cells	PEAKS043145
EXP041772		Saccharomyces cerevisiae	W303 (wt); MATalpha ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ HTZ1-2L-3FLAG:KanMX	EXP041764	1232	normal	Q12692	S. cerevisiae cells	PEAKS043146
EXP041773		Saccharomyces cerevisiae	W303 (wt); MATalpha ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ HTZ1-2L-3FLAG:KanMX	EXP041765	1232	normal	Q12692	S. cerevisiae cells	PEAKS043147
EXP041794	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	EXP041774	1232	normal	P03069	S. cerevisiae cells	PEAKS043148
EXP041795	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	EXP041775	1232	normal	P03069	S. cerevisiae cells	PEAKS043149
EXP041796	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	EXP041776	1232	normal	P03069	S. cerevisiae cells	PEAKS043150
EXP041797	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	EXP041777	1232	normal	P38165	S. cerevisiae cells	PEAKS043151
EXP041798	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	EXP041778	1232	normal	P38165	S. cerevisiae cells	PEAKS043152
EXP041799	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	EXP041779	1232	normal	P38165	S. cerevisiae cells	PEAKS043153
EXP041800	gcn4	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	EXP041780	1232	normal	P03069	S. cerevisiae cells	PEAKS043154
EXP041801	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	EXP041781	1232	normal	P03069	S. cerevisiae cells	PEAKS043155
EXP041802	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	EXP041782	1232	normal	P03069	S. cerevisiae cells	PEAKS043156
EXP041803	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	EXP041783	1232	normal	P38165	S. cerevisiae cells	PEAKS043157
EXP041804	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	EXP041784	1232	normal	P38165	S. cerevisiae cells	PEAKS043158
EXP041805	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	EXP041785	1232	normal	P38165	S. cerevisiae cells	PEAKS043159
EXP041806	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI4-myc	EXP041790	1232	normal	P25302	S. cerevisiae cells	PEAKS043160
EXP041807	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI4-myc; SWI6-knockout (co-factor)	EXP041791	1232	normal	P25302	S. cerevisiae cells	PEAKS043161
EXP041808	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); NRG1-myc; SUT1-knockout (co-factor)	EXP041786	1232	normal	Q03125	S. cerevisiae cells	PEAKS043162
EXP041809	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); NRG1-myc	EXP041787	1232	normal	Q03125	S. cerevisiae cells	PEAKS043163
EXP041810	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SUT1-myc; NRG1-knockout (co-factor)	EXP041788	1232	normal	P53032	S. cerevisiae cells	PEAKS043164
EXP041811	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SUT1-myc	EXP041789	1232	normal	P53032	S. cerevisiae cells	PEAKS043165
EXP041812	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI6-myc	EXP041792	1232	normal	P09959	S. cerevisiae cells	PEAKS043166
EXP041813	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI6-myc; SWI4-knockout (co-factor)	EXP041793	1232	normal	P09959	S. cerevisiae cells	PEAKS043167
EXP041834	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	EXP041814	1232	normal	P22082	S. cerevisiae cells	PEAKS043168
EXP041835	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	EXP041815	1232	normal	P22082	S. cerevisiae cells	PEAKS043169
EXP041836	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041816	1232	normal	P22082	S. cerevisiae cells	PEAKS043170
EXP041837	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041817	1232	normal	P22082	S. cerevisiae cells	PEAKS043171
EXP041838	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	EXP041818	1232	normal	P22082	S. cerevisiae cells	PEAKS043172
EXP041839	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	EXP041819	1232	normal	P22082	S. cerevisiae cells	PEAKS043173
EXP041840	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041820	1232	normal	P22082	S. cerevisiae cells	PEAKS043174
EXP041841	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041821	1232	normal	P22082	S. cerevisiae cells	PEAKS043175
EXP041842	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	EXP041822	1232	normal	P22082	S. cerevisiae cells	PEAKS043176
EXP041843	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041823	1232	normal	P22082	S. cerevisiae cells	PEAKS043177
EXP041844	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	EXP041824	1232	normal	P22082	S. cerevisiae cells	PEAKS043178
EXP041845	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041825	1232	normal	P22082	S. cerevisiae cells	PEAKS043179
EXP041846	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; unstressed	EXP041826	1232	normal	P22082	S. cerevisiae cells	PEAKS043180
EXP041847	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; unstressed	EXP041827	1232	normal	P22082	S. cerevisiae cells	PEAKS043181
EXP041848	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041828	1232	normal	P22082	S. cerevisiae cells	PEAKS043182
EXP041849	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041829	1232	normal	P22082	S. cerevisiae cells	PEAKS043183
EXP041850	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; unstressed	EXP041830	1232	normal	P22082	S. cerevisiae cells	PEAKS043184
EXP041851	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; unstressed	EXP041831	1232	normal	P22082	S. cerevisiae cells	PEAKS043185
EXP041852	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041832	1232	normal	P22082	S. cerevisiae cells	PEAKS043186
EXP041853	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041833	1232	normal	P22082	S. cerevisiae cells	PEAKS043187
EXP041855	Custom rabbit polyclonal anti-Rap1	Saccharomyces cerevisiae		EXP041854	1232	normal	P11938	S. cerevisiae cells	PEAKS043188
EXP041856	Custom mouse monoclonal anti-myc	Saccharomyces cerevisiae	myc-tagged Fhl1	EXP041854	1232	normal	P39521	S. cerevisiae cells	PEAKS043189
EXP041857	Anti-Flag from Sigma (#F1804)	Saccharomyces cerevisiae	Flag-tagged Fhl1	EXP041854	1232	normal	P39521	S. cerevisiae cells	PEAKS043190
EXP041858	Custom mouse monoclonal anti-myc	Saccharomyces cerevisiae	myc-tagged Fhl1 with deletion of forkhead domain (Fhl1-?FH-Myc)	EXP041854	1232	normal	P39521	S. cerevisiae cells	PEAKS043191
EXP041859	Anti-Flag from Sigma (#F1804)	Saccharomyces cerevisiae	Flag-tagged Fhl1 with deletion of forkhead domain (Fhl1-?FH-Flag)	EXP041854	1232	normal	P39521	S. cerevisiae cells	PEAKS043192
EXP041860	Anti-Flag from Sigma (#F1804)	Saccharomyces cerevisiae		EXP041854	1232	normal	Q03973	S. cerevisiae cells	PEAKS043193
EXP041861	Custom mouse monoclonal anti-myc	Saccharomyces cerevisiae		EXP041854	1232	normal	P39520	S. cerevisiae cells	PEAKS043194
EXP041862	none	Saccharomyces cerevisiae		NULL	1232	bio_control	A0A023PXA5	S. cerevisiae cells	PEAKS043195
EXP041867	anti-flag Sigma F3165	Saccharomyces cerevisiae	wild type (W303; LS142); no break Chr. VI	EXP041863	1232	normal	P13586	S. cerevisiae cells	PEAKS043196
EXP041868	anti-flag Sigma F3165	Saccharomyces cerevisiae	wild type (W303; LS143); break Chr. VI	EXP041864	1232	normal	P13586	S. cerevisiae cells	PEAKS043197
EXP041869	anti-flag Sigma F3165	Saccharomyces cerevisiae	Scc2-4 mutant (W303; LS147); no break Chr. VI	EXP041865	1232	normal	P13586	S. cerevisiae cells	PEAKS043198
EXP041870	anti-flag Sigma F3165	Saccharomyces cerevisiae	Scc2-4 mutant (W303; LS147); break Chr. VI	EXP041866	1232	normal	P13586	S. cerevisiae cells	PEAKS043199
EXP041874	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC2882; genotype: Rsc8-9xMyc	EXP041871	1232	normal	P43609	S. cerevisiae cells	PEAKS043200
EXP041875	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC601 p3018; genotype: Sth1-2xFlag	EXP041872	1232	normal	P32597	S. cerevisiae cells	PEAKS043201
EXP041876	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC2883; genotype: Ioc3-13xMyc	EXP041873	1232	normal	P43596	S. cerevisiae cells	PEAKS043202
EXP041877	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC3010; genotype: Snf2-13xMyc	EXP041873	1232	normal	P22082	S. cerevisiae cells	PEAKS043203
EXP041881	TAP	Saccharomyces cerevisiae	strain: w3031a; YPD G1 phase	EXP041879	1232	bio_control	P32558	S. cerevisiae cells	PEAKS043205
EXP041880	TAP	Saccharomyces cerevisiae	YPD G1 phase; Spt16 TAP tagged	EXP041878	1232	normal	P32558	S. cerevisiae cells	PEAKS043204
EXP041897	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); log cells	EXP041882	1232	normal	P32561	S. cerevisiae cells	PEAKS043206
EXP041898	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); quiescent cells	EXP041883	1232	normal	P32561	S. cerevisiae cells	PEAKS043207
EXP041899	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); rapamycin-treated log cells	EXP041884	1232	normal	P32561	S. cerevisiae cells	PEAKS043208
EXP041900	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); thiolutin-treated log cells	EXP041885	1232	normal	P32561	S. cerevisiae cells	PEAKS043209
EXP041901	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); diauxic shift cells	EXP041886	1232	normal	P32561	S. cerevisiae cells	PEAKS043210
EXP041902	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); log cells	EXP041887	1232	normal	P32561	S. cerevisiae cells	PEAKS043211
EXP041903	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); quiescent cells	EXP041888	1232	normal	P32561	S. cerevisiae cells	PEAKS043212
EXP041904	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); rapamycin-treated log cells	EXP041889	1232	normal	P32561	S. cerevisiae cells	PEAKS043213
EXP041905	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); thiolutin-treated log cells	EXP041890	1232	normal	P32561	S. cerevisiae cells	PEAKS043214
EXP041906	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; log cells	EXP041891	1232	normal	P29055	S. cerevisiae cells	PEAKS043215
EXP041907	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; diauxic shift cells	EXP041892	1232	normal	P29055	S. cerevisiae cells	PEAKS043216
EXP041908	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; quiescent cells	EXP041893	1232	normal	P29055	S. cerevisiae cells	PEAKS043217
EXP041909	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; log cells	EXP041894	1232	normal	P29055	S. cerevisiae cells	PEAKS043218
EXP041910	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; diauxic shift cells	EXP041895	1232	normal	P29055	S. cerevisiae cells	PEAKS043219
EXP041911	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; quiescent cells	EXP041896	1232	normal	P29055	S. cerevisiae cells	PEAKS043220
EXP041914	anti-Myc antibody (9E10) [made in-house at MSKCC]	Saccharomyces cerevisiae	Bas1-Myc	EXP041912	1219	normal	P22035	SK1 meiotic cells (4 hours)	PEAKS043221
EXP041915	anti-Myc antibody (9E10) [made in-house at MSKCC]	Saccharomyces cerevisiae	Ino4-Myc	EXP041913	1219	normal	P13902	SK1 meiotic cells (4 hours)	PEAKS043222
EXP041919	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	wild type; strain: AM1145 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	EXP041916	1232	normal	P13586	S. cerevisiae cells	PEAKS043223
EXP041920	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	ssc4-m35::HIS3 mutant; strain: AM15537 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	EXP041917	1232	normal	P13586	S. cerevisiae cells	PEAKS043224
EXP041921	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	wild type (scc4::HIS3); strain: AM15540 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	EXP041918	1232	normal	P13586	S. cerevisiae cells	PEAKS043225
EXP041932	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	wild type	EXP041922	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043226
EXP041933	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	wild type	EXP041923	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043227
EXP041934	Anti-Hop1 (N. Hollingsworth)	Saccharomyces cerevisiae	wild type	EXP041924	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043228
EXP041935	Anti-3HA (Cat#: 11867431001, Roche Applied Science)	Saccharomyces cerevisiae	genotype: Rec8::3HA	EXP041925	1382	normal	Q12188	SK1 meiotic cells (3 hours)	PEAKS043229
EXP041936	Anti-3HA (Cat#: 11867431001, Roche Applied Science)	Saccharomyces cerevisiae	genotype: Rec8::3HA	EXP041926	1382	normal	Q12188	SK1 meiotic cells (3 hours)	PEAKS043230
EXP041937	Anti-3HA (Cat#: 11867431001, Roche Applied Science)	Saccharomyces cerevisiae	genotype: Smc3::3HA	EXP041927	1382	normal	P47037	SK1 meiotic cells (3 hours)	PEAKS043231
EXP041938	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: rec8 delta (mutant)	EXP041928	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043232
EXP041939	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: rec8 delta (mutant)	EXP041929	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043233
EXP041940	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: pREC8-SCC1::3HA, rec8 delta (mutant)	EXP041930	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043234
EXP041941	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: pREC8-SCC1::3HA, rec8 delta (mutant)	EXP041931	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043235
EXP041945	Anti-Zip1	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	EXP041942	1383	normal	P31111	SK1 diploid cells	PEAKS043236
EXP041946	Anti-Zip1	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	EXP041943	1383	normal	P31111	SK1 diploid cells	PEAKS043237
EXP041947	Anti-Zip1	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	EXP041944	1383	normal	P31111	SK1 diploid cells	PEAKS043238
EXP041951	Anti-HA	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	EXP041948	1383	normal	Q12188	SK1 diploid cells	PEAKS043239
EXP041952	Anti-HA	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	EXP041949	1383	normal	Q12188	SK1 diploid cells	PEAKS043240
EXP041953	Anti-HA	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	EXP041950	1383	normal	Q12188	SK1 diploid cells	PEAKS043241
EXP041956	Anti-FLAG M2  (F1804,Sigma)	Saccharomyces cerevisiae	genotype: wild type (scc4::HIS3); S-phase cells	EXP041954	1232	normal	Q04002	S. cerevisiae cells	PEAKS043242
EXP041957	Anti-FLAG M2  (F1804,Sigma)	Saccharomyces cerevisiae	genotype: ssc4-m35::HIS3; S-phase cells	EXP041955	1232	normal	Q04002	S. cerevisiae cells	PEAKS043243
EXP041958	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	Fresh SC medium for 5 minutes; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	PEAKS043244
EXP041959	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	Fresh SC medium with 1M Sorbitol for 5 minutes; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	PEAKS043245
EXP041960	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	none; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	PEAKS043246
EXP041961	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	10nM alphaF for 30 minutes; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	PEAKS043247
EXP041962	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 1; strain: BY5764: CEN.PK MATa	NULL	1379	normal	P33748	YMC OX phase S. cerevisiae cells	PEAKS043248
EXP041963	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 2; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33748	YMC RB phase S. cerevisiae cells	PEAKS043249
EXP041964	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 3; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33748	YMC RB phase S. cerevisiae cells	PEAKS043250
EXP041965	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 4; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33748	YMC RC phase S. cerevisiae cells	PEAKS043251
EXP041966	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 5; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33748	YMC RC phase S. cerevisiae cells	PEAKS043252
EXP041967	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 6; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33748	YMC RC phase S. cerevisiae cells	PEAKS043253
EXP041968	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 1; strain: BY5764: CEN.PK MATa	NULL	1379	normal	P33749	YMC OX phase S. cerevisiae cells	PEAKS043254
EXP041969	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 2; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33749	YMC RB phase S. cerevisiae cells	PEAKS043255
EXP041970	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 3; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33749	YMC RB phase S. cerevisiae cells	PEAKS043256
EXP041971	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 4; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33749	YMC RC phase S. cerevisiae cells	PEAKS043257
EXP041972	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 5; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33749	YMC RC phase S. cerevisiae cells	PEAKS043258
EXP041973	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 6; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33749	YMC RC phase S. cerevisiae cells	PEAKS043259
EXP041982	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041974	1232	bio_control	A0A023PXA5	S. cerevisiae cells	PEAKS043260
EXP041983	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041975	1232	normal	P10659	S. cerevisiae cells	PEAKS043261
EXP041984	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041976	1232	normal	P10659	S. cerevisiae cells	PEAKS043262
EXP041985	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041977	1232	normal	P40510	S. cerevisiae cells	PEAKS043263
EXP041986	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041978	1232	normal	P40510	S. cerevisiae cells	PEAKS043264
EXP041987	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041979	1232	normal	P00549	S. cerevisiae cells	PEAKS043265
EXP041988	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041980	1232	normal	P00549	S. cerevisiae cells	PEAKS043266
EXP041989	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041981	1232	normal	P38827	S. cerevisiae cells	PEAKS043267
EXP041996	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_YJM789; grown in YPD	EXP041990	1232	normal	Q12172	S. cerevisiae cells	PEAKS043268
EXP041997	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_YJM789; grown in YPD + 4NQO	EXP041991	1232	normal	Q12172	S. cerevisiae cells	PEAKS043269
EXP041998	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96; grown in YPD	EXP041992	1232	normal	Q12172	S. cerevisiae cells	PEAKS043270
EXP041999	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96; grown in YPD + 4NQO	EXP041993	1232	normal	Q12172	S. cerevisiae cells	PEAKS043271
EXP042000	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96-I775E; grown in YPD	EXP041994	1232	normal	Q12172	S. cerevisiae cells	PEAKS043272
EXP042001	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96-I775E; grown in YPD + 4NQO	EXP041995	1232	normal	Q12172	S. cerevisiae cells	PEAKS043273
EXP042003	anti-c-Myc EZview resin (Sigma E6654)	Saccharomyces cerevisiae	Ubp8-Myc	EXP042002	1232	normal	P50102	S. cerevisiae cells	PEAKS043274
EXP042004	anti-c-Myc EZview resin (Sigma E6654)	Saccharomyces cerevisiae	Sgf73-Myc	EXP042002	1232	normal	P53165	S. cerevisiae cells	PEAKS043275
EXP042007	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Smc3 E1155Q mutation	EXP042005	1232	normal	P47037	S. cerevisiae cells	PEAKS043276
EXP042008	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Smc3 E1155Q K112Q K113Q mutation	EXP042006	1232	normal	P47037	S. cerevisiae cells	PEAKS043277
EXP042016	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR627; Smc1 D1164E	EXP042009	1232	normal	P32908	S. cerevisiae cells	PEAKS043278
EXP042017	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR625; Smc1 L1129V	EXP042010	1232	normal	P32908	S. cerevisiae cells	PEAKS043279
EXP042018	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR645; Smc1 wild type	EXP042011	1232	normal	P32908	S. cerevisiae cells	PEAKS043280
EXP042019	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR777; Smc3 L1126	EXP042012	1232	normal	P47037	S. cerevisiae cells	PEAKS043281
EXP042020	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR776; Smc3 wild type	EXP042013	1232	normal	P47037	S. cerevisiae cells	PEAKS043282
EXP042021	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR736; Smc3 D1161E	EXP042014	1232	normal	P47037	S. cerevisiae cells	PEAKS043283
EXP042022	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR733; Smc3 wild type	EXP042015	1232	normal	P47037	S. cerevisiae cells	PEAKS043284
EXP042071	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 0 hr in meiosis	EXP042023	1385	normal	P32841	meiotic culture	PEAKS043285
EXP042072	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 2 hr in meiosis	EXP042024	1385	normal	P32841	meiotic culture	PEAKS043286
EXP042073	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 2.5 hr in meiosis	EXP042025	1385	normal	P32841	meiotic culture	PEAKS043287
EXP042074	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 3 hr in meiosis	EXP042026	1385	normal	P32841	meiotic culture	PEAKS043288
EXP042075	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 3.5 hr in meiosis	EXP042027	1385	normal	P32841	meiotic culture	PEAKS043289
EXP042076	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 4 hr in meiosis	EXP042028	1385	normal	P32841	meiotic culture	PEAKS043290
EXP042077	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 4.5 hr in meiosis	EXP042029	1385	normal	P32841	meiotic culture	PEAKS043291
EXP042078	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 5 hr in meiosis	EXP042030	1385	normal	P32841	meiotic culture	PEAKS043292
EXP042079	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 5.5 hr in meiosis	EXP042031	1385	normal	P32841	meiotic culture	PEAKS043293
EXP042080	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 6 hr in meiosis	EXP042032	1385	normal	P32841	meiotic culture	PEAKS043294
EXP042081	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 7 hr in meiosis	EXP042033	1385	normal	P32841	meiotic culture	PEAKS043295
EXP042082	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 8 hr in meiosis	EXP042034	1385	normal	P32841	meiotic culture	PEAKS043296
EXP042083	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 0 hr in meiosis	EXP042035	1385	normal	P32841	meiotic culture	PEAKS043297
EXP042084	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 2 hr in meiosis	EXP042036	1385	normal	P32841	meiotic culture	PEAKS043298
EXP042085	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 2.5 hr in meiosis	EXP042037	1385	normal	P32841	meiotic culture	PEAKS043299
EXP042086	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 3 hr in meiosis	EXP042038	1385	normal	P32841	meiotic culture	PEAKS043300
EXP042087	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 3.5 hr in meiosis	EXP042039	1385	normal	P32841	meiotic culture	PEAKS043301
EXP042088	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 4 hr in meiosis	EXP042040	1385	normal	P32841	meiotic culture	PEAKS043302
EXP042089	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 4.5 hr in meiosis	EXP042041	1385	normal	P32841	meiotic culture	PEAKS043303
EXP042090	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 5 hr in meiosis	EXP042042	1385	normal	P32841	meiotic culture	PEAKS043304
EXP042091	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 5.5 hr in meiosis	EXP042043	1385	normal	P32841	meiotic culture	PEAKS043305
EXP042092	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 6 hr in meiosis	EXP042044	1385	normal	P32841	meiotic culture	PEAKS043306
EXP042093	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 7 hr in meiosis	EXP042033	1385	normal	P32841	meiotic culture	PEAKS043307
EXP042094	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 8 hr in meiosis	EXP042046	1385	normal	P32841	meiotic culture	PEAKS043308
EXP042095	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 0 hr in meiosis	EXP042047	1385	normal	P32841	meiotic culture	PEAKS043309
EXP042096	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 1 hr in meiosis	EXP042048	1385	normal	P32841	meiotic culture	PEAKS043310
EXP042097	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 1.5 hr in meiosis	EXP042049	1385	normal	P32841	meiotic culture	PEAKS043311
EXP042098	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 2 hr in meiosis	EXP042050	1385	normal	P32841	meiotic culture	PEAKS043312
EXP042099	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 2.5 hr in meiosis	EXP042051	1385	normal	P32841	meiotic culture	PEAKS043313
EXP042100	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 3 hr in meiosis	EXP042052	1385	normal	P32841	meiotic culture	PEAKS043314
EXP042101	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 3.5 hr in meiosis	EXP042053	1385	normal	P32841	meiotic culture	PEAKS043315
EXP042102	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 4 hr in meiosis	EXP042054	1385	normal	P32841	meiotic culture	PEAKS043316
EXP042103	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 4.5 hr in meiosis	EXP042055	1385	normal	P32841	meiotic culture	PEAKS043317
EXP042104	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 5 hr in meiosis	EXP042056	1385	normal	P32841	meiotic culture	PEAKS043318
EXP042105	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 6 hr in meiosis	EXP042057	1385	normal	P32841	meiotic culture	PEAKS043319
EXP042106	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 7 hr in meiosis	EXP042058	1385	normal	P32841	meiotic culture	PEAKS043320
EXP042107	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 0 hr in meiosis	EXP042059	1385	normal	P32841	meiotic culture	PEAKS043321
EXP042108	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 1 hr in meiosis	EXP042060	1385	normal	P32841	meiotic culture	PEAKS043322
EXP042109	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 1.5 hr in meiosis	EXP042061	1385	normal	P32841	meiotic culture	PEAKS043323
EXP042110	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 2 hr in meiosis	EXP042062	1385	normal	P32841	meiotic culture	PEAKS043324
EXP042111	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 2.5 hr in meiosis	EXP042063	1385	normal	P32841	meiotic culture	PEAKS043325
EXP042112	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 3 hr in meiosis	EXP042064	1385	normal	P32841	meiotic culture	PEAKS043326
EXP042113	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 3.5 hr in meiosis	EXP042065	1385	normal	P32841	meiotic culture	PEAKS043327
EXP042114	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 4 hr in meiosis	EXP042066	1385	normal	P32841	meiotic culture	PEAKS043328
EXP042115	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 4.5 hr in meiosis	EXP042067	1385	normal	P32841	meiotic culture	PEAKS043329
EXP042116	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 5 hr in meiosis	EXP042068	1385	normal	P32841	meiotic culture	PEAKS043330
EXP042117	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 6 hr in meiosis	EXP042069	1385	normal	P32841	meiotic culture	PEAKS043331
EXP042118	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 7 hr in meiosis	EXP042070	1385	normal	P32841	meiotic culture	PEAKS043332
EXP042120	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1	EXP042119	1232	normal	P43572	S. cerevisiae cells	PEAKS043333
EXP042121	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1 Yng2-W247A	EXP042119	1232	normal	P43572	S. cerevisiae cells	PEAKS043334
EXP042122	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1 delta-eaf7	EXP042119	1232	normal	P43572	S. cerevisiae cells	PEAKS043335
EXP042123	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1 Yng2-W247A delta_eaf7	EXP042119	1232	normal	P43572	S. cerevisiae cells	PEAKS043336
EXP042124	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 0 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043337
EXP042125	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 1 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043338
EXP042126	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	2 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043339
EXP042127	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 5 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043340
EXP042128	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 20 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043341
EXP042129	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 0 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043342
EXP042130	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 1 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043343
EXP042131	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 2 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043344
EXP042132	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 5 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043345
EXP042133	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 20 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	PEAKS043346
EXP042136	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (SPT16-myc); wild type cells	EXP042134	1232	normal	P32558	S. cerevisiae cells	PEAKS043347
EXP042137	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (SPT16-myc); mot1-42 cells 	EXP042134	1232	normal	P32558	S. cerevisiae cells	PEAKS043348
EXP042138	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (MOT1-myc); wild type cells 	EXP042135	1232	normal	P32333	S. cerevisiae cells	PEAKS043349
EXP042139	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (MOT1-myc); spt16-197 cells	EXP042135	1232	normal	P32333	S. cerevisiae cells	PEAKS043350
EXP042142		Saccharomyces cerevisiae	 Abf1 TAP-tagged strain	EXP042140	1385	normal	P14164	meiotic culture	PEAKS043351
EXP042143		Saccharomyces cerevisiae	Reb1 TAP-tagged strain	EXP042141	1385	normal	P21538	meiotic culture	PEAKS043352
EXP042145		Saccharomyces cerevisiae	treatment: none; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043353
EXP042146		Saccharomyces cerevisiae	0 min after MNase 0.046875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043354
EXP042147		Saccharomyces cerevisiae	30 min after MNase 0.046875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043355
EXP042148		Saccharomyces cerevisiae	0 min after MNase 0.1875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043356
EXP042149		Saccharomyces cerevisiae	30 min after MNase 0.1875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043357
EXP042150		Saccharomyces cerevisiae	0 min after MNase 0.75 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043358
EXP042151		Saccharomyces cerevisiae	30 min after MNase 0.75 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043359
EXP042152		Saccharomyces cerevisiae	0 min after MNase 3.0 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043360
EXP042153		Saccharomyces cerevisiae	30 min after MNase 3.0 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	PEAKS043361
EXP042160	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042154	1232	normal	P23293	S. cerevisiae cells	PEAKS043362
EXP042161	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042155	1232	normal	Q03957	S. cerevisiae cells	PEAKS043363
EXP042162	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042156	1232	normal	Q04089	S. cerevisiae cells	PEAKS043364
EXP042163	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042157	1232	normal	P53064	S. cerevisiae cells	PEAKS043365
EXP042164	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042158	1232	normal	P38827	S. cerevisiae cells	PEAKS043366
EXP042165	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042159	1232	normal	P46995	S. cerevisiae cells	PEAKS043367
EXP042166	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW330 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, RGR1-13xMyc::HPHr)	NULL	1232	normal	P19263	S. cerevisiae cells	PEAKS043368
EXP042167	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW330 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, RGR1-13xMyc::HPHr)	NULL	1232	normal	P19263	S. cerevisiae cells	PEAKS043369
EXP042168	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW328 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, GAL11-13xMyc::HPHr)	NULL	1232	normal	P04385	S. cerevisiae cells	PEAKS043370
EXP042169	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW328 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, GAL11-13xMyc::HPHr)	NULL	1232	normal	P04385	S. cerevisiae cells	PEAKS043371
EXP042170	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: YJ146 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB2-13xMyc::HPHr)	NULL	1232	normal	P34162	S. cerevisiae cells	PEAKS043372
EXP042171	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: YJ146 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB2-13xMyc::HPHr)	NULL	1232	normal	P34162	S. cerevisiae cells	PEAKS043373
EXP042172	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: YJ141 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED8-13xMyc::HPHr)	NULL	1232	normal	P38304	S. cerevisiae cells	PEAKS043374
EXP042173	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: YJ141 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED8-13xMyc::HPHr)	NULL	1232	normal	P38304	S. cerevisiae cells	PEAKS043375
EXP042174	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: YJ147 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB7-13xMyc::HPHr)	NULL	1232	normal	P47822	S. cerevisiae cells	PEAKS043376
EXP042175	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: YJ147 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB7-13xMyc::HPHr)	NULL	1232	normal	P47822	S. cerevisiae cells	PEAKS043377
EXP042176	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW332 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB6-13xMyc::HPHr)	NULL	1232	normal	P32570	S. cerevisiae cells	PEAKS043378
EXP042177	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW332 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB6-13xMyc::HPHr)	NULL	1232	normal	P32570	S. cerevisiae cells	PEAKS043379
EXP042178	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW329 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED7-13xMyc::HPHr)	NULL	1232	normal	Q08278	S. cerevisiae cells	PEAKS043380
EXP042179	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW329 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED7-13xMyc::HPHr)	NULL	1232	normal	Q08278	S. cerevisiae cells	PEAKS043381
EXP042180	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW333 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB10-13xMyc::HPHr)	NULL	1232	normal	P39073	S. cerevisiae cells	PEAKS043382
EXP042181	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW333 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB10-13xMyc::HPHr)	NULL	1232	normal	P39073	S. cerevisiae cells	PEAKS043383
EXP042189	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Snf11 deletion	EXP042182	1232	normal	P22082	S. cerevisiae cells	PEAKS043384
EXP042190	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Swp73 deletion	EXP042183	1232	normal	P22082	S. cerevisiae cells	PEAKS043385
EXP042191	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Swp82 deletion	EXP042184	1232	normal	P22082	S. cerevisiae cells	PEAKS043386
EXP042192	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Swi3 deletion	EXP042185	1232	normal	P22082	S. cerevisiae cells	PEAKS043387
EXP042193	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Snf6 deletion	EXP042186	1232	normal	P22082	S. cerevisiae cells	PEAKS043388
EXP042194	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Snf5 deletion	EXP042187	1232	normal	P22082	S. cerevisiae cells	PEAKS043389
EXP042195	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	none	EXP042188	1232	normal	P22082	S. cerevisiae cells	PEAKS043390
EXP042197	anti-GST (GE Healthcare Life Sciences, cat# 27-4577-01, lot# 316319)	Saccharomyces cerevisiae	strain: BY4741 MATa his3{delta}1 leu2{delta}0 met15{delta}0 ura3{delta}0 pEGH 2{mu} URA3 promGAL1-10-GST-GCN4	EXP042196	1232	normal	P03069	S. cerevisiae cells	PEAKS043391
EXP042209	anti-Red1	Saccharomyces cerevisiae	strain: H119 (wild type)	EXP042198	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043392
EXP042210	anti-Red1	Saccharomyces cerevisiae	strain: H119 (wild type)	EXP042199	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043393
EXP042211	anti-Hop1	Saccharomyces cerevisiae	strain: H119 (wild type)	EXP042200	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043394
EXP042212	anti-Hop1	Saccharomyces cerevisiae	strain: H6408 (wild type)	EXP042201	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043395
EXP042213	anti-Red1	Saccharomyces cerevisiae	strain: H7660 (rec8-delta)	EXP042202	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043396
EXP042214	anti-Red1	Saccharomyces cerevisiae	strain: H7772 (rec8-delta)	EXP042203	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043397
EXP042215	anti-Hop1	Saccharomyces cerevisiae	strain: H7660 (rec8-delta)	EXP042202	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043398
EXP042216	anti-Hop1	Saccharomyces cerevisiae	strain: H7772 (rec8-delta)	EXP042203	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043399
EXP042217	anti-Red1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042204	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043400
EXP042218	anti-Red1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042205	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043401
EXP042219	anti-Hop1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042204	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043402
EXP042220	anti-Hop1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042205	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043403
EXP042221	anti-Red1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042206	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043404
EXP042222	anti-Red1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042207	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS043405
EXP042223	anti-Hop1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042206	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043406
EXP042224	anti-Hop1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042207	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS043407
EXP042225	Mock	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042208	1382	bio_control	A0A023PXA5	SK1 meiotic cells (3 hours)	PEAKS043408
EXP042227	Sba1 (Freeman et al., 2000)	Saccharomyces cerevisiae	strain: BY4741	EXP042226	1232	normal	P28707	S. cerevisiae cells	PEAKS043409
EXP042230	anti-TAP antibody (Thermo Fisher Scientific, Waltham, MA; #CAB1001, Lot #RL240352) 	Saccharomyces cerevisiae	YP + 2% galactose media	EXP042228	1232	normal	P39705	S. cerevisiae cells	PEAKS043410
EXP042231	anti-TAP antibody (Thermo Fisher Scientific, Waltham, MA; #CAB1001, Lot #RL240352) 	Saccharomyces cerevisiae	YPD media	EXP042229	1232	normal	P39705	S. cerevisiae cells	PEAKS043411
EXP042232	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: W303-1a (SF1); genotype: MATa ade2-1 can1-100 his3-11 leu2-3,112 trp1 ura3-1 GAL	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043412
EXP042233	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: SF4; genotype: sir3-delta::TRP1 in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043413
EXP042234	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL1 (DMY4350); genotype: sir3{delta}wH::TRP1 in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043414
EXP042235	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: ADR2973; genotype: sir4-I1311N in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043415
EXP042236	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL2 (DMY4351); genotype: sir4-I1311N sir3{delta}wH::TRP1 in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043416
EXP042237	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: SF1 + pJR104 (pDM602); plasmid genotype: SIR3 under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043417
EXP042238	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL1 + pCL4 (pDM1798); plasmid genotype: sir3{delta}wH under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043418
EXP042239	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: ADR2973 + pJR104; plasmid genotype: SIR3 under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043419
EXP042240	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL2 + pCL4; plasmid genotype: sir3{delta}wH under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	PEAKS043420
EXP042248	anti-Myc	Saccharomyces cerevisiae		EXP042241	1232	normal	P36012	S. cerevisiae cells	PEAKS043421
EXP042249	anti-Myc	Saccharomyces cerevisiae	cdc15-2::LEU2	EXP042242	1232	normal	P43618	S. cerevisiae cells	PEAKS043422
EXP042250	anti-Myc	Saccharomyces cerevisiae	hydroxyurea	EXP042243	1232	normal	P43618	S. cerevisiae cells	PEAKS043423
EXP042251	anti-Myc	Saccharomyces cerevisiae	nocodazole	EXP042244	1232	normal	P43618	S. cerevisiae cells	PEAKS043424
EXP042252	anti-Myc	Saccharomyces cerevisiae	37oC	EXP042245	1232	normal	P43618	S. cerevisiae cells	PEAKS043425
EXP042253	anti-Myc	Saccharomyces cerevisiae	cdc15-2::LEU2, âˆ†ctf3::URA3	EXP042246	1232	normal	P43618	S. cerevisiae cells	PEAKS043426
EXP042254	anti-Myc	Saccharomyces cerevisiae	cdc15-2::LEU2, âˆ†ctf3::URA3; nocodazole	EXP042247	1232	normal	P43618	S. cerevisiae cells	PEAKS043427
EXP042256	human c-myc	Saccharomyces cerevisiae	yIN219 strain	EXP042255	1386	normal	P38830	W303a Strain	PEAKS043428
EXP042257	human c-myc	Saccharomyces cerevisiae	yIN218 strain; Pichia pastoris Ndt80	EXP042255	1386	normal	P38830	W303a Strain	PEAKS043429
EXP042259	human c-myc	Saccharomyces cerevisiae	yIN209 strain	EXP042258	1383	normal	A0A023PXA5	SK1 diploid cells	PEAKS043430
EXP042261	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; PAF1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043431
EXP042262	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; CTR9 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043432
EXP042263	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; LEO1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043433
EXP042264	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; CDC73 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043434
EXP042265	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; HTZ1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043435
EXP042266	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; RTF1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043436
EXP042267	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; SET1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043437
EXP042268	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; RCO1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043438
EXP042269	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; SET2 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043439
EXP042270	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; SPT4 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043440
EXP042271	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; WT	EXP042260	1232	normal	P32657	S. cerevisiae cells	PEAKS043441
EXP042274	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED3-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P40356	S. cerevisiae cells	PEAKS043442
EXP042275	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED7-8xGLY-13xMYC-KANMX 	EXP042272	1232	normal	Q08278	S. cerevisiae cells	PEAKS043443
EXP042276	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED14-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P19263	S. cerevisiae cells	PEAKS043444
EXP042277	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED15-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P19659	S. cerevisiae cells	PEAKS043445
EXP042278	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED17-8xGLY-13xMYC-KANMX 	EXP042272	1232	normal	P32569	S. cerevisiae cells	PEAKS043446
EXP042279	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED19-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P25046	S. cerevisiae cells	PEAKS043447
EXP042280	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa SSN8-8xGLY13xMYC-KANMX	EXP042272	1232	normal	P47821	S. cerevisiae cells	PEAKS043448
EXP042281	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED3- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P40356	S. cerevisiae cells	PEAKS043449
EXP042282	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED14- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P19263	S. cerevisiae cells	PEAKS043450
EXP042283	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED15- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P19659	S. cerevisiae cells	PEAKS043451
EXP042284	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED17- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P32569	S. cerevisiae cells	PEAKS043452
EXP042285	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED19- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P25046	S. cerevisiae cells	PEAKS043453
EXP042286	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa SSN8- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P47821	S. cerevisiae cells	PEAKS043454
EXP042287	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	NULL	1232	bio_control	A0A023IRJ6	S. cerevisiae cells	PEAKS043455
EXP042289	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATa, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100; YF2229 strain	EXP042288	1232	normal	P13393	S. cerevisiae cells	PEAKS043456
EXP042290	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_0min	EXP042288	1232	normal	P46677	S. cerevisiae cells	PEAKS043457
EXP042291	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_60min	EXP042288	1232	normal	P46677	S. cerevisiae cells	PEAKS043458
EXP042292	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_0min	EXP042288	1232	normal	P13393	S. cerevisiae cells	PEAKS043459
EXP042293	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_60min	EXP042288	1232	normal	P13393	S. cerevisiae cells	PEAKS043460
EXP042294	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_0min	EXP042288	1232	normal	P46677	S. cerevisiae cells	PEAKS043461
EXP042295	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_60min	EXP042288	1232	normal	P46677	S. cerevisiae cells	PEAKS043462
EXP042296	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_0min	EXP042288	1232	normal	P13393	S. cerevisiae cells	PEAKS043463
EXP042297	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_60min	EXP042288	1232	normal	P13393	S. cerevisiae cells	PEAKS043464
EXP042298	anti-HA	Saccharomyces cerevisiae	0 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	PEAKS043465
EXP042299	anti-HA	Saccharomyces cerevisiae	Hos1 depletion; 0 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	PEAKS043466
EXP042300	anti-HA	Saccharomyces cerevisiae	10 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	PEAKS043467
EXP042301	anti-HA	Saccharomyces cerevisiae	Hos1 depletion; 10 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	PEAKS043468
EXP042302	anti-HA	Saccharomyces cerevisiae	15 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	PEAKS043469
EXP042303	anti-HA	Saccharomyces cerevisiae	Hos1 depletion; 15 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	PEAKS043470
EXP042305	Anti-Myc (Clontech, catalog# 631206, lot# 1602362A)	Saccharomyces cerevisiae		EXP042304	1386	normal	Q06211	W303a Strain	PEAKS043471
EXP042307	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	rad53-1; media: YPD+HU; S phase	EXP042306	1232	normal	P22336	S. cerevisiae cells	PEAKS043472
EXP042308	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	wild type; media: YPD+HU; S phase	NULL	1232	normal	P53091	S. cerevisiae cells	PEAKS043473
EXP042309	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	rad53-1; media: YPD+HU; S phase	EXP042306	1232	normal	P53091	S. cerevisiae cells	PEAKS043474
EXP042312	anti-GFP	Caenorhabditis elegans	pha-4 transgenic (GFP:3xFLAG tag) worm; strain: OP37	EXP042310	1388	normal	Q17381	whole worms (developmental stage: embryo)	PEAKS043475
EXP042313	anti-GFP	Caenorhabditis elegans	starved L1;pha-4 transgenic (GFP:3xFLAG tag) worm; strain: OP37	EXP042311	1387	normal	Q17381	whole worms (developmental stage: L1)	PEAKS043476
EXP042316	anti-GFP	Caenorhabditis elegans	strain: OP32; DPY27 transgenic worms (GFP-tagged)	EXP042314	1388	normal	P48996	whole worms (developmental stage: embryo)	PEAKS043477
EXP042317	anti-GFP	Caenorhabditis elegans	strain: OP32; DPY27 transgenic worms (GFP-tagged)	EXP042315	1388	normal	P48996	whole worms (developmental stage: embryo)	PEAKS043478
EXP042320	anti-GFP	Caenorhabditis elegans	daf-16 transgenic (GFP-tagged) worm; strain: TJ356	EXP042318	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	PEAKS043479
EXP042321	anti-GFP	Caenorhabditis elegans	daf-16 transgenic (GFP-tagged) worm; strain: TJ356	EXP042319	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	PEAKS043480
EXP042324	anti-GFP	Caenorhabditis elegans	mab-5 transgenic (GFP-tagged) worm; strain: OP26	EXP042322	1390	normal	P10038	whole worms (developmental stage: L3)	PEAKS043481
EXP042325	anti-GFP	Caenorhabditis elegans	mab-5 transgenic (GFP-tagged) worm; strain: OP26	EXP042323	1390	normal	P10038	whole worms (developmental stage: L3)	PEAKS043482
EXP042327	anti-GFP	Caenorhabditis elegans	genotype: CEH-14:GFP:3xFLAG; strain: OP73 	EXP042326	1202	normal	P20271	whole worms (developmental stage: L2)	PEAKS043483
EXP042330	anti-GFP	Caenorhabditis elegans	genotype: EOR-1:GFP:3xFLAG; strain: OP81	EXP042328	1390	normal	G5EDU4	whole worms (developmental stage: L3)	PEAKS043484
EXP042331	anti-GFP	Caenorhabditis elegans	genotype: EOR-1:GFP:3xFLAG; strain: OP81	EXP042329	1390	normal	G5EDU4	whole worms (developmental stage: L3)	PEAKS043485
EXP042334	anti-GFP	Caenorhabditis elegans	genotype: HLH-8:GFP:3xFLAG; strain: OP74	EXP042332	1390	normal	Q11094	whole worms (developmental stage: L3)	PEAKS043486
EXP042335	anti-GFP	Caenorhabditis elegans	genotype: HLH-8:GFP:3xFLAG; strain: OP74	EXP042333	1390	normal	Q11094	whole worms (developmental stage: L3)	PEAKS043487
EXP042337	DPY-27	Caenorhabditis elegans	Treatment: N2 strain	EXP042336	1390	normal	P48996	whole worms (developmental stage: L3)	PEAKS043488
EXP042340	SDQ0820 EPC1	Caenorhabditis elegans	strain: N2	EXP042338	1390	normal	G5EC14	whole worms (developmental stage: L3)	PEAKS043489
EXP042341	SDQ0820 EPC1	Caenorhabditis elegans	strain: N2	EXP042339	1390	normal	G5EC14	whole worms (developmental stage: L3)	PEAKS043490
EXP042461	GFP	Caenorhabditis elegans	pGES-1 EFL-1:GFP:FLAG whole animal; YL418 strain	EXP042450	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS043545
EXP042462	GFP	Caenorhabditis elegans	pGES-1 DPL-1:GFP:FLAG whole animal; YL448 strain	EXP042451	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS043546
EXP042463	GFP	Caenorhabditis elegans	pGES-1 LIN-35:GFP:FLAG whole animal; YL398 strain	EXP042452	1387	normal	G5EDT1	whole worms (developmental stage: L1)	PEAKS043547
EXP042464	HPL2	Caenorhabditis elegans	pGES-1 HPL-2:GFP:FLAG whole animal; YL416 strain	EXP042453	1387	normal	G5EDE2	whole worms (developmental stage: L1)	PEAKS043548
EXP042465	GFPd	Caenorhabditis elegans	Plin-35_LIN-35:GFP:FLAG whole animal; YL409 strain	EXP042454	1387	normal	G5EDT1	whole worms (developmental stage: L1)	PEAKS043549
EXP042466	GFP	Caenorhabditis elegans	Pdpl-1_DPL-1:GFP:FLAG whole animal; YL425 strain	EXP042455	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS043550
EXP042467	GFP	Caenorhabditis elegans	Pefl-1 EFL-1:GFP:FLAG whole animal; YL424 strain	EXP042456	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS043551
EXP042468	GFP	Caenorhabditis elegans	Pmex-5 LIN-35:GFP:FLAG whole animal; YL468 strain	EXP042457	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	PEAKS043552
EXP042469	GFP	Caenorhabditis elegans	Ppie-1 LIN-35:GFP:FLAG whole animal; YL402 strain	EXP042458	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	PEAKS043553
EXP042470	GFP	Caenorhabditis elegans	Ppie-1_DPL-1:GFP:FLAG whole animal; YL390 strain	EXP042459	1235	normal	Q22703	whole worms (developmental stage: young adults)	PEAKS043554
EXP042471	GFP	Caenorhabditis elegans	Ppie-1 EFL-1:GFP:FLAG whole animal; YL445 strain	EXP042460	1235	normal	G5EF11	whole worms (developmental stage: young adults)	PEAKS043555
EXP042473	DPY-27 polyclonal rabbit antibody (#699) was generated in: "CHUANG, P. T., D. G. ALBERTSON and B. J. MEYER, 1994 DPY-27:a chromosome condensation protein homolog that regulates C. elegans dosage compensation through association with the X chromosome. Cell 79: 459-474."	Caenorhabditis elegans	strain: N2; wild type	EXP042472	1388	normal	P48996	whole worms (developmental stage: embryo)	PEAKS043556
EXP042477	anti-GFP (polyclonal goat IgG; produced in Hyman lab)	Caenorhabditis elegans	strain: N2; NHR-25::GFP	EXP042474	1387	normal	Q19345	whole worms (developmental stage: L1)	PEAKS043557
EXP042478	anti-GFP (polyclonal goat IgG; produced in Hyman lab)	Caenorhabditis elegans	strain: N2; NHR-25::GFP	EXP042475	1387	normal	Q19345	whole worms (developmental stage: L1)	PEAKS043558
EXP042479	anti-GFP (polyclonal goat IgG; produced in Hyman lab)	Caenorhabditis elegans	strain: N2; PHA-4::GFP	EXP042476	1387	normal	Q17381	whole worms (developmental stage: L1)	PEAKS043559
EXP042481	SDQ3897_NPP13 [Novus Biologicals, catalog# 48580002, lot# G3048-202, Animal SDQ3897]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	Q9BKT9	whole worms (mixed-stage embryos)	PEAKS043560
EXP042482	SDQ0839_TBP1 [Novus Biologicals, catalog# 29610002, lot# G3048-022, Animal SDQ0839]	Caenorhabditis elegans	N2 strain; Empty vector RNAi	EXP042480	1392	normal	P32085	whole worms (mixed-stage embryos)	PEAKS043561
EXP042483	SDQ0839_TBP1 [Novus Biologicals, catalog# 29610002, lot# G3048-022, Animal SDQ0839]	Caenorhabditis elegans	N2 strain; NPP-13 RNAi	EXP042480	1392	normal	P32085	whole worms (mixed-stage embryos)	PEAKS043562
EXP044359	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: N2 strain	EXP044356	1390	normal	P48996	whole worms (developmental stage: L3)	PEAKS044517
EXP042485	SDQ4154_IMB1 [not commercial]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	Q9BIB8	whole worms (mixed-stage embryos)	PEAKS043564
EXP042486	SY1539_NPP3 [not commercial]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	Q21436	whole worms (mixed-stage embryos)	PEAKS043565
EXP042487	SDQ0839_TBP1 [Novus Biologicals, catalog# 29610002, lot# G3048-022, Animal SDQ0839]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	P32085	whole worms (mixed-stage embryos)	PEAKS043566
EXP044358	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: MT14911 strain	EXP044355	1388	normal	P48996	whole worms (developmental stage: embryo)	PEAKS044516
EXP042493	CAPG-1 SDQ3967 Rabbit polyclonal is against the antigen MPPKKRIRGPKLPALREEKSTGTDVASDESFNESADFLNNEELNNDQNDAENTVLSEGVSTLRINENMTKEDRACISAALFIKKRVVESIRTVFQSRDDI May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	G5EFJ4	whole worms (mixed-stage embryos)	PEAKS043568
EXP042494	CAPG-2 SDQ4484 Rabbit polyclonal to 808-907 aa is against the antigen IPKWMNKQCDLMEDDEENIFKNHREIVESLRQFHKRVSETDYWDEDSAKRMMHHFMLFSIVSASSKNDDEAYDDPRDEDYKPPHFISLALIKFILKEKSL May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q20818	whole worms (mixed-stage embryos)	PEAKS043569
EXP042495	DPY-26 JL00003 Rabbit polyclonal to 40-1262 aa.  (PMID:19853451) is against the antigen 40-1262 aa	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	G5EGE9	whole worms (mixed-stage embryos)	PEAKS043570
EXP042496	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS043571
EXP042497	DPY-28 SDQ4564 Rabbit polyclonal is against the antigen QQQPTRNNDGLSGFKSITEIIAEADNNIPSEQIDKDIDSFSSYSDISDWRGIPKFFPSLSSLSRRASTYENWENRFKVVDYLVSCSGALKDSVSDYVADY May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q9U2M1	whole worms (mixed-stage embryos)	PEAKS043572
EXP042498	HCP-6 KH-HCP6 Rabbit Polyclonal to 1708-1722 aa sequence CKSAQAYHLHNIFEEDEES  (PMID:19119011)	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q95Y84	whole worms (mixed-stage embryos)	PEAKS043573
EXP042499	HTZ1 BK00001 mouse ascites polyclonal against HTZ-1 specific C-terminal peptide N-PGKPGAPGQGPQ-C (PMID:18787694)	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q27511	whole worms (mixed-stage embryos)	PEAKS043574
EXP042500	KLE-2 SDQ3898 Rabbit polyclonal is against the antigen MTRNAPPGQESTDLAWLVTPAKDLVENFSIDVLKALAGYLEVIRQESEDTDNQVDAATTYRLFDFQRACRIIQGSCAVYGRKVDHVYELTISVVDLVENK May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	P34341	whole worms (mixed-stage embryos)	PEAKS043575
EXP042501	MIX-1 JL0004 Rabbit polyclonal to 837-1244 aa. (PMID:19853451) is against the antigen 837-1244 aa	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q09591	whole worms (mixed-stage embryos)	PEAKS043576
EXP042502	PQN-85 SDQ4481 Rabbit polyclonal is against the antigen QQQPVQQIQRQQPIAQPIPQHTIPPSTSNQFQQQIQSAASSIFDSSVISSHQKLYEEQCRQIEKERKEQEERKRKQELEEQRKRNEELKRLRIAEEKRLL May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q95XZ5	whole worms (mixed-stage embryos)	PEAKS043577
EXP042503	SMC-4 OD0039 Rabbit polyclonal from Arshad Desai Lab	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q20060	whole worms (mixed-stage embryos)	PEAKS043578
EXP042504	DPY-26 JL00003 Rabbit polyclonal to 40-1262 aa.  (PMID:19853451) is against the antigen 40-1262 aa	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	G5EGE9	whole worms (mixed-stage embryos)	PEAKS043579
EXP042505	HCP-6 KH-HCP6 Rabbit Polyclonal to 1708-1722 aa sequence CKSAQAYHLHNIFEEDEES  (PMID:19119011)	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	Q95Y84	whole worms (mixed-stage embryos)	PEAKS043580
EXP042506	PQN-85 SDQ4481 Rabbit polyclonal is against the antigen QQQPVQQIQRQQPIAQPIPQHTIPPSTSNQFQQQIQSAASSIFDSSVISSHQKLYEEQCRQIEKERKEQEERKRKQELEEQRKRNEELKRLRIAEEKRLL May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	Q95XZ5	whole worms (mixed-stage embryos)	PEAKS043581
EXP042507	KLE-2 SDQ3942 Rabbit polyclonal is against the antigen MTRNAPPGQESTDLAWLVTPAKDLVENFSIDVLKALAGYLEVIRQESEDTDNQVDAATTYRLFDFQRACRIIQGSCAVYGRKVDHVYELTISVVDLVENK May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	P34341	whole worms (mixed-stage embryos)	PEAKS043582
EXP042508	KLE-2 SDQ3942 Rabbit polyclonal is against the antigen MTRNAPPGQESTDLAWLVTPAKDLVENFSIDVLKALAGYLEVIRQESEDTDNQVDAATTYRLFDFQRACRIIQGSCAVYGRKVDHVYELTISVVDLVENK May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042491	1390	normal	P34341	whole worms (developmental stage: L3)	PEAKS043583
EXP042519	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; tra-1(e1834) heterozygote	EXP042517	1390	normal	P34708	whole worms (developmental stage: L3)	PEAKS043586
EXP042520	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; tra-1(e1834) homozygote	EXP042518	1390	normal	P34708	whole worms (developmental stage: L3)	PEAKS043587
EXP042521	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment	EXP042513	1202	normal	P34708	whole worms (developmental stage: L2)	PEAKS043588
EXP042522	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment	NULL	1390	normal	P34708	whole worms (developmental stage: L3)	PEAKS043589
EXP042523	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; glp-4 (bn2)	EXP042515	1235	normal	P34708	whole worms (developmental stage: young adults)	PEAKS043590
EXP042524	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; spe-11(hc77)	EXP042516	1235	normal	P34708	whole worms (developmental stage: young adults)	PEAKS043591
EXP042525	anti-GFP Abcam ab290	Caenorhabditis elegans	Treatment: JA1597 strain	NULL	1391	normal	D3YT77	whole worms (developmental stage: late embryo)	PEAKS043592
EXP042531	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	5% Triton X-100; OP179 strain	EXP042526	1389	normal	P91868	whole worms (developmental stage: L4/young adults)	PEAKS043593
EXP042532	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	5% Triton X-100; OP179 strain	EXP042527	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS043594
EXP042533	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	1% Triton X-100; OP179 strain	EXP042528	1387	normal	P91868	whole worms (developmental stage: L1)	PEAKS043595
EXP042534	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	1% Triton X-100; YL457 strain	EXP042529	1393	normal	P91868	young adults, germline tissue	PEAKS043596
EXP042535	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	Triton X-100; YL524 strain	EXP042530	1394	normal	P91868	young adults, somatic cells	PEAKS043597
EXP042542	EAP-1 antibody	Caenorhabditis elegans	genotype: wild type	EXP042536	1235	normal	P45968	whole worms (developmental stage: young adults)	PEAKS043598
EXP042543	EAP-1 antibody	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G10	EXP042538	1235	normal	P45968	whole worms (developmental stage: young adults)	PEAKS043599
EXP042544	EAP-1 antibody	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G20	EXP042539	1235	normal	P45968	whole worms (developmental stage: young adults)	PEAKS043600
EXP042545	EAP-1 antibody	Caenorhabditis elegans	genotype: eap1-null mutant (strain: ok3432)	EXP042541	1235	bio_control	P45968	whole worms (developmental stage: young adults)	PEAKS043601
EXP042546	EAP-1 antibody	Caenorhabditis elegans	genotype: wild type	EXP042537	1235	normal	P45968	whole worms (developmental stage: young adults)	PEAKS043602
EXP042547	EAP-1 antibody	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G20	EXP042540	1235	normal	P45968	whole worms (developmental stage: young adults)	PEAKS043603
EXP042550	anti GFP (abcam 290)	Caenorhabditis elegans	strain: HML214; genotype: LIN42 GFP-tagged	NULL	1389	normal	Q65ZG8	whole worms (developmental stage: L4/young adults)	PEAKS043604
EXP042551	anti GFP (abcam 290)	Caenorhabditis elegans	strain: HML214; genotype: LIN42 GFP-tagged	NULL	1389	normal	Q65ZG8	whole worms (developmental stage: L4/young adults)	PEAKS043605
EXP042552	anti LIN-42(KEA/11 Rabbit 2, PrimmBiotech)	Caenorhabditis elegans	strain: HML214; genotype: LIN42 GFP-tagged	EXP042548	1389	normal	Q65ZG8	whole worms (developmental stage: L4/young adults)	PEAKS043606
EXP043417	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP301, genotype: unc-119(tm4063) III; wgIs301., sex:mixed	EXP043385	1387	normal	Q9U325	whole worms (developmental stage: L1)	PEAKS043607
EXP043418	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP703, genotype: unc-119(tm4063); wgIs703 [spr-3::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042930	1389	normal	Q17768	whole worms (developmental stage: L4/young adults)	PEAKS043608
EXP043419	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:mixed	EXP042946	1389	normal	Q86MJ3	whole worms (developmental stage: L4/young adults)	PEAKS043609
EXP043420	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP523, genotype: unc-119(tm4063) III; wgIs523., sex:hermaphrodite	EXP042737	1387	normal	P34555	whole worms (developmental stage: L1)	PEAKS043610
EXP043421	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP198, genotype: unc-119(ed3) III; wgIs198., sex:mixed	EXP042762	1390	normal	P41846	whole worms (developmental stage: L3)	PEAKS043611
EXP043422	goat-anti-GFP-UC	Drosophila melanogaster	strain: corto-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=corto-GFP.FPTB}VK00037, sex:mixed	EXP042557	1407	normal	P41046	whole organism (development stage: embryonic)	PEAKS043612
EXP043423	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP043151	1387	normal	Q09228	whole worms (developmental stage: L1)	PEAKS043613
EXP043424	ab290	Drosophila melanogaster	strain: Eip74EF-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Eip74EF-GFP.FLAG}VK00037	EXP043045	1407	normal	P20105	whole organism (development stage: embryonic)	PEAKS043614
EXP043425	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042789	1392	normal	Q966B8	whole worms (mixed-stage embryos)	PEAKS043615
EXP043426	goat-anti-GFP-UC	Drosophila melanogaster	strain: tai-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tai-GFP.FLAG}VK00033, sex:mixed	EXP043027	1400	normal	M9ND53	whole organism (development stage: wandering third instar larva)	PEAKS043616
EXP043427	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8145-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=nom-GFP.FPTB}attP40, sex:mixed	EXP043323	1407	normal	Q9VHM7	whole organism (development stage: embryonic)	PEAKS043617
EXP043428	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043041	1389	normal	Q17381	whole worms (developmental stage: L4/young adults)	PEAKS043618
EXP043429	non-commercial Lpt modENCODE antibody 1	Drosophila melanogaster	strain: 13T-exd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=exd-EGFP.S}VK00033	EXP043293	1407	normal	Q9W1H0	whole organism (development stage: embryonic)	PEAKS043619
EXP043430	goat-anti-GFP-UC	Drosophila melanogaster	strain: 9T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=slp2-EGFP.S}VK00033/TM3, Sb[1], sex:mixed	EXP043277	1407	normal	H5V8D4	whole organism (development stage: embryonic)	PEAKS043620
EXP043431	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP042915	1390	normal	G5EBU4	whole worms (developmental stage: L3)	PEAKS043621
EXP043432	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m5-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)m5-HLH-GFP.FPTB}attP-40, sex:mixed	EXP043393	1407	normal	P13096	whole organism (development stage: embryonic)	PEAKS043622
EXP043433	goat-anti-GFP-UC	Drosophila melanogaster	strain: D-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=D-GFP.FPTB}attP40, sex:mixed	EXP043173	1407	normal	M9PFL2	whole organism (development stage: embryonic)	PEAKS043623
EXP043434	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pdp1-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Pdp1[MI01532]/TM6B, sb, Tb, Hu, sex:mixed	EXP042597	1407	normal	Q24217	whole organism (development stage: embryonic)	PEAKS043624
EXP043435	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP311, sex:hermaphrodite	EXP043026	1391	normal	Q95PX3	whole worms (developmental stage: late embryo)	PEAKS043625
EXP043436	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG14655-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG14655-GFP.FPTB}attP40, sex:mixed	EXP043003	1404	normal	Q9VN56	whole organism (development stage: pupa)	PEAKS043626
EXP043437	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP239, genotype: unc-119(ed3) III; wgIs239., sex:mixed	EXP043222	1389	normal	P41999	whole worms (developmental stage: L4/young adults)	PEAKS043627
EXP043438	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP512, genotype: unc-119(tm4063) III; wgIs512., sex:hermaphrodite	EXP042811	1387	normal	Q09441	whole worms (developmental stage: L1)	PEAKS043628
EXP043439	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(var)3-9-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=E(var)3-9-GFP.FTBP}VK00037, sex:mixed	EXP042970	1407	normal	Q9VHJ3	whole organism (development stage: embryonic)	PEAKS043629
EXP043440	goat-anti-GFP-UC	Drosophila melanogaster	strain: AntP-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Antp[MI02272]/TM6B, sb, Tb, Hu, sex:mixed	EXP042842	1407	normal	P02833	whole organism (development stage: embryonic)	PEAKS043630
EXP043441	goat-anti-GFP-UC	Drosophila melanogaster	strain: Su(H)-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Su(H)-GFP.FLAG}attP2, sex:mixed	EXP042964	1407	normal	P28159	whole organism (development stage: embryonic)	PEAKS043631
EXP043442	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17181-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Kah-GFP.FPTB}attP-40, sex:mixed	EXP043341	1407	normal	Q9W0P9	whole organism (development stage: embryonic)	PEAKS043632
EXP043443	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr4-GFP.FSTF}VK00033, sex:mixed	EXP042754	1408	normal	Q9W539	whole organism (development stage: prepupa)	PEAKS043633
EXP043444	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042825	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS043634
EXP043445	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043269	1390	normal	G5ECF7	whole worms (developmental stage: L3)	PEAKS043635
EXP043446	goat-anti-GFP-UC	Drosophila melanogaster	strain: pho-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pho-GFP.FPTB}VK00033, sex:mixed	EXP042687	1407	normal	Q8ST83	whole organism (development stage: embryonic)	PEAKS043636
EXP043447	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP373, genotype: unc-119(tm4063) III; wgIs373., sex:mixed	EXP042688	1390	normal	Q9XVV3	whole worms (developmental stage: L3)	PEAKS043637
EXP043448	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP342, genotype: unc-119(ed3) III; wgIs342., sex:mixed	EXP042841	1389	normal	P34707	whole worms (developmental stage: L4/young adults)	PEAKS043638
EXP043449	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8216-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=spab-GFP.FPTB}attP40, sex:mixed	EXP043367	1408	normal	A1Z7M0	whole organism (development stage: prepupa)	PEAKS043639
EXP043450	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP656, genotype: unc-119 (tm4063) III; wgIs656, sex:mixed	EXP042728	1405	normal	Q9TYT0	whole organism (development stage: early embryonic)	PEAKS043640
EXP043451	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL472, genotype: unc-119(ed3) III; vrEx66 [pMEX-5::HPL-2:GFP:FLAG::HPL-2 3-UTR, unc-119 (+)]), sex:mixed	EXP042830	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	PEAKS043641
EXP043452	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP178, genotype: unc-119(ed3) III; wgIs178., sex:mixed	EXP042973	1387	normal	P34707	whole worms (developmental stage: L1)	PEAKS043642
EXP043453	goat-anti-GFP-UC	Drosophila melanogaster	strain: crp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=crp-GFP.FPTB}VK00033, sex:mixed	EXP043149	1407	normal	Q9V406	whole organism (development stage: embryonic)	PEAKS043643
EXP043454	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox100B-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Sox100B-GFP.FPTB}attP40 / CyO, sex:mixed	EXP043380	1407	normal	Q9VA17	whole organism (development stage: embryonic)	PEAKS043644
EXP043455	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP500, genotype: unc-119(tm4063) III; wgIs500., sex:mixed	EXP042880	1391	normal	P34522	whole worms (developmental stage: late embryo)	PEAKS043645
EXP043456	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042615	1387	normal	G5ECF7	whole worms (developmental stage: L1)	PEAKS043646
EXP043457	goat-anti-GFP-UC	Drosophila melanogaster	strain: 3T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=en-EGFP.S}VK00033, sex:mixed	EXP043320	1407	normal	P02836	whole organism (development stage: embryonic)	PEAKS043647
EXP044357	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: CB428 strain	EXP044354	1388	normal	P48996	whole worms (developmental stage: embryo)	PEAKS044515
EXP043459	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10209-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10209-GFP.FPTB}VK00033, sex:mixed	EXP043059	1407	normal	Q7K3Q3	whole organism (development stage: embryonic)	PEAKS043649
EXP043460	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8944-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG8944-RB-GFP-GFP.FPTB}VK00033, sex:mixed	EXP043410	1407	normal	Q9VXQ6	whole organism (development stage: embryonic)	PEAKS043650
EXP043461	goat-anti-GFP-UC	Drosophila melanogaster	strain: tx-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tx-GFP.FTBP}VK00037, sex:mixed	EXP042714	1407	normal	P41894	whole organism (development stage: embryonic)	PEAKS043651
EXP043462	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP105, genotype: unc119(ed3);wgIs105(dpl-1::TY1 EGFP FLAG;unc119), sex:mixed	EXP043268	1389	normal	Q22703	whole worms (developmental stage: L4/young adults)	PEAKS043652
EXP043463	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12942-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG12942-GFP.FPTB}VK00033, sex:mixed	EXP042579	1407	normal	Q7JW60	whole organism (development stage: embryonic)	PEAKS043653
EXP043464	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP484, sex:hermaphrodite	EXP042608	1235	normal	O17025	whole worms (developmental stage: young adults)	PEAKS043654
EXP043465	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP57, genotype: unc-119(ed3) III; wgIs57., sex:mixed	EXP043190	1202	normal	G5EFF4	whole worms (developmental stage: L2)	PEAKS043655
EXP043466	goat-anti-GFP-UC	Drosophila melanogaster	strain: Trl-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Trl[MI02741]/TM6B, sb, Tb, Hu, sex:mixed	EXP043288	1407	normal	A4V1Y6	whole organism (development stage: embryonic)	PEAKS043656
EXP043467	goat-anti-GFP-UC	Caenorhabditis elegans	strain: GOU883, sex:hermaphrodite	EXP042658	1387	normal	Q23045	whole worms (developmental stage: L1)	PEAKS043657
EXP043468	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7928-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=ZIPIC-GFP.FPTB}attP40, sex:mixed	EXP043136	1407	normal	Q9VAB8	whole organism (development stage: embryonic)	PEAKS043658
EXP043469	goat-anti-GFP-UC	Caenorhabditis elegans	strain: ZM7247, genotype: daf-16(mu86);daf-2(e1370) III; hpSi4II (Pmyo-3 GFP::daf-16a), sex:hermaphrodite	EXP042868	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	PEAKS043659
EXP043470	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP709, genotype: unc-119(tm4063); wgIs709 [T23F11.4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042951	1391	normal	Q22696	whole worms (developmental stage: late embryo)	PEAKS043660
EXP043471	KW1-dm-D1	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	Q9W4S7	Kc167 (development stage: embryonic)	PEAKS043661
EXP043472	non-commercial Sin3A modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043272	1407	normal	A1Z927	whole organism (development stage: embryonic)	PEAKS043662
EXP043473	goat-anti-GFP-UC	Drosophila melanogaster	strain: HLH54F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HLH54F-GFP.FTBP}VK00033, sex:mixed	EXP042712	1407	normal	Q0IGU7	whole organism (development stage: embryonic)	PEAKS043663
EXP043474	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1792-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG1792-GFP.FPTB}VK00037, sex:mixed	EXP042846	1407	normal	Q9V9V8	whole organism (development stage: embryonic)	PEAKS043664
EXP043475	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:mixed	EXP042584	1202	normal	P28515	whole worms (developmental stage: L2)	PEAKS043665
EXP043476	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18619-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG18619-GFP.FTBP}VK00033, sex:mixed	EXP042685	1407	normal	Q8IPC7	whole organism (development stage: embryonic)	PEAKS043666
EXP043477	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP598, genotype: unc-119(tm4063) III; wgIs598, sex:mixed	EXP043339	1235	normal	Q22798	whole worms (developmental stage: young adults)	PEAKS043667
EXP043478	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17186-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17186-GFP.FPTB}attP40, sex:mixed	EXP042867	1407	normal	Q9VDT2	whole organism (development stage: embryonic)	PEAKS043668
EXP043479	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hand-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hand-GFP.FPTB}VK00033, sex:mixed	EXP043398	1407	normal	Q9VL05	whole organism (development stage: embryonic)	PEAKS043669
EXP043480	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mes4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mes4-GFP.FPTB}VK00033, sex:mixed	EXP042661	1407	normal	Q9W256	whole organism (development stage: embryonic)	PEAKS043670
EXP043481	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP563, genotype: unc-119(tm4063) III; wgIs563., sex:mixed	EXP042613	1235	normal	Q18909	whole worms (developmental stage: young adults)	PEAKS043671
EXP043482	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP321, genotype: unc-119(tm4063) III; wgIs321., sex:mixed	EXP042758	1387	normal	G5EGF8	whole worms (developmental stage: L1)	PEAKS043672
EXP043483	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP640, genotype: unc-119(tm4063) III; wgIs640., sex:mixed	EXP042794	1405	normal	Q20709	whole organism (development stage: early embryonic)	PEAKS043673
EXP043484	ab24726	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042962	1407	normal	P05205	whole organism (development stage: embryonic)	PEAKS043674
EXP043485	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG14962-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Asciz-GFP.FPTB}attP40, sex:mixed	EXP042704	1407	normal	Q9VZU1	whole organism (development stage: embryonic)	PEAKS043675
EXP043486	goat-anti-GFP-UC	Drosophila melanogaster	strain: Suvar2-10-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Su(var)2-10-GFP.FPTB}VK00037, sex:mixed	EXP043334	1407	normal	Q7KNF5	whole organism (development stage: embryonic)	PEAKS043676
EXP043487	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	EXP042797	1391	normal	Q10655	whole worms (developmental stage: late embryo)	PEAKS043677
EXP043488	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP476, genotype: unc-119(tm4063) III; wgIs476., sex:hermaphrodite	EXP043404	1387	normal	P13528	whole worms (developmental stage: L1)	PEAKS043678
EXP043489	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hmr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hmr-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042717	1407	normal	Q86CW5	whole organism (development stage: embryonic)	PEAKS043679
EXP043490	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18476-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG18476-GFP.FTBP}VK00037, sex:mixed	EXP043357	1407	normal	Q9VGK1	whole organism (development stage: embryonic)	PEAKS043680
EXP043491	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP043278	1389	normal	G5EFY7	whole worms (developmental stage: L4/young adults)	PEAKS043681
EXP043492	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox15-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Sox15-GFP.FPTB}VK00033, sex:mixed	EXP042890	1408	normal	P40657	whole organism (development stage: prepupa)	PEAKS043682
EXP043493	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9883-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9883-GFP.FTBP}VK00033, sex:mixed	EXP043221	1407	normal	Q9VQD6	whole organism (development stage: embryonic)	PEAKS043683
EXP043494	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP043408	1387	normal	Q966B8	whole worms (developmental stage: L1)	PEAKS043684
EXP043495	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG30403-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG30403-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP043377	1407	normal	Q8MLV3	whole organism (development stage: embryonic)	PEAKS043685
EXP043496	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042785	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS043686
EXP043497	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043266	1392	normal	G5ECF7	whole worms (mixed-stage embryos)	PEAKS043687
EXP043498	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: Hr46-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr46-GFP.FLAG}VK00033/TM3, Sb[1]	EXP042979	1407	normal	P91943	whole organism (development stage: embryonic)	PEAKS043688
EXP043499	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:hermaphrodite	EXP043004	1202	normal	Q93560	whole worms (developmental stage: L2)	PEAKS043689
EXP043500	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP631, genotype: unc-119(tm4063) III; wgIs631, sex:mixed	EXP043108	1391	normal	O45080	whole worms (developmental stage: late embryo)	PEAKS043690
EXP043501	goat-anti-GFP-UC	Drosophila melanogaster	strain: vri-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=vri-GFP.FPTB}VK00033, sex:mixed	EXP043096	1408	normal	Q7KTN9	whole organism (development stage: prepupa)	PEAKS043691
EXP043502	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP517, genotype: unc-119(tm4063) III; wgIs517., sex:mixed	EXP042808	1391	normal	Q17922	whole worms (developmental stage: late embryo)	PEAKS043692
EXP043503	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP043244	1387	normal	P91868	whole worms (developmental stage: L1)	PEAKS043693
EXP043504	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP043184	1390	normal	O02274	whole worms (developmental stage: L3)	PEAKS043694
EXP043505	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3995-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG3995-GFP.FPTB}TBD, sex:mixed	EXP042642	1407	normal	Q9VEP0	whole organism (development stage: embryonic)	PEAKS043695
EXP043506	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP043215	1202	normal	P34684	whole worms (developmental stage: L2)	PEAKS043696
EXP043507	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP043079	1410	normal	Q9N5D6	whole organism (development stage: dauer)	PEAKS043697
EXP043508	goat-anti-GFP-UC	Drosophila melanogaster	strain: Met-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Met-GFP.FTBP}VK00031, sex:mixed	EXP042854	1408	normal	Q9VYW2	whole organism (development stage: prepupa)	PEAKS043698
EXP043509	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042887	1387	normal	O02316	whole worms (developmental stage: L1)	PEAKS043699
EXP043510	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP345, genotype: unc-119(ed3) III; wgIs345., sex:mixed	EXP043007	1387	normal	Q18037	whole worms (developmental stage: L1)	PEAKS043700
EXP043511	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP609, genotype: unc-119(tm4063) III; wgIs609, sex:mixed	EXP042801	1235	normal	O61845	whole worms (developmental stage: young adults)	PEAKS043701
EXP043512	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP522, genotype: unc-119(tm4063) III; wgIs522., sex:hermaphrodite	EXP042812	1387	normal	Q93246	whole worms (developmental stage: L1)	PEAKS043702
EXP043513	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP70, genotype: unc-119(ed3) III; wgIs70., sex:mixed	EXP042745	1392	normal	Q21502	whole worms (mixed-stage embryos)	PEAKS043703
EXP043514	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13204-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=zf30C-GFP.FPTB}VK00033, sex:mixed	EXP043361	1404	normal	A1Z8K2	whole organism (development stage: pupa)	PEAKS043704
EXP043515	goat-anti-GFP-UC	Drosophila melanogaster	strain: l(3)neo38-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=l(3)neo38-GFP.FPTB}attP40, sex:mixed	EXP043252	1407	normal	Q8SZN9	whole organism (development stage: embryonic)	PEAKS043705
EXP043516	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP659, genotype: unc-119(tm4063) III; wgIs659, sex:mixed	EXP043107	1392	normal	Q18955	whole worms (mixed-stage embryos)	PEAKS043706
EXP043517	goat-anti-GFP-UC	Drosophila melanogaster	strain: HmgD-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HmgD-GFP.FTBP}VK00033, sex:mixed	EXP042583	1407	normal	C0MJA0	whole organism (development stage: embryonic)	PEAKS043707
EXP043518	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP389, genotype: unc-119(tm4063) III; wgIs389., sex:mixed	EXP042982	1391	normal	P41936	whole worms (developmental stage: late embryo)	PEAKS043708
EXP043519	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP520, genotype: unc-119(tm4063) III; wgIs520., sex:hermaphrodite	EXP043387	1391	normal	Q94178	whole worms (developmental stage: late embryo)	PEAKS043709
EXP043520	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:mixed	EXP043073	1202	normal	Q19345	whole worms (developmental stage: L2)	PEAKS043710
EXP043521	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3065-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG3065-GFP.FTBP}VK00033, sex:mixed	EXP043089	1407	normal	Q2MGN0	whole organism (development stage: embryonic)	PEAKS043711
EXP043522	ab290	Drosophila melanogaster	strain: Hr78-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr78-GFP.FLAG}VK00037	EXP043308	1400	normal	Q24142	whole organism (development stage: wandering third instar larva)	PEAKS043712
EXP043523	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13624-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG13624-GFP.FPTB}VK00037, sex:mixed	EXP042827	1407	normal	Q9VC61	whole organism (development stage: embryonic)	PEAKS043713
EXP043524	goat-anti-GFP-UC	Drosophila melanogaster	strain: tin-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=tin-GFP.FPTB}VK00037 / CyO, sex:mixed	EXP043329	1407	normal	B6IDS0	whole organism (development stage: embryonic)	PEAKS043714
EXP043525	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP602, sex:mixed	EXP043019	1389	normal	Q9N5D6	whole worms (developmental stage: L4/young adults)	PEAKS043715
EXP043526	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP528, genotype: wgIs528(snu-23::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0094_4B11);unc-119(+));unc-119 (tm4063), sex:hermaphrodite	EXP042848	1387	normal	P34670	whole worms (developmental stage: L1)	PEAKS043716
EXP043527	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP342, genotype: unc-119(ed3) III; wgIs342., sex:mixed	EXP042667	1390	normal	P34707	whole worms (developmental stage: L3)	PEAKS043717
EXP043528	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	EXP042755	1387	normal	Q19691	whole worms (developmental stage: L1)	PEAKS043718
EXP043529	goat-anti-GFP-UC	Drosophila melanogaster	strain: gfzf-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=gfzf-GFP-GFP.FPTB}VK00037, sex:mixed	EXP042623	1407	normal	Q6NP69	whole organism (development stage: embryonic)	PEAKS043719
EXP043530	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP565, genotype: unc-119(tm4063) III; wgIs565., sex:mixed	EXP043025	1235	normal	A5JYU2	whole worms (developmental stage: young adults)	PEAKS043720
EXP043531	goat-anti-GFP-UC	Drosophila melanogaster	strain: dmrt93B-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=dmrt93B-GFP.FPTB}attP-40, sex:mixed	EXP042969	1400	normal	Q9VDF1	whole organism (development stage: wandering third instar larva)	PEAKS043721
EXP043532	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP99, genotype: unc-119(ed3) III; wgIs99., sex:mixed	EXP043406	1392	normal	Q10902	whole worms (mixed-stage embryos)	PEAKS043722
EXP043533	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	EXP042899	1389	normal	Q27395	whole worms (developmental stage: L4/young adults)	PEAKS043723
EXP043534	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP77, genotype: unc-119(ed3) III; wgIs77, sex:mixed	EXP043283	1387	normal	Q18694	whole worms (developmental stage: L1)	PEAKS043724
EXP043535	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG14965-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG14965-GFP.FTBP}VK00037, sex:mixed	EXP043202	1407	normal	Q960J7	whole organism (development stage: embryonic)	PEAKS043725
EXP043536	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP743, genotype: unc-119(tm4063); wgIs743 [lin-54::TY1::EGFP::3xFLAG(Fosmid: lin-54) + unc-119(+)], sex:mixed	EXP043412	1235	normal	Q95QD7	whole worms (developmental stage: young adults)	PEAKS043726
EXP043537	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP463, genotype: unc-119(tm4063) III; wgIs463., sex:hermaphrodite	EXP042862	1389	normal	Q9XVJ1	whole worms (developmental stage: L4/young adults)	PEAKS043727
EXP043538	goat-anti-GFP-UC	Drosophila melanogaster	strain: ab-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ab-GFP.FLAG}VK00033, sex:mixed	EXP042721	1407	normal	Q9W1P8	whole organism (development stage: embryonic)	PEAKS043728
EXP043539	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP043176	1235	normal	Q9N5D6	whole worms (developmental stage: young adults)	PEAKS043729
EXP043540	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043037	1407	normal	P91943	whole organism (development stage: embryonic)	PEAKS043730
EXP043541	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP043307	1391	normal	O17593	whole worms (developmental stage: late embryo)	PEAKS043731
EXP043542	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP042876	1387	normal	G5ECN8	whole worms (developmental stage: L1)	PEAKS043732
EXP043543	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sry-delta-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Sry-delta-GFP.FPTB}VK00037, sex:mixed	EXP043327	1407	normal	P07664	whole organism (development stage: embryonic)	PEAKS043733
EXP043544	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9876-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9876-GFP.FPTB}VK00033, sex:mixed	EXP042609	1407	normal	Q9W1U7	whole organism (development stage: embryonic)	PEAKS043734
EXP043545	Aviva-KW3-D-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042796	1407	normal	M9PFL2	whole organism (development stage: embryonic)	PEAKS043735
EXP043546	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP043296	1202	normal	Q09228	whole worms (developmental stage: L2)	PEAKS043736
EXP043547	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mad-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mad-GFP.FLAG}VK00033, sex:mixed	EXP043194	1407	normal	P42003	whole organism (development stage: embryonic)	PEAKS043737
EXP043548	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP82, genotype: unc-119(tm4063) III; wgIs82., sex:mixed	EXP042858	1390	normal	P34326	whole worms (developmental stage: L3)	PEAKS043738
EXP043549	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP529, genotype: unc-119(tm4063) III; wgIs529., sex:hermaphrodite	EXP042889	1389	normal	Q09534	whole worms (developmental stage: L4/young adults)	PEAKS043739
EXP043550	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4617-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG4617-GFP.FPTB}VK00033, sex:mixed	EXP042684	1407	normal	Q9W3S4	whole organism (development stage: embryonic)	PEAKS043740
EXP043551	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042711	1390	normal	G5ECG2	whole worms (developmental stage: L3)	PEAKS043741
EXP043552	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP042997	1389	normal	O02274	whole worms (developmental stage: L4/young adults)	PEAKS043742
EXP043553	goat-anti-GFP-UC	Drosophila melanogaster	strain: OdsH-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=OdsH-GFP.FPTB}VK00033, sex:mixed	EXP042571	1408	normal	Q9VX20	whole organism (development stage: prepupa)	PEAKS043743
EXP043554	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP241, genotype: unc-119(ed3) III; wgIs241., sex:mixed	EXP042776	1389	normal	G5EE18	whole worms (developmental stage: L4/young adults)	PEAKS043744
EXP043555	goat-anti-GFP-UC	Drosophila melanogaster	strain: jing-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=jing-GFP.FPTB}VK00033, sex:mixed	EXP042780	1407	normal	A8DY48	whole organism (development stage: embryonic)	PEAKS043745
EXP043556	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP506, genotype: unc-119(tm4063) III; wgIs506., sex:hermaphrodite	EXP043356	1387	normal	G5EE07	whole worms (developmental stage: L1)	PEAKS043746
EXP043557	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11723-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG11723-GFP.FTBP}VK00033, sex:mixed	EXP043124	1407	normal	Q9VQ77	whole organism (development stage: embryonic)	PEAKS043747
EXP043558	goat-anti-GFP-UC	Drosophila melanogaster	strain: p53-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}p53[MI01307]/TM6B, sb, Tb, Hu, sex:mixed	EXP042883	1407	normal	Q9N6D8	whole organism (development stage: embryonic)	PEAKS043748
EXP043559	goat-anti-GFP-UC	Drosophila melanogaster	strain: Smox-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Smox-GFP.FLAG}VK00033, sex:mixed	EXP043165	1408	normal	O96660	whole organism (development stage: prepupa)	PEAKS043749
EXP043560	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	EXP043010	1235	normal	G5EEG1	whole worms (developmental stage: young adults)	PEAKS043750
EXP043561	sc-25761	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	P28159	Kc167 (development stage: embryonic)	PEAKS043751
EXP043562	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr83-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr83-GFP.FPTB}VK00037, sex:mixed	EXP043047	1400	normal	Q9VI12	whole organism (development stage: wandering third instar larva)	PEAKS043752
EXP064983	anti-Trl (anti-GAF)	Drosophila melanogaster	Treatment: Treatment: Treatment: none; Strain: Iso1; Strain: Iso1; Strain: Iso1	EXP064981	1417	normal	Q08605	8-16 h embryo	PEAKS059557
EXP043564	goat-anti-GFP-UC	Drosophila melanogaster	strain: lbe-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=lbe-GFP.FTBP}VK00037, sex:mixed	EXP043061	1407	normal	Q7KS77	whole organism (development stage: embryonic)	PEAKS043754
EXP043565	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9797-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG7987-GFP.FPTB}attP-40, sex:mixed	EXP043348	1407	normal	Q9VHM3	whole organism (development stage: embryonic)	PEAKS043755
EXP043566	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP533, genotype: unc-119(tm4063) III; wgIs533, sex:hermaphrodite	EXP042589	1391	normal	P41934	whole worms (developmental stage: late embryo)	PEAKS043756
EXP043567	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1233-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG1233-GFP.FPTB}attP-40, sex:mixed	EXP042761	1407	normal	Q9I7U7	whole organism (development stage: embryonic)	PEAKS043757
EXP043568	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP383, genotype: unc-119(tm4063) III; wgIs383., sex:hermaphrodite	EXP043297	1235	normal	G4SGI5	whole worms (developmental stage: young adults)	PEAKS043758
EXP043569	goat-anti-GFP-UC	Drosophila melanogaster	strain: pdm3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pdm3-GFP.FPTB}VK00033, sex:mixed	EXP043322	1408	normal	B7YZU0	whole organism (development stage: prepupa)	PEAKS043759
EXP043570	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18599-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG18599-GFP.FPTB}attP40, sex:mixed	EXP043126	1407	normal	Q9VEA3	whole organism (development stage: embryonic)	PEAKS043760
EXP043571	goat-anti-GFP-UC	Drosophila melanogaster	strain: nau-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=nau-GFP.FPTB}attP40, sex:mixed	EXP043309	1407	normal	P22816	whole organism (development stage: embryonic)	PEAKS043761
EXP043572	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP240, genotype: unc-119(ed3) III; wgIs240., sex:mixed	EXP043099	1389	normal	Q9N5S3	whole worms (developmental stage: L4/young adults)	PEAKS043762
EXP043573	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP636, genotype: unc-119(tm4063) III; wgIs636, sex:mixed	EXP042727	1235	normal	Q22289	whole worms (developmental stage: young adults)	PEAKS043763
EXP043574	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL402, genotype: unc119(ed3)III; vrIs56[pPIE-1::LIN-35::GFP FLAG: LIN-35 3â€™UTR, unc-119 (+)], sex:mixed	EXP042665	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	PEAKS043764
EXP043575	goat-anti-GFP-UC	Drosophila melanogaster	strain: 1T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=bcd-EGFP.S}VK00037, sex:mixed	EXP043209	1407	normal	P09081	whole organism (development stage: embryonic)	PEAKS043765
EXP043576	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP543, sex:hermaphrodite	EXP043409	1235	normal	Q09620	whole worms (developmental stage: young adults)	PEAKS043766
EXP043577	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6808-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6808-GFP.FPTB}attP40, sex:mixed	EXP043193	1408	normal	Q7YZ91	whole organism (development stage: prepupa)	PEAKS043767
EXP043578	goat-anti-GFP-UC	Drosophila melanogaster	strain: 16T-GFP, genotype: y[1] w[*]; PBac{eGFP w[+mC]=ems-EGFP.S}VK00037/Tm3, sb, sex:mixed	EXP043379	1407	normal	P18488	whole organism (development stage: embryonic)	PEAKS043768
EXP043579	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1529-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG1529-GFP.FPTB}VK00033, sex:mixed	EXP042720	1407	normal	B7Z152	whole organism (development stage: embryonic)	PEAKS043769
EXP043580	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13123-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG13123-GFP.FPTB}VK00033, sex:mixed	EXP043217	1407	normal	Q9VL80	whole organism (development stage: embryonic)	PEAKS043770
EXP043581	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL577, sex:hermaphrodite	EXP042893	1235	normal	O01789	whole worms (developmental stage: young adults)	PEAKS043771
EXP043582	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL487, sex:hermaphrodite	EXP043249	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS043772
EXP043583	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042850	1390	normal	O02316	whole worms (developmental stage: L3)	PEAKS043773
EXP043584	ab290	Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	EXP042716	1407	normal	P42283	whole organism (development stage: embryonic)	PEAKS043774
EXP043585	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043030	1387	normal	Q9N5S3	whole worms (developmental stage: L1)	PEAKS043775
EXP043586	goat-anti-GFP-UC	Drosophila melanogaster	strain: foxo-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=foxo-GFP.FLAG}VK00037, sex:mixed	EXP042760	1400	normal	Q95V55	whole organism (development stage: wandering third instar larva)	PEAKS043776
EXP043587	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP64, genotype: unc-119(ed3) III; wgIs64, sex:mixed	EXP043291	1392	normal	P22980	whole worms (mixed-stage embryos)	PEAKS043777
EXP043588	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP043031	1202	normal	G5EBU4	whole worms (developmental stage: L2)	PEAKS043778
EXP043589	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10565-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10565-GFP.FPTB}VK00037, sex:mixed	EXP043191	1407	normal	Q9VP77	whole organism (development stage: embryonic)	PEAKS043779
EXP043590	goat-anti-GFP-UC	Drosophila melanogaster	strain: CHES-1-like-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CHES-1-like-EGFP.S}VK00033, sex:mixed	EXP042875	1407	normal	Q9W3Q5	whole organism (development stage: embryonic)	PEAKS043780
EXP043591	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP724, genotype: unc-119(tm4063); wgIs724 [attf-5::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042697	1235	normal	Q22173	whole worms (developmental stage: young adults)	PEAKS043781
EXP043592	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP042644	1389	normal	Q17905	whole worms (developmental stage: L4/young adults)	PEAKS043782
EXP043593	goat-anti-GFP-UC	Drosophila melanogaster	strain: brk-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=brk-GFP.FPTB}VK00033, sex:mixed	EXP042719	1400	normal	Q9XTN4	whole organism (development stage: wandering third instar larva)	PEAKS043783
EXP043594	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP043196	1387	normal	G5EBU4	whole worms (developmental stage: L1)	PEAKS043784
EXP043595	goat-anti-GFP-UC	Drosophila melanogaster	strain: sage-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=sage-GFP.FTBP}VK00037, sex:mixed	EXP042605	1400	normal	Q9VHG3	whole organism (development stage: wandering third instar larva)	PEAKS043785
EXP043596	goat-anti-GFP-UC	Drosophila melanogaster	strain: lab-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=lab-GFP.FPTB}attP40, sex:mixed	EXP043129	1407	normal	P10105	whole organism (development stage: embryonic)	PEAKS043786
EXP043597	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP487, sex:hermaphrodite	EXP042743	1405	normal	O01519	whole organism (development stage: early embryonic)	PEAKS043787
EXP043598	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP670, genotype: unc-119(tm4063); wgIs670 [sdz-12::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043185	1389	normal	Q9BLC4	whole worms (developmental stage: L4/young adults)	PEAKS043788
EXP043599	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042953	1389	normal	G5EG44	whole worms (developmental stage: L4/young adults)	PEAKS043789
EXP043600	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP568, genotype: unc-119(tm4063) III; wgIs568, sex:mixed	EXP042977	1390	normal	Q21789	whole worms (developmental stage: L3)	PEAKS043790
EXP043601	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP043044	1389	normal	O17894	whole worms (developmental stage: L4/young adults)	PEAKS043791
EXP043602	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 10T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dfd-EGFP.S}VK00037	EXP042603	1407	normal	Q7KS72	whole organism (development stage: embryonic)	PEAKS043792
EXP043603	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP81, genotype: unc-119(ed3) III; wgIs81., sex:mixed	EXP042563	1390	normal	G5EDU4	whole worms (developmental stage: L3)	PEAKS043793
EXP043604	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP120, genotype: unc-119(ed3) III; wgIs120., sex:mixed	EXP043200	1391	normal	Q22909	whole worms (developmental stage: late embryo)	PEAKS043794
EXP043605	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP82, genotype: unc-119(tm4063) III; wgIs82., sex:mixed	EXP042718	1202	normal	P34326	whole worms (developmental stage: L2)	PEAKS043795
EXP043606	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP358, genotype: unc-119(tm4063) III; wgIs358., sex:hermaphrodite	EXP042856	1389	normal	P91306	whole worms (developmental stage: L4/young adults)	PEAKS043796
EXP043607	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL507, sex:hermaphrodite	EXP042630	1235	normal	Q22703	whole worms (developmental stage: young adults)	PEAKS043797
EXP043608	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043182	1389	normal	Q23521	whole worms (developmental stage: L4/young adults)	PEAKS043798
EXP043609	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP483, genotype: unc-119(tm4063) III; wgIs483., sex:hermaphrodite	EXP043337	1387	normal	O17025	whole worms (developmental stage: L1)	PEAKS043799
EXP043610	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043167	1387	normal	Q23294	whole worms (developmental stage: L1)	PEAKS043800
EXP043611	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4424-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG4424-GFP.FPTB}TBD, sex:mixed	EXP042572	1407	normal	Q9VDQ6	whole organism (development stage: embryonic)	PEAKS043801
EXP043612	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043386	1389	normal	Q17381	whole worms (developmental stage: L4/young adults)	PEAKS043802
EXP043614	goat-anti-GFP-UC	Drosophila melanogaster	strain: Camta-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Camta[MI04570]/SM6a, sex:mixed	EXP043188	1407	normal	B7YZU5	whole organism (development stage: embryonic)	PEAKS043804
EXP043615	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042757	1407	normal	P20482	whole organism (development stage: embryonic)	PEAKS043805
EXP043616	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP553, genotype: unc-119(tm4063) III; wgIs553., sex:mixed	EXP043158	1235	normal	O02224	whole worms (developmental stage: young adults)	PEAKS043806
EXP043617	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL651, genotype: let-607(tm1423); unc-119(ed3) III; vrIs121[LET-607 fosmid, unc-119 (+)], sex:mixed	EXP042765	1235	normal	O44743	whole worms (developmental stage: young adults)	PEAKS043807
EXP043618	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP474, genotype: unc-119(tm4063) III; wgIs474., sex:hermaphrodite	EXP042766	1235	normal	U4PEA1	whole worms (developmental stage: young adults)	PEAKS043808
EXP043619	goat-anti-GFP-UC	Drosophila melanogaster	strain: jumu-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}jumu[MI00438]/TM6B, sb, Tb, Hu, sex:mixed	EXP043114	1407	normal	Q9XTP7	whole organism (development stage: embryonic)	PEAKS043809
EXP043620	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP696, genotype: unc-119(tm4063) III; wgIs696., sex:mixed	EXP042998	1392	normal	Q21494	whole worms (mixed-stage embryos)	PEAKS043810
EXP043621	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL479, sex:hermaphrodite	EXP042991	1235	normal	G5EF11	whole worms (developmental stage: young adults)	PEAKS043811
EXP043622	goat-anti-GFP-UC	Drosophila melanogaster	strain: pb-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pb-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042865	1407	normal	P31264	whole organism (development stage: embryonic)	PEAKS043812
EXP043623	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP32, genotype: unc-119(ed3) III; wgIs32, sex:mixed	EXP043335	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS043813
EXP043624	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:hermaphrodite	EXP043394	1391	normal	Q86MH8	whole worms (developmental stage: late embryo)	PEAKS043814
EXP043625	goat-anti-GFP-UC	Drosophila melanogaster	strain: BtbVII-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=BtbVII-GFP.FPTB}attP40, sex:mixed	EXP042872	1407	normal	Q9VZU5	whole organism (development stage: embryonic)	PEAKS043815
EXP043626	goat-anti-GFP-UC	Drosophila melanogaster	strain: Atf-2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Atf-2-GFP.FLAG}VK00033, sex:mixed	EXP042599	1407	normal	Q2PE13	whole organism (development stage: embryonic)	PEAKS043816
EXP043627	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pdp1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pdp1-GFP.FPTB}VK00037/SM5, sex:mixed	EXP043374	1407	normal	Q24217	whole organism (development stage: embryonic)	PEAKS043817
EXP043628	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP513, genotype: unc-119(tm4063) III; wgIs513., sex:hermaphrodite	EXP043354	1391	normal	O44131	whole worms (developmental stage: late embryo)	PEAKS043818
EXP043629	goat-anti-GFP-UC	Drosophila melanogaster	strain: crc-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}crc[MI02300]/TM6B, sb, Tb, Hu, sex:mixed	EXP043039	1407	normal	Q9VID3	whole organism (development stage: embryonic)	PEAKS043819
EXP043630	goat-anti-GFP-UC	Drosophila melanogaster	strain: Med-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Med-GFP.FLAG}VK00037, sex:mixed	EXP042678	1407	normal	O62609	whole organism (development stage: embryonic)	PEAKS043820
EXP043631	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL409, genotype: unc-119(ed3)III; vrIs60 [pLIN-35::LIN-35:GFP:FLAG::LIN-35 3â€™UTR, unc-119 (+)]), sex:mixed	EXP043032	1387	normal	G5EDT1	whole worms (developmental stage: L1)	PEAKS043821
EXP043632	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1647-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG1647-GFP.FPTB}VK00037, sex:mixed	EXP043183	1407	normal	Q9VAT1	whole organism (development stage: embryonic)	PEAKS043822
EXP043633	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP401, sex:hermaphrodite	EXP043146	1235	normal	H9G332	whole worms (developmental stage: young adults)	PEAKS043823
EXP043634	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP043000	1387	normal	Q17905	whole worms (developmental stage: L1)	PEAKS043824
EXP043635	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP43, genotype: unc-119(ed3) III; wgIs43., sex:mixed	EXP042933	1390	normal	P41828	whole worms (developmental stage: L3)	PEAKS043825
EXP043636	goat-anti-GFP-UC	Drosophila melanogaster	strain: mirr-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=mirr-GFP.FPTB}attP40, sex:mixed	EXP042567	1407	normal	Q9VU01	whole organism (development stage: embryonic)	PEAKS043826
EXP043637	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP698, genotype: unc-119(tm4063) III; wgIs698., sex:mixed	EXP042916	1391	normal	O45103	whole worms (developmental stage: late embryo)	PEAKS043827
EXP043638	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042619	1390	normal	G5EG44	whole worms (developmental stage: L3)	PEAKS043828
EXP043639	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP323, sex:hermaphrodite	EXP043119	1391	normal	G5ECT8	whole worms (developmental stage: late embryo)	PEAKS043829
EXP043640	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW12085, genotype: pat-9(mNG^SEC^3xFlag::pat-9]) X, sex:mixed	EXP043134	1391	normal	Q22829	whole worms (developmental stage: late embryo)	PEAKS043830
EXP043641	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042936	1392	normal	P91868	whole worms (mixed-stage embryos)	PEAKS043831
EXP043642	goat-anti-GFP-UC	Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	EXP043280	1400	normal	M9PGS2	whole organism (development stage: wandering third instar larva)	PEAKS043832
EXP043643	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3163-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG3163-GFP.FPTB}VK00033, sex:mixed	EXP043091	1407	normal	Q9W1C8	whole organism (development stage: embryonic)	PEAKS043833
EXP043644	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6792-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG6792-GFP.FPTB}VK00033 / tm6C, sb[1], sex:mixed	EXP042614	1408	normal	Q9VKC4	whole organism (development stage: prepupa)	PEAKS043834
EXP043645	ab290	Drosophila melanogaster	strain: Abd-B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Abd-B-EGFP.S}VK00037/SM57	EXP043159	1400	normal	P09087	whole organism (development stage: wandering third instar larva)	PEAKS043835
EXP043646	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP68, genotype: unc-119(ed3) III; wgIs68., sex:hermaphrodite	EXP042989	1391	normal	G5EE86	whole worms (developmental stage: late embryo)	PEAKS043836
EXP043647	goat-anti-GFP-UC	Drosophila melanogaster	strain: foxo-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}foxo[MI00493]/TM6B, sb, Tb, Hu, sex:mixed	EXP043002	1400	normal	Q95V55	whole organism (development stage: wandering third instar larva)	PEAKS043837
EXP043648	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043381	1390	normal	Q17381	whole worms (developmental stage: L3)	PEAKS043838
EXP043649	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12071-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG12071-GFP.FPTB}attP40, sex:mixed	EXP043023	1407	normal	Q9VA29	whole organism (development stage: embryonic)	PEAKS043839
EXP043650	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP477, genotype: unc-119(tm4063) III; wgIs477., sex:hermaphrodite	EXP043164	1390	normal	Q18299	whole worms (developmental stage: L3)	PEAKS043840
EXP043651	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP042815	1390	normal	G5ECN8	whole worms (developmental stage: L3)	PEAKS043841
EXP043652	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	EXP043262	1390	normal	Q27395	whole worms (developmental stage: L3)	PEAKS043842
EXP043653	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	EXP042881	1389	normal	O44505	whole worms (developmental stage: L4/young adults)	PEAKS043843
EXP043654	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043144	1392	normal	Q17381	whole worms (mixed-stage embryos)	PEAKS043844
EXP043655	goat-anti-GFP-UC	Drosophila melanogaster	strain: MESR4-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=MESR4-GFP.FPTB}VK00033, sex:mixed	EXP042921	1407	normal	A1ZAV3	whole organism (development stage: embryonic)	PEAKS043845
EXP043656	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10702, sex:hermaphrodite	EXP043145	1391	normal	Q10007	whole worms (developmental stage: late embryo)	PEAKS043846
EXP043657	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP219, genotype: unc-119(ed3) III; wgIs219., sex:mixed	EXP043105	1389	normal	Q11178	whole worms (developmental stage: L4/young adults)	PEAKS043847
EXP043658	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11762-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG11762-GFP.FPTB}attP40, sex:mixed	EXP043095	1408	normal	Q9VHM6	whole organism (development stage: prepupa)	PEAKS043848
EXP043659	Aviva-KW3-h-D1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042656	1407	normal	P14003	whole organism (development stage: embryonic)	PEAKS043849
EXP043660	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP042934	1387	normal	O62183	whole worms (developmental stage: L1)	PEAKS043850
EXP043661	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	EXP043270	1390	normal	Q10655	whole worms (developmental stage: L3)	PEAKS043851
EXP043662	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	EXP043098	1391	normal	G5EEG1	whole worms (developmental stage: late embryo)	PEAKS043852
EXP043663	goat-anti-GFP-UC	Drosophila melanogaster	strain: dpn-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}dpn[MI00051]/TM6B, sb, Tb, Hu, sex:mixed	EXP042693	1407	normal	Q26263	whole organism (development stage: embryonic)	PEAKS043853
EXP043664	goat-anti-GFP-UC	Drosophila melanogaster	strain: fu2-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=fu2-GFP-GFP.FPTB}VK00033, sex:mixed	EXP043168	1407	normal	Q9VLK8	whole organism (development stage: embryonic)	PEAKS043854
EXP043665	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG5245-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG5245-GFP.FTBP}VK00037, sex:mixed	EXP043353	1407	normal	Q9VG72	whole organism (development stage: embryonic)	PEAKS043855
EXP043666	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL551, sex:hermaphrodite	EXP043366	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS043856
EXP043667	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox14-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox14-GFP.FTBP}VK00033, sex:mixed	EXP042594	1408	normal	P40656	whole organism (development stage: prepupa)	PEAKS043857
EXP043668	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:hermaphrodite	EXP042948	1389	normal	Q86MJ3	whole worms (developmental stage: L4/young adults)	PEAKS043858
EXP043669	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP581, genotype: unc-119(tm4063) III; wgIs581., sex:mixed	EXP043247	1235	normal	O18065	whole worms (developmental stage: young adults)	PEAKS043859
EXP043670	goat-anti-GFP-UC	Drosophila melanogaster	strain: acj6-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=acj6-GFP.FPTB}VK00033, sex:mixed	EXP043284	1408	normal	P24350	whole organism (development stage: prepupa)	PEAKS043860
EXP043671	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL581, sex:hermaphrodite	EXP042690	1235	normal	Q9XUB3	whole worms (developmental stage: young adults)	PEAKS043861
EXP043672	goat-anti-GFP-UC	Drosophila melanogaster	strain: br-rj-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=br.Z2-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043336	1400	normal	Q01295	whole organism (development stage: wandering third instar larva)	PEAKS043862
EXP043673	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15514-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG15514-GFP.FPTB}attP40, sex:mixed	EXP043038	1407	normal	Q9VAF2	whole organism (development stage: embryonic)	PEAKS043863
EXP043674	goat-anti-GFP-UC	Drosophila melanogaster	strain: gcm2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=gcm2-GFP.FLAG}VK00033, sex:mixed	EXP043204	1407	normal	Q9VLA2	whole organism (development stage: embryonic)	PEAKS043864
EXP043675	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP55, genotype: unc-119(ed3) III; wgIs55., sex:hermaphrodite	EXP043100	1391	normal	P09088	whole worms (developmental stage: late embryo)	PEAKS043865
EXP043676	ab24726	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042861	1407	normal	P05205	whole organism (development stage: embryonic)	PEAKS043866
EXP043677	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042590	1202	normal	Q966B8	whole worms (developmental stage: L2)	PEAKS043867
EXP043678	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP240, genotype: unc-119(ed3) III; wgIs240., sex:mixed	EXP042722	1202	normal	Q9N5S3	whole worms (developmental stage: L2)	PEAKS043868
EXP043679	goat-anti-GFP-UC	Drosophila melanogaster	strain: Lpt-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Lpt-GFP.FPTB}VK00033, sex:mixed	EXP042645	1408	normal	Q9W1H0	whole organism (development stage: prepupa)	PEAKS043869
EXP043680	goat-anti-GFP-UC	Drosophila melanogaster	strain: Jarid2-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=Jarid2-GFP.FPTB}attP40, sex:mixed	EXP043351	1407	normal	Q9VT00	whole organism (development stage: embryonic)	PEAKS043870
EXP043681	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4854-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG4854-GFP.FTBP}VK00037, sex:mixed	EXP043011	1407	normal	Q9VDQ5	whole organism (development stage: embryonic)	PEAKS043871
EXP043682	goat-anti-GFP-UC	Drosophila melanogaster	strain: trh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=trh-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042898	1407	normal	Q24119	whole organism (development stage: embryonic)	PEAKS043872
EXP043683	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4318-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG4318-GFP.FTBP}VK00033, sex:mixed	EXP042672	1408	normal	Q9VYG4	whole organism (development stage: prepupa)	PEAKS043873
EXP043684	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP462, genotype: unc-119(tm4063) III; wgIs462., sex:hermaphrodite	EXP043236	1387	normal	G5EFQ5	whole worms (developmental stage: L1)	PEAKS043874
EXP043685	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP685, genotype: unc-119(tm4063) III; wgIs685., sex:mixed	EXP043289	1235	normal	Q18605	whole worms (developmental stage: young adults)	PEAKS043875
EXP043686	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042724	1390	normal	G5EFY7	whole worms (developmental stage: L3)	PEAKS043876
EXP043687	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	EXP043369	1387	normal	Q11107	whole worms (developmental stage: L1)	PEAKS043877
EXP043688	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr46-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr46-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP043177	1407	normal	A8DY91	whole organism (development stage: embryonic)	PEAKS043878
EXP043689	goat-anti-GFP-UC	Drosophila melanogaster	strain: btn-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=btn-GFP.FTBP}VK00037, sex:mixed	EXP043318	1407	normal	Q9VCY0	whole organism (development stage: embryonic)	PEAKS043879
EXP043690	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9437-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG9437-GFP.FPTB}VK00033, sex:mixed	EXP042742	1407	normal	Q9W2K3	whole organism (development stage: embryonic)	PEAKS043880
EXP043691	ab290	Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	EXP042626	1403	normal	M9PGS2	whole organism	PEAKS043881
EXP043692	non-commercial CG8478 modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042891	1407	normal	E1JIH4	whole organism (development stage: embryonic)	PEAKS043882
EXP043693	non-commercial hth modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042978	1407	normal	O46339	whole organism (development stage: embryonic)	PEAKS043883
EXP043694	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	EXP043287	1390	normal	O44505	whole worms (developmental stage: L3)	PEAKS043884
EXP043695	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP042911	1202	normal	Q17381	whole worms (developmental stage: L2)	PEAKS043885
EXP043696	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP105, genotype: unc119(ed3);wgIs105(dpl-1::TY1 EGFP FLAG;unc119), sex:mixed	EXP043364	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS043886
EXP043697	goat-anti-GFP-UC	Caenorhabditis elegans	strain: LW1254, genotype: jjIs1254[Im486.2: pJKL723.2(sma-9C2::gfp+unc-119(+) ]; unc-119(ed4), sex:hermaphrodite	EXP042968	1202	normal	Q22190	whole worms (developmental stage: L2)	PEAKS043887
EXP043698	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL418, genotype: unc-119(ed3)III; vrIs65[pGES-1::EFL-1::GFP FLAG:EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043225	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS043888
EXP043699	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP509, genotype: unc-119(tm4063) III; wgIs509., sex:hermaphrodite	EXP043005	1391	normal	A8WFJ9	whole worms (developmental stage: late embryo)	PEAKS043889
EXP043700	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	EXP042654	1202	normal	Q11107	whole worms (developmental stage: L2)	PEAKS043890
EXP043701	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1602-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG1602-GFP.FTBP}VK00033, sex:mixed	EXP043127	1407	normal	Q8MSB3	whole organism (development stage: embryonic)	PEAKS043891
EXP043702	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7556-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7556-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042795	1407	normal	Q9VWL4	whole organism (development stage: embryonic)	PEAKS043892
EXP043703	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4707-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG4707-GFP.FPTB}VK00033, sex:mixed	EXP043261	1407	normal	Q9W137	whole organism (development stage: embryonic)	PEAKS043893
EXP043704	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:mixed	EXP042591	1391	normal	Q86MH8	whole worms (developmental stage: late embryo)	PEAKS043894
EXP043705	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP524, genotype: unc-119(tm4063) III; wgIs524., sex:hermaphrodite	EXP042568	1391	normal	Q94165	whole worms (developmental stage: late embryo)	PEAKS043895
EXP043706	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7786-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG7786-GFP.FPTB}VK00033, sex:mixed	EXP043349	1407	normal	A1ZAC2	whole organism (development stage: embryonic)	PEAKS043896
EXP043707	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP682, genotype: unc-119(tm4063); wgIs682 [Y5F2A.4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043014	1389	normal	Q9XWL0	whole worms (developmental stage: L4/young adults)	PEAKS043897
EXP043708	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL482, sex:hermaphrodite	EXP043053	1235	normal	Q17694	whole worms (developmental stage: young adults)	PEAKS043898
EXP043709	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP339, genotype: unc-119(ed3) III; wgIs339., sex:mixed	EXP043058	1202	normal	A5JYV4	whole worms (developmental stage: L2)	PEAKS043899
EXP043710	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP676, genotype: unc-119(tm4063); wgIs676 [ztf-22::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042807	1235	normal	Q9NAG7	whole worms (developmental stage: young adults)	PEAKS043900
EXP043711	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL468, genotype: unc-119(ed3)III; vrIs93 [pMEX-5::LIN-35:GFP:FLAG::LIN-35 3â€™UTR, unc-119 (+)]), sex:mixed	EXP043243	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	PEAKS043901
EXP043712	goat-anti-GFP-UC	Drosophila melanogaster	strain: snoo-MiMIC, genotype: y[1] w[*]; Mi{eGFP=MIC}snoo[MI07577]/TM6B, sb, Tb, Hu, sex:mixed	EXP042896	1404	normal	Q00G30	whole organism (development stage: pupa)	PEAKS043902
EXP043713	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hmx-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Hmx[MI02025]/TM6B, sb, Tb, Hu, sex:mixed	EXP043263	1407	normal	B4F5U4	whole organism (development stage: embryonic)	PEAKS043903
EXP043714	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	EXP042707	1387	normal	Q9TZI2	whole worms (developmental stage: L1)	PEAKS043904
EXP043715	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10470, genotype: stIs10470 [tbx-8::TY1::EGFP::3xFLAG; unc-119(+)]; unc-119(ed3), sex:mixed	EXP042919	1392	normal	Q22292	whole worms (mixed-stage embryos)	PEAKS043905
EXP043716	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP465, genotype: unc-119(tm4063) III; wgIs465., sex:hermaphrodite	EXP042696	1235	normal	O44637	whole worms (developmental stage: young adults)	PEAKS043906
EXP043717	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP383, genotype: unc-119(tm4063) III; wgIs383., sex:hermaphrodite	EXP043258	1389	normal	G4SGI5	whole worms (developmental stage: L4/young adults)	PEAKS043907
EXP043718	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	EXP042800	1390	normal	Q19691	whole worms (developmental stage: L3)	PEAKS043908
EXP043719	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6254-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6254-GFP.FPTB}attP40, sex:mixed	EXP042966	1407	normal	Q9VH18	whole organism (development stage: embryonic)	PEAKS043909
EXP043720	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG30431-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG30431-GFP.FTBP}VK00033, sex:mixed	EXP042849	1407	normal	Q4V6Y7	whole organism (development stage: embryonic)	PEAKS043910
EXP043721	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL474, genotype: lin-35(n745) I; unc-119(ed3) III; vrIs64[pGES-1::HPL-2::GFP FLAG: HPL-2 3-UTR, unc-119 (+)], sex:mixed	EXP043042	1387	normal	G5EDE2	whole worms (developmental stage: L1)	PEAKS043911
EXP043722	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13775-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG13775-GFP.FTBP}VK00033, sex:mixed	EXP042894	1407	normal	Q9VM61	whole organism (development stage: embryonic)	PEAKS043912
EXP043723	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8319-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG8319-GFP.FPTB}attP40, sex:mixed	EXP043017	1408	normal	Q9VHA4	whole organism (development stage: prepupa)	PEAKS043913
EXP043724	non-commercial CG8478 modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042771	1403	normal	E1JIH4	whole organism	PEAKS043914
EXP043725	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1620-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG1620-GFP-GFP.FPTB}VK00033, sex:female	EXP043205	1399	normal	E1JGZ3	whole organism (development stage: adult)	PEAKS043915
EXP043726	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL424, genotype: unc-119(ed3)III; vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP042810	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS043916
EXP043727	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP614, genotype: unc-119(tm4063); wgIs614 [ztf-3::TY1::EGFP::3xFLAG +;unc-119(+)], sex:mixed	EXP042643	1235	normal	Q9N5V6	whole worms (developmental stage: young adults)	PEAKS043917
EXP043728	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6276-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6276-GFP.FPTB}attP40, sex:mixed	EXP042817	1408	normal	Q9VF93	whole organism (development stage: prepupa)	PEAKS043918
EXP043729	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG16779-MiMIC, genotype: y[1] w[*]; Mi{eGFP=MIC}CG16779[MI06036]/TM6B, sb, Tb, Hu, sex:mixed	EXP043020	1408	normal	Q9VHD1	whole organism (development stage: prepupa)	PEAKS043919
EXP043730	ab290	Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	EXP042662	1407	normal	M9PGS2	whole organism (development stage: embryonic)	PEAKS043920
EXP043731	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pum-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}pum[MI04825]/TM6B, sb, Tb, Hu, sex:mixed	EXP042633	1407	normal	P25822	whole organism (development stage: embryonic)	PEAKS043921
EXP043732	goat-anti-GFP-UC	Drosophila melanogaster	strain: Clk-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Clk-GFP.FPTB}attP40, sex:male	EXP042954	1399	normal	O61735	whole organism (development stage: adult)	PEAKS043922
EXP043733	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	EXP043264	1387	normal	Q27395	whole worms (developmental stage: L1)	PEAKS043923
EXP043734	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: NC1639, genotype: [wdIs49 (pttr39::UNC-55a::GFP; dpy-20+) III, sex:mixed	EXP042554	1391	normal	G5ECR9	whole worms (developmental stage: late embryo)	PEAKS043924
EXP043735	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 10T-Dfd-GFP, genotype: y[1] M{vas-int.Dm}ZH-2A w[*]; PBac{y[+]-attP-3B}VK00033	EXP042783	1407	normal	Q7KS72	whole organism (development stage: embryonic)	PEAKS043925
EXP043736	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP042736	1389	normal	G5ECN8	whole worms (developmental stage: L4/young adults)	PEAKS043926
EXP043737	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: NC1639, genotype: [wdIs49 (pttr39::UNC-55a::GFP; dpy-20+) III, sex:mixed	EXP043016	1202	normal	G5ECR9	whole worms (developmental stage: L2)	PEAKS043927
EXP043738	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd102C-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=-GFP.FPTB}VK00033 / Tm6c, sex:mixed	EXP043294	1407	normal	Q9V481	whole organism (development stage: embryonic)	PEAKS043928
EXP043739	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: XE1464, genotype: unc-119(ed3) III;, sex:mixed	EXP043192	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	PEAKS043929
EXP043740	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP043250	1387	normal	O02274	whole worms (developmental stage: L1)	PEAKS043930
EXP043741	goat-anti-GFP-UC	Drosophila melanogaster	strain: ets3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets65A-GFP.FLAG}VK00037, sex:mixed	EXP043189	1407	normal	P29774	whole organism (development stage: embryonic)	PEAKS043931
EXP043742	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042907	1202	normal	G5ECG2	whole worms (developmental stage: L2)	PEAKS043932
EXP043743	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG34376-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ADD1-GFP.FPTB}attP40 / CyO, sex:mixed	EXP042683	1407	normal	Q9VD04	whole organism (development stage: embryonic)	PEAKS043933
EXP043744	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP427, genotype: unc-119(ed3) III; wgIs427., sex:mixed	EXP042629	1202	normal	Q9XTV4	whole worms (developmental stage: L2)	PEAKS043934
EXP043745	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP042691	1389	normal	P34684	whole worms (developmental stage: L4/young adults)	PEAKS043935
EXP043746	goat-anti-GFP-UC	Drosophila melanogaster	strain: TFAM-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=TFAM-GFP.FPTB}attP40, sex:mixed	EXP043121	1407	normal	Q86BR8	whole organism (development stage: embryonic)	PEAKS043936
EXP043747	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP043372	1390	normal	O17593	whole worms (developmental stage: L3)	PEAKS043937
EXP043748	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP432, genotype: unc-119(tm4063) III; wgIs432., sex:mixed	EXP042636	1389	normal	Q21148	whole worms (developmental stage: L4/young adults)	PEAKS043938
EXP043749	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP042860	1389	normal	O62183	whole worms (developmental stage: L4/young adults)	PEAKS043939
EXP043750	non-commercial CG8478 modENCODE antibody 1	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP042769	1197	normal	E1JIH4	S2-DRSC (embryonic stem cells)	PEAKS043940
EXP043751	goat-anti-GFP-UC	Drosophila melanogaster	strain: cwo-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=cwo-GFP.FPTB}attP40, sex:mixed	EXP042561	1407	normal	Q9VGZ5	whole organism (development stage: embryonic)	PEAKS043941
EXP043752	Aviva-KW3-h-D1	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	P14003	Kc167 (development stage: embryonic)	PEAKS043942
EXP043753	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP611, genotype: unc-119(tm4063); wgIs611 [sup-37::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042952	1387	normal	Q8MNV9	whole worms (developmental stage: L1)	PEAKS043943
EXP043754	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP652, genotype: unc-119(tm4063) III; wgIs652, sex:mixed	EXP043347	1387	normal	Q9TZK1	whole worms (developmental stage: L1)	PEAKS043944
EXP043755	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042814	1387	normal	G5ECF7	whole worms (developmental stage: L1)	PEAKS043945
EXP043756	sc-28208	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP042769	1197	normal	Q9W4S7	S2-DRSC (embryonic stem cells)	PEAKS043946
EXP043757	goat-anti-GFP-UC	Drosophila melanogaster	strain: eyg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=eyg-GFP.FPTB}VK00037/SM5, sex:mixed	EXP043180	1407	normal	Q9VTX7	whole organism (development stage: embryonic)	PEAKS043947
EXP043758	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP536, genotype: unc-119(tm4063) III; wgIs536, sex:hermaphrodite	EXP042941	1387	normal	Q93348	whole worms (developmental stage: L1)	PEAKS043948
EXP043759	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3407-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG3407-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042932	1407	normal	Q9VQV3	whole organism (development stage: embryonic)	PEAKS043949
EXP043760	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP167, genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119), sex:mixed	EXP042580	1390	normal	G5EFF5	whole worms (developmental stage: L3)	PEAKS043950
EXP043761	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9609-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG9609-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042582	1407	normal	Q9VXB4	whole organism (development stage: embryonic)	PEAKS043951
EXP043762	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP63, sex:hermaphrodite	EXP042971	1391	normal	Q11094	whole worms (developmental stage: late embryo)	PEAKS043952
EXP043763	ab4811	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043259	1407	normal	A1Z768	whole organism (development stage: embryonic)	PEAKS043953
EXP043764	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042836	1202	normal	O02316	whole worms (developmental stage: L2)	PEAKS043954
EXP043765	goat-anti-GFP-UC	Drosophila melanogaster	strain: maf-S-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=maf-S-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042784	1407	normal	Q4QPP9	whole organism (development stage: embryonic)	PEAKS043955
EXP043766	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dhr51-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr51-GFP.FLAG}VK00033, sex:mixed	EXP043024	1407	normal	A1ZA01	whole organism (development stage: embryonic)	PEAKS043956
EXP043767	goat-anti-GFP-UC	Drosophila melanogaster	strain: chif-RA-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=chif-RA-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042999	1407	normal	Q9NK54	whole organism (development stage: embryonic)	PEAKS043957
EXP043768	goat-anti-GFP-UC	Drosophila melanogaster	strain: zfh2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=zfh2-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043368	1407	normal	P28167	whole organism (development stage: embryonic)	PEAKS043958
EXP043769	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP043302	1390	normal	Q09228	whole worms (developmental stage: L3)	PEAKS043959
EXP043770	goat-anti-GFP-UC	Drosophila melanogaster	strain: dm-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dm-GFP.FPTB}VK00033, sex:mixed	EXP043029	1407	normal	Q9VP06	whole organism (development stage: embryonic)	PEAKS043960
EXP043771	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7368-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG7368-GFP.FPTB}attP-40 / tm6C, sb[1], sex:mixed	EXP043155	1408	normal	Q9VTK6	whole organism (development stage: prepupa)	PEAKS043961
EXP043772	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10669-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG10669-GFP.FPTB}attP40, sex:mixed	EXP042566	1408	normal	Q9VBR9	whole organism (development stage: prepupa)	PEAKS043962
EXP043773	goat-anti-GFP-UC	Drosophila melanogaster	strain: side-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}side[MI00149]/TM6B, sb, Tb, Hu, sex:mixed	EXP042903	1407	normal	Q9VJ16	whole organism (development stage: embryonic)	PEAKS043963
EXP043774	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12768-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG12768-GFP.FPTB}attP40, sex:male	EXP042885	1399	normal	Q9VNP4	whole organism (development stage: adult)	PEAKS043964
EXP043775	goat-anti-GFP-UC	Drosophila melanogaster	strain: NfI-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=NfI-GFP.FPTB}VK00033, sex:mixed	EXP042700	1407	normal	Q86P06	whole organism (development stage: embryonic)	PEAKS043965
EXP043776	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG5204-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG5204-GFP.FPTB}VK00033, sex:male	EXP042909	1399	normal	Q9VK36	whole organism (development stage: adult)	PEAKS043966
EXP043777	goat-anti-GFP-UC	Caenorhabditis elegans	strain: AGK541, genotype: (armSi1[Pmex5::UNC-130::GFP::tbb-2 3'UTR; cb-unc-119(+)II]; unc-119(ed3)III; niDf199IV), sex:hermaphrodite	EXP043390	1235	normal	Q18694	whole worms (developmental stage: young adults)	PEAKS043967
EXP043778	Aviva-KW3-psq-D2	Drosophila melanogaster	genotype: e/se	EXP042787	1397	normal	A1Z8A6	Kc167 (development stage: embryonic)	PEAKS043968
EXP043779	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043137	1389	normal	Q23521	whole worms (developmental stage: L4/young adults)	PEAKS043969
EXP043780	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP658, genotype: unc-119(tm4063) III; wgIs658., sex:mixed	EXP043181	1235	normal	Q19306	whole worms (developmental stage: young adults)	PEAKS043970
EXP043781	goat-anti-GFP-UC	Drosophila melanogaster	strain: chif-RB-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=chif-RB-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042702	1407	normal	Q9NK54	whole organism (development stage: embryonic)	PEAKS043971
EXP043782	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mio-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mio-GFP.FPTB}VK00033, sex:mixed	EXP042857	1400	normal	Q9VID4	whole organism (development stage: wandering third instar larva)	PEAKS043972
EXP043783	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP537, genotype: unc-119(tm4063) III; wgIs537, sex:hermaphrodite	EXP042821	1235	normal	G5EEH5	whole worms (developmental stage: young adults)	PEAKS043973
EXP043784	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042709	1389	normal	G5EG44	whole worms (developmental stage: L4/young adults)	PEAKS043974
EXP043785	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP042671	1202	normal	O17894	whole worms (developmental stage: L2)	PEAKS043975
EXP043786	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042871	1202	normal	Q9N5D6	whole worms (developmental stage: L2)	PEAKS043976
EXP043787	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP478, genotype: unc-119(tm4063) III; wgIs478., sex:hermaphrodite	EXP042638	1235	normal	P91437	whole worms (developmental stage: young adults)	PEAKS043977
EXP043788	44960002	Caenorhabditis elegans	strain: MT10430, genotype: lin-35(n745) I., sex:mixed	EXP042601	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS043978
EXP043789	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP154, genotype: unc-119(ed3) III; wgIs154, sex:hermaphrodite	EXP043240	1387	normal	G5EDE1	whole worms (developmental stage: L1)	PEAKS043979
EXP043790	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP544, genotype: unc-119(tm4063) III; wgIs544, sex:hermaphrodite	EXP043365	1391	normal	G5EG34	whole worms (developmental stage: late embryo)	PEAKS043980
EXP043791	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP361, genotype: unc-119(tm4063) III; wgIs361., sex:mixed	EXP042983	1202	normal	G5EBL9	whole worms (developmental stage: L2)	PEAKS043981
EXP043792	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pif1B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pif1B-GFP.FPTB}VK00037, sex:mixed	EXP043012	1404	normal	Q9VHL6	whole organism (development stage: pupa)	PEAKS043982
EXP043793	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mnt-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mnt-GFP.FPTB}VK00033/TM3, Sb[1], sex:female	EXP042874	1399	normal	E1JJD1	whole organism (development stage: adult)	PEAKS043983
EXP043794	goat-anti-GFP-UC	Drosophila melanogaster	strain: lilli-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lilli-GFP.FPTB}VK00033, sex:mixed	EXP043169	1407	normal	Q9VQI9	whole organism (development stage: embryonic)	PEAKS043984
EXP043795	goat-anti-GFP-UC	Drosophila melanogaster	strain: sv-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sv-GFP.FPTB}VK00033, sex:mixed	EXP042912	1400	normal	Q8IM96	whole organism (development stage: wandering third instar larva)	PEAKS043985
EXP043796	KW0:TTK-7691	Drosophila melanogaster	genotype: e/se	EXP043295	1397	normal	P17789	Kc167 (development stage: embryonic)	PEAKS043986
EXP043797	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP727, genotype: unc-119(tm4063); wgIs727 [ceh-83::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042698	1392	normal	O16749	whole worms (mixed-stage embryos)	PEAKS043987
EXP043798	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP460, genotype: unc-119(tm4063) III; wgIs460., sex:hermaphrodite	EXP042647	1235	normal	O76668	whole worms (developmental stage: young adults)	PEAKS043988
EXP043799	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP208, genotype: unc-119(ed3) III; wgIs208., sex:mixed	EXP042805	1235	normal	G5EGN8	whole worms (developmental stage: young adults)	PEAKS043989
EXP043800	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043147	1390	normal	O16748	whole worms (developmental stage: L3)	PEAKS043990
EXP043801	goat-anti-GFP-UC	Drosophila melanogaster	strain: Kr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Kr-GFP.FTBP}VK00033, sex:mixed	EXP042588	1407	normal	P07247	whole organism (development stage: embryonic)	PEAKS043991
EXP043802	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	EXP042782	1202	normal	Q9TZI2	whole worms (developmental stage: L2)	PEAKS043992
EXP043803	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP391, genotype: unc-119(ed3) III; wgIs391(med-1::TY1 EGFP FLAG C; unc-119(+)), sex:hermaphrodite	EXP043255	1396	normal	G5EF71	whole organism (development stage: midembryonic)	PEAKS043993
EXP043804	goat-anti-GFP-UC	Drosophila melanogaster	strain: chn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=chn-GFP.FPTB}VK00033, sex:mixed	EXP042598	1407	normal	Q7YU81	whole organism (development stage: embryonic)	PEAKS043994
EXP043805	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042957	1202	normal	G5ECF7	whole worms (developmental stage: L2)	PEAKS043995
EXP043806	goat-anti-GFP-UC	Drosophila melanogaster	strain: emc-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=emc-GFP.FTBP}VK00037, sex:mixed	EXP043301	1407	normal	P18491	whole organism (development stage: embryonic)	PEAKS043996
EXP043807	goat-anti-GFP-UC	Drosophila melanogaster	strain: br-re-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=br.Z1-GFP.FPTB}VK00037, sex:mixed	EXP042706	1400	normal	Q01295	whole organism (development stage: wandering third instar larva)	PEAKS043997
EXP043808	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP688, genotype: unc-119(tm4063) III; wgIs688., sex:mixed	EXP042960	1235	normal	Q19335	whole worms (developmental stage: young adults)	PEAKS043998
EXP043809	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043383	1403	normal	P91943	whole organism	PEAKS043999
EXP043810	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9727-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG9727-GFP.FTBP}VK00037, sex:mixed	EXP042961	1407	normal	Q9VI23	whole organism (development stage: embryonic)	PEAKS044000
EXP043811	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP488, genotype: unc-119(tm4063) III; wgIs488., sex:hermaphrodite	EXP042778	1391	normal	Q95PV3	whole worms (developmental stage: late embryo)	PEAKS044001
EXP043812	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043148	1387	normal	G5ECF7	whole worms (developmental stage: L1)	PEAKS044002
EXP043813	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP043064	1392	normal	G5ECN8	whole worms (mixed-stage embryos)	PEAKS044003
EXP043814	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042942	1389	normal	Q65CM0	whole worms (developmental stage: L4/young adults)	PEAKS044004
EXP043815	non-commercial br modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043360	1407	normal	Q01295	whole organism (development stage: embryonic)	PEAKS044005
EXP043816	goat-anti-GFP-UC	Caenorhabditis elegans	strain: xtl1186, sex:hermaphrodite	EXP042628	1235	normal	Q93156	whole worms (developmental stage: young adults)	PEAKS044006
EXP043817	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042753	1390	normal	Q65CM0	whole worms (developmental stage: L3)	PEAKS044007
EXP043818	goat-anti-GFP-UC	Drosophila melanogaster	strain: scrt-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=scrt-GFP.FPTB}attP40, sex:mixed	EXP042558	1407	normal	Q9VZK2	whole organism (development stage: embryonic)	PEAKS044008
EXP043819	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2116-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2116-GFP.FPTB}VK00033, sex:mixed	EXP042925	1407	normal	Q9W3J9	whole organism (development stage: embryonic)	PEAKS044009
EXP043820	goat-anti-GFP-UC	Drosophila melanogaster	strain: Meics-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=Meics-GFP.FPTB}attP40, sex:mixed	EXP042959	1407	normal	O96395	whole organism (development stage: embryonic)	PEAKS044010
EXP043821	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8632-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ZnT49B-GFP.FTBP}VK00033, sex:mixed	EXP043332	1408	normal	A1Z936	whole organism (development stage: prepupa)	PEAKS044011
EXP043822	goat-anti-GFP-UC	Drosophila melanogaster	strain: NK7.1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NK7.1-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042564	1407	normal	Q9VFK4	whole organism (development stage: embryonic)	PEAKS044012
EXP043823	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sry-beta-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=sry-Beta-GFP.FPTB}attP-40, sex:mixed	EXP042773	1407	normal	P07665	whole organism (development stage: embryonic)	PEAKS044013
EXP043824	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP327, genotype: unc-119(ed3) III; wgIs327., sex:mixed	EXP042639	1392	normal	P46505	whole worms (mixed-stage embryos)	PEAKS044014
EXP043825	goat-anti-GFP-UC	Drosophila melanogaster	strain: MTF-1-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=MTF-1-GFP.FPTB}attP-40, sex:mixed	EXP042819	1407	normal	Q8IQC5	whole organism (development stage: embryonic)	PEAKS044015
EXP043826	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL485, sex:hermaphrodite	EXP042627	1235	normal	Q7JNN6	whole worms (developmental stage: young adults)	PEAKS044016
EXP043827	non-commercial insv modENCODE antibody 1	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	Q8SYK5	Kc167 (development stage: embryonic)	PEAKS044017
EXP043828	goat-anti-GFP-UC	Drosophila melanogaster	strain: vfl-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=vfl-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043226	1407	normal	Q9VWC6	whole organism (development stage: embryonic)	PEAKS044018
EXP043829	goat-anti-GFP-UC	Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	EXP043197	1400	normal	A1Z8A6	whole organism (development stage: wandering third instar larva)	PEAKS044019
EXP043830	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9305-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9305-GFP.FTBP}VK00033, sex:mixed	EXP043414	1407	normal	Q9VJZ3	whole organism (development stage: embryonic)	PEAKS044020
EXP043831	goat-anti-GFP-UC	Drosophila melanogaster	strain: svp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=svp-GFP.FLAG}VK00037/SM5, sex:mixed	EXP043063	1408	normal	P16375	whole organism (development stage: prepupa)	PEAKS044021
EXP043832	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG32264-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG32264-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042992	1400	normal	D4G7A5	whole organism (development stage: wandering third instar larva)	PEAKS044022
EXP043833	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP202, genotype: unc-119(ed3) III; wgIs202., sex:mixed	EXP042829	1391	normal	P56407	whole worms (developmental stage: late embryo)	PEAKS044023
EXP043834	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP443, sex:hermaphrodite	EXP042747	1391	normal	O01996	whole worms (developmental stage: late embryo)	PEAKS044024
EXP043835	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10631-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10631-GFP.FTBP}VK00033	EXP042944	1408	normal	Q9VIS5	whole organism (development stage: prepupa)	PEAKS044025
EXP043836	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dp-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dp-GFP.FPTB}VK00033, sex:mixed	EXP043175	1407	normal	Q24318	whole organism (development stage: embryonic)	PEAKS044026
EXP043837	goat-anti-GFP-UC	Drosophila melanogaster	strain: dsf-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dsf-GFP.FLAG}VK00033, sex:mixed	EXP042822	1400	normal	Q9VML1	whole organism (development stage: wandering third instar larva)	PEAKS044027
EXP043838	goat-anti-GFP-UC	Drosophila melanogaster	strain: dac-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dac-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042674	1408	normal	Q8IP20	whole organism (development stage: prepupa)	PEAKS044028
EXP043839	goat-anti-GFP-UC	Drosophila melanogaster	strain: odd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=odd-GFP.FPTB}VK00033, sex:mixed	EXP042562	1407	normal	P23803	whole organism (development stage: embryonic)	PEAKS044029
EXP043840	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP552, genotype: unc-119(tm4063) III; wgIs552., sex:mixed	EXP043303	1387	normal	Q18419	whole worms (developmental stage: L1)	PEAKS044030
EXP043841	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP418, genotype: unc-119(tm4063) III; wgIs418., sex:hermaphrodite	EXP042663	1391	normal	Q18248	whole worms (developmental stage: late embryo)	PEAKS044031
EXP043842	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 10T-Dfd-GFP, genotype: y[1] M{vas-int.Dm}ZH-2A w[*]; PBac{y[+]-attP-3B}VK00033	EXP043401	1400	normal	Q7KS72	whole organism (development stage: wandering third instar larva)	PEAKS044032
EXP043843	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP385, genotype: unc-119(tm4063) III; wgIs385., sex:hermaphrodite	EXP042859	1235	normal	O17890	whole worms (developmental stage: young adults)	PEAKS044033
EXP064982	anti-Yki	Drosophila melanogaster	Treatment: Treatment: Treatment: none; Strain: Iso1; Strain: Iso1; Strain: Iso1	EXP064981	1417	normal	Q45VV3	8-16 h embryo	PEAKS059556
EXP043845	goat-anti-GFP-UC	Drosophila melanogaster	strain: Eip93F-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Eip93F[MI05200]/TM6B, sb, Tb, Hu, sex:mixed	EXP042879	1408	normal	Q9VD60	whole organism (development stage: prepupa)	PEAKS044035
EXP043846	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL497, sex:hermaphrodite	EXP043324	1235	normal	Q22092	whole worms (developmental stage: young adults)	PEAKS044036
EXP043847	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP26, genotype: unc-119(ed3) III; wgIs26 [unc-119(+) mab-5::TY1::EGFP::3xFLAG], sex:mixed	EXP042963	1390	normal	P10038	whole worms (developmental stage: L3)	PEAKS044037
EXP043848	goat-anti-GFP-UC	Drosophila melanogaster	strain: YL-1-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=YL-1-GFP.FPTB}VK00033, sex:mixed	EXP043292	1407	normal	Q9VKM6	whole organism (development stage: embryonic)	PEAKS044038
EXP043849	goat-anti-GFP-UC	Drosophila melanogaster	strain: HLHm7-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HLHm7-GFP.FTBP}VK00037, sex:mixed	EXP043066	1407	normal	P13097	whole organism (development stage: embryonic)	PEAKS044039
EXP043850	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18764-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG18764-GFP.FPTB}attP-40, sex:mixed	EXP042715	1407	normal	Q9I7J8	whole organism (development stage: embryonic)	PEAKS044040
EXP043851	goat-anti-GFP-UC	Drosophila melanogaster	strain: cnc-GFP, genotype: W[*]; PBac{eGFP w[+mC]=cnc-GFP.FTBP}VK00037, sex:mixed	EXP042750	1400	normal	P20482	whole organism (development stage: wandering third instar larva)	PEAKS044041
EXP043852	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP51, genotype: unc-119(ed3) III; wgIs51., sex:mixed	EXP042804	1392	normal	Q11107	whole worms (mixed-stage embryos)	PEAKS044042
EXP043853	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP042631	1390	normal	O62183	whole worms (developmental stage: L3)	PEAKS044043
EXP043854	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP042988	1202	normal	Q21701	whole worms (developmental stage: L2)	PEAKS044044
EXP043855	goat-anti-GFP-UC	Drosophila melanogaster	strain: jim-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=jim-GFP.FPTB}VK00037, sex:mixed	EXP043009	1400	normal	Q7KAH0	whole organism (development stage: wandering third instar larva)	PEAKS044045
EXP043856	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP193, genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119), sex:mixed	EXP043093	1390	normal	S6EZL2	whole worms (developmental stage: L3)	PEAKS044046
EXP043857	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP042602	1389	normal	Q09228	whole worms (developmental stage: L4/young adults)	PEAKS044047
EXP043858	goat-anti-GFP-UC	Caenorhabditis elegans	strain: AGK541, genotype: (armSi1[Pmex5::UNC-130::GFP::tbb-2 3'UTR; cb-unc-119(+)II]; unc-119(ed3)III; niDf199IV), sex:hermaphrodite	EXP043103	1389	normal	Q18694	whole worms (developmental stage: L4/young adults)	PEAKS044048
EXP043859	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP332, genotype: unc-119(tm4063) III; wgIs332., sex:mixed	EXP042976	1389	normal	Q20448	whole worms (developmental stage: L4/young adults)	PEAKS044049
EXP043860	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG32006-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG32006-GFP.FTBP}VK00033, sex:mixed	EXP043118	1408	normal	Q8IMA2	whole organism (development stage: prepupa)	PEAKS044050
EXP043861	goat-anti-GFP-UC	Drosophila melanogaster	strain: slou-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=slou-EGFP.S}VK00037/SM5, sex:mixed	EXP043013	1407	normal	P22807	whole organism (development stage: embryonic)	PEAKS044051
EXP043862	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pif1A-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pif1A-GFP.FPTB}VK00037, sex:mixed	EXP042792	1404	normal	B7Z0G1	whole organism (development stage: pupa)	PEAKS044052
EXP043863	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP485, sex:hermaphrodite	EXP043154	1235	normal	Q86S28	whole worms (developmental stage: young adults)	PEAKS044053
EXP043864	44960002	Caenorhabditis elegans	strain: N2, genotype: C. elegans wild isolate., sex:hermaphrodite	EXP042734	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS044054
EXP043865	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP27, genotype: unc-119(ed3) III; wgIs27., sex:mixed	EXP043171	1392	normal	P10038	whole worms (mixed-stage embryos)	PEAKS044055
EXP043866	ab290	Drosophila melanogaster	strain: Notch-GFP, genotype: PBac{y[+]-attP-3B}VK00033	EXP042847	1400	normal	M9NE67	whole organism (development stage: wandering third instar larva)	PEAKS044056
EXP043867	goat-anti-GFP-UC	Caenorhabditis elegans	strain: ZM8745, genotype: daf-16(mu86);daf-2(e1370) III; hpSi15 (Pges-1 GFP::daf-16a), sex:hermaphrodite	EXP043317	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	PEAKS044057
EXP043868	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043162	1389	normal	O16748	whole worms (developmental stage: L4/young adults)	PEAKS044058
EXP043869	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12155-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG12155-GFP.FPTB}VK00033, sex:mixed	EXP043227	1407	normal	Q9W3Q2	whole organism (development stage: embryonic)	PEAKS044059
EXP043870	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP496, sex:hermaphrodite	EXP042729	1235	normal	B9ZSG9	whole worms (developmental stage: young adults)	PEAKS044060
EXP043871	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP508, genotype: unc-119(tm4063) III; wgIs508., sex:hermaphrodite	EXP042610	1235	normal	Q9XWS3	whole worms (developmental stage: young adults)	PEAKS044061
EXP043872	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dip3-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dip3-GFP.FPTB}VK00031, sex:mixed	EXP042705	1407	normal	Q7JZD5	whole organism (development stage: embryonic)	PEAKS044062
EXP043873	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP343, genotype: unc-119(ed3) III; wgIs343., sex:mixed	EXP043242	1202	normal	O17208	whole worms (developmental stage: L2)	PEAKS044063
EXP043874	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042739	1390	normal	Q9N5D6	whole worms (developmental stage: L3)	PEAKS044064
EXP043875	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043234	1387	normal	O16748	whole worms (developmental stage: L1)	PEAKS044065
EXP043876	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18011-GFP, sex:mixed	EXP043246	1407	normal	Q7K1V0	whole organism (development stage: embryonic)	PEAKS044066
EXP043877	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6654-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6654-GFP.FPTB}attP40, sex:mixed	EXP043101	1407	normal	Q9VFB9	whole organism (development stage: embryonic)	PEAKS044067
EXP043878	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3838-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG3838-GFP.FTBP}VK00033/TM3, sex:mixed	EXP043153	1407	normal	Q9VLA6	whole organism (development stage: embryonic)	PEAKS044068
EXP043879	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP471, genotype: unc-119(tm4063) III; wgIs471., sex:hermaphrodite	EXP043131	1391	normal	H2KZR6	whole worms (developmental stage: late embryo)	PEAKS044069
EXP043880	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP042793	1389	normal	O17593	whole worms (developmental stage: L4/young adults)	PEAKS044070
EXP043881	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6765-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6765-GFP.FPTB}attP40, sex:mixed	EXP042560	1407	normal	Q9VSL1	whole organism (development stage: embryonic)	PEAKS044071
EXP043882	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043355	1387	normal	G5ECF7	whole worms (developmental stage: L1)	PEAKS044072
EXP043883	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP043376	1390	normal	Q17905	whole worms (developmental stage: L3)	PEAKS044073
EXP043884	goat-anti-GFP-UC	Drosophila melanogaster	strain: Jra-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Jra-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP043214	1400	normal	P18289	whole organism (development stage: wandering third instar larva)	PEAKS044074
EXP043885	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP106, genotype: unc-119(ed3) III; wgIs106., sex:mixed	EXP042604	1387	normal	G5EG44	whole worms (developmental stage: L1)	PEAKS044075
EXP043886	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP102, genotype: unc-119(tm4063) III; wgIs102., sex:mixed	EXP042559	1389	normal	Q21502	whole worms (developmental stage: L4/young adults)	PEAKS044076
EXP043887	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP357, genotype: unc-119(tm4063) III; wgIs357., sex:mixed	EXP043328	1387	normal	O45756	whole worms (developmental stage: L1)	PEAKS044077
EXP043888	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP708, genotype: unc-119(tm4063); wgIs708 [C38D4.7::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042926	1391	normal	Q18512	whole worms (developmental stage: late embryo)	PEAKS044078
EXP043889	goat-anti-GFP-UC	Drosophila melanogaster	strain: repo-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=repo-GFP.FTBP}VK00037/CyO, sex:mixed	EXP043070	1407	normal	Q7KSE4	whole organism (development stage: embryonic)	PEAKS044079
EXP043890	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP164, sex:hermaphrodite	EXP043141	1391	normal	J7S155	whole worms (developmental stage: late embryo)	PEAKS044080
EXP043891	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:male	EXP042831	1399	normal	P20482	whole organism (development stage: adult)	PEAKS044081
EXP043892	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17568-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG17568-GFP.FPTB}VK00033, sex:mixed	EXP042931	1407	normal	Q9VIY9	whole organism (development stage: embryonic)	PEAKS044082
EXP043893	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	EXP043133	1391	normal	G5EEG1	whole worms (developmental stage: late embryo)	PEAKS044083
EXP043894	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hnf4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hnf4-GFP.FLAG}VK00033, sex:mixed	EXP043208	1400	normal	P49866	whole organism (development stage: wandering third instar larva)	PEAKS044084
EXP043895	goat-anti-GFP-UC	Drosophila melanogaster	strain: bsh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bsh-GFP.FTBP}VK00033, sex:mixed	EXP043143	1407	normal	Q04787	whole organism (development stage: embryonic)	PEAKS044085
EXP043896	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15073-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG15073-GFP.FTBP}VK00033, sex:mixed	EXP043338	1407	normal	A1ZBC5	whole organism (development stage: embryonic)	PEAKS044086
EXP043897	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP538, genotype: unc-119(tm4063) III; wgIs538, sex:hermaphrodite	EXP043120	1235	normal	Q18277	whole worms (developmental stage: young adults)	PEAKS044087
EXP043898	ab290	Drosophila melanogaster	strain: Stat92E-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Stat92E-GFP.FLAG}VK00037	EXP042877	1407	normal	Q24151	whole organism (development stage: embryonic)	PEAKS044088
EXP043899	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP572, genotype: unc-119(tm4063); wgIs572 [gei-17::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043077	1235	normal	Q94361	whole worms (developmental stage: young adults)	PEAKS044089
EXP043900	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG33213-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG33213-GFP.FTBP}VK00037, sex:mixed	EXP042659	1407	normal	Q9VAY8	whole organism (development stage: embryonic)	PEAKS044090
EXP043901	ab290	Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	EXP043054	1400	normal	P42283	whole organism (development stage: wandering third instar larva)	PEAKS044091
EXP043902	goat-anti-GFP-UC	Drosophila melanogaster	strain: kay-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=kay-GFP.FLAG}VK00037, sex:male	EXP043363	1399	normal	A8MPH9	whole organism (development stage: adult)	PEAKS044092
EXP043903	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2120-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2120-GFP.FTBP}VK00033	EXP042958	1407	normal	Q0IGR3	whole organism (development stage: embryonic)	PEAKS044093
EXP043904	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1832-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG1832-GFP.FPTB}VK00033, sex:mixed	EXP043391	1407	normal	Q9V9N4	whole organism (development stage: embryonic)	PEAKS044094
EXP043905	goat-anti-GFP-UC	Drosophila melanogaster	strain: Neu2-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=Neu2-GFP.FPTB}VK00037, sex:mixed	EXP042824	1407	normal	B6VQ99	whole organism (development stage: embryonic)	PEAKS044095
EXP043906	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hsf-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Hsf-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042981	1407	normal	P22813	whole organism (development stage: embryonic)	PEAKS044096
EXP043907	goat-anti-GFP-UC	Drosophila melanogaster	strain: Fer1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer1-GFP.FPTB}attP40, sex:mixed	EXP042802	1407	normal	Q9VI67	whole organism (development stage: embryonic)	PEAKS044097
EXP043908	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 5T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=eve-EGFP.S}VK00033	EXP042569	1407	normal	F9W320	whole organism (development stage: embryonic)	PEAKS044098
EXP043909	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP370, genotype: unc-119(tm4063) III; wgIs370., sex:hermaphrodite	EXP042710	1391	normal	Q22910	whole worms (developmental stage: late embryo)	PEAKS044099
EXP043910	goat-anti-GFP-UC	Drosophila melanogaster	strain: Rel-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Rel-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042699	1400	normal	Q94527	whole organism (development stage: wandering third instar larva)	PEAKS044100
EXP043911	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP534, genotype: unc-119(tm4063) III; wgIs534, sex:hermaphrodite	EXP042920	1389	normal	Q20082	whole worms (developmental stage: L4/young adults)	PEAKS044101
EXP043912	goat-anti-GFP-UC	Drosophila melanogaster	strain: sqz-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=zen-GFP.FPTB}attP40, sex:mixed	EXP043265	1407	normal	U3PU53	whole organism (development stage: embryonic)	PEAKS044102
EXP043913	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP515, genotype: unc-119(tm4063) III; wgIs515., sex:hermaphrodite	EXP042870	1387	normal	Q09565	whole worms (developmental stage: L1)	PEAKS044103
EXP043914	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043116	1390	normal	Q23521	whole worms (developmental stage: L3)	PEAKS044104
EXP043915	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:mixed	EXP043271	1391	normal	Q86MJ3	whole worms (developmental stage: late embryo)	PEAKS044105
EXP043916	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13296-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG13296-GFP.FPTB}attP40, sex:mixed	EXP043170	1407	normal	Q9VRV0	whole organism (development stage: embryonic)	PEAKS044106
EXP043917	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	EXP042832	1202	normal	O44505	whole worms (developmental stage: L2)	PEAKS044107
EXP043918	goat-anti-GFP-UC	Drosophila melanogaster	strain: da-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=da-GFP.FTBP}VK00033, sex:mixed	EXP042651	1407	normal	P11420	whole organism (development stage: embryonic)	PEAKS044108
EXP043919	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP587, genotype: unc-119(tm4063) III; wgIs587., sex:mixed	EXP043069	1391	normal	Q9XV35	whole worms (developmental stage: late embryo)	PEAKS044109
EXP043920	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP043254	1202	normal	G5EG44	whole worms (developmental stage: L2)	PEAKS044110
EXP043921	goat-anti-GFP-UC	Drosophila melanogaster	strain: Crg-1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Crg-1-GFP.FTBP}VK00033, sex:mixed	EXP043113	1399	normal	Q8IRT6	whole organism (development stage: adult)	PEAKS044111
EXP043922	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP701, genotype: unc-119(tm4063); wgIs701 [sem-2::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043257	1392	normal	Q8T3B9	whole worms (mixed-stage embryos)	PEAKS044112
EXP043923	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP566, genotype: unc-119(tm4063) III; wgIs566, sex:hermaphrodite	EXP043086	1391	normal	Q18590	whole worms (developmental stage: late embryo)	PEAKS044113
EXP043924	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP605, genotype: unc-119(tm4063) III; wgIs605., sex:mixed	EXP043111	1405	normal	O76561	whole organism (development stage: early embryonic)	PEAKS044114
EXP043925	goat-anti-GFP-UC	Drosophila melanogaster	strain: insv-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=insv-GFP.FTBP}VK00033, sex:mixed	EXP042570	1407	normal	Q8SYK5	whole organism (development stage: embryonic)	PEAKS044115
EXP043926	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9705-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG9705-GFP.FPTB}attP40, sex:mixed	EXP043102	1400	normal	Q9VVA0	whole organism (development stage: wandering third instar larva)	PEAKS044116
EXP043927	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042878	1392	normal	Q9N5D6	whole worms (mixed-stage embryos)	PEAKS044117
EXP043928	goat-anti-GFP-UC	Drosophila melanogaster	strain: A3-3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Atf3-GFP.FPTB}VK00033, sex:mixed	EXP042950	1407	normal	Q9XZS8	whole organism (development stage: embryonic)	PEAKS044118
EXP043929	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP541, genotype: unc-119(tm4063) III; wgIs541, sex:hermaphrodite	EXP042866	1396	normal	G5EGE2	whole organism (development stage: midembryonic)	PEAKS044119
EXP043930	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m-delta-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)mdelta-HLH-GFP.FPTB}attP-40, sex:mixed	EXP043273	1407	normal	Q01071	whole organism (development stage: embryonic)	PEAKS044120
EXP043931	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042775	1389	normal	Q9N5D6	whole worms (developmental stage: L4/young adults)	PEAKS044121
EXP043932	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12236-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG12236-GFP-GFP.FPTB}VK00033, sex:mixed	EXP043028	1407	normal	Q9W458	whole organism (development stage: embryonic)	PEAKS044122
EXP043933	goat-anti-GFP-UC	Drosophila melanogaster	strain: Blimp-1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Blimp-1-GFP.FPTB}attP40, sex:mixed	EXP042855	1408	normal	Q9VRN4	whole organism (development stage: prepupa)	PEAKS044123
EXP043934	sc-25761	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042656	1407	normal	P28159	whole organism (development stage: embryonic)	PEAKS044124
EXP043935	goat-anti-GFP-UC	Drosophila melanogaster	strain: Bteb2-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Bteb2-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042852	1407	normal	Q0IGQ2	whole organism (development stage: embryonic)	PEAKS044125
EXP043936	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP042816	1387	normal	O16748	whole worms (developmental stage: L1)	PEAKS044126
EXP043937	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP042767	1390	normal	Q21701	whole worms (developmental stage: L3)	PEAKS044127
EXP043938	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP518, genotype: unc-119(tm4063) III; wgIs518., sex:hermaphrodite	EXP042681	1389	normal	Q94407	whole worms (developmental stage: L4/young adults)	PEAKS044128
EXP043939	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6813-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6813-GFP.FPTB}attP40, sex:mixed	EXP043110	1407	normal	Q9VGL1	whole organism (development stage: embryonic)	PEAKS044129
EXP043940	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP590, genotype: unc-119(tm4063); wgIs590 [zip-4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042713	1387	normal	H2L0N3	whole worms (developmental stage: L1)	PEAKS044130
EXP043941	goat-anti-GFP-UC	Drosophila melanogaster	strain: Six4-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=Six4-GFP.FPTB}attP-40, sex:mixed	EXP043207	1407	normal	Q9Y1P6	whole organism (development stage: embryonic)	PEAKS044131
EXP043942	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL425, genotype: unc-119(ed3)III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043346	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS044132
EXP043943	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6683-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CG6683-GFP.FPTB}attP40, sex:mixed	EXP042620	1407	normal	Q9VSL0	whole organism (development stage: embryonic)	PEAKS044133
EXP043944	goat-anti-GFP-UC	Drosophila melanogaster	strain: rgr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=rgr-GFP.FPTB}VK00033, sex:mixed	EXP042777	1400	normal	E1JH10	whole organism (development stage: wandering third instar larva)	PEAKS044134
EXP043945	goat-anti-GFP-UC	Drosophila melanogaster	strain: sens-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=FTSF.GFP-sens}VK00022, sex:mixed	EXP043128	1407	normal	Q9N658	whole organism (development stage: embryonic)	PEAKS044135
EXP043946	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP606, genotype: unc-119(tm4063) III; wgIs606, sex:mixed	EXP043006	1235	normal	Q7YWZ7	whole worms (developmental stage: young adults)	PEAKS044136
EXP043947	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042888	1390	normal	G5ECF7	whole worms (developmental stage: L3)	PEAKS044137
EXP043948	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP569, genotype: unc-119(tm4063); wgIs569 [nhr-111::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042618	1389	normal	O45521	whole worms (developmental stage: L4/young adults)	PEAKS044138
EXP043949	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dad-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Dad-GFP.FLAG}VK00037, sex:mixed	EXP042565	1407	normal	Q5U110	whole organism (development stage: embryonic)	PEAKS044139
EXP043950	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP462, genotype: unc-119(tm4063) III; wgIs462., sex:hermaphrodite	EXP042752	1391	normal	G5EFQ5	whole worms (developmental stage: late embryo)	PEAKS044140
EXP043951	goat-anti-GFP-UC	Drosophila melanogaster	strain: pzg-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=pzg-GFP.FPTB}attP40, sex:mixed	EXP043310	1407	normal	Q9VP57	whole organism (development stage: embryonic)	PEAKS044141
EXP043952	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP646, genotype: unc-119(tm4063) III; wgIs646, sex:mixed	EXP042914	1235	normal	Q18508	whole worms (developmental stage: young adults)	PEAKS044142
EXP043953	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15812-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG15812-GFP.FPTB}attP40, sex:mixed	EXP042799	1407	normal	Q9VZU3	whole organism (development stage: embryonic)	PEAKS044143
EXP043954	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042732	1389	normal	O02316	whole worms (developmental stage: L4/young adults)	PEAKS044144
EXP043955	goat-anti-GFP-UC	Drosophila melanogaster	strain: salr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=salr-GFP.FPTB}VK00033, sex:mixed	EXP042741	1408	normal	Q9VKH3	whole organism (development stage: prepupa)	PEAKS044145
EXP043956	goat-anti-GFP-UC	Drosophila melanogaster	strain: shn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=shn-GFP.FPTB}VK00033, sex:mixed	EXP042985	1407	normal	Q0E9C5	whole organism (development stage: embryonic)	PEAKS044146
EXP043957	goat-anti-GFP-UC	Drosophila melanogaster	strain: tio-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tio-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042779	1407	normal	M9PDE2	whole organism (development stage: embryonic)	PEAKS044147
EXP043958	goat-anti-GFP-UC	Drosophila melanogaster	strain: esn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=esn-GFP.FPTB}VK00033, sex:mixed	EXP042668	1408	normal	Q7K579	whole organism (development stage: prepupa)	PEAKS044148
EXP043959	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP525, genotype: unc-119(tm4063) III; wgIs525, sex:hermaphrodite	EXP042666	1387	normal	Q9GZC9	whole worms (developmental stage: L1)	PEAKS044149
EXP043960	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7987-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG7987-GFP.FPTB}attP-40, sex:mixed	EXP042649	1407	normal	Q29R10	whole organism (development stage: embryonic)	PEAKS044150
EXP043961	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m-beta-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=E(spl)mbeta-HLH-GFP.FPTB}attP40, sex:mixed	EXP042624	1407	normal	Q01069	whole organism (development stage: embryonic)	PEAKS044151
EXP043962	goat-anti-GFP-UC	Drosophila melanogaster	strain: cato-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=cato-GFP.FTBP}VK00033, sex:mixed	EXP042772	1407	normal	Q0IGT4	whole organism (development stage: embryonic)	PEAKS044152
EXP043963	sc-28208	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043316	1400	normal	Q9W4S7	whole organism (development stage: wandering third instar larva)	PEAKS044153
EXP043964	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP517, genotype: unc-119(tm4063) III; wgIs517., sex:hermaphrodite	EXP043081	1387	normal	Q17922	whole worms (developmental stage: L1)	PEAKS044154
EXP043965	KW0:GRO	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042955	1403	normal	P16371	whole organism	PEAKS044155
EXP043966	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:mixed	EXP042725	1389	normal	Q86MH8	whole worms (developmental stage: L4/young adults)	PEAKS044156
EXP043967	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP707, genotype: unc-119(tm4063) III; wgIs707., sex:mixed	EXP042748	1392	normal	Q93727	whole worms (mixed-stage embryos)	PEAKS044157
EXP043968	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3281-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG3281-GFP.FPTB}attP40, sex:mixed	EXP042940	1407	normal	Q9VGG0	whole organism (development stage: embryonic)	PEAKS044158
EXP043969	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL457, genotype: unc-119(ed3)III;vrIs87[pPIE-1::GEI-11::GFP::GEI-11 3'UTR,unc-119(+), sex:mixed	EXP043343	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS044159
EXP043970	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4282-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG4282-GFP.FTBP}VK00033, sex:mixed	EXP043228	1407	normal	Q8T092	whole organism (development stage: embryonic)	PEAKS044160
EXP043971	goat-anti-GFP-UC	Drosophila melanogaster	strain: net-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=net-GFP.FPTB}VK00033, sex:mixed	EXP042592	1408	normal	Q9VPI8	whole organism (development stage: prepupa)	PEAKS044161
EXP043972	goat-anti-GFP-UC	Drosophila melanogaster	strain: cic-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=cic-GFP.FPTB}VK00037, sex:mixed	EXP042902	1399	normal	Q9U1H0	whole organism (development stage: adult)	PEAKS044162
EXP043973	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042774	1392	normal	Q65CM0	whole worms (mixed-stage embryos)	PEAKS044163
EXP043974	goat-anti-GFP-UC	Caenorhabditis elegans	strain: XIL99, sex:mixed	EXP042845	1387	normal	Q09604	whole worms (developmental stage: L1)	PEAKS044164
EXP043975	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7045-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7045-GFP.FTBP}VK00037, sex:male	EXP043088	1399	normal	Q9VCZ5	whole organism (development stage: adult)	PEAKS044165
EXP043976	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	EXP043055	1235	normal	G5EEG1	whole worms (developmental stage: young adults)	PEAKS044166
EXP043977	goat-anti-GFP-UC	Caenorhabditis elegans	strain: TH184, genotype:  unc-119(ed3) III; ddIs101, sex:hermaphrodite	EXP043075	1390	normal	G5EEL9	whole worms (developmental stage: L3)	PEAKS044167
EXP043978	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP042790	1387	normal	P34684	whole worms (developmental stage: L1)	PEAKS044168
EXP043979	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	EXP043396	1387	normal	G5ECU7	whole worms (developmental stage: L1)	PEAKS044169
EXP043980	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP315, sex:hermaphrodite	EXP043216	1391	normal	P20271	whole worms (developmental stage: late embryo)	PEAKS044170
EXP043981	goat-anti-GFP-UC	Drosophila melanogaster	strain: dpn-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=dpn-GFP.FPTB}VK00033, sex:mixed	EXP043203	1407	normal	Q26263	whole organism (development stage: embryonic)	PEAKS044171
EXP043982	non-commercial Orc2 modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043231	1407	normal	Q24168	whole organism (development stage: embryonic)	PEAKS044172
EXP043983	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd85E-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=fd85E-GFP.FPTB}attP-40 / CyO, sex:mixed	EXP042763	1408	normal	Q9VH87	whole organism (development stage: prepupa)	PEAKS044173
EXP043984	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10274-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CG10274-GFP.FPTB}attP40, sex:mixed	EXP042886	1407	normal	A8JNL9	whole organism (development stage: embryonic)	PEAKS044174
EXP043985	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP043362	1389	normal	Q9N5D6	whole worms (developmental stage: L4/young adults)	PEAKS044175
EXP043986	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP130, genotype: unc-119(ed3) III; wgIs130., sex:mixed	EXP043319	1202	normal	Q22190	whole worms (developmental stage: L2)	PEAKS044176
EXP043987	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP100, genotype: unc-119(tm4063) III; wgIs100., sex:hermaphrodite	EXP042987	1387	normal	O17617	whole worms (developmental stage: L1)	PEAKS044177
EXP043988	goat-anti-GFP-UC	Drosophila melanogaster	strain: gro-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=gro-GFP.FLAG}attP16, sex:mixed	EXP042553	1407	normal	P16371	whole organism (development stage: embryonic)	PEAKS044178
EXP043989	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP429, genotype: unc-119(tm4063) III; wgIs429., sex:hermaphrodite	EXP042632	1235	normal	Q19753	whole worms (developmental stage: young adults)	PEAKS044179
EXP043990	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043340	1392	normal	Q9N5S3	whole worms (mixed-stage embryos)	PEAKS044180
EXP043991	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:mixed	EXP043350	1392	normal	Q93560	whole worms (mixed-stage embryos)	PEAKS044181
EXP043992	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP27, genotype: unc-119(ed3) III; wgIs27., sex:mixed	EXP043036	1202	normal	P10038	whole worms (developmental stage: L2)	PEAKS044182
EXP043993	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL576, sex:hermaphrodite	EXP043160	1389	normal	O01789	whole worms (developmental stage: L4/young adults)	PEAKS044183
EXP043994	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10654-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG10654-GFP.FPTB}attP-40 / CyO, sex:mixed	EXP043286	1407	normal	Q9VTY7	whole organism (development stage: embryonic)	PEAKS044184
EXP043995	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042660	1389	normal	P91868	whole worms (developmental stage: L4/young adults)	PEAKS044185
EXP043996	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2875-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2875-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP043046	1407	normal	Q9W4R1	whole organism (development stage: embryonic)	PEAKS044186
EXP043997	goat-anti-GFP-UC	Drosophila melanogaster	strain: fru-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}fru[MI06350]/TM6B, sb, Tb, Hu, sex:mixed	EXP043276	1400	normal	Q8IN81	whole organism (development stage: wandering third instar larva)	PEAKS044187
EXP043998	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP043260	1392	normal	O02274	whole worms (mixed-stage embryos)	PEAKS044188
EXP043999	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP043195	1390	normal	P34684	whole worms (developmental stage: L3)	PEAKS044189
EXP044000	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(z)-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=E(z)-GFP.FTBP}VK00037, sex:mixed	EXP043326	1408	normal	P42124	whole organism (development stage: prepupa)	PEAKS044190
EXP044001	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042786	1202	normal	G5EG44	whole worms (developmental stage: L2)	PEAKS044191
EXP044002	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP043021	1387	normal	G5EG44	whole worms (developmental stage: L1)	PEAKS044192
EXP044003	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP043312	1390	normal	P91868	whole worms (developmental stage: L3)	PEAKS044193
EXP044004	goat-anti-GFP-UC	Drosophila melanogaster	strain: Max-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Max-GFP.FTBP}VK00037, sex:mixed	EXP043403	1407	normal	M9NDC9	whole organism (development stage: embryonic)	PEAKS044194
EXP044005	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP312, genotype: unc-119(ed3) III; wgIs312, sex:hermaphrodite	EXP043315	1387	normal	O17862	whole worms (developmental stage: L1)	PEAKS044195
EXP044006	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP042581	1387	normal	Q09228	whole worms (developmental stage: L1)	PEAKS044196
EXP044007	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043198	1202	normal	Q9N5S3	whole worms (developmental stage: L2)	PEAKS044197
EXP044008	ab290	Drosophila melanogaster	strain: Stat92E-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Stat92E-GFP.FLAG}VK00037	EXP043117	1407	normal	Q24151	whole organism (development stage: embryonic)	PEAKS044198
EXP044009	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP608, genotype: unc-119(tm4063); wgIs608 [Y55F3AM.14::TY::EGFP::3xFLAG(p_wTRG5_insertion_c_0075_1C04) + unc-119(+)], sex:mixed	EXP043085	1202	normal	Q9N360	whole worms (developmental stage: L2)	PEAKS044199
EXP044010	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10316, sex:hermaphrodite	EXP043083	1235	normal	A0A131MCL4	whole worms (developmental stage: young adults)	PEAKS044200
EXP044011	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP042680	1387	normal	O16748	whole worms (developmental stage: L1)	PEAKS044201
EXP044012	goat-anti-GFP-UC	Drosophila melanogaster	strain: wek-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=wek-GFP.FPTB}VK00033, sex:mixed	EXP043057	1407	normal	M9PFY1	whole organism (development stage: embryonic)	PEAKS044202
EXP044013	non-commercial Tbp modENCODE antibody 1	Drosophila melanogaster	strain: 13T-exd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=exd-EGFP.S}VK00033	EXP043293	1407	normal	P20227	whole organism (development stage: embryonic)	PEAKS044203
EXP044014	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042622	1387	normal	Q9N5D6	whole worms (developmental stage: L1)	PEAKS044204
EXP044015	goat-anti-GFP-UC	Drosophila melanogaster	strain: NC2beta-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NC2Beta-GFP.FTBP}VK00033, sex:mixed	EXP043097	1407	normal	Q9VJQ5	whole organism (development stage: embryonic)	PEAKS044205
EXP044016	goat-anti-GFP-UC	Drosophila melanogaster	strain: topi-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=topi-GFP.FTBP}VK00037, sex:mixed	EXP042703	1408	normal	T2FFH5	whole organism (development stage: prepupa)	PEAKS044206
EXP044017	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP578, genotype: unc-119(tm4063) III; wgIs578, sex:hermaphrodite	EXP043241	1391	normal	Q93705	whole worms (developmental stage: late embryo)	PEAKS044207
EXP044018	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP558, genotype: unc-119(tm4063) III; wgIs558., sex:mixed	EXP042578	1391	normal	H2L008	whole worms (developmental stage: late embryo)	PEAKS044208
EXP044019	goat-anti-GFP-UC	Drosophila melanogaster	strain: woc-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=woc-GFP.FTBP}VK00037, sex:mixed	EXP042746	1400	normal	A8JRE3	whole organism (development stage: wandering third instar larva)	PEAKS044209
EXP044020	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP511, genotype: unc-119(tm4063) III; wgIs511., sex:hermaphrodite	EXP043388	1387	normal	O02274	whole worms (developmental stage: L1)	PEAKS044210
EXP044021	goat-anti-GFP-UC	Drosophila melanogaster	strain: ss-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ss-GFP.A.FPTB}VK00037, sex:mixed	EXP042695	1408	normal	Q9VEV9	whole organism (development stage: prepupa)	PEAKS044211
EXP044022	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9139-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Rabex-5-GFP.FTBP}VK00037, sex:mixed	EXP042835	1408	normal	Q9W0H9	whole organism (development stage: prepupa)	PEAKS044212
EXP044023	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd59A-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=fd59A-GFP.FPTB}attP40, sex:mixed	EXP043210	1408	normal	Q02361	whole organism (development stage: prepupa)	PEAKS044213
EXP044024	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP481, genotype: unc-119(tm4063) III; wgIs481., sex:hermaphrodite	EXP043281	1387	normal	Q17370	whole worms (developmental stage: L1)	PEAKS044214
EXP044025	non-commercial prd modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042877	1407	normal	P06601	whole organism (development stage: embryonic)	PEAKS044215
EXP044026	ab290	Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	EXP043402	1407	normal	P42283	whole organism (development stage: embryonic)	PEAKS044216
EXP044027	non-commercial scute modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043092	1407	normal	P10084	whole organism (development stage: embryonic)	PEAKS044217
EXP044028	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP532, genotype: unc-119(tm4063) III; wgIs532, sex:hermaphrodite	EXP042996	1387	normal	Q9U2V2	whole worms (developmental stage: L1)	PEAKS044218
EXP044029	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP416, genotype: unc-119(tm4063) III; wgIs416., sex:mixed	EXP043274	1389	normal	Q09602	whole worms (developmental stage: L4/young adults)	PEAKS044219
EXP044030	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP114, genotype: unc-119(tm4063) III; wgIs114., sex:mixed	EXP043345	1387	normal	Q93520	whole worms (developmental stage: L1)	PEAKS044220
EXP044031	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL390, genotype: unc119(ed3)III; vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043123	1235	normal	Q22703	whole worms (developmental stage: young adults)	PEAKS044221
EXP044032	goat-anti-GFP-UC	Drosophila melanogaster	strain: Esplmgamma-HLH-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)mgamma-HLH-GFP.FPTB}attP-40 / CyO, sex:mixed	EXP042853	1407	normal	Q01070	whole organism (development stage: embryonic)	PEAKS044222
EXP044033	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP429, genotype: unc-119(tm4063) III; wgIs429., sex:mixed	EXP042586	1235	normal	Q19753	whole worms (developmental stage: young adults)	PEAKS044223
EXP044034	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL478, sex:hermaphrodite	EXP042882	1235	normal	G5EF11	whole worms (developmental stage: young adults)	PEAKS044224
EXP044035	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP687, genotype: unc-119(tm4063) III; wgIs687., sex:mixed	EXP043378	1391	normal	Q21578	whole worms (developmental stage: late embryo)	PEAKS044225
EXP044036	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP638, genotype: unc-119(tm4063) III; wgIs638., sex:mixed	EXP042576	1235	normal	B3GWA6	whole worms (developmental stage: young adults)	PEAKS044226
EXP044037	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043035	1202	normal	Q23521	whole worms (developmental stage: L2)	PEAKS044227
EXP044038	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP645, genotype: unc-119(tm4063) III; wgIs645, sex:mixed	EXP043104	1392	normal	Q18533	whole worms (mixed-stage embryos)	PEAKS044228
EXP044039	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP622, genotype: unc-119(tm4063) III; wgIs622, sex:mixed	EXP043174	1391	normal	Q93779	whole worms (developmental stage: late embryo)	PEAKS044229
EXP044040	goat-anti-GFP-UC	Drosophila melanogaster	strain: ac-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ac-GFP.FPTB}VK00033/TM2, sex:mixed	EXP043359	1407	normal	P10083	whole organism (development stage: embryonic)	PEAKS044230
EXP044041	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP699, genotype: unc-119(tm4063); wgIs699 [ceh-43::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043282	1392	normal	Q18273	whole worms (mixed-stage embryos)	PEAKS044231
EXP044042	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP746, genotype: unc-119(tm4063); wgIs746 [tbp-1::TY1 EGFP 3xFLAG(GlyStock16H06_GlyStock16H06) + unc-119(+)], sex:mixed	EXP043232	1235	normal	P32085	whole worms (developmental stage: young adults)	PEAKS044232
EXP044043	goat-anti-GFP-UC	Drosophila melanogaster	strain: ftz-f1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ftz-f1-GFP.FLAG}VK00037, sex:mixed	EXP042596	1407	normal	P33244	whole organism (development stage: embryonic)	PEAKS044233
EXP044044	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10462-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10462-GFP.FTBP}VK00033, sex:mixed	EXP043235	1407	normal	M9NEU8	whole organism (development stage: embryonic)	PEAKS044234
EXP044045	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL557, sex:hermaphrodite	EXP043074	1235	normal	Q09249	whole worms (developmental stage: young adults)	PEAKS044235
EXP044046	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP388, genotype: unc-119(ed3) III; wgIs388, sex:hermaphrodite	EXP042935	1391	normal	Q21192	whole worms (developmental stage: late embryo)	PEAKS044236
EXP044047	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG31388-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG31388-GFP.FTBP}VK00037, sex:mixed	EXP042670	1407	normal	Q9VGQ5	whole organism (development stage: embryonic)	PEAKS044237
EXP044048	goat-anti-GFP-UC	Drosophila melanogaster	strain: crp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=crp-GFP.FPTB}VK00033, sex:mixed	EXP042986	1407	normal	Q9V406	whole organism (development stage: embryonic)	PEAKS044238
EXP044049	non-commercial lov modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042634	1407	normal	P14083	whole organism (development stage: embryonic)	PEAKS044239
EXP044050	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP90, genotype: unc-119(ed3) III; wgIs90., sex:mixed	EXP043400	1389	normal	P41829	whole worms (developmental stage: L4/young adults)	PEAKS044240
EXP044051	goat-anti-GFP-UC	Drosophila melanogaster	strain: az2-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=az2-GFP.FPTB}VK00033, sex:mixed	EXP043389	1407	normal	Q5BIC3	whole organism (development stage: embryonic)	PEAKS044241
EXP044052	goat-anti-GFP-UC	Drosophila melanogaster	strain: cyc-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=cyc-GFP.FTBP}VK00037, sex:mixed	EXP043325	1408	normal	O61734	whole organism (development stage: prepupa)	PEAKS044242
EXP044053	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:mixed	EXP043022	1390	normal	Q19345	whole worms (developmental stage: L3)	PEAKS044243
EXP044054	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP154, genotype: unc-119(ed3) III; wgIs154, sex:hermaphrodite	EXP042917	1391	normal	G5EDE1	whole worms (developmental stage: late embryo)	PEAKS044244
EXP044055	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: EcR-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=EcR-EGFP.S}VK00033	EXP043267	1403	normal	P34021	whole organism	PEAKS044245
EXP044056	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP78, genotype: unc-119(ed3) III; wgIs78, sex:hermaphrodite	EXP043008	1391	normal	Q10924	whole worms (developmental stage: late embryo)	PEAKS044246
EXP044057	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043084	1202	normal	O16748	whole worms (developmental stage: L2)	PEAKS044247
EXP044058	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP173, sex:hermaphrodite	EXP043122	1391	normal	N1NSG8	whole worms (developmental stage: late embryo)	PEAKS044248
EXP044059	goat-anti-GFP-UC	Drosophila melanogaster	strain: ewg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ewg-GFP.FPTB}VK00033, sex:mixed	EXP043094	1407	normal	Q24312	whole organism (development stage: embryonic)	PEAKS044249
EXP044060	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043219	1390	normal	G5ECF7	whole worms (developmental stage: L3)	PEAKS044250
EXP044061	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6854-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG45071-GFP.FPTB}attP40/CyO, sex:mixed	EXP043299	1407	normal	Q9VUL1	whole organism (development stage: embryonic)	PEAKS044251
EXP044062	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP471, genotype: unc-119(tm4063) III; wgIs471., sex:hermaphrodite	EXP042637	1202	normal	H2KZR6	whole worms (developmental stage: L2)	PEAKS044252
EXP044063	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP043399	1392	normal	O17894	whole worms (mixed-stage embryos)	PEAKS044253
EXP044064	goat-anti-GFP-UC	Drosophila melanogaster	strain: Xbp1-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Xbp1-GFP.FPTB}VK00033, sex:mixed	EXP042577	1407	normal	Q9VUG3	whole organism (development stage: embryonic)	PEAKS044254
EXP044065	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17912-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=BuGZ-GFP.FPTB}VK00033, sex:mixed	EXP042938	1407	normal	Q9VJI6	whole organism (development stage: embryonic)	PEAKS044255
EXP044066	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043132	1400	normal	P91943	whole organism (development stage: wandering third instar larva)	PEAKS044256
EXP044067	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12744-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG12744-GFP.FTBP}VK00033, sex:mixed	EXP042929	1407	normal	E2QC93	whole organism (development stage: embryonic)	PEAKS044257
EXP044068	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:female	EXP042701	1399	normal	P20482	whole organism (development stage: adult)	PEAKS044258
EXP044069	goat-anti-GFP-UC	Drosophila melanogaster	strain: GATAd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=GATAd-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042731	1400	normal	Q9VKZ0	whole organism (development stage: wandering third instar larva)	PEAKS044259
EXP044070	goat-anti-GFP-UC	Drosophila melanogaster	strain: pnt-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}pnt[MI02427]/TM6B, sb, Tb, Hu, sex:mixed	EXP043279	1407	normal	P51023	whole organism (development stage: embryonic)	PEAKS044260
EXP044071	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7056-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=HHEX-GFP.FPTB}attP40, sex:mixed	EXP042607	1407	normal	Q9VDF0	whole organism (development stage: embryonic)	PEAKS044261
EXP044072	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP620, genotype: unc-119(tm4063) III; wgIs620, sex:mixed	EXP043033	1405	normal	Q93352	whole organism (development stage: early embryonic)	PEAKS044262
EXP044073	goat-anti-GFP-UC	Drosophila melanogaster	strain: ADD1-MiMIC-GFP, genotype: y[1] w[*]; Mi{y[+mDint2]=MIC}ADD1[MI09552], sex:mixed	EXP042892	1407	normal	A1Z8R2	whole organism (development stage: embryonic)	PEAKS044263
EXP044074	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:hermaphrodite	EXP042744	1392	normal	P28515	whole worms (mixed-stage embryos)	PEAKS044264
EXP044075	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL448, genotype: unc-119(ed3)III; vrIs83 [pGES-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP042947	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS044265
EXP044076	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:hermaphrodite	EXP043405	1389	normal	Q86MH8	whole worms (developmental stage: L4/young adults)	PEAKS044266
EXP044077	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: EcR-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=EcR-EGFP.S}VK00033	EXP042764	1403	normal	P34021	whole organism	PEAKS044267
EXP044078	goat-anti-GFP-UC	Drosophila melanogaster	strain: CTCF-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CTCF-GFP.FPTB}attP40, sex:mixed	EXP042844	1407	normal	Q9VS55	whole organism (development stage: embryonic)	PEAKS044268
EXP044079	non-commercial su(Hw) modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043034	1407	normal	P08970	whole organism (development stage: embryonic)	PEAKS044269
EXP044080	goat-anti-GFP-UC	Drosophila melanogaster	strain: Usf-GFP, sex:mixed	EXP042756	1407	normal	Q9W4J8	whole organism (development stage: embryonic)	PEAKS044270
EXP044081	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP124, genotype: unc-119(ed3) III; wgIs124., sex:mixed	EXP042673	1387	normal	O02219	whole worms (developmental stage: L1)	PEAKS044271
EXP044082	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP372, genotype: unc-119(tm4063) III; wgIs372., sex:hermaphrodite	EXP043238	1391	normal	Q21374	whole worms (developmental stage: late embryo)	PEAKS044272
EXP044083	Aviva-KW4-mod(mdg4)-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042972	1400	normal	Q86B87	whole organism (development stage: wandering third instar larva)	PEAKS044273
EXP044084	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11398-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG11398-GFP.FPTB}VK00033, sex:mixed	EXP043331	1407	normal	Q9V3X8	whole organism (development stage: embryonic)	PEAKS044274
EXP044085	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP662, genotype: unc-119(tm4063) III; wgIs662, sex:mixed	EXP042768	1235	normal	O01441	whole worms (developmental stage: young adults)	PEAKS044275
EXP044086	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:hermaphrodite	EXP043187	1389	normal	Q19345	whole worms (developmental stage: L4/young adults)	PEAKS044276
EXP044087	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP239, genotype: unc-119(ed3) III; wgIs239., sex:mixed	EXP043161	1202	normal	P41999	whole worms (developmental stage: L2)	PEAKS044277
EXP044088	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	EXP042904	1389	normal	Q11107	whole worms (developmental stage: L4/young adults)	PEAKS044278
EXP044089	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m3-HLH-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)m3-HLH-GFP.FPTB}attP-40, sex:mixed	EXP042949	1407	normal	Q01068	whole organism (development stage: embryonic)	PEAKS044279
EXP044090	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OR3350, sex:hermaphrodite	EXP043411	1389	normal	G5EGD2	whole worms (developmental stage: L4/young adults)	PEAKS044280
EXP044091	goat-anti-GFP-UC	Drosophila melanogaster	strain: CrebA-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}CrebA[MI06441]/TM6B, sb, Tb, Hu, sex:mixed	EXP043256	1400	normal	Q1LZ07	whole organism (development stage: wandering third instar larva)	PEAKS044281
EXP044092	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:hermaphrodite	EXP043163	1391	normal	G5EFY7	whole worms (developmental stage: late embryo)	PEAKS044282
EXP044093	goat-anti-GFP-UC	Drosophila melanogaster	strain: NC2alpha-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NC2alpha-GFP.FPTB}VK00033, sex:mixed	EXP043130	1407	normal	Q8MLV5	whole organism (development stage: embryonic)	PEAKS044283
EXP044094	goat-anti-GFP-UC	Drosophila melanogaster	strain: bab2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bab2-GFP.FPTB}VK00037/SM5, sex:mixed	EXP043087	1407	normal	Q9W0K4	whole organism (development stage: embryonic)	PEAKS044284
EXP044095	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG31627-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG31627-GFP.FPTB}VK00033, sex:mixed	EXP043140	1408	normal	Q8INU1	whole organism (development stage: prepupa)	PEAKS044285
EXP044096	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP720, genotype: unc-119(tm4063); wgIs720 [lsl-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043407	1235	normal	O02273	whole worms (developmental stage: young adults)	PEAKS044286
EXP044097	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL529, sex:hermaphrodite	EXP042675	1235	normal	O44743	whole worms (developmental stage: young adults)	PEAKS044287
EXP044098	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12104-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12104-GFP.FTBP}VK00037, sex:mixed	EXP043223	1407	normal	Q9W0D2	whole organism (development stage: embryonic)	PEAKS044288
EXP044099	non-commercial Orc2 modENCODE antibody 1	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP042556	1197	normal	Q24168	S2-DRSC (embryonic stem cells)	PEAKS044289
EXP044100	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP673, genotype: unc-119 (tm4063) III; wgIs673, sex:mixed	EXP042574	1391	normal	Q9NLC2	whole worms (developmental stage: late embryo)	PEAKS044290
EXP044101	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP391, genotype: unc-119(ed3) III; wgIs391(med-1::TY1 EGFP FLAG C; unc-119(+)), sex:mixed	EXP042895	1392	normal	G5EF71	whole worms (mixed-stage embryos)	PEAKS044291
EXP044102	non-commercial fru modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043142	1407	normal	Q8IN81	whole organism (development stage: embryonic)	PEAKS044292
EXP044103	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OR3349, sex:mixed	EXP042937	1389	normal	G5EGD2	whole worms (developmental stage: L4/young adults)	PEAKS044293
EXP044104	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP196, genotype: unc-119(ed3) III; wgIs196., sex:mixed	EXP042965	1387	normal	Q93727	whole worms (developmental stage: L1)	PEAKS044294
EXP044105	non-commercial Sin3A modENCODE antibody 1	Drosophila melanogaster	genotype: e/se	EXP043295	1397	normal	A1Z927	Kc167 (development stage: embryonic)	PEAKS044295
EXP044106	goat-anti-GFP-UC	Drosophila melanogaster	strain: ovo-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ovo-GFP.FPTB}VK00033/TM3, Sb[1], sex:female	EXP043109	1399	normal	P51521	whole organism (development stage: adult)	PEAKS044296
EXP044107	goat-anti-GFP-UC	Drosophila melanogaster	strain: kni-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=kni-GFP.FPTB}attP40, sex:mixed	EXP042833	1407	normal	P10734	whole organism (development stage: embryonic)	PEAKS044297
EXP044108	goat-anti-GFP-UC	Drosophila melanogaster	strain: D19B-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=D19B-GFP.FPTB}attP40, sex:mixed	EXP043300	1407	normal	Q9VRV4	whole organism (development stage: embryonic)	PEAKS044298
EXP044109	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP043344	1387	normal	Q21701	whole worms (developmental stage: L1)	PEAKS044299
EXP044110	goat-anti-GFP-UC	Drosophila melanogaster	strain: Eip78C-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Eip78C-GFP.FLAG}VK00037, sex:mixed	EXP042694	1408	normal	P45447	whole organism (development stage: prepupa)	PEAKS044300
EXP044111	non-commercial Stat92E modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042771	1403	normal	Q24151	whole organism	PEAKS044301
EXP044112	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8089-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG8089-GFP.FPTB}VK00033, sex:mixed	EXP043330	1407	normal	Q4V3F5	whole organism (development stage: embryonic)	PEAKS044302
EXP044113	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3919-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG3919-GFP.FTBP}VK00037, sex:mixed	EXP042820	1408	normal	Q7KUK4	whole organism (development stage: prepupa)	PEAKS044303
EXP044114	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP470, genotype: unc-119(tm4063) III; wgIs470., sex:hermaphrodite	EXP042641	1389	normal	P91547	whole worms (developmental stage: L4/young adults)	PEAKS044304
EXP044115	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10543-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10543-GFP.FTBP}VK00037, sex:mixed	EXP043358	1407	normal	Q86BG2	whole organism (development stage: embryonic)	PEAKS044305
EXP044116	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP042905	1390	normal	O17894	whole worms (developmental stage: L3)	PEAKS044306
EXP044117	goat-anti-GFP-UC	Drosophila melanogaster	strain: mod(mdg4)-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=mod(mdg4)-GFP.FTBP}VK00037, sex:mixed	EXP042975	1400	normal	Q86B87	whole organism (development stage: wandering third instar larva)	PEAKS044307
EXP044118	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043213	1407	normal	P91943	whole organism (development stage: embryonic)	PEAKS044308
EXP044119	goat-anti-GFP-UC	Drosophila melanogaster	strain: mam-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}mam[MI03814]/SM6a, sex:mixed	EXP042730	1407	normal	P21519	whole organism (development stage: embryonic)	PEAKS044309
EXP044120	goat-anti-GFP-UC	Drosophila melanogaster	strain: pad-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=pad-GFP.FPTB}attP40, sex:female	EXP043416	1399	normal	Q9VEW6	whole organism (development stage: adult)	PEAKS044310
EXP044121	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP739, genotype: unc-119(tm4063); wgIs739 [ceh-19::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042908	1391	normal	P26797	whole worms (developmental stage: late embryo)	PEAKS044311
EXP044122	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP550, genotype: unc-119(tm4063) III; wgIs550., sex:mixed	EXP043298	1235	normal	H2KYD3	whole worms (developmental stage: young adults)	PEAKS044312
EXP044123	goat-anti-GFP-UC	Drosophila melanogaster	strain: toe-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=toe-GFP.FPTB}VK00037, sex:male	EXP042913	1399	normal	Q8T0M4	whole organism (development stage: adult)	PEAKS044313
EXP044124	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP579, genotype: unc-119(tm4063) III; wgIs579., sex:mixed	EXP042652	1235	normal	Q09477	whole worms (developmental stage: young adults)	PEAKS044314
EXP044125	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG16863-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG16863-GFP.FPTB}VK00033, sex:mixed	EXP042993	1407	normal	Q0E8Q6	whole organism (development stage: embryonic)	PEAKS044315
EXP044126	goat-anti-GFP-UC	Drosophila melanogaster	strain: 15T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=h-EGFP.S}VK00037, sex:mixed	EXP043060	1400	normal	P14003	whole organism (development stage: wandering third instar larva)	PEAKS044316
EXP044127	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP042834	1392	normal	Q21701	whole worms (mixed-stage embryos)	PEAKS044317
EXP044128	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042733	1387	normal	G5ECG2	whole worms (developmental stage: L1)	PEAKS044318
EXP044129	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP248, sex:hermaphrodite	EXP043314	1389	normal	O17514	whole worms (developmental stage: L4/young adults)	PEAKS044319
EXP044130	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042625	1387	normal	G5ECF7	whole worms (developmental stage: L1)	PEAKS044320
EXP044131	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP425, genotype: unc-119(tm4063) III; wgIs425., sex:mixed	EXP043135	1202	normal	Q09636	whole worms (developmental stage: L2)	PEAKS044321
EXP044132	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP042650	1391	normal	Q17381	whole worms (developmental stage: late embryo)	PEAKS044322
EXP044133	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11902-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG11902-GFP.FPTB}VK00037 / CyO, sex:mixed	EXP043150	1408	normal	Q9VBR8	whole organism (development stage: prepupa)	PEAKS044323
EXP044134	goat-anti-GFP-UC	Drosophila melanogaster	strain: ss-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ss-GFP.CD.FPTB}VK00037, sex:mixed	EXP042676	1408	normal	Q9VEV9	whole organism (development stage: prepupa)	PEAKS044324
EXP044135	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL563, sex:hermaphrodite	EXP042798	1235	normal	Q9XUB3	whole worms (developmental stage: young adults)	PEAKS044325
EXP044136	Aviva-KW3-Trl-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042980	1407	normal	A4V1Y6	whole organism (development stage: embryonic)	PEAKS044326
EXP044137	Aviva-KW3-hkb-D1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042939	1407	normal	Q9VN10	whole organism (development stage: embryonic)	PEAKS044327
EXP044138	goat-anti-GFP-UC	Drosophila melanogaster	strain: lz-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lz-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043050	1408	normal	Q9W349	whole organism (development stage: prepupa)	PEAKS044328
EXP044139	non-commercial CTCF modENCODE antibody 2	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP043125	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	PEAKS044329
EXP044140	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 8T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=tll-EGFP.S}VK00037	EXP043112	1407	normal	P18102	whole organism (development stage: embryonic)	PEAKS044330
EXP044141	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP043080	1202	normal	P91868	whole worms (developmental stage: L2)	PEAKS044331
EXP044142	non-commercial hth modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:mixed	EXP043092	1407	normal	O46339	whole organism (development stage: embryonic)	PEAKS044332
EXP044143	Aviva-KW4-Hr39-D1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042901	1407	normal	Q05192	whole organism (development stage: embryonic)	PEAKS044333
EXP044144	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP493, genotype: unc-119(tm4063) III; wgIs493., sex:hermaphrodite	EXP042990	1391	normal	H9G2Q0	whole worms (developmental stage: late embryo)	PEAKS044334
EXP044145	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP178, genotype: unc-119(ed3) III; wgIs178., sex:mixed	EXP042838	1202	normal	P34707	whole worms (developmental stage: L2)	PEAKS044335
EXP044146	goat-anti-GFP-UC	Drosophila melanogaster	strain: Ash1-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ash1-GFP.FPTB}attP-40, sex:mixed	EXP043248	1407	normal	Q9VW15	whole organism (development stage: embryonic)	PEAKS044336
EXP044147	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP615, genotype: unc-119(tm4063) III; wgIs615, sex:mixed	EXP042686	1391	normal	Q965P0	whole worms (developmental stage: late embryo)	PEAKS044337
EXP044148	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042621	1403	normal	P20482	whole organism	PEAKS044338
EXP044149	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP92, sex:hermaphrodite	EXP042573	1391	normal	G5EBL3	whole worms (developmental stage: late embryo)	PEAKS044339
EXP044150	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pita-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pita-GFP.FPTB}VK00033, sex:mixed	EXP043068	1407	normal	Q9W1N1	whole organism (development stage: embryonic)	PEAKS044340
EXP044151	non-commercial scute modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042974	1407	normal	P10084	whole organism (development stage: embryonic)	PEAKS044341
EXP044152	Aviva-KW3-psq-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043370	1403	normal	A1Z8A6	whole organism	PEAKS044342
EXP044153	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP62, genotype: unc-119(ed3) III; wgIs62, sex:mixed	EXP042682	1202	normal	P20154	whole worms (developmental stage: L2)	PEAKS044343
EXP044154	sc-25761	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043382	1407	normal	P28159	whole organism (development stage: embryonic)	PEAKS044344
EXP044155	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	EXP042828	1390	normal	G5EEG1	whole worms (developmental stage: L3)	PEAKS044345
EXP044156	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP117, genotype: unc-119(ed3) III; wgIs117., sex:mixed	EXP042791	1391	normal	Q21272	whole worms (developmental stage: late embryo)	PEAKS044346
EXP044157	goat-anti-GFP-UC	Drosophila melanogaster	strain: SuHw-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=su(Hw)-GFP.FPTB}attP40, sex:mixed	EXP042906	1407	normal	P08970	whole organism (development stage: embryonic)	PEAKS044347
EXP044158	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP418, genotype: unc-119(tm4063) III; wgIs418., sex:mixed	EXP043052	1202	normal	Q18248	whole worms (developmental stage: L2)	PEAKS044348
EXP044159	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP241, genotype: unc-119(ed3) III; wgIs241., sex:mixed	EXP043201	1390	normal	G5EE18	whole worms (developmental stage: L3)	PEAKS044349
EXP044160	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP489, genotype: unc-119(tm4063) III; wgIs489., sex:hermaphrodite	EXP042873	1391	normal	O62412	whole worms (developmental stage: late embryo)	PEAKS044350
EXP044161	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: Cad-GFP-7T, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=cad-EGFP.S}VK00033	EXP042922	1407	normal	P09085	whole organism (development stage: embryonic)	PEAKS044351
EXP044162	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6854-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG45071-GFP.FPTB}attP40/CyO, sex:mixed	EXP042945	1408	normal	Q9VUL1	whole organism (development stage: prepupa)	PEAKS044352
EXP044163	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP480, genotype: unc-119(tm4063) III; wgIs480., sex:hermaphrodite	EXP043206	1387	normal	Q9GTD4	whole worms (developmental stage: L1)	PEAKS044353
EXP044164	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11617-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG11617-GFP.FPTB}VK00033, sex:mixed	EXP043218	1399	normal	Q9VPL4	whole organism (development stage: adult)	PEAKS044354
EXP044165	goat-anti-GFP-UC	Drosophila melanogaster	strain: ATbp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ATbp-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042806	1407	normal	Q86P48	whole organism (development stage: embryonic)	PEAKS044355
EXP044166	goat-anti-GFP-UC	Drosophila melanogaster	strain: tj-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tj-GFP.FPTB}VK00033, sex:female	EXP042669	1399	normal	Q9VIW0	whole organism (development stage: adult)	PEAKS044356
EXP044167	PRB-291C	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042861	1407	normal	P05205	whole organism (development stage: embryonic)	PEAKS044357
EXP044168	goat-anti-GFP-UC	Drosophila melanogaster	strain: Eip75B-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Eip75B[MI03665], sex:mixed	EXP043305	1408	normal	P13055	whole organism (development stage: prepupa)	PEAKS044358
EXP044169	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP594, genotype: unc-119(tm4063) III; wgIs594, sex:mixed	EXP042635	1235	normal	A0A078BQN7	whole worms (developmental stage: young adults)	PEAKS044359
EXP044170	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042843	1390	normal	G5EFY7	whole worms (developmental stage: L3)	PEAKS044360
EXP044171	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP677, genotype: unc-119(tm4063) III; wgIs677, sex:mixed	EXP043233	1391	normal	Q966L8	whole worms (developmental stage: late embryo)	PEAKS044361
EXP044172	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17385-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=nerfin-1-GFP.FPTB}VK00033, sex:mixed	EXP042928	1407	normal	Q4V6X9	whole organism (development stage: embryonic)	PEAKS044362
EXP044173	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042612	1387	normal	G5ECF7	whole worms (developmental stage: L1)	PEAKS044363
EXP044174	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP043043	1202	normal	O62183	whole worms (developmental stage: L2)	PEAKS044364
EXP044175	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP190, genotype: unc-119(ed3) III; wgIs190., sex:mixed	EXP042924	1387	normal	G5ED66	whole worms (developmental stage: L1)	PEAKS044365
EXP044176	goat-anti-GFP-UC	Drosophila melanogaster	strain: B-H2-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=B-H2-GFP.FPTB}VK00033, sex:mixed	EXP042611	1407	normal	Q24256	whole organism (development stage: embryonic)	PEAKS044366
EXP044177	goat-anti-GFP-UC	Drosophila melanogaster	strain: BEAF-32-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=BEAF-32-GFP.FPTB}VK00033, sex:mixed	EXP042648	1407	normal	Q94513	whole organism (development stage: embryonic)	PEAKS044367
EXP044178	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP510, genotype: unc-119(tm4063) III; wgIs510., sex:hermaphrodite	EXP043082	1389	normal	Q8WQF4	whole worms (developmental stage: L4/young adults)	PEAKS044368
EXP044179	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(bx)-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=E(bx)-GFP.FPTB}attP-40, sex:mixed	EXP042826	1407	normal	Q9W0T1	whole organism (development stage: embryonic)	PEAKS044369
EXP044180	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP702, genotype: unc-119(tm4063); wgIs702 [flh-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043395	1392	normal	A7DTF1	whole worms (mixed-stage embryos)	PEAKS044370
EXP044181	goat-anti-GFP-UC	Drosophila melanogaster	strain: Su(var)3-7-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Su(var)3-7-GFP.FTBP}VK00037, sex:mixed	EXP042595	1407	normal	P20193	whole organism (development stage: embryonic)	PEAKS044371
EXP044182	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	EXP042616	1387	normal	Q10655	whole worms (developmental stage: L1)	PEAKS044372
EXP044183	goat-anti-GFP-UC	Drosophila melanogaster	strain: Lhr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Lhr-GFP.FPTB}VK00033, sex:mixed	EXP043229	1407	normal	Q95RV3	whole organism (development stage: embryonic)	PEAKS044373
EXP044184	goat-anti-GFP-UC	Drosophila melanogaster	strain: org-1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=org-1-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042735	1407	normal	Q9W3F4	whole organism (development stage: embryonic)	PEAKS044374
EXP044185	goat-anti-GFP-UC	Drosophila melanogaster	strain: Vsx1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Vsx1-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042657	1407	normal	Q9W4B2	whole organism (development stage: embryonic)	PEAKS044375
EXP044186	non-commercial prd modENCODE antibody 2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042877	1407	normal	P06601	whole organism (development stage: embryonic)	PEAKS044376
EXP044187	goat-anti-GFP-UC	Drosophila melanogaster	strain: grn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=grn-GFP.FPTB}VK00037, sex:mixed	EXP042897	1407	normal	P91623	whole organism (development stage: embryonic)	PEAKS044377
EXP044188	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr39-RC-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr39-GFP.C.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043051	1408	normal	Q05192	whole organism (development stage: prepupa)	PEAKS044378
EXP044189	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP215, genotype: unc-119(ed3) III; wgIs215., sex:mixed	EXP043220	1389	normal	H2L0N7	whole worms (developmental stage: L4/young adults)	PEAKS044379
EXP044190	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP042927	1389	normal	Q9N5S3	whole worms (developmental stage: L4/young adults)	PEAKS044380
EXP044191	goat-anti-GFP-UC	Drosophila melanogaster	strain: d.ets6-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets21C-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP043065	1408	normal	A8DYS7	whole organism (development stage: prepupa)	PEAKS044381
EXP044192	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	EXP043304	1390	normal	Q9TZI2	whole worms (developmental stage: L3)	PEAKS044382
EXP044193	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12219-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12219-GFP.FPTB}VK00033, sex:mixed	EXP043211	1407	normal	Q9W409	whole organism (development stage: embryonic)	PEAKS044383
EXP044194	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP62, genotype: unc-119(ed3) III; wgIs62, sex:mixed	EXP043152	1391	normal	P20154	whole worms (developmental stage: late embryo)	PEAKS044384
EXP044195	goat-anti-GFP-UC	Drosophila melanogaster	strain: caup-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=caup-GFP.FTBP}VK00037/CyO, sex:mixed	EXP042918	1407	normal	P54269	whole organism (development stage: embryonic)	PEAKS044385
EXP044196	goat-anti-GFP-UC	Drosophila melanogaster	strain: sima-RB-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sima-GFP.B.FPTB}VK00037, sex:mixed	EXP042884	1407	normal	Q24167	whole organism (development stage: embryonic)	PEAKS044386
EXP044197	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP395, genotype: unc-119(tm4063) III; wgIs395., sex:mixed	EXP043040	1387	normal	P52906	whole worms (developmental stage: L1)	PEAKS044387
EXP044198	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP54, genotype: unc-119(ed3) III; wgIs54., sex:mixed	EXP042655	1390	normal	P17486	whole worms (developmental stage: L3)	PEAKS044388
EXP044199	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP043333	1392	normal	Q17905	whole worms (mixed-stage embryos)	PEAKS044389
EXP044200	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	EXP042689	1390	normal	G5ECU7	whole worms (developmental stage: L3)	PEAKS044390
EXP044201	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL445, genotype: unc119(ed3)III; vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043285	1235	normal	G5EF11	whole worms (developmental stage: young adults)	PEAKS044391
EXP044202	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr38-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr38-GFP.FLAG}VK00033, sex:mixed	EXP042869	1408	normal	P49869	whole organism (development stage: prepupa)	PEAKS044392
EXP044203	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP202, genotype: unc-119(ed3) III; wgIs202., sex:mixed	EXP043253	1390	normal	P56407	whole worms (developmental stage: L3)	PEAKS044393
EXP044204	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL398, genotype: unc119(ed3)III; vrIs55[pGES-1::LIN-35::GFP FLAG: LIN-35 3â€™UTR, unc-119 (+)], sex:mixed	EXP043313	1387	normal	G5EDT1	whole worms (developmental stage: L1)	PEAKS044394
EXP044205	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	EXP042851	1390	normal	G5EEG1	whole worms (developmental stage: L3)	PEAKS044395
EXP044206	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP042910	1389	normal	G5EBU4	whole worms (developmental stage: L4/young adults)	PEAKS044396
EXP044207	goat-anti-GFP-UC	Drosophila melanogaster	strain: zf30C-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=dmrt11E-GFP.FPTB}VK00033, sex:mixed	EXP043290	1407	normal	Q9VL91	whole organism (development stage: embryonic)	PEAKS044397
EXP044208	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox102F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox102F-GFP.FPTB}VK00033, sex:mixed	EXP042679	1408	normal	Q9V480	whole organism (development stage: prepupa)	PEAKS044398
EXP044209	goat-anti-GFP-UC	Drosophila melanogaster	strain: Chrac-16-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Chrac-16-GFP.FTBP}VK00033, sex:mixed	EXP042923	1407	normal	Q9V452	whole organism (development stage: embryonic)	PEAKS044399
EXP044210	goat-anti-GFP-UC	Drosophila melanogaster	strain: Delg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets97D-GFP.FLAG}VK00037, sex:mixed	EXP042640	1407	normal	Q04688	whole organism (development stage: embryonic)	PEAKS044400
EXP044211	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd64A-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=FoxL1-GFP.FPTB}attP-40, sex:mixed	EXP042840	1407	normal	D3PFH7	whole organism (development stage: embryonic)	PEAKS044401
EXP044212	goat-anti-GFP-UC	Drosophila melanogaster	strain: Myb-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=Myb-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP043062	1407	normal	Q53YG3	whole organism (development stage: embryonic)	PEAKS044402
EXP044213	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP521, genotype: unc-119(tm4063) III; wgIs521, sex:hermaphrodite	EXP042664	1389	normal	Q18919	whole worms (developmental stage: L4/young adults)	PEAKS044403
EXP044214	goat-anti-GFP-UC	Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	EXP043018	1407	normal	A1Z8A6	whole organism (development stage: embryonic)	PEAKS044404
EXP044215	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP185, genotype: unc-119(ed3) III; wgIs185., sex:mixed	EXP042723	1390	normal	Q95QA9	whole worms (developmental stage: L3)	PEAKS044405
EXP044216	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP81, genotype: unc-119(ed3) III; wgIs81., sex:mixed	EXP042600	1390	normal	G5EDU4	whole worms (developmental stage: L3)	PEAKS044406
EXP044217	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042738	1389	normal	Q966B8	whole worms (developmental stage: L4/young adults)	PEAKS044407
EXP044218	non-commercial CTCF modENCODE antibody 2	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP043139	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	PEAKS044408
EXP044219	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043371	1235	normal	Q17381	whole worms (developmental stage: young adults)	PEAKS044409
EXP044220	goat-anti-GFP-UC	Drosophila melanogaster	strain: Tup-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=tup-GFP.FPTB}VK00031, sex:mixed	EXP043306	1407	normal	Q9VJ37	whole organism (development stage: embryonic)	PEAKS044410
EXP044221	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043179	1389	normal	Q23294	whole worms (developmental stage: L4/young adults)	PEAKS044411
EXP044222	goat-anti-GFP-UC	Drosophila melanogaster	strain: kay-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=kay-GFP.FLAG}VK00037, sex:mixed	EXP042994	1407	normal	A8MPH9	whole organism (development stage: embryonic)	PEAKS044412
EXP044223	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12659-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG12659-GFP.FPTB}VK00033, sex:mixed	EXP043237	1407	normal	Q9W3D4	whole organism (development stage: embryonic)	PEAKS044413
EXP044224	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:mixed	EXP042555	1387	normal	Q93560	whole worms (developmental stage: L1)	PEAKS044414
EXP044225	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP222, genotype: unc-119(ed3) III; wgIs222., sex:mixed	EXP043166	1389	normal	G5EFF5	whole worms (developmental stage: L4/young adults)	PEAKS044415
EXP044226	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP043090	1387	normal	O17593	whole worms (developmental stage: L1)	PEAKS044416
EXP044227	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042740	1389	normal	G5ECG2	whole worms (developmental stage: L4/young adults)	PEAKS044417
EXP044228	goat-anti-GFP-UC	Drosophila melanogaster	strain: ey-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ey-GFP.FPTB}VK00033, sex:mixed	EXP043245	1400	normal	O18381	whole organism (development stage: wandering third instar larva)	PEAKS044418
EXP044229	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10325, sex:hermaphrodite	EXP043015	1235	normal	Q9NH52	whole worms (developmental stage: young adults)	PEAKS044419
EXP044230	goat-anti-GFP-UC	Drosophila melanogaster	strain: bigmax-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=bigmax-GFP.FPTB}attP40, sex:mixed	EXP042692	1407	normal	Q9VB47	whole organism (development stage: embryonic)	PEAKS044420
EXP044231	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042724	1390	normal	G5EFY7	whole worms (developmental stage: L3)	PEAKS044421
EXP044232	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP210, genotype: unc-119(ed3) III; wgIs210., sex:hermaphrodite	EXP043106	1387	normal	Q69YW8	whole worms (developmental stage: L1)	PEAKS044422
EXP044233	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG5180-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG5180-GFP.FPTB}attP40, sex:mixed	EXP042770	1407	normal	B7Z0N0	whole organism (development stage: embryonic)	PEAKS044423
EXP044234	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	EXP043415	1391	normal	Q19691	whole worms (developmental stage: late embryo)	PEAKS044424
EXP044235	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP214, genotype: unc-119(ed3) III; wgIs214., sex:mixed	EXP042803	1235	normal	Q9N5H8	whole worms (developmental stage: young adults)	PEAKS044425
EXP044236	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP90, genotype: unc-119(ed3) III; wgIs90., sex:mixed	EXP043212	1202	normal	P41829	whole worms (developmental stage: L2)	PEAKS044426
EXP044237	non-commercial Dll modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042587	1403	normal	P20009	whole organism	PEAKS044427
EXP044238	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4328-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG4328-GFP.FPTB}attP40, sex:mixed	EXP042956	1407	normal	Q9VTW3	whole organism (development stage: embryonic)	PEAKS044428
EXP044239	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr96-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=FTSF.GFP-Hr96}VK00037, sex:female	EXP043178	1399	normal	Q24143	whole organism (development stage: adult)	PEAKS044429
EXP044240	non-commercial su(Hw) modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042771	1403	normal	P08970	whole organism	PEAKS044430
EXP044241	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP642, genotype: unc-119 (tm4063) III; wgIs642, sex:mixed	EXP042677	1405	normal	Q10938	whole organism (development stage: early embryonic)	PEAKS044431
EXP044242	ab290	Drosophila melanogaster	strain: Hr78-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr78-GFP.FLAG}VK00037	EXP043224	1407	normal	Q24142	whole organism (development stage: embryonic)	PEAKS044432
EXP044243	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP539, genotype: unc-119(tm4063) III; wgIs539, sex:hermaphrodite	EXP042653	1387	normal	Q9XUK7	whole worms (developmental stage: L1)	PEAKS044433
EXP044244	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4820-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG4820-GFP.FTBP}VK00037, sex:mixed	EXP042575	1407	normal	A8JQX6	whole organism (development stage: embryonic)	PEAKS044434
EXP044245	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP560, genotype: unc-119(tm4063) III; wgIs560, sex:mixed	EXP042984	1405	normal	Q10666	whole organism (development stage: early embryonic)	PEAKS044435
EXP044246	goat-anti-GFP-UC	Caenorhabditis elegans	strain: CS152, genotype: sma-3(wk30);qcIs[gfp::sma-3+rol-6], sex:hermaphrodite	EXP043001	1202	normal	P45896	whole worms (developmental stage: L2)	PEAKS044436
EXP044247	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042943	1387	normal	G5EFY7	whole worms (developmental stage: L1)	PEAKS044437
EXP044248	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP86, genotype: unc-119(ed3) III; wgIs86., sex:mixed	EXP042839	1202	normal	H2KZM4	whole worms (developmental stage: L2)	PEAKS044438
EXP044249	goat-anti-GFP-UC	Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	EXP043199	1400	normal	A1Z8A6	whole organism (development stage: wandering third instar larva)	PEAKS044439
EXP044250	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8359-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=hng2-GFP.FPTB}attP40, sex:mixed	EXP043072	1407	normal	Q9VHL0	whole organism (development stage: embryonic)	PEAKS044440
EXP044251	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:mixed	EXP042781	1390	normal	P28515	whole worms (developmental stage: L3)	PEAKS044441
EXP044252	goat-anti-GFP-UC	Drosophila melanogaster	strain: ind-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ind-GFP.FPTB}attP-40, sex:mixed	EXP042759	1407	normal	E1JH47	whole organism (development stage: embryonic)	PEAKS044442
EXP044253	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP124, genotype: unc-119(ed3) III; wgIs124., sex:mixed	EXP042617	1389	normal	O02219	whole worms (developmental stage: L4/young adults)	PEAKS044443
EXP044254	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP222, genotype: unc-119(ed3) III; wgIs222., sex:mixed	EXP043392	1390	normal	G5EFF5	whole worms (developmental stage: L3)	PEAKS044444
EXP044255	goat-anti-GFP-UC	Drosophila melanogaster	strain: fkh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=fkh-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042818	1408	normal	P14734	whole organism (development stage: prepupa)	PEAKS044445
EXP044256	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP200, genotype: unc-119(ed3) III; wgIs200., sex:mixed	EXP043115	1202	normal	Q21836	whole worms (developmental stage: L2)	PEAKS044446
EXP044257	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP042751	1391	normal	Q23294	whole worms (developmental stage: late embryo)	PEAKS044447
EXP044258	goat-anti-GFP-UC	Drosophila melanogaster	strain: her-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=her-GFP.FTBP}VK00033/TM3, Sb[1], sex:mixed	EXP043311	1407	normal	Q9VJJ6	whole organism (development stage: embryonic)	PEAKS044448
EXP044259	goat-anti-GFP-UC	Drosophila melanogaster	strain: disco-r-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=disco-r-EGFP.S}VK00033/TM3, Sb[1], sex:mixed	EXP042813	1407	normal	Q9VXJ5	whole organism (development stage: embryonic)	PEAKS044449
EXP044260	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP651, genotype: unc-119(tm4063); wgIs651 [bed-3::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042864	1392	normal	Q19787	whole worms (mixed-stage embryos)	PEAKS044450
EXP044261	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP169, genotype: unc-119(ed3) III; wgIs169., sex:mixed	EXP043373	1392	normal	Q22812	whole worms (mixed-stage embryos)	PEAKS044451
EXP044262	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL521, genotype: unc-119(ed3) III; vrIs117 [pPIE-1::LIN-35:GFP:FLAG::PUF-5 3'UTR, unc-119 (+)]), sex:mixed	EXP043156	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	PEAKS044452
EXP044263	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043321	1387	normal	Q9N5S3	whole worms (developmental stage: L1)	PEAKS044453
EXP044264	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP111, genotype: unc-119(ed3) III; wgIs111, sex:hermaphrodite	EXP043251	1391	normal	D0VWN0	whole worms (developmental stage: late embryo)	PEAKS044454
EXP044265	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP102, genotype: unc-119(tm4063) III; wgIs102., sex:mixed	EXP042749	1387	normal	Q21502	whole worms (developmental stage: L1)	PEAKS044455
EXP044266	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP43, genotype: unc-119(ed3) III; wgIs43., sex:mixed	EXP043230	1202	normal	P41828	whole worms (developmental stage: L2)	PEAKS044456
EXP044267	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 5T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=eve-EGFP.S}VK00033	EXP043413	1407	normal	F9W320	whole organism (development stage: embryonic)	PEAKS044457
EXP044268	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP516, genotype: unc-119(tm4063) III; wgIs516., sex:hermaphrodite	EXP043397	1389	normal	Q23175	whole worms (developmental stage: L4/young adults)	PEAKS044458
EXP044269	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP589, genotype: unc-119(tm4063); wgIs589 [gei-8::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043375	1389	normal	P34333	whole worms (developmental stage: L4/young adults)	PEAKS044459
EXP044270	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP312, genotype: unc-119(ed3) III; wgIs312, sex:hermaphrodite	EXP042606	1389	normal	O17862	whole worms (developmental stage: L4/young adults)	PEAKS044460
EXP044271	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043048	1202	normal	Q23294	whole worms (developmental stage: L2)	PEAKS044461
EXP044272	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043049	1390	normal	Q23294	whole worms (developmental stage: L3)	PEAKS044462
EXP044273	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP562, genotype: unc-119(tm4063) III; wgIs562, sex:hermaphrodite	EXP042809	1391	normal	O44712	whole worms (developmental stage: late embryo)	PEAKS044463
EXP044274	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15011-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG15011-GFP.FPTB}VK00033, sex:mixed	EXP042900	1407	normal	Q9VZF2	whole organism (development stage: embryonic)	PEAKS044464
EXP044275	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP252, sex:hermaphrodite	EXP042593	1389	normal	Q9XVS4	whole worms (developmental stage: L4/young adults)	PEAKS044465
EXP044276	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042967	1387	normal	Q65CM0	whole worms (developmental stage: L1)	PEAKS044466
EXP044277	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG16815-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG16815-GFP.FPTB}VK00033, sex:mixed	EXP043384	1407	normal	Q9VK15	whole organism (development stage: embryonic)	PEAKS044467
EXP044278	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP502, genotype: unc-119(tm4063) III; wgIs502., sex:hermaphrodite	EXP042995	1405	normal	Q17561	whole organism (development stage: early embryonic)	PEAKS044468
EXP044279	goat-anti-GFP-UC	Drosophila melanogaster	strain: achi-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=achi-GFP.FTBP}VK00033, sex:mixed	EXP043239	1408	normal	Q7JR08	whole organism (development stage: prepupa)	PEAKS044469
EXP044280	goat-anti-GFP-UC	Drosophila melanogaster	strain: luna-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}luna[MI05859]/SM6a, sex:mixed	EXP043071	1407	normal	Q8MR37	whole organism (development stage: embryonic)	PEAKS044470
EXP044281	goat-anti-GFP-UC	Caenorhabditis elegans	strain: QP0661, sex:hermaphrodite	EXP042726	1235	normal	O45134	whole worms (developmental stage: young adults)	PEAKS044471
EXP044282	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042585	1390	normal	Q966B8	whole worms (developmental stage: L3)	PEAKS044472
EXP044283	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:hermaphrodite	EXP042646	1391	normal	Q86MJ3	whole worms (developmental stage: late embryo)	PEAKS044473
EXP044284	goat-anti-GFP-UC	Drosophila melanogaster	strain: ERR-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ERR-GFP.FSTF}VK00037, sex:mixed	EXP042823	1407	normal	Q9VSE9	whole organism (development stage: embryonic)	PEAKS044474
EXP044285	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP324, genotype: unc-119(ed3) III; wgIs324., sex:mixed	EXP043078	1202	normal	O17646	whole worms (developmental stage: L2)	PEAKS044475
EXP044286	goat-anti-GFP-UC	Drosophila melanogaster	strain: OdsH-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=OdsH-GFP.FPTB}VK00033	EXP042837	1400	normal	Q9VX20	whole organism (development stage: wandering third instar larva)	PEAKS044476
EXP044287	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG34406-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG44002-GFP.FTBP}VK00033, sex:mixed	EXP043186	1408	normal	Q9VRC5	whole organism (development stage: prepupa)	PEAKS044477
EXP044288	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP195, sex:hermaphrodite	EXP043352	1389	normal	Q23541	whole worms (developmental stage: L4/young adults)	PEAKS044478
EXP044289	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	EXP043056	1389	normal	G5ECU7	whole worms (developmental stage: L4/young adults)	PEAKS044479
EXP044290	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP573, genotype: unc-119(tm4063) III; wgIs573, sex:mixed	EXP043157	1405	normal	Q18612	whole organism (development stage: early embryonic)	PEAKS044480
EXP044291	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP042788	1202	normal	O02274	whole worms (developmental stage: L2)	PEAKS044481
EXP044292	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP476, genotype: unc-119(tm4063) III; wgIs476., sex:hermaphrodite	EXP043342	1391	normal	P13528	whole worms (developmental stage: late embryo)	PEAKS044482
EXP044293	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP399, genotype: unc-119(tm4063) III; wgIs399., sex:hermaphrodite	EXP043067	1235	normal	Q19723	whole worms (developmental stage: young adults)	PEAKS044483
EXP044294	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP73, genotype: unc-119(ed3) III; wgIs73, sex:mixed	EXP042863	1202	normal	P20271	whole worms (developmental stage: L2)	PEAKS044484
EXP044295	goat-anti-GFP-UC	Drosophila melanogaster	strain: sc-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sc-GFP.FPTB}VK00033, sex:mixed	EXP043172	1407	normal	P10084	whole organism (development stage: embryonic)	PEAKS044485
EXP044296	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL416, genotype: unc119(ed3)III; vrIs64[pGES-1::HPL-2::GFP FLAG: HPL-2 3â€™UTR, unc-119 (+)], sex:mixed	EXP043275	1387	normal	G5EDE2	whole worms (developmental stage: L1)	PEAKS044486
EXP044299	anti-SDC-3	Caenorhabditis elegans	strain: N2	EXP044297	1388	normal	P34706	whole worms (developmental stage: embryo)	PEAKS044487
EXP044300	anti-SDC-3	Caenorhabditis elegans	strain: sdc-2(y93) with RNAi against sdc-2	EXP044298	1388	normal	P34706	whole worms (developmental stage: embryo)	PEAKS044488
EXP044302	anti-TDP-1	Caenorhabditis elegans	strain: tdp-1(ok803); temperature: 20C	EXP044301	1235	normal	D0VWM8	whole worms (developmental stage: young adults)	PEAKS044489
EXP044303	anti-TDP-1	Caenorhabditis elegans	strain: tdp-1(ok803); temperature: 20C	EXP044301	1235	normal	D0VWM8	whole worms (developmental stage: young adults)	PEAKS044490
EXP044305	ATFS-1 antibody	Caenorhabditis elegans	treated with spg-7(RNAi); wildtype	EXP044304	1389	normal	Q23272	whole worms (developmental stage: L4/young adults)	PEAKS044491
EXP044310	anti-DAF-16	Caenorhabditis elegans	strain: daf-2 (e1370); temperature:20 Â°C	EXP044306	1411	normal	O16850	whole worms (mix stage culture)	PEAKS044492
EXP044311	anti-DAF-16	Caenorhabditis elegans	strain: Wild-type (N2); temperature:20 Â°C	EXP044307	1411	normal	O16850	whole worms (mix stage culture)	PEAKS044493
EXP044312	anti-DAF-16	Caenorhabditis elegans	strain: daf-16(mgDf50) knocked down by RNAi;daf-2 (e1370); temperature:20 Â°C	EXP044308	1411	bio_control	O16850	whole worms (mix stage culture)	PEAKS044494
EXP044313	anti-DAF-16	Caenorhabditis elegans	strain: daf-16(mgDf50) knocked down by RNAi; temperature:20 Â°C	EXP044309	1411	bio_control	O16850	whole worms (mix stage culture)	PEAKS044495
EXP044316	anti-LEM2 SDQ3891	Caenorhabditis elegans	strain: N2	EXP044315	1392	normal	Q9XTB5	whole worms (mixed-stage embryos)	PEAKS044496
EXP044319	BH00001 LIN52	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	Q10120	whole worms (developmental stage: L3)	PEAKS044497
EXP044320	BH00001 LIN52	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	Q10120	whole worms (developmental stage: L3)	PEAKS044498
EXP044323	BH00003 LIN37	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	Q23482	whole worms (developmental stage: L3)	PEAKS044499
EXP044324	BH00003 LIN37	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	Q23482	whole worms (developmental stage: L3)	PEAKS044500
EXP044327	BH00004_LIN54	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	Q95QD7	whole worms (developmental stage: L3)	PEAKS044501
EXP044328	BH00004_LIN54	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	Q95QD7	whole worms (developmental stage: L3)	PEAKS044502
EXP044331	BH00005 LIN9	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	P30630	whole worms (developmental stage: L3)	PEAKS044503
EXP044332	BH00005 LIN9	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	P30630	whole worms (developmental stage: L3)	PEAKS044504
EXP044335	JA00011 LIN35	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	G5EDT1	whole worms (developmental stage: L3)	PEAKS044505
EXP044336	JA00011 LIN35	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	G5EDT1	whole worms (developmental stage: L3)	PEAKS044506
EXP044339	JL00002 SDC3	Caenorhabditis elegans	strain: N2	EXP044337	1390	normal	P34706	whole worms (developmental stage: L3)	PEAKS044507
EXP044340	JL00002 SDC3	Caenorhabditis elegans	strain: N2	EXP044338	1390	normal	P34706	whole worms (developmental stage: L3)	PEAKS044508
EXP044342	SDQ2370 LIN53	Caenorhabditis elegans	N2 strain	EXP044318	1390	normal	P90916	whole worms (developmental stage: L3)	PEAKS044509
EXP044344	SDQ3590 EFL1	Caenorhabditis elegans	N2 strain	EXP044318	1390	normal	G5EF11	whole worms (developmental stage: L3)	PEAKS044510
EXP044346	SDQ3599 DPL1	Caenorhabditis elegans	N2 strain	EXP044318	1390	normal	Q22703	whole worms (developmental stage: L3)	PEAKS044511
EXP044348	SDQ4470 TAG315	Caenorhabditis elegans	N2 strain	EXP044347	1390	normal	Q95PV7	whole worms (developmental stage: L3)	PEAKS044512
EXP044350	SDQ4526 SFC1	Caenorhabditis elegans	N2 strain	EXP044347	1390	normal	Q22093	whole worms (developmental stage: L3)	PEAKS044513
EXP044352	JL00001 DPY27	Caenorhabditis elegans	N2 strain	EXP044351	1390	normal	P48996	whole worms (developmental stage: L3)	PEAKS044514
EXP044374	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 20Â°C to desired stage	EXP044371	1235	normal	G5EFT5	whole worms (developmental stage: young adults)	PEAKS044525
EXP044375	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 34Â°C to desired stage	EXP044371	1235	normal	G5EFT5	whole worms (developmental stage: young adults)	PEAKS044526
EXP044377	anti-CEBP1	Caenorhabditis elegans		EXP044376	1411	normal	Q18909	whole worms (mix stage culture)	PEAKS044527
EXP044379	anti-GFP (gift from Kevin White)	Caenorhabditis elegans	YL529 strain	EXP044378	1235	normal	O44743	whole worms (developmental stage: young adults)	PEAKS044528
EXP044381	HPL-2 (Strategic Diagnostics Inc., Q2324)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	PEAKS044529
EXP044382	LET-418 (Strategic Diagnostics Inc., Q3861)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	G5EBZ4	whole worms (developmental stage: young adults)	PEAKS044530
EXP044383	LIN-13 (Strategic Diagnostics Inc., Q0838)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	Q11107	whole worms (developmental stage: young adults)	PEAKS044531
EXP044384	LIN-61 (Strategic Diagnostics Inc., Q3520)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	B2D6M2	whole worms (developmental stage: young adults)	PEAKS044532
EXP044385	MET-2 (Strategic Diagnostics Inc., Q2943)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	P17512	whole worms (developmental stage: young adults)	PEAKS044533
EXP044394	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: wild type	EXP044387	1391	normal	Q22703	whole worms (developmental stage: late embryo)	PEAKS044534
EXP044395	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	Q22703	whole worms (developmental stage: late embryo)	PEAKS044535
EXP044396	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q22703	whole worms (developmental stage: late embryo)	PEAKS044536
EXP044397	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q22703	whole worms (developmental stage: late embryo)	PEAKS044537
EXP044398	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q22703	whole worms (developmental stage: late embryo)	PEAKS044538
EXP044399	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q22703	whole worms (developmental stage: late embryo)	PEAKS044539
EXP044400	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: wild type	EXP044387	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	PEAKS044540
EXP044401	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: wild type	EXP044389	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	PEAKS044541
EXP044402	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	PEAKS044542
EXP044403	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	PEAKS044543
EXP044404	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	PEAKS044544
EXP044405	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	PEAKS044545
EXP044406	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: wild type	EXP044386	1391	normal	G5EDT1	whole worms (developmental stage: late embryo)	PEAKS044546
EXP044407	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	G5EDT1	whole worms (developmental stage: late embryo)	PEAKS044547
EXP044408	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	bio_control	G5EDT1	whole worms (developmental stage: late embryo)	PEAKS044548
EXP044409	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	bio_control	G5EDT1	whole worms (developmental stage: late embryo)	PEAKS044549
EXP044410	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044386	1391	normal	P30630	whole worms (developmental stage: late embryo)	PEAKS044550
EXP044411	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	P30630	whole worms (developmental stage: late embryo)	PEAKS044551
EXP044412	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	P30630	whole worms (developmental stage: late embryo)	PEAKS044552
EXP044413	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	P30630	whole worms (developmental stage: late embryo)	PEAKS044553
EXP044414	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	P30630	whole worms (developmental stage: late embryo)	PEAKS044554
EXP044415	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	P30630	whole worms (developmental stage: late embryo)	PEAKS044555
EXP044416	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q23482	whole worms (developmental stage: late embryo)	PEAKS044556
EXP044417	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q23482	whole worms (developmental stage: late embryo)	PEAKS044557
EXP044418	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q23482	whole worms (developmental stage: late embryo)	PEAKS044558
EXP044419	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q23482	whole worms (developmental stage: late embryo)	PEAKS044559
EXP044420	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044387	1391	normal	Q10120	whole worms (developmental stage: late embryo)	PEAKS044560
EXP044421	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044389	1391	normal	Q10120	whole worms (developmental stage: late embryo)	PEAKS044561
EXP044422	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q10120	whole worms (developmental stage: late embryo)	PEAKS044562
EXP044423	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q10120	whole worms (developmental stage: late embryo)	PEAKS044563
EXP045879	anti-Zelda antibody (Harrison et al., 2011, PLoS Genet. 7(10):e1002266)	Drosophila melanogaster	Treatment: Treatment: Treatment: Oregon R; mitotic cycle 12-c14d; zelda wt	EXP045878	1407	normal	M9NES1	whole organism (development stage: embryonic)	PEAKS045650
EXP054099	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: starved by washing cells 2x in PBS; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054092	521	normal	Q9UHB7	KH2 (embryonic stem cells)	PEAKS051026
EXP054100	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: treated with serum for 30 minutes; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054093	521	normal	O00472	KH2 (embryonic stem cells)	PEAKS051027
EXP054101	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: treated with serum for 30 minutes; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054093	521	normal	Q9UHB7	KH2 (embryonic stem cells)	PEAKS051028
EXP054102	His tag Cdk9 (amino acids 204-372)	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054090	521	normal	Q99J95	KH2 (embryonic stem cells)	PEAKS051029
EXP054104	EBNA1 (Advance Biotechnology, 13-210-100 monoclonal antibody)	Homo sapiens		EXP054103	767	normal	Q99848	Raji (Burkitt lymphoma)	PEAKS051030
EXP054106	anti-Tat (Abcam, ab43014)	Homo sapiens	Genotype: expression HIV Tat protein	EXP054105	509	normal	P17735	Jurkat (T-cells)	PEAKS051031
EXP054107	SPT20_3006 (Laszlo Tora, Rabbit polyclonal)	Homo sapiens		NULL	78	normal	Q8NEM7	HeLa (cervical adenocarcinoma)	PEAKS051032
EXP054108	SPT20_3006 (Laszlo Tora, Rabbit polyclonal)	Homo sapiens		NULL	356	normal	Q8NEM7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051033
EXP054111	anti-V5 (Invitrogen, R960-25, #771149)	Homo sapiens		EXP054110	219	normal	O94907	DLD-1 (colon adenocarcinoma)	PEAKS051034
EXP054117	RB1 (Cell signalling 4H1)	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	EXP054112	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051035
EXP054118	p107 (sc-C18)	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	EXP054112	489	normal	P28749	IMR90 (lung fibroblasts)	PEAKS051036
EXP054119	RBL2 (sc-C20)	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	EXP054112	489	normal	Q08999	IMR90 (lung fibroblasts)	PEAKS051037
EXP054120	anti-acetyl-CBP/p300 (Cell signaling technology, 4771/lot 2, rabbit polyclonal)	Homo sapiens	Developmental stage: adult (45yr); Sex: male; 	NULL	884	normal	Q09472	heart	PEAKS051038
EXP054121	anti-acetyl-CBP/p300 (Cell signaling technology, 4771/lot 2, rabbit polyclonal)	Homo sapiens	Developmental stage: fetus (gestational week 16); Sex: male; 	NULL	884	normal	Q09472	heart	PEAKS051039
EXP054122	anti-acetyl-CBP/p300 (Cell signaling technology, 4771/lot 2, rabbit polyclonal)	Mus musculus	Developmental stage: adult (45yr); Sex: mixed; Strain: CD-1;	NULL	53	normal	B2RWS6	heart	PEAKS051040
EXP054123	anti-MEF2C	Homo sapiens	Treatment: DMSO for 4 hr; Passage: within 6 passage;	NULL	472	normal	Q06413	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS051041
EXP054124	anti-MEF2C	Homo sapiens	Treatment: statin for 4 hr; Passage: within 6 passage;	NULL	472	normal	Q06413	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS051042
EXP054128	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: untreated; Source: cells were pooled from five different donors;	NULL	881	normal	O60885	CD4+ T-cells	PEAKS051046
EXP054129	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: 500nM JQ1 treated for 24hr; Source: cells were pooled from five different donors;	NULL	881	normal	O60885	CD4+ T-cells	PEAKS051047
EXP054131	AFF4 antibody (Lin et al. 2010)	Homo sapiens		EXP054130	10	normal	Q9UHB7	HEK293T (embryonic kidney)	PEAKS051048
EXP054133	RELA (f-6, Santa-Cruz)	Homo sapiens	Treatment: TNFa induction (12 hours); 	EXP054132	38	normal	Q04206	A549 (lung carcinoma)	PEAKS051049
EXP054135	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-RING1B; 	EXP054134	2615	normal	Q99496	293T-Rex	PEAKS051050
EXP054136	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-RYBP; 	EXP054134	2615	normal	Q8N488	293T-Rex	PEAKS051051
EXP054553	anti-p300 ( our lab,  Byun et al, Nature Comm. 3, 633, 2012)	Homo sapiens	Genotype: HSP70K71E-EGFP; 	EXP054551	421	normal	Q09472	HEK293 (embryonic kidney)	PEAKS051340
EXP054854	anti-Cdk7 (Bethyl, A300-405A)	Homo sapiens	Treatment: treated with 500nM THZ-2-102 for 12 hours;	NULL	509	normal	P50613	Jurkat (T-cells)	PEAKS051545
EXP055738	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: vehicle (NaH2PO4, 50mM);	EXP055733	848	normal	Q06609	U2OS (osteosarcoma)	PEAKS052110
EXP055739	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: vehicle (NaH2PO4, 50mM);	EXP055734	848	normal	Q06609	U2OS (osteosarcoma)	PEAKS052111
EXP055740	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	EXP055735	848	normal	Q06609	U2OS (osteosarcoma)	PEAKS052112
EXP055741	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	EXP055736	848	normal	Q06609	U2OS (osteosarcoma)	PEAKS052113
EXP044424	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q10120	whole worms (developmental stage: late embryo)	PEAKS044564
EXP044425	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q10120	whole worms (developmental stage: late embryo)	PEAKS044565
EXP044426	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044386	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	PEAKS044566
EXP044427	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	PEAKS044567
EXP044428	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	PEAKS044568
EXP044429	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	PEAKS044569
EXP044430	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	PEAKS044570
EXP044431	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	PEAKS044571
EXP044434	anti-GFP (Abcam ab290)	Caenorhabditis elegans	strain: SX2966	EXP044432	1411	normal	Q9NAD6	whole worms (mix stage culture)	PEAKS044572
EXP044435	anti-GFP (Abcam ab290)	Caenorhabditis elegans	strain: SX2966	EXP044433	1411	normal	Q9NAD6	whole worms (mix stage culture)	PEAKS044573
EXP044466	SDC-2	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044453	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044574
EXP044467	SDC-2	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044454	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044575
EXP044468	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044436	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044576
EXP044469	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044455	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044577
EXP044470	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044456	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044578
EXP044471	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044455	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044579
EXP044472	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044437	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044580
EXP044473	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044457	1392	normal	Q10661	whole worms (mixed-stage embryos)	PEAKS044581
EXP044474	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044458	1392	normal	Q10661	whole worms (mixed-stage embryos)	PEAKS044582
EXP044475	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044453	1392	normal	Q10661	whole worms (mixed-stage embryos)	PEAKS044583
EXP044476	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044438	1392	normal	Q10661	whole worms (mixed-stage embryos)	PEAKS044584
EXP044477	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044437	1392	normal	Q10661	whole worms (mixed-stage embryos)	PEAKS044585
EXP044478	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044453	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044586
EXP044479	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044459	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044587
EXP044480	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044460	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044588
EXP044481	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044456	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044589
EXP044482	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY2205 strain	EXP044441	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044590
EXP044483	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY2205 strain	EXP044442	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044591
EXP044484	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	EXP044439	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044592
EXP044485	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	EXP044439	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044593
EXP044486	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	EXP044443	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044594
EXP044487	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044444	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044595
EXP044488	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044445	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044596
EXP044489	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044446	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044597
EXP044490	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044444	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044598
EXP044491	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044444	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044599
EXP044492	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044445	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044600
EXP044493	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044446	1392	normal	P34706	whole worms (mixed-stage embryos)	PEAKS044601
EXP044494	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC54 strain	EXP044447	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044602
EXP044495	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC54 strain	EXP044448	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044603
EXP044496	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC64 strain	EXP044449	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044604
EXP044497	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC64 strain	EXP044449	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044605
EXP044498	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC64 strain	EXP044449	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044606
EXP044499	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	EXP044450	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044607
EXP044500	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	EXP044451	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044608
EXP044501	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	EXP044452	1392	normal	P48996	whole worms (mixed-stage embryos)	PEAKS044609
EXP044502	SDC-2	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044455	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	PEAKS044610
EXP044505	anti-GFP	Caenorhabditis elegans	strain: sgIs1 (Strain F); genotype: NHR-6::GFP	EXP044503	1390	normal	P41829	whole worms (developmental stage: L3)	PEAKS044611
EXP044506	anti-GFP	Caenorhabditis elegans	strain: sgIs2 (Strain I); genotype: NHR-6::GFP	EXP044504	1389	normal	P41829	whole worms (developmental stage: L4/young adults)	PEAKS044612
EXP044511	anti-GFP	Caenorhabditis elegans	strain: HW1023; genotype: xrn-2::gfp	EXP044507	1389	normal	Q9U299	whole worms (developmental stage: L4/young adults)	PEAKS044613
EXP044512	anti-GFP	Caenorhabditis elegans	strain: HW1023; genotype: xrn-2::gfp	EXP044508	1389	normal	Q9U299	whole worms (developmental stage: L4/young adults)	PEAKS044614
EXP044513		Caenorhabditis elegans	strain: N2; genotype: wild type	EXP044509	1389	bio_control	A0A023T4K3	whole worms (developmental stage: L4/young adults)	PEAKS044615
EXP044514		Caenorhabditis elegans	strain: N2; genotype: wild type	EXP044510	1389	bio_control	A0A023T4K3	whole worms (developmental stage: L4/young adults)	PEAKS044616
EXP044520	Wapl	Drosophila melanogaster	iPDS5	EXP044515	1244	normal	Q9W517	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044617
EXP044521	Wapl	Drosophila melanogaster	iBrca2	EXP044515	1244	normal	Q9W517	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044618
EXP044522	SA	Drosophila melanogaster	iWapl	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044619
EXP044523	SA	Drosophila melanogaster	iPds5	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044620
EXP044524	SA	Drosophila melanogaster	iPds5; iWapl	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044621
EXP044525	SA	Drosophila melanogaster	iPds5; iBrca2	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044622
EXP044526	SA	Drosophila melanogaster	iBrca2	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044623
EXP044527	Rad21	Drosophila melanogaster	iPds5	EXP044515	1244	normal	A0A021WW32	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044624
EXP044528	Pds5	Drosophila melanogaster	iWapl	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044625
EXP044529	Pds5	Drosophila melanogaster	iRad21	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044626
EXP044530	Pds5	Drosophila melanogaster	iNipped-B	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044627
EXP044531	Pds5	Drosophila melanogaster	iBrca2	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044628
EXP044532	Nipped-B	Drosophila melanogaster	iWapl	EXP044515	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044629
EXP044533	Nipped-B	Drosophila melanogaster	iPds5	EXP044515	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044630
EXP044534	Brca2	Drosophila melanogaster	iPds5	EXP044515	1244	normal	Q9W157	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS044631
EXP044535	PSC	Drosophila melanogaster		NULL	1397	normal	P35820	Kc167 (development stage: embryonic)	PEAKS044632
EXP044537	MSL3-TAP ChIP	Drosophila melanogaster		EXP044536	1412	normal	P50536	whole organism (development stage: larvae)	PEAKS044633
EXP044539	HSF	Drosophila melanogaster	heat shock	EXP044538	1197	normal	P22813	S2-DRSC (embryonic stem cells)	PEAKS044634
EXP044540	HSF	Drosophila melanogaster	heat shock; HSF knock-down	EXP044538	1197	bio_control	P22813	S2-DRSC (embryonic stem cells)	PEAKS044635
EXP044541	HSF	Drosophila melanogaster		EXP044538	1197	normal	P22813	S2-DRSC (embryonic stem cells)	PEAKS044636
EXP044542	HSF	Drosophila melanogaster	HSF knock-down	EXP044538	1197	bio_control	P22813	S2-DRSC (embryonic stem cells)	PEAKS044637
EXP044552	goat anti GFP	Drosophila melanogaster	21 day female flies	EXP044543	1399	normal	P09085	whole organism (development stage: adult)	PEAKS044638
EXP044554	goat anti GFP	Drosophila melanogaster		EXP044545	1415	normal	P09085	4-8 h embryo	PEAKS044640
EXP044559	caudal	Drosophila melanogaster		EXP044551	1400	normal	P09085	whole organism (development stage: wandering third instar larva)	PEAKS044645
EXP044560	HDAC11	Drosophila melanogaster		EXP044544	1413	normal	Q9VC26	0-12 h embryo	PEAKS044646
EXP044561	HDAC6	Drosophila melanogaster		EXP044544	1413	normal	C5I798	0-12 h embryo	PEAKS044647
EXP044562	HDAC3	Drosophila melanogaster		EXP044544	1413	normal	Q7KTS4	0-12 h embryo	PEAKS044648
EXP044563	HDAC1	Drosophila melanogaster		EXP044544	1413	normal	Q94517	0-12 h embryo	PEAKS044649
EXP044564	HDAC4a	Drosophila melanogaster		EXP044544	1413	normal	M9NEF2	0-12 h embryo	PEAKS044650
EXP044568	anti-AGO2 mAb 9D6	Drosophila melanogaster		EXP044565	1242	normal	Q9VUQ5	S2 cells	PEAKS044651
EXP044569	anti-AGO2 mAb 9D6	Drosophila melanogaster		EXP044566	1443	normal	Q9VUQ5	S3 cells (Schneider 3)	PEAKS044652
EXP044570	antiAGO2 pAb Mueller [PMID:16934003]	Drosophila melanogaster		EXP044567	1242	normal	Q9VUQ5	S2 cells	PEAKS044653
EXP044576	KW4-Pcl-D2	Drosophila melanogaster		EXP044575	1418	normal	Q24459	0-8 h embryo	PEAKS044656
EXP044578	KW3-disco-D2	Drosophila melanogaster		EXP042796	1418	normal	P23792	0-8 h embryo	PEAKS044657
EXP044580	cad-GFP	Drosophila melanogaster	3 day female	EXP044579	1399	normal	P09085	whole organism (development stage: adult)	PEAKS044658
EXP044672	sc-585	Homo sapiens		EXP044592	1181	normal	Q09472	upper lobe of left lung	PEAKS044659
EXP044673	sc-994	Homo sapiens		EXP010539	430	normal	Q96ST3	HepG2 (hepatoblastoma)	PEAKS044660
EXP044674	61717	Homo sapiens		EXP039034	514	normal	P49736	K562 (myelogenous leukemia)	PEAKS044661
EXP044675	sc-585	Homo sapiens		EXP010581	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044662
EXP044676	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	O60216	A549 (lung carcinoma)	PEAKS044663
EXP044677	A300-868A	Homo sapiens		EXP039034	514	normal	O00267	K562 (myelogenous leukemia)	PEAKS044664
EXP044678	ARP40368_P050	Homo sapiens		EXP044665	430	normal	P14866	HepG2 (hepatoblastoma)	PEAKS044665
EXP044679	sc-585	Homo sapiens		EXP039181	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044666
EXP044680	ab992	Homo sapiens		EXP010131	514	normal	O60216	K562 (myelogenous leukemia)	PEAKS044667
EXP044681	5246S	Homo sapiens		EXP044640	1419	normal	Q15910	GM23248	PEAKS044668
EXP044682	sc-585	Homo sapiens		EXP010318	376	normal	Q09472	WA01 (H1, human embryonic stem cells)	PEAKS044669
EXP044683	sc-101388	Homo sapiens		EXP010671	514	normal	Q9NYF8	K562 (myelogenous leukemia)	PEAKS044670
EXP044684	ab992	Homo sapiens		EXP010228	430	normal	O60216	HepG2 (hepatoblastoma)	PEAKS044671
EXP044685	sc-994	Homo sapiens		EXP010671	514	normal	Q96ST3	K562 (myelogenous leukemia)	PEAKS044672
EXP044686	sc-585	Homo sapiens		EXP010228	430	normal	Q09472	HepG2 (hepatoblastoma)	PEAKS044673
EXP044687	GTX114455	Homo sapiens		EXP044665	430	normal	P35269	HepG2 (hepatoblastoma)	PEAKS044674
EXP044688	HPA017013	Homo sapiens		EXP039076	356	normal	O43670	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044675
EXP044689	sc-101167	Homo sapiens		EXP010318	376	normal	Q15545	WA01 (H1, human embryonic stem cells)	PEAKS044676
EXP044690	ab992	Homo sapiens	6Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	normal	O60216	SK-N-SH (neuroblastoma)	PEAKS044677
EXP044691	sc-585	Homo sapiens	6Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	normal	Q09472	SK-N-SH (neuroblastoma)	PEAKS044678
EXP044692	ab992	Homo sapiens		EXP010318	376	normal	O60216	WA01 (H1, human embryonic stem cells)	PEAKS044679
EXP044693	sc-585	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	normal	Q09472	T47D (invasive ductal carcinoma)	PEAKS044680
EXP044694	sc-994	Homo sapiens		EXP010318	376	normal	Q96ST3	WA01 (H1, human embryonic stem cells)	PEAKS044681
EXP044695	A303-223A	Homo sapiens		EXP044628	430	normal	Q13148	HepG2 (hepatoblastoma)	PEAKS044682
EXP044696	sc-101388	Homo sapiens		EXP010137	356	normal	Q9NYF8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044683
EXP044697	GTX100469	Homo sapiens		EXP039020	430	normal	Q06609	HepG2 (hepatoblastoma)	PEAKS044684
EXP044698	A303-923A	Homo sapiens		EXP044671	430	normal	Q9NW64	HepG2 (hepatoblastoma)	PEAKS044685
EXP044699	sc-994	Homo sapiens		EXP010507	712	normal	Q96ST3	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS044686
EXP044700	A303-595A	Homo sapiens		EXP039034	514	normal	Q92785	K562 (myelogenous leukemia)	PEAKS044687
EXP044701	sc-994	Homo sapiens		EXP010101	733	normal	Q96ST3	PFSK1 (primitive neuroectodermal tumor)	PEAKS044688
EXP044702	sc-994	Homo sapiens		EXP010505	665	normal	Q96ST3	SK-N-SH (neuroblastoma)	PEAKS044689
EXP044703	sc-585	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044690
EXP044704	A300-294A	Homo sapiens		EXP044631	430	normal	P35637	HepG2 (hepatoblastoma)	PEAKS044691
EXP044705	A302-524A	Homo sapiens		EXP010781	430	normal	Q14781	HepG2 (hepatoblastoma)	PEAKS044692
EXP044706	A301-341A	Homo sapiens		EXP039242	356	normal	Q9UBN7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044693
EXP044707	ab109398	Homo sapiens		EXP040205	113	normal	Q15910	MCF7 (Invasive ductal breast carcinoma)	PEAKS044694
EXP044708	ab992	Homo sapiens		EXP010137	356	normal	O60216	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044695
EXP044709	sc-6296	Homo sapiens		EXP010228	430	normal	Q92769	HepG2 (hepatoblastoma)	PEAKS044696
EXP044710	sc-6296	Homo sapiens		EXP010131	514	normal	Q92769	K562 (myelogenous leukemia)	PEAKS044697
EXP044711	A303-670A	Homo sapiens		EXP044613	430	normal	Q08170	HepG2 (hepatoblastoma)	PEAKS044698
EXP044712	sc-9571	Homo sapiens		EXP044664	514	normal	P08621	K562 (myelogenous leukemia)	PEAKS044699
EXP044713	SAB2100398	Homo sapiens		EXP039220	356	normal	Q03701	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044700
EXP044714	A303-245A	Homo sapiens		EXP039077	514	normal	Q96JP5	K562 (myelogenous leukemia)	PEAKS044701
EXP044715	sc-101167	Homo sapiens		EXP010671	514	normal	Q15545	K562 (myelogenous leukemia)	PEAKS044702
EXP044716	sc-6298	Homo sapiens		EXP010781	430	normal	Q13547	HepG2 (hepatoblastoma)	PEAKS044703
EXP044717	sc-6296	Homo sapiens		EXP010318	376	normal	Q92769	WA01 (H1, human embryonic stem cells)	PEAKS044704
EXP044718	A303-241A	Homo sapiens		EXP039216	514	normal	Q96BR9	K562 (myelogenous leukemia)	PEAKS044705
EXP044719	A300-608A	Homo sapiens		EXP039034	514	normal	Q9NYF8	K562 (myelogenous leukemia)	PEAKS044706
EXP044720	sc-585	Homo sapiens		EXP010832	665	normal	Q09472	SK-N-SH (neuroblastoma)	PEAKS044707
EXP044721	A300-608A	Homo sapiens		EXP039061	430	normal	Q9NYF8	HepG2 (hepatoblastoma)	PEAKS044708
EXP044722	sc-585	Homo sapiens		EXP010824	504	normal	Q09472	Ishikawa (endometrial adenocarcinoma)	PEAKS044709
EXP044723	ab992	Homo sapiens		EXP010917	38	normal	O60216	A549 (lung carcinoma)	PEAKS044710
EXP044724	sc-101004	Homo sapiens		EXP010900	417	normal	Q13185	HCT-116 (colon carcinoma)	PEAKS044711
EXP044725	JH39.2.2F10	Homo sapiens		EXP039120	514	normal	Q14202	K562 (myelogenous leukemia)	PEAKS044712
EXP044726	A303-596A	Homo sapiens		EXP039034	514	normal	Q92785	K562 (myelogenous leukemia)	PEAKS044713
EXP044727	sc-6296	Homo sapiens		EXP010799	113	normal	Q92769	MCF7 (Invasive ductal breast carcinoma)	PEAKS044714
EXP044728	A302-869A	Homo sapiens		EXP039034	514	normal	Q99496	K562 (myelogenous leukemia)	PEAKS044715
EXP044729	ab992	Homo sapiens		EXP010799	113	normal	O60216	MCF7 (Invasive ductal breast carcinoma)	PEAKS044716
EXP044730	sc-585	Homo sapiens		EXP010799	113	normal	Q09472	MCF7 (Invasive ductal breast carcinoma)	PEAKS044717
EXP044731	ab992	Homo sapiens		EXP010824	504	normal	O60216	Ishikawa (endometrial adenocarcinoma)	PEAKS044718
EXP044732	sc-71910	Homo sapiens		EXP010546	514	normal	P29590	K562 (myelogenous leukemia)	PEAKS044719
EXP044733	sc-271530	Homo sapiens		EXP010780	430	normal	O95243	HepG2 (hepatoblastoma)	PEAKS044720
EXP044734	5246BF	Homo sapiens		EXP039172	618	normal	Q15910	MM1.S (plasma cell myeloma)	PEAKS044721
EXP044735	sc-71910	Homo sapiens		EXP010918	356	normal	P29590	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044722
EXP044736	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q8WTR7	HEK293 (embryonic kidney)	PEAKS044723
EXP044737	sc-81411	Homo sapiens		EXP010546	514	normal	Q13263	K562 (myelogenous leukemia)	PEAKS044724
EXP044738	ab992	Homo sapiens		EXP010900	417	normal	O60216	HCT-116 (colon carcinoma)	PEAKS044725
EXP044739	sc-994	Homo sapiens		EXP010900	417	normal	Q96ST3	HCT-116 (colon carcinoma)	PEAKS044726
EXP044740	sc-994	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	normal	Q96ST3	A549 (lung carcinoma)	PEAKS044727
EXP044741	sc-101004	Homo sapiens		EXP010546	514	normal	Q13185	K562 (myelogenous leukemia)	PEAKS044728
EXP054055	HDAC2 (YangShi lab,  A300-705A)	Homo sapiens	Treatment: None;	NULL	376	normal	Q92769	WA01 (H1, human embryonic stem cells)	PEAKS050986
EXP054060	JMJD2A (Bethyl Laboratories, A300-861A-1)	Homo sapiens	Treatment: None;	NULL	376	normal	O75164	WA01 (H1, human embryonic stem cells)	PEAKS050991
EXP054056	CHD7 (Bethyl Laboratories, A301-223A-1)	Homo sapiens	Treatment: None;	NULL	376	normal	Q9P2D1	WA01 (H1, human embryonic stem cells)	PEAKS050987
EXP054059	CHD7 (Bethyl Laboratories, A301-223A-1)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9P2D1	K562 (myelogenous leukemia)	PEAKS050990
EXP044746	A303-616A	Homo sapiens		EXP039077	514	normal	O75081	K562 (myelogenous leukemia)	PEAKS044733
EXP054067	P300 (Rabbit Polyclonal Antigen Affinity Purified, Unconjugated, Liquid)	Homo sapiens	Treatment: None;	NULL	376	normal	Q09472	WA01 (H1, human embryonic stem cells)	PEAKS050998
EXP054051	SIRT6 (abcam,ab48192 )	Homo sapiens	Treatment: None;	NULL	376	normal	Q8N6T7	WA01 (H1, human embryonic stem cells)	PEAKS050982
EXP054052	SETDB1 (Proteintech, 11231-1-AP)	Homo sapiens	Treatment: None;	NULL	514	normal	Q15047	K562 (myelogenous leukemia)	PEAKS050983
EXP044750	39875	Homo sapiens		EXP010906	880	normal	Q15910	B-cells	PEAKS044737
EXP044751	F1804	Homo sapiens		EXP039140	430	normal	Q8N7H5	HepG2 (hepatoblastoma)	PEAKS044738
EXP044752	HPA000815	Homo sapiens		EXP039161	10	normal	Q969R5	HEK293T (embryonic kidney)	PEAKS044739
EXP044753	39875,39639	Homo sapiens		EXP010775	376	normal	Q15910	WA01 (H1, human embryonic stem cells)	PEAKS044740
EXP044754	39875	Homo sapiens		EXP010730	918	normal	Q15910	myotube	PEAKS044741
EXP044755	39875	Homo sapiens		EXP010573	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS044742
EXP044756	sc-17824	Homo sapiens		EXP039275	879	normal	P08047	liver	PEAKS044743
EXP044757	05-689	Homo sapiens		EXP010775	376	normal	P45973	WA01 (H1, human embryonic stem cells)	PEAKS044744
EXP044758	39875	Homo sapiens		EXP010656	423	normal	Q15910	HeLa S3 (cervical adenocarcinoma)	PEAKS044745
EXP044759	39875	Homo sapiens		EXP010404	220	normal	Q15910	DND41 (acute lymphoblastic leukemia)	PEAKS044746
EXP054073	PCAF (Bethyl Laboratories, A301-666A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q92831	K562 (myelogenous leukemia)	PEAKS051004
EXP054071	RNF2 (Bethyl Laboratories, A302-869A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q99496	K562 (myelogenous leukemia)	PEAKS051002
EXP044762	A300-135A	Homo sapiens		EXP039020	430	normal	Q13315	HepG2 (hepatoblastoma)	PEAKS044749
EXP054070	SIRT6 (abcam, ab48192)	Homo sapiens	Treatment: None;	NULL	514	normal	Q8N6T7	K562 (myelogenous leukemia)	PEAKS051001
EXP054069	SUZ12 (Millipore, 05-1317)	Homo sapiens	Treatment: None;	NULL	514	normal	Q15022	K562 (myelogenous leukemia)	PEAKS051000
EXP044765	RN025P	Homo sapiens		EXP044604	514	normal	Q15366	K562 (myelogenous leukemia)	PEAKS044752
EXP054066	CHD4  (Bethyl Laboratories, A301-081A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q14839	K562 (myelogenous leukemia)	PEAKS050997
EXP054062	HDAC6 (Bethyl Laboratories, A301-341A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9UBN7	K562 (myelogenous leukemia)	PEAKS050993
EXP054065	PHF8 (Bethyl Laboratories, A301-772A)	Homo sapiens	Treatment: None;	NULL	974	normal	Q9UPP1	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS050996
EXP054078	HDAC6 (Bethyl Laboratories, A301-341A)	Homo sapiens	Treatment: None;	NULL	376	normal	Q9UBN7	WA01 (H1, human embryonic stem cells)	PEAKS051009
EXP054081	CBP (Santa Cruz Biotechnology, sc-369)	Homo sapiens	Treatment: None;	NULL	514	normal	Q92793	K562 (myelogenous leukemia)	PEAKS051012
EXP054074	CBX2 (Bethyl Laboratories, A302-524A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q14781	K562 (myelogenous leukemia)	PEAKS051005
EXP054079	SAP30 (Active Motif, 39731)	Homo sapiens	Treatment: None;	NULL	376	normal	O75446	WA01 (H1, human embryonic stem cells)	PEAKS051010
EXP044773	F1804	Homo sapiens		EXP039140	430	normal	Q7RTV0	HepG2 (hepatoblastoma)	PEAKS044760
EXP054080	SUZ12 (Millipore, 05-1317)	Homo sapiens	Treatment: None;	NULL	376	normal	Q15022	WA01 (H1, human embryonic stem cells)	PEAKS051011
EXP054077	LSD1 (Bethyl Laboratories, A300-215A)	Homo sapiens	Treatment: None;	NULL	514	normal	O60341	K562 (myelogenous leukemia)	PEAKS051008
EXP054075	CBX3 (Santa Cruz Biotechnology, SC-101004)	Homo sapiens	Treatment: None;	NULL	514	normal	Q13185	K562 (myelogenous leukemia)	PEAKS051006
EXP054076	CBX8 (Bethyl Laboratories, A300-882A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9HC52	K562 (myelogenous leukemia)	PEAKS051007
EXP044778	HPA001429	Homo sapiens		EXP039020	430	normal	O60934	HepG2 (hepatoblastoma)	PEAKS044765
EXP044779	ab290	Homo sapiens		EXP039092	421	normal	Q8TBC5	HEK293 (embryonic kidney)	PEAKS044766
EXP044780	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	O60216	A549 (lung carcinoma)	PEAKS044767
EXP044781	sc-585	Mus musculus		EXP044608	53	normal	B2RWS6	heart	PEAKS044768
EXP044782	3737S	Homo sapiens		EXP039106	514	normal	Q15022	K562 (myelogenous leukemia)	PEAKS044769
EXP044783	sc-585	Homo sapiens		EXP044606	1163	normal	Q09472	transverse colon	PEAKS044770
EXP044784	RN025P	Homo sapiens		EXP044668	430	normal	Q15366	HepG2 (hepatoblastoma)	PEAKS044771
EXP044785	HPA039874	Homo sapiens		EXP039020	430	normal	Q99623	HepG2 (hepatoblastoma)	PEAKS044772
EXP044786	T5327	Homo sapiens		EXP039220	356	normal	P26651	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044773
EXP044787	A300-864A	Homo sapiens		EXP044634	430	normal	O43251	HepG2 (hepatoblastoma)	PEAKS044774
EXP044788	F1804	Homo sapiens		EXP039140	430	normal	P14316	HepG2 (hepatoblastoma)	PEAKS044775
EXP044789	ab290	Homo sapiens		EXP039092	421	normal	Q8N446	HEK293 (embryonic kidney)	PEAKS044776
EXP044790	61719	Homo sapiens		EXP039034	514	normal	P25205	K562 (myelogenous leukemia)	PEAKS044777
EXP044791	F1804	Homo sapiens		EXP039140	430	normal	Q6PML9	HepG2 (hepatoblastoma)	PEAKS044778
EXP044792	5246BF	Homo sapiens		EXP040217	725	normal	Q15910	PC3(bone mets prostate adenocarcinoma)	PEAKS044779
EXP044793	ab109398	Homo sapiens		EXP039091	686	normal	Q15910	OCI-LY3 (diffuse large B-cell lymphoma)	PEAKS044780
EXP044794	T5327	Homo sapiens		EXP039036	430	normal	P26651	HepG2 (hepatoblastoma)	PEAKS044781
EXP044795	A300-027A	Homo sapiens		EXP039240	113	normal	P61201	MCF7 (Invasive ductal breast carcinoma)	PEAKS044782
EXP044796	A300-705A	Homo sapiens		EXP039132	38	normal	Q92769	A549 (lung carcinoma)	PEAKS044783
EXP044797	sc-110	Homo sapiens		EXP039302	879	normal	P18146	liver	PEAKS044784
EXP044798	39639	Homo sapiens		EXP040205	113	normal	Q15910	MCF7 (Invasive ductal breast carcinoma)	PEAKS044785
EXP044799	A300-215A	Homo sapiens		EXP039132	38	normal	O60341	A549 (lung carcinoma)	PEAKS044786
EXP044800	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 minute	EXP040216	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044787
EXP044801	39639	Homo sapiens		EXP044607	1180	normal	Q15910	neural cell	PEAKS044788
EXP044802	61537	Homo sapiens		EXP039034	514	normal	Q9H8M2	K562 (myelogenous leukemia)	PEAKS044789
EXP044803	RN019P	Homo sapiens		EXP044597	514	normal	P61978	K562 (myelogenous leukemia)	PEAKS044790
EXP044804	A300-656A	Homo sapiens		EXP039034	514	normal	Q99623	K562 (myelogenous leukemia)	PEAKS044791
EXP044805	ab290	Homo sapiens		EXP039092	421	normal	Q9BWE0	HEK293 (embryonic kidney)	PEAKS044792
EXP044806	A302-267A	Homo sapiens		EXP039076	356	normal	Q03111	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044793
EXP044807	A303-331A	Homo sapiens		EXP039216	514	normal	Q8IYH5	K562 (myelogenous leukemia)	PEAKS044794
EXP044808	GTX103229	Homo sapiens		EXP039240	113	normal	O60934	MCF7 (Invasive ductal breast carcinoma)	PEAKS044795
EXP044809	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	O60216	A549 (lung carcinoma)	PEAKS044796
EXP044810	ab109398	Homo sapiens		EXP039024	927	normal	Q15910	PC9 (lung adenocarcinoma)	PEAKS044797
EXP044811	ab992	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	O60216	A549 (lung carcinoma)	PEAKS044798
EXP044812	A300-705A	Homo sapiens		EXP039242	356	normal	Q92769	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044799
EXP044813	ab9263	Homo sapiens		EXP039081	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS044800
EXP044814	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044801
EXP044815	sc-585	Homo sapiens		EXP044650	1157	normal	Q09472	stomach	PEAKS044802
EXP044816	5053	Homo sapiens		EXP044590	514	normal	Q9UL18	K562 (myelogenous leukemia)	PEAKS044803
EXP044817	sc-585	Homo sapiens		EXP044653	1163	normal	Q09472	transverse colon	PEAKS044804
EXP044818	F1804	Homo sapiens		EXP039140	430	normal	Q9H5V7	HepG2 (hepatoblastoma)	PEAKS044805
EXP044819	ab109398	Homo sapiens		EXP040196	1184	normal	Q15910	GM23338	PEAKS044806
EXP044820	13/61725	Homo sapiens		EXP039034	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS044807
EXP044821	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	O60216	A549 (lung carcinoma)	PEAKS044808
EXP044822	612155	Homo sapiens		EXP039216	514	normal	Q12906	K562 (myelogenous leukemia)	PEAKS044809
EXP044823	A302-079A	Homo sapiens		EXP044665	430	normal	Q01081	HepG2 (hepatoblastoma)	PEAKS044810
EXP044824	F1804	Homo sapiens		EXP039140	430	normal	Q14919	HepG2 (hepatoblastoma)	PEAKS044811
EXP044825	5246S,5246BF	Homo sapiens		EXP044642	289	normal	Q15910	SK-N-MC (Askin tumor)	PEAKS044812
EXP044826	sc-585	Homo sapiens		EXP044589	1169	normal	Q09472	sigmoid colon	PEAKS044813
EXP044827	09-868	Homo sapiens		EXP039132	38	normal	Q9UPP1	A549 (lung carcinoma)	PEAKS044814
EXP044828	sc-71910	Homo sapiens		EXP010799	113	normal	P29590	MCF7 (Invasive ductal breast carcinoma)	PEAKS044815
EXP044829	sc-994	Homo sapiens		EXP010799	113	normal	Q96ST3	MCF7 (Invasive ductal breast carcinoma)	PEAKS044816
EXP044830	39533	Homo sapiens		EXP039034	514	normal	Q92769	K562 (myelogenous leukemia)	PEAKS044817
EXP044831	ab109398	Homo sapiens		EXP040203	665	normal	Q15910	SK-N-SH (neuroblastoma)	PEAKS044818
EXP044832	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044819
EXP044833	GTX100469	Homo sapiens		EXP039188	356	normal	Q06609	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044820
EXP044834	goat-anti-GFP-UC	Homo sapiens		EXP044594	514	normal	Q9BY41	K562 (myelogenous leukemia)	PEAKS044821
EXP044835	5246S	Homo sapiens		EXP039248	900	normal	Q15910	hepatocytes	PEAKS044822
EXP044836	RN081PW	Homo sapiens		EXP044613	430	normal	Q13242	HepG2 (hepatoblastoma)	PEAKS044823
EXP044837	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS044824
EXP044838	F1804	Homo sapiens		EXP039140	430	normal	O95201	HepG2 (hepatoblastoma)	PEAKS044825
EXP044839	sc-585	Homo sapiens		EXP044625	1129	normal	Q09472	suprapubic skin	PEAKS044826
EXP044840	ab109398	Homo sapiens		EXP040197	417	normal	Q15910	HCT-116 (colon carcinoma)	PEAKS044827
EXP044841	39639	Homo sapiens		EXP039024	927	normal	Q15910	PC9 (lung adenocarcinoma)	PEAKS044828
EXP044842	A300-285A	Homo sapiens		EXP039034	514	normal	Q6P1N0	K562 (myelogenous leukemia)	PEAKS044829
EXP044843	A300-882A	Homo sapiens		EXP010775	376	normal	Q9HC52	WA01 (H1, human embryonic stem cells)	PEAKS044830
EXP044844	sc-585	Homo sapiens		EXP044658	1179	normal	Q09472	tibial nerve	PEAKS044831
EXP044845	61222	Homo sapiens		EXP039086	514	normal	O94953	K562 (myelogenous leukemia)	PEAKS044832
EXP044846	A301-081A	Homo sapiens		EXP010781	430	normal	Q14839	HepG2 (hepatoblastoma)	PEAKS044833
EXP044847	ab290	Homo sapiens		EXP039092	421	normal	Q6ZNC4	HEK293 (embryonic kidney)	PEAKS044834
EXP044848	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	O60216	A549 (lung carcinoma)	PEAKS044835
EXP044849	sc-585	Homo sapiens		EXP044636	1129	normal	Q09472	suprapubic skin	PEAKS044836
EXP044850	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044837
EXP044851	A301-068A	Homo sapiens		EXP044619	514	normal	P49756	K562 (myelogenous leukemia)	PEAKS044838
EXP044852	A303-810A	Homo sapiens		EXP039216	514	normal	Q9HBM6	K562 (myelogenous leukemia)	PEAKS044839
EXP044853	sc-585	Homo sapiens		EXP044581	1150	normal	Q09472	ovary	PEAKS044840
EXP044854	A300-109A	Homo sapiens		EXP039242	356	normal	Q15291	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044841
EXP044855	201004	Homo sapiens		EXP044634	430	normal	P13010	HepG2 (hepatoblastoma)	PEAKS044842
EXP044856	A302-869A	Homo sapiens		EXP010775	376	normal	Q99496	WA01 (H1, human embryonic stem cells)	PEAKS044843
EXP044857	A301-459A	Homo sapiens		EXP039161	10	normal	Q6P4R8	HEK293T (embryonic kidney)	PEAKS044844
EXP044858	sc-585	Mus musculus		EXP010910	53	normal	B2RWS6	heart	PEAKS044845
EXP044859	sc-585	Mus musculus		EXP010789	117	normal	B2RWS6	Bruce4 (embryonic stem cells)	PEAKS044846
EXP044860	40967	Homo sapiens		EXP039034	514	normal	Q13547	K562 (myelogenous leukemia)	PEAKS044847
EXP044861	F1804	Homo sapiens		EXP039198	514	normal	P17036	K562 (myelogenous leukemia)	PEAKS044848
EXP044862	ARP40368_P050	Homo sapiens		EXP044630	514	normal	P14866	K562 (myelogenous leukemia)	PEAKS044849
EXP044863	39980	Homo sapiens		EXP039198	514	normal	P83916	K562 (myelogenous leukemia)	PEAKS044850
EXP044864	A301-460A	Homo sapiens		EXP039034	514	normal	Q6P4R8	K562 (myelogenous leukemia)	PEAKS044851
EXP044865	F1804	Homo sapiens		EXP039140	430	normal	P41161	HepG2 (hepatoblastoma)	PEAKS044852
EXP044866	eGFP	Homo sapiens		EXP044600	514	normal	Q9BY41	K562 (myelogenous leukemia)	PEAKS044853
EXP044867	A300-933A	Homo sapiens		EXP039132	38	normal	Q96KQ7	A549 (lung carcinoma)	PEAKS044854
EXP044868	A300-650A	Homo sapiens		EXP039034	514	normal	Q9UHI6	K562 (myelogenous leukemia)	PEAKS044855
EXP044869	A302-267A	Homo sapiens		EXP039074	113	normal	Q03111	MCF7 (Invasive ductal breast carcinoma)	PEAKS044856
EXP044870	TFIIIC-110 4286	Homo sapiens		EXP010597	514	normal	Q8WUA4	K562 (myelogenous leukemia)	PEAKS044857
EXP044871	sc-225	Homo sapiens		EXP010597	514	normal	Q00403	K562 (myelogenous leukemia)	PEAKS044858
EXP044872	C8741	Homo sapiens		EXP039046	113	normal	Q13363	MCF7 (Invasive ductal breast carcinoma)	PEAKS044859
EXP044873	NB100-61076	Homo sapiens		EXP010597	514	normal	Q15651	K562 (myelogenous leukemia)	PEAKS044860
EXP044874	4295	Homo sapiens		EXP010597	514	normal	Q9HAW0	K562 (myelogenous leukemia)	PEAKS044861
EXP044875	ab48192	Homo sapiens		EXP010597	514	normal	Q8N6T7	K562 (myelogenous leukemia)	PEAKS044862
EXP044876	128	Homo sapiens		EXP010597	514	normal	Q92994	K562 (myelogenous leukemia)	PEAKS044863
EXP044877	2663	Homo sapiens		EXP010597	514	normal	A6H8Y1	K562 (myelogenous leukemia)	PEAKS044864
EXP044878	sc-585	Homo sapiens		EXP044645	1179	normal	Q09472	tibial nerve	PEAKS044865
EXP044879	sc-585	Homo sapiens		EXP044626	1129	normal	Q09472	suprapubic skin	PEAKS044866
EXP044880	ZZZ3	Homo sapiens		EXP010027	423	normal	Q8IYH5	HeLa S3 (cervical adenocarcinoma)	PEAKS044867
EXP044881	ZZZ3	Homo sapiens		EXP010122	356	normal	Q8IYH5	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044868
EXP044882	128	Homo sapiens		EXP010027	423	normal	Q92994	HeLa S3 (cervical adenocarcinoma)	PEAKS044869
EXP044883	2663	Homo sapiens		EXP010027	423	normal	A6H8Y1	HeLa S3 (cervical adenocarcinoma)	PEAKS044870
EXP044884	4295	Homo sapiens		EXP010027	423	normal	Q9HAW0	HeLa S3 (cervical adenocarcinoma)	PEAKS044871
EXP044885	TFIIIC-110 4286	Homo sapiens		EXP010027	423	normal	Q8WUA4	HeLa S3 (cervical adenocarcinoma)	PEAKS044872
EXP044886	sc-12419	Homo sapiens		EXP010597	514	normal	O60583	K562 (myelogenous leukemia)	PEAKS044873
EXP044887	A301-672A	Homo sapiens		EXP039034	514	normal	Q6W2J9	K562 (myelogenous leukemia)	PEAKS044874
EXP044888	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044875
EXP044889	2676	Homo sapiens		EXP010122	356	normal	Q92830	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044876
EXP044890	SPT20 (3006)	Homo sapiens		EXP010122	356	normal	Q8NEM7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044877
EXP044891	sc-585	Homo sapiens		EXP044588	1140	normal	Q09472	subcutaneous adipose tissue	PEAKS044878
EXP044892	A300-650A	Homo sapiens		EXP039240	113	normal	Q9UHI6	MCF7 (Invasive ductal breast carcinoma)	PEAKS044879
EXP044893	NB100-68209	Homo sapiens		EXP039036	430	normal	P51610	HepG2 (hepatoblastoma)	PEAKS044880
EXP044894	RN019P	Homo sapiens		EXP044612	430	normal	P61978	HepG2 (hepatoblastoma)	PEAKS044881
EXP044895	A303-607A	Homo sapiens		EXP039034	514	normal	Q15645	K562 (myelogenous leukemia)	PEAKS044882
EXP044896	ab290	Homo sapiens		EXP039092	421	normal	Q9BV97	HEK293 (embryonic kidney)	PEAKS044883
EXP044897	A300-712A	Homo sapiens		EXP039034	514	normal	Q13547	K562 (myelogenous leukemia)	PEAKS044884
EXP044898	ab992	Homo sapiens		EXP039108	1180	normal	O60216	neural cell	PEAKS044885
EXP044899	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 25 minute	EXP040199	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044886
EXP044900	A300-609A	Homo sapiens		EXP039034	514	normal	Q9NYF8	K562 (myelogenous leukemia)	PEAKS044887
EXP044901	A302-531A	Homo sapiens		EXP039077	514	normal	Q9BVI0	K562 (myelogenous leukemia)	PEAKS044888
EXP044902	A5016	Homo sapiens		EXP044669	430	normal	Q6UN15	HepG2 (hepatoblastoma)	PEAKS044889
EXP044903	ab992	Homo sapiens		EXP010769	38	normal	O60216	A549 (lung carcinoma)	PEAKS044890
EXP044904	ab9263	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS044891
EXP044905	C8741	Homo sapiens		EXP039232	10	normal	Q13363	HEK293T (embryonic kidney)	PEAKS044892
EXP044906	sc-585	Mus musculus		EXP044663	561	normal	B2RWS6	lung	PEAKS044893
EXP044907	A300-195A	Homo sapiens		EXP039034	514	normal	P33992	K562 (myelogenous leukemia)	PEAKS044894
EXP044908	A300-713A	Homo sapiens		EXP039034	514	normal	Q13547	K562 (myelogenous leukemia)	PEAKS044895
EXP044909	NB100-61057	Homo sapiens		EXP039167	423	normal	P35659	HeLa S3 (cervical adenocarcinoma)	PEAKS044896
EXP044910	3737BF	Homo sapiens		EXP039242	356	normal	Q15022	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044897
EXP044911	A300-275A	Homo sapiens		EXP039034	514	normal	Q13263	K562 (myelogenous leukemia)	PEAKS044898
EXP044912	ab28179	Homo sapiens		EXP039046	113	normal	P35269	MCF7 (Invasive ductal breast carcinoma)	PEAKS044899
EXP044913	ab109398	Homo sapiens		EXP039107	221	normal	Q15910	DOHH2 (diffuse large B-cell lymphoma)	PEAKS044900
EXP044914	A300-411A	Homo sapiens		EXP039216	514	normal	Q14686	K562 (myelogenous leukemia)	PEAKS044901
EXP044915	ab290	Homo sapiens		EXP039092	421	normal	Q96BR9	HEK293 (embryonic kidney)	PEAKS044902
EXP044916	A301-459A	Homo sapiens		EXP039240	113	normal	Q6P4R8	MCF7 (Invasive ductal breast carcinoma)	PEAKS044903
EXP044917	goat-anti-GFP-UC	Homo sapiens		EXP044627	514	normal	Q9UHI6	K562 (myelogenous leukemia)	PEAKS044904
EXP044918	A301-459A	Homo sapiens		EXP039034	514	normal	Q6P4R8	K562 (myelogenous leukemia)	PEAKS044905
EXP044919	ab68480	Homo sapiens		EXP044664	514	normal	Q9BUJ2	K562 (myelogenous leukemia)	PEAKS044906
EXP044920	ab290	Homo sapiens		EXP039092	421	normal	Q96DT7	HEK293 (embryonic kidney)	PEAKS044907
EXP044921	40968	Homo sapiens		EXP039216	514	normal	O15379	K562 (myelogenous leukemia)	PEAKS044908
EXP044922	sc-585	Homo sapiens		EXP044598	1169	normal	Q09472	sigmoid colon	PEAKS044909
EXP044923	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044910
EXP044924	A304-216A	Homo sapiens		EXP039216	514	normal	Q96JM3	K562 (myelogenous leukemia)	PEAKS044911
EXP044925	sc-585	Homo sapiens		EXP044591	1175	normal	Q09472	prostate gland	PEAKS044912
EXP044926	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 20 minute	EXP040219	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044913
EXP044927	sc-585	Homo sapiens		EXP044595	1158	normal	Q09472	vagina	PEAKS044914
EXP044928	ab10483	Homo sapiens		EXP044583	421	normal	Q13263	HEK293 (embryonic kidney)	PEAKS044915
EXP044929	39977	Homo sapiens		EXP010918	356	normal	P45973	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044916
EXP044930	A300-815A	Homo sapiens		EXP039034	514	normal	O15164	K562 (myelogenous leukemia)	PEAKS044917
EXP044931	A302-268A	Homo sapiens		EXP039034	514	normal	Q03111	K562 (myelogenous leukemia)	PEAKS044918
EXP044932	sc-585	Homo sapiens		EXP044651	440	normal	Q09472	HMEC (human mammary epithelial cells)	PEAKS044919
EXP044933	F1804	Homo sapiens		EXP039140	430	normal	O95251	HepG2 (hepatoblastoma)	PEAKS044920
EXP044934	ab10480	Homo sapiens		EXP039242	356	normal	Q13185	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044921
EXP044935	sc-25388	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039289	1145	normal	P37275	bipolar neuron	PEAKS044922
EXP044936	GTX106820	Homo sapiens		EXP039163	356	normal	Q13951	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044923
EXP044937	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	O60216	A549 (lung carcinoma)	PEAKS044924
EXP044938	ab68301	Homo sapiens		EXP039199	665	normal	O14647	SK-N-SH (neuroblastoma)	PEAKS044925
EXP044939	A300-371A	Homo sapiens		EXP039240	113	normal	Q8TAD8	MCF7 (Invasive ductal breast carcinoma)	PEAKS044926
EXP044940	A300-000A	Homo sapiens		EXP039216	514	normal	P38398	K562 (myelogenous leukemia)	PEAKS044927
EXP044941	RN011P	Homo sapiens		EXP044656	430	normal	P26599	HepG2 (hepatoblastoma)	PEAKS044928
EXP044942	ab109398	Homo sapiens		EXP039248	900	normal	Q15910	hepatocytes	PEAKS044929
EXP044943	sc-585	Homo sapiens		EXP044670	440	normal	Q09472	HMEC (human mammary epithelial cells)	PEAKS044930
EXP044944	A300-489A	Homo sapiens		EXP010781	430	normal	Q9UBL3	HepG2 (hepatoblastoma)	PEAKS044931
EXP044945	2676	Mus musculus		EXP010613	1144	normal	Q9JHD2	CH12.LX (Mouse lymphoma)	PEAKS044932
EXP044946	NB100-60411	Mus musculus		EXP010613	1144	normal	P40201	CH12.LX (Mouse lymphoma)	PEAKS044933
EXP044947	NB600-1263	Mus musculus		EXP010613	1144	normal	Q60520	CH12.LX (Mouse lymphoma)	PEAKS044934
EXP044948	goat-anti-GFP-UC	Homo sapiens		EXP044633	514	normal	Q9BRQ0	K562 (myelogenous leukemia)	PEAKS044935
EXP044949	NB100-74650	Mus musculus		EXP010613	1144	normal	Q6NZF1	CH12.LX (Mouse lymphoma)	PEAKS044936
EXP044950	NB100-68209	Mus musculus		EXP010613	1144	normal	Q61191	CH12.LX (Mouse lymphoma)	PEAKS044937
EXP044951	ab65767	Mus musculus		EXP010613	1144	normal	Q6P1E1	CH12.LX (Mouse lymphoma)	PEAKS044938
EXP044952	NB100-74650	Mus musculus		EXP010793	230	normal	Q6NZF1	ES-E14 (E14, embryonic stem cells)	PEAKS044939
EXP044953	NB100-68209	Mus musculus		EXP010793	230	normal	Q61191	ES-E14 (E14, embryonic stem cells)	PEAKS044940
EXP044954	sc-585	Homo sapiens		EXP044637	1167	normal	Q09472	esophagus muscularis mucosa	PEAKS044941
EXP044955	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044942
EXP044956	ab68301	Mus musculus		EXP010613	1144	normal	E9PZM4	CH12.LX (Mouse lymphoma)	PEAKS044943
EXP044957	ab9263	Mus musculus		EXP010613	1144	normal	Q9CW03	CH12.LX (Mouse lymphoma)	PEAKS044944
EXP044958	sc-32912	Mus musculus		EXP010613	1144	normal	P19426	CH12.LX (Mouse lymphoma)	PEAKS044945
EXP044959	ab992	Mus musculus		EXP010613	1144	normal	Q61550	CH12.LX (Mouse lymphoma)	PEAKS044946
EXP044960	sc-584	Mus musculus		EXP010613	1144	normal	B2RWS6	CH12.LX (Mouse lymphoma)	PEAKS044947
EXP044961	sc-585	Homo sapiens		EXP044618	1156	normal	Q09472	gastroesophageal sphincter	PEAKS044948
EXP044962	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 minute	EXP040212	38	normal	Q09472	A549 (lung carcinoma)	PEAKS044949
EXP044963	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS044950
EXP044964	ab10483	Homo sapiens		EXP010651	421	normal	Q13263	HEK293 (embryonic kidney)	PEAKS044951
EXP044965	A301-112A	Homo sapiens		EXP044619	514	normal	Q14151	K562 (myelogenous leukemia)	PEAKS044952
EXP044966	SUZ12	Homo sapiens		EXP010587	376	normal	Q15022	WA01 (H1, human embryonic stem cells)	PEAKS044953
EXP044967	612044	Homo sapiens		EXP010587	376	normal	P56545	WA01 (H1, human embryonic stem cells)	PEAKS044954
EXP044968	ab10483	Homo sapiens		EXP010823	514	normal	Q13263	K562 (myelogenous leukemia)	PEAKS044955
EXP044969	39548	Homo sapiens		EXP039022	514	normal	Q9UBB5	K562 (myelogenous leukemia)	PEAKS044956
EXP044970	200093	Homo sapiens		EXP044664	514	normal	Q8N163	K562 (myelogenous leukemia)	PEAKS044957
EXP044971	6964S	Homo sapiens		EXP039106	514	normal	P35226	K562 (myelogenous leukemia)	PEAKS044958
EXP044972	11231-1-AP	Homo sapiens		EXP010823	514	normal	Q15047	K562 (myelogenous leukemia)	PEAKS044959
EXP044973	3737S	Homo sapiens		EXP039161	10	normal	Q15022	HEK293T (embryonic kidney)	PEAKS044960
EXP044974	sc-9571	Homo sapiens		EXP044665	430	normal	P08621	HepG2 (hepatoblastoma)	PEAKS044961
EXP044975	NB600-1263	Mus musculus		EXP010644	1174	normal	Q60520	MEL cell line	PEAKS044962
EXP044976	NB100-68209	Mus musculus		EXP010644	1174	normal	Q61191	MEL cell line	PEAKS044963
EXP044977	ab65767	Mus musculus		EXP010644	1174	normal	Q6P1E1	MEL cell line	PEAKS044964
EXP044978	NB100-74650	Mus musculus		EXP010644	1174	normal	Q6NZF1	MEL cell line	PEAKS044965
EXP044979	2676	Mus musculus		EXP010644	1174	normal	Q9JHD2	MEL cell line	PEAKS044966
EXP044980	NB100-60411	Mus musculus		EXP010644	1174	normal	P40201	MEL cell line	PEAKS044967
EXP044981	sc-584	Mus musculus		EXP010644	1174	normal	B2RWS6	MEL cell line	PEAKS044968
EXP044982	ab9263	Mus musculus		EXP010644	1174	normal	Q9CW03	MEL cell line	PEAKS044969
EXP044983	sc-585	Mus musculus		EXP010644	1174	normal	B2RWS6	MEL cell line	PEAKS044970
EXP044984	A301-545A	Homo sapiens		EXP039034	514	normal	Q5VUA4	K562 (myelogenous leukemia)	PEAKS044971
EXP044985	ab68301	Mus musculus		EXP010644	1174	normal	E9PZM4	MEL cell line	PEAKS044972
EXP044986	ab992	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010644	1174	normal	Q61550	MEL cell line	PEAKS044973
EXP044987	sc-32912	Mus musculus		EXP010644	1174	normal	P19426	MEL cell line	PEAKS044974
EXP044988	goat-anti-GFP-UC	Homo sapiens		EXP044629	514	normal	Q15545	K562 (myelogenous leukemia)	PEAKS044975
EXP044989	ab992	Mus musculus		EXP010644	1174	normal	Q61550	MEL cell line	PEAKS044976
EXP044990	sc-17796	Homo sapiens		EXP010725	423	normal	P51532	HeLa S3 (cervical adenocarcinoma)	PEAKS044977
EXP044991	6964S	Homo sapiens		EXP039074	113	normal	P35226	MCF7 (Invasive ductal breast carcinoma)	PEAKS044978
EXP044992	SUZ12	Homo sapiens		EXP010048	244	normal	Q15022	NT2-D1 (embryonic carcinoma)	PEAKS044979
EXP044993	11231-1-AP	Homo sapiens		EXP010823	514	normal	Q15047	K562 (myelogenous leukemia)	PEAKS044980
EXP044994	5246S,39639	Homo sapiens		EXP040214	887	normal	Q15910	neural progenitors	PEAKS044981
EXP044995	HPA003575	Homo sapiens		EXP039076	356	normal	Q8IYM9	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044982
EXP044996	sc-585	Homo sapiens		EXP039108	1180	normal	Q09472	neural cell	PEAKS044983
EXP044997	sc-9140	Homo sapiens		EXP039114	430	normal	P12755	HepG2 (hepatoblastoma)	PEAKS044984
EXP044998	sc-585	Homo sapiens		EXP044646	1181	normal	Q09472	upper lobe of left lung	PEAKS044985
EXP044999	A300-291A	Homo sapiens		EXP039290	430	normal	Q14498	HepG2 (hepatoblastoma)	PEAKS044986
EXP045000	A302-344A	Homo sapiens		EXP039034	514	normal	P51825	K562 (myelogenous leukemia)	PEAKS044987
EXP045001	sc-585	Homo sapiens		EXP010745	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044988
EXP045002	sc-584	Homo sapiens		EXP010834	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044989
EXP045003	A301-218A	Homo sapiens		EXP010834	356	normal	O14646	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044990
EXP045004	SAB2100398	Homo sapiens		EXP039106	514	normal	Q03701	K562 (myelogenous leukemia)	PEAKS044991
EXP045005	ab24550	Homo sapiens		EXP010834	356	normal	Q9BZK7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044992
EXP045006	NB600-1263	Homo sapiens		EXP010834	356	normal	Q96ST3	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044993
EXP045007	ab9263	Homo sapiens		EXP010834	356	normal	Q9UQE7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044994
EXP045008	A300-000A	Homo sapiens		EXP010834	356	normal	P38398	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044995
EXP045009	ab68301	Homo sapiens		EXP010834	356	normal	O14647	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044996
EXP045010	ab992	Homo sapiens		EXP010834	356	normal	O60216	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044997
EXP045011	A300-291A	Homo sapiens		EXP044664	514	normal	Q14498	K562 (myelogenous leukemia)	PEAKS044998
EXP045012	ab4731	Homo sapiens		EXP010834	356	normal	Q96S55	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS044999
EXP045013	ab992	Homo sapiens		EXP039275	879	normal	O60216	liver	PEAKS045000
EXP045014	NB600-1263	Homo sapiens		EXP010714	376	normal	Q96ST3	WA01 (H1, human embryonic stem cells)	PEAKS045001
EXP045015	ab28179	Homo sapiens		EXP010714	376	normal	P35269	WA01 (H1, human embryonic stem cells)	PEAKS045002
EXP045016	A303-555A	Homo sapiens		EXP039077	514	normal	Q9UI36	K562 (myelogenous leukemia)	PEAKS045003
EXP045017	A300-371A	Homo sapiens		EXP039034	514	normal	Q8TAD8	K562 (myelogenous leukemia)	PEAKS045004
EXP045018	11231-1-AP	Homo sapiens		EXP044583	421	normal	Q15047	HEK293 (embryonic kidney)	PEAKS045005
EXP045019	A300-489A	Homo sapiens		EXP010775	376	normal	Q9UBL3	WA01 (H1, human embryonic stem cells)	PEAKS045006
EXP045020	A303-148A	Homo sapiens		EXP039077	514	normal	Q9UHK0	K562 (myelogenous leukemia)	PEAKS045007
EXP045021	sc-553	Homo sapiens		EXP039095	879	normal	P19793	liver	PEAKS045008
EXP045022	ab992	Homo sapiens		EXP010255	430	normal	O60216	HepG2 (hepatoblastoma)	PEAKS045009
EXP045023	sc-13067	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	normal	Q9UBK2	HepG2 (hepatoblastoma)	PEAKS045010
EXP045024	NB600-1263	Homo sapiens		EXP039118	38	normal	Q96ST3	A549 (lung carcinoma)	PEAKS045011
EXP045025	A300-000A	Homo sapiens		EXP010255	430	normal	P38398	HepG2 (hepatoblastoma)	PEAKS045012
EXP045026	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	O60216	A549 (lung carcinoma)	PEAKS045013
EXP045027	sc-584	Homo sapiens		EXP010255	430	normal	Q09472	HepG2 (hepatoblastoma)	PEAKS045014
EXP045028	ab9263	Homo sapiens		EXP010255	430	normal	Q9UQE7	HepG2 (hepatoblastoma)	PEAKS045015
EXP045029	ab68301	Homo sapiens		EXP010255	430	normal	O14647	HepG2 (hepatoblastoma)	PEAKS045016
EXP045030	ab992	Homo sapiens		EXP010066	489	normal	O60216	IMR90 (lung fibroblasts)	PEAKS045017
EXP045031	NB100-68209	Homo sapiens		EXP010530	514	normal	P51610	K562 (myelogenous leukemia)	PEAKS045018
EXP045032	NB100-74650	Homo sapiens		EXP010530	514	normal	O75152	K562 (myelogenous leukemia)	PEAKS045019
EXP045033	ab65767	Homo sapiens		EXP010530	514	normal	Q9ULJ6	K562 (myelogenous leukemia)	PEAKS045020
EXP045034	NB100-60411	Homo sapiens		EXP010066	489	normal	O14646	IMR90 (lung fibroblasts)	PEAKS045021
EXP045035	NB100-68209	Homo sapiens		EXP010054	423	normal	P51610	HeLa S3 (cervical adenocarcinoma)	PEAKS045022
EXP045036	ab992	Homo sapiens		EXP010714	376	normal	O60216	WA01 (H1, human embryonic stem cells)	PEAKS045023
EXP045037	ab68301	Homo sapiens		EXP010054	423	normal	O14647	HeLa S3 (cervical adenocarcinoma)	PEAKS045024
EXP045038	ab9263	Homo sapiens		EXP010054	423	normal	Q9UQE7	HeLa S3 (cervical adenocarcinoma)	PEAKS045025
EXP045039	SPT20 (3006)	Homo sapiens		EXP010027	423	normal	Q8NEM7	HeLa S3 (cervical adenocarcinoma)	PEAKS045026
EXP045040	2676	Homo sapiens		EXP010027	423	normal	Q92830	HeLa S3 (cervical adenocarcinoma)	PEAKS045027
EXP045041	ab68301	Homo sapiens		EXP010714	376	normal	O14647	WA01 (H1, human embryonic stem cells)	PEAKS045028
EXP045042	HPA008472	Homo sapiens		EXP039188	356	normal	P12757	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045029
EXP045043	A301-218A	Homo sapiens		EXP010714	376	normal	O14646	WA01 (H1, human embryonic stem cells)	PEAKS045030
EXP045044	9313S	Homo sapiens		EXP039076	356	normal	P06400	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045031
EXP045045	A300-000A	Homo sapiens		EXP010714	376	normal	P38398	WA01 (H1, human embryonic stem cells)	PEAKS045032
EXP045046	F1804	Homo sapiens		EXP039140	430	normal	Q9H334	HepG2 (hepatoblastoma)	PEAKS045033
EXP045047	sc-16189	Homo sapiens		EXP010725	423	normal	Q12824	HeLa S3 (cervical adenocarcinoma)	PEAKS045034
EXP045048	ab109398	Homo sapiens		EXP039110	687	normal	Q15910	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS045035
EXP045049	SAB2100398	Homo sapiens		EXP010255	430	normal	Q03701	HepG2 (hepatoblastoma)	PEAKS045036
EXP045050	sc-585	Homo sapiens		EXP044654	1167	normal	Q09472	esophagus muscularis mucosa	PEAKS045037
EXP045051	A303-596A	Homo sapiens		EXP039188	356	normal	Q92785	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045038
EXP045052	sc-584	Homo sapiens		EXP010054	423	normal	Q09472	HeLa S3 (cervical adenocarcinoma)	PEAKS045039
EXP045053	ab28179	Homo sapiens		EXP010054	423	normal	P35269	HeLa S3 (cervical adenocarcinoma)	PEAKS045040
EXP045054	ab109398	Homo sapiens		EXP039053	1095	normal	Q15910	Loucy (adult T acute lymphoblastic leukemia)	PEAKS045041
EXP045055	ab992	Homo sapiens		EXP010054	423	normal	O60216	HeLa S3 (cervical adenocarcinoma)	PEAKS045042
EXP045056	A300-000A	Homo sapiens		EXP010054	423	normal	P38398	HeLa S3 (cervical adenocarcinoma)	PEAKS045043
EXP045057	ab290	Homo sapiens		EXP039092	421	normal	Q96MN9	HEK293 (embryonic kidney)	PEAKS045044
EXP045058	11/61721	Homo sapiens		EXP039034	514	normal	P33992	K562 (myelogenous leukemia)	PEAKS045045
EXP045059	ab109398	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039252	1145	normal	Q15910	bipolar neuron	PEAKS045046
EXP045060	F1804	Homo sapiens		EXP039140	430	normal	Q9H0E3	HepG2 (hepatoblastoma)	PEAKS045047
EXP045061	sc-585	Homo sapiens		EXP039167	423	normal	Q09472	HeLa S3 (cervical adenocarcinoma)	PEAKS045048
EXP045062	ab9263	Homo sapiens		EXP010530	514	normal	Q9UQE7	K562 (myelogenous leukemia)	PEAKS045049
EXP045063	ab24550	Homo sapiens		EXP010530	514	normal	Q9BZK7	K562 (myelogenous leukemia)	PEAKS045050
EXP045064	NB600-270	Homo sapiens		EXP010530	514	normal	Q9BZK7	K562 (myelogenous leukemia)	PEAKS045051
EXP045065	sc-585	Homo sapiens		EXP010530	514	normal	Q09472	K562 (myelogenous leukemia)	PEAKS045052
EXP045066	sc-16189	Homo sapiens		EXP010630	514	normal	Q12824	K562 (myelogenous leukemia)	PEAKS045053
EXP045067	sc-17796	Homo sapiens		EXP010630	514	normal	P51532	K562 (myelogenous leukemia)	PEAKS045054
EXP045068	ab992	Homo sapiens		EXP010911	665	normal	O60216	SK-N-SH (neuroblastoma)	PEAKS045055
EXP045069	sc-584	Homo sapiens		EXP010911	665	normal	Q09472	SK-N-SH (neuroblastoma)	PEAKS045056
EXP045070	ab9263	Homo sapiens		EXP010911	665	normal	Q9UQE7	SK-N-SH (neuroblastoma)	PEAKS045057
EXP045071	sc-48343	Homo sapiens		EXP010530	514	normal	Q09472	K562 (myelogenous leukemia)	PEAKS045058
EXP045072	ab68301	Homo sapiens		EXP010530	514	normal	O14647	K562 (myelogenous leukemia)	PEAKS045059
EXP045073	ab28179	Homo sapiens		EXP010530	514	normal	P35269	K562 (myelogenous leukemia)	PEAKS045060
EXP045074	F1804	Homo sapiens		EXP039140	430	normal	P24278	HepG2 (hepatoblastoma)	PEAKS045061
EXP045075	sc-585	Mus musculus		EXP044666	5	normal	B2RWS6	liver	PEAKS045062
EXP045076	HPA028794	Homo sapiens		EXP039020	430	normal	Q8N3X6	HepG2 (hepatoblastoma)	PEAKS045063
EXP045077	ab109398	Homo sapiens		EXP044640	1419	normal	Q15910	GM23248	PEAKS045064
EXP045078	3737S	Homo sapiens		EXP039074	113	normal	Q15022	MCF7 (Invasive ductal breast carcinoma)	PEAKS045065
EXP045079	F1804	Homo sapiens		EXP039140	430	normal	Q8N883	HepG2 (hepatoblastoma)	PEAKS045066
EXP045080	A303-603A	Homo sapiens		EXP039077	514	normal	Q96BD5	K562 (myelogenous leukemia)	PEAKS045067
EXP045081	3378S	Homo sapiens		EXP039036	430	normal	Q92831	HepG2 (hepatoblastoma)	PEAKS045068
EXP045082	A303-170A	Homo sapiens		EXP039161	10	normal	P51858	HEK293T (embryonic kidney)	PEAKS045069
EXP045083	NB100-68209	Homo sapiens		EXP039046	113	normal	P51610	MCF7 (Invasive ductal breast carcinoma)	PEAKS045070
EXP045084	JH39.2.2F10	Homo sapiens		EXP039159	430	normal	Q14202	HepG2 (hepatoblastoma)	PEAKS045071
EXP045085	RN093PW	Homo sapiens		EXP044668	430	normal	O43172	HepG2 (hepatoblastoma)	PEAKS045072
EXP045086	sc-13145	Homo sapiens		EXP039036	430	normal	O75182	HepG2 (hepatoblastoma)	PEAKS045073
EXP045087	A304-217A	Homo sapiens		EXP039034	514	normal	Q96JM3	K562 (myelogenous leukemia)	PEAKS045074
EXP045088	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045075
EXP045089	HPA017013	Homo sapiens		EXP039074	113	normal	O43670	MCF7 (Invasive ductal breast carcinoma)	PEAKS045076
EXP045090	A300-813A	Homo sapiens		EXP039034	514	normal	P51532	K562 (myelogenous leukemia)	PEAKS045077
EXP045091	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045078
EXP045092	5694S	Homo sapiens		EXP039106	514	normal	Q99496	K562 (myelogenous leukemia)	PEAKS045079
EXP045093	A300-608A	Homo sapiens		EXP039188	356	normal	Q9NYF8	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045080
EXP045094	A303-877A	Homo sapiens		EXP039034	514	normal	P51532	K562 (myelogenous leukemia)	PEAKS045081
EXP045095	6964S	Homo sapiens		EXP039188	356	normal	P35226	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045082
EXP045096	5694S	Homo sapiens		EXP039114	430	normal	Q99496	HepG2 (hepatoblastoma)	PEAKS045083
EXP045097	goat-anti-GFP-UC	Homo sapiens		EXP044624	514	normal	Q6NZI2	K562 (myelogenous leukemia)	PEAKS045084
EXP045098	sc-585	Homo sapiens		EXP044605	1158	normal	Q09472	vagina	PEAKS045085
EXP045099	201004	Homo sapiens		EXP044648	514	normal	P13010	K562 (myelogenous leukemia)	PEAKS045086
EXP045100	5246S,39639	Homo sapiens		EXP040204	288	normal	Q15910	A673 (Ewing sarcoma)	PEAKS045087
EXP045101	A303-665A	Homo sapiens		EXP044665	430	normal	P26368	HepG2 (hepatoblastoma)	PEAKS045088
EXP045102	A301-940A	Homo sapiens		EXP039020	430	normal	O43660	HepG2 (hepatoblastoma)	PEAKS045089
EXP045103	RN046PW	Homo sapiens		EXP044656	430	normal	O60506	HepG2 (hepatoblastoma)	PEAKS045090
EXP045104	A303-665A	Homo sapiens		EXP044664	514	normal	P26368	K562 (myelogenous leukemia)	PEAKS045091
EXP045105	HPA008472	Homo sapiens		EXP039034	514	normal	P12757	K562 (myelogenous leukemia)	PEAKS045092
EXP045106	A300-253A	Homo sapiens		EXP039216	514	normal	Q7Z589	K562 (myelogenous leukemia)	PEAKS045093
EXP045107	RN024P	Homo sapiens		EXP044665	430	normal	Q15365	HepG2 (hepatoblastoma)	PEAKS045094
EXP045108	A5016	Homo sapiens		EXP044616	514	normal	Q6UN15	K562 (myelogenous leukemia)	PEAKS045095
EXP045109	T1705	Homo sapiens		EXP039034	514	normal	Q13148	K562 (myelogenous leukemia)	PEAKS045096
EXP045110	61203	Homo sapiens		EXP044593	356	normal	O75530	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045097
EXP045111	A301-081A	Homo sapiens		EXP039242	356	normal	Q14839	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045098
EXP045112	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045099
EXP045113	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	O60216	A549 (lung carcinoma)	PEAKS045100
EXP045114	T1705	Homo sapiens		EXP039074	113	normal	Q13148	MCF7 (Invasive ductal breast carcinoma)	PEAKS045101
EXP045115	GTX114210	Homo sapiens		EXP039049	514	normal	Q13148	K562 (myelogenous leukemia)	PEAKS045102
EXP045116	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045103
EXP045117	F1804	Homo sapiens		EXP039140	430	normal	Q06330	HepG2 (hepatoblastoma)	PEAKS045104
EXP045118	RN011P	Homo sapiens		EXP044590	514	normal	P26599	K562 (myelogenous leukemia)	PEAKS045105
EXP045119	F1804	Homo sapiens		EXP039140	430	normal	Q9Y4C1	HepG2 (hepatoblastoma)	PEAKS045106
EXP045120	ab992	Homo sapiens		EXP010597	514	normal	O60216	K562 (myelogenous leukemia)	PEAKS045107
EXP045121	ab145	Homo sapiens		EXP010597	514	normal	Q13426	K562 (myelogenous leukemia)	PEAKS045108
EXP045122	A302-079A	Homo sapiens		EXP044664	514	normal	Q01081	K562 (myelogenous leukemia)	PEAKS045109
EXP045123	goat-anti-GFP-UC	Homo sapiens		EXP044641	514	normal	O95997	K562 (myelogenous leukemia)	PEAKS045110
EXP045124	A301-477A	Homo sapiens		EXP039216	514	normal	O94953	K562 (myelogenous leukemia)	PEAKS045111
EXP045125	RN079PW	Homo sapiens		EXP044644	514	normal	Q16629	K562 (myelogenous leukemia)	PEAKS045112
EXP045126	F1804	Homo sapiens		EXP039198	514	normal	Q15072	K562 (myelogenous leukemia)	PEAKS045113
EXP045127	sc-585	Homo sapiens		EXP044611	1169	normal	Q09472	sigmoid colon	PEAKS045114
EXP045128	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045115
EXP045129	C8741	Homo sapiens		EXP039034	514	normal	Q13363	K562 (myelogenous leukemia)	PEAKS045116
EXP045130	A300-027A	Homo sapiens		EXP039216	514	normal	P61201	K562 (myelogenous leukemia)	PEAKS045117
EXP045131	5246S,5246BF	Homo sapiens		EXP040197	417	normal	Q15910	HCT-116 (colon carcinoma)	PEAKS045118
EXP045132	A301-748A	Homo sapiens		EXP039034	514	normal	Q9NR48	K562 (myelogenous leukemia)	PEAKS045119
EXP045133	5246S,39639	Homo sapiens		EXP040213	685	normal	Q15910	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS045120
EXP045134	ab992	Homo sapiens		EXP039274	879	normal	O60216	liver	PEAKS045121
EXP045135	A303-595A	Homo sapiens		EXP039046	113	normal	Q92785	MCF7 (Invasive ductal breast carcinoma)	PEAKS045122
EXP045136	A300-864A	Homo sapiens		EXP044590	514	normal	O43251	K562 (myelogenous leukemia)	PEAKS045123
EXP045137	sc-585	Homo sapiens		EXP044602	1154	normal	Q09472	omental fat pad	PEAKS045124
EXP045138	sc-13145	Homo sapiens		EXP039216	514	normal	O75182	K562 (myelogenous leukemia)	PEAKS045125
EXP045139	A301-419A	Homo sapiens		EXP039216	514	normal	Q96NB3	K562 (myelogenous leukemia)	PEAKS045126
EXP045140	RN024P	Homo sapiens		EXP044604	514	normal	Q15365	K562 (myelogenous leukemia)	PEAKS045127
EXP045141	NRSF	Homo sapiens		EXP039134	1184	normal	Q13127	GM23338	PEAKS045128
EXP045142	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	O60216	A549 (lung carcinoma)	PEAKS045129
EXP045143	A300-956A	Homo sapiens		EXP039034	514	normal	Q9Y2W1	K562 (myelogenous leukemia)	PEAKS045130
EXP045144	sc-585	Homo sapiens		EXP044622	1163	normal	Q09472	transverse colon	PEAKS045131
EXP045145	sc-585	Mus musculus		EXP044601	810	normal	B2RWS6	stomach	PEAKS045132
EXP045146	9313S	Homo sapiens		EXP039077	514	normal	P06400	K562 (myelogenous leukemia)	PEAKS045133
EXP045147	F1804	Homo sapiens		EXP039140	430	normal	P50548	HepG2 (hepatoblastoma)	PEAKS045134
EXP045148	sc-17796	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039209	1145	normal	P51532	bipolar neuron	PEAKS045135
EXP045149	ab28179	Homo sapiens		EXP039036	430	normal	P35269	HepG2 (hepatoblastoma)	PEAKS045136
EXP045150	ab109398	Homo sapiens		EXP040217	725	normal	Q15910	PC3(bone mets prostate adenocarcinoma)	PEAKS045137
EXP045151	sc-585	Homo sapiens		EXP044617	1154	normal	Q09472	omental fat pad	PEAKS045138
EXP045152	3737S	Homo sapiens		EXP039036	430	normal	Q15022	HepG2 (hepatoblastoma)	PEAKS045139
EXP045153	A303-923A	Homo sapiens		EXP044619	514	normal	Q9NW64	K562 (myelogenous leukemia)	PEAKS045140
EXP045154	GTX100469	Homo sapiens		EXP039034	514	normal	Q06609	K562 (myelogenous leukemia)	PEAKS045141
EXP045155	NB600-1263	Homo sapiens		EXP039046	113	normal	Q96ST3	MCF7 (Invasive ductal breast carcinoma)	PEAKS045142
EXP045156	A300-215A	Homo sapiens		EXP010775	376	normal	O60341	WA01 (H1, human embryonic stem cells)	PEAKS045143
EXP045157	A302-271A	Homo sapiens		EXP039034	514	normal	Q13772	K562 (myelogenous leukemia)	PEAKS045144
EXP045158	HPA003575	Homo sapiens		EXP039240	113	normal	Q8IYM9	MCF7 (Invasive ductal breast carcinoma)	PEAKS045145
EXP045159	T5327	Homo sapiens		EXP039167	423	normal	P26651	HeLa S3 (cervical adenocarcinoma)	PEAKS045146
EXP045160	A300-933A	Homo sapiens		EXP039034	514	normal	Q96KQ7	K562 (myelogenous leukemia)	PEAKS045147
EXP045161	T1705	Homo sapiens		EXP039076	356	normal	Q13148	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045148
EXP045162	A303-223A	Homo sapiens		EXP044590	514	normal	Q13148	K562 (myelogenous leukemia)	PEAKS045149
EXP045163	ab68480	Homo sapiens		EXP044665	430	normal	Q9BUJ2	HepG2 (hepatoblastoma)	PEAKS045150
EXP045164	A302-293A	Homo sapiens		EXP044619	514	normal	P42696	K562 (myelogenous leukemia)	PEAKS045151
EXP045165	sc-585	Homo sapiens		EXP044615	1154	normal	Q09472	omental fat pad	PEAKS045152
EXP045166	A300-541A	Homo sapiens		EXP039216	514	normal	Q96L91	K562 (myelogenous leukemia)	PEAKS045153
EXP045167	RN069PW	Homo sapiens		EXP044644	514	normal	Q96PK6	K562 (myelogenous leukemia)	PEAKS045154
EXP045168	A301-418A	Homo sapiens		EXP039216	514	normal	Q96NB3	K562 (myelogenous leukemia)	PEAKS045155
EXP045169	A303-169A	Homo sapiens		EXP039034	514	normal	P51858	K562 (myelogenous leukemia)	PEAKS045156
EXP045170	HPA003575	Homo sapiens		EXP039076	356	normal	Q8IYM9	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045157
EXP045171	39548	Homo sapiens		EXP039151	113	normal	Q9UBB5	MCF7 (Invasive ductal breast carcinoma)	PEAKS045158
EXP045172	sc-585	Homo sapiens		EXP044635	1154	normal	Q09472	omental fat pad	PEAKS045159
EXP045173	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045160
EXP045174	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	O60216	A549 (lung carcinoma)	PEAKS045161
EXP045175	A300-216A	Homo sapiens		EXP039216	514	normal	O60341	K562 (myelogenous leukemia)	PEAKS045162
EXP045176	A300-215A	Homo sapiens		EXP039216	514	normal	O60341	K562 (myelogenous leukemia)	PEAKS045163
EXP045177	ab68301	Homo sapiens		EXP039081	38	normal	O14647	A549 (lung carcinoma)	PEAKS045164
EXP045178	A303-170A	Homo sapiens		EXP039076	356	normal	P51858	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045165
EXP045179	ab109398	Homo sapiens		EXP039172	618	normal	Q15910	MM1.S (plasma cell myeloma)	PEAKS045166
EXP045180	goat-anti-GFP-UC	Homo sapiens		EXP044603	514	normal	P52657	K562 (myelogenous leukemia)	PEAKS045167
EXP045181	sc-585	Homo sapiens		EXP044632	1149	normal	Q09472	testis	PEAKS045168
EXP045182	A300-294A	Homo sapiens		EXP044590	514	normal	P35637	K562 (myelogenous leukemia)	PEAKS045169
EXP045183	sc-585	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045170
EXP045184	39980	Homo sapiens		EXP039159	430	normal	P83916	HepG2 (hepatoblastoma)	PEAKS045171
EXP045185	sc-585	Homo sapiens		EXP044643	1140	normal	Q09472	subcutaneous adipose tissue	PEAKS045172
EXP045186	H00027161-M01	Homo sapiens		EXP044634	430	normal	Q9UKV8	HepG2 (hepatoblastoma)	PEAKS045173
EXP045187	200093	Homo sapiens		EXP044599	430	normal	Q8N163	HepG2 (hepatoblastoma)	PEAKS045174
EXP045188	ab134916	Homo sapiens		EXP044630	514	normal	Q92804	K562 (myelogenous leukemia)	PEAKS045175
EXP045189	F1804	Homo sapiens		EXP039140	430	normal	Q9BYH8	HepG2 (hepatoblastoma)	PEAKS045176
EXP045190	ab109398	Homo sapiens		EXP039113	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS045177
EXP045191	F1804	Homo sapiens		EXP039140	430	normal	P35869	HepG2 (hepatoblastoma)	PEAKS045178
EXP045192	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 15 minute	EXP040194	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045179
EXP045193	goat-anti-GFP-UC	Homo sapiens		EXP044609	514	normal	Q9BTC0	K562 (myelogenous leukemia)	PEAKS045180
EXP045194	A300-215A	Homo sapiens		EXP039242	356	normal	O60341	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045181
EXP045195	GTX109642	Homo sapiens		EXP039020	430	normal	Q92769	HepG2 (hepatoblastoma)	PEAKS045182
EXP045196	ab134916	Homo sapiens		EXP044631	430	normal	Q92804	HepG2 (hepatoblastoma)	PEAKS045183
EXP045197	A301-341A	Homo sapiens		EXP010781	430	normal	Q9UBN7	HepG2 (hepatoblastoma)	PEAKS045184
EXP045198	F1804	Homo sapiens		EXP039140	430	normal	Q06547	HepG2 (hepatoblastoma)	PEAKS045185
EXP045199	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045186
EXP045200	ARP58479_P050	Homo sapiens		EXP044634	430	normal	P31943	HepG2 (hepatoblastoma)	PEAKS045187
EXP045201	ARP58479_P050	Homo sapiens		EXP044664	514	normal	P31943	K562 (myelogenous leukemia)	PEAKS045188
EXP045202	GTX114455	Homo sapiens		EXP044657	514	normal	P35269	K562 (myelogenous leukemia)	PEAKS045189
EXP045203	39977	Homo sapiens		EXP039049	514	normal	P45973	K562 (myelogenous leukemia)	PEAKS045190
EXP045204	F1804	Homo sapiens		EXP039140	430	normal	Q9Y2G1	HepG2 (hepatoblastoma)	PEAKS045191
EXP045205	A300-705A	Homo sapiens		EXP039034	514	normal	Q92769	K562 (myelogenous leukemia)	PEAKS045192
EXP045206	3364	Homo sapiens		EXP044657	514	normal	Q9NRR4	K562 (myelogenous leukemia)	PEAKS045193
EXP045207	A301-985A50	Homo sapiens		EXP010781	430	normal	O60885	HepG2 (hepatoblastoma)	PEAKS045194
EXP045208	A302-584A	Homo sapiens		EXP039034	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS045195
EXP045209	5053	Homo sapiens		EXP044634	430	normal	Q9UL18	HepG2 (hepatoblastoma)	PEAKS045196
EXP045210	sc-585	Mus musculus		EXP044638	5	normal	B2RWS6	liver	PEAKS045197
EXP045211	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045198
EXP045212	A300-816A	Homo sapiens		EXP039034	514	normal	O15164	K562 (myelogenous leukemia)	PEAKS045199
EXP045213	HPA019653	Homo sapiens		EXP039034	514	normal	Q06547	K562 (myelogenous leukemia)	PEAKS045200
EXP045214	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045201
EXP045215	ab109398	Homo sapiens		EXP040201	816	normal	Q15910	SU-DHL-6 (diffuse large B-cell lymphoma)	PEAKS045202
EXP045216	sc-585	Homo sapiens		EXP044639	1181	normal	Q09472	upper lobe of left lung	PEAKS045203
EXP045217	A301-985A50	Homo sapiens		EXP010582	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS045204
EXP045218	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045205
EXP045219	sc-585	Homo sapiens		EXP044586	1181	normal	Q09472	upper lobe of left lung	PEAKS045206
EXP045220	HPA017013	Homo sapiens		EXP039061	430	normal	O43670	HepG2 (hepatoblastoma)	PEAKS045207
EXP045221	A301-081A	Homo sapiens		EXP039132	38	normal	Q14839	A549 (lung carcinoma)	PEAKS045208
EXP045222	GTX114210	Homo sapiens		EXP039105	356	normal	Q13148	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045209
EXP045223	sc-585	Homo sapiens		EXP044647	1169	normal	Q09472	sigmoid colon	PEAKS045210
EXP045224	A302-267A	Homo sapiens		EXP039034	514	normal	Q03111	K562 (myelogenous leukemia)	PEAKS045211
EXP045225	F1804	Homo sapiens		EXP039140	430	normal	O60341	HepG2 (hepatoblastoma)	PEAKS045212
EXP045226	ab290	Homo sapiens		EXP039092	421	normal	Q9H4Q4	HEK293 (embryonic kidney)	PEAKS045213
EXP045227	A302-870A	Homo sapiens		EXP039034	514	normal	Q99496	K562 (myelogenous leukemia)	PEAKS045214
EXP045228	RN080PW	Homo sapiens		EXP044644	514	normal	P84103	K562 (myelogenous leukemia)	PEAKS045215
EXP045229	sc-585	Homo sapiens		EXP044623	1156	normal	Q09472	gastroesophageal sphincter	PEAKS045216
EXP045230	sc-585	Homo sapiens		EXP044620	1156	normal	Q09472	gastroesophageal sphincter	PEAKS045217
EXP045231	NB100-68209	Homo sapiens		EXP039220	356	normal	P51610	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045218
EXP045232	F1804	Homo sapiens		EXP039140	430	normal	O15550	HepG2 (hepatoblastoma)	PEAKS045219
EXP045233	39664	Homo sapiens		EXP039086	514	normal	Q99496	K562 (myelogenous leukemia)	PEAKS045220
EXP045234	GTX103229	Homo sapiens		EXP039076	356	normal	O60934	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045221
EXP045235	A303-593A	Homo sapiens		EXP039077	514	normal	O43439	K562 (myelogenous leukemia)	PEAKS045222
EXP045236	F1804	Homo sapiens		EXP044584	430	normal	O60216	HepG2 (hepatoblastoma)	PEAKS045223
EXP045237	A300-191A	Homo sapiens		EXP039034	514	normal	P49736	K562 (myelogenous leukemia)	PEAKS045224
EXP045238	HPA007128	Homo sapiens		EXP039020	430	normal	Q6P4R8	HepG2 (hepatoblastoma)	PEAKS045225
EXP045239	ab24550	Homo sapiens		EXP039036	430	normal	Q9BZK7	HepG2 (hepatoblastoma)	PEAKS045226
EXP045240	T1705	Homo sapiens		EXP039232	10	normal	Q13148	HEK293T (embryonic kidney)	PEAKS045227
EXP045241	HPA003575	Homo sapiens		EXP039020	430	normal	Q8IYM9	HepG2 (hepatoblastoma)	PEAKS045228
EXP045242	goat-anti-GFP-UC	Homo sapiens		EXP044587	514	normal	P29084	K562 (myelogenous leukemia)	PEAKS045229
EXP045243	A302-730A	Homo sapiens		EXP039034	514	normal	Q9BRQ0	K562 (myelogenous leukemia)	PEAKS045230
EXP045244	sc-585	Homo sapiens		EXP044660	1157	normal	Q09472	stomach	PEAKS045231
EXP045245	sc-585	Homo sapiens		EXP044621	1157	normal	Q09472	stomach	PEAKS045232
EXP045246	A300-489A	Homo sapiens		EXP039242	356	normal	Q9UBL3	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045233
EXP045247	sc-585	Homo sapiens		EXP044614	1167	normal	Q09472	esophagus muscularis mucosa	PEAKS045234
EXP045248	A301-546A	Homo sapiens		EXP039216	514	normal	Q5VUA4	K562 (myelogenous leukemia)	PEAKS045235
EXP045249	ab9263	Homo sapiens		EXP039044	489	normal	Q9UQE7	IMR90 (lung fibroblasts)	PEAKS045236
EXP045250	ab68301	Mus musculus		EXP010793	230	normal	E9PZM4	ES-E14 (E14, embryonic stem cells)	PEAKS045237
EXP045251	sc-585	Homo sapiens		EXP044652	1129	normal	Q09472	suprapubic skin	PEAKS045238
EXP045252	sc-585	Homo sapiens		EXP044585	1150	normal	Q09472	ovary	PEAKS045239
EXP045253	A302-585A	Homo sapiens		EXP039034	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS045240
EXP045254	4783	Homo sapiens		EXP044630	514	normal	Q8WVV9	K562 (myelogenous leukemia)	PEAKS045241
EXP045255	ab65767	Homo sapiens		EXP039106	514	normal	Q9ULJ6	K562 (myelogenous leukemia)	PEAKS045242
EXP045256	ab290	Homo sapiens		EXP039092	421	normal	Q8N7E2	HEK293 (embryonic kidney)	PEAKS045243
EXP045257	goat-anti-GFP-UC	Homo sapiens		EXP044667	514	normal	Q9H8N7	K562 (myelogenous leukemia)	PEAKS045244
EXP045258	A302-498A	Homo sapiens		EXP044619	514	normal	Q96I25	K562 (myelogenous leukemia)	PEAKS045245
EXP045259	sc-585	Homo sapiens		EXP044610	1140	normal	Q09472	subcutaneous adipose tissue	PEAKS045246
EXP045260	HPA000815	Homo sapiens		EXP039034	514	normal	Q969R5	K562 (myelogenous leukemia)	PEAKS045247
EXP045261	A301-736A	Homo sapiens		EXP039034	514	normal	Q9NRY4	K562 (myelogenous leukemia)	PEAKS045248
EXP045262	A300-215A	Homo sapiens		EXP010781	430	normal	O60341	HepG2 (hepatoblastoma)	PEAKS045249
EXP045263	RN081PW	Homo sapiens		EXP044644	514	normal	Q13242	K562 (myelogenous leukemia)	PEAKS045250
EXP045264	sc-585	Homo sapiens		EXP044655	440	normal	Q09472	HMEC (human mammary epithelial cells)	PEAKS045251
EXP045265	F1804	Homo sapiens		EXP039140	430	normal	Q9UID6	HepG2 (hepatoblastoma)	PEAKS045252
EXP045266	61731	Homo sapiens		EXP039216	514	normal	O43542	K562 (myelogenous leukemia)	PEAKS045253
EXP045267	A303-170A	Homo sapiens		EXP039074	113	normal	P51858	MCF7 (Invasive ductal breast carcinoma)	PEAKS045254
EXP045268	A300-882A	Homo sapiens		EXP039132	38	normal	Q9HC52	A549 (lung carcinoma)	PEAKS045255
EXP045269	HPA004734	Homo sapiens		EXP039188	356	normal	Q02080	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045256
EXP045270	A300-821A	Homo sapiens		EXP044619	514	normal	Q96T37	K562 (myelogenous leukemia)	PEAKS045257
EXP045271	A300-933A	Homo sapiens		EXP010781	430	normal	Q96KQ7	HepG2 (hepatoblastoma)	PEAKS045258
EXP045272	A303-170A	Homo sapiens		EXP039034	514	normal	P51858	K562 (myelogenous leukemia)	PEAKS045259
EXP045273	39875	Homo sapiens		EXP010863	356	normal	Q15910	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045260
EXP045274	39875	Homo sapiens		EXP010845	440	normal	Q15910	HMEC (human mammary epithelial cells)	PEAKS045261
EXP054049	RBBP5 (Bethyl Laboratories, A300-109A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q15291	K562 (myelogenous leukemia)	PEAKS050980
EXP054045	SAP30 (Active Motif, 39731)	Homo sapiens	Treatment: None;	NULL	514	normal	O75446	K562 (myelogenous leukemia)	PEAKS050976
EXP054047	HDAC2 (Bethyl Laboratories, A300-705A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q92769	K562 (myelogenous leukemia)	PEAKS050978
EXP054050	PHF8 (Bethyl Laboratories, A301-772A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9UPP1	K562 (myelogenous leukemia)	PEAKS050981
EXP054044	CHD1 (Bethyl Laboratories, A301-218A)	Homo sapiens	Treatment: None;	NULL	376	normal	O14646	WA01 (H1, human embryonic stem cells)	PEAKS050975
EXP045280	39875	Homo sapiens		EXP010005	670	normal	Q15910	fibroblast of dermis	PEAKS045267
EXP045281	39875	Homo sapiens		EXP010792	215	normal	Q15910	keratinocytes	PEAKS045268
EXP045282	39875	Homo sapiens		EXP010367	450	normal	Q15910	skeletal muscles and myoblasts	PEAKS045269
EXP045283	39875	Homo sapiens		EXP010781	430	normal	Q15910	HepG2 (hepatoblastoma)	PEAKS045270
EXP045284	39875	Homo sapiens		EXP010103	72	normal	Q15910	astrocytes	PEAKS045271
EXP045285	ab109398	Homo sapiens		EXP040214	887	normal	Q15910	neural progenitors	PEAKS045272
EXP045286	sc-585	Homo sapiens		EXP044649	440	normal	Q09472	HMEC (human mammary epithelial cells)	PEAKS045273
EXP045287	39875	Homo sapiens		EXP010582	514	normal	Q15910	K562 (myelogenous leukemia)	PEAKS045274
EXP054048	HDAC1 (Santa Cruz Biotechnology, SC-6298)	Homo sapiens	Treatment: None;	NULL	514	normal	Q13547	K562 (myelogenous leukemia)	PEAKS050979
EXP045289	sc-585	Homo sapiens		EXP044596	1157	normal	Q09472	stomach	PEAKS045276
EXP054086	RBBP5 (Bethyl Laboratories, A300-109A)	Homo sapiens	Treatment: None;	NULL	376	normal	Q15291	WA01 (H1, human embryonic stem cells)	PEAKS051017
EXP054082	CHD1 (Bethyl Laboratories, A301-218A)	Homo sapiens	Treatment: None;	NULL	514	normal	O14646	K562 (myelogenous leukemia)	PEAKS051013
EXP045292	T5327	Homo sapiens		EXP039106	514	normal	P26651	K562 (myelogenous leukemia)	PEAKS045279
EXP045293	sc-585	Homo sapiens		EXP044661	1167	normal	Q09472	esophagus muscularis mucosa	PEAKS045280
EXP045294	5246S	Homo sapiens		EXP040196	1184	normal	Q15910	GM23338	PEAKS045281
EXP045295	ab174657	Homo sapiens		EXP039188	356	normal	Q969S3	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS045282
EXP045296	A302-524A	Homo sapiens		EXP039132	38	normal	Q14781	A549 (lung carcinoma)	PEAKS045283
EXP045297	ab9263	Homo sapiens		EXP039108	1180	normal	Q9UQE7	neural cell	PEAKS045284
EXP045298	NB100-74650	Homo sapiens		EXP039118	38	normal	O75152	A549 (lung carcinoma)	PEAKS045285
EXP045299	F1804	Homo sapiens		EXP044582	113	normal	O60216	MCF7 (Invasive ductal breast carcinoma)	PEAKS045286
EXP045300	A300-417A	Homo sapiens		EXP039216	514	normal	Q01844	K562 (myelogenous leukemia)	PEAKS045287
EXP045301	sc-585	Homo sapiens		EXP040210	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045288
EXP045302	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	Q09472	A549 (lung carcinoma)	PEAKS045289
EXP045303	GTX103229	Homo sapiens		EXP039034	514	normal	O60934	K562 (myelogenous leukemia)	PEAKS045290
EXP045304	ab992	Homo sapiens		EXP039112	38	normal	O60216	A549 (lung carcinoma)	PEAKS045291
EXP045305	ab70892	Homo sapiens		EXP010781	430	normal	P29375	HepG2 (hepatoblastoma)	PEAKS045292
EXP045306	T5327	Homo sapiens		EXP039118	38	normal	P26651	A549 (lung carcinoma)	PEAKS045293
EXP045307	5694BF	Homo sapiens		EXP039132	38	normal	Q99496	A549 (lung carcinoma)	PEAKS045294
EXP045308	NB600-1263	Homo sapiens		EXP039106	514	normal	Q96ST3	K562 (myelogenous leukemia)	PEAKS045295
EXP045309	sc-17824	Homo sapiens		EXP039302	879	normal	P08047	liver	PEAKS045296
EXP045310	goat-anti-GFP-UC	Homo sapiens		EXP044662	514	normal	Q13418	K562 (myelogenous leukemia)	PEAKS045297
EXP045311	#200580	Homo sapiens		EXP044657	514	normal	Q15424	K562 (myelogenous leukemia)	PEAKS045298
EXP045312	A302-756A	Homo sapiens		EXP039077	514	normal	P35269	K562 (myelogenous leukemia)	PEAKS045299
EXP045313	RN093PW	Homo sapiens		EXP044604	514	normal	O43172	K562 (myelogenous leukemia)	PEAKS045300
EXP045314	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045301
EXP045315	09-868	Homo sapiens		EXP010781	430	normal	Q9UPP1	HepG2 (hepatoblastoma)	PEAKS045302
EXP045316	GTX100469	Homo sapiens		EXP039074	113	normal	Q06609	MCF7 (Invasive ductal breast carcinoma)	PEAKS045303
EXP045317	sc-110	Homo sapiens		EXP039275	879	normal	P18146	liver	PEAKS045304
EXP045318	sc-585	Homo sapiens		EXP044659	1140	normal	Q09472	subcutaneous adipose tissue	PEAKS045305
EXP045319	4783	Homo sapiens		EXP044634	430	normal	Q8WVV9	HepG2 (hepatoblastoma)	PEAKS045306
EXP045320	A302-345A	Homo sapiens		EXP039034	514	normal	P51825	K562 (myelogenous leukemia)	PEAKS045307
EXP045321	ab9263	Homo sapiens		EXP039112	38	normal	Q9UQE7	A549 (lung carcinoma)	PEAKS045308
EXP045322	NB100-60411	Homo sapiens		EXP039046	113	normal	O14646	MCF7 (Invasive ductal breast carcinoma)	PEAKS045309
EXP045337	anti-CBP	Drosophila melanogaster	Female	EXP045327	1409	normal	M9PH39	multi-cellular organism (development stage: adult)	PEAKS045310
EXP045338	anti-CBP	Drosophila melanogaster	Male	EXP045328	1409	normal	M9PH39	multi-cellular organism (development stage: adult)	PEAKS045311
EXP045339	anti-CBP	Drosophila melanogaster		EXP045329	1422	normal	M9PH39	whole organism (developmental stage: E12-16)	PEAKS045312
EXP045340	anti-CBP	Drosophila melanogaster		EXP045330	1421	normal	M9PH39	whole organism (developmental stage: E4-8)	PEAKS045313
EXP045341	anti-CBP	Drosophila melanogaster		EXP045331	1427	normal	M9PH39	whole organism (developmental stage: L1)	PEAKS045314
EXP045342	anti-CBP	Drosophila melanogaster		EXP045332	1428	normal	M9PH39	whole organism (developmental stage: L3)	PEAKS045315
EXP045343	anti-CBP	Drosophila melanogaster		EXP045333	1401	normal	M9PH39	multi-cellular organism (development stage: pupa)	PEAKS045316
EXP045344	anti-CBP	Drosophila melanogaster		EXP045324	1423	normal	M9PH39	whole organism (developmental stage: E16-20)	PEAKS045317
EXP045345	anti-CBP	Drosophila melanogaster		EXP045325	1425	normal	M9PH39	whole organism (developmental stage: E20-24)	PEAKS045318
EXP045346	anti-CBP	Drosophila melanogaster		EXP045323	1426	normal	M9PH39	whole organism (developmental stage: E0-4)	PEAKS045319
EXP045347	anti-CBP	Drosophila melanogaster		EXP045336	1424	normal	M9PH39	whole organism (developmental stage: E8-12)	PEAKS045320
EXP045351	rbCBP	Drosophila melanogaster		EXP045350	1414	normal	M9MS40	0-4 h embryo	PEAKS045322
EXP045353	disco	Drosophila melanogaster		EXP045352	1417	normal	P23792	8-16 h embryo	PEAKS045323
EXP045355	KW3-kni-D2	Drosophila melanogaster		EXP045354	1417	normal	P10734	8-16 h embryo	PEAKS045324
EXP045357	ASH2	Drosophila melanogaster	Treatment: none	EXP045356	1439	normal	Q94545	wing imaginal disc (developmental stage: L3)	PEAKS045325
EXP045359	NW-GFP-Goat[Dfd]	Drosophila melanogaster		EXP045358	1418	normal	P07548	0-8 h embryo	PEAKS045326
EXP045365	NW-GFP-Goat[eve]	Drosophila melanogaster		EXP045364	1417	normal	P06602	8-16 h embryo	PEAKS045329
EXP045367	CTCF-C	Drosophila melanogaster	white prepupae stage	EXP045366	1408	normal	Q9VS55	whole organism (development stage: prepupa)	PEAKS045330
EXP045369	Trx-C	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P20659	S2-DRSC (embryonic stem cells)	PEAKS045331
EXP045370	Psc	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P35820	S2-DRSC (embryonic stem cells)	PEAKS045332
EXP045371	Ph	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P11346	S2-DRSC (embryonic stem cells)	PEAKS045333
EXP045372	Pc	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P26017	S2-DRSC (embryonic stem cells)	PEAKS045334
EXP045374	Trl	Drosophila melanogaster		EXP045373	1418	normal	Q08605	0-8 h embryo	PEAKS045335
EXP045376	CG8478	Drosophila melanogaster		EXP045375	1420	normal	E1JIH4	16-24 h embryo	PEAKS045336
EXP045380	KW3-Trl-D2	Drosophila melanogaster		EXP045379	1417	normal	Q08605	8-16 h embryo	PEAKS045338
EXP045386	Trem	Drosophila melanogaster	Adult Female	EXP045385	1399	normal	Q8SXZ3	whole organism (development stage: adult)	PEAKS045341
EXP045388	KW3-Kr-D2	Drosophila melanogaster		EXP045387	1420	normal	P07247	16-24 h embryo	PEAKS045342
EXP045392	anti-Bonus-[GP37]	Drosophila melanogaster		EXP045391	1420	normal	Q9U3Y7	16-24 h embryo	PEAKS045344
EXP045394	lid	Drosophila melanogaster	Treatment: tissue: wing imaginal discs	EXP045393	1400	normal	Q9VMJ7	whole organism (development stage: wandering third instar larva)	PEAKS045345
EXP045396	KW4-Fer3-D1	Drosophila melanogaster		EXP045395	1420	normal	Q9VGJ5	16-24 h embryo	PEAKS045346
EXP045398	anti-cbt	Drosophila melanogaster		EXP045397	1420	normal	Q4R0P9	16-24 h embryo	PEAKS045347
EXP045400	Yki-91	Drosophila melanogaster		EXP045399	1426	normal	Q45VV3	whole organism (developmental stage: E0-4)	PEAKS045348
EXP045402	exd-GFP	Drosophila melanogaster		EXP045401	1420	normal	P40427	16-24 h embryo	PEAKS045349
EXP045406	Hr4_GFP	Drosophila melanogaster		EXP045405	1413	normal	Q9W539	0-12 h embryo	PEAKS045351
EXP045408	KW3-Trl-D2	Drosophila melanogaster	white pre-pupae	EXP045407	1408	normal	Q08605	whole organism (development stage: prepupa)	PEAKS045352
EXP045411	anti-SuHw	Drosophila melanogaster		EXP045409	1242	normal	A0A0B4K6W1	S2 cells	PEAKS045353
EXP045412	anti-SuHw	Drosophila melanogaster		EXP045410	1242	normal	A0A0B4K6W1	S2 cells	PEAKS045354
EXP045415	guinea pig 1 anti-l(3)mbt 1244-1477aa (glycine elution)	Drosophila melanogaster	temperature: 25C; w1118 strain	EXP045413	1400	normal	Q9VB52	whole organism (development stage: wandering third instar larva)	PEAKS045355
EXP045416	guinea pig 1 anti-l(3)mbt 1244-1477aa (glycine elution)	Drosophila melanogaster	temperature: 25C; Canton S strain	EXP045414	1400	normal	Q9VB52	whole organism (development stage: wandering third instar larva)	PEAKS045356
EXP045421	FLAG	Drosophila melanogaster	MEF2+ cells	EXP045418	1430	normal	Q8I8V0	FACS isolated muscle cells	PEAKS045357
EXP045422	FLAG	Drosophila melanogaster	Elav+ cells	EXP045419	1431	normal	Q8I8V0	FACS isolated neuronal cells	PEAKS045358
EXP045424	anti-CP190	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045359
EXP045425	anti-CP190	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045360
EXP045426	anti-CP190	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045361
EXP045427	anti-Su(Hw)	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	P08970	Kc167 (development stage: embryonic)	PEAKS045362
EXP045428	anti-Su(Hw)	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	P08970	Kc167 (development stage: embryonic)	PEAKS045363
EXP045429	anti-Su(Hw)	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	P08970	Kc167 (development stage: embryonic)	PEAKS045364
EXP045430	anti-dCTCF	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045365
EXP045431	anti-dCTCF	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045366
EXP045432	anti-dCTCF	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045367
EXP045433	anti-BEAF32B	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045368
EXP045434	anti-BEAF32B	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045369
EXP045435	anti-BEAF32B	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045370
EXP045439	anti-ZLD	Drosophila melanogaster	Oregon R strain; mitotic cycles 8-9	NULL	1407	normal	Q7YU17	whole organism (development stage: embryonic)	PEAKS045374
EXP045440	anti-ZLD	Drosophila melanogaster	Oregon R strain; mitotic cycles 13-14	NULL	1407	normal	Q7YU17	whole organism (development stage: embryonic)	PEAKS045375
EXP045441	anti-ZLD	Drosophila melanogaster	Oregon R strain; late mitotic cycle 14	NULL	1407	normal	Q7YU17	whole organism (development stage: embryonic)	PEAKS045376
EXP045442	Ash1C	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	PEAKS045377
EXP045443	Ash1N	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	PEAKS045378
EXP045444	FSH_ID166 [raised against the N-terminal, common part of FSH-S and FSH-L, protein 1.2]	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	PEAKS045379
EXP045445	FSH_ID173 [raised against protein 4.1 (recognizes FSH-L only)]	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	PEAKS045380
EXP045447	Hsp90	Drosophila melanogaster		EXP045446	1197	normal	M9PBL3	S2-DRSC (embryonic stem cells)	PEAKS045381
EXP045448	orc2 (steve bell lab, MIT)	Drosophila melanogaster	salivary gland; OrR genotype	NULL	1400	normal	Q24168	whole organism (development stage: wandering third instar larva)	PEAKS045382
EXP045449	orc2 (steve bell lab, MIT)	Drosophila melanogaster	salivary gland; SuUR genotype	NULL	1400	normal	Q24168	whole organism (development stage: wandering third instar larva)	PEAKS045383
EXP045452	Anti-FLAG M2	Drosophila melanogaster		EXP045450	1242	normal	P22813	S2 cells	PEAKS045384
EXP045453	Anti-FLAG M2	Drosophila melanogaster		EXP045451	1242	normal	P22813	S2 cells	PEAKS045385
EXP045454	CP190	Drosophila melanogaster	Interphase	NULL	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045386
EXP045455	CP190	Drosophila melanogaster	Mitosis	NULL	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045387
EXP045456	dCTCF	Drosophila melanogaster	Interphase	NULL	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045388
EXP045457	dCTCF	Drosophila melanogaster	Mitosis	NULL	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045389
EXP045458	BEAF	Drosophila melanogaster	Interphase	NULL	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045390
EXP045459	BEAF	Drosophila melanogaster	Mitosis	NULL	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045391
EXP045460	Su(Hw)	Drosophila melanogaster	Mitosis	NULL	1397	normal	P08970	Kc167 (development stage: embryonic)	PEAKS045392
EXP045465	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; wild type; Canton S strain; ovary	EXP045462	1399	normal	P08970	whole organism (development stage: adult)	PEAKS045393
EXP045466	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; su(Hw)fv strain; ovary	EXP045464	1399	normal	P08970	whole organism (development stage: adult)	PEAKS045394
EXP045470	gp anti-Yan	Drosophila melanogaster		EXP045469	1434	normal	Q01842	whole organism (developmental stage: embryonic stage 11)	PEAKS045396
EXP045478	rb-?-Jarid2 (Masamitsu Yamaguchi)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045473	1400	normal	Q9VT00	whole organism (development stage: wandering third instar larva)	PEAKS045398
EXP045479	rb-?-Jarid2 (Masamitsu Yamaguchi)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045474	1400	normal	Q9VT00	whole organism (development stage: wandering third instar larva)	PEAKS045399
EXP045480	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045473	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	PEAKS045400
EXP045481	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045474	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	PEAKS045401
EXP045482	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: eye-antenna imaginal disc	EXP045475	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	PEAKS045402
EXP045483	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: eye-antenna imaginal disc; Jarid2 mutant	EXP045476	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	PEAKS045403
EXP045484	rb-?-Jarid2 (Masamitsu Yamaguchi)	Drosophila melanogaster	Treatment: none	EXP045477	1400	normal	Q9VT00	whole organism (development stage: wandering third instar larva)	PEAKS045404
EXP045485	Su(z)12	Drosophila melanogaster	Treatment: none	EXP045477	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	PEAKS045405
EXP045490	rabbit anti-Drosophila CBP	Drosophila melanogaster	genotype: w1118 (wild type)	EXP045488	1435	normal	M9MS40	2-4 h embryo	PEAKS045407
EXP045491	rabbit anti-Drosophila CBP	Drosophila melanogaster	genotype: gd7 (lacking intranuclear Dorsal)	EXP045489	1435	normal	M9MS40	2-4 h embryo	PEAKS045408
EXP045501	CG16778	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045500	1420	normal	P14083	16-24 h embryo	PEAKS045413
EXP045505	Fru	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045504	1420	normal	Q8IN81	16-24 h embryo	PEAKS045415
EXP045507	sr	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045506	1420	normal	Q7JP26	16-24 h embryo	PEAKS045416
EXP045515	jim	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045514	1417	normal	Q7KAH0	8-16 h embryo	PEAKS045420
EXP045517	sr	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045516	1417	normal	Q7JP26	8-16 h embryo	PEAKS045421
EXP045523	Kr	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045522	1397	normal	P07247	Kc167 (development stage: embryonic)	PEAKS045424
EXP045529	en	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045528	1400	normal	P02836	whole organism (development stage: wandering third instar larva)	PEAKS045427
EXP045573	BEAF	Drosophila melanogaster		EXP045572	1418	normal	Q94513	0-8 h embryo	PEAKS045449
EXP045574	anti-JIL-1	Drosophila melanogaster	Treatment: none; Sex: Female; Development stage: late embryo	NULL	1397	normal	Q9V3I5	Kc167 (development stage: embryonic)	PEAKS045450
EXP045575	Mod(mdg4)	Drosophila melanogaster		NULL	1397	normal	Q86B87	Kc167 (development stage: embryonic)	PEAKS045451
EXP045576	Mod(mdg4)BTB	Drosophila melanogaster		NULL	1397	normal	Q86B87	Kc167 (development stage: embryonic)	PEAKS045452
EXP045577	l(3)mbt	Drosophila melanogaster		NULL	1397	normal	Q9VB52	Kc167 (development stage: embryonic)	PEAKS045453
EXP045579	dm	Drosophila melanogaster	strain: iso1 (y; bw cn sp)	EXP045578	1418	normal	Q9W4S7	0-8 h embryo	PEAKS045454
EXP045580	ASH1N	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	PEAKS045455
EXP045581	ASH1C	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	PEAKS045456
EXP045582	FSH-S	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	PEAKS045457
EXP045583	FSH-S and FSH-L	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	PEAKS045458
EXP045585	polyclonal rabbit MSL1, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P50535	S2 cells	PEAKS045459
EXP045586	polyclonal rabbit MSL2, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P50534	S2 cells	PEAKS045460
EXP045587	polyclonal rabbit MSL3, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P50536	S2 cells	PEAKS045461
EXP045588	polyclonal rabbit MOF SA 4897, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	O02193	S2 cells	PEAKS045462
EXP045589	mle	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P24785	S2 cells	PEAKS045463
EXP045594	none (streptavidin-coated beads used to pulldown biotinlyated PH)	Drosophila melanogaster	350ng/ml (880nM) colchicine for 15hrs	EXP045590	1242	normal	P11346	S2 cells	PEAKS045464
EXP045595	none (streptavidin-coated beads used to pulldown biotinlyated PH)	Drosophila melanogaster		EXP045591	1242	normal	P11346	S2 cells	PEAKS045465
EXP045596	PSC custom made rabbit polyclonal antibody that was affinity purified (described in Francis et al., 2009. PMID: 19303136)	Drosophila melanogaster	350ng/ml (880nM) colchicine for 15hrs	EXP045592	1242	normal	P35820	S2 cells	PEAKS045466
EXP045597	PSC custom made rabbit polyclonal antibody that was affinity purified (described in Francis et al., 2009. PMID: 19303136)	Drosophila melanogaster		EXP045593	1242	normal	P35820	S2 cells	PEAKS045467
EXP045599	Lmd1 [Cunha et al. 2010 PLoS Genet 6(7): e1001014]	Drosophila melanogaster		EXP045598	1436	normal	Q7K9G4	primary mesodermal cells (developmental stage: E11-12)	PEAKS045468
EXP045600	Lmd2 [Cunha et al. 2010 PLoS Genet 6(7): e1001014]	Drosophila melanogaster		EXP045598	1436	normal	Q7K9G4	primary mesodermal cells (developmental stage: E11-12)	PEAKS045469
EXP045603	anti-Yki	Drosophila melanogaster	Treatment: Treatment: Treatment: Iso1 strain; Wing imaginal disc	EXP045602	1428	normal	Q45VV3	whole organism (developmental stage: L3)	PEAKS045470
EXP045606	anti-Trl (antii-GAF)	Drosophila melanogaster	Treatment: Treatment: Treatment: Iso1 strain; Wing imaginal disc	EXP045602	1428	normal	Q08605	whole organism (developmental stage: L3)	PEAKS045473
EXP045610	CLAMP	Drosophila melanogaster	control RNAi 	EXP045607	1397	normal	Q961A1	Kc167 (development stage: embryonic)	PEAKS045474
EXP045611	CLAMP	Drosophila melanogaster	MSL2 RNAi	EXP045608	1200	normal	Q961A1	S2-DGRC (embryonic stem cells)	PEAKS045475
EXP045612	CLAMP	Drosophila melanogaster	control RNAi	EXP045609	1200	normal	Q961A1	S2-DGRC (embryonic stem cells)	PEAKS045476
EXP045617	rabbit anti-Dp1	Drosophila melanogaster		EXP045616	1437	normal	Q7KN75	SR2+ (embryonic cells)	PEAKS045479
EXP045618	Myc (sc-28208)	Drosophila melanogaster	cells in interphase	NULL	1397	normal	Q9W4S7	Kc167 (development stage: embryonic)	PEAKS045480
EXP045619	Myc (sc-28208)	Drosophila melanogaster	cells in mitosis	NULL	1397	normal	Q9W4S7	Kc167 (development stage: embryonic)	PEAKS045481
EXP045620	DREF Rabbit polyclonal	Drosophila melanogaster	cells in mitosis	NULL	1397	normal	Q94883	Kc167 (development stage: embryonic)	PEAKS045482
EXP045621	DREF Rabbit polyclonal	Drosophila melanogaster	total cells	NULL	1397	normal	Q94883	Kc167 (development stage: embryonic)	PEAKS045483
EXP045623	BEAF-32B (Bushey et. al 2009)	Drosophila melanogaster	strain: Oregon-R	EXP045622	1438	normal	Q94513	wing imaginal tissue (developmental stage: L3)	PEAKS045484
EXP045624	anti-GAF	Drosophila melanogaster		NULL	1197	normal	A4V1Y6	S2-DRSC (embryonic stem cells)	PEAKS045485
EXP045625	anti-GAF	Drosophila melanogaster	S2 cells depleted of GAF by RNAi	NULL	1197	bio_control	A4V1Y6	S2-DRSC (embryonic stem cells)	PEAKS045486
EXP045631	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045626	1435	normal	P10627	2-4 h embryo	PEAKS045487
EXP045632	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045627	1435	normal	P10627	2-4 h embryo	PEAKS045488
EXP045633	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045628	1435	normal	P10627	2-4 h embryo	PEAKS045489
EXP045634	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045629	1435	normal	P10627	2-4 h embryo	PEAKS045490
EXP045635	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045630	1435	normal	P10627	2-4 h embryo	PEAKS045491
EXP045637	Su(Hw)	Drosophila melanogaster		EXP045636	1244	normal	P08970	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045492
EXP045638	Shep, guinea pig	Drosophila melanogaster		EXP045636	1244	normal	Q8MSV2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045493
EXP045639	Shep, rabbit	Drosophila melanogaster		EXP045636	1244	normal	Q8MSV2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045494
EXP045640	Mod(mdg4)2.2, guinea pig	Drosophila melanogaster		EXP045636	1244	normal	A0A0B4K6B8	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045495
EXP045641	Mod(mdg4)2.2, rabbit	Drosophila melanogaster		EXP045636	1244	normal	A0A0B4K6B8	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045496
EXP045642	Brinker	Drosophila melanogaster	strain: Canton S	NULL	1439	normal	Q9XTN4	wing imaginal disc (developmental stage: L3)	PEAKS045497
EXP045643	Cabut	Drosophila melanogaster	strain: Canton S	NULL	1439	normal	Q8IPV7	wing imaginal disc (developmental stage: L3)	PEAKS045498
EXP045646	CP190 antibody (rabbit)	Drosophila melanogaster		EXP045644	1197	normal	Q24478	S2-DRSC (embryonic stem cells)	PEAKS045499
EXP045647	CP190 antibody (rabbit)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	Q24478	S2-DRSC (embryonic stem cells)	PEAKS045500
EXP045648	Su(Hw) antibody 406 (rabbit)	Drosophila melanogaster		EXP045644	1197	normal	P08970	S2-DRSC (embryonic stem cells)	PEAKS045501
EXP045649	Su(Hw) antibody 406 (rabbit)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	P08970	S2-DRSC (embryonic stem cells)	PEAKS045502
EXP045650	Mod(mdg4)2.2 antibody (rabbit)	Drosophila melanogaster		EXP045644	1197	normal	A0A0B4K6B8	S2-DRSC (embryonic stem cells)	PEAKS045503
EXP045651	Mod(mdg4)2.2 antibody (rabbit)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	A0A0B4K6B8	S2-DRSC (embryonic stem cells)	PEAKS045504
EXP045652	dCTCF antibody 68 (rat)	Drosophila melanogaster		EXP045644	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	PEAKS045505
EXP045653	dCTCF antibody 68 (rat)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	PEAKS045506
EXP045657	anti-TBP (rabbit poly-antibody)	Drosophila melanogaster	Treatment: none; Development stage: post-MBT embryo, 2-4 hours AEL	EXP045655	5001	normal	P20227	Oregon-R (Developmental stage: post-MBT 2 to 4 hours AEL)	PEAKS045507
EXP045658	anti-TBP (rabbit poly-antibody)	Drosophila melanogaster	Treatment: none; Development stage: MBT embryo, 2-3 hours AEL	EXP045654	3335	normal	P20227	Oregon R (Developmental stage: MBT 2 to 3hrs AEL)	PEAKS045508
EXP045659	anti-TBP (rabbit poly-antibody)	Drosophila melanogaster	Treatment: none; Development stage: pre-MBT embryo, 1-2 hours AEL	EXP045656	5002	normal	P20227	Oregon-R (Developmental stage: pre-MBT 1 to 2 hours AEL)	PEAKS045509
EXP045666	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045660	1445	normal	O61735	head, adult	PEAKS045510
EXP045667	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045661	1445	normal	O61734	head, adult	PEAKS045511
EXP045668	V5 (Sigma)	Drosophila melanogaster	mock; no V5-tag; ZT13	EXP045662	1445	bio_control	Q9VDC3	head, adult	PEAKS045512
EXP045669	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045663	1444	normal	O61735	body, adult	PEAKS045513
EXP045670	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045664	1444	normal	O61734	body, adult	PEAKS045514
EXP045671	V5 (Sigma)	Drosophila melanogaster	mock; no V5-tag; ZT13	EXP045665	1444	bio_control	Q9VDC3	body, adult	PEAKS045515
EXP045674	PAP antibody (Sigma P1291)	Drosophila melanogaster	male	EXP045672	1412	normal	Q8T079	whole organism (development stage: larvae)	PEAKS045516
EXP045675	PAP antibody (Sigma P1291)	Drosophila melanogaster	female	EXP045673	1412	normal	Q8T079	whole organism (development stage: larvae)	PEAKS045517
EXP045678	su(Hw)	Drosophila melanogaster		EXP045676	1242	normal	P08970	S2 cells	PEAKS045518
EXP045679	Su(Hw)	Drosophila melanogaster		EXP045677	1443	normal	P08970	S3 cells (Schneider 3)	PEAKS045519
EXP045680	Rrp40	Drosophila melanogaster		EXP045677	1443	normal	Q8IPX7	S3 cells (Schneider 3)	PEAKS045520
EXP045681	Rrp6	Drosophila melanogaster		EXP045677	1443	normal	Q9VFF3	S3 cells (Schneider 3)	PEAKS045521
EXP045682	Rrp40	Drosophila melanogaster		EXP045676	1242	normal	Q8IPX7	S2 cells	PEAKS045522
EXP045683	Rrp6	Drosophila melanogaster		EXP045676	1242	normal	Q9VFF3	S2 cells	PEAKS045523
EXP045686	anti-Abrupt (a polyclonal rabbit antibody from Steven Crews)	Drosophila melanogaster	strain: UAS-ab55 (Cook et al. 2004)	EXP045684	1446	normal	Q24174	eye/antennal imaginal discs	PEAKS045524
EXP045687	anti-Abrupt (a polyclonal rabbit antibody from Steven Crews)	Drosophila melanogaster	strain: FRT82B, scrib1 (Bilder and Perrimon 2000)	EXP045685	1446	normal	Q24174	eye/antennal imaginal discs	PEAKS045525
EXP045692	dFOXO	Drosophila melanogaster	strain: chico heterozygous mutants; gender: female	EXP045688	1447	normal	Q95V55	whole organism (age: 15 day old)	PEAKS045526
EXP045693	dFOXO	Drosophila melanogaster	strain: chico heterozygous mutants; gender: female	EXP045689	1447	normal	Q95V55	whole organism (age: 15 day old)	PEAKS045527
EXP045694	dFOXO	Drosophila melanogaster	strain: IPC ablation mutants; gender: female	EXP045690	1447	normal	Q95V55	whole organism (age: 15 day old)	PEAKS045528
EXP045695	dFOXO	Drosophila melanogaster	strain: IPC ablation mutants; gender: female	EXP045691	1447	normal	Q95V55	whole organism (age: 15 day old)	PEAKS045529
EXP045697	BEAF (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	Q94513	KC167 (developmental stage: 6-12h embryo)	PEAKS045530
EXP045698	CP190 (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS045531
EXP045699	CTCF (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	Q9VS55	KC167 (developmental stage: 6-12h embryo)	PEAKS045532
EXP045700	SuHw (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	A0A0B4K6W1	KC167 (developmental stage: 6-12h embryo)	PEAKS045533
EXP045702	anti-Yki	Drosophila melanogaster		EXP045701	1242	normal	Q45VV3	S2 cells	PEAKS045534
EXP045704	CP190	Drosophila melanogaster		EXP045703	1242	normal	Q24478	S2 cells	PEAKS045535
EXP045705	CG8436	Drosophila melanogaster		EXP045703	1242	normal	A0A0B4LGV6	S2 cells	PEAKS045536
EXP045706	CG9740	Drosophila melanogaster		EXP045703	1242	normal	Q9VHG6	S2 cells	PEAKS045537
EXP045708	anti-EcR monoclonal antibody (DDA2.7) developed by C. Thummel in D. Hogness laboratory	Drosophila melanogaster		EXP045707	1242	normal	P34021	S2 cells	PEAKS045538
EXP045709	anti-EcR monoclonal antibody (DDA2.7) developed by C. Thummel in D. Hogness laboratory	Drosophila melanogaster	cells treated with ecdysone (41 Î¼M; 10 mg of 20-hydroxyecdysone (Sigma; cat. no. H5142) per 500 ml of growth medium)	EXP045707	1242	normal	P34021	S2 cells	PEAKS045539
EXP045711	rabbit polyclonal antibody specific to Fs(1)h long isoform	Drosophila melanogaster	long isoform IP	EXP045710	1397	normal	P13709	Kc167 (development stage: embryonic)	PEAKS045540
EXP045712	rabbit polyclonal antibody to both isoforms of Fs(1)h	Drosophila melanogaster	long and short isoform IP	EXP045710	1397	normal	P13709	Kc167 (development stage: embryonic)	PEAKS045541
EXP045714	anti-GFP	Drosophila melanogaster		EXP045713	1449	normal	P51521	12-14 h embryo	PEAKS045542
EXP045716	anti-V5 (Invitrogen)	Drosophila melanogaster	transfected with pMT5.1- DSXF -V5-His B	EXP045715	1242	normal	P23023	S2 cells	PEAKS045543
EXP045717	anti-V5 (Invitrogen)	Drosophila melanogaster	transfected with pMT5.1- DSXM-V5-His B	EXP045715	1242	normal	P23023	S2 cells	PEAKS045544
EXP045719	M1BP antisera generated in a rabbit using recombinant M1BP isolated from E. coli.	Drosophila melanogaster		EXP045718	1450	normal	Q9VHM3	S2R+ (late embryonic stage cells)	PEAKS045545
EXP045732	sc-25761	Drosophila melanogaster		EXP043076	1397	normal	P28159	Kc167 (development stage: embryonic)	PEAKS045546
EXP045734	ab290	Drosophila melanogaster		EXP045721	1400	normal	P07207	whole organism (development stage: wandering third instar larva)	PEAKS045548
EXP045738	ab290	Drosophila melanogaster		EXP045723	1400	normal	Q24142	whole organism (development stage: wandering third instar larva)	PEAKS045552
EXP045739	ab290	Drosophila melanogaster		EXP045724	1417	normal	Q24142	8-16 h embryo	PEAKS045553
EXP045744	KW1-br-core	Drosophila melanogaster		EXP045729	1418	normal	Q01295	0-8 h embryo	PEAKS045558
EXP045745	KW0-cnc	Drosophila melanogaster	female	EXP045730	1399	normal	P20482	whole organism (development stage: adult)	PEAKS045559
EXP045751	Bicoid (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P09081	whole organism (development stage: embryonic)	PEAKS045562
EXP045752	Bicoid, counter-purified agians D. virilis protein (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P09081	whole organism (development stage: embryonic)	PEAKS045563
EXP045753	GT  (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P39572	whole organism (development stage: embryonic)	PEAKS045564
EXP045754	GT  (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P39572	whole organism (development stage: embryonic)	PEAKS045565
EXP045755	HB (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P05084	whole organism (development stage: embryonic)	PEAKS045566
EXP045756	HB, counter-purified agians D. virilis protein (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P05084	whole organism (development stage: embryonic)	PEAKS045567
EXP045757	KR (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P07247	whole organism (development stage: embryonic)	PEAKS045568
EXP045758	KR, counter-purified agians D. virilis protein (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P07247	whole organism (development stage: embryonic)	PEAKS045569
EXP045759	Bicoid (Li et al. 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P09081	whole organism (development stage: embryonic)	PEAKS045570
EXP045760	GT  (Li et al. 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P39572	whole organism (development stage: embryonic)	PEAKS045571
EXP045761	HB (Li et al., 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P05084	whole organism (development stage: embryonic)	PEAKS045572
EXP045762	KR (Li et al., 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P07247	whole organism (development stage: embryonic)	PEAKS045573
EXP045764	Mouse monoclonal to Ago2, gift from M. Siomi	Drosophila melanogaster		EXP045763	1242	normal	Q9VUQ5	S2 cells	PEAKS045574
EXP045766	CP190 rabbit	Drosophila melanogaster		EXP045765	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045575
EXP045767	Mod(mdg4)2.2 guinea pig	Drosophila melanogaster		EXP045765	1397	normal	A0A0B4K6B8	Kc167 (development stage: embryonic)	PEAKS045576
EXP045768	Mod(mdg4)2.2 rabbit	Drosophila melanogaster		EXP045765	1397	normal	A0A0B4K6B8	Kc167 (development stage: embryonic)	PEAKS045577
EXP045769	Rump 10c3	Drosophila melanogaster		EXP045765	1397	normal	Q9VHC7	Kc167 (development stage: embryonic)	PEAKS045578
EXP045770	Rump 5g4	Drosophila melanogaster		EXP045765	1397	normal	Q9VHC7	Kc167 (development stage: embryonic)	PEAKS045579
EXP045771	Shep guinea pig	Drosophila melanogaster		EXP045765	1397	normal	Q8MSV2	Kc167 (development stage: embryonic)	PEAKS045580
EXP045772	Shep rabbit	Drosophila melanogaster		EXP045765	1397	normal	Q8MSV2	Kc167 (development stage: embryonic)	PEAKS045581
EXP045773	Su(Hw) rabbit	Drosophila melanogaster		EXP045765	1397	normal	P08970	Kc167 (development stage: embryonic)	PEAKS045582
EXP045774	anti-TBP 517 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	P20227	Stage 5 embryos	PEAKS045583
EXP045775	anti-TBP 518 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	P20227	Stage 5 embryos	PEAKS045584
EXP045776	anti-Trf2 274 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	Q07DP5	Stage 5 embryos	PEAKS045585
EXP045777	anti-Trf2 275 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	Q07DP5	Stage 5 embryos	PEAKS045586
EXP045780	CP190	Drosophila melanogaster		EXP045778	1400	normal	Q24478	whole organism (development stage: wandering third instar larva)	PEAKS045587
EXP045781	CP190	Drosophila melanogaster	Ibf2/cg9740 KO	EXP045779	1400	normal	Q24478	whole organism (development stage: wandering third instar larva)	PEAKS045588
EXP045783	CP190	Drosophila melanogaster	mutant Beaf	EXP045782	1242	normal	Q24478	S2 cells	PEAKS045589
EXP045784	CP190	Drosophila melanogaster	wild type Beaf	EXP045782	1242	normal	Q24478	S2 cells	PEAKS045590
EXP045786	guinea pig anti-So (from I. Rebay)	Drosophila melanogaster	eye-antennal imaginal discs	EXP045785	1400	normal	Q27350	whole organism (development stage: wandering third instar larva)	PEAKS045591
EXP045788	anti-Beaf32	Drosophila melanogaster		EXP045787	1242	normal	Q94513	S2 cells	PEAKS045592
EXP045789	anti-polycomb	Drosophila melanogaster	Treatment: none	NULL	1450	normal	P26017	S2R+ (late embryonic stage cells)	PEAKS045593
EXP045790	anti-trl	Drosophila melanogaster	Treatment: none	NULL	1450	normal	Q08605	S2R+ (late embryonic stage cells)	PEAKS045594
EXP045791	anti-adf1	Drosophila melanogaster	Treatment: none	NULL	1450	normal	P05552	S2R+ (late embryonic stage cells)	PEAKS045595
EXP045792	anti-pho	Drosophila melanogaster	Treatment: none	NULL	1450	normal	Q8ST83	S2R+ (late embryonic stage cells)	PEAKS045596
EXP045793	anti-polycomb	Drosophila melanogaster	Treatment: none	NULL	1451	normal	P26017	S2 (Schneider 2)	PEAKS045597
EXP045794	anti-polycomb	Drosophila melanogaster	Treatment: none	NULL	1244	normal	P26017	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045598
EXP045795	anti-pho	Drosophila melanogaster	Treatment: none	NULL	1451	normal	Q8ST83	S2 (Schneider 2)	PEAKS045599
EXP045796	anti-trl	Drosophila melanogaster	Treatment: none	NULL	1451	normal	Q08605	S2 (Schneider 2)	PEAKS045600
EXP045797	anti-adf1	Drosophila melanogaster	Treatment: none	NULL	1451	normal	P05552	S2 (Schneider 2)	PEAKS045601
EXP045799	anti-Pita	Drosophila melanogaster		EXP045798	1451	normal	Q9W1N1	S2 (Schneider 2)	PEAKS045602
EXP045800	anti-ZIPIC	Drosophila melanogaster		EXP045798	1451	normal	Q9VAB8	S2 (Schneider 2)	PEAKS045603
EXP045805	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: hh-gal4>UASt-HA::Lsd1 (epitope tagged Lsd1)	EXP045801	1454	normal	Q9VCI3	ovary (cap cells and terminal filament cells)	PEAKS045604
EXP045806	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: hh-gal4>UASt-HA::Lsd1 (epitope tagged Lsd1)	EXP045802	1454	normal	Q9VCI3	ovary (cap cells and terminal filament cells)	PEAKS045605
EXP045807	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: c587-gal4>UASp-HA::Lsd1 (epitope tagged Lsd1)	EXP045803	1455	normal	Q9VCI3	ovary (escort cells and early follicle cells)	PEAKS045606
EXP045808	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: c587-gal4>UASp-HA::Lsd1 (epitope tagged Lsd1)	EXP045804	1455	normal	Q9VCI3	ovary (escort cells and early follicle cells)	PEAKS045607
EXP045810	JIL-1 monoclonal antibody 5C9	Drosophila melanogaster	Treatment: Salivary Gland Cells	EXP045809	1400	normal	Q9V3I5	whole organism (development stage: wandering third instar larva)	PEAKS045608
EXP045812	Anti-Yki	Drosophila melanogaster	eye disks	EXP045811	1400	normal	Q45VV3	whole organism (development stage: wandering third instar larva)	PEAKS045609
EXP045813	Anti-Sd	Drosophila melanogaster	eye disks	EXP045811	1400	normal	P30052	whole organism (development stage: wandering third instar larva)	PEAKS045610
EXP045816	Bcd	Drosophila melanogaster		EXP045814	1229	normal	P09081	1-3 h embryo	PEAKS045611
EXP045817	Bcd	Drosophila melanogaster	zelda mutant	EXP045815	1229	normal	P09081	1-3 h embryo	PEAKS045612
EXP045828	anti-CTCF	Drosophila melanogaster	Treatment: parasegment 7	EXP045820	1456	normal	Q9VS55	5-13 h embryo	PEAKS045613
EXP045829	anti-Ph (residues 772-984)	Drosophila melanogaster	Treatment: whole embryo	EXP045818	1456	normal	P11346	5-13 h embryo	PEAKS045614
EXP045830	anti-Ph (residues 772-984)	Drosophila melanogaster	Treatment: parasegment 7	EXP045821	1456	normal	P11346	5-13 h embryo	PEAKS045615
EXP045831	anti-Pc	Drosophila melanogaster	Treatment: parasegment 7	EXP045822	1456	normal	P26017	5-13 h embryo	PEAKS045616
EXP045832	anti-Pc	Drosophila melanogaster	Treatment: whole embryo	EXP045823	1456	normal	P26017	5-13 h embryo	PEAKS045617
EXP045833	anti-SU(Z)12	Drosophila melanogaster	Treatment: parasegment 7	EXP045824	1456	normal	Q9NJG9	5-13 h embryo	PEAKS045618
EXP045834	anti-SU(Z)12	Drosophila melanogaster	Treatment: whole embryo	EXP045819	1456	normal	Q9NJG9	5-13 h embryo	PEAKS045619
EXP045835	anti-CP190	Drosophila melanogaster	Treatment: whole embryo	EXP045825	1456	normal	Q24478	5-13 h embryo	PEAKS045620
EXP045836	anti-CP190	Drosophila melanogaster	Treatment: parasegment 7	EXP045826	1456	normal	Q24478	5-13 h embryo	PEAKS045621
EXP045837	anti-CTCF	Drosophila melanogaster	Treatment: whole embryo	EXP045827	1456	normal	Q9VS55	5-13 h embryo	PEAKS045622
EXP045839	Polycomb	Drosophila melanogaster		EXP045838	1242	normal	P26017	S2 cells	PEAKS045623
EXP045840	Velo	Drosophila melanogaster		EXP045838	1242	normal	Q9VRY4	S2 cells	PEAKS045624
EXP045841	SUMO	Drosophila melanogaster		EXP045838	1242	normal	O97102	S2 cells	PEAKS045625
EXP045843	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; rhino knock-down	EXP045842	2203	bio_control	Q7JXA8	ovary	PEAKS045626
EXP045844	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; deadlock knock-down	EXP045842	2203	normal	Q7JXA8	ovary	PEAKS045627
EXP045845	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; cutoff knock-down	EXP045842	2203	normal	Q7JXA8	ovary	PEAKS045628
EXP045846	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult	EXP045842	2203	normal	Q9VIF5	ovary	PEAKS045629
EXP045847	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; deadlock knock-down	EXP045842	2203	bio_control	Q9VIF5	ovary	PEAKS045630
EXP045848	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult	EXP045842	2203	normal	Q9V629	ovary	PEAKS045631
EXP045849	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; cutoff knock-down	EXP045842	2203	bio_control	Q9V629	ovary	PEAKS045632
EXP045850	Rhi	Drosophila melanogaster	Treatment: 4-6 days old adult	EXP045842	2203	normal	Q7JXA8	ovary	PEAKS045633
EXP045851	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; piwi knock-down	EXP045842	2203	normal	Q7JXA8	ovary	PEAKS045634
EXP045856	SUUR (made in-house)	Drosophila melanogaster	Treatment: none	EXP045852	1458	normal	Q9VTE2	egg chambers, stage 10	PEAKS045635
EXP045857	Cdc45 (made in-house)	Drosophila melanogaster	Treatment: none	EXP045852	1458	normal	O96989	egg chambers, stage 10	PEAKS045636
EXP045858	SUUR (made in-house)	Drosophila melanogaster	Treatment: none	EXP045854	1459	normal	Q9VTE2	egg chambers, pooled stage 12 and 13	PEAKS045637
EXP045859	Cdc45 (made in-house)	Drosophila melanogaster	Treatment: none	EXP045854	1459	normal	O96989	egg chambers, pooled stage 12 and 13	PEAKS045638
EXP045860	PARP-1 (Active motif-39559)	Drosophila melanogaster	late embryonic cells	NULL	1242	normal	P35875	S2 cells	PEAKS045639
EXP045863	PRB-291C	Drosophila melanogaster	Treatment: Treatment: 1-5 day old adults	EXP045861	2203	normal	P05205	ovary	PEAKS045640
EXP045864	PRB-291C	Drosophila melanogaster	Treatment: Treatment: 1-5 day old adults; piwiNt/piwi2 (mutant)	EXP045862	2203	normal	P05205	ovary	PEAKS045641
EXP045867	MSL2	Drosophila melanogaster	salivary gland	EXP045865	1412	normal	P50534	whole organism (development stage: larvae)	PEAKS045642
EXP045868	MOF	Drosophila melanogaster	salivary gland	EXP045865	1412	normal	O02193	whole organism (development stage: larvae)	PEAKS045643
EXP045869	MSL1	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	EXP045866	1412	normal	P50535	whole organism (development stage: larvae)	PEAKS045644
EXP045870	MSL2	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	EXP045866	1412	normal	P50534	whole organism (development stage: larvae)	PEAKS045645
EXP045871	MOF	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	EXP045866	1412	normal	O02193	whole organism (development stage: larvae)	PEAKS045646
EXP045875	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	male salivary glands	EXP045872	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	PEAKS045647
EXP045876	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	female salivary glands	EXP045873	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	PEAKS045648
EXP045877	in house MOF antibody raised in rabbit	Drosophila melanogaster	lacO-roX2+p	EXP045874	1400	normal	O02193	whole organism (development stage: wandering third instar larva)	PEAKS045649
EXP045880	anti-Zelda antibody (Harrison et al., 2011, PLoS Genet. 7(10):e1002266)	Drosophila melanogaster	Treatment: Treatment: Treatment: Oregon R; mitotic cycle 12-c14d; zelda mutant	EXP045878	1407	normal	M9NES1	whole organism (development stage: embryonic)	PEAKS045651
EXP045882	CTCF	Drosophila melanogaster	Eye-Antennal discs	EXP045881	1400	normal	Q9VS55	whole organism (development stage: wandering third instar larva)	PEAKS045652
EXP045885	anti-E(Z), Carrington & Jones, Development (1996).	Drosophila melanogaster		EXP045883	1460	normal	P42124	0-16 h embryo	PEAKS045653
EXP045886	anti-E(Z), Carrington & Jones, Development (1996).	Drosophila melanogaster		EXP045884	1460	normal	P42124	0-16 h embryo	PEAKS045654
EXP045890	pan Mouse IgG dynabeads	Drosophila melanogaster		EXP045887	2203	normal	Q7JXA8	ovary	PEAKS045655
EXP045891	GFP-4C9	Drosophila melanogaster		EXP045888	2203	normal	Q9V629	ovary	PEAKS045656
EXP045892	GFP-4C9	Drosophila melanogaster		EXP045889	2203	normal	Q9V629	ovary	PEAKS045657
EXP045894	Santa cruz goat polyclonal #sc-15813	Drosophila melanogaster	yw strain	EXP045893	1435	normal	P28159	2-4 h embryo	PEAKS045658
EXP045895	Santa cruz rabbit polyclonal #sc-25761	Drosophila melanogaster	yw strain	EXP045893	1435	normal	P28159	2-4 h embryo	PEAKS045659
EXP045900	PH	Drosophila melanogaster	Treatment: none	EXP045896	1462	normal	P11346	16-18 h embryo	PEAKS045660
EXP045901	PHO	Drosophila melanogaster	Treatment: PH del mutant	EXP045897	1462	normal	Q8ST83	16-18 h embryo	PEAKS045661
EXP045902	PC	Drosophila melanogaster	Treatment: PH del mutant	EXP045897	1462	normal	P26017	16-18 h embryo	PEAKS045662
EXP045903	PC	Drosophila melanogaster	Treatment: none	EXP045898	1462	normal	P26017	16-18 h embryo	PEAKS045663
EXP045904	PHO	Drosophila melanogaster	Treatment: none	EXP045898	1462	normal	Q8ST83	16-18 h embryo	PEAKS045664
EXP045905	PHO	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	Q8ST83	4-12 h embryo	PEAKS045665
EXP045906	PC	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	P26017	4-12 h embryo	PEAKS045666
EXP045907	DSP1	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	Q24537	4-12 h embryo	PEAKS045667
EXP045908	PH	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	P11346	4-12 h embryo	PEAKS045668
EXP045911	Ph	Drosophila melanogaster		EXP045909	1242	normal	P11346	S2 cells	PEAKS045669
EXP045912	Ph	Drosophila melanogaster	mutant (PH-ML)	EXP045910	1242	normal	P11346	S2 cells	PEAKS045670
EXP045913	Pc (Pirrotta Lab; affinity purified)	Drosophila melanogaster	Treatment: grown at 25C	NULL	1463	normal	P26017	EZ2-2 (E(z) temperature sensitive cells)	PEAKS045671
EXP045917	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	salivary glands; female	EXP045914	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	PEAKS045672
EXP045918	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	salivary glands; male	EXP045915	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	PEAKS045673
EXP045919	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	salivary glands; male; mof2 mutant	EXP045916	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	PEAKS045674
EXP045921	anti-GFP	Drosophila melanogaster		EXP045920	1446	normal	P13002	eye/antennal imaginal discs	PEAKS045675
EXP045924	BEAF	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045676
EXP045925	BEAF	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q94513	Kc167 (development stage: embryonic)	PEAKS045677
EXP045926	CapH2	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	PEAKS045678
EXP045927	CapH2	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	PEAKS045679
EXP045928	CBP	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	M9MS40	Kc167 (development stage: embryonic)	PEAKS045680
EXP045929	CBP	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	M9MS40	Kc167 (development stage: embryonic)	PEAKS045681
EXP045930	CP190	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045682
EXP045931	CTCF	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045683
EXP045932	DREF	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q94883	Kc167 (development stage: embryonic)	PEAKS045684
EXP045933	DREF	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q94883	Kc167 (development stage: embryonic)	PEAKS045685
EXP045934	Fs1h-L	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	M9PJC7	Kc167 (development stage: embryonic)	PEAKS045686
EXP045935	L3mbt	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VB52	Kc167 (development stage: embryonic)	PEAKS045687
EXP045936	L3mbt	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VB52	Kc167 (development stage: embryonic)	PEAKS045688
EXP045937	Pc_RJ	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	P26017	Kc167 (development stage: embryonic)	PEAKS045689
EXP045938	Pc_RJ	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	P26017	Kc167 (development stage: embryonic)	PEAKS045690
EXP045939	Pc_VP	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	P26017	Kc167 (development stage: embryonic)	PEAKS045691
EXP045940	Rad21	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	PEAKS045692
EXP045941	SuHw	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	A0A0B4K6W1	Kc167 (development stage: embryonic)	PEAKS045693
EXP045942	pzg	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VP57	Kc167 (development stage: embryonic)	PEAKS045694
EXP045943	pzg	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VP57	Kc167 (development stage: embryonic)	PEAKS045695
EXP045944	TFIIIC	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	PEAKS045696
EXP045945	TFIIIC	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	PEAKS045697
EXP045946	CTCF	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	PEAKS045698
EXP045947	CP190	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045699
EXP045948	CapH2	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q8INL2	Kc167 (development stage: embryonic)	PEAKS045700
EXP045949	CBP	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	M9PH39	Kc167 (development stage: embryonic)	PEAKS045701
EXP045950	Rad21	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	PEAKS045702
EXP045951	Fs1h-L	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	M9PJC7	Kc167 (development stage: embryonic)	PEAKS045703
EXP045952	Chromator	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q8T9D1	Kc167 (development stage: embryonic)	PEAKS045704
EXP045953	Chromator	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q8T9D1	Kc167 (development stage: embryonic)	PEAKS045705
EXP045954	Modmdg4	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	A0A0B4K6B8	Kc167 (development stage: embryonic)	PEAKS045706
EXP045958	HP1a polyclonal (rabbit)	Drosophila melanogaster	Treatment: none	EXP045955	1400	normal	P05205	whole organism (development stage: wandering third instar larva)	PEAKS045707
EXP045959	HP1a polyclonal (rabbit)	Drosophila melanogaster	Treatment: CDK12 knockdown	EXP045956	1400	normal	P05205	whole organism (development stage: wandering third instar larva)	PEAKS045708
EXP045960	CDK12 polyclonal (rabbit)	Drosophila melanogaster	Treatment: none	EXP045957	1400	normal	Q9VP22	whole organism (development stage: wandering third instar larva)	PEAKS045709
EXP045963	ELAV	Drosophila melanogaster		EXP045961	1464	normal	P16914	6-8 h embryo	PEAKS045710
EXP045964	ELAV	Drosophila melanogaster		EXP045962	1465	normal	P16914	10-12 h embryo	PEAKS045711
EXP045967	anti-V5 agarose affinity gel (Sigma, catalog# A7345, lot# 021M4839)	Drosophila melanogaster		EXP045965	1460	normal	P83949	0-16 h embryo	PEAKS045712
EXP045968	Ubx	Drosophila melanogaster	wt, no V5-tag	EXP045966	1460	bio_control	P83949	0-16 h embryo	PEAKS045713
EXP045971	affinity-purified rabbit antibody raised against aa 2540-3190 in Drosophila CBP (nejire)	Drosophila melanogaster		EXP045969	1242	normal	M9MS40	S2 cells	PEAKS045714
EXP045972	affinity-purified guinea-pig antibody raised against aa 1-178 in Drosophila CBP (nejire)	Drosophila melanogaster		EXP045970	1242	normal	M9MS40	S2 cells	PEAKS045715
EXP045974	goat anti-Su(H) pAb (Santa Cruz Biotechnology, catalog# sc-15813, lot# I1704)	Drosophila melanogaster		EXP045973	1197	normal	P28159	S2-DRSC (embryonic stem cells)	PEAKS045716
EXP045979	Zld	Drosophila melanogaster	wt	EXP045975	1466	normal	Q7YU17	2-3 h embryo	PEAKS045717
EXP045980	Dl	Drosophila melanogaster	wt	EXP045977	1466	normal	P15330	2-3 h embryo	PEAKS045718
EXP045981	Dl	Drosophila melanogaster	Zld(-)	NULL	1466	normal	P15330	2-3 h embryo	PEAKS045719
EXP045982	Zld	Drosophila melanogaster	gd7	EXP045976	1466	normal	M9NES1	2-3 h embryo	PEAKS045720
EXP045985	E(Z) from Kahn et al., 2006	Drosophila melanogaster		EXP045983	1467	normal	P42124	Psc4-1 (Psc/Su(z)2 ) cell line	PEAKS045721
EXP045986	E(Z) from Kahn et al., 2006	Drosophila melanogaster		EXP045984	1468	normal	P42124	Ras3 cell line	PEAKS045722
EXP045988	cg1894	Drosophila melanogaster		EXP045987	1242	normal	Q9VAV6	S2 cells	PEAKS045723
EXP045991	Anti-V5 antibody (Abcam; ab9116)	Drosophila melanogaster	GFP-KD	EXP045989	1242	normal	Q9VFF3	S2 cells	PEAKS045724
EXP045992	Anti-V5 antibody (Abcam; ab9116)	Drosophila melanogaster	Su(var)3-9 KD	EXP045990	1242	normal	Q9VFF3	S2 cells	PEAKS045725
EXP045994	mouse-raised STAT92E antibody (self-made);	Drosophila melanogaster	strain: W1118; genotype: esgts>Upd STAT92E (intestines ectopically expressing Upd and STAT92E in the progenitor cells)	EXP045993	1469	normal	Q24151	intestines (developmental stage: adult)	PEAKS045726
EXP045997	Mix of 3 anti-COL home made monoclonal antibodies	Drosophila melanogaster		EXP045995	1470	normal	P56721	whole organism (developmental stage: E13-14)	PEAKS045727
EXP045999	CTCF guinea-pig polyclonal	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	Q8TA44	Kc167 (development stage: embryonic)	PEAKS045728
EXP046000	dSmad2 sheep polyclonal (R&D systems cat#AF7948)	Drosophila melanogaster		EXP045998	1397	normal	O96660	Kc167 (development stage: embryonic)	PEAKS045729
EXP046001	dSmad2 sheep polyclonal (R&D systems cat#AF7948)	Drosophila melanogaster	RNAi depletion of CTCF	EXP045998	1397	normal	O96660	Kc167 (development stage: embryonic)	PEAKS045730
EXP046002	Mad rabbit polyclonal	Drosophila melanogaster		EXP045998	1397	normal	P42003	Kc167 (development stage: embryonic)	PEAKS045731
EXP046003	Mad rabbit polyclonal	Drosophila melanogaster	RNAi depletion of CTCF	EXP045998	1397	normal	P42003	Kc167 (development stage: embryonic)	PEAKS045732
EXP046004	Mad rabbit polyclonal 	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	P42003	Kc167 (development stage: embryonic)	PEAKS045733
EXP046005	Medea rabbit polyclonal 	Drosophila melanogaster		EXP045998	1397	normal	O62609	Kc167 (development stage: embryonic)	PEAKS045734
EXP046006	Medea rabbit polyclonal 	Drosophila melanogaster	RNAi depletion of CTCF	EXP045998	1397	normal	O62609	Kc167 (development stage: embryonic)	PEAKS045735
EXP046007	Medea rabbit polyclonal 	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	O62609	Kc167 (development stage: embryonic)	PEAKS045736
EXP046008	Schnurri rabbit polyclonal	Drosophila melanogaster		EXP045998	1397	normal	Q0E9C5	Kc167 (development stage: embryonic)	PEAKS045737
EXP046009	Schnurri rabbit polyclonal	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	Q0E9C5	Kc167 (development stage: embryonic)	PEAKS045738
EXP046013	gaf	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	Q08605	2-4 h embryo	PEAKS045739
EXP046014	Pc (d-220) (Santa Cruz, catalog #sc-25762)	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	P26017	2-4 h embryo	PEAKS045740
EXP046015	Custom GenScript Sna (Full length) 134626-2	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	P08044	2-4 h embryo	PEAKS045741
EXP046016	cbp	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	M9PH39	2-4 h embryo	PEAKS045742
EXP046017	Custom GenScript Mad (aa 147-455)	Drosophila melanogaster	Treatment: gd7 genotype	EXP046011	1435	normal	P42003	2-4 h embryo	PEAKS045743
EXP046018	Custom GenScript Zen (full length)	Drosophila melanogaster	Treatment: gd7 genotype	EXP046011	1435	normal	P09089	2-4 h embryo	PEAKS045744
EXP046019	zld	Drosophila melanogaster	Treatment: gd7 genotype	EXP046011	1435	normal	M9NES1	2-4 h embryo	PEAKS045745
EXP046020	Custom GenScript Dl (aa 39-346) 126740-44	Drosophila melanogaster	Treatment: tl10b genotype	EXP046012	1435	normal	P15330	2-4 h embryo	PEAKS045746
EXP046021	zld	Drosophila melanogaster	Treatment: tl10b genotype	EXP046012	1435	normal	M9NES1	2-4 h embryo	PEAKS045747
EXP046022	Custom Covance Twi (aa 340-490)	Drosophila melanogaster	Treatment: tl10b genotype	EXP046012	1435	normal	P10627	2-4 h embryo	PEAKS045748
EXP046026	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 5% sucrose for 6 hours (contol conditions); gender: female	EXP046023	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	PEAKS045749
EXP046027	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 5% sucrose for 6 hours (contol conditions); gender: female	EXP046023	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	PEAKS045750
EXP046028	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 6 hours of 20mM paraquat in 5% sucose (oxidative stress); gender: female	EXP046024	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	PEAKS045751
EXP046029	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 6 hours of 20mM paraquat in 5% sucose (oxidative stress); gender: female	EXP046024	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	PEAKS045752
EXP046030	KDM5	Drosophila melanogaster	Treatment: Treatment: genotype: w1118 (wild type); gender: female	EXP046025	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	PEAKS045753
EXP046032	anti-GAF	Drosophila melanogaster		EXP046031	1976	normal	Q08605	imaginal discs and salivary glands (developmental stage: L3)	PEAKS045754
EXP046037	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: Su(z)124-null	EXP046033	1977	normal	P35820	S12-26I3	PEAKS045755
EXP046038	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: Su(z)124-null	EXP046034	1977	normal	P35820	S12-26I3	PEAKS045756
EXP046039	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: none	EXP046035	1468	normal	P35820	Ras3 cell line	PEAKS045757
EXP046040	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: none	EXP046036	1468	normal	P35820	Ras3 cell line	PEAKS045758
EXP046045	sin3	Drosophila melanogaster	HA-tagged SIN3 187 isoform	EXP046041	1451	normal	O77025	S2 (Schneider 2)	PEAKS045759
EXP046046	Anti-HA-Agarose antibody (Sigma)	Drosophila melanogaster	HA-tagged SIN3 187 isoform	EXP046042	1451	normal	O77025	S2 (Schneider 2)	PEAKS045760
EXP046047	Anti-HA-Agarose antibody (Sigma)	Drosophila melanogaster	HA-tagged SIN3 220 isoform	EXP046043	1451	normal	O77025	S2 (Schneider 2)	PEAKS045761
EXP046048	Anti-HA-Agarose antibody (Sigma)	Drosophila melanogaster	HA-tagged SIN3 220 isoform	EXP046044	1451	normal	O77025	S2 (Schneider 2)	PEAKS045762
EXP046050	anti-SMARCAD1 (ASNA), custom-made antibodies	Drosophila melanogaster		EXP046049	1451	normal	Q9VL72	S2 (Schneider 2)	PEAKS045763
EXP046051	anti-CBP, custom-made antibodies	Drosophila melanogaster		EXP046049	1451	normal	M9PH39	S2 (Schneider 2)	PEAKS045764
EXP046053	anti-CREB (lab made antibodies)	Drosophila melanogaster	Treatment: 1 day after spaced training; strain: CS10	NULL	1978	normal	Q9VWW0	mushroom body	PEAKS045765
EXP046054	anti-CRTC (lab made antibodies)	Drosophila melanogaster	Treatment: 1 day after spaced training; strain: CS10	NULL	1978	normal	Q9VVJ8	mushroom body	PEAKS045766
EXP046056	anti-Deformed	Drosophila melanogaster	Strain: Oregon R (wild type)	EXP046055	1979	normal	P07548	5-9.5 h embryo	PEAKS045767
EXP046061	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046057	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	PEAKS045768
EXP046062	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046058	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	PEAKS045769
EXP046063	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046059	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	PEAKS045770
EXP046064	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046060	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	PEAKS045771
EXP046067	polyclonal goat anti-GFP antibody	Drosophila melanogaster	genotype: fkh-GAL4::UAS-rib-GFP	EXP046065	1982	normal	P14734	whole organism (developmental stage: embryonic stage 11-16))	PEAKS045772
EXP046068	polyclonal goat anti-GFP antibody	Drosophila melanogaster	genotype: sage-GAL4::UAS-rib-GFP	EXP046066	1982	normal	Q9VHG3	whole organism (developmental stage: embryonic stage 11-16))	PEAKS045773
EXP046071	anti-PC	Drosophila melanogaster	Treatment: none	EXP046069	1983	normal	P26017	eye imaginal disc (developmental stage: L3)	PEAKS045774
EXP046072	anti-PH	Drosophila melanogaster	Treatment: none	EXP046069	1983	normal	P11346	eye imaginal disc (developmental stage: L3)	PEAKS045775
EXP046073	anti-PC	Drosophila melanogaster	Treatment: none	EXP046070	1439	normal	P26017	wing imaginal disc (developmental stage: L3)	PEAKS045776
EXP046074	anti-PH	Drosophila melanogaster	Treatment: none	EXP046070	1439	normal	P11346	wing imaginal disc (developmental stage: L3)	PEAKS045777
EXP046075	anti-HP1, Covance (#291C)	Drosophila melanogaster	genotype: 291C Antibodies in GFP-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045778
EXP046076	anti-HP1, Covance (#291C)	Drosophila melanogaster	genotype: 291C Antibodies in Piwi-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045779
EXP046077	anti-HP1, DSHB (#C1A9)	Drosophila melanogaster	genotype: C1A9 Antibodies in GFP-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045780
EXP046078	anti-HP1, DSHB (#C1A9)	Drosophila melanogaster	genotype: C1A9 Antibodies in Piwi-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045781
EXP046083	CAP-D3 	Drosophila melanogaster	strain: Oregon R	EXP046079	1450	normal	Q9VMQ4	S2R+ (late embryonic stage cells)	PEAKS045782
EXP046084	YZ384 (Longworth lab)	Drosophila melanogaster	strain: Oregon R	EXP046081	1450	normal	Q9VMQ4	S2R+ (late embryonic stage cells)	PEAKS045783
EXP046099	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: GFP (control)	EXP046085	1985	normal	P50534	Kc	PEAKS045784
EXP046100	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: GFP (control)	EXP046086	1985	normal	P50534	Kc	PEAKS045785
EXP046101	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: SXL construct 1	EXP046087	1985	normal	P50534	Kc	PEAKS045786
EXP046102	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: SXL construct 1	EXP046088	1985	normal	P50534	Kc	PEAKS045787
EXP046103	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 1	EXP046089	1985	normal	P50534	Kc	PEAKS045788
EXP046104	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 1	EXP046090	1985	normal	P50534	Kc	PEAKS045789
EXP046105	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 1	EXP046091	1985	normal	P50534	Kc	PEAKS045790
EXP046106	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 1	EXP046092	1985	normal	P50534	Kc	PEAKS045791
EXP046107	MSL2	Drosophila melanogaster	days of treatment: 3;  RNAi: SXL construct 2	EXP046093	1985	normal	P50534	Kc	PEAKS045792
EXP046108	MSL2	Drosophila melanogaster	days of treatment: 3;  RNAi: SXL construct 2	EXP046094	1985	normal	P50534	Kc	PEAKS045793
EXP046109	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 2	EXP046095	1985	normal	P50534	Kc	PEAKS045794
EXP046110	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 2	EXP046096	1985	normal	P50534	Kc	PEAKS045795
EXP046111	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 2	EXP046097	1985	normal	P50534	Kc	PEAKS045796
EXP046112	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 2	EXP046098	1985	normal	P50534	Kc	PEAKS045797
EXP046118	MSL2	Drosophila melanogaster	GST RNAi (control)	EXP046113	1451	normal	P50534	S2 (Schneider 2)	PEAKS045798
EXP046119	MSL2	Drosophila melanogaster	GST RNAi (control)	EXP046114	1451	normal	P50534	S2 (Schneider 2)	PEAKS045799
EXP046120	MSL2	Drosophila melanogaster	MLE RNAi	EXP046115	1451	normal	P50534	S2 (Schneider 2)	PEAKS045800
EXP046121	MSL2	Drosophila melanogaster	MLE RNAi	EXP046116	1451	normal	P50534	S2 (Schneider 2)	PEAKS045801
EXP046122	MSL2	Drosophila melanogaster	MLE RNAi	EXP046117	1451	normal	P50534	S2 (Schneider 2)	PEAKS045802
EXP046125	anti-Pho	Drosophila melanogaster	Treatment: genotype: ry	EXP046123	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	PEAKS045803
EXP046126	anti-Ph	Drosophila melanogaster	Treatment: genotype: ry	EXP046124	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	PEAKS045804
EXP046127	anti-En	Drosophila melanogaster	Treatment: genotype: ry	NULL	1986	normal	P02836	CNS and imaginal disks (developmental stage: L3)	PEAKS045805
EXP046130	Pita (rabbit, aa 550-683)	Drosophila melanogaster	strain: Oregon-R	EXP046128	1413	normal	Q9W1N1	0-12 h embryo	PEAKS045806
EXP046131	ZIPIC (rabbit, aa 84-257)	Drosophila melanogaster	strain: Oregon-R	EXP046128	1413	normal	Q9VAB8	0-12 h embryo	PEAKS045807
EXP046132	Zw5 (rabbit, aa 98-302)	Drosophila melanogaster	strain: Oregon-R	EXP046128	1413	normal	Q9U9D0	0-12 h embryo	PEAKS045808
EXP046135	anti-Ph	Drosophila melanogaster	genotype: ry- enPREs deleted	EXP046133	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	PEAKS045809
EXP046136	anti-Ph	Drosophila melanogaster	genotype: ry- invPREs deleted	EXP046134	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	PEAKS045810
EXP046137	anti-Ph	Drosophila melanogaster	genotype: ry- invPREs-enPREs deleted	NULL	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	PEAKS045811
EXP046138	anti-Pho	Drosophila melanogaster	genotype: ry- invPREs-enPREs deleted	NULL	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	PEAKS045812
EXP046139	anti-Pho	Drosophila melanogaster	genotype: ry- invPREs deleted	NULL	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	PEAKS045813
EXP046140	anti-Pho	Drosophila melanogaster	genotype: ry- enPREs deleted	NULL	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	PEAKS045814
EXP046142	antiCg (custom-made)	Drosophila melanogaster	Treatment: genotype: ry- wild type	EXP046141	1976	normal	Q9NI49	imaginal discs and salivary glands (developmental stage: L3)	PEAKS045815
EXP046143	anti-Ph (a kind gift from Donna Arndt-Jovin)	Drosophila melanogaster	Treatment: genotype: cgA22 mutant	NULL	1976	normal	P11346	imaginal discs and salivary glands (developmental stage: L3)	PEAKS045816
EXP046144	GAF	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q08605	Kc167 (development stage: embryonic)	PEAKS045817
EXP046145	Ibf1	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VHG5	Kc167 (development stage: embryonic)	PEAKS045818
EXP046146	Ibf2	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VHG6	Kc167 (development stage: embryonic)	PEAKS045819
EXP046147	Pita	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9W1N1	Kc167 (development stage: embryonic)	PEAKS045820
EXP046148	ZIPIC	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VAB8	Kc167 (development stage: embryonic)	PEAKS045821
EXP046149	Nup98	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VCH5	Kc167 (development stage: embryonic)	PEAKS045822
EXP046153	anti-HP1a antibody (C1A9, DSHB)	Drosophila melanogaster	Control (RNAi EGFP)	EXP046150	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045823
EXP046154	anti-HP1a antibody (C1A9, DSHB)	Drosophila melanogaster	Piwi-Knockdown (RNAi Piwi)	EXP046151	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045824
EXP046155	anti-HP1a antibody (C1A9, DSHB)	Drosophila melanogaster	H1-Knockdown (RNAi H1)	EXP046152	1984	normal	P05205	OSC (Ovarian Somatic Cells)	PEAKS045825
EXP046166	creb	Drosophila melanogaster	strain: CS10	EXP046156	1978	normal	Q1LZ07	mushroom body	PEAKS045835
EXP046167	anti-CRTC (lab made antibodies)	Drosophila melanogaster	spaced trained 1d; strain: CS10	EXP046156	1978	normal	Q9VVJ8	mushroom body	PEAKS045836
EXP046168	crtc	Drosophila melanogaster	strain: CS10	EXP046156	1978	normal	Q9VVJ8	mushroom body	PEAKS045837
EXP046169	anti-CREB (lab made antibodies)	Drosophila melanogaster	spaced trained 1d; strain: CS10	EXP046156	1978	normal	Q1LZ07	mushroom body	PEAKS045838
EXP046171	anti-GFP Ab (ab290, Abcam)	Drosophila melanogaster	strain: Bloomington 42269; DAC-GFP	EXP046170	1987	normal	Q9VJK6	eye-antennal discs (developmental stage: L3)	PEAKS045839
EXP046176	Pc from Poux et al., 2001	Drosophila melanogaster	genotype: Su(z)124 mutant	EXP046172	1977	normal	P26017	S12-26I3	PEAKS045840
EXP046177	Pc from Poux et al., 2001	Drosophila melanogaster	genotype: Su(z)124 mutant	EXP046173	1977	normal	P26017	S12-26I3	PEAKS045841
EXP046178	Pc from Poux et al., 2001	Drosophila melanogaster		EXP046174	1468	normal	P26017	Ras3 cell line	PEAKS045842
EXP046179	Pc from Poux et al., 2001	Drosophila melanogaster		EXP046175	1468	normal	P26017	Ras3 cell line	PEAKS045843
EXP046185	C-terminal anti-GRH	Drosophila melanogaster		EXP046180	1988	normal	P13002	2-3 hrs AEL embryo	PEAKS045844
EXP046186	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046180	1988	normal	P13002	2-3 hrs AEL embryo	PEAKS045845
EXP046187	C-terminal anti-GRH	Drosophila melanogaster		EXP046181	1989	normal	P13002	5-6 hrs AEL embryo	PEAKS045846
EXP046188	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046181	1989	normal	P13002	5-6 hrs AEL embryo	PEAKS045847
EXP046189	C-terminal anti-GRH	Drosophila melanogaster		EXP046182	1990	normal	P13002	11-12 hrs AEL embryo	PEAKS045848
EXP046190	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046182	1990	normal	P13002	11-12 hrs AEL embryo	PEAKS045849
EXP046191	C-terminal anti-GRH	Drosophila melanogaster		EXP046183	1991	normal	P13002	15-16 hrs AEL embryo	PEAKS045850
EXP046192	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046183	1991	normal	P13002	15-16 hrs AEL embryo	PEAKS045851
EXP046193	C-terminal anti-GRH	Drosophila melanogaster		EXP046184	1439	normal	P13002	wing imaginal disc (developmental stage: L3)	PEAKS045852
EXP046197	Gcn5 rabbit polyclonal antibody (5 ug/IP)	Drosophila melanogaster	CP190 RNAi	EXP046194	1985	normal	O76216	Kc	PEAKS045853
EXP046198	Gcn5 rabbit polyclonal antibody (5 ug/IP)	Drosophila melanogaster	GFP RNAi (Control)	EXP046195	1985	normal	O76216	Kc	PEAKS045854
EXP046199	Gcn5 rabbit polyclonal antibody (5 ug/IP)	Drosophila melanogaster	GFP RNAi (Control)	EXP046196	1451	normal	O76216	S2 (Schneider 2)	PEAKS045855
EXP046202	anti-CLAMP (SDix, Cat# 4988.00.02, Lot# G3131-080A02; PMID 22844249)	Drosophila melanogaster	gender: female	EXP046200	1428	normal	Q9V9N4	whole organism (developmental stage: L3)	PEAKS045856
EXP046203	anti-CLAMP (SDix, Cat# 4988.00.02, Lot# G3131-080A02; PMID 22844249)	Drosophila melanogaster	gender: female	EXP046201	1428	normal	Q9V9N4	whole organism (developmental stage: L3)	PEAKS045857
EXP046205	Nipped-B	Drosophila melanogaster		EXP046204	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045858
EXP046206	SA	Drosophila melanogaster		EXP046204	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045859
EXP046207	TBPH	Drosophila melanogaster		EXP046204	1244	normal	O97468	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045860
EXP046208	Lark	Drosophila melanogaster		EXP046204	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045861
EXP046209	Nipped-B	Drosophila melanogaster	TBPH RNAi treatment	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045862
EXP046210	SA	Drosophila melanogaster	TBPH RNAi treatment	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045863
EXP046211	Nipped-B	Drosophila melanogaster	Lark RNAi treatment	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045864
EXP046212	SA	Drosophila melanogaster	Lark RNAi treatment	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045865
EXP046213	TBPH	Drosophila melanogaster	Nipped-B RNAi treatment	NULL	1244	normal	O97468	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045866
EXP046214	Lark	Drosophila melanogaster	Nipped-B RNAi treatment	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045867
EXP046215	Nipped-B	Drosophila melanogaster	10 micromolar triptolide treatment (4 hour)	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045868
EXP046216	TBPH	Drosophila melanogaster	10 micromolar triptolide treatment (1 hour)	NULL	1244	normal	O97468	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045869
EXP046217	Lark	Drosophila melanogaster	10 micromolar triptolide treatment (1 hour)	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045870
EXP046218	Lark	Drosophila melanogaster	10 micromolar triptolide treatment (2 hour)	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045871
EXP046219	Lark	Drosophila melanogaster	10 micromolar triptolide treatment (4 hour)	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS045872
EXP046220	Nipped-B	Drosophila melanogaster	gender: yw male	NULL	1439	normal	Q7PLI2	wing imaginal disc (developmental stage: L3)	PEAKS045873
EXP046221	TBPH	Drosophila melanogaster	gender: yw male	NULL	1439	normal	O97468	wing imaginal disc (developmental stage: L3)	PEAKS045874
EXP046222	Lark	Drosophila melanogaster	gender: yw male	NULL	1439	normal	Q94901	wing imaginal disc (developmental stage: L3)	PEAKS045875
EXP046225	sc	Drosophila melanogaster	7 days at 29Â°C; genotype: 3HA-scÂ transgene	EXP046223	1469	normal	P10084	intestines (developmental stage: adult)	PEAKS045876
EXP046226	esg	Drosophila melanogaster	7 days at 29Â°C; genotype: 3HA-esg transgene	EXP046224	1469	normal	P25932	intestines (developmental stage: adult)	PEAKS045877
EXP046228		Drosophila melanogaster	GalNAz feeding	EXP046227	1451	normal	Q7KJA9	S2 (Schneider 2)	PEAKS045878
EXP046229	Pho antibody	Drosophila melanogaster		EXP046227	1451	normal	Q8ST83	S2 (Schneider 2)	PEAKS045879
EXP046360	rabbit ?ROW	Drosophila melanogaster		EXP046358	1451	normal	A0A0B4KER0	S2 (Schneider 2)	PEAKS045961
EXP046359	rabbit ?WOC	Drosophila melanogaster		EXP046358	1451	normal	A8JRE3	S2 (Schneider 2)	PEAKS045960
EXP046232		Drosophila melanogaster	GalNAz feeding; wild type	NULL	1404	normal	Q7KJA9	whole organism (development stage: pupa)	PEAKS045882
EXP046233		Drosophila melanogaster	GalNAz feeding; strain: sxc6/sxc7 null	NULL	1404	bio_control	Q7KJA9	whole organism (development stage: pupa)	PEAKS045883
EXP046235	y14	Drosophila melanogaster		EXP046234	1451	normal	Q9V535	S2 (Schneider 2)	PEAKS045884
EXP046238	anti-HP1a (Covance, PRB-291C, Lot #D14JF02175)	Drosophila melanogaster	genotype: HWT	EXP046237	1428	normal	P05205	whole organism (developmental stage: L3)	PEAKS045885
EXP046239	anti-HP1a (Covance, PRB-291C, Lot #D14JF02175)	Drosophila melanogaster	genotype: K9R	EXP046236	1428	normal	P05205	whole organism (developmental stage: L3)	PEAKS045886
EXP046241	CTCF (PMID: 15678159)	Drosophila melanogaster	Treatment: none	EXP046240	1407	normal	Q9VS55	whole organism (development stage: embryonic)	PEAKS045887
EXP046242	anti-TFIIA rabbit polyclonal, Kadonaga lab	Drosophila melanogaster		NULL	1397	normal	P52654	Kc167 (development stage: embryonic)	PEAKS045888
EXP046243	anti-TFIIB rabbit polyclonal, Kadonaga lab	Drosophila melanogaster		NULL	1397	normal	P29052	Kc167 (development stage: embryonic)	PEAKS045889
EXP046245	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	PEAKS045890
EXP046246	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	PEAKS045891
EXP046247	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P29555	Kc167 (development stage: embryonic)	PEAKS045892
EXP046248	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P09087	Kc167 (development stage: embryonic)	PEAKS045893
EXP046249	anti-GFP	Drosophila melanogaster	mutant Ubx	EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	PEAKS045894
EXP046250	anti-GFP	Drosophila melanogaster	Ubx-GFP and Hth expression	EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	PEAKS045895
EXP046252	anti-Su(Hw) guinea pig antibody (Baxley et al., 2011)	Drosophila melanogaster	su(Hw)M393 allele	EXP046251	2203	normal	P08970	ovary	PEAKS045896
EXP046254	MLF	Drosophila melanogaster		EXP046253	1451	normal	Q9NKV0	S2 (Schneider 2)	PEAKS045897
EXP046255	DnaJ1	Drosophila melanogaster		EXP046253	1451	normal	Q24133	S2 (Schneider 2)	PEAKS045898
EXP046257	atro	Drosophila melanogaster		EXP046256	1451	normal	Q8T9N4	S2 (Schneider 2)	PEAKS045899
EXP046259	Rabbit anti-Atro sera (SG2524)	Drosophila melanogaster		EXP046258	1451	normal	Q8T9N4	S2 (Schneider 2)	PEAKS045900
EXP046267	Aly	Drosophila melanogaster		EXP046260	2160	bio_control	Q2PNM9	testis	PEAKS045901
EXP046268	Kmg	Drosophila melanogaster		EXP046261	2160	normal	Q9VK36	testis	PEAKS045902
EXP046269	anti-Kmg	Drosophila melanogaster	UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	EXP046262	2160	normal	Q9VK36	testis	PEAKS045903
EXP046270	Dmi2	Drosophila melanogaster		EXP046263	2160	normal	O97159	testis	PEAKS045904
EXP046271	Dmi2	Drosophila melanogaster	UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	EXP046264	2160	normal	O97159	testis	PEAKS045905
EXP046272	Aly-HA	Drosophila melanogaster	alyP-Aly-HA; UAS-RNAi-kmg (VDRC# 107395); TM6b	EXP046265	2160	normal	Q2PNM9	testis	PEAKS045906
EXP046273	Aly-HA	Drosophila melanogaster	alyP-Aly-HA; UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	EXP046266	2160	normal	Q2PNM9	testis	PEAKS045907
EXP046275	anti_Trr (Johnston et al., 2011)	Drosophila melanogaster		EXP046274	1445	normal	Q8IRW8	head, adult	PEAKS045908
EXP046277	UpSET	Drosophila melanogaster		EXP046276	2161	normal	Q8T0K2	12-24 hrs embryo	PEAKS045909
EXP046281	polyclonal antibody against fly Ash1 from rabbit	Drosophila melanogaster	Treatment: siAsh1	EXP046279	1451	bio_control	Q9VW15	S2 (Schneider 2)	PEAKS045910
EXP046282	polyclonal antibody against fly Ash1 from rabbit	Drosophila melanogaster	Treatment: siMrg15	EXP046280	1451	normal	Q9VW15	S2 (Schneider 2)	PEAKS045911
EXP046283	polyclonal antibody against fly Mrg15 from rabbit	Drosophila melanogaster	Treatment: siAsh1	EXP046279	1451	normal	Q9Y0I1	S2 (Schneider 2)	PEAKS045912
EXP046284	polyclonal antibody against fly Mrg15 from rabbit	Drosophila melanogaster	Treatment: siMrg15	EXP046280	1451	bio_control	Q9Y0I1	S2 (Schneider 2)	PEAKS045913
EXP046285	Normal Rabbit IgGÂ #2729 from CST Ltd.	Drosophila melanogaster	Treatment: none	NULL	1451	normal	A1Z7S1	S2 (Schneider 2)	PEAKS045914
EXP046286	polyclonal antibody against fly Ash1 from rabbit	Drosophila melanogaster	Treatment: none	EXP046278	1451	normal	Q9VW15	S2 (Schneider 2)	PEAKS045915
EXP046287	polyclonal antibody against fly Mrg15 from rabbit	Drosophila melanogaster	Treatment: none	EXP046278	1451	normal	Q9Y0I1	S2 (Schneider 2)	PEAKS045916
EXP046289	e(pc)	Drosophila melanogaster		EXP046288	2160	normal	P26017	testis	PEAKS045917
EXP046291	anti-MSL2 (Becker lab)	Drosophila melanogaster	Treatment: none	EXP046290	1451	normal	P50534	S2 (Schneider 2)	PEAKS045918
EXP046295	Nup98	Drosophila melanogaster	Treatment: wild type	EXP046292	1451	normal	A1YK24	S2 (Schneider 2)	PEAKS045919
EXP046296	Nup98	Drosophila melanogaster	Treatment: Nup98 overexpression	EXP046292	1451	normal	A1YK24	S2 (Schneider 2)	PEAKS045920
EXP046297	Nup98	Drosophila melanogaster	Treatment: none	EXP046293	2163	normal	A1YK24	brain, third instar larva	PEAKS045921
EXP046298	none	Drosophila melanogaster	Treatment: none	NULL	2163	normal	A0A0B4KGX3	brain, third instar larva	PEAKS045922
EXP046299	Elys (This study)	Drosophila melanogaster	Treatment: none	EXP046294	2163	normal	Q9VWE6	brain, third instar larva	PEAKS045923
EXP046300	Nup93 	Drosophila melanogaster	Treatment: none	EXP046294	2163	normal	Q9XZ06	brain, third instar larva	PEAKS045924
EXP046305	anti-LPT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-C2398A	EXP046302	2164	normal	Q9W1H0	brain, adult	PEAKS045925
EXP046306	anti-LPT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-WT	EXP046303	2164	normal	Q9W1H0	brain, adult	PEAKS045926
EXP046307	anti-LPT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-Y2383F	EXP046304	2164	normal	Q9W1H0	brain, adult	PEAKS045927
EXP046308	anti-TRR-NT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-WT	EXP046301	2164	normal	Q8IRW8	brain, adult	PEAKS045928
EXP046309	anti-TRR-NT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-C2398A	EXP046301	2164	normal	Q8IRW8	brain, adult	PEAKS045929
EXP046310	anti-TRR-NT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-Y2383F	EXP046301	2164	normal	Q8IRW8	brain, adult	PEAKS045930
EXP046313	anti-CP190	Drosophila melanogaster		EXP046311	1451	normal	Q24478	S2 (Schneider 2)	PEAKS045931
EXP046314	anti-CP190	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	EXP046312	1451	normal	Q24478	S2 (Schneider 2)	PEAKS045932
EXP046315	Anti-dCTCF (N3)	Drosophila melanogaster		EXP046311	1451	normal	Q9VS55	S2 (Schneider 2)	PEAKS045933
EXP046316	Anti-dCTCF (N3)	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	EXP046312	1451	normal	Q9VS55	S2 (Schneider 2)	PEAKS045934
EXP046317	Anti-FLAG-M2	Drosophila melanogaster		EXP046311	1451	normal	O97102	S2 (Schneider 2)	PEAKS045935
EXP046318	Anti-FLAG-M2	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	EXP046312	1451	normal	O97102	S2 (Schneider 2)	PEAKS045936
EXP046320	anti-dBigH1 (PÃ©rez-Montero et al., 2013)	Drosophila melanogaster		EXP046319	2165	normal	Q8MSC4	testes, adult	PEAKS045937
EXP046324	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w1118.tm3; ;	EXP046321	2203	normal	Q7JXA8	ovary	PEAKS045938
EXP046325	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w; rhi[18-5]/ rhi[18-7]; ; Rhino KO	EXP046322	2203	bio_control	Q7JXA8	ovary	PEAKS045939
EXP046326	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w, moon_FS1{delta}1/moon_FS2{delta}28; ; moonshiner KO	EXP046323	2203	normal	Q7JXA8	ovary	PEAKS045940
EXP046327	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w ; Pld{delta}prom[m1-1] ;	EXP046321	2203	normal	Q7JXA8	ovary	PEAKS045941
EXP046329	M1BP	Drosophila melanogaster		EXP046328	1450	normal	Q9VHM3	S2R+ (late embryonic stage cells)	PEAKS045942
EXP046330	TAF1 (TAF250)	Drosophila melanogaster		EXP046328	1450	normal	P51123	S2R+ (late embryonic stage cells)	PEAKS045943
EXP046331	TRF2	Drosophila melanogaster		EXP046328	1450	normal	Q07DP5	S2R+ (late embryonic stage cells)	PEAKS045944
EXP046333	GFP (Abcam, ab290)	Drosophila melanogaster		EXP046332	1451	normal	P26017	S2 (Schneider 2)	PEAKS045945
EXP046342	rabbit-anti-sgf11	Drosophila melanogaster		EXP046334	1229	normal	Q9VVR6	1-3 h embryo	PEAKS045946
EXP046343	rabbit-anti-sgf11	Drosophila melanogaster		EXP046335	1229	normal	Q9VVR6	1-3 h embryo	PEAKS045947
EXP046344	rabbit-anti-sgf11	Drosophila melanogaster		EXP046336	1229	normal	Q9VVR6	1-3 h embryo	PEAKS045948
EXP046345	rabbit-anti-nonstop	Drosophila melanogaster		EXP046337	1229	normal	Q9VVR1	1-3 h embryo	PEAKS045949
EXP046346	rabbit-anti-nonstop	Drosophila melanogaster		EXP046336	1229	normal	Q9VVR1	1-3 h embryo	PEAKS045950
EXP046347	rabbit-anti-ada2b	Drosophila melanogaster		EXP046338	1229	normal	Q8I8V0	1-3 h embryo	PEAKS045951
EXP046348	rabbit-anti-ada2b	Drosophila melanogaster		EXP046339	1229	normal	Q8I8V0	1-3 h embryo	PEAKS045952
EXP046349	rabbit-anti-ada2b	Drosophila melanogaster		EXP046340	1229	normal	Q8I8V0	1-3 h embryo	PEAKS045953
EXP046350	rabbit-anti-ada2b	Drosophila melanogaster		EXP046341	1229	normal	Q8I8V0	1-3 h embryo	PEAKS045954
EXP046351	rabbit-anti-spt3	Drosophila melanogaster		EXP046338	1229	normal	Q29R40	1-3 h embryo	PEAKS045955
EXP046352	rabbit-anti-spt3	Drosophila melanogaster		EXP046339	1229	normal	Q29R40	1-3 h embryo	PEAKS045956
EXP046353	rabbit-anti-spt3	Drosophila melanogaster		EXP046341	1229	normal	Q29R40	1-3 h embryo	PEAKS045957
EXP046356	anti-Myc	Drosophila melanogaster		EXP046354	1439	normal	Q95TJ9	wing imaginal disc (developmental stage: L3)	PEAKS045958
EXP046357	anti-Myc	Drosophila melanogaster		EXP046355	1439	normal	Q95TJ9	wing imaginal disc (developmental stage: L3)	PEAKS045959
EXP046361	guinea pig ?Z4	Drosophila melanogaster		EXP046358	1451	normal	Q9VP57	S2 (Schneider 2)	PEAKS045962
EXP046363	rad21	Drosophila melanogaster		EXP046362	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	PEAKS045963
EXP046364	barren	Drosophila melanogaster	Interphase	EXP046362	1397	normal	Q9VIP9	Kc167 (development stage: embryonic)	PEAKS045964
EXP046365	barren	Drosophila melanogaster	Asynchronous	EXP046362	1397	normal	Q9VIP9	Kc167 (development stage: embryonic)	PEAKS045965
EXP046366	CAPH2	Drosophila melanogaster	Interphase	EXP046362	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	PEAKS045966
EXP046367	CAPH2	Drosophila melanogaster	Asynchronous	EXP046362	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	PEAKS045967
EXP046368	chromator	Drosophila melanogaster		EXP046362	1397	normal	Q86BS3	Kc167 (development stage: embryonic)	PEAKS045968
EXP046369	GAF	Drosophila melanogaster		EXP046362	1397	normal	A4V1Y6	Kc167 (development stage: embryonic)	PEAKS045969
EXP046370	CP190	Drosophila melanogaster		EXP046362	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045970
EXP046371	dTFIIIC220	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	PEAKS045971
EXP046372	Cohesin (Rad21)	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	PEAKS045972
EXP046373	CAPH2	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	PEAKS045973
EXP046374	CP190	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	Q24478	Kc167 (development stage: embryonic)	PEAKS045974
EXP046375	dTFIIIC220	Drosophila melanogaster		EXP046362	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	PEAKS045975
EXP046387	HMR	Drosophila melanogaster	Treatment: untreated	EXP046377	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045976
EXP046388	HP1a	Drosophila melanogaster	Treatment: untreated	EXP046377	1197	normal	P05205	S2-DRSC (embryonic stem cells)	PEAKS045977
EXP046389	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: untreated	EXP046379	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045978
EXP046390	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: untreated	EXP046379	1197	normal	P05205	S2-DRSC (embryonic stem cells)	PEAKS045979
EXP046391	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: untreated	EXP046380	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045980
EXP046392	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: untreated	EXP046381	1197	normal	P05205	S2-DRSC (embryonic stem cells)	PEAKS045981
EXP046393	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: Ctrl RNAi	EXP046382	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045982
EXP046394	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: HMR RNAi	EXP046383	1197	bio_control	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045983
EXP046395	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: CP190 RNAi	EXP046384	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045984
EXP046396	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: Ctrl RNAi	EXP046385	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045985
EXP046397	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: HMR RNAi	EXP046386	1197	bio_control	Q86CW5	S2-DRSC (embryonic stem cells)	PEAKS045986
EXP046398	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: Ctrl RNAi	EXP046382	1197	normal	P05205	S2-DRSC (embryonic stem cells)	PEAKS045987
EXP046399	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: HMR RNAi	EXP046383	1197	normal	P05205	S2-DRSC (embryonic stem cells)	PEAKS045988
EXP046470	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2202, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2202-GFP.FPTB}VK00033	EXP046455	1407	normal	Q9VZ63	whole organism (development stage: embryonic)	PEAKS045989
EXP046471	ab290	Drosophila melanogaster	strain: dl-large-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=dl-GFP.FTBP}VK00033	EXP046425	1400	normal	P15330	whole organism (development stage: wandering third instar larva)	PEAKS045990
EXP046472	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP745, genotype: wgIs745Â [mxl-3::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046441	1389	normal	Q18711	whole worms (developmental stage: L4/young adults)	PEAKS045991
EXP046473	goat-anti-GFP-UC	Drosophila melanogaster	strain: Fer3, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer3-GFP.FPTB}attP40	EXP046421	1407	normal	C0MK09	whole organism (development stage: embryonic)	PEAKS045992
EXP046474	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8NCP5	HEK293 (embryonic kidney)	PEAKS045993
EXP046475	F1804	Homo sapiens		EXP039140	430	normal	Q9UGU5	HepG2 (hepatoblastoma)	PEAKS045994
EXP046476	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG31365, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG31365-GFP.FPTB} attP40, sex:mixed	EXP046418	1407	normal	Q8T051	whole organism (development stage: embryonic)	PEAKS045995
EXP046477	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP769, genotype: unc-119(tm4063); wgls769 [sptf-2::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046461	1235	normal	Q22678	whole worms (developmental stage: young adults)	PEAKS045996
EXP046478	goat-anti-GFP-UC	Drosophila melanogaster	strain: D1, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=D1-GFP.FPTB}attP40	EXP046415	1404	normal	A4V2K7	whole organism (development stage: pupa)	PEAKS045997
EXP046479	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG33017, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG33017-GFP.FPTB}VK00033/TM6C, Sb[1], sex:male	EXP046409	1399	normal	A1ZAC8	whole organism (development stage: adult)	PEAKS045998
EXP046480	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7101, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7101-GFP.FPTB}VK00033/TM6C, Sb[1], sex:female	EXP046459	1399	normal	Q9VWP7	whole organism (development stage: adult)	PEAKS045999
EXP046481	goat-anti-GFP-UC	Drosophila melanogaster	strain: HmgZ, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=HmgZ-GFP.FPTB} VK00033, sex:mixed	EXP046402	1407	normal	Q06943	whole organism (development stage: embryonic)	PEAKS046000
EXP046482	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP344, genotype: unc-119(tm4063); wgIs344 [F49E12.6::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046448	1387	normal	Q20619	whole worms (developmental stage: L1)	PEAKS046001
EXP046483	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP752, genotype: unc-119(tm4063); wgIs752 [somi-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046413	1235	normal	Q8I4H1	whole worms (developmental stage: young adults)	PEAKS046002
EXP046484	goat-anti-GFP-UC	Drosophila melanogaster	strain: salr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=salr-GFP.FPTB}VK00033, sex:mixed	EXP046449	1408	normal	Q9VKH3	whole organism (development stage: prepupa)	PEAKS046003
EXP046485	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hey, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=Hey-GFP.FPTB} VK00033, sex:mixed	EXP046401	1407	normal	Q7KM13	whole organism (development stage: embryonic)	PEAKS046004
EXP046486	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q86W11	HEK293 (embryonic kidney)	PEAKS046005
EXP046487	goat-anti-GFP-UC	Drosophila melanogaster	strain: Fer2, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer2-GFP.FPTB}attP40	EXP046435	1407	normal	Q9VEY3	whole organism (development stage: embryonic)	PEAKS046006
EXP046488	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP749, genotype: wgIs749Â [tlf-1::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046454	1235	normal	B2D6P4	whole worms (developmental stage: young adults)	PEAKS046007
EXP046489	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP639, genotype: wgIs639Â [ham-2::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046457	1392	normal	A3RMS3	whole worms (mixed-stage embryos)	PEAKS046008
EXP046490	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG34367, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG34367-GFP.FPTB}VK00033	EXP046430	1404	normal	A2RVG7	whole organism (development stage: pupa)	PEAKS046009
EXP046491	goat-anti-GFP-UC	Drosophila melanogaster	strain: run, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=run-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046438	1407	normal	P22814	whole organism (development stage: embryonic)	PEAKS046010
EXP046492	goat-anti-GFP-UC	Drosophila melanogaster	strain: Abd-B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Abd-B-EGFP.S}VK00037/SM57	EXP046410	1407	normal	P09087	whole organism (development stage: embryonic)	PEAKS046011
EXP046493	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP756, genotype: unc-119(tm4063); wgIs756 [ceh-13::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046414	1405	normal	P17488	whole organism (development stage: early embryonic)	PEAKS046012
EXP046494	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7271, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG7271-GFP.FPTB}attP40	EXP046412	1407	normal	Q9VVQ2	whole organism (development stage: embryonic)	PEAKS046013
EXP046495	goat-anti-GFP-UC	Drosophila melanogaster	strain: CrebB, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=CrebB-GFP.FPTB} VK00033, sex:mixed	EXP046446	1407	normal	C6SUU1	whole organism (development stage: embryonic)	PEAKS046014
EXP046496	goat-anti-GFP-UC	Drosophila melanogaster	strain: stwl, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=stwl-GFP.FPTB}attP40	EXP046439	1407	normal	Q9VUE5	whole organism (development stage: embryonic)	PEAKS046015
EXP046497	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP349, genotype: unc-119(ed3) III; wgIs349., sex:mixed	EXP046431	1392	normal	P46581	whole worms (mixed-stage embryos)	PEAKS046016
EXP046498	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9817, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG43347-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046433	1407	normal	Q9W2T1	whole organism (development stage: embryonic)	PEAKS046017
EXP046499	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8281, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG8281-GFP.FPTB}attP40	EXP046423	1407	normal	Q9VSB8	whole organism (development stage: embryonic)	PEAKS046018
EXP046500	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP660, genotype: unc-119(tm4063); wgIs660 [hmg-4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046432	1405	normal	P41848	whole organism (development stage: early embryonic)	PEAKS046019
EXP046501	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8290, genotype: y[1] w[*]; PBac {y[+mDint2] w[+mC]=ADD1-GFP.FPTB} VK00033, sex:mixed	EXP046419	1407	normal	A1Z8R2	whole organism (development stage: embryonic)	PEAKS046020
EXP046502	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17359, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17359-GFP.FPTB}attP40	EXP046444	1407	normal	Q9VUB3	whole organism (development stage: embryonic)	PEAKS046021
EXP046503	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8N8E2	HEK293 (embryonic kidney)	PEAKS046022
EXP046504	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd96Cb, genotype: y[1] w[*]; P{y[+mDint2] w[+mC]=fd96Cb-GFP.FPTB}attP40/CyO	EXP046451	1407	normal	P32029	whole organism (development stage: embryonic)	PEAKS046023
EXP046505	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	P17032	HEK293 (embryonic kidney)	PEAKS046024
EXP046506	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP744, genotype: wgIs744Â [hlh-13::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046463	1391	normal	Q20561	whole worms (developmental stage: late embryo)	PEAKS046025
EXP046507	goat-anti-GFP-UC	Caenorhabditis elegans	strain: IG1654, genotype: frSi12[pNP157(akir-1p::AKIR-1::GFP)]II, sex:mixed	EXP046467	1235	normal	Q966L3	whole worms (developmental stage: young adults)	PEAKS046026
EXP046508	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q13118	HEK293 (embryonic kidney)	PEAKS046027
EXP046509	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP740, genotype: wgIs740Â [lin-32::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046411	1392	normal	Q10574	whole worms (mixed-stage embryos)	PEAKS046028
EXP046510	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP628, genotype: wgIs628(ccch-3::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0161_4E04);unc-119(+));unc-119 (tm4063), sex:mixed	EXP046456	1235	normal	Q23170	whole worms (developmental stage: young adults)	PEAKS046029
EXP046511	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox102F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox102F-GFP.FPTB}VK00033	EXP046422	1407	normal	Q9V480	whole organism (development stage: embryonic)	PEAKS046030
EXP046512	goat-anti-GFP-UC	Drosophila melanogaster	strain: Su(var)2-HP2, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Su(var)2-HP2-GFP.FPTB}VK00033	EXP046464	1407	normal	A1Z9S6	whole organism (development stage: embryonic)	PEAKS046031
EXP046513	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9948, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG9948-GFP.FPTB}attP40	EXP046465	1404	normal	Q9VRZ6	whole organism (development stage: pupa)	PEAKS046032
EXP046514	goat-anti-GFP-UC	Drosophila melanogaster	strain: gsb-n, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=gsb-n-GFP.FPTB}attP40	EXP046429	1407	normal	P09083	whole organism (development stage: embryonic)	PEAKS046033
EXP046515	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q6P9A3	HEK293 (embryonic kidney)	PEAKS046034
EXP046516	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7745, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG7745-GFP.FPTB}VK00033	EXP046447	1407	normal	Q7K3E9	whole organism (development stage: embryonic)	PEAKS046035
EXP046517	goat-anti-GFP-UC	Drosophila melanogaster	strain: salm, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=salm-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046405	1407	normal	P39770	whole organism (development stage: embryonic)	PEAKS046036
EXP046518	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8301, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG8301-GFP.FPTB} attP40, sex:mixed	EXP046420	1404	normal	Q9VHA9	whole organism (development stage: pupa)	PEAKS046037
EXP046519	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q6AZW8	HEK293 (embryonic kidney)	PEAKS046038
EXP046520	goat-anti-GFP-UC	Drosophila melanogaster	strain: gl, genotype: w[1118]; P {y[+t7.7] w[+mC]=gl-GFP.FPTB} attP40, sex:mixed	EXP046445	1404	normal	P13360	whole organism (development stage: pupa)	PEAKS046039
EXP046521	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP742, genotype: wgIs742Â [C02F12.10::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046453	1387	normal	A3FPJ2	whole worms (developmental stage: L1)	PEAKS046040
EXP046522	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP757, genotype: unc-119(tm4063); wgls757 [F57A8.1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046400	1235	normal	G5EDE0	whole worms (developmental stage: young adults)	PEAKS046041
EXP046523	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8N587	HEK293 (embryonic kidney)	PEAKS046042
EXP046524	goat-anti-GFP-UC	Drosophila melanogaster	strain: schlank, genotype: y[1] w[*]; PBac {y[+mDint2] w[+mC]=schlank-GFP.FPTB} VK00033/TM6C, Sb[1], sex:mixed	EXP046458	1407	normal	Q9W423	whole organism (development stage: embryonic)	PEAKS046043
EXP046525	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP362, genotype: unc-119(tm4063) III; wgIs362., sex:mixed	EXP046450	1387	normal	Q21836	whole worms (developmental stage: L1)	PEAKS046044
EXP046526	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP643, genotype: wgIs643Â [hlh-17::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046466	1387	normal	O45489	whole worms (developmental stage: L1)	PEAKS046045
EXP046527	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP396, genotype: unc-119(tm4063) III; wgIs396., sex:mixed	EXP046406	1389	normal	P34474	whole worms (developmental stage: L4/young adults)	PEAKS046046
EXP046528	goat-anti-GFP-UC	Drosophila melanogaster	strain: oc, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=oc-GFP.FPTB}VK00033	EXP046426	1407	normal	M9PGN9	whole organism (development stage: embryonic)	PEAKS046047
EXP046529	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17802, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG17802-GFP.FPTB} attP40, sex:mixed	EXP046407	1407	normal	Q8SX40	whole organism (development stage: embryonic)	PEAKS046048
EXP046530	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP760, genotype: unc-119(tm4063); wgIs760 [ceh-8::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046462	1387	normal	Q94398	whole worms (developmental stage: L1)	PEAKS046049
EXP046531	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q86XU0	HEK293 (embryonic kidney)	PEAKS046050
EXP046532	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RAF1713, genotype: rrrSi400[Pets-4::ets-4-GFP::ets-4 3'UTR, unc-119(+)]Â II; unc-119(ed3) III, sex:mixed	EXP046452	1235	normal	A8WFJ9	whole worms (developmental stage: young adults)	PEAKS046051
EXP046533	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP748, genotype: wgIs748(ceh-6::TY1 EGFP 3xFLAG(P000007_A02_9H01);unc-119(+));unc-119 (ed3); VC2010, sex:mixed	EXP046428	1391	normal	P20268	whole worms (developmental stage: late embryo)	PEAKS046052
EXP046534	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP754, genotype: wgIs754Â [T20F7.1::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046427	1389	normal	O02169	whole worms (developmental stage: L4/young adults)	PEAKS046053
EXP046535	goat-anti-GFP-UC	Drosophila melanogaster	strain: bsh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bsh-GFP.FTBP}VK00033	EXP046424	1407	normal	Q04787	whole organism (development stage: embryonic)	PEAKS046054
EXP046536	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12299, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12299-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046442	1407	normal	Q9VKQ7	whole organism (development stage: embryonic)	PEAKS046055
EXP046537	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd3F-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=fd3F-GFP.FPTB}VK00033	EXP046468	1407	normal	Q7JXV9	whole organism (development stage: embryonic)	PEAKS046056
EXP046538	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10431-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10431-GFP.FPTB}VK00033, sex:mixed	EXP046436	1407	normal	Q9VJ27	whole organism (development stage: embryonic)	PEAKS046057
EXP046539	ab290	Drosophila melanogaster	strain: dl-small-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dl-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP046443	1400	normal	P15330	whole organism (development stage: wandering third instar larva)	PEAKS046058
EXP046540	goat-anti-GFP-UC	Drosophila melanogaster	strain: exex, genotype: w[1118]; P{y[+t7.7] w[+mC]=exex-GFP.FPTB}attP40	EXP046404	1407	normal	Q9VSC2	whole organism (development stage: embryonic)	PEAKS046059
EXP046541	goat-anti-GFP-UC	Drosophila melanogaster	strain: PHDP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=PHDP-GFP.FPTB}VK00033	EXP046460	1407	normal	Q9W1H7	whole organism (development stage: embryonic)	PEAKS046060
EXP046542	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP768, genotype: unc-119(tm4063); wgls768 [lin-14::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046437	1387	normal	Q21446	whole worms (developmental stage: L1)	PEAKS046061
EXP046543	goat-anti-GFP-UC	Drosophila melanogaster	strain: Blimp-1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Blimp-1-GFP.FPTB}attP40	EXP046440	1407	normal	Q9VRN4	whole organism (development stage: embryonic)	PEAKS046062
EXP046544	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP139, genotype: wgIs139(ceh-27::TY1 EGFP 3xFLAG(P000007_F10); unc-119(+));unc-119(ed3), sex:mixed	EXP046416	1235	normal	Q9XVN4	whole worms (developmental stage: young adults)	PEAKS046063
EXP046545	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q99676	HEK293 (embryonic kidney)	PEAKS046064
EXP046546	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17806, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17806-GFP.FPTB}attP40	EXP046434	1404	normal	Q9VEF3	whole organism (development stage: pupa)	PEAKS046065
EXP046547	goat-anti-GFP-UC	Drosophila melanogaster	strain: unpg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=unpg-GFP.FTBP}VK00033/TM6C, Sb[1]	EXP046469	1407	normal	Q4V5A3	whole organism (development stage: embryonic)	PEAKS046066
EXP046548	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q8TC21	HEK293 (embryonic kidney)	PEAKS046067
EXP046549	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q9UKT9	HEK293 (embryonic kidney)	PEAKS046068
EXP046550	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP700, genotype: wgIs700(drap-1::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0086_1E01);unc-119(+));unc-119 (tm4063), sex:mixed	EXP046408	1392	normal	Q86G95	whole worms (mixed-stage embryos)	PEAKS046069
EXP046551	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1621, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=Coop-GFP.FPTB} VK00033/TM6C, Sb[1], sex:mixed	EXP046403	1408	normal	Q7JUZ9	whole organism (development stage: prepupa)	PEAKS046070
EXP046552	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13894, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG13894-GFP.FPTB}attP40	EXP046417	1407	normal	Q9W0N5	whole organism (development stage: embryonic)	PEAKS046071
EXP046553	CHD8	Rattus norvegicus	Treatment: none	NULL	696	normal	Q9JIX5	oligodendrocyte progenitors	PEAKS046072
EXP046554	CHD8	Rattus norvegicus	Treatment: none	NULL	218	normal	Q9JIX5	oligodendrocytes	PEAKS046073
EXP046555	Rabbit anti-Chd7:Â Cell signaling Technology; #6505; 1	Rattus norvegicus	Treatment: none	NULL	696	normal	D3ZAP7	oligodendrocyte progenitors	PEAKS046074
EXP046558	yy1	Rattus norvegicus	treatment: 45 Gy radiation; sex: male; age: 4 weeks	EXP046556	2166	normal	Q8CHJ4	skin tissue	PEAKS046075
EXP046559		Rattus norvegicus	sex: male; age: 4 weeks	EXP046557	2166	normal	Q8CHJ4	skin tissue	PEAKS046076
EXP046561	Seh1l	Rattus norvegicus		EXP046560	696	normal	Q7TP06	oligodendrocyte progenitors	PEAKS046077
EXP046562	Seh1l	Rattus norvegicus		EXP046560	482	normal	Q7TP06	immature oligodendrocytes	PEAKS046078
EXP046568	Anti-pSpt5 antibody (custom made from 21st Century Biochemicals, Marlboro, MA; Sanso et al. 2012)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046563	1263	normal	O13936	whole cells	PEAKS046079
EXP046569	Anti-Myc epitope (EMD Millipore, 05-724)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046563	1263	normal	O13936	whole cells	PEAKS046080
EXP046570	Anti-pSpt5 antibody (custom made from 21st Century Biochemicals, Marlboro, MA; Sanso et al. 2012)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046564	1263	normal	O13936	whole cells	PEAKS046081
EXP046571	Anti-Myc epitope (EMD Millipore, 05-724)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046564	1263	normal	O13936	whole cells	PEAKS046082
EXP046572	Anti-pSpt5 antibody (custom made from 21st Century Biochemicals, Marlboro, MA; Sanso et al. 2012)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 dis2-11 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046566	1263	normal	O13936	whole cells	PEAKS046083
EXP046573	Anti-Myc epitope (EMD Millipore, 05-724)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 dis2-11 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046566	1263	normal	O13936	whole cells	PEAKS046084
EXP046574	anti-FLAG	Arabidopsis thaliana	Treatment: pCLF::EBS-CLF transformed into clf mutant background; Columbia-0	NULL	1341	normal	P93831	10 day old seedlings	PEAKS046085
EXP046575	anti-FLAG	Arabidopsis thaliana	Treatment: ebs mutant; pEBS::EBS-FLAG; Columbia-0	NULL	1341	normal	F4JL28	10 day old seedlings	PEAKS046086
EXP046576	anti-FLAG	Arabidopsis thaliana	Treatment: ebs mutant; pEBS::EBS?C-FLAG; Columbia-0	NULL	1341	normal	F4JL28	10 day old seedlings	PEAKS046087
EXP046578	LHY antiserum	Arabidopsis thaliana		EXP046577	1339	normal	Q6R0H1	seedling	PEAKS046088
EXP046580	Anti-FLAG (Sigma, F7425)	Arabidopsis thaliana		EXP046579	1339	normal	F4JL28	seedling	PEAKS046089
EXP046582	Anti-HA (Sigma, H 6908)	Arabidopsis thaliana		EXP046581	1339	normal	Q9FEN9	seedling	PEAKS046090
EXP046583	Anti-Cnp1 (from Allshire lab)	Schizosaccharomyces pombe		NULL	1263	normal	Q9Y812	whole cells	PEAKS046091
EXP046584	Anti-Cnp1 (from Allshire lab)	Schizosaccharomyces pombe	ccp1 deletion	NULL	1263	normal	Q9Y812	whole cells	PEAKS046092
EXP046585	Anti-Cnp1 (from Allshire lab)	Schizosaccharomyces pombe	gar2 deletion	NULL	1263	normal	Q9Y812	whole cells	PEAKS046093
EXP046596	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: wild type	EXP046588	1366	normal	P48732	5 day old seedlings	PEAKS046095
EXP046597	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: wild type	EXP046589	1366	normal	P48732	5 day old seedlings	PEAKS046096
EXP046598	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: wild type	EXP046590	1366	normal	P48732	5 day old seedlings	PEAKS046097
EXP046599	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: wild type	EXP046591	1366	normal	P48732	5 day old seedlings	PEAKS046098
EXP046600	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: det1-1	EXP046592	1366	normal	P48732	5 day old seedlings	PEAKS046099
EXP046601	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: det1-1	EXP046593	1366	normal	P48732	5 day old seedlings	PEAKS046100
EXP046602	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: det1-1	EXP046594	1366	normal	P48732	5 day old seedlings	PEAKS046101
EXP046603	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: det1-1	EXP046595	1366	normal	P48732	5 day old seedlings	PEAKS046102
EXP046615	Antibody against a C-terminal peptide of SEP3	Arabidopsis thaliana	Genotype: wild type; Method: over pcr amplification;	EXP046614	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	PEAKS046111
EXP046624	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: native	EXP046616	2167	normal	O81821	5 weeks old leaves	PEAKS046112
EXP046625	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: native	EXP046617	2167	normal	O81821	5 weeks old leaves	PEAKS046113
EXP046626	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: native	EXP046618	2167	normal	O81821	5 weeks old leaves	PEAKS046114
EXP046627	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: native	EXP046619	2167	normal	O81821	5 weeks old leaves	PEAKS046115
EXP046628	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046620	2167	normal	O81821	5 weeks old leaves	PEAKS046116
EXP046629	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046621	2167	normal	O81821	5 weeks old leaves	PEAKS046117
EXP046630	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046622	2167	normal	O81821	5 weeks old leaves	PEAKS046118
EXP046631	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046623	2167	normal	O81821	5 weeks old leaves	PEAKS046119
EXP046632	anti-GFP antibody (ab290; ABCAM)	Arabidopsis thaliana	Genotype: LDL1pro::LDL:GFP	EXP046611	1344	normal	Q8VXV7	14 day old seedling	PEAKS046120
EXP046633	anti-GTP	Arabidopsis thaliana	Treatment: blue light treated; Ecotype: Ws; Genotype: HY5 mutant;	EXP046604	1231	normal	A0A1P8BB55	whole plants	PEAKS046121
EXP046634	anti-GTP	Arabidopsis thaliana	Treatment: red light treated; Ecotype: Ws; Genotype: HY5 mutant;	EXP046604	1231	normal	A0A1P8BB55	whole plants	PEAKS046122
EXP046637	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Teratmen: 10 uM DMSO, 4hours (Light etiolated); Tagline: ypet; Acctssion: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	PEAKS046123
EXP046638	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Teratmen:10 uM DMSO, 4hours (Light long day); Tagline: ypet; Acctssion: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	PEAKS046124
EXP046639	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 4hours (Light long day);Tagline:ypet; Accession: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	PEAKS046125
EXP046640	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 72 hours on LS plates (Light long day);Tagline:ypet; Accession: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	PEAKS046126
EXP046641	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM Dex, 4hour (Light long day); Tagline:ypet; Accession: ARR1.2ypet; Genotype: ARR1DDK; 	EXP046635	2168	normal	Q940D0	whole 3 days seedings	PEAKS046127
EXP046642	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM DMSO, 4 hours (Light long day);Tagline:ypet; Accession: ARR102ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	PEAKS046128
EXP046643	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 72 hours (Light long day);Tagline:ypet; Accession: ARR10ypet16;	EXP046635	2168	normal	O49397	whole 3 days seedings	PEAKS046129
EXP046644	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM DMSO, 4 hours (Light long day);Tagline:ypet; Accession: ARR12ypet;	EXP046635	2168	normal	P62598	whole 3 days seedings	PEAKS046130
EXP046645	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 4 hours (Light long day);Tagline:ypet; Accession: ARR12ypet;	EXP046635	2168	normal	P62598	whole 3 days seedings	PEAKS046131
EXP046646	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 4 hours on LS plates (Lightlong day); Tagline:ypet; Accession: ARR14ypet;	EXP046635	2168	normal	Q8L9Y3	whole 3 days seedings	PEAKS046132
EXP046663	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046647	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	PEAKS046133
EXP046664	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype;	EXP046648	2170	normal	Q08032	YMC S phase S cerevisiae cells	PEAKS046134
EXP046665	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046649	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	PEAKS046135
EXP046666	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype with rtt105-del;	EXP046650	2170	normal	Q08032	YMC S phase S cerevisiae cells	PEAKS046136
EXP046667	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046651	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	PEAKS046137
EXP046668	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046652	2170	normal	P53091	YMC S phase S cerevisiae cells	PEAKS046138
EXP046669	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046653	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	PEAKS046139
EXP046670	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046654	2170	normal	P53091	YMC S phase S cerevisiae cells	PEAKS046140
EXP046671	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046655	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	PEAKS046141
EXP046672	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT;	EXP046656	2170	normal	Q08032	YMC S phase S cerevisiae cells	PEAKS046142
EXP046673	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046657	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	PEAKS046143
EXP046674	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046658	2170	normal	Q08032	YMC S phase S cerevisiae cells	PEAKS046144
EXP046675	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046659	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	PEAKS046145
EXP046676	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: G1 phase; Genotype: WT;	EXP046660	2170	normal	P53091	YMC S phase S cerevisiae cells	PEAKS046146
EXP046677	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046661	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	PEAKS046147
EXP046678	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046662	2170	normal	P53091	YMC S phase S cerevisiae cells	PEAKS046148
EXP046696	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: WT strain(K23889);	EXP046679	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046149
EXP046697	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: Smc3-Scc1 fusion strain (K24838);	EXP046680	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046150
EXP046698	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: Strain K26797 (containing 3XminiAID-tagged smc3 in the endogenous locus and Smc3 wild type expressed from an ectopic locus);	EXP046681	2171	normal	A6ZQG7	Exponentially growing S.cerevisiae cells	PEAKS046151
EXP046699	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: Strain K26611 (containing 3XminiAID tagged-smc3 and smc1DD in their respective endogenous locus, and smc3AAA mutant expressed from an ectopic locus); released conditions: arrested in G1, synthetic auxin (indole-3-acetic acid) was added to 1 mM 30 min before release. The culture was released into YPD containing 1mM auxin and nocodazole to arrest the cultures in G2;	EXP046682	2172	normal	A6ZQG7	YMC G2 phase S.cerevisiae cells	PEAKS046152
EXP046700	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype:strain K699 (untagged control);	EXP046683	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046153
EXP046701	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: K24327 (ectopic Smc1);	EXP046684	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046154
EXP046702	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: K24327 (ectopic Smc1);	NULL	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046155
EXP046703	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26839 (ectopic Smc1) containing Scc2-PK6;	EXP046686	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046156
EXP046704	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K25646 (ectopic smc1 E1158Q) containing Scc2-PK6;	EXP046687	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046157
EXP046705	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26840 (ectopic smc1DDD E1158Q) containing Scc2-PK6;	EXP046688	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046158
EXP046706	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K14324 containing a deletion of the endogenous SMC1 gene and expressing the wild type Smc1 from an ectopic locus;	EXP046689	2171	bio_control	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046159
EXP046707	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K15226 containing a deletion of the endogenous SMC1 gene and expressing the smc1 K650D,K661D mutant from an ectopic locus;	EXP046690	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046160
EXP046708	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K15322 containing a deletion of the endogenous SMC1 gene and expressing the smc1 K554D,K661D mutant from an ectopic locus;	EXP046691	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046161
EXP046709	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: strain K26982, expressing smc1 K554D K661D and Smc3AAA-HA mutant from ectopic loci and containing the deletion of the SMC1 gene;	EXP046692	2171	normal	A6ZQG7	Exponentially growing S.cerevisiae cells	PEAKS046162
EXP046710	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: strain K26983, expressing wild type Smc3-HA and wild type Smc1 from ectopic loci and containing the deletion of the SMC1 gene;	EXP046693	2171	normal	A6ZQG7	Exponentially growing S.cerevisiae cells	PEAKS046163
EXP046711	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26756 (expressing the wild type Smc3 from the endogenous locus and the smc1DDD mutant from an ectopic locus);	EXP046694	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046164
EXP046712	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26757 (expressing smc1 DDD mutant from an ectopic locus and smc3AAA mutant from the endogenous locus;	EXP046695	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	PEAKS046165
EXP046730	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1220	bio_control	A0A023PXA5	SK1	PEAKS046181
EXP046731	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2173	normal	A0A023PXA5	SK1 miotic cells(0 hours)	PEAKS046182
EXP046732	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2174	normal	A0A023PXA5	SK1 miotic cells(2 hour)	PEAKS046183
EXP046733	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	PEAKS046184
EXP046734	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2175	normal	A0A023PXA5	SK1 miotic cells(6 hours)	PEAKS046185
EXP046735	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Wildtype;	EXP046728	1220	normal	A0A023PXA5	SK1	PEAKS046186
EXP046736	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Wildtype;	EXP046728	2177	normal	A0A023PXA5	SK1 meiotic cells (0 hours)	PEAKS046187
EXP046737	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Wildtype;	EXP046728	2176	normal	A0A023PXA5	Sk1 meiotic (2 hours)	PEAKS046188
EXP046738	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Wildtype;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	PEAKS046189
EXP046739	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Wildtype;	EXP046728	2178	normal	A0A023PXA5	SK1 meiotic cells (6 hours)	PEAKS046190
EXP046740	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1220	normal	A0A023PXA5	SK1	PEAKS046191
EXP046741	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2177	normal	A0A023PXA5	SK1 meiotic cells (0 hours)	PEAKS046192
EXP046742	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2176	normal	A0A023PXA5	Sk1 meiotic (2 hours)	PEAKS046193
EXP046743	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	PEAKS046194
EXP046744	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2178	normal	A0A023PXA5	SK1 meiotic cells (6 hours)	PEAKS046195
EXP046745	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1220	normal	A0A023PXA5	SK1	PEAKS046196
EXP046746	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2177	normal	A0A023PXA5	SK1 meiotic cells (0 hours)	PEAKS046197
EXP046747	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2176	normal	A0A023PXA5	Sk1 meiotic (2 hours)	PEAKS046198
EXP046748	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	PEAKS046199
EXP046749	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2178	normal	A0A023PXA5	SK1 meiotic cells (6 hours)	PEAKS046200
EXP046758	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added Top1-AID (Topoisomerases);	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046209
EXP046763	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with dextrose; Genotype: Gal - HO;	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046214
EXP046777	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged cft2; 	EXP046773	2179	normal	Q12102	S. cerevisiae cell extract	PEAKS046221
EXP046778	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Ref2; 	NULL	2179	normal	P42073	S. cerevisiae cell extract	PEAKS046222
EXP046779	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Syc1; 	NULL	2179	normal	Q08553	S. cerevisiae cell extract	PEAKS046223
EXP046780	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Yth1;	NULL	2179	normal	Q06102	S. cerevisiae cell extract	PEAKS046224
EXP046781	anti - Hsf1 (Erkine et al., 1996) 	Saccharomyces cerevisiae	Treatment: non heat shock, 30 degrees; Genotype: Wildtype; 	NULL	1219	normal	P10961	SK1 meiotic cells (4 hours)	PEAKS046225
EXP046782	anti - Hsf1 (Erkine et al., 1996) 	Saccharomyces cerevisiae	Treatment: 5 min heat shock, 39 degree; Genotype: Wildtype;	NULL	1219	normal	P10961	SK1 meiotic cells (4 hours)	PEAKS046226
EXP046783	anti - Hsf1 (Erkine et al., 1996) 	Saccharomyces cerevisiae	Treatment: 120 min heat shock, 39 degree; Genotype: Wildtype;	NULL	1219	normal	P10961	SK1 meiotic cells (4 hours)	PEAKS046227
EXP046796	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 0 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046784	2180	normal	P21651	meiotic culture in prophase	PEAKS046228
EXP046797	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 0.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046785	2180	normal	P21651	meiotic culture in prophase	PEAKS046229
EXP046798	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 1 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046786	2180	normal	P21651	meiotic culture in prophase	PEAKS046230
EXP046799	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 1.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046788	2180	normal	P21651	meiotic culture in prophase	PEAKS046231
EXP046800	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046788	2180	normal	P21651	meiotic culture in prophase	PEAKS046232
EXP046801	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046789	2180	normal	P21651	meiotic culture in prophase	PEAKS046233
EXP046802	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 3 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046790	2180	normal	P21651	meiotic culture in prophase	PEAKS046234
EXP046803	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 3.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046791	2180	normal	P21651	meiotic culture in prophase	PEAKS046235
EXP046804	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046792	2180	normal	P21651	meiotic culture in prophase	PEAKS046236
EXP046805	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046793	2180	normal	P21651	meiotic culture in prophase	PEAKS046237
EXP046806	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046794	2180	normal	P21651	meiotic culture in prophase	PEAKS046238
EXP046807	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046795	2180	normal	P21651	meiotic culture in prophase	PEAKS046239
EXP046835	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: Wildtype REC114Myc;	EXP046808	2180	normal	P32841	meiotic culture in prophase	PEAKS046240
EXP046836	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: Wildtype REC114Myc;	EXP046809	2180	normal	P32841	meiotic culture in prophase	PEAKS046241
EXP046837	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: Wildtype REC114Myc;	EXP046810	2180	normal	P32841	meiotic culture in prophase	PEAKS046242
EXP046838	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114 -Myc-zip3;	EXP046811	2180	normal	P32841	meiotic culture in prophase	PEAKS046243
EXP046839	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114 -Myc-zip3;	EXP046812	2180	normal	P32841	meiotic culture in prophase	PEAKS046244
EXP046840	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114 -Myc-zip3;	EXP046813	2180	normal	P32841	meiotic culture in prophase	PEAKS046245
EXP046841	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	EXP046814	2180	normal	P32841	meiotic culture in prophase	PEAKS046246
EXP046842	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	EXP046815	2180	normal	P32841	meiotic culture in prophase	PEAKS046247
EXP046843	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	EXP046816	2180	normal	P32841	meiotic culture in prophase	PEAKS046248
EXP046844	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	EXP046817	2180	normal	P32841	meiotic culture in prophase	PEAKS046249
EXP046845	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	EXP046818	2180	normal	P32841	meiotic culture in prophase	PEAKS046250
EXP046846	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	EXP046819	2180	normal	P32841	meiotic culture in prophase	PEAKS046251
EXP046847	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1;	EXP046820	2180	bio_control	P32841	meiotic culture in prophase	PEAKS046252
EXP046848	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1;	EXP046821	2180	normal	P32841	meiotic culture in prophase	PEAKS046253
EXP046849	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1;	EXP046822	2180	normal	P32841	meiotic culture in prophase	PEAKS046254
EXP046850	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with red1;	EXP046823	2180	normal	P32841	meiotic culture in prophase	PEAKS046255
EXP046851	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with red1;	EXP046824	2180	normal	P32841	meiotic culture in prophase	PEAKS046256
EXP046852	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with red1;	EXP046825	2180	normal	P32841	meiotic culture in prophase	PEAKS046257
EXP046853	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with rec8;	EXP046826	2180	normal	P32841	meiotic culture in prophase	PEAKS046258
EXP046854	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with rec8;	EXP046827	2180	normal	P32841	meiotic culture in prophase	PEAKS046259
EXP046855	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with rec8;	EXP046828	2180	normal	P32841	meiotic culture in prophase	PEAKS046260
EXP046856	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1 and red1;	EXP046829	2180	normal	P32841	meiotic culture in prophase	PEAKS046261
EXP046857	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1 and red1;	EXP046833	2180	normal	P32841	meiotic culture in prophase	PEAKS046262
EXP046858	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1 and red1;	EXP046831	2180	normal	P32841	meiotic culture in prophase	PEAKS046263
EXP046859	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	EXP046832	2180	normal	P32841	meiotic culture in prophase	PEAKS046264
EXP046860	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	EXP046833	2180	normal	P32841	meiotic culture in prophase	PEAKS046265
EXP046861	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	EXP046834	2180	normal	P32841	meiotic culture in prophase	PEAKS046266
EXP046937	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatment: OD 600; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: wild type strain K21388;	EXP046862	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046267
EXP046938	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatment: OD 600; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: wild type strain K21388;	EXP046863	2182	normal	Q04002	10 S.cerevisiae and glabrata at G1 phase	PEAKS046268
EXP046939	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: untargged wildtype strain K699;	EXP046864	2181	normal	N1P3Y5	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046269
EXP046940	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, release in the presence of methionine; Source: 10 units S.cerevisiae strain K699 and 5 units Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046865	2183	normal	Q04002	S.cervisiae, C. glabrata after30 min after G1	PEAKS046270
EXP046941	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046866	2184	normal	Q04002	10 units S. cervisiae 5 units C.glabrata after 45 min in G1	PEAKS046271
EXP046942	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046867	2185	normal	Q04002	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046272
EXP046943	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1 strain K25222;	EXP046868	2183	normal	Q04002	S.cervisiae, C. glabrata after30 min after G1	PEAKS046273
EXP046944	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1 strain K25222;	EXP046869	2184	normal	Q04002	10 units S. cervisiae 5 units C.glabrata after 45 min in G1	PEAKS046274
EXP046945	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K25222; Genotype: MET- Scc1 strain K25222;	EXP046870	2185	normal	Q04002	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046275
EXP046946	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046873	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046276
EXP046947	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25467 and Candida glabrata strain K23308; Genotype: smc3E1155Q  strain K25467;	EXP046874	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046277
EXP046948	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046875	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046278
EXP046949	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25370 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25370;	EXP046876	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046279
EXP046950	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25373 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25373;	EXP046877	2181	normal	P40541	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046280
EXP046951	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17438 and Candida glabrata strain K23308; Genotype: Wildtype strain K17438;	EXP046878	2181	normal	P40541	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046281
EXP046952	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25376 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25376;	EXP046879	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046282
EXP046953	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K19012; Genotype: Wildtype strain K19012;	EXP046880	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046283
EXP046954	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22390 and Candida glabrata strain K23308; Genotype: no ts scc2 with no ectopic strain K22390;	EXP046881	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046284
EXP046955	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24188 and Candida glabrata strain K23308; Genotype: contains ts scc2 with ectopic copy containing mutations K788E H789E strain K24188;	EXP046882	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046285
EXP046956	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24185 and Candida glabrata strain K23308; Genotype: strain containing ts scc2 with a WT ectopic copy strain K24185;	EXP046883	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046286
EXP046957	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25186 and Candida glabrata strain K23308; Genotype: with an ectopic copy of scc2K788E H789E strain K25186;	EXP046884	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046287
EXP046958	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25185 and Candida glabrata strain K23308; Genotype: with a WT ectopic copy of Scc2 strain K25185;	EXP046885	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046288
EXP046959	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24687 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain  K24687;	EXP046886	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046289
EXP046960	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24744 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc4ts strain K24744;	EXP046887	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046290
EXP046961	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22001 and Candida glabrata strain K23308; Genotype: scc4ts strain K22001;	EXP046888	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046291
EXP046962	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046889	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046292
EXP046963	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25053 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K25053;	EXP046890	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046293
EXP046964	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25418 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc4del strain K25418;	EXP046891	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046294
EXP046965	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: Wildtype untargged strain K699;	EXP046892	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046295
EXP046966	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25054 and Candida glabrata strain K23308; Genotype: Wildtype strain K25054;	EXP046893	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046296
EXP046967	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, arrested in GAL- SIC1; Source: S.cerevisiae strain K25988 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K25988;	EXP046894	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046297
EXP046968	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, arrested in GAl - SIC1; Source: S.cerevisiae strain K25999 and Candida glabrata strain K23308; Genotype: Wildtype strain K25999;	EXP046895	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046298
EXP046969	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD arrested in GAL-SIC1; Source: S.cerevisiae strain K26244 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K26244;	EXP046896	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046299
EXP046970	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD arrested in GAL-SIC1; Source:S.cerevisiae strain K26292 and Candida glabrata strain K23308; Genotype: Wildtype strain K26292;	EXP046897	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046300
EXP046971	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26270 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26270;	EXP046898	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046301
EXP046972	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26277 and Candida glabrata strain K23308; Genotype: Wildtype Pds5 strain K26277;	EXP046899	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046302
EXP046973	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26273 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26273;	EXP046900	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046303
EXP046974	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26274 and Candida glabrata strain K23308; Genotype: Wiltype pds5 strain K26274;	EXP046901	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046304
EXP046975	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26362 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-206 and 244-251 deleted K26362;	EXP046902	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046305
EXP046976	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25995 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-206 deleted K25995;	EXP046903	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046306
EXP046977	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25896 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-256 deleted K25896	EXP046904	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046307
EXP046978	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25997 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 207-256 deleted K25997;	EXP046905	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046308
EXP046979	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17184 and Candida glabrata strain K23308; Genotype: expressing WT Scc1 K17184;	EXP046906	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046309
EXP046980	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: expressing untagged WT Scc1 K699;	EXP046907	2181	normal	A6ZQG7	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046310
EXP046981	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26251 and Candida glabrata strain K23308; Genotype: MET-Scc1V137K strain K26251;	EXP046908	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046311
EXP046982	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K216248 and Candida glabrata strain K23308; Genotype: MET-Scc1 wild type strain K26248;	EXP046909	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046312
EXP046983	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1Untagged strain K25222;	EXP046910	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046313
EXP046984	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD addition of 5mM auxin 30 min prior to release from pheromone to deplete Pds5; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26270;	EXP046911	2187	bio_control	Q12158	10 units S. cervisiae and 5 units C.glabrata G2 fase	PEAKS046314
EXP046985	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD addition of 5mM auxin 30 min prior to release from pheromone to deplete Pds5; Source: S.cerevisiae strain K26277 and Candida glabrata strain K23308; Genotype: Wildtype Pds5 strain K26277;	EXP046912	2187	normal	Q12158	10 units S. cervisiae and 5 units C.glabrata G2 fase	PEAKS046315
EXP046986	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K20891 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of wapl deletion K20891;	EXP046913	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046316
EXP046987	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K20891 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of wildtype strain K22388;	EXP046914	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046317
EXP046988	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25644 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25644;	EXP046915	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046318
EXP046989	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25640 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25640;	EXP046916	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046319
EXP046990	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25637 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25637;	EXP046917	2181	normal	N1P3Y5	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046320
EXP046991	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17438 and Candida glabrata strain K23308; Genotype: Wildtype strain K17438;	EXP046918	2181	normal	N1P3Y5	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046321
EXP046992	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25652 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25652;	EXP046919	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046322
EXP046993	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest Pds5 - PK strain K25448;	EXP046920	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046323
EXP046994	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25625 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest Scc1 - PK strain K25625;	EXP046921	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046324
EXP046995	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: Wildtype strain K25448;	EXP046922	2188	normal	Q04264	G2 arrested cells	PEAKS046325
EXP046996	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25625 and Candida glabrata strain K23308; Genotype: strain K25625;	EXP046923	2188	normal	Q12158	G2 arrested cells	PEAKS046326
EXP046997	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24687 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K24687;	EXP046924	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046327
EXP046998	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc1 deletion K24745;	EXP046925	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046328
EXP046999	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046926	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046329
EXP047000	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 deletion strain K24745;	EXP046927	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046330
EXP047001	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 and chl4 deletion strain K24745;	EXP046928	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	PEAKS046331
EXP047002	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 and chl4 deletion strain K24745;	EXP046930	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046332
EXP047003	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: cc2E822K L937F, scc4 deletion  strain K24745;	EXP046930	2182	normal	Q12158	10 S.cerevisiae and glabrata at G1 phase	PEAKS046333
EXP047004	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: scc4m35 strain K25049;	EXP046931	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046334
EXP047005	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046932	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	PEAKS046335
EXP047006	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype:  scc4m35 strain (K24745);	EXP046933	2182	normal	Q12158	10 S.cerevisiae and glabrata at G1 phase	PEAKS046336
EXP047007	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, nokodazole; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc4m35 strain K24745;	EXP046934	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046337
EXP047008	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of scc3K404E strain K26286;	EXP046935	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046338
EXP047009	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26281 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of scc3K404E wapl deletion  strain K26281;	EXP046936	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	PEAKS046339
EXP047010	anti-Mcm2 (catalog number SC-6680; Santa Cruz)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: wildtype; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046340
EXP047011	anti-Mcm2 (catalog number SC-6680; Santa Cruz)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: mutation mcm2DENQ; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046341
EXP047012	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: wildtype; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046342
EXP047013	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: mutation mcm2DENQ; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046343
EXP047035	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	EXP047020	2189	normal	P22336	G1 S.cerevisiae cells	PEAKS046350
EXP047036	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	EXP047021	2189	normal	P22336	G1 S.cerevisiae cells	PEAKS046351
EXP047037	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	EXP047022	2190	normal	P22336	Early S phase S. cerevisiae cells	PEAKS046352
EXP047038	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	EXP047023	2190	normal	P22336	Early S phase S. cerevisiae cells	PEAKS046353
EXP047039	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: delation rtt105; 	EXP047024	2189	normal	P22336	G1 S.cerevisiae cells	PEAKS046354
EXP047040	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: delation rtt105; 	EXP047025	2189	normal	P22336	G1 S.cerevisiae cells	PEAKS046355
EXP047041	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: delation rtt105;	EXP047027	2190	normal	P22336	Early S phase S. cerevisiae cells	PEAKS046356
EXP047042	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 72 min , 16 degree; Genotype: wildtype; 	EXP047029	2191	normal	P22336	S phase S. cerevisiae cells	PEAKS046357
EXP047043	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 96 min, 16 degree; Genotype: wildtype; 	EXP047030	2191	normal	P22336	S phase S. cerevisiae cells	PEAKS046358
EXP047044	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 72 min, 16 degree; Genotype: delation rtt105; 	EXP047031	2191	normal	P22336	S phase S. cerevisiae cells	PEAKS046359
EXP047045	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 96 min, 16 degree; Genotype: delation rtt105; 	EXP047032	2191	normal	P22336	S phase S. cerevisiae cells	PEAKS046360
EXP047046	anti Rfa2	Saccharomyces cerevisiae	Treatment: arrested at HU for 72 min, 16 degree; Genotype: wildtype; 	EXP047033	2191	normal	P26754	S phase S. cerevisiae cells	PEAKS046361
EXP047047	anti Rfa2	Saccharomyces cerevisiae	Treatment: arrested at HU for 72 min, 16 degree; Genotype:delation rtt105; 	EXP047034	2191	normal	P26754	S phase S. cerevisiae cells	PEAKS046362
EXP047052	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 control lambda; 	NULL	2192	normal	P29056	Cell pellet	PEAKS046367
EXP047053	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 control lambda; 	NULL	2192	normal	P29056	Cell pellet	PEAKS046368
EXP047054	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 treat pileup; 	NULL	2192	bio_control	P29056	Cell pellet	PEAKS046369
EXP047055	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 treat pileup; 	NULL	2192	normal	P29056	Cell pellet	PEAKS046370
EXP047056	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 control lambda; 	NULL	2192	bio_control	P29056	Cell pellet	PEAKS046371
EXP047057	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 treat pileup; 	NULL	2192	bio_control	P29056	Cell pellet	PEAKS046372
EXP047058	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046373
EXP047059	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046374
EXP047060	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046375
EXP047061	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046376
EXP047062	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046377
EXP047063	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype:W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046378
EXP047064	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046379
EXP047065	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046380
EXP047066	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046381
EXP047067	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046382
EXP047068	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046383
EXP047069	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046384
EXP047070	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046385
EXP047071	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	PEAKS046386
EXP047074	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047072	1390	normal	P91868	whole worms (developmental stage: L3)	PEAKS046387
EXP047075	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047073	1390	normal	P91868	whole worms (developmental stage: L3)	PEAKS046388
EXP047078	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047076	1390	normal	G5ECN8	whole worms (developmental stage: L3)	PEAKS046389
EXP047079	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047077	1390	normal	G5ECN8	whole worms (developmental stage: L3)	PEAKS046390
EXP047082	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047080	1387	normal	G5ECG2	whole worms (developmental stage: L1)	PEAKS046391
EXP047083	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047081	1387	normal	G5ECG2	whole worms (developmental stage: L1)	PEAKS046392
EXP047086	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs500(ceh-26::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047084	1391	normal	P34522	whole worms (developmental stage: late embryo)	PEAKS046393
EXP047087	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs500(ceh-26::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047085	1391	normal	P34522	whole worms (developmental stage: late embryo)	PEAKS046394
EXP047090	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex Hermophrodite;	EXP047088	1235	normal	G5EF11	whole worms (developmental stage: young adults)	PEAKS046395
EXP047091	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex Hermophrodite;	EXP047089	1235	normal	G5EF11	whole worms (developmental stage: young adults)	PEAKS046396
EXP047094	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermophrodite;	EXP047092	1235	normal	Q22703	whole worms (developmental stage: young adults)	PEAKS046397
EXP047095	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermophrodite;	EXP047093	1390	normal	Q22703	whole worms (developmental stage: L3)	PEAKS046398
EXP047098	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex: Hermaphrodite;	EXP047096	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS046399
EXP047099	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex: Hermaphrodite;	EXP047097	1387	normal	G5EF11	whole worms (developmental stage: L1)	PEAKS046400
EXP047102	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermaphrodite; 	EXP047100	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS046401
EXP047103	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermaphrodite; 	EXP047101	1387	normal	Q22703	whole worms (developmental stage: L1)	PEAKS046402
EXP047106	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047104	1387	normal	G5ECN8	whole worms (developmental stage: L1)	PEAKS046403
EXP047107	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047105	1387	normal	G5ECN8	whole worms (developmental stage: L1)	PEAKS046404
EXP047110	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs184(lin-15B::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047108	2193	normal	Q27395	whole worms(developmental stage L4)	PEAKS046405
EXP047111	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs184(lin-15B::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047109	2193	normal	Q27395	whole worms(developmental stage L4)	PEAKS046406
EXP047114	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs305(nhr-11::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1202	normal	Q23294	whole worms (developmental stage: L2)	PEAKS046407
EXP047115	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs305(nhr-11::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047113	1202	normal	Q23294	whole worms (developmental stage: L2)	PEAKS046408
EXP047118	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119); Sex: Hermaphrodite;	EXP047116	1390	normal	S6EZL2	whole worms (developmental stage: L3)	PEAKS046409
EXP047119	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119); Sex: Hermaphrodite;	EXP047117	1390	normal	S6EZL2	whole worms (developmental stage: L3)	PEAKS046410
EXP047122	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047120	1390	normal	G5EFF5	whole worms (developmental stage: L3)	PEAKS046411
EXP047123	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047121	1390	normal	G5EFF5	whole worms (developmental stage: L3)	PEAKS046412
EXP047126	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc119(ed3);wgIs114(F16B12.6::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047124	1387	normal	Q93520	whole worms (developmental stage: L1)	PEAKS046413
EXP047127	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc119(ed3);wgIs114(F16B12.6::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047125	1387	normal	Q93520	whole worms (developmental stage: L1)	PEAKS046414
EXP047130	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047128	1202	bio_control	P91868	whole worms (developmental stage: L2)	PEAKS046415
EXP047131	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047129	1202	bio_control	P91868	whole worms (developmental stage: L2)	PEAKS046416
EXP047134	anti-GFP	Caenorhabditis elegans	Genotype:unc-119(ed3) III; wgIs81 [unc-119(+) eor-1::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite; 	EXP047132	1390	normal	G5EDU4	whole worms (developmental stage: L3)	PEAKS046417
EXP047135	anti-GFP	Caenorhabditis elegans	Genotype:unc-119(ed3) III; wgIs81 [unc-119(+) eor-1::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite; 	EXP047133	1390	normal	G5EDU4	whole worms (developmental stage: L3)	PEAKS046418
EXP047138	anti-GFP	Caenorhabditis elegans	Treatmen:fed; Genotype: unc119(ed3);wgIs301(mef-2::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047136	1387	normal	Q9U325	whole worms (developmental stage: L1)	PEAKS046419
EXP047139	anti-GFP	Caenorhabditis elegans	Treatmen:fed; Genotype: unc119(ed3);wgIs301(mef-2::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047137	1387	normal	Q9U325	whole worms (developmental stage: L1)	PEAKS046420
EXP047142	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047140	1390	normal	G5ECG2	whole worms (developmental stage: L3)	PEAKS046421
EXP047143	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047141	1390	normal	G5ECG2	whole worms (developmental stage: L3)	PEAKS046422
EXP047146	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047144	2193	normal	G5ECG2	whole worms(developmental stage L4)	PEAKS046423
EXP047147	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047145	2193	normal	G5ECG2	whole worms(developmental stage L4)	PEAKS046424
EXP047150	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs355(ZK377.2::TY1 EGFP FLAG; unc-119(+)); Sex: Hermaphrodite; 	EXP047148	1202	normal	G5EBF1	whole worms (developmental stage: L2)	PEAKS046425
EXP047151	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs355(ZK377.2::TY1 EGFP FLAG; unc-119(+)); Sex: Hermaphrodite; 	EXP047149	1202	normal	G5EBF1	whole worms (developmental stage: L2)	PEAKS046426
EXP047154	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: Genotype: set9 with gfp;	EXP047152	2193	normal	O44498	whole worms(developmental stage L4)	PEAKS046427
EXP047155	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: Genotype: set9 with gfp;	EXP047153	2193	normal	O44498	whole worms(developmental stage L4)	PEAKS046428
EXP047156	set26	Caenorhabditis elegans	Treatment: Genotype: set26 with gfp;	EXP047152	2193	normal	Q9U263	whole worms(developmental stage L4)	PEAKS046429
EXP047157	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: Genotype: set26 with gfp;	EXP047153	2193	normal	Q9U263	whole worms(developmental stage L4)	PEAKS046430
EXP047160	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: mutante hpl-2; Strain: N2 Bristol;	EXP047158	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	PEAKS046431
EXP047161	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: mutante hpl-2; Strain: N2 Bristol;	EXP047158	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	PEAKS046432
EXP047162	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: tdp-1 mutante; 	NULL	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	PEAKS046433
EXP047163	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: tdp-1 mutante; 	NULL	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	PEAKS046434
EXP047166	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119), transgene nhr-77; Sex: Hermaphrodite;	EXP047164	1202	normal	O02316	whole worms (developmental stage: L2)	PEAKS046435
EXP047167	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119), transgene nhr-77; Sex: Hermaphrodite;	EXP047165	1202	normal	O02316	whole worms (developmental stage: L2)	PEAKS046436
EXP047170	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047168	1390	normal	O02316	whole worms (developmental stage: L3)	PEAKS046437
EXP047171	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047169	1390	normal	O02316	whole worms (developmental stage: L3)	PEAKS046438
EXP047174	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047172	2193	normal	O02316	whole worms(developmental stage L4)	PEAKS046439
EXP047175	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047173	2193	normal	O02316	whole worms(developmental stage L4)	PEAKS046440
EXP047178	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs226(nhr-116::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047176	1202	normal	G5EE21	whole worms (developmental stage: L2)	PEAKS046441
EXP047179	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs226(nhr-116::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047177	1202	normal	G5EE21	whole worms (developmental stage: L2)	PEAKS046442
EXP047182	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc-119(ed3); wgIs212(F45C12.2:TY1 EGFP FLAG; unc-119(+)); Sex: hermophrodite; 	EXP047180	1387	normal	O16748	whole worms (developmental stage: L1)	PEAKS046443
EXP047183	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc-119(ed3); wgIs212(F45C12.2:TY1 EGFP FLAG; unc-119(+)); Sex: hermophrodite; 	EXP047181	1387	normal	O16748	whole worms (developmental stage: L1)	PEAKS046444
EXP047186	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047184	2194	normal	Q9N5D6	whole worms(develomental stage: day 4 young adult)	PEAKS046445
EXP047187	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047185	2194	normal	Q9N5D6	whole worms(develomental stage: day 4 young adult)	PEAKS046446
EXP047190	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs83(zag-1::TY1 EGFP FLAG;unc119); Sex; hermophrodite;	EXP047188	2193	normal	G5EBU4	whole worms(developmental stage L4)	PEAKS046447
EXP047191	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs83(zag-1::TY1 EGFP FLAG;unc119); Sex; hermophrodite;	EXP047189	2193	normal	G5EBU4	whole worms(developmental stage L4)	PEAKS046448
EXP047194	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs234(T24H10.7:TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047192	2193	normal	G5ECU7	whole worms(developmental stage L4)	PEAKS046449
EXP047195	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs234(T24H10.7:TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047193	2193	normal	G5ECU7	whole worms(developmental stage L4)	PEAKS046450
EXP047198	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs236(elk-2::TY1 EGFP FLAG;unc119); Sex: hermaphrodite;	EXP047196	1390	normal	H2L2J7	whole worms (developmental stage: L3)	PEAKS046451
EXP047199	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs236(elk-2::TY1 EGFP FLAG;unc119); Sex: hermaphrodite;	EXP047197	1390	normal	H2L2J7	whole worms (developmental stage: L3)	PEAKS046452
EXP047204	Go-ChIP-Grade Purified anti-SSRP1 Antibody	Homo sapiens	Stage: 13 - 18; 	EXP047200	2195	normal	Q08945	human secondary fibroblast	PEAKS046455
EXP047205	Go-ChIP-Grade Purified anti-SSRP1 Antibody	Homo sapiens	Stage: 13 - 18; 	EXP047201	2195	normal	Q08945	human secondary fibroblast	PEAKS046456
EXP047206	SPT16 (D7I2K) Rabbit mAb	Homo sapiens	Stage: 13 - 18; 	EXP047200	2195	normal	Q9Y5B9	human secondary fibroblast	PEAKS046457
EXP047207	SPT16 (D7I2K) Rabbit mAb	Homo sapiens	Stage: 13 - 18; 	EXP047201	2195	normal	Q9Y5B9	human secondary fibroblast	PEAKS046458
EXP047258	anti-BRD1 (Abcam, ab71877)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047242	455	normal	O95696	HUES64 (embryonic stem cells)	PEAKS046487
EXP047259	anti-BRD1 (Abcam, ab71877)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047243	455	normal	O95696	HUES64 (embryonic stem cells)	PEAKS046488
EXP047260	anti-RING1B (Abcam, ab3832)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047244	455	normal	Q99496	HUES64 (embryonic stem cells)	PEAKS046489
EXP047261	anti-RING1B (Abcam, ab3832)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047245	455	normal	Q99496	HUES64 (embryonic stem cells)	PEAKS046490
EXP047262	BioTAP-N-Br140	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047246	2197	normal	Q7JVP4	whole organism (developmental stage: embryo 12 - 24)	PEAKS046491
EXP047263	BioTAP-N-Br140	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047247	2197	normal	Q7JVP4	whole organism (developmental stage: embryo 12 - 24)	PEAKS046492
EXP047264	anti-Fs(1)h (a kind gift from Dr. Igor B. Dawid)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047248	2197	normal	P13709	whole organism (developmental stage: embryo 12 - 24)	PEAKS046493
EXP047265	anti-Fs(1)h (a kind gift from Dr. Igor B. Dawid)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047249	2197	normal	P13709	whole organism (developmental stage: embryo 12 - 24)	PEAKS046494
EXP047266	anti-Fs(1)h (a kind gift from Dr. Igor B. Dawid)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047250	2197	normal	P13709	whole organism (developmental stage: embryo 12 - 24)	PEAKS046495
EXP047267	BioTAP-N-Br140	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	EXP047251	2198	normal	Q7JVP4	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	PEAKS046496
EXP047268	BioTAP-N-Fs(1)h	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	EXP047252	2198	normal	P13709	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	PEAKS046497
EXP047269	BioTAP-C-Fs(1)h	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	EXP047253	2198	normal	P13709	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	PEAKS046498
EXP047272	anti-GFP	Drosophila melanogaster	Treatment: IMAGO line with ato-gfp;	EXP047270	2163	normal	P48987	brain, third instar larva	PEAKS046499
EXP047273	anti-GFP	Drosophila melanogaster	Treatment: IMAGO line with ato-gfp;	EXP047271	2163	normal	P48987	brain, third instar larva	PEAKS046500
EXP047278	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	P51825	NCI-H2171 (small cell lung carcinoma)	PEAKS046501
EXP047279	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	P51825	NCI-H2171 (small cell lung carcinoma)	PEAKS046502
EXP047280	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	P51825	SW1271 (small cell lung carcinoma)	PEAKS046503
EXP047281	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	P51825	SW1271 (small cell lung carcinoma)	PEAKS046504
EXP047282	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	Q9UHB7	NCI-H2171 (small cell lung carcinoma)	PEAKS046505
EXP047283	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	Q9UHB7	NCI-H2171 (small cell lung carcinoma)	PEAKS046506
EXP047284	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	Q9UHB7	SW1271 (small cell lung carcinoma)	PEAKS046507
EXP047285	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	Q9UHB7	SW1271 (small cell lung carcinoma)	PEAKS046508
EXP047286	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	O00472	NCI-H2171 (small cell lung carcinoma)	PEAKS046509
EXP047287	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	O00472	NCI-H2171 (small cell lung carcinoma)	PEAKS046510
EXP047288	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	O00472	SW1271 (small cell lung carcinoma)	PEAKS046511
EXP047289	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	O00472	SW1271 (small cell lung carcinoma)	PEAKS046512
EXP047290	c-Myc (D3N8F) Rabbit mAb	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	P01106	NCI-H2171 (small cell lung carcinoma)	PEAKS046513
EXP047291	c-Myc (D3N8F) Rabbit mAb	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	P01106	HEK293T (embryonic kidney)	PEAKS046514
EXP047292	c-Myc (D3N8F) Rabbit mAb	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	P01106	HEK293T (embryonic kidney)	PEAKS046515
EXP047293	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	P51825	HEK293T (embryonic kidney)	PEAKS046516
EXP047294	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	P51825	HEK293T (embryonic kidney)	PEAKS046517
EXP047295	AFF4 antibody	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	Q9UHB7	HEK293T (embryonic kidney)	PEAKS046518
EXP047296	AFF4 antibody	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	Q9UHB7	HEK293T (embryonic kidney)	PEAKS046519
EXP047297	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	O00472	HEK293T (embryonic kidney)	PEAKS046520
EXP047298	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	O00472	HEK293T (embryonic kidney)	PEAKS046521
EXP047313	Guinea pig anti-Yan antibody (1:500), Webber et al. (2013) Genetics, 193:633-649	Drosophila melanogaster	Genotype: w1118; 	EXP047307	1434	normal	Q01842	whole organism (developmental stage: embryonic stage 11)	PEAKS046528
EXP047314	Guinea pig anti-Yan antibody (1:500), Webber et al. (2013) Genetics, 193:633-649	Drosophila melanogaster	Genotype: pnt -/- (pnt Delta88);	EXP047308	1434	normal	Q01842	whole organism (developmental stage: embryonic stage 11)	PEAKS046529
EXP047315	anti-Groucho antibody (1:200), Negre et al. (2011) Nature, 471:527-531	Drosophila melanogaster	Genotype: w1118;	EXP047310	1434	normal	P16371	whole organism (developmental stage: embryonic stage 11)	PEAKS046530
EXP047316	anti-Groucho antibody (1:200), Negre et al. (2011) Nature, 471:527-531	Drosophila melanogaster	Genotype: pnt -/- (pnt AF397);	EXP047310	1434	normal	P16371	whole organism (developmental stage: embryonic stage 11)	PEAKS046531
EXP047317	rabbit anti-GFP antibody (1:100), Invitrogen A6455, Lot# 1603336	Drosophila melanogaster	Genotype: PBac{pnt-GFP.FPTB}VK00037;  	EXP047311	1434	normal	P51022	whole organism (developmental stage: embryonic stage 11)	PEAKS046532
EXP047318	rabbit anti-GFP antibody (1:100), Invitrogen A6455, Lot# 1603336	Drosophila melanogaster	Genotype: yan-/-(yanE833), Pbac{pnt-GFP.FPTB}VK00037;	EXP047312	1434	normal	P51022	whole organism (developmental stage: embryonic stage 11)	PEAKS046533
EXP047323	input	Drosophila melanogaster	Treatment: mock; Sex: female; 	NULL	1448	normal	A0A0B4K692	KC167 (developmental stage: 6-12h embryo)	PEAKS046534
EXP047324	input	Drosophila melanogaster	Treatment: mock; Sex: female; 	NULL	1448	normal	A0A0B4K692	KC167 (developmental stage: 6-12h embryo)	PEAKS046535
EXP047325	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: mock; Sex: female; 	EXP047319	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	PEAKS046536
EXP047326	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: mock; Sex: female; 	EXP047320	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	PEAKS046537
EXP047327	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: dslaminb; Sex: female; 	EXP047321	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	PEAKS046538
EXP047328	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: dslamind; Sex: female; 	EXP047322	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	PEAKS046539
EXP047333	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047329	1397	normal	P92204	Kc167 (development stage: embryonic)	PEAKS046540
EXP047334	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047330	1397	normal	P92204	Kc167 (development stage: embryonic)	PEAKS046541
EXP047335	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: siAGO2; Genotype: Ago2 knockdown; Sex: female; 	EXP047331	1397	normal	P92204	Kc167 (development stage: embryonic)	PEAKS046542
EXP047336	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: siAGO2; Genotype: Ago2 knockdown; Sex: female; 	EXP047332	1397	normal	P92204	Kc167 (development stage: embryonic)	PEAKS046543
EXP047341	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047337	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	PEAKS046544
EXP047342	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047338	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	PEAKS046545
EXP047343	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: triptolide (transcription inhibitor); Sex: female; 	EXP047339	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	PEAKS046546
EXP047344	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: triptolide (transcription inhibitor); Sex: female; 	EXP047340	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	PEAKS046547
EXP047345	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is near 10; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	PEAKS046548
EXP047346	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is 11; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	PEAKS046549
EXP047374	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	EXP047354	1445	normal	P05205	head, adult	PEAKS046556
EXP047375	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	EXP047355	1445	normal	P05205	head, adult	PEAKS046557
EXP047376	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	EXP047356	1445	normal	P05205	head, adult	PEAKS046558
EXP047377	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  AGO2 1-1-7 mutant;	EXP047357	1445	normal	P05205	head, adult	PEAKS046559
EXP047378	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  AGO2 1-1-7 mutant;	EXP047358	1445	normal	P05205	head, adult	PEAKS046560
EXP047379	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	EXP047359	1445	normal	P05205	head, adult	PEAKS046561
EXP047380	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	EXP047360	1445	normal	P05205	head, adult	PEAKS046562
EXP047381	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	EXP047361	1445	normal	P05205	head, adult	PEAKS046563
EXP047382	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  Top3b 26;AGO2 1-1-7 double mutant;	EXP047362	1445	normal	P05205	head, adult	PEAKS046564
EXP047383	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  Top3b 26;AGO2 1-1-7 double mutant;	EXP047363	1445	normal	P05205	head, adult	PEAKS046565
EXP047384	FLAG 	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	Q9VUQ5	head, adult	PEAKS046566
EXP047385	FLAG	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	Q9VUQ5	head, adult	PEAKS046567
EXP047386	anti-Top3b	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	O96651	head, adult	PEAKS046568
EXP047387	anti-Top3b	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	O96651	head, adult	PEAKS046569
EXP047388	anti-Top3b	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	O96651	head, adult	PEAKS046570
EXP047389	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	P05205	head, adult	PEAKS046571
EXP047390	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26 mutant;	NULL	1445	normal	P05205	head, adult	PEAKS046572
EXP047391	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bWT complementation;	NULL	1445	normal	P05205	head, adult	PEAKS046573
EXP047392	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bY332F mutant complementation;	NULL	1445	normal	P05205	head, adult	PEAKS046574
EXP047393	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bDRGG mutant complementation;	NULL	1445	normal	P05205	head, adult	PEAKS046575
EXP047402	GFP-Trap ChromoTek	Drosophila melanogaster	Treatment: Genotype: mal-d[delta]7;	EXP047394	2203	normal	Q6B4I4	ovary	PEAKS046576
EXP047403	AC-74 (A2228)	Drosophila melanogaster	Treatment: Genotype: mal-d[delta]7;	EXP047394	2203	normal	P10987	ovary	PEAKS046577
EXP047404	AC-74 (A2228)	Drosophila melanogaster	Treatment: Genotype: tub mal-d3xGFP;	EXP047394	2203	normal	P10987	ovary	PEAKS046578
EXP047405	GFP-Trap ChromoTek	Drosophila melanogaster	Treatment: Genotype: tub mal-d3xGFP;	EXP047394	2203	normal	Q6B4I4	ovary	PEAKS046579
EXP047406	AC-15 (A1978)	Drosophila melanogaster	Treatment: Genotype: w1118;	EXP047401	2203	normal	P10987	ovary	PEAKS046580
EXP047417	Anti-Wds antibody (Cat# 40630002) Novus Biologicals	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1244	normal	Q9V3J8	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS046591
EXP047418	Anti-Wds antibody (Cat# 40630002) Novus Biologicals	Drosophila melanogaster	Treatment: Genotype: DMAD-siRNA knockdown;	NULL	1244	normal	Q9V3J8	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS046592
EXP047433	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047427	2204	bio_control	Q24168	Oregon R (developmental stage: 68h AEL)	PEAKS046596
EXP047434	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047428	2204	normal	Q24168	Oregon R (developmental stage: 68h AEL)	PEAKS046597
EXP047435	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047429	2205	normal	Q24168	Oregon R (developmental stage: 92h AEL)	PEAKS046598
EXP047436	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047430	2205	normal	Q24168	Oregon R (developmental stage: 92h AEL)	PEAKS046599
EXP047437	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047431	2206	normal	Q24168	Oregon R (developmental stage: late 3 WL)	PEAKS046600
EXP047438	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047432	2206	normal	Q24168	Oregon R (developmental stage: late 3 WL)	PEAKS046601
EXP047441	Monoclonal against Drosophila BRM (non-commercial)	Drosophila melanogaster	Source: endogenus BRM IP; 	EXP047439	1242	normal	P25439	S2 cells	PEAKS046602
EXP047442	Monoclonal against Drosophila BRM (non-commercial)	Drosophila melanogaster	Source: endogenus BRM IP; 	EXP047440	1451	normal	P25439	S2 (Schneider 2)	PEAKS046603
EXP047446	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + F821A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046606
EXP047447	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + D824A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046607
EXP047448	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046608
EXP047449	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + WT ATAC1 rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046609
EXP047450	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: shNT control vector;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046610
EXP047451	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + D824A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046611
EXP047452	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + F821A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046612
EXP047453	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: shNT control vector;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046613
EXP047454	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + WT ATAC1 rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046614
EXP047456	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS046615
EXP051014	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2207	normal	P04637	LOXIMVI	PEAKS049014
EXP051015	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2208	normal	P04637	UO31	PEAKS049015
EXP051016	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2209	normal	P04637	A498	PEAKS049016
EXP051017	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	848	normal	P04637	U2OS (osteosarcoma)	PEAKS049017
EXP051018	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	1573	normal	P04637	SK-MEL-5 (Cutaneous melanoma)	PEAKS049018
EXP051019	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2210	normal	P04637	MALME3	PEAKS049019
EXP051020	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	1490	normal	P04637	NCI-H460 (Large cell lung carcinoma)	PEAKS049020
EXP051021	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	38	normal	P04637	A549 (lung carcinoma)	PEAKS049021
EXP051022	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS049022
EXP051023	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2211	normal	P04637	UACC62	PEAKS049023
EXP051024	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2212	normal	P04637	UACC257	PEAKS049024
EXP047468	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS046627
EXP051025	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2212	normal	P04637	UACC257	PEAKS049025
EXP051026	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2213	normal	P04637	RPE	PEAKS049026
EXP047471	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens		EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS046630
EXP047472	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens		EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS046631
EXP047473	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: Decitabine; 	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS046632
EXP047474	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: Decitabine;	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	PEAKS046633
EXP047484	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	EXP047475	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046634
EXP047485	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	EXP047476	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046635
EXP047486	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	EXP047477	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046636
EXP047487	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	EXP047478	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046637
EXP047488	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	EXP047479	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046638
EXP047489	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	EXP047480	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046639
EXP047490	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	EXP047481	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046640
EXP047491	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	EXP047482	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046641
EXP047492	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	EXP047483	583	normal	P01106	MCF10A (breast epithelial cells)	PEAKS046642
EXP047493	NLS-HBx-RFP	Mus musculus	Treatment: Source: liver; TumourStage: non-transformed;	NULL	2214	normal	A1A546	murine hepatocytes (MMH-D3)	PEAKS046643
EXP047494	HBx	Homo sapiens	Treatment: Source: liver; TumourStage: transformed;	NULL	2215	normal	O43504	HepG2.2.15	PEAKS046644
EXP047495	HBx	Homo sapiens	Treatment: Source: liver; TumourStage: transformed;	NULL	2216	normal	O43504	HepG2 H1.3 (human hepatocytes)	PEAKS046645
EXP047496	HBx	Homo sapiens	Treatment: Source: liver; TumourStage: primary cell-like;	NULL	2217	normal	O43504	HepaRG	PEAKS046646
EXP047498	C/EBP? (Santa Cruz, sc-150x)	Homo sapiens	Treatment: C/EBPÎ²-overexpressed;	EXP047497	438	normal	Q15125	HL-60 (acute myeloid leukemia)	PEAKS046647
EXP047505	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: DMSO 0.1%; Cell type: essential thrombocythemia;	EXP047499	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS046648
EXP047506	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: DMSO 0.1%; Cell type: essential thrombocythemia;	EXP047500	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS046649
EXP047507	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: CA 25 nM; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS046650
EXP047508	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: CA 25 nM; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS046651
EXP047509	STAT1 pS727 (Life Tech #44-382G) 	Homo sapiens	Treatment: untreated; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS046652
EXP047510	STAT1 pS727 (Life Tech #44-382G) 	Homo sapiens	Treatment: untreated; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS046653
EXP047514	TRIM24 (Bethyl A300-851A)	Homo sapiens	Treatment: 24h DMSO;	EXP047511	2219	normal	O15164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS046654
EXP047515	TRIM24 (Bethyl A300-851A)	Homo sapiens	Treatment: 24h 2.5 ÂµM IACS-9571;	EXP047512	2219	normal	O15164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS046655
EXP047516	TRIM24 (Bethyl A300-851A)	Homo sapiens	Treatment: dTRIM24 24h;	NULL	2219	normal	O15164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS046656
EXP047520	anti-OCT4 (sc-8628, Santa Cruz Biotechnology);	Homo sapiens		NULL	376	normal	Q01860	WA01 (H1, human embryonic stem cells)	PEAKS046659
EXP047521	anti-OCT4 (sc-8628, Santa Cruz Biotechnology);	Homo sapiens		NULL	2222	normal	Q01860	1% H1 ESCs with 99% fibroblsat	PEAKS046660
EXP047522	anti-PAX5 (sc-1974, Santa Cruz Biotechnology);	Homo sapiens		EXP047517	2221	normal	Q02548	2nd trimester human fetal testis	PEAKS046661
EXP047523	anti-PRDM1 (C14A4, Cell Signaling Technology);	Homo sapiens		EXP047517	2221	normal	O75626	2nd trimester human fetal testis	PEAKS046662
EXP047534	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	EXP047524	2224	normal	Q92754	UCLA1 hESCs	PEAKS046663
EXP047535	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	EXP047525	2224	normal	Q92754	UCLA1 hESCs	PEAKS046664
EXP047536	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	EXP047526	2224	normal	Q92754	UCLA1 hESCs	PEAKS046665
EXP047537	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p33; Treatment: 5 days in 5iLAF;	EXP047527	2224	normal	Q92754	UCLA1 hESCs	PEAKS046666
EXP047538	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	EXP047528	2224	normal	Q92754	UCLA1 hESCs	PEAKS046667
EXP047539	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	EXP047529	2224	normal	Q92754	UCLA1 hESCs	PEAKS046668
EXP047540	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	EXP047530	2224	normal	Q92754	UCLA1 hESCs	PEAKS046669
EXP047541	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: No Induc;	EXP047531	2224	normal	Q92754	UCLA1 hESCs	PEAKS046670
EXP047542	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C;	EXP047532	2224	normal	Q92754	UCLA1 hESCs	PEAKS046671
EXP047543	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C;	EXP047533	2224	normal	Q92754	UCLA1 hESCs	PEAKS046672
EXP047544	anti-NIPBL	Mus musculus	Treatment: Source: pancreatic beta cell line;	NULL	1043	normal	Q6KCD5	MIN6 (insulinoma)	PEAKS046673
EXP047545	anti-MAU2	Mus musculus	Treatment: Source: pancreatic beta cell line;	NULL	1043	normal	Q9D2X5	MIN6 (insulinoma)	PEAKS046674
EXP047552	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: resting;Day:0;	EXP047546	938	normal	O75444	Th17-cells	PEAKS046675
EXP047553	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047547	938	normal	O75444	Th17-cells	PEAKS046676
EXP047554	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10- lymphocytes; ActivationState: resting;Day:0;	EXP047546	938	normal	O75444	Th17-cells	PEAKS046677
EXP047555	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047547	938	normal	O75444	Th17-cells	PEAKS046678
EXP047556	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: resting;Day:0;	EXP047548	938	normal	O75444	Th17-cells	PEAKS046679
EXP047557	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047549	938	normal	O75444	Th17-cells	PEAKS046680
EXP047558	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10- lymphocytes; ActivationState: resting;Day:0;	EXP047548	938	normal	O75444	Th17-cells	PEAKS046681
EXP047559	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10-  lymphocytes; ActivationState: resting; Day: 5;	EXP047549	938	normal	O75444	Th17-cells	PEAKS046682
EXP047560	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: resting;Day:0;	EXP047550	938	normal	O75444	Th17-cells	PEAKS046683
EXP047561	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047551	938	normal	O75444	Th17-cells	PEAKS046684
EXP047562	anti-JMJD6 ab10526(Abcam)	Homo sapiens	Treatment: without estrogen (E2) for 1 h;	NULL	113	normal	Q6NYC1	MCF7 (Invasive ductal breast carcinoma)	PEAKS046685
EXP047563	anti-JMJD6 ab10526(Abcam)	Homo sapiens	Treatment: with estrogen (E2) for 1 h;	NULL	113	normal	Q6NYC1	MCF7 (Invasive ductal breast carcinoma)	PEAKS046686
EXP047564	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: without estrogen (E2) for 1 h; CellType: with siCTL;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	PEAKS046687
EXP047565	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: with estrogen (E2) for 1 h; CellType: with siCTL;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	PEAKS046688
EXP047566	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: without estrogen (E2) for 1 h; CellType: with siJMJD6;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	PEAKS046689
EXP047567	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: with estrogen (E2) for 1 h; CellType: with siJMJD6;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	PEAKS046690
EXP047569	Prep1 Santa-Cruz N15 (sc-6245)	Homo sapiens		EXP047568	78	normal	P55347	HeLa (cervical adenocarcinoma)	PEAKS046691
EXP047572	Anti-RUNX1/AML1 antibody (ab23980,Abcam,GR309729-1)	Homo sapiens	Treatment: Treatment: DMSO for 6 hr; CellType: human inv(16) leukemia cell line;	EXP047570	592	normal	Q01196	ME-1 (acute myeloid leukemia )	PEAKS046692
EXP047573	Anti-RUNX1/AML1 antibody (ab23980,Abcam,GR309729-1)	Homo sapiens	Treatment: Treatment: Al-10-49 (1uM) for 6 hr; CellType: human inv(16) leukemia cell line;	EXP047571	592	normal	Q01196	ME-1 (acute myeloid leukemia )	PEAKS046693
EXP047579	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 1000nM, 4h; Internalid: J3756;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046694
EXP047580	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 100nM, 4h; Internalid: J3758;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046695
EXP047581	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 1nM, 4h; Internalid: J2600, J2609;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046696
EXP047582	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J3764;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046697
EXP047583	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 35nM, 4h; Internalid: J2601, J2610;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046698
EXP047584	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J3764;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046699
EXP047585	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J2608, J2778;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046700
EXP047586	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J3764;	EXP047576	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS046701
EXP047587	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: without treatment; InternalID: j2386;	NULL	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	PEAKS046702
EXP047590	anti-ETS1 antibody (Aviva Systems Biology Catalog #: P100604_T100)	Homo sapiens		EXP047588	2227	normal	P14921	HEYA8 Ovarian cancer cell	PEAKS046703
EXP047591	anti-ETS1 antibody (Aviva Systems Biology Catalog #: P100604_T100)	Homo sapiens		EXP047589	701	normal	P14921	OVCAR8 (high grade ovarian serous adenocarcinoma)	PEAKS046704
EXP047594	anti-MYC	Homo sapiens	Treatment: Genotype: scramble shRNA;	EXP047592	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS046705
EXP047595	anti-MYC	Homo sapiens	Treatment: Genotype: Dpy30 shRNA;	NULL	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS046706
EXP047602	custom made antibody for SA1 (STAG1)	Homo sapiens	Passage: less than 10;	EXP047596	440	normal	Q8WVM7	HMEC (human mammary epithelial cells)	PEAKS046707
EXP047603	custom made antibody for SA2 (STAG2)	Homo sapiens	Passage: less than 10;	EXP047596	440	normal	Q8N3U4	HMEC (human mammary epithelial cells)	PEAKS046708
EXP047604	custom made antibody for SMC1	Homo sapiens	Passage: less than 10;	EXP047596	440	normal	Q14683	HMEC (human mammary epithelial cells)	PEAKS046709
EXP047605	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	PEAKS046710
EXP047606	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	PEAKS046711
EXP047607	custom made antibody for SMC1	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q14683	MCF10A (breast epithelial cells)	PEAKS046712
EXP047608	Zmym2 antibody was a generous gift from H. Yu (UT Southwestern, US)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q9UBW7	MCF10A (breast epithelial cells)	PEAKS046713
EXP047609	custom made antibody for SA1 (STAG1)	Homo sapiens	Passage: less then 10; CellType: primary cells; 	EXP047598	2229	normal	Q8WVM7	HCAEC (human coronary artery endothelial cells)	PEAKS046714
EXP047610	custom made antibody for SA2 (STAG2)	Homo sapiens	Passage: less then 10; CellType: primary cells; 	EXP047598	2229	normal	Q8N3U4	HCAEC (human coronary artery endothelial cells)	PEAKS046715
EXP047611	custom made antibody for SMC1	Homo sapiens	Passage: less then 10; CellType: primary cells; 	EXP047598	2229	normal	Q14683	HCAEC (human coronary artery endothelial cells)	PEAKS046716
EXP047624	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: untreated; 	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046729
EXP047625	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: untreated; 	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046730
EXP047626	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046731
EXP047627	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046732
EXP047628	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046733
EXP047629	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046734
EXP047630	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046735
EXP047631	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046736
EXP047632	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046737
EXP047633	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	PEAKS046738
EXP047652	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: DMSO 6hr; 	EXP047640	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS046739
EXP047653	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: DMSO 6hr; 	EXP047641	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS046740
EXP047654	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: JQ1 6hr;	EXP047642	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS046741
EXP047655	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: JQ1 6hr;	EXP047643	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS046742
EXP047656	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: siYAPTAZ; Genotype: YAP/TAZ depletion;	EXP047644	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS046743
EXP047657	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: siYAPTAZ; Genotype: YAP/TAZ depletion;	EXP047639	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS046744
EXP047659	c-Jun (H-79, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr;  	EXP047658	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	PEAKS046745
EXP047660	c-Jun (H-79, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr;  	EXP047658	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	PEAKS046746
EXP047661	c-Jun (H-79, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1Î¼M for 1hr; 	EXP047658	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	PEAKS046747
EXP047662	ERalpha (H-20, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr;  	EXP047658	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046748
EXP047663	ERalpha (H-20, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr;  	EXP047658	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046749
EXP047664	ERalpha (H-20, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1Î¼M for 1hr; 	EXP047658	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046750
EXP047665	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046751
EXP047666	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046752
EXP047667	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: ethanol; Genotype: SKH1;	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046753
EXP047668	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: estradiol; Genotype: SKH1;	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046754
EXP047669	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046755
EXP047670	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046756
EXP047671	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: SKH1;	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046757
EXP047672	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: SKH1;	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS046758
EXP047673	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046759
EXP047674	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046760
EXP047675	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: ethanol; Genotype: Kkasumi1;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046761
EXP047676	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: estradiol; Genotype: Kkasumi1;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046762
EXP047677	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046763
EXP047678	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046764
EXP047679	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: Kkasumi1;	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046765
EXP047680	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: Kkasumi1;	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046766
EXP047684	Santa Cruz ARID2 (E-3) sc-1666117 mouse monoclonal ab - 5 ug (lot# G2712)	Homo sapiens	Treatment: without shRNA;	EXP047681	30	normal	Q68CP9	RCC 7860 (Renal cell carcinoma)	PEAKS046767
EXP047685	Santa Cruz ARID2 (E-3) sc-1666117 mouse monoclonal ab - 5 ug (lot# G2712)	Homo sapiens	Treatment: PBRM1 knockdown shRNA;	EXP047682	30	normal	Q68CP9	RCC 7860 (Renal cell carcinoma)	PEAKS046768
EXP047686	Santa Cruz ARID2 (E-3) sc-1666117 mouse monoclonal ab - 5 ug (lot# G2712)	Homo sapiens	Treatment: PBRM1 knockdown shRNA;	EXP047683	30	normal	Q68CP9	RCC 7860 (Renal cell carcinoma)	PEAKS046769
EXP047699	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p19; 	EXP047687	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046770
EXP047700	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p19; 	EXP047688	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046771
EXP047701	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p19; 	EXP047689	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046772
EXP047702	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p20; 	EXP047690	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046773
EXP047703	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p20; 	EXP047691	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046774
EXP047704	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p20; 	EXP047692	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046775
EXP047705	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p21; 	EXP047693	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046776
EXP047706	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p21; 	EXP047694	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046777
EXP047707	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p21; 	EXP047695	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046778
EXP047708	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p22; 	EXP047696	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046779
EXP047709	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p22; 	EXP047697	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046780
EXP047710	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p22; 	EXP047698	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS046781
EXP047711	Affinity purified Gcn4 antibody (HL2871)	Saccharomyces cerevisiae	Treatment: sulfometuron added; Growth: for mid - long fase(OD600 about 0.6 to 0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0; Strain: BY4741 	NULL	1232	normal	P03069	S. cerevisiae cells	PEAKS046782
EXP047712	Affinity purified Gcn4 antibody (HL2871)	Saccharomyces cerevisiae	Treatment: without adding sulfometuron; Growth: for mid - long fase(OD600 about 0.6 -0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0; Strain: BY4741	NULL	1232	normal	P03069	S. cerevisiae cells	PEAKS046783
EXP047713	Affinity purified Gcn4 antibody (HL2871)	Saccharomyces cerevisiae	Treatment: sulfometuron added; Growth: to mid-long fase (OD600 about 0.6 -0.8);Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0 gcn4Î”::kanMX4; Strain: F731 	NULL	1232	normal	P03069	S. cerevisiae cells	PEAKS046784
EXP047714	anti-Myc antibody (11-667-149-001)	Saccharomyces cerevisiae	Treatment: without adding sulfometuron; Growth: for mid - long fase(OD600 0.6 -0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0 SPT15-myc13::HIS3MX6; Strain: HQY366 	NULL	1232	normal	A0A023PXA5	S. cerevisiae cells	PEAKS046785
EXP047715	anti-Myc antibody (11-667-149-001)	Saccharomyces cerevisiae	Treatment: sulfometuron added; Growth: for mid - long fase(OD600 0.6 -0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0 SPT15-myc13::HIS3MX6; Strain: HQY366	NULL	1232	normal	A0A023PXA5	S. cerevisiae cells	PEAKS046786
EXP047717	clone 6E5 (homemade antibody; also available at Active Motif Inc. catalog#61095)	Homo sapiens	TumorType: hepatocellular carcinoma; Tissue: pooled cells; Source: liver;	EXP047716	2230	bio_control	O60315	SNU398	PEAKS046787
EXP047720	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: brd1 ko; 	EXP047718	2231	normal	Q64287	small pre-B cells	PEAKS046788
EXP047723	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: PreB;	EXP047718	2231	normal	Q64287	small pre-B cells	PEAKS046791
EXP047726	NF90 (mAb DRBP76; BD)	Homo sapiens	Source: erythroleikemia cells; 	NULL	514	normal	Q12906	K562 (myelogenous leukemia)	PEAKS046794
EXP047727	antibody GFI1 (Santa Cruz, N-20, polyclonal, Lot H3012 )	Homo sapiens		NULL	516	normal	Q99684	Kasumi-1 (acute myeloblastic leukemia)	PEAKS046795
EXP047728	antibody AML1-ETO (Diagenode, A706, polyclonal)	Mus musculus	Genotype: gfil1 KO;	NULL	2232	normal	Q03347	KP66(mouse sleen cells)	PEAKS046796
EXP047729	antibody AML1-ETO (Diagenode, A706, polyclonal)	Mus musculus	Genotype: wildtype gfi1;	NULL	2233	normal	Q03347	WT132(mouse spleen)	PEAKS046797
EXP047752	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: mock infected 6hr	NULL	466	normal	O60216	MDM(monocyte derived macrophages)	PEAKS046798
EXP047753	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: H5N1 IAV infected 6hr	EXP047730	466	normal	O60216	MDM(monocyte derived macrophages)	PEAKS046799
EXP047754	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: H5N1-dNS1 IAV infected 6hr	EXP047730	466	normal	O60216	MDM(monocyte derived macrophages)	PEAKS046800
EXP047755	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	EXP047730	466	normal	O60216	MDM(monocyte derived macrophages)	PEAKS046801
EXP047756	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: mock infected 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS046802
EXP047757	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: H5N1 IAV infected 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS046803
EXP047758	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: H5N1-dNS1 IAV infected 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS046804
EXP047759	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS046805
EXP047760	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr + Flavopiridol 3h, IAV NS1(EP mRNA)	EXP047731	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046806
EXP047761	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: IFNb treated 6hr, eGFP(EP mRNA)	EXP047731	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046807
EXP047762	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: IFNb treated 6hr, IAV NS1(EP mRNA)	EXP047731	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046808
EXP047763	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated,eGFP (EP mRNA), siCtrl (siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046809
EXP047764	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP (EP mRNA), siCtrl (siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046810
EXP047765	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated, IAV NS1 (EP mRNA), siCtrl (siRNA)	EXP047732	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046811
EXP047766	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr,  IAV NS1 (EP mRNA), siCtrl (siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046812
EXP047767	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr + Flavopiridol 3hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046813
EXP047768	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046814
EXP047769	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	EXP047733	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046815
EXP047770	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr + Flavopiridol 3hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046816
EXP047771	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046817
EXP047772	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siWAPL(siRNA)	EXP047734	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046818
EXP047773	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046819
EXP047774	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA), siCtrl(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046820
EXP047775	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siCtrl(siRNA)	EXP047737	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046821
EXP047776	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 0hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046822
EXP047777	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046823
EXP047778	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046824
EXP047779	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046825
EXP047780	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	EXP047733	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046826
EXP047781	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046827
EXP047782	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046828
EXP047783	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siWAPL(siRNA)	EXP047734	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046829
EXP047784	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046830
EXP047785	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated	EXP047735	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046831
EXP047786	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 20min	EXP047736	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046832
EXP047787	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 25min	EXP047737	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046833
EXP047788	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 30min	EXP047738	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046834
EXP047789	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 45min	EXP047739	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046835
EXP047790	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 60min	EXP047740	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046836
EXP047791	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 120min	EXP047741	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046837
EXP047792	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 150min + Flavopiridol 30min	EXP047742	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046838
EXP047793	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 180min + Flavopiridol 60min	EXP047743	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046839
EXP047794	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 360min + Flavopiridol 240min	EXP047744	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046840
EXP047795	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment:  Flavopiridol 240min	EXP047745	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046841
EXP047796	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: untreated	EXP047735	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046842
EXP047797	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 20min	EXP047736	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046843
EXP047798	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Pam3csk4 treated (025m)	EXP047737	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046844
EXP047799	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 30min	EXP047738	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046845
EXP047800	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 45min	EXP047739	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046846
EXP047801	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 60min	EXP047740	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046847
EXP047802	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 120min	EXP047741	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046848
EXP047803	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 150min + Flavopiridol 30min	EXP047742	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046849
EXP047804	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 180min + Flavopiridol 60min	EXP047743	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046850
EXP047805	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 360min + Flavopiridol 240min	EXP047744	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046851
EXP047806	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment:  Flavopiridol 240min	EXP047745	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046852
EXP047807	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated	EXP047746	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046853
EXP047808	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: dexamethasone 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046854
EXP047809	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046855
EXP047810	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046856
EXP047811	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: untreated	EXP047746	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046857
EXP047812	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: dexamethasone 6hr	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS046858
EXP047813	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	P17676	THP-1 (acute monocytic leukemia)	PEAKS046859
EXP047814	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	P17676	THP-1 (acute monocytic leukemia)	PEAKS046860
EXP047815	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: untreated, IAV NS1(EP mRNA)	EXP047750	2334	normal	P17676	THP-1 (acute monocytic leukemia)	PEAKS046861
EXP047816	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA)	NULL	2334	normal	P17676	THP-1 (acute monocytic leukemia)	PEAKS046862
EXP047817	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS046863
EXP047818	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS046864
EXP047819	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: untreated, IAV NS1(EP mRNA)	EXP047750	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS046865
EXP047820	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA)	EXP047751	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS046866
EXP047821	p65, Santa Cruz: sc-372	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	O43245	THP-1 (acute monocytic leukemia)	PEAKS046867
EXP047822	p65, Santa Cruz: sc-372	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	Q04206	THP-1 (acute monocytic leukemia)	PEAKS046868
EXP047823	FOS, Santa Cruz: sc-7202	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	P01100	THP-1 (acute monocytic leukemia)	PEAKS046869
EXP047824	FOS, Santa Cruz: sc-7202	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	P01100	THP-1 (acute monocytic leukemia)	PEAKS046870
EXP047825	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: mock infected 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS046871
EXP047826	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: H5N1 IAV infected 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS046872
EXP047827	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: H5N1-dNS1 IAV infected 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS046873
EXP047828	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS046874
EXP047829	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046875
EXP047830	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	PEAKS046876
EXP047831	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: Wildtype; Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046877
EXP047832	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: Sen1-AID adeed (DNA - RNA helicases); 288C	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046878
EXP047833	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added h1D-h2D(RNase); Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046879
EXP047834	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added h1D-h2D (RNase), Sen1-AID (RNA-DNA helicase); Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046880
EXP047835	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added h1D-h2D( RNase),Top1-AID (Topoisomerases); Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046881
EXP047836	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 2% galactose; Genotype: Gal - HO; Strain: JKM	NULL	1232	normal	P06778	S. cerevisiae cells	PEAKS046882
EXP047837	M2 anti-FLAGAffinity purified DNA	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: flag-targged Brr6N;	EXP046764	1232	normal	P53062	S. cerevisiae cells	PEAKS046883
EXP047838	M2 anti-FLAGAffinity purified DNA	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: flag-targged Brr6N delta C4N;	EXP046765	1232	normal	P53062	S. cerevisiae cells	PEAKS046884
EXP047839		Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: Wiltype(empty vector);	EXP046766	1232	normal	A0A023IRJ6	S. cerevisiae cells	PEAKS046885
EXP047840	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in HU for 90 min; Genotype: wildtype; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046886
EXP047841	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in HU for 90 min; Genotype:mutation mcm2DENQ; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046887
EXP047842	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in HU for 90 min; Genotype: mutation {delta} mrc1; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	PEAKS046888
EXP047843	anti-myc antibody (abcam ab9132)	Saccharomyces cerevisiae	Genotype: MATa his3{delta}_1, leu2{delta}_0, met15{delta}_0, ura3{delta}_0CBP80-myc13::NAT; Source: Cbp20 tagged strain; 	NULL	1232	normal	Q08920	S. cerevisiae cells	PEAKS046889
EXP047844	anti-myc antibody (abcam ab9132)	Saccharomyces cerevisiae	Genotype: MATa his3{delta}_1, leu2{delta}_0, met15{delta}_0, ura3{delta}_0RNT1-myc13::NAT; Source: Rnt1 tagged strain; 	NULL	1232	normal	Q02555	S. cerevisiae cells	PEAKS046890
EXP047845	Anti-HA tag antibody 	Caenorhabditis elegans	Genotype: BAT1753 [hmg-3(bar24[hmg-3::3xHA]) I];	NULL	2193	normal	O01683	whole worms(developmental stage L4)	PEAKS046891
EXP047849	anti-E(z) (rabbit polyclonal raised against bacterially expressed full length E(z))	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	M9PHZ5	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046892
EXP047850	anti-Pc (Santa Cruz Biotech Inc, sc25762)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	P26017	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046893
EXP047851	anti-Ph (Donna-Arndt-Jovin)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	P39769	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046894
EXP047852	anti-Pho (Brown et al., 2003)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	Q8ST83	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046895
EXP047853	anti-Psc (Nicole Francis)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	P35820	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046896
EXP047854	anti-Spps (Brown and Kassis 2010)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	A0A0B4KHC8	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046897
EXP047855	anti-E(z) (rabbit polyclonal raised against bacterially expressed full length E(z))	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	A0A021WW32	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046898
EXP047856	anti-Ph (Donna-Arndt-Jovin)	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	P39769	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046899
EXP047857	anti-Pho (Brown et al., 2003)	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	Q8ST83	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046900
EXP047858	anti-Psc (Nicole Francis)	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	P35820	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046901
EXP047859	anti-Ph (Donna-Arndt-Jovin)	Drosophila melanogaster	Treatment: Genotype: Pho knockout;	EXP047848	2196	normal	P39769	imaginal discs and brains (developmental stage: third instar larval)	PEAKS046902
EXP047860	anti-Dll antibody (sc-15858, Santa Cruz Biotechnology)	Drosophila melanogaster	Genotype: yw; 	EXP047299	2200	normal	P20009	leg imaginal discs (developmental stage: L3)	PEAKS046903
EXP047861	anti-GFP antibody (ab290, Abcam)	Drosophila melanogaster	Genotype: Sp1-GFP (BAC); 	EXP047300	2200	normal	Q9U1K4	leg imaginal discs (developmental stage: L3)	PEAKS046904
EXP047862	CLAMP (3 nL of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is late 14; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	PEAKS046905
EXP047863	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is 13; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	PEAKS046906
EXP047864	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is 12; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	PEAKS046907
EXP047866	AC-74 (A2228)	Drosophila melanogaster	Treatment: Genotype: w1118;	EXP047401	2203	normal	P10987	ovary	PEAKS046908
EXP047867	anti-DMAD	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1244	normal	M9NEY8	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS046909
EXP047868	Pc, Santa Cruz #sc-25762	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1244	normal	P26017	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS046910
EXP047869	Pc, Santa Cruz #sc-25762	Drosophila melanogaster	Treatment: Genotype: DMAD-siRNA knockdown;	NULL	1244	normal	P26017	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS046911
EXP047870	GFP-Trap_A (gta-20, Chromotek, Germany)	Drosophila melanogaster	Genotype: atf3 mutatnt; Sex: male; Title: Contol;	EXP047419	1444	bio_control	Q9XZS8	body, adult	PEAKS046912
EXP047871	GFP-Trap_A (gta-20, Chromotek, Germany)	Drosophila melanogaster	Genotype: atf3 mutatnt; Sex: male; 	EXP047423	1444	normal	Q9XZS8	body, adult	PEAKS046913
EXP047872	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: shNT control vector;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	PEAKS046914
EXP047873	anti-OCT4 (sc-8628, Santa Cruz Biotechnology);	Homo sapiens		EXP047517	2221	normal	Q01860	2nd trimester human fetal testis	PEAKS046915
EXP047874	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047601	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	PEAKS046916
EXP047875	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047601	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	PEAKS046917
EXP047876	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG1 siRNAs;	EXP047600	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	PEAKS046918
EXP047877	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG1 siRNAs;	EXP047600	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	PEAKS046919
EXP047878	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG2 siRNAs;	EXP047599	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	PEAKS046920
EXP047879	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG2 siRNAs;	EXP047599	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	PEAKS046921
EXP047880	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: brd1 ko low DNA; 	EXP047718	2231	normal	Q64287	small pre-B cells	PEAKS046922
EXP047881	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: PreB low DNA;	EXP047718	2231	normal	Q64287	small pre-B cells	PEAKS046923
EXP047882	Antibody against Flag (Sigma, M2)	Homo sapiens	Genotype: control untreated	NULL	741	normal	Q03164	CD34+ hematopoietic stem progenitor cells	PEAKS046924
EXP047884	Abcam ab182560	Homo sapiens	Treatment: Source: ADR1A was profield in parental RMG-1	EXP047883	2235	normal	O14497	RMG-1	PEAKS046925
EXP047888	CS-129-100, Diagenode	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	PEAKS046926
EXP047889	ab28379, abcam	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	PEAKS046927
EXP047890	CS-129-100, Diagenode	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	PEAKS046928
EXP047891	ab28379, abcam	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	PEAKS046929
EXP047892	CS-129-100, Diagenode	Homo sapiens	Treatment:min doxycicline TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	PEAKS046930
EXP047893	CS-129-100, Diagenode	Homo sapiens	Treatment:doxycicline and TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	PEAKS046931
EXP047894	CS-129-100, Diagenode	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	Q06945	MDA-MB-231 (breast adenocarcinoma)	PEAKS046932
EXP047895	CS-129-100, Diagenode	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	Q06945	MDA-MB-231 (breast adenocarcinoma)	PEAKS046933
EXP047896	CS-129-100, Diagenode	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	Q06945	HCC1954 (ductal breast carcinoma)	PEAKS046934
EXP047897	CS-129-100, Diagenode	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	Q06945	HCC1954 (ductal breast carcinoma)	PEAKS046935
EXP047898	CS-129-100, Diagenode	Homo sapiens	CellType: Immortalized human mammary epithelial cells Treatment: Doxycicline	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	PEAKS046936
EXP047899	ab28379, abcam	Homo sapiens	CellType: immortalized human mammary epithelial cells Treatment:TGF--beta	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	PEAKS046937
EXP047900	ab28379, abcam	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	PEAKS046938
EXP047901	ab28379, abcam	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	PEAKS046939
EXP047902	ab28379, abcam	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	P84022	HCC1954 (ductal breast carcinoma)	PEAKS046940
EXP047903	ab28379, abcam	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	P84022	HCC1954 (ductal breast carcinoma)	PEAKS046941
EXP047906	CTCF	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P49711	WA09 (embryonic stem cells)	PEAKS046942
EXP047907	CTCF	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P49711	WA09 (embryonic stem cells)	PEAKS046943
EXP047908	ZNF143	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P52747	WA09 (embryonic stem cells)	PEAKS046944
EXP047909	ZNF143	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P52747	WA09 (embryonic stem cells)	PEAKS046945
EXP047910	NANOG	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q9H9S0	WA09 (embryonic stem cells)	PEAKS046946
EXP047911	NANOG	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q9H9S0	WA09 (embryonic stem cells)	PEAKS046947
EXP047912	KLF4	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	O43474	WA09 (embryonic stem cells)	PEAKS046948
EXP047913	KLF4	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	O43474	WA09 (embryonic stem cells)	PEAKS046949
EXP047914	OCT4	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q01860	WA09 (embryonic stem cells)	PEAKS046950
EXP047915	OCT4	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q01860	WA09 (embryonic stem cells)	PEAKS046951
EXP047916	RING1B	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q99496	WA09 (embryonic stem cells)	PEAKS046952
EXP047917	RING1B	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q99496	WA09 (embryonic stem cells)	PEAKS046953
EXP047918	cFos	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P01100	WA09 (embryonic stem cells)	PEAKS046954
EXP047919	cFos	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P01100	WA09 (embryonic stem cells)	PEAKS046955
EXP047920	Brg1	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P51532	WA09 (embryonic stem cells)	PEAKS046956
EXP047921	Brg1	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P51532	WA09 (embryonic stem cells)	PEAKS046957
EXP047922	HSF1	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q00613	WA09 (embryonic stem cells)	PEAKS046958
EXP047923	HSF1	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q00613	WA09 (embryonic stem cells)	PEAKS046959
EXP047924	HSF1	Homo sapiens	Treatment: Treatment: under heat shock conditions and kinase inhibitors	EXP047905	396	normal	Q00613	WA09 (embryonic stem cells)	PEAKS046960
EXP047925	WAPL	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q7Z5K2	WA09 (embryonic stem cells)	PEAKS046961
EXP047926	WAPL	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q7Z5K2	WA09 (embryonic stem cells)	PEAKS046962
EXP047927	NIPBL	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q6KC79	WA09 (embryonic stem cells)	PEAKS046963
EXP047928	NIPBL	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q6KC79	WA09 (embryonic stem cells)	PEAKS046964
EXP047929	CTCF	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P49711	WA09 (embryonic stem cells)	PEAKS046965
EXP047930	CTCF	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P49711	WA09 (embryonic stem cells)	PEAKS046966
EXP047931	Rad21	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	O60216	WA09 (embryonic stem cells)	PEAKS046967
EXP047932	Rad21	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	O60216	WA09 (embryonic stem cells)	PEAKS046968
EXP047933	Rad21	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	O60216	WA09 (embryonic stem cells)	PEAKS046969
EXP047934	Rad21	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	O60216	WA09 (embryonic stem cells)	PEAKS046970
EXP047937	EGR1 bethyl A303-390A	Homo sapiens	Treatment: Treatment: untreated	EXP047935	438	normal	P18146	HL-60 (acute myeloid leukemia)	PEAKS046971
EXP047938	EGR1 bethyl A303-390A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	P18146	HL-60 (acute myeloid leukemia)	PEAKS046972
EXP047939	INTS13  vendor/catalog#: Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), infected with shRNA against EGR1 (EGR1-KD)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	PEAKS046973
EXP047940	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), intected with control shRNA (against LUCIFERASE)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	PEAKS046974
EXP047941	NAB2 ThermoFisher PA5-2792	Homo sapiens	Treatment: Treatment: untreated	EXP047935	438	normal	Q15742	HL-60 (acute myeloid leukemia)	PEAKS046975
EXP047942	NAB2 ThermoFisher PA5-2792	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	Q15742	HL-60 (acute myeloid leukemia)	PEAKS046976
EXP047943	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: none	NULL	2237	normal	Q9NVM9	CD34+(diferentiated monocytes, cord blood)	PEAKS046977
EXP047954	INTS11 Bethyl A301-274A	Homo sapiens	Treatment: Treatment: untreated	NULL	438	normal	Q5TA45	HL-60 (acute myeloid leukemia)	PEAKS046988
EXP047955	INTS11 Bethyl A301-274A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	Q5TA45	HL-60 (acute myeloid leukemia)	PEAKS046989
EXP047956	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: Treatment: untreated	NULL	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	PEAKS046990
EXP047957	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	PEAKS046991
EXP047960	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS046993
EXP047961	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS046994
EXP047962	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS046995
EXP047963	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS046996
EXP047965	Goat anti PDX1 (Christopher V. E., Wright)	Homo sapiens	Treatment: none	EXP047964	2238	normal	P52945	iPS (derived pancreatic precursor cells)	PEAKS046997
EXP047969	TEAD1 (BD Bioscience, Cat# 610923)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	P28347	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS046998
EXP047970	TRPS1 (self-made affinity-purified antibody raised against aa 920-1281)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	Q9UHF7	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS046999
EXP047971	YAP	Homo sapiens	Treatment: Genotype: wildtype Treatment: yap 5sa induced by doxycycline for 18hr	EXP047966	128	normal	P46937	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS047000
EXP047972	CtBP2 (BD Bioscience, Cat# 612044)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	P56545	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS047001
EXP047973	HDAC3 (Cell Signaling, Cat# 85057)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	O15379	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS047002
EXP047974	CtBP2 (BD Bioscience, Cat# 612044)	Homo sapiens	Treatment: Genotype: TRPS1 KO	EXP047967	128	normal	P56545	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS047003
EXP047975	HDAC3 (Cell Signaling, Cat# 85057)	Homo sapiens	Treatment: Genotype: TRPS1 KO	EXP047967	128	normal	O15379	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS047004
EXP047976	TEAD1 (BD Bioscience, Cat# 610923)	Homo sapiens	Treatment: none	EXP047968	111	normal	P28347	T47D (invasive ductal carcinoma)	PEAKS047005
EXP047977	TRPS1 (self-made affinity-purified antibody raised against aa 920-1281)	Homo sapiens	Treatment: none	EXP047968	111	normal	Q9UHF7	T47D (invasive ductal carcinoma)	PEAKS047006
EXP047982	Homemade (ref. Morey et al., Cell Stem Cell, 2015)	Homo sapiens	Treatment: Modifications: parentall cells	EXP047978	2239	normal	Q99496	heart-derived sendai virus reprogrammed induced pluripotent stem cell)	PEAKS047007
EXP047983	Homemade (ref. Morey et al., Cell Stem Cell, 2015)	Homo sapiens	Treatment: CellType: mammary gland fibrocystic disease epithelial cells Modifications: Parental cells	EXP047979	583	normal	Q99496	MCF10A (breast epithelial cells)	PEAKS047008
EXP047984	Active Motif # 39663	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047980	2301	normal	Q99496	MDA-MB-231 (breast adenocarcinoma)	PEAKS047009
EXP047985	Santa Cruz # sc-10744 X	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047980	2301	normal	P35227	MDA-MB-231 (breast adenocarcinoma)	PEAKS047010
EXP047986	Bethyl Laboratories # A301-985A100	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047980	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS047011
EXP047987	Active Motif # 39663	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047981	111	normal	Q99496	T47D (invasive ductal carcinoma)	PEAKS047012
EXP047988	PCGF2	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047981	111	normal	P35227	T47D (invasive ductal carcinoma)	PEAKS047013
EXP047989	Diagenode # C15100066	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047981	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS047014
EXP047992	MCM7 (Fujita et al., PMID 8626784; Fujita et al., PMID 9099751)	Homo sapiens		NULL	78	normal	P33993	HeLa (cervical adenocarcinoma)	PEAKS047015
EXP047993	MCM7 (Fujita et al., PMID 8626784; Fujita et al., PMID 9099751)	Homo sapiens		NULL	78	normal	P33993	HeLa (cervical adenocarcinoma)	PEAKS047016
EXP047995	endogenous AR antibody (Santa Cruz Biotechnology)	Homo sapiens		EXP047994	2240	normal	P10275	HDF(human dermal fibroblasts)	PEAKS047017
EXP047996	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	Treatment: 0.3 uM CBL0100 , 1.5 hr	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047018
EXP047997	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	Treatment: no treatment, control	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047019
EXP047998	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	Treatment: 3 uM CBL0137 ,1.5 hr	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047020
EXP047999	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	treatment: 3 uM Aclacinomycin A , 1.5 hr	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047021
EXP048002	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-SHB_1-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	PEAKS047022
EXP048003	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: GK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152_3-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	PEAKS047023
EXP048004	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-CCDC85C_3-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	PEAKS047024
EXP048005	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	PEAKS047025
EXP048008	G4 	Homo sapiens		EXP048006	514	normal	E2RYF6	K562 (myelogenous leukemia)	PEAKS047026
EXP048009	G4	Homo sapiens		EXP048007	514	normal	E2RYF6	K562 (myelogenous leukemia)	PEAKS047027
EXP048011	ZNF341 (Atlas Antibodies,HPA024607, Lot:R12522)	Homo sapiens		EXP048010	976	normal	Q9BYN7	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS047028
EXP048012	ZNF341 (monoclonal customized antibody)	Homo sapiens		EXP048010	976	normal	Q9BYN7	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS047029
EXP048017	Abcam ab14820	Homo sapiens	Treatment: none	EXP048013	1593	normal	Q8WTS6	WA07 (H7, human embryonic stem cells)	PEAKS047030
EXP048018	Abcam ab14820	Homo sapiens	Treatment: none	EXP048014	2241	normal	Q8WTS6	mesoderm stage cells differentiated from H7	PEAKS047031
EXP048019	Abcam ab14820	Homo sapiens	Treatment: none	EXP048015	2242	normal	Q8WTS6	cardiac progenitor stage cells differentiated from H7	PEAKS047032
EXP048020	Abcam ab14820	Homo sapiens	Treatment: none	EXP048016	2243	normal	Q8WTS6	cardiomyocytes stage differentiated from H7	PEAKS047033
EXP048029	TUBG1	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest	EXP048021	583	bio_control	P23258	MCF10A (breast epithelial cells)	PEAKS047034
EXP048030	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest	EXP048022	583	bio_control	P23258	MCF10A (breast epithelial cells)	PEAKS047035
EXP048031	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest	EXP048023	583	normal	P23258	MCF10A (breast epithelial cells)	PEAKS047036
EXP048032	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest	EXP048024	583	normal	P23258	MCF10A (breast epithelial cells)	PEAKS047037
EXP048033	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048025	583	normal	P23258	MCF10A (breast epithelial cells)	PEAKS047038
EXP048034	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048026	583	normal	P23258	MCF10A (breast epithelial cells)	PEAKS047039
EXP048035	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048027	583	normal	P23258	MCF10A (breast epithelial cells)	PEAKS047040
EXP048036	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048028	583	normal	P23258	MCF10A (breast epithelial cells)	PEAKS047041
EXP048047	anti-SS18 Cell Signaling D6I4Z	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	PEAKS047042
EXP048048	anti-SS18	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048038	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	PEAKS047043
EXP048049	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q92922	Aska-SS (Biphasic synovial sarcoma)	PEAKS047044
EXP048050	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	Q92922	Aska-SS (Biphasic synovial sarcoma)	PEAKS047045
EXP048051	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	P51532	Aska-SS (Biphasic synovial sarcoma)	PEAKS047046
EXP048052	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	P51532	Aska-SS (Biphasic synovial sarcoma)	PEAKS047047
EXP048053	anti-BAF200	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q68CP9	Aska-SS (Biphasic synovial sarcoma)	PEAKS047048
EXP048054	anti-BAF200	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	Q68CP9	Aska-SS (Biphasic synovial sarcoma)	PEAKS047049
EXP048055	anti-SUZ12	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q15022	Aska-SS (Biphasic synovial sarcoma)	PEAKS047050
EXP048056	anti-SUZ12	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	Q15022	Aska-SS (Biphasic synovial sarcoma)	PEAKS047051
EXP048057	anti-SS18	Homo sapiens	Treatment: Treatment: shRNA shCt Genotype: BAF47 KO	EXP048039	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	PEAKS047052
EXP048058	anti-SS18	Homo sapiens	Treatment: Treatment: shRNA shSSX Genotype: BAF47 KO	EXP048040	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	PEAKS047053
EXP048059	anti-SS18 Cell Signaling D6I4Z	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048041	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	PEAKS047054
EXP048060	anti-SS18 Cell Signaling D6I4Z	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048042	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	PEAKS047055
EXP048061	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048041	2530	normal	Q92922	SYO-1(Biphasic synovial sarcoma)	PEAKS047056
EXP048062	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048041	2530	normal	P51532	SYO-1(Biphasic synovial sarcoma)	PEAKS047057
EXP048063	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048043	2253	normal	Q92922	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047058
EXP048064	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048043	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047059
EXP048065	anti-SS18	Homo sapiens	Treatment: Treatment: naive	EXP048044	2247	normal	Q15532	CRL7250(fibroblast)	PEAKS047060
EXP048066	anti-V5 Cell Signaling D3H8Q	Homo sapiens	Treatment: Treatment: shRNA SS18	EXP048045	670	normal	P41161	fibroblast of dermis	PEAKS047061
EXP048067	anti-V5 Cell Signaling D3H8Q	Homo sapiens	Treatment: Treatment: shRNA sSS18-SSX	EXP048046	670	normal	A0A075B6J1	fibroblast of dermis	PEAKS047062
EXP048068	anti-SUZ12 Cell Signaling D39F6	Homo sapiens	Treatment: Treatment: shRNA SS18	EXP048045	670	normal	Q15022	fibroblast of dermis	PEAKS047063
EXP048069	anti-SUZ12 Cell Signaling D39F6	Homo sapiens	Treatment: Treatment: shRNA SS18-SSX	EXP048046	670	normal	Q15022	fibroblast of dermis	PEAKS047064
EXP048070	anti-HA ( Abcam #ab9110 #GR261166-6)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , ethanol Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	O15164	LNCaP (prostate carcinoma)	PEAKS047065
EXP048071	anti HA ( Abcam #ab9110 #GR261166-6)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , 10nM R1881 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	O15164	LNCaP (prostate carcinoma)	PEAKS047066
EXP048072	anti-TRIM28 (Abcam #ab10483 #GR17300-19)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , ethanol Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	PEAKS047067
EXP048073	anti-TRIM28 (Abcam #ab10483 #GR17300-19)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , 10nM R1881 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	PEAKS047068
EXP048074	anti-AR (Santa Cruz #sc-816x #J216) 	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation ,  ethanol,  knockout control Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047069
EXP048075	anti-AR (Santa Cruz #sc-816x #J216) 	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation, ethanol, shTRIM24 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047070
EXP048076	anti-AR (Santa Cruz #sc-816x #J216) 	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation, ethanol , shTRIM28 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047071
EXP048081	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048077	2248	normal	P20823	NY8 (pancreatic cancer-derived cells)	PEAKS047072
EXP048082	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048078	2248	normal	P20823	NY8 (pancreatic cancer-derived cells)	PEAKS047073
EXP048083	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048079	2249	normal	P20823	NY15 (pancreatic cancer-derived cells)	PEAKS047074
EXP048084	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048080	2249	normal	P20823	NY15 (pancreatic cancer-derived cells)	PEAKS047075
EXP048089	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:synchronized	EXP048085	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS047076
EXP048090	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:synchronized	EXP048086	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS047077
EXP048091	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:unsynchronized	EXP048087	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS047078
EXP048092	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:unsynchronized	EXP048088	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS047079
EXP048094	MBL D221-3 (Abcam)	Homo sapiens	Treatment: G1/S synchronized with 40ng/ml Nocodazole for 16hr	EXP048093	78	normal	P11226	HeLa (cervical adenocarcinoma)	PEAKS047080
EXP048095	MBL D221-3 (Abcam)	Homo sapiens	Treatment: G2/M synchronized with 40ng/ml Nocodazole for 20hr	EXP048093	78	normal	P11226	HeLa (cervical adenocarcinoma)	PEAKS047081
EXP048100	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048096	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047082
EXP048101	CHD7 (Bethyl, A301-223A)	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048097	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047083
EXP048102	HA (Roche, clone 3F10)	Homo sapiens	Treatment: Genotype: HA-tag F10 knockin CellLine:	EXP048098	2250	normal	P00742	hiPSC derived It-NES	PEAKS047084
EXP048104	P300 (Santa Cruz,  sc-48343)	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048103	2250	normal	Q09472	hiPSC derived It-NES	PEAKS047086
EXP048106	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype	EXP048105	1143	normal	Q9P2D1	iPSC (induced pluripotent stem cells)	PEAKS047088
EXP048108	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype	EXP048107	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047090
EXP048110	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NE	EXP048109	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047092
EXP048112	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NE	EXP048111	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047094
EXP048114	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NCC (neural crest cell)	EXP048113	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047096
EXP048116	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NCC (neural crest cell)	EXP048115	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047098
EXP048117	CHD7	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048099	2250	normal	Q9P2D1	hiPSC derived It-NES	PEAKS047099
EXP048120	anti-NRF1 antibody (Cell Signaling, D5B10)	Homo sapiens	Treatment: 1 uM MG132 for 4 hr	EXP048118	423	normal	Q14494	HeLa S3 (cervical adenocarcinoma)	PEAKS047100
EXP048121	anti-NRF1 antibody (Cell Signaling, D5B10)	Homo sapiens	Treatment: 1 uM MG132 for 4 hr	EXP048119	423	normal	Q14494	HeLa S3 (cervical adenocarcinoma)	PEAKS047101
EXP048131	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: no shRNA	EXP048127	2253	normal	A0AVK6	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047102
EXP048132	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HA tagged HS-SY-II parental line Treatment: shRNA REN.713	EXP048123	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047103
EXP048133	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shRNA REN.713	EXP048122	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047104
EXP048134	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HA tagged HS-SY-II parental line, knockdown of SS18-SSX1 Treatment: shRNA REN.713	EXP048128	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047105
EXP048135	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna SSX.1274 against SS18-SSX1	EXP048125	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047106
EXP048136	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna KDM2B.4395 against KDM2B	EXP048126	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047107
EXP048137	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna REN.713 against KDM2B	EXP048124	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047108
EXP048138	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna SSX.1274 against SS18-SSX1	EXP048125	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047109
EXP048139	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna KDM2B.4395 against KDM2B	EXP048126	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047110
EXP048140	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line HA tagged Treatment: shrna SSX. 1274 against SS18-SSX1	EXP048129	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047111
EXP048141	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line HA tagged Treatment: shrna KDM2B.4395 against KDM2B	EXP048130	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047112
EXP048142	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: none	EXP048128	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	PEAKS047113
EXP048148	Flag (Sigma, M2)	Homo sapiens	Treatment: ethanol vehicle for 3 hr Passages: 20-25	EXP048146	2254	normal	Q92731	MDA-MB-231ERb(triple negative breast cancer)	PEAKS047114
EXP048149	Flag (Sigma, M2)	Homo sapiens	Treatment: 1 nM estradiol for 3 hr Passage: 20-25	EXP048147	2254	normal	Q92731	MDA-MB-231ERb(triple negative breast cancer)	PEAKS047115
EXP048150	Flag (Sigma, M2)	Homo sapiens	Treatment: 10 nM LY500307 for 3 hr Passage: 20-25	EXP048151	2254	normal	Q92731	MDA-MB-231ERb(triple negative breast cancer)	PEAKS047116
EXP048154	Brg1 antibody Abcam ab110641	Homo sapiens	Treatment: SMARCA4 induced using +doxycycline(0.5 microg/ml) for 5 days, treated with IACS-10759 (1000nM) for 24 hr pior to extraction Genotype: pINDUCER20-SMARCA4 viral vector stably transduced in H1299 cell lines	EXP048152	375	normal	P51532	NCI-H1299 (large cell lung carcinoma)	PEAKS047117
EXP048155	Brg1 antibody Abcam ab110641	Homo sapiens	Treatment: SMARCA4 induced using -doxycycline(0.5 microg/ml) for 5 days, treated with IACS-10759 (1000nM) for 24 hr pior to extraction Genotype: pINDUCER20-SMARCA4 viral vector stably transduced in H1299 cell lines	EXP048153	375	normal	P51532	NCI-H1299 (large cell lung carcinoma)	PEAKS047118
EXP048157	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	PEAKS047119
EXP048158	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	PEAKS047120
EXP048159	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	PEAKS047121
EXP048160	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	PEAKS047122
EXP048161	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	PEAKS047123
EXP048162	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	PEAKS047124
EXP048163	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	PEAKS047125
EXP048164	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	PEAKS047126
EXP048165	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	PEAKS047127
EXP048166	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	PEAKS047128
EXP048167	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	PEAKS047129
EXP048168	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	PEAKS047130
EXP048173	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Long	EXP048169	741	normal	P52926	CD34+ hematopoietic stem progenitor cells	PEAKS047131
EXP048174	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Long	EXP048170	741	normal	P52926	CD34+ hematopoietic stem progenitor cells	PEAKS047132
EXP048175	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Short	EXP048171	2222	normal	P52926	1% H1 ESCs with 99% fibroblsat	PEAKS047133
EXP048176	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Short	EXP048172	741	normal	P52926	CD34+ hematopoietic stem progenitor cells	PEAKS047134
EXP048177	anti-ER? (Bethyl Laboratories, A300-498A )	Homo sapiens	Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS047135
EXP048178	anti-ER? (Bethyl Laboratories, A300-498A )	Homo sapiens	Treatment: 100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS047136
EXP048179	anti-ER? (Bethyl Laboratories, A300-498A )	Homo sapiens	Treatment: a cocktail of 10 ÂµM forskolin plus 100 ÂµM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS047137
EXP048180	pCREB1 (Cell Signalling Technology, 87G3, lot 14)	Homo sapiens	Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line   	NULL	587	normal	P16220	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS047138
EXP048181	pCREB1 (Cell Signalling Technology, 87G3, lot 14)	Homo sapiens	Treatment:100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P16220	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS047139
EXP048182	pCREB1 (Cell Signalling Technology, 87G3, lot 14)	Homo sapiens	Treatment:a cocktail of 10 ÂµM forskolin plus 100 ÂµM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P16220	MDA-MB-134 (invasive lobular breast carcinoma)	PEAKS047140
EXP048188	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: Tissue: Peripheral blood	EXP048183	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS047141
EXP048189	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: Tissue: Peripheral blood	EXP048184	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS047142
EXP048190	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	EXP048185	2257	normal	Q01196	pre-B-lymphoblast cells with BCP-ALL	PEAKS047143
EXP048191	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	EXP048186	2257	normal	Q01196	pre-B-lymphoblast cells with BCP-ALL	PEAKS047144
EXP048192	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	EXP048187	2257	normal	Q01196	pre-B-lymphoblast cells with BCP-ALL	PEAKS047145
EXP048194	BRD4 (Active Motif #A301-985A1)	Homo sapiens	Treatment: Treatment: baseline Source: B-Chronic Lymphocytic Leukemia (CLL) cels	EXP048193	2259	normal	O60885	primary B-CLL cells	PEAKS047146
EXP048195	BRD4 (Active Motif #A301-985A1)	Homo sapiens	Treatment: Treatment: 4 hours stimulation with 3.2uM of CpG oligonucleotide Source: B-Chronic Lymphocytic Leukemia (CLL) cels	EXP048193	2259	normal	O60885	primary B-CLL cells	PEAKS047147
EXP048196	BRD4 (Active Motif #A301-985A1)	Homo sapiens	Treatment: Treatment: 4 hours stimulation with 3.2uM of CpG oligonucleotide + 1 uM of BET inhibitor (PLX51107) Source: B-Chronic Lymphocytic Leukemia (CLL) cels	EXP048193	2259	normal	O60885	primary B-CLL cells	PEAKS047148
EXP048197	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047149
EXP048198	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047150
EXP048199	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047151
EXP048200	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047152
EXP048201	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047153
EXP048202	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047154
EXP048203	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047155
EXP048204	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047156
EXP048205	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047157
EXP048206	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047158
EXP048207	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047159
EXP048208	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047160
EXP048209	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047161
EXP048210	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047162
EXP048211	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047163
EXP048212	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 012Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047164
EXP048213	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047165
EXP048214	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047166
EXP048215	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047167
EXP048216	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047168
EXP048217	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047169
EXP048218	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047170
EXP048219	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047171
EXP048220	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047172
EXP048221	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047173
EXP048222	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047174
EXP048223	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047175
EXP048224	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047176
EXP048225	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047177
EXP048226	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047178
EXP048227	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047179
EXP048228	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047180
EXP048229	CTCF (D31H2) XP (Cell Signaling Technology, cat # 3418) 	Homo sapiens	Treatment: Sex: female Passages: 3-10 Stage: neural progenitor cells, undifferentiated Treatment: Prior to differentiation, cells were seeded at 3.5 x 10^6 per T75 flask containing complete growth medium and incubated at 37 Â°C for 24 hr	NULL	2260	normal	P49711	LUHMES (lund human mesencephalic cells)	PEAKS047181
EXP048230	CTCF (D31H2) XP (Cell Signaling Technology, cat # 3418) 	Homo sapiens	Treatment: Sex: female Passages: 3-10 Stage: dopaminergic neurons, differentiated Treatment: For induction of differentiation, culture medium was changed to freshly prepare DMEM:F12 with 2 mM L-glutamine, 1X N-2, 1 mM cAMP (Carbosynth, Cat # ND07996), 1 mg/mL tetracycline (Sigma, Cat # T7660), and 2 ng/mL glial cell line-derived neurotrophic factor (GDNF) (Sigma, Cat # G1777)	NULL	2260	normal	P49711	LUHMES (lund human mesencephalic cells)	PEAKS047182
EXP048231	ER HC-20 (Santa Cruz sc-543)	Homo sapiens	Treatment: Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS047183
EXP048232	GR E-20 (Santa Cruz sc-1003)	Homo sapiens	Treatment: Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour	NULL	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	PEAKS047184
EXP048233	ER HC-20 (Santa Cruz sc-543)	Homo sapiens	Treatment: Treatment: 10 nM Estradiol for 1 hour	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS047185
EXP048234	GR E-20 (Santa Cruz sc-1003)	Homo sapiens	Treatment: Treatment: 100 nM Dexamethasone for 1 hour	NULL	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	PEAKS047186
EXP048235	ER HC-20 (Santa Cruz sc-543)	Homo sapiens	Treatment: Treatment: DMSO (vehicle) for 1 hour	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS047187
EXP048236	GR E-20 (Santa Cruz sc-1003)	Homo sapiens	Treatment: Treatment: DMSO (vehicle) for 1 hour	NULL	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	PEAKS047188
EXP048240	p65 (Santa Cruz Biotechnology, sc-372-x)	Homo sapiens	CellType: clear cell renall cell carcinoma	EXP048237	2261	normal	Q04206	NRCC	PEAKS047189
EXP048241	ZHX2 (Genetex, 112232)	Homo sapiens	CellType: clear cell renall cell carcinoma	EXP048238	2261	normal	Q9Y6X8	NRCC	PEAKS047190
EXP048242	ZHX2 (Genetex, 112232)	Homo sapiens	CellType: clear cell renall cell carcinoma	EXP048239	2261	normal	Q9Y6X8	NRCC	PEAKS047191
EXP048243	HA (Abcam Ab9110)	Homo sapiens	Treatment: pBABE retroviral vector, control	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	PEAKS047192
EXP048244	HA (cell signaling C29F4)	Homo sapiens	Treatment: pBABE retroviral vector, control	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	PEAKS047193
EXP048245	HA (Abcam Ab9110)	Homo sapiens	Treatment: pBABE retroviral vector, D4476 60 uM for 48 hr befort crosslinking	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	PEAKS047194
EXP048246	HA (cell signaling C29F4)	Homo sapiens	Treatment: pBABE retroviral vector, D4476 60 uM for 48 hr befort crosslinking	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	PEAKS047195
EXP048248	STAT2 (Santa Cruz, sc-476)	Homo sapiens	Treatment: mock Source: cervix	EXP048247	78	normal	P52630	HeLa (cervical adenocarcinoma)	PEAKS047196
EXP048249	STAT2 (Santa Cruz, sc-476)	Homo sapiens	Treatment: 1000 units/ml  interferon alpha for 2 hr Source: cervix	EXP048247	78	normal	P52630	HeLa (cervical adenocarcinoma)	PEAKS047197
EXP048250	IRF9 (Santa Cruz, sc-496)	Homo sapiens	Treatment: mock Source: cervix	EXP048247	78	normal	Q00978	HeLa (cervical adenocarcinoma)	PEAKS047198
EXP048251	IRF9 (Santa Cruz, sc-496)	Homo sapiens	Treatment: 1000 units/ml  interferon alpha 2 hr Source: cervix	EXP048247	78	normal	Q00978	HeLa (cervical adenocarcinoma)	PEAKS047199
EXP048252	STAT1 (Santa Cruz, sc-345)	Homo sapiens	Treatment: mock Source: cervix	EXP048247	78	normal	P42224	HeLa (cervical adenocarcinoma)	PEAKS047200
EXP048253	STAT1 (Santa Cruz, sc-345)	Homo sapiens	Treatmnet: 1000 units/ml interferon alpha for 2hr Source: cervix	EXP048247	78	normal	P42224	HeLa (cervical adenocarcinoma)	PEAKS047201
EXP048266	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#45	EXP048254	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047202
EXP048267	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #45	EXP048255	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047203
EXP048268	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #45	EXP048256	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047204
EXP048269	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#90	EXP048257	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047205
EXP048270	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #90	EXP048258	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047206
EXP048271	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #90	EXP048259	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047207
EXP048272	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#104	EXP048260	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047208
EXP048273	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #104	EXP048261	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047209
EXP048274	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #104	EXP048262	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047210
EXP048275	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#116	EXP048263	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047211
EXP048276	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #116	EXP048264	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047212
EXP048277	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #116	EXP048265	2263	normal	P04637	PHA-simulated human T-lynphocytes	PEAKS047213
EXP048282	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shKMT2D Treatment: Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80 degree	EXP048278	215	bio_control	O14686	keratinocytes	PEAKS047214
EXP048283	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	EXP048279	215	normal	O14686	keratinocytes	PEAKS047215
EXP048284	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shKMT2D Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	EXP048280	215	normal	O14686	keratinocytes	PEAKS047216
EXP048285	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	EXP048281	215	normal	O14686	keratinocytes	PEAKS047217
EXP048286	anti-p63 (4A4) (Santa Cruz Biotechnology, sc-8431)	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	NULL	215	normal	Q9H3D4	keratinocytes	PEAKS047218
EXP048287	Anti-BRD4: Bethyl laboratories; cat# A301-985A100; lot# A301-985A100-6	Homo sapiens	Treatment: 2.5 ng ml-1 TNFalfa for 0hr CellType: human colon cancer 	NULL	821	normal	O60885	SW480 (colon adenocarcinoma)	PEAKS047219
EXP048288	Anti-BRD4: Bethyl laboratories; cat# A301-985A100; lot# A301-985A100-6	Homo sapiens	Treatment: 2.5 ng ml-1 TNFalfa for 16hr CellType: human colon cancer 	NULL	821	normal	O60885	SW480 (colon adenocarcinoma)	PEAKS047220
EXP048291	HDAC2 (Abcam [ab12169])	Homo sapiens	Treatment: Treatment: 32nM DMSO Passage: 80-85	EXP048289	438	normal	Q92769	HL-60 (acute myeloid leukemia)	PEAKS047221
EXP048292	HDAC2 (Abcam [ab12169])	Homo sapiens	Treatment: Treatment: 32 nM TPA Passage: 80-85	EXP048290	438	normal	Q92769	HL-60 (acute myeloid leukemia)	PEAKS047222
EXP048297	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Treatment: tonsil 	EXP048293	327	normal	Q02080	germinal center B-cells	PEAKS047223
EXP048298	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Treatment: tonsil 	EXP048294	327	normal	Q02080	germinal center B-cells	PEAKS047224
EXP048299	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Genotype: wiltype MEF2B	EXP048295	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	PEAKS047225
EXP048300	anti-Flag (M2, F3165, Sigma) and anti-HA (ab9110, Abcam)	Homo sapiens	Genotype: wiltype MEF2B with Flag and HA	EXP048295	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	PEAKS047226
EXP048301	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Genotype: MEF2B- D83V mutant	NULL	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	PEAKS047227
EXP048302	anti-Flag (M2, F3165, Sigma) and anti-HA (ab9110, Abcam)	Homo sapiens	Genotype: MEF2B- D83V mutant with flag and HA	EXP048296	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	PEAKS047228
EXP048303	p53 polyclonal Ab (Diagenode, C15410083)	Homo sapiens	Treatment: untreated control Sex: female Age:15 years Tissue: bone	NULL	848	normal	P04637	U2OS (osteosarcoma)	PEAKS047229
EXP048304	p53 polyclonal Ab (Diagenode, C15410083)	Homo sapiens	Treatment:2hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone	NULL	848	normal	P04637	U2OS (osteosarcoma)	PEAKS047230
EXP048305	p53 polyclonal Ab (Diagenode, C15410083)	Homo sapiens	Treatment:4hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone	NULL	848	normal	P04637	U2OS (osteosarcoma)	PEAKS047231
EXP048306	Anti-Myc Tag Antibody, clone 4A6 (Millipore,#05-724MG)	Homo sapiens	Treatment: transfected with pcDNA3..1-vector CellType: Papillary thyroid carcinoma Passages: 6-9	NULL	2264	normal	O43435	BCPAP (Poorly differentiated thyroid gland carcinoma)	PEAKS047232
EXP048307	Anti-Myc Tag Antibody, clone 4A6 (Millipore,#05-724MG)	Homo sapiens	Treatment: transfected with pcDNA3.1-TBX1 CellType: Papillary thyroid carcinoma Passages: 6-9	NULL	2264	normal	O43435	BCPAP (Poorly differentiated thyroid gland carcinoma)	PEAKS047233
EXP048310	anti-Flag (Sigma, F1804, lot# SLBT7654)	Homo sapiens	Treatment: no 	EXP048308	514	normal	Q6DJT9	K562 (myelogenous leukemia)	PEAKS047234
EXP048311	anti-Flag (Sigma, F1804, lot# SLBT7654)	Homo sapiens	Treatment: no 	EXP048309	514	normal	Q6DJT9	K562 (myelogenous leukemia)	PEAKS047235
EXP048312	anti-USF2 (SantaCruz, #sc-293443, lot# C2217)	Homo sapiens	Treatment: no 	EXP048308	514	normal	Q15853	K562 (myelogenous leukemia)	PEAKS047236
EXP048313	anti-USF2 (SantaCruz, #sc-293443, lot# C2217)	Homo sapiens	Treatment: no 	EXP048309	514	normal	Q15853	K562 (myelogenous leukemia)	PEAKS047237
EXP048323	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	EXP048318	417	normal	O43167	HCT-116 (colon carcinoma)	PEAKS047238
EXP048324	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	EXP048319	417	normal	O43167	HCT-116 (colon carcinoma)	PEAKS047239
EXP048325	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	EXP048320	417	normal	O43167	HCT-116 (colon carcinoma)	PEAKS047240
EXP048326	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-DNMT3B	EXP048321	417	normal	Q9UBC3	HCT-116 (colon carcinoma)	PEAKS047241
EXP048327	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-DNMT3B	EXP048322	417	normal	Q9UBC3	HCT-116 (colon carcinoma)	PEAKS047242
EXP048330	anti-RAD21 ChIP-grade (Abcam, ab992)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048328	2265	normal	O60216	HeLa-Tet-On	PEAKS047243
EXP048331	anti-NIPBL (Bethyl Laboratories, A301-779A)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048328	2265	normal	Q6KC79	HeLa-Tet-On	PEAKS047244
EXP048332	anti-RAD21 ChIP-grade (Abcam, ab992)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048329	2265	normal	O60216	HeLa-Tet-On	PEAKS047245
EXP048333	anti-NIPBL (Bethyl Laboratories, A301-779A)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048329	2265	normal	Q6KC79	HeLa-Tet-On	PEAKS047246
EXP048334	anti-MCM2 (Bethyl Laboratories, A300-191A)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048328	2265	normal	P49736	HeLa-Tet-On	PEAKS047247
EXP048335	RCOR1 (07-455 from Merck Millipore)	Homo sapiens	Treatment: Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UKL0	THP-1 (acute monocytic leukemia)	PEAKS047248
EXP048336	RCOR1 (07-455 from Merck Millipore)	Homo sapiens	Treatment: Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UKL0	THP-1 (acute monocytic leukemia)	PEAKS047249
EXP048337	SPI1 (2258 from Cell Signaling)	Homo sapiens	Treatment: Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS047250
EXP048338	SPI1 (2258 from Cell Signaling)	Homo sapiens	Treatment: Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS047251
EXP048339	MLL4 (kindly provided by Dr Kai Ge; Wang et al., 2016)	Homo sapiens	Treatment: Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UMN6	THP-1 (acute monocytic leukemia)	PEAKS047252
EXP048340	MLL4 (kindly provided by Dr Kai Ge; Wang et al., 2016)	Homo sapiens	Treatment: Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UMN6	THP-1 (acute monocytic leukemia)	PEAKS047253
EXP048345	LSD1 (Abcam, cat#17721)	Homo sapiens	Treatment: Treatment: control	EXP048341	1004	normal	O60341	A137 ER-, PR-, HER2- breast cancer cells	PEAKS047254
EXP048346	LSD1 (Abcam, cat#17721)	Homo sapiens	Treatment: Treatment: control	EXP048342	1004	normal	O60341	A137 ER-, PR-, HER2- breast cancer cells	PEAKS047255
EXP048347	LSD1 (Abcam, cat#17721)	Mus musculus	Treatment: Treatment: control Tissue: B16 tumor transplanted in C56BL/6 mice Source: ex vivo scramble	EXP048343	2266	normal	Q6ZQ88	B16 tumor	PEAKS047256
EXP048348	LSD1 (Abcam, cat#17721)	Mus musculus	Treatment: Treatment: control Tissue: B16 tumor transplanted in C56BL/6 mice Source: LCD1 knockout	EXP048344	2266	normal	Q6ZQ88	B16 tumor	PEAKS047257
EXP048354	SMAD2	Homo sapiens	Treatment: PBS 	EXP048353	2267	normal	Q15796	aortic smooth muscle	PEAKS047261
EXP048357	SMAD2	Homo sapiens	Treatment: TGF beta at 0.5 ng/ml daily for 10 days	EXP048356	2267	normal	Q15796	aortic smooth muscle	PEAKS047264
EXP048360	Pygo2 (S3I4; Tzenov et al., J Clin Path.69, pp. 518-26, 2015 )	Homo sapiens	Treatment: no treatment	EXP048358	423	normal	Q9BRQ0	HeLa S3 (cervical adenocarcinoma)	PEAKS047265
EXP048361	Pygo2 (S3I4; Tzenov et al., J Clin Path.69, pp. 518-26, 2015 )	Homo sapiens	Treatment: no treatment	EXP048359	423	normal	Q9BRQ0	HeLa S3 (cervical adenocarcinoma)	PEAKS047266
EXP048369	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: none	EXP048368	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047267
EXP048370	MED1(Bethyl; Cat#A300-793A;)	Mus musculus	Treatment: none	EXP048368	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047268
EXP048371	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Passage: p1	EXP048362	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047269
EXP048372	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Passage: p10	EXP048363	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047270
EXP048373	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048364	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047271
EXP048374	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048365	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047272
EXP048375	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048364	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047273
EXP048376	MED1 (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048364	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047274
EXP048377	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048365	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047275
EXP048378	MED1 (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048365	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047276
EXP048379	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048366	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047277
EXP048380	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048367	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047278
EXP048381	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048366	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047279
EXP048382	MED1	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048366	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047280
EXP048383	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048367	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047281
EXP048384	MED1	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048367	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS047282
EXP048393	anti-GR (Santa Cruz M-20)	Homo sapiens	Treatment: Treatment: 1hr EtOH	EXP048385	2269	normal	P04150	A1-2 (breast cancer cells)	PEAKS047283
EXP048394	anti-GR (Santa Cruz M-20)	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P04150	A1-2 (breast cancer cells)	PEAKS047284
EXP048395	lab-made rabbit anti-Brg1	Homo sapiens	Treatment: Treatment: 1hr EtOH	EXP048385	2269	normal	P51532	A1-2 (breast cancer cells)	PEAKS047285
EXP048396	lab-made rabbit anti-Brg1	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P51532	A1-2 (breast cancer cells)	PEAKS047286
EXP048397	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr EtOH	EXP048387	2269	normal	P55317	A1-2 (breast cancer cells)	PEAKS047287
EXP048398	Cell Signaling D13C9	Homo sapiens	Treatment: 1hr EtOH	EXP048387	2269	normal	P23771	A1-2 (breast cancer cells)	PEAKS047288
EXP048399	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P55317	A1-2 (breast cancer cells)	PEAKS047289
EXP048400	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P23771	A1-2 (breast cancer cells)	PEAKS047290
EXP048401	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048389	2272	normal	P55317	A1A3(breast cancer cells)	PEAKS047291
EXP048402	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048389	2272	normal	P23771	A1A3(breast cancer cells)	PEAKS047292
EXP048403	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048390	2272	normal	P55317	A1A3(breast cancer cells)	PEAKS047293
EXP048404	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048390	2272	normal	P23771	A1A3(breast cancer cells)	PEAKS047294
EXP048405	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048391	2272	normal	P55317	A1A3(breast cancer cells)	PEAKS047295
EXP048406	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048391	2272	normal	P23771	A1A3(breast cancer cells)	PEAKS047296
EXP048407	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048392	2272	normal	P55317	A1A3(breast cancer cells)	PEAKS047297
EXP048408	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048392	2272	normal	P23771	A1A3(breast cancer cells)	PEAKS047298
EXP048410	anti-TCF4 antibody K-12, sc-48947 (Santa Cruz, lot# A2507)	Homo sapiens	CellType: Sh-SY5Y ATCC (validated)  	EXP048409	664	normal	P15884	SH-SY5Y (neuroblastoma)	PEAKS047299
EXP048411	anti-TCF4 antibody N-16, sc-48949 (Santa Cruz, lot# A2507)	Homo sapiens	CellType: Sh-SY5Y ATCC (validated)  	EXP048409	664	normal	P15884	SH-SY5Y (neuroblastoma)	PEAKS047300
EXP048413	SALL4 (Cell Signaling Technolog, cat# 8459BF, Lot 2)	Homo sapiens	Treatment: CellType: hepatocarcinoma	EXP048412	2230	normal	Q9UJQ4	SNU398	PEAKS047301
EXP048436	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048414	949	bio_control	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047302
EXP048437	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048415	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047303
EXP048438	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048416	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047304
EXP048439	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048417	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047305
EXP048440	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048418	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047306
EXP048441	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048419	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047307
EXP048442	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048420	949	normal	Q6ISB3	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047308
EXP048443	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048421	949	normal	Q6ISB3	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047309
EXP048444	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048422	949	normal	Q6ISB3	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047310
EXP048445	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048423	2273	normal	P55317	MCF7 WS8 cells	PEAKS047311
EXP048446	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048424	2273	normal	P55317	MCF7 WS8 cells	PEAKS047312
EXP048447	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048425	2273	normal	P55317	MCF7 WS8 cells	PEAKS047313
EXP048448	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048426	2273	normal	P55317	MCF7 WS8 cells	PEAKS047314
EXP048449	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048427	2273	normal	P55317	MCF7 WS8 cells	PEAKS047315
EXP048450	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048428	2273	normal	P55317	MCF7 WS8 cells	PEAKS047316
EXP048451	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048429	2273	normal	P55317	MCF7 WS8 cells	PEAKS047317
EXP048452	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048430	2273	normal	P55317	MCF7 WS8 cells	PEAKS047318
EXP048453	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048431	2273	normal	P55317	MCF7 WS8 cells	PEAKS047319
EXP048454	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048432	2273	normal	Q6ISB3	MCF7 WS8 cells	PEAKS047320
EXP048455	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048433	2273	normal	Q6ISB3	MCF7 WS8 cells	PEAKS047321
EXP048456	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048434	2273	normal	Q6ISB3	MCF7 WS8 cells	PEAKS047322
EXP048457	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048435	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS047323
EXP048459	Anti-ZNF341 (8B3.1)	Homo sapiens	Genotype: empty vector Patient: hyper-IgE syndrome(HIES) 	NULL	2274	normal	Q9BYN7	EBV-B cells	PEAKS047324
EXP048460	Anti-ZNF341 (8B3.1)	Homo sapiens	Genotype: ZNF341 isoform-1 Patient: hyper-IgE syndrome(HIES) 	NULL	2274	normal	Q9BYN7	EBV-B cells	PEAKS047325
EXP048461	Anti-ZNF341 (8B3.1)	Homo sapiens	Genotype: ZNF341 isoform-2  Patient: hyper-IgE syndrome(HIES) 	EXP048458	2274	normal	Q9BYN7	EBV-B cells	PEAKS047326
EXP048462	Anti-ZNF341 (8B3.1)	Homo sapiens	Treatment: T cells were activated by incubation for 24-48 hr with antibodies against CD3 and CD28 Patient: hyper-IgE syndrome(HIES) 	NULL	2275	normal	Q9BYN7	HIES (T-cells)	PEAKS047327
EXP048464	ELF1 (sc-631, Santa Cruz Biotechnology)	Homo sapiens	Source: immortalized normal prostate cells	NULL	781	normal	P32519	RWPE1 (prostate epithelial cells)	PEAKS047328
EXP048465	ELF1 (sc-631, Santa Cruz Biotechnology)	Homo sapiens	Source: bone mets prostate adenocarcinoma	EXP048463	725	normal	P32519	PC3(bone mets prostate adenocarcinoma)	PEAKS047329
EXP048467	anti-NRF2 (Santa Cruz, sc-13032, lot C1416)	Homo sapiens	CellType: human lung adenocarcinoma epithelial A549 cells Genotype: wildtype 	EXP048466	38	normal	Q16236	A549 (lung carcinoma)	PEAKS047330
EXP048468	BRD2 (rabbit polyclonal)	Homo sapiens	Treatment: Treatment: 500 nM JQ1 24h	NULL	2277	normal	P25440	NCI-H23 (non-small lung adenocarcinoma)	PEAKS047331
EXP048469	BRD2	Homo sapiens	Treatment: Treatment:500nM DMSO 24hr	NULL	2277	normal	P25440	NCI-H23 (non-small lung adenocarcinoma)	PEAKS047332
EXP048474	CFP1, non-commercial Ab from Bob Roeder	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	Q9P0U4	adult erythroblasts	PEAKS047333
EXP048475	CFP1 (ab56035), from Abcam	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	Q9P0U4	adult erythroblasts	PEAKS047334
EXP048476	HCF1 (A301-400A)	Homo sapiens	Treatment: NumberofSonications: 1	EXP048472	2279	normal	P51610	adult erythroblasts	PEAKS047335
EXP048477	Menin (A300-105A)	Homo sapiens	Treatment: NumberofSonications: 2	EXP048471	2279	normal	O00255	adult erythroblasts	PEAKS047336
EXP048478	RbBP5 (A300-109A)	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	Q15291	adult erythroblasts	PEAKS047337
EXP048479	SET1 (A300-289A)	Homo sapiens	Treatment: NumberofSonications: 1	EXP048472	2279	normal	O15047	adult erythroblasts	PEAKS047338
EXP048480	UTX (A302-374A) from Bethyl Labs	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	O15550	adult erythroblasts	PEAKS047339
EXP048481	CFP1, non-commercial Ab from Bob Roeder	Homo sapiens	Treatment: NumberofSonications: 1	EXP048473	2278	normal	Q9P0U4	EBV-transformed-B-lymphoblasts	PEAKS047340
EXP048482	CFP1 (ab56035), from Abcam	Homo sapiens	Treatment: NumberofSonications: 1	EXP048473	2278	normal	Q9P0U4	EBV-transformed-B-lymphoblasts	PEAKS047341
EXP048484	anti-FLAG antibody	Homo sapiens	Infection: retrovirus expressing FLAG-ERG Treatment: nearly confluent 150 mm dishes were treated with 1% formaldehyde, and harvested in Farnham lysis buffer and a crude nuclear pellet collected after centrifugation	EXP048483	781	normal	P11308	RWPE1 (prostate epithelial cells)	PEAKS047342
EXP048485	anti-FLAG antibody	Homo sapiens	Infection: retrovirus expressing FLAG-EHF Treatment: nearly confluent 150 mm dishes were treated with 1% formaldehyde, and harvested in Farnham lysis buffer and a crude nuclear pellet collected after centrifugation	EXP048483	781	normal	Q9NZC4	RWPE1 (prostate epithelial cells)	PEAKS047343
EXP048488	rabbit anti-Sox9 (Millipore, AB5535)	Homo sapiens	CellType: ES-derived RPE cells	EXP048486	2280	normal	P48436	hES-PRE	PEAKS047344
EXP048489	rabbit anti-Sox9 (Millipore, AB5535)	Homo sapiens	CellType: ES-derived RPE cells	EXP048487	2280	normal	P48436	hES-PRE	PEAKS047345
EXP048490	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #1	NULL	435	normal	Q92826	prostate tumor	PEAKS047346
EXP048491	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #2	NULL	435	normal	Q92826	prostate tumor	PEAKS047347
EXP048492	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #3	NULL	435	normal	Q92826	prostate tumor	PEAKS047348
EXP048493	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #4	NULL	435	normal	Q92826	prostate tumor	PEAKS047349
EXP048494	anti-FOXA1 (Abcam, ab23738, #GR 176970-2)	Homo sapiens	Treatment: Patient: #1	NULL	435	normal	P55317	prostate tumor	PEAKS047350
EXP048495	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #2	NULL	435	normal	P55317	prostate tumor	PEAKS047351
EXP048496	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #3	NULL	435	normal	P55317	prostate tumor	PEAKS047352
EXP048497	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #4	NULL	435	normal	P55317	prostate tumor	PEAKS047353
EXP048500	GFP	Arabidopsis thaliana	Treatment: no DSG	EXP048498	2281	normal	Q9STM3	flowers, 5-week-old plants	PEAKS047354
EXP048501	GFP	Arabidopsis thaliana	Treatment: DSG	EXP048499	2281	normal	Q9STM3	flowers, 5-week-old plants	PEAKS047355
EXP048502	GFP	Arabidopsis thaliana	Treatment: DSG	EXP048499	2281	normal	Q9STM3	flowers, 5-week-old plants	PEAKS047356
EXP048503	GFP	Arabidopsis thaliana	Treatment: DSG; triple mutant	EXP048499	2281	bio_control	Q9STM3	flowers, 5-week-old plants	PEAKS047357
EXP048504	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047358
EXP048505	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047359
EXP048506	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047360
EXP048507	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047361
EXP048508	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047362
EXP048509	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047363
EXP048510	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047364
EXP048511	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	PEAKS047365
EXP048512	TRPS1	Homo sapiens	Treatment: none	NULL	817	normal	Q9UHF7	SUM159PT (Triple negative breast cancer)	PEAKS047366
EXP048513	TRPS1	Homo sapiens	Treatment: none	NULL	817	normal	Q9UHF7	SUM159PT (Triple negative breast cancer)	PEAKS047367
EXP048514	TRPS1	Homo sapiens	Treatment: none	NULL	817	normal	Q9UHF7	SUM159PT (Triple negative breast cancer)	PEAKS047368
EXP048515	TRPS1	Homo sapiens	Treatment: none	NULL	934	normal	Q9UHF7	HOT1 tumor derived from a human glioblastoma	PEAKS047369
EXP048516	TRPS1	Homo sapiens	Treatment: none	NULL	934	normal	Q9UHF7	HOT1 tumor derived from a human glioblastoma	PEAKS047370
EXP048517	TRPS1	Homo sapiens	Treatment: none	NULL	934	normal	Q9UHF7	HOT1 tumor derived from a human glioblastoma	PEAKS047371
EXP048522	GATAD2A	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	PEAKS047376
EXP048523	GATAD2A	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	PEAKS047377
EXP048524	GATAD2A	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	PEAKS047378
EXP048525	GATAD2A	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	PEAKS047379
EXP048526	GATAD2B	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	PEAKS047380
EXP048527	GATAD2B	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	PEAKS047381
EXP048528	GATAD2B	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	PEAKS047382
EXP048529	GATAD2B	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	PEAKS047383
EXP048533	SKP2 antibody (ab68455, Abcam)	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	EXP048530	417	normal	Q13309	HCT-116 (colon carcinoma)	PEAKS047384
EXP048534	SKP2 antibody (ab68455, Abcam)	Homo sapiens	Treatment: Genotype: RepID knockout CellType: cultured cancer cell line	EXP048531	417	normal	Q13309	HCT-116 (colon carcinoma)	PEAKS047385
EXP048535	CDT2 antibody (ab72264, Abcam)	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	NULL	848	normal	Q9NZJ0	U2OS (osteosarcoma)	PEAKS047386
EXP048536	CUL4A antibody (ab92554, Abcam)	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	NULL	848	normal	Q13619	U2OS (osteosarcoma)	PEAKS047387
EXP048547	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048537	2219	normal	Q9NPA5	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS047388
EXP048548	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048538	2219	normal	Q9NPA5	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS047389
EXP048549	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS047390
EXP048550	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS047391
EXP048551	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048541	677	normal	Q9NPA5	NOMO-1 (acute monocytic leukemia)	PEAKS047392
EXP048552	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048542	677	normal	Q9NPA5	NOMO-1 (acute monocytic leukemia)	PEAKS047393
EXP048553	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	EXP048543	677	normal	A0AVK6	NOMO-1 (acute monocytic leukemia)	PEAKS047394
EXP048554	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	EXP048542	677	normal	A0AVK6	NOMO-1 (acute monocytic leukemia)	PEAKS047395
EXP048555	ZFP64(Proteintech Group,17187-1-AP)	Mus musculus	Source: acute myeloid leukemia	EXP048546	614	normal	Q99KE8	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS047396
EXP048556	ZFP64(Proteintech Group,17187-1-AP)	Mus musculus	Source: acute myeloid leukemia	EXP048546	614	normal	Q99KE8	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	PEAKS047397
EXP048558	SMAD3	Homo sapiens	CellLine: A549	EXP048557	192	normal	P84022	HCASMC (Human coronary artery smooth muscle cells)	PEAKS047398
EXP048560	JDP2 (Santa Cruz sc-23456X)	Homo sapiens		EXP048559	1095	normal	Q8WYK2	Loucy (adult T acute lymphoblastic leukemia)	PEAKS047399
EXP048564	Abcam ab110641	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	EXP048561	781	normal	P51532	RWPE1 (prostate epithelial cells)	PEAKS047400
EXP048565	Cell Signaling 11966	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	EXP048561	781	normal	P51531	RWPE1 (prostate epithelial cells)	PEAKS047401
EXP048566	Snf5	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	EXP048561	781	normal	Q12824	RWPE1 (prostate epithelial cells)	PEAKS047402
EXP048567	FOS	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P01100	MCF10A-ER-Src	PEAKS047403
EXP048568	FOS	Homo sapiens	Genotype: transformed	NULL	2284	normal	P01100	MCF10A-ER-Src	PEAKS047404
EXP048569	JUNB	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P17275	MCF10A-ER-Src	PEAKS047405
EXP048570	JUNB	Homo sapiens	Genotype: transformed	NULL	2284	normal	P17275	MCF10A-ER-Src	PEAKS047406
EXP048571	JUN	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P05412	MCF10A-ER-Src	PEAKS047407
EXP048572	JUN	Homo sapiens	Genotype: transformed	NULL	2284	normal	P05412	MCF10A-ER-Src	PEAKS047408
EXP048573	NFKB1	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P19838	MCF10A-ER-Src	PEAKS047409
EXP048574	NFKB1	Homo sapiens	Genotype: transformed	NULL	2284	normal	P19838	MCF10A-ER-Src	PEAKS047410
EXP048575	STAT3	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P40763	MCF10A-ER-Src	PEAKS047411
EXP048576	STAT3	Homo sapiens	Genotype: transformed	NULL	2284	normal	P40763	MCF10A-ER-Src	PEAKS047412
EXP048578	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	DMSO	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047413
EXP048579	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	H3B-6545	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047414
EXP048580	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Saturated H3B-6545	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047415
EXP048581	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	800	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047416
EXP048582	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Rad1901	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047417
EXP048583	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	H3B-5942	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047418
EXP048584	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Saturated H3B-5942	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047419
EXP048585	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Tamoxifen	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047420
EXP048586	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Fulvestrant	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047421
EXP048587	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	E2	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047422
EXP048590	Mouse monoclonal anti-RPA32 (RPA ChIP on MEF 4-3 cells, Millipore NA19L-100UG; RRID:AB_565123)	Homo sapiens	Treatment: DMSO for 9hrs CellType: Human epithelial breast cancer cells; passage-immortalized	EXP048588	2301	normal	P15927	MDA-MB-231 (breast adenocarcinoma)	PEAKS047423
EXP048591	Mouse monoclonal anti-RPA32 (RPA ChIP on MEF 4-3 cells, Millipore NA19L-100UG; RRID:AB_565123)	Homo sapiens	Treatment: 0.5 uM VE-822 + 0.2 uM aphidicolin for 9hrs CellType: Human epithelial breast cancer cells; passage-immortalized 	EXP048589	2301	normal	P15927	MDA-MB-231 (breast adenocarcinoma)	PEAKS047424
EXP048593	anti-p53	Homo sapiens	Treatment: Treatment: etoposide (100uM, 6hrs) Source: IMR90 fetal lung fibroblasts Passage: #30-35	EXP048592	489	normal	P04637	IMR90 (lung fibroblasts)	PEAKS047425
EXP048594	anti-MLL4 provided by Kai Ge (NIH)	Homo sapiens	Treatment: Treatment: TNF for 16 hr CellType: colon cancer cells	NULL	821	normal	Q9UMN6	SW480 (colon adenocarcinoma)	PEAKS047426
EXP048595	anti-p53 (FL393, sc6243)	Homo sapiens	Treatment: treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable control (LacZ) knockdown	NULL	821	normal	P04637	SW480 (colon adenocarcinoma)	PEAKS047427
EXP048596	anti-p53 (FL393, sc6243)	Homo sapiens	Treatment: treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable p53 knockdown	NULL	821	normal	P04637	SW480 (colon adenocarcinoma)	PEAKS047428
EXP048597	HA (Santa Cruz, sc-7392)	Homo sapiens	Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS047429
EXP048598	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype:Stable ESR1-YAP1 fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS047430
EXP048599	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype: stable ESR1-PCDH11X fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS047431
EXP048600	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype: stable ESR1-NOP2 fusion expressing model Treatment: hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS047432
EXP048601	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype: stable YFP-HA expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS047433
EXP048603	anti-AR (Santa Cruz H-280)	Homo sapiens	Genotype: empty vector Tissue: skin Treatment: Cells were transfected with pcDNA3.1(-) empty vector control for 24 hr, post-seeding using Lipofectamine 2000	EXP048602	36	normal	P10275	A375 (malignant melanoma)	PEAKS047434
EXP048604	anti-AR (Santa Cruz H-280)	Homo sapiens	Genotype: empty vector Tissue: skin Treatment: Cells were transfected with pcDNA3.1(-) vector expressing SLNCR1 for 24 hr, post-seeding using Lipofectamine 2000	EXP048602	36	normal	P10275	A375 (malignant melanoma)	PEAKS047435
EXP048606	anti-EGR1 (Cell Signaling, 44D5)	Homo sapiens	Tissue: skin TumorStage: malignant melanoma Treatment: 	EXP048605	36	normal	P18146	A375 (malignant melanoma)	PEAKS047436
EXP048607	CTCF antibody 61311 Active Motif	Homo sapiens	Treatment: none	NULL	417	normal	P49711	HCT-116 (colon carcinoma)	PEAKS047437
EXP048609	Santa Cruz HC-20 and the monoclonal ER Ab10 antibodies	Homo sapiens		EXP048608	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047438
EXP048612	D5S6H-lot 1 (Cell Signaling Technology)	Homo sapiens	Treatment: 1uM 3-MC for 24 hr 	EXP048610	2285	normal	P35869	GM01310 ( Transformed lymphovlasoid cell line )	PEAKS047439
EXP048613	D5S6H-lot 1 (Cell Signaling Technology)	Homo sapiens	Treatment: 0.1 % DMSO for 24 hr	EXP048611	2285	normal	P35869	GM01310 ( Transformed lymphovlasoid cell line )	PEAKS047440
EXP048614	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment:control, no triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	PEAKS047441
EXP048615	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 2 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	PEAKS047442
EXP048616	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 5 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	PEAKS047443
EXP048617	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 10 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	PEAKS047444
EXP048618	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 20 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	PEAKS047445
EXP048631	anti-GFPE	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048619	781	normal	P13631	RWPE1 (prostate epithelial cells)	PEAKS047446
EXP048632	anti-GFPE	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048620	781	normal	P13631	RWPE1 (prostate epithelial cells)	PEAKS047447
EXP048633	anti-GFPE	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048623	781	normal	P13631	RWPE1 (prostate epithelial cells)	PEAKS047448
EXP048634	anti-GFPE	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048624	781	normal	P13631	RWPE1 (prostate epithelial cells)	PEAKS047449
EXP048635	anti-GFPE	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048627	781	normal	P13631	RWPE1 (prostate epithelial cells)	PEAKS047450
EXP048636	anti-GFPE	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048628	781	normal	P13631	RWPE1 (prostate epithelial cells)	PEAKS047451
EXP048639	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 0 hr (control) Passage: 2-5 	EXP048637	92	normal	Q04206	BJAB (Burkitt lymphoma)	PEAKS047452
EXP048640	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 0 hr (control) Passage: 2-5 	EXP048638	92	normal	Q04206	BJAB (Burkitt lymphoma)	PEAKS047453
EXP048641	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 1 hr Passage: 2-5 	EXP048637	92	normal	Q04206	BJAB (Burkitt lymphoma)	PEAKS047454
EXP048642	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 1 hr Passage: 2-5 	EXP048638	92	normal	Q04206	BJAB (Burkitt lymphoma)	PEAKS047455
EXP048643	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 4 hr Passage: 2-5 	EXP048637	92	normal	Q04206	BJAB (Burkitt lymphoma)	PEAKS047456
EXP048644	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 4 hr Passage: 2-5 	EXP048638	92	normal	Q04206	BJAB (Burkitt lymphoma)	PEAKS047457
EXP048646	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: ActA, 50 ng/ml, 1.5hr	EXP048645	111	normal	Q15796	T47D (invasive ductal carcinoma)	PEAKS047458
EXP048647	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: Palbo, 1microM, 24hr, ActA, 50 ng/ml, 1.5hr	EXP048645	111	normal	Q15796	T47D (invasive ductal carcinoma)	PEAKS047459
EXP048650	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: ActA, 50 ng/ml, 1.5hr	EXP048648	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	PEAKS047460
EXP048651	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: Palbo, 1microM, 24hr, ActA, 50 ng/ml, 1.5hr	EXP048649	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	PEAKS047461
EXP048655	CTCF, Active Motif #61311	Homo sapiens	Treatment: Treatment: mock infected, time post infection 24 hr	EXP048652	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS047462
EXP048656	CTCF, Active Motif #61311	Homo sapiens	Treatment: Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025	EXP048653	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS047463
EXP048657	CTCF, Active Motif #61311	Homo sapiens	Treatment: Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025	EXP048654	466	normal	P49711	MDM(monocyte derived macrophages)	PEAKS047464
EXP048658	anti-ZNF207 (Santa Cruz Biotechnology, Inc.,  sc-271942)	Homo sapiens		NULL	396	normal	O43670	WA09 (embryonic stem cells)	PEAKS047465
EXP048659	NCAPH2 (Bethyl: A302-275A)	Homo sapiens	Passage:10-13	NULL	421	normal	Q6IBW4	HEK293 (embryonic kidney)	PEAKS047466
EXP048662	anti-BMI1; Bethyl Laboratories; A301-694A	Homo sapiens		EXP048660	2287	normal	P35226	LCL (lymphoblastoid cell line)	PEAKS047467
EXP048663	anti-SUZ12; Abcam; ab12073	Homo sapiens		EXP048661	2287	normal	Q15022	LCL (lymphoblastoid cell line)	PEAKS047468
EXP048668	BCL6	Homo sapiens	Treatment: DMSO	EXP048666	38	normal	P41182	A549 (lung carcinoma)	PEAKS047469
EXP048669	BCL6	Homo sapiens	Treatment: 1uM for 6 hr of OTX015	EXP048667	38	normal	P41182	A549 (lung carcinoma)	PEAKS047470
EXP048670	BRD3	Homo sapiens	Treatment: DMSO	EXP048666	38	normal	Q15059	A549 (lung carcinoma)	PEAKS047471
EXP048672	LDB1	Homo sapiens		EXP048671	2288	normal	Q86U70	AML (monocytes and acute myeloid leukemia)	PEAKS047472
EXP048685	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047473
EXP048686	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 	EXP048674	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047474
EXP048687	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: DMSO for 45 min  Genotype: TET2 knockout Passage: 6-10 	EXP048675	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047475
EXP048688	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: TET2 knockout Passage: 6-10 	EXP048676	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047476
EXP048689	TET2_NTD (homemade)	Homo sapiens	Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047477
EXP048690	TET2_NTD (homemade)	Homo sapiens	Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047478
EXP048691	TET2_NTD (homemade)	Homo sapiens	Genotype: TET2 knockout Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047479
EXP048692	ESR1	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047480
EXP048693	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS047481
EXP048694	anti-TET2_NTD (homemade)	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047482
EXP048695	anti-TET2_NTD (homemade)	Homo sapiens	Treatment: Tamoxifen for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047483
EXP048696	anti-MLL3 (homemade)	Homo sapiens	Treatment: DMSO for 45 min Passage: 6-10 	EXP048677	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	PEAKS047484
EXP048697	anti-MLL3 (homemade)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Passage: 6-10 	EXP048678	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	PEAKS047485
EXP048698	anti-MLL3 (homemade)	Homo sapiens	Treatment: no targeting shRNA  Passage: 6-10 	EXP048679	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	PEAKS047486
EXP048699	anti-MLL3 (homemade)	Homo sapiens	Treatment: shRNA target MLL3  Passage: 6-10 	EXP048680	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	PEAKS047487
EXP048700	anti-TET2_NTD (homemade)	Homo sapiens	Treatment: shRNA target TET2  Passage: 6-10 	EXP048682	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047488
EXP048701	anti-TET2 (Cell Signaling Technology)	Homo sapiens	Genotype: wildtype TET2 Passage: 6-10 	EXP048683	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047489
EXP048702	anti-TET2 (Cell Signaling Technology)	Homo sapiens	Genotype: TET2 knockout Passage: 6-10 	EXP048684	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	PEAKS047490
EXP048703	anti-UTX (homemade)	Homo sapiens	Genotype: parental cells Passage: 6-10 	NULL	113	normal	O15550	MCF7 (Invasive ductal breast carcinoma)	PEAKS047491
EXP048714	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048709	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047502
EXP048715	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048709	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047503
EXP048716	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048710	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047504
EXP048717	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048710	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047505
EXP048718	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048712	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047506
EXP048719	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048712	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047507
EXP048720	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048713	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047508
EXP048721	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048713	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047509
EXP048722	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048726	2291	bio_control	Q16665	RCC4 (kidney cancer cell line)	PEAKS047510
EXP048723	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048727	2291	normal	Q16665	RCC4 (kidney cancer cell line)	PEAKS047511
EXP048724	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048726	2291	normal	Q99814	RCC4 (kidney cancer cell line)	PEAKS047512
EXP048725	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048727	2291	normal	Q99814	RCC4 (kidney cancer cell line)	PEAKS047513
EXP048728	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048730	2291	normal	A0AVK6	RCC4 (kidney cancer cell line)	PEAKS047516
EXP048729	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048731	2291	normal	A0AVK6	RCC4 (kidney cancer cell line)	PEAKS047517
EXP048734	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048732	430	normal	A0AVK6	HepG2 (hepatoblastoma)	PEAKS047522
EXP048735	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048733	430	normal	A0AVK6	HepG2 (hepatoblastoma)	PEAKS047523
EXP048736	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048732	430	normal	Q16665	HepG2 (hepatoblastoma)	PEAKS047524
EXP048737	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048733	430	normal	Q16665	HepG2 (hepatoblastoma)	PEAKS047525
EXP048738	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048732	430	normal	Q99814	HepG2 (hepatoblastoma)	PEAKS047526
EXP048739	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048733	430	normal	Q99814	HepG2 (hepatoblastoma)	PEAKS047527
EXP048740	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	EXP048704	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047528
EXP048741	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	EXP048704	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047529
EXP048742	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	EXP048704	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047530
EXP048743	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048705	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047531
EXP048744	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048705	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047532
EXP048745	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048705	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047533
EXP048746	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	EXP048706	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047534
EXP048747	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	EXP048706	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047535
EXP048748	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	EXP048706	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047536
EXP048749	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	EXP048707	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047537
EXP048750	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	EXP048707	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047538
EXP048751	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	EXP048707	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047539
EXP048752	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048755	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	PEAKS047540
EXP048753	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048755	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	PEAKS047541
EXP048754	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048755	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	PEAKS047542
EXP048756	FOXA2	Homo sapiens	Phase: P (proliferative)	NULL	2292	normal	Q9Y261	endometrium	PEAKS047543
EXP048757	FOXA2	Homo sapiens	Phase: MS (mid-secretory)	NULL	2292	normal	Q9Y261	endometrium	PEAKS047544
EXP048759	4439 (Anti-JARID1B antibody, ABE239, EMD Millipore)	Homo sapiens	Treatment: hormone-deprived for at least 3 days and then treated with vehicle for 45 minutes	EXP048758	113	normal	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	PEAKS047545
EXP048760	2469 (non-commercial, unpublished)	Homo sapiens	Treatment: hormone-deprived for at least 3 days and then treated with vehicle for 45 minutes	EXP048758	113	normal	P29375	MCF7 (Invasive ductal breast carcinoma)	PEAKS047546
EXP048761	2469 (non-commercial, unpublished)	Homo sapiens	Treatment: hormone-deprived for at least 3 days and then treated with 100 nM 17|2-estradiol (Sigma) for 45 minutes	EXP048758	113	normal	P29375	MCF7 (Invasive ductal breast carcinoma)	PEAKS047547
EXP048763	MTA2 (Santa Cruz, sc-28731)	Homo sapiens		EXP048762	417	normal	O94776	HCT-116 (colon carcinoma)	PEAKS047548
EXP048764	EZH2 (Abcam, ab3748)	Homo sapiens		EXP048762	417	normal	Q15910	HCT-116 (colon carcinoma)	PEAKS047549
EXP048765	EZH2 (Abcam, ab3748)	Homo sapiens		EXP048762	417	normal	Q15910	HCT-116 (colon carcinoma)	PEAKS047550
EXP048772	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048766	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047551
EXP048773	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048767	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047552
EXP048774	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048768	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047553
EXP048775	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048769	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047554
EXP048776	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048770	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047555
EXP048777	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048771	1008	normal	Q08945	HT1080 (fibrosarcoma)	PEAKS047556
EXP048778	YAP (H125)X  (Santa Cruz Biotechnologies,#sc1540, #c-1904)	Homo sapiens	Treatment: no treatment	NULL	2293	normal	P46937	OVCAR5 (ovarian cancer cell line)	PEAKS047557
EXP048780	YAP Santa Cruz	Homo sapiens		EXP048779	2294	normal	P18509	H69	PEAKS047558
EXP048781	YAP	Homo sapiens		EXP048779	2294	normal	P46937	H69	PEAKS047559
EXP048782	TEAD	Homo sapiens		EXP048779	2294	normal	P28347	H69	PEAKS047560
EXP048783	Monoclonal ANTI-FLAGÂ® M2 antibody (Sigma Aldrich, Cat# F1804)	Homo sapiens	Grnotype: cells transformed with adenovirus 5 DNA for BRD7 overexpression 	NULL	421	normal	Q9NPI1	HEK293 (embryonic kidney)	PEAKS047561
EXP048784	Monoclonal ANTI-FLAGÂ® M2 antibody (Sigma Aldrich, Cat# F1804)	Homo sapiens	Grnotype: wildtype  	NULL	421	normal	Q9NPI1	HEK293 (embryonic kidney)	PEAKS047562
EXP048785	BPTF; Kindly obtained from Ramin Shiekhattar	Homo sapiens	unstimulated cells	NULL	2295	normal	Q12830	T47D-MTVL	PEAKS047563
EXP048786	BPTF; Kindly obtained from Ramin Shiekhattar	Homo sapiens	stimulated cells with 30 minutes	NULL	2295	normal	Q12830	T47D-MTVL	PEAKS047564
EXP048787	anti-HP1? (Mab 3450)	Homo sapiens	unstimulated cells	NULL	2295	normal	Q13185	T47D-MTVL	PEAKS047565
EXP048788	anti-HP1? (Mab 3450)	Homo sapiens	stimulated cells with 30 minutes	NULL	2295	normal	Q13185	T47D-MTVL	PEAKS047566
EXP048789	abcam anti-LSD1	Homo sapiens	unstimulated cells	NULL	2295	normal	O60341	T47D-MTVL	PEAKS047567
EXP048790	abcam anti-LSD1	Homo sapiens	stimulated cells with 30 minutes	NULL	2295	normal	O60341	T47D-MTVL	PEAKS047568
EXP048791	anti-CTCF	Homo sapiens		NULL	712	normal	P49711	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS047569
EXP048792	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Minicircle	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047570
EXP048793	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Minicircle	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047571
EXP048794	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Episomal vector	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047572
EXP048795	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Episomal vector	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047573
EXP048796	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	2296	normal	Q92769	HES-2 (embryonic stem cells)	PEAKS047574
EXP048797	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	1593	normal	Q92769	WA07 (H7, human embryonic stem cells)	PEAKS047575
EXP048798	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	396	normal	Q92769	WA09 (embryonic stem cells)	PEAKS047576
EXP048799	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	878	normal	Q92769	embryonic stem cells	PEAKS047577
EXP048800	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	LentiVirus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047578
EXP048801	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	LentiVirus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047579
EXP048802	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	2298	normal	Q92769	LSJ-1	PEAKS047580
EXP048803	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	2299	normal	Q92769	LSJ-2	PEAKS047581
EXP048804	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	mRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047582
EXP048805	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	mRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047583
EXP048806	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Sendai Virus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047584
EXP048807	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Sendai Virus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047585
EXP048808	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	microRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047586
EXP048809	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	microRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	PEAKS047587
EXP048812	EP400 (Bethyl, A300-541A)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048810	2297	normal	Q96L91	MKL-1 (Merkel cell carcinoma)	PEAKS047588
EXP048813	Max (Santa Cruz, SC-197)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048810	2297	normal	P61244	MKL-1 (Merkel cell carcinoma)	PEAKS047589
EXP048814	EP400 (Bethyl, A300-541A)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048811	2297	normal	Q96L91	MKL-1 (Merkel cell carcinoma)	PEAKS047590
EXP048815	Max (Santa Cruz, SC-197)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048811	2297	normal	P61244	MKL-1 (Merkel cell carcinoma)	PEAKS047591
EXP048817	CTCF (Millipore 07-729)	Homo sapiens	EtOH	EXP048816	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS047592
EXP048818	CTCF (Millipore 07-729)	Homo sapiens	100 nM 1,25(OH)2D3	EXP048816	2334	normal	P49711	THP-1 (acute monocytic leukemia)	PEAKS047593
EXP048820	CARM1 (Epicypher, 13-0006)	Homo sapiens		EXP048819	113	normal	Q86X55	MCF7 (Invasive ductal breast carcinoma)	PEAKS047594
EXP048821	MED12 (Bethyl, A300-774A)	Homo sapiens		EXP048819	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	PEAKS047595
EXP048824	Cocktail of mouse mAbs to HIRA 	Homo sapiens		EXP048822	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS047596
EXP048825	Cocktail of mouse mAbs to HIRA 	Homo sapiens	2000U/ml recombinant human IFN-Î² (PBL-11410-2)	NULL	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS047597
EXP048835	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: untreated	EXP048826	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047598
EXP048836	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: 100 nM Doxorubicin	EXP048827	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047599
EXP048837	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment:1 uMCDK4 inhibitor PD0332991	EXP048828	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047600
EXP048838	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: coultured in DME-HG media containing only 0.5 % serum-starved	EXP048829	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047601
EXP048839	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: untreated	EXP048830	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047602
EXP048840	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: 100 nM Doxorubicin	EXP048831	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047603
EXP048841	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment:1 uMCDK4 inhibitor PD0332991	EXP048832	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047604
EXP048842	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: coultured in DME-HG media containing only 0.5 % serum-starved	EXP048833	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	PEAKS047605
EXP048844	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens	Cell line: cervical adenocarcinoma epithelial cell line Genotype: wildtype with GFP-EMSY	EXP048843	78	normal	Q7Z589	HeLa (cervical adenocarcinoma)	PEAKS047606
EXP048845	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens	Cell line: cervical adenocarcinoma epithelial cell line Genotype: GFP-EMSY, Znf131 knockdown	EXP048843	78	normal	Q7Z589	HeLa (cervical adenocarcinoma)	PEAKS047607
EXP048846	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens	Cell line: cervical adenocarcinoma epithelial cell line Genotype: wildtype with GFP-GATAD1	EXP048843	78	normal	Q8WUU5	HeLa (cervical adenocarcinoma)	PEAKS047608
EXP048848	PRMT5 (Bethyl Labs A300-849A)	Homo sapiens	Treatment: no treatment	EXP048847	2301	normal	O14744	MDA-MB-231 (breast adenocarcinoma)	PEAKS047609
EXP048850	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens	Treatment: D,L-sulforaphane (SFN) for 5 hr	EXP048849	87	normal	Q16236	BEAS-2B (bronchial epithelium)	PEAKS047610
EXP048851	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens	Treatment: 0.1% (v/v) DMSO as vehicle for 5 hr	NULL	87	normal	Q16236	BEAS-2B (bronchial epithelium)	PEAKS047611
EXP048853	Brd4 (Bethyl, #A301-985A)	Homo sapiens	Treatmnet: untreated	EXP048852	1573	normal	O60885	SK-MEL-5 (Cutaneous melanoma)	PEAKS047612
EXP048856	HNF1 (sc-8986x, Santa Cruz, #E1603)	Homo sapiens	Treatment: untreated 	EXP048854	2255	normal	P20823	HEE (human epididymis epithelial cells)	PEAKS047613
EXP048857	HNF1, sc-8986x	Homo sapiens	Treatment: untreated 	EXP048855	2255	normal	P20823	HEE (human epididymis epithelial cells)	PEAKS047614
EXP048875	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 34 	EXP048869	2306	normal	P49711	ID00014 (lymphoblastoid cell, DiGeorge syndrome)	PEAKS047623
EXP048876	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell 	EXP048880	2305	normal	P49711	ID00015 (lymphoblastoid cell)	PEAKS047624
EXP048877	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 11	EXP048872	2306	normal	P49711	ID00014 (lymphoblastoid cell, DiGeorge syndrome)	PEAKS047625
EXP051028	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 6	EXP048867	2303	normal	P49711	GM17942 (lymphoblastoid cell)	PEAKS049028
EXP048879	anti-HA antibody (ab9110)	Homo sapiens		NULL	78	normal	O15391	HeLa (cervical adenocarcinoma)	PEAKS047627
EXP051029	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell Age: no	EXP048866	356	normal	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS049029
EXP048884	N-MYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: DMSO for 4 hr	EXP048882	2307	normal	P04198	IMR-5 (Neuroblastoma)	PEAKS047629
EXP048885	N-MYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 1uM CD532 for 4 hr	EXP048882	2307	normal	P04198	IMR-5 (Neuroblastoma)	PEAKS047630
EXP048886	GTF3C5 (Bethyl, A301-242A)	Homo sapiens	Treatment: DMSO for 4 hr	EXP048882	2307	normal	Q9Y5Q8	IMR-5 (Neuroblastoma)	PEAKS047631
EXP048887	GTF3C5 (Bethyl, A301-242A)	Homo sapiens	Treatment: 1uM CD532 for 4 hr	EXP048882	2307	normal	Q9Y5Q8	IMR-5 (Neuroblastoma)	PEAKS047632
EXP048888	CTCF (abcam, ab70303)	Homo sapiens		EXP048883	2307	normal	P49711	IMR-5 (Neuroblastoma)	PEAKS047633
EXP048889	RAD21 (Bethyl, A300-080A)	Homo sapiens		EXP048883	2307	normal	O60216	IMR-5 (Neuroblastoma)	PEAKS047634
EXP048893	anti-FXR1 (Sigma, HPA018246)	Homo sapiens		EXP048890	2308	normal	P51114	NCI-H358 (human nnon small cell lung cancer cell line)	PEAKS047635
EXP048894	anti-STAT1 (Santa Cruz, sc-345; CST, 14994S)	Homo sapiens		EXP048891	2308	normal	P42224	NCI-H358 (human nnon small cell lung cancer cell line)	PEAKS047636
EXP048895	anti-STAT3 (Santa Cruz, sc-482; CST, 12640S)	Homo sapiens		EXP048891	2308	normal	P40763	NCI-H358 (human nnon small cell lung cancer cell line)	PEAKS047637
EXP048896	anti-FXR1 (Sigma, HPA018246)	Homo sapiens		EXP048892	59	normal	P51114	AGS (gastric adenocarcinoma)	PEAKS047638
EXP048897	anti-FXR2 (Invitrogen, PA5-28979)	Homo sapiens		EXP048892	59	normal	P51116	AGS (gastric adenocarcinoma)	PEAKS047639
EXP048898	anti-STAT1 (Santa Cruz, sc-345; CST, 14994S)	Homo sapiens		EXP048892	59	normal	P42224	AGS (gastric adenocarcinoma)	PEAKS047640
EXP048899	anti-STAT3 (Santa Cruz, sc-482; CST, 12640S)	Homo sapiens		EXP048892	59	normal	P40763	AGS (gastric adenocarcinoma)	PEAKS047641
EXP048900	AR Antibody (H-280) (Santa Cruz, sc-13062)	Homo sapiens	Treatment: vehicle (DMSO) of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive	NULL	2310	normal	P10275	LNCaP-abl (Prostate carcinoma)	PEAKS047642
EXP048901	AR Antibody (H-280) (Santa Cruz, sc-13062)	Homo sapiens	Treatment: EPZ-6438 of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive	NULL	2310	normal	P10275	LNCaP-abl (Prostate carcinoma)	PEAKS047643
EXP048902	AR Antibody (H-280) (Santa Cruz, sc-13062)	Homo sapiens	Treatment: GSK126 of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive	NULL	2310	normal	P10275	LNCaP-abl (Prostate carcinoma)	PEAKS047644
EXP048904	TCF7L1 (Santa Cruz, sc-8635)	Homo sapiens	Treatment: none Passage: 44	EXP048903	396	normal	Q9HCS4	WA09 (embryonic stem cells)	PEAKS047645
EXP048909	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048905	2311	normal	P50549	GIST-T1 (Gastrointestinal stromal tumor)	PEAKS047646
EXP048910	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048906	2312	normal	P50549	GIST882 (Gastrointestinal stromal tumor)	PEAKS047647
EXP048911	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048907	36	normal	P50549	A375 (malignant melanoma)	PEAKS047648
EXP048912	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048908	2313	normal	P50549	COLO800 (human melanoma cells)	PEAKS047649
EXP048914	FOXA1(ab5089,abcam)	Homo sapiens	Treatment: ethanol 	EXP048913	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS047650
EXP048915	FOXA1(ab5089,abcam)	Homo sapiens	Treatment: R1881	NULL	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS047651
EXP048920	AR(N-20, Santa Cruz)	Homo sapiens	Treatment: non-target siNT+R1881	EXP048913	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047656
EXP048921	AR(N-20, Santa Cruz)	Homo sapiens	treatment: targeting ARV1/3/4/7 siARVs+R1881	EXP048913	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047657
EXP048922	AR(N-20, Santa Cruz)	Homo sapiens	Treatment: targeting AR exon 7 siARFL+ ethanol	EXP048913	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047658
EXP048923	HA (Sigma, H6908)	Homo sapiens	Treatment: untreated 	NULL	2315	normal	X5C3Z9	pre- leukemia stem cells (CD34+ human cord blood cells)	PEAKS047659
EXP048924	anti-FOXO1 (Abcam ab39670)	Homo sapiens	Treatment: untreated 	NULL	2315	normal	Q12778	pre- leukemia stem cells (CD34+ human cord blood cells)	PEAKS047660
EXP048925	anti-p53	Homo sapiens	Treatment: no treatment, control	NULL	985	normal	P04637	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS047661
EXP048926	MYCN	Homo sapiens	mTreatment: mycn-low lvl induced by 16 hr doxycycline	NULL	985	normal	P04198	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS047662
EXP048927	MYCN	Homo sapiens	Treatment: mycn-high lvl induced by 16 hr doxycycline	NULL	2316	normal	P04198	MYCN3 (neuroblastoma cell line with inducible MYCN expression)	PEAKS047663
EXP048944	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	PEAKS047680
EXP048945	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	PEAKS047681
EXP048946	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	PEAKS047682
EXP048947	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	PEAKS047683
EXP048948	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	PEAKS047684
EXP048949	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	PEAKS047685
EXP048950	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	PEAKS047686
EXP048951	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	PEAKS047687
EXP048952	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	PEAKS047688
EXP048953	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: iPS protocol 3s2 Passage: 20	NULL	1143	normal	Q01860	iPSC (induced pluripotent stem cells)	PEAKS047689
EXP048954	Sox2 (R&D Systems AF2018)	Homo sapiens	Genotype: wildtype Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	PEAKS047690
EXP048955	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	PEAKS047691
EXP048956	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	PEAKS047692
EXP048957	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: iPS protocol 3s2 Passage: 20	NULL	2238	normal	P48431	iPS (derived pancreatic precursor cells)	PEAKS047693
EXP048958	Klf4 (R&D Systems AF3640)	Homo sapiens	Genotype: wildtype Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	PEAKS047694
EXP048959	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	PEAKS047695
EXP048960	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	PEAKS047696
EXP048961	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: iPS protocol 3s2 Passage: 20	NULL	2238	normal	O43474	iPS (derived pancreatic precursor cells)	PEAKS047697
EXP048962	Myc (R&D Systems AF3696)	Homo sapiens	Genotype: wildtype Passage: 8 	NULL	950	normal	P01106	MRC-5 (fetal lung fibroblasts)	PEAKS047698
EXP048963	Myc (R&D Systems AF3696)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P01106	MRC-5 (fetal lung fibroblasts)	PEAKS047699
EXP048964	Myc (R&D Systems AF3696)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P01106	MRC-5 (fetal lung fibroblasts)	PEAKS047700
EXP048966	anti-SMAD2/3 antibody (#610843, BD Transduction Laboratories) 	Homo sapiens	Treatment: TGF-beta3, 5 ng/ml, 1.5hr	EXP048965	583	normal	Q15796	MCF10A (breast epithelial cells)	PEAKS047701
EXP048967	anti-SMAD2/3 antibody (#610843, BD Transduction Laboratories) 	Homo sapiens	Treatment: TGF-beta3, 5 ng/ml, 16hr	EXP048965	583	normal	Q15796	MCF10A (breast epithelial cells)	PEAKS047702
EXP048969	GATA4(Thermo fisher,MA5-15532)	Homo sapiens		EXP048968	38	normal	P43694	A549 (lung carcinoma)	PEAKS047703
EXP048970	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: DMSO for 3 hours	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	PEAKS047704
EXP048971	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: DMSO for 3 hours, EGF simulation 20 min, 100ng/ml	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	PEAKS047705
EXP048972	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: 1 uM ERK inhibitor for 3 hours	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	PEAKS047706
EXP048973	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: 1 uM ERK inhibitor for 3 hours, EGF simulation 20 min, 100ng/ml	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	PEAKS047707
EXP048974	anti-TET2	Homo sapiens	Treatment: DMSO for 24 hr	NULL	2319	normal	Q6N021	MCF12A (human mammary epithelial cells)	PEAKS047708
EXP048975	anti-RARb	Homo sapiens	Treatment: DMSO for 24 hr	NULL	2319	normal	P10826	MCF12A (human mammary epithelial cells)	PEAKS047709
EXP048976	5hmc	Homo sapiens	Treatment: DMSO for 24 hr	NULL	2319	normal	Q96FZ2	MCF12A (human mammary epithelial cells)	PEAKS047710
EXP048977	TET3	Homo sapiens	Treatment: ATRA for 24 hr	NULL	2319	normal	O43151	MCF12A (human mammary epithelial cells)	PEAKS047711
EXP048978	RARb	Homo sapiens	Treatment: ATRA for 24 hr	NULL	2319	normal	P10826	MCF12A (human mammary epithelial cells)	PEAKS047712
EXP048979	5hmc	Homo sapiens	Treatment: ATRA for 24 hr	NULL	2319	normal	Q96FZ2	MCF12A (human mammary epithelial cells)	PEAKS047713
EXP048981	Bethyl rabbit anti-SMC1 (A300-055A)	Homo sapiens	Treatment: 10 million cells were crosslinked with formaldehyde and used in the experiment Tissue: neonatal foreskin 	EXP048980	2320	normal	Q14683	primary human epidermal keratinocytes	PEAKS047714
EXP048986	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048982	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047715
EXP048987	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	EXP048983	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047716
EXP048988	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048982	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS047717
EXP048989	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	EXP048983	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS047718
EXP048990	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048982	70	normal	Q14541	LNCaP (prostate carcinoma)	PEAKS047719
EXP048991	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	EXP048983	70	normal	Q14541	LNCaP (prostate carcinoma)	PEAKS047720
EXP048992	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048984	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047721
EXP048993	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	EXP048985	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047722
EXP048994	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048984	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS047723
EXP048995	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	EXP048985	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS047724
EXP048996	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048984	7	normal	Q14541	22RV1 (prostate carcinoma)	PEAKS047725
EXP048997	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	EXP048985	7	normal	Q14541	22RV1 (prostate carcinoma)	PEAKS047726
EXP049000	Anti-ERG Clone 9FY (Biocare, Catalog# CM421 C, Lot #021715)	Homo sapiens	Treatment: no Genotype: expressing point-mutant(S96E) of ERF	EXP048998	781	normal	P11308	RWPE1 (prostate epithelial cells)	PEAKS047727
EXP049001	Anti-ERG Clone 9FY (Biocare, Catalog# CM421 C, Lot #021715)	Homo sapiens	Treatment: no Genotype: expressing point-mutant(S96E) of ERF	EXP048999	781	normal	P11308	RWPE1 (prostate epithelial cells)	PEAKS047728
EXP049002	Anti-V5 Agarose (Affinity Gel antibody, clone V5-10 Sigma, #A7345)	Homo sapiens	Genotype: empty V5 vector cds	NULL	421	normal	Q9Y6X0	HEK293 (embryonic kidney)	PEAKS047729
EXP049003	Anti-V5 Agarose (Affinity Gel antibody, clone V5-10 Sigma, #A7345)	Homo sapiens	Genotype: SETBP1 G870S vector cds	NULL	421	normal	Q9Y6X0	HEK293 (embryonic kidney)	PEAKS047730
EXP049004	Anti-V5 Agarose (Affinity Gel antibody, clone V5-10 Sigma, #A7345)	Homo sapiens	Genotype: SETBP1 wildtype	NULL	421	normal	Q9Y6X0	HEK293 (embryonic kidney)	PEAKS047731
EXP049009	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DMSO 4 hours	EXP049005	915	normal	P10275	hNSC (neural stem cells)	PEAKS047732
EXP049010	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DHT 100nM 4 hours	EXP049007	915	normal	P10275	hNSC (neural stem cells)	PEAKS047733
EXP049013	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DHT 10nM 4 hours	EXP049006	915	normal	P10275	hNSC (neural stem cells)	PEAKS047736
EXP049014	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: Testosterone 100nM 4 hours	EXP049008	915	normal	P10275	hNSC (neural stem cells)	PEAKS047737
EXP049017	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DMSO 4 hours	EXP049015	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047738
EXP049018	AR (3279.4 homemade)	Homo sapiens	Treatment: DMSO 4 hours	EXP049015	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047739
EXP049019	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DHT 100nM 4 hours	EXP049016	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047740
EXP049020	AR (3279.4 homemade)	Homo sapiens	Treatment: DHT 100nM 4 hours	EXP049016	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047741
EXP049023	FoxA1 (ab5089)	Homo sapiens	Treatment: not applicable Stage:adult  Tissue: transitional cell papilloma	EXP049021	2323	normal	P55317	RT4 (Bladder carcinoma cells)	PEAKS047742
EXP049024	FoxA1 (ab5089)	Homo sapiens	Treatment: not applicable Stage:adult  Tissue: transitional cell papilloma	EXP049022	2323	normal	P55317	RT4 (Bladder carcinoma cells)	PEAKS047743
EXP049027	anti-FOSL1 antibody (Santa Cruz Biotechnoloy, catalog# sc-183, lot# 12314)	Homo sapiens	Treatment: resting CD4+ T cells were activated using anti-CD3/CD28 beads (Invitrogen Dynabeads Human T-Activator CD3/CD28, Cat# 11131D)  Tissue: blood	EXP049025	881	normal	P15407	CD4+ T-cells	PEAKS047744
EXP049028	anti-FOSL1 antibody (Santa Cruz Biotechnoloy, catalog# sc-183, lot# 12314)	Homo sapiens	Treatment: stimulated  Tissue: blood	EXP049026	881	normal	P15407	CD4+ T-cells	PEAKS047745
EXP049037	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049029	2324	normal	P38398	TC32 (Ewing's sarcoma)	PEAKS047746
EXP049038	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 0.05 uM Etoposide for 6 hours	EXP049030	2324	normal	P38398	TC32 (Ewing's sarcoma)	PEAKS047747
EXP049039	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049031	290	normal	P38398	EWS502 (Ewing sarcoma)	PEAKS047748
EXP049040	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 0.25 uM Etoposide for 6 hours	EXP049032	290	normal	P38398	EWS502 (Ewing sarcoma)	PEAKS047749
EXP049041	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049033	489	normal	P38398	IMR90 (lung fibroblasts)	PEAKS047750
EXP049042	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 6 uM Etoposide for 6 hours	EXP049034	489	normal	P38398	IMR90 (lung fibroblasts)	PEAKS047751
EXP049043	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049035	848	normal	P38398	U2OS (osteosarcoma)	PEAKS047752
EXP049044	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 6 uM Etoposide for 6 hours	EXP049036	848	normal	P38398	U2OS (osteosarcoma)	PEAKS047753
EXP049052	anti-Notch1, Cell Signaling #3608	Homo sapiens	Treatment: Superconfluent, untreated Passage: 4	EXP049051	472	normal	P46531	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047754
EXP049053	anti-RBPJ, Cell Signaling #5313	Homo sapiens	Treatment: Superconfluent, untreated Passage: 4	EXP049051	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047755
EXP049054	anti-NF-?B/RelA, Santa Cruz Biotechnology sc-372	Homo sapiens	Treatment: confluent, treated with Scr siRNA Passage: 4	EXP049045	472	normal	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047756
EXP049055	anti-NF-?B/RelA, Santa Cruz Biotechnology sc-372	Homo sapiens	Treatment: confluent, treated with Scr siRNA and stimulated with IL-1beta Passage: 4	EXP049046	472	normal	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047757
EXP049056	anti-NF-?B/RelA, Santa Cruz Biotechnology sc-372	Homo sapiens	Treatment: confluent, treated with Notch1 siRNA and stimulated with IL-1beta Passsage: 4	EXP049047	472	normal	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047758
EXP049058	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0hr (untreated) Genotype: wildtype cells	EXP049057	2325	normal	P18847	CS1AN CVCL_L471 + CSB	PEAKS047759
EXP049059	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr Genotype: wildtype cells	EXP049057	2325	normal	P18847	CS1AN CVCL_L471 + CSB	PEAKS047760
EXP049060	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 24hr Genotype: wildtype cells	EXP049057	2325	normal	P18847	CS1AN CVCL_L471 + CSB	PEAKS047761
EXP049061	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 Genotype: mutant cells 	EXP049057	2326	normal	P18847	CS1AN (Cockayne syndrome)	PEAKS047762
EXP049062	MDM2 (Santa Cruz, sc-965x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0 hr (untreated) Genotype: wildtype cells	EXP049057	2325	normal	Q00987	CS1AN CVCL_L471 + CSB	PEAKS047763
EXP049063	MDM2 (Santa Cruz, sc-965x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8r Genotype: wildtype cells	EXP049057	2326	normal	Q00987	CS1AN (Cockayne syndrome)	PEAKS047764
EXP049064	CSB (rabbit polyclonal, #3222)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0hr Genotype: wildtype cells	EXP049057	2325	normal	Q03468	CS1AN CVCL_L471 + CSB	PEAKS047765
EXP049065	CSB (rabbit polyclonal, #3222)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr Genotype: wildtype cells	EXP049057	2325	normal	Q03468	CS1AN CVCL_L471 + CSB	PEAKS047766
EXP049066	PSMD-1 (Abcam, ab140682)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr+ lactacystin 3hr Genotype: wildtype cells 	EXP049057	2325	normal	Q99460	CS1AN CVCL_L471 + CSB	PEAKS047767
EXP049067	PSMB5 (Santa Cruz, sc-55009)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr+ lactacystin 3hr Genotype: wildtype cells 	EXP049057	2325	normal	P28074	CS1AN CVCL_L471 + CSB	PEAKS047768
EXP049068	CSA (Abcam, ab137033)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0hr Genotype: wildtype cells	EXP049057	2325	normal	Q13216	CS1AN CVCL_L471 + CSB	PEAKS047769
EXP049069	CSA (Abcam, ab137033)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr Genotype: wildtype cells	EXP049057	2325	normal	Q13216	CS1AN CVCL_L471 + CSB	PEAKS047770
EXP049074	Anti-ZEB1 (Antibody SC-25388 Lot. H1513)	Homo sapiens	Treatment: none	NULL	2327	normal	P37275	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	PEAKS047771
EXP049075	Anti-ZEB1 (Antibody SC-25388 Lot. G2315)	Homo sapiens	Treatment: none	EXP049071	774	normal	P37275	RKO (colon carcinoma cell)	PEAKS047772
EXP049076	Anti-ZEB1 (Antibody SC-25388 Lot. K1615)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of MiaPaca2 cells electroporated with plasmids pX330A_D10A-1x2 containing Cas9 nickase	NULL	2327	normal	P37275	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	PEAKS047773
EXP049077	Anti-ZEB1 (Antibody SC-25388 Lot. K1615)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of MiaPaca2 cells electroporated with two plasmids pX330A_D10A-1x2 driving the expression of the Cas9-nickase and different pairs of gRNAs designed to target the repeated genomic region upstream MIR200A/B locus 	NULL	2327	normal	P37275	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	PEAKS047774
EXP049078	Anti-CTCF (Antibody Millipore Rb Antiserum 07-729 Lot. 2275585)	Homo sapiens	Treatment: none	NULL	2327	normal	P49711	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	PEAKS047775
EXP049080	SMAD2/3 (R&D, AF3797)	Homo sapiens	Treatment: 5 nM TGFb  for 1 hr	EXP049079	712	normal	Q15796	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS047776
EXP049084	anti HA tag antibody (Sigma,H6908)	Mus musculus	Treatmen: formaldehyde cross-linking Genotype: stable expression of HA-tagged Cbx7, clone 12D Sex: female Strain: CAST/Ei x 129/Sv/Jae	EXP049083	2331	normal	Q8VDS3	undifferentiated embryonic stem cells	PEAKS047777
EXP049087	KLF5, Abcam, ab137676	Homo sapiens	Treatment: untreated Tumor: Head and neck squamous cell carcinomas	NULL	2332	normal	Q13887	BICR31 (Tongue squamous cell carcinoma cell)	PEAKS047778
EXP049088	p300, Bethyl Lab, A300-358	Homo sapiens	Treatment: untreated 	NULL	2332	normal	Q09472	BICR31 (Tongue squamous cell carcinoma cell)	PEAKS047779
EXP049089	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 D418N	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047780
EXP049090	V5, Thermo Scientific, R960-25	Homo sapiens	treatment: Over-expressing KLF5 D418N	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047781
EXP049091	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: over-expressing KLF5 E419K	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047782
EXP049092	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419K	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047783
EXP049093	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419Q	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047784
EXP049094	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419Q	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047785
EXP049095	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047786
EXP049096	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	PEAKS047787
EXP049097	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419Q	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	PEAKS047788
EXP049098	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 D418N	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	PEAKS047789
EXP049099	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	PEAKS047790
EXP049100	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	PEAKS047791
EXP049105	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Treatment: sh Scramble viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049101	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	PEAKS047792
EXP049106	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Genotype: underexpressed TRF2 Treatment: sh TRF2 viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049102	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	PEAKS047793
EXP049107	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Genotype: overexpressed TRF2 Treatment: pWPIR-TRF2-IRES-GFP viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049103	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	PEAKS047794
EXP049108	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Genotype: empty vector Treatment: pWPIR-IRES-GFP viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049104	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	PEAKS047795
EXP049109	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: untreated, control	NULL	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS047796
EXP049110	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 15 min	NULL	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS047797
EXP049111	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 30 min	NULL	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS047798
EXP049112	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 60 min	NULL	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS047799
EXP049113	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: untreated, control	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS047800
EXP049114	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 15 min	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS047801
EXP049115	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 30 min	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS047802
EXP049116	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 60 min	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS047803
EXP049120	PU.1 (Santa Cruz sc-22805 X)	Homo sapiens	Treatment: 100nM VDR ligand 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) for 24 hrs Cell type: human monocytic cell line	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS047807
EXP049121	PU.1 (Santa Cruz sc-22805 X)	Homo sapiens	Treatment: EtOH (vehicle) for 24hrs Cell type: human monocytic cell line	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS047808
EXP049127	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: undifferentiated 	EXP049122	892	normal	O14646	MSC (mesenchymal stem cells)	PEAKS047809
EXP049128	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: adipocyte differentiated (Ad), siRNA treatment was performed 36 hours before differentiation induction. After 2 days of differentiation a second siRNA transfection was performed	EXP049123	892	normal	O14646	MSC (mesenchymal stem cells)	PEAKS047810
EXP049129	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: osteoblast (Ob), siRNA treatment was performed 36 hours before differentiation induction. After 2 days of differentiation a second siRNA transfection was performed	EXP049124	892	normal	O14646	MSC (mesenchymal stem cells)	PEAKS047811
EXP049130	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: undifferentiated 	NULL	2336	normal	O14646	hFOB 1.19 (fetal osteoblast)	PEAKS047812
EXP049131	MLL (AT71-Ab1542, Diagenode)	Homo sapiens	Genotype: translocation MLL-AF9	NULL	2288	normal	Q03164	AML (monocytes and acute myeloid leukemia)	PEAKS047813
EXP049133	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: DMSO (0.1%) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS047814
EXP049134	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: NVP-2 (250 nM) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS047815
EXP049135	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: SNS-032 (250 nM) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS047816
EXP049136	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: THAL-SNS-032 (250 nM) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS047817
EXP049139	anti-DDX21 (Novus Biologicals BP100-1781)	Homo sapiens	Treatment: untreated, control	EXP049137	78	normal	Q9NR30	HeLa (cervical adenocarcinoma)	PEAKS047818
EXP049140	anti-DDX21 (Novus Biologicals BP100-1781)	Homo sapiens	Treatment: treated with iPol 1 for 1 hr 	EXP049138	78	normal	Q9NR30	HeLa (cervical adenocarcinoma)	PEAKS047819
EXP049141	anti-DDX21 (Novus Biologicals BP100-1781)	Homo sapiens	Treatment:  transfected with pools of siRNA targeting FCOF1	EXP049137	78	normal	Q9NR30	HeLa (cervical adenocarcinoma)	PEAKS047820
EXP049142	anti-TCOF1 (Novus Biologicals NBP1-86909)	Homo sapiens	Treatment: untreated, control	EXP049137	78	normal	Q13428	HeLa (cervical adenocarcinoma)	PEAKS047821
EXP049186	AR (Santa Cruz, catalog# sc-816, mix of 4 lot#s B2114, H2914, A0515, J0614)	Homo sapiens	Treatment: control	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047865
EXP049187	AR (Santa Cruz, catalog# sc-816, mix of 4 lot#s B2114, H2914, A0515, J0614)	Homo sapiens	Treatment: exclude	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047866
EXP049226	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: skin 	EXP049189	36	normal	O60885	A375 (malignant melanoma)	PEAKS054027
EXP049227	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 50nM THZ1 for 48 hrs Tissue:skin	EXP049188	36	normal	O60885	A375 (malignant melanoma)	PEAKS054028
EXP049228	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Vemurafenib (PTKi) for 48 hrs Tissue: skin 	EXP049190	36	normal	O60885	A375 (malignant melanoma)	PEAKS054029
EXP049229	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uMVemurafenib(PTKi) and 50 nM THZ1 for 48 hrs Tissue: skin	EXP049191	36	normal	O60885	A375 (malignant melanoma)	PEAKS054030
EXP049230	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 200nM GSK1120212 for 48 hrs Tissue: lung	EXP049192	38	normal	O60885	A549 (lung carcinoma)	PEAKS054031
EXP049231	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 150nM THZ1 for 48 hrs Tissue: lung	EXP049193	38	normal	O60885	A549 (lung carcinoma)	PEAKS054032
EXP049232	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: lung	EXP049194	38	normal	O60885	A549 (lung carcinoma)	PEAKS054033
EXP049233	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 150nM THZ1 and 200nM GSK1120212 for 48 hrs Tissue: lung	EXP049195	38	normal	O60885	A549 (lung carcinoma)	PEAKS054034
EXP049234	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 50nM THZ1 and 250 nM Crizotinib for 48 hrs Tissue: lung	EXP049196	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	PEAKS054035
EXP049235	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: lung	EXP049197	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	PEAKS054036
EXP049236	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 50 nM THZ1 for 48 hrs Tissue: lung	EXP049198	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	PEAKS054037
EXP049237	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 250 nM Crizotinib for 48 hrs Tissue: lung	EXP049199	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	PEAKS054038
EXP049238	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment:100 nM  Lapatinib and 25 nM THZ1 for 48 hrs Tissue: stomach	EXP049201	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	PEAKS054039
EXP049239	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: stomach	EXP049200	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	PEAKS054040
EXP049240	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100 nM Lapatinib for 48 hrs Tissue: stomach	EXP049202	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	PEAKS054041
EXP049241	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 25 nM THZ1 for 48 hrs Tissue: stomach	EXP049203	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	PEAKS054042
EXP049242	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Erlotinib for 48 hrs Tissue: lung	NULL	927	normal	O60885	PC9 (lung adenocarcinoma)	PEAKS054043
EXP049243	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Erlotinib and  100nM THZ1 for 48 hrs Tissue: lung 	EXP049208	927	normal	O60885	PC9 (lung adenocarcinoma)	PEAKS054044
EXP049244	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs  Tissue: lung	EXP049206	927	normal	O60885	PC9 (lung adenocarcinoma)	PEAKS054045
EXP049245	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1 % DMSO for 48 hrs Tissue: lung	EXP049206	927	normal	O60885	PC9 (lung adenocarcinoma)	PEAKS054046
EXP049246	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Erlotinib for 48 hrs Tissue: lung	EXP049204	927	normal	O60885	PC9 (lung adenocarcinoma)	PEAKS054047
EXP049247	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100nM THZ1 for 48 hrs Tissue: lung	EXP049205	927	normal	O60885	PC9 (lung adenocarcinoma)	PEAKS054048
EXP049248	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1 uM BGJ for 48 hrs Tissue: bladder	EXP049213	2339	normal	O60885	RT-112 (Bladder carcinoma)	PEAKS054049
EXP049249	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: bladder	EXP049211	2339	normal	O60885	RT-112 (Bladder carcinoma)	PEAKS047890
EXP049250	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100nM THZ1 for 48 hrs Tissue: bladder	EXP049210	2339	normal	O60885	RT-112 (Bladder carcinoma)	PEAKS047891
EXP049251	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100 nM THZ1 and 1 uM BGJ for 48 hrs Tissue: bladdeer	EXP049212	2339	normal	O60885	RT-112 (Bladder carcinoma)	PEAKS047892
EXP049252	AR (Santa Cruz, catalog# sc-816, mix of 4 lot#s B2114, H2914, A0515, J0614)	Homo sapiens	Treatment: case	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047893
EXP049255	NKX2-5	Homo sapiens	Treatment: no	EXP049254	878	normal	P52952	embryonic stem cells	PEAKS047894
EXP049256	NKX2-5	Homo sapiens	Treatment: no	EXP049253	89	normal	P52952	BGO3 (embryonic stem cells)	PEAKS047895
EXP049258	NR0B1 antibody (Cell Signaling Technology)	Homo sapiens	Treatment: no	EXP049257	1490	normal	P51843	NCI-H460 (Large cell lung carcinoma)	PEAKS047896
EXP049260	HIF1A (PM14)	Homo sapiens	Passage: 4-6	EXP049259	472	normal	Q16665	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047897
EXP049261	EPAS1 (PM9)	Homo sapiens	Passage: 4-6	EXP049259	472	normal	Q99814	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047898
EXP049262	ARNT (Novus, NB-100-110)	Homo sapiens	Passage: 4-6	EXP049259	472	normal	P27540	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS047899
EXP049275	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs 	EXP049263	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047900
EXP049276	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs 	EXP049264	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047901
EXP049277	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout	EXP049265	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047902
EXP049278	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout	EXP049266	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047903
EXP049279	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and vector	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047904
EXP049280	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and vector	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047905
EXP049281	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype	EXP049269	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047906
EXP049282	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype	EXP049270	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047907
EXP049283	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs  Genotype: Bag-1L wildtype	EXP049271	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047908
EXP049284	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L wildtype	EXP049272	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047909
EXP049285	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs 	EXP049273	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047910
EXP049286	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout	EXP049274	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS047911
EXP049287	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	430	normal	Q9Y261	HepG2 (hepatoblastoma)	PEAKS047912
EXP049288	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	430	normal	Q9Y261	HepG2 (hepatoblastoma)	PEAKS047913
EXP049289	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2343	normal	Q9Y261	KerCT (keratenocytes)	PEAKS047914
EXP049290	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2343	normal	Q9Y261	KerCT (keratenocytes)	PEAKS047915
EXP049291	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2343	normal	Q9Y261	KerCT (keratenocytes)	PEAKS047916
EXP049292	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2344	normal	Q9Y261	definitive endoderm(dEN, ES derived)	PEAKS047917
EXP049293	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2344	normal	Q9Y261	definitive endoderm(dEN, ES derived)	PEAKS047918
EXP049294	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: cTermCDT1	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047919
EXP049295	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens		NULL	93	normal	A0AVK6	BJ (fibroblasts)	PEAKS047920
EXP049296	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens		NULL	38	normal	A0AVK6	A549 (lung carcinoma)	PEAKS047921
EXP049297	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: wildtype FOCA2	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047922
EXP049298	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: CDT1 mimo FOXA2	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047923
EXP049299	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047924
EXP049300	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo release	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047925
EXP049301	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: Fochnf1a coexpression FOXA2	NULL	93	normal	P41161	BJ (fibroblasts)	PEAKS047926
EXP049302	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 unind	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047927
EXP049303	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL 	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047928
EXP049304	GATA4 (M167-3; Lot 4)	Homo sapiens	Genotype: V5-untarged	NULL	93	normal	P43694	BJ (fibroblasts)	PEAKS047929
EXP049305	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL 	NULL	38	normal	Q9Y261	A549 (lung carcinoma)	PEAKS047930
EXP049306	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: Mimo FOXA2	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047931
EXP049307	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo released 	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047932
EXP049308	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 {delta}C	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047933
EXP049309	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 {delta}N	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047934
EXP049318	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049310	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	PEAKS047935
EXP049319	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049310	937	normal	Q15022	G401 (rhabdoid tumor of the kidney)	PEAKS047936
EXP049320	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049311	937	bio_control	P51532	G401 (rhabdoid tumor of the kidney)	PEAKS047937
EXP049321	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47, expresed Tissue: Malignant rhabdoid tumor	EXP049311	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	PEAKS047938
EXP049322	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049311	937	normal	Q15022	G401 (rhabdoid tumor of the kidney)	PEAKS047939
EXP051030	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049313	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS049030
EXP051031	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049313	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS049031
EXP051032	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049313	2345	normal	Q15022	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS049032
EXP049326	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047943
EXP049327	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047944
EXP049328	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q15022	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047945
EXP049329	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049314	2346	normal	P51532	HS-ES-2M (Epithelioid sarcoma)	PEAKS047946
EXP049330	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2346	normal	Q92922	HS-ES-2M (Epithelioid sarcoma)	PEAKS047947
EXP049331	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2346	normal	Q15022	HS-ES-2M (Epithelioid sarcoma)	PEAKS047948
EXP049332	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049315	2346	normal	P51532	HS-ES-2M (Epithelioid sarcoma)	PEAKS047949
EXP049333	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049315	2346	normal	Q92922	HS-ES-2M (Epithelioid sarcoma)	PEAKS047950
EXP049334	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049315	2346	normal	Q15022	HS-ES-2M (Epithelioid sarcoma)	PEAKS047951
EXP049335	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049316	2347	normal	P51532	VA-ES-BJ (Epithelioid sarcoma)	PEAKS047952
EXP049336	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049316	2347	normal	Q92922	VA-ES-BJ (Epithelioid sarcoma)	PEAKS047953
EXP049337	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049316	2347	normal	Q15022	VA-ES-BJ (Epithelioid sarcoma)	PEAKS047954
EXP049338	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049317	2347	normal	P51532	VA-ES-BJ (Epithelioid sarcoma)	PEAKS047955
EXP049339	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049317	2347	normal	Q92922	VA-ES-BJ (Epithelioid sarcoma)	PEAKS047956
EXP049340	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049317	2347	normal	Q15022	VA-ES-BJ (Epithelioid sarcoma)	PEAKS047957
EXP049341	anti-SS18	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049312	2345	normal	Q15532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047958
EXP049342	anti-SS18	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q15532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047959
EXP049343	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049310	937	normal	P51532	G401 (rhabdoid tumor of the kidney)	PEAKS047960
EXP049344	BAF200	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049312	2345	normal	Q68CP9	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047961
EXP049345	BAF200	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q68CP9	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS047962
EXP049349	HSF1 (Cell Signaling 4356)	Homo sapiens	Treatment: no	EXP049346	199	normal	Q00613	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS047963
EXP049350	HSF1 (Cell Signaling 4356)	Homo sapiens	Treatment: no	EXP049347	2348	normal	Q00613	P12 (P12-Ichikawa, Childhood T acute lymphoblastic leukemia)	PEAKS047964
EXP049351	MYC (Santa Cruz Biotech, N262)	Homo sapiens	Treatment: no	EXP049348	199	normal	P01106	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS047965
EXP049352	anti-LSD1 (ab17721)	Homo sapiens	Treatment: DMSo vehicle	NULL	2288	normal	O60341	AML (monocytes and acute myeloid leukemia)	PEAKS047966
EXP049353	anti-LSD1 (ab17721)	Homo sapiens	Treatment: LSD1 inhibitor OG86	NULL	2288	normal	O60341	AML (monocytes and acute myeloid leukemia)	PEAKS047967
EXP049354	anti-GFI1 (ab21061)	Homo sapiens	Treatment: DMSo vehicle	NULL	2288	normal	Q99684	AML (monocytes and acute myeloid leukemia)	PEAKS047968
EXP049355	anti-GFI1 (ab21061)	Homo sapiens	Treatment: LSD1 inhibitor OG86	NULL	2288	normal	Q99684	AML (monocytes and acute myeloid leukemia)	PEAKS047969
EXP049356	anti-MYB (ab45150) (Abcam)	Homo sapiens	Treatment: DMSo vehicle	NULL	2288	normal	P10242	AML (monocytes and acute myeloid leukemia)	PEAKS047970
EXP049357	anti-MYB (ab45150) (Abcam)	Homo sapiens	Treatment: LSD1 inhibitor OG86	NULL	2288	normal	P10242	AML (monocytes and acute myeloid leukemia)	PEAKS047971
EXP049359	anti-ZZZ3 (SAB4501106, WB 1:1000)	Homo sapiens	Genotype: shNT control vector	EXP049358	375	normal	Q8IYH5	NCI-H1299 (large cell lung carcinoma)	PEAKS047972
EXP049360	anti-ZZZ3 (SAB4501106, WB 1:1000)	Homo sapiens	Genotype: YEATS2 knockdown	EXP049358	375	normal	Q8IYH5	NCI-H1299 (large cell lung carcinoma)	PEAKS047973
EXP049362	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: no treatment	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	PEAKS047974
EXP049363	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: LPS	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	PEAKS047975
EXP049364	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	treatment: TNFalfa	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	PEAKS047976
EXP049365	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: Pam2CSK4	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	PEAKS047977
EXP049366	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: Poly I:C	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	PEAKS047978
EXP049367	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: M tri-DAP	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	PEAKS047979
EXP049371	SMAD3, Abcam 28379	Homo sapiens	Treatment: Untreated	EXP049368	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	PEAKS047980
EXP049372	pSMAD1/5, Cell Signaling Technologies 11971	Homo sapiens	Treatment: Untreated	EXP049368	2301	normal	Q15797	MDA-MB-231 (breast adenocarcinoma)	PEAKS047981
EXP049373	SMAD3, Abcam 28379	Homo sapiens	Treatment: 2 ng/mLTGF beta, 1 hr	EXP049369	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	PEAKS047982
EXP049374	pSMAD1/5, Cell Signaling Technologies 11971	Homo sapiens	Treatment: 2 ng/mLTGF beta, 1 hr	EXP049369	2301	normal	Q15797	MDA-MB-231 (breast adenocarcinoma)	PEAKS047983
EXP049375	anti-OCT4 (Active Motif: 39811: lot 16210001)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	Q01860	BJ (fibroblasts)	PEAKS047984
EXP049376	anti-V5 (M167-3; Lot 4)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	P43694	BJ (fibroblasts)	PEAKS047985
EXP049377	anti-V5 (M167-3; Lot 4)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells, FOXA2 and GATA4 coexpressing	NULL	93	normal	P43694	BJ (fibroblasts)	PEAKS047986
EXP049378	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: addition of 200 uM mimosine over night Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047987
EXP049379	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: addition of 200 uM mimosine over night Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047988
EXP049380	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Genotype: clonal FOXA2 doxycycline inducible cells, OXA2 GATA4 Coexpressing	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047989
EXP049381	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells, CDT1	NULL	93	normal	Q9Y261	BJ (fibroblasts)	PEAKS047990
EXP049385	anti-Che-1 (Bethyl, A301-032A)	Homo sapiens		EXP049383	646	normal	P06276	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS047992
EXP049390	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: vehicle (charcoal stripped) for 6 hrs  TF: full-length AR (AR-FL)	EXP049386	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047993
EXP049391	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: 10 nM DHT for 6 hrs TF: full-length AR (AR-FL)	EXP049387	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047994
EXP049392	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: 10 nM DHT+ 500 nM JQ1 for 6 hrs  TF: full-length AR (AR-FL)	EXP049388	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047995
EXP049393	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: 10 nM DHT+10 uM MDV3100 TF: full-length AR (AR-FL)	EXP049389	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS047996
EXP049394	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: vehicle (charcoal stripped) for 6 hrs	EXP049386	7	normal	O60885	22RV1 (prostate carcinoma)	PEAKS047997
EXP049395	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: 10 nM DHT for 6 hrs 	EXP049387	7	normal	O60885	22RV1 (prostate carcinoma)	PEAKS047998
EXP049396	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: 10 nM DHT + 500 nM JQ1 for 6 hrs 	EXP049388	7	normal	O60885	22RV1 (prostate carcinoma)	PEAKS047999
EXP049397	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: 10 nM DHT + 10 uM MDV3100 for 6 hrs 	EXP049389	7	normal	O60885	22RV1 (prostate carcinoma)	PEAKS048000
EXP049398	anti-ZFX (ThermoFisher)	Homo sapiens	Treatment: charcoal stripped	EXP049386	7	normal	P17010	22RV1 (prostate carcinoma)	PEAKS048001
EXP049399	anti-ZFX serum (from Dr Huck-Hui Ng)	Homo sapiens	Treatment: charcoal stripped	EXP049386	7	normal	P17010	22RV1 (prostate carcinoma)	PEAKS048002
EXP049401	Abcam ab45150 Anti-v-Myb and c-Myb	Homo sapiens	Treatment: none	EXP049400	641	normal	P10242	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS048003
EXP049402	Abcam ab45150 Anti-v-Myb and c-Myb	Homo sapiens	Treatment: TG3 control peptide	EXP049400	641	normal	P10242	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS048004
EXP049403	Abcam ab45150 Anti-v-Myb and c-Myb	Homo sapiens	Treatment: MYBMIM peptide	EXP049400	641	normal	P10242	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS048005
EXP049407	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 0h	EXP049404	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048006
EXP049408	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 1h	EXP049405	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048007
EXP049409	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 24h	EXP049406	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048008
EXP049410	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 0h	EXP049404	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048009
EXP049411	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 1h	EXP049405	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048010
EXP049412	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 24h	EXP049406	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048011
EXP049413	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 0h	EXP049404	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048012
EXP049414	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 1h	EXP049405	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048013
EXP049415	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 24h	EXP049406	620	normal	Q8N895	monocyte-derived dendritic cells	PEAKS048014
EXP049417	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Genotype: EWS/FLI knockdown Passage: 15-18	EXP049416	1086	normal	Q01844	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048015
EXP049418	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Treatment: EWS/FLI knockdown + {delta}22 rescue Passage: 15-18	EXP049416	1086	normal	Q01844	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048016
EXP049419	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Treatment: EWS/FLI knockdown + Mut9 rescue Passage: 15-18	EXP049416	1086	normal	Q01844	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048017
EXP049427	BRD2 (Bethyl Laboratories, A302-583A)	Homo sapiens	Treatment: untreated 	EXP049420	794	normal	P25440	SK-MEL-147 (melanoma)	PEAKS048018
EXP049428	BRD2 (Bethyl Laboratories, A302-583A)	Homo sapiens	Treatment: treated with 10nM JQ1 (JQ1(+)) for 6 hours	EXP049420	794	normal	P25440	SK-MEL-147 (melanoma)	PEAKS048019
EXP049429	BRD4 (Bethyl Laboratories, A301-985A)	Homo sapiens	Treatment: untreated 	EXP049420	794	normal	O60885	SK-MEL-147 (melanoma)	PEAKS048020
EXP049430	BRD4 (Bethyl Laboratories, A301-985A)	Homo sapiens	Treatment: treated with 10nM JQ1 (JQ1(+)) for 6 hours	EXP049420	794	normal	O60885	SK-MEL-147 (melanoma)	PEAKS048021
EXP049431	MED1 (Bethyl Laboratories, A300-793A)	Homo sapiens	Treatment: untreated	EXP049420	794	normal	O95243	SK-MEL-147 (melanoma)	PEAKS048022
EXP049440	AR (santacruz H-280)	Homo sapiens	Treatment: 24h ethanol	EXP049432	985	normal	P10275	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS048023
EXP049441	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049433	70	bio_control	P10275	LNCaP (prostate carcinoma)	PEAKS048024
EXP049442	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049434	2351	normal	P10275	LTAD (long term androgen deprivation)	PEAKS048025
EXP049443	COBLL1 (Abcam#64465)	Homo sapiens	Treatment: 24h ethanol	EXP049435	2351	normal	Q53SF7	LTAD (long term androgen deprivation)	PEAKS048026
EXP049444	PSF	Homo sapiens	Treatment: 24h ethanol	EXP049435	2351	normal	P23246	LTAD (long term androgen deprivation)	PEAKS048027
EXP049445	COBLL1 (Abcam#64465)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049436	2351	normal	Q53SF7	LTAD (long term androgen deprivation)	PEAKS048028
EXP049446	PSF (sigma#WH0006421M2)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049436	2351	normal	P23246	LTAD (long term androgen deprivation)	PEAKS048029
EXP049447	PSF (sigma#WH0006421M2)	Homo sapiens	Treatment: 24h DHT 10 nM siCTBP1-AS treated	EXP049436	2351	normal	P23246	LTAD (long term androgen deprivation)	PEAKS048030
EXP049448	PSF (sigma#WH0006421M2)	Homo sapiens	Treatment: 24h ethanol siCTBP1-AS treated	EXP049435	2351	normal	P23246	LTAD (long term androgen deprivation)	PEAKS048031
EXP049449	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 10 nM	EXP049437	2352	normal	P10275	VCaP and LTAD cells	PEAKS048032
EXP049450	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049437	2352	normal	P10275	VCaP and LTAD cells	PEAKS048033
EXP049451	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 10 nM siControl treated	EXP049438	2351	normal	P10275	LTAD (long term androgen deprivation)	PEAKS048034
EXP049452	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 10 nM siCOBLL1 treated	EXP049439	2351	normal	P10275	LTAD (long term androgen deprivation)	PEAKS048035
EXP049455	METTL3 (Bethyl Laboratories, #A301-568A,#1)	Homo sapiens	Genotype: wildtype	EXP049453	2219	normal	Q86U44	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS048036
EXP049456	METTL14 (Abcam, ab98166, #GR277753-1)	Homo sapiens	Genotype: wildtype	EXP049453	2219	normal	Q9HCE5	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS048037
EXP049465	IRF4 antibody (Santa Cruz Biotechnology, sc6059 and sc11450 (1:1 mix))	Homo sapiens		EXP049457	2353	normal	Q15306	KK1 (Adult T acute lymphoblastic leukemia)	PEAKS048038
EXP049466	IRF4 antibody (Santa Cruz Biotechnology, sc6059 and sc11450 (1:1 mix))	Homo sapiens		EXP049458	2354	normal	Q15306	ST-1 (Adult T acute lymphoblastic leukemia)	PEAKS048039
EXP049467	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: BirA enzyme were transduced with N-terminally tagged BATF3 (pRCMV/TO-flag-BIOTIN-BATF3-puro)	EXP049459	2354	normal	Q9NR55	ST-1 (Adult T acute lymphoblastic leukemia)	PEAKS048040
EXP049468	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: untreated 	EXP049460	2353	normal	Q9NR55	KK1 (Adult T acute lymphoblastic leukemia)	PEAKS048041
EXP049469	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: untreated 	EXP049461	2354	normal	Q9NR55	ST-1 (Adult T acute lymphoblastic leukemia)	PEAKS048042
EXP049470	Rabbit-polyclonal-HBZ serum 	Homo sapiens	Treatment: cells that stably expressed the BirA enzyme were transduced with N-terminally tagged HBZ (pRCMV/TO-flag-BIOTIN-HBZ-puro)	EXP049462	2353	normal	P02008	KK1 (Adult T acute lymphoblastic leukemia)	PEAKS048043
EXP049471	Rabbit-polyclonal-HBZ serum 	Homo sapiens	Treatment: cells that stably expressed the BirA enzyme were transduced with N-terminally tagged HBZ (pRCMV/TO-flag-BIOTIN-HBZ-puro)	EXP049463	2354	normal	P02008	ST-1 (Adult T acute lymphoblastic leukemia)	PEAKS048044
EXP049472	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: DMSO for 24 hrs	EXP049457	2353	normal	O60885	KK1 (Adult T acute lymphoblastic leukemia)	PEAKS048045
EXP049473	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: 500 nM JQ1 for 24 hrs	EXP049457	2353	normal	O60885	KK1 (Adult T acute lymphoblastic leukemia)	PEAKS048046
EXP049474	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: DMSO for 24 hrs	EXP049458	2354	normal	O60885	ST-1 (Adult T acute lymphoblastic leukemia)	PEAKS048047
EXP049475	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: 250 nM JQ1 for 24 hrs	EXP049458	2354	normal	O60885	ST-1 (Adult T acute lymphoblastic leukemia)	PEAKS048048
EXP049476	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: BirA enzyme were transduced with N-terminally tagged BATF3 (pRCMV/TO-flag-BIOTIN-BATF3-puro)	EXP049464	2353	normal	Q9NR55	KK1 (Adult T acute lymphoblastic leukemia)	PEAKS048049
EXP049479	PHOX2B (Santa Cruz, sc376997X,#H0712)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	Q99453	BE2C	PEAKS048050
EXP049480	HAND2 (Santa Cruz, sc9409X, #c230) 	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P61296	BE2C	PEAKS048051
EXP049481	GATA3 (Thermo Fisher, MA1028 , #PE203382)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P23771	Kelly (neuroblastoma)	PEAKS048052
EXP049482	n-Myc (Abcam, Ab16898, #GR291423-1)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P04198	BE2C	PEAKS048053
EXP049483	ISL1 (DSHB, 40.3A4, #8/22/13)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P61371	BE2C	PEAKS048054
EXP049484	TBX2 (Abcam, ab33298, #GR90328-1)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	Q13207	BE2C	PEAKS048055
EXP049485	ISL1 (DSHB, 40.3A4, #8/22/13)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P61371	Kelly (neuroblastoma)	PEAKS048056
EXP049486	HAND2 (Santa Cruz, sc9409X, #c230) 	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P61296	Kelly (neuroblastoma)	PEAKS048057
EXP049487	GATA3 (Thermo Fisher, MA1028 , #PE203382)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P23771	BE2C	PEAKS048058
EXP049488	n-Myc (Abcam, Ab16898, #GR291423-1)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P04198	Kelly (neuroblastoma)	PEAKS048059
EXP049489	PHOX2B (Santa Cruz,sc-376997, #A0517)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	Q99453	Kelly (neuroblastoma)	PEAKS048060
EXP049490	TBX2 (Abcam, ab33298, #GR90328-1)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	Q13207	Kelly (neuroblastoma)	PEAKS048061
EXP049491	E2F1 (BD-554213 and sc-193)	Homo sapiens	Treatment: CDT for 72 hrs Genotype: knockdown with shRB of RB	NULL	70	normal	Q01094	LNCaP (prostate carcinoma)	PEAKS048062
EXP049492	E2F1 (BD-554213 and sc-193)	Homo sapiens	Treatment: CDT for 72 hrs Genotype: knockdown with shCON of CON	NULL	70	normal	Q01094	LNCaP (prostate carcinoma)	PEAKS048063
EXP049515	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: wildtype ER-alfa	EXP049507	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048086
EXP049516	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: wildtype ER-alfa	EXP049508	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048087
EXP049517	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: wildtype ER-alfa 	EXP049509	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048088
EXP049518	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: wildtype ER-alfa 	EXP049510	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048089
EXP049519	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: transduced with ER-alfa L540Q	EXP049511	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048090
EXP049520	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: transduced with ER-alfa L540Q	EXP049512	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048091
EXP049521	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: transduced with ER-alfa L540Q	EXP049513	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048092
EXP049522	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: transduced with ER-alfa L540Q	EXP049514	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048093
EXP049525	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: wildtype ER-alfa	EXP049523	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048096
EXP049526	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: wildtype ER-alfa	EXP049524	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048097
EXP049530	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS048101
EXP049531	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS048102
EXP049532	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS048103
EXP049533	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS048104
EXP049534	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	PEAKS048105
EXP049535	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	PEAKS048106
EXP049536	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	PEAKS048107
EXP049537	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 45  min Genotype: ER-alfa L540Q	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	PEAKS048108
EXP049538	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	PEAKS048109
EXP049539	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	PEAKS048110
EXP049540	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	PEAKS048111
EXP049541	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa L540Q	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	PEAKS048112
EXP049542	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: transduced with ER-alfa L540Q	EXP049527	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	PEAKS048113
EXP049559	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS048130
EXP049560	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS048131
EXP049573	AR (sc-816; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS048144
EXP049574	AR (sc-816; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS048145
EXP049575	ARID1a (sc-32761x; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	O14497	LNCaP (prostate carcinoma)	PEAKS048146
EXP049576	ARID1a (sc-32761x; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	O14497	LNCaP (prostate carcinoma)	PEAKS048147
EXP049577	BRG1 (A300-813A; Bethyl)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	P51532	LNCaP (prostate carcinoma)	PEAKS048148
EXP049578	BRG1 (A300-813A; Bethyl)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	P51532	LNCaP (prostate carcinoma)	PEAKS048149
EXP049579	FOXA1 (sc-6554; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS048150
EXP049580	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS048151
EXP049581	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS048152
EXP049582	TLE3 (ab94972; Abcam)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q04726	LNCaP (prostate carcinoma)	PEAKS048153
EXP049583	TLE3 (ab94972; Abcam)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q04726	LNCaP (prostate carcinoma)	PEAKS048154
EXP049584	TRIM28 (ab10483; Abcam)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	PEAKS048155
EXP049585	TRIM28 (ab10483; Abcam)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	PEAKS048156
EXP049586	WDHD1 (m15-104; CDI labs)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	O75717	LNCaP (prostate carcinoma)	PEAKS048157
EXP049587	WDHD1 (m15-104; CDI labs)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	O75717	LNCaP (prostate carcinoma)	PEAKS048158
EXP049608	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: wildtype	EXP049588	514	bio_control	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048159
EXP049609	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: wildtype	EXP049589	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048160
EXP049610	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MORC2 knockout	EXP049590	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048161
EXP049611	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MORC2 knockout	EXP049591	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048162
EXP049612	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MPP8 knockout	EXP049592	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048163
EXP049613	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MPP8 knockout	EXP049593	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048164
EXP049614	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: TASOR knockout	EXP049594	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048165
EXP049615	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: TASOR knockout	EXP049595	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	PEAKS048166
EXP049616	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: wildtype	EXP049588	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048167
EXP049617	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: wildtype	EXP049589	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048168
EXP049618	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MORC2 knockout	EXP049590	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048169
EXP049619	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MORC2 knockout	EXP049591	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048170
EXP049620	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MPP8 knockout	EXP049592	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048171
EXP049621	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MPP8 knockout	EXP049593	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048172
EXP049622	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: TASOR knockout	EXP049594	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048173
EXP049623	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: TASOR knockout	EXP049595	514	normal	Q99549	K562 (myelogenous leukemia)	PEAKS048174
EXP049624	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: wildtype	EXP049588	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048175
EXP049625	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: wildtype	EXP049589	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048176
EXP049626	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: MORC2 knockout	EXP049590	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048177
EXP049627	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: MORC2 knockout	EXP049591	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048178
EXP049628	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens		EXP049592	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048179
EXP049629	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens		EXP049593	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048180
EXP049630	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: TASOR knockout	EXP049594	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048181
EXP049631	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: TASOR knockout	EXP049595	514	normal	Q9UK61	K562 (myelogenous leukemia)	PEAKS048182
EXP049632	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 400 nM BAY 1238097 (D4) Tissue: skin	EXP049634	2355	normal	O60885	CHL-1 (Melanoma)	PEAKS048183
EXP049635	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM OTX-015 Tissue: skin	EXP049637	2355	normal	O60885	CHL-1 (Melanoma)	PEAKS048186
EXP049638	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM DMSO Tissue: skin	EXP049640	2355	normal	O60885	CHL-1 (Melanoma)	PEAKS048189
EXP049641	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 400 nM BAY 1238097 (D4) Tissue: skin	EXP049643	2355	normal	O60885	CHL-1 (Melanoma)	PEAKS048192
EXP049644	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM OTX-015 Tissue: skin	EXP049646	2355	normal	O60885	CHL-1 (Melanoma)	PEAKS048195
EXP049647	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM DMSO Tissue: skin	EXP049649	2355	normal	O60885	CHL-1 (Melanoma)	PEAKS048198
EXP049652	GR (gift of Miles Pufall)	Homo sapiens	Treatment: EtOH for 4 hr	EXP049650	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048201
EXP049653	GR (gift of Miles Pufall)	Homo sapiens	Treatment: EtOH for 4 hr	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048202
EXP049654	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr	EXP049651	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048203
EXP049655	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048204
EXP049656	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-GFP transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048205
EXP049657	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-GFP transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048206
EXP049658	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-KLF15 transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048207
EXP049659	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-KLF15 transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	PEAKS048208
EXP049662	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 0.1% DMSO + 1 nM ethanol for 4 hrs	EXP049660	761	normal	P10275	R1-AD1 (prostate cancer)	PEAKS048209
EXP049663	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 0.1% DMSO + 1 nM DHT for 4 hrs	EXP049660	761	normal	P10275	R1-AD1 (prostate cancer)	PEAKS048210
EXP049664	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 50 uM VPC14449 + 1 nM ethanol for 4 hrs	EXP049660	761	normal	P10275	R1-AD1 (prostate cancer)	PEAKS048211
EXP049665	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 0.1% DMSO for 4 hrs	EXP049661	762	normal	P10275	R1-D567 (prostate cancer)	PEAKS048212
EXP049666	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 50 uM VPC14449 for 4 hrs	EXP049661	762	normal	P10275	R1-D567 (prostate cancer)	PEAKS048213
EXP049687	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049668	2357	normal	O15516	BA10 (brodmann area 10)	PEAKS048214
EXP049688	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049670	2357	normal	O15516	BA10 (brodmann area 10)	PEAKS048215
EXP049689	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049672	2357	normal	O15516	BA10 (brodmann area 10)	PEAKS048216
EXP049690	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049674	2357	normal	O15516	BA10 (brodmann area 10)	PEAKS048217
EXP049691	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049676	2357	normal	O15516	BA10 (brodmann area 10)	PEAKS048218
EXP049692	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049678	2358	normal	O15516	BA40 (brodmann area 40)	PEAKS048219
EXP049693	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049680	2358	normal	O15516	BA40 (brodmann area 40)	PEAKS048220
EXP049694	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049682	2358	normal	O15516	BA40 (brodmann area 40)	PEAKS048221
EXP049695	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049684	2358	normal	O15516	BA40 (brodmann area 40)	PEAKS048222
EXP049696	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049686	2358	normal	O15516	BA40 (brodmann area 40)	PEAKS048223
EXP049703	anti-TCF4	Homo sapiens	Treatment: none	EXP049701	664	normal	P15884	SH-SY5Y (neuroblastoma)	PEAKS048226
EXP049704	anti-TCF4	Homo sapiens	Treatment: none	EXP049702	664	normal	P15884	SH-SY5Y (neuroblastoma)	PEAKS048227
EXP049717	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	NULL	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	PEAKS048228
EXP049718	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: p3 -4	EXP049706	2359	normal	Q09472	CPCs (cardiac progenitor cancer cells)	PEAKS048229
EXP049719	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4	EXP049707	258	normal	Q09472	endothelial cells	PEAKS048230
EXP049720	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049710	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	PEAKS048231
EXP049721	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4 	EXP049709	2360	normal	Q09472	fibroblasts	PEAKS048232
EXP049722	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049710	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	PEAKS048233
EXP049723	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049711	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	PEAKS048234
EXP049724	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: p3 -4	EXP049712	2359	normal	Q09472	CPCs (cardiac progenitor cancer cells)	PEAKS048235
EXP049725	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4	EXP049713	258	normal	Q09472	endothelial cells	PEAKS048236
EXP049726	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049714	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	PEAKS048237
EXP049727	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4 	EXP049715	2360	normal	Q09472	fibroblasts	PEAKS048238
EXP049728	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049716	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	PEAKS048239
EXP049732	UCHL1 (R&D Systems: MAB6007)	Homo sapiens	Treatment: none Crosslinking: 1% formaldehyde	EXP049729	223	normal	P09936	DU145 (prostate carcinoma)	PEAKS048240
EXP049733	UCHL1 (R&D Systems: MAB6007)	Homo sapiens	Treatment: none Crosslinking: 1mM DSP and 1% formaldehyde	EXP049730	223	normal	P09936	DU145 (prostate carcinoma)	PEAKS048241
EXP049734	UCHL1 (R&D Systems: MAB6007)	Homo sapiens	Treatment: none Crosslinking: 1mM DSP and 1% formaldehyde	EXP049731	10	normal	P09936	HEK293T (embryonic kidney)	PEAKS048242
EXP049743	BAP1_NTD (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q92560	CAL51(Breast carcinoma)	PEAKS048243
EXP049744	BAP1_NTD (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q92560	CAL51(Breast carcinoma)	PEAKS048244
EXP049745	Suz12(CST)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q86V15	CAL51(Breast carcinoma)	PEAKS048245
EXP049746	Suz12(CST)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q86V15	CAL51(Breast carcinoma)	PEAKS048246
EXP049747	MLL3_MR (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: MLL3 Exon8 knockout	EXP049736	2361	normal	Q8NEZ4	CAL51(Breast carcinoma)	PEAKS048247
EXP049748	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: UTX knockout	EXP049739	2361	normal	O15550	CAL51(Breast carcinoma)	PEAKS048248
EXP049749	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: UTX wildtype	EXP049740	2361	normal	O15550	CAL51(Breast carcinoma)	PEAKS048249
EXP049750	BAP1_FL (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q92560	CAL51(Breast carcinoma)	PEAKS048250
EXP049751	BAP1_FL (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q92560	CAL51(Breast carcinoma)	PEAKS048251
EXP049752	MLL3_MR (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q8NEZ4	CAL51(Breast carcinoma)	PEAKS048252
EXP049753	MLL3_MR (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q8NEZ4	CAL51(Breast carcinoma)	PEAKS048253
EXP049754	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	O15550	CAL51(Breast carcinoma)	PEAKS048254
EXP049755	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	O15550	CAL51(Breast carcinoma)	PEAKS048255
EXP049756	CTCF (abcam, ab70303)	Homo sapiens	Genotype: wildtype	NULL	455	normal	P49711	HUES64 (embryonic stem cells)	PEAKS048256
EXP049757	CTCF (abcam, ab70303)	Homo sapiens	Genotype: CTCF knockout	NULL	455	normal	P49711	HUES64 (embryonic stem cells)	PEAKS048257
EXP049758	RAD21 (abcam, ab992)	Homo sapiens	Genotype: RAD21 wildtype	NULL	455	normal	O60216	HUES64 (embryonic stem cells)	PEAKS048258
EXP049759	RAD21 (abcam, ab992)	Homo sapiens	Genotype: RAD21 knockout	NULL	455	normal	O60216	HUES64 (embryonic stem cells)	PEAKS048259
EXP049761	ARID5B antibody (HPA015037, Sigma)	Homo sapiens		EXP049760	509	normal	Q14865	Jurkat (T-cells)	PEAKS048260
EXP049763	PAF1 (Santa Cruz, catalog# sc-74797)	Homo sapiens		EXP049762	417	normal	P28328	HCT-116 (colon carcinoma)	PEAKS048261
EXP049764	PAF1 (Abcam, catalog# ab20662, lot# GR243511-1)	Homo sapiens		EXP049762	417	normal	P28328	HCT-116 (colon carcinoma)	PEAKS048262
EXP049765	HA (ROCHE #11867423001)	Homo sapiens	GFP	NULL	288	bio_control	O14503	A673 (Ewing sarcoma)	PEAKS048263
EXP049766	HA (ROCHE #11867423001)	Homo sapiens		NULL	288	normal	Q01844	A673 (Ewing sarcoma)	PEAKS048264
EXP049767	SMARCA2 (Active Motif #39805)	Homo sapiens	shEWSFLI1	NULL	289	normal	P51531	SK-N-MC (Askin tumor)	PEAKS048265
EXP049768	SMARCA2 (Active Motif #39805)	Homo sapiens	shGFP	NULL	289	normal	P51531	SK-N-MC (Askin tumor)	PEAKS048266
EXP049769	BAF155 (generated in-house epitope=aa924-1004; C-terminus)	Homo sapiens		NULL	289	normal	Q92922	SK-N-MC (Askin tumor)	PEAKS048267
EXP049770	BAF155 (generated in-house epitope=aa924-1004; C-terminus)	Homo sapiens	shEWSFLI1	NULL	289	normal	Q92922	SK-N-MC (Askin tumor)	PEAKS048268
EXP049771	BAF155 (generated in-house epitope=aa924-1004; C-terminus)	Homo sapiens	shGFP	NULL	289	normal	Q92922	SK-N-MC (Askin tumor)	PEAKS048269
EXP049773	Anti-ONECUT2 antibody produced in rabbit (Sigma-Aldrich, catalog#)	Homo sapiens		EXP049772	7	normal	O95948	22RV1 (prostate carcinoma)	PEAKS048270
EXP049776	MAML1 (Cell Signaling, catalog #12166)	Homo sapiens	Treatment: untreated	NULL	2363	normal	Q92585	REC-1 (Mantle cell lymphoma)	PEAKS048271
EXP049777	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: untreated 	NULL	2363	normal	Q06330	REC-1 (Mantle cell lymphoma)	PEAKS048272
EXP049778	MAML1 (Cell Signaling, catalog #12166)	Homo sapiens	Treatment: untreated 	EXP049774	2364	normal	Q92585	SP-49 (Mantle cell lymphoma)	PEAKS048273
EXP049779	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: untreated 	EXP049774	2364	normal	Q06330	SP-49 (Mantle cell lymphoma)	PEAKS048274
EXP049780	NICD1 (Cell Signaling, catalog #4147)	Homo sapiens	Treatment: GSI-mock-washout	NULL	2363	normal	P46531	REC-1 (Mantle cell lymphoma)	PEAKS048275
EXP049781	NICD1 (Cell Signaling, catalog #4147)	Homo sapiens	Treatment: GSI-washout	NULL	2363	normal	P46531	REC-1 (Mantle cell lymphoma)	PEAKS048276
EXP049782	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: GSI-mock-washout	NULL	2363	normal	Q06330	REC-1 (Mantle cell lymphoma)	PEAKS048277
EXP049783	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: GSI-washout	NULL	2363	normal	Q06330	REC-1 (Mantle cell lymphoma)	PEAKS048278
EXP049785	BMI1 antibody	Homo sapiens		EXP049784	130	normal	P35226	LNCaP C4-2 (prostate carcinoma)	PEAKS048279
EXP049786	AR antibody	Homo sapiens		EXP049784	130	normal	P10275	LNCaP C4-2 (prostate carcinoma)	PEAKS048280
EXP049791	c-myb (Bethyl, catalog# A304-136A, lot# A304-136A-1)	Homo sapiens	Treatment: 3 mg/mL vehicle for 3 days	EXP049787	65	normal	P10242	U937 (adult acute monocytic leukemia)	PEAKS048281
EXP049792	c-myb (Bethyl, catalog# A304-136A, lot# A304-136A-1)	Homo sapiens	Treatment: 3 mg/mL ATRA for 3 days	EXP049788	65	normal	P10242	U937 (adult acute monocytic leukemia)	PEAKS048282
EXP049793	RAR (Santa Cruz, catalog# sc-773X, lot# B1715)	Homo sapiens	Treatment: 3 mg/mL vehicle for 3 days	EXP049789	65	normal	P10276	U937 (adult acute monocytic leukemia)	PEAKS048283
EXP049794	RAR (Santa Cruz, catalog# sc-773X, lot# B1715)	Homo sapiens	Treatment: 3 mg/mL ATRA for 3 days	EXP049790	65	normal	P10276	U937 (adult acute monocytic leukemia)	PEAKS048284
EXP049795	GABP-a (Santa Cruz sc-28312 X)	Homo sapiens	Treatment: 100 nM ethanol for 24 hrs	NULL	2334	normal	Q06546	THP-1 (acute monocytic leukemia)	PEAKS048285
EXP049796	GABP-a (Santa Cruz sc-28312 X)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 24 hrs	NULL	2334	normal	Q06546	THP-1 (acute monocytic leukemia)	PEAKS048286
EXP049800	Hoxc5 (HPA026794, Sigma, lot# R28092)	Homo sapiens	Hoxc5 overexpression	EXP049797	725	normal	Q00444	PC3(bone mets prostate adenocarcinoma)	PEAKS048287
EXP049801	PBX4 (HPA049859, Sigma, lot# R59734)	Homo sapiens	Pbx4 overexpression	EXP049798	725	normal	Q9BYU1	PC3(bone mets prostate adenocarcinoma)	PEAKS048288
EXP049802	Hoxc5 (HPA026794, Sigma, lot# R28092)	Homo sapiens		EXP049799	725	normal	Q00444	PC3(bone mets prostate adenocarcinoma)	PEAKS048289
EXP049805	alpha-HMGB1 (4F10), DSHB	Homo sapiens	proliferating	EXP049803	472	normal	P09429	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS048290
EXP049806	hmgb2	Homo sapiens	proliferating	EXP049803	472	normal	P26583	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS048291
EXP049807	alpha-HMGB2, ab67282, Abcam, lot# GR149806	Homo sapiens	proliferating	EXP049804	489	normal	P26583	IMR90 (lung fibroblasts)	PEAKS048292
EXP049808	alpha-HMGB2, ab67282, Abcam, lot# GR149806	Homo sapiens	senescent	EXP049804	489	normal	P26583	IMR90 (lung fibroblasts)	PEAKS048293
EXP049809	alpha-HMGB1, ab18256, Abcam	Homo sapiens	proliferating	EXP049804	489	normal	P09429	IMR90 (lung fibroblasts)	PEAKS048294
EXP049814	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: 24hrs, Oligomycin Genotype: wildtype Tissue: spleen	EXP049810	2366	normal	Q61550	activated B-cells	PEAKS048295
EXP049815	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: no	EXP049811	2366	normal	Q61550	activated B-cells	PEAKS048296
EXP049816	Nipbl (Bethyl Laboratories; A301-779A)	Mus musculus	Genotype: wildtype Tissue: spleen	NULL	2367	normal	Q6KCD5	ES cells (plasmacytomas)	PEAKS048297
EXP049817	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: flavopiridol 2 hrs Genotype: wildtype Tissue: spleen	NULL	2366	normal	Q61550	activated B-cells	PEAKS048298
EXP049818	Anti-NIPBL (Bethy Laboratories; catalog# A301-779A, lot# A301-779A-3)	Mus musculus	Treatment: for activating 24 hr treatment Genotype: wildtype Tissue: spleen	NULL	2366	normal	Q6KCD5	activated B-cells	PEAKS048299
EXP049819	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment:  for activating 24 hr treatment Genotype: wildtype Tissue: spleen	NULL	2366	normal	Q61550	activated B-cells	PEAKS048300
EXP049820	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: no Genotype: wildtype 	EXP049812	178	normal	Q61550	CH12 (lymphoma)	PEAKS048301
EXP049821	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: no Genotype: CTCFmZF9to11 	EXP049812	178	normal	Q61550	CH12 (lymphoma)	PEAKS048302
EXP049822	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: wildtype 	EXP049812	178	normal	Q61164	CH12 (lymphoma)	PEAKS048303
EXP049823	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: CTCFmZF9to11 	EXP049812	178	normal	Q61164	CH12 (lymphoma)	PEAKS048304
EXP049824	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: wildtype 	NULL	2367	normal	Q61164	ES cells (plasmacytomas)	PEAKS048305
EXP049825	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: SA deletion	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS048306
EXP049826	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: half SA deletion	NULL	80	normal	A1A546	B lymphoblastic leukemia	PEAKS048307
EXP049827	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: activating 30 hrs and HU treated  Genotype: wildtype	EXP049813	2366	normal	A1A546	activated B-cells	PEAKS048308
EXP049828	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: activated, 30hr, UH no treated Genotype: wildtype	EXP049813	2366	normal	Q61164	activated B-cells	PEAKS048309
EXP049829	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: activated, 24 hrs Genotype: wildtype	EXP049813	2366	normal	A1A546	activated B-cells	PEAKS048310
EXP049830	Nipbl (Bethyl Laboratories; A301-779A)	Mus musculus	Treatment: activated, 30 hrs, HU treated Genotype: wildtype	NULL	2366	normal	Q6KCD5	activated B-cells	PEAKS048311
EXP049831	Nipbl (Bethyl Laboratories; A301-779A)	Mus musculus	Treatment: activated, 30 hrs, HU untreated Genotype: wildtype	NULL	2366	normal	A1A546	activated B-cells	PEAKS048312
EXP049832	abcam; ab992	Mus musculus	Treatment: activated, 30 hrs, HU treated Genotype: wildtype	NULL	2366	normal	A1A546	activated B-cells	PEAKS048313
EXP049833	abcam; ab992	Mus musculus	Treatment: activated, 30 hrs, HU untreated Genotype: wildtype	NULL	2366	normal	A1A546	activated B-cells	PEAKS048314
EXP049834	anti-lamin A/C (Santa Cruz sc-7292)	Homo sapiens		NULL	1572	normal	P02545	skin fibroblast	PEAKS048315
EXP049835	anti-lamin B1 (rabbit polyclonal; Abcam, cat# 16048)	Homo sapiens		NULL	1572	normal	P20700	skin fibroblast	PEAKS048316
EXP049838	Anti-BCL11a polyclonal (Bethyl Labs BL1797)	Homo sapiens		EXP049836	646	normal	Q9H165	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS048317
EXP049839	Anti-BCL11a polyclonal (Bethyl Labs BL1797)	Homo sapiens		EXP049837	767	normal	Q9H165	Raji (Burkitt lymphoma)	PEAKS048318
EXP049841	BRD2 (Proteintech, 22236-1-AP)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	P25440	U87 (glioblastoma)	PEAKS048319
EXP049842	BRD2 (Proteintech, 22236-1-AP)	Homo sapiens	Treatment: 500 nM dBET6 for 24 hr	EXP049840	849	normal	P25440	U87 (glioblastoma)	PEAKS048320
EXP049843	BRD2 (Proteintech, 22236-1-AP)	Homo sapiens	Treatment: 500 nM dBET6 for 2 hr	EXP049840	849	normal	P25440	U87 (glioblastoma)	PEAKS048321
EXP049844	BRD3 (Bethyl, A302-367A)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	Q15059	U87 (glioblastoma)	PEAKS048322
EXP049845	BRD3 (Bethyl, A302-367A)	Homo sapiens	Treatment: 500 nM dBET6 for 24 hr	EXP049840	849	normal	Q15059	U87 (glioblastoma)	PEAKS048323
EXP049846	BRD3 (Bethyl, A302-367A)	Homo sapiens	Treatment: 500 nM dBET6 for 2 hr	EXP049840	849	normal	Q15059	U87 (glioblastoma)	PEAKS048324
EXP049847	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	O60885	U87 (glioblastoma)	PEAKS048325
EXP049848	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500 nM dBET6 for 24 hr	EXP049840	849	normal	O60885	U87 (glioblastoma)	PEAKS048326
EXP049849	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500 nM dBET6 for 2 hr	EXP049840	849	normal	O60885	U87 (glioblastoma)	PEAKS048327
EXP049850	E2F1 (Cell Signalling Technology, 3742S)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	Q01094	U87 (glioblastoma)	PEAKS048328
EXP049851	BRD4 (Bethyl, A301-985A, A301-985A-1)	Homo sapiens	Treatment: DMSO	NULL	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS048329
EXP049852	BRD4 (Bethyl, A301-985A, A301-985A-1)	Homo sapiens	Treatment: JQ1 2 hrs 	NULL	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS048330
EXP049853	BRD4 (Bethyl, A301-985A, A301-985A-1)	Homo sapiens	Treatment: JQ1 6 hrs 	NULL	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS048331
EXP049854	NUP98 (Cell Signaling, C39a3, 2598)	Homo sapiens	Treatment: no	NULL	514	normal	P52948	K562 (myelogenous leukemia)	PEAKS048332
EXP049855	NUP153 (BioLegend, 906201, B215613)	Homo sapiens	Ntreatment: no	NULL	514	normal	P49790	K562 (myelogenous leukemia)	PEAKS048333
EXP049863	CTNNB1 	Homo sapiens	Treatment: Activin A for 15 hr Genotype: wildtype	EXP049856	376	normal	P35222	WA01 (H1, human embryonic stem cells)	PEAKS048334
EXP049864	beta-Catenin	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	EXP049859	376	normal	P35222	WA01 (H1, human embryonic stem cells)	PEAKS048335
EXP049865	Smad2_3	Homo sapiens	Treatment: Activin A for 15 hr Genotype: wildtype	EXP049856	376	normal	Q15796	WA01 (H1, human embryonic stem cells)	PEAKS048336
EXP049866	Smad2_3	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	EXP049859	376	normal	Q15796	WA01 (H1, human embryonic stem cells)	PEAKS048337
EXP049867	TEAD4	Homo sapiens	Treatment: None Genotype: wildtype hESC	EXP049858	376	normal	Q15561	WA01 (H1, human embryonic stem cells)	PEAKS048338
EXP049868	YAP	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP wildtype	EXP049857	376	normal	P46937	WA01 (H1, human embryonic stem cells)	PEAKS048339
EXP049869	YAP	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	EXP049862	376	normal	P46937	WA01 (H1, human embryonic stem cells)	PEAKS048340
EXP049872	anti-APC (a polyclonal antibody recognizing the C-terminal 50 amino acids of APC, catalog #A300-981A, Bethyl Laboratories, Inc.)	Homo sapiens	Genotype: APC wildtype, CTNNB1{delta}Ser45	EXP049870	417	normal	P25054	HCT-116 (colon carcinoma)	PEAKS048341
EXP049873	anti-APC (a polyclonal antibody recognizing the C-terminal 50 amino acids of APC, catalog #A300-981A, Bethyl Laboratories, Inc.)	Homo sapiens	Genotype: APC wildtype, CTNNB1{delta}Ser45	EXP049871	417	normal	P25054	HCT-116 (colon carcinoma)	PEAKS048342
EXP049877	anti-TFCP2 (CST #80784)	Homo sapiens		EXP049874	2368	normal	Q12800	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	PEAKS048343
EXP049878	anti-TFCP2 (CST #80784)	Homo sapiens		EXP049875	2368	normal	Q12800	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	PEAKS048344
EXP049879	anti-TFCP2 (CST #80784)	Homo sapiens		EXP049876	2368	normal	Q12800	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	PEAKS048345
EXP049880	anti-YAP (CST #14074)	Homo sapiens		EXP049874	2368	normal	P46937	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	PEAKS048346
EXP049881	anti-YAP (CST #14074)	Homo sapiens		EXP049875	2368	normal	P46937	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	PEAKS048347
EXP049882	anti-YAP (CST #14074)	Homo sapiens		EXP049876	2368	normal	P46937	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	PEAKS048348
EXP049885	TET1	Homo sapiens	Treatment: no Genotype: wildtype	EXP049883	2369	normal	Q8NFU7	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS048349
EXP049886	DNMT3B	Homo sapiens	Treatment: no Genotype: wildtype	EXP049883	2369	normal	Q9UBC3	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS048350
EXP049887	DNMT3B	Homo sapiens	Treatment: no Genotype: Inactivating mutations in TET1, TET2 and TET3	EXP049884	2369	normal	Q9UBC3	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS048351
EXP049892	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS048352
EXP049893	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS048353
EXP049894	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS048354
EXP049895	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS048355
EXP049896	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048356
EXP049897	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048357
EXP049898	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048358
EXP049899	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048359
EXP049900	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS048360
EXP049901	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS048361
EXP049902	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS048362
EXP049903	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P55317	T47D (invasive ductal carcinoma)	PEAKS048363
EXP049904	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048364
EXP049905	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048365
EXP049906	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048366
EXP049907	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS048367
EXP049910	YY1(Santa Cruz, 281X)	Mus musculus		EXP049908	252	normal	Q00899	V6.5 (embryonic stem cells)	PEAKS048368
EXP049911	YY1(Abcam, ab109237)	Homo sapiens		EXP049909	509	normal	P25490	Jurkat (T-cells)	PEAKS048369
EXP049915	GR	Mus musculus	Treatment: untreated Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	NULL	373	normal	P06537	granulocyte macrophage progenitors	PEAKS048370
EXP049916	GR	Mus musculus	Treatment: Dex, 100nm, 45 min Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	NULL	373	normal	P06537	granulocyte macrophage progenitors	PEAKS048371
EXP049917	GR	Homo sapiens	Treatment: untreated Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	P04150	THP-1 (acute monocytic leukemia)	PEAKS048372
EXP049918	GR	Homo sapiens	Treatment: Dex, 100 nM, 1hour Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	P04150	THP-1 (acute monocytic leukemia)	PEAKS048373
EXP049919	Ncoa2	Homo sapiens	Treatment: untreated Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	PEAKS048374
EXP049920	GRIP1	Homo sapiens	Treatment: Dex, 100nm, 1hour Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	PEAKS048375
EXP049921	pS469-GRIP1	Homo sapiens	Treatment: untreated Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	PEAKS048376
EXP049922	pS469-GRIP1	Homo sapiens	Treatment: Dex, 100nm, 1hour Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	PEAKS048377
EXP049923	GRIP1	Mus musculus	Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	EXP049914	373	normal	Q61026	granulocyte macrophage progenitors	PEAKS048378
EXP049924	GRIP1	Mus musculus	Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	EXP049914	373	normal	Q61026	granulocyte macrophage progenitors	PEAKS048379
EXP049936	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM DHT for 45 mins Genotype: ER+/PR+	EXP049927	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048380
EXP049937	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10nM Estradiol + 10 nM DHT for 45 mins Genotype: ER+/PR+	EXP049928	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048381
EXP049938	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: Vehicle for 60 mins Genotype: ER+/PR+	EXP049929	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048382
EXP049939	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM Estradiol for 75 mins Genotype: ER+/PR+	EXP049930	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048383
EXP049940	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+	EXP049931	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048384
EXP049941	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 15 mins of 10nM Estradiol and then 10nM Estradiol + 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+	EXP049932	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048385
EXP049942	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM Aldosterone for 45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048386
EXP049943	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10nM Estradiol + 10 nM Aldosterone for 45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048387
EXP049944	none (INPUT)	Homo sapiens	10nM Estradiol + 10 nM Dexamethasone	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048388
EXP049945	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: Vehicle for4 hrs Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048389
EXP049946	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM E2 for4 hrs Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048390
EXP049947	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM R5020 for45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048391
EXP049948	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM E2 + 10 nM R5020 for45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048392
EXP049949	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatmet: Vehicle, 45 min Genotype: ER+/PR+	EXP049925	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048393
EXP049950	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM Estradiol for 45 mins Genotype: ER+/PR+	EXP049926	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS048394
EXP049959	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049955	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048397
EXP049960	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049956	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048398
EXP049961	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049957	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048399
EXP049962	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049958	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	PEAKS048400
EXP049963	C/EBPÃŽÂ² (Santa Cruz, sc-150x)	Mus musculus		NULL	2372	normal	P28033	32D	PEAKS048401
EXP049964	JMJD3 (Abcam, ab85392)	Mus musculus		NULL	2372	normal	Q5NCY0	32D	PEAKS048402
EXP049967	STAT3 (Santa Cruz, sc-482x, lot B0615)	Mus musculus	Strain: B6D2F1 Genotype: CD34 positive	EXP049965	253	normal	P42227	EML -C1(EML, clone 1)	PEAKS048403
EXP049968	SOX4 (Santa Cruz, sc-17326x, lot D2012)	Mus musculus	Strain: B6D2F1 Genotype: CD34 positive	EXP049965	253	normal	Q06831	EML -C1(EML, clone 1)	PEAKS048404
EXP049969	GABPa (Santa Cruz, sc-22810x, lot c2912)	Mus musculus	Strain: B6D2F1 Genotype: CD34 negative	EXP049966	253	normal	Q00422	EML -C1(EML, clone 1)	PEAKS048405
EXP049971	anti-Cebpa (Santa Cruz, sc-61)	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	EXP049970	2373	normal	P53566	MA9 transformed mouse leukemia	PEAKS048406
EXP049972	anti-Cebpa (Santa Cruz, sc-61)	Mus musculus	Treatment: LSD1 inhibitor GSK-LSD1 Genotype: MLL-AF9 fusion	EXP049970	2373	normal	P53566	MA9 transformed mouse leukemia	PEAKS048407
EXP049973	anti-LSD1 (Abcam, ab17721)	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	EXP049970	2373	normal	Q6ZQ88	MA9 transformed mouse leukemia	PEAKS048408
EXP049974	anti-PU.1 (Santa Cruz, sc-352)	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	EXP049970	2373	normal	O35295	MA9 transformed mouse leukemia	PEAKS048409
EXP049975	anti-PU.1 (Santa Cruz, sc-352)	Mus musculus	Treatment: LSD1 inhibitor GSK-LSD1 Genotype: MLL-AF9 fusion	EXP049970	2373	normal	O35295	MA9 transformed mouse leukemia	PEAKS048410
EXP049984	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00153981)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049978	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048411
EXP049985	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00127062)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049980	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048412
EXP049986	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00153981)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049983	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048413
EXP049987	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00144219)	Mus musculus	Treatment: DMSO treatment for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049976	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048414
EXP049988	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00127062)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049977	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048415
EXP049989	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00144219)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 9hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049979	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048416
EXP049990	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00127062)	Mus musculus	Treatment: 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049981	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048417
EXP049991	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00144219)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs in TIM KD MEFs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049982	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	PEAKS048418
EXP049996	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049992	2	normal	A2A935	mESCs (mouse embryonic stem cells)	PEAKS048419
EXP049997	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1 knockout Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049993	2	normal	A2A935	mESCs (mouse embryonic stem cells)	PEAKS048420
EXP049998	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049994	2	normal	A2A935	mESCs (mouse embryonic stem cells)	PEAKS048421
EXP049999	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1 knockout Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049995	2	normal	A2A935	mESCs (mouse embryonic stem cells)	PEAKS048422
EXP050002	anit-Flag M2 (Sigma, F1804)	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype 	EXP050000	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS048423
EXP050003	anti-Tet1	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype 	EXP050000	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS048424
EXP050004	anit-Flag M2 (Sigma, F1804)	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a knockout	EXP050001	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS048425
EXP050005	anti-Tet1	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a knockout	EXP050001	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS048426
EXP050008	PU.1 (Santa Cruz Biotechnology, #sc-352)	Mus musculus	Strain: C57BL/6 Genotype: UTX wildtype	EXP050006	549	normal	P17433	Lin- bone marrow hematopoietic progenitor cells	PEAKS048427
EXP050009	PU.1 (Santa Cruz Biotechnology, #sc-352)	Mus musculus	Strain: C57BL/6 Genotype: UTX knockout	EXP050007	549	normal	P17433	Lin- bone marrow hematopoietic progenitor cells	PEAKS048428
EXP050010	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: brain 	NULL	919	normal	Q91VN1	oligodendrocyte progenitors	PEAKS048429
EXP050011	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: Zfp191knockout  Tissue: brain 	NULL	919	normal	Q91VN1	oligodendrocyte progenitors	PEAKS048430
EXP050012	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: wildtype  Tissue: brain Developmental stage: postnatal day (P) 7 	NULL	2374	normal	Q91VN1	oligodendrocyte	PEAKS048431
EXP050013	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: Zfp191 knockout  Tissue: brain Developmental stage: postnatal day (P) 7 	NULL	2374	normal	Q91VN1	oligodendrocyte	PEAKS048432
EXP050018	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050014	18	normal	O09100	3T3-L1 (embryonic fibroblasts)	PEAKS048433
EXP050019	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050015	18	normal	O09100	3T3-L1 (embryonic fibroblasts)	PEAKS048434
EXP050020	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050016	127	normal	O09100	C3H10T1/2 (embryonic fibroblasts)	PEAKS048435
EXP050021	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050017	127	normal	O09100	C3H10T1/2 (embryonic fibroblasts)	PEAKS048436
EXP050025	Hdac1 antibody, Diagenode (cat# C15410325-50)	Mus musculus	Strain: C57BL/6 Passage: 16-19 Treatment: no treatment Cell line:Bry	EXP050022	275	normal	O09106	embryonic stem cell-derived hemogenic endothelium	PEAKS048437
EXP050026	Hdac2 antibody, abcam (cat# ab7029)	Mus musculus	Strain: C57BL/6 Passage: 16-19 Treatment: no treatment Cell line:Bry	EXP050022	275	normal	P70288	embryonic stem cell-derived hemogenic endothelium	PEAKS048438
EXP050027	Hdac1 antibody, Diagenode (cat# C15410325-50)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment  Cell line:Hd1loxlox	EXP050023	275	normal	O09106	embryonic stem cell-derived hemogenic endothelium	PEAKS048439
EXP050028	Hdac2 antibody, abcam (cat# ab7029)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment  Cell line:Hd1loxlox	EXP050024	275	normal	P70288	embryonic stem cell-derived hemogenic endothelium	PEAKS048440
EXP050029	Hdac1 antibody, Diagenode (cat# C15410325-50)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment Cell line:Hd2lox 	EXP050024	275	normal	O09106	embryonic stem cell-derived hemogenic endothelium	PEAKS048441
EXP050030	Hdac2 antibody, abcam (cat# ab7029)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment Cell line:Hd2lox 	EXP050024	275	normal	P70288	embryonic stem cell-derived hemogenic endothelium	PEAKS048442
EXP050047	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050031	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048443
EXP050048	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050032	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048444
EXP050049	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050033	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048445
EXP050050	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050034	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048446
EXP050051	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050035	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048447
EXP050052	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050036	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048448
EXP050053	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050031	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048449
EXP050054	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050032	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048450
EXP050055	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050033	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048451
EXP050056	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050034	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048452
EXP050057	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050035	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048453
EXP050058	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050036	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048454
EXP050059	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050037	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048455
EXP050060	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050037	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048456
EXP050061	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050038	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048457
EXP050062	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050038	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048458
EXP050063	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050039	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048459
EXP050064	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050040	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048460
EXP050065	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050041	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048461
EXP050066	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050042	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048462
EXP050067	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050043	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048463
EXP050068	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050044	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048464
EXP050069	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050045	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048465
EXP050070	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050046	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048466
EXP050071	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050039	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048467
EXP050072	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050040	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048468
EXP050073	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050041	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048469
EXP050074	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050042	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048470
EXP050075	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050043	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048471
EXP050076	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050044	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048472
EXP050077	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050045	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048473
EXP050078	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050046	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	PEAKS048474
EXP050079	Mouse anti-HA tag (Diagenode, catalog# C15200190, lot# 001)	Mus musculus	Treatment: 1 ug/mL Dox for 18 hours Genotype: pINDUCER20b-HA-NUR77	NULL	91	normal	P12813	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS048475
EXP050085	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048476
EXP050086	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048477
EXP050087	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048478
EXP050088	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048479
EXP050089	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048480
EXP050090	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048481
EXP050091	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048482
EXP050092	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	PEAKS048483
EXP050093	OCT4 (Santa Cruz, SC8628)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	P20263	V6.5 (embryonic stem cells)	PEAKS048484
EXP050094	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048485
EXP050095	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048486
EXP050096	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048487
EXP050097	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048488
EXP050098	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048489
EXP050099	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048490
EXP050100	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	PEAKS048491
EXP050101	MYC (Santa Cruz, sc 764)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	P01108	V6.5 (embryonic stem cells)	PEAKS048492
EXP050102	MYC (Santa Cruz, sc 764)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	906	normal	P01108	induced pluripotent stem cells	PEAKS048493
EXP050103	MYC (Santa Cruz, sc 764)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	595	normal	P01108	MEF-1 (mouse embryonic fibroblasts)	PEAKS048494
EXP050104	R&D AF3158	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048495
EXP050105	R&D AF3158	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048496
EXP050106	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048497
EXP050107	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048498
EXP050108	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048499
EXP050109	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048500
EXP050110	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048501
EXP050111	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	PEAKS048502
EXP050112	R&D AF3158	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	Q60793	V6.5 (embryonic stem cells)	PEAKS048503
EXP050113	R&D AF3158	Mus musculus	Genotype: Mbd3f/- cell line	NULL	906	normal	Q60793	induced pluripotent stem cells	PEAKS048504
EXP050114	R&D AF3158	Mus musculus	Genotype: Mbd3f/- cell line	NULL	595	normal	Q60793	MEF-1 (mouse embryonic fibroblasts)	PEAKS048505
EXP050115	Millipore AB5603	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048506
EXP050116	Millipore AB5603	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048507
EXP050117	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048508
EXP050118	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048509
EXP050119	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048510
EXP050120	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048511
EXP050121	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048512
EXP050122	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	PEAKS048513
EXP050123	Millipore AB5603	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	A1A546	V6.5 (embryonic stem cells)	PEAKS048514
EXP050124	Millipore AB5603	Mus musculus	Genotype: Mbd3f/- cell line	NULL	906	normal	A1A546	induced pluripotent stem cells	PEAKS048515
EXP050125	OCT4 (Santa Cruz, SC8628)	Mus musculus	Genotype: MBD3flox/- Treatment: DOX inducible OSKM reprogramming Title: reanalyzed for GSE49766 	NULL	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	PEAKS048516
EXP050126	Rad21 (cat# Ab992)	Mus musculus	Sex: male Strain: Crl:CD1(ICR) (Charles River, strain code #022)	NULL	5	normal	Q61550	liver	PEAKS048517
EXP050127	Millipore anti CTCF (cat# 07-779)	Mus musculus	Sex: male Strain: Crl:CD1(ICR) (Charles River, strain code #022)	NULL	5	normal	Q61164	liver	PEAKS048518
EXP050129	CTCF N2.2	Mus musculus	Stable integrate: N/A Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	PEAKS048519
EXP050130	CTCF N2.2	Mus musculus	Stable integrate: pBI-EGFP-FLAG-mCtcfl and pTA-N Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	PEAKS048520
EXP050131	CTCFL S6	Mus musculus	Stable integrate: N/A Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	A2APF3	NIH 3T3 (embryonic fibroblasts)	PEAKS048521
EXP050132	CTCFL S6	Mus musculus	Stable integrate: pBI-EGFP-FLAG-mCtcfl and pTA-N Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	A2APF3	NIH 3T3 (embryonic fibroblasts)	PEAKS048522
EXP050133	CTCF N2.2	Mus musculus	Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	EXP050128	705	normal	Q61164	P19 (embryonic carcinoma)	PEAKS048523
EXP050134	CTCFL S6	Mus musculus	Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	EXP050128	705	normal	A2APF3	P19 (embryonic carcinoma)	PEAKS048524
EXP050135	Prdm16 antibody R&D Systems (AF6295)	Mus musculus	Strain: C57BL6/J Developmental stage: 8 - 12 week 	NULL	2377	normal	A2A935	interscapular brown adipose	PEAKS048525
EXP050142	C/EBP ? (Santa Cruz sc-61 X)	Mus musculus	Strain: C57BL/6 Treatment: Stem cell (10ng/mL IL3, 10ng/mL IL6 100mg/mL SCF) for 7 days	EXP050136	2379	normal	P53566	line-bone marrow untransformed myeloid progenitors	PEAKS048526
EXP050143	C/EBP ? (Santa Cruz sc-61 X)	Mus musculus	Genotype: HOXA9/MEIS1-transformed  Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow	EXP050137	2378	normal	P53566	HMM (HOXA9 transormed myeloblasts)	PEAKS048527
EXP050144	MLL4 #3 (Ge lab)	Mus musculus	Genotype: HOXA9/MEIS1-transformed  Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow	EXP050137	2378	normal	Q6PDK2	HMM (HOXA9 transormed myeloblasts)	PEAKS048528
EXP050145	C/EBP ? (Santa Cruz sc-61 X)	Mus musculus	Genotype: HOXA9 inactivation Treatment: culture conditions Myeloid (10ng/mL IL3) + 4OHT for 25 -31 days wash off Source: Lin- bone marrow 	EXP050138	2378	normal	P53566	HMM (HOXA9 transormed myeloblasts)	PEAKS048529
EXP050146	HA (Abcam ab9110	Mus musculus	Genotype: viral transduction Hoxa9/Meis1 Treatment: culture conditions B cell (5ng/mL IL7, 5ng/mL Flt3L) for 25 -31 days Source: Lin- bone marrow 	EXP050139	2380	normal	P09631	HMB (HOXA9 transformed proB lymphoblast)	PEAKS048530
EXP050151	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow	EXP050147	2381	normal	Q03347	Lin- BM derived DN1 cells	PEAKS048531
EXP050152	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow	EXP050148	2381	normal	Q03347	Lin- BM derived DN1 cells	PEAKS048532
EXP050153	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+	EXP050149	2382	normal	Q03347	Lin- BM derived DN3 cells	PEAKS048533
EXP050154	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+	EXP050150	2382	normal	Q03347	Lin- BM derived DN3 cells	PEAKS048534
EXP050155	BRD4, Bethyl Labs A301-985A-100	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	Q9ESU6	hemogenic endothelium	PEAKS048535
EXP050156	BRD4, Bethyl Labs A301-985A-100	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	Q9ESU6	hemogenic endothelium	PEAKS048536
EXP050157	CDK9, Santa Cruz sc8338X	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	Q99J95	hemogenic endothelium	PEAKS048537
EXP050158	CDK9, Santa Cruz sc8338X	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	Q99J95	hemogenic endothelium	PEAKS048538
EXP050159	CDK9, Santa Cruz sc8338X	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX and JQ1	NULL	868	normal	Q99J95	hemogenic endothelium	PEAKS048539
EXP050160	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	P26323	hemogenic endothelium	PEAKS048540
EXP050161	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: JQ1, no DOX, uniduced 	NULL	868	normal	P26323	hemogenic endothelium	PEAKS048541
EXP050162	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	P26323	hemogenic endothelium	PEAKS048542
EXP050163	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: JQ1, induced by treatment with DOX 	NULL	868	normal	P26323	hemogenic endothelium	PEAKS048543
EXP050164	HA (for RUNX1), Sigma H6908	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	Q03347	hemogenic endothelium	PEAKS048544
EXP050165	HA (for RUNX1), Sigma H6908	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	Q03347	hemogenic endothelium	PEAKS048545
EXP050166	HA (for RUNX1), Sigma H6908	Mus musculus	Strain: 129P2/OlaHsd Treatment: JQ1, induced by treatment with DOX 	NULL	868	normal	Q03347	hemogenic endothelium	PEAKS048546
EXP050167	Ldb1, Abcam ab96799	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	P70662	hemogenic endothelium	PEAKS048547
EXP050168	Ldb1, Abcam ab96799	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	P70662	hemogenic endothelium	PEAKS048548
EXP050171	anti-HA (Abcam ab9111)	Mus musculus	Treatment: mock treated Strain: C57BL/6N Genotype: mESHA-Tet1	EXP050169	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS048549
EXP050172	anti-HA (Abcam ab9111)	Mus musculus	Treatment: treated with RNAse H1 Strain: C57BL/6N Genotype: mESHA-Tet1	EXP050170	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	PEAKS048550
EXP050174	Dlx1 made by Bora Lee	Mus musculus	Tissue: mouse hypothalamus	EXP050173	2383	normal	Q64317	E16 mouse emryo brain	PEAKS048551
EXP050175	homemade anti-Tbx4 (1695a)	Mus musculus	Strain: CD1 Tissue: hindlimb Source: e11.5 HL-buds Genotype: wildtype	NULL	995	normal	P70325	E11.5 hindlimb	PEAKS048552
EXP050176	Hoxc10 (ab153904, AbCam)	Mus musculus	Strain: CD1 Tissue: hindlimb Source: e11.5 HL-buds Genotype: wildtype	NULL	995	normal	P31257	E11.5 hindlimb	PEAKS048553
EXP050177	HoxC10(L-17) (sc-33003, Santa Cruz, Lot L1015)	Mus musculus	Strain: CD1 Tissue: hindlimb Source: e11.5 HL-buds Genotype: wildtype	NULL	995	normal	P31257	E11.5 hindlimb	PEAKS048554
EXP050179	anti-ANP32e (Abcam ab5993)	Mus musculus	Strain: C57BL/6 Treatment: Sham Source: normal heart Age: 12 week old Sex: male	EXP050178	53	normal	P97822	heart	PEAKS048555
EXP050180	anti-ANP32e (Abcam ab5993)	Mus musculus	Strain: C57BL/6 Treatment: Transaortic coarctation (TAC) for 4days Source: Hypertrophied heart Age: 12 week old Sex: male	EXP050178	53	normal	P97822	heart	PEAKS048556
EXP050182	KDM6A	Mus musculus	Source: pancreas Genotype: KDM6A knockout Treatment: noneSex: female	EXP050181	2385	normal	O70546	Cell line established from K6A murine pancreatic cancer	PEAKS048557
EXP050183	KDM6A	Mus musculus	Source: pancreas Genotype: KDM6A wildtype Treatment: noneSex: female	EXP050181	2385	normal	O70546	Cell line established from K6A murine pancreatic cancer	PEAKS048558
EXP050184	KMT2D	Mus musculus	Source: pancreas Genotype: KDM6A knockout Treatment: noneSex: female	EXP050181	2385	normal	Q6PDK2	Cell line established from K6A murine pancreatic cancer	PEAKS048559
EXP050185	KMT2D	Mus musculus	Source: pancreas Genotype: KDM6A wildtype Treatment: noneSex: female	EXP050181	2385	normal	Q6PDK2	Cell line established from K6A murine pancreatic cancer	PEAKS048560
EXP050186	anti-L3mbtl1	Mus musculus	Treatment: no Developmental stage: post natal 7-8 days Strain: C57BL6/129 Genotype: wildtype	NULL	987	normal	A2A5N8	hippocampus	PEAKS048561
EXP050187	anti-L3mbtl1	Mus musculus	Treatment: no Developmental stage: post natal 7-8 days Strain: C57BL6/129 Genotype: L3mbtl1-/- (L3mbtl1 knockout))	NULL	987	normal	A2A5N8	hippocampus	PEAKS048562
EXP050191	ERRg antibody	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	EXP050188	523	normal	P62509	kidney	PEAKS048563
EXP050192	ERRg antibody	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	EXP050189	523	normal	P62509	kidney	PEAKS048564
EXP050193	HNF1b antibody	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	EXP050190	523	normal	P27889	kidney	PEAKS048565
EXP050202	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sham Age: 6-8 weeks Strain: C57BL/6	EXP050194	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048566
EXP050203	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sham Age: 6-8 weeks Strain: C57BL/6	EXP050195	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048567
EXP050204	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sciatic nerve injury Age 6-8 weels Strain: C57BL/6	EXP050196	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048568
EXP050205	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sciatic nerve injury Age 6-8 weels Strain: C57BL/6	EXP050197	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048569
EXP050206	HDAC3 Millipore 17-10238	Mus musculus	Treatment: laminectomy Age: 6-8 weeks old Strain: C57BL/6	EXP050198	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048570
EXP050207	HDAC3 Millipore 17-10238	Mus musculus	Treatment: laminectomy Age: 6-8 weeks old Strain: C57BL/6	EXP050199	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048571
EXP050208	HDAC3 Millipore 17-10238	Mus musculus	Treatment: spinal cord dorsal column injury Age: 6-8 weeks Strain: C57BL/6 	EXP050200	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048572
EXP050209	HDAC3 Millipore 17-10238	Mus musculus	Treatment: spinal cord dorsal column injury Age: 6-8 weeks Strain: C57BL/6 	EXP050201	2387	normal	O88895	DRG (Dorsal Root Ganglia)	PEAKS048573
EXP050210	RAR (Santa Cruz sc-773X, Lot. B2414)	Mus musculus	Genotype: wildtype Strain: CD1	NULL	2388	normal	P11416	E11.5 proximal forelimb buds	PEAKS048574
EXP050211	RAR (Santa Cruz sc-773X, Lot. B2414)	Mus musculus	Genotype: wildtype Strain: CD1	NULL	2389	normal	P11416	E11.5 distal forelimb buds	PEAKS048575
EXP050218	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	EXP050212	2387	normal	P05627	DRG (Dorsal Root Ganglia)	PEAKS048576
EXP050219	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	EXP050213	2387	normal	P05627	DRG (Dorsal Root Ganglia)	PEAKS048577
EXP050220	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	EXP050214	2387	normal	P05627	DRG (Dorsal Root Ganglia)	PEAKS048578
EXP050221	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	EXP050215	2387	normal	P05627	DRG (Dorsal Root Ganglia)	PEAKS048579
EXP050222	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	EXP050216	2387	normal	P05627	DRG (Dorsal Root Ganglia)	PEAKS048580
EXP050223	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	EXP050217	2387	normal	P05627	DRG (Dorsal Root Ganglia)	PEAKS048581
EXP050226	KAP1(active motif, 1Tb-A9)	Mus musculus	Strain: C57BL/6 Tissue: spleen 	EXP050224	2390	normal	Q62318	Treg (regulatory T cells)	PEAKS048582
EXP050227	KAP1(active motif, 1Tb-A9)	Mus musculus	Strain: C57BL/6 Tissue: spleen 	EXP050225	2390	normal	Q62318	Treg (regulatory T cells)	PEAKS048583
EXP050228	NELF-A	Mus musculus	Treatment: MEFs were treated with 2 uM 4-HT for 72h Tissue: primary mouse embryonic fibroblasts Genotype: wildtype (Rosa26ERT2-cre/+)	NULL	595	normal	Q8BG30	MEF-1 (mouse embryonic fibroblasts)	PEAKS048584
EXP050229	NELF-A	Mus musculus	Treatment: MEFs were treated with 2 uM 4-HT for 72h Tissue: primary mouse embryonic fibroblasts Genotype: Supt5hFl/- Rosa26ERT2-cre/+	NULL	595	normal	Q8BG30	MEF-1 (mouse embryonic fibroblasts)	PEAKS048585
EXP050233	anti-SRF antibody (clone D71A9; Cell Signaling Technology)	Mus musculus	Source: Neural progenitor cells expressing no ectopic gene 	EXP050230	2391	normal	Q9JM73	differentiated neural progenitor cells	PEAKS048586
EXP050234	anti-SRF antibody (clone D71A9; Cell Signaling Technology)	Mus musculus	Treatment: transgene of Srf was introduced retrovirally Source: Neural progenitor cells overexpressing Srf	EXP050231	2391	normal	Q9JM73	differentiated neural progenitor cells	PEAKS048587
EXP050235	anti-SRF antibody (clone D71A9; Cell Signaling Technology)	Mus musculus	Source: Hepatoblasts (expressing no ectopic gene) 	EXP050232	2392	normal	Q9JM73	fetal liver	PEAKS048588
EXP050242	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C57BL/6N Sex: male	EXP050236	5	normal	P35582	liver	PEAKS048589
EXP050243	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C57BL/6N Sex: male	EXP050237	5	normal	P35582	liver	PEAKS048590
EXP050244	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C57BL/6N Sex: male	EXP050238	5	normal	P35582	liver	PEAKS048591
EXP050245	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C3H/HeN Sex: male	EXP050239	5	normal	P35582	liver	PEAKS048592
EXP050246	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C3H/HeN Sex: male	EXP050240	5	normal	P35582	liver	PEAKS048593
EXP050247	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C3H/HeN Sex: male	EXP050241	5	normal	P35582	liver	PEAKS048594
EXP050250	SC-584X and SC-585X (santa cruz)	Mus musculus	Strain: C57BL6/J Treatment: cultured for 5 days, on Day5, cells were re-stimulated with a-CD3 for 5hours and collected	EXP050248	2393	normal	B2RWS6	CD4+ T helper 9	PEAKS048595
EXP050251	SC-584X and SC-585X (santa cruz)	Mus musculus	Strain: C57BL6/J Treatment: cultured for 5 days, on Day5, cells were re-stimulated with a-CD3 for 5hours and collected	EXP050249	2393	normal	B2RWS6	CD4+ T helper 9	PEAKS048596
EXP050253	HDAC4 (Santa Cruz, sc-11418)	Mus musculus	Passage: 30 -32 Strain: C3H Tissue: Skeletal muscle	EXP050252	1153	normal	Q6NZM9	C2C12 (myoblasts)	PEAKS048597
EXP050257	BioGenes 1C	Mus musculus	72 hours after 4-OHT treatment	EXP050254	198	normal	Q07802	pre-pro-B-cells	PEAKS048598
EXP050258	BioGenes 1C	Mus musculus	24 hours after 4-OHT treatment	EXP050255	198	normal	Q07802	pre-pro-B-cells	PEAKS048599
EXP050259	BioGenes 1C	Mus musculus	CD19+ stage after 4-OHT treatment	EXP050256	105	normal	Q07802	pro-B cells	PEAKS048600
EXP050266	cREL (sc-71x)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	Q91XD7	CD8-positive dendritic cells	PEAKS048601
EXP050267	cREL (sc-71x)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	Q91XD7	CD8-positive dendritic cells	PEAKS048602
EXP050268	cREL (sc-71x)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	Q91XD7	CD8-positive dendritic cells	PEAKS048603
EXP050269	IRF3 (Cell Signalling Technology, D83B9, no. 4302)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P70671	CD8-positive dendritic cells	PEAKS048604
EXP050270	IRF3 (Cell Signalling Technology, D83B9, no. 4302)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P70671	CD8-positive dendritic cells	PEAKS048605
EXP050271	IRF3 (Cell Signalling Technology, D83B9, no. 4302)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P70671	CD8-positive dendritic cells	PEAKS048606
EXP050272	IRF5 (Abcam ab21689)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P56477	CD8-positive dendritic cells	PEAKS048607
EXP050273	IRF5 (Abcam ab21689)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P56477	CD8-positive dendritic cells	PEAKS048608
EXP050274	IRF5 (Abcam ab21689)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P56477	CD8-positive dendritic cells	PEAKS048609
EXP050275	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P23611	CD8-positive dendritic cells	PEAKS048610
EXP050276	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050261	2394	normal	P23611	CD8-positive dendritic cells	PEAKS048611
EXP050277	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P23611	CD8-positive dendritic cells	PEAKS048612
EXP050278	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050263	2394	normal	P23611	CD8-positive dendritic cells	PEAKS048613
EXP050279	IRF8 (sc-6058)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P23611	CD8-positive dendritic cells	PEAKS048614
EXP050280	IRF8 (sc-6058)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050265	2394	normal	P23611	CD8-positive dendritic cells	PEAKS048615
EXP050281	JUNB (sc-46x)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P09450	CD8-positive dendritic cells	PEAKS048616
EXP050282	JUNB (sc-46x)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P09450	CD8-positive dendritic cells	PEAKS048617
EXP050283	JUNB (sc-46x)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P09450	CD8-positive dendritic cells	PEAKS048618
EXP050284	p300 (sc-585)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	B2RWS6	CD8-positive dendritic cells	PEAKS048619
EXP050285	p300 (sc-585)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050261	2394	normal	B2RWS6	CD8-positive dendritic cells	PEAKS048620
EXP050286	p300 (sc-585)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	B2RWS6	CD8-positive dendritic cells	PEAKS048621
EXP050287	p300 (sc-585)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050263	2394	normal	B2RWS6	CD8-positive dendritic cells	PEAKS048622
EXP050288	p300 (sc-585)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	B2RWS6	CD8-positive dendritic cells	PEAKS048623
EXP050289	p300 (sc-585)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050265	2394	normal	B2RWS6	CD8-positive dendritic cells	PEAKS048624
EXP050290	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	O35295	CD8-positive dendritic cells	PEAKS048625
EXP050291	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050261	2394	normal	O35295	CD8-positive dendritic cells	PEAKS048626
EXP050292	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	O35295	CD8-positive dendritic cells	PEAKS048627
EXP050293	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050263	2394	normal	O35295	CD8-positive dendritic cells	PEAKS048628
EXP050294	PU.1 (sc-352)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	O35295	CD8-positive dendritic cells	PEAKS048629
EXP050295	PU.1 (sc-352)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050265	2394	normal	O35295	CD8-positive dendritic cells	PEAKS048630
EXP050296	STAT1 (sc-346)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P42225	CD8-positive dendritic cells	PEAKS048631
EXP050297	STAT1 (sc-346)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P42225	CD8-positive dendritic cells	PEAKS048632
EXP050298	STAT1 (sc-346)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P42225	CD8-positive dendritic cells	PEAKS048633
EXP050299	BioGenes 1C	Mus musculus	6 hrs after doxycycline treatment	NULL	198	normal	Q07802	pre-pro-B-cells	PEAKS048634
EXP050302	Pax5 (sc-1974X0	Mus musculus	Genotype:  Ebf1-/- Treatment: B cell progenitors  were transduced with a Tet-on Pax5 inducible expression retroviral construc, the transduced cells were treated with 1ug/ml doxycycline to initate Pax5 expression, cells were harvested 6 hours after treatment 	EXP050300	2395	normal	Q02650	Ebf1-deficient B cell progenitors	PEAKS048635
EXP050303	Pax5 (sc-1974X0	Mus musculus	Genotype: Ebf1-/-  Treatment: RERTCre B cell progenitors were transduced with a Cre-based inducible EBF1 expression retroviral construct, the transduced cells were treated with 2uM 4-hydroxy-tamoxifen (4-OHT) to initiate EBF1 expression for 5days	EXP050301	2395	normal	Q02650	Ebf1-deficient B cell progenitors	PEAKS048636
EXP050310	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: wildtype	EXP050304	965	normal	Q9Z2D6	frontal cortex	PEAKS048637
EXP050311	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: wildtype	EXP050305	965	normal	Q9Z2D6	frontal cortex	PEAKS048638
EXP050312	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: wildtype	EXP050306	965	normal	Q9Z2D6	frontal cortex	PEAKS048639
EXP050313	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	EXP050307	965	normal	Q9Z2D6	frontal cortex	PEAKS048640
EXP050314	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	EXP050308	965	normal	Q9Z2D6	frontal cortex	PEAKS048641
EXP050315	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	EXP050309	965	normal	Q9Z2D6	frontal cortex	PEAKS048642
EXP050317	Sox30 (Abclonal, A11715)	Mus musculus	Developmental stage: round spermatids Genotyp: wildtype Tissue: testis  	EXP050316	2397	normal	Q8CGW4	germ cells	PEAKS048643
EXP050318	Sox30 (Abclonal, A11715)	Mus musculus	Developmental stage: round spermatids Genotyp: Sox30 knock out by FRT/FRT Tissue: testis  	EXP050316	2397	normal	Q8CGW4	germ cells	PEAKS048644
EXP050319	Sox30 (Abclonal, A11715)	Mus musculus	Developmental stage: round spermatids Genotyp: Sox30 global knock out Tissue: testis  	EXP050316	2397	normal	Q8CGW4	germ cells	PEAKS048645
EXP050321	anti-YAP (Cell Signaling 14074)	Mus musculus	Genotype: Tetracycline-inducible YAPS127A Strain: Camargo et al Curr Biol. 2007 Dec 4;17(23):2054-60 	EXP050320	2392	normal	P46938	fetal liver	PEAKS048646
EXP050322	anti-TEAD4 (Abcam ab58310)	Mus musculus	Genotype: Tetracycline-inducible YAPS127A Strain: Camargo et al Curr Biol. 2007 Dec 4;17(23):2054-60 	EXP050320	2392	normal	Q62296	fetal liver	PEAKS048647
EXP050323	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: wildtype Strain: 129/sv	NULL	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	PEAKS048648
EXP050324	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: NFAT5 knockout Strain: 129/sv	NULL	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	PEAKS048649
EXP050327	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: wildtype Strain: 129/sv 	EXP050325	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	PEAKS048650
EXP050328	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: NFAT5 knockout Strain: 129/sv 	EXP050326	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	PEAKS048651
EXP050335	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: untreated	EXP050329	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS048652
EXP050336	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 1 hr	EXP050330	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS048653
EXP050337	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 6 hrs	EXP050331	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS048654
EXP050338	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: untreated	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS048655
EXP050339	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 1 hr	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS048656
EXP050340	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 6 hrs	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS048657
EXP050342	FLAG (Sigma, F7425, lot 085M4774V)	Mus musculus	Treatment: no Strain: Balb/c	EXP050341	2399	normal	P26323	EWS-FLI1-induced murine Ewing sarcoma cells	PEAKS048658
EXP050352	R&D goat anti-Sox2 (AF2018)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: wildtype	EXP050346	2401	normal	P48432	lung epithelial cells	PEAKS048661
EXP050353	R&D goat anti-Sox2 (AF2018)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression and Nkx2-1 deletion	EXP050347	2401	normal	P48432	lung epithelial cells	PEAKS048662
EXP050354	R&D goat anti-Sox2 (AF2018)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression	EXP050348	2401	normal	P48432	lung epithelial cells	PEAKS048663
EXP050357	Anti-CHD4 antibody [3F2/4] - ChIP Grade, Abcam, catalog# ab70469, mouse monoclonal	Mus musculus	Strain: CD1 Genotype: wildtype	EXP050355	2402	normal	Q6PDQ2	E10.0 cardiac tissue	PEAKS048664
EXP050358	Anti-CHD4 antibody [3F2/4] - ChIP Grade, Abcam, catalog# ab70469, mouse monoclonal	Mus musculus	Strain: CD1 Genotype: wildtype	EXP050356	2402	normal	Q6PDQ2	E10.0 cardiac tissue	PEAKS048665
EXP050360	anti-Bcl11b (A300-385A-2) from Bethyl	Mus musculus	Source: late Th2 Genotype: wildtype 	EXP050359	499	normal	Q99PV8	Th2-cells	PEAKS048666
EXP050361	anti-GATA3 (L50-823) from BD Biosciences	Mus musculus	Source: late Th2 Genotype: wildtype 	EXP050359	499	normal	P23772	Th2-cells	PEAKS048667
EXP050364	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS for 0hr Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	PEAKS048668
EXP050365	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS for 1hr Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	PEAKS048669
EXP050366	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS for 3hrs Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	PEAKS048670
EXP050367	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS+ 100 nM Dex  for 1hr Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	PEAKS048671
EXP050368	BRD4 (Abcam, ab84776)	Mus musculus	Treatment: 10 ng/ml LPS for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6 	NULL	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS048672
EXP050369	BRD4 (Abcam, ab84776)	Mus musculus	Treatment: 10 ng/ml LPS + 100 nM dexfor  45 minutes Age: 8-12 weeks Sex: male  Strain: C57BL/6	NULL	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS048673
EXP050370	BRD4 (Abcam, ab84776)	Mus musculus	Treatment: 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	NULL	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS048674
EXP050371	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	PEAKS048675
EXP050372	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: 100 nM LPS for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	PEAKS048676
EXP050373	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: 10 ng/ml LPS + 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	PEAKS048677
EXP050374	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: untrated Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	PEAKS048678
EXP050375	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/mL LPS for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	PEAKS048679
EXP050376	p65 (Santa Cruz Biotech, sc-372X)	Mus musculus	Treatment: 10 ng/mL + 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050363	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS048680
EXP050377	p65 (Santa Cruz Biotech, sc-372X)	Mus musculus	Treatment: untreated Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050363	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS048681
EXP050379	PU.1 antibody; In lab described in PMID:17403683	Mus musculus	CSF1 only	EXP050378	2396	normal	P17433	bone marrow myeloid cells	PEAKS048682
EXP050380	PU.1 antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 36h	EXP050378	2396	normal	P17433	bone marrow myeloid cells	PEAKS048683
EXP050381	PU.1 antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 72h	EXP050378	2396	normal	P17433	bone marrow myeloid cells	PEAKS048684
EXP050382	MITF antibody; In lab described in PMID:17403683	Mus musculus	CSF1 only	EXP050378	2396	normal	Q08874	bone marrow myeloid cells	PEAKS048685
EXP050383	MITF antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 36h	EXP050378	2396	normal	Q08874	bone marrow myeloid cells	PEAKS048686
EXP050384	MITF antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 72h	EXP050378	2396	normal	Q08874	bone marrow myeloid cells	PEAKS048687
EXP050386		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	PEAKS048688
EXP050387		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	PEAKS048689
EXP050388		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	PEAKS048690
EXP050389		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	PEAKS048691
EXP050390		Mus musculus	Tet1 -/-	EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	PEAKS048692
EXP050391	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible WT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS048693
EXP050392	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible WT EED rescue 36hr Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS048694
EXP050393	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible MT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS048695
EXP050394	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible MT EED rescue 36hrs Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS048696
EXP050395	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048697
EXP050396	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 36hr Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048698
EXP050397	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible MT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048699
EXP050398	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible MT EED rescue 36hrs Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048700
EXP050399	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, JARID2/MTF2 WT Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048701
EXP050400	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, JARID2 knockout Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048702
EXP050401	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048703
EXP050402	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, JARID2/MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048704
EXP050403	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, JARID2/MTF2 WT Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048705
EXP050404	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, JARID2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048706
EXP050405	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048707
EXP050406	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, JARID2/MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048708
EXP050407	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8 days, JARID2/MTF2 WT Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048709
EXP050408	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8 days, MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048710
EXP050409	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8 days, JARID2/MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS048711
EXP050411	p300 (Santa Cruz_sc-584)	Mus musculus	Strain: C3H Cell type: proliferating myoblasts	EXP050410	1153	normal	B2RWS6	C2C12 (myoblasts)	PEAKS048712
EXP050412	p300 (Santa Cruz_sc-584)	Mus musculus	Strain: C3H Cell type: differentiated myoblast for 24 hrs	EXP050410	1153	normal	B2RWS6	C2C12 (myoblasts)	PEAKS048713
EXP050415	CTCF (Millipore 07-729)	Mus musculus	Genotype: B220+CD19+CD43-CD25+IgM- Age: 3 months Tissue: bone marrow Strain: C57BL/6  	EXP050413	2404	normal	Q61164	flow sorted pre-B cells	PEAKS048714
EXP050416	CTCF (Millipore 07-729)	Mus musculus	Genotype: B220+CD19+CD43-CD25+IgM- Age: 18 -22  months Tissue: bone marrow Strain: C57BL/6  	EXP050414	2404	normal	Q61164	flow sorted pre-B cells	PEAKS048715
EXP050445	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Rod_I_Y-8602 Strain: C57BL/6	EXP050417	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048716
EXP050446	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-rM0401 Strain: C57BL/6	EXP050418	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048717
EXP050447	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-rM0405 Strain: C57BL/6	EXP050419	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048718
EXP050448	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-208.03 Strain: C57BL/6	EXP050420	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048719
EXP050449	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-208.04 Strain: C57BL/6	EXP050421	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048720
EXP050450	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_I_Y-207.11 Strain: C57BL/6	EXP050422	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048721
EXP050451	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-rCr33.01 Strain: C57BL/6	EXP050423	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048722
EXP050452	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-rCr33.04 Strain: C57BL/6	EXP050424	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048723
EXP050453	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-Cr143.01 Strain: C57BL/6	EXP050425	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048724
EXP050454	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-263.08 Strain: C57BL/6	EXP050426	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048725
EXP050455	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Amac_M_Y-30.02 Strain: C57BL/6	EXP050427	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048726
EXP050456	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_Y-209.11 Strain: C57BL/6	EXP050428	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048727
EXP050457	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_Y-209.12 Strain: C57BL/6	EXP050429	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048728
EXP050458	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_Y-209.13 Strain: C57BL/6	EXP050430	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048729
EXP050459	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_M_Y-257.03 Strain: C57BL/6	EXP050431	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048730
EXP050460	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: RodFibr_F_Y-FNR07 Strain: C57BL/6	EXP050432	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048731
EXP050461	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_N-rM0408 Strain: C57BL/6	EXP050433	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048732
EXP050462	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: MullFibr_F_N-FCR01 Strain: C57BL/6	EXP050434	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048733
EXP050463	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: MullFibr_F_N-FCR02 Strain: C57BL/6	EXP050435	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048734
EXP050464	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: AmacFibr_F_N-fG140.02 Strain: C57BL/6	EXP050435	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048735
EXP050465	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_N-rCr33.05 Strain: C57BL/6	EXP050437	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048736
EXP050466	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_N-rCr263.4 Strain: C57BL/6	EXP050438	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048737
EXP050467	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_N-rCh209.04 Strain: C57BL/6	EXP050439	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048738
EXP050468	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_N-rCr143.02 Strain: C57BL/6	EXP050440	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048739
EXP050469	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Amac_I_N-rG79.04 Strain: C57BL/6	EXP050441	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048740
EXP050470	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_M_N-rCh257.4 Strain: C57BL/6	EXP050442	906	normal	Q9ESU6	induced pluripotent stem cells	PEAKS048741
EXP050471	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Rod_I_Y-8602 Strain: C57BL/6	EXP050417	906	normal	Q61164	induced pluripotent stem cells	PEAKS048742
EXP050472	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-rM0401 Strain: C57BL/6	EXP050418	906	normal	Q61164	induced pluripotent stem cells	PEAKS048743
EXP050473	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-rM0405 Strain: C57BL/6	EXP050419	906	normal	Q61164	induced pluripotent stem cells	PEAKS048744
EXP050474	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-208.03 Strain: C57BL/6	EXP050420	906	normal	Q61164	induced pluripotent stem cells	PEAKS048745
EXP050475	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-208.04 Strain: C57BL/6	EXP050421	906	normal	Q61164	induced pluripotent stem cells	PEAKS048746
EXP050476	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_I_Y-207.11 Strain: C57BL/6	EXP050422	906	normal	Q61164	induced pluripotent stem cells	PEAKS048747
EXP050477	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-rCr33.01 Strain: C57BL/6	EXP050423	906	normal	Q61164	induced pluripotent stem cells	PEAKS048748
EXP050478	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-rCr33.04 Strain: C57BL/6	EXP050424	906	normal	Q61164	induced pluripotent stem cells	PEAKS048749
EXP050479	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-Cr143.01 Strain: C57BL/6	EXP050425	906	normal	Q61164	induced pluripotent stem cells	PEAKS048750
EXP050480	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-263.08 Strain: C57BL/6	EXP050426	906	normal	Q61164	induced pluripotent stem cells	PEAKS048751
EXP050481	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Amac_M_Y-30.02 Strain: C57BL/6	EXP050427	906	normal	Q61164	induced pluripotent stem cells	PEAKS048752
EXP050482	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_Y-209.11 Strain: C57BL/6	EXP050428	906	normal	Q61164	induced pluripotent stem cells	PEAKS048753
EXP050483	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_Y-209.12 Strain: C57BL/6	EXP050429	906	normal	Q61164	induced pluripotent stem cells	PEAKS048754
EXP050484	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_Y-209.13 Strain: C57BL/6	EXP050430	906	normal	Q61164	induced pluripotent stem cells	PEAKS048755
EXP050485	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_M_Y-257.03 Strain: C57BL/6	EXP050431	906	normal	Q61164	induced pluripotent stem cells	PEAKS048756
EXP050486	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: RodFibr_F_Y-FNR07 Strain: C57BL/6	EXP050432	906	normal	Q61164	induced pluripotent stem cells	PEAKS048757
EXP050487	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_N-rM0408 Strain: C57BL/6	EXP050433	906	normal	Q61164	induced pluripotent stem cells	PEAKS048758
EXP050488	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: MullFibr_F_N-FCR01 Strain: C57BL/6	NULL	906	normal	Q61164	induced pluripotent stem cells	PEAKS048759
EXP050489	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: MullFibr_F_N-FCR02 Strain: C57BL/6	EXP050435	906	normal	Q61164	induced pluripotent stem cells	PEAKS048760
EXP050490	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: AmacFibr_F_N-fG140.02 Strain: C57BL/6	EXP050435	906	normal	Q61164	induced pluripotent stem cells	PEAKS048761
EXP050491	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_N-rCr33.05 Strain: C57BL/6	EXP050437	906	normal	Q61164	induced pluripotent stem cells	PEAKS048762
EXP050492	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_N-rCr263.4 Strain: C57BL/6	EXP050438	906	normal	Q61164	induced pluripotent stem cells	PEAKS048763
EXP050493	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_N-rCh209.04 Strain: C57BL/6	EXP050439	906	normal	Q61164	induced pluripotent stem cells	PEAKS048764
EXP050494	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_N-rCr143.02 Strain: C57BL/6	EXP050440	906	normal	Q61164	induced pluripotent stem cells	PEAKS048765
EXP050495	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Amac_I_N-rG79.04 Strain: C57BL/6	EXP050441	906	normal	Q61164	induced pluripotent stem cells	PEAKS048766
EXP050496	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_M_N-rCh257.4 Strain: C57BL/6	EXP050442	906	normal	Q61164	induced pluripotent stem cells	PEAKS048767
EXP050497	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: CTCF-NRL-Rod_M_N-P21 Strain: C57BL/6	EXP050443	2405	normal	Q61164	NRL-GFP sorted Rod cell postnatal day 21	PEAKS048768
EXP050498	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: CTCF-NRL-Rod_M_N-P6 Strain: C57BL/6	EXP050444	2406	normal	Q61164	NRL-GFP sorted Rod cell postnatal day 6	PEAKS048769
EXP050501	Anti-LSD1 polyclonal antibody (Abcam: ab177721)	Mus musculus	Cell ctatus: differentiating Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 48 hours	EXP050499	1153	normal	Q6ZQ88	C2C12 (myoblasts)	PEAKS048770
EXP050502	Anti-LSD1 polyclonal antibody (Abcam: ab177721)	Mus musculus	Cell ctatus: differentiating Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 120 hours	EXP050500	1153	normal	Q6ZQ88	C2C12 (myoblasts)	PEAKS048771
EXP050504	NRF2 (sc-13032,Santa Cruz)	Mus musculus	Treatment: sesame oil for 2 hr Sex: male Strain: C57BL/6 Age: 28 days 	EXP050503	5	normal	Q60795	liver	PEAKS048772
EXP050505	NRF2 (sc-13032,Santa Cruz)	Mus musculus	Treatment: 30 ug/kg TCDD for 2 hr Sex: male Strain: C57BL/6 Age: 28 days 	EXP050503	5	normal	Q60795	liver	PEAKS048773
EXP050510	anti-CTCF	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/-  Treatment: cultured with IL7	EXP050506	105	normal	Q61164	pro-B cells	PEAKS048774
EXP050511	anti-CTCF	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- u+ 	EXP050507	503	normal	Q61164	pre-B cells	PEAKS048775
EXP050512	anti-Rad21	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- u+ 	EXP050507	503	normal	Q61550	pre-B cells	PEAKS048776
EXP050513	anti-Rad21	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- 	EXP050508	140	normal	Q61550	CD4- CD8- T cells	PEAKS048777
EXP050514	anti-Rad21	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/-  	EXP050509	171	normal	Q61550	CD4+ CD8+ T cells	PEAKS048778
EXP050518	Bethyl A301-985A	Mus musculus	Vehicle	EXP050515	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	PEAKS048779
EXP050519	Bethyl A301-985A	Mus musculus	Vehicle	EXP050516	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	PEAKS048780
EXP050520	Bethyl A301-985A	Mus musculus	JQ1	EXP050517	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	PEAKS048781
EXP050523	PGC-1alfa (Millipore, ST1204)	Mus musculus	Treatment: Cold exposure 4 C degree for 6hrs Strain: C57BL/6 Genotype: wildtype	EXP050521	116	normal	O70343	brown adipocytes	PEAKS048782
EXP050524	PGC-1alfa (Millipore, ST1204)	Mus musculus	Treatment: Cold exposure 4 C degree for 6hrs Strain: C57BL/6 Genotype: wildtype	EXP050522	116	normal	O70343	brown adipocytes	PEAKS048783
EXP050527	TBP (Abcam #51841)	Mus musculus		EXP050525	1064	normal	P29037	JM8.N4 (embryonic stem cells)	PEAKS048784
EXP050528	TBP (Abcam #51841)	Mus musculus		EXP050526	1064	normal	P29037	JM8.N4 (embryonic stem cells)	PEAKS048785
EXP051041	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q6PDQ2	lin-bone marrow	PEAKS049035
EXP051042	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q6PDQ2	lin-bone marrow	PEAKS049036
EXP051043	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q6PDQ2	lin-bone marrow	PEAKS049037
EXP051044	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q6PDQ2	lin-bone marrow	PEAKS049038
EXP051045	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q9R190	lin-bone marrow	PEAKS049039
EXP051046	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q9R190	lin-bone marrow	PEAKS049040
EXP051047	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q9R190	lin-bone marrow	PEAKS049041
EXP051048	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q9R190	lin-bone marrow	PEAKS049042
EXP051049	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	P70288	lin-bone marrow	PEAKS049043
EXP051050	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	P70288	lin-bone marrow	PEAKS049044
EXP051051	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	P70288	lin-bone marrow	PEAKS049045
EXP051052	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	P70288	lin-bone marrow	PEAKS049046
EXP051053	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q8VIG1	lin-bone marrow	PEAKS049047
EXP051054	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q8VIG1	lin-bone marrow	PEAKS049048
EXP051055	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q8VIG1	lin-bone marrow	PEAKS049049
EXP051056	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q8VIG1	lin-bone marrow	PEAKS049050
EXP051057	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q9CQJ4	lin-bone marrow	PEAKS049051
EXP051058	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q9CQJ4	lin-bone marrow	PEAKS049052
EXP051059	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q9CQJ4	lin-bone marrow	PEAKS049053
EXP051060	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q9CQJ4	lin-bone marrow	PEAKS049054
EXP051061	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q6ZQ88	lin-bone marrow	PEAKS049055
EXP051062	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q6ZQ88	lin-bone marrow	PEAKS049056
EXP051063	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q6ZQ88	lin-bone marrow	PEAKS049057
EXP051064	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q6ZQ88	lin-bone marrow	PEAKS049058
EXP051065	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q03347	lin-bone marrow	PEAKS049059
EXP051066	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q03347	lin-bone marrow	PEAKS049060
EXP051067	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q03347	lin-bone marrow	PEAKS049061
EXP051068	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q03347	lin-bone marrow	PEAKS049062
EXP051069	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	Q6PDQ2	Scid.adh.2c2 cells	PEAKS049063
EXP051070	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	Q6PDQ2	Scid.adh.2c2 cells	PEAKS049064
EXP051071	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	P70288	Scid.adh.2c2 cells	PEAKS049065
EXP051072	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	P70288	Scid.adh.2c2 cells	PEAKS049066
EXP051073	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	Q9R190	Scid.adh.2c2 cells	PEAKS049067
EXP051074	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	Q9R190	Scid.adh.2c2 cells	PEAKS049068
EXP051075	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	Q8VIG1	Scid.adh.2c2 cells	PEAKS049069
EXP051076	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	Q8VIG1	Scid.adh.2c2 cells	PEAKS049070
EXP051080	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q6PDQ2	NIH 3T3 (embryonic fibroblasts)	PEAKS049071
EXP051081	HDAC1 (Abcam, ab7028)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	O09106	NIH 3T3 (embryonic fibroblasts)	PEAKS049072
EXP051082	HDAC2 (Abcam, ab7029)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	P70288	NIH 3T3 (embryonic fibroblasts)	PEAKS049073
EXP051083	Mbd2/3 (Abcam, ab45027)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q8C255	NIH 3T3 (embryonic fibroblasts)	PEAKS049074
EXP051084	MTA1 (Santa Cruz, sc-9446)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q8K4B0	NIH 3T3 (embryonic fibroblasts)	PEAKS049075
EXP051085	Rbbp4 (Abcam, ab79416)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q60972	NIH 3T3 (embryonic fibroblasts)	PEAKS049076
EXP051086	MTA1 (Santa Cruz, sc-9446)	Mus musculus	Genotype: wildtype Treatment: transduced with GFP-Luciferase/OFP-Luciferase	EXP051078	675	normal	Q8K4B0	NIH 3T3 (embryonic fibroblasts)	PEAKS049077
EXP051087	MTA1 (Santa Cruz, sc-9446)	Mus musculus	Treatment: OFP-H3.3A/GFP-H3.3B Genotype: H3.3 Knockdown	EXP051079	675	normal	Q8K4B0	NIH 3T3 (embryonic fibroblasts)	PEAKS049078
EXP051088	Rbbp4 (Abcam, ab79416)	Mus musculus	Genotype: wildtype Treatment: transduced with GFP-Luciferase/OFP-Luciferase	EXP051078	675	normal	Q60972	NIH 3T3 (embryonic fibroblasts)	PEAKS049079
EXP051089	Rbbp4 (Abcam, ab79416)	Mus musculus	Treatment: OFP-H3.3A/GFP-H3.3B Genotype: H3.3 Knockdown	EXP051079	675	normal	Q60972	NIH 3T3 (embryonic fibroblasts)	PEAKS049080
EXP051090	SRC-3 (5E11) Rabbit mAbÂ #2126 CST	Mus musculus	Strain: C57BL/6 Age: 10 weeks old Sex: male	NULL	5	normal	O09000	liver	PEAKS049081
EXP051093	Rabbit anti-Ash1L (#A301-749A; Bethyl laboratories)	Mus musculus	Treatment: DMEM containing 2% donor horse serum (EuroClone) 24 hours (day1)	EXP051091	1153	normal	Q99MY8	C2C12 (myoblasts)	PEAKS049082
EXP051095	anti-FLAG	Mus musculus	Genotype: Asxl1 knock in Source: c-Kit+Bone Marrow cells	EXP051094	2396	normal	P59598	bone marrow myeloid cells	PEAKS049083
EXP051096	anti-Asxl1	Mus musculus	Genotype: Asxl1 wildtype Source: c-Kit+Bone Marrow cells	NULL	2396	bio_control	P59598	bone marrow myeloid cells	PEAKS049084
EXP051097	anti-Asxl1	Mus musculus	Genotype: Asxl1 knock in Source: c-Kit+Bone Marrow cells	EXP051094	2396	normal	P59598	bone marrow myeloid cells	PEAKS049085
EXP051098	anti-PPAR? (H100), Santa Cruz, sc7196x, K1010	Mus musculus	Genotype: PPARG knockout Strain: C57BL/6 Age: 8.5 weeks	NULL	2412	normal	P23204	thioglycollate-elicited peritoneal macrophages	PEAKS049086
EXP051099	anti-PPAR? (H100), Santa Cruz, sc7196x, K1010	Mus musculus	Genotype: PPARG wildtype Strain: C57BL/6 Age: 8.5 weeks	NULL	2412	normal	P23204	thioglycollate-elicited peritoneal macrophages	PEAKS049087
EXP051101	anti-CEBPB	Mus musculus	Genotype: IL10Ra-Expressing Strain: C57/Bl6 Source: D5 differentiated cells Treatment: untreated	EXP051100	2413	normal	P28033	iBAd	PEAKS049088
EXP051102	anti-CEBPB	Mus musculus	Genotype: IL10Ra-Expressing Strain: C57/Bl6 Source: D5 differentiated cells Treatment: treated with IL10	EXP051100	2413	normal	P28033	iBAd	PEAKS049089
EXP051138	Runx1 (Vendor: Santa Cruz, Cat#sc365644)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051111	81	normal	Q03347	BMDM (bone marrow-derived macrophages)	PEAKS049090
EXP051139	Runx1 (Vendor: Santa Cruz, Cat#sc365644)	Mus musculus	C57BL/6J strain	EXP051112	81	normal	Q03347	BMDM (bone marrow-derived macrophages)	PEAKS049091
EXP051140	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; C57BL/6J x SPRET/EiJ	EXP051115	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049092
EXP051141	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	C57BL/6J x SPRET/EiJ	EXP051116	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049093
EXP051142	input	Mus musculus	KLA 1h; PWK/PhJ strain	NULL	81	normal	B5DC71	BMDM (bone marrow-derived macrophages)	PEAKS049094
EXP051143	input	Mus musculus	PWK/PhJ strain	NULL	81	normal	B5DC71	BMDM (bone marrow-derived macrophages)	PEAKS049095
EXP051144	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051121	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049096
EXP051145	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	SPRET/EiJ strain	EXP051122	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049097
EXP051146	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051121	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049098
EXP051147	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	SPRET/EiJ strain	EXP051122	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049099
EXP051148	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051123	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049100
EXP051149	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051123	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049101
EXP051150	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	SPRET/EiJ strain	EXP051124	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049102
EXP051151	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	SPRET/EiJ strain	EXP051124	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049103
EXP051152	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051125	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049104
EXP051153	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051125	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049105
EXP051154	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	PWK/PhJ strain	EXP051126	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049106
EXP051155	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	PWK/PhJ strain	EXP051126	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049107
EXP051156	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	PWK/PhJ strain	EXP051120	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049108
EXP051157	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051117	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049109
EXP051158	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051119	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049110
EXP051159	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	PWK/PhJ strain	EXP051118	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049111
EXP051160	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051127	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049112
EXP051161	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051127	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049113
EXP051162	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	NOD/ShiLtJ strain	EXP051129	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049114
EXP051163	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	NOD/ShiLtJ strain	EXP051129	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049115
EXP051164	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	NOD/ShiLtJ strain	EXP051130	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049116
EXP051165	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	NOD/ShiLtJ strain	EXP051130	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049117
EXP051166	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051128	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049118
EXP051167	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051128	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049119
EXP051168	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; C57BL/6J x PWK/PhJ	EXP051113	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049120
EXP051169	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	C57BL/6J x PWK/PhJ	EXP051114	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049121
EXP051170	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051131	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049122
EXP051171	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051131	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049123
EXP051172	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	C57BL/6J strain	EXP051132	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049124
EXP051173	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	C57BL/6J strain	EXP051132	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049125
EXP051174	Usf2 (Vendor: Santa Cruz, Cat#sc-862X)	Mus musculus	C57BL/6J strain	EXP051133	81	normal	Q64705	BMDM (bone marrow-derived macrophages)	PEAKS049126
EXP051175	Usf2 (Vendor: Santa Cruz, Cat#sc-862X)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051134	81	normal	Q64705	BMDM (bone marrow-derived macrophages)	PEAKS049127
EXP051176	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051108	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049128
EXP051177	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	C57BL/6J strain	EXP051110	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049129
EXP051178	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051107	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049130
EXP051179	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	C57BL/6J strain	EXP051109	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049131
EXP051180	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; BALB/cJ	EXP051135	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049132
EXP051181	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	BALB/cJ	EXP051136	81	normal	P28033	BMDM (bone marrow-derived macrophages)	PEAKS049133
EXP051182	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	BALB/cJ	EXP051137	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049134
EXP051183	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	BALB/cJ	EXP051137	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049135
EXP051184	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; BALB/cJ	EXP051106	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049136
EXP051185	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	BALB/cJ	EXP051136	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS049137
EXP051186	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; BALB/cJ	EXP051105	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049138
EXP051187	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; BALB/cJ	EXP051104	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS049139
EXP051200	Active Motif 61537	Mus musculus	Treatment: DMSO Cell type: mESC	EXP051188	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	PEAKS049140
EXP051201	Active Motif 61537	Mus musculus	Treatment: I-BRD9 for six hours Cell type: mESC	EXP051189	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	PEAKS049141
EXP051202	Active Motif 61537	Mus musculus	Treatment: I-BRD9 for 24 hours Cell type: mESC	EXP051190	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	PEAKS049142
EXP051203	anti-ARID1A (Santa Cruz sc-32761)	Mus musculus	Cell type: mEsc	EXP051191	252	normal	A2BH40	V6.5 (embryonic stem cells)	PEAKS049143
EXP051204	anti-ARID1A (Santa Cruz sc-32761)	Mus musculus	Cell type: mEsc	EXP051192	252	normal	A1A546	V6.5 (embryonic stem cells)	PEAKS049144
EXP051205	anti-BRD4 (Bethyl, A301-985A)	Mus musculus	Treatment: DMSO for 24 hrs Cell type: mESC	EXP051193	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS049145
EXP051206	anti-BRD4 (Bethyl, A301-985A)	Mus musculus	Treatment: 3 uM I-BRD9 for 24 hours Cell type: mESC	EXP051194	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS049146
EXP051207	anti-BRD4 (Bethyl, A301-985A)	Mus musculus	Cell type: mESC 	NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS049147
EXP051208	Abcam 110641	Mus musculus	Treatment: DMSO for 24 hrs Cell type: mESC	EXP051196	252	normal	A1A546	V6.5 (embryonic stem cells)	PEAKS049148
EXP051209	Abcam 110641	Mus musculus	Treatment: 3 uM I-BRD9 for 24 hours Cell type: mESC	EXP051197	252	normal	A1A546	V6.5 (embryonic stem cells)	PEAKS049149
EXP051210	Abcam 110641	Mus musculus	Cell type: mESC 	EXP051198	252	normal	A1A546	V6.5 (embryonic stem cells)	PEAKS049150
EXP051211	Active Motif 61537	Mus musculus	Cell type: mESC Treatment: 500 nM JQ1 for 24 hours	EXP051199	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	PEAKS049151
EXP051213	ETV5 (Proteintech, 13011-1-AP)	Mus musculus	Strain: C57BL/6 Age: 10-12 weeks 	EXP051212	2414	normal	Q9CXC9	AT-2 (Alveolar type II cells)	PEAKS049152
EXP051215	EZH2	Mus musculus	EZH2 WT	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS049153
EXP051216	EZH2	Mus musculus	EZH2 KO	EXP051214	230	bio_control	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS049154
EXP051217	EZH2	Mus musculus	EZH2 WT	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS049155
EXP051218	EZH2	Mus musculus	EZH2-P132S rescue 	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS049156
EXP051219	EZH2	Mus musculus	EZH2-F145L rescue 	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS049157
EXP051224	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Prdm16 flox/flox(wildtype)	EXP051220	866	normal	A2A935	E15.5 embryonic cortex	PEAKS049158
EXP051225	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Prdm16 flox/flox(wildtype)	EXP051221	866	normal	A2A935	E15.5 embryonic cortex	PEAKS049159
EXP051226	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Emx1Ires-Cre (Prdm16 knockout)	EXP051222	866	normal	A2A935	E15.5 embryonic cortex	PEAKS049160
EXP051227	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Emx1Ires-Cre (Prdm16 knockout)	EXP051223	866	normal	A2A935	E15.5 embryonic cortex	PEAKS049161
EXP051228	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a-/- (knockout)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS049162
EXP051229	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1-/- , Dnmt3a-/- (knockouts)	NULL	13	normal	Q80U70	2TS22C (embryonic stem cells)	PEAKS049163
EXP051230	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1-/- (knockout)	NULL	13	normal	Q80U70	2TS22C (embryonic stem cells)	PEAKS049164
EXP051231	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: wild type	NULL	13	normal	Q80U70	2TS22C (embryonic stem cells)	PEAKS049165
EXP051234	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Krt14-RFP, Krt10-H2B-GFP	EXP051232	2415	normal	Q9CQJ4	epidermal progenitor cells	PEAKS049166
EXP051235	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Krt14-RFP, Krt10-H2B-GFP	EXP051233	2415	normal	Q9CQJ4	epidermal progenitor cells	PEAKS049167
EXP051237	Auts2 (Sigma, Cat# HPA000390, RRID:AB_1845218)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	A0A087WPF7	epidermal progenitor cells	PEAKS049168
EXP051238	Bmi1 (Cell Signaling, Cat# 5856S, RRID:AB_10838137)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	P25916	epidermal progenitor cells	PEAKS049169
EXP051239	Bmi1 (Cell Signaling, Cat# 5856S, RRID:AB_10838137)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	P25916	epidermal progenitor cells	PEAKS049170
EXP051240	Rybp (Millipore, Cat# ab3637, RRID:AB_2285466)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	Q8CCI5	epidermal progenitor cells	PEAKS049171
EXP051241	Rybp (Millipore, Cat# ab3637, RRID:AB_2285466)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	Q8CCI5	epidermal progenitor cells	PEAKS049172
EXP051243	Auts2 (Sigma, Cat# HPA000390, RRID:AB_1845218)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	A0A087WPF7	epidermal progenitor cells	PEAKS049173
EXP051244	Kdm2b (Abcam, Cat# ab137547)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	Q6P1G2	epidermal progenitor cells	PEAKS049174
EXP051245	Cbx8 (Bethyl Labs, Cat# A300-882A, RRID:AB_2071525)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	Q9QXV1	epidermal progenitor cells	PEAKS049175
EXP051246	L3mbtl2 (Active Motif, Cat# 39570, RRID:AB_2615062)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	P59178	epidermal progenitor cells	PEAKS049176
EXP051251	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	EXP051247	2415	normal	Q9CQJ4	epidermal progenitor cells	PEAKS049177
EXP051252	Suz12 (Active Motif, Cat# 39357, RRID:AB_2614929)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	EXP051247	2415	normal	Q80U70	epidermal progenitor cells	PEAKS049178
EXP051253	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Ring1a-/- Ring1b-/I53A	EXP051249	2415	normal	Q9CQJ4	epidermal progenitor cells	PEAKS049179
EXP051254	Suz12 (Active Motif, Cat# 39357, RRID:AB_2614929)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Ring1a-/- Ring1b-/I53A	EXP051249	2415	normal	Q80U70	epidermal progenitor cells	PEAKS049180
EXP051259	Foxk1	Mus musculus		EXP051258	12	normal	P42128	MEF (mouse embryonic fibroblasts)	PEAKS049181
EXP051262	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Treatment: treated with 1.5% 1,6-hexanediol for 30 minutes 	EXP051260	252	normal	Q925J9	V6.5 (embryonic stem cells)	PEAKS049182
EXP051263	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Treatment: untreated	EXP051261	252	normal	Q925J9	V6.5 (embryonic stem cells)	PEAKS049183
EXP051264	Brd4 (Bethyl,A301-985A)	Mus musculus	Treatment: treated with 1.5% 1,6-hexanediol for 30 minutes 	EXP051260	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS049184
EXP051265	Brd4 (Bethyl,A301-985A)	Mus musculus	Treatment: untreated	EXP051261	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS049185
EXP051268	SET1A (Abcam, ab70378 )	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: +/- Nup98 knockdown 	EXP051266	400	normal	E9PYH6	hematopoietic progenitors	PEAKS049186
EXP051269	SET1A (Abcam, ab70378 )	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: +/- Nup98 knockdown, depleted of Nup98 	EXP051266	400	normal	E9PYH6	hematopoietic progenitors	PEAKS049187
EXP051270	Nup98 (P671, Cell Signaling Technology, #2292)	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: Nup98 wildtype 	NULL	400	normal	Q6PFD9	hematopoietic progenitors	PEAKS049188
EXP051271	Sigma - Flag M2 (affinity gel, #A2220)	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: Flag-Nup98-Nsd1	EXP051266	400	normal	Q6PFD9	hematopoietic progenitors	PEAKS049189
EXP051272	Nup98	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: Nup98-Nsd1  	EXP051266	400	normal	Q6PFD9	hematopoietic progenitors	PEAKS049190
EXP051273	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot A)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: wildtype Strain: C57BL/6	NULL	2417	normal	O35185	GM-CSF-cultured bone marrow	PEAKS049191
EXP051274	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot A)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: KO (Bhlhe40-/-) Strain: C57BL/6 	NULL	2417	normal	O35185	GM-CSF-cultured bone marrow	PEAKS049192
EXP051275	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot C1)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: wildtype Strain: C57BL/6 Source: TH1-polarizedÂ CD4+Â T cells 	NULL	1058	normal	O35185	CD4+ T-cells	PEAKS049193
EXP051276	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot C1)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: KO (Bhlhe40-/-) Strain: C57BL/6  Source: TH1-polarizedÂ CD4+Â T cells	NULL	1058	normal	O35185	CD4+ T-cells	PEAKS049194
EXP051279	MafK (Santa Cruz, CAT#sc-22831, Lot#12804)	Mus musculus		EXP051277	675	normal	Q61827	NIH 3T3 (embryonic fibroblasts)	PEAKS049195
EXP051280	MafK (Santa Cruz, CAT#sc-22831, Lot#12804)	Mus musculus		EXP051278	2418	normal	Q61827	RAW267.4 (murine monocyte/macrophages-like)	PEAKS049196
EXP051287	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051281	1153	normal	Q9CW03	C2C12 (myoblasts)	PEAKS049197
EXP051288	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051282	126	normal	Q9CW03	C2C12 (myotubes)	PEAKS049198
EXP051289	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: transfected SMC3 siDDR with RNAiMAX	NULL	126	normal	Q9CW03	C2C12 (myotubes)	PEAKS049199
EXP051290	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051284	1153	normal	Q9CW03	C2C12 (myoblasts)	PEAKS049200
EXP051291	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051285	126	normal	Q9CW03	C2C12 (myotubes)	PEAKS049201
EXP051292	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: transfected SMC3 siDDR with RNAiMAX	EXP051286	126	normal	Q9CW03	C2C12 (myotubes)	PEAKS049202
EXP051294	Pax5	Mus musculus	Strain: C57BL/6 Genotype: RAG-/-Âµ+ Source: Bone marrow and spleen cells	EXP051293	503	normal	Q02650	pre-B cells	PEAKS049203
EXP051300	FS2 (homemade)	Mus musculus	stably expressing ectopic FS2PWWP2A	EXP051295	230	normal	Q69Z61	ES-E14 (E14, embryonic stem cells)	PEAKS049204
EXP051301	FS2 (homemade)	Mus musculus	stably expressing ectopic PWWP-deleted PWWP2A	EXP051295	230	bio_control	Q69Z61	ES-E14 (E14, embryonic stem cells)	PEAKS049205
EXP051302	FS2 (homemade)	Mus musculus		NULL	230	normal	Q91WD5	ES-E14 (E14, embryonic stem cells)	PEAKS049206
EXP051303	Hdac1 (Abcam #Ab7028)	Mus musculus	stably expressing ectopic FS2PWWP2A	EXP051295	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	PEAKS049207
EXP051304	Hdac1 (Abcam #Ab7028)	Mus musculus	stably expressing FS2 vector	EXP051296	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	PEAKS049208
EXP051305	Hdac1 (Abcam #Ab7028) + H2Av (Active Motif #61686)	Mus musculus		EXP051297	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	PEAKS049209
EXP051306	Mta2 (Abcam #Ab8106) + H2Av (Active Motif #61686)	Mus musculus		EXP051297	230	normal	Q9R190	ES-E14 (E14, embryonic stem cells)	PEAKS049210
EXP051307	Hdac1 (Abcam #Ab7028) + H2Av (Active Motif #61686)	Mus musculus	double PWWP2A/B knockout	EXP051298	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	PEAKS049211
EXP051308	Mta2 (Abcam #Ab8106) + H2Av (Active Motif #61686)	Mus musculus	double PWWP2A/B knockout	EXP051298	230	normal	Q9R190	ES-E14 (E14, embryonic stem cells)	PEAKS049212
EXP051309	Hdac1 (Abcam #Ab7028) + H2Av (Active Motif #61686)	Mus musculus	double PWWP2A/B knockout	EXP051299	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	PEAKS049213
EXP051310	Mta2 (Abcam #Ab8106) + H2Av (Active Motif #61686)	Mus musculus		EXP051299	230	normal	Q9R190	ES-E14 (E14, embryonic stem cells)	PEAKS049214
EXP051311	FS2 (homemade)	Mus musculus		NULL	230	normal	Q91WD5	ES-E14 (E14, embryonic stem cells)	PEAKS049215
EXP051312	FS2 (homemade)	Mus musculus	stably expressing ectopic FS2PWWP2B	EXP051295	230	normal	E9Q9M8	ES-E14 (E14, embryonic stem cells)	PEAKS049216
EXP051313	pwwp2a	Mus musculus		EXP051295	230	normal	Q69Z61	ES-E14 (E14, embryonic stem cells)	PEAKS049217
EXP051319	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: wildtype  Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051314	198	normal	Q64261	pre-pro-B-cells	PEAKS049218
EXP051320	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: wildtype  Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051315	198	normal	Q64261	pre-pro-B-cells	PEAKS049219
EXP051321	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051316	198	normal	Q64261	pre-pro-B-cells	PEAKS049220
EXP051322	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051317	198	normal	Q64261	pre-pro-B-cells	PEAKS049221
EXP051323	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051318	198	normal	Q64261	pre-pro-B-cells	PEAKS049222
EXP051325	Smad4 antibody (04-1033, Millipore)	Mus musculus	Strain: C57BL/6 Age: Embryonic day 12.5&13.5	EXP051324	2419	normal	P97471	forelimb	PEAKS049223
EXP051328	anti-Nanog (#8785, Cell Signaling Technology)	Mus musculus		EXP051326	230	normal	Q80Z64	ES-E14 (E14, embryonic stem cells)	PEAKS049224
EXP051329	anti-Sox2 (#23064, Cell Signaling Technology)	Mus musculus		EXP051326	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS049225
EXP051330	anti-Oct4 (#5677, Cell Signaling Technology)	Mus musculus		EXP051326	230	normal	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS049226
EXP051331	anti-Uhrf1 (sc98817, Santa Cruz)	Mus musculus		EXP051326	230	normal	Q8VDF2	ES-E14 (E14, embryonic stem cells)	PEAKS049227
EXP051332	anti-Nanog (#8785, Cell Signaling Technology)	Mus musculus	Uhrf1 KO	EXP051327	230	normal	Q80Z64	ES-E14 (E14, embryonic stem cells)	PEAKS049228
EXP051333	anti-Sox2 (#23064, Cell Signaling Technology)	Mus musculus	Uhrf1 KO	EXP051327	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	PEAKS049229
EXP051334	anti-Oct4 (#5677, Cell Signaling Technology)	Mus musculus	Uhrf1 KO	EXP051327	230	normal	P20263	ES-E14 (E14, embryonic stem cells)	PEAKS049230
EXP051337	Sp9-rabbit(PMID: 27452460)	Mus musculus		EXP051335	2420	normal	Q64HY3	E13.5 basal ganglia	PEAKS049231
EXP051338	Sp9-rabbit(PMID: 27452460)	Mus musculus		EXP051336	2422	normal	Q64HY3	E16.5 basal ganglia	PEAKS049232
EXP051340	ELL2	Mus musculus		EXP051339	2423	normal	Q3UKU1	AxJ (hybrid B-cells)	PEAKS049233
EXP051343	Trim33 (Bethyl, A301-060A)	Mus musculus	Stage: Primary Th17 cells Tissue: spleen and lymph nodes Strain: C57BL/6 	EXP051341	2421	normal	Q99PP7	naive CD4+T cells	PEAKS049234
EXP051344	Trim33 (Bethyl, A301-060A)	Mus musculus	Stage: Primary Th17 cells Tissue: spleen and lymph nodes Strain: C57BL/6 	EXP051342	2421	normal	Q99PP7	naive CD4+T cells	PEAKS049235
EXP051346	anti-Ikaros Polyclonal rabbit made in house	Mus musculus	Strain: C57BL/6 Treatmetn: grown 24h without IL7 supernatant in the presence of 100nM of 4OH-Tamoxifen	EXP051345	2424	normal	Q03267	BH1 (Pre-B-cells)	PEAKS049236
EXP051347	PPARg (Perseus #PP-A3409A)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6	NULL	81	normal	P37238	BMDM (bone marrow-derived macrophages)	PEAKS049237
EXP051348	PPARg (Perseus #PP-A3409A)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 20ng/ul IL-4 /DMSO exposure	NULL	81	normal	P37238	BMDM (bone marrow-derived macrophages)	PEAKS049238
EXP051349	PPARg (Perseus #PP-A3409A)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 1uM GW9662 exposure	NULL	81	normal	P37238	BMDM (bone marrow-derived macrophages)	PEAKS049239
EXP051350	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049240
EXP051351	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of DMSO exposure	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049241
EXP051352	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 20ng/ul IL-4/ 1uM GW9662 exposure	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049242
EXP051353	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Genotype: wildtype	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049243
EXP051354	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 TGenotype: wildtype Treatment: followed by 24 hours of 20ng/ul IL-4 exposure 	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049244
EXP051355	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Genotype: Pparg knockout	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049245
EXP051356	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 20ng/ul IL-4 exposure Genotype: Pparg knockout 	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	PEAKS049246
EXP051357	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Genotype: wildtype	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS049247
EXP051358	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of IL-4 exposure  Genotype: Pparg knockout	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS049248
EXP051359	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6  Genotype: Pparg knockout	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS049249
EXP051360	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of IL-4 exposure  Genotype: Pparg knockout	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	PEAKS049250
EXP051362	Anti-Tead1 (BD 610922)	Mus musculus	9 weeks post tamoxifen	EXP051361	513	normal	P30051	K14CreER SmoM2 (basal cell carcinoma)	PEAKS049251
EXP051363	Anti-Tead4 (ab58310 â€“ Abcam)	Mus musculus	9 weeks post tamoxifen	EXP051361	513	normal	Q62296	K14CreER SmoM2 (basal cell carcinoma)	PEAKS049252
EXP051367	Smc1 (Bethyl, A300-055A)	Mus musculus	WT	EXP051364	230	normal	Q9CU62	ES-E14 (E14, embryonic stem cells)	PEAKS049253
EXP051368	Med1 (Santa Cruz, sc-5334)	Mus musculus	siCtrl	EXP051365	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	PEAKS049254
EXP051369	Med12 (Abcam, Ab70842)	Mus musculus	siCtrl	EXP051365	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049255
EXP051370	Carey Lab	Mus musculus	siCtrl	EXP051365	230	normal	P62915	ES-E14 (E14, embryonic stem cells)	PEAKS049256
EXP051371	Esrrb (Perseus Proteomics,PP-H6705-00)	Mus musculus	siCtrl	EXP051365	230	normal	Q61539	ES-E14 (E14, embryonic stem cells)	PEAKS049257
EXP051372	TAF2 (Novus, NBP1-21371)	Mus musculus	siCtrl	EXP051365	230	normal	Q8C176	ES-E14 (E14, embryonic stem cells)	PEAKS049258
EXP051373	Med26 (Santa Cruz, sc-1521)	Mus musculus	siCtrl	EXP051365	230	normal	Q7TN02	ES-E14 (E14, embryonic stem cells)	PEAKS049259
EXP051374	Med1 (Santa Cruz, sc-5334)	Mus musculus	siEsrrb	EXP051366	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	PEAKS049260
EXP051375	Med12 (Abcam, Ab70842)	Mus musculus	siEsrrb	EXP051366	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049261
EXP051376	Carey Lab	Mus musculus	siEsrrb	EXP051366	230	normal	P62915	ES-E14 (E14, embryonic stem cells)	PEAKS049262
EXP051377	Esrrb (Perseus Proteomics,PP-H6705-00)	Mus musculus	siEsrrb	EXP051366	230	normal	Q61539	ES-E14 (E14, embryonic stem cells)	PEAKS049263
EXP051379	anti-YAP1 (US Biological; Y1200-01D)	Mus musculus	Tissue: sham Phenotype: wildtype Strain: C57BL/6J Sex: male 	EXP051378	53	normal	P46938	heart	PEAKS049264
EXP051380	anti-YAP1 (US Biological; Y1200-01D)	Mus musculus	Tissue:transverse aortic constriction Phenotype: wildtype Strain: C57BL/6J Sex: male 	EXP051378	53	normal	P46938	heart	PEAKS049265
EXP051381	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1; Lactation day 1	NULL	572	normal	P42230	mammary gland	PEAKS049266
EXP051382	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1; Lactation day 1	NULL	572	normal	P06537	mammary gland	PEAKS049267
EXP051383	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE2-delE3; Lactation day 1	NULL	572	normal	P42230	mammary gland	PEAKS049268
EXP051384	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE2-delE3; Lactation day 1	NULL	572	normal	P06537	mammary gland	PEAKS049269
EXP051385	STAT3 (Santa Cruz, sc-482)	Mus musculus	WT; lactation day 10	NULL	523	normal	P42227	kidney	PEAKS049270
EXP051386	GR (Thermo Scientific, PA1-511A)	Mus musculus	WT; lactation day 10	NULL	523	normal	P06537	kidney	PEAKS049271
EXP051387	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-E12-Ramp3; lactation day 10	NULL	523	normal	P06537	kidney	PEAKS049272
EXP051388	STAT3 (Santa Cruz, sc-482)	Mus musculus	Wap-E12-Ramp3; lactation day 10	NULL	523	normal	P42227	kidney	PEAKS049273
EXP051389	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-E12-Ramp3; lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049274
EXP051390	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-E2-Ramp3; lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049275
EXP051391	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE3; lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049276
EXP051392	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE2-delE3; lactation day 10	NULL	572	normal	P06537	mammary gland	PEAKS049277
EXP051393	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE2-delE3; lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049278
EXP051394	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE3; Lactation day 10	NULL	572	normal	P06537	mammary gland	PEAKS049279
EXP051395	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE3; Lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049280
EXP051396	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE3; Lactation day 1	NULL	572	normal	P06537	mammary gland	PEAKS049281
EXP051397	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE3; Lactation day 1	NULL	572	normal	P42230	mammary gland	PEAKS049282
EXP051398	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1; Lactation day 10	NULL	572	normal	P06537	mammary gland	PEAKS049283
EXP051399	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1; Lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049284
EXP051400	MED1 (Bethyl Laboratory, A300-793A)	Mus musculus	WT; Lactation day 10	NULL	572	normal	Q925J9	mammary gland	PEAKS049285
EXP051401	GR (Thermo Scientific, PA1-511A)	Mus musculus	WT; Lactation day 10	NULL	572	normal	P06537	mammary gland	PEAKS049286
EXP051402	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	WT; Lactation day 10	NULL	572	normal	P42230	mammary gland	PEAKS049287
EXP051403	GR (Thermo Scientific, PA1-511A)	Mus musculus	WT; Lactation day 1	NULL	572	normal	P06537	mammary gland	PEAKS049288
EXP051404	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	WT; Lactation day 1	NULL	572	normal	P42230	mammary gland	PEAKS049289
EXP051405	DMC1 (Santa Cruz, sc-8973)	Mus musculus	Age: adult Genotype: Cxxc1 heterozygous with Stra8-iCre	NULL	803	normal	Q61880	spermatocytes	PEAKS049290
EXP051406	DMC1 (Santa Cruz, sc-8973)	Mus musculus	Age: adult Genotype: Cxxc1-knockout with Stra8-iCre	NULL	803	normal	Q61880	spermatocytes	PEAKS049291
EXP051409	anti-Pou2f3 antibody (Santa Cruz #SC330)	Mus musculus	Strain: C57BL/6J	EXP051408	2426	normal	P31362	intestinal tuft cells	PEAKS049292
EXP051415	Anti-Chd7 (Cell Signaling; 6505)	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	EXP051411	2427	normal	A2AJK6	cortex and corpus callosum	PEAKS049293
EXP051416	Anti-Chd7 (Cell Signaling; 6505)	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	EXP051413	2427	normal	A2AJK6	cortex and corpus callosum	PEAKS049294
EXP051417	Anti-Chd8 (Bethyl; A301-224A)	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	EXP051414	2427	normal	Q09XV5	cortex and corpus callosum	PEAKS049295
EXP051419	Anti-Flag M2 Affinity Gel(Sigma, A2220)	Mus musculus	Strain: C57BL/6 Genotype: Hira3XFlag-HA/3XFlag-HA	EXP051418	2	normal	Q61666	mESCs (mouse embryonic stem cells)	PEAKS049296
EXP051420	Anti-Flag M2 Affinity Gel(Sigma, A2220)	Mus musculus	Strain: C57BL/6 Genotype: Ubn13XFlag-HA/3XFlag-HA	NULL	2	normal	Q4G0F8	mESCs (mouse embryonic stem cells)	PEAKS049297
EXP051421	Anti-Flag M2 Affinity Gel(Sigma, A2220)	Mus musculus	Strain: C57BL/6 Genotype: Ubn23XFlag-HA/3XFlag-HA	NULL	2	normal	Q80WC1	mESCs (mouse embryonic stem cells)	PEAKS049298
EXP051432	DPPA2 (Millipore, MAB4356)	Mus musculus	Decription: control Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051422	12	normal	Q9CWH0	MEF (mouse embryonic fibroblasts)	PEAKS049299
EXP051433	DPPA4 (R&D, Systems AF3730)	Mus musculus	Decription: control Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051422	12	normal	Q8CCG4	MEF (mouse embryonic fibroblasts)	PEAKS049300
EXP051434	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051423	12	normal	Q9CWH0	MEF (mouse embryonic fibroblasts)	PEAKS049301
EXP051435	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: DPPA2 and DPPA4 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051424	12	normal	Q9CWH0	MEF (mouse embryonic fibroblasts)	PEAKS049302
EXP051436	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: DPPA2 and DPPA4  overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051424	12	normal	Q8CCG4	MEF (mouse embryonic fibroblasts)	PEAKS049303
EXP051437	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: DPPA4 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051425	12	normal	Q8CCG4	MEF (mouse embryonic fibroblasts)	PEAKS049304
EXP051438	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: wildtype Strain: 129 	EXP051427	2	normal	Q9CWH0	mESCs (mouse embryonic stem cells)	PEAKS049305
EXP051439	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: wildtype Strain: 129 	EXP051427	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	PEAKS049306
EXP051440	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: Dppa2 ChIP from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	EXP051428	2429	normal	Q9CWH0	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049307
EXP051441	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: Dppa4 ChIP from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	EXP051428	2429	normal	Q8CCG4	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049308
EXP051442	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: Dppa2 and Dppa4 overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	normal	Q9CWH0	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049309
EXP051443	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: Dppa2 ChIP from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	normal	Q8CCG4	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049310
EXP051449	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: wildtype Treatment: culture conditions NPC medium	EXP051445	138	normal	Q9DA79	neural progenitors	PEAKS049311
EXP051450	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: culture conditions NPC medium	EXP051445	138	normal	Q6PDQ2	neural progenitors	PEAKS049312
EXP051451	GFP (Abcam, ab290)	Mus musculus	Genotype: ZFP296-BAC Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	E9Q6W4	R1 (embryonic stem cells)	PEAKS049313
EXP051452	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051444	765	normal	Q60520	R1 (embryonic stem cells)	PEAKS049314
EXP051453	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051446	765	normal	Q9DA79	R1 (embryonic stem cells)	PEAKS049315
EXP051454	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051446	765	normal	Q6PDQ2	R1 (embryonic stem cells)	PEAKS049316
EXP051455	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051446	765	normal	Q60520	R1 (embryonic stem cells)	PEAKS049317
EXP051456	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	Q9DA79	R1 (embryonic stem cells)	PEAKS049318
EXP051457	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	Q6PDQ2	R1 (embryonic stem cells)	PEAKS049319
EXP051458	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	Q60520	R1 (embryonic stem cells)	PEAKS049320
EXP051459	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	EXP051448	765	normal	Q9DA79	R1 (embryonic stem cells)	PEAKS049321
EXP051460	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	EXP051448	765	normal	Q6PDQ2	R1 (embryonic stem cells)	PEAKS049322
EXP051461	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	EXP051448	765	normal	Q60520	R1 (embryonic stem cells)	PEAKS049323
EXP051462	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051444	765	normal	Q9DA79	R1 (embryonic stem cells)	PEAKS049324
EXP051463	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051444	765	normal	Q6PDQ2	R1 (embryonic stem cells)	PEAKS049325
EXP051466	SUMO-1 (Abcam, ab32058)	Mus musculus	Ubc9-WT	EXP051464	750	normal	P63166	E13.5 embryonic fibroblasts	PEAKS049326
EXP051467	SUMO-1 (Abcam, ab32058)	Mus musculus	Ubc9-KO	EXP051465	750	normal	P63166	E13.5 embryonic fibroblasts	PEAKS049327
EXP051468	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Ubc9-WT	EXP051464	750	normal	P61957	E13.5 embryonic fibroblasts	PEAKS049328
EXP051469	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Ubc9-KO	EXP051465	750	normal	P61957	E13.5 embryonic fibroblasts	PEAKS049329
EXP051471	HNF4A	Mus musculus	Strain: liver Age: 8 weeks old Sample: ZT4 	EXP051470	5	normal	P49698	liver	PEAKS049330
EXP051472	HNF4A	Mus musculus	Strain: liver Age: 8 weeks old Sample: ZT6 	EXP051470	5	normal	P49698	liver	PEAKS049331
EXP051477	Hmgn2	Mus musculus	Source: undifferentiated P19 EC cells	EXP051473	705	normal	P09602	P19 (embryonic carcinoma)	PEAKS049332
EXP051480	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: KPS1 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	EXP051478	2431	normal	P48432	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	PEAKS049333
EXP051481	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: KPS2 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	EXP051478	2431	normal	P48432	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	PEAKS049334
EXP051482	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: KPS3 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	EXP051478	2431	normal	P48432	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	PEAKS049335
EXP051483	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model	EXP051479	2432	normal	P48432	Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model; infected with Ad5-CMV-Cre virus; harvested approximately 10 months post-infection.	PEAKS049336
EXP051484	SOX17 (R&D Systems AF1924)	Mus musculus	Strain: C57BL/6  Genotype: wildtype Sex: female	NULL	132	normal	Q61473	uterus	PEAKS049337
EXP051486	Sox9	Mus musculus	Confluence: subconfluent Treatment: Cells were crosslinked for 10 min and sonicated using Covaris sonicator	EXP051485	18	normal	Q04887	3T3-L1 (embryonic fibroblasts)	PEAKS049338
EXP051487	ZMYND8 (HPA020949, Sigma-Aldrich)	Mus musculus	Genotype: ZMYND8 knockout	NULL	178	normal	A2A479	CH12 (lymphoma)	PEAKS049339
EXP051488	ZMYND8 (HPA020949, Sigma-Aldrich)	Mus musculus	Genotype: wildtype	NULL	178	normal	A2A479	CH12 (lymphoma)	PEAKS049340
EXP051489	ZMYND8 (HPA020949, Sigma-Aldrich)	Mus musculus	Genotype: Cd19-Cre/+ Tissue: Splenocytes	NULL	2433	normal	A2A479	primary B cells	PEAKS049341
EXP051490	anti-Nanog rabbit polyclonal (made in-house)	Mus musculus	Sorted fraction: Esrrb-High	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS049342
EXP051491	anti-Nanog rabbit polyclonal (made in-house)	Mus musculus	Sorted fraction: Esrrb-Medium	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS049343
EXP051492	anti-Nanog rabbit polyclonal (made in-house)	Mus musculus	Sorted fraction: Esrrb-Negative	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS049344
EXP051493	goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, Cat # SC-8628)	Mus musculus	Sorted fraction: Esrrb-High	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS049345
EXP051494	goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, Cat # SC-8628)	Mus musculus	Sorted fraction: Esrrb-Medium	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS049346
EXP051495	goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, Cat # SC-8628)	Mus musculus	Sorted fraction: Esrrb-Negative	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS049347
EXP051500	TBR1 (Santa Cruz Biotech, Cat# sc-48816 X)	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	EXP051496	193	normal	Q64336	cortex	PEAKS049348
EXP051501	TBR1 (Santa Cruz Biotech, Cat# sc-48816 X)	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	EXP051498	193	normal	Q64336	cortex	PEAKS049349
EXP051506	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing Empty vector	EXP051502	2435	normal	P26323	Ba/F3-Mpl	PEAKS049350
EXP051507	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing WT Calreticuline (CALR)	EXP051503	2435	normal	P26323	Ba/F3-Mpl	PEAKS049351
EXP051508	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing del Calreticuline (CALR)	EXP051504	2435	normal	P26323	Ba/F3-Mpl	PEAKS049352
EXP051509	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing INS Calreticuline (CALR)	EXP051505	2435	normal	P26323	Ba/F3-Mpl	PEAKS049353
EXP051512	Oct4 (Santa Cruz, sc-8628X, #A2414)	Mus musculus	Treatment: DMSO for 24 hrs	EXP051510	252	normal	P20263	V6.5 (embryonic stem cells)	PEAKS049354
EXP051513	Oct4 (Santa Cruz, sc-8628X, #A2414)	Mus musculus	Treament: dTAG-47, 100 nM for 24 hrs	EXP051511	252	normal	P20263	V6.5 (embryonic stem cells)	PEAKS049355
EXP051514	Med1/TRAP220 (Bethyl, A300-793A, #7)	Mus musculus	Treatment: DMSO for 24 hrs	EXP051510	252	normal	Q925J9	V6.5 (embryonic stem cells)	PEAKS049356
EXP051515	Med1/TRAP220 (Bethyl, A300-793A, #7)	Mus musculus	Treament: dTAG-47, 100 nM for 24 hrs	EXP051511	252	normal	Q925J9	V6.5 (embryonic stem cells)	PEAKS049357
EXP051517	NFIA, Sigma, HPA006111	Mus musculus		EXP051516	2430	normal	Q02780	ESC-derived glial progenitor cells	PEAKS049358
EXP051518	Sox3, Muhr-lab	Mus musculus		EXP051516	2430	normal	P53784	ESC-derived glial progenitor cells	PEAKS049359
EXP051519	Sox9, Millipore, AB5535	Mus musculus		EXP051516	2430	normal	Q04887	ESC-derived glial progenitor cells	PEAKS049360
EXP051521	rabbit anti-SOX4 (Diagenode, CS-129-100)	Mus musculus	Strain: CD1 Age: E14.5 Treatment: untreated 	EXP051520	2436	normal	Q06831	embryonic neural stem cells	PEAKS049361
EXP051523	Cfp1 (BETHYL, A303-161A)	Mus musculus	Tissue: Testes Strain: C57Bl/6 Age: P21	EXP051522	803	normal	Q8BGU5	spermatocytes	PEAKS049362
EXP051525	anti-PU.1 (Santa Cruz, T-20)	Mus musculus	Strain: C56BL/6 Cell type: Conventional dendritic cells	EXP051524	104	normal	P17433	dendritic cells	PEAKS049363
EXP051526	anti-PU.1 (Santa Cruz, T-20)	Mus musculus	Strain: C56BL/6 Cell type: Plasmacytoid dentritic cells	EXP051524	104	normal	P17433	dendritic cells	PEAKS049364
EXP051529	Biotin	Mus musculus	Strain: Balb/c Genotype: Raw-Bap-Ipr1-P2A-BirA	EXP051527	91	normal	Q8BVK9	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS049365
EXP051530	anti-Flag	Mus musculus	Strain: Balb/c Genotype: Raw-Bap-Ipr1-P2A-BirA	EXP051528	91	normal	Q8BVK9	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS049366
EXP051531	Arid1a (Cell Signaling Technology, #12354)	Mus musculus	Passage: 10-12 Strain: C57BL/6 Genotype: wildtype 	NULL	2437	normal	A2BH40	intestinal spheroid	PEAKS049367
EXP051533	anti-JARID2 BL3844(kindly provided by Eric W. McIntush, Bethyl Laboratories, Inc.)	Mus musculus	Strain: C57BL/6 	NULL	437	normal	Q62315	HL-1 (cardiac muscle cells)	PEAKS049368
EXP051535	anti-SET (ab85389, Abcam)	Mus musculus		EXP051534	765	normal	Q9EQU5	R1 (embryonic stem cells)	PEAKS049369
EXP051537	Ctcf antibody (Millipore, catalog#07-729, lot#DAM1772428)	Mus musculus	Passage: 28 -31 Day:0 Strain: C57BL/6 Celltype: preosteoblast	NULL	581	normal	Q61164	MC3T3-E1 (preosteoblasts)	PEAKS049370
EXP051538	Ctcf antibody (Millipore, catalog#07-729, lot#DAM1772428)	Mus musculus	Passage: 28 -31 Day:9 Strain: C57BL/6 Celltype: matrix-depositing osteoblast	EXP051536	581	normal	Q61164	MC3T3-E1 (preosteoblasts)	PEAKS049371
EXP051539	Ctcf antibody (Millipore, catalog#07-729, lot#DAM1772428)	Mus musculus	Passage: 28 -31 Day:28 Strain: C57BL/6 Celltype: mineralizing osteoblast	NULL	581	normal	Q61164	MC3T3-E1 (preosteoblasts)	PEAKS049372
EXP051540	Brd4 (Bethyl IHC-00396)	Mus musculus	Treatment: 1uL/1mL DMSO	NULL	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	PEAKS049373
EXP051541	Brd4 (Bethyl IHC-00396)	Mus musculus	Treatment: 1 uM MS417 BET-inhibitor	NULL	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	PEAKS049374
EXP051544	Anti-Notch1(Abcam, ab27526 )	Mus musculus	Source: cell Treatment: Cells are treated with 100 ng/ml of lipopolysaccharide (LPS) for 4 hours to induce M1 phenotype Cell type: macrophage-like, Abelson leukemia virus transformed	EXP051542	91	normal	Q01705	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS049375
EXP051545	Anti-Notch1(Abcam, ab27526 )	Mus musculus	Source: mitochondria Treatment: Cells are treated with 100 ng/ml of lipopolysaccharide (LPS) for 4 hours to induce M1 phenotype Cell type: macrophage-like, Abelson leukemia virus transformed	EXP051543	91	normal	Q01705	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS049376
EXP051549	anti-CTCF	Mus musculus	Treatment: C57BL/6	EXP051546	499	normal	Q61164	Th2-cells	PEAKS049377
EXP051550	anti-CTCF	Mus musculus	Treatment: C57BL/6 Genotype: wildtype	NULL	243	normal	Q61164	EL4 (lymphoma)	PEAKS049378
EXP051551	anti-CTCF	Mus musculus	Treatment: C57BL/6 Genotype: CTCF-motif knockout Treatment: Genome Editing was carried out by CRISPR/Cas9 system 	EXP051548	243	normal	Q61164	EL4 (lymphoma)	PEAKS049379
EXP051556	MyoD (Santa Cruz, catalog# sc-304; lot# C0812)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	EXP051552	1153	normal	P10085	C2C12 (myoblasts)	PEAKS049380
EXP051557	Myogenin (Santa Cruz, catalog# sc-12732; lot# J0813)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	EXP051552	1153	normal	P12979	C2C12 (myoblasts)	PEAKS049381
EXP051558	MyoD (Santa Cruz, catalog# sc-304; lot# C0812)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	EXP051554	1153	normal	P10085	C2C12 (myoblasts)	PEAKS049382
EXP051559	Myogenin (Santa Cruz, catalog# sc-12732; lot# J0813)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	EXP051554	1153	normal	P12979	C2C12 (myoblasts)	PEAKS049383
EXP051560	TDP-43 (Abcam, catalog# ab41972; lot# GR200025-1)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	EXP051554	1153	normal	Q921F2	C2C12 (myoblasts)	PEAKS049384
EXP051561	TDP-43 (Abcam, catalog# ab41972; lot# GR200025-1)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	EXP051552	1153	normal	Q921F2	C2C12 (myoblasts)	PEAKS049385
EXP051563	anti-Nrf2	Mus musculus	Genotype: wildtype Developmental stage: Postnatal day 6	EXP051562	2438	normal	Q60795	heart ventricels	PEAKS049386
EXP051564	anti-Flag BioM2 antibody (Sigma-Aldrich)	Mus musculus	Genotype: wildtype Developmental stage: Postnatal day 6 Treatment: 	EXP051562	2438	normal	P97474	heart ventricels	PEAKS049387
EXP051566	anti-SMRT Abcam, ab24551 Lot# GR140820-1	Mus musculus	Treatment: Strain: C57BL/6J	EXP051565	2	normal	Q9WU42	mESCs (mouse embryonic stem cells)	PEAKS049388
EXP051567	anti-NCoR Millipore, ABE251, Lot#2153059	Mus musculus	Treatment: Strain: C57BL/6J-OG2 Treatment: OSKM Day:9	NULL	2439	normal	Q60974	Intermediate pluripotent reprogramed cells	PEAKS049389
EXP051568	anti-SMRT Abcam, ab24551 Lot# GR140820-1	Mus musculus	Treatment: Strain: C57BL/6J-OG2 Treatment: OSKM Day:9	NULL	2439	normal	Q9WU42	Intermediate pluripotent reprogramed cells	PEAKS049390
EXP051573	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days	EXP051571	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049392
EXP051574	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days	EXP051571	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049393
EXP051575	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days; Kmt2b-/-	EXP051572	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049394
EXP051576	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days; Kmt2b-/-	EXP051572	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049395
EXP051580	anti-Blimp1 (Novus, clone 3H2-E8)	Mus musculus	Genotype: wildtype clone1 Strain: C57Bl6/J;129/SvEv Source: Day 2 differentiated trophoblast stem cells	EXP051577	2440	normal	Q60636	differentiated trophoblast stem cells	PEAKS049396
EXP051581	anti-Blimp1 (Novus, clone 3H2-E8)	Mus musculus	Genotype: wildtype clone2 Strain: C57Bl6/J;129/SvEv Source: Day 2 trophoblast giant cells	EXP051578	2440	normal	Q60636	differentiated trophoblast stem cells	PEAKS049397
EXP051582	anti-Blimp1 (Novus, clone 3H2-E8)	Mus musculus	Genotype: mutant clone Strain: C57Bl6/J;129/SvEv Source: Day 2 trophoblast giant cells	EXP051579	2440	bio_control	Q60636	differentiated trophoblast stem cells	PEAKS049398
EXP051584	Ezh2, Cell Signalling, cat no: 5246 , lot: 6	Mus musculus	Passage: 4-5 Strain: C57BL/6	EXP051583	253	normal	P24270	EML -C1(EML, clone 1)	PEAKS049399
EXP051585	Runx1, Abcam, cat no: ab23980, lot: GR184947-1	Mus musculus	Passage: 4-5 Strain: C57BL/6	EXP051583	253	normal	Q03347	EML -C1(EML, clone 1)	PEAKS049400
EXP051587	smad2	Mus musculus		EXP051586	2441	normal	Q62432	squamous cell carcinoma	PEAKS049401
EXP051590	anti-Gtf3c1	Mus musculus	Strain: C57BL/6J  Treatment: untreated	EXP051588	2443	normal	Q8K284	DIV6 (Primary cortical neurons)	PEAKS049402
EXP051591	anti-Gtf3c1	Mus musculus	Strain: C57BL/6J Treatment: 50 mM KCl for 45 min	EXP051589	2443	normal	Q8K284	DIV6 (Primary cortical neurons)	PEAKS049403
EXP051596	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	Treatment PBS primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051592	53	normal	Q3TKT4	heart	PEAKS049404
EXP051597	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	Treatment PBS primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051593	53	normal	Q3TKT4	heart	PEAKS049405
EXP051598	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	TreatmentTbeta4-primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051594	53	normal	Q3TKT4	heart	PEAKS049406
EXP051599	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	TreatmentTbeta4-primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051595	53	normal	Q3TKT4	heart	PEAKS049407
EXP051602	Ptf1a antibody (kindly supplied by Bernardette BrÃ©ant)	Mus musculus	Genotype: Ela1-myc mice Age: 8 weeks-old	EXP051600	713	normal	Q9QX98	pancreas	PEAKS049408
EXP051603	c-Myc antibody (N262, Santa Cruz) 	Mus musculus	Genotype: Ela1-myc mice Age: 8 weeks-old	EXP051601	713	normal	P01108	pancreas	PEAKS049409
EXP051604	JunD (sc-74, Santa Cruz)	Mus musculus	Genotype: wildtype Strain: C57BL/6 Tissue: spleen Treament: stimulated ex vivo with plate-bound anti-CD3 and anti-CD28 antibodies	NULL	2444	normal	P15066	pre-activated CD8+ T cells	PEAKS049410
EXP051605	JunD (sc-74, Santa Cruz)	Mus musculus	Genotype: Bach2-/- Strain: C57BL/6 Tissue: spleen Treament: stimulated ex vivo with plate-bound anti-CD3 and anti-CD28 antibodies	NULL	2444	normal	P15066	pre-activated CD8+ T cells	PEAKS049411
EXP051606	p300 (sc-586, Santa Cruz)	Mus musculus	Genotype: wildtype Strain: C57BL/6 Tissue: spleen 	NULL	2444	normal	B2RWS6	pre-activated CD8+ T cells	PEAKS049412
EXP051610	anti-SPOC1	Mus musculus	Strain: C57Bl/6 Genotype: wildtype Age: 5 weeks	EXP051607	32	normal	Q3V230	testis	PEAKS049413
EXP051611	anti-SPOC1	Mus musculus	Strain: C57Bl/6 Genotype: Phf13-/- Age: 5 weeks	EXP051608	32	normal	Q3V230	testis	PEAKS049414
EXP051612	anti-SPOC1	Mus musculus	Strain: C57Bl/6 Genotype: Phf13-/- Age: 5 weeks	EXP051609	32	normal	Q3V230	testis	PEAKS049415
EXP051613	anti-Bcl11b, Bethyl (Cat# A300-385A)	Mus musculus	Tissue: Thymus Strain: C57BL/6	NULL	171	normal	Q99PV8	CD4+ CD8+ T cells	PEAKS049416
EXP051614	againt BCL11B, Bethyl (Cat# A300-385A)	Mus musculus	Tissue: Peripheral lymph node Strain: C57BL/6	NULL	2421	normal	Q99PV8	naive CD4+T cells	PEAKS049417
EXP051618	anti-p63	Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: wildtype Source: E18.5 derived primary murine keratinocytes	EXP051615	936	normal	O88898	primary keratinocytes	PEAKS049418
EXP051619	anti-p63	Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: TAp63-/-  Source: E18.5 derived primary murine keratinocytes	EXP051616	936	normal	O88898	primary keratinocytes	PEAKS049419
EXP051620	anti-p63	Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: {delta}Np63-/-  Source: E18.5 derived primary murine keratinocytes	EXP051617	936	normal	O88898	primary keratinocytes	PEAKS049420
EXP051624	anti-Bcl11b Bethyl (Cat# A300-383A)	Mus musculus	Treatment: fixed with EGS Strain: C57BL/6 Tissue: thymocyte Age: adult (11 weeks) Sex: male Genotype: wildtype	EXP051621	2446	normal	Q99PV8	total thymocytes	PEAKS049421
EXP051625	anti-Bcl11b Bethyl (Cat# A300-383A)	Mus musculus	Treatment: fixed with formaldehyde Strain: C57BL/6 Tissue: thymocyte Age: adult (11 weeks) Sex: male Genotype: wildtype	EXP051622	2446	normal	Q99PV8	total thymocytes	PEAKS049422
EXP051626	anti-Bcl11b Bethyl (Cat# A300-383A)	Mus musculus	Treatment: fixed with formaldehyde Strain: C57BL/6 Tissue: thymocyte Age: adult (8.1 weeks) Sex: male Genotype: wildtype	EXP051623	2446	normal	Q99PV8	total thymocytes	PEAKS049423
EXP051640	brg1 (sc10768x ,santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	EXP051627	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	PEAKS049424
EXP051641	brg1 (sc10768x ,santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	EXP051628	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	PEAKS049425
EXP051642	phf5a (sc82995x, santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	normal	P83870	mESCs (mouse embryonic stem cells)	PEAKS049426
EXP051643	phf5a	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 flox flox parental	NULL	2	normal	P83870	mESCs (mouse embryonic stem cells)	PEAKS049427
EXP051644	ssrp1 (sc73546, santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	normal	Q08943	mESCs (mouse embryonic stem cells)	PEAKS049428
EXP051645	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051636	765	normal	Q3TKT4	R1 (embryonic stem cells)	PEAKS049429
EXP051646	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051636	765	normal	Q61103	R1 (embryonic stem cells)	PEAKS049430
EXP051647	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051639	765	normal	Q3TKT4	R1 (embryonic stem cells)	PEAKS049431
EXP051648	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051639	765	normal	Q61103	R1 (embryonic stem cells)	PEAKS049432
EXP051649	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051638	765	normal	Q61103	R1 (embryonic stem cells)	PEAKS049433
EXP051650	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051637	765	normal	Q3TKT4	R1 (embryonic stem cells)	PEAKS049434
EXP051651	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051637	765	normal	Q61103	R1 (embryonic stem cells)	PEAKS049435
EXP051652	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051638	765	normal	Q3TKT4	R1 (embryonic stem cells)	PEAKS049436
EXP051653	baf155 (sc-365543X, santa cruz)	Mus musculus	Strain : 129/Ola	NULL	2	normal	P97496	mESCs (mouse embryonic stem cells)	PEAKS049437
EXP051654	baz1a	Mus musculus	Strain : 129/Ola	NULL	2	normal	O88379	mESCs (mouse embryonic stem cells)	PEAKS049438
EXP051655	brg1 (sc10768x, santa cruz)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	PEAKS049439
EXP051656	phf5a (sc82995x, santa cruz )	Mus musculus	Strain : 129/Ola	NULL	2	normal	P83870	mESCs (mouse embryonic stem cells)	PEAKS049440
EXP051657	ruvbl1 (06-1299,upstate)	Mus musculus	Strain : 129/Ola	NULL	2	normal	P60122	mESCs (mouse embryonic stem cells)	PEAKS049441
EXP051658	ruvbl2	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q9WTM5	mESCs (mouse embryonic stem cells)	PEAKS049442
EXP051659	sap18 (ab31748, abcam )	Mus musculus	Strain : 129/Ola	NULL	2	normal	O55128	mESCs (mouse embryonic stem cells)	PEAKS049443
EXP051660	smc3 (ab9263, abcam )	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q9CW03	mESCs (mouse embryonic stem cells)	PEAKS049444
EXP051661	srsf1 (am39544, active motif)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q6PDM2	mESCs (mouse embryonic stem cells)	PEAKS049445
EXP051662	srsf2 (sc53518, santa cruz)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q62093	mESCs (mouse embryonic stem cells)	PEAKS049446
EXP051663	sur2 (550429, BD pharmingen)	Mus musculus	Strain : 129/Ola	NULL	2	normal	P70170	mESCs (mouse embryonic stem cells)	PEAKS049447
EXP051664	wstf (ab51256, abcam)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q9Z277	mESCs (mouse embryonic stem cells)	PEAKS049448
EXP051665	brg1 (sc10768x ,santa cruz)	Mus musculus	Strain : 129/Ola Genotype: MLL3/4 flox flox parental	NULL	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	PEAKS049449
EXP051666	med12 (A300-772A, bethyl)	Mus musculus	Strain : 129/Ola	NULL	2	normal	A2AGH6	mESCs (mouse embryonic stem cells)	PEAKS049450
EXP051667	med1 (sc8998, santa cruz)	Mus musculus	Strain: 129/Ola  	NULL	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS049451
EXP051668	phrf1 (A302-044A, bethyl )	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	normal	A6H619	mESCs (mouse embryonic stem cells)	PEAKS049452
EXP051669	phrf1	Mus musculus	Strain: 129/C57 	NULL	2	normal	A6H619	mESCs (mouse embryonic stem cells)	PEAKS049453
EXP051670	phrf1	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 flox flox parental	NULL	2	normal	A6H619	mESCs (mouse embryonic stem cells)	PEAKS049454
EXP051692	Smc3	Mus musculus	Genotype: wildtype	EXP051675	230	normal	Q9CW03	ES-E14 (E14, embryonic stem cells)	PEAKS049455
EXP051693	Smc3	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	EXP051677	230	normal	Q9CW03	ES-E14 (E14, embryonic stem cells)	PEAKS049456
EXP051694	Med1	Mus musculus	Genotype: wildtype	EXP051675	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	PEAKS049457
EXP051695	Med1	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	EXP051676	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	PEAKS049458
EXP051696	Med12	Mus musculus	Genotype: wildtype	EXP051675	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049459
EXP051697	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	EXP051676	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049460
EXP051698	Med23	Mus musculus	Genotype: wildtype	NULL	230	normal	Q80YQ2	ES-E14 (E14, embryonic stem cells)	PEAKS049461
EXP051699	Med23	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	NULL	230	normal	Q80YQ2	ES-E14 (E14, embryonic stem cells)	PEAKS049462
EXP051700	Med12	Mus musculus	Genotype: wildtype Day: 0	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049463
EXP051701	Rad21	Mus musculus	Genotype: wildtype Day: 0	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049464
EXP051702	Med12	Mus musculus	Genotype: wildtype Day: 1	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049465
EXP051703	Rad21	Mus musculus	Genotype: wildtype Day: 1	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049466
EXP051704	Med12	Mus musculus	Genotype: wildtype Day: 1.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049467
EXP051705	Rad21	Mus musculus	Genotype: wildtype Day: 1.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049468
EXP051706	Med12	Mus musculus	Genotype: wildtype Day: 2	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049469
EXP051707	Rad21	Mus musculus	Genotype: wildtype Day: 2	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049470
EXP051708	Med12	Mus musculus	Genotype: wildtype Day: 2.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049471
EXP051709	Rad21	Mus musculus	Genotype: wildtype Day: 2.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049472
EXP051710	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049473
EXP051711	Rad21	Mus musculus	Genotype: wildtype Day: 3	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049474
EXP051712	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 0	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049475
EXP051713	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 0	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049476
EXP051714	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049477
EXP051715	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049478
EXP051716	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049479
EXP051717	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049480
EXP051718	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049481
EXP051719	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049482
EXP051720	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049483
EXP051721	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049484
EXP051722	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	PEAKS049485
EXP051723	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049486
EXP051724	CTCF	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) dead Cas9 protein (dCas9) without  MLL3SET domain 	NULL	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS049487
EXP051725	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) dead Cas9 protein (dCas9) without  MLL3SET domain 	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049488
EXP051726	CTCF	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout), dCas9-MLL3SET fusion protein	NULL	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS049489
EXP051727	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout), dCas9-MLL3SET fusion protein	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049490
EXP051728	Rad21	Mus musculus	Genotype: wildtype	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049491
EXP051729	Rad21	Mus musculus	Genotype: MLL3/4 enzymatically dead	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	PEAKS049492
EXP051734	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 knockout Strain: 129sv/C57BL6J Sex: Female	EXP051730	115	normal	Q921N8	brown adipose tissue	PEAKS049493
EXP051735	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 wildtype Strain: 129sv/C57BL6J Sex: Female	EXP051731	115	normal	Q921N8	brown adipose tissue	PEAKS049494
EXP051736	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 knockout Strain: 129sv/C57BL6J Sex: male	EXP051732	115	normal	Q921N8	brown adipose tissue	PEAKS049495
EXP051737	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 wildtype Strain: 129sv/C57BL6J Sex: male	EXP051733	115	normal	Q921N8	brown adipose tissue	PEAKS049496
EXP051738	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: wildtype Treatment: untreated	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	PEAKS049497
EXP051739	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: wildtype Treatment: treated with FCCP	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	PEAKS049498
EXP051741	Flag (Sigma M2) + HA tag (F-7), Santa Cruz Biotechnologies, sc-7392	Mus musculus	Genotype: stably expressing FHA-Srap1(wildtype) Passsage: 3-5 Strain: 129SVxC57/BL6 	EXP051740	2447	normal	Q8R1M0	cultured embryonic stem cells (ES cells)	PEAKS049499
EXP051743	anti-Zac1	Mus musculus		EXP051742	1245	normal	Q9JLQ4	Neuro-2A cells	PEAKS049500
EXP051744	Rad21, abcam ab992	Mus musculus	Treament: treated with KLA for either 1hr or 6hrs	NULL	2448	normal	Q61550	46C (embryonic stem cell)	PEAKS049501
EXP051745	Rad21, abcam ab992	Mus musculus	Treatment: treated with KLA for either 1hr or 6hrs	NULL	732	normal	Q61550	peritoneal macrophages	PEAKS049502
EXP051746	Rad21, abcam ab992	Mus musculus	Treatment: no	NULL	2448	normal	Q61550	46C (embryonic stem cell)	PEAKS049503
EXP051748	Myc N262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA, tet-Myc	EXP051747	5	normal	P01108	liver	PEAKS049504
EXP051749	MycN262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA (wildtype)	EXP051747	5	normal	P01108	liver	PEAKS049505
EXP051750	TEAD4 (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA, tet-Myc	EXP051747	5	normal	Q62296	liver	PEAKS049506
EXP051751	TEAD (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA (wildtype)	EXP051747	5	normal	Q62296	liver	PEAKS049507
EXP051752	MycN262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA, tet-YAP	EXP051747	5	normal	P01108	liver	PEAKS049508
EXP051753	MycN262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA, tet-YAP, tet-Myc	EXP051747	5	normal	P01108	liver	PEAKS049509
EXP051754	TEAD (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA, tet-YAP	EXP051747	5	normal	Q62296	liver	PEAKS049510
EXP051755	TEAD (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA, tet-YAP, tet-Myc	EXP051747	5	normal	Q62296	liver	PEAKS049511
EXP051756	YAP 63.7(Santa Cruz, sc101199)	Mus musculus	Genotype: R26-rtTA, tet-YAP	EXP051747	5	normal	P46938	liver	PEAKS049512
EXP051757	YAP 63.7(Santa Cruz, sc101199)	Mus musculus	Genotype: R26-rtTA, tet-YAP, tet-Myc	EXP051747	5	normal	P46938	liver	PEAKS049513
EXP051759	Myc N262 (Santa Cruz, sc 764)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	EXP051758	22	normal	P01108	3T9 fibroblasts	PEAKS049514
EXP051760	TEAD4 (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	EXP051758	22	normal	Q62296	3T9 fibroblasts	PEAKS049515
EXP051761	YAP 63.7(Santa Cruz, sc101199)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	EXP051758	22	normal	P46938	3T9 fibroblasts	PEAKS049516
EXP051766	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI1-3xFLAG Sex: female	EXP051762	2	normal	P47806	mESCs (mouse embryonic stem cells)	PEAKS049517
EXP051767	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI2-3xFLAG Sex: female	EXP051763	2	normal	Q0VGT2	mESCs (mouse embryonic stem cells)	PEAKS049518
EXP051768	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI1-3xFLAG Sex: female	EXP051764	2	normal	P47806	mESCs (mouse embryonic stem cells)	PEAKS049519
EXP051769	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI2-3xFLAG Sex: female	EXP051765	2	normal	Q0VGT2	mESCs (mouse embryonic stem cells)	PEAKS049520
EXP051772	Oct4	Mus musculus	Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming 	EXP051770	12	normal	P20263	MEF (mouse embryonic fibroblasts)	PEAKS049521
EXP051773	Smad3	Mus musculus	Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming 	EXP051770	12	normal	Q8BUN5	MEF (mouse embryonic fibroblasts)	PEAKS049522
EXP051774	Smad3	Mus musculus	Treatment: no Genotype: Smad3CA expression Source: day 3 of reprogramming 	EXP051771	12	normal	Q8BUN5	MEF (mouse embryonic fibroblasts)	PEAKS049523
EXP051776	Rabbit anti-SOX2 polyclonal antibody (Millipore, AB5603)	Mus musculus	Sex: male Age: 1-2 months Strain: C57BL/6 Treatment: transduced with SOX2	EXP051775	193	normal	P48432	cortex	PEAKS049524
EXP051777	HNF6 (Santa Cruz, sc-13050)	Mus musculus	Genotype: wildtype Strain: c57bl	NULL	5	normal	O08755	liver	PEAKS049525
EXP051778	HNF6 (Santa Cruz, sc-13050)	Mus musculus	Genotype: TET2 and TET3 was deleted after birth in hepatocytes Strain: c57bl	NULL	5	normal	O08755	liver	PEAKS049526
EXP051781	CBX2 (Bethyl Laboratories Inc. A302-524A)	Mus musculus	Genotype: wildtype 	EXP051779	204	normal	P30658	D3 (embryonic stem cells)	PEAKS049527
EXP051782	CBX2 (Bethyl Laboratories Inc. A302-524A)	Mus musculus	Genotype: compaction mutant CBX2 (KRA) Treatment: appropriate amounts of doxycycline for 48 hrs	EXP051780	204	normal	P30658	D3 (embryonic stem cells)	PEAKS049528
EXP051784	Anti-KAP1 (ab10843)	Mus musculus	Genotype: wildtype	EXP051783	12	normal	Q62318	MEF (mouse embryonic fibroblasts)	PEAKS049529
EXP051785	Anti-FOXO1A (abcam , ab39670)	Mus musculus	Treatment: 0.1% ethanol	NULL	401	normal	Q9R1E0	C10 (pre-B-cells)	PEAKS049530
EXP051786	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treatment: 0.1% ethanol	NULL	401	normal	Q07802	C10 (pre-B-cells)	PEAKS049531
EXP051787	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treamtent: 100 nM of beta-estradiol (Calbiochem) and grown with 10 nM of IL-3 and CSF-1 for 0.3 hr	NULL	401	normal	Q8K5B8	C10 (pre-B-cells)	PEAKS049532
EXP051788	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treamtent: 100 nM of beta-estradiol (Calbiochem) and grown with 10 nM of IL-3 and CSF-1 for 12 hrs	NULL	401	normal	Q8K5B8	C10 (pre-B-cells)	PEAKS049533
EXP051789	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treamtent: 100 nM of beta-estradiol (Calbiochem) and grown with 10 nM of IL-3 and CSF-1 for 24 hrs	NULL	401	normal	Q8K5B8	C10 (pre-B-cells)	PEAKS049534
EXP051791	anti-HA	Mus musculus	Tissue: pancreas Strain: C57BL/6	EXP051790	2449	normal	P54841	Mile Sven 1 (MS1, mouse endothelial cells)	PEAKS049535
EXP051793	Anti-LSD1 polyclonal antibody (Abcam: ab177721)	Mus musculus	Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 48 hours	EXP051792	1153	normal	Q6ZQ88	C2C12 (myoblasts)	PEAKS049536
EXP051797	anti- flag (Sigma, F3165)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	P47239	AtT-20 (pituitary tumor)	PEAKS049537
EXP051798	Tpit (Pulichino et al. 2003)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	Q99ME7	AtT-20 (pituitary tumor)	PEAKS049538
EXP051799	GR (Santa Cruz, Sc1004)	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	P06537	AtT-20 (pituitary tumor)	PEAKS049539
EXP051800	GR (Santa Cruz, Sc1004)	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	P06537	AtT-20 (pituitary tumor)	PEAKS049540
EXP051801	p300 (Santa Cruz, Sc585)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	B2RWS6	AtT-20 (pituitary tumor)	PEAKS049541
EXP051802	p300 (Santa Cruz, Sc585)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	B2RWS6	AtT-20 (pituitary tumor)	PEAKS049542
EXP051803	Stat3 Sc482+Sc7993-R	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	P42227	AtT-20 (pituitary tumor)	PEAKS049543
EXP051804	Stat3 Sc482+Sc7993-R	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	P42227	AtT-20 (pituitary tumor)	PEAKS049544
EXP051805	anti- flag (Sigma, F3165)	Mus musculus	Treatment: 3 days of 0.1% ethanol Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing chimera of 3x flag-Pax7 	EXP051795	75	normal	P47239	AtT-20 (pituitary tumor)	PEAKS049545
EXP051806	anti- flag (Sigma, F3165)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	P97798	AtT-20 (pituitary tumor)	PEAKS049546
EXP051807	Tpit (Pulichino et al. 2003)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20  Genotype: expressing 3x flag-ER-Pax7	EXP051795	75	normal	Q99ME7	AtT-20 (pituitary tumor)	PEAKS049547
EXP051808	anti- flag (Sigma, F3165)	Mus musculus	Treatment: >20 days of 4-hydroxy-tamoxifen followed by 18 days of Ethanol Cell type:  Genotype:3x flag-ER-Pax10 Cell type: pituitary corticotroph cell Passage: 10-20   	EXP051795	75	normal	P47239	AtT-20 (pituitary tumor)	PEAKS049548
EXP051809	Stat3 (Sc482+Sc7993-R)	Mus musculus	Treatment: 30 minutes of LIF and Dexamethasone, >20 days of 4-hydroxy-tamoxifen Cell type:  Genotype:3x flag-ER-Pax8 Cell type: pituitary corticotroph cell Passage: 10-20   	EXP051795	75	normal	P42227	AtT-20 (pituitary tumor)	PEAKS049549
EXP051810	Stat3 (Sc482+Sc7993-R)	Mus musculus	Treatment: 30 minutes of LIF and Dexamethasone, >20 days of 4-hydroxy-tamoxifen followed by 18 days of Ethanol treatment Cell type:  Genotype:3x flag-ER-Pax9 Cell type: pituitary corticotroph cell Passage: 10-20   	EXP051795	75	normal	P42227	AtT-20 (pituitary tumor)	PEAKS049550
EXP051811	CTCF (millipore, 07-729)	Mus musculus	Treatment: none Passage: 10-20 Cell type: pituitary corticotroph cell Genotype: expressing 3x flag-Neo	EXP051795	75	normal	Q61164	AtT-20 (pituitary tumor)	PEAKS049551
EXP051812	SMC1 (Bethyl, A300-055A)	Mus musculus	Genotype: wildtype Passage: 10-20 Cell type: pituitary corticotroph cell	EXP051795	75	normal	Q9CU62	AtT-20 (pituitary tumor)	PEAKS049552
EXP051813	ASH2 (Bethyl A300-489A)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	Q91X20	AtT-20 (pituitary tumor)	PEAKS049553
EXP051814	ASH2 (Bethyl A300-489A)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	Q91X20	AtT-20 (pituitary tumor)	PEAKS049554
EXP051816	setd2 (Life, LS-C341561)	Mus musculus	Genotype: setd2 f/f  Age: 6 week Strain: C57BL/6 	EXP051815	142	normal	E9Q5F9	intestine	PEAKS049555
EXP051824	anti-Brd4, Bethyl Laboratories A301-985A50	Mus musculus	Treatment: Serum LIF	EXP051817	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	PEAKS049556
EXP051825	anti-Brd4, Bethyl Laboratories A301-985A50	Mus musculus	Treatment: Serum LIF + 2i(3 uM CHIR99021  and 1 uM PD0325901)	EXP051818	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	PEAKS049557
EXP051826	anti-Brd4, Bethyl Laboratories A301-985A50	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 	EXP051819	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	PEAKS049558
EXP051827	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF	EXP051820	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS049559
EXP051828	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF + 2i(3 uM CHIR99021  and 1 uM PD0325901)	EXP051821	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS049560
EXP051829	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 	EXP051822	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS049561
EXP051830	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 + 2i(3 uM CHIR99021  and 1 uM PD0325901)	EXP051823	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS049562
EXP051833	Anti-SMAD3 antibody (Abcam #ab28379 [ChIP grade])	Mus musculus	Strain: C57BL/6J Age: 4 months Genotype: wildtype Sex: male 	EXP051831	2450	normal	Q8BUN5	striatum	PEAKS049563
EXP051834	Anti-SMAD3 antibody (Abcam #ab28379 [ChIP grade])	Mus musculus	Strain: C57BL/6J Age: 4 months Genotype: Q111/+ Sex: male 	EXP051832	2450	normal	Q8BUN5	striatum	PEAKS049564
EXP051836	E2A (sc-349X, Santa Cruz Biotechnology)	Mus musculus	Genotype: E12 knockout Strain: C57BL/6J Age: E12.5 embryo 	EXP051835	2775	normal	P15806	neural stem cells	PEAKS049565
EXP051837	E2A (sc-349X, Santa Cruz Biotechnology)	Mus musculus	Genotype: E47 knockout Strain: C57BL/6J Age: E12.5 embryo 	EXP051835	2775	normal	P15806	neural stem cells	PEAKS049566
EXP051838	E2A (sc-349X, Santa Cruz Biotechnology)	Mus musculus	Genotype: wildtype Strain: C57BL/6J Age: E12.5 embryo 	EXP051835	2775	normal	P15806	neural stem cells	PEAKS049567
EXP051846	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	P01101	primary fibroblasts	PEAKS049568
EXP051847	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	P01101	primary fibroblasts	PEAKS049569
EXP051848	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P01101	primary fibroblasts	PEAKS049570
EXP051849	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P01101	primary fibroblasts	PEAKS049571
EXP051850	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: Fos -/- ( FOS knockout) Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P01101	primary fibroblasts	PEAKS049572
EXP051851	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: Fos -/- ( FOS knockout) Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P01101	primary fibroblasts	PEAKS049573
EXP051852	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	P47930	primary fibroblasts	PEAKS049574
EXP051853	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	P47930	primary fibroblasts	PEAKS049575
EXP051854	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P47930	primary fibroblasts	PEAKS049576
EXP051855	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P47930	primary fibroblasts	PEAKS049577
EXP051856	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	P15066	primary fibroblasts	PEAKS049578
EXP051857	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	P15066	primary fibroblasts	PEAKS049579
EXP051858	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P15066	primary fibroblasts	PEAKS049580
EXP051859	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P15066	primary fibroblasts	PEAKS049581
EXP051860	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051843	2452	normal	P01101	primary fibroblasts	PEAKS049582
EXP051861	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051844	2452	normal	P01101	primary fibroblasts	PEAKS049583
EXP051862	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment:starved with 0.5% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051839	2452	normal	P15066	primary fibroblasts	PEAKS049584
EXP051863	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051843	2452	normal	P15066	primary fibroblasts	PEAKS049585
EXP051864	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment:starved with 0.5% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051840	2452	normal	P15066	primary fibroblasts	PEAKS049586
EXP051865	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051844	2452	normal	P15066	primary fibroblasts	PEAKS049587
EXP051866	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049588
EXP051867	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049589
EXP051868	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051841	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049590
EXP051869	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049591
EXP051870	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049592
EXP051871	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051845	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049593
EXP051872	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049594
EXP051873	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049595
EXP051874	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051841	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049596
EXP051875	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049597
EXP051876	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049598
EXP051877	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051845	2452	normal	Q3TKT4	primary fibroblasts	PEAKS049599
EXP051881	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: wildtype	EXP051879	1058	normal	P70315	CD4+ T-cells	PEAKS049600
EXP051882	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: spleen Strain: C57BL/6 Genotype: wildtype	EXP051880	2453	normal	P70315	spleen CD4+ T cells	PEAKS049601
EXP051883	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: wildtype	EXP051879	1058	normal	P70315	CD4+ T-cells	PEAKS049602
EXP051884	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: WASp I296T	EXP051879	1058	normal	P70315	CD4+ T-cells	PEAKS049603
EXP051885	CEBPA (14AA, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1- cKit+ CD150- CD41- FcgRII/III(hi) CD115+  Tissue: bone marrow  	NULL	2458	normal	P53566	CFU-M	PEAKS049604
EXP051886	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1- cKit+ CD150- CD41- FcgRII/III(hi) CD115+  Tissue: bone marrow  	NULL	2458	normal	P17433	CFU-M	PEAKS049605
EXP051887	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1+, ckit  Tissue: bone marrow  	NULL	2454	normal	P17433	LSK	PEAKS049606
EXP051888	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105-  Tissue: bone marrow  	NULL	2455	normal	P17433	preGM	PEAKS049607
EXP051889	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: CEBPA knockout, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105-  Tissue: bone marrow  	NULL	2455	normal	P17433	preGM	PEAKS049608
EXP051890	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, FcgRII/III+  Tissue: bone marrow  	NULL	2456	normal	P17433	GMP	PEAKS049609
EXP051891	CEBPA (14AA, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105-  Tissue: bone marrow  	NULL	2455	normal	P53566	preGM	PEAKS049610
EXP051892	CEBPA (14AA, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1-cKit+ CD150- CD41- FcgRII/III(hi) CD115-  Tissue: bone marrow  	NULL	2457	normal	P53566	CFU-G	PEAKS049611
EXP051893	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1-cKit+ CD150- CD41- FcgRII/III(hi) CD115-  Tissue: bone marrow  	NULL	2457	normal	P17433	CFU-G	PEAKS049612
EXP051896	anti-E2A antibody (V-18, Santa Cruz Biotechnology, Lot G0814)	Mus musculus	Tissue: thymus Strain: L-DKO mice (deficient in Id2 and Id3)  Age: 3-5 weeks Sorting: CD1dTet- CD4+ CD8+	EXP051894	2459	normal	P15806	double-positive (DP) CD4+/CD8+ thymocyte	PEAKS049613
EXP051897	anti-E2A antibody (V-18, Santa Cruz Biotechnology, Lot G0814)	Mus musculus	Tissue: thymus Strain: L-DKO mice (deficient in Id2 and Id3)  Age: 3-5 weeks Sorting: CD1dTet+ TCR-beta+	EXP051895	2460	normal	P15806	iNKT (Invariant Natural Killer T cells)	PEAKS049614
EXP051905	FLAG (Sigma, #F1804)	Mus musculus	Genotype: Six2DE-Six2BF Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	Q62232	kidney	PEAKS049615
EXP051906	FLAG (Sigma, #F1804)	Mus musculus	Genotype: Six2DE-Hoxd11BF Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	P23813	kidney	PEAKS049616
EXP051907	Wt1 (ProteinTech, 12609-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051903	660	normal	P22561	nephron progenitors	PEAKS049617
EXP051908	Wt1 (ProteinTech, 12609-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051904	660	normal	P22561	nephron progenitors	PEAKS049618
EXP051909	CTCF (D31H2) XPÂ® Rabbit mAb	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051903	660	normal	Q61164	nephron progenitors	PEAKS049619
EXP051910	CTCF (D31H2) XPÂ® Rabbit mAb	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051904	660	normal	Q61164	nephron progenitors	PEAKS049620
EXP051911	Six2 (Proteintech,11562-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: C57BL/6J	EXP051901	523	normal	Q62232	kidney	PEAKS049621
EXP051912	Six2 (Proteintech,11562-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: SJL/J	EXP051902	523	normal	Q62232	kidney	PEAKS049622
EXP051913	Six2 (Proteintech,11562-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	Q62232	kidney	PEAKS049623
EXP051914	FLAG (Sigma, #F1804)	Mus musculus	Genotype: Six2DE-Osr1BF Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	Q9WVG7	kidney	PEAKS049624
EXP051915	Wt1 (ProteinTech, 12609-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	P22561	kidney	PEAKS049625
EXP051917	anti-Nrdc (purified monoclonal)	Mus musculus	Genotype: wildtype  Strain: C57BL/6	EXP051916	12	normal	Q8BHG1	MEF (mouse embryonic fibroblasts)	PEAKS049626
EXP051919	Anti-Ssrp1 (Biolegends)	Mus musculus		EXP051918	230	normal	Q08943	ES-E14 (E14, embryonic stem cells)	PEAKS049627
EXP051920	Anti-Supt16 (Cell Signaling)	Mus musculus		EXP051918	230	normal	Q920B9	ES-E14 (E14, embryonic stem cells)	PEAKS049628
EXP051930	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	EXP051921	103	normal	Q9CW03	bone marrow	PEAKS049629
EXP051931	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	EXP051922	103	normal	Q9CW03	bone marrow	PEAKS049630
EXP051932	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051923	103	normal	Q9CW03	bone marrow	PEAKS049631
EXP051933	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051924	103	normal	Q9CW03	bone marrow	PEAKS049632
EXP051934	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	EXP051925	103	normal	Q9CW03	bone marrow	PEAKS049633
EXP051935	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	EXP051926	103	normal	Q9CW03	bone marrow	PEAKS049634
EXP051936	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	EXP051921	103	normal	Q61164	bone marrow	PEAKS049635
EXP051937	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051923	103	normal	Q61164	bone marrow	PEAKS049636
EXP051938	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051924	103	normal	Q61164	bone marrow	PEAKS049637
EXP051939	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	EXP051925	103	normal	Q61164	bone marrow	PEAKS049638
EXP051940	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment:15 min without actinomycin-d,  Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	PEAKS049639
EXP051941	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment:30 min without actinomycin-d,  Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	PEAKS049640
EXP051942	SMC3 (Abcam, ab9263, GR290533-2)	Mus musculus	Treatment:60 min without actinomycin-d,  Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	PEAKS049641
EXP051943	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	EXP051927	103	normal	Q9CW03	bone marrow	PEAKS049642
EXP051944	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	EXP051928	103	normal	Q9CW03	bone marrow	PEAKS049643
EXP051945	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	EXP051929	103	normal	Q9CW03	bone marrow	PEAKS049644
EXP051946	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: 15 min with 10 ug/ml actinomycin-d Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	PEAKS049645
EXP051947	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: 30 min with 10 ug/ml actinomycin-d Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	PEAKS049646
EXP051948	SMC3 (Abcam, ab9263, GR290533-2)	Mus musculus	Treatment: 60 min with 10 ug/ml actinomycin-d Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	PEAKS049647
EXP051950	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (SSEA1+) Sex: male Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E12.5  Strain: C57BL/6	EXP051949	2407	normal	Q60636	primordial germ cell	PEAKS049648
EXP051951	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (SSEA1+) Sex: female Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E12.5  Strain: C57BL/6	NULL	2407	normal	Q60636	primordial germ cell	PEAKS049649
EXP051952	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (KIT+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E6.5  Strain: C57BL/6	NULL	2407	normal	Q60636	primordial germ cell	PEAKS049650
EXP051953	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (KIT+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E9.5  Strain: C57BL/6	NULL	2407	normal	Q60636	primordial germ cell	PEAKS049651
EXP051954	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (GFP+, EPCAM+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1)   Strain: C57BL/6	NULL	2462	normal	Q60636	embryonic intestinal epithelium	PEAKS049652
EXP051955	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (GFP+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1)   Strain: C57BL/6	NULL	2463	normal	Q60636	photoreceptor precursor	PEAKS049653
EXP051956	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (GFP+, CD138+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1)   Strain: C57BL/6	NULL	723	normal	Q60636	plasmablasts	PEAKS049654
EXP051958	PDX1 (Millipore 07-696)	Mus musculus	Strain: C57BL/6J Cell line: NB490 	EXP051957	2464	normal	P52946	pancreatic acinar cells	PEAKS049655
EXP051959	PDX1 (Abcam ab47383)	Mus musculus	Strain: C57BL/6J Cell line: NB490 	EXP051957	2464	normal	P52946	pancreatic acinar cells	PEAKS049656
EXP051961	PDX1 (Millipore 07-696)	Mus musculus	Cell line: NB490	EXP051960	1118	normal	P52946	pancreatic ductal adenocarcinoma	PEAKS049657
EXP051963	PDX1 (Millipore 07-696)	Mus musculus	Source: NB490 cell line	EXP051962	1118	normal	P52946	pancreatic ductal adenocarcinoma	PEAKS049658
EXP051966	anti-ISL1 rabbit monoclonal (Abcam #EP4182)	Mus musculus	Genotype: wildtype Strain: CD1 Age: E14.5	EXP051964	2465	normal	P61372	embryonic genital tubercle	PEAKS049659
EXP051967	anti-ISL1 rabbit monoclonal (Abcam #EP4182)	Mus musculus	Genotype: wildtype Strain: CD1 Age: E14.5	EXP051965	2465	normal	P61372	embryonic genital tubercle	PEAKS049660
EXP051970	anti-scl	Mus musculus	Genotype: Etv2 knockout iSCL Treatment: EB formation Tissue: embryoid body Source: Flk1+ mesodermal cells	EXP051968	2	normal	P22091	mESCs (mouse embryonic stem cells)	PEAKS049661
EXP051971	anti-scl	Mus musculus	Genotype: Etv2 knockout iETV2 Treatment: EB formation Tissue: embryoid body Source: Flk1+ mesodermal cells	EXP051969	2	normal	P22091	mESCs (mouse embryonic stem cells)	PEAKS049662
EXP051973	anti-SPIN1 antibody (custom SPIN1-5867)	Mus musculus	Strain: C57BL/6 Age: 10-day-old mice Source: skeletal muscle	EXP051972	2466	normal	Q61142	primary myoblasts	PEAKS049663
EXP051975	anti-BMI1	Mus musculus	Age: 6-8 weeks-old mice Strain: C57BL/6 Treatment: received a single dose of 20 mg/kg Paraquat (i.p.) dissolved in PBS	EXP051974	2467	normal	P25916	Sca1+CD45- cardiac cells	PEAKS049664
EXP051976	anti-BMI1	Mus musculus	Age: 6-8 weeks-old mice Strain: C57BL/6 Treatment: only received PBS	EXP051974	2467	normal	P25916	Sca1+CD45- cardiac cells	PEAKS049665
EXP051979	anti-Tcf1	Mus musculus	Genotype: Tcf7+/+ Source: IL-2 activated Splenic NK cells Strain: B6	EXP051977	2468	normal	P22361	spleen natural killer cells	PEAKS049666
EXP051980	anti-Tcf1	Mus musculus	Genotype: Tcf7-/- (knockout) Source: IL-2 activated Splenic NK cells Strain: B6.129 Tcf7Tm1Cle	EXP051978	2468	normal	P22361	spleen natural killer cells	PEAKS049667
EXP051984	Anti-Dnmt3b antibody-ChIP Grade  (ab2851, Abcam)	Mus musculus	pool1 samples	EXP051981	2471	normal	O88509	enteric precursor cells	PEAKS049668
EXP051985	Anti-Dnmt3b antibody-ChIP Grade  (ab2851, Abcam)	Mus musculus	pool2 samples	EXP051982	2471	normal	O88509	enteric precursor cells	PEAKS049669
EXP051986	Anti-Dnmt3b antibody-ChIP Grade  (ab2851, Abcam)	Mus musculus	pool3 samples	EXP051983	2471	normal	O88509	enteric precursor cells	PEAKS049670
EXP051988	Zfp281 (Abcam #ab101318)	Mus musculus		EXP051987	2472	normal	Q99LI5	OEC2 (Epiblast stem cells)	PEAKS049671
EXP052003	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment:grown in Lif and 2i (GSKi and MEKi), Doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051989	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS049672
EXP052004	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment:grown in Lif and 2i (GSKi and MEKi), Doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051990	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS049673
EXP052005	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment: doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051993	2470	normal	Q9CU62	epiblast cells	PEAKS049674
EXP052006	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment: doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051992	2470	normal	Q9CU62	epiblast cells	PEAKS049675
EXP052007	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051993	2470	normal	Q8K5C0	epiblast cells	PEAKS049676
EXP052008	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051994	2470	normal	Q8K5C0	epiblast cells	PEAKS049677
EXP052009	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051993	2470	normal	Q9CU62	epiblast cells	PEAKS049678
EXP052010	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051994	2470	normal	Q9CU62	epiblast cells	PEAKS049679
EXP052011	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051995	2470	normal	Q8K5C0	epiblast cells	PEAKS049680
EXP052012	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051996	2470	normal	Q8K5C0	epiblast cells	PEAKS049681
EXP052013	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051995	2470	normal	Q9CU62	epiblast cells	PEAKS049682
EXP052014	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051996	2470	normal	Q9CU62	epiblast cells	PEAKS049683
EXP052015	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP051999	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS049684
EXP052016	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP051998	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS049685
EXP052017	HA	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052001	2	normal	P63058	mESCs (mouse embryonic stem cells)	PEAKS049686
EXP052018	HA	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052002	2	normal	P63058	mESCs (mouse embryonic stem cells)	PEAKS049687
EXP052019	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052001	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS049688
EXP052020	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052002	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS049689
EXP052022	ab109517	Mus musculus		EXP052021	2473	normal	P61372	E12.5-14.5 sympathetic neurons	PEAKS049690
EXP052027	alfa-CFP1f (Rabbit polyclonal, This Study)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052025	2474	normal	Q8BGU5	C127	PEAKS049691
EXP052028	alfa-CFP1f (Rabbit polyclonal, This Study)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052026	2474	normal	Q8BGU5	C127	PEAKS049692
EXP052029	alfa-KDM2B (Rabbit polyclonal, Farcas et al., 2012)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052025	2474	normal	Q6P1G2	C127	PEAKS049693
EXP052030	alfa-KDM2B (Rabbit polyclonal, Farcas et al., 2012)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052026	2474	normal	Q6P1G2	C127	PEAKS049694
EXP052031	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052025	2474	normal	Q8BGU5	C127	PEAKS049695
EXP052032	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052026	2474	normal	Q8BGU5	C127	PEAKS049696
EXP052033	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC mutant	EXP052025	2474	normal	Q8BGU5	C127	PEAKS049697
EXP052034	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC mutant	EXP052026	2474	normal	Q8BGU5	C127	PEAKS049698
EXP052035	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: PHD mutant	EXP052025	2474	normal	Q8BGU5	C127	PEAKS049699
EXP052036	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: PHD mutant	EXP052026	2474	normal	Q8BGU5	C127	PEAKS049700
EXP052037	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC and PHD mutant 	EXP052025	2474	normal	Q8BGU5	C127	PEAKS049701
EXP052038	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC and PHD mutant 	EXP052026	2474	normal	Q8BGU5	C127	PEAKS049702
EXP052039	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: SID mutant	EXP052025	2474	normal	Q8BGU5	C127	PEAKS049703
EXP052040	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: SID mutant	EXP052026	2474	normal	Q8BGU5	C127	PEAKS049704
EXP052044	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052041	2475	normal	Q9Z0S2	mature olfactory sensory neurons	PEAKS049705
EXP052045	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052042	2475	normal	Q9Z0S2	mature olfactory sensory neurons	PEAKS049706
EXP052046	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052041	2475	normal	Q07802	mature olfactory sensory neurons	PEAKS049707
EXP052047	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052042	2475	normal	Q07802	mature olfactory sensory neurons	PEAKS049708
EXP052048	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMP-IRES-Cre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q07802	mature olfactory sensory neurons	PEAKS049709
EXP052049	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMP-IRES-Cre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q9Z0S2	mature olfactory sensory neurons	PEAKS049710
EXP052050	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMPcre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q07802	mature olfactory sensory neurons	PEAKS049711
EXP052051	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMPcre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q9Z0S2	mature olfactory sensory neurons	PEAKS049712
EXP052055	RelA (ab7970, Abcam)	Mus musculus	Genotype: wildtype Treatment: LPS for 0h (untreated) Strain: C57BL/6J	EXP052052	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049713
EXP052056	RelA (ab7970, Abcam)	Mus musculus	Genotype: wildtype Treatment: LPS for 3hrs  Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049714
EXP052057	RelA (ab7970, Abcam)	Mus musculus	Genotype: wildtype Treatment: LPS for 8hrs  Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049715
EXP052058	Ikaros (M-20, Santa Cruz)	Mus musculus	Genotype: wildtype Treatment: LPS for 0h (untreated) Strain: C57BL/6J	NULL	81	normal	Q03267	BMDM (bone marrow-derived macrophages)	PEAKS049716
EXP052059	Ikaros (M-20, Santa Cruz)	Mus musculus	Genotype: wildtype Treatment: LPS for 3hrs  Strain: C57BL/6J	NULL	81	normal	Q03267	BMDM (bone marrow-derived macrophages)	PEAKS049717
EXP052060	Ikaros (M-20, Santa Cruz)	Mus musculus	Genotype: wildtype Treatment: LPS for 8hrs  Strain: C57BL/6J	NULL	81	normal	Q03267	BMDM (bone marrow-derived macrophages)	PEAKS049718
EXP052061	RelA (ab7970, Abcam)	Mus musculus	Genotype: littermate control Treatment: LPS for 0hrs (untreated) Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049719
EXP052062	RelA (ab7970, Abcam)	Mus musculus	Genotype: littermate control Treatment: LPS for 3h (untreated) Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049720
EXP052063	RelA (ab7970, Abcam)	Mus musculus	Genotype: littermate control Treatment: LPS for 8hrs (untreated) Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049721
EXP052066	anti-G9a; Sigma (G6919)	Mus musculus	Strain: C57BL/6J Genotype: alphaMHC-MerCreMer +/-	EXP052064	2476	normal	Q9Z148	cardiac myocytes	PEAKS049722
EXP052067	anti-Mef2c; Abcam (ab43796)	Mus musculus	Strain: C57BL/6J Genotype: alphaMHC-MerCreMer +/-	EXP052064	2476	normal	Q8CFN5	cardiac myocytes	PEAKS049723
EXP052068	anti-G9a; Sigma (G6919)	Mus musculus	Strain: C57BL/6J Genotype: G9a flox/flox (G9a knockout), alphaMHC-MerCreMer +/-	EXP052065	2476	normal	Q9Z148	cardiac myocytes	PEAKS049724
EXP052069	anti-Mef2c; Abcam (ab43796)	Mus musculus	Strain: C57BL/6J Genotype: G9a flox/flox (G9a knockout), alphaMHC-MerCreMer +/-	EXP052065	2476	normal	Q8CFN5	cardiac myocytes	PEAKS049725
EXP052072	anti-G9a; Sigma (G6919)	Mus musculus	Treatment: No treatment Strain: C57BL/6J	EXP052070	2476	normal	Q9Z148	cardiac myocytes	PEAKS049726
EXP052073	anti-G9a; Sigma (G6919)	Mus musculus	Treatment: transverse aortic constriction (TAC) for 1 week Strain: C57BL/6J	EXP052071	2476	normal	Q9Z148	cardiac myocytes	PEAKS049727
EXP052093	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	EXP052076	2477	normal	P17433	Lin- FLP derived CD25+	PEAKS049728
EXP052094	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	EXP052077	2477	normal	P17433	Lin- FLP derived CD25+	PEAKS049729
EXP052095	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049730
EXP052096	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049731
EXP052097	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049732
EXP052098	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049733
EXP052099	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049734
EXP052100	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049735
EXP052101	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049736
EXP052102	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049737
EXP052103	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049738
EXP052104	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049739
EXP052105	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049740
EXP052106	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049741
EXP052107	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049742
EXP052108	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049743
EXP052109	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049744
EXP052110	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049745
EXP052111	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1WTHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	PEAKS049746
EXP052112	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1WTHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	PEAKS049747
EXP052113	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1ENGHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	PEAKS049748
EXP052114	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1ETSHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	PEAKS049749
EXP052115	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-PU1WTHA Strain: CB17-Prkdc<scid> mice 	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049750
EXP052116	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Transduced with Lzr-PU1WTHA	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049751
EXP052117	Rabbit anti-Ets1 polyclonal IgG (sc-350x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Unperturbed (DSG+FA) Strain: CB17-Prkdc<scid> mice	EXP052092	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049752
EXP052118	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052082	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049753
EXP052119	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 24 hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052083	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049754
EXP052120	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 2hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049755
EXP052121	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052084	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049756
EXP052122	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 8hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049757
EXP052123	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 24hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052085	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	PEAKS049758
EXP052125	Rabbit anti-TOX1 antibody (Abcam ab155768, lot GR124281-8)	Mus musculus	Pathogen: LCMV-OVA Source: adoptively transferred OT-1 Strain: C57BL/6 Genotype: wild type 	EXP052124	2479	normal	Q66JW3	CD8+ T-cells	PEAKS049759
EXP052126	Rabbit anti-TOX1 antibody (Abcam ab155768, lot GR124281-8)	Mus musculus	Pathogen: LCMV-OVA Source: adoptively transferred OT-1 Strain: C57BL/6 Genotype: Tox-deficient 	NULL	2479	normal	Q66JW3	CD8+ T-cells	PEAKS049760
EXP052127	Kdm2b	Mus musculus	Treatment: none Source: reprogramming cells, day 14	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	PEAKS049761
EXP052128	Kdm2b	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 14	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	PEAKS049762
EXP052129	Ring1b(CST,5694)	Mus musculus	Treatment: none Source: reprogramming cells, day 9	NULL	2480	normal	Q9CQJ4	somatic reprogramming cells	PEAKS049763
EXP052130	Ring1b(CST,5694)	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 9	NULL	2480	normal	Q9CQJ4	somatic reprogramming cells	PEAKS049764
EXP052131	Kdm2b-Flag: Sigma,F1804	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 6	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	PEAKS049765
EXP052132	Kdm2b-Flag: Sigma, F1804	Mus musculus	Treatment: none Source: reprogramming cells, day 6	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	PEAKS049766
EXP052133	Kdm2b	Mus musculus	Treatment: none Source: reprogramming cells, day 9	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	PEAKS049767
EXP052134	Kdm2b	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 9	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	PEAKS049768
EXP052136	Mtf2 (Aviva System Biology ARP34292, lot QC49692-42166)	Mus musculus	Treatment: no Genotype: EED knockout Source: EED -/- cell line 	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS049769
EXP052137	Mtf2 (Aviva System Biology ARP34292, lot QC49692-42166)	Mus musculus	Genotype: wildtype Treatment: no	EXP052135	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS049770
EXP052138	Jarid2 (Novus Biologicals NB100-2214, Lot E2)	Mus musculus	Genotype: wildtype Treatment: no	EXP052135	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS049771
EXP052139	Jarid2 (Novus Biologicals NB100-2214, Lot E2)	Mus musculus	Treatment: no Source: Mtf2 GT/GT cell line Genotype: gene trapping cassette disrupting Mtf CDS 	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	PEAKS049772
EXP052140	Mtf2 (Aviva System Biology ARP34292, lot QC49692-42166)	Mus musculus	Treatment: no Genotype: Jarid2 knockout	NULL	2481	normal	Q02395	E4 (embryonic stem cells)	PEAKS049773
EXP052142	anti-phospho-STAT5 (Thermofisher Scientific #716900)	Mus musculus	Treatment: treated with 10 u/ml erythropoietin for 30 mins Antibody: antibody against STAT5a and STAT5b	EXP052141	1085	normal	P42230	J2E (erythroid cells)	PEAKS049774
EXP052145	JARID2 (in house)	Mus musculus	Genotype: wildtype Source: E14Tga2	EXP052144	2	normal	Q62315	mESCs (mouse embryonic stem cells)	PEAKS049775
EXP052146	HA-tag (Abcam,ab9110)	Mus musculus	Genotype: inducible WT EED rescue 0hr  Strain: C57BL/6	EXP052143	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	PEAKS049776
EXP052147	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8days, JARID2 knockout Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS049777
EXP052149	RXR? (Santa Cruz_sc-553)	Mus musculus		EXP052148	1153	normal	P28700	C2C12 (myoblasts)	PEAKS049778
EXP052150	RXR? (Santa Cruz_sc-553)	Mus musculus	50 nM bexarotene for 24 hrs	EXP052148	1153	normal	P28700	C2C12 (myoblasts)	PEAKS049779
EXP052152	TET3 (Millipore ABE290, LN: RA1205021)	Mus musculus	Genotype: TET3	EXP052151	230	normal	Q8BG87	ES-E14 (E14, embryonic stem cells)	PEAKS049780
EXP052153	TET3 (Millipore ABE290, LN: RA1205021)	Mus musculus	Genotype: TET3-CXXC	EXP052151	230	normal	K9JH93	ES-E14 (E14, embryonic stem cells)	PEAKS049781
EXP052158	Anti-JMJD1B, Bethyl, Cat# A300-883A	Mus musculus	Genotype: wildtype 	EXP052154	2482	normal	Q6ZPY7	total bone marrow	PEAKS049782
EXP052159	Anti-PRMT5, Millipore, Cat# 07-405	Mus musculus	Genotype: wildtype 	EXP052154	2482	normal	Q8CIG8	total bone marrow	PEAKS049783
EXP052160	Anti-JMJD1B, Bethyl, Cat# A300-883A	Mus musculus	Genotype: JMJD1B knockout Treatment: Gene-trap knockout	EXP052155	2482	normal	Q6ZPY7	total bone marrow	PEAKS049784
EXP052164	 DPPA4 antibody (R&D systems AF3730)	Mus musculus	Source: 3T3 cells ectopically expressing Dppa4	EXP052161	17	normal	Q8CCG4	3T3 (embryonic fibroblasts)	PEAKS049785
EXP052165	 DPPA4 antibody (R&D systems AF3730)	Mus musculus	Source: embryonic carcinoma cells	EXP052162	705	normal	Q8CCG4	P19 (embryonic carcinoma)	PEAKS049786
EXP052166	 DPPA4 antibody (R&D systems AF3730)	Mus musculus	Source: embryonic stem cells	EXP052163	230	normal	Q8CCG4	ES-E14 (E14, embryonic stem cells)	PEAKS049787
EXP052169	CTCF	Mus musculus	Treatment: shRNA infected, shCtrl Genotype: wildtype	EXP052167	1221	normal	Q61164	AML12	PEAKS049788
EXP052170	CTCF	Mus musculus	Treatment: shRNA infected, shU Genotype: HNRNPU knockdown	EXP052168	1221	normal	Q61164	AML12	PEAKS049789
EXP052171	RAD21	Mus musculus	Treatment: shRNA infected, shControl 	EXP052167	1221	normal	Q61550	AML12	PEAKS049790
EXP052172	RAD21	Mus musculus	Treatment: shRNA infected, shU Genotype: HNRNPU knockdown	EXP052168	1221	normal	Q61550	AML12	PEAKS049791
EXP052175	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 0hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049792
EXP052176	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 4hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049793
EXP052177	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 8hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049794
EXP052178	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 12hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049795
EXP052179	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 24hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049796
EXP052180	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 48hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049797
EXP052181	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 0hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049798
EXP052182	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 4hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049799
EXP052183	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 8hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049800
EXP052184	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 12hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049801
EXP052185	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 24hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049802
EXP052186	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 48hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	PEAKS049803
EXP052187	anti-Bmal1	Mus musculus	Treatment: LPS (bacterial lipopolysaccharide) 0hr Strain: C57BL/6J Source: mouse peritoneal macrophage	NULL	732	normal	Q9WTL8	peritoneal macrophages	PEAKS049804
EXP052188	anti-Bmal1	Mus musculus	Treatment: LPS (bacterial lipopolysaccharide) 0hr Strain: C57BL/6J Source: mouse peritoneal macrophage	NULL	732	normal	Q9WTL8	peritoneal macrophages	PEAKS049805
EXP052189	anti-Bmal1	Mus musculus	Treatment: LPS (bacterial lipopolysaccharide) 0hr Strain: C57BL/6J Source: mouse peritoneal macrophage	NULL	732	normal	Q9WTL8	peritoneal macrophages	PEAKS049806
EXP052190	anti-Lamin-B1 (Abcam, ab16048, #GR228534-1)	Mus musculus	Treatment: TGF- beta at a final concentration of 1-5 ng/ml, 0 hr	NULL	2484	normal	P14733	NMuMG (mammary epithelial cells)	PEAKS049807
EXP052191	anti-Lamin-B1 (Abcam, ab16048, #GR228534-1)	Mus musculus	Treatment: TGF- beta for at a final concentration of 1-5 ng/ml, 8 hr	NULL	2484	normal	P14733	NMuMG (mammary epithelial cells)	PEAKS049808
EXP052192	anti-Lamin-B1 (Abcam, ab16048, #GR228534-1)	Mus musculus	Treatment: TGF- beta at a final concentration of 1-5 ng/ml, 24 hr	NULL	2484	normal	P14733	NMuMG (mammary epithelial cells)	PEAKS049809
EXP052195	Foxg1 antibody	Mus musculus	Develomental stage: embryonic day 14-15 Strain: CD1	EXP052193	193	normal	Q60987	cortex	PEAKS049810
EXP052196	Foxg1 antibody	Mus musculus	Develomental stage: embryonic day 14-15 Strain: CD1	EXP052194	193	normal	Q60987	cortex	PEAKS049811
EXP052202	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052198	2485	normal	Q61164	in-vitro differentiated neural progenitor cells (NPC)	PEAKS049812
EXP052203	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052199	2485	normal	Q61164	in-vitro differentiated neural progenitor cells (NPC)	PEAKS049813
EXP052204	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052198	2485	normal	Q9CQJ4	in-vitro differentiated neural progenitor cells (NPC)	PEAKS049814
EXP052205	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052199	2485	normal	Q9CQJ4	in-vitro differentiated neural progenitor cells (NPC)	PEAKS049815
EXP052206	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052200	2486	normal	Q61164	in-vitro differentiated cortical neurons (CN)	PEAKS049816
EXP052207	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052201	2486	normal	Q61164	in-vitro differentiated cortical neurons (CN)	PEAKS049817
EXP052208	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052200	2486	normal	Q9CQJ4	in-vitro differentiated cortical neurons (CN)	PEAKS049818
EXP052209	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052201	2486	normal	Q9CQJ4	in-vitro differentiated cortical neurons (CN)	PEAKS049819
EXP052210	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Oct4-GFP Protocol: sorting GFP+	EXP052197	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS049820
EXP052211	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Oct4-GFP Protocol: sorting GFP+	EXP052197	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS049821
EXP052212	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day2	NULL	2487	normal	Q61164	primary cells (short term)	PEAKS049822
EXP052213	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day4	NULL	2487	normal	Q61164	primary cells (short term)	PEAKS049823
EXP052214	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day6	NULL	2487	normal	Q61164	primary cells (short term)	PEAKS049824
EXP052215	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day8	NULL	2487	normal	Q61164	primary cells (short term)	PEAKS049825
EXP052218	anti-HTATSF1 (produced in rabbit against mouse HTATSF1 peptide SGNNLSGNDEFDEQLR-C)	Mus musculus	Treatment: no treatment Genotype: tatsf1 flox/flox CreERT2	EXP052216	2	normal	Q8BGC0	mESCs (mouse embryonic stem cells)	PEAKS049826
EXP052219	anti-HTATSF1 (produced in rabbit against mouse HTATSF1 peptide SGNNLSGNDEFDEQLR-C)	Mus musculus	Treatment: no treatment Genotype: tatsf1 flox/flox CreERT2	EXP052217	2	normal	Q8BGC0	mESCs (mouse embryonic stem cells)	PEAKS049827
EXP052222	CTCF (Active Motif Cat# 61311)	Mus musculus	Tissue: Left ventricle Strain :C57BL/6 Genotype: wildtype	EXP052220	2476	normal	Q61164	cardiac myocytes	PEAKS049828
EXP052223	CTCF (Active Motif Cat# 61311)	Mus musculus	Tissue: Left ventricle Strain :C57BL/6 Genotype: CTCF knockout	EXP052221	2476	normal	Q61164	cardiac myocytes	PEAKS049829
EXP052225	p65 (Santa Cruz, cat# sc-372X, GH2651)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	Q04207	primary hepatocytes	PEAKS049830
EXP052226	CEBPB (Santa Cruz, cat# sc-150X, GH2100)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	P28033	primary hepatocytes	PEAKS049831
EXP052227	c-Jun (CST, 60A8 #9165 GH2197)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	P05627	primary hepatocytes	PEAKS049832
EXP052228	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment:  DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049833
EXP052229	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) + DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049834
EXP052230	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-6 (10ng/ml) + DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049835
EXP052231	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) and IL-6 (10ng/ml) + DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049836
EXP052232	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: no treatment	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049837
EXP052233	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049838
EXP052234	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-6 (10ng/ml) for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049839
EXP052235	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) and IL-6 (10ng/ml) for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	PEAKS049840
EXP052238	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: C57BL/6 Genotype: wildtype	EXP052236	12	normal	Q61687	MEF (mouse embryonic fibroblasts)	PEAKS049841
EXP052239	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: foetal liver	NULL	267	normal	Q61687	erythroid cells	PEAKS049842
EXP052240	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: N/A  	EXP052237	12	normal	Q61687	MEF (mouse embryonic fibroblasts)	PEAKS049843
EXP052241	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: N/A Genotype: Suv39h1/2 knockouts	NULL	12	normal	Q61687	MEF (mouse embryonic fibroblasts)	PEAKS049844
EXP052242	P63 antibody, Cell Signaling, #4892	Mus musculus	Genotype: wildtype Tissue: Skin	NULL	2491	normal	O88898	cultured keratinocytes	PEAKS049845
EXP052243	anti-Smyd2 (Santa Cruz, Catalog# sc-79084, Lot# H2014)	Mus musculus	Tissue: kidney Strain: C57BL/6 Genotype: Pkd1 wildtype Developmental stage: Embryo	NULL	2492	normal	Q8R5A0	renal epithelial cells	PEAKS049846
EXP052244	anti-Smyd2 (Santa Cruz, Catalog# sc-79084, Lot# H2014)	Mus musculus	Tissue: kidney Strain: C57BL/6 Genotype: Pkd1 knockout Developmental stage: Embryo	NULL	2492	normal	Q8R5A0	renal epithelial cells	PEAKS049847
EXP052248	BD Pharmingen 556604 Rat anti-MASH1 (ASCL1)	Mus musculus	Treatment: no doxycycline Source: SA-tTA-Ascl1 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	EXP052245	2	normal	Q02067	mESCs (mouse embryonic stem cells)	PEAKS049848
EXP052249	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	treatment: doxycycline Source: SA-tTA-Ascl2 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	normal	O35885	mESCs (mouse embryonic stem cells)	PEAKS049849
EXP052250	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	treatment: no doxycycline Source: SA-tTA-Ascl1 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	EXP052246	2	normal	O35885	mESCs (mouse embryonic stem cells)	PEAKS049850
EXP052251	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	Treatment: doxycycline Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	normal	P10085	mESCs (mouse embryonic stem cells)	PEAKS049851
EXP052252	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	Treatment: no doxycycline no Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	EXP052247	2	normal	P10085	mESCs (mouse embryonic stem cells)	PEAKS049852
EXP052258	anti-TCF7L2 (17-10109, Millipore)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic)	EXP052253	2493	normal	Q924A0	cardiac ventricles	PEAKS049853
EXP052259	anti-TCF7L2 (17-10109, Millipore)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic)	EXP052254	2493	normal	Q924A0	cardiac ventricles	PEAKS049854
EXP052260	anti-TCF7L2 (17-10109, Millipore)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, Wildtype for beta-catenin (normal)	EXP052255	2493	normal	Q924A0	cardiac ventricles	PEAKS049855
EXP052262	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: control 	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS049856
EXP052263	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: MTF2 knockout	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS049857
EXP052264	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: MTF2 wildtype rescue	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS049858
EXP052265	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: MTF2 K339A rescue	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS049859
EXP052266	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: control 	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS049860
EXP052267	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: MTF2 knockout	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS049861
EXP052268	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: MTF2 wildtype rescue	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS049862
EXP052269	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: MTF2 K339A rescue	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS049863
EXP052271	Flag antibody (Sigma, F1804, SLBB7188)	Mus musculus	Strain: C57BL/6 Treatment: doxycycline (Dox) (1ug/ml) for 3 days Genotype: transgenic carrying the tetO-OSKM transgene and Oct4-GFP/Rosa26-M2rtTA 	EXP052270	2429	normal	G3UX03	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049864
EXP052276	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: wildtype 	EXP052272	2476	normal	P14733	cardiac myocytes	PEAKS049865
EXP052277	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: wildtype 	EXP052273	2	normal	P14733	mESCs (mouse embryonic stem cells)	PEAKS049866
EXP052278	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: CMV-creERT, Hdac3 f/fÂ  (Hdac3 knockout)	EXP052274	2	normal	P14733	mESCs (mouse embryonic stem cells)	PEAKS049867
EXP052279	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: CMV-creERT, Hdac3 f/fÂ  (Hdac3 knockout) Treatment: tamoxifen 	EXP052275	2	normal	P14733	mESCs (mouse embryonic stem cells)	PEAKS049868
EXP052290	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052280	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049869
EXP052291	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052281	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049870
EXP052292	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052282	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049871
EXP052293	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052283	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049872
EXP052294	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052284	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049873
EXP052295	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052285	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049874
EXP052296	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052286	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049875
EXP052297	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052287	2494	normal	Q01147	mpkCCD (clone 11)	PEAKS049876
EXP052298	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052288	2494	normal	P28033	mpkCCD (clone 11)	PEAKS049877
EXP052299	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052282	2494	normal	P28033	mpkCCD (clone 11)	PEAKS049878
EXP052300	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052289	2494	normal	P28033	mpkCCD (clone 11)	PEAKS049879
EXP052301	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052286	2494	normal	P28033	mpkCCD (clone 11)	PEAKS049880
EXP052305	LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Genotype: wildtype Passage: 3-5  Characteristic: myogenic differentiation day1	EXP052302	1153	normal	Q6ZQ88	C2C12 (myoblasts)	PEAKS049881
EXP052306	LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Genotype: wildtype Passage: 3-5  Characteristic: adipogenic differentiation day1	EXP052303	1153	normal	Q6ZQ88	C2C12 (myoblasts)	PEAKS049882
EXP052307	LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Genotype: Overexpression of Lsd1 Passage: 3-5  Characteristic: adipogenic differentiation day1	EXP052304	1153	normal	Q6ZQ88	C2C12 (myoblasts)	PEAKS049883
EXP052308	Anti-IRF4 (M-17) (Santa Cruz Biotechnology, sc-6059x)	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: spleen  	NULL	2390	normal	Q64287	Treg (regulatory T cells)	PEAKS049884
EXP052309	Anti-IRF4 (M-17) (Santa Cruz Biotechnology, sc-6059x)	Mus musculus	Strain: C57BL/6 Genotype: p65 (RELA) knockout Tissue: spleen  	NULL	2390	normal	Q64287	Treg (regulatory T cells)	PEAKS049885
EXP052310	Anti-NFkB/p65 (C-20) (Santa Cruz Biotechnology, sc-372)	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: spleen  	NULL	2390	normal	Q04207	Treg (regulatory T cells)	PEAKS049886
EXP052314	anti-Flag ( sigma m1804)	Mus musculus	Source: reprogramming cells, day3	EXP052312	2429	normal	O88574	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049887
EXP052315	anti-Flag ( sigma m1804)	Mus musculus	Source: reprogramming cells, day7	EXP052313	2429	normal	O88574	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049888
EXP052316	anti-SIN3A (AB3479)	Mus musculus	Source: reprogramming cells, day3	NULL	2429	normal	Q60520	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049889
EXP052317	anti-SIN3A (AB3479)	Mus musculus	Source: reprogramming cells, day7	NULL	2429	normal	Q60520	MREF (Mouse Reprogramming Embryonic Fibroblasts)	PEAKS049890
EXP052319	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 0 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	PEAKS049891
EXP052320	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 10 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	PEAKS049892
EXP052321	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 20 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	PEAKS049893
EXP052322	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 30 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	PEAKS049894
EXP052323	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 2hrs Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	PEAKS049895
EXP052324	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 4 hrsTreatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	PEAKS049896
EXP052325	anti-Miz (10E2) (home-made)	Mus musculus	Genotype: wildtype Source: embryonic fibroblasts, E13.5 	NULL	22	normal	Q8C5D8	3T9 fibroblasts	PEAKS049897
EXP052326	anti-Miz (10E2) (home-made)	Mus musculus	Genotype: wildtype Source: embryonic fibroblasts, E13.5 	NULL	2433	normal	Q8C5D8	primary B cells	PEAKS049898
EXP052330	p300 antibody(santa-cruz, sc-585)	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: wildtype Strain: C57BL/6	EXP052327	498	normal	B2RWS6	Th17-cells	PEAKS049899
EXP052331	p300 antibody(santa-cruz, sc-585)	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: TRIM28 fl/flx CD4cre (Trim28 knockout) Strain: C57BL/6	EXP052328	498	normal	B2RWS6	Th17-cells	PEAKS049900
EXP052332	TRIM28 antibody(Active Motif, 61173)	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: wildtype Strain: C57BL/6	EXP052329	498	normal	Q62318	Th17-cells	PEAKS049901
EXP052336	anti-cbx7 (Rabbit pAb, Abcam, ab21873)	Mus musculus	Genotype: wildtype Source: ebryonic stem cells 	EXP052334	233	normal	Q8VDS3	E14TG2A (embryonic stem cells)	PEAKS049902
EXP052337	anti-Ring1b (Rabbit pAb, In-house)	Mus musculus	Genotype: wildtype Source: ebryonic stem cells 	EXP052335	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS049903
EXP052338	anti-HA (Rabbit pAb, BioLegend, 902301)	Mus musculus	Genotype: Cbx6-3Ã—HA Source: ebryonic stem cells 	EXP052333	233	normal	Q9DBY5	E14TG2A (embryonic stem cells)	PEAKS049904
EXP052339	CDX2 antibody (Cell Signaling Technology	Mus musculus	Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	P43241	jejunal epithelial cells	PEAKS049905
EXP052340	PBRM1/BAF180 antibody (Bethyl Laboratories, A301-591A)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q8BSQ9	jejunal epithelial cells	PEAKS049906
EXP052341	PBRM1/BAF180 antibody (Bethyl Laboratories, A301-591A)	Mus musculus	Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q8BSQ9	jejunal epithelial cells	PEAKS049907
EXP052342	MED1 antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q925J9	jejunal epithelial cells	PEAKS049908
EXP052343	CTCF antibody (EMD Millipore, 07-729)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q61164	jejunal epithelial cells	PEAKS049909
EXP052344	CDX2 antibody (Cell Signaling Technology	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	P43241	jejunal epithelial cells	PEAKS049910
EXP052345	KDM6A antibody (Cell Signaling Technology, 33510)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	O70546	jejunal epithelial cells	PEAKS049911
EXP052346	KDM6A antibody (Cell Signaling Technology, 33510)	Mus musculus	Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	O70546	jejunal epithelial cells	PEAKS049912
EXP052360	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: wildtype, FS2-FBXL19 Passage: 30-36  	EXP052359	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	PEAKS049925
EXP052350	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: transgene K49A FS2-FBXL19, CxxC point mutant Passage: 30-36  	EXP052357	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	PEAKS049916
EXP052351	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: transgene K49A FS2-FBXL19, CxxC point mutant Passage: 30-36  	EXP052358	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	PEAKS049917
EXP052352	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: {delta} CxxC_FBXL19_FS2 transgene, CxxC deletion mutant Passage: 30-36  	EXP052357	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	PEAKS049918
EXP052353	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: {delta} CxxC_FBXL19_FS2 transgene, CxxC deletion mutant Passage: 30-36  	EXP052358	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	PEAKS049919
EXP052365	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Cell line: Fbxl19 fl/fl (Fbxl19) Treatment: untreated Passage: 13-20	EXP052361	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	PEAKS049926
EXP052366	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Cell line: Fbxl19 fl/fl (Fbxl19) Treatment: untreated Passage: 13-20	EXP052362	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	PEAKS049927
EXP052367	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen for 96 hrs Genotype: Fbxl19 fl/fl (Fbxl19 knockout) Passage: 13-20	EXP052363	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	PEAKS049928
EXP052368	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen for 96 hrs Genotype: Fbxl19 fl/fl (Fbxl19 knockout) Passage: 13-20	EXP052364	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	PEAKS049929
EXP052371	anti-FLAG (Sigma, catalog# F1804)	Mus musculus	Strain: C57BL6  Genotype: FLAG tagged-Mbd1	EXP052369	2497	normal	Q9Z2E2	dentate gyrus	PEAKS049930
EXP052372	anti-FLAG (Sigma, catalog# F1804)	Mus musculus	Strain: C57BL6  Genotype: FLAG tagged-Mbd1	EXP052370	2497	normal	Q9Z2E2	dentate gyrus	PEAKS049931
EXP052379	SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype	EXP052378	252	normal	E9PYH6	V6.5 (embryonic stem cells)	PEAKS049932
EXP052380	SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype	EXP052373	252	normal	E9PYH6	V6.5 (embryonic stem cells)	PEAKS049933
EXP052381	SET1A (Homemade, #919)	Mus musculus	Treatment: supplemented with MEK inhibitor, GSK3 inhibitor, and LIF (2i/LIF) Genotype: Set1A SET deletion	NULL	252	normal	E9PYH6	V6.5 (embryonic stem cells)	PEAKS049934
EXP052396	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052382	12	normal	P63166	MEF (mouse embryonic fibroblasts)	PEAKS049935
EXP052397	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052383	12	normal	P63166	MEF (mouse embryonic fibroblasts)	PEAKS049936
EXP052398	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052382	12	normal	P61957	MEF (mouse embryonic fibroblasts)	PEAKS049937
EXP052399	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052383	12	normal	P61957	MEF (mouse embryonic fibroblasts)	PEAKS049938
EXP052400	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052384	2	normal	P63166	mESCs (mouse embryonic stem cells)	PEAKS049939
EXP052401	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052385	2	normal	P63166	mESCs (mouse embryonic stem cells)	PEAKS049940
EXP052402	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052384	2	normal	P61957	mESCs (mouse embryonic stem cells)	PEAKS049941
EXP052403	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052385	2	normal	P61957	mESCs (mouse embryonic stem cells)	PEAKS049942
EXP052404	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052386	12	normal	P20263	MEF (mouse embryonic fibroblasts)	PEAKS049943
EXP052405	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052387	12	normal	P20263	MEF (mouse embryonic fibroblasts)	PEAKS049944
EXP052406	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052386	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	PEAKS049945
EXP052407	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052387	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	PEAKS049946
EXP052408	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052386	12	normal	P48432	MEF (mouse embryonic fibroblasts)	PEAKS049947
EXP052409	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052387	12	normal	P48432	MEF (mouse embryonic fibroblasts)	PEAKS049948
EXP052410	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052388	12	normal	P20263	MEF (mouse embryonic fibroblasts)	PEAKS049949
EXP052411	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052389	12	normal	P20263	MEF (mouse embryonic fibroblasts)	PEAKS049950
EXP052412	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052388	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	PEAKS049951
EXP052413	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052389	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	PEAKS049952
EXP052414	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052388	12	normal	P48432	MEF (mouse embryonic fibroblasts)	PEAKS049953
EXP052415	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052389	12	normal	P48432	MEF (mouse embryonic fibroblasts)	PEAKS049954
EXP052417	Mll4 (Homemade, #825)	Mus musculus	Genotype: Mll4 NT deletion	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	PEAKS049955
EXP052418	Mll4 (Homemade, #825)	Mus musculus	Genotype: MLL4 SET deletion	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	PEAKS049956
EXP052419	Lsd1 (Abcam 17721)	Mus musculus	Genotype: wildtype	EXP052416	252	normal	Q6ZQ88	V6.5 (embryonic stem cells)	PEAKS049957
EXP052420	Mll4 (Homemade, #825)	Mus musculus	Genotype: Mll4 knockout Treatment: shRNA knockdown	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	PEAKS049958
EXP052421	Mll4 (Homemade, #825)	Mus musculus	Genotype: wildtype Treatment: no	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	PEAKS049959
EXP052423	TEAD1 (Mouse, Santa Cruz Biotechnology sc-393976)	Mus musculus	Tissue: primary cultured nerve tumor cells Genotype: Lats1 fl/fl (lats1 knockout), Lats2 fl/+, CcGFP fl/+,Dhh-Cre	EXP052422	2498	normal	P30051	nerve tumor cells	PEAKS049960
EXP052434	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: wildtype	EXP052424	483	normal	Q9ESU6	brown preadipocytes	PEAKS049961
EXP052435	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: wildtype	EXP052427	483	normal	Q9ESU6	brown preadipocytes	PEAKS049962
EXP052436	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	EXP052425	483	normal	Q9ESU6	brown preadipocytes	PEAKS049963
EXP052437	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	EXP052428	483	normal	Q9ESU6	brown preadipocytes	PEAKS049964
EXP052438	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: wildtype	EXP052426	483	normal	Q9ESU6	brown preadipocytes	PEAKS049965
EXP052439	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: wildtype	EXP052429	483	normal	Q9ESU6	brown preadipocytes	PEAKS049966
EXP052440	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Brd4-flox/flox (knockout) 	EXP052430	483	normal	Q9ESU6	brown preadipocytes	PEAKS049967
EXP052441	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: Brd4-flox/flox (knockout) 	EXP052431	483	normal	Q9ESU6	brown preadipocytes	PEAKS049968
EXP052442	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: Brd4-flox/flox (knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	PEAKS049969
EXP052443	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Strain: C57BL/6J  Stage: Differentiated myocytes Genotype: wildtype	NULL	1153	normal	Q9ESU6	C2C12 (myoblasts)	PEAKS049970
EXP052444	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Mll3-/- brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Mll3-/- (knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	PEAKS049971
EXP052445	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalizedMll3-/-; Mll4f/f brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Mll3-/- and Mll4flox/flox (double knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	PEAKS049972
EXP052446	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Mll3-/- brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2)Genotype: Mll3-/- (knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	PEAKS049973
EXP052447	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalizedMll3-/-; Mll4f/f brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: Mll3-/- and Mll4flox/flox (double knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	PEAKS049974
EXP052449	ASXL1 (Santa Cruz sc-85283)	Mus musculus	Passage: 5 -10 Genotype: wildtype	EXP052448	2499	normal	P59598	BM-derived MSPCs (bone marrow-derived mesenchymal stem/progenitor cells)	PEAKS049975
EXP052453	anti-IRF8	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	P23611	CD4+ T-cells	PEAKS049976
EXP052454	anti-PU.1	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	P17433	CD4+ T-cells	PEAKS049977
EXP052455	anti-IRF4	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	Q64287	CD4+ T-cells	PEAKS049978
EXP052456	anti-BATF	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	O35284	CD4+ T-cells	PEAKS049979
EXP052457	anti-ETV6	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	P97360	CD4+ T-cells	PEAKS049980
EXP052458	anti-IRF8	Mus musculus	Source:Th2 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	normal	P23611	CD4+ T-cells	PEAKS049981
EXP052459	anti-ETV6	Mus musculus	Source:Th2 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	normal	P97360	CD4+ T-cells	PEAKS049982
EXP052462	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv + anti-CD3/CD28 stimulation Tissue: Spleens+Lymph nodes	EXP052460	2501	normal	Q04207	Tconv (conventional T cells)	PEAKS049983
EXP052463	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv + anti-CD3/CD28 stimulation Tissue: Spleens+Lymph nodes	EXP052461	2501	normal	Q04207	Tconv (conventional T cells)	PEAKS049984
EXP052464	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv unstimulated Tissue: Spleens+Lymph nodes	EXP052460	2501	normal	Q04207	Tconv (conventional T cells)	PEAKS049985
EXP052465	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv unstimulated Tissue: Spleens+Lymph nodes	EXP052461	2501	normal	Q04207	Tconv (conventional T cells)	PEAKS049986
EXP052466	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg + anti-CD3/CD28 stimulationTissue: Spleens+Lymph nodes	EXP052460	1053	normal	Q04207	Treg cells from lymph nodes and spleen	PEAKS049987
EXP052467	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg + anti-CD3/CD28 stimulation Tissue: Spleens+Lymph nodes	EXP052461	1053	normal	Q04207	Treg cells from lymph nodes and spleen	PEAKS049988
EXP052468	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg unstimulated Tissue: Spleens+Lymph nodes	EXP052460	1053	normal	Q04207	Treg cells from lymph nodes and spleen	PEAKS049989
EXP052469	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg unstimulated Tissue: Spleens+Lymph nodes	EXP052461	1053	normal	Q04207	Treg cells from lymph nodes and spleen	PEAKS049990
EXP052472	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: 4-hydroxy-tamoxifen for at least 7days Background: cell line RAS lox/lox	EXP052470	2	normal	P70459	mESCs (mouse embryonic stem cells)	PEAKS049991
EXP052473	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: 4-hydroxy-tamoxifen for at least 7days Background: cell line RAS lox/lox	EXP052471	2	normal	P70459	mESCs (mouse embryonic stem cells)	PEAKS049992
EXP052474	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert)  Background: cell line RAS lox/lox	EXP052470	2	normal	P70459	mESCs (mouse embryonic stem cells)	PEAKS049993
EXP052475	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert)  Background: cell line RAS lox/lox	EXP052471	2	normal	P70459	mESCs (mouse embryonic stem cells)	PEAKS049994
EXP052476	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF knockout, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: no for at least 7days Background: cell line RAS lox/lox	EXP052470	2	normal	P70459	mESCs (mouse embryonic stem cells)	PEAKS049995
EXP052477	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF knockout, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: no for at least 7days Background: cell line RAS lox/lox	EXP052471	2	normal	P70459	mESCs (mouse embryonic stem cells)	PEAKS049996
EXP052482	Mll2 (Generated in Shilatifard lab (PubMed id: 23934151))	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	O08550	mESCs (mouse embryonic stem cells)	PEAKS049997
EXP052483	Mll2 (Generated in Shilatifard lab (PubMed id: 23934151))	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	O08550	mESCs (mouse embryonic stem cells)	PEAKS049998
EXP052484	CTCF (Millipore, 07-729)	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS049999
EXP052485	CTCF (Millipore, 07-729)	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS050000
EXP052486	Ring1b (Homemade (PubMed id: 22226355))	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS050001
EXP052487	Ring1b (Homemade (PubMed id: 22226355))	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS050002
EXP052488	Suz12 (Abcam, ab12073)	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS050003
EXP052489	Suz12 (Abcam, ab12073)	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS050004
EXP052490	anti-Ctip2 (Bcl11b) (abcam ab18465)	Mus musculus	Genotype: Bcl11b fl/fl (knockout) CD4cre+ Strain: C57BL/6	NULL	171	bio_control	Q99PV8	CD4+ CD8+ T cells	PEAKS050005
EXP052491	anti-Ctip2 (Bcl11b) (abcam ab18465)	Mus musculus	Genotype: wildtype Strain: C57BL/6 Treatment: infected with Heligmosomoides polygyrus	NULL	1058	normal	Q99PV8	CD4+ T-cells	PEAKS050006
EXP052493	rabbit anti-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: HA-GADD45a Strain: C57BL/6N	NULL	12	normal	P48316	MEF (mouse embryonic fibroblasts)	PEAKS050007
EXP052496	rabbit a-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: HA-ING1 Strain: C57BL/6N Age: embryonic day E15.5 Passage: 4	EXP052494	12	normal	Q9QXV3	MEF (mouse embryonic fibroblasts)	PEAKS050008
EXP052497	rabbit a-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: HA-ING1 Strain: C57BL/6N Age: embryonic day E15.5 Passage: 4	EXP052495	12	normal	Q9QXV3	MEF (mouse embryonic fibroblasts)	PEAKS050009
EXP052502	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: high fat diet Sex: male Strain: C57BL/6	EXP052498	187	normal	P49698	colon epithelium	PEAKS050010
EXP052503	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: high fat diet Sex: male Strain: C57BL/6	EXP052499	187	normal	P49698	colon epithelium	PEAKS050011
EXP052504	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: low fat diet Sex: male Strain: C57BL/6	EXP052500	187	normal	P49698	colon epithelium	PEAKS050012
EXP052505	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: low fat diet Sex: male Strain: C57BL/6	EXP052501	187	normal	P49698	colon epithelium	PEAKS050013
EXP052508	anti-FLAG	Mus musculus	Passage: 10 Strain: C57BL/6	EXP052506	138	normal	A0A286YCP2	neural progenitors	PEAKS050014
EXP052509	anti-Nup153	Mus musculus	Passage: 10 Strain: C57BL/6	EXP052507	138	normal	A0A286YCP2	neural progenitors	PEAKS050015
EXP052510	E2f1	Mus musculus	Growth: serum conditions	NULL	2	normal	Q61501	mESCs (mouse embryonic stem cells)	PEAKS050016
EXP052511	E2f1	Mus musculus	Growth: 2i conditions	NULL	13	normal	Q61501	2TS22C (embryonic stem cells)	PEAKS050017
EXP052515	N-terminal SPEN ( Abnova, PAB20849)	Mus musculus	Tissue: testes Treatment: untreated control Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050018
EXP052516	N-terminal SPEN ( Abnova, PAB20849)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050019
EXP052517	N-terminal SPEN ( Abnova, PAB20849)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050020
EXP052518	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: untreated control Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050021
EXP052519	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050022
EXP052520	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 30 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050023
EXP052521	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 30 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050024
EXP052522	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min and 4hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050025
EXP052523	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 15 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050026
EXP052524	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 30 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050027
EXP052525	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 30 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050028
EXP052526	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 30 min and 4hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	PEAKS050029
EXP052527	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes/spermatocytes Treatment: untreated control Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	PEAKS050030
EXP052528	internal SPEN (Abcam, ab72266)	Mus musculus	testes/spermatocytes Treatment: heat shocked at 43 degrees Celsius for 30 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	PEAKS050031
EXP052529	internal SPEN (Abcam, ab72266)	Mus musculus	Treatment: heat shocked at 43 degrees Celsius for 30 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	PEAKS050032
EXP052530	internal SPEN (Abcam, ab72266)	Mus musculus	Treatment: heat shocked at 43 degrees Celsius for 30 min and 4hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	PEAKS050033
EXP052534	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: Hop2-/- (Psmc3ip-/-) Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	PEAKS050034
EXP052535	Anti-DMC1 GP1 custom	Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	PEAKS050035
EXP052536	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype:Prdm9-/- Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	PEAKS050036
EXP052537	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: Dnmt3L-/- Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	PEAKS050037
EXP052538	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: Hop2-/- (Psmc3ip-/-) Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	PEAKS050038
EXP052539	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	PEAKS050039
EXP052540	Anti-DMC1 GP1 custom	Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: 15.5 days post coitum 	EXP052533	2505	normal	Q61880	ovary	PEAKS050040
EXP052541	LMO2 (R&D systems AF2726)	Mus musculus	Genotype: wildtype 	NULL	2507	normal	P25801	embryonic stem cells derived Flk-1+ cells	PEAKS050041
EXP052542	LMO2 (R&D systems AF2726)	Mus musculus	Genotype: Lmo2-/- (knockout) 	NULL	2507	normal	P25801	embryonic stem cells derived Flk-1+ cells	PEAKS050042
EXP052543	TAL1 (Santa Cruz sc-12984X)	Mus musculus	Genotype: wildtype 	NULL	2507	normal	P22091	embryonic stem cells derived Flk-1+ cells	PEAKS050043
EXP052544	TAL1 (Santa Cruz sc-12984X)	Mus musculus	Genotype: Lmo2-/- (knockout) 	NULL	2507	normal	P22091	embryonic stem cells derived Flk-1+ cells	PEAKS050044
EXP052545	Ldb1 (Abcam ab96799)	Mus musculus	Genotype: wildtype 	NULL	2507	normal	P70662	embryonic stem cells derived Flk-1+ cells	PEAKS050045
EXP052546	Ldb1 (Abcam ab96799)	Mus musculus	Genotype: Lmo2-/- (knockout) 	NULL	2507	normal	P70662	embryonic stem cells derived Flk-1+ cells	PEAKS050046
EXP052551	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052547	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050047
EXP052552	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052547	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050048
EXP052553	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052548	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050049
EXP052554	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052548	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050050
EXP052555	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052549	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050051
EXP052556	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052549	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050052
EXP052557	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052550	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050053
EXP052558	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052550	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	PEAKS050054
EXP052559	TAF3 (Millipore 07-1802; Lot#3008423)	Rattus norvegicus	Treatment: Source: Serotonergic tissue culture cells Type: Undifferentiated	NULL	2509	normal	D3ZPB7	RN46A-B14	PEAKS050055
EXP052560	TAF3 (Millipore 07-1802; Lot#3008423)	Rattus norvegicus	Treatment: Source: Serotonergic tissue culture cells Type: Differentiated	NULL	2509	normal	D3ZPB7	RN46A-B14	PEAKS050056
EXP052566	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052561	1046	normal	P41738	liver	PEAKS050057
EXP052567	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052562	1046	normal	P41738	liver	PEAKS050058
EXP052568	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052563	1046	normal	P41738	liver	PEAKS050059
EXP052569	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052564	1046	normal	P41738	liver	PEAKS050060
EXP052570	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052565	1046	normal	P41738	liver	PEAKS050061
EXP052582	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours Tissue: Rat aortic smooth muscle cell	EXP052571	2510	normal	A0A0G2JYV0	RASMC	PEAKS050062
EXP052583	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours Tissue: Rat aortic smooth muscle cell	EXP052574	2510	normal	A0A0G2JYV0	RASMC	PEAKS050063
EXP052584	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours Tissue: Rat aortic smooth muscle cell	EXP052572	2510	normal	A0A0G2JYV0	RASMC	PEAKS050064
EXP052585	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours Tissue: Rat aortic smooth muscle cell	EXP052575	2510	normal	A0A0G2JYV0	RASMC	PEAKS050065
EXP052586	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	EXP052573	2510	normal	A0A0G2JYV0	RASMC	PEAKS050066
EXP052587	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	EXP052576	2510	normal	A0A0G2JYV0	RASMC	PEAKS050067
EXP052590	NF1 (Santa Cruz, sc-5567, B2613)	Rattus norvegicus	Strain:Sprague-Dawley  Treatment: none	EXP052588	2511	normal	P97526	differentiated neural stem cell	PEAKS050068
EXP052591	NF1 (Santa Cruz, sc-5567, B2613)	Rattus norvegicus	Strain:Sprague-Dawley  Treatment: vitamin C	EXP052589	2511	normal	P97526	differentiated neural stem cell	PEAKS050069
EXP052600	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 25 	EXP052592	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050070
EXP052601	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 50 	EXP052593	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050071
EXP052602	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 75 	EXP052594	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050072
EXP052603	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 100 	EXP052595	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050073
EXP052604	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 125 	EXP052596	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050074
EXP052605	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 150 	EXP052597	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050075
EXP052606	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 175 	EXP052598	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050076
EXP052607	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 200 	EXP052599	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050077
EXP052608	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 25 	EXP052592	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050078
EXP052609	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 50 	EXP052593	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050079
EXP052610	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 75 	EXP052594	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050080
EXP052611	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 100 	EXP052595	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050081
EXP052612	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 125 	EXP052596	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050082
EXP052613	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 150 	EXP052597	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050083
EXP052614	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 175 	EXP052598	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050084
EXP052615	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 200 	EXP052599	2514	normal	Q9Y812	Fission Yeast strains	PEAKS050085
EXP052619	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D52_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052616	1263	normal	O14335	whole cells	PEAKS050086
EXP052620	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052616	1263	normal	O14335	whole cells	PEAKS050087
EXP052621	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052617	1263	normal	O14335	whole cells	PEAKS050088
EXP052622	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glycerol Strain: D52_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052618	1263	normal	O14335	whole cells	PEAKS050089
EXP052623	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D96_Tup11-TAP Genotype:h+ ura4-d18 leu1-32 ade6-m216 tup11::TAP-KanMX6	EXP052616	1263	normal	Q09715	whole cells	PEAKS050090
EXP052624	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D96_Tup11-TAP Genotype:h+ ura4-d18 leu1-32 ade6-m216 tup11::TAP-KanMX6	EXP052617	1263	normal	Q09715	whole cells	PEAKS050091
EXP052625	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D96_Tup11-TAP Genotype:h+ ura4-d18 leu1-32 ade6-m216 tup11::TAP-KanMX6	EXP052618	1263	normal	Q09715	whole cells	PEAKS050092
EXP052626	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D102_Rst2-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 rst2::TAP-KanMX6	EXP052616	1263	normal	P78871	whole cells	PEAKS050093
EXP052627	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D102_Rst2-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 rst2::TAP-KanMX6	EXP052617	1263	normal	P78871	whole cells	PEAKS050094
EXP052628	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D102_Rst2-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 rst2::TAP-KanMX6	EXP052618	1263	normal	P78871	whole cells	PEAKS050095
EXP052629	anti-RBR1 (provided by Willhelm Gruissem (ETH, Zurich, Switzerland) and affinity-purified by Hirofumi Harashima in our lab)	Arabidopsis thaliana	days after subculture: 3 Ecotype: Landsberg erecta	NULL	2515	normal	Q9LKZ3	MM2d cell culture	PEAKS050096
EXP052634	anti-Flag M2 Magnetic beads (Sigma, Cat# M8823)	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: pSOG1::SOG1-3xFLAG Time after IR: 20 min	EXP052630	1341	normal	Q6NQK2	10 day old seedlings	PEAKS050097
EXP052635	anti-Flag M2 Magnetic beads (Sigma, Cat# M8823)	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: pSOG1::SOG1-3xFLAG Time after IR: 1hr 	EXP052631	1341	normal	Q6NQK2	10 day old seedlings	PEAKS050098
EXP052638	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	sham operated	EXP052636	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050099
EXP052639	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	sham operated	EXP052636	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050100
EXP052640	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	sham operated	EXP052636	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050101
EXP052641	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050102
EXP052642	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050103
EXP052643	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050104
EXP052644	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	PEAKS050105
EXP052649	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::GFP	EXP052645	1344	normal	Q8H159	14 day old seedling	PEAKS050106
EXP052650	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	EXP052646	1344	normal	Q8GYC1	14 day old seedling	PEAKS050107
EXP052651	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	EXP052647	1344	normal	Q8GYC1	14 day old seedling	PEAKS050108
EXP052652	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	EXP052648	1344	normal	Q8GYC1	14 day old seedling	PEAKS050109
EXP052654	anti-GFP antibody	Arabidopsis thaliana	Genotype: SUVH1-GFP in wild type Conditions: 16 hr light/8 hr dark	EXP052653	1339	normal	Q9FF80	seedling	PEAKS050110
EXP052659	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-lsw2 Source: Asynchronous growth in liquid YPD	EXP052655	1232	normal	Q08773	S. cerevisiae cells	PEAKS050111
EXP052660	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-lsw2 Source: Asynchronous growth in liquid YPD	EXP052656	1232	normal	Q08773	S. cerevisiae cells	PEAKS050112
EXP052661	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-Nhp10 Source: Asynchronous growth in liquid YPD	EXP052657	1232	normal	Q03435	S. cerevisiae cells	PEAKS050113
EXP052662	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-Nhp10 Source: Asynchronous growth in liquid YPD	EXP052658	1232	normal	Q03435	S. cerevisiae cells	PEAKS050114
EXP052674	 9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052663	2517	normal	P38170	Log cells	PEAKS050115
EXP052675	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052664	2517	normal	P38170	Log cells	PEAKS050116
EXP052676	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052665	2517	normal	P38170	Log cells	PEAKS050117
EXP052677	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc Type: All Replicates Merged data	EXP052666	2517	normal	P38170	Log cells	PEAKS050118
EXP052678	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052667	2518	normal	P38170	Quiescent cells	PEAKS050119
EXP052679	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052668	2518	normal	P38170	Quiescent cells	PEAKS050120
EXP052680	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052669	2518	normal	P38170	Quiescent cells	PEAKS050121
EXP052681	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc Type: All Replicates Merged data	EXP052670	2518	normal	P38170	Quiescent cells	PEAKS050122
EXP052682	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 7066 and 7068 Genotype: SMC4 knockout, BRN1::myc Treatment: doxycycline Type: All Replicates Merged data	EXP052671	2518	normal	P38170	Quiescent cells	PEAKS050123
EXP052683	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6891 and 6892 Genotype: BRN1::myc, msn2 Type: All Replicates Merged data	EXP052672	2518	normal	P38170	Quiescent cells	PEAKS050124
EXP052684	M2 anti-FLAG (Sigma, catalog #F1804)	Saccharomyces cerevisiae	Strain: 7072 and 7073 Genotype: MSN2::FLAG BRN1::myc, msn2 Type: All Replicates Merged data	EXP052673	2518	normal	P33748	Quiescent cells	PEAKS050125
EXP052722	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052685	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050126
EXP052723	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052686	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050127
EXP052724	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052687	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050128
EXP052725	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052688	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050129
EXP052726	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052689	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050130
EXP052727	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8104 Source: meotic time 3 hours Genotype: dot1{delta} (deletion)	EXP052690	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050131
EXP052728	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8104 Source: meotic time 3 hours Genotype: dot1{delta} (deletion)	EXP052691	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050132
EXP052729	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8583 Source: meotic time 3 hours Genotype: dot1{delta},set1{delta} (deletions)	EXP052692	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050133
EXP052730	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8583 Source: meotic time 3 hours Genotype: dot1{delta},set1{delta} (deletions)	EXP052693	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050134
EXP052731	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8115 Source: meotic time 3 hours Genotype: dot1{delta},rec8{delta} (deletions)	EXP052698	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050135
EXP052732	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8115 Source: meotic time 3 hours Genotype: dot1{delta},rec8{delta} (deletions)	EXP052699	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050136
EXP052733	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8584 Source: meotic time 3 hours Genotype: set1{delta} (deletion)	EXP052696	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050137
EXP052734	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8584 Source: meotic time 3 hours Genotype: set1{delta} (deletion)	EXP052697	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050138
EXP052735	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8151 Source: meotic time 3 hours Genotype: rec8{delta} (deletion)	EXP052698	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050139
EXP052736	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8151 Source: meotic time 3 hours Genotype: rec8{delta} (deletion)	EXP052699	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050140
EXP052737	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9120 Source: meotic time 3 hours Genotype: hop1{delta} (deletion)	EXP052700	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050141
EXP052738	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9120 Source: meotic time 3 hours Genotype: hop1{delta} (deletion)	EXP052701	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050142
EXP052739	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8218 Source: meotic time 3 hours Genotype: ycs4S/RED1	EXP052702	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050143
EXP052740	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8218 Source: meotic time 3 hours Genotype: ycs4S/RED1	EXP052703	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050144
EXP052741	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8220 Source: meotic time 3 hours Genotype: red1/RED1	EXP052704	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050145
EXP052742	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8220 Source: meotic time 3 hours Genotype: red1/RED1	EXP052705	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050146
EXP052743	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/ycs4S	NULL	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050147
EXP052744	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/ycs4S	NULL	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050148
EXP052745	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/red1	EXP052708	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050149
EXP052746	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/red1	EXP052709	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050150
EXP052747	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052710	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050151
EXP052748	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 10% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052711	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050152
EXP052749	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 15% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052718	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050153
EXP052750	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 20% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052713	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050154
EXP052751	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 25% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052714	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050155
EXP052752	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 30% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052715	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050156
EXP052753	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052716	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050157
EXP052754	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052717	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050158
EXP052755	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 15% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052718	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050159
EXP052756	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 20% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052719	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050160
EXP052757	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 25% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052720	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050161
EXP052758	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 30% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052721	2519	normal	P14291	Cell suspension in synchronous meiosis	PEAKS050162
EXP052759	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin Strain: YSK426 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SNF2-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	PEAKS050163
EXP052760	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin Strain: YSK426 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SNF2-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	PEAKS050164
EXP052761	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin Strain: YSK423 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ISW2-FRB-HIS3MX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	PEAKS050165
EXP052762	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin Strain: YSK423 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ISW2-FRB-HIS3MX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	PEAKS050166
EXP052763	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: no auxin Strain: YSK492 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	PEAKS050167
EXP052764	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: 30 minutes auxin (3-IAA) Strain: YSK492 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	PEAKS050168
EXP052765	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: no auxin Strain: YSK491 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; ISW1-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	PEAKS050169
EXP052766	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: 30 minutes auxin (3-IAA) Strain: YSK426 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; ISW1-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	PEAKS050170
EXP052767	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin Strain: YSK474 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 CHD1-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	PEAKS050171
EXP052768	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin Strain: YSK474 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 CHD1-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	PEAKS050172
EXP052769	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: no rapamycin/auxin Strain: YSK495 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	PEAKS050173
EXP052770	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin 30 minutes auxin Strain: YSK495 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	PEAKS050174
EXP052774	anti-Spt6	Saccharomyces cerevisiae	Treatment: Genotype: spt6-S8A	EXP052771	1232	normal	P23615	S. cerevisiae cells	PEAKS050175
EXP052775	anti-Spt6	Saccharomyces cerevisiae	Treatment: Genotype: spt6-S8E	EXP052772	1232	normal	P23615	S. cerevisiae cells	PEAKS050176
EXP052776	anti-Spt6	Saccharomyces cerevisiae	Treatment: Genotype: wildtype	EXP052773	1232	normal	P23615	S. cerevisiae cells	PEAKS050177
EXP052785	anti-Flag	Saccharomyces cerevisiae	Treatment: none Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052777	2189	normal	P46946	G1 S.cerevisiae cells	PEAKS050178
EXP052786		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052779	2189	normal	P46946	G1 S.cerevisiae cells	PEAKS050179
EXP052787		Saccharomyces cerevisiae	Treatment: none Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052781	2191	normal	P46946	S phase S. cerevisiae cells	PEAKS050180
EXP052788		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052783	2191	normal	P46946	S phase S. cerevisiae cells	PEAKS050181
EXP052868	anti-Rbf (mouse, DX3/DX5, ratio 1:1, Du W. et al, Genes Dev. 1996;10(10):1206-18)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052866	2523	normal	Q24472	flight muscles	PEAKS050205
EXP052869	anti-Rbf (mouse, DX3/DX5, ratio 1:1, Du W. et al, Genes Dev. 1996;10(10):1206-18)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052867	2523	normal	Q24472	flight muscles	PEAKS050206
EXP052883	anti-HMR	Drosophila melanogaster	Treatment: induced (CuSO4 250 uM) Genotype: pMT - HMR-FLAG-HA 	EXP052880	1451	normal	Q7YU57	S2 (Schneider 2)	PEAKS050213
EXP052884	anti-HMR	Drosophila melanogaster	uninduced	EXP052881	1451	normal	Q7YU57	S2 (Schneider 2)	PEAKS050214
EXP052885	anti-HMR	Drosophila melanogaster	Treatment: uninduced Genotype: pMT - HMR-FLAG-HA 	EXP052882	1451	normal	Q7YU57	S2 (Schneider 2)	PEAKS050215
EXP052896	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052886	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050216
EXP052897	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052887	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050217
EXP052898	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052888	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050218
EXP052899	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052889	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050219
EXP052900	anti-CLAMP	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052890	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050220
EXP052901	anti-CLAMP	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052891	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050221
EXP052902	anti-CLAMP	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052889	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050222
EXP052903	anti-CLAMP	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052893	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050223
EXP052904	anti-CLAMP	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052894	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050224
EXP052905	anti-CLAMP	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052895	1451	normal	Q8IGP5	S2 (Schneider 2)	PEAKS050225
EXP052906	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052886	1451	normal	P50534	S2 (Schneider 2)	PEAKS050226
EXP052907	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052887	1451	normal	P50534	S2 (Schneider 2)	PEAKS050227
EXP052908	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052888	1451	normal	P50534	S2 (Schneider 2)	PEAKS050228
EXP052909	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052889	1451	normal	P50534	S2 (Schneider 2)	PEAKS050229
EXP052910	MSL2	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052890	1451	normal	P50534	S2 (Schneider 2)	PEAKS050230
EXP052911	MSL2	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052891	1451	normal	P50534	S2 (Schneider 2)	PEAKS050231
EXP052912	MSL2	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052892	1451	normal	P50534	S2 (Schneider 2)	PEAKS050232
EXP052913	MSL2	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052893	1451	normal	P50534	S2 (Schneider 2)	PEAKS050233
EXP052914	MSL2	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052894	1451	normal	P50534	S2 (Schneider 2)	PEAKS050234
EXP052915	MSL2	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052895	1451	normal	P50534	S2 (Schneider 2)	PEAKS050235
EXP052916	PADI2 antibody (z-22, Santa Cruz,sc-133877,#E1214  )	Homo sapiens	Treatment: Untreated Source: T47D PADI2 T0	NULL	111	normal	Q9Y2J8	T47D (invasive ductal carcinoma)	PEAKS050236
EXP052917	PADI2 antibody (z-22, Santa Cruz,sc-133877,#H0715 )	Homo sapiens	Treatment: Untreated Source: T47D PADI2 T0	NULL	111	normal	Q9Y2J8	T47D (invasive ductal carcinoma)	PEAKS050237
EXP052940	FOXA1 (Abcam)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	EXP052918	2524	normal	P55317	LNCaP95	PEAKS050238
EXP052941	FOXA1 (Abcam)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	EXP052920	2524	normal	P55317	LNCaP95	PEAKS050239
EXP052942	FOXA1 (Abcam)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	EXP052922	2524	normal	P55317	LNCaP95	PEAKS050240
EXP052943	HOXB13	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	EXP052924	2524	normal	Q92826	LNCaP95	PEAKS050241
EXP052944	HOXB13	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	EXP052925	2524	normal	Q92826	LNCaP95	PEAKS050242
EXP052945	HOXB13	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	EXP052926	2524	normal	Q92826	LNCaP95	PEAKS050243
EXP052946	AR (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	EXP052926	2524	normal	P10275	LNCaP95	PEAKS050244
EXP052947	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052923	2524	normal	P10275	LNCaP95	PEAKS050245
EXP052948	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	EXP052932	2524	normal	P10275	LNCaP95	PEAKS050246
EXP052949	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shGFP	EXP052933	2524	normal	P10275	LNCaP95	PEAKS050247
EXP052950	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	EXP052925	2524	normal	P10275	LNCaP95	PEAKS050248
EXP052951	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052928	2524	normal	P10275	LNCaP95	PEAKS050249
EXP052952	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) 	EXP052936	2524	normal	P10275	LNCaP95	PEAKS050250
EXP052953	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052937	2524	normal	P10275	LNCaP95	PEAKS050251
EXP052954	AR (N-20, Santa-Cruz Biotechnology)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) 	EXP052938	2524	normal	P10275	LNCaP95	PEAKS050252
EXP052955	AR (N-20, Santa-Cruz Biotechnology)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052939	2524	normal	P10275	LNCaP95	PEAKS050253
EXP052958	CDK9 (H169, santa-cruz, sc-8338)	Homo sapiens	Treatment: 0.1% DMSO for 3 hrs	EXP052956	520	normal	P50750	Kelly (neuroblastoma)	PEAKS050254
EXP052959	CDK9 (H169, santa-cruz, sc-8338)	Homo sapiens	Treatment: 1uM CYC065 for 3hrs 	EXP052957	520	normal	P50750	Kelly (neuroblastoma)	PEAKS050255
EXP052962	KDM5A	Homo sapiens	Genotype: wildtype 	EXP052960	417	normal	P29375	HCT-116 (colon carcinoma)	PEAKS050256
EXP052963	KDM5A	Homo sapiens	Genotype: wildtype 	EXP052961	417	normal	P29375	HCT-116 (colon carcinoma)	PEAKS050257
EXP052964	anti-Glucocorticoid receptor (N499)	Homo sapiens	Treatment: 90min with 0.02% ethanol Genotype: traslocation t(9;22)(q34;11) ? BCR-ABL1 e1-a2 fusion	NULL	2525	normal	P04150	SUP-B15 (Childhood B acute lymphoblastic leukemia)	PEAKS050258
EXP052965	Glucocorticoid receptor N499	Homo sapiens	Treatment: 1uM dexamethasone in 0.02% ethanol Genotype: traslocation t(9;22)(q34;11) ? BCR-ABL1 e1-a2 fusion	NULL	2525	normal	P04150	SUP-B15 (Childhood B acute lymphoblastic leukemia)	PEAKS050259
EXP052970	BRD4	Homo sapiens	Treatment: vehicle for 24 hrs Status: naÃ¯ve	EXP052966	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	PEAKS050260
EXP052971	BRD4	Homo sapiens	Treatment: vehicle for 24 hrs Status: resistant	EXP052967	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	PEAKS050261
EXP052972	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs Status: naÃ¯ve	EXP052968	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	PEAKS050262
EXP052973	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs Status: resistant	EXP052969	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	PEAKS050263
EXP052976	BCL6 (Santa Cruz N3, sc-858)	Homo sapiens	Treatment: untreated (control siRNA)	EXP052974	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS050264
EXP052977	BCL6 (Santa Cruz N3, sc-858)	Homo sapiens	Treatment: BCL6 targeted siRNA	EXP052975	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS050265
EXP052978	LSD1 (abcam 17721)	Homo sapiens	Treatment: untreated (control siRNA)	EXP052974	685	normal	O60341	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS050266
EXP052979	LSD1 (abcam 17721)	Homo sapiens	Treatment: BCL6 targeted siRNA	EXP052975	685	normal	O60341	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS050267
EXP052981	TFAP2A (sc-12726, Santa Cruz)	Homo sapiens	Genotype: wildtype Treatment: hiPSC differentiation into hNCC (passage 2)	EXP052980	1143	normal	P05549	iPSC (induced pluripotent stem cells)	PEAKS050268
EXP052982	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siControl every 24 hours, 100nM of DHT for 2 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS050269
EXP052983	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siControl every 24 hours, 100nM of ETOH for 2 hrs, 100nM of ETOH for 2 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS050270
EXP052984	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siLINC00844 every 24 hours, 100nM of DHT for 2 hrs Genotype: transfected with siLINC00844 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS050271
EXP052985	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siLINC00844 every 24 hours, 100nM of ETOH for 2 hrs Genotype: transfected with siLINC00844 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS050272
EXP052992	MEIS1 (Abcam, ab19867)	Homo sapiens		EXP052991	1086	normal	O00470	A-673 clone Asp114 (Ewing sarcoma)	PEAKS050276
EXP052995	HA antibody (Cell Signaling, Catalog # C29F4)	Homo sapiens	Genotype: inducible Glis3 expression Treatment:none Doxycycline, 12 hrs Source: G3- human embryonic stem cells 	EXP052993	2526	normal	Q8NEA6	H9	PEAKS050277
EXP052996	HA antibody (Cell Signaling, Catalog # C29F4)	Homo sapiens	Genotype: inducible Glis3 expression Treatment: with Doxycycline , 12 hrs Source: G3- human embryonic stem cells 	EXP052994	2526	normal	Q8NEA6	H9	PEAKS050278
EXP052999	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged N1671A p300-BRPHZT (mutant) 	EXP052998	375	normal	Q99720	NCI-H1299 (large cell lung carcinoma)	PEAKS050279
EXP053000	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged N1671A p300-BRPHZT (mutant) 	EXP052998	375	normal	Q09472	NCI-H1299 (large cell lung carcinoma)	PEAKS050280
EXP053001	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged WT p300-BRPHZT 	EXP052998	375	normal	Q99720	NCI-H1299 (large cell lung carcinoma)	PEAKS050281
EXP053002	FLI1 (Santa Cruz, sc-356)	Homo sapiens		NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS050282
EXP053003	FLI1 (Abcam, ab15289)	Homo sapiens		NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS050283
EXP053004	ERG (Abcam, ab136152)	Homo sapiens		NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS050284
EXP053017	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	EXP053005	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050285
EXP053018	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	EXP053006	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050286
EXP053019	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	EXP053007	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050287
EXP053020	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	EXP053008	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050288
EXP053021	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	EXP053009	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050289
EXP053022	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	EXP053010	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050290
EXP053023	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	EXP053011	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050291
EXP053024	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	EXP053012	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050292
EXP053025	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	EXP053013	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050293
EXP053026	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	EXP053014	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050294
EXP053027	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	EXP053015	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050295
EXP053028	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	EXP053016	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	PEAKS050296
EXP053031	ZNF768 (mAb, 7D6)	Homo sapiens		EXP053029	767	normal	Q9H5H4	Raji (Burkitt lymphoma)	PEAKS050297
EXP053032	ZNF768 (mAb, 7D6)	Homo sapiens		EXP053030	848	normal	Q9H5H4	U2OS (osteosarcoma)	PEAKS050298
EXP053041	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	EXP053033	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050299
EXP053042	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell	EXP053034	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050300
EXP053043	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053035	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050301
EXP053044	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	EXP053036	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050302
EXP053045	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell	EXP053037	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050303
EXP053046	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 30 min  Source: T47D whole cell	EXP053038	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050304
EXP053047	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053039	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050305
EXP053048	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050306
EXP053049	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: triploide, no stress  Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050307
EXP053050	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050308
EXP053051	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050309
EXP053052	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050310
EXP053053	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	110 mM NaCl	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS050311
EXP053054	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050312
EXP053055	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: no stess, + triptolide Source: T47D whole cell 	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050313
EXP053056	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050314
EXP053057	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050315
EXP053058	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  + 60 min isotonic Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050316
EXP053059	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + 60 min isotonic Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050317
EXP053060	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050318
EXP053061	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: no stress Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050319
EXP053062	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: 110 mM NaCl for 60  min +  60 min isotonic Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS050320
EXP053071	anti-SRF	Homo sapiens	Treatment: No treatment, no TPA  Source: HEL-iMKL1 cells	EXP053063	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050321
EXP053072	anti-SRF	Homo sapiens	Treatment: No treatment, no TPA  Source: HEL-iMKL1 cells	EXP053064	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050322
EXP053073	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells	EXP053065	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050323
EXP053074	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells	EXP053066	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050324
EXP053075	anti-SRF	Homo sapiens	Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells	EXP053067	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050325
EXP053076	anti-SRF	Homo sapiens	Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells	EXP053068	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050326
EXP053077	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed	EXP053069	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050327
EXP053078	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed	EXP053070	2528	normal	P11831	HEL (Erythro Leukemia)	PEAKS050328
EXP053086	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	P51532	EOL-1 (Acute myeloid leukemia)	PEAKS050329
EXP053087	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9H8M2	EOL-1 (Acute myeloid leukemia)	PEAKS050330
EXP053088	BRD9 (Abcam, 66443 #GR144569-1)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9H8M2	EOL-1 (Acute myeloid leukemia)	PEAKS050331
EXP053089	GLTSCR1 (Santa Cruz, SC-240516, #A2313  )	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9NZM4	EOL-1 (Acute myeloid leukemia)	PEAKS050332
EXP053090	SMARCC1 (homemade)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q92922	EOL-1 (Acute myeloid leukemia)	PEAKS050333
EXP053091	BRD7 (CST, 14910, #1)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9NPI1	EOL-1 (Acute myeloid leukemia)	PEAKS050334
EXP053092	DPF2 (Abcam, ab134942, #YJ031611CS)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q92785	EOL-1 (Acute myeloid leukemia)	PEAKS050335
EXP053093	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	P49711	EOL-1 (Acute myeloid leukemia)	PEAKS050336
EXP053094	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	P51532	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050337
EXP053095	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q9H8M2	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050338
EXP053096	BRD7 (CST, 14910, #1)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q9NPI1	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050339
EXP053097	DPF2 (Abcam, ab134942, #YJ031611CS)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q92785	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050340
EXP053098	GLTSCR1 (Santa Cruz, SC-240516, #A2313  )	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q9NZM4	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050341
EXP053099	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	P49711	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050342
EXP053100	SS18 (CST, 21792s,  Lot 1)	Homo sapiens	Treatment: lentivirally infected with shControl	EXP053081	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	PEAKS050343
EXP053101	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with shControl	EXP053081	2530	normal	Q9H8M2	SYO-1(Biphasic synovial sarcoma)	PEAKS050344
EXP053102	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: lentivirally infected with shControl	EXP053081	2530	normal	P49711	SYO-1(Biphasic synovial sarcoma)	PEAKS050345
EXP053103	SS18 (CST, 21792s,  Lot 1)	Homo sapiens	Treatment: lentivirally infected with shSSX vector	EXP053082	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	PEAKS050346
EXP053104	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with shSSX vector	EXP053082	2530	normal	Q9H8M2	SYO-1(Biphasic synovial sarcoma)	PEAKS050347
EXP053105	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: untreated	EXP053083	509	normal	Q9H8M2	Jurkat (T-cells)	PEAKS050348
EXP053106	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: untreated	EXP053083	509	normal	P49711	Jurkat (T-cells)	PEAKS050349
EXP053107	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with empty vector control 	NULL	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050350
EXP053108	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with vector containing SMARCB1l	NULL	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050351
EXP053109	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	EXP053084	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050352
EXP053110	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: DMSO control for 7 days	EXP053085	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050353
EXP053111	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: lentivirally infected with empty vector control	NULL	2345	normal	P49711	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050354
EXP053112	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with pLKO shScramble	NULL	2531	normal	Q9H8M2	Aska-SS (Biphasic synovial sarcoma)	PEAKS050355
EXP053113	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with shSSX1	NULL	2531	normal	Q9H8M2	Aska-SS (Biphasic synovial sarcoma)	PEAKS050356
EXP053114	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	NULL	2219	normal	P51532	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050357
EXP053115	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	EXP053084	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050358
EXP053116	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: DMSO control for 7 days	EXP053085	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS050359
EXP053171	HA-tag (CST, 3724S)	Homo sapiens	Treatment: exogenous 3xHA tagged BRD9-N216 Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050386
EXP053172	HA-tag (CST, 3724S)	Homo sapiens	Treatment: exogenous 3xHA tagged BRD9-wildtype Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050387
EXP053173	HA-tag (CST, 3724S)	Homo sapiens	Treatment: BI7273 10uM 24h Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050388
EXP053174	HA-tag (CST, 3724S)	Homo sapiens	Treatment: DMSO 24h, BI7273 matched Passage:12 Cell type: SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050389
EXP053175	HA-tag (CST, 3724S)	Homo sapiens	Treatment: DMSO 24h, dBRD9A matched Passage:12 Cell type: SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050390
EXP053176	HA-tag (CST, 3724S)	Homo sapiens	dBRD9-A 100nM 24h	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050391
EXP053177	HA-tag (CST, 3724S)	Homo sapiens	Treatment: DMSO 24h Passage: 12 Cell type:  SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050392
EXP053178	HA-tag (CST, 3724S)	Homo sapiens	Treatment: dBRD9-A 100nM 24hrs Passage: 12 Cell type:  SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	PEAKS050393
EXP053191	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	EXP053179	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050394
EXP053192	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	EXP053180	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050395
EXP053193	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	EXP053181	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050396
EXP053194	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 for 30 mins	EXP053182	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050397
EXP053195	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 for 30 mins	EXP053183	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050398
EXP053196	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 for 30 mins	EXP053184	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050399
EXP053197	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 1 uM TPA for 30 mins	EXP053185	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050400
EXP053198	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 1 uM TPA for 30 mins	EXP053186	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050401
EXP053199	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 1 uM TPA for 30 mins	EXP053187	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050402
EXP053200	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	EXP053188	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050403
EXP053201	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	EXP053189	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050404
EXP053202	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	EXP053190	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS050405
EXP053204	BRD4 (Bethyl, cat: A301-985A100, lot: A301-985A50-6)	Homo sapiens		EXP053203	840	normal	O60885	TT (hereditary thyroid gland medullary carcinoma)	PEAKS050406
EXP053207	TRPS1 ChIP antibody	Homo sapiens	Treatment: none	EXP053205	111	normal	Q9UHF7	T47D (invasive ductal carcinoma)	PEAKS050407
EXP053208	TRPS1 ChIP antibody	Homo sapiens	Treatment: none	EXP053206	111	normal	Q9UHF7	T47D (invasive ductal carcinoma)	PEAKS050408
EXP053212	HA-Tag (C29F4) Rabbit mAb (CST #3724)	Homo sapiens	Genotype: overexpress E2A Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	NULL	516	normal	P15923	Kasumi-1 (acute myeloblastic leukemia)	PEAKS050409
EXP053213	HEB	Homo sapiens	Genotype: overexpress HEB Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	EXP053210	516	normal	Q99081	Kasumi-1 (acute myeloblastic leukemia)	PEAKS050410
EXP053214	HA-Tag (C29F4) Rabbit mAb (CST #3724)	Homo sapiens	Genotype: overexpress E2-2 Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	EXP053211	516	normal	P15884	Kasumi-1 (acute myeloblastic leukemia)	PEAKS050411
EXP053224	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: FA (control); Donor: LNCAP_AR_FA	EXP053215	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS050412
EXP053225	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: LNCAP_AR_DSG	EXP053215	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS050413
EXP053226	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: LNCAP_FOXA1_FA	EXP053215	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS050414
EXP053227	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: LNCAP_FOXA1_DSG	EXP053215	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS050415
EXP053228	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: FA (control); Donor: MCF7_ER_FA	EXP053216	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050416
EXP053229	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: MCF7_ER_DSG	EXP053216	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050417
EXP053230	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: MCF7_FOXA1_FA	EXP053216	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS050418
EXP053231	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: MCF7_FOXA1_DSG	EXP053216	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS050419
EXP053232	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: FA (control); Donor: P2_AR_FA	EXP053218	2538	normal	P10275	primary prostate cancer	PEAKS050420
EXP053233	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: P2_AR_DSG	EXP053217	2538	normal	P10275	primary prostate cancer	PEAKS050421
EXP053234	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: P2_FOXA1_FA	NULL	2538	normal	P55317	primary prostate cancer	PEAKS050422
EXP053235	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: P2_FOXA1_DSG	EXP053217	2538	normal	P55317	primary prostate cancer	PEAKS050423
EXP053236	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: FA (control); Donor: B3_ER_FA	EXP053220	2539	normal	P03372	primary breast cancer	PEAKS050424
EXP053237	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: B3_ER_DSG	EXP053219	2539	normal	P03372	primary breast cancer	PEAKS050425
EXP053238	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: B4_FOXA1_FA	EXP053220	2539	normal	P55317	primary breast cancer	PEAKS050426
EXP053239	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: B4_FOXA1_DSG	EXP053219	2539	normal	P55317	primary breast cancer	PEAKS050427
EXP053240	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: FA (control); Donor: E3_ER_FA	EXP053222	2540	normal	P03372	primary endometrium cancer	PEAKS050428
EXP053241	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: E2_ER_DSG	EXP053221	2540	normal	P03372	primary endometrium cancer	PEAKS050429
EXP053242	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: FA (control); Donor: G2_AR_DSG	EXP053223	2538	normal	P10275	primary prostate cancer	PEAKS050430
EXP053243	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: G2_FOXA1_DSG	EXP053223	2538	normal	P55317	primary prostate cancer	PEAKS050431
EXP053244		Homo sapiens	Source: Surface Ectoderm Cells Genotype: wildtype Treatment: Day 7 of differentiation with RA/BMP4	NULL	2526	normal	A0A023HHK9	H9	PEAKS050432
EXP053245		Homo sapiens	Source: Surface Ectoderm Cells Genotype: p63-/- (knockout) Treatment: Day 7 of differentiation with RA/BMP4	NULL	2526	normal	A0A023HHK9	H9	PEAKS050433
EXP053252	HA (Covance, MMS-101P)	Homo sapiens	Genotype: overexpressing HA-tagged ZNF445 	EXP053246	376	normal	P59923	WA01 (H1, human embryonic stem cells)	PEAKS050434
EXP053253	HA (Covance, MMS-101P)	Mus musculus	Strain: Castaneous/Black6 Genotype: overexpressing HA-tagged ZFP445	EXP053247	2447	normal	Q8R2V3	cultured embryonic stem cells (ES cells)	PEAKS050435
EXP053254	HA (Covance, MMS-101P)	Mus musculus	Strain: Black6/Castaneous Genotype: overexpressing HA-tagged ZFP445	EXP053248	2447	normal	Q8R2V3	cultured embryonic stem cells (ES cells)	PEAKS050436
EXP053255	HA (Covance, MMS-101P)	Mus musculus	Strain: Black6/Castaneous Genotype: overexpressing HA-tagged ZFP445	EXP053249	2447	normal	Q8R2V3	cultured embryonic stem cells (ES cells)	PEAKS050437
EXP053256	HA (Covance, MMS-101P)	Homo sapiens	Genotype: overexpressing HA-tagged ZFP57	EXP053250	376	normal	O14503	WA01 (H1, human embryonic stem cells)	PEAKS050438
EXP053257	anti-KAP1 (AbCam, ab10483)	Homo sapiens	Sorce: TKD hES Genotype: knockdown for DNA methyltransferases DNMT1, DNMT3A, DNMT3B	NULL	376	normal	Q13263	WA01 (H1, human embryonic stem cells)	PEAKS050439
EXP053259	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2532	normal	O95243	bone marrow-derived mesenchymal stromal cells	PEAKS050440
EXP053260	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2534	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation day 7	PEAKS050441
EXP053261	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2535	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation day 3	PEAKS050442
EXP053262	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2536	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation day 1	PEAKS050443
EXP053263	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2537	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation 4 hrs	PEAKS050444
EXP053264	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2541	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation 4 hrs	PEAKS050445
EXP053265	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2542	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 1	PEAKS050446
EXP053266	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2543	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 3	PEAKS050447
EXP053267	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2544	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 7	PEAKS050448
EXP053268	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2545	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 14	PEAKS050449
EXP053272	anti-MYC	Homo sapiens	Treatment: none	EXP053271	1549	normal	P61244	COLO-829 (melanoma)	PEAKS050452
EXP053273	V5 (Invitrogen #46-0705)	Homo sapiens	Genotype: Expressing LHX9-V5 open reading frame Tissue: colon	NULL	417	normal	Q9NQ69	HCT-116 (colon carcinoma)	PEAKS050453
EXP053274	V5 (Invitrogen #46-0705)	Homo sapiens	Genotype:Expressing LHX9-V5 open reading frame and shKRAS Tissue: colon	NULL	417	normal	Q9NQ69	HCT-116 (colon carcinoma)	PEAKS050454
EXP053277	anti-STAT3	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053275	2548	normal	P40763	JB6 (Human anaplastic large cell lymphoma)	PEAKS050455
EXP053278	anti-STAT3	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053275	2548	normal	P40763	JB6 (Human anaplastic large cell lymphoma)	PEAKS050456
EXP053279	anti-CEBPb	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053275	2548	normal	P17676	JB6 (Human anaplastic large cell lymphoma)	PEAKS050457
EXP053280	CEBP beta	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053275	2548	normal	P17676	JB6 (Human anaplastic large cell lymphoma)	PEAKS050458
EXP053281	anti-STAT3	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053276	2549	normal	P40763	SU-DHL-1 (Anaplastic large cell lymphoma)	PEAKS050459
EXP053282	anti-STAT3	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053276	2549	normal	P40763	SU-DHL-1 (Anaplastic large cell lymphoma)	PEAKS050460
EXP053283	anti-CEBPb	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053276	2549	normal	P17676	SU-DHL-1 (Anaplastic large cell lymphoma)	PEAKS050461
EXP053284	anti-CEBPb	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053276	2549	normal	P17676	SU-DHL-1 (Anaplastic large cell lymphoma)	PEAKS050462
EXP053294	rabbit polyclonal anti-MYC antibody (produced in-house)N-262	Homo sapiens	Treatment: 1ug/mL doxycycline for 7 days prior to harvest Genotype: wildtype MYC Passage: 10 -15  Cell type: neuroblastoma cell line	EXP053293	790	normal	P01106	Tet21N (neuroblastoma)	PEAKS050467
EXP053296	anti-CTCF	Homo sapiens	Source: Pancreas 	EXP053295	2552	normal	P49711	EndoC-BH1 (human pancreatic beta cell line)	PEAKS050468
EXP053301	BCL6 (Santa Cruz N3, sc-858)	Homo sapiens		NULL	815	normal	P41182	SU-DHL-4 (diffuse large B-cell lymphoma)	PEAKS050470
EXP053302	LSD1 (abcam 17721)	Homo sapiens		NULL	815	normal	O60341	SU-DHL-4 (diffuse large B-cell lymphoma)	PEAKS050471
EXP053315	CHAF1B (Novus: 88235)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	Q9D0N7	MLL-AF9 Leukemic Cells	PEAKS050480
EXP053316	CHAF1B (Novus: 88235)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	Q9D0N7	MLL-AF9 Leukemic Cells	PEAKS050481
EXP053317	anti-PCNA (Cell Signaling: 13110)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	P17918	MLL-AF9 Leukemic Cells	PEAKS050482
EXP053318	anti-Runx2 (Cell Signaling: 12556)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	Q08775	MLL-AF9 Leukemic Cells	PEAKS050483
EXP053319	anti-Runx2 (Cell Signaling: 12556)	Mus musculus	Genotype: C1B knockout Strain: C57BL/6  Treatment: treated with 10-7M B-estradiol daily for two days (48 hours)	EXP053311	2553	normal	Q08775	MLL-AF9 Leukemic Cells	PEAKS050484
EXP053320	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens		EXP053312	2219	normal	Q13112	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050485
EXP053321	anti-CHAF1A(Novus: 74608)	Homo sapiens		EXP053312	2219	normal	Q13111	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050486
EXP053322	anti-CEBPA (Cell Signaling: 8178)	Homo sapiens		EXP053312	2219	normal	P49715	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS050487
EXP053323	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens		EXP053313	65	normal	Q13112	U937 (adult acute monocytic leukemia)	PEAKS050488
EXP053324	anti-CEBPA (Cell Signaling: 8178)	Homo sapiens		EXP053313	65	normal	P49715	U937 (adult acute monocytic leukemia)	PEAKS050489
EXP053325	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens	Treatment: shRNA Genotype: shControl 	EXP053313	65	normal	Q13112	U937 (adult acute monocytic leukemia)	PEAKS050490
EXP053326	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens		EXP053314	509	normal	Q13112	Jurkat (T-cells)	PEAKS050491
EXP053327	anti-GATA3 (Cell Signaling: 5852)	Homo sapiens		EXP053314	509	normal	P23771	Jurkat (T-cells)	PEAKS050492
EXP053328	anti-CEBPA (Cell Signaling: 8178)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	P53566	MLL-AF9 Leukemic Cells	PEAKS050493
EXP053329	anti-CEBPA (Cell Signaling: 8178)	Mus musculus	Genotype: C1B knockout Strain: C57BL/6  Treatment: treated with 10-7M B-estradiol daily for two days (48 hours)	EXP053311	2553	normal	P53566	MLL-AF9 Leukemic Cells	PEAKS050494
EXP053330	Abcam: ab15289	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	A1A546	MLL-AF9 Leukemic Cells	PEAKS050495
EXP053331	Abcam: ab15289	Mus musculus	Genotype: C1B knockout Strain: C57BL/6  Treatment: treated with 10-7M B-estradiol daily for two days (48 hours)	EXP053311	2553	normal	A1A546	MLL-AF9 Leukemic Cells	PEAKS050496
EXP053332	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens	Treatment: shRNA Genotype: shCHAF1B knockout	EXP053313	65	bio_control	A0AVK6	U937 (adult acute monocytic leukemia)	PEAKS050497
EXP053334	pS118-ER (Cell Signaling, #2511, lot 16J4)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050498
EXP053335	pS118-ER (Cell Signaling, #2511, lot 16J4)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050499
EXP053336	pS118-ER (Abcam, ab32396, lot GR139357-5)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050500
EXP053337	pS118-ER (Abcam, ab32396, lot GR139357-5)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050501
EXP053338	pS118-ER (Santa Cruz, sc-12915, lot A1614)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050502
EXP053339	pS118-ER (Santa Cruz, sc-12915, lot A1614)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050503
EXP053340	ER (Santa Cruz, sc-543, lot F0316)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: wildtype ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050504
EXP053341	ER (Santa Cruz, sc-543, lot F0316)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: wildtype-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS050505
EXP053343	SMARCA4 antibody (abcam, ab110641)	Homo sapiens		EXP053342	650	normal	P51532	NCI-H1703 (squamous cell lung carcinoma )	PEAKS050506
EXP053346	Ah Receptor Antibody (H-211) (Santa Cruz, catalog# sc-5579)	Homo sapiens	Treatment: TCDD (2,3,7,8-Tetrachlorodibenzodioxin) added to a final concentration of 2 nM  Source: embryonic stem cells (ESC)	EXP053344	2554	normal	P35869	MEL1 (Mucosal melanoma)	PEAKS050507
EXP053347	Ah Receptor Antibody (H-211) (Santa Cruz, catalog# sc-5579)	Homo sapiens	Treatment: TCDD (2,3,7,8-Tetrachlorodibenzodioxin) added to a final concentration of 2 nM  Source: embryonic stem cells (ESC)	EXP053345	2554	normal	P35869	MEL1 (Mucosal melanoma)	PEAKS050508
EXP053349	p63 (Active Motif 39739)	Homo sapiens	Treatment: Doxycycline for 2 days  Geenotype: TetO:Tp63+/-  	EXP053348	2555	normal	Q9H3D4	surface ectoderm cells	PEAKS050509
EXP053350	p63 (Active Motif 39739)	Homo sapiens	Treatment: Day 7 of differentiation with RA/BMP4 Genotype: wildtype Source: background cell line WA 09	EXP053348	2555	normal	Q9H3D4	surface ectoderm cells	PEAKS050510
EXP053351	p63 (Active Motif 39739)	Homo sapiens	Treatment: Day 0 of epidermal differentiation Genotype: wildtype Source: background cell line WA 09 	EXP053348	2556	normal	Q9H3D4	human keratinocytes	PEAKS050511
EXP053358	anti-NCOA2 (Bethyl A300-346A)	Homo sapiens	Treatment: 10nM beta-estradiol, 100nM medroxyprogesterone acetate, and 1mM cAMP	EXP053357	256	normal	Q15596	endometrial stromal cells	PEAKS050516
EXP053361	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 0.1 % EtOH for 2 hrs 	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	PEAKS050518
EXP053362	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 2 hrs	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	PEAKS050519
EXP053363	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 0.1 % EtOH for 8 hrs 	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	PEAKS050520
EXP053364	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 8 hrs	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	PEAKS050521
EXP053365	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 0.1 % EtOH for 24 hrs 	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	PEAKS050522
EXP053366	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 24 hrs	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	PEAKS050523
EXP053367	CBP (Abcam, ab2832)	Homo sapiens	Tissue: Term placenta Source: Placenta	NULL	2558	normal	Q92793	cytotrophoblast	PEAKS050524
EXP053368	HDAC1 (Santa Cruz Biotech, sc-7872)	Homo sapiens	Tissue: Term placenta Source: Placenta	NULL	2558	normal	Q13547	cytotrophoblast	PEAKS050525
EXP053369	RelB (Santa Cruz Biotech, sc-226)	Homo sapiens	Tissue: Term placenta Source: Placenta	NULL	2558	normal	Q01201	cytotrophoblast	PEAKS050526
EXP053371	anti-human SOD1 primary antibody (Abcam; ab16831)	Homo sapiens	Treatment: under normal conditons	EXP053370	78	normal	P00441	HeLa (cervical adenocarcinoma)	PEAKS050527
EXP053372	anti-human SOD1 primary antibody (Abcam; ab16831)	Homo sapiens	Treatment: treated with hydrogen 0.4 mM peroxide	EXP053370	78	normal	P00441	HeLa (cervical adenocarcinoma)	PEAKS050528
EXP053373	anti-human SOD1 primary antibody (Abcam; ab16831)	Homo sapiens	Treatment: treated with 50 uM LD100	EXP053370	78	normal	P00441	HeLa (cervical adenocarcinoma)	PEAKS050529
EXP053374	SIPA1 (Santa Cruz SC-137043)	Homo sapiens	Source: breast cancer cell	NULL	2301	normal	Q96FS4	MDA-MB-231 (breast adenocarcinoma)	PEAKS050530
EXP053376	anti-myc	Homo sapiens	Genotype: myc-PRH	EXP053375	152	normal	Q03014	CC-LP-1 (intrahepatic cholangiocarcinoma)	PEAKS050531
EXP053379	Proteintech, 10597-1-AP	Homo sapiens	day 30	NULL	1005	normal	Q9UBP5	iPSC-derived cardiomyocytes	PEAKS050534
EXP053380	Sigma, SAB1411331	Homo sapiens	day 30	NULL	1005	normal	Q99593	iPSC-derived cardiomyocytes	PEAKS050535
EXP053381	Active Motif, 61213	Homo sapiens	day30	NULL	1005	normal	P24468	iPSC-derived cardiomyocytes	PEAKS050536
EXP053382	anti-Dicer	Homo sapiens	Treatment: DNA damage	NULL	2560	normal	Q9UPY3	U20S AsiSI	PEAKS050537
EXP053383	anti-Dicer	Homo sapiens	Treatment: DNA damage	NULL	2560	normal	Q9UPY3	U20S AsiSI	PEAKS050538
EXP053385	anti-FLAG antibody	Mus musculus	Genotype: FLAG-Rsf1	NULL	252	normal	A0A0U1RNQ5	V6.5 (embryonic stem cells)	PEAKS050539
EXP053387	TFEB (#4240, CST)	Homo sapiens	Strain: endothelial cells from umbilical cords newborn healthy humans	EXP053386	472	normal	P19484	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS050540
EXP053390	anti-USP7 (Bethyl, catalog# A300-033A, lot# Lot A300-033A-7)	Homo sapiens	untreated	EXP053389	199	normal	Q93009	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS050541
EXP053391	anti-USP7 (Bethyl, catalog# A300-033A, lot# Lot A300-033A-7)	Homo sapiens	untreated	EXP053388	509	normal	Q93009	Jurkat (T-cells)	PEAKS050542
EXP053393	ChIP Grade OTX2 - Abcam - ab21990	Homo sapiens		EXP053392	1083	normal	P32243	D283 Med (medulloblastoma)	PEAKS050543
EXP053395	abcam #ab23980	Homo sapiens	day 0 of differentiation	EXP053394	2562	normal	Q01196	Dombi23 (primary keratinocytes)	PEAKS050544
EXP053398	Anti-HTT antibody (Abcam #ab109115,  Lot # GR155234-1)	Mus musculus	Q111/+ genotype; 4 months	EXP053396	2450	normal	P42859	striatum	PEAKS050545
EXP053399	Anti-HTT antibody (Abcam #ab109115,  Lot # GR155234-1)	Mus musculus	WT; 4 months	EXP053397	2450	normal	P42859	striatum	PEAKS050546
EXP053400	Ezh2	Mus musculus	WT; CD4+, CXCR5+, SLAM-low, CD44-high, and CD62L low	NULL	501	normal	Q61188	T follicular helpers	PEAKS050547
EXP053401	Ezh2	Mus musculus	CD4-cre, Ezh2 fl/fl; CD4+, CD62L high, CD44 low to medium	NULL	501	bio_control	Q61188	T follicular helpers	PEAKS050548
EXP053402	Tcf1	Mus musculus	WT; CD4+, CXCR5+, SLAM-low, CD44-high, and CD62L low	NULL	501	normal	P22361	T follicular helpers	PEAKS050549
EXP053403	Tcf1	Mus musculus	CD4-Cre, Tcf1 fl/fl; CD4+, CD62L high, CD44 low to medium	NULL	501	bio_control	P22361	T follicular helpers	PEAKS050550
EXP053420	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050551
EXP053421	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050552
EXP053422	MLL2 C-terminus (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	normal	Q9UMN6	HEK293T (embryonic kidney)	PEAKS050553
EXP053423	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	EXP053405	2563	normal	Q03164	HEK293T-C49	PEAKS050554
EXP053424	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	EXP053405	2563	normal	Q03164	HEK293T-C49	PEAKS050555
EXP053425	MLL2 C-terminus (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	EXP053405	2563	normal	Q9UMN6	HEK293T-C49	PEAKS050556
EXP053426	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9  Cell type: embyronic kidney cells	EXP053406	2564	normal	Q03164	HEK293T-C104	PEAKS050557
EXP053427	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053406	2564	normal	Q03164	HEK293T-C104	PEAKS050558
EXP053428	MLL2 C-terminus (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053406	2564	normal	Q9UMN6	HEK293T-C104	PEAKS050559
EXP053429	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: non-targeting dsRNA 	EXP053407	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050560
EXP053430	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: non-targeting dsRNA 	EXP053407	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050561
EXP053431	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: human MLL1 dsRNA 	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050562
EXP053432	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: human MLL1 dsRNA 	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050563
EXP053433	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with non-targeting dsRNA 	EXP053414	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050564
EXP053434	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with non-targeting dsRNA 	EXP053414	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050565
EXP053435	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with human MLL1 dsRNA	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050566
EXP053436	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with human MLL1 dsRNA	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050567
EXP053437	MLL1 C-terminus (CST)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053411	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	PEAKS050568
EXP053438	MLL1 N-terminus (CST)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053411	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	PEAKS050569
EXP053439	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053412	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	PEAKS050570
EXP053440	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053412	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	PEAKS050571
EXP053441	ELL2 (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: overexpressed with MLLAF4 	EXP053413	10	normal	O00472	HEK293T (embryonic kidney)	PEAKS050572
EXP053442	ELL2 (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and overexpressed with MLLAF4 	EXP053414	10	normal	O00472	HEK293T (embryonic kidney)	PEAKS050573
EXP053443	MLL1 C-terminus (CST)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053415	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050574
EXP053444	MLL1 C-terminus (CST)	Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	EXP053416	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050575
EXP053445	MLL1 C-terminus (CST)	Homo sapiens	Treatment: TTP22 Passage: Low passages (6-10) Genotype: wildtype 	EXP053417	10	normal	Q03164	HEK293T (embryonic kidney)	PEAKS050576
EXP053446	AFF4 (homemade)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053418	541	normal	Q9UHB7	SEM (childhood B acute lymphoblastic leukemia)	PEAKS050577
EXP053447	ELL2 (homemade)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	NULL	541	normal	O00472	SEM (childhood B acute lymphoblastic leukemia)	PEAKS050578
EXP053448	AFF4 (homemade)	Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	EXP053419	541	normal	Q9UHB7	SEM (childhood B acute lymphoblastic leukemia)	PEAKS050579
EXP053449	ELL2 (homemade)	Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	EXP053419	541	normal	O00472	SEM (childhood B acute lymphoblastic leukemia)	PEAKS050580
EXP053452	anti DEDAF (AB3637,) Millipore	Mus musculus	Genotype: wildtype Source: single FLK1+mesoderm  Strain: C57Bl/6 X Sv129 Age: day 3.75	EXP053450	2565	normal	Q8CCI5	embryonic stem cells derived embryonic bodies	PEAKS050581
EXP053453	anti DEDAF (AB3637,) Millipore	Mus musculus	Genotype: wildtype Source: single FLK1+mesoderm  Strain: C57Bl/6 X Sv129 Age: day 3.75	EXP053451	2565	normal	Q8CCI5	embryonic stem cells derived embryonic bodies	PEAKS050582
EXP053456	SCL rabbit anti-serum (in-house)	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 3.5	EXP053454	2565	normal	P22091	embryonic stem cells derived embryonic bodies	PEAKS050583
EXP053457	SCL rabbit anti-serum (in-house)	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 3.5	EXP053455	2565	normal	P22091	embryonic stem cells derived embryonic bodies	PEAKS050584
EXP053459	ETO2 (sc-9741x,santa cruz)	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 4	EXP053458	2565	normal	O54972	embryonic stem cells derived embryonic bodies	PEAKS050585
EXP053460	anti-HIF1A	Mus musculus	Genotype: wildtype Treament: no	NULL	965	normal	Q61221	frontal cortex	PEAKS050586
EXP053461	anti-HIF1A	Mus musculus	Genotype: wildtype Treament: environmental stress	NULL	965	normal	Q61221	frontal cortex	PEAKS050587
EXP053463	alfa-FLAG (Sigma, catalog# F3165, lot# 114K6081)	Mus musculus	Genotype: 3xFLAG-Hlf/Hlf-IRES-GFP Source: Lin-Sca-1+c-Kit+ (LSK) - hematopoietic stem/progenitor cells	EXP053462	2454	normal	Q8BW74	LSK	PEAKS050588
EXP053464	c-Myc (N-262) (Santa Cruz, SC-764x, cat# G2916)	Mus musculus	Strain:C57BL/6  Genotype: wildtype	NULL	12	normal	P01108	MEF (mouse embryonic fibroblasts)	PEAKS050589
EXP053465	c-Myc (N-262) (Santa Cruz, SC-764x, cat# G2916)	Mus musculus	Strain:C57BL/6  Genotype: PIN1 knockout	NULL	12	normal	P01108	MEF (mouse embryonic fibroblasts)	PEAKS050590
EXP053466	Anti-V5 agarose beads (Sigma-Aldrich V5-10)	Mus musculus	Genotype: Prdm1(IhCd2/+) Strain: C57BL/6	NULL	2567	normal	Q60636	In-vitro, Pro-B cell culture	PEAKS050591
EXP053487	SmcHD1 (in house)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053467	2568	normal	Q6P5D8	clonal MEF	PEAKS050592
EXP053488	SmcHD1 (in house)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053468	2568	normal	Q6P5D8	clonal MEF	PEAKS050593
EXP053489	SmcHD1 (in house)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q6P5D8	clonal MEF	PEAKS050594
EXP053490	SmcHD1 (in house)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q6P5D8	clonal MEF	PEAKS050595
EXP053491	SmcHD1 (in house)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053471	2568	normal	Q6P5D8	clonal MEF	PEAKS050596
EXP053492	SmcHD1 (in house)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053472	2568	normal	Q6P5D8	clonal MEF	PEAKS050597
EXP053493	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053467	2568	normal	Q61550	clonal MEF	PEAKS050598
EXP053494	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053468	2568	normal	Q61550	clonal MEF	PEAKS050599
EXP053495	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q61550	clonal MEF	PEAKS050600
EXP053496	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053470	2568	normal	Q61550	clonal MEF	PEAKS050601
EXP053497	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053473	2568	normal	Q61550	clonal MEF	PEAKS050602
EXP053498	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053474	2568	normal	Q61550	clonal MEF	PEAKS050603
EXP053499	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053485	2568	normal	Q61550	clonal MEF	PEAKS050604
EXP053500	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053486	2568	normal	Q61550	clonal MEF	PEAKS050605
EXP053501	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053467	2568	normal	Q61164	clonal MEF	PEAKS050606
EXP053502	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053468	2568	normal	Q61164	clonal MEF	PEAKS050607
EXP053503	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q61164	clonal MEF	PEAKS050608
EXP053504	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053470	2568	normal	Q61164	clonal MEF	PEAKS050609
EXP053505	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053473	2568	normal	Q61164	clonal MEF	PEAKS050610
EXP053506	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053474	2568	normal	Q61164	clonal MEF	PEAKS050611
EXP053507	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053483	2568	normal	Q61164	clonal MEF	PEAKS050612
EXP053508	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053484	2568	normal	Q61164	clonal MEF	PEAKS050613
EXP053509	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053485	2568	normal	Q61164	clonal MEF	PEAKS050614
EXP053510	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053486	2568	normal	Q61164	clonal MEF	PEAKS050615
EXP053513	Rabbit anti-Cbfb polyclonal pAb	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053511	845	normal	Q08024	ILC2 (type 2 Innate lympoid cells)	PEAKS050616
EXP053514	Mouse anti-GATA3 mAb (BD L50-823)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053511	845	normal	P23772	ILC2 (type 2 Innate lympoid cells)	PEAKS050617
EXP053515	Rabbit anti-Cbfb pAb	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	Q08024	ILC2 (type 2 Innate lympoid cells)	PEAKS050618
EXP053516	Mouse anti-GATA3 mAb (BD L50-823)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	P23772	ILC2 (type 2 Innate lympoid cells)	PEAKS050619
EXP053517	Rabbit anti-Runx1 pAb (Abcam ab23980)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	Q03347	ILC2 (type 2 Innate lympoid cells)	PEAKS050620
EXP053518	Rabbit anti-Runx3 mAb (CST D6E2)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	Q64131	ILC2 (type 2 Innate lympoid cells)	PEAKS050621
EXP053523	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: Lif (leukemia inhibitory factor) for 3 days Genotype: expressing BirA	NULL	506	normal	P46938	J1 (embryonic stem cells)	PEAKS050624
EXP053524	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: without Lif (leukemia inhibitory factor) for 3 days Genotype: expressing BirA	NULL	506	normal	P46938	J1 (embryonic stem cells)	PEAKS050625
EXP053525	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: Lif (leukemia inhibitory factor) for 3 days Genotype: expressing Yap1 by Flagbio	NULL	506	normal	P46938	J1 (embryonic stem cells)	PEAKS050626
EXP053526	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: without Lif (leukemia inhibitory factor) for 3 days Genotype: expressing Yap1 by Flagbio	NULL	506	normal	P46938	J1 (embryonic stem cells)	PEAKS050627
EXP053531	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: SmoM2 overexpression	EXP053527	2570	normal	Q0VGT2	medulloblastoma	PEAKS050628
EXP053532	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: SmoM2 overexpression	EXP053528	2570	normal	Q0VGT2	medulloblastoma	PEAKS050629
EXP053533	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: Sufu;Spop double knockout	EXP053529	2570	normal	Q0VGT2	medulloblastoma	PEAKS050630
EXP053534	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: Sufu;Spop double knockout	EXP053530	2570	normal	Q0VGT2	medulloblastoma	PEAKS050631
EXP053537	MeCP2 (Chen WG et al. Science 2003)	Mus musculus	Age: 8 weeks Tissue: cortex Strain: C57BL/6	EXP053535	2571	normal	Q9Z2D6	CamkIIa-positive nuclei	PEAKS050632
EXP053538	MeCP2 (Chen WG et al. Science 2003)	Mus musculus	Age: 8 weeks Tissue: cortex Strain: C57BL/6	EXP053536	2571	normal	Q9Z2D6	CamkIIa-positive nuclei	PEAKS050633
EXP053540	Anti-KLF4 polyclonal Ab (R&D system, cat#AF3158)	Mus musculus	Passage: 11	EXP053539	2572	normal	Q60793	Akt (5MOI, mouse prostate stem cell line)	PEAKS050634
EXP053546	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	 Genotype: wildtype Treatment: Mock for 6 hrs	EXP053542	2573	normal	P56477	bone marrow dendritic cells	PEAKS050635
EXP053547	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	 Genotype: wildtype Treatment: Mock for 12 hrs	EXP053543	2573	normal	P56477	bone marrow dendritic cells	PEAKS050636
EXP053548	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	Treatment: infected with WNV for 6 hrs Genotype: wildtype	EXP053544	2573	normal	P56477	bone marrow dendritic cells	PEAKS050637
EXP053549	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	Treatment: infected with WNV for 12 hrs Genotype: wildtype	EXP053545	2573	normal	P56477	bone marrow dendritic cells	PEAKS050638
EXP053551	PGR (sc-7208, Santa Cruz)	Mus musculus	Strain: CBA x C57BL/6 F1 Age: 21 days 	EXP053550	2574	normal	Q00175	peri-ovulatory granulosa cells	PEAKS050639
EXP053552	PGR (sc-7208, Santa Cruz)	Mus musculus	Strain: CBA x C57BL/6 F1 Age: 21 days 	EXP053550	2574	normal	Q00175	peri-ovulatory granulosa cells	PEAKS050640
EXP053557	SMAD4 (Cell Signaling)	Mus musculus	Treatment: no	EXP053553	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	PEAKS050641
EXP053558	SMAD4 (Cell Signaling)	Mus musculus	Treatment: simulation by BMP9/10 recombinant protein	EXP053556	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	PEAKS050642
EXP053559	SMAD4 (Cell Signaling)	Mus musculus	Treatment: no	EXP053556	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	PEAKS050643
EXP053560	SMAD4 (Cell Signaling)	Mus musculus	Treatment: Simulation by BMP9/10 recombinant protein	EXP053554	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	PEAKS050644
EXP053561	CTCF (Active motif: 613111)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1	NULL	2576	normal	Q61164	G4 (embryonic stem cells)	PEAKS050645
EXP053562	RAD21 (Abcam: ab992)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1	NULL	2576	normal	Q61550	G4 (embryonic stem cells)	PEAKS050646
EXP053563	CTCF (Active motif: 613111)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1DelCTCF	NULL	2576	normal	Q61164	G4 (embryonic stem cells)	PEAKS050647
EXP053564	RAD21 (Abcam: ab992)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1DelCTCF	NULL	2576	normal	Q61550	G4 (embryonic stem cells)	PEAKS050648
EXP053565	CTCF (Active motif: 613111)	Mus musculus	Genotype: Inv1	NULL	2576	normal	Q61164	G4 (embryonic stem cells)	PEAKS050649
EXP053566	RAD21 (Abcam: ab992)	Mus musculus	Genotype: Inv1	NULL	2576	normal	Q61550	G4 (embryonic stem cells)	PEAKS050650
EXP053568	Thoc5 (Bethyl, cat#A302-119A)	Mus musculus	Source:VSMC_Thoc5 Strain: C57BL/6 Passage: 4-8	EXP053567	2268	normal	Q8BKT7	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS050651
EXP053569	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 0 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	PEAKS050652
EXP053570	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 4 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	PEAKS050653
EXP053571	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 8 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	PEAKS050654
EXP053572	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 24 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	PEAKS050655
EXP053573	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 0hrs Dox Genotype: wildtype	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	PEAKS050656
EXP053591	p65 (Abcam, Ab7970)	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053574	5	normal	Q04207	liver	PEAKS050657
EXP053592	p65 Abcam  Ab7970	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053575	5	normal	Q04207	liver	PEAKS050658
EXP053593	p65 Abcam  Ab7970	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053576	5	normal	Q04207	liver	PEAKS050659
EXP053594	p65 Abcam  Ab7970	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053577	5	normal	Q04207	liver	PEAKS050660
EXP053595	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053576	5	normal	Q9WTL8	liver	PEAKS050661
EXP053596	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	NULL	5	normal	Q9WTL8	liver	PEAKS050662
EXP053597	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053577	5	normal	Q9WTL8	liver	PEAKS050663
EXP053598	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053578	5	normal	Q9WTL8	liver	PEAKS050664
EXP053599	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053574	5	normal	O08785	liver	PEAKS050665
EXP053600	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053575	5	normal	O08785	liver	PEAKS050666
EXP053601	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053576	5	normal	O08785	liver	PEAKS050667
EXP053602	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053577	5	normal	O08785	liver	PEAKS050668
EXP053603	p65  (Santa Cruz, sc-372)	Mus musculus	Age: adult Strain: C57BL/6 Conditions: diet regular chow Sex: male 	EXP053579	5	normal	Q04207	liver	PEAKS050669
EXP053604	p65, Santa Cruz sc-372	Mus musculus	Age: adult Strain: C57BL/6 Conditions: diet regular chow Sex: male 	EXP053580	5	normal	Q04207	liver	PEAKS050670
EXP053605	p65 (Santa Cruz, sc-372)	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated fat diet Sex: male 	EXP053581	5	normal	Q04207	liver	PEAKS050671
EXP053606	p65 (Santa Cruz, sc-372)	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated fat diet Sex: male 	EXP053582	5	normal	Q04207	liver	PEAKS050672
EXP053607	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053583	5	normal	O08785	liver	PEAKS050673
EXP053608	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053583	5	normal	Q9WTL8	liver	PEAKS050674
EXP053609	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053584	5	normal	O08785	liver	PEAKS050675
EXP053610	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053585	5	normal	Q9WTL8	liver	PEAKS050676
EXP053611	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053586	5	normal	O08785	liver	PEAKS050677
EXP053612	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053587	5	normal	Q9WTL8	liver	PEAKS050678
EXP053613	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053588	5	normal	O08785	liver	PEAKS050679
EXP053614	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053589	5	normal	Q9WTL8	liver	PEAKS050680
EXP053615	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr Genotype: wildtype	EXP053590	12	normal	Q9WTL8	MEF (mouse embryonic fibroblasts)	PEAKS050681
EXP053618	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: pre-prandial injection with vehicle	NULL	5	normal	P06537	liver	PEAKS050682
EXP053619	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding, pre-prandial injection with vehicle	NULL	5	normal	P06537	liver	PEAKS050683
EXP053620	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding, pre-prandial injection with 1mg/kg dex	NULL	5	normal	P06537	liver	PEAKS050684
EXP053621	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: none	EXP053616	5	normal	P06537	liver	PEAKS050685
EXP053622	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding	EXP053617	5	normal	P06537	liver	PEAKS050686
EXP053623	FoxO1 (sc-11350, Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: none	EXP053616	5	normal	Q9R1E0	liver	PEAKS050687
EXP053624	FoxO1 (sc-11350, Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding	EXP053617	5	normal	Q9R1E0	liver	PEAKS050688
EXP053626	anti-Trim33 (Bethyl A301-060A)	Mus musculus	Strain: Outbred - B6:129Sv Passage: From 8 to 12 Age: day 6 Cell type: Day 6 embryoid bodies from mouse embryonic stem cells	EXP053625	208	normal	Q99PP7	embryoid body (day 6)	PEAKS050689
EXP053627	anti-CTCF (Active Motif 61311)	Mus musculus	Strain: Outbred - B6:129Sv Passage: From 8 to 12 Age: day 6 Cell type: Day 6 embryoid bodies from mouse embryonic stem cells	EXP053625	208	normal	Q61164	embryoid body (day 6)	PEAKS050690
EXP053630	STAT3 Ab (124H6, Cell Signaling Technology)	Mus musculus	Genotype: STAT3 wildtype Strain: C57BL/6	EXP053628	2577	normal	P42227	cultured GC B cells	PEAKS050691
EXP053631	STAT3 Ab (124H6, Cell Signaling Technology)	Mus musculus	Genotype: STAT3 knockout Strain: C57BL/6	EXP053629	2577	normal	P42227	cultured GC B cells	PEAKS050692
EXP053634	Anti-AR antibody K183	Mus musculus	Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: wildtype Tissue: Caput epididymis (containing initial segment)	EXP053632	150	normal	P19091	caput epididymis	PEAKS050693
EXP053635	Anti-AR antibody K183	Mus musculus	Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: ArKI Tissue: Caput epididymis (containing initial segment)	EXP053633	150	normal	P19091	caput epididymis	PEAKS050694
EXP053636	anti-JunB	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre JUNB+/+(wildtype) Strain: C57BL/6	NULL	1053	normal	P09450	Treg cells from lymph nodes and spleen	PEAKS050695
EXP053637	anti-IRF4	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre JUNB+/+(wildtype) Strain: C57BL/6	NULL	1053	normal	Q64287	Treg cells from lymph nodes and spleen	PEAKS050696
EXP053638	anti-BATF	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre JUNB+/+(wildtype) Strain: C57BL/6	NULL	1053	normal	O35284	Treg cells from lymph nodes and spleen	PEAKS050697
EXP053639	IRF4	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre Foxp3cre JUNB -/-(knockout) Strain: C57BL/6	NULL	1053	normal	Q64287	Treg cells from lymph nodes and spleen	PEAKS050698
EXP053646	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053640	2568	normal	Q61164	clonal MEF	PEAKS050699
EXP053647	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053641	2568	normal	Q61164	clonal MEF	PEAKS050700
EXP053648	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053642	2568	normal	Q61164	clonal MEF	PEAKS050701
EXP053649	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053643	2568	normal	Q61164	clonal MEF	PEAKS050702
EXP053650	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053644	2568	normal	Q61164	clonal MEF	PEAKS050703
EXP053651	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053645	2568	normal	Q61164	clonal MEF	PEAKS050704
EXP053652	MYOD1 antibody 	Mus musculus	Sex: male Strain: C57bl6 Time: collection on 24 hour timecourse	NULL	2578	normal	P10085	Gastrocnemius muscle	PEAKS050705
EXP053654	Nrf2 (Santa Cruz, sc-13032)	Mus musculus	Strain: C57BL/6 Genotype: wildtype	EXP053653	2579	normal	Q60795	esophagus	PEAKS050706
EXP053655	Nrf2 (Santa Cruz, sc-13032)	Mus musculus	Strain: C57BL/6 Genotype: Nrf2 knockout	EXP053653	2579	normal	Q60795	esophagus	PEAKS050707
EXP053656	Nrf2 (Santa Cruz, sc-13032)	Mus musculus	Strain: C57BL/6 Genotype: Keap1 knockout	EXP053653	2579	normal	Q60795	esophagus	PEAKS050708
EXP053666	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	Q61539	Tg2a	PEAKS050709
EXP053667	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	Q61539	Tg2a	PEAKS050710
EXP053668	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	Q61539	Tg2a	PEAKS050711
EXP053669	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	Q61539	Tg2a	PEAKS050712
EXP053670	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	Q80Z64	Tg2a	PEAKS050713
EXP053671	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	Q80Z64	Tg2a	PEAKS050714
EXP053672	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	Q80Z64	Tg2a	PEAKS050715
EXP053673	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	Q80Z64	Tg2a	PEAKS050716
EXP053674	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	Q80Z64	Tg2a	PEAKS050717
EXP053675	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	Q80Z64	Tg2a	PEAKS050718
EXP053676	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	P20263	Tg2a	PEAKS050719
EXP053677	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	P20263	Tg2a	PEAKS050720
EXP053678	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053659	2580	normal	P20263	Tg2a	PEAKS050721
EXP053679	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053660	2580	normal	P20263	Tg2a	PEAKS050722
EXP053680	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	P20263	Tg2a	PEAKS050723
EXP053681	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	P20263	Tg2a	PEAKS050724
EXP053682	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	P20263	Tg2a	PEAKS050725
EXP053683	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053664	2580	normal	P20263	Tg2a	PEAKS050726
EXP053684	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	normal	P20263	Tg2a	PEAKS050727
EXP053685	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	P20263	Tg2a	PEAKS050728
EXP053686	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	P48432	Tg2a	PEAKS050729
EXP053687	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	P48432	Tg2a	PEAKS050730
EXP053688	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053659	2580	normal	P48432	Tg2a	PEAKS050731
EXP053689	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053660	2580	normal	P48432	Tg2a	PEAKS050732
EXP053690	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	NULL	2580	normal	P48432	Tg2a	PEAKS050733
EXP053691	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	P48432	Tg2a	PEAKS050734
EXP053692	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	P48432	Tg2a	PEAKS050735
EXP053693	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	P48432	Tg2a	PEAKS050736
EXP053694	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053664	2580	normal	P48432	Tg2a	PEAKS050737
EXP053695	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	P48432	Tg2a	PEAKS050738
EXP053696	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	Q61539	Tg2a	PEAKS050739
EXP053697	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	Q61539	Tg2a	PEAKS050740
EXP053698	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	normal	P48432	Tg2a	PEAKS050741
EXP053701	anti-TBR2/Eomes antibodies (ab23345, abcam)	Mus musculus	Tissue: spleen and lymph nodes Genotype: OT-I transgenic Age: 6-8 weeks Strain: C57BL/6	EXP053699	2479	normal	O54839	CD8+ T-cells	PEAKS050742
EXP053702	anti-TBR2/Eomes antibodies (ab23345, abcam)	Mus musculus	Tissue: spleen and lymph nodes Genotype: OT-I transgenic, Eomes-overexpressing  Age: 6-8 weeks Strain: C57BL/6	EXP053700	2479	normal	O54839	CD8+ T-cells	PEAKS050743
EXP053704	Rabbit polyclonal, anti-Gfi1 antibody, GNE-CJS-2 (4ug)	Mus musculus	Strain: C57BL/6	EXP053703	2582	normal	P70338	murine medulloblastoma tumor	PEAKS050744
EXP053705	Rabbit polyclonal, anti-Lsd1(Abcam, #ab17721 (4ug))	Mus musculus	Strain: C57BL/6	EXP053703	2582	normal	Q6ZQ88	murine medulloblastoma tumor	PEAKS050745
EXP053709	ZBTB16	Mus musculus	Tissue: bone marrow-derived progenitor cells Genotype: PLZF-Flag	EXP053708	23	normal	A3KMN0	416B (hematopoietic precursor cells)	PEAKS050746
EXP053716	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053712	2	normal	P70348	mESCs (mouse embryonic stem cells)	PEAKS050747
EXP053717	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053713	2	normal	P70348	mESCs (mouse embryonic stem cells)	PEAKS050748
EXP053718	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053714	2	normal	P70348	mESCs (mouse embryonic stem cells)	PEAKS050749
EXP053719	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053715	2	normal	P70348	mESCs (mouse embryonic stem cells)	PEAKS050750
EXP053721	anti-VDR	Mus musculus	Treatment: none Genotype: wildtype	EXP053720	62	normal	P48281	alveolar macrophages	PEAKS050751
EXP053722	anti-VDR	Mus musculus	Treatment: 50 nM Vitamin D3 for 24 hrs Genotype: wildtype	EXP053720	62	normal	P48281	alveolar macrophages	PEAKS050752
EXP053724	GFP (Abcam, lot ab290)	Mus musculus	Strain: C57BL/6 Source: Microglia isolated from mPGC-1? mice at 24 h after ischemic stroke	EXP053723	605	normal	O70343	microglia	PEAKS050753
EXP053727	p65 antibody (AbCam, Ab7970)	Mus musculus	Treatment: saline 	EXP053725	5	normal	Q04207	liver	PEAKS050754
EXP053728	p65 antibody (AbCam Ab7970)	Mus musculus	Treatment: LPS	EXP053726	5	normal	Q04207	liver	PEAKS050755
EXP053731	Lamin B1 (Abcam, ab16048, Lot GB95643-1)	Mus musculus	Background strain: CD1 Age: Embryonic day 9.5  Tissue: Whole Heart, pooled 3 litters	EXP053729	53	normal	P14733	heart	PEAKS050756
EXP053732	Lamin B1 (Abcam, ab16048, Lot GB95643-1)	Mus musculus	Background strain: CD1 Age: Embryonic day 12.5  Tissue: Whole Heart, pooled 6 embryos	EXP053730	53	normal	P14733	heart	PEAKS050757
EXP053734	anti-FOXO1 (sc-11350 (H-128))	Mus musculus	Strain: C57BL/6J Age: 8 weeks Developmental stage: day 4.5 of pseudopregnancy	EXP053733	132	normal	Q9R1E0	uterus	PEAKS050758
EXP053736	anti-TCF1 (SantaCruz, sc-13025)	Mus musculus	Genotype: wildtype Strain: C57BL/6	EXP053735	2459	normal	P22361	double-positive (DP) CD4+/CD8+ thymocyte	PEAKS050759
EXP053737	anti-TCF1 (SantaCruz, sc-13025)	Mus musculus	Genotype: TCRbeta knockout Sox13 ECFP KI/+ Strain: C57BL/6	EXP053735	2584	normal	P22361	sorted gd T thymocytes	PEAKS050760
EXP053739	anti-TCF1 (SantaCruz, sc-13025)	Mus musculus	Genotype: TCRbeta KO.Sox13tg+.Sox13 ECFP KI/+ Strain: C57BL/6	EXP053738	2584	normal	P22361	sorted gd T thymocytes	PEAKS050761
EXP053741	anti-Sox13 (Abcam, ab96776)	Mus musculus	Genotype: TCRbeta knockout Sox13 ECFP KI/+ Strain: C57BL/6	EXP053740	2584	normal	Q04891	sorted gd T thymocytes	PEAKS050762
EXP053743	ASXL1 (Santa Cruz, sc-85283)	Mus musculus	Strain: C57BL/6 Passage: 5-10 Genotype: wildtype	EXP053742	2499	normal	P59598	BM-derived MSPCs (bone marrow-derived mesenchymal stem/progenitor cells)	PEAKS050763
EXP053745	Bach1 (A1-6; made in-house)	Mus musculus	Treatment: No stimulation	EXP053744	2585	normal	P97302	M1 (myeloid leukemia)	PEAKS050764
EXP053746	Bach2 (Bach2N2; made in-house)	Mus musculus	Treatment: No stimulation	EXP053744	2585	normal	P97303	M1 (myeloid leukemia)	PEAKS050765
EXP053747	NF-E2 p18 (c-16) (Santa Cruz, catalog# sc-477, lot# C0606)	Mus musculus	Treatment: No stimulation	EXP053744	2585	normal	Q07279	M1 (myeloid leukemia)	PEAKS050766
EXP053749	HDAC3	Mus musculus	Genotype: wildtype Strain: C57BL/6 Age: 3-4 month	EXP053748	2586	normal	O88895	hypothalamus	PEAKS050767
EXP053751	anti-Hdac1 (Bethyl, A300-713A)	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	EXP053750	1117	normal	O09106	primary T-cells	PEAKS050768
EXP053752	anti-Hdac4 (Bethyl, A303-467A)	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	EXP053750	1117	normal	Q6NZM9	primary T-cells	PEAKS050769
EXP053753	anti-Hdac7 (Santa Cruz,sc-11421)	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	EXP053750	1117	normal	A1A546	primary T-cells	PEAKS050770
EXP053756	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt2 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	PEAKS050771
EXP053757	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt6 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	PEAKS050772
EXP053758	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt10 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	PEAKS050773
EXP053759	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt14 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	PEAKS050774
EXP053760	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt18 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	PEAKS050775
EXP053761	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt22 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	PEAKS050776
EXP053762	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt2 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	PEAKS050777
EXP053763	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt6 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	PEAKS050778
EXP053764	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt10 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	PEAKS050779
EXP053765	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt14 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	PEAKS050780
EXP053766	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt18 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	PEAKS050781
EXP053767	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt22 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	PEAKS050782
EXP053769	Zeb1 (SantaCruz; clone H-102; #SC25388)	Mus musculus		NULL	204	normal	Q64318	D3 (embryonic stem cells)	PEAKS050783
EXP053774	HDAC2 (SC-7899)	Rattus norvegicus	Treatment: FGF for 6 hrs; Passage: 2; 	EXP053770	2587	normal	B1WBY8	NSC (neural stem cells)	PEAKS050784
EXP053775	HDAC3 (SC-11417)	Rattus norvegicus	Treatment: FGF for 6 hrs; Passage: 2; 	EXP053770	2587	normal	Q6P6W3	NSC (neural stem cells)	PEAKS050785
EXP053776	HDAC2 (SC-7899)	Rattus norvegicus	Treatment: FGF for 24 hrs; Passage: 2; 	EXP053772	2587	normal	B1WBY8	NSC (neural stem cells)	PEAKS050786
EXP053777	HDAC3 (SC-11417)	Rattus norvegicus	Treatment: FGF for 24 hrs; Passage: 2; 	EXP053772	2587	normal	Q6P6W3	NSC (neural stem cells)	PEAKS050787
EXP053779	LSD1 (CST, 2184s)	Rattus norvegicus	Tissue: brain; Developmental stage: embryonic 15.5 days; Strain: Sprague Dawley;	EXP053778	2588	normal	P97609	embryonic cerebral cortex	PEAKS050788
EXP053780	Hdac3 (Abcam ab7030)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	752	normal	Q6P6W3	oligodendrocyte precursors	PEAKS050789
EXP053781	Hdac3 (Abcam ab7030)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	218	normal	Q6P6W3	oligodendrocytes	PEAKS050790
EXP053782	p300 (Santa Cruz sc-585)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	752	normal	Q91XT0	oligodendrocyte precursors	PEAKS050791
EXP053783	p300 (Santa Cruz sc-585)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	218	normal	Q91XT0	oligodendrocytes	PEAKS050792
EXP053784	HMGB2 (abcam, ab67282)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: none; Age: 1 day old;	NULL	2589	normal	P52925	NRVM (Primary neonatal rat ventricular myocytes)	PEAKS050793
EXP053785	HMGB2 (abcam, ab67282)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: 10uM phenylephrine (PHE, Sigma, P-6126), 48hrs; Age: 1 day old;	NULL	2589	normal	P52925	NRVM (Primary neonatal rat ventricular myocytes)	PEAKS050794
EXP053786	anti-SUZ12 (CST, catalog# 3737, lot# 3))	Rattus norvegicus	Strain: Brown Norway Rat; 	NULL	752	normal	A0A0G2JV08	oligodendrocyte precursors	PEAKS050795
EXP053788	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	Treatment: none;	NULL	2590	normal	A0A0G2JYV0	NRVM (neonatal rat ventricular myocytes)	PEAKS050796
EXP053789	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	Treatment: phenylepherine;	NULL	2590	normal	A0A0G2JYV0	NRVM (neonatal rat ventricular myocytes)	PEAKS050797
EXP053790	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	Treatment: phenylepherine and mir9mimic; 	EXP053787	2590	normal	A0A0G2JYV0	NRVM (neonatal rat ventricular myocytes)	PEAKS050798
EXP053793	BRD4 (Cat. No. A301-985A100; Bethyl, Montgomery, TX)	Rattus norvegicus	Treatment: none; Passage: 3-6; Strain: Sprague-Dawley;	EXP053791	2592	normal	D3ZGX8	VSMC (Vascular Smooth Muscle Cells )	PEAKS050799
EXP053794	BRD4 (Cat. No. A301-985A100; Bethyl, Montgomery, TX)	Rattus norvegicus	Treatment: Angiotensin II for 3 hours; Passage: 3-6; Strain: Sprague-Dawley;	EXP053792	2592	normal	D3ZGX8	VSMC (Vascular Smooth Muscle Cells )	PEAKS050800
EXP053819	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053795	1232	normal	P53946	S. cerevisiae cells	PEAKS050801
EXP053820	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053795	1232	normal	P32333	S. cerevisiae cells	PEAKS050802
EXP053821	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde 	EXP053796	1232	normal	P53946	S. cerevisiae cells	PEAKS050803
EXP053822	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde 	EXP053796	1232	normal	P32333	S. cerevisiae cells	PEAKS050804
EXP053823	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053797	1232	normal	Q92317	S. cerevisiae cells	PEAKS050805
EXP053824	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc, sir3{del}; Treatment: crosslinked with 1% formaldehyde 	EXP053798	1232	normal	Q92317	S. cerevisiae cells	PEAKS050806
EXP053825	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	EXP053799	1232	normal	P32333	S. cerevisiae cells	PEAKS050807
EXP053826	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc, crosslinked with 1% formaldehyde; 	EXP053800	1232	normal	Q92317	S. cerevisiae cells	PEAKS050808
EXP053827	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Ino80-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	EXP053801	1232	normal	P53115	S. cerevisiae cells	PEAKS050809
EXP053828	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, MOT1-13Myc, Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053802	1232	normal	P32333	S. cerevisiae cells	PEAKS050810
EXP053829	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc; Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours,crosslinked with 1% formaldehyde; 	NULL	1232	normal	Q92317	S. cerevisiae cells	PEAKS050811
EXP053830	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Ino80-13Myc; Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053817	1232	normal	P53115	S. cerevisiae cells	PEAKS050812
EXP053831	Anti murine Mot1 antibody (Abcam, ab72285 )	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053805	2	normal	E9QAE3	mESCs (mouse embryonic stem cells)	PEAKS050813
EXP053832	Anti INO80 (Proteintech (18810-1-AP)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053805	2	normal	Q6ZPV2	mESCs (mouse embryonic stem cells)	PEAKS050814
EXP053833	Anti NC2-beta antibody (Abcam, ab50783)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053805	2	normal	Q91WV0	mESCs (mouse embryonic stem cells)	PEAKS050815
EXP053834	Anti Med1 antibody (SC-5334x)	Mus musculus	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053806	1232	normal	Q925J9	S. cerevisiae cells	PEAKS050816
EXP053835	Anti Med1 antibody (SC-5334x)	Mus musculus	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053807	1232	normal	Q925J9	S. cerevisiae cells	PEAKS050817
EXP053836	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde; 	EXP053808	1232	normal	P53946	S. cerevisiae cells	PEAKS050818
EXP053837	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde; 	EXP053808	1232	normal	P32333	S. cerevisiae cells	PEAKS050819
EXP053838	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde; 	EXP053809	1232	normal	P53946	S. cerevisiae cells	PEAKS050820
EXP053839	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde; 	EXP053809	1232	normal	P32333	S. cerevisiae cells	PEAKS050821
EXP053840	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-13myc; Treatment: crosslinked with 1% formaldehyde; 	EXP053810	1232	normal	Q92317	S. cerevisiae cells	PEAKS050822
EXP053841	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc, sir3{del}; Treatment: crosslinked with 1% formaldehyde; 	EXP053811	1232	normal	Q92317	S. cerevisiae cells	PEAKS050823
EXP053842	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, bar1{delta}; Treatment: crosslinked with 1% formaldehyde; 	EXP053812	1232	normal	P32333	S. cerevisiae cells	PEAKS050824
EXP053843	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-13myc, bar1{delta}; Treatment: crosslinked with 1% formaldehyde 	EXP053813	1232	normal	Q92317	S. cerevisiae cells	PEAKS050825
EXP053844	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Ino80-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	EXP053814	1232	normal	P53115	S. cerevisiae cells	PEAKS050826
EXP053845	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, MOT1-13Myc, Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053815	1232	normal	P32333	S. cerevisiae cells	PEAKS050827
EXP053846	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc; Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours,crosslinked with 1% formaldehyde; 	EXP053816	1232	normal	Q92317	S. cerevisiae cells	PEAKS050828
EXP053847	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Ino80-13Myc; Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053817	1232	normal	P53115	S. cerevisiae cells	PEAKS050829
EXP053848	Anti murine Mot1 antibody (Abcam, ab72285 )	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053818	2	normal	E9QAE3	mESCs (mouse embryonic stem cells)	PEAKS050830
EXP053849	Anti INO80 (Proteintech (18810-1-AP)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053818	2	normal	Q6ZPV2	mESCs (mouse embryonic stem cells)	PEAKS050831
EXP053850	Anti NC2-beta antibody (Abcam, ab50783)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053818	2	normal	Q91WV0	mESCs (mouse embryonic stem cells)	PEAKS050832
EXP053853	anti-ELL (in house Rabbit, aa 301-584)	Drosophila melanogaster		EXP053851	1451	normal	Q9VW51	S2 (Schneider 2)	PEAKS050833
EXP053854	anti-Ice1 (in house Rabbit, CG13550, aa 1-192)	Drosophila melanogaster		EXP053851	1451	normal	Q9W1R4	S2 (Schneider 2)	PEAKS050834
EXP053855	anti-Lilli (in house Guinea Pig, aa 1427-1673)	Drosophila melanogaster		EXP053851	1451	normal	Q9VQI9	S2 (Schneider 2)	PEAKS050835
EXP053856	anti-ELL(custom, see Lin et al. 2010 (Mol. Cell)	Mus musculus	Cell type: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP053852	521	normal	O08856	KH2 (embryonic stem cells)	PEAKS050836
EXP053860	alfa-Trr (#570, Ali Shilatifard)	Drosophila melanogaster	Genotype: wildtype;	EXP053858	1451	normal	Q8IRW8	S2 (Schneider 2)	PEAKS050837
EXP053861	(rb) alfa-dUTX (#663, Ali Shilatifard)	Drosophila melanogaster	Genotype: wildtype;	EXP053857	1451	normal	M9MRG4	S2 (Schneider 2)	PEAKS050838
EXP053862	(rb) alfa-LPT (#470, Ali Shilatifard)	Drosophila melanogaster	Genotype: wildtype;	EXP053857	1451	normal	A0A0B4LGG6	S2 (Schneider 2)	PEAKS050839
EXP053863	(rb) ?-dUTX (#663, Ali Shilatifard)	Drosophila melanogaster	Genotype: Trr knockout;	EXP053857	1451	normal	M9MRG4	S2 (Schneider 2)	PEAKS050840
EXP053864	(rb) ?-LPT (#470, Ali Shilatifard)	Drosophila melanogaster	Genotype: Trr knockout;	EXP053859	1451	normal	A0A0B4LGG6	S2 (Schneider 2)	PEAKS050841
EXP053872	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	PEAKS050842
EXP053873	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053867	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	PEAKS050843
EXP053874	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053870	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	PEAKS050844
EXP053875	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053871	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	PEAKS050845
EXP053876	CDK9 (Santa Cruz, sc-484)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	P50750	HCT-116 (colon carcinoma)	PEAKS050846
EXP053877	CDK9 (Santa Cruz, sc-484)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	NULL	417	normal	P50750	HCT-116 (colon carcinoma)	PEAKS050847
EXP053878	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	O00472	HCT-116 (colon carcinoma)	PEAKS050848
EXP053879	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053867	417	normal	O00472	HCT-116 (colon carcinoma)	PEAKS050849
EXP053880	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053870	417	normal	O00472	HCT-116 (colon carcinoma)	PEAKS050850
EXP053881	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053871	417	normal	O00472	HCT-116 (colon carcinoma)	PEAKS050851
EXP053882	LEO1 (Bethyl, A300-175A)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	Q8WVC0	HCT-116 (colon carcinoma)	PEAKS050852
EXP053883	LEO1 (Bethyl, A300-175A)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053870	417	normal	Q8WVC0	HCT-116 (colon carcinoma)	PEAKS050853
EXP053888	Trr (homemade)	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	NULL	1451	normal	Q8IRW8	S2 (Schneider 2)	PEAKS050854
EXP053889	TrxCT (homemade)	Drosophila melanogaster	Antibody: C - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053884	1451	normal	Q8IRW8	S2 (Schneider 2)	PEAKS050855
EXP053890	TrxCT (homemade)	Drosophila melanogaster	Antibody: C - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053885	1451	normal	Q8IRW8	S2 (Schneider 2)	PEAKS050856
EXP053891	TrxNT (homemade)	Drosophila melanogaster	Antibody: N - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053884	1451	normal	Q8IRW8	S2 (Schneider 2)	PEAKS050857
EXP053892	TrxNT (homemade)	Drosophila melanogaster	Antibody: N - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053885	1451	normal	Q8IRW8	S2 (Schneider 2)	PEAKS050858
EXP053893	dSet1 (homemade)	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053884	1451	normal	Q5LJZ2	S2 (Schneider 2)	PEAKS050859
EXP053894	dSet1 (homemade)	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053885	1451	normal	Q5LJZ2	S2 (Schneider 2)	PEAKS050860
EXP053895	anti-HCE (Glover-Cutter et al NSMB. 15:71, 2008)	Homo sapiens	Genotype: wildtype; Treatment: treated with 10mM NM-PP1 for 24 hr;	NULL	417	normal	O60942	HCT-116 (colon carcinoma)	PEAKS050861
EXP053896	rabbit anti-HCE (Glover-Cutter et al NSMB. 15:71, 2008)	Homo sapiens	Genotype: Cdk7as mutant; Treatment: treated with 10mM NM-PP1 for 24 hr;	NULL	417	normal	O60942	HCT-116 (colon carcinoma)	PEAKS050862
EXP053903	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: DMSO;	EXP053897	2593	normal	O60885	J-Lat A72	PEAKS050863
EXP053904	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: DMSO;	EXP053897	2593	normal	P51532	J-Lat A72	PEAKS050864
EXP053905	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053898	2593	normal	O60885	J-Lat A72	PEAKS050865
EXP053906	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053898	2593	normal	P51532	J-Lat A72	PEAKS050866
EXP053907	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: DMSO;	EXP053899	2593	normal	O60885	J-Lat A72	PEAKS050867
EXP053908	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: DMSO;	EXP053899	2593	normal	P51532	J-Lat A72	PEAKS050868
EXP053909	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053900	2593	normal	O60885	J-Lat A72	PEAKS050869
EXP053910	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053900	2593	normal	P51532	J-Lat A72	PEAKS050870
EXP053911	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: DMSO;	EXP053901	2593	normal	O60885	J-Lat A72	PEAKS050871
EXP053912	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053902	2593	normal	O60885	J-Lat A72	PEAKS050872
EXP053915	HPIP antibody (Proteintech, 2102-1-AP)	Homo sapiens	Source: Cartilage; Passage: Primary; 	EXP053913	2595	normal	Q96AQ6	chondrocytes	PEAKS050873
EXP053916	HPIP antibody (Proteintech, 2102-1-AP)	Homo sapiens	Source: Cartilage; Passage: Primary; 	EXP053914	2595	normal	Q96AQ6	chondrocytes	PEAKS050874
EXP053917	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	O14646	A549 (lung carcinoma)	PEAKS050875
EXP053918	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	O14646	A549 (lung carcinoma)	PEAKS050876
EXP053919	CTBP1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q13363	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050877
EXP053920	CTBP1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q13363	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050878
EXP053921	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	O14646	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050879
EXP053922	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	O14646	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050880
EXP053923	CBX8	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9HC52	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050881
EXP053924	CBX8	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9HC52	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050882
EXP053925	CBX3	Homo sapiens		NULL	376	normal	Q13185	WA01 (H1, human embryonic stem cells)	PEAKS050883
EXP053926	CBX3	Homo sapiens		NULL	376	normal	Q13185	WA01 (H1, human embryonic stem cells)	PEAKS050884
EXP053927	RING1	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q06587	K562 (myelogenous leukemia)	PEAKS050885
EXP053928	RING1	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q06587	K562 (myelogenous leukemia)	PEAKS050886
EXP053929	PAF1	Homo sapiens		NULL	376	normal	P28328	WA01 (H1, human embryonic stem cells)	PEAKS050887
EXP053930	PAF1	Homo sapiens		NULL	376	normal	P28328	WA01 (H1, human embryonic stem cells)	PEAKS050888
EXP053931	CHD7	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9P2D1	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050889
EXP053932	CHD7	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9P2D1	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS050890
EXP053933	KMT2B	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q9UMN6	K562 (myelogenous leukemia)	PEAKS050891
EXP053934	KMT2B	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q9UMN6	K562 (myelogenous leukemia)	PEAKS050892
EXP053935	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	P61964	A549 (lung carcinoma)	PEAKS050893
EXP053936	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	P61964	A549 (lung carcinoma)	PEAKS050894
EXP053937	CBX2	Homo sapiens		NULL	376	normal	Q14781	WA01 (H1, human embryonic stem cells)	PEAKS050895
EXP053938	CBX2	Homo sapiens		NULL	376	normal	Q14781	WA01 (H1, human embryonic stem cells)	PEAKS050896
EXP053939	CHD7	Homo sapiens	Developmental stage: adult; Passage: 8;	NULL	38	normal	Q9P2D1	A549 (lung carcinoma)	PEAKS050897
EXP053940	CHD7	Homo sapiens	Developmental stage: adult; Passage: 8;	NULL	38	normal	Q9P2D1	A549 (lung carcinoma)	PEAKS050898
EXP053941	WDR5	Homo sapiens		NULL	376	normal	P61964	WA01 (H1, human embryonic stem cells)	PEAKS050899
EXP053942	WDR5	Homo sapiens		NULL	376	normal	P61964	WA01 (H1, human embryonic stem cells)	PEAKS050900
EXP053943	RING1	Homo sapiens		NULL	376	normal	Q06587	WA01 (H1, human embryonic stem cells)	PEAKS050901
EXP053944	RING1	Homo sapiens		NULL	376	normal	Q06587	WA01 (H1, human embryonic stem cells)	PEAKS050902
EXP053945	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS050903
EXP053946	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS050904
EXP053954	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053947	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS050905
EXP053955	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053948	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS050906
EXP053956	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053949	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS050907
EXP053957	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053950	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS050908
EXP053958	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053947	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS050909
EXP053959	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053948	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS050910
EXP053960	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shNS;	EXP053949	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS050911
EXP053961	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shNS;	EXP053950	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS050912
EXP053970	anti-RING1B	Homo sapiens		NULL	396	normal	Q99496	WA09 (embryonic stem cells)	PEAKS050921
EXP053971	anti-SUZ12	Mus musculus	Genotype: 129SvJae x C57BL/6; 	NULL	252	normal	Q80U70	V6.5 (embryonic stem cells)	PEAKS050922
EXP053972	anti-Ring1b	Mus musculus	Genotype: 129SvJae x C57BL/6; 	NULL	252	normal	Q9CQJ4	V6.5 (embryonic stem cells)	PEAKS050923
EXP053974	Bdp1 (CS914)	Homo sapiens		EXP053973	2596	normal	A6H8Y1	IMR90hTert	PEAKS050924
EXP053975	Brf1 (CS146, #5)	Homo sapiens		EXP053973	2596	normal	Q07352	IMR90hTert	PEAKS050925
EXP053976	anti-SNAP45	Homo sapiens		EXP053973	2596	normal	Q13487	IMR90hTert	PEAKS050926
EXP053980	pFM2	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr positive;	EXP053978	980	normal	Q9NQX1	RH4 (alveolar rhabdomyosarcoma)	PEAKS050927
EXP053981	pFM2	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr positive;	EXP053979	980	normal	Q9NQX1	RH4 (alveolar rhabdomyosarcoma)	PEAKS050928
EXP053982	pFM2	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr negative;	EXP053977	2598	normal	Q9NQX1	RD (Embryonal rhabdomyosarcoma)	PEAKS050929
EXP053984	anti-pRb	Homo sapiens	Developmental stage: Growing; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS050930
EXP053985	p130	Homo sapiens	Developmental stage: Quiescent; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	PEAKS050931
EXP053986	p130	Homo sapiens	Developmental stage: Senescent; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	PEAKS050932
EXP053987	pRb	Homo sapiens	Developmental stage: Quiescent; Treatment: expressing shRNA targeting RB; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS050933
EXP053988	p130	Homo sapiens	Developmental stage: Quiescent; Treatment: expressing shRNA targeting p130; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	PEAKS050934
EXP053989	pRb	Homo sapiens	Developmental stage: Senescent; Treatment: expressing shRNA targeting RB; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS050935
EXP053990	RBL2	Homo sapiens	Developmental stage: Senescent; Treatment: expressing shRNA targeting 130; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	PEAKS050936
EXP053991	pRb	Homo sapiens	Developmental stage: Quiescent; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS050937
EXP053992	pRb	Homo sapiens	Developmental stage: Senescent; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS050938
EXP053994	anti-RPB90 (R. Roeder)	Homo sapiens		EXP053993	423	normal	Q07352	HeLa S3 (cervical adenocarcinoma)	PEAKS050939
EXP053995	BRF2 (ab17011, abcam)	Homo sapiens		EXP053993	423	normal	Q9HAW0	HeLa S3 (cervical adenocarcinoma)	PEAKS050940
EXP054000	anti-PHF8 (rabbit Abcam ab35471)	Homo sapiens	Treatment: cultured with serum;	EXP053996	423	normal	Q9UPP1	HeLa S3 (cervical adenocarcinoma)	PEAKS050941
EXP054001	rabbit Abcam ab35471 (PHF8)	Homo sapiens	Treatment: cultured with serum;	EXP053997	10	normal	Q9UPP1	HEK293T (embryonic kidney)	PEAKS050942
EXP054002	rabbit Abcam ab35471 (PHF8)	Homo sapiens	Treatment: 4 days cultured without serum;	EXP053998	2599	normal	Q9UPP1	Hs68 (Canavan disease)	PEAKS050943
EXP054003	rabbit Abcam ab35471 (PHF8)	Homo sapiens	Treatment: 4 days without, 4 hours with serum;	EXP053999	2599	normal	Q9UPP1	Hs68 (Canavan disease)	PEAKS050944
EXP054004	anti-CBP	Homo sapiens	Characteristic: time after stimulation 0;	NULL	2600	normal	Q92793	T98G (Glioblastoma)	PEAKS050945
EXP054005	anti-p300	Homo sapiens	Characteristic: time after stimulation 0;	NULL	2600	normal	Q09472	T98G (Glioblastoma)	PEAKS050946
EXP054006	anti-CBP	Homo sapiens	Characteristic: time after stimulation 30 mins;	NULL	2600	normal	Q92793	T98G (Glioblastoma)	PEAKS050947
EXP054007	anti-p300	Homo sapiens	Characteristic: time after stimulation 30 mins;	NULL	2600	normal	Q09472	T98G (Glioblastoma)	PEAKS050948
EXP054008	Anti-PHF8 antibody( abcam, lot# AP266823, ab36068)	Homo sapiens		NULL	78	normal	Q9UPP1	HeLa (cervical adenocarcinoma)	PEAKS050949
EXP054010	TX516 (polyclonal anti TDRD3)	Homo sapiens		EXP054009	113	normal	Q9H7E2	MCF7 (Invasive ductal breast carcinoma)	PEAKS050950
EXP054011	anti- IGF-I Receptor beta (Cell Signaling Technology, 3027)	Homo sapiens		NULL	2601	normal	P08069	DFB (malignant melanoma cell line)	PEAKS050951
EXP054013	anti-DDX5  (Abcam, ab21696, #830301)	Homo sapiens		EXP054012	423	normal	P17844	HeLa S3 (cervical adenocarcinoma)	PEAKS050952
EXP054016	p300 (Santa Cruz,  Biotechnologies, sc-585)	Homo sapiens		EXP054014	396	normal	Q09472	WA09 (embryonic stem cells)	PEAKS050953
EXP054017	anti-BRG1	Homo sapiens		EXP054014	396	normal	P51532	WA09 (embryonic stem cells)	PEAKS050954
EXP054018	p300 (Santa Cruz,  Biotechnologies, sc-585)	Homo sapiens		EXP054015	2602	normal	Q09472	H9-derived NEC (neuroectodermal sphere cells)	PEAKS050955
EXP054019	Suz12	Homo sapiens		NULL	89	normal	Q15022	BGO3 (embryonic stem cells)	PEAKS050956
EXP054020	hDot1L (Abcam, ab64077, #881913)	Homo sapiens		NULL	245	normal	Q8TEK3	NCCIT (testicular embryonic carcinoma)	PEAKS050957
EXP054021	SetDB1 (Santa Cruz, SC-66884, #A2809)	Homo sapiens		NULL	2603	normal	Q15047	WM262 (Melanoma)	PEAKS050958
EXP054022	SetDB1 (Santa Cruz, SC-66884, #A2809)	Homo sapiens		NULL	24	normal	Q15047	451Lu (WM-451Lu, Melanoma)	PEAKS050959
EXP054023	MCAF1 (Bethyl, A300-169A, #A300-169A-1)	Homo sapiens		NULL	2603	normal	Q6VMQ6	WM262 (Melanoma)	PEAKS050960
EXP054068	P300 (Rabbit Polyclonal Antigen Affinity Purified, Unconjugated, Liquid)	Homo sapiens	Treatment: None;	NULL	516	normal	Q09472	Kasumi-1 (acute myeloblastic leukemia)	PEAKS050999
EXP054085	p300 (Santa Cruz Biotech, sc-585)	Homo sapiens	Treatment: None;	NULL	514	normal	Q09472	K562 (myelogenous leukemia)	PEAKS051016
EXP054088	anti-IkappaBalpha	Homo sapiens		NULL	2320	normal	P25963	primary human epidermal keratinocytes	PEAKS051019
EXP054089	anti-p300 (Santa Cruz Biotechnology,sc-585, #B2511 )	Homo sapiens	Treatment: none;	NULL	796	normal	Q09472	SKNO-1 (acute myeloid leukemia)	PEAKS051020
EXP054137	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF1; 	EXP054134	2615	normal	Q9BSM1	293T-Rex	PEAKS051052
EXP054138	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF2; 	EXP054134	2615	normal	P35227	293T-Rex	PEAKS051053
EXP054139	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF4; 	EXP054134	2615	normal	P35226	293T-Rex	PEAKS051054
EXP054140	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF5; 	EXP054134	2615	normal	Q86SE9	293T-Rex	PEAKS051055
EXP054141	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF6; 	EXP054134	2615	normal	Q9BYE7	293T-Rex	PEAKS051056
EXP054142	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-CBX2; 	EXP054134	2615	normal	Q14781	293T-Rex	PEAKS051057
EXP054143	anti-RING1B (Bethyl, A302-869A, #1 )	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	Q99496	293T-Rex	PEAKS051058
EXP054144	anti-RYBP (Sigma, PRS2227, #22270004)	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	Q8N488	293T-Rex	PEAKS051059
EXP054145	anti-PCGF4 (Bethyl, A301-694A, #2)	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	P35226	293T-Rex	PEAKS051060
EXP054146	anti-CBX2 (Abcam, ab80044, GR6867-1)	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	Q14781	293T-Rex	PEAKS051061
EXP054148	anti-PAF1 (Bethyl laboratories, A301-047A)	Homo sapiens	Treatment: Flag-NS1 virus for 0 hrs (none, uninfected);	NULL	38	normal	P28328	A549 (lung carcinoma)	PEAKS051062
EXP054149	anti-PAF1 (Bethyl laboratories, A301-047A)	Homo sapiens	Treatment: Flag-NS1 virus for 12 hrs; 	NULL	38	normal	P28328	A549 (lung carcinoma)	PEAKS051063
EXP054150	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: Flag-NS1 virus for 0 hrs (none, uninfected);	NULL	38	normal	Q9Y6Y0	A549 (lung carcinoma)	PEAKS051064
EXP054151	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: Flag-NS1 virus for 12 hrs; 	NULL	38	normal	Q9Y6Y0	A549 (lung carcinoma)	PEAKS051065
EXP054152	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: control non-targeting siRNA pool, Flag-NS1 virus for 12 hrs;	EXP054147	38	normal	Q9Y6Y0	A549 (lung carcinoma)	PEAKS051066
EXP054153	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: siRNA pools targeted to human PAF1, Flag-NS1 virus for 12 hrs;	EXP054147	38	normal	Q9Y6Y0	A549 (lung carcinoma)	PEAKS051067
EXP054154	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: siRNA pools targeted to human CHD1, Flag-NS1 virus for 12 hrs;	EXP054147	38	normal	Q9Y6Y0	A549 (lung carcinoma)	PEAKS051068
EXP054156	p300 Antibody (Santa Cruz, sc-585, #H2610)	Homo sapiens		EXP054155	113	normal	Q09472	MCF7 (Invasive ductal breast carcinoma)	PEAKS051069
EXP054158	anti-TTF2 (sheep antibody)	Homo sapiens		EXP054157	78	normal	O00358	HeLa (cervical adenocarcinoma)	PEAKS051070
EXP054159	anti-TTF2 (rabbit antibody)	Homo sapiens		EXP054157	78	normal	O00358	HeLa (cervical adenocarcinoma)	PEAKS051071
EXP054160	anti-Xrn2 (rabbit  antibody)	Homo sapiens		EXP054157	78	normal	Q9H0D6	HeLa (cervical adenocarcinoma)	PEAKS051072
EXP054161	anti-Dcp1a (rabbit  antibody)	Homo sapiens		EXP054157	78	normal	Q9NPI6	HeLa (cervical adenocarcinoma)	PEAKS051073
EXP054163	CtBP (Santa Cruz, #H-440)	Homo sapiens	Passage: 15-18;  	EXP054162	113	normal	Q13363	MCF7 (Invasive ductal breast carcinoma)	PEAKS051074
EXP054167	SetDB1 (Santa Cruz, SC-66884)	Homo sapiens		EXP054164	2617	normal	Q15047	WM853.2 (Melanoma)	PEAKS051075
EXP054168	Lamin B1 (Abcam, ab16048, #953293)	Homo sapiens		NULL	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051076
EXP054169	anti-HCF1	Homo sapiens		NULL	2618	normal	P51610	H293T	PEAKS051077
EXP054170	anti-p300 (Santa Cruz antibody, sc-585x, Lot#E2610)	Homo sapiens		NULL	849	normal	Q09472	U87 (glioblastoma)	PEAKS051078
EXP054173	anti-Orc1	Homo sapiens		NULL	423	normal	Q13415	HeLa S3 (cervical adenocarcinoma)	PEAKS051079
EXP054175	p300 (Santa Cruz, Catalog: SC-585XS, Lot#:  E2209]	Homo sapiens		EXP054174	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS051080
EXP054177	anti-CSB (N-Terminus 1B1, Mouse monoclonal)	Homo sapiens	Genotype: UVSS1 knockout; 	EXP054176	2619	normal	Q03468	SV40 (Immortalized Fibroblast)	PEAKS051081
EXP054179	anti-CDK8 (Santa Cruz, sc-1521, K1510)	Homo sapiens	Treatment: normoxia for 24 hrs;	EXP054178	417	normal	P49336	HCT-116 (colon carcinoma)	PEAKS051082
EXP054180	anti-CDK8 (Santa Cruz, sc-1521, K1510)	Homo sapiens	Treatment: hypoxia (1%O2) for 24hrs;	EXP054178	417	normal	P49336	HCT-116 (colon carcinoma)	PEAKS051083
EXP054191	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	EXP054181	2615	normal	O14503	293T-Rex	PEAKS051084
EXP054192	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	EXP054181	2615	normal	Q9UQR0	293T-Rex	PEAKS051085
EXP054193	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	EXP054181	2615	normal	P35226	293T-Rex	PEAKS051086
EXP054194	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054182	2615	normal	O14503	293T-Rex	PEAKS051087
EXP054195	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054182	2615	normal	Q9UQR0	293T-Rex	PEAKS051088
EXP054196	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054182	2615	normal	P35226	293T-Rex	PEAKS051089
EXP054197	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054183	2615	normal	O14503	293T-Rex	PEAKS051090
EXP054198	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054183	2615	normal	Q9UQR0	293T-Rex	PEAKS051091
EXP054199	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054183	2615	normal	P35226	293T-Rex	PEAKS051092
EXP054200	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: none; 	EXP054184	514	normal	Q9UQR0	K562 (myelogenous leukemia)	PEAKS051093
EXP054201	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: none;	EXP054184	514	normal	P35226	K562 (myelogenous leukemia)	PEAKS051094
EXP054202	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054185	2615	normal	O14503	293T-Rex	PEAKS051095
EXP054203	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054185	2615	normal	Q9UQR0	293T-Rex	PEAKS051096
EXP054204	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054185	2615	normal	P35226	293T-Rex	PEAKS051097
EXP054205	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054186	2615	normal	O14503	293T-Rex	PEAKS051098
EXP054206	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054186	2615	normal	Q9UQR0	293T-Rex	PEAKS051099
EXP054207	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054186	2615	normal	P35226	293T-Rex	PEAKS051100
EXP054208	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054187	2615	normal	O14503	293T-Rex	PEAKS051101
EXP054209	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054187	2615	normal	Q9UQR0	293T-Rex	PEAKS051102
EXP054210	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054187	2615	normal	P35226	293T-Rex	PEAKS051103
EXP054211	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054188	2615	normal	O14503	293T-Rex	PEAKS051104
EXP054212	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054188	2615	normal	Q9UQR0	293T-Rex	PEAKS051105
EXP054213	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054188	2615	normal	P35226	293T-Rex	PEAKS051106
EXP054214	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054189	2615	normal	O14503	293T-Rex	PEAKS051107
EXP054215	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054189	2615	normal	Q9UQR0	293T-Rex	PEAKS051108
EXP054216	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054189	2615	normal	P35226	293T-Rex	PEAKS051109
EXP054217	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054190	2615	normal	O14503	293T-Rex	PEAKS051110
EXP054218	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054190	2615	normal	Q9UQR0	293T-Rex	PEAKS051111
EXP054219	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054190	2615	normal	P35226	293T-Rex	PEAKS051112
EXP054221	Smc1 (Bethyl, A300-055A)	Homo sapiens	Source: Lymphoblastoid cells; 	EXP054220	2620	normal	Q14683	HLS554P	PEAKS051113
EXP054222	Nipbl (Bethyl, A301-779A)	Homo sapiens	Source: Lymphoblastoid cells; 	EXP054220	2620	normal	Q6KC79	HLS554P	PEAKS051114
EXP054224	DNMT1 (Santa Cruz, sc-10219)	Homo sapiens	Cell status: undifferentiated; 	EXP054223	245	normal	P26358	NCCIT (testicular embryonic carcinoma)	PEAKS051115
EXP054225	DNMT3A (Santa Cruz, sc-20703))	Homo sapiens	Cell status: undifferentiated; 	EXP054223	245	normal	Q9Y6K1	NCCIT (testicular embryonic carcinoma)	PEAKS051116
EXP054226	DNMT3B (Novus, NB300-516)	Homo sapiens	Cell status: undifferentiated; 	EXP054223	245	normal	Q9UBC3	NCCIT (testicular embryonic carcinoma)	PEAKS051117
EXP054227	DNMT1 (Santa Cruz, sc-10219)	Homo sapiens	Cell status: differentiated;	EXP054223	245	normal	P26358	NCCIT (testicular embryonic carcinoma)	PEAKS051118
EXP054228	DNMT3A (Santa Cruz, sc-20703))	Homo sapiens	Cell status: differentiated;	EXP054223	245	normal	Q9Y6K1	NCCIT (testicular embryonic carcinoma)	PEAKS051119
EXP054229	DNMT3B (Novus, NB300-516)	Homo sapiens	Cell status: differentiated;	EXP054223	245	normal	Q9UBC3	NCCIT (testicular embryonic carcinoma)	PEAKS051120
EXP054231	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	881	normal	P51532	CD4+ T-cells	PEAKS051121
EXP054232	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2622	normal	P51532	HSC (hematopoietic stem cells )	PEAKS051122
EXP054233	anti-p300 (Santa Cruz, SC-585X, lot D1509)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2622	normal	Q09472	HSC (hematopoietic stem cells )	PEAKS051123
EXP054234	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2623	normal	P51532	CD36	PEAKS051124
EXP054235	anti-p300 (Santa Cruz, SC-585X, lot D1509)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2623	normal	Q09472	CD36	PEAKS051125
EXP054236	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	EXP054230	880	bio_control	P51532	B-cells	PEAKS051126
EXP054238	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	P25440	HEK293 (embryonic kidney)	PEAKS051127
EXP054239	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	Q15059	HEK293 (embryonic kidney)	PEAKS051128
EXP054240	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	O60885	HEK293 (embryonic kidney)	PEAKS051129
EXP054241	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	P45973	HEK293 (embryonic kidney)	PEAKS051130
EXP054242	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	P83916	HEK293 (embryonic kidney)	PEAKS051131
EXP054245	anti-c-Myc (Sigma, monoclonal, Clone 9E10)	Homo sapiens	Genotype: myc-tagged pcDNA3-NME2, NME2 induced;	EXP054243	38	normal	P22392	A549 (lung carcinoma)	PEAKS051132
EXP054246	anti-nm23-h2 (L-16)	Homo sapiens	Genotype: wildtype;	EXP054244	38	normal	P22392	A549 (lung carcinoma)	PEAKS051133
EXP054248	anti-Ago1 (Wako, 2A7)	Homo sapiens		EXP054247	725	normal	Q9UL18	PC3(bone mets prostate adenocarcinoma)	PEAKS051134
EXP054249	anti-Ago2 (Wako, 4G8)	Homo sapiens		EXP054247	725	normal	Q9UKV8	PC3(bone mets prostate adenocarcinoma)	PEAKS051135
EXP054250	anti-BRCA1 (rabbit polyclonal I-20, Santa Cruz, sc646)	Homo sapiens		NULL	583	normal	P38398	MCF10A (breast epithelial cells)	PEAKS051136
EXP054251	anti-PALB2 (rabbit polyclonal, Bethyl, A301-246A)	Homo sapiens		NULL	583	normal	Q86YC2	MCF10A (breast epithelial cells)	PEAKS051137
EXP054252	anti-BRCA1 (mouse monoclonal D-9)	Homo sapiens		NULL	583	normal	P38398	MCF10A (breast epithelial cells)	PEAKS051138
EXP054254	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: none;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	PEAKS051139
EXP054255	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: EGF 100ng/ml stimulation for 20 mins;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	PEAKS051140
EXP054256	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: doxycycline 1microgr/ml 72hrs;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	PEAKS051141
EXP054257	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Genotype: depletion of INTS11; Treatment: doxycycline 1microgr/ml 72hrs and EGF stimulation for 20 minutes with 100ng/ml;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	PEAKS051142
EXP054258	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: none;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	PEAKS051143
EXP054259	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: EGF 100ng/ml stimulation for 20 mins;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	PEAKS051144
EXP054260	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: doxycycline 1microgr/ml 72hrs;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	PEAKS051145
EXP054261	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Genotype: depletion of INTS11; Treatment: doxycycline 1microgr/ml 72hrs and EGF stimulation for 20 minutes with 100ng/ml;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	PEAKS051146
EXP054262	anti-INTS11 (rabbit polyclonal, Bethyl, A301-274A)	Homo sapiens	Genotype: wildtype; Treatment: none;	EXP054253	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	PEAKS051147
EXP054263	anti-INTS11 (rabbit polyclonal, Bethyl, A301-274A)	Homo sapiens	Genotype: wildtype; Treatment: EGF stimulation 100ng/ml for 20 mins;	EXP054253	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	PEAKS051148
EXP054265	anti-ARRB1	Homo sapiens	Treatment: serum starvation for 36 hours; Cell type: NSCLC (Non-Small Cell Lung Carcinoma); Passage: 4;	EXP054264	38	normal	P49407	A549 (lung carcinoma)	PEAKS051149
EXP054266	anti-ARRB1	Homo sapiens	Treatment: serum starvation for 36 hours and stimulated with 1 uM nicotine for 24 hours; Cell type: NSCLC; Passage: 4;	EXP054264	38	normal	P49407	A549 (lung carcinoma)	PEAKS051150
EXP054273	anti-CBX6 (MRO19, in house rabbit polyclonal)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	normal	O95503	BF (human fibroblasts)	PEAKS051151
EXP054274	anti-CBX7 (AB-21873, ABCAM)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	normal	O95931	BF (human fibroblasts)	PEAKS051152
EXP054275	anti-CBX8 (A300-882a, BETHYL)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	normal	Q9HC52	BF (human fibroblasts)	PEAKS051153
EXP054276	anti-RING1 (2820 from Cell Signalling Lab, LRI)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054268	2624	normal	Q06587	BF (human fibroblasts)	PEAKS051154
EXP054277	anti-RING2 (Mouse Mab from H. Koseki)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054269	2624	normal	Q92506	BF (human fibroblasts)	PEAKS051155
EXP054278	anti-CBX6 (MRO19 - in house rabbit polyclonal)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054270	2599	normal	O95503	Hs68 (Canavan disease)	PEAKS051156
EXP054279	anti-CBX7 (AB-21873, ABCAM)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054270	2599	normal	A0AVK6	Hs68 (Canavan disease)	PEAKS051157
EXP054280	anti-CBX8 (A300-882a, BETHYL)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054270	2599	normal	Q9HC52	Hs68 (Canavan disease)	PEAKS051158
EXP054281	anti-RING1 (2820 from Cell Signalling Lab, LRI)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054271	2599	normal	Q06587	Hs68 (Canavan disease)	PEAKS051159
EXP054282	anti-RING2 (Mouse Mab from H. Koseki)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054271	2599	normal	Q92506	Hs68 (Canavan disease)	PEAKS051160
EXP054283	anti-CBX7 (AB-21873, ABCAM)	Homo sapiens	Tissue: normal foreskin; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054272	2599	normal	O95931	Hs68 (Canavan disease)	PEAKS051161
EXP054284	anti-CBX8 (A300-882a, BETHYL)	Homo sapiens	Tissue: normal foreskin; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054272	2599	normal	Q9HC52	Hs68 (Canavan disease)	PEAKS051162
EXP054289	SIRT3 (Santa Cruz, P-19, #L0409)	Homo sapiens	Treatment: none;	EXP054285	848	normal	Q9NTG7	U2OS (osteosarcoma)	PEAKS051163
EXP054290	SIRT3 (Santa Cruz, P-19, #L0409)	Homo sapiens	Treatment: UV- irradiated with 400 J/m2;	EXP054285	848	normal	Q9NTG7	U2OS (osteosarcoma)	PEAKS051164
EXP054291	SIRT3 (Santa Cruz, P-19, #L0409)	Homo sapiens	Genotype: stable SIRT3 knockdown, retroviral expression of shRNAs against SIRT3; Treatment: shRNAs against SIRT3;	EXP054288	848	normal	Q9NTG7	U2OS (osteosarcoma)	PEAKS051165
EXP054293	V5-Agarose (Sigma Aldrich: 021M4839)	Homo sapiens	Treatment: V5-MBD2;	EXP054292	78	normal	Q9UBB5	HeLa (cervical adenocarcinoma)	PEAKS051166
EXP054294	V5-Agarose (Sigma Aldrich: 021M4839)	Homo sapiens	Treatment: V5-MBD3;	EXP054292	78	normal	O95983	HeLa (cervical adenocarcinoma)	PEAKS051167
EXP054299	anti-lamin A/C (Millipore, MAB3211 )	Homo sapiens	PAssage: 16; Sex: male; 	EXP054295	2625	normal	P02545	HGFDFN168 (forearm skin biopsy, fibroblasts)	PEAKS051168
EXP054300	anti-lamin A/C N18 (Santa Cruz, sc-6215)	Homo sapiens	PAssage: 16; Sex: male; 	EXP054296	2625	normal	P02545	HGFDFN168 (forearm skin biopsy, fibroblasts)	PEAKS051169
EXP054301	anti-lamin A/C (Millipore, MAB3211 )	Homo sapiens	PAssage: 16; Sex: male; 	EXP054297	2626	normal	P02545	HGADFN167 (primary fibroblasts with Hutchinson-Gilford progeria syndrome)	PEAKS051170
EXP054302	anti-lamin A/C N18 (Santa Cruz, sc-6215)	Homo sapiens	PAssage: 16; Sex: male; 	EXP054298	2626	normal	P02545	HGADFN167 (primary fibroblasts with Hutchinson-Gilford progeria syndrome)	PEAKS051171
EXP054305	anti-SUMO2	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	P61956	WI-38 (lung fibroblasts)	PEAKS051172
EXP054306	anti-UBC9	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	P63279	WI-38 (lung fibroblasts)	PEAKS051173
EXP054307	anti-SUMO2	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	P61956	WI-38 (lung fibroblasts)	PEAKS051174
EXP054308	anti-UBC9	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	P63279	WI-38 (lung fibroblasts)	PEAKS051175
EXP054309	anti-PIASy	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	Q8N2W9	WI-38 (lung fibroblasts)	PEAKS051176
EXP054310	anti-PIASy	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	Q8N2W9	WI-38 (lung fibroblasts)	PEAKS051177
EXP054311	anti-SUMO1	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	P63165	WI-38 (lung fibroblasts)	PEAKS051178
EXP054312	anti-SUMO1	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	P63165	WI-38 (lung fibroblasts)	PEAKS051179
EXP054313	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	PEAKS051180
EXP054314	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051181
EXP054315	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 50nM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051182
EXP054316	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 5nM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051183
EXP054317	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 5uM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051184
EXP054318	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051185
EXP054319	anti-Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	PEAKS051186
EXP054320	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	849	normal	O60885	U87 (glioblastoma)	PEAKS051187
EXP054321	anti-Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 500nM JQ1 treatment for 6hr; 	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	PEAKS051188
EXP054322	anti-Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 500nM JQ1 treatment for 6hr; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	PEAKS051189
EXP054323	anti-Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	PEAKS051190
EXP054324	Anti-EED (Millipore, cat# 05-1320, Lot# NG1841057)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	O75530	DU145 (prostate carcinoma)	PEAKS051191
EXP054325	Anti-EED (Millipore, cat# 05-1320, Lot# NG1841057)	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	O75530	DU145 (prostate carcinoma)	PEAKS051192
EXP054326	Anti-RING1A (rabbit, Cell Signaling, cat# 2820, lot# 1)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	Q06587	DU145 (prostate carcinoma)	PEAKS051193
EXP054327	Anti-RING1A (rabbit, Cell Signaling, cat# 2820, lot# 1)	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	Q06587	DU145 (prostate carcinoma)	PEAKS051194
EXP054328	Anti-RING1B (rabbit, Cell Signaling, cat# 5694, lot# 1)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	Q99496	DU145 (prostate carcinoma)	PEAKS051195
EXP054329	Anti-RING1B (rabbit, Cell Signaling, cat# 5694, lot# 1)	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	Q99496	DU145 (prostate carcinoma)	PEAKS051196
EXP054330	Anti-BMI1 (rabbit, Cell Signaling, cat# 6964, lot# 1)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	P35226	DU145 (prostate carcinoma)	PEAKS051197
EXP054331	Anti-BMI1 [rabbit, Cell Signaling, cat# 6964, lot# 1]	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	P35226	DU145 (prostate carcinoma)	PEAKS051198
EXP054332	p300 (rabbit polyclonal anti?p300 (C?20), Santa Cruz Biotechnology, catalog number = SC-585, Lot number = L2704)	Mus musculus	Developmental stage: E11.5; Strain: 129/C57BL/6; 	NULL	313	normal	B2RWS6	forebrain	PEAKS051199
EXP054333	acCBP/p300 (rabbit polyclonal, Cell Signaling Technology, catalog number = 4771,  lot number = 2)	Mus musculus	Developmental stage: P0; Strain: 129/C57BL/6; 	NULL	193	normal	B2RWS6	cortex	PEAKS051200
EXP054334	acCBP/p300 (rabbit polyclonal, Cell Signaling Technology, catalog number = 4771,  lot number = 2)	Homo sapiens	Developmental stage: gestational week 20; 	NULL	2627	normal	Q09472	fetal cortex	PEAKS051201
EXP054335	CENP-A (Enzo life science, ADI-KAM-CC006-E)	Homo sapiens	Genotype: CenH3 over-expression; 	NULL	423	normal	P49450	HeLa S3 (cervical adenocarcinoma)	PEAKS051202
EXP054336	CENP-A (Enzo life science, ADI-KAM-CC006-E)	Homo sapiens	Genotype: wildtype; 	NULL	423	normal	P49450	HeLa S3 (cervical adenocarcinoma)	PEAKS051203
EXP054337	anti-Flag M2 Agarose beads (Sigma Aldrich)	Homo sapiens	Genotype: CenH3 over-expression; 	NULL	423	normal	P49450	HeLa S3 (cervical adenocarcinoma)	PEAKS051204
EXP054339	Anti-c-Myc (Sigma, Cat#: A7470-1ML, Agarose Affinity Gel)	Homo sapiens	Genotype: wildtype Myc-Idax;	EXP054338	10	normal	Q9H2H0	HEK293T (embryonic kidney)	PEAKS051205
EXP054341	anti-TAF3 (Strategic Diagnostics,SDIX)	Homo sapiens	Passage: 15-18; 	EXP054340	417	normal	Q5VWG9	HCT-116 (colon carcinoma)	PEAKS051206
EXP054342	anti-AR (N20) (Santa Cruz Biotechnology, Santa Cruz, CA)	Homo sapiens	Treatment: vehicle, control;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS051207
EXP054343	anti-AR (N20) (Santa Cruz Biotechnology, Santa Cruz, CA)	Homo sapiens	Treatment: 10 nm DHT;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS051208
EXP054344	Mtg16 ( santa cruz biotech, C20)	Homo sapiens		EXP032594	147	normal	O75081	CAL-1 (plasmacytoid dendritic neoplasm)	PEAKS051209
EXP054347	anti-KAP1 (aa 20â€“418, RBCC, F. R. Santoni de Sio et al.,. Blood 119, 4675, 2012)	Mus musculus	Tissue: bone marrow; Age: 8- to 12-wk-old; Strain: mix strain;	EXP054346	2628	normal	Q62318	CD71+Ter119+ cells (facs sorted)	PEAKS051210
EXP054349	anti-Smc3	Homo sapiens	Genotype: RAD21cv; Treatment: TEV Treated, transfected with a plasmid expressing HRV protease; 	EXP054348	10	normal	Q9UQE7	HEK293T (embryonic kidney)	PEAKS051211
EXP054350	INO80 (Abcam, ab118787, lot GR69872-4)	Homo sapiens	Treatment: incubatedÂ withÂ IL-2 with anti-CD3 and anti-CD28 antibodies;	NULL	881	normal	Q9ULG1	CD4+ T-cells	PEAKS051212
EXP054351	SRCAP (Abcam, ab99408, lot GR58857-1)	Homo sapiens	Treatment: incubatedÂ withÂ IL-2 with anti-CD3 and anti-CD28 antibodies;	NULL	985	normal	Q6ZRS2	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS051213
EXP054355	CENP-A (Abcam, ab13939)	Homo sapiens		EXP054352	2629	normal	P49450	PDNC4 (fibroblast)	PEAKS051214
EXP054356	CENP-A (Abcam, ab13939)	Homo sapiens		EXP054353	2630	normal	P49450	IMS13q (lymphoblast)	PEAKS051215
EXP054357	CENP-A (Abcam, ab13939)	Homo sapiens		EXP054354	2631	normal	P49450	MS4221 (lymphoblast)	PEAKS051216
EXP054360	E2F4 (sc-866, santa cruz, Lot-A2804)	Homo sapiens	Treatment:  treated with 100nm Tamoxifen for 48hrs;	EXP054358	113	normal	Q16254	MCF7 (Invasive ductal breast carcinoma)	PEAKS051217
EXP054361	E2F4 (sc-866, santa cruz, Lot-A2804)	Homo sapiens	Treatment: treated with 100nm ICI 182780 for 48hrs;	EXP054358	113	normal	Q16254	MCF7 (Invasive ductal breast carcinoma)	PEAKS051218
EXP054362	ER; sc-534 (santa cruz) Lot-(HC-20)	Homo sapiens	MCF7 xenograft tumour in mouse	EXP054358	113	normal	O00321	MCF7 (Invasive ductal breast carcinoma)	PEAKS051219
EXP054363	GREB1 (ab72999, abcam, Lot-ab12563)	Homo sapiens	Treatment: xenograft tumour in mouse;	EXP054358	113	normal	Q4ZG55	MCF7 (Invasive ductal breast carcinoma)	PEAKS051220
EXP054364	COT2 (R&D systems ,PP-H7147-00, Lot A2)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	P24468	MCF7 (Invasive ductal breast carcinoma)	PEAKS051221
EXP054365	KLF4 (R&D systems, AF3640, Lot xvh0310101)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	O43474	MCF7 (Invasive ductal breast carcinoma)	PEAKS051222
EXP054366	RXRA  (sc-553, santa cruz, Lot E0411)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	P19793	MCF7 (Invasive ductal breast carcinoma)	PEAKS051223
EXP054367	TLE3 (ab94972, abcam, Lot GR54354-1)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	Q04726	MCF7 (Invasive ductal breast carcinoma)	PEAKS051224
EXP054368	ER (sc-534, santa cruz, Lot-HC-20)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS051225
EXP054369	GREB1 (ab72999, abcam, Lot-ab12563)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	Q4ZG55	MCF7 (Invasive ductal breast carcinoma)	PEAKS051226
EXP054370	GREB1 (ab72999, abcam, Lot-ab12563)	Homo sapiens	Treatment:  4 hours of 100nM ICI 182780;	EXP054358	113	normal	Q4ZG55	MCF7 (Invasive ductal breast carcinoma)	PEAKS051227
EXP054373	anti-MBD3 antibody (Abcam; ab91458)	Homo sapiens		EXP054371	113	normal	O95983	MCF7 (Invasive ductal breast carcinoma)	PEAKS051228
EXP054374	anti-MBD3 antibody (Abcam; ab91458)	Homo sapiens		EXP054372	2301	normal	O95983	MDA-MB-231 (breast adenocarcinoma)	PEAKS051229
EXP054376	anti-XPB (Rabbit Polyclonal, Novus Biologicals, NB100-61060)	Homo sapiens		EXP054375	1008	normal	P19447	HT1080 (fibrosarcoma)	PEAKS051230
EXP054377	anti-XPD (Rabbit Polyclonal, Santa Cruz Biotechnology, sc-20696)	Homo sapiens		EXP054375	1008	normal	P18074	HT1080 (fibrosarcoma)	PEAKS051231
EXP054379	ASF1a (equimolar mixture of Ms mAbs MPH7, MPB1, MPD5, Ambagala et al., 2009)	Homo sapiens		EXP054378	78	normal	Q9Y294	HeLa (cervical adenocarcinoma)	PEAKS051232
EXP054380	HIRA (equimolar mixture of Ms mAbs WC15, WC19, WC117, WC 119, Hall et al., 2001)	Homo sapiens		EXP054378	78	normal	P54198	HeLa (cervical adenocarcinoma)	PEAKS051233
EXP054381	UBN1(Rb pAb, Banumathy et al., 2009)	Homo sapiens		EXP054378	78	normal	Q9NPG3	HeLa (cervical adenocarcinoma)	PEAKS051234
EXP054389	SFMBT1 (custom rb4731, LOT#110518)	Homo sapiens	Developmental stage: asynchronous population;	EXP054382	423	normal	Q9UHJ3	HeLa S3 (cervical adenocarcinoma)	PEAKS051235
EXP054390	LSD1 (custom protein A purified)	Homo sapiens	Developmental stage: asynchronous population;	EXP054382	423	normal	O60341	HeLa S3 (cervical adenocarcinoma)	PEAKS051236
EXP054391	CoREST (Bethyl, A300-130A, LOT#A300-130A-1)	Homo sapiens	Developmental stage: asynchronous population;	EXP054382	423	normal	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	PEAKS051237
EXP054392	SFMBT1 (custom rb4731, LOT#110518)	Homo sapiens	Developmental stage: G1 phase;	EXP054383	423	normal	Q9UHJ3	HeLa S3 (cervical adenocarcinoma)	PEAKS051238
EXP054393	LSD1 (custom protein A purified)	Homo sapiens	Developmental stage: G1 phase;	EXP054383	423	normal	O60341	HeLa S3 (cervical adenocarcinoma)	PEAKS051239
EXP054394	CoREST (Bethyl, A300-130A, LOT#A300-130A-1)	Homo sapiens	Developmental stage: G1 phase;	EXP054383	423	normal	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	PEAKS051240
EXP054395	SFMBT1 (custom rb4731, LOT#110518)	Homo sapiens	Developmental stage: S phase;	EXP054385	423	normal	Q9UHJ3	HeLa S3 (cervical adenocarcinoma)	PEAKS051241
EXP054396	LSD1 (custom protein A purified)	Homo sapiens	Developmental stage: S phase;	EXP054385	423	normal	O60341	HeLa S3 (cervical adenocarcinoma)	PEAKS051242
EXP054397	CoREST (Bethyl, A300-130A, LOT#A300-130A-1)	Homo sapiens	Developmental stage: S phase;	EXP054385	423	normal	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	PEAKS051243
EXP054398	SFMBT1 (custom rb1219, LOT#110518)	Mus musculus		EXP054387	2632	normal	Q9JMD1	pachynema cells	PEAKS051244
EXP054399	LSD1 (custom protein A purified)	Mus musculus		EXP054387	2632	normal	Q6ZQ88	pachynema cells	PEAKS051245
EXP054400	SFMBT1 (custom rb1219, LOT#110518)	Mus musculus		EXP054388	2633	normal	Q9JMD1	spermatids	PEAKS051246
EXP054401	LSD1 (custom protein A purified)	Mus musculus		EXP054388	2633	normal	Q6ZQ88	spermatids	PEAKS051247
EXP054403	CENPA (Stressgen, KAM-CC006)	Homo sapiens		EXP054402	2634	normal	P49450	HuRef (Lymphoblast)	PEAKS051248
EXP054404	PHF6 (Bethyl, A301-451A)	Homo sapiens		NULL	509	normal	Q8IWS0	Jurkat (T-cells)	PEAKS051249
EXP054408	Med1/TRAP220 (Bethyl, A303-876A)	Homo sapiens	Treatment: bioruptor 20 cycles-3x10*6 cells, 12 min fix; 	EXP054406	618	normal	O95243	MM1.S (plasma cell myeloma)	PEAKS051250
EXP054409	Brd4 (Bethyl, cgA301-985A-1)	Homo sapiens	Treatment: none; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051251
EXP054410	Brd4 (Bethyl, A301-985A)	Homo sapiens		NULL	1573	normal	O60885	SK-MEL-5 (Cutaneous melanoma)	PEAKS051252
EXP054411	Cdk7 (Bethyl A300-405A)	Homo sapiens	Treatment: none; 	EXP054407	618	normal	P50613	MM1.S (plasma cell myeloma)	PEAKS051253
EXP054414	Anti-SMCHD1 (Rabbit polyclonal IgG, Sigma-Aldrich, HPA039441, #R36066)	Homo sapiens		EXP054412	417	normal	A6NHR9	HCT-116 (colon carcinoma)	PEAKS051254
EXP054415	anti-FANCD2	Homo sapiens	Treatment: none; 	NULL	10	normal	Q9BXW9	HEK293T (embryonic kidney)	PEAKS051255
EXP054416	anti-FANCD2	Homo sapiens	Treatment: UV treatment (30J);	NULL	10	normal	Q9BXW9	HEK293T (embryonic kidney)	PEAKS051256
EXP054418	anti-myc tag (Abcam, ab9132)	Homo sapiens	Passage: p8; 	EXP054417	2635	normal	P46531	primary aortic valve endothelial cells	PEAKS051257
EXP054420	anti-ING2 (epitomics, 3683-1)	Homo sapiens		EXP054419	774	normal	Q9H160	RKO (colon carcinoma cell)	PEAKS051258
EXP054421	anti-ING5 (abcam, ab96851)	Homo sapiens		EXP054419	774	normal	Q8WYH8	RKO (colon carcinoma cell)	PEAKS051259
EXP054422	anti-brpf2 (abcam, ab71877)	Homo sapiens		EXP054419	774	normal	O95696	RKO (colon carcinoma cell)	PEAKS051260
EXP054427	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054424	489	normal	P51608	IMR90 (lung fibroblasts)	PEAKS051261
EXP054428	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054425	417	normal	P51608	HCT-116 (colon carcinoma)	PEAKS051262
EXP054429	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054426	417	normal	P51608	HCT-116 (colon carcinoma)	PEAKS051263
EXP054430	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054423	489	normal	P51608	IMR90 (lung fibroblasts)	PEAKS051264
EXP054432	anti-human BDP1 (CS914, raised against peptide CSDRYRIYKAQK, like CS913, Schramm, 2000 #97)	Homo sapiens		EXP054431	489	normal	A6H8Y1	IMR90 (lung fibroblasts)	PEAKS051265
EXP054433	ZMYND110 (home-made)	Homo sapiens	Genotype: wildtype; 	NULL	848	bio_control	Q15326	U2OS (osteosarcoma)	PEAKS051266
EXP054434	ZMYND11, home-made	Homo sapiens	Genotype: shRNA control;	NULL	848	bio_control	Q15326	U2OS (osteosarcoma)	PEAKS051267
EXP054435	ZMYND11, home-made	Homo sapiens	Genotype: shZMYND11;	NULL	848	normal	Q15326	U2OS (osteosarcoma)	PEAKS051268
EXP054436	S2P, Covance MMS-129R	Homo sapiens	Genotype: shCTRL;	NULL	848	bio_control	O43462	U2OS (osteosarcoma)	PEAKS051269
EXP054437	S2P, Covance MMS-129R	Homo sapiens	Genotype: shZMYND11;	NULL	848	normal	O43462	U2OS (osteosarcoma)	PEAKS051270
EXP054441	Nup98 (Cell Signaling #2292 )	Homo sapiens		EXP054438	455	normal	P52948	HUES64 (embryonic stem cells)	PEAKS051271
EXP054442	Nup98 (Cell Signaling #2292 )	Homo sapiens		EXP054439	2636	normal	P52948	HUES6-derived neural progenitor cells	PEAKS051272
EXP054443	Nup98 (Cell Signaling #2292 )	Homo sapiens		NULL	2637	normal	P52948	HUES6-derived neurons	PEAKS051273
EXP054444	Nup98 (Cell Signaling #2292 )	Homo sapiens		EXP054440	489	normal	P52948	IMR90 (lung fibroblasts)	PEAKS051274
EXP054445	Nup98 (Cell Signaling #2598)	Homo sapiens		EXP054440	489	normal	P52948	IMR90 (lung fibroblasts)	PEAKS051275
EXP054447	anti-beta-catenin (Cell Signaling, #9562)	Homo sapiens	Source: Five pooled donors; 	EXP054446	1531	normal	P35222	regulatory T cell	PEAKS051276
EXP054450	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6 hours; 	NULL	849	normal	O60885	U87 (glioblastoma)	PEAKS051277
EXP054451	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 for 6 hours; 	NULL	849	normal	O60885	U87 (glioblastoma)	PEAKS051278
EXP054452	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 5nM JQ1 for 6 hours; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	PEAKS051279
EXP054453	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 50nM JQ1 for 6 hours; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	PEAKS051280
EXP054454	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 5000nM JQ1 for 6 hours; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	PEAKS051281
EXP054455	Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 50nM JQ1 for 6 hours; 	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	PEAKS051282
EXP054456	Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 5000nM JQ1 for 6 hours; 	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	PEAKS051283
EXP054457	IRF4 (Santa Cruz, SC-6059)	Homo sapiens		NULL	618	normal	Q15306	MM1.S (plasma cell myeloma)	PEAKS051284
EXP054458	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 150nM JQ1 for 6 hours; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	PEAKS051285
EXP054459	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6 hours; 	EXP054448	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	PEAKS051286
EXP054460	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 for 6 hours; 	EXP054449	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	PEAKS051287
EXP054473	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: no 4OHT;	EXP054467	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051288
EXP054474	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: no 4OHT;	EXP054468	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051289
EXP054475	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: no 4OHT;	EXP054469	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051290
EXP054476	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	EXP054470	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051291
EXP054477	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	EXP054471	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051292
EXP054478	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	EXP054472	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051293
EXP054481	anti-CSB	Homo sapiens	Genotype: wildtype; 	EXP054479	2360	normal	Q03468	fibroblasts	PEAKS051294
EXP054482	anti-CSB	Homo sapiens	Genotype: CSB{delta}N1;	EXP054480	2360	normal	Q03468	fibroblasts	PEAKS051295
EXP054485	antibody against BRD4 (Abcam, ab46199)	Homo sapiens	Treatment: shRNA against BRD4shRNA against BRD4;	EXP054483	10	normal	O60885	HEK293T (embryonic kidney)	PEAKS051296
EXP054486	antibody against BRD4 (Abcam, ab75898)	Homo sapiens	Treatment: shRNA against BRD4shRNA against BRD4;	EXP054484	10	normal	O60885	HEK293T (embryonic kidney)	PEAKS051297
EXP054489	Cdk7 (Abcam, AB9516)	Homo sapiens		EXP054487	509	normal	P50613	Jurkat (T-cells)	PEAKS051298
EXP054490	Cdk7 (Bethyl, A300-405A)	Homo sapiens	Treatment: Treated with DMSO for 6 hours;	NULL	618	normal	P50613	MM1.S (plasma cell myeloma)	PEAKS051299
EXP054491	Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: Treated with DMSO for 6 hours;	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	PEAKS051300
EXP054511	CTCF	Homo sapiens		EXP054492	339	normal	P49711	GM10847 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051301
EXP054512	SA1	Homo sapiens		EXP054492	339	normal	Q8WVM7	GM10847 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051302
EXP054513	CTCF	Homo sapiens		EXP054493	356	normal	P49711	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051303
EXP054514	SA1	Homo sapiens		EXP054493	356	normal	Q8WVM7	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051304
EXP054515	CTCF	Homo sapiens		EXP054494	2640	normal	P49711	GM12890 (Lymphoblastoid Cell Lines)	PEAKS051305
EXP054516	SA1	Homo sapiens		EXP054494	2640	normal	Q8WVM7	GM12890 (Lymphoblastoid Cell Lines)	PEAKS051306
EXP054517	CTCF	Homo sapiens		EXP054495	357	normal	P49711	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS051307
EXP054518	SA1	Homo sapiens		EXP054495	357	normal	Q8WVM7	GM12891 (male B- cells lymphoblastoid cell line)	PEAKS051308
EXP054519	CTCF	Homo sapiens		EXP054496	358	normal	P49711	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS051309
EXP054520	SA1	Homo sapiens		EXP054496	358	normal	Q8WVM7	GM12892 (female B-cells lymphoblastoid cell line)	PEAKS051310
EXP054521	CTCF	Homo sapiens		EXP054497	2643	normal	P49711	GM18486 (Lymphoblastoid Cell Lines)	PEAKS051311
EXP054522	SA1	Homo sapiens		EXP054497	2643	normal	Q8WVM7	GM18486 (Lymphoblastoid Cell Lines)	PEAKS051312
EXP054523	CTCF	Homo sapiens		EXP054498	362	normal	P49711	GM18505 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051313
EXP054524	SA1	Homo sapiens		EXP054498	362	normal	Q8WVM7	GM18505 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051314
EXP054525	CTCF	Homo sapiens		EXP054499	363	normal	P49711	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	PEAKS051315
EXP054526	SA1	Homo sapiens		EXP054499	363	normal	Q8WVM7	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	PEAKS051316
EXP054527	CTCF	Homo sapiens		EXP054500	364	normal	P49711	GM18951 (B-cells Lymphoblastoid Cell Lines)	PEAKS051317
EXP054528	SA1	Homo sapiens		EXP054500	364	normal	Q8WVM7	GM18951 (B-cells Lymphoblastoid Cell Lines)	PEAKS051318
EXP054529	CTCF	Homo sapiens		EXP054501	365	normal	P49711	GM19099 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051319
EXP054530	SA1	Homo sapiens		EXP054501	365	normal	Q8WVM7	GM19099 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051320
EXP054531	CTCF	Homo sapiens		EXP054502	366	normal	P49711	GM19193 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051321
EXP054532	SA1	Homo sapiens		EXP054502	366	normal	Q8WVM7	GM19193 (female B-cells Lymphoblastoid Cell Lines)	PEAKS051322
EXP054533	CTCF	Homo sapiens		EXP054503	367	normal	P49711	GM19238 (female B-cells lymphoblastoid cell lines)	PEAKS051323
EXP054534	SA1	Homo sapiens		EXP054503	367	normal	Q8WVM7	GM19238 (female B-cells lymphoblastoid cell lines)	PEAKS051324
EXP054535	CTCF	Homo sapiens		EXP054504	368	normal	P49711	GM19239 (male B-cells lymphoblastoid cell line)	PEAKS051325
EXP054536	SA1	Homo sapiens		EXP054504	368	normal	Q8WVM7	GM19239 (male B-cells lymphoblastoid cell line)	PEAKS051326
EXP054537	CTCF	Homo sapiens		EXP054505	369	normal	P49711	GM19240 (B cells Lymphoblastoid Cell Lines)	PEAKS051327
EXP054538	SA1	Homo sapiens		EXP054505	369	normal	Q8WVM7	GM19240 (B cells Lymphoblastoid Cell Lines)	PEAKS051328
EXP054539	CTCF	Homo sapiens		EXP054506	2652	normal	P49711	GM02255 (Lymphoblastoid Cell Lines)	PEAKS051329
EXP054540	SA1	Homo sapiens		EXP054506	2652	normal	Q8WVM7	GM02255 (Lymphoblastoid Cell Lines)	PEAKS051330
EXP054541	CTCF	Homo sapiens		EXP054507	2653	normal	P49711	2588 (Lymphoblastoid Cell Lines)	PEAKS051331
EXP054542	SA1	Homo sapiens		EXP054507	2653	normal	Q8WVM7	2588 (Lymphoblastoid Cell Lines)	PEAKS051332
EXP054543	CTCF	Homo sapiens		EXP054508	2654	normal	P49711	GM02610 (Lymphoblastoid Cell Lines)	PEAKS051333
EXP054544	SA1	Homo sapiens		EXP054508	2654	normal	Q8WVM7	GM02610 (Lymphoblastoid Cell Lines)	PEAKS051334
EXP054545	CTCF	Homo sapiens		EXP054509	2655	normal	P49711	GM02630 (Fanconi anemi)	PEAKS051335
EXP054546	SA1	Homo sapiens		EXP054509	2655	normal	Q8WVM7	GM02630 (Fanconi anemi)	PEAKS051336
EXP054547	CTCF	Homo sapiens		EXP054510	2656	normal	P49711	MS-1 (Small cell lung carcinoma)	PEAKS051337
EXP054548	SA1	Homo sapiens		EXP054510	2656	normal	Q8WVM7	MS-1 (Small cell lung carcinoma)	PEAKS051338
EXP054550	Mouse monoclonal anti-CSB N Terminus (1B1)	Homo sapiens	Treatment: menadione; 	EXP054549	2360	normal	Q03468	fibroblasts	PEAKS051339
EXP054554	anti-p300 ( our lab,  Byun et al, Nature Comm. 3, 633, 2012)	Homo sapiens	Genotype: pCI1-EGFP; 	EXP054552	421	normal	Q09472	HEK293 (embryonic kidney)	PEAKS051341
EXP054555	anti-CBP  (cat# ab2832 , ABCAM)	Homo sapiens	Genotype: HSP70K71E-EGFP; 	EXP054551	421	normal	Q92793	HEK293 (embryonic kidney)	PEAKS051342
EXP054556	anti-CBP  (cat# ab2832 , ABCAM)	Homo sapiens	Genotype: pCI1-EGFP; 	EXP054552	421	normal	Q92793	HEK293 (embryonic kidney)	PEAKS051343
EXP054557	CBP (Santa Cruz, SC-369)	Mus musculus	Strain: C57BL/6-129; 	NULL	252	normal	P45481	V6.5 (embryonic stem cells)	PEAKS051344
EXP054558	MBD3 (Santa Cruz, SC-9402)	Mus musculus	Strain: C57BL/6-129; 	NULL	252	normal	Q9DA79	V6.5 (embryonic stem cells)	PEAKS051345
EXP054559	anti-Ronin (Lab Generated (Zwaka), G4275)	Mus musculus	Strain: C57BL/6-129; 	NULL	252	normal	Q9JJD0	V6.5 (embryonic stem cells)	PEAKS051346
EXP054560	anti-P300 (SC-585, Santa Cruz biotechnology)	Homo sapiens		NULL	421	normal	Q09472	HEK293 (embryonic kidney)	PEAKS051347
EXP054561	CDK9 (2316S, Cell Signaling Technology)	Homo sapiens	Treatment: siRNA empty vector; 	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS051348
EXP054562	CDK9 (2316S, Cell Signaling Technology)	Homo sapiens	Treatment: siRNA against JMJD6 ; 	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS051349
EXP054563	CDK9 (2316S, Cell Signaling Technology)	Homo sapiens	Treatment: siRNA against BRD4; 	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS051350
EXP054564	Janti-MJD6 (ab10526, Abcam)	Homo sapiens		NULL	78	normal	Q6NYC1	HeLa (cervical adenocarcinoma)	PEAKS051351
EXP054565	anti-Brd4 (ab46199, Abcam)	Homo sapiens		NULL	78	normal	O60885	HeLa (cervical adenocarcinoma)	PEAKS051352
EXP054566	Janti-MJD6 (ab10526, Abcam)	Homo sapiens		NULL	421	bio_control	Q6NYC1	HEK293 (embryonic kidney)	PEAKS051353
EXP054567	anti-Brd4 (ab46199, Abcam)	Homo sapiens		NULL	421	bio_control	O60885	HEK293 (embryonic kidney)	PEAKS051354
EXP054570	anti-V5 (Abcam ab9116, lot# 754608)	Homo sapiens	Genotype: HMEL-BRAF-RNF2 overexpressing; 	EXP054568	2657	normal	Q99496	HMEL-BRAFV600E (human immortalized melanocytes)	PEAKS051355
EXP054571	anti-V5 (Abcam ab9116, lot# 754608)	Homo sapiens	Genotype: HMEL-BRAF-RNF2 overexpressing; Source: tumor cells;	EXP054569	2657	normal	Q99496	HMEL-BRAFV600E (human immortalized melanocytes)	PEAKS051356
EXP054572	anti-LSD1 (Abcam, ab17721, lot GR79477-2)	Homo sapiens	Treatment: none; Conditions: cells were starved in phenol-red-free medium supplemented with 10% charcoal stripped FBS for 3 days	NULL	70	normal	O60341	LNCaP (prostate carcinoma)	PEAKS051357
EXP054573	anti-LSD1 (Abcam, ab17721, lot GR79477-2)	Homo sapiens	Treatment: none; Conditions: cells were starved in phenol-red-free medium supplemented with 10% charcoal stripped FBS for 3 days	NULL	71	normal	O60341	VCaP (prostate carcinoma)	PEAKS051358
EXP054574	anti-SETX	Homo sapiens	Treatment: non infected; 	NULL	38	normal	Q7Z333	A549 (lung carcinoma)	PEAKS051359
EXP054575	anti-SETX	Homo sapiens	Treatment: infected by Influenza PR8{delta}NS1;	NULL	38	normal	Q7Z333	A549 (lung carcinoma)	PEAKS051360
EXP054577	CIITA (Brown, JA et al. Nucleic acids research, 1998. 26:4128-36)	Homo sapiens		EXP054576	767	normal	P33076	Raji (Burkitt lymphoma)	PEAKS051361
EXP054578	CIITA (Rockland Immunochemicals, 100-401-249)	Homo sapiens		EXP054576	767	normal	P33076	Raji (Burkitt lymphoma)	PEAKS051362
EXP054579	CIITA (Diagenode, C15410062)	Homo sapiens		EXP054576	767	normal	P33076	Raji (Burkitt lymphoma)	PEAKS051363
EXP054580	SPT5 (H-300) (Santa Cruz, sc-28678)	Homo sapiens		NULL	78	normal	O00267	HeLa (cervical adenocarcinoma)	PEAKS051364
EXP054581	NELF-A (A-20) (Santa Cruz, sc-23599)	Homo sapiens		NULL	78	normal	Q9H3P2	HeLa (cervical adenocarcinoma)	PEAKS051365
EXP054583	against KAP1 (aa 20â€“418, RBCC, F. R. Santoni de Sio et al.,. Blood 119, 4675, 2012)	Homo sapiens	Treatment: 5 days of HCMV infection;  Source: mixed patients;	EXP054582	166	normal	Q13263	CD34+ hematopoietic stem cells	PEAKS051366
EXP054586	PKCtheta (sc-212, SantaCruz)	Homo sapiens	Treatment: none;	EXP054584	113	normal	Q04759	MCF7 (Invasive ductal breast carcinoma)	PEAKS051367
EXP054587	PKCtheta (sc-212, SantaCruz)	Homo sapiens	Treatment: 0.65 ng/ml for 60hrs PMA;	EXP054585	113	normal	Q04759	MCF7 (Invasive ductal breast carcinoma)	PEAKS051368
EXP054589	Lamin B1 (Abcam, catalog #ab16048, lot#953293 )	Homo sapiens		EXP054588	489	normal	P20700	IMR90 (lung fibroblasts)	PEAKS051369
EXP054596	mose monoclonal p300 (custom generated; 1A3_F8)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051370
EXP054597	mose monoclonal p300 (custom generated; 1F4_E10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051371
EXP054598	mose monoclonal p300 (custom generated; 1F4_E10)	Homo sapiens		EXP054591	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051372
EXP054599	mose monoclonal p300 (custom generated; 2E10_D10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051373
EXP054600	mose monoclonal p300 (custom generated; 2F4_A8)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051374
EXP054601	mose monoclonal p300 (custom generated; 2F6_F7)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051375
EXP054602	mose monoclonal p300 (custom generated; 3B4_G6)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051376
EXP054603	mose monoclonal p300 (custom generated; 3H6_B6)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051377
EXP054604	mose monoclonal p300 (custom generated; 4C5_A1)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051378
EXP054605	mose monoclonal p300 (custom generated; 5D2_A1)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051379
EXP054606	mose monoclonal p300 (custom generated; 5F7_C9)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051380
EXP054607	mose monoclonal p300 (custom generated; 7H5_F2)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051381
EXP054608	p300 (Santa Cruz, sc-585, E3113)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051382
EXP054609	p300 (Santa Cruz, sc-585, F2711)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051383
EXP054610	mouse monoclonal GABP (Santa Cruz, sc-28312)	Homo sapiens		NULL	356	normal	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051384
EXP054611	NRSF (mouse monoclonal, custom generated, Johnson et al. 2007, PMID: 17540862)	Homo sapiens		NULL	356	normal	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051385
EXP054612	SPI1/PU.1(Santa Cruz, sc-22805)	Homo sapiens		NULL	356	normal	P17947	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051386
EXP054613	Kaiso/ZBTB33 (Santa Cruz, sc-23871)	Homo sapiens		NULL	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051387
EXP054614	mouse monoclonal NRSF	Homo sapiens		EXP054590	356	normal	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051388
EXP054615	mouse monoclonal NRSF	Homo sapiens		NULL	509	normal	Q13127	Jurkat (T-cells)	PEAKS051389
EXP054616	mouse monoclonal GABP (Santa Cruz, sc-28312)	Homo sapiens		NULL	356	normal	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051390
EXP054617	NRSF (custom generated, Johnson et al. 2007, PMID: 17540862)	Homo sapiens		EXP054590	356	normal	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051391
EXP054618	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051392
EXP054619	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens	Characteristic: robotic ChIP-seq; 	EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051393
EXP054620	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens	Characteristic: robotic ChIP-seq; 	EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051394
EXP054621	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051395
EXP054622	p300 (Santa Cruz sc-585, Lot#E3113)	Homo sapiens	Characteristic: robotic ChIP-seq; 	NULL	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051396
EXP054623	SPI1/PU.1 (Santa Cruz, sc-22805)	Homo sapiens		NULL	356	normal	P17947	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051397
EXP054624	SPI1/PU.1 (Santa Cruz, sc-22805)	Homo sapiens	Characteristic: robotic ChIP-seq; 	NULL	356	normal	P17947	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051398
EXP054625	Kaiso/ZBTB33 (Santa Cruz, sc-23871)	Homo sapiens		NULL	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051399
EXP054626	Kaiso/ZBTB33 (Santa Cruz, sc-23871)	Homo sapiens	Characteristic: robotic ChIP-seq; 	NULL	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051400
EXP054631	anti-BAHD1 (C mouse monoclonal antibody, clone HPC4, 11814508001, Roche)	Homo sapiens		EXP054627	421	normal	Q8TBE0	HEK293 (embryonic kidney)	PEAKS051401
EXP054632	anti-BAHD1 (C mouse monoclonal antibody, clone HPC4, 11814508001, Roche)	Homo sapiens		EXP054628	421	normal	Q8TBE0	HEK293 (embryonic kidney)	PEAKS051402
EXP054636	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6 hours;	EXP054635	2660	normal	O60885	LY-1 (Diffuse Large B-Cell Lymphoma)	PEAKS051403
EXP054637	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 for 6 hours;	EXP054634	2660	normal	O60885	LY-1 (Diffuse Large B-Cell Lymphoma)	PEAKS051404
EXP054638	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: none;	EXP054633	2660	normal	O95243	LY-1 (Diffuse Large B-Cell Lymphoma)	PEAKS051405
EXP054641	CDK8 (Santa Cruz, SC-1521)	Homo sapiens		EXP054639	452	normal	P49336	HT29 (colon adenocarcinoma)	PEAKS051406
EXP054642	CDK8 (Santa Cruz, SC-1521)	Homo sapiens		EXP054640	821	normal	P49336	SW480 (colon adenocarcinoma)	PEAKS051407
EXP054643	anti-PGC7	Homo sapiens		NULL	10	normal	Q6W0C5	HEK293T (embryonic kidney)	PEAKS051408
EXP054644	anti-TET3	Homo sapiens		NULL	10	normal	O43151	HEK293T (embryonic kidney)	PEAKS051409
EXP054645	CDK2	Homo sapiens	Treatment: none;	NULL	2295	normal	P24941	T47D-MTVL	PEAKS051410
EXP054646	CDK2	Homo sapiens	Treatment: progestin for 5min;	NULL	2295	normal	P24941	T47D-MTVL	PEAKS051411
EXP054647	CDK2	Homo sapiens	Treatment: progestin for 30min;	NULL	2295	normal	P24941	T47D-MTVL	PEAKS051412
EXP054648	PARP1	Homo sapiens	Treatment: none;	NULL	2295	normal	P09874	T47D-MTVL	PEAKS051413
EXP054649	PARP1	Homo sapiens	Treatment: progestin for 5min;	NULL	2295	normal	P09874	T47D-MTVL	PEAKS051414
EXP054650	PARP1	Homo sapiens	Treatment: progestin for 30min;	NULL	2295	normal	P09874	T47D-MTVL	PEAKS051415
EXP054652	Anti-beta catenin(H102) (Santa Cruz, sc-7199)	Homo sapiens	Passage: 10 to 15;	EXP054651	821	normal	P35222	SW480 (colon adenocarcinoma)	PEAKS051416
EXP054654	anti-JMJD2C	Homo sapiens	Treatment: shCtrl;	EXP054653	2661	normal	Q9H3R0	KYSE-150 (Esophageal squamous cell carcinoma)	PEAKS051417
EXP054655	anti-JMJD2C	Homo sapiens	Treatment: shJMJD2C;	EXP054653	2661	normal	Q9H3R0	KYSE-150 (Esophageal squamous cell carcinoma)	PEAKS051418
EXP054658	LMNA (Santa Cruz, sc-7292)	Homo sapiens	Passage: 5-7;	EXP054656	2662	normal	P02545	Lonza CC-2511 (normal dermal fibroblasts)	PEAKS051419
EXP054659	anti-LMNA (Santa Cruz, sc-7292)	Homo sapiens	Passage: 5-7;	EXP054657	2663	normal	P02545	normal primary dermal fibroblasts	PEAKS051420
EXP054661	MLL N-terminus (Bethyl 086A)	Homo sapiens	Source: umbilical cord blood; Genotype: HSPC-MA9;	EXP054660	2664	normal	Q03164	CD34+ cells	PEAKS051421
EXP054662	AF9 C-terminus (Bethyl 597A)	Homo sapiens	Source: umbilical cord blood; Genotype: HSPC-MA9;	EXP054660	2664	normal	P42568	CD34+ cells	PEAKS051422
EXP054667	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: vehicle (naÃ¯ve);	EXP054663	2665	normal	O60885	KOPT-K1 (Childhood T acute lymphoblastic leukemia)	PEAKS051423
EXP054668	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: 1uM gamma Secretase inhibitor over 7weeks;	EXP054664	2665	normal	O60885	KOPT-K1 (Childhood T acute lymphoblastic leukemia)	PEAKS051424
EXP054669	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: vehicle (naÃ¯ve);	EXP054665	220	normal	O60885	DND41 (acute lymphoblastic leukemia)	PEAKS051425
EXP054670	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: 1uM gamma Secretase inhibitor over 7weeks;	EXP054666	220	normal	O60885	DND41 (acute lymphoblastic leukemia)	PEAKS051426
EXP054672	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing MEL18-GFP fusion protein;	EXP054671	514	normal	P35227	K562 (myelogenous leukemia)	PEAKS051427
EXP054673	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing RINGA1-GFP fusion protein;	EXP054671	514	normal	Q06587	K562 (myelogenous leukemia)	PEAKS051428
EXP054674	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing RINGB1-GFP fusion protein;	EXP054671	514	normal	Q99496	K562 (myelogenous leukemia)	PEAKS051429
EXP054675	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing BMI1-GFP fusion protein;	EXP054671	514	normal	P35226	K562 (myelogenous leukemia)	PEAKS051430
EXP054676	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing PCGF1-GFP fusion protein;	EXP054671	514	normal	Q9BSM1	K562 (myelogenous leukemia)	PEAKS051431
EXP054677	CBX2 Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing CBX2-GFP fusion protein;	EXP054671	514	normal	Q14781	K562 (myelogenous leukemia)	PEAKS051432
EXP054678	anti-KDM2B (Abcam, ab137547)	Homo sapiens		NULL	2288	normal	Q8NHM5	AML (monocytes and acute myeloid leukemia)	PEAKS051433
EXP054679	anti-KDM2B (Abcam, ab137547)	Homo sapiens		NULL	2288	normal	Q8NHM5	AML (monocytes and acute myeloid leukemia)	PEAKS051434
EXP054681	anti-MBD2 Antibody (Rabbit, Bethyl Laboratories, A301-632)	Homo sapiens	Genotype: TTE-MBD2;	EXP054680	113	normal	Q9UBB5	MCF7 (Invasive ductal breast carcinoma)	PEAKS051435
EXP054683	TERF1	Homo sapiens		EXP054682	2287	normal	P54274	LCL (lymphoblastoid cell line)	PEAKS051436
EXP054684	TERF2	Homo sapiens		EXP054682	2287	normal	Q15554	LCL (lymphoblastoid cell line)	PEAKS051437
EXP054685	anti-RELA (Santa Cruz Biotechnology, #sc-372)	Homo sapiens		NULL	356	normal	Q04206	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051438
EXP054686	anti-RELB (Santa Cruz Biotechnology, #sc-226)	Homo sapiens		NULL	356	normal	Q01201	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051439
EXP054687	c-REL (Santa Cruz Biotechnology, #sc-71)	Homo sapiens		NULL	356	normal	Q04864	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051440
EXP054688	NFKB1 (Santa Cruz Biotechnology, #sc-1190)	Homo sapiens		NULL	356	normal	P19838	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051441
EXP054689	NFKB2 (Bethyl Laboratories, #A300-BL7039)	Homo sapiens		NULL	356	normal	Q00653	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051442
EXP054692	WDR5 (Bethyl Labs, A302-429A)	Homo sapiens	Treatment: EtOH;	EXP054690	70	normal	P61964	LNCaP (prostate carcinoma)	PEAKS051443
EXP054693	WDR5 (Bethyl Labs, A302-429A)	Homo sapiens	Treatment: R1881;	EXP054691	70	normal	P61964	LNCaP (prostate carcinoma)	PEAKS051444
EXP054696	anti-pDNA-PKcs (Abcam, ab18192)	Homo sapiens	Treatment: 300 nM solvent (methanol) for 4 hrs;	EXP054694	2599	normal	P78527	Hs68 (Canavan disease)	PEAKS051445
EXP054697	anti-pDNA-PKcs (Abcam, ab18192)	Homo sapiens	Treatment: 300 nM 4-hydroxy tamoxifen (OHT) for 4 hhrs;	EXP054695	2599	normal	P78527	Hs68 (Canavan disease)	PEAKS051446
EXP054698	anti-MEL18 (Santa Cruz, sc-10744)	Homo sapiens	Treatment: 300 nM solvent (methanol) for 4 hrs;	EXP054694	2599	normal	P35227	Hs68 (Canavan disease)	PEAKS051447
EXP054699	anti-MEL18 (Santa Cruz, sc-10744)	Homo sapiens	Treatment: 300 nM 4-hydroxy tamoxifen (OHT) for 4 hhrs;	EXP054695	2599	normal	P35227	Hs68 (Canavan disease)	PEAKS051448
EXP054700	anti-ARRB1 (A1CT , gift from Pr R. Lefkowitz)	Homo sapiens	Genotype: parental, endogenous levels of ARRB1;	NULL	130	normal	P49407	LNCaP C4-2 (prostate carcinoma)	PEAKS051449
EXP054701	anti-ARRB1 (A1CT , gift from Pr R. Lefkowitz)	Homo sapiens	Genotype: stably expressing nuclear ARRB1;	NULL	130	normal	P49407	LNCaP C4-2 (prostate carcinoma)	PEAKS051450
EXP054702	anti-p300 (C-20, Santa Cruz, sc-585)	Homo sapiens	Genotype: stably expressing nuclear ARRB1;	NULL	130	normal	Q09472	LNCaP C4-2 (prostate carcinoma)	PEAKS051451
EXP054703	anti-ARRB1 (A1CT , gift from Pr R. Lefkowitz)	Homo sapiens		NULL	916	normal	P49407	prostate	PEAKS051452
EXP054704	anti-p300 (C-20, Santa Cruz, sc-585)	Homo sapiens	Genotype: parental, endogenous levels of ARRB1;	NULL	130	normal	Q09472	LNCaP C4-2 (prostate carcinoma)	PEAKS051453
EXP054707	anti-PRDM11 (antibody 1, rabbit polyclonal, non-commercial)	Homo sapiens		EXP054706	847	normal	Q9NQV5	U2932 (diffuse large B-cell lymphoma)	PEAKS051454
EXP054708	anti-PRDM11 (antibody 2, rabbit polyclonal, non-commercial)	Homo sapiens		EXP054706	847	normal	Q9NQV5	U2932 (diffuse large B-cell lymphoma)	PEAKS051455
EXP054713	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens	Developmental stage: proliferating; 	EXP054709	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS051456
EXP054714	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens	Developmental stage: replicative senescent; 	EXP054710	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS051457
EXP054715	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens		EXP054711	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS051458
EXP054716	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens	Developmental stage: oncogene induced senescence;	EXP054712	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS051459
EXP054717	Dicer	Homo sapiens		NULL	421	normal	Q9UPY3	HEK293 (embryonic kidney)	PEAKS051460
EXP054720	JMJD3 (abgent, AP1022a)	Homo sapiens	Treatment: treated with control GSKJ5 inhibito;	EXP054718	199	normal	O15054	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS051461
EXP054721	JMJD3 (abgent, AP1022a)	Homo sapiens	Treatment: treated with control GSKJ5 inhibito;	EXP054719	199	normal	O15054	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS051462
EXP054723	DDX21 (Novus Biologicals,  Cat# BP100-1781)	Homo sapiens		EXP054722	421	normal	Q9NR30	HEK293 (embryonic kidney)	PEAKS051463
EXP054729	AGO1 (Millipore, (clone 6D8.2) cat 04-083)	Homo sapiens		EXP054726	113	normal	Q9UL18	MCF7 (Invasive ductal breast carcinoma)	PEAKS051464
EXP054730	HP1 alpha (Abcam, Ab9057)	Homo sapiens		EXP054728	113	normal	P45973	MCF7 (Invasive ductal breast carcinoma)	PEAKS051465
EXP054731	AGO1 (Millipore, (clone 6D8.2) cat 04-083)	Homo sapiens		EXP054727	583	normal	Q9UL18	MCF10A (breast epithelial cells)	PEAKS051466
EXP054732	HP1 alpha (Abcam, Ab9057)	Homo sapiens		EXP054727	583	normal	P45973	MCF10A (breast epithelial cells)	PEAKS051467
EXP054733	anti-AGO1 (4B8-clone, 4B8 (SAB4200084-200UL)	Homo sapiens		EXP054724	113	normal	Q9UL18	MCF7 (Invasive ductal breast carcinoma)	PEAKS051468
EXP054734	anti-AGO1 (4B8-clone, 4B8 (SAB4200084-200UL)	Homo sapiens		EXP054725	583	normal	Q9UL18	MCF10A (breast epithelial cells)	PEAKS051469
EXP054736	anti-APOBEC3B (Rabbit polyclonal, antiserum prepared by immunising with overlapping peptides)	Homo sapiens	Treatment: Ethanol (vehicle);	EXP054735	113	normal	Q9UH17	MCF7 (Invasive ductal breast carcinoma)	PEAKS051470
EXP054737	APOBEC3B ( Rabbit polyclonal, antiserum prepared by immunising with overlapping peptides)	Homo sapiens	Treatment: Estrogen (100 nM);	NULL	113	normal	Q9UH17	MCF7 (Invasive ductal breast carcinoma)	PEAKS051471
EXP054739	anti-LSD1 (Abcam, ab17721)	Homo sapiens	Treatment: 17-20;	EXP054738	2667	normal	O60341	PC-3M-luc (human prostate carcinoma)	PEAKS051472
EXP054742	anti-LMNA (Santa Cruz, sc-7292)	Homo sapiens	Source: sonicated chromatin;	EXP054740	78	normal	P02545	HeLa (cervical adenocarcinoma)	PEAKS051473
EXP054743	anti-LMNA (Santa Cruz, sc-7292)	Homo sapiens	Source: micrococcal nuclease-digested chromatin;	EXP054741	78	normal	A0AVK6	HeLa (cervical adenocarcinoma)	PEAKS051474
EXP054744	LMNB1(Abcam, ab16048)	Homo sapiens	Source: micrococcal nuclease-digested chromatin;	NULL	78	normal	Q13751	HeLa (cervical adenocarcinoma)	PEAKS051475
EXP054745	CHD8 (N terminus, Abcam, ab114126, #GR62009-12)	Mus musculus	Strain: C57BL6J; Developmental stage: Embryonic Day 17.5; Tissue: frontal cortex;	NULL	625	normal	Q09XV5	embryonic cortex	PEAKS051476
EXP054746	CHD8 (N terminus, Abcam, ab114126, #GR62009-12)	Mus musculus	Strain: C57BL6J; Developmental stage: embryonic day 17.5; Tissue: occipital cortex;	NULL	866	normal	Q09XV5	E15.5 embryonic cortex	PEAKS051477
EXP054747	CHD8 (N terminus, Abcam, ab114126, #GR62009-12)	Homo sapiens		NULL	915	normal	Q9HCK8	hNSC (neural stem cells)	PEAKS051478
EXP054750	CDK9 (Santa Cruz)	Homo sapiens	Treatment: treated with DMSO;	EXP054748	36	normal	P50750	A375 (malignant melanoma)	PEAKS051479
EXP054751	CDK9 (Santa Cruz)	Homo sapiens	Treatment: 25 uM A771726 for 48 hrs;	EXP054749	36	normal	P50750	A375 (malignant melanoma)	PEAKS051480
EXP054752	HEXIM1 (Abcam)	Homo sapiens	Treatment: treated with DMSO;	EXP054748	36	normal	O94992	A375 (malignant melanoma)	PEAKS051481
EXP054753	HEXIM1 (Abcam)	Homo sapiens	Treatment: 25 uM A771726 for 48 hrs;	EXP054749	36	normal	O94992	A375 (malignant melanoma)	PEAKS051482
EXP054755	ALKBH3 (Millipore, #09-882)	Homo sapiens		EXP054754	725	normal	Q96Q83	PC3(bone mets prostate adenocarcinoma)	PEAKS051483
EXP054758	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: untreated; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	EXP054756	417	bio_control	P11387	HCT-116 (colon carcinoma)	PEAKS051484
EXP054759	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: siTop1; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051485
EXP054760	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: CPT (Camptothecin, a topoisomerase I inhibitor); Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051486
EXP054761	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: CPT (Camptothecin, a topoisomerase I inhibitor); Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051487
EXP054762	anti-BRD4 (A301-985A)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	EXP054756	417	normal	O60885	HCT-116 (colon carcinoma)	PEAKS051488
EXP054763	anti-BRD4 (A301-985A)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	O60885	HCT-116 (colon carcinoma)	PEAKS051489
EXP054764	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	EXP054756	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051490
EXP054765	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051491
EXP054766	anti-BRD4 (A301-985A)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	EXP054757	417	bio_control	O60885	HCT-116 (colon carcinoma)	PEAKS051492
EXP054767	anti-BRD4 (A301-985A)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	NULL	417	normal	O60885	HCT-116 (colon carcinoma)	PEAKS051493
EXP054768	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	EXP054757	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051494
EXP054769	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	PEAKS051495
EXP054772	anti-KAP1 (Custom rabbit antibody, 60?l per IP)	Homo sapiens		EXP054770	376	normal	Q13263	WA01 (H1, human embryonic stem cells)	PEAKS051496
EXP054773	anti-KAP1 (AbCam, ab10483)	Homo sapiens		EXP054771	376	normal	Q13263	WA01 (H1, human embryonic stem cells)	PEAKS051497
EXP054775	Anti-HA Agarose (Thermo Scientific, 26181)	Homo sapiens		EXP054774	2668	normal	Q99496	HES-3 (embryonic stem cell)	PEAKS051498
EXP054782	anti-GFP (Abcam, ab290)	Homo sapiens		EXP054778	2326	normal	Q03468	CS1AN (Cockayne syndrome)	PEAKS051499
EXP054783	anti-GFP	Homo sapiens		EXP054781	2326	normal	Q03468	CS1AN (Cockayne syndrome)	PEAKS051500
EXP054786	LSD1 (ab-17721; Abcam)	Homo sapiens	Treatment: LSD1+8a shRNA; Developmental stage: B0; 	NULL	664	normal	O60341	SH-SY5Y (neuroblastoma)	PEAKS051501
EXP054787	LSD1 (ab-17721; Abcam)	Homo sapiens	Treatment: control shRNA; Developmental stage: B0; 	EXP054785	664	normal	O60341	SH-SY5Y (neuroblastoma)	PEAKS051502
EXP054788	LSD1 (ab-17721; Abcam)	Homo sapiens	Treatment: control shRNA; Developmental stage: B3; 	EXP054785	664	normal	O60341	SH-SY5Y (neuroblastoma)	PEAKS051503
EXP054789	SVIL (S8695; Sigma)	Homo sapiens	Treatment: SVIL shRNA; Developmental stage: B3; 	EXP054784	664	normal	O95425	SH-SY5Y (neuroblastoma)	PEAKS051504
EXP054790	SVIL (S8695; Sigma)	Homo sapiens	Treatment: control shRNA; Developmental stage: B3; 	EXP054785	664	normal	O95425	SH-SY5Y (neuroblastoma)	PEAKS051505
EXP054793	Mouse anti-HA antibody (Covance, catalog# MMS-101P)	Mus musculus	Strain: C57BL/6; Treatment: 2 days after doxycycline induction of Gm6871-HA expression vector expression; Genotype: overexpressing HA-tagged Gm6871; 	EXP054791	2669	normal	E9PZ63	ES3 (ebryonic stem cells)	PEAKS051506
EXP054794	anti-KAP1 antibody (Custom rabbit, 5ug per IP)	Mus musculus	Strain: 129S4/SvJae; Genotype: wildtype; 	EXP054792	506	normal	Q62318	J1 (embryonic stem cells)	PEAKS051507
EXP054797	anti-PSF (clone 39-1; Santa Cruz Biotechnology, sc-101137, Lot # L1012)	Homo sapiens	Treatment: none;	EXP054795	113	normal	P23246	MCF7 (Invasive ductal breast carcinoma)	PEAKS051508
EXP054798	anti-PSF (clone 39-1; Santa Cruz Biotechnology, sc-101137, Lot # L1012)	Homo sapiens	Treatment: none;	EXP054796	113	normal	P23246	MCF7 (Invasive ductal breast carcinoma)	PEAKS051509
EXP054800	anti-EGFP (polyclonal goat )	Homo sapiens		EXP054799	422	normal	P38432	HeLa Kyoto (cervical adenocarcinoma)	PEAKS051510
EXP054804	anti-Beta-Catenin (R&D systems, AF1329)	Homo sapiens	Treatment: none; 	EXP054801	2670	normal	P35222	SA121 (embryonic stem cell)	PEAKS051511
EXP054805	anti-Beta-Catenin (R&D systems, AF1329)	Homo sapiens	Treatment: 3mM CHIR99021 (CHIR) for 6 hrs; 	EXP054802	2670	normal	P35222	SA121 (embryonic stem cell)	PEAKS051512
EXP054806	anti-Beta-Catenin (R&D systems, AF1329)	Homo sapiens	Treatment: 3mM CHIR99021+ 10mM SB431542 (CHIR+SB) for 6 hrs; 	EXP054803	2670	normal	P35222	SA121 (embryonic stem cell)	PEAKS051513
EXP054807	Anti- CK2a Abcam (Cat. No. Ab70774)	Homo sapiens	Passage: 40-45; Treatment: 100 nM DHT for 2.5 hrs;	NULL	70	normal	P68400	LNCaP (prostate carcinoma)	PEAKS051514
EXP054809	p68 antibody (Bethyl Laboratories, catalog# A300-523A, lot# A300-523A-1)	Homo sapiens		EXP054808	2671	normal	P17844	NTERA-2 (embryonal carcinoma)	PEAKS051515
EXP054810	anti-PAR2	Homo sapiens	Passage: 15-18; Treatment: stimulated with peptide SLGKV; 	NULL	421	normal	P55085	HEK293 (embryonic kidney)	PEAKS051516
EXP054811	BRD2	Homo sapiens	Treatment: DMSO (0.1%) for 16 hrs; 	NULL	562	normal	P25440	LX-2 (hepatic stellate cells)	PEAKS051517
EXP054812	BRD2	Homo sapiens	Treatment:500 nM JQ1 for 16 hrs; 	NULL	562	normal	P25440	LX-2 (hepatic stellate cells)	PEAKS051518
EXP054813	BRD3	Homo sapiens	Treatment: DMSO (0.1%) for 16 hrs; 	NULL	562	normal	Q15059	LX-2 (hepatic stellate cells)	PEAKS051519
EXP054814	BRD3	Homo sapiens	Treatment:500 nM JQ1 for 16 hrs; 	NULL	562	normal	Q15059	LX-2 (hepatic stellate cells)	PEAKS051520
EXP054815	BRD4	Homo sapiens	Treatment: DMSO (0.1%) for 16 hrs; 	NULL	562	normal	O60885	LX-2 (hepatic stellate cells)	PEAKS051521
EXP054816	BRD4	Homo sapiens	Treatment:500 nM JQ1 for 16 hrs; 	NULL	562	normal	O60885	LX-2 (hepatic stellate cells)	PEAKS051522
EXP054819	p53 (EMD Millipore (DO1))	Homo sapiens	Treatment: DMSO for 6hrs; Passage: 30-35; 	EXP054817	489	normal	P04637	IMR90 (lung fibroblasts)	PEAKS051523
EXP054820	p53 (EMD Millipore (DO1))	Homo sapiens	Treatment: nutlin3a (5uM final) for 6hrs; Passage: 30-35; 	EXP054818	489	normal	P04637	IMR90 (lung fibroblasts)	PEAKS051524
EXP054821	EED (Millipore 17-10034)	Homo sapiens		NULL	167	normal	O75530	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS051525
EXP054822	SUZ12 (Abcam ab12073; Active Motif 39357, lot 29111002)	Homo sapiens		NULL	167	normal	Q15022	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS051526
EXP054823	NFE2 (Santa Cruz Biotechnology sc-291)	Homo sapiens		NULL	167	normal	Q16621	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS051527
EXP054824	TAL1 (Santa Cruz Biotechnology sc-12984)	Homo sapiens		NULL	167	normal	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	PEAKS051528
EXP054825	anti-p300 (N-15) (Santa Cruz, catalog# sc-584)	Homo sapiens	Treatment: mock-infected;	NULL	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS051529
EXP054826	anti-p300 (N-15) (Santa Cruz, catalog# sc-584)	Homo sapiens	Treatment: dl1500 infected;	NULL	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS051530
EXP054829	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: mock-infected;	EXP054827	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051531
EXP054830	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: dl1500-infected;	EXP054828	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051532
EXP054835	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: dl312-infected;	EXP054831	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051533
EXP054836	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: e1aWT-infected;	EXP054832	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051534
EXP054837	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: P300 binding mutant-infected;	EXP054833	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051535
EXP054838	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: RB binding mutant-infected; 	EXP054834	489	normal	P06400	IMR90 (lung fibroblasts)	PEAKS051536
EXP054840	anti-LSD2 (polyclonal antibody, raised in rabbits by administering recombinant human LSD2 protein (region 26 â€“ 822))	Homo sapiens		EXP054839	430	normal	Q8NB78	HepG2 (hepatoblastoma)	PEAKS051537
EXP054845	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054841	1149	normal	Q14565	testis	PEAKS051538
EXP054846	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054842	1149	normal	Q14565	testis	PEAKS051539
EXP054847	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054844	1149	normal	Q14565	testis	PEAKS051540
EXP054848	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054843	1149	normal	Q14565	testis	PEAKS051541
EXP054850	CSL (Cell Signaling RBPSUH Cat.No. 5313)	Homo sapiens	Tissue: abdomen skin; Passage: 4-6;	EXP054849	2663	normal	Q14406	normal primary dermal fibroblasts	PEAKS051542
EXP054851	CSL (Eurogentech, Seraign, Belgium - Affinity purified rabbit polyclonal -Epitopes: aa 209-224, aa 426-440 )	Homo sapiens	Tissue: abdomen skin; Passage: 4-6;	EXP054849	2663	normal	Q14406	normal primary dermal fibroblasts	PEAKS051543
EXP054855	anti-Cdk7 (Bethyl, A300-405A)	Homo sapiens	Treatment: treated with DMSO/vehicle for 12 hours;	NULL	509	normal	P50613	Jurkat (T-cells)	PEAKS051546
EXP054856	anti-Cdk7 (Bethyl, A300-405A)	Mus musculus		NULL	252	normal	Q03147	V6.5 (embryonic stem cells)	PEAKS051547
EXP054857	anti-cdk8 (Santa Cruz, SC-1521)	Mus musculus		NULL	252	normal	Q8R3L8	V6.5 (embryonic stem cells)	PEAKS051548
EXP054859	ELK3 (2005, in house)	Homo sapiens		EXP054858	472	normal	P41970	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS051549
EXP054862	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	EXP054860	396	normal	O60885	WA09 (embryonic stem cells)	PEAKS051550
EXP054863	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	EXP054861	396	normal	O60885	WA09 (embryonic stem cells)	PEAKS051551
EXP054864	BRD2 (Bethyl, A302-583A)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	EXP054860	396	normal	P25440	WA09 (embryonic stem cells)	PEAKS051552
EXP054865	BRD2 (Bethyl, A302-583A)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	EXP054861	396	normal	P25440	WA09 (embryonic stem cells)	PEAKS051553
EXP054866	BRD3 (Bethyl, A302-368A)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	EXP054860	396	normal	Q15059	WA09 (embryonic stem cells)	PEAKS051554
EXP054867	BRD3 (Bethyl, A302-368A)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	EXP054861	396	normal	Q15059	WA09 (embryonic stem cells)	PEAKS051555
EXP054870	ZNF486 (abcam ab104878, lot#GR52278-1)	Homo sapiens		EXP054868	878	normal	Q96H40	embryonic stem cells	PEAKS051556
EXP054871	ZNF486 (abcam ab104878, lot#GR52278-1)	Homo sapiens		EXP054869	878	normal	Q96H40	embryonic stem cells	PEAKS051557
EXP054872	KAP1 ChIP (abcam ab10483, lot#GR17300)	Homo sapiens		EXP054869	878	normal	Q13263	embryonic stem cells	PEAKS051558
EXP054874	anti-AF9 (Sigma, HPA001824)	Homo sapiens	Genotype: 3Flag-AF9 stable;	EXP054873	78	normal	P42568	HeLa (cervical adenocarcinoma)	PEAKS051559
EXP054875	anti-FLAG (Sigma M2)	Homo sapiens	Genotype: 3Flag-AF9 stable;	EXP054873	78	normal	P42568	HeLa (cervical adenocarcinoma)	PEAKS051560
EXP054878	AUTS2 (house made)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	A0A087WPF7	brain	PEAKS051561
EXP054879	RING1B (form Luciano Di Croce)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	Q9CQJ4	brain	PEAKS051562
EXP054880	BMI1 (Bethyl, A301-694A, lot# A301-694A-3)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	P25916	brain	PEAKS051563
EXP054881	P300 (Santa Cruz, sc585, lot# B0413)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	B2RWS6	brain	PEAKS051564
EXP054882	anti-HA (abcam, ab9110, lot# GR20600-2)	Homo sapiens	Passage: 15-20; 	EXP054877	11	normal	Q8WXX7	HEK293-T-Rex (embryonic kidney)	PEAKS051565
EXP054885	Anti-INTS3 (Bethyl Laboratories, A302-051A)	Homo sapiens		EXP054883	2672	normal	Q68E01	HeLa-LTR-Luciferase cells	PEAKS051566
EXP054886	Anti-NELF-E (Millipore, ABE48)	Homo sapiens		EXP054883	2672	normal	P18615	HeLa-LTR-Luciferase cells	PEAKS051567
EXP054887	Anti-Spt5 (BD Transduction Laboratories, 611106)	Homo sapiens		EXP054883	2672	normal	O00267	HeLa-LTR-Luciferase cells	PEAKS051568
EXP054888	Anti-INTS13/Asun (Bethyl Laboratories)	Homo sapiens		EXP054883	2672	normal	Q9NVM9	HeLa-LTR-Luciferase cells	PEAKS051569
EXP054889	Anti-INTS11	Homo sapiens		NULL	2672	normal	Q5TA45	HeLa-LTR-Luciferase cells	PEAKS051570
EXP054892	DEK (Abcam, ab-74975)	Homo sapiens		EXP054890	65	normal	P35659	U937 (adult acute monocytic leukemia)	PEAKS051571
EXP054893	DEK (Abcam, ab-74975)	Homo sapiens		EXP054891	65	normal	P35659	U937 (adult acute monocytic leukemia)	PEAKS051572
EXP054895	anti-LEDGF/p75 (Bethyl, A300-848)	Homo sapiens	Source: infected chronic HIV-1 subtype C infection cohort; 	EXP054894	2614	normal	O75475	primary CD4+ T-cells	PEAKS051573
EXP054896	anti-USP7 (Bethyl, catalog# A300-033A)	Homo sapiens		NULL	11	normal	Q93009	HEK293-T-Rex (embryonic kidney)	PEAKS051574
EXP054902	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO- CD62L+ CD127hi CD25-; 	EXP054897	2614	normal	Q04759	primary CD4+ T-cells	PEAKS051575
EXP054903	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127lo CD25- (effector memory);	EXP054898	2614	normal	Q04759	primary CD4+ T-cells	PEAKS051576
EXP054904	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127hi CD25- (resting memory);	EXP054899	2614	normal	Q04759	primary CD4+ T-cells	PEAKS051577
EXP054905	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127hi CD25+ (activated memory);	EXP054900	2614	normal	Q04759	primary CD4+ T-cells	PEAKS051578
EXP054906	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: none;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	PEAKS051579
EXP054907	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: PMA and Ionomycin;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	PEAKS051580
EXP054908	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: prestimulation;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	PEAKS051581
EXP054909	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: prestimulation and PMA and Ionomycin;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	PEAKS051582
EXP054914	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS wildtype; Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	NULL	2674	normal	O60885	dermal transformed fibroblasts	PEAKS051583
EXP054915	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS wildtype; Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	EXP054911	2674	normal	O60885	dermal transformed fibroblasts	PEAKS051584
EXP054916	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS-HGPS (Hutchinson Gilford Progeria Syndrome); Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	EXP054912	2674	normal	O60885	dermal transformed fibroblasts	PEAKS051585
EXP054917	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS-HGPS (Hutchinson Gilford Progeria Syndrome); Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	EXP054913	2674	normal	O60885	dermal transformed fibroblasts	PEAKS051586
EXP054918	anti-SSu72 (Genetex catalog number: GTX116436)	Homo sapiens	Passage: 40-55; Developmental stage: pluripotent; 	NULL	376	normal	Q9NP77	WA01 (H1, human embryonic stem cells)	PEAKS051587
EXP054920	anti-CHD8 (Bethyl A301-224A)	Homo sapiens	Genotype: shRNA targeting GFP;	EXP054919	2675	normal	Q9HCK8	GM8330-8-derived NPC	PEAKS051588
EXP054921	anti-CHD7 (Bethyl A301-223A)	Homo sapiens	Genotype: shRNA targeting GFP;	EXP054919	2675	normal	Q9P2D1	GM8330-8-derived NPC	PEAKS051589
EXP054922	anti-CHD8 (Novus Biological NB100-60418)	Homo sapiens	Genotype: shRNA targeting GFP;	EXP054919	2675	normal	Q9HCK8	GM8330-8-derived NPC	PEAKS051590
EXP054923	PARP-1 (Active motif-39559)	Homo sapiens	Passage: 10 -15; 	NULL	113	normal	P09874	MCF7 (Invasive ductal breast carcinoma)	PEAKS051591
EXP054924	PARP-1 (Active motif-39559)	Homo sapiens	Passage: 10 -15; 	NULL	2301	normal	P09874	MDA-MB-231 (breast adenocarcinoma)	PEAKS051592
EXP054925	anti-NIPBL Antibody (Bethyl, A301-779A)	Homo sapiens	Genotype: wildtype; 	NULL	768	normal	Q6KC79	Ramos (Burkitt lymphoma)	PEAKS051593
EXP054928	anti-PAF1  (Bethyl, A300-172A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	P28328	THP-1 (acute monocytic leukemia)	PEAKS051594
EXP054929	anti-CDC73 (Bethyl, A300-170A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	Q6P1J9	THP-1 (acute monocytic leukemia)	PEAKS051595
EXP054930	anti-LEO1 (Bethyl, A300-175A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	Q8WVC0	THP-1 (acute monocytic leukemia)	PEAKS051596
EXP054931	anti-CTR9 (Bethyl, A301-395A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	Q6PD62	THP-1 (acute monocytic leukemia)	PEAKS051597
EXP054932	anti-LEO1 (Bethyl, A300-175A)	Homo sapiens	Treatment: DMSO; Genotype: wild type (control); 	NULL	2334	normal	Q8WVC0	THP-1 (acute monocytic leukemia)	PEAKS051598
EXP054933	anti-LEO1 (Bethyl, A300-175A)	Homo sapiens	Treatment: Flavopiridol;	NULL	2334	normal	Q8WVC0	THP-1 (acute monocytic leukemia)	PEAKS051599
EXP054934	anti-PAF1 (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY56 (control); Genotype: vector control;	NULL	2334	normal	P28328	THP-1 (acute monocytic leukemia)	PEAKS051600
EXP054935	anti-PAF1 (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY136 (PAF1 shRNA #1); Genotype: PAF1 knockdown;	NULL	2334	normal	P28328	THP-1 (acute monocytic leukemia)	PEAKS051601
EXP054936	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: pMY56 (control); Genotype: vector control;	NULL	2334	normal	P50750	THP-1 (acute monocytic leukemia)	PEAKS051602
EXP054937	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: pMY136 (PAF1 shRNA #1); Genotype: PAF1 knockdown;	NULL	2334	normal	P50750	THP-1 (acute monocytic leukemia)	PEAKS051603
EXP054938	anti-PAF1  (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY56 (control); genotype: vector control; 	EXP054927	153	normal	P28328	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS051604
EXP054939	anti-PAF1  (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY137 (PAF1 shRNA #2); Genotype: PAF1 knockdown;	EXP054927	153	normal	P28328	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS051605
EXP054940	anti-CDK12 (LSBio, LS-A7350)	Homo sapiens	Treatment: pMY56 (control); Genotype: vector control; 	EXP054927	153	normal	Q9NYV4	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS051606
EXP054941	anti-CDK12 (LSBio, LS-A7350)	Homo sapiens	Treatment: pMY136 (PAF1 shRNA #1); Genotype: PAF1 knockdown;	EXP054927	153	normal	Q9NYV4	CCRF-CEM (T acute lymphoblastic leukemia)	PEAKS051607
EXP054943	anti-KDM3A (Millipore Biotech (Billerica, MA, USA), 09-823)	Homo sapiens	Treatment: 37 degree, 1hr;	EXP054942	509	normal	Q9Y4C1	Jurkat (T-cells)	PEAKS051608
EXP054945	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: none; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	PEAKS051609
EXP054946	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: R5020 for 5 min;	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	PEAKS051610
EXP054947	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: EtOH for 5 min; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	PEAKS051611
EXP054948	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: R5020 45 min; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	PEAKS051612
EXP054949	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: EtOH 45 min; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	PEAKS051613
EXP054951	anti-Notch (home-made)	Homo sapiens	Developmental stage: 5 days expansion;  Source: Hematopoietic progenitor cells; 	EXP054950	2664	normal	P46531	CD34+ cells	PEAKS051614
EXP054954	anti-BRD4 (Bethyl, A301-085A)	Homo sapiens	Treatment: DMSO for 24hrs;	EXP054952	985	normal	O60885	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS051615
EXP054955	anti-BRD4 (Bethyl, A301-085A)	Homo sapiens	Treatment: PD-032901 (2uM) + JQ1 (100nM) for 24hrs;	EXP054953	985	normal	O60885	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	PEAKS051616
EXP054956	Rad21	Homo sapiens		NULL	356	normal	O60216	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051617
EXP054957	anti-BRD4 (Bethyl Labs, A301-985A, lot# A301-985A-1)	Homo sapiens	Treatment: EBV-infected;	NULL	356	normal	O60885	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS051618
EXP054960	anti-MBD2 (a custom-made rabbit polyclonalcorresponding to the N-terminal part Covalab, Villeurbanne, Lyon, Perriaud et al. Curr. Pharm. Des 2013)	Homo sapiens		EXP054958	2678	normal	Q9UBB5	HMEC-hTERT	PEAKS051619
EXP054961	anti-MBD2 (a custom-made rabbit polyclonalcorresponding to the N-terminal part Covalab, Villeurbanne, Lyon, Perriaud et al. Curr. Pharm. Des 2013)	Homo sapiens		EXP054959	442	normal	Q9UBB5	HMLER (mammary epithelial cells)	PEAKS051620
EXP054962	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: proliferating, undifferentiated; 	NULL	2679	normal	P02545	pre-adipocytes	PEAKS051621
EXP054963	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: non-proliferating (confluent), undifferentiated; 	NULL	2679	normal	P02545	pre-adipocytes	PEAKS051622
EXP054964	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: Non-proliferating, differentiated for 1 day; 	NULL	2679	normal	P02545	pre-adipocytes	PEAKS051623
EXP054965	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: non-proliferating, differentiated for 3 day; 	NULL	2679	normal	P02545	pre-adipocytes	PEAKS051624
EXP054966	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: non-proliferating, differentiated for 9 day; 	NULL	2679	normal	P02545	pre-adipocytes	PEAKS051625
EXP054969	anti-lamin B1 (Abcam, #ab16048)	Homo sapiens		EXP054967	489	normal	Q03252	IMR90 (lung fibroblasts)	PEAKS051626
EXP054970	anti-lamin B1 (Abcam, #ab16048)	Homo sapiens		EXP054968	489	normal	Q03252	IMR90 (lung fibroblasts)	PEAKS051627
EXP054971	LC3 (Cell Signaling Technology #3868)	Homo sapiens		EXP054967	489	normal	Q9GZQ8	IMR90 (lung fibroblasts)	PEAKS051628
EXP054972	LC3 (Cell Signaling Technology #3868)	Homo sapiens		EXP054968	489	normal	Q9GZQ8	IMR90 (lung fibroblasts)	PEAKS051629
EXP054982	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: DMSO 3 hrs;	NULL	2680	normal	O60885	SUM159R	PEAKS051630
EXP054983	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: JQ1 3 hrs;	NULL	2680	normal	O60885	SUM159R	PEAKS051631
EXP054984	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: DMSO 3 hrs;	EXP054974	817	normal	O60885	SUM159PT (Triple negative breast cancer)	PEAKS051632
EXP054985	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: JQ1 3 hrs;	NULL	817	normal	O60885	SUM159PT (Triple negative breast cancer)	PEAKS051633
EXP054986	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054975	2681	normal	O60885	HCC1395 (Ductal breast carcinoma)	PEAKS051634
EXP054987	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2681	normal	O60885	HCC1395 (Ductal breast carcinoma)	PEAKS051635
EXP054988	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054976	2682	normal	O60885	MDA-MB-436 (Invasive ductal carcinoma)	PEAKS051636
EXP054989	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2682	normal	O60885	MDA-MB-436 (Invasive ductal carcinoma)	PEAKS051637
EXP054990	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054977	2683	normal	O60885	SUM 1315 (Invasive ductal carcinoma)	PEAKS051638
EXP054991	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2683	normal	O60885	SUM 1315 (Invasive ductal carcinoma)	PEAKS051639
EXP054992	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054978	2684	normal	O60885	SUM149R	PEAKS051640
EXP054993	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2684	normal	O60885	SUM149R	PEAKS051641
EXP054994	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054979	2685	normal	O60885	SUM149	PEAKS051642
EXP054995	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2685	normal	O60885	SUM149	PEAKS051643
EXP054996	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054980	818	normal	O60885	SUM185PE (ductal breast carcinoma)	PEAKS051644
EXP054997	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	818	normal	O60885	SUM185PE (ductal breast carcinoma)	PEAKS051645
EXP054998	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054981	111	normal	O60885	T47D (invasive ductal carcinoma)	PEAKS051646
EXP054999	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	111	normal	O60885	T47D (invasive ductal carcinoma)	PEAKS051647
EXP055002	DYRK1A antibody (ab69811)	Homo sapiens	Tissue: brain; 	EXP055000	2600	normal	Q13627	T98G (Glioblastoma)	PEAKS051648
EXP055003	DYRK1A antibody (ab69811)	Homo sapiens	Tissue: brain; Growing condition: serum starvation; 	EXP055000	2600	normal	Q13627	T98G (Glioblastoma)	PEAKS051649
EXP055004	DYRK1A antibody (ab69811)	Homo sapiens		EXP055001	78	normal	Q13627	HeLa (cervical adenocarcinoma)	PEAKS051650
EXP055006	anti-BRPF3 (homemade rabbit, from X-J Yang, McGill univ)	Homo sapiens		NULL	774	normal	Q9ULD4	RKO (colon carcinoma cell)	PEAKS051651
EXP055007	anti-BRPF3 (homemade rabbit, from X-J Yang, McGill univ)	Homo sapiens	Treatment: mimosine 0.5mM for 22h;	NULL	774	normal	Q9ULD4	RKO (colon carcinoma cell)	PEAKS051652
EXP055008	anti-BRPF3 (homemade rabbit, from X-J Yang, McGill univ)	Homo sapiens	Treatment: mimosine 0.5mM for 22h, cells released 3h and HU-3mM treated for 1h30;	EXP055005	774	normal	Q9ULD4	RKO (colon carcinoma cell)	PEAKS051653
EXP055010	anti-WDR5 (CST,13105)	Homo sapiens	Passage: 16-19;Treatment: nonspecific shRNA virus;	EXP055009	2686	normal	Q86V15	BGC-823 (Gastric adenocarcinoma)	PEAKS051654
EXP055011	anti-WDR5 (CST,13105)	Homo sapiens	Genotype: WDR5 knockout; Passage: 16-19; Treatment: nonspecific shRNA adenovirus against human lncRNA PRLG;	EXP055009	2686	normal	Q86V15	BGC-823 (Gastric adenocarcinoma)	PEAKS051655
EXP055012	anti-KAT2A (CST,3305)	Homo sapiens	Passage: 16-19;Treatment: nonspecific shRNA virus;	EXP055009	2686	normal	Q92830	BGC-823 (Gastric adenocarcinoma)	PEAKS051656
EXP055013	anti-KAT2A (CST,3305)	Homo sapiens	Genotype: KAT2A knockout; Passage: 16-19; Treatment: nonspecific shRNA adenovirus against human lncRNA PRLG;	EXP055009	2686	normal	Q92830	BGC-823 (Gastric adenocarcinoma)	PEAKS051657
EXP055016	anti-Mdm2 N20 (Santa Cruz, catalog# sc-813, lot# JO412)	Homo sapiens	Genotype: overexpressing mdm2; 	EXP055014	375	normal	Q00987	NCI-H1299 (large cell lung carcinoma)	PEAKS051658
EXP055017	anti-Mdm2 N20 (Santa Cruz, catalog# sc-813, lot# JO412)	Homo sapiens	Genotype: knockout mdm2; 	EXP055015	375	normal	Q00987	NCI-H1299 (large cell lung carcinoma)	PEAKS051659
EXP055020	anti-CHD1 (Bethyl, catalog# A301-218A, lot# A301-218A-1)	Homo sapiens	Treatment: DHT 10-7M 210 min; Passage: 10;	EXP055018	70	normal	O14646	LNCaP (prostate carcinoma)	PEAKS051660
EXP055021	anti-CHD1 (Bethyl, catalog# A301-218A, lot# A301-218A-1)	Homo sapiens	Treatment: none; Passage: 10;	EXP055018	70	normal	O14646	LNCaP (prostate carcinoma)	PEAKS051661
EXP055022	anti-CHD1 (Bethyl, catalog# A301-218A, lot# A301-218A-1)	Homo sapiens	Treatment: DHT 10-7M 210 min; Passage: 10; Genotype: CHD1 knockdown;	EXP055019	70	normal	O14646	LNCaP (prostate carcinoma)	PEAKS051662
EXP055024	UTX (home made 9838P mixed with A302-374A)	Homo sapiens		EXP055023	509	normal	O15550	Jurkat (T-cells)	PEAKS051663
EXP055027	Goat polyclonal anti-MIF(Abcam ab38146)	Homo sapiens	Treatment: DMSO(0.1%) for 15 min;	EXP055025	78	normal	P03971	HeLa (cervical adenocarcinoma)	PEAKS051664
EXP055028	Goat polyclonal anti-MIF(Abcam ab38146)	Homo sapiens	Treatment: 50 uM MNNG for 15 min;	EXP055026	78	normal	P03971	HeLa (cervical adenocarcinoma)	PEAKS051665
EXP055046	CDK8_b1	Homo sapiens	Treatment: untreated;	EXP055029	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	PEAKS051666
EXP055047	CDK8_b1	Homo sapiens	Treatment: untreated;	EXP055030	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	PEAKS051667
EXP055048	MED1	Homo sapiens	Treatment: untreated;	EXP055031	2687	normal	O95243	MOLM14 (Adult acute myeloid leukemia)	PEAKS051668
EXP055049	BRD4	Homo sapiens	Treatment: DMSO;	EXP055032	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	PEAKS051669
EXP055050	BRD4	Homo sapiens	Treatment: CA25;	EXP055033	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	PEAKS051670
EXP055051	CDK8	Homo sapiens	Treatment: untreated;	EXP055034	2218	normal	P49336	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS051671
EXP055052	CDK8	Homo sapiens	Treatment: untreated;	EXP055035	2218	normal	P49336	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS051672
EXP055053	CDK8	Homo sapiens	Treatment: untreated;	EXP055036	641	normal	P49336	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051673
EXP055054	CDK8	Homo sapiens	Treatment: untreated;	EXP055037	514	normal	P49336	K562 (myelogenous leukemia)	PEAKS051674
EXP055055	CDK8	Homo sapiens	Treatment: DMSO;	EXP055038	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	PEAKS051675
EXP055056	CDK8	Homo sapiens	Treatment: DMSO;	EXP055039	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	PEAKS051676
EXP055057	CDK8	Homo sapiens	Treament: iBET151_500;	EXP055040	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	PEAKS051677
EXP055058	CDK8	Homo sapiens	Treament: iBET151_500;	EXP055041	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	PEAKS051678
EXP055059	BRD4	Homo sapiens	Treatment: DMSO;	EXP055042	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	PEAKS051679
EXP055060	BRD4	Homo sapiens	Treatment: DMSO;	EXP055043	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	PEAKS051680
EXP055061	BRD4	Homo sapiens	Treament: iBET151_500;	EXP055044	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	PEAKS051681
EXP055062	BRD4	Homo sapiens	Treament: iBET151_500;	EXP055045	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	PEAKS051682
EXP055067	pEGFR (Cell Signaling, D63B4)	Homo sapiens	Treatment: none (control); Genotype: phosphoEGFR (Tyr845);	EXP055065	423	normal	P00533	HeLa S3 (cervical adenocarcinoma)	PEAKS051683
EXP055068	pEGFR (Cell Signaling, D63B4)	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoEGFR (Tyr845);	EXP055066	423	normal	P00533	HeLa S3 (cervical adenocarcinoma)	PEAKS051684
EXP055069	pErk1/2 (Cell Signaling, 4370P)	Homo sapiens	Treatment: none (control); Genotype: phosphoErk1/2 (Thr202/Tyr204);	EXP055065	423	normal	P27361	HeLa S3 (cervical adenocarcinoma)	PEAKS051685
EXP055070	pErk1/2 (Cell Signaling, 4370P)	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoErk1/2 (Thr202/Tyr204);	EXP055066	423	normal	P27361	HeLa S3 (cervical adenocarcinoma)	PEAKS051686
EXP055071	Mek1/2 (Cell Signaling, 9121S)	Homo sapiens	Treatment: none (control); Genotype: phosphoMek1/2 (Ser217/221);	EXP055065	423	normal	Q02750	HeLa S3 (cervical adenocarcinoma)	PEAKS051687
EXP055072	Mek1/2 (Cell Signaling, 9121S)	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoMek1/2 (Ser217/221);	EXP055066	423	normal	Q02750	HeLa S3 (cervical adenocarcinoma)	PEAKS051688
EXP055076	CENP-A (Santa Cruz, sc-22787 & sc-11277)	Homo sapiens		EXP055073	821	normal	P49450	SW480 (colon adenocarcinoma)	PEAKS051689
EXP055077	CENP-A (Santa Cruz, sc-22787 & sc-11277)	Homo sapiens		NULL	2688	normal	P49450	HcoEpiC (Human normal colon cell line)	PEAKS051690
EXP055078	CENP-A (Santa Cruz, sc-22787 & sc-11277)	Homo sapiens		EXP055074	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS051691
EXP055079	HJURP (Bethyl, A302-822A)	Homo sapiens		EXP055073	821	normal	Q8NCD3	SW480 (colon adenocarcinoma)	PEAKS051692
EXP055080	HJURP (Bethyl, A302-822A)	Homo sapiens		EXP055074	78	normal	Q8NCD3	HeLa (cervical adenocarcinoma)	PEAKS051693
EXP055081	CNOT3 (Novus Biologicals, catalog# H00004849_M01, lot# A1171-4B8)	Homo sapiens		NULL	417	normal	O75175	HCT-116 (colon carcinoma)	PEAKS051694
EXP055082	CNOT3 (Novus Biologicals, catalog# H00004849_M01, lot# A1171-4B8)	Homo sapiens		NULL	2689	normal	O75175	primary colorectal carcinoma	PEAKS051695
EXP055085	LSD1	Homo sapiens	Treatment: DMSO;	EXP055083	2690	normal	O60341	NCI-H526 (Small cell lung carcinoma)	PEAKS051696
EXP055086	LSD1	Homo sapiens	Treatment: 1 uM GSK2879552 for 24 hours;	EXP055084	2690	normal	O60341	NCI-H526 (Small cell lung carcinoma)	PEAKS051697
EXP055089	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: control, non heat shock (37 degree C); Time point: 30 min	EXP055087	514	normal	P61956	K562 (myelogenous leukemia)	PEAKS051698
EXP055090	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: heat shock (30min at 43 degree C); Time point: 30 min	EXP055088	514	normal	P61956	K562 (myelogenous leukemia)	PEAKS051699
EXP055091	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against HSF1, non heat shock (37 degree C); Time point: 30 min; Genotype: HSF1 knockdown	NULL	514	normal	P61956	K562 (myelogenous leukemia)	PEAKS051700
EXP055092	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against HSF1, heat shock (30min at 43 degree C); Time point: 30 min; Genotype: HSF1 knockdown	EXP055088	514	normal	P61956	K562 (myelogenous leukemia)	PEAKS051701
EXP055093	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against SCR, non heat shock (37 degree C); Time point: 30 min	EXP055087	514	normal	P61956	K562 (myelogenous leukemia)	PEAKS051702
EXP055094	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against SCR, heat shock (30min at 43 degree C); Time point: 30 min	EXP055088	514	normal	P61956	K562 (myelogenous leukemia)	PEAKS051703
EXP055095	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: heat shock (30min at 43 degree C);; Time point: 30 min	NULL	71	normal	P61956	VCaP (prostate carcinoma)	PEAKS051704
EXP055096	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: heat shock and recovery (30min at 43 degree C followed by 1h at 37 degree C); Time point: 90 min	NULL	71	normal	P61956	VCaP (prostate carcinoma)	PEAKS051705
EXP055097	anti-PIAS1 (Abcam, catalog ab77231, lot YI122105C)	Homo sapiens	Treatment: heat shock (30min at 43 degree C); Time point: 30 min	NULL	71	normal	O75925	VCaP (prostate carcinoma)	PEAKS051706
EXP055098	anti-PIAS1 (Abcam, catalog ab77231, lot YI122105C)	Homo sapiens	Treatment: heat shock and recovery (30min at 43 degree C followed by 1h at 37 degree C); Time point: 90 min	NULL	71	normal	O75925	VCaP (prostate carcinoma)	PEAKS051707
EXP055099	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: control siRNA, non heat shock (37 degree C); Time point: 30 min	NULL	71	normal	P11226	VCaP (prostate carcinoma)	PEAKS051708
EXP055100	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: control siRNA, heat shock (30min at 43 degree C); Time point: 30 min	NULL	71	normal	P11226	VCaP (prostate carcinoma)	PEAKS051709
EXP055101	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: siRNA against PIAS1, non heat shock (37 degree C); Time point: 30 min; Genotype: PIAS1 knockdown	NULL	71	normal	P11226	VCaP (prostate carcinoma)	PEAKS051710
EXP055102	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: siRNA against PIAS1, heat shock (30min at 43 degree C); Time point: 30 min; Genotype: PIAS1 knockdown	NULL	71	normal	P11226	VCaP (prostate carcinoma)	PEAKS051711
EXP055103	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: 3 hours of 1uM Triptolide; Time point: 3 hours	NULL	71	normal	P61956	VCaP (prostate carcinoma)	PEAKS051712
EXP055104	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: 3 hours of 100uM DBR (5,6-Dichlorobenzimidazole 1-beta-D-ribofuranoside); Time point: 3 hours	NULL	71	normal	P61956	VCaP (prostate carcinoma)	PEAKS051713
EXP055107	Anti-Top2Beta (made in-house)	Homo sapiens	Treatment: untreated control;	EXP055105	113	normal	Q6LC06	MCF7 (Invasive ductal breast carcinoma)	PEAKS051714
EXP055108	Anti-Top2Beta (made in-house)	Homo sapiens	Treatment: 10 nM Estradiol for 30 mins; 	EXP055106	113	normal	Q6LC06	MCF7 (Invasive ductal breast carcinoma)	PEAKS051715
EXP055115	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: DMSO for 48 hrs;	EXP055109	10	normal	Q96KQ7	HEK293T (embryonic kidney)	PEAKS051716
EXP055116	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: DMSO for 96 hrs;	NULL	10	normal	Q96KQ7	HEK293T (embryonic kidney)	PEAKS051717
EXP055117	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: UNC0638 for 48 hrs;	EXP055111	10	normal	Q96KQ7	HEK293T (embryonic kidney)	PEAKS051718
EXP055118	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: UNC0638 for 96 hrs;	EXP055112	10	normal	Q96KQ7	HEK293T (embryonic kidney)	PEAKS051719
EXP055119	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: NS;	EXP055113	10	normal	Q96KQ7	HEK293T (embryonic kidney)	PEAKS051720
EXP055120	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: siWIZ;	EXP055114	10	normal	Q96KQ7	HEK293T (embryonic kidney)	PEAKS051721
EXP055127	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: wildtype MEF2B-V5;	EXP055121	2691	normal	Q02080	HEK293-A	PEAKS051722
EXP055128	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: wildtype MEF2B-V5;	EXP055122	2691	normal	Q02080	HEK293-A	PEAKS051723
EXP055129	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: K4E-MEF2B-V5;	EXP055123	2691	normal	Q02080	HEK293-A	PEAKS051724
EXP055130	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: K4E-MEF2B-V5;	EXP055124	2691	normal	Q02080	HEK293-A	PEAKS051725
EXP055131	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: D83V-MEF2B-V5;	EXP055125	2691	normal	Q02080	HEK293-A	PEAKS051726
EXP055132	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: D83V-MEF2B-V5;	EXP055126	2691	normal	Q02080	HEK293-A	PEAKS051727
EXP055135	anti-CDK9 (Santa Cruz)	Homo sapiens	Treatment: DMSO;	EXP055133	36	normal	P50750	A375 (malignant melanoma)	PEAKS051728
EXP055136	anti-CDK9 (Santa Cruz)	Homo sapiens	Treatment: 25 uM A771726;	EXP055134	36	normal	P50750	A375 (malignant melanoma)	PEAKS051729
EXP055137	anti-HEXIM1 (Abcam)	Homo sapiens	Treatment: DMSO;	EXP055133	36	normal	O94992	A375 (malignant melanoma)	PEAKS051730
EXP055138	anti-HEXIM1 (Abcam)	Homo sapiens	Treatment: 25 uM A771726;	EXP055134	36	normal	O94992	A375 (malignant melanoma)	PEAKS051731
EXP055140	anti-AF9 (NOVUS, NB100-1566)	Homo sapiens	Developmental stage: Day 12 ; 	EXP055139	2692	normal	P42568	differentiated NPC cells	PEAKS051732
EXP055141	anti-TET2 (Abiocode, R-1086)	Homo sapiens	Developmental stage: Day 12 ; 	EXP055139	2692	normal	Q6N021	differentiated NPC cells	PEAKS051733
EXP055143	MED1 (Bethyl, catalog# A300-793A, lot# A300-793A)	Homo sapiens	Treatment: siRNA control; 	NULL	454	bio_control	O95243	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS051734
EXP055144	MED1 (Bethyl, catalog# A300-793A, lot# A300-793A)	Homo sapiens	Treatment: siYAP/TAZ; 	EXP055142	454	normal	O95243	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS051735
EXP055145	SMC1 (Bethyl, catalog# A300-005A, lot# A300-055A-3)	Homo sapiens	Treatment: siRNA control; 	EXP055142	454	bio_control	Q14683	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS051736
EXP055146	SMC1 (Bethyl, catalog# A300-005A, lot# A300-055A-3)	Homo sapiens	Treatment: siYAP/TAZ; 	EXP055142	454	normal	Q14683	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS051737
EXP055147	CDK9 (Santa Cruz, catalog# sc-484, lot# I0414)	Homo sapiens	Treatment: siRNA control; 	EXP055142	454	bio_control	P50750	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS051738
EXP055148	CDK9 (Santa Cruz, catalog# sc-484, lot# I0414)	Homo sapiens	Treatment: siYAP/TAZ; 	EXP055142	454	normal	P50750	HuCCT1 (intrahepatic cholangiocarcinoma)	PEAKS051739
EXP055151	anti-DAXX (sc-7001)	Homo sapiens	Genotype: wildtype; 	EXP055149	725	normal	Q9UER7	PC3(bone mets prostate adenocarcinoma)	PEAKS051740
EXP055152	anti-DAXX (sc-7001)	Homo sapiens	Genotype: DAXX knockdown; 	EXP055150	725	normal	Q9UER7	PC3(bone mets prostate adenocarcinoma)	PEAKS051741
EXP055153	anti-DNMT1 (sc-10219)	Homo sapiens	Genotype: wildtype; 	EXP055149	725	normal	P26358	PC3(bone mets prostate adenocarcinoma)	PEAKS051742
EXP055154	anti-DNMT1 (sc-10219)	Homo sapiens	Genotype: DAXX knockdown; 	NULL	725	normal	P26358	PC3(bone mets prostate adenocarcinoma)	PEAKS051743
EXP055156	anti-WRN antibody	Homo sapiens		EXP055155	421	normal	Q14191	HEK293 (embryonic kidney)	PEAKS051744
EXP055159	AGO2 (Millipore 04-642)	Homo sapiens	Treatment: untreated;	EXP055158	514	normal	Q9UKV8	K562 (myelogenous leukemia)	PEAKS051745
EXP055160	AGO2 (Abcam, ab57113)	Homo sapiens	Treatment: untreated;	EXP055158	514	normal	Q9UKV8	K562 (myelogenous leukemia)	PEAKS051746
EXP055165	E2F1 (sc-193, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q01094	hTERT-RPE1	PEAKS051747
EXP055166	CASP8AP2 (sc-9088, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q9UKL3	hTERT-RPE1	PEAKS051748
EXP055167	NPAT (sc-67007, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q14207	hTERT-RPE1	PEAKS051749
EXP055168	HINFP (sc-49818, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q9BQA5	hTERT-RPE1	PEAKS051750
EXP055169	E2F1 (sc-193, Santa Cruz Biotechnology)	Homo sapiens		EXP055164	848	normal	Q01094	U2OS (osteosarcoma)	PEAKS051751
EXP055170	CASP8AP2 (sc-9088, Santa Cruz Biotechnology)	Homo sapiens		NULL	848	normal	Q9UKL3	U2OS (osteosarcoma)	PEAKS051752
EXP055171	NPAT (sc-67007, Santa Cruz Biotechnology)	Homo sapiens		EXP055164	848	normal	Q14207	U2OS (osteosarcoma)	PEAKS051753
EXP055172	HINFP (sc-49818, Santa Cruz Biotechnology)	Homo sapiens		EXP055164	848	normal	Q9BQA5	U2OS (osteosarcoma)	PEAKS051754
EXP055176	TRIM24 (Bethyl, A300-815A)	Homo sapiens	Treatment: vehicle (ETOH) for 4 hrs;	EXP055173	70	normal	O15164	LNCaP (prostate carcinoma)	PEAKS051755
EXP055177	TRIM24 (Bethyl, A300-815A)	Homo sapiens	Treatment: 10nM DHT for 4 hrs;	EXP055174	70	normal	O15164	LNCaP (prostate carcinoma)	PEAKS051756
EXP055178	TRIM24 (Bethyl, A300-815A)	Homo sapiens	Treatment: vehicle (ETOH) for 4 hrs;	EXP055175	2310	normal	O15164	LNCaP-abl (Prostate carcinoma)	PEAKS051757
EXP055179	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: cR1; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051758
EXP055180	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: cR2; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051759
EXP055181	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: cR2; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051760
EXP055182	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: Db; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051761
EXP055183	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R1b knockout; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051762
EXP055184	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R2b knockout; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051763
EXP055185	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: wildtype; Sex: female;	NULL	44	normal	P15919	T-cells	PEAKS051764
EXP055186	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: Db; Sex: female;	NULL	44	normal	P21784	T-cells	PEAKS051765
EXP055187	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: wildtype; Sex: female;	NULL	44	normal	P21784	T-cells	PEAKS051766
EXP055188	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: cR1; Sex: female;	NULL	44	normal	P21784	T-cells	PEAKS051767
EXP055189	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: cR2; Sex: female;	NULL	44	normal	P21784	T-cells	PEAKS051768
EXP055190	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R1b knockout; Sex: female;	NULL	44	normal	P21784	T-cells	PEAKS051769
EXP055191	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R2b knockout; Sex: female;	NULL	44	normal	P21784	T-cells	PEAKS051770
EXP055192	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: Db; Sex: female;	NULL	2695	normal	P15919	CD19+ bone marrow cell	PEAKS051771
EXP055193	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: R1b kncokout; Sex: pooled male and female;	NULL	2695	normal	P15919	CD19+ bone marrow cell	PEAKS051772
EXP055194	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: R1b kncokout; Sex: pooled male and female;	NULL	2695	normal	P15919	CD19+ bone marrow cell	PEAKS051773
EXP055195	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: BD; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	PEAKS051774
EXP055196	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: R2b kncokout; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	PEAKS051775
EXP055197	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: wildtype; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	PEAKS051776
EXP055198	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: BD; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	PEAKS051777
EXP055199	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: V-ABL; Sex: pooled male and female;	NULL	2425	normal	P15919	a pool of both sham and transverse aortic constriction	PEAKS051778
EXP055200	RAG1	Homo sapiens	Age: Mixture: 4 months or 1.5 years;	NULL	882	normal	P15918	T-cells	PEAKS051779
EXP055201	RAG2	Homo sapiens	Age: 4 months;	NULL	882	normal	P55895	T-cells	PEAKS051780
EXP055202	RAG1	Homo sapiens	Age: 4 months or 1.5 years; 	NULL	882	normal	P15918	T-cells	PEAKS051781
EXP055204	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q05BQ5	K562 (myelogenous leukemia)	PEAKS051782
EXP055205	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q9H2F5	K562 (myelogenous leukemia)	PEAKS051783
EXP055206	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q92993	K562 (myelogenous leukemia)	PEAKS051784
EXP055207	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q9H2F5	K562 (myelogenous leukemia)	PEAKS051785
EXP055210	anti-V5 antibody (Cat# R960CUS, Life Technologies)	Homo sapiens		EXP055208	421	normal	P57682	HEK293 (embryonic kidney)	PEAKS051786
EXP055211	anti-V5 antibody (Cat# R960CUS, Life Technologies)	Homo sapiens		EXP055209	421	normal	P57682	HEK293 (embryonic kidney)	PEAKS051787
EXP055213	Anti-CENP-A (Abcam anti-CENP-A Ab13939)	Homo sapiens		EXP055212	2634	normal	P49450	HuRef (Lymphoblast)	PEAKS051788
EXP055214	Anti-CENP-T (Abcam cat #Ab114120)	Homo sapiens		EXP055212	2634	normal	Q96BT3	HuRef (Lymphoblast)	PEAKS051789
EXP055217	SMAR1/BANP (Bethyl Laboratories, A300-279A)	Homo sapiens	Genotype: wildtype; 	EXP055215	417	normal	Q8N9N5	HCT-116 (colon carcinoma)	PEAKS051790
EXP055218	SMAR1/BANP (Bethyl Laboratories, A300-279A)	Homo sapiens	Genotype: p53 knockout; 	EXP055216	417	normal	Q8N9N5	HCT-116 (colon carcinoma)	PEAKS051791
EXP055219	ORC2 antibody (Santa Cruz, sc-28742)	Homo sapiens		NULL	514	normal	Q13416	K562 (myelogenous leukemia)	PEAKS051792
EXP055222	LMTK3 (monoclonal antibody (M02), clone 2H6, Abnova, H00114783-M02)	Homo sapiens		EXP055220	113	normal	Q96Q04	MCF7 (Invasive ductal breast carcinoma)	PEAKS051793
EXP055223	LMTK3 (monoclonal antibody (M02), clone 2H6, Abnova, H00114783-M02)	Homo sapiens		EXP055221	2301	normal	Q96Q04	MDA-MB-231 (breast adenocarcinoma)	PEAKS051794
EXP055229	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055224	514	normal	Q8NHM5	K562 (myelogenous leukemia)	PEAKS051795
EXP055230	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055225	1205	normal	Q8NHM5	Reh (ATCC CRL-8286)	PEAKS051796
EXP055231	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055226	2525	normal	Q8NHM5	SUP-B15 (Childhood B acute lymphoblastic leukemia)	PEAKS051797
EXP055232	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		NULL	220	normal	Q8NHM5	DND41 (acute lymphoblastic leukemia)	PEAKS051798
EXP055233	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055227	444	normal	Q8NHM5	HPB-ALL (T acute lymphoblastic leukemia)	PEAKS051799
EXP055234	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		NULL	509	normal	Q8NHM5	Jurkat (T-cells)	PEAKS051800
EXP055235	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055228	61	normal	Q8NHM5	ALL-SIL (acute lymphoblastic leukemia)	PEAKS051801
EXP055250	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: none;	EXP055236	2696	normal	O60885	TC-797	PEAKS051802
EXP055251	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: none;	EXP055237	2696	normal	O60885	TC-797	PEAKS051803
EXP055252	BRD4 long form (anti-BRD4-L, against long isoforms of BRD4, Active Motif, catalog no. 39909)	Homo sapiens	Treatment: none;	EXP055236	2696	normal	O15534	TC-797	PEAKS051804
EXP055253	BRD4 long form (anti-BRD4-L, against long isoforms of BRD4, Active Motif, catalog no. 39909)	Homo sapiens	Treatment: none;	EXP055237	2696	normal	O60885	TC-797	PEAKS051805
EXP055254	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055236	2696	normal	O60885	TC-797	PEAKS051806
EXP055255	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055237	2696	normal	O60885	TC-797	PEAKS051807
EXP055256	anti-P300 (10 ul, Bethyl, catalog no. A300-358A)	Homo sapiens	Treatment: none;	EXP055238	2696	normal	Q09472	TC-797	PEAKS051808
EXP055257	anti-P300 (10 ul, Bethyl, catalog no. A300-358A)	Homo sapiens	Treatment: none;	EXP055239	2696	normal	Q09472	TC-797	PEAKS051809
EXP055258	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055240	2696	normal	O60885	TC-797	PEAKS051810
EXP055259	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055241	2697	normal	O60885	1015 (MNC, Grayson et al. 2014)	PEAKS051811
EXP055260	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055242	2697	normal	O60885	1015 (MNC, Grayson et al. 2014)	PEAKS051812
EXP055261	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055243	2698	normal	O60885	PER-403 (Kees et al. 1991)	PEAKS051813
EXP055262	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055244	2699	normal	O60885	10326 (NMC, French et al. 2008)	PEAKS051814
EXP055263	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: 4hr  JQ1 (final concentration of 500 nM);	EXP055245	2696	normal	O60885	TC-797	PEAKS051815
EXP055264	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: 4hr  JQ1 (final concentration of 500 nM);	EXP055245	2696	normal	O60885	TC-797	PEAKS051816
EXP055265	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: No Tetracycline was added to the media;	EXP055246	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051817
EXP055266	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: No Tetracycline was added to the media;	EXP055246	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051818
EXP055267	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	2h -incubation time period with Tetracycline (final concentration of 1ug/ml).	EXP055247	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051819
EXP055268	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	2h -incubation time period with Tetracycline (final concentration of 1ug/ml).	EXP055247	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051820
EXP055269	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: 7hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055248	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051821
EXP055270	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: 7hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055248	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051822
EXP055271	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: 3hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055249	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051823
EXP055272	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: 3hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055249	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	PEAKS051824
EXP055281	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055273	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	PEAKS051825
EXP055282	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: Doxycycline induced SMARCA4 reexpresion;	EXP055273	937	normal	P51532	G401 (rhabdoid tumor of the kidney)	PEAKS051826
EXP055283	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: untreated;	EXP055274	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	PEAKS051827
EXP055284	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: untreated;	EXP055274	937	normal	P51532	G401 (rhabdoid tumor of the kidney)	PEAKS051828
EXP055285	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: untreated;	EXP055275	2700	normal	Q92922	BT-16 (atypical teratoid/rhabdoid tumor)	PEAKS051829
EXP055286	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: untreated;	EXP055275	2700	normal	P51532	BT-16 (atypical teratoid/rhabdoid tumor)	PEAKS051830
EXP055287	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055276	2700	normal	Q92922	BT-16 (atypical teratoid/rhabdoid tumor)	PEAKS051831
EXP055288	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055276	2700	normal	P51532	BT-16 (atypical teratoid/rhabdoid tumor)	PEAKS051832
EXP055289	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: untreated;	EXP055279	2701	normal	Q92922	TTC-549 (extrarenal rhabdoid tumor)	PEAKS051833
EXP055290	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: untreated;	EXP055279	2701	normal	P51532	TTC-549 (extrarenal rhabdoid tumor)	PEAKS051834
EXP055291	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055280	2701	normal	Q92922	TTC-549 (extrarenal rhabdoid tumor)	PEAKS051835
EXP055292	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: Doxycycline induced SMARCA4 reexpresion;	EXP055280	2701	normal	P51532	TTC-549 (extrarenal rhabdoid tumor)	PEAKS051836
EXP055295	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Genotype: Parental;	EXP055293	417	normal	P51532	HCT-116 (colon carcinoma)	PEAKS051837
EXP055296	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Genotype: Parental;	EXP055293	417	normal	Q92922	HCT-116 (colon carcinoma)	PEAKS051838
EXP055297	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Genotype: Homozygous ARID1A-knockout;	EXP055294	417	normal	P51532	HCT-116 (colon carcinoma)	PEAKS051839
EXP055298	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Genotype: Homozygous ARID1A-knockout;	EXP055294	417	normal	Q92922	HCT-116 (colon carcinoma)	PEAKS051840
EXP055300	anti-Flag (Sigma, catalog# F1804, lot# SLBF6631)	Homo sapiens	Genotype: transiently expressing Flag-Za;	EXP055299	78	normal	Q9UM89	HeLa (cervical adenocarcinoma)	PEAKS051841
EXP055307	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: DMSO for 4 days;	EXP055301	796	normal	O60341	SKNO-1 (acute myeloid leukemia)	PEAKS051842
EXP055308	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM RN-1 for 4 days; 	EXP055302	796	normal	O60341	SKNO-1 (acute myeloid leukemia)	PEAKS051843
EXP055309	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM GSK690 for 4 days;	EXP055303	796	normal	O60341	SKNO-1 (acute myeloid leukemia)	PEAKS051844
EXP055310	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: DMSO for 72 hrs;	EXP055304	516	normal	O60341	Kasumi-1 (acute myeloblastic leukemia)	PEAKS051845
EXP055311	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM RN-1 for 72 hrs; 	EXP055305	516	normal	O60341	Kasumi-1 (acute myeloblastic leukemia)	PEAKS051846
EXP055312	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM GSK690 for 72 hrs;	EXP055306	516	normal	O60341	Kasumi-1 (acute myeloblastic leukemia)	PEAKS051847
EXP055314	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 0.1% DMSO;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051848
EXP055315	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 500nM I-BET151;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051849
EXP055316	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 5uM SGC0946;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051850
EXP055317	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 500nM I-BET151 and 5uM SGC0946;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051851
EXP055318	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 0.1% DMSO;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051852
EXP055319	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 5uM SGC0946 for 8hrs;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051853
EXP055320	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 5uM SGC0946 for 8 hrs and washout;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS051854
EXP055323	KDM3B (Millipore, 09-816)	Homo sapiens	Treatment: siRNA control;	EXP055321	417	normal	Q7LBC6	HCT-116 (colon carcinoma)	PEAKS051855
EXP055324	KDM3B (Millipore, 09-816)	Homo sapiens	Treatment: siRNA treatment; Genotype: KDM3B knockout; 	EXP055322	417	normal	Q7LBC6	HCT-116 (colon carcinoma)	PEAKS051856
EXP055328	anti-P300 (Santa Cruz, sc-585X)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP055326	2702	normal	Q09472	LP-1 (plasma cell myeloma)	PEAKS051857
EXP055329	anti-P300 (Santa Cruz, sc-585X)	Homo sapiens	Treatment: 2.5 uM SGC-CBP30;	EXP055325	2702	normal	Q09472	LP-1 (plasma cell myeloma)	PEAKS051858
EXP055330	anti-BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP055326	2702	normal	O60885	LP-1 (plasma cell myeloma)	PEAKS051859
EXP055331	anti-BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.25 uM CPI267203;	EXP055327	2702	normal	O60885	LP-1 (plasma cell myeloma)	PEAKS051860
EXP055332	anti-P300 (Santa Cruz, sc-585X)	Homo sapiens	Treatment: 0.25 uM CPI267203;	EXP055327	2702	normal	Q09472	LP-1 (plasma cell myeloma)	PEAKS051861
EXP055333	anti-BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 2.5 uM SGC-CBP30;	EXP055325	2702	normal	O60885	LP-1 (plasma cell myeloma)	PEAKS051862
EXP055334	CDK12 (Greenleaf Lab)	Homo sapiens	Treatment: 0.1% DMSO for 6 hrs;	NULL	509	normal	Q9NYV4	Jurkat (T-cells)	PEAKS051863
EXP055336	KAP1 (Abcam; ab22553)	Homo sapiens		EXP055335	417	normal	Q13263	HCT-116 (colon carcinoma)	PEAKS051864
EXP055337	Larp7 (Sigma; av40847)	Homo sapiens		EXP055335	417	normal	Q4G0J3	HCT-116 (colon carcinoma)	PEAKS051865
EXP055338	Hexim1 (Abcam; ab25388)	Homo sapiens		EXP055335	417	normal	O94992	HCT-116 (colon carcinoma)	PEAKS051866
EXP055339	Cdk9 (C-20) (SCBT; sc-484)	Homo sapiens		EXP055335	417	normal	P50750	HCT-116 (colon carcinoma)	PEAKS051867
EXP055340	anti-Xrn2 (aa402-537, affinity pure Brannan et al Mol Cell 46, 311-324, 2012 )	Homo sapiens	Source: HEK293 Flp-in T-REx pcDNA5 HA-Xrn2 WT;	NULL	421	normal	Q9H0D6	HEK293 (embryonic kidney)	PEAKS051868
EXP055341	anti-BRD4 (N-terminal antibody kindly provided by Prof. Cheng Ming Chiang)	Homo sapiens	Passage: 5; 	NULL	583	normal	O60885	MCF10A (breast epithelial cells)	PEAKS051869
EXP055346	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055342	2703	normal	P23769	TF-1 (erythroleukemia)	PEAKS051870
EXP055347	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055343	2703	normal	P23769	TF-1 (erythroleukemia)	PEAKS051871
EXP055348	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055344	2703	normal	P23769	TF-1 (erythroleukemia)	PEAKS051872
EXP055349	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055345	2703	normal	P23769	TF-1 (erythroleukemia)	PEAKS051873
EXP055350	RUNX1 (Clone: sc-365644, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055342	2703	normal	Q01196	TF-1 (erythroleukemia)	PEAKS051874
EXP055351	RUNX1 (Clone: sc-365644, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055343	2703	normal	Q01196	TF-1 (erythroleukemia)	PEAKS051875
EXP055352	RUNX1 (Clone: sc-365644, Santa Cruz Biotechnology)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055344	2703	normal	Q01196	TF-1 (erythroleukemia)	PEAKS051876
EXP055353	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055342	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	PEAKS051877
EXP055354	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055343	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	PEAKS051878
EXP055355	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055344	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	PEAKS051879
EXP055356	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055345	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	PEAKS051880
EXP055365	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055357	417	normal	O60885	HCT-116 (colon carcinoma)	PEAKS051881
EXP055366	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055358	452	normal	O60885	HT29 (colon adenocarcinoma)	PEAKS051882
EXP055367	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055359	2704	normal	O60885	COLO 205 (colon adenocarcinoma)	PEAKS051883
EXP055368	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055360	418	normal	O60885	HCT-15 (colon carcinoma)	PEAKS051884
EXP055369	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055361	821	normal	O60885	SW480 (colon adenocarcinoma)	PEAKS051885
EXP055370	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055362	185	normal	O60885	COLO-320 (colon adenocarcinoma)	PEAKS051886
EXP055371	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055363	557	normal	O60885	LS180 (colon cancer)	PEAKS051887
EXP055372	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055364	2705	normal	O60885	COLO 741 (melanoma)	PEAKS051888
EXP055374	SMN (Santa Cruz pAb Cat # H-195)	Homo sapiens		NULL	421	normal	Q16637	HEK293 (embryonic kidney)	PEAKS051889
EXP055375	GFP (Abcam pAb Cat# 290)	Homo sapiens		NULL	421	normal	Q16637	HEK293 (embryonic kidney)	PEAKS051890
EXP055377	FUS (sc-47711, Santa Cruz)	Homo sapiens		EXP055376	421	normal	P35637	HEK293 (embryonic kidney)	PEAKS051891
EXP055378	EWS (sc-48404, Santa Cruz)	Homo sapiens		EXP055376	421	normal	Q01844	HEK293 (embryonic kidney)	PEAKS051892
EXP055379	TAF15	Homo sapiens		EXP055376	421	normal	Q16514	HEK293 (embryonic kidney)	PEAKS051893
EXP055384	anti-EP400 (Abcam, ab70301)	Homo sapiens		EXP055380	848	normal	Q96L91	U2OS (osteosarcoma)	PEAKS051894
EXP055385	anti-EP400 (Abcam, ab70301)	Homo sapiens		EXP055381	848	normal	Q96L91	U2OS (osteosarcoma)	PEAKS051895
EXP055386	anti-EP400 (Abcam, ab70301)	Homo sapiens		EXP055382	848	normal	Q96L91	U2OS (osteosarcoma)	PEAKS051896
EXP055387	anti-MED26 (Santa Cruz Biotechnology, sc-48776)	Homo sapiens	TReatment: mock siRNA (GFP) for 72 hr;	EXP055383	848	bio_control	O95402	U2OS (osteosarcoma)	PEAKS051897
EXP055388	anti-MED26 (Santa Cruz Biotechnology, sc-48776)	Homo sapiens	Treatment: siEP400 for 72 hrs; Genotype: EP400 knockout;	EXP055383	848	normal	O95402	U2OS (osteosarcoma)	PEAKS051898
EXP055393	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055389	767	normal	Q99848	Raji (Burkitt lymphoma)	PEAKS051899
EXP055394	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055390	640	normal	Q99848	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS051900
EXP055395	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055391	2287	normal	Q99848	LCL (lymphoblastoid cell line)	PEAKS051901
EXP055396	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055392	2706	normal	Q99848	C666-1 (nasopharyngeal carcinoma)	PEAKS051902
EXP055403	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: proliferating;	EXP055397	489	normal	O60885	IMR90 (lung fibroblasts)	PEAKS051903
EXP055404	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: quiescent;	EXP055398	489	normal	O60885	IMR90 (lung fibroblasts)	PEAKS051904
EXP055405	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: senescent;	EXP055399	489	normal	O60885	IMR90 (lung fibroblasts)	PEAKS051905
EXP055406	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: proliferating;	EXP055400	489	normal	O60885	IMR90 (lung fibroblasts)	PEAKS051906
EXP055407	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: quiescent;	EXP055401	489	normal	O60885	IMR90 (lung fibroblasts)	PEAKS051907
EXP055408	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: senescent;	EXP055402	489	normal	O60885	IMR90 (lung fibroblasts)	PEAKS051908
EXP055412	anti-p300 antibody (Abcam #54984)	Homo sapiens	Treatment: none;	EXP055409	725	normal	Q09472	PC3(bone mets prostate adenocarcinoma)	PEAKS051909
EXP055413	anti-p300 antibody (Abcam #54984)	Homo sapiens	Treatment: none;	EXP055410	725	normal	Q09472	PC3(bone mets prostate adenocarcinoma)	PEAKS051910
EXP055414	anti-p300 antibody (Abcam #54984)	Homo sapiens	Treatment: 30 um MnTE-2PyP for 24 hours;	EXP055411	725	normal	Q09472	PC3(bone mets prostate adenocarcinoma)	PEAKS051911
EXP055417	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens	Characteristic: in vivo intrancranial tumor;	EXP055415	2707	normal	Q6NYC1	IN528 (Primary Patient Derived Tumor Model)	PEAKS051912
EXP055418	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens	Characteristic: serum free cell culture;	EXP055416	2707	normal	Q6NYC1	IN528 (Primary Patient Derived Tumor Model)	PEAKS051913
EXP055419	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens		NULL	2708	normal	Q6NYC1	3565 (Primary Patient Derived Tumor Model)	PEAKS051914
EXP055420	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens	Characteristic: cells were collected;	NULL	2708	normal	Q6NYC1	3565 (Primary Patient Derived Tumor Model)	PEAKS051915
EXP055426	RBPJ (Abcam, ab25949, lot GR169397-1)	Homo sapiens	Treatment: chronic 1 uM dasatinib;	EXP055421	2350	normal	Q06330	LAL-B (All-B patient-derived cell line)	PEAKS051916
EXP055427	RBPJ (Abcam, ab25949, lot GR169397-1)	Homo sapiens	Treatment: 12 day 1 uM dasatinib;	EXP055423	2350	normal	Q06330	LAL-B (All-B patient-derived cell line)	PEAKS051917
EXP055428	RBPJ (Abcam, ab25949, lot GR169397-1)	Homo sapiens	Treatment: none;	EXP055424	2350	normal	Q06330	LAL-B (All-B patient-derived cell line)	PEAKS051918
EXP055429	cleaved Notch1 (Val1744) (CST, 4147, lot 4)	Homo sapiens	Treatment: chronic 1 uM dasatinib;	EXP055421	2350	normal	P46531	LAL-B (All-B patient-derived cell line)	PEAKS051919
EXP055430	cleaved Notch1 (Val1744) (CST, 4147, lot 4)	Homo sapiens	Treatment: 12 day 1 uM dasatinib;	EXP055423	2350	normal	P46531	LAL-B (All-B patient-derived cell line)	PEAKS051920
EXP055431	cleaved Notch1 (Val1744) (CST, 4147, lot 4)	Homo sapiens	Treatment: none;	EXP055424	2350	normal	P46531	LAL-B (All-B patient-derived cell line)	PEAKS051921
EXP055435	PHF2 Antibody (Cell Signaling Technology, Catalog #3497, Lot#2)	Homo sapiens		EXP055433	2709	normal	O75151	NAMEC8 (spontaneously immortalized)	PEAKS051922
EXP055436	PHF2 Antibody (Cell Signaling Technology, Catalog #3497, Lot#2)	Homo sapiens	Treatment: treating with cholera toxin every 2 days over a period of 14 days;	EXP055434	2710	normal	O75151	N8-CTx cells derived from NAMEC8	PEAKS051923
EXP055438	anti-HA antibody (Cell Signaling; C29F4)	Homo sapiens	Treatment: HA-Tet2;	EXP055437	10	normal	Q6N021	HEK293T (embryonic kidney)	PEAKS051924
EXP055439	anti-HA antibody (Cell Signaling; C29F4)	Homo sapiens	Treatment: HA-MBD3L2;	EXP055437	10	normal	Q8NHZ7	HEK293T (embryonic kidney)	PEAKS051925
EXP055441	anti-PARP1 antibody (Active Motif; lot# 00909001; catalog# 39561)	Homo sapiens		EXP055440	10	normal	P09874	HEK293T (embryonic kidney)	PEAKS051926
EXP055445	anti-H1T (rabbit polyclonal antibody, prepared in-house)	Homo sapiens		EXP055442	59	normal	P22492	AGS (gastric adenocarcinoma)	PEAKS051927
EXP055446	anti-H1T (rabbit polyclonal antibody, prepared in-house)	Homo sapiens		EXP055443	2301	normal	P22492	MDA-MB-231 (breast adenocarcinoma)	PEAKS051928
EXP055447	anti-H1T (rabbit polyclonal antibody, prepared in-house)	Mus musculus	Strain: 129S4/SvJae;	EXP055444	506	normal	Q07133	J1 (embryonic stem cells)	PEAKS051929
EXP055449	Med12 (A-300-774A)	Homo sapiens	Developmental stage: 6 days expanded;	EXP055448	741	normal	Q93074	CD34+ hematopoietic stem progenitor cells	PEAKS051930
EXP055450	MBD3	Homo sapiens		NULL	2301	normal	O95983	MDA-MB-231 (breast adenocarcinoma)	PEAKS051931
EXP055475	PARP-1	Mus musculus		EXP055451	12	normal	P11103	MEF (mouse embryonic fibroblasts)	PEAKS051932
EXP055476	PARP-1	Mus musculus		EXP055452	12	normal	P11103	MEF (mouse embryonic fibroblasts)	PEAKS051933
EXP055477	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP;	EXP055453	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051934
EXP055478	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP;	EXP055454	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051935
EXP055479	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055455	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051936
EXP055480	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055456	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051937
EXP055481	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, GFP;	EXP055459	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051938
EXP055482	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, GFP;	EXP055460	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051939
EXP055483	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, HDAg-S;	EXP055461	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051940
EXP055484	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, HDAg-S;	EXP055462	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051941
EXP055485	NELFE	Homo sapiens	Genotype: PARP-1 knockdown; Treatment: vehicle, GFP;	EXP055463	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051942
EXP055486	NELFE	Homo sapiens	Genotype: PARP-1 knockdown; Treatment: vehicle, GFP;	EXP055464	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051943
EXP055487	NELFE	Homo sapiens	Genotype: PARP-1 Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055465	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051944
EXP055488	NELFE	Homo sapiens	Genotype: PARP-1 Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055466	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051945
EXP055489	NELFE	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP;	EXP055467	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051946
EXP055490	NELFE	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP;	EXP055468	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	PEAKS051947
EXP055491	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype;	EXP055469	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	PEAKS051948
EXP055492	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype;	EXP055470	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	PEAKS051949
EXP055493	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant;	EXP055471	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	PEAKS051950
EXP055494	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant;	EXP055472	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	PEAKS051951
EXP055496	TRIM28	Homo sapiens	Treatment: Control (none);	EXP055495	113	normal	Q13263	MCF7 (Invasive ductal breast carcinoma)	PEAKS051952
EXP055499	EPOP (Ab1)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	PEAKS051953
EXP055500	EPOP (Ab1)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	PEAKS051954
EXP055501	EPOP (Ab2)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	PEAKS051955
EXP055502	EPOP (Ab2)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	PEAKS051956
EXP055503	EPOP (Ab3, Active Motif #61753)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	PEAKS051957
EXP055504	EPOP (Ab3, Active Motif #61753)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	PEAKS051958
EXP055505	USP7 (Bethyl, A300-033A)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q6A4J8	mESCs (mouse embryonic stem cells)	PEAKS051959
EXP055506	USP7 (Bethyl, A300-033A)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q6A4J8	mESCs (mouse embryonic stem cells)	PEAKS051960
EXP055507	Elongin B (abcam, ab168836)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	P62869	mESCs (mouse embryonic stem cells)	PEAKS051961
EXP055508	Elongin B (abcam, ab168836)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	P62869	mESCs (mouse embryonic stem cells)	PEAKS051962
EXP055509	anti-p300 (Santa Cruz, SC-584)	Homo sapiens	Genotype: parental;	NULL	875	normal	Q09472	ZR-75-30 (invasive ductal carcinoma)	PEAKS051963
EXP055512	RPA2 (Abcam, catalog# ab16850, lot# GR88602-1)	Homo sapiens	Developmental stage: asynchronization;	EXP055510	78	normal	P15927	HeLa (cervical adenocarcinoma)	PEAKS051964
EXP055513	RPA2 (Abcam, catalog# ab16850, lot# GR88602-1)	Homo sapiens	Developmental stage: asynchronization;	EXP055511	78	normal	P15927	HeLa (cervical adenocarcinoma)	PEAKS051965
EXP055514	RPA1 (gifted by Dr. Bruce Stillman)	Homo sapiens	Developmental stage: asynchronization;	NULL	78	normal	P27694	HeLa (cervical adenocarcinoma)	PEAKS051966
EXP055516	anti-SRPK1 (Abcam, catalog# ab90527)	Homo sapiens		EXP055515	583	normal	Q96SB4	MCF10A (breast epithelial cells)	PEAKS051967
EXP055517	anti-SRPK2 (Bethyl Labs, catalog# A302-467A)	Homo sapiens		EXP055515	583	normal	P78362	MCF10A (breast epithelial cells)	PEAKS051968
EXP055518	SON antibody (recognizing the N-terminus of SON, amino acids 74-88 of human SON)	Homo sapiens		NULL	514	normal	P18583	K562 (myelogenous leukemia)	PEAKS051969
EXP055519	SON antibody (Abcam, ab121759)	Homo sapiens		NULL	514	normal	P18583	K562 (myelogenous leukemia)	PEAKS051970
EXP055527	TERT	Homo sapiens		EXP055525	33	normal	O14746	A2780 (ovarian carcinoma)	PEAKS051971
EXP055528	TERT	Homo sapiens		EXP055526	417	normal	O14746	HCT-116 (colon carcinoma)	PEAKS051972
EXP055529	TERT	Homo sapiens		EXP055520	2711	normal	O14746	P493 (Lymphoma derived)	PEAKS051973
EXP055530	TERT	Homo sapiens		EXP055521	2712	normal	O14746	hESC-1 (Embryonic stem cells)	PEAKS051974
EXP055531	TERT	Homo sapiens		EXP055522	2713	normal	O14746	hESC-3 (Embryonic stem cells)	PEAKS051975
EXP055532	TERT	Homo sapiens		EXP055523	2714	normal	O14746	BLM (Amelanotic melanoma)	PEAKS051976
EXP055533	TERT	Homo sapiens		EXP055524	2207	normal	O14746	LOXIMVI	PEAKS051977
EXP055535	anti-BRD4 (Bethyl Laboratories, catalog# A301-985A, lot# A301-985A50-4)	Homo sapiens	Treatment: 125 nM DMSO for 40 min; 	EXP055534	699	normal	O60885	OVCAR3 (high grade ovarian serous adenocarcinoma)	PEAKS051978
EXP055536	anti-BRD4 (Bethyl Laboratories, catalog# A301-985A, lot# A301-985A50-4)	Homo sapiens	Treatment: 125 nM JQ1 for 40 min; 	EXP055534	699	normal	O60885	OVCAR3 (high grade ovarian serous adenocarcinoma)	PEAKS051979
EXP055540	SUZ12 (CST, 3737)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	Q15022	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051980
EXP055541	SUZ12 (CST, 3737)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	Q15022	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051981
EXP055542	EZH2 (CST, 5246)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	Q15910	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051982
EXP055543	EZH2 (CST, 5246)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	Q15910	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051983
EXP055544	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	P25440	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051984
EXP055545	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	P25440	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051985
EXP055546	BRD4 (CST, 13440)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	O60885	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051986
EXP055547	BRD4 (CST, 13440)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	O60885	SF8628 (Diffuse intrinsic pontine glioma)	PEAKS051987
EXP055548	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	P25440	SU-DIPG-IV (diffuse intrinsic pontine glioma)	PEAKS051988
EXP055549	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	P25440	SU-DIPG-IV (diffuse intrinsic pontine glioma)	PEAKS051989
EXP055550	SUZ12 (CST, 3737)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	Q15022	SU-DIPG-IV (diffuse intrinsic pontine glioma)	PEAKS051990
EXP055551	EZH2 (CST, 5246)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	Q15910	SU-DIPG-IV (diffuse intrinsic pontine glioma)	PEAKS051991
EXP055554	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: DMSO;	EXP055552	2337	normal	O60885	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS051992
EXP055555	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: JQ1;	EXP055552	2337	normal	O60885	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS051993
EXP055556	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: dBET6;	EXP055552	2337	normal	O60885	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS051994
EXP055557	anti-CDK9 (Santa Cruz, C-20)	Homo sapiens	Treatment: DMSO;	NULL	2337	normal	P50750	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS051995
EXP055558	anti-CDK9 (Santa Cruz, C-20)	Homo sapiens	Treatment: JQ1;	EXP055553	2337	normal	P50750	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS051996
EXP055559	anti-CDK9 (Santa Cruz, C-20)	Homo sapiens	Treatment: dBET6;	EXP055553	2337	normal	P50750	MOLT-4 (Adult T acute lymphoblastic leukemia)	PEAKS051997
EXP055566	Brd9 (ab66443; Abcam)	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	EXP055560	2717	normal	Q3UQU0	RN2 (acute myeloid leukemia)	PEAKS051998
EXP055567	Brg1 (ab110641; Abcam)	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	EXP055560	2717	normal	Q3TKT4	RN2 (acute myeloid leukemia)	PEAKS051999
EXP055568	BRD9 (ab66443; Abcam)	Homo sapiens	Treatment: none; Genotype: MLL-AF9/KrasG13D;	EXP055561	677	normal	Q9H8M2	NOMO-1 (acute monocytic leukemia)	PEAKS052000
EXP055569	BRD9 (A303-781A; Bethyl)	Homo sapiens	Treatment: none; Genotype: MLL-AF9/KrasG13D;	EXP055561	677	normal	Q9H8M2	NOMO-1 (acute monocytic leukemia)	PEAKS052001
EXP055570	FLAG (F1804; Sigma)	Mus musculus	Treatment: DMSO; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	EXP055562	2717	normal	Q3UQU0	RN2 (acute myeloid leukemia)	PEAKS052002
EXP055571	FLAG (F1804; Sigma)	Mus musculus	Treatment: BI-7273; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	EXP055563	2717	normal	Q3UQU0	RN2 (acute myeloid leukemia)	PEAKS052003
EXP055572	Brg1 (ab110641; Abcam)	Mus musculus	Treatment: DMSO; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	EXP055564	2717	normal	Q3TKT4	RN2 (acute myeloid leukemia)	PEAKS052004
EXP055573	Brg1 (ab110641; Abcam)	Mus musculus	Treatment: BI-7273; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	EXP055565	2717	normal	Q3TKT4	RN2 (acute myeloid leukemia)	PEAKS052005
EXP055576	EFP (BD, 610570, lot 5061873)	Homo sapiens		EXP055574	120	normal	Q14258	BT-549 (breast invasive ductal carcinoma)	PEAKS052006
EXP055577	EFP (BD, 610570, lot 5061873)	Homo sapiens		EXP055575	2301	normal	Q14258	MDA-MB-231 (breast adenocarcinoma)	PEAKS052007
EXP055579	INTS12 (Sigma cat. num. HPA03577)	Homo sapiens	Donor: 195307; Passage: 3; Source: Lonza;	EXP055578	2718	normal	Q96CB8	HBEC (Human bronchial epithelial cells)	PEAKS052008
EXP055580	INTS12 (Sigma cat. num. HPA03577)	Homo sapiens	Donor: 7F3158; Passage: 3; Source: Lonza;	EXP055578	2718	normal	Q96CB8	HBEC (Human bronchial epithelial cells)	PEAKS052009
EXP055582	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: Control;	EXP055581	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS052010
EXP055583	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Genotype: ENL knockout; Treatment: CRISPR knockout;	EXP055581	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS052011
EXP055584	anti-Flag M2 (Sigma F3165)	Homo sapiens	genotype: Control (wildtype ENL)	EXP055581	2219	normal	Q03111	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS052012
EXP055585	anti-FLAG (Sigma F1804)	Homo sapiens	control	NULL	641	normal	Q03111	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052013
EXP055588	MCM3 (Bethyl, A300-192A)	Homo sapiens	Developmental stage: arrested in G1/S phase; 	EXP055587	2619	normal	P25205	SV40 (Immortalized Fibroblast)	PEAKS052014
EXP055589	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-{delta}A; 	EXP055586	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	PEAKS052015
EXP055590	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-{delta}B; 	EXP055586	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	PEAKS052016
EXP055591	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-{delta}AB; 	EXP055586	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	PEAKS052017
EXP055592	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-PIP Q374A, I376A, I377A; 	EXP055587	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	PEAKS052018
EXP055593	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2 wildtype; 	EXP055587	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	PEAKS052019
EXP055596	anti-PGBD5 (orb13159,Biorbyt, Berkeley, CA, USA)	Homo sapiens		EXP055594	937	normal	Q8N414	G401 (rhabdoid tumor of the kidney)	PEAKS052020
EXP055597	anti-GFP (Cell Signaling #2955, lot 4B10)	Homo sapiens	Genotype: PGBD5-GFP;	EXP055595	2719	normal	Q8N414	RPE (retina epithelial cells immortalized with hTERT)	PEAKS052021
EXP055598	Mouse anti-GFP, Cell Signaling #2955, lot 4B10	Homo sapiens	Genotype: triple mutant PGBD5-GFP;	EXP055595	2719	normal	Q8N414	RPE (retina epithelial cells immortalized with hTERT)	PEAKS052022
EXP055602	anti-ORCA 	Homo sapiens	Developmental stage: early-G1;	EXP055599	848	normal	Q13501	U2OS (osteosarcoma)	PEAKS052023
EXP055603	anti-ORCA 	Homo sapiens	Developmental stage: mid-G1;	EXP055600	848	normal	Q13501	U2OS (osteosarcoma)	PEAKS052024
EXP055604	anti-ORCA 	Homo sapiens	Developmental stage: late-G1;	EXP055601	848	normal	Q13501	U2OS (osteosarcoma)	PEAKS052025
EXP055606	anti-TERT (abcam, ab32020, Lot YI021602CR)	Homo sapiens		EXP055605	2720	normal	O14746	VA13 (transformed lung fibroblasts)	PEAKS052026
EXP055609	anti-DDX11 antibody (ab66971, Abcam)	Homo sapiens	Genotype: CONCR knockout;	EXP055607	38	normal	Q96FC9	A549 (lung carcinoma)	PEAKS052027
EXP055610	anti-DDX11 antibody (ab66971, Abcam)	Homo sapiens	Genotype: none;	EXP055608	38	normal	Q96FC9	A549 (lung carcinoma)	PEAKS052028
EXP055612	anti-KDM2B (Gearhart, et al. Mol Cell Biol 2006; 26:6880-6889)	Homo sapiens		EXP055611	685	normal	Q8NHM5	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS052029
EXP055621	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055613	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052030
EXP055622	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055614	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052031
EXP055623	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055615	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052032
EXP055624	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055616	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052033
EXP055625	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055617	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052034
EXP055626	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055618	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052035
EXP055627	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055619	2721	normal	P02545	HSF (primary dermal fibroblasts)	PEAKS052036
EXP055628	anti-Flag (Sigma F-1804)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055620	78	normal	P02545	HeLa (cervical adenocarcinoma)	PEAKS052037
EXP055629	anti-Flag (Sigma F-1804)	Homo sapiens	Passage: 5-7; Genotype: L647R LMNA mutant; 	EXP055620	78	normal	P02545	HeLa (cervical adenocarcinoma)	PEAKS052038
EXP055630	anti-Flag (Sigma F-1804)	Homo sapiens	Passage: 5-7; Genotype: R388P LMNA mutant; 	EXP055620	78	normal	P02545	HeLa (cervical adenocarcinoma)	PEAKS052039
EXP055633	ZMYND8 (Bethyl Laboratory, A302-089A)	Homo sapiens		EXP055631	421	normal	Q9ULU4	HEK293 (embryonic kidney)	PEAKS052040
EXP055634	Flag (Sigma, F1804)	Homo sapiens	Genotype: Flag-ZMYND8;	EXP055632	421	normal	Q9ULU4	HEK293 (embryonic kidney)	PEAKS052041
EXP055638	anti-ENL (Cell Signalling, 14893)	Homo sapiens	Treatment: none;	EXP055635	641	normal	Q03111	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052042
EXP055639	anti-HA beads (Pierce, 88836)	Homo sapiens	Treatment: none; Genotype: ENL-FKBP (ENL knockout);	EXP055635	641	normal	Q03111	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052043
EXP055640	anti-ENL (Cell Signalling, 14893)	Homo sapiens	Treatment: none;	EXP055636	2219	normal	Q03111	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS052044
EXP055641	anti-AFF4 (Abcam, Ab57077)	Homo sapiens	Treatment: 0.01% DMSO for 6 hr; Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	Q9UHB7	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052045
EXP055642	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: 0.01% DMSO for 6 hr; Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	P50750	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052046
EXP055643	anti-AFF4 (Abcam, Ab57077)	Homo sapiens	Treatment: 0.01% DMSO, 500 nM dTAG-13 for 6 hr; Genotype: Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	Q9UHB7	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052047
EXP055644	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: 0.01% DMSO, 500 nM dTAG-13 for 6 hr; Genotype: Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	P50750	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052048
EXP055646	anti-Myc	Homo sapiens	Treatment: Hydroxyurea was added to media for 3 hours;	EXP055645	78	normal	Q9H668	HeLa (cervical adenocarcinoma)	PEAKS052049
EXP055647	anti-G9a	Homo sapiens	Characteristic: sorting marker CD133;	NULL	2722	normal	Q96KQ7	T5088 (colon cancer stem cells)	PEAKS052050
EXP055648	anti-G9a	Homo sapiens	Characteristic: sorting marker CD133; Genotype: shG9a-DNG9a;	NULL	2722	normal	Q96KQ7	T5088 (colon cancer stem cells)	PEAKS052051
EXP055649	anti-G9a	Homo sapiens	Characteristic: sorting marker CD133; Genotype: shGLP-DNG9a;	NULL	2722	normal	Q96KQ7	T5088 (colon cancer stem cells)	PEAKS052052
EXP055651	anti-Ino80 (proteintech, 18810-1-AP)	Homo sapiens	Genotype: wildtype;	EXP055650	36	normal	Q9ULG1	A375 (malignant melanoma)	PEAKS052053
EXP055657	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens		EXP055652	36	normal	O95243	A375 (malignant melanoma)	PEAKS052054
EXP055658	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens	Treatment: infected with lenti-viral based shNT; 	EXP055653	36	normal	O95243	A375 (malignant melanoma)	PEAKS052055
EXP055659	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens	infected with lenti-viral based shIno80; Genotype: shIno80;	EXP055654	36	normal	O95243	A375 (malignant melanoma)	PEAKS052056
EXP055660	anti-Ino80 (proteintech, 18810-1-AP)	Homo sapiens		EXP055655	794	normal	Q9ULG1	SK-MEL-147 (melanoma)	PEAKS052057
EXP055661	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens		EXP055655	794	normal	O95243	SK-MEL-147 (melanoma)	PEAKS052058
EXP055662	anti-Ino80 (proteintech, 18810-1-AP)	Homo sapiens		EXP055656	601	normal	Q9ULG1	melanocytes	PEAKS052059
EXP055664	anti-sGC-beta1 (Sigma G4405, lot 021M4843)	Homo sapiens	Genotype: overexpressing sGC-beta1;	EXP055663	1009	normal	Q02153	U87MG(glioblastoma)	PEAKS052060
EXP055667	BRD4 (Bethyl, A301-985A50)	Homo sapiens	Treatment: empty vector added;	EXP055665	2723	normal	O60885	7250 (Fibroblast cell line)	PEAKS052061
EXP055668	BRD4 (Bethyl, A301-985A50)	Homo sapiens	Treatment: PAX3-FOXO vector added;	EXP055666	2723	normal	O60885	7250 (Fibroblast cell line)	PEAKS052062
EXP055669	anti-BRG1  (Abcam, ab110641, EPNCIR111A)	Homo sapiens	Treatment: 0 mins after progestin R5020 treatment; 	NULL	111	normal	P51532	T47D (invasive ductal carcinoma)	PEAKS055846
EXP055670	anti-BRG1  (Abcam, ab110641, EPNCIR111A)	Homo sapiens	Treatment: 30 mins after progestin R5020 treatment; 	NULL	111	normal	P51532	T47D (invasive ductal carcinoma)	PEAKS055847
EXP055671	anti-RAG1 	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 5 weeks; Sex: male; 	NULL	44	normal	P15919	T-cells	PEAKS052065
EXP055674	BRD4	Homo sapiens	Treatment: not treated;	EXP055672	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052066
EXP055675	BRD4	Homo sapiens	Treatment: not treated;	EXP055673	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052067
EXP055676	BRD2	Homo sapiens	Treatment: not treated;	EXP055672	640	normal	P25440	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052068
EXP055677	BRD2	Homo sapiens	Treatment: not treated;	EXP055673	640	normal	P25440	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052069
EXP055678	BRD3	Homo sapiens	Treatment: not treated;	EXP055672	640	normal	Q15059	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052070
EXP055679	BRD3	Homo sapiens	Treatment: not treated;	EXP055673	640	normal	Q15059	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052071
EXP055680	BRD4	Homo sapiens	Treatment: vehicle for 24 hours;	EXP055672	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052072
EXP055681	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs;	EXP055672	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052073
EXP055682	BRD4	Homo sapiens	Treatment: vehicle for 24 hours;	EXP055673	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052074
EXP055683	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs;	EXP055673	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS052075
EXP055685	Kap1 (AbCam 10483)	Homo sapiens		EXP055684	502	normal	Q13263	iPSC-derived neural progenitor cells	PEAKS052076
EXP055686	ASXL2 antibody (Bethyl, A302-037A)	Homo sapiens	Genotype: fusion protein AML-ETO;	NULL	796	normal	Q76L83	SKNO-1 (acute myeloid leukemia)	PEAKS052077
EXP055689	anti-KAP1 (Abcam, ab10483)	Homo sapiens	Developmental stage: primed;	EXP055687	2724	normal	Q13263	WIBR3 (embryonic stem cell)	PEAKS052078
EXP055690	anti-KAP1 (Abcam, ab10483)	Homo sapiens	Developmental stage: naive;	EXP055688	2724	normal	Q13263	WIBR3 (embryonic stem cell)	PEAKS052079
EXP055691	anti-HMGB2 (Abcam, ab67282, #GR149806-19)	Homo sapiens	Conditions: RAS-induced senescent cells;	NULL	489	normal	P26583	IMR90 (lung fibroblasts)	PEAKS052080
EXP055692	anti-HMGB2 (Abcam, ab67282, #GR149806-19)	Homo sapiens	Conditions: growing cells;	NULL	489	normal	P26583	IMR90 (lung fibroblasts)	PEAKS052081
EXP055693	p300 (Bethyl, A300-358A/3)	Homo sapiens		NULL	976	normal	Q09472	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS052082
EXP055696	anti-SPT5 (Santa Cruz, sc-28878, #L1713)	Homo sapiens	Passage: Multiple;	EXP055694	92	normal	O00267	BJAB (Burkitt lymphoma)	PEAKS052083
EXP055697	anti-TRIM28 (Abcam, ab622553, #GR229743-11 )	Homo sapiens	Passage: Multiple;	EXP055694	92	normal	Q13263	BJAB (Burkitt lymphoma)	PEAKS052084
EXP055698	Rad21 (AbCam 992)	Homo sapiens	Treatment: vehicle for 8hrs; Developmental stage: exponential growth phase;	NULL	417	normal	O60216	HCT-116 (colon carcinoma)	PEAKS052085
EXP055699	Rad21 (AbCam, 992)	Homo sapiens	Treatment: 250 nM daunorubicin for 8hrs; Developmental stage: exponential growth phase;	NULL	417	normal	O60216	HCT-116 (colon carcinoma)	PEAKS052086
EXP055702	anti-HDAC1 (Millipore, 17-10199)	Homo sapiens		EXP055700	618	normal	Q13547	MM1.S (plasma cell myeloma)	PEAKS052087
EXP055703	anti-HDAC4 (Abcam, AB1437)	Homo sapiens		EXP055700	618	normal	P56524	MM1.S (plasma cell myeloma)	PEAKS052088
EXP055704	anti-HDAC3 (Millipore, 17-10238)	Homo sapiens		EXP055700	618	normal	O15379	MM1.S (plasma cell myeloma)	PEAKS052089
EXP055705	anti-HDAC2 (Millipore, 17-10237)	Homo sapiens		EXP055700	618	normal	Q92769	MM1.S (plasma cell myeloma)	PEAKS052090
EXP055706	anti-CCND2 (Santa Cruz, SC-181)	Homo sapiens		EXP055701	618	normal	P30279	MM1.S (plasma cell myeloma)	PEAKS052091
EXP055707	anti-CDKN1B (Santa Cruz, SC-528)	Homo sapiens		EXP055701	618	normal	P46527	MM1.S (plasma cell myeloma)	PEAKS052092
EXP055708	anti-CDKN1B (Santa Cruz, SC-1641)	Homo sapiens		EXP055701	618	normal	P46527	MM1.S (plasma cell myeloma)	PEAKS052093
EXP055709	anti-CCND2 (Santa Cruz, SC-593)	Homo sapiens		EXP055701	618	normal	P30279	MM1.S (plasma cell myeloma)	PEAKS052094
EXP055714	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055710	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS052095
EXP055715	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055711	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS052096
EXP055716	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055712	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052097
EXP055717	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055713	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS052098
EXP055718	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: DMSO;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	PEAKS052099
EXP055719	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hrs;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	PEAKS052100
EXP055720	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: DMSO;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	PEAKS052101
EXP055721	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hrs;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	PEAKS052102
EXP055722	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: DMSO;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	PEAKS052103
EXP055725	CREBBP (Santa Cruz, sc369, Rabbit polyclonal)	Homo sapiens	Tissue: tonsil;	EXP055723	327	normal	Q92793	germinal center B-cells	PEAKS052104
EXP055726	CREBBP (Santa Cruz, sc369, Rabbit polyclonal)	Homo sapiens	Tissue: tonsil;	EXP055724	327	normal	Q92793	germinal center B-cells	PEAKS052105
EXP055727	Lamin B1 (Abcam ab1648)	Homo sapiens	Genotype: wildtype;	NULL	2725	normal	P20700	BL-2 (Burkitt lymphoma)	PEAKS052106
EXP055728	Lamin B1 (Abcam ab1648)	Homo sapiens	Genotype: Somatic hypermutation;	NULL	2725	normal	P20700	BL-2 (Burkitt lymphoma)	PEAKS052107
EXP055731	TAZ antibody	Homo sapiens	Genotype: TIAM1 knockout;	EXP055729	821	normal	Q16635	SW480 (colon adenocarcinoma)	PEAKS052108
EXP055732	TAZ antibody	Homo sapiens	Genotype: wildtype;	EXP055730	821	normal	Q16635	SW480 (colon adenocarcinoma)	PEAKS052109
EXP055742	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	EXP055737	848	normal	Q06609	U2OS (osteosarcoma)	PEAKS052114
EXP055745	CHD1 antibody (Bethyl, #A301-218A)	Homo sapiens	Treatment: shRNA control; Genotype: wildtype;	EXP055743	725	normal	O14646	PC3(bone mets prostate adenocarcinoma)	PEAKS052115
EXP055746	CHD1 antibody (Bethyl, #A301-218A)	Homo sapiens	Treatment: shCHD1; Genotype: CHD1 knockout;	EXP055744	725	normal	O14646	PC3(bone mets prostate adenocarcinoma)	PEAKS052116
EXP055749	FGFR1 (Abcam, ab10646)	Homo sapiens	Treatment: neuronal media for 2 days;	EXP055747	2726	normal	P11362	iPSC derived NPC	PEAKS052117
EXP055750	FGFR1 (Abcam, ab10646)	Homo sapiens	Treatment: neuronal media for 2 days; Source: patient with Schizophrenia;	EXP055748	2726	normal	P11362	iPSC derived NPC	PEAKS052118
EXP055751	NOTCH (obtained from Dr. Jon C. Aster)	Homo sapiens	Treatment: neuronal media for 2 days; Source: patient with Schizophrenia;	EXP055748	2726	normal	P46531	iPSC derived NPC	PEAKS052119
EXP055754	NIPBL (Bethyl, A301-779A)	Homo sapiens		EXP055752	356	normal	Q6KC79	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS052120
EXP055755	NIPBL (Bethyl, A301-779A)	Homo sapiens		EXP055753	356	normal	Q6KC79	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS052121
EXP055756	SMC1A (Bethyl, A300-055A)	Homo sapiens		EXP055752	356	normal	Q14683	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS052122
EXP055757	SMC1A (Bethyl, A300-055A)	Homo sapiens		EXP055753	356	normal	Q14683	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS052123
EXP055758	MED1 (Bethyl, A300-793A)	Homo sapiens		EXP055752	356	normal	O95243	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS052124
EXP055759	MED1 (Bethyl, A300-793A)	Homo sapiens		EXP055753	356	normal	O95243	GM12878 (female B-cells lymphoblastoid cell line)	PEAKS052125
EXP055760	anti-p300 (Santa Cruz, #sc-585X)	Homo sapiens	Tissue: Peripheral Blood; Cell markers: CD3+CD8+CD4-CD45RO-CD27+;	NULL	2727	normal	Q09472	naive CD8+ T cells	PEAKS052126
EXP055761	anti-p300 (Santa Cruz, #sc-585X)	Homo sapiens	Tissue: Peripheral Blood; Cell markers: CD3+CD8+CD4-CD45RO+;	NULL	2728	normal	Q09472	memory CD8+ T cells	PEAKS052127
EXP055763	anti-mTOR	Homo sapiens	Treatment: treated for 48h with  vehicle (EtOH);	EXP055762	70	normal	P42345	LNCaP (prostate carcinoma)	PEAKS052128
EXP055764	anti-mTOR	Homo sapiens	Treatment: treated for 48h with 10 nM R1881; 	EXP055762	70	normal	P42345	LNCaP (prostate carcinoma)	PEAKS052129
EXP055765	anti-MED1	Homo sapiens		NULL	2729	normal	O95243	THRS (tyrosine hydroxylase reporter stem cell line) derived to dopaminergic neurons	PEAKS052130
EXP055768	anti-p27 (Santa Cruz, catalog# sc-528, lot# I 2115)	Homo sapiens	Developmental stage: G0 synchronized;	EXP055766	417	normal	P46527	HCT-116 (colon carcinoma)	PEAKS052131
EXP055769	anti-p27 (Santa Cruz, catalog# sc-528, lot# I 2115)	Homo sapiens	Developmental stage: asynchronously growing;	EXP055767	417	normal	P46527	HCT-116 (colon carcinoma)	PEAKS052132
EXP055770	anti-SREBP2 antibody (Cayman, Michigan, USA)	Homo sapiens	Treatment: Control (pH =7.4);	NULL	712	normal	Q12772	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS052133
EXP055771	anti-SREBP2 antibody (Cayman, Michigan, USA)	Homo sapiens	Treatment: low pH (pH=6.8);	NULL	712	normal	Q12772	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS052134
EXP055772	anti-Menin/MEN1 (A300-115A,Bethyl)	Homo sapiens		NULL	111	normal	O00255	T47D (invasive ductal carcinoma)	PEAKS052135
EXP055773	anti-Menin/MEN1 (A300-115A,Bethyl)	Homo sapiens		NULL	583	normal	O00255	MCF10A (breast epithelial cells)	PEAKS052136
EXP055774	HA.11 (BioLegend, 901502)	Homo sapiens	Time: 24 hours after transfection; Genotype: plasmid encoding for a HA-tagged form of DUX4;	NULL	376	normal	Q9UBX2	WA01 (H1, human embryonic stem cells)	PEAKS052137
EXP055775	anti-LMO1	Homo sapiens		NULL	509	normal	P25800	Jurkat (T-cells)	PEAKS052138
EXP055778	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens		EXP055776	417	normal	Q96EB6	HCT-116 (colon carcinoma)	PEAKS052139
EXP055779	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens		EXP055776	417	normal	P33993	HCT-116 (colon carcinoma)	PEAKS052140
EXP055780	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: G1 phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	PEAKS052141
EXP055781	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: early S phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	PEAKS052142
EXP055782	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: middle S phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	PEAKS052143
EXP055783	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: late S phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	PEAKS052144
EXP055784	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: G2 phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	PEAKS052145
EXP055785	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: G1 phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS052146
EXP055786	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: early S phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS052147
EXP055787	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: middle phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS052148
EXP055788	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: late S phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS052149
EXP055789	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: G2 phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	PEAKS052150
EXP055790	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens		EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	PEAKS052151
EXP055795	anti-CTCF	Homo sapiens	Genotype: wildtype;	EXP055791	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	PEAKS052152
EXP055796	anti-CTCF	Homo sapiens	Genotype: Wapl knockout;	EXP055792	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	PEAKS052153
EXP055797	anti-CTCF	Homo sapiens	Genotype: SCC4 knockout;	EXP055793	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	PEAKS052154
EXP055798	anti-CTCF	Homo sapiens	Genotype: Wapl and SCC4 knockout;	EXP055794	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	PEAKS052155
EXP055799	anti-SMC1	Homo sapiens	Genotype: wildtype;	EXP055791	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	PEAKS052156
EXP055800	anti-SMC1	Homo sapiens	Genotype: Wapl knockout;	EXP055792	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	PEAKS052157
EXP055801	anti-SMC1	Homo sapiens	Genotype: SCC4 knockout;	EXP055793	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	PEAKS052158
EXP055802	anti-SMC1	Homo sapiens	Genotype: Wapl and SCC4 knockout;	EXP055794	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	PEAKS052159
EXP055805	Anti-KMT2D, HPA035977, Sigma	Homo sapiens	Treatment: DMSO for 4 hrs; Passage: 5 to 10;	EXP055803	111	normal	O14686	T47D (invasive ductal carcinoma)	PEAKS052160
EXP055806	Anti-KMT2D, HPA035977, Sigma	Homo sapiens	Treatment: BYL719 1uM for 4hrs; Passage: 5 to 10;	EXP055804	111	normal	O14686	T47D (invasive ductal carcinoma)	PEAKS052161
EXP055814	anti-V5 (Sigma-Aldrich, A7345)	Homo sapiens	Genotype: MORC2 knockout, V5-tagged MORC2;	EXP055810	78	normal	Q9Y6X9	HeLa (cervical adenocarcinoma)	PEAKS052162
EXP055815	anti-V5 (Sigma-Aldrich, A7345)	Homo sapiens	Genotype: V5-tagged W505A MORC2 mutant, MORC2 knockout;	EXP055811	78	normal	Q9Y6X9	HeLa (cervical adenocarcinoma)	PEAKS052163
EXP055816	anti-V5 (Sigma-Aldrich, A7345)	Homo sapiens	Genotype: HUSH triple knockout, V5-tagged MORC2	EXP055812	78	normal	Q9Y6X9	HeLa (cervical adenocarcinoma)	PEAKS052164
EXP055817	anti-TASOR	Homo sapiens		EXP055813	78	normal	Q9UK61	HeLa (cervical adenocarcinoma)	PEAKS052165
EXP055822	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3B wildtype;	EXP055818	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	PEAKS052166
EXP055823	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3BA603T wildtype;	EXP055819	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	PEAKS052167
EXP055824	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3BA603T/STP807ins;	EXP055820	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	PEAKS052168
EXP055825	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3BV699G/R54X;	EXP055821	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	PEAKS052169
EXP055826	anti-NELF-A (J Cell Biochem. 107, 131-139)	Homo sapiens		NULL	2732	normal	Q9H3P2	normal breast	PEAKS052170
EXP055828	anti-UTX	Homo sapiens		EXP055827	113	normal	O15550	MCF7 (Invasive ductal breast carcinoma)	PEAKS052171
EXP055829	NCAPH2 (Bethyl: A302-275A)	Homo sapiens	Passage: 10-13; Genotype: wildtype;	NULL	421	normal	Q6IBW4	HEK293 (embryonic kidney)	PEAKS052172
EXP055830	NCAPH2 (Bethyl: A302-275A)	Homo sapiens	Passage: 10-13; Genotype: SET1 knockout;	NULL	421	normal	Q6IBW4	HEK293 (embryonic kidney)	PEAKS052173
EXP055833	anti-CHD4	Homo sapiens	Genotype: -DOC1;	EXP055831	2733	normal	Q14839	SCC9 (tongue squamous cell carcinoma)	PEAKS052174
EXP055834	anti-CHD4	Homo sapiens	Genotype: +DOC1;	EXP055832	2733	normal	Q14839	SCC9 (tongue squamous cell carcinoma)	PEAKS052175
EXP055835	anti-BRD4	Homo sapiens	Treatment: vehicle (DMSO) for 1 hr;	NULL	2734	normal	O60885	Akata-Zta (cell line infected by Epstein-Barr virus)	PEAKS052176
EXP055836	anti-BRD4	Homo sapiens	Treatment: 1 uM JQ1 for 1 hr;	NULL	2734	normal	O60885	Akata-Zta (cell line infected by Epstein-Barr virus)	PEAKS052177
EXP055837	Suz12 (D39F6, Cell Signaling, rabbit monoclonal)	Homo sapiens		NULL	2735	normal	Q15022	Lu130 (Small cell lung carcinoma)	PEAKS052178
EXP055839	ANTI-FLAG(R) M2 antibody	Homo sapiens		EXP055838	65	normal	P18433	U937 (adult acute monocytic leukemia)	PEAKS052179
EXP055842	Brg1 (from anki.ostlund Farrant (Stockholm University))	Mus musculus	Tissue: Connective tissue; Developmental stage: 10.5 day old embryos; Strain: BALB/c; Genotype: Actb +/+;	EXP055840	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	PEAKS052180
EXP055843	Brg1 (from anki.ostlund Farrant (Stockholm University))	Mus musculus	Tissue: Connective tissue; Developmental stage: 10.5 day old embryos; Strain: BALB/c; Genotype: Actb knockout;	EXP055841	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	PEAKS052181
EXP055844	anti-p300	Mus musculus	Developmental stage: day 11.5 (e11.5); Strain: CD1; Sex: mixed male/female;	NULL	313	normal	B2RWS6	forebrain	PEAKS052182
EXP055845	anti-p300	Mus musculus	Developmental stage: day 11.5 (e11.5); Strain: CD1; Sex: mixed male/female;	NULL	1147	normal	B2RWS6	midbrain	PEAKS052183
EXP055846	anti-p300	Mus musculus	Developmental stage: day 11.5 (e11.5); Strain: CD1; Sex: mixed male/female;	NULL	547	normal	B2RWS6	limb	PEAKS052184
EXP055848	anti-Brg/Brm antibody (Clone J1, Khavari et al., 1993, Nature, PMID: 8232556)	Mus musculus	Source: E14Tg2a murine ES cells; Genotype: Brg knockout;	EXP055847	506	normal	Q6DIC0	J1 (embryonic stem cells)	PEAKS052185
EXP055849	PCL2 (MTF2)	Mus musculus		NULL	765	normal	Q02395	R1 (embryonic stem cells)	PEAKS052186
EXP055850	jmjd3	Mus musculus	Treatment: LPS (lipopolysaccharide) + IFNgamma (interferon gamma ) treated for 2hrs;	NULL	81	normal	Q5NCY0	BMDM (bone marrow-derived macrophages)	PEAKS052187
EXP055851	anti-Eset antibody (rabbit polyclonal )	Mus musculus	Treatment: unperturbed;	NULL	230	normal	O88974	ES-E14 (E14, embryonic stem cells)	PEAKS052188
EXP055853	anti-SetDB1	Mus musculus	Treatment: none; 	EXP055852	252	normal	O88974	V6.5 (embryonic stem cells)	PEAKS052189
EXP055856	anti-LSD1 (Abcam #07-449)	Mus musculus	Strain: 129SV; Passage: 13-18;	EXP055854	963	normal	Q6ZQ88	embryonic stem cells from stran 129	PEAKS052190
EXP055857	NelfA (Santa Cruz (A-20), sc-23599)	Mus musculus		NULL	252	normal	Q8BG30	V6.5 (embryonic stem cells)	PEAKS052191
EXP055858	Supt5 (gift from Yuki Yamaguchi and Hiroshi Handa (Wada et al., 1998))	Mus musculus		NULL	252	normal	O55201	V6.5 (embryonic stem cells)	PEAKS052192
EXP055859	Ctr9 (Bethyl labs, A301-395)	Mus musculus		NULL	252	normal	Q62018	V6.5 (embryonic stem cells)	PEAKS052193
EXP055861	anti-RAP1	Mus musculus	Genotype: wildtype RAP1; 	EXP055860	2737	normal	Q91VL8	SV40-large T immortalized mouse embryonic fibroblast	PEAKS052194
EXP055862	anti-RAP1	Mus musculus	Genotype: RAP1 knockout;	NULL	2737	normal	Q91VL8	SV40-large T immortalized mouse embryonic fibroblast	PEAKS052195
EXP055863	RAG2 (rabbit polyclonal antibody raised to RAG2 aa 70-516 (Leu and Schatz, PMID: 7565717))	Mus musculus	Genotype: R2 knockout;	NULL	2446	normal	P21784	total thymocytes	PEAKS052196
EXP055864	RAG2 (rabbit polyclonal antibody raised to RAG2 aa 70-516 (Leu and Schatz, PMID: 7565717))	Mus musculus	Genotype: D708A-R1 knockout; 	NULL	2446	normal	P21784	total thymocytes	PEAKS052197
EXP055865	RAG2 (rabbit polyclonal antibody raised to RAG2 aa 70-516 (Leu and Schatz, PMID: 7565717))	Mus musculus	Genotype: wildtype;	NULL	2446	normal	P21784	total thymocytes	PEAKS052198
EXP055867	LUZP1 (Rabbit sera)	Mus musculus	Strain: 129P2/OlaHsd; Passage: 25-30;	EXP055866	230	normal	Q8R4U7	ES-E14 (E14, embryonic stem cells)	PEAKS052199
EXP055868	CHD7 (Abcam, ab31824, batch #215651)	Mus musculus	Strain: R1; 	NULL	2	normal	A2AJK6	mESCs (mouse embryonic stem cells)	PEAKS052200
EXP055869	p300 (Santa Cruz, sc-585, batch # unknown)	Mus musculus	Strain: R1; 	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	PEAKS052201
EXP055870	anti-p300 antibody (Santa Cruz Biotechnology, SC-585, Lot L2704)	Mus musculus	Developmental stage: embryonic day 11.5 (e11.5); Sex: Mixed male / female; Strain: CD-1;	NULL	247	normal	B2RWS6	embryonic heart	PEAKS052202
EXP055871	anti-p300 antibody (Santa Cruz Biotechnology, SC-585, Lot L2704)	Mus musculus	Developmental stage: embryonic day 11.5 (e11.5); Sex: Mixed male / female; Strain: CD-1;	NULL	2739	normal	B2RWS6	embryonic midbrain	PEAKS052203
EXP055875	anti-Sin3A (Santa Cruz Biotechnology, sc-767, D1505)	Mus musculus	Genotype: C3H;	EXP055873	126	normal	Q60520	C2C12 (myotubes)	PEAKS052204
EXP055876	anti-Sin3A (Santa Cruz Biotechnology, sc-767, D1505)	Mus musculus	Genotype: C3H;	EXP055874	126	normal	Q60520	C2C12 (myotubes)	PEAKS052205
EXP055877	anti-Sin3B  (Santa Cruz Biotechnology, sc-767, H0904)	Mus musculus	Genotype: C3H;	EXP055873	126	normal	Q62141	C2C12 (myotubes)	PEAKS052206
EXP055878	anti-Sin3A (Santa Cruz Biotechnology, sc-767, I2908)	Mus musculus	Genotype: C3H;	EXP055872	1153	normal	Q60520	C2C12 (myoblasts)	PEAKS052207
EXP055879	anti-Sin3B  (Santa Cruz Biotechnology, sc-767, H0904)	Mus musculus	Genotype: C3H;	EXP055872	1153	normal	Q62141	C2C12 (myoblasts)	PEAKS052208
EXP055880	anti-Sin3B  (Santa Cruz Biotechnology, sc-767, H0904)	Mus musculus	Genotype: C3H;	EXP055874	126	normal	Q62141	C2C12 (myotubes)	PEAKS052209
EXP055884	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP055881	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052210
EXP055885	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055881	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052211
EXP055886	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055882	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052212
EXP055887	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055883	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052213
EXP055888	anti-CBX7 (Abcam, ab21873)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP055881	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS052214
EXP055889	anti-CBX7 (Abcam, ab21873)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055881	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS052215
EXP055891	BRG1 (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Strain: Balb/C; Age: 4-6 week mice; Tissue: spleens and lymph nodes;	EXP055890	2740	normal	Q3TKT4	naive CD4+ T helper	PEAKS052216
EXP055892	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2741	normal	Q3TKT4	resting Th1 CD4+ T helper cells	PEAKS052217
EXP055893	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2742	normal	Q3TKT4	resting Th2 CD4+ T helper cells	PEAKS052218
EXP055894	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2743	normal	Q3TKT4	stimulated Th1 CD4+ T helper cells	PEAKS052219
EXP055895	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2744	normal	Q3TKT4	stimulated Th2 CD4+ T helper cells	PEAKS052220
EXP055896	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2745	normal	Q3TKT4	stimulated Th17 CD4+ T helper cells	PEAKS052221
EXP055898	anti-Suz12 (Abcam, ab12073-100, 418328)	Mus musculus	Strain: C57BL/6 x 129; Treatment: 2i serum-free medium;	EXP055897	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052222
EXP055899	anti-Suz12 (Abcam, ab12073-100, 418328)	Mus musculus	Strain: C57BL/6 x 129; Treatment: serum medium;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052223
EXP055900	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: C57BL/6 x 129; Treatment: 2i serum-free medium;	EXP055897	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052224
EXP055901	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: C57BL/6 x 129; Treatment: serum medium;	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052225
EXP055902	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: 129/Ola; Treatment: serum medium;	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052226
EXP055903	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: 129/Ola; Treatment: 2i serum-free medium;	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052227
EXP055906	anti-eGFP (raised against His-tagged full-length eGFP and affinity-purified with GST-tagged full-length eGFP)	Mus musculus		EXP055904	763	normal	Q61550	R1/E (embryonic stem cells)	PEAKS052228
EXP055907	anti-eGFP (raised against His-tagged full-length eGFP and affinity-purified with GST-tagged full-length eGFP)	Mus musculus	Developmental stage: differentiation day 12;	EXP055905	2746	normal	Q61550	R1/E-derived ebryoid bodies	PEAKS052229
EXP055909	anti-Nelf-b (purified polyclonal)	Mus musculus	Genotype: Nelf-b knockout; Strain: mixed background of 129/SvJ, C57BL/6, and FVB;	EXP055908	12	normal	Q8C4Y3	MEF (mouse embryonic fibroblasts)	PEAKS052230
EXP055911	anti-AID (Rabbit polyclonal described in Chaudhuri et al., Nature 2003)	Mus musculus	Genotype: AID knockout; 	EXP055910	2366	normal	Q8BJ51	activated B-cells	PEAKS052231
EXP055912	anti-Spt5 (H300) (Santa Cruz Biotechnology)	Mus musculus	Strain: C57BL/6; 	EXP055910	2366	normal	A1A546	activated B-cells	PEAKS052232
EXP055913	anti-AID (Rabbit polyclonal described in Chaudhuri et al., Nature 2003)	Mus musculus	Strain: C57BL/6; 	EXP055910	2366	normal	Q8BJ51	activated B-cells	PEAKS052233
EXP055915	anti-Cbp antibody 	Mus musculus	Strain: C57BL/6-cast; 	EXP055914	2747	normal	P45481	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	PEAKS052234
EXP055916	anti-Ezh2 (Active Motif, 39639)	Mus musculus	Strain: C3H; Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	Q61188	C2C12 (myoblasts)	PEAKS052235
EXP055917	Ezh1	Mus musculus	Strain: C3H; Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	P70351	C2C12 (myoblasts)	PEAKS052236
EXP055918	Ezh1	Mus musculus	Developmental stage: 24-hours differentiated Myotubes; Strain: C3H; 	NULL	126	normal	P70351	C2C12 (myotubes)	PEAKS052237
EXP055919	Ezh1	Mus musculus	Developmental stage: 24-hours differentiated Myotubes; Strain: C3H; 	NULL	1153	normal	P70351	C2C12 (myoblasts)	PEAKS052238
EXP055920	anti-Suz12 (Millipore, NG1800878, 17-661)	Mus musculus	Strain: C3H; Developmental stage: Proliferating Myoblasts;	NULL	126	normal	Q80U70	C2C12 (myotubes)	PEAKS052239
EXP055921	anti-Suz12 (Millipore, NG1800878, 17-661)	Mus musculus	Developmental stage: 24-hours differentiated Myotubes; Strain: C3H; 	NULL	1153	normal	Q80U70	C2C12 (myoblasts)	PEAKS052240
EXP055924	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 9R/13R cross; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q61880	adult testis	PEAKS052241
EXP055925	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 13R/9R and 9R/13R crosses; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q61880	adult testis	PEAKS052242
EXP055926	RAD51 (H92) (Santa Cruz, sc 8349, D2209)	Mus musculus	Strain: 13R/9R cross; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q08297	adult testis	PEAKS052243
EXP055927	RAD51 (H92) (Santa Cruz, sc 8349, D2209)	Mus musculus	Strain: 9R/13R cross; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q08297	adult testis	PEAKS052244
EXP055928	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: C57BL/6J/129R cross; Genotype: Spo11 -/-  (knockout);	EXP055922	2748	normal	Q61880	adult testis	PEAKS052245
EXP055929	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 13R/9R cross; Genotype: Hop2 -/- (knockout);	NULL	2748	normal	Q61880	adult testis	PEAKS052246
EXP055930	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 9R/13R cross; Genotype: wildtype;	EXP055923	2748	normal	Q61880	adult testis	PEAKS052247
EXP055931	anti-Dpy-30 (unreleased product from Bethyl Laboratories, developed by Christina Hughes (David Allis lab, Rockefeller University) through Bethyl)	Mus musculus		NULL	230	normal	Q99LT0	ES-E14 (E14, embryonic stem cells)	PEAKS052248
EXP055936	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: Pcl3-shRNA; Genotype: Suz12^Suz12TAP/+, Pcl3 knockout;	EXP055934	2749	normal	Q80U70	BayGenomics ES cell line XG122 (embryonic stem cells)	PEAKS052249
EXP055937	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: shRNA control; Genotype: Suz12^Suz12TAP/+;	EXP055935	2749	normal	Q80U70	BayGenomics ES cell line XG122 (embryonic stem cells)	PEAKS052250
EXP055938	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: Pcl3-shRNA7; Genotype: Pcl3-TAP, Pcl3 wildtype knockout;	EXP055932	2749	normal	Q9CXG9	BayGenomics ES cell line XG122 (embryonic stem cells)	PEAKS052251
EXP055939	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: Pcl3-shRNA6; Genotype: Pcl3-TAP, Pcl3 wildtype knockout;	EXP055933	2749	normal	Q9CXG9	BayGenomics ES cell line XG122 (embryonic stem cells)	PEAKS052252
EXP055941	anti-FLAG	Mus musculus	Genotype: expressing BirA; 	EXP055940	602	normal	Q9QYE3	erythroleukemic cells	PEAKS052253
EXP055943	anti-Ezh2	Mus musculus	Source: E12.5 heart apex. 120 hearts; Tissue: heart apex;	EXP055942	95	normal	Q61188	E12.5 embryonic heart	PEAKS052254
EXP055944	anti-Smc1 (Bethyl, A301-779A)	Mus musculus	Treatment: DMSO for 1 hr;	NULL	252	normal	Q9CU62	V6.5 (embryonic stem cells)	PEAKS052255
EXP055945	anti-Smc1 (Bethyl, A301-779A)	Mus musculus	Treatment: 1 uM flavopiridol for 1 hr;	NULL	252	normal	Q9CU62	V6.5 (embryonic stem cells)	PEAKS052256
EXP055947	Anti Ezh2 [Diagenode (http://www.diagenode.com/en/index.php); Cat. no.: CS-039-100; Lot no.: 001]	Mus musculus	Strain: C57BL/6; Tissue: brain; Passage:  2-3 (cultured as neurospheres);	EXP055946	2775	normal	Q61188	neural stem cells	PEAKS052257
EXP055948	Anti Ezh2 [Diagenode (http://www.diagenode.com/en/index.php); Cat. no.: CS-039-100; Lot no.: 001]	Mus musculus	Strain: C57BL/6; Tissue: brain; Passage:  0 (single time monolayer cultures);	EXP055946	2750	normal	Q61188	pOLs (pre-myelinating oligodendrocytes)	PEAKS052258
EXP055949	anti-Mbd3 (Abcam, ab3755)	Mus musculus	Genotype: Tet1 knockout;	NULL	2	normal	Q9DA79	mESCs (mouse embryonic stem cells)	PEAKS052259
EXP055950	anti-Mbd3 (Abcam, ab3755)	Mus musculus	Genotype: Brg1 knockout;	NULL	2	normal	Q9DA79	mESCs (mouse embryonic stem cells)	PEAKS052260
EXP055951	anti-Mbd3 (Abcam, ab3755)	Mus musculus	Genotype: wildtype;	NULL	2	normal	Q9DA79	mESCs (mouse embryonic stem cells)	PEAKS052261
EXP055956	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: Unstimulated; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055952	159	normal	Q9Z2D6	cortical neurons	PEAKS052262
EXP055957	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055953	159	normal	Q9Z2D6	cortical neurons	PEAKS052263
EXP055958	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: Unstimulated; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055954	159	normal	Q9Z2D6	cortical neurons	PEAKS052264
EXP055959	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055955	159	normal	Q9Z2D6	cortical neurons	PEAKS052265
EXP055960	Anti-pS421 MeCP2  (Custom antibody)	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055955	159	normal	Q9Z2D6	cortical neurons	PEAKS052266
EXP055961	anti-Tnni2 (Santa Cruz biotechnology, sc-30486)	Mus musculus	Strain: 129sv; Genotype: del175k mutant; 	NULL	2752	normal	P13412	primary osteoblast	PEAKS052267
EXP055962	anti-Tnni2 (Santa Cruz biotechnology, sc-30486)	Mus musculus	Strain: 129sv; Genotype: wildtype; 	NULL	2752	normal	P13412	primary osteoblast	PEAKS052268
EXP055965	anti-SA1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	NULL	12	normal	Q9D3E6	MEF (mouse embryonic fibroblasts)	PEAKS052269
EXP055966	anti-SA2	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	NULL	12	normal	O35638	MEF (mouse embryonic fibroblasts)	PEAKS052270
EXP055967	anti-SA2	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	NULL	12	normal	O35638	MEF (mouse embryonic fibroblasts)	PEAKS052271
EXP055968	anti-SMC1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	EXP055964	12	normal	Q9CU62	MEF (mouse embryonic fibroblasts)	PEAKS052272
EXP055969	anti-SMC3	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	EXP055964	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	PEAKS052273
EXP055970	SMC3	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: SA1 knockout;	EXP055964	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	PEAKS052274
EXP055971	anti-SA1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: SA1 knockout; 	EXP055964	12	normal	Q9D3E6	MEF (mouse embryonic fibroblasts)	PEAKS052275
EXP055972	anti-SMC1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: SA1 knockout; 	EXP055964	12	normal	Q9CU62	MEF (mouse embryonic fibroblasts)	PEAKS052276
EXP055975	anti-JmjD2d (clone 1-7)	Mus musculus	Treatment: unstimulated;	EXP055973	104	normal	Q3U2K5	dendritic cells	PEAKS052277
EXP055976	anti-JmjD2d (clone 1-7)	Mus musculus	Treatment: stimulated for 2h with 100ng/ml LPS;	EXP055974	104	normal	Q3U2K5	dendritic cells	PEAKS052278
EXP055978	anti-CapD3 (Tatsuya Hirano, AFR319-3L)	Mus musculus	Treatment: none;	NULL	252	normal	Q6ZQK0	V6.5 (embryonic stem cells)	PEAKS052279
EXP055979	anti-CapD3 (Tatsuya Hirano, AFR319-3L)	Mus musculus	Treatment: 200 ng/ml nocodazole;	EXP055977	252	normal	Q6ZQK0	V6.5 (embryonic stem cells)	PEAKS052280
EXP055980	anti-CapG (Tatsuya Hirano, AFR310-4L)	Mus musculus	Treatment: none;	NULL	252	normal	P24452	V6.5 (embryonic stem cells)	PEAKS052281
EXP055981	anti-CapG (Tatsuya Hirano, AFR310-4L)	Mus musculus	Treatment: 200 ng/ml nocodazole;	EXP055977	252	normal	P24452	V6.5 (embryonic stem cells)	PEAKS052282
EXP055982	anti-Rad21 (Bethyl, A300-080A)	Mus musculus	Treatment: none;	NULL	252	normal	Q61550	V6.5 (embryonic stem cells)	PEAKS052283
EXP055984	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Treatment: BSA; Strain: C57BL/6;	EXP055983	81	normal	O88895	BMDM (bone marrow-derived macrophages)	PEAKS052284
EXP055985	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Treatment: IL4; Strain: C57BL/6;	EXP055983	81	normal	O88895	BMDM (bone marrow-derived macrophages)	PEAKS052285
EXP055987	anti-Ring1B (A-20)	Mus musculus		EXP055986	2753	normal	Q9CQJ4	OS25 (embryonic stem cells)	PEAKS052286
EXP055990	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	NULL	2748	normal	Q61880	adult testis	PEAKS052287
EXP055991	anti-RAD51 (H92) (Santa Cruz,sc 8349,  D2209)	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	EXP055988	2748	normal	Q08297	adult testis	PEAKS052288
EXP055992	anti-RAD51 (H92) (Santa Cruz,sc 8349,  D2209)	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	EXP055989	2748	normal	Q08297	adult testis	PEAKS052289
EXP055993	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Genotype: wildtype; Background strain: 9R female x 13R male F1;	NULL	2748	normal	Q61880	adult testis	PEAKS052290
EXP055995	anti-Notch1	Mus musculus	Genotype: Notch1-IC over-expressing;	EXP055994	2754	normal	Q01705	T-ALL (Acute Lymphoblastic Leukemia)	PEAKS052291
EXP055997	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Srain: B6;129P2-Prdm9tm1Ymat/J; Genotype: Prdm9 knockout;	NULL	32	normal	Q61880	testis	PEAKS052292
EXP055998	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: C57Bl/6J; Genotype: wildtype;	NULL	32	normal	Q61880	testis	PEAKS052293
EXP055999	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: B10.F-H2pb1/(13R)J; Genotype: wildtype;	NULL	32	normal	Q61880	testis	PEAKS052294
EXP056000	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: B11.S-H2t4/(9R)/J; Genotype: wildtype;	NULL	32	normal	Q61880	testis	PEAKS052295
EXP056001	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: B10.F-H2pb1/(13R)J X B11.S-H2t4/(9R)/J; Genotype: wildtype;	EXP055996	32	normal	Q61880	testis	PEAKS052296
EXP056003	anti-CTCF (Millipore, 07-729)	Mus musculus		EXP010869	624	normal	Q61164	E14.5 limb	PEAKS052298
EXP056004	CTCF	Mus musculus		NULL	1053	normal	Q61164	Treg cells from lymph nodes and spleen	PEAKS052299
EXP056005	anti-Brg1 (Lab Generated (Crabtree) J1)	Mus musculus		NULL	252	normal	Q3TKT4	V6.5 (embryonic stem cells)	PEAKS052300
EXP056006	anti-Brd4 (Bethyl, A301-985A)	Mus musculus		NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS052301
EXP056007	anti-SA2 (Bethyl, A300-158A)	Mus musculus		NULL	252	normal	O35638	V6.5 (embryonic stem cells)	PEAKS052302
EXP056008	anti-SA1 (Bethyl, A300-157A)	Mus musculus		NULL	252	normal	Q9D3E6	V6.5 (embryonic stem cells)	PEAKS052303
EXP056010	anti-M2 Flag (Sigma, A2220)	Mus musculus	Genotype: Flag-Cbx7; Strain: C57BL/6;	NULL	2755	normal	Q8VDS3	bone marrow hematopoietic stem/progenitor cells	PEAKS052304
EXP056011	anti-M2 Flag (Sigma, A2220)	Mus musculus	Genotype: Flag-Cbx8; Strain: C57BL/6;	NULL	2755	normal	Q9QXV1	bone marrow hematopoietic stem/progenitor cells	PEAKS052305
EXP056013	anti-KAP1 (RBCC, Schultz et al. Genes Dev. 2001)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: wildtype;	EXP056012	2756	normal	Q62318	B cell enriched splenocytes	PEAKS052306
EXP056014	anti-KAP1 (RBCC, Schultz et al. Genes Dev. 2001)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: KAP1 knockout;	EXP056012	2756	normal	Q62318	B cell enriched splenocytes	PEAKS052307
EXP056019	anti-Ezh2	Mus musculus	Sex: Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: 27;	EXP056015	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052308
EXP056020	anti-Ezh2	Mus musculus	Developmental stage: day 7; Sex Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: passage 27; 	NULL	216	normal	Q61188	differentiated embryonic stem cells	PEAKS052309
EXP056021	anti-Ezh2	Mus musculus	Sex: Female; Strain: F1: 129S1 x CastEiJ; Passage: 14;	EXP056018	12	normal	Q61188	MEF (mouse embryonic fibroblasts)	PEAKS052310
EXP056028	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP032583	626	normal	Q3TKT4	E11.5 embryonic face	PEAKS052311
EXP056029	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056022	2757	normal	Q3TKT4	E11.5 embryonic forebrain	PEAKS052312
EXP056030	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056023	2758	normal	Q3TKT4	E11.5 embryonic limb	PEAKS052313
EXP056031	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056024	2759	normal	Q3TKT4	E11.5 embryonic neural tube	PEAKS052314
EXP056032	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	PEAKS052315
EXP056033	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	627	normal	Q3TKT4	E11.5 embryonic hindbrain	PEAKS052316
EXP056034	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056025	2760	normal	Q3TKT4	E11.5 embryonic heart	PEAKS052317
EXP056035	p300 anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056026	626	normal	B2RWS6	E11.5 embryonic face	PEAKS052318
EXP056036	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2756	normal	B2RWS6	B cell enriched splenocytes	PEAKS052319
EXP056037	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056027	2761	normal	Q3TKT4	E11.5 embryonic midbrain	PEAKS052320
EXP056039	anti-Mof (Santa Cruz)	Mus musculus	Passage: 15-18; Strain: C57BL/6;	EXP056038	2	normal	Q9D1P2	mESCs (mouse embryonic stem cells)	PEAKS052321
EXP056044	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 0 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056040	5	normal	Q8BRH4	liver	PEAKS052322
EXP056045	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056041	5	normal	Q8BRH4	liver	PEAKS052323
EXP056046	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 12 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056042	5	normal	Q8BRH4	liver	PEAKS052324
EXP056047	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056043	5	normal	Q8BRH4	liver	PEAKS052325
EXP056048	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056041	5	normal	Q8BRH4	liver	PEAKS052326
EXP056049	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056043	5	normal	Q8BRH4	liver	PEAKS052327
EXP056050	anti-Mll3 (Abcam, ab71200)	Mus musculus	Genotype: Mll3 knockout; Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056041	5	normal	Q8BRH4	liver	PEAKS052328
EXP056051	anti-Mll3 (Abcam, ab71200)	Mus musculus	Genotype: Mll3 knockout; Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056043	5	normal	Q8BRH4	liver	PEAKS052329
EXP056055	anti-Fbxl10 (custom-made)	Mus musculus	Treatment: shScr (control);	EXP056052	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	PEAKS052330
EXP056056	Fbxl10 (custom-made)	Mus musculus	Treatment: shFbxl10;	EXP056054	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	PEAKS052331
EXP056057	anti-Ring1B (custom-made)	Mus musculus	Treatment: shScr (control);	EXP056052	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052332
EXP056058	anti-Ring1B (custom-made)	Mus musculus	Treatment: shFbxl10;	EXP056054	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052333
EXP056059	IgG (Thermo scientific, 23212, lot LI150449)	Mus musculus	Treatment: shFbxl10;	NULL	2	normal	O08917	mESCs (mouse embryonic stem cells)	PEAKS052334
EXP056060	Ring1B (custom-made)	Mus musculus	Genotype: Ring1b knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052335
EXP056061	Ring1B (custom-made)	Mus musculus	Genotype: Suz12 knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052336
EXP056062	Ring1B (custom-made)	Mus musculus	Genotype: Ring1b wildtype;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052337
EXP056066	anti-RBP-J (E. Kieff, rabbit polyclonal)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	EXP056063	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052338
EXP056067	anti-RBP-J (E. Kieff, rabbit polyclonal)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs	NULL	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052339
EXP056068	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	EXP056063	1153	normal	B2RWS6	C2C12 (myoblasts)	PEAKS052340
EXP056069	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs	NULL	1153	normal	B2RWS6	C2C12 (myoblasts)	PEAKS052341
EXP056070	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs;	NULL	1153	normal	B2RWS6	C2C12 (myoblasts)	PEAKS052342
EXP056071	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs	NULL	1153	normal	B2RWS6	C2C12 (myoblasts)	PEAKS052343
EXP056072	anti-RBP-J (1F1 rat monoclonal, Ascenion)	Mus musculus	Treatment: doxycycline; Genotype: NICDGFP;	EXP056064	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052344
EXP056073	anti-RBP-J (1F1 rat monoclonal, Ascenion)	Mus musculus	Treatment: doxycycline;	EXP056065	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052345
EXP056074	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	EXP056063	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052346
EXP056075	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs	NULL	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052347
EXP056076	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs;	NULL	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052348
EXP056077	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs	NULL	1153	normal	P31266	C2C12 (myoblasts)	PEAKS052349
EXP056079	anti-ELL3 (A fragment of human  (aa 1-248) was expressed as His-tag fusion protein in pET-16b, purified on NTA-agarose according to Qiagenâ€™s protocol and sent to Pocono Rabbit Farm and Labs for immunization into rabbits)	Mus musculus	Strain: C57BL/6 (female) x 129/S (male); Source: murine embryonic stem cells;	EXP056078	2	normal	Q80VR2	mESCs (mouse embryonic stem cells)	PEAKS052350
EXP056081	anti-JMJD3 (affinity purified antibody against mouse, Dr. K. Helin)	Mus musculus	Treatment: TGFb (Millipore) was used at a final concentration of 5 ng/ml for 3hrs; Developmental stage: e12.5; Tissue: cerebral cortex; Genotype: wildtype;	EXP056080	2775	normal	Q5NCY0	neural stem cells	PEAKS052351
EXP056083	anti-MECP2 (Sigma, 9317)	Mus musculus	Strain: 129/C57BL6; Genotype: wildtype; Sex: male; 	EXP056082	2736	normal	Q9Z2D6	whole brain	PEAKS052352
EXP056085	anti-KAP1 (RBCC,amino acids 20â€“418)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: wildtype; Tissue: Total thymocytes;	EXP056084	2762	normal	Q62318	T-cells progenitors	PEAKS052353
EXP056086	anti-KAP1 (RBCC,amino acids 20â€“418)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: Kap1 knockout; Tissue: Total thymocytes;	EXP056084	2762	normal	Q62318	T-cells progenitors	PEAKS052354
EXP056088	Anti-OGT (O-Linked N-Acetylglucosamine Transferase antibody sold, Abcam, catalog# ab50273)	Mus musculus	Strain: 129/Ola; 	EXP056087	230	normal	Q8CGY8	ES-E14 (E14, embryonic stem cells)	PEAKS052355
EXP056093	anti-Brdt (Immunopurified rabbit anti-Brdt produced against the recombinant protein.]	Mus musculus	Strain: C57BL/6; Sex: male; Developmental stage: meiotic; Genotype: wildtype; 	EXP056089	803	normal	Q91Y44	spermatocytes	PEAKS052356
EXP056094	anti-Brdt [Immunopurified rabbit anti-Brdt produced against the recombinant protein.]	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Sex: male; Developmental stage: post-meiotic;	EXP056090	636	normal	Q91Y44	round spermatids	PEAKS052357
EXP056095	anti-Brdt	Mus musculus	Strain: C57BL/6; Sex: male; Developmental stage: meiotic; Genotype: Brdt BD1 deletion; 	EXP056091	803	normal	Q91Y44	spermatocytes	PEAKS052358
EXP056096	anti-Brdt	Mus musculus	Genotype:  Brdt BD1 deletion; Strain: C57BL/6; Sex: male; Developmental stage: post-meiotic;	EXP056092	636	normal	Q91Y44	round spermatids	PEAKS052359
EXP056097	anti-SRF (Santa Cruz Biotechnology, sc-335)	Mus musculus	Treatment: sictrl; Background cell line: C3H/HeN; 	NULL	2763	normal	Q9JM73	10T1/2	PEAKS052360
EXP056098	anti-SRF (Santa Cruz Biotechnology, sc-335)	Mus musculus	Treatment: siMed23; Background cell line: C3H/HeN; Genotype: knockdown Med23;	NULL	845	normal	Q9JM73	ILC2 (type 2 Innate lympoid cells)	PEAKS052361
EXP056100	anti-Lsd1 (Abcam, ab17721)	Mus musculus	Tissue: bone marrow; 	EXP056099	2764	normal	Q6ZQ88	32D granuolocytic progenitor cells	PEAKS052362
EXP056102	anti-FLAG (Sigma, catalog# A2220)	Mus musculus	Strain: C57BL/6; Genotype: BAP1-3X Flag Tagged KI; Passage: Primary cells;	EXP056101	81	normal	Q6RHR9	BMDM (bone marrow-derived macrophages)	PEAKS052363
EXP056103	anti-HCF1 (Bethyl Laboratories, catalog# A301-399A)	Mus musculus	Strain: C57BL/6; Genotype: BAP1wildtype; Passage: Primary cells;	NULL	81	normal	Q61191	BMDM (bone marrow-derived macrophages)	PEAKS052364
EXP056104	anti-OGT1 (Sigma, catalog# 06264)	Mus musculus	Strain: C57BL/6; Genotype: BAP1wildtype; Passage: Primary cells;	NULL	81	normal	O55242	BMDM (bone marrow-derived macrophages)	PEAKS052365
EXP056107	anti-Ezh2 (Cell signaling Technology, 5246)	Mus musculus	Genotype: wildtype; 	EXP056105	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS052366
EXP056108	anti-Ezh2 (Cell signaling Technology, 5246)	Mus musculus	Genotype: Kdm2b knockout;	EXP056106	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS052367
EXP056109	anti-Flag (Sigma, F7425)	Mus musculus	Genotype: wildtype; 	EXP056105	230	normal	Q6P1G2	ES-E14 (E14, embryonic stem cells)	PEAKS052368
EXP056110	anti-Flag (Sigma, F7425)	Mus musculus	Genotype: Kdm2b knockout;	EXP056106	230	normal	Q6P1G2	ES-E14 (E14, embryonic stem cells)	PEAKS052369
EXP056111	anti-Ring1b (Cell signaling Technology, 5694)	Mus musculus	Genotype: wildtype; 	EXP056105	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS052370
EXP056112	anti-Ring1b (Cell signaling Technology, 5694)	Mus musculus	Genotype: Kdm2b knockout;	EXP056106	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS052371
EXP056116	anti-CTCF (Abcam, ab70303)	Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, cecle stage G1;	EXP056113	96	normal	Q61164	trophoblast stem cells	PEAKS052372
EXP056117	anti-CTCF (Abcam, ab70303)	Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, S cycle stage;	EXP056114	96	normal	Q61164	trophoblast stem cells	PEAKS052373
EXP056118	anti-CTCF (Abcam, ab70303)	Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, cycle stage M;	EXP056115	96	normal	Q61164	trophoblast stem cells	PEAKS052374
EXP056121	anti-p300 (Santa Cruz, sc-585)	Mus musculus	Strain: C57BL/6-ICR; Genotype: Tdg fl/fl; 	EXP056119	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	PEAKS052375
EXP056122	anti-p300 (Santa Cruz, sc-585)	Mus musculus	Strain: C57BL/6-ICR; Genotype: Tdg -/- knockout; 	EXP056120	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	PEAKS052376
EXP056125	anti-Suz12 (Abcam, #12073)	Mus musculus	Genotype: wildtype; 	EXP056123	233	normal	Q80U70	E14TG2A (embryonic stem cells)	PEAKS052377
EXP056126	anti-Phf19 (OpenBiosystems, costum made)	Mus musculus	Genotype: wildtype; 	EXP056124	233	normal	Q9CXG9	E14TG2A (embryonic stem cells)	PEAKS052378
EXP056129	anti-CTCF (Upstate, 07-729)	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl +/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	NULL	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS052379
EXP056130	anti-CTCF (Upstate, 07-729)	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl -/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	NULL	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	PEAKS052380
EXP056131	WCE	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl +/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	EXP056127	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	PEAKS052381
EXP056132	WCE	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl -/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	EXP056128	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	PEAKS052382
EXP056134	anti-PHF19 (custom produced rabbit polyclonal )	Mus musculus		EXP056133	230	normal	Q9CXG9	ES-E14 (E14, embryonic stem cells)	PEAKS052383
EXP056135	anti-TET2 antibody (in-house made mouse )	Mus musculus	Strain: C57BL/6; 	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	PEAKS052384
EXP056136	anti-OGT antibody (Novus, NBP1-32791)	Mus musculus	Strain: C57BL/6; 	NULL	2	normal	Q8CGY8	mESCs (mouse embryonic stem cells)	PEAKS052385
EXP056139	anti-KAP1 (Tronolab, rabbit polyclonal SY 3267-68)	Mus musculus	Genotype: KAP1 wildtype; 	EXP056137	2669	normal	Q62318	ES3 (ebryonic stem cells)	PEAKS052386
EXP056140	anti-KAP1 (Tronolab, rabbit polyclonal SY 3267-68)	Mus musculus	Genotype: KAP1 knockout; Treatment: 4 days post 4-OHT inducible CRE;	EXP056138	2669	normal	Q62318	ES3 (ebryonic stem cells)	PEAKS052387
EXP056141	anti-RAD51(H-92) (Santa Cruz, sc-8349, lot#H1810)	Mus musculus	Genotype: Rif1F/FCd19Cre/+;	NULL	2765	normal	Q08297	splenocyte (B lymphocytes)	PEAKS052388
EXP056142	anti-RAD51(H-92) (Santa Cruz, sc-8349, lot#H1810)	Mus musculus	Genotype: Cd19Cre/+;	NULL	2765	normal	Q08297	splenocyte (B lymphocytes)	PEAKS052389
EXP056143	anti-Rad51	Mus musculus	Genotype: 53BP1knockout; Strain: C57BL/6; 	NULL	2366	normal	Q08297	activated B-cells	PEAKS052390
EXP056144	anti-Rad51	Mus musculus	Genotype: 53BP1knockout; Strain: C57BL/6; Developmental stage: cell cycle SG2M; 	NULL	2366	normal	Q08297	activated B-cells	PEAKS052391
EXP056145	anti-Rad51	Mus musculus	Genotype: AIDwt; Strain: C57BL/6; 	NULL	2366	normal	Q08297	activated B-cells	PEAKS052392
EXP056146	Rad51 (Santa Cruz, sc-8349, H1810 )	Mus musculus	Strain: C57BL/6; Genotype: AIDtg_53BP1 knockout;	NULL	2366	normal	Q08297	activated B-cells	PEAKS052393
EXP056149	anti-Ring1B (Ab generated in Di CroceÂ´s lab)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS052394
EXP056150	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	PEAKS052395
EXP056151	anti-Suz12 (Abcam, ab12073)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052396
EXP056152	anti-RYBP (Millipore, #3637)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	PEAKS052397
EXP056157	Med1/TRAP220 (Bethyl, Catalog No.A300-793A)	Mus musculus	Strain: C57BL/6-129; 	EXP056153	873	normal	Q925J9	ZHBTc4 (embryonic stem cells)	PEAKS052398
EXP056158	Med1/TRAP220 (Bethyl, Catalog No.A300-793A)	Mus musculus	Treatment: 2 ug/mL dox for 48 hrs; 	EXP056154	873	normal	Q925J9	ZHBTc4 (embryonic stem cells)	PEAKS052399
EXP056159	Med1/TRAP220 (Bethyl, Catalog No.A300-793A)	Mus musculus	Strain: C57BL/6-129;	EXP056155	2767	normal	Q925J9	38B9 (pro-B-cell)	PEAKS052400
EXP056161	anti-HDAC3 (Abcam, catalog# 7030)	Mus musculus	Genotype: NS-DADm; Strain: C57Bl/6; Treatment: livers were removed at ZT10, 5pm;	EXP056160	5	normal	O88895	liver	PEAKS052401
EXP056162	anti-HDAC3 (Abcam, catalog# 7030)	Mus musculus	Genotype: wildtype; Strain: C57Bl/6; Treatment: livers were removed at ZT10, 5pm;	EXP056160	5	normal	O88895	liver	PEAKS052402
EXP056163	anti-Aurora B (ab2254, Abcam)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	O70126	CD43 negative resting B cells	PEAKS052403
EXP056164	anti-Ring1B (D139-3, MBL)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q9CQJ4	CD43 negative resting B cells	PEAKS052404
EXP056165	anti-Cbx7 (ab31765, Abcam)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q8VDS3	CD43 negative resting B cells	PEAKS052405
EXP056166	anti-USP16 (sc-130906, Santa Cruz)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q99LG0	CD43 negative resting B cells	PEAKS052406
EXP056167	anti-Ezh2 (39875, Active Motif)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q61188	CD43 negative resting B cells	PEAKS052407
EXP056168	anti-Aurora B (ab2254, Abcam)	Mus musculus	Treatment: 250 nM 4-hydroxytamoxifen for 48hrs; Genotype: Aurora B knockout;	NULL	2769	normal	O70126	CD43 negative resting B cells	PEAKS052408
EXP056169	anti-Ring1B (D139-3, MBL)	Mus musculus	Treatment: 250 nM 4-hydroxytamoxifen for 48hrs; Genotype: RING1B knockout;	NULL	2769	normal	Q9CQJ4	CD43 negative resting B cells	PEAKS052409
EXP056170	anti-Ring1B	Mus musculus	Strain: C57BL/6; Developmental stage: embryonic day 12.5; Genotype: wildtype; 	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS052410
EXP056171	anti-Ring1B	Mus musculus	Strain: C57BL/6; Developmental stage: embryonic day 12.5; Genotype: Phc2 mutant (L307R); 	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS052411
EXP056173	anti-Ldb1 (antibody N-18, Santa Cruz)	Mus musculus	Genotype: Flk1+ BL-CFCs; Source: hemangioblast equivalent cells; 	EXP056172	214	normal	P70662	embryoid body (day 4)	PEAKS052412
EXP056176	anti-PHF20 antibody (Cell signaling, 3934S, #1)	Mus musculus	Strain: C57BL/6; 	EXP056174	2770	normal	Q8BLG0	embryonic stem cells-derived neural progenitor cells	PEAKS052413
EXP056177	anti-Wdr5 antibody (Bethyl, A302-429A-1)	Mus musculus	Strain: C57BL/6; 	EXP056174	2770	normal	P61965	embryonic stem cells-derived neural progenitor cells	PEAKS052414
EXP056178	anti-PHF20 antibody (Cell signaling, 3934S, #1)	Mus musculus	Strain: C57BL/6; 	EXP056174	2770	normal	Q8BLG0	embryonic stem cells-derived neural progenitor cells	PEAKS052415
EXP056179	anti-Wdr5 antibody (Bethyl, A302-429A-1)	Mus musculus	Strain: C57BL/6; 	EXP056175	2770	normal	P61965	embryonic stem cells-derived neural progenitor cells	PEAKS052416
EXP056180	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	P48754	activated B-cells	PEAKS052417
EXP056181	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	Q8CG46	activated B-cells	PEAKS052418
EXP056182	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	P48754	activated B-cells	PEAKS052419
EXP056183	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: 53BP1 knockout; 	NULL	2366	normal	P48754	activated B-cells	PEAKS052420
EXP056184	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	Q8CG46	activated B-cells	PEAKS052421
EXP056185	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: 53BP1 knockout; 	NULL	2366	normal	Q8CG46	activated B-cells	PEAKS052422
EXP056186	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 10 mM hydroxyurea for 6 hrs; Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	P48754	activated B-cells	PEAKS052423
EXP056187	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 10 mM hydroxyurea for 6 hrs; Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	Q8CG46	activated B-cells	PEAKS052424
EXP056188	anti-TRIM33 (A301-059A, Bethyl, lot: A301-059A1)	Mus musculus	Strain: BALB/c; Genotype: wildtype;	NULL	91	normal	Q99PP7	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052425
EXP056189	anti-TRIM33 (A301-059A, Bethyl, lot: A301-059A1)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	81	normal	Q99PP7	BMDM (bone marrow-derived macrophages)	PEAKS052426
EXP056190	anti-Spt6	Mus musculus	Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	Q62383	C2C12 (myoblasts)	PEAKS052427
EXP056191	anti-Spt6	Mus musculus	Developmental stage: 48-hours differentiated Myotubes;	NULL	126	normal	Q62383	C2C12 (myotubes)	PEAKS052428
EXP056192	anti-KDM6A	Mus musculus	Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	O70546	C2C12 (myoblasts)	PEAKS052429
EXP056193	anti-KDM6A	Mus musculus	Developmental stage: 48-hours differentiated Myotubes;	NULL	1153	normal	O70546	C2C12 (myoblasts)	PEAKS052430
EXP056194	anti-KDM6A	Mus musculus	Developmental stage: Proliferating Myoblasts; Genotype: KDM6A knockout;	NULL	1153	normal	O70546	C2C12 (myoblasts)	PEAKS052431
EXP056197	anti-Cbx3 (Millipore, 05-690; clone 42s2)	Mus musculus		EXP056195	2	normal	P23198	mESCs (mouse embryonic stem cells)	PEAKS052432
EXP056198	anti-Cbx3 (Millipore, 05-690; clone 42s2)	Mus musculus		EXP056196	2771	normal	P23198	fibroblast derived partially reprogrammed cells	PEAKS052433
EXP056199	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: ES maintianence-feeder free;	NULL	230	normal	Q04692	ES-E14 (E14, embryonic stem cells)	PEAKS052434
EXP056200	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: ES maintianence-feeder free; Sex: female; Strain: OCT4-deltaPE-GFP x C57BL/6;	NULL	2	normal	Q04692	mESCs (mouse embryonic stem cells)	PEAKS052435
EXP056201	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: CI-Amidine treatment;	NULL	230	normal	Q04692	ES-E14 (E14, embryonic stem cells)	PEAKS052436
EXP056202	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: Smarcad1 RNAi; Genotype: Smarcad1 knockout;	NULL	230	normal	Q04692	ES-E14 (E14, embryonic stem cells)	PEAKS052437
EXP056208	anti-FLAG (Sigma M2 F1804)	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	EXP056203	216	normal	Q3TKT4	differentiated embryonic stem cells	PEAKS052438
EXP056209	anti-FLAG (Sigma M2 F1804)	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	EXP056204	216	normal	Q3TKT4	differentiated embryonic stem cells	PEAKS052439
EXP056210	anti-FLAG (Sigma M2 F1804)	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	EXP056205	216	normal	Q3TKT4	differentiated embryonic stem cells	PEAKS052440
EXP056211	anti-SUZ12 (Bethyl A302-407A)	Mus musculus	Treatment: tetrahydrofuran (THF); Genotype: Brg1f/f; Actin-CreER; Time: day 4;	EXP056206	216	normal	Q80U70	differentiated embryonic stem cells	PEAKS052441
EXP056212	anti-SUZ12 (Bethyl A302-407A)	Mus musculus	Treatment: 200 nM 4-OHT in tetrahydrofuran (THF); Genotype: Brg1f/f; Actin-CreER; Time: day 4;	EXP056207	216	normal	Q80U70	differentiated embryonic stem cells	PEAKS052442
EXP056214	anti-HA (ab9110)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	PEAKS052443
EXP056215	anti-HA (ab9110)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	PEAKS052444
EXP056216	Anti-SRSF1 (32-4500)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	PEAKS052445
EXP056217	anti-SRSF2(Fu and Maniatis, 1990)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	PEAKS052446
EXP056218	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF2 wildtype; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	PEAKS052447
EXP056219	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF2 knockout; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	PEAKS052448
EXP056220	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF1 wildtype; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	PEAKS052449
EXP056221	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF1 knockout; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	PEAKS052450
EXP056222	anti-CDK9 (mAb #2316)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q99J95	MEF (mouse embryonic fibroblasts)	PEAKS052451
EXP056223	anti-HEXIM1 (Abcam, ab25388)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q8R409	MEF (mouse embryonic fibroblasts)	PEAKS052452
EXP056226	anti-RBPJ antibody (custom-made)	Mus musculus	Developmental stage: cycling cells (containing 95% interphase and 5% mitosis cells); 	EXP056224	292	normal	P31266	F9 (embryonal carcinoma)	PEAKS052453
EXP056227	anti-RBPJ antibody (custom-made)	Mus musculus	Developmental stage: mitotic cells; 	EXP056225	292	normal	P31266	F9 (embryonal carcinoma)	PEAKS052454
EXP056231	anti-Ezh2 (BD Transduction Laboratories ref : 612666)	Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	EXP056228	839	normal	Q61188	TT2 (embryonic stem cells)	PEAKS052455
EXP056232	anti-G9a (Cell Signalling Technologies ref : 3306S)	Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	EXP056228	839	normal	Q9Z148	TT2 (embryonic stem cells)	PEAKS052456
EXP056233	anti-G9a (Cell Signalling Technologies ref : 3306S)	Mus musculus	Strain: C57BL/6 female and CBA male; Genotype: G9a and GLP knockout;	EXP056230	839	normal	Q9Z148	TT2 (embryonic stem cells)	PEAKS052457
EXP056234	anti-Ezh2 (BD Transduction Laboratories ref : 612666)	Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	EXP056229	839	normal	Q61188	TT2 (embryonic stem cells)	PEAKS052458
EXP056235	anti-Ezh2 (BD Transduction Laboratories ref : 612666)	Mus musculus	Strain: C57BL/6 female and CBA male; Genotype: G9a and GLP knockout;	EXP056230	839	normal	Q61188	TT2 (embryonic stem cells)	PEAKS052459
EXP056237	Anti-SNF2beta/BRG1 Antibody (Upstate, 07-478, DAM1718075)	Mus musculus	Developmental stage: E13.5;	EXP056236	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	PEAKS052460
EXP056239	Anti-Brd4 (Bethyl, A301-985A)	Mus musculus	Treatment: sham; Strain: C57Bl/6J;	EXP056238	53	normal	Q9ESU6	heart	PEAKS052461
EXP056241	anti-CDK9 (C20 antibody, Santa Cruz Biotechnology, C20, sc-484)	Mus musculus		EXP056240	2774	normal	Q99J95	MEL-c88(Mouse erythroid leukemia)	PEAKS052462
EXP056242	anti-Stat3	Mus musculus	Treatment: PBS; Age: 10-12 weeks; Genotype: gp130F/F; 	NULL	323	normal	P42227	gastric tumors	PEAKS052463
EXP056243	anti-Stat3	Mus musculus	Treatment: IL6; Age: 10-12 weeks; Genotype: gp130F/F; 	NULL	323	normal	P42227	gastric tumors	PEAKS052464
EXP056244	anti-Stat3	Mus musculus	Treatment: IL11; Age: 10-12 weeks; Genotype: gp130F/F; 	NULL	323	normal	P42227	gastric tumors	PEAKS052465
EXP056245	anti-RING1B antibody (PMID: 11289226)	Mus musculus	Age: 11 dpc; Strain: C57BL/6; 	NULL	313	normal	Q9CQJ4	forebrain	PEAKS052466
EXP056246	anti-RING1B antibody (PMID: 11289226)	Mus musculus	Age: 11 dpc; Strain: C57BL/6; 	NULL	1147	normal	Q9CQJ4	midbrain	PEAKS052467
EXP056247	anti-RING1B antibody (PMID: 11289226)	Mus musculus	Age: 11 dpc; Strain: C57BL/6; 	NULL	2419	normal	Q9CQJ4	forelimb	PEAKS052468
EXP056250	anti-Med1 (Bethyl Laboratories, A300-793A, lot A300-793A-1)	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	EXP056248	171	normal	Q925J9	CD4+ CD8+ T cells	PEAKS052469
EXP056251	anti-NIPBL (Bethyl Laboratories, A301-779A, lot A301-779A-2)	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	EXP056248	171	normal	Q6KCD5	CD4+ CD8+ T cells	PEAKS052470
EXP056252	anti-Rad21 (Abcam, ab992, Multiple Lots)	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	EXP056249	171	normal	Q61550	CD4+ CD8+ T cells	PEAKS052471
EXP056255	anti-Rad21 (Abcam, ab992)	Mus musculus		EXP056253	2775	normal	Q61550	neural stem cells	PEAKS052472
EXP056256	anti-Rad21 (Abcam, ab992)	Mus musculus		EXP056254	885	normal	Q61550	astrocytes	PEAKS052473
EXP056257	anti-Ezh2 (D2C9) (Cell Signaling, #5246)	Mus musculus	Treatment: shGFP; 	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS052474
EXP056258	anti-Ezh2 (D2C9) (Cell Signaling, #5246)	Mus musculus	Treatment: shDnmt3L; 	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS052475
EXP056259	anti-p300 (SC-585)	Mus musculus	Developmental stage: e11.5; Strain: CD1;	NULL	2776	normal	B2RWS6	craniofacial tissue	PEAKS052476
EXP056261	anti-EZH2 (in-house)	Mus musculus		EXP056260	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS052477
EXP056262	anti-EZH2 (in-house)	Mus musculus	Treatment: EtOH;	EXP056260	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS052478
EXP056263	anti-SUZ12 (Cell signaling, cat# 3737)	Mus musculus		EXP056260	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052479
EXP056264	anti-SUZ12 (Cell signaling, cat# 3737)	Mus musculus	Treatment: EtOH;	EXP056260	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052480
EXP056266	anti-TAF7L	Mus musculus	Age: 3-month old; Genotype: wildtype;	EXP056265	32	normal	Q9D3R9	testis	PEAKS052481
EXP056268	anti-Brg1 (H-88) (Santa Cruz Biotechnologies, SC-10768, F1312)	Mus musculus	Strain: C57BL/6; Tissue: skin; Age: newborn; 	EXP056267	2777	normal	Q3TKT4	primary epidermal keratinocytes	PEAKS052482
EXP056269	anti-Flag antibody	Mus musculus	Treatment: without Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	PEAKS052483
EXP056270	anti-Flag antibody	Mus musculus	Treatment: Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	PEAKS052484
EXP056271	anti-Flag antibody	Mus musculus	Treatment: without Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	PEAKS052485
EXP056272	anti-Flag antibody	Mus musculus	Treatment: Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	PEAKS052486
EXP056277	anti-Ezh2 (polyclonal, Diagenode, pAb-039-050, #002)	Mus musculus	Tissue: spleen; Strain: C57BL/6; 	EXP056275	2779	normal	Q61188	naive CD4+ Th1 cells	PEAKS052487
EXP056278	anti-Ezh2 (polyclonal, Diagenode, pAb-039-050, #002)	Mus musculus	Tissue: spleen; Strain: C57BL/6; 	EXP056276	2780	normal	Q61188	naive CD4+ Th2 cells	PEAKS052488
EXP056281	anti-PGC-1 (Monoclonal ANTI-FLAG, M2 Antibody, Sigma)	Mus musculus		EXP056279	126	normal	O70343	C2C12 (myotubes)	PEAKS052489
EXP056282	anti-PGC-1 (Monoclonal ANTI-FLAG, M2 Antibody, Sigma)	Mus musculus		EXP056280	126	normal	O70343	C2C12 (myotubes)	PEAKS052490
EXP056283	anti-MCRS1 ( Proteintech, 11362-1-AP)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	Q99L90	mESCs (mouse embryonic stem cells)	PEAKS052491
EXP056284	MCRS1 (Proteintech, 11362-1-AP)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	Q99L90	mESCs (mouse embryonic stem cells)	PEAKS052492
EXP056285	MSL1 (in-house, Rabbit Polyclonal, Final Bleed)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	Q6PDM1	mESCs (mouse embryonic stem cells)	PEAKS052493
EXP056286	MSL1 (in-house, Rabbit Polyclonal, Final Bleed)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	Q6PDM1	mESCs (mouse embryonic stem cells)	PEAKS052494
EXP056287	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	Q69ZF8	mESCs (mouse embryonic stem cells)	PEAKS052495
EXP056288	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	Q69ZF8	mESCs (mouse embryonic stem cells)	PEAKS052496
EXP056289	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	A2RSY1	mESCs (mouse embryonic stem cells)	PEAKS052497
EXP056290	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	A2RSY1	mESCs (mouse embryonic stem cells)	PEAKS052498
EXP056291	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032807	138	normal	Q69ZF8	neural progenitors	PEAKS052499
EXP056292	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032808	138	normal	Q69ZF8	neural progenitors	PEAKS052500
EXP056293	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032807	138	normal	A2RSY1	neural progenitors	PEAKS052501
EXP056294	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032808	138	normal	A2RSY1	neural progenitors	PEAKS052502
EXP056297	anti-Brd4 (Bethyl, A301-985A, A301-985A-1)	Mus musculus	Treatment: DMSO;	EXP056295	1225	normal	Q9ESU6	MLL-AF9/NrasG12D AML	PEAKS052503
EXP056298	anti-Brg1 (Abcam, ab4081)	Mus musculus	Treatment: DMSO;	EXP056295	1225	normal	Q3TKT4	MLL-AF9/NrasG12D AML	PEAKS052504
EXP056300	anti-Med12 (Bethyl, A300-774A, lotA300-774A-)1	Mus musculus		EXP056299	1105	normal	A2AGH6	E12.5 embryonic distal forelimb	PEAKS052505
EXP056301	anti-FLAG (Sigma anti-FLAG M2 agarose beads catalog #A2220)	Mus musculus	Genotype: K510R-Chd1; 	NULL	12	normal	P40201	MEF (mouse embryonic fibroblasts)	PEAKS052506
EXP056302	anti-FLAG (Sigma anti-FLAG M2 agarose beads catalog #A2220)	Mus musculus	Genotype: wildtype Chd1;	NULL	12	normal	P40201	MEF (mouse embryonic fibroblasts)	PEAKS052507
EXP056304	anti-KDM2B ab (Farcas et al., 2012; PMID 23256043)	Mus musculus	Passage: p10-p20; Treatment: untreated; Genotype: KDM2Bfl/fl ES cells;	NULL	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	PEAKS052508
EXP056305	anti-KDM2B ab (Farcas et al., 2012; PMID 23256043)	Mus musculus	Genotype: KDM2Bfl/fl ES cells; Passage: p10-p20; Treatment: 4-hydroxy tamoxifen (800 nM) for 72 hrs;	NULL	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	PEAKS052509
EXP056306	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Passage: p10-p20; Treatment: untreated; Genotype: KDM2Bfl/fl ES cells;	NULL	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	PEAKS052510
EXP056307	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Genotype: KDM2Bfl/fl ES cells; Passage: p10-p20; Treatment: 4-hydroxy tamoxifen (800 nM) for 72 hrs;	NULL	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	PEAKS052511
EXP056308	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Passage: p10-p20; Treatment: untreated; Genotype: KDM2Bfl/fl ES cells;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052512
EXP056309	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Genotype: KDM2Bfl/fl ES cells; Passage: p10-p20; Treatment: 4-hydroxy tamoxifen (800 nM) for 72 hrs;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052513
EXP056312	anti-Grhl3 (custom made)	Mus musculus	Treatment: depilation; 	EXP056311	2782	normal	Q5FWH3	adult epidermis	PEAKS052514
EXP056313	anti-Grhl3 (custom made)	Mus musculus	Treatment: imiquimod;	EXP056311	2782	normal	Q5FWH3	adult epidermis	PEAKS052515
EXP056314	anti-Grhl3 (custom made)	Mus musculus		EXP056310	2781	normal	Q5FWH3	E16.5 whole embryonic mouse skin	PEAKS052516
EXP056315	anti-Msl1 (3208)	Mus musculus	Developmental stage: E14; Passage: P26; Genotype: wildtype; Genotype: 129P2/OlaHsd;	NULL	2	normal	Q6PDM1	mESCs (mouse embryonic stem cells)	PEAKS052517
EXP056316	anti-Nsl1 (3130)	Mus musculus	Developmental stage: E14; Passage: P26; Genotype: wildtype; Genotype: 129P2/OlaHsd;	NULL	2	normal	Q80TG1	mESCs (mouse embryonic stem cells)	PEAKS052518
EXP056318	anti-Jmjd2c	Mus musculus	Treatment: absence for 96 hrs;  Strain: C57BL/6; Genotype: conditional Jmjd2c knockout;	EXP056317	2	normal	Q8VCD7	mESCs (mouse embryonic stem cells)	PEAKS052519
EXP056319	Jmjd2c	Mus musculus	Treatment: 500 nM OHT for 96 hrs; Strain: C57BL/6; Genotype: conditional Jmjd2c knockout;	EXP056317	2	normal	Q8VCD7	mESCs (mouse embryonic stem cells)	PEAKS052520
EXP056321	anti-Jmjd2c	Mus musculus	Strain: C57BL/6; Genotype: conditional Jmjd2c knockout; Treatment:absence for 72 hrs;  	EXP056320	12	normal	Q8VCD7	MEF (mouse embryonic fibroblasts)	PEAKS052521
EXP056322	anti-Jmjd2c	Mus musculus	Strain: C57BL/6; Genotype: conditional Jmjd2c knockout; Treatment:500 nM OHT for 72 hrs;  	EXP056320	12	normal	Q8VCD7	MEF (mouse embryonic fibroblasts)	PEAKS052522
EXP056324	Cbx8	Mus musculus	Treatment: untreated; 	EXP056323	1126	normal	Q9QXV1	E14TG2a.4 (embryonic stem cells)	PEAKS052523
EXP056325	Cbx8	Mus musculus	Treatment: 1 uM all trans retinoic acid (RA) for 72hrs;	EXP056323	1126	normal	Q9QXV1	E14TG2a.4 (embryonic stem cells)	PEAKS052524
EXP056327	anti-Laminin B (Santa-Cruz, California)	Mus musculus	Genotype: wildtype; Strain: SV129;	NULL	776	normal	P14733	retinal pigmented epithelium	PEAKS052525
EXP056328	anti-Laminin B (Santa-Cruz, California)	Mus musculus	Genotype: wildtype; Strain: SV129;	NULL	663	normal	P14733	neural retina	PEAKS052526
EXP056329	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs 100uM dipyridyl; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP wildtype;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	PEAKS052527
EXP056330	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs ethanol vehicle; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP wildtype;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	PEAKS052528
EXP056331	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs ethanol vehicle; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP knockout;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	PEAKS052529
EXP056332	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs 100uM dipyridyl; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP knockout;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	PEAKS052530
EXP056334	anti-CAP-D3	Mus musculus	Genotype: Rb +/+; Passage: Proliferating passage 4;	EXP056333	12	normal	Q6ZQK0	MEF (mouse embryonic fibroblasts)	PEAKS052531
EXP056335	anti-CAP-D3	Mus musculus	Genotype: Rb deleta L /delta;	EXP056333	12	normal	Q6ZQK0	MEF (mouse embryonic fibroblasts)	PEAKS052532
EXP056338	anti-Scml2 (Rabbit, produced in-house; Hasegawa et al.)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	EXP056336	2783	normal	Q8BJ51	germline stem cells	PEAKS052533
EXP056339	anti-Rnf2 (Mouse, MBL, catalog#D139-3, lot#014)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	EXP056336	2783	normal	Q9CQJ4	germline stem cells	PEAKS052534
EXP056340	anti-Bmi1 (Millipore, catalog#05-637, lot#2019726)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	EXP056336	2783	normal	P25916	germline stem cells	PEAKS052535
EXP056341	anti-Scml2 (Rabbit , produced in-house; Hasegawa et al.)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP056337	2784	normal	Q8BJ51	pachytene spermatocytes	PEAKS052536
EXP056343	PARP-1 (rabbit polyclonal anti-PARP, ab6079)	Mus musculus	tREATMENT: Saline for 7 days; Strain: C57BL/6;	EXP056342	682	normal	P11103	nucleus accumbens cells	PEAKS052537
EXP056344	PARP-1 (rabbit polyclonal anti-PARP, ab6079)	Mus musculus	Treatment: 20 mg/kg chronic cocaine for 7 days; Strain: C57BL/6;	EXP056342	682	normal	P11103	nucleus accumbens cells	PEAKS052538
EXP056347	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	PEAKS052539
EXP056348	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	PEAKS052540
EXP056349	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	PEAKS052541
EXP056350	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	PEAKS052542
EXP056351	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052543
EXP056352	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052544
EXP056353	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052545
EXP056354	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052546
EXP056355	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052547
EXP056356	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052548
EXP056357	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052549
EXP056358	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052550
EXP056363	anti-FLAG (M2) (Sigma,F1804)	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: Hand2 3xFLAG;	EXP056360	2785	normal	Q61039	limb bud, hearts, branchial arches	PEAKS052551
EXP056364	anti-FLAG , M2 (Sigma, Cat.-No.: F1804)	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: Hand2 3xFLAG;	EXP056362	546	normal	Q61039	limb bud	PEAKS052552
EXP056366	anti-TAF9B	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	EXP056365	180	normal	Q6NZA9	motor neurons	PEAKS052553
EXP056368	anti-Brd4 (Bethyl, A301-985A50)	Mus musculus		EXP056367	636	normal	Q9ESU6	round spermatids	PEAKS052554
EXP056370	anti-Notch1 mAb (D1E11, Cell Signaling Technology)	Mus musculus	Tissue: thymus; Strain: C57BL/6;  Age: post natal day 0-3; Genotype: wildtype; 	EXP056369	2786	normal	Q01705	gamma delta T cells	PEAKS052555
EXP056372	anti-GTF2B (sc-225)	Mus musculus	Age: 12 week; Strain: C57BL/6; 	EXP056371	53	normal	P62915	heart	PEAKS052556
EXP056373	anti-GTF2B (sc-225)	Mus musculus	Age: 12 week; Strain: C57BL/6; Pathology: Hypertrophied heart subjected to Transaortic coarctation (TAC) for 4days	NULL	53	normal	P62915	heart	PEAKS052557
EXP056374	anti-GTF2B (sc-225)	Mus musculus	Age: 1-2 age; Strain: C57BL/6; Patholodgy: Postnatal heart;	NULL	53	normal	P62915	heart	PEAKS052558
EXP056375	anti-GSK3b	Mus musculus	Passage: 20-25; Strain: C5;	NULL	12	normal	Q9WV60	MEF (mouse embryonic fibroblasts)	PEAKS052559
EXP056376	anti-FLAG (Sigma, F1804)	Mus musculus	Genotype: wildtype Dnmt3a2; Passage: 7 to 10;	NULL	506	normal	O88508	J1 (embryonic stem cells)	PEAKS052560
EXP056377	anti-FLAG (Sigma, F1804)	Mus musculus	Genotype: wildtype bulk Dnmt3a2; Passage: 7 to 10;	NULL	506	normal	O88508	J1 (embryonic stem cells)	PEAKS052561
EXP056379	anti-YAP	Mus musculus	Developmental stage: adult;	EXP056378	53	normal	P46938	heart	PEAKS052562
EXP056380	Anti-GPS2	Mus musculus	Treatment: day 0 of induced adipogenesis;	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	PEAKS052563
EXP056381	Anti-GPS2	Mus musculus	Treatment: day 6 of induced adipogenesis;	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	PEAKS052564
EXP056382	anti-KMD4A antibody (Abcam, ab47984)	Mus musculus	Treatment: siRNA control;	NULL	18	normal	Q8BW72	3T3-L1 (embryonic fibroblasts)	PEAKS052565
EXP056383	anti-KMD4A antibody (Abcam, ab47984)	Mus musculus	Treatment: siRNAs specific for GPS2;	NULL	18	normal	Q8BW72	3T3-L1 (embryonic fibroblasts)	PEAKS052566
EXP056385	anti- PPARGC1A (Bethyl Laboratory, cat no. IHC-00029)	Mus musculus	Strain: C57/L; Genotype: derivative of the BW7756 mouse hepatoma; 	EXP056384	2787	normal	O70343	Hepa1-6 (Hepatocellular carcinoma )	PEAKS052567
EXP056391	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Age: 9 weeks; Strain: Black Swiss; Genotype: wild type;	EXP056386	53	normal	Q8BP71	heart	PEAKS052568
EXP056392	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Age: 9 weeks; Strain: Black Swiss; Genotype: wild type;	EXP056386	53	normal	Q80U70	heart	PEAKS052569
EXP056393	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: negative control siRNA; Passage: 6-10;	EXP056387	12	bio_control	Q8BP71	MEF (mouse embryonic fibroblasts)	PEAKS052570
EXP056394	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: RBFox2 siRNA; Genotye: RBFox2 knockout; Passage: 6-10;	EXP056388	12	normal	Q8BP71	MEF (mouse embryonic fibroblasts)	PEAKS052571
EXP056395	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: negative control siRNA; Passage: 6-10;	EXP056387	12	normal	Q80U70	MEF (mouse embryonic fibroblasts)	PEAKS052572
EXP056396	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: RBFox2 siRNA; Genotye: RBFox2 knockout; Passage: 6-10;	EXP056388	12	normal	Q80U70	MEF (mouse embryonic fibroblasts)	PEAKS052573
EXP056397	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: 100uM DRB for 3 hours; Passage: 6-10;	EXP056389	12	normal	Q8BP71	MEF (mouse embryonic fibroblasts)	PEAKS052574
EXP056398	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 100uM DRB for 3 hours; Passage: 6-10;	EXP056389	12	normal	Q80U70	MEF (mouse embryonic fibroblasts)	PEAKS052575
EXP056399	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: SUZ12 siRNA; Genotype: SUZ12 knockout; Passage: 6-10;	EXP056390	12	normal	Q8BP71	MEF (mouse embryonic fibroblasts)	PEAKS052576
EXP056400	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 100 uM DRB for 6 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052577
EXP056401	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 10 uM Triptolide for 3 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052578
EXP056402	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 0 hrs of DRB;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052579
EXP056403	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 100 uM DRB for 12 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052580
EXP056404	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment:  Triptolide for 0 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052581
EXP056405	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 10 uM Triptolide for 9 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052582
EXP056406	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Culture conditions: serum; Genotype: wildtype; Time of differentiation: 72 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052583
EXP056407	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Culture conditions: serum; Genotype: SUZ12 knockout; Time of differentiation: 0 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052584
EXP056410	anti-NUCKS (Rabbit polyclonal antibody is generated by i-DNA Biotechnology Pte Ltd by immunizing rabbits with bacterially expressed full-length NUCKS protein)	Mus musculus	Strain: C57BL/6; 	EXP056409	2489	normal	Q80XU3	primary hepatocytes	PEAKS052585
EXP056413	anti-HP1b (1MOD-1A9-AS, euromedex)	Mus musculus	Strain: 129P2/Ola; 	EXP056411	2770	normal	P83917	embryonic stem cells-derived neural progenitor cells	PEAKS052586
EXP056414	anti-HP1b (1MOD-1A9-AS, euromedex)	Mus musculus	Strain: 129P2/Ola; 	EXP056412	2770	normal	P83917	embryonic stem cells-derived neural progenitor cells	PEAKS052587
EXP056415	anti-Suv39h1 (ab12405, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056411	2770	normal	O54864	embryonic stem cells-derived neural progenitor cells	PEAKS052588
EXP056416	anti-Suv39h1 (ab12405, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056412	2770	normal	O54864	embryonic stem cells-derived neural progenitor cells	PEAKS052589
EXP056417	anti-Suv39h2 (ab71683, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056411	2770	normal	Q9EQQ0	embryonic stem cells-derived neural progenitor cells	PEAKS052590
EXP056418	anti-Suv39h2 (ab71683, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056412	2770	normal	Q9EQQ0	embryonic stem cells-derived neural progenitor cells	PEAKS052591
EXP056423	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved;	EXP056419	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	PEAKS052592
EXP056424	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved and re-fed;	EXP056420	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	PEAKS052593
EXP056425	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: 500 nM JQ1 for 30 mins; Culture conditions: serum starved and re-fed;	EXP056421	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	PEAKS052594
EXP056426	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: none; Culture conditions: continuous culture;	EXP056422	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	PEAKS052595
EXP056427	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved;	EXP056419	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	PEAKS052596
EXP056428	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved and re-fed;	EXP056420	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	PEAKS052597
EXP056429	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: 500 nM JQ1 for 30 mins; Culture conditions: serum starved and re-fed;	EXP056421	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	PEAKS052598
EXP056430	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: none; Culture conditions: continuous culture;	EXP056422	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	PEAKS052599
EXP056431	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: Nlrc5 flux/flux; Strain: C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	PEAKS052600
EXP056432	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: Nlrc5-/- (knockout); Strain: C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	PEAKS052601
EXP056433	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: Rfx5-/- (knockout); Strain: mixed Sv129/C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	PEAKS052602
EXP056434	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: wildtype; Strain: C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	PEAKS052603
EXP056437	anti-CTCF	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	EXP056436	713	normal	Q61164	pancreas	PEAKS052604
EXP056438	anti-SA1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	NULL	193	normal	Q9D3E6	cortex	PEAKS052605
EXP056439	anti-SMC1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	NULL	193	normal	Q9CU62	cortex	PEAKS052606
EXP056440	anti-SA1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	EXP056436	713	normal	Q9D3E6	pancreas	PEAKS052607
EXP056441	anti-SMC1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	EXP056436	713	normal	Q9CU62	pancreas	PEAKS052608
EXP056442	anti-SA1	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8-10 week old;  Developmental stage: E17.5 embryo;	EXP056436	2736	normal	Q9D3E6	whole brain	PEAKS052609
EXP056443	anti-SMC1	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8-10 week old;  Developmental stage: E17.5 embryo;	EXP056436	2736	normal	Q9CU62	whole brain	PEAKS052610
EXP056444	anti-SMC1	Mus musculus	Genotype: SMC1 knockout; Strain: C57BL/6; Age: 8-10 week old;  Developmental stage: E17.5 embryo;	EXP056436	2736	normal	Q9CU62	whole brain	PEAKS052611
EXP056447	anti-Rad21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP056445	495	normal	Q61550	intestinal crypt cells	PEAKS052612
EXP056448	anti-Rad21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6 Genotype: Apc min/+; 	EXP056446	2789	normal	Q61550	small intestinal adenoma	PEAKS052613
EXP056450	anti-Pwp1 (Santa Cruz, sc-107983)	Mus musculus		EXP056449	230	normal	Q99LL5	ES-E14 (E14, embryonic stem cells)	PEAKS052614
EXP056460	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056451	2790	normal	Q925J9	partially reprogrammed colony 23	PEAKS052615
EXP056461	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056452	2790	normal	Q925J9	partially reprogrammed colony 23	PEAKS052616
EXP056462	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Cell type: NGFP iPSC;	EXP056453	906	normal	Q925J9	induced pluripotent stem cells	PEAKS052617
EXP056463	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Cell type: NGFP2;	EXP056454	12	normal	Q925J9	MEF (mouse embryonic fibroblasts)	PEAKS052618
EXP056464	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056455	2791	normal	Q925J9	OSKM4 induced iPSC into somatic cells	PEAKS052619
EXP056465	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056456	2792	normal	Q925J9	OSKM8 induced iPSC into somatic cells	PEAKS052620
EXP056466	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056457	2793	normal	Q925J9	SNEL3 iPSC	PEAKS052621
EXP056467	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056458	2794	normal	Q925J9	SNEL4 iPSC	PEAKS052622
EXP056468	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056459	252	normal	Q925J9	V6.5 (embryonic stem cells)	PEAKS052623
EXP056469	Med1/TRAP220 (Santa Cruz, SC-5334)	Mus musculus		EXP056459	252	normal	Q925J9	V6.5 (embryonic stem cells)	PEAKS052624
EXP056473	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	EXP056470	313	normal	Q9Z2D6	forebrain	PEAKS052625
EXP056474	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	EXP056471	25	normal	Q9Z2D6	cerebellum	PEAKS052626
EXP056475	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	EXP056472	25	normal	Q9Z2D6	cerebellum	PEAKS052627
EXP056478	anti-Ezh2 antibody (Diagenode)	Mus musculus	Genotype: Dicer lox/lox; 	EXP056476	2795	normal	Q61188	DTCM23 (embryonic stem cells)	PEAKS052628
EXP056479	anti-Ezh2 antibody (Diagenode)	Mus musculus	Genotype: Dicer knockout, Dicer deficient;	EXP056477	2795	normal	Q61188	DTCM23 (embryonic stem cells)	PEAKS052629
EXP056481	anti-PRDM9	Mus musculus	Age: 12 days post-partum; Strain: B6xCAST F1 Hybrid;	EXP056480	32	normal	Q96EQ9	testis	PEAKS052630
EXP056483	beta Catenin antiboy (Cell Signaling 4176, various lot)	Mus musculus	Treatment: none stress; Strain: C57BL/6;	EXP056482	682	normal	Q02248	nucleus accumbens cells	PEAKS052631
EXP056484	beta Catenin antiboy (Cell Signaling 4176, various lot)	Mus musculus	Treatment: 10 day chronic social defeat stress; Strain: C57BL/6;	EXP056482	682	normal	Q02248	nucleus accumbens cells	PEAKS052632
EXP056485	beta Catenin antiboy (Cell Signaling 4176, various lot)	Mus musculus	Treatment: 10 day chronic social defeat stress, resilient; Strain: C57BL/6;	EXP056482	682	normal	Q02248	nucleus accumbens cells	PEAKS052633
EXP056488	Med1 (Crsp1/Trap220, Bethyl Laboratories, catalog# A300-793A, lot# A300-793A-2)	Mus musculus	Age: P52-60; Strain: CD-1; Sex: Female; Tissue: back skin; Sorting markers: integrin alfa6, CD34 and Sca1;	EXP056486	2796	normal	Q925J9	HFSC (Telogen quiescent hair follicle stem cells)	PEAKS052634
EXP056489	Med1 (Crsp1/Trap220, Bethyl Laboratories, catalog# A300-793A, lot# A300-793A-2)	Mus musculus	Age: P28-P30; Strain: K14-H2BGFP (Tumbar et al., 2004); Sex: Female; Tissue: back skin; Sorting markers: GFP, integrin alfa6, CD34 and Sca1;	EXP056487	2797	normal	Q925J9	TAC (transit-amplifying cells)	PEAKS052635
EXP056491	Anti-Smc1a (Bethyl Laboratories, catalog number A300-055A)	Mus musculus	Genotype: wildtype; Age: 6 weeks old; Treatment: Conditional deletion of Rad21;	EXP056490	2459	normal	Q9CU62	double-positive (DP) CD4+/CD8+ thymocyte	PEAKS052636
EXP056501	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	EXP056492	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052637
EXP056502	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	EXP056493	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052638
EXP056503	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	EXP056494	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052639
EXP056504	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	EXP056495	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052640
EXP056505	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	EXP056496	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052641
EXP056506	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	EXP056497	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052642
EXP056507	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	EXP056498	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052643
EXP056508	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	EXP056499	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052644
EXP056509	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	EXP056500	2798	normal	Q61550	resting mature murine splenic B lymphocytes	PEAKS052645
EXP056512	anti-Notch1 (antisera made in lab)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056510	2799	normal	Q01705	primary murine T-ALL (acute lymphocytic leukemia) cells	PEAKS052646
EXP056513	anti-Notch1 (antisera made in lab)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056511	2799	normal	Q01705	primary murine T-ALL (acute lymphocytic leukemia) cells	PEAKS052647
EXP056514	anti-RBPSUH (Cell signaling, 5313)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056510	2799	normal	P31266	primary murine T-ALL (acute lymphocytic leukemia) cells	PEAKS052648
EXP056515	anti-RBPSUH (Cell signaling, 5313)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056511	2799	normal	P31266	primary murine T-ALL (acute lymphocytic leukemia) cells	PEAKS052649
EXP056519	anti-FLAG antibody (Sigma, F2426)	Mus musculus	Treatment: Lhx5-FLAG expression with Doxycycline induced; Strain: C57BL/6;	EXP056516	1245	normal	P61375	Neuro-2A cells	PEAKS052650
EXP056520	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: none (untreated); Tissue: Spleen; Strain: C57BL/6;	NULL	2800	normal	P42227	pre-activated CD4+ T cells	PEAKS052651
EXP056521	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: IL-21 for 1hr; Tissue: Spleen; Strain: C57BL/6;	NULL	2800	normal	P42227	pre-activated CD4+ T cells	PEAKS052652
EXP056522	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: none (untreated); Tissue: Spleen; Strain: C57BL/6;	NULL	2801	normal	P42227	splenic conventional dendritic cells	PEAKS052653
EXP056523	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: IL-21 for 1hr; Tissue: Spleen; Strain: C57BL/6;	NULL	2801	normal	P42227	splenic conventional dendritic cells	PEAKS052654
EXP056527	anti-SUZ12 (Abcam, 12073)	Mus musculus	Treatment: mock;	EXP056524	2802	normal	Q80U70	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS052655
EXP056528	anti-SUZ12 (Abcam, 12073)	Mus musculus	Treatment: 3 uM UNC2400 for 4 days;	EXP056525	2802	normal	Q80U70	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS052656
EXP056529	anti-SUZ12 (Abcam, 12073)	Mus musculus	Treatment: 3 uM UNC1999 for 4 days;	EXP056526	2802	normal	Q80U70	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS052657
EXP056531	anti-Kap1 (homemade rabbit polylconal antibody)	Mus musculus	Developmental stage: proliferating myoblasts; 	EXP056530	1153	normal	Q62318	C2C12 (myoblasts)	PEAKS052658
EXP056533	anti-Usp16	Mus musculus		EXP056532	2747	normal	Q99LG0	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	PEAKS052659
EXP056534	pCREB (Millipore, Ser 133, 06-519)	Mus musculus	Treatment: DMSO vehicle for 1 hour;	NULL	581	normal	Q01147	MC3T3-E1 (preosteoblasts)	PEAKS052660
EXP056535	pCREB (Millipore, Ser 133, 06-519)	Mus musculus	Treatment: 100nM fsk for 1 hour;	NULL	581	normal	Q01147	MC3T3-E1 (preosteoblasts)	PEAKS052661
EXP056536	Anti- LSD1 (Abcam,Cat. No. ab17721)	Mus musculus	Treatment: KCl for 0 hrs; Passage: R26/LSD1n DIV10;	NULL	2803	normal	Q6ZQ88	primary cortical neuron	PEAKS052662
EXP056537	Anti- LSD1 (Abcam,Cat. No. ab17721)	Mus musculus	Treatment: 55 nM KCl for 1hr; Passage: R26/LSD1n DIV10;	NULL	2803	normal	P24270	primary cortical neuron	PEAKS052663
EXP056538	Anti- LSD1 Abcam (Cat. No. ab17721)	Mus musculus	Genotype: LSD1 knockout; 	NULL	2803	normal	P24270	primary cortical neuron	PEAKS052664
EXP056539	Anti- LSD1 Abcam (Cat. No. ab17721)	Mus musculus	Genotype: LSD1 knockout; 	NULL	2803	normal	P24270	primary cortical neuron	PEAKS052665
EXP056540	Anti- FLAG (M2 Sigma, Cat. No. A2220)	Mus musculus	Treatment: KCl for 0 hrs; Passage: R26/LSD1n DIV10;	NULL	2803	normal	Q6ZQ88	primary cortical neuron	PEAKS052666
EXP056541	Anti- FLAG (M2 Sigma, Cat. No. A2220)	Mus musculus	Treatment: 55 nM KCl for 1hr; Passage: R26/LSD1n DIV10;	NULL	2803	normal	Q6ZQ88	primary cortical neuron	PEAKS052667
EXP056544	anti-Brwd1 (E15, sc-83517; Lot J1508)	Mus musculus	Strain: C57BL/6; 	EXP056542	2231	normal	Q921C3	small pre-B cells	PEAKS052668
EXP056545	anti-Brwd1 (E15, sc-83517; Lot J1508)	Mus musculus	Strain: C57BL/6; 	EXP056543	2231	normal	Q921C3	small pre-B cells	PEAKS052669
EXP056548	anti-BRD2 (Bethyl Labs, A302-583A-2)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	2804	normal	Q7JJ13	5.3S (haematopoietic progenitors)	PEAKS052670
EXP056549	anti-BRD3 (Bethyl Labs, A302-368A-1)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	2804	normal	Q8K2F0	5.3S (haematopoietic progenitors)	PEAKS052671
EXP056550	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	2804	normal	Q9ESU6	5.3S (haematopoietic progenitors)	PEAKS052672
EXP056551	anti-BRD2 (Bethyl Labs, A302-583A-2)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	2804	normal	Q7JJ13	5.3S (haematopoietic progenitors)	PEAKS052673
EXP056552	anti-BRD3 (Bethyl Labs, A302-368A-1)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	2804	normal	Q8K2F0	5.3S (haematopoietic progenitors)	PEAKS052674
EXP056553	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	2804	normal	Q9ESU6	5.3S (haematopoietic progenitors)	PEAKS052675
EXP056554	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	EXP056546	400	normal	Q9ESU6	hematopoietic progenitors	PEAKS052676
EXP056555	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	EXP056547	400	normal	Q9ESU6	hematopoietic progenitors	PEAKS052677
EXP056556	anti-B-catenin	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	EXP056547	400	normal	Q02248	hematopoietic progenitors	PEAKS052678
EXP056557	anti-B-catenin	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	EXP056546	400	normal	Q02248	hematopoietic progenitors	PEAKS052679
EXP056558	B-catenin	Mus musculus	Phenotype: BET inhibitor resistant + DKK; Strain: C57BL/6; Treatment: 600nM I-BET151; 	EXP056546	400	normal	Q02248	hematopoietic progenitors	PEAKS052680
EXP056562	Brd2 (Bethyl; IHC-00612)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056559	1117	normal	Q7JJ13	primary T-cells	PEAKS052681
EXP056563	Brd4 (Bethyl; IHC-00396)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056559	1117	normal	Q9ESU6	primary T-cells	PEAKS052682
EXP056564	Brd4 (Bethyl; IHC-00396)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q9ESU6	primary T-cells	PEAKS052683
EXP056565	Brd4 (Bethyl; IHC-00396)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; Genotype: STat3 knockout;	EXP056560	1117	normal	Q9ESU6	primary T-cells	PEAKS052684
EXP056566	Nipbl (Bethyl; A301-779A)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q6KCD5	primary T-cells	PEAKS052685
EXP056567	Smc1 (Bethyl; A300-055A)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q9CU62	primary T-cells	PEAKS052686
EXP056568	Smc3 (Abcam; ab9263)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q9CW03	primary T-cells	PEAKS052687
EXP056572	RAD23B	Mus musculus	Genotype: wildtype; 	EXP056569	204	normal	P54728	D3 (embryonic stem cells)	PEAKS052688
EXP056573	RAD23B	Mus musculus	Genotype: wildtype; 	EXP056570	204	normal	P54728	D3 (embryonic stem cells)	PEAKS052689
EXP056574	RAD23B	Mus musculus	Genotype: Xpc-/- (knockout);	EXP056571	2	normal	P54728	mESCs (mouse embryonic stem cells)	PEAKS052690
EXP056575	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Treatment: absence (control); Strain: C57Bl/6; Genotype: Jmjd2a(f/f), Rosa26::CreERT2;	NULL	2	normal	Q8BW72	mESCs (mouse embryonic stem cells)	PEAKS052691
EXP056576	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Treatment: 500 nM OHT for up to 12 days; Strain: C57Bl/6; Genotype: Jmjd2a(f/f), Rosa26::CreERT2;	NULL	2	normal	Q8BW72	mESCs (mouse embryonic stem cells)	PEAKS052692
EXP056577	anti-V5	Mus musculus	Genotype: V5-tagged Fbxl10;	NULL	18	normal	Q6P1G2	3T3-L1 (embryonic fibroblasts)	PEAKS052693
EXP056578	anti-RING1B	Mus musculus	Genotype: V5-tagged Fbxl10;	NULL	18	normal	Q9CQJ4	3T3-L1 (embryonic fibroblasts)	PEAKS052694
EXP056579	anti-RING1B	Mus musculus	Genotype: V5-tagged dF-box mutant Fbxl10;	NULL	18	normal	Q9CQJ4	3T3-L1 (embryonic fibroblasts)	PEAKS052695
EXP056580	anti-RING1B	Mus musculus	Genotype: empty vector;	NULL	18	normal	Q9CQJ4	3T3-L1 (embryonic fibroblasts)	PEAKS052696
EXP056583	Anti-Sirt1 (Upstate, 07-131)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; 	EXP056581	2806	normal	Q923E4	quiescent satellite cells	PEAKS052697
EXP056584	Anti-Sirt1 (Upstate, 07-131)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; 	EXP056582	2807	normal	Q923E4	proliferating satellite cells	PEAKS052698
EXP056592	Aff3 (Homemade#182)	Mus musculus		EXP056585	252	normal	P51827	V6.5 (embryonic stem cells)	PEAKS052699
EXP056593	Aff3 (Homemade#182)	Mus musculus		EXP056586	252	normal	P51827	V6.5 (embryonic stem cells)	PEAKS052700
EXP056594	Aff3 (Homemade#13)	Mus musculus		EXP056585	252	normal	P51827	V6.5 (embryonic stem cells)	PEAKS052701
EXP056595	Aff3 (Homemade#182)	Mus musculus	Strain: KH2;	EXP056587	2	normal	P51827	mESCs (mouse embryonic stem cells)	PEAKS052702
EXP056596	Aff3 (Homemade#182)	Mus musculus	Strain: AG MEF; 	EXP056590	12	normal	P51827	MEF (mouse embryonic fibroblasts)	PEAKS052703
EXP056597	Aff3 (Homemade#182)	Mus musculus	Strain: PG MEF; 	EXP056591	12	normal	P51827	MEF (mouse embryonic fibroblasts)	PEAKS052704
EXP056598	Aff3 (Homemade#182)	Mus musculus	Strain: TC1; Genotype: wildtype; 	NULL	2	normal	P51827	mESCs (mouse embryonic stem cells)	PEAKS052705
EXP056599	Aff3 (Homemade#182)	Mus musculus	Strain: TC1; Genotype: Zfp57 knockout;	EXP056589	2	normal	P51827	mESCs (mouse embryonic stem cells)	PEAKS052706
EXP056601	anti-HP1b(Euromedex 1MOD-1A9-AS, lot# 091809)	Mus musculus	Strain: 129P2/Ola;	EXP056600	2	normal	P83917	mESCs (mouse embryonic stem cells)	PEAKS052707
EXP056604	anti-Oct4	Mus musculus	Treatment: 0 hr treatment; Strain: C57BL/6;	EXP056602	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS052708
EXP056605	anti-Oct4	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	EXP056603	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS052709
EXP056606	anti-Spt16	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	EXP056603	2	normal	A1A546	mESCs (mouse embryonic stem cells)	PEAKS052710
EXP056607	anti-Jmjd1c	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	EXP056603	2	normal	Q69ZK6	mESCs (mouse embryonic stem cells)	PEAKS052711
EXP056609	EZH1 (gift from Sartorelli, Mousavi et al. Mol. Cell 2012)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: E2 knockout;	EXP056608	573	normal	Q61188	mammary tissue	PEAKS052712
EXP056610	EZH1 (gift from Sartorelli, Mousavi et al. Mol. Cell 2012)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: MMTV-Cre, wildtype;	EXP056608	573	normal	Q61188	mammary tissue	PEAKS052713
EXP056611	EZH2 (Diagenode, cat# C15410039 and lot# 003)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: E2 knockout;	EXP056608	573	normal	Q61188	mammary tissue	PEAKS052714
EXP056612	EZH2 (Diagenode, cat# C15410039 and lot# 003)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: MMTV-Cre, wildtype;	EXP056608	573	normal	Q61188	mammary tissue	PEAKS052715
EXP056614	anti-Setdb1 (Santa Cruz, H-300 sc-66884)	Mus musculus	treatment: none;	EXP056613	126	normal	O88974	C2C12 (myotubes)	PEAKS052716
EXP056615	anti-Setdb1 (Santa Cruz, H-300 sc-66884)	Mus musculus	Treatment: DMSO for 24 hrs;	EXP056613	126	normal	O88974	C2C12 (myotubes)	PEAKS052717
EXP056616	anti-Setdb1 (Santa Cruz, H-300 sc-66884)	Mus musculus	Treatment: 50 ng/ml Wnt-3a (#1324-WN, R&D systems) for 24 hrs;	EXP056613	126	normal	O88974	C2C12 (myotubes)	PEAKS052718
EXP056619	Sirt6 (Cell Signaling Technology, 12486 in a ratio of 1ml/2e7 cells)	Mus musculus	Treatment: No; Genotype: wildtype;	EXP056617	963	normal	P59941	embryonic stem cells from stran 129	PEAKS052719
EXP056620	Sirt6 (Cell Signaling Technology, 12486 in a ratio of 1ml/2e7 cells)	Mus musculus	Treatment: No; Genotype: Sirt6 knockout;	EXP056618	963	normal	P59941	embryonic stem cells from stran 129	PEAKS052720
EXP056621	Sirt6 (Cell Signaling Technology, 12486 in a ratio of 5ml/2e7 cells)	Mus musculus	Treatment: No; Genotype: Sirt6 knockout;	EXP056618	963	normal	P59941	embryonic stem cells from stran 129	PEAKS052721
EXP056623	anti-FLAG (Sigma,F7425)	Mus musculus	Strain: 129/Ola; Developmental stage: 2 days;	EXP056622	216	normal	O09106	differentiated embryonic stem cells	PEAKS052722
EXP056625	anti-FLAG M2 (Sigma, M8823)	Mus musculus	Genotype: stable Flag-Set1a; Treatment: treated with 1ug/ml puromycin;	EXP056624	176	normal	E9PYH6	CGR8 (embryonic stem cells)	PEAKS052723
EXP056626	SUMO1 (Y299 monoclonal antibody)	Mus musculus	Genotype: UBC9 wildtype; Treatment: none;	NULL	2808	normal	P63166	bone marrow derived dendritic cells	PEAKS052724
EXP056627	SUMO1 (Y299 monoclonal antibody)	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 2 hours;	NULL	2808	normal	P63166	bone marrow derived dendritic cells	PEAKS052725
EXP056628	SUMO2	Mus musculus	Genotype: UBC9 wildtype; Treatment: none;	NULL	2808	normal	P61957	bone marrow derived dendritic cells	PEAKS052726
EXP056629	SUMO2	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 2 hours;	NULL	2808	normal	P61957	bone marrow derived dendritic cells	PEAKS052727
EXP056630	SUMO1 (Y299 monoclonal antibody)	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 1 hours;	NULL	2808	normal	P63166	bone marrow derived dendritic cells	PEAKS052728
EXP056631	SUMO2	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 1 hours;	NULL	2808	normal	P61957	bone marrow derived dendritic cells	PEAKS052729
EXP056635	HEY1	Homo sapiens	None	NULL	514	normal	Q9Y5J3	K562 (myelogenous leukemia)	PEAKS052730
EXP056636	HEY1	Homo sapiens	Treatment: None;	NULL	430	normal	Q9Y5J3	HepG2 (hepatoblastoma)	PEAKS052731
EXP056637	BCL3	Homo sapiens	Treatment: None;	NULL	514	normal	P20749	K562 (myelogenous leukemia)	PEAKS052732
EXP056638	anti-PML (Millipore, catalog# 05-718, lot# 2684855)	Mus musculus	Treatment: untreated; Developmental stage: Proliferating; genotype: wildtype; Strain: C57BL/6; Passage: 10-15;  	NULL	12	normal	Q60953	MEF (mouse embryonic fibroblasts)	PEAKS052733
EXP056639	anti-PML (Millipore, catalog# 05-718, lot# 2684855)	Mus musculus	Treatment: untreated; Developmental stage: Proliferating; genotype: PML knockout; Strain: C57BL/6; Passage: 10-15;  	NULL	12	normal	Q60953	MEF (mouse embryonic fibroblasts)	PEAKS052734
EXP056640	anti-ESR1 (Santa Cruz Biotechnology, sc-8002X)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Tissue: spleen;	NULL	41	normal	P19785	B-cells	PEAKS052735
EXP056641	anti-Nbs1 (Abcam, ab32074)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Tissue: spleen;	NULL	41	normal	Q9R207	B-cells	PEAKS052736
EXP056642	anti-Nbs1 (Abcam, ab32074)	Mus musculus	Genotype: Aid knockout; Strain: C57BL/6; Tissue: spleen;	NULL	41	normal	Q9R207	B-cells	PEAKS052737
EXP056646	Setdb1 (Santa Cruz Biotechnology, sc-66884, lot L1812)	Mus musculus	Sex: female; Genotype: Setdb1+/+ Xist-deltaA/+; Strain: 129/C57 dams x CAST sires;	EXP056643	750	normal	O88974	E13.5 embryonic fibroblasts	PEAKS052738
EXP056647	Setdb1 (Santa Cruz Biotechnology, sc-66884, lot L1812)	Mus musculus	Sex: male; Genotype: Setdb1+/+ X/Y; Strain: 129/C57 dams x CAST sires;	EXP056644	750	normal	O88974	E13.5 embryonic fibroblasts	PEAKS052739
EXP056648	Setdb1 (Santa Cruz Biotechnology, sc-66884, lot L1812)	Mus musculus	Treatment: shSetdb1; Sex: female; Genotype: Setdb1+/gt Xist-deltaA/+; Strain: 129/C57 dams x CAST sires;	EXP056645	750	normal	O88974	E13.5 embryonic fibroblasts	PEAKS052740
EXP056651	anti-Flag (Sigma F1804)	Mus musculus		EXP056650	506	normal	Q3URQ0	J1 (embryonic stem cells)	PEAKS052741
EXP056654	anti-GPS2 (N-terminal home raised)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;  Age: 12-16 weeks;	EXP056652	81	normal	Q921N8	BMDM (bone marrow-derived macrophages)	PEAKS052742
EXP056655	anti-GPS2 (N-terminal home raised)	Mus musculus	Strain: C57BL/6; Genotype: GPS2 knockout;  Age: 12-16 weeks;	EXP056652	81	normal	Q921N8	BMDM (bone marrow-derived macrophages)	PEAKS052743
EXP056656	anti-GPS2 (C-terminal home raised)	Mus musculus		EXP056653	91	normal	Q921N8	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052744
EXP056657	anti-GPS2 (N-terminal home raised)	Mus musculus		EXP056653	91	normal	Q921N8	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052745
EXP056660	anti-Suz12 (Abcam, ab12073)	Mus musculus	Treatment: No Tamoxifen; Genotype: Ezh2 wildtype; 	EXP056658	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052746
EXP056661	anti-Ezh2 (Cell Signaling, #3147)	Mus musculus	Treatment: No Tamoxifen; Genotype: Ezh2 wildtype; 	EXP056658	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052747
EXP056662	anti-Suz12 (Abcam, ab12073)	Mus musculus	Genotype: Ezh2 knockout; Treatment: treated with 800 nM 4-hydroxy-tamoxifen for 96 hours;	EXP056659	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052748
EXP056663	anti-Ezh2 (Cell Signaling, #3147)	Mus musculus	Genotype: Ezh2 knockout; Treatment: treated with 800 nM 4-hydroxy-tamoxifen for 96 hours;	EXP056659	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052749
EXP056664	anti-p300(Bethyl, A300-358A)	Mus musculus	Treatment: No Rnase;Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	PEAKS052750
EXP056665	anti-p300(Bethyl, A300-358A)	Mus musculus	Treatment: plus RNase; Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	PEAKS052751
EXP056666	anti-Suz12 (Abcam, ab12073)	Mus musculus	Treatment: No Rnase;Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052752
EXP056667	anti-Suz12 (Abcam, ab12073)	Mus musculus	Treatment: plus RNase; Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052753
EXP056671	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 6 weeks;	EXP056668	965	normal	Q9Z2D6	frontal cortex	PEAKS052754
EXP056672	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 6 weeks;	EXP056669	965	normal	Q9Z2D6	frontal cortex	PEAKS052755
EXP056673	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8 weeks;	EXP056670	965	normal	Q9Z2D6	frontal cortex	PEAKS052756
EXP056674	anti-MYO1C	Mus musculus	Passage: 20-25; Strain: C5;	NULL	12	normal	Q9WTI7	MEF (mouse embryonic fibroblasts)	PEAKS052757
EXP056676	anti-GFP	Mus musculus	Genotype: Mecp2-/y, MECP2-EGFP; Age: 7 weeks;	EXP056675	2586	normal	Q9Z2D6	hypothalamus	PEAKS052758
EXP056680	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	PEAKS052759
EXP056681	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) for 9 hrs;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	PEAKS052760
EXP056682	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: Triptolide (TRI) for 4 hrs;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	PEAKS052761
EXP056683	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: RNase H1 overexpression;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	PEAKS052762
EXP056684	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	PEAKS052763
EXP056685	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) for 9 hrs;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	PEAKS052764
EXP056686	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: Triptolide (TRI) for 4 hrs;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	PEAKS052765
EXP056687	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: RNase H1 overexpression;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	PEAKS052766
EXP056688	Suz12 (A302-407A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056678	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052767
EXP056689	Suz12 (A302-407A; Bethyl)	Mus musculus		EXP056678	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052768
EXP056690	Suz12 (A302-407A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056679	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052769
EXP056691	Suz12 (A302-407A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: RNase H1 overexpression;	EXP056679	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS052770
EXP056692	anti-Brg1	Mus musculus	Treatment: vehicle;	NULL	2809	normal	Q3TKT4	iBATs (immortalized brown adipocytes)	PEAKS052771
EXP056693	anti-Brg1	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	Q3TKT4	iBATs (immortalized brown adipocytes)	PEAKS052772
EXP056694	anti-Arid1a	Mus musculus	Treatment: vehicle;	NULL	2809	normal	A2BH40	iBATs (immortalized brown adipocytes)	PEAKS052773
EXP056695	anti-Arid1a	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	A2BH40	iBATs (immortalized brown adipocytes)	PEAKS052774
EXP056696	anti-Ppar-g	Mus musculus	Treatment: vehicle;	NULL	2809	normal	P37238	iBATs (immortalized brown adipocytes)	PEAKS052775
EXP056697	anti-Ppar-g	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	P37238	iBATs (immortalized brown adipocytes)	PEAKS052776
EXP056698	anti-Jmjd1a	Mus musculus	Treatment: vehicle;	NULL	2809	normal	Q6PCM1	iBATs (immortalized brown adipocytes)	PEAKS052777
EXP056699	anti-Jmjd1a	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	Q6PCM1	iBATs (immortalized brown adipocytes)	PEAKS052778
EXP056702	Smyd3 antiserum (raised in-house in rabbits injected with full length recombinant Smyd3 protein)	Mus musculus	Genotype: wildtype; Age: 8.5 months; Strain: C57BL6/CBA;	EXP056700	5	normal	Q9CWR2	liver	PEAKS052779
EXP056703	Smyd3 antiserum (raised in-house in rabbits injected with full length recombinant Smyd3 protein)	Mus musculus	Genotype: wildtype; Age: 8.5 months; Strain: C57BL6/CBA;	EXP056701	5	normal	Q9CWR2	liver	PEAKS052780
EXP056705	Mel18 (Santa Cruz, catalog: H-115-X, lot: D0903)	Mus musculus		NULL	233	normal	P23798	E14TG2A (embryonic stem cells)	PEAKS052781
EXP056706	Mel18 (Santa Cruz, catalog: H-115-X, lot: D0903)	Mus musculus		EXP056704	2810	normal	P23798	E14Tg2A derived mesoderm precursors	PEAKS052782
EXP056707	Cbx2 (Bethyl, catalog:A302-524A, lot: A302-524A-1)	Mus musculus		EXP056704	2810	normal	P30658	E14Tg2A derived mesoderm precursors	PEAKS052783
EXP056708	Ring1b (Home-made)	Mus musculus		EXP056704	2810	normal	Q9CQJ4	E14Tg2A derived mesoderm precursors	PEAKS052784
EXP056709	RYBP (Millipore, catalog: Ab3637, lot: 2066315)	Mus musculus		EXP056704	2810	normal	Q8CCI5	E14Tg2A derived mesoderm precursors	PEAKS052785
EXP056710	Brd2 (Bethyl A302-583A, lot 1)	Mus musculus	Genotype: wildtype; Treatment: none;	NULL	252	normal	Q7JJ13	V6.5 (embryonic stem cells)	PEAKS052786
EXP056711	Brd2 (Bethyl A302-583A, lot 1)	Mus musculus	Genotype: H2A.Z(WT)-YFP; Treatment: expressing wild type H2A.Z;	NULL	252	normal	Q7JJ13	V6.5 (embryonic stem cells)	PEAKS052787
EXP056712	Brd4 (Bethyl A301-985A50, lot 3)	Mus musculus	Genotype: H2A.Z(WT)-YFP; Treatment: expressing wild type H2A.Z;	NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS052788
EXP056713	Brd2 (Bethyl A302-583A, lot 1)	Mus musculus	Treatment: H2A.Z(K3R3)-YFP; Genotype: expressing a ubiquitin mutant version of H2A.Z;	NULL	252	normal	Q7JJ13	V6.5 (embryonic stem cells)	PEAKS052789
EXP056714	Brd4 (Bethyl A301-985A50, lot 3)	Mus musculus	Treatment: H2A.Z(K3R3)-YFP; Genotype: expressing a ubiquitin mutant version of H2A.Z;	NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	PEAKS052790
EXP056716	Anti-Trim33 (Bethyl Laboratories, A301-060A)	Mus musculus	Strain:FVB; Age: 84 days post partum; Genotype: Trim33 +/+;	EXP056715	32	normal	Q99PP7	testis	PEAKS052791
EXP056718	anti-beta-actin (clone AC74, Sigma Aldrich)	Mus musculus	Strain: C5; Passage: 20-25;	EXP056717	12	normal	P60710	MEF (mouse embryonic fibroblasts)	PEAKS052792
EXP056719	anti-WSTF (Abcam, ab50850)	Mus musculus	Strain: C5; Passage: 20-25;	EXP056717	12	normal	Q9Z277	MEF (mouse embryonic fibroblasts)	PEAKS052793
EXP056720	anti-SNF2h (Abcam, ab3749)	Mus musculus	Strain: C5; Passage: 20-25;	EXP056717	12	normal	Q91ZW3	MEF (mouse embryonic fibroblasts)	PEAKS052794
EXP056721	GATA1 (sc265)	Mus musculus	Strain: 129;	NULL	265	normal	P17679	G1E (embryonic stem cells)	PEAKS052795
EXP056722	GATA1 (sc265)	Mus musculus	Strain: 129; Treatment: none;	NULL	319	normal	P17679	G1E-ER4 (embryonic stem cells)	PEAKS052796
EXP056723	GATA1 (sc265)	Mus musculus	Strain: 129; Treatment: 3 hours with 10 nM beta-estradiol (Hardison);	NULL	319	normal	P17679	G1E-ER4 (embryonic stem cells)	PEAKS052797
EXP056724	GATA1 (sc265)	Mus musculus	Strain: 129; Treatment: 24 hours with 10 nM beta-estradiol (Hardison);	NULL	319	normal	P17679	G1E-ER4 (embryonic stem cells)	PEAKS052798
EXP056725	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: none; 	NULL	265	normal	P22091	G1E (embryonic stem cells)	PEAKS052799
EXP056726	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: none; 	NULL	319	normal	P22091	G1E-ER4 (embryonic stem cells)	PEAKS052800
EXP056727	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: 3 hours  with 10 nM beta-estradiol (Hardison)	NULL	319	normal	P22091	G1E-ER4 (embryonic stem cells)	PEAKS052801
EXP056728	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: 24 hours  with 10 nM beta-estradiol (Hardison)	NULL	319	normal	P22091	G1E-ER4 (embryonic stem cells)	PEAKS052802
EXP056730	anti-Brg1/Brm (J1, Khavari et al., 1993).	Mus musculus	Genotype: CAG-CreER, Rosa26-SmoM2; 	EXP056729	2570	normal	Q3TKT4	medulloblastoma	PEAKS052803
EXP056736	anti-OTX2 (R&D, catalog# AF1979, lot# KNO0211051)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	EXP056731	2812	normal	P80206	basal ganglia and septum	PEAKS052804
EXP056737	anti-OTX2 (R&D, catalog# AF1979, lot# KNO0211051)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	EXP056733	2812	normal	P80206	basal ganglia and septum	PEAKS052805
EXP056738	anti-OTX2 (R&D, catalog# AF1979, lot# KNO0211051)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	EXP056735	2812	normal	P80206	basal ganglia and septum	PEAKS052806
EXP056743	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; 	EXP056739	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS052807
EXP056744	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; 	EXP056740	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS052808
EXP056745	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; Genotype: Ring1B I53A/I53A;	EXP056741	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052809
EXP056746	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; Genotype: Ring1B I53A/I53A;	EXP056742	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052810
EXP056747	anti-RING1B (Activ Motif 39664, Lot. 23012002)	Mus musculus	Developmental stage: E11.5; Strain: CD1;	NULL	2813	normal	Q9CQJ4	proximal forelimb bud	PEAKS052811
EXP056748	anti-RING1B (Activ Motif 39664, Lot. 23012002)	Mus musculus	Developmental stage: E11.5; Strain: CD1;	NULL	2814	normal	Q9CQJ4	distal forelimb bud	PEAKS052812
EXP056753	anti-Lap2a (8C10-1H11, hybridoma supernatant)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	Q61029	fibroblasts	PEAKS052813
EXP056754	anti-Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	P48678	fibroblasts	PEAKS052814
EXP056755	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	P48678	fibroblasts	PEAKS052815
EXP056756	Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056750	897	normal	P48678	fibroblasts	PEAKS052816
EXP056757	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056750	897	normal	P48678	fibroblasts	PEAKS052817
EXP056758	anti-Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056751	897	normal	P48678	fibroblasts	PEAKS052818
EXP056759	anti-Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056752	897	normal	P48678	fibroblasts	PEAKS052819
EXP056760	Lap2alpha 8C10-1H11, hybridoma supernatant	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056751	897	normal	A1A546	fibroblasts	PEAKS052820
EXP056761	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus		EXP056751	897	normal	P48678	fibroblasts	PEAKS052821
EXP056762	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus		EXP056752	897	normal	P48678	fibroblasts	PEAKS052822
EXP056763	anti-LaminB1 (Proteintech, 12987-1-AP)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	P14733	fibroblasts	PEAKS052823
EXP056764	anti-LaminB1 (Proteintech, 12987-1-AP)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056751	897	normal	P14733	fibroblasts	PEAKS052824
EXP056766	Anti-HA	Mus musculus	Genotype: Atad2 TAP-tag; 	EXP056765	2448	normal	Q8CDM1	46C (embryonic stem cell)	PEAKS052825
EXP056768	anti-Notch1	Mus musculus	Strain: CD1; 	EXP056767	2815	normal	Q01705	mK4	PEAKS052826
EXP056773	anti-HA (sc-7392, Santa Cruz Biotechnology)	Mus musculus	Treatment: CRISPR and donor plasmids were co-transfected ; 	EXP056769	292	normal	Q9QWF0	F9 (embryonal carcinoma)	PEAKS052827
EXP056774	anti-HA (sc-7392, Santa Cruz Biotechnology)	Mus musculus	Treatment: transient transfection of pCAG-HA-ZFP809 (isoform 2);	EXP056770	668	normal	G3X9G7	ES-D3 embryonic stem cell-derived neurons	PEAKS052828
EXP056775	Anti-Sumo2/3 (abcam, Cat #:ab3742, Lot:GR54180-2)	Mus musculus		EXP056771	230	normal	P61957	ES-E14 (E14, embryonic stem cells)	PEAKS052829
EXP056776	anti-KAP-1 (Affinity Purified,Â  1mg/ml, A300-274A,BETHYL)	Mus musculus		EXP056772	230	normal	Q62318	ES-E14 (E14, embryonic stem cells)	PEAKS052830
EXP056779	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Genotype: wild-type; Strain: B6.129P2(C)-Mecp2tm1.1Bird/J X C57BL/6J;	EXP056777	2929	normal	Q9Z2D6	olfactory epithelium	PEAKS052831
EXP056780	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Genotype: wild-type; Strain: B6.129P2(C)-Mecp2tm1.1Bird/J X C57BL/6J;	EXP056778	2929	normal	Q9Z2D6	olfactory epithelium	PEAKS052832
EXP056784	BRD4 (A301-985A; Bethyl)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056781	2717	normal	Q9ESU6	RN2 (acute myeloid leukemia)	PEAKS052833
EXP056785	NSD3 (polyclonal antibody made in house raised against the peptide: PTDYYHSEIPNTRPHEC)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056781	2717	normal	Q6P2L6	RN2 (acute myeloid leukemia)	PEAKS052834
EXP056786	CHD8 (#A301-224A; Bethyl)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056781	2717	normal	Q09XV5	RN2 (acute myeloid leukemia)	PEAKS052835
EXP056787	CHD8 (#A301-224A; Bethyl)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056783	2717	normal	Q09XV5	RN2 (acute myeloid leukemia)	PEAKS052836
EXP056788	NSD3 (polyclonal antibody made in house raised against the peptide: PTDYYHSEIPNTRPHEC)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056783	2717	normal	Q6P2L6	RN2 (acute myeloid leukemia)	PEAKS052837
EXP056799	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Mus musculus	Genotype: wildtype; Strain: B6/129;	EXP056793	12	normal	P97496	MEF (mouse embryonic fibroblasts)	PEAKS052838
EXP056800	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Mus musculus	Genotype: wildtype; Strain: B6/129;	EXP056793	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	PEAKS052839
EXP056801	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	EXP056791	12	normal	P97496	MEF (mouse embryonic fibroblasts)	PEAKS052840
EXP056802	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	EXP056792	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	PEAKS052841
EXP056803		Mus musculus	Genotype: wildtype; Strain: B6/129;	NULL	12	normal	A0A023J5X2	MEF (mouse embryonic fibroblasts)	PEAKS052842
EXP056805	anti-Ring1B (home made)	Mus musculus		EXP056804	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS052843
EXP056806	anti-Dzip3 (home made)	Mus musculus		EXP056804	230	normal	Q7TPV2	ES-E14 (E14, embryonic stem cells)	PEAKS052844
EXP056809	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day3;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052845
EXP056810	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day3;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052846
EXP056811	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day 1;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052847
EXP056812	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day 1;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052848
EXP056813	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: Serum medium growth cells;	EXP056807	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052849
EXP056814	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: Serum medium growth cells;	EXP056807	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052850
EXP056815	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: 2i medium growth cells;	EXP056808	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052851
EXP056816	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: 2i medium growth cells;	EXP056808	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052852
EXP056822	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	EXP056817	987	normal	O88895	hippocampus	PEAKS052853
EXP056823	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	EXP056818	987	normal	O88895	hippocampus	PEAKS052854
EXP056824	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	EXP056819	987	normal	O88895	hippocampus	PEAKS052855
EXP056825	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Age: P45;	EXP056820	987	normal	O88895	hippocampus	PEAKS052856
EXP056826	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: Mecp2 knockout; Age: P45;	EXP056821	987	normal	O88895	hippocampus	PEAKS052857
EXP056833	anti-Leo1	Mus musculus		NULL	1153	normal	Q5XJE5	C2C12 (myoblasts)	PEAKS052858
EXP056834	anti-Leo1	Mus musculus		EXP056828	126	normal	Q5XJE5	C2C12 (myotubes)	PEAKS052859
EXP056835	anti-Paf1	Mus musculus		EXP056829	1153	normal	P55098	C2C12 (myoblasts)	PEAKS052860
EXP056836		Mus musculus		EXP056830	126	normal	P55098	C2C12 (myotubes)	PEAKS052861
EXP056837	anti-Rtf1	Mus musculus		EXP056831	1153	normal	A2AQ19	C2C12 (myoblasts)	PEAKS052862
EXP056838	anti-Rtf1	Mus musculus		EXP056832	126	normal	A2AQ19	C2C12 (myotubes)	PEAKS052863
EXP056840	anti-MED1 (Bethyl lab, A300-793A)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: 1 day of lactation;	EXP056839	572	normal	Q925J9	mammary gland	PEAKS052864
EXP056843	Dnmt3b (ab122932)	Mus musculus	Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	EXP056841	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052865
EXP056844	Dnmt3b (ab122932)	Mus musculus	Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	EXP056842	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052866
EXP056845	Dnmt3b (ab122932)	Mus musculus	Treatment: control shRNA; Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052867
EXP056846	Dnmt3b (ab122932)	Mus musculus	Treatment: empry vector; Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052868
EXP056847	Dnmt3b (ab122932)	Mus musculus	Treatment: Dnmt3b wildtype transfected; Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052869
EXP056848	Dnmt3b (ab122932)	Mus musculus	Treatment: Dnmt3b V725G wildtype transfected; Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052870
EXP056849	Dnmt3b (ab122932)	Mus musculus	Treatment: Setd2 shRNA; Genotype: Setd2 knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	PEAKS052871
EXP056850	Dnmt3a (Abcam ab13888, mouse)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/+); 	NULL	12	normal	O88508	MEF (mouse embryonic fibroblasts)	PEAKS052872
EXP056851	Dnmt3a (Abcam ab2850, rabbit)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/+); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS052873
EXP056852	Dnmt3a (Abcam ab13888, mouse)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/-); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS052874
EXP056853	Dnmt3a (Abcam ab2850, rabbit)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/-); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS052875
EXP056854	Dnmt3a (Abcam ab13888, mouse)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(-/m); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS052876
EXP056855	Dnmt3a (Abcam ab2850, rabbit)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(-/m); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS052877
EXP056859	anti-SETDB1	Mus musculus		EXP056856	839	normal	O88974	TT2 (embryonic stem cells)	PEAKS052878
EXP056860	anti-SETDB1	Mus musculus		EXP056857	213	normal	O88974	mesenchymal stem cells	PEAKS052879
EXP056861	anti-SETDB1	Mus musculus	Developmental stage: day 6 of differentiation; 	NULL	20	normal	O88974	3T3-L1-derived adipocytes	PEAKS052880
EXP056862	anti-SETDB1	Mus musculus	Treatment: control siRNA;	NULL	21	bio_control	O88974	3T3-L1-derived preadipocytes and adipocytes	PEAKS052881
EXP056863	anti-SETDB1	Mus musculus	Treatment: siRNA targeting Mbd1; Genotype: Mbd1 knockout;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	PEAKS052882
EXP056864	anti-SETDB1	Mus musculus	Treatment: siRNA targeting Mcaf1; Genotype: Mcaf1 knockout;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	PEAKS052883
EXP056865	anti-SETDB1	Mus musculus	Treatment: none;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	PEAKS052884
EXP056866	anti-SETDB1	Mus musculus	Treatment: siRNA targeting Setdb1; Genotype: Setdb1 knockout;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	PEAKS052885
EXP056867	anti-SETDB1	Mus musculus		EXP056858	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	PEAKS052886
EXP056868	anti-MBD1	Mus musculus		EXP056858	21	normal	Q9Z2E2	3T3-L1-derived preadipocytes and adipocytes	PEAKS052887
EXP056889	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056869	2930	normal	P25916	primary B220 B cells	PEAKS052888
EXP056890	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056869	2930	normal	O88559	primary B220 B cells	PEAKS052889
EXP056891	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056871	1058	normal	P25916	CD4+ T-cells	PEAKS052890
EXP056892	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056871	1058	normal	O88559	CD4+ T-cells	PEAKS052891
EXP056893	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056873	76	normal	P25916	Th1-cells	PEAKS052892
EXP056894	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056873	76	normal	O88559	Th1-cells	PEAKS052893
EXP056895	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056875	499	normal	P25916	Th2-cells	PEAKS052894
EXP056896	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056875	499	normal	O88559	Th2-cells	PEAKS052895
EXP056897	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056877	2742	normal	P25916	resting Th2 CD4+ T helper cells	PEAKS052896
EXP056898	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056877	2742	normal	O88559	resting Th2 CD4+ T helper cells	PEAKS052897
EXP056899	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056880	2930	normal	Q61188	primary B220 B cells	PEAKS052898
EXP056900	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056881	1058	normal	Q61188	CD4+ T-cells	PEAKS052899
EXP056901	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Strain: C57BL/6;	EXP056883	2931	normal	Q61188	B6N-22 (embryonic stem cell)	PEAKS052900
EXP056902	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Strain: C57BL/6;	NULL	2931	normal	P25916	B6N-22 (embryonic stem cell)	PEAKS052901
EXP056903	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Strain: C57BL/6;	NULL	2931	normal	O88559	B6N-22 (embryonic stem cell)	PEAKS052902
EXP056904	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Strain: C57BL/6;	EXP056885	2931	normal	Q61188	B6N-22 (embryonic stem cell)	PEAKS052903
EXP056905	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Strain: C57BL/6;	EXP056885	2931	normal	O88559	B6N-22 (embryonic stem cell)	PEAKS052904
EXP056906	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056886	1058	normal	Q61188	CD4+ T-cells	PEAKS052905
EXP056907	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056871	1058	normal	O88559	CD4+ T-cells	PEAKS052906
EXP056908	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056887	499	normal	Q61188	Th2-cells	PEAKS052907
EXP056909	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056887	499	normal	O88559	Th2-cells	PEAKS052908
EXP056910	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6; Treatment: 10 nM TSA;	EXP056888	499	normal	Q61188	Th2-cells	PEAKS052909
EXP056911	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6; Treatment: 10 nM TSA;	EXP056888	499	normal	O88559	Th2-cells	PEAKS052910
EXP056913	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Genotype: B6/Humanized; Strain: C57BL/6J;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052911
EXP056914	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Genotype: Humanized/Humanized; Strain: C57BL/6J;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052912
EXP056915	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Genotype: PWD/PWD; Strain: PWD/PhJ;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052913
EXP056916	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: PWD/B6;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052914
EXP056917	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: PWD/Humanized;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052915
EXP056918	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: B6/PWD;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052916
EXP056919	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: Humanized/PWD;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052917
EXP056920	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: B6/CAST;	NULL	2932	normal	Q61880	whole adult testis	PEAKS052918
EXP056923	anti-DDX5 (Abcam, ab10261, #GR101334-5)	Mus musculus	Genotype: DX5+/+, CD4Cre+; Strain: C57BL/6; Age: 6-8 weeks;	EXP056921	498	normal	Q61656	Th17-cells	PEAKS052919
EXP056924	anti-DDX5 (Abcam, ab10261, #GR101334-5)	Mus musculus	Genotype: DX5+/+, CD4Cre+; Strain: C57BL/6; Age: 6-8 weeks;	EXP056922	498	normal	Q61656	Th17-cells	PEAKS052920
EXP056925	anti-FLAG antibody (Sigma F3165)	Mus musculus		NULL	230	normal	Q8K3Y3	ES-E14 (E14, embryonic stem cells)	PEAKS052921
EXP056927	anti-FLAG	Mus musculus	Genotype: BRG-FLAG; 	EXP056926	1027	normal	Q3TKT4	P0 retina	PEAKS052922
EXP056930	anti-Suz12 (Abcam, ab12073)	Mus musculus	Strain: R1; 	EXP056928	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052923
EXP056931	anti-Ezh2 (Diagenode, pAB-039-050)	Mus musculus	Strain: R1; 	EXP056928	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052924
EXP056932	anti-Ring1b (D22F2, Cell Signaling)	Mus musculus	Strain: R1; 	EXP056928	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052925
EXP056933	anti-Pcgf2 (sc-10744x, Santa Cruz)	Mus musculus	Strain: R1; 	EXP056928	2	normal	P23798	mESCs (mouse embryonic stem cells)	PEAKS052926
EXP056934	anti-Suz12 (Abcam, ab12073)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052927
EXP056935	anti-Ezh2 (Diagenode, pAB-039-050)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	Q61188	mESCs (mouse embryonic stem cells)	PEAKS052928
EXP056936	anti-Ring1b (D22F2, Cell Signaling)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052929
EXP056937	anti-Pcgf2 (sc-10744x, Santa Cruz)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	P23798	mESCs (mouse embryonic stem cells)	PEAKS052930
EXP056938	anti-GFP (abcam, ab290)	Mus musculus	Strain: R1; 	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052931
EXP056941	anti-Brd4 (A301-985A, Bethyl)	Mus musculus	Treatment: DMSO for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056939	2717	normal	Q9ESU6	RN2 (acute myeloid leukemia)	PEAKS052932
EXP056942	anti-Brd4 (A301-985A, Bethyl)	Mus musculus	Treatment: 500nM JQ1 for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056940	2717	normal	Q9ESU6	RN2 (acute myeloid leukemia)	PEAKS052933
EXP056943	anti-Med1 (A300-793A, Bethyl)	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	NULL	2717	normal	Q925J9	RN2 (acute myeloid leukemia)	PEAKS052934
EXP056944	anti-Med1 (A300-793A, Bethyl)	Mus musculus	Treatment: DMSO for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056939	2717	normal	Q925J9	RN2 (acute myeloid leukemia)	PEAKS052935
EXP056945	anti-Med1 (A300-793A, Bethyl)	Mus musculus	Treatment: 500nM JQ1 for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056940	2717	normal	Q925J9	RN2 (acute myeloid leukemia)	PEAKS052936
EXP056947	anti-PHF6 (A301-451A, Bethyl)	Mus musculus	Genotype: BCR-ABL1 overexpressed p19 null; Strain: C57BL/6J; 	EXP056946	2933	normal	Q9D4J7	pre-B cell leukemia	PEAKS052937
EXP056953	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: B10.F-H2pb1/(13R)J; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	PEAKS052938
EXP056954	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: B10.F-H2pb1/(13R)J; Paternal strain: C57Bl/6J;	EXP056948	32	normal	Q61880	testis	PEAKS052939
EXP056955	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	PEAKS052940
EXP056956	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: C3H/HeJ;	NULL	32	normal	Q61880	testis	PEAKS052941
EXP056957	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: PWD/PhJ;	NULL	32	normal	Q61880	testis	PEAKS052942
EXP056958	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: B10.F-H2pb1/(13R)J;	EXP056949	32	normal	Q61880	testis	PEAKS052943
EXP056959	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: CAST/EiJ;	EXP056950	32	normal	Q61880	testis	PEAKS052944
EXP056960	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052945
EXP056961	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: C3H/HeJ;	NULL	32	normal	Q61880	testis	PEAKS052946
EXP056962	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	PEAKS052947
EXP056963	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	PEAKS052948
EXP056964	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: CAST/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052949
EXP056965	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052950
EXP056966	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ; Paternal strain: CAST/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052951
EXP056967	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	PEAKS052952
EXP056968	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052953
EXP056969	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ Paternal strain: C57Bl/6J;	EXP056951	32	normal	Q61880	testis	PEAKS052954
EXP056970	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: MOLF/EiJ; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052955
EXP056971	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: MOLF/EiJ; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	PEAKS052956
EXP056972	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: MOLF/EiJ; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	PEAKS052957
EXP056973	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: PWD/PhJ;	NULL	32	normal	Q61880	testis	PEAKS052958
EXP056974	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	PEAKS052959
EXP056975	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	PEAKS052960
EXP056976	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: C3H/HeJ;	NULL	32	normal	Q61880	testis	PEAKS052961
EXP056977	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: CAST/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052962
EXP056978	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	PEAKS052963
EXP056979	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: B6;129P2-Prdm9<tm1Ymat>/J; Paternal strain: B6;129P2-Prdm9<tm1Ymat>/J;	NULL	32	normal	Q61880	testis	PEAKS052964
EXP056981	p300 (santa cruz sc-585 X, lot j2214)	Mus musculus	Treatment: shMed12; Genotype: Med12 knokout;	NULL	445	normal	B2RWS6	HPC7 (haematopoietic multipotent progenitors)	PEAKS052965
EXP056982	p300 (santa cruz sc-585 X, lot j2214)	Mus musculus	Treatment: shSCR;	NULL	445	normal	B2RWS6	HPC7 (haematopoietic multipotent progenitors)	PEAKS052966
EXP056983	Med12 (bethyl-A300-774A, lot 1)	Mus musculus		EXP056980	445	normal	A2AGH6	HPC7 (haematopoietic multipotent progenitors)	PEAKS052967
EXP056984	p300 (santa cruz sc-585 X, lot j2214)	Mus musculus		EXP056980	445	normal	B2RWS6	HPC7 (haematopoietic multipotent progenitors)	PEAKS052968
EXP056987	anti-HA antibody (ab9110, Abcam)	Mus musculus	Genotype: overexpressing HA-tagged Fbxl10; 	EXP056985	12	normal	Q6P1G2	MEF (mouse embryonic fibroblasts)	PEAKS052969
EXP056988	anti-HA antibody (ab9110, Abcam)	Mus musculus	Genotype: overexpressing HA-tagged Fbxl10;  Treatment: 1 ug/ml doxycycline for 48hrs;	EXP056986	12	normal	Q6P1G2	MEF (mouse embryonic fibroblasts)	PEAKS052970
EXP056994	AF9 (Sigma HPA001824)	Mus musculus	Treatment: unstimulated;	EXP056989	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052971
EXP056995	AF9 (Sigma HPA001824)	Mus musculus	Treatment: 100 ng\\mL LPS for 2 hrs;	EXP056990	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052972
EXP056996	anti-FLAG-M2 (Sigma F1804)	Mus musculus	Treatment: unstimulated; Genotype: FLAG-AF9;	EXP056991	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052973
EXP056997	anti-FLAG-M2 (Sigma F1804)	Mus musculus	Treatment: 100 ng\\mL LPS for 2 hrs; Genotype: FLAG-AF9;	EXP056992	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052974
EXP056998	anti-FLAG-M2 (Sigma F1804)	Mus musculus	Genotype: FLAG-AF9; Treatment: Crotonate pre-treatment, 10mM sodium crotonate for 16 hrs prior to 100 ng\\mL LPS for 2 hrs;	EXP056993	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	PEAKS052975
EXP057003	anti-Brd4 (Abcam 128874)	Mus musculus		EXP056999	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	PEAKS052976
EXP057004	anti-Brd4 (Abcam 128874)	Mus musculus		EXP057000	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	PEAKS052977
EXP057005	anti-Brd4 (Abcam 128874)	Mus musculus		EXP057001	237	normal	Q9ESU6	embryoid body	PEAKS052978
EXP057006	anti-Brd4 (Abcam 128874)	Mus musculus		EXP057002	237	normal	Q9ESU6	embryoid body	PEAKS052979
EXP057008	anti-DEDAF (Millipore, AB3637, lot 2426983)	Mus musculus	Genotype: wildtype; Passage: 13-19; 	EXP057007	2934	normal	Q8CCI5	MPI-II (embryonic stem cell)	PEAKS052980
EXP057011	anti-ACSS2 (Cell Signaling 3658, lot# 1)	Mus musculus	Strain: C57BL/6;	NULL	2935	normal	Q9QXG4	CAD (undifferentiated neurons)	PEAKS052981
EXP057012	anti-ACSS2 (Thermo MA5-145810, lot# QD2005961)	Mus musculus	Strain: C57BL/6;	NULL	2935	normal	Q9QXG4	CAD (undifferentiated neurons)	PEAKS052982
EXP057013	anti-ACSS2 (Cell Signaling 3658, lot# 1)	Mus musculus	Strain: C57BL/6;	EXP057010	2936	normal	Q9QXG4	CAD differentiated neurons	PEAKS052983
EXP057014	anti-ACSS2 (Thermo MA5-145810, lot# QD2005961)	Mus musculus	Strain: C57BL/6;	EXP057010	2936	normal	Q9QXG4	CAD differentiated neurons	PEAKS052984
EXP057026	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Arid1a knockout;	EXP057022	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052985
EXP057027	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Arid1a knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052986
EXP057028	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype:  expressing E861K Smarca4V5; Passage: 15-20;	EXP057015	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052987
EXP057029	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing E882K Smarca4V5; Passage: 15-20;	EXP057016	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052988
EXP057030	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing G784E Smarca4V5; Passage: 15-20;	EXP057017	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052989
EXP057031	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing K785R Smarca4V5; Passage: 15-20;	EXP057018	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052990
EXP057032	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing R885H Smarca4V5; Passage: 15-20;	EXP057019	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052991
EXP057033	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing wildtype Smarca4V5; Passage: 15-20;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052992
EXP057034	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing Y860H Smarca4V5; Passage: 15-20;	EXP057021	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052993
EXP057035	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052994
EXP057036	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS052995
EXP057037	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Arid1a knockout;	EXP057022	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052996
EXP057038	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Arid1a knockout;	EXP057023	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052997
EXP057039	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057024	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052998
EXP057040	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057025	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS052999
EXP057041	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057024	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS053000
EXP057042	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057025	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS053001
EXP057043	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing wildtype Smarca4V5; Passage: 15-20;	EXP057020	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS053002
EXP057044	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing G784E Smarca4V5; Passage: 15-20;	EXP057017	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS053003
EXP057055	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight, 1 hr Media replacement containing 10 ?M SB-431542; Passage: p19;	EXP057045	2937	normal	Q62432	embryonic teratoma	PEAKS053004
EXP057056	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 1 hr 20 ng/ml Activin A; Passage: p19;	EXP057046	2937	normal	Q62432	embryonic teratoma	PEAKS053005
EXP057057	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 8 hr 20 ng/ml Activin A; Passage: p19;	EXP057047	2937	normal	Q62432	embryonic teratoma	PEAKS053006
EXP057058	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: none; Passage: p19;	EXP057048	2937	normal	Q62432	embryonic teratoma	PEAKS053007
EXP057059	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight, 1 hr Media replacement containing 10 ?M SB-431542; Passage: p19;	EXP057050	2937	normal	Q62432	embryonic teratoma	PEAKS053008
EXP057060	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 1 hr 20 ng/ml Activin A; Passage: p19;	EXP057051	2937	normal	Q62432	embryonic teratoma	PEAKS053009
EXP057061	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 8 hr 20 ng/ml Activin A; Passage: p19;	EXP057052	2937	normal	Q62432	embryonic teratoma	PEAKS053010
EXP057062	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: none; Passage: p19;	EXP057053	2937	normal	Q62432	embryonic teratoma	PEAKS053011
EXP057064	anti-Setdb1 (Santa Cruz, SC-66884X)	Mus musculus	Strain: C57BL/6; Genotype: Rag2 knockout;	NULL	105	normal	O88974	pro-B cells	PEAKS053012
EXP057065	anti-Setdb1 (Themo Scientific, PA5-30334)	Mus musculus	Strain: C57BL/6; Genotype: Rag2 knockout;	NULL	105	normal	O88974	pro-B cells	PEAKS053013
EXP057067	Sap130 (A302-491A: Bethyl laboratories)	Mus musculus	Stage: E12.5; Strain: C57BL/6;	EXP057066	247	normal	Q8BIH0	embryonic heart	PEAKS053014
EXP057070	Ezh2 (Cell signalling, 5264)	Mus musculus	Growth conditions: quiescence via serum-deprivation; Developmental stage: E13.5; Passage: 4;	EXP057068	12	normal	Q61188	MEF (mouse embryonic fibroblasts)	PEAKS053015
EXP057071	Ezh2 (Cell signalling, 5264)	Mus musculus	Genotype: mutant Rb; Growth conditions: quiescence via serum-deprivation; Developmental stage: E13.5; Passage: 4;	EXP057069	12	normal	Q61188	MEF (mouse embryonic fibroblasts)	PEAKS053016
EXP057076	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; Treatment: none Doxycycline, shRNA against MED12;	EXP057072	1493	normal	Q9ESU6	acute myeloid leukemia	PEAKS053017
EXP057077	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D, MED12 knockout; Strain: C57BL/6; Treatment: Doxycycline, shRNA against MED12;	EXP057073	1493	normal	Q9ESU6	acute myeloid leukemia	PEAKS053018
EXP057078	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; Treatment: none Doxycycline, shRNA against MED23;	EXP057074	1493	normal	Q9ESU6	acute myeloid leukemia	PEAKS053019
EXP057079	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D, MED12 knockout; Strain: C57BL/6; Treatment: Doxycycline, shRNA against MED23;	EXP057075	1493	normal	Q9ESU6	acute myeloid leukemia	PEAKS053020
EXP057083	anti-MORC3 antibody (100-401-N96S, Rockland)	Mus musculus		EXP057080	252	normal	F7BJB9	V6.5 (embryonic stem cells)	PEAKS053021
EXP057084	anti-MORC3 antibody (100-401-N96S, Rockland)	Mus musculus		EXP057081	252	normal	F7BJB9	V6.5 (embryonic stem cells)	PEAKS053022
EXP057085	anti-MORC3 antibody (100-401-N96S, Rockland)	Mus musculus		EXP057082	252	normal	F7BJB9	V6.5 (embryonic stem cells)	PEAKS053023
EXP057087	anti-Lsd1 (20752)	Mus musculus	Developmental stage: E3.5; Passage: 15-20;	EXP057086	96	normal	Q6ZQ88	trophoblast stem cells	PEAKS053024
EXP057089	anti-Med1	Mus musculus	Treatment: phenyhydrazine treated ; Tissue: spleen;  Strain: C57Bl6;	EXP057088	267	normal	Q925J9	erythroid cells	PEAKS053025
EXP057098	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057090	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053026
EXP057099	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057091	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053027
EXP057100	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057092	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053028
EXP057101	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057093	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053029
EXP057102	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057094	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053030
EXP057103	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057095	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053031
EXP057104	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057096	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053032
EXP057105	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057097	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053033
EXP057106	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057090	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053034
EXP057107	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057091	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053035
EXP057108	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057092	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053036
EXP057109	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057093	216	normal	Q9CQJ4	differentiated embryonic stem cells	PEAKS053037
EXP057111	anti-Kat2b (Abcam, ab12188)	Mus musculus	Age: adult, 10-12 weeks old;	EXP057110	898	normal	Q9JHD1	pancreatic islets	PEAKS053038
EXP057115	anti-Cbx2 (Santa Cruz, sc-19297)	Mus musculus		EXP057112	506	normal	P30658	J1 (embryonic stem cells)	PEAKS053039
EXP057116	anti-Ezh2(D2C9) (Cell Signaling, 5246S)	Mus musculus		EXP057112	506	normal	Q61188	J1 (embryonic stem cells)	PEAKS053040
EXP057117	anti-RNF2 (Bethyl, A302-869A)	Mus musculus		EXP057113	506	normal	Q9CQJ4	J1 (embryonic stem cells)	PEAKS053041
EXP057118	anti-RNF2 (Bethyl, A302-869A)	Mus musculus		EXP057114	2939	normal	Q9CQJ4	NSC cells derived by differentiation of J1 ESC	PEAKS053042
EXP057119	anti-Elongin B (abcam, ab168836)	Mus musculus		NULL	2	normal	P62869	mESCs (mouse embryonic stem cells)	PEAKS053043
EXP057120	anti-Elongin B (abcam, ab168836)	Mus musculus	Genotype: Elongin B knockout;	NULL	2	normal	P62869	mESCs (mouse embryonic stem cells)	PEAKS053044
EXP057124	anti-HDAC3	Mus musculus	Age: 4-months old;  Genotype: HDAC3 wildtype; Strain: C57B/6;	EXP057121	2940	normal	O88895	quadriceps muscle	PEAKS053045
EXP057125	anti-HDAC3	Mus musculus	Age: 4-months old;  Genotype: HDAC3 wildtype; Strain: C57B/6;	EXP057122	2940	normal	O88895	quadriceps muscle	PEAKS053046
EXP057126	anti-HDAC3	Mus musculus	Age: 4-months old;  Genotype: HDAC3 Knock-out; Strain: C57B/6;	EXP057123	2940	normal	O88895	quadriceps muscle	PEAKS053047
EXP057136	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: EGFP knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053048
EXP057137	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: EGFP knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053049
EXP057138	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Dnmt1 knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053050
EXP057139	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Dnmt1 knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053051
EXP057140	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Tet1 knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053052
EXP057141	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Tet1 knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053053
EXP057142	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Mbd3 knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053054
EXP057143	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Mbd3 knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053055
EXP057144	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: EGFP knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053056
EXP057145	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: EGFP knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053057
EXP057146	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Dnmt1 knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053058
EXP057147	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Dnmt1 knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053059
EXP057148	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Tet1 knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053060
EXP057149	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Tet1 knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053061
EXP057150	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Mbd2 knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053062
EXP057151	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Mbd2 knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053063
EXP057152	anti-Flag M2 (Sigma F1804)	Mus musculus	Genotype: EGFP knockout,  Mbd3abc-FLAG;	EXP057131	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053064
EXP057153	anti-Flag M2 (Sigma F1804)	Mus musculus	Genotype: Dnmt1 knockout,  6XHIS-3XFLAG tag-Mbd3abc;	EXP057131	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053065
EXP057154		Mus musculus	Genotype: Tet1 knockout,  Genotype: Dnmt1 knockout,  6XHIS-3XFLAG tag-Mbd3abc;;	EXP057131	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053066
EXP057155	Mbd2 antibody (Bethyl)	Mus musculus		EXP057132	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053067
EXP057156	Mbd3 antibody (Bethyl)	Mus musculus		EXP057132	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053068
EXP057157	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057133	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053069
EXP057158	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057134	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053070
EXP057159	Mbd3 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057133	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053071
EXP057160	Mbd3 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057134	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053072
EXP057161	Dnmt1 antibody (bethyl)	Mus musculus	Genotype: wildtype; 	EXP057135	230	normal	P13864	ES-E14 (E14, embryonic stem cells)	PEAKS053073
EXP057162	Dnmt1 antibody (bethyl)	Mus musculus	Genotype: Dnmt1 knockout; 	EXP057135	230	normal	P13864	ES-E14 (E14, embryonic stem cells)	PEAKS053074
EXP057163	Dnmt1 antibody (bethyl)	Mus musculus	Genotype: Mbd3 knockout;	EXP057135	230	normal	P13864	ES-E14 (E14, embryonic stem cells)	PEAKS053075
EXP057165	anti-HIRA (WC15 )	Mus musculus	Strain: CD1; Developmental stage: E12.5;  Genotype: wildtype;	EXP057164	247	normal	Q61666	embryonic heart	PEAKS053076
EXP057167	anti-Flag(Sigma,  F3165)	Mus musculus		EXP057166	230	normal	Q9QZL6	ES-E14 (E14, embryonic stem cells)	PEAKS053077
EXP057168	anti-NCAPH2 (Bethyl, A302-275A)	Mus musculus	Treatment: shTFIIIC; Genotype: TFIIIC knockout;	NULL	252	normal	Q8BSP2	V6.5 (embryonic stem cells)	PEAKS053078
EXP057169	anti-NCAPH2 (Bethyl, A302-275A)	Mus musculus	Treatment: shGFP;	NULL	252	normal	Q8BSP2	V6.5 (embryonic stem cells)	PEAKS053079
EXP057171	Nacc1 antibody (abcam,ab29047)	Mus musculus		EXP057170	2941	normal	Q7TSZ8	N2A (neuroblastoma)	PEAKS053080
EXP057175	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA (Luc control);	EXP057172	675	normal	Q9WVG7	NIH 3T3 (embryonic fibroblasts)	PEAKS053081
EXP057176	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA H2A.Z; Genotype: H2A.Z knockdown;	EXP057173	675	normal	Q9WVG7	NIH 3T3 (embryonic fibroblasts)	PEAKS053082
EXP057177	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA Osr; Genotype: Osr1 knockdown;	EXP057174	675	normal	Q9WVG7	NIH 3T3 (embryonic fibroblasts)	PEAKS053083
EXP057179	anti-Suz12	Mus musculus	Strain: C57BL/6; Genotype: Lgr5Gfp-CreERT2;	EXP057178	195	normal	Q80U70	crypt cells	PEAKS053084
EXP057184	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in 100?units/ml LIF (Millipore, cat. ESG1107);	EXP057180	765	normal	Q80U70	R1 (embryonic stem cells)	PEAKS053085
EXP057185	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in  50nM 4-hydroxytamoxifen (OHT) (Sigma, cat. H6278);	EXP057181	765	normal	Q80U70	R1 (embryonic stem cells)	PEAKS053086
EXP057186	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in 100?units/ml LIF (Millipore, cat. ESG1107);	EXP057182	765	normal	Q80U70	R1 (embryonic stem cells)	PEAKS053087
EXP057187	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in  50nM 4-hydroxytamoxifen (OHT) (Sigma, cat. H6278);	EXP057183	765	normal	Q80U70	R1 (embryonic stem cells)	PEAKS053088
EXP057188	anti-Sin3a	Mus musculus		NULL	230	normal	Q60520	ES-E14 (E14, embryonic stem cells)	PEAKS053089
EXP057189	anti-Fam60a	Mus musculus		NULL	230	normal	Q8C8M1	ES-E14 (E14, embryonic stem cells)	PEAKS053090
EXP057190	anti-Sin3a	Mus musculus		NULL	675	normal	Q60520	NIH 3T3 (embryonic fibroblasts)	PEAKS053091
EXP057191	anti-Fam60a	Mus musculus		NULL	675	normal	Q8C8M1	NIH 3T3 (embryonic fibroblasts)	PEAKS053092
EXP057192		Mus musculus	Treatment: non-targeting pLKO.1 shScrambled;	NULL	230	normal	A0A023J5X2	ES-E14 (E14, embryonic stem cells)	PEAKS053093
EXP057193		Mus musculus	Treatment: pLKO.1 targeting mouse Fam60a; Genotype: Fam60a knockdown; 	NULL	230	normal	A0A023J5X2	ES-E14 (E14, embryonic stem cells)	PEAKS053094
EXP057196	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: IWP2; Genotype: Wnt3 knockout;	EXP057194	260	normal	Q9CQJ4	epiblast stem cells	PEAKS053095
EXP057197	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: IWP2; Genotype: Wnt3 knockout;	EXP057195	260	normal	Q9CQJ4	epiblast stem cells	PEAKS053096
EXP057198	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: 72hrs rsCHIR99021; Genotype: Wnt3 knockout;	NULL	260	normal	Q9CQJ4	epiblast stem cells	PEAKS053097
EXP057199	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: 5hrs Wnt3a 125 ng/ml; Genotype: Wnt3 knockout;	NULL	260	normal	Q9CQJ4	epiblast stem cells	PEAKS053098
EXP057202	anti-FLAG M2 (Sigma, catalog# F1804)	Mus musculus	Generation: F1; Strain: B6/129; Age: 8-week-old; 	EXP057200	193	normal	Q61818	cortex	PEAKS053099
EXP057203	anti-FLAG M2 (Sigma, catalog# F1804)	Mus musculus	Generation: F1; Strain: B6/129; Age: 8-week-old; 	EXP057201	193	normal	Q61818	cortex	PEAKS053100
EXP057204	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: control;	NULL	2942	normal	Q8BW72	L-GMP transformed with MLL-AF9	PEAKS053101
EXP057205	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: 500nM OHT 4-hydroxytamoxifen for 96hrs;	NULL	2942	normal	Q8BW72	L-GMP transformed with MLL-AF9	PEAKS053102
EXP057206	anti-Jmjd2c (ktwl)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: control;	NULL	2942	normal	Q8VCD7	L-GMP transformed with MLL-AF9	PEAKS053103
EXP057207	anti-Jmjd2c (ktwl)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: 500nM OHT 4-hydroxytamoxifen for 96hrs;	NULL	2942	normal	Q8VCD7	L-GMP transformed with MLL-AF9	PEAKS053104
EXP057208	anti-STAT5 (R&D Systems, AF1584)	Mus musculus	Strain: C57Bl.6; Treatment: none;	NULL	2581	normal	P42232	spleen and lymph nodes	PEAKS055848
EXP057209	anti-STAT5 (R&D Systems, AF1584)	Mus musculus	Strain: C57Bl.6; Treatment: stimulation with TSLP (40 ng/ml, R&D) for 25 minutes; 	NULL	2581	normal	P42232	spleen and lymph nodes	PEAKS055849
EXP057211	anti-LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Strain: C57BL/6 N; Passage: 2-3; 	EXP057210	2944	normal	Q6ZQ88	differentiated primary brown adipocytes	PEAKS053107
EXP057220	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057212	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	PEAKS053108
EXP057221	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057213	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	PEAKS053109
EXP057222	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057214	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	PEAKS053110
EXP057223	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057215	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	PEAKS053111
EXP057224	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057216	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	PEAKS053112
EXP057225	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057217	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	PEAKS053113
EXP057226	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057218	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	PEAKS053114
EXP057227	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057219	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	PEAKS053115
EXP057228	anti-CRTC2	Mus musculus	Treatment: 10 uM Forskolin;	NULL	19	normal	Q3U182	3T3-L1-derived preadipocytes	PEAKS053116
EXP057229	anti-CRTC2	Mus musculus	Treatment: 500 nM P6 + 10 uM Forskolin;	NULL	19	normal	Q3U182	3T3-L1-derived preadipocytes	PEAKS053117
EXP057236	RYBP (Millipore, AB3637)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057230	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	PEAKS053118
EXP057237	RYBP (Millipore, AB3637)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057231	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	PEAKS053119
EXP057238	RYBP (Millipore, AB3637)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057232	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	PEAKS053120
EXP057239	RYBP (Millipore, AB3637)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057233	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	PEAKS053121
EXP057240	RYBP (Millipore, AB3637)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057234	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	PEAKS053122
EXP057241	RYBP (Millipore, AB3637)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057235	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	PEAKS053123
EXP057242	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057230	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053124
EXP057243	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057231	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053125
EXP057244	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057232	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053126
EXP057245	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057233	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053127
EXP057246	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057234	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053128
EXP057247	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057235	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053129
EXP057248	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057230	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS053130
EXP057249	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057231	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS053131
EXP057250	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057232	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS053132
EXP057251	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057233	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS053133
EXP057252	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057234	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS053134
EXP057253	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057235	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS053135
EXP057256	anti-Chd4  (Abcam, ab72418)	Mus musculus	Genotype: wildtype; Developmental stage: P22;	EXP057254	25	normal	Q6PDQ2	cerebellum	PEAKS053136
EXP057257	anti-Chd4  (Abcam, ab72418)	Mus musculus	Genotype: Chd4 knockout;  Developmental stage: P22;	EXP057255	25	normal	Q6PDQ2	cerebellum	PEAKS053137
EXP057259	anti-ASXL1	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP057258	2945	normal	P59598	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	PEAKS053138
EXP057260	anti-SMC1A	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP057258	2945	normal	Q9CU62	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	PEAKS053139
EXP057261	anti-SMC1A	Mus musculus	Genotype: SMC1A knockout; Strain: C57BL/6;	NULL	2945	normal	Q9CU62	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	PEAKS053140
EXP057262	anti-RAD21	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP057258	2945	normal	Q61550	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	PEAKS053141
EXP057263	anti-RAD21	Mus musculus	Genotype: RAD21 knockout; Strain: C57BL/6;	NULL	2945	normal	Q61550	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	PEAKS053142
EXP057265	anti-EZH2 (Active Motif, cat # 3990)	Mus musculus	Strain: C57BL/6; 	EXP057264	2946	normal	Q61188	primary colon epithelial cell	PEAKS053143
EXP057267	anti-Pcgf6 (Santa Cruz, sc-160649)	Mus musculus		EXP057266	151	normal	Q99NA9	CCE (embryonic stem cells)	PEAKS053144
EXP057268	anti-Pcgf6 (Abcam, ab48010)	Mus musculus		EXP057266	151	normal	Q99NA9	CCE (embryonic stem cells)	PEAKS053145
EXP057269	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: 20 mg/kg cocaine; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	PEAKS053146
EXP057270	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: 0.9% Saline; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	PEAKS053147
EXP057271	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: none, normal control; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	PEAKS053148
EXP057272	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: Resilient; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	PEAKS053149
EXP057273	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: Susceptible; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	PEAKS053150
EXP057278	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057274	2947	normal	Q9Z2D6	promyelocytes	PEAKS053151
EXP057279	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057275	2947	normal	Q9Z2D6	promyelocytes	PEAKS053152
EXP057280	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057276	2948	normal	Q9Z2D6	granulocytes	PEAKS053153
EXP057281	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057277	2948	normal	Q9Z2D6	granulocytes	PEAKS053154
EXP057282	anti-Ezh2 (Cell signaling, 5246S, lot unknown)	Mus musculus	Genotype: Y641F Ezh2; Treatment: modification by TALEN;	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS053155
EXP057283	anti-Ezh2 (Cell signaling, 5246S, lot unknown)	Mus musculus	Genotype: wildtype Ezh2; 	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	PEAKS053156
EXP057285	anti- Lmo2 (AF2726, R&D Systems)	Mus musculus	Source: 4 days post SLHR induction;	EXP057284	12	normal	P25801	MEF (mouse embryonic fibroblasts)	PEAKS053157
EXP057289	anti-Leo1 antibody (serum purified)	Mus musculus	Treatment: shControl; 	EXP057286	1153	normal	Q5XJE5	C2C12 (myoblasts)	PEAKS053158
EXP057290	anti-Leo1 antibody (serum purified)	Mus musculus	Treatment: shControl; 	EXP057287	126	normal	Q5XJE5	C2C12 (myotubes)	PEAKS053159
EXP057291	anti-Leo1 antibody (serum purified)	Mus musculus	Treatment: shPhf5a; Genotype: Phf5a knockout; 	EXP057288	126	normal	Q5XJE5	C2C12 (myotubes)	PEAKS053160
EXP057294	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: EGFP knockdown, 3XFLAG Mbd3;	NULL	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053161
EXP057295	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd3 knockdown, 3XFLAG Mbd3;	NULL	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053162
EXP057296	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd2 knockdown, 3XFLAG Mbd3;	NULL	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	PEAKS053163
EXP057297	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: EGFP knockdown, , 3XFLAG Mbd2;	NULL	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053164
EXP057298	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd3 knockdown, 3XFLAG Mbd2;	NULL	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053165
EXP057299	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd2 knockdown, 3XFLAG Mbd2;	NULL	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	PEAKS053166
EXP057300	anti-Flag antibody	Mus musculus	Treatment: none;  Strain: C57BL/6; 	NULL	2	normal	Q99NA9	mESCs (mouse embryonic stem cells)	PEAKS053167
EXP057301	anti-Flag antibody	Mus musculus	Treatment: OHT for 4 days;  Strain: C57BL/6; 	NULL	2	normal	Q99NA9	mESCs (mouse embryonic stem cells)	PEAKS053168
EXP057302	anti-Flag antibody	Mus musculus	Treatment: OHT for 8 days;  Strain: C57BL/6; 	NULL	2	normal	Q99NA9	mESCs (mouse embryonic stem cells)	PEAKS053169
EXP057303	Ring1b antibody (Clone#3)	Mus musculus	Treatment: none;  Strain: C57BL/6; Genotype: Ring1A/B double knockout; 	NULL	2	bio_control	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053170
EXP057304	Ring1b antibody (Clone#3)	Mus musculus	Treatment: none;  Strain: C57BL/6; Genotype: Bmil/Mel18 double knockout; 	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS053171
EXP057306	anti-HA 	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: HDUX4 codon-altered; 	NULL	1153	normal	A1JVI8	C2C12 (myoblasts)	PEAKS053172
EXP057307	anti-DUX4 (MO488, MO489 )	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: HDUX4 codon-altered; 	NULL	1153	normal	A1JVI8	C2C12 (myoblasts)	PEAKS053173
EXP057308	anti-DUX (A-19)	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: mDUX codon-altered; 	EXP057305	1153	normal	A1JVI8	C2C12 (myoblasts)	PEAKS053174
EXP057309	anti-mDUX (S-20)	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: mDUX codon-altered; 	EXP057305	1153	normal	A1JVI8	C2C12 (myoblasts)	PEAKS053175
EXP057313	anti-KAP1 (Trono laboratory, rabbit polyclonal S23470)	Mus musculus	Genotype: wildtype Kap1 loxP/loxP; Developmental stage: E3; Strain: C57BL/6; 	EXP057310	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS053176
EXP057314	anti-KAP1 (Trono laboratory, rabbit polyclonal S23470)	Mus musculus	Genotype: wildtype Kap1 loxP/loxP; Developmental stage: E3; Strain: C57BL/6; 	EXP057311	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS053177
EXP057315	anti-KAP1 (Trono laboratory, rabbit polyclonal S23470)	Mus musculus		EXP057312	2787	normal	Q62318	Hepa1-6 (Hepatocellular carcinoma )	PEAKS053178
EXP057316	anti-SETDB1 (Sripathy, Stevens et al. 2006)	Mus musculus		EXP057312	2787	normal	Q8BJ51	Hepa1-6 (Hepatocellular carcinoma )	PEAKS053179
EXP057319	anti-SMC3 (Abcam, ab9263)	Mus musculus	Genotype: wildtype Smc1b; Strain: C57BL/6; Tissue: testes; 	EXP057317	803	normal	Q9CW03	spermatocytes	PEAKS053180
EXP057320	anti-SMC3 (Abcam, ab9263)	Mus musculus	Genotype: N-terminally LAP-tagged Smc1b; Strain: C57BL/6; Tissue: testes; 	EXP057318	803	normal	Q9CW03	spermatocytes	PEAKS053181
EXP057322	anti-Tet3 (gift from Dr. Guoliang Xu, PMID: 21892189)	Mus musculus	Strain: C57BL/6; 	EXP057321	2770	normal	Q8BG87	embryonic stem cells-derived neural progenitor cells	PEAKS053182
EXP057324	anti-Ezh2 antibody (Santa Cruz H-80,sc-25383,H0213)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP057323	2479	normal	Q61188	CD8+ T-cells	PEAKS053183
EXP057331	Anti-Cbx3 antibody (Millipore, 05-690; clone 42s2)	Mus musculus	Treatment: none; Background cell line: V6.5;	EXP057325	280	normal	P23198	embryonic stem cell-derived neural progenitors	PEAKS053184
EXP057332	Anti-Med26 (sc-48776)	Mus musculus	Treatment: control siRNA transfection; Background cell line: V6.5;	EXP057326	280	bio_control	Q7TN02	embryonic stem cell-derived neural progenitors	PEAKS053185
EXP057333	Anti-Med26 (sc-48776)	Mus musculus	Treatment: Cbx3 siRNA transfection; Background cell line: V6.5; Genotype: Cbx3 knockout; 	EXP057327	280	normal	Q7TN02	embryonic stem cell-derived neural progenitors	PEAKS053186
EXP057334	Anti-Cdk8 antibody (sc-1521)	Mus musculus	Treatment: control siRNA transfection; Background cell line: V6.5;	EXP057328	280	bio_control	Q8R3L8	embryonic stem cell-derived neural progenitors	PEAKS053187
EXP057335	Anti-Cdk8 antibody (sc-1521)	Mus musculus	Treatment: Cbx3 siRNA transfection; Background cell line: V6.5; Genotype: Cbx3 knockout;	EXP057329	280	normal	Q8R3L8	embryonic stem cell-derived neural progenitors	PEAKS053188
EXP057336	Anti-Cbx3 antibody (Millipore, 05-690; clone 42s2)	Mus musculus	Treatment: none; Background cell line: V6.5;	EXP057330	280	normal	P23198	embryonic stem cell-derived neural progenitors	PEAKS053189
EXP057339	anti-Ring1b	Mus musculus		EXP057337	506	normal	Q9CQJ4	J1 (embryonic stem cells)	PEAKS053190
EXP057340	anti-Phc1	Mus musculus		EXP057337	506	normal	Q64028	J1 (embryonic stem cells)	PEAKS053191
EXP057341	anti-Cbx7	Mus musculus		EXP057337	506	normal	Q8VDS3	J1 (embryonic stem cells)	PEAKS053192
EXP057342	anti-Cbx2	Mus musculus		EXP057337	506	normal	P30658	J1 (embryonic stem cells)	PEAKS053193
EXP057343	anti-Ezh2	Mus musculus		EXP057337	506	normal	Q61188	J1 (embryonic stem cells)	PEAKS053194
EXP057344	anti-Ring1b	Mus musculus		EXP057338	2949	normal	Q9CQJ4	J1 embryonic stem cells derived neural progenitors cells	PEAKS053195
EXP057345	anti-Cbx8	Mus musculus		EXP057338	2949	normal	Q9QXV1	J1 embryonic stem cells derived neural progenitors cells	PEAKS053196
EXP057346	anti-Cbx2	Mus musculus		EXP057338	2949	normal	P30658	J1 embryonic stem cells derived neural progenitors cells	PEAKS053197
EXP057347	anti-Ezh2	Mus musculus		EXP057338	2949	normal	Q61188	J1 embryonic stem cells derived neural progenitors cells	PEAKS053198
EXP057350	anti-HDAC3	Mus musculus	Strain: C57BL/6J; Age: 10 weeks; Treatment: corn oil vehicle daily for 5 days 2 weeks; Genotype: wildtype (HDAC3 f/f); 	EXP057348	898	normal	O88895	pancreatic islets	PEAKS053199
EXP057351	anti-HDAC3	Mus musculus	Strain: C57BL/6J; Age: 10 weeks; Treatment: gavaged tamoxifen (2mg/day)e daily for 5 days 2 weeks; Genotype: HDAC3beta knockout; 	EXP057349	898	normal	O88895	pancreatic islets	PEAKS053200
EXP057358	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	EXP057352	193	normal	Q9Z2D6	cortex	PEAKS053201
EXP057359	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	EXP057353	193	normal	Q9Z2D6	cortex	PEAKS053202
EXP057360	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	EXP057354	193	normal	Q9Z2D6	cortex	PEAKS053203
EXP057361	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	EXP057355	193	normal	Q9Z2D6	cortex	PEAKS053204
EXP057362	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	EXP057356	193	normal	Q9Z2D6	cortex	PEAKS053205
EXP057363	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	EXP057357	193	normal	Q9Z2D6	cortex	PEAKS053206
EXP057368	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057364	498	normal	Q7JJ13	Th17-cells	PEAKS053207
EXP057369	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057365	498	normal	Q7JJ13	Th17-cells	PEAKS053208
EXP057370	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057364	498	normal	Q9ESU6	Th17-cells	PEAKS053209
EXP057371	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057365	498	normal	Q9ESU6	Th17-cells	PEAKS053210
EXP057372	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057366	498	normal	Q9ESU6	Th17-cells	PEAKS053211
EXP057373	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057367	498	normal	Q9ESU6	Th17-cells	PEAKS053212
EXP057374	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057366	498	normal	Q7JJ13	Th17-cells	PEAKS053213
EXP057375	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057367	498	normal	Q7JJ13	Th17-cells	PEAKS053214
EXP057377	anti-ACSS2 (Thermo MA5-145810, QD2005961)	Mus musculus	Sex: male; Strain: C57BL/6;	EXP057376	987	normal	Q9QXG4	hippocampus	PEAKS053215
EXP057378	Dnmt3a (Santa Cruz, H-295)	Mus musculus	Genotype: wildtype; Sex: female; Age: 14 weeks; Strain: CU Black Six; Treatment: DMBA and TPA;	NULL	2950	normal	O88508	back skin	PEAKS053216
EXP057379	Dnmt3a (Santa Cruz, H-295)	Mus musculus	Genotype: Dnmt3a knockout; Sex: female; Age: 14 weeks; Strain: CU Black Six; Treatment: DMBA and TPA;	NULL	2950	normal	O88508	back skin	PEAKS053217
EXP057382	anti-Lap1	Mus musculus	Sex: male; Strain: Balb/c;	EXP057380	32	normal	P97449	testis	PEAKS053218
EXP057383	anti-Lap1	Mus musculus	Sex: male; Strain: Balb/c;	EXP057381	987	normal	P97449	hippocampus	PEAKS053219
EXP057384	anti-Lap1	Mus musculus	Sex: male; Strain: Balb/c; Source: technical replicate;	NULL	32	normal	P97449	testis	PEAKS053220
EXP057386	anti-Sox2 (R&D Systems, AF2018)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	P48432	differentiated embryonic stem cells	PEAKS053221
EXP057387	anti-T (Santa Cruz, sc-17743)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	P20293	differentiated embryonic stem cells	PEAKS053222
EXP057388	anti-Tbx6 (this paper)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	P70327	differentiated embryonic stem cells	PEAKS053223
EXP057389	anti-beta-catenin (Invitrogen, 71-2700)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	Q02248	differentiated embryonic stem cells	PEAKS053224
EXP057392	anti-Chd7 (Cell Siganling)	Mus musculus	Developmental stage: P7; Strain: C57BL/6;	EXP057390	2951	normal	A2AJK6	granule neuron progenitor	PEAKS053225
EXP057393	anti-Chd7 (Cell Siganling)	Mus musculus	Developmental stage: P7; Strain: C57BL/6; Genotype: Chd7 knockout;	NULL	2951	normal	A2AJK6	granule neuron progenitor	PEAKS053226
EXP057394	anti-Top2b (Santa Cruz)	Mus musculus	Developmental stage: P7; Strain: C57BL/6;	EXP057391	2952	normal	Q64511	granule neuron	PEAKS053227
EXP057395	anti-Top2b (Santa Cruz)	Mus musculus	Developmental stage: P7; Strain: C57BL/6; Genotype: Chd7 knockout;	NULL	2952	normal	Q64511	granule neuron	PEAKS053228
EXP057399	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	Treatment: cultured in serum/LIF conditions;	EXP057397	230	normal	Q8VCD7	ES-E14 (E14, embryonic stem cells)	PEAKS053229
EXP057400	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	Treatment: cultured in serum/LIF conditions;	EXP057398	230	normal	Q8VCD7	ES-E14 (E14, embryonic stem cells)	PEAKS053230
EXP057401	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	Treatment: cultured in 2i/LIF conditions;	EXP057396	230	normal	Q8VCD7	ES-E14 (E14, embryonic stem cells)	PEAKS053231
EXP057403	HP1gamma (Millipore, MAB3450, lot 2021184)	Mus musculus	Treatment: tranfected with siGFP for 48hrs; 	EXP057402	230	bio_control	P23198	ES-E14 (E14, embryonic stem cells)	PEAKS053232
EXP057404	HP1gamma (Millipore, MAB3450, lot 2021184)	Mus musculus	Treatment: tranfected with siHP1g for 48hrs; Genotype: HP1gamma knockout;	EXP057402	230	normal	P23198	ES-E14 (E14, embryonic stem cells)	PEAKS053233
EXP057412	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: C57BL/6JOlaHsd;   Source: B6; 	EXP057405	32	normal	Q96EQ9	testis	PEAKS053234
EXP057413	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: C57BL/6JOlaHsd;   Source: B6; 	EXP057406	32	normal	Q96EQ9	testis	PEAKS053235
EXP057414	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm;  Source: RJ2; 	EXP057407	32	normal	Q96EQ9	testis	PEAKS053236
EXP057415	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm;  Source: RJ2; 	EXP057408	32	normal	Q96EQ9	testis	PEAKS053237
EXP057416	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: 129P2-Prdm9tm1Ymat/J; Genotype: prdm9 knockout; 	EXP057409	32	normal	Q96EQ9	testis	PEAKS053238
EXP057417	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: Spo11tm1M; Genotype: Spo11tm1 knockout; 	EXP057410	32	normal	Q96EQ9	testis	PEAKS053239
EXP057418	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: Spo11tm1M; Genotype: Spo11tm1 knockout; 	EXP057411	32	normal	Q96EQ9	testis	PEAKS053240
EXP057419	anti-DMC1 (Santa Cruz, C-20)	Mus musculus	Age: 5 weeks post-partum; Strain: C57BL/6JOlaHsd; Source: B6;	NULL	32	normal	Q61880	testis	PEAKS053241
EXP057420	anti-DMC1 (Santa Cruz, C-20)	Mus musculus	Age: 5 weeks post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm; Source: RJ2;	NULL	32	normal	Q61880	testis	PEAKS053242
EXP057424	Anti-HP1 antibody (Millipore)	Mus musculus	Treatment: shLuc; 	EXP057421	765	bio_control	Q61687	R1 (embryonic stem cells)	PEAKS053243
EXP057425	Anti-HP1 antibody (Millipore)	Mus musculus	Treatment: shSmyd5; Genotype: Smyd5 kncokout;	EXP057422	765	normal	Q61687	R1 (embryonic stem cells)	PEAKS053244
EXP057426	Anti-FLAG antibody (Sigma)	Mus musculus		EXP057423	765	normal	Q3TYX3	R1 (embryonic stem cells)	PEAKS053245
EXP057429	anti-KAP1 (custom rabbit polyclonal)	Mus musculus		EXP057427	506	normal	Q62318	J1 (embryonic stem cells)	PEAKS053246
EXP057430	anti-KAP1 (custom rabbit polyclonal)	Mus musculus		EXP057428	506	normal	Q62318	J1 (embryonic stem cells)	PEAKS053247
EXP057433	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Strain: C57BL/6;	EXP057431	1117	normal	Q7JJ13	primary T-cells	PEAKS053248
EXP057434	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Strain: C57BL/6;	EXP057432	1117	normal	Q7JJ13	primary T-cells	PEAKS053249
EXP057435	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Strain: C57BL/6;	EXP057431	1117	normal	Q9ESU6	primary T-cells	PEAKS053250
EXP057436	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Strain: C57BL/6;	EXP057432	1117	normal	Q9ESU6	primary T-cells	PEAKS053251
EXP057440	Anti-Jmjd2a (Cell Signaling, Catalog Nr #5328)	Mus musculus	Strain: C57BL6; Genotype: Kdm4a knockout; Developmental stage: 2.5 dpc; 	EXP057438	132	normal	Q8BW72	uterus	PEAKS053252
EXP057441	Anti-Jmjd2a (Cell Signaling, Catalog Nr #5328)	Mus musculus	Strain: C57BL6; Genotype: wildtype; Developmental stage: 2.5 dpc; 	EXP057437	132	normal	Q8BW72	uterus	PEAKS053253
EXP057443	anti-CDYL	Mus musculus	Strain: C57BL/6; Age: 6-8 weeks;	EXP057442	987	normal	Q9WTK2	hippocampus	PEAKS053254
EXP057444	Anti-p300 (Santa Cruz, sc-585)	Mus musculus	Genotype: UTX Wildtype; 	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	PEAKS053255
EXP057445	Anti-UTX (Bethyl laboratories, A302-374A)	Mus musculus	Genotype: UTX Wildtype; 	NULL	2	normal	O70546	mESCs (mouse embryonic stem cells)	PEAKS053256
EXP057448	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-EZH1; 	EXP057446	247	normal	P70351	embryonic heart	PEAKS053257
EXP057449	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-EZH1; 	EXP057447	247	normal	P70351	embryonic heart	PEAKS053258
EXP057450	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-GFP; 	EXP057446	247	bio_control	P70351	embryonic heart	PEAKS053259
EXP057451	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-GFP; 	EXP057447	247	bio_control	P70351	embryonic heart	PEAKS053260
EXP057455	anti-Mll3/4 (custom)	Mus musculus	Genotype: catalytically-deficient Mll3/4; 	EXP057454	765	normal	Q8BRH4	R1 (embryonic stem cells)	PEAKS053261
EXP057456	anti-Mll3/4 (custom)	Mus musculus	Genotype: wildtype; 	EXP057452	765	normal	Q8BRH4	R1 (embryonic stem cells)	PEAKS053262
EXP057457	anti-Mll3/4 (custom)	Mus musculus	Genotype: Mll3/4 double knockout;	EXP057453	765	normal	Q8BRH4	R1 (embryonic stem cells)	PEAKS053263
EXP057459	anti-MLL2 (Homemade, #9173)	Mus musculus	Genotype: wildtype;	EXP057458	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS053264
EXP057460	anti-MLL4 (Homemade, #825)	Mus musculus	Genotype: wildtype;	EXP057458	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	PEAKS053265
EXP057461	anti-SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype;	EXP057458	252	normal	E9PYH6	V6.5 (embryonic stem cells)	PEAKS053266
EXP057462	anti-MLL2 (Homemade, #9173)	Mus musculus	Genotype: wildtype; Treatment: RA-induced differentiation;	NULL	252	normal	O08550	V6.5 (embryonic stem cells)	PEAKS053267
EXP057463	MLL4 (Homemade, #825)	Mus musculus	Genotype: wildtype; Treatment: RA-induced differentiation;	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	PEAKS053268
EXP057464	anti-SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype; Treatment: RA-induced differentiation;	NULL	252	normal	E9PYH6	V6.5 (embryonic stem cells)	PEAKS053269
EXP057469	anti-ERF (PA5-30237)	Mus musculus	Treatment: vehicle;	EXP057465	2953	normal	P70459	prostate organoids	PEAKS053270
EXP057470	anti-ERF (PA5-30237)	Mus musculus	Treatment: vehicle;	EXP057466	2953	normal	P70459	prostate organoids	PEAKS053271
EXP057471	anti-ERF (PA5-30237)	Mus musculus	Treatment: 100ng/mL doxycycline;	EXP057467	2953	normal	P70459	prostate organoids	PEAKS053272
EXP057472	anti-ERF (PA5-30237)	Mus musculus	Treatment: 100ng/mL doxycycline;	EXP057468	2953	normal	P70459	prostate organoids	PEAKS053273
EXP057475	anti-Menin (Bethyl, A300-105A)	Mus musculus	Strain: C57BL/6;  Age: Five-day cultured Th2 cells;	EXP057473	499	normal	O88559	Th2-cells	PEAKS053274
EXP057476	anti-Menin (Bethyl, A300-105A)	Mus musculus	Strain: C57BL/6;  Age: Three-week cultured Th2 cells ;	EXP057474	499	normal	O88559	Th2-cells	PEAKS053275
EXP057478	anti-Chd8 (Abcam ab114126)	Mus musculus	Genotype: wildtype; Strain: C57BL/6N; Developmental stage: P56; 	EXP057477	313	normal	Q09XV5	forebrain	PEAKS053276
EXP057481	Anti-PR antibody (H-190, Santa Cruz, cat# sc-7208)	Rattus norvegicus	Genotype: Cdkn1b+/+; Age: 9 weeks; Strain:ACI;	EXP057479	2962	normal	Q63449	mammary gland	PEAKS054050
EXP057482	Anti-PR antibody (H-190, Santa Cruz, cat# sc-7208)	Rattus norvegicus	Genotype: Cdkn1b knockout; Age: 9 weeks; Strain:ACI;	EXP057480	2962	normal	Q63449	mammary gland	PEAKS054051
EXP057485	Anti-FLAG(M2)	Rattus norvegicus	Genotype:stable expression pCDNA3 vector; Passage:18-20;	EXP057483	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	PEAKS054052
EXP057486	anti-FLAG(1804)	Rattus norvegicus	Genotype:stable expression pCDNA3 vector; Passage:18-20;	EXP057483	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	PEAKS054053
EXP057487	Anti-FLAG(M2)	Rattus norvegicus	Genotype:stable expression human alpha1ACT; Passage:18-20;	EXP057484	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	PEAKS054054
EXP057488	anti-FLAG(1804)	Rattus norvegicus	Genotype:stable expression human alpha1ACT; Passage:18-20;	EXP057484	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	PEAKS054055
EXP057491	anti-RING1B (Cell Signaling D22F2); H2A? (Active Motif 104597)	Danio rerio	Genotype: myl7:GFP_rnf2 +/+t; Developmental stage: 3 dpf; Strain: TU/TLF mixed background; 	EXP057489	2964	normal	Q803I4	3 dpf embryo	PEAKS054056
EXP057492	anti-RING1B (Cell Signaling D22F2); H2A? (Active Motif 104597)	Danio rerio	Genotype: myl7:GFP_rnf2 knockout; Developmental stage: 3 dpf; Strain: TU/TLF mixed background; 	EXP057490	2964	normal	Q803I4	3 dpf embryo	PEAKS054057
EXP057495	anti-Myc (monoclonal 9E10)	Saccharomyces cerevisiae	Genotype:MATa SCC2-13xMyc::KanMX ade2-1 trp1-1 ura3-1 chrIII (t0D, t1D, t3D, t4D, t5D, t6D, t7D, t8D+t9D::LEU2), T1+T7::HIS3;	EXP057494	2968	normal	P23285	ROY5151 W-303 strain	PEAKS054058
EXP057496	anti-Myc (monoclonal 9E10)	Saccharomyces cerevisiae	Strain: ROY4825 W-303; Genotype:MATa SCC2-13xMyc::KanMX ADE2 his3-11,15 leu2-3, 112 lys2D trp1-1 ura3-1;	EXP057493	2969	normal	P23285	ROY4825 W-303 strain	PEAKS054059
EXP057509	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: SET2-H366N ;	EXP057501	2970	normal	P46995	FY3182 strain log phase	PEAKS054062
EXP057510	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: SET2-H366N ;	EXP057502	2970	normal	P46995	FY3182 strain log phase	PEAKS054063
EXP057511	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 mutant;	EXP057503	2971	normal	P46995	FY3180 strain log phase	PEAKS054064
EXP057512	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 mutant;	EXP057504	2971	normal	P46995	FY3180 strain log phase	PEAKS054065
EXP057513	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 and SET2-H366N mutant;	EXP057505	2972	normal	P46995	FY3181 log phase	PEAKS054066
EXP057514	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 and SET2-H366N mutant;	EXP057506	2972	normal	P46995	FY3181 log phase	PEAKS054067
EXP057515	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: wildtype;	EXP057507	2973	normal	P46995	FY3179 log phase	PEAKS054068
EXP057516	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: wildtype;	EXP057508	2973	normal	P46995	FY3179 log phase	PEAKS054069
EXP057535	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057517	2520	normal	P08638	whole cells	PEAKS054070
EXP057536	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057518	2520	normal	P08638	whole cells	PEAKS054071
EXP057537	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057519	2520	normal	P08638	whole cells	PEAKS054072
EXP057538	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057520	2520	normal	P08638	whole cells	PEAKS054073
EXP057539	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057521	2520	normal	P08638	whole cells	PEAKS054074
EXP057540	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057522	2520	normal	P08638	whole cells	PEAKS054075
EXP057541	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057523	2520	normal	A0A250WE75	whole cells	PEAKS054076
EXP057542	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057524	2520	normal	A0A250WE75	whole cells	PEAKS054077
EXP057543	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057525	2520	normal	A0A250WE75	whole cells	PEAKS054078
EXP057544	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057526	2520	normal	A0A250WE75	whole cells	PEAKS054079
EXP057545	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057527	2520	normal	A0A250WE75	whole cells	PEAKS054080
EXP057546	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057522	2520	normal	A0A250WE75	whole cells	PEAKS054081
EXP057547	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057529	2520	normal	P32862	whole cells	PEAKS054082
EXP057548	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057530	2520	normal	P32862	whole cells	PEAKS054083
EXP057549	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057531	2520	normal	P32862	whole cells	PEAKS054084
EXP057550	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057532	2520	normal	P32862	whole cells	PEAKS054085
EXP057551	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057533	2520	normal	P32862	whole cells	PEAKS054086
EXP057552	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057534	2520	normal	P32862	whole cells	PEAKS054087
EXP057554	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GALACTOSE 2%, 60 mins after treatment; Genotype: GAL1p-SFP1-TAP::URA3 MATa;	EXP057553	2974	normal	P32432	YHL201 strain	PEAKS054088
EXP057555	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: RAFFINOSE2%, 0 mins after treatment; Genotype: GAL1p-SFP1-TAP::URA3 MATa;	EXP057553	2974	normal	P32432	YHL201 strain	PEAKS054089
EXP057556	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GLUCOSE 2%; Genotype: SFP1_TAP::URA3leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2975	normal	P32432	YHL38 strain	PEAKS054090
EXP057557	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: RAFFINOSE2%; Genotype: SFP1_TAP::URA3leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2975	normal	P32432	YHL38 strain	PEAKS054091
EXP057558	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GALACTOSE2%; Genotype: SFP1_TAP::URA3leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2975	normal	P32432	YHL38 strain	PEAKS054092
EXP057559	Anti-MYC	Saccharomyces cerevisiae	Treatment: Rapamycin, 20min after treatment; Genotype: TBP-MYC::G418,tor1-1 fpr1{delta}::Nat RPL13A-2XFKB12::TRP1 SFP1-FRB-KanMX MAT{alpha};	NULL	2976	normal	P13393	YSK420 strain	PEAKS054093
EXP057560	Anti-MYC	Saccharomyces cerevisiae	Treatment: no Rapamycin; Genotype: TBP-MYC::G418,tor1-1 fpr1{delta}::Nat RPL13A-2XFKB12::TRP1 SFP1-FRB-KanMX MAT{alpha};	NULL	2976	normal	P13393	YSK420 strain	PEAKS054094
EXP057565	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: none; Genotype: Sko1-WT; 	EXP057561	1386	normal	Q02100	W303a Strain	PEAKS054095
EXP057566	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: none; Genotype: Sko1-MT; 	EXP057562	1386	normal	Q02100	W303a Strain	PEAKS054096
EXP057567	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: 0.4 M NaCl for 5 min; Genotype: Sko1-WT; 	EXP057563	1386	normal	Q02100	W303a Strain	PEAKS054097
EXP057568	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: 0.4 M NaCl for 5 min; Genotype: Sko1-MT; 	EXP057564	1386	normal	Q02100	W303a Strain	PEAKS054098
EXP057569	anti-HA	Saccharomyces cerevisiae	Conditions: SL, 0.17% yeast nitrogen base without amino acids; Genotype: CEN.PK; MATa; RPH1-HA-HYG;	NULL	2520	normal	P39956	whole cells	PEAKS054099
EXP057570	anti-HA	Saccharomyces cerevisiae	Conditions: SL, containing 0.5% ammonium sulfate (Difco), 2% lactate; Genotype: CEN.PK; MATa; RPH1-HA-HYG;	NULL	2520	normal	P39956	whole cells	PEAKS054100
EXP057571	anti-HA	Saccharomyces cerevisiae	Conditions: YPL, 1% yeast extract, 2% peptone and 2% lactate; Genotype: CEN.PK; MATa; RPH1-S412A-HA-HYG;	NULL	2520	normal	P39956	whole cells	PEAKS054101
EXP057572	anti-HA	Saccharomyces cerevisiae	Conditions: YPL, 1% yeast extract, 2% peptone and 2% lactate; Genotype: CEN.PK; MATa; RPH1-HA-HYG; ppm1::kanMX;	NULL	2520	normal	P39956	whole cells	PEAKS054102
EXP057573	anti-HA	Saccharomyces cerevisiae	Conditions: YPL, 1% yeast extract, 2% peptone and 2% lactate; Genotype: CEN.PK; MATa; RPH1-HA-HYG;	NULL	2520	normal	P39956	whole cells	PEAKS054103
EXP057574	anti-HA(Pierce catno:88837)	Saccharomyces cerevisiae	Genotype: Cse4-HA;	NULL	2191	bio_control	P36012	S phase S. cerevisiae cells	PEAKS054104
EXP057575	anti-TFIIB 	Saccharomyces cerevisiae	Genotype: Spt16 anchor-away; Treatment: no raptomicyn;	NULL	2978	normal	P29055	YJ127 strain	PEAKS054105
EXP057576	anti-TFIIB 	Saccharomyces cerevisiae	Genotype: Spt16 anchor-away; Treatment: raptomicyn;	NULL	2978	normal	P29055	YJ127 strain	PEAKS054106
EXP057589	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057577	2979	normal	Q08562	budding yeast	PEAKS054107
EXP057590	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057578	2979	normal	Q08562	budding yeast	PEAKS054108
EXP057591	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057579	2979	normal	Q08562	budding yeast	PEAKS054109
EXP057592	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057580	2979	normal	Q08562	budding yeast	PEAKS054110
EXP057593	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057581	2979	normal	P06786	budding yeast	PEAKS054111
EXP057594	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057582	2979	normal	P06786	budding yeast	PEAKS054112
EXP057595	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057583	2979	normal	P06786	budding yeast	PEAKS054113
EXP057596	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057584	2979	normal	P06786	budding yeast	PEAKS054114
EXP057597	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: uls1 delta;	EXP057585	2979	normal	P06786	budding yeast	PEAKS054115
EXP057598	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: uls1 delta;	EXP057586	2979	normal	P06786	budding yeast	PEAKS054116
EXP057599	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine); Genotype: uls1 delta;	EXP057587	2979	normal	P06786	budding yeast	PEAKS054117
EXP057600	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine); Genotype: uls1 delta;	EXP057584	2979	normal	P06786	budding yeast	PEAKS054118
EXP057607	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA cdc4-1; 	EXP057601	2980	normal	P36012	S288C strain	PEAKS054119
EXP057608	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA cdc4-1; 	EXP057602	2980	normal	P36012	S288C strain	PEAKS054120
EXP057609	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA met30-6;	EXP057603	2980	normal	P36012	S288C strain	PEAKS054121
EXP057610	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA met30-6;	EXP057604	2980	normal	P36012	S288C strain	PEAKS054122
EXP057611	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA(wildtype);	EXP057605	2980	normal	P36012	S288C strain	PEAKS054123
EXP057612	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA(wildtype);	EXP057606	2980	normal	P36012	S288C strain	PEAKS054124
EXP057621	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Gat1-Myc; Conditions: grown in proline-containing medium;	EXP057615	2520	normal	P43574	whole cells	PEAKS054125
EXP057622	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Dal80-Myc; Conditions: grown in proline-containing medium;	EXP057616	2520	normal	P26343	whole cells	PEAKS054126
EXP057623	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Gat1-Myc; Conditions: grown in proline-containing medium;	EXP057619	2520	normal	A6ZTW2	whole cells	PEAKS054127
EXP057624	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Dal80-Myc; Conditions: grown in proline-containing medium;	EXP057620	2520	normal	P26343	whole cells	PEAKS054128
EXP057631	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057625	2193	normal	A7DTF0	whole worms(developmental stage L4)	PEAKS054129
EXP057632	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057626	2193	normal	A7DTF0	whole worms(developmental stage L4)	PEAKS054130
EXP057633	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057627	2193	normal	A7DTF0	whole worms(developmental stage L4)	PEAKS054131
EXP057634	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057628	2981	normal	A7DTF0	N2 strain (developmental stage L4)	PEAKS054132
EXP057635	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057629	2981	normal	A7DTF0	N2 strain (developmental stage L4)	PEAKS054133
EXP057636	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057630	2981	normal	A7DTF0	N2 strain (developmental stage L4)	PEAKS054134
EXP057638	anti-PRDE-1	Caenorhabditis elegans		EXP057637	1235	normal	O17828	whole worms (developmental stage: young adults)	PEAKS054135
EXP057639	anti-SNPC4	Caenorhabditis elegans		EXP057637	1235	normal	P91868	whole worms (developmental stage: young adults)	PEAKS054136
EXP057640	anti-TOFU4	Caenorhabditis elegans		EXP057637	1235	normal	O01819	whole worms (developmental stage: young adults)	PEAKS054137
EXP057641	anti-TOFU5	Caenorhabditis elegans		EXP057637	1235	normal	Q23096	whole worms (developmental stage: young adults)	PEAKS054138
EXP057644	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	EXP057642	2982	normal	Q45EK2	DLS395 strain (day1 adult)	PEAKS054139
EXP057645	anti-HA (mIgG1, Pierce, 26181)	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	EXP057642	2982	normal	Q45EK2	DLS395 strain (day1 adult)	PEAKS054140
EXP057646	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: ceh-60(rhd116), gaIs285;	NULL	2983	normal	Q45EK2	DLS396 strain(day 1 adult)	PEAKS054141
EXP057647	anti-GFP (3E6, Thermo Fisher, A-11120)	Caenorhabditis elegans	Genotype: ceh-60(rhd116); gaIs285; Comment: isoform 7a;	NULL	2983	normal	Q9N5D6	DLS396 strain(day 1 adult)	PEAKS054142
EXP057648	anti-FLAG (M2, Sigma-Aldrich, F1804)	Caenorhabditis elegans	Genotype: unc-119(tm4063); wgIs201;	EXP057643	2984	normal	G5EFY7	OP201 strain(day 1 adult)	PEAKS054143
EXP057649	anti-FLAG (M2, Sigma-Aldrich, F1804)	Caenorhabditis elegans	Genotype: ceh-60(ok1485), wgIs201;	NULL	2985	normal	G5EFY7	DLS422 strain(day 1 adult)	PEAKS054144
EXP057650	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	NULL	2986	normal	Q45EK2	DLS395(day 1 adult)	PEAKS054145
EXP057651	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: pqm-1(ok485), ceh-60(rhd116);	NULL	2987	normal	Q45EK2	DLS435(day 1 adult)	PEAKS054146
EXP057652	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial PA14 exposure for 4 hrs; Genotype: wildtype;	NULL	2981	normal	B3GWA6	N2 strain (developmental stage L4)	PEAKS054147
EXP057653	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial OP50 exposure for 4 hrs; Genotype: atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	PEAKS054148
EXP057654	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial PA14 exposure for 4 hrs; Genotype: atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	PEAKS054149
EXP057655	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial OP50 exposure for 4 hrs; Genotype: pmk-1 mutation, pmk-1(km25);atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	PEAKS054150
EXP057656	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial PA14 exposure for 4 hrs; Genotype: pmk-1 mutation, pmk-1(km25);atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	PEAKS054151
EXP057666	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans	Genotype: wildtype;	EXP057657	2988	normal	Q9XTB5	N2 strain	PEAKS054152
EXP057667	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans	Genotype: wildtype;	EXP057658	2988	normal	Q9XTB5	N2 strain	PEAKS054153
EXP057668	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans	Genotype: wildtype;	EXP057659	2988	normal	Q9XTB5	N2 strain	PEAKS054154
EXP057669	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057660	2989	normal	Q9XTB5	met-2(n4256) III strain	PEAKS054155
EXP057670	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057661	2989	normal	Q9XTB5	met-2(n4256) III strain	PEAKS054156
EXP057671	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057662	2989	normal	Q9XTB5	met-2(n4256) III strain	PEAKS054157
EXP057672	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057663	2990	normal	Q9XTB5	set-25(n5021) III	PEAKS054158
EXP057673	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057664	2990	normal	Q9XTB5	set-25(n5021) III	PEAKS054159
EXP057674	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057665	2990	normal	Q9XTB5	set-25(n5021) III	PEAKS054160
EXP057687	anti-suhw(Guinea pig serum against Su(Hw), Moshkovich and Lei, 2010 PMID: 21852534)	Drosophila melanogaster	Treatment: mock;	EXP057684	1448	normal	A0A0B4K6W1	KC167 (developmental stage: 6-12h embryo)	PEAKS054161
EXP057688	anti-suhw(Guinea pig serum against Su(Hw), Moshkovich and Lei, 2010 PMID: 21852534)	Drosophila melanogaster	Treatment: mock;	EXP057675	1448	normal	A0A0B4K6W1	KC167 (developmental stage: 6-12h embryo)	PEAKS054162
EXP057689	anti-mod (Van Bortle et al., 2012, PMID: 22722341)	Drosophila melanogaster	Treatment: mock;	EXP057676	1448	normal	A0A0B4K6B8	KC167 (developmental stage: 6-12h embryo)	PEAKS054163
EXP057690	anti-clamp (sdix, Cat no# 4988.00.02)	Drosophila melanogaster	Treatment: mock;	EXP057677	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054164
EXP057691	anti-cp190 (Pai et al. 2004, PMID: 15574329)	Drosophila melanogaster	Treatment: mock;	EXP057678	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS054165
EXP057692	anti-mod (Van Bortle et al., 2012, PMID: 22722341)	Drosophila melanogaster	Treatment: mock;	EXP057679	1448	normal	A0A0B4K6B8	KC167 (developmental stage: 6-12h embryo)	PEAKS054166
EXP057693	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: mock;	EXP057680	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054167
EXP057694	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: mock;	EXP057681	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054168
EXP057695	anti-clamp (sdix, Cat no# 4988.00.02)	Drosophila melanogaster	Treatment: mock;	EXP057682	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054169
EXP057696	anti-cp190 (Pai et al. 2004, PMID: 15574329)	Drosophila melanogaster	Treatment: mock;	EXP057683	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS054170
EXP057697	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: dsCLAMP;	EXP057685	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054171
EXP057698	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: dsCLAMP;	EXP057686	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054172
EXP057704	anti-HA (Santa Cruz,F-7)	Drosophila melanogaster		EXP057702	1450	normal	Q9VHS8	S2R+ (late embryonic stage cells)	PEAKS054173
EXP057705	anti-HA (Santa Cruz,F-7)	Drosophila melanogaster		EXP057703	1450	normal	Q9V535	S2R+ (late embryonic stage cells)	PEAKS054174
EXP057709	anti-dLsd1 (Dyson team in Boston [PMID 17462898])	Drosophila melanogaster	Genotype: w1118; 	EXP057706	2203	normal	B7Z0G7	ovary	PEAKS054175
EXP057710	anti-dLsd1 (Dyson team in Boston [PMID 17462898])	Drosophila melanogaster	Genotype: w1118; 	EXP057707	2203	normal	B7Z0G7	ovary	PEAKS054176
EXP057711	anti-dLsd1 (Dyson team in Boston [PMID 17462898])	Drosophila melanogaster	Genotype: w1118; 	EXP057708	2203	normal	B7Z0G7	ovary	PEAKS054177
EXP057713	UPF1 Antibody (Generated in Lab)	Drosophila melanogaster		EXP057712	1451	normal	Q9VYS3	S2 (Schneider 2)	PEAKS054178
EXP057718	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057714	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054179
EXP057719	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057714	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS054180
EXP057720	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057715	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054181
EXP057721	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057715	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS054182
EXP057722	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057716	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054183
EXP057723	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057716	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS054184
EXP057724	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057717	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	PEAKS054185
EXP057725	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057717	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	PEAKS054186
EXP057726	anti-Cap-H2	Drosophila melanogaster	Treatment: none;	NULL	1448	normal	A0A0C4DHE3	KC167 (developmental stage: 6-12h embryo)	PEAKS054187
EXP057727	anti-Cap-H2	Drosophila melanogaster	Treatment: 3 hours Flv treatment;	NULL	1448	normal	A0A0C4DHE3	KC167 (developmental stage: 6-12h embryo)	PEAKS054188
EXP057728	anti-Rad21	Drosophila melanogaster	Treatment: none;	NULL	1448	normal	Q9UB09	KC167 (developmental stage: 6-12h embryo)	PEAKS054189
EXP057729	anti-Rad21	Drosophila melanogaster	Treatment: 3 hours Flv treatment;	NULL	1448	normal	Q9UB09	KC167 (developmental stage: 6-12h embryo)	PEAKS054190
EXP057737	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RNAse treatment;	EXP057735	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054191
EXP057738	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RNAse treatment;	EXP057736	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054192
EXP057739	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none; 	EXP057731	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054193
EXP057740	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none; Genotype: Mago knockdown;	EXP057732	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054194
EXP057744	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	Age: adult; Genotype: w[1118]; 	NULL	2203	normal	Q7JXA8	ovary	PEAKS054195
EXP057745	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	Age: adult; Genotype: w[1118], rhi[18-5] / rhi[18-7] (rhino knockout); 	EXP057742	2203	normal	Q7JXA8	ovary	PEAKS054196
EXP057746	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	Age: adult; Genotype: w[1118], nxf3[FS1_A3-5] / nxf3[FS3_B1-4] (nxf3 knockout);	EXP057743	2203	normal	Q7JXA8	ovary	PEAKS054197
EXP057754	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: Rnase T1;	EXP057752	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054198
EXP057755	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: Rnase T1;	EXP057753	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054199
EXP057756	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none;	EXP057748	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054200
EXP057757	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none; Genotype: Mago knockdown;	EXP057749	1450	normal	P49028	S2R+ (late embryonic stage cells)	PEAKS054201
EXP057759	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none RnaseT1;	EXP057758	1450	normal	Q9VHC0	S2R+ (late embryonic stage cells)	PEAKS054202
EXP057760	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RnaseT1;	NULL	1450	normal	Q9VHC0	S2R+ (late embryonic stage cells)	PEAKS054203
EXP057762	anti-Pitx1 (Santa Cruz, 18922)	Homo sapiens	Source: Head and neck squamous cell carcinoma;	EXP057761	1552	normal	P78337	tongue	PEAKS054204
EXP057763	anti-Sox2 (R&D, AF2018)	Homo sapiens	Source: Head and neck squamous cell carcinoma;	EXP057761	1552	normal	P48431	tongue	PEAKS054205
EXP057764	anti-TP63 (Cell Signaling, 13109)	Homo sapiens	Source: Head and neck squamous cell carcinoma;	EXP057761	1552	normal	Q9H3D4	tongue	PEAKS054206
EXP057766	anti-HNF4a	Homo sapiens	Developmental stage: day 8;	EXP057765	1143	normal	P41235	iPSC (induced pluripotent stem cells)	PEAKS054207
EXP057769	anti-DNMT3B	Homo sapiens	Genotype: wildtype(control); 	EXP057767	1143	normal	Q9UBC3	iPSC (induced pluripotent stem cells)	PEAKS054208
EXP057770	anti-DNMT3B	Homo sapiens	Genotype: SALL3 knockout;	NULL	1143	normal	Q9UBC3	iPSC (induced pluripotent stem cells)	PEAKS054209
EXP057771	anti-SALL3	Homo sapiens		EXP057768	1143	normal	Q9BXA9	iPSC (induced pluripotent stem cells)	PEAKS054210
EXP057788	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Treatment: dBET6;	EXP057776	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054211
EXP057789	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Treatment: dBET6;	EXP057777	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054212
EXP057790	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Tratment: DMSO;	EXP057778	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054213
EXP057791	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Tratment: DMSO;	EXP057779	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054214
EXP057792	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: dBET6;	EXP057776	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054215
EXP057793	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: dBET6;	EXP057777	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054216
EXP057794	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Tratment: DMSO;	EXP057778	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054217
EXP057795	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Tratment: DMSO;	EXP057779	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054218
EXP057796	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: mock; 	NULL	1507	normal	A0A023HHK9	HAP1 (chronic myelogenous leukemia)	PEAKS054219
EXP057797	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Genotype: MTHFD1, clone C8;	EXP057781	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054220
EXP057798	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Genotype: MTHFD1, clone C8;	EXP057781	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054221
EXP057799	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Genotype: MTHFD1, clone F5;	EXP057783	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054222
EXP057800	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Genotype: MTHFD1, clone F5;	EXP057783	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054223
EXP057801	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057786	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054224
EXP057802	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057787	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS054225
EXP057803	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057786	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054226
EXP057804	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057787	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	PEAKS054227
EXP057813	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057809	489	normal	Q92793	IMR90 (lung fibroblasts)	PEAKS054228
EXP057814	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057810	489	normal	Q92793	IMR90 (lung fibroblasts)	PEAKS054229
EXP057815	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: replicative senescence;	EXP057811	489	normal	Q92793	IMR90 (lung fibroblasts)	PEAKS054230
EXP057816	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: replicative senescence;	EXP057812	489	normal	Q92793	IMR90 (lung fibroblasts)	PEAKS054231
EXP057817	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057809	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS054232
EXP057818	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057810	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS054233
EXP057819	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: replicative senescence;	EXP057811	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS054234
EXP057820	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: replicative senescence;	EXP057812	489	normal	Q09472	IMR90 (lung fibroblasts)	PEAKS054235
EXP057821	anti-HIF1A	Homo sapiens	Treatment: siCtrl;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	PEAKS054236
EXP057822	anti-HIF1A	Homo sapiens	Treatment: siOC2; Genotype: OC2 knockout ;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	PEAKS054237
EXP057823	anti-Flag	Homo sapiens	Treatment: normoxia;	NULL	70	normal	O95948	LNCaP (prostate carcinoma)	PEAKS054238
EXP057824	anti-Flag	Homo sapiens	Treatment: hypoxia(0.2% O2);	NULL	70	normal	O95948	LNCaP (prostate carcinoma)	PEAKS054239
EXP057825	anti-HIF2A	Homo sapiens	Treatment: hypoxia(0.2% O2);	NULL	725	normal	Q99814	PC3(bone mets prostate adenocarcinoma)	PEAKS054240
EXP057826	anti-HIF1A	Homo sapiens	Treatment: hypoxia(0.2% O2), siCtrl;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	PEAKS054241
EXP057827	anti-HIF1A	Homo sapiens	Treatment: hypoxia(0.2% O2), siSMAD3; Genotype: SMAD3 knockout;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	PEAKS054242
EXP057828	anti-SMAD3	Homo sapiens	Treatment: hypoxia (0.2% O2);	NULL	725	normal	P84022	PC3(bone mets prostate adenocarcinoma)	PEAKS054243
EXP057834	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057830	430	normal	P06213	HepG2 (hepatoblastoma)	PEAKS054244
EXP057835	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057829	430	normal	P06213	HepG2 (hepatoblastoma)	PEAKS054245
EXP057836	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057831	664	normal	P06213	SH-SY5Y (neuroblastoma)	PEAKS054246
EXP057837	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057832	664	normal	P06213	SH-SY5Y (neuroblastoma)	PEAKS054247
EXP057838	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens	Treatment: serum starvation;	EXP057833	430	normal	P06213	HepG2 (hepatoblastoma)	PEAKS054248
EXP057841	anti-53BP1(Abcam,ab36823)	Homo sapiens	Genotype: wildtype;	EXP057840	395	normal	Q12888	H9-derived neural progenitors	PEAKS054249
EXP057842	anti-53BP1(Novus,NB100-304)	Homo sapiens	Genotype: wildtype;	EXP057840	395	normal	Q12888	H9-derived neural progenitors	PEAKS054250
EXP057843	anti-UTX(Abcam,ab84190)	Homo sapiens	Genotype: wildtype;	EXP057840	395	normal	O15550	H9-derived neural progenitors	PEAKS054251
EXP057844	anti-UTX(Abcam,ab91231)	Homo sapiens	Genotype: wildtype;	NULL	396	normal	O15550	WA09 (embryonic stem cells)	PEAKS054252
EXP057845	anti-UTX (Bethyl,A302-374A)	Homo sapiens	Genotype: wildtype; 	NULL	934	normal	O15550	HOT1 tumor derived from a human glioblastoma	PEAKS054253
EXP057846	anti-53BP1(Abcam,ab36823)	Homo sapiens	Genotype: wildtype;	EXP057839	396	normal	Q12888	WA09 (embryonic stem cells)	PEAKS054254
EXP057847	anti-53BP1(Novus,NB100-304)	Homo sapiens	Genotype: wildtype;	EXP057839	396	normal	Q12888	WA09 (embryonic stem cells)	PEAKS054255
EXP057848	anti-UTX(Abcam,ab84190)	Homo sapiens	Genotype: wildtype;	EXP057839	396	normal	O15550	WA09 (embryonic stem cells)	PEAKS054256
EXP057849	anti-UTX (Bethyl,A302-374A)	Homo sapiens	Genotype: 53BP1 KO;	NULL	395	normal	O15550	H9-derived neural progenitors	PEAKS054257
EXP057850	anti-53BP1 (Novus,NB100-304)	Homo sapiens	Genotype: UTX knockdown;	NULL	396	normal	Q12888	WA09 (embryonic stem cells)	PEAKS054258
EXP057857	anti-ERa	Homo sapiens	Treatment: untreated;	EXP057851	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054259
EXP057858	anti-CTCF	Homo sapiens	Treatment: untreated;	EXP057851	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054260
EXP057859	anti-ERa	Homo sapiens	Treatment: treated with E2 for 1 hr;	EXP057852	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054261
EXP057860	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 1 hr;	EXP057852	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054262
EXP057861	anti-ERa	Homo sapiens	Treatment: treated with E2 for 4 hrs;	EXP057853	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054263
EXP057862	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 4 hrs;	EXP057853	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054264
EXP057863	anti-ERa	Homo sapiens	Treatment: treated with E2 for 16 hrs;	EXP057854	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054265
EXP057864	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 16 hrs;	EXP057854	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054266
EXP057865	anti-ERa	Homo sapiens	Treatment: treated with E2 for 24 hrs;	EXP057855	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054267
EXP057866	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 24 hrs;	EXP057855	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	PEAKS054268
EXP057867	anti-ERa	Homo sapiens		EXP057856	2992	normal	P03372	MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line)	PEAKS054269
EXP057868	anti-CTCF	Homo sapiens		EXP057856	2992	normal	P49711	MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line)	PEAKS054270
EXP057869	anti-HIF-1alpha (Bethyl Laboratories, Cat.# A300-286A)	Homo sapiens	Treatment: 1% O2;	NULL	2301	normal	Q16665	MDA-MB-231 (breast adenocarcinoma)	PEAKS054271
EXP057870	anti-ZMYND8 (Bethyl Laboratories, Cat.#A302-089A)	Homo sapiens	Treatment: 1% O2;	NULL	2301	normal	Q9ULU4	MDA-MB-231 (breast adenocarcinoma)	PEAKS054272
EXP057879	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	EXP057873	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054273
EXP057880	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	EXP057874	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054274
EXP057881	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	EXP057877	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054275
EXP057882	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	EXP057878	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054276
EXP057883	TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: starvation, no-serum;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054277
EXP057884	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: SF, addition of FBS into the no-serum culture after cell-starved for for 24 h;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054278
EXP057885	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Treatment: starvation, no-serum;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054279
EXP057886	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Conditions:SF, addition of FBS into the no-serum culture after cell-starved for for 24 h;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	PEAKS054280
EXP057893	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: EGFP transfection;	EXP057887	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	PEAKS054281
EXP057894	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: EGFP transfection;	EXP057888	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	PEAKS054282
EXP057895	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: OMOMYC transfection;	EXP057889	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	PEAKS054283
EXP057896	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: OMOMYC transfection;	EXP057890	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	PEAKS054284
EXP057897	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: SNF5 transfection;	EXP057891	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	PEAKS054285
EXP057898	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: SNF5 transfection;	EXP057892	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	PEAKS054286
EXP057899	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with DMSO (Veh control) for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 12;	NULL	2993	normal	P04150	monocytes from periferal blood	PEAKS054287
EXP057900	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with 1 micromolar (1uM) TA for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 12;	NULL	2993	normal	P04150	monocytes from periferal blood	PEAKS054288
EXP057901	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with DMSO (Veh control) for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 11;	NULL	911	normal	P04150	macrophages	PEAKS054289
EXP057902	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with 1 micromolar (1uM) TA for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 11;	NULL	911	normal	P04150	macrophages	PEAKS054290
EXP057911	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057903	2994	normal	Q15796	definitive endoderm from HUES8	PEAKS054291
EXP057912	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057903	2994	normal	P05412	definitive endoderm from HUES8	PEAKS054292
EXP057913	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057903	2994	normal	Q92908	definitive endoderm from HUES8	PEAKS054293
EXP057914	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057904	2994	normal	Q15796	definitive endoderm from HUES8	PEAKS054294
EXP057915	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057904	2994	normal	Q92908	definitive endoderm from HUES8	PEAKS054295
EXP057916	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	Q15796	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054296
EXP057917	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	P05412	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054297
EXP057918	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057906	2994	normal	Q15796	definitive endoderm from HUES8	PEAKS054298
EXP057919	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057906	2994	normal	P05412	definitive endoderm from HUES8	PEAKS054299
EXP057920	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057906	2994	normal	Q92908	definitive endoderm from HUES8	PEAKS054300
EXP057921	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057907	2994	normal	Q15796	definitive endoderm from HUES8	PEAKS054301
EXP057922	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057907	2994	normal	Q92908	definitive endoderm from HUES8	PEAKS054302
EXP057923	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057908	2369	normal	Q15796	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054303
EXP057924	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057908	2369	normal	P05412	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054304
EXP057925	anti-OCT4	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	Q01860	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054305
EXP057926	anti-NANOG	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	Q9H9S0	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054306
EXP057927	anti-OCT4	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057908	2369	normal	Q01860	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054307
EXP057928	anti-NANOG	Homo sapiens	Genotype: SOX17-GFP knockout;	NULL	2369	normal	Q9H9S0	HUES8 (Embryonic stem cell, blastocyst stage)	PEAKS054308
EXP057929	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057909	2994	normal	Q15796	definitive endoderm from HUES8	PEAKS054309
EXP057930	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057909	2994	normal	Q92908	definitive endoderm from HUES8	PEAKS054310
EXP057931	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057910	2994	normal	Q15796	definitive endoderm from HUES8	PEAKS054311
EXP057932	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057910	2994	normal	Q92908	definitive endoderm from HUES8	PEAKS054312
EXP057937	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens		EXP057936	2995	normal	P20700	proliferating adipose stem cells (ASC)	PEAKS054313
EXP057938	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens	Developmental stage: day 0;	EXP057935	2996	normal	P20700	adipose stem cells	PEAKS054314
EXP057939	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens	Developmental stage: day 1;	EXP057933	2996	normal	P20700	adipose stem cells	PEAKS054315
EXP057940	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens	Developmental stage: day 3;	EXP057934	2996	normal	P20700	adipose stem cells	PEAKS054316
EXP057945	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after HySp5 transfection;	EXP057941	421	normal	Q6BEB4	HEK293 (embryonic kidney)	PEAKS054317
EXP057946	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after HySp5_dDBD transfection;	EXP057942	421	normal	Q6BEB4	HEK293 (embryonic kidney)	PEAKS054318
EXP057947	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after zFSp5 transfection;	EXP057943	421	normal	Q6BEB4	HEK293 (embryonic kidney)	PEAKS054319
EXP057948	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after zFSp5_dDBD transfection;	EXP057944	421	normal	Q6BEB4	HEK293 (embryonic kidney)	PEAKS054320
EXP057949	anti-Flag (Sigma, catalog# F1804, lot# SLBT7654) antibody	Homo sapiens	Treatment: treated started from 5 uM,  increased to 10 uM, 15uM and finally 20 uM;	NULL	2997	normal	P51532	TOV-21G (Ovarian clear cell adenocarcinoma)	PEAKS054321
EXP057950	anti-Flag (Sigma, catalog# F1804, lot# SLBT7654) antibody	Homo sapiens	Treatment: treated started from 5 uM,  increased to 10 uM, 15uM and finally 20 uM;	NULL	2998	normal	P51532	resistant clone 3 TOV21G (Ovarian clear cell adenocarcinoma)	PEAKS054322
EXP057959	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057951	2999	normal	P04637	foreskin fibroblast	PEAKS054323
EXP057960	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057952	2999	normal	P04637	foreskin fibroblast	PEAKS054324
EXP057961	anti-p63	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057953	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	PEAKS054325
EXP057962	anti-p63	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057954	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	PEAKS054326
EXP057963	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057953	583	normal	P04637	MCF10A (breast epithelial cells)	PEAKS054327
EXP057964	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057954	583	normal	P04637	MCF10A (breast epithelial cells)	PEAKS054328
EXP057965	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057955	583	normal	P04637	MCF10A (breast epithelial cells)	PEAKS054329
EXP057966	anti-p63	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057955	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	PEAKS054330
EXP057967	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057956	583	normal	P04637	MCF10A (breast epithelial cells)	PEAKS054331
EXP057968	anti-p63	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057956	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	PEAKS054332
EXP057969	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057957	2999	normal	P04637	foreskin fibroblast	PEAKS054333
EXP057970	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057958	2999	normal	P04637	foreskin fibroblast	PEAKS054334
EXP057973	anti-BRD2 (Proteintech, #22236-1-AP)	Homo sapiens		EXP057971	3000	normal	P25440	LPS141 (Dedifferentiated liposarcoma)	PEAKS054335
EXP057974	anti-BRD3 (Bethyl, #A302-367A)	Homo sapiens		EXP057971	3000	normal	Q15059	LPS141 (Dedifferentiated liposarcoma)	PEAKS054336
EXP057975	anti-BRD4 (Bethyl, #A301-985A, lot4)	Homo sapiens		EXP057971	3000	normal	O60885	LPS141 (Dedifferentiated liposarcoma)	PEAKS054337
EXP057976	anti-FOSL2 (Santa Cruz, #sc-604X)	Homo sapiens		EXP057971	3000	normal	P15408	LPS141 (Dedifferentiated liposarcoma)	PEAKS054338
EXP057977	anti-pan-RUNX (Abcam, #ab92336)	Homo sapiens		EXP057971	3000	normal	Q01196	LPS141 (Dedifferentiated liposarcoma)	PEAKS054339
EXP057978	anti-DIT3 (Cell Signaling Technology, #2895)	Homo sapiens		EXP057972	3001	normal	P35638	MLS 402-91 (Myxoid liposarcoma)	PEAKS054340
EXP057979	anti-BRD4 (Bethyl, #A301-985A, lot4)	Homo sapiens		EXP057972	3001	normal	O60885	MLS 402-91 (Myxoid liposarcoma)	PEAKS054341
EXP057984	anti-CENP-A	Homo sapiens	Developmental stage: Asynchronous;	EXP057980	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS054342
EXP057985	anti-CENP-A	Homo sapiens	Developmental stage: G1;	EXP057982	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS054343
EXP057986	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	EXP057983	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS054344
EXP057987	anti-CENP-A	Homo sapiens	Developmental stage: Asynchronous;	EXP057981	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS054345
EXP057988	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	NULL	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS054346
EXP057989	anti-CENP-A	Homo sapiens	Developmental stage: S4;	NULL	78	normal	P49450	HeLa (cervical adenocarcinoma)	PEAKS054347
EXP057990	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	NULL	78	normal	A0AVK6	HeLa (cervical adenocarcinoma)	PEAKS054348
EXP057992	anti-MLLT3 (Genetex, GTX102835)	Homo sapiens		EXP057991	3003	normal	P42568	hSPC CD34+CD38-/lowCD90+	PEAKS054349
EXP057993	anti-MLLT3 (Genetex, GTX102835)	Homo sapiens		NULL	3002	normal	P42568	erythroblasts CD34-CD71+CD235a+	PEAKS054350
EXP057994	anti-V5(Abcam, ab15828)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: control;  Treatment: lentivirus infection with empty vector;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	PEAKS054351
EXP057995	anti-V5(Abcam, ab15828)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: MLLT3 overexpression; Treatment: lentivirus infection with MLLT3 overexpression;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	PEAKS054352
EXP057996	anti-MLLT3(Genetex, GTX102835)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: control;  Treatment: lentivirus infection with empty vector;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	PEAKS054353
EXP057997	anti-MLLT3(Genetex, GTX102835)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: MLLT3 overexpression; Treatment: lentivirus infection with MLLT3 overexpression;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	PEAKS054354
EXP057998	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	PEAKS054355
EXP057999	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	PEAKS054356
EXP058000	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Bone marrow; Age: 55-60; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	PEAKS054357
EXP058001	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Venous blood; Age: 65-70; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	PEAKS054358
EXP058002	anti-HMGA1 antibody (Abcam, Cat. No. 129153, lot GR211599-2)	Homo sapiens	Treatment: infected with RAS;	NULL	489	normal	P17096	IMR90 (lung fibroblasts)	PEAKS054359
EXP058003	anti-HMGA1 antibody (Abcam, Cat. No. 129153, lot GR211599-2)	Homo sapiens	Treatment: infected with vector control;	NULL	489	normal	P17096	IMR90 (lung fibroblasts)	PEAKS054360
EXP058020	anti-BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058004	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	PEAKS054361
EXP058021	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058005	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	PEAKS054362
EXP058022	anti-BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: trasfection pWZL-empty;	EXP058006	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	PEAKS054363
EXP058023	anti-BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: trasfection pWZL-NMYCwt;	EXP058006	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	PEAKS054364
EXP058024	anti-NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058007	3007	normal	P04198	SH-EP-NMYCER	PEAKS054365
EXP058025	anti-NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058008	3007	normal	P04198	SH-EP-NMYCER	PEAKS054366
EXP058026	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058009	3007	normal	P38398	SH-EP-NMYCER	PEAKS054367
EXP058027	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, 5uM etoposide for 2 hrs;	EXP058009	3007	normal	P38398	SH-EP-NMYCER	PEAKS054368
EXP058028	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, 5uM etoposide for 2 hrs; 	EXP058009	3007	normal	P38398	SH-EP-NMYCER	PEAKS054369
EXP058029	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, 10nM flavopiridol for 2 hrs;	EXP058009	3007	normal	P38398	SH-EP-NMYCER	PEAKS054370
EXP058030	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, 10nM flavopiridol for 2 hrs; 	EXP058009	3007	normal	P38398	SH-EP-NMYCER	PEAKS054371
EXP058031	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058009	3007	normal	P38398	SH-EP-NMYCER	PEAKS054372
EXP058032	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, shBRCA1#1;	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	PEAKS054373
EXP058033	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs,shBRCA1#1; 	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	PEAKS054374
EXP058034	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, shSCR;	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	PEAKS054375
EXP058035	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, shSCR; 	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	PEAKS054376
EXP058036	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: pRRL-NMYC;	EXP058011	3006	normal	P04198	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	PEAKS054377
EXP058037	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058012	3007	normal	P04198	SH-EP-NMYCER	PEAKS054378
EXP058038	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058013	3007	normal	P04198	SH-EP-NMYCER	PEAKS054379
EXP058039	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058014	3007	normal	P04198	SH-EP-NMYCER	PEAKS054380
EXP058040	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058015	3007	normal	P04198	SH-EP-NMYCER	PEAKS054381
EXP058041	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Genotype: control; 	NULL	3008	normal	Q01196	cord blood CD34 cells	PEAKS054382
EXP058042	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Genotype: RUNX1mut transduced;	NULL	3008	normal	Q01196	cord blood CD34 cells	PEAKS054383
EXP058043	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 31 day;Genotype: control; 	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	PEAKS054384
EXP058044	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 31 day; Treatment: dox; Genotype: DOX-induced RUNX1mut;	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	PEAKS054385
EXP058045	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 34 day; Genotype: control; 	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	PEAKS054386
EXP058046	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 34 day; Treatment: dox; Genotype: DOX-induced RUNX1mut;	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	PEAKS054387
EXP058049	anti-NELFA (Santa Cruz, sc-23599)	Homo sapiens	Treatment: none; Condition: heat shock;	EXP058047	514	normal	Q9H3P2	K562 (myelogenous leukemia)	PEAKS054388
EXP058050	anti-NELFE (Sigma, A81919)	Homo sapiens	Treatment: none; Condition: heat shock;	EXP058047	514	normal	P18615	K562 (myelogenous leukemia)	PEAKS054389
EXP058051	anti-NELFA (Santa Cruz, sc-23599)	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	EXP058048	514	normal	Q9H3P2	K562 (myelogenous leukemia)	PEAKS054390
EXP058052	anti-NELFE (Sigma, A81919)	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	EXP058048	514	normal	P18615	K562 (myelogenous leukemia)	PEAKS054391
EXP058053	anti-p38 (MAPK14,E229, ab170099)	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	EXP058048	514	normal	Q16539	K562 (myelogenous leukemia)	PEAKS054392
EXP058054	anti-p38 (MAPK14,E229, ab170099)	Homo sapiens	Treatment: none; Condition: Heat-Shock;	EXP058047	514	normal	Q16539	K562 (myelogenous leukemia)	PEAKS054393
EXP058063	c Jun (Cell Signaling; 9165S)	Homo sapiens		EXP058055	2301	normal	P05412	MDA-MB-231 (breast adenocarcinoma)	PEAKS054394
EXP058064	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058056	2301	normal	P05412	MDA-MB-231 (breast adenocarcinoma)	PEAKS054395
EXP058065	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058057	3009	normal	P05412	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	PEAKS054396
EXP058066	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058058	3009	normal	P05412	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	PEAKS054397
EXP058067	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058059	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054398
EXP058068	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058060	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054399
EXP058069	cJun (Cell Signaling; 9165S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058061	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054400
EXP058070	cJun (Cell Signaling; 9165S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058062	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054401
EXP058071	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058055	2301	normal	P46527	MDA-MB-231 (breast adenocarcinoma)	PEAKS054402
EXP058072	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058056	2301	normal	P46527	MDA-MB-231 (breast adenocarcinoma)	PEAKS054403
EXP058073	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058057	3009	normal	P46527	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	PEAKS054404
EXP058074	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058058	3009	normal	P46527	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	PEAKS054405
EXP058075	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058059	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054406
EXP058076	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058060	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054407
EXP058077	p27 (Cell Signaling; 3686S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058061	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054408
EXP058078	p27 (Cell Signaling; 3686S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058062	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	PEAKS054409
EXP058084	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Treatment: shRNA; Genotype: CDH1 knockdown;	EXP058079	3011	normal	Q13127	CRC107 (colorectal cancer metastatic stem cells)	PEAKS054410
EXP058085	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid dissociation;	EXP058080	3011	normal	Q13127	CRC107 (colorectal cancer metastatic stem cells)	PEAKS054411
EXP058086	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid integrity;	EXP058081	3011	normal	Q13127	CRC107 (colorectal cancer metastatic stem cells)	PEAKS054412
EXP058087	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid dissociation;	EXP058082	3012	normal	Q13127	CRC121 (colorectal cancer metastatic stem cells)	PEAKS054413
EXP058088	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid integrity;	EXP058083	3012	normal	Q13127	CRC121 (colorectal cancer metastatic stem cells)	PEAKS054414
EXP058091	anti-FoxN3 (Abgent, AP19255B)	Homo sapiens		EXP058089	430	normal	O00409	HepG2 (hepatoblastoma)	PEAKS054415
EXP058092	anti-FoxN3 (Abgent, AP19255B)	Homo sapiens		EXP058090	430	normal	O00409	HepG2 (hepatoblastoma)	PEAKS054416
EXP058099	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058095	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS054418
EXP058100	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058096	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS054419
EXP058101	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058095	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS054420
EXP058102	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058096	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS054421
EXP058103	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058098	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS054422
EXP058104	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058097	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS054423
EXP058105	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058097	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS054424
EXP058106	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058098	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	PEAKS054425
EXP058110	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treatment: DMSO for 24 hours;	EXP058107	2311	normal	O60885	GIST-T1 (Gastrointestinal stromal tumor)	PEAKS054426
EXP058111	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treament: 500 nM of Imatinib;	EXP058108	2311	normal	O60885	GIST-T1 (Gastrointestinal stromal tumor)	PEAKS054427
EXP058112	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treatment: 500 nM of JQ1;	EXP058109	2311	normal	O60885	GIST-T1 (Gastrointestinal stromal tumor)	PEAKS054428
EXP058113	anti-EZH2	Homo sapiens	Genotype: wildtype; Passage: 30-60;	NULL	878	normal	Q15910	embryonic stem cells	PEAKS054429
EXP058114	anti-EZH2	Homo sapiens	Genotype: Bach1 knockout; Passage: 30-60;	NULL	878	normal	Q15910	embryonic stem cells	PEAKS054430
EXP058116	anti-mettl3	Homo sapiens		EXP058115	78	normal	Q86U44	HeLa (cervical adenocarcinoma)	PEAKS054431
EXP058118	anti-HA (C29F4, Rabbit mAb, CST #3724)	Homo sapiens		EXP058117	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	PEAKS054432
EXP058123	anti-CREBBP	Homo sapiens		EXP058119	687	normal	Q92793	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS054433
EXP058124	anti-EP300	Homo sapiens		EXP058119	687	normal	Q09472	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS054434
EXP058125	anti-MED1	Homo sapiens		EXP058119	687	normal	O95243	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS054435
EXP058126	anti-FOXP1 (ab4729, Rabbit, 2 ug)	Homo sapiens	Source: Primary tonsilar B cells;	EXP058120	3014	normal	Q9H334	naive IgD+ B cells	PEAKS054436
EXP058127	anti-FOXP1 (ab4729, Rabbit, 2 ug)	Homo sapiens	Source: Primary tonsilar B cells;	EXP058121	3015	normal	Q9H334	germinal center CD77+ B cells	PEAKS054437
EXP058128	anti-FOXP1	Homo sapiens		EXP058122	687	normal	Q9H334	OCI-LY7 (diffuse large B-cell lymphoma)	PEAKS054438
EXP058131	anti-Cdx2	Mus musculus	Strain: C57BL6; Developmental stage: E16.5; Genotype: Wild-Type(Cdx2 f/f; vil-Cre-ERT2 X Cdx2 f/f; vil-Cre-ERT2);	EXP058129	3018	normal	P43241	embryonic whole tissue from midgut	PEAKS054439
EXP058132	anti-Cdx2	Mus musculus	Strain: CD1; Developmental stage: E17.5;	EXP058129	3018	normal	P43241	embryonic whole tissue from midgut	PEAKS054440
EXP058133	anti-Cdx2	Mus musculus	Strain: mixed; Developmental stage: adult;	EXP058129	3017	normal	P43241	villus epithelium	PEAKS054441
EXP058134	anti-CDX2	Homo sapiens	Treatment: none; Genotype: wildtype; Donor: patient 1; 	NULL	3021	normal	Q99626	duodenal cells	PEAKS054442
EXP058135	anti-CDX2	Homo sapiens	Treatment: none; Genotype: wildtype; Donor: patient 2; 	NULL	3021	normal	Q99626	duodenal cells	PEAKS054443
EXP058136	anti-CDX2	Mus musculus	Strain: CD1; Developmental stage: E17.5;	EXP058129	2781	normal	P43241	E16.5 whole embryonic mouse skin	PEAKS054444
EXP058137	anti-CDX2	Homo sapiens	Genotype: wildtype; 	EXP058130	3019	normal	Q99626	Wnt+Fgf-specified intestinal culture cells	PEAKS054445
EXP058138	anti-CDX2	Homo sapiens	Treatment: Doxycycline; Genotype: wildtype; Source: induced CDX2 culture cells;	EXP058130	3020	normal	Q99626	naive endoderm	PEAKS054446
EXP058140	antiSpt5 (D3 X scbt; Lot:B1309)	Homo sapiens	Treatment: siCTR;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	PEAKS054447
EXP058141	antiSpt5 (D3 X scbt; Lot:B1309)	Homo sapiens	Treatment: siMYC; Genotype: MYC knockout;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	PEAKS054448
EXP058142	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: Dox - 12-16 hours (when dox is added)/48 hours, siMYC; Genotype: MYC knockout + MYC activation;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	PEAKS054449
EXP058143	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: Dox - 12-16 hours (when dox is added)/48 hours, siCTR; Genotype: MYC activation;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	PEAKS054450
EXP058144	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: DMSO - 12-16 hours (when dox is added)/48 hours	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	PEAKS054451
EXP058145	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: THZ1;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	PEAKS054452
EXP058180	anti-BRG1 (abcam, ab110641)	Homo sapiens		EXP058179	7	normal	P51532	22RV1 (prostate carcinoma)	PEAKS054471
EXP058181	anti-BRG1 (abcam, ab110641)	Homo sapiens	Genotype: PTEN knockdown;	EXP058179	7	normal	P51532	22RV1 (prostate carcinoma)	PEAKS054472
EXP058183	Anti-Flag (F1804, Monoclonal M2 Ab Sigma)	Homo sapiens	Genotype: FLAG-KLF6; Treatment: FLAG-KLF6;	EXP058182	3022	normal	Q99612	786-M1A (Renal cell carcinoma)	PEAKS054473
EXP058186	CTCF (Pugacheva et al, 2015)	Homo sapiens		NULL	665	normal	P49711	SK-N-SH (neuroblastoma)	PEAKS054474
EXP058187	Rad21 (Abcam ab992)	Homo sapiens		NULL	665	normal	O60216	SK-N-SH (neuroblastoma)	PEAKS054475
EXP058188	CTCF (Pugacheva et al, 2015)	Homo sapiens		NULL	10	normal	P49711	HEK293T (embryonic kidney)	PEAKS054476
EXP058189	anti-CTCF	Mus musculus	Genotype: tetotet3iresgfp, omptta (overexpressing Tet3);	EXP058184	3023	normal	Q61164	olfactory neurons	PEAKS054477
EXP058190	anti-CTCF	Mus musculus	Genotype: tetogfp, omptta;	EXP058185	3023	normal	Q61164	olfactory neurons	PEAKS054478
EXP058193	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vehicle;	EXP058191	781	normal	P11473	RWPE1 (prostate epithelial cells)	PEAKS054479
EXP058194	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vehicle;	EXP058192	781	normal	P11473	RWPE1 (prostate epithelial cells)	PEAKS054480
EXP058195	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vitamin D;	EXP058191	781	normal	P11473	RWPE1 (prostate epithelial cells)	PEAKS054481
EXP058196	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vitamin D;	EXP058192	781	normal	P11473	RWPE1 (prostate epithelial cells)	PEAKS054482
EXP058198	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-washout;	NULL	1001	normal	P46531	MDA-MB-157 (triple negative breast carcinoma)	PEAKS054483
EXP058199	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-mock-washout;	NULL	1001	normal	P46531	MDA-MB-157 (triple negative breast carcinoma)	PEAKS054484
EXP058200	anti-RBPJ (D10A4mCST, cat# 5313)	Homo sapiens	Treatment: GSI-washout;	NULL	1001	normal	Q06330	MDA-MB-157 (triple negative breast carcinoma)	PEAKS054485
EXP058201	anti-RBPJ (D10A4mCST, cat# 5313)	Homo sapiens	Treatment: GSI-mock-washout;	NULL	1001	normal	Q06330	MDA-MB-157 (triple negative breast carcinoma)	PEAKS054486
EXP058202	anti-SMC1a (Bethyl, cat# A300-055A)	Homo sapiens	Treatment: untreated;	EXP058197	1001	normal	Q14683	MDA-MB-157 (triple negative breast carcinoma)	PEAKS054487
EXP058203	anti-CTCF (EMD Millipore cat# 07-729)	Homo sapiens	Treatment: untreated;	EXP058197	1001	normal	P49711	MDA-MB-157 (triple negative breast carcinoma)	PEAKS054488
EXP058207	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-washout;	EXP058206	3026	normal	P46531	HCC-1599(ductal breast carcinoma)	PEAKS054489
EXP058208	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-mock-washout;	EXP058205	3026	normal	P46531	HCC-1599(ductal breast carcinoma)	PEAKS054490
EXP058209	anti-RBPJ (D10A4, CST, cat# 5313)	Homo sapiens	Treatment: GSI-washout;	EXP058206	3026	normal	Q06330	HCC-1599(ductal breast carcinoma)	PEAKS054491
EXP058210	anti-RBPJ (D10A4, CST, cat# 5313)	Homo sapiens	Treatment: GSI-mock-washouts;	EXP058205	3026	normal	Q06330	HCC-1599(ductal breast carcinoma)	PEAKS054492
EXP058211	Jun D Antibody (329, sc-74)	Homo sapiens	Genotype: control (scrambled shRNA);	NULL	516	normal	P05412	Kasumi-1 (acute myeloblastic leukemia)	PEAKS054493
EXP058212	Jun D Antibody (329, sc-74)	Homo sapiens	Genotype: RUNX1/ETO knockdown;	NULL	516	normal	P05412	Kasumi-1 (acute myeloblastic leukemia)	PEAKS054494
EXP058213	GATA-2 (H-116, Santa Cruz)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, GATA2 wildtype;	NULL	592	normal	P23769	ME-1 (acute myeloid leukemia )	PEAKS054495
EXP058214	GATA-2 (H-116) Santa Cruz	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, GATA2 knockdown;	NULL	592	normal	P23769	ME-1 (acute myeloid leukemia )	PEAKS054496
EXP058215	anti-MYH11 ( Novus Biologicals)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, MYH11 wildtype;	NULL	592	normal	P35749	ME-1 (acute myeloid leukemia )	PEAKS054497
EXP058216	anti-RUNX1 (ab23980, abcam)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, RUNX1 wildtype;	NULL	592	normal	Q01196	ME-1 (acute myeloid leukemia )	PEAKS054498
EXP058217	anti-RUNX1 (ab23980, abcam)	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, RUNX1 knockdown;	NULL	592	normal	Q01196	ME-1 (acute myeloid leukemia )	PEAKS054499
EXP058218	anti-CBFB (sc-20693x, Santa Cruz)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, CBFB wildtype;	NULL	592	normal	Q13951	ME-1 (acute myeloid leukemia )	PEAKS054500
EXP058219	anti-CBFB (sc-20693x, Santa Cruz)	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, CBFB knockdown;	NULL	592	normal	Q13951	ME-1 (acute myeloid leukemia )	PEAKS054501
EXP058220	anti-MYH11 ( Novus Biologicals)	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, MYH11 knockdown;	NULL	592	normal	P35749	ME-1 (acute myeloid leukemia )	PEAKS054502
EXP058223	anti-six2 (Proteintech, cat#11562-1-AP)	Homo sapiens	Genotype: six2 overexpression;	EXP058221	113	normal	Q9NPC8	MCF7 (Invasive ductal breast carcinoma)	PEAKS054503
EXP058224	anti-six2 (Proteintech, cat#11562-1-AP)	Homo sapiens	Genotype: six2 overexpression;	EXP058222	113	normal	Q9NPC8	MCF7 (Invasive ductal breast carcinoma)	PEAKS054504
EXP058225	anti-ESR1 (Santacruz biotechnology, HC-20)	Homo sapiens	Treatment: with Estrogen; 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054505
EXP058226	anti-ESR1 (Santacruz biotechnology, HC-20)	Homo sapiens	Treatment: with Estrogen +1,6-Hexanediol; 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS054506
EXP058227	anti-GATA3(Santacruz biotechnology, HG3-31)	Homo sapiens	Treatment: with Estrogen; 	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS054507
EXP058228	anti-GATA3(Santacruz biotechnology, HG3-31)	Homo sapiens	Treatment: with Estrogen +1,6-Hexanediol; 	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS054508
EXP058229	anti-AP-2gamma(Santacruz biotechnology, H-77)	Homo sapiens	Treatment: with Estrogen; 	NULL	113	normal	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS054509
EXP058230	anti-AP-2gamma(Santacruz biotechnology, H-77)	Homo sapiens	Treatment: with Estrogen +1,6-Hexanediol; 	NULL	113	normal	Q92754	MCF7 (Invasive ductal breast carcinoma)	PEAKS054510
EXP058235	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054511
EXP058236	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054512
EXP058237	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054513
EXP058238	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054514
EXP058239	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: none;	NULL	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054515
EXP058240	45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: none;	NULL	3027	normal	A0A126GW21	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054516
EXP058241	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: none;	NULL	3028	normal	Q92922	SCCOHT-1	PEAKS054517
EXP058242	BAF45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: none;	NULL	3028	normal	Q92785	SCCOHT-1	PEAKS054518
EXP058243	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054519
EXP058244	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054520
EXP058245	BAF45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054521
EXP058246	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054522
EXP058247	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054523
EXP058248	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054524
EXP058249	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054525
EXP058250	BAF45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054526
EXP058251	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054527
EXP058252	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054528
EXP058253	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054529
EXP058254	45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054530
EXP058255	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054531
EXP058256	DPF2 (Abcam, ab134942)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054532
EXP058257	MLL3 (homemade, PMID: 29404406)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q8NEZ4	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054533
EXP058258	MLL3 (homemade, PMID: 29404406)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q8NEZ4	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054534
EXP058259	MLL3 (homemade, PMID: 29404406)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q8NEZ4	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054535
EXP058260	MLL4 (homemade, PMID: 29404406)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q9UMN6	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054536
EXP058261	MLL4, homemade (PMID: 29404406)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q9UMN6	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054537
EXP058262	MLL4, homemade (PMID: 29404406)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q9UMN6	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054538
EXP058263	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054539
EXP058264	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	PEAKS054540
EXP058267	anti-Gfi1b	Homo sapiens	Treatment: none wnt; 	EXP058265	514	normal	Q5VTD9	K562 (myelogenous leukemia)	PEAKS054541
EXP058268	anti-Gfi1b	Homo sapiens	Treatment: Wnt3a;	EXP058266	514	normal	Q5VTD9	K562 (myelogenous leukemia)	PEAKS054542
EXP058269	anti-Beta-Catenin	Homo sapiens	Treatment: none wnt; 	EXP058265	514	normal	P35222	K562 (myelogenous leukemia)	PEAKS054543
EXP058270	anti-Beta-Catenin	Homo sapiens	Treatment: Wnt3a;	EXP058266	514	normal	P35222	K562 (myelogenous leukemia)	PEAKS054544
EXP058271	anti-LSD1	Homo sapiens	Treatment: none wnt; 	EXP058265	514	normal	O60341	K562 (myelogenous leukemia)	PEAKS054545
EXP058272	anti-LSD1	Homo sapiens	Treatment: Wnt3a;	EXP058266	514	normal	O60341	K562 (myelogenous leukemia)	PEAKS054546
EXP058274	anti-G9a (abcam, #40452)	Homo sapiens		EXP058273	3029	normal	Q96KQ7	RH41(Alveolar rhabdomyosarcoma)	PEAKS054547
EXP058276	TCF4 (PMID 27846392)	Homo sapiens	Treatment: 60 ng/ml Tetracyclin for 24 hrs; Genotype: inducible TCF4 expression;	EXP058275	813	normal	P15884	SU-DHL-2 (anaplastic large cell lymphoma)	PEAKS054548
EXP058278	TCF4 (PMID 27846392)	Homo sapiens	Treatment: 60ng/ml  Tetracyclin for 24 hrs; Genotype: inducible TCF4 expression;	EXP058277	835	normal	P15884	TMD8 (diffuse large B-cell lymphoma)	PEAKS054549
EXP058279	anti-LMNA (Santa Cruz mouse monoclonal, sc7292x)	Homo sapiens	Treatment: None;	NULL	430	normal	P02545	HepG2 (hepatoblastoma)	PEAKS054550
EXP058280	anti-LMNB1(Abcam rabbit polyclonal, Ab16048)	Homo sapiens	Treatment: None;	NULL	430	normal	P20700	HepG2 (hepatoblastoma)	PEAKS054551
EXP058281	anti-LMNA (Santa Cruz mouse monoclonal, sc7292x)	Homo sapiens	Treatment: 10 uM CsA for 72 hrs;	NULL	430	normal	P02545	HepG2 (hepatoblastoma)	PEAKS054552
EXP058282	anti-LMNB1(Abcam rabbit polyclonal, Ab16048)	Homo sapiens	Treatment: 10 uM CsA for 72 hrs;	NULL	430	normal	P20700	HepG2 (hepatoblastoma)	PEAKS054553
EXP058284	anti-HA-tag (Cell Signaling Technology: 3724)	Homo sapiens	Genotype: wildtype tumor derived cell line; 	EXP058283	937	normal	Q9H8M2	G401 (rhabdoid tumor of the kidney)	PEAKS054554
EXP058286	anti-PTEN (6H2.1, Millipore, 04-035)	Homo sapiens	Genotype: PTEN wildtype; 	EXP058285	78	normal	P60484	HeLa (cervical adenocarcinoma)	PEAKS054555
EXP058287	anti-PTEN (138G6, Cell Signaling, 9559)	Homo sapiens	Genotype: PTEN wildtype; 	EXP058285	78	normal	P60484	HeLa (cervical adenocarcinoma)	PEAKS054556
EXP058288	SPT5 (Bethyl Laboratories, A300-868A)	Homo sapiens	Genotype: PTEN wildtype; 	EXP058285	78	normal	O00267	HeLa (cervical adenocarcinoma)	PEAKS054557
EXP058289	SPT5 (Bethyl Laboratories, A300-868A)	Homo sapiens	Genotype: CRISPR-PTEN KO;	NULL	78	normal	O00267	HeLa (cervical adenocarcinoma)	PEAKS054558
EXP058302	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: wildtype;	EXP058290	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054559
EXP058303	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: wildtype;	EXP058291	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054560
EXP058304	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18A expressing;	EXP058292	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054561
EXP058305	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18A expressing;	EXP058293	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054562
EXP058306	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 Y22A expressing;	EXP058294	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054563
EXP058307	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 Y22A expressing;	EXP058295	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054564
EXP058308	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18G21Y22A expressing;	EXP058296	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054565
EXP058309	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18G21Y22A expressing;	EXP058297	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054566
EXP058310	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KNR-A expressing; 	EXP058298	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054567
EXP058311	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KNR-A expressing; 	EXP058299	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054568
EXP058312	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KYNR-A expressing;	EXP058300	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054569
EXP058313	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KYNR-A expressing;	EXP058301	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	PEAKS054570
EXP058316	AR (Santa Cruz, sc-816)	Homo sapiens	Genotype: Renilla knockout; Treatment: shRenilla; 	EXP058314	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS054571
EXP058317	AR (Santa Cruz, sc-816)	Homo sapiens	Genotype: GREB1 knockout; Treatment: shGREB1; 	EXP058315	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS054572
EXP058328	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: female; Age: 59; Group: control;	EXP058318	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054573
EXP058329	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 43; Group: control;	EXP058319	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054574
EXP058330	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 23; Group: control;	EXP058320	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054575
EXP058331	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 19; Group: control;	EXP058321	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054576
EXP058332	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 34; Group: control;	NULL	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054577
EXP058333	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 56; Group: DCM (Dilated Cardiomyopathy);	EXP058323	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054578
EXP058334	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 38; Group: DCM (Dilated Cardiomyopathy);	EXP058324	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054579
EXP058335	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: female; Age: 66; Group: DCM (Dilated Cardiomyopathy);	EXP058325	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054580
EXP058336	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 49; Group: DCM (Dilated Cardiomyopathy);	EXP058326	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054581
EXP058337	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 45; Group: DCM (Dilated Cardiomyopathy);	EXP058327	3030	normal	P02545	cardiac myocyte nuclei	PEAKS054582
EXP058340	anti-p65(sc-372, Santa Cruz)	Homo sapiens	Treatment: TNF-a for 12hrs;	EXP058338	421	normal	O43245	HEK293 (embryonic kidney)	PEAKS054583
EXP058341	anti-p65(sc-372, Santa Cruz)	Homo sapiens	Treatment: TNF-a for 0 (control);	EXP058339	421	normal	O43245	HEK293 (embryonic kidney)	PEAKS054584
EXP058346	LSD1 (Bethyl Laboratories A300-215A, LOT# 2)	Homo sapiens	Treatment: DMSO; Genotype: wildtype; 	EXP058342	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054585
EXP058347	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: DMSO; Genotype: wildtype; 	EXP058342	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054586
EXP058348	LSD1 (Bethyl Laboratories A300-215A, LOT# 2	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: wildtype; 	EXP058343	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054587
EXP058349	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: wildtype; 	EXP058343	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054588
EXP058350	LSD1 (Bethyl Laboratories A300-215A, LOT# 2	Homo sapiens	Treatment: DMSO; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058344	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054589
EXP058351	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: DMSO; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058344	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054590
EXP058352	LSD1 (Bethyl Laboratories A300-215A, LOT# 2	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058345	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054591
EXP058353	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058345	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	PEAKS054592
EXP058360	anti-p65 (abcam)	Homo sapiens	Treatment: TNF for 0 mins; 	EXP058358	472	normal	O43245	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054593
EXP058361	anti-p65 (abcam)	Homo sapiens	Treatment: TNF for 30 mins; 	NULL	472	normal	O43245	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054594
EXP058362	anti-p65 (abcam)	Homo sapiens	Treatment: TNF for 60 mins; 	EXP058359	472	normal	O43245	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054595
EXP058363	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 0 mins; 	EXP058354	472	normal	Q6ZMT4	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054596
EXP058364	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 60 mins; 	EXP058355	472	normal	Q6ZMT4	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054597
EXP058365	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 0 mins; 	EXP058356	472	normal	O15550	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054598
EXP058366	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 60 mins; 	EXP058357	472	normal	O15550	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054599
EXP058370	anti-HA antibody (11867423001, Roche)	Homo sapiens		EXP058367	430	normal	Q9HCE5	HepG2 (hepatoblastoma)	PEAKS054600
EXP058371	anti-HA antibody (11867423001, Roche)	Homo sapiens		EXP058368	430	normal	Q9HCE5	HepG2 (hepatoblastoma)	PEAKS054601
EXP058372	anti-HA antibody (11867423001, Roche)	Homo sapiens	Treatment: 100 uM DRB for 3 hrs;	EXP058369	430	normal	Q9HCE5	HepG2 (hepatoblastoma)	PEAKS054602
EXP058375	anti-ISL1(abcam)	Homo sapiens		EXP058373	3031	normal	P61371	SGC-7901(Gastric carcinoma)	PEAKS054603
EXP058376	anti-ISL1(abcam)	Homo sapiens		EXP058374	3031	normal	P61371	SGC-7901(Gastric carcinoma)	PEAKS054604
EXP058381	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: none; 	EXP058377	1008	normal	P49711	HT1080 (fibrosarcoma)	PEAKS054605
EXP058382	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: 3 uM final concentration of CBL0137 for 6hrs;	EXP058378	1008	normal	P49711	HT1080 (fibrosarcoma)	PEAKS054606
EXP058383	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: none; 	EXP058379	1008	normal	P49711	HT1080 (fibrosarcoma)	PEAKS054607
EXP058384	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: 3 uM final concentration of CBL0137 for 6hrs;	EXP058380	1008	normal	P49711	HT1080 (fibrosarcoma)	PEAKS054608
EXP058388	anti-Oct1 (Bethyl, A310-610A)	Homo sapiens		EXP058385	417	normal	P14859	HCT-116 (colon carcinoma)	PEAKS054609
EXP058389	anti-Oct1 (Bethyl, A310-610A)	Homo sapiens		EXP058386	417	normal	P14859	HCT-116 (colon carcinoma)	PEAKS054610
EXP058390	anti-Oct1 (Bethyl, A310-610A)	Homo sapiens		EXP058387	417	normal	P14859	HCT-116 (colon carcinoma)	PEAKS054611
EXP058393	anti-FOXA1 (abcam, 23738)	Homo sapiens	Treatment: DHT10 nM for 24 hrs;	EXP058391	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS054612
EXP058394	anti-FOXA1 (abcam, 23738)	Homo sapiens	Treatment: ethanol (Vehicle) treatment for 24 hrs;	NULL	7	normal	P55317	22RV1 (prostate carcinoma)	PEAKS054613
EXP058395	anti-OCT1 (Abcam, ab15112)	Homo sapiens	Treatment: DHT10 nM for 24 hrs;	EXP058392	7	normal	P14859	22RV1 (prostate carcinoma)	PEAKS054614
EXP058396	anti-OCT1 (Abcam, ab15112)	Homo sapiens	Treatment: ethanol (Vehicle) treatment for 24 hrs;	NULL	7	normal	P14859	22RV1 (prostate carcinoma)	PEAKS054615
EXP058399	anti-VDR (C-20x, sc-1008x, rabbit polyclonal, Santa Cruz)	Homo sapiens	Treatment: 50 nM EtOH (vehicle) for 2 hrs;	EXP058397	3032	normal	P11473	primary prostate epithelial cells	PEAKS054616
EXP058400	anti-VDR (C-20x, sc-1008x, rabbit polyclonal, Santa Cruz)	Homo sapiens	Treatment: 50 nM 1,25-VitaminD3  for 2 hrs;	EXP058398	3032	normal	P11473	primary prostate epithelial cells	PEAKS054617
EXP058402	anti-ERG (sc-354X, Santa Cruz Biotechnology)	Homo sapiens	Treatment: none;	EXP058401	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054618
EXP058404	MED1 (A300-793A, Bethyl Laboratories)	Homo sapiens	Treatment: control siRNA treated;	EXP058403	472	normal	O95243	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054619
EXP058405	MED1 (A300-793A, Bethyl Laboratories)	Homo sapiens	Treatment: ERG siRNA treated; Genotype: ERG knockout;	EXP058403	472	normal	O95243	HUVEC-C (HUVEC, umbilical vein endothelial cells)	PEAKS054620
EXP058407	anti-SMARCA4 (abcam 110641)	Homo sapiens		EXP058406	3033	normal	P51532	CD34+ iPSC-differentiated NSC	PEAKS054621
EXP058410	anti-MLXIP (Rabbit Polyclonal Antibody, Proteintech; 13614-1-AP)	Homo sapiens	Treatment: treated with DMEM with normal pH (~pH 7.2; 3.7 g/L sodium bicarbonate);	EXP058408	78	normal	Q9HAP2	HeLa (cervical adenocarcinoma)	PEAKS054622
EXP058411	anti-MLXIP (Rabbit Polyclonal Antibody, Proteintech; 13614-1-AP)	Homo sapiens	Treatment: treated with DMEM with low pH (~pH 6.7; 0.37 g/L sodium bicarbonate);	EXP058409	78	normal	Q9HAP2	HeLa (cervical adenocarcinoma)	PEAKS054623
EXP058414	anti-PLZF (SantaCruz, sc-22839)	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	EXP058412	892	normal	Q05516	MSC (mesenchymal stem cells)	PEAKS054624
EXP058415	anti-PLZF (SantaCruz, sc-22839)	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	EXP058413	892	normal	Q05516	MSC (mesenchymal stem cells)	PEAKS054625
EXP058416	anti-SUZ12 (Cell Signalling, 3737)	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	EXP058412	892	normal	Q15022	MSC (mesenchymal stem cells)	PEAKS054626
EXP058417	anti-SUZ12 (Cell Signalling, 3737)	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	EXP058413	892	normal	Q15022	MSC (mesenchymal stem cells)	PEAKS054627
EXP058418	anti-RNF2 (NAS, RRID:AB_2755047)	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	EXP058412	892	normal	Q99496	MSC (mesenchymal stem cells)	PEAKS054628
EXP058419	anti-RNF2 (NAS, RRID:AB_2755047)	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	EXP058413	892	normal	Q99496	MSC (mesenchymal stem cells)	PEAKS054629
EXP058427	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated; Conditions: day4 of differentiation;	EXP058420	216	normal	P24610	differentiated embryonic stem cells	PEAKS054630
EXP058428	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 1-day;	EXP058421	216	normal	P24610	differentiated embryonic stem cells	PEAKS054631
EXP058429	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 6-day; Conditions: day9 of differentiation; 	EXP058424	216	normal	P24610	differentiated embryonic stem cells	PEAKS054632
EXP058430	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 6-day; Conditions: day9 of differentiation; 	EXP058425	216	normal	P24610	differentiated embryonic stem cells	PEAKS054633
EXP058431	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Homo sapiens	Treatment: doxycycline 1-day; Conditions: day 6 of differentiation; 	EXP058426	2526	normal	P23760	H9	PEAKS054634
EXP058432	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated;	NULL	675	normal	P24610	NIH 3T3 (embryonic fibroblasts)	PEAKS054635
EXP058433	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 1-day;	NULL	675	normal	P24610	NIH 3T3 (embryonic fibroblasts)	PEAKS054636
EXP058434	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated; Conditions: day4 of differentiation;	EXP058422	216	normal	P24610	differentiated embryonic stem cells	PEAKS054637
EXP058435	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 1-day;	EXP058423	216	normal	P24610	differentiated embryonic stem cells	PEAKS054638
EXP058440	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: none	EXP058436	71	normal	P23769	VCaP (prostate carcinoma)	PEAKS054639
EXP058441	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hours	EXP058437	71	normal	P23769	VCaP (prostate carcinoma)	PEAKS054640
EXP058442	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: Treatment: none;	EXP058438	71	normal	P23769	VCaP (prostate carcinoma)	PEAKS054641
EXP058443	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hours	EXP058439	71	normal	P23769	VCaP (prostate carcinoma)	PEAKS054642
EXP058446	CHD4 (Abcam, Cat. ab70469, Clone: 3F2/4)	Homo sapiens	Treatment: shControl;	EXP058444	65	normal	Q14839	U937 (adult acute monocytic leukemia)	PEAKS054643
EXP058447	CHD4 (Abcam, Cat. ab70469, Clone: 3F2/4)	Homo sapiens	Treatment: shKDM6A; Genotype: KDM6A knockout;	EXP058445	65	normal	Q14839	U937 (adult acute monocytic leukemia)	PEAKS054644
EXP058453	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #1; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	EXP058448	620	normal	Q8N884	monocyte-derived dendritic cells	PEAKS054645
EXP058454	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #2; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	EXP058449	620	normal	Q8N884	monocyte-derived dendritic cells	PEAKS054646
EXP058455	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #3; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	EXP058451	620	normal	Q8N884	monocyte-derived dendritic cells	PEAKS054647
EXP058458	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT for 24 hrs;	EXP058456	2524	normal	P10275	LNCaP95	PEAKS054648
EXP058459	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT for 24 hrs;	EXP058457	2524	normal	P10275	LNCaP95	PEAKS054649
EXP058460	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT and Py-Im polyamide for 24 hrs;	EXP058456	2524	normal	P10275	LNCaP95	PEAKS054650
EXP058461	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT and Py-Im polyamide for 24 hrs;	EXP058457	2524	normal	P10275	LNCaP95	PEAKS054651
EXP058462	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: vehicle (DMSO) for 24 hrs;	EXP058456	2524	normal	P10275	LNCaP95	PEAKS054652
EXP058463	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: vehicle (DMSO) for 24 hrs;	EXP058457	2524	normal	P10275	LNCaP95	PEAKS054653
EXP058466	ANTI-FLAG M2(Sigma, F3165)	Homo sapiens	Conditions: attached;	EXP058464	650	normal	Q01892	NCI-H1703 (squamous cell lung carcinoma )	PEAKS054654
EXP058467	ANTI-FLAG M2(Sigma, F3165)	Homo sapiens	Conditions: suspended;	EXP058465	650	normal	Q01892	NCI-H1703 (squamous cell lung carcinoma )	PEAKS054655
EXP058470	anti-TFAP2C (Santa Cruz, Cat #sc-8977X)	Homo sapiens	Genotype: TetO-TFAP2C; Treatment:  with Dox for 7 days; Developmental stage: early differentiaiton;	EXP058468	3034	normal	Q92754	embryonic stem cells differentiated to early epidemal cells	PEAKS054656
EXP058471	anti-TFAP2C (Santa Cruz, Cat #sc-8977X)	Homo sapiens	Genotype: TetO-TFAP2C; Treatment:  with Dox for 7 days; Developmental stage: early differentiaiton;	EXP058469	3034	normal	Q92754	embryonic stem cells differentiated to early epidemal cells	PEAKS054657
EXP058477	anti- Max (sc-197, C-17, lot #C3016)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 0 hrs;	EXP058473	708	normal	P61244	P493-6 (B-cell lymphoma)	PEAKS054658
EXP058478	anti- Max (sc-197, C-17, lot #C3016)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 24 hrs;	EXP058474	708	normal	P61244	P493-6 (B-cell lymphoma)	PEAKS054659
EXP058479	anti- Max (sc-197, C-17, lot #C3016)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 4 hrs;	EXP058476	708	normal	P61244	P493-6 (B-cell lymphoma)	PEAKS054660
EXP058480	anti-MYC (ab56)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 0 hrs;	EXP058472	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS054661
EXP058481	anti-MYC (ab56)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 24 hrs;	EXP058474	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS054662
EXP058482	anti-MYC (ab56)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 4 hrs;	EXP058475	708	normal	P01106	P493-6 (B-cell lymphoma)	PEAKS054663
EXP058485	anti-CTCF (17-10044, Millipore)	Homo sapiens	Treatment: control (none);	EXP058483	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS054664
EXP058486	anti-CTCF (17-10044, Millipore)	Homo sapiens	Treatment: 0.5 ug/ml TPA for 24 hrs;	EXP058484	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS054665
EXP058487	anti-HA (ab9110, Abcam)	Homo sapiens	Treatment: control (none);	EXP058484	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS054666
EXP058488	anti-HA (ab9110, Abcam)	Homo sapiens	Treatment: 0.5 ug/ml TPA for 24 hrs;	EXP058484	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS054667
EXP058495	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Genotype: wildtype; 	EXP058489	93	normal	O43474	BJ (fibroblasts)	PEAKS054668
EXP058496	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Genotype: wildtype; 	EXP058490	93	normal	O43474	BJ (fibroblasts)	PEAKS054669
EXP058497	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Genotype: wildtype; 	EXP058489	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054670
EXP058498	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Genotype: wildtype; 	EXP058490	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054671
EXP058499	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058491	93	normal	O43474	BJ (fibroblasts)	PEAKS054672
EXP058500	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058492	93	normal	O43474	BJ (fibroblasts)	PEAKS054673
EXP058501	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058491	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054674
EXP058502	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058492	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054675
EXP058503	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058493	93	normal	O43474	BJ (fibroblasts)	PEAKS054676
EXP058504	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058494	93	normal	O43474	BJ (fibroblasts)	PEAKS054677
EXP058505	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058493	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054678
EXP058506	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058494	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054679
EXP058507	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: p63 vector; Genotype: wildtype;	NULL	93	normal	Q9H3D4	BJ (fibroblasts)	PEAKS054680
EXP058511	anti-SMC3(RRID: AB_307122, Catalog: ab9263; Lot: GR3221084-1)	Homo sapiens	Treatment: unstimmulated;	EXP058508	3036	normal	Q9UQE7	neutrophils from periferal blood	PEAKS054681
EXP058512	RRID: AB_441965; Catalog: 07-729; Lots: 2628833; 2575743; 2757161	Homo sapiens	Treatment: via co-culture with E. coli strain K1 at an MOI;	EXP058509	3036	normal	O60682	neutrophils from periferal blood	PEAKS054682
EXP058513	anti-SMC3(RRID: AB_307122, Catalog: ab9263; Lot: GR3221084-1)	Homo sapiens	Treatment: via co-culture with E. coli strain K1 at an MOI;	EXP058509	3036	normal	Q9UQE7	neutrophils from periferal blood	PEAKS054683
EXP058514	anti-RAD21(RRID: AB_2176601, Catalog: ab992; Lots: GR214359-1; GR235487-1)	Homo sapiens	Treatment: unstimmulated;	EXP058508	3036	normal	O60216	neutrophils from periferal blood	PEAKS054684
EXP058515	anti-RAD21(RRID: AB_2176601, Catalog: ab992; Lots: GR214359-1; GR235487-1)	Homo sapiens	Treatment: 25nM PMA (Promega, cat# V1171);	EXP058510	3036	normal	O60216	neutrophils from periferal blood	PEAKS054685
EXP058516	anti-CTCF(RRID: AB_441965, Catalog: 07-729; Lots: 2628833; 2575743; 2757161)	Homo sapiens	Treatment: unstimmulated;	EXP058508	3036	normal	P49711	neutrophils from periferal blood	PEAKS054686
EXP058517	anti-CTCF(RRID: AB_441965, Catalog: 07-729; Lots: 2628833; 2575743; 2757161)	Homo sapiens	Treatment: 25nM PMA (Promega, cat# V1171);	EXP058510	3036	normal	P49711	neutrophils from periferal blood	PEAKS054687
EXP058518	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: 10-7M R1881 (synthetic testosterone) for 4 hrs; Donor: PCDF1; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	PEAKS054688
EXP058519	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: DMSO for 4 hrs; Donor: PCDF1; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	PEAKS054689
EXP058520	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: DMSO for 4 hrs; Donor: PCDF2; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	PEAKS054690
EXP058521	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: 10-7M R1881 (synthetic testosterone) for 4 hrs; Donor: PCDF2; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	PEAKS054691
EXP058523	anti-PTEN-alfa/beta (a gift from Professor Yuxin Yin)	Homo sapiens	Treatment: infected lentivirus;	EXP058522	801	normal	P60484	SMMC-7721 (hepatocellular carcinoma)	PEAKS054692
EXP058524	anti-WDR5 (NOVAS, Cat# NBP1-30063)	Homo sapiens	Treatment: infected lentivirus;	EXP058522	801	normal	P04040	SMMC-7721 (hepatocellular carcinoma)	PEAKS054693
EXP058530	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Abcam Cat# ab134391)	Homo sapiens	Treatment: siControl;	EXP058525	78	normal	O94913	HeLa (cervical adenocarcinoma)	PEAKS054694
EXP058531	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Abcam Cat# ab134391)	Homo sapiens	Treatment: untreated;	EXP058526	78	normal	O94913	HeLa (cervical adenocarcinoma)	PEAKS054695
EXP058532	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Bethyl Cat# A303-705A)	Homo sapiens	Treatment: siControl;	EXP058525	78	normal	O94913	HeLa (cervical adenocarcinoma)	PEAKS054696
EXP058533	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Bethyl Cat# A303-705A)	Homo sapiens	Treatment: untreated;	EXP058526	78	normal	O94913	HeLa (cervical adenocarcinoma)	PEAKS054697
EXP058534	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Treament: siControl; Genotype: wildtype;	EXP058525	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	PEAKS054698
EXP058535	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Treament: siControl; Genotype: wildtype;	EXP058527	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	PEAKS054699
EXP058536	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Genotype: PCF11 knock-down (5 nM); Treatment: siPCF11;	EXP058528	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	PEAKS054700
EXP058537	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Genotype: PCF11 knock-down (5 nM); Treatment: siPCF11;	EXP058529	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	PEAKS054701
EXP058540	IKZF1 antibody (GeneTex, GTX129438)	Homo sapiens	Treatment: none;	NULL	3038	normal	Q13422	ARP-1(Plasma cell myeloma)	PEAKS054702
EXP058541	IKZF1 antibody (GeneTex, GTX129438)	Homo sapiens	Treatment: none;	EXP058538	618	normal	Q13422	MM1.S (plasma cell myeloma)	PEAKS054703
EXP058542	IKZF1 antibody (GeneTex, GTX129438)	Homo sapiens	Treatment: none;	EXP058539	1511	normal	Q13422	RPMI8226 (Plasma cell myeloma)	PEAKS054704
EXP058547	anti-EZH2	Homo sapiens	Treatment: vector control;	EXP058544	3039	normal	Q15910	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	PEAKS054705
EXP058548	anti-EZH2	Homo sapiens	Treatment: vector control; Genotype: FBP1 WT;	EXP058545	3039	normal	Q15910	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	PEAKS054706
EXP058549	anti-EZH2	Homo sapiens	Treatment: vector control; Genotype: FBP1 S169A;	EXP058546	3039	normal	Q15910	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	PEAKS054707
EXP058560	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058551	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS054708
EXP058561	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058551	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS054709
EXP058562	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058551	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS054710
EXP058563	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058553	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS054711
EXP058564	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058553	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS054712
EXP058565	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058553	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	PEAKS054713
EXP058566	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058555	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054714
EXP058567	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058555	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054715
EXP058568	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058555	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054716
EXP058569	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058557	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054717
EXP058570	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058557	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054718
EXP058571	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058557	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054719
EXP058572	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058559	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054720
EXP058573	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058559	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054721
EXP058574	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058559	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	PEAKS054722
EXP058575	CTCF antibody (Cell Signaling Technology; #3418)	Homo sapiens		NULL	36	normal	P49711	A375 (malignant melanoma)	PEAKS054723
EXP058578	anti-MYOD(Santa Cruz, M-318 sc-760)	Homo sapiens	Genotype: mouse MYOD overexpression;	EXP058576	3041	normal	P15172	IMR90-derived myoblast	PEAKS054724
EXP058579	anti-MYOD(Santa Cruz, M-318 sc-760)	Homo sapiens	Genotype: mouse MYOD overexpression;	EXP058577	3040	normal	P15172	IMR90-derived myotube	PEAKS054725
EXP058581	anti-Myocardin	Homo sapiens	Genotype: MYOCD overexpression; Treatment: pWPI vector;	EXP058580	38	normal	Q8IZQ8	A549 (lung carcinoma)	PEAKS054726
EXP058584	anti-eGFP	Homo sapiens	Treatment: none;	EXP058582	2993	normal	Q12772	monocytes from periferal blood	PEAKS054727
EXP058585	eGFP	Homo sapiens	Treatment: none;	EXP058583	2993	normal	Q12772	monocytes from periferal blood	PEAKS054728
EXP058586	anti-SREBP2 (Abcam, ab30682)	Homo sapiens	Treatment: none;	EXP058582	2993	normal	Q12772	monocytes from periferal blood	PEAKS054729
EXP058587	anti-SREBP2 (Abcam, ab30682)	Homo sapiens	Treatment: none;	EXP058583	2993	normal	Q12772	monocytes from periferal blood	PEAKS054730
EXP058588	anti-SREBP2 (Abcam, ab30682)	Homo sapiens	Treatment: TNF (10ng/ml) for 16 hours;	NULL	2993	normal	Q12772	monocytes from periferal blood	PEAKS054731
EXP058590	anti-RUNX1	Homo sapiens	Treatment: lentiviruses that inducibly express RUNX1, 1 ug/ml doxycycline for 24; Genotype: RUNX1-deleted; 	EXP058589	583	normal	Q01196	MCF10A (breast epithelial cells)	PEAKS054732
EXP058594	anti-HIRA(mouse mAbs, gift from Professor Peter Adams )	Homo sapiens	Treatment: Control (none interferon stimulation), Short-hairpin control(shControl); Genotype: wildtype;	EXP058591	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS054733
EXP058595	anti-HIRA(mouse mAbs, gift from Professor Peter Adams )	Homo sapiens	Treatment: Interferon Stimuated, Short-hairpin control(shControl); Genotype: wildtype;	EXP058592	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS054734
EXP058596	anti-HIRA(mouse mAbs, gift from Professor Peter Adams )	Homo sapiens	Treatment: Interferon Stimuated,shPML; Genotype: Short-hairpin targeting PML;	EXP058593	489	normal	P54198	IMR90 (lung fibroblasts)	PEAKS054735
EXP058597	anti-ISL1(Abcam, ab20670 )	Homo sapiens	Genotype: overexpression of ISL1; Treatment: transfected by ISL1 Lentivirus;	NULL	1474	normal	P61371	HuH7 (hepatocellular carcinoma)	PEAKS054736
EXP058599	anti-STAT3 (Santa,Cruz sc-482)	Homo sapiens	Treatment: DMSOfor 2 hrs;	EXP058598	3042	normal	P40763	FaDu(Hypopharyngeal squamous cell carcinoma)	PEAKS054737
EXP058600	anti-STAT3 (Santa,Cruz sc-482)	Homo sapiens	Treatment: 1 uM BB608 for 2 hours;	EXP058598	3042	normal	P40763	FaDu(Hypopharyngeal squamous cell carcinoma)	PEAKS054738
EXP058601	anti-STAT1 (Santa Cruz,sc-345)	Homo sapiens	Treatment: DMSOfor 2 hrs;	EXP058598	3042	normal	P42224	FaDu(Hypopharyngeal squamous cell carcinoma)	PEAKS054739
EXP058602	anti-STAT1 (Santa Cruz,sc-345)	Homo sapiens	Treatment: 1 uM BB608 for 2 hours;	EXP058598	3042	normal	P42224	FaDu(Hypopharyngeal squamous cell carcinoma)	PEAKS054740
EXP058611	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siControl;	EXP058603	1564	normal	P46531	pulmonary artery endothelial cell	PEAKS054741
EXP058612	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siControl;	EXP058604	1564	normal	P46531	pulmonary artery endothelial cell	PEAKS054742
EXP058613	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058605	1564	normal	P46531	pulmonary artery endothelial cell	PEAKS054743
EXP058614	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058606	1564	normal	P46531	pulmonary artery endothelial cell	PEAKS054744
EXP058615	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siControl;	EXP058607	1564	normal	Q09472	pulmonary artery endothelial cell	PEAKS054745
EXP058616	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siControl;	EXP058608	1564	normal	Q09472	pulmonary artery endothelial cell	PEAKS054746
EXP058617	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058609	1564	normal	Q09472	pulmonary artery endothelial cell	PEAKS054747
EXP058618	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058610	1564	normal	Q09472	pulmonary artery endothelial cell	PEAKS054748
EXP058620	anti-RAD51 (Santa Cruz sc8349)	Homo sapiens	Treatment: 4-Hydroxytamoxifen (4OHT) 300 nM for 2hrs; Genotype: MCF10A-AsiSIER;	NULL	583	normal	Q06609	MCF10A (breast epithelial cells)	PEAKS054749
EXP058621	anti-NBS1 (Abcam, ab32074)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	O60934	MCF10A (breast epithelial cells)	PEAKS054750
EXP058622	anti-RAD51 (Santa Cruz sc8349)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	Q06609	MCF10A (breast epithelial cells)	PEAKS054751
EXP058623	anti-TOP2B (Abcam, Ab58442)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	Q02880	MCF10A (breast epithelial cells)	PEAKS054752
EXP058624	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Treatment: 4-Hydroxytamoxifen (4OHT) 300 nM for 2hrs; Genotype: MCF10A-AsiSIER;	NULL	583	normal	Q13426	MCF10A (breast epithelial cells)	PEAKS054753
EXP058625	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	Q13426	MCF10A (breast epithelial cells)	PEAKS054754
EXP058626	anti-TOP1 (Abcam, ab3825)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	P11387	MCF10A (breast epithelial cells)	PEAKS054755
EXP058627	anti-PARP1 (Active Motif, #39559)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	P09874	MCF10A (breast epithelial cells)	PEAKS054756
EXP058628	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Genotype: MCF10A-AsiSIER; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) 20 mM, 30 min;	NULL	583	normal	Q13426	MCF10A (breast epithelial cells)	PEAKS054757
EXP058629	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Genotype: MCF10A-AsiSIER; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) 20 mM, 30 min+washout 1 hour;	NULL	583	normal	Q13426	MCF10A (breast epithelial cells)	PEAKS054758
EXP058630	anti-NBS1 (Abcam, ab32074)	Homo sapiens	Treatment: 4-Hydroxytamoxifen (4OHT) 300 nM for 2hrs; Genotype: MCF10A-AsiSIER;	NULL	583	normal	O60934	MCF10A (breast epithelial cells)	PEAKS054759
EXP058639	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: 1 mM JQ1 was diluted 1:2000 to 500 nM final concentration for 12 hrs;	EXP058635	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	PEAKS054762
EXP058640	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: 1 mM JQ1 was diluted 1:2000 to 500 nM final concentration for 12 hrs;	EXP058636	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	PEAKS054763
EXP058641	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: DMSO was diluted 1:2000 to 0.05% for 12 hrs;	EXP058637	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	PEAKS054764
EXP058642	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: DMSO was diluted 1:2000 to 0.05% for 12 hrs;	EXP058638	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	PEAKS054765
EXP058643	anti-Lamin A/C (Santa Cruz, #sc7292)	Homo sapiens		NULL	738	normal	P02545	PrEC (prostate cells)	PEAKS054766
EXP058644	anti-Lamin B1 (Abcam, #ab16048)	Homo sapiens		NULL	738	normal	P20700	PrEC (prostate cells)	PEAKS054767
EXP058645	anti-Lamin A/C (Santa Cruz, #sc7292)	Homo sapiens		NULL	70	normal	P02545	LNCaP (prostate carcinoma)	PEAKS054768
EXP058646	anti-Lamin B1 (Abcam, #ab16048)	Homo sapiens		NULL	70	normal	P20700	LNCaP (prostate carcinoma)	PEAKS054769
EXP058649	anti-Abeta (4G8, SIG-39220, Covance)	Homo sapiens		EXP058647	509	normal	P05067	Jurkat (T-cells)	PEAKS054770
EXP058650	anti-Abeta (4G8, SIG-39220, Covance)	Homo sapiens		EXP058648	509	normal	P05067	Jurkat (T-cells)	PEAKS054771
EXP058653	anti-STAT5 (sc-835X, Santa Cruz Biotechnology, lot# A0915)	Mus musculus	Treatment: retrovirally transduced with GFP alone (MIG);	EXP058651	3044	normal	P42230	hepatopoietic stem cells	PEAKS054772
EXP058654	anti-STAT5 (sc-835X, Santa Cruz Biotechnology, lot# A0915)	Mus musculus	Treatment: retrovirally transduced with BCR-ABL and GFP (BCR-ABL);	EXP058652	3044	normal	P42230	hepatopoietic stem cells	PEAKS054773
EXP058658	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058655	2441	normal	P70314	squamous cell carcinoma	PEAKS054774
EXP058659	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	P70314	squamous cell carcinoma	PEAKS054775
EXP058660	anti-Sox2 (R&D, AF2018)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	P48432	squamous cell carcinoma	PEAKS054776
EXP058661	anti-TP63 (Cell Signaling, 13109)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	O88898	squamous cell carcinoma	PEAKS054777
EXP058662	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	P70314	squamous cell carcinoma	PEAKS054778
EXP058663	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Genotype: Pitx1 knockout; Strain: C57BL/6;  Tissue: skin;	EXP058657	2441	normal	P70314	squamous cell carcinoma	PEAKS054779
EXP058664	anti-Sox2 (R&D, AF2018)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	P48432	squamous cell carcinoma	PEAKS054780
EXP058665	anti-TP63 (Cell Signaling, 13109)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	O88898	squamous cell carcinoma	PEAKS054781
EXP058666	anti-Klf4 (R&D, AF3758)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	Q60793	squamous cell carcinoma	PEAKS054782
EXP058667	anti-Klf4 (R&D, AF3758)	Mus musculus	Conditions: high calcium (1.5mM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	Q60793	squamous cell carcinoma	PEAKS054783
EXP058668	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	EXP058656	2441	normal	P70314	squamous cell carcinoma	PEAKS054784
EXP058669	anti-Klf4 (R&D, AF3758)	Mus musculus	Treatment: 15,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	Q60793	squamous cell carcinoma	PEAKS054785
EXP058670	anti-Klf4 (R&D, AF3758)	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	EXP058656	2441	normal	Q60793	squamous cell carcinoma	PEAKS054786
EXP058672	anti-Ring1b	Mus musculus	Age: postnatal 5 days; Strain: CD1; Treatment: mice were intraperitoneal injected with one dose EdU (3.3 ug per g body weight) and scarified after 24 hours;	EXP058671	3045	normal	Q9CQJ4	incisor pulp	PEAKS054787
EXP058677	anti-Asxl1 (Santa Cruz ASXL1 6E2, Lot J0316)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	P59598	mESCs (mouse embryonic stem cells)	PEAKS054788
EXP058678	anti-Asxl1 (Santa Cruz ASXL1 6E2, Lot J0316)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	P59598	mESCs (mouse embryonic stem cells)	PEAKS054789
EXP058679	anti-BAP1(Santa Cruz, C-4, Lot B2117)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	PEAKS054790
EXP058680	anti-BAP1(Santa Cruz, C-4, Lot B2117)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	PEAKS054791
EXP058681	anti-O-GlcNAc (Santa Cruz, CTD110.6, Lot G0715)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	Q8CGY8	mESCs (mouse embryonic stem cells)	PEAKS054792
EXP058682	anti-O-GlcNAc (Santa Cruz, CTD110.6, Lot G0715)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	Q8CGY8	mESCs (mouse embryonic stem cells)	PEAKS054793
EXP058683	anti-MPND (Invitrogen PA5-68860, Lot T02553192B)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	Q3TV65	mESCs (mouse embryonic stem cells)	PEAKS054794
EXP058684	anti-MPND (Invitrogen PA5-68860, Lot T02553192B)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	Q3TV65	mESCs (mouse embryonic stem cells)	PEAKS054795
EXP058687	anti-CTCF(Cell Signaling Technology, rabbit  antibody)	Mus musculus	Developmental stage: E13.5;	EXP058685	827	normal	Q61164	telencephalon	PEAKS054796
EXP058688	anti-CTCF(Cell Signaling Technology, rabbit  antibody)	Mus musculus	Developmental stage: E13.5;	EXP058686	3046	normal	Q61164	medial ganglionic eminence	PEAKS054797
EXP058690	anti-YY1 (rabbit polyclonal antibody, Santa Cruz Biotechnology, SC-1703, Lot#B1115)	Mus musculus	Source: activated satellite cells; Age: adult;	EXP058689	3047	normal	Q00899	muscle satellite cells	PEAKS054798
EXP058692	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	PEAKS054799
EXP058693	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: 100 nM Dexamethasone for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	PEAKS054800
EXP058694	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	PEAKS054801
EXP058695	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: 100 nM Dexamethasone for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	PEAKS054802
EXP058696	anti-GR-cocktail (Santa Cruz Biotechnology, sc-1004, lot # C1116; ABR, PA1-511A, lot # 019-147; Thermo Fisher Scientific, BuGR2, lot # PI200288)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS054803
EXP058697	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054804
EXP058698	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	EXP058691	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054805
EXP058699	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054806
EXP058700	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	EXP058691	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054807
EXP058701	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054808
EXP058702	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054809
EXP058703	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054810
EXP058704	anti-GR-cocktail (Santa Cruz Biotechnology, sc-1004, lot # C1116; ABR, PA1-511A, lot # 019-147; Thermo Fisher Scientific, BuGR2, lot # PI200288)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054811
EXP058705	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054812
EXP058706	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	PEAKS054813
EXP058707	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS054814
EXP058708	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS054815
EXP058709	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS054816
EXP058710	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS054817
EXP058712	anti-Med1 (Behtyl Labs #A300-793A)	Mus musculus	Treatment: none;	EXP058711	942	normal	Q925J9	NS5 (neural stem cells)	PEAKS054818
EXP058713	anti-Jmjd1c (Merck Millipore #17-10262)	Mus musculus	Treatment: none;	EXP058711	942	normal	Q69ZK6	NS5 (neural stem cells)	PEAKS054819
EXP058714	anti-Carm1 (Cell Signaling Technology #12495)	Mus musculus	Treatment: none;	EXP058711	942	normal	Q9WVG6	NS5 (neural stem cells)	PEAKS054820
EXP058719	anti-BRG1 (ab110641)	Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: wildtype;	EXP058715	212	normal	Q3TKT4	dermal fibroblasts	PEAKS054821
EXP058720	anti-BRG1 (ab110641)	Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: Post XCI deletion of Xist on inactive X-chromosome;	EXP058717	212	normal	Q3TKT4	dermal fibroblasts	PEAKS054822
EXP058723	anti-FOXL2 (Novus, NB100-1277)	Mus musculus	Strain: CD1; Developmental stage: E14.5; Sex: female;	EXP058721	3049	normal	O88470	fetal ovary	PEAKS054823
EXP058724	anti-FOXL2 (Novus, NB100-1277)	Mus musculus	Strain: CD1; Developmental stage: E14.5; Sex: female;	EXP058722	3049	normal	O88470	fetal ovary	PEAKS054824
EXP058727	anti-DDX5 (Abcam, ab10261, Lot# GR183991-1)	Mus musculus	Tissue: testis;	EXP058725	3050	normal	Q61656	undifferentiated spermatogonia	PEAKS054825
EXP058728	anti-DDX5 (Abcam, ab10261, Lot# GR183991-1)	Mus musculus	Tissue: testis;	EXP058726	3050	normal	Q61656	undifferentiated spermatogonia	PEAKS054826
EXP058730	anti-FLAG(Sigma F1804)	Mus musculus	Treatment: DMSO; Genotype: Fbio-tagged WDR43;	NULL	2	normal	Q6ZQL4	mESCs (mouse embryonic stem cells)	PEAKS054827
EXP058731	anti-FLAG(Sigma F1804)	Mus musculus	Treatment: DRB; Genotype: Fbio-tagged WDR43;	NULL	2	normal	Q6ZQL4	mESCs (mouse embryonic stem cells)	PEAKS054828
EXP058732	anti-FLAG(Sigma F1804)	Mus musculus	Treatment: ActD; Genotype: Fbio-tagged WDR43;	NULL	2	normal	Q6ZQL4	mESCs (mouse embryonic stem cells)	PEAKS054829
EXP058733	anti-FLAG (Sigma F1804)	Mus musculus	Treatment: none; Genotype: Fbio-tagged UTP3;	NULL	2	normal	Q9JI13	mESCs (mouse embryonic stem cells)	PEAKS054830
EXP058734	anti-FLAG (Sigma F1804)	Mus musculus	Treatment: none; Genotype: Fbio-tagged UTP6;	NULL	2	normal	Q8VCY6	mESCs (mouse embryonic stem cells)	PEAKS054831
EXP058735	anti-FLAG( affinity gel, sigma A2220; M-280 Streptavidin, Invitrogen  60210)	Mus musculus	Treatment: none; Genotype: Fbio-tagged Safb1;	EXP058729	2	normal	O55242	mESCs (mouse embryonic stem cells)	PEAKS054832
EXP058738	anti-JUNB (Cell Signaling, 3753S)	Mus musculus	Strain: MRP8-Cre-ires/GFP (PU.1WT); Genotype: HoxER-PU.1 wildtype;	EXP058736	3051	normal	P09450	neutrophils derived from immortalized progenitors	PEAKS054833
EXP058739	anti-JUNB (Cell Signaling, 3753S)	Mus musculus	Strain: MRP8-Cre-ires/GFP:PU.1f/f (PU.1 KO); Genotype: HoxER-PU.1 knockout;	EXP058737	3051	normal	P09450	neutrophils derived from immortalized progenitors	PEAKS054834
EXP058742	anti-PU.1 (Santa Cruz, sc-352X)	Mus musculus	Treatment: unstimulated; Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1;	EXP058740	3051	normal	P17433	neutrophils derived from immortalized progenitors	PEAKS054835
EXP058743	anti-PU.1 (Santa Cruz, sc-352X)	Mus musculus	Treatment: stimulated for 1 hour with Candida albicans (heat-inactivated); Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1;	EXP058741	3051	normal	P17433	neutrophils derived from immortalized progenitors	PEAKS054836
EXP058746	anti-Foxg1 (Active Motif 61211)	Mus musculus	Day: 9; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	EXP058745	3052	normal	P35582	intestinal villus epithelial cells	PEAKS054837
EXP058747	anti-Foxg1 (Active Motif 61211)	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	NULL	3052	normal	Q60987	intestinal villus epithelial cells	PEAKS054838
EXP058749	anti-Foxg1 (Active Motif 61211)	Mus musculus	Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	NULL	3052	normal	Q60987	intestinal villus epithelial cells	PEAKS054840
EXP058754	anti-Foxg1 (Active Motif 61211)	Mus musculus	Day: 9; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	EXP058745	3052	normal	Q60987	intestinal villus epithelial cells	PEAKS054845
EXP058751	anti-Suz12  (Cell Signaling D39F6)	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	EXP058744	3052	normal	Q80U70	intestinal villus epithelial cells	PEAKS054842
EXP058752	anti-Foxa1(Abcam, ab5089)	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	EXP058744	3052	normal	P35582	intestinal villus epithelial cells	PEAKS054843
EXP058753	anti-Foxa1(Abcam, ab5089)	Mus musculus	Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	NULL	3052	normal	P35582	intestinal villus epithelial cells	PEAKS054844
EXP058759	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:C57Bl6;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout;	NULL	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS054846
EXP058760	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:C57Bl6;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout;	NULL	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS054847
EXP058761	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:C57Bl6;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout;	NULL	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS054848
EXP058762	anti-PPARg (sc-7196, C26H12, C15410133)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P37238	BMDM (bone marrow-derived macrophages)	PEAKS054849
EXP058763	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS054850
EXP058764	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS054851
EXP058765	anti-Cebpa (sc-61)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P53566	BMDM (bone marrow-derived macrophages)	PEAKS054852
EXP058766		Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P53566	BMDM (bone marrow-derived macrophages)	PEAKS054853
EXP058767	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS054854
EXP058768	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS054855
EXP058769	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS054856
EXP058770	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS054857
EXP058771	anti-Fra2 (sc-166102)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P47930	BMDM (bone marrow-derived macrophages)	PEAKS054858
EXP058772	anti-Fra2 (sc-166102)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P47930	BMDM (bone marrow-derived macrophages)	PEAKS054859
EXP058773	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS054860
EXP058774	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS054861
EXP058775	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS054862
EXP058776	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS054863
EXP058777	anti-PU.1 (sc-352)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS054864
EXP058778	anti-PU.1 (sc-352)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P17433	BMDM (bone marrow-derived macrophages)	PEAKS054865
EXP058779	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS054866
EXP058780	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	PEAKS054867
EXP058781	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS054868
EXP058782	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P05627	BMDM (bone marrow-derived macrophages)	PEAKS054869
EXP058783	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS054870
EXP058784	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P01101	BMDM (bone marrow-derived macrophages)	PEAKS054871
EXP058785	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS054872
EXP058786	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P09450	BMDM (bone marrow-derived macrophages)	PEAKS054873
EXP058787	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS054874
EXP058788	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P15066	BMDM (bone marrow-derived macrophages)	PEAKS054875
EXP058793	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Rec8 -/-(knockout);	EXP058789	32	normal	Q61880	testis	PEAKS054876
EXP058794	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Rec8 -/-(knockout);	EXP058790	32	normal	Q61880	testis	PEAKS054877
EXP058795	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Stag3 -/-, Rec8 -/-(double knockout);	EXP058791	32	normal	Q61880	testis	PEAKS054878
EXP058796	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain: C57BL/6N; Genotype: wildtype;	EXP058792	32	normal	Q61880	testis	PEAKS054879
EXP058797	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Stag3 -/-(knockout);	NULL	32	normal	Q61880	testis	PEAKS054880
EXP058799	anti-BRG1(Abcam, ab110641, Lot No.GR150844-36)	Mus musculus	Strain: C57BL/6;  Genotype: wildtype;	EXP058798	187	normal	Q3TKT4	colon epithelium	PEAKS054881
EXP058816	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058800	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054882
EXP058817	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout;	EXP058801	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054883
EXP058818	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058806	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054884
EXP058819	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058807	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054885
EXP058820	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058808	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054886
EXP058821	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058809	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054887
EXP058822	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058810	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054888
EXP058823	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058811	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054889
EXP058824	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058812	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054890
EXP058825	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058813	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054891
EXP058826	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058802	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054892
EXP058827	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout;	EXP058803	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054893
EXP058828	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout, Snf2h wiltype add-back;	EXP058804	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054894
EXP058829	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h ko, Snf2h mutant add-back;	EXP058805	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	PEAKS054895
EXP058830	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout, Snf2h wiltype add-back;	EXP058814	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054896
EXP058831	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h ko, Snf2h mutant add-back;	EXP058815	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054897
EXP058840	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	PEAKS054898
EXP058841	anti-Hand2 (Diagenode, C15200054)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	Q61039	MEF (mouse embryonic fibroblasts)	PEAKS054899
EXP058842	anti-Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	PEAKS054900
EXP058843	anti-Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	P70326	MEF (mouse embryonic fibroblasts)	PEAKS054901
EXP058844	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	PEAKS054902
EXP058845	anti-Hand2 (Diagenode, C15200054)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q61039	MEF (mouse embryonic fibroblasts)	PEAKS054903
EXP058846	Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	PEAKS054904
EXP058847	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	P70326	MEF (mouse embryonic fibroblasts)	PEAKS054905
EXP058848	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: GMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	PEAKS054906
EXP058849	Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: GMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	PEAKS054907
EXP058850	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: GMT for 2 days; Strain: C57BL/6;	NULL	12	normal	P70326	MEF (mouse embryonic fibroblasts)	PEAKS054908
EXP058851	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Strain: C57BL/6; Developmental stage: p4;	NULL	3053	normal	Q08369	heart ventricle	PEAKS054909
EXP058852	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Strain: C57BL/6; Developmental stage: p4;	NULL	3053	normal	P70326	heart ventricle	PEAKS054910
EXP058853	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058836	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	PEAKS054911
EXP058854	anti-Hand2 (Diagenode, C15200054)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058837	12	normal	Q61039	MEF (mouse embryonic fibroblasts)	PEAKS054912
EXP058855	Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058838	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	PEAKS054913
EXP058856	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058839	12	normal	P70326	MEF (mouse embryonic fibroblasts)	PEAKS054914
EXP058859	anti-AR	Mus musculus	Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout;	EXP058857	3054	normal	P19091	prostate cancer	PEAKS054915
EXP058860	anti-ERG	Mus musculus	Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout;	EXP058857	3054	normal	P81270	prostate cancer	PEAKS054916
EXP058861	anti-AR	Mus musculus	Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout;	EXP058858	3054	normal	P19091	prostate cancer	PEAKS054917
EXP058862	anti-ERG	Mus musculus	Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout;	EXP058858	3054	normal	P81270	prostate cancer	PEAKS054918
EXP058863	anti-GPS2	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	PEAKS054919
EXP058864	anti-GPS2	Mus musculus	Genotype: GPS2 knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	PEAKS054920
EXP058865	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	PEAKS054921
EXP058866	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: GPS2 knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	PEAKS054922
EXP058867	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: PPARa wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	PEAKS054923
EXP058868	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: PPARa knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	PEAKS054924
EXP058869	anti-GPS2	Mus musculus	Genotype: PPARa wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	PEAKS054925
EXP058870	anti-GPS2	Mus musculus	Genotype: PPARa knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	PEAKS054926
EXP058871	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	PEAKS054927
EXP058872	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: PPARa knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	PEAKS054928
EXP058873	anti-GPS2	Mus musculus	Genotype: NCOR wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	PEAKS054929
EXP058874	anti-GPS2	Mus musculus	Genotype: NCOR knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	PEAKS054930
EXP058875	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: NCOR wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	PEAKS054931
EXP058876	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: NCOR knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	PEAKS054932
EXP058877	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	PEAKS054933
EXP058878	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: GPS2 knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	PEAKS054934
EXP058883	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058879	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS054935
EXP058884	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058880	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS054936
EXP058885	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	EXP058881	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS054937
EXP058886	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	EXP058882	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	PEAKS054938
EXP058887	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058879	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS054939
EXP058888	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058880	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS054940
EXP058889	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	EXP058881	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS054941
EXP058890	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058882	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	PEAKS054942
EXP058893	anti-Bcl6 (polyconal guinea pig anti mouse ,custom)	Mus musculus	Genotype: Adipoq-Cre;Sun1-sfGFP-myc; Strain: C57BL/6;	EXP058891	4	normal	P41183	inguinal white adipose tissue	PEAKS054943
EXP058894	anti-Bcl6 (polyconal guinea pig anti mouse ,custom)	Mus musculus	Genotype: Adipoq-Cre;Sun1-sfGFP-myc; Strain: C57BL/6;	EXP058892	3055	normal	P41183	perigonadal adipose tissue	PEAKS054944
EXP058898	anti-Ascl1 (Abcam ab74065)	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iAscl1.V5);	EXP058895	2565	normal	Q02067	embryonic stem cells derived embryonic bodies	PEAKS054945
EXP058899	anti-Neurog2 (Santa Cruz SC-19233)	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	P70447	embryonic stem cells derived embryonic bodies	PEAKS054946
EXP058900	anti-HA (Abcam, ab9110)	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iAscl1[bHLH:Ngn2].HA);	EXP058897	2565	normal	Q9QX98	embryonic stem cells derived embryonic bodies	PEAKS054947
EXP058901	anti-Ascl1 (Abcam ab74065)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	Q02067	embryonic stem cells derived embryonic bodies	PEAKS054948
EXP058902	anti-Brn2 (Santa Cruz SC-6029)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	P31360	embryonic stem cells derived embryonic bodies	PEAKS054949
EXP058903	anti-Ebf2 (R&D Systems AF7006)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	O08792	embryonic stem cells derived embryonic bodies	PEAKS054950
EXP058904	anti-Onecut2 (R&D Systems AF6294)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	Q6XBJ3	embryonic stem cells derived embryonic bodies	PEAKS054951
EXP058905	anti-Neurog2 (Santa Cruz SC-19233)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	P70447	embryonic stem cells derived embryonic bodies	PEAKS054952
EXP058906	anti-Brn2 (Santa Cruz SC-6029)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	P31360	embryonic stem cells derived embryonic bodies	PEAKS054953
EXP058907	anti-Ebf2 (R&D Systems AF7006)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	O08792	embryonic stem cells derived embryonic bodies	PEAKS054954
EXP058908	anti-Onecut2 (R&D Systems AF6294)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	Q6XBJ3	embryonic stem cells derived embryonic bodies	PEAKS054955
EXP058913	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: TET1/2 double knockout;	EXP058909	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054956
EXP058914	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: TET1/2 double knockout;	EXP058910	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054957
EXP058915	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: wildtype;	EXP058911	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054958
EXP058916	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: wildtype;	EXP058912	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS054959
EXP058919	anti-HCFC1  (from: Cell. 1993 Jul 16;74(1):115-25.PMID : 8392914 )	Mus musculus	Day: 0; Strain: Hcfc1 hepKO/Y; Sex: male; Age: 12 -14 weeks; Genotype: HCF-1;	EXP058917	5	normal	Q61191	liver	PEAKS054960
EXP058920	anti-HCFC1  (from: Cell. 1993 Jul 16;74(1):115-25.PMID : 8392914 )	Mus musculus	Day: 4; Strain: Hcfc1 hepKO/Y; Sex: male; Age: 12 -14 weeks; Genotype: HCF-1;	EXP058918	5	normal	Q61191	liver	PEAKS054961
EXP058927	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058921	3056	normal	P70278	postnatal testis	PEAKS054962
EXP058928	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058922	3056	normal	P70278	postnatal testis	PEAKS054963
EXP058929	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058923	3056	normal	P70278	postnatal testis	PEAKS054964
EXP058930	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058924	3056	normal	P70278	postnatal testis	PEAKS054965
EXP058931	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058925	3056	normal	P70278	postnatal testis	PEAKS054966
EXP058932	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058926	3056	normal	P70278	postnatal testis	PEAKS054967
EXP058935	anti-TET2 antibody	Mus musculus	Genotype: Tet2fl/fl (wildtype);Treatment: endogenous epitope tag empty vector; 	EXP058933	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	PEAKS054968
EXP058936	anti-TET2 antibody	Mus musculus	Genotype: Tet2-/- (knockout);Treatment: endogenous epitope tag empty vector; 	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	PEAKS054969
EXP058937	anti-FLAG M2(Sigma, A2220)	Mus musculus	Genotype: Tet2fl/fl; Treatment: endogenous epitope tag 2x-Flag TET2; 	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	PEAKS054970
EXP058938	anti-FLAG M2(Sigma, A2220)	Mus musculus	Genotype: Tet2fl/fl; Treatment: endogenous epitope tag empty vector;  Source: parental cells;	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	PEAKS054971
EXP058943	anti-TET2 antibody	Mus musculus	Genotype: Tet2fl/fl, AML1-ETO; Treatment: MigR1-AML1-ETO;	EXP058939	3057	normal	Q4JK59	immortalized hematopoietic cells	PEAKS054972
EXP058944	anti-TET2 antibody	Mus musculus	Genotype: Tet2-/-(knockout), AML1-ETO; Treatment: MigR1-AML1-ETO;	NULL	3057	normal	Q4JK59	immortalized hematopoietic cells	PEAKS054973
EXP058945	anti-TET2 antibody	Mus musculus	Genotype: Npm1+/cA; Fl3+/ITD;	EXP058941	1493	normal	Q4JK59	acute myeloid leukemia	PEAKS054974
EXP058946	anti-TET2 antibody	Mus musculus	Genotype: Npm1+/cA; Fl3+/ITD; Tet2-/-; 	NULL	1493	normal	Q4JK59	acute myeloid leukemia	PEAKS054975
EXP058948	anti-SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054976
EXP058949	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054977
EXP058950	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1, Ezh2  knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054978
EXP058951	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: EZh2Y726D;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054979
EXP058952	anti-RING1B(home made)	Mus musculus	Genotype: wildtype; 	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS054980
EXP058953	anti-RING1B(home made)	Mus musculus	Genotype: Ezh2  knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS054981
EXP058954	anti-RING1B(home made)	Mus musculus	Genotype: Ezh1, Ezh2 knockout knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS054982
EXP058955	anti-RING1B(home made)	Mus musculus	Genotype: EZh2Y726D;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS054983
EXP058956	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1  knockout, EZh2Y726D; Treatment: DMSO;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054984
EXP058957	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1  knockout, EZh2Y726D; Treatment: MG132;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054985
EXP058958	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1, Ezh2 knockout, resEZH2;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054986
EXP058959	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1, Ezh2 knockout, resEZH2Y731D;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054987
EXP058960	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1 knockout, Ezh2R685C;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS054988
EXP058962	anti-AHCY (MBL RN126PW (rabbit))	Mus musculus	Genotype: wildtype; 	EXP058961	230	normal	P50247	ES-E14 (E14, embryonic stem cells)	PEAKS054989
EXP058963	anti-Med12(A300-774A, Bethyl laboratories)	Mus musculus	Strain: CD1;	NULL	3058	normal	A2AGH6	sperm	PEAKS054990
EXP058964	anti-ZNF143(16618-1-AP, Proteintech)	Mus musculus	Strain: CD1;	NULL	3058	normal	O70230	sperm	PEAKS054991
EXP058965	anti-Foxa1(ab5089, Abcam)	Mus musculus	Strain: CD1;	NULL	3058	normal	P35582	sperm	PEAKS054992
EXP058966	anti-ESR1(sc-543, Santa Cruz)	Mus musculus	Strain: CD1;	NULL	3058	normal	P19785	sperm	PEAKS054993
EXP058967	anti-AR(sc-816, Santa Cruz)	Mus musculus	Strain: CD1;	NULL	3058	normal	P19091	sperm	PEAKS054994
EXP058970	Lef1 (Cell Signaling)	Mus musculus	Genotype: K14deltaNLef; Strain: C57BL6/CBA;	EXP058969	936	normal	P27782	primary keratinocytes	PEAKS054995
EXP058971	anti-EZH2 (pAb-039-050)	Mus musculus	Treatment: cells were mock transfected for 48 hrs;	NULL	2448	normal	Q61188	46C (embryonic stem cell)	PEAKS054996
EXP058972	anti-EZH2 (pAb-039-050)	Mus musculus	Treatment: cells were transfected with RNaseH1-GFP construct for 48 hrs;	NULL	2448	normal	Q61188	46C (embryonic stem cell)	PEAKS054997
EXP058973	anti-SUZ12 (A302-407A)	Mus musculus	Treatment: cells were mock transfected for 48 hrs;	NULL	2448	normal	Q80U70	46C (embryonic stem cell)	PEAKS054998
EXP058974	anti-SUZ12 (A302-407A)	Mus musculus	Treatment: cells were transfected with RNaseH1-GFP construct for 48 hrs;	NULL	2448	normal	Q80U70	46C (embryonic stem cell)	PEAKS054999
EXP058976	anti-VP16 antibody (Santa Cruz, sc-7545)	Mus musculus	Genotype: vp16 tagged srf; Strain: ICR;	EXP058975	3059	normal	Q9JM73	newborn neurons	PEAKS055000
EXP058979	anti-Foxp1	Mus musculus	Strain: FBV/N;	EXP058977	3060	normal	P58462	mammary basal epithelial cells	PEAKS055001
EXP058980	anti-Foxp1	Mus musculus	Strain: FBV/N;	EXP058978	3061	normal	P58462	mammary luminal epithelial cells	PEAKS055002
EXP058982	anti-Brg1	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	Q3TKT4	E14TG2A (embryonic stem cells)	PEAKS055003
EXP058983	anti-Brg1	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	Q3TKT4	E14TG2A (embryonic stem cells)	PEAKS055004
EXP058984	anti-Esrrb	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS055005
EXP058985	anti-Esrrb	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS055006
EXP058986	anti-Oct4	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	P20263	E14TG2A (embryonic stem cells)	PEAKS055007
EXP058987	anti-Oct4	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	P20263	E14TG2A (embryonic stem cells)	PEAKS055008
EXP058988	anti-Sox2	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS055009
EXP058989	anti-Sox2	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS055010
EXP058994	anti-Hoxa13 (home-made)	Mus musculus	Developmental stage: E11;Genotype: wildtype; Strain: ICR;	EXP058990	546	normal	Q62424	limb bud	PEAKS055011
EXP058995	anti-Hoxa13 (home-made)	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	EXP058991	546	normal	Q62424	limb bud	PEAKS055012
EXP058996	anti-Hoxa11 (home-made)	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	EXP058991	546	normal	P31311	limb bud	PEAKS055013
EXP058997	anti-Hoxa11 (home-made)	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	EXP058992	546	normal	P31311	limb bud	PEAKS055014
EXP058998	anti-Hoxa13 (home-made)	Mus musculus	Developmental stage: E12.5;Genotype: wildtype; Strain: ICR;	EXP058993	546	normal	Q62424	limb bud	PEAKS055015
EXP059011	anti-BCL6	Mus musculus	Genotype: Bcl6 fl/fl, Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	normal	P41183	liver	PEAKS055016
EXP059012	anti-BCL6	Mus musculus	Genotype: Bcl6 fl/fl (wildtype); Strain:C57BL/6; Conditions: lib fed; 	EXP058999	5	normal	P41183	liver	PEAKS055017
EXP059013	anti-BCL6	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059000	5	normal	P41183	liver	PEAKS055018
EXP059014	anti-BCL6	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted; 	EXP059001	5	normal	P41183	liver	PEAKS055019
EXP059015	anti-BCL6	Mus musculus	Genotype: Ppara-/-(knockout); Strain:C57BL/6; Conditions: lib fed; 	EXP059002	5	normal	P41183	liver	PEAKS055020
EXP059016	anti-BCL6	Mus musculus	Genotype: Ppard fl/wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059003	5	normal	P41183	liver	PEAKS055021
EXP059017	anti-BCL6	Mus musculus	Genotype: Ppard fl/fl(knockout), Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	EXP059004	5	normal	P41183	liver	PEAKS055022
EXP059018	anti-PPARa	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059005	5	normal	P23204	liver	PEAKS055023
EXP059019	anti-PPARa	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted; 	EXP059006	5	normal	P23204	liver	PEAKS055024
EXP059020	anti-PPARa	Mus musculus	Genotype: Bcl6 fl/fl(wildtype); Strain:C57BL/6; Conditions: lib fed; 	EXP059007	5	normal	P23204	liver	PEAKS055025
EXP059021	anti-PPARa	Mus musculus	Genotype: Bcl6 fl/fl(knockout), Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	EXP059008	5	normal	P23204	liver	PEAKS055026
EXP059022	anti-PPARd	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059009	5	normal	P35396	liver	PEAKS055027
EXP059023	anti-PPARd	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted ; 	EXP059010	5	normal	P35396	liver	PEAKS055028
EXP059025	anti-CTCF( clone D31H2 , Rabbit , Cell Signaling Technology, #3418)	Mus musculus	Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant;	NULL	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS055029
EXP059026	anti-Phospho-CTCF (Ser224) (Rabbit, Cell Signaling Technology, this study)	Mus musculus	Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant;	EXP059024	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS055030
EXP059027	anti-Tcf1	Mus musculus	Phenotype: TCRb+, CD4+, CD25-, Foxp3-Cre-GFP-; Genotype: wildtype;	NULL	3063	normal	P22361	conventional CD4+ T cells	PEAKS055031
EXP059028	anti-Tcf1	Mus musculus	Phenotype: TCRb+, CD4+, CD25+, Foxp3-Cre-GFP+; Genotype: wildtype;	NULL	1053	normal	P22361	Treg cells from lymph nodes and spleen	PEAKS055032
EXP059029	anti-Tcf1	Mus musculus	Phenotype: TCRb+, CD4+; Genotype: Tcf1 deficient;	NULL	3062	normal	P22361	effector CD4+ T cells	PEAKS055033
EXP059031	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of BRACHYURY; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P20293	NIH 3T3 (embryonic fibroblasts)	PEAKS055034
EXP059032	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of CDX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P43241	NIH 3T3 (embryonic fibroblasts)	PEAKS055035
EXP059033	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of DLX1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q64317	NIH 3T3 (embryonic fibroblasts)	PEAKS055036
EXP059034	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of DLX6; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P70397	NIH 3T3 (embryonic fibroblasts)	PEAKS055037
EXP059035	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of DUXBL; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q7TNE6	NIH 3T3 (embryonic fibroblasts)	PEAKS055038
EXP059036	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of EBF1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q07802	NIH 3T3 (embryonic fibroblasts)	PEAKS055039
EXP059037	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of FOXA1-RR; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P35582	NIH 3T3 (embryonic fibroblasts)	PEAKS055040
EXP059038	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of FOXA1-SW; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P35582	NIH 3T3 (embryonic fibroblasts)	PEAKS055041
EXP059039	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of HLF;  Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q8BW74	NIH 3T3 (embryonic fibroblasts)	PEAKS055042
EXP059040	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of MAX; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P28574	NIH 3T3 (embryonic fibroblasts)	PEAKS055043
EXP059041	 Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of NANOG; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q80Z64	NIH 3T3 (embryonic fibroblasts)	PEAKS055044
EXP059042	anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of PRR3; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q811B5	NIH 3T3 (embryonic fibroblasts)	PEAKS055045
EXP059043	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of RHOX11; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q810N8	NIH 3T3 (embryonic fibroblasts)	PEAKS055046
EXP059044	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of SIX6; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q9QZ28	NIH 3T3 (embryonic fibroblasts)	PEAKS055047
EXP059045	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of SOX15; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P43267	NIH 3T3 (embryonic fibroblasts)	PEAKS055048
EXP059046	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of TEAD1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P30051	NIH 3T3 (embryonic fibroblasts)	PEAKS055049
EXP059047	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of THAP4; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q6P3Z3	NIH 3T3 (embryonic fibroblasts)	PEAKS055050
EXP059048	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of TOX3; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q80W03	NIH 3T3 (embryonic fibroblasts)	PEAKS055051
EXP059049	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of ZFP319; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q9ERR8	NIH 3T3 (embryonic fibroblasts)	PEAKS055052
EXP059050	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of BHLHB8; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q9QYC3	NIH 3T3 (embryonic fibroblasts)	PEAKS055053
EXP059051	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of FOXA1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P35582	NIH 3T3 (embryonic fibroblasts)	PEAKS055054
EXP059052	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of OCT4; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P20263	NIH 3T3 (embryonic fibroblasts)	PEAKS055055
EXP059053	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of SOX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P48432	NIH 3T3 (embryonic fibroblasts)	PEAKS055056
EXP059061	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: wildtype;	EXP059054	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS055057
EXP059062	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1 knockout;	EXP059055	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS055058
EXP059063	anti-BAP1 (Genentech, PRO424270)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1-C91A;	EXP059056	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	PEAKS055059
EXP059064	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: wildtype;	EXP059057	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS055060
EXP059065	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: RNF2 knockout;	EXP059058	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS055061
EXP059066	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1 knockout;	EXP059059	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS055062
EXP059074	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: 25 days; Genotype: Overexpression OCT4; Treatment: pMSCV mediated virus;	EXP059068	906	normal	P20263	induced pluripotent stem cells	PEAKS055064
EXP059075	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus;	EXP059068	906	normal	Q9JM73	induced pluripotent stem cells	PEAKS055065
EXP059076	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: 25 days; Genotype: Overexpression OCT4, caMKL1 blocked; Treatment: pMSCV mediated virus;	EXP059069	906	normal	P20263	induced pluripotent stem cells	PEAKS055066
EXP059077	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus;	EXP059069	906	normal	Q9JM73	induced pluripotent stem cells	PEAKS055067
EXP059078	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus;	EXP059070	906	normal	Q9JM73	induced pluripotent stem cells	PEAKS055068
EXP059079	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus;	EXP059071	906	normal	Q9JM73	induced pluripotent stem cells	PEAKS055069
EXP059080	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: p20-30; Genotype: wildtype; Treatment: none;	EXP059072	906	normal	P20263	induced pluripotent stem cells	PEAKS055070
EXP059081	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: p20-30; Genotype: caMKL1 blocked; Treatment: none;	EXP059073	906	normal	P20263	induced pluripotent stem cells	PEAKS055071
EXP059082	anti-Foxp1(EMD Millipore ABE68)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1f/f(knockout);  Activation status: pooled;	NULL	1053	normal	P58462	Treg cells from lymph nodes and spleen	PEAKS055072
EXP059083	anti-Foxp1(EMD Millipore ABE68)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1+/+; Activation status: pooled;	NULL	1053	normal	P58462	Treg cells from lymph nodes and spleen	PEAKS055073
EXP059084	anti-Foxp1(EMD Millipore ABE68)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1+/+; Activation status: CD62Lhi;	NULL	2501	normal	P58462	Tconv (conventional T cells)	PEAKS055074
EXP059085	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1+/+; Activation status: pooled;	NULL	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	PEAKS055075
EXP059086	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre, Foxp1f/f(knockout); Activation status: pooled;	NULL	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	PEAKS055076
EXP059087	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre, Foxp1+/+; Activation status: CD62Lhi;	NULL	2501	normal	Q99JB6	Tconv (conventional T cells)	PEAKS055077
EXP059088	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre, Foxp1f/f(knockout); Activation status: CD62Lhi;	NULL	2501	normal	Q99JB6	Tconv (conventional T cells)	PEAKS055078
EXP059089	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: wildtype; Developmental stage: L10;	NULL	572	normal	P42230	mammary gland	PEAKS055079
EXP059090	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: Wap super enhancer fused to Tbrg4(seTbrg); Developmental stage: L10; Treatment: CRISPR/Cas9;	NULL	572	normal	P42230	mammary gland	PEAKS055080
EXP059091	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: deletion Tbrg4, wap super-enhancer; Developmental stage: L10;Treatment: CRISPR/Cas9;	NULL	572	normal	P42230	mammary gland	PEAKS055081
EXP059092	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: wildtype Tbrg4; Developmental stage: L10; 	NULL	572	normal	P42230	mammary gland	PEAKS055082
EXP059094	anti-MEF2C (Santa Cruz, Catalog #sc-313)	Mus musculus	Genotype: wildtype;	EXP059093	53	normal	Q8CFN5	heart	PEAKS055083
EXP059095	anti-MEF2C (Santa Cruz, Catalog #sc-313)	Mus musculus	Genotype: JP2NT overexpression;	NULL	53	normal	Q8CFN5	heart	PEAKS055084
EXP059096	anti-TBP (Abcam, Catalog #ab51841)	Mus musculus	Genotype: wildtype;	NULL	53	normal	P29037	heart	PEAKS055085
EXP059097	anti-TBP (Abcam, Catalog #ab51841)	Mus musculus	Genotype: JP2NT overexpression;	NULL	53	normal	P29037	heart	PEAKS055086
EXP059098	anti-HA tag (Abcam, Catalog #ab9110)	Mus musculus	Genotype: wildtype;	EXP059093	53	normal	Q9ET78	heart	PEAKS055087
EXP059104	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	EXP059099	885	normal	O35426	astrocytes	PEAKS055088
EXP059105	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	EXP059100	885	normal	O35426	astrocytes	PEAKS055089
EXP059106	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	EXP059101	885	normal	O35426	astrocytes	PEAKS055090
EXP059107	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: none(naive);	EXP059102	885	normal	O35426	astrocytes	PEAKS055091
EXP059108	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: none(naive);	EXP059103	885	normal	O35426	astrocytes	PEAKS055092
EXP059109	anti-Suz12	Mus musculus	Source: thymus;  Strain: C57BL/6; Genotype: wildtype - CD4+/CD8+ (double positive);	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	PEAKS055093
EXP059110	anti-Suz12	Mus musculus	Source: thymus;  Strain: C57BL/6; Genotype: Suz12  inactivated, CD4+/CD8+ (double positive); Treatment: Cas9-mediated inactivation of Suz12;	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	PEAKS055094
EXP059111	anti-Suz12	Mus musculus	Source: thymus;  Strain: C57BL/6; Genotype: JAK3 mutant, CD8+ (single positive);	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	PEAKS055095
EXP059112	anti-Suz12	Mus musculus	Source: thymus; Strain: C57BL/6; Genotype: JAK3 mutant, Suz12 inactivated, CD8+ (single positive); Treatment: Cas9-mediated inactivation of Suz12;	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	PEAKS055096
EXP059119	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta1-FLAG knocked into endogenous Mta1 locus; 	EXP059113	2	normal	Q8K4B0	mESCs (mouse embryonic stem cells)	PEAKS055097
EXP059120	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta1-FLAG knocked into endogenous Mta1 locus; 	EXP059114	2	normal	Q8K4B0	mESCs (mouse embryonic stem cells)	PEAKS055098
EXP059121	Anti-GFP	Mus musculus	Strain: 129/Ola; Genotype: Mta2-GFP knocked in to the endogenous Mta2 locus; 	EXP059115	2	normal	Q9R190	mESCs (mouse embryonic stem cells)	PEAKS055099
EXP059122	Anti-GFP	Mus musculus	Strain: 129/Ola; Genotype: Mta2-GFP knocked in to the endogenous Mta2 locus; 	EXP059116	2	normal	Q9R190	mESCs (mouse embryonic stem cells)	PEAKS055100
EXP059123	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta3-FLAG knocked in to the endogenous Mta3 locus; 	EXP059117	2	normal	Q924K8	mESCs (mouse embryonic stem cells)	PEAKS055101
EXP059124	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta3-FLAG knocked in to the endogenous Mta3 locus; 	EXP059118	2	normal	Q924K8	mESCs (mouse embryonic stem cells)	PEAKS055102
EXP059128	anti-UBTF	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP059125	3065	normal	P25976	bone-marrow derived primary pre B cells	PEAKS055103
EXP059129	anti-UBTF	Mus musculus	Genotype: premalignant; Strain: C57BL/6;	EXP059126	3065	normal	P25976	bone-marrow derived primary pre B cells	PEAKS055104
EXP059130	anti-UBTF	Mus musculus	Genotype: malignant; Strain: C57BL/6;	EXP059127	3065	normal	P25976	bone-marrow derived primary pre B cells	PEAKS055105
EXP059131	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: overexprssing H3.3K27M; Treatment: Lentivurses;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	PEAKS055106
EXP059132	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: overexprssing H3.3K27R; Treatment: Lentivurses;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	PEAKS055107
EXP059133	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: overexprssing EZHIP; Treatment: Lentivurses;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	PEAKS055108
EXP059134	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: EED floxed; Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	PEAKS055109
EXP059135	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: EED deletion; Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	PEAKS055110
EXP059136	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: Lentivurses; Genotype: overexprssing H3.3K27M;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS055111
EXP059137	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: Lentivurses;Genotype: overexprssing H3.3K27R;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS055112
EXP059138	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: Lentivurses;Genotype: overexprssing EZHIP;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS055113
EXP059139	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout ; Genotype: overexprssing EED floxed;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS055114
EXP059140	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout ; Genotype: overexprssing EED deletion;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	PEAKS055115
EXP059141	anti-Lef1 antibody (C18A7, Cell Signaling Technology)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Phenotype: TCRb+, CD4+, CD25-;	NULL	2501	normal	P27782	Tconv (conventional T cells)	PEAKS055116
EXP059142	anti-Lef1 antibody (C18A7, Cell Signaling Technology)	Mus musculus	Genotype: Lef1 deficient; Strain: C57BL/6; Phenotype: TCRb+, CD4+;	NULL	1058	bio_control	P27782	CD4+ T-cells	PEAKS055117
EXP059143	anti-DMC1	Mus musculus	Age: adult; Strain: (C57BL/6J x CAST/Eij)F1; Genotype: PRDM9-Humanized/CAST;	NULL	32	normal	Q61880	testis	PEAKS055118
EXP059145	anti-Tralpha	Mus musculus	Genotype: expresses HsaCrex-Thra-Tag; Age: Post-natal day 15;	EXP059144	53	normal	P63058	heart	PEAKS055119
EXP059148	anti-GFP (Trap_MA, Chromotek , cat#gtma-20)	Mus musculus	Donor: mouse #1; Age: 6-8 weeks; Strain: C57BL/6N-Mb21d1tm1Ciphe; Genotype: GFP-cGAS knockout;	EXP059146	2808	normal	Q8C6L5	bone marrow derived dendritic cells	PEAKS055120
EXP059149	anti-GFP (Trap_MA, Chromotek , cat#gtma-20)	Mus musculus	Donor: mouse #2 and #3;  Age: 6-8 weeks; Strain: C57BL/6N-Mb21d1tm1Ciphe; Genotype: GFP-cGAS knockout;	EXP059147	2808	normal	Q8C6L5	bone marrow derived dendritic cells	PEAKS055121
EXP059152	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Age: 8 weeks; Strain: C57BL/6J; Source: Olfactory epithelium;	EXP059150	2475	normal	Q9Z2D6	mature olfactory sensory neurons	PEAKS055122
EXP059153	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Age: 8 weeks; Strain: C57BL/6J; Source: Olfactory epithelium;	EXP059151	2475	normal	Q9Z2D6	mature olfactory sensory neurons	PEAKS055123
EXP059161	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708;	NULL	230	normal	F8VPP0	ES-E14 (E14, embryonic stem cells)	PEAKS055124
EXP059162	anti-TRIM28 (Abcam ab10484)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	EXP059156	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS055125
EXP059163	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	EXP059156	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	PEAKS055126
EXP059164	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 deletion, overexpression;	EXP059157	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	PEAKS055127
EXP059165	anti-TRIM28 (Abcam ab10484)	Mus musculus		EXP059158	230	normal	P97469	ES-E14 (E14, embryonic stem cells)	PEAKS055128
EXP059166	anti-TRIM28 (Abcam ab10484)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 deletion, overexpression;	EXP059159	2	normal	P97469	mESCs (mouse embryonic stem cells)	PEAKS055129
EXP059167	anti-HA (Abcm, ab9110)	Mus musculus	Treatment: none; Genotype: HA-ZFP708 overexpression;	EXP059160	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	PEAKS055130
EXP059168	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	EXP059154	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	PEAKS055131
EXP059177	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059169	2	normal	P70662	mESCs (mouse embryonic stem cells)	PEAKS055132
EXP059178	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	P70662	mESCs (mouse embryonic stem cells)	PEAKS055133
EXP059179	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059170	2	normal	P70662	mESCs (mouse embryonic stem cells)	PEAKS055134
EXP059180	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	P70662	mESCs (mouse embryonic stem cells)	PEAKS055135
EXP059181	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059173	2	normal	P70662	mESCs (mouse embryonic stem cells)	PEAKS055136
EXP059182	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059174	2	normal	P70662	mESCs (mouse embryonic stem cells)	PEAKS055137
EXP059183	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059169	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS055138
EXP059184	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059171	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS055139
EXP059185	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059170	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS055140
EXP059186	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS055141
EXP059187	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059169	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS055142
EXP059188	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059171	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS055143
EXP059189	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059170	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS055144
EXP059190	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS055145
EXP059191	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059173	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS055146
EXP059192	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059174	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS055147
EXP059199	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed DPPA2; Treatment: transfected with appropriate plasmid; 	EXP059193	2	normal	Q9CWH0	mESCs (mouse embryonic stem cells)	PEAKS055148
EXP059200	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed DPPA2; Treatment: transfected with appropriate plasmid; 	EXP059194	2	normal	Q9CWH0	mESCs (mouse embryonic stem cells)	PEAKS055149
EXP059201	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 fl (ENSMUST00000096045 isoform); Treatment: transfected with appropriate plasmid; 	EXP059195	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	PEAKS055150
EXP059202	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 fl (ENSMUST00000096045 isoform); Treatment: transfected with appropriate plasmid; 	EXP059196	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	PEAKS055151
EXP059203	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 short (ENSMUST00000050705 isoform); Treatment: transfected with appropriate plasmid; 	EXP059197	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	PEAKS055152
EXP059204	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 short (ENSMUST00000050705 isoform); Treatment: transfected with appropriate plasmid; 	EXP059198	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	PEAKS055153
EXP059209	anti-Ty1	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059205	2466	normal	Q9D030	primary myoblasts	PEAKS055154
EXP059210	anti-Ty1	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059206	2466	normal	Q9D030	primary myoblasts	PEAKS055155
EXP059211	anti-MyoD	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059205	2466	normal	P10085	primary myoblasts	PEAKS055156
EXP059212	anti-MyoD	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059206	2466	normal	P10085	primary myoblasts	PEAKS055157
EXP059213	anti-Ty1	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059207	2466	normal	Q9D030	primary myoblasts	PEAKS055158
EXP059214	anti-MyoD	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059207	2466	normal	P10085	primary myoblasts	PEAKS055159
EXP059215	anti-Ty1	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059208	2466	normal	Q9D030	primary myoblasts	PEAKS055160
EXP059216	anti-MyoD	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059208	2466	normal	P10085	primary myoblasts	PEAKS055161
EXP059217	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs, 200 ng/ml nocodazole, JQ1; Strain: C57BL/6; Developmental stage: mitosis;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	PEAKS055162
EXP059218	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs; Strain: C57BL/6; Developmental stage: interphase;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	PEAKS055163
EXP059219	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs, 200 ng/ml nocodazole; Strain: C57BL/6; Developmental stage: mitosis;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	PEAKS055164
EXP059220	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs, 10 uM ro3306; Strain: C57BL/6; Developmental stage: mitosis;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	PEAKS055165
EXP059222	anti-IRF8 (Cell Signaling Technology, clone D20D8)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell;	EXP059221	2581	normal	P23611	spleen and lymph nodes	PEAKS055166
EXP059223	Anti-PU.1 (Santa Cruz, sc-390405x)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell;	EXP059221	2581	normal	P17433	spleen and lymph nodes	PEAKS055167
EXP059226	anti-RUNX1	Mus musculus	Sex: Female; Developmental stage: E14.5; Strain: CD1;	EXP059224	3049	normal	Q03347	fetal ovary	PEAKS055168
EXP059227	anti-RUNX1	Mus musculus	Sex: Female; Developmental stage: E14.5; Strain: CD1;	EXP059225	3049	normal	Q03347	fetal ovary	PEAKS055169
EXP059229	anti-Cdx2(Savory et al., 2009b)	Mus musculus	Genotype: wildtype; Developmental stage: E8.5; Strain: Mixed; Source: whole embryo;	EXP059228	1497	normal	P43241	embryo	PEAKS055170
EXP059231	anti-hnrnp-k (Abcam, ab70492)	Mus musculus		EXP059230	233	normal	P61979	E14TG2A (embryonic stem cells)	PEAKS055171
EXP059232	anti-Etv6 (Santa Cruz, sc-8546x)	Mus musculus		NULL	445	normal	P97360	HPC7 (haematopoietic multipotent progenitors)	PEAKS055172
EXP059233	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	PEAKS055173
EXP059234	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	PEAKS055174
EXP059235	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 78 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	PEAKS055175
EXP059236	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 79 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	PEAKS055176
EXP059237	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 80 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	PEAKS055177
EXP059238	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 81 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	PEAKS055178
EXP059239	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Luc knockdown; Treatment: 82 hours knockdown induction with Doxycycline;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	PEAKS055179
EXP059240	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Luc knockdown; Treatment: 83 hours knockdown induction with Doxycycline;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	PEAKS055180
EXP059241	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 84 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	PEAKS055181
EXP059242	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 85 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	PEAKS055182
EXP059243	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 86 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	PEAKS055183
EXP059244	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 87 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	PEAKS055184
EXP059245	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Luc knockdown; Treatment: 88 hours knockdown induction with Doxycycline;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	PEAKS055185
EXP059246	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Luc knockdown; Treatment: 89 hours knockdown induction with Doxycycline;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	PEAKS055186
EXP059247	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 90 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	PEAKS055187
EXP059248	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 91 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	PEAKS055188
EXP059249	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 92 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	PEAKS055189
EXP059250	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 93 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	PEAKS055190
EXP059251	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Luc knockdown; Treatment: 94 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS055191
EXP059252	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Luc knockdown; Treatment: 95 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS055192
EXP059253	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 96 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS055193
EXP059254	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 97 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS055194
EXP059255	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 98 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS055195
EXP059256	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 99 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	PEAKS055196
EXP059257	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	PEAKS055197
EXP059258	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	PEAKS055198
EXP059259	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Stag2 knockdown; Treatment: 78 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	PEAKS055199
EXP059260	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Stag2 knockdown; Treatment: 79 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	PEAKS055200
EXP059261	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 80 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61164	HPC7 derived erythroid cells	PEAKS055201
EXP059262	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 81 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61164	HPC7 derived erythroid cells	PEAKS055202
EXP059263	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 4 U/l EPO;  Genotype: Stag2 knockdown; Treatment: 82 hours knock-down induction with Doxycycline;	NULL	3067	normal	Q61164	HPC7 derived erythroid cells	PEAKS055203
EXP059264	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 83 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	PEAKS055204
EXP059265	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 84 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	PEAKS055205
EXP059266	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO;  Genotype: Stag2 knockdown; Treatment: 85 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	PEAKS055206
EXP059267	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Stag2 knockdown; Treatment: 86 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	PEAKS055207
EXP059268	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 72 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61550	myeloid malignancies	PEAKS055208
EXP059269	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 73 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61550	myeloid malignancies	PEAKS055209
EXP059270	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 74 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q9CU62	myeloid malignancies	PEAKS055210
EXP059271	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 75 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q9CU62	myeloid malignancies	PEAKS055211
EXP059272	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61164	myeloid malignancies	PEAKS055212
EXP059273	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61164	myeloid malignancies	PEAKS055213
EXP059274	anti-Sox2 (R&D system, MAB2018)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Source: brain;	NULL	3069	normal	P48432	cerebral endothelial cells	PEAKS055214
EXP059275	anti-Sox2 (R&D system, MAB2018)	Mus musculus	Genotype: Mgp knockout; Strain: C57BL/6; Source: brain;	NULL	3069	normal	P48432	cerebral endothelial cells	PEAKS055215
EXP059280	anti-MLL4	Mus musculus	Treatment: mock; Genotype: Mof(flox/flox),CreER;	EXP059279	483	normal	Q6PDK2	brown preadipocytes	PEAKS055216
EXP059281	anti-MLL4	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), wildtype;	EXP059278	483	normal	Q6PDK2	brown preadipocytes	PEAKS055217
EXP059282	anti-MLL4	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), CreER;	EXP059276	483	normal	Q6PDK2	brown preadipocytes	PEAKS055218
EXP059283	anti-MLL4	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), CreER, K274R;	EXP059277	483	normal	Q6PDK2	brown preadipocytes	PEAKS055219
EXP059288	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: not treated, not infectred;	EXP059284	2484	normal	P02340	NMuMG (mammary epithelial cells)	PEAKS055220
EXP059289	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: 0.5 uM  Adriamycin for 8hrs, not infectred;	EXP059285	2484	normal	P02340	NMuMG (mammary epithelial cells)	PEAKS055221
EXP059290	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: not treated, infected with L-pWPI empy vector;	EXP059286	2484	normal	P02340	NMuMG (mammary epithelial cells)	PEAKS055222
EXP059291	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: not treated, infected with L-pWPI-MycER;	EXP059287	2484	normal	P02340	NMuMG (mammary epithelial cells)	PEAKS055223
EXP059294	anti-Sox2 (Santa cruz sc-17320)	Mus musculus	Strain: mixed C57BL/6 x DBA; Source: hippocamus;	EXP059292	3070	normal	P48432	hippocamus-derived neural progenitor cells	PEAKS055224
EXP059295	anti-Sox2 (Santa cruz sc-17320)	Mus musculus	Strain: mixed C57BL/6 x DBA; Source: hippocamus;	EXP059293	3070	normal	P48432	hippocamus-derived neural progenitor cells	PEAKS055225
EXP059326	anti-Fs(1)hSL(rabbit,Igor Dawid)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	P13709	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055252
EXP059327	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055253
EXP059328	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055254
EXP059329	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055255
EXP059330	anti-Fs(1)hSL(rabbit,Igor Dawid)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	P13709	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055256
EXP059331	anti-MED1 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q9VP05	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055257
EXP059332	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055258
EXP059333	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055259
EXP059334	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletin;	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055260
EXP059335	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055261
EXP059336	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055262
EXP059337	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055263
EXP059338	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: MED30 RNAi; Genotype: MED30 depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055264
EXP059339	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: Rad21 RNAi; Genotype: Rad21 depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055265
EXP059340	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055266
EXP059341	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055267
EXP059342	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055268
EXP059343	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletion;	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055269
EXP059344	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055270
EXP059345	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055271
EXP059346	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: MED30 RNAi; Genotype: MED30 depletion;	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055272
EXP059347	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: Rad21 RNAi; Genotype: Rad21 depletion;	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055273
EXP059348	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055274
EXP059349	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055275
EXP059350	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletion;	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055276
EXP059351	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	PEAKS055277
EXP059374	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 kcl, uninfected Strain: C57BL/6J;	EXP059352	3064	normal	Q61324	embryonic cortices	PEAKS055278
EXP059375	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 kcl, uninfected Strain: C57BL/6J;	EXP059353	3064	normal	Q61324	embryonic cortices	PEAKS055279
EXP059376	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 kcl, uninfected Strain: C57BL/6J;	EXP059354	3064	normal	Q61324	embryonic cortices	PEAKS055280
EXP059377	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, uninfected; Strain: C57BL/6J;	EXP059365	3064	normal	Q61324	embryonic cortices	PEAKS055281
EXP059378	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, ctlshrna; Strain: C57BL/6J;	EXP059355	3064	normal	Q61324	embryonic cortices	PEAKS055282
EXP059380	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q61324	embryonic cortices	PEAKS055284
EXP059382	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, ctlshrna; Strain: C57BL/6J;	EXP059369	3064	normal	Q61324	embryonic cortices	PEAKS055286
EXP059456	anti-PK (SV5-Pk1)	Schizosaccharomyces pombe	Genotype: cdc10-V50 mcm2+-9PK;	EXP059454	3072	normal	P40377	KM79 strain at G1phase	PEAKS055358
EXP059384	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, ctlshrna; Strain: C57BL/6J;	EXP059357	3064	normal	Q61324	embryonic cortices	PEAKS055288
EXP059446	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059358	3064	normal	Q61324	embryonic cortices	PEAKS055350
EXP059386	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, ctlshrna; Strain: C57BL/6J;	EXP059371	3064	normal	Q61324	embryonic cortices	PEAKS055290
EXP059445	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	NULL	3064	normal	Q61324	embryonic cortices	PEAKS055349
EXP059388	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, ctlshrna; Strain: C57BL/6J;	EXP059370	3064	normal	Q61324	embryonic cortices	PEAKS055292
EXP059455	anti-PK (SV5-Pk1)	Schizosaccharomyces pombe	Genotype: cdc10-V50 orc4+-9PK;	EXP059453	3071	normal	Q9Y794	KM81 strain at G1 phase	PEAKS055357
EXP059447	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0 ka (kainic acid), uninfected; Strain: C57BL/6J; Age: adult;	EXP059372	987	normal	Q61324	hippocampus	PEAKS055351
EXP059448	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 ka (kainic acid), uninfected; Strain: C57BL/6J; Age: adult;	EXP059373	987	normal	Q61324	hippocampus	PEAKS055352
EXP059394	anti-hdac3(sc11416X)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	O88895	embryonic cortices	PEAKS055298
EXP059395	anti-hdac3(sc11416X)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	O88895	embryonic cortices	PEAKS055299
EXP059396	anti-hdac3(sc11416X)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	O88895	embryonic cortices	PEAKS055300
EXP059397	anti-hdac3(sc11416X)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	O88895	embryonic cortices	PEAKS055301
EXP059399	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q9WU42	embryonic cortices	PEAKS055303
EXP059400	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	Q9WU42	embryonic cortices	PEAKS055304
EXP059401	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	Q9WU42	embryonic cortices	PEAKS055305
EXP059402	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	Q9WU42	embryonic cortices	PEAKS055306
EXP059403	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059362	3064	normal	Q9WU42	embryonic cortices	PEAKS055307
EXP059404	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059354	3064	normal	Q9WU42	embryonic cortices	PEAKS055308
EXP059405	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059355	3064	normal	Q9WU42	embryonic cortices	PEAKS055309
EXP059406	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q9WU42	embryonic cortices	PEAKS055310
EXP059407	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059356	3064	normal	Q9WU42	embryonic cortices	PEAKS055311
EXP059408	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059358	3064	normal	Q9WU42	embryonic cortices	PEAKS055312
EXP059409	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059355	3064	normal	Q9WU42	embryonic cortices	PEAKS055313
EXP059410	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q9WU42	embryonic cortices	PEAKS055314
EXP059412	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059358	3064	normal	Q9WU42	embryonic cortices	PEAKS055316
EXP059413	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059369	3064	normal	Q9WU42	embryonic cortices	PEAKS055317
EXP059414	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q9WU42	embryonic cortices	PEAKS055318
EXP059452	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 0 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059356	3064	normal	Q9WU42	embryonic cortices	PEAKS055356
EXP059416	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059359	3064	normal	Q9WU42	embryonic cortices	PEAKS055320
EXP059417	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059371	3064	normal	Q9WU42	embryonic cortices	PEAKS055321
EXP059418	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059357	3064	normal	Q9WU42	embryonic cortices	PEAKS055322
EXP059419	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, ncor2shrna; Strain: C57BL/6J; Genotype: ncor2 knockout;	EXP059367	3064	normal	Q9WU42	embryonic cortices	PEAKS055323
EXP059420	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, ncor2shrna; Strain: C57BL/6J; Genotype: ncor2 knockout;	EXP059368	3064	normal	Q9WU42	embryonic cortices	PEAKS055324
EXP059421	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q9WU42	embryonic cortices	PEAKS055325
EXP059422	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0.5 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	normal	Q9WU42	embryonic cortices	PEAKS055326
EXP059423	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 1 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	normal	Q9WU42	embryonic cortices	PEAKS055327
EXP059424	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059365	3064	normal	Q9WU42	embryonic cortices	PEAKS055328
EXP059425	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, n4shrna; Strain: C57BL/6J; Genotype: NPAS4 knockout;	NULL	3064	normal	Q8BGD7	embryonic cortices	PEAKS055329
EXP059426	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, n4shrna; Strain: C57BL/6J; Genotype: NPAS4 knockout;	NULL	3064	normal	Q8BGD7	embryonic cortices	PEAKS055330
EXP059427	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q8BGD7	embryonic cortices	PEAKS055331
EXP059428	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	Q8BGD7	embryonic cortices	PEAKS055332
EXP059429	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059362	3064	normal	Q8BGD7	embryonic cortices	PEAKS055333
EXP059430	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	Q8BGD7	embryonic cortices	PEAKS055334
EXP059451	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q8BGD7	embryonic cortices	PEAKS055355
EXP059435	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	Q8BGD7	embryonic cortices	PEAKS055339
EXP059436	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059354	3064	normal	Q8BGD7	embryonic cortices	PEAKS055340
EXP059449	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J;Genotype: ARNT2 knockout;	EXP059358	3064	normal	Q8BGD7	embryonic cortices	PEAKS055353
EXP059450	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J;Genotype: ARNT2 knockout;	EXP059359	3064	normal	Q8BGD7	embryonic cortices	PEAKS055354
EXP059441	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q9QXE7	embryonic cortices	PEAKS055345
EXP059442	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	Q9QXE7	embryonic cortices	PEAKS055346
EXP059443	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	Q9QXE7	embryonic cortices	PEAKS055347
EXP059444	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	Q9QXE7	embryonic cortices	PEAKS055348
EXP059474	anti-GFP	Arabidopsis thaliana	Ecotype: Col-0;	NULL	1341	normal	F4IIH6	10 day old seedlings	PEAKS055368
EXP059475	anti-GFP	Arabidopsis thaliana	Ecotype: Col-0;	NULL	1341	normal	P93831	10 day old seedlings	PEAKS055369
EXP059476	anti-GFP	Arabidopsis thaliana	Ecotype: Col-0;	NULL	1341	normal	Q9ZSM8	10 day old seedlings	PEAKS055370
EXP059477	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: Col;	NULL	1341	normal	Q9STM3	10 day old seedlings	PEAKS055371
EXP059478	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: drm1-2, drm2-2, cmt2-7, cmt3-11 quadruple mutant;	NULL	1341	normal	Q9STM3	10 day old seedlings	PEAKS055372
EXP059479	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: met1-1;	NULL	1341	normal	Q9STM3	10 day old seedlings	PEAKS055373
EXP059480	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: ref6-5;	NULL	1341	normal	Q9STM3	10 day old seedlings	PEAKS055374
EXP059483	anti-Myc (sigma, C3956)	Arabidopsis thaliana	Condions: dark grown; Genotype: wildtype;	EXP059481	1343	normal	Q8LPR5	4 day old seedlings	PEAKS055375
EXP059484	anti-Myc (sigma, C3956)	Arabidopsis thaliana	Condions: dark grown;Genotype: TCP4 overexpression;	EXP059482	1343	normal	Q8LPR5	4 day old seedlings	PEAKS055376
EXP059485	anti-HA	Arabidopsis thaliana	Genotype: wild type(Col);	NULL	3073	normal	C0SUT9	5 weeks rosette leafs 5 and 6	PEAKS055377
EXP059486	anti-HA	Arabidopsis thaliana	Genotype: JMJ16 knockout;	NULL	3073	normal	C0SUT9	5 weeks rosette leafs 5 and 6	PEAKS055378
EXP059489	anti-HA (Roche, Mouse monoclonal 12CA5)	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059487	3074	normal	Q08490	SK1 meiotic cells (75 mins)	PEAKS055379
EXP059490	anti-HA (Roche, Mouse monoclonal 12CA5)	Saccharomyces cerevisiae	Genotype: spo13 deletion;	EXP059488	3074	normal	Q08490	SK1 meiotic cells (75 mins)	PEAKS055380
EXP059493	anti-FLAG (Sigma,Mouse monoclonal, M2 )	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059491	3074	normal	P23624	SK1 meiotic cells (75 mins)	PEAKS055381
EXP059494	anti-FLAG (Sigma,Mouse monoclonal, M2 )	Saccharomyces cerevisiae	Genotype: rec8 deletion;	EXP059492	3074	normal	P23624	SK1 meiotic cells (75 mins)	PEAKS055382
EXP059496	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	P53165	SC507 strain	PEAKS055383
EXP059497	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	P53165	SC507 strain	PEAKS055384
EXP059498	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	A6ZWK1	SC507 strain	PEAKS055385
EXP059499	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	A6ZWK1	SC507 strain	PEAKS055386
EXP059500	anti-FLAG	Saccharomyces cerevisiae	Genotype: sgf73 deletion;	NULL	3075	normal	A6ZWK1	SC507 strain	PEAKS055387
EXP059501	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	P29055	SC507 strain	PEAKS055388
EXP059502	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	P29055	SC507 strain	PEAKS055389
EXP059503	anti-FLAG	Saccharomyces cerevisiae	Genotype: sgf73 deletion;	NULL	3075	normal	P29055	SC507 strain	PEAKS055390
EXP059504	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	Q12159	SC507 strain	PEAKS055391
EXP059505	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	Q12159	SC507 strain	PEAKS055392
EXP059506	anti-FLAG	Saccharomyces cerevisiae	Genotype: sgf73 deletion;	NULL	3075	normal	Q12159	SC507 strain	PEAKS055393
EXP059507	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype; Conditions: before heat shock;	EXP059495	3075	normal	P53165	SC507 strain	PEAKS055394
EXP059508	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1; Conditions: before heat shock;	NULL	3075	normal	P53165	SC507 strain	PEAKS055395
EXP059509	anti-FLAG	Saccharomyces cerevisiae	Genotype: spt20 deletion; Conditions: before heat shock;	NULL	3075	normal	P53165	SC507 strain	PEAKS055396
EXP059510	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype; Conditions: 42 degrees  heat shock for 20 mins;	EXP059495	3075	normal	P53165	SC507 strain	PEAKS055397
EXP059511	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1; Conditions: 42 degrees  heat shock for 20 mins;	NULL	3075	normal	P53165	SC507 strain	PEAKS055398
EXP059512	anti-FLAG	Saccharomyces cerevisiae	Genotype: spt20 deletion; Conditions: 42 degrees  heat shock for 20 mins;	NULL	3075	normal	P53165	SC507 strain	PEAKS055399
EXP059514	anti-HA (Roche,Mouse monoclonal 12CA5 )	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059513	3074	normal	Q12188	SK1 meiotic cells (75 mins)	PEAKS055400
EXP059519	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 14 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059515	3076	normal	Q95V55	whole body	PEAKS055401
EXP059520	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 14 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059516	3076	normal	Q95V55	whole body	PEAKS055402
EXP059521	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 35 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059517	3076	normal	Q95V55	whole body	PEAKS055403
EXP059522	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 35 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059518	3076	normal	Q95V55	whole body	PEAKS055404
EXP059564	anti-ARID1A	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055419
EXP059565	anti-ARID1A	Homo sapiens	Genotype: wildtype;	EXP059552	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055420
EXP059566	anti-ARID1B	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	Q8NFD5	HAP1 (chronic myelogenous leukemia)	PEAKS055421
EXP059567	anti-ARID2	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	Q68CP9	HAP1 (chronic myelogenous leukemia)	PEAKS055422
EXP059568	anti-ARID2	Homo sapiens	Genotype: wildtype;	EXP059552	1507	normal	Q68CP9	HAP1 (chronic myelogenous leukemia)	PEAKS055423
EXP059569	anti-BRD4	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	PEAKS055424
EXP059570	anti-PBRM1	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	Q86U86	HAP1 (chronic myelogenous leukemia)	PEAKS055425
EXP059571	anti-SMARCA2	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	P51531	HAP1 (chronic myelogenous leukemia)	PEAKS055426
EXP059572	anti-SMARCA4	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	P51532	HAP1 (chronic myelogenous leukemia)	PEAKS055427
EXP059573	anti-SMARCA4	Homo sapiens	Genotype: wildtype;	EXP059552	1507	normal	P51532	HAP1 (chronic myelogenous leukemia)	PEAKS055428
EXP059589	anti-Zfp281 (abcam, ab101318)	Mus musculus	Strain:CD-1;	EXP059587	96	normal	Q99LI5	trophoblast stem cells	PEAKS055440
EXP059590	anti-Zfp281 (abcam, ab101318)	Mus musculus	Strain:CD-1;	EXP059588	96	normal	Q99LI5	trophoblast stem cells	PEAKS055441
EXP059644	anti-AR(Santa Cruz Biotechnology,SC816X,F1515)	Homo sapiens	Chromosome: 2;	NULL	916	normal	P10275	prostate	PEAKS055483
EXP059645	anti-AR(Santa Cruz Biotechnology,SC816X,F1515)	Homo sapiens	Chromosome: 2;	NULL	435	normal	P10275	prostate tumor	PEAKS055484
EXP059647	anti-pSTAT3(phosphoTyr705, #9145S, Cell signaling)	Homo sapiens	Treatment: DMSO for 4 hrs;	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	PEAKS055485
EXP059648	anti-pSTAT3(phosphoTyr705, #9145S, Cell signaling)	Homo sapiens	Treatment: AZD1480 for 4 hrs;	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	PEAKS055486
EXP059649	anti-STAT3(SC-482X, Santa Cruz)	Homo sapiens	Treatment: 10 ug/ml alpha-IgM for 24hrs;	EXP059646	1625	normal	P40763	naive B cell	PEAKS055487
EXP059650	anti-BRD4 (Abcam, 128874)	Homo sapiens	Treatment: 0nM CEM87, sgMYOD; Genotype: MYOD knockout;	NULL	421	normal	O60885	HEK293 (embryonic kidney)	PEAKS055488
EXP059651	anti-BRD4 (Abcam, 128874)	Homo sapiens	Treatment: 50nM CEM87, sgMYOD; Genotype: MYOD knockout;	NULL	421	normal	O60885	HEK293 (embryonic kidney)	PEAKS055489
EXP059652	anti-BRD4 (Abcam, 128874)	Homo sapiens	Treatment: 50nM CEM87, sgNonTargeting;	NULL	421	normal	O60885	HEK293 (embryonic kidney)	PEAKS055490
EXP059655	anti-BRD9, Active Motifs, catalog number: 61538	Homo sapiens		EXP059653	65	normal	Q9H8M2	U937 (adult acute monocytic leukemia)	PEAKS055491
EXP059656	anti-BRD9, Active Motifs, catalog number: 61538	Homo sapiens		EXP059654	423	normal	Q9H8M2	HeLa S3 (cervical adenocarcinoma)	PEAKS055492
EXP059658	anti-pCREB (EMD Millipore, 06-519, lot# 3108493)	Homo sapiens	Sex: female;	EXP059657	772	normal	P16220	renal cortex	PEAKS055493
EXP059659	anti-VDR (Santa Cruz, C-20, sc-1008, lot# H1216)	Homo sapiens	Sex: female;	EXP059657	772	normal	P11473	renal cortex	PEAKS055494
EXP059661	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Genotype: wildtype; Treatment: 1 hr 10nM E2;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS055495
EXP059662	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: wildtype;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS055496
EXP059663	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: ETV4 ectopic expression;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS055497
EXP059664	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: ETV4 ectopic expression;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS055498
EXP059665	anti-FLAG M2(Sigma)	Homo sapiens	Treatment: 1 hr 0.1% DMSO; Genotype: ETV4 ectopic expression;	NULL	111	normal	P43268	T47D (invasive ductal carcinoma)	PEAKS055499
EXP059666	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 0.1% DMSO; Genotype: wildtype;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS055500
EXP059667	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: ETV4,knockout and ectopic expression;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS055501
EXP059668	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Genotype: ETV4 knockout; Treatment: 1 hr 10nM E2;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS055502
EXP059669	anti-KLF4(R&D Systems RRID:AB_2130224)	Homo sapiens	Conditions: 4iLA media;	NULL	2724	normal	O43474	WIBR3 (embryonic stem cell)	PEAKS055503
EXP059670	anti-KLF4(R&D Systems RRID:AB_2130224)	Homo sapiens	Conditions: DMEM+FBS media; Genotype: KLF4 overexpression;	NULL	1507	normal	O43474	HAP1 (chronic myelogenous leukemia)	PEAKS055504
EXP059672	anti-MLLT3(Genetex, GTX102835)	Homo sapiens		EXP059671	514	normal	P42568	K562 (myelogenous leukemia)	PEAKS055505
EXP059902	p300 (Santa Cruz, catalog# sc-584, lot# I2712)	Mus musculus	Time: day 5; Treatment: iCre, RA, SAG on day 2,DAPT on day 4;	NULL	3134	normal	B2RWS6	Ainv15-derived spinal motor neurons	PEAKS055850
EXP059903	p300 (Santa Cruz, catalog# sc-584, lot# I2712)	Mus musculus	Time: day 6; Treatment: iCre, RA, SAG on day 2,DAPT on day 4,5;	NULL	3134	normal	B2RWS6	Ainv15-derived spinal motor neurons	PEAKS055851
EXP040544	agarose crosslinked with a GFP-binding peptide	Mus musculus	Wild type; low-iodine diet (LID) for 2 weeks	EXP040542	1006	bio_control	Q03288	thyroid gland	PEAKS055828
EXP040545	agarose crosslinked with a GFP-binding peptide	Mus musculus	GLIS3-EGFP-fusion; low-iodine diet (LID) for 2 weeks	EXP040543	1006	normal	Q6XP49	thyroid gland	PEAKS055829
EXP040891	ESR? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	vehicle for 30 min	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS055706
EXP047944	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), infected with shRNA against shLUC	NULL	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	PEAKS055783
EXP047945	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: untreated	NULL	509	normal	Q9NVM9	Jurkat (T-cells)	PEAKS055784
EXP051027	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	NULL	509	normal	Q9NVM9	Jurkat (T-cells)	PEAKS055785
EXP047947	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: none	NULL	157	normal	Q9NVM9	CD14+ monocytes	PEAKS055786
EXP047948	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: none	NULL	466	normal	Q9NVM9	MDM(monocyte derived macrophages)	PEAKS055787
EXP047949	NAB2, ThermoFisher PA5-27925	Homo sapiens	Treatment: none	NULL	157	normal	Q15742	CD14+ monocytes	PEAKS055788
EXP047950	NAB2, ThermoFisher PA5-27925	Homo sapiens	Treatment: none	NULL	466	normal	Q15742	MDM(monocyte derived macrophages)	PEAKS055789
EXP047951	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: infected with shRNA against EGR1 (EGR1 KD)	NULL	269	normal	Q9NVM9	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS055790
EXP047952	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: infected with shRNA against NAB2 (NAB2 KD)	NULL	269	normal	Q9NVM9	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS055791
EXP047953	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: infected with shRNA against shLUC	NULL	269	normal	Q9NVM9	CD34+ bone marrow cell-derived erythroid progenitors	PEAKS055792
EXP047958	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), infected with shRNA against shNAB2 (NAB2 KD)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	PEAKS055793
EXP048518	HDAC2	Homo sapiens	Treatment: none	NULL	2222	normal	Q92769	1% H1 ESCs with 99% fibroblsat	PEAKS055698
EXP048519	HDAC2	Homo sapiens	Treatment: none	NULL	2222	normal	Q92769	1% H1 ESCs with 99% fibroblsat	PEAKS055699
EXP048520	MTA2	Homo sapiens	Treatment: none	NULL	2222	normal	O94776	1% H1 ESCs with 99% fibroblsat	PEAKS055700
EXP048521	MTA2	Homo sapiens	Treatment: none	NULL	2222	normal	O94776	1% H1 ESCs with 99% fibroblsat	PEAKS055701
EXP048860	anti-FLAG	Homo sapiens	TNF (20 ng/ml) for 15 min	EXP048858	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS055858
EXP048861	anti-FLAG	Homo sapiens	TNF (20 ng/ml) for 60 min	EXP048858	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS055859
EXP048862	anti-RelA/p65	Homo sapiens	TNF (20 ng/ml) for 15 min	EXP048859	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS055860
EXP048863	anti-RelA/p65	Homo sapiens	TNF (20 ng/ml) for 60 min	EXP048859	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS055861
EXP048864	anti-FLAG	Homo sapiens	TNF (20 ng/ml) for 30 min	EXP048858	421	normal	O15527	HEK293 (embryonic kidney)	PEAKS055862
EXP048865	anti-RelA/p65	Homo sapiens	TNF (20 ng/ml) for 30 min	EXP048859	421	normal	Q04206	HEK293 (embryonic kidney)	PEAKS055863
EXP049384	anti-Che-1 (Bethyl, A301-032A)	Homo sapiens		EXP049382	2350	normal	P06276	LAL-B (All-B patient-derived cell line)	PEAKS055845
EXP049699	CSE1L	Homo sapiens	Genotype: B2-1-BirA-CSE1L-Avi Developmental stage:  fetus 	EXP049697	421	normal	P55060	HEK293 (embryonic kidney)	PEAKS055687
EXP049700	CSE1L	Homo sapiens	Genotype: B2-1-BirA Developmental stage:  fetus 	EXP049698	421	normal	P55060	HEK293 (embryonic kidney)	PEAKS055688
EXP049953	HIC-1 antibody (Santa Cruz, sc-271499)	Homo sapiens	Treatment: no Tissue: cord blood	EXP049951	2371	normal	Q14526	iTreg cells (human induced regulatory T cells )	PEAKS055840
EXP049954	HIC-1 antibody (Santa Cruz, sc-271499)	Homo sapiens	Treatment: no Tissue: cord blood	EXP049952	2371	normal	Q14526	iTreg cells (human induced regulatory T cells )	PEAKS055841
EXP050344	Bmal1 (ab93806; LOT: GR279846-2)	Mus musculus	Treatment: Zeitgeber Time 4 Strain: C57BL/6J Sex: male Genotype: wildtype	EXP050343	2400	normal	Q9WTL8	gastrocnemius	PEAKS055685
EXP050345	Rev-erb? (#23678 and #27401 produced by Ron Evans)	Mus musculus	Treatment: Zeitgeber Time 8 Strain: C57BL/6J Sex: male Genotype: wildtype	EXP050343	2400	normal	Q3UV55	gastrocnemius	PEAKS055686
EXP052789	anti-GFP antibody (Roche Cat#11814460001, Lot#19958500)	Caenorhabditis elegans	Strain: VL648 Treatment: incubated at 20Â°C overnight with 1%  DMSO Genotype: VL648 unc-119(ed3); wwIs22 [Pnhr-86::nhr-86ORF::GFP unc-119(+)]	NULL	1389	normal	Q965W2	whole worms (developmental stage: L4/young adults)	PEAKS055727
EXP052790	anti-GFP antibody (Roche Cat#11814460001, Lot#19958500)	Caenorhabditis elegans	Strain: VL648 Treatment: incubated at 20Â°C overnight with 70 uM R24 Genotype: VL648 unc-119(ed3); wwIs22 [Pnhr-86::nhr-86ORF::GFP unc-119(+)]	NULL	1389	normal	Q965W2	whole worms (developmental stage: L4/young adults)	PEAKS055728
EXP052845	CBP-1 (SDIX LLC, SDQ3582 non-commercial cbp-1 modENCODE antibody 1)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052805	2521	normal	P34545	whole worms (mixed embryo)	PEAKS055729
EXP052846	CBP-1 (SDIX LLC, SDQ3582 non-commercial cbp-1 modENCODE antibody 1)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052807	2521	normal	P34545	whole worms (mixed embryo)	PEAKS055730
EXP052847	MDT-15	Caenorhabditis elegans	Treatment: Strain: N2	EXP052837	2521	normal	Q21955	whole worms (mixed embryo)	PEAKS055731
EXP052848	MDT-15	Caenorhabditis elegans	Treatment: Strain: N2	EXP052828	2521	normal	Q21955	whole worms (mixed embryo)	PEAKS055732
EXP052849	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052819	2521	normal	Q95XZ5	whole worms (mixed embryo)	PEAKS055733
EXP052850	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052825	2521	normal	Q95XZ5	whole worms (mixed embryo)	PEAKS055734
EXP052851	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052824	2521	normal	Q95XZ5	whole worms (mixed embryo)	PEAKS055735
EXP052852	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052810	2521	normal	Q95XZ5	whole worms (mixed embryo)	PEAKS055736
EXP052853	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052811	2521	normal	Q95XZ5	whole worms (mixed embryo)	PEAKS055737
EXP052854	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052823	2521	normal	Q95XZ5	whole worms (mixed embryo)	PEAKS055738
EXP052855	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052799	2521	normal	Q17381	whole worms (mixed embryo)	PEAKS055739
EXP052856	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052801	2521	normal	Q17381	whole worms (mixed embryo)	PEAKS055740
EXP052857	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052812	2521	normal	Q17381	whole worms (mixed embryo)	PEAKS055741
EXP052858	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052800	2521	normal	Q17381	whole worms (mixed embryo)	PEAKS055742
EXP052859	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052802	2521	normal	Q17381	whole worms (mixed embryo)	PEAKS055743
EXP052860	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052813	2521	normal	Q17381	whole worms (mixed embryo)	PEAKS055744
EXP052861	DPY-27 (Covance Research Products Inc, JL00001_DPY27)	Caenorhabditis elegans	Treatment: Strain: 15eh1	EXP052830	1390	normal	P48996	whole worms (developmental stage: L3)	PEAKS055745
EXP052862	DPY-27 (Covance Research Products Inc, JL00001_DPY27)	Caenorhabditis elegans	Treatment: Strain: 15eh1	EXP052831	1390	normal	P48996	whole worms (developmental stage: L3)	PEAKS055746
EXP052863	SDC-3 (Covance Research Products Inc, JL00002_SDC3)	Caenorhabditis elegans	Treatment: Strain: GW638	EXP052798	2521	normal	P34706	whole worms (mixed embryo)	PEAKS055747
EXP052864	CAPG-1 (Novus, 53230002)	Caenorhabditis elegans	Treatment: Strain: GW638	EXP052798	2521	normal	G5EFJ4	whole worms (mixed embryo)	PEAKS055748
EXP052865	CBP-1 (SDIX LLC, SDQ3582 non-commercial cbp-1 modENCODE antibody 1)	Caenorhabditis elegans	Treatment: Strain: N2	EXP052844	2521	normal	P34545	whole worms (mixed embryo)	PEAKS055749
EXP052870	anti-DP (rabbit, #212, Dimova et al., Genes Dev. 2003;17: 2308-2320)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052866	2523	normal	Q24318	flight muscles	PEAKS055838
EXP052871	anti-DP (rabbit, #212, Dimova et al., Genes Dev. 2003;17: 2308-2320)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052867	2523	normal	Q24318	flight muscles	PEAKS055839
EXP052876	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment:mock Sex: female Genotype: control Source: embryo	EXP052872	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	PEAKS055689
EXP052877	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment:mock Sex: female Genotype: control Source: embryo	EXP052873	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	PEAKS055690
EXP052878	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment: siAGO2 Sex: female Genotype: Ago2 knockdown Source: embryo	EXP052874	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	PEAKS055691
EXP052879	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment: siAGO2 Sex: female Genotype: Ago2 knockdown Source: embryo	EXP052875	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	PEAKS055692
EXP052988	FLAG-M2 beads(Sigma, M8823)	Homo sapiens	Genotype: stably expressed FLAG tag-CTCF	EXP052987	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS055752
EXP052989	CTCF(Active motif, 61311)	Homo sapiens	Genotype: stably expressed FLAG tag alone	NULL	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	PEAKS055753
EXP052990	RAD21(abcam,ab992)	Homo sapiens	Genotype: stably expressed FLAG tag alone	EXP052987	423	normal	O60216	HeLa S3 (cervical adenocarcinoma)	PEAKS055754
EXP053143	anti-Hop1	Saccharomyces cerevisiae	ndj1? ndt80? T=6	EXP053120	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055794
EXP053144	anti-Hop1	Saccharomyces cerevisiae	tel1? ndt80? T=6 	EXP053121	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055795
EXP053145	anti-Hop1	Saccharomyces cerevisiae	sir3? ndt80? T=6	EXP053122	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055796
EXP053146	anti-Hop1	Saccharomyces cerevisiae	Ndj1-FRB ndt80? T=6	EXP053123	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055797
EXP053147	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; ndt80? T=3	EXP053124	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055798
EXP053148	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; ndt80? T=6	EXP053125	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055799
EXP053149	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; pch2? ndt80? T=6	EXP053126	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055800
EXP053150	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; pch2? ndt80? T=3	EXP053127	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055801
EXP053151	anti-Hop1	Saccharomyces cerevisiae	esc1? ndt80? T=6	EXP053128	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055802
EXP053152	anti-Hop1	Saccharomyces cerevisiae	sir2? ndt80? T=6	EXP053129	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055803
EXP053153	anti-Hop1	Saccharomyces cerevisiae	sir2? ndt80? T=3	EXP053130	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055804
EXP053154	anti-Hop1	Saccharomyces cerevisiae	nup2? ndt80? T=6	EXP053131	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055805
EXP053155	anti-Hop1	Saccharomyces cerevisiae	nup2? ndt80? T=3	EXP053132	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055806
EXP053156	anti-Red1	Saccharomyces cerevisiae	ndt80? T=6	EXP053133	2178	normal	P14291	SK1 meiotic cells (6 hours)	PEAKS055807
EXP053157	anti-Red1	Saccharomyces cerevisiae	ndt80? T=3	EXP053134	1382	normal	P14291	SK1 meiotic cells (3 hours)	PEAKS055808
EXP053158	anti-Rad51	Saccharomyces cerevisiae	ndt80? T=8	EXP053135	2527	normal	P25454	SK1 meiotic cells (8 hours)	PEAKS055809
EXP053159	anti-Hop1	Saccharomyces cerevisiae	wild type T=4	EXP053136	1219	normal	P20050	SK1 meiotic cells (4 hours)	PEAKS055810
EXP053160	anti-Hop1	Saccharomyces cerevisiae	wild type T=3	EXP053137	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055811
EXP053161	anti-Hop1	Saccharomyces cerevisiae	wild type T=2	EXP053138	2176	normal	P20050	Sk1 meiotic (2 hours)	PEAKS055812
EXP053162	anti-Mek1	Saccharomyces cerevisiae	ndt80? T=3	EXP053118	1382	normal	P24719	SK1 meiotic cells (3 hours)	PEAKS055813
EXP053163	anti-Hop1	Saccharomyces cerevisiae	ndt80? T=3	EXP053139	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055814
EXP053164	anti-Mek1	Saccharomyces cerevisiae	ndt80? T=6	EXP053119	2178	normal	P24719	SK1 meiotic cells (6 hours)	PEAKS055815
EXP053165	anti-Hop1	Saccharomyces cerevisiae	ndt80? T=6	EXP053140	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055816
EXP053166	anti-Hop1	Saccharomyces cerevisiae	pch2? ndt80? T=3	EXP053141	1382	normal	P20050	SK1 meiotic cells (3 hours)	PEAKS055817
EXP053167	anti-Hop1	Saccharomyces cerevisiae	pch2? ndt80? T=6	EXP053142	2178	normal	P20050	SK1 meiotic cells (6 hours)	PEAKS055818
EXP053168	anti-Zip1 (abcam yC-19)	Saccharomyces cerevisiae		EXP053117	2178	normal	P31111	SK1 meiotic cells (6 hours)	PEAKS055819
EXP053269	PPARg(Santa Cruz Biotechnology, Cat# sc-7196)	Homo sapiens	Treatment: treated with rosiglitazone for 48h beginning at day 21 Passage: 3-4 Source: Adipocytes 	NULL	2547	normal	P37231	hASC (derived adipocytes)	PEAKS055707
EXP053270	PPARg(Santa Cruz Biotechnology, Cat# sc-7196)	Homo sapiens	Source: Adipose tissue   Passage: 3-4  Source: Adipose tissue   Passage: 3-4 	NULL	2546	normal	P37231	adipose	PEAKS055708
EXP053289	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treatment: edited with CRISPR gRNAs or ssODNs	EXP053285	2550	normal	P49711	angelman Syndrome iPSC	PEAKS055694
EXP053290	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treatment: edited with CRISPR gRNAs or ssODNs	EXP053286	2550	normal	P49711	angelman Syndrome iPSC	PEAKS055695
EXP053291	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treament: none	EXP053287	2551	normal	P49711	Prader-Willi Syndrome iPSC	PEAKS055696
EXP053292	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treament: none	EXP053288	2551	normal	P49711	Prader-Willi Syndrome iPSC	PEAKS055697
EXP053298	HA beads(FF AGM90054)	Homo sapiens	Treatment: Overexpressing FLAG-TET2 and HA-SNIP1 after SNIP1 knockdown	EXP053297	10	normal	Q8TAD8	HEK293T (embryonic kidney)	PEAKS055940
EXP053303	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS055907
EXP053304	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS055908
EXP053305	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs, Fbxo22 depletion (shFbxo)	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS055909
EXP053306	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs, Fbxo22 depletion	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS055910
EXP053307	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	PEAKS055911
EXP053308	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	PEAKS055912
EXP053309	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs, Fbxo22 depletion (shFbxo)	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	PEAKS055913
EXP053310	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs, Fbxo22 depletion	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	PEAKS055914
EXP053353	BRD4 (39909, Lot#24317004, Active Motif)	Homo sapiens	WT	EXP053352	430	normal	O60885	HepG2 (hepatoblastoma)	PEAKS055679
EXP053354	C/EBPB (sc-150, Lot#G1814, Santa Cruz Biotechnology)	Homo sapiens	WT	EXP053352	430	normal	P17676	HepG2 (hepatoblastoma)	PEAKS055680
EXP053355	BRD4 (39909, Lot#24317004, Active Motif)	Homo sapiens	C/EBP? enh-/-	EXP053352	430	normal	O60885	HepG2 (hepatoblastoma)	PEAKS055681
EXP053356	C/EBPB (sc-150, Lot#G1814, Santa Cruz Biotechnology)	Homo sapiens	C/EBP? enh-/-	EXP053352	430	normal	P17676	HepG2 (hepatoblastoma)	PEAKS055682
EXP053360	anti-FLAG	Homo sapiens	Treatment: 1 ug/ml doxycycline treated cells Genotype: TRExBCBL1-3xFLAG-RTA 	EXP053359	2557	normal	O43251	recombinant KSHV+ PEL cell line	PEAKS055693
EXP053377	anti-CMYC	Homo sapiens	Source: tumor cell Tissue: breast Genotype: C-MYC overexpression 	NULL	2559	normal	Q16158	UACC-812 (Invasive ductal carcinoma)	PEAKS055938
EXP053378	anti-CMYC	Homo sapiens	Source: tumor cell Tissue: breast Genotype: UACC-812 flag cell line	NULL	2559	normal	Q16158	UACC-812 (Invasive ductal carcinoma)	PEAKS055939
EXP053521	anti-Foxp3	Mus musculus	Genotype: wildtype Strain: WT-B6 	EXP053519	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	PEAKS055683
EXP053522	Foxp3	Mus musculus	Genotype: mutant M370I Strain: M370I-Tg-B6 	EXP053520	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	PEAKS055684
EXP053962	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053951	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS055830
EXP053963	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053952	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS055831
EXP053964	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shNS;	EXP053951	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS055832
EXP053965	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shNS;	EXP053952	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS055833
EXP053966	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBRM;	NULL	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS055834
EXP053967	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053953	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS055835
EXP053968	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053953	430	normal	P51532	HepG2 (hepatoblastoma)	PEAKS055836
EXP053969	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shBRM;	NULL	430	normal	P51531	HepG2 (hepatoblastoma)	PEAKS055837
EXP057499	anti-Flag antibody (M2-antiflag, Sigma)	Saccharomyces cerevisiae	Genotype: Hmo1tag, Control plasmid expressed; Treatment: teamperature 37 for 2hr 15mins; Cell cycle: log cells;	EXP057497	2517	normal	Q03973	Log cells	PEAKS055929
EXP057500	anti-Flag antibody (M2-antiflag, Sigma)	Saccharomyces cerevisiae	Genotype: Hmo1tag;top2-1;top1<delta>, Ecoli TopA expression using plasmid; Treatment: teamperature 37 for 2hr 15mins; Cell cycle: log cells;	EXP057498	2517	normal	Q03973	Log cells	PEAKS055930
EXP058094	Smad4 (Cell signaling ,#46535, lot 2)	Mus musculus		EXP058093	3013	normal	P97471	duodenum epithelium	PEAKS055750
EXP058161	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058146	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS055709
EXP058162	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058147	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS055710
EXP058163	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058148	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS055711
EXP058164	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058149	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS055712
EXP058165	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058150	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS055713
EXP058166	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058151	514	normal	P61964	K562 (myelogenous leukemia)	PEAKS055714
EXP058167	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058152	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055715
EXP058168	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058153	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055716
EXP058169	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058154	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055717
EXP058170	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058155	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055718
EXP058171	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058156	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055719
EXP058172	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058157	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055720
EXP058173	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058158	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055721
EXP058174	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058159	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055722
EXP058175	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058160	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055723
EXP058176	anti-WDR5 (Bethyl , A302-429A)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058152	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055724
EXP058177	anti-WDR5 (Bethyl , A302-429A)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058153	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055725
EXP058178	anti-WDR5 (Bethyl , A302-429A)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058154	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS055726
EXP058633	anti-Flag (Sigma)	Homo sapiens	Genotype: TRA1-60+; Day of reprogramming: day 2;	EXP058631	3043	normal	Q01860	somatic cells reprogrammed into pluripotent stem cells	PEAKS055843
EXP058634	anti-Flag (Sigma)	Homo sapiens	Genotype: TRA1-60+; Day of reprogramming: day 10;	NULL	3043	normal	Q03052	somatic cells reprogrammed into pluripotent stem cells	PEAKS055844
EXP059067	anti-FLAG (Millipore, M8823)	Mus musculus	Genotype: wildtype; Age: E3.5-4.5 days; Strain: C57BL/6;	EXP059060	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	PEAKS055751
EXP059465	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: SPT6L{delta}SH2-GFP;	EXP059462	1341	normal	A8MS85	10 day old seedlings	PEAKS055915
EXP059466	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype:Spt6L{delta}YqgF{delta}SH2-GFP;	EXP059457	1341	normal	A8MS85	10 day old seedlings	PEAKS055916
EXP059467	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype:Spt6L{delta}HtH{delta}SH2-GFP;	EXP059458	1341	normal	A8MS85	10 day old seedlings	PEAKS055917
EXP059468	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6LSH{delta}2-GFP;	EXP059459	1341	normal	A8MS85	10 day old seedlings	PEAKS055918
EXP059469	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L{delta}YqgF-GFP;	EXP059460	1341	normal	A8MS85	10 day old seedlings	PEAKS055919
EXP059470	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L{delta}HtH-GFP;	EXP059461	1341	normal	A8MS85	10 day old seedlings	PEAKS055920
EXP059471	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: SPT6L-GFP;	NULL	1341	normal	A8MS85	10 day old seedlings	PEAKS055921
EXP059472	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L-GFP; Treatment: DMSO 1hr;	EXP059463	1341	normal	A8MS85	10 day old seedlings	PEAKS055922
EXP059473	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L-GFP; Treatment: 10 uM flavopiridol for 1hr;	EXP059464	1341	normal	A8MS85	10 day old seedlings	PEAKS055923
EXP059528	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-Dfd; Treatment: 2 mM CuSO4; Conditions: 24 hour induction;	EXP059523	1448	normal	P07548	KC167 (developmental stage: 6-12h embryo)	PEAKS055766
EXP059529	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-Ubx; Treatment: 1 mM CuSO4; Conditions: 18 hour induction;	EXP059524	1448	normal	P83949	KC167 (developmental stage: 6-12h embryo)	PEAKS055767
EXP059530	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-AbdB; Treatment: 0.5 mM CuSO4; Conditions: 24 hour induction;	EXP059525	1448	normal	P09087	KC167 (developmental stage: 6-12h embryo)	PEAKS055768
EXP059531	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-gcm; Treatment: 2.5 mM CuSO4; Conditions: 24 hour induction;	EXP059526	1448	normal	Q27403	KC167 (developmental stage: 6-12h embryo)	PEAKS055769
EXP059532	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-Hth-eGFP; Treatment: 1 mM CuSO4; Conditions: 18 hour induction;	EXP059527	1448	normal	O46339	KC167 (developmental stage: 6-12h embryo)	PEAKS055770
EXP059542	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-Lab-eGFP;	EXP059533	1448	normal	P10105	KC167 (developmental stage: 6-12h embryo)	PEAKS055757
EXP059543	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-pb;	EXP059534	1448	normal	P31264	KC167 (developmental stage: 6-12h embryo)	PEAKS055758
EXP059544	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-Dfd;	EXP059535	1448	normal	P07548	KC167 (developmental stage: 6-12h embryo)	PEAKS055759
EXP059545	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-Scr;	EXP059536	1448	normal	P09077	KC167 (developmental stage: 6-12h embryo)	PEAKS055760
EXP059546	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-Antp;	EXP059537	1448	normal	P02833	KC167 (developmental stage: 6-12h embryo)	PEAKS055761
EXP059547	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT_eGFP-Ubx;	EXP059538	1448	normal	P83949	KC167 (developmental stage: 6-12h embryo)	PEAKS055762
EXP059548	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-AbdA;	EXP059539	1448	normal	P29555	KC167 (developmental stage: 6-12h embryo)	PEAKS055763
EXP059549	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-AbdB;	EXP059540	1448	normal	P09087	KC167 (developmental stage: 6-12h embryo)	PEAKS055764
EXP059550	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-Hth-eGFP;	EXP059541	1448	normal	O46339	KC167 (developmental stage: 6-12h embryo)	PEAKS055765
EXP059574	anti-ARID1A	Homo sapiens	Genotype: ARID1A knockout;	EXP059557	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055931
EXP059575	anti-ARID1A	Homo sapiens	Genotype: ARID1B knockout;	EXP059558	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055932
EXP059576	anti-ARID1A	Homo sapiens	Genotype: knockout BCL7B;	EXP059559	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055933
EXP059577	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCA2;	EXP059560	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055934
EXP059578	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCA4;	EXP059561	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055935
EXP059579	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCC1;	EXP059562	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055936
EXP059580	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCC2;	EXP059563	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	PEAKS055937
EXP059583	anti-KDM3A (A301-538A, Bethyl Laboratories, Montgomery, TX)	Homo sapiens	Treatment: Lentiviral vector pL-KDM3A; Genotype: KDM3A knockout;	EXP059581	7	normal	Q9Y4C1	22RV1 (prostate carcinoma)	PEAKS055771
EXP059584	anti-AR (PG21, 06-680, Sigma EMD Millipore, Darmstadt, Germany)	Homo sapiens	Treatment: Lentiviral vector pL-KDM3A; Genotype: KDM3A knockout;	EXP059581	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS055772
EXP059585	anti-KDM3A (A301-538A, Bethyl Laboratories, Montgomery, TX)	Homo sapiens	Treatment: shKDM3A(shRNA); Genotype: KDM3A knockout;	EXP059582	7	normal	Q9Y4C1	22RV1 (prostate carcinoma)	PEAKS055773
EXP059586	anti-AR (PG21, 06-680, Sigma EMD Millipore, Darmstadt, Germany)	Homo sapiens	Treatment: shKDM3A(shRNA); Genotype: KDM3A knockout;	EXP059582	7	normal	P10275	22RV1 (prostate carcinoma)	PEAKS055774
EXP059593	anti-AR (N20)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS055891
EXP059594	anti-AR (N20)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS055892
EXP059595	anti-AR (N20)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS055893
EXP059596	anti-AR (N20)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS055894
EXP059597	anti-HIF(ab2185)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	Q16665	LNCaP (prostate carcinoma)	PEAKS055895
EXP059598	anti-HIF(ab2185)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	Q16665	LNCaP (prostate carcinoma)	PEAKS055896
EXP059599	anti-HIF(ab2185)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	Q16665	LNCaP (prostate carcinoma)	PEAKS055897
EXP059600	anti-HIF(ab2185)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	Q16665	LNCaP (prostate carcinoma)	PEAKS055898
EXP059601	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	P48163	LNCaP (prostate carcinoma)	PEAKS055899
EXP059602	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	P48163	LNCaP (prostate carcinoma)	PEAKS055900
EXP059603	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	P48163	LNCaP (prostate carcinoma)	PEAKS055901
EXP059604	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	P48163	LNCaP (prostate carcinoma)	PEAKS055902
EXP059605	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	Q16798	LNCaP (prostate carcinoma)	PEAKS055903
EXP059606	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	Q16798	LNCaP (prostate carcinoma)	PEAKS055904
EXP059607	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	Q16798	LNCaP (prostate carcinoma)	PEAKS055905
EXP059608	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	Q16798	LNCaP (prostate carcinoma)	PEAKS055906
EXP059619	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059609	3078	normal	Q92908	embryonic stem cells derived definitive endoderm	PEAKS055866
EXP059620	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059610	3078	normal	Q92908	embryonic stem cells derived definitive endoderm	PEAKS055867
EXP059621	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	Q92908	embryonic stem cells-derived foregut	PEAKS055868
EXP059622	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	Q92908	embryonic stem cells-derived foregut	PEAKS055869
EXP059623	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	Q92908	embryonic stem cell-derived pancreatic cells	PEAKS055870
EXP059624	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	Q92908	embryonic stem cell-derived pancreatic cells	PEAKS055871
EXP059625	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059609	3078	normal	P43694	embryonic stem cells derived definitive endoderm	PEAKS055872
EXP059626	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059610	3078	normal	P43694	embryonic stem cells derived definitive endoderm	PEAKS055873
EXP059627	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	P43694	embryonic stem cells-derived foregut	PEAKS055874
EXP059628	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	P43694	embryonic stem cells-derived foregut	PEAKS055875
EXP059629	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	P43694	embryonic stem cell-derived pancreatic cells	PEAKS055876
EXP059630	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	P43694	embryonic stem cell-derived pancreatic cells	PEAKS055877
EXP059631	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059609	3078	normal	Q9Y261	embryonic stem cells derived definitive endoderm	PEAKS055878
EXP059632	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059610	3078	normal	Q9Y261	embryonic stem cells derived definitive endoderm	PEAKS055879
EXP059633	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	Q9Y261	embryonic stem cells-derived foregut	PEAKS055880
EXP059634	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	Q9Y261	embryonic stem cells-derived foregut	PEAKS055881
EXP059635	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	Q9Y261	embryonic stem cell-derived pancreatic cells	PEAKS055882
EXP059636	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	Q9Y261	embryonic stem cell-derived pancreatic cells	PEAKS055883
EXP059637	anti-HNF1B	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	P35680	embryonic stem cells-derived foregut	PEAKS055884
EXP059638	anti-HNF1B	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	P35680	embryonic stem cells-derived foregut	PEAKS055885
EXP059639	anti-PDX1	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	P52945	embryonic stem cell-derived pancreatic cells	PEAKS055886
EXP059640	anti-PDX1	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	P52945	embryonic stem cell-derived pancreatic cells	PEAKS055887
EXP059641	anti-GATA6	Homo sapiens	Genotype: FOXA2 -/-(knockout);	EXP059616	3078	normal	Q92908	embryonic stem cells derived definitive endoderm	PEAKS055888
EXP059642	anti-GATA6	Homo sapiens	Genotype: FOXA2 -/-(knockout);	EXP059617	3079	normal	Q92908	embryonic stem cells-derived foregut	PEAKS055889
EXP059643	anti-GATA6	Homo sapiens	Genotype: FOXA2 -/-(knockout);	EXP059618	431	normal	Q92908	embryonic stem cell-derived pancreatic cells	PEAKS055890
EXP059679	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: high level of OCT4;	EXP059673	3081	normal	Q01860	A2B5+ iOPCs(H)(foreskin fibroblasts)	PEAKS055506
EXP059680	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: high level of OCT4;	EXP059674	3081	normal	Q01860	A2B5+ iOPCs(H)(foreskin fibroblasts)	PEAKS055507
EXP059681	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: high level of OCT4;	EXP059675	3081	normal	Q01860	A2B5+ iOPCs(H)(foreskin fibroblasts)	PEAKS055508
EXP059682	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: medium level of OCT4;	EXP059676	3082	normal	Q01860	A2B5+ iOPCs(M)(foreskin fibroblasts)	PEAKS055509
EXP059683	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: medium level of OCT4;	EXP059677	3082	normal	Q01860	A2B5+ iOPCs(M)(foreskin fibroblasts)	PEAKS055510
EXP059684	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens		EXP059678	396	normal	Q01860	WA09 (embryonic stem cells)	PEAKS055511
EXP059685	anti-CTCF(Cell Signaling monoclonal, D31H2, Cat# 3418)	Homo sapiens	Genotype: wildtype; Passage: 7 to 13; Sex: female;	NULL	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS055512
EXP059690	anti-Alyref FLAG(Sigma)	Homo sapiens		EXP059686	10	normal	Q86V81	HEK293T (embryonic kidney)	PEAKS055513
EXP059691	anti-Alyref FLAG(Sigma)	Homo sapiens		EXP059687	10	normal	Q86V81	HEK293T (embryonic kidney)	PEAKS055514
EXP059692	anti-FLAG(Sigma)	Homo sapiens		EXP059688	10	normal	Q9Y3Y2	HEK293T (embryonic kidney)	PEAKS055515
EXP059693	Nxf1 anti-FLAG(Sigma)	Homo sapiens		EXP059689	10	normal	Q9UBU9	HEK293T (embryonic kidney)	PEAKS055516
EXP059694	anti-STAT5 (C-17, sc-835 X, rabbit polyclonal )	Homo sapiens	Treatment: transfected with empty vector;	NULL	219	normal	P42229	DLD-1 (colon adenocarcinoma)	PEAKS055517
EXP059695	anti-BCL6 (N-3, sc-858 X, rabbit polyclonal )	Homo sapiens	Treatment: transfected with empty vector;	NULL	219	normal	P41182	DLD-1 (colon adenocarcinoma)	PEAKS055518
EXP059696	anti-STAT5 (C-17, sc-835 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 activation; Treatment: transfected with pEGFP-C1199Tiam1 and treated with vehicle;	NULL	219	normal	P42229	DLD-1 (colon adenocarcinoma)	PEAKS055519
EXP059697	anti-STAT5 (C-17, sc-835 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 inhibition; Treatment: transfected with pEGFP-C1199Tiam1 and treated with 20 microM EHT;	NULL	219	normal	P42229	DLD-1 (colon adenocarcinoma)	PEAKS055520
EXP059698	anti-BCL6 (N-3, sc-858 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 inhibition; Treatment: transfected with pEGFP-C1199Tiam1 and treated with 20 microM EHT;	NULL	219	normal	P41182	DLD-1 (colon adenocarcinoma)	PEAKS055521
EXP059699	anti-BCL6 (N-3, sc-858 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 activation; Treatment: transfected with pEGFP-C1199Tiam1 and treated with vehicle;	NULL	219	normal	P41182	DLD-1 (colon adenocarcinoma)	PEAKS055522
EXP059700	anti-PU.1	Mus musculus	Treatment: untreated; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	PEAKS055775
EXP059701		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 4 days; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	PEAKS055776
EXP059702		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 8 days; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	PEAKS055777
EXP059703		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 12 days; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	PEAKS055778
EXP059704		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 12 days; Genotype: PU.1 knockdown;	NULL	3083	normal	P17433	AML246	PEAKS055779
EXP059705		Mus musculus	Treatment:4 days doxycycline off; Genotype: PU.1 knockdown;	NULL	3083	normal	P17433	AML246	PEAKS055780
EXP059706		Mus musculus	Treatment:8 days doxycycline off; Genotype: PU.1 knockdown;	NULL	3083	normal	P17433	AML246	PEAKS055781
EXP059707		Mus musculus	Treatment:12 days doxycycline off;	NULL	3083	normal	P17433	AML246	PEAKS055782
EXP059709	anti-IRF2	Mus musculus	Passage: 18-20; Strain: B6/129; Treatment: 1ug/ml Doxycycline;	EXP059708	3084	normal	P23906	primary iKAP colorectal cancer	PEAKS055531
EXP059710	anti-BATF (pab4003, Brookwood Biochemical, rabbit polyclonal)	Mus musculus	Strain: C57BL/6J; Time: 0 hrs; Age:8-12 weeks; Treatment:none ; Genotype:wildtype;	NULL	917	normal	O35284	spleen	PEAKS055532
EXP059711	anti-BATF (pab4003, Brookwood Biochemical, rabbit polyclonal)	Mus musculus	Strain: C57BL/6J; Time: 72hrs; Age:8-12 weeks; Treatment: LPS (25ug/mL) and IL-4 (10ng/mL); Genotype: Tet2/3 wildtype (Tet2-flox, Tet3-flox, Rosa26-LSL-YFP);	NULL	917	normal	O35284	spleen	PEAKS055533
EXP059712	anti-BATF (pab4003, Brookwood Biochemical, rabbit polyclonal)	Mus musculus	Strain: C57BL/6J; Time: 72hrs; Age:8-12 weeks; Treatment: LPS (25ug/mL) and IL-4 (10ng/mL); Genotype: Tet2/3 duoble knockout (CreERT2, Tet2-flox, Tet3-flox, Rosa26-LSL-YFP);	NULL	917	normal	O35284	spleen	PEAKS055534
EXP059714	anti-Tet2 (ab124297, Abcam)	Mus musculus	Genotype: wildtype B6;  Age: 8-12 weeks; Strain:C57BL/6J; Treatment: activated with LPS (25ug/mL) and IL-4 (10ng/mL) for 72h;	EXP059713	917	normal	Q4JK59	spleen	PEAKS055535
EXP059719	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p12; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059715	3085	normal	Q3TKT4	spermatogenic cells	PEAKS055536
EXP059720	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p12; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059716	3085	normal	Q3TKT4	spermatogenic cells	PEAKS055537
EXP059721	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p18; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059717	3085	normal	Q3TKT4	spermatogenic cells	PEAKS055538
EXP059722	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p18; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059718	3085	normal	Q3TKT4	spermatogenic cells	PEAKS055539
EXP059723	anti-LRH-1 (R&D PP-H2325-00)	Mus musculus	Strain: C57BL/6; Genotype: LRH-1 +/+; Treatment: none (before ovulatory signal);	NULL	2268	normal	P45448	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS055864
EXP059724	anti-LRH-1 (R&D PP-H2325-00)	Mus musculus	Strain: C57BL/6; Genotype: LRH-1 +/+; Treatment: following ovulatory signal;	NULL	2268	normal	P45448	primary vascular smooth muscle cell (C57BL/6 mice)	PEAKS055865
EXP059727	Anti-RBPJ (Cell Signaling, #5313)	Mus musculus	Treatment: None; Strain: RD1;	EXP059725	3086	normal	P31266	brain pericytes	PEAKS055542
EXP059728	Anti-RBPJ (Cell Signaling, #5313)	Mus musculus	Treatment: None; Strain: RD1;	EXP059726	3086	normal	P31266	brain pericytes	PEAKS055543
EXP059730	anti-BCOR (RRID, AB_2750631)	Mus musculus	Genotype: wildtype; Strain: C57BL/6NCr;	EXP059729	43	normal	Q8CGN4	CD4+ Th17+ T-cells	PEAKS055544
EXP059732	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:20; Conditions: 2i medium;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	PEAKS055545
EXP059733	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:32; Conditions: 2i medium;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	PEAKS055546
EXP059734	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:20; Conditions: withdrawn from 2i for 16h;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	PEAKS055547
EXP059735	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:32; Conditions: withdrawn from 2i for 16h;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	PEAKS055548
EXP059736	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 1903.4 parental; Conditions:2i medium;	EXP059731	3087	bio_control	Q9CXC9	RGd2(embryonic stem cells)	PEAKS055549
EXP059737	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 1903.4 parental; Conditions: withdrawn from 2i for 16h;	NULL	3087	bio_control	Q9CXC9	RGd2(embryonic stem cells)	PEAKS055550
EXP059739	anti-Pcgf1	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055551
EXP059740	anti-Pcgf1	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055552
EXP059741	anti-Pcgf1	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055553
EXP059742	anti-Pcgf1	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055554
EXP059743	anti-Pcgf1	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055555
EXP059744	Pcgf2	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055556
EXP059745	Pcgf2	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055557
EXP059746	Pcgf2	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055558
EXP059747	Pcgf2	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055559
EXP059748	Pcgf2	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055560
EXP059749	Pcgf3	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055561
EXP059750	Pcgf3	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055562
EXP059751	Pcgf3	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055563
EXP059752	Pcgf3	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055564
EXP059753	Pcgf3	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055565
EXP059754	Pcgf6	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055566
EXP059755	Pcgf6	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055567
EXP059756	Pcgf6	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055568
EXP059757	Pcgf6	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055569
EXP059758	Pcgf6	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055570
EXP059759	Ring1b	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055571
EXP059760	Ring1b	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055572
EXP059761	Ring1b	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055573
EXP059762	Ring1b	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055574
EXP059763	Ring1b	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055575
EXP059764	Suz12	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055576
EXP059765	Suz12	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055577
EXP059766	Suz12	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055578
EXP059767	Suz12	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055579
EXP059768	Suz12	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055580
EXP059769	Pcgf1	Mus musculus	Genotype: Ezh1/2-/-(knockout); 	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055581
EXP059770	Pcgf2	Mus musculus	Genotype: Ezh1/2-/-(knockout); 	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055582
EXP059771	Pcgf1	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055583
EXP059772	Pcgf2	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055584
EXP059773	Pcgf3	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055585
EXP059774	Pcgf6	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055586
EXP059775	Pcgf1	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	PEAKS055587
EXP059776	Pcgf2	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS055588
EXP059777	Pcgf3	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055589
EXP059778	Pcgf6	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055590
EXP059779	Ring1b	Mus musculus	Genotype: Pcgf1/2/4-/-(triple knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055591
EXP059780	Suz12	Mus musculus	Genotype: Pcgf1/2/4-/-(triple knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055592
EXP059781	Ring1b	Mus musculus	Genotype: Pcgf1/2/4-/-(triple knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055593
EXP059782	Ring1b	Mus musculus	Genotype: Pcgf3/5/6-/-(triple knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS055594
EXP059783	Suz12	Mus musculus	Genotype: Pcgf3/5/6-/-(triple knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS055595
EXP059784	Pcgf6	Mus musculus	Treatment: shMGA; Genotype: MGA knockout;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055596
EXP059785	Pcgf6	Mus musculus	Treatment: shMGAdHLH; Genotype: MGAdHLH knockout;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055597
EXP059786	Pcgf6	Mus musculus	Treatment: shE2F6; Genotype: E2F6knockout;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055598
EXP059787	Pcgf6	Mus musculus	Treatment: shE2F6-MGAdHLH; Genotype: E2F6, MGA(double knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055599
EXP059788	Wdr5	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	P61965	ES-E14 (E14, embryonic stem cells)	PEAKS055600
EXP059789	Pcgf3	Mus musculus	Treatment: shCntrl;	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055601
EXP059790	Pcgf3	Mus musculus	Genotype: Usf1 knockout; Treatment: shRNA;	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055602
EXP059791	Pcgf3	Mus musculus	Genotype: Usf2 knockout; Treatment: shRNA;	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	PEAKS055603
EXP059792	Usf1	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q61069	ES-E14 (E14, embryonic stem cells)	PEAKS055604
EXP059793	Pcgf6	Mus musculus	Treatment: shCntrl;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS055605
EXP059795	anti-Runx1 (in-house Antibody)	Mus musculus	Genotype: Nf1fl/fl(knockout),DhhCre; Strain: C57BL/6-I129; Treatment: shRNA;	EXP059794	3088	normal	Q03347	primary neurofibroma cells	PEAKS055606
EXP059796	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i4; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055607
EXP059797	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i5; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055608
EXP059798	CTCF (Diagenode:C15410210)	Mus musculus	Genotype: wildtype CTCF; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055609
EXP059799	anti-Rad21 (Abcam,ab992)	Mus musculus	Genotype: deltaCTCF i4i5; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61550	fetal limb bud and midbrain	PEAKS055610
EXP059800	anti-Rad21 (Abcam,ab992)	Mus musculus	Genotype: deltaCTCF i4i5ZRS; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61550	fetal limb bud and midbrain	PEAKS055611
EXP059801	anti-Rad21 (Abcam,ab992)	Mus musculus	Genotype: wildtype; Developmental stage: E10.5; Strain: Bl.6;	NULL	3089	normal	Q61550	fetal limb bud and midbrain	PEAKS055612
EXP059802	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: delta-CTCF i4i5ZRSreg; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055613
EXP059803	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i4i5; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055614
EXP059804	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i4i5ZRS; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055615
EXP059805	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: wildtype; Developmental stage: E10.5; Strain: Bl.6;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	PEAKS055616
EXP059807	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment: none;	EXP059806	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	PEAKS055617
EXP059808	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment: 1uM Dex (Sigma, D-2915) for 3 hrs;	NULL	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	PEAKS055618
EXP059809	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment: 1uM Dex (Sigma, D-2915) and 1000u/ml recombinant TNF for 3 hrs;	NULL	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	PEAKS055619
EXP059810	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment:  1000u/ml recombinant TNF for 3 hrs;	NULL	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	PEAKS055620
EXP059812	anti-Foxh1(Abcam, 49133)	Mus musculus	Disease: acute myeloid leukemia; Strain: C57BL/6; Treatment: shRNA; Genotype: Ren knockout; Time: day 7;	EXP059811	2747	normal	O88621	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	PEAKS055621
EXP059815	anti-Dec1 (Bhlhe40, NB100-1800, lot C1, Novus Biologicals)	Mus musculus	Treatment: untreated; Strain: C57BL/6; Sex: male; 	EXP059813	3091	normal	O35185	peritoneal lavage	PEAKS055622
EXP059816	anti-Dec1 (Bhlhe40, NB100-1800, lot C1, Novus Biologicals)	Mus musculus	Treatment: IL-4c injections; Strain: C57BL/6; Sex: male; 	EXP059814	3091	normal	O35185	peritoneal lavage	PEAKS055623
EXP059820	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 6 hrs; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	PEAKS055624
EXP059821	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 8 hrs; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	PEAKS055625
EXP059822	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 12 hrs; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	PEAKS055626
EXP059823	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: 21 day; Treatment: vehile; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	PEAKS055627
EXP059824	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: 21 day; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	PEAKS055628
EXP059825	anti-SMC1(Active Motif #61067)	Mus musculus	Age: 21 day; Treatment: vehile; Strain: C57BL/6J; 	EXP059819	132	normal	Q9CU62	uterus	PEAKS055629
EXP059826	anti-SMC1(Active Motif #61067)	Mus musculus	Age: 21 day; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline; Strain: C57BL/6J; 	EXP059819	132	normal	Q9CU62	uterus	PEAKS055630
EXP059827	anti-SMC1(Active Motif #61067)	Mus musculus	Age: 21 day; Treatment: 1 mg P4 dissolved in sesame oil; Strain: C57BL/6J; 	EXP059819	132	normal	Q9CU62	uterus	PEAKS055631
EXP059829	anti-Isl1 (Developmental Studies Hybridoma Bank (DSHB) clone 39.4D5)	Mus musculus	Strain: C57BL/6; Developmental stage: E8.25-E9; Source: anterior part of embryos;	EXP059828	3092	normal	P61372	embryos	PEAKS055632
EXP059831	anti-Isl1 (Developmental Studies Hybridoma Bank (DSHB) clone 39.4D5)	Mus musculus	Developmental stage: day 5 derived cells;	EXP059830	3093	normal	P61372	E14Tg derived cardiac progenitor cells	PEAKS055633
EXP059834	anti-Rad21	Mus musculus	Genotype: Ai32 fl/fl; Age: 6-8weeks;	EXP059832	25	normal	Q61550	cerebellum	PEAKS055634
EXP059835	anti-Rad21	Mus musculus	Genotype: Atoh1-CRE, Ai32 fl/fl; Age: 6-8weeks;	EXP059833	25	normal	Q61550	cerebellum	PEAKS055635
EXP059836	anti-CTCF	Mus musculus	Genotype: Ai32 fl/fl; Age: 6-8weeks;	EXP059832	25	normal	Q61164	cerebellum	PEAKS055636
EXP059837	anti-CTCF	Mus musculus	Genotype: Atoh1-CRE, Ai32 fl/fl; Age: 6-8weeks;	EXP059833	25	normal	Q61164	cerebellum	PEAKS055637
EXP059838	Anti-CTCF (rabbit polyclonal,Millipore,07-729)	Mus musculus	Genotype: Lig4-/-(knockout); Strain: C57BL/6;	NULL	3094	normal	Q61164	Abelson-transformed pre-B cell	PEAKS055638
EXP059839	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Lig4-/-(knockout); Strain: C57BL/6;	NULL	3094	normal	Q61550	Abelson-transformed pre-B cell	PEAKS055639
EXP059840	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	PEAKS055640
EXP059841	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Smc3-/-(knockout); Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	PEAKS055641
EXP059842	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Wapl f/f; Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	PEAKS055642
EXP059843	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Wapl f/f + Cre; Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	PEAKS055643
EXP059844	anti-Top2b(rabbit polyclonal, Santa Cruz, sc13059, clone H-286)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	12	normal	Q64511	MEF (mouse embryonic fibroblasts)	PEAKS055644
EXP059845	anti-Top2b(rabbit polyclonal, Santa Cruz, sc13059, clone H-286)	Mus musculus	Genotype: Smc3-/-(knockout); Strain: C57BL/6;	NULL	12	normal	Q64511	MEF (mouse embryonic fibroblasts)	PEAKS055645
EXP059846	anti-Top2b(rabbit polyclonal, Santa Cruz, sc13059, clone H-286)	Mus musculus	Genotype: Wapl f/f + Cre; Strain: C57BL/6;	NULL	12	normal	Q64511	MEF (mouse embryonic fibroblasts)	PEAKS055646
EXP059847	anti-Flag (Sigma, F3165)	Mus musculus	Treatment: mock gRNA;	NULL	3095	normal	P30882	2B4(T cell hybridoma)	PEAKS055647
EXP059848	anti-Flag (Sigma, F3165)	Mus musculus	Treatment: gRNA specific to the Ccl5 promoter; Genotype: Ccl5 knockout;	NULL	3095	normal	P30882	2B4(T cell hybridoma)	PEAKS055648
EXP059849	anti-Mi2b	Mus musculus	Age: adult; Strain: C57BL/6 x 129/Sv; Source: large pre-B; Genotype: wildtype;	NULL	3065	normal	Q6PDQ2	bone-marrow derived primary pre B cells	PEAKS055755
EXP059850	anti-CTCF	Mus musculus	Age: adult; Strain: C57BL/6 x 129/Sv; Source: large pre-B; Genotype: wildtype;	NULL	3065	normal	Q61164	bone-marrow derived primary pre B cells	PEAKS055756
EXP059853	Anti-CBFb	Mus musculus	Strain: C57Bl/6; 	EXP059851	1588	normal	Q08024	CD4-positive helper T cell	PEAKS055651
EXP059854	Anti-CBFb	Mus musculus	Strain: C57Bl/6; 	EXP059852	2479	normal	Q08024	CD8+ T-cells	PEAKS055652
EXP059857	anti-PU.1(Santa Cruz Technology, sc-352, Lot#B0513)	Mus musculus	Time: day0; Treatment: none;	NULL	3096	normal	P17433	MEL(mouse erythroleukemia cells)	PEAKS055653
EXP059858	anti-PU.1(Santa Cruz Technology, sc-352, Lot#B0513)	Mus musculus	Time: day5; Treatment: 2% DMSO (VWR) added to the medium;	EXP059856	3096	normal	P17433	MEL(mouse erythroleukemia cells)	PEAKS055654
EXP059859	anti-PU.1 (T-21, Santa Cruz )	Mus musculus	Source: spleen cells of leukaemic recipient; Treatment: dox for 2 days,GFP-shRNA; Strain: C57BL/6; Immunophenotype: PU.1 High;Genotype: p53 knockout, GFP-shPU.1;	NULL	917	normal	P17433	spleen	PEAKS055852
EXP059860	anti-PU.1 (T-21, Santa Cruz )	Mus musculus	Source: spleen cells of leukaemic recipient; Treatment: untreated; Strain: C57BL/6; Immunophenotype: PU.1 Low;	NULL	917	normal	P17433	spleen	PEAKS055853
EXP059861	anti-Esrrb	Mus musculus	Strain: F1; Conditions: cultured in 2i medium for 3 days;	NULL	2	normal	Q61539	mESCs (mouse embryonic stem cells)	PEAKS055657
EXP059862	anti-Esrrb	Mus musculus	Strain: F1; Conditions: cultured in 2i medium for 3 days; Genotype: Restoration of a polymorphic ESRRB motif; Treatment: CRISPR/Cas9; 	NULL	2	normal	Q61539	mESCs (mouse embryonic stem cells)	PEAKS055658
EXP059863	anti-Esrrb	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS055659
EXP059864	anti-Esrrb	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS055660
EXP059865	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS055661
EXP059866	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS055662
EXP059867	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q60793	E14TG2A (embryonic stem cells)	PEAKS055663
EXP059868	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q60793	E14TG2A (embryonic stem cells)	PEAKS055664
EXP059869	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	P45448	E14TG2A (embryonic stem cells)	PEAKS055665
EXP059870	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	P45448	E14TG2A (embryonic stem cells)	PEAKS055666
EXP059871	anti-CTCF (Millipore, 07-729)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS055667
EXP059872	anti-CTCF (Millipore, 07-729)	Mus musculus	Conditions: cultured in EpiLSCs medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS055668
EXP059873	anti-CTCF (Millipore, 07-729)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS055669
EXP059874	anti-SMC1 (Bethyl, A300-055A)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS055670
EXP059875	anti-SMC1 (Bethyl, A300-055A)	Mus musculus	Conditions: cultured in EpiLSCs medium;	NULL	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS055671
EXP059876	anti-SMC1 (Bethyl, A300-055A)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS055672
EXP059877	anti-YY1 (Active Motif, 61779)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q00899	E14TG2A (embryonic stem cells)	PEAKS055673
EXP059878	anti-YY1 (Active Motif, 61779)	Mus musculus	Conditions: cultured in EpiLSCs medium;	NULL	233	normal	Q00899	E14TG2A (embryonic stem cells)	PEAKS055674
EXP059879	anti-YY1 (Active Motif, 61779)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q00899	E14TG2A (embryonic stem cells)	PEAKS055675
EXP059881	anti-ESR1(ThermoScientific cat. #MS-315-P, clone TE111.5D11)	Mus musculus	Treatment: induced with 200 nM tamoxifen at final concentration for 3 hrs; Genotype: transgene CDA-KLF1-ER;	EXP059880	267	normal	P19785	erythroid cells	PEAKS055842
EXP059882	anti-Lhx2	Mus musculus	Treatment: transgene Chx10-Cre eGFP; Developmental stage: E14; Strain: CD1; Genotype: Lhx2 knockout;	NULL	3097	normal	Q9Z0S2	retinal progenitor cells	PEAKS055677
EXP059883	anti-Lhx2	Mus musculus	Treatment: transgene Chx10-Cre eGFP; Developmental stage: post-natal day 2; Strain: CD1; Genotype: Lhx2 knockout;	NULL	3097	normal	Q9Z0S2	retinal progenitor cells	PEAKS055678
EXP059885	anti-CTCF (Millipore 07-729, Lot#2275585)	Homo sapiens		EXP059884	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS055702
EXP059886	anti-TAP(Sigma i5006-100MG, Lot#SLBM2617V)	Saccharomyces cerevisiae	Genotype: TAP -tag abf1;  Source: GRF88, MATa his4-38, S288C background;	NULL	3099	normal	P14164	BY4741 strain	PEAKS055703
EXP059887	anti-TAP(Sigma i5006-100MG, Lot#SLBM2617V)	Saccharomyces cerevisiae	Genotype: TAP -tag Reb1;  Source: GRF88, MATa his4-38, S288C background;	NULL	3099	normal	A6ZZE3	BY4741 strain	PEAKS055704
EXP059888	anti-TAP(Sigma i5006-100MG, Lot#SLBM2617V)	Saccharomyces cerevisiae	Genotype: TAP -tag Reb1;  Source: GRF88, MATa his4-38, S288C background;	NULL	3099	normal	P39001	BY4741 strain	PEAKS055705
EXP059890	anti-TAP	Saccharomyces cerevisiae	Treatment: 2% (w/v) glucose;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	PEAKS055854
EXP059891	anti-TAP	Saccharomyces cerevisiae	Treatment: 2% (w/v) glucose;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	PEAKS055855
EXP059892	anti-TAP	Saccharomyces cerevisiae	Treatment: 1% (v/v) ethanol;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	PEAKS055856
EXP059893	anti-TAP	Saccharomyces cerevisiae	Treatment: 1% (v/v) ethanol;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	PEAKS055857
EXP059897	anti-TFIIB	Saccharomyces cerevisiae	Conditions: 37 deegre C; Genotype: wildtype;	NULL	3120	normal	P29055	log phase strain FY3126	PEAKS055924
EXP059898	anti-TFIIB	Saccharomyces cerevisiae	Conditions: 37 deegre C; Genotype: spt6-1004;	NULL	3121	normal	P29055	log phase strain FY3127	PEAKS055925
EXP059899	anti-TFIIB	Saccharomyces cerevisiae	Conditions: 37 deegre C; Genotype: spt6-1004;	NULL	3121	normal	P29055	log phase strain FY3127	PEAKS055926
EXP059900	anti-Spt6	Saccharomyces cerevisiae	Conditions: 30 deegre C; Genotype: wildtype;	NULL	3122	normal	P23615	log phase strain FY3128	PEAKS055927
EXP059901	anti-Spt6	Saccharomyces cerevisiae	Conditions: 30 deegre C; Genotype: wildtype;	NULL	3122	normal	P23615	log phase strain FY3128	PEAKS055928
EXP059906	anti-dl (rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	P15330	2-4 h embryo	PEAKS055820
EXP059907	anti-dl (rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	P15330	2-4 h embryo	PEAKS055821
EXP059908	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	Q9U1H0	2-4 h embryo	PEAKS055822
EXP059909	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	Q9U1H0	2-4 h embryo	PEAKS055823
EXP059910	no antibody	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	A0A0B4KH43	2-4 h embryo	PEAKS055824
EXP059911	no antibody	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	A0A0B4KH43	2-4 h embryo	PEAKS055825
EXP059912	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: gd7 mutant;	EXP059904	1435	normal	Q9U1H0	2-4 h embryo	PEAKS055826
EXP059913	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: gd7 mutant;	EXP059905	1435	normal	Q9U1H0	2-4 h embryo	PEAKS055827
EXP059918	anti-Avi	Danio rerio	Treatment: Strain: TgBAC(foxd3-Avi-2A-Citrine)ox161 x Tg(ubiq:NLS-BirA-2A-Cherry)ox114; Deveolpmental stage: 75% epiboly;	EXP059914	2512	normal	F1R5S7	Neural crest (foxd3 cells)	PEAKS055941
EXP059919	anti-Avi	Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 1-2 somites;	EXP059915	2512	normal	F1R5S7	Neural crest (foxd3 cells)	PEAKS055942
EXP059920	anti-Avi	Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 5-6 somites;	NULL	2512	normal	F1R5S7	Neural crest (foxd3 cells)	PEAKS055943
EXP059921	anti-Avi	Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 14 somites;	NULL	2512	normal	F1R5S7	Neural crest (foxd3 cells)	PEAKS055944
EXP059922	anti-ORC()	Saccharomyces cerevisiae	Treatment: 10 ug/ml nocodazole for 2 hrs; Genotype: wildtype; Conditions: temperature 23 degree C; Developmantal stage: G2;	NULL	3208	normal	P32833	w303 strain	PEAKS055945
EXP059923	anti myc (Millipore cat no:05-419, 9E10)	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	3255	normal	P32657	TOH1303 strain	PEAKS055946
EXP059924		Caenorhabditis elegans		NULL	1387	normal	A0A023T4K3	whole worms (developmental stage: L1)	PEAKS055947
EXP059925	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	PEAKS055948
EXP059926	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	PEAKS055949
EXP059927	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	PEAKS055950
EXP059928	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	PEAKS055951
EXP059929	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055952
EXP059930	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055953
EXP059931	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055954
EXP059932	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055955
EXP059933	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055956
EXP059934	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055957
EXP059935	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055958
EXP059936	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	PEAKS055959
EXP059937	anti-bcd	Drosophila melanogaster	Genotype: w {bcd>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055960
EXP059938	anti-bcd	Drosophila melanogaster	Genotype: w {bcd>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055961
EXP059939	anti-bcd	Drosophila melanogaster	Genotype: w {bcd>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055962
EXP059940	anti-bcd	Drosophila melanogaster	Genotype: w {mtrm>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055963
EXP059941	anti-bcd	Drosophila melanogaster	Genotype: w {mtrm>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055964
EXP059942	anti-bcd	Drosophila melanogaster	Genotype: w {mtrm>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055965
EXP059943	anti-bcd	Drosophila melanogaster	Genotype: w {alphaTub75c>GFP-bcd-sqh3'UTR}attP40/+ bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055966
EXP059944	anti-bcd	Drosophila melanogaster	Genotype: w {alphaTub75c>GFP-bcd-sqh3'UTR}attP40/+ bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055967
EXP059945	anti-bcd	Drosophila melanogaster	Genotype: w {alphaTub75c>GFP-bcd-sqh3'UTR}attP40/+ bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055968
EXP059946	anti-bcd	Drosophila melanogaster	Genotype: w {GFP-bcd[085]}attP40 bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055969
EXP059947	anti-bcd	Drosophila melanogaster	Genotype: w {GFP-bcd[085]}attP40 bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055970
EXP059948	anti-bcd	Drosophila melanogaster	Genotype: w {GFP-bcd[085]}attP40 bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055971
EXP059949	anti-bcd	Drosophila melanogaster	Genotype: y w p{GFP-Bcd} bcd[E1] nos[L7] tsl[4];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055972
EXP059950	anti-bcd	Drosophila melanogaster	Genotype: y w p{GFP-Bcd} bcd[E1] nos[L7] tsl[4];	NULL	3343	normal	P09081	NC14 embryo	PEAKS055973
EXP059954	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM nutlin for 2 hrs;	EXP059952	38	normal	P04637	A549 (lung carcinoma)	PEAKS055974
EXP059955	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM nutlin for 2 hrs;	EXP059952	38	normal	P04637	A549 (lung carcinoma)	PEAKS055975
EXP059956	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM  nutlin for 2 hrs and treated with TGFB for 5 days at 2.5ng/ml prior;	EXP059953	38	normal	P04637	A549 (lung carcinoma)	PEAKS055976
EXP059957	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM  nutlin for 2 hrs and treated with TGFB for 5 days at 2.5ng/ml prior;	EXP059953	38	normal	P04637	A549 (lung carcinoma)	PEAKS055977
EXP059959	anti-SIRT6 (Abcam, ab62739)	Homo sapiens	Treatment: Treatment: untreated; Genotype: wildtype;	EXP059958	3369	normal	Q8N6T7	SK-MEL-239 (Melanoma)	PEAKS055978
EXP059960	anti-SIRT6 (Abcam, ab62739)	Homo sapiens	Treatment: Genotype: SIRT6 happloinsufficient cells;	NULL	3369	normal	Q8N6T7	SK-MEL-239 (Melanoma)	PEAKS055979
EXP059961	anti-SIRT6 (Abcam, ab62739)	Homo sapiens	Treatment: Genotype: SIRT6 knockout; Treatment: untreated;	NULL	3369	normal	Q8N6T7	SK-MEL-239 (Melanoma)	PEAKS055980
EXP059963	anti-BRD2 (Bethyl Laboratories, A302-583A)	Homo sapiens		EXP059962	3726	normal	P25440	NHM1 (foreskin)	PEAKS055981
EXP059964	anti-BRD4 (Bethyl Laboratories, A301-985A)	Homo sapiens		EXP059962	3726	normal	O60885	NHM1 (foreskin)	PEAKS055982
EXP059965	anti-CTCF (Millipore 07-729)	Homo sapiens		EXP049420	794	normal	P49711	SK-MEL-147 (melanoma)	PEAKS055983
EXP059966	anti-FOSL2 (Santa Cruz SC-604)	Homo sapiens		EXP049420	794	normal	P15408	SK-MEL-147 (melanoma)	PEAKS055984
EXP059967	anti-TEAD4 (Santa Cruz SC-101184)	Homo sapiens		EXP049420	794	normal	Q15561	SK-MEL-147 (melanoma)	PEAKS055985
EXP059968	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: adult;	NULL	196	normal	P43241	jejunal crypt intestinal epithelial cells	PEAKS055986
EXP059969	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: E17;	NULL	3018	normal	P43241	embryonic whole tissue from midgut	PEAKS055987
EXP059970	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: E14;	NULL	3863	normal	P43241	E14 embryonic epithelial cells from the small intestine	PEAKS055988
EXP059971	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: E13;	NULL	3018	normal	P43241	embryonic whole tissue from midgut	PEAKS055989
EXP059973	anti-BRG1 (EPNCIR11A, made in collaboration with Epitomics, Burlingame, CA)	Mus musculus	Treatment: Dexamethasone treatment: 100 nM for 1h;	NULL	14	normal	Q3TKT4	3134 (mammary adenocarcinoma)	PEAKS055990
EXP059974	anti-BRG1 (EPNCIR11A, made in collaboration with Epitomics, Burlingame, CA)	Mus musculus	Treatment: Dexamethasone treatment: 100 nM for 1h;	NULL	14	normal	Q3TKT4	3134 (mammary adenocarcinoma)	PEAKS055991
EXP059976	Anti-GR (Santa Cruz, cat# sc8992)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: Strain: Sprague Dawley; Treatment: Ethanol cfor 1 hr;	EXP059975	4178	normal	P06536	neonatal rat ventricular myocytes	PEAKS055992
EXP059977	Anti-GR (Santa Cruz, cat# sc8992)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: 100 nM Dexamethasone for 1 hr;	NULL	4178	normal	P06536	neonatal rat ventricular myocytes	PEAKS055993
EXP059980	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: female; Age: P0;	EXP059978	4179	normal	P15207	ventral mesenchymal pad of urogenital sinus	PEAKS055994
EXP059981	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: female; Age: P0;	EXP059978	4180	normal	P15207	smooth muscle, peri-urethral mesenchyme and urethral epithelium (SU) of urogenital sinus	PEAKS055995
EXP059982	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: male; Age: P0;	EXP059979	4181	normal	P15207	ventral prostate of urogenital sinus	PEAKS055996
EXP059983	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: male; Age: P0;	EXP059979	4182	normal	P15207	dorsal/dorsolateral prostate (DP) of urogenital sinus	PEAKS055997
EXP059989	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059984	898	normal	Q01147	pancreatic islets	PEAKS055998
EXP059990	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059985	898	normal	Q01147	pancreatic islets	PEAKS055999
EXP059991	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059984	898	normal	Q3U182	pancreatic islets	PEAKS056000
EXP059992	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059985	898	normal	Q3U182	pancreatic islets	PEAKS056001
EXP059993	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059986	2489	normal	Q01147	primary hepatocytes	PEAKS056002
EXP059994	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059987	2489	normal	Q01147	primary hepatocytes	PEAKS056003
EXP059995	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059986	2489	normal	Q3U182	primary hepatocytes	PEAKS056004
EXP059996	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059987	2489	normal	Q3U182	primary hepatocytes	PEAKS056005
EXP059997	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056006
EXP059998	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056007
EXP059999	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056008
EXP060000	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056009
EXP060001	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056010
EXP060002	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056011
EXP060003	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056012
EXP060004	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056013
EXP060005	anti-CRTC2 (rabbit serum, 6865 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	Q3LRZ1	INS-1E (pancreatic beta-cells)	PEAKS056014
EXP060006	anti-CRTC2 (rabbit serum, 6865 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	Q3LRZ1	INS-1E (pancreatic beta-cells)	PEAKS056015
EXP060007	anti-CBP(rabbit serum, 5613 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	Q6JHU9	INS-1E (pancreatic beta-cells)	PEAKS056016
EXP060008	anti-CBP(rabbit serum, 5613 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	Q6JHU9	INS-1E (pancreatic beta-cells)	PEAKS056017
EXP060009	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-GFP;	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056018
EXP060010	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-GFP;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056019
EXP060011	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-ACREB;	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056020
EXP060012	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-ACREB;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056021
EXP060013	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-GFP;	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056022
EXP060014	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-GFP;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056023
EXP060015	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-ACREB;	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056024
EXP060016	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-ACREB;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056025
EXP060017	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056026
EXP060018	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056027
EXP060019	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatmet: 3 hours 1 uM JQ1;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056028
EXP060020	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + 3 hours 1 uM JQ1;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056029
EXP060021	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056030
EXP051570	Reverb-alpha	Mus musculus	Treatment: Treatment: genotype: wildtype	EXP051569	498	normal	Q3UV55	Th17-cells	PEAKS057908
EXP060022	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056031
EXP060023	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 3 hours 10 uM A485;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056032
EXP060024	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + 3 hours 10 uM A485;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	PEAKS056033
EXP060025	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	Q64289	INS-1E (pancreatic beta-cells)	PEAKS056034
EXP060026	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	Q64289	INS-1E (pancreatic beta-cells)	PEAKS056035
EXP060027	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA);	NULL	493	normal	Q64289	INS-1E (pancreatic beta-cells)	PEAKS056036
EXP060028	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1i; Genotype: NeuroD1i knockout;	NULL	493	normal	Q64289	INS-1E (pancreatic beta-cells)	PEAKS056037
EXP060029	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA);	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056038
EXP060030	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-Usi (non-specific shRNA);	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056039
EXP060031	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1i; Genotype: NeuroD1i knockout;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056040
EXP060032	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1i + 1 hour 10 uM forskolin; Genotype: NeuroD1i knockout;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056041
EXP060033	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA) + 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056042
EXP060034	anti-PDX1(serum, 5538 rabbit)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA) + 1 hour 10 uM forskolin;	NULL	493	normal	P52947	INS-1E (pancreatic beta-cells)	PEAKS056043
EXP060035	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-PDX1i +  1 hour 10 uM forskolin; Genotype: PDX1i knockout;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	PEAKS056044
EXP060036	anti-PDX1(serum, 5538 rabbit)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-PDX1i + 1 hour 10 uM forskolin; Genotype: PDX1i knockout;	NULL	493	normal	P52947	INS-1E (pancreatic beta-cells)	PEAKS056045
EXP060037	anti-CREB(rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-GFP;	NULL	4185	normal	P15337	AR42J (rat digestive system neoplasms)	PEAKS056046
EXP060038	anti-CREB(rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1; Genotype: NeuroD1 knockout;	NULL	4185	normal	P15337	AR42J (rat digestive system neoplasms)	PEAKS056047
EXP060042	anti-Brg1(Customized , polyclonal antibody)	Danio rerio	Strain: Tubingen;	EXP060039	4187	normal	Q7ZSY3	256-cells stage	PEAKS056048
EXP060043	anti-Brg1(Customized , polyclonal antibody)	Danio rerio	Strain: Tubingen;	EXP060040	4188	normal	Q7ZSY3	sphere stage embryos	PEAKS056049
EXP060044	anti-Brg1(Customized , polyclonal antibody)	Danio rerio	Strain: Tubingen;	EXP060041	4189	normal	Q7ZSY3	epiboly,30% stage	PEAKS056050
EXP060046	anti-Ezh2 (Cell Signaling 5246S)	Danio rerio	Genotype: MZezh2-/-; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	NULL	4190	normal	Q08BS4	whole embryo	PEAKS056051
EXP060047	anti-Ezh2 (Cell Signaling 5246S)	Danio rerio	Genotype: wildtype; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	EXP060045	4190	normal	Q08BS4	whole embryo	PEAKS056052
EXP060048	anti-RING1B (Cell Signaling 5694S)	Danio rerio	Genotype: wildtype; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	EXP060045	4190	normal	Q803I4	whole embryo	PEAKS056053
EXP060049	anti-RING1B (Cell Signaling 5694S)	Danio rerio	Genotype: MZezh2-/-; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	NULL	4190	normal	Q803I4	whole embryo	PEAKS056054
EXP060050	anti-Sox3	Danio rerio	Genotype: wildtype;	NULL	1254	normal	Q6EJB7	24 hpf embryo	PEAKS056055
EXP060051	anti-Sox3	Danio rerio	Genotype: wildtype;	NULL	3179	normal	Q6EJB7	epiboly, 80%	PEAKS056056
EXP060052	anti-p63	Danio rerio	Genotype: wildtype;	NULL	1254	normal	A0A0R4IHL8	24 hpf embryo	PEAKS056057
EXP060053	anti-p63	Danio rerio	Genotype: wildtype;	NULL	4191	normal	A0A0R4IHL8	36hpf embryos	PEAKS056058
EXP060054	anti-p63	Danio rerio	Genotype: wildtype;	NULL	3179	normal	A0A0R4IHL8	epiboly, 80%	PEAKS056059
EXP060055	anti-Sox3	Danio rerio	Genotype: tp63 -/-;	NULL	4191	normal	Q6EJB7	36hpf embryos	PEAKS056060
EXP060056	anti-Sox3	Danio rerio	Genotype: wildtype;	NULL	4191	normal	Q6EJB7	36hpf embryos	PEAKS056061
EXP060058	anti-HA Antibody (ab9110 abcam)	Danio rerio	Genotype: Npas4l-HA;	EXP060057	4190	normal	P0DOC7	whole embryo	PEAKS056062
EXP060059	Anti-eGFP (Torrey Pine Biolabs, 0715119, Protein A purified rabbit IgG)	Danio rerio	Genotype: eGFP-tagged FoxH1;	NULL	4192	normal	Q9I9E1	6hpf epiboly-stage	PEAKS056063
EXP060066	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	EXP060060	1263	normal	O94603	whole cells	PEAKS056064
EXP060067	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	EXP060061	1263	normal	O94603	whole cells	PEAKS056065
EXP060068	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	EXP060063	1263	normal	O94603	whole cells	PEAKS056066
EXP060069	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	EXP060064	1263	normal	O94603	whole cells	PEAKS056067
EXP060073	Anti-Myc (tag, clone 4A6 (Millipore 05-724, lot 2720363)	Arabidopsis thaliana	Genotype: bdrs expressing Myc tag-BDR1; Age: 8-day old;	EXP060071	4195	normal	Q8RWG1	8-day old seedlings	PEAKS056068
EXP060074	anti-FPA (polyclonal, NEBNext Ultra II DNA library Prep kit (E7645))	Arabidopsis thaliana		NULL	4195	normal	Q8LPQ9	8-day old seedlings	PEAKS056069
EXP060076	anti-Flag (Sigma-Aldrich, F1804)	Arabidopsis thaliana	Genotype: mbd9-3 flag; Ecotype: Col-0;	EXP060075	4197	normal	Q9SGH2	13 days shoots	PEAKS056070
EXP060078	Anti-Myc tag( clone 4A6 (Millipore 05-724, lot 2824030))	Arabidopsis thaliana	Genotype: bdrs expressing Myc tag-BDR1; Ecotype: Col-0;	EXP060077	4195	normal	Q8RWG1	8-day old seedlings	PEAKS056071
EXP060081	anti-Flag (agarose beads, Sigma)	Saccharomyces cerevisiae	Genotype: MATa his3-<delta>200 leu2-3,112 lys2-801 trp1-1 ura3-52 ULP2-6xGly-3xFlag::HIS3MX6;	EXP060079	4201	normal	P40537	MHY7863 strain	PEAKS056072
EXP060082	anti-Flag (agarose beads, Sigma)	Saccharomyces cerevisiae	Genotype: MATa his3-<delta>200 leu2-3,112 lys2-801 trp1-1 ura3-52 ULP2-6xGly-3xFlag::HIS3MX6;	EXP060080	4201	normal	P40537	MHY7863 strain	PEAKS056073
EXP060085	Anti-myc (9E10)	Saccharomyces cerevisiae	Genotype: wildtype;	EXP060083	4206	normal	Q12267	ML152 strain	PEAKS056074
EXP060086	Anti-myc (9E10)	Saccharomyces cerevisiae	Genotype: wildtype;	EXP060084	4206	normal	Q12267	ML152 strain	PEAKS056075
EXP060087	Anti-myc (9E10)	Saccharomyces cerevisiae	Genotype: SIR2 deletion;	NULL	4208	normal	Q12267	ML160 strain	PEAKS056076
EXP060091	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: wildtype;	EXP060088	2193	normal	Q8MNT9	whole worms(developmental stage L4)	PEAKS056077
EXP060092	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: wildtype;	EXP060089	2193	normal	Q23670	whole worms(developmental stage L4)	PEAKS056078
EXP060093	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: nmad-1 deletion;	EXP060090	2193	normal	Q23670	whole worms(developmental stage L4)	PEAKS056079
EXP060098	anti-DPY-27	Caenorhabditis elegans	Genotype: wildtype;	EXP060094	3125	normal	P48996	N2 strain (mixed embryos)	PEAKS056080
EXP060099	anti-SDC-3	Caenorhabditis elegans	Genotype: wildtype;	EXP060094	3125	normal	P34706	N2 strain (mixed embryos)	PEAKS056081
EXP060100	anti-DPY-27	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) rex-14(y738) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060095	3125	normal	P48996	N2 strain (mixed embryos)	PEAKS056082
EXP060101	anti-SDC-3	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) rex-14(y738) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060095	3125	normal	P34706	N2 strain (mixed embryos)	PEAKS056083
EXP060102	anti-DPY-27	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) yIs197(rex-32) rex-14(y738) yIs201(rex-8) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060096	3125	normal	P48996	N2 strain (mixed embryos)	PEAKS056084
EXP060103	anti-SDC-3	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) yIs197(rex-32) rex-14(y738) yIs201(rex-8) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060096	3125	normal	P34706	N2 strain (mixed embryos)	PEAKS056085
EXP060104	anti-SDC-3	Caenorhabditis elegans	Genotype: yIs196(rex-14) yIs190(rex-47) yIs192(rex-8) I; rex-14(y738) rex-47(y671) rex-8(y737) X;	EXP060097	3125	normal	P34706	N2 strain (mixed embryos)	PEAKS056086
EXP060111	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	EXP060105	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	PEAKS056087
EXP060112	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	EXP060106	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	PEAKS056088
EXP060113	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	EXP060107	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	PEAKS056089
EXP060114	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	EXP060108	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	PEAKS056090
EXP060115	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	EXP060109	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	PEAKS056091
EXP060116	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	EXP060110	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	PEAKS056092
EXP060119	anti- GFP (from Kevin White's lab, University of Chicago)	Drosophila melanogaster	Genotype: GFP-tagged CG7804; Developmental stage: mixed pupae;	EXP060117	4210	normal	Q9VUN2	mixed pupae embryos	PEAKS056093
EXP060120	anti-GFP (from Kevin White's lab, University of Chicago)	Drosophila melanogaster	Genotype: GFP-tagged TBPH; Developmental stage: mixed pupae;	EXP060118	4210	normal	O97468	mixed pupae embryos	PEAKS056094
EXP060121	anti-Pc	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	P26017	Kc167 (development stage: embryonic)	PEAKS056095
EXP060122	anti-EcR	Drosophila melanogaster	Conditions: after 3 hours 20-HE;	NULL	1397	normal	P34021	Kc167 (development stage: embryonic)	PEAKS056096
EXP060123	Pc	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	P26017	Kc167 (development stage: embryonic)	PEAKS056097
EXP060124	anti-ISWI	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	Q24368	Kc167 (development stage: embryonic)	PEAKS056098
EXP060125	anti-EcR	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	P34021	Kc167 (development stage: embryonic)	PEAKS056099
EXP060126	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	PEAKS056100
EXP060127	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype;	NULL	127	normal	O88509	C3H10T1/2 (embryonic fibroblasts)	PEAKS056101
EXP060128	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A I310N;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	PEAKS056102
EXP060129	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype, SETD2 knockout; Treatment: sgSETD2;	NULL	127	normal	P63058	C3H10T1/2 (embryonic fibroblasts)	PEAKS056103
EXP060130	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype, SETD2 knockout; Treatment: sgSETD2;	NULL	127	normal	O88509	C3H10T1/2 (embryonic fibroblasts)	PEAKS056104
EXP060131	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype, NSD1/2 knockout; Treatment: sgNSD1;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	PEAKS056105
EXP060132	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype, NSD1/2 knockout; Treatment: sgNSD1/2;	NULL	127	normal	O88509	C3H10T1/2 (embryonic fibroblasts)	PEAKS056106
EXP060133	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype, sgNsd1/Nsd2/Setd2 knockouts; Treatment: sgNsd1/Nsd2/Setd2;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	PEAKS056107
EXP060134	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype;	NULL	252	normal	O88508	V6.5 (embryonic stem cells)	PEAKS056108
EXP060135	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: Dnmt3a knockout; Treatment: sgDnmt3a;	NULL	252	normal	O88508	V6.5 (embryonic stem cells)	PEAKS056109
EXP060136	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A2 wildtype, Nsd1 knockout; Treatment: sgNsd1;	NULL	252	normal	O88508	V6.5 (embryonic stem cells)	PEAKS056110
EXP060137	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype;	NULL	252	normal	O88509	V6.5 (embryonic stem cells)	PEAKS056111
EXP060138	anti-Flag	Drosophila melanogaster		NULL	4217	normal	P28159	whole organism (developmenta stage: embryo 9-16)	PEAKS056112
EXP060139	anti-Flag	Drosophila melanogaster		NULL	4217	normal	P28159	whole organism (developmenta stage: embryo 9-16)	PEAKS056113
EXP060145	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with NaCl only;	EXP060141	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056114
EXP060146	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with ICI;	EXP060142	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056115
EXP060147	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens		EXP060140	4219	normal	P55317	mice breast cancer cells from PDX mice	PEAKS056116
EXP060148	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with ICI;	EXP060144	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056117
EXP060149	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with NaCl only;	EXP060143	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056118
EXP060150	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin and ICI;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056119
EXP060151	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin, herceptin and ICI;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056120
EXP060152	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin and ICI;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056121
EXP060153	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	PEAKS056122
EXP060156	anti-HNF4A	Homo sapiens	Conditions: high glucose;	EXP060154	4220	normal	P41235	HCCLM3 (hepatocellular carcinoma)	PEAKS056123
EXP060157	anti-HNF4A	Homo sapiens	Conditions: low glucose;	EXP060155	4220	normal	P41235	HCCLM3 (hepatocellular carcinoma)	PEAKS056124
EXP060164	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060158	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056125
EXP060165	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060159	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056126
EXP060166	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060158	520	normal	O60885	Kelly (neuroblastoma)	PEAKS056127
EXP060167	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060159	520	normal	O60885	Kelly (neuroblastoma)	PEAKS056128
EXP060168	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060158	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056129
EXP060169	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060159	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056130
EXP060170	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060160	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056131
EXP060171	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060161	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056132
EXP060172	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060160	520	normal	O60885	Kelly (neuroblastoma)	PEAKS056133
EXP060173	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060161	520	normal	O60885	Kelly (neuroblastoma)	PEAKS056134
EXP060174	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060160	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056135
EXP060175	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060161	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056136
EXP060176	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060162	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056137
EXP060177	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060163	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056138
EXP060178	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060162	520	normal	O60885	Kelly (neuroblastoma)	PEAKS056139
EXP060179	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060163	520	normal	O60885	Kelly (neuroblastoma)	PEAKS056140
EXP060180	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060162	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056141
EXP060181	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060163	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056142
EXP060184	anti-SIRT7 (Cell Signalling, 5360, Lot 1)	Mus musculus	Strain: 129s2; Genotype: wildtype;	EXP060182	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	PEAKS056143
EXP060185	anti-SIRT7 (Cell Signalling, 5360, Lot 1)	Homo sapiens		EXP060183	514	normal	Q9NRC8	K562 (myelogenous leukemia)	PEAKS056144
EXP060191	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	EXP060186	4222	normal	P11473	colonic stem cells	PEAKS056145
EXP060192	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	EXP060187	4222	normal	P11473	colonic stem cells	PEAKS056146
EXP060193	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	EXP060188	4222	normal	P11473	colonic stem cells	PEAKS056147
EXP060194	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	EXP060189	4222	normal	P11473	colonic stem cells	PEAKS056148
EXP060195	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	EXP060190	4222	normal	P11473	colonic stem cells	PEAKS056149
EXP060196	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	EXP060190	4222	normal	P11473	colonic stem cells	PEAKS056150
EXP060199	anti-GATA2 (H-116: sc-9008, Santa Cruz)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	EXP060197	1143	normal	P23769	iPSC (induced pluripotent stem cells)	PEAKS056151
EXP060200	anti-GATA2 (H-116: sc-9008, Santa Cruz)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	EXP060198	1143	normal	P23769	iPSC (induced pluripotent stem cells)	PEAKS056152
EXP060201	anti-GATA2 (H-116: sc-9008, Santa Cruz)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	NULL	4223	normal	P23769	embryoid bodies	PEAKS056153
EXP060203	anti-IKZF3 (ab139408, Abcam)	Homo sapiens		EXP060202	3035	normal	Q9UKT9	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056154
EXP060204	anti-IKAROS (ab26083, Abcam)	Homo sapiens		EXP060202	3035	normal	Q13422	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056155
EXP060205	anti-MTA2 (ab8106, Abcam)	Homo sapiens		EXP060202	3035	normal	O94776	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056156
EXP060206	anti-Mi2 (ab72418, Abcam)	Homo sapiens		EXP060202	3035	normal	Q14839	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056157
EXP060207	anti-Bob1 (sc-955, Santa Cruz)	Homo sapiens		EXP060202	3035	normal	Q16633	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056158
EXP060208	anti-OCT2 (sc233, Santa Cruz)	Homo sapiens		EXP060202	3035	normal	P09086	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056159
EXP060209	anti-HDAC2 (Abcam, ab7029)	Homo sapiens		EXP060202	3035	normal	Q92769	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	PEAKS056160
EXP060217	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 0-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060210	4224	normal	P10276	iPS-derived cells during chondrocyte differentiation	PEAKS056161
EXP060218	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 0-2 days; Treatment: 2C method; Tissue: Foreskin;	EXP060210	4224	normal	P10276	iPS-derived cells during chondrocyte differentiation	PEAKS056162
EXP060219	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 2-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060211	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056163
EXP060220	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 2-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060211	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056164
EXP060221	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 3-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060212	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056165
EXP060222	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 3-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060212	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056166
EXP060223	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 4-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060213	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056167
EXP060224	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 4-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060213	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056168
EXP060225	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 5-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060214	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056169
EXP060226	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 5-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060214	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056170
EXP060227	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 7-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060215	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056171
EXP060228	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 7-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060215	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056172
EXP060229	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 9-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060216	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056173
EXP060230	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 9-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060216	4225	normal	P10276	iPS-derived chondrocytes	PEAKS056174
EXP060231	anti-ETS1 (501A, Bethyl Labs)	Homo sapiens		NULL	4226	normal	P14921	SCC25 (Tongue squamous cell carcinoma)	PEAKS056175
EXP060232	anti-ETS1(C20, Santa Cruz)	Homo sapiens		NULL	4226	normal	P14921	SCC25 (Tongue squamous cell carcinoma)	PEAKS056176
EXP060236	anti-MYC (AF3696, R&D systems)	Homo sapiens	Treatment: DMSO for 4 hrs;	EXP060234	70	normal	P01106	LNCaP (prostate carcinoma)	PEAKS056177
EXP060239	anti-Fra-1 (R-20,sc-605, Santa Cruz)	Homo sapiens		EXP060238	120	normal	P15407	BT-549 (breast invasive ductal carcinoma)	PEAKS056178
EXP060240	anti-DDX5 (ab21696, Abcam)	Homo sapiens		EXP060238	120	normal	P17844	BT-549 (breast invasive ductal carcinoma)	PEAKS056179
EXP060245	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: wildtype;	EXP060241	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	PEAKS056180
EXP060246	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: wildtype;	EXP060242	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	PEAKS056181
EXP060247	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: PWWP domain knockout;	EXP060243	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	PEAKS056182
EXP060248	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: PWWP domain knockout;	EXP060244	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	PEAKS056183
EXP060255	anti-p63	Homo sapiens		NULL	4232	normal	Q9H3D4	MCF10DCIS cells	PEAKS056184
EXP060256	anti-TCF7	Homo sapiens	Genotype: BRCA1 mutation;	EXP060249	4231	normal	P36402	breast organoids from normal woman	PEAKS056185
EXP060257	anti-TCF7	Homo sapiens	Genotype: BRCA1 mutation;	EXP060250	4231	normal	P36402	breast organoids from normal woman	PEAKS056186
EXP060258	anti-TCF7	Homo sapiens	Genotype: BRCA2 mutation;	EXP060251	4231	normal	P36402	breast organoids from normal woman	PEAKS056187
EXP060259	anti-TCF7	Homo sapiens	Genotype: BRCA2 mutation;	EXP060252	4231	normal	P36402	breast organoids from normal woman	PEAKS056188
EXP060260	anti-TCF7	Homo sapiens	Genotype: normal;	EXP060253	4231	normal	P36402	breast organoids from normal woman	PEAKS056189
EXP060261	anti-TCF7	Homo sapiens	Genotype: BRCA1 mutation;	EXP060254	4231	normal	P36402	breast organoids from normal woman	PEAKS056190
EXP060262	anti-p63	Homo sapiens		NULL	4231	normal	Q9H3D4	breast organoids from normal woman	PEAKS056191
EXP060263	anti-p63	Homo sapiens	Genotype: BRCA1-mut;	NULL	4231	normal	Q9H3D4	breast organoids from normal woman	PEAKS056192
EXP060264	anti-p63	Homo sapiens	Genotype: BRCA2-mut;	NULL	4231	normal	Q9H3D4	breast organoids from normal woman	PEAKS056193
EXP060266	anti-AR (Abcam, ab74272)	Homo sapiens	Treatment: DMSO for 16 hrs;	EXP060265	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056194
EXP060267	anti-AR (Abcam, ab74272)	Homo sapiens	Treatment: 10 uM UPF-1069 for 16 hrs;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056195
EXP060268	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: DMSO for 16 hrs;	EXP060265	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS056196
EXP060269	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: 10 uM UPF-1069 for 16 hrs;	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS056197
EXP060277	anti-ETO (Diagenode, C15310197)	Homo sapiens	Genotype: wildtype;	EXP060270	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056198
EXP060278	anti-TAF1 (Santa Cruz, sc-735)	Homo sapiens	Genotype: wildtype;	EXP060272	516	normal	P21675	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056199
EXP060279	anti-TAF1 (Santa Cruz, sc-735)	Homo sapiens	Genotype: wildtype;	EXP060273	516	normal	P21675	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056200
EXP060280	anti-TAF1 (Santa Cruz, sc-735)	Homo sapiens	Genotype: wildtype;	EXP060274	516	normal	P21675	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056201
EXP060281	anti-ETO (Diagenode, C15310197)	Homo sapiens	Genotype: wildtype;	EXP060275	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056202
EXP060282	anti-P300 (Diagenode, C15200211)	Homo sapiens	Genotype: wildtype;	EXP060271	516	normal	Q09472	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056203
EXP060283	anti-P300 (Santa Cruz sc-585)	Homo sapiens	Genotype: wildtype;	EXP060276	516	normal	Q09472	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056204
EXP060284	anti-ETO (polyclonal antibody (Diagenode, C15310197))	Homo sapiens	Genotype: shControl-AE;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056205
EXP060285	anti-ETO (polyclonal antibody (Diagenode, C15310197))	Homo sapiens	Genotype: shTAF1-AE;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056206
EXP060294	anti-BORIS	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060286	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056207
EXP060295	anti-BORIS	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060287	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056208
EXP060296	anti-CTCF	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060286	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056209
EXP060297	anti-CTCF	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060287	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056210
EXP060298	anti-SMC1	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060286	520	normal	Q14683	Kelly (neuroblastoma)	PEAKS056211
EXP060299	anti-SMC1	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060287	520	normal	Q14683	Kelly (neuroblastoma)	PEAKS056212
EXP060300	anti-BORIS	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060290	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056213
EXP060301	anti-BORIS	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060291	520	normal	Q8NI51	Kelly (neuroblastoma)	PEAKS056214
EXP060302	anti-CTCF	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060290	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056215
EXP060303	anti-CTCF	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060291	520	normal	P49711	Kelly (neuroblastoma)	PEAKS056216
EXP060304	anti-SMC1	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060290	520	normal	Q14683	Kelly (neuroblastoma)	PEAKS056217
EXP060305	anti-SMC1	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060291	520	normal	Q14683	Kelly (neuroblastoma)	PEAKS056218
EXP060309	anti-MYCN	Homo sapiens	Treatment: 1 uM TAE684 for 48 hrs; Conditions: tae response resistant;	EXP060307	520	normal	P04198	Kelly (neuroblastoma)	PEAKS056219
EXP060310	anti-MYCN	Homo sapiens	Treatment: 1 uM TAE684 for 48 hrs; Conditions: tae response resistant;	EXP060308	520	normal	P04198	Kelly (neuroblastoma)	PEAKS056220
EXP060311	anti-MYCN	Homo sapiens	Treatment: DMSO for 48 hrs; Conditions: tae response sensitive;	EXP060306	520	normal	P04198	Kelly (neuroblastoma)	PEAKS056221
EXP060316	anti-BORIS	Homo sapiens		EXP060312	2324	normal	Q8NI51	TC32 (Ewing's sarcoma)	PEAKS056222
EXP060317	anti-BORIS	Homo sapiens		EXP060313	2324	normal	Q8NI51	TC32 (Ewing's sarcoma)	PEAKS056223
EXP060318	anti-SMC1	Homo sapiens		EXP060312	2324	normal	Q14683	TC32 (Ewing's sarcoma)	PEAKS056224
EXP060319	anti-SMC1	Homo sapiens		EXP060313	2324	normal	Q14683	TC32 (Ewing's sarcoma)	PEAKS056225
EXP060320	anti-BORIS	Homo sapiens	Conditions: post-chemotherapy;	EXP060314	4233	normal	Q8NI51	TC-71(Ewing sarcoma cells)	PEAKS056226
EXP060321	anti-BORIS	Homo sapiens	Conditions: post-chemotherapy;	EXP060315	4233	normal	Q8NI51	TC-71(Ewing sarcoma cells)	PEAKS056227
EXP060322	anti-SMC1	Homo sapiens	Conditions: post-chemotherapy;	EXP060314	4233	normal	Q14683	TC-71(Ewing sarcoma cells)	PEAKS056228
EXP060323	anti-SMC1	Homo sapiens	Conditions: post-chemotherapy;	EXP060315	4233	normal	Q14683	TC-71(Ewing sarcoma cells)	PEAKS056229
EXP060328	anti-LIN9 (Bethyl A300-BL3981)	Mus musculus	Treatment: none;	EXP060324	4234	normal	Q8C735	KPL1 (Invasive ductal carcinoma)	PEAKS056230
EXP060329	anti-LIN9 (Bethyl A300-BL3981)	Mus musculus	Treatment: 10 nM 4-OHT for 72 hrs;	EXP060325	4234	normal	Q8C735	KPL1 (Invasive ductal carcinoma)	PEAKS056231
EXP060330	anti-YAP (Novus NB110-58358)	Mus musculus	Treatment: none;	EXP060324	4234	normal	P46938	KPL1 (Invasive ductal carcinoma)	PEAKS056232
EXP060331	anti-YAP (Novus NB110-58358)	Mus musculus	Treatment: 10 nM 4-OHT for 72 hrs;	EXP060325	4234	normal	P46938	KPL1 (Invasive ductal carcinoma)	PEAKS056233
EXP060332	anti-LIN9 (Bethyl A300-BL3981)	Homo sapiens	Treatment: none;	EXP060326	583	normal	Q5TKA1	MCF10A (breast epithelial cells)	PEAKS056234
EXP060333	anti-LIN9 (Bethyl A300-BL3981)	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	EXP060327	583	normal	Q5TKA1	MCF10A (breast epithelial cells)	PEAKS056235
EXP060334	anti-YAP (Novus NB110-58358)	Homo sapiens	Treatment: none;	EXP060326	583	normal	P46937	MCF10A (breast epithelial cells)	PEAKS056236
EXP060335	anti-YAP (Novus NB110-58358)	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	NULL	583	normal	P46937	MCF10A (breast epithelial cells)	PEAKS056237
EXP060336	anti-B-MYB (Santa Cruz sc-724)	Homo sapiens	Treatment: none;	EXP060326	583	normal	P10244	MCF10A (breast epithelial cells)	PEAKS056238
EXP060337	anti-B-MYB (Santa Cruz sc-724)	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	EXP060327	583	normal	P10244	MCF10A (breast epithelial cells)	PEAKS056239
EXP060344	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: N/A;	EXP060338	4235	normal	P49711	T cells from peripheral blood	PEAKS056240
EXP060345	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: N/A;	EXP060339	4236	normal	P49711	T-ALL cells from peripheral blood	PEAKS056241
EXP060346	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: N/A;	EXP060340	4236	normal	P49711	T-ALL cells from peripheral blood	PEAKS056242
EXP060347	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: DMSO treatment;	EXP060341	509	normal	P49711	Jurkat (T-cells)	PEAKS056243
EXP060348	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: DMSO treatment;	EXP060342	199	normal	P49711	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS056244
EXP060349	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: 1 uM gSI treatment for 72 hrs;	EXP060343	199	normal	P49711	CUTLL1 (T-cell lymphoblastic lymphoma 1)	PEAKS056245
EXP060350	anti-HDAC2  (Abcam cat7029 lotGR88809-14 pAb)	Homo sapiens	Treatment: untreated;	NULL	980	normal	Q92769	RH4 (alveolar rhabdomyosarcoma)	PEAKS056246
EXP060351	anti-Sox8 (Abcam, ab104245, rabbit pAb)	Homo sapiens	Treatment: untreated;	NULL	980	normal	P57073	RH4 (alveolar rhabdomyosarcoma)	PEAKS056247
EXP060352	anti-HDAC2  (Abcam cat7029 lotGR88809-14 pAb)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	Q92769	RH4 (alveolar rhabdomyosarcoma)	PEAKS056248
EXP060353	anti-HDAC2  (Abcam cat7029 lotGR88809-14 pAb)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	Q92769	RH4 (alveolar rhabdomyosarcoma)	PEAKS056249
EXP060354	Anti-HDAC1( Abcam, ab7028)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	Q13547	RH4 (alveolar rhabdomyosarcoma)	PEAKS056250
EXP060355	anti-YY-1 antibody (ab109237)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P25490	RH4 (alveolar rhabdomyosarcoma)	PEAKS056251
EXP060356	anti-YY-1 antibody (ab109237)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P25490	RH4 (alveolar rhabdomyosarcoma)	PEAKS056252
EXP060357	anti-HDAC3 (Abcam, ab7030)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	O15379	RH4 (alveolar rhabdomyosarcoma)	PEAKS056253
EXP060358	anti-HDAC3 (Abcam, ab7030)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	O15379	RH4 (alveolar rhabdomyosarcoma)	PEAKS056254
EXP060359	MYOD SantaCruz (M-318) sc-760	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P15172	RH4 (alveolar rhabdomyosarcoma)	PEAKS056255
EXP060360	MYOD SantaCruz (M-318) sc-760	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P15172	RH4 (alveolar rhabdomyosarcoma)	PEAKS056256
EXP060361	anti-SOX8 (Abcam, ab104245)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P57073	RH4 (alveolar rhabdomyosarcoma)	PEAKS056257
EXP060362	anti-SOX8 (Abcam, ab104245)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P57073	RH4 (alveolar rhabdomyosarcoma)	PEAKS056258
EXP060363	anti-MYOG (Thermo, cat # MA1-41042)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P15173	RH4 (alveolar rhabdomyosarcoma)	PEAKS056259
EXP060364	anti-MYOG (Thermo, cat # MA1-41042)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P15173	RH4 (alveolar rhabdomyosarcoma)	PEAKS056260
EXP060365	anti-Rad21 (Santa Cruz, ChIP Grade ab992)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	O60216	RH4 (alveolar rhabdomyosarcoma)	PEAKS056261
EXP060366	anti-Rad21 (Santa Cruz, ChIP Grade ab992)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	O60216	RH4 (alveolar rhabdomyosarcoma)	PEAKS056262
EXP060368	anti-ARID4B antibody (CAT#: A302-233A, LOT#: A302-233A-1,Bethyl Laboratories)	Homo sapiens		EXP060367	725	normal	Q4LE39	PC3(bone mets prostate adenocarcinoma)	PEAKS056263
EXP060380	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	EXP060369	396	normal	P49711	WA09 (embryonic stem cells)	PEAKS056264
EXP060381	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	EXP060370	396	normal	P49711	WA09 (embryonic stem cells)	PEAKS056265
EXP060382	anti-CTCF	Homo sapiens	Time point: day 5; Genotype: expressing a H2B-GFP fusion protein;	EXP060372	4238	normal	P49711	WA09 derived cardiac mesoderm	PEAKS056266
EXP060383	anti-CTCF	Homo sapiens	Time point: day 5; Genotype: expressing a H2B-GFP fusion protein;	EXP060373	4238	normal	P49711	WA09 derived cardiac mesoderm	PEAKS056267
EXP060384	anti-CTCF	Homo sapiens	Time point: day 7; Genotype: expressing a H2B-GFP fusion protein;	EXP060374	4239	normal	P49711	WA09 derived cardiac progenitor cells	PEAKS056268
EXP060385	anti-CTCF	Homo sapiens	Time point: day 7; Genotype: expressing a H2B-GFP fusion protein;	EXP060375	4239	normal	P49711	WA09 derived cardiac progenitor cells	PEAKS056269
EXP060386	anti-CTCF	Homo sapiens	Time point: day 15; Genotype: expressing a H2B-GFP fusion protein;	EXP060376	4240	normal	P49711	WA09 derived primitive cardiomyocite	PEAKS056270
EXP060387	anti-CTCF	Homo sapiens	Time point: day 15; Genotype: expressing a H2B-GFP fusion protein;	EXP060377	4240	normal	P49711	WA09 derived primitive cardiomyocite	PEAKS056271
EXP060388	anti-CTCF	Homo sapiens	Time point: day 80; Genotype: expressing a H2B-GFP fusion protein;	EXP060378	4241	normal	P49711	WA09 derived ventricular cardiomyocyte	PEAKS056272
EXP060389	anti-SMC3	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	EXP060379	396	normal	Q9UQE7	WA09 (embryonic stem cells)	PEAKS056273
EXP060390	anti-CTCF	Homo sapiens	Time point: day 2; Genotype: expressing a H2B-GFP fusion protein;	EXP060371	4237	normal	P49711	WA09 derived mesoderm	PEAKS056274
EXP060393	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: DMSO 48hrs;	EXP060391	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056275
EXP060394	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056276
EXP060395	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056277
EXP060396	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056278
EXP060397	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: DMSO 48hrs;	EXP060391	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056279
EXP060398	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056280
EXP060399	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056281
EXP060400	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056282
EXP060401	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: NTsiRNA 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056283
EXP060402	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2AsiRNA 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056284
EXP060403	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2BsiRNA 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056285
EXP060404	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: control siRNA and 100nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056286
EXP060405	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2AsiRNA and 100nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056287
EXP060406	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2BsiRNA and 100nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056288
EXP060407	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: DMSO 48hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	PEAKS056289
EXP060408	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	PEAKS056290
EXP060409	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	PEAKS056291
EXP060410	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	PEAKS056292
EXP060411	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: control siRNA 48 hrs; 	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	PEAKS056293
EXP060412	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2B siRNA 48hrs;	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	PEAKS056294
EXP060413	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treament: control siRNA and 500nM JQ1 48hrs;	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	PEAKS056295
EXP060414	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2B and 500nM JQ1 48hrs;	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	PEAKS056296
EXP060415	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: DMSO 48hrs rDNA;	EXP060392	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056297
EXP060416	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs rDNA;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056298
EXP060417	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs rDNA;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056299
EXP060418	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs rDNA;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	PEAKS056300
EXP060419	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: DMSO 48hrs rDNA;	EXP060392	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056301
EXP060420	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs rDNA;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056302
EXP060421	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs rDNA;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056303
EXP060422	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs rDNA;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	PEAKS056304
EXP060423	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: DMSO 48hrs;	EXP060391	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	PEAKS056305
EXP060424	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	PEAKS056306
EXP060425	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	PEAKS056307
EXP060426	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	PEAKS056308
EXP060433	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060427	233	normal	Q99JF8	E14TG2A (embryonic stem cells)	PEAKS056309
EXP060434	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: wildtype; Time point: 5 days;	EXP060428	4242	normal	Q99JF8	E14Tga2 derived embryoid bodies	PEAKS056310
EXP060435	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060427	233	normal	Q3UMU9	E14TG2A (embryonic stem cells)	PEAKS056311
EXP060436	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: wildtype; Time point: 5 days;	EXP060428	4242	normal	Q3UMU9	E14Tga2 derived embryoid bodies	PEAKS056312
EXP060437	anti-SPT16(Cell Signaling, #12191)	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060427	233	normal	Q920B9	E14TG2A (embryonic stem cells)	PEAKS056313
EXP060438	SPT16, Cell Signaling, #12191	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060428	4242	normal	Q920B9	E14Tga2 derived embryoid bodies	PEAKS056314
EXP060439	anti-FLAG (Sigma, #A2220)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	2615	normal	O75475	293T-Rex	PEAKS056315
EXP060440	anti-FLAG (Sigma, #A2220)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	2615	normal	Q7Z4V5	293T-Rex	PEAKS056316
EXP060441	anti-SPT16 (Cell Signaling, #12191)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	EXP060429	2615	normal	Q9Y5B9	293T-Rex	PEAKS056317
EXP060442	anti-HDGF2 (Proteintech, #15134-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	EXP060431	467	normal	Q7Z4V5	myoblasts	PEAKS056318
EXP060443	anti-HDGF2 (Proteintech, #15134-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	EXP060432	918	normal	Q7Z4V5	myotube	PEAKS056319
EXP060444	anti-LEDGF (Proteintech, #25504-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	467	normal	O75475	myoblasts	PEAKS056320
EXP060445	anti-LEDGF (Proteintech, #25504-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	918	normal	O75475	myotube	PEAKS056321
EXP060446	anti-SPT16 (Cell Signaling, #12191)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	467	normal	Q9Y5B9	myoblasts	PEAKS056322
EXP060447	anti-SPT16 (Cell Signaling, #12191)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	918	normal	Q9Y5B9	myotube	PEAKS056323
EXP060448	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	NULL	233	normal	Q3UMU9	E14TG2A (embryonic stem cells)	PEAKS056324
EXP060449	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: HDGF2 knockout; Time point: 0 days;	NULL	233	normal	Q3UMU9	E14TG2A (embryonic stem cells)	PEAKS056325
EXP060450	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	NULL	233	normal	Q99JF8	E14TG2A (embryonic stem cells)	PEAKS056326
EXP060451	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: LEDGF knockout; Time point: 0 days;	NULL	233	normal	Q99JF8	E14TG2A (embryonic stem cells)	PEAKS056327
EXP060463	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP-N-Myc;	EXP060452	70	normal	P04198	LNCaP (prostate carcinoma)	PEAKS056328
EXP060464	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP-N-Myc;	EXP060453	70	normal	P04198	LNCaP (prostate carcinoma)	PEAKS056329
EXP060465	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP-N-Myc;	EXP060454	70	normal	P04198	LNCaP (prostate carcinoma)	PEAKS056330
EXP060466	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP-N-Myc;	EXP060455	70	normal	P04198	LNCaP (prostate carcinoma)	PEAKS056331
EXP060467	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: wildtype;	EXP060456	70	normal	P04198	LNCaP (prostate carcinoma)	PEAKS056332
EXP060468	MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: wildtype;	EXP060457	70	normal	P04198	LNCaP (prostate carcinoma)	PEAKS056333
EXP060469	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: castrated;  Genotype: 22Rv1-xeno N-Myc;	EXP060458	4243	normal	P04198	22Rv1 xenografts	PEAKS056334
EXP060470	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: castrated;  Genotype: 22Rv1-xeno N-Myc;	EXP060459	4243	normal	P04198	22Rv1 xenografts	PEAKS056335
EXP060471	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: Intact;  Genotype: 22Rv1-xeno N-Myc;	EXP060460	4243	normal	P04198	22Rv1 xenografts	PEAKS056336
EXP060472	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: Intact;  Genotype: 22Rv1-xeno N-Myc;	EXP060461	4243	normal	P04198	22Rv1 xenografts	PEAKS056337
EXP060473	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens		EXP060462	4244	normal	P04198	PM154 organoids	PEAKS056338
EXP060474	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP NMYC;	EXP060452	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS056339
EXP060475	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP NMYC;	EXP060454	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS056340
EXP060476	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP wildtype;	EXP060456	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS056341
EXP060477	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP wildtype;	EXP060457	70	normal	Q92826	LNCaP (prostate carcinoma)	PEAKS056342
EXP060478	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: DHT; Genotype: LNCaP NMYC;	EXP060452	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS056343
EXP060479	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP NMYC;	EXP060454	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS056344
EXP060482	anti-AR	Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056345
EXP060483	anti-CHD1	Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	normal	O14646	LNCaP (prostate carcinoma)	PEAKS056346
EXP060484	anti-cMyc	Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	normal	Q16158	LNCaP (prostate carcinoma)	PEAKS056347
EXP060485	anti-AR	Homo sapiens	Treatment: 10nM DHT 3 hours, sgCHD1; Genotype: CHD1 knockout;	EXP060481	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056348
EXP060486	anti-AR	Homo sapiens	Treatment: 10nM DHT 3 hours, sgControl; Genotype: sgControl;	EXP060480	70	bio_control	P10275	LNCaP (prostate carcinoma)	PEAKS056349
EXP060488	anti-ETV6 (HPA000264, Sigma Aldrich)	Homo sapiens		EXP060487	1205	normal	P41212	Reh (ATCC CRL-8286)	PEAKS056350
EXP060489	anti-RUNX1 (ab23980, Abcam)	Homo sapiens		EXP060487	1205	normal	Q01196	Reh (ATCC CRL-8286)	PEAKS056351
EXP060497	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: N/A;	EXP060490	541	normal	P49711	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056352
EXP060498	anti-FLI1 (Abcam ab15289)	Homo sapiens	Treatment: N/A;	EXP060491	541	normal	Q01543	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056353
EXP060499	anti-RUNX2 (CST 8486/1)	Homo sapiens	Treatment: N/A;	EXP060492	541	normal	Q13950	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056354
EXP060500	anti-SPI1 (CST 2258/1)	Homo sapiens	Treatment: N/A;	EXP060493	541	normal	P17947	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056355
EXP060501	anti-ELF1 (Bethyl A301-443A)	Homo sapiens	Treatment: N/A;	EXP060494	541	normal	P32519	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056356
EXP060502	anti-ERG (CST 97249)	Homo sapiens	Treatment: N/A;	EXP060495	541	normal	P11308	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056357
EXP060503	anti-MYB (Abcam ab109127)	Homo sapiens	Treatment: N/A;	EXP060496	541	normal	P10242	SEM (childhood B acute lymphoblastic leukemia)	PEAKS056358
EXP060505	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: Vehicle for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056359
EXP060506	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: E2 for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056360
EXP060507	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: Fulvestrant for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056361
EXP060508	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: 4OH Tamoxifen for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056362
EXP060509	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: GDC-0927 for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056363
EXP060510	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: GNE-274 for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056364
EXP060515	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: control;	EXP060511	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	PEAKS056365
EXP060516	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: control;	EXP060512	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	PEAKS056366
EXP060517	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: 100 uM L-kynurenine for 1 hr;	EXP060513	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	PEAKS056367
EXP060518	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: 100 uM L-kynurenine for 1 hr;	EXP060514	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	PEAKS056368
EXP060521	anti-Lamin A/C (Abcam ab8984)	Homo sapiens	Genotype:LMNA WT/Corr-WT; Time point: day 40 of differentiation; 	EXP060519	4259	normal	P02545	iPSC derived cardiomyocytes	PEAKS056369
EXP060522	anti-Lamin A/C (Abcam ab8984)	Homo sapiens	Genotype:LMNA WT/MT; Time point: day 40 of differentiation; 	EXP060520	4259	normal	P02545	iPSC derived cardiomyocytes	PEAKS056370
EXP060523	anti-Lamin A/C (Santa Cruz Biotechnology sc-376248)	Homo sapiens	Genotype:LMNA WT/Corr-WT; Time point: day 40 of differentiation; 	EXP060519	4259	normal	P02545	iPSC derived cardiomyocytes	PEAKS056371
EXP060524	anti-Lamin A/C (Santa Cruz Biotechnology sc-376248)	Homo sapiens	Genotype:LMNA WT/MT; Time point: day 40 of differentiation; 	EXP060520	4259	normal	P02545	iPSC derived cardiomyocytes	PEAKS056372
EXP060525	anti-CEBPA (Santa Cruz sc-61, lot#J0407)	Mus musculus	Strain: C57BL/6; Tissue: Whole bone marrow, cKIT enriched, FACs isolated;	NULL	4260	normal	P53566	p30-GMP-blast cells from bone marrow	PEAKS056373
EXP060526	anti-CEBPA (Santa Cruz sc-61, lot#J0407)	Mus musculus	Strain: C57BL/6; Tissue: Whole bone marrow, cKIT enriched, FACs isolated;	NULL	103	normal	P53566	bone marrow	PEAKS056374
EXP060529	anti-REST (17-641, Millipore)	Homo sapiens		EXP060527	70	normal	Q13127	LNCaP (prostate carcinoma)	PEAKS056375
EXP060530	anti-REST (17-641, Millipore)	Homo sapiens		EXP060528	70	normal	Q13127	LNCaP (prostate carcinoma)	PEAKS056376
EXP060533	Anti-ELK1 antibody( E277, abcam,ab32106)	Homo sapiens	Conditions: control;	EXP060531	4261	normal	P19419	dermal skin	PEAKS056377
EXP060534	Anti-ELK1 antibody( E277, abcam,ab32106)	Homo sapiens	Conditions: mechanic loading;	EXP060532	4261	normal	P19419	dermal skin	PEAKS056378
EXP060536	anti-MYBL2 antibody (monoclonal rabbit, Abcam, ref: 76009)	Homo sapiens		EXP060535	288	normal	P10244	A673 (Ewing sarcoma)	PEAKS056379
EXP060539	anti-ARID1A (rabbit, Abcam, cat. no. ab182560)	Homo sapiens	Genotype: wildtype;	EXP060537	2235	normal	O14497	RMG-1	PEAKS056380
EXP060540	anti-CAP-H2 (rabbit Bethyl, cat. no. A302-276A)	Homo sapiens	Genotype: wildtype;	EXP060537	2235	normal	Q6IBW4	RMG-1	PEAKS056381
EXP060541	anti-CAP-H2 (rabbit Bethyl, cat. no. A302-276A)	Homo sapiens	Genotype: ARID1A knockout;	EXP060538	2235	normal	Q6IBW4	RMG-1	PEAKS056382
EXP060542	anti-SNF5 (rabbit , Bethyl, cat. no. A301-087A)	Homo sapiens	Genotype: wildtype;	EXP060537	2235	normal	Q12824	RMG-1	PEAKS056383
EXP060543	anti-SNF5 (rabbit , Bethyl, cat. no. A301-087A)	Homo sapiens	Genotype: ARID1A knockout;	EXP060538	2235	normal	Q12824	RMG-1	PEAKS056384
EXP060566		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	normal	A0A023T4K3	whole worms(developmental stage L4)	PEAKS056385
EXP060567		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	normal	A0A023T4K3	whole worms(developmental stage L4)	PEAKS056386
EXP060568	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060548	2193	normal	G5EDU7	whole worms(developmental stage L4)	PEAKS056387
EXP060569	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060549	2193	normal	G5EDU7	whole worms(developmental stage L4)	PEAKS056388
EXP060570	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060550	2193	normal	G5EDU7	whole worms(developmental stage L4)	PEAKS056389
EXP060571	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060551	2193	normal	G5EDU7	whole worms(developmental stage L4)	PEAKS056390
EXP060574	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF746;	EXP060572	10	normal	Q6NUN9	HEK293T (embryonic kidney)	PEAKS056391
EXP060575	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF213;	EXP060572	10	normal	O14771	HEK293T (embryonic kidney)	PEAKS056392
EXP060576	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF256;	EXP060572	10	normal	Q9Y2P7	HEK293T (embryonic kidney)	PEAKS056393
EXP060577	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZKSCAN8;	EXP060572	10	normal	Q15776	HEK293T (embryonic kidney)	PEAKS056394
EXP060578	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF20;	EXP060572	10	normal	P17024	HEK293T (embryonic kidney)	PEAKS056395
EXP060579	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF597;	EXP060572	10	normal	Q96LX8	HEK293T (embryonic kidney)	PEAKS056396
EXP060580	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF215;	EXP060572	10	normal	Q9UL58	HEK293T (embryonic kidney)	PEAKS056397
EXP060581	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF746_Ti;	EXP060573	10	normal	Q6NUN9	HEK293T (embryonic kidney)	PEAKS056398
EXP060598	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060582	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056399
EXP060599	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060583	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056400
EXP060600	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060584	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056401
EXP060601	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060585	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056402
EXP060602	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060586	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056403
EXP060603	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060587	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056404
EXP060604	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060588	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056405
EXP060605	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060589	514	normal	P25440	K562 (myelogenous leukemia)	PEAKS056406
EXP060606	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060590	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056407
EXP060607	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060591	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056408
EXP060608	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060592	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056409
EXP060609	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060593	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056410
EXP060610	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060594	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056411
EXP060611	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060595	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056412
EXP060612	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060596	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056413
EXP060613	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060597	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056414
EXP060614	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060582	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056415
EXP060615	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060583	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056416
EXP060616	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060584	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056417
EXP060617	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060585	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056418
EXP060618	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060586	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056419
EXP060619	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060587	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056420
EXP060620	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060588	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056421
EXP060621	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060589	514	normal	Q15059	K562 (myelogenous leukemia)	PEAKS056422
EXP060622	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060590	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056423
EXP060623	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060591	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056424
EXP060624	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060592	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056425
EXP060625	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060593	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056426
EXP060626	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060594	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056427
EXP060627	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060595	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056428
EXP060628	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060596	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056429
EXP060629	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060597	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056430
EXP060630	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060582	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056431
EXP060631	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060583	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056432
EXP060632	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060584	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056433
EXP060633	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060585	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056434
EXP060634	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060586	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056435
EXP060635	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060587	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056436
EXP060636	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060588	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056437
EXP060637	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060589	514	normal	O60885	K562 (myelogenous leukemia)	PEAKS056438
EXP060638	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060590	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056439
EXP060639	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060591	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056440
EXP060640	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060592	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056441
EXP060641	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060593	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056442
EXP060642	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060594	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056443
EXP060643	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060595	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056444
EXP060644	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060596	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056445
EXP060645	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060597	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	PEAKS056446
EXP060646	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	PEAKS056447
EXP060647	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	PEAKS056448
EXP060648	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment: treated with stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	PEAKS056449
EXP060649	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment:Resting;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	PEAKS056450
EXP060650	anti-SMC1 (Bethyl Laboratories A300-055A)	Homo sapiens	IFNg-LPS	NULL	4262	normal	Q14683	monocyte-derived macrophages from peripheral blood	PEAKS056451
EXP060651	anti-SMC1 (Bethyl Laboratories A300-055A)	Homo sapiens	Treatment: treated with stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	Q14683	monocyte-derived macrophages from peripheral blood	PEAKS056452
EXP060652	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: IL10;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	PEAKS056453
EXP060653	anti-CEBPB (Santa Cruz sc-150)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P17676	monocyte-derived macrophages from peripheral blood	PEAKS056454
EXP060654	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P17947	monocyte-derived macrophages from peripheral blood	PEAKS056455
EXP060655	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	PEAKS056456
EXP060656	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	PEAKS056457
EXP060657	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment:Resting;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	PEAKS056458
EXP060658	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: treated with stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	PEAKS056459
EXP060671	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	EXP060659	113	normal	Q05925	MCF7 (Invasive ductal breast carcinoma)	PEAKS056460
EXP060672	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	EXP060660	4263	normal	Q05925	SUM149PT (Inflammatory breast carcinoma)	PEAKS056461
EXP060673	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	EXP060661	817	normal	Q05925	SUM159PT (Triple negative breast cancer)	PEAKS056462
EXP060674	anti-CTNNB1	Homo sapiens	Genotype: EN1 overexpression;	EXP060662	113	normal	P35222	MCF7 (Invasive ductal breast carcinoma)	PEAKS056463
EXP060675	anti-CTNNB1	Homo sapiens	Genotype: LacZ control;	EXP060667	113	normal	P35222	MCF7 (Invasive ductal breast carcinoma)	PEAKS056464
EXP060676	anti-CTNNB1	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, no doxycycline;	EXP060664	4263	normal	P35222	SUM149PT (Inflammatory breast carcinoma)	PEAKS056465
EXP060677	anti-CTNNB1	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, doxycycline for 24 hrs;	EXP060665	4263	normal	P35222	SUM149PT (Inflammatory breast carcinoma)	PEAKS056466
EXP060678	anti-TLE3	Homo sapiens	Genotype: EN1 over-expression;	EXP060662	113	normal	Q04726	MCF7 (Invasive ductal breast carcinoma)	PEAKS056467
EXP060679	anti-TLE3	Homo sapiens	Genotype: LacZ control;	EXP060663	113	normal	Q04726	MCF7 (Invasive ductal breast carcinoma)	PEAKS056468
EXP060680	anti-TLE3	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, no doxycycline;	EXP060664	4263	normal	Q04726	SUM149PT (Inflammatory breast carcinoma)	PEAKS056469
EXP060681	anti-TLE3	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, doxycycline for 24 hrs;	EXP060665	4263	normal	Q04726	SUM149PT (Inflammatory breast carcinoma)	PEAKS056470
EXP060682	anti-TLE3	Homo sapiens	Treatment: no doxycycline;	EXP060669	817	normal	Q04726	SUM159PT (Triple negative breast cancer)	PEAKS056471
EXP060683	anti-TLE3	Homo sapiens	Treatment: doxycycline;	EXP060670	817	normal	Q04726	SUM159PT (Triple negative breast cancer)	PEAKS056472
EXP060684	anti-FOXA1	Homo sapiens	Genotype: EN1 over-expression;	EXP060662	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS056473
EXP060685	anti-FOXA1	Homo sapiens	Genotype: LacZ control;	EXP060663	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS056474
EXP060686	anti-EN1	Homo sapiens	Genotype: EN1 overexpression;	NULL	113	normal	Q05925	MCF7 (Invasive ductal breast carcinoma)	PEAKS056475
EXP060687	anti-EN1	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	4263	normal	Q05925	SUM149PT (Inflammatory breast carcinoma)	PEAKS056476
EXP060688	anti-EN1	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	817	normal	Q05925	SUM159PT (Triple negative breast cancer)	PEAKS056477
EXP060689	anti-CBX8 (C15410333, Diagenode)	Homo sapiens	Treatment: untreated;	NULL	514	normal	Q9HC52	K562 (myelogenous leukemia)	PEAKS056478
EXP060690	anti-CBX8 (C15410333, Diagenode)	Homo sapiens	Conditions: 1hr, 44C (heat shock);	NULL	514	normal	Q9HC52	K562 (myelogenous leukemia)	PEAKS056479
EXP060691	anti-GFP (ab290, Abcam)	Homo sapiens	Treatment: untreated;	NULL	514	normal	Q14781	K562 (myelogenous leukemia)	PEAKS056480
EXP060692	anti-GFP (ab290, Abcam)	Homo sapiens	Conditions: 1hr, 44C (heat shock);	NULL	514	normal	Q14781	K562 (myelogenous leukemia)	PEAKS056481
EXP060701	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Treatment: APR 48 hrs; Genotype: Med14Nsmash;	NULL	178	normal	Q7TN02	CH12 (lymphoma)	PEAKS056482
EXP060702	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: APR 60 hrs; Genotype: Med14Nsmash;	EXP060693	178	normal	Q61550	CH12 (lymphoma)	PEAKS056483
EXP060703	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q61164	CH12 (lymphoma)	PEAKS056484
EXP060704	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q61164	CH12 (lymphoma)	PEAKS056485
EXP060705	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q7TN02	CH12 (lymphoma)	PEAKS056486
EXP060706	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q7TN02	CH12 (lymphoma)	PEAKS056487
EXP060707	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q6KCD5	CH12 (lymphoma)	PEAKS056488
EXP060708	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q6KCD5	CH12 (lymphoma)	PEAKS056489
EXP060709	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q61550	CH12 (lymphoma)	PEAKS056490
EXP060710	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q61550	CH12 (lymphoma)	PEAKS056491
EXP060711	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q61164	CH12 (lymphoma)	PEAKS056492
EXP060712	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q61164	CH12 (lymphoma)	PEAKS056493
EXP060713	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: wildtype; Treatment: APR 48 hrs;	NULL	178	normal	Q7TN02	CH12 (lymphoma)	PEAKS056494
EXP060714	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q7TN02	CH12 (lymphoma)	PEAKS056495
EXP060715	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q7TN02	CH12 (lymphoma)	PEAKS056496
EXP060716	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q6KCD5	CH12 (lymphoma)	PEAKS056497
EXP060717	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q6KCD5	CH12 (lymphoma)	PEAKS056498
EXP060718	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: wildtype; Treatment: APR 60 hrs;	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS056499
EXP060719	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q61550	CH12 (lymphoma)	PEAKS056500
EXP060720	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q61550	CH12 (lymphoma)	PEAKS056501
EXP060721	anti-Med26 (Cell signalling technologies, 13641S)	Homo sapiens	Treatment: auxin; Genotype: Rad21Degron;	EXP060699	417	normal	O95402	HCT-116 (colon carcinoma)	PEAKS056502
EXP060722	anti-Med26 (Cell signalling technologies, 13641S)	Homo sapiens	Treatment: untreated; Genotype: Rad21Degron;	EXP060700	417	normal	O95402	HCT-116 (colon carcinoma)	PEAKS056503
EXP060723	anti-Rad21 (Abcam, ab992)	Homo sapiens	Treatment: auxin; Genotype: Rad21Degron;	EXP060699	417	normal	O60216	HCT-116 (colon carcinoma)	PEAKS056504
EXP060724	anti-Rad21 (Abcam, ab992)	Homo sapiens	Treatment: untreated; Genotype: Rad21Degron;	EXP060700	417	normal	O60216	HCT-116 (colon carcinoma)	PEAKS056505
EXP060728	anti-CTCF (CST #3418; lot 1)	Homo sapiens	Donor: G523;	EXP060725	332	normal	P49711	glioblastoma cells	PEAKS056506
EXP060729	anti-CTCF (CST #3418; lot 1)	Homo sapiens	Donor: G567;	EXP060726	332	normal	P49711	glioblastoma cells	PEAKS056507
EXP060730	anti-CTCF (CST #3418; lot 1)	Homo sapiens	Donor: G583;	EXP060727	332	normal	P49711	glioblastoma cells	PEAKS056508
EXP060731	anti-YY1 (Santa Cruz sc-7341, 1:100)	Mus musculus	Genotype: wildtype;	NULL	2	normal	Q00899	mESCs (mouse embryonic stem cells)	PEAKS056509
EXP060732	anti-YY1 (Santa Cruz sc-7341, 1:100)	Mus musculus	Genotype: Tet1/2/3 triple knockout;	NULL	2	normal	Q00899	mESCs (mouse embryonic stem cells)	PEAKS056510
EXP060735	anti-TRF1 (GeneTex, cat#32935)	Homo sapiens	Treatment: iciHHV6 infected;	EXP060733	1186	normal	P54274	smooth muscle cell	PEAKS056511
EXP060736	anti-TRF1 (GeneTex, cat#32935)	Homo sapiens	Treatment: HHV6 infected;	EXP060734	421	normal	P54274	HEK293 (embryonic kidney)	PEAKS056512
EXP060737	anti-TRF2 (GeneTex, cat#13579)	Homo sapiens	Treatment: iciHHV6 infected;	EXP060733	1186	normal	P62380	smooth muscle cell	PEAKS056513
EXP060738	anti-TRF2 (GeneTex, cat#13579)	Homo sapiens	Treatment: HHV6 infected;	EXP060734	421	normal	P62380	HEK293 (embryonic kidney)	PEAKS056514
EXP060739	anti-CTCF	Homo sapiens	Treatment: pLV dCas9-KRAB;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	PEAKS056515
EXP060740	anti-CTCF	Homo sapiens	Treatment: pLV dCas9-KRAB + P1 gRNA;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	PEAKS056516
EXP060741	anti-CTCF	Homo sapiens	Treatment: dCas9-Dnmt3a3l + P3 gRNA;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	PEAKS056517
EXP060742	anti-CTCF	Homo sapiens	Treatment: dCas9-Dnmt3a3l + KRAB-dCas9 + P1 + P3 gRNA;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	PEAKS056518
EXP060743	anti-CTCF	Homo sapiens	Treatment: control;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	PEAKS056519
EXP060745	anti-HNRNPK (Bethyl Laboratories A300-674A)	Homo sapiens	Genotype: wildtype; Tissue: Neonatal foreskin;	EXP060744	3363	normal	P61978	primary epidermal keratinocytes	PEAKS056520
EXP060767	SMARCA2 (Bethyl A301-015A)	Homo sapiens	Genotype: wildtype;	EXP060746	887	normal	P51531	neural progenitors	PEAKS056521
EXP060768	SMARCA2 (Bethyl A301-015A)	Homo sapiens	Genotype: K755R/+;	EXP060747	887	normal	P51531	neural progenitors	PEAKS056522
EXP060769	SMARCA2 (Bethyl A301-015A)	Homo sapiens	Genotype: R1159Q/+;	EXP060748	887	normal	P51531	neural progenitors	PEAKS056523
EXP060770	FOSL2 (Cell signaling Technology 19967)	Homo sapiens	Genotype: wildtype;	EXP060749	887	normal	P15408	neural progenitors	PEAKS056524
EXP060771	FOSL2 (Cell signaling Technology 19967)	Homo sapiens	Genotype: K755R/+;	EXP060750	887	normal	P15408	neural progenitors	PEAKS056525
EXP060772	FOSL2 (Cell signaling Technology 19967)	Homo sapiens	Genotype: R1159Q/+;	EXP060751	887	normal	P15408	neural progenitors	PEAKS056526
EXP060773	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: wildtype;	EXP060752	887	normal	P51532	neural progenitors	PEAKS056527
EXP060774	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: K755R/+;	EXP060753	887	normal	P51532	neural progenitors	PEAKS056528
EXP060775	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: R1159Q/+;	EXP060754	887	normal	P51532	neural progenitors	PEAKS056529
EXP060776	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: wildtype;	EXP060755	887	normal	P51532	neural progenitors	PEAKS056530
EXP060777	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: K755R/+;	EXP060756	887	normal	P51532	neural progenitors	PEAKS056531
EXP060778	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: R1159Q/+;	EXP060757	887	normal	P51532	neural progenitors	PEAKS056532
EXP060779	anti-SMARCA2 (Abcam ab15597)	Homo sapiens	Genotype: wildtype;	EXP060755	887	normal	P51531	neural progenitors	PEAKS056533
EXP060780	anti-SMARCA2 (Abcam ab15597)	Homo sapiens	Genotype: K755R/+;	EXP060756	887	normal	P51531	neural progenitors	PEAKS056534
EXP060781	anti-SMARCA2 (Abcam ab15597)	Homo sapiens	Genotype: R1159Q/+;	EXP060757	887	normal	P51531	neural progenitors	PEAKS056535
EXP060782	anti-SOX2 (Cell signaling Technology 5024S)	Homo sapiens	Genotype: wildtype;	EXP060758	887	normal	P48431	neural progenitors	PEAKS056536
EXP060783	anti-SOX2 (Cell signaling Technology 5024S)	Homo sapiens	Genotype: K755R/+;	EXP060759	887	normal	P48431	neural progenitors	PEAKS056537
EXP060784	anti-SOX2 (Cell signaling Technology 5024S)	Homo sapiens	Genotype: R1159Q/+;	EXP060760	887	normal	P48431	neural progenitors	PEAKS056538
EXP060785	anti-SOX3 (Novus biology AF2569)	Homo sapiens	Genotype: wildtype;	EXP060758	887	normal	P41225	neural progenitors	PEAKS056539
EXP060786	anti-SOX3 (Novus biology AF2569)	Homo sapiens	Genotype: K755R/+;	EXP060759	887	normal	P41225	neural progenitors	PEAKS056540
EXP060787	anti-SOX3 (Novus biology AF2569)	Homo sapiens	Genotype: R1159Q/+;	EXP060760	887	normal	P41225	neural progenitors	PEAKS056541
EXP060788	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: Lenriviral expressed WT SMARCA2-AM;	EXP060761	887	normal	P51531	neural progenitors	PEAKS056542
EXP060789	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: Lenriviral expressed R1159Q SMARCA2-AM;	EXP060762	887	normal	P51531	neural progenitors	PEAKS056543
EXP060790	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: wildtype; Treatment: non-targeting siRNA for 72 hours;	EXP060763	887	normal	P51532	neural progenitors	PEAKS056544
EXP060791	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: SOX2 and SOX3 knockout; Treatment: SOX2 and SOX3 siRNA for 72 hours;	EXP060764	887	normal	P51532	neural progenitors	PEAKS056545
EXP060792	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: K755R/+; Treatment: non-targeting siRNA for 72 hours;	EXP060765	887	normal	P51531	neural progenitors	PEAKS056546
EXP060793	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: K755R/+ and FOSL1, FOSL2 and JUNB knockout; Treatment: FOSL1, FOSL2 and JUNB siRNA for 72 hours;	EXP060766	887	normal	P51531	neural progenitors	PEAKS056547
EXP060794	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: K755R/+; Treatment: non-targeting siRNA for 72 hours;	EXP060765	887	normal	P51532	neural progenitors	PEAKS056548
EXP060795	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: K755R/+ and FOSL1, FOSL2 and JUNB knockout; Treatment: FOSL1, FOSL2 and JUNB siRNA for 72 hours;	EXP060766	887	normal	P51532	neural progenitors	PEAKS056549
EXP060798	anti-Rta	Homo sapiens	Treatmet: reactivated viral infection;	EXP060796	4264	normal	O43251	BC-3 (Primary effusion lymphoma)	PEAKS056550
EXP060799	anti-RBP-Jk	Homo sapiens	Treatmet: reactivated viral infection;	EXP060796	4264	normal	Q06330	BC-3 (Primary effusion lymphoma)	PEAKS056551
EXP060800	anti-RBP-Jk	Homo sapiens	Treatmet: latent viral infection;	EXP060797	4264	normal	Q06330	BC-3 (Primary effusion lymphoma)	PEAKS056552
EXP060801	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056553
EXP060802	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Genotype: wildtype;	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS056554
EXP060803	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: control plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056555
EXP060804	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: wildtype plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056556
EXP060805	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: TR1 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056557
EXP060806	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: TR2 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056558
EXP060807	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + control plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056559
EXP060808	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + control plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056560
EXP060809	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + wt plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056561
EXP060810	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + wt plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056562
EXP060811	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + TR1 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056563
EXP060812	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + TR1 plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056564
EXP060813	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + TR2 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056565
EXP060814	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + TR2 plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	PEAKS056566
EXP060815	anti-ZBTB7A (R&D Systems, catalog# MAB3496, lot# CDOR0109121, Human, Mouse)	Homo sapiens	Treatment: 10% FBS; Conditions: none	NULL	71	normal	O95365	VCaP (prostate carcinoma)	PEAKS056567
EXP060816	anti-ZBTB7A (R&D Systems, catalog# MAB3496, lot# CDOR0109121, Human, Mouse)	Homo sapiens	Treatment: 5% CSS containing phenol red free RPMI 1640; Conditions: none	NULL	71	normal	O95365	VCaP (prostate carcinoma)	PEAKS056568
EXP060817	anti-ZBTB7A (R&D Systems, catalog# MAB3496, lot# CDOR0109121, Human, Mouse)	Homo sapiens	Treatment: 10 nM DHT for 4 hours; Conditions: none	NULL	71	normal	O95365	VCaP (prostate carcinoma)	PEAKS056569
EXP060820	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing Satb1 full length protein;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	PEAKS056570
EXP060821	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing Satb1 without homeodomain (HD);	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	PEAKS056571
EXP060822	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing Satb1 N terminal domain and CUT1 domain;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	PEAKS056572
EXP060823	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing N-terminal domain of Satb1;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	PEAKS056573
EXP060824	GFP antibody	Homo sapiens	Treatment: camptothecin for 2 hrs;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	PEAKS056574
EXP060825	GFP antibody	Homo sapiens	Treatment: ICRF-193 for 2 hrs;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	PEAKS056575
EXP060826	anti-Satb1	Mus musculus	Genotype: expressing Satb1 full length protein;	EXP060819	4267	normal	Q60611	Vl3-2m (T cells lymphocytes)	PEAKS056576
EXP060827	anti-CTCF antibody (Millipore #07-729)	Homo sapiens	Time point: day0 (proliferation);	NULL	2562	normal	P49711	Dombi23 (primary keratinocytes)	PEAKS056577
EXP060828	anti-CTCF antibody (Millipore #07-729)	Homo sapiens	Time point: day0 (proliferation);	NULL	4268	normal	P49711	R204W (keratinocytes)	PEAKS056578
EXP060829	anti-CTCF antibody (Millipore #07-729)	Homo sapiens	Time point: day0 (proliferation);	NULL	4269	normal	P49711	R304W (keratinocytes)	PEAKS056579
EXP060836	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060830	395	normal	Q05086	H9-derived neural progenitors	PEAKS056580
EXP060837	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060831	395	normal	Q05086	H9-derived neural progenitors	PEAKS056581
EXP060838	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060830	395	normal	Q05086	H9-derived neural progenitors	PEAKS056582
EXP060839	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060831	395	normal	Q05086	H9-derived neural progenitors	PEAKS056583
EXP060840	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060832	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	PEAKS056584
EXP060841	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060833	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	PEAKS056585
EXP060842	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060832	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	PEAKS056586
EXP060843	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060833	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	PEAKS056587
EXP060844	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060834	396	normal	Q05086	WA09 (embryonic stem cells)	PEAKS056588
EXP060845	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060835	396	normal	Q05086	WA09 (embryonic stem cells)	PEAKS056589
EXP060846	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060834	396	normal	Q05086	WA09 (embryonic stem cells)	PEAKS056590
EXP060847	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060835	396	normal	Q05086	WA09 (embryonic stem cells)	PEAKS056591
EXP060848	Anti-IRF2BP2 antibody (A303190A, Bethyl laboratories)	Homo sapiens	Treatment: ethanol for 1hr, steroid-depleted medium, 48 hrs; Genotype: expressing GR;	NULL	421	normal	Q7Z5L9	HEK293 (embryonic kidney)	PEAKS056592
EXP060849	Anti-IRF2BP2 antibody (A303190A, Bethyl laboratories)	Homo sapiens	Treatment: dexamethasone, 100 nM for 1hr, steroid-depleted medium, 48 hrs; Genotype: expressing GR;	NULL	421	normal	Q7Z5L9	HEK293 (embryonic kidney)	PEAKS056593
EXP060851	anti-PRMT3 (Abcam, Cambridge, UK)	Homo sapiens		EXP060850	892	normal	O60678	MSC (mesenchymal stem cells)	PEAKS056594
EXP060856	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER eGFP empty;	EXP060852	4273	normal	P51532	Mel270 (Uveal melanoma)	PEAKS056595
EXP060857	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER eGFP empty;	EXP060852	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	PEAKS056596
EXP060858	anti-BRD9 (Abcam ab137245)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	EXP060853	4273	normal	Q9H8M2	Mel270 (Uveal melanoma)	PEAKS056597
EXP060859	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	EXP060853	4273	normal	P51532	Mel270 (Uveal melanoma)	PEAKS056598
EXP060860	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	EXP060853	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	PEAKS056599
EXP060861	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER-FLAG-SF3B1_K700E ;	EXP060854	4273	normal	P51532	Mel270 (Uveal melanoma)	PEAKS056600
EXP060862	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER-FLAG-SF3B1_K700E ;	EXP060854	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	PEAKS056601
EXP060863	anti-BRD9 (Abcam ab137245)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	EXP060855	4273	normal	Q9H8M2	Mel270 (Uveal melanoma)	PEAKS056602
EXP060864	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	EXP060855	4273	normal	P51532	Mel270 (Uveal melanoma)	PEAKS056603
EXP060865	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	EXP060855	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	PEAKS056604
EXP060868	anti-LSD1 (abcam, rabbit, ab17721)	Homo sapiens		EXP060866	2297	normal	O60341	MKL-1 (Merkel cell carcinoma)	PEAKS056605
EXP060869	anti-LSD1 (abcam, rabbit, ab17721)	Homo sapiens		EXP060867	2297	normal	O60341	MKL-1 (Merkel cell carcinoma)	PEAKS056606
EXP060870	anti-RCOR2 (Proteintech, rabbit, 23969-1-AP)	Homo sapiens		EXP060866	2297	normal	Q8IZ40	MKL-1 (Merkel cell carcinoma)	PEAKS056607
EXP060871	anti-RCOR2 (Proteintech, rabbit, 23969-1-AP)	Homo sapiens		EXP060867	2297	normal	Q8IZ40	MKL-1 (Merkel cell carcinoma)	PEAKS056608
EXP060872	anti-ATOH1	Homo sapiens		EXP060866	2297	normal	Q92858	MKL-1 (Merkel cell carcinoma)	PEAKS056609
EXP060873	anti-ATOH1	Homo sapiens		EXP060867	2297	normal	Q92858	MKL-1 (Merkel cell carcinoma)	PEAKS056610
EXP060874	anti-MED1	Homo sapiens	Treatment: AR stimulation in presence of enzalutamide for 6 hrs; Time point: 6 hours	NULL	71	normal	O95243	VCaP (prostate carcinoma)	PEAKS056611
EXP060875	anti-AR	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056612
EXP060876	anti-AR	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056613
EXP060878	anti-MED1	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	70	normal	O95243	LNCaP (prostate carcinoma)	PEAKS056615
EXP060879	anti-MED1	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	70	normal	O95243	LNCaP (prostate carcinoma)	PEAKS056616
EXP060880	anti-MED1	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	70	normal	O95243	LNCaP (prostate carcinoma)	PEAKS056617
EXP060881	anti-MED1	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	71	normal	O95243	VCaP (prostate carcinoma)	PEAKS056618
EXP060882	anti-AR	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS056619
EXP060883	anti-AR	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS056620
EXP060884	anti-AR	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS056621
EXP060885	anti-MED1	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	71	normal	O95243	VCaP (prostate carcinoma)	PEAKS056622
EXP060886	anti-MED1	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	71	normal	O95243	VCaP (prostate carcinoma)	PEAKS056623
EXP060887	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	PEAKS056624
EXP060888	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	PEAKS056625
EXP060889	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	PEAKS056626
EXP060890	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	PEAKS056627
EXP060891	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS056628
EXP060892	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	PEAKS056629
EXP060893	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	111	normal	Q15561	T47D (invasive ductal carcinoma)	PEAKS056630
EXP060894	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	111	normal	Q15561	T47D (invasive ductal carcinoma)	PEAKS056631
EXP060895	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	111	normal	A6NDR6	T47D (invasive ductal carcinoma)	PEAKS056632
EXP060896	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	111	normal	A6NDR6	T47D (invasive ductal carcinoma)	PEAKS056633
EXP060897	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, Control shRNA;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056634
EXP060898	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr,TEAD4 shRNA; Genotype: TEAD4  knockout;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056635
EXP060899	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, YAP1 shRNA; Genotype: YAP1 knockout;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056636
EXP060900	anti-MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: ethanol for 1 hrs, control shRNA;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	PEAKS056637
EXP060901	MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, control shRNA;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	PEAKS056638
EXP060902	MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: ethanol for 1 hrs, YAP1 shRNA; Genotype: YAP1 knockout;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	PEAKS056639
EXP060903	MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, YAP1 shRNA; Genotype: YAP1 knockout;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	PEAKS056640
EXP060904	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056641
EXP060905	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	PEAKS056642
EXP060906	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	PEAKS056643
EXP060907	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM ICI182780  for 24 hours;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS056644
EXP060908	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: 100 nM ICI182780  for 24 hours;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	PEAKS056645
EXP060909	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: 100 nM ICI182780  for 24 hours;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	PEAKS056646
EXP060914	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060910	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056647
EXP060915	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060911	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056648
EXP060916	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060912	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056649
EXP060917	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060913	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056650
EXP060918	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060910	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056651
EXP060919	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060911	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056652
EXP060920	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060912	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056653
EXP060921	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060913	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056654
EXP060922	anti-GR (IA1)	Homo sapiens	Treatment: ethanol for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056655
EXP060923	anti-GR (IA1)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056656
EXP060924	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) +  100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056657
EXP060925	anti-GR (IA1)	Homo sapiens	Treatment: ethanol for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056658
EXP060926	anti-GR (IA1)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056659
EXP060927	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) + 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056660
EXP060928	anti-GR (356)	Homo sapiens	Treatment: ethanol for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056661
EXP060929	anti-GR (356)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056662
EXP060930	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) +  100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056663
EXP060931	anti-GR (356)	Homo sapiens	Treatment: ethanol for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056664
EXP060932	anti-GR (356)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056665
EXP060933	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) + 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056666
EXP060942	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 11x;  Time point: day 9 of differentiation;	EXP060934	4274	normal	P51608	LUHMES-derived neurons	PEAKS056667
EXP060943	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 4x;  Time point: day 9 of differentiation;	EXP060935	4274	normal	P51608	LUHMES-derived neurons	PEAKS056668
EXP060944	anti- MeCP2	Homo sapiens	Genotype: MeCP2 knockout; Time point: day 9 of differentiation;	EXP060936	4274	normal	P51608	LUHMES-derived neurons	PEAKS056669
EXP060945	anti- MeCP2	Homo sapiens	Genotype: wildtype; Time point: day 9 of differentiation;	EXP060937	4274	normal	P51608	LUHMES-derived neurons	PEAKS056670
EXP060946	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 11x;  Time point: day 9 of differentiation;	EXP060938	4274	normal	P51608	LUHMES-derived neurons	PEAKS056671
EXP060947	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 4x;  Time point: day 9 of differentiation;	EXP060939	4274	normal	P51608	LUHMES-derived neurons	PEAKS056672
EXP060948	anti- MeCP2	Homo sapiens	Genotype: MeCP2 knockout; Time point: day 9 of differentiation;	EXP060940	4274	normal	P51608	LUHMES-derived neurons	PEAKS056673
EXP060949	anti- MeCP2	Homo sapiens	Genotype: wildtype; Time point: day 9 of differentiation;	EXP060941	4274	normal	P51608	LUHMES-derived neurons	PEAKS056674
EXP060950	anit-PDX1 (Christopher V. E., Wright, Goat )	Homo sapiens	Genotype: PDX1P33T/+;	NULL	2238	normal	P52945	iPS (derived pancreatic precursor cells)	PEAKS056675
EXP060953	anti-Ebf1 (ABE1294, Millipore, Rabbit polyclonal )	Homo sapiens		EXP060951	646	normal	Q9UH73	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056676
EXP060954	anti-Ebf1 (ABE1294, Millipore, Rabbit polyclonal )	Homo sapiens		EXP060952	646	normal	Q9UH73	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056677
EXP060955	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060951	646	normal	Q02548	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056678
EXP060956	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060952	646	normal	Q02548	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056679
EXP060957	anti-Ikzf1 (ab26083, Abcam, Rabbit polyclonal IgG)	Homo sapiens		EXP060951	646	normal	Q13422	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056680
EXP060958	anti-Ikzf1 (ab26083, Abcam, Rabbit polyclonal IgG)	Homo sapiens		EXP060952	646	normal	Q13422	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056681
EXP060959	anti-RUNX1 (ab23980, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060951	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056682
EXP060960	anti-RUNX1 (ab23980, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060952	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	PEAKS056683
EXP060965	anti-SREBP2 (Cayman, #10007663)	Homo sapiens	Treatment: vehicle for 24 hrs;	EXP060961	412	normal	Q12772	HCC70 (ductal breast carcinoma)	PEAKS056684
EXP060966	anti-SREBP2 (Cayman, #10007663)	Homo sapiens	Treatment: 5 uM XY018 for 24 hrs;	EXP060962	412	normal	Q12772	HCC70 (ductal breast carcinoma)	PEAKS056685
EXP060967	anti-ROR-gamma (rabbit serum was generated by Covance, using purified GST-human RORgamma fragment, amino acids 79-301, expressed in Escherichia coli)	Homo sapiens	Treatment: vehicle for 24 hrs;	EXP060963	412	normal	P51449	HCC70 (ductal breast carcinoma)	PEAKS056686
EXP060968	anti-ROR-gamma (rabbit serum was generated by Covance, using purified GST-human RORgamma fragment, amino acids 79-301, expressed in Escherichia coli)	Homo sapiens	Treatment: 5 uM XY018 for 24 hrs;	EXP060964	412	normal	P51449	HCC70 (ductal breast carcinoma)	PEAKS056687
EXP060972	anti-EZH2 (Cell Signalling - 5246S, 1:40)	Homo sapiens	Cell type:neopslatic stage untransformed;	EXP060969	2240	normal	Q15910	HDF(human dermal fibroblasts)	PEAKS056688
EXP060973	anti-EZH2 (Cell Signalling - 5246S, 1:40)	Homo sapiens	Cell type: neopslatic stage preneoplastic;	NULL	2240	normal	Q15910	HDF(human dermal fibroblasts)	PEAKS056689
EXP060974	anti-EZH2 (Cell Signalling - 5246S, 1:40)	Homo sapiens	Cell type: neopslatic stage transformed;	EXP060971	2240	normal	Q15910	HDF(human dermal fibroblasts)	PEAKS056690
EXP060977	anti-p50 (#3035, Cell Signaling, Danvers, MA, USA)	Homo sapiens	Donor: donor 171;	EXP060975	4278	normal	P19838	CD4+ T cells from blood	PEAKS056691
EXP060978	anti-p50 (#3035, Cell Signaling, Danvers, MA, USA)	Homo sapiens	Donor: donor 206;	EXP060976	4278	normal	P19838	CD4+ T cells from blood	PEAKS056692
EXP060979	anti-p65 (ab16502, Abcam, Cambridge, UK)	Homo sapiens	Donor: donor 171;	EXP060975	4278	normal	Q04206	CD4+ T cells from blood	PEAKS056693
EXP060980	anti-p65 (ab16502, Abcam, Cambridge, UK)	Homo sapiens	Donor: donor 206;	EXP060976	4278	normal	Q04206	CD4+ T cells from blood	PEAKS056694
EXP060981	anti-MondoA (ProteinTech, catalog # 13614-1-AP, lot # 00042515)	Homo sapiens	Genotype: wildtype;	NULL	451	normal	Q9HAP2	skeletal muscle myotubes	PEAKS056695
EXP060982	anti-MondoA (ProteinTech, catalog # 13614-1-AP, lot # 00042515)	Homo sapiens	Genotype: MondoA knockout;	NULL	451	normal	Q9HAP2	skeletal muscle myotubes	PEAKS056696
EXP060985	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		NULL	741	normal	O75081	CD34+ hematopoietic stem progenitor cells	PEAKS056697
EXP060986	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		EXP060983	516	normal	O75081	Kasumi-1 (acute myeloblastic leukemia)	PEAKS056698
EXP060987	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		EXP060984	65	normal	O75081	U937 (adult acute monocytic leukemia)	PEAKS056699
EXP060988	anti-HA (abcam, ab9110)	Homo sapiens	Genotype: pN1-LS174T Snail1-HA cells; Treatment: uninduced;	NULL	3383	normal	O95863	primary T-helper 1 CD4+ cells	PEAKS056700
EXP060989	anti-HA (abcam, ab9110)	Homo sapiens	Genotype: pN1-LS174T Snail1-HA cells; Treatment: 0.1 mg/ml doxycycline for 6hrs;	NULL	3383	normal	O95863	primary T-helper 1 CD4+ cells	PEAKS056701
EXP061005	anti-ZIC5CT289 (homemade)	Homo sapiens		EXP060990	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056702
EXP061006	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP060991	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056703
EXP061007	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP060992	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056704
EXP061008	anti-ZIC5FL290 (homemade)	Homo sapiens		EXP060993	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056705
EXP061009	anti-ZIC5FL290 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP060994	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056706
EXP061010	anti-ZIC5CT289 (homemade)	Homo sapiens	Genotype: overexpressed with GFP-Zic5;	NULL	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056707
EXP061011	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with non-targeting dsRNA;	EXP060995	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056708
EXP061012	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with CTNNB1 dsRNA; Genotype: CTNNB1 knockout;	EXP060996	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056709
EXP061013	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with non-targeting dsRNA;	EXP060997	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056710
EXP061014	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with TCF7L2 dsRNA; Genotype: TCF7L2 knockout;	EXP060998	3011	normal	A0AVK6	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056711
EXP061015	anti-TCF7L2 (CST)	Homo sapiens		EXP060999	3011	normal	Q9NQB0	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056712
EXP061016	anti-TCF7L2 (CST)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP061000	3011	normal	Q9NQB0	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056713
EXP061017	anti-TCF7L2 (CST)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP061001	3011	normal	Q9NQB0	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056714
EXP061018	anti-ZIC2 (Abcam)	Homo sapiens		EXP061002	3011	normal	O95409	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056715
EXP061019	anti-ZIC2 (Abcam)	Homo sapiens	Treatment: knocked out of ZIC2 gene by CRISPR/Cas9; Genotype: ZIC2 knockout;	EXP061003	3011	normal	O95409	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056716
EXP061020	anti-ZIC2 (Abcam)	Homo sapiens	Treatment: knocked out of ZIC2 gene by CRISPR/Cas9; Genotype: ZIC2 knockout;	EXP061004	3011	normal	O95409	CRC107 (colorectal cancer metastatic stem cells)	PEAKS056717
EXP061021	anti-IRF9 (D2T8M, Cell Signaling Technology Cat# 76684)	Homo sapiens	Treatment: 90min with 250 IU/mL of IFN-beta;	NULL	2334	normal	Q00978	THP-1 (acute monocytic leukemia)	PEAKS056718
EXP061022	anti-IRF9 (D2T8M, Cell Signaling Technology Cat# 76684)	Homo sapiens		NULL	2334	normal	Q00978	THP-1 (acute monocytic leukemia)	PEAKS056719
EXP061023	anti-Stat1 (D4Y6Z, Cell Signaling Technology Cat# 14995, RRID:AB_2716280)	Homo sapiens	Treatment: 90min with 250 IU/mL of IFN-beta;	NULL	2334	normal	P42224	THP-1 (acute monocytic leukemia)	PEAKS056720
EXP061024	anti-Stat1 (D4Y6Z, Cell Signaling Technology Cat# 14995, RRID:AB_2716280)	Homo sapiens		NULL	2334	normal	P42224	THP-1 (acute monocytic leukemia)	PEAKS056721
EXP061025	anti-Stat2 (D9J7L, Cell Signaling Technology Cat#72604)	Homo sapiens	Treatment: 90min with 250 IU/mL of IFN-beta;	NULL	2334	normal	P52630	THP-1 (acute monocytic leukemia)	PEAKS056722
EXP061026	anti-Stat2 (D9J7L, Cell Signaling Technology Cat#72604)	Homo sapiens		NULL	2334	normal	P52630	THP-1 (acute monocytic leukemia)	PEAKS056723
EXP061029	anti-CREB (rabbit serum, 244)	Homo sapiens	Treatment: retrovirus mediated trasduction of pBabe vector;	EXP061027	38	normal	P16220	A549 (lung carcinoma)	PEAKS056724
EXP061030	anti-CRTC2 (rabbit serum, 6865 )	Homo sapiens	Treatment: retrovirus mediated trasduction of pBabe vector;	EXP061027	38	normal	Q53ET0	A549 (lung carcinoma)	PEAKS056725
EXP061031	anti-CREB (rabbit serum, 244)	Homo sapiens	Treatment: retrovirus mediated transduction of pBabe-LKB1; Genotype:LKB1 expression; 	EXP061028	38	normal	P16220	A549 (lung carcinoma)	PEAKS056726
EXP061032	anti-CRTC2 (rabbit serum, 6865 )	Homo sapiens	Treatment: retrovirus mediated transduction of pBabe-LKB1; Genotype:LKB1 expression; 	EXP061028	38	normal	Q53ET0	A549 (lung carcinoma)	PEAKS056727
EXP061033	anti-NMYC antibody (sc-53993)	Homo sapiens		NULL	4289	normal	P04198	CHP-134 (Neuroblastoma)	PEAKS056728
EXP061034	anti-JMJD6 antibody (ab64575)	Homo sapiens		NULL	4289	normal	Q6NYC1	CHP-134 (Neuroblastoma)	PEAKS056729
EXP061036	anti-ARID1A antibody (12354, Cell Signaling)	Homo sapiens	Genotype: wildtype;	EXP061035	4290	normal	O14497	12Z (endometriotic epithelial cells)	PEAKS056730
EXP061038	anti-Deaf1 (PMID: 14507979)	Homo sapiens		EXP061037	4291	normal	O75398	GMA24A1F (Keratinocytes cell)	PEAKS056731
EXP061044	anti-YAP (D8H1X, Cell Signaling Technology Cat#14074, Rabbit monoclonal )	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	P46937	HEK293 (embryonic kidney)	PEAKS056732
EXP061045	anti-YAP (D8H1X, Cell Signaling Technology Cat#14074, Rabbit monoclonal )	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	P46937	HEK293 (embryonic kidney)	PEAKS056733
EXP061046	anti-TEF1 (a.k.a. TEAD1 (31/TEF1) BD Transduction Laboratories Cat#610922, Mouse monoclonal)	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	P28347	HEK293 (embryonic kidney)	PEAKS056734
EXP061047	anti-TEF1 (a.k.a. TEAD1 (31/TEF1) BD Transduction Laboratories Cat#610922, Mouse monoclonal)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	P28347	HEK293 (embryonic kidney)	PEAKS056735
EXP061048	anti-TEF-3 (a.k.a. TEAD4 (N-G2) Santa Cruz Cat#sc-101184, Mouse monoclonal)	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	Q15561	HEK293 (embryonic kidney)	PEAKS056736
EXP061049	anti-TEF-3 (a.k.a. TEAD4 (N-G2) Santa Cruz Cat#sc-101184, Mouse monoclonal)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	Q15561	HEK293 (embryonic kidney)	PEAKS056737
EXP061050	anti-RAD21 (abcam Cat#ab992,Rabbit polyclonal )	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	O60216	HEK293 (embryonic kidney)	PEAKS056738
EXP061051	anti-RAD21 (abcam Cat#ab992,Rabbit polyclonal )	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	O60216	HEK293 (embryonic kidney)	PEAKS056739
EXP061052	anti-RAD21 (abcam Cat#ab992, Rabbit polyclonal )	Homo sapiens	Treatment: siCtrl;	EXP061042	421	normal	O60216	HEK293 (embryonic kidney)	PEAKS056740
EXP061053	anti-RAD21 (abcam Cat#ab992, Rabbit polyclonal )	Homo sapiens	Treatment: siE1A, siYAP,siTAZ; Genotype: YAP, TAZ, E1A triple knockout;	EXP061043	421	normal	O60216	HEK293 (embryonic kidney)	PEAKS056741
EXP061054	none (input)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	NULL	421	normal	A0AVK6	HEK293 (embryonic kidney)	PEAKS056742
EXP061056	anti-Snail	Homo sapiens		EXP061055	78	normal	O95863	HeLa (cervical adenocarcinoma)	PEAKS056743
EXP061057	anti-MTA1	Homo sapiens		EXP061055	78	normal	Q13330	HeLa (cervical adenocarcinoma)	PEAKS056744
EXP061058	anti-PRMT5	Homo sapiens		EXP061055	78	normal	O14744	HeLa (cervical adenocarcinoma)	PEAKS056745
EXP061063	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061059	817	normal	P84022	SUM159PT (Triple negative breast cancer)	PEAKS056746
EXP061064	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061060	817	normal	P84022	SUM159PT (Triple negative breast cancer)	PEAKS056747
EXP061065	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061061	864	normal	P84022	WHIM12 (breast cancer)	PEAKS056748
EXP061066	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061062	864	normal	P84022	WHIM12 (breast cancer)	PEAKS056749
EXP061068	anti-SPT6 (Novus Biologicals, NB100-2582)	Homo sapiens	Treatment: DMSO for 4.5 hrs;	EXP061067	417	normal	Q7KZ85	HCT-116 (colon carcinoma)	PEAKS056750
EXP061069	anti-SPT6 (Novus Biologicals, NB100-2582)	Homo sapiens	Treatment: 5 uM 3-MB-PP1 for 4.5 hrs;	NULL	417	normal	Q7KZ85	HCT-116 (colon carcinoma)	PEAKS056751
EXP061071	anti-FOXO1	Homo sapiens	Treatment: untreated;	EXP061070	685	normal	Q12778	OCI-LY1 (diffuse large B-cell lymphoma)	PEAKS056752
EXP061072	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	PEAKS056753
EXP061073	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	PEAKS056754
EXP061074	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	PEAKS056755
EXP061075	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: resting;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	PEAKS056756
EXP061079	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRa-CTCF;	EXP061076	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS056757
EXP061080	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRk-CTCF;	EXP061077	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS056758
EXP061081	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRi-CTCF;	EXP061078	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS056759
EXP061082	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRa-CTCF;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS056760
EXP061083	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRk-CTCF;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS056761
EXP061084	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRi-CTCF;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS056762
EXP061085	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R175H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056763
EXP061086	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: Y220C p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056764
EXP061087	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: M237I p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056765
EXP061088	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R248Q p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056766
EXP061089	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R273H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056767
EXP061090	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R282W p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056768
EXP061091	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: p53 knockout;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056769
EXP061092	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype:  p53 wildtype;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056770
EXP061093	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R175H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056771
EXP061094	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: Y220C p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056772
EXP061095	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: Y220C p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056773
EXP061096	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R248Q p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056774
EXP061097	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R273H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056775
EXP061098	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R282W p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056776
EXP061099	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: p53 knockout;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056777
EXP061100	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: wildtype;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	PEAKS056778
EXP061101	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R175H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056779
EXP061102	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: Y220C p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056780
EXP061103	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: M237I p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056781
EXP061104	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R248Q p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056782
EXP061105	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R273H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056783
EXP061106	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R282W p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056784
EXP061107	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: p53 knockout;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056785
EXP061108	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype:  p53 wildtype;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056786
EXP061109	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R175H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056787
EXP061110	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: Y220C p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056788
EXP061111	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: M237I p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056789
EXP061112	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R248Q p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056790
EXP061113	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R273H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056791
EXP061114	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R282W p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056792
EXP061115	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: p53 knockout;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056793
EXP061116	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: p53 wildtype;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS056794
EXP061119	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: wild type NSD2 allele inactivated;	EXP061117	1183	normal	P49711	KMS-11 (Plasma cell myeloma)	PEAKS056795
EXP061120	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: overexpressed NSD2 allele inactivated;	EXP061118	1183	normal	P49711	KMS-11 (Plasma cell myeloma)	PEAKS056796
EXP061121	anti-Tcf21 antibody (Sigma #HPA013189)	Homo sapiens		NULL	192	normal	O43680	HCASMC (Human coronary artery smooth muscle cells)	PEAKS056797
EXP061123	anti-BMI1 (active motif, 39993)	Homo sapiens		EXP061122	725	normal	P35226	PC3(bone mets prostate adenocarcinoma)	PEAKS056798
EXP061124	anti-RNF2 (MBL, D139-3)	Homo sapiens		EXP061122	725	normal	Q99496	PC3(bone mets prostate adenocarcinoma)	PEAKS056799
EXP061125	anti-PCGF1 (santa cruz, Sc-515371)	Homo sapiens		EXP061122	725	normal	Q9BSM1	PC3(bone mets prostate adenocarcinoma)	PEAKS056800
EXP061126	anti-PHC2 (active motif, 39661)	Homo sapiens		EXP061122	725	normal	Q8IXK0	PC3(bone mets prostate adenocarcinoma)	PEAKS056801
EXP061127	anti-KDM2B (millipore, 09-864)	Homo sapiens		EXP061122	725	normal	Q8NHM5	PC3(bone mets prostate adenocarcinoma)	PEAKS056802
EXP061129	anti-CTCF (characterized in PMID:15731119, custom mouse monoclonal )	Homo sapiens	Genotype: stably expressing Empty Vector (EV);	EXP061128	4295	normal	P49711	FT282 (normal human fallopian tube tissue)	PEAKS056803
EXP061130	anti-CTCF (characterized in PMID:15731119, custom mouse monoclonal )	Homo sapiens	Genotype: stably expressing BORIS;	NULL	4295	normal	P49711	FT282 (normal human fallopian tube tissue)	PEAKS056804
EXP061131	anti-BORIS  (characterized in PMID: 21659515, custom mouse monoclonal )	Homo sapiens	Genotype: stably expressing BORIS;	NULL	4295	normal	Q8NI51	FT282 (normal human fallopian tube tissue)	PEAKS056805
EXP061133	anti-RELA antibody (NFKB p65 (c20): sc-372)	Homo sapiens	Treatment: None;	EXP061132	3042	normal	Q04206	FaDu(Hypopharyngeal squamous cell carcinoma)	PEAKS056806
EXP061134	anti-RELA antibody (NFKB p65 (c20): sc-372)	Homo sapiens	Treatment: LPS at 1ug/mL for 60 minutes;	NULL	3042	normal	Q04206	FaDu(Hypopharyngeal squamous cell carcinoma)	PEAKS056807
EXP061136	anti-Fra-1 (sc-376148X, lot G0814, Santa Cruz Biotechnology)	Homo sapiens		EXP061135	2301	normal	P15407	MDA-MB-231 (breast adenocarcinoma)	PEAKS056808
EXP061137	anti-Fra-2 (sc-13017X, lot J2403, Santa Cruz Biotechnology)	Homo sapiens		EXP061135	2301	normal	P15408	MDA-MB-231 (breast adenocarcinoma)	PEAKS056809
EXP061142	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP061138	4296	normal	Q9NYV4	143B (Osteosarcoma)	PEAKS056810
EXP061143	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: 200 nM E9 for 6 hrs;	EXP061139	4296	normal	Q9NYV4	143B (Osteosarcoma)	PEAKS056811
EXP061144	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP061140	1486	normal	Q9NYV4	MG63 (Osteosarcoma )	PEAKS056812
EXP061145	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: 200 nM E9 for 6 hrs;	EXP061141	1486	normal	Q9NYV4	MG63 (Osteosarcoma )	PEAKS056813
EXP061150	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment: DMSO; Genotype: HA-tagged LSF;	EXP061146	10	normal	Q12800	HEK293T (embryonic kidney)	PEAKS056814
EXP061151	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment:  5 uM RSL1 ligand for 24 hrs; Genotype: HA-tagged LSF;	EXP061147	10	normal	Q12800	HEK293T (embryonic kidney)	PEAKS056815
EXP061152	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment: DMSO; Genotype: HA-tagged LSF;	EXP061148	10	normal	Q12800	HEK293T (embryonic kidney)	PEAKS056816
EXP061153	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment:  5 uM RSL1 ligand for 24 hrs; Genotype: HA-tagged LSF;	EXP061149	10	normal	Q12800	HEK293T (embryonic kidney)	PEAKS056817
EXP061156	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: D538G ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056818
EXP061157	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: D538G Clone1 ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056819
EXP061158	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: D538G ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056820
EXP061159	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: D538G clone 2 ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056821
EXP061160	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: D538G ESR1 clone 3 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056822
EXP061161	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: D538G ESR1 clone 1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056823
EXP061162	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: wildtype clone 1 ESR1;	EXP061154	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056824
EXP061163	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: wildtype clone 1 ESR1;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056825
EXP061164	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: wildtype clone 2 ESR1;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056826
EXP061165	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: wildtype clone 2 ESR1;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	PEAKS056827
EXP061170	anti-non-phospho beta-catenin antibody (Cell Signaling Technology, 8814)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	EXP061168	4297	normal	P35222	iPS-derived dermal fibroblasts	PEAKS056828
EXP061171	anti-non-phospho beta-catenin antibody (Cell Signaling Technology, 8814)	Homo sapiens	Time point: 3 days of differentiation; Conditions:  altered 2C protocols;	NULL	4297	normal	P35222	iPS-derived dermal fibroblasts	PEAKS056829
EXP061172	anti-non-phospho beta-catenin antibody (Cell Signaling Technology, 8814)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  altered 2C protocols;	EXP061166	4297	normal	P35222	iPS-derived dermal fibroblasts	PEAKS056830
EXP061173	anti-human RARa antibody (Perseus Proteomics, PP-H1920-00, Mouse)	Homo sapiens	Time point: 5 days of differentiation; Conditions:  altered 2C protocols;	EXP061167	4297	normal	P10276	iPS-derived dermal fibroblasts	PEAKS056831
EXP061174	anti-human RARa antibody (Perseus Proteomics, PP-H1920-00, Mouse)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	EXP061168	4297	normal	P10276	iPS-derived dermal fibroblasts	PEAKS056832
EXP061175	anti-human RARa antibody (Perseus Proteomics, PP-H1920-00, Mouse)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	EXP061169	4297	normal	P10276	iPS-derived dermal fibroblasts	PEAKS056833
EXP061176	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS056834
EXP061177	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  untreated;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	PEAKS056835
EXP061178	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  Progesterone;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	PEAKS056836
EXP061179	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS056837
EXP061180	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	PEAKS056838
EXP061181	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	PEAKS056839
EXP061182	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS056840
EXP061183	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone, siControl;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS056841
EXP061184	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS056842
EXP061185	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS056843
EXP061186	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS056844
EXP061187	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  Progesterone, siControl;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS056845
EXP061188	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS056846
EXP061189	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  Progesterone, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	PEAKS056847
EXP061190	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	PEAKS056848
EXP061191	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  Progesterone, siControl;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	PEAKS056849
EXP061192	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	PEAKS056850
EXP061193	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  Progesterone, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	PEAKS056851
EXP061195	anti-KLF5	Homo sapiens		EXP061194	4298	normal	Q13887	ESO-26 (Gastroesophageal junction adenocarcinoma)	PEAKS056852
EXP061196	anti-Flag	Homo sapiens		EXP061194	4298	normal	P78545	ESO-26 (Gastroesophageal junction adenocarcinoma)	PEAKS056853
EXP061197	anti-GATA6	Homo sapiens		EXP061194	4298	normal	Q92908	ESO-26 (Gastroesophageal junction adenocarcinoma)	PEAKS056854
EXP061201	anti-Menin (Bethyl, INC, rabbit, polyclonal)	Homo sapiens		EXP061198	4299	normal	O00255	PNT1A (human post pubertal prostate normal)	PEAKS056855
EXP061202	anti-Menin (Bethyl, INC, rabbit, polyclonal)	Homo sapiens		EXP061199	70	normal	O00255	LNCaP (prostate carcinoma)	PEAKS056856
EXP061203	anti-Menin (Bethyl, INC, rabbit, polyclonal)	Homo sapiens		EXP061200	2667	normal	O00255	PC-3M-luc (human prostate carcinoma)	PEAKS056857
EXP061204	anti-c-myc antibody	Homo sapiens	Treatment: siRNA control; 	NULL	219	normal	P01106	DLD-1 (colon adenocarcinoma)	PEAKS056858
EXP061205	anti-c-myc antibody	Homo sapiens	Treatment: siRNA lncRNA-AF339830;  Genotype: lncRNA-AF339830 knockout;	NULL	219	normal	P01106	DLD-1 (colon adenocarcinoma)	PEAKS056859
EXP061207	anti-FLAG (Sigma Life Sciences, F1804)	Homo sapiens	Treatment: retrovirally-infected; Genotype: FLAG tagged MED25;	EXP061206	725	normal	Q71SY5	PC3(bone mets prostate adenocarcinoma)	PEAKS056860
EXP061208	anti-ETV4 (Aviva Systems Biology, ARP32262)	Homo sapiens	Treatment: retrovirally-infected; Genotype: FLAG tagged MED25;	EXP061206	725	normal	P43268	PC3(bone mets prostate adenocarcinoma)	PEAKS056861
EXP061211	anti-BRCA2	Homo sapiens		EXP061209	4221	normal	P51587	hTERT-HME1(Telomerase immortalized cell line)	PEAKS056862
EXP061212	anti-BRCA2	Homo sapiens		EXP061210	4221	normal	P51587	hTERT-HME1(Telomerase immortalized cell line)	PEAKS056863
EXP061217	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: DMSO for 24 hrs;	EXP061213	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	PEAKS056864
EXP061218	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: DMSO for 24 hrs;	EXP061214	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	PEAKS056865
EXP061219	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: GSK-LSD1 (2 mM) for 2 days;	EXP061215	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	PEAKS056866
EXP061220	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: GSK-LSD1 (2 mM) for 2 days;	EXP061216	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	PEAKS056867
EXP061230	anti-HA (F-7)	Homo sapiens	Treatment: EtOH; 	EXP061221	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056868
EXP061231	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 5 mins;	EXP061222	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056869
EXP061232	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 10 mins;	EXP061223	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056870
EXP061233	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 15 mins;	EXP061224	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056871
EXP061234	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 30 mins;	EXP061225	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056872
EXP061235	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 60 mins;	EXP061226	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056873
EXP061236	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 90 mins;	EXP061227	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056874
EXP061237	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 360 mins;	EXP061228	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056875
EXP061238	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 1440 mins;	EXP061229	421	normal	P20226	HEK293 (embryonic kidney)	PEAKS056876
EXP061248	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 8 days;	EXP061239	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS056877
EXP061249	anti-Suz12 (Active Motif 39357)	Homo sapiens	Treatment: DMSO 8 days;	EXP061239	1138	normal	Q15022	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS056878
EXP061250	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatmen: 1.5uM CPI360 8 days;	NULL	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS056879
EXP061251	anti-Suz12 (Active Motif 39357)	Homo sapiens	Treatmen: 1.5uM CPI360 8 days;	NULL	1138	normal	Q15022	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS056880
EXP061252	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5uM CPI360 4 days;	NULL	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS056881
EXP061253	anti-Suz12 (Active Motif 39357)	Homo sapiens	Treatment: 1.5uM CPI360 4 days;	NULL	1138	normal	Q15022	KARPAS-422 (diffuse large B-cell lymphoma)	PEAKS056882
EXP061254	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061240	3607	normal	Q15910	KMS-28BM (Plasma cell myeloma)	PEAKS056883
EXP061255	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5um CPI360 4 days;	NULL	3607	normal	Q15910	KMS-28BM (Plasma cell myeloma)	PEAKS056884
EXP061256	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061241	4301	normal	Q15910	KMS-28PE (Plasma cell myeloma)	PEAKS056885
EXP061257	Millipore 07-689	Homo sapiens	1.5uM CPI360 4 days	NULL	4301	normal	Q15910	KMS-28PE (Plasma cell myeloma)	PEAKS056886
EXP061258	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 10 days;	EXP061242	4302	normal	Q15910	RL (Diffuse large B-cell lymphoma)	PEAKS056887
EXP061259	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 5uM CPI169 10 days;	EXP061243	4302	normal	Q15910	RL (Diffuse large B-cell lymphoma)	PEAKS056888
EXP061260	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061244	1511	normal	Q15910	RPMI8226 (Plasma cell myeloma)	PEAKS056889
EXP061261	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5um CPI360 4 days;	EXP061245	1511	normal	Q15910	RPMI8226 (Plasma cell myeloma)	PEAKS056890
EXP061262	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061246	816	normal	Q15910	SU-DHL-6 (diffuse large B-cell lymphoma)	PEAKS056891
EXP061263	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5uM Compound 1 4 days;	EXP061247	816	normal	Q15910	SU-DHL-6 (diffuse large B-cell lymphoma)	PEAKS056892
EXP061264	anti-EGR1 Ab (sc-189X)	Homo sapiens	Treatment: DMSO, ethanol; Genotype: B-RAF-V600E expression;	NULL	2616	normal	P18146	BJ1-hTERT (Human fibroblast telomerase immortalized cell line)	PEAKS056893
EXP061265	anti-EGR1 Ab (sc-189X)	Homo sapiens	Treatment: DMSO, doxycycline 1000 ng mL-1; Genotype: B-RAF-V600E expression;	NULL	2616	normal	P18146	BJ1-hTERT (Human fibroblast telomerase immortalized cell line)	PEAKS056894
EXP061266	anti-EGR1 Ab (sc-189X)	Homo sapiens	Treatment: clobetasol 2nM, doxycycline 1000 ng mL-1; Genotype: B-RAF-V600E expression;	NULL	2616	normal	P18146	BJ1-hTERT (Human fibroblast telomerase immortalized cell line)	PEAKS056895
EXP061267	Anti-Flag	Homo sapiens		NULL	10	normal	P27694	HEK293T (embryonic kidney)	PEAKS056896
EXP061268	Anti-Flag	Homo sapiens		NULL	10	normal	P38159	HEK293T (embryonic kidney)	PEAKS056897
EXP061271	anti-GR(GR-356)	Homo sapiens	Treatment: vehicle, shCtrl;	EXP061269	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056898
EXP061272	anti-GR(GR-356)	Homo sapiens	Treatment: dexamethasone (100 nM) for 10 minutes, shCtrl;	EXP061270	87	normal	P04150	BEAS-2B (bronchial epithelium)	PEAKS056899
EXP061274	anti-p63 (CST, 13109S)	Homo sapiens		EXP061273	4303	normal	Q9H3D4	ME-180 (Human papillomavirus-related cervical squamous cell carcinoma)	PEAKS056900
EXP061276	anti-BRD4	Homo sapiens	Cell type: low stem cell potential;	EXP061275	2320	normal	O60885	primary human epidermal keratinocytes	PEAKS056901
EXP061277	anti-BRD4	Homo sapiens	Cell type: high stem cell potential.;	EXP061275	2320	normal	O60885	primary human epidermal keratinocytes	PEAKS056902
EXP061282	anti-HA	Homo sapiens	Treatment: no treatment, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061278	2320	normal	P14316	primary human epidermal keratinocytes	PEAKS056903
EXP061283	anti-HA	Homo sapiens	Treatment: no treatment, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061279	2320	normal	P14316	primary human epidermal keratinocytes	PEAKS056904
EXP061284	anti-HA	Homo sapiens	Treatment: treated with 1ug/ml Doxycycline for 3 days plus 2 days with 2ug/ml Doxycycline, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061280	2320	normal	P14316	primary human epidermal keratinocytes	PEAKS056905
EXP061285	anti-HA	Homo sapiens	Treatment: treated with 1ug/ml Doxycycline for 3 days plus 2 days with 2ug/ml Doxycycline, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061281	2320	normal	P14316	primary human epidermal keratinocytes	PEAKS056906
EXP061289	anti-beta-catenin (CST)	Homo sapiens	Treatment: Control;	EXP061287	430	normal	P35222	HepG2 (hepatoblastoma)	PEAKS056907
EXP061290	anti-beta-catenin (CST)	Homo sapiens	Treatment: DOX (1ug/mL) for 48 hour;	EXP061286	430	normal	P35222	HepG2 (hepatoblastoma)	PEAKS056908
EXP061291	anti-FLAG(Abcam)	Homo sapiens	Treatment: DOX (1ug/mL) for 48 hour;	EXP061288	430	normal	P43694	HepG2 (hepatoblastoma)	PEAKS056909
EXP061296	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061292	417	normal	P51608	HCT-116 (colon carcinoma)	PEAKS056910
EXP061297	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061293	417	normal	P51608	HCT-116 (colon carcinoma)	PEAKS056911
EXP061298	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061294	4304	normal	P51608	DKO-1 (Colon adenocarcinoma)	PEAKS056912
EXP061299	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061295	4304	normal	P51608	DKO-1 (Colon adenocarcinoma)	PEAKS056913
EXP061301	anti-CTCF antibody(Active Motif, Catalog No: 61311)	Homo sapiens		EXP061300	4306	normal	P49711	ocular melanoma cells	PEAKS056914
EXP061302	anti-ZNF274	Homo sapiens	Sex: female;  Donor: ENCDO000ABF;	NULL	421	normal	Q96GC6	HEK293 (embryonic kidney)	PEAKS056915
EXP061303	anti-GFP	Homo sapiens	Sex: female; Age: 53 year; Donor: ENCDO000AAD;	NULL	514	normal	Q9UQR1	K562 (myelogenous leukemia)	PEAKS056916
EXP061304	anti-XRCC5	Homo sapiens		NULL	430	normal	P13010	HepG2 (hepatoblastoma)	PEAKS056917
EXP061305	anti-HNRNPH1	Homo sapiens		NULL	430	normal	P31943	HepG2 (hepatoblastoma)	PEAKS056918
EXP061306	anti-SAFB	Homo sapiens		NULL	514	normal	Q15424	K562 (myelogenous leukemia)	PEAKS056919
EXP061307	anti-ZNF274	Homo sapiens		NULL	417	normal	Q96GC6	HCT-116 (colon carcinoma)	PEAKS056920
EXP061308	anti-TARDBP	Homo sapiens		NULL	430	normal	Q13148	HepG2 (hepatoblastoma)	PEAKS056921
EXP061309	anti-AGO2	Homo sapiens		NULL	430	normal	Q9UKV8	HepG2 (hepatoblastoma)	PEAKS056922
EXP061310	anti-GFP	Homo sapiens		NULL	514	normal	Q9NUA8	K562 (myelogenous leukemia)	PEAKS056923
EXP061311	anti-KDM5A	Homo sapiens		NULL	376	normal	P29375	WA01 (H1, human embryonic stem cells)	PEAKS056924
EXP061312	anti-GFP	Homo sapiens		NULL	514	normal	Q14119	K562 (myelogenous leukemia)	PEAKS056925
EXP061313	anti-CCAR2	Homo sapiens		NULL	430	normal	Q8N163	HepG2 (hepatoblastoma)	PEAKS056926
EXP061314	anti-GFP	Homo sapiens		NULL	514	normal	Q9H8N7	K562 (myelogenous leukemia)	PEAKS056927
EXP061315	anti-XRCC5	Homo sapiens		NULL	514	normal	P13010	K562 (myelogenous leukemia)	PEAKS056928
EXP061316	anti-CTCF	Homo sapiens	Sex: male; Age: 37 year; Donor: ENCDO845WKR;	NULL	4307	normal	P49711	body of pancreas	PEAKS056929
EXP061317	anti-HNRNPH1	Homo sapiens		NULL	514	normal	P31943	K562 (myelogenous leukemia)	PEAKS056930
EXP061318	anti-CCAR2	Homo sapiens		NULL	514	normal	Q8N163	K562 (myelogenous leukemia)	PEAKS056931
EXP061319	anti-RBM39	Homo sapiens		NULL	514	normal	Q14498	K562 (myelogenous leukemia)	PEAKS056932
EXP061320	anti-CTCF	Homo sapiens	Sex: female; Age: 51 years; Donor: ENCDO271OUW;	NULL	1181	normal	P49711	upper lobe of left lung	PEAKS056933
EXP061321	anti-SRSF9	Homo sapiens		NULL	514	normal	Q13242	K562 (myelogenous leukemia)	PEAKS056934
EXP061322	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056935
EXP061323	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 0.1uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056936
EXP061324	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 0.7uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056937
EXP061325	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056938
EXP061326	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 + 0.1uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056939
EXP061327	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 0.4uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056940
EXP061328	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12 hrs 1nM R1881 0.7uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS056941
EXP061329	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056942
EXP061330	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 0.1uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056943
EXP061331	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 0.7uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056944
EXP061332	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056945
EXP061333	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 + 0.1uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056946
EXP061334	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 0.4uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056947
EXP061335	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12 hrs 1nM R1881 0.7uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	PEAKS056948
EXP061337	anti-PML antibody (PG-M3, sc-966 HRP, Santa Cruz, conjugated with horse-radish peroxidase )	Homo sapiens		EXP061336	672	normal	O95394	normal dermal fibroblasts	PEAKS056949
EXP061339	anti-BRG1 (Abcam Catalog# B8184)	Homo sapiens		EXP061338	78	normal	P51532	HeLa (cervical adenocarcinoma)	PEAKS056950
EXP061340	anti-SMARCAL1 (Custom synthesised polyclonal antibody, Merk, india)	Homo sapiens		EXP061338	78	normal	Q9NZC9	HeLa (cervical adenocarcinoma)	PEAKS056951
EXP061347	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol;	NULL	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	PEAKS056952
EXP061348	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens		NULL	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	PEAKS056953
EXP061349	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siContrl;	EXP061341	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	PEAKS056954
EXP061350	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: EtOH, shControl;	EXP061342	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	PEAKS056955
EXP061351	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siKdm2a; Genotype: Kdm2a knockout;	EXP061343	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	PEAKS056956
EXP061352	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: EtOH, siKdm2a; Genotype: Kdm2a knockout;	EXP061344	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	PEAKS056957
EXP061353	anti-HA-tag (ab9110, abcam)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol;	NULL	113	normal	Q9Y2K7	MCF7 (Invasive ductal breast carcinoma)	PEAKS056958
EXP061354	anti-HA-tag (ab9110, abcam)	Homo sapiens	Treatment: EtOH;	NULL	113	normal	Q9Y2K7	MCF7 (Invasive ductal breast carcinoma)	PEAKS056959
EXP061356	anti-CTCF	Homo sapiens	Developmental stage: asynchronous cell stage;	EXP061355	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS056960
EXP061357	anti-CTCF	Homo sapiens	Developmental stage: mitosis cell stage;	EXP061355	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS056961
EXP061360	anti-HIF1a (Rabbit Polyclonal in whole antiserum)	Homo sapiens	Conditions: 1% O2 level for 16hrs;	EXP061358	26	normal	Q16665	501Mel (melanoma)	PEAKS056962
EXP061361	anti-HIF1b (Novus Biologicals, NB100-110, Rabbit Polyclonal in whole antiserum)	Homo sapiens	Conditions: 1% O2 level for 16hrs;	EXP061358	26	normal	P27540	501Mel (melanoma)	PEAKS056963
EXP061362	anti-HIF2a (Rabbit Polyclonal in whole antiserum)	Homo sapiens	Conditions: 1% O2 level for 16hrs;	EXP061358	26	normal	Q99814	501Mel (melanoma)	PEAKS056964
EXP061363	anti-SmcHD1 (antiserum)	Homo sapiens	Treatment: none;	NULL	664	normal	A6NHR9	SH-SY5Y (neuroblastoma)	PEAKS056965
EXP061364	anti-SmcHD1 (antiserum)	Homo sapiens	Treatment: DNA demethylating agent 5azaC for 72 hrs;	NULL	664	normal	A6NHR9	SH-SY5Y (neuroblastoma)	PEAKS056966
EXP061367	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype;	EXP061365	5	normal	O35426	liver	PEAKS056967
EXP061368	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype;	EXP061366	5	normal	O35426	liver	PEAKS056968
EXP061369	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Conditions: fed;	NULL	5	normal	O35426	liver	PEAKS056969
EXP061370	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Conditions: fasted;	NULL	5	normal	O35426	liver	PEAKS056970
EXP061371	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: Ern1 knockout;	NULL	5	normal	O35426	liver	PEAKS056971
EXP061375	anti-Flag (M2, Sigma)	Mus musculus	Genotype: Kdm4b knockout, Flag-KDM4B retrovirus;	EXP061373	197	normal	Q91VY5	adipocytes	PEAKS056972
EXP061377	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout, GFP;	NULL	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	PEAKS056973
EXP061378	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout (wildtype);	EXP061376	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	PEAKS056974
EXP061379	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout, deltaMBD;	NULL	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	PEAKS056975
EXP061380	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout, delta CC;	NULL	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	PEAKS056976
EXP061383	anti-Gli2 (homemade)	Mus musculus	Genotype: Sufu, Spop double knockout;	EXP061381	4310	normal	Q0VGT2	E17.5 intestine	PEAKS056977
EXP061384	anti-Gli2 (homemade)	Mus musculus	Genotype: Sufu, Spop double knockout;	EXP061382	4310	normal	Q0VGT2	E17.5 intestine	PEAKS056978
EXP061388	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4 wildtype;	EXP061386	3787	normal	P20263	MEF reprogramming intermediates to iPSC	PEAKS056979
EXP061389	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4 wildtype;	EXP061387	3787	normal	P20263	MEF reprogramming intermediates to iPSC	PEAKS056980
EXP061390	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 7 of reprogramming; Genotype: oct4 wildtype;	NULL	3787	normal	P20263	MEF reprogramming intermediates to iPSC	PEAKS056981
EXP061391	anti-Oct6 Antibody (Santa Cruz biotech;sc-11661 X; G0606)	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4 wildtype;	EXP061386	3787	normal	P21952	MEF reprogramming intermediates to iPSC	PEAKS056982
EXP061392	anti-Oct6 Antibody (Santa Cruz biotech;sc-11661 X; G0606)	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4 wildtype;	EXP061387	3787	normal	P21952	MEF reprogramming intermediates to iPSC	PEAKS056983
EXP061393	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4YR mutant;	EXP061386	3787	normal	P20263	MEF reprogramming intermediates to iPSC	PEAKS056984
EXP061394	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4YR mutant;	EXP061387	3787	normal	P20263	MEF reprogramming intermediates to iPSC	PEAKS056985
EXP061395	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct4SK mutant;	EXP061386	3787	normal	P48432	MEF reprogramming intermediates to iPSC	PEAKS056986
EXP061396	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 5 of reprogramming; Genotype: Oct4SK mutant;	EXP061387	3787	normal	P48432	MEF reprogramming intermediates to iPSC	PEAKS056987
EXP061397	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct6SK mutant;	EXP061386	3787	normal	P48432	MEF reprogramming intermediates to iPSC	PEAKS056988
EXP061398	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 5 of reprogramming; Genotype: Oct6SK mutant;	EXP061387	3787	normal	P48432	MEF reprogramming intermediates to iPSC	PEAKS056989
EXP061399	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 1 of reprogramming; Genotype: YRSK;	EXP061386	3787	normal	P48432	MEF reprogramming intermediates to iPSC	PEAKS056990
EXP061400	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 5 of reprogramming; Genotype: YRSK;	EXP061387	3787	normal	P48432	MEF reprogramming intermediates to iPSC	PEAKS056991
EXP061401	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct4SM mutant,SMSK ;	EXP061386	3787	normal	P20263	MEF reprogramming intermediates to iPSC	PEAKS056992
EXP061402	anti-Oct6 Antibody (Santa Cruz biotech;sc-11661 X; G0606)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct4SM mutant,SMSK ;	EXP061386	3787	normal	P21952	MEF reprogramming intermediates to iPSC	PEAKS056993
EXP061404	anti-V5 Tag (R960-25 Life Technologies)	Mus musculus		EXP061403	4311	normal	Q5XJV7	neural stem cells derived from telencephalic cortex of E14.5 embryos	PEAKS056994
EXP061407	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Strain: C57Bl/6J; Genotype: wildtype; Age: adult;	EXP061406	32	normal	Q61880	testis	PEAKS056995
EXP061408	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Strain: PWD/Ph; Genotype: wildtype; Age: adult;	EXP061405	32	normal	Q61880	testis	PEAKS056996
EXP061409	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Genotype: Prdm9-/- (tm1Ymat/tm1Ymat); Strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	PEAKS056997
EXP061410	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Genotype: Prdm9-/- (tm1Ymat/tm1Ymat); Strain: C57Bl/6J x C57Bl/6J F7;	NULL	32	normal	Q61880	testis	PEAKS056998
EXP061411	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Genotype: Prdm9-/- (tm1Ymat/tm1Ymat); Strain: PWD/Ph;	NULL	32	normal	Q61880	testis	PEAKS056999
EXP061414	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	EXP061412	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057000
EXP061415	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057001
EXP061416	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057002
EXP061417	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: LSD1i+IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057003
EXP061418	anti-PU.1/SPI1 (sc325, Santa Cruz Biotechnology)	Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	EXP061412	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057004
EXP061419	anti-PU.1/SPI1 (sc325, Santa Cruz Biotechnology)	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057005
EXP061420	anti-PU.1/SPI1 (sc325, Santa Cruz Biotechnology)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057006
EXP061421	anti-Med1/CRSP1/Trap220 (A300-793A, Bethyl Labs)	Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	EXP061412	2802	normal	Q925J9	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057007
EXP061422	anti-Med1/CRSP1/Trap220 (A300-793A, Bethyl Labs)	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	Q925J9	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057008
EXP061423	anti-Med1/CRSP1/Trap220 (A300-793A, Bethyl Labs)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q925J9	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057009
EXP061424	anti-KDM1A/LSD1 (ab17721, Abcam)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q6ZQ88	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057010
EXP061425	anti-KDM1A/LSD1 (ab17721, Abcam)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q6ZQ88	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057011
EXP061426	anti-Irf8 (5628S, Cell signaling)Â 	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	P23611	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057012
EXP061427	anti-Irf8 (5628S, Cell signaling)Â 	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	P23611	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057013
EXP061428	PU.1/SPI1(2258S, Cell Signaling)	Mus musculus	Treatment: IBET, Scrambled; Conditions: I-BET Resistant;	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057014
EXP061429	PU.1/SPI1(2258S, Cell Signaling)	Mus musculus	Treatment: IBET, Irf8 shRNA; Conditions: I-BET Resistant; Genotype: Irf8 knockout; 	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	PEAKS057015
EXP061431	anti-Yap (14074 cell signal)	Mus musculus	Age: postnatal 10 weeks; Genotype: wildtype; Strain: C57Bl/6, 129Sv; Conditions: DDC diet;	EXP061430	429	normal	P46938	hepatocytes	PEAKS057016
EXP061432	anti-Yap (14074 cell signal)	Mus musculus	Age: postnatal 10 weeks; Genotype: Arid1a liver-specific knockout; Strain: C57Bl/6, 129Sv; Conditions: DDC diet;	NULL	429	normal	P46938	hepatocytes	PEAKS057017
EXP061433	anti-Klf4 (R&D cat. numb.#F3158)	Mus musculus	Conditions: cultured in 2i condition;	NULL	252	normal	Q60793	V6.5 (embryonic stem cells)	PEAKS057018
EXP061434	anti-Klf4 (R&D cat. numb.#F3158)	Mus musculus	Time point: reprogramming - day 6; Treatment: cultured with dox and ascorbic acid for the number of days indicated;	NULL	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057019
EXP061435	anti-Klf4 (R&D cat. numb.#F3158)	Mus musculus	Time point: reprogramming - day 3; Treatment: cultured with dox and ascorbic acid for the number of days indicated;	NULL	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057020
EXP061446	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061436	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057021
EXP061447	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061437	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057022
EXP061448	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 6; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061438	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057023
EXP061449	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 6; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061439	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057024
EXP061450	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium;	EXP061442	252	normal	Q60793	V6.5 (embryonic stem cells)	PEAKS057025
EXP061451	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium;	EXP061443	252	normal	Q60793	V6.5 (embryonic stem cells)	PEAKS057026
EXP061452	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium with 2i (1uM MEK inhibitor) and 3uM GSK3 inhibitor;	EXP061444	252	normal	Q60793	V6.5 (embryonic stem cells)	PEAKS057027
EXP061453	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium with 2i (1uM MEK inhibitor) and 3uM GSK3 inhibitor;	EXP061445	252	normal	Q60793	V6.5 (embryonic stem cells)	PEAKS057028
EXP061454	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061441	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	PEAKS057029
EXP061456	anti-FLAG (M2 agarose, Sigma, A2220)	Mus musculus	Sex: female; Strain: C57BL/6; Tissue: isolated uteri from wild-type C57BL/6J female (eight weeks old) and then made endometrium fragments by using Miltex Medical Biopsy Punch Dermal 2 mm OR Grade;	NULL	4317	normal	O08537	endometriotic lesions	PEAKS057030
EXP061457	anti-FLAG (M2 agarose, Sigma, A2220)	Mus musculus	Sex: female; Strain: C57BL/6; Tissue: isolated uteri from wild-type C57BL/6J female (eight weeks old) and then made endometrium fragments by using Miltex Medical Biopsy Punch Dermal 2 mm OR Grade;	EXP061455	4316	normal	O08537	eutopic endometrium	PEAKS057031
EXP061462	anti-SFMBT2 (generated inhouse, Miri K et al., 2013, protein G Dynabeads (ThermoFisher Scientific #100009D))	Mus musculus	Treatment: Sonicated;	EXP061458	96	normal	Q5DTW2	trophoblast stem cells	PEAKS057032
EXP061463	anti-SFMBT2 (generated inhouse, Miri K et al., 2013, protein G Dynabeads (ThermoFisher Scientific #100009D))	Mus musculus	Treatment: Sonicated; Genotype: stably transfected FLAG-SFMBT2;	NULL	96	normal	Q5DTW2	trophoblast stem cells	PEAKS057033
EXP061464	anti-SFMBT2 (generated inhouse, Miri K et al., 2013, protein G Dynabeads (ThermoFisher Scientific #100009D))	Mus musculus	Treatment: Micrococcal nuclease-digested;	EXP061460	96	normal	Q5DTW2	trophoblast stem cells	PEAKS057034
EXP061465	FLAG-conjugated magnetic beads (Sigma Aldrich #M8823, lot# SLBM0090V)	Mus musculus	Treatment: Micrococcal nuclease-digested; Genotype: stably transfected FLAG-SFMBT2;	EXP061461	96	normal	Q5DTW2	trophoblast stem cells	PEAKS057035
EXP061474	anti-KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	EXP061466	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057036
EXP061475	anti-KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	EXP061467	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057037
EXP061476	anti-KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	EXP061468	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057038
EXP061477	KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	EXP061469	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057039
EXP061478	KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	EXP061470	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057040
EXP061479	KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	EXP061471	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057041
EXP061480	anti-GFP (#A-11122)	Mus musculus	Genotype: Chr4-cl wildtype; Strain: B6; Condtions: 20% FCS media;	EXP061472	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057042
EXP061481	anti-GFP (#A-11122)	Mus musculus	Genotype: Chr4-cl knockout; Strain: B6; Condtions: 20% FCS media;	EXP061473	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057043
EXP061487	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	Q8K293	F9 (embryonal carcinoma)	PEAKS057044
EXP061488	AW146154	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	E9Q3U2	F9 (embryonal carcinoma)	PEAKS057045
EXP061489	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	P63058	F9 (embryonal carcinoma)	PEAKS057046
EXP061490	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	Q32P14	F9 (embryonal carcinoma)	PEAKS057047
EXP061491	anti-HA (ab9110)	Mus musculus	Genotype: Gm13139 overexpression, SB transposon; 	EXP061486	292	normal	Q8R1N3	F9 (embryonal carcinoma)	PEAKS057048
EXP061492	anti-HA (ab9110)	Mus musculus	Genotype: Gm13150 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	H3BLB0	F9 (embryonal carcinoma)	PEAKS057049
EXP061493	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13152 overexpression, SB transposon; 	EXP061486	292	normal	Q6NXV0	F9 (embryonal carcinoma)	PEAKS057050
EXP061494	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13154 overexpression, SB transposon; 	EXP061486	292	normal	Q5U4F7	F9 (embryonal carcinoma)	PEAKS057051
EXP061495	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, pCW57.1 (addgene #41393); 	EXP061486	292	normal	A2A7A2	F9 (embryonal carcinoma)	PEAKS057052
EXP061496	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13212 overexpression, SB transposon; 	EXP061486	292	normal	B1ASQ6	F9 (embryonal carcinoma)	PEAKS057053
EXP061497	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13225cst- overexpression, SB transposon; 	EXP061486	292	normal	B1AVN4	F9 (embryonal carcinoma)	PEAKS057054
EXP061498	anti-HA (ab9110)	Mus musculus	Genotype: Gm13235 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	L7MUC9	F9 (embryonal carcinoma)	PEAKS057055
EXP061499	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13247 overexpression, SB transposon; 	EXP061486	292	normal	A2A8V6	F9 (embryonal carcinoma)	PEAKS057056
EXP061500	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13251 overexpression, SB transposon; 	EXP061486	292	normal	B1ASD8	F9 (embryonal carcinoma)	PEAKS057057
EXP061501	anti-HA (ab9110)	Mus musculus	Genotype: Gm13051 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6; 	EXP061482	2	normal	A2BG90	mESCs (mouse embryonic stem cells)	PEAKS057058
EXP061502	anti-HA (ab9110)	Mus musculus	Genotype: Gm14326 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2BFG5	F9 (embryonal carcinoma)	PEAKS057059
EXP061503	anti-HA (ab9110)	Mus musculus	Genotype: Gm14391 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	Q8C1K5	F9 (embryonal carcinoma)	PEAKS057060
EXP061504	anti-FLAG (F1804)	Mus musculus	Genotype: Gm14393 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A2ARW5	F9 (embryonal carcinoma)	PEAKS057061
EXP061505	anti-HA (ab9110)	Mus musculus	Genotype: Gm14399 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061483	2	normal	A2ARW7	mESCs (mouse embryonic stem cells)	PEAKS057062
EXP061506	anti-HA (ab9110)	Mus musculus	Genotype: Gm14401 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061483	2	normal	A2ARV7	mESCs (mouse embryonic stem cells)	PEAKS057063
EXP061507	anti-HA (ab9110)	Mus musculus	Genotype: Gm14406 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A2BFU6	F9 (embryonal carcinoma)	PEAKS057064
EXP061508	anti-HA (ab9110)	Mus musculus	Genotype: Gm14410 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2ARW1	F9 (embryonal carcinoma)	PEAKS057065
EXP061509	anti-HA (ab9110)	Mus musculus	Genotype: Gm14412 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2ARR7	F9 (embryonal carcinoma)	PEAKS057066
EXP061510	anti-HA (ab9110)	Mus musculus	Genotype: Gm14418 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A2ARR5	F9 (embryonal carcinoma)	PEAKS057067
EXP061511	anti-HA (ab9110)	Mus musculus	Genotype: Gm14419 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061483	2	normal	A2ARL5	mESCs (mouse embryonic stem cells)	PEAKS057068
EXP061512	anti-FLAG (F1804)	Mus musculus	Genotype: Gm14420 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061483	2	normal	B1AYE1	mESCs (mouse embryonic stem cells)	PEAKS057069
EXP061513	anti-HA (ab9110)	Mus musculus	Genotype: Gm14436 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2BE20	F9 (embryonal carcinoma)	PEAKS057070
EXP061514	anti-HA (ab9110)	Mus musculus	Genotype: Gm14443 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061482	2	normal	A2ARX0	mESCs (mouse embryonic stem cells)	PEAKS057071
EXP061515	anti-HA (ab9110)	Mus musculus	Genotype: Gm4631 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061483	2	normal	F7CEW8	mESCs (mouse embryonic stem cells)	PEAKS057072
EXP061516	anti-HA (ab9110)	Mus musculus	Genotype: Gm6710 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2ART0	F9 (embryonal carcinoma)	PEAKS057073
EXP061517	anti-HA (ab9110)	Mus musculus	Genotype: Gm8898 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061483	2	normal	A2ART1	mESCs (mouse embryonic stem cells)	PEAKS057074
EXP061518	anti-HA (ab9110)	Mus musculus	Genotype: Rex2 overexpression, SB transposon; 	EXP061486	292	normal	A2AWF2	F9 (embryonal carcinoma)	PEAKS057075
EXP061519	anti-HA (ab9110)	Mus musculus	Genotype: Zfp273 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	F6UQD0	F9 (embryonal carcinoma)	PEAKS057076
EXP061520	anti-HA (ab9110)	Mus musculus	Genotype: Zfp429 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	M0QWC3	F9 (embryonal carcinoma)	PEAKS057077
EXP061521	anti-HA (ab9110)	Mus musculus	Genotype: Zfp456 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	B2RUK9	F9 (embryonal carcinoma)	PEAKS057078
EXP061522	anti-HA (ab9110)	Mus musculus	Genotype: Zfp457 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A286YD11	F9 (embryonal carcinoma)	PEAKS057079
EXP061523	anti-HA (ab9110)	Mus musculus	Genotype: Zfp458 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	Q6P5C7	F9 (embryonal carcinoma)	PEAKS057080
EXP061524	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp46 overexpression, SB transposon; 	EXP061486	292	normal	D3Z7M1	F9 (embryonal carcinoma)	PEAKS057081
EXP061525	anti-HA (ab9110)	Mus musculus	Genotype: Zfp493 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A1Y7VP64	F9 (embryonal carcinoma)	PEAKS057082
EXP061526	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp534 overexpression, SB transposon; 	EXP061486	292	normal	A2A7A1	F9 (embryonal carcinoma)	PEAKS057083
EXP061527	anti-HA (ab9110)	Mus musculus	Genotype: Zfp58 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	E9PY65	F9 (embryonal carcinoma)	PEAKS057084
EXP061528	anti-HA (ab9110)	Mus musculus	Genotype: Zfp595 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	B9EIT6	F9 (embryonal carcinoma)	PEAKS057085
EXP061529	anti-HA (ab9110)	Mus musculus	Genotype: Zfp599 overexpression, SB transposon; 	EXP061486	292	normal	E9PWP1	F9 (embryonal carcinoma)	PEAKS057086
EXP061530	anti-HA (ab9110)	Mus musculus	Genotype: Zfp600 overexpression, SB transposon; 	EXP061486	292	normal	A2A7U9	F9 (embryonal carcinoma)	PEAKS057087
EXP061531	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp617 overexpression, SB transposon; 	EXP061486	292	normal	D3Z0X4	F9 (embryonal carcinoma)	PEAKS057088
EXP061532	anti-HA (ab9110)	Mus musculus	Genotype: Zfp661 overexpression, SB transposon; 	EXP061486	292	normal	Q8BIQ3	F9 (embryonal carcinoma)	PEAKS057089
EXP061533	anti-HA (ab9110)	Mus musculus	Genotype: Zfp709 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	F6R4Z5	F9 (embryonal carcinoma)	PEAKS057090
EXP061534	anti-HA (ab9110)	Mus musculus	Genotype: Zfp712 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	E9PXJ4	F9 (embryonal carcinoma)	PEAKS057091
EXP061535	anti-HA (ab9110)	Mus musculus	Genotype: Zfp738 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	B8JJX8	F9 (embryonal carcinoma)	PEAKS057092
EXP061536	anti-HA (ab9110)	Mus musculus	Genotype: Zfp759 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A286YDZ7	F9 (embryonal carcinoma)	PEAKS057093
EXP061537	anti-HA (ab9110)	Mus musculus	Genotype: Zfp808 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A0A1Y7VJ92	F9 (embryonal carcinoma)	PEAKS057094
EXP061538	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp810 overexpression, pCW57.1 (addgene #41393); 	EXP061486	292	normal	A0A1L1SUL0	F9 (embryonal carcinoma)	PEAKS057095
EXP061539	anti-HA (ab9110)	Mus musculus	Genotype: Zfp872 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A1L1SRW1	F9 (embryonal carcinoma)	PEAKS057096
EXP061540	anti-HA (ab9110)	Mus musculus	Genotype: Zfp874a overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A0A286YD52	F9 (embryonal carcinoma)	PEAKS057097
EXP061541	anti-HA (ab9110)	Mus musculus	Genotype: Zfp874b overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A286YDG9	F9 (embryonal carcinoma)	PEAKS057098
EXP061542	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp882 overexpression, SB transposon; 	EXP061486	292	normal	D3Z2V3	F9 (embryonal carcinoma)	PEAKS057099
EXP061543	anti-HA (ab9110)	Mus musculus	Genotype: Zfp92 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	Q62396	F9 (embryonal carcinoma)	PEAKS057100
EXP061544	anti-HA (ab9110)	Mus musculus	Genotype: Zfp931 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061482	2	normal	D3YWJ2	mESCs (mouse embryonic stem cells)	PEAKS057101
EXP061545	anti-HA (ab9110)	Mus musculus	Genotype: Zfp933 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	Q3V2G0	F9 (embryonal carcinoma)	PEAKS057102
EXP061546	anti-HA (ab9110)	Mus musculus	Genotype: Zfp935 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A0A1Y7VP04	F9 (embryonal carcinoma)	PEAKS057103
EXP061547	anti-HA (ab9110)	Mus musculus	Genotype: Zfp938 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	E9Q9G3	F9 (embryonal carcinoma)	PEAKS057104
EXP061548	anti-HA (ab9110)	Mus musculus	Genotype: Zfp953 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	Q3UPV7	F9 (embryonal carcinoma)	PEAKS057105
EXP061549	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp961 overexpression, SB transposon; 	EXP061486	292	normal	A0A1D5RMJ2	F9 (embryonal carcinoma)	PEAKS057106
EXP061550	anti-HA (ab9110)	Mus musculus	Genotype: Zkscan17 overexpression, SB transposon; 	EXP061486	292	normal	Q5SXI5	F9 (embryonal carcinoma)	PEAKS057107
EXP061551	anti-HA (ab9110)	Mus musculus	Genotype: Gm14296 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	E9Q3Y3	F9 (embryonal carcinoma)	PEAKS057108
EXP061553	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	EXP061552	3926	normal	P42225	bone marrow derived macrophage	PEAKS057109
EXP061554	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	EXP061552	3926	normal	Q9WVL2	bone marrow derived macrophage	PEAKS057110
EXP061555	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q61179	bone marrow derived macrophage	PEAKS057111
EXP061556	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	PEAKS057112
EXP061557	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	PEAKS057113
EXP061558	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q61179	bone marrow derived macrophage	PEAKS057114
EXP061559	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	PEAKS057115
EXP061560	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	PEAKS057116
EXP061561	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q61179	bone marrow derived macrophage	PEAKS057117
EXP061562	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: untreated; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	PEAKS057118
EXP061563	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: untreated; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	PEAKS057119
EXP061564	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	PEAKS057120
EXP061565	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	PEAKS057121
EXP061566	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	PEAKS057122
EXP061567	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	PEAKS057123
EXP061572	anti-Spt6 (Novus,NB100-2582, Rabbit polyclonal )	Mus musculus	Treatment: siNS for 2d (final concentration of 50 nM);	EXP061568	1153	normal	Q62383	C2C12 (myoblasts)	PEAKS057124
EXP061573	Rabbit polyclonal anti-Spt6 (Novus,NB100-2582)	Mus musculus	Treatment: siPaf1 for 2d (final concentration of 50 nM); Genotype: Paf1 knockout;	EXP061569	1153	normal	Q62383	C2C12 (myoblasts)	PEAKS057125
EXP061574	anti-SUPT5H (Bethyl,A300-868A, Rabbit polyclonal )	Mus musculus	Treatment: +dox (1 ug/ml Dox) for 4 days; Genotype: conditional Paf1 knockout;	EXP061570	1153	normal	O55201	C2C12 (myoblasts)	PEAKS057126
EXP061575	anti-SUPT5H (Bethyl,A300-868A, Rabbit polyclonal )	Mus musculus	Treatment: no dox (1 ug/ml Dox) treatment; Genotype: conditional Paf1 knockout;	EXP061571	1153	normal	O55201	C2C12 (myoblasts)	PEAKS057127
EXP061576	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057128
EXP061577	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057129
EXP061578	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-neg; Time point: day 3;	NULL	1556	normal	P35583	mesoderm	PEAKS057130
EXP061579	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-neg; Time point: day 3;	NULL	1556	normal	P35583	mesoderm	PEAKS057131
EXP061580	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-pos; Time point: day 5;	NULL	254	normal	P35583	endodermal cells	PEAKS057132
EXP061581	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-pos; Time point: day 5;	NULL	254	normal	P35583	endodermal cells	PEAKS057133
EXP061582	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-neg; Time point: day 3;	NULL	1556	normal	Q08369	mesoderm	PEAKS057134
EXP061583	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-pos; Time point: day 5;	NULL	254	normal	Q08369	endodermal cells	PEAKS057135
EXP061584	anti-Nanog (Bethyl lab; A300-397-A)	Mus musculus	Treatment: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-neg/Sox17-Cherry-neg; Time point: day 0;	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	PEAKS057136
EXP061585	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 1;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057137
EXP061586	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 1;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057138
EXP061587	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 4;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057139
EXP061588	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 4;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057140
EXP061589	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057141
EXP061590	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	PEAKS057142
EXP061591	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	Q08369	mESCs (mouse embryonic stem cells)	PEAKS057143
EXP061592	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	Q08369	mESCs (mouse embryonic stem cells)	PEAKS057144
EXP061594	anti-TLE3 (Proteintech 11372-1-AP)	Mus musculus		NULL	4338	normal	Q08122	eWAT-derived primary adipocytes	PEAKS057145
EXP061595	anti-TLE3 (Proteintech 11372-1-AP)	Mus musculus		EXP061593	4337	normal	Q08122	iWAT-derived primary adipocytes	PEAKS057146
EXP061596	anti-TLE3 (Proteintech 11372-1-AP)	Mus musculus		NULL	4339	normal	Q08122	BAT-derived primary adipocytes	PEAKS057147
EXP061600	anti-PRDM15 antibody	Mus musculus	Strain: E mu-Myc transgenic;	EXP061597	4340	normal	E9Q8T2	B cells from primary mouse lymphoma	PEAKS057148
EXP061601	anti-PRDM15 antibody	Mus musculus	Strain: E mu-Myc transgenic;	EXP061598	4340	normal	E9Q8T2	B cells from primary mouse lymphoma	PEAKS057149
EXP061602	anti-PRDM15 antibody	Mus musculus	Strain: E mu-Myc transgenic;	EXP061599	4340	normal	E9Q8T2	B cells from primary mouse lymphoma	PEAKS057150
EXP061605	anti-SPT16 (Santa Cruz, sc-28734X)	Mus musculus	Genotype: wildtype;	EXP061603	81	normal	Q920B9	BMDM (bone marrow-derived macrophages)	PEAKS057151
EXP061606	anti-SPT16(Santa Cruz, sc-28734X)	Mus musculus	Genotype: Trim33 knockout;	EXP061604	81	normal	Q920B9	BMDM (bone marrow-derived macrophages)	PEAKS057152
EXP061607	anti-Ring1b(Chiacchiera, Rossi, Sriganesh Jammula, et al. 2016, home-made lab)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	160	normal	Q9CQJ4	hair follicle stem cells	PEAKS057153
EXP061608	anti-Ring1b(Chiacchiera, Rossi, Sriganesh Jammula, et al. 2016, home-made lab)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	52	normal	Q9CQJ4	intestinal stem cells	PEAKS057154
EXP061611	anti-EZH2 (Cell Signaling #5246)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	EXP061610	96	normal	Q61188	trophoblast stem cells	PEAKS057155
EXP061612	anti-EZH2 (Cell Signaling #5246)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	NULL	96	normal	Q61188	trophoblast stem cells	PEAKS057156
EXP061613	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Airn truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057157
EXP061614	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Airn truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057158
EXP061615	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Kcnq1ot1 truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057159
EXP061616	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Kcnq1ot1 truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057160
EXP061617	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: CRISPR-a no guide RNA;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057161
EXP061618	SMC1 (Bethyl A300-055A)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	EXP061610	96	normal	Q9CU62	trophoblast stem cells	PEAKS057162
EXP061619	SMC1 (Bethyl A300-055A)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	NULL	96	normal	Q9CU62	trophoblast stem cells	PEAKS057163
EXP061620	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Full length Xist inserted at Rosa26 locus; Time point: 0hrs;	EXP061609	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057164
EXP061621	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Full length Xist inserted at Rosa26 locus; Time point: 12 hrs;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057165
EXP061622	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Full length Xist inserted at Rosa26 locus; Time point: 72 hrs;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057166
EXP061623	anti-CTCF	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	EXP061610	96	normal	Q61164	trophoblast stem cells	PEAKS057167
EXP061624	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: CRISPR-a Airn-targeting guide RNA;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	PEAKS057168
EXP061626	anti-ACAA2 (Origene Technologies  TA506126)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: sham;	NULL	53	normal	Q8BWT1	heart	PEAKS057169
EXP061627	anti-ACAA2 (Origene Technologies  TA506126)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: Transaortic coarctation for 7 days;	NULL	53	normal	Q8BWT1	heart	PEAKS057170
EXP061628	anti-OGDH (Cell Signalling Technologies 26865)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: sham;	NULL	53	normal	Q60597	heart	PEAKS057171
EXP061629	anti-OGDH (Cell Signalling Technologies 26865)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: Transaortic coarctation for 7 days;	NULL	53	normal	Q60597	heart	PEAKS057172
EXP061631	anti-FLAG antibody (Sigma, mouse )	Mus musculus	Treatment: transduced with Sox4-Flag lentivirus; Genotype: Krt14-Cre, Sox11fl/fl, Sox4fl/fl; Strain: mixed 129SvEx:C57BL/6;	EXP061630	936	normal	Q06831	primary keratinocytes	PEAKS057173
EXP061632	anti-FLAG antibody (Sigma, mouse )	Mus musculus	Treatment: transduced with Sox11-Flag lentivirus; Genotype: Krt14-Cre, Sox11fl/fl, Sox4fl/fl; Strain: mixed 129SvEx:C57BL/6;	EXP061630	936	normal	Q7M6Y2	primary keratinocytes	PEAKS057174
EXP061639	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: unstimulated; Strain: C57BL/6;	EXP061633	4344	normal	Q04207	vascular smooth muscle cells of aorta	PEAKS057175
EXP061640	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha; Strain: C57BL/6;	EXP061634	4344	normal	Q04207	vascular smooth muscle cells of aorta	PEAKS057176
EXP061641	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha + 4hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061635	4344	normal	Q04207	vascular smooth muscle cells of aorta	PEAKS057177
EXP061642	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10ng/ml, murine IFN gamma; Strain: C57BL/6;	EXP061636	4344	normal	Q04207	vascular smooth muscle cells of aorta	PEAKS057178
EXP061643	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10 ng/ml, murine IFN alpha + 4 hrs 1ug/ml, LPS; Strain: C57BL/6;	EXP061637	4344	normal	Q04207	vascular smooth muscle cells of aorta	PEAKS057179
EXP061644	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 4 hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061638	4344	normal	Q04207	vascular smooth muscle cells of aorta	PEAKS057180
EXP061645	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: unstimulated; Strain: C57BL/6;	EXP061633	4344	normal	P42225	vascular smooth muscle cells of aorta	PEAKS057181
EXP061646	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha; Strain: C57BL/6;	EXP061634	4344	normal	P42225	vascular smooth muscle cells of aorta	PEAKS057182
EXP061647	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha + 4hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061635	4344	normal	P42225	vascular smooth muscle cells of aorta	PEAKS057183
EXP061648	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10ng/ml, murine IFN gamma; Strain: C57BL/6;	EXP061636	4344	normal	P42225	vascular smooth muscle cells of aorta	PEAKS057184
EXP061649	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10 ng/ml, murine IFN alpha + 4 hrs 1ug/ml, LPS; Strain: C57BL/6;	EXP061637	4344	normal	P42225	vascular smooth muscle cells of aorta	PEAKS057185
EXP061650	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 4 hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061638	4344	normal	P42225	vascular smooth muscle cells of aorta	PEAKS057186
EXP061658	anti-Foxp3	Mus musculus	Genotype: Bcl11b f/f Foxp3-IRES-YFP-Cre (Bcl11b knockout); Strain: C57BL/6;	EXP061651	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	PEAKS057187
EXP061659	anti-Foxp3	Mus musculus	Genotype: Bcl11b f/f Foxp3-IRES-YFP-Cre (Bcl11b knockout); Strain: C57BL/6;	EXP061652	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	PEAKS057188
EXP061660	anti-Bcl11b	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061654	4346	normal	Q99PV8	sorted CD4+ YFP+ Treg cells	PEAKS057189
EXP061661	anti-Bcl11b	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061655	4346	normal	Q99PV8	sorted CD4+ YFP+ Treg cells	PEAKS057190
EXP061662	anti-Bcl11b	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061656	4346	normal	Q99PV8	sorted CD4+ YFP+ Treg cells	PEAKS057191
EXP061663	anti-Foxp3	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061654	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	PEAKS057192
EXP061664	anti-Foxp3	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061655	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	PEAKS057193
EXP061665	anti-Bcl11b	Mus musculus	Genotype: Foxp3-GFP knockout; Strain: C57BL/6;	EXP061653	4347	normal	Q99PV8	sorted CD4+ GFP+ Treg cells	PEAKS057194
EXP061666	anti-Bcl11b	Mus musculus	Genotype:Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061657	4348	normal	Q99PV8	sorted CD4+YFP+ naive T cells	PEAKS057195
EXP061669	anti-Olig2 (Millipore, ab9610)	Mus musculus		EXP061667	25	normal	Q9EQW6	cerebellum	PEAKS057196
EXP061670	anti-Olig2 (Millipore, ab9610)	Mus musculus		EXP061668	2570	normal	Q9EQW6	medulloblastoma	PEAKS057197
EXP061673	anti-HA (Cell Signaling Technology (CST), #3724, C29F4)	Mus musculus	Genotype: Zbtb24 knockout;	EXP061671	506	normal	Q80X44	J1 (embryonic stem cells)	PEAKS057198
EXP061674	anti-HA (Cell Signaling Technology (CST), #3724, C29F4)	Mus musculus	Genotype: Zbtb24 knockout;	EXP061672	506	normal	Q80X44	J1 (embryonic stem cells)	PEAKS057199
EXP061676	anti-Ash2l (Active Motif, 39099)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061675	4349	normal	Q91X20	E14.5 dorsal cortex	PEAKS057200
EXP061678	Anti-FLAG antibody	Mus musculus	Genotype: Zscan4 overexpression; Treatment: transfected with 1000ng pCMV-tag2 vector;	EXP061677	506	normal	Q80VJ6	J1 (embryonic stem cells)	PEAKS057201
EXP061681	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	EXP061679	906	normal	Q80U70	induced pluripotent stem cells	PEAKS057202
EXP061682	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	EXP061679	906	normal	Q80U70	induced pluripotent stem cells	PEAKS057203
EXP061683	anti-TRF1 (custom)	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	EXP061679	906	normal	P70371	induced pluripotent stem cells	PEAKS057204
EXP061684	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	EXP061680	906	normal	Q80U70	induced pluripotent stem cells	PEAKS057205
EXP061685	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	EXP061680	906	normal	Q80U70	induced pluripotent stem cells	PEAKS057206
EXP061686	anti-TRF1 (custom)	Mus musculus	Conditions: 2i; Treatment: shRNA  control, shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	EXP061680	906	normal	P70371	induced pluripotent stem cells	PEAKS057207
EXP061689	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061687	5	normal	P28700	liver	PEAKS057208
EXP061690	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061688	5	normal	P28700	liver	PEAKS057209
EXP061691	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061687	5	normal	P53566	liver	PEAKS057210
EXP061692	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061688	5	normal	P53566	liver	PEAKS057211
EXP061693	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061687	5	normal	P28033	liver	PEAKS057212
EXP061694	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061688	5	normal	P28033	liver	PEAKS057213
EXP061695	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28700	liver	PEAKS057214
EXP061696	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28700	liver	PEAKS057215
EXP061697	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P53566	liver	PEAKS057216
EXP061698	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P53566	liver	PEAKS057217
EXP061699	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28033	liver	PEAKS057218
EXP061700	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28033	liver	PEAKS057219
EXP061702	anti-PHF2 (Cell signaling D45A2)	Mus musculus	Strain: C57BL/6J;	EXP061701	4356	normal	Q9WTU0	E12.5 neural stem cells	PEAKS057220
EXP061704	anti-BCL6 antibody (Cell Signaling Technology #5650)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff Cre- BAT; Sex: male;	EXP061703	2377	normal	P41183	interscapular brown adipose	PEAKS057221
EXP061705	anti-BCL6 antibody (Cell Signaling Technology #5650)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff UCP1Cre+ BAT; Sex: male;	NULL	2377	normal	P41183	interscapular brown adipose	PEAKS057222
EXP061706	anti-ERRa antibody (Cell Signaling Technology #13826S)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff Cre- BAT; Sex: male;	EXP061703	2377	normal	P19785	interscapular brown adipose	PEAKS057223
EXP061707	anti-ERRa antibody (Cell Signaling Technology #13826S)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff UCP1Cre+ BAT; Sex: male;	NULL	2377	normal	P19785	interscapular brown adipose	PEAKS057224
EXP061716	anti-CTCF (CST, #3418)	Mus musculus	Genotype: wildtype; Strain:129;	EXP061710	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057225
EXP061717	anti-CTCF (CST, #3418)	Mus musculus	Genotype: wildtype; Strain:129;	EXP061711	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057226
EXP061718	anti-CTCF (CST, #3418)	Mus musculus	Genotype: TDG knockout; Strain:129;	EXP061714	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057227
EXP061719	anti-CTCF (CST, #3418)	Mus musculus	Genotype: TDG knockout; Strain:129;	EXP061715	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057228
EXP061721	anti-Esrrb antibody (Perseus Proteomics)	Mus musculus		EXP061720	4358	normal	Q61539	F4 (trophoblast stem cells)	PEAKS057229
EXP061726	anti-SUZ12 (Cell Signaling: D39F6)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061722	4359	normal	Q80U70	E12.5 proximal forelimb bud	PEAKS057230
EXP061727	anti-SUZ12 (Cell Signaling: D39F6)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061722	4360	normal	Q80U70	E12.5 distal forelimb bud	PEAKS057231
EXP061728	anti-SUZ12 (Cell Signaling: D39F6)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061723	4360	normal	Q80U70	E12.5 distal forelimb bud	PEAKS057232
EXP061729	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061724	4359	normal	Q9CQJ4	E12.5 proximal forelimb bud	PEAKS057233
EXP061730	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: Prrx1Cre, EedDel/Flox; Strain: mixed background C57Bl/6 x 129;	EXP061725	4359	normal	Q9CQJ4	E12.5 proximal forelimb bud	PEAKS057234
EXP061731	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: Prrx1Cre, EedDel/Flox; Strain: mixed background C57Bl/6 x 129;	EXP061725	4360	normal	Q9CQJ4	E12.5 distal forelimb bud	PEAKS057235
EXP061732	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061724	4360	normal	Q9CQJ4	E12.5 distal forelimb bud	PEAKS057236
EXP061737	anti-Scm1a (Bethyl Laboratories Inc. A300-055A)	Mus musculus	Genotype:wildtype;	EXP061733	1064	normal	Q9CU62	JM8.N4 (embryonic stem cells)	PEAKS057237
EXP061738	anti-CTCF (Abcam ab128873)	Mus musculus	Genotype:wildtype;	EXP061733	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	PEAKS057238
EXP061739	anti-Scm1a (Bethyl Laboratories Inc. A300-055A)	Mus musculus	Genotype:{delta}RBR (N576_D611del::GDGAGLINS-3xHA);	EXP061735	1064	normal	Q9CU62	JM8.N4 (embryonic stem cells)	PEAKS057239
EXP061740	anti-CTCF (Abcam ab128873)	Mus musculus	Genotype:{delta}RBR (N576_D611del::GDGAGLINS-3xHA);	EXP061735	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	PEAKS057240
EXP061745	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061741	4362	normal	Q925J9	diaphragm skeletal muscle	PEAKS057241
EXP061746	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061742	4363	normal	Q925J9	extensor digitorum longus skeletal muscle	PEAKS057242
EXP061747	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061743	2940	normal	Q925J9	quadriceps muscle	PEAKS057243
EXP061748	anti-Nfat (Millipore MABS409, mouse monoclonal)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061743	2940	normal	O88942	quadriceps muscle	PEAKS057244
EXP061749	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061744	4364	normal	Q925J9	soleus skeletal muscle	PEAKS057245
EXP061750	anti-Nfat (Millipore MABS409, mouse monoclonal)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061744	4364	normal	O88942	soleus skeletal muscle	PEAKS057246
EXP061752	anti-ZFP57 (Abcam, ab45341, lot 754226)	Mus musculus	Genotype: wildtype; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS057247
EXP061753	anti-ZFP57 (Abcam, ab45341, lot 754226)	Mus musculus	Genotype: ZFP57 knockout; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q8C6P8	mESCs (mouse embryonic stem cells)	PEAKS057248
EXP061754	anti-KAP1 (Abcam, ab10483, lot J0809)	Mus musculus	Genotype: wildtype; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057249
EXP061755	anti-KAP1 (Abcam, ab10483, lot J0809)	Mus musculus	Genotype: ZFP57 knockout; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q62318	mESCs (mouse embryonic stem cells)	PEAKS057250
EXP061758	anti-TET1 (Active Motif, 61741)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: wildtype;	EXP061756	965	normal	Q3URK3	frontal cortex	PEAKS057251
EXP061759	anti-TET1 (Active Motif, 91171)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: wildtype;	EXP061756	965	normal	Q3URK3	frontal cortex	PEAKS057252
EXP061760	anti-TET1 (Active Motif, 61741)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: Egr1 knockout;	EXP061757	965	normal	Q3URK3	frontal cortex	PEAKS057253
EXP061761	anti-TET1 (Active Motif, 91171)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: Egr1 knockout;	EXP061757	965	normal	Q3URK3	frontal cortex	PEAKS057254
EXP061765	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 48 hrs HA;	EXP061764	4367	normal	Q07802	G1297 (EWS/ATF1 -iduced sarcoma cell line)	PEAKS057255
EXP061766	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 4 days HA;	EXP061764	4367	normal	Q07802	G1297 (EWS/ATF1 -iduced sarcoma cell line)	PEAKS057256
EXP061767	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 48 hrs HA;	EXP061764	4367	normal	Q80Z64	G1297 (EWS/ATF1 -iduced sarcoma cell line)	PEAKS057257
EXP061768	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 4 days HA;	EXP061764	4367	normal	Q80Z64	G1297 (EWS/ATF1 -iduced sarcoma cell line)	PEAKS057258
EXP061769	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	EXP061762	4367	normal	P81269	G1297 (EWS/ATF1 -iduced sarcoma cell line)	PEAKS057259
EXP061770	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	EXP061763	4368	normal	P81269	sarcoma iPSC-derived MEFs	PEAKS057260
EXP061776	anti-Dlx1 (lab-made, described in paper)	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061771	4372	normal	Q64317	E11.5 ganglionic eminences	PEAKS057261
EXP061777	anti-Dlx1 (lab-made, described in paper)	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061772	4373	normal	Q61039	E13.5 ganglionic eminences	PEAKS057262
EXP061778	anti-Dlx1 (lab-made, described in paper)	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4374	normal	Q61039	E16.5 ganglionic eminences	PEAKS057263
EXP061779	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061771	4372	normal	P40764	E11.5 ganglionic eminences	PEAKS057264
EXP061780	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061774	4373	normal	P40764	E13.5 ganglionic eminences	PEAKS057265
EXP061781	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061773	4374	normal	P40764	E16.5 ganglionic eminences	PEAKS057266
EXP061782	anti-Dlx5 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061771	4372	normal	P70396	E11.5 ganglionic eminences	PEAKS057267
EXP061783	anti-Dlx5 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061775	4373	normal	P70396	E13.5 ganglionic eminences	PEAKS057268
EXP061784	anti-Dlx5 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061773	4374	normal	P70396	E16.5 ganglionic eminences	PEAKS057269
EXP061785	anti-CBP (sc583x) 	Mus musculus	Age: 3-6 month; Treatment: Saline; Strain: C57BL/6J;	NULL	4375	normal	P45481	hippocampal excitatory neurons	PEAKS057270
EXP061786	anti-CBP (sc583x) 	Mus musculus	Age: 3-6 month; Treatment: induction of SE by Kainic Acid (KA); Strain: C57BL/6J;	NULL	4375	normal	P45481	hippocampal excitatory neurons	PEAKS057271
EXP061789	anti-Smad2 (Cell Signaling Technology, 5339S)	Mus musculus		EXP061787	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	PEAKS057272
EXP061790	anti-Smad3 (Cell Signaling Technology, 9523S)	Mus musculus		EXP061787	1126	normal	Q8BUN5	E14TG2a.4 (embryonic stem cells)	PEAKS057273
EXP061791	anti-Smad4 (Santa Cruz, 7966X and Abcam, 40759)	Mus musculus		EXP061787	1126	normal	P97471	E14TG2a.4 (embryonic stem cells)	PEAKS057274
EXP061792	anti-Foxh1 (Abcam, 49133)	Mus musculus		EXP061787	1126	normal	O88621	E14TG2a.4 (embryonic stem cells)	PEAKS057275
EXP061793	anti-Smad2 (Cell Signaling Technology, 5339S)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	Q62432	E14TG2a.4 derived embryoid body	PEAKS057276
EXP061794	anti-Smad2 (Cell Signaling Technology, 5339S)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	Q62432	E14TG2a.4 derived embryoid body	PEAKS057277
EXP061795	anti-Smad3 (Cell Signaling Technology, 9523S)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	Q8BUN5	E14TG2a.4 derived embryoid body	PEAKS057278
EXP061796	anti-Smad3 (Cell Signaling Technology, 9523S)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	Q8BUN5	E14TG2a.4 derived embryoid body	PEAKS057279
EXP061797	anti-Smad4 (Santa Cruz, 7966X and Abcam, 40759)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	P97471	E14TG2a.4 derived embryoid body	PEAKS057280
EXP061798	anti-Smad4 (Santa Cruz, 7966X and Abcam, 40759)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	P97471	E14TG2a.4 derived embryoid body	PEAKS057281
EXP061799	anti-Foxh1 (Abcam, 49133)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	O88621	E14TG2a.4 derived embryoid body	PEAKS057282
EXP061800	anti-Foxh1 (Abcam, 49133)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	O88621	E14TG2a.4 derived embryoid body	PEAKS057283
EXP061809	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061801	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057284
EXP061810	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061802	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057285
EXP061811	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061803	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057286
EXP061812	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061804	2	normal	Q61164	mESCs (mouse embryonic stem cells)	PEAKS057287
EXP061813	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061805	2	normal	Q61550	mESCs (mouse embryonic stem cells)	PEAKS057288
EXP061814	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061806	2	normal	Q61550	mESCs (mouse embryonic stem cells)	PEAKS057289
EXP061815	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061807	2	normal	Q61550	mESCs (mouse embryonic stem cells)	PEAKS057290
EXP061816	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061808	2	normal	Q61550	mESCs (mouse embryonic stem cells)	PEAKS057291
EXP061817	anti-CTCF (Active motif: 613111)	Mus musculus	Genotype: wildtype;	NULL	4377	normal	Q61164	E12.5 limb bud	PEAKS057292
EXP061818	anti-IRF3 (D83B9, Cell Signaling)	Mus musculus	Treatment: 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) for 90 mins;	NULL	2394	normal	P70671	CD8-positive dendritic cells	PEAKS057293
EXP061819	anti-IRF5 (ab21689, Abcam)	Mus musculus	Treatment:Â 1 mM class B CpG oligonucleotide (1826) for 90 mins;	NULL	2394	normal	P56477	CD8-positive dendritic cells	PEAKS057294
EXP061820	anti-IRF9 (AF5629, R&D Systems)	Mus musculus	Treatment: 10U IFN-beta for 90 mins;	NULL	2394	normal	Q61179	CD8-positive dendritic cells	PEAKS057295
EXP061822	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: DMSO;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057296
EXP061823	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: Triptolide for 1 hr;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057297
EXP061824	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: Triptolide for 4 hrs;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057298
EXP061825	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: mock;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057299
EXP061826	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: Rnase treatment;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057300
EXP061827	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Genotype: wildtype;  Conditions: grown with 500mM of indole-3-acetic acid (IAA, chemical analog of auxin) in the medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057301
EXP061828	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Genotype: ZF1 mutation;  Conditions: grown with 500mM of indole-3-acetic acid (IAA, chemical analog of auxin) in the medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057302
EXP061829	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Genotype: ZF10 mutation;  Conditions: grown with 500mM of indole-3-acetic acid (IAA, chemical analog of auxin) in the medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS057303
EXP061833	anti-Flag	Mus musculus	Genotype: expressing Pax7;	EXP061831	4380	normal	P47239	AlphaT3-1	PEAKS057304
EXP061834	anti-Neurod1 (Poulin et al. Mol. Cell. Biol 20, 4826-4837 (2000))	Mus musculus		NULL	75	normal	Q60867	AtT-20 (pituitary tumor)	PEAKS057305
EXP061835	anti-Sox2 (Abcam (Ab59776))	Mus musculus	Genotype: expressing Sox2;	NULL	75	normal	P48432	AtT-20 (pituitary tumor)	PEAKS057306
EXP061836	anti-EZH2 (Cell Signaling Technology, 5246S, lot:7)	Mus musculus	Genotype: wildtype;	NULL	2508	normal	Q61188	embryonic stem cells-derived clonal neural progenitor cells	PEAKS057307
EXP061837	anti-EZH2 (Cell Signaling Technology, 5246S, lot:7)	Mus musculus	Genotype: Smchd1-/-;	NULL	2508	normal	Q61188	embryonic stem cells-derived clonal neural progenitor cells	PEAKS057308
EXP061839	c-Myc N262 (Santa Cruz sc764)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	EXP061838	4383	normal	P01108	primary naive B-cells from spleen	PEAKS057309
EXP061840	anti-c-Myc N262 (Santa Cruz sc764, N262)	Mus musculus	Treatment: LPS (50 ug/ml) for 2 hrs; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	normal	P01108	primary naive B-cells from spleen	PEAKS057310
EXP061841	c-Myc N262 (Santa Cruz sc764)	Mus musculus	Treatment: LPS (50 ug/ml) for 4 hrs; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	normal	P01108	primary naive B-cells from spleen	PEAKS057311
EXP061842	c-Myc N262 (Santa Cruz sc764)	Mus musculus	Treatment: LPS (50 ug/ml) for 8 hrs; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	normal	P01108	primary naive B-cells from spleen	PEAKS057312
EXP061852	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus		EXP061843	4384	normal	Q03267	230-238 (murine PreB cells cell line)	PEAKS057313
EXP061853	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus		EXP061844	4384	normal	Q03347	230-238 (murine PreB cells cell line)	PEAKS057314
EXP061854	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal )	Mus musculus		EXP061844	4384	normal	Q02650	230-238 (murine PreB cells cell line)	PEAKS057315
EXP061855	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	EXP061845	105	normal	Q03267	pro-B cells	PEAKS057316
EXP061856	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal )	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	EXP061846	105	normal	Q02650	pro-B cells	PEAKS057317
EXP061857	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	EXP061846	105	normal	Q03347	pro-B cells	PEAKS057318
EXP061858	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus	Genotype: Pax5 knockout; Strain: C57BL6/J;	EXP061847	105	normal	Q03267	pro-B cells	PEAKS057319
EXP061859	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus	Genotype: Pax5 knockout; Strain: C57BL6/J;	EXP061848	105	normal	Q03347	pro-B cells	PEAKS057320
EXP061860	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus	Genotype: Ebf1 knockout; Strain: C57BL6/J;	EXP061849	105	normal	Q03267	pro-B cells	PEAKS057321
EXP061861	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus	Genotype: Ebf1 knockout; Strain: C57BL6/J;	EXP061850	105	normal	Q03347	pro-B cells	PEAKS057322
EXP061862	anti-FLI1 (ab15289, Abcam, Rabbit polyclonal IgG) 	Mus musculus		EXP061851	4384	normal	P26323	230-238 (murine PreB cells cell line)	PEAKS057323
EXP061863	anti-DMC1 (C-20, lot #D2215, Santa Cruz, goat polyclonal)	Mus musculus	Genotype: wildtype; Strain: C57BL/6JCrl;  Age: adult; Sex: male;	NULL	32	normal	Q61880	testis	PEAKS057324
EXP061864	anti-DMC1 (C-20, lot #D2215, Santa Cruz, goat polyclonal)	Mus musculus	Genotype: Ankrd31 knockout; Strain: C57BL/6JCrl;  Age: adult; Sex: male;	NULL	32	normal	Q61880	testis	PEAKS057325
EXP061865	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: wildtype;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	PEAKS057326
EXP061866	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	PEAKS057327
EXP061867	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	PEAKS057328
EXP061868	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	PEAKS057329
EXP061869	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 knockout;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	PEAKS057330
EXP061870	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: wildtype;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	PEAKS057331
EXP061871	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	PEAKS057332
EXP061872	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	PEAKS057333
EXP061873	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	PEAKS057334
EXP061874	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 knockout;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	PEAKS057335
EXP061875	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: wildtype;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	PEAKS057336
EXP061876	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	PEAKS057337
EXP061877	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	PEAKS057338
EXP061878	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	PEAKS057339
EXP061879	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: wildtype;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	PEAKS057340
EXP061880	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	PEAKS057341
EXP061881	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	PEAKS057342
EXP061882	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	PEAKS057343
EXP061885	anti-SA1 antibody (STAG1, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: serum;	EXP061884	2	normal	Q9D3E6	mESCs (mouse embryonic stem cells)	PEAKS057344
EXP061886	anti-SA2 antibody (STAG2, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: serum;	EXP061884	2	normal	O35638	mESCs (mouse embryonic stem cells)	PEAKS057345
EXP061887	anti-SMC1 (custom made antibody)	Mus musculus	Strain: 129/Sv;  Conditions: serum;	EXP061884	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	PEAKS057346
EXP061888	anti-SA1 antibody (STAG1, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: 2i;	EXP061883	2	normal	Q9D3E6	mESCs (mouse embryonic stem cells)	PEAKS057347
EXP061889	anti-SA2 antibody (STAG2, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: 2i;	EXP061883	2	normal	O35638	mESCs (mouse embryonic stem cells)	PEAKS057348
EXP061890	anti-cbfb	Mus musculus	Strain: B6/Cast F1;	NULL	4095	normal	Q08024	naive CD8 T cells from spleen	PEAKS057349
EXP061891	anti-cbfb	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q08024	activated CD8 T cell from spleen	PEAKS057350
EXP061892	anti-eomes	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	O54839	activated CD8 T cell from spleen	PEAKS057351
EXP061893	anti-tbet	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q9JKD8	activated CD8 T cell from spleen	PEAKS057352
EXP061894	anti-cbfb	Mus musculus	Strain: B6/Cast F1;	NULL	4095	normal	Q08024	naive CD8 T cells from spleen	PEAKS057353
EXP061895	anti-cbfb	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q08024	activated CD8 T cell from spleen	PEAKS057354
EXP061896	anti-eomes	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	O54839	activated CD8 T cell from spleen	PEAKS057355
EXP061897	anti-tbet	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q9JKD8	activated CD8 T cell from spleen	PEAKS057356
EXP061898	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Aebp2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057357
EXP061899	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Epop knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057358
EXP061900	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057359
EXP061901	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057360
EXP061902	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057361
EXP061903	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	O09102	mESCs (mouse embryonic stem cells)	PEAKS057362
EXP061904	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout +Flag-SUZ12 ;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057363
EXP061905	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype:Suz12 knockout Flag-SUZ12-C2;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057364
EXP061906	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype:Suz12 knockout  Flag-SUZ12-DeltaC2;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057365
EXP061907	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS057366
EXP061908	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS057367
EXP061909	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 knockout;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS057368
EXP061910	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout + Flag-SUZ12;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS057369
EXP061911	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout + Flag-SUZ12-C2;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS057370
EXP061912	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 knockout;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	PEAKS057371
EXP061913	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	PEAKS057372
EXP061914	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	PEAKS057373
EXP061915	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 knockout;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	PEAKS057374
EXP061916	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 knockout;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	PEAKS057375
EXP061917	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 + Aebp2 + Epop triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057376
EXP061918	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Epop + Aebp2 triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057377
EXP061919	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Epop + Jarid2 triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057378
EXP061920	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Jarid2 + Aebp2 triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057379
EXP061921	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057380
EXP061922	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057381
EXP061923	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Epop double knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057382
EXP061924	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 + Aebp2 double knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057383
EXP061925	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Jarid2 double knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057384
EXP061926	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Jarid2 + Aebp2 + Epop triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057385
EXP061928	anti-ZEB1 (Santa Cruz Biotechnologies, Cat.No.sc25388)	Mus musculus	Strain: ICR;	EXP061927	4410	normal	Q64318	E14.5 dissociated primary cortical cells from forebrain cortex	PEAKS057386
EXP061929	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: stimulated for 90 mins with 250 IU/mL of IFNb (PBL interferon source); Genotype: wildtype;	NULL	12	normal	Q61179	MEF (mouse embryonic fibroblasts)	PEAKS057387
EXP061930	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: stimulated for 90 mins with 250 IU/mL of IFNb (PBL interferon source); Genotype: wildtype;	NULL	12	normal	P42225	MEF (mouse embryonic fibroblasts)	PEAKS057388
EXP061931	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: stimulated for 90 mins with 250 IU/mL of IFNb (PBL interferon source); Genotype: wildtype;	NULL	12	normal	Q9WVL2	MEF (mouse embryonic fibroblasts)	PEAKS057389
EXP061932	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment:none; Genotype: wildtype;	NULL	12	normal	Q61179	MEF (mouse embryonic fibroblasts)	PEAKS057390
EXP061933	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment:none; Genotype: wildtype;	NULL	12	normal	P42225	MEF (mouse embryonic fibroblasts)	PEAKS057391
EXP061934	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment:none; Genotype: wildtype;	NULL	12	normal	Q9WVL2	MEF (mouse embryonic fibroblasts)	PEAKS057392
EXP062839	anti-BACH1 (AF577, R&D)	Mus musculus	Treatment: NAC-Treated, sg1BACH1; Genotype: KrasG12D/+, KrasG12D/+, BACH1 knockout; Strain: mixed C57BL/6-129/Sv	NULL	3647	normal	P97302	mixed cell lines(RP23-51O13, RP23-302D24, RP23-67F18)	PEAKS058067
EXP062840	anti-BACH1 (AF577, R&D)	Mus musculus	Treatment: Control; Genotype: KrasG12D/+; Strain: mixed C57BL/6-129/Sv	NULL	3647	normal	P97302	mixed cell lines(RP23-51O13, RP23-302D24, RP23-67F18)	PEAKS058068
EXP062841	anti-BACH1 (AF577, R&D)	Mus musculus	Treatment: NAC-treated (drinking water of mice); Genotype: KrasG12D/+; Strain: mixed C57BL/6-129/Sv	NULL	3647	normal	P97302	mixed cell lines(RP23-51O13, RP23-302D24, RP23-67F18)	PEAKS058069
EXP061945	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: none; Strain: 129s2;	EXP061941	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	PEAKS057399
EXP061946	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: Glucose starvation; Strain: 129s2;	EXP061942	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	PEAKS057400
EXP061947	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: none; Strain: 129s2;	EXP061943	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	PEAKS057401
EXP061948	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: Glucose starvation; Strain: 129s2;	EXP061944	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	PEAKS057402
EXP061949	anti-MED1 (Santa Cruz, sc-8998)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	Q925J9	liver	PEAKS057403
EXP061950	anti-MED1 (Santa Cruz, sc-8998)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	Q925J9	liver	PEAKS057404
EXP061951	anti-NCOR1 (Abcam, ab24552)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	Q60974	liver	PEAKS057405
EXP061952	anti-NCOR1 (Abcam, ab24552)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	Q60974	liver	PEAKS057406
EXP061953	anti-CBP (Santa Cruz, sc-369)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	P45481	liver	PEAKS057407
EXP061954	anti-CBP (Santa Cruz, sc-369)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	P45481	liver	PEAKS057408
EXP061955	anti-HDAC3 (Santa Cruz, sc-11417)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	O88895	liver	PEAKS057409
EXP061956	anti-HDAC3 (Santa Cruz, sc-11417)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	O88895	liver	PEAKS057410
EXP061957	anti-HDAC3 (Santa Cruz, sc-11417)	Mus musculus	Treatment: PTU; Genotype: L-NCORdeltaID;	NULL	5	normal	O88895	liver	PEAKS057411
EXP061965	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: non-synchronized;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061958	5	normal	P14733	liver	PEAKS057412
EXP061966	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T0 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061959	5	normal	P14733	liver	PEAKS057413
EXP061967	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T6 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061960	5	normal	P14733	liver	PEAKS057414
EXP061968	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T12 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061961	5	normal	P14733	liver	PEAKS057415
EXP061969	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T18 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061962	5	normal	P14733	liver	PEAKS057416
EXP061970	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T24 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061963	5	normal	P14733	liver	PEAKS057417
EXP061971	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T30 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061964	5	normal	P14733	liver	PEAKS057418
EXP061976	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: empty vehicle vector;	EXP061972	2953	normal	P19091	prostate organoids	PEAKS057419
EXP061977	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: empty vehicle vector;	EXP061972	2953	normal	P35582	prostate organoids	PEAKS057420
EXP061978	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: overexpression of Foxa1 FE255del;	EXP061973	2953	normal	P19091	prostate organoids	PEAKS057421
EXP061979	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: overexpression of Foxa1 FE255del;	EXP061973	2953	normal	P35582	prostate organoids	PEAKS057422
EXP061980	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: overexpression of Foxa1 R219S;	EXP061974	2953	normal	P19091	prostate organoids	PEAKS057423
EXP061981	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: overexpression of Foxa1 R219S;	EXP061974	2953	normal	P35582	prostate organoids	PEAKS057424
EXP061982	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: overexpression of Foxa1 WT;	EXP061975	2953	normal	P19091	prostate organoids	PEAKS057425
EXP061983	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: overexpression of Foxa1 WT;	EXP061975	2953	normal	P35582	prostate organoids	PEAKS057426
EXP061988	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: exposed to chronic cold (4C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061984	115	normal	Q3UV55	brown adipose tissue	PEAKS057427
EXP061989	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: exposed to chronic cold (4C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061985	115	normal	Q3UV55	brown adipose tissue	PEAKS057428
EXP061990	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: thermoneutrality (29C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061986	115	normal	Q3UV55	brown adipose tissue	PEAKS057429
EXP061991	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: thermoneutrality (29C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061987	115	normal	Q3UV55	brown adipose tissue	PEAKS057430
EXP061996	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Rag -/- ; Cell type: Abelson cells;	EXP061992	503	normal	P17433	pre-B cells	PEAKS057431
EXP061997	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Art -/-  ; Cell type: Abelson cells;	EXP061993	503	normal	P17433	pre-B cells	PEAKS057432
EXP061998	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells; Treatment: none treatment;	EXP061994	503	normal	P17433	pre-B cells	PEAKS057433
EXP061999	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Rag -/-, SPIC-tet ; Cell type: Abelson cells; Treatment: DOX  treatment;	EXP061994	503	normal	P17433	pre-B cells	PEAKS057434
EXP062000	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Art -/- , SPIC-tet; Cell type: Abelson cells; Treatment: none dox;	NULL	503	normal	P17433	pre-B cells	PEAKS057435
EXP062001	anti-HA (ab9110, Abcam)	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells; Treatment: DOX  treatment;	NULL	503	normal	Q6P3D7	pre-B cells	PEAKS057436
EXP062002	anti-BCLAF1 (A300-608A, Bethyl Laboratories)	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells; Treatment: DOX  treatment;	NULL	503	normal	Q8K019	pre-B cells	PEAKS057437
EXP062005	anti-TCF7L2 (Cell signaling #2569 lot#4)	Mus musculus	Genotype: Tcf7l2 knockout; Strain: C57BL/6; Passage: 10-13;	EXP062003	4420	normal	Q924A0	immortalized primary preadipocytes	PEAKS057438
EXP062006	anti-TCF7L2 (Cell signaling #2569 lot#4)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Passage: 10-13;	EXP062004	4420	normal	Q924A0	immortalized primary preadipocytes	PEAKS057439
EXP062007	anti-EZH2 (Diagenode, C15410039, 3?g)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1105	normal	Q61188	E12.5 embryonic distal forelimb	PEAKS057440
EXP062008	anti-EZH2 (Diagenode, C15410039, 3?g)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1198	normal	Q61188	E12.5 embryonic proximal forelimbs	PEAKS057441
EXP062009	anti-RING1B (Active Motif ,39664, 4ug)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1105	normal	Q9CQJ4	E12.5 embryonic distal forelimb	PEAKS057442
EXP062010	anti-RING1B (Active Motif ,39664, 4ug)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1198	normal	Q9CQJ4	E12.5 embryonic proximal forelimbs	PEAKS057443
EXP062012	anti-ERa (Santa Cruz, sc-542)	Mus musculus	Strain: BALB/c; Age: 6 weeks; Genotype: wildtype; Treatment: treated with 17beta Estradiol for 2 hours;	EXP062011	572	normal	P19785	mammary gland	PEAKS057444
EXP062017	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Sg1-sgRNA expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062014	4422	normal	Q61550	v-Abl transformed pro-B cells	PEAKS057445
EXP062018	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062013	4422	normal	Q61550	v-Abl transformed pro-B cells	PEAKS057446
EXP062019	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	normal	Q61550	v-Abl transformed pro-B cells	PEAKS057447
EXP062020	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Ig2b-del/del, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	normal	Q61550	v-Abl transformed pro-B cells	PEAKS057448
EXP062021	anti-NIPBL antibody (Bethyl Laboratories, A301-779A) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062015	4422	normal	Q6KCD5	v-Abl transformed pro-B cells	PEAKS057449
EXP062022	anti-NIPBL antibody (Bethyl Laboratories, A301-779A) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Sg1-sgRNA expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062016	4422	normal	Q6KCD5	v-Abl transformed pro-B cells	PEAKS057450
EXP062027	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062023	965	normal	D3YY81	frontal cortex	PEAKS057451
EXP062028	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062023	965	normal	D3Z7U4	frontal cortex	PEAKS057452
EXP062029	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062024	965	normal	D3YY81	frontal cortex	PEAKS057453
EXP062030	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062024	965	normal	D3Z7U4	frontal cortex	PEAKS057454
EXP062031	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062025	965	normal	D3YY81	frontal cortex	PEAKS057455
EXP062032	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062025	965	normal	D3Z7U4	frontal cortex	PEAKS057456
EXP062033	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062026	965	normal	D3YY81	frontal cortex	PEAKS057457
EXP062034	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062026	965	normal	D3Z7U4	frontal cortex	PEAKS057458
EXP062036	anti-Gli2 antibody (R&D AF3526)	Mus musculus	Strain: Swiss Webster; Genotype: wildtype;	EXP062035	4428	normal	Q0VGT2	E10.5 head	PEAKS057459
EXP062046	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062037	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057460
EXP062047	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062038	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057461
EXP062048	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062039	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057462
EXP062049	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062040	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057463
EXP062050	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062041	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057464
EXP062051	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062042	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057465
EXP062052	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062038	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057466
EXP062053	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062039	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057467
EXP062054	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062040	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057468
EXP062055	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062041	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057469
EXP062056	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062038	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057470
EXP062057	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062039	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057471
EXP062058	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062040	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057472
EXP062059	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062041	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057473
EXP062060	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062043	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057474
EXP062061	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expression of  Mef2c; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062044	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057475
EXP062062	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expression of Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062045	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	PEAKS057476
EXP062067	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: untreated;	EXP062063	233	normal	Q925J9	E14TG2A (embryonic stem cells)	PEAKS057477
EXP062068	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: untreated;	EXP062064	233	normal	Q925J9	E14TG2A (embryonic stem cells)	PEAKS057478
EXP062069	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062065	233	normal	Q925J9	E14TG2A (embryonic stem cells)	PEAKS057479
EXP062070	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062066	233	normal	Q925J9	E14TG2A (embryonic stem cells)	PEAKS057480
EXP062071	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: untreated;	EXP062063	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057481
EXP062072	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: untreated;	EXP062064	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057482
EXP062073	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062065	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057483
EXP062074	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062066	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057484
EXP062075	anti-GFP (abcam, ab290)	Mus musculus	Age: 3 months; Sex: male; Strain: mixed 129J-C57BL/6; Genotype: wildtype;	NULL	898	normal	Q9R1E0	pancreatic islets	PEAKS057485
EXP062078	Anti-CXXC5 Antibody (CST 84546S)	Mus musculus	Genotype: CXXC5 knockout; Strain: mixed 129/C57BL/6; Passage: 15-18;	EXP062077	2	normal	Q91WA4	mESCs (mouse embryonic stem cells)	PEAKS057486
EXP062079	Anti-CXXC5 Antibody (CST 84546S)	Mus musculus	Genotype: CXXC5 Wild type; Strain: mixed 129/C57BL/6; Passage: 15-18;	EXP062076	2	normal	Q91WA4	mESCs (mouse embryonic stem cells)	PEAKS057487
EXP062080	anti-FLAG M2 SIGMA (F3165)	Mus musculus	Genotype: expressing 3x flag-Creb3l2;	NULL	75	normal	Q8BH52	AtT-20 (pituitary tumor)	PEAKS057488
EXP062081	anti-XBP1 (M-186 Santa Cruz, Sc-7160)	Mus musculus		NULL	75	normal	O35426	AtT-20 (pituitary tumor)	PEAKS057489
EXP062085	anti-Nr4a1 (ChIP-antibody, 14-5964-82, clone 357, ebioscience)	Mus musculus	Genotype: Nr4a1 overexpressed ; Strain: C57BL/6;	EXP062082	4457	normal	P12813	primed CD4+ T cells	PEAKS057490
EXP062086	HA (Cat3724, clone C29F4, Cell signaling technology)	Mus musculus	Genotype: HA-Nr4a1; Strain: C57BL/6; Treatment: in vitro activation by TCR/Co-stimulation;	EXP062083	4458	normal	P12813	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057491
EXP062087	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype:RV-Nr4a1;  Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057492
EXP062088	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype: RV-vector;Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057493
EXP062089	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype: c-jun knockout; Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057494
EXP062090	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype: wildtype; Treatment: in vitro activation by TCR/Co-stimulation; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057495
EXP062091	anti-Batf (PAB4003, Brookwood biomedical)	Mus musculus	Genotype:RV-Nr4a1;  Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	O35284	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057496
EXP062092	anti-Batf (PAB4003, Brookwood biomedical)	Mus musculus	Genotype: RV-vector;Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	O35284	activated CD4+ T cells from spleen and peripheral lymoh organs	PEAKS057497
EXP062097	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062093	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057498
EXP062098	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062094	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057499
EXP062099	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: treated with 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062095	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057500
EXP062100	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: treated with 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062096	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057501
EXP062109	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062101	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057502
EXP062110	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062102	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057503
EXP062111	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062103	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057504
EXP062112	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057505
EXP062113	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062101	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057506
EXP062114	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062102	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057507
EXP062115	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062103	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057508
EXP062116	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062104	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057509
EXP062117	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062105	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057510
EXP062118	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062106	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057511
EXP062119	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062107	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057512
EXP062120	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062108	233	normal	Q61539	E14TG2A (embryonic stem cells)	PEAKS057513
EXP062121	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062105	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057514
EXP062122	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062106	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057515
EXP062123	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062107	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057516
EXP062124	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062108	233	normal	P48432	E14TG2A (embryonic stem cells)	PEAKS057517
EXP062128	anti-FLAG antibody (Sigma, F3165)	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062125	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057518
EXP062129	anti-FLAG antibody (Sigma, F3165)	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062126	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057519
EXP062130	anti-FLAG antibody (Sigma, F3165)	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062127	233	normal	Q99K74	E14TG2A (embryonic stem cells)	PEAKS057520
EXP062135	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062131	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057521
EXP062136	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062132	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057522
EXP062137	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062133	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057523
EXP062138	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062134	233	normal	P29037	E14TG2A (embryonic stem cells)	PEAKS057524
EXP062140	anti-GR coctail (Thermo MA1-510, Santa Cruz #SC-1008)	Mus musculus	Treatment: untreated; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 0 hrs;	NULL	2474	normal	P06537	C127	PEAKS057525
EXP062141	anti-GR coctail (Thermo MA1-510, Santa Cruz #SC-1008)	Mus musculus	Treatment: 600 nM Corticosterone for 1 hr; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 1 hr;	EXP062139	2474	normal	P06537	C127	PEAKS057526
EXP062142	anti-GR coctail (Thermo MA1-510, Santa Cruz #SC-1008)	Mus musculus	Treatment: 600 nM Corticosterone for 1 hr; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 12 hrs;	NULL	2474	normal	P06537	C127	PEAKS057527
EXP062155	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062143	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	PEAKS057528
EXP062156	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062144	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	PEAKS057529
EXP062157	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062145	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	PEAKS057530
EXP062158	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062146	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	PEAKS057531
EXP062159	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062147	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	PEAKS057532
EXP062160	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062148	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	PEAKS057533
EXP062161	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062149	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	PEAKS057534
EXP062162	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062150	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	PEAKS057535
EXP062163	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062151	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	PEAKS057536
EXP062164	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062152	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	PEAKS057537
EXP062165	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062153	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	PEAKS057538
EXP062166	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062154	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	PEAKS057539
EXP062172	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #3;	NULL	4461	normal	Q08943	immortalized mouse skin fibroblasts	PEAKS057540
EXP062173	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062168	4462	normal	Q08943	transformed mouse skin fibroblasts	PEAKS057541
EXP062174	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062170	4462	normal	Q08943	transformed mouse skin fibroblasts	PEAKS057542
EXP062175	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062171	4462	normal	Q08943	transformed mouse skin fibroblasts	PEAKS057543
EXP062176	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062167	4461	normal	Q08943	immortalized mouse skin fibroblasts	PEAKS057544
EXP062177	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #3;	EXP062169	4462	normal	Q08943	transformed mouse skin fibroblasts	PEAKS057545
EXP062187	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 KO; Time point: Zeitgeber Time 8;	EXP062178	5	normal	Q9WTL8	liver	PEAKS057546
EXP062188	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 20;	EXP062179	5	normal	Q9WTL8	liver	PEAKS057547
EXP062189	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 20;	EXP062180	5	normal	Q9WTL8	liver	PEAKS057548
EXP062190	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 8;	EXP062181	5	normal	Q9WTL8	liver	PEAKS057549
EXP062191	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 8;	EXP062182	5	normal	Q9WTL8	liver	PEAKS057550
EXP062192	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 20;	EXP062183	5	normal	Q9WTL8	liver	PEAKS057551
EXP062193	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 20;	EXP062184	5	normal	Q9WTL8	liver	PEAKS057552
EXP062194	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 8;	EXP062185	5	normal	Q9WTL8	liver	PEAKS057553
EXP062195	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 8;	EXP062186	5	normal	Q9WTL8	liver	PEAKS057554
EXP062199	anti-Bcl6 (Santa Cruz Biotechnology; Cat# sc-858, RRID:AB_2063450)	Mus musculus	Time point: day 12 of differentiation;	EXP062196	4465	normal	P41183	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	PEAKS057555
EXP062200	anti-Bcl6 (Santa Cruz Biotechnology; Cat# sc-858, RRID:AB_2063450)	Mus musculus	Time point: day 12 of differentiation;	EXP062197	4465	normal	P41183	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	PEAKS057556
EXP062201	anti-Bcl6 (Santa Cruz Biotechnology; Cat# sc-858, RRID:AB_2063450)	Mus musculus	Time point: day 12 of differentiation;	EXP062198	4465	normal	P41183	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	PEAKS057557
EXP062214	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062202	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057558
EXP062215	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062203	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057559
EXP062216	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062204	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057560
EXP062217	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062205	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057561
EXP062218	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062206	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057562
EXP062219	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062207	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057563
EXP062220	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062208	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057564
EXP062221	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062209	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057565
EXP062222	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062210	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057566
EXP062223	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062211	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057567
EXP062224	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062212	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057568
EXP062225	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062213	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	PEAKS057569
EXP062227	anti-myc antibody (5ug clone 9E10 â€“ Roche)	Mus musculus	Treatment: Not treated;Time point: day 4 of differentiation;	EXP062226	4467	normal	P40646	E14Tg2a differentiating mES cells	PEAKS057570
EXP062228	anti-myc antibody (5ug clone 9E10 â€“ Roche)	Mus musculus	Treatment: doxycycline treated for 24 hrs; Time point: day 4 of differentiation;	NULL	4467	normal	P40646	E14Tg2a differentiating mES cells	PEAKS057571
EXP062230	anti-Stat6 ( Cell Signaling Technology, Cat#5397)	Mus musculus	Treatment: Stimulated for 1 hr with IL-4; Genotype: wildtype; Strain: C57BL/6;	EXP062229	732	normal	P52633	peritoneal macrophages	PEAKS057572
EXP062231	anti-Stat6 ( Cell Signaling Technology, Cat#5397)	Mus musculus	Treatment: Stimulated for 1 hr with IL-4; Genotype: Trim24 knockout; Strain: C57BL/6;	NULL	732	normal	P52633	peritoneal macrophages	PEAKS057573
EXP062233	anti-MafG (PMID: 22965115)	Mus musculus	Genotype: MafF-/-::MafG-/-::MafK-/-:T-NG2; Treatment: Vehcle for 4 hrs;	EXP062232	12	normal	O54790	MEF (mouse embryonic fibroblasts)	PEAKS057574
EXP062234	anti-MafG (PMID: 22965115)	Mus musculus	Genotype: MafF-/-::MafG-/-::MafK-/-:T-NG2; Treatment: 100 uM Diethyl Maleate for 4 hrs;	NULL	12	normal	O54790	MEF (mouse embryonic fibroblasts)	PEAKS057575
EXP062236	anti-Bhlhe40 (Novus Biologicals, NB100-1800, lot C2)	Mus musculus	Genotype: Bhlhe40+/+Bhlhe41+/+ (wildtype); Strain: C57BL/6;	EXP062235	62	normal	O35185	alveolar macrophages	PEAKS057576
EXP062244	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 02; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062237	5	normal	P28700	liver	PEAKS057577
EXP062245	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 06; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062238	5	normal	P28700	liver	PEAKS057578
EXP062246	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 10; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062239	5	normal	P28700	liver	PEAKS057579
EXP062247	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 14; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062240	5	normal	P28700	liver	PEAKS057580
EXP062248	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 18; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062241	5	normal	P28700	liver	PEAKS057581
EXP062249	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 22; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	normal	P28700	liver	PEAKS057582
EXP062250	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 26; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062243	5	normal	P28700	liver	PEAKS057583
EXP062257	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062251	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057584
EXP062258	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062252	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057585
EXP062259	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062253	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057586
EXP062260	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062254	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057587
EXP062261	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062255	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057588
EXP062262	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062256	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057589
EXP062263	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062251	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057590
EXP062264	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062252	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057591
EXP062265	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062253	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057592
EXP062266	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062254	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057593
EXP062267	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062255	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057594
EXP062268	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062256	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057595
EXP062269	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062251	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057596
EXP062270	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062252	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057597
EXP062271	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062253	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057598
EXP062272	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062254	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057599
EXP062273	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062255	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057600
EXP062274	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062256	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057601
EXP062275	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057602
EXP062276	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057603
EXP062277	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057604
EXP062278	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057605
EXP062279	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057606
EXP062280	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057607
EXP062281	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:Untreated;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	PEAKS057608
EXP062282	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:Untreated;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	PEAKS057609
EXP062283	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:Untreated;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	PEAKS057610
EXP062288	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: none;	EXP062284	5	normal	P23204	liver	PEAKS057611
EXP062289	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: none;	EXP062285	5	normal	P23204	liver	PEAKS057612
EXP062290	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: Wy-14,643 (50mg/kg) was intragastrically injected to mice twice a day;	EXP062286	5	normal	P23204	liver	PEAKS057613
EXP062291	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: Wy-14,643 (50mg/kg) was intragastrically injected to mice twice a day;	EXP062287	5	normal	P23204	liver	PEAKS057614
EXP062293	anti-TCF4 (Santa Cruz, H-125, sc13027, lot C0707)	Mus musculus	Treatment: vehicle;	EXP062292	575	normal	Q60722	bone marrow-derived mesenchymal stem cells	PEAKS057615
EXP062294	anti-TCF4 (Santa Cruz, H-125, sc13027, lot C0707)	Mus musculus	Treatment: LiCl for 3 hrs;	NULL	575	normal	Q60722	bone marrow-derived mesenchymal stem cells	PEAKS057616
EXP062296	anti-Egr1	Mus musculus	Strain: C57BL6N/129SvEv; Age: 6 weeks;	EXP062295	965	normal	P08046	frontal cortex	PEAKS057617
EXP062298	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: None; Genotype: Control-ATG;	EXP062297	23	normal	Q03347	416B (hematopoietic precursor cells)	PEAKS057618
EXP062299	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: None; Genotype: Control-ATG;	EXP062297	23	normal	A2AJK6	416B (hematopoietic precursor cells)	PEAKS057619
EXP062300	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: Control-ATG;	NULL	23	normal	Q03347	416B (hematopoietic precursor cells)	PEAKS057620
EXP062301	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: Control-ATG;	NULL	23	normal	A2AJK6	416B (hematopoietic precursor cells)	PEAKS057621
EXP062302	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: None; Genotype: CBFB-MYH11;	NULL	23	normal	Q03347	416B (hematopoietic precursor cells)	PEAKS057622
EXP062303	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: None; Genotype: CBFB-MYH11;	NULL	23	normal	A2AJK6	416B (hematopoietic precursor cells)	PEAKS057623
EXP062304	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: CBFB-MYH11;	NULL	23	normal	Q03347	416B (hematopoietic precursor cells)	PEAKS057624
EXP062305	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: CBFB-MYH11;	NULL	23	normal	A2AJK6	416B (hematopoietic precursor cells)	PEAKS057625
EXP062307	anti-PGR antibody (Santa Cruz #sc-7208)	Mus musculus	Conditions: ovariectomized; Strain: C57BL6/6J, 129 mixed strain; Age: 8-10 weeks;	EXP062306	132	normal	Q00175	uterus	PEAKS057626
EXP062308	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: CTD diet; Genotype: wildtype;	NULL	860	normal	Q80TJ7	ventral prostate	PEAKS057627
EXP062309	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: CTD diet; Genotype: Hi-MYC;	NULL	860	normal	Q80TJ7	ventral prostate	PEAKS057628
EXP062310	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: high-fat diet; Genotype: wildtype;	NULL	860	normal	Q80TJ7	ventral prostate	PEAKS057629
EXP062311	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: high-fat diet; Genotype: Hi-MYC;	NULL	860	normal	Q80TJ7	ventral prostate	PEAKS057630
EXP062312	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4194	normal	Q9Y812	Nott519 strain	PEAKS057631
EXP062313	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4389	normal	Q9Y812	Nott520 strain	PEAKS057632
EXP062314	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1  deletion;	NULL	4390	normal	Q9Y812	Nott688 strain	PEAKS057633
EXP062315	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1  deletion;	NULL	4391	normal	Q9Y812	Nott689 strain	PEAKS057634
EXP062316	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4392	normal	Q9Y812	Nott850 strain	PEAKS057635
EXP062317	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4393	normal	Q9Y812	Nott851 strain	PEAKS057636
EXP062318	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Empty vector + Cnp1  deletion;	NULL	4394	normal	Q9Y812	Nott631 strain	PEAKS057637
EXP062319	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Empty vector + Cnp1  deletion;	NULL	4395	normal	Q9Y812	Nott632 strain	PEAKS057638
EXP062320	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 5.9kb Cnp1 before deletion;	NULL	4397	normal	Q9Y812	Nott819 strain	PEAKS057639
EXP062321	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 5.9kb Cnp1  deletion;	NULL	4398	normal	Q9Y812	Nott820 strain	PEAKS057640
EXP062322	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 5.9kb Cnp1  deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057641
EXP062323	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057642
EXP062324	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 before deletion;	NULL	4399	normal	Q9Y812	Nott817 strain	PEAKS057643
EXP062325	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 before deletion;	NULL	4400	normal	Q9Y812	Nott818 strain	PEAKS057644
EXP062326	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057645
EXP062327	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057646
EXP062328	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 before deletion;	NULL	4401	normal	Q9Y812	Nott493 strain	PEAKS057647
EXP062329	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 before deletion;	NULL	4402	normal	Q9Y812	Nott494 strain	PEAKS057648
EXP062330	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 deletion;	NULL	4403	normal	Q9Y812	Nott678 strain	PEAKS057649
EXP062331	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 deletion;	NULL	4404	normal	Q9Y812	Nott679 strain	PEAKS057650
EXP062332	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057651
EXP062333	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057652
EXP062334	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057653
EXP062335	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	PEAKS057654
EXP062336	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 before deletion;	NULL	4405	normal	Q9Y812	Nott821 strain	PEAKS057655
EXP062337	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 before deletion;	NULL	4464	normal	Q9Y812	Nott822 strain	PEAKS057656
EXP062338	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 deletion;	NULL	4466	normal	Q9Y812	Nott833 strain	PEAKS057657
EXP062339	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 deletion;	NULL	4480	normal	Q9Y812	Nott834 strain	PEAKS057658
EXP062340	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 ade6;	NULL	4481	normal	Q9Y812	Nott376 strain	PEAKS057659
EXP062341	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 ade6;	NULL	4482	normal	Q9Y812	Nott377 strain	PEAKS057660
EXP062342	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 at neo cen;	NULL	4483	normal	Q9Y812	Nott810 strain	PEAKS057661
EXP062343	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 at neo cen;	NULL	4484	normal	Q9Y812	Nott802 strain	PEAKS057662
EXP062344	anti-CENP-A	Schizosaccharomyces pombe	Genotype: 5.3kb Cnp1 before deletion;	NULL	4485	normal	Q9Y812	Nott823 strain	PEAKS057663
EXP062345	anti-CENP-A	Schizosaccharomyces pombe	Genotype: 5.3kb Cnp1 before deletion;	NULL	4486	normal	Q9Y812	Nott824 strain	PEAKS057664
EXP062346	anti-CENP-A	Schizosaccharomyces pombe	Genotype: GC rich Cnp1 before deletion;	NULL	4487	normal	Q9Y812	Nott860 strain	PEAKS057665
EXP062347	anti-CENP-A	Schizosaccharomyces pombe	Genotype: GC rich Cnp1 before deletion;	NULL	4488	normal	Q9Y812	Nott861 strain	PEAKS057666
EXP062348	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Alphoid Cnp1 before deletion;	NULL	4489	normal	Q9Y812	Nott496 strain	PEAKS057667
EXP062349	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Alphoid Cnp1 before deletion;	NULL	4490	normal	Q9Y812	Nott497 strain	PEAKS057668
EXP062350	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Empty vector + Cnp3 deletion;	NULL	4396	normal	Q9Y812	Nott775 strain	PEAKS057669
EXP062372	anti-ESR1	Homo sapiens	Age: 37;	EXP062351	4491	normal	P03372	ER+ breast tumor	PEAKS057670
EXP062373	anti-ESR1	Homo sapiens	Age: 39;	EXP062352	4491	normal	P03372	ER+ breast tumor	PEAKS057671
EXP062374	anti-ESR1	Homo sapiens	Age: 38;	EXP062353	4491	normal	P03372	ER+ breast tumor	PEAKS057672
EXP062375	anti-ESR1	Homo sapiens	Age: 41;	EXP062354	4491	normal	P03372	ER+ breast tumor	PEAKS057673
EXP062376	anti-ESR1	Homo sapiens	Age: 48;	NULL	4491	normal	P03372	ER+ breast tumor	PEAKS057674
EXP062377	anti-ESR1	Homo sapiens	Age: 43;	EXP062356	4491	normal	P03372	ER+ breast tumor	PEAKS057675
EXP062378	anti-ESR1	Homo sapiens	Age: 38;	EXP062357	4491	normal	P03372	ER+ breast tumor	PEAKS057676
EXP062379	anti-ESR1	Homo sapiens	Age: 48;	EXP062358	4491	normal	P03372	ER+ breast tumor	PEAKS057677
EXP062380	anti-ESR1	Homo sapiens	Age: 37;	EXP062359	4491	normal	P03372	ER+ breast tumor	PEAKS057678
EXP062381	anti-ESR1	Homo sapiens	Age: 55;	EXP062360	4491	normal	P03372	ER+ breast tumor	PEAKS057679
EXP062382	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062367	4492	normal	P03372	normal mature luminal breast cells	PEAKS057680
EXP062383	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062368	4492	normal	P03372	normal mature luminal breast cells	PEAKS057681
EXP062384	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062369	4492	normal	P03372	normal mature luminal breast cells	PEAKS057682
EXP062385	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062370	4492	normal	P03372	normal mature luminal breast cells	PEAKS057683
EXP062386	anti-ESR1	Homo sapiens	Genotype: ER+;	NULL	4492	normal	P03372	normal mature luminal breast cells	PEAKS057684
EXP062387	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: 10 nM E2 for 45 minutes; Genotype: wildtype;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS057685
EXP062388	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	EXP062371	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS057686
EXP062389	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: 10 nM E2 for 45 minutes; Genotype: CRISPR GRHL2;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS057687
EXP062390	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: 10 nM E2 for 45 minutes; Genotype: CRISPR GRHL2;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS057688
EXP062391	Anti-GRHL2 (HPA004820 , Sigma)	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	NULL	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	PEAKS057689
EXP062392	Anti-GRHL2 (HPA004820 , Sigma)	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	NULL	111	normal	Q6ISB3	T47D (invasive ductal carcinoma)	PEAKS057690
EXP062403	SRSF1 (Bethyl Cat#A302-052A)	Homo sapiens		EXP062401	430	normal	Q07955	HepG2 (hepatoblastoma)	PEAKS057691
EXP062404	SRSF3 (MBL Cat# RN080PW)	Homo sapiens		EXP062401	430	normal	P84103	HepG2 (hepatoblastoma)	PEAKS057692
EXP062405	SRSF4 (Bethyl Cat# A303-670A)	Homo sapiens		EXP062401	430	normal	Q08170	HepG2 (hepatoblastoma)	PEAKS057693
EXP062406	SRSF7 (MBL Cat# RN079PW)	Homo sapiens		EXP062401	430	normal	Q16629	HepG2 (hepatoblastoma)	PEAKS057694
EXP062407	SRSF9 (MBL Cat# RN081PW)	Homo sapiens		EXP062401	430	normal	Q13242	HepG2 (hepatoblastoma)	PEAKS057695
EXP062408	U2AF1 (Bethyl Cat# A302-079A)	Homo sapiens		EXP062401	430	normal	Q01081	HepG2 (hepatoblastoma)	PEAKS057696
EXP062409	U2AF2 (Bethyl Cat# A303-665A)	Homo sapiens		EXP062401	430	normal	P26368	HepG2 (hepatoblastoma)	PEAKS057697
EXP062410	HNRNPC (Santa Cruz Biotechnology Cat# sc-10037)	Homo sapiens		EXP062401	430	normal	P07910	HepG2 (hepatoblastoma)	PEAKS057698
EXP062411	HNRNPH1 (Aviva Cat# ARP58479_P050)	Homo sapiens		EXP062401	430	normal	P31943	HepG2 (hepatoblastoma)	PEAKS057699
EXP062412	HNRNPK (MBL Cat# RN019P)	Homo sapiens		EXP062401	430	normal	P61978	HepG2 (hepatoblastoma)	PEAKS057700
EXP062413	HNRNPL (Aviva Cat# ARP40368_P050)	Homo sapiens		EXP062401	430	normal	P14866	HepG2 (hepatoblastoma)	PEAKS057701
EXP062414	HNRNPLL (Cell Signaling Technology Cat# 4783S)	Homo sapiens		EXP062401	430	normal	Q8WVV9	HepG2 (hepatoblastoma)	PEAKS057702
EXP062415	HNRNPUL1 (Abcam Cat# ab68480)	Homo sapiens		EXP062401	430	normal	Q9BUJ2	HepG2 (hepatoblastoma)	PEAKS057703
EXP062416	PTBP1 (MBL Cat# RN011P)	Homo sapiens		EXP062401	430	normal	P26599	HepG2 (hepatoblastoma)	PEAKS057704
EXP062417	PCBP1 (MBL Cat# RN024P)	Homo sapiens		EXP062401	430	normal	Q15365	HepG2 (hepatoblastoma)	PEAKS057705
EXP062418	PCBP2 (MBL Cat# RN025P)	Homo sapiens		EXP062401	430	normal	Q15366	HepG2 (hepatoblastoma)	PEAKS057706
EXP062419	FUS (Bethyl Cat# A300-294A)	Homo sapiens		EXP062401	430	normal	P35637	HepG2 (hepatoblastoma)	PEAKS057707
EXP062420	TAF15 (Abcam Cat# ab134916)	Homo sapiens		EXP062401	430	normal	Q92804	HepG2 (hepatoblastoma)	PEAKS057708
EXP062421	SNRNP70 (Santa Cruz Biotechnology Cat# sc-9571)	Homo sapiens		EXP062401	430	normal	P08621	HepG2 (hepatoblastoma)	PEAKS057709
EXP062422	PRPF4 (MBL Cat# RN093PW)	Homo sapiens		EXP062401	430	normal	O43172	HepG2 (hepatoblastoma)	PEAKS057710
EXP062423	FIP1L1 (Abclonal Cat# #A5016)	Homo sapiens		EXP062401	430	normal	Q6UN15	HepG2 (hepatoblastoma)	PEAKS057711
EXP062424	RBFOX2 (Bethyl Cat# A300-864A)	Homo sapiens		EXP062401	430	normal	O43251	HepG2 (hepatoblastoma)	PEAKS057712
EXP062425	RBM22 (Bethyl Cat# A303-923A)	Homo sapiens		EXP062401	430	normal	Q9NW64	HepG2 (hepatoblastoma)	PEAKS057713
EXP062426	RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062401	430	normal	P49756	HepG2 (hepatoblastoma)	PEAKS057714
EXP062427	RBM39 (Bethyl Cat# A300-291A)	Homo sapiens		EXP062401	430	normal	Q14498	HepG2 (hepatoblastoma)	PEAKS057715
EXP062428	AGO1 (Cell Signaling Technology Cat# 5053)	Homo sapiens		EXP062401	430	normal	Q9UL18	HepG2 (hepatoblastoma)	PEAKS057716
EXP062429	AGO2 (Abnova Cat# H00027161-M01)	Homo sapiens		EXP062401	430	normal	Q9UKV8	HepG2 (hepatoblastoma)	PEAKS057717
EXP062430	SAFB2 (Bethyl Cat# A301-112A)	Homo sapiens		EXP062401	430	normal	Q14151	HepG2 (hepatoblastoma)	PEAKS057718
EXP062431	NONO (Santa Cruz Biotechnology  Cat# sc-166702)	Homo sapiens		EXP062401	430	normal	Q15233	HepG2 (hepatoblastoma)	PEAKS057719
EXP062432	GTF2F1 (GeneTex Cat# GTX114455)	Homo sapiens		EXP062401	430	normal	P35269	HepG2 (hepatoblastoma)	PEAKS057720
EXP062433	SFPQ (Bethyl Cat# A301-321A)	Homo sapiens		EXP062401	430	normal	P23246	HepG2 (hepatoblastoma)	PEAKS057721
EXP062434	TARDBP (Bethyl Cat# A303-223A)	Homo sapiens		EXP062401	430	normal	Q13148	HepG2 (hepatoblastoma)	PEAKS057722
EXP062435	XRCC5 (Zen BioScience Cat# 201004)	Homo sapiens		EXP062401	430	normal	P13010	HepG2 (hepatoblastoma)	PEAKS057723
EXP062436	CCAR2 (Zen BioScience Cat# 200093)	Homo sapiens		EXP062401	430	normal	Q8N163	HepG2 (hepatoblastoma)	PEAKS057724
EXP062437	SRSF1 (Bethyl Cat#A302-052A)	Homo sapiens		EXP062402	514	normal	Q07955	K562 (myelogenous leukemia)	PEAKS057725
EXP062438	SRSF3 (MBL Cat# RN080PW)	Homo sapiens		EXP062402	514	normal	P84103	K562 (myelogenous leukemia)	PEAKS057726
EXP062439	SRSF4 (Bethyl Cat# A303-670A)	Homo sapiens		EXP062402	514	normal	Q08170	K562 (myelogenous leukemia)	PEAKS057727
EXP062440	SRSF7 (MBL Cat# RN079PW)	Homo sapiens		EXP062402	514	normal	Q16629	K562 (myelogenous leukemia)	PEAKS057728
EXP062441	SRSF9 (MBL Cat# RN081PW)	Homo sapiens		EXP062402	514	normal	Q13242	K562 (myelogenous leukemia)	PEAKS057729
EXP062442	U2AF1 (Bethyl Cat# A302-079A)	Homo sapiens		EXP062402	514	normal	Q01081	K562 (myelogenous leukemia)	PEAKS057730
EXP062443	U2AF2 (Bethyl Cat# A303-665A)	Homo sapiens		EXP062402	514	normal	P26368	K562 (myelogenous leukemia)	PEAKS057731
EXP062444	HNRNPC (Santa Cruz Biotechnology Cat# sc-10037)	Homo sapiens		EXP062402	514	normal	P07910	K562 (myelogenous leukemia)	PEAKS057732
EXP062445	HNRNPH1 (Aviva Cat# ARP58479_P050)	Homo sapiens		EXP062402	514	normal	P31943	K562 (myelogenous leukemia)	PEAKS057733
EXP062446	HNRNPK (MBL Cat# RN019P)	Homo sapiens		EXP062402	514	normal	P61978	K562 (myelogenous leukemia)	PEAKS057734
EXP062447	HNRNPL (Aviva Cat# ARP40368_P050)	Homo sapiens		EXP062402	514	normal	P14866	K562 (myelogenous leukemia)	PEAKS057735
EXP062448	HNRNPLL (Cell Signaling Technology Cat# 4783S)	Homo sapiens		EXP062402	514	normal	Q8WVV9	K562 (myelogenous leukemia)	PEAKS057736
EXP062449	HNRNPUL1 (Abcam Cat# ab68480)	Homo sapiens		EXP062402	514	normal	Q9BUJ2	K562 (myelogenous leukemia)	PEAKS057737
EXP062450	PTBP1 (MBL Cat# RN011P)	Homo sapiens		EXP062402	514	normal	P26599	K562 (myelogenous leukemia)	PEAKS057738
EXP062451	PCBP1 (MBL Cat# RN024P)	Homo sapiens		EXP062402	514	normal	Q15365	K562 (myelogenous leukemia)	PEAKS057739
EXP062452	PCBP2 (MBL Cat# RN025P)	Homo sapiens		EXP062402	514	normal	Q15366	K562 (myelogenous leukemia)	PEAKS057740
EXP062453	FUS (Bethyl Cat# A300-294A)	Homo sapiens		EXP062402	514	normal	P35637	K562 (myelogenous leukemia)	PEAKS057741
EXP062454	TAF15 (Abcam Cat# ab134916)	Homo sapiens		EXP062402	514	normal	Q92804	K562 (myelogenous leukemia)	PEAKS057742
EXP062455	SNRNP70 (Santa Cruz Biotechnology Cat# sc-9571)	Homo sapiens		EXP062402	514	normal	P08621	K562 (myelogenous leukemia)	PEAKS057743
EXP062456	PRPF4 (MBL Cat# RN093PW)	Homo sapiens		EXP062402	514	normal	O43172	K562 (myelogenous leukemia)	PEAKS057744
EXP062457	FIP1L1 (Abclonal Cat# #A5016)	Homo sapiens		EXP062402	514	normal	Q6UN15	K562 (myelogenous leukemia)	PEAKS057745
EXP062458	RBFOX2 (Bethyl Cat# A300-864A)	Homo sapiens		EXP062402	514	normal	O43251	K562 (myelogenous leukemia)	PEAKS057746
EXP062459	RBM22 (Bethyl Cat# A303-923A)	Homo sapiens		EXP062402	514	normal	Q9NW64	K562 (myelogenous leukemia)	PEAKS057747
EXP062460	RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062402	514	normal	P49756	K562 (myelogenous leukemia)	PEAKS057748
EXP062461	RBM39 (Bethyl Cat# A300-291A)	Homo sapiens		EXP062402	514	normal	Q14498	K562 (myelogenous leukemia)	PEAKS057749
EXP062462	AGO1 (Cell Signaling Technology Cat# 5053)	Homo sapiens		EXP062402	514	normal	Q9UL18	K562 (myelogenous leukemia)	PEAKS057750
EXP062463	SAFB (Zen BioScience Cat# 200580)	Homo sapiens		EXP062402	514	normal	Q15424	K562 (myelogenous leukemia)	PEAKS057751
EXP062464	SAFB2 (Bethyl Cat# A301-112A)	Homo sapiens		EXP062402	514	normal	Q14151	K562 (myelogenous leukemia)	PEAKS057752
EXP062465	NONO (Santa Cruz Biotechnology  Cat# sc-166702)	Homo sapiens		EXP062402	514	normal	Q15233	K562 (myelogenous leukemia)	PEAKS057753
EXP062466	GTF2F1 (GeneTex Cat# GTX114455)	Homo sapiens		EXP062402	514	normal	P35269	K562 (myelogenous leukemia)	PEAKS057754
EXP062467	SFPQ (Bethyl Cat# A301-321A)	Homo sapiens		EXP062402	514	normal	P23246	K562 (myelogenous leukemia)	PEAKS057755
EXP062468	TARDBP (Bethyl Cat# A303-223A)	Homo sapiens		EXP062402	514	normal	Q13148	K562 (myelogenous leukemia)	PEAKS057756
EXP062469	XRCC5 (Zen BioScience Cat# 201004)	Homo sapiens		EXP062402	514	normal	P13010	K562 (myelogenous leukemia)	PEAKS057757
EXP062470	CCAR2 (Zen BioScience Cat# 200093)	Homo sapiens		EXP062402	514	normal	Q8N163	K562 (myelogenous leukemia)	PEAKS057758
EXP062471	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062393	430	normal	P49756	HepG2 (hepatoblastoma)	PEAKS057759
EXP062472	RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062394	430	normal	P49756	HepG2 (hepatoblastoma)	PEAKS057760
EXP062473	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens	Genotype: YY1 knockout;	EXP062395	430	normal	P49756	HepG2 (hepatoblastoma)	PEAKS057761
EXP062474	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens	Genotype: YY1 knockout;	EXP062396	430	normal	P49756	HepG2 (hepatoblastoma)	PEAKS057762
EXP062475	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens		EXP062397	430	normal	P25490	HepG2 (hepatoblastoma)	PEAKS057763
EXP062476	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens		EXP062398	430	normal	P25490	HepG2 (hepatoblastoma)	PEAKS057764
EXP062477	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens	Genotype: RBM25 knockout;	EXP062399	430	normal	P25490	HepG2 (hepatoblastoma)	PEAKS057765
EXP062478	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens	Genotype: RBM25 knockout;	EXP062400	430	normal	P25490	HepG2 (hepatoblastoma)	PEAKS057766
EXP062479	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: wip1[delta] (meiotic progeny of wip1[delta]/+, carrying the inactivated Centromere 1); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057767
EXP062480	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf1[delta] (meiotic progeny of mhf1[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057768
EXP062481	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057769
EXP062482	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 1); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057770
EXP062483	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: wip1[delta] (meiotic progeny of wip1[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057771
EXP062484	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057772
EXP062485	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf1[delta] (meiotic progeny of mhf1[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057773
EXP062486	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057774
EXP062487	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057775
EXP062488	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	PEAKS057776
EXP062489	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2[delta] (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057777
EXP062490	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057778
EXP062491	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Genotype: mhf2[delta] (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057779
EXP062492	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057780
EXP062493	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1); Developmental stage: log phase	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057781
EXP062494	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2[delta] (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057782
EXP062495	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057783
EXP062496	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2[delta] (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057784
EXP062497	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+clr4+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057785
EXP062498	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2[delta]clr4[delta] (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057786
EXP062499	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2[delta]clr4[delta] (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057787
EXP062500	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+clr4+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057788
EXP062501	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: wip1+ (meiotic progeny of wip1{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057789
EXP062502	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf1+ (meiotic progeny of mhf1{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057790
EXP062503	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (meiotic progeny of mhf2{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057791
EXP062504	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (meiotic progeny of mhf2{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057792
EXP062505	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057793
EXP062506	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057794
EXP062507	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057795
EXP062508	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057796
EXP062509	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057797
EXP062510	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057798
EXP062511	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057799
EXP062512	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057800
EXP062513	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057801
EXP062514	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057802
EXP062515	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057803
EXP062516	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057804
EXP062517	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057805
EXP062518	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057806
EXP062519	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057807
EXP062520	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057808
EXP062521	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057809
EXP062522	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057810
EXP062523	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057811
EXP062524	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057812
EXP062525	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057813
EXP062526	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057814
EXP062527	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057815
EXP062528	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057816
EXP062529	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057817
EXP062530	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057818
EXP062531	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057819
EXP062532	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Developmental stage: log phase; Genotype: mhf2+ (carrying the spreading of Cnp1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057820
EXP062533	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: clr4{delta} (carrying no inactivated Centromere 1/2/3); Developmental stage: log phase; Conditions: 29 C	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057821
EXP062534	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2{delta}clr4{delta} (carrying the inactivated Centromere 2); Developmental stage: log phase; Conditions: 29 C	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057822
EXP062535	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2+clr4{delta} (carrying the inactivated Centromere 1); Developmental stage: log phase; Conditions: 29 C	NULL	4494	normal	Q9Y812	fission yeast haploid cells	PEAKS057823
EXP062536	anti-SIN3 (Novus Biologicals, Q5986)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	2988	normal	A5JYW9	N2 strain	PEAKS057824
EXP062537	anti-SIN3 (Novus Biologicals, Q5986)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	4495	normal	A5JYW9	cfp-1(tm6369) strain	PEAKS057825
EXP062538	anti-HDA1 (Novus Biologicals, Q2354)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	2988	normal	O17695	N2 strain	PEAKS057826
EXP062539	anti-HDA1 (Novus Biologicals, Q2354)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	4495	normal	O17695	cfp-1(tm6369) strain	PEAKS057827
EXP062540	anti-SIN3 (Novus Biologicals, Q6013)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	2988	normal	A5JYW9	N2 strain	PEAKS057828
EXP062547	anti-JIL-1 (R69AP)	Drosophila melanogaster	Treatment: none	EXP062542	1451	normal	Q9V3I5	S2 (Schneider 2)	PEAKS057829
EXP062548	anti-JIL-1 (R69AP)	Drosophila melanogaster	Treatment: none	EXP062543	1451	normal	Q9V3I5	S2 (Schneider 2)	PEAKS057830
EXP062549	anti-JIL-1 (R69AP)	Drosophila melanogaster	Treatment: none	NULL	1451	normal	Q9V3I5	S2 (Schneider 2)	PEAKS057831
EXP062550	anti-JIL-1 (R69S)	Drosophila melanogaster	Treatment: none	EXP062544	1451	normal	Q9V3I5	S2 (Schneider 2)	PEAKS057832
EXP062551	anti-JIL-1 (Hope)	Drosophila melanogaster	Treatment: none	EXP062544	1451	normal	Q9V3I5	S2 (Schneider 2)	PEAKS057833
EXP062552	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062542	1451	normal	P50536	S2 (Schneider 2)	PEAKS057834
EXP062553	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062545	1451	normal	P50536	S2 (Schneider 2)	PEAKS057835
EXP062554	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062546	1451	normal	P50536	S2 (Schneider 2)	PEAKS057836
EXP062555	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062541	1985	normal	P50536	Kc	PEAKS057837
EXP062558	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: gst RNAi	EXP062556	1451	normal	P50536	S2 (Schneider 2)	PEAKS057838
EXP062559	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: jil-1_2 RNAi	EXP062557	1451	normal	P50536	S2 (Schneider 2)	PEAKS057839
EXP062564	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: EtOH for 45 min	EXP062560	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	PEAKS057840
EXP062565	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: EtOH for 45 min	EXP062561	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	PEAKS057841
EXP062566	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: 100 nM E2 for 45 mins	EXP062562	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	PEAKS057842
EXP062567	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: 100 nM E2 for 45 mins	EXP062563	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	PEAKS057843
EXP062569	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: none	EXP062568	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS057844
EXP062570	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: Nutlin treatment	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS057845
EXP062571	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: Negative control siRNA transfected	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS057846
EXP062572	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: siRNA against iASSP transfected; Genotype: iASSP knockout	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	PEAKS057847
EXP062573	anti-AR	Homo sapiens	Treatment: 10nM DHT for 4 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS057848
EXP062574	anti-AR	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 4 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS057849
EXP062575	anti-AR	Homo sapiens	Treatment: vehicle for 4 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS057850
EXP062576	anti-AR	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 48 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS057851
EXP062577	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 48 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057852
EXP062578	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 4 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057853
EXP062579	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated S2101  for 48 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057854
EXP062580	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated S2101  for 4 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057855
EXP062581	anti-FOXA1	Homo sapiens	Treatment: vehicle for 4 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057856
EXP062582	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	712	normal	Q9Y261	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS057857
EXP062583	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	4496	normal	Q9Y261	PANC1 clonal cell line	PEAKS057858
EXP062584	Anti-Flag (Sigma M2 F3165 lot. SLBN8915V)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	2329	normal	O75603	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057859
EXP062585	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	4497	normal	Q9Y261	CFPAC1 clonal cell line	PEAKS057860
EXP062586	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057861
EXP062587	Anti-JUNB (Antibody sc73X Lot K0311)	Homo sapiens	Treatment: none	NULL	2329	normal	P17275	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057862
EXP062588	Anti-FOS (Antibody Sigma HPA018531 - Lot E106326)	Homo sapiens	Treatment: none	NULL	2329	normal	P01100	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057863
EXP062589	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	4497	normal	Q9Y261	CFPAC1 clonal cell line	PEAKS057864
EXP062590	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: HNF1B knockout	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057865
EXP062591	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: Empty vector overexpressing	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057866
EXP062592	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057867
EXP062593	Anti-Flag (Sigma M2 F3165 lot. SLBN8915V)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	2329	normal	P17481	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057868
EXP062594	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: Empty vector overexpressing	NULL	712	normal	Q9Y261	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS057869
EXP062595	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	712	normal	Q9Y261	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS057870
EXP062596	Anti-HNF1B (HPA2083)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	712	normal	P35680	PANC1 (pancreatic ductal adenocarcinoma)	PEAKS057871
EXP062597	Anti-FOXA1 (Ab23738 Lot GR139681-1)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961); Genotype: wildtype	NULL	2329	normal	P55317	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057872
EXP062598	Anti-FOXA1 (Ab23738 Lot GR139681-1)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961) carring the expression of wt Cas9 and a guide RNA targeting FOXA1 gene; Genotype: FOXA1 knockout	NULL	2329	normal	P55317	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057873
EXP062599	Anti-FOXA1 (Ab23738 Lot GR139681-1)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells electroporated with plasmid pX330A_D10A-1x4 containing Cas9 nickase (Multiplex CRISPR/Cas9 Assembly System Kit; Addgene # 1000000055) and guides targeting FOXA2 gene.; Genotype: FOXA2 knockout	NULL	2329	normal	P55317	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057874
EXP062600	Anti-FOXA2 (Antibody sc-6554 Lot. A1014)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961); Genotype: wildtype	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057875
EXP062601	Anti-FOXA2 (Antibody sc-6554 Lot. A1014)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells electroporated with plasmid pX330A_D10A-1x4 containing Cas9 nickase (Multiplex CRISPR/Cas9 Assembly System Kit; Addgene # 1000000055) and guides targeting FOXA2 gene.; Genotype: FOXA2 knockout	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057876
EXP062602	Anti-FOXA2 (Antibody sc-6554 Lot. A1014)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961) carring the expression of wt Cas9 and a guide RNA targeting FOXA1 gene; Genotype: FOXA1 knockout	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	PEAKS057877
EXP062605	anti-HIF-1alpha (Novus, NB100-134)	Homo sapiens	Treatment: none; Conditions: Hypoxia	EXP062603	4498	normal	Q16665	EA.hy 926 (human umbilical vein endothelial cell line)	PEAKS057878
EXP062606	anti-HIF-1alpha (Novus, NB100-134)	Homo sapiens	Treatment: TEPA treated; Conditions: Hypoxia	EXP062604	4498	normal	Q16665	EA.hy 926 (human umbilical vein endothelial cell line)	PEAKS057879
EXP062607	anti-PU.1 (T-21, Santa Cruz)	Homo sapiens	Treatment: no LPS added, collection day 10; Conditions: GM-CSF + IL4	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS057880
EXP062608	anti-PU.1 (T-21, Santa Cruz)	Homo sapiens	Treatment: LPS added at day 7, collection day 10; Conditions: GM-CSF + IL4	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS057881
EXP062609	anti-PU.1 (T-21, Santa Cruz)	Mus musculus	Treatment: no LPS added, collection day 10; Conditions: GM-CSF + IL4	NULL	914	normal	P17433	monocyte-derived dendritic cells	PEAKS057882
EXP062610	anti-PU.1 (T-21, Santa Cruz)	Mus musculus	Treatment: LPS added at day 7, collection day 10; Conditions: GM-CSF + IL4	NULL	914	normal	P17433	monocyte-derived dendritic cells	PEAKS057883
EXP062611	anti-BRD4 (A301-985A50)	Homo sapiens	Treatment: none	NULL	4500	normal	O60885	HCC1937 (breast cancer)	PEAKS057884
EXP062612	anti-BRD4 (A301-985A50)	Homo sapiens	Treatment: none	NULL	3115	normal	O60885	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	PEAKS057885
EXP062615	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	EXP062613	1089	normal	P10275	breast tumor xenograft	PEAKS057886
EXP062616	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P10275	breast tumor xenograft	PEAKS057887
EXP062617	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	NULL	1089	normal	P10275	breast tumor xenograft	PEAKS057888
EXP062618	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P10275	breast tumor xenograft	PEAKS057889
EXP062619	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	EXP062614	1089	normal	P10275	breast tumor xenograft	PEAKS057890
EXP062620	FOXA1	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	EXP062614	1089	normal	P55317	breast tumor xenograft	PEAKS057891
EXP062621	anti-FOXA1 (abcam, ab5089 + ab23738, gr122110-14 gr292351-2)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P55317	breast tumor xenograft	PEAKS057892
EXP062622	anti-ER (Santa Cruz Biotechnology, Thermo, sc-543, MS-315-P1ABX, c2114, 315X1510A)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P03372	breast tumor xenograft	PEAKS057893
EXP062623	anti-ER (Santa Cruz Biotechnology, Thermo, sc-543, MS-315-P1ABX, c2114, 315X1510A)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	NULL	1089	normal	P03372	breast tumor xenograft	PEAKS057894
EXP062624	Anti-RENT1 (UPF1) (Bethyl Laboratories, A301-902A)	Homo sapiens	Treatment: none; Age: 69 years adult; Phenotype: adenocarcinoma	NULL	4501	normal	Q92900	mammary gland breast cancer cells derived from metastatic site pleural effusion	PEAKS057895
EXP062626	anti-CTCF(SC-28198 and SC-271514, Santa Cruz Biotechnology)	Homo sapiens	Treatment: shRNA lentiviruses, non-targeting; Genotype: cggbp1  endogenous	NULL	10	normal	P49711	HEK293T (embryonic kidney)	PEAKS057896
EXP062627	SC-28198 and SC-271514 (Santa Cruz Biotechnology)	Homo sapiens	Treatment: shRNA lentiviruses CGGBP1-silencing; Genotype: cggbp1  knockdown	NULL	10	normal	P49711	HEK293T (embryonic kidney)	PEAKS057897
EXP062628	SC-28198 and SC-271514 (Santa Cruz Biotechnology)	Homo sapiens	Treatment: shRNA lentiviruses CGGBP1-overexpressing; Genotype: CGGBP1-overexpressing	NULL	10	normal	P49711	HEK293T (embryonic kidney)	PEAKS057898
EXP062629	anti-NCoR Millipore, ABE251, Lot#2153059	Mus musculus	Treatment: None	NULL	2756	normal	Q60974	B cell enriched splenocytes	PEAKS057899
EXP062630	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: None	NULL	2756	normal	O08917	B cell enriched splenocytes	PEAKS057900
EXP062631	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: None	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057901
EXP062632	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+FLAG control transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057902
EXP062633	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+HDAC3-YF transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057903
EXP062634	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+FLAG control transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057904
EXP062635	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+HDAC3-YF transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057905
EXP062636	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+FLAG control transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057906
EXP062637	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+HDAC3-YF transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	PEAKS057907
EXP062643	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 0	EXP062638	3715	normal	P14921	WA01 (H1-hESC) derived cardiomyocyte	PEAKS057909
EXP062644	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 2	EXP062639	3715	normal	P15036	WA01 (H1-hESC) derived cardiomyocyte	PEAKS057910
EXP062645	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 5	EXP062640	3715	normal	A0AVK6	WA01 (H1-hESC) derived cardiomyocyte	PEAKS057911
EXP062646	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 9	EXP062641	3715	normal	A0AVK6	WA01 (H1-hESC) derived cardiomyocyte	PEAKS057912
EXP062647	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 14	EXP062642	3715	normal	A0AVK6	WA01 (H1-hESC) derived cardiomyocyte	PEAKS057913
EXP062654	Anti-SOX2	Homo sapiens	Treatment: Treatment: none	EXP062648	4502	normal	P48431	2102EP (Embryonal carcinoma)	PEAKS057914
EXP062655	Anti-SOX2	Homo sapiens	Treatment: Treatment: none	EXP062649	4502	normal	P48431	2102EP (Embryonal carcinoma)	PEAKS057915
EXP062656	Anti-SOX2	Homo sapiens	Treatment: Treatment: none	EXP062650	4502	normal	P48431	2102EP (Embryonal carcinoma)	PEAKS057916
EXP062657	Anti-SOX17	Homo sapiens	Treatment: Treatment: none	EXP062651	4503	normal	Q9H6I2	TCam-2 (Testicular seminoma)	PEAKS057917
EXP062658	Anti-SOX17	Homo sapiens	Treatment: Treatment: none	EXP062652	4503	normal	Q9H6I2	TCam-2 (Testicular seminoma)	PEAKS057918
EXP062659	Anti-SOX17	Homo sapiens	Treatment: Treatment: none	EXP062653	4503	normal	Q9H6I2	TCam-2 (Testicular seminoma)	PEAKS057919
EXP062661	anti-TCF12 (CST11825, Danvers, MA, USA)	Homo sapiens	Treatment: none	EXP062660	3039	normal	Q99081	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	PEAKS057920
EXP062666	anti-CTCF	Homo sapiens	Treatment: none	EXP062662	519	normal	P49711	KB (cervical adenocarcinoma)	PEAKS057921
EXP062667	anti-CTCF	Homo sapiens	Treatment: 10ng/ml IL-1alpha for 1 hr	EXP062663	519	normal	P49711	KB (cervical adenocarcinoma)	PEAKS057922
EXP062668	anti-CTCF	Homo sapiens	Treatment: 1uM 5Z-7-oxozeaenol for 1 hr	EXP062664	519	normal	P49711	KB (cervical adenocarcinoma)	PEAKS057923
EXP062669	anti-CTCF	Homo sapiens	Treatment: 10ng/ml IL-1alpha + 1uM 5Z-7-oxozeaenol for 1 hr	EXP062665	519	normal	P49711	KB (cervical adenocarcinoma)	PEAKS057924
EXP062674	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	EXP062670	4513	normal	Q15306	CAR-T cells	PEAKS057925
EXP062675	anti-JUN (Active Motif, #39309)	Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	EXP062670	4513	normal	P05412	CAR-T cells	PEAKS057926
EXP062676	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	EXP062671	4513	normal	Q15306	CAR-T cells	PEAKS057927
EXP062677	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062672	4513	normal	Q15306	CAR-T cells	PEAKS057928
EXP062678	anti-JUN (Active Motif, #39309)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062672	4513	normal	P05412	CAR-T cells	PEAKS057929
EXP062679	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062673	4513	normal	Q15306	CAR-T cells	PEAKS057930
EXP062680	anti-JUN (Active Motif, #39309)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062673	4513	normal	P05412	CAR-T cells	PEAKS057931
EXP062688	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	NULL	4514	normal	P48431	LK-2 (Squamous cell lung carcinoma)	PEAKS057932
EXP062689	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	EXP062685	4515	normal	P48431	NCI-H520 (Squamous cell lung carcinoma)	PEAKS057933
EXP062690	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	NULL	413	normal	P48431	HCC95 (squamous cell lung carcinoma)	PEAKS057934
EXP062691	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	EXP062682	4516	normal	P48431	KNS62 (Squamous cell lung carcinoma)	PEAKS057935
EXP062692	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	EXP062683	4517	normal	P48431	HCC2814 (Squamous cell lung carcinoma)	PEAKS057936
EXP062693	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none; Genotype: GFP	EXP062686	4514	normal	P48431	LK-2 (Squamous cell lung carcinoma)	PEAKS057937
EXP062694	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none; Genotype: DNp63	EXP062687	4514	normal	P48431	LK-2 (Squamous cell lung carcinoma)	PEAKS057938
EXP062695	anti-p63 (Santa Cruz, sc-8431)	Homo sapiens	Treatment: none; Genotype: DNp63	EXP062687	4514	normal	Q9H3D4	LK-2 (Squamous cell lung carcinoma)	PEAKS057939
EXP062696	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	PEAKS057940
EXP062697	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	PEAKS057941
EXP062698	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	PEAKS057942
EXP062699	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	PEAKS057943
EXP062700	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	PEAKS057944
EXP062701	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	PEAKS057945
EXP062702	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	PEAKS057946
EXP062703	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	PEAKS057947
EXP062704	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057948
EXP062705	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057949
EXP062706	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057950
EXP062707	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS057951
EXP062717	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	EXP062708	3668	normal	Q15797	CD34+ hematopoietic stem/progenitor cell from cord blood	PEAKS057952
EXP062718	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	EXP062708	3668	normal	P15976	CD34+ hematopoietic stem/progenitor cell from cord blood	PEAKS057953
EXP062719	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	EXP062708	3668	normal	P23769	CD34+ hematopoietic stem/progenitor cell from cord blood	PEAKS057954
EXP062720	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	EXP062709	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	PEAKS057955
EXP062721	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	EXP062709	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	PEAKS057956
EXP062722	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	EXP062709	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	PEAKS057957
EXP062723	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	EXP062710	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	PEAKS057958
EXP062724	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	EXP062710	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	PEAKS057959
EXP062725	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	EXP062711	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	PEAKS057960
EXP062726	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	EXP062712	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	PEAKS057961
EXP062727	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	EXP062712	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	PEAKS057962
EXP062728	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	EXP062713	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	PEAKS057963
EXP062729	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	EXP062714	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	PEAKS057964
EXP062730	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	EXP062715	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	PEAKS057965
EXP062731	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	EXP062714	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	PEAKS057966
EXP062732	anti-SMAD2 (Cell Signaling Technology, 5339S)	Homo sapiens	Treatment: none; Time point: day 0	EXP062716	3668	normal	Q15796	CD34+ hematopoietic stem/progenitor cell from cord blood	PEAKS057967
EXP062733	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: No treatment; Genotype: Stably transfected with empty vector	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	PEAKS057968
EXP062734	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: 10 nM  Docetaxel for 24 hours; Genotype: Stably transfected with empty vector	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	PEAKS057969
EXP062735	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: No treatment; Genotype: Stably transfected with Caspase-3 cDNA	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	PEAKS057970
EXP062736	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: 10 nM  Docetaxel for 24 hours; Genotype: Stably transfected with Caspase-3 cDNA	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	PEAKS057971
EXP062739	anti-HA (GeneTex, GTX29110)	Homo sapiens	Treatment: none; Genotype: HA-tagged ZNF322A overexpressing	EXP062737	1490	normal	Q6U7Q0	NCI-H460 (Large cell lung carcinoma)	PEAKS057972
EXP062740	anti-HA (GeneTex, GTX29110)	Homo sapiens	Treatment: none; Genotype: HA-tagged ZNF322A overexpressing	EXP062738	1490	normal	Q6U7Q0	NCI-H460 (Large cell lung carcinoma)	PEAKS057973
EXP062742	anti-Phf21b	Mus musculus	Treatment: none; Time point: Day2 differentiated	EXP062741	1245	normal	Q8C966	Neuro-2A cells	PEAKS057974
EXP062743	anti-Phf21b	Mus musculus	Treatment: none	NULL	2	normal	Q8C966	mESCs (mouse embryonic stem cells)	PEAKS057975
EXP062747	anti-p300	Mus musculus	Treatment: none; Strain: TS3.5	NULL	506	normal	B2RWS6	J1 (embryonic stem cells)	PEAKS057976
EXP062748	anti-Arid3a	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q62431	trophoblast stem cells	PEAKS057977
EXP062749	Bbx	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8VBW5	trophoblast stem cells	PEAKS057978
EXP062750	Bbx	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8VBW5	trophoblast stem cells	PEAKS057979
EXP062751	Bhlhe40	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O35185	trophoblast stem cells	PEAKS057980
EXP062752	Bhlhe40	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O35185	trophoblast stem cells	PEAKS057981
EXP062753	Cbfa2t3	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O54972	trophoblast stem cells	PEAKS057982
EXP062754	Cbfa2t3	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O54972	trophoblast stem cells	PEAKS057983
EXP062755	Creb3l2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8BH52	trophoblast stem cells	PEAKS057984
EXP062756	Creb3l2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8BH52	trophoblast stem cells	PEAKS057985
EXP062757	Ctcf	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q61164	trophoblast stem cells	PEAKS057986
EXP062758	Elf5	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8VDK3	trophoblast stem cells	PEAKS057987
EXP062759	Eomes	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O54839	trophoblast stem cells	PEAKS057988
EXP062760	Eomes	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O54839	trophoblast stem cells	PEAKS057989
EXP062761	Ets2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P15037	trophoblast stem cells	PEAKS057990
EXP062762	Ets2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	P15037	trophoblast stem cells	PEAKS057991
EXP062763	Fbxo21	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8VDH1	trophoblast stem cells	PEAKS057992
EXP062764	Fbxo21	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8VDH1	trophoblast stem cells	PEAKS057993
EXP062765	Foxj2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q9ES18	trophoblast stem cells	PEAKS057994
EXP062766	Foxj2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q9ES18	trophoblast stem cells	PEAKS057995
EXP062767	Hic2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q9JLZ6	trophoblast stem cells	PEAKS057996
EXP062768	Hic2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q9JLZ6	trophoblast stem cells	PEAKS057997
EXP062769	Hopx	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8R1H0	trophoblast stem cells	PEAKS057998
EXP062770	Hpox	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	A1A546	trophoblast stem cells	PEAKS057999
EXP062771	Id2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P41136	trophoblast stem cells	PEAKS058000
EXP062772	Id2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	P41136	trophoblast stem cells	PEAKS058001
EXP062773	Irf2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P23906	trophoblast stem cells	PEAKS058002
EXP062774	Irf2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	P23906	trophoblast stem cells	PEAKS058003
EXP062775	Lrrfip1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q3UZ39	trophoblast stem cells	PEAKS058004
EXP062776	Lrrfip1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q3UZ39	trophoblast stem cells	PEAKS058005
EXP062777	Maff	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O54791	trophoblast stem cells	PEAKS058006
EXP062778	Maff	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O54791	trophoblast stem cells	PEAKS058007
EXP062779	Mafk	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q61827	trophoblast stem cells	PEAKS058008
EXP062780	Mafk	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q61827	trophoblast stem cells	PEAKS058009
EXP062781	Med12	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	A2AGH6	trophoblast stem cells	PEAKS058010
EXP062782	Mef2d	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q63943	trophoblast stem cells	PEAKS058011
EXP062783	Mef2d	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q63943	trophoblast stem cells	PEAKS058012
EXP062784	Meis1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q60954	trophoblast stem cells	PEAKS058013
EXP062785	anti-p300	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	B2RWS6	trophoblast stem cells	PEAKS058014
EXP062786	Pcgf5	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q3UK78	trophoblast stem cells	PEAKS058015
EXP062787	Pcgf5	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q3UK78	trophoblast stem cells	PEAKS058016
EXP062788	Pou3f1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P21952	trophoblast stem cells	PEAKS058017
EXP062789	Smad6	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O35182	trophoblast stem cells	PEAKS058018
EXP062790	Smad6	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O35182	trophoblast stem cells	PEAKS058019
EXP062791	Tbx20	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q9ES03	trophoblast stem cells	PEAKS058020
EXP062792	Tbx20	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q9ES03	trophoblast stem cells	PEAKS058021
EXP062793	Tead4	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q62296	trophoblast stem cells	PEAKS058022
EXP062794	Tead4	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q62296	trophoblast stem cells	PEAKS058023
EXP062795	Tfap2c	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q61312	trophoblast stem cells	PEAKS058024
EXP062796	Zfpm1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O35615	trophoblast stem cells	PEAKS058025
EXP062797	Zfpm1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O35615	trophoblast stem cells	PEAKS058026
EXP062798	cFos	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P01101	trophoblast stem cells	PEAKS058027
EXP062799	Bbx	Mus musculus	Treatment: none; Strain: TS3.5; Time point: 3 days of differentiation; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8VBW5	differentiated trophoblast stem cells	PEAKS058028
EXP062800	Creb3l2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8BH52	differentiated trophoblast stem cells	PEAKS058029
EXP062801	Elf5	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8VDK3	differentiated trophoblast stem cells	PEAKS058030
EXP062802	Ets2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P15037	differentiated trophoblast stem cells	PEAKS058031
EXP062803	Foxj2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q9ES18	differentiated trophoblast stem cells	PEAKS058032
EXP062804	Hic2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q9JLZ6	differentiated trophoblast stem cells	PEAKS058033
EXP062805	Hopx	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8R1H0	differentiated trophoblast stem cells	PEAKS058034
EXP062806	Irf2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P23906	differentiated trophoblast stem cells	PEAKS058035
EXP062807	Maff	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	O54791	differentiated trophoblast stem cells	PEAKS058036
EXP062808	Mafk	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q61827	differentiated trophoblast stem cells	PEAKS058037
EXP062809	Meis1	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q60954	differentiated trophoblast stem cells	PEAKS058038
EXP062810	Pcgf5	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q3UK78	differentiated trophoblast stem cells	PEAKS058039
EXP062811	Pou3f1	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P21952	differentiated trophoblast stem cells	PEAKS058040
EXP062812	Tfap2c	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q61312	differentiated trophoblast stem cells	PEAKS058041
EXP062813	Zfpm1	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	O35615	differentiated trophoblast stem cells	PEAKS058042
EXP062814	cFos	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P01101	differentiated trophoblast stem cells	PEAKS058043
EXP062815	anti-p300	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	B2RWS6	differentiated trophoblast stem cells	PEAKS058044
EXP062817	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	4102	normal	P48432	B cells derived iPSC	PEAKS058045
EXP062818	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 0 hrs	EXP062816	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS058046
EXP062819	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS058047
EXP062820	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	PEAKS058048
EXP062821	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 48 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	PEAKS058049
EXP062822	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	PEAKS058050
EXP062823	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	PEAKS058051
EXP062824	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 96 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	PEAKS058052
EXP062825	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	PEAKS058053
EXP062826	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	PEAKS058054
EXP062827	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P48432	mESCs (mouse embryonic stem cells)	PEAKS058055
EXP062828	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P48432	mESCs (mouse embryonic stem cells)	PEAKS058056
EXP062829	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 0 hrs	EXP062816	2	normal	P48432	mESCs (mouse embryonic stem cells)	PEAKS058057
EXP062830	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	PEAKS058058
EXP062831	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 48 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	PEAKS058059
EXP062832	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	PEAKS058060
EXP062833	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	PEAKS058061
EXP062834	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 96 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	PEAKS058062
EXP062835	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: none; Genotype: SBR knockout	NULL	693	normal	P20263	OG2 transgenetic mouse embryonic stem cells	PEAKS058063
EXP062836	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: treated with doxycycline; Genotype: OCT4-HALO	NULL	873	normal	P20263	ZHBTc4 (embryonic stem cells)	PEAKS058064
EXP062837	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: treated with doxycycline; Genotype: YPet-OCT4	NULL	873	normal	P20263	ZHBTc4 (embryonic stem cells)	PEAKS058065
EXP062838	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: treated with doxycycline; Genotype: YPet-SOX2	NULL	13	normal	P48432	2TS22C (embryonic stem cells)	PEAKS058066
EXP062843	anti-NKX2-1 (Abcam #133737 lot#GR154535-1)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	PEAKS058070
EXP062844	anti-NKX2-1 (Millipore #07-601 lot#2887266)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	PEAKS058071
EXP062845	anti-NKX2-1 (Abcam#76013 lot#GR297063-2)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	PEAKS058072
EXP062846	anti-NKX2-1 (Abcam #133737 lot#GR154535-1)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	PEAKS058073
EXP062847	anti-CTCF (Millipore 07-729)	Mus musculus	Treatment: methylated adaptors and bisulfite converted	NULL	521	normal	Q61164	KH2 (embryonic stem cells)	PEAKS058074
EXP062848	anti-CTCF (Millipore 07-729)	Mus musculus	Treatment: methylated adaptors not converted	NULL	521	normal	Q61164	KH2 (embryonic stem cells)	PEAKS058075
EXP062849	anti-CTCF (Millipore 07-729)	Mus musculus	Treatment: Nextera adaptors	NULL	521	normal	Q61164	KH2 (embryonic stem cells)	PEAKS058076
EXP062850	anti-KLF4 (R&D AF3158)	Mus musculus	Treatment: none; Genotype: KLF4 knockout	NULL	521	normal	Q60793	KH2 (embryonic stem cells)	PEAKS058077
EXP062851	anti-KLF4 (R&D AF3158)	Mus musculus	Treatment: none; Genotype: KLF4 knockout  that re-express WT Klf4	NULL	521	normal	Q60793	KH2 (embryonic stem cells)	PEAKS058078
EXP062852	anti-KLF4 (R&D AF3158)	Mus musculus	Treatment: none; Genotype: KLF4 knockout that re-express R462A mutant Klf4	NULL	521	normal	Q60793	KH2 (embryonic stem cells)	PEAKS058079
EXP062858	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	EXP062853	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	PEAKS058080
EXP062859	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	EXP062854	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	PEAKS058081
EXP062860	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	NULL	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	PEAKS058082
EXP062861	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	NULL	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	PEAKS058083
EXP062862	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: with aCD40/IL4 stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062856	4520	normal	Q6KCD5	primary mature splenic B cells	PEAKS058084
EXP062863	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062855	4520	normal	Q6KCD5	primary mature splenic B cells	PEAKS058085
EXP062864	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	EXP062853	4519	normal	Q61550	CH12F3 (Mouse lymphoma)	PEAKS058086
EXP062865	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	EXP062854	4519	normal	Q61550	CH12F3 (Mouse lymphoma)	PEAKS058087
EXP062866	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	EXP062857	4519	normal	Q61550	CH12F3 (Mouse lymphoma)	PEAKS058088
EXP062867	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062855	4520	normal	Q61550	primary mature splenic B cells	PEAKS058089
EXP062868	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: with aCD40/IL4 stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062856	4520	normal	Q61550	primary mature splenic B cells	PEAKS058090
EXP062871	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062869	103	normal	P17433	bone marrow	PEAKS058091
EXP062872	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	NULL	917	normal	P17433	spleen	PEAKS058092
EXP062873	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Staag2 wildtype	EXP062870	103	normal	P17433	bone marrow	PEAKS058093
EXP062874	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Staag2 wildtype	NULL	917	normal	P17433	spleen	PEAKS058094
EXP062881	anti-CTCF (Cell Signaling, 3418S)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062875	549	normal	Q61164	Lin- bone marrow hematopoietic progenitor cells	PEAKS058095
EXP062882	anti-CTCF (Cell Signaling, 3418S)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062876	549	normal	Q61164	Lin- bone marrow hematopoietic progenitor cells	PEAKS058096
EXP062883	Stag1 (Bethyl, A302-579A)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062877	4523	normal	Q9D3E6	Lin- hematopoietic stem and progenitor cells (HSPCs) from spleen	PEAKS058097
EXP062884	Stag1 (Bethyl, A302-579A)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062878	4523	normal	Q9D3E6	Lin- hematopoietic stem and progenitor cells (HSPCs) from spleen	PEAKS058098
EXP062885	anti-Smc1a (Active Motif, 61067)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062879	4524	normal	Q9CU62	hematopoietic stem and progenitor cells	PEAKS058099
EXP062886	anti-Smc3 (Bethyl, A300-060A)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062879	4524	normal	Q9CW03	hematopoietic stem and progenitor cells	PEAKS058100
EXP062887	anti-Smc1a (Active Motif, 61067)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062880	4524	normal	Q9CU62	hematopoietic stem and progenitor cells	PEAKS058101
EXP062888	anti-Smc3 (Bethyl, A300-060A)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062880	4524	normal	Q9CW03	hematopoietic stem and progenitor cells	PEAKS058102
EXP062893	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: Female; Strain: C57BL/6	EXP062890	25	normal	Q60929	cerebellum	PEAKS058103
EXP062894	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: male; Strain: C57BL/6	NULL	25	normal	Q60929	cerebellum	PEAKS058104
EXP062895	anti-MEF2D (Greenberg Lab)	Mus musculus	Treatment: none; Genotype: MEF2D Conditional knockout; Sex: Female; Strain: C57BL/6	EXP062892	25	normal	Q63943	cerebellum	PEAKS058105
EXP062896	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2A Control; Sex: Female; Strain: C57BL/6	EXP062889	25	normal	Q60929	cerebellum	PEAKS058106
EXP062897	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2D Conditional knockout; Sex: Female; Strain: C57BL/6	EXP062892	25	normal	Q60929	cerebellum	PEAKS058107
EXP062898	anti-MEF2D (Greenberg Lab)	Mus musculus	Treatment: none; Genotype: MEF2A Control; Sex: Female; Strain: C57BL/6	EXP062891	25	normal	Q63943	cerebellum	PEAKS058108
EXP062899	anti-MEF2D (Greenberg Lab)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: Female; Strain: C57BL/6	EXP062890	25	normal	Q63943	cerebellum	PEAKS058109
EXP062902	anti-YAP1 (Novus #NB110-58358)	Mus musculus	Treatment: none; Genotype: Salv knockout; Age: postnatal day 8; Strain: 129	EXP062900	3053	normal	P46938	heart ventricle	PEAKS058110
EXP062903	anti-YAP1 Antibody (Novus #NB110-58358)	Mus musculus	Treatment: none; Genotype: Salv knockout; Age: postnatal day 12; Strain: 129	EXP062901	3053	normal	P46938	heart ventricle	PEAKS058111
EXP062916	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062904	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058112
EXP062917	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062905	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058113
EXP062918	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062906	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058114
EXP062919	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062907	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058115
EXP062920	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062908	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058116
EXP062921	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062909	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058117
EXP062922	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062910	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058118
EXP062923	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062911	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058119
EXP062924	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062912	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058120
EXP062925	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062913	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058121
EXP062926	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062914	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058122
EXP062927	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062915	4573	normal	D4A6Q6	nucleus accumbens	PEAKS058123
EXP062932	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062928	4576	normal	P41739	hippocampal neurons	PEAKS058124
EXP062933	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062929	4576	normal	P41739	hippocampal neurons	PEAKS058125
EXP062934	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062928	4576	normal	P41739	hippocampal neurons	PEAKS058126
EXP062935	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062929	4576	normal	P41739	hippocampal neurons	PEAKS058127
EXP062936	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	normal	Q8CJH6	hippocampal neurons	PEAKS058128
EXP062937	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	normal	Q8CJH6	hippocampal neurons	PEAKS058129
EXP062938	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062930	4576	normal	P41739	hippocampal neurons	PEAKS058130
EXP062939	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062931	4576	normal	P41739	hippocampal neurons	PEAKS058131
EXP062940	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062930	4576	normal	P41739	hippocampal neurons	PEAKS058132
EXP062941	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062931	4576	normal	P41739	hippocampal neurons	PEAKS058133
EXP062942	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062930	4576	normal	Q8CJH6	hippocampal neurons	PEAKS058134
EXP062943	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062931	4576	normal	Q8CJH6	hippocampal neurons	PEAKS058135
EXP062946	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype	EXP062945	4582	normal	P40848	logarithmic growing cells	PEAKS058136
EXP062947	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: swd22 delta	NULL	4582	normal	P40848	logarithmic growing cells	PEAKS058137
EXP062952	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 9	HEXP003911	1263	normal	O94529	whole cells	PEAKS058138
EXP062953	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 9	HEXP003912	1263	normal	O94529	whole cells	PEAKS058139
EXP062954	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 10	EXP062949	1263	normal	O94529	whole cells	PEAKS058140
EXP062955	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 10	EXP062949	1263	normal	O94529	whole cells	PEAKS058141
EXP062956	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 11	EXP062950	1263	normal	O94529	whole cells	PEAKS058142
EXP062957	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 11	EXP062951	1263	normal	O94529	whole cells	PEAKS058143
EXP062958	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 12	HEXP003911	1263	normal	O94267	whole cells	PEAKS058144
EXP062959	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 12	HEXP003912	1263	normal	O94267	whole cells	PEAKS058145
EXP062960	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 13	EXP062949	1263	normal	O94267	whole cells	PEAKS058146
EXP062961	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 13	EXP062949	1263	normal	O94267	whole cells	PEAKS058147
EXP062962	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 14	EXP062950	1263	normal	O94267	whole cells	PEAKS058148
EXP062963	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 14	EXP062951	1263	normal	O94267	whole cells	PEAKS058149
EXP062966	anti-HA	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062964	1263	normal	Q9Y7X8	whole cells	PEAKS058150
EXP062967	anti-HA	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062965	1263	normal	Q9Y7X8	whole cells	PEAKS058151
EXP062968	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062964	1263	normal	P24488	whole cells	PEAKS058152
EXP062969	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062965	1263	normal	P24488	whole cells	PEAKS058153
EXP062974	anti-GFP (Polyclonal)	Arabidopsis thaliana	Treatment: JA 2hrs; Genotype: expressing MYC3 YpET	NULL	1339	normal	Q9FIP9	seedling	PEAKS058154
EXP062975	anti-GFP (Polyclonal)	Arabidopsis thaliana	Treatment: JA 2hrs; Genotype: expressing MYC2 YpET	NULL	1339	normal	Q39204	seedling	PEAKS058155
EXP062978	anti-GFP (Tag Antibody, A-11120, Thermo Fisher Scientific)	Arabidopsis thaliana	Treatment: none; Genotype: PHE1::PHE1-GFP	EXP062976	4589	normal	O80805	silique	PEAKS058156
EXP062979	anti-GFP (Tag Antibody, A-11120, Thermo Fisher Scientific)	Arabidopsis thaliana	Treatment: none; Genotype: PHE1::PHE1-GFP	EXP062977	4589	normal	O80805	silique	PEAKS058157
EXP062982	anti-IRT1	Arabidopsis thaliana	Treatment: none; Conditions: no ferum (Fe)	EXP062980	1362	normal	Q38856	roots	PEAKS058158
EXP062983	anti-IRT1	Arabidopsis thaliana	Treatment: none; Conditions: ferum (Fe)	EXP062981	1362	normal	Q38856	roots	PEAKS058159
EXP062985	anti-FLAG	Arabidopsis thaliana	Treatment: none; Genotype: PIE1-Flag + wild type	EXP062984	1339	normal	Q7X9V2	seedling	PEAKS058160
EXP062986	anti-FLAG	Arabidopsis thaliana	Treatment: none; Genotype: CHR11-Flag + wild type	EXP062984	1339	normal	Q8RWY3	seedling	PEAKS058161
EXP062989	anti-RFP-trap (rta-100; ChromoTek)	Arabidopsis thaliana	Treatment: 2 hrs 25 microM dexamethasone; Ecotype: Columbia-0; Genotype: pUBI10 mCherry-GR-linker-WUS	EXP062987	4587	normal	Q9SB92	whole seedlings 5 days after germination	PEAKS058162
EXP062990	antibody: RFP-trap (rta-100; ChromoTek)	Arabidopsis thaliana	Treatment: 2 hrs 25 microM dexamethasone; Ecotype: Columbia-0	EXP062988	4587	normal	Q9SB92	whole seedlings 5 days after germination	PEAKS058163
EXP062995	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: Wildtype Swr1-Myc-Tag	EXP062991	3099	normal	Q05471	BY4741 strain	PEAKS058164
EXP062996	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: del-Htz1 Swr1-Myc-Tag	EXP062992	3099	normal	Q05471	BY4741 strain	PEAKS058165
EXP062997	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: Wildtype Ino80-Myc-Tag	EXP062993	3099	normal	A6ZU34	BY4741 strain	PEAKS058166
EXP062998	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: del-Htz1 Ino80-Myc-Tag	EXP062994	3099	normal	A6ZU34	BY4741 strain	PEAKS058167
EXP063002	anti-V5 (BioRad, cat# MCA1360G)	Saccharomyces cerevisiae	Treatment: Diamide 0 min; Time point: 0 min; Genotype: HSF1 V5-tagged	EXP062999	3099	normal	P10961	BY4741 strain	PEAKS058168
EXP063003	anti-V5 (BioRad, cat# MCA1360G)	Saccharomyces cerevisiae	Treatment: Diamide 30 min; Time point: 30 min; Genotype: HSF1 V5-tagged	EXP063000	3099	normal	P10961	BY4741 strain	PEAKS058169
EXP063004	anti-V5 (BioRad, cat# MCA1360G)	Saccharomyces cerevisiae	Treatment: Diamide 60 min; Time point: 60 min; Genotype: HSF1 V5-tagged	EXP063001	3099	normal	P10961	BY4741 strain	PEAKS058170
EXP063006	anti-FLAG (monoclonal antibody M2, Sigma)	Saccharomyces cerevisiae	Treatment: none; Genotype: His6-Flag3; Time point: 4 hrs	NULL	4591	normal	P51979	meiotic cells of strain VBD1421	PEAKS058171
EXP063007	anti-FLAG (monoclonal antibody M2, Sigma)	Saccharomyces cerevisiae	Treatment: none; Genotype: His6-Flag3; Time point: 4 hrs	NULL	4591	normal	P51979	meiotic cells of strain VBD1421	PEAKS058172
EXP063008	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs; Source: pCUP1-IME1-synchronized meiosis	NULL	4592	normal	Q12083	meiotic cells of strain VBD1837	PEAKS058173
EXP063009	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4592	normal	Q12083	meiotic cells of strain VBD1837	PEAKS058174
EXP063010	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs; Source: pCUP1-IME1-synchronized meiosis	NULL	4593	normal	Q12083	meiotic cells of strain VBD1841	PEAKS058175
EXP063011	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4593	normal	Q12083	meiotic cells of strain VBD1841	PEAKS058176
EXP063012	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4594	normal	Q12083	meiotic cells of strain VBD2026	PEAKS058177
EXP063013	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4593	normal	Q12083	meiotic cells of strain VBD1841	PEAKS058178
EXP063014	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Full length Set1	HEXP004023	4595	normal	P38827	exponential growing culture of strain BY4741	PEAKS058179
EXP063015	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Set1 N-term (1-200) deletion	HEXP004024	4595	normal	P38827	exponential growing culture of strain BY4741	PEAKS058180
EXP063016	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Nrd1CID fusion to Set1 N-terminal deletion	HEXP004025	4595	normal	P53617	exponential growing culture of strain BY4741	PEAKS058181
EXP063017	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Full length Set1	HEXP004026	4595	normal	P38827	exponential growing culture of strain BY4741	PEAKS058182
EXP063018	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Set1 N-term (1-200) deletion	HEXP004027	4595	normal	P38827	exponential growing culture of strain BY4741	PEAKS058183
EXP063019	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Nrd1CID fusion to Set1 N-terminal deletion	HEXP004028	4595	normal	P53617	exponential growing culture of strain BY4741	PEAKS058184
EXP063022	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4; Developmental stage: Asyncrhonous cell culture	NULL	4600	normal	P30665	strain YSM266-4	PEAKS058185
EXP063023	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4601	normal	P30665	strain YMS1289-7	PEAKS058186
EXP063024	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4 rrm3D::HPHMX4; Developmental stage: Asyncrhonous cell culture	NULL	4602	normal	P30665	strain YMS1294_5-1	PEAKS058187
EXP063025	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4 rrm3D::HPHMX4 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4603	normal	P30665	strain YMS1299-13	PEAKS058188
EXP063026	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6; Developmental stage: Asyncrhonous cell culture	NULL	4604	normal	Q08032	strain YMS461-2	PEAKS058189
EXP063027	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4605	normal	Q08032	strain YMS1288-3	PEAKS058190
EXP063028	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6 rrm3D::HPHMX4; Developmental stage: Asyncrhonous cell culture	NULL	4606	normal	Q08032	strain YMS1293_4-1	PEAKS058191
EXP063029	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6 rrm3D::HPHMX4 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4607	normal	Q08032	strain YMS1298-7	PEAKS058192
EXP063030	Anti-MYC	Saccharomyces cerevisiae	Treatment: alpha-Factor for 2.5 hrs and then release with pronase; Genotype: w303 MATa RAD5+ bar1D Mcm4-3FLAG::KANMX TOP1-13MYC::HIS3MX4; Developmental stage: ealy S phase time point (45min at 18C)	NULL	4596	normal	P04786	strain YMS1539-5	PEAKS058193
EXP063031	Anti-MYC	Saccharomyces cerevisiae	Treatment: alpha-Factor for 2.5 hrs and then release with pronase; Genotype: W303 MATa RAD5+ bar1D Mcm4-3FLAG::KANMX TOP1-13MYC::HIS3MX4 tof1D::LEU2; Developmental stage: ealy S phase time point (45min at 18C)	NULL	4597	normal	P04786	strain YMS1540-9	PEAKS058194
EXP063036	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 16 hrs culture	EXP063032	4608	normal	P11938	strain JDY86	PEAKS058195
EXP063037	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 16 hrs culture	EXP063033	4608	normal	P11938	strain JDY86	PEAKS058196
EXP063038	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 14 days culture	EXP063034	4608	normal	P11938	strain JDY86	PEAKS058197
EXP063039	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 14 days culture	EXP063035	4608	normal	P11938	strain JDY86	PEAKS058198
EXP063053	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063040	4609	normal	P06701	strain JDY86 H3E50A	PEAKS058199
EXP063054	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063041	4610	normal	P06701	strain JDY86 H4H18A	PEAKS058200
EXP063055	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063042	4610	normal	P06701	strain JDY86 H4H18A	PEAKS058201
EXP063056	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063043	4611	normal	P06701	strain JDY86 H4K16Q	PEAKS058202
EXP063057	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063044	4611	normal	P06701	strain JDY86 H4K16Q	PEAKS058203
EXP063058	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063045	4608	normal	P06701	strain JDY86	PEAKS058204
EXP063059	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063046	4608	normal	P06701	strain JDY86	PEAKS058205
EXP063060	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063047	4609	normal	P06701	strain JDY86 H3E50A	PEAKS058206
EXP063061	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063048	4609	normal	P06701	strain JDY86 H3E50A	PEAKS058207
EXP063062	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063049	4610	normal	P06701	strain JDY86 H4H18A	PEAKS058208
EXP063063	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063050	4610	normal	P06701	strain JDY86 H4H18A	PEAKS058209
EXP063064	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063051	4611	normal	P06701	strain JDY86 H4K16Q	PEAKS058210
EXP063065	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063052	4608	normal	P06701	strain JDY86	PEAKS058211
EXP063066	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta; Conditions: no stimulated; GTRD_Rep_Group: 18	NULL	3099	normal	P13393	BY4741 strain	PEAKS058212
EXP063067	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta; Conditions: stimulated; GTRD_Rep_Group: 19	NULL	3099	normal	P13393	BY4741 strain	PEAKS058213
EXP063068	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta ino80delta::kanMX4; Conditions: no stimulated; GTRD_Rep_Group: 20	NULL	4612	normal	P13393	strain YR092	PEAKS058214
EXP063069	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta ino80delta::kanMX4; Conditions: stimulated; GTRD_Rep_Group: 21	NULL	4612	normal	P13393	strain YR092	PEAKS058215
EXP063071	anti-FLAG M2 antibody (Sigma, F1804, Monoclonal)	Caenorhabditis elegans	Treatment: none; Sex: hermaphrodite worms; Genotype: LONP1-FLAG	EXP063070	3129	normal	O44952	N2 strain(Developmental stage: L4 larvae)	PEAKS058216
EXP063073	anti-IntS1	Drosophila melanogaster	Treatment: untreated	EXP063072	4622	normal	Q9W1C5	DL1 cells	PEAKS058217
EXP063074	anti-IntS12	Drosophila melanogaster	Treatment: untreated	EXP063072	4622	normal	Q9VBB3	DL1 cells	PEAKS058218
EXP063079	anti-Pho (Papp and MÃ¼ller 2006)	Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 2-4 hrs old embryo; Developmental stage: 2-4 hrs old embryo	EXP063075	4623	normal	Q8ST83	Oregon R (Developmental stage: 2-4 hrs embryos)	PEAKS058219
EXP063080	anti-Pho (Papp and MÃ¼ller 2006)	Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 14-16 hrs old embryo; Developmental stage: 14-16 hrs old embryo	EXP063076	4624	normal	Q8ST83	Oregon R (Developmental stage: 14 - 16 hrs)	PEAKS058220
EXP063085	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA wildtype; Genotype: wildtype	EXP063081	4627	normal	P05205	adult ovaries	PEAKS058221
EXP063086	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA against SUMO ligase (Su(var)2-10); Genotype: shSu(var)2-10	NULL	4627	normal	P05205	adult ovaries	PEAKS058222
EXP063087	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA wildtype; Genotype: wildtype	EXP063083	4627	normal	P05205	adult ovaries	PEAKS058223
EXP063088	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA against SUMO ligase (Su(var)2-10); Genotype: shSu(var)2-10	EXP063084	4627	normal	P05205	adult ovaries	PEAKS058224
EXP063095	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egfp; Genotype: egfp knockout; Time point: 4 days	EXP063089	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	PEAKS058225
EXP063096	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egg; Genotype: egg knockout; Time point: 4 days	EXP063090	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	PEAKS058226
EXP063097	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egfp; Genotype: egfp knockout; Time point: 4 days	EXP063091	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	PEAKS058227
EXP063098	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egg; Genotype: egg knockout; Time point: 4 days	EXP063092	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	PEAKS058228
EXP063099	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against piwi; Genotype: piwi knockout; Time point: 4 days	EXP063093	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	PEAKS058229
EXP063100	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against wde; Genotype: wde knockout; Time point: 4 days	EXP063094	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	PEAKS058230
EXP063112	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q9VR17	2-4 h embryo	PEAKS058231
EXP063113	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q9VQD6	2-4 h embryo	PEAKS058232
EXP063114	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q9VR19	2-4 h embryo	PEAKS058233
EXP063115	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q8SYK5	2-4 h embryo	PEAKS058234
EXP063116	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q9VR17	2-4 h embryo	PEAKS058235
EXP063117	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q9VQD6	2-4 h embryo	PEAKS058236
EXP063118	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q9VR19	2-4 h embryo	PEAKS058237
EXP063119	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q8SYK5	2-4 h embryo	PEAKS058238
EXP063120	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q9VR17	2-4 h embryo	PEAKS058239
EXP063121	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q9VQD6	2-4 h embryo	PEAKS058240
EXP063122	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q9VR19	2-4 h embryo	PEAKS058241
EXP063123	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q8SYK5	2-4 h embryo	PEAKS058242
EXP063124	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	EXP063110	1435	normal	Q9VR17	2-4 h embryo	PEAKS058243
EXP063125	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	normal	Q9VQD6	2-4 h embryo	PEAKS058244
EXP063126	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	normal	Q9VR19	2-4 h embryo	PEAKS058245
EXP063127	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	normal	Q8SYK5	2-4 h embryo	PEAKS058246
EXP063128	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q9VR17	2-4 h embryo	PEAKS058247
EXP063129	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q9VQD6	2-4 h embryo	PEAKS058248
EXP063130	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q9VR19	2-4 h embryo	PEAKS058249
EXP063131	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q8SYK5	2-4 h embryo	PEAKS058250
EXP063164	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063132	4629	normal	Q961A1	embryo (Developmental stage: nuclear cycle 11)	PEAKS058251
EXP063165	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063134	4629	normal	Q961A1	embryo (Developmental stage: nuclear cycle 11)	PEAKS058252
EXP063166	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063134	4629	normal	P50536	embryo (Developmental stage: nuclear cycle 11)	PEAKS058253
EXP063167	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063136	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	PEAKS058254
EXP063168	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063137	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	PEAKS058255
EXP063169	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063140	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	PEAKS058256
EXP063170	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063141	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	PEAKS058257
EXP063171	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063140	4630	normal	P50536	embryo (Developmental stage: nuclear cycle 12)	PEAKS058258
EXP063172	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063141	4630	normal	P50536	embryo (Developmental stage: nuclear cycle 12)	PEAKS058259
EXP063173	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063144	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	PEAKS058260
EXP063174	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063145	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	PEAKS058261
EXP063175	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063148	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	PEAKS058262
EXP063176	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063149	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	PEAKS058263
EXP063177	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063148	4631	normal	P50536	embryo (Developmental stage: nuclear cycle 13)	PEAKS058264
EXP063178	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063149	4631	normal	P50536	embryo (Developmental stage: nuclear cycle 13)	PEAKS058265
EXP063179	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063152	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	PEAKS058266
EXP063180	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063153	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	PEAKS058267
EXP063181	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063156	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	PEAKS058268
EXP063182	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063157	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	PEAKS058269
EXP063183	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063156	4632	normal	P50536	embryo (Developmental stage: nuclear cycle 14)	PEAKS058270
EXP063184	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063157	4632	normal	P50536	embryo (Developmental stage: nuclear cycle 14)	PEAKS058271
EXP063185	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063160	1435	normal	Q961A1	2-4 h embryo	PEAKS058272
EXP063186	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063162	1435	normal	Q961A1	2-4 h embryo	PEAKS058273
EXP063187	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063162	1435	normal	P50536	2-4 h embryo	PEAKS058274
EXP063190	anti-Elys (Pascual-Garcia et al., 2017)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063188	1451	normal	Q9VWE6	S2 (Schneider 2)	PEAKS058275
EXP063191	anti-Nup107 (this study)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063188	1451	normal	Q9V466	S2 (Schneider 2)	PEAKS058276
EXP063192	anti-Nup93 (Pascual-Garcia et al., 2017)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063188	1451	normal	Q9XZ06	S2 (Schneider 2)	PEAKS058277
EXP063194	anti-dCTCF (aa 612-818, rat )	Drosophila melanogaster	Treatment: Treatment: none; Strain: Oregon-R; Developmental stage: 0-12 hrs  after egg-laying; Strain: Oregon-R; Developmental stage: 0-12 hrs  after egg-laying	EXP063193	4636	normal	Q9VS55	OregonR (Developmental stage: 0-12h after egg-laying embryos)	PEAKS058278
EXP063203	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: GST RNAi; Genotype: wildtype	EXP063195	4637	normal	Q86CW5	L2-4	PEAKS058279
EXP063204	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: dCenpC RNAi; Genotype: dCenpC knockout	EXP063196	4637	normal	Q86CW5	L2-4	PEAKS058280
EXP063205	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: control induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro	EXP063197	4637	normal	Q7YU87	L2-4	PEAKS058281
EXP063206	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: HMR+LHR induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro (HMR+LHR over-expression)	EXP063198	4637	normal	Q7YU87	L2-4	PEAKS058282
EXP063207	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: GST RNAi; Genotype: wildtype	EXP063199	4637	normal	Q86CW5	L2-4	PEAKS058283
EXP063208	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: dCenpC RNAi; Genotype: dCenpC knockout	EXP063200	4637	normal	Q86CW5	L2-4	PEAKS058284
EXP063209	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: control induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro	EXP063201	4637	normal	Q7YU87	L2-4	PEAKS058285
EXP063210	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: HMR+LHR induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro (HMR+LHR over-expression)	EXP063202	4637	normal	Q7YU87	L2-4	PEAKS058286
EXP063213	anti-GFP	Drosophila melanogaster	Treatment: none; Genotype: knock in IMAGO line ato:GFP	EXP063211	1983	normal	P48987	eye imaginal disc (developmental stage: L3)	PEAKS058287
EXP063214	anti-GFP	Drosophila melanogaster	Treatment: none; Genotype: knock in IMAGO line ato:GFP	EXP063212	1983	normal	P48987	eye imaginal disc (developmental stage: L3)	PEAKS058288
EXP063218	anti-ATRX (Abcam, ab97508)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX wildtype	EXP063215	4638	normal	P46100	SK-N-FI (Neuroblastoma)	PEAKS058289
EXP063219	anti-ATRX (Abcam, ab97508)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063216	4639	normal	P46100	SKNMM (metastatic neuroblastoma)	PEAKS058290
EXP063220	anti-REST (Millipore, 07-579)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063216	4639	normal	Q13127	SKNMM (metastatic neuroblastoma)	PEAKS058291
EXP063221	anti-ATRX (Abcam, ab97508)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063217	4640	normal	P46100	CHLA-90 (neuroblastoma)	PEAKS058292
EXP063222	anti-REST (Millipore, 07-579)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063217	4640	normal	Q13127	CHLA-90 (neuroblastoma)	PEAKS058293
EXP063227	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS058294
EXP063228	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS058295
EXP063229	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS058296
EXP063230	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS058297
EXP063231	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS058298
EXP063232	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	PEAKS058299
EXP063233	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063225	4643	normal	P55317	HEC-1-A (Endometrial adenocarcinoma)	PEAKS058300
EXP063234	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063225	4643	normal	P55317	HEC-1-A (Endometrial adenocarcinoma)	PEAKS058301
EXP063235	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063225	4643	normal	P55317	HEC-1-A (Endometrial adenocarcinoma)	PEAKS058302
EXP063237	anti-Gli1 (R&D catalog number AF3324)	Homo sapiens	Treatment: 0.5ug/mL of Shh ligand for 48 hours; Time point: 48 hours; Source: primary cells	EXP063236	4644	normal	P08151	chondrosarcoma	PEAKS058303
EXP063238	anti-Gli2 (R&D catalog number AF3526)	Homo sapiens	Treatment: 0.5ug/mL of Shh ligand for 48 hours; Time point: 48 hours; Source: primary cells	EXP063236	4644	normal	P10070	chondrosarcoma	PEAKS058304
EXP063239	anti-CTCF (Millipore 07-729, rabbit)	Homo sapiens	Treatment: none; Developmental stage: Mixed (asynchronous); Genotype: wildtype	NULL	4645	normal	P49711	MDA-MB-435 (amelanotic melanoma)	PEAKS058305
EXP063240	anti-pT431 CTCF (custom, rabbit )	Homo sapiens	Treatment: none; Developmental stage: Mitosis (nocodazole-arrested); Genotype: pT431 CTCF	NULL	4645	normal	P49711	MDA-MB-435 (amelanotic melanoma)	PEAKS058306
EXP063244	anti-HA (Abcam,ab9110)	Homo sapiens	Treatment: none; Genotype: retrovirally transduced ONECUT2	EXP063241	38	normal	O95948	A549 (lung carcinoma)	PEAKS058307
EXP063245	anti-HA (Abcam,ab9110)	Homo sapiens	Treatment: none; Genotype: retrovirally transduced ONECUT2	EXP063243	38	normal	O95948	A549 (lung carcinoma)	PEAKS058308
EXP063252	anti-PU1 (Santa Cruz, sc352X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Time point: day 0	EXP063246	4646	normal	P17947	mobilised peripheral blood CD34+ erythrocyte precursors cells	PEAKS058309
EXP063253	anti-KLF1 (Abcam, ab2483)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Time point: day 5	EXP063247	4646	normal	Q13351	mobilised peripheral blood CD34+ erythrocyte precursors cells	PEAKS058310
EXP063254	anti-PU1 (Santa Cruz, sc352X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: empty control	EXP063248	514	normal	P17947	K562 (myelogenous leukemia)	PEAKS058311
EXP063255	anti-PU1 (Santa Cruz, sc352X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: overexpressinng PU1	EXP063249	514	normal	P17947	K562 (myelogenous leukemia)	PEAKS058312
EXP063256	anti-SMAD1 (Santa Cruz, sc7965X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: empty control	EXP063250	514	normal	Q15797	K562 (myelogenous leukemia)	PEAKS058313
EXP063257	anti-SMAD1 (Santa Cruz, sc7965X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: overexpressinng PU1	EXP063251	514	normal	Q15797	K562 (myelogenous leukemia)	PEAKS058314
EXP063259	anti-FLAG M2 (Sigma-Aldrich, Merck, catalog# F3165)	Homo sapiens	Treatment: lentiviral infection LV-FLAG-ATOH8; Genotype: stably expressing FLAG-ATOH8	EXP063258	1564	normal	Q96SQ7	pulmonary artery endothelial cell	PEAKS058315
EXP063262	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: Ethanol (0.01% final); Genotype: pcDNA6/TR and pcDNA4/TO, Invitrogen	EXP063260	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058316
EXP063263	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10-8M Estradiol (Sigma); Genotype: pcDNA6/TR and pcDNA4/TO, Invitrogen	EXP063261	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058317
EXP063264	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: Ethanol (0.01% final); Genotype: ectopically expressing a dominant form of the MKL1 protein (cDNA6/TR and pcDNA4/TO -MKL1 deltaN200, Invitrogen)	EXP063260	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058318
EXP063265	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10-8M Estradiol (Sigma); Genotype: ectopically expressing a dominant form of the MKL1 protein (cDNA6/TR and pcDNA4/TO -MKL1 deltaN200, Invitrogen)	EXP063261	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058319
EXP063266	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: GG allels (non-carrier (G) allele); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	PEAKS058320
EXP063267	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: CC allels,  ((C) allele of rs10846744 SNP associated with cardiovascular disease (CVD)); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	PEAKS058321
EXP063268	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: GG allels (non-carrier (G) allele); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	PEAKS058322
EXP063269	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: CC allels,  ((C) allele of rs10846744 SNP associated with cardiovascular disease (CVD)); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	PEAKS058323
EXP063271	Anti-WDR5 (Antibody from Diego Pasini Lab)	Homo sapiens	Treatment: Cells were infected with pRSI-U6-shLuc-UbiC-TagRFP-2A-Puro vector and selectioned with 3Âµg/ml of Puromycin; Genotype: wildtype	NULL	4232	normal	P61964	MCF10DCIS cells	PEAKS058324
EXP063272	Anti-WDR5 (Antibody from Diego Pasini Lab)	Homo sapiens	Treatment: Cells were infected with pRSI-U6-shWDR5-UbiC-TagRFP-2A-Puro vector and selectioned with 3Âµg/ml of Puromycin; Genotype: WDR5 silenced	NULL	4232	normal	P61964	MCF10DCIS cells	PEAKS058325
EXP063274	anti-TRIM24 (Novus Biologicals)	Homo sapiens	Treatment: Estrogen (10 nM) for 3 hours	EXP063273	113	normal	O15164	MCF7 (Invasive ductal breast carcinoma)	PEAKS058326
EXP063275	anti-TRIM24 (Novus Biologicals)	Homo sapiens	Treatment: Ethanol as vehicle control	EXP063273	113	normal	O15164	MCF7 (Invasive ductal breast carcinoma)	PEAKS058327
EXP063284	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063276	4654	normal	P41235	SNU-16 (Gastric adenocarcinoma)	PEAKS058328
EXP063285	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063277	4655	normal	P41235	OCUM-1 (Signet ring cell gastric adenocarcinoma)	PEAKS058329
EXP063286	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063278	4656	normal	P41235	IM95 (Gastric adenocarcinoma)	PEAKS058330
EXP063287	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063279	4657	normal	P41235	ISt-1 (Gastric carcinoma)	PEAKS058331
EXP063288	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063280	518	normal	P41235	KATOIII (signet ring cell gastric adenocarcinoma)	PEAKS058332
EXP063289	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063281	4658	normal	P41235	NUGC4 (Signet ring cell gastric adenocarcinoma)	PEAKS058333
EXP063290	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063282	870	normal	P41235	YCC3 (gastric adenocarcinoma)	PEAKS058334
EXP063291	anti-HNF4a	Homo sapiens	Treatment: Treatment: none; Genotype: HNF4a overexpressing; Genotype: HNF4a overexpressing	EXP063283	4659	normal	P41235	HFE-145 (Normal gastric epithelial cells)	PEAKS058335
EXP063292	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058336
EXP063293	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: HOTTIP knockout	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058337
EXP063294	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: CBS79 knockout	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058338
EXP063295	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: CBS79 knockout - VP-HOTTIP	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058339
EXP063310	anti-cFOS (Cell Signaling #2250)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	P01100	activated primary CD4+ T cells from blood	PEAKS058340
EXP063311	anti-JUNB (Cell Signaling #3753)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	P17275	activated primary CD4+ T cells from blood	PEAKS058341
EXP063312	anti-NFAT1 (Cell Signaling #5861)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	Q13469	activated primary CD4+ T cells from blood	PEAKS058342
EXP063313	anti-NFAT1 (Cell Signaling #5861)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	Q13469	activated primary CD4+ T cells from blood	PEAKS058343
EXP063314	ant-NFAT2 (Cell Signaling #8032)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	O95644	activated primary CD4+ T cells from blood	PEAKS058344
EXP063315	anti-NFkB1  (Cell Signaling #12540)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	P19838	activated primary CD4+ T cells from blood	PEAKS058345
EXP063320	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058346
EXP063321	anti-FLAG (clone M2, Sigma Aldrich, Mouse monoclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058347
EXP063322	anti-CAP-H2 (Bethyl Laboratories, A302-276A, lot #A1, Rabbit polyclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058348
EXP063323	anti-CAP-H2 (Bethyl Laboratories, A302-276A, lot #A1, Rabbit polyclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	Q6IBW4	IMR90 derived OIS (Oncogene-Induced Senescence) cells	PEAKS058349
EXP063324	anti-CTCF (Millipore, 07-729, lot# 2475698, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	P49711	IMR90 (lung fibroblasts)	PEAKS058350
EXP063325	anti-CTCF (Millipore, 07-729, lot# 2475698, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	P49711	IMR90 derived OIS (Oncogene-Induced Senescence) cells	PEAKS058351
EXP063326	anti-SMC1 (Bethyl Laboratories, A300-055A, lot# A4, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	P05067	IMR90 (lung fibroblasts)	PEAKS058352
EXP063327	anti-SMC1 (Bethyl Laboratories, A300-055A, lot# A4, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	P05067	IMR90 derived OIS (Oncogene-Induced Senescence) cells	PEAKS058353
EXP063328	anti-SMC2 (Bethyl Laboratories, A300-058A), lot #A3, Rabbit polyclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	O95347	IMR90 derived OIS (Oncogene-Induced Senescence) cells	PEAKS058354
EXP063329	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: control; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058355
EXP063330	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: Triptolide for 5min; Genotype: wildtype; Karyotype: Normal diploid; Time point: 5min; Genotype: wildtype; Karyotype: Normal diploid; Time point: 5min	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058356
EXP063331	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: Triptolide for 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058357
EXP063332	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: alpha-amanitin for 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058358
EXP063333	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: alpha-amanitin for 60 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 60 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 60 mins	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	PEAKS058359
EXP063334	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	Q6IBW4	IMR90 derived OIS (Oncogene-Induced Senescence) cells	PEAKS058360
EXP063335	anti-FLAG (clone M2, Sigma Aldrich, Mouse monoclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	Q6IBW4	IMR90 derived OIS (Oncogene-Induced Senescence) cells	PEAKS058361
EXP063338	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: Treatment: none	EXP063336	949	normal	P49711	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	PEAKS058362
EXP063339	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: Treatment: none	EXP063337	4671	normal	P49711	MCF7-FasR (fulvestrant-resistant Invasive ductal carcinoma)	PEAKS058363
EXP063340	anti-AR antibody	Homo sapiens	Treatment: DHT (1xE-08M) for 72hrs; Disease: Polycystic ovary syndrome	NULL	256	normal	P10275	endometrial stromal cells	PEAKS058364
EXP063343	anti-LMO1 (A300-BL1145,140916 )	Homo sapiens	Treatment: none; Donor: 20180324_7010	EXP063341	520	normal	P25800	Kelly (neuroblastoma)	PEAKS058365
EXP063344	anti-LMO1 (A300-BL1145,140916 )	Homo sapiens	Treatment: none; Donor: 20180324_7009	EXP063342	520	normal	P25800	Kelly (neuroblastoma)	PEAKS058366
EXP063345	anti-ASCL1 (Santa Cruz, sc-374104X, I0711)	Homo sapiens	Treatment: none; Donor: 20180324_7006	NULL	520	normal	P50553	Kelly (neuroblastoma)	PEAKS058367
EXP063354	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063346	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	PEAKS058368
EXP063355	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063346	111	normal	A6H8Y1	T47D (invasive ductal carcinoma)	PEAKS058369
EXP063356	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063347	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	PEAKS058370
EXP063357	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063347	111	normal	A6H8Y1	T47D (invasive ductal carcinoma)	PEAKS058371
EXP063358	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063348	583	normal	Q8WUA4	MCF10A (breast epithelial cells)	PEAKS058372
EXP063359	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063348	583	normal	A6H8Y1	MCF10A (breast epithelial cells)	PEAKS058373
EXP063360	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063349	583	normal	Q8WUA4	MCF10A (breast epithelial cells)	PEAKS058374
EXP063361	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063349	583	normal	A6H8Y1	MCF10A (breast epithelial cells)	PEAKS058375
EXP063362	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063350	2600	normal	Q8WUA4	T98G (Glioblastoma)	PEAKS058376
EXP063363	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063351	2600	normal	Q8WUA4	T98G (Glioblastoma)	PEAKS058377
EXP063364	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063352	489	normal	Q8WUA4	IMR90 (lung fibroblasts)	PEAKS058378
EXP063365	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	489	normal	Q8WUA4	IMR90 (lung fibroblasts)	PEAKS058379
EXP063366	anti-CTCF (Millipore 07-729, rabbit polyclonal)	Homo sapiens	Treatment: none; Conditions: serum starved	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS058380
EXP063367	anti-H3K18ac (in house rabbit polyclonal antibody )	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	normal	H3K18ac	T47D (invasive ductal carcinoma)	PEAKS058381
EXP063368	anti-CTCF (Millipore 07-729, rabbit polyclonal)	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	PEAKS058382
EXP063369	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: reserum	EXP063353	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	PEAKS058383
EXP063370	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: reserum	NULL	2600	normal	Q8WUA4	T98G (Glioblastoma)	PEAKS058384
EXP063371	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: siCTRL (control); Genotype: wildtype	NULL	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	PEAKS058385
EXP063372	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: siRNA against ADNP; Genotype: ADNP knockout	NULL	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	PEAKS058386
EXP063373	anti-GTF3C1 (Novus Biologicals, NB100-606570)	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	normal	Q12789	T47D (invasive ductal carcinoma)	PEAKS058387
EXP063375	anti-HOXB8  (Abcam, cat# ab125727)	Homo sapiens	Treatment: none	EXP063374	514	normal	P17481	K562 (myelogenous leukemia)	PEAKS058388
EXP063376	anti-CTCF (ab70303)	Homo sapiens	Treatment: Control mismatch; Genotype: wildtype	NULL	516	normal	P49711	Kasumi-1 (acute myeloblastic leukemia)	PEAKS058389
EXP063377	anti-CTCF (ab70303)	Homo sapiens	Treatment: siRNA adainst RUNX1/ETO; Genotype: RUNX1/ETO knockout	NULL	516	normal	P49711	Kasumi-1 (acute myeloblastic leukemia)	PEAKS058390
EXP063378	anti-LDB1 (ab96799)	Homo sapiens	Treatment: Control mismatch; Genotype: wildtype	NULL	516	normal	Q86U70	Kasumi-1 (acute myeloblastic leukemia)	PEAKS058391
EXP063379	anti-LDB1 (ab96799)	Homo sapiens	Treatment: siRNA adainst RUNX1/ETO; Genotype: RUNX1/ETO knockout	NULL	516	normal	Q86U70	Kasumi-1 (acute myeloblastic leukemia)	PEAKS058392
EXP063381	anti-FLAG (Millipore Sigma, F1804)	Arabidopsis thaliana	Treatment: none; Ecotype: Col-0; Genotype: myc2 MYC2::MYC2-FLAG	EXP063380	4674	normal	Q39204	rosette leaves	PEAKS058393
EXP063382	anti-FLAG (Millipore Sigma, F1804)	Arabidopsis thaliana	Treatment: 25 min touch treatment; Ecotype: Col-0; Genotype: myc2 MYC2::MYC2-FLAG; Time point: 25 mins	EXP063380	4674	normal	Q39204	rosette leaves	PEAKS058394
EXP063389	anti-ATXN7L3(Bethyl Labs cat# A302-800A)	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	EXP063383	417	normal	Q14CW9	HCT-116 (colon carcinoma)	PEAKS058395
EXP063390	anti-ATXN7L3(Bethyl Labs cat# A302-800A)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063384	417	normal	Q14CW9	HCT-116 (colon carcinoma)	PEAKS058396
EXP063391	anti-GCN5 (Santa Cruz cat# sc-20698)	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	EXP063383	417	normal	Q92830	HCT-116 (colon carcinoma)	PEAKS058397
EXP063392	anti-GCN5 (Santa Cruz cat# sc-20698)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063384	417	normal	Q92830	HCT-116 (colon carcinoma)	PEAKS058398
EXP063393	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: Thaps treated, sh RNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063385	417	normal	O95243	HCT-116 (colon carcinoma)	PEAKS058399
EXP063394	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: shRNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063386	417	normal	O95243	HCT-116 (colon carcinoma)	PEAKS058400
EXP063395	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: Thaps treated, shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063387	417	normal	O95243	HCT-116 (colon carcinoma)	PEAKS058401
EXP063396	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063388	417	normal	O95243	HCT-116 (colon carcinoma)	PEAKS058402
EXP063397	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: Thaps treated, sh RNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063385	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	PEAKS058403
EXP063398	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: shRNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063386	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	PEAKS058404
EXP063399	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: Thaps treated, shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063387	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	PEAKS058405
EXP063400	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063388	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	PEAKS058406
EXP063401	anti-USP22 (Novus Biologicals cat# NBP1-49644)	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	EXP063383	417	normal	Q9UPT9	HCT-116 (colon carcinoma)	PEAKS058407
EXP063402	anti-USP22 (Novus Biologicals cat# NBP1-49644)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063384	417	normal	Q9UPT9	HCT-116 (colon carcinoma)	PEAKS058408
EXP063403	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: vehicle (DMSO) for 24 hrs; Genotype: wildtype; Time point: 24 hours	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	PEAKS058409
EXP063404	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10 nM R1881 for 3 hrs; Genotype: wildtype; Time point: 24 hours	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	PEAKS058410
EXP063405	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10nM Thapsigargin for 3 hrs; Genotype: wildtype; Time point: 3 hrs	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	PEAKS058411
EXP063406	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10nM Thapsigargin for 3 hrs; Genotype: wildtype; Time point: 3 hrs	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	PEAKS058412
EXP063407	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10nM Thapsigargin for 3 hrs; Genotype: ERN1 Knockout; Time point: 3 hrs	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	PEAKS058413
EXP063411	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: treated with 500 U/ml IFN-beta for 0 hrs; Time point: 0 hrs	EXP063408	38	normal	P32519	A549 (lung carcinoma)	PEAKS058414
EXP063412	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: treated with 500 U/ml IFN-beta for 6 hrs; Time point: 6 hrs	NULL	38	normal	P32519	A549 (lung carcinoma)	PEAKS058415
EXP063413	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: none	EXP063409	38	normal	P32519	A549 (lung carcinoma)	PEAKS058416
EXP063414	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: none	EXP063410	38	normal	P32519	A549 (lung carcinoma)	PEAKS058417
EXP063417	anti-BCOR antibody (A310-672A, Bethyl Laboratories, rabbit polyclonal )	Homo sapiens	Treatment: steroid-depleted medium, 72h, ethanol, 1hr; Time point: 73 hrs; Genotype: wildtype	EXP063415	71	normal	Q6W2J9	VCaP (prostate carcinoma)	PEAKS058418
EXP063418	anti-BCOR antibody (A310-672A, Bethyl Laboratories, rabbit polyclonal )	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881, 10nM for 1hr; Time point: 73 hrs; Genotype: wildtype	EXP063416	71	normal	Q6W2J9	VCaP (prostate carcinoma)	PEAKS058419
EXP063419	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72hrs, ethanol for 1hr, siBCOR transfection for 72h; Time point: 73 hrs; Genotype: BCOR knockout	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS058420
EXP063420	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881 10nM for 1hr, siBCOR transfection for 72hrs; Time point: 73 hrs; Genotype: BCOR knockout	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS058421
EXP063421	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72hrs, ethanol for 1hr, siNON transfection for 72hrs; Time point: 73 hrs; Genotype: wildtype	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS058422
EXP063422	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881, 10nM for 1hr, siNON transfection for 72hrs; Time point: 73 hrs; Genotype: wildtype	NULL	71	normal	P10275	VCaP (prostate carcinoma)	PEAKS058423
EXP063439	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063427	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058424
EXP063440	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063428	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058425
EXP063441	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063429	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058426
EXP063442	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063430	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058427
EXP063443	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063431	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058428
EXP063444	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 72 hrs + 6 hrs; Genotype: wildtype; Time point: 72 hrs + 6 hrs; Genotype: wildtype; Time point: 72 hrs + 6 hrs; Genotype: wildtype	EXP063432	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058429
EXP063445	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063427	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058430
EXP063446	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063428	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058431
EXP063447	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063429	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058432
EXP063448	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063430	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058433
EXP063449	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063431	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058434
EXP063450	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063432	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058435
EXP063451	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063427	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	PEAKS058436
EXP063452	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063428	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	PEAKS058437
EXP063453	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063429	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	PEAKS058438
EXP063454	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063430	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	PEAKS058439
EXP063455	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063431	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	PEAKS058440
EXP063456	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063432	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	PEAKS058441
EXP063457	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058442
EXP063458	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058443
EXP063459	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058444
EXP063460	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058445
EXP063461	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063437	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058446
EXP063462	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058447
EXP063463	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	PEAKS058448
EXP063464	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	PEAKS058449
EXP063465	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	PEAKS058450
EXP063466	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	PEAKS058451
EXP063467	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063437	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	PEAKS058452
EXP063468	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	PEAKS058453
EXP063469	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058454
EXP063470	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058455
EXP063471	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058456
EXP063472	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058457
EXP063473	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	NULL	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058458
EXP063474	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058459
EXP063475	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	PEAKS058460
EXP063476	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	PEAKS058461
EXP063477	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	PEAKS058462
EXP063478	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	PEAKS058463
EXP063479	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063437	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	PEAKS058464
EXP063480	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	PEAKS058465
EXP063481	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	PEAKS058466
EXP063482	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	PEAKS058467
EXP063483	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: Vehicle; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	PEAKS058468
EXP063484	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	PEAKS058469
EXP063485	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063423	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058470
EXP063486	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063424	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058471
EXP063487	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063423	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058472
EXP063488	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063424	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	PEAKS058473
EXP063489	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063425	874	normal	P51532	ZR-75-1 (invasive ductal carcinoma)	PEAKS058474
EXP063490	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063426	874	normal	P51532	ZR-75-1 (invasive ductal carcinoma)	PEAKS058475
EXP063491	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063425	874	normal	O14497	ZR-75-1 (invasive ductal carcinoma)	PEAKS058476
EXP063492	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063426	874	normal	O14497	ZR-75-1 (invasive ductal carcinoma)	PEAKS058477
EXP063495	anti-HA (901501, BioLegend)	Homo sapiens	Treatment: hDFs transduced with rtTA and tet-HA-ETV2, without doxycycline; Genotype: rtTA and tet-HA-ETV2; Time point: day 7	EXP063493	4693	normal	O00321	ETV2-induced endothelial cells (iECs) from human fibroblasts	PEAKS058478
EXP063496	anti-HA (901501, BioLegend)	Homo sapiens	Treatment: hDFs transduced with rtTA and tet-HA-ETV2 with doxycycline and DMSO for 7 days; Genotype: rtTA and tet-HA-ETV2; Time point: day 7	EXP063494	4693	normal	O00321	ETV2-induced endothelial cells (iECs) from human fibroblasts	PEAKS058479
EXP063498	anti-SRF (Santa Cruz sc-335)	Homo sapiens	Treatment: none	EXP063497	192	normal	P11831	HCASMC (Human coronary artery smooth muscle cells)	PEAKS058480
EXP063507	anti-BAF155	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063499	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	PEAKS058481
EXP063508	anti-BRG1	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063499	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058482
EXP063509	anti-BAF155	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063499	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	PEAKS058483
EXP063510	anti-BRG1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063500	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058484
EXP063511	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063501	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058485
EXP063512	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063502	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058486
EXP063513	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063503	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058487
EXP063514	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063504	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058488
EXP063515	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-2; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063505	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058489
EXP063516	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-2; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063506	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058490
EXP063519	anti-Bach1 (House made (A1-6))	Homo sapiens	Treatment: none	EXP063517	4695	normal	O14867	AsPC-1 (Pancreatic ductal adenocarcinoma)	PEAKS058491
EXP063520	anti-Bach1 (House made (A1-6))	Homo sapiens	Treatment: none	EXP063518	4696	normal	O14867	SW1990 (Pancreatic adenocarcinoma)	PEAKS058492
EXP063523	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP063521	1177	normal	Q09472	LNCaP clone FGC	PEAKS058493
EXP063524	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	PEAKS058494
EXP063525	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	PEAKS058495
EXP063526	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 and A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	PEAKS058496
EXP063527	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP063522	1177	normal	Q09472	LNCaP clone FGC	PEAKS058497
EXP063528	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	PEAKS058498
EXP063529	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	PEAKS058499
EXP063530	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 and A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	PEAKS058500
EXP063533	anti-FOXA1 (abcam, ab23738, lot GR176970-2)	Homo sapiens	Treatment: Treatment: Treatment: no Dox; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days	EXP063531	2991	normal	P55317	MCF7L-P(immortalized breast epithelial cell line)	PEAKS058501
EXP063534	anti-FOXA1 (abcam, ab23738, lot GR176970-2)	Homo sapiens	Treatment: Treatment: Treatment: 1 ug/ml Dox for 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days	EXP063532	2991	normal	P55317	MCF7L-P(immortalized breast epithelial cell line)	PEAKS058502
EXP063542	anti-CTCF	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	EXP063535	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058503
EXP063543	anti-ESR1	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	EXP063535	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058504
EXP063544	anti-FoxA1	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	EXP063535	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058505
EXP063545	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	EXP063536	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058506
EXP063546	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	EXP063536	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058507
EXP063547	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	EXP063536	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058508
EXP063548	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	EXP063539	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058509
EXP063549	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	EXP063537	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058510
EXP063550	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	EXP063537	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058511
EXP063551	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	EXP063537	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058512
EXP063552	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	EXP063538	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058513
EXP063553	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	EXP063538	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058514
EXP063554	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	EXP063538	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058515
EXP063555	anti-CTCF	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	EXP063540	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058516
EXP063556	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	EXP063539	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058517
EXP063557	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	EXP063539	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058518
EXP063558	anti-ESR1	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	EXP063540	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058519
EXP063559	anti-FoxA1	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	EXP063540	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058520
EXP063560	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	EXP063541	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS058521
EXP063561	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	EXP063541	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058522
EXP063562	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	EXP063541	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058523
EXP063570	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	P51532	SAH (induced pluripotent stem cell line)	PEAKS058524
EXP063571	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	Q12824	SAH (induced pluripotent stem cell line)	PEAKS058525
EXP063572	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	Q92922	SAH (induced pluripotent stem cell line)	PEAKS058526
EXP063573	SUZ12 (Cell Signaling Tech., 3737S, lot: 6)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	Q15022	SAH (induced pluripotent stem cell line)	PEAKS058527
EXP063574	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	P51532	SAH (induced pluripotent stem cell line)	PEAKS058528
EXP063575	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	Q12824	SAH (induced pluripotent stem cell line)	PEAKS058529
EXP063576	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	Q92922	SAH (induced pluripotent stem cell line)	PEAKS058530
EXP063577	SUZ12 (Cell Signaling Tech., 3737S, lot: 6)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	Q15022	SAH (induced pluripotent stem cell line)	PEAKS058531
EXP063578	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058532
EXP063579	SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058533
EXP063580	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058534
EXP063581	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	EXP063565	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058535
EXP063582	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	NULL	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058536
EXP063583	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	NULL	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058537
EXP063584	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058538
EXP063585	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058539
EXP063586	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058540
EXP063587	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058541
EXP063588	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058542
EXP063589	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058543
EXP063590	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058544
EXP063591	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058545
EXP063592	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058546
EXP063593	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: lentivirus: SMARCB1 Empty; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058547
EXP063594	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	EXP063566	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058548
EXP063595	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058549
EXP063596	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058550
EXP063597	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	PEAKS058551
EXP063600	CDK9	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS058552
EXP063601	CDK9	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T2 mutant	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS058553
EXP063602	CDK9	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS058554
EXP063603	CDK9	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged wild type human ENL	NULL	421	normal	P50750	HEK293 (embryonic kidney)	PEAKS058555
EXP063604	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged wild type human ENL	EXP063598	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058556
EXP063605	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058557
EXP063606	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1-Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL T1-Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058558
EXP063607	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058559
EXP063608	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2-Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL T2-Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058560
EXP063609	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058561
EXP063610	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3-Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL T3-Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058562
EXP063611	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Expressing empty vector; Genotype: wildtype with  empty vector	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058563
EXP063612	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058564
EXP063613	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged wild type human ENL	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058565
EXP063614	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058566
EXP063615	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058567
EXP063616	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	PEAKS058568
EXP063617	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	EXP063599	1475	normal	Q03111	HK-2	PEAKS058569
EXP063618	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	EXP063599	1475	normal	Q03111	HK-2	PEAKS058570
EXP063619	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	EXP063599	1475	normal	Q03111	HK-2	PEAKS058571
EXP063620	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	EXP063599	1475	normal	Q03111	HK-2	PEAKS058572
EXP063621	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM Non-Target siRNA pool; Genotype: wildtype; Time point: 144 hrs	NULL	70	normal	P49711	LNCaP (prostate carcinoma)	PEAKS058573
EXP063622	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM CTCF target siRNA pool; Genotype: CTCF  knockout; Time point: 144 hrs	NULL	70	normal	P49711	LNCaP (prostate carcinoma)	PEAKS058574
EXP063623	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM Non-Target siRNA pool; Genotype: wildtype; Time point: 144 hrs	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	PEAKS058575
EXP063624	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM CTCF target siRNA pool; Genotype: CTCF  knockout; Time point: 144 hrs	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	PEAKS058576
EXP063625	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM Non-Target siRNA pool; Genotype: wildtype; Time point: 144 hrs; Source: Low Cell sample	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	PEAKS058577
EXP063626	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM CTCF target siRNA pool; Genotype: CTCF  knockout; Time point: 144 hrs; Source: Low Cell sample	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	PEAKS058578
EXP063629	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: none; Genotype: wildtype; Time point: 48 hrs	EXP063627	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	PEAKS058579
EXP063630	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: Doxcycline for 48 hrs; Genotype: transfected CASZ1b expression; Time point: 48 hrs	EXP063628	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	PEAKS058580
EXP063633	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: wildtype; Time point: 48 hrs	EXP063632	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	PEAKS058581
EXP063634	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: 100 nM trametinib for 48 hrs; Genotype: MEK inhibitor trametinib induces; Time point: 48 hrs	EXP063632	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	PEAKS058582
EXP063636	anti-HSP90B (Abcam, ab53497)	Homo sapiens	Treatment: none; Conditions: control	EXP063635	514	bio_control	P08238	K562 (myelogenous leukemia)	PEAKS058583
EXP063637	anti-SCC1 (Abcam ab992)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1507	normal	O60216	HAP1 (chronic myelogenous leukemia)	PEAKS058584
EXP063638	anti-SCC1 (Abcam ab992)	Homo sapiens	Treatment: none; Genotype: CTCF Y226A, F228A mutant	NULL	1507	normal	O60216	HAP1 (chronic myelogenous leukemia)	PEAKS058585
EXP063639	anti-CTCF (Cell Signaling 3418S)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	PEAKS058586
EXP063640	anti-CTCF (Cell Signaling 3418S)	Homo sapiens	Treatment: none; Genotype: CTCF Y226A, F228A mutant	NULL	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	PEAKS058587
EXP063642	anti-GR (P-20, sc-1002, Santa Cruz Biotechnology) and anti-GR (PA1-511A, Thermo Fisher Scientific)	Homo sapiens	Treatment: none; Time point: 0 hr	EXP063641	2269	normal	P04150	A1-2 (breast cancer cells)	PEAKS058588
EXP063643	Mix: anti-GR, P-20, sc-1002, Santa Cruz Biotechnology and anti-GR, PA1-511A, Thermo Fisher Scientific	Homo sapiens	Treatment: 10 nM Dex for 1 hr; Time point: 1 hr	NULL	2269	normal	P04150	A1-2 (breast cancer cells)	PEAKS058589
EXP063644	Mix: anti-GR, P-20, sc-1002, Santa Cruz Biotechnology and anti-GR, PA1-511A, Thermo Fisher Scientific	Homo sapiens	Treatment: 10 nM R5020 for 1 hr; Time point: 1 hr	NULL	2269	normal	P04150	A1-2 (breast cancer cells)	PEAKS058590
EXP063645	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: none; Time point: 0 hr	EXP063641	2269	normal	P06401	A1-2 (breast cancer cells)	PEAKS058591
EXP063646	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10 nM R5020 for 1 hr; Time point: 1 hr	NULL	2269	normal	P06401	A1-2 (breast cancer cells)	PEAKS058592
EXP063647	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: none; Time point: 0 hr; Source: used as control in this work	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS058593
EXP063648	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10 nM R5020 for 1 hr; Time point: 1 hr; Source: used as control in this work	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	PEAKS058594
EXP063649	anti-SMC3	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	PEAKS058595
EXP063650	anti-GFP	Homo sapiens	Treatment: none; Genotype: wildtype, EGFP-STAG1	NULL	422	normal	Q969W9	HeLa Kyoto (cervical adenocarcinoma)	PEAKS058596
EXP063651	anti-GFP	Homo sapiens	Treatment: none; Genotype: wildtype, STAG2-EGFP	NULL	422	normal	Q8N3U4	HeLa Kyoto (cervical adenocarcinoma)	PEAKS058597
EXP063652	anti-CTCF	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	PEAKS058598
EXP063657	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063653	974	normal	Q8TEK3	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058599
EXP063658	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	974	normal	Q8TEK3	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058600
EXP063659	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063653	974	normal	O00255	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058601
EXP063660	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	974	normal	O00255	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058602
EXP063661	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063653	974	normal	Q03164	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058603
EXP063662	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	974	normal	Q03164	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058604
EXP063663	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063654	2219	normal	Q8TEK3	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058605
EXP063664	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	EXP063655	2219	normal	Q8TEK3	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058606
EXP063665	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: DMSO 0.33% for 4 days; Time point: 4 days	NULL	2219	normal	O00255	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058607
EXP063666	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: 330nM VTP-50469 for 4 hrs; Time point: 4 days	NULL	2219	normal	O00255	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058608
EXP063667	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063654	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058609
EXP063668	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	EXP063655	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	PEAKS058610
EXP063669	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063656	779	normal	Q8TEK3	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058611
EXP063670	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	779	normal	Q8TEK3	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058612
EXP063671	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063656	779	normal	O00255	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058613
EXP063672	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	779	normal	O00255	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058614
EXP063673	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063656	779	normal	Q03164	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058615
EXP063674	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	779	normal	Q03164	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058616
EXP063675	anti-HA (Millipore, catalog# 05-904)	Mus musculus	Treatment: AdCre transduction, harvested after 72hrs; Strain: FVB; Genotype: WcrH, P53F/F; Time point: 72 hrs	NULL	902	normal	P19785	mammary epithelial cells	PEAKS058617
EXP063676	anti-HA (Millipore, catalog# 05-904)	Mus musculus	Treatment: AdCre transduction, harvested after 72hrs; Strain: FVB; Genotype: WcrH, P53F/F, HA-hERa; Time point: 72 hrs	NULL	902	normal	P19785	mammary epithelial cells	PEAKS058618
EXP063677	anti-HA (Millipore, catalog# 05-904)	Mus musculus	Treatment: AdCre transduction, harvested after 72hrs; Strain: FVB; Genotype: WcrH, P53F/F, HA-mERa; Time point: 72 hrs	NULL	902	normal	P19785	mammary epithelial cells	PEAKS058619
EXP063678	anti-HA (Millipore, catalog# 05-904)	Homo sapiens	Treatment: Full medium; Genotype: wildtype	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058620
EXP063694	anti-FLAG (SIGMA, F1804)	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: FLAG-NPM1 expressing	EXP063681	2	normal	Q61937	mESCs (mouse embryonic stem cells)	PEAKS058621
EXP063695	anti-FLAG (SIGMA, F1804)	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: FLAG-NPM1 expressing	EXP063682	2	normal	Q61937	mESCs (mouse embryonic stem cells)	PEAKS058622
EXP063696	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063685	514	normal	O14980	K562 (myelogenous leukemia)	PEAKS058623
EXP063697	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063686	1226	normal	O14980	OCI-AML3	PEAKS058624
EXP063698	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063687	1095	normal	O14980	Loucy (adult T acute lymphoblastic leukemia)	PEAKS058625
EXP063699	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: KPT-330; Strain: 129/Ola	EXP063688	1095	normal	O14980	Loucy (adult T acute lymphoblastic leukemia)	PEAKS058626
EXP063700	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063689	438	normal	O14980	HL-60 (acute myeloid leukemia)	PEAKS058627
EXP063701	anti-Crm1 (Bethyl Laboratories, A300-469A)	Homo sapiens	Treatment: none; Strain: 129/Ola	EXP063690	1095	normal	O14980	Loucy (adult T acute lymphoblastic leukemia)	PEAKS058628
EXP063702	anti-Nup214(Bethyl Laboratories, A300-716A)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063691	1095	normal	P35658	Loucy (adult T acute lymphoblastic leukemia)	PEAKS058629
EXP063703	anti-Nup214(Bethyl Laboratories, A300-716A)	Homo sapiens	Treatment: KPT-330; Strain: 129/Ola	EXP063692	1095	normal	P35658	Loucy (adult T acute lymphoblastic leukemia)	PEAKS058630
EXP063704	anti-NPM1(mutant)(ThermoFischer, PA1-46356)	Homo sapiens	Treatment: none; Strain: 129/Ola	EXP063693	1226	normal	P06748	OCI-AML3	PEAKS058631
EXP063715	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	P01100	myometrium	PEAKS058632
EXP063716	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	P01100	myometrium	PEAKS058633
EXP063717	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	P01100	myometrium	PEAKS058634
EXP063718	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	P01100	myometrium	PEAKS058635
EXP063719	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	P01100	myometrium	PEAKS058636
EXP063720	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	P01100	leiomyoma	PEAKS058637
EXP063721	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063711	4705	normal	P01100	leiomyoma	PEAKS058638
EXP063722	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	P01100	leiomyoma	PEAKS058639
EXP063723	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	P01100	leiomyoma	PEAKS058640
EXP063724	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	P01100	leiomyoma	PEAKS058641
EXP063725	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	P05412	myometrium	PEAKS058642
EXP063726	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	P05412	myometrium	PEAKS058643
EXP063727	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	P05412	myometrium	PEAKS058644
EXP063728	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	P05412	myometrium	PEAKS058645
EXP063729	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	P05412	myometrium	PEAKS058646
EXP063730	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	P05412	leiomyoma	PEAKS058647
EXP063731	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063711	4705	normal	P05412	leiomyoma	PEAKS058648
EXP063732	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	P05412	leiomyoma	PEAKS058649
EXP063733	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	P05412	leiomyoma	PEAKS058650
EXP063734	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	P05412	leiomyoma	PEAKS058651
EXP063735	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	P49336	myometrium	PEAKS058652
EXP063736	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	P49336	myometrium	PEAKS058653
EXP063737	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	P49336	myometrium	PEAKS058654
EXP063738	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	P49336	myometrium	PEAKS058655
EXP063739	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	P49336	myometrium	PEAKS058656
EXP063740	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	P49336	leiomyoma	PEAKS058657
EXP063741	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063711	4705	normal	P49336	leiomyoma	PEAKS058658
EXP063742	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	P49336	leiomyoma	PEAKS058659
EXP063743	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	P49336	leiomyoma	PEAKS058660
EXP063744	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	P49336	leiomyoma	PEAKS058661
EXP063745	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	Q93074	myometrium	PEAKS058662
EXP063746	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	Q93074	myometrium	PEAKS058663
EXP063747	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	Q93074	myometrium	PEAKS058664
EXP063748	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	Q93074	myometrium	PEAKS058665
EXP063749	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	Q93074	myometrium	PEAKS058666
EXP063750	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	Q93074	leiomyoma	PEAKS058667
EXP063751	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063711	4705	normal	Q93074	leiomyoma	PEAKS058668
EXP063752	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	Q93074	leiomyoma	PEAKS058669
EXP063753	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	Q93074	leiomyoma	PEAKS058670
EXP063754	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	Q93074	leiomyoma	PEAKS058671
EXP063774	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A	NULL	4713	normal	P17947	primary B cells from peripheral blood	PEAKS058672
EXP063775	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: C	NULL	4713	normal	P17947	primary B cells from peripheral blood	PEAKS058673
EXP063776	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058674
EXP063777	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: D	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058675
EXP063778	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058676
EXP063779	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: D	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058677
EXP063780	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: E	EXP063755	3036	normal	P17947	neutrophils from periferal blood	PEAKS058678
EXP063781	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: F	EXP063756	3036	normal	P17947	neutrophils from periferal blood	PEAKS058679
EXP063782	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: G	EXP063757	4714	normal	P17947	breast-derived primary mast cells	PEAKS058680
EXP063783	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: H	EXP063758	4714	normal	P17947	breast-derived primary mast cells	PEAKS058681
EXP063784	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058682
EXP063785	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: K	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058683
EXP063786	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058684
EXP063787	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 18 hrs	EXP063759	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058685
EXP063788	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 18 hrs	EXP063760	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058686
EXP063789	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 27 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058687
EXP063790	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 42 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058688
EXP063791	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 42 hrs	EXP063760	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058689
EXP063792	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 66 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058690
EXP063793	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: L; Time point: 96 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058691
EXP063794	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: M; Time point: 96 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058692
EXP063795	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 7 days	NULL	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058693
EXP063796	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 18 hrs	EXP063760	620	normal	P17947	monocyte-derived dendritic cells	PEAKS058694
EXP063797	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 4 hrs	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058695
EXP063798	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 4 hrs	NULL	2993	normal	P17947	monocytes from periferal blood	PEAKS058696
EXP063799	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 18 hrs	EXP063763	2993	normal	P17947	monocytes from periferal blood	PEAKS058697
EXP063800	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 7 days	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS058698
EXP063801	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: N; Time point: 7 days	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS058699
EXP063802	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: P; Time point: 7 days	EXP063764	466	normal	P17947	MDM(monocyte derived macrophages)	PEAKS058700
EXP063803	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063765	4715	normal	P17947	EM-3 (Childhood chronic myelogenous leukemia, BCR-ABL1 positive)	PEAKS058701
EXP063804	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063766	974	normal	P17947	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	PEAKS058702
EXP063805	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063767	47	normal	P17947	KG1 (acute myeloid leukemia)	PEAKS058703
EXP063806	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063768	648	normal	P17947	NB4 (acute promyelocytic leukemia )	PEAKS058704
EXP063807	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063769	65	normal	P17947	U937 (adult acute monocytic leukemia)	PEAKS058705
EXP063808	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063770	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS058706
EXP063809	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with PMAVD3_PU.1	EXP063772	2334	normal	P17947	THP-1 (acute monocytic leukemia)	PEAKS058707
EXP063810	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881; Genotype: GFP+pGIPZ	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058708
EXP063811	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058709
EXP063812	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058710
EXP063813	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058711
EXP063814	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058712
EXP063815	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058713
EXP063816	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058714
EXP063817	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058715
EXP063818	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058716
EXP063819	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058717
EXP063820	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: GFP+pGIPZ	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058718
EXP063821	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058719
EXP063822	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058720
EXP063823	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058721
EXP063824	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058722
EXP063825	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058723
EXP063826	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058724
EXP063827	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058725
EXP063828	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881; Genotype: GFP+pGIPZ	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058726
EXP063829	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058727
EXP063830	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058728
EXP063831	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058729
EXP063832	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058730
EXP063833	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058731
EXP063834	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058732
EXP063835	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058733
EXP063836	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058734
EXP063837	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol; Genotype: GFP+pGIPZ	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058735
EXP063838	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058736
EXP063839	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058737
EXP063840	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058738
EXP063841	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058739
EXP063842	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058740
EXP063843	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058741
EXP063844	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058742
EXP063845	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	PEAKS058743
EXP063850	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 20134; Age: 80; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058744
EXP063851	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 20138; Age: 92; Sex: male; Disease: Alzheimer's disease; Braak stage: 3	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058745
EXP063852	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2016018; Age: 78; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058746
EXP063853	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2016029; Age: 83; Sex: male; Disease: normal; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058747
EXP063854	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017001; Age: 91; Sex: female; Disease: Alzheimer's disease; Braak stage: 3	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058748
EXP063855	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017011; Age: 83; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058749
EXP063856	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017014; Age: 81; Sex: female; Disease: normal; Braak stage: 1	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058750
EXP063857	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017025; Age: 70; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058751
EXP063858	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017039; Age: 84; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058752
EXP063859	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 201704; Age: 72; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058753
EXP063860	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2018001; Age: 87; Sex: Alzheimer's disease; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058754
EXP063861	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2018006; Age: 84; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	PEAKS058755
EXP063862	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 20134; Age: 80; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058756
EXP063863	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 20138; Age: 92; Sex: male; Disease: Alzheimer's disease; Braak stage: 3	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058757
EXP063864	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2016018; Age: 78; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058758
EXP063865	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2016029; Age: 83; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058759
EXP063866	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017011; Age: 83; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058760
EXP063867	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017014; Age: 81; Sex: female; Disease: normal; Braak stage: 1	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058761
EXP063868	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017025; Age: 70; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058762
EXP063869	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017039; Age: 84; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058763
EXP063870	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 201704; Age: 72; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058764
EXP063871	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2018001; Age: 87; Sex: Alzheimer's disease; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058765
EXP063872	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2018006; Age: 84; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	PEAKS058766
EXP063873	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: 20180807; Age: 72; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058767
EXP063874	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad11; Age: 91; Sex: female; Disease: Alzheimer's disease; Braak stage: none	EXP063846	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058768
EXP063875	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad16; Age: 95; Sex: female; Disease: Alzheimer's disease; Braak stage: none	EXP063847	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058769
EXP063876	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad1; Age: 69; Sex: male; Disease: Alzheimer's disease; Braak stage: none	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058770
EXP063877	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad7; Age: 86; Sex: male; Disease: Alzheimer's disease; Braak stage: none	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058771
EXP063878	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: c13; Age: 69; Sex: male; Disease: normal; Braak stage: none	EXP063849	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058772
EXP063879	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: c23; Age: 86; Sex: female; Disease: normal; Braak stage: none	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058773
EXP063880	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: c31; Age: 80; Sex: male; Disease: normal; Braak stage: none	EXP063849	4716	normal	P10827	brain prefrontal cortex region tissues	PEAKS058774
EXP063882	anti-TTF-1 (#MS-699-P, Lab Vision Corporation, Fremont, CA, USA)	Homo sapiens	Treatment: none	EXP063881	4717	normal	P43699	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	PEAKS058775
EXP063883	anti-ASCL1 (#556604, BD Biosciences, Franklin Lakes, NJ, USA)	Homo sapiens	Treatment: none	EXP063881	4717	normal	P50553	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	PEAKS058776
EXP063884	anti-CTCF	Homo sapiens	Treatment: none	NULL	4718	normal	P49711	MutuI-LCL (lymphoblastoid cells)	PEAKS058777
EXP063885	anti-CTCF	Homo sapiens	Treatment: none	NULL	640	normal	P49711	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	PEAKS058778
EXP063887	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 A1 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	PEAKS058779
EXP063888	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 C7 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	PEAKS058780
EXP063889	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 Mut3 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	PEAKS058781
EXP063890	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 Hyll6 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	PEAKS058782
EXP063891	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	38	normal	P27540	A549 (lung carcinoma)	PEAKS058783
EXP063892	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	417	normal	P27540	HCT-116 (colon carcinoma)	PEAKS058784
EXP063893	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	725	normal	P27540	PC3(bone mets prostate adenocarcinoma)	PEAKS058785
EXP063894	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	111	normal	P27540	T47D (invasive ductal carcinoma)	PEAKS058786
EXP063896	anti-HAT1 (Abcam ab194296)	Homo sapiens	Treatment: none	EXP063895	430	normal	O14929	HepG2 (hepatoblastoma)	PEAKS058787
EXP063897	anti-SNF5 (ChIP Grade, ab12167)	Homo sapiens	Treatment: None; Genotype: Stably expressing hTERT gene, inducible expression of ER Ras	NULL	4725	normal	Q12824	proliferating fibroblasts	PEAKS058788
EXP063898	anti-SNF5 (ChIP Grade, ab12167)	Homo sapiens	Treatment: ASO_CTRL transient transfection, cells collected after 36 hours; Genotype: Stably expressing hTERT gene, inducible expression of ER Ras; Time point: 36 hrs	NULL	4725	normal	Q12824	proliferating fibroblasts	PEAKS058789
EXP063899	anti-SNF5 (ChIP Grade, ab12167)	Homo sapiens	Treatment: ASO_LINC#3 transient transfection, cells collected after 36 hours; Genotype: Stably expressing hTERT gene, inducible expression of ER Ras, ASO_LINC#3; Time point: 36 hrs	NULL	4725	normal	Q12824	proliferating fibroblasts	PEAKS058790
EXP063902	anti-CTCF (Abcam ab70303, 5 Âµg)	Homo sapiens	Treatment: none	EXP063900	4727	normal	P49711	GBM39 (Human brain tumor)	PEAKS058791
EXP063903	anti-CTCF (Abcam ab70303, 5 Âµg)	Homo sapiens	Treatment: none	EXP063901	4727	normal	P49711	GBM39 (Human brain tumor)	PEAKS058792
EXP063904	anti-SMC3 (Abcam ab9263, 5 Âµg)	Homo sapiens	Treatment: none	EXP063900	4727	normal	Q9UQE7	GBM39 (Human brain tumor)	PEAKS058793
EXP063905	anti-SMC3 (Abcam ab9263, 5 Âµg)	Homo sapiens	Treatment: none	EXP063901	4727	normal	Q9UQE7	GBM39 (Human brain tumor)	PEAKS058794
EXP063910	anti-ERa (santa cruze, sc-543x,Lot # E3014 )	Homo sapiens	Treatment: Treatment: shCTRL; Genotype: wildtype; Genotype: wildtype	EXP063906	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058795
EXP063911	anti-FOXA1 (Abcam,ab170933, Lot # GR3257262-1)	Homo sapiens	Treatment: Treatment: shCTRL; Genotype: wildtype; Genotype: wildtype	NULL	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058796
EXP063912	anti-ERa (santa cruze, sc-543x,Lot # E3014 )	Homo sapiens	Treatment: Treatment: shRNA against NR2F2; Genotype: NR2F2 knockout; Genotype: NR2F2 knockout	EXP063907	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058797
EXP063913	anti-FOXA1 (Abcam,ab170933, Lot # GR3257262-1)	Homo sapiens	Treatment: Treatment: shRNA against NR2F2; Genotype: NR2F2 knockout; Genotype: NR2F2 knockout	EXP063907	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058798
EXP063914	anti-NR2F2 (active motif, 61213?Lot 10216002)	Homo sapiens	Treatment: Treatment: treated with vehicle  for 12 hrs; Genotype: wildtype; Time point: 12 hrs; Genotype: wildtype; Time point: 12 hrs	EXP063908	113	normal	P24468	MCF7 (Invasive ductal breast carcinoma)	PEAKS058799
EXP063915	anti-NR2F2 (active motif, 61213?Lot 10216002)	Homo sapiens	Treatment: Treatment: treated with 10 nM estrogen  for 12 hrs; Genotype: wildtype; Time point: 12 hrs; Genotype: wildtype; Time point: 12 hrs	EXP063909	113	normal	P24468	MCF7 (Invasive ductal breast carcinoma)	PEAKS058800
EXP063917	anti-ESR1	Homo sapiens	Treatment: none; Conditions: cultured continuously for 14 days in medium containig 10nM 17-beta-estradiol in 0.1% DMSO; Time point: 14 days	EXP063916	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058801
EXP063918	anti-ESR1	Homo sapiens	Treatment: none; Conditions: cultured continuously for 14 days in medium containig 0.1% DMSO; Time point: 14 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058802
EXP063919	anti-ESR1	Homo sapiens	Treatment: none; Conditions: cultured continuously for 4 days in medium containig 0.1% DMSO,and then cultured continuously for 10 days in medium containig 10nM 17-beta-estradiol in 0.1% DMSO; Time point: 14 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058803
EXP063921	anti-HDAC4 (Paroni et al, 2004 PMID 15075374 )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063920	4730	normal	P56524	SK-UT-1 (Uterine corpus leiomyosarcoma)	PEAKS058804
EXP063922	anti-HDAC9 (Di Giorgio et al, 2019 NAR submitted)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063920	4730	normal	Q9UKV0	SK-UT-1 (Uterine corpus leiomyosarcoma)	PEAKS058805
EXP063923	anti-MEF2D (BD Biosciences, clone 9 610775)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063920	4730	normal	Q14814	SK-UT-1 (Uterine corpus leiomyosarcoma)	PEAKS058806
EXP063927	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle proliferative phase	EXP063924	2292	normal	P06401	endometrium	PEAKS058807
EXP063928	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle mid-secretory phase	EXP063924	2292	normal	P06401	endometrium	PEAKS058808
EXP063929	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle proliferative phase	EXP063925	2292	normal	P06401	endometrium	PEAKS058809
EXP063930	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle mid-secretory phase	EXP063926	2292	normal	P06401	endometrium	PEAKS058810
EXP063931	anti-ER (Santacruz, Cat# sc-543, clone HC-20, Lot # A1F0316)	Homo sapiens	Treatment: DMSO for 7 days; Time point: 7 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058811
EXP063932	anti-ER (Santacruz, Cat# sc-543, clone HC-20, Lot # A1F0316)	Homo sapiens	Treatment: 500 nM Abemaciclib for 7 days; Time point: 7 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058812
EXP063933	anti-TRPS1 (sc-26974, Santa Cruz)	Mus musculus	Treatment: none; Genotype: no TRPS1 insertions	NULL	4731	normal	Q925H1	breast cancer cells	PEAKS058813
EXP063934	anti-TRPS1 (sc-26974, Santa Cruz)	Mus musculus	Treatment: none; Genotype: TRPS1 insertions	NULL	4731	normal	Q925H1	breast cancer cells	PEAKS058814
EXP063935	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Treatment: sgScr (control sgRNA); Genotype: wildtype	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS058815
EXP063936	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Treatment: sgRNA aginst TRPS1; Genotype: TRPS1 knockout	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS058816
EXP063937	anti-TRPS1 (AF4838, R&D)	Homo sapiens	Treatment: siNT (control siNT); Genotype: wildtype	NULL	113	normal	Q9UHF7	MCF7 (Invasive ductal breast carcinoma)	PEAKS058817
EXP063938	anti-TRPS1 (AF4838, R&D)	Homo sapiens	Treatment: siRNA against GATA3; Genotype: GATA3 knockout	NULL	113	normal	Q9UHF7	MCF7 (Invasive ductal breast carcinoma)	PEAKS058818
EXP063939	anti-TRPS1 (AF4838, R&D)	Homo sapiens	Treatment: none	NULL	113	normal	Q9UHF7	MCF7 (Invasive ductal breast carcinoma)	PEAKS058819
EXP063940	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Treatment: none	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	PEAKS058820
EXP063942	anti-FLAG M2 (Sigma-Aldrich, Catalog number M8823)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063941	4664	normal	O15550	WA01 (H1 hESC) -derived neural progenitor cells	PEAKS058821
EXP063943	anti-FOXA1	Homo sapiens	Treatment: treated with doxycycline for 2 days; Genotype: wildtype	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058822
EXP063944	anti-FOXA1	Homo sapiens	Treatment: treated with doxycycline for 2 days; Genotype: overexpressing D226G FOXA1	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058823
EXP063945	anti-FOXA1	Homo sapiens	Treatment: treated with doxycycline for 2 days; Genotype: overexpressing M253K FOXA1	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	PEAKS058824
EXP063947	anti-ESR1 (Estrogen Receptor alfa (D8H8) Rabbit mAb #8644, from CST)	Homo sapiens	Treatment: DMSO for 1 hour; Time point: 1 hr	EXP063946	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058825
EXP063948	anti-ESR1 (Estrogen Receptor alfa (D8H8) Rabbit mAb #8644, from CST)	Homo sapiens	Treatment: 10 nM estrogen for 1 hour; Time point: 1 hr	EXP063946	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058826
EXP063949	anti-ESR1 (Estrogen Receptor alfa (D8H8) Rabbit mAb #8644, from CST)	Homo sapiens	Treatment: 20 uM OBHS for 1 hour; Time point: 1 hr	EXP063946	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058827
EXP063951	anti-CHD4	Homo sapiens	Treatment: none	EXP063950	26	normal	Q14839	501Mel (melanoma)	PEAKS058828
EXP063956	anti-BMAL1	Homo sapiens	Treatment: none; Donor: 387	EXP063952	3548	normal	O00327	glioblastoma stem cells	PEAKS058829
EXP063957	anti-BMAL1	Homo sapiens	Treatment: none; Donor: 3565	EXP063953	3548	normal	O00327	glioblastoma stem cells	PEAKS058830
EXP063958	anti-BMAL1	Homo sapiens	Treatment: none; Donor: ENSA	EXP063954	915	normal	O00327	hNSC (neural stem cells)	PEAKS058831
EXP063959	anti-BMAL1	Homo sapiens	Treatment: none; Donor: hNP1	EXP063955	915	normal	O00327	hNSC (neural stem cells)	PEAKS058832
EXP063964	anti-CTCF (CST:#3418)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063960	1008	normal	P49711	HT1080 (fibrosarcoma)	PEAKS058833
EXP063965	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063960	1008	normal	P45973	HT1080 (fibrosarcoma)	PEAKS058834
EXP063966	anti-CTCF (CST:#3418)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063961	1008	normal	P49711	HT1080 (fibrosarcoma)	PEAKS058835
EXP063967	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063961	1008	normal	P45973	HT1080 (fibrosarcoma)	PEAKS058836
EXP063968	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063962	417	normal	P45973	HCT-116 (colon carcinoma)	PEAKS058837
EXP063969	anti-HP1beta (CST:8676S)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063962	417	normal	P83916	HCT-116 (colon carcinoma)	PEAKS058838
EXP063970	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063963	4304	normal	P45973	DKO-1 (Colon adenocarcinoma)	PEAKS058839
EXP063971	anti-HP1beta (CST:8676S)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063963	4304	normal	P83916	DKO-1 (Colon adenocarcinoma)	PEAKS058840
EXP063978	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A1	EXP063972	1149	normal	P10243	testis	PEAKS058841
EXP063979	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A8	EXP063973	1149	normal	P10243	testis	PEAKS058842
EXP063980	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A10	EXP063974	1149	normal	P10243	testis	PEAKS058843
EXP063981	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A16	EXP063975	1149	normal	P10243	testis	PEAKS058844
EXP063982	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A17	EXP063976	1149	normal	P10243	testis	PEAKS058845
EXP063983	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: S1	EXP063977	909	normal	P10243	kidney	PEAKS058846
EXP063984	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 1 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 1; Time point: day 1	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	PEAKS058847
EXP063985	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 2 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 2; Time point: day 2	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	PEAKS058848
EXP063986	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 3 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 3; Time point: day 3	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	PEAKS058849
EXP063987	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 4 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 4; Time point: day 4	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	PEAKS058850
EXP063988	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: none	NULL	4752	normal	P18146	primary monocytes	PEAKS058851
EXP063989	anti-CDH4 (ABCAM, Rabbit polyclonal, AB72418)	Homo sapiens	Treatment: day 4 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 4; Time point: day 4	NULL	466	normal	P55283	MDM(monocyte derived macrophages)	PEAKS058852
EXP063990	anti-ESR1 (sc-8002 and ab32063)	Homo sapiens	Treatment: 7 days stripped cells; Time point: 7 days; Genotype: wildtype	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058853
EXP063991	anti-ESR1 (sc-8002 and ab32063)	Homo sapiens	Treatment: Estradiol for 1 hr; Time point: 1 hr; Genotype: wildtype	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058854
EXP063992	anti-ESR1 (sc-8002 and ab32063)	Homo sapiens	Treatment: Estradiol for 1 hr; Time point: 1 hr; Genotype: CRISPR-based deletion of TFF1	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058855
EXP063995	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA control; Genotype: wildtype; Genotype: wildtype	EXP063993	4753	normal	O43623	JR-1 (Embryonal rhabdomyosarcoma. Derived from metastatic site: Lung)	PEAKS058856
EXP063996	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA control; Genotype: wildtype; Genotype: wildtype	EXP063994	4754	normal	O43623	CTR (Rhabdomyosarcoma)	PEAKS058857
EXP063997	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	4754	normal	O43623	CTR (Rhabdomyosarcoma)	PEAKS058858
EXP063998	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: DMSO; Genotype: wildtype; Genotype: wildtype	NULL	4754	normal	O43623	CTR (Rhabdomyosarcoma)	PEAKS058859
EXP063999	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: Trametinib 100 nM; Genotype: wildtype; Genotype: wildtype	NULL	4754	normal	O43623	CTR (Rhabdomyosarcoma)	PEAKS058860
EXP064000	anti-MYOD (Santa Cruz, sc-760, M-318)	Homo sapiens	Treatment: Treatment: shCtrl; Genotype: wildtype; Genotype: wildtype	EXP063994	4754	normal	P15172	CTR (Rhabdomyosarcoma)	PEAKS058861
EXP064001	anti-MYOD (Santa Cruz, sc-760, M-318)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	4754	normal	P15172	CTR (Rhabdomyosarcoma)	PEAKS058862
EXP064002	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shCtrl; Genotype: wildtype; Genotype: wildtype	NULL	2598	normal	O43623	RD (Embryonal rhabdomyosarcoma)	PEAKS058863
EXP064003	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	2598	normal	O43623	RD (Embryonal rhabdomyosarcoma)	PEAKS058864
EXP064004	anti-MyoD (Santa Cruz, cat sc-32758, lot I1113)	Homo sapiens	Treatment: Treatment: shCtrl; Genotype: wildtype; Genotype: wildtype	NULL	2598	normal	P15172	RD (Embryonal rhabdomyosarcoma)	PEAKS058865
EXP064005	anti-MyoD (Santa Cruz, cat sc-32758, lot I1113)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	2598	normal	P15172	RD (Embryonal rhabdomyosarcoma)	PEAKS058866
EXP064011	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 wildtype native; GTRD_Rep_Group: none	EXP064006	1263	normal	P40381	whole cells	PEAKS058867
EXP064012	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 (no tag Flag control) native; GTRD_Rep_Group: none	NULL	1263	normal	A0ZWU1	whole cells	PEAKS058868
EXP064013	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 wildtype native; GTRD_Rep_Group: none	EXP064007	1263	normal	P40381	whole cells	PEAKS058869
EXP064014	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058870
EXP064015	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT H3K9R; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058871
EXP064016	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Flag-swi6 WT; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058872
EXP064017	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Rix1-myc; GTRD_Rep_Group: none	NULL	1263	normal	P87243	whole cells	PEAKS058873
EXP064018	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Rix1-myc swi6delta; GTRD_Rep_Group: none	NULL	1263	normal	P87243	whole cells	PEAKS058874
EXP064019	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Rix1-myc clr4delta; GTRD_Rep_Group: none	NULL	1263	normal	P87243	whole cells	PEAKS058875
EXP064020	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Mdn1-myc; GTRD_Rep_Group: none	NULL	1263	normal	O94248	whole cells	PEAKS058876
EXP064021	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Mdn1-myc swi6delta; GTRD_Rep_Group: none	NULL	1263	normal	O94248	whole cells	PEAKS058877
EXP064022	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Mdn1-myc clr4delta; GTRD_Rep_Group: none	NULL	1263	normal	O94248	whole cells	PEAKS058878
EXP064023	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT dcr1delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058879
EXP064024	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT dcr1delta taz1delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058880
EXP064025	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Npp106-GFP; GTRD_Rep_Group: none	EXP064009	1263	normal	O14310	whole cells	PEAKS058881
EXP064026	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Npp106-GFP clr4delta; GTRD_Rep_Group: none	EXP064009	1263	normal	O14310	whole cells	PEAKS058882
EXP064027	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy1964 h- Nup211-GFP; GTRD_Rep_Group: none	EXP064010	1263	normal	O74424	whole cells	PEAKS058883
EXP064028	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy1964 h- Nup211-GFP clr4delta; GTRD_Rep_Group: none	EXP064010	1263	normal	O74424	whole cells	PEAKS058884
EXP064029	anti-Swi6 (home made antibody)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 swi6delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058885
EXP064030	anti-Swi6 (home made antibody)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 WT; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058886
EXP064031	anti-Swi6 (home made antibody)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 npp106delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	PEAKS058887
EXP064033	anti-AIB1 (CST 2126, Lot 4)	Homo sapiens	Treatment: none	EXP064032	583	normal	Q9Y6Q9	MCF10A (breast epithelial cells)	PEAKS058888
EXP064034	anti-TEAD4 (sc-101184)	Homo sapiens	Treatment: none	EXP064032	583	normal	Q15561	MCF10A (breast epithelial cells)	PEAKS058889
EXP064035	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: Nonpregnant at the proliferative phase; Donor: NP1	NULL	4704	normal	P06401	myometrium	PEAKS058890
EXP064036	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: Nonpregnant at the proliferative phase; Donor: NP2	NULL	4704	normal	P06401	myometrium	PEAKS058891
EXP064037	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: 38-42 weeks estimated gestational age; Donor: TP1	NULL	4704	normal	P06401	myometrium	PEAKS058892
EXP064038	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: 38-42 weeks estimated gestational age; Donor: TP2	NULL	4704	normal	P06401	myometrium	PEAKS058893
EXP064040	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: none	EXP064039	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS058894
EXP064041	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: estrogen treated for 1hour (10nM); Time point: 1 hrs	NULL	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS058895
EXP064042	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: estrogen treated for 2hours (10nM); Time point: 2 hrs	NULL	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS058896
EXP064043	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: none; Time point: 15 mins; Conditions: subjected to hyperthermia (43 degree celsius) for 15minutes	NULL	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	PEAKS058897
EXP064047	anti-CTCF	Homo sapiens	Treatment: control siRNA; Genotype: wildtype	NULL	4755	normal	P49711	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	PEAKS058898
EXP064048	anti-Rad21	Homo sapiens	Treatment: control siRNA; Genotype: wildtype	EXP064044	4755	normal	O60216	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	PEAKS058899
EXP064049	anti-CTCF	Homo sapiens	Treatment: siRNA against CTCF; Genotype: CTCF knockout	EXP064045	4755	normal	P49711	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	PEAKS058900
EXP064050	anti-Rad21	Homo sapiens	Treatment: siRNA against CTCF; Genotype: CTCF knockout	EXP064045	4755	normal	O60216	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	PEAKS058901
EXP064051	anti-CTCF	Homo sapiens	Treatment: siRNA against Rad21; Genotype: Rad21 knockout	EXP064046	4755	normal	P49711	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	PEAKS058902
EXP064052	anti-Rad21	Homo sapiens	Treatment: siRNA against Rad21; Genotype: Rad21 knockout	EXP064046	4755	normal	O60216	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	PEAKS058903
EXP064055	anti-THAP11 (sheep, R & D Systems AF5727)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064053	421	normal	Q96EK4	HEK293 (embryonic kidney)	PEAKS058904
EXP064056	anti-THAP11 (sheep, R & D Systems AF5727)	Homo sapiens	Treatment: none; Genotype: THAP11-F80L homozygous	EXP064054	421	normal	Q96EK4	HEK293 (embryonic kidney)	PEAKS058905
EXP064064	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064057	4756	normal	P04198	COG-N-415 (Neuroblastoma)	PEAKS058906
EXP064065	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064058	520	normal	P01106	Kelly (neuroblastoma)	PEAKS058907
EXP064066	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064059	4759	normal	P04198	LA-N-5 (Neuroblastoma. Derived from metastatic site: Bone marrow)	PEAKS058908
EXP064067	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064060	1101	normal	P04198	NB-1643 (neuroblastoma)	PEAKS058909
EXP064068	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064061	1195	normal	P01106	NB69 (neuroblastoma)	PEAKS058910
EXP064069	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064061	1195	normal	P04198	NB69 (neuroblastoma)	PEAKS058911
EXP064070	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064062	1194	normal	P01106	SK-N-AS (neuroblastoma)	PEAKS058912
EXP064071	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064063	665	normal	P01106	SK-N-SH (neuroblastoma)	PEAKS058913
EXP064073	anti-ASF1A	Homo sapiens	Treatment: none	EXP064072	4762	normal	Q9Y294	NCI-H2009 (Lung adenocarcinoma. Derived from metastatic site: Lymph node)	PEAKS058914
EXP064076	anti-GFP (abcam ab290)	Homo sapiens	Treatment: With Auxin; Conditions: 4i medium; Genotype: PGC-competent 4i hESCs (WIS2-NANOS3-T2A-tdTomato)	NULL	878	normal	Q9GZV8	embryonic stem cells	PEAKS058915
EXP064077	anti-GFP (abcam ab290)	Homo sapiens	Treatment: No auxin; Conditions: 4i medium; Genotype: PGC-competent 4i hESCs (WIS2-NANOS3-T2A-tdTomato)	EXP064074	878	normal	Q9GZV8	embryonic stem cells	PEAKS058916
EXP064078	anti-GFP (abcam ab290)	Homo sapiens	Treatment: No auxin	EXP064075	4767	normal	Q9GZV8	primordial germ cell-like cells	PEAKS058917
EXP064080	anti-TEAD1 (Abcam: 133533)	Homo sapiens	Treatment: none	EXP064079	2262	normal	P28347	primary human neonatal keratinocytes	PEAKS058918
EXP064082	anti-FLAG	Homo sapiens	Treatment: none	EXP064081	4664	normal	O15054	WA01 (H1 hESC) -derived neural progenitor cells	PEAKS058919
EXP064083	anti-CTCF (Cell Signaling #3418, rabbit)	Homo sapiens	Treatment: none; Donor: GBM3565	NULL	4769	normal	P49711	glioblastoma patient-derived cell model	PEAKS058920
EXP064084	anti-CTCF (Cell Signaling #3418, rabbit)	Homo sapiens	Treatment: none	NULL	4707	normal	P49711	GSC23 (Glioblastoma)	PEAKS058921
EXP064091	anti-cJUN	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	EXP064085	2262	normal	P05412	primary human neonatal keratinocytes	PEAKS058922
EXP064092	anti-cJUN	Homo sapiens	Treatment: Treatment: none; Genotype: Mi2 knockout; Genotype: Mi2 knockout	EXP064087	2262	normal	P05412	primary human neonatal keratinocytes	PEAKS058923
EXP064093	anti-JunB	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	EXP064085	2262	normal	P17275	primary human neonatal keratinocytes	PEAKS058924
EXP064096	anti-Aiolos (D1C1E, Rabbit mAb Cell Signaling Technology, Cat#15103)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q9UKT9	Ramos (Burkitt lymphoma)	PEAKS058925
EXP064097	anti-BCL6 (Cell Signaling Technology,Cat#5650)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P41182	Ramos (Burkitt lymphoma)	PEAKS058926
EXP064098	c-Rel (Cell Signaling Technology, Cat#12659)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q04864	Ramos (Burkitt lymphoma)	PEAKS058927
EXP064099	anti-E2A (Cell Signaling Technology, Cat#12258)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	P15923	Ramos (Burkitt lymphoma)	PEAKS058928
EXP064100	anti-ELF1 (Bethyl, A301-443A)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P32519	Ramos (Burkitt lymphoma)	PEAKS058929
EXP064101	anti-ELF2 (Invitrogen, Cat#52247)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q15723	Ramos (Burkitt lymphoma)	PEAKS058930
EXP064102	anti-Helios (D8W4X, Cell Signaling Technology, Cat#4247)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q9UKS7	Ramos (Burkitt lymphoma)	PEAKS058931
EXP064103	anti-Ikaros (D10E5 Rabbit mAb, Cell Signaling Technology,Cat#9034)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	Q13422	Ramos (Burkitt lymphoma)	PEAKS058932
EXP064104	anti-IRF4 (Cell Signaling Technology, Cat#34964)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q15306	Ramos (Burkitt lymphoma)	PEAKS058933
EXP064105	anti-IRF8 (Cell Signaling Technology, Cat#5628)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q02556	Ramos (Burkitt lymphoma)	PEAKS058934
EXP064106	anti-MEF2B (Abcam, Cat#33540)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q02080	Ramos (Burkitt lymphoma)	PEAKS058935
EXP064107	anti-NFKB1 (Cell Signaling Technology, Cat#12540)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P19838	Ramos (Burkitt lymphoma)	PEAKS058936
EXP064108	anti-Nuclear Pore Proteins (Abcam, Cat#24609)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	P57740	Ramos (Burkitt lymphoma)	PEAKS058937
EXP064109	anti-p65 (Cell Signaling Technology, Cat#8242)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q04206	Ramos (Burkitt lymphoma)	PEAKS058938
EXP064110	anti-Pax5 (Novus, Cat#NBP2-29905)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q02548	Ramos (Burkitt lymphoma)	PEAKS058939
EXP064111	anti-PU.1 (Cell Signaling Technology, Cat#2258)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P17947	Ramos (Burkitt lymphoma)	PEAKS058940
EXP064112	anti-Rad21 (Abcam, Cat#4321)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	O60216	Ramos (Burkitt lymphoma)	PEAKS058941
EXP064113	anti-Spt5 (Santa Cruz Biotechnology, H-300x; Cat#sc-28678; RRID: AB_668824)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	O00267	Ramos (Burkitt lymphoma)	PEAKS058942
EXP064114	anti-YY1 (Santa Cruz Biotechnology, Cat#7341X)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P25490	Ramos (Burkitt lymphoma)	PEAKS058943
EXP064115	anti-YY2 (Sigma, Cat#HPA030335)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	O15391	Ramos (Burkitt lymphoma)	PEAKS058944
EXP064116	anti-ZEB1 (Proteintech, Cat#21544-1-AP)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P37275	Ramos (Burkitt lymphoma)	PEAKS058945
EXP064119	anti-TTF-1 (#MS-699-P, Lab Vision Corporation, Fremont, CA, USA)	Homo sapiens	Treatment: untreated	EXP064117	4717	normal	P43699	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	PEAKS058946
EXP064120	anti-ASCL1 (#556604, BD Biosciences, Franklin Lakes, NJ, USA)	Homo sapiens	Treatment: untreated	EXP064117	4717	normal	P50553	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	PEAKS058947
EXP064121	anti-TTF-1 (#MS-699-P, Lab Vision Corporation, Fremont, CA, USA)	Homo sapiens	Treatment: untreated	EXP064118	388	normal	P43699	NCI-H441 (squamous cell lung carcinoma )	PEAKS058948
EXP064123	anti-LSD1 (abcam, ab17721)	Homo sapiens	Treatment: none; Genotype: LSD1 knockdown	EXP064122	821	normal	O60341	SW480 (colon adenocarcinoma)	PEAKS058949
EXP064124	anti-LSD1 (abcam, ab17721)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064122	821	bio_control	O60341	SW480 (colon adenocarcinoma)	PEAKS058950
EXP064127	anti-HA tag (abcam: ab9110)	Homo sapiens	Treatment: Veh control; Time point: 6 hrs; Genotype: wildtype	NULL	113	bio_control	Q02962	MCF7 (Invasive ductal breast carcinoma)	PEAKS058951
EXP064128	anti-HA tag (abcam: ab9110)	Homo sapiens	Treatment: 50ng/m doxycycline for 6 hrs; Time point: 6 hrs; Genotype: PAX2 oeverexpression	EXP064125	113	normal	Q02962	MCF7 (Invasive ductal breast carcinoma)	PEAKS058952
EXP064129	anti-HA tag (abcam: ab9110)	Homo sapiens	Treatment: 50ng/ml doxycycline+ 1 uM tamoxifen for 6 hrs; Time point: 6 hrs; Genotype: PAX2 oeverexpression	EXP064126	113	normal	Q02962	MCF7 (Invasive ductal breast carcinoma)	PEAKS058953
EXP064131	anti-RBBP4 (Epigentek, catA-2703 lotA511004 pAb)	Homo sapiens	Treatment: none; Conditions: NuRD Complex	NULL	980	normal	Q09028	RH4 (alveolar rhabdomyosarcoma)	PEAKS058954
EXP064132	anti-FLAG (Sigma Aldrich, clone M2, catF1804)	Homo sapiens	Treatment: CHD4 - nFlag; Conditions: NuRD Complex; Genotype: wildtype, CHD4 flag tagged	EXP064130	980	normal	Q14839	RH4 (alveolar rhabdomyosarcoma)	PEAKS058955
EXP064139	anti-BAF155 (Santa Cruz, SC-9746)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064133	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	PEAKS058956
EXP064140	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064133	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058957
EXP064141	anti-BAF155 (Santa Cruz, SC-9746)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064138	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	PEAKS058958
EXP064142	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064138	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	PEAKS058959
EXP064143	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064134	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058960
EXP064144	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064135	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058961
EXP064145	anti-GRHL1 (Novus Biologicals, NBP1-81321)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064134	113	normal	Q9NZI5	MCF7 (Invasive ductal breast carcinoma)	PEAKS058962
EXP064146	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064136	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058963
EXP064147	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064137	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	PEAKS058964
EXP064148	anti-GRHL1 (Novus Biologicals, NBP1-81321)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064136	113	normal	Q9NZI5	MCF7 (Invasive ductal breast carcinoma)	PEAKS058965
EXP064150	anti-EGR1 (Cell Signaling 4154)	Homo sapiens	Treatment: none	EXP064149	4258	normal	P18146	T HESCs (Telomerase immortalized cell line)	PEAKS058966
EXP064152	anti-HA (Rabbit-Sigma-H6908)	Homo sapiens	Treatment: none	EXP064151	4272	normal	Q9HCK8	WA09 (H9) hESC-derived neurons	PEAKS058967
EXP064153	anti-CHD8 (Rabbit-Bethyl lab-A301-224A)	Homo sapiens	Treatment: none	EXP064151	4272	normal	Q9HCK8	WA09 (H9) hESC-derived neurons	PEAKS058968
EXP064155	anti-Nrf2 (Santa Cruz Biotechnology)	Homo sapiens	Treatment: none	EXP064154	38	normal	Q16236	A549 (lung carcinoma)	PEAKS058969
EXP064156	anti-Twist1 (Abcam, ab50887)	Homo sapiens	Treatment: 600 uM metformin for 48hrs	NULL	4779	normal	Q15672	PLC/PRF/5 (Hepatocellular carcinoma)	PEAKS058970
EXP064157	anti-YY1 (Abcam, ab109237)	Homo sapiens	Treatment: 600 uM metformin for 48h rs	NULL	4779	normal	P25490	PLC/PRF/5 (Hepatocellular carcinoma)	PEAKS058971
EXP064158	anti-Twist1 (Abcam, ab50887)	Homo sapiens	Treatment: control	NULL	4779	normal	Q15672	PLC/PRF/5 (Hepatocellular carcinoma)	PEAKS058972
EXP064159	anti-PU.1 (Santa Cruz, catalog# sc-352X)	Homo sapiens	Treatment: none	NULL	4780	normal	P17947	U937-PR9 (acute promyeloid leukemia)	PEAKS058973
EXP064160	anti-PU.1 (Santa Cruz, catalog# sc-352X)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	P17947	U937-PR9 (acute promyeloid leukemia)	PEAKS058974
EXP064161	anti-CEBPB (Santa Cruz, catalog# sc-150X)	Homo sapiens	Treatment: none	NULL	4780	normal	P17676	U937-PR9 (acute promyeloid leukemia)	PEAKS058975
EXP064162	anti-CEBPB (Santa Cruz, catalog# sc-150X)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	P17676	U937-PR9 (acute promyeloid leukemia)	PEAKS058976
EXP064163	anti-IRF1 (Santa Cruz, catalog# sc-497)	Homo sapiens	Treatment: none	NULL	4780	normal	P10914	U937-PR9 (acute promyeloid leukemia)	PEAKS058977
EXP064164	anti-IRF1 (Santa Cruz, catalog# sc-497)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	P10914	U937-PR9 (acute promyeloid leukemia)	PEAKS058978
EXP064165	anti-P300 (Abcam, catalog# ab14984)	Homo sapiens	Treatment: none	NULL	4780	normal	Q09472	U937-PR9 (acute promyeloid leukemia)	PEAKS058979
EXP064166	anti-P300 (Abcam, catalog# ab14984)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	Q09472	U937-PR9 (acute promyeloid leukemia)	PEAKS058980
EXP064171	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media for 48 hrs, veh for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064167	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058981
EXP064172	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media for 48 hrs, E2 for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064168	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058982
EXP064173	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media with Dox for 48 hrs, veh for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064169	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058983
EXP064174	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media with Dox for 48 hrs, E2 for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064170	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	PEAKS058984
EXP064176	anti-BCL6 (Rabbit, 2ug, 4242, Cell Signaling)	Homo sapiens	Treatment: none	EXP064175	779	normal	P41182	RS4-11 (adult B acute lymphoblastic leukemia)	PEAKS058985
EXP064178	anti-Notch1 (provided by Dr. Jon C. Aster)	Homo sapiens	Treatment: none	EXP064177	509	normal	P46531	Jurkat (T-cells)	PEAKS058986
EXP064179	anti-CTNNB1 (BD Bioscience, 610154)	Homo sapiens	Treatment: none	EXP064177	509	normal	P35222	Jurkat (T-cells)	PEAKS058987
EXP064181	anti-Myc (Santa Cruz Biotechnology, Catalog#: sc-764, Antibody name: N262, Lot#: D0413)	Homo sapiens	Treatment: none	EXP064180	2711	normal	P01106	P493 (Lymphoma derived)	PEAKS058988
EXP064182	anti-Myc (Santa Cruz Biotechnology, Catalog#: sc-764, Antibody name: N262, Lot#: D0413)	Homo sapiens	Treatment: MST-312	NULL	2711	normal	P01106	P493 (Lymphoma derived)	PEAKS058989
EXP064183	anti-FLAG (M2 Affinity Gel, Sigma)	Homo sapiens	Treatment: none; Genotype: pNTAP-2Ã—flag expression vectors	NULL	10	normal	Q9H8Y1	HEK293T (embryonic kidney)	PEAKS058990
EXP064185	anti-LSD1	Homo sapiens	Treatment: treated with 5-Azacitidine; Genotype: TET2 knockdown	NULL	4786	normal	O60341	acute myeloid leukemia (AML)	PEAKS058991
EXP064188	anti-NELFE (Milipore, Cat# ABE48)	Homo sapiens	Treatment: none	EXP064186	848	normal	P18615	U2OS (osteosarcoma)	PEAKS058992
EXP064189	anti-NELFE (Milipore, Cat# ABE48)	Homo sapiens	Treatment: none	EXP064187	848	normal	P18615	U2OS (osteosarcoma)	PEAKS058993
EXP064191	anti-KDM4C antibody (Bethyl Laboratories, A300-885A)	Homo sapiens	Treatment: 50 ng/mL Wnt-3a for 4 hours	EXP064190	4787	normal	Q9H3R0	SW1783 (Anaplastic astrocytoma)	PEAKS058994
EXP064192	anti-TCF4 antibody (Cell signaling, #2569)	Homo sapiens	Treatment: 50 ng/mL Wnt-3a for 4 hours	EXP064190	4787	normal	P15884	SW1783 (Anaplastic astrocytoma)	PEAKS058995
EXP064201	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Donor: 1; Donor: 1	EXP064193	4789	normal	P49711	alveolar type 2 cells (AT2 cells)	PEAKS058996
EXP064202	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Time point: day 4 of differentiation; Donor: 1; Time point: day 4 of differentiation; Donor: 1; Time point: day 4 of differentiation	EXP064194	4791	normal	P49711	in vitro differentiated AT1-like cells	PEAKS058997
EXP064203	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Time point: day 6 of differentiation; Donor: 1; Time point: day 6 of differentiation; Donor: 1; Time point: day 6 of differentiation	EXP064195	4791	normal	P49711	in vitro differentiated AT1-like cells	PEAKS058998
EXP064204	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Donor: 2; Donor: 2	EXP064196	4789	normal	P49711	alveolar type 2 cells (AT2 cells)	PEAKS058999
EXP064205	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Time point: day 4 of differentiation; Donor: 2; Time point: day 4 of differentiation; Donor: 2; Time point: day 4 of differentiation	EXP064197	4791	normal	P49711	in vitro differentiated AT1-like cells	PEAKS059000
EXP064206	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Time point: day 6 of differentiation; Donor: 2; Time point: day 6 of differentiation; Donor: 2; Time point: day 6 of differentiation	EXP064198	4791	normal	P49711	in vitro differentiated AT1-like cells	PEAKS059001
EXP064207	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 3; Donor: 3; Donor: 3	EXP064199	4789	normal	P49711	alveolar type 2 cells (AT2 cells)	PEAKS059002
EXP064208	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 3; Time point: day 6 of differentiation; Donor: 3; Time point: day 6 of differentiation; Donor: 3; Time point: day 6 of differentiation	EXP064200	4791	normal	P49711	in vitro differentiated AT1-like cells	PEAKS059003
EXP064210	anti-SOX4 antibody (CS-129-100, Diagenode)	Homo sapiens	Treatment: Treatment: 1 ug/ml of doxycycline for 16 hrs; Time point: 16 hrs; Time point: 16 hrs	NULL	4792	normal	Q06945	HMLE-S4	PEAKS059004
EXP064211	anti-SOX4 antibody (CS-129-100, Diagenode)	Homo sapiens	Treatment: Treatment: no doxycycline	EXP064209	4792	normal	Q06945	HMLE-S4	PEAKS059005
EXP064213	anti-Flag M2 (Sigma, F1804?	Mus musculus	Treatment: Treatment: Treatment: none; Genotype: Esrrb overexpression; Genotype: Esrrb overexpression; Genotype: Esrrb overexpression	EXP064212	96	normal	Q61539	trophoblast stem cells	PEAKS059006
EXP064214	anti-FLAG (M2) antibody (Sigma)	Mus musculus	Treatment: none; Genotype: wildtype (emrty vector)	NULL	4793	normal	Q9JJP2	Th1 cells from spleen	PEAKS059007
EXP064215	anti-FLAG (M2) antibody (Sigma)	Mus musculus	Treatment: none; Genotype: Trp73 overexpressed	NULL	4793	normal	Q9JJP2	Th1 cells from spleen	PEAKS059008
EXP064217	anti-MLL1	Mus musculus	Treatment: Treatment: untreated; Developmental stage: blastocyst derived; Genotype: Mll1fl/fl, Cre-ER TM; Strain: C57BL/6J; Developmental stage: blastocyst derived; Genotype: Mll1fl/fl, Cre-ER TM; Strain: C57BL/6J	EXP064216	2	normal	P55200	mESCs (mouse embryonic stem cells)	PEAKS059009
EXP064219	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 0 hrs; Genotype: GR knockout	NULL	5	normal	P06537	liver	PEAKS059010
EXP064220	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 0 hrs	NULL	5	normal	P06537	liver	PEAKS059011
EXP064221	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 4 hrs	NULL	5	normal	P06537	liver	PEAKS059012
EXP064222	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 8 hrs	NULL	5	normal	P06537	liver	PEAKS059013
EXP064223	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 12 hrs	NULL	5	normal	P06537	liver	PEAKS059014
EXP064224	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 16 hrs	NULL	5	normal	P06537	liver	PEAKS059015
EXP064225	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 20 hrs	NULL	5	normal	P06537	liver	PEAKS059016
EXP064226	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 0 hrs	NULL	5	normal	P06537	liver	PEAKS059017
EXP064227	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 4 hrs	NULL	5	normal	P06537	liver	PEAKS059018
EXP064228	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 8 hrs	NULL	5	normal	P06537	liver	PEAKS059019
EXP064229	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 12 hrs	NULL	5	normal	P06537	liver	PEAKS059020
EXP064230	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 16 hrs	NULL	5	normal	P06537	liver	PEAKS059021
EXP064231	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 20 hrs	NULL	5	normal	P06537	liver	PEAKS059022
EXP064232	anti-PPARalpha (Santa Cruz, sc-9000X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 12 hrs	NULL	5	normal	P23204	liver	PEAKS059023
EXP064233	anti-PPARalpha (Santa Cruz, sc-9000X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 12 hrs	NULL	5	normal	P23204	liver	PEAKS059024
EXP064239	anti-KLF5 antibody (Millipore: 07-1580)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064234	4794	normal	Q9Z0Z7	B6ES (Embryonic stem cells cell line)	PEAKS059025
EXP064240	anti-TEAD4 antibody (Abcam: ab58310)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064235	4794	normal	Q62296	B6ES (Embryonic stem cells cell line)	PEAKS059026
EXP064241	anti-KLF5 antibody (Millipore: 07-1580)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064236	4795	normal	Q9Z0Z7	B6TS (trophoblast stem cells cell line)	PEAKS059027
EXP064242	anti-TEAD4 antibody (Abcam: ab58310)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064237	4795	normal	Q62296	B6TS (trophoblast stem cells cell line)	PEAKS059028
EXP064243	anti-TEAD4 antibody (Abcam: ab58310)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064238	4795	normal	Q62296	B6TS (trophoblast stem cells cell line)	PEAKS059029
EXP064245	anti-NCoR1	Mus musculus	Treatment: before CpG ligand activation; Time point: 0 hrs; Genotype: wildtype; Strain: C57BL/6	EXP064244	4796	normal	Q60974	DC1940 (dendritic cells cell line)	PEAKS059030
EXP064246	anti-NCoR1	Mus musculus	Treatment: 6 hrs after CpG ligand activation; Time point: 6 hrs; Genotype: wildtype; Strain: C57BL/6	NULL	4796	normal	Q60974	DC1940 (dendritic cells cell line)	PEAKS059031
EXP064247	anti-Pu1	Mus musculus	Treatment: before CpG ligand activation; Time point: 0 hrs; Genotype: wildtype; Strain: C57BL/6	EXP064244	4796	normal	P17433	DC1940 (dendritic cells cell line)	PEAKS059032
EXP064248	anti-Pu1	Mus musculus	Treatment: 6 hrs after CpG ligand activation; Time point: 6 hrs; Genotype: wildtype; Strain: C57BL/6	NULL	4796	normal	P17433	DC1940 (dendritic cells cell line)	PEAKS059033
EXP064252	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064249	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	PEAKS059034
EXP064253	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064250	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	PEAKS059035
EXP064254	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064251	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	PEAKS059036
EXP064255	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064251	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	PEAKS059037
EXP064256	anti-Gli2  (homemade)	Mus musculus	Treatment: Treatment: none; Genotype: Sufu, Spop double knockout; Genotype: Sufu, Spop double knockout	HEXP005600	4800	normal	Q0VGT2	E17.5 stomach	PEAKS059038
EXP064259	anti-HA antibody 	Mus musculus	Treatment: 2% matrigel added at EB day 1, dox added at 12 hrs; Genotype: Wdr5 knockout, hWDR5 rescue; Time point: day 6	EXP064257	2565	normal	P61965	embryonic stem cells derived embryonic bodies	PEAKS059039
EXP064260	anti-HA antibody 	Mus musculus	Treatment: 2% matrigel added at EB day 1, dox added at 48 hrs; Genotype: Wdr5 knockout, hWDR5 rescue; Time point: day 6	EXP064258	2565	normal	P61965	embryonic stem cells derived embryonic bodies	PEAKS059040
EXP064263	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: no CuSO4, Insulinâ€“Transferrinâ€“Selenium-A supplement; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	EXP064261	2466	normal	Q07243	primary myoblasts	PEAKS059041
EXP064264	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: no CuSO4, Insulinâ€“Transferrinâ€“Selenium-A supplement; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	EXP064262	2466	normal	Q07243	primary myoblasts	PEAKS059042
EXP064265	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: no CuSO4; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	NULL	2466	normal	Q07243	primary myoblasts	PEAKS059043
EXP064266	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: 100 uM CuSO4Â ; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	NULL	2466	normal	Q07243	primary myoblasts	PEAKS059044
EXP064268	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 +/+; Sex: male; Age: 12 days post partum	NULL	3056	normal	Q61880	postnatal testis	PEAKS059045
EXP064269	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 +/-; Sex: male; Age: 12 days post partum	NULL	3056	normal	Q61880	postnatal testis	PEAKS059046
EXP064270	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 -/- (Ankrd31 knockout); Sex: male; Age: 12 days post partum	NULL	3056	normal	Q61880	postnatal testis	PEAKS059047
EXP064271	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 -/- (Ankrd31 knockout); Sex: male; Age: 12 days post partum	NULL	2748	normal	Q61880	adult testis	PEAKS059048
EXP064272	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: wildtype; Sex: male; Age: Adult	EXP064267	2748	normal	Q61880	adult testis	PEAKS059049
EXP064273	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Prdm9 -/- (Prdm9 knockout); Sex: male; Age: Adult	NULL	2748	normal	Q61880	adult testis	PEAKS059050
EXP064276	anti-CTCF (Abcam ab70303)	Mus musculus	Treatment: none	EXP064274	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS059051
EXP064277	anti-CTCF (Abcam ab70303)	Mus musculus	Treatment: none	EXP064275	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	PEAKS059052
EXP064278	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	PEAKS059053
EXP064279	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 24 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	PEAKS059054
EXP064280	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	PEAKS059055
EXP064281	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 24 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	PEAKS059056
EXP064282	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	PEAKS059057
EXP064283	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	PEAKS059058
EXP064284	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: Th17 culture conditions (20 ng/ml IL-6; 5 ng/ml human TGFb; 10 ng/ml IL-1b, 10 ug/ml anti-IL-4, and 10 ug/ml anti-IFNg) for 48 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 2 days	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	PEAKS059059
EXP064285	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	NULL	4811	normal	O35284	naive CD4+ T cells spleen and lymph nodes	PEAKS059060
EXP064286	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	PEAKS059061
EXP064287	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	PEAKS059062
EXP064288	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	PEAKS059063
EXP064289	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	PEAKS059064
EXP064290	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	NULL	4811	normal	Q61164	naive CD4+ T cells spleen and lymph nodes	PEAKS059065
EXP064291	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6	NULL	4811	normal	Q61164	naive CD4+ T cells spleen and lymph nodes	PEAKS059066
EXP064292	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059067
EXP064293	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059068
EXP064294	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059069
EXP064295	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059070
EXP064296	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: Th17 culture conditions (20 ng/ml IL-6; 5 ng/ml human TGFb; 10 ng/ml IL-1b, 10 ug/ml anti-IL-4, and 10 ug/ml anti-IFNg) for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059071
EXP064297	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: Th17 culture conditions (20 ng/ml IL-6; 5 ng/ml human TGFb; 10 ng/ml IL-1b, 10 ug/ml anti-IL-4, and 10 ug/ml anti-IFNg) for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059072
EXP064298	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059073
EXP064299	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: Ets1c knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059074
EXP064300	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059075
EXP064301	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: Ets1c knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059076
EXP064302	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	PEAKS059077
EXP064303	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	PEAKS059078
EXP064304	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	PEAKS059079
EXP064305	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	PEAKS059080
EXP064306	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6	NULL	4140	normal	O35284	naive CD4 T cells spleen/lymh nodes	PEAKS059081
EXP064307	CTCF	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059082
EXP064308	CTCF	Mus musculus	Treatment: 20 ng/ml IL-6 for 24 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	PEAKS059083
EXP064309	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	PEAKS059084
EXP064310	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	PEAKS059085
EXP064313	anti-Mef2 (sc-313, Santa Cruz Biotechnology)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064311	4813	normal	Q8C854	prefrontal cortex	PEAKS059086
EXP064314	anti-Mef2 (sc-313, Santa Cruz Biotechnology)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064312	4813	normal	Q8C854	prefrontal cortex	PEAKS059087
EXP064315	anti-LSD1 (ab17721, Abcam)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064311	4813	normal	Q6ZQ88	prefrontal cortex	PEAKS059088
EXP064316	anti-LSD1 (ab17721, Abcam)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064312	4813	normal	Q6ZQ88	prefrontal cortex	PEAKS059089
EXP064317	anti-Setd1a (A300-289, Bethyl)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064311	4813	normal	E9PYH6	prefrontal cortex	PEAKS059090
EXP064318	anti-Setd1a (A300-289, Bethyl)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064312	4813	normal	E9PYH6	prefrontal cortex	PEAKS059091
EXP064321	anti-Mtg16 (Abcam, ab33072)	Mus musculus	Treatment: Tamoxifen induced RBPJ knock-out; Genotype: Rbpj knockout; Time point: day 4	EXP064319	4814	normal	O54972	intestinal crypt epithelial cells	PEAKS059092
EXP064322	anti-Mtg16 (Abcam, ab33072)	Mus musculus	Treatment: Tamoxifen induced RBPJ knock-out; Genotype: Rbpj knockout; Time point: day 4	EXP064320	4814	normal	O54972	intestinal crypt epithelial cells	PEAKS059093
EXP064331	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064323	5	normal	P49698	liver	PEAKS059094
EXP064332	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064324	5	normal	P49698	liver	PEAKS059095
EXP064333	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064325	5	normal	P49698	liver	PEAKS059096
EXP064334	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064326	5	normal	P49698	liver	PEAKS059097
EXP064335	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064327	5	normal	P53566	liver	PEAKS059098
EXP064336	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064328	5	normal	P53566	liver	PEAKS059099
EXP064337	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064329	5	normal	P53566	liver	PEAKS059100
EXP064338	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064330	5	normal	P53566	liver	PEAKS059101
EXP064343	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: wildtype; Passage: Proliferating passage 4	EXP064339	750	normal	Q8K284	E13.5 embryonic fibroblasts	PEAKS059102
EXP064344	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: wildtype; Passage: Proliferating passage 4	EXP064340	750	normal	Q8K284	E13.5 embryonic fibroblasts	PEAKS059103
EXP064345	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: Rb1L/L; Passage: Proliferating passage 4	EXP064341	750	normal	Q8K284	E13.5 embryonic fibroblasts	PEAKS059104
EXP064346	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: Rb1L/L; Passage: Proliferating passage 4	EXP064342	750	normal	Q8K284	E13.5 embryonic fibroblasts	PEAKS059105
EXP064349	anti-C-Myc(N-262, Santa Cruz, catalog# sc-764, lot# 12613)	Mus musculus	Treatment: sh Control; Genotype: wildtype	EXP064347	252	normal	P01108	V6.5 (embryonic stem cells)	PEAKS059106
EXP064350	anti-C-Myc(N-262, Santa Cruz, catalog# sc-764, lot# 12613)	Mus musculus	Treatment: shRNA against Zfp281; Genotype: Zfp281 knockout	EXP064348	252	normal	P01108	V6.5 (embryonic stem cells)	PEAKS059107
EXP064352	anti-PRDM15 Antibody (Guccione lab)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064351	4825	normal	E9Q8T2	E6.5 embryos	PEAKS059108
EXP064354	anti-PRDM15 Antibody (Guccione lab)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064353	2	normal	E9Q8T2	mESCs (mouse embryonic stem cells)	PEAKS059109
EXP064357	anti-PPARb (Thermo Fisher, Cat# PA1-823A)	Mus musculus	Treatment: none; Genotype: ectopic expression of PPARb; Passage: 7; Strain: FvB/C57BL6 hybrid	EXP064355	4827	normal	P35396	neural stem cell derived oligodendrocyte	PEAKS059110
EXP064358	anti-HA (Cell Signaling Technology, #3724S)	Mus musculus	Treatment: none; Genotype: ectopic expression of PPARb; Passage: 7; Strain: FvB/C57BL6 hybrid	EXP064355	4827	normal	P35396	neural stem cell derived oligodendrocyte	PEAKS059111
EXP064359	anti-PPARb (Thermo Fisher, Cat# PA1-823A)	Mus musculus	Treatment: none; Strain: C57BL6	EXP064356	4828	normal	P35396	brain oligodendrocyte	PEAKS059112
EXP064360	anti-GR ( Proteintech 24050-1-AP)	Mus musculus	Treatment: 16h 1 uM Dex in EtOH + 3 100ng/ul LPS in PBS; Strain: C57BL/6; Sex: male; Genotype: GR wt / wt	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS059113
EXP064361	anti-GR ( Proteintech 24050-1-AP)	Mus musculus	Treatment: 16h 1 uM Dex in EtOH + 3 100ng/ul LPS in PBS; Strain: C57BL/6; Sex: male; Genotype: GR Zn / Zn (GR mutant)	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS059114
EXP064362	anti-GR ( Proteintech 24050-1-AP)	Mus musculus	Treatment: 16h 1 uM Dex in EtOH + 3 100ng/ul LPS in PBS; Strain: C57BL/6; Sex: male; Genotype: GR knockout	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	PEAKS059115
EXP064364	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	EXP064363	34	normal	O54839	A2Lox.cre (embryonic stem cells)	PEAKS059116
EXP064365	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	EXP064363	34	normal	P20293	A2Lox.cre (embryonic stem cells)	PEAKS059117
EXP064366	anti-V5 (BioRad, MCA1360, Lot. 0915)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury + Eomes-V5	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	PEAKS059118
EXP064367	anti-V5 (BioRad, MCA1360, Lot. 0915)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) + dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury + Eomes-V5	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	PEAKS059119
EXP064368	anti-V5 (BioRad, MCA1360, Lot. 0915)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) + dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury + Eomes-VP16	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	PEAKS059120
EXP064369	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) +  5 mg/ml dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	PEAKS059121
EXP064370	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) +  5 mg/ml dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	NULL	34	normal	P20293	A2Lox.cre (embryonic stem cells)	PEAKS059122
EXP064383	anti-LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064371	4830	normal	Q9Z0Y9	Kupffer cell	PEAKS059123
EXP064384	LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064372	4830	normal	Q9Z0Y9	Kupffer cell	PEAKS059124
EXP064385	LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: in vitro 7 day cultured BMDMs, GW3965 18hrs; Strain: C57BL/6J; Genotype: wildtype	EXP064373	81	normal	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	PEAKS059125
EXP064386	LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: in vitro 7 day cultured BMDMs, GW3965 18hrs; Strain: C57BL/6J; Genotype: wildtype	EXP064374	81	normal	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	PEAKS059126
EXP064387	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064375	4831	normal	P97471	Kupffer cell nuclei	PEAKS059127
EXP064388	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064376	4831	normal	P97471	Kupffer cell nuclei	PEAKS059128
EXP064389	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064377	81	normal	P97471	BMDM (bone marrow-derived macrophages)	PEAKS059129
EXP064390	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064378	81	normal	P97471	BMDM (bone marrow-derived macrophages)	PEAKS059130
EXP064391	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064379	4831	normal	P31266	Kupffer cell nuclei	PEAKS059131
EXP064392	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064380	4831	normal	P31266	Kupffer cell nuclei	PEAKS059132
EXP064393	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064381	81	normal	P31266	BMDM (bone marrow-derived macrophages)	PEAKS059133
EXP064394	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064382	81	normal	P31266	BMDM (bone marrow-derived macrophages)	PEAKS059134
EXP064399	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb fl/fl  (wildtype)	EXP064395	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS059135
EXP064400	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb fl/fl  (wildtype)	EXP064396	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS059136
EXP064401	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb knockout	EXP064397	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS059137
EXP064402	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb knockout	EXP064398	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	PEAKS059138
EXP064403	GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 weekd control Diet (Research Diet, D12329); Time point: 6 a.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	PEAKS059139
EXP064404	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 wk High Fat Diet (Research Diet, D12331); Time point: 6 a.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	PEAKS059140
EXP064405	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 weekd control Diet (Research Diet, D12329); Time point: 6 p.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	PEAKS059141
EXP064406	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 wk High Fat Diet (Research Diet, D12331); Time point: 6 p.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	PEAKS059142
EXP064413	anti-CTCF	Mus musculus	Treatment: none; Developmental stage: asynchronized	EXP064407	4837	normal	Q61164	G1E-ER4 derived erythroid cells	PEAKS059143
EXP064414	anti-CTCF	Mus musculus	Treatment: synchronized with 200ng/ml nocodazole for 7-8.5 hrs; Developmental stage: synchronized to pro-metaphase	EXP064408	4837	normal	Q61164	G1E-ER4 derived erythroid cells	PEAKS059144
EXP064415	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5hrs , released for nocodazole for 25 mins; Developmental stage: ana/telo phase	EXP064409	4837	normal	Q61164	G1E-ER4 derived erythroid cells	PEAKS059145
EXP064416	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 60 mins; Developmental stage: early G1	EXP064410	4837	normal	Q61164	G1E-ER4 derived erythroid cells	PEAKS059146
EXP064417	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 120 mins; Developmental stage: mid G1	EXP064411	4837	normal	Q61164	G1E-ER4 derived erythroid cells	PEAKS059147
EXP064418	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 240 mins; Developmental stage: late G1	EXP064412	4837	normal	Q61164	G1E-ER4 derived erythroid cells	PEAKS059148
EXP064419	anti-Rad21	Mus musculus	Treatment: none; Developmental stage: asynchronized	EXP064407	4837	normal	Q61550	G1E-ER4 derived erythroid cells	PEAKS059149
EXP064420	anti-Rad21	Mus musculus	Treatment: synchronized with 200ng/ml nocodazole for 7-8.5 hrs; Developmental stage: synchronized to pro-metaphase	EXP064408	4837	normal	Q61550	G1E-ER4 derived erythroid cells	PEAKS059150
EXP064421	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5hrs , released for nocodazole for 25 mins; Developmental stage: ana/telo phase	EXP064409	4837	normal	Q61550	G1E-ER4 derived erythroid cells	PEAKS059151
EXP064422	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 60 mins; Developmental stage: early G1	EXP064410	4837	normal	Q61550	G1E-ER4 derived erythroid cells	PEAKS059152
EXP064423	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 120 mins; Developmental stage: mid G1	EXP064411	4837	normal	Q61550	G1E-ER4 derived erythroid cells	PEAKS059153
EXP064424	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 240 mins; Developmental stage: late G1	EXP064412	4837	normal	Q61550	G1E-ER4 derived erythroid cells	PEAKS059154
EXP064429	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Mock; Genotype: HNF-1beta knockout	EXP064426	478	normal	Q02248	IMCD3 inner medullary collecting duct)	PEAKS059155
EXP064430	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Wnt3a (100ng/ml) for 16hrs; Genotype: HNF-1beta knockout	NULL	478	normal	Q02248	IMCD3 inner medullary collecting duct)	PEAKS059156
EXP064431	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Mock; Genotype: wildtype	EXP064428	478	normal	Q02248	IMCD3 inner medullary collecting duct)	PEAKS059157
EXP064432	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Wnt3a (100ng/ml) for 16hrs; Genotype: wildtype	NULL	478	normal	Q02248	IMCD3 inner medullary collecting duct)	PEAKS059158
EXP064433	anti-NELF-E (Abcam, cat# ab28038)	Mus musculus	Treatment: none; Genotype: Wildtype; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	P19426	mESCs (mouse embryonic stem cells)	PEAKS059159
EXP064434	anti-NELF-E (Abcam, cat# ab28038)	Mus musculus	Treatment: none; Genotype: SIRT6 knockout; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	P19426	mESCs (mouse embryonic stem cells)	PEAKS059160
EXP064435	anti-LEO1 (Bethyl Laboratories. Inc, cat# A300-175A)	Mus musculus	Treatment: none; Genotype: Wildtype; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	Q5XJE5	mESCs (mouse embryonic stem cells)	PEAKS059161
EXP064436	anti-LEO1 (Bethyl Laboratories. Inc, cat# A300-175A)	Mus musculus	Treatment: none; Genotype: SIRT6 knockout; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	Q5XJE5	mESCs (mouse embryonic stem cells)	PEAKS059162
EXP064437	anti-Kap1  (Abcam, ab10483)	Mus musculus	Treatment: none; Age: 3 months; Strain: C57BL/6	NULL	5	normal	Q62318	liver	PEAKS059163
EXP064438	anti-Kap1  (Abcam, ab10483)	Mus musculus	Treatment: none; Age: 21 months; Strain: C57BL/6	NULL	5	normal	Q62318	liver	PEAKS059164
EXP064439	anti-Setdb1 (Proteintech, 11231-1-AP)	Mus musculus	Treatment: none; Age: 3 months; Strain: C57BL/6	NULL	5	normal	O88974	liver	PEAKS059165
EXP064440	anti-Setdb1 (Proteintech, 11231-1-AP)	Mus musculus	Treatment: none; Age: 21 months; Strain: C57BL/6	NULL	5	normal	O88974	liver	PEAKS059166
EXP064441	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 0 hrs	NULL	5	bio_control	O35426	liver	PEAKS059167
EXP064442	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 4 hrs	NULL	5	bio_control	O35426	liver	PEAKS059168
EXP064443	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 8 hrs	NULL	5	bio_control	O35426	liver	PEAKS059169
EXP064444	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 12 hrs	NULL	5	bio_control	O35426	liver	PEAKS059170
EXP064445	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 16 hrs	NULL	5	bio_control	O35426	liver	PEAKS059171
EXP064446	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 20 hrs	NULL	5	bio_control	O35426	liver	PEAKS059172
EXP064447	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 24 hrs	NULL	5	bio_control	O35426	liver	PEAKS059173
EXP064448	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 28 hrs	NULL	5	bio_control	O35426	liver	PEAKS059174
EXP064449	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 32 hrs	NULL	5	bio_control	O35426	liver	PEAKS059175
EXP064450	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 36 hrs	NULL	5	bio_control	O35426	liver	PEAKS059176
EXP064451	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 40 hrs	NULL	5	bio_control	O35426	liver	PEAKS059177
EXP064452	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 44 hrs	NULL	5	bio_control	O35426	liver	PEAKS059178
EXP064453	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: XBP1 liver-specific knockout; Time point: 0 hrs	NULL	5	bio_control	O35426	liver	PEAKS059179
EXP064454	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005918	3087	normal	Q99LI5	RGd2(embryonic stem cells)	PEAKS059180
EXP064455	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005919	3087	normal	Q99LI5	RGd2(embryonic stem cells)	PEAKS059181
EXP064456	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005920	3087	normal	Q99LI5	RGd2(embryonic stem cells)	PEAKS059182
EXP064457	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005921	3087	normal	Q99LI5	RGd2(embryonic stem cells)	PEAKS059183
EXP064458	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005918	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059184
EXP064459	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005919	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059185
EXP064460	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005920	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059186
EXP064461	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005921	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059187
EXP064462	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: Zfp281 knockout	HEXP005922	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059188
EXP064463	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: Zfp281 knockout	HEXP005923	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059189
EXP064464	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: Zfp281 knockout; Time point: 32 hrs	HEXP005924	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059190
EXP064465	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: Zfp281 knockout; Time point: 32 hrs	HEXP005925	3087	normal	Q62520	RGd2(embryonic stem cells)	PEAKS059191
EXP064474	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064470	2411	normal	P23772	Scid.adh.2c2 cells	PEAKS059192
EXP064475	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064471	2411	normal	P23772	Scid.adh.2c2 cells	PEAKS059193
EXP064476	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064472	4855	normal	P23772	ILC2/b6 cells	PEAKS059194
EXP064477	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064473	4855	normal	P23772	ILC2/b6 cells	PEAKS059195
EXP064478	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064470	2411	normal	Q99PV8	Scid.adh.2c2 cells	PEAKS059196
EXP064479	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064471	2411	normal	Q99PV8	Scid.adh.2c2 cells	PEAKS059197
EXP064480	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064472	4855	normal	Q99PV8	ILC2/b6 cells	PEAKS059198
EXP064481	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064473	4855	normal	Q99PV8	ILC2/b6 cells	PEAKS059199
EXP064482	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064470	2411	normal	Q03347	Scid.adh.2c2 cells	PEAKS059200
EXP064483	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064471	2411	normal	Q03347	Scid.adh.2c2 cells	PEAKS059201
EXP064484	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064472	4855	normal	Q03347	ILC2/b6 cells	PEAKS059202
EXP064485	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064473	4855	normal	Q03347	ILC2/b6 cells	PEAKS059203
EXP064486	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064470	2411	normal	Q64131	Scid.adh.2c2 cells	PEAKS059204
EXP064487	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064471	2411	normal	Q64131	Scid.adh.2c2 cells	PEAKS059205
EXP064488	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064472	4855	normal	Q64131	ILC2/b6 cells	PEAKS059206
EXP064489	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064473	4855	normal	Q64131	ILC2/b6 cells	PEAKS059207
EXP064502	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Genotype: wildtype; Developmental stage: cell cycle I	EXP064490	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059208
EXP064503	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064491	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059209
EXP064504	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064492	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059210
EXP064505	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064493	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059211
EXP064506	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064494	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059212
EXP064507	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064495	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059213
EXP064508	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064498	1153	normal	Q61164	C2C12 (myoblasts)	PEAKS059214
EXP064509	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064499	1153	normal	Q61164	C2C12 (myoblasts)	PEAKS059215
EXP064510	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064500	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	PEAKS059216
EXP064511	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064501	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	PEAKS059217
EXP064512	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064490	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS059218
EXP064513	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064491	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS059219
EXP064514	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064493	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS059220
EXP064515	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064494	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	PEAKS059221
EXP064516	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: no auxin; Developmental stage: cell cycle I; Genotype: CTC FAID	EXP064496	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059222
EXP064517	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: 0.5mM auxin (IAA Sigma, I5148) for 2hrs; Developmental stage: cell cycle I	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059223
EXP064518	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: no auxin; Developmental stage: cell cycle M	EXP064497	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059224
EXP064519	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: 0.5mM auxin (IAA Sigma, I5148) for 2hrs; Developmental stage: cell cycle M	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	PEAKS059225
EXP064524	anti-Pax6	Mus musculus	Treatment: none; Genotype: wildtype	EXP064520	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	PEAKS059226
EXP064525	anti-Pax6	Mus musculus	Treatment: none; Genotype: wildtype	EXP064521	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	PEAKS059227
EXP064526	anti-Pax6	Mus musculus	Treatment: none; Genotype: Paupar knockout	EXP064522	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	PEAKS059228
EXP064527	anti-Pax6	Mus musculus	Treatment: none; Genotype: Paupar knockout	EXP064523	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	PEAKS059229
EXP064529	anti-NIPBL (A301-779A Bethyl)	Mus musculus	Treatment: normal proliferation	EXP064528	705	normal	Q6KCD5	P19 (embryonic carcinoma)	PEAKS059230
EXP064531	anti-Raly (Abcam, Ab170105)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	EXP064530	2787	normal	Q64012	Hepa1-6 (Hepatocellular carcinoma )	PEAKS059231
EXP064532	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, +FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing , BRCA1-/- 53BP1_S25A	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	PEAKS059232
EXP064533	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, +FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, BRCA1-/-	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	PEAKS059233
EXP064534	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, +FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, wildtype	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	PEAKS059234
EXP064535	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, without FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, BRCA1-/-	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	PEAKS059235
EXP064536	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, without FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing , BRCA1-/- 53BP1_S25A	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	PEAKS059236
EXP064537	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, without FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, wildtype	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	PEAKS059237
EXP064539	anti-TOP2B (SantaCruz â€“ sc13059)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064538	4863	normal	Q64511	thymocytes isolated from thymus	PEAKS059238
EXP064540	anti-TOP2B (Novus Biologicals - NB100-40842)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064538	4863	normal	Q64511	thymocytes isolated from thymus	PEAKS059239
EXP064541	anti-TOP2A (Abcam - ab52934)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064538	4863	normal	Q01320	thymocytes isolated from thymus	PEAKS059240
EXP064544	anti-MyoD (SC-760)	Mus musculus	Treatment: pyruvate added; Strain: C57BL/6	EXP064542	4865	normal	P10085	myotube differentiated from primary myoblasts	PEAKS059241
EXP064545	anti-MyoD (SC-760)	Mus musculus	Treatment: no pyruvate; Strain: C57BL/6	EXP064543	4865	normal	P10085	myotube differentiated from primary myoblasts	PEAKS059242
EXP064546	Anti-OCT4 (CST #5677S)	Mus musculus	Treatment: Untreated for 26 hours; Time point: 26 hrs; Genotype: wildtype	NULL	13	normal	P20263	2TS22C (embryonic stem cells)	PEAKS059243
EXP064547	Anti-OCT4 (CST #5677S)	Mus musculus	Treatment: 1 ug/ml doxycycline for 26 hours; Time point: 26 hrs; Genotype: Sox2 knockout	NULL	13	normal	P20263	2TS22C (embryonic stem cells)	PEAKS059244
EXP064548	Anti-BRG1 (Abcam #ab110641)	Mus musculus	Treatment: Untreated for 26 hours; Time point: 26 hrs; Genotype: wildtype	NULL	13	normal	Q3TKT4	2TS22C (embryonic stem cells)	PEAKS059245
EXP064549	Anti-BRG1 (Abcam #ab110641)	Mus musculus	Treatment: 1 ug/ml doxycycline for 26 hours; Time point: 26 hrs; Genotype: Sox2 knockout	NULL	13	normal	Q3TKT4	2TS22C (embryonic stem cells)	PEAKS059246
EXP064552	anti-p65 (D14E12, Rabbit mAb (Cell Signaling Technology, #8242))	Mus musculus	Treatment: control; Genotype: wildtype	EXP064550	4877	normal	Q04207	fibro-inflammatory progenitors from white adipose tissues	PEAKS059247
EXP064553	anti-p65 (D14E12, Rabbit mAb (Cell Signaling Technology, #8242))	Mus musculus	Treatment: Mural-Zfp423 transgenic; Genotype: Zfp423 transgene structure	EXP064551	4877	normal	Q04207	fibro-inflammatory progenitors from white adipose tissues	PEAKS059248
EXP064559	anti-HELLS (Millipore/Sigma, ABD41 lot# 3069868)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: B6-Prdm9CAST-KI	EXP064557	32	normal	Q60848	testis	PEAKS059249
EXP064560	anti-HELLS (Millipore/Sigma, ABD41 lot# 3069868)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: B6-Prdm9CAST-KI	EXP064558	32	normal	Q60848	testis	PEAKS059250
EXP064561	H3K4me3 (Millipore/Sigma #07-473; lot: 3018770)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: Hells knockout; GTRD_Rep_Group: 17	NULL	4878	normal	O08917	male germ cells from testis	PEAKS059251
EXP064562	anti-DMC1 (Santa Cruz sc-8973, lot: K2614)	Mus musculus	Treatment: none; Age: 6 weeks old; Genotype: Hells het	EXP064555	2748	normal	Q61880	adult testis	PEAKS059252
EXP064563	anti-DMC1 (Santa Cruz sc-8973, lot: K2614)	Mus musculus	Treatment: none; Age: 6 weeks old; Genotype: Hells knockout	EXP064556	2748	normal	Q61880	adult testis	PEAKS059253
EXP064565	anti-HA	Mus musculus	Treatment: Treatment: none; Genotype: wildtype (Tox2-HA-RV-GFP); Age: 7-8 weeks; Strain: C57BL/6; Genotype: wildtype (Tox2-HA-RV-GFP); Age: 7-8 weeks; Strain: C57BL/6	EXP064564	4812	normal	E9Q0B9	follicular T helper cells from spleen and lymph nodes	PEAKS059254
EXP064566	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg fulvestrant/ICI182780 (ICI) for 1 hr; Strain: C57BL/6J; Genotype: ERalpha AF-2 mutant; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	PEAKS059255
EXP064567	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg tamoxifen for 1 hr; Strain: C57BL/6J; Genotype: ERalpha AF-2 mutant; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	PEAKS059256
EXP064568	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 50 ul DMSO for 1 hr; Strain: C57BL/6J; Genotype: ERalpha AF-2 mutant; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	PEAKS059257
EXP064569	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg fulvestrant/ICI182780 (ICI); Strain: C57BL/6J; Genotype: wildtype; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	PEAKS059258
EXP064570	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg tamoxifen for 1 hr; Strain: C57BL/6J; Genotype: wildtype; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	PEAKS059259
EXP064571	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 50 ul DMSO for 1 hr; Strain: C57BL/6J; Genotype: wildtype; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	PEAKS059260
EXP064573	anti-SUZ12	Mus musculus	Treatment: Treatment: none; Genotype: Wildtype; Genotype: Wildtype	EXP064572	233	normal	Q80U70	E14TG2A (embryonic stem cells)	PEAKS059261
EXP064574	anti-SUZ12	Mus musculus	Treatment: Treatment: none; Genotype: Zfc3h1 knockout; Genotype: Zfc3h1 knockout	NULL	233	normal	Q80U70	E14TG2A (embryonic stem cells)	PEAKS059262
EXP064575	anti-GR (ProteinTech, 24050-AP)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week control Diet (Research Diet, D12329); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	PEAKS059263
EXP064576	anti-GR (ProteinTech, 24050-AP)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week HFD Diet (Research Diets, D12331); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	PEAKS059264
EXP064577	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week control Diet (Research Diet, D12329); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	PEAKS059265
EXP064578	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week HFD Diet (Research Diets, D12331); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	PEAKS059266
EXP064579	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 0 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 0 hrs; Conditions: 13 week HFD Diet (Research Diets, D12331); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	PEAKS059267
EXP064580	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 0 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 0 hrs; Conditions: 16 week control Diet (Research Diet, D12329); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	PEAKS059268
EXP064581	anti-HA (Abcam, ab9110)	Mus musculus	Treatment: none; Genotype: Shox2HA-DsRed	NULL	4889	normal	P70390	anterior palate	PEAKS059269
EXP064583	anti-Zc3h10	Mus musculus	Treatment: none; Conditions: Mice were maintained on chow diet until 12 weeks of age; Age: 12 weeks; Strain: c57bl/6j	EXP064582	115	normal	Q8R205	brown adipose tissue	PEAKS059270
EXP064592	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064588	313	normal	Q9Z2D6	forebrain	PEAKS059271
EXP064593	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064589	313	normal	Q9Z2D6	forebrain	PEAKS059272
EXP064594	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064590	313	normal	Q9Z2D6	forebrain	PEAKS059273
EXP064595	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064591	313	normal	Q9Z2D6	forebrain	PEAKS059274
EXP064596	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064588	313	normal	Q9Z2D6	forebrain	PEAKS059275
EXP064597	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064589	313	normal	Q9Z2D6	forebrain	PEAKS059276
EXP064598	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064590	313	normal	Q9Z2D6	forebrain	PEAKS059277
EXP064599	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064591	313	normal	Q9Z2D6	forebrain	PEAKS059278
EXP064602	anti-Elk-1 (Santa Cruz, sc-355X)	Mus musculus	Treatment: none; Genotype: wildtype; Age: 8 weeks; Disease: none; Source: R6/1	EXP064600	2450	normal	P41969	striatum	PEAKS059279
EXP064603	anti-Elk-1 (Santa Cruz, sc-355X)	Mus musculus	Treatment: none; Genotype: R6/1; Age: 8 weeks; Disease: Huntingtonâ€™s disease; Source: R6/1	EXP064601	2450	normal	P41969	striatum	PEAKS059280
EXP064607	anti-Flag (Shanghai Genomics Technology, 4110-20)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype, Zscan4-flag	EXP064604	12	normal	Q80VJ6	MEF (mouse embryonic fibroblasts)	PEAKS059281
EXP064608	anti-RAG1 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype	NULL	3094	normal	P15919	Abelson-transformed pre-B cell	PEAKS059282
EXP064609	anti-RAG1 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK	NULL	3094	normal	P15919	Abelson-transformed pre-B cell	PEAKS059283
EXP064610	anti-RAG1 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK-RS	NULL	3094	normal	P15919	Abelson-transformed pre-B cell	PEAKS059284
EXP064611	anti-RAG2 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype	NULL	3094	normal	P21784	Abelson-transformed pre-B cell	PEAKS059285
EXP064612	anti-RAG2 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK	NULL	3094	normal	P21784	Abelson-transformed pre-B cell	PEAKS059286
EXP064613	anti-RAG2 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK-RS	NULL	3094	normal	P21784	Abelson-transformed pre-B cell	PEAKS059287
EXP064618	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP064614	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS059288
EXP064619	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP064615	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS059289
EXP064620	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: 2.5 uM EPZ-6438 for 24 hrs; Time point: 24 hrs	EXP064615	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS059290
EXP064621	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: 2.5 uM EPZ-6438 for 24 hrs; Time point: 24 hrs	EXP064617	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	PEAKS059291
EXP064623	anti-p53 (Novocastra #CM5P)	Mus musculus	Treatment: none; Conditions: serum growth conditions; Strain: 129/Ola	EXP064622	2	normal	P02340	mESCs (mouse embryonic stem cells)	PEAKS059292
EXP064624	anti-p53 (Novocastra #CM5P)	Mus musculus	Treatment: none; Conditions: 2i growth conditions; Strain: 129/Ola	EXP064622	2	normal	P02340	mESCs (mouse embryonic stem cells)	PEAKS059293
EXP064626	anti-ThPOK (SantaCruz, sc-79127X)	Mus musculus	Treatment: Th1 cells were stimulated for 2hrs with 5ug/mL anti-CD3, 3ug/mL anti-CD28, 10ng/mL IL-12, 10ng/ul IL18 and 400U/ml IFNg; Source: Cells were polarized into the Th1 helper cells for 6 days using plate-bound anti-CD3 (5ug/mL), in complete RPMI medium (RPMI-1610, 10% FBS, 1X P/S and 1X non-essential amino acids) containing anti-CD28 (3ug/mL), IL-12 (10ng/mL), IL-2 (10ng/mL) and anti-IL-4 (10ug/mL), with medium replenished after 3 days; Strain: C57BL6/J	EXP064625	4902	normal	Q64321	primary naive CD4+ T cells from spleen and lymph nodes polarized to Th1 (T helper 1) cells	PEAKS059294
EXP064627	anti-RXR (sc-774)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 3 months; Sex: male	NULL	81	normal	P28700	BMDM (bone marrow-derived macrophages)	PEAKS059295
EXP064628	anti-RXR (sc-774)	Mus musculus	Treatment: none; Strain: 129Sv/E14; Developmental stage: adipocyte day 21 of differentiation	NULL	4903	normal	P28700	embryonic stem cell derived adipocytes	PEAKS059296
EXP064629	anti-PPARg (Perseus #PP-A3409A)	Mus musculus	Treatment: none; Strain: 129Sv/E14; Developmental stage: adipocyte day 21 of differentiation	NULL	4903	normal	P37238	embryonic stem cell derived adipocytes	PEAKS059297
EXP064630	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB500G; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	PEAKS059298
EXP064631	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB503; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	PEAKS059299
EXP064632	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB502; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	PEAKS059300
EXP064633	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB499; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	PEAKS059301
EXP064636	anti-CTCF (Millipore, 07-729, lot 2517762)	Mus musculus	Treatment: none; Strain: C57BL6; Age: adult; Cell type: CD4-, CD8-, IL7Ra-, CD11b-, Ly6g-, CD45R-, Ter119-, cKit+, Sca1+	EXP064634	3973	normal	Q61164	LSK (Lin(neg)/c-Kit(+)/Sca-1(+)) cells from bone marrow	PEAKS059302
EXP064640	anti-T-bet serum (9856, Custom rabbit )	Mus musculus	Treatment: none; Strain: Balb/c; Genotype: wildtype	EXP064637	4914	normal	Q9JKD8	induced T-regulatory cell (iTreg) from spleen and lymph nodes	PEAKS059303
EXP064641	anti-T-bet serum (9856, Custom rabbit )	Mus musculus	Treatment: none; Strain: Balb/c; Genotype: wildtype	EXP064638	4914	normal	Q9JKD8	induced T-regulatory cell (iTreg) from spleen and lymph nodes	PEAKS059304
EXP064642	anti-T-bet serum (9856, Custom rabbit )	Mus musculus	Treatment: none; Strain: Balb/c; Genotype: T-bet knockout	EXP064639	4914	normal	Q9JKD8	induced T-regulatory cell (iTreg) from spleen and lymph nodes	PEAKS059305
EXP064645	anti-Foxp3 (Santa Cruz S-31738 and eBioscience FJK-16)	Mus musculus	Treatment: none; Strain: Balb/c	EXP064643	4914	normal	Q99JB6	induced T-regulatory cell (iTreg) from spleen and lymph nodes	PEAKS059306
EXP064646	anti-Foxp3 (Santa Cruz S-31738 and eBioscience FJK-16)	Mus musculus	Treatment: none; Strain: Balb/c; Source: were polarized with 20 ng/ml IL-2 (Biolegend) and polarized with 20 ng/ml IL-12 (eBioscience) and 10 ?g/ml anti-IL-4 (BioXCell)	EXP064644	4902	normal	Q99JB6	primary naive CD4+ T cells from spleen and lymph nodes polarized to Th1 (T helper 1) cells	PEAKS059307
EXP064648	anti-Nkx2.2 (monoclonal antibody, Protein G affinity purified supernatant from hybridomas (74.5A5-b) developed by Prof. Thomas M Jessell, Columbia University, USA, and obtained from Developmental Studies Hybridoma Bank, University of Iowa, USA)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: p7	EXP064647	4915	normal	P42586	oligodendrocyte progenitor cell from cortex	PEAKS059308
EXP064649	anti-Nkx2.2 (monoclonal antibody, Protein G affinity purified supernatant from hybridomas (74.5A5-b) developed by Prof. Thomas M Jessell, Columbia University, USA, and obtained from Developmental Studies Hybridoma Bank, University of Iowa, USA)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: p7	EXP064647	4916	normal	P42586	oligodendrocyte from cortex	PEAKS059309
EXP064652	anti-E2F6 (Abcam: ab53061)	Mus musculus	Treatment: none; Strain: BL6/129ola; Genotype: wildtype; Sex: female	EXP064650	2	normal	O54917	mESCs (mouse embryonic stem cells)	PEAKS059310
EXP064653	anti-E2F6 (Abcam: ab53061)	Mus musculus	Treatment: none; Strain: BL6/129ola; Genotype: E2f6 knockout; Sex: male	EXP064651	2	normal	O54917	mESCs (mouse embryonic stem cells)	PEAKS059311
EXP064655	anti-Glyr1 (14833-1-AP, Proteintech Group)	Mus musculus	Treatment: none	EXP064654	230	normal	Q922P9	ES-E14 (E14, embryonic stem cells)	PEAKS059312
EXP064656	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 hrs; Strain: c57bl/6; Genotype: wildtype; Time point: 0 hrs; Strain: c57bl/6	HEXP006173	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	PEAKS059313
EXP064657	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: none; Genotype: NSD2 knockout; Time point: 0 hrs; Strain: c57bl/6; Genotype: NSD2 knockout; Time point: 0 hrs; Strain: c57bl/6	HEXP006175	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	PEAKS059314
EXP064658	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: IFN-Beta for 16 hrs; Genotype: wildtype; Time point: 16 hrs; Strain: c57bl/6; Genotype: wildtype; Time point: 16 hrs; Strain: c57bl/6	HEXP006174	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	PEAKS059315
EXP064659	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: IFN-Beta for 16 hrs; Genotype: NSD2 knockout; Time point: 16 hrs; Strain: c57bl/6; Genotype: NSD2 knockout; Time point: 16 hrs; Strain: c57bl/6	HEXP006176	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	PEAKS059316
EXP064663	anti-Sox2 (Millipore, AB5603)	Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	EXP064660	2376	normal	P48432	secondary MEF cells	PEAKS059317
EXP064664	anti-Sox2 (Millipore, AB5603)	Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	EXP064661	2376	normal	P48432	secondary MEF cells	PEAKS059318
EXP064665	anti-Klf4	Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	EXP064662	2376	normal	Q60793	secondary MEF cells	PEAKS059319
EXP064667	anti-Jmjd2a (abcam, ab70786)	Mus musculus	Treatment: cells were stimulated with anti-mouse CD40 , IL-21 , and HEL; Genotype: Tg(IghelMD4)4Ccg; Strain: C57BL/6	EXP064666	4921	normal	Q8BW72	B220+ B cells from spleen	PEAKS059320
EXP064668	anti-Jmjd2c (abcam, ab85454)	Mus musculus	Treatment: cells were stimulated with anti-mouse CD40 , IL-21 , and HEL; Genotype: Tg(IghelMD4)4Ccg; Strain: C57BL/6	EXP064666	4921	normal	Q8VCD7	B220+ B cells from spleen	PEAKS059321
EXP064676	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing the DMSO; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	EXP064669	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059322
EXP064677	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing 1 uM PFI-3; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059323
EXP064678	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing 5 uM PFI-3; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059324
EXP064679	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing 10 uM PFI-3; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059325
EXP064680	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059326
EXP064681	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1-BirA-IVT-mRNA transfection; Genotype: PU1-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059327
EXP064682	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1 deletionQ-BirA-IVT-mRNA transfection; Genotype: PU1 deletionQ-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 deletionQ-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059328
EXP064683	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1 deletionA-BirA-IVT-mRNA transfection; Genotype: PU1 deletionA-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 deletionA-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059329
EXP064684	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059330
EXP064685	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059331
EXP064686	anti-ETS1 (Santa Cruz, #sc-350X)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064670	4712	normal	P14921	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059332
EXP064687	anti-FLI1 (Abcam, #ab15289)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064670	4712	normal	Q01543	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059333
EXP064688	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064670	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059334
EXP064689	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	EXP064671	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059335
EXP064690	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	EXP064671	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059336
EXP064691	anti-ETS1 (Santa Cruz, #sc-350X)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064672	4712	normal	P14921	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059337
EXP064692	anti-FLI1 (Abcam, #ab15289)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064672	4712	normal	Q01543	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059338
EXP064693	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064672	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059339
EXP064694	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: PU.1 deletion P-mRNA transfection; Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059340
EXP064695	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1 deletion P-mRNA transfection; Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059341
EXP064696	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1 deletion P-mRNA transfection; Genotype: PU.1 deleltion AQP; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deleltion AQP; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059342
EXP064697	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059343
EXP064698	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059344
EXP064699	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	1224	normal	P17947	TALL1 (T-Acute Lymphoblastic Leukemia)	PEAKS059345
EXP064700	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1 mut-IVT-mRNA transfection; Genotype: PU1 mutation; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 mutation; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	1224	normal	P17947	TALL1 (T-Acute Lymphoblastic Leukemia)	PEAKS059346
EXP064701	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059347
EXP064702	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059348
EXP064703	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU1 deletionQ-IVT-mRNA transfection; Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059349
EXP064704	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	430	normal	P17947	HepG2 (hepatoblastoma)	PEAKS059350
EXP064705	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	430	normal	P17947	HepG2 (hepatoblastoma)	PEAKS059351
EXP064706	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1 deletionQ-IVT-mRNA transfection; Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059352
EXP064707	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059353
EXP064708	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059354
EXP064709	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059355
EXP064710	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	PEAKS059356
EXP064717	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: expressed BORIS from vector (of pMy-MouseCTCFbiotag-T2A-mOrange)	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059357
EXP064718	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: stably expressed BORIS	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059358
EXP064719	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed BORIS	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059359
EXP064720	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed BORIS	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059360
EXP064721	anti-BORIS  (characterized in PMID: 21659515, custom mouse monoclonal)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed BORIS	NULL	178	normal	A2APF3	CH12 (lymphoma)	PEAKS059361
EXP064722	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N1mutant of CTCF(aa1-30) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(aa1-30), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059362
EXP064723	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N1mutant of CTCF(aa1-30) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(aa1-30), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059363
EXP064724	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N2mutant of CTCF(aa1-87) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N2mutant of CTCF(aa1-87), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059364
EXP064725	Anti-NIPBL (Bethy Laboratories; catalog# A301-779A)	Mus musculus	Treatment: none; Genotype: wildtype	NULL	178	normal	Q6KCD5	CH12 (lymphoma)	PEAKS059365
EXP064726	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059366
EXP064727	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with 8mM of the PARP-1 inhibitor 3-aminobenzamide (3-ABA); Genotype: wildtype	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059367
EXP064728	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with 8mM of the PARP-1 inhibitor 3-aminobenzamide (3-ABA); Genotype: wildtype	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059368
EXP064729	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with DMSO (8mM); Genotype: wildtype	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059369
EXP064730	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with DMSO (8mM); Genotype: wildtype	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059370
EXP064731	anti-CTCF (mouse monoclonal SantaCruz, SC-271514, B-5)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS059371
EXP064732	anti-CTCF (rabbit polyclonal Millipore, 07-729)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS059372
EXP064733	Mix of CTCF rabbit polyclonal ABs(Novus Biologicals: NB100-56494, NB100-947, NB500-194, Abcam: ab70303; Bethyl Laboratories: A300-543A, A300-544A, A300-542A).	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS059373
EXP064734	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: Chimera2 vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene, stably expressed CTCF and BORIS Chimera2 tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059374
EXP064735	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: Chimera4 vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene, stably expressed CTCF and BORIS Chimera4 tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059375
EXP064736	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: none; Genotype: wildtype	EXP064716	178	normal	Q61164	CH12 (lymphoma)	PEAKS059376
EXP064737	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: none; Genotype: wildtype	EXP064716	178	normal	Q61550	CH12 (lymphoma)	PEAKS059377
EXP064738	anti-BORIS  (characterized in PMID: 21659515, custom mouse monoclonal)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: expressed BORIS from vector (of pMy-MouseCTCFbiotag-T2A-mOrange)	NULL	178	normal	A2APF3	CH12 (lymphoma)	PEAKS059378
EXP064739	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: none; Genotype: homozygous deletion of ZF9-11 in CTCF gene	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059379
EXP064740	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: none; Genotype: homozygous deletion of ZF9-11 in CTCF gene	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059380
EXP064741	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: Fl-CTCF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed Full-Length CTCF, tagged with V5 Tag at the C-terminu	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059381
EXP064742	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: Fl-CTCF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed Full-Length CTCF, tagged with V5 Tag at the C-terminu	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059382
EXP064743	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: Fl-CTCF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed Full-Length CTCF, tagged with V5 Tag at the C-terminu	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059383
EXP064744	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CTCF (N-terminus+11ZFs) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF (N-terminus+11ZFs), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059384
EXP064745	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CTCF (N-terminus+11ZFs) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF (N-terminus+11ZFs), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059385
EXP064746	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: CTCF (N-terminus+11ZFs) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF (N-terminus+11ZFs), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059386
EXP064747	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: (11ZFs+C-terminus) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, expressed truncated CTCF (11ZFs+C-terminus), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059387
EXP064748	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: (11ZFs+C-terminus) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, expressed truncated CTCF (11ZFs+C-terminus), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059388
EXP064749	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: (11ZFs+C-terminus) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, expressed truncated CTCF (11ZFs+C-terminus), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q9CXC9	CH12 (lymphoma)	PEAKS059389
EXP064750	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N1mutant of CTCF(aa1-30) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(aa1-30), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059390
EXP064751	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N2mutant of CTCF(aa1-87) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N2mutant of CTCF(aa1-87), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059391
EXP064752	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N2mutant of CTCF(aa1-87) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N2mutant of CTCF(aa1-87), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059392
EXP064753	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N3mutant of CTCF(aa90-186) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N3mutant of CTCF(aa90-186), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059393
EXP064754	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N3mutant of CTCF(aa90-186) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N3mutant of CTCF(aa90-186), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059394
EXP064755	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N3mutant of CTCF(aa90-186) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N3mutant of CTCF(aa90-186), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059395
EXP064756	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N4mutant of CTCF(aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N4mutant of CTCF(aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059396
EXP064757	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N4mutant of CTCF(aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N4mutant of CTCF(aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059397
EXP064758	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N4mutant of CTCF(aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N4mutant of CTCF(aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059398
EXP064759	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N6mutant of CTCF(The N-terminus truncated to aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N6mutant of CTCF(The N-terminus truncated to aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059399
EXP064760	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N6mutant of CTCF(The N-terminus truncated to aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N6mutant of CTCF(The N-terminus truncated to aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059400
EXP064761	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N5mutant of CTCF(11 aa mutations) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(11 aa mutations), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059401
EXP064762	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N5mutant of CTCF(11 aa mutations) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(11 aa mutations), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	PEAKS059402
EXP064763	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N5mutant of CTCF(11 aa mutations) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(11 aa mutations), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	PEAKS059403
EXP064764	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	EXP064714	178	normal	Q61550	CH12 (lymphoma)	PEAKS059404
EXP064765	anti-V5 (Tag Monoclonal Antibody, ThermoFisher, Catalog # R960-25)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	EXP064714	178	normal	Q61164	CH12 (lymphoma)	PEAKS059405
EXP064766	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CTCF with the first two ZFs deleted vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed mutant CTCF with the first two ZFs deleted, tagged with V5 Tag at the C-terminus)	EXP064715	178	normal	Q61550	CH12 (lymphoma)	PEAKS059406
EXP064767	anti-V5 (Tag Monoclonal Antibody, ThermoFisher, Catalog # R960-25)	Mus musculus	Treatment: CTCF with the first two ZFs deleted vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed mutant CTCF with the first two ZFs deleted, tagged with V5 Tag at the C-terminus)	EXP064715	178	normal	Q61164	CH12 (lymphoma)	PEAKS059407
EXP064768	anti-CTCF (custom mouse monoclonal, characterized in PMID:15731119)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	PEAKS059408
EXP064769	anti-CTCF (custom mouse monoclonal, characterized in PMID:15731119)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064712	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	PEAKS059409
EXP064770	anti-RAD21(Abcam, ab992)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064712	113	normal	O60216	MCF7 (Invasive ductal breast carcinoma)	PEAKS059410
EXP064771	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Mus musculus	Treatment: CTCF with the first two ZFs deleted vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed mutant CTCF with the first two ZFs deleted, tagged with V5 Tag at the C-terminus)	EXP064715	178	normal	Q61164	CH12 (lymphoma)	PEAKS059411
EXP064773	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006309	313	normal	Q9Z2D6	forebrain	PEAKS059412
EXP064774	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006310	313	normal	Q9Z2D6	forebrain	PEAKS059413
EXP064775	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006311	313	normal	Q9Z2D6	forebrain	PEAKS059414
EXP064776	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006312	313	normal	Q9Z2D6	forebrain	PEAKS059415
EXP064777	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006314	313	normal	Q9Z2D6	forebrain	PEAKS059416
EXP064778	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006315	313	normal	Q9Z2D6	forebrain	PEAKS059417
EXP064779	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006316	313	normal	Q9Z2D6	forebrain	PEAKS059418
EXP064780	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006317	313	normal	Q9Z2D6	forebrain	PEAKS059419
EXP064781	anti-YY1 (Abcam ab109237)	Mus musculus	Treatment: Treatment: Treatment: none; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo	NULL	4922	normal	Q00899	E16.5 cortical neurons	PEAKS059420
EXP064782	anti-YY1 (Abcam ab109237)	Mus musculus	Treatment: Treatment: Treatment: 6 hrs KCl; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo	EXP064772	4922	normal	Q00899	E16.5 cortical neurons	PEAKS059421
EXP064784	anti-PCGF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS059422
EXP064785	anti-PCGF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS059423
EXP064786	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059424
EXP064787	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059425
EXP064788	anti-PCGF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS059426
EXP064789	anti-RING1B	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS059427
EXP064790	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059428
EXP064791	anti-RING1B	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS059429
EXP064792	anti-SUZ12	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059430
EXP064793	anti-RING1B	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS059431
EXP064794	anti-RING1B	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	PEAKS059432
EXP064795	anti-PCGF6	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS059433
EXP064796	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059434
EXP064797	anti-PCGF6	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS059435
EXP064798	anti-PCGF6	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS059436
EXP064799	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059437
EXP064800	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059438
EXP064801	anti-PCGF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	PEAKS059439
EXP064802	anti-PCGF6	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	PEAKS059440
EXP064803	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059441
EXP064804	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: RING1B missense mutations I53S; Time point: 48 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059442
EXP064805	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: RING1B missense mutations I53S; Time point: 48 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059443
EXP064806	anti-AEBP2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	PEAKS059444
EXP064807	anti-Cbx7	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	PEAKS059445
EXP064808	anti-EPOP	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	PEAKS059446
EXP064809	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059447
EXP064810	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059448
EXP064811	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S, MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059449
EXP064812	anti-Rybp	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	PEAKS059450
EXP064813	anti-JARID2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059451
EXP064814	anti-MTF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059452
EXP064815	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: Parental RING1B; Time point: 48 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059453
EXP064816	MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: Parental RING1B; Time point: 48 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059454
EXP064817	anti-AEBP2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	PEAKS059455
EXP064818	anti-Cbx7	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	PEAKS059456
EXP064819	anti-EPOP	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	PEAKS059457
EXP064820	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059458
EXP064821	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059459
EXP064822	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B, MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059460
EXP064823	anti-Rybp	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	PEAKS059461
EXP064824	anti-AEBP2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	PEAKS059462
EXP064825	anti-Cbx7	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	PEAKS059463
EXP064826	anti-EPOP	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	PEAKS059464
EXP064827	anti-JARID2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059465
EXP064828	anti-MTF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059466
EXP064829	anti-SUZ12	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B, MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059467
EXP064830	anti-Rybp	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	PEAKS059468
EXP064831	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: wildtype; Time point: 48 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059469
EXP064832	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: wildtype; Time point: 48 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059470
EXP064833	anti-AEBP2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	PEAKS059471
EXP064834	anti-Cbx7	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	PEAKS059472
EXP064835	anti-EPOP	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	PEAKS059473
EXP064836	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059474
EXP064837	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059475
EXP064838	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	PEAKS059476
EXP064839	anti-Rybp	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	PEAKS059477
EXP064840	anti-JARID2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	PEAKS059478
EXP064841	anti-MTF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	PEAKS059479
EXP064846	anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: Treatment: none; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0	EXP064844	4948	normal	Q500V5	14 day old leaves	PEAKS059480
EXP064847	anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: Treatment: none; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0	EXP064845	4948	normal	Q500V5	14 day old leaves	PEAKS059481
EXP064848	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	PEAKS059482
EXP064849	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	PEAKS059483
EXP064850	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	PEAKS059484
EXP064851	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	2178	normal	Q03012	SK1 meiotic cells (6 hours)	PEAKS059485
EXP064852	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4962	normal	Q03012	SK1 meiotic cells (6.5 hours)	PEAKS059486
EXP064853	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	PEAKS059487
EXP064854	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	PEAKS059488
EXP064855	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	PEAKS059489
EXP064856	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	PEAKS059490
EXP064857	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	PEAKS059491
EXP064858	myc Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	PEAKS059492
EXP064859	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	2178	normal	Q03012	SK1 meiotic cells (6 hours)	PEAKS059493
EXP064860	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4962	normal	Q03012	SK1 meiotic cells (6.5 hours)	PEAKS059494
EXP064861	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	PEAKS059495
EXP064862	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	PEAKS059496
EXP064863	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	PEAKS059497
EXP064864	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	2178	normal	Q03012	SK1 meiotic cells (6 hours)	PEAKS059498
EXP064865	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4962	normal	Q03012	SK1 meiotic cells (6.5 hours)	PEAKS059499
EXP064868	anti-IgG (Sigma-Aldrich; I5381-5MG)	Saccharomyces cerevisiae	Treatment: none; Genotype: wildtype	EXP064866	1232	normal	P47156	S. cerevisiae cells	PEAKS059500
EXP064869	anti-IgG (Sigma-Aldrich; I5381-5MG)	Saccharomyces cerevisiae	Treatment: none; Genotype: wildtype	EXP064867	1232	normal	P39081	S. cerevisiae cells	PEAKS059501
EXP064906	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	EXP064870	2520	normal	P22336	whole cells	PEAKS059502
EXP064907	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	NULL	2520	normal	P22336	whole cells	PEAKS059503
EXP064908	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064872	2520	normal	P22336	whole cells	PEAKS059504
EXP064909	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064873	2520	normal	P22336	whole cells	PEAKS059505
EXP064910	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064874	2520	normal	P22336	whole cells	PEAKS059506
EXP064911	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064875	2520	normal	P22336	whole cells	PEAKS059507
EXP064912	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064876	2520	normal	P22336	whole cells	PEAKS059508
EXP064913	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064877	2520	normal	P22336	whole cells	PEAKS059509
EXP064914	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064878	2520	normal	P22336	whole cells	PEAKS059510
EXP064915	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064879	2520	normal	P22336	whole cells	PEAKS059511
EXP064916	RPA anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064880	2520	normal	P22336	whole cells	PEAKS059512
EXP064917	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064881	2520	normal	P22336	whole cells	PEAKS059513
EXP064918	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	EXP064882	2520	normal	P25454	whole cells	PEAKS059514
EXP064919	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	EXP064883	2520	normal	P25454	whole cells	PEAKS059515
EXP064920	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064884	2520	normal	P25454	whole cells	PEAKS059516
EXP064921	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064885	2520	normal	P25454	whole cells	PEAKS059517
EXP064922	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064886	2520	normal	P25454	whole cells	PEAKS059518
EXP064923	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064887	2520	normal	P25454	whole cells	PEAKS059519
EXP064924	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064888	2520	normal	P25454	whole cells	PEAKS059520
EXP064925	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064889	2520	normal	P25454	whole cells	PEAKS059521
EXP064926	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064890	2520	normal	P25454	whole cells	PEAKS059522
EXP064927	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064891	2520	normal	P25454	whole cells	PEAKS059523
EXP064928	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064892	2520	normal	P25454	whole cells	PEAKS059524
EXP064929	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064893	2520	normal	P25454	whole cells	PEAKS059525
EXP064930	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: HTZ1 deletion; Time point: 0 hour	EXP064894	2520	normal	P25454	whole cells	PEAKS059526
EXP064931	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: HTZ1 deletion; Time point: 0 hour	EXP064895	2520	normal	P25454	whole cells	PEAKS059527
EXP064932	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 1 hour	EXP064896	2520	normal	P25454	whole cells	PEAKS059528
EXP064933	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 1 hour	EXP064897	2520	normal	P25454	whole cells	PEAKS059529
EXP064934	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 4 hour	EXP064898	2520	normal	P25454	whole cells	PEAKS059530
EXP064935	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 4 hour	EXP064899	2520	normal	P25454	whole cells	PEAKS059531
EXP064936	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion, HTZ1 deletion; Time point: 0 hour	EXP064900	2520	normal	P25454	whole cells	PEAKS059532
EXP064937	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion, HTZ1 deletion; Time point: 0 hour	EXP064901	2520	normal	P25454	whole cells	PEAKS059533
EXP064938	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 1 hour	EXP064902	2520	normal	P25454	whole cells	PEAKS059534
EXP064939	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 1 hour	EXP064903	2520	normal	P25454	whole cells	PEAKS059535
EXP064940	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 4 hour	EXP064904	2520	normal	P25454	whole cells	PEAKS059536
EXP064941	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 4 hour	EXP064905	2520	normal	P25454	whole cells	PEAKS059537
EXP064979	anti-ey (provided by Dr. U. Walldorf)	Drosophila melanogaster	Treatment: Treatment: none; Strain: Canton S	EXP064978	1987	normal	O18381	eye-antennal discs (developmental stage: L3)	PEAKS059554
EXP064980	anti-ey (provided by Dr. U. Walldorf)	Drosophila melanogaster	Treatment: Treatment: none; Strain: Canton S	EXP064978	1987	normal	O18381	eye-antennal discs (developmental stage: L3)	PEAKS059555
id	antibody	specie	treatment	control_id	cell_id	experiment_type	tf_uniprot_id	title	NULL
EXP000488	sc-8334	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000489	sc-345	Homo sapiens	IFN gamma	EXP000490	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000389	STAT5A	Mus musculus	IL-2	NULL	44	unspecified	P42230	T-cells	NULL
EXP000480	custom made against Tcfcp2l1	Mus musculus	NULL	EXP000488	2	unspecified	Q3UNW5	mESCs (mouse embryonic stem cells)	NULL
EXP000481	07-729 (Upstate)	Mus musculus	NULL	EXP000488	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP000482	custom made against Zfx	Mus musculus	NULL	EXP000488	2	unspecified	P17012	mESCs (mouse embryonic stem cells)	NULL
EXP000483	sc-482 (Upstate)	Mus musculus	NULL	EXP000488	2	unspecified	P42227	mESCs (mouse embryonic stem cells)	NULL
EXP000484	custom made against Klf4	Mus musculus	NULL	EXP000488	2	unspecified	Q60793	mESCs (mouse embryonic stem cells)	NULL
EXP000485	custom made against Esrrb	Mus musculus	NULL	EXP000488	2	unspecified	Q61539	mESCs (mouse embryonic stem cells)	NULL
EXP000486	custom made against c-Myc	Mus musculus	NULL	EXP000488	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	NULL
EXP000487	custom made against n-Myc	Mus musculus	NULL	EXP000488	2	unspecified	P03966	mESCs (mouse embryonic stem cells)	NULL
EXP000376	NULL	Mus musculus	ZT22	NULL	5	chip_control	NULL	liver	NULL
EXP000377	preimmune serum (preV27)	Homo sapiens	NULL	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000375	NULL	Mus musculus	ZT10	NULL	5	chip_control	NULL	liver	NULL
EXP000372	NCoR	Mus musculus	ZT22	EXP000376	5	unspecified	Q60974	liver	NULL
EXP000373	Rev-erba	Mus musculus	ZT10	EXP000375	5	unspecified	Q3UV55	liver	NULL
EXP000370	EOMES	Homo sapiens	NULL	EXP000369	396	unspecified	O95936	WA09 (embryonic stem cells)	NULL
EXP000278	Combined anti-DUX4 C-terminus rabbit polyclonal antibodies MO488 and MO489	Homo sapiens	myoblasts transduced with lentivirus carrying DUX4	EXP000279	467	unspecified	Q9UBX2	myoblasts	NULL
EXP000277	anti-CTCF	Mus musculus	NULL	NULL	41	unspecified	Q61164	B-cells	NULL
EXP000276		Homo sapiens	NULL	EXP000275	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000275	NULL	Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000274	Jarid1b-DAIN	Mus musculus	NULL	NULL	230	unspecified	Q80Y84	ES-E14 (E14, embryonic stem cells)	NULL
EXP000273	TCF7L1 (M-20)	Mus musculus	24 hours of adipogenic stimuli	NULL	18	unspecified	Q9Z1J1	3T3-L1 (embryonic fibroblasts)	NULL
EXP000272	NULL	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000271	yy1	Mus musculus	NULL	EXP000272	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP000379	NFYA (Santa Cruz H-209 sc-10779, Lot D2408)	Homo sapiens	NULL	EXP000377	514	unspecified	P23511	K562 (myelogenous leukemia)	NULL
EXP000653	sc-15022	Homo sapiens	DHT	EXP030990	70	unspecified	Q99801	LNCaP (prostate carcinoma)	NULL
EXP000897	input	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000623	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	E2	NULL	111	unspecified	P55317	T47D (invasive ductal carcinoma)	NULL
EXP000578	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	430	unspecified	P49116	HepG2 (hepatoblastoma)	NULL
EXP000579	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	356	unspecified	P49116	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000574	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	423	unspecified	Q96GC6	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000575	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	356	unspecified	Q96GC6	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000576	Epitomics monoclonal rabbit anti ELK1	Homo sapiens	NULL	NULL	423	unspecified	P19419	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000577	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	514	unspecified	P49116	K562 (myelogenous leukemia)	NULL
EXP000570	anti-BAF155 (H-76), Santa Cruz Biotechnology, sc-10756	Homo sapiens	NULL	NULL	423	unspecified	Q92922	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000571	anti-BAF170 (H-116), Santa Cruz Biotechnology, sc-10757	Homo sapiens	NULL	NULL	423	unspecified	Q8TAQ2	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000572	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	514	unspecified	Q96GC6	K562 (myelogenous leukemia)	NULL
EXP000573	abnova mouse polyclonal anti-ZNF274	Homo sapiens	NULL	NULL	430	unspecified	Q96GC6	HepG2 (hepatoblastoma)	NULL
EXP000475	REC-RCAB0002PF (Cosmo Bio)	Mus musculus	NULL	EXP000488	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP000474	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	E2 for 24hr	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000477	sc-17320	Mus musculus	NULL	EXP000488	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP000476	sc-8628	Mus musculus	NULL	EXP000488	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP000471	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	DMSO	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000470	input	Mus musculus	IFNÎ² for 6 hour	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000473	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	E2 for 4hr	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000472	ER?, Santa Cruz Biotechnology, sc-8005 X	Homo sapiens	E2 for 1hr	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000772	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000773	356	unspecified	Q04206	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000773	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000770	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000771	363	unspecified	Q04206	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP000771	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	363	chip_control	NULL	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP000479	05-379 (Upstate)	Mus musculus	NULL	EXP000488	2	unspecified	Q61501	mESCs (mouse embryonic stem cells)	NULL
EXP000478	sc-7965	Mus musculus	NULL	EXP000488	2	unspecified	P70340	mESCs (mouse embryonic stem cells)	NULL
EXP000774	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000775	357	unspecified	Q04206	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP000775	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	357	chip_control	NULL	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP000240	IgG	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP000279		Homo sapiens	NULL	NULL	467	chip_control	NULL	myoblasts	NULL
EXP000371	NCoR	Mus musculus	ZT10	EXP000375	5	unspecified	Q60974	liver	NULL
EXP000509	p73 beta isoform	Homo sapiens	NULL	EXP000507	783	unspecified	O15350	SaOS2 (osteosarcoma)	NULL
EXP000508	p73 alpha isoform	Homo sapiens	NULL	EXP000507	783	unspecified	O15350	SaOS2 (osteosarcoma)	NULL
EXP000501	RXR	Mus musculus	Day 4 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	NULL
EXP000500	RXR	Mus musculus	Day 3 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	NULL
EXP000503	Flag M2	Mus musculus	NULL	EXP000504	2	unspecified	P43241	mESCs (mouse embryonic stem cells)	NULL
EXP000502	RXR	Mus musculus	Day 6 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	NULL
EXP000505	STAT1	Homo sapiens	IFNgamma	NULL	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000504	NULL	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000507	input	Homo sapiens	NULL	NULL	783	chip_control	NULL	SaOS2 (osteosarcoma)	NULL
EXP000506	STAT1	Homo sapiens		NULL	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000835	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 6h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000834	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 1h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000837	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 48h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000836	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	Tamoxifen, 24h	NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000831	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 48h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000830	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 24h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000119	normal rabbit IgG	Mus musculus	NULL	NULL	5	chip_control	NULL	liver	NULL
EXP000116	Taf1 (L-20)	Mus musculus	NULL	NULL	44	unspecified	Q80UV9	T-cells	NULL
EXP000114	Ets1 (C-20) sc-350x	Mus musculus	NULL	NULL	44	unspecified	P27577	T-cells	NULL
EXP000839	Streptavidin (NanoLink Streptavidin Magnetic Microspheres (Vendor: SoluLink, cat# M1002-010, lot# LM041609))	Mus musculus	GW3965, 1h	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP000838	Biotin-tagged LXRb bound to NanoLink Streptavidin Magnetic Microspheres (Vendor: SoluLink, cat# M1002-010, lot# LM041609)	Mus musculus	GW3965, 1h	EXP000839	91	unspecified	Q60644	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP000057	ERa(HC20 Santa Cruz)	Homo sapiens	NULL	NULL	2301	unspecified	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP000056	Normal Rabbit Serum<Upstate#12-370>	Mus musculus	NULL	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP000055	STAT6<SantaCruz#sc981>	Mus musculus	STAT6 KO	EXP000056	499	unspecified	P52633	Th2-cells	NULL
EXP000054	STAT6<SantaCruz#sc981>	Mus musculus	NULL	EXP000056	499	unspecified	P52633	Th2-cells	NULL
EXP051004	STAT4<SantaCruz#sc486>	Mus musculus	STAT4 KO	NULL	76	unspecified	P42228	Th1-cells	NULL
EXP051003	STAT4<SantaCruz#sc486>	Mus musculus	NULL	NULL	76	unspecified	P42228	Th1-cells	NULL
EXP000051		Mus musculus	NULL	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP000865	CTCF (07-729), DAM1421463	Mus musculus	RAG1 KO	NULL	105	unspecified	Q61164	pro-B cells	NULL
EXP000058	ERa(HC20 Santa Cruz)	Homo sapiens	NULL	NULL	2301	unspecified	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP000206	IgG	Homo sapiens	NULL	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP000207	IgG	Homo sapiens	E2	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP000204	ER beta	Homo sapiens	NULL	EXP000206	848	unspecified	Q92731	U2OS (osteosarcoma)	NULL
EXP000205	ER beta	Homo sapiens	E2	EXP000207	848	unspecified	Q92731	U2OS (osteosarcoma)	NULL
EXP000202	E2F4	Homo sapiens	NULL	EXP000203	335	unspecified	Q16254	GM06990 (female B-cells)	NULL
EXP000203		Homo sapiens	NULL	NULL	335	chip_control	NULL	GM06990 (female B-cells)	NULL
EXP000949	TCF7L2	Homo sapiens	bio	EXP000960	65	unspecified	Q9NQB0	U937 (adult acute monocytic leukemia)	NULL
EXP000628	Rabbit IgG	Mus musculus	control KD	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000238	REST	Mus musculus	NULL	NULL	252	unspecified	Q8VIG1	V6.5 (embryonic stem cells)	NULL
EXP000200	ap2	Homo sapiens	NULL	EXP000201	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000629	Tet1 rabbit polyclonal antibodies	Mus musculus	Tet1 KD	EXP000628	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000233	sc-858	Homo sapiens	NULL	EXP000234	512	unspecified	P41182	JURL-MK1 (chronic myelogenous leukemia)	NULL
EXP000232	sc-8005	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000231	sc-8005	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000945	input	Homo sapiens	bmp	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000944	SMAD1	Homo sapiens	dorso	EXP000959	514	unspecified	Q15797	K562 (myelogenous leukemia)	NULL
EXP000345	sc-1008	Homo sapiens	calcitriol	EXP000342	340	unspecified	P11473	GM10855 (female B-cells)	NULL
EXP000234	input	Homo sapiens	NULL	NULL	512	chip_control	NULL	JURL-MK1 (chronic myelogenous leukemia)	NULL
EXP000602	HNF4	Homo sapiens	NULL	NULL	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP000603	GABP	Homo sapiens	NULL	NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	NULL
EXP000600	07-079	Homo sapiens	NULL	NULL	673	unspecified	P49711	normal epidermal keratinocytes	NULL
EXP000601	FOXA2	Homo sapiens	NULL	NULL	430	unspecified	Q9Y261	HepG2 (hepatoblastoma)	NULL
EXP000609	IMG-124A	Homo sapiens	NULL	NULL	93	unspecified	P62380	BJ (fibroblasts)	NULL
EXP000650	sc-816	Homo sapiens	ethanol	EXP030990	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP000785	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	1058	unspecified	P23772	CD4+ T-cells	NULL
EXP000784	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	140	unspecified	P23772	CD4- CD8- T cells	NULL
EXP000620	cFos - Cat# sc-7202, Santa Cruz	Homo sapiens	NULL	NULL	113	unspecified	P01100	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000938	input	Homo sapiens	NULL	NULL	459	chip_control	NULL	hematopoietic stem cells and progenitors	NULL
EXP000939	GATA1	Homo sapiens	bio	EXP000959	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP000288	ERalpha	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000289	ERalpha	Homo sapiens	Tamoxifen	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000286	input	Mus musculus	NULL	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP000287	ERalpha	Homo sapiens	NULL	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000284	FoxO1	Mus musculus	NULL	EXP000286	503	unspecified	Q9R1E0	pre-B cells	NULL
EXP000285	Pax5	Mus musculus	NULL	EXP000286	503	unspecified	Q02650	pre-B cells	NULL
EXP000282		Mus musculus	NULL	NULL	713	chip_control	NULL	pancreas	NULL
EXP000283	LRH-1	Mus musculus	NULL	EXP000282	713	unspecified	P45448	pancreas	NULL
EXP000280	Runx2 Flag tagged	Homo sapiens	NULL	EXP000281	129	unspecified	Q13950	LNCaP C4-2B (prostate carcinoma)	NULL
EXP000281	input	Homo sapiens	NULL	NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP000788	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	498	unspecified	P23772	Th17-cells	NULL
EXP000624	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	NULL	NULL	111	unspecified	P55317	T47D (invasive ductal carcinoma)	NULL
EXP000518	stat6	Homo sapiens	Act+IL-4 for 4hr	NULL	881	unspecified	P42226	CD4+ T-cells	NULL
EXP000625	Tet1 rabbit polyclonal antibodies	Mus musculus	wild-type	EXP000627	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000519	tcf4	Homo sapiens	NULL	EXP000522	188	unspecified	Q9NQB0	LS174T (colon adenocarcinoma)	NULL
EXP000626	Tet1 rabbit polyclonal antibodies	Mus musculus	control KD	EXP000628	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000309	Jun	Homo sapiens	NULL	NULL	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP000308	HNF4g	Homo sapiens	NULL	NULL	430	unspecified	Q14541	HepG2 (hepatoblastoma)	NULL
EXP000307	HNF4a AB domain	Homo sapiens	NULL	NULL	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP000306	HNF4a F domain	Homo sapiens	NULL	NULL	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP000305	input	Mus musculus	NULL	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP000304	KDM2A	Mus musculus	NULL	EXP000305	252	unspecified	P59997	V6.5 (embryonic stem cells)	NULL
EXP000303	CFP1 (Sc-25391 â€“ Santa Cruz)	Mus musculus	NULL	NULL	143	unspecified	Q9CWW7	brain	NULL
EXP000302	input	Homo sapiens	NULL	NULL	510	chip_control	NULL	Jurkat E6.1 (T-cells)	NULL
EXP000300	RUNX monoclonal from Nancy Speck	Homo sapiens	NULL	EXP000302	510	unspecified	Q01196	Jurkat E6.1 (T-cells)	NULL
EXP000736	anti-ERG	Homo sapiens	Treatment: none	NULL	66	normal	P11308	prostate cancer	NULL
EXP000737	anti-ERG	Homo sapiens	Treatment: none	NULL	66	normal	P11308	prostate cancer	NULL
EXP000734	anti-ERG	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP000735	anti-ERG	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P11308	LNCaP (prostate carcinoma)	NULL
EXP000732	anti-AR	Homo sapiens	Treatment: ethanol; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP000733	anti-AR	Homo sapiens	Treatment: R1881; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP000730	anti-AR	Homo sapiens	Treatment: ethanol; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP000731	anti-AR	Homo sapiens	Treatment: R1881; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP000738	anti-AR	Homo sapiens	Treatment: none	NULL	604	normal	P10275	metastatic prostate cancer tissue	NULL
EXP000739	anti-ERG	Homo sapiens	Treatment: none	NULL	604	normal	P11308	metastatic prostate cancer tissue	NULL
EXP000172	Jarid2	Mus musculus	NULL	EXP000176	543	unspecified	Q62315	LF2 (embryonic stem cells)	NULL
EXP000673	gata2	Homo sapiens	NULL	EXP000671	472	unspecified	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000672	cfos	Homo sapiens	NULL	EXP000671	472	unspecified	P01100	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000146		Homo sapiens	input sample	NULL	557	chip_control	NULL	LS180 (colon cancer)	NULL
EXP000671	input	Homo sapiens	NULL	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000517	stat6	Homo sapiens	Act for 4hr	NULL	881	unspecified	P42226	CD4+ T-cells	NULL
EXP000670	GATA3	Homo sapiens		NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP001018	input	Homo sapiens	NULL	NULL	297	chip_control	NULL	FB8470 (fibroblasts)	NULL
EXP001019	input	Homo sapiens	NULL	NULL	296	chip_control	NULL	FB0167P (progeria fibroblasts)	NULL
EXP001014	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	NULL
EXP001015	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	NULL
EXP001016	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	NULL
EXP001017	input	Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP001010	in-house polyclonal Ab against RXRa and RAR	Mus musculus	NULL	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP001011	in-house polyclonal Ab against RXRa	Mus musculus	NULL	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP001012	in-house polyclonal Ab against RXRa	Mus musculus	NULL	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP001013	ER-alpha	Homo sapiens	E2	NULL	386	unspecified	P03372	H3396 (breast carcinoma)	NULL
EXP000545	ab16509	Mus musculus	25ng/ml Activin	EXP000548	233	unspecified	Q62432	E14TG2A (embryonic stem cells)	NULL
EXP000428	input	Homo sapiens	NULL	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP000429	FLAG(Sigma, cat# F1804, lot# 080M6035)	Homo sapiens	NULL	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP000859	anti-V5 (Abcam, ab15828)	Mus musculus	NULL	EXP000860	60	unspecified	P09633	Ainv15 (embryonic stem cells)	NULL
EXP000543	input	Mus musculus	NULL	NULL	151	chip_control	NULL	CCE (embryonic stem cells)	NULL
EXP000542	Oct4	Mus musculus	NULL	EXP000543	151	unspecified	P20263	CCE (embryonic stem cells)	NULL
EXP000422	Smad1	Mus musculus	NULL	EXP000420	265	unspecified	P70340	G1E (embryonic stem cells)	NULL
EXP000423	Rabbit anti RBPJ	Homo sapiens	NULL	EXP000424	474	unspecified	Q06330	IB4 (lymphocytes)	NULL
EXP000420		Mus musculus	NULL	NULL	265	chip_control	NULL	G1E (embryonic stem cells)	NULL
EXP000674	ZNF143	Homo sapiens	NULL	EXP000675	199	unspecified	P52747	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP000549	input	Mus musculus	1/5000 DMSO	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP000548	input	Mus musculus	25ng/ml Activin	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP000424	input	Homo sapiens	NULL	NULL	474	chip_control	NULL	IB4 (lymphocytes)	NULL
EXP000425	input	Homo sapiens	NULL	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP000170	scl	Mus musculus	NULL	EXP000171	300	unspecified	P22091	fetal liver erythroblasts	NULL
EXP000171		Mus musculus	NULL	NULL	300	chip_control	NULL	fetal liver erythroblasts	NULL
EXP000855	SC-352	Mus musculus	NULL	EXP000847	15	unspecified	P17433	38B9 (A-MuLV pre-B-cells)	NULL
EXP000013	IgG (Millipore)	Mus musculus	NULL	NULL	285	chip_control	NULL	embryonic stem cell-drived neurons	NULL
EXP000012	CTCF	Mus musculus	NULL	EXP000011	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP000011	None	Mus musculus	NULL	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000854	MyoD	Mus musculus	day 5	NULL	580	unspecified	P10085	MC1R(20):tetMyod1(14) (embryonic stem cells)	NULL
EXP000017	Sox11 (M. Wegner)	Mus musculus	NULL	EXP000013	285	unspecified	Q7M6Y2	embryonic stem cell-drived neurons	NULL
EXP051002	Sox2 (Millipore)	Mus musculus	NULL	NULL	280	unspecified	P48432	embryonic stem cell-derived neural progenitors	NULL
EXP051001	Sox3 (T. Edlund)	Mus musculus	NULL	NULL	280	unspecified	P53784	embryonic stem cell-derived neural progenitors	NULL
EXP051000	Sox3 (T. Edlund)	Mus musculus	NULL	NULL	1153	unspecified	P53784	C2C12 (myoblasts)	NULL
EXP000019	NULL	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000018	sc-8628	Mus musculus	NULL	EXP000019	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP000547	ab16509	Mus musculus	10uM SB	EXP000550	233	unspecified	Q62432	E14TG2A (embryonic stem cells)	NULL
EXP000175	Jarid1a	Mus musculus	NULL	EXP000176	543	unspecified	Q3UXZ9	LF2 (embryonic stem cells)	NULL
EXP000295	MYC	Homo sapiens	NULL	NULL	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	NULL
EXP000546	ab16509	Mus musculus	1/5000 DMSO	EXP000549	233	unspecified	Q62432	E14TG2A (embryonic stem cells)	NULL
EXP000176	input	Mus musculus	NULL	NULL	543	chip_control	NULL	LF2 (embryonic stem cells)	NULL
EXP000294	KLF4	Homo sapiens	NULL	NULL	376	unspecified	O43474	WA01 (H1, human embryonic stem cells)	NULL
EXP000793	Fli1 (santa cruz, cat#sc356X, Lot#L0407)	Mus musculus	NULL	NULL	2479	unspecified	P26323	CD8+ T-cells	NULL
EXP000177	Estrogen Receptor (ER)	Homo sapiens	hormone starved for 3 days, treated with 1% ethanol for 45 minutes	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000297	OCT4	Homo sapiens	NULL	NULL	376	unspecified	Q01860	WA01 (H1, human embryonic stem cells)	NULL
EXP000884	sc-543	Homo sapiens	ETOH (ethanol)	EXP000892	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP000885	sc-543	Homo sapiens	E2	EXP000890	504	unspecified	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP000886	sc-543	Homo sapiens	E2	EXP000890	504	unspecified	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP000887	ER?	Homo sapiens	ETOH (ethanol)	EXP000891	239	unspecified	P03372	ECC-1 (endometrial adenocarcinoma)	NULL
EXP000880	TBP (Santa Cruz sc-204, LOT H0508)	Mus musculus		NULL	91	unspecified	P29037	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP000881	sc-543	Homo sapiens	ETOH (ethanol)	EXP000889	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000882	sc-543	Homo sapiens	E2	EXP000889	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000883	sc-543	Homo sapiens	ETOH (ethanol)	EXP000892	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP000291	GATA-1	Mus musculus	NULL	NULL	600	unspecified	P17679	SK-MEL-86 (melanoma)	NULL
EXP000888	sc-543	Homo sapiens	E2	EXP000891	239	unspecified	P03372	ECC-1 (endometrial adenocarcinoma)	NULL
EXP000889	input	Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000290	ERalpha	Homo sapiens	Fulvestrant	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000293	4A4 against p63	Homo sapiens	NULL	NULL	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP000292	H129 against p63	Homo sapiens	NULL	NULL	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP000074	anti p65	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000905	FOXA2	Mus musculus	NULL	EXP000906	5	unspecified	P35583	liver	NULL
EXP000826	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	PU.1 KO	NULL	190	unspecified	P17433	myeloid cells	NULL
EXP000868	E2A.E12(V-18) (sc-349)	Mus musculus	NULL	NULL	171	unspecified	P15806	CD4+ CD8+ T cells	NULL
EXP000869	ATRX H300 (Santa Cruz Biotechnology, batch G0105)	Homo sapiens	NULL	EXP000870	460	unspecified	P46100	primary erythroblasts	NULL
EXP000901	input	Homo sapiens	NULL	NULL	792	chip_control	NULL	Simpson Golabi Behmel Syndrome adipocytes	NULL
EXP000900	anti-NFYA	Mus musculus	NULL	NULL	828	unspecified	P23708	terminally differentiated neurons	NULL
EXP000648	input	Mus musculus	NULL	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP000122	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	NULL
EXP000426	ETV4(Aviva Systems Biology, cat# ARP32263, lot# QC1723)	Homo sapiens	NULL	EXP000425	725	unspecified	P43268	PC3(bone mets prostate adenocarcinoma)	NULL
EXP000644	input	Mus musculus	NULL	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP000642	PPARgamma	Mus musculus	day 2 of differentiation	EXP000644	19	unspecified	P37238	3T3-L1-derived preadipocytes	NULL
EXP000643	PPARgamma	Mus musculus	day 6 of differentiation	EXP000644	19	unspecified	P37238	3T3-L1-derived preadipocytes	NULL
EXP000864	FKHR (H-128) (sc-11350)	Mus musculus	RAG1 KO	NULL	105	unspecified	Q9R1E0	pro-B cells	NULL
EXP000427	JUND(Santa Cruz Biotechnology, cat# sc-74, lot# C0310)	Homo sapiens	NULL	NULL	725	unspecified	P17535	PC3(bone mets prostate adenocarcinoma)	NULL
EXP000167	input	Mus musculus	NULL	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP000166	ctcf	Mus musculus	NULL	EXP000167	252	unspecified	Q61164	V6.5 (embryonic stem cells)	NULL
EXP000165		Mus musculus	NULL	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP000164	GATA1	Mus musculus	NULL	EXP000165	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP000088	CTCF (Millipore 07-729)	Mus musculus	NULL	EXP000090	105	unspecified	Q61164	pro-B cells	NULL
EXP000160	input	Homo sapiens	NULL	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP000085	anti-Scl/Tal1	Mus musculus	NULL	EXP000087	549	unspecified	P22091	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP000086	anti-Gata2	Mus musculus	NULL	EXP000087	549	unspecified	O09100	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP000087	IgG	Mus musculus	NULL	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP000080	rabbit anti-YY1 polyclonal	Homo sapiens	NULL	EXP000081	881	unspecified	P25490	CD4+ T-cells	NULL
EXP000081	normal rabbit IgG	Homo sapiens	NULL	NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP000082	goat-anti-eGFP, raised against His-tagged full-length eGFP and affinity-purified with GST-tagged full-length eGFP	Mus musculus	NULL	EXP000083	763	unspecified	Q61164	R1/E (embryonic stem cells)	NULL
EXP000083	Goat IgG isotype control	Mus musculus	NULL	NULL	763	chip_control	NULL	R1/E (embryonic stem cells)	NULL
EXP000677	anti-CTCF (SantaCruz #15914)	Mus musculus	Dnmt1/3a/3b KO	EXP000676	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP000125	Bcl6 antibody N-3	Mus musculus	NULL	EXP000119	5	unspecified	P41183	liver	NULL
EXP000178	Estrogen Receptor (ER)	Homo sapiens	hormone starved for 3 days, treated with 10 nM Î²-estradiol for 45 minutes	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000124	Bcl6 antibody N-3	Mus musculus	NULL	EXP000119	5	unspecified	P41183	liver	NULL
EXP000159	nrsf	Homo sapiens	NULL	EXP000160	509	unspecified	Q13127	Jurkat (T-cells)	NULL
EXP000001	Input	Homo sapiens	NULL	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP000129	input	Homo sapiens	NULL	NULL	290	chip_control	NULL	EWS502 (Ewing sarcoma)	NULL
EXP000676	input	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000349	E2F4	Mus musculus	NULL	EXP000350	12	unspecified	Q8R0K9	MEF (mouse embryonic fibroblasts)	NULL
EXP000348	phospho-Stat3 (14-6727, ebiosciences, CA)	Mus musculus	IL-6, IL-23	NULL	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP000179	anti-HA	Mus musculus	NULL	EXP000180	2	unspecified	P45448	mESCs (mouse embryonic stem cells)	NULL
EXP000343	none	Homo sapiens	NULL	NULL	341	chip_control	NULL	GM10861 (female B-cells)	NULL
EXP000342	none	Homo sapiens	NULL	NULL	340	chip_control	NULL	GM10855 (female B-cells)	NULL
EXP000341	scl	Mus musculus	NULL	EXP000335	236	unspecified	P22091	embryonic stem cell-derived haematopoietic cells	NULL
EXP000340	runx1	Mus musculus	NULL	EXP000335	236	unspecified	Q03347	embryonic stem cell-derived haematopoietic cells	NULL
EXP000778	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	NULL
EXP000344	sc-1008	Homo sapiens		EXP000342	340	unspecified	P11473	GM10855 (female B-cells)	NULL
EXP000262	anti-SMAD1/5	Homo sapiens	50 ng/ml BMP-4	NULL	470	unspecified	Q99717	pulmonary arterial smooth muscle cells	NULL
EXP000264	ERalpha	Homo sapiens	NULL	EXP000265	848	unspecified	P03372	U2OS (osteosarcoma)	NULL
EXP000265	input	Homo sapiens	NULL	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP000266	Goat anti-GFP (kindly provided by Kevin P White, University of Chicago)	Mus musculus	NULL	EXP000267	53	unspecified	Q9ES03	heart	NULL
EXP000267	input	Mus musculus	NULL	NULL	53	chip_control	NULL	heart	NULL
EXP000268	HA tagged ZFP57	Mus musculus	NULL	NULL	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP000269	HA tagged ZFP57	Mus musculus	NULL	NULL	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP000533	PPARgamma	Mus musculus	NULL	NULL	732	unspecified	P37238	peritoneal macrophages	NULL
EXP000047	GR (Santa Cruz Biotechnologies, sc-1004; and Affinity BioReagents, PA1-511A)	Mus musculus	NULL	NULL	19	unspecified	P06537	3T3-L1-derived preadipocytes	NULL
EXP000675	input	Homo sapiens	NULL	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP000858	Smad3	Mus musculus	TGFÎ² 5 ng/ml for 2 hour	EXP000847	15	unspecified	Q8BUN5	38B9 (A-MuLV pre-B-cells)	NULL
EXP000776	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	NULL
EXP000777	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	NULL
EXP000581	sc-13030X	Homo sapiens	NULL	NULL	423	unspecified	P28324	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000580	rabbit anti TR4 (JD Engel lab)	Homo sapiens	NULL	NULL	423	unspecified	P49116	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000583	RUNX1	Homo sapiens		EXP000582	183	unspecified	Q01196	CMK (acute megakaryoblastic leukemia)	NULL
EXP000582		Homo sapiens		NULL	183	chip_control	NULL	CMK (acute megakaryoblastic leukemia)	NULL
EXP000585	RUNX1	Homo sapiens		EXP000584	514	unspecified	Q01196	K562 (myelogenous leukemia)	NULL
EXP000584		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000587	RUNX1	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	Q01196	K562 (myelogenous leukemia)	NULL
EXP000333	gata2	Mus musculus	NULL	EXP000335	236	unspecified	O09100	embryonic stem cell-derived haematopoietic cells	NULL
EXP000589	FOS	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	P01100	K562 (myelogenous leukemia)	NULL
EXP000588	GATA1	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP000936	input	Homo sapiens	NULL	NULL	743	chip_control	NULL	proerythroblasts	NULL
EXP000330		Mus musculus	NULL	NULL	25	chip_control	NULL	cerebellum	NULL
EXP000466	input	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000467	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ³ for 6 hour	EXP000468	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP000464	input	Mus musculus	IFNÎ² for 6 hour	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000465	anti-STAT1? (santa cruz: sc-417)	Mus musculus		EXP000466	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP000462	input	Mus musculus	IFNÎ³ for 6 hour	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000463	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ² for 6 hour	EXP000464	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP000460	input	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000461	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ³ for 6 hour	EXP000462	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP000747	RAR	Homo sapiens		NULL	851	unspecified	P10276	UPR9 (hematopoietic stem cells)	NULL
EXP000746	RXR	Homo sapiens		NULL	69	unspecified	P19793	acute promyelocytic leukemia blasts	NULL
EXP000745	RAR	Homo sapiens	24 hours ATRA	EXP000751	648	unspecified	P10276	NB4 (acute promyelocytic leukemia )	NULL
EXP000744	RXR	Homo sapiens	24 hours ATRA	EXP000751	648	unspecified	P19793	NB4 (acute promyelocytic leukemia )	NULL
EXP000743	RXR	Homo sapiens		NULL	69	unspecified	P19793	acute promyelocytic leukemia blasts	NULL
EXP000742	RAR	Homo sapiens		EXP000751	648	unspecified	P10276	NB4 (acute promyelocytic leukemia )	NULL
EXP000468	input	Mus musculus	IFNÎ³ for 6 hour	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000469	anti-STAT1? (santa cruz: sc-417)	Mus musculus	IFNÎ² for 6 hour	EXP000470	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP000251		Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000627	Rabbit IgG	Mus musculus	wild-type	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000334	gfi1b	Mus musculus	NULL	EXP000335	236	unspecified	O70237	embryonic stem cell-derived haematopoietic cells	NULL
EXP000335	IgG	Mus musculus	NULL	NULL	236	chip_control	NULL	embryonic stem cell-derived haematopoietic cells	NULL
EXP000725	anti-AR	Homo sapiens	Treatment: siRNA against ERG; Conditions: cells were hormone starved for 48 hours; Genotype: ERG knokdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP000688	polyclonal anti-RARg	Mus musculus	24hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	NULL
EXP000726	anti-ERG	Homo sapiens	Treatment: siRNA against ERG; Conditions: cells were hormone starved for 48 hours; Genotype: ERG knokdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP001025	CTCF	Homo sapiens	NULL	EXP001019	296	unspecified	P49711	FB0167P (progeria fibroblasts)	NULL
EXP001024	cMYC	Homo sapiens	NULL	EXP001018	297	unspecified	P01106	FB8470 (fibroblasts)	NULL
EXP001027	CTCF	Homo sapiens	NULL	EXP001020	391	unspecified	P49711	D54 (H54, Human glioblastoma)	NULL
EXP001026	cMYC	Homo sapiens	NULL	EXP001019	296	unspecified	P01106	FB0167P (progeria fibroblasts)	NULL
EXP001021	CTCF	Homo sapiens	NULL	EXP001017	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP001020	input	Homo sapiens	NULL	NULL	391	chip_control	NULL	D54 (H54, Human glioblastoma)	NULL
EXP001023	CTCF	Homo sapiens	NULL	EXP001018	297	unspecified	P49711	FB8470 (fibroblasts)	NULL
EXP001022	cMYC	Homo sapiens	NULL	EXP001017	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000512	NFI (H300): sc-5567, SantaCruz Biotechnology	Mus musculus	NFI-C KO	EXP000513	12	unspecified	P70255	MEF (mouse embryonic fibroblasts)	NULL
EXP000513		Mus musculus	NULL	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000510	DO1 against p53	Homo sapiens	NULL	EXP000507	783	unspecified	P04637	SaOS2 (osteosarcoma)	NULL
EXP000511	NFI (H300): sc-5567, SantaCruz Biotechnology	Mus musculus	NULL	EXP000513	12	unspecified	P70255	MEF (mouse embryonic fibroblasts)	NULL
EXP000516	stat6	Homo sapiens	Act+IL-4 for 1hr	NULL	881	unspecified	P42226	CD4+ T-cells	NULL
EXP001028	cMYC	Homo sapiens	NULL	EXP001020	391	unspecified	P01106	D54 (H54, Human glioblastoma)	NULL
EXP000514	stat6	Homo sapiens	NULL	NULL	881	unspecified	P42226	CD4+ T-cells	NULL
EXP000515	stat6	Homo sapiens	Act for 1hr	NULL	881	unspecified	P42226	CD4+ T-cells	NULL
EXP000494	PPARg	Mus musculus	Day 3 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000718	IgG	Mus musculus	Stat5 KO empty vector, Growth hormone	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000719	sc-835	Mus musculus	Stat5 overexpression	EXP000713	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	NULL
EXP000123	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	NULL
EXP000827	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000824	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	The cells were spin-infected with a retrovirus expressing truncated E2A (lacking both activation domains) fused to the estrogen receptor ligand binding domain, as well as hCD25 from a second cistron. After 16 h in culture, cells were treated with tamoxifen (1 ÂµM final concentration) for 6 h. Cells expressing hCD25 were then enriched magnetically (Miltenyi).	NULL	198	unspecified	P17433	pre-pro-B-cells	NULL
EXP000825	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	The cells were spin-infected with a retrovirus expressing full length E2A fused to the estrogen receptor ligand binding domain, as well as hCD25 from a second cistron. After 16 h in culture, cells were treated with tamoxifen (1 ÂµM final concentration) for 6 h. Cells expressing hCD25 were then enriched magnetically (Miltenyi).	NULL	198	unspecified	P17433	pre-pro-B-cells	NULL
EXP000822	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	EBF KO	NULL	198	unspecified	P17433	pre-pro-B-cells	NULL
EXP000823	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	RAG1 KO	NULL	105	unspecified	P17433	pro-B cells	NULL
EXP000820	input	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP000821	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	E2A KO	NULL	198	unspecified	P17433	pre-pro-B-cells	NULL
EXP000040		Mus musculus	NULL	NULL	21	chip_control	NULL	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP000041	SCBT, Cat# SC-7196X, Lot# A0380	Mus musculus	NULL	EXP000040	20	unspecified	P37238	3T3-L1-derived adipocytes	NULL
EXP000042	Call Signaling Technologies, Cat# 2443, Lot# 5/29/2007	Mus musculus	NULL	EXP000040	20	unspecified	P37238	3T3-L1-derived adipocytes	NULL
EXP000043	Upstate, Cat# 07-729, Lot# 1350637	Mus musculus	NULL	EXP000040	19	unspecified	Q61164	3T3-L1-derived preadipocytes	NULL
EXP000044	Upstate, Cat# 07-729, Lot# 1350637	Mus musculus	NULL	EXP000040	20	unspecified	Q61164	3T3-L1-derived adipocytes	NULL
EXP000045	CEBP? (Santa Cruz Biotechnologies, sc-150)	Mus musculus	NULL	EXP000048	18	unspecified	P28033	3T3-L1 (embryonic fibroblasts)	NULL
EXP000046	CEBP? (Santa Cruz Biotechnologies, sc-150)	Mus musculus	NULL	EXP000051	19	unspecified	P28033	3T3-L1-derived preadipocytes	NULL
EXP000829	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 6h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000495	PPARg	Mus musculus	Day 4 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000242	VDR	Homo sapiens	1Î±,25(OH)2D3	EXP000240	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP000121	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	NULL
EXP000241	VDR	Homo sapiens		EXP000240	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP000710	T-bet	Mus musculus	NULL	NULL	76	unspecified	Q9JKD8	Th1-cells	NULL
EXP000965	R&D Systems AF4248	Homo sapiens	NULL	EXP000966	396	unspecified	O75593	WA09 (embryonic stem cells)	NULL
EXP000712	IgG	Mus musculus	Growth hormone	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000120	STAT5 antibody C-17	Mus musculus	NULL	EXP000119	5	unspecified	P42230	liver	NULL
EXP000713	IgG	Mus musculus	Stat5 overexpression	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000387	STAT5B	Mus musculus	2 rounds priming	EXP000384	76	unspecified	P42232	Th1-cells	NULL
EXP000386	STAT5A	Mus musculus	2 rounds priming	EXP000384	76	unspecified	P42230	Th1-cells	NULL
EXP000385	STAT4	Mus musculus	2 rounds priming	EXP000384	76	unspecified	P42228	Th1-cells	NULL
EXP000959	input	Homo sapiens	bio	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000228	normal IgG (Santa Cruz sc-2028)	Homo sapiens	NULL	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP000381	anti-Flag	Mus musculus	NULL	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP000380	NFYB (Diagenode pAb-007-100, Lot TF-0010)	Homo sapiens	NULL	EXP000377	514	unspecified	P25208	K562 (myelogenous leukemia)	NULL
EXP000224	anti-GABP-alpha (sc-22810)	Homo sapiens	NULL	EXP000225	165	unspecified	Q06546	CD34+CD133+ hematopoietic progenitors	NULL
EXP000225	IgG	Homo sapiens	NULL	NULL	165	chip_control	NULL	CD34+CD133+ hematopoietic progenitors	NULL
EXP000226	anti-TAL1 Ab (Santa Cruz sc-12984)	Homo sapiens	NULL	EXP000228	509	unspecified	P17542	Jurkat (T-cells)	NULL
EXP000227	anti-TAL1 Ab (Santa Cruz sc-12984)	Homo sapiens	NULL	NULL	743	unspecified	P17542	proerythroblasts	NULL
EXP000220	anti-ETV1 (Abcam Ab81086, lot#787879)	Homo sapiens	NULL	EXP000219	331	unspecified	P50549	GIST48 (gastrointestinal stromal tumor)	NULL
EXP000954	input	Homo sapiens	bmp	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000223	IgG	Homo sapiens	NULL	NULL	552	chip_control	NULL	LN229 (glioblastoma)	NULL
EXP000637	C/EBPdelta	Mus musculus	day 0 of differentiation	EXP000644	19	unspecified	Q00322	3T3-L1-derived preadipocytes	NULL
EXP000636	C/EBPbeta	Mus musculus	day 2 of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	NULL
EXP000635	C/EBPbeta	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	NULL
EXP000634	C/EBPbeta	Mus musculus	2 hours of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	NULL
EXP000633	C/EBPbeta	Mus musculus	day 0 of differentiation	EXP000644	19	unspecified	P28033	3T3-L1-derived preadipocytes	NULL
EXP000632	CTCF	Mus musculus	NULL	NULL	578	unspecified	Q61164	mature B-cells	NULL
EXP000347	sc-1008	Homo sapiens	calcitriol	EXP000343	341	unspecified	P11473	GM10861 (female B-cells)	NULL
EXP000630	CTCF	Mus musculus	NULL	NULL	171	unspecified	Q61164	CD4+ CD8+ T cells	NULL
EXP000048		Mus musculus	NULL	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP000638	C/EBPdelta	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	Q00322	3T3-L1-derived preadipocytes	NULL
EXP000958	TCF7L2	Homo sapiens	bio	EXP000959	514	unspecified	Q9NQB0	K562 (myelogenous leukemia)	NULL
EXP000709	IgG	Mus musculus	E2F3 KO	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000384	IgG	Mus musculus	2 rounds priming	NULL	76	chip_control	NULL	Th1-cells	NULL
EXP000314	IgG	Mus musculus	NULL	NULL	141	chip_control	NULL	retina	NULL
EXP000315	Crx	Mus musculus	NULL	EXP000314	141	unspecified	O54751	retina	NULL
EXP000316	Crx	Mus musculus	Nrl KO	EXP000317	141	unspecified	O54751	retina	NULL
EXP000317	IgG	Mus musculus	Nrl KO	NULL	141	chip_control	NULL	retina	NULL
EXP000318	rabbit polyclonal to KLF1	Mus musculus	NULL	EXP000319	267	unspecified	P46099	erythroid cells	NULL
EXP000250	HIF-2 alpha	Homo sapiens	NULL	EXP000251	113	unspecified	Q99814	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000253		Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000252	HIF-1 beta	Homo sapiens	NULL	EXP000253	113	unspecified	P27540	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000952	CEBP	Homo sapiens	bmp	EXP000954	514	unspecified	P49715	K562 (myelogenous leukemia)	NULL
EXP000953	SMAD1	Homo sapiens	bmp	EXP000954	514	unspecified	Q15797	K562 (myelogenous leukemia)	NULL
EXP000950	input	Homo sapiens	bmp	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP000951	input	Homo sapiens	dmso	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP000956	GATA2	Homo sapiens	NULL	EXP000959	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP000222	Sox2 antibody (Abcam cat#ab59776)	Homo sapiens	NULL	EXP000223	552	unspecified	P48431	LN229 (glioblastoma)	NULL
EXP000388	STAT5A	Mus musculus		NULL	44	unspecified	P42230	T-cells	NULL
EXP000659	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000421	Gata1	Mus musculus	NULL	EXP000420	265	unspecified	P17679	G1E (embryonic stem cells)	NULL
EXP000556	sc-8977 (H-77)	Homo sapiens	estradiol	NULL	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000557	ab5089	Homo sapiens	ethanol	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000554	input	Homo sapiens	NULL	NULL	402	chip_control	NULL	pancreatic islets	NULL
EXP000555	sc-8977 (H-77)	Homo sapiens	ethanol	NULL	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000552	07-729  (Millipore)	Homo sapiens	NULL	EXP000554	402	unspecified	P49711	pancreatic islets	NULL
EXP000550	input	Mus musculus	10uM SB	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP000551	ab70303	Homo sapiens	NULL	EXP000554	402	unspecified	P49711	pancreatic islets	NULL
EXP000417		Mus musculus	NULL	NULL	265	chip_control	NULL	G1E (embryonic stem cells)	NULL
EXP000416	input	Homo sapiens		NULL	563	chip_control	NULL	LY-2 (invasive ductal carcinoma)	NULL
EXP000415	SRC1	Homo sapiens	tamoxifen	EXP000416	563	unspecified	Q15788	LY-2 (invasive ductal carcinoma)	NULL
EXP000414	sc-8995	Homo sapiens		EXP000416	563	unspecified	Q15788	LY-2 (invasive ductal carcinoma)	NULL
EXP000411	input	Homo sapiens	Treatment: AR stimulated with 1nM R1881 for 4 hours; Time point: 4 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP000410	input	Homo sapiens	Treatment: AR stimulated with 1nM R1881 for 4 hours; Time point: 4 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP000004	anti-GFP(ab290-050)	Homo sapiens	NULL	NULL	422	chip_control	NULL	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP000005	anti-GFP(ab290-050) GATAD1 tagged	Homo sapiens	NULL	EXP000004	422	unspecified	Q8WUU5	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP000828	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	Tamoxifen, 1h	NULL	759	unspecified	P17433	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000631	CTCF	Mus musculus	NULL	NULL	105	unspecified	Q61164	pro-B cells	NULL
EXP000002	Oct1	Homo sapiens	H2O2 1hr	EXP000001	78	unspecified	P14859	HeLa (cervical adenocarcinoma)	NULL
EXP000904	input	Homo sapiens	NULL	NULL	879	chip_control	NULL	liver	NULL
EXP000907	sc-7196X	Homo sapiens	NULL	EXP000901	792	unspecified	P37231	Simpson Golabi Behmel Syndrome adipocytes	NULL
EXP001003	input	Homo sapiens	NULL	NULL	94	chip_control	NULL	BL41(Burkitt lymphoma)	NULL
EXP000906	input	Mus musculus	NULL	NULL	5	chip_control	NULL	liver	NULL
EXP000929	GATA2	Homo sapiens	NULL	EXP000930	459	unspecified	P23769	hematopoietic stem cells and progenitors	NULL
EXP000779	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	NULL
EXP000903	FOXA2	Homo sapiens	NULL	EXP000904	879	unspecified	Q9Y261	liver	NULL
EXP000128	HA	Homo sapiens	NULL	EXP000129	290	unspecified	Q01543	EWS502 (Ewing sarcoma)	NULL
EXP000649	CTCF (Upstate, 07-729, Lot #DAM1421463)	Mus musculus	NULL	EXP000648	230	unspecified	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP000862	E2A.E12(V-18) (sc-349)	Mus musculus	RAG1 KO	NULL	105	unspecified	P15806	pro-B cells	NULL
EXP000639	GR	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P06537	3T3-L1-derived preadipocytes	NULL
EXP000647	CTCF (Upstate, 07-729, Lot #DAM1421463)	Mus musculus	NULL	EXP000648	230	unspecified	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP000860	input	Mus musculus	NULL	NULL	60	chip_control	NULL	Ainv15 (embryonic stem cells)	NULL
EXP000916	input	Homo sapiens	BRG1 KD shLuc control	NULL	168	chip_control	NULL	CD36+ erythroid cells	NULL
EXP000917	input	Homo sapiens	BRG1 RNAi KD	NULL	168	chip_control	NULL	CD36+ erythroid cells	NULL
EXP000914	ab-11852	Homo sapiens	BRG1 KD shLuc control	EXP000916	168	unspecified	P15976	CD36+ erythroid cells	NULL
EXP000915	input	Homo sapiens		NULL	166	chip_control	NULL	CD34+ hematopoietic stem cells	NULL
EXP000912	sc-12984	Homo sapiens	BRG1 KD shLuc control	EXP000916	168	unspecified	P17542	CD36+ erythroid cells	NULL
EXP000913	ab-11852	Homo sapiens	BRG1 RNAi KD	EXP000917	168	unspecified	P15976	CD36+ erythroid cells	NULL
EXP000910	07-729	Homo sapiens	BRG1 RNAi KD	EXP000917	168	unspecified	P49711	CD36+ erythroid cells	NULL
EXP000911	sc-12984	Homo sapiens	BRG1 RNAi KD	EXP000917	168	unspecified	P17542	CD36+ erythroid cells	NULL
EXP000857	Smad3	Mus musculus	TGFÎ² 2.5 ng/ml for 2 hour	EXP000848	1153	unspecified	Q8BUN5	C2C12 (myoblasts)	NULL
EXP000856	MyoD	Mus musculus	NULL	EXP000848	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP000679	polyclonal anti-RXRa	Mus musculus	48hr ethanol	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP000678	anti-CTCF (SantaCruz #15914)	Mus musculus	NULL	EXP000676	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP000853	Smad3	Mus musculus	+Myod1, day 5	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	NULL
EXP000852	Smad3	Mus musculus	-Myod1, day 5	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	NULL
EXP000851	Smad3	Mus musculus	Activin, +Myod1, day 2	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	NULL
EXP000850	Smad3	Mus musculus	Activin, -Myod1, day 2	NULL	580	unspecified	Q8BUN5	MC1R(20):tetMyod1(14) (embryonic stem cells)	NULL
EXP000071	anti p65	Homo sapiens	DMSO	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000070	anti p65	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000073	anti p65	Homo sapiens	TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000072	anti p65	Homo sapiens	TA	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000075	anti p65	Homo sapiens	DMSO	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000640	Stat5a	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P42230	3T3-L1-derived preadipocytes	NULL
EXP000077	anti GR	Homo sapiens	DMSO	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000076	anti p65	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000078	anti GR	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000641	RXR	Mus musculus	4 hours of differentiation	EXP000644	19	unspecified	P28700	3T3-L1-derived preadipocytes	NULL
EXP000535	PU.1	Mus musculus	NULL	NULL	732	unspecified	P17433	peritoneal macrophages	NULL
EXP000989	sc-764X	Homo sapiens	NULL	NULL	673	unspecified	P01106	normal epidermal keratinocytes	NULL
EXP000988	input	Homo sapiens	NULL	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000985	input	Homo sapiens	NULL	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP000984	input	Homo sapiens	NULL	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000987	input	Homo sapiens	NULL	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000986	sc-764X	Homo sapiens	NULL	EXP000987	472	unspecified	P01106	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000981	TAL1	Mus musculus	NULL	EXP000975	266	unspecified	P22091	erythroblasts	NULL
EXP000980	GATA1	Mus musculus	NULL	EXP000975	266	unspecified	P17679	erythroblasts	NULL
EXP000983	sc-764X	Homo sapiens	NULL	NULL	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	NULL
EXP000982	input	Homo sapiens	NULL	NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000431	GABPA(Santa Cruz Biotechnology, cat# sc-22810, lot# B2009)	Homo sapiens	NULL	NULL	781	unspecified	Q06546	RWPE1 (prostate epithelial cells)	NULL
EXP000658	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000430	ETS1(Santa Cruz Biotechnology, cat# sc-350, lot# E1010)	Homo sapiens	NULL	EXP000428	781	unspecified	P14921	RWPE1 (prostate epithelial cells)	NULL
EXP000433	FLAG(Sigma, cat# F1804, lot# 080M6035)	Homo sapiens	NULL	EXP000429	781	unspecified	P50549	RWPE1 (prostate epithelial cells)	NULL
EXP000432	FLAG(Sigma, cat# F1804, lot# 080M6035)	Homo sapiens	NULL	EXP000429	781	unspecified	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP000358	YY1	Mus musculus	NULL	NULL	280	unspecified	Q00899	embryonic stem cell-derived neural progenitors	NULL
EXP000359	FLAG and HA	Mus musculus	NULL	EXP000360	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	NULL
EXP000354	FLI1	Homo sapiens	NULL	EXP000356	598	unspecified	Q01543	megakaryocytes	NULL
EXP000355	SCL	Homo sapiens	NULL	EXP000356	598	unspecified	P17542	megakaryocytes	NULL
EXP000356	Rabbit-IgG	Homo sapiens	NULL	NULL	598	chip_control	NULL	megakaryocytes	NULL
EXP000357	YY1	Mus musculus	NULL	NULL	252	unspecified	Q00899	V6.5 (embryonic stem cells)	NULL
EXP000350	input	Mus musculus	NULL	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000351	GATA1	Homo sapiens	NULL	EXP000356	598	unspecified	P15976	megakaryocytes	NULL
EXP000352	GATA2	Homo sapiens	NULL	EXP000356	598	unspecified	P23769	megakaryocytes	NULL
EXP000353	RUNX1	Homo sapiens	NULL	EXP000356	598	unspecified	Q01196	megakaryocytes	NULL
EXP000215	IgG	Mus musculus	inactivated MYB	NULL	190	chip_control	NULL	myeloid cells	NULL
EXP000214	IgG	Mus musculus	activated MYB	NULL	190	chip_control	NULL	myeloid cells	NULL
EXP000217	ER Ab-10	Mus musculus	activated MYB	EXP000214	190	unspecified	P06876	myeloid cells	NULL
EXP000216	ER Ab-10	Mus musculus	inactivated MYB	EXP000215	190	unspecified	P06876	myeloid cells	NULL
EXP000211	anti-PU.1 (T-21) (sc-352)	Mus musculus	NULL	EXP000210	602	unspecified	P17433	erythroleukemic cells	NULL
EXP000210		Mus musculus	NULL	NULL	602	chip_control	NULL	erythroleukemic cells	NULL
EXP000212	anti-PU.1 (T-21) (sc-352)	Mus musculus	NULL	NULL	271	unspecified	P17433	embryonic stem cell-derived erythroid progenitors	NULL
EXP000436	Jun-D	Homo sapiens	NULL	NULL	356	unspecified	P17535	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000219	input	Homo sapiens	NULL	NULL	331	chip_control	NULL	GIST48 (gastrointestinal stromal tumor)	NULL
EXP000218	TBP 	Mus musculus	NULL	NULL	252	unspecified	P29037	V6.5 (embryonic stem cells)	NULL
EXP000383	FoxA2	Mus musculus	NULL	NULL	5	unspecified	P35583	liver	NULL
EXP000185	Jarid2	Mus musculus	Jarid2 depletion	NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP000184	Jarid2	Mus musculus	NULL	NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP000955	GATA1	Homo sapiens	NULL	EXP000959	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP000181	Srf	Mus musculus	NULL	NULL	437	unspecified	Q9JM73	HL-1 (cardiac muscle cells)	NULL
EXP000180	anti-HA	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000183	input	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000182	tbx3	Mus musculus	NULL	EXP000183	2	unspecified	P70324	mESCs (mouse embryonic stem cells)	NULL
EXP000567	IgG	Homo sapiens	NULL	NULL	603	chip_control	NULL	mesenchymal stem cells-derived adipocytes	NULL
EXP000832	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus	PU.1 KO	NULL	190	unspecified	P28033	myeloid cells	NULL
EXP000189	input	Mus musculus	NULL	NULL	15	chip_control	NULL	38B9 (A-MuLV pre-B-cells)	NULL
EXP000188	anti-EBF1b	Mus musculus	NULL	EXP000189	15	unspecified	Q07802	38B9 (A-MuLV pre-B-cells)	NULL
EXP000169		Mus musculus	NULL	NULL	300	chip_control	NULL	fetal liver erythroblasts	NULL
EXP000168	scl	Mus musculus	NULL	EXP000169	300	unspecified	P22091	fetal liver erythroblasts	NULL
EXP000329	?-p53-pS15 (Cell Signaling)	Homo sapiens	Etoposide	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP000328	?-p53-pS15 (Cell Signaling)	Homo sapiens	Actinomycin D	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP000459	anti-STAT1? (santa cruz: sc-417)	Mus musculus		EXP000460	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP000458	input	Homo sapiens	NULL	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP000596	07-079	Homo sapiens	NULL	NULL	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP000597	07-079	Homo sapiens	NULL	NULL	423	unspecified	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000595	IgG	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000321	sc-126, sc-372	Homo sapiens	NULL	NULL	884	unspecified	P04637	heart	NULL
EXP000320	sc-126, sc-372	Homo sapiens	NULL	NULL	884	unspecified	P04637	heart	NULL
EXP000323	Phospho-STAT3(Ser727)	Mus musculus	NULL	NULL	498	unspecified	P42227	Th17-cells	NULL
EXP000322	anti-EGR1 antibody (H-588, Santa Cruz Biotechnology)	Homo sapiens	PMA 10 ng/ml for 2 hr	NULL	514	unspecified	P18146	K562 (myelogenous leukemia)	NULL
EXP000325	DO1 (BD PharMingen)	Homo sapiens	Etoposide	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP000324	DO1 (BD PharMingen)	Homo sapiens	Actinomycin D	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP000327	?-p53-pS15 (Cell Signaling)	Homo sapiens	Etoposide	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP000326	?-p53-pS15 (Cell Signaling)	Homo sapiens	Actinomycin D	NULL	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP000750	RXR	Homo sapiens	5 hours zinc	NULL	851	unspecified	P19793	UPR9 (hematopoietic stem cells)	NULL
EXP000592	Tet1-C	Mus musculus	Tet1 KO	EXP000595	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000752	RAR sc-773	Mus musculus		EXP000754	406	unspecified	P11416	HBG3 (embryonic stem cells)	NULL
EXP000753	RAR sc-773	Mus musculus	retinoic acid	EXP000755	406	unspecified	P11416	HBG3 (embryonic stem cells)	NULL
EXP000754	input	Mus musculus		NULL	406	chip_control	NULL	HBG3 (embryonic stem cells)	NULL
EXP000755	input	Mus musculus	retinoic acid	NULL	406	chip_control	NULL	HBG3 (embryonic stem cells)	NULL
EXP000756	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000757	366	unspecified	Q04206	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000593	Tet1-N	Mus musculus	NULL	EXP000595	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000691	GR	Homo sapiens	NULL	EXP030492	70	unspecified	P04150	LNCaP (prostate carcinoma)	NULL
EXP000690	input	Mus musculus	NULL	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP000692	GR	Homo sapiens	siFoxA1	EXP030492	70	unspecified	P04150	LNCaP (prostate carcinoma)	NULL
EXP000695	AR	Homo sapiens	siFoxA1	EXP030492	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP000590	FOS	Homo sapiens	24 hours following induction with TPA	EXP000586	514	unspecified	P53539	K562 (myelogenous leukemia)	NULL
EXP000697	FoxA1	Homo sapiens	siFoxA1	EXP030492	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP000696	FoxA1	Homo sapiens	NULL	EXP030492	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP000408	AR	Homo sapiens	Treatment: vehicle; Time point: 4 hours	EXP000411	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP000591	Tet1-C	Mus musculus	NULL	EXP000595	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000409	AR	Homo sapiens	Treatment: AR stimulated with 1nM R1881 for 4 hours; Time point: 4 hours	EXP000411	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP000909	07-729	Homo sapiens	BRG1 KD shLuc control	EXP000916	168	unspecified	P49711	CD36+ erythroid cells	NULL
EXP000439	c-Myc	Homo sapiens	NULL	NULL	356	unspecified	P01106	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000741	RXR	Homo sapiens		EXP000751	648	unspecified	P19793	NB4 (acute promyelocytic leukemia )	NULL
EXP000453	CTCF	Homo sapiens	NULL	EXP000454	94	unspecified	P49711	BL41(Burkitt lymphoma)	NULL
EXP000452	Normal Rabbit IgG	Homo sapiens	NULL	NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP000908	07-729	Homo sapiens		EXP000915	166	unspecified	P49711	CD34+ hematopoietic stem cells	NULL
EXP000451	CTCF	Homo sapiens	NULL	EXP000452	92	unspecified	P49711	BJAB (Burkitt lymphoma)	NULL
EXP000438	Max	Homo sapiens	NULL	NULL	356	unspecified	P61244	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000919	sc-12984	Homo sapiens	CD34 WT	EXP000915	166	unspecified	P17542	CD34+ hematopoietic stem cells	NULL
EXP000450	IgG	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000863	EBF (H00001879-M01), 08344-1C2	Mus musculus	RAG1 KO	NULL	105	unspecified	Q07802	pro-B cells	NULL
EXP000529	SC-8332	Homo sapiens	D3	EXP000527	397	unspecified	Q15796	H9-derived endodermal progenitors	NULL
EXP000528	SC-8332	Homo sapiens	D0	EXP000527	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP000527	input	Homo sapiens	NULL	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP000457	sc-66870	Homo sapiens	NULL	EXP000458	78	unspecified	Q96AV8	HeLa (cervical adenocarcinoma)	NULL
EXP000524	GATA2	Homo sapiens	NULL	EXP000105	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP000523	GATA1	Homo sapiens	NULL	EXP000105	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP000522	input	Homo sapiens	NULL	NULL	188	chip_control	NULL	LS174T (colon adenocarcinoma)	NULL
EXP000521	tcf4	Homo sapiens	NULL	EXP000522	188	unspecified	Q9NQB0	LS174T (colon adenocarcinoma)	NULL
EXP000520	tcf4	Homo sapiens	NULL	EXP000522	188	unspecified	Q9NQB0	LS174T (colon adenocarcinoma)	NULL
EXP000026	anti-Tip60 Ab	Homo sapiens		EXP000028	881	unspecified	Q92993	CD4+ T-cells	NULL
EXP000455	sc126X [200mg/0.1ml]	Homo sapiens	NULL	EXP000456	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP000598	07-079	Homo sapiens	NULL	NULL	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000454	Normal Rabbit IgG	Homo sapiens	NULL	NULL	94	chip_control	NULL	BL41(Burkitt lymphoma)	NULL
EXP000134	VDR	Homo sapiens	vehicle control	EXP000146	557	unspecified	P11473	LS180 (colon cancer)	NULL
EXP000699	ERa	Homo sapiens	ethanol	EXP000700	386	unspecified	P03372	H3396 (breast carcinoma)	NULL
EXP000136	RXR	Homo sapiens	vehicle control	EXP000146	557	unspecified	P19793	LS180 (colon cancer)	NULL
EXP000137	RXR	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	P19793	LS180 (colon cancer)	NULL
EXP000039	NANOG	Homo sapiens	NULL	NULL	376	unspecified	Q9H9S0	WA01 (H1, human embryonic stem cells)	NULL
EXP000038	SOX2 	Homo sapiens	NULL	NULL	376	unspecified	P48431	WA01 (H1, human embryonic stem cells)	NULL
EXP000132	HA	Homo sapiens	NULL	EXP000133	472	unspecified	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000133	input	Homo sapiens	NULL	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000035	BCL6	Mus musculus		EXP000032	81	unspecified	P41183	BMDM (bone marrow-derived macrophages)	NULL
EXP000034	p65	Mus musculus		EXP000032	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP000037	BCL6	Mus musculus	3 hr LPS stimulated macrophages	EXP000032	81	unspecified	P41183	BMDM (bone marrow-derived macrophages)	NULL
EXP000036	p65	Mus musculus	3 hr LPS stimulated macrophages	EXP000032	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP000031	scl	Mus musculus	NULL	NULL	236	unspecified	P22091	embryonic stem cell-derived haematopoietic cells	NULL
EXP000032	IgG	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP000537	E2F1 	Homo sapiens	NULL	NULL	78	unspecified	Q01094	HeLa (cervical adenocarcinoma)	NULL
EXP000902	sc-7196X	Mus musculus	NULL	NULL	197	unspecified	P37238	adipocytes	NULL
EXP000599	07-079	Homo sapiens	NULL	NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP000861	E2A.E12(V-18) (sc-349)	Mus musculus	EBF KO	NULL	198	unspecified	P15806	pre-pro-B-cells	NULL
EXP000310	Fos	Homo sapiens	NULL	NULL	514	unspecified	P01100	K562 (myelogenous leukemia)	NULL
EXP000311	Myc	Homo sapiens	NULL	NULL	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP000757	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	366	chip_control	NULL	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000758	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000759	362	unspecified	Q04206	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000313	Jarid2	Mus musculus	NULL	NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP000759	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	362	chip_control	NULL	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000866	E2A.E12(V-18) (sc-349)	Mus musculus	E2A KO, 1h	NULL	198	unspecified	P15806	pre-pro-B-cells	NULL
EXP000783	rabbit IgG	Mus musculus	dextran	NULL	41	chip_control	NULL	B-cells	NULL
EXP000782	ASH2	Mus musculus	dextran	EXP000783	41	unspecified	O35885	B-cells	NULL
EXP000781	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	NULL
EXP000780	CTCF	Homo sapiens	NULL	NULL	566	unspecified	P49711	lymphoblastoid cells	NULL
EXP000787	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	76	unspecified	P23772	Th1-cells	NULL
EXP000786	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	2479	unspecified	P23772	CD8+ T-cells	NULL
EXP000969	ab28379	Homo sapiens	NULL	EXP000972	396	unspecified	P84022	WA09 (embryonic stem cells)	NULL
EXP000968	R&D Systems AF3797	Homo sapiens	NULL	EXP000972	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP000967	sc-8332	Homo sapiens	NULL	EXP000972	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP000966	input	Homo sapiens	NULL	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP000789	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	44	unspecified	P23772	T-cells	NULL
EXP000964	R&D Systems AF2097	Homo sapiens	NULL	EXP000966	396	unspecified	Q13485	WA09 (embryonic stem cells)	NULL
EXP000963	ab28379	Homo sapiens	NULL	EXP000966	396	unspecified	P84022	WA09 (embryonic stem cells)	NULL
EXP000962	R&D Systems AF3797	Homo sapiens	NULL	EXP000966	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP000961	sc-8332	Homo sapiens	NULL	EXP000966	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP000960	input	Homo sapiens	bio	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP000141	TCF4	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	Q9NQB0	LS180 (colon cancer)	NULL
EXP000140	TCF4	Homo sapiens	vehicle control	EXP000146	557	unspecified	Q9NQB0	LS180 (colon cancer)	NULL
EXP000143	CEBPb	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	P17676	LS180 (colon cancer)	NULL
EXP000142	CEBPb	Homo sapiens	vehicle control	EXP000146	557	unspecified	P17676	LS180 (colon cancer)	NULL
EXP000145	CDX2	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	Q99626	LS180 (colon cancer)	NULL
EXP000144	CDX2	Homo sapiens	vehicle control	EXP000146	557	unspecified	Q99626	LS180 (colon cancer)	NULL
EXP000147		Mus musculus	NULL	NULL	645	chip_control	NULL	myotubes	NULL
EXP000319	input	Mus musculus	NULL	NULL	267	chip_control	NULL	erythroid cells	NULL
EXP000149	SP1	Homo sapiens	NULL	NULL	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP000148	Sox6	Mus musculus	NULL	EXP000147	645	unspecified	P40645	myotubes	NULL
EXP000867	E2A.E12(V-18) (sc-349)	Mus musculus	E2A KO, 6h	NULL	198	unspecified	P15806	pre-pro-B-cells	NULL
EXP000701	GATA1 made in-house	Homo sapiens	NULL	EXP000702	460	unspecified	P15976	primary erythroblasts	NULL
EXP000700	input	Homo sapiens	estrogen	NULL	386	chip_control	NULL	H3396 (breast carcinoma)	NULL
EXP000365	normal mouse IgG	Homo sapiens	NULL	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP000707	E2F3	Mus musculus	E2F3 KO	EXP000709	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	NULL
EXP000706	E2F3	Mus musculus	NULL	EXP000708	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	NULL
EXP000819	Oct2 (Vendor: Santa Cruz, cat# sc-233)	Mus musculus		EXP000820	41	unspecified	Q00196	B-cells	NULL
EXP000818	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		EXP000820	41	unspecified	P17433	B-cells	NULL
EXP000705	ab9110	Mus musculus	NULL	NULL	642	chip_control	NULL	myeloblasts	NULL
EXP000813	Cell Signaling Technologies, Cat# 2443, Lot# 5/29/2007	Homo sapiens	time point 4	EXP000807	404	unspecified	P37231	hASC (preadipocytes)	NULL
EXP000812	SCBT, Cat# SC-7196X, Lot# A0380	Homo sapiens	time point 4	EXP000807	404	unspecified	P37231	hASC (preadipocytes)	NULL
EXP000811	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 4	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	NULL
EXP000810	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 3	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	NULL
EXP000817	input	Mus musculus		NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP000816	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus		EXP000817	732	unspecified	P28033	peritoneal macrophages	NULL
EXP000815	C/EBPa (Vendor: Santa Cruz, cat# sc-61, lot# D0108)	Mus musculus		EXP000817	732	unspecified	P53566	peritoneal macrophages	NULL
EXP000814	PU.1	Mus musculus		EXP000817	732	unspecified	P17433	peritoneal macrophages	NULL
EXP000497	RXR	Mus musculus	Day 0 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	NULL
EXP000496	PPARg	Mus musculus	Day 6 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000493	PPARg	Mus musculus	Day 2 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000492	PPARg	Mus musculus	Day 1 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000491	PPARg	Mus musculus	Day 0 of differentiation	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000490	input	Homo sapiens	IFN gamma	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000714	IgG	Mus musculus	Stat5 overexpression, Growth hormone	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000715	sc-835	Mus musculus	Stat5 KO, Growth hormone	EXP000716	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	NULL
EXP000716	IgG	Mus musculus	Stat5 KO, Growth hormone	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000717	sc-835	Mus musculus	Stat5 KO empty vector, Growth hormone	EXP000718	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	NULL
EXP000369	input	Homo sapiens	NULL	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP000711	sc-835	Mus musculus	Growth hormone	EXP000712	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	NULL
EXP000499	RXR	Mus musculus	Day 2 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	NULL
EXP000498	RXR	Mus musculus	Day 1 of differentiation	NULL	18	unspecified	P28700	3T3-L1 (embryonic fibroblasts)	NULL
EXP000895	CDX2	Mus musculus	NULL	EXP000896	496	unspecified	P43241	intestinal villus	NULL
EXP000398	STAT5B	Homo sapiens		NULL	882	unspecified	P51692	T-cells	NULL
EXP000399	STAT5B	Homo sapiens	IL-2	NULL	882	unspecified	P51692	T-cells	NULL
EXP000390	STAT5B	Mus musculus		NULL	44	unspecified	P42232	T-cells	NULL
EXP000391	STAT5B	Mus musculus	IL-2	NULL	44	unspecified	P42232	T-cells	NULL
EXP000392	STAT1	Homo sapiens		NULL	882	unspecified	P42224	T-cells	NULL
EXP000393	STAT1	Homo sapiens	IFNg	NULL	882	unspecified	P42224	T-cells	NULL
EXP000394	STAT4	Homo sapiens		NULL	882	unspecified	Q14765	T-cells	NULL
EXP000395	STAT4	Homo sapiens	IL-12	NULL	882	unspecified	Q14765	T-cells	NULL
EXP000396	STAT5A	Homo sapiens		NULL	882	unspecified	P42229	T-cells	NULL
EXP000397	STAT5A	Homo sapiens	IL-2	NULL	882	unspecified	P42229	T-cells	NULL
EXP000794	Fli1 (santa cruz, cat#sc356X, Lot#L0407)	Mus musculus	NULL	NULL	499	unspecified	P26323	Th2-cells	NULL
EXP000948	SMAD1	Homo sapiens	bmp	EXP000950	65	unspecified	Q15797	U937 (adult acute monocytic leukemia)	NULL
EXP000456	input	Homo sapiens	NULL	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP000563	input	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000560	ER	Homo sapiens		EXP000563	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000708	IgG	Mus musculus	NULL	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP000566	sc-9144X	Homo sapiens	NULL	EXP000567	603	unspecified	Q00613	mesenchymal stem cells-derived adipocytes	NULL
EXP000565	sc-9314X	Homo sapiens	NULL	EXP000567	603	unspecified	P49715	mesenchymal stem cells-derived adipocytes	NULL
EXP000564	sc-1082X	Homo sapiens	NULL	EXP000567	603	unspecified	Q16254	mesenchymal stem cells-derived adipocytes	NULL
EXP000769	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	364	chip_control	NULL	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP000768	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000769	364	unspecified	Q04206	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP000406	AR	Homo sapiens	Treatment: vehicle; Time point: 4 hours	EXP000410	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP000407	AR	Homo sapiens	Treatment: AR stimulated with 1nM R1881 for 4 hours; Time point: 4 hours	EXP000410	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP000761	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	365	chip_control	NULL	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000760	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000761	365	unspecified	Q04206	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000763	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	361	chip_control	NULL	GM15510 (B-cells)	NULL
EXP000762	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000763	361	unspecified	Q04206	GM15510 (B-cells)	NULL
EXP000765	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	358	chip_control	NULL	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP000764	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000765	358	unspecified	Q04206	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP000767	normal rabbit IgG	Homo sapiens	TNF-alpha induced (6h)	NULL	339	chip_control	NULL	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000766	NF?B p65 (C-20) rabbit polyclonal antibody	Homo sapiens	TNF-alpha induced (6h)	EXP000767	339	unspecified	Q04206	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP000941	GATA2	Homo sapiens	bio	EXP000959	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP000940	GATA1	Homo sapiens	bmp	EXP000945	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP000943	SMAD1	Homo sapiens	bmp	EXP000945	514	unspecified	Q15797	K562 (myelogenous leukemia)	NULL
EXP000796	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	2479	unspecified	P23772	CD8+ T-cells	NULL
EXP000942	GATA2	Homo sapiens	bmp	EXP000945	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP000681	polyclonal anti-RXRa	Mus musculus	6hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP000947	CEBPA	Homo sapiens	dmso	EXP000951	65	unspecified	P49715	U937 (adult acute monocytic leukemia)	NULL
EXP000795	Ets1 (santa cruz, cat#sc111X, Lot#G1905)	Mus musculus	NULL	NULL	499	unspecified	P27577	Th2-cells	NULL
EXP000946	CEBPA	Homo sapiens	bio	EXP000960	65	unspecified	P49715	U937 (adult acute monocytic leukemia)	NULL
EXP000797	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	171	unspecified	P23772	CD4+ CD8+ T cells	NULL
EXP000686	polyclonal anti-RARg	Mus musculus	2hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	NULL
EXP000201	non-specific IgG (Upstate)	Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000664	tet1	Mus musculus		EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000970	R&D Systems AF2097	Homo sapiens	NULL	EXP000972	396	unspecified	Q13485	WA09 (embryonic stem cells)	NULL
EXP000666	tet1	Mus musculus	tet1_mut2	EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000667	rabbit polyclonal antibody against mouse Tet1 (made in-house)	Mus musculus		EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000844	Oct4	Homo sapiens	NULL	EXP000849	89	unspecified	Q01860	BGO3 (embryonic stem cells)	NULL
EXP000845	Smad3	Homo sapiens	NULL	EXP000849	89	unspecified	P84022	BGO3 (embryonic stem cells)	NULL
EXP000662	input	Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000847	IgG	Mus musculus	NULL	NULL	15	chip_control	NULL	38B9 (A-MuLV pre-B-cells)	NULL
EXP000105	input	Homo sapiens	NULL	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000104		Homo sapiens	NULL	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP000107	rabbit anti-E2F6 (Santa Cruz Biotechnology, catalog# sc-22823x)	Homo sapiens	NULL	EXP000105	514	unspecified	O75461	K562 (myelogenous leukemia)	NULL
EXP000101	SMAD1/5	Homo sapiens	BMP-6	EXP001029	472	unspecified	Q15797	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000100	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	NULL
EXP000103	rabbit anti-ELK4 (SantaCruz, catalog # sc13030-X)	Homo sapiens	NULL	EXP000104	421	unspecified	P28324	HEK293 (embryonic kidney)	NULL
EXP000102	SMAD1/5	Homo sapiens	BMP-9	EXP001029	472	unspecified	Q15797	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP000062	input	Homo sapiens	NULL	NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP000063	anti GR	Homo sapiens	DMSO	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000061	custom made PRDM14	Homo sapiens	NULL	EXP000062	878	unspecified	Q9GZV8	embryonic stem cells	NULL
EXP000066	anti GR	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000067	anti GR	Homo sapiens	DMSO	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000064	anti GR	Homo sapiens	TA	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000065	anti GR	Homo sapiens	TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000790	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	44	unspecified	P23772	T-cells	NULL
EXP000068	anti GR	Homo sapiens	TA+TNFÎ±	NULL	78	unspecified	P04150	HeLa (cervical adenocarcinoma)	NULL
EXP000069	anti p65	Homo sapiens	DMSO	NULL	78	unspecified	Q04206	HeLa (cervical adenocarcinoma)	NULL
EXP000791	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	647	unspecified	P23772	natural killer T cells	NULL
EXP000833	C/EBPb (Vendor: Santa Cruz, cat# sc-150, lot# D0808)	Mus musculus		NULL	759	unspecified	P28033	PUER (PU.1-deficient myeloid progenitors)	NULL
EXP000878	HNF4A (Santa Cruz 8987 and Santa Cruz 6547)	Homo sapiens	differentiated cells	EXP000879	145	unspecified	P41235	Caco-2 (colon adenocarcinoma)	NULL
EXP000792	Fli1 (santa cruz, cat#sc356X, Lot#L0407)	Mus musculus	NULL	NULL	2479	unspecified	P26323	CD8+ T-cells	NULL
EXP000998	sc-764	Homo sapiens	NULL	EXP001003	94	unspecified	P01106	BL41(Burkitt lymphoma)	NULL
EXP000999	sc-764	Homo sapiens	NULL	EXP001004	768	unspecified	P01106	Ramos (Burkitt lymphoma)	NULL
EXP000996	sc-764	Homo sapiens	NULL	EXP001001	144	unspecified	P01106	CA-46 (Burkitt lymphoma)	NULL
EXP000997	sc-764	Homo sapiens	NULL	EXP001002	100	unspecified	P01106	Blue1 (sporadic Burkitt lymphoma)	NULL
EXP000994	sc-764X	Homo sapiens	NULL	EXP000988	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP000995	sc-764	Homo sapiens	NULL	EXP001000	767	unspecified	P01106	Raji (Burkitt lymphoma)	NULL
EXP000992	07-729	Homo sapiens	NULL	EXP000985	430	unspecified	P49711	HepG2 (hepatoblastoma)	NULL
EXP000993	sc-764X	Homo sapiens	NULL	EXP000985	430	unspecified	P01106	HepG2 (hepatoblastoma)	NULL
EXP000990	sc-764X	Homo sapiens	NULL	EXP000982	356	unspecified	P01106	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000991	sc-764X	Homo sapiens	NULL	EXP000984	423	unspecified	P01106	HeLa S3 (cervical adenocarcinoma)	NULL
EXP000871	ATRX H300 (Santa Cruz Biotechnology, batch G0105)	Mus musculus	NULL	EXP000872	230	unspecified	Q61687	ES-E14 (E14, embryonic stem cells)	NULL
EXP000703	ab9110	Mus musculus	NULL	EXP000705	642	unspecified	P25425	myeloblasts	NULL
EXP000654	ab5089	Homo sapiens	ethanol	EXP030990	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP000657	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000661	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000651	sc-816	Homo sapiens	DHT	EXP030990	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP000799	npas4	Mus musculus		EXP000805	159	unspecified	Q8BGD7	cortical neurons	NULL
EXP000611		Homo sapiens	NULL	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP000610	IMG-148A	Homo sapiens	NULL	EXP000611	93	unspecified	P62380	BJ (fibroblasts)	NULL
EXP000613	TAL1	Homo sapiens	NULL	EXP000612	154	unspecified	P17542	CD133+ umbilical cord blood cells	NULL
EXP000612	input	Homo sapiens	NULL	NULL	154	chip_control	NULL	CD133+ umbilical cord blood cells	NULL
EXP000615	IKZF1	Homo sapiens	NULL	EXP000612	154	unspecified	Q13422	CD133+ umbilical cord blood cells	NULL
EXP000614	Pu.1	Homo sapiens	NULL	EXP000612	154	unspecified	P17947	CD133+ umbilical cord blood cells	NULL
EXP000617	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	E2	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000616	MEIS1	Homo sapiens	NULL	EXP000612	154	unspecified	O00470	CD133+ umbilical cord blood cells	NULL
EXP000619	cFos - Cat# sc-7202, Santa Cruz	Homo sapiens	E2	NULL	113	unspecified	P01100	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000618	FOXA1 - Cat# AB4124, Chemicon	Homo sapiens	NULL	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000652	sc-15022	Homo sapiens	ethanol	EXP030990	70	unspecified	Q99801	LNCaP (prostate carcinoma)	NULL
EXP000208	IgG	Homo sapiens	NULL	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP000209	Oct4	Homo sapiens	NULL	EXP000208	396	unspecified	Q01860	WA09 (embryonic stem cells)	NULL
EXP000196	anti-ZNF711	Homo sapiens	NULL	NULL	664	unspecified	Q9Y462	SH-SY5Y (neuroblastoma)	NULL
EXP000346	sc-1008	Homo sapiens	NULL	EXP000343	341	unspecified	P11473	GM10861 (female B-cells)	NULL
EXP000194		Homo sapiens	NULL	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP000192	CTCF	Homo sapiens	NULL	EXP000194	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP000193		Homo sapiens	NULL	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP000190	OCT4	Homo sapiens	NULL	EXP000193	376	unspecified	Q01860	WA01 (H1, human embryonic stem cells)	NULL
EXP000191	NANOG	Homo sapiens	NULL	EXP000194	376	unspecified	Q9H9S0	WA01 (H1, human embryonic stem cells)	NULL
EXP000364	anti-PU.1	Homo sapiens	NULL	EXP000365	2334	unspecified	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP000928	AB32631	Mus musculus	NULL	NULL	252	unspecified	Q8C796	V6.5 (embryonic stem cells)	NULL
EXP000299	ETS1 sc355 from Santa Cruz Biotechnology	Homo sapiens	NULL	EXP000302	510	unspecified	P14921	Jurkat E6.1 (T-cells)	NULL
EXP000298	TAFII	Homo sapiens	NULL	NULL	376	unspecified	P21675	WA01 (H1, human embryonic stem cells)	NULL
EXP000382	anti-Flag	Mus musculus	NULL	EXP000381	1153	unspecified	P13297	C2C12 (myoblasts)	NULL
EXP000526	ZNF263	Homo sapiens	NULL	NULL	514	unspecified	O14978	K562 (myelogenous leukemia)	NULL
EXP000923	Santa Cruz N-20	Homo sapiens	DHT, siFoxA1	EXP000926	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP000921	Santa Cruz N-20	Homo sapiens	DHT	EXP000926	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP000927	Upstate 07-574	Mus musculus	NULL	NULL	252	unspecified	Q8VIG1	V6.5 (embryonic stem cells)	NULL
EXP000926	input	Homo sapiens	DHT	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP000925	ab5089	Homo sapiens	DHT	EXP000926	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP000924	ab5089	Homo sapiens	vehicle	EXP000926	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP000840	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP000665	tet1	Mus musculus	tet1_mut1	EXP000668	2	unspecified	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP000751		Homo sapiens		NULL	648	chip_control	NULL	NB4 (acute promyelocytic leukemia )	NULL
EXP000842	Smad3	Mus musculus	NULL	NULL	252	unspecified	Q8BUN5	V6.5 (embryonic stem cells)	NULL
EXP000332	Fli1	Mus musculus	NULL	EXP000335	236	unspecified	P26323	embryonic stem cell-derived haematopoietic cells	NULL
EXP000338	meis1	Mus musculus	NULL	EXP000335	236	unspecified	P25425	embryonic stem cell-derived haematopoietic cells	NULL
EXP000339	pu.1	Mus musculus	NULL	EXP000335	236	unspecified	P17433	embryonic stem cell-derived haematopoietic cells	NULL
EXP000448	IgG	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000449	ab62126	Mus musculus	NULL	EXP000450	2	unspecified	P29037	mESCs (mouse embryonic stem cells)	NULL
EXP000444	FOXP1	Homo sapiens	NULL	EXP000443	396	unspecified	Q9H334	WA09 (embryonic stem cells)	NULL
EXP010000	2899	Homo sapiens		EXP010929	430	unspecified	P49711	HepG2 (hepatoblastoma)	NULL
EXP000447	anti-TAF1	Mus musculus	NULL	EXP000448	2	unspecified	Q80UV9	mESCs (mouse embryonic stem cells)	NULL
EXP000440	sc-349x	Mus musculus		EXP000442	44	unspecified	P15806	T-cells	NULL
EXP000441	sc-349x	Mus musculus	anti-CD3e Ab injection	EXP000442	44	unspecified	P15806	T-cells	NULL
EXP000442		Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP000443		Homo sapiens	NULL	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP000621	cJun - Cat# sc-45, Santa Cruz	Homo sapiens	E2	NULL	113	unspecified	P05412	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000724	anti-ERG	Homo sapiens	Treatment: non-silencing control siRNA; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP000727	anti-AR	Homo sapiens	Treatment: None	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP000689	polyclonal anti-RARg	Mus musculus	48hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	NULL
EXP000721	anti-FoxA1	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP000720	sc-835	Mus musculus	Stat5 overexpression, Growth hormone	EXP000714	12	unspecified	P42230	MEF (mouse embryonic fibroblasts)	NULL
EXP000723	anti-AR	Homo sapiens	Treatment: non-silencing control siRNA; Conditions: cells were hormone starved for 48 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP000722	anti-FoxA1	Homo sapiens	Treatment: regular medium; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP000682	polyclonal anti-RXRa	Mus musculus	24hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP000683	polyclonal anti-RXRa	Mus musculus	48hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP000680	polyclonal anti-RXRa	Mus musculus	2hr ATRA	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP000663	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000729	anti-AR	Homo sapiens	Treatment: 1nm R1881; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP000728	anti-AR	Homo sapiens	Treatment: 10nm R1881; Conditions: cells were hormone starved for 48 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP000684	polyclonal anti-RXRa	Mus musculus	48hr ATRA, RXRa KO	EXP000690	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP000685	polyclonal anti-RARg	Mus musculus	48hr ethanol	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	NULL
EXP000848	IgG	Mus musculus	NULL	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP000849	input	Homo sapiens	NULL	NULL	89	chip_control	NULL	BGO3 (embryonic stem cells)	NULL
EXP000668	input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000586		Homo sapiens	24 hours following induction with TPA	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP000669	GATA3	Homo sapiens	estradiol (E2)	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000934	SMAD1	Homo sapiens	NULL	EXP000930	459	unspecified	Q15797	hematopoietic stem cells and progenitors	NULL
EXP001009	anti-V5 (Abcam, ab15828)	Mus musculus		NULL	60	chip_control	NULL	Ainv15 (embryonic stem cells)	NULL
EXP001008	anti-Flag (Sigma, F1804-200UG)	Mus musculus	+Dox	EXP001009	60	unspecified	P09633	Ainv15 (embryonic stem cells)	NULL
EXP000029	anti Tip60 Ab	Homo sapiens		EXP000027	881	unspecified	Q92993	CD4+ T-cells	NULL
EXP000935	TCF7L2	Homo sapiens	NULL	EXP000938	459	unspecified	Q9NQB0	hematopoietic stem cells and progenitors	NULL
EXP000841	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus	LXRD KO	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP001002	input	Homo sapiens	NULL	NULL	100	chip_control	NULL	Blue1 (sporadic Burkitt lymphoma)	NULL
EXP001001	input	Homo sapiens	NULL	NULL	144	chip_control	NULL	CA-46 (Burkitt lymphoma)	NULL
EXP001000	input	Homo sapiens	NULL	NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP001007	anti-V5 (Abcam, ab15828)	Mus musculus	+Dox	EXP001009	60	unspecified	P09633	Ainv15 (embryonic stem cells)	NULL
EXP001006	anti-V5 (Abcam, ab15828)	Mus musculus	+Dox	EXP001009	60	unspecified	Q9EQW6	Ainv15 (embryonic stem cells)	NULL
EXP001005	Olig2 (Millipore, ab9610)	Mus musculus		EXP001009	60	unspecified	Q9EQW6	Ainv15 (embryonic stem cells)	NULL
EXP001004	input	Homo sapiens	NULL	NULL	768	chip_control	NULL	Ramos (Burkitt lymphoma)	NULL
EXP000937	input	Homo sapiens	NULL	NULL	743	chip_control	NULL	proerythroblasts	NULL
EXP000534	PPARgamma	Mus musculus	NULL	NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP000419	Smad1	Mus musculus	NULL	EXP000417	265	unspecified	P70340	G1E (embryonic stem cells)	NULL
EXP000536	C/EBPbeta	Mus musculus	NULL	NULL	732	unspecified	P28033	peritoneal macrophages	NULL
EXP000702	input	Homo sapiens	NULL	NULL	460	chip_control	NULL	primary erythroblasts	NULL
EXP000331	Sigma F9291	Mus musculus	NULL	EXP000330	25	unspecified	P48985	cerebellum	NULL
EXP000930	input	Homo sapiens	NULL	NULL	459	chip_control	NULL	hematopoietic stem cells and progenitors	NULL
EXP000360	FLAG and HA	Mus musculus	NULL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP000418	Gata2	Mus musculus	NULL	EXP000417	265	unspecified	O09100	G1E (embryonic stem cells)	NULL
EXP000435	MafA (Abcam ab17976 lot 950583)	Mus musculus	NULL	NULL	898	unspecified	Q8CF90	pancreatic islets	NULL
EXP000434	NeuroD1 (Santa Cruz sc-1084 X lot H1709)	Mus musculus	NULL	NULL	898	unspecified	Q60867	pancreatic islets	NULL
EXP000437	c-Fos	Homo sapiens	NULL	NULL	356	unspecified	P01100	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP000931	GATA1	Homo sapiens	NULL	EXP000936	743	unspecified	P15976	proerythroblasts	NULL
EXP000655	ab5089	Homo sapiens	DHT	EXP030990	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP000932	GATA1	Homo sapiens	NULL	EXP000937	743	unspecified	P15976	proerythroblasts	NULL
EXP000933	SMAD1	Homo sapiens	NULL	EXP000937	743	unspecified	Q15797	proerythroblasts	NULL
EXP000704	ab9110	Mus musculus	NULL	EXP000705	642	unspecified	P09631	myeloblasts	NULL
EXP000028	Rabbit IgG	Homo sapiens		NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP000135	VDR	Homo sapiens	1,25(OH)2D3	EXP000146	557	unspecified	P11473	LS180 (colon cancer)	NULL
EXP000363	anti-pan-RXR	Homo sapiens	NULL	EXP000365	2334	unspecified	P19793	THP-1 (acute monocytic leukemia)	NULL
EXP000027	Goat IgG	Homo sapiens		NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP000698	Santa Cruz HC20	Homo sapiens	estrogen	EXP000700	386	unspecified	P03372	H3396 (breast carcinoma)	NULL
EXP000022	sc-8635	Mus musculus	NULL	EXP000019	2	unspecified	Q9Z1J1	mESCs (mouse embryonic stem cells)	NULL
EXP000020	AF2018	Mus musculus	NULL	EXP000019	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP000021	bl1662	Mus musculus	NULL	EXP000019	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP000870	input	Homo sapiens	NULL	NULL	460	chip_control	NULL	primary erythroblasts	NULL
EXP000687	polyclonal anti-RARg	Mus musculus	6hr ATRA	EXP000690	292	unspecified	P28705	F9 (embryonal carcinoma)	NULL
EXP000843	Smad3	Mus musculus	Activin	NULL	252	unspecified	Q8BUN5	V6.5 (embryonic stem cells)	NULL
EXP000558	anti-FoxA1	Homo sapiens	estradiol	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000559	ER	Homo sapiens	Estrogen	EXP000563	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000893	Rfx1	Mus musculus	NULL	NULL	138	unspecified	P48377	neural progenitors	NULL
EXP000892	input	Homo sapiens	NULL	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP000891	input	Homo sapiens	NULL	NULL	239	chip_control	NULL	ECC-1 (endometrial adenocarcinoma)	NULL
EXP000890	input	Homo sapiens	NULL	NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP000337	lyl1	Mus musculus	NULL	EXP000335	236	unspecified	P27792	embryonic stem cell-derived haematopoietic cells	NULL
EXP000896	input	Mus musculus	NULL	NULL	496	chip_control	NULL	intestinal villus	NULL
EXP000362	anti-PPARg	Homo sapiens	NULL	EXP000365	2334	unspecified	P37231	THP-1 (acute monocytic leukemia)	NULL
EXP000899	anti-NFYA	Mus musculus	NULL	NULL	138	unspecified	P23708	neural progenitors	NULL
EXP000898	anti-NFYA	Mus musculus	NULL	EXP000897	2	unspecified	P23708	mESCs (mouse embryonic stem cells)	NULL
EXP000249	HIF-1 alpha	Homo sapiens	NULL	EXP000251	113	unspecified	Q16665	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000660	mouse anti-HA (Covance, catalog # MMS-101P)	Homo sapiens	NULL	EXP000662	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000622	cJun - Cat# sc-45, Santa Cruz	Homo sapiens	NULL	NULL	113	unspecified	P05412	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000879	input	Homo sapiens	differentiated cells	NULL	145	chip_control	NULL	Caco-2 (colon adenocarcinoma)	NULL
EXP000971	R&D Systems AF4248	Homo sapiens	NULL	EXP000972	396	unspecified	O75593	WA09 (embryonic stem cells)	NULL
EXP000972	input	Homo sapiens	NULL	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP000973	input	Mus musculus	NULL	NULL	265	chip_control	NULL	G1E (embryonic stem cells)	NULL
EXP000974	GATA1	Mus musculus	E2	NULL	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP000975	input	Mus musculus	NULL	NULL	266	chip_control	NULL	erythroblasts	NULL
EXP000976	TAL1	Mus musculus	NULL	EXP000973	265	unspecified	P22091	G1E (embryonic stem cells)	NULL
EXP000977	GATA2	Mus musculus	NULL	EXP000973	265	unspecified	O09100	G1E (embryonic stem cells)	NULL
EXP000978	GATA2	Mus musculus	E2	NULL	319	unspecified	O09100	G1E-ER4 (embryonic stem cells)	NULL
EXP000979	TAL1	Mus musculus	E2	NULL	319	unspecified	P22091	G1E-ER4 (embryonic stem cells)	NULL
EXP000873	CDX2 (Bethyl Labs BL3194)	Homo sapiens	proliferating cells	EXP000879	145	unspecified	Q99626	Caco-2 (colon adenocarcinoma)	NULL
EXP000872	input	Mus musculus	NULL	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP000798	anti-Gata3 (558686, BD bioscience)	Mus musculus	NULL	NULL	499	unspecified	P23772	Th2-cells	NULL
EXP000874	CDX2 (Bethyl Labs BL3194)	Homo sapiens	differentiated cells	EXP000879	145	unspecified	Q99626	Caco-2 (colon adenocarcinoma)	NULL
EXP000877	HNF4A (Santa Cruz 8987 and Santa Cruz 6547)	Homo sapiens	proliferating cells	EXP000879	145	unspecified	P41235	Caco-2 (colon adenocarcinoma)	NULL
EXP000876	GATA6 (Santa Cruz 7244 and Santa Cruz 9055)	Homo sapiens	differentiated cells	EXP000879	145	unspecified	Q92908	Caco-2 (colon adenocarcinoma)	NULL
EXP000661	input	Homo sapiens	NULL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP000099	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	NULL
EXP000098	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	NULL
EXP000092	mixture of STAT5a (PA-ST5A: R&D) and STAT5b (PA-ST5B: R&D) antibodies, 2 ul each per IP	Mus musculus	NULL	NULL	498	unspecified	P42230	Th17-cells	NULL
EXP000091	5 ug of STAT3 (14-6727: eBioScience) per IP	Mus musculus	NULL	NULL	498	unspecified	P42227	Th17-cells	NULL
EXP000090	input	Mus musculus	NULL	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP000097	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	NULL
EXP000096	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	NULL
EXP000095	BMAL1	Mus musculus	NULL	EXP000094	5	unspecified	Q9WTL8	liver	NULL
EXP000094	input	Mus musculus	NULL	NULL	5	chip_control	NULL	liver	NULL
EXP000749	RXR	Homo sapiens		NULL	851	unspecified	P19793	UPR9 (hematopoietic stem cells)	NULL
EXP000748	RAR	Homo sapiens	5 hours zinc	NULL	851	unspecified	P10276	UPR9 (hematopoietic stem cells)	NULL
EXP000875	GATA6 (Santa Cruz 7244 and Santa Cruz 9055)	Homo sapiens	proliferating cells	EXP000879	145	unspecified	Q92908	Caco-2 (colon adenocarcinoma)	NULL
EXP000846	Smad2/3	Mus musculus	Activin	NULL	252	unspecified	Q62432	V6.5 (embryonic stem cells)	NULL
EXP000808	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 1	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	NULL
EXP000809	Upstate, Cat# 07-729, Lot# 1350637	Homo sapiens	time point 2	EXP000807	404	unspecified	P49711	hASC (preadipocytes)	NULL
EXP000804	H300 (Sc-13029)	Mus musculus	KCL	EXP000806	159	unspecified	Q9JM73	cortical neurons	NULL
EXP000805	input	Mus musculus		NULL	159	chip_control	NULL	cortical neurons	NULL
EXP000806	input	Mus musculus	KCL	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP000807	input	Homo sapiens	NULL	NULL	404	chip_control	NULL	hASC (preadipocytes)	NULL
EXP000800	npas4	Mus musculus	KCL	EXP000806	159	unspecified	Q8BGD7	cortical neurons	NULL
EXP000801	Santa Cruz (Sc-186)	Mus musculus		EXP000806	159	unspecified	Q01147	cortical neurons	NULL
EXP000802	Santa Cruz (Sc-186)	Mus musculus	KCL	EXP000806	159	unspecified	Q01147	cortical neurons	NULL
EXP000803	H300 (Sc-13029)	Mus musculus		EXP000805	159	unspecified	Q9JM73	cortical neurons	NULL
EXP010001	sc-33759	Homo sapiens		EXP010428	376	unspecified	Q9H9S0	WA01 (H1, human embryonic stem cells)	NULL
EXP010002	NRSF	Homo sapiens		EXP010120	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010003	sc-7874	Mus musculus		EXP010644	1174	unspecified	P06876	MEL cell line	NULL
EXP010004	2899	Homo sapiens		EXP010053	353	unspecified	P49711	GM12873 (female B-cells)	NULL
EXP054028	Input	Homo sapiens	Treatment: None;	NULL	2607	chip_control	NULL	NHDF-Ad (adult dermal fibroblasts)	NULL
EXP010006		Mus musculus		NULL	912	chip_control	NULL	megakaryocytes	NULL
EXP010007		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010008	H00010127-A01	Homo sapiens		EXP010287	421	unspecified	O14978	HEK293 (embryonic kidney)	NULL
EXP010009	NB100-1800	Mus musculus		EXP010613	1144	unspecified	O35185	CH12.LX (Mouse lymphoma)	NULL
EXP010010	sc-357	Homo sapiens		EXP010538	430	unspecified	Q99081	HepG2 (hepatoblastoma)	NULL
EXP010011	sc-357	Homo sapiens		EXP010539	430	unspecified	Q99081	HepG2 (hepatoblastoma)	NULL
EXP010012	sc-268	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	unspecified	P23771	T47D (invasive ductal carcinoma)	NULL
EXP010013	sc-229	Homo sapiens		EXP010726	430	unspecified	P22415	HepG2 (hepatoblastoma)	NULL
EXP010014	sc-12984	Mus musculus		EXP010710	265	unspecified	P22091	G1E (embryonic stem cells)	NULL
EXP010017		Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010018	sc-8983	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	unspecified	P22415	SK-N-SH (neuroblastoma)	NULL
EXP010019	sc-866	Mus musculus		EXP010644	1174	unspecified	Q8R0K9	MEL cell line	NULL
EXP010020	H00010127-A01	Homo sapiens		EXP010823	514	unspecified	O14978	K562 (myelogenous leukemia)	NULL
EXP010021	sc-188	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P18847	A549 (lung carcinoma)	NULL
EXP010022	sc-28312	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q06546	A549 (lung carcinoma)	NULL
EXP010023		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010024	sc-183	Homo sapiens		EXP010428	376	unspecified	P15407	WA01 (H1, human embryonic stem cells)	NULL
EXP010025	sc-735	Homo sapiens		EXP010318	376	unspecified	P21675	WA01 (H1, human embryonic stem cells)	NULL
EXP010026	2899	Homo sapiens		EXP010827	408	unspecified	P49711	HBMEC (human brain microvascular endothelial cells)	NULL
EXP010027		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010028	sc-17824	Homo sapiens		EXP010375	356	unspecified	P08047	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010029	sc-1694	Homo sapiens		EXP010255	430	unspecified	P05412	HepG2 (hepatoblastoma)	NULL
EXP010030		Homo sapiens		NULL	648	chip_control	NULL	NB4 (acute promyelocytic leukemia )	NULL
EXP010031	ab60931	Mus musculus		EXP010265	1174	unspecified	Q64705	MEL cell line	NULL
EXP010032	sc-477	Homo sapiens		EXP010255	430	unspecified	O60675	HepG2 (hepatoblastoma)	NULL
EXP010033	sc-553	Homo sapiens		EXP010726	430	unspecified	P19793	HepG2 (hepatoblastoma)	NULL
EXP010035	sc-764	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010036	sc-22805	Homo sapiens		EXP010141	357	unspecified	P17947	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010037	sc-185	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P20749	A549 (lung carcinoma)	NULL
EXP010038	ab50322	Homo sapiens		EXP010530	514	unspecified	O60675	K562 (myelogenous leukemia)	NULL
EXP010039		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010040	sc-1694	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP010041	sc-6556	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP010042	sc-269	Homo sapiens		EXP010619	664	unspecified	P23771	SH-SY5Y (neuroblastoma)	NULL
EXP010043	2899	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010815	665	unspecified	P49711	SK-N-SH (neuroblastoma)	NULL
EXP010044	sc-12732	Mus musculus		EXP010882	1153	unspecified	P12979	C2C12 (myoblasts)	NULL
EXP010045	M8194	Homo sapiens		EXP010530	514	unspecified	Q9ULX9	K562 (myelogenous leukemia)	NULL
EXP010046	2899	Homo sapiens		EXP010744	354	unspecified	P49711	GM12874 (male B-cells)	NULL
EXP010047	GATA-1	Homo sapiens		EXP010823	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP010049	sc-28312	Homo sapiens		EXP010671	514	unspecified	Q06546	K562 (myelogenous leukemia)	NULL
EXP010051		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010052		Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP010054	sc-2027	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010056	sc-150	Homo sapiens		EXP010530	514	unspecified	P17676	K562 (myelogenous leukemia)	NULL
EXP010057	AF4185	Homo sapiens		EXP010530	514	unspecified	P50539	K562 (myelogenous leukemia)	NULL
EXP010058	sc-7202	Homo sapiens	(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	NULL
EXP010059		Mus musculus		NULL	1174	chip_control	NULL	MEL cell line	NULL
EXP010060		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010062		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010063	sc-631	Homo sapiens		EXP010489	430	unspecified	P32519	HepG2 (hepatoblastoma)	NULL
EXP010064	sc-197	Homo sapiens		EXP010027	423	unspecified	P61244	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010065	HPA006672	Homo sapiens		EXP010054	423	unspecified	P17029	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010066	sc-2027	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP010067	ab55744	Homo sapiens		EXP010714	376	unspecified	Q16656	WA01 (H1, human embryonic stem cells)	NULL
EXP010068	sc-6553	Homo sapiens		EXP010489	430	unspecified	P55317	HepG2 (hepatoblastoma)	NULL
EXP010069	sc-482	Homo sapiens	(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	EXP010052	583	unspecified	P40763	MCF10A (breast epithelial cells)	NULL
EXP010070	sc-497	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P10914	K562 (myelogenous leukemia)	NULL
EXP010071	sc-1703	Homo sapiens		EXP010048	244	unspecified	P25490	NT2-D1 (embryonic carcinoma)	NULL
EXP010072	2569	Homo sapiens		EXP010476	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	NULL
EXP010073	16618-1-AP	Homo sapiens		EXP010714	376	unspecified	P52747	WA01 (H1, human embryonic stem cells)	NULL
EXP010074	sc-17824	Homo sapiens		EXP010428	376	unspecified	P08047	WA01 (H1, human embryonic stem cells)	NULL
EXP010075	AF4185	Homo sapiens		EXP010054	423	unspecified	P50539	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010076		Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010077	sc-643	Homo sapiens		EXP010023	430	unspecified	Q02086	HepG2 (hepatoblastoma)	NULL
EXP010078	sc-281	Homo sapiens		EXP010137	356	unspecified	P25490	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010079	sc-1694	Mus musculus		EXP010613	1144	unspecified	P05627	CH12.LX (Mouse lymphoma)	NULL
EXP010080	sc-17824	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P08047	A549 (lung carcinoma)	NULL
EXP010081	sc-12984	Homo sapiens		EXP010630	514	unspecified	P17542	K562 (myelogenous leukemia)	NULL
EXP010082	sc-345	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P42224	K562 (myelogenous leukemia)	NULL
EXP010083	sc-764	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010084	2899	Homo sapiens		EXP010814	1146	unspecified	P49711	epithelial cell of proximal tubule	NULL
EXP010085	sc-14700	Homo sapiens		EXP010530	514	unspecified	O14867	K562 (myelogenous leukemia)	NULL
EXP010086	sc-268	Homo sapiens		EXP010876	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010087	sc-764	Homo sapiens		EXP010530	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010088	sc-357	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q99081	A549 (lung carcinoma)	NULL
EXP010089	sc-5916	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010555	504	unspecified	P49711	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010090		Homo sapiens		NULL	893	chip_control	NULL	erythroblasts	NULL
EXP010091	CTCF	Mus musculus		EXP010910	53	unspecified	Q61164	heart	NULL
EXP010092	sc-13030	Homo sapiens		EXP010669	423	unspecified	P28324	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010093		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054853	Med1/TRAP220 (Bethyl, A300-793A-2)	Homo sapiens		EXP054852	2608	normal	O95243	HSMM (skeletal muscle myoblasts)	NULL
EXP010095	sc-645	Homo sapiens		EXP010513	376	unspecified	Q02446	WA01 (H1, human embryonic stem cells)	NULL
EXP010096	2569	Homo sapiens		EXP010876	113	unspecified	Q9NQB0	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010097	sc-233	Homo sapiens		EXP010060	356	unspecified	P09086	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010098	ab19489	Homo sapiens		EXP010581	356	unspecified	Q9H165	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010100	sc-476	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P52630	K562 (myelogenous leukemia)	NULL
EXP010101		Homo sapiens		NULL	733	chip_control	NULL	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010102	sc-764	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010103		Homo sapiens		NULL	72	chip_control	NULL	astrocytes	NULL
EXP010104	ab19489	Homo sapiens		EXP010580	356	unspecified	Q9H165	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010105	TR4	Homo sapiens		EXP010673	430	unspecified	P49116	HepG2 (hepatoblastoma)	NULL
EXP054036	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	440	normal	P49711	HMEC (human mammary epithelial cells)	NULL
EXP054033	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054025	2606	normal	P49711	NHLF (lung fibroblasts)	NULL
EXP010108	2899	Homo sapiens		EXP010786	38	unspecified	P49711	A549 (lung carcinoma)	NULL
EXP010109	sc-229	Homo sapiens		EXP010428	376	unspecified	P22415	WA01 (H1, human embryonic stem cells)	NULL
EXP010110	ab60931	Homo sapiens		EXP010255	430	unspecified	Q15853	HepG2 (hepatoblastoma)	NULL
EXP010111	sc-13125	Homo sapiens		EXP010630	514	unspecified	P17480	K562 (myelogenous leukemia)	NULL
EXP010112	sc-8987	Homo sapiens		EXP010539	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP010114	sc-5916	Homo sapiens		EXP010489	430	unspecified	P49711	HepG2 (hepatoblastoma)	NULL
EXP010115	sc-482	Homo sapiens		EXP010054	423	unspecified	P40763	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010116	2899	Homo sapiens		EXP010397	863	unspecified	P49711	WERI-Rb-1 (retinoblastoma)	NULL
EXP010117	07-729	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	Q61164	G1E-ER4 (embryonic stem cells)	NULL
EXP010118	sc-22827	Homo sapiens		EXP010122	356	unspecified	Q16621	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010119	sc-188	Homo sapiens		EXP010597	514	unspecified	P18847	K562 (myelogenous leukemia)	NULL
EXP010120		Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010122		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010124		Homo sapiens		NULL	289	chip_control	NULL	SK-N-MC (Askin tumor)	NULL
EXP010127	sc-28312	Homo sapiens		EXP010093	356	unspecified	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010128	sc-101184	Homo sapiens		EXP010546	514	unspecified	Q15561	K562 (myelogenous leukemia)	NULL
EXP010129	sc-28312	Homo sapiens		EXP010094	356	unspecified	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010130		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010131		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010132	sc-137065	Homo sapiens		EXP010122	356	unspecified	Q9UH73	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010133	sc-197	Mus musculus		EXP010883	644	unspecified	P28574	myocytes	NULL
EXP010134	07-729	Mus musculus		EXP010059	1174	unspecified	Q61164	MEL cell line	NULL
EXP010135	sc-150	Homo sapiens		EXP010255	430	unspecified	P17676	HepG2 (hepatoblastoma)	NULL
EXP010137		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010138	sc-150	Homo sapiens		EXP010066	489	unspecified	P17676	IMR90 (lung fibroblasts)	NULL
EXP010139	sc-98174	Homo sapiens		EXP010671	514	unspecified	Q9NVV9	K562 (myelogenous leukemia)	NULL
EXP010140	sc-197	Homo sapiens		EXP010587	376	unspecified	P61244	WA01 (H1, human embryonic stem cells)	NULL
EXP010141		Homo sapiens		NULL	357	chip_control	NULL	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010142	sc-357	Mus musculus		EXP010883	644	unspecified	Q61286	myocytes	NULL
EXP010143	sc-197	Homo sapiens		EXP010255	430	unspecified	P61244	HepG2 (hepatoblastoma)	NULL
EXP010144	07-729	Homo sapiens	45 min with 100 nM Estradiol (Crawford)	EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010145	sc-631	Homo sapiens		EXP010130	514	unspecified	P32519	K562 (myelogenous leukemia)	NULL
EXP010146	sc-1694	Homo sapiens		EXP010054	423	unspecified	P05412	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010147		Homo sapiens		NULL	893	chip_control	NULL	erythroblasts	NULL
EXP010149	sc-1694	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP010150	sc-197	Homo sapiens		EXP010745	356	unspecified	P61244	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010151	sc-23871	Homo sapiens		EXP010403	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	NULL
EXP010152	sc-265	Mus musculus		EXP010710	265	unspecified	P17679	G1E (embryonic stem cells)	NULL
EXP010153	sc-313	Homo sapiens		EXP010671	514	unspecified	Q02078	K562 (myelogenous leukemia)	NULL
EXP010154	2899	Homo sapiens		EXP010801	648	unspecified	P49711	NB4 (acute promyelocytic leukemia )	NULL
EXP010155	sc-6553	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	unspecified	P55317	T47D (invasive ductal carcinoma)	NULL
EXP010156	sc-110	Homo sapiens		EXP010094	356	unspecified	P18146	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010157		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010158		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010159		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010160	sc-553	Homo sapiens		EXP010428	376	unspecified	P19793	WA01 (H1, human embryonic stem cells)	NULL
EXP010161	sc-23871	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q86T24	A549 (lung carcinoma)	NULL
EXP010162	sc-335	Homo sapiens		EXP010489	430	unspecified	P11831	HepG2 (hepatoblastoma)	NULL
EXP010163		Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010164	sc-233	Homo sapiens		EXP010141	357	unspecified	P09086	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010165	sc-100974	Homo sapiens		EXP010580	356	unspecified	Q16520	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010166	ab85725	Homo sapiens		EXP010530	514	unspecified	P56270	K562 (myelogenous leukemia)	NULL
EXP010167	sc-98982	Homo sapiens		EXP010671	514	unspecified	Q8NI51	K562 (myelogenous leukemia)	NULL
EXP010169	sc-100974	Homo sapiens		EXP010581	356	unspecified	Q16520	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010171		Homo sapiens		NULL	733	chip_control	NULL	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010173		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010174	2899	Homo sapiens		EXP010802	420	unspecified	P49711	esophageal epithelial cells	NULL
EXP010175	200-401-194	Homo sapiens		EXP010714	376	unspecified	P48382	WA01 (H1, human embryonic stem cells)	NULL
EXP010177	ab50322	Homo sapiens		EXP010066	489	unspecified	O60675	IMR90 (lung fibroblasts)	NULL
EXP010178	sc-22823	Homo sapiens		EXP010823	514	unspecified	O75461	K562 (myelogenous leukemia)	NULL
EXP010179	sc-1975	Homo sapiens		EXP010375	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010180	ab55744	Homo sapiens		EXP010255	430	unspecified	Q16656	HepG2 (hepatoblastoma)	NULL
EXP010181	CTCF	Mus musculus		EXP010923	5	unspecified	Q61164	liver	NULL
EXP010182	sc-350	Homo sapiens		EXP010137	356	unspecified	P14921	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010183	sc-74	Homo sapiens		EXP010122	356	unspecified	P17535	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010184	eGFP	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010185	sc-81188	Homo sapiens		EXP010513	376	unspecified	P15336	WA01 (H1, human embryonic stem cells)	NULL
EXP010187	sc-188	Homo sapiens		EXP010489	430	unspecified	P18847	HepG2 (hepatoblastoma)	NULL
EXP010188	sc-74442	Homo sapiens		EXP010546	514	unspecified	P42229	K562 (myelogenous leukemia)	NULL
EXP010189	sc-482	Homo sapiens	36 h with 0.01% Ethanol	EXP010052	583	unspecified	P40763	MCF10A (breast epithelial cells)	NULL
EXP010190	200-401-194	Homo sapiens		EXP010255	430	unspecified	P48382	HepG2 (hepatoblastoma)	NULL
EXP010191	sc-55706	Homo sapiens		EXP010379	514	unspecified	Q8N196	K562 (myelogenous leukemia)	NULL
EXP010192	sc-197	Homo sapiens		EXP010030	648	unspecified	P61244	NB4 (acute promyelocytic leukemia )	NULL
EXP010193	sc-15914	Homo sapiens		EXP010066	489	unspecified	P49711	IMR90 (lung fibroblasts)	NULL
EXP010194	ab60931	Homo sapiens		EXP010745	356	unspecified	Q15853	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010195	2899	Homo sapiens		EXP010925	114	unspecified	P49711	bronchial epithelial cells	NULL
EXP010196	sc-267	Homo sapiens		EXP010671	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP010197	2899	Homo sapiens		EXP010790	441	unspecified	P49711	HMF (human mammary fibroblasts)	NULL
EXP010198	sc-101023	Homo sapiens		EXP010403	430	unspecified	O14503	HepG2 (hepatoblastoma)	NULL
EXP010199	sc-110	Homo sapiens		EXP010137	356	unspecified	P18146	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010200	ab85725	Homo sapiens		EXP010255	430	unspecified	P56270	HepG2 (hepatoblastoma)	NULL
EXP010201	sc-735	Homo sapiens		EXP010158	430	unspecified	P21675	HepG2 (hepatoblastoma)	NULL
EXP010202	NRSF	Homo sapiens		EXP010171	733	unspecified	Q13127	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010203	2899	Homo sapiens		EXP010877	414	unspecified	P49711	HCFaa (cardiac fibroblasts - adult atrial)	NULL
EXP010204	sc-6553	Homo sapiens		EXP010539	430	unspecified	P55317	HepG2 (hepatoblastoma)	NULL
EXP010205	sc-735	Homo sapiens		EXP010157	430	unspecified	P21675	HepG2 (hepatoblastoma)	NULL
EXP010206	2899	Homo sapiens		EXP010830	1141	unspecified	P49711	BE2C	NULL
EXP010207	9115	Homo sapiens		EXP010054	423	unspecified	O75626	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010210		Homo sapiens		NULL	733	chip_control	NULL	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010211	sc-1002	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P04150	HepG2 (hepatoblastoma)	NULL
EXP010212	NB100-279	Homo sapiens		EXP010255	430	unspecified	Q99856	HepG2 (hepatoblastoma)	NULL
EXP010213	sc-281	Homo sapiens		EXP010062	356	unspecified	P25490	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010214	2899	Homo sapiens		EXP010898	55	unspecified	P49711	AG04450 (fibroblasts)	NULL
EXP010217	sc-604	Homo sapiens		EXP010726	430	unspecified	P15408	HepG2 (hepatoblastoma)	NULL
EXP010218	ab62126	Homo sapiens		EXP010745	356	unspecified	P20226	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010219	CTCF	Mus musculus		EXP010930	81	unspecified	Q61164	BMDM (bone marrow-derived macrophages)	NULL
EXP010220	eGFP	Homo sapiens		EXP010847	514	unspecified	P17275	K562 (myelogenous leukemia)	NULL
EXP010222	05-379	Homo sapiens		EXP010027	423	unspecified	Q01094	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010223	2899	Homo sapiens		EXP010851	423	unspecified	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010224	06-325	Homo sapiens		EXP010597	514	unspecified	P18846	K562 (myelogenous leukemia)	NULL
EXP010225	sc-150	Homo sapiens		EXP010769	38	unspecified	P17676	A549 (lung carcinoma)	NULL
EXP010227		Homo sapiens	DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder)	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010228		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010229	sc-866	Homo sapiens	(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	EXP010486	583	unspecified	Q16254	MCF10A (breast epithelial cells)	NULL
EXP010230	H00010782-A01	Homo sapiens		EXP010823	514	unspecified	Q96GC6	K562 (myelogenous leukemia)	NULL
EXP010231	ab24166	Homo sapiens		EXP010530	514	unspecified	Q9UKL0	K562 (myelogenous leukemia)	NULL
EXP010232	sc-9082	Homo sapiens		EXP010054	423	unspecified	Q14653	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010234	MMS-101P	Homo sapiens		EXP010027	423	unspecified	Q01094	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010235	sc-23871	Homo sapiens		EXP010278	417	unspecified	Q86T24	HCT-116 (colon carcinoma)	NULL
EXP010236	sc-101058	Homo sapiens		EXP010489	430	unspecified	P55317	HepG2 (hepatoblastoma)	NULL
EXP010237	sc-12984	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	P22091	G1E-ER4 (embryonic stem cells)	NULL
EXP010240	sc-764	Homo sapiens		EXP010113	472	unspecified	P01106	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010241	2569	Homo sapiens		EXP010669	423	unspecified	Q9NQB0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010243	sc-150	Homo sapiens		EXP010054	423	unspecified	P17676	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010245	sc-197	Homo sapiens		EXP010054	423	unspecified	P61244	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010246	2899	Homo sapiens		EXP010686	344	unspecified	P49711	GM12864 (male B-cells)	NULL
EXP010247	sc-74	Homo sapiens		EXP010714	376	unspecified	P17535	WA01 (H1, human embryonic stem cells)	NULL
EXP010248	ab50322	Mus musculus		EXP010613	1144	unspecified	Q61827	CH12.LX (Mouse lymphoma)	NULL
EXP010249	sc-1703	Homo sapiens		EXP010704	358	unspecified	P25490	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP010250	2899	Homo sapiens		EXP010922	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010251	sc-1974	Homo sapiens		EXP010704	358	unspecified	Q02548	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP010252	07-729	Homo sapiens		EXP010061	391	unspecified	P49711	D54 (H54, Human glioblastoma)	NULL
EXP010253	sc-98982	Homo sapiens		EXP010379	514	unspecified	Q8NI51	K562 (myelogenous leukemia)	NULL
EXP010254	ab12000	Mus musculus		EXP010677	1144	unspecified	Q02650	CH12.LX (Mouse lymphoma)	NULL
EXP010255	sc-2027	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010256	sc-281	Homo sapiens		EXP010489	430	unspecified	P25490	HepG2 (hepatoblastoma)	NULL
EXP010257	sc-22805	Homo sapiens		EXP010581	356	unspecified	P17947	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010258	sc-55706	Homo sapiens		EXP010419	514	unspecified	Q8N196	K562 (myelogenous leukemia)	NULL
EXP010259	sc-55706	Homo sapiens		EXP010415	514	unspecified	Q8N196	K562 (myelogenous leukemia)	NULL
EXP010260	sc-7202	Homo sapiens		EXP010597	514	unspecified	P01100	K562 (myelogenous leukemia)	NULL
EXP010261	sc-15914	Mus musculus		EXP010644	1174	unspecified	Q61164	MEL cell line	NULL
EXP010262	sc-866	Homo sapiens		EXP010745	356	unspecified	Q16254	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010263	sc-197	Mus musculus		EXP010613	1144	unspecified	P28574	CH12.LX (Mouse lymphoma)	NULL
EXP010264	NRSF	Homo sapiens		EXP010645	665	unspecified	Q13127	SK-N-SH (neuroblastoma)	NULL
EXP010265	sc-2025	Mus musculus		NULL	1174	chip_control	NULL	MEL cell line	NULL
EXP010266	NRSF	Homo sapiens		EXP010039	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054039	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2608	normal	P49711	HSMM (skeletal muscle myoblasts)	NULL
EXP010269	2899	Homo sapiens		EXP010784	434	unspecified	P49711	HFF-Myc (fetal fibroblasts)	NULL
EXP010271	sc-6553	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010555	504	unspecified	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010272	2899	Homo sapiens		EXP010819	56	unspecified	P49711	AG09309 (fibroblasts)	NULL
EXP010273	sc-281	Homo sapiens		EXP010428	376	unspecified	P25490	WA01 (H1, human embryonic stem cells)	NULL
EXP010274	1277-1	Homo sapiens		EXP010745	356	unspecified	P19419	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010275	sc-350	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P14921	A549 (lung carcinoma)	NULL
EXP010276	sc-15914	Homo sapiens		EXP010530	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP010277	sc-30189	Homo sapiens		EXP010054	423	unspecified	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010278		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP010279	ab16046	Homo sapiens		EXP010124	289	unspecified	O15409	SK-N-MC (Askin tumor)	NULL
EXP010280	sc-335	Homo sapiens		EXP010137	356	unspecified	P11831	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010281		Mus musculus		NULL	266	chip_control	NULL	erythroblasts	NULL
EXP010282	sc-1974	Homo sapiens		EXP010580	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010283	sc-197	Homo sapiens		EXP010732	472	unspecified	P61244	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010284	CTCF	Mus musculus		EXP010888	523	unspecified	Q61164	kidney	NULL
EXP010285	2569	Homo sapiens		EXP010221	712	unspecified	Q9NQB0	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010286	eGFP	Homo sapiens		EXP010184	514	unspecified	P22736	K562 (myelogenous leukemia)	NULL
EXP010287		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP010289		Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010290	sc-9008	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	O09100	G1E-ER4 (embryonic stem cells)	NULL
EXP010292		Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010295	2899	Homo sapiens		EXP010778	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010296	NRSF	Homo sapiens	None	EXP010737	849	unspecified	Q13127	U87 (glioblastoma)	NULL
EXP010297	sc-15914	Homo sapiens		EXP010122	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010298	sc-281	Homo sapiens		EXP010700	357	unspecified	P25490	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010299	sc-9081	Homo sapiens		EXP010428	376	unspecified	Q01860	WA01 (H1, human embryonic stem cells)	NULL
EXP010300	sc-350	Homo sapiens		EXP010671	514	unspecified	P14921	K562 (myelogenous leukemia)	NULL
EXP010301	CTCF	Mus musculus		EXP010817	1165	unspecified	Q61164	cortical plate	NULL
EXP010302	sc-5916	Homo sapiens		EXP010130	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP010304	sc-5916	Homo sapiens		EXP010131	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP010305	2899	Homo sapiens		EXP010881	54	unspecified	P49711	AG04449 (fibroblasts)	NULL
EXP010306	ab55744	Homo sapiens		EXP010725	423	unspecified	Q16656	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010307	sc-110	Homo sapiens		EXP010428	376	unspecified	P18146	WA01 (H1, human embryonic stem cells)	NULL
EXP010308	sc-7202	Homo sapiens	36 h with 0.01% Ethanol	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	NULL
EXP010309	CTCF	Mus musculus		EXP010885	103	unspecified	Q61164	bone marrow	NULL
EXP010310	sc-335	Homo sapiens		EXP010428	376	unspecified	P11831	WA01 (H1, human embryonic stem cells)	NULL
EXP010312	sc-23871	Homo sapiens		EXP010489	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	NULL
EXP010313	sc-1703	Homo sapiens		EXP010122	356	unspecified	P25490	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010314	NRSF	Homo sapiens		EXP010318	376	unspecified	Q13127	WA01 (H1, human embryonic stem cells)	NULL
EXP010315	sc-22823	Homo sapiens		EXP010131	514	unspecified	O75461	K562 (myelogenous leukemia)	NULL
EXP010316	sc-497	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P10914	K562 (myelogenous leukemia)	NULL
EXP010317	sc-22823	Homo sapiens		EXP010130	514	unspecified	O75461	K562 (myelogenous leukemia)	NULL
EXP010318		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP010319	sc-735	Homo sapiens		EXP010101	733	unspecified	P21675	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010320	sc-735	Homo sapiens		EXP010671	514	unspecified	P21675	K562 (myelogenous leukemia)	NULL
EXP010322	2899	Homo sapiens		EXP010838	93	unspecified	P49711	BJ (fibroblasts)	NULL
EXP010323	NRSF	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q13127	A549 (lung carcinoma)	NULL
EXP010324	2899	Homo sapiens		EXP010783	57	unspecified	P49711	AG09319 (fibroblasts)	NULL
EXP010325	sc-28312	Homo sapiens		EXP010157	430	unspecified	Q06546	HepG2 (hepatoblastoma)	NULL
EXP010327	sc-28312	Homo sapiens		EXP010158	430	unspecified	Q06546	HepG2 (hepatoblastoma)	NULL
EXP010329	sc-265	Mus musculus		EXP010281	266	unspecified	P17679	erythroblasts	NULL
EXP010330	sc-281	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P25490	A549 (lung carcinoma)	NULL
EXP010332	sc-764	Homo sapiens		EXP010027	423	unspecified	P01106	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010333	sc-291	Homo sapiens		EXP010597	514	unspecified	Q16621	K562 (myelogenous leukemia)	NULL
EXP010334	sc-23871	Homo sapiens		EXP010726	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	NULL
EXP054042	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	149	normal	P49711	osteoblasts	NULL
EXP010336	sc-229	Homo sapiens		EXP010093	356	unspecified	P22415	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010337	sc-229	Homo sapiens		EXP010094	356	unspecified	P22415	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010339	sc-764	Homo sapiens		EXP010597	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010340	sc-1694	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP010342	sc-764	Mus musculus		EXP010644	1174	unspecified	P01108	MEL cell line	NULL
EXP054034	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054024	472	normal	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010344	ab19489	Homo sapiens		EXP010428	376	unspecified	Q9H165	WA01 (H1, human embryonic stem cells)	NULL
EXP010345	2899	Homo sapiens		EXP010706	345	unspecified	P49711	GM12865 (female B-cells)	NULL
EXP010347	sc-497	Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	EXP010418	514	unspecified	P10914	K562 (myelogenous leukemia)	NULL
EXP010348	sc-74	Mus musculus		EXP010613	1144	unspecified	P15066	CH12.LX (Mouse lymphoma)	NULL
EXP010349	NB100-1800	Homo sapiens		EXP010530	514	unspecified	O14503	K562 (myelogenous leukemia)	NULL
EXP010350	H00010782-A01	Homo sapiens		EXP010673	430	unspecified	Q96GC6	HepG2 (hepatoblastoma)	NULL
EXP010351	sc-735	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P21675	A549 (lung carcinoma)	NULL
EXP010352	2899	Homo sapiens		EXP010913	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP010353	NF-YA	Homo sapiens		EXP010745	356	unspecified	P23511	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010354	sc-74442	Homo sapiens		EXP010159	514	unspecified	P42229	K562 (myelogenous leukemia)	NULL
EXP010355	ab62126	Mus musculus		EXP010265	1174	unspecified	P29037	MEL cell line	NULL
EXP010357	sc-8987	Homo sapiens		EXP010489	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP010360	sc-1694	Homo sapiens		EXP010732	472	unspecified	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010361	1277-1	Homo sapiens		EXP010054	423	unspecified	P19419	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010362	sc-335	Homo sapiens		EXP010094	356	unspecified	P11831	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010363	sc-335	Homo sapiens		EXP010093	356	unspecified	P11831	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010364	sc-1694	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP054087	PLU1 (YangShi lab)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9UGL1	K562 (myelogenous leukemia)	NULL
EXP054054	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	220	normal	P49711	DND41 (acute lymphoblastic leukemia)	NULL
EXP010367		Homo sapiens		NULL	450	chip_control	NULL	skeletal muscles and myoblasts	NULL
EXP010368		Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010369	sc-197	Homo sapiens		EXP010131	514	unspecified	P61244	K562 (myelogenous leukemia)	NULL
EXP010370	sc-197	Homo sapiens		EXP010130	514	unspecified	P61244	K562 (myelogenous leukemia)	NULL
EXP010371	2565	Homo sapiens		EXP010669	423	unspecified	Q9NQB0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010372	ab62126	Homo sapiens		EXP010630	514	unspecified	P20226	K562 (myelogenous leukemia)	NULL
EXP010373	GATA-1	Homo sapiens		EXP010090	893	unspecified	P15976	erythroblasts	NULL
EXP054037	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2607	normal	P49711	NHDF-Ad (adult dermal fibroblasts)	NULL
EXP010375		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010376	ab85725	Homo sapiens		EXP010745	356	unspecified	P56270	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010377	NRSF	Homo sapiens		EXP010381	423	unspecified	Q13127	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010378	sc-30189	Homo sapiens		EXP010745	356	unspecified	Q9UKL0	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010379		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010380	sc-866	Mus musculus		EXP010613	1144	unspecified	Q8R0K9	CH12.LX (Mouse lymphoma)	NULL
EXP010381		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010382	sc-32758	Mus musculus		EXP010816	644	unspecified	P10085	myocytes	NULL
EXP010383	2899	Homo sapiens		EXP010798	58	unspecified	P49711	AG10803 (fibroblasts)	NULL
EXP010384	H00010782-A01	Homo sapiens		EXP010389	336	unspecified	Q96GC6	GM08714 (female B-cells)	NULL
EXP010385	sc-764	Homo sapiens		EXP010599	423	unspecified	P01106	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010386		Homo sapiens		NULL	358	chip_control	NULL	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP010387	07-729	Mus musculus		EXP010677	1144	unspecified	Q61164	CH12.LX (Mouse lymphoma)	NULL
EXP010388	sc-764	Homo sapiens	4 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P01106	MCF10A (breast epithelial cells)	NULL
EXP010389		Homo sapiens		NULL	336	chip_control	NULL	GM08714 (female B-cells)	NULL
EXP010391	sc-735	Homo sapiens		EXP010505	665	unspecified	P21675	SK-N-SH (neuroblastoma)	NULL
EXP010392	sc-6059	Homo sapiens		EXP010581	356	unspecified	Q15306	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010393	sc-6059	Homo sapiens		EXP010580	356	unspecified	Q15306	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010394	sc-188	Homo sapiens		EXP010671	514	unspecified	P18847	K562 (myelogenous leukemia)	NULL
EXP010395	2899	Homo sapiens		EXP010629	352	unspecified	P49711	GM12872 (male B-cells)	NULL
EXP010396	sc-9144	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	Q00613	HepG2 (hepatoblastoma)	NULL
EXP054094	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054090	521	normal	Q3UKU1	KH2 (embryonic stem cells)	NULL
EXP010398	H00010782-A01	Homo sapiens		EXP010048	244	unspecified	Q96GC6	NT2-D1 (embryonic carcinoma)	NULL
EXP010399	sc-6554	Homo sapiens		EXP010489	430	unspecified	Q9Y261	HepG2 (hepatoblastoma)	NULL
EXP010400	16618-1-AP	Homo sapiens		EXP010054	423	unspecified	P52747	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010401	sc-631	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P32519	A549 (lung carcinoma)	NULL
EXP010402	IKZF1_(IkN)	Homo sapiens		EXP010122	356	unspecified	Q13422	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010403		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010404		Homo sapiens		NULL	220	chip_control	NULL	DND41 (acute lymphoblastic leukemia)	NULL
EXP010405	NRSF	Mus musculus		EXP010816	644	unspecified	Q8VIG1	myocytes	NULL
EXP010406	ab55744	Homo sapiens		EXP010745	356	unspecified	Q16656	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010407	SAB1404509	Homo sapiens		EXP010630	514	unspecified	P17480	K562 (myelogenous leukemia)	NULL
EXP010408	sc-23871	Homo sapiens		EXP010228	430	unspecified	Q86T24	HepG2 (hepatoblastoma)	NULL
EXP010409	CTCF	Mus musculus		EXP010894	162	unspecified	Q61164	olfactory bulb	NULL
EXP010410	sc-5916	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	unspecified	P49711	T47D (invasive ductal carcinoma)	NULL
EXP010411	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010412	sc-866	Mus musculus		EXP010883	644	unspecified	Q8R0K9	myocytes	NULL
EXP010413	07-729	Mus musculus		EXP010710	265	unspecified	Q61164	G1E (embryonic stem cells)	NULL
EXP010415		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010416	sc-74	Homo sapiens		EXP010530	514	unspecified	P17535	K562 (myelogenous leukemia)	NULL
EXP010418		Homo sapiens	Interferon alpha treatment - 6 hours (Snyder)	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP054852	None	Homo sapiens		NULL	405	chip_control	NULL	human astrocytes from spinal cord	NULL
EXP054032	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	376	normal	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP010421	sc-28312	Homo sapiens		EXP010428	376	unspecified	Q06546	WA01 (H1, human embryonic stem cells)	NULL
EXP010422	2569	Homo sapiens		EXP010673	430	unspecified	Q9NQB0	HepG2 (hepatoblastoma)	NULL
EXP010423	sc-5916	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010638	38	unspecified	P49711	A549 (lung carcinoma)	NULL
EXP010424	sc-2026	Mus musculus		NULL	1174	chip_control	NULL	MEL cell line	NULL
EXP010425	GATA-1	Mus musculus		EXP010424	1174	unspecified	P17679	MEL cell line	NULL
EXP054030	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054027	2605	normal	P49711	HNEK (epidermal keratinocytes)	NULL
EXP010429	07-729	Homo sapiens		EXP010599	423	unspecified	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010430	ab62126	Homo sapiens		EXP010714	376	unspecified	P20226	WA01 (H1, human embryonic stem cells)	NULL
EXP010431	sc-553	Homo sapiens		EXP010062	356	unspecified	P19793	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010432	sc-553	Homo sapiens		EXP010060	356	unspecified	P19793	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010433	2899	Homo sapiens		EXP010889	955	unspecified	P49711	primary foreskin fibroblasts	NULL
EXP010434	ab50322	Homo sapiens		EXP010054	423	unspecified	O60675	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010435	sc-764	Homo sapiens		EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010437	sc-81192	Homo sapiens		EXP010023	430	unspecified	P10244	HepG2 (hepatoblastoma)	NULL
EXP010438	2899	Homo sapiens		EXP010867	215	unspecified	P49711	keratinocytes	NULL
EXP010439	sc-22805	Homo sapiens		EXP010415	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP010440	NRSF	Homo sapiens		EXP010101	733	unspecified	Q13127	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010441	eGFP	Homo sapiens		EXP010795	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP010442	sc-22805	Homo sapiens		EXP010419	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP010443	TR4	Homo sapiens		EXP010027	423	unspecified	P49116	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010444	AF4185	Mus musculus		EXP010613	1144	unspecified	P50540	CH12.LX (Mouse lymphoma)	NULL
EXP010446	sc-891	Homo sapiens		EXP010375	356	unspecified	P40426	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010447	ab60931	Homo sapiens		EXP010714	376	unspecified	Q15853	WA01 (H1, human embryonic stem cells)	NULL
EXP010448	sc-8984	Homo sapiens	For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	EXP010545	430	unspecified	P36956	HepG2 (hepatoblastoma)	NULL
EXP010449	sc-764	Homo sapiens	45 min with 100 nM Estradiol (Crawford)	EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010450	sc-15914	Mus musculus		EXP010613	1144	unspecified	Q61164	CH12.LX (Mouse lymphoma)	NULL
EXP054043	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010452	sc-1694	Homo sapiens		EXP010597	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP010453	ab62126	Homo sapiens		EXP010054	423	unspecified	P20226	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010454	sc-866	Homo sapiens		EXP010027	423	unspecified	Q16254	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010455	sc-150	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P17676	HepG2 (hepatoblastoma)	NULL
EXP010456	sc-137065	Homo sapiens		EXP010580	356	unspecified	Q9UH73	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010457	2899	Homo sapiens		EXP010829	1160	unspecified	P49711	HRE (Human Renal Epithelial cells)	NULL
EXP010458	sc-150	Homo sapiens		EXP010714	376	unspecified	P17676	WA01 (H1, human embryonic stem cells)	NULL
EXP010459	sc-137065	Homo sapiens		EXP010581	356	unspecified	Q9UH73	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010460	NF-YA	Homo sapiens		EXP010054	423	unspecified	P23511	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010461	sc-1703	Homo sapiens		EXP010131	514	unspecified	P25490	K562 (myelogenous leukemia)	NULL
EXP010462	NRSF	Homo sapiens		EXP010210	733	unspecified	Q13127	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010463	sc-1703	Homo sapiens		EXP010130	514	unspecified	P25490	K562 (myelogenous leukemia)	NULL
EXP010464	2899	Homo sapiens		EXP010916	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP010465	sc-55706	Homo sapiens		EXP010428	376	unspecified	Q8N196	WA01 (H1, human embryonic stem cells)	NULL
EXP010467	sc-5916	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	unspecified	P49711	A549 (lung carcinoma)	NULL
EXP010468	CTCF	Mus musculus		EXP010920	561	unspecified	Q61164	lung	NULL
EXP010469	sc-13268	Homo sapiens		EXP010137	356	unspecified	Q06413	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010470	NB100-1800	Homo sapiens		EXP010745	356	unspecified	O14503	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010471	200-401-194	Homo sapiens		EXP010745	356	unspecified	P48382	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010472	2899	Homo sapiens		EXP010854	421	unspecified	P49711	HEK293 (embryonic kidney)	NULL
EXP010473	NB100-1800	Homo sapiens		EXP010255	430	unspecified	O14503	HepG2 (hepatoblastoma)	NULL
EXP010477	sc-185	Homo sapiens		EXP010137	356	unspecified	P20749	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010478	2899	Homo sapiens		EXP010908	473	unspecified	P49711	human villous mesenchymal fibroblast cells	NULL
EXP010479	sc-197	Mus musculus		EXP010644	1174	unspecified	P28574	MEL cell line	NULL
EXP010480	sc-32758	Mus musculus		EXP010859	644	unspecified	P10085	myocytes	NULL
EXP010481	sc-34508	Homo sapiens		EXP010671	514	unspecified	O95365	K562 (myelogenous leukemia)	NULL
EXP010482	sc-229	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010638	38	unspecified	P22415	A549 (lung carcinoma)	NULL
EXP010483	sc-764	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010485	sc-764	Homo sapiens		EXP010030	648	unspecified	P01106	NB4 (acute promyelocytic leukemia )	NULL
EXP010486		Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP010488	sc-1975	Homo sapiens		EXP010581	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010489		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010490	2899	Homo sapiens		EXP010812	1152	unspecified	P49711	fibroblast of pulmonary artery	NULL
EXP010491	sc-55706	Homo sapiens		EXP010671	514	unspecified	Q8N196	K562 (myelogenous leukemia)	NULL
EXP010493	sc-74	Homo sapiens		EXP010428	376	unspecified	P17535	WA01 (H1, human embryonic stem cells)	NULL
EXP010494	sc-764	Homo sapiens		EXP010714	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	NULL
EXP010495	sc-281	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	unspecified	P25490	SK-N-SH (neuroblastoma)	NULL
EXP010496	sc-55706	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	Q8N196	A549 (lung carcinoma)	NULL
EXP010497	sc-345	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P42224	K562 (myelogenous leukemia)	NULL
EXP010498	sc-10757	Homo sapiens		EXP010725	423	unspecified	Q8TAQ2	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010499	NRSF	Homo sapiens		EXP010094	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010500	2899	Homo sapiens		EXP010921	67	unspecified	P49711	aortic adventitial fibroblasts	NULL
EXP010501	NRSF	Homo sapiens		EXP010093	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010502	2899	Homo sapiens		EXP010805	416	unspecified	P49711	HCPEpiC (choroid plexus epithelial cells)	NULL
EXP010503	AP-2alpha	Homo sapiens	None	EXP010027	423	unspecified	P05549	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010504	sc-764	Homo sapiens	36 h with 0.01% Ethanol	EXP010486	583	unspecified	P01106	MCF10A (breast epithelial cells)	NULL
EXP010505		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010506	ab55744	Homo sapiens		EXP010530	514	unspecified	Q16656	K562 (myelogenous leukemia)	NULL
EXP010507		Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010508	NF-YB	Homo sapiens		EXP010054	423	unspecified	P25208	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010509	sc-281	Homo sapiens		EXP010278	417	unspecified	P25490	HCT-116 (colon carcinoma)	NULL
EXP010510	CTCF	Mus musculus		EXP010835	1174	unspecified	Q61164	MEL cell line	NULL
EXP010511	sc-7202	Homo sapiens	4 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	NULL
EXP010512		Homo sapiens	6 ?M all-trans-retinoic acid (CHEBI:15367) for 48 hour	NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010513		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP010514	07-729	Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	unspecified	P49711	SK-N-SH (neuroblastoma)	NULL
EXP010515	sc-476	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P52630	K562 (myelogenous leukemia)	NULL
EXP010516	ZNF217	Homo sapiens		EXP010876	113	unspecified	O75362	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010518	sc-8821	Homo sapiens		EXP010530	514	unspecified	Q99856	K562 (myelogenous leukemia)	NULL
EXP010519	NF-YA	Homo sapiens		EXP010597	514	unspecified	P23511	K562 (myelogenous leukemia)	NULL
EXP010520	NF-YB	Homo sapiens		EXP010597	514	unspecified	P25208	K562 (myelogenous leukemia)	NULL
EXP010521	sc-1703	Homo sapiens		EXP010823	514	unspecified	P25490	K562 (myelogenous leukemia)	NULL
EXP010522	sc-32758	Mus musculus		EXP010662	644	unspecified	P10085	myocytes	NULL
EXP010523	sc-81335	Homo sapiens		EXP010023	430	unspecified	P08651	HepG2 (hepatoblastoma)	NULL
EXP010524	ab85725	Homo sapiens		EXP010054	423	unspecified	P56270	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010527	sc-265	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010292	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP010528	sc-643	Homo sapiens		EXP010130	514	unspecified	Q02086	K562 (myelogenous leukemia)	NULL
EXP010529	sc-197	Homo sapiens		EXP010530	514	unspecified	P61244	K562 (myelogenous leukemia)	NULL
EXP010530	sc-2027	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010531	TR4	Homo sapiens		EXP010122	356	unspecified	P49116	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010532	sc-482	Homo sapiens		EXP010745	356	unspecified	P40763	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010535	sc-229	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P22415	A549 (lung carcinoma)	NULL
EXP010536	sc-357	Homo sapiens		EXP010581	356	unspecified	Q99081	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010537	sc-357	Homo sapiens		EXP010580	356	unspecified	Q99081	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010538		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010539		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010540	sc-271940	Homo sapiens		EXP010546	514	unspecified	P24468	K562 (myelogenous leukemia)	NULL
EXP010541	RevXlinkChromatin	Homo sapiens	None	NULL	849	chip_control	NULL	U87 (glioblastoma)	NULL
EXP054040	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2609	normal	P49711	NA-A (astrocytes)	NULL
EXP010544	M8194	Homo sapiens		EXP010255	430	unspecified	Q9ULX9	HepG2 (hepatoblastoma)	NULL
EXP010545		Homo sapiens	For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010546		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010547	sc-482	Homo sapiens	12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P40763	MCF10A (breast epithelial cells)	NULL
EXP010548	sc-631	Homo sapiens		EXP010228	430	unspecified	P32519	HepG2 (hepatoblastoma)	NULL
EXP010549	16618-1-AP	Homo sapiens		EXP010530	514	unspecified	P52747	K562 (myelogenous leukemia)	NULL
EXP010550	TR4	Homo sapiens		EXP010823	514	unspecified	P49116	K562 (myelogenous leukemia)	NULL
EXP010551	sc-604	Homo sapiens		EXP010403	430	unspecified	P15408	HepG2 (hepatoblastoma)	NULL
EXP010552	GATA-2	Homo sapiens		EXP010007	472	unspecified	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010553	sc-9082	Homo sapiens		EXP010745	356	unspecified	Q14653	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010554	sc-335	Mus musculus		EXP010859	644	unspecified	Q9JM73	myocytes	NULL
EXP010555		Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010557	sc-32758	Mus musculus		EXP010882	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP010558		Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010559	AP-2gamma	Homo sapiens	None	EXP010027	423	unspecified	Q92754	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010561	sc-74	Mus musculus		EXP010644	1174	unspecified	P15066	MEL cell line	NULL
EXP010562	sc-7202	Homo sapiens		EXP010027	423	unspecified	P01100	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010563	sc-23871	Homo sapiens		EXP010671	514	unspecified	Q86T24	K562 (myelogenous leukemia)	NULL
EXP010564	sc-188	Homo sapiens		EXP010539	430	unspecified	P18847	HepG2 (hepatoblastoma)	NULL
EXP010565	CTCF	Mus musculus		EXP010875	139	unspecified	Q61164	thymus	NULL
EXP010566	sc-345	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010289	423	unspecified	P42224	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010567	sc-6558	Homo sapiens		EXP010489	430	unspecified	Q14541	HepG2 (hepatoblastoma)	NULL
EXP010568	sc-335	Homo sapiens		EXP010671	514	unspecified	P11831	K562 (myelogenous leukemia)	NULL
EXP010569	NRSF	Homo sapiens		EXP010158	430	unspecified	Q13127	HepG2 (hepatoblastoma)	NULL
EXP010570	NRSF	Homo sapiens		EXP010157	430	unspecified	Q13127	HepG2 (hepatoblastoma)	NULL
EXP010571	2569	Homo sapiens		EXP010651	421	unspecified	Q9NQB0	HEK293 (embryonic kidney)	NULL
EXP010572	sc-150	Homo sapiens		EXP010228	430	unspecified	P17676	HepG2 (hepatoblastoma)	NULL
EXP054024	Input	Homo sapiens	Treatment: None;	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010574	sc-349	Mus musculus		EXP010816	644	unspecified	P15806	myocytes	NULL
EXP010576	sc-12732	Mus musculus		EXP010859	644	unspecified	P12979	myocytes	NULL
EXP010577	sc-188	Homo sapiens		EXP010428	376	unspecified	P18847	WA01 (H1, human embryonic stem cells)	NULL
EXP010578	sc-229	Homo sapiens		EXP010671	514	unspecified	P22415	K562 (myelogenous leukemia)	NULL
EXP010580		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010582		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP054025	Input	Homo sapiens	Treatment: None;	NULL	2606	chip_control	NULL	NHLF (lung fibroblasts)	NULL
EXP010584	eGFP	Homo sapiens		EXP010788	514	unspecified	P17535	K562 (myelogenous leukemia)	NULL
EXP010585	NRSF	Homo sapiens	None	EXP010541	849	unspecified	Q13127	U87 (glioblastoma)	NULL
EXP010586	sc-735	Homo sapiens		EXP010386	358	unspecified	P21675	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP010587		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP010588	eGFP	Homo sapiens		EXP010865	514	unspecified	P01100	K562 (myelogenous leukemia)	NULL
EXP010590	2899	Homo sapiens		EXP010779	399	unspecified	P49711	astrocytes of cerebellum	NULL
EXP010591	sc-5916	Homo sapiens		EXP010428	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP010593	sc-7202	Homo sapiens		EXP010007	472	unspecified	P01100	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010594	sc-604	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	unspecified	P15408	A549 (lung carcinoma)	NULL
EXP010595	16618-1-AP	Homo sapiens		EXP010122	356	unspecified	P52747	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010596	sc-14700	Homo sapiens		EXP010714	376	unspecified	O14867	WA01 (H1, human embryonic stem cells)	NULL
EXP010597		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010598	sc-12984	Mus musculus		EXP010281	266	unspecified	P22091	erythroblasts	NULL
EXP010600	sc-25388	Homo sapiens		EXP010062	356	unspecified	P37275	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010602	NF-YB	Homo sapiens		EXP010745	356	unspecified	P25208	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010606	ab16046	Homo sapiens		EXP010697	733	unspecified	O15409	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010607	sc-1974	Homo sapiens		EXP010700	357	unspecified	Q02548	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010608	sc-17824	Homo sapiens		EXP010539	430	unspecified	P08047	HepG2 (hepatoblastoma)	NULL
EXP010609	2899	Homo sapiens		EXP010741	355	unspecified	P49711	GM12875 (female B-cells)	NULL
EXP010610	sc-17824	Homo sapiens		EXP010538	430	unspecified	P08047	HepG2 (hepatoblastoma)	NULL
EXP010611	sc-74	Homo sapiens		EXP010255	430	unspecified	P17535	HepG2 (hepatoblastoma)	NULL
EXP010612	CTCF	Mus musculus		EXP010896	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP010613	sc-2027	Mus musculus		NULL	1144	chip_control	NULL	CH12.LX (Mouse lymphoma)	NULL
EXP010614	sc-55706	Homo sapiens		EXP010060	356	unspecified	Q8N196	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010615	sc-55706	Homo sapiens		EXP010062	356	unspecified	Q8N196	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010616	ab50322	Mus musculus		EXP010644	1174	unspecified	Q61827	MEL cell line	NULL
EXP010617	sc-229	Homo sapiens		EXP010403	430	unspecified	P22415	HepG2 (hepatoblastoma)	NULL
EXP010618	sc-636	Homo sapiens		EXP010228	430	unspecified	P49716	HepG2 (hepatoblastoma)	NULL
EXP010619		Homo sapiens		NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP010620	sc-357	Homo sapiens		EXP010428	376	unspecified	Q99081	WA01 (H1, human embryonic stem cells)	NULL
EXP010621	200-401-194	Homo sapiens		EXP010054	423	unspecified	P48382	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010622	07-729	Homo sapiens		EXP010328	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP010623	2899	Homo sapiens		EXP010811	446	unspecified	P49711	HPF (pulmonary fibroblasts isolated from lung tissue)	NULL
EXP010624	2899	Homo sapiens		EXP010902	440	unspecified	P49711	HMEC (human mammary epithelial cells)	NULL
EXP010625	ab19489	Homo sapiens		EXP010428	376	unspecified	Q9H165	WA01 (H1, human embryonic stem cells)	NULL
EXP010626	sc-643	Homo sapiens		EXP010513	376	unspecified	Q02086	WA01 (H1, human embryonic stem cells)	NULL
EXP010627	sc-28312	Homo sapiens		EXP010381	423	unspecified	Q06546	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010628	ab50322	Homo sapiens		EXP010255	430	unspecified	O60675	HepG2 (hepatoblastoma)	NULL
EXP010630	sc-2025	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010631	sc-197	Homo sapiens		EXP010597	514	unspecified	P61244	K562 (myelogenous leukemia)	NULL
EXP010632	sc-101023	Homo sapiens		EXP010769	38	unspecified	O14503	A549 (lung carcinoma)	NULL
EXP010634	ab50322	Homo sapiens		EXP010714	376	unspecified	O60675	WA01 (H1, human embryonic stem cells)	NULL
EXP010635	sc-12984	Mus musculus		EXP010059	1174	unspecified	P22091	MEL cell line	NULL
EXP010637	sc-74	Homo sapiens		EXP010054	423	unspecified	P17535	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010638		Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010640	sc-101023	Homo sapiens		EXP010489	430	unspecified	O14503	HepG2 (hepatoblastoma)	NULL
EXP010641	sc-9082	Homo sapiens		EXP010255	430	unspecified	Q14653	HepG2 (hepatoblastoma)	NULL
EXP010642	sc-13030	Homo sapiens		EXP010651	421	unspecified	P28324	HEK293 (embryonic kidney)	NULL
EXP010643	H00010782-A01	Homo sapiens		EXP010122	356	unspecified	Q96GC6	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010644	sc-2027	Mus musculus		NULL	1174	chip_control	NULL	MEL cell line	NULL
EXP010645		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010646	sc-8984	Homo sapiens	DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder)	EXP010227	430	unspecified	P36956	HepG2 (hepatoblastoma)	NULL
EXP010647	sc-345	Homo sapiens	30 m of Interferon alpha (Snyder)	EXP010765	514	unspecified	P42224	K562 (myelogenous leukemia)	NULL
EXP010648	sc-17824	Homo sapiens		EXP010671	514	unspecified	P08047	K562 (myelogenous leukemia)	NULL
EXP010650	H00010782-A01	Homo sapiens		EXP010669	423	unspecified	Q96GC6	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010651		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP010653	NRSF	Homo sapiens		EXP010228	430	unspecified	Q13127	HepG2 (hepatoblastoma)	NULL
EXP010654	sc-349	Homo sapiens		EXP010062	356	unspecified	P15923	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010655	sc-349	Homo sapiens		EXP010060	356	unspecified	P15923	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010656		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010658	ab60931	Mus musculus		EXP010703	1144	unspecified	Q64705	CH12.LX (Mouse lymphoma)	NULL
EXP010659	sc-9008	Mus musculus		EXP010710	265	unspecified	O09100	G1E (embryonic stem cells)	NULL
EXP010660	NRSF	Homo sapiens		EXP010173	665	unspecified	Q13127	SK-N-SH (neuroblastoma)	NULL
EXP010661	2899	Homo sapiens		EXP010912	415	unspecified	P49711	HCM (cardiac myocytes)	NULL
EXP010662		Mus musculus		NULL	644	chip_control	NULL	myocytes	NULL
EXP010663	2899	Homo sapiens		EXP010794	448	unspecified	P49711	retinal pigment epithelial cells	NULL
EXP010664	2899	Homo sapiens		EXP010601	343	unspecified	P49711	GM12801 (male B-cells)	NULL
EXP010666	sc-7202	Homo sapiens		EXP010122	356	unspecified	P01100	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010667	sc-101184	Homo sapiens		EXP010023	430	unspecified	Q15561	HepG2 (hepatoblastoma)	NULL
EXP010668	GATA-2	Homo sapiens		EXP010823	514	unspecified	P23769	K562 (myelogenous leukemia)	NULL
EXP010669		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010671		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010672	sc-23871	Homo sapiens		EXP010580	356	unspecified	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010673		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010674	sc-23871	Homo sapiens		EXP010581	356	unspecified	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010675	AF4185	Homo sapiens		EXP010745	356	unspecified	P50539	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010676		Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP010677		Mus musculus		NULL	1144	chip_control	NULL	CH12.LX (Mouse lymphoma)	NULL
EXP010678	sc-30189	Homo sapiens		EXP010530	514	unspecified	Q9UKL0	K562 (myelogenous leukemia)	NULL
EXP010679	2899	Homo sapiens		EXP010808	438	unspecified	P49711	HL-60 (acute myeloid leukemia)	NULL
EXP010680	CTCF	Mus musculus		EXP010839	25	unspecified	Q61164	cerebellum	NULL
EXP010681	sc-66882	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	unspecified	P11474	HepG2 (hepatoblastoma)	NULL
EXP010682	sc-735	Homo sapiens		EXP010141	357	unspecified	P21675	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010683	sc-313	Homo sapiens		EXP010137	356	unspecified	Q02078	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010684	sc-150	Mus musculus		EXP010883	644	unspecified	P28033	myocytes	NULL
EXP010685	sc-30189	Homo sapiens		EXP010255	430	unspecified	Q9UKL0	HepG2 (hepatoblastoma)	NULL
EXP010687	200-401-194	Homo sapiens		EXP010530	514	unspecified	P48382	K562 (myelogenous leukemia)	NULL
EXP010688	AF4185	Mus musculus		EXP010644	1174	unspecified	P50540	MEL cell line	NULL
EXP010689	sc-233	Homo sapiens		EXP010581	356	unspecified	P09086	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010690	sc-269	Homo sapiens		EXP010876	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010692	07-729	Homo sapiens		EXP010113	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010693	H00010782-M01	Homo sapiens		EXP010823	514	unspecified	Q96GC6	K562 (myelogenous leukemia)	NULL
EXP010694	sc-150	Homo sapiens		EXP010546	514	unspecified	P17676	K562 (myelogenous leukemia)	NULL
EXP010695	GATA-1	Homo sapiens		EXP010147	893	unspecified	P15976	erythroblasts	NULL
EXP010696	2899	Homo sapiens		EXP010904	405	unspecified	P49711	human astrocytes from spinal cord	NULL
EXP010697		Homo sapiens		NULL	733	chip_control	NULL	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP010698	sc-74	Homo sapiens		EXP010403	430	unspecified	P17535	HepG2 (hepatoblastoma)	NULL
EXP010699	MMS-101P	Homo sapiens		EXP010876	113	unspecified	Q01094	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010700		Homo sapiens		NULL	357	chip_control	NULL	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010701	sc-101058	Homo sapiens		EXP010539	430	unspecified	P55317	HepG2 (hepatoblastoma)	NULL
EXP010703	sc-2025	Mus musculus		NULL	1144	chip_control	NULL	CH12.LX (Mouse lymphoma)	NULL
EXP010704		Homo sapiens		NULL	358	chip_control	NULL	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP010705	sc-10756	Homo sapiens		EXP010725	423	unspecified	Q92922	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010707	sc-12732	Mus musculus		EXP010816	644	unspecified	P12979	myocytes	NULL
EXP010708	2899	Homo sapiens		EXP010928	145	unspecified	P49711	Caco-2 (colon adenocarcinoma)	NULL
EXP010709	07-729	Mus musculus		EXP010882	1153	unspecified	Q61164	C2C12 (myoblasts)	NULL
EXP010710		Mus musculus		NULL	265	chip_control	NULL	G1E (embryonic stem cells)	NULL
EXP010711	sc-1694	Homo sapiens		EXP010714	376	unspecified	P05412	WA01 (H1, human embryonic stem cells)	NULL
EXP010713	sc-553	Homo sapiens		EXP010403	430	unspecified	P19793	HepG2 (hepatoblastoma)	NULL
EXP010714	sc-2027	Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP010715	AF4185	Homo sapiens		EXP010714	376	unspecified	P50539	WA01 (H1, human embryonic stem cells)	NULL
EXP010716	NRSF	Homo sapiens		EXP010051	665	unspecified	Q13127	SK-N-SH (neuroblastoma)	NULL
EXP010717	sc-631	Homo sapiens		EXP010137	356	unspecified	P32519	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010718		Homo sapiens		NULL	149	chip_control	NULL	osteoblasts	NULL
EXP010719	sc-345	Homo sapiens		EXP010122	356	unspecified	P42224	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010720	sc-22805	Homo sapiens		EXP010062	356	unspecified	P17947	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010721	sc-34508	Homo sapiens		EXP010228	430	unspecified	O95365	HepG2 (hepatoblastoma)	NULL
EXP010722	ab60931	Homo sapiens		EXP010530	514	unspecified	Q15853	K562 (myelogenous leukemia)	NULL
EXP010723	ab60931	Homo sapiens		EXP010725	423	unspecified	Q15853	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010724	sc-497	Homo sapiens	Interferon gamma treatment - 6 hours (Snyder)	EXP010163	514	unspecified	P10914	K562 (myelogenous leukemia)	NULL
EXP010725	sc-2025	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010726		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010728	NRSF	Homo sapiens		EXP010062	356	unspecified	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010729	NRSF	Homo sapiens		EXP010558	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010730		Homo sapiens		NULL	918	chip_control	NULL	myotube	NULL
EXP010731		Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010732		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010733	sc-891	Homo sapiens		EXP010581	356	unspecified	P40426	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010734	2899	Homo sapiens		EXP010924	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010735	CTCF	Mus musculus		EXP010836	32	unspecified	Q61164	testis	NULL
EXP010736	sc-866	Homo sapiens		EXP010823	514	unspecified	Q16254	K562 (myelogenous leukemia)	NULL
EXP010737	RevXlinkChromatin	Homo sapiens	None	NULL	849	chip_control	NULL	U87 (glioblastoma)	NULL
EXP010738	sc-735	Homo sapiens		EXP010381	423	unspecified	P21675	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010739	NRSF	Homo sapiens		EXP010507	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP054041	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2610	normal	P49711	HSMM dirived skeletal muscle myotubes	NULL
EXP010742	sc-17824	Homo sapiens		EXP010580	356	unspecified	P08047	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010743	sc-345	Homo sapiens	Interferon gamma treatment - 30 minutes (Snyder)	EXP010731	514	unspecified	P42224	K562 (myelogenous leukemia)	NULL
EXP054096	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: treated with 0.3 uM of all-trans retinoic acid for 6 hours; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054091	521	normal	Q3UKU1	KH2 (embryonic stem cells)	NULL
EXP010745	sc-2025	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010746	sc-110	Homo sapiens		EXP010671	514	unspecified	P18146	K562 (myelogenous leukemia)	NULL
EXP010748	sc-229	Mus musculus		EXP010883	644	unspecified	Q61069	myocytes	NULL
EXP010749	ab62126	Homo sapiens		EXP010255	430	unspecified	P20226	HepG2 (hepatoblastoma)	NULL
EXP010750	sc-183	Homo sapiens		EXP010671	514	unspecified	P15407	K562 (myelogenous leukemia)	NULL
EXP010751	sc-22823	Homo sapiens		EXP010027	423	unspecified	O75461	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010752	GATA-2	Homo sapiens		EXP010619	664	unspecified	P23769	SH-SY5Y (neuroblastoma)	NULL
EXP010753	sc-12732	Mus musculus		EXP010662	644	unspecified	P12979	myocytes	NULL
EXP010754	sc-229	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	unspecified	P22415	A549 (lung carcinoma)	NULL
EXP010756	sc-764	Homo sapiens		EXP010328	514	unspecified	P01106	K562 (myelogenous leukemia)	NULL
EXP010757	sc-735	Homo sapiens		EXP010581	356	unspecified	P21675	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010759	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010760	ab62126	Mus musculus		EXP010703	1144	unspecified	P29037	CH12.LX (Mouse lymphoma)	NULL
EXP010761	NRSF	Homo sapiens		EXP010671	514	unspecified	Q13127	K562 (myelogenous leukemia)	NULL
EXP010762	sc-1974	Homo sapiens		EXP010375	356	unspecified	Q02548	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010763	10007663	Homo sapiens	For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	EXP010545	430	unspecified	Q12772	HepG2 (hepatoblastoma)	NULL
EXP010764	sc-764	Mus musculus		EXP010613	1144	unspecified	P01108	CH12.LX (Mouse lymphoma)	NULL
EXP010765		Homo sapiens	30 m of Interferon alpha (Snyder)	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010766	2899	Homo sapiens		EXP010901	335	unspecified	P49711	GM06990 (female B-cells)	NULL
EXP010768	2899	Homo sapiens		EXP010787	867	unspecified	P49711	WI-38 (lung fibroblasts)	NULL
EXP010769	sc-2027	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010770	sc-7202	Homo sapiens	12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	EXP010486	583	unspecified	P01100	MCF10A (breast epithelial cells)	NULL
EXP010772	sc-188	Homo sapiens		EXP010137	356	unspecified	P18847	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010773	sc-150	Mus musculus		EXP010662	644	unspecified	P28033	myocytes	NULL
EXP010774	sc-197	Homo sapiens		EXP010769	38	unspecified	P61244	A549 (lung carcinoma)	NULL
EXP010775		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP001029		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010777	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	358	chip_control	NULL	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP010780		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP054026	Input	Homo sapiens	Treatment: None;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010782		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP054098	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: starved by washing cells 2x in PBS; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054092	521	normal	O00472	KH2 (embryonic stem cells)	NULL
EXP054090	none	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP010788	eGFP	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010789		Mus musculus		NULL	117	chip_control	NULL	Bruce4 (embryonic stem cells)	NULL
EXP010791		Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP054027	Input	Homo sapiens	Treatment: None;	NULL	2605	chip_control	NULL	HNEK (epidermal keratinocytes)	NULL
EXP010793	sc-2027	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP010795	Input	Homo sapiens	NULL	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010796		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010797		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010799		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054097	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: treated with 0.3 uM of all-trans retinoic acid for 6 hours; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054091	521	normal	Q9ESC8	KH2 (embryonic stem cells)	NULL
EXP010803	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010806	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	363	chip_control	NULL	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP010807		Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010809		Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP054093	none	Homo sapiens	Treatment: treated with serum for 30 minutes; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP054126	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: 500nM JQ1 treated for 24hr; Source: Freshly isolated human cells;	NULL	881	normal	O60885	CD4+ T-cells	NULL
EXP010816		Mus musculus		NULL	644	chip_control	NULL	myocytes	NULL
EXP010817		Mus musculus		NULL	1165	chip_control	NULL	cortical plate	NULL
EXP054029	Control	Homo sapiens	Treatment: None;	NULL	157	chip_control	NULL	CD14+ monocytes	NULL
EXP010820		Mus musculus		NULL	799	chip_control	NULL	small intestine	NULL
EXP010821	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	339	chip_control	NULL	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP010822		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP054113	none	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP010824		Homo sapiens		NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010825	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	366	chip_control	NULL	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP010828		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP054092	none	Homo sapiens	Treatment: starved by washing cells 2x in PBS; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP054091	none	Mus musculus	Treatment: treated with 0.3 uM of all-trans retinoic acid for 6 hours; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP010831		Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010832		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010834	sc-2027	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010835		Mus musculus		NULL	1174	chip_control	NULL	MEL cell line	NULL
EXP010836		Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP010837	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	362	chip_control	NULL	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP010839		Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP010840		Mus musculus		NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010841	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	364	chip_control	NULL	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP010843		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010844		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010845		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP010847	eGFP	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP054127	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: untreated; Source: Freshly isolated human cells;	NULL	878	normal	O60885	embryonic stem cells	NULL
EXP010849		Mus musculus	7 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010850	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	357	chip_control	NULL	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP010855	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	361	chip_control	NULL	GM15510 (B-cells)	NULL
EXP010856		Homo sapiens		NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010857		Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP010858		Mus musculus		NULL	917	chip_control	NULL	spleen	NULL
EXP010859		Mus musculus		NULL	644	chip_control	NULL	myocytes	NULL
EXP010860		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP010861		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010863		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010864		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010865	Input	Homo sapiens	NULL	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010868		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010869		Mus musculus		NULL	547	chip_control	NULL	limb	NULL
EXP010870		Homo sapiens		NULL	1180	chip_control	NULL	neural cell	NULL
EXP010871		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010872		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP054125	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: untreated; Source: Freshly isolated human cells;	NULL	881	normal	O60885	CD4+ T-cells	NULL
EXP010874		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP056002	anti-CTCF (Millipore, 07-729)	Mus musculus	Developmental stage: Embryonic day 14.5;	EXP010880	2736	normal	Q61164	whole brain	NULL
EXP054112	none	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP010879		Mus musculus	3 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010880		Mus musculus		NULL	143	chip_control	NULL	brain	NULL
EXP010882		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP010883		Mus musculus		NULL	644	chip_control	NULL	myocytes	NULL
EXP010885		Mus musculus		NULL	103	chip_control	NULL	bone marrow	NULL
EXP010887		Mus musculus	30 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010888		Mus musculus		NULL	523	chip_control	NULL	kidney	NULL
EXP010892		Homo sapiens		NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP010894		Mus musculus		NULL	162	chip_control	NULL	olfactory bulb	NULL
EXP010895		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010896		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP010897		Mus musculus	14 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP010899		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP010900		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP010905		Homo sapiens		NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP054058	Control	Homo sapiens	Treatment: None;	NULL	164	normal	A0AVK6	CD20+ B-cells	NULL
EXP010910		Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP010911	sc-2027	Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010917		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010918		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010919		Homo sapiens		NULL	1180	chip_control	NULL	neural cell	NULL
EXP010920		Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP010923		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP010927	sc-2027	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	NULL	365	chip_control	NULL	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054095	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054090	521	normal	Q9ESC8	KH2 (embryonic stem cells)	NULL
EXP010930		Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP010931		Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	NULL	1174	chip_control	NULL	MEL cell line	NULL
EXP010933	2899	Homo sapiens		NULL	346	unspecified	P49711	GM12866 (male B-cells)	NULL
EXP010934	sc-101184	Homo sapiens		EXP010796	113	unspecified	Q15561	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010935	sc-1694	Homo sapiens		EXP010530	514	unspecified	P05412	K562 (myelogenous leukemia)	NULL
EXP010936	sc-110	Homo sapiens		EXP010799	113	unspecified	P18146	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010938	200-401-194	Homo sapiens		EXP010066	489	unspecified	P48382	IMR90 (lung fibroblasts)	NULL
EXP010939	sc-17834	Homo sapiens		EXP010843	356	unspecified	O95644	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010941	sc-268	Homo sapiens		EXP010832	665	unspecified	P23771	SK-N-SH (neuroblastoma)	NULL
EXP010942	sc-12984	Mus musculus		EXP010006	912	unspecified	P22091	megakaryocytes	NULL
EXP010945	sc-604	Homo sapiens		EXP010895	113	unspecified	P15408	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010946	2899	Homo sapiens		NULL	348	unspecified	P49711	GM12868 (female B-cells)	NULL
EXP010947	sc-229	Mus musculus		EXP010828	1153	unspecified	Q61069	C2C12 (myoblasts)	NULL
EXP010948	07-729	Homo sapiens		EXP010813	910	unspecified	P49711	lung	NULL
EXP010949	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010841	364	unspecified	Q04206	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP010950	sc-356	Mus musculus		EXP010006	912	unspecified	P26323	megakaryocytes	NULL
EXP010951	sc-271940	Homo sapiens		EXP010895	113	unspecified	P24468	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054031	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	EXP054026	430	normal	P49711	HepG2 (hepatoblastoma)	NULL
EXP054072	NCoR (Bethyl Laboratories, A301-145A)	Homo sapiens	Treatment: None;	NULL	514	normal	O75376	K562 (myelogenous leukemia)	NULL
EXP010954	sc-240	Homo sapiens		EXP010864	430	unspecified	P16220	HepG2 (hepatoblastoma)	NULL
EXP054083	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: 1 h with 0.02% Ethanol;	NULL	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP010956	MafK_(ab50322)	Mus musculus	None	EXP010793	230	unspecified	Q61827	ES-E14 (E14, embryonic stem cells)	NULL
EXP010957	NB100-1800	Mus musculus		EXP010644	1174	unspecified	O35185	MEL cell line	NULL
EXP010958	sc-281	Homo sapiens		EXP010671	514	unspecified	P25490	K562 (myelogenous leukemia)	NULL
EXP010959	sc-240	Homo sapiens		EXP010822	514	unspecified	P16220	K562 (myelogenous leukemia)	NULL
EXP010960	sc-636	Homo sapiens		EXP010822	514	unspecified	P49716	K562 (myelogenous leukemia)	NULL
EXP010961	sc-281	Homo sapiens		EXP010874	665	unspecified	P25490	SK-N-SH (neuroblastoma)	NULL
EXP010962	sc-150	Mus musculus		EXP010828	1153	unspecified	P28033	C2C12 (myoblasts)	NULL
EXP010963	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010964	200-401-194	Homo sapiens		EXP010911	665	unspecified	P48382	SK-N-SH (neuroblastoma)	NULL
EXP010965	07-729	Homo sapiens		EXP010914	909	unspecified	P49711	kidney	NULL
EXP054053	PLU1 (YangShi lab)	Homo sapiens	Treatment: None;	NULL	376	normal	Q9UGL1	WA01 (H1, human embryonic stem cells)	NULL
EXP054063	REST (Millipore, 17-641 )	Homo sapiens	Treatment: None;	NULL	514	normal	Q13127	K562 (myelogenous leukemia)	NULL
EXP010968	sc-28312	Homo sapiens		EXP010832	665	unspecified	Q06546	SK-N-SH (neuroblastoma)	NULL
EXP010969	sc-101184	Homo sapiens		EXP010899	417	unspecified	Q15561	HCT-116 (colon carcinoma)	NULL
EXP010970	sc-101184	Homo sapiens		EXP010900	417	unspecified	Q15561	HCT-116 (colon carcinoma)	NULL
EXP010971	07-729	Homo sapiens		EXP010810	360	unspecified	P49711	GM13977 (female B-cells)	NULL
EXP010972	sc-229	Homo sapiens		EXP010871	665	unspecified	P22415	SK-N-SH (neuroblastoma)	NULL
EXP010973	NRSF	Homo sapiens		EXP010856	504	unspecified	Q13127	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010974	sc-265	Mus musculus	24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010807	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP010975	sc-150	Homo sapiens		EXP010856	504	unspecified	P17676	Ishikawa (endometrial adenocarcinoma)	NULL
EXP010977	ab50322	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010931	1174	unspecified	Q61827	MEL cell line	NULL
EXP010978	sc-13125	Mus musculus		EXP010265	1174	unspecified	P25976	MEL cell line	NULL
EXP010979	sc-28312	Homo sapiens		EXP010799	113	unspecified	Q06546	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010980	sc-22823	Homo sapiens		EXP010860	376	unspecified	O75461	WA01 (H1, human embryonic stem cells)	NULL
EXP010983	sc-313	Homo sapiens		EXP010872	665	unspecified	Q02078	SK-N-SH (neuroblastoma)	NULL
EXP010984	sc-265	Mus musculus		EXP010006	912	unspecified	P17679	megakaryocytes	NULL
EXP010985	sc-764	Homo sapiens		EXP010852	430	unspecified	P01106	HepG2 (hepatoblastoma)	NULL
EXP010986	sc-240	Homo sapiens		EXP010860	376	unspecified	P16220	WA01 (H1, human embryonic stem cells)	NULL
EXP010987	2899	Homo sapiens		NULL	350	unspecified	P49711	GM12870 (male B-cells)	NULL
EXP010988	HPA004051	Mus musculus		EXP010613	1144	unspecified	E9Q1A5	CH12.LX (Mouse lymphoma)	NULL
EXP010989	sc-74	Homo sapiens		EXP010900	417	unspecified	P17535	HCT-116 (colon carcinoma)	NULL
EXP010990	CTCF	Mus musculus		EXP010880	143	unspecified	Q61164	brain	NULL
EXP010991	sc-74	Homo sapiens		EXP010899	417	unspecified	P17535	HCT-116 (colon carcinoma)	NULL
EXP010992	sc-101184	Homo sapiens		EXP010868	38	unspecified	Q15561	A549 (lung carcinoma)	NULL
EXP010993	NRSF	Homo sapiens		EXP010870	1180	unspecified	Q13127	neural cell	NULL
EXP010994	sc-197	Homo sapiens		EXP010832	665	unspecified	P61244	SK-N-SH (neuroblastoma)	NULL
EXP010995	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010927	365	unspecified	Q04206	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP010996	07-729	Homo sapiens		EXP010873	337	unspecified	P49711	GM10248 (male B-cells)	NULL
EXP010997	sc-81188	Homo sapiens		EXP010843	356	unspecified	P15336	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010999	sc-17824	Homo sapiens		EXP010899	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP011000	sc-17824	Homo sapiens		EXP010900	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP011001	sc-357	Homo sapiens		EXP010874	665	unspecified	Q99081	SK-N-SH (neuroblastoma)	NULL
EXP011002	H00010782-M01	Homo sapiens		EXP010587	376	unspecified	Q96GC6	WA01 (H1, human embryonic stem cells)	NULL
EXP011004	sc-101184	Homo sapiens		EXP010797	113	unspecified	Q15561	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011005	sc-266	Homo sapiens		EXP010630	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP011006	2899	Homo sapiens		EXP010926	955	unspecified	P49711	primary foreskin fibroblasts	NULL
EXP011007	sc-30189	Mus musculus		EXP010613	1144	unspecified	Q8CFE3	CH12.LX (Mouse lymphoma)	NULL
EXP011008	sc-631	Homo sapiens		EXP010895	113	unspecified	P32519	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011009	sc-66882	Homo sapiens		EXP010834	356	unspecified	P11474	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011010	07-729	Homo sapiens		EXP010852	430	unspecified	P49711	HepG2 (hepatoblastoma)	NULL
EXP011011	GATA-1	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010931	1174	unspecified	P17679	MEL cell line	NULL
EXP011012	sc-22810	Mus musculus		EXP010644	1174	unspecified	Q00422	MEL cell line	NULL
EXP011013	sc-265	Mus musculus	14 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010897	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP011014	sc-74	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	P17535	A549 (lung carcinoma)	NULL
EXP011015	sc-553	Homo sapiens		EXP010872	665	unspecified	P19793	SK-N-SH (neuroblastoma)	NULL
EXP011016	sc-631	Homo sapiens		EXP010832	665	unspecified	P32519	SK-N-SH (neuroblastoma)	NULL
EXP011017	HPA004051	Mus musculus		EXP010793	230	unspecified	E9Q1A5	ES-E14 (E14, embryonic stem cells)	NULL
EXP011018	sc-271940	Homo sapiens		EXP010799	113	unspecified	P24468	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011019	NRSF	Homo sapiens		EXP010895	113	unspecified	Q13127	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011020	sc-150	Homo sapiens		EXP010782	38	unspecified	P17676	A549 (lung carcinoma)	NULL
EXP011021	sc-13125	Mus musculus		EXP010613	1144	unspecified	P25976	CH12.LX (Mouse lymphoma)	NULL
EXP011022	07-729	Homo sapiens		EXP010848	38	unspecified	P49711	A549 (lung carcinoma)	NULL
EXP011023	sc-81335	Homo sapiens		EXP010832	665	unspecified	P08651	SK-N-SH (neuroblastoma)	NULL
EXP011024	07-729	Homo sapiens		EXP010915	1177	unspecified	P49711	LNCaP clone FGC	NULL
EXP011025	sc-74	Homo sapiens		EXP010832	665	unspecified	P17535	SK-N-SH (neuroblastoma)	NULL
EXP011026	sc-197	Mus musculus		EXP010828	1153	unspecified	P28574	C2C12 (myoblasts)	NULL
EXP011027	sc-636	Homo sapiens		EXP010861	514	unspecified	P49716	K562 (myelogenous leukemia)	NULL
EXP011028	AF4185	Homo sapiens		EXP010673	430	unspecified	P50539	HepG2 (hepatoblastoma)	NULL
EXP011029	sc-150	Homo sapiens		EXP010868	38	unspecified	P17676	A549 (lung carcinoma)	NULL
EXP011030	sc-265	Mus musculus	30 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010887	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP011031	sc-6554	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	Q9Y261	A549 (lung carcinoma)	NULL
EXP011032	HPA006672	Mus musculus		EXP010613	1144	unspecified	Q8BGS3	CH12.LX (Mouse lymphoma)	NULL
EXP011033	sc-335	Homo sapiens		EXP010900	417	unspecified	P11831	HCT-116 (colon carcinoma)	NULL
EXP011034	sc-335	Homo sapiens		EXP010899	417	unspecified	P11831	HCT-116 (colon carcinoma)	NULL
EXP011037	sc-5916	Homo sapiens		EXP010899	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP011038	sc-5916	Homo sapiens		EXP010900	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP011039	sc-764	Homo sapiens		EXP010866	356	unspecified	P01106	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011040	sc-604	Homo sapiens		EXP010872	665	unspecified	P15408	SK-N-SH (neuroblastoma)	NULL
EXP054035	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP011042	sc-357	Homo sapiens		EXP010824	504	unspecified	Q99081	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011043	sc-268	Homo sapiens		EXP010895	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011044	sc-150	Homo sapiens		EXP010899	417	unspecified	P17676	HCT-116 (colon carcinoma)	NULL
EXP011045	07-729	Homo sapiens		EXP010878	370	unspecified	P49711	GM20000 (B-cells)	NULL
EXP011046	sc-150	Homo sapiens		EXP010900	417	unspecified	P17676	HCT-116 (colon carcinoma)	NULL
EXP011047	sc-81325	Homo sapiens		EXP010843	356	unspecified	Q9BTC8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011048	sc-502	Homo sapiens		EXP010832	665	unspecified	Q08050	SK-N-SH (neuroblastoma)	NULL
EXP011049	sc-764	Homo sapiens		EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011050	sc-101184	Homo sapiens		EXP010782	38	unspecified	Q15561	A549 (lung carcinoma)	NULL
EXP011051	07-729	Homo sapiens		NULL	368	unspecified	P49711	GM19239 (male B-cells lymphoblastoid cell line)	NULL
EXP011053	CTCF	Mus musculus		EXP010820	799	unspecified	Q61164	small intestine	NULL
EXP011054	sc-268	Homo sapiens		EXP010782	38	unspecified	P23771	A549 (lung carcinoma)	NULL
EXP011055	sc-281	Homo sapiens		EXP010856	504	unspecified	P25490	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011056	sc-240	Homo sapiens		EXP010918	356	unspecified	P16220	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011057	sc-764	Homo sapiens		NULL	376	unspecified	P01106	WA01 (H1, human embryonic stem cells)	NULL
EXP011058	sc-74	Homo sapiens		EXP010834	356	unspecified	P17535	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011059	sc-150	Homo sapiens		EXP010824	504	unspecified	P17676	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011061	CTCF	Mus musculus		EXP010858	917	unspecified	Q61164	spleen	NULL
EXP011064	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010837	362	unspecified	Q04206	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP011065	sc-553	Homo sapiens		EXP010832	665	unspecified	P19793	SK-N-SH (neuroblastoma)	NULL
EXP011066	sc-22810	Mus musculus		EXP010613	1144	unspecified	Q00422	CH12.LX (Mouse lymphoma)	NULL
EXP011067	sc-313	Homo sapiens		EXP010832	665	unspecified	Q02078	SK-N-SH (neuroblastoma)	NULL
EXP011069	sc-265	Mus musculus	7 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010849	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP011070	sc-604	Homo sapiens		EXP010799	113	unspecified	P15408	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011072	sc-15914	Homo sapiens		EXP010769	38	unspecified	P49711	A549 (lung carcinoma)	NULL
EXP011073	sc-6554	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	Q9Y261	A549 (lung carcinoma)	NULL
EXP011074	sc-74	Homo sapiens		EXP010895	113	unspecified	P17535	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011075	sc-110	Homo sapiens		EXP010856	504	unspecified	P18146	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011077	sc-268	Homo sapiens		EXP010874	665	unspecified	P23771	SK-N-SH (neuroblastoma)	NULL
EXP011078	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010850	357	unspecified	Q04206	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP011079	sc-271940	Homo sapiens		EXP010780	430	unspecified	P24468	HepG2 (hepatoblastoma)	NULL
EXP011080	sc-101184	Homo sapiens		EXP010872	665	unspecified	Q15561	SK-N-SH (neuroblastoma)	NULL
EXP011081	sc-502	Homo sapiens		EXP010843	356	unspecified	Q08050	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011082	NRSF	Homo sapiens		EXP010824	504	unspecified	Q13127	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011083	sc-335	Homo sapiens		EXP010856	504	unspecified	P11831	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011084	sc-268	Homo sapiens		EXP010917	38	unspecified	P23771	A549 (lung carcinoma)	NULL
EXP011085	CTCF	Mus musculus		EXP010869	547	unspecified	Q61164	limb	NULL
EXP011087	ab85725	Mus musculus		EXP010644	1174	unspecified	P56671	MEL cell line	NULL
EXP011088	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010777	358	unspecified	Q04206	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP054064	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2612	normal	P49711	RO01746 (CD14+ monocytes)	NULL
EXP054084	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: 1 h with 100 nM Dexamethasone;	NULL	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP011092	ab55744	Homo sapiens		EXP010911	665	unspecified	Q16656	SK-N-SH (neuroblastoma)	NULL
EXP011093	sc-30189	Mus musculus		EXP010644	1174	unspecified	Q8CFE3	MEL cell line	NULL
EXP011094	sc-502	Homo sapiens		EXP010856	504	unspecified	Q08050	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011095	07-729	Homo sapiens		NULL	215	unspecified	P49711	keratinocytes	NULL
EXP011096	sc-5916	Homo sapiens		EXP010796	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011097	sc-25388	Homo sapiens		EXP010780	430	unspecified	P37275	HepG2 (hepatoblastoma)	NULL
EXP011098	sc-605	Mus musculus		EXP010828	1153	unspecified	P48755	C2C12 (myoblasts)	NULL
EXP011099	sc-240	Homo sapiens		EXP010780	430	unspecified	P16220	HepG2 (hepatoblastoma)	NULL
EXP011100	sc-631	Homo sapiens		EXP010874	665	unspecified	P32519	SK-N-SH (neuroblastoma)	NULL
EXP011101	sc-197	Homo sapiens		EXP010895	113	unspecified	P61244	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011102	sc-240	Homo sapiens		EXP010824	504	unspecified	P16220	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011103	sc-764	Homo sapiens		EXP010769	38	unspecified	P01106	A549 (lung carcinoma)	NULL
EXP011104	sc-891	Homo sapiens		EXP010832	665	unspecified	P40426	SK-N-SH (neuroblastoma)	NULL
EXP011107	sc-735	Homo sapiens		EXP010856	504	unspecified	P21675	Ishikawa (endometrial adenocarcinoma)	NULL
EXP054046	JARID1A (abcam, ab26049)	Homo sapiens	Treatment: None;	NULL	376	normal	P29375	WA01 (H1, human embryonic stem cells)	NULL
EXP011109	sc-197	Homo sapiens		EXP010872	665	unspecified	P61244	SK-N-SH (neuroblastoma)	NULL
EXP011110	sc-502	Homo sapiens		EXP010799	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011111	sc-764	Homo sapiens		EXP010288	113	unspecified	P01106	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011112	sc-350	Mus musculus		EXP010613	1144	unspecified	P27577	CH12.LX (Mouse lymphoma)	NULL
EXP011113	sc-15914	Homo sapiens		EXP010911	665	unspecified	P49711	SK-N-SH (neuroblastoma)	NULL
EXP011114	ab85725	Mus musculus		EXP010613	1144	unspecified	P56671	CH12.LX (Mouse lymphoma)	NULL
EXP011115	sc-891	Homo sapiens		EXP010872	665	unspecified	P40426	SK-N-SH (neuroblastoma)	NULL
EXP011116	07-729	Homo sapiens		NULL	358	unspecified	P49711	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP011117	sc-357	Homo sapiens		EXP010856	504	unspecified	Q99081	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011118	sc-74	Homo sapiens		EXP010874	665	unspecified	P17535	SK-N-SH (neuroblastoma)	NULL
EXP011119	HPA004051	Homo sapiens		EXP010530	514	unspecified	Q8TF68	K562 (myelogenous leukemia)	NULL
EXP011120	sc-22805	Homo sapiens		EXP010892	438	unspecified	P17947	HL-60 (acute myeloid leukemia)	NULL
EXP011121	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010806	363	unspecified	Q04206	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP011122	sc-25388	Homo sapiens		EXP010864	430	unspecified	P37275	HepG2 (hepatoblastoma)	NULL
EXP011124	HPA004051	Homo sapiens		EXP010745	356	unspecified	Q8TF68	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011125	07-729	Homo sapiens		EXP010886	338	unspecified	P49711	GM10266 (male B-cells)	NULL
EXP011126	sc-197	Homo sapiens		EXP010856	504	unspecified	P61244	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011127	07-729	Homo sapiens		EXP010846	633	unspecified	P49711	spleen	NULL
EXP011128	sc-74	Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	unspecified	P17535	A549 (lung carcinoma)	NULL
EXP011129	sc-101184	Homo sapiens		EXP010513	376	unspecified	Q15561	WA01 (H1, human embryonic stem cells)	NULL
EXP011130	sc-101184	Homo sapiens		EXP010832	665	unspecified	Q15561	SK-N-SH (neuroblastoma)	NULL
EXP011131	sc-28312	Homo sapiens		EXP010895	113	unspecified	Q06546	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011132	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010855	361	unspecified	Q04206	GM15510 (B-cells)	NULL
EXP011133	sc-197	Homo sapiens		EXP010780	430	unspecified	P61244	HepG2 (hepatoblastoma)	NULL
EXP011134	sc-81335	Homo sapiens		EXP010843	356	unspecified	P08651	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011135	sc-265	Mus musculus	3 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison)	EXP010879	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP011136	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010825	366	unspecified	Q04206	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP011137	sc-735	Homo sapiens		EXP010870	1180	unspecified	P21675	neural cell	NULL
EXP011138	sc-891	Homo sapiens		EXP010782	38	unspecified	P40426	A549 (lung carcinoma)	NULL
EXP011139	sc-81335	Homo sapiens		EXP010874	665	unspecified	P08651	SK-N-SH (neuroblastoma)	NULL
EXP011140	10007663	Homo sapiens		EXP010834	356	unspecified	Q12772	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011141	07-729	Homo sapiens	12 hrs with 1 nM Methyltrienolone (R1881) (Crawford)	EXP010915	1177	unspecified	P49711	LNCaP clone FGC	NULL
EXP011142	sc-229	Homo sapiens		EXP010856	504	unspecified	P22415	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011143	sc-150	Homo sapiens		EXP010843	356	unspecified	P17676	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011144	AF4185	Homo sapiens		EXP010066	489	unspecified	P50539	IMR90 (lung fibroblasts)	NULL
EXP011145	sc-197	Homo sapiens		EXP010860	376	unspecified	P61244	WA01 (H1, human embryonic stem cells)	NULL
EXP011146	sc-183	Homo sapiens		EXP010900	417	unspecified	P15407	HCT-116 (colon carcinoma)	NULL
EXP011147	sc-183	Homo sapiens		EXP010899	417	unspecified	P15407	HCT-116 (colon carcinoma)	NULL
EXP011148	sc-197	Homo sapiens		EXP010899	417	unspecified	P61244	HCT-116 (colon carcinoma)	NULL
EXP011149	sc-197	Homo sapiens		EXP010900	417	unspecified	P61244	HCT-116 (colon carcinoma)	NULL
EXP011150	sc-502	Homo sapiens		EXP010824	504	unspecified	Q08050	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011151	sc-110	Homo sapiens		EXP010899	417	unspecified	P18146	HCT-116 (colon carcinoma)	NULL
EXP011152	sc-110	Homo sapiens		EXP010900	417	unspecified	P18146	HCT-116 (colon carcinoma)	NULL
EXP054061	NSD2 (abcam, ab75359)	Homo sapiens	Treatment: None;	NULL	514	normal	O96028	K562 (myelogenous leukemia)	NULL
EXP011154	sc-74442	Homo sapiens		EXP010843	356	unspecified	P42229	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011155	sc-22805	Homo sapiens		EXP010905	438	unspecified	P17947	HL-60 (acute myeloid leukemia)	NULL
EXP011156	sc-8984	Homo sapiens		EXP010834	356	unspecified	P36956	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011157	NRSF	Homo sapiens		EXP010791	712	unspecified	Q13127	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP011158	sc-188	Homo sapiens		EXP010899	417	unspecified	P18847	HCT-116 (colon carcinoma)	NULL
EXP011159	sc-229	Homo sapiens		EXP010900	417	unspecified	P22415	HCT-116 (colon carcinoma)	NULL
EXP011160	sc-229	Homo sapiens		EXP010899	417	unspecified	P22415	HCT-116 (colon carcinoma)	NULL
EXP011162	sc-188	Homo sapiens		EXP010900	417	unspecified	P18847	HCT-116 (colon carcinoma)	NULL
EXP011163	2899	Homo sapiens		NULL	347	unspecified	P49711	GM12867 (female B-cells)	NULL
EXP011164	sc-350	Mus musculus		EXP010644	1174	unspecified	P27577	MEL cell line	NULL
EXP011165	sc-101184	Homo sapiens		EXP010856	504	unspecified	Q15561	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011166	sc-28312	Homo sapiens		EXP010874	665	unspecified	Q06546	SK-N-SH (neuroblastoma)	NULL
EXP011167	sc-81335	Homo sapiens		EXP010824	504	unspecified	P08651	Ishikawa (endometrial adenocarcinoma)	NULL
EXP051006	2899	Homo sapiens		EXP039117	446	unspecified	P49711	HPF (pulmonary fibroblasts isolated from lung tissue)	NULL
EXP011169	07-729	Homo sapiens		EXP010288	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011170	NRSF	Homo sapiens		EXP010899	417	unspecified	Q13127	HCT-116 (colon carcinoma)	NULL
EXP011171	NRSF	Homo sapiens		EXP010900	417	unspecified	Q13127	HCT-116 (colon carcinoma)	NULL
EXP011172	ab85725	Homo sapiens		EXP010066	489	unspecified	P56270	IMR90 (lung fibroblasts)	NULL
EXP011173	07-729	Homo sapiens		EXP010866	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011174	2899	Homo sapiens		NULL	349	unspecified	P49711	GM12869 (female B-cells)	NULL
EXP011175	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010803	356	unspecified	Q04206	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011176	sc-197	Homo sapiens		EXP010782	38	unspecified	P61244	A549 (lung carcinoma)	NULL
EXP011177	sc-372	Homo sapiens	human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	EXP010821	339	unspecified	Q04206	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP011178	sc-502	Homo sapiens		EXP010874	665	unspecified	Q08050	SK-N-SH (neuroblastoma)	NULL
EXP011179	sc-271940	Homo sapiens		EXP010864	430	unspecified	P24468	HepG2 (hepatoblastoma)	NULL
EXP011180	ab60931	Mus musculus		EXP010644	1174	unspecified	Q64705	MEL cell line	NULL
EXP011181	1277-1	Homo sapiens		EXP010530	514	unspecified	P19419	K562 (myelogenous leukemia)	NULL
EXP011182	AF4185	Homo sapiens		EXP010911	665	unspecified	P50539	SK-N-SH (neuroblastoma)	NULL
EXP011183	sc-604	Homo sapiens		EXP010832	665	unspecified	P15408	SK-N-SH (neuroblastoma)	NULL
EXP011184	sc-34508	Homo sapiens		EXP010856	504	unspecified	O95365	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011185	sc-197	Homo sapiens		EXP010799	113	unspecified	P61244	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011186	07-729	Homo sapiens		NULL	367	unspecified	P49711	GM19238 (female B-cells lymphoblastoid cell lines)	NULL
EXP011187	sc-101553	Homo sapiens		EXP010843	356	unspecified	Q13761	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011188	sc-5916	Homo sapiens		EXP010895	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011189	2899	Homo sapiens		NULL	351	unspecified	P49711	GM12871 (male B-cells)	NULL
EXP011190	HPA006672	Mus musculus		EXP010644	1174	unspecified	Q8BGS3	MEL cell line	NULL
EXP011191	sc-265	Mus musculus		EXP010840	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP011192	sc-74	Homo sapiens		EXP010911	665	unspecified	P17535	SK-N-SH (neuroblastoma)	NULL
EXP011193	07-729	Homo sapiens		NULL	369	unspecified	P49711	GM19240 (B cells Lymphoblastoid Cell Lines)	NULL
EXP011194	sc-23871	Homo sapiens		EXP010832	665	unspecified	Q86T24	SK-N-SH (neuroblastoma)	NULL
EXP011195	sc-240	Homo sapiens		EXP010856	504	unspecified	P16220	Ishikawa (endometrial adenocarcinoma)	NULL
EXP054057	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	2611	normal	P49711	CD20+	NULL
EXP011197	NRSF	Homo sapiens		EXP010905	438	unspecified	Q13127	HL-60 (acute myeloid leukemia)	NULL
EXP011198	07-729	Homo sapiens		EXP010932	920	unspecified	P49711	pancreas	NULL
EXP011199	07-729	Homo sapiens		EXP010890	1159	unspecified	P49711	medulloblastoma	NULL
EXP011200	sc-81335	Homo sapiens		EXP010856	504	unspecified	P08651	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011201	07-729	Homo sapiens		NULL	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP011202	sc-335	Homo sapiens		EXP010797	113	unspecified	P11831	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011203	sc-335	Homo sapiens		EXP010796	113	unspecified	P11831	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011204	sc-28312	Homo sapiens		EXP010905	438	unspecified	Q06546	HL-60 (acute myeloid leukemia)	NULL
EXP011205	sc-197	Homo sapiens		EXP010824	504	unspecified	P61244	Ishikawa (endometrial adenocarcinoma)	NULL
EXP011207	sc-22823	Homo sapiens		EXP010782	38	unspecified	O75461	A549 (lung carcinoma)	NULL
EXP011208	sc-15914	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010931	1174	unspecified	Q61164	MEL cell line	NULL
EXP011209	sc-735	Homo sapiens		EXP010919	1180	unspecified	P21675	neural cell	NULL
EXP011210	NRSF	Homo sapiens		EXP010919	1180	unspecified	Q13127	neural cell	NULL
EXP011211	sc-502	Homo sapiens		EXP010895	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011212	sc-240	Homo sapiens		EXP010844	356	unspecified	P16220	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011213	CTCF	Mus musculus		EXP010789	117	unspecified	Q61164	Bruce4 (embryonic stem cells)	NULL
EXP011214	07-729	Homo sapiens		EXP010884	359	unspecified	P49711	GM13976 (female B-cells)	NULL
EXP011215	sc-197	Homo sapiens		EXP010864	430	unspecified	P61244	HepG2 (hepatoblastoma)	NULL
EXP011216	sc-735	Homo sapiens		EXP010796	113	unspecified	P21675	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011217	sc-735	Homo sapiens		EXP010797	113	unspecified	P21675	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011218	sc-110	Homo sapiens		EXP010895	113	unspecified	P18146	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011219	sc-357	Homo sapiens		EXP010832	665	unspecified	Q99081	SK-N-SH (neuroblastoma)	NULL
EXP011220	sc-30189	Homo sapiens		EXP010066	489	unspecified	Q9UKL0	IMR90 (lung fibroblasts)	NULL
EXP011221	sc-357	Homo sapiens		EXP010797	113	unspecified	Q99081	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011222	sc-281	Homo sapiens		EXP010832	665	unspecified	P25490	SK-N-SH (neuroblastoma)	NULL
EXP011223	sc-150	Homo sapiens		EXP010895	113	unspecified	P17676	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011224	sc-229	Homo sapiens		EXP010832	665	unspecified	P22415	SK-N-SH (neuroblastoma)	NULL
EXP054038	CTCF (Millipore, 07-729)	Homo sapiens	Treatment: None;	NULL	356	normal	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011226	sc-357	Homo sapiens		EXP010796	113	unspecified	Q99081	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP011227	sc-6327	Homo sapiens		EXP010745	356	unspecified	P39880	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011228	sc-6327	Homo sapiens		EXP010530	514	unspecified	P39880	K562 (myelogenous leukemia)	NULL
EXP011230	sc-74	Homo sapiens		EXP010857	111	unspecified	P17535	T47D (invasive ductal carcinoma)	NULL
EXP011231	07-729	Homo sapiens		NULL	357	unspecified	P49711	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP011232	ab50322	Homo sapiens		EXP010745	356	unspecified	O60675	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP011233	sc-631	Homo sapiens		EXP010899	417	unspecified	P32519	HCT-116 (colon carcinoma)	NULL
EXP011234	sc-631	Homo sapiens		EXP010900	417	unspecified	P32519	HCT-116 (colon carcinoma)	NULL
EXP011235	HPA004051	Mus musculus		EXP010644	1174	unspecified	E9Q1A5	MEL cell line	NULL
EXP030000	INPUT	Homo sapiens		NULL	553	chip_control	NULL	LoVo (colorectal adenocarcinoma)	NULL
EXP030001	IgG	Homo sapiens		NULL	553	chip_control	NULL	LoVo (colorectal adenocarcinoma)	NULL
EXP030002	MEF2C	Homo sapiens		EXP030000	553	unspecified	Q06413	LoVo (colorectal adenocarcinoma)	NULL
EXP030003	MEF2A	Homo sapiens		EXP030000	553	unspecified	Q02078	LoVo (colorectal adenocarcinoma)	NULL
EXP030004	ZNF639	Homo sapiens		EXP030000	553	unspecified	Q9UID6	LoVo (colorectal adenocarcinoma)	NULL
EXP030005	ZNF250	Homo sapiens		EXP030000	553	unspecified	P15622	LoVo (colorectal adenocarcinoma)	NULL
EXP030006	HOXD13	Homo sapiens		EXP030000	553	unspecified	P35453	LoVo (colorectal adenocarcinoma)	NULL
EXP030007	RORA	Homo sapiens		EXP030000	553	unspecified	P35398	LoVo (colorectal adenocarcinoma)	NULL
EXP030008	REST	Homo sapiens		EXP030000	553	unspecified	Q13127	LoVo (colorectal adenocarcinoma)	NULL
EXP030009	MXI1	Homo sapiens		EXP030000	553	unspecified	P50539	LoVo (colorectal adenocarcinoma)	NULL
EXP030010	HOXD11	Homo sapiens		EXP030000	553	unspecified	P31277	LoVo (colorectal adenocarcinoma)	NULL
EXP030011	FOXF1	Homo sapiens		EXP030000	553	unspecified	Q12946	LoVo (colorectal adenocarcinoma)	NULL
EXP030012	FOXF2	Homo sapiens		EXP030000	553	unspecified	Q12947	LoVo (colorectal adenocarcinoma)	NULL
EXP030013	PATZ1	Homo sapiens		EXP030000	553	unspecified	Q9HBE1	LoVo (colorectal adenocarcinoma)	NULL
EXP030014	BHLHB3	Homo sapiens		EXP030000	553	unspecified	Q9C0J9	LoVo (colorectal adenocarcinoma)	NULL
EXP030015	RCOR1	Homo sapiens		EXP030000	553	unspecified	Q9UKL0	LoVo (colorectal adenocarcinoma)	NULL
EXP030016	BARHL1	Homo sapiens		EXP030000	553	unspecified	Q9BZE3	LoVo (colorectal adenocarcinoma)	NULL
EXP030017	RXRA	Homo sapiens		EXP030000	553	unspecified	P19793	LoVo (colorectal adenocarcinoma)	NULL
EXP030018	EOMES	Homo sapiens		EXP030000	553	unspecified	O95936	LoVo (colorectal adenocarcinoma)	NULL
EXP030019	HNF4G	Homo sapiens		EXP030000	553	unspecified	Q14541	LoVo (colorectal adenocarcinoma)	NULL
EXP030020	TOX4	Homo sapiens		EXP030000	553	unspecified	O94842	LoVo (colorectal adenocarcinoma)	NULL
EXP030021	ZNF236	Homo sapiens		EXP030000	553	unspecified	Q9UL36	LoVo (colorectal adenocarcinoma)	NULL
EXP030022	MSX1	Homo sapiens		EXP030000	553	unspecified	P28360	LoVo (colorectal adenocarcinoma)	NULL
EXP030023	HNF4A	Homo sapiens		EXP030000	553	unspecified	P41235	LoVo (colorectal adenocarcinoma)	NULL
EXP030024	JUN	Homo sapiens		EXP030000	553	unspecified	P05412	LoVo (colorectal adenocarcinoma)	NULL
EXP030025	FOXG1	Homo sapiens		EXP030000	553	unspecified	P55316	LoVo (colorectal adenocarcinoma)	NULL
EXP030026	TGIF1	Homo sapiens		EXP030000	553	unspecified	Q15583	LoVo (colorectal adenocarcinoma)	NULL
EXP030027	MYBL1	Homo sapiens		EXP030000	553	unspecified	P10243	LoVo (colorectal adenocarcinoma)	NULL
EXP030028	MYBL2	Homo sapiens		EXP030000	553	unspecified	P10244	LoVo (colorectal adenocarcinoma)	NULL
EXP030029	HESX1	Homo sapiens		EXP030000	553	unspecified	Q9UBX0	LoVo (colorectal adenocarcinoma)	NULL
EXP030030	T	Homo sapiens		EXP030000	553	unspecified	O15178	LoVo (colorectal adenocarcinoma)	NULL
EXP030031	LYL1	Homo sapiens		EXP030000	553	unspecified	P12980	LoVo (colorectal adenocarcinoma)	NULL
EXP030032	CASZ1	Homo sapiens		EXP030000	553	unspecified	Q86V15	LoVo (colorectal adenocarcinoma)	NULL
EXP030033	ARNTL2	Homo sapiens		EXP030000	553	unspecified	Q8WYA1	LoVo (colorectal adenocarcinoma)	NULL
EXP030034	VEZF1	Homo sapiens		EXP030000	553	unspecified	Q14119	LoVo (colorectal adenocarcinoma)	NULL
EXP030035	ESRRA	Homo sapiens		EXP030000	553	unspecified	P11474	LoVo (colorectal adenocarcinoma)	NULL
EXP030036	KLF13	Homo sapiens		EXP030000	553	unspecified	Q9Y2Y9	LoVo (colorectal adenocarcinoma)	NULL
EXP030037	KLF10	Homo sapiens		EXP030000	553	unspecified	Q13118	LoVo (colorectal adenocarcinoma)	NULL
EXP030038	KLF11	Homo sapiens		EXP030000	553	unspecified	O14901	LoVo (colorectal adenocarcinoma)	NULL
EXP030039	TFCP2	Homo sapiens		EXP030000	553	unspecified	Q12800	LoVo (colorectal adenocarcinoma)	NULL
EXP030040	KLF15	Homo sapiens		EXP030000	553	unspecified	Q9UIH9	LoVo (colorectal adenocarcinoma)	NULL
EXP030041	USF2	Homo sapiens		EXP030000	553	unspecified	Q15853	LoVo (colorectal adenocarcinoma)	NULL
EXP030042	ZNF217	Homo sapiens		EXP030000	553	unspecified	O75362	LoVo (colorectal adenocarcinoma)	NULL
EXP030043	MZF1	Homo sapiens		EXP030000	553	unspecified	P28698	LoVo (colorectal adenocarcinoma)	NULL
EXP030044	BACH1	Homo sapiens		EXP030000	553	unspecified	O14867	LoVo (colorectal adenocarcinoma)	NULL
EXP030045	ELF1	Homo sapiens		EXP030000	553	unspecified	P32519	LoVo (colorectal adenocarcinoma)	NULL
EXP030046	HNF1B	Homo sapiens		EXP030000	553	unspecified	P35680	LoVo (colorectal adenocarcinoma)	NULL
EXP030047	ELF2	Homo sapiens		EXP030000	553	unspecified	Q15723	LoVo (colorectal adenocarcinoma)	NULL
EXP030048	HNF1A	Homo sapiens		EXP030000	553	unspecified	P20823	LoVo (colorectal adenocarcinoma)	NULL
EXP030049	ELF3	Homo sapiens		EXP030000	553	unspecified	P78545	LoVo (colorectal adenocarcinoma)	NULL
EXP030050	FOXA2	Homo sapiens		EXP030000	553	unspecified	Q9Y261	LoVo (colorectal adenocarcinoma)	NULL
EXP030051	ELF4	Homo sapiens		EXP030000	553	unspecified	Q99607	LoVo (colorectal adenocarcinoma)	NULL
EXP030052	YBX1	Homo sapiens		EXP030000	553	unspecified	P67809	LoVo (colorectal adenocarcinoma)	NULL
EXP030053	EVI1	Homo sapiens		EXP030000	553	unspecified	Q03112	LoVo (colorectal adenocarcinoma)	NULL
EXP030054	HSF1	Homo sapiens		EXP030000	553	unspecified	Q00613	LoVo (colorectal adenocarcinoma)	NULL
EXP030055	HSF2	Homo sapiens		EXP030000	553	unspecified	Q03933	LoVo (colorectal adenocarcinoma)	NULL
EXP030056	SPIB	Homo sapiens		EXP030000	553	unspecified	Q01892	LoVo (colorectal adenocarcinoma)	NULL
EXP030057	HSF4	Homo sapiens		EXP030000	553	unspecified	Q9ULV5	LoVo (colorectal adenocarcinoma)	NULL
EXP030058	GATAD1	Homo sapiens		EXP030000	553	unspecified	Q8WUU5	LoVo (colorectal adenocarcinoma)	NULL
EXP030059	MYB	Homo sapiens		EXP030000	553	unspecified	P10242	LoVo (colorectal adenocarcinoma)	NULL
EXP030060	MYC	Homo sapiens		EXP030000	553	unspecified	P01106	LoVo (colorectal adenocarcinoma)	NULL
EXP030061	ZNF281	Homo sapiens		EXP030000	553	unspecified	Q9Y2X9	LoVo (colorectal adenocarcinoma)	NULL
EXP030062	BATF3	Homo sapiens		EXP030000	553	unspecified	Q9NR55	LoVo (colorectal adenocarcinoma)	NULL
EXP030063	AR	Homo sapiens		EXP030000	553	unspecified	P10275	LoVo (colorectal adenocarcinoma)	NULL
EXP030064	GMEB2	Homo sapiens		EXP030000	553	unspecified	Q9UKD1	LoVo (colorectal adenocarcinoma)	NULL
EXP030065	GMEB1	Homo sapiens		EXP030000	553	unspecified	Q9Y692	LoVo (colorectal adenocarcinoma)	NULL
EXP030066	TP53	Homo sapiens		EXP030000	553	unspecified	P04637	LoVo (colorectal adenocarcinoma)	NULL
EXP030067	ZNF143	Homo sapiens		EXP030000	553	unspecified	P52747	LoVo (colorectal adenocarcinoma)	NULL
EXP030068	FOSB	Homo sapiens		EXP030000	553	unspecified	P53539	LoVo (colorectal adenocarcinoma)	NULL
EXP030069	MXD1	Homo sapiens		EXP030000	553	unspecified	Q05195	LoVo (colorectal adenocarcinoma)	NULL
EXP030070	MXD3	Homo sapiens		EXP030000	553	unspecified	Q9BW11	LoVo (colorectal adenocarcinoma)	NULL
EXP030071	FOXC1	Homo sapiens		EXP030000	553	unspecified	Q12948	LoVo (colorectal adenocarcinoma)	NULL
EXP030072	CLOCK	Homo sapiens		EXP030000	553	unspecified	O15516	LoVo (colorectal adenocarcinoma)	NULL
EXP030073	CREM	Homo sapiens		EXP030000	553	unspecified	Q03060	LoVo (colorectal adenocarcinoma)	NULL
EXP030074	FOXD2	Homo sapiens		EXP030000	553	unspecified	O60548	LoVo (colorectal adenocarcinoma)	NULL
EXP030075	ZNF266	Homo sapiens		EXP030000	553	unspecified	Q14584	LoVo (colorectal adenocarcinoma)	NULL
EXP030076	ZNF263	Homo sapiens		EXP030000	553	unspecified	O14978	LoVo (colorectal adenocarcinoma)	NULL
EXP030077	MYF6	Homo sapiens		EXP030000	553	unspecified	P23409	LoVo (colorectal adenocarcinoma)	NULL
EXP030078	LMX1B	Homo sapiens		EXP030000	553	unspecified	O60663	LoVo (colorectal adenocarcinoma)	NULL
EXP030079	TP73	Homo sapiens		EXP030000	553	unspecified	O15350	LoVo (colorectal adenocarcinoma)	NULL
EXP030080	RLF	Homo sapiens		EXP030000	553	unspecified	Q13129	LoVo (colorectal adenocarcinoma)	NULL
EXP030081	MEF2D	Homo sapiens		EXP030000	553	unspecified	Q14814	LoVo (colorectal adenocarcinoma)	NULL
EXP030082	ZBTB4	Homo sapiens		EXP030000	553	unspecified	Q9P1Z0	LoVo (colorectal adenocarcinoma)	NULL
EXP030083	ZBTB2	Homo sapiens		EXP030000	553	unspecified	Q8N680	LoVo (colorectal adenocarcinoma)	NULL
EXP030084	NR5A2	Homo sapiens		EXP030000	553	unspecified	O00482	LoVo (colorectal adenocarcinoma)	NULL
EXP030085	ZNF581	Homo sapiens		EXP030000	553	unspecified	Q9P0T4	LoVo (colorectal adenocarcinoma)	NULL
EXP030086	JDP2	Homo sapiens		EXP030000	553	unspecified	Q8WYK2	LoVo (colorectal adenocarcinoma)	NULL
EXP030087	PDX1	Homo sapiens		EXP030000	553	unspecified	P52945	LoVo (colorectal adenocarcinoma)	NULL
EXP030088	NR2E3	Homo sapiens		EXP030000	553	unspecified	Q9Y5X4	LoVo (colorectal adenocarcinoma)	NULL
EXP030089	ZIC2	Homo sapiens		EXP030000	553	unspecified	O95409	LoVo (colorectal adenocarcinoma)	NULL
EXP030090	RELA	Homo sapiens		EXP030000	553	unspecified	Q04206	LoVo (colorectal adenocarcinoma)	NULL
EXP030091	RELB	Homo sapiens		EXP030000	553	unspecified	Q01201	LoVo (colorectal adenocarcinoma)	NULL
EXP030092	HES7	Homo sapiens		EXP030000	553	unspecified	Q9BYE0	LoVo (colorectal adenocarcinoma)	NULL
EXP030093	GRHL1	Homo sapiens		EXP030000	553	unspecified	Q9NZI5	LoVo (colorectal adenocarcinoma)	NULL
EXP030094	CSDA	Homo sapiens		EXP030000	553	unspecified	P16989	LoVo (colorectal adenocarcinoma)	NULL
EXP030095	GRHL2	Homo sapiens		EXP030000	553	unspecified	Q6ISB3	LoVo (colorectal adenocarcinoma)	NULL
EXP030096	DDIT3	Homo sapiens		EXP030000	553	unspecified	P35638	LoVo (colorectal adenocarcinoma)	NULL
EXP030097	JUNB	Homo sapiens		EXP030000	553	unspecified	P17275	LoVo (colorectal adenocarcinoma)	NULL
EXP030098	ZNF3	Homo sapiens		EXP030000	553	unspecified	P17036	LoVo (colorectal adenocarcinoma)	NULL
EXP030099	ASCL2	Homo sapiens		EXP030000	553	unspecified	Q99929	LoVo (colorectal adenocarcinoma)	NULL
EXP030100	HHEX	Homo sapiens		EXP030000	553	unspecified	Q03014	LoVo (colorectal adenocarcinoma)	NULL
EXP030101	HIF1A	Homo sapiens		EXP030000	553	unspecified	Q16665	LoVo (colorectal adenocarcinoma)	NULL
EXP030102	TCFL5	Homo sapiens		EXP030000	553	unspecified	Q9UL49	LoVo (colorectal adenocarcinoma)	NULL
EXP030103	MNX1	Homo sapiens		EXP030000	553	unspecified	P50219	LoVo (colorectal adenocarcinoma)	NULL
EXP030104	TFAP2A	Homo sapiens		EXP030000	553	unspecified	P05549	LoVo (colorectal adenocarcinoma)	NULL
EXP030105	NFE2L1	Homo sapiens		EXP030000	553	unspecified	Q14494	LoVo (colorectal adenocarcinoma)	NULL
EXP030106	NFE2L2	Homo sapiens		EXP030000	553	unspecified	Q16236	LoVo (colorectal adenocarcinoma)	NULL
EXP030107	NFE2L3	Homo sapiens		EXP030000	553	unspecified	Q9Y4A8	LoVo (colorectal adenocarcinoma)	NULL
EXP030108	TFE3	Homo sapiens		EXP030000	553	unspecified	P19532	LoVo (colorectal adenocarcinoma)	NULL
EXP030109	TFEB	Homo sapiens		EXP030000	553	unspecified	P19484	LoVo (colorectal adenocarcinoma)	NULL
EXP030110	ATF1	Homo sapiens		EXP030000	553	unspecified	P18846	LoVo (colorectal adenocarcinoma)	NULL
EXP030111	ATF2	Homo sapiens		EXP030000	553	unspecified	P15336	LoVo (colorectal adenocarcinoma)	NULL
EXP030112	ARNT	Homo sapiens		EXP030000	553	unspecified	P27540	LoVo (colorectal adenocarcinoma)	NULL
EXP030113	MEIS2	Homo sapiens		EXP030000	553	unspecified	O14770	LoVo (colorectal adenocarcinoma)	NULL
EXP030114	OVOL2	Homo sapiens		EXP030000	553	unspecified	Q9BRP0	LoVo (colorectal adenocarcinoma)	NULL
EXP030115	TEL	Homo sapiens		EXP030000	553	unspecified	P41212	LoVo (colorectal adenocarcinoma)	NULL
EXP030116	TEAD4	Homo sapiens		EXP030000	553	unspecified	Q15561	LoVo (colorectal adenocarcinoma)	NULL
EXP030117	JUND	Homo sapiens		EXP030000	553	unspecified	P17535	LoVo (colorectal adenocarcinoma)	NULL
EXP030118	TFDP2	Homo sapiens		EXP030000	553	unspecified	Q14188	LoVo (colorectal adenocarcinoma)	NULL
EXP030119	TFDP1	Homo sapiens		EXP030000	553	unspecified	Q14186	LoVo (colorectal adenocarcinoma)	NULL
EXP030120	EPAS1	Homo sapiens		EXP030000	553	unspecified	Q99814	LoVo (colorectal adenocarcinoma)	NULL
EXP030121	FOXA1	Homo sapiens		EXP030000	553	unspecified	P55317	LoVo (colorectal adenocarcinoma)	NULL
EXP030122	NR4A2	Homo sapiens		EXP030000	553	unspecified	P43354	LoVo (colorectal adenocarcinoma)	NULL
EXP030123	NR4A1	Homo sapiens		EXP030000	553	unspecified	P22736	LoVo (colorectal adenocarcinoma)	NULL
EXP030124	WHSC1	Homo sapiens		EXP030000	553	unspecified	O96028	LoVo (colorectal adenocarcinoma)	NULL
EXP030125	TEAD2	Homo sapiens		EXP030000	553	unspecified	Q15562	LoVo (colorectal adenocarcinoma)	NULL
EXP030126	NEUROG3	Homo sapiens		EXP030000	553	unspecified	Q9Y4Z2	LoVo (colorectal adenocarcinoma)	NULL
EXP030127	ATF6	Homo sapiens		EXP030000	553	unspecified	P18850	LoVo (colorectal adenocarcinoma)	NULL
EXP030128	ATF5	Homo sapiens		EXP030000	553	unspecified	Q9Y2D1	LoVo (colorectal adenocarcinoma)	NULL
EXP030129	ATF7	Homo sapiens		EXP030000	553	unspecified	P17544	LoVo (colorectal adenocarcinoma)	NULL
EXP030130	HIVEP3	Homo sapiens		EXP030000	553	unspecified	Q5T1R4	LoVo (colorectal adenocarcinoma)	NULL
EXP030131	HIVEP1	Homo sapiens		EXP030000	553	unspecified	P15822	LoVo (colorectal adenocarcinoma)	NULL
EXP030132	E2F1	Homo sapiens		EXP030000	553	unspecified	Q01094	LoVo (colorectal adenocarcinoma)	NULL
EXP030133	E2F2	Homo sapiens		EXP030000	553	unspecified	Q14209	LoVo (colorectal adenocarcinoma)	NULL
EXP030134	E2F3	Homo sapiens		EXP030000	553	unspecified	O00716	LoVo (colorectal adenocarcinoma)	NULL
EXP030135	E2F4	Homo sapiens		EXP030000	553	unspecified	Q16254	LoVo (colorectal adenocarcinoma)	NULL
EXP030136	E2F7	Homo sapiens		EXP030000	553	unspecified	Q96AV8	LoVo (colorectal adenocarcinoma)	NULL
EXP030137	E2F8	Homo sapiens		EXP030000	553	unspecified	A0AVK6	LoVo (colorectal adenocarcinoma)	NULL
EXP030138	CTCF	Homo sapiens		EXP030000	553	unspecified	P49711	LoVo (colorectal adenocarcinoma)	NULL
EXP030139	PAX2	Homo sapiens		EXP030000	553	unspecified	Q02962	LoVo (colorectal adenocarcinoma)	NULL
EXP030140	FEV	Homo sapiens		EXP030000	553	unspecified	Q99581	LoVo (colorectal adenocarcinoma)	NULL
EXP030141	MAX	Homo sapiens		EXP030000	553	unspecified	P61244	LoVo (colorectal adenocarcinoma)	NULL
EXP030142	BARX1	Homo sapiens		EXP030000	553	unspecified	Q9HBU1	LoVo (colorectal adenocarcinoma)	NULL
EXP030143	MAZ	Homo sapiens		EXP030000	553	unspecified	P56270	LoVo (colorectal adenocarcinoma)	NULL
EXP030144	BARX2	Homo sapiens		EXP030000	553	unspecified	Q9UMQ3	LoVo (colorectal adenocarcinoma)	NULL
EXP030145	HEY1	Homo sapiens		EXP030000	553	unspecified	Q9Y5J3	LoVo (colorectal adenocarcinoma)	NULL
EXP030146	ZNF407	Homo sapiens		EXP030000	553	unspecified	Q9C0G0	LoVo (colorectal adenocarcinoma)	NULL
EXP030147	NFIL3	Homo sapiens		EXP030000	553	unspecified	Q16649	LoVo (colorectal adenocarcinoma)	NULL
EXP030148	FOSL1	Homo sapiens		EXP030000	553	unspecified	P15407	LoVo (colorectal adenocarcinoma)	NULL
EXP030149	ZNF280D	Homo sapiens		EXP030000	553	unspecified	Q6N043	LoVo (colorectal adenocarcinoma)	NULL
EXP030150	OTX1	Homo sapiens		EXP030000	553	unspecified	P32242	LoVo (colorectal adenocarcinoma)	NULL
EXP030151	ESR1	Homo sapiens		EXP030000	553	unspecified	P03372	LoVo (colorectal adenocarcinoma)	NULL
EXP030152	CDC5L	Homo sapiens		EXP030000	553	unspecified	Q99459	LoVo (colorectal adenocarcinoma)	NULL
EXP030153	HMGA1	Homo sapiens		EXP030000	553	unspecified	P17096	LoVo (colorectal adenocarcinoma)	NULL
EXP030154	NCOA1	Homo sapiens		EXP030000	553	unspecified	Q15788	LoVo (colorectal adenocarcinoma)	NULL
EXP030155	HOXC11	Homo sapiens		EXP030000	553	unspecified	O43248	LoVo (colorectal adenocarcinoma)	NULL
EXP030156	NCOA3	Homo sapiens		EXP030000	553	unspecified	Q9Y6Q9	LoVo (colorectal adenocarcinoma)	NULL
EXP030157	HOXC13	Homo sapiens		EXP030000	553	unspecified	P31276	LoVo (colorectal adenocarcinoma)	NULL
EXP030158	IRX3	Homo sapiens		EXP030000	553	unspecified	P78415	LoVo (colorectal adenocarcinoma)	NULL
EXP030159	IRX5	Homo sapiens		EXP030000	553	unspecified	P78411	LoVo (colorectal adenocarcinoma)	NULL
EXP030160	IRX2	Homo sapiens		EXP030000	553	unspecified	Q9BZI1	LoVo (colorectal adenocarcinoma)	NULL
EXP030161	NR3C2	Homo sapiens		EXP030000	553	unspecified	P08235	LoVo (colorectal adenocarcinoma)	NULL
EXP030162	NFYC	Homo sapiens		EXP030000	553	unspecified	Q13952	LoVo (colorectal adenocarcinoma)	NULL
EXP030163	NFYB	Homo sapiens		EXP030000	553	unspecified	P25208	LoVo (colorectal adenocarcinoma)	NULL
EXP030164	NFYA	Homo sapiens		EXP030000	553	unspecified	P23511	LoVo (colorectal adenocarcinoma)	NULL
EXP030165	NR3C1	Homo sapiens		EXP030000	553	unspecified	P04150	LoVo (colorectal adenocarcinoma)	NULL
EXP030166	MSX2	Homo sapiens		EXP030000	553	unspecified	P35548	LoVo (colorectal adenocarcinoma)	NULL
EXP030167	TFAM	Homo sapiens		EXP030000	553	unspecified	Q00059	LoVo (colorectal adenocarcinoma)	NULL
EXP030168	HIC2	Homo sapiens		EXP030000	553	unspecified	Q96JB3	LoVo (colorectal adenocarcinoma)	NULL
EXP030169	CEBPZ	Homo sapiens		EXP030000	553	unspecified	P35638	LoVo (colorectal adenocarcinoma)	NULL
EXP030170	NFATC4	Homo sapiens		EXP030000	553	unspecified	Q14934	LoVo (colorectal adenocarcinoma)	NULL
EXP030171	NFATC3	Homo sapiens		EXP030000	553	unspecified	Q12968	LoVo (colorectal adenocarcinoma)	NULL
EXP030172	NFATC1	Homo sapiens		EXP030000	553	unspecified	O95644	LoVo (colorectal adenocarcinoma)	NULL
EXP030173	CEBPB	Homo sapiens		EXP030000	553	unspecified	P17676	LoVo (colorectal adenocarcinoma)	NULL
EXP030174	CEBPE	Homo sapiens		EXP030000	553	unspecified	Q15744	LoVo (colorectal adenocarcinoma)	NULL
EXP030175	CREB1	Homo sapiens		EXP030000	553	unspecified	P16220	LoVo (colorectal adenocarcinoma)	NULL
EXP030176	CEBPG	Homo sapiens		EXP030000	553	unspecified	P53567	LoVo (colorectal adenocarcinoma)	NULL
EXP030177	ISL1	Homo sapiens		EXP030000	553	unspecified	P61371	LoVo (colorectal adenocarcinoma)	NULL
EXP030178	ISL2	Homo sapiens		EXP030000	553	unspecified	Q96A47	LoVo (colorectal adenocarcinoma)	NULL
EXP030179	ID2	Homo sapiens		EXP030000	553	unspecified	Q02363	LoVo (colorectal adenocarcinoma)	NULL
EXP030180	ID1	Homo sapiens		EXP030000	553	unspecified	P41134	LoVo (colorectal adenocarcinoma)	NULL
EXP030181	DBP	Homo sapiens		EXP030000	553	unspecified	Q10586	LoVo (colorectal adenocarcinoma)	NULL
EXP030182	ZBED4	Homo sapiens		EXP030000	553	unspecified	O75132	LoVo (colorectal adenocarcinoma)	NULL
EXP030183	HEYL	Homo sapiens		EXP030000	553	unspecified	Q9NQ87	LoVo (colorectal adenocarcinoma)	NULL
EXP030184	ID4	Homo sapiens		EXP030000	553	unspecified	P47928	LoVo (colorectal adenocarcinoma)	NULL
EXP030185	ID3	Homo sapiens		EXP030000	553	unspecified	Q02535	LoVo (colorectal adenocarcinoma)	NULL
EXP030186	CDX1	Homo sapiens		EXP030000	553	unspecified	P47902	LoVo (colorectal adenocarcinoma)	NULL
EXP030187	CDX2	Homo sapiens		EXP030000	553	unspecified	Q99626	LoVo (colorectal adenocarcinoma)	NULL
EXP030188	STAT5A	Homo sapiens		EXP030000	553	unspecified	P42229	LoVo (colorectal adenocarcinoma)	NULL
EXP030189	BBX	Homo sapiens		EXP030000	553	unspecified	Q8WY36	LoVo (colorectal adenocarcinoma)	NULL
EXP030190	CREB3L2	Homo sapiens		EXP030000	553	unspecified	Q70SY1	LoVo (colorectal adenocarcinoma)	NULL
EXP030191	CREB3L1	Homo sapiens		EXP030000	553	unspecified	Q96BA8	LoVo (colorectal adenocarcinoma)	NULL
EXP030192	CREB3L4	Homo sapiens		EXP030000	553	unspecified	Q8TEY5	LoVo (colorectal adenocarcinoma)	NULL
EXP030193	RARA	Homo sapiens		EXP030000	553	unspecified	P10276	LoVo (colorectal adenocarcinoma)	NULL
EXP030194	PITX3	Homo sapiens		EXP030000	553	unspecified	O75364	LoVo (colorectal adenocarcinoma)	NULL
EXP030195	PITX1	Homo sapiens		EXP030000	553	unspecified	P78337	LoVo (colorectal adenocarcinoma)	NULL
EXP030196	RARG	Homo sapiens		EXP030000	553	unspecified	P13631	LoVo (colorectal adenocarcinoma)	NULL
EXP030197	EMX1	Homo sapiens		EXP030000	553	unspecified	Q04741	LoVo (colorectal adenocarcinoma)	NULL
EXP030198	YY1	Homo sapiens		EXP030000	553	unspecified	P25490	LoVo (colorectal adenocarcinoma)	NULL
EXP030199	NKX2-8	Homo sapiens		EXP030000	553	unspecified	O15522	LoVo (colorectal adenocarcinoma)	NULL
EXP030200	HES1	Homo sapiens		EXP030000	553	unspecified	Q14469	LoVo (colorectal adenocarcinoma)	NULL
EXP030201	PRDM4	Homo sapiens		EXP030000	553	unspecified	Q9UKN5	LoVo (colorectal adenocarcinoma)	NULL
EXP030202	HES5	Homo sapiens		EXP030000	553	unspecified	Q5TA89	LoVo (colorectal adenocarcinoma)	NULL
EXP030203	HES4	Homo sapiens		EXP030000	553	unspecified	Q9HCC6	LoVo (colorectal adenocarcinoma)	NULL
EXP030204	HES2	Homo sapiens		EXP030000	553	unspecified	Q9Y543	LoVo (colorectal adenocarcinoma)	NULL
EXP030205	MNT	Homo sapiens		EXP030000	553	unspecified	Q99583	LoVo (colorectal adenocarcinoma)	NULL
EXP030206	PRDM1	Homo sapiens		EXP030000	553	unspecified	O75626	LoVo (colorectal adenocarcinoma)	NULL
EXP030207	NKX2.2	Homo sapiens		EXP030000	553	unspecified	O95096	LoVo (colorectal adenocarcinoma)	NULL
EXP030208	HOXA13	Homo sapiens		EXP030000	553	unspecified	P31271	LoVo (colorectal adenocarcinoma)	NULL
EXP030209	HOXA11	Homo sapiens		EXP030000	553	unspecified	P31270	LoVo (colorectal adenocarcinoma)	NULL
EXP030210	HOXB13	Homo sapiens		EXP030000	553	unspecified	Q92826	LoVo (colorectal adenocarcinoma)	NULL
EXP030211	NR1H2	Homo sapiens		EXP030000	553	unspecified	P55055	LoVo (colorectal adenocarcinoma)	NULL
EXP030212	TAL1	Homo sapiens		EXP030000	553	unspecified	P17542	LoVo (colorectal adenocarcinoma)	NULL
EXP030213	LHX1	Homo sapiens		EXP030000	553	unspecified	P48742	LoVo (colorectal adenocarcinoma)	NULL
EXP030214	LHX2	Homo sapiens		EXP030000	553	unspecified	P50458	LoVo (colorectal adenocarcinoma)	NULL
EXP030215	LHX3	Homo sapiens		EXP030000	553	unspecified	Q9UBR4	LoVo (colorectal adenocarcinoma)	NULL
EXP030216	HOXA10	Homo sapiens		EXP030000	553	unspecified	P31260	LoVo (colorectal adenocarcinoma)	NULL
EXP030217	LHX4	Homo sapiens		EXP030000	553	unspecified	Q969G2	LoVo (colorectal adenocarcinoma)	NULL
EXP030218	NKX2-1	Homo sapiens		EXP030000	553	unspecified	P43699	LoVo (colorectal adenocarcinoma)	NULL
EXP030219	LHX5	Homo sapiens		EXP030000	553	unspecified	Q9H2C1	LoVo (colorectal adenocarcinoma)	NULL
EXP030220	LHX6	Homo sapiens		EXP030000	553	unspecified	Q9UPM6	LoVo (colorectal adenocarcinoma)	NULL
EXP030221	NKX2-5	Homo sapiens		EXP030000	553	unspecified	P52952	LoVo (colorectal adenocarcinoma)	NULL
EXP030222	NKX2-3	Homo sapiens		EXP030000	553	unspecified	Q8TAU0	LoVo (colorectal adenocarcinoma)	NULL
EXP030223	NR1H3	Homo sapiens		EXP030000	553	unspecified	Q13133	LoVo (colorectal adenocarcinoma)	NULL
EXP030224	PLAG1	Homo sapiens		EXP030000	553	unspecified	Q6DJT9	LoVo (colorectal adenocarcinoma)	NULL
EXP030225	KLF5	Homo sapiens		EXP030000	553	unspecified	Q13887	LoVo (colorectal adenocarcinoma)	NULL
EXP030226	IKZF5	Homo sapiens		EXP030000	553	unspecified	Q9H5V7	LoVo (colorectal adenocarcinoma)	NULL
EXP030227	AEBP2	Homo sapiens		EXP030000	553	unspecified	Q6ZN18	LoVo (colorectal adenocarcinoma)	NULL
EXP030228	KLF6	Homo sapiens		EXP030000	553	unspecified	Q99612	LoVo (colorectal adenocarcinoma)	NULL
EXP030229	SMAD5	Homo sapiens		EXP030000	553	unspecified	Q99717	LoVo (colorectal adenocarcinoma)	NULL
EXP030230	SMAD4	Homo sapiens		EXP030000	553	unspecified	Q13485	LoVo (colorectal adenocarcinoma)	NULL
EXP030231	SMAD3	Homo sapiens		EXP030000	553	unspecified	P84022	LoVo (colorectal adenocarcinoma)	NULL
EXP030232	SMAD2	Homo sapiens		EXP030000	553	unspecified	Q15796	LoVo (colorectal adenocarcinoma)	NULL
EXP030233	SMAD1	Homo sapiens		EXP030000	553	unspecified	Q15797	LoVo (colorectal adenocarcinoma)	NULL
EXP030234	ZBTB44	Homo sapiens		EXP030000	553	unspecified	Q8NCP5	LoVo (colorectal adenocarcinoma)	NULL
EXP030235	UBP1	Homo sapiens		EXP030000	553	unspecified	Q9NZI7	LoVo (colorectal adenocarcinoma)	NULL
EXP030236	NKX6-1	Homo sapiens		EXP030000	553	unspecified	P78426	LoVo (colorectal adenocarcinoma)	NULL
EXP030237	DLX2	Homo sapiens		EXP030000	553	unspecified	Q07687	LoVo (colorectal adenocarcinoma)	NULL
EXP030238	DLX1	Homo sapiens		EXP030000	553	unspecified	P56177	LoVo (colorectal adenocarcinoma)	NULL
EXP030239	NR1I2	Homo sapiens		EXP030000	553	unspecified	O75469	LoVo (colorectal adenocarcinoma)	NULL
EXP030240	DLX6	Homo sapiens		EXP030000	553	unspecified	P56179	LoVo (colorectal adenocarcinoma)	NULL
EXP030241	DLX4	Homo sapiens		EXP030000	553	unspecified	Q92988	LoVo (colorectal adenocarcinoma)	NULL
EXP030242	RBPJ	Homo sapiens		EXP030000	553	unspecified	Q06330	LoVo (colorectal adenocarcinoma)	NULL
EXP030243	ZFHX3	Homo sapiens		EXP030000	553	unspecified	Q15911	LoVo (colorectal adenocarcinoma)	NULL
EXP030244	TCF12	Homo sapiens		EXP030000	553	unspecified	Q99081	LoVo (colorectal adenocarcinoma)	NULL
EXP030245	KLF3	Homo sapiens		EXP030000	553	unspecified	P57682	LoVo (colorectal adenocarcinoma)	NULL
EXP030246	PPARA	Homo sapiens		EXP030000	553	unspecified	Q07869	LoVo (colorectal adenocarcinoma)	NULL
EXP030247	ZBTB33	Homo sapiens		EXP030000	553	unspecified	Q86T24	LoVo (colorectal adenocarcinoma)	NULL
EXP030248	EVX1	Homo sapiens		EXP030000	553	unspecified	P49640	LoVo (colorectal adenocarcinoma)	NULL
EXP030249	MITF	Homo sapiens		EXP030000	553	unspecified	O75030	LoVo (colorectal adenocarcinoma)	NULL
EXP030250	PPARG	Homo sapiens		EXP030000	553	unspecified	P37231	LoVo (colorectal adenocarcinoma)	NULL
EXP030251	ZBTB39	Homo sapiens		EXP030000	553	unspecified	O15060	LoVo (colorectal adenocarcinoma)	NULL
EXP030252	NFKB1	Homo sapiens		EXP030000	553	unspecified	P19838	LoVo (colorectal adenocarcinoma)	NULL
EXP030253	NFKB2	Homo sapiens		EXP030000	553	unspecified	Q00653	LoVo (colorectal adenocarcinoma)	NULL
EXP030254	GLI2	Homo sapiens		EXP030000	553	unspecified	P10070	LoVo (colorectal adenocarcinoma)	NULL
EXP030255	GLI3	Homo sapiens		EXP030000	553	unspecified	P10071	LoVo (colorectal adenocarcinoma)	NULL
EXP030256	GLI1	Homo sapiens		EXP030000	553	unspecified	P08151	LoVo (colorectal adenocarcinoma)	NULL
EXP030257	FERD3L	Homo sapiens		EXP030000	553	unspecified	Q96RJ6	LoVo (colorectal adenocarcinoma)	NULL
EXP030258	NR2F6	Homo sapiens		EXP030000	553	unspecified	P10588	LoVo (colorectal adenocarcinoma)	NULL
EXP030259	ZFAT	Homo sapiens		EXP030000	553	unspecified	Q9P243	LoVo (colorectal adenocarcinoma)	NULL
EXP030260	SNAPC4	Homo sapiens		EXP030000	553	unspecified	Q5SXM2	LoVo (colorectal adenocarcinoma)	NULL
EXP030261	ZBTB24	Homo sapiens		EXP030000	553	unspecified	O43167	LoVo (colorectal adenocarcinoma)	NULL
EXP030262	ETV7	Homo sapiens		EXP030000	553	unspecified	Q9Y603	LoVo (colorectal adenocarcinoma)	NULL
EXP030263	MLLT7	Homo sapiens		EXP030000	553	unspecified	P98177	LoVo (colorectal adenocarcinoma)	NULL
EXP030264	THAP4	Homo sapiens		EXP030000	553	unspecified	Q8WY91	LoVo (colorectal adenocarcinoma)	NULL
EXP030265	EHF	Homo sapiens		EXP030000	553	unspecified	Q9NZC4	LoVo (colorectal adenocarcinoma)	NULL
EXP030266	CIC	Homo sapiens		EXP030000	553	unspecified	Q96RK0	LoVo (colorectal adenocarcinoma)	NULL
EXP030267	ZBTB17	Homo sapiens		EXP030000	553	unspecified	Q13105	LoVo (colorectal adenocarcinoma)	NULL
EXP030268	STAT6	Homo sapiens		EXP030000	553	unspecified	P42226	LoVo (colorectal adenocarcinoma)	NULL
EXP030269	STAT4	Homo sapiens		EXP030000	553	unspecified	Q14765	LoVo (colorectal adenocarcinoma)	NULL
EXP030270	NR1D1	Homo sapiens		EXP030000	553	unspecified	P20393	LoVo (colorectal adenocarcinoma)	NULL
EXP030271	XBP1	Homo sapiens		EXP030000	553	unspecified	P17861	LoVo (colorectal adenocarcinoma)	NULL
EXP030272	BCL11A	Homo sapiens		EXP030000	553	unspecified	Q9H165	LoVo (colorectal adenocarcinoma)	NULL
EXP030273	BCL6	Homo sapiens		EXP030000	553	unspecified	P41182	LoVo (colorectal adenocarcinoma)	NULL
EXP030274	HBP1	Homo sapiens		EXP030000	553	unspecified	O60381	LoVo (colorectal adenocarcinoma)	NULL
EXP030275	TLX1	Homo sapiens		EXP030000	553	unspecified	P31314	LoVo (colorectal adenocarcinoma)	NULL
EXP030276	ETV4	Homo sapiens		EXP030000	553	unspecified	P43268	LoVo (colorectal adenocarcinoma)	NULL
EXP030277	TBX3	Homo sapiens		EXP030000	553	unspecified	O15119	LoVo (colorectal adenocarcinoma)	NULL
EXP030278	STAT1	Homo sapiens		EXP030000	553	unspecified	P42224	LoVo (colorectal adenocarcinoma)	NULL
EXP030279	SNAI1	Homo sapiens		EXP030000	553	unspecified	O95863	LoVo (colorectal adenocarcinoma)	NULL
EXP030280	STAT3	Homo sapiens		EXP030000	553	unspecified	P40763	LoVo (colorectal adenocarcinoma)	NULL
EXP030281	STAT2	Homo sapiens		EXP030000	553	unspecified	P52630	LoVo (colorectal adenocarcinoma)	NULL
EXP030282	UBTF	Homo sapiens		EXP030000	553	unspecified	P17480	LoVo (colorectal adenocarcinoma)	NULL
EXP030283	MEOX2	Homo sapiens		EXP030000	553	unspecified	P50222	LoVo (colorectal adenocarcinoma)	NULL
EXP030284	NEUROD2	Homo sapiens		EXP030000	553	unspecified	Q15784	LoVo (colorectal adenocarcinoma)	NULL
EXP030285	PBX1	Homo sapiens		EXP030000	553	unspecified	P40424	LoVo (colorectal adenocarcinoma)	NULL
EXP030286	PBX3	Homo sapiens		EXP030000	553	unspecified	P40426	LoVo (colorectal adenocarcinoma)	NULL
EXP030287	PBX2	Homo sapiens		EXP030000	553	unspecified	P40425	LoVo (colorectal adenocarcinoma)	NULL
EXP030288	NHLH1	Homo sapiens		EXP030000	553	unspecified	Q02575	LoVo (colorectal adenocarcinoma)	NULL
EXP030289	MYOD1	Homo sapiens		EXP030000	553	unspecified	P15172	LoVo (colorectal adenocarcinoma)	NULL
EXP030290	ARNT2	Homo sapiens		EXP030000	553	unspecified	Q9HBZ2	LoVo (colorectal adenocarcinoma)	NULL
EXP030291	FOXO1	Homo sapiens		EXP030000	553	unspecified	Q12778	LoVo (colorectal adenocarcinoma)	NULL
EXP030292	FOXO3	Homo sapiens		EXP030000	553	unspecified	O43524	LoVo (colorectal adenocarcinoma)	NULL
EXP030293	HOXD1	Homo sapiens		EXP030000	553	unspecified	Q9GZZ0	LoVo (colorectal adenocarcinoma)	NULL
EXP030294	FOXO4	Homo sapiens		EXP030000	553	unspecified	P98177	LoVo (colorectal adenocarcinoma)	NULL
EXP030295	HOXC6	Homo sapiens		EXP030000	553	unspecified	P09630	LoVo (colorectal adenocarcinoma)	NULL
EXP030296	GATA1	Homo sapiens		EXP030000	553	unspecified	P15976	LoVo (colorectal adenocarcinoma)	NULL
EXP030297	GATA2	Homo sapiens		EXP030000	553	unspecified	P23769	LoVo (colorectal adenocarcinoma)	NULL
EXP030298	HOXC8	Homo sapiens		EXP030000	553	unspecified	P31273	LoVo (colorectal adenocarcinoma)	NULL
EXP030299	ATOH1	Homo sapiens		EXP030000	553	unspecified	Q92858	LoVo (colorectal adenocarcinoma)	NULL
EXP030300	GATA6	Homo sapiens		EXP030000	553	unspecified	Q92908	LoVo (colorectal adenocarcinoma)	NULL
EXP030301	GATA4	Homo sapiens		EXP030000	553	unspecified	P43694	LoVo (colorectal adenocarcinoma)	NULL
EXP030302	SATB1	Homo sapiens		EXP030000	553	unspecified	Q01826	LoVo (colorectal adenocarcinoma)	NULL
EXP030303	ARNTL	Homo sapiens		EXP030000	553	unspecified	O00327	LoVo (colorectal adenocarcinoma)	NULL
EXP030304	HOXD9	Homo sapiens		EXP030000	553	unspecified	P28356	LoVo (colorectal adenocarcinoma)	NULL
EXP030305	HOXD4	Homo sapiens		EXP030000	553	unspecified	P09016	LoVo (colorectal adenocarcinoma)	NULL
EXP030306	MYNN	Homo sapiens		EXP030000	553	unspecified	Q9NPC7	LoVo (colorectal adenocarcinoma)	NULL
EXP030307	TSHZ1	Homo sapiens		EXP030000	553	unspecified	Q6ZSZ6	LoVo (colorectal adenocarcinoma)	NULL
EXP030308	SOX3	Homo sapiens		EXP030000	553	unspecified	P41225	LoVo (colorectal adenocarcinoma)	NULL
EXP030309	TFAP2	Homo sapiens		EXP030000	553	unspecified	P05549	LoVo (colorectal adenocarcinoma)	NULL
EXP030310	SOX2	Homo sapiens		EXP030000	553	unspecified	P48431	LoVo (colorectal adenocarcinoma)	NULL
EXP030311	SOX4	Homo sapiens		EXP030000	553	unspecified	Q06945	LoVo (colorectal adenocarcinoma)	NULL
EXP030312	SOX9	Homo sapiens		EXP030000	553	unspecified	P48436	LoVo (colorectal adenocarcinoma)	NULL
EXP030313	SRF	Homo sapiens		EXP030000	553	unspecified	P11831	LoVo (colorectal adenocarcinoma)	NULL
EXP030314	HOXA1	Homo sapiens		EXP030000	553	unspecified	P49639	LoVo (colorectal adenocarcinoma)	NULL
EXP030315	HOXA2	Homo sapiens		EXP030000	553	unspecified	O43364	LoVo (colorectal adenocarcinoma)	NULL
EXP030316	FOXQ1	Homo sapiens		EXP030000	553	unspecified	Q9C009	LoVo (colorectal adenocarcinoma)	NULL
EXP030317	HOXA4	Homo sapiens		EXP030000	553	unspecified	Q00056	LoVo (colorectal adenocarcinoma)	NULL
EXP030318	HOXA5	Homo sapiens		EXP030000	553	unspecified	P20719	LoVo (colorectal adenocarcinoma)	NULL
EXP030319	HOXA6	Homo sapiens		EXP030000	553	unspecified	P31267	LoVo (colorectal adenocarcinoma)	NULL
EXP030320	HOXA7	Homo sapiens		EXP030000	553	unspecified	P31268	LoVo (colorectal adenocarcinoma)	NULL
EXP030321	HOXA9	Homo sapiens		EXP030000	553	unspecified	P31269	LoVo (colorectal adenocarcinoma)	NULL
EXP030322	NKX3-1	Homo sapiens		EXP030000	553	unspecified	Q99801	LoVo (colorectal adenocarcinoma)	NULL
EXP030323	BHLHE40	Homo sapiens		EXP030000	553	unspecified	O14503	LoVo (colorectal adenocarcinoma)	NULL
EXP030324	RUNX1	Homo sapiens		EXP030000	553	unspecified	Q01196	LoVo (colorectal adenocarcinoma)	NULL
EXP030325	CREBL2	Homo sapiens		EXP030000	553	unspecified	O60519	LoVo (colorectal adenocarcinoma)	NULL
EXP030326	SREBF1	Homo sapiens		EXP030000	553	unspecified	P36956	LoVo (colorectal adenocarcinoma)	NULL
EXP030327	MAFG	Homo sapiens		EXP030000	553	unspecified	O15525	LoVo (colorectal adenocarcinoma)	NULL
EXP030328	MAFF	Homo sapiens		EXP030000	553	unspecified	Q9ULX9	LoVo (colorectal adenocarcinoma)	NULL
EXP030329	RFX5	Homo sapiens		EXP030000	553	unspecified	P48382	LoVo (colorectal adenocarcinoma)	NULL
EXP030330	MAFB	Homo sapiens		EXP030000	553	unspecified	Q9Y5Q3	LoVo (colorectal adenocarcinoma)	NULL
EXP030331	RFX7	Homo sapiens		EXP030000	553	unspecified	Q2KHR2	LoVo (colorectal adenocarcinoma)	NULL
EXP030332	MAFK	Homo sapiens		EXP030000	553	unspecified	O60675	LoVo (colorectal adenocarcinoma)	NULL
EXP030333	FOXP3	Homo sapiens		EXP030000	553	unspecified	Q9BZS1	LoVo (colorectal adenocarcinoma)	NULL
EXP030334	FOXP1	Homo sapiens		EXP030000	553	unspecified	Q9H334	LoVo (colorectal adenocarcinoma)	NULL
EXP030335	SREBF2	Homo sapiens		EXP030000	553	unspecified	Q12772	LoVo (colorectal adenocarcinoma)	NULL
EXP030336	FOXP2	Homo sapiens		EXP030000	553	unspecified	O15409	LoVo (colorectal adenocarcinoma)	NULL
EXP030337	HOXB4	Homo sapiens		EXP030000	553	unspecified	P17483	LoVo (colorectal adenocarcinoma)	NULL
EXP030338	HOXB1	Homo sapiens		EXP030000	553	unspecified	P14653	LoVo (colorectal adenocarcinoma)	NULL
EXP030339	SALL4	Homo sapiens		EXP030000	553	unspecified	Q9UJQ4	LoVo (colorectal adenocarcinoma)	NULL
EXP030340	HOXB2	Homo sapiens		EXP030000	553	unspecified	P14652	LoVo (colorectal adenocarcinoma)	NULL
EXP030341	HOXB7	Homo sapiens		EXP030000	553	unspecified	P09629	LoVo (colorectal adenocarcinoma)	NULL
EXP030342	HOXB8	Homo sapiens		EXP030000	553	unspecified	P17481	LoVo (colorectal adenocarcinoma)	NULL
EXP030343	HOXB5	Homo sapiens		EXP030000	553	unspecified	P09067	LoVo (colorectal adenocarcinoma)	NULL
EXP030344	HOXB6	Homo sapiens		EXP030000	553	unspecified	P17509	LoVo (colorectal adenocarcinoma)	NULL
EXP030345	RFX1	Homo sapiens		EXP030000	553	unspecified	P22670	LoVo (colorectal adenocarcinoma)	NULL
EXP030346	RFX2	Homo sapiens		EXP030000	553	unspecified	P48378	LoVo (colorectal adenocarcinoma)	NULL
EXP030347	ZNF84	Homo sapiens		EXP030000	553	unspecified	P51523	LoVo (colorectal adenocarcinoma)	NULL
EXP030348	ZNF83	Homo sapiens		EXP030000	553	unspecified	P51522	LoVo (colorectal adenocarcinoma)	NULL
EXP030349	FOXK1	Homo sapiens		EXP030000	553	unspecified	P85037	LoVo (colorectal adenocarcinoma)	NULL
EXP030350	FOXK2	Homo sapiens		EXP030000	553	unspecified	Q01167	LoVo (colorectal adenocarcinoma)	NULL
EXP030351	FOS	Homo sapiens		EXP030000	553	unspecified	P01100	LoVo (colorectal adenocarcinoma)	NULL
EXP030352	ALX4	Homo sapiens		EXP030000	553	unspecified	Q9H161	LoVo (colorectal adenocarcinoma)	NULL
EXP030353	ERM	Homo sapiens		EXP030000	553	unspecified	P41161	LoVo (colorectal adenocarcinoma)	NULL
EXP030354	EGR1	Homo sapiens		EXP030000	553	unspecified	P18146	LoVo (colorectal adenocarcinoma)	NULL
EXP030355	EGR2	Homo sapiens		EXP030000	553	unspecified	P11161	LoVo (colorectal adenocarcinoma)	NULL
EXP030356	FOXJ2	Homo sapiens		EXP030000	553	unspecified	Q9P0K8	LoVo (colorectal adenocarcinoma)	NULL
EXP030357	EGR4	Homo sapiens		EXP030000	553	unspecified	Q05215	LoVo (colorectal adenocarcinoma)	NULL
EXP030358	DMRT1	Homo sapiens		EXP030000	553	unspecified	Q9Y5R6	LoVo (colorectal adenocarcinoma)	NULL
EXP030359	DMRT2	Homo sapiens		EXP030000	553	unspecified	Q9Y5R5	LoVo (colorectal adenocarcinoma)	NULL
EXP030360	LEF1	Homo sapiens		EXP030000	553	unspecified	Q9UJU2	LoVo (colorectal adenocarcinoma)	NULL
EXP030361	MSC	Homo sapiens		EXP030000	553	unspecified	O60682	LoVo (colorectal adenocarcinoma)	NULL
EXP030362	MIXL1	Homo sapiens		EXP030000	553	unspecified	Q9H2W2	LoVo (colorectal adenocarcinoma)	NULL
EXP030363	GZF1	Homo sapiens		EXP030000	553	unspecified	Q9H116	LoVo (colorectal adenocarcinoma)	NULL
EXP030364	CUX1	Homo sapiens		EXP030000	553	unspecified	P39880	LoVo (colorectal adenocarcinoma)	NULL
EXP030365	GLIS3	Homo sapiens		EXP030000	553	unspecified	Q8NEA6	LoVo (colorectal adenocarcinoma)	NULL
EXP030366	GLIS2	Homo sapiens		EXP030000	553	unspecified	Q9BZE0	LoVo (colorectal adenocarcinoma)	NULL
EXP030367	FOXM1	Homo sapiens		EXP030000	553	unspecified	Q08050	LoVo (colorectal adenocarcinoma)	NULL
EXP030368	GLIS1	Homo sapiens		EXP030000	553	unspecified	Q8NBF1	LoVo (colorectal adenocarcinoma)	NULL
EXP030369	CTCFL	Homo sapiens		EXP030000	553	unspecified	Q8NI51	LoVo (colorectal adenocarcinoma)	NULL
EXP030370	TCF7L2	Homo sapiens		EXP030000	553	unspecified	Q9NQB0	LoVo (colorectal adenocarcinoma)	NULL
EXP030371	TCF7L1	Homo sapiens		EXP030000	553	unspecified	Q9HCS4	LoVo (colorectal adenocarcinoma)	NULL
EXP030372	RAX2	Homo sapiens		EXP030000	553	unspecified	Q96IS3	LoVo (colorectal adenocarcinoma)	NULL
EXP030373	HAND1	Homo sapiens		EXP030000	553	unspecified	O96004	LoVo (colorectal adenocarcinoma)	NULL
EXP030374	NFAT5	Homo sapiens		EXP030000	553	unspecified	O94916	LoVo (colorectal adenocarcinoma)	NULL
EXP030375	HINFP	Homo sapiens		EXP030000	553	unspecified	Q9BQA5	LoVo (colorectal adenocarcinoma)	NULL
EXP030376	ZBTB7B	Homo sapiens		EXP030000	553	unspecified	O15156	LoVo (colorectal adenocarcinoma)	NULL
EXP030377	ERF	Homo sapiens		EXP030000	553	unspecified	P50548	LoVo (colorectal adenocarcinoma)	NULL
EXP030378	ERG	Homo sapiens		EXP030000	553	unspecified	P11308	LoVo (colorectal adenocarcinoma)	NULL
EXP030379	IRF9	Homo sapiens		EXP030000	553	unspecified	Q00978	LoVo (colorectal adenocarcinoma)	NULL
EXP030380	SP1	Homo sapiens		EXP030000	553	unspecified	P08047	LoVo (colorectal adenocarcinoma)	NULL
EXP030381	SP2	Homo sapiens		EXP030000	553	unspecified	Q02086	LoVo (colorectal adenocarcinoma)	NULL
EXP030382	SP3	Homo sapiens		EXP030000	553	unspecified	Q02447	LoVo (colorectal adenocarcinoma)	NULL
EXP030383	IRF8	Homo sapiens		EXP030000	553	unspecified	Q02556	LoVo (colorectal adenocarcinoma)	NULL
EXP030384	IRF1	Homo sapiens		EXP030000	553	unspecified	P10914	LoVo (colorectal adenocarcinoma)	NULL
EXP030385	IRF2	Homo sapiens		EXP030000	553	unspecified	P14316	LoVo (colorectal adenocarcinoma)	NULL
EXP030386	IRF3	Homo sapiens		EXP030000	553	unspecified	Q14653	LoVo (colorectal adenocarcinoma)	NULL
EXP030387	IRF4	Homo sapiens		EXP030000	553	unspecified	Q15306	LoVo (colorectal adenocarcinoma)	NULL
EXP030388	NFIB	Homo sapiens		EXP030000	553	unspecified	O00712	LoVo (colorectal adenocarcinoma)	NULL
EXP030389	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP030390	none	Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP030391	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP030392	none	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP030393	none	Homo sapiens		NULL	450	chip_control	NULL	skeletal muscles and myoblasts	NULL
EXP030394	none	Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP030395	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030396	none	Homo sapiens		NULL	673	chip_control	NULL	normal epidermal keratinocytes	NULL
EXP030397	none	Homo sapiens		NULL	446	chip_control	NULL	HPF (pulmonary fibroblasts isolated from lung tissue)	NULL
EXP030398	CTCF	Homo sapiens		EXP030389	356	unspecified	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP030399	CTCF	Homo sapiens		EXP030390	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP030400	CTCF	Homo sapiens		EXP030391	430	unspecified	P49711	HepG2 (hepatoblastoma)	NULL
EXP030401	CTCF	Homo sapiens		EXP030392	440	unspecified	P49711	HMEC (human mammary epithelial cells)	NULL
EXP030402	CTCF	Homo sapiens		EXP030393	450	unspecified	P49711	skeletal muscles and myoblasts	NULL
EXP030403	CTCF	Homo sapiens		EXP030394	472	unspecified	P49711	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP030404	CTCF	Homo sapiens		EXP030395	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP030405	CTCF	Homo sapiens		EXP030396	673	unspecified	P49711	normal epidermal keratinocytes	NULL
EXP030406	CTCF	Homo sapiens		EXP030397	446	unspecified	P49711	HPF (pulmonary fibroblasts isolated from lung tissue)	NULL
EXP030407	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030408	kdm5a	Mus musculus		EXP030407	2	unspecified	Q3UXZ9	mESCs (mouse embryonic stem cells)	NULL
EXP030409	rbp2	Mus musculus		EXP030407	2	unspecified	Q3UXZ9	mESCs (mouse embryonic stem cells)	NULL
EXP030410	rbp2	Mus musculus	kdm5a KO	EXP030407	2	unspecified	Q3UXZ9	mESCs (mouse embryonic stem cells)	NULL
EXP030411	None	Homo sapiens		NULL	510	chip_control	NULL	Jurkat E6.1 (T-cells)	NULL
EXP030412	TCF12/HEB	Homo sapiens		EXP030411	510	unspecified	Q99081	Jurkat E6.1 (T-cells)	NULL
EXP030413	TCF3/E2A	Homo sapiens		EXP030411	510	unspecified	P15923	Jurkat E6.1 (T-cells)	NULL
EXP030414	GATA3	Homo sapiens		EXP030411	510	unspecified	P23771	Jurkat E6.1 (T-cells)	NULL
EXP030415	TAL1	Homo sapiens		EXP030411	510	unspecified	P17542	Jurkat E6.1 (T-cells)	NULL
EXP030416	RUNX1	Homo sapiens		EXP030411	510	unspecified	Q01196	Jurkat E6.1 (T-cells)	NULL
EXP030417		Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030418	ab23980 (lot number728911)	Homo sapiens		EXP030417	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030419		Homo sapiens		NULL	39	chip_control	NULL	AB32 (normal breast cells)	NULL
EXP030420		Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP030421		Homo sapiens		EXP030419	39	unspecified	P06401	AB32 (normal breast cells)	NULL
EXP030422		Homo sapiens		EXP030420	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP030423	Glucocorticoid Receptor	Mus musculus	Dexamethasone treated, unstimulated	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP030424	Glucocorticoid Receptor	Mus musculus	Dexamethasone treated, LPS-stimulated	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP030425	p65	Mus musculus	Dexamethasone treated, LPS-stimulated	NULL	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP030426	cJun	Mus musculus	LPS-stimulated	NULL	81	unspecified	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP030427	cJun	Mus musculus	Dexamethasone treated, LPS-stimulated	NULL	81	unspecified	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP030428	GRIP1	Mus musculus	LPS-stimulated macrophages	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP030429	GRIP1	Mus musculus	Dexamethasone treated, LPS-stimulated macrophages	NULL	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP030430	IRF3	Mus musculus	LPS-stimulated macrophages	NULL	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP030431	IRF3	Mus musculus	Dexamethasone treated, LPS-stimulated macrophages	NULL	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP030432	n/a	Homo sapiens		NULL	468	chip_control	NULL	neonatal keratinocytes	NULL
EXP030433	anti-p63 4A4	Homo sapiens	progenitor	EXP030432	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP030434	anti-p63 4A4	Homo sapiens	differentiated	EXP030432	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP030435	none	Mus musculus		NULL	805	chip_control	NULL	spleen-derived erythroleukemic cells	NULL
EXP030436	non-specific IgG	Mus musculus		NULL	805	chip_control	NULL	spleen-derived erythroleukemic cells	NULL
EXP030437	none	Mus musculus		NULL	805	chip_control	NULL	spleen-derived erythroleukemic cells	NULL
EXP030438	Spi-1	Mus musculus		EXP030435	805	unspecified	P17433	spleen-derived erythroleukemic cells	NULL
EXP030439	Spi-1	Mus musculus		EXP030437	805	unspecified	P17433	spleen-derived erythroleukemic cells	NULL
EXP030440	none	Mus musculus		NULL	647	chip_control	NULL	natural killer T cells	NULL
EXP030441	IgG	Mus musculus		NULL	647	chip_control	NULL	natural killer T cells	NULL
EXP051005	anti-EGR2 (Krox-20)	Mus musculus		NULL	44	unspecified	P08152	T-cells	NULL
EXP030443	anti-EGR2 (Krox-20)	Mus musculus		EXP030440	647	unspecified	P08152	natural killer T cells	NULL
EXP030444	None	Homo sapiens		NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP030445	hoxc9	Homo sapiens		EXP030444	82	unspecified	P31274	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP030446	IgG	Homo sapiens	EtOH	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030447	ERa	Homo sapiens	estradiol	EXP030446	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030448	anti-RAR	Mus musculus	all trans retinoic acid	NULL	2	unspecified	P11416	mESCs (mouse embryonic stem cells)	NULL
EXP030449	anti-RAR	Mus musculus	all trans retinoic acid	NULL	2	unspecified	P11416	mESCs (mouse embryonic stem cells)	NULL
EXP030450	IgG, sc-2027, lot number C0411	Mus musculus	differentiated TNF	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP030451	abcam 7970, lot number GR51446-1	Mus musculus	differentiated TNF	EXP030450	18	unspecified	Q04207	3T3-L1 (embryonic fibroblasts)	NULL
EXP030452	NA	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP030453	Ebf1 (custom-made against murine Ebf1b)	Mus musculus		EXP030452	41	unspecified	Q07802	B-cells	NULL
EXP030454	anti-Foxo3a (FKHRL1 (H-144))	Mus musculus		NULL	81	unspecified	Q9WVH4	BMDM (bone marrow-derived macrophages)	NULL
EXP030455	none (input)	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP030456	anti-CLK (Novus Biological; #NB100-126; lot B1)	Mus musculus		EXP030455	5	unspecified	O08785	liver	NULL
EXP030457	anti-BMAL1 (Abcam; #ab3350-200; lot 805009)	Mus musculus		EXP030455	5	unspecified	Q9WTL8	liver	NULL
EXP030458	IgG	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP030459	NcoA3	Mus musculus		EXP030458	230	unspecified	O09000	ES-E14 (E14, embryonic stem cells)	NULL
EXP030460	normal rabbit IgG (Santa Cruz, sc2027)	Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP030461	anti-SNAPC 190 (SNAAD17A) mouse monoclonal (Santa Cruz, sc-81379)	Homo sapiens		EXP030460	583	unspecified	Q5SXM2	MCF10A (breast epithelial cells)	NULL
EXP030462	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		NULL	578	chip_control	NULL	mature B-cells	NULL
EXP051033	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		NULL	105	unspecified	Q02650	pro-B cells	NULL
EXP051034	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		NULL	105	unspecified	Q02650	pro-B cells	NULL
EXP030465	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		EXP030462	578	unspecified	Q02650	mature B-cells	NULL
EXP030466	Dynabeads M-280 Streptavidin (Invitrogen)	Mus musculus		EXP030462	578	unspecified	Q02650	mature B-cells	NULL
EXP030467	(G22) sc-133592, lot A2109	Homo sapiens		NULL	78	unspecified	P85037	HeLa (cervical adenocarcinoma)	NULL
EXP030468	(H-140) sc-134550, lot A1110	Homo sapiens		NULL	78	unspecified	P85037	HeLa (cervical adenocarcinoma)	NULL
EXP030469	NONE, INPUT	Homo sapiens		NULL	444	chip_control	NULL	HPB-ALL (T acute lymphoblastic leukemia)	NULL
EXP030470	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Homo sapiens		NULL	514	unspecified	P52747	K562 (myelogenous leukemia)	NULL
EXP030471	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Homo sapiens		NULL	11	unspecified	P52747	HEK293-T-Rex (embryonic kidney)	NULL
EXP030472	ZNF143	Homo sapiens		EXP030469	444	unspecified	P52747	HPB-ALL (T acute lymphoblastic leukemia)	NULL
EXP030473	HA, 12CA5 antibody, (Roche Applied Science)	Homo sapiens	0h Induction with 1Âµg/mL ofdoxycycline	NULL	307	unspecified	P52747	FLP143HA (embryonic kidney)	NULL
EXP030474	HA, 12CA5 antibody, (Roche Applied Science)	Homo sapiens	4h Induction with 1Âµg/mL ofdoxycycline	NULL	307	unspecified	P52747	FLP143HA (embryonic kidney)	NULL
EXP030475	ZNF76, mouse monoclonal (Santa Cruz Biotechnology, cat. #sc-81147)	Homo sapiens	4h Induction with 1Âµg/mL ofdoxycycline	NULL	308	unspecified	Q9NYW8	FLP76 (embryonic kidney)	NULL
EXP030476	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Mus musculus		NULL	675	unspecified	O70230	NIH 3T3 (embryonic fibroblasts)	NULL
EXP030477	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Mus musculus		NULL	506	unspecified	O70230	J1 (embryonic stem cells)	NULL
EXP030478	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Mus musculus		NULL	12	unspecified	O70230	MEF (mouse embryonic fibroblasts)	NULL
EXP030479	ZNF143, rabbit polyclonal raised against a C-terminal epitope of ZNF143 (Myslinski et al JBC 2006)	Homo sapiens		NULL	423	unspecified	P52747	HeLa S3 (cervical adenocarcinoma)	NULL
EXP030480	SRC-1 (Santa Cruz, M-341, sc-8495)	Homo sapiens	ethanol	NULL	557	unspecified	Q15788	LS180 (colon cancer)	NULL
EXP030481	SRC-1 (Santa Cruz, M-341, sc-8495)	Homo sapiens	10-7M 1,25-dihydroxyvitamin D3	NULL	557	unspecified	Q15788	LS180 (colon cancer)	NULL
EXP030482	NCoR (Santa Cruz, C-20, sc-1609)	Homo sapiens	ethanol	NULL	557	unspecified	O75376	LS180 (colon cancer)	NULL
EXP030483	NCoR (Santa Cruz, C-20, sc-1609)	Homo sapiens	10-7M 1,25-dihydroxyvitamin D3	NULL	557	unspecified	O75376	LS180 (colon cancer)	NULL
EXP030484	SMRT (Affinity Bioreagents, PA1-843)	Homo sapiens	ethanol	NULL	557	unspecified	Q9Y618	LS180 (colon cancer)	NULL
EXP030485	SMRT (Affinity Bioreagents, PA1-843)	Homo sapiens	10-7M 1,25-dihydroxyvitamin D3	NULL	557	unspecified	Q9Y618	LS180 (colon cancer)	NULL
EXP030486	none	Mus musculus		NULL	134	chip_control	NULL	embryo trunk (day 11.5)	NULL
EXP030487	none	Mus musculus		NULL	134	chip_control	NULL	embryo trunk (day 11.5)	NULL
EXP030488	none	Mus musculus		NULL	134	chip_control	NULL	embryo trunk (day 11.5)	NULL
EXP030489	Meis1/2 (K830, K844)	Mus musculus		EXP030486	134	unspecified	Q60954	embryo trunk (day 11.5)	NULL
EXP030490	Prep1/2 (N15 Santa Cruz)	Mus musculus		EXP030487	134	unspecified	O70477	embryo trunk (day 11.5)	NULL
EXP030491	Pbx1 (4342 CST)	Mus musculus		EXP030488	134	unspecified	P41778	embryo trunk (day 11.5)	NULL
EXP030492	anti-IgG (rabbit, Santa Cruz, sc-2027)	Homo sapiens	Treatment: 2 hours of 100nm DHT or 100nm DEX, siRNA against FoxA1; Time point: 2 hours; Genotype: FoxA1 depletion	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP030493	anti-mIgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: 2 hours of 100 nM DEX; Time point: 2 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP030494	anti-rIgG (sc-2027, SantaCruz)	Homo sapiens	Treatment: 2 hours of 100 nM DHT; Time point: 2 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP030495	anti-mIgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: 2 hours of 100 nM DEX; Time point: 2 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP030496	anti-AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: Vehicle; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030497	anti-AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 1000 nM Bica; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030498	anti-GR (Widen et al. 2000)	Homo sapiens	Treatment: 2 hours of 100 nM DEX; Time point: 2 hours	EXP030493	70	normal	P04150	LNCaP (prostate carcinoma)	NULL
EXP030499	anti-GR (BuGr2, Millipore and Mab-010-050, Diagenode)	Homo sapiens	Treatment: 2 hours of 100 nM DEX; Time point: 2 hours	EXP030494	71	normal	P04150	VCaP (prostate carcinoma)	NULL
EXP030500	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 100 nM DHT; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030501	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 100 nM DHT+Dex; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030502	anti-GR (BuGr2, Millipore and Mab-010-050, Diagenode)	Homo sapiens	Treatment: 2 hours of 100 nM Dex; Time point: 2 hours	EXP030493	70	normal	P04150	LNCaP (prostate carcinoma)	NULL
EXP030503	anti-GR (BuGr2, Millipore and Mab-010-050, Diagenode)	Homo sapiens	Treatment: 2 hours of 100 nM DHT+Dex; Time point: 2 hours	EXP030493	70	normal	P04150	LNCaP (prostate carcinoma)	NULL
EXP030504	non-commercial (Kang et al, 2004)	Homo sapiens	Treatment: 2 hours of 100nm DHT or 100nm DEX, siRNA against FoxA1; Time point: 2 hours; Genotype: FoxA1 depletion	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030505	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 1000 nM CPA; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030506	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 1000 nM RU486; Time point: 2 hours	EXP030492	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP030507	AR (Kang et al. 2004; Sahu et al. 2011)	Homo sapiens	Treatment: 2 hours of 100 nM DHT; Time point: 2 hours	EXP030494	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP030508	none	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP030509	p53	Homo sapiens		EXP030508	396	unspecified	P04637	WA09 (embryonic stem cells)	NULL
EXP030510	p53	Homo sapiens	DOX	EXP030508	396	unspecified	P04637	WA09 (embryonic stem cells)	NULL
EXP030511	p53	Homo sapiens	Retinoic Acid	EXP030508	396	unspecified	P04637	WA09 (embryonic stem cells)	NULL
EXP030512	IgG Santa Cruz (sc-2028)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP030513	NKX3.1 Santa Cruz (sc-15022)	Homo sapiens		EXP030512	70	unspecified	Q99801	LNCaP (prostate carcinoma)	NULL
EXP030514	sc-6554	Mus musculus		NULL	177	unspecified	P35583	embryonic stem cell-derived endodermal cells	NULL
EXP030515		Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP030516	sc-592, Santa Cruz Biotechnology	Mus musculus		EXP030515	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP030517	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP030518	KDM2A	Mus musculus		EXP030517	252	unspecified	P59997	V6.5 (embryonic stem cells)	NULL
EXP030519		Homo sapiens		NULL	1123	chip_control	NULL	breast tumor	NULL
EXP030520	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030521	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030522	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030523	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030524	SC-543 (Santa Cruz)	Homo sapiens	good	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030525	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030526	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030527	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030528	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030529	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030530	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030531	SC-543 (Santa Cruz)	Homo sapiens	poor	EXP030519	1123	unspecified	P03372	breast tumor	NULL
EXP030532		Mus musculus		NULL	140	chip_control	NULL	CD4- CD8- T cells	NULL
EXP030533	Millipore 07-729	Mus musculus		EXP030532	140	unspecified	Q61164	CD4- CD8- T cells	NULL
EXP030534	None WCE	Homo sapiens	24 hr	NULL	880	chip_control	NULL	B-cells	NULL
EXP030535	c-Myc	Homo sapiens	24 hr	EXP030534	880	unspecified	P01106	B-cells	NULL
EXP030536	Max	Homo sapiens	24 hr	EXP030534	880	unspecified	P61244	B-cells	NULL
EXP030537		Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP030538	Grhl3 (Andersen Lab)	Homo sapiens		EXP030537	215	unspecified	Q8TE85	keratinocytes	NULL
EXP030539	Flag M2, Sigma	Homo sapiens		NULL	798	chip_control	NULL	SK-OV-3 (ovarian serous cystadenocarcinoma)	NULL
EXP030540	Flag M2, Sigma	Homo sapiens		EXP030539	798	unspecified	Q03112	SK-OV-3 (ovarian serous cystadenocarcinoma)	NULL
EXP030541	Gata2	Mus musculus		NULL	576	unspecified	O09100	mast cells	NULL
EXP030542	Gfi1	Mus musculus		NULL	576	unspecified	P70338	mast cells	NULL
EXP030543	IgG, Sigma, I8140	Mus musculus		NULL	425	chip_control	NULL	hematopoietic stem cells	NULL
EXP030544	Cebpa, Santa Cruz 14-AA	Mus musculus		EXP030543	425	unspecified	P53566	hematopoietic stem cells	NULL
EXP030545	Cebpa: Santa Cruz 14-AA	Mus musculus		NULL	400	unspecified	P53566	hematopoietic progenitors	NULL
EXP030546	Cebpa: Santa Cruz 14-AA	Mus musculus		NULL	643	unspecified	P28033	Tot2 (myeloid progenitor cell line)	NULL
EXP030547	none (INPUT)	Homo sapiens		NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP030548	BCL6	Homo sapiens		EXP030547	327	unspecified	P41182	germinal center B-cells	NULL
EXP030549	SMRT	Homo sapiens		EXP030547	327	unspecified	Q9Y618	germinal center B-cells	NULL
EXP030550	Rabbit IgG (Bethyl, ref: P120-101 lot: P120-101-8)	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP030551	Rabbit IgG (Bethyl, ref: P120-101 lot: P120-101-8)	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP030552	CTCF (Millipore ref: 07-729 lot: DAM1772428)	Mus musculus	stimulated	EXP030550	41	unspecified	Q61164	B-cells	NULL
EXP030553	CTCF (Millipore ref: 07-729 lot: DAM1772428)	Mus musculus		NULL	41	unspecified	Q61164	B-cells	NULL
EXP030554	None	Homo sapiens		NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP030555	Upstate 07-729	Homo sapiens		EXP030554	618	unspecified	P49711	MM1.S (plasma cell myeloma)	NULL
EXP030556	none (input)	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP030557	none (input)	Mus musculus	Ascl1	NULL	138	chip_control	NULL	neural progenitors	NULL
EXP030558	none (input)	Homo sapiens		NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP030559	none (input)	Homo sapiens		NULL	463	chip_control	NULL	epidermal keratinocytes	NULL
EXP030560	none (input)	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP030561	none (input)	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP030562	none (input)	Mus musculus		NULL	138	chip_control	NULL	neural progenitors	NULL
EXP030563	none (input)	Mus musculus	BAM factors	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP030564	none (input)	Mus musculus	BAM factors	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP030565	Ascl1 (ab74065)	Mus musculus		EXP030556	12	unspecified	Q02067	MEF (mouse embryonic fibroblasts)	NULL
EXP030566	Ascl1 (ab74065)	Mus musculus	Ascl1	EXP030557	138	unspecified	Q02067	neural progenitors	NULL
EXP030567	Ascl1 (ab74065)	Homo sapiens		EXP030558	2360	unspecified	P50553	fibroblasts	NULL
EXP030568	Ascl1 (ab74065)	Homo sapiens		EXP030559	463	unspecified	P50553	epidermal keratinocytes	NULL
EXP030569	Brn2 (ab15828)	Mus musculus		EXP030560	12	unspecified	P31360	MEF (mouse embryonic fibroblasts)	NULL
EXP030570	Brn2 (ab15828)	Mus musculus	BAM factors	EXP030561	12	unspecified	P31360	MEF (mouse embryonic fibroblasts)	NULL
EXP030571	Santa Cruz Biotechnology SC-6029	Mus musculus		EXP030562	138	unspecified	P31360	neural progenitors	NULL
EXP030572	Myt1l (ab15828)	Mus musculus	BAM factors	EXP030563	12	unspecified	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP030573	Ascl1 (ab74065)	Mus musculus	BAM factors	EXP030564	12	unspecified	Q02067	MEF (mouse embryonic fibroblasts)	NULL
EXP030574	anti-HA (Roche 11867423001)	Mus musculus		NULL	213	unspecified	Q64249	mesenchymal stem cells	NULL
EXP030575	NR6A1	Mus musculus		NULL	213	unspecified	Q64249	mesenchymal stem cells	NULL
EXP030576	immunoglobulin G	Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP030578	anti-A-MYB	Mus musculus		EXP030576	32	unspecified	P51960	testis	NULL
EXP030580	none	Mus musculus		NULL	133	chip_control	NULL	corneal epithelium	NULL
EXP030581	ESE-3A (E-15) antibody [Santa Cruz Biotechnology, Catalog# sc-15450, Lot# I1704]	Mus musculus		EXP030580	133	unspecified	O70273	corneal epithelium	NULL
EXP030582	None	Mus musculus		NULL	632	chip_control	NULL	prostate	NULL
EXP030583	None	Mus musculus		NULL	632	chip_control	NULL	prostate	NULL
EXP030584	None	Mus musculus		NULL	632	chip_control	NULL	prostate	NULL
EXP030585	None	Mus musculus		NULL	632	chip_control	NULL	prostate	NULL
EXP030586	Rabbit Anti-AR (Epitomics Clone ER179)	Mus musculus		EXP030582	632	unspecified	P19091	prostate	NULL
EXP030587	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030582	632	unspecified	P81270	prostate	NULL
EXP030588	Rabbit Anti-AR (Epitomics Clone ER179)	Mus musculus		EXP030583	632	unspecified	P19091	prostate	NULL
EXP030589	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030583	632	unspecified	P81270	prostate	NULL
EXP030590	androgen	Mus musculus		EXP030584	632	unspecified	P19091	prostate	NULL
EXP030591	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030584	632	unspecified	P81270	prostate	NULL
EXP030592	Rabbit Anti-AR (Epitomics Clone ER179)	Mus musculus		EXP030585	632	unspecified	P19091	prostate	NULL
EXP030593	Rabbit Anti-ERG (Epitomics Clone EPR3864)	Mus musculus		EXP030585	632	unspecified	P81270	prostate	NULL
EXP030594	none	Mus musculus		NULL	476	chip_control	NULL	neural tube	NULL
EXP030595	none	Mus musculus		NULL	713	chip_control	NULL	pancreas	NULL
EXP030596	ptf1a	Mus musculus		NULL	827	unspecified	Q9QX98	telencephalon	NULL
EXP030597	Lab generated rabbit anti-Ptf1a (AN255/256)	Mus musculus		EXP030594	476	unspecified	Q9QX98	neural tube	NULL
EXP030598	Lab generated rabbit anti-Ptf1a (AN255/256)	Mus musculus		EXP030595	713	unspecified	Q9QX98	pancreas	NULL
EXP030599	Lab generated rabbit anti-Rbpj(Tx857)	Mus musculus		EXP030594	476	unspecified	P31266	neural tube	NULL
EXP030600	Lab generated rabbit anti-Rbpjl (AN2165/2166)	Mus musculus		EXP030595	713	unspecified	O08674	pancreas	NULL
EXP030601	Goat anti-Foxa2 (Santa cruz;Hnf3b M-20 #6554)	Mus musculus		EXP030595	713	unspecified	P35583	pancreas	NULL
EXP030602	none (input)	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP030603	Anti-FLAG M2 Affinity Gel (Sigma)	Mus musculus		EXP030602	53	unspecified	P97474	heart	NULL
EXP030604	FOXA2	Mus musculus		NULL	132	unspecified	P35583	uterus	NULL
EXP030605	FOXA2	Mus musculus		NULL	132	unspecified	P35583	uterus	NULL
EXP030606	rabbit IgG	Homo sapiens		NULL	610	chip_control	NULL	mixed LNCaP lines (prostate carcinoma)	NULL
EXP030607	rabbit IgG	Homo sapiens	NA	NULL	611	chip_control	NULL	mixed LuCaPs lines (prostate carcinoma)	NULL
EXP030608	AR	Homo sapiens		EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030609	AR	Homo sapiens	1 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030610	AR	Homo sapiens	100 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030611	AR	Homo sapiens		EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030612	AR	Homo sapiens	1 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030613	AR	Homo sapiens	100 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030614	AR	Homo sapiens		EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030615	AR	Homo sapiens	1 nM  DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030616	AR	Homo sapiens	100 nM DHT	EXP030606	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030617	AR	Homo sapiens		EXP030607	560	unspecified	P10275	LuCaP73 (prostate carcinoma)	NULL
EXP030618	AR	Homo sapiens		EXP030607	559	unspecified	P10275	LuCaP69 (prostate carcinoma)	NULL
EXP030619	input	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP030620	input	Mus musculus		NULL	132	chip_control	NULL	uterus	NULL
EXP030621	ESR1	Mus musculus		EXP030619	5	unspecified	P19785	liver	NULL
EXP030622	ESR1	Mus musculus		EXP030620	132	unspecified	P19785	uterus	NULL
EXP030623	none	Homo sapiens		NULL	683	chip_control	NULL	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP030624	none	Homo sapiens		NULL	684	chip_control	NULL	OCI-LY19 (diffuse large B-cell lymphoma)	NULL
EXP030625	none	Homo sapiens		NULL	686	chip_control	NULL	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP030626	none	Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP030627	none	Homo sapiens		NULL	812	chip_control	NULL	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP030628	none	Homo sapiens		NULL	813	chip_control	NULL	SU-DHL-2 (anaplastic large cell lymphoma)	NULL
EXP030629	none	Homo sapiens		NULL	815	chip_control	NULL	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP030630	none	Homo sapiens		NULL	816	chip_control	NULL	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP030631	none	Homo sapiens		NULL	847	chip_control	NULL	U2932 (diffuse large B-cell lymphoma)	NULL
EXP030632	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030623	683	unspecified	P40763	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP030633	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030624	684	unspecified	P40763	OCI-LY19 (diffuse large B-cell lymphoma)	NULL
EXP030634	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030625	686	unspecified	P40763	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP030635	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030626	687	unspecified	P40763	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP030636	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030627	812	unspecified	P40763	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP030637	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030628	813	unspecified	P40763	SU-DHL-2 (anaplastic large cell lymphoma)	NULL
EXP030638	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030629	815	unspecified	P40763	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP030639	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030630	816	unspecified	P40763	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP030640	STAT3 (Santa Cruz, sc-482X)	Homo sapiens		EXP030631	847	unspecified	P40763	U2932 (diffuse large B-cell lymphoma)	NULL
EXP030641		Mus musculus	GW3965 2h	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP030642		Mus musculus	none	NULL	570	chip_control	NULL	macrophages	NULL
EXP030643	sc-372	Mus musculus		EXP030642	570	unspecified	Q04207	macrophages	NULL
EXP030644	sc-372	Mus musculus		EXP030642	570	unspecified	Q04207	macrophages	NULL
EXP030645	sc-372	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP030642	570	unspecified	Q04207	macrophages	NULL
EXP030646	sc-372	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP030642	570	unspecified	Q04207	macrophages	NULL
EXP030648	Santa Cruz Biotechnology, Inc. : sc-2028	Homo sapiens		NULL	371	chip_control	NULL	GP5d (colon adenocarcinoma)	NULL
EXP030649	Santa Cruz Biotechnology, Inc. : sc-2025	Homo sapiens		NULL	371	chip_control	NULL	GP5d (colon adenocarcinoma)	NULL
EXP030650	Santa Cruz Biotechnology, Inc. : sc-2027	Homo sapiens		NULL	371	chip_control	NULL	GP5d (colon adenocarcinoma)	NULL
EXP030651	Santa Cruz Biotechnology, Inc. : sc-2028	Homo sapiens	siRAD21	NULL	371	chip_control	NULL	GP5d (colon adenocarcinoma)	NULL
EXP030652	Santa Cruz Biotechnology, Inc. : sc-2025	Homo sapiens	siRAD21	NULL	371	chip_control	NULL	GP5d (colon adenocarcinoma)	NULL
EXP030653	Santa Cruz Biotechnology, Inc. : sc-2027	Homo sapiens	siRAD21	NULL	371	chip_control	NULL	GP5d (colon adenocarcinoma)	NULL
EXP030654	Santa Cruz Biotechnology, Inc. : sc-15914 X	Homo sapiens		EXP030648	371	unspecified	P49711	GP5d (colon adenocarcinoma)	NULL
EXP030655	Santa Cruz Biotechnology, Inc. : sc-8987	Homo sapiens		EXP030650	371	unspecified	P41235	GP5d (colon adenocarcinoma)	NULL
EXP030656	Abcam : ab28837	Homo sapiens		EXP030650	371	unspecified	P17535	GP5d (colon adenocarcinoma)	NULL
EXP030657	Santa Cruz Biotechnology, Inc. : sc-22797	Homo sapiens		EXP030650	371	unspecified	Q13887	GP5d (colon adenocarcinoma)	NULL
EXP030658	Abcam : ab32	Homo sapiens		EXP030650	371	unspecified	P01106	GP5d (colon adenocarcinoma)	NULL
EXP030659	Abcam : ab21635	Homo sapiens		EXP030650	371	unspecified	Q13127	GP5d (colon adenocarcinoma)	NULL
EXP030660	Santa Cruz Biotechnology, Inc. : sc-10659 X	Homo sapiens		EXP030648	371	unspecified	P48378	GP5d (colon adenocarcinoma)	NULL
EXP030661	Santa Cruz Biotechnology, Inc. : sc-15914 X	Homo sapiens	siRAD21	EXP030651	371	unspecified	P49711	GP5d (colon adenocarcinoma)	NULL
EXP030662	Santa Cruz Biotechnology, Inc. : sc-8987	Homo sapiens	siRAD21	EXP030653	371	unspecified	P41235	GP5d (colon adenocarcinoma)	NULL
EXP030663	Abcam : ab28837	Homo sapiens	siRAD21	EXP030653	371	unspecified	P17535	GP5d (colon adenocarcinoma)	NULL
EXP030664	Santa Cruz Biotechnology, Inc. : sc-22797	Homo sapiens	siRAD21	EXP030653	371	unspecified	Q13887	GP5d (colon adenocarcinoma)	NULL
EXP030665	Abcam : ab32	Homo sapiens	siRAD21	EXP030653	371	unspecified	P01106	GP5d (colon adenocarcinoma)	NULL
EXP030666	Abcam : ab21635	Homo sapiens	siRAD21	EXP030653	371	unspecified	Q13127	GP5d (colon adenocarcinoma)	NULL
EXP030667	Santa Cruz Biotechnology, Inc. : sc-10659 X	Homo sapiens	siRAD21	EXP030651	371	unspecified	P48378	GP5d (colon adenocarcinoma)	NULL
EXP030668		Homo sapiens	DEX 100nM	NULL	555	chip_control	NULL	LREX' (prostate cancer)	NULL
EXP030669		Homo sapiens	DHT 1nM	NULL	555	chip_control	NULL	LREX' (prostate cancer)	NULL
EXP030670	GT	Homo sapiens	DEX 100nM	EXP030668	555	unspecified	P04150	LREX' (prostate cancer)	NULL
EXP030671	AR	Homo sapiens	DHT 1nM	EXP030669	555	unspecified	P10275	LREX' (prostate cancer)	NULL
EXP030672	anti-Cebpa (Santa Cruz, catalog: sc-61, lot: k1009)	Mus musculus		NULL	41	unspecified	P53566	B-cells	NULL
EXP030673	anti-Cebpa (Santa Cruz, catalog: sc-61, lot: k1009)	Mus musculus	Estradiol for 18h	NULL	41	unspecified	P53566	B-cells	NULL
EXP030674	Anti-KDM5B antibody (Abcam; ab50958)	Mus musculus		NULL	765	unspecified	Q80Y84	R1 (embryonic stem cells)	NULL
EXP030675	SC-543	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030676	SC-543	Homo sapiens		NULL	409	unspecified	P03372	HCC-1428 (breast adenocarcinoma)	NULL
EXP030677	Monoclonal ANTI-FLAG M2 antibody	Mus musculus		NULL	247	chip_control	NULL	embryonic heart	NULL
EXP030678	Monoclonal ANTI-FLAG M2 antibody	Mus musculus		EXP030677	247	unspecified	Q61602	embryonic heart	NULL
EXP030679	none	Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP030680	none	Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP030681	C/EBPbeta	Mus musculus		EXP030679	483	unspecified	P28033	brown preadipocytes	NULL
EXP030682	C/EBPbeta	Mus musculus		EXP030679	483	unspecified	P28033	brown preadipocytes	NULL
EXP030683	C/EBPbeta	Mus musculus		EXP030680	483	unspecified	P28033	brown preadipocytes	NULL
EXP030684	C/EBPbeta	Mus musculus		EXP030680	483	unspecified	P28033	brown preadipocytes	NULL
EXP030685	MLL4	Mus musculus		EXP030679	483	unspecified	O08550	brown preadipocytes	NULL
EXP030686	MLL4	Mus musculus		EXP030680	483	unspecified	O08550	brown preadipocytes	NULL
EXP030687	none	Mus musculus	Standard Serum	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030688	Utf1 (Abcam, ab24273)	Mus musculus	Standard Serum	EXP030687	2	unspecified	Q6J1H4	mESCs (mouse embryonic stem cells)	NULL
EXP030689	Utf1 (Abcam, ab24273)	Mus musculus	Standard Serum	EXP030687	2	unspecified	Q6J1H4	mESCs (mouse embryonic stem cells)	NULL
EXP030693	none	Rattus norvegicus		NULL	727	chip_control	NULL	PCCL3 (thyroid cells)	NULL
EXP030694	PAX8	Rattus norvegicus		EXP030693	727	unspecified	P51974	PCCL3 (thyroid cells)	NULL
EXP030695	None	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP030696	ZNF143; Polyclonal anti-ZNF143 (ZNF143, {Cold Spring Harbor, 19164 #4})	Homo sapiens		EXP030695	78	unspecified	P52747	HeLa (cervical adenocarcinoma)	NULL
EXP030697	THAP11; polyclonal anti-THAP11 (G4275, {Dejosez, 2008 #99})	Homo sapiens		EXP030695	78	unspecified	Q96EK4	HeLa (cervical adenocarcinoma)	NULL
EXP030698	GABP; polyclonal anti-GABPa (sc-22810)	Homo sapiens		EXP030695	78	unspecified	Q06546	HeLa (cervical adenocarcinoma)	NULL
EXP030699	YY1; polyclonal anti-YY1 (sc-1703)	Homo sapiens		EXP030695	78	unspecified	P25490	HeLa (cervical adenocarcinoma)	NULL
EXP030700	IgG	Homo sapiens		NULL	99	chip_control	NULL	blood monocytes/macrophages	NULL
EXP030701	PU.1	Homo sapiens		EXP030700	98	unspecified	P17947	blood monocytes	NULL
EXP030702	ebp	Homo sapiens		EXP030700	98	unspecified	P17676	blood monocytes	NULL
EXP030703	PU.1	Homo sapiens		EXP030700	466	unspecified	P17947	MDM(monocyte derived macrophages)	NULL
EXP030704	C/EBPbeta	Homo sapiens		EXP030700	466	unspecified	P17676	MDM(monocyte derived macrophages)	NULL
EXP030705	EGR2	Homo sapiens		EXP030700	466	unspecified	P11161	MDM(monocyte derived macrophages)	NULL
EXP030706	anti-MLL1	Mus musculus		NULL	614	unspecified	P55200	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP030707	none	Homo sapiens		NULL	185	chip_control	NULL	COLO-320 (colon adenocarcinoma)	NULL
EXP030708	CDX2 Ab	Homo sapiens		EXP030707	185	unspecified	Q99626	COLO-320 (colon adenocarcinoma)	NULL
EXP030709	CDX2 Ab (clone CDX2-88)	Homo sapiens		EXP030707	185	unspecified	Q99626	COLO-320 (colon adenocarcinoma)	NULL
EXP030710		Homo sapiens		NULL	774	chip_control	NULL	RKO (colon carcinoma cell)	NULL
EXP030711	ab70183	Homo sapiens		EXP030710	774	unspecified	O95251	RKO (colon carcinoma cell)	NULL
EXP030712	none	Mus musculus	none	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP030713	M2 (Sigma Aldrich)	Mus musculus		EXP030712	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP030714	M2 (Sigma Aldrich)	Mus musculus		EXP030712	18	unspecified	P05627	3T3-L1 (embryonic fibroblasts)	NULL
EXP030715	17-600 (Millipore)	Mus musculus	DMSO	EXP030712	18	unspecified	Q01147	3T3-L1 (embryonic fibroblasts)	NULL
EXP030716	17-600 (Millipore)	Mus musculus	lactacystin	EXP030712	18	unspecified	Q01147	3T3-L1 (embryonic fibroblasts)	NULL
EXP030717	CTCF	Mus musculus		NULL	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP030718	V5	Mus musculus		NULL	2	unspecified	A2APF3	mESCs (mouse embryonic stem cells)	NULL
EXP030719	CTCFL	Mus musculus		NULL	2	unspecified	A2APF3	mESCs (mouse embryonic stem cells)	NULL
EXP030720	none	Mus musculus		NULL	536	chip_control	NULL	lateral telencephalon	NULL
EXP030721	A300-797A	Mus musculus		EXP030720	536	unspecified	A2A5K6	lateral telencephalon	NULL
EXP030722	A300-798A	Mus musculus		EXP030720	536	unspecified	A2A5K6	lateral telencephalon	NULL
EXP030723	anti-Flag antibody	Mus musculus		NULL	871	chip_control	NULL	ZHBTc4 F-Oct4 (embryonic stem cells)	NULL
EXP030724	anti-Flag antibody	Mus musculus		EXP030723	871	unspecified	P20263	ZHBTc4 F-Oct4 (embryonic stem cells)	NULL
EXP030725	none	Mus musculus	TGFb	NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP030726	Smad3	Mus musculus	TGFb	EXP030725	2775	unspecified	Q8BUN5	neural stem cells	NULL
EXP030727	none	Homo sapiens		NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP030728	A300-086A	Homo sapiens		EXP030727	779	unspecified	Q03164	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP030729	none	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP030730	anti-AR (Santa Cruz (N-20))	Homo sapiens		EXP030729	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030731	none	Homo sapiens	none	NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP030732	none	Homo sapiens	none	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP030733	none	Homo sapiens	none	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP030734	AR	Homo sapiens	EtOH vehicle treated	EXP030732	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030735	AR	Homo sapiens	EtOH vehicle treated	EXP030733	7	unspecified	P10275	22RV1 (prostate carcinoma)	NULL
EXP030736	AR	Homo sapiens	DHT treated (4h)	EXP030733	7	unspecified	P10275	22RV1 (prostate carcinoma)	NULL
EXP030737	FOXA1	Homo sapiens	EtOH vehicle treated	EXP030731	129	unspecified	P55317	LNCaP C4-2B (prostate carcinoma)	NULL
EXP030738	FOXA1	Homo sapiens	DHT treated (4h)	EXP030731	129	unspecified	P55317	LNCaP C4-2B (prostate carcinoma)	NULL
EXP030739	AR	Homo sapiens	EtOH vehicle treated	EXP030731	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP030740	AR	Homo sapiens	DHT treated (16h)	EXP030731	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP030741	androgen	Homo sapiens	DHT treated (4h)	EXP030732	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP030742		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030743		Homo sapiens		NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP030744	ab5089	Homo sapiens	siNT	EXP030742	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030745	ab5089	Homo sapiens	siGATA	EXP030742	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030746	sc-543	Homo sapiens	siNT, E2 100nM for 3h	EXP030743	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP030747	sc-543	Homo sapiens	siGATA, E2 100nM for 3h	EXP030743	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP030748	sc-248	Homo sapiens	E2 100nM for 3h	EXP030742	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030749	sc-248	Homo sapiens		EXP030742	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030750	sc-543	Homo sapiens	siNT, E2 100nM for 3h	EXP030742	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030751	sc-543	Homo sapiens	siGATA, E2 100nM for 3h	EXP030742	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030752	CTCF (Pugacheva et. al. 2005 Hum Mol Genet 14, 953-965)	Mus musculus		NULL	96	unspecified	Q61164	trophoblast stem cells	NULL
EXP030753	sc-7208	Homo sapiens	RU486	NULL	538	unspecified	P06401	uterine leiomyoma smooth muscle cells	NULL
EXP030754	sc-7208	Homo sapiens	RU486	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP030755		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP030756		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP030757		Mus musculus	stimulated with LPS for 6hrs	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP030758		Mus musculus		NULL	499	chip_control	NULL	Th2-cells	NULL
EXP030759	sc-6059	Mus musculus		EXP030755	498	unspecified	Q64287	Th17-cells	NULL
EXP030760	BATF	Mus musculus		EXP030755	498	unspecified	O35284	Th17-cells	NULL
EXP030761	sc-6059	Mus musculus		EXP030758	499	unspecified	Q64287	Th2-cells	NULL
EXP030762	sc-6059	Mus musculus		EXP030756	830	unspecified	Q64287	Th0-cells	NULL
EXP030763	sc-6059	Mus musculus	stimulated with LPS for 6hrs	EXP030757	104	unspecified	Q64287	dendritic cells	NULL
EXP030764	None	Mus musculus		NULL	573	chip_control	NULL	mammary tissue	NULL
EXP030765	None	Mus musculus	stat5a-null	NULL	573	chip_control	NULL	mammary tissue	NULL
EXP030766	Santa Cruz, sc-1081	Mus musculus		EXP030764	573	unspecified	P42230	mammary tissue	NULL
EXP030767	Santa Cruz, sc-835	Mus musculus		EXP030764	573	unspecified	P42232	mammary tissue	NULL
EXP030768	Santa Cruz, sc-1081	Mus musculus	stat5a-null	EXP030765	573	unspecified	P42230	mammary tissue	NULL
EXP030769	Santa Cruz, sc-835	Mus musculus	stat5a-null	EXP030765	573	unspecified	P42232	mammary tissue	NULL
EXP030770	TFAP2C monoclonal antibody SC-12762X (Santa Cruz Biotechnology, Santa Cruz, CA)	Homo sapiens		NULL	36	unspecified	Q92754	A375 (malignant melanoma)	NULL
EXP030771	none	Homo sapiens		NULL	511	chip_control	NULL	T-REx-Jurkat (T-cells)	NULL
EXP030772	sc-8563	Homo sapiens		EXP030771	511	unspecified	Q01196	T-REx-Jurkat (T-cells)	NULL
EXP030773	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030774	GFP (Abcam, ab290)	Mus musculus		EXP030773	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	NULL
EXP030775	none, input	Homo sapiens	Combination of the 4 conditions	NULL	157	chip_control	NULL	CD14+ monocytes	NULL
EXP030776	none, input	Homo sapiens	Combination of the 4 conditions	NULL	157	chip_control	NULL	CD14+ monocytes	NULL
EXP030777	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF (10ng/ml)	EXP030775	157	unspecified	P42224	CD14+ monocytes	NULL
EXP030778	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF (10ng/ml) and stimulated with LPS (50ng/ml) for 3 hours	EXP030775	157	unspecified	P42224	CD14+ monocytes	NULL
EXP030779	IRF1 (Santa Cruz sc-497)	Homo sapiens	MCSF (10ng/ml)	EXP030776	157	unspecified	P10914	CD14+ monocytes	NULL
EXP030780	IRF1 (Santa Cruz sc-497)	Homo sapiens	MCSF (10ng/ml) and IFN-gamma (100U/ml) for 24 hours	EXP030776	157	unspecified	P10914	CD14+ monocytes	NULL
EXP030781	IRF1 (Santa Cruz sc-497)	Homo sapiens	MCSF (10ng/ml) and stimulated with LPS (50ng/ml) for 6 hours	EXP030776	157	unspecified	P10914	CD14+ monocytes	NULL
EXP030782	IRF1 (Santa Cruz sc-497)	Homo sapiens	Cultured with MCSF (10ng/ml) and IFN-gamma (100U/ml) for 24 hours, stimulated with LPS (50ng/ml) for 6 hours	EXP030776	157	unspecified	P10914	CD14+ monocytes	NULL
EXP030783	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF 10ng/ml and IFN-gamma 100U/ml for 24 hours	EXP030775	157	unspecified	P42224	CD14+ monocytes	NULL
EXP030784	STAT1 (Santa Cruz sc-345)	Homo sapiens	MCSF (10ng/ml) and IFN-gamma (100U/ml) for 24 hours, stimulated with LPS (50ng/ml) for 3 hours	EXP030775	157	unspecified	P42224	CD14+ monocytes	NULL
EXP030785		Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP030786		Homo sapiens		NULL	777	chip_control	NULL	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP030787	ZFX	Homo sapiens		EXP030785	677	unspecified	P17010	NOMO-1 (acute monocytic leukemia)	NULL
EXP030788	ZFX	Homo sapiens		EXP030786	777	unspecified	P17010	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP030789	Mash1	Mus musculus		NULL	804	unspecified	Q02067	spinal cord	NULL
EXP030790	IgG (sc-2027, Santa Cruz, Lot#A2412)	Homo sapiens	no treatment	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030791	IgG (sc-2027, Santa Cruz, Lot#A2412)	Homo sapiens	30 min at 42C	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030792	none	Homo sapiens	30 min at 42C	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030793	IgG (sc-2027, Santa Cruz, Lot#A2412)	Homo sapiens	no treatment	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030794	IgG (sc-2027, Santa Cruz, Lot#A2412)	Homo sapiens	30 min at 42C	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030795	none	Homo sapiens	30 min at 42C	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP030796	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	no treatment	EXP030790	514	unspecified	Q00613	K562 (myelogenous leukemia)	NULL
EXP030797	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	no treatment	EXP030790	514	unspecified	Q03933	K562 (myelogenous leukemia)	NULL
EXP030798	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	30 min at 42C	EXP030791	514	unspecified	Q00613	K562 (myelogenous leukemia)	NULL
EXP030799	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	30 min at 42C	EXP030791	514	unspecified	Q03933	K562 (myelogenous leukemia)	NULL
EXP030800	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	no treatment	EXP030793	514	unspecified	Q00613	K562 (myelogenous leukemia)	NULL
EXP030801	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	no treatment	EXP030793	514	unspecified	Q03933	K562 (myelogenous leukemia)	NULL
EXP030802	HSF1 (SPA-901, Enzo, Lot#09011025)	Homo sapiens	30 min at 42C	EXP030794	514	unspecified	Q00613	K562 (myelogenous leukemia)	NULL
EXP030803	HSF2 (Ã–stling et al., 2007, J. Biol. Chem., 282: 7077-7086)	Homo sapiens	30 min at 42C	EXP030794	514	unspecified	Q03933	K562 (myelogenous leukemia)	NULL
EXP030804	Total Input	Homo sapiens		NULL	766	chip_control	NULL	R3/R4 erythroid cells	NULL
EXP030805	GATA1	Homo sapiens		EXP030804	766	unspecified	P15976	R3/R4 erythroid cells	NULL
EXP030806	KLF1	Homo sapiens		EXP030804	766	unspecified	Q13351	R3/R4 erythroid cells	NULL
EXP030807	NFE2	Homo sapiens		EXP030804	766	unspecified	Q16621	R3/R4 erythroid cells	NULL
EXP030809	sc-7196	Mus musculus		NULL	115	unspecified	P37238	brown adipose tissue	NULL
EXP030810	sc-7196	Mus musculus		NULL	3	unspecified	P37238	epididymal white adipose tissue	NULL
EXP030811	Input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030812	Santa Cruz SC-8628X	Mus musculus		EXP030811	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP030813	R&D Systems MAB2018	Mus musculus		EXP030811	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP030814	Bethyl A300-397A	Mus musculus		EXP030811	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP030815	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP030816	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP030817	USF1	Mus musculus		EXP030815	5	unspecified	Q61069	liver	NULL
EXP030818	USF1	Mus musculus		EXP030816	5	unspecified	Q61069	liver	NULL
EXP030819	USF1	Mus musculus		EXP030815	5	unspecified	Q61069	liver	NULL
EXP030820	USF1	Mus musculus		EXP030815	5	unspecified	Q61069	liver	NULL
EXP030821	CLOCK (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	O08785	liver	NULL
EXP030822	CLOCK (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030816	5	unspecified	O08785	liver	NULL
EXP030823	CLOCK (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	O08785	liver	NULL
EXP030824	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	Q9WTL8	liver	NULL
EXP030825	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus	C57BL/6J, liver, Clock delta 19	EXP030816	5	unspecified	Q9WTL8	liver	NULL
EXP030826	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	Q9WTL8	liver	NULL
EXP030827	BMAL1 (Lee et al. 2001, Cell 107, 855-867)	Mus musculus		EXP030815	5	unspecified	Q9WTL8	liver	NULL
EXP030828	N/A	Homo sapiens		NULL	1521	chip_control	NULL	Namalwa (Burkitt lymphoma)	NULL
EXP030829	IRF3 (Abcam, ab76367)	Homo sapiens		EXP030828	1521	unspecified	Q14653	Namalwa (Burkitt lymphoma)	NULL
EXP030830	IRF3 (Abcam, ab76367)	Homo sapiens	sendai virus	EXP030828	1521	unspecified	Q14653	Namalwa (Burkitt lymphoma)	NULL
EXP030831	NF?B p65 (Abcam, ab7970)	Homo sapiens		EXP030828	1521	unspecified	Q04206	Namalwa (Burkitt lymphoma)	NULL
EXP030832	NF?B p65 (Abcam, ab7970)	Homo sapiens	sendai virus	EXP030828	1521	unspecified	Q04206	Namalwa (Burkitt lymphoma)	NULL
EXP030833	Non-immune Serum (control for the RUNX1 and AML1-ETO ChIP-Seqs)	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030834	Non-immune Serum (control for the AP4 ChIP-Seqs)	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030835	anti-RUNX1 (c-terminus) [Yoram Groner lab, Weizmann Institute]	Homo sapiens		EXP030833	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030836	anti-RUNX1 (n-terminus) [Yoram Groner lab, Weizmann Institute]	Homo sapiens		EXP030833	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030837	anti-AP4 [Takeshi Egawa]	Homo sapiens		EXP030834	516	unspecified	Q01664	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030838	none	Homo sapiens		NULL	114	chip_control	NULL	bronchial epithelial cells	NULL
EXP030839	none	Homo sapiens		NULL	114	chip_control	NULL	bronchial epithelial cells	NULL
EXP030840	none	Homo sapiens		NULL	114	chip_control	NULL	bronchial epithelial cells	NULL
EXP030841	GRHL2	Homo sapiens		EXP030838	114	unspecified	Q6ISB3	bronchial epithelial cells	NULL
EXP030842	GRHL2	Homo sapiens		EXP030839	114	unspecified	Q6ISB3	bronchial epithelial cells	NULL
EXP030843	GRHL2	Homo sapiens		EXP030840	114	unspecified	Q6ISB3	bronchial epithelial cells	NULL
EXP030844	rabbit IgG (I5006, Sigma)	Mus musculus		NULL	917	chip_control	NULL	spleen	NULL
EXP030845	rabbit IgG (I5006, Sigma)	Mus musculus		NULL	917	chip_control	NULL	spleen	NULL
EXP030846	ERG-1/2/3 (clone C-17, Sc354X, Santa Cruz)	Mus musculus		EXP030844	917	unspecified	P81270	spleen	NULL
EXP030847	ERG-1/2/3 (clone C-17, Sc354X, Santa Cruz)	Mus musculus		EXP030845	917	unspecified	P81270	spleen	NULL
EXP030848		Homo sapiens	Doxo	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP030849		Homo sapiens	vehicle	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP030850	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	Doxo	EXP030848	566	unspecified	P04637	lymphoblastoid cells	NULL
EXP030851	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	vehicle	EXP030849	566	unspecified	P04637	lymphoblastoid cells	NULL
EXP030852		Homo sapiens	nutlin-3	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP030853	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	nutlin-3	EXP030852	566	unspecified	P04637	lymphoblastoid cells	NULL
EXP030854		Homo sapiens	ionizing radiation	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP030855	mouse monoclonal anti-human p53 (BD Pharmingen, cat# 554294)	Homo sapiens	ionizing radiation	EXP030854	566	unspecified	P04637	lymphoblastoid cells	NULL
EXP030856	IgG: Sigma, I8140	Mus musculus		NULL	400	chip_control	NULL	hematopoietic progenitors	NULL
EXP030857	Cebpa: Santa Cruz 14-AA	Mus musculus		EXP030856	400	unspecified	P53566	hematopoietic progenitors	NULL
EXP030858	07-729 from Millipore	Mus musculus		NULL	266	unspecified	Q61164	erythroblasts	NULL
EXP030859	ab11852 from Abcam	Mus musculus		NULL	266	unspecified	P17679	erythroblasts	NULL
EXP030860	SC-477 from Santa Crus	Mus musculus		NULL	266	unspecified	Q07279	erythroblasts	NULL
EXP030861	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP030862	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP030863	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP030864	LHX2	Mus musculus		EXP030861	160	unspecified	Q9Z0S2	hair follicle stem cells	NULL
EXP030865	LHX2	Mus musculus		EXP030862	160	unspecified	Q9Z0S2	hair follicle stem cells	NULL
EXP030866	LHX2	Mus musculus		EXP030863	160	unspecified	Q9Z0S2	hair follicle stem cells	NULL
EXP030867	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP030868	TCF3	Mus musculus		EXP030867	160	unspecified	Q9Z1J1	hair follicle stem cells	NULL
EXP030869	sc-8631	Mus musculus		EXP030867	160	unspecified	Q924A0	hair follicle stem cells	NULL
EXP030870	none	Mus musculus	0.1% DMSO (Vehicle) for 1 hour	NULL	20	chip_control	NULL	3T3-L1-derived adipocytes	NULL
EXP030871	none	Mus musculus	1 Î¼M rosiglitazone / 0.1% DMSO for 1 hour	NULL	20	chip_control	NULL	3T3-L1-derived adipocytes	NULL
EXP030872	anti-C/EBP? (sc-61; Santa Cruz)	Mus musculus	0.1% DMSO (Vehicle) for 1 hour	EXP030870	20	unspecified	P53566	3T3-L1-derived adipocytes	NULL
EXP030873	anti-C/EBP? (sc-61; Santa Cruz)	Mus musculus	1 Î¼M rosiglitazone / 0.1% DMSO for 1 hour	EXP030871	20	unspecified	P53566	3T3-L1-derived adipocytes	NULL
EXP030874	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	0.1% DMSO (Vehicle) for 1 hour	EXP030870	20	unspecified	P37238	3T3-L1-derived adipocytes	NULL
EXP030875	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	1 Î¼M rosiglitazone / 0.1% DMSO for 1 hour	EXP030871	20	unspecified	P37238	3T3-L1-derived adipocytes	NULL
EXP030876	NFATc1 (generated by our laboratories)	Homo sapiens		NULL	472	unspecified	O95644	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP030877	NFATc1 (generated by our laboratories)	Homo sapiens	VEGF for 1h	NULL	472	unspecified	O95644	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP030878	none	Mus musculus		NULL	234	chip_control	NULL	E15.5 embryonic kidney	NULL
EXP030879	anti-p53 antibody (Santa Cruz Biotech; catalog# sc-6243; lot# C1609)	Mus musculus		EXP030878	234	unspecified	P02340	E15.5 embryonic kidney	NULL
EXP030880	CTCF  cell type: CD4+ T cells	Homo sapiens		NULL	881	unspecified	P49711	CD4+ T-cells	NULL
EXP030881	CTCF  cell type: HeLa cells	Homo sapiens		NULL	78	unspecified	P49711	HeLa (cervical adenocarcinoma)	NULL
EXP030882	CTCF  cell type: Jurkat cells	Homo sapiens		NULL	509	unspecified	P49711	Jurkat (T-cells)	NULL
EXP030883	none	Mus musculus		NULL	429	chip_control	NULL	hepatocytes	NULL
EXP030884	none	Mus musculus		NULL	20	chip_control	NULL	3T3-L1-derived adipocytes	NULL
EXP030885	C/EBPalpha	Mus musculus		EXP030883	429	unspecified	P53566	hepatocytes	NULL
EXP030886	FOXA2	Mus musculus		EXP030883	429	unspecified	P35583	hepatocytes	NULL
EXP030887	FOXA1	Mus musculus		EXP030883	429	unspecified	P35582	hepatocytes	NULL
EXP030888	E2F4	Mus musculus		EXP030883	429	unspecified	Q8R0K9	hepatocytes	NULL
EXP030889	C/EBPalpha	Mus musculus		EXP030884	20	unspecified	P53566	3T3-L1-derived adipocytes	NULL
EXP030890	E2F4	Mus musculus		EXP030884	20	unspecified	Q8R0K9	3T3-L1-derived adipocytes	NULL
EXP030891	anti-p53	Homo sapiens		NULL	93	unspecified	P04637	BJ (fibroblasts)	NULL
EXP030892	anti-p53	Homo sapiens	p53 KO	NULL	93	unspecified	P04637	BJ (fibroblasts)	NULL
EXP030893	none	Mus musculus		NULL	437	chip_control	NULL	HL-1 (cardiac muscle cells)	NULL
EXP030894	gata4	Mus musculus		EXP030893	437	unspecified	Q08369	HL-1 (cardiac muscle cells)	NULL
EXP030895	mef2a	Mus musculus		EXP030893	437	unspecified	Q60929	HL-1 (cardiac muscle cells)	NULL
EXP030896	nkx2-5	Mus musculus		EXP030893	437	unspecified	P42582	HL-1 (cardiac muscle cells)	NULL
EXP030897	srf	Mus musculus		EXP030893	437	unspecified	Q9JM73	HL-1 (cardiac muscle cells)	NULL
EXP030898	tbx5	Mus musculus		EXP030893	437	unspecified	P70326	HL-1 (cardiac muscle cells)	NULL
EXP030899	sc357	Homo sapiens		NULL	516	unspecified	Q99081	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP030900	sc353	Homo sapiens		NULL	796	unspecified	P11308	SKNO-1 (acute myeloid leukemia)	NULL
EXP030901	sc356	Homo sapiens		NULL	796	unspecified	Q01543	SKNO-1 (acute myeloid leukemia)	NULL
EXP030902	ERG	Homo sapiens		NULL	65	unspecified	P11308	U937 (adult acute monocytic leukemia)	NULL
EXP030903	ERG	Homo sapiens		NULL	65	unspecified	P11308	U937 (adult acute monocytic leukemia)	NULL
EXP030904	ERG	Homo sapiens		NULL	69	unspecified	P11308	acute promyelocytic leukemia blasts	NULL
EXP030905	RUNX1	Homo sapiens		NULL	796	unspecified	Q01196	SKNO-1 (acute myeloid leukemia)	NULL
EXP030906	ERG	Homo sapiens		NULL	113	unspecified	P11308	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030907	ERG	Homo sapiens		NULL	514	unspecified	P11308	K562 (myelogenous leukemia)	NULL
EXP030908	ERG	Homo sapiens	72 hrs dox	NULL	514	unspecified	P11308	K562 (myelogenous leukemia)	NULL
EXP030909	antibody FLI1 (Abcam, Ab15289)	Homo sapiens		NULL	648	unspecified	Q01543	NB4 (acute promyelocytic leukemia )	NULL
EXP030910	antibody FLI1 (Abcam, Ab15289)	Homo sapiens		NULL	850	unspecified	Q01543	acute leukemia	NULL
EXP030911	antibody FLI1 (Abcam, Ab15289)	Homo sapiens	5 hrs zinc	NULL	850	unspecified	Q01543	acute leukemia	NULL
EXP030912		Mus musculus		NULL	904	chip_control	NULL	myoblasts	NULL
EXP030913		Mus musculus	10 hours in differentiating medium	NULL	644	chip_control	NULL	myocytes	NULL
EXP030914		Mus musculus	48 hours in differentiating medium	NULL	645	chip_control	NULL	myotubes	NULL
EXP030915		Mus musculus		NULL	897	chip_control	NULL	fibroblasts	NULL
EXP030916		Mus musculus		NULL	904	chip_control	NULL	myoblasts	NULL
EXP030917	myf5	Mus musculus		EXP030912	904	unspecified	P24699	myoblasts	NULL
EXP030918	myod	Mus musculus		EXP030912	904	unspecified	P10085	myoblasts	NULL
EXP030919	myod	Mus musculus	10 hours in differentiating medium	EXP030913	644	unspecified	P10085	myocytes	NULL
EXP030920	myod	Mus musculus	48 hours in differentiating medium	EXP030914	645	unspecified	P10085	myotubes	NULL
EXP030921	myod	Mus musculus		EXP030915	897	unspecified	P10085	fibroblasts	NULL
EXP030922	snai1	Mus musculus		EXP030916	904	unspecified	Q02085	myoblasts	NULL
EXP030923	input_DNA	Homo sapiens	vehicle	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030924	input_DNA	Homo sapiens	oestrogen	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030925	input_DNA	Homo sapiens	oestrogen, CTCF siRNA	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030926	input_DNA	Homo sapiens	oestrogen	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030927	input_DNA	Homo sapiens	none	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP030928	santa cruz, sc-543	Homo sapiens	oestrogen	EXP030924	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030929	santa cruz, sc-543	Homo sapiens	vehicle	EXP030923	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030930	HNF4a	Homo sapiens	none	EXP030927	430	unspecified	P41235	HepG2 (hepatoblastoma)	NULL
EXP030931	CTCF	Homo sapiens	oestrogen, CTCF siRNA	EXP030925	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030932	CTCF	Homo sapiens	oestrogen	EXP030926	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030933	Millipore, 07-729	Homo sapiens	oestrogen	EXP030924	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP030934	Millipore, 07-729	Homo sapiens	none	EXP030927	430	unspecified	P49711	HepG2 (hepatoblastoma)	NULL
EXP030935	santa cruz, sc-9314	Homo sapiens	none	EXP030927	430	unspecified	P49715	HepG2 (hepatoblastoma)	NULL
EXP030936		Mus musculus		NULL	904	chip_control	NULL	myoblasts	NULL
EXP030937	Pax7	Mus musculus		EXP030936	904	unspecified	P47239	myoblasts	NULL
EXP030938	Pax3	Mus musculus		EXP030936	904	unspecified	P24610	myoblasts	NULL
EXP030947	none	Mus musculus	untreated	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030948	none	Mus musculus	adriamycin	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030949	sc-1312	Mus musculus	untreated	EXP030947	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	NULL
EXP030950	sc-1312	Mus musculus	adriamycin	EXP030948	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	NULL
EXP030951	anti-p53S18P	Mus musculus	untreated	EXP030947	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	NULL
EXP030952	anti-p53S18P	Mus musculus	adriamycin	EXP030948	2	unspecified	P02340	mESCs (mouse embryonic stem cells)	NULL
EXP030953	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP030954	B-Myb	Homo sapiens		EXP030953	78	unspecified	P10244	HeLa (cervical adenocarcinoma)	NULL
EXP030955	anti-SMRT	Mus musculus		NULL	81	unspecified	Q9WU42	BMDM (bone marrow-derived macrophages)	NULL
EXP030956	anti-NCoR	Mus musculus		NULL	81	unspecified	Q60974	BMDM (bone marrow-derived macrophages)	NULL
EXP030957	anti-SMRT	Mus musculus		NULL	81	unspecified	Q9WU42	BMDM (bone marrow-derived macrophages)	NULL
EXP030958	anti-NCoR	Mus musculus		NULL	81	unspecified	Q60974	BMDM (bone marrow-derived macrophages)	NULL
EXP030959	input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP030960	anti-REST (Santa Cruz, #H-290)	Mus musculus		EXP030959	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP030961	anti-REST (Santa Cruz, #H-290)	Mus musculus		EXP030959	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP030962	anti-REST (Santa Cruz, #H-290)	Mus musculus		EXP030959	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP030963	anti-REST (Santa Cruz, #H-290)	Mus musculus		NULL	138	unspecified	Q8VIG1	neural progenitors	NULL
EXP030964	anti-REST (Santa Cruz, #H-290)	Mus musculus		NULL	138	unspecified	Q8VIG1	neural progenitors	NULL
EXP030965	anti-REST (Santa Cruz, #H-290)	Mus musculus		NULL	138	unspecified	Q8VIG1	neural progenitors	NULL
EXP030966	Invtrogen, monoclonal antibody ST3-5G7	Mus musculus		NULL	104	unspecified	P42227	dendritic cells	NULL
EXP030967	Invtrogen, monoclonal antibody ST3-5G7	Mus musculus	IL21	NULL	104	unspecified	P42227	dendritic cells	NULL
EXP030968	Invtrogen, monoclonal antibody ST3-5G7	Mus musculus	IL-21 and GM-CSF	NULL	104	unspecified	P42227	dendritic cells	NULL
EXP030969	R&D systems, anti-stat 5B serum PA-ST5B	Mus musculus		NULL	104	unspecified	P42232	dendritic cells	NULL
EXP030970	R&D systems, anti-stat 5B serum PA-ST5B	Mus musculus	IL21	NULL	104	unspecified	P42232	dendritic cells	NULL
EXP030971	R&D systems, anti-stat 5B serum PA-ST5B	Mus musculus	IL-21 and GM-CSF	NULL	104	unspecified	P42232	dendritic cells	NULL
EXP030972	none	Mus musculus		NULL	8	chip_control	NULL	266-6 (pancreatic acinar tumor)	NULL
EXP030973	Ptf1a  (Beta Cell Biology Consortium)	Mus musculus		EXP030972	8	unspecified	Q9QX98	266-6 (pancreatic acinar tumor)	NULL
EXP030974	None	Homo sapiens	none	NULL	33	chip_control	NULL	A2780 (ovarian carcinoma)	NULL
EXP030975	SMAD4 (20% Cell Signaling Technology, 80% Santa Cruz Biotechnology)	Homo sapiens	none	EXP030974	33	unspecified	Q13485	A2780 (ovarian carcinoma)	NULL
EXP030976	SMAD4 (20% Cell Signaling Technology, 80% Santa Cruz Biotechnology)	Homo sapiens	TGF-beta	EXP030974	33	unspecified	Q13485	A2780 (ovarian carcinoma)	NULL
EXP030977		Mus musculus	Th1	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP030978		Mus musculus	Th2	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP030979	GATA3	Mus musculus	Th1	EXP030977	1058	unspecified	P23772	CD4+ T-cells	NULL
EXP030980	GATA3	Mus musculus	Th2	EXP030978	1058	unspecified	P23772	CD4+ T-cells	NULL
EXP030981	IgG	Homo sapiens	pooled	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP030982	anti LXR alpha and beta	Homo sapiens	vehicle	EXP030981	2334	unspecified	Q13133	THP-1 (acute monocytic leukemia)	NULL
EXP030983	anti LXR alpha and beta	Homo sapiens	T09	EXP030981	2334	unspecified	Q13133	THP-1 (acute monocytic leukemia)	NULL
EXP030984	Sox2 produced in-house	Mus musculus	control	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP030985	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP030986	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP030987	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP030988	Sox2 produced in-house	Mus musculus	Tet	NULL	873	unspecified	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP030989	Sox2 produced in-house	Mus musculus	Tet	NULL	13	unspecified	P48432	2TS22C (embryonic stem cells)	NULL
EXP030990	none	Homo sapiens	Treatment: none; Growth: Human LNCaP prostate cancer cells were maintained in RPMI Medium 1640 (Gibco) supplemented with 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, 100 units/ml penicillin, 100 Ã‚Âµg/ml streptomycin, and 30 Ã‚Âµg/ml gentamycin in a 37Ã‚Â°C incubator with 5% CO2. Prior to vehicle/drug stimulation, ~4 millions cells were seeded into 150 mm dish and starved with phenol red-free RPMI Medium 1640 containing 5% charcoal-dextran treated FBS (Hyclone) and the same amount of sodium pyruvate, penicillin, streptomycin and gentamycin as mentioned earlier for at least 72 hrs to ~80% confluence.	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP030991	anti-AP4 (sc-18593 (N-17), lot D2903)	Homo sapiens	Treatment: 2 hours of 100nM DHT; Growth: cells were maintained in RPMI Medium 1640 (Gibco) supplemented with 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, 100 units/ml penicillin, 100 ug/ml streptomycin, and 30 ug/ml gentamycin in a 37C incubator with 5% CO2. Prior to vehicle/drug stimulation, ~4 millions cells were seeded into 150 mm dish and starved with phenol red-free RPMI Medium 1640 containing 5% charcoal-dextran treated FBS (Hyclone) and the same amount of sodium pyruvate, penicillin, streptomycin and gentamycin as mentioned earlier for at least 72 hrs to ~80% confluence.	EXP030990	70	normal	Q01664	LNCaP (prostate carcinoma)	NULL
EXP030992	--	Homo sapiens		NULL	661	chip_control	NULL	H9-derived neural crest cells	NULL
EXP030993	--	Homo sapiens		NULL	661	chip_control	NULL	H9-derived neural crest cells	NULL
EXP030994	NR2F1 (PP-H8132-00, Perseus Proteomics)	Homo sapiens		EXP030993	661	unspecified	P10589	H9-derived neural crest cells	NULL
EXP030995	NR2F2 (PP-H7147-00, Perseus Proteomics)	Homo sapiens		EXP030993	661	unspecified	P24468	H9-derived neural crest cells	NULL
EXP030996	ap2	Homo sapiens		EXP030992	661	unspecified	P05549	H9-derived neural crest cells	NULL
EXP030997	none	Homo sapiens	Treatment: none; Time point: 0 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP030998	anti-AR (Santa Cruz, sc-815x, D1709)	Homo sapiens	Treatment: none; Time point: 0 hours	EXP030997	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP030999	anti-AR (Santa Cruz, sc-815x, D1709)	Homo sapiens	Treatment: 2 hours of DHT; Time point: 2 hours	EXP030997	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031000	anti-AR (Santa Cruz, sc-815x, D1709)	Homo sapiens	Treatment: 18 hours of DHT; Time point: 18 hours	EXP030997	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031001	anti-ERG (Santa Cruz, sc-353, lot l2509)	Homo sapiens	Treatment: none; Time point: 0 hours	EXP030997	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP031002	anti-ERG (Santa Cruz, sc-353, lot l2509)	Homo sapiens	Treatment: 2 hours of DHT; Time point: 2 hours	EXP030997	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP031003	anti-ERG (Santa Cruz, sc-353, lot l2509)	Homo sapiens	Treatment: 18 hours of DHT; Time point: 18 hours	EXP030997	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP031004	none (Input)	Mus musculus		NULL	193	chip_control	NULL	cortex	NULL
EXP031005	none (Input)	Mus musculus		NULL	103	chip_control	NULL	bone marrow	NULL
EXP031006	none (Input)	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP031007	none (Input)	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP031008	none (Input)	Mus musculus		NULL	523	chip_control	NULL	kidney	NULL
EXP031009	none (Input)	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031010	none (Input)	Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP031011	none (Input)	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP031012	none (Input)	Mus musculus		NULL	117	chip_control	NULL	Bruce4 (embryonic stem cells)	NULL
EXP031013	None	Mus musculus		NULL	622	chip_control	NULL	E14.5 brain	NULL
EXP031014	None	Mus musculus		NULL	623	chip_control	NULL	E14.5 heart	NULL
EXP031015	None	Mus musculus		NULL	624	chip_control	NULL	E14.5 limb	NULL
EXP031016	None	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031017	None	Mus musculus		NULL	142	chip_control	NULL	intestine	NULL
EXP031018	None	Mus musculus		NULL	162	chip_control	NULL	olfactory bulb	NULL
EXP031019	None	Mus musculus		NULL	631	chip_control	NULL	placenta	NULL
EXP031020	None	Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP031021	None	Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP031022	none (Input)	Mus musculus		NULL	917	chip_control	NULL	spleen	NULL
EXP031023	CTCF	Mus musculus		EXP031004	193	unspecified	Q61164	cortex	NULL
EXP031024	CTCF	Mus musculus		EXP031005	103	unspecified	Q61164	bone marrow	NULL
EXP031025	CTCF	Mus musculus		EXP031006	25	unspecified	Q61164	cerebellum	NULL
EXP031026	CTCF	Mus musculus		EXP031007	53	unspecified	Q61164	heart	NULL
EXP031027	CTCF	Mus musculus		EXP031008	523	unspecified	Q61164	kidney	NULL
EXP031028	CTCF	Mus musculus		EXP031009	5	unspecified	Q61164	liver	NULL
EXP031029	CTCF	Mus musculus		EXP031010	561	unspecified	Q61164	lung	NULL
EXP031030	CTCF	Mus musculus		EXP031022	917	unspecified	Q61164	spleen	NULL
EXP031031	CTCF	Mus musculus		EXP031011	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP031032	CTCF	Mus musculus		EXP031012	117	unspecified	Q61164	Bruce4 (embryonic stem cells)	NULL
EXP031033	CTCF	Mus musculus		EXP031013	622	unspecified	Q61164	E14.5 brain	NULL
EXP031034	CTCF	Mus musculus		EXP031014	623	unspecified	Q61164	E14.5 heart	NULL
EXP031035	CTCF	Mus musculus		EXP031015	624	unspecified	Q61164	E14.5 limb	NULL
EXP031036	CTCF	Mus musculus		EXP031016	5	unspecified	Q61164	liver	NULL
EXP031037	CTCF	Mus musculus		EXP031017	142	unspecified	Q61164	intestine	NULL
EXP031038	CTCF	Mus musculus		EXP031018	162	unspecified	Q61164	olfactory bulb	NULL
EXP031039	CTCF	Mus musculus		EXP031019	631	unspecified	Q61164	placenta	NULL
EXP031040	CTCF	Mus musculus		EXP031020	32	unspecified	Q61164	testis	NULL
EXP031041	CTCF	Mus musculus		EXP031021	139	unspecified	Q61164	thymus	NULL
EXP031043	none (INPUT)	Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP031045	none (INPUT)	Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP031046	none (INPUT)	Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP031047	input	Homo sapiens		NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP031049	BCL6 (N3-antibody)	Homo sapiens		EXP031043	685	unspecified	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP031051	SMRT	Homo sapiens		EXP031045	685	unspecified	Q9Y618	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP031052	NCOR	Homo sapiens		EXP031046	685	unspecified	O75376	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP031053	BCL6 N-3	Homo sapiens		EXP031047	327	unspecified	P41182	germinal center B-cells	NULL
EXP031054	IgG	Mus musculus		NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP031055	ab23980-100	Mus musculus	Runx1+/VE-cadherin+/CD41+	EXP031054	216	unspecified	Q03347	differentiated embryonic stem cells	NULL
EXP031056	ab23980-100	Mus musculus	Runx1+/VE-cadherin+/CD41-	EXP031054	216	unspecified	Q03347	differentiated embryonic stem cells	NULL
EXP031057	ab23980-100	Mus musculus	Runx1+/VE-cadherin-/CD41+	EXP031054	216	unspecified	Q03347	differentiated embryonic stem cells	NULL
EXP031058		Homo sapiens	doxycycline 24 hours	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP031059		Homo sapiens	doxycycline 48 hours	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP031060	elf5	Homo sapiens	doxycycline 24 hours	EXP031058	111	unspecified	Q9UKW6	T47D (invasive ductal carcinoma)	NULL
EXP031061	elf5	Homo sapiens	doxycycline 48 hours	EXP031059	111	unspecified	Q9UKW6	T47D (invasive ductal carcinoma)	NULL
EXP031062	none	Mus musculus		NULL	550	chip_control	NULL	Lin- SCA+ CD34+ hematopoietic stem cells	NULL
EXP031063	none	Mus musculus		NULL	550	chip_control	NULL	Lin- SCA+ CD34+ hematopoietic stem cells	NULL
EXP031064	SC8589	Mus musculus		EXP031062	550	unspecified	Q00417	Lin- SCA+ CD34+ hematopoietic stem cells	NULL
EXP031065	anti-AML(RUNX1) rabbit polyclonal antibody	Mus musculus		EXP031063	550	unspecified	Q03347	Lin- SCA+ CD34+ hematopoietic stem cells	NULL
EXP031066	None	Mus musculus		NULL	301	chip_control	NULL	fetal liver precursors	NULL
EXP031067	None	Mus musculus		NULL	301	chip_control	NULL	fetal liver precursors	NULL
EXP031068	None	Mus musculus		NULL	301	chip_control	NULL	fetal liver precursors	NULL
EXP031069	None	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP031070	None	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP031071	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031066	301	unspecified	P17433	fetal liver precursors	NULL
EXP031072	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031067	301	unspecified	P17433	fetal liver precursors	NULL
EXP031073	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031068	301	unspecified	P17433	fetal liver precursors	NULL
EXP031074	PU.1 (Santa cruz sc-352)	Mus musculus		EXP031070	44	unspecified	P17433	T-cells	NULL
EXP031075	GATA3 (Santa cruz sc-268)	Mus musculus		EXP031066	301	unspecified	P23772	fetal liver precursors	NULL
EXP031076	GATA3 (Santa cruz sc-268)	Mus musculus		EXP031068	301	unspecified	P23772	fetal liver precursors	NULL
EXP031077	GATA3 (Santa cruz sc-268)	Mus musculus		EXP031070	44	unspecified	P23772	T-cells	NULL
EXP031078	Anti-Androgen Receptor (AR)	Homo sapiens		NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP031079	Anti-Androgen Receptor (AR)	Homo sapiens		NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP031080	None	Homo sapiens		NULL	886	chip_control	NULL	Th1-cells	NULL
EXP031081	None	Homo sapiens		NULL	907	chip_control	NULL	Th2-cells	NULL
EXP031082	T-bet; Antibody vendor: Lab produced (Szabo et al., Nature 2000).	Homo sapiens		EXP031080	886	unspecified	Q9UL17	Th1-cells	NULL
EXP031083	GATA-3; Antibody vendor: Santa Cruz; Antibody catalog number:sc-22206; Antibody lot number: F1306	Homo sapiens		EXP031080	886	unspecified	P23771	Th1-cells	NULL
EXP031084	GATA-3; Antibody vendor: Santa Cruz; Antibody catalog number:sc-22206; Antibody lot number: F1306	Homo sapiens		EXP031081	907	unspecified	P23771	Th2-cells	NULL
EXP031085	none	Mus musculus		NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP031086	sc-9008	Mus musculus		EXP031085	320	unspecified	O09100	G1ME (megakaryocyte progenitor cell line)	NULL
EXP031087	sc-7392	Mus musculus		EXP031085	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP031088	sc-350	Mus musculus		EXP031085	320	unspecified	P27577	G1ME (megakaryocyte progenitor cell line)	NULL
EXP031089	anti-V5 (Abcam, ab15828)	Mus musculus	none	NULL	60	chip_control	NULL	Ainv15 (embryonic stem cells)	NULL
EXP031090	anti-V5 (Abcam, ab15828, Lot: 103968)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P50481	Ainv15 (embryonic stem cells)	NULL
EXP031091	anti-Isl1/2 (gift from Dr. T. Jessell)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P61372	Ainv15 (embryonic stem cells)	NULL
EXP031092	anti-V5 (Abcam, ab15828)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	Q62066	Ainv15 (embryonic stem cells)	NULL
EXP031093	anti-Isl1/2 (gift from Dr. T. Jessell)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P61372	Ainv15 (embryonic stem cells)	NULL
EXP031094	anti-Isl1/2 (gift from Dr. T. Jessell)	Mus musculus	+Dox 48hrs	EXP031089	60	unspecified	P61372	Ainv15 (embryonic stem cells)	NULL
EXP031095	None	Mus musculus		NULL	48	chip_control	NULL	adherent peritoneal exudate macrophages	NULL
EXP031096	None	Mus musculus		NULL	48	chip_control	NULL	adherent peritoneal exudate macrophages	NULL
EXP031097	anti-STAT3 (Santa Cruz sc-482)	Mus musculus		EXP031095	48	unspecified	P42227	adherent peritoneal exudate macrophages	NULL
EXP031098	anti-STAT3 (Santa Cruz sc-482)	Mus musculus	Il10	EXP031096	48	unspecified	P42227	adherent peritoneal exudate macrophages	NULL
EXP031099	ab21061	Mus musculus		NULL	615	unspecified	P70338	bone marrow progenitors	NULL
EXP031100	none	Homo sapiens		NULL	468	chip_control	NULL	neonatal keratinocytes	NULL
EXP031101	p63 (4A4)	Homo sapiens		EXP031100	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP031102	none	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP031103	none	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP031104	homemade Aiolos	Mus musculus		EXP031102	171	unspecified	O08900	CD4+ CD8+ T cells	NULL
EXP031105	homemade Ikaros (Ikzf1)	Mus musculus		EXP031103	171	unspecified	Q03267	CD4+ CD8+ T cells	NULL
EXP031106	anti-AR (Santa Cruz, sc-816)	Homo sapiens	Treatment: 4 hours of 10nM DHT; Growth: Cells were incubated in DMEM supplemented with 5% charcoal/dextran-treated FBS for 3 days; Time point: 4 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031107	anti-AR (Santa Cruz, sc-816)	Homo sapiens	Treatment: 4 hours of 10nM DHT; Growth: Cells were incubated in DMEM supplemented with 5% charcoal/dextran-treated FBS for 3 days; Time point: 4 hours	NULL	859	normal	P10275	VCS2 (prostate carcinoma)	NULL
EXP031108	None	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP031109	None	Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP031110	Bethyl,A301.034A	Homo sapiens		EXP031108	514	unspecified	P41229	K562 (myelogenous leukemia)	NULL
EXP031111	Bethyl,A301-145A	Homo sapiens		EXP031108	514	unspecified	O75376	K562 (myelogenous leukemia)	NULL
EXP031112	Abcam,ab73539	Homo sapiens		EXP031108	514	unspecified	O96028	K562 (myelogenous leukemia)	NULL
EXP031113	Millipore,17-641	Homo sapiens		EXP031108	514	unspecified	Q13127	K562 (myelogenous leukemia)	NULL
EXP031114	Abcam,ab26049	Homo sapiens		EXP031109	376	unspecified	P29375	WA01 (H1, human embryonic stem cells)	NULL
EXP031115	Abcam,ab26049	Homo sapiens		EXP031109	376	unspecified	P29375	WA01 (H1, human embryonic stem cells)	NULL
EXP031116	Bethyl,A301.813A	Homo sapiens		EXP031109	376	unspecified	Q9UGL1	WA01 (H1, human embryonic stem cells)	NULL
EXP031117	Bethyl,A301.034A	Homo sapiens		EXP031109	376	unspecified	P41229	WA01 (H1, human embryonic stem cells)	NULL
EXP031118	A custom antibody	Homo sapiens		EXP031108	514	unspecified	Q9UGL1	K562 (myelogenous leukemia)	NULL
EXP031119	none	Homo sapiens	Treatment: Pooled; Time point: 30 min; Conditions: 37C, 5%CO2	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP031120	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031121	AR	Homo sapiens	Treatment: 30 mins of 0.1% DMSO (Vehicle ); Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031122	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 0.1uM Compound 30; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031123	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 1uM Compound 30; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031124	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 10uM Compound 30; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031125	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 0.1uM Compound 26; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031126	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 1uM Compound 26; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031127	AR	Homo sapiens	Treatment: 30 mins of 1nM R1881 and 10uM Compound 26; Time point: 30 min; Conditions: 37C, 5%CO2	EXP031119	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP031128	none	Mus musculus	none	NULL	704	chip_control	NULL	P19C6 (embryonic carcinoma)	NULL
EXP031129	none	Mus musculus	all-trans retinoic acid (RA)	NULL	704	chip_control	NULL	P19C6 (embryonic carcinoma)	NULL
EXP031130	ab19867	Mus musculus	all-trans retinoic acid (RA)	EXP031129	704	unspecified	Q60954	P19C6 (embryonic carcinoma)	NULL
EXP031131	Anti-Tet1	Mus musculus		EXP031128	704	unspecified	Q3URK3	P19C6 (embryonic carcinoma)	NULL
EXP031132	Anti-Tet1	Mus musculus	all-trans retinoic acid (RA)	EXP031129	704	unspecified	Q3URK3	P19C6 (embryonic carcinoma)	NULL
EXP031133	IgG	Mus musculus	50nM TPA	NULL	533	chip_control	NULL	L8057 (megakaryoblastic leukemia)	NULL
EXP031134	IgG	Mus musculus		NULL	533	chip_control	NULL	L8057 (megakaryoblastic leukemia)	NULL
EXP031135		Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP031136		Mus musculus	Runx1KO	NULL	44	chip_control	NULL	T-cells	NULL
EXP031137	Runx1	Mus musculus	50nM TPA	EXP031133	533	unspecified	Q03347	L8057 (megakaryoblastic leukemia)	NULL
EXP031138	Runx1	Mus musculus		EXP031134	533	unspecified	Q03347	L8057 (megakaryoblastic leukemia)	NULL
EXP031139	Runx1	Mus musculus		EXP031135	44	unspecified	Q03347	T-cells	NULL
EXP031140	Runx1	Mus musculus	Runx1KO	EXP031136	44	unspecified	Q03347	T-cells	NULL
EXP031141	Foxa1	Mus musculus		NULL	5	unspecified	P35582	liver	NULL
EXP031142	na	Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP031143	Ikaros-N terminal Ab (IkN)	Mus musculus		EXP031142	139	bio_control	Q03267	thymus	NULL
EXP031144	Ikaros-N terminal Ab (IkN)	Mus musculus		EXP031142	139	bio_control	Q03267	thymus	NULL
EXP031145	Ikaros-N terminal Ab (IkN)	Mus musculus		EXP031142	139	unspecified	Q03267	thymus	NULL
EXP031146	None	Homo sapiens		NULL	153	chip_control	NULL	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP031147	None	Homo sapiens		NULL	825	chip_control	NULL	T-cell acute lymphoblastic leukemia	NULL
EXP031148	None	Homo sapiens		NULL	825	chip_control	NULL	T-cell acute lymphoblastic leukemia	NULL
EXP031149	Santa Cruz SC-349	Homo sapiens		EXP031146	153	unspecified	P15923	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP031150	Santa Cruz SC-22206	Homo sapiens		EXP031146	153	unspecified	P23771	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP031151	Santa Cruz SC-357	Homo sapiens		EXP031146	153	unspecified	Q99081	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP031152	Santa Cruz SC-8563	Homo sapiens		EXP031146	153	unspecified	Q01196	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP031153	Santa Cruz SC-12984	Homo sapiens		EXP031146	153	unspecified	P17542	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP031154	Santa Cruz SC-12984	Homo sapiens		EXP031147	825	unspecified	P17542	T-cell acute lymphoblastic leukemia	NULL
EXP031155	Santa Cruz SC-12984	Homo sapiens		EXP031148	825	unspecified	P17542	T-cell acute lymphoblastic leukemia	NULL
EXP031156	none	Homo sapiens	Dox + Arvanil + BMP7	NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP031157	sc-188	Homo sapiens	Dox + Arvanil + BMP7	EXP031156	332	unspecified	P18847	glioblastoma cells	NULL
EXP031158	none	Mus musculus		NULL	208	chip_control	NULL	embryoid body (day 6)	NULL
EXP031159	none	Mus musculus		NULL	237	chip_control	NULL	embryoid body	NULL
EXP031160	none	Mus musculus		NULL	237	chip_control	NULL	embryoid body	NULL
EXP031161	anti-HoxB4	Mus musculus		EXP031158	208	unspecified	P10284	embryoid body (day 6)	NULL
EXP031162	anti-HoxB4	Mus musculus		EXP031159	237	unspecified	P10284	embryoid body	NULL
EXP031163	HoxB4	Mus musculus		EXP031160	237	unspecified	P10284	embryoid body	NULL
EXP031164	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031165	REV-ERB alpha	Mus musculus		EXP031164	5	unspecified	Q3UV55	liver	NULL
EXP031166	REV-ERB beta	Mus musculus		EXP031164	5	unspecified	Q60674	liver	NULL
EXP031167	sc-551	Mus musculus		NULL	184	unspecified	P11416	CMTi-1 (embryonic stem cells)	NULL
EXP031168	sc-551	Mus musculus	shH2A.Z	NULL	184	unspecified	P11416	CMTi-1 (embryonic stem cells)	NULL
EXP031169	Abcam: Ab19857	Mus musculus		NULL	184	unspecified	P20263	CMTi-1 (embryonic stem cells)	NULL
EXP031170	Abcam: Ab19857	Mus musculus	shH2A.Z	NULL	184	unspecified	P20263	CMTi-1 (embryonic stem cells)	NULL
EXP031171	ab7970	Homo sapiens		NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031172	ab7970	Homo sapiens	TNF 10ng/ml for 30 min	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031173	input	Homo sapiens		NULL	45	chip_control	NULL	acute myeloblastic leukemia	NULL
EXP031174		Homo sapiens		NULL	45	chip_control	NULL	acute myeloblastic leukemia	NULL
EXP031175	ETO(C20)sc ( lot number F1809)	Homo sapiens		NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031176	ETO(C20)sc ( lot number F1809)	Homo sapiens		NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031177	ETO (E/S19)	Homo sapiens		EXP031173	45	unspecified	Q01196	acute myeloblastic leukemia	NULL
EXP031178	ETO (E/S19)	Homo sapiens		EXP031174	45	unspecified	Q01196	acute myeloblastic leukemia	NULL
EXP031179	none	Mus musculus		NULL	634	chip_control	NULL	villus	NULL
EXP031180	Bethyl BL3194, lotA300-691A-1	Mus musculus		EXP031179	634	unspecified	P43241	villus	NULL
EXP031181	HNF4? c-19 (Santa Cruz 6547, lot c1810)	Mus musculus		EXP031179	634	unspecified	P49698	villus	NULL
EXP031182	HNF4? c-19 (Santa Cruz 6547, lot c1810)	Mus musculus		EXP031179	634	unspecified	P49698	villus	NULL
EXP031183	Bethyl BL3194, lotA300-691A-1	Mus musculus		EXP031179	634	unspecified	P43241	villus	NULL
EXP031184		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP031185	Anti-FLAG M2	Homo sapiens		EXP031184	423	unspecified	Q14119	HeLa S3 (cervical adenocarcinoma)	NULL
EXP031186	control	Homo sapiens		NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP031187	HIF-2alpha (PM9)	Homo sapiens		EXP031186	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	NULL
EXP031188	HIF-1beta (Novus Biologicals, NB100-110)	Homo sapiens		EXP031186	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	NULL
EXP031189	preimmune serum	Mus musculus		NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP031190	two MyoD antibody raised in rabbits by our lab (6196 and 6975) and previously described (Tapscott et al., 1988)	Mus musculus		EXP031189	705	unspecified	P10085	P19 (embryonic carcinoma)	NULL
EXP031191	two MyoD antibody raised in rabbits by our lab (6196 and 6975) and previously described (Tapscott et al., 1988)	Mus musculus		NULL	12	unspecified	P10085	MEF (mouse embryonic fibroblasts)	NULL
EXP031192	none	Mus musculus		NULL	132	chip_control	NULL	uterus	NULL
EXP031193	PR	Mus musculus	oil	EXP031192	132	unspecified	Q00175	uterus	NULL
EXP031194	PR	Mus musculus	P4	EXP031192	132	unspecified	Q00175	uterus	NULL
EXP031195	PR	Mus musculus	P4	EXP031192	132	unspecified	Q00175	uterus	NULL
EXP031196	streptavidin	Mus musculus		NULL	1	chip_control	NULL	IB10 (embryonic stem cells)	NULL
EXP031197	streptavidin	Mus musculus		NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP031198	streptavidin	Mus musculus		EXP031196	1	unspecified	P41230	IB10 (embryonic stem cells)	NULL
EXP031199	streptavidin	Mus musculus		EXP031197	280	unspecified	P41230	embryonic stem cell-derived neural progenitors	NULL
EXP031200	none	Rattus norvegicus		NULL	784	chip_control	NULL	Schwann cells	NULL
EXP031201	EGR2 (Abcam)	Rattus norvegicus		EXP031200	784	unspecified	P51774	Schwann cells	NULL
EXP031202	SOX10 (Santa Cruz Biotechnology, sc-17342x)	Rattus norvegicus		EXP031200	784	unspecified	O55170	Schwann cells	NULL
EXP031203	IgG	Mus musculus		NULL	143	chip_control	NULL	brain	NULL
EXP031204	IgG	Mus musculus		NULL	143	chip_control	NULL	brain	NULL
EXP031205	CTCF	Mus musculus		EXP031203	143	unspecified	Q61164	brain	NULL
EXP031206	CTCF	Mus musculus		EXP031204	143	unspecified	Q61164	brain	NULL
EXP031207		Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP031208	Tbx3 (A-20)	Mus musculus		EXP031207	53	unspecified	P70324	heart	NULL
EXP031209	Gata4 (C-20)	Mus musculus		EXP031207	53	unspecified	Q08369	heart	NULL
EXP031210	Nkx2-5 (N-19)	Mus musculus		EXP031207	53	unspecified	Q8CB76	heart	NULL
EXP031211	anti-N-CoR	Homo sapiens	siCTL	NULL	10	unspecified	O75376	HEK293T (embryonic kidney)	NULL
EXP031212	anti-N-CoR	Homo sapiens	siGPS2	NULL	10	unspecified	O75376	HEK293T (embryonic kidney)	NULL
EXP031213		Mus musculus		NULL	429	chip_control	NULL	hepatocytes	NULL
EXP031214	Tcf4 (mouse monoclonal, clone 6H5-3)	Mus musculus		EXP031213	429	unspecified	Q924A0	hepatocytes	NULL
EXP031215	anti-LXR alpha and beta	Mus musculus	Bexarotene	NULL	5	unspecified	Q9Z0Y9	liver	NULL
EXP031216	anti-LXR alpha and beta	Mus musculus	Control	NULL	5	unspecified	Q9Z0Y9	liver	NULL
EXP031217	anti-LXR alpha and beta	Mus musculus	T0901317	NULL	5	unspecified	Q9Z0Y9	liver	NULL
EXP031218	SC-9000	Mus musculus	Control	NULL	5	unspecified	P23204	liver	NULL
EXP031219	SC-9000	Mus musculus	Control	NULL	5	unspecified	P23204	liver	NULL
EXP031220	SC-553	Mus musculus	Bexarotene	NULL	5	unspecified	P28700	liver	NULL
EXP031221	SC-553	Mus musculus	Control	NULL	5	unspecified	P28700	liver	NULL
EXP031222	SC-553	Mus musculus	T0901317	NULL	5	unspecified	P28700	liver	NULL
EXP031223	SC-553	Mus musculus	Bexarotene	NULL	5	unspecified	P28700	liver	NULL
EXP031224	SC-553	Mus musculus	Control	NULL	5	unspecified	P28700	liver	NULL
EXP031225	SC-553	Mus musculus	T0901317	NULL	5	unspecified	P28700	liver	NULL
EXP031226	none	Mus musculus		NULL	272	chip_control	NULL	cardiac progenitors	NULL
EXP031227	anti-YY1	Mus musculus		EXP031226	272	unspecified	Q00899	cardiac progenitors	NULL
EXP031228	none, input DNA	Mus musculus	Differentiating	NULL	271	chip_control	NULL	embryonic stem cell-derived erythroid progenitors	NULL
EXP031229	polyclonal rabbit a-GATA-1 produced in-house (H Im et al. PNAS 2005)	Mus musculus	Proliferating	NULL	271	unspecified	P17679	embryonic stem cell-derived erythroid progenitors	NULL
EXP031230	polyclonal rabbit a-GATA-1 produced in-house (H Im et al. PNAS 2005)	Mus musculus	Differentiating	EXP031228	271	unspecified	P17679	embryonic stem cell-derived erythroid progenitors	NULL
EXP031231	rabbit IgG	Homo sapiens		NULL	219	chip_control	NULL	DLD-1 (colon adenocarcinoma)	NULL
EXP031232	aFOXO3 (H144)	Homo sapiens		EXP031231	219	unspecified	O43524	DLD-1 (colon adenocarcinoma)	NULL
EXP031233	none	Mus musculus		NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP031234	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031235	none	Mus musculus		NULL	138	chip_control	NULL	neural progenitors	NULL
EXP031236	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031237	none	Mus musculus		NULL	138	chip_control	NULL	neural progenitors	NULL
EXP031238	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031239	Sox2	Mus musculus		EXP031238	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP031240	Santa Cruz, SC-6029	Mus musculus		EXP031234	2	unspecified	P31360	mESCs (mouse embryonic stem cells)	NULL
EXP031241	R & D Systems (R&D), AF2018	Mus musculus		EXP031234	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP031242	Santa Cruz, SC-6029	Mus musculus		EXP031235	138	unspecified	P31360	neural progenitors	NULL
EXP031243	R & D Systems (R&D), AF2018	Mus musculus		EXP031235	138	unspecified	P48432	neural progenitors	NULL
EXP031244	Santa Cruz, SC-6029	Mus musculus		EXP031236	2	unspecified	P31360	mESCs (mouse embryonic stem cells)	NULL
EXP031245	R & D Systems (R&D), AF2018	Mus musculus		EXP031236	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP031246	Santa Cruz, SC-6029	Mus musculus		EXP031237	138	unspecified	P31360	neural progenitors	NULL
EXP031247	R & D Systems (R&D), AF2018	Mus musculus		EXP031237	138	unspecified	P48432	neural progenitors	NULL
EXP031248	R & D Systems (R&D), AF2018	Mus musculus		EXP031233	280	unspecified	P48432	embryonic stem cell-derived neural progenitors	NULL
EXP031249	Santa Cruz, SC-6029	Mus musculus		EXP031233	280	unspecified	P31360	embryonic stem cell-derived neural progenitors	NULL
EXP031250		Mus musculus		NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP031251	HA-tag antibody (Santa Crruz Biotechnology, sc-7392)	Mus musculus		EXP031250	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP031252	anti-CHOP	Mus musculus	Tunicamycin	NULL	12	unspecified	P35639	MEF (mouse embryonic fibroblasts)	NULL
EXP031253	anti-CHOP	Mus musculus	Tunicamycin	NULL	12	bio_control	P35639	MEF (mouse embryonic fibroblasts)	NULL
EXP031254	anti-ATF4	Mus musculus	Tunicamycin	NULL	12	unspecified	Q06507	MEF (mouse embryonic fibroblasts)	NULL
EXP031255	anti-ATF4	Mus musculus	Tunicamycin	NULL	12	bio_control	Q06507	MEF (mouse embryonic fibroblasts)	NULL
EXP031256	NA	Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP031257	NA	Mus musculus		NULL	564	chip_control	NULL	lymph nodes	NULL
EXP031258	anti EBF1 #0647 homemade	Mus musculus		EXP031256	105	unspecified	Q07802	pro-B cells	NULL
EXP031259	anti EBF1 #0647 homemade	Mus musculus		EXP031257	564	unspecified	Q07802	lymph nodes	NULL
EXP031260	anti-Nkx3.1 (Santa Cruz Biotechnology, sc-15022)	Mus musculus		NULL	632	bio_control	P97436	prostate	NULL
EXP031261	anti-Nkx3.1 (Santa Cruz Biotechnology, sc-15022)	Mus musculus		NULL	632	unspecified	P97436	prostate	NULL
EXP031262	anti-Nkx3.1 (Santa Cruz Biotechnology, sc-15022)	Mus musculus		NULL	632	unspecified	P97436	prostate	NULL
EXP031263	Cux2	Mus musculus		NULL	5	unspecified	P70298	liver	NULL
EXP031264	Cux2	Mus musculus		NULL	5	unspecified	P70298	liver	NULL
EXP031265		Mus musculus		NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP031266	CTCF	Mus musculus		EXP031265	675	unspecified	Q61164	NIH 3T3 (embryonic fibroblasts)	NULL
EXP031267	none	Mus musculus	LPS, 0 min	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP031268	none	Mus musculus	LPS, 120 min	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP031269	none	Mus musculus	LPS, 30 min	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP031270	none	Mus musculus	LPS, 60 min	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP031271	ab81937	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P30561	dendritic cells	NULL
EXP031272	ab81937	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P30561	dendritic cells	NULL
EXP031273	ab81937	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P30561	dendritic cells	NULL
EXP031274	ab81937	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P30561	dendritic cells	NULL
EXP031275	Upstate 07-729	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q61164	dendritic cells	NULL
EXP031276	Upstate 07-729	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q61164	dendritic cells	NULL
EXP031277	Upstate 07-729	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q61164	dendritic cells	NULL
EXP031278	Upstate 07-729	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q61164	dendritic cells	NULL
EXP031279	sc-193	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q61501	dendritic cells	NULL
EXP031280	sc-193	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q61501	dendritic cells	NULL
EXP031281	sc-193	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q61501	dendritic cells	NULL
EXP031282	sc-193	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q61501	dendritic cells	NULL
EXP031283	sc-512	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q8R0K9	dendritic cells	NULL
EXP031284	sc-512	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q8R0K9	dendritic cells	NULL
EXP031285	sc-512	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q8R0K9	dendritic cells	NULL
EXP031286	sc-512	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q8R0K9	dendritic cells	NULL
EXP031287	sc-351	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q99K36	dendritic cells	NULL
EXP031288	sc-351	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q99K36	dendritic cells	NULL
EXP031289	sc-351	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q99K36	dendritic cells	NULL
EXP031290	sc-351	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q99K36	dendritic cells	NULL
EXP031291	Bethyl NB100-134	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q61221	dendritic cells	NULL
EXP031292	Bethyl NB100-134	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q61221	dendritic cells	NULL
EXP031293	Bethyl NB100-134	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q61221	dendritic cells	NULL
EXP031294	Bethyl NB100-134	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q61221	dendritic cells	NULL
EXP031295	sc-640, ab52520	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P15314	dendritic cells	NULL
EXP031296	sc-640, ab52520	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P15314	dendritic cells	NULL
EXP031297	sc-640, ab52520	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P15314	dendritic cells	NULL
EXP031298	sc-640, ab52520	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P15314	dendritic cells	NULL
EXP031299	sc-46, ab28838	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P09450	dendritic cells	NULL
EXP031300	sc-46, ab28838	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P09450	dendritic cells	NULL
EXP031301	sc-46, ab28838	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P09450	dendritic cells	NULL
EXP031302	sc-46, ab28838	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P09450	dendritic cells	NULL
EXP031303	sc-20690	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P08152	dendritic cells	NULL
EXP031304	sc-20690	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P08152	dendritic cells	NULL
EXP031305	sc-20690	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P08152	dendritic cells	NULL
EXP031306	sc-20690	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P08152	dendritic cells	NULL
EXP031307	Maff	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	O54791	dendritic cells	NULL
EXP031308	Maff	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	O54791	dendritic cells	NULL
EXP031309	Maff	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	O54791	dendritic cells	NULL
EXP031310	Maff	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	O54791	dendritic cells	NULL
EXP031311	sc-352	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P17433	dendritic cells	NULL
EXP031312	sc-352	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P17433	dendritic cells	NULL
EXP031313	sc-352	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P17433	dendritic cells	NULL
EXP031314	PU.1	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P17433	dendritic cells	NULL
EXP031315	sc-226, Bethyl A302-183A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q04863	dendritic cells	NULL
EXP031316	sc-226, Bethyl A302-183A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q04863	dendritic cells	NULL
EXP031317	sc-226, Bethyl A302-183A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q04863	dendritic cells	NULL
EXP031318	sc-226, Bethyl A302-183A	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q04863	dendritic cells	NULL
EXP031319	sc-372, Bethyl A301-824A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q04207	dendritic cells	NULL
EXP031320	sc-372, Bethyl A301-824A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q04207	dendritic cells	NULL
EXP031321	sc-372, Bethyl A301-824A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q04207	dendritic cells	NULL
EXP031322	p65	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q04207	dendritic cells	NULL
EXP031323	sc-8564, ab61753	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q03347	dendritic cells	NULL
EXP031324	sc-8564, ab61753	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q03347	dendritic cells	NULL
EXP031325	sc-8564, ab61753	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q03347	dendritic cells	NULL
EXP031326	Bethyl A302-406A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P42227	dendritic cells	NULL
EXP031327	Bethyl A302-406A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P42227	dendritic cells	NULL
EXP031328	Bethyl A302-406A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P42227	dendritic cells	NULL
EXP031329	Bethyl A302-406A	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P42227	dendritic cells	NULL
EXP031330	sc-188, ab70005-100	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q60765	dendritic cells	NULL
EXP031331	sc-188, ab70005-100	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q60765	dendritic cells	NULL
EXP031332	sc-188, ab70005-100	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q60765	dendritic cells	NULL
EXP031333	sc-188, ab70005-100	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q60765	dendritic cells	NULL
EXP031334	sc-200, ab28830-100	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q06507	dendritic cells	NULL
EXP031335	sc-70, sc-71	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P15307	dendritic cells	NULL
EXP031336	sc-70, sc-71	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P15307	dendritic cells	NULL
EXP031337	sc-70, sc-71	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P15307	dendritic cells	NULL
EXP031338	sc-70, sc-71	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P15307	dendritic cells	NULL
EXP031339	sc-150	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P28033	dendritic cells	NULL
EXP031340	sc-150	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P28033	dendritic cells	NULL
EXP031341	sc-150	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P28033	dendritic cells	NULL
EXP031342	sc-150	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P28033	dendritic cells	NULL
EXP031343	sc-110, ab54966-100	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P08046	dendritic cells	NULL
EXP031344	sc-110, ab54966-100	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P08046	dendritic cells	NULL
EXP031345	sc-110, ab54966-100	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P08046	dendritic cells	NULL
EXP031346	sc-110, ab54966-100	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P08046	dendritic cells	NULL
EXP031347	sc-498, ab65048	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P23906	dendritic cells	NULL
EXP031348	sc-498, ab65048	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P23906	dendritic cells	NULL
EXP031349	sc-498, ab65048	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P23906	dendritic cells	NULL
EXP031350	sc-498, ab65048	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P23906	dendritic cells	NULL
EXP031351	sc-6059	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q64287	dendritic cells	NULL
EXP031352	sc-6059	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q64287	dendritic cells	NULL
EXP031353	sc-6059	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q64287	dendritic cells	NULL
EXP031354	sc-6059	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q64287	dendritic cells	NULL
EXP031355	sc-114	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P25799	dendritic cells	NULL
EXP031356	sc-114	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P25799	dendritic cells	NULL
EXP031357	sc-114	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P25799	dendritic cells	NULL
EXP031358	sc-114	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P25799	dendritic cells	NULL
EXP031359	sc-346, Bethyl A302-753A	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	P42225	dendritic cells	NULL
EXP031360	sc-346, Bethyl A302-753A	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P42225	dendritic cells	NULL
EXP031361	sc-346, Bethyl A302-753A	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	P42225	dendritic cells	NULL
EXP031362	sc-346, Bethyl A302-753A	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	P42225	dendritic cells	NULL
EXP031363	sc-839, ab53149	Mus musculus	LPS, 0 min	EXP031267	104	unspecified	Q9WVL2	dendritic cells	NULL
EXP031364	sc-839, ab53149	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q9WVL2	dendritic cells	NULL
EXP031365	sc-839, ab53149	Mus musculus	LPS, 30 min	EXP031269	104	unspecified	Q9WVL2	dendritic cells	NULL
EXP031366	sc-839, ab53149	Mus musculus	LPS, 60 min	EXP031270	104	unspecified	Q9WVL2	dendritic cells	NULL
EXP031367	Rel	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	P15307	dendritic cells	NULL
EXP031368	Relb	Mus musculus	LPS, 120 min	EXP031268	104	unspecified	Q04863	dendritic cells	NULL
EXP031369		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP031370	taf1	Mus musculus		EXP031369	230	unspecified	Q80UV9	ES-E14 (E14, embryonic stem cells)	NULL
EXP031371		Homo sapiens		NULL	245	chip_control	NULL	NCCIT (testicular embryonic carcinoma)	NULL
EXP031372	ab19857	Homo sapiens		NULL	245	unspecified	Q01860	NCCIT (testicular embryonic carcinoma)	NULL
EXP031373	ab19857	Homo sapiens	SNF5 overexpression	EXP031371	245	unspecified	Q01860	NCCIT (testicular embryonic carcinoma)	NULL
EXP031374	none	Mus musculus		NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP031375	CTCF (Millipore;  07-729 DAM1772428)	Mus musculus		EXP031374	280	unspecified	Q61164	embryonic stem cell-derived neural progenitors	NULL
EXP031376	sc-12762	Homo sapiens		NULL	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031377	sc-12762	Homo sapiens		NULL	119	unspecified	Q92754	BT-474 (breast invasive ductal carcinoma)	NULL
EXP031378	sc-12762	Homo sapiens		NULL	590	unspecified	Q92754	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031379	sc-12762	Homo sapiens		NULL	758	unspecified	Q92754	SK-BR-3 (breast adenocarcinoma)	NULL
EXP031380	None	Homo sapiens	cMyc expression released for 0 hours	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP031381	None	Homo sapiens	cMyc expression released for 1 hour	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP031382	None	Homo sapiens	cMyc expression released for 24 hours	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP031383	None	Homo sapiens		NULL	374	chip_control	NULL	NCI-H128 (small cell lung carcinoma)	NULL
EXP031384	None	Homo sapiens		NULL	849	chip_control	NULL	U87 (glioblastoma)	NULL
EXP031385	None	Homo sapiens		NULL	384	chip_control	NULL	NCI-H2171 (small cell lung carcinoma)	NULL
EXP031386	None	Homo sapiens	DMSO	NULL	880	chip_control	NULL	B-cells	NULL
EXP031387	Santa Cruz SC-764	Homo sapiens	cMyc expression released for 24 hours	EXP031382	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP031388	Santa Cruz SC-764	Homo sapiens	cMyc expression released for 0 hours	EXP031380	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP031389	Santa Cruz SC-764	Homo sapiens	cMyc expression released for 1 hours	EXP031381	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP031390	c-Myc	Homo sapiens		EXP031384	849	unspecified	P01106	U87 (glioblastoma)	NULL
EXP031391	Santa Cruz SC-197	Homo sapiens	cMyc expression released for 0 hours	EXP031380	708	unspecified	P61244	P493-6 (B-cell lymphoma)	NULL
EXP031392	Santa Cruz SC-197	Homo sapiens	cMyc expression released for 1 hours	EXP031381	708	unspecified	P61244	P493-6 (B-cell lymphoma)	NULL
EXP031393	Santa Cruz SC-197	Homo sapiens	cMyc expression released for 24 hours	EXP031382	708	unspecified	P61244	P493-6 (B-cell lymphoma)	NULL
EXP031394	Santa Cruz SC-197	Homo sapiens		EXP031384	849	unspecified	P61244	U87 (glioblastoma)	NULL
EXP031395	Santa Cruz SC-197	Homo sapiens	DMSO	EXP031386	880	unspecified	P61244	B-cells	NULL
EXP031396	Santa Cruz SC-764	Homo sapiens		EXP031383	374	unspecified	P01106	NCI-H128 (small cell lung carcinoma)	NULL
EXP031397	Santa Cruz SC-197	Homo sapiens		EXP031383	374	unspecified	P61244	NCI-H128 (small cell lung carcinoma)	NULL
EXP031398	Santa Cruz SC-764	Homo sapiens		EXP031385	384	unspecified	P01106	NCI-H2171 (small cell lung carcinoma)	NULL
EXP031399	Santa Cruz SC-197	Homo sapiens		EXP031385	384	unspecified	P61244	NCI-H2171 (small cell lung carcinoma)	NULL
EXP031400	Santa Cruz SC-764	Homo sapiens	DMSO	EXP031386	880	unspecified	P01106	B-cells	NULL
EXP031401	Rev-erb(beta)	Mus musculus	time 5pm/ZT10	NULL	5	unspecified	Q60674	liver	NULL
EXP031402	Rev-erb(beta)	Mus musculus	time 5am/ZT22	NULL	5	unspecified	Q60674	liver	NULL
EXP031403	Rev-erb(alpha)	Mus musculus	Rev-erb alpha KO	NULL	5	unspecified	Q3UV55	liver	NULL
EXP031404		Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031405	Anti-V5 Agarose Affinity Gel antibody produced in mouse purified    immunoglobulin, clone V5-10	Mus musculus		EXP031404	2	unspecified	P22227	mESCs (mouse embryonic stem cells)	NULL
EXP031406	none	Mus musculus	vehicle and estradiol	NULL	132	chip_control	NULL	uterus	NULL
EXP031407	ER alpha (sc-542, lot# D1310, Santa Cruz)	Mus musculus	vehicle	EXP031406	132	unspecified	P19785	uterus	NULL
EXP031408	ER alpha (sc-542, lot# D1310, Santa Cruz)	Mus musculus	estradiol	EXP031406	132	unspecified	P19785	uterus	NULL
EXP031409		Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP031410	ab19857	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	Q01860	BJ (fibroblasts)	NULL
EXP031411	AF2018	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	P48431	BJ (fibroblasts)	NULL
EXP031412	AF3640	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	O43474	BJ (fibroblasts)	NULL
EXP031413	AF3696	Homo sapiens	dox-inducible Oct4, Sox2, cMyc +1 ug/ml dox for 48 hours	EXP031409	93	unspecified	P01106	BJ (fibroblasts)	NULL
EXP031414	ab19857	Homo sapiens	1 ug/ml dox for 48 hours	NULL	93	unspecified	Q01860	BJ (fibroblasts)	NULL
EXP031415	c-Myc	Homo sapiens	1 ug/ml dox for 48 hours	NULL	93	unspecified	P01106	BJ (fibroblasts)	NULL
EXP031416	IgG	Homo sapiens		NULL	89	chip_control	NULL	BGO3 (embryonic stem cells)	NULL
EXP031417	Abcam AB28379	Homo sapiens	Activin A 48 hours	EXP031416	89	unspecified	P84022	BGO3 (embryonic stem cells)	NULL
EXP031418	Abcam AB28379	Homo sapiens	Activin A 2 hours	EXP031416	89	unspecified	P84022	BGO3 (embryonic stem cells)	NULL
EXP031419	Abcam AB28379	Homo sapiens	Activin A 0 hours	EXP031416	89	unspecified	P84022	BGO3 (embryonic stem cells)	NULL
EXP031420	None	Mus musculus		NULL	319	chip_control	NULL	G1E-ER4 (embryonic stem cells)	NULL
EXP031421	None	Mus musculus		NULL	73	chip_control	NULL	G1E-derived erythroid cells	NULL
EXP031422	GATA1 (Santacruz,clone N6, sc-265)	Mus musculus		EXP031420	319	unspecified	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP031423	GATA1 (Santacruz,clone N6, sc-265)	Mus musculus		EXP031421	73	unspecified	P17679	G1E-derived erythroid cells	NULL
EXP031424	IgG (N-20; Santa Cruz; sc-651)	Homo sapiens		NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP031425	p53 (FL-393; Santa Cruz; sc-6243)	Homo sapiens		EXP031424	2360	unspecified	P04637	fibroblasts	NULL
EXP031426	Rabbit IgG	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP031427	Rabbit IgG	Mus musculus	IL-2 for 1 hr	NULL	44	chip_control	NULL	T-cells	NULL
EXP031428	Rabbit IgG	Mus musculus	mutatnt Stat5a and Stat5b that form dimers but not tetramers	NULL	44	chip_control	NULL	T-cells	NULL
EXP031429	Rabbit IgG	Mus musculus	IL-2 for 1 hr, mutatnt Stat5a and Stat5b that form dimers but not tetramers	NULL	44	chip_control	NULL	T-cells	NULL
EXP031430	Anti-Stat5A	Mus musculus		EXP031426	44	unspecified	P42230	T-cells	NULL
EXP031431	Anti-Stat5B	Mus musculus		EXP031426	44	unspecified	P42232	T-cells	NULL
EXP031432	Anti-Stat5A	Mus musculus	IL-2 for 1 hr	EXP031427	44	unspecified	P42230	T-cells	NULL
EXP031433	Anti-Stat5B	Mus musculus	IL-2 for 1 hr	EXP031427	44	unspecified	P42232	T-cells	NULL
EXP031434	Anti-Stat5A	Mus musculus	mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031428	44	unspecified	P42230	T-cells	NULL
EXP031435	Anti-Stat5B	Mus musculus	mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031428	44	unspecified	P42232	T-cells	NULL
EXP031436	Anti-Stat5A	Mus musculus	IL-2 for 1 hr, mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031429	44	unspecified	P42230	T-cells	NULL
EXP031437	Anti-Stat5B	Mus musculus	IL-2 for 1 hr, mutatnt Stat5a and Stat5b that form dimers but not tetramers	EXP031429	44	unspecified	P42232	T-cells	NULL
EXP031438	none	Homo sapiens	2-trimester fetal liver	NULL	167	chip_control	NULL	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031439	none	Homo sapiens	adult bone marrow	NULL	167	chip_control	NULL	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031440	none	Homo sapiens	adult bone marrow	NULL	167	chip_control	NULL	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031441	sc-12984	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031442	sc-12984	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031443	sc-291	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	Q16621	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031444	sc-291	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	Q16621	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031445	Millipore 07-729	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	P49711	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031446	Millipore 07-729	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	P49711	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031447	ab11852	Homo sapiens	2-trimester fetal liver	EXP031438	167	unspecified	P15976	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031448	ab11852	Homo sapiens	adult bone marrow	EXP031439	167	unspecified	P15976	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031449	ab55331 and ABE115	Homo sapiens	adult bone marrow	EXP031440	167	unspecified	P14316	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP031450	Santa Cruz SC-2025	Mus musculus	conconavalin for 4 hours	NULL	44	chip_control	NULL	T-cells	NULL
EXP031451	Santa Cruz SC-2025	Mus musculus	conconavalin for 14 hours	NULL	44	chip_control	NULL	T-cells	NULL
EXP031452	Santa Cruz SC-2025	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP031453	Santa Cruz SC-2025	Mus musculus	LPS and 10058-F4 for 4 hours	NULL	41	chip_control	NULL	B-cells	NULL
EXP031454	Santa Cruz SC-2025	Mus musculus	LPS for 4 hours	NULL	41	chip_control	NULL	B-cells	NULL
EXP031455	Clontech, 632460	Mus musculus	conconavalin for 4 hours	EXP031450	44	unspecified	P01108	T-cells	NULL
EXP031456	Clontech, 632460	Mus musculus	conconavalin for 14 hours	EXP031451	44	unspecified	P01108	T-cells	NULL
EXP031457	Clontech, 632460	Mus musculus		EXP031452	41	unspecified	P01108	B-cells	NULL
EXP031458	Clontech, 632460	Mus musculus	LPS and 10058-F4 for 4 hours	EXP031453	41	unspecified	P01108	B-cells	NULL
EXP031459	Clontech, 632460	Mus musculus	LPS for 4 hours	EXP031454	41	unspecified	P01108	B-cells	NULL
EXP031460	rabbit IgG (G2018, Sigma)	Mus musculus	LIF, Dex+LIF, Dex (control pooled from different experiments)	NULL	75	chip_control	NULL	AtT-20 (pituitary tumor)	NULL
EXP031461	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	Mus musculus	LIF	EXP031460	75	unspecified	P42227	AtT-20 (pituitary tumor)	NULL
EXP031462	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	Mus musculus	Dex+LIF	EXP031460	75	unspecified	P42227	AtT-20 (pituitary tumor)	NULL
EXP031463	GR (sc-1004) from SantaCruz	Mus musculus	Dex+LIF	EXP031460	75	unspecified	P06537	AtT-20 (pituitary tumor)	NULL
EXP031464	GR (sc-1004) from SantaCruz	Mus musculus	Dex	EXP031460	75	unspecified	P06537	AtT-20 (pituitary tumor)	NULL
EXP031465		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031466	PBX1 monoclonal antibody (M01)	Homo sapiens		EXP031465	113	unspecified	P40424	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031467	Purified IgG1 k isotype control (BD Biosciences, Cat. No. 554121, Lot #70274)	Mus musculus		NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP031468	none	Mus musculus		NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP031469	TEAD4 (Abcam, Cat. No. ab58310, Lot #GR33778-1)	Mus musculus		EXP031467	96	unspecified	Q62296	trophoblast stem cells	NULL
EXP031470		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP031471	c-Jun, SantaCruz: sc-1694x	Mus musculus		EXP031470	1153	unspecified	P05627	C2C12 (myoblasts)	NULL
EXP031472	rabbit IgG antibody (Invitrogen)	Homo sapiens	 10 uM D,L-sulforaphane for 5 hours	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP031473	rabbit IgG antibody (Invitrogen)	Homo sapiens		NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP031474	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens	 10 uM D,L-sulforaphane for 5 hours	EXP031472	566	unspecified	Q16236	lymphoblastoid cells	NULL
EXP031475	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens		EXP031473	566	unspecified	Q16236	lymphoblastoid cells	NULL
EXP031476	none	Homo sapiens		NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP031477	ERG	Homo sapiens		EXP031476	781	unspecified	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP031478	none	Mus musculus		NULL	809	chip_control	NULL	STHdhQ7 (striatal cells)	NULL
EXP031479	none	Mus musculus		NULL	808	chip_control	NULL	STHdhQ111 (striatal cells)	NULL
EXP031480	sc-9144	Mus musculus		EXP031478	809	unspecified	P38532	STHdhQ7 (striatal cells)	NULL
EXP031481	sc-9144	Mus musculus		EXP031479	808	unspecified	P38532	STHdhQ111 (striatal cells)	NULL
EXP031482	sc-9144	Mus musculus	cells were heat-shocked at 42Â°C for six hours	EXP031478	809	unspecified	P38532	STHdhQ7 (striatal cells)	NULL
EXP031483	sc-9144	Mus musculus	cells were heat-shocked at 42Â°C for six hours	EXP031479	808	unspecified	P38532	STHdhQ111 (striatal cells)	NULL
EXP031484	none	Homo sapiens		NULL	562	chip_control	NULL	LX-2 (hepatic stellate cells)	NULL
EXP031485	Sc-1008x	Homo sapiens		EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	NULL
EXP031486	Sc-1008x	Homo sapiens	100nM calcipotriol	EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	NULL
EXP031487	ab28379	Homo sapiens	100nM calcipotriol + 1ng/ml TGFb	EXP031484	562	unspecified	P84022	LX-2 (hepatic stellate cells)	NULL
EXP031488	ab28379	Homo sapiens	1ng/ml TGFb	EXP031484	562	unspecified	P84022	LX-2 (hepatic stellate cells)	NULL
EXP031489	Sc-1008x	Homo sapiens	100nM calcipotriol + 1ng/ml TGFb	EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	NULL
EXP031490	Sc-1008x	Homo sapiens	1ng/ml TGFb	EXP031484	562	unspecified	P11473	LX-2 (hepatic stellate cells)	NULL
EXP031491	None	Mus musculus		NULL	503	chip_control	NULL	pre-B cells	NULL
EXP031492	Rabbit anti-C-terminal Ikaros	Mus musculus		EXP031491	503	unspecified	Q03267	pre-B cells	NULL
EXP031493	Anti-haemagglutinin (HA) (Covance).	Mus musculus		EXP031491	503	unspecified	Q03267	pre-B cells	NULL
EXP031494		Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP031495	sc-502	Homo sapiens		EXP031494	848	unspecified	Q08050	U2OS (osteosarcoma)	NULL
EXP031496	snapc4	Homo sapiens		NULL	489	unspecified	Q5SXM2	IMR90 (lung fibroblasts)	NULL
EXP031497	mix of monoclonal antibodies YL8 and YL15	Homo sapiens		NULL	78	unspecified	Q01860	HeLa (cervical adenocarcinoma)	NULL
EXP031498	HOXA9	Homo sapiens		NULL	541	unspecified	P31269	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP031499	MEIS1	Homo sapiens		NULL	541	unspecified	O00470	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP031500		Mus musculus		NULL	124	unspecified	P63058	C17.2a (neural progenitors)	NULL
EXP031501		Mus musculus		NULL	124	unspecified	P37242	C17.2a (neural progenitors)	NULL
EXP031502	RXR	Mus musculus		NULL	124	unspecified	P28700	C17.2a (neural progenitors)	NULL
EXP031503	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	LPS (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031504	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	LPS (10 ng/ml) for 24hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031505	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031506	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031507	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	TNFa (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031508	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	TGFb1 (1 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031509	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	IL1b (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031510	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	MALP2 (1 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031511	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus	CpG (100 nM) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031512	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6ko ctrl	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031513	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6ko ctrl, IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031514	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6ko	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031515	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat6 ko, IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031516	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko ctrl	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031517	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko ctrl, IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031518	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031519	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	stat1ko, IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031520	Santa Cruz Biotechnology, sc-981	Mus musculus		NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP031521	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 15min	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP031522	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 30min	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP031523	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 1hrs	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP031524	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 2hrs	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP031525	Santa Cruz Biotechnology, sc-981	Mus musculus	IL4 (10 ng/ml) for 4hrs	NULL	81	unspecified	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP031526	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031527	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 30min	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031528	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 1hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031529	anti-PU.1 (rabbit polyclonal against the N-terminus (aa. 1-100))	Mus musculus	IFNg (100 ng/ml) for 2hrs	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031530	Santa Cruz Biotechnology, sc-592	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP031531	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 30min	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP031532	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 1hrs	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP031533	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 2hrs	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP031534	Santa Cruz Biotechnology, sc-46	Mus musculus		NULL	81	unspecified	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP031535	Santa Cruz Biotechnology, sc-46	Mus musculus	LPS (10 ng/ml) for 4hrs	NULL	81	unspecified	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP031536	Santa Cruz Biotechnology, sc-592	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP031537	Santa Cruz Biotechnology, sc-592	Mus musculus	IFNg (100 ng/ml) for 4hrs	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP031538	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP031539	Mouse IgG [Santa Cruz, Cat#2025, Lot#B1710]	Homo sapiens		NULL	79	chip_control	NULL	BCBL-1 (B-cell lymphoma)	NULL
EXP031540	rabbit anti-CTCF	Homo sapiens		EXP031539	79	unspecified	P49711	BCBL-1 (B-cell lymphoma)	NULL
EXP031541	ab46540	Homo sapiens	pooled patient1,2,3	NULL	730	chip_control	NULL	mononuclear cells from periferal blood	NULL
EXP031542	ab21689	Homo sapiens	patient1	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	NULL
EXP031543	ab21689	Homo sapiens	patient3	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	NULL
EXP031544	ab21689	Homo sapiens	patient4, immune complexes	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	NULL
EXP031545	ab21689	Homo sapiens	patient6, immune complexes	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	NULL
EXP031546	sc-486	Homo sapiens	patient1	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031547	sc-486	Homo sapiens	patient2	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031548	sc-486	Homo sapiens	patient3	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031549	sc-486	Homo sapiens	patient4, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031550	sc-486	Homo sapiens	patient5, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031551	sc-486	Homo sapiens	patient5, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031552	sc-486	Homo sapiens	patient6, 500 U/ml of IFN-Î±2b	EXP031541	730	unspecified	Q14765	mononuclear cells from periferal blood	NULL
EXP031553	ab21689	Homo sapiens	patient2	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	NULL
EXP031554	ab21689	Homo sapiens	patient5, immune complexes	EXP031541	730	unspecified	Q13568	mononuclear cells from periferal blood	NULL
EXP031555	CTCF	Homo sapiens		NULL	738	unspecified	P49711	PrEC (prostate cells)	NULL
EXP031556	CTCF	Homo sapiens		NULL	70	unspecified	P49711	LNCaP (prostate carcinoma)	NULL
EXP031557	anti-T-bet antibody (sc-21749, Santa Cruz)	Mus musculus		NULL	76	unspecified	Q9JKD8	Th1-cells	NULL
EXP031558		Mus musculus	MSCV-IRF8 transduced	NULL	643	chip_control	NULL	Tot2 (myeloid progenitor cell line)	NULL
EXP031559	goat anti-IRF8 antibody (C-19; Santa Cruz Biotechnology)	Mus musculus	MSCV-IRF8 transduced	EXP031558	643	unspecified	P23611	Tot2 (myeloid progenitor cell line)	NULL
EXP031560	rabbit anti-PU.1 antibody (sc-352, Santa Cruz)	Mus musculus	MSCV-IRF8 transduced	EXP031558	643	unspecified	P17433	Tot2 (myeloid progenitor cell line)	NULL
EXP031561	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP031562	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	106	chip_control	NULL	BPE (mammary epithelial cells)	NULL
EXP031563	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	heat shock	NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP031564	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	106	chip_control	NULL	BPE (mammary epithelial cells)	NULL
EXP031565	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP031566	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	107	chip_control	NULL	BPLER (mammary epithelial cells)	NULL
EXP031567	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP031568	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	heat shock	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP031569	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	650	chip_control	NULL	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP031570	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP031571	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	822	chip_control	NULL	SW620 (colon adenocarcinoma)	NULL
EXP031572	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	418	chip_control	NULL	HCT-15 (colon carcinoma)	NULL
EXP031573	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP031574	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031575	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	388	chip_control	NULL	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP031576	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	758	chip_control	NULL	SK-BR-3 (breast adenocarcinoma)	NULL
EXP031577	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	657	chip_control	NULL	NCI-H838 (lung adenocarcinoma)	NULL
EXP031578	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	118	chip_control	NULL	BT-20 (breast invasive ductal carcinoma)	NULL
EXP031579	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	1123	chip_control	NULL	breast tumor	NULL
EXP031580	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	1123	chip_control	NULL	breast tumor	NULL
EXP031581	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	718	chip_control	NULL	colon cancer	NULL
EXP031582	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens		NULL	718	chip_control	NULL	colon cancer	NULL
EXP031583	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031561	440	unspecified	Q00613	HMEC (human mammary epithelial cells)	NULL
EXP031584	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031562	106	unspecified	Q00613	BPE (mammary epithelial cells)	NULL
EXP031585	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031565	440	unspecified	Q00613	HMEC (human mammary epithelial cells)	NULL
EXP031586	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031566	107	unspecified	Q00613	BPLER (mammary epithelial cells)	NULL
EXP031587	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031567	583	unspecified	Q00613	MCF10A (breast epithelial cells)	NULL
EXP031588	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	heat shock	EXP031568	583	unspecified	Q00613	MCF10A (breast epithelial cells)	NULL
EXP031589	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031569	650	unspecified	Q00613	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP031590	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031570	874	unspecified	Q00613	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP031591	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031571	822	unspecified	Q00613	SW620 (colon adenocarcinoma)	NULL
EXP031592	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031572	418	unspecified	Q00613	HCT-15 (colon carcinoma)	NULL
EXP031593	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031573	452	unspecified	Q00613	HT29 (colon adenocarcinoma)	NULL
EXP031594	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031574	113	unspecified	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031595	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031575	388	unspecified	Q00613	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP031596	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031576	758	unspecified	Q00613	SK-BR-3 (breast adenocarcinoma)	NULL
EXP031597	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031577	657	unspecified	Q00613	NCI-H838 (lung adenocarcinoma)	NULL
EXP031598	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031578	118	unspecified	Q00613	BT-20 (breast invasive ductal carcinoma)	NULL
EXP031599	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	heat shock	EXP031564	106	unspecified	Q00613	BPE (mammary epithelial cells)	NULL
EXP031600	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	heat shock	EXP031563	440	unspecified	Q00613	HMEC (human mammary epithelial cells)	NULL
EXP031601	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031579	1123	unspecified	Q00613	breast tumor	NULL
EXP031602	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031580	1123	unspecified	Q00613	breast tumor	NULL
EXP031603	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031581	718	unspecified	Q00613	colon cancer	NULL
EXP031604	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens		EXP031582	718	unspecified	Q00613	colon cancer	NULL
EXP031605		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031606	none	Homo sapiens	hypoxia	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031607	HIF1? [Novus Biologicals NB100-134 lot.K2]	Homo sapiens		EXP031605	472	unspecified	Q16665	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031608	HIF1? [Novus Biologicals NB100-134 lot.K2]	Homo sapiens	hypoxia	EXP031606	472	unspecified	Q16665	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031609	YY1 (Santa Cruz Biotechnology, sc-1703X)	Homo sapiens		NULL	376	unspecified	P25490	WA01 (H1, human embryonic stem cells)	NULL
EXP031610		Homo sapiens		NULL	777	chip_control	NULL	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP031611	TCF3/E2A	Homo sapiens		EXP031610	777	unspecified	P15923	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP031612	GATA3	Homo sapiens		EXP031610	777	unspecified	P23771	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP031613	TCF12/HEB	Homo sapiens		EXP031610	777	unspecified	Q99081	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP031614	TAL1	Homo sapiens		EXP031610	777	unspecified	P17542	RPMI-8402 (T acute lymphoblastic leukemia)	NULL
EXP031615	None	Homo sapiens	asynchronously cycling	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP031616	None	Homo sapiens	mitotic block and release	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP031617	FoxA1	Homo sapiens	mitotic block and release	EXP031616	1474	unspecified	P55317	HuH7 (hepatocellular carcinoma)	NULL
EXP031618	FoxA1	Homo sapiens	asynchronously cycling	EXP031615	1474	unspecified	P55317	HuH7 (hepatocellular carcinoma)	NULL
EXP031619	SP1 (Santa Cruz sc-17824)	Mus musculus		NULL	96	unspecified	O89090	trophoblast stem cells	NULL
EXP031620	TBP (Abcam ab818)	Mus musculus		NULL	96	unspecified	P29037	trophoblast stem cells	NULL
EXP031621	CTCF (Pugacheva et. al. 2005 Hum Mol Genet 14, 953-965)	Mus musculus		NULL	96	unspecified	Q61164	trophoblast stem cells	NULL
EXP031622	WCE	Mus musculus		NULL	60	chip_control	NULL	Ainv15 (embryonic stem cells)	NULL
EXP031623	anti-V5 (Abcam, ab15828)	Mus musculus	+RA +Hh +Dox +FGF	EXP031622	60	unspecified	P43241	Ainv15 (embryonic stem cells)	NULL
EXP031624	anti-V5 (Abcam, ab15828)	Mus musculus	+RA +Hh +Dox	EXP031622	60	unspecified	P43241	Ainv15 (embryonic stem cells)	NULL
EXP031625	IgG (Santa Cruz Biotechnology, Sc-2027)	Mus musculus		NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP031626	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031627	IgG (Santa Cruz Biotechnology, Sc-2027)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031628	CTCF (Millipore, 07-729, lot DAM1682158)	Mus musculus		EXP031625	216	unspecified	Q61164	differentiated embryonic stem cells	NULL
EXP031629	CTCF (Millipore, 07-729, lot DAM1682158)	Mus musculus		EXP031627	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP031630	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031631	streptavidin beads	Mus musculus		EXP031630	2	unspecified	Q6J1H4	mESCs (mouse embryonic stem cells)	NULL
EXP031632	Rabbit IgG (R&D, AB-105-C, ER11)	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP031633	Rabbit IgG (R&D, AB-105-C, ER11)	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP031634	Rabbit IgG (R&D, AB-105-C, ER11)	Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP031635	IRF4 (Santa Cruz, sc-6059)	Mus musculus		EXP031632	41	unspecified	Q64287	B-cells	NULL
EXP031636	IRF4 (Santa Cruz, sc-6059)	Mus musculus	IL21	EXP031632	41	unspecified	Q64287	B-cells	NULL
EXP031637	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus		EXP031633	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP031638	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	IL21	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP031639	IRF8 (from Keiko Ozato, not commercial available)	Mus musculus		EXP031633	1058	unspecified	P23611	CD4+ T-cells	NULL
EXP031640	IRF8 (from Keiko Ozato, not commercial available)	Mus musculus	IL21	NULL	1058	unspecified	P23611	CD4+ T-cells	NULL
EXP031641	cJUN (Abcam, ab31419, GR30-33)	Mus musculus		EXP031633	1058	unspecified	P05627	CD4+ T-cells	NULL
EXP031642	cJUN (Abcam, ab31419, GR30-33)	Mus musculus	IL21	EXP031633	1058	unspecified	P05627	CD4+ T-cells	NULL
EXP031643	STAT3 (Invitrogen, 13-7000)	Mus musculus		EXP031633	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP031644	STAT3 (Invitrogen, 13-7000)	Mus musculus	IL21	EXP031633	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP031645	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus		EXP031633	1058	unspecified	O35284	CD4+ T-cells	NULL
EXP031646	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	IL21, IRF4KO	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP031647	cJUN (Abcam, ab31419, GR30-33)	Mus musculus	IL21, IRF4KO	EXP031633	1058	unspecified	P05627	CD4+ T-cells	NULL
EXP031648	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus	IRF4KO	EXP031633	1058	unspecified	O35284	CD4+ T-cells	NULL
EXP031649	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus	IL21, IRF4KO	EXP031633	1058	unspecified	O35284	CD4+ T-cells	NULL
EXP031650	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus	BATFKO, IL21	EXP031633	1058	unspecified	O35284	CD4+ T-cells	NULL
EXP031651	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	BATFKO	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP031652	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus	BATFKO, IL21	EXP031633	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP031653	BATF (from Ken Murphy [rabbit ], not commercial available)	Mus musculus		EXP031634	498	unspecified	O35284	Th17-cells	NULL
EXP031654	IRF4 (Santa Cruz, sc-6059, k1209)	Mus musculus		EXP031634	498	unspecified	Q64287	Th17-cells	NULL
EXP031655	JunB (Santa Cruz, sc-73, k0311)	Mus musculus		EXP031634	498	unspecified	P09450	Th17-cells	NULL
EXP031656	cJUN (Abcam, ab31419, GR30-33)	Mus musculus		EXP031634	498	unspecified	P05627	Th17-cells	NULL
EXP031657	JunD (Santa Cruz, sc-74, J-1411)	Mus musculus		EXP031634	498	unspecified	P15066	Th17-cells	NULL
EXP031658	STAT3 (Invitrogen, 13-7000)	Mus musculus		EXP031634	498	unspecified	P42227	Th17-cells	NULL
EXP031659	IgG antibodies (Santa Cruz, sc-2025)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031660	Tfe3 (Santa Cruz, sc-5958)	Mus musculus		EXP031659	2	unspecified	Q64092	mESCs (mouse embryonic stem cells)	NULL
EXP031661	Tfe3 (Santa Cruz, sc-5958)	Mus musculus	shFlcn	EXP031659	2	unspecified	Q64092	mESCs (mouse embryonic stem cells)	NULL
EXP031662	Tfe3 (Santa Cruz, sc-5958)	Mus musculus	shTfe3	EXP031659	2	unspecified	Q64092	mESCs (mouse embryonic stem cells)	NULL
EXP031663	none (input control)	Mus musculus		NULL	660	chip_control	NULL	nephron progenitors	NULL
EXP031664	none (input control)	Mus musculus		NULL	660	chip_control	NULL	nephron progenitors	NULL
EXP031665	six2	Mus musculus		EXP031663	660	unspecified	Q62232	nephron progenitors	NULL
EXP031666	six2	Mus musculus		EXP031664	660	unspecified	Q62232	nephron progenitors	NULL
EXP031667	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031668	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031670	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031671	BMAL1	Mus musculus		EXP031667	5	unspecified	Q9WTL8	liver	NULL
EXP031672	BMAL1	Mus musculus		EXP031670	5	unspecified	Q9WTL8	liver	NULL
EXP031673	CLOCK	Mus musculus		EXP031668	5	unspecified	O08785	liver	NULL
EXP031674	NPAS2	Mus musculus		NULL	5	unspecified	P97460	liver	NULL
EXP031675	none	Homo sapiens		NULL	651	chip_control	NULL	NCI-H1819 (lung adenocarcinoma)	NULL
EXP031676	none	Homo sapiens		NULL	653	chip_control	NULL	NCI-H2087 (non-small cell lung adenocarcinoma)	NULL
EXP031677	none	Homo sapiens		NULL	655	chip_control	NULL	NCI-H3122 (lung adenocarcinoma)	NULL
EXP031678	NKX2-1 [Bethyl Laboratories, BL4000]	Homo sapiens		EXP031675	651	unspecified	P43699	NCI-H1819 (lung adenocarcinoma)	NULL
EXP031679	NKX2-1 [Bethyl Laboratories, BL4000]	Homo sapiens		EXP031676	653	unspecified	P43699	NCI-H2087 (non-small cell lung adenocarcinoma)	NULL
EXP031680	FOXA1 [Abcam, ab23738 (lot 947435)]	Homo sapiens		EXP031677	655	unspecified	P55317	NCI-H3122 (lung adenocarcinoma)	NULL
EXP031681	NKX2-1 [Bethyl Laboratories, BL4000]	Homo sapiens		EXP031677	655	unspecified	P43699	NCI-H3122 (lung adenocarcinoma)	NULL
EXP031682	None	Mus musculus		NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP031683	None	Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP031684	CTCF (07-729, Millipore), lot# DAM1772428	Mus musculus		EXP031682	198	unspecified	Q61164	pre-pro-B-cells	NULL
EXP031685	CTCF (07-729, Millipore), lot# DAM1772428	Mus musculus		EXP031683	105	unspecified	Q61164	pro-B cells	NULL
EXP031686	c-Myc (sc764x, Santa Cruz), lot# H0107	Mus musculus		EXP031683	105	unspecified	P01108	pro-B cells	NULL
EXP031687	none	Mus musculus		NULL	217	chip_control	NULL	hematopoietic cells	NULL
EXP031688	Anti-HA	Mus musculus		EXP031687	217	unspecified	Q03347	hematopoietic cells	NULL
EXP031689	Anti-HA	Mus musculus	dox	EXP031687	217	unspecified	Q03347	hematopoietic cells	NULL
EXP031690	sc-356	Mus musculus		EXP031687	217	unspecified	P26323	hematopoietic cells	NULL
EXP031691	sc-356	Mus musculus	dox	EXP031687	868	unspecified	P26323	hemogenic endothelium	NULL
EXP031692	sc-150	Mus musculus		EXP031687	217	unspecified	P28033	hematopoietic cells	NULL
EXP031693	sc-12984	Mus musculus		EXP031687	217	unspecified	P22091	hematopoietic cells	NULL
EXP031694	sc-12984	Mus musculus	dox	EXP031687	217	unspecified	P22091	hematopoietic cells	NULL
EXP031695	sc-356	Mus musculus		NULL	400	unspecified	P26323	hematopoietic progenitors	NULL
EXP031696	sc-12984	Mus musculus		EXP031687	217	unspecified	P22091	hematopoietic cells	NULL
EXP031697	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP031698	anti-FLAG, clone M2	Mus musculus		EXP031697	1058	unspecified	Q99JB6	CD4+ T-cells	NULL
EXP031699	Anti-rabbit IgG antibody	Homo sapiens	none	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP031700		Homo sapiens	none	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP031701	E2F7 antibody	Homo sapiens	growing	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	NULL
EXP031702	E2F7 antibody	Homo sapiens	quiescent	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	NULL
EXP031703	E2F7 antibody	Homo sapiens	infected with Ras	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	NULL
EXP031704	E2F7 antibody	Homo sapiens	infected with Ras and RB hairpin	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	NULL
EXP031705	E2F7 antibody	Homo sapiens	infected with Ras and E2F7 hairpin	EXP031699	489	unspecified	Q96AV8	IMR90 (lung fibroblasts)	NULL
EXP031706	ab2410	Rattus norvegicus		NULL	218	chip_control	NULL	oligodendrocytes	NULL
EXP031707	ab136253	Rattus norvegicus		EXP031706	218	unspecified	G3V612	oligodendrocytes	NULL
EXP031708	None	Mus musculus		NULL	76	chip_control	NULL	Th1-cells	NULL
EXP031709	T-bet (Lab produced (Szabo et al., Nature 2000))	Mus musculus		EXP031708	76	unspecified	Q9JKD8	Th1-cells	NULL
EXP031710	T-bet (Lab produced (Szabo et al., Nature 2000))	Mus musculus	TbetKO	EXP031708	76	unspecified	Q9JKD8	Th1-cells	NULL
EXP031711	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP031712	none	Mus musculus	endogenously biotinylated foxo1	NULL	44	chip_control	NULL	T-cells	NULL
EXP031713	Foxo1 antibody (Abcam, Ab39670, lot#GR16346-7)	Mus musculus		EXP031711	44	unspecified	Q9R1E0	T-cells	NULL
EXP031714	Strepdavidin	Mus musculus	endogenously biotinylated foxo1	EXP031712	44	unspecified	Q9R1E0	T-cells	NULL
EXP031715	GATA2	Mus musculus	P4	NULL	132	unspecified	O09100	uterus	NULL
EXP031716		Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP031717	Elf1	Mus musculus		EXP031716	1058	unspecified	Q60775	CD4+ T-cells	NULL
EXP031718	Elf1	Mus musculus		EXP031716	1058	unspecified	Q60775	CD4+ T-cells	NULL
EXP031719	ets1	Mus musculus		EXP031716	1058	unspecified	P27577	CD4+ T-cells	NULL
EXP031720	Ets1	Mus musculus		EXP031716	1058	unspecified	P27577	CD4+ T-cells	NULL
EXP031721	cbfb	Mus musculus		EXP031716	1058	unspecified	P23708	CD4+ T-cells	NULL
EXP031722	cbfb	Mus musculus		EXP031716	1058	unspecified	P23708	CD4+ T-cells	NULL
EXP031723	foxp3	Mus musculus		EXP031716	1058	unspecified	Q99JB6	CD4+ T-cells	NULL
EXP031724	foxm1	Homo sapiens	DMSO	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031725	foxm1	Homo sapiens	thiostrepton	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031726	foxm1	Homo sapiens	DMSO	NULL	2301	unspecified	Q08050	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP031727	foxm1	Homo sapiens	thiostrepton	NULL	2301	unspecified	Q08050	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP031728		Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP031729	ab12132	Mus musculus		EXP031728	105	unspecified	Q00899	pro-B cells	NULL
EXP031730	none	Mus musculus		NULL	898	chip_control	NULL	pancreatic islets	NULL
EXP031731	Nkx-6.1	Mus musculus		EXP031730	898	unspecified	Q99MA9	pancreatic islets	NULL
EXP031732	none	Homo sapiens		NULL	867	chip_control	NULL	WI-38 (lung fibroblasts)	NULL
EXP031733	none	Homo sapiens	WI-38, passage 95	NULL	867	chip_control	NULL	WI-38 (lung fibroblasts)	NULL
EXP031734	CTCF	Homo sapiens		EXP031732	867	unspecified	P49711	WI-38 (lung fibroblasts)	NULL
EXP031735	CTCF	Homo sapiens		EXP031733	867	unspecified	P49711	WI-38 (lung fibroblasts)	NULL
EXP031736	none, input DNA	Homo sapiens	TNF-treated cells (45 min)	NULL	175	chip_control	NULL	cervical carcinoma	NULL
EXP031737	p65 (Santa Cruz, C-20, Cat no. SC372)	Homo sapiens	DMSO	EXP031736	175	unspecified	Q04206	cervical carcinoma	NULL
EXP031738	p65 (Santa Cruz, C-20, Cat no. SC372)	Homo sapiens	TNF	EXP031736	175	unspecified	Q04206	cervical carcinoma	NULL
EXP031739	p65 (Santa Cruz, C-20, Cat no. SC372)	Homo sapiens	TNF-MST	EXP031736	175	unspecified	Q04206	cervical carcinoma	NULL
EXP031740	None	Homo sapiens		NULL	384	chip_control	NULL	NCI-H2171 (small cell lung carcinoma)	NULL
EXP031741	None	Homo sapiens		NULL	374	chip_control	NULL	NCI-H128 (small cell lung carcinoma)	NULL
EXP031742	Max	Homo sapiens		EXP031740	384	unspecified	P61244	NCI-H2171 (small cell lung carcinoma)	NULL
EXP031743	Max	Homo sapiens		EXP031741	374	unspecified	P61244	NCI-H128 (small cell lung carcinoma)	NULL
EXP031744	cMyc	Homo sapiens		EXP031741	374	unspecified	P01106	NCI-H128 (small cell lung carcinoma)	NULL
EXP031745	cMyc	Homo sapiens		EXP031740	384	unspecified	P01106	NCI-H2171 (small cell lung carcinoma)	NULL
EXP031746		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031747	sc350x	Homo sapiens	VEGF, 0 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031748	sc350x	Homo sapiens	VEGF, 1 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031749	sc350x	Homo sapiens	VEGF, 4 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031750	sc350x	Homo sapiens	VEGF, 12 hours	EXP031746	472	unspecified	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031751	Monoclonal ANTI-FLAG M2, Clone M2 (SIGMA, F1804)	Mus musculus		NULL	282	chip_control	NULL	embryonic stem cell-derived neural progenitor-like cells	NULL
EXP031752	Monoclonal ANTI-FLAG M2, Clone M2 (SIGMA, F1804)	Mus musculus		EXP031751	282	unspecified	P63015	embryonic stem cell-derived neural progenitor-like cells	NULL
EXP031753	Monoclonal ANTI-FLAG M2, Clone M2 (SIGMA, F1804)	Mus musculus		EXP031751	282	unspecified	P97360	embryonic stem cell-derived neural progenitor-like cells	NULL
EXP031755	Rabbit IgG (R&D Systems)	Mus musculus		NULL	831	chip_control	NULL	Th9-cells	NULL
EXP031756	STAT5B	Mus musculus		EXP031755	831	unspecified	P42232	Th9-cells	NULL
EXP031757	STAT6 (Santa Cruz, M-20, sc-981)	Mus musculus		EXP031755	831	unspecified	P52633	Th9-cells	NULL
EXP031758	STAT5B	Mus musculus	Th9 conditions 0 hours	NULL	831	unspecified	P42232	Th9-cells	NULL
EXP031759	STAT5B	Mus musculus	Th9 conditions 16 hours	NULL	831	unspecified	P42232	Th9-cells	NULL
EXP031760	STAT5B	Mus musculus	Th9 conditions 72 hours	NULL	831	unspecified	P42232	Th9-cells	NULL
EXP031761	STAT5B	Mus musculus	Th9 conditions 72 hours, antiIL2 antibody	NULL	831	unspecified	P42232	Th9-cells	NULL
EXP031762	STAT6	Mus musculus	Th9 conditions 72 hours	NULL	831	unspecified	P52633	Th9-cells	NULL
EXP031763	STAT6	Mus musculus	Th9 conditions 72 hours, antiIL2 antibody	NULL	831	unspecified	P52633	Th9-cells	NULL
EXP031764	GATA4	Mus musculus		NULL	2	unspecified	Q08369	mESCs (mouse embryonic stem cells)	NULL
EXP031765	GATA4	Mus musculus		NULL	2	unspecified	Q08369	mESCs (mouse embryonic stem cells)	NULL
EXP031766	GATA4	Mus musculus	Dexamethasone	NULL	305	unspecified	Q08369	Flk1+ embryonic stem cell-derived mesodermal progenitors	NULL
EXP031767	GATA4	Mus musculus	Dexamethasone	NULL	305	unspecified	Q08369	Flk1+ embryonic stem cell-derived mesodermal progenitors	NULL
EXP031768	anti-Progesterone receptor	Homo sapiens	unstimulated cells	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP031769	anti-Progesterone receptor	Homo sapiens	progestin R5020 5 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP031770	anti-Progesterone receptor	Homo sapiens	progestin R5020 30 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP031771	anti-Progesterone receptor	Homo sapiens	progestin R5020 60 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP031772	anti-Progesterone receptor	Homo sapiens	progestin R5020 360 minutes	EXP031768	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP031773	none (input)	Mus musculus	none	NULL	491	chip_control	NULL	inguinal white adipous tissue-derived adipocytes	NULL
EXP031774	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	none	EXP031773	262	unspecified	P37238	white adipocytes	NULL
EXP031775	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	none	EXP031773	491	unspecified	P37238	inguinal white adipous tissue-derived adipocytes	NULL
EXP031776	anti-PPAR? (sc-7196; Santa Cruz)	Mus musculus	none	EXP031773	116	unspecified	P37238	brown adipocytes	NULL
EXP031777	none	Mus musculus		NULL	475	chip_control	NULL	embryonic hindlimb	NULL
EXP031778	Pitx1	Mus musculus		EXP031777	475	unspecified	P70314	embryonic hindlimb	NULL
EXP031779	none	Homo sapiens		NULL	49	chip_control	NULL	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	NULL
EXP031780	anti-PPAR-gamma	Homo sapiens		EXP031779	49	unspecified	P37231	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	NULL
EXP031781	anti-CEBP-alpha	Homo sapiens		EXP031779	49	unspecified	P49715	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	NULL
EXP031782	anti-LXR	Homo sapiens		EXP031779	49	unspecified	Q13133	SGBS (Simpson-Golabi-Behmel syndrome) adipocytes	NULL
EXP031783	none	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP031784	Anti-CTCF	Mus musculus		EXP031783	171	unspecified	Q61164	CD4+ CD8+ T cells	NULL
EXP031785		Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP031786	Anti-CTCF	Mus musculus		EXP031785	105	unspecified	Q61164	pro-B cells	NULL
EXP031787	none	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP031788	anti-Stat5a	Mus musculus	cognate P1A antigen	EXP031787	2479	unspecified	P42230	CD8+ T-cells	NULL
EXP031789	IgG from rabbit serum (Sigma Aldrich, I5006)	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031790	sc-5579	Homo sapiens		EXP031789	113	unspecified	P35869	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031791	sc-5580	Homo sapiens		EXP031789	113	unspecified	P27540	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031792	IgG (in-house)	Mus musculus		NULL	50	chip_control	NULL	C3H10T1/2-derived adipocytes	NULL
EXP031793	IgG (in-house)	Mus musculus		NULL	127	chip_control	NULL	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP031794	PPAR? (sc-7196)	Mus musculus		EXP031792	50	unspecified	P37238	C3H10T1/2-derived adipocytes	NULL
EXP031795	PPAR? (sc-7196)	Mus musculus		EXP031793	127	unspecified	P37238	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP031796	anti-TBP (abcam 62126)	Mus musculus		EXP031792	50	unspecified	P29037	C3H10T1/2-derived adipocytes	NULL
EXP031797	anti-TBP (abcam 62126)	Mus musculus		EXP031793	127	unspecified	P29037	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP031798		Homo sapiens		NULL	69	chip_control	NULL	acute promyelocytic leukemia blasts	NULL
EXP031799	REST	Homo sapiens		EXP031798	69	unspecified	Q13127	acute promyelocytic leukemia blasts	NULL
EXP031800	NA	Homo sapiens		NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP031801	Runx1	Homo sapiens		EXP031800	541	unspecified	Q01196	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP031802		Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	NULL	662	chip_control	NULL	neuralized embryoid body	NULL
EXP031803	GliFLAG	Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	EXP031802	662	unspecified	P47806	neuralized embryoid body	NULL
EXP031804	Sox2	Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	EXP031802	662	unspecified	P48432	neuralized embryoid body	NULL
EXP031805	Foxa2	Mus musculus	all trans retinoic acid (RA) and SAG for 3 days before harvested	EXP031802	662	unspecified	P35583	neuralized embryoid body	NULL
EXP031806	None	Mus musculus		NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP031807	None	Mus musculus		NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP031808	Eomes (Abcam, ab23345-100, lot 798757)	Mus musculus		EXP031806	96	unspecified	O54839	trophoblast stem cells	NULL
EXP031809	Eomes (Abcam, ab23345-100, lot 798757)	Mus musculus		EXP031807	96	unspecified	O54839	trophoblast stem cells	NULL
EXP031810	Elf5 (Santa Cruz, sc-9645x, lot D2109)	Mus musculus		EXP031806	96	unspecified	Q8VDK3	trophoblast stem cells	NULL
EXP031811	Elf5 (Santa Cruz, sc-9645x, lot D2109)	Mus musculus		EXP031807	96	unspecified	Q8VDK3	trophoblast stem cells	NULL
EXP031812	Cdx2 (Bethyl Labs, A300-691-A, lot A300-691-A1)	Mus musculus		EXP031806	96	unspecified	P43241	trophoblast stem cells	NULL
EXP031813		Mus musculus		NULL	546	chip_control	NULL	limb bud	NULL
EXP031814	CTCF (Millipore, Cat. No. 07-729, Lot No. JCB1881349)	Mus musculus		EXP031813	546	unspecified	Q61164	limb bud	NULL
EXP031815	CTCF (Millipore, Cat. No. 07-729, Lot No. DAM1745366)	Mus musculus		EXP031813	314	unspecified	Q61164	forelimb bud	NULL
EXP031816	CTCF (Millipore, Cat. No. 07-729, Lot No. DAM1745366)	Mus musculus		EXP031813	436	unspecified	Q61164	hind limb bud	NULL
EXP031817	none	Mus musculus		NULL	912	chip_control	NULL	megakaryocytes	NULL
EXP031818	anti-p45 antibody by Bresnick EH	Mus musculus		EXP031817	912	unspecified	Q07279	megakaryocytes	NULL
EXP031819	None	Homo sapiens		NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP031820	c-Myc	Homo sapiens		EXP031819	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP031821	Max	Homo sapiens		EXP031819	708	unspecified	P61244	P493-6 (B-cell lymphoma)	NULL
EXP031822	IgG	Mus musculus	0 hours after partial hepatectomy	NULL	5	chip_control	NULL	liver	NULL
EXP031823	Sc-61	Mus musculus	0 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031824	Sc-61	Mus musculus	3 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031825	Sc-61	Mus musculus	8 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031826	Sc-61	Mus musculus	16 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031827	Sc-61	Mus musculus	24 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031828	Sc-61	Mus musculus	36 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031829	Sc-61	Mus musculus	48 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031830	Sc-61	Mus musculus	168 hours after partial hepatectomy	EXP031822	5	unspecified	P53566	liver	NULL
EXP031831	Sc-150	Mus musculus	0 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031832	Sc-150	Mus musculus	3 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031833	Sc-150	Mus musculus	8 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031834	Sc-150	Mus musculus	16 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031835	Sc-150	Mus musculus	24 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031836	Sc-150	Mus musculus	36 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031837	Sc-150	Mus musculus	48 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031838	Sc-150	Mus musculus	168 hours after partial hepatectomy	EXP031822	5	unspecified	P28033	liver	NULL
EXP031839	Sc-110x	Mus musculus	36 hours after partial hepatectomy	EXP031822	5	unspecified	P08046	liver	NULL
EXP031840	Olig2 (Millipore, Ab9610)	Rattus norvegicus	mitogen treatment	NULL	752	unspecified	G3V612	oligodendrocyte precursors	NULL
EXP031841	Olig2 (Millipore, Ab9610)	Rattus norvegicus	T3 treatment	NULL	482	unspecified	G3V612	immature oligodendrocytes	NULL
EXP031842	Olig2 (Millipore, Ab9610)	Rattus norvegicus	T3 treatment	NULL	749	unspecified	G3V612	mature oligodendrocytes	NULL
EXP031843	None	Mus musculus		NULL	503	chip_control	NULL	pre-B cells	NULL
EXP031844	Rabbit anti-C-terminal Ikaros [from Stephen Smale Lab]	Mus musculus		EXP031843	503	unspecified	Q03267	pre-B cells	NULL
EXP031845	Anti-mouse IgG [Santa Cruz Biotechnology, Mouse monoclonal antibody, Catalog number: Sc-2025, Lot: C1111]	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP031846	p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909]	Homo sapiens		NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP031847	p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909]	Homo sapiens	senescent	NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP031848	p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909]	Homo sapiens	senescent, p53 KO	NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP031849	IgG	Mus musculus		NULL	103	chip_control	NULL	bone marrow	NULL
EXP031850	Scl/Tal1	Mus musculus		EXP031849	103	unspecified	P22091	bone marrow	NULL
EXP031851	Gata1	Mus musculus		EXP031849	103	unspecified	P17679	bone marrow	NULL
EXP031852	none	Mus musculus	17Î²-estradiol for 24 hours and then 17Î²-estradiol plus progesterone for 6 hrs	NULL	572	chip_control	NULL	mammary gland	NULL
EXP031853	sc-7208	Mus musculus	17Î²-estradiol for 24 hours and then 17Î²-estradiol plus progesterone for 6 hrs	EXP031852	572	unspecified	Q00175	mammary gland	NULL
EXP031854	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP031855	NF1B	Mus musculus		EXP031854	160	unspecified	P97863	hair follicle stem cells	NULL
EXP031856	S17S anti-Erf rabbit polyclonal antibody	Mus musculus	starved	NULL	12	unspecified	P70459	MEF (mouse embryonic fibroblasts)	NULL
EXP031857	S17S anti-Erf rabbit polyclonal antibody	Mus musculus	exponential	NULL	12	unspecified	P70459	MEF (mouse embryonic fibroblasts)	NULL
EXP031858	no	Homo sapiens	no treat	NULL	302	chip_control	NULL	fetal lung fibroblasts	NULL
EXP031859	no	Homo sapiens	TNF-Î± (10ng/mL) 1hr	NULL	302	chip_control	NULL	fetal lung fibroblasts	NULL
EXP031860	no	Homo sapiens	TNF-Î± (10ng/mL) 1hr	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031861	NF-?B p65 (Santa Cruz sc-372)	Homo sapiens	no treat	EXP031858	302	unspecified	Q04206	fetal lung fibroblasts	NULL
EXP031862	NF-?B p65 (Santa Cruz sc-372)	Homo sapiens	TNF-Î± (10ng/mL) 1hr	EXP031859	302	unspecified	Q04206	fetal lung fibroblasts	NULL
EXP031863	CTCF (Millipore 07-729)	Homo sapiens	no treat	EXP031858	302	unspecified	P49711	fetal lung fibroblasts	NULL
EXP031864	NF-?B p65 (Santa Cruz sc-372)	Homo sapiens	TNF-Î± (10ng/mL) 1hr	EXP031860	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP031865	CTCF	Homo sapiens		NULL	98	unspecified	P49711	blood monocytes	NULL
EXP031866	CTCF	Homo sapiens		NULL	466	unspecified	P49711	MDM(monocyte derived macrophages)	NULL
EXP031867	IgG antibody	Homo sapiens		NULL	263	chip_control	NULL	EPT1 (primary prostate cells)	NULL
EXP031868	anti-p63	Homo sapiens		EXP031867	259	unspecified	Q9H3D4	EP156T (primary prostate cells)	NULL
EXP031869	Mef2Da1 antibody control (antibody blocked with peptide)	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP031870	Mef2Da2 antibody control (antibody blocked with peptide)	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP031871	Mef2Da1	Mus musculus		EXP031869	1153	unspecified	Q63943	C2C12 (myoblasts)	NULL
EXP031872	Mef2Da2	Mus musculus		EXP031870	1153	unspecified	Q63943	C2C12 (myoblasts)	NULL
EXP031873	anti-Myc (Santa Cruz sc-764)	Homo sapiens		NULL	78	unspecified	P01106	HeLa (cervical adenocarcinoma)	NULL
EXP031874	anti-Max (Santa Cruz sc-197)	Homo sapiens		NULL	78	unspecified	P61244	HeLa (cervical adenocarcinoma)	NULL
EXP031875	None	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP031876	cMyc (9402), Cell signaling	Mus musculus		EXP031875	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	NULL
EXP031877	Nanog (A300-397A), Bethyl Laboratories	Mus musculus		EXP031875	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP031878	Oct4(N-19)(sc-8628), Santa Cruz Biotechnology	Mus musculus		EXP031875	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP031879	cMyc (9402), Cell signaling	Mus musculus	jmjd2b KD	EXP031875	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	NULL
EXP031880	Oct4(N-19)(sc-8628), Santa Cruz Biotechnology	Mus musculus	jmjd2b KD	EXP031875	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP031881	cMyc (9402), Cell signaling	Mus musculus	jmjd2c KD	EXP031875	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	NULL
EXP031882	Nanog (A300-397A), Bethyl Laboratories	Mus musculus	jmjd2c KD	EXP031875	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP031883	Oct4(N-19)(sc-8628), Santa Cruz Biotechnology	Mus musculus	jmjd2c KD	EXP031875	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP031884	Nanog (A300-397A), Bethyl Laboratories	Mus musculus	jmjd2b KD	EXP031875	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP031885	n/a	Mus musculus		NULL	609	chip_control	NULL	lung adenocarcinoma	NULL
EXP031886	n/a	Mus musculus		NULL	609	chip_control	NULL	lung adenocarcinoma	NULL
EXP031887	n/a	Mus musculus		NULL	609	chip_control	NULL	lung adenocarcinoma	NULL
EXP031888	n/a	Mus musculus		NULL	609	chip_control	NULL	lung adenocarcinoma	NULL
EXP031889	n/a	Mus musculus	Nkx2-1 negative	NULL	609	chip_control	NULL	lung adenocarcinoma	NULL
EXP031890	n/a	Mus musculus	Nkx2-1 negative	NULL	609	chip_control	NULL	lung adenocarcinoma	NULL
EXP031891	BL4000	Mus musculus		EXP031885	609	unspecified	P50220	lung adenocarcinoma	NULL
EXP031892	BL4000	Mus musculus		EXP031886	609	unspecified	P50220	lung adenocarcinoma	NULL
EXP031893	sc-6553	Mus musculus		EXP031887	609	unspecified	P35582	lung adenocarcinoma	NULL
EXP031894	sc-6553	Mus musculus		EXP031888	609	unspecified	P35582	lung adenocarcinoma	NULL
EXP031895	sc-6553	Mus musculus	Nkx2-1 negative	EXP031889	609	unspecified	P35582	lung adenocarcinoma	NULL
EXP031896	sc-6553	Mus musculus	Nkx2-1 negative	EXP031890	609	unspecified	P35582	lung adenocarcinoma	NULL
EXP031897		Mus musculus		NULL	572	chip_control	NULL	mammary gland	NULL
EXP031898	sc-543	Mus musculus		EXP031897	572	unspecified	P19785	mammary gland	NULL
EXP031899	IgG (Santa Cruz, sc-2027, lot J2909)	Mus musculus		NULL	809	chip_control	NULL	STHdhQ7 (striatal cells)	NULL
EXP031900	IgG (Santa Cruz, sc-2027, lot J2909)	Mus musculus		NULL	808	chip_control	NULL	STHdhQ111 (striatal cells)	NULL
EXP031901	Fra-2 (Santa Cruz, sc-604x, lot I0210)	Mus musculus		EXP031899	809	unspecified	P47930	STHdhQ7 (striatal cells)	NULL
EXP031902	Fra-2 (Santa Cruz, sc-604x, lot I0210)	Mus musculus		EXP031900	808	unspecified	P47930	STHdhQ111 (striatal cells)	NULL
EXP031903	Jund (Santa Cruz, sc-74x, lot B0111)	Mus musculus		EXP031899	809	unspecified	P15066	STHdhQ7 (striatal cells)	NULL
EXP031904	Jund (Santa Cruz, sc-74x, lot B0111)	Mus musculus		EXP031900	808	unspecified	P15066	STHdhQ111 (striatal cells)	NULL
EXP031905	Sox2 (R&D, MAB2018, lot KGQ0311111)	Mus musculus		EXP031899	809	unspecified	P48432	STHdhQ7 (striatal cells)	NULL
EXP031906	Santa Cruz Tech. rIgG (sc-2027)	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP031907	Epitomics ERR? (2131-1)	Mus musculus		EXP031906	5	unspecified	O08580	liver	NULL
EXP031908	IgG	Homo sapiens	PR infected	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP031909		Homo sapiens	PR infected	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP031910		Homo sapiens	PR infected + Progesterone	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP031911		Homo sapiens	PR infected	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP031912		Homo sapiens	Control	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP031913		Homo sapiens	PR infected	EXP031909	258	unspecified	P06401	endothelial cells	NULL
EXP031914		Homo sapiens	PR infected + Progesterone	EXP031910	258	unspecified	P06401	endothelial cells	NULL
EXP031915		Homo sapiens		EXP031912	258	unspecified	P06401	endothelial cells	NULL
EXP031916	none	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031917	none	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031918	anti-ETO (home made, antigen-purified)	Homo sapiens		EXP031916	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031919	anti-HEB (Santa Cruz; sc-357)	Homo sapiens		EXP031917	516	unspecified	Q99081	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031920	anti-E2A (Santa Cruz; sc-763)	Homo sapiens		EXP031917	516	unspecified	P15923	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP031921	none	Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP031922	TSC22D3	Mus musculus		EXP031921	498	unspecified	Q9Z2S7	Th17-cells	NULL
EXP031923	None (input control)	Homo sapiens		NULL	385	chip_control	NULL	H295R (adrenal cortex carcinoma)	NULL
EXP031924	SF-1 (Millipore, catalog# 07-618, lot# JBC1355794)	Homo sapiens		EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	NULL
EXP031925	SF-1 (Millipore, catalog# 07-618, lot# JBC1355794)	Homo sapiens	overexpressed SF-1	EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	NULL
EXP031926	SF-1 (Perseus Proteomics, catalog# PP-N1665-00, lot# A-2)	Homo sapiens		EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	NULL
EXP031927	SF-1 (Perseus Proteomics, catalog# PP-N1665-00, lot# A-2)	Homo sapiens	overexpressed SF-1	EXP031923	385	unspecified	Q13285	H295R (adrenal cortex carcinoma)	NULL
EXP031928	none	Homo sapiens		NULL	613	chip_control	NULL	MKN28 (gastric tubular adenocarcinoma)	NULL
EXP031929	none	Homo sapiens		NULL	802	chip_control	NULL	SNU216 (gastric tubular adenocarcinoma)	NULL
EXP031930	TEAD4 (Abnova, H00007004-M01, 11105-5H3)	Homo sapiens		EXP031928	613	unspecified	Q15561	MKN28 (gastric tubular adenocarcinoma)	NULL
EXP031931	TEAD4 (Abnova, H00007004-M01, 11105-5H3)	Homo sapiens		EXP031929	802	unspecified	Q15561	SNU216 (gastric tubular adenocarcinoma)	NULL
EXP031932		Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP031933	BACH2	Homo sapiens		EXP031932	687	unspecified	Q9BYV9	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP031934	Bcl-6 Antibody (N-3)	Homo sapiens		EXP031932	687	unspecified	P41182	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP031935	none	Homo sapiens	none	NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP031936	none	Homo sapiens	none	NULL	1521	chip_control	NULL	Namalwa (Burkitt lymphoma)	NULL
EXP031937	none	Homo sapiens	Mifepristone	NULL	532	chip_control	NULL	L428 (Hodgkin lymphoma)	NULL
EXP031938	Pax-5 antibody (C-20)	Homo sapiens	none	EXP031935	767	unspecified	Q02548	Raji (Burkitt lymphoma)	NULL
EXP031939	Pax-5 antibody (C-20)	Homo sapiens	none	EXP031936	1521	unspecified	Q02548	Namalwa (Burkitt lymphoma)	NULL
EXP031940	Pax-5 antibody (C-20)	Homo sapiens	Mifepristone	EXP031937	532	unspecified	Q02548	L428 (Hodgkin lymphoma)	NULL
EXP031941	none	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP031942	none	Mus musculus		NULL	723	chip_control	NULL	plasmablasts	NULL
EXP031943	CTCF	Mus musculus		EXP031941	41	unspecified	Q61164	B-cells	NULL
EXP031944	CTCF	Mus musculus		EXP031942	723	unspecified	Q61164	plasmablasts	NULL
EXP031945	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP031946	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP031947	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP031948	anti-V5 antibody (Cat# R960-CUS, Life Technologies, Carlsbad, CA)	Mus musculus		EXP031945	12	unspecified	Q60980	MEF (mouse embryonic fibroblasts)	NULL
EXP031949	klf3	Mus musculus		EXP031946	12	bio_control	Q60980	MEF (mouse embryonic fibroblasts)	NULL
EXP031950	anti-V5 antibody (Cat# R960-CUS, Life Technologies, Carlsbad, CA)	Mus musculus		EXP031947	12	bio_control	Q60980	MEF (mouse embryonic fibroblasts)	NULL
EXP031951	Tbx3 (Santa Cruz)	Mus musculus		NULL	2	unspecified	P70324	mESCs (mouse embryonic stem cells)	NULL
EXP031952	Tbx3 (Santa Cruz)	Mus musculus		NULL	237	unspecified	P70324	embryoid body	NULL
EXP031953	Nanog (Santa Cruz)	Mus musculus		NULL	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP031954	Nanog (Santa Cruz)	Mus musculus		NULL	237	unspecified	Q80Z64	embryoid body	NULL
EXP031955	Tbx3 (A-20)	Mus musculus		NULL	53	unspecified	P70324	heart	NULL
EXP031956	none	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP031957	Santa Cruz; sc-32758	Mus musculus		EXP031956	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP031958	Santa Cruz; sc-12732	Mus musculus		EXP031956	1153	unspecified	P12979	C2C12 (myoblasts)	NULL
EXP031959	CEBPb [CEBP B:(C-19): sc-150, lot:#I1010]	Mus musculus	No treatment	NULL	212	unspecified	P28033	dermal fibroblasts	NULL
EXP031960	CEBPb [CEBP B:(C-19): sc-150, lot:#I1010]	Mus musculus	Thapsigargin treatment for 3 hrs	NULL	212	unspecified	P28033	dermal fibroblasts	NULL
EXP031961	ATF4 [CREB-2 (C-20): sc-200, Lot#J2011]	Mus musculus	Thapsigargin treatment for 3 hrs	NULL	212	unspecified	Q06507	dermal fibroblasts	NULL
EXP031962	none	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP031963	anti-Runx1	Mus musculus		EXP031962	171	unspecified	Q03347	CD4+ CD8+ T cells	NULL
EXP031964	input	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP031965	input	Homo sapiens	R1881 10 nM treatment	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP031966	PSF	Homo sapiens	ethanol (Vehicle) treatment	EXP031964	70	unspecified	P23246	LNCaP (prostate carcinoma)	NULL
EXP031967	PSF	Homo sapiens	R1881 10 nM treatment	EXP031965	70	unspecified	P23246	LNCaP (prostate carcinoma)	NULL
EXP031968	anti-Rabbit IgG antibody (sc-2027, Santa Cruz)	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP031969	anti-ZNF322 antibody (sc-102205, Santa Cruz)	Mus musculus		EXP031968	230	unspecified	Q8BZ89	ES-E14 (E14, embryonic stem cells)	NULL
EXP031970	IgG	Homo sapiens		NULL	166	chip_control	NULL	CD34+ hematopoietic stem cells	NULL
EXP031971	ERG (Santa Cruz, sc-354X), A2510 & H1612	Homo sapiens		EXP031970	166	unspecified	P11308	CD34+ hematopoietic stem cells	NULL
EXP031972	FLI1 (Abcam ab15289), GR46872-1	Homo sapiens		EXP031970	166	unspecified	Q01543	CD34+ hematopoietic stem cells	NULL
EXP031973	SCL (Santa Cruz, sc-12984X), B2312	Homo sapiens		EXP031970	166	unspecified	P17542	CD34+ hematopoietic stem cells	NULL
EXP031974	LYL1 (Abcam, ab30334-200), 383134	Homo sapiens		EXP031970	166	unspecified	P12980	CD34+ hematopoietic stem cells	NULL
EXP031975	GATA2 (Santa Cruz, sc-9008x) I0109	Homo sapiens		EXP031970	166	unspecified	P23769	CD34+ hematopoietic stem cells	NULL
EXP031976	RUNX1 (Abcam, ab23980-100), 700492	Homo sapiens		EXP031970	166	unspecified	Q01196	CD34+ hematopoietic stem cells	NULL
EXP031977	NA	Homo sapiens		NULL	590	chip_control	NULL	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031978	sc-764 Santa Cruz	Homo sapiens	6h DHT	EXP031977	590	unspecified	P01106	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031979	sc-816 Santa Cruz	Homo sapiens	16h DHT	EXP031977	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031980	ab23738 Abcam	Homo sapiens	16h DHT	EXP031977	590	unspecified	P55317	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031981	sc-8631 Santa Cruz	Homo sapiens	16h DHT	EXP031977	590	unspecified	Q9NQB0	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031982	tcf7l2	Homo sapiens		EXP031977	590	unspecified	Q9NQB0	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP031983	non-immune serum	Mus musculus		NULL	912	chip_control	NULL	megakaryocytes	NULL
EXP031984	anti-Runx1	Mus musculus		EXP031983	912	unspecified	Q03347	megakaryocytes	NULL
EXP031985	rabbit anti-IgG [Abcam,catalog #37415, lot #905012]	Mus musculus		NULL	102	chip_control	NULL	BMiFLT3(15-3) (murine acute lymphoblastic leukemia)	NULL
EXP031986	rabbit anti-Runx1 [generated against a C-terminal peptide (kindly provided by Y. Groner and D. Levanon (Weizmann Institute, Rehovot))]	Mus musculus		EXP031985	102	unspecified	Q03347	BMiFLT3(15-3) (murine acute lymphoblastic leukemia)	NULL
EXP031987	sc-E20	Homo sapiens	1 micromolar dexamethasone	NULL	537	unspecified	P04150	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP031988	sc-E20	Homo sapiens	EtOH	NULL	537	unspecified	P04150	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP031989	sc-372X	Homo sapiens	1 micromolar dexamethasone	NULL	537	unspecified	P19838	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP031990	sc-372X	Homo sapiens	EtOH	NULL	537	unspecified	P19838	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP031991	Mix of GR Antibody (Santa Cruz Biotech, catalog# sc-1004) and Glucocorticoid Receptor Antibody (Thermo Scientific, catalog# PA1-511A)	Mus musculus	Ad-lib fed	NULL	5	unspecified	P06537	liver	NULL
EXP031992	C/EBP ? Antibody (Santa Cruz Biotech, catalog# sc-150)	Mus musculus	Ad-lib fed	NULL	5	unspecified	P28033	liver	NULL
EXP031993	CREB-1 Antibody (Santa Cruz Biotech, catalog# sc-186)	Mus musculus	Fasted 24h	NULL	5	unspecified	Q01147	liver	NULL
EXP031994	CREB	Mus musculus	Fasted 24h, Re-fed 2h	NULL	5	unspecified	Q01147	liver	NULL
EXP031995	sc-543	Homo sapiens	1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031996	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	DMSO	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031997	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	Cycloheximide (10 ÂµM)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP031998	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	DMSO	NULL	567	chip_control	NULL	M0-91 (acute myeloid leukemia)	NULL
EXP031999	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	27A (20 nM)	NULL	567	chip_control	NULL	M0-91 (acute myeloid leukemia)	NULL
EXP032000	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	27A (100 nM)	NULL	567	chip_control	NULL	M0-91 (acute myeloid leukemia)	NULL
EXP032001	IGG (Santa Cruz, sc-2027, Lot# C2210)	Homo sapiens	Cycloheximide (10 ÂµM)	NULL	567	chip_control	NULL	M0-91 (acute myeloid leukemia)	NULL
EXP032002	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	DMSO	EXP031998	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	NULL
EXP032003	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	DMSO	EXP031996	113	unspecified	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032004	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	Cycloheximide (10 ÂµM)	EXP031997	113	unspecified	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032005	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	27A (20 nM)	EXP031999	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	NULL
EXP032006	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	27A (100 nM)	EXP032000	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	NULL
EXP032007	HSF1 (H-311, Santa Cruz, sc-9144, Lot# J0510)	Homo sapiens	Cycloheximide (10 ÂµM)	EXP032001	567	unspecified	Q00613	M0-91 (acute myeloid leukemia)	NULL
EXP032008	IgG	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP032009	IgG	Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP032010	SC-1703	Mus musculus		EXP032008	1153	unspecified	Q00899	C2C12 (myoblasts)	NULL
EXP032011	AB58066	Mus musculus		EXP032008	1153	unspecified	Q00899	C2C12 (myoblasts)	NULL
EXP032012	SC-1703	Mus musculus		EXP032009	126	unspecified	Q00899	C2C12 (myotubes)	NULL
EXP032013	Streptavidin T1 dynabeads (Invitrogen)	Mus musculus		NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP032014	Streptavidin T1 dynabeads (Invitrogen)	Mus musculus		EXP032013	91	unspecified	Q3UV55	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP032015	Streptavidin T1 dynabeads (Invitrogen)	Mus musculus		EXP032013	91	unspecified	Q60674	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP032016	anti-PU.1 (Santa Cruz, SC-352)	Mus musculus		EXP032013	91	unspecified	P17433	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP032017	anti-PU.1 (Santa Cruz, SC-352)	Mus musculus		EXP032013	91	unspecified	P17433	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP032018	none (input lysate)	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP032019	anti-Bach2 - rabbit antibody (generated in-house, Tohoku University)	Mus musculus		EXP032018	1058	unspecified	P97303	CD4+ T-cells	NULL
EXP032020	sc-20693	Homo sapiens	none	NULL	592	unspecified	P23511	ME-1 (acute myeloid leukemia )	NULL
EXP032021	A1329	Homo sapiens	none	NULL	592	unspecified	P23511	ME-1 (acute myeloid leukemia )	NULL
EXP032022	ab23980	Homo sapiens	none	NULL	592	unspecified	Q01196	ME-1 (acute myeloid leukemia )	NULL
EXP032023	MAb-002-100	Homo sapiens	none	NULL	592	unspecified	P20226	ME-1 (acute myeloid leukemia )	NULL
EXP032024	sc-357	Homo sapiens	none	NULL	592	unspecified	Q99081	ME-1 (acute myeloid leukemia )	NULL
EXP032025	sc-9008	Homo sapiens	none	NULL	592	unspecified	P23769	ME-1 (acute myeloid leukemia )	NULL
EXP032026	sc-12984	Homo sapiens	none	NULL	592	unspecified	P17542	ME-1 (acute myeloid leukemia )	NULL
EXP032027	sc-356	Homo sapiens	none	NULL	592	unspecified	Q01543	ME-1 (acute myeloid leukemia )	NULL
EXP032028	sc-631	Homo sapiens	none	NULL	592	unspecified	P32519	ME-1 (acute myeloid leukemia )	NULL
EXP032029	sc-354	Homo sapiens	none	NULL	592	unspecified	P11308	ME-1 (acute myeloid leukemia )	NULL
EXP032030	sc-22805	Homo sapiens	none	NULL	592	unspecified	P17947	ME-1 (acute myeloid leukemia )	NULL
EXP032031	CBFB	Homo sapiens	none	NULL	45	unspecified	P23511	acute myeloblastic leukemia	NULL
EXP032032	A1329	Homo sapiens	3 days Tet free medium	NULL	65	unspecified	P23511	U937 (adult acute monocytic leukemia)	NULL
EXP032033	A1329	Homo sapiens	Tet (1 mM) containing medium	NULL	65	unspecified	P23511	U937 (adult acute monocytic leukemia)	NULL
EXP032034	input	Mus musculus	veh	NULL	5	chip_control	NULL	liver	NULL
EXP032035	input	Mus musculus	dex	NULL	5	chip_control	NULL	liver	NULL
EXP032036	C/EBPbeta sc-150, santa cruz	Mus musculus	dex adGFP	EXP032035	5	unspecified	P28033	liver	NULL
EXP032037	C/EBPbeta sc-150, santa cruz	Mus musculus	dex adDN-C/EBP	EXP032035	5	unspecified	P28033	liver	NULL
EXP032038	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	veh	EXP032034	5	unspecified	P06537	liver	NULL
EXP032039	C/EBPbeta sc-150, santa cruz	Mus musculus	veh	EXP032034	5	unspecified	P28033	liver	NULL
EXP032040	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	dex	EXP032035	5	unspecified	P06537	liver	NULL
EXP032041	C/EBPbeta sc-150, santa cruz	Mus musculus	dex	EXP032035	5	unspecified	P28033	liver	NULL
EXP032042	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	dex adGFP	EXP032035	5	unspecified	P06537	liver	NULL
EXP032043	cocktail of PA-510A and PA-511A from Affinity BioReagents and sc-1004 from Santa Cruz	Mus musculus	dex adDN-C/EBP	EXP032035	5	unspecified	P06537	liver	NULL
EXP032044		Mus musculus	Dexamethasone + Estradiol for 30 minutes	NULL	29	chip_control	NULL	7438 (mammary carcinoma)	NULL
EXP032045		Mus musculus	Dexamethasone + Estradiol for 30 minutes	NULL	629	chip_control	NULL	mammary cells	NULL
EXP032046	GR	Mus musculus	untreated	EXP032045	629	unspecified	P06537	mammary cells	NULL
EXP032047	GR	Mus musculus	Dexamethasone for 30 minutes	EXP032045	629	unspecified	P06537	mammary cells	NULL
EXP032048	GR	Mus musculus	Estradiol for 30 minutes	EXP032045	629	unspecified	P06537	mammary cells	NULL
EXP032049	GR	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032045	629	unspecified	P06537	mammary cells	NULL
EXP032050	ER	Mus musculus	untreated	EXP032045	629	unspecified	P19785	mammary cells	NULL
EXP032051	ER	Mus musculus	Dexamethasone for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	NULL
EXP032052	ER	Mus musculus	Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	NULL
EXP032053	ER	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	NULL
EXP032054	ER	Mus musculus	Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	NULL
EXP032055	estrogen	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032045	629	unspecified	P19785	mammary cells	NULL
EXP032056	GR	Mus musculus	untreated	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	NULL
EXP032057	GR	Mus musculus	Dexamethasone for 30 minutes	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	NULL
EXP032058	GR	Mus musculus	Estradiol for 30 minutes	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	NULL
EXP032059	GR	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032044	29	unspecified	P06537	7438 (mammary carcinoma)	NULL
EXP032060	ER	Mus musculus	untreated	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	NULL
EXP032061	ER	Mus musculus	Dexamethasone for 30 minutes	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	NULL
EXP032062	ER	Mus musculus	Estradiol for 30 minutes	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	NULL
EXP032063	ER	Mus musculus	Dexamethasone + Estradiol for 30 minutes	EXP032044	29	unspecified	P19785	7438 (mammary carcinoma)	NULL
EXP032064	anti-Oct4 (Abcam, ab19857, GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	NULL
EXP032065	anti-FOXA2 (R&D, AF2400, ULB 0311101)	Homo sapiens		NULL	456	unspecified	Q9Y261	HUES64-derived endodermal cells	NULL
EXP032066	anti-SOX2 (SC, sc-17320 X, 3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	NULL
EXP032067	anti-Nanog (R&D, AF1997, KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	NULL
EXP032068	none	Mus musculus	0.2ug/ml doxorubicin for 6h	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP032069	none	Mus musculus	0.2ug/ml doxorubicin for 6h	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP032070	anti-p53	Mus musculus	0.2ug/ml doxorubicin for 6h	EXP032068	12	unspecified	P02340	MEF (mouse embryonic fibroblasts)	NULL
EXP032071	anti-p53	Mus musculus	0.2ug/ml doxorubicin for 6h	EXP032069	12	unspecified	P02340	MEF (mouse embryonic fibroblasts)	NULL
EXP032072	none	Mus musculus	immobilized anti-CD3 mAb	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP032073	anti-EGR2 (PRB-236P,Covance)	Mus musculus	immobilized anti-CD3 mAb	EXP032072	1058	unspecified	P08152	CD4+ T-cells	NULL
EXP032074	anti-EGR2 (PRB-236P,Covance)	Mus musculus	immobilized anti-CD3 mAb	EXP032072	1058	unspecified	P08152	CD4+ T-cells	NULL
EXP032075	input	Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP032076	NR2F2	Mus musculus		EXP032075	141	unspecified	P43135	retina	NULL
EXP032077	none	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr and formaldehyde	NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP032078	none	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr and formaldehyde	NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP032079	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	NULL
EXP032080	anti-PU.1	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032077	732	unspecified	P17433	peritoneal macrophages	NULL
EXP032081	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	NULL
EXP032082	anti-PU.1	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032078	732	unspecified	P17433	peritoneal macrophages	NULL
EXP032083	anti-C/EBPa	Mus musculus	no treatment	NULL	732	unspecified	P53566	peritoneal macrophages	NULL
EXP032084	anti-C/EBPa	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032077	732	unspecified	P53566	peritoneal macrophages	NULL
EXP032085	anti-C/EBPa	Mus musculus	no treatment	NULL	732	unspecified	P53566	peritoneal macrophages	NULL
EXP032086	anti-C/EBPa	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032078	732	unspecified	P53566	peritoneal macrophages	NULL
EXP032087	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	NULL
EXP032088	anti-C/EBPa	Mus musculus	no treatment	NULL	732	unspecified	P53566	peritoneal macrophages	NULL
EXP032089	anti-PU.1	Mus musculus	no treatment	NULL	732	unspecified	P17433	peritoneal macrophages	NULL
EXP032090	anti-p65	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032077	732	unspecified	Q04207	peritoneal macrophages	NULL
EXP032091	anti-p65	Mus musculus	100 ng/ml Kdo2-LipidA 1 hr	EXP032078	732	unspecified	Q04207	peritoneal macrophages	NULL
EXP032092	none	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP032093	anti-Irf4 (Santa Cruz; sc-6059)	Mus musculus	stimulated for 1 day	EXP032092	41	unspecified	Q64287	B-cells	NULL
EXP032094	anti-Irf4 (Santa Cruz; sc-6059)	Mus musculus	stimulated for 3 days	EXP032092	41	unspecified	Q64287	B-cells	NULL
EXP032095	anti-PU.1 (Santa Cruz; sc-352)	Mus musculus	stimulated for 1 day	EXP032092	41	unspecified	P17433	B-cells	NULL
EXP032096	anti-PU.1 (Santa Cruz; sc-352)	Mus musculus	stimulated for 3 days	EXP032092	41	unspecified	P17433	B-cells	NULL
EXP032097	none, input	Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP032098		Mus musculus	stabilized form of beta-catenin	NULL	139	chip_control	NULL	thymus	NULL
EXP032099	Tcf1	Mus musculus		EXP032097	139	unspecified	Q00417	thymus	NULL
EXP032100	Tcf1	Mus musculus	stabilized form of beta-catenin	EXP032098	139	unspecified	Q00417	thymus	NULL
EXP032101	None	Homo sapiens	DMSO	NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP032102	E2F1	Homo sapiens	DMSO	EXP032101	685	unspecified	Q01094	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP032103	BCL6	Homo sapiens	DMSO	EXP032101	685	unspecified	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP032104		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032105	RXRalpha	Mus musculus		EXP032104	5	unspecified	P28700	liver	NULL
EXP032106	RAR? antibody	Mus musculus		EXP032104	5	unspecified	P11416	liver	NULL
EXP032107	ctcf	Homo sapiens		NULL	97	unspecified	P49711	blood lymphocytes	NULL
EXP032108	TFAP4, HPA001912, Sigma	Homo sapiens		NULL	219	unspecified	Q01664	DLD-1 (colon adenocarcinoma)	NULL
EXP032109		Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032110		Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032111	Foxo1 antibody (Abcam, Ab39670)	Mus musculus		EXP032109	2479	unspecified	Q9R1E0	CD8+ T-cells	NULL
EXP032112	Streptavidin	Mus musculus		EXP032110	2479	unspecified	Q9R1E0	CD8+ T-cells	NULL
EXP032113	None	Homo sapiens	Treatment: None	NULL	66	chip_control	NULL	prostate cancer	NULL
EXP032114	anti-ETV1 (Rabbit, Abcam 81086, Lot 787879)	Homo sapiens	Treatment: None	EXP032113	66	normal	P50549	prostate cancer	NULL
EXP032115	anti-AR (Rabbit, Epitomics Clone ER179)	Homo sapiens	Treatment: 3 days of crambled shRNA infection; Time point: 3 days; Conditions: MOI 5	EXP032113	66	normal	P10275	prostate cancer	NULL
EXP032116	anti-AR (Rabbit, Epitomics Clone ER179)	Homo sapiens	Treatment: 3 days of ETV1sh2 infection; Time point: 3 days; Conditions: MOI 5	EXP032113	66	normal	P10275	prostate cancer	NULL
EXP032117	anti-p53	Homo sapiens	0.1% DMSO for 24 hr	EXP032118	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP032118	none	Homo sapiens	0.1% DMSO for 24 hr	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032119	anti-p53	Homo sapiens		EXP032120	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP032120	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032121	anti-p53	Homo sapiens	0.6 ug/ml Doxorubicin for 24 hr	EXP032122	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP032122	none	Homo sapiens	0.6 ug/ml Doxorubicin for 24 hr	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032123	anti-p53	Homo sapiens	10 uM Nutlin-3 for 24 hr	EXP032124	848	unspecified	P04637	U2OS (osteosarcoma)	NULL
EXP032124	none	Homo sapiens	10 uM Nutlin-3 for 24 hr	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032125	none	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP032126	anti-HA ChIP-grade (ab9110), Abcam	Homo sapiens		EXP032125	421	unspecified	P67809	HEK293 (embryonic kidney)	NULL
EXP032127		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032128		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032129		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032130		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032131		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032132		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032133	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032134	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032135	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032136	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032137	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032138	anti-CLK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032139	anti-CLK	Mus musculus		EXP032127	5	unspecified	O08785	liver	NULL
EXP032140	anti-CLK	Mus musculus		EXP032128	5	unspecified	O08785	liver	NULL
EXP032141	anti-CLK	Mus musculus		EXP032129	5	unspecified	O08785	liver	NULL
EXP032142	anti-CLK	Mus musculus		EXP032130	5	unspecified	O08785	liver	NULL
EXP032143	anti-CLK	Mus musculus		EXP032131	5	unspecified	O08785	liver	NULL
EXP032144	anti-CLK	Mus musculus		EXP032132	5	unspecified	O08785	liver	NULL
EXP045878	none	Drosophila melanogaster	Treatment: Treatment: Treatment: Oregon R; mitotic cycle 14(c-d); zelda wt	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP032148	none	Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP032149	anti-CTCF	Mus musculus		EXP032148	105	unspecified	Q61164	pro-B cells	NULL
EXP032150	anti-MAFK	Homo sapiens		NULL	687	unspecified	O60675	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP032151	none (input)	Mus musculus		NULL	268	chip_control	NULL	erythroid progenitors	NULL
EXP032152	none (input)	Mus musculus		NULL	266	chip_control	NULL	erythroblasts	NULL
EXP032153	anti-EKLF	Mus musculus		EXP032151	268	unspecified	P46099	erythroid progenitors	NULL
EXP032154	anti-EKLF	Mus musculus		EXP032152	266	unspecified	P46099	erythroblasts	NULL
EXP032155		Homo sapiens	N/A	NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP032156	anti-Flag M2 (ERbeta)	Homo sapiens	10nM E2	EXP032155	128	unspecified	Q92731	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP032157		Homo sapiens	Vehicle	EXP032155	128	unspecified	Q92731	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP032158	rIgG (sc-2027, SantaCruz)	Mus musculus	castrated+vehicle	NULL	632	chip_control	NULL	prostate	NULL
EXP032159	rIgG (sc-2027, SantaCruz)	Mus musculus	castrated+testosterone	NULL	632	chip_control	NULL	prostate	NULL
EXP032160	mIgG (sc-2025, SantaCruz)	Mus musculus	castrated+testosterone	NULL	632	chip_control	NULL	prostate	NULL
EXP032161	rIgG (sc-2027, SantaCruz)	Mus musculus	castrated+testosterone	NULL	523	chip_control	NULL	kidney	NULL
EXP032162	mIgG (sc-2025, SantaCruz)	Mus musculus	castrated+testosterone	NULL	523	chip_control	NULL	kidney	NULL
EXP032163	rIgG (sc-2027, SantaCruz)	Mus musculus	intact	NULL	150	chip_control	NULL	caput epididymis	NULL
EXP032164	mIgG (sc-2025, SantaCruz)	Mus musculus	intact	NULL	150	chip_control	NULL	caput epididymis	NULL
EXP032165	FOXA1 (ab23738, Abcam)	Mus musculus	castrated+vehicle	EXP032158	632	unspecified	P35582	prostate	NULL
EXP032166	HNF4a (ab41898, Abcam)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P49698	prostate	NULL
EXP032167	AP2a (ab52222, Abcam)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P34056	prostate	NULL
EXP032168	AR (Sahu et al. 2011)	Mus musculus	castrated+vehicle	EXP032161	523	unspecified	P19091	kidney	NULL
EXP032169	HNF4	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P49698	kidney	NULL
EXP032170	FOXA1 (ab23738, Abcam)	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P35582	kidney	NULL
EXP032171	AP2a (ab52222, Abcam)	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P34056	kidney	NULL
EXP032172	AR (Sahu et al. 2011)	Mus musculus	castrated+vehicle	EXP032163	150	unspecified	P19091	caput epididymis	NULL
EXP032173	FOXA1 (ab23738, Abcam)	Mus musculus	intact	EXP032163	150	unspecified	P35582	caput epididymis	NULL
EXP032174	HNF4a (ab41898, Abcam)	Mus musculus	intact	EXP032163	150	unspecified	P49698	caput epididymis	NULL
EXP032175	AR (Sahu et al. 2011)	Mus musculus	castrated+vehicle	EXP032158	632	unspecified	P19091	prostate	NULL
EXP032176	AR (Sahu et al. 2011)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P19091	prostate	NULL
EXP032177	FOXA1 (ab23738, Abcam)	Mus musculus	castrated+testosterone	EXP032159	632	unspecified	P35582	prostate	NULL
EXP032178	AR (Sahu et al. 2011)	Mus musculus	castrated+testosterone	EXP032161	523	unspecified	P19091	kidney	NULL
EXP032179	HNF4a (ab41898, Abcam)	Mus musculus	castrated+vehicle	EXP032161	523	unspecified	P49698	kidney	NULL
EXP032180	AR (Sahu et al. 2011)	Mus musculus	intact	EXP032163	150	unspecified	P19091	caput epididymis	NULL
EXP032181	AP2a (ab52222, Abcam)	Mus musculus	castrated+vehicle	EXP032163	150	unspecified	P34056	caput epididymis	NULL
EXP032182	AP2a (ab52222, Abcam)	Mus musculus	intact	EXP032163	150	unspecified	P34056	caput epididymis	NULL
EXP032183	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP032184	custom antibody	Homo sapiens		EXP032183	78	unspecified	Q00059	HeLa (cervical adenocarcinoma)	NULL
EXP032185	No Antibody	Mus musculus		NULL	742	chip_control	NULL	primary adult neural progenitors	NULL
EXP032186	No Antibody	Mus musculus	LY	NULL	742	chip_control	NULL	primary adult neural progenitors	NULL
EXP032187	Ascl1: Abcam ab74065, lot# 830280	Mus musculus		EXP032185	742	unspecified	Q02067	primary adult neural progenitors	NULL
EXP032188	Foxo3-NFL: Brunet Lab (Greer et al., 2007 PMID 17900900)	Mus musculus	LY	EXP032186	742	unspecified	Q9WVH4	primary adult neural progenitors	NULL
EXP032189	IgG (DAKO)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032192	IgG (DAKO)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032193	anti-Jarid2	Mus musculus		EXP032189	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP032194	anti-Jarid2 (Novus Biologicals)	Mus musculus		EXP032192	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP032195	anti-REST	Mus musculus		EXP032189	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP032198	anti-REST	Mus musculus		EXP032192	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP032199	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032200	IgG	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032201	anti-Blimp1	Mus musculus		EXP032199	44	unspecified	Q60636	T-cells	NULL
EXP032202	none	Mus musculus	adeno-LACZ	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP032203	none	Mus musculus	adeno-PU1	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP032204	PPARg H-100 (Santa Cruz, sc-7196x)	Mus musculus	adeno-LACZ	EXP032202	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP032205	PPARg H-100 (Santa Cruz, sc-7196x)	Mus musculus	adeno-PU1	EXP032203	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP032206	PU.1 T-21 (Santa Cruz, sc-352x)	Mus musculus	adeno-PU1	EXP032203	18	unspecified	P17433	3T3-L1 (embryonic fibroblasts)	NULL
EXP032207	none	Homo sapiens	dexamethasone	NULL	461	chip_control	NULL	embryonic kidney	NULL
EXP032208	IgG (Santa Cruz, sc-2027, lot # A2412)	Homo sapiens	dexamethasone	NULL	461	chip_control	NULL	embryonic kidney	NULL
EXP032209	GR (Santa Cruz, sc-1003, lot # D1812)	Homo sapiens	dexamethasone	EXP032208	461	unspecified	P04150	embryonic kidney	NULL
EXP032210	GR (Santa Cruz, sc-1003, lot # D1812)	Homo sapiens	dexamethasone, stably expressing wt GR	EXP032208	461	unspecified	P04150	embryonic kidney	NULL
EXP032211	GR (Santa Cruz, sc-1003, lot # D1812)	Homo sapiens	dexamethasone, stably expressing SUMOylation-defective GR	EXP032208	461	unspecified	P04150	embryonic kidney	NULL
EXP032212	input	Homo sapiens		NULL	635	chip_control	NULL	MRC-iPS-25 (induced pluripotent stem cells)	NULL
EXP032213	input	Homo sapiens	MEG3 IncRNA overexpression	NULL	635	chip_control	NULL	MRC-iPS-25 (induced pluripotent stem cells)	NULL
EXP032214	JARID2	Homo sapiens		EXP032212	635	unspecified	Q92833	MRC-iPS-25 (induced pluripotent stem cells)	NULL
EXP032215	JARID2	Homo sapiens	MEG3 IncRNA overexpression	EXP032213	635	unspecified	Q92833	MRC-iPS-25 (induced pluripotent stem cells)	NULL
EXP032216	input	Homo sapiens		NULL	63	chip_control	NULL	AM-iPS-6 (induced pluripotent cells)	NULL
EXP032217	input	Homo sapiens		NULL	64	chip_control	NULL	AM-iPS-8 (induced pluripotent cells)	NULL
EXP032218	input	Homo sapiens		NULL	240	chip_control	NULL	Edom-iPS-2 (induced pluripotent stem cells)	NULL
EXP032219	input	Homo sapiens		NULL	635	chip_control	NULL	MRC-iPS-25 (induced pluripotent stem cells)	NULL
EXP032220	input	Homo sapiens		NULL	853	chip_control	NULL	UtE-iPS-11 (induced pluripotent stem cells)	NULL
EXP032221	input	Homo sapiens		NULL	854	chip_control	NULL	UtE-iPS-4 (induced pluripotent stem cells)	NULL
EXP032222	input	Homo sapiens		NULL	855	chip_control	NULL	UtE-iPS-6 (induced pluripotent stem cells)	NULL
EXP032223	input	Homo sapiens		NULL	856	chip_control	NULL	UtE-iPS-7 (induced pluripotent stem cells)	NULL
EXP032224	JARID2	Homo sapiens		EXP032216	63	unspecified	Q92833	AM-iPS-6 (induced pluripotent cells)	NULL
EXP032225	JARID2	Homo sapiens		EXP032217	64	unspecified	Q92833	AM-iPS-8 (induced pluripotent cells)	NULL
EXP032226	JARID2	Homo sapiens		EXP032219	635	unspecified	Q92833	MRC-iPS-25 (induced pluripotent stem cells)	NULL
EXP032227	JARID2	Homo sapiens		EXP032220	853	unspecified	Q92833	UtE-iPS-11 (induced pluripotent stem cells)	NULL
EXP032228	JARID2	Homo sapiens		EXP032221	854	unspecified	Q92833	UtE-iPS-4 (induced pluripotent stem cells)	NULL
EXP032229	JARID2	Homo sapiens		EXP032222	855	unspecified	Q92833	UtE-iPS-6 (induced pluripotent stem cells)	NULL
EXP032230	JARID2	Homo sapiens		EXP032223	856	unspecified	Q92833	UtE-iPS-7 (induced pluripotent stem cells)	NULL
EXP032231	JARID2	Homo sapiens		EXP032218	240	unspecified	Q92833	Edom-iPS-2 (induced pluripotent stem cells)	NULL
EXP032232	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP032233	G18 (Santa Cruz, sc-5986)	Homo sapiens		EXP032232	2301	unspecified	Q13105	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP032234	none	Mus musculus	day 6 of pregnancy	NULL	572	chip_control	NULL	mammary gland	NULL
EXP032235	none	Mus musculus	L1	NULL	572	chip_control	NULL	mammary gland	NULL
EXP032236	none	Mus musculus	day 13 of pregnancy	NULL	572	chip_control	NULL	mammary gland	NULL
EXP032237	STAT5A (Santa Cruz, sc-1081)	Mus musculus	day 6 of pregnancy	EXP032234	572	unspecified	P42230	mammary gland	NULL
EXP032238	STAT5A (Santa Cruz, sc-1081, lot# J3007)	Mus musculus	L1	EXP032235	572	unspecified	P42230	mammary gland	NULL
EXP032239	STAT5A (Santa Cruz, sc-1081, lot# J3007)	Mus musculus		EXP032236	572	unspecified	P42230	mammary gland	NULL
EXP032240		Mus musculus	none	NULL	570	chip_control	NULL	macrophages	NULL
EXP032241		Mus musculus	Kdo2 Lipid A (KLA) 1h	NULL	570	chip_control	NULL	macrophages	NULL
EXP032242	PU.1 (Santa Cruz sc-352)	Mus musculus	none	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032243	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	P17433	macrophages	NULL
EXP032244	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032245	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 12h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032246	PU.1 (Santa Cruz sc-352)	Mus musculus	Kdo2 Lipid A (KLA) 24h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032247	p65 (Santa Cruz sc-372)	Mus musculus	none	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032248	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	Q04207	macrophages	NULL
EXP032249	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032250	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 24h	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032251	p65 (Santa Cruz sc-372)	Mus musculus	none	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032252	p65 (Santa Cruz sc-372)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	Q04207	macrophages	NULL
EXP032253	C/EBPa (Santa Cruz sc-61)	Mus musculus	none	EXP032240	570	unspecified	P53566	macrophages	NULL
EXP032254	C/EBPa (Santa Cruz sc-61)	Mus musculus	Kdo2 Lipid A (KLA) 1h	EXP032241	570	unspecified	P53566	macrophages	NULL
EXP032255	PU.1 (Santa Cruz sc-352)	Mus musculus	DMSO 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032256	PU.1 (Santa Cruz sc-352)	Mus musculus	Flavopiridol 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032257	p65 (Santa Cruz sc-372)	Mus musculus	DMSO 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032258	p65 (Santa Cruz sc-372)	Mus musculus	Flavopiridol 7h, Kdo2 Lipid A (KLA) 6h	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032259	PU.1 (Santa Cruz sc-352)	Mus musculus	DMSO 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032260	PU.1 (Santa Cruz sc-352)	Mus musculus	IBET 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	P17433	macrophages	NULL
EXP032261	p65 (Santa Cruz sc-372)	Mus musculus	DMSO 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032262	p65 (Santa Cruz sc-372)	Mus musculus	IBET 2h, Kdo2 Lipid A (KLA) 1h	EXP032240	570	unspecified	Q04207	macrophages	NULL
EXP032263	IgG	Mus musculus		NULL	151	chip_control	NULL	CCE (embryonic stem cells)	NULL
EXP032264	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	NULL
EXP032265	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	NULL
EXP032266	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	NULL
EXP032267	anti-GFP(Prdm4)	Mus musculus		EXP032263	151	unspecified	Q80V63	CCE (embryonic stem cells)	NULL
EXP032268	anti-ER-alpha	Homo sapiens	10nM E2, 45 minutes	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032269	anti-SPDEF	Homo sapiens	Full media	NULL	113	unspecified	O95238	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032270	None	Homo sapiens		NULL	385	chip_control	NULL	H295R (adrenal cortex carcinoma)	NULL
EXP032271	anti-NRSF/REST	Homo sapiens		EXP032270	385	unspecified	Q13127	H295R (adrenal cortex carcinoma)	NULL
EXP032272	NRSF/REST Millipore #07-579	Homo sapiens	doxycycline 1mg/mL for 3 days	EXP032270	385	unspecified	Q13127	H295R (adrenal cortex carcinoma)	NULL
EXP032273	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032274	anti-GATA4	Mus musculus		EXP032273	5	unspecified	Q08369	liver	NULL
EXP032275	MyoD (C-20, Santa Cruz)	Mus musculus		NULL	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP032276	MyoD (C-20, Santa Cruz)	Mus musculus		NULL	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP032277	MyoG (M-225, Santa Cruz)	Mus musculus		NULL	1153	unspecified	P12979	C2C12 (myoblasts)	NULL
EXP032278	IgG	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032279	anti-EGR2	Mus musculus	TCR	EXP032278	44	unspecified	P08152	T-cells	NULL
EXP032280	anti-EGR2	Mus musculus	TCR	EXP032278	44	unspecified	P08152	T-cells	NULL
EXP032281	anti-EGR2	Mus musculus	TCR	EXP032278	44	unspecified	P08152	T-cells	NULL
EXP032282	anti-HA	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032283	anti-HA	Homo sapiens		NULL	113	unspecified	O00482	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032284	anti-ER-alpha	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032285	anti-ER-alpha	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032286	none	Homo sapiens		NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP032287	Santa Cruz SOX2 (sc-17320)	Homo sapiens	non-targeting siRNA	EXP032286	915	unspecified	P48431	hNSC (neural stem cells)	NULL
EXP032288	Santa Cruz SOX2 (sc-17320)	Homo sapiens	RMST siRNA	EXP032286	915	unspecified	P48431	hNSC (neural stem cells)	NULL
EXP032289	Klf4 (SC-20691, Santa Cruz)	Mus musculus		NULL	902	unspecified	Q60793	mammary epithelial cells	NULL
EXP032290		Mus musculus	anti-CD3, anti-CD28 and recombinant hIL-2	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032291	anti-IRF4	Mus musculus	anti-CD3, anti-CD28 and recombinant hIL-2	EXP032290	2479	unspecified	Q64287	CD8+ T-cells	NULL
EXP032293	none	Homo sapiens	hypoxia and glucose deprivation	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP032294	none	Homo sapiens		NULL	449	chip_control	NULL	HS578T (invasive ductal breast carcinoma)	NULL
EXP032295	XBP1 (Biolegend, 619502)	Homo sapiens	hypoxia and glucose deprivation	NULL	2301	unspecified	P17861	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP032296	XBP1 (Biolegend, 619502)	Homo sapiens	hypoxia and glucose deprivation	EXP032293	111	unspecified	P17861	T47D (invasive ductal carcinoma)	NULL
EXP032297	XBP1 (Biolegend, 619502)	Homo sapiens	hypoxia and glucose deprivation	EXP032294	449	unspecified	P17861	HS578T (invasive ductal breast carcinoma)	NULL
EXP032298	XBP1 (Biolegend, 619502)	Homo sapiens		NULL	2301	unspecified	P17861	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP032299	Non-immune rabbit serum	Mus musculus		NULL	806	chip_control	NULL	natural killer cells	NULL
EXP032300	Runx3 poly clonal home made	Mus musculus		EXP032299	806	unspecified	Q64131	natural killer cells	NULL
EXP032301	Non-immune rabbit serum	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032302	Non-immune rabbit serum	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032303	Runx3 poly clonal home made	Mus musculus		EXP032301	2479	unspecified	Q64131	CD8+ T-cells	NULL
EXP032304	Runx3 poly clonal home made	Mus musculus		EXP032302	2479	unspecified	Q64131	CD8+ T-cells	NULL
EXP032305	Non-immune rabbit serum	Mus musculus		NULL	806	chip_control	NULL	natural killer cells	NULL
EXP032306	Non-immune rabbit serum	Mus musculus		NULL	806	chip_control	NULL	natural killer cells	NULL
EXP032307	Runx3 poly clonal home made	Mus musculus		EXP032305	806	unspecified	Q64131	natural killer cells	NULL
EXP032308	Runx3 poly clonal home made	Mus musculus		EXP032306	806	unspecified	Q64131	natural killer cells	NULL
EXP032309	Non-immune rabbit serum	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032310	Non-immune rabbit serum	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032311	Runx3 poly clonal home made	Mus musculus		EXP032310	2479	unspecified	Q64131	CD8+ T-cells	NULL
EXP032312	Runx3 poly clonal home made	Mus musculus		EXP032309	2479	unspecified	Q64131	CD8+ T-cells	NULL
EXP032313	none	Mus musculus	D7 of adipogenesis	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP032314	none	Mus musculus	D7 of adipogenesis, MLL4 KO	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP032315	MLL4	Mus musculus	D0 of adipogenesis	EXP032313	483	unspecified	O08550	brown preadipocytes	NULL
EXP032316	MLL4	Mus musculus	D2 of adipogenesis	EXP032313	483	unspecified	O08550	brown preadipocytes	NULL
EXP032317	MLL4	Mus musculus	D7 of adipogenesis	EXP032313	483	unspecified	O08550	brown preadipocytes	NULL
EXP032318	MLL4	Mus musculus	D0 of adipogenesis, MLL4 KO	EXP032314	483	unspecified	O08550	brown preadipocytes	NULL
EXP032319	MLL4	Mus musculus	D2 of adipogenesis, MLL4 KO	EXP032314	483	unspecified	O08550	brown preadipocytes	NULL
EXP032320	MLL4	Mus musculus	D7 of adipogenesis, MLL4 KO	EXP032314	483	unspecified	O08550	brown preadipocytes	NULL
EXP032321		Mus musculus	Non-immune rabbit serum	NULL	806	chip_control	NULL	natural killer cells	NULL
EXP032322	anti-Runx3	Mus musculus		EXP032321	806	unspecified	Q64131	natural killer cells	NULL
EXP032323	IgG	Mus musculus		NULL	299	chip_control	NULL	FDCP-Mix (multipotent stem cells)	NULL
EXP032324	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032325	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	NULL
EXP032326	anti-Pu.1	Mus musculus		EXP032323	299	unspecified	P17433	FDCP-Mix (multipotent stem cells)	NULL
EXP032327	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032328	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	NULL
EXP032329	anti-Pu.1	Mus musculus		EXP032323	299	unspecified	P17433	FDCP-Mix (multipotent stem cells)	NULL
EXP032330	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032331	Pu.1	Mus musculus		EXP032323	299	unspecified	P17433	FDCP-Mix (multipotent stem cells)	NULL
EXP032332	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	NULL
EXP032333	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	NULL
EXP032334	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032335	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032336	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	NULL
EXP032337	anti-Gata1	Mus musculus		EXP032323	299	unspecified	P17679	FDCP-Mix (multipotent stem cells)	NULL
EXP032338	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032339	anti-Gata2	Mus musculus		EXP032323	299	unspecified	O09100	FDCP-Mix (multipotent stem cells)	NULL
EXP032340	none	Homo sapiens		NULL	918	chip_control	NULL	myotube	NULL
EXP051007	anti-MyoD	Homo sapiens		NULL	467	unspecified	P15172	myoblasts	NULL
EXP032342	anti-MyoD	Homo sapiens		EXP032340	918	unspecified	P15172	myotube	NULL
EXP051008	anti-MyoD	Homo sapiens		NULL	773	unspecified	P15172	rhabdomyosarcoma	NULL
EXP032344	anti-C/EBPalpha	Mus musculus		NULL	483	unspecified	P53566	brown preadipocytes	NULL
EXP032345	anti-C/EBPalpha	Mus musculus		NULL	483	unspecified	P53566	brown preadipocytes	NULL
EXP032346	anti-C/EBPbeta	Mus musculus		NULL	483	unspecified	P28033	brown preadipocytes	NULL
EXP032347	anti-C/EBPbeta	Mus musculus		NULL	483	unspecified	P28033	brown preadipocytes	NULL
EXP032348	anti-PPARgamma	Mus musculus		NULL	483	unspecified	P37238	brown preadipocytes	NULL
EXP032349	anti-PPARgamma	Mus musculus		NULL	483	unspecified	P37238	brown preadipocytes	NULL
EXP032350	none	Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP032351	none	Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP032352	none	Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP032353	none	Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP032354	anti-MyoD	Mus musculus		EXP032350	483	unspecified	P10085	brown preadipocytes	NULL
EXP032355	anti-MyoD	Mus musculus		EXP032351	483	unspecified	P10085	brown preadipocytes	NULL
EXP032356	anti-MyoD	Mus musculus		EXP032352	483	unspecified	P10085	brown preadipocytes	NULL
EXP032357	anti-MyoD	Mus musculus		EXP032353	483	unspecified	P10085	brown preadipocytes	NULL
EXP032358	anti-MLL4	Mus musculus		EXP032350	483	unspecified	O08550	brown preadipocytes	NULL
EXP032359	anti-MLL4	Mus musculus		EXP032351	483	unspecified	O08550	brown preadipocytes	NULL
EXP032360	anti-MLL4	Mus musculus		EXP032352	483	unspecified	O08550	brown preadipocytes	NULL
EXP032361	anti-MLL4	Mus musculus		EXP032353	483	unspecified	O08550	brown preadipocytes	NULL
EXP032362	anti-C/EBPalpha	Mus musculus		NULL	81	unspecified	P53566	BMDM (bone marrow-derived macrophages)	NULL
EXP032363	none	Mus musculus	Prdm14-mVenus reporter	NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP032364	none	Mus musculus	Blimp1-mVenus reporter	NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP032365	SMAD1(BMR00479)	Mus musculus	12h, Blimp1-mVenus reporter	EXP032364	206	unspecified	P70340	epiblast-like cells	NULL
EXP032366	SMAD1(BMR00479)	Mus musculus	24h, Blimp1-mVenus reporter	EXP032364	206	unspecified	P70340	epiblast-like cells	NULL
EXP032367	SMAD1(BMR00479)	Mus musculus	36h, Blimp1-mVenus reporter	EXP032364	206	unspecified	P70340	epiblast-like cells	NULL
EXP032368	SMAD1(BMR00479)	Mus musculus	36h, Prdm14-mVenus reporter	EXP032363	206	unspecified	P70340	epiblast-like cells	NULL
EXP032369	T (sc-17743)	Mus musculus	Prdm14-mVenus reporter	EXP032363	206	unspecified	P20293	epiblast-like cells	NULL
EXP032370	TCF1 (CST#2203)	Mus musculus	Blimp1-mVenus reporter	EXP032364	206	unspecified	Q00417	epiblast-like cells	NULL
EXP032371	none	Mus musculus		NULL	492	chip_control	NULL	group 2 innate lymphoid cells (ILC2s)	NULL
EXP032372	anti-Gfi1 (a custom rabbit polyclonal antibody raised against N- and C-terminal peptides)	Mus musculus		EXP032371	492	unspecified	P70338	group 2 innate lymphoid cells (ILC2s)	NULL
EXP032373	anti-MITF	Homo sapiens		NULL	601	unspecified	O75030	melanocytes	NULL
EXP032374	anti-MITF	Homo sapiens		NULL	601	unspecified	O75030	melanocytes	NULL
EXP032375	anti-MITF	Homo sapiens	DMSO (control)	NULL	1549	unspecified	O75030	COLO-829 (melanoma)	NULL
EXP032376	anti-MITF	Homo sapiens	BRAF inhibitor PLX4032 (Vemurafenib)	NULL	1549	unspecified	O75030	COLO-829 (melanoma)	NULL
EXP032377		Rattus norvegicus	E20	NULL	908	chip_control	NULL	kidney	NULL
EXP032378		Rattus norvegicus	P13	NULL	908	chip_control	NULL	kidney	NULL
EXP032379		Rattus norvegicus	Adult	NULL	908	chip_control	NULL	kidney	NULL
EXP032380	Hnf4a (Santa Cruz, sc-8987)	Rattus norvegicus	E20	EXP032377	908	unspecified	P22449	kidney	NULL
EXP032381	Hnf4a (Santa Cruz, sc-8987)	Rattus norvegicus	P13	EXP032378	908	unspecified	P22449	kidney	NULL
EXP032382	Hnf4a (Santa Cruz, sc-8987)	Rattus norvegicus	Adult	EXP032379	908	unspecified	P22449	kidney	NULL
EXP032383	IgG (Santa Cruz, sc2027)	Homo sapiens	estrogen	NULL	587	chip_control	NULL	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP032384	None	Homo sapiens		NULL	587	chip_control	NULL	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP032385	ER? (Santa Cruz, HC-20)	Homo sapiens	estrogen	EXP032383	587	unspecified	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP032386	ER? (Santa Cruz, HC-20)	Homo sapiens	EtOH	EXP032384	587	unspecified	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP032387	SMRT	Mus musculus	ZT10	NULL	5	unspecified	Q9WU42	liver	NULL
EXP032388	SMRT	Mus musculus	ZT22	NULL	5	unspecified	Q9WU42	liver	NULL
EXP032389	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP032390	none	Mus musculus		NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP032391	(rb) ?-MLL4 (#403; Ali  Shilatifard)	Homo sapiens		EXP032389	417	unspecified	Q9UMN6	HCT-116 (colon carcinoma)	NULL
EXP032392	(rb) ?-MLL4 (#403; Ali  Shilatifard)	Mus musculus		EXP032390	521	unspecified	O08550	KH2 (embryonic stem cells)	NULL
EXP032393	none	Mus musculus		NULL	872	chip_control	NULL	ZHBTc4-TS (trophoblast stem cells)	NULL
EXP032394	none	Mus musculus		NULL	241	chip_control	NULL	EGFP-TS3.5 TS (trophoblast stem cells)	NULL
EXP032395	Sox2 raised by ourselves	Mus musculus		EXP032393	872	unspecified	P48432	ZHBTc4-TS (trophoblast stem cells)	NULL
EXP032396	Tfap2c (sc-8977, Santa Cruz)	Mus musculus		EXP032393	872	unspecified	Q61312	ZHBTc4-TS (trophoblast stem cells)	NULL
EXP032397	Cdx2 (CDX2-88, BioGenex)	Mus musculus		EXP032393	872	unspecified	P43241	ZHBTc4-TS (trophoblast stem cells)	NULL
EXP032398	Sox2 raised by ourselves	Mus musculus		EXP032394	241	unspecified	P48432	EGFP-TS3.5 TS (trophoblast stem cells)	NULL
EXP032399	STAT1(sc-592, SantaCruz)	Mus musculus		NULL	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP032400	none	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032401	TCF7L2 (Cell Signaling Technology  C48H11, 2569)	Homo sapiens		EXP032400	70	unspecified	Q9NQB0	LNCaP (prostate carcinoma)	NULL
EXP032402	none	Homo sapiens	GSI 72 hrs	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032403	none	Homo sapiens	GSI 72 hrs, wash out 4 hrs	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032404	ETS1 (santa cruz sc-350)	Homo sapiens	vehicle	NULL	199	unspecified	P14921	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032405	GABPA (santa cruz sc-22810)	Homo sapiens	vehicle	NULL	199	unspecified	Q06546	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032406	RUNX1 (Abcam ab23980	Homo sapiens	vehicle	NULL	199	unspecified	Q01196	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032407	Rabbit anti RBPJ	Homo sapiens	GSI 72 hrs	EXP032402	199	unspecified	Q06330	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032408	Rabbit anti RBPJ	Homo sapiens	GSI 72 hrs, wash out 4 hrs	EXP032403	199	unspecified	Q06330	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP032409	prdm5 ab1	Mus musculus		NULL	12	unspecified	Q9CXE0	MEF (mouse embryonic fibroblasts)	NULL
EXP032410	prdm5 ab2	Mus musculus		NULL	12	unspecified	Q9CXE0	MEF (mouse embryonic fibroblasts)	NULL
EXP032411	IgG	Homo sapiens		NULL	59	chip_control	NULL	AGS (gastric adenocarcinoma)	NULL
EXP032412	IgG	Homo sapiens		NULL	457	chip_control	NULL	HuG-1 (gastric tubular adenocarcinoma)	NULL
EXP032413	GATA6	Homo sapiens		EXP032411	59	unspecified	Q92908	AGS (gastric adenocarcinoma)	NULL
EXP032414	GATA6	Homo sapiens		EXP032412	457	unspecified	Q92908	HuG-1 (gastric tubular adenocarcinoma)	NULL
EXP032415	None	Homo sapiens		NULL	256	chip_control	NULL	endometrial stromal cells	NULL
EXP032416	NR2F2 (Active Motif, Cat#61213)	Homo sapiens		EXP032415	256	unspecified	P24468	endometrial stromal cells	NULL
EXP032417	none	Mus musculus	none	NULL	573	chip_control	NULL	mammary tissue	NULL
EXP032418	Stat5	Mus musculus	Ezh2 KO	EXP032417	573	unspecified	P42230	mammary tissue	NULL
EXP032419	Stat5	Mus musculus	none	EXP032417	573	unspecified	P42230	mammary tissue	NULL
EXP032420	none	Mus musculus	no	NULL	844	chip_control	NULL	TX1072 (embryonic stem cells)	NULL
EXP032421	none	Mus musculus	Doxycycline 1 ug/mL	NULL	844	chip_control	NULL	TX1072 (embryonic stem cells)	NULL
EXP032422	none	Mus musculus	Doxycycline 1 ug/mL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032423	none	Mus musculus	Doxycycline 1 ug/mL	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032424	JARID2	Mus musculus	no	EXP032422	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP032425	JARID2	Mus musculus	Doxycycline 1 ug/mL	EXP032422	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP032426	JARID2	Mus musculus	no	EXP032423	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP032427	JARID2	Mus musculus	Doxycycline 1 ug/mL	EXP032423	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP032428	JARID2	Mus musculus	no	EXP032420	844	unspecified	Q62315	TX1072 (embryonic stem cells)	NULL
EXP032429	JARID2	Mus musculus	Doxycycline 1 ug/mL	EXP032421	844	unspecified	Q62315	TX1072 (embryonic stem cells)	NULL
EXP032430	anti-FOXM1	Homo sapiens		NULL	423	unspecified	Q08050	HeLa S3 (cervical adenocarcinoma)	NULL
EXP032431	anti-NFATc1	Mus musculus		NULL	160	unspecified	O88942	hair follicle stem cells	NULL
EXP032432	none	Homo sapiens		NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP032433	none	Homo sapiens		NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP032434	anti-ZFHX4	Homo sapiens		EXP032432	332	unspecified	Q86UP3	glioblastoma cells	NULL
EXP032435	anti-ZFHX4	Homo sapiens		EXP032433	332	unspecified	Q86UP3	glioblastoma cells	NULL
EXP032436	input DNA	Homo sapiens	4h DMSO	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP032437	input DNA	Homo sapiens	4h SB431542	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP032438	normal rabbit IgG	Homo sapiens	4h DMSO	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP032439	normal rabbit IgG	Homo sapiens	4h SB431542	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP032440	anti-TEAD4	Homo sapiens	4h DMSO	EXP032436	396	unspecified	Q15561	WA09 (embryonic stem cells)	NULL
EXP032441	anti-TEAD4	Homo sapiens	4h SB431542	EXP032437	396	unspecified	Q15561	WA09 (embryonic stem cells)	NULL
EXP032442	anti-SMAD2	Homo sapiens	4h DMSO	EXP032436	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP032443	anti-SMAD2	Homo sapiens	4h SB431542	EXP032439	396	unspecified	Q15796	WA09 (embryonic stem cells)	NULL
EXP032444	anti-p65	Homo sapiens	none	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP032445	anti-p65	Homo sapiens	10ng/ml IL-1alpha for 1 h	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP032446	anti-AR	Homo sapiens	siControl	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032447	anti-AR	Homo sapiens	siGATA2	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032448	anti-FoxA1	Homo sapiens		NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP032449	anti-PU.1	Mus musculus	LPS	NULL	104	unspecified	P17433	dendritic cells	NULL
EXP032450	anti-BATF	Mus musculus	LPS	NULL	104	unspecified	O35284	dendritic cells	NULL
EXP032451	anti-JunB	Mus musculus	LPS	NULL	104	unspecified	P09450	dendritic cells	NULL
EXP032452	anti-Ascl2	Mus musculus	Empty vector transfected	NULL	1058	unspecified	O35885	CD4+ T-cells	NULL
EXP032453	anti-Ascl2	Mus musculus	Ascl2 vector transfected	NULL	1058	unspecified	O35885	CD4+ T-cells	NULL
EXP032454		Homo sapiens		NULL	167	chip_control	NULL	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP032455	anti-GATA1	Homo sapiens		EXP032454	167	unspecified	P15976	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP032456	anti-TAL1	Homo sapiens		EXP032454	167	unspecified	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP032457	anti-GFI1B	Homo sapiens		EXP032454	167	unspecified	Q5VTD9	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP032458	anti-ICSBP	Mus musculus		NULL	104	unspecified	P23611	dendritic cells	NULL
EXP032459	anti-ICSBP	Mus musculus		NULL	104	unspecified	P23611	dendritic cells	NULL
EXP032460	anti-ICSBP	Mus musculus		NULL	104	unspecified	P23611	dendritic cells	NULL
EXP032461	Custom GFP antibody	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032462	Custom GFP antibody from MPI-CBG "anti-GFP 2007" (Vermeulen et al., 2010)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032463	Custom GFP antibody	Mus musculus		EXP032461	2	unspecified	Q9CWW7	mESCs (mouse embryonic stem cells)	NULL
EXP032464	Custom GFP antibody	Mus musculus		EXP032461	2	unspecified	O35885	mESCs (mouse embryonic stem cells)	NULL
EXP032465	Custom GFP antibody	Mus musculus		EXP032461	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP032466	Custom GFP antibody from MPI-CBG "anti-GFP 2007" (Vermeulen et al., 2010)	Mus musculus		EXP032462	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP032467	Custom GFP antibody from MPI-CBG "anti-GFP 2007" (Vermeulen et al., 2010)	Mus musculus		EXP032462	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP032468	Rabbit IgG Abcam, ab37415	Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP032469	Zrf1 Ab generated in Di CroceÂ´s lab	Mus musculus		EXP032468	233	unspecified	P54103	E14TG2A (embryonic stem cells)	NULL
EXP032470	NA	Mus musculus	untreated	NULL	14	chip_control	NULL	3134 (mammary adenocarcinoma)	NULL
EXP032471	NA	Mus musculus	untreated	NULL	14	chip_control	NULL	3134 (mammary adenocarcinoma)	NULL
EXP032472	Snf2h	Mus musculus	untreated	EXP032470	14	unspecified	Q91ZW3	3134 (mammary adenocarcinoma)	NULL
EXP032473	Snf2h	Mus musculus	untreated	EXP032471	14	unspecified	Q91ZW3	3134 (mammary adenocarcinoma)	NULL
EXP032474	n.a.	Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP032475	anti V5 (clone V5-10)-agarose, Sigma A7345	Mus musculus		EXP032474	105	unspecified	Q07802	pro-B cells	NULL
EXP032476	pu.1	Mus musculus		EXP032474	105	unspecified	P17433	pro-B cells	NULL
EXP032477	anti IRF4 (M-17), Santa Cruz sc-6059x, lot:E0608	Mus musculus		EXP032474	105	unspecified	Q64287	pro-B cells	NULL
EXP032478	ikaros	Mus musculus		EXP032474	105	unspecified	Q03267	pro-B cells	NULL
EXP032479	ikaros	Mus musculus		NULL	171	unspecified	Q03267	CD4+ CD8+ T cells	NULL
EXP032480	ikaros	Mus musculus		NULL	198	unspecified	Q03267	pre-pro-B-cells	NULL
EXP032481		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032482	RARa	Mus musculus		EXP032481	5	unspecified	P11416	liver	NULL
EXP032483	RARb	Mus musculus		EXP032481	5	unspecified	P22605	liver	NULL
EXP032484	RXRa	Mus musculus		EXP032481	5	unspecified	P28700	liver	NULL
EXP032485	RARa	Mus musculus	RA-treatment	EXP032481	5	unspecified	P11416	liver	NULL
EXP032486	RARb	Mus musculus	RA-treatment	EXP032481	5	unspecified	P22605	liver	NULL
EXP032487	RXRa	Mus musculus	RA-treatment	EXP032481	5	unspecified	P28700	liver	NULL
EXP032488	CLOCK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032489	CLOCK	Mus musculus		NULL	5	unspecified	O08785	liver	NULL
EXP032490	BMAL1	Mus musculus		NULL	5	unspecified	Q9WTL8	liver	NULL
EXP032491	BMAL1	Mus musculus		NULL	5	unspecified	Q9WTL8	liver	NULL
EXP032492		Homo sapiens	Untreated	NULL	563	chip_control	NULL	LY-2 (invasive ductal carcinoma)	NULL
EXP032493	hoxc11	Homo sapiens	Tamoxifen	EXP032492	563	unspecified	O43248	LY-2 (invasive ductal carcinoma)	NULL
EXP032494	hoxc11	Homo sapiens	Untreated	EXP032492	563	unspecified	O43248	LY-2 (invasive ductal carcinoma)	NULL
EXP032495	OTX2	Mus musculus		NULL	776	unspecified	P80206	retinal pigmented epithelium	NULL
EXP032496	GFP (Abcam, Cambridge, UK)	Mus musculus		NULL	776	unspecified	P80206	retinal pigmented epithelium	NULL
EXP032497	OTX2 (R&D systems, Minneapolis, MN, USA)	Mus musculus		NULL	663	unspecified	P80206	neural retina	NULL
EXP032498	GFP (Abcam, Cambridge, UK)	Mus musculus		NULL	663	unspecified	P80206	neural retina	NULL
EXP032499	none	Mus musculus		NULL	865	chip_control	NULL	cornea	NULL
EXP032500	SRF (Santa Cruz Biotechnology, sc-335, Lot# I2712)	Mus musculus	Dstn1-corn mutant	EXP032499	865	unspecified	Q9JM73	cornea	NULL
EXP032501	SRF (Santa Cruz Biotechnology, sc-335, Lot# I2712)	Mus musculus		EXP032499	865	unspecified	Q9JM73	cornea	NULL
EXP032502	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP032503	none	Mus musculus		NULL	160	chip_control	NULL	hair follicle stem cells	NULL
EXP032504	none	Mus musculus		NULL	494	chip_control	NULL	interfollicular epidermal cells	NULL
EXP032505	AB5535	Mus musculus		EXP032502	160	unspecified	Q04887	hair follicle stem cells	NULL
EXP032506	AB5535	Mus musculus		EXP032503	160	unspecified	Q04887	hair follicle stem cells	NULL
EXP032507	AB5535	Mus musculus		EXP032504	494	unspecified	Q04887	interfollicular epidermal cells	NULL
EXP032508		Mus musculus	oct6 overexpressed ESC	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032509	oct6	Mus musculus	oct6 overexpressed ESC	EXP032508	2	unspecified	P21952	mESCs (mouse embryonic stem cells)	NULL
EXP032510	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032511	anti-FoxA1	Homo sapiens		EXP032510	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP032512	anti-FoxA1	Homo sapiens		EXP032510	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP032513	anti-AR	Homo sapiens	hormone-deprived	EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032514	anti-AR	Homo sapiens	hormone-deprived	EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032515	anti-AR	Homo sapiens		EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032516	anti-AR	Homo sapiens		EXP032510	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032517	none, input	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP032518	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032519	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032520	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032521	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032522	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032523	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032524	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032525	sc-553	Mus musculus		EXP032517	5	unspecified	P28700	liver	NULL
EXP032526	none	Mus musculus		NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032527	none	Mus musculus	15% fetal calf serum for 30 min	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032528	none	Mus musculus	Latrunculin B 0.3uM	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032529	none	Mus musculus	U0126 10uM	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032530	sc-335	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032531	sc-335	Mus musculus	U0126 10uM	EXP032529	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032532	ab32106	Mus musculus		EXP032526	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032533	ab32106	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032534	ab32106	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032535	ab32106	Mus musculus	U0126 10uM	EXP032529	675	unspecified	P41969	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032536	sc-13030	Mus musculus		EXP032526	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032537	sc-13030	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032538	sc-13030	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032539	sc-13030	Mus musculus	U0126 10uM	EXP032529	675	unspecified	P41158	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032540	anti-Net 1996	Mus musculus		EXP032526	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032541	anti-Net 1996	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032542	anti-Net 1996	Mus musculus	Latrunculin B 0.3uM	EXP032528	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032543	anti-Net 1996	Mus musculus	U0126 10uM	EXP032529	675	unspecified	P41971	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032544	sc-335	Mus musculus		EXP032526	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032545	sc-335	Mus musculus	15% fetal calf serum for 30 min	EXP032527	675	unspecified	Q9JM73	NIH 3T3 (embryonic fibroblasts)	NULL
EXP032546	none	Mus musculus		NULL	254	chip_control	NULL	endodermal cells	NULL
EXP032547	anti-Cdx2 (anti-V5)	Mus musculus	+Dox +FGF	NULL	60	unspecified	P43241	Ainv15 (embryonic stem cells)	NULL
EXP032548	anti-Cdx2 truncated (anti-Flag)	Mus musculus	+Dox +FGF	NULL	60	unspecified	P43241	Ainv15 (embryonic stem cells)	NULL
EXP032549	anti-Cdx2 (anti-V5)	Mus musculus	none	NULL	756	bio_control	P43241	motor neuron progenitors	NULL
EXP032550	anti-Cdx2 (anti-V5)	Mus musculus		EXP032546	254	unspecified	P43241	endodermal cells	NULL
EXP032551	None	Mus musculus		NULL	676	chip_control	NULL	NKC (pancreatic cancer cells)	NULL
EXP032552	anti-NFATc1	Mus musculus		EXP032551	676	unspecified	O88942	NKC (pancreatic cancer cells)	NULL
EXP032553	anti-NFATc1	Mus musculus		EXP032551	676	unspecified	O88942	NKC (pancreatic cancer cells)	NULL
EXP032554	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032555	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032556	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032557	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032558	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032559	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032560	none	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP032561	anti-STAT5	Homo sapiens		EXP032554	169	unspecified	P42229	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032562	anti-STAT5	Homo sapiens		EXP032555	169	unspecified	P42229	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032563	anti-STAT5	Homo sapiens		EXP032554	170	unspecified	P42229	CD4+ CD25- T-cells	NULL
EXP032564	anti-STAT5	Homo sapiens		EXP032556	170	unspecified	P42229	CD4+ CD25- T-cells	NULL
EXP032565	anti-ETS1	Homo sapiens		EXP032555	169	unspecified	P14921	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032566	anti-ETS1	Homo sapiens		EXP032554	169	unspecified	P14921	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032567	anti-ETS1	Homo sapiens		EXP032560	169	unspecified	P14921	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032568	anti-ETS1	Homo sapiens		EXP032554	170	unspecified	P14921	CD4+ CD25- T-cells	NULL
EXP032569	anti-ETS1	Homo sapiens		EXP032560	170	unspecified	P14921	CD4+ CD25- T-cells	NULL
EXP032570	anti-RUNX1	Homo sapiens		EXP032554	169	unspecified	Q01196	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032571	anti-RUNX1	Homo sapiens		EXP032554	170	unspecified	Q01196	CD4+ CD25- T-cells	NULL
EXP032572	anti-RUNX1	Homo sapiens		EXP032560	170	unspecified	Q01196	CD4+ CD25- T-cells	NULL
EXP032573	anti-FOXP3	Homo sapiens		EXP032554	169	unspecified	Q9BZS1	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032574	anti-FOXP3	Homo sapiens		EXP032555	169	unspecified	Q9BZS1	CD4+ CD25+ CD45RA+ T-cells	NULL
EXP032575	anti-FOXP3	Homo sapiens		EXP032554	170	unspecified	Q9BZS1	CD4+ CD25- T-cells	NULL
EXP032576	anti-FOXP3	Homo sapiens		EXP032559	170	unspecified	Q9BZS1	CD4+ CD25- T-cells	NULL
EXP032577	anti-AP-2?	Homo sapiens		NULL	113	unspecified	P05549	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032578	IgG	Homo sapiens		NULL	469	chip_control	NULL	primary endothelial colony-forming cells	NULL
EXP032579	anti-TAL1	Homo sapiens		EXP032578	469	unspecified	P17542	primary endothelial colony-forming cells	NULL
EXP032580		Mus musculus		NULL	627	chip_control	NULL	E11.5 embryonic hindbrain	NULL
EXP032581		Mus musculus		NULL	627	chip_control	NULL	E11.5 embryonic hindbrain	NULL
EXP032582		Mus musculus		NULL	627	chip_control	NULL	E11.5 embryonic hindbrain	NULL
EXP032583		Mus musculus		NULL	626	chip_control	NULL	E11.5 embryonic face	NULL
EXP032584	ncoa1	Mus musculus		EXP032580	627	unspecified	P70365	E11.5 embryonic hindbrain	NULL
EXP032585	ncoa2	Mus musculus		EXP032581	627	unspecified	Q61026	E11.5 embryonic hindbrain	NULL
EXP032586	smarcc2	Mus musculus		EXP032582	627	unspecified	Q6PDG5	E11.5 embryonic hindbrain	NULL
EXP032587	smarcc2	Mus musculus		EXP032583	626	unspecified	Q6PDG5	E11.5 embryonic face	NULL
EXP032588		Mus musculus	ethanol vehicle	NULL	581	chip_control	NULL	MC3T3-E1 (preosteoblasts)	NULL
EXP032589		Mus musculus	100nM 1,25(OH)2D3	NULL	581	chip_control	NULL	MC3T3-E1 (preosteoblasts)	NULL
EXP032590	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	ethanol vehicle	EXP032588	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	NULL
EXP032591	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	ethanol vehicle	EXP032588	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	NULL
EXP032592	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	ethanol vehicle	EXP032589	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	NULL
EXP032593	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	ethanol vehicle	EXP032589	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	NULL
EXP032594	none	Homo sapiens		NULL	147	chip_control	NULL	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP032595	E2-2 Ab is a rabbit monoclonal Ab generated in Dr. Louis Staudt's lab	Homo sapiens		EXP032594	147	unspecified	P15884	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP032596	none (input control)	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP032597	none (input control)	Homo sapiens	Doxycycline 1ug/ml for 30 hours	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032598	none (input control)	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032599	IgG rabbit (sigma, I5006)	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP032600	IgG rabbit (sigma, I5006)	Mus musculus	Doxycycline 1ug/ml for 30 hours	NULL	44	chip_control	NULL	T-cells	NULL
EXP032601	IgG rabbit (sigma, I5006)	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032602	none	Mus musculus	Doxycycline 1ug/ml for 30 hours	NULL	44	chip_control	NULL	T-cells	NULL
EXP032603	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032604	IgG rabbit (sigma, I5006)	Mus musculus		NULL	715	chip_control	NULL	pancreatic carcinoma	NULL
EXP032605	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP032606	c-Myc antibody (N262) [Santa Cruz,  catalog# sc764]	Homo sapiens		EXP032596	78	unspecified	P01106	HeLa (cervical adenocarcinoma)	NULL
EXP032607	anti-Miz (residues 637-803) antibody [non-commercial; lab-prepared]	Homo sapiens		EXP032596	78	unspecified	Q13105	HeLa (cervical adenocarcinoma)	NULL
EXP032608	anti-c-Myc (N262) [Santa Cruz, catalog# sc764]	Homo sapiens	Doxycycline 1ug/ml for 30 hours	EXP032597	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP032609	anti-c-Myc (N262) [Santa Cruz, catalog# sc764]	Homo sapiens		EXP032598	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP032610	anti-Miz (10E2)	Homo sapiens	Doxycycline 1ug/ml for 30 hours	EXP032597	848	unspecified	Q13105	U2OS (osteosarcoma)	NULL
EXP032611	anti-Miz (10E2)	Homo sapiens		EXP032598	848	unspecified	Q13105	U2OS (osteosarcoma)	NULL
EXP032612	N262 (Santa Cruz, sc764)	Mus musculus	Doxycycline 1ug/ml for 30 hours	EXP032600	44	unspecified	P01108	T-cells	NULL
EXP032613	N262 (Santa Cruz, sc764)	Mus musculus		EXP032601	44	unspecified	P01108	T-cells	NULL
EXP032614	10E2	Mus musculus	Doxycycline 1ug/ml for 30 hours	EXP032600	44	unspecified	Q60821	T-cells	NULL
EXP032615	10E2	Mus musculus		EXP032601	44	unspecified	Q60821	T-cells	NULL
EXP032616	N262 (Santa Cruz, sc764)	Mus musculus		EXP032604	715	unspecified	P01108	pancreatic carcinoma	NULL
EXP032617	10E2	Mus musculus		EXP032604	715	unspecified	Q60821	pancreatic carcinoma	NULL
EXP032618	N262 (Santa Cruz, sc764)	Mus musculus		NULL	12	unspecified	P01108	MEF (mouse embryonic fibroblasts)	NULL
EXP032619	10E2	Mus musculus		EXP032605	12	unspecified	Q60821	MEF (mouse embryonic fibroblasts)	NULL
EXP032620		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032621		Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP032622		Homo sapiens		NULL	818	chip_control	NULL	SUM185PE (ductal breast carcinoma)	NULL
EXP032623		Homo sapiens		NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP032624		Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP032625		Homo sapiens		NULL	411	chip_control	NULL	HCC2157 (ductal breast carcinoma)	NULL
EXP032626	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032620	113	unspecified	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032627	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siJARID1B	EXP032620	113	unspecified	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032628	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siCTCF	EXP032620	113	unspecified	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032629	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032621	111	unspecified	Q9UGL1	T47D (invasive ductal carcinoma)	NULL
EXP032630	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032622	818	unspecified	Q9UGL1	SUM185PE (ductal breast carcinoma)	NULL
EXP032631	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siCTCF	EXP032622	818	unspecified	Q9UGL1	SUM185PE (ductal breast carcinoma)	NULL
EXP032632	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032623	817	unspecified	Q9UGL1	SUM159PT (Triple negative breast cancer)	NULL
EXP032633	CTCF (Millipore, 07-729)	Homo sapiens	siControl	EXP032623	817	unspecified	P49711	SUM159PT (Triple negative breast cancer)	NULL
EXP032634	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032624	2301	unspecified	Q9UGL1	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP032635	JARID1B (Novus Biologicals, 22260002)	Homo sapiens	siControl	EXP032625	411	unspecified	Q9UGL1	HCC2157 (ductal breast carcinoma)	NULL
EXP032636	none	Mus musculus		NULL	823	chip_control	NULL	T29 (T-cell leukemia)	NULL
EXP032637	none	Mus musculus		NULL	823	chip_control	NULL	T29 (T-cell leukemia)	NULL
EXP032638	none	Mus musculus		NULL	823	chip_control	NULL	T29 (T-cell leukemia)	NULL
EXP032639	T6719; Institute of Immunology, Kyoto ; lot: 901119	Mus musculus		EXP032636	823	unspecified	P31266	T29 (T-cell leukemia)	NULL
EXP032640	T6719; Institute of Immunology, Kyoto ; lot: 901119	Mus musculus		EXP032637	823	unspecified	P31266	T29 (T-cell leukemia)	NULL
EXP032641	in house anti-Ikaros rabbit polyclonal antibody ; lot: A3	Mus musculus		EXP032638	823	unspecified	Q03267	T29 (T-cell leukemia)	NULL
EXP032642	normal rabbit IgG (sc-2027, Santa Cruz)	Homo sapiens		NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP032643	none	Homo sapiens		NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP032644	Fra-1 (R-20, Santa Cruz)	Homo sapiens		EXP032642	120	unspecified	P15407	BT-549 (breast invasive ductal carcinoma)	NULL
EXP032645	c-Jun (H-79, Santa Cruz)	Homo sapiens		EXP032642	120	unspecified	P05412	BT-549 (breast invasive ductal carcinoma)	NULL
EXP032646	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Infection with 3XFlagIRESZsGFP	NULL	161	chip_control	NULL	neurosphere cells	NULL
EXP032647	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Infection with 3XFlagIRESZsGFP	NULL	161	chip_control	NULL	neurosphere cells	NULL
EXP032648	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Uninfected	NULL	161	chip_control	NULL	neurosphere cells	NULL
EXP032649	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Uninfected	NULL	161	chip_control	NULL	neurosphere cells	NULL
EXP032650	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Infection with 3XFlagFezf2IRESZsGFP	EXP032646	161	unspecified	Q9ESP5	neurosphere cells	NULL
EXP032651	anti-FLAG M2 (Sigma, F1804)	Mus musculus	Infection with 3XFlagFezf2IRESZsGFP	EXP032647	161	unspecified	Q61079	neurosphere cells	NULL
EXP032652	none	Homo sapiens		NULL	530	chip_control	NULL	KYSE70 (esophageal squamous carcinoma)	NULL
EXP032653	none	Homo sapiens		NULL	840	chip_control	NULL	TT (hereditary thyroid gland medullary carcinoma)	NULL
EXP032654	none	Homo sapiens		NULL	413	chip_control	NULL	HCC95 (squamous cell lung carcinoma)	NULL
EXP032655	none	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP032656	SOX2	Homo sapiens		EXP032652	530	unspecified	P48431	KYSE70 (esophageal squamous carcinoma)	NULL
EXP032657	p63	Homo sapiens		EXP032652	530	unspecified	Q9H3D4	KYSE70 (esophageal squamous carcinoma)	NULL
EXP032658	SOX2	Homo sapiens		EXP032653	840	unspecified	P48431	TT (hereditary thyroid gland medullary carcinoma)	NULL
EXP032659	p63	Homo sapiens		EXP032653	840	unspecified	Q9H3D4	TT (hereditary thyroid gland medullary carcinoma)	NULL
EXP032660	SOX2	Homo sapiens		EXP032654	413	unspecified	P48431	HCC95 (squamous cell lung carcinoma)	NULL
EXP032661	p63	Homo sapiens		EXP032654	413	unspecified	Q9H3D4	HCC95 (squamous cell lung carcinoma)	NULL
EXP032662	SOX2	Homo sapiens		EXP032655	396	unspecified	P48431	WA09 (embryonic stem cells)	NULL
EXP032663	LRH-1	Homo sapiens		NULL	113	unspecified	O00482	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032664	none	Homo sapiens	5Î¼M Nutlin-3a for 24hr	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032665	p53 Antibody (DO-1)	Homo sapiens	5Î¼M Nutlin-3a for 24hr	EXP032664	113	unspecified	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032666	Rabbit IgG (Millipore, 12-370)	Homo sapiens		NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP032667	Rabbit IgG (Millipore, 12-370)	Homo sapiens		NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP032668	anti PU.1 (Santa Cruz Biotechnology, sc-352X, lot D2011)	Homo sapiens		EXP032666	466	unspecified	P17947	MDM(monocyte derived macrophages)	NULL
EXP032669	anti PU.1 (Santa Cruz Biotechnology, sc-352X, lot D2011)	Homo sapiens		EXP032667	466	unspecified	P17947	MDM(monocyte derived macrophages)	NULL
EXP032670	none	Mus musculus		NULL	43	chip_control	NULL	CD4+ Th17+ T-cells	NULL
EXP032671	none	Mus musculus	mir155 KO	NULL	43	chip_control	NULL	CD4+ Th17+ T-cells	NULL
EXP032672	Jarid2 (Abcam, ab48137)	Mus musculus		EXP032670	43	unspecified	Q62315	CD4+ Th17+ T-cells	NULL
EXP032673	Jarid2 (Abcam, ab48137)	Mus musculus	mir155 KO	EXP032671	43	unspecified	Q62315	CD4+ Th17+ T-cells	NULL
EXP032674	c-Maf  (Santa Cruz, M-153)	Mus musculus		EXP032670	43	unspecified	P54843	CD4+ Th17+ T-cells	NULL
EXP032675	c-Maf  (Santa Cruz, M-153)	Mus musculus	mir155 KO	EXP032671	43	unspecified	P54843	CD4+ Th17+ T-cells	NULL
EXP032676	none (input)	Homo sapiens		NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP032677	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens		EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032678	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032679	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	+FoxA1 high	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032680	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens		EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	NULL
EXP032681	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	+FoxA1	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	NULL
EXP032682	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	+FoxA1 high	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	NULL
EXP032683	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	C562S+FoxA1	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	NULL
EXP032684	Anti-FOXA1 antibody (Abcam, cat#ab23738,lot# GR77830-1)	Homo sapiens	Q640X+FoxA1	EXP032676	223	unspecified	P55317	DU145 (prostate carcinoma)	NULL
EXP032685	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	C562S	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032686	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	C562S+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032687	androgen	Homo sapiens	Q640X	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032688	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	Q640X+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032689	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	G568W	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032690	Anti-Androgen Receptor (AR) Antibody, PG-21 (Millipore, cat#06-680, lot#JBC1939961)	Homo sapiens	G568W+FoxA1	EXP032676	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP032691	ctcf	Mus musculus		NULL	445	unspecified	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP032692	E2A	Mus musculus		NULL	445	unspecified	P15806	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP032693	ctcf	Mus musculus		NULL	576	unspecified	Q61164	mast cells	NULL
EXP032694	e2a	Mus musculus		NULL	576	unspecified	P15806	mast cells	NULL
EXP032695	erg	Mus musculus		NULL	576	unspecified	P81270	mast cells	NULL
EXP032696	fli1	Mus musculus		NULL	576	unspecified	P26323	mast cells	NULL
EXP032697	gata2	Mus musculus		NULL	576	unspecified	O09100	mast cells	NULL
EXP032698	Meis1	Mus musculus		NULL	576	unspecified	Q60954	mast cells	NULL
EXP032699	pu.1	Mus musculus		NULL	576	unspecified	P17433	mast cells	NULL
EXP032700	runx1	Mus musculus		NULL	576	unspecified	Q03347	mast cells	NULL
EXP032701	scl	Mus musculus		NULL	576	unspecified	P22091	mast cells	NULL
EXP032702	mitf	Mus musculus		NULL	576	unspecified	Q08874	mast cells	NULL
EXP032703	cfos	Mus musculus		NULL	576	unspecified	P01101	mast cells	NULL
EXP032704	Dynabeads  MyOneTM Streptavidin T1	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032705	anti-IgG	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032706	Dynabeads  MyOneTM Streptavidin T1	Mus musculus		EXP032704	2	unspecified	P01108	mESCs (mouse embryonic stem cells)	NULL
EXP032707	anti-Max	Mus musculus		EXP032705	2	unspecified	P28574	mESCs (mouse embryonic stem cells)	NULL
EXP032708	none	Mus musculus	ZT02	NULL	5	chip_control	NULL	liver	NULL
EXP032709	none	Mus musculus	ZT06	NULL	5	chip_control	NULL	liver	NULL
EXP032710	none	Mus musculus	ZT10	NULL	5	chip_control	NULL	liver	NULL
EXP032711	none	Mus musculus	ZT14	NULL	5	chip_control	NULL	liver	NULL
EXP032712	none	Mus musculus	ZT18	NULL	5	chip_control	NULL	liver	NULL
EXP032713	none	Mus musculus	ZT22	NULL	5	chip_control	NULL	liver	NULL
EXP032714	SREBP1	Mus musculus	ZT02	EXP032708	5	unspecified	Q9WTN3	liver	NULL
EXP032715	SREBP1	Mus musculus	ZT06	EXP032709	5	unspecified	Q9WTN3	liver	NULL
EXP032716	SREBP1	Mus musculus	ZT10	EXP032710	5	unspecified	Q9WTN3	liver	NULL
EXP032717	SREBP1	Mus musculus	ZT14	EXP032711	5	unspecified	Q9WTN3	liver	NULL
EXP032718	SREBP1	Mus musculus	ZT18	EXP032712	5	unspecified	Q9WTN3	liver	NULL
EXP032719	SREBP1	Mus musculus	ZT22	EXP032713	5	unspecified	Q9WTN3	liver	NULL
EXP032720	Input control	Mus musculus		NULL	104	chip_control	NULL	dendritic cells	NULL
EXP032721	Input control	Mus musculus		NULL	104	chip_control	NULL	dendritic cells	NULL
EXP032722	Runx3poly clonal home made	Mus musculus		EXP032720	104	unspecified	Q64131	dendritic cells	NULL
EXP032723	Runx3poly clonal home made	Mus musculus		EXP032721	104	unspecified	Q64131	dendritic cells	NULL
EXP032724		Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP032725		Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP032726	anti-Oct4	Mus musculus		EXP032724	506	unspecified	P20263	J1 (embryonic stem cells)	NULL
EXP032727	anti-Klf4	Mus musculus		EXP032724	506	unspecified	Q60793	J1 (embryonic stem cells)	NULL
EXP032728	anti-Oct4	Mus musculus		EXP032725	506	unspecified	P20263	J1 (embryonic stem cells)	NULL
EXP032729	anti-Klf4	Mus musculus		EXP032725	506	unspecified	Q60793	J1 (embryonic stem cells)	NULL
EXP032730	none (input)	Homo sapiens		NULL	188	chip_control	NULL	LS174T (colon adenocarcinoma)	NULL
EXP032731	anti-GATA6	Homo sapiens		EXP032730	188	unspecified	Q92908	LS174T (colon adenocarcinoma)	NULL
EXP032732	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: time 0; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP032733	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: vehicle; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP032734	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP032735	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: vehicle; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP032736	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP032737	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP032738	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: time 0; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032732	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP032739	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: vehicle; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032733	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP032740	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: 1 nM methyltrienolone (R1881); Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032733	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP032741	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: time 0; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032734	71	normal	Q06546	VCaP (prostate carcinoma)	NULL
EXP032742	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: vehicle; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032735	71	normal	Q06546	VCaP (prostate carcinoma)	NULL
EXP032743	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: 1 nM methyltrienolone (R1881); Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032735	71	normal	Q06546	VCaP (prostate carcinoma)	NULL
EXP032744	anti-GABPa (Santa Cruz, SC-22810)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032736	509	normal	Q06546	Jurkat (T-cells)	NULL
EXP032745	anti-ERG (Santa Cruz, SC-816X)	Homo sapiens	Treatment: none; Conditions: cells were grown to 75-80% confluence and then transferred to media supplemented with charcoal-stripped serum for 48 hrs	EXP032737	509	normal	P11308	Jurkat (T-cells)	NULL
EXP032746	None	Mus musculus		NULL	176	chip_control	NULL	CGR8 (embryonic stem cells)	NULL
EXP032747	Klf4	Mus musculus		EXP032746	176	unspecified	Q60793	CGR8 (embryonic stem cells)	NULL
EXP032748	Klf5	Mus musculus		EXP032746	176	unspecified	Q9Z0Z7	CGR8 (embryonic stem cells)	NULL
EXP032749	Klf4	Mus musculus	KLF4 overexpression	EXP032746	176	unspecified	Q60793	CGR8 (embryonic stem cells)	NULL
EXP032750	Klf5	Mus musculus	KLF5 overexpression	EXP032746	176	unspecified	Q9Z0Z7	CGR8 (embryonic stem cells)	NULL
EXP032751	input	Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP032752	SOX4	Mus musculus		EXP032751	105	unspecified	Q06831	pro-B cells	NULL
EXP032753	PPAR?/?	Homo sapiens	DMSO, normoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP032754	PPAR?/?	Homo sapiens	PPARbeta/delta agonist, normoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP032755	PPAR?/?	Homo sapiens	DMSO, hypoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP032756	PPAR?/?	Homo sapiens	PPARbeta/delta agonist, hypoxia	NULL	472	unspecified	Q03181	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP032757	none	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP032758	MLL1	Mus musculus		EXP032757	1153	unspecified	P55200	C2C12 (myoblasts)	NULL
EXP032759	CTCF	Homo sapiens	DNMT1KO	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP032760	CTCF	Homo sapiens	DNMT3BKO	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP032761	CTCF	Homo sapiens	No special treatment	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP032762	CTCF	Homo sapiens	 DNMT1KO, DNMT3BKO	NULL	417	unspecified	P49711	HCT-116 (colon carcinoma)	NULL
EXP032763	CTCF	Homo sapiens		NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP032764	CTCF	Homo sapiens	5-aza-2â€™-deoxycytidine (decitabine; Sigma, A3656) dissolved in DMSO to 10mM. Drug was administered at 1uM daily for 3 days. Control K562 cells were mock treated with DMSO.	NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP032765	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP032766	Anti-PU.1 (in-house rabbit polyclonal against the N-Terminal (aa. 1-100))	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP032767	None	Mus musculus		NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP032768	None	Mus musculus		NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP032769	Nrf1 (ab55744, Abcam)	Mus musculus		EXP032767	18	unspecified	Q9WU00	3T3-L1 (embryonic fibroblasts)	NULL
EXP032770	Nrf1 (ab55744, Abcam)	Mus musculus		EXP032768	18	unspecified	Q9WU00	3T3-L1 (embryonic fibroblasts)	NULL
EXP032771	rIgG (sc-2027, SantaCruz)	Mus musculus		NULL	150	chip_control	NULL	caput epididymis	NULL
EXP032772	rIgG (sc-2027, SantaCruz)	Mus musculus	specificity affecting androgen receptor knock-in	NULL	150	chip_control	NULL	caput epididymis	NULL
EXP032773	rIgG (sc-2027, SantaCruz)	Mus musculus		NULL	860	chip_control	NULL	ventral prostate	NULL
EXP032774	AR (Sahu et al. 2011)	Mus musculus		EXP032771	150	unspecified	P19091	caput epididymis	NULL
EXP032775	AR (Sahu et al. 2011)	Mus musculus		EXP032771	150	unspecified	P19091	caput epididymis	NULL
EXP032776	AR (Sahu et al. 2011)	Mus musculus	specificity affecting androgen receptor knock-in	EXP032772	150	unspecified	P19091	caput epididymis	NULL
EXP032777	AR (Sahu et al. 2011)	Mus musculus	specificity affecting androgen receptor knock-in	EXP032772	150	unspecified	P19091	caput epididymis	NULL
EXP032778	AR (Sahu et al. 2011)	Mus musculus		EXP032773	860	unspecified	P19091	ventral prostate	NULL
EXP032779	AR (Sahu et al. 2011)	Mus musculus	specificity affecting androgen receptor knock-in	NULL	860	unspecified	P19091	ventral prostate	NULL
EXP032780	p65	Homo sapiens	vehicle	NULL	40	unspecified	Q04206	AC16 (normal cardiomyocytes)	NULL
EXP032781	p65	Homo sapiens	TNFÎ±	NULL	40	unspecified	Q04206	AC16 (normal cardiomyocytes)	NULL
EXP032782	monoclonal anti-p53 (Santa Cruz Biotechnology)	Homo sapiens		NULL	783	unspecified	P04637	SaOS2 (osteosarcoma)	NULL
EXP032783	none (input)	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032784	none (input)	Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP032785	none (input)	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032786	none (input)	Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP032787	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032783	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032788	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032784	111	unspecified	P23771	T47D (invasive ductal carcinoma)	NULL
EXP032789	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032785	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032790	GATA3 serum (generated in rabbits using recombinant 6x histidine tag-fused GATA3 full-length wild-type protein)	Homo sapiens		EXP032786	111	unspecified	P23771	T47D (invasive ductal carcinoma)	NULL
EXP032791	input	Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP032792	sc-7208	Homo sapiens		EXP032791	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP032793	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	NULL
EXP032794	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	NULL
EXP032795	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	NULL
EXP032796	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	NULL
EXP032797	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	NULL
EXP032798	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	NULL
EXP032799	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	NULL
EXP032800	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P48281	MC3T3-E1 (preosteoblasts)	NULL
EXP032801	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	ethanol vehicle	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	NULL
EXP032802	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28700	MC3T3-E1 (preosteoblasts)	NULL
EXP032803	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	P28033	MC3T3-E1 (preosteoblasts)	NULL
EXP032804	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	100nM 1,25(OH)2D3	NULL	581	unspecified	Q08775	MC3T3-E1 (preosteoblasts)	NULL
EXP032805	none	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032806	none	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032807	none	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	NULL	138	chip_control	NULL	neural progenitors	NULL
EXP032808	none	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	NULL	138	chip_control	NULL	neural progenitors	NULL
EXP032809	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032805	2	unspecified	Q9D1P2	mESCs (mouse embryonic stem cells)	NULL
EXP032810	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032806	2	unspecified	Q9D1P2	mESCs (mouse embryonic stem cells)	NULL
EXP032811	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032807	138	unspecified	Q9D1P2	neural progenitors	NULL
EXP032812	MYST1 (BETHYL, A3000992A)	Mus musculus		EXP032808	138	unspecified	Q9D1P2	neural progenitors	NULL
EXP032813	rabbit IgG (pre-immune rabbit serum)	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032814	custom made antiserum for Tcf1	Mus musculus		EXP032813	2479	unspecified	Q00417	CD8+ T-cells	NULL
EXP032815	Input chromatin	Mus musculus	10 nM beta-estradiol (E2)	NULL	68	chip_control	NULL	aortic cells	NULL
EXP032816	Input chromatin	Mus musculus	10 nM beta-estradiol (E2)	NULL	68	chip_control	NULL	aortic cells	NULL
EXP032817	Input chromatin	Mus musculus	10 nM beta-estradiol (E2)	NULL	5	chip_control	NULL	liver	NULL
EXP032818	Input chromatin	Mus musculus	10 nM beta-estradiol (E2)	NULL	5	chip_control	NULL	liver	NULL
EXP032819	anti mouse ER-alpha	Mus musculus	10 nM beta-estradiol (E2)	EXP032815	68	unspecified	P19785	aortic cells	NULL
EXP032820	estrogen	Mus musculus	10 nM beta-estradiol (E2)	EXP032816	68	unspecified	O08537	aortic cells	NULL
EXP032821	anti mouse ER-alpha	Mus musculus	10 nM beta-estradiol (E2)	EXP032817	5	unspecified	P19785	liver	NULL
EXP032822	estrogen	Mus musculus	10 nM beta-estradiol (E2)	EXP032818	5	unspecified	P19785	liver	NULL
EXP032823	HNF4A (ab41898, Abcam, lot # GR4841-13)	Mus musculus	water only	NULL	187	unspecified	P49698	colon epithelium	NULL
EXP032824	HNF4A (ab41898, Abcam, lot # GR4841-13)	Mus musculus	3% DSS	NULL	187	unspecified	P49698	colon epithelium	NULL
EXP032825	anti-Sp1 antibody (Santa Cruz sc-17824X)	Mus musculus		NULL	230	unspecified	O89090	ES-E14 (E14, embryonic stem cells)	NULL
EXP032826	anti-Sp1 antibody (Santa Cruz sc-17824X)	Mus musculus		NULL	306	unspecified	O89090	Flk+ cKit+ progenitors	NULL
EXP032827	FLAG-M2 monoclonal (Sigma, F3165)	Mus musculus		NULL	546	chip_control	NULL	limb bud	NULL
EXP032828	FLAG-M2 monoclonal (Sigma, F3165)	Mus musculus		EXP032827	546	unspecified	Q61602	limb bud	NULL
EXP032829		Homo sapiens	CARM1 KO	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032830		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032831	BAF155	Homo sapiens	CARM1 KO	EXP032829	113	unspecified	Q92922	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032832	BAF155	Homo sapiens		EXP032830	113	unspecified	Q92922	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032833	isotype IgG control	Homo sapiens	none	NULL	469	chip_control	NULL	primary endothelial colony-forming cells	NULL
EXP032834	isotype IgG control	Homo sapiens	100 ng/ml final TSA	NULL	469	chip_control	NULL	primary endothelial colony-forming cells	NULL
EXP032835	anti-TAL1 (C-21, Santa-Cruz)	Homo sapiens	none	EXP032833	469	unspecified	P17542	primary endothelial colony-forming cells	NULL
EXP032836	anti-TAL1 (C-21, Santa-Cruz)	Homo sapiens	100 ng/ml final TSA	EXP032834	469	unspecified	P17542	primary endothelial colony-forming cells	NULL
EXP032837	anti-YY1 (Santa Cruz, catalog# SC-1703, lot# E0511)	Mus musculus		NULL	196	unspecified	Q00899	jejunal crypt intestinal epithelial cells	NULL
EXP032838	Rabbit Control IgG ChIP Grade ab46540	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032839	ER? (Santa Cruz Biotechnology; sc-534X, sc-7207X)	Homo sapiens	siCtrl	EXP032838	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032840	ER? (Santa Cruz Biotechnology; sc-534X, sc-7207X)	Homo sapiens	siERalpha	EXP032838	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032841	control IgG	Mus musculus		NULL	902	chip_control	NULL	mammary epithelial cells	NULL
EXP032842	antibody against Ovol2	Mus musculus		EXP032841	902	unspecified	Q8CIV7	mammary epithelial cells	NULL
EXP032843	none	Mus musculus		NULL	577	chip_control	NULL	matrix-depositing osteoblasts	NULL
EXP051009	Runx2 antibody (M70, Santa Cruz Biotechnologies, Inc.)	Mus musculus		NULL	739	unspecified	Q08775	MC3T3-E1 subclone 4 (preosteoblasts)	NULL
EXP032845	Runx2 antibody (M70, Santa Cruz Biotechnologies, Inc.)	Mus musculus		EXP032843	577	unspecified	Q08775	matrix-depositing osteoblasts	NULL
EXP032846	Runx2 antibody (M70, Santa Cruz Biotechnologies, Inc.)	Mus musculus		NULL	607	unspecified	Q08775	mineralizing osteoblasts	NULL
EXP032847		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032848		Homo sapiens	Bicalutamide	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032849		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032850		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032851		Homo sapiens	Bicalutamide	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032852		Homo sapiens	Bicalutamide	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP032853	anti-AR	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032854	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032855	anti-AR	Homo sapiens	BICALUTAMIDE	EXP032852	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032856	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032857	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032858	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032859	anti-AR	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032860	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032861	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032862	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032863	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032864	anti-AR	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032865	anti-E2F1	Homo sapiens	BICALUTAMIDE	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032866	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032867	anti-AR	Homo sapiens	Vehicle	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP032868	anti-E2F1	Homo sapiens	Vehicle	NULL	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP032869	anti-AR	Homo sapiens	Ethanol	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	NULL
EXP032870	anti-AR	Homo sapiens	Ethanol	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	NULL
EXP032871	anti-AR	Homo sapiens	10 nM R1881	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	NULL
EXP032872	anti-AR	Homo sapiens	10 nM R1881	NULL	421	unspecified	P10275	HEK293 (embryonic kidney)	NULL
EXP032873	none	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP032874	none	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP032875	anti-AR	Homo sapiens	Ethanol	EXP032873	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	NULL
EXP032876	anti-AR	Homo sapiens	Ethanol	EXP032874	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	NULL
EXP032877	anti-AR	Homo sapiens	10 nM R1881	EXP032873	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	NULL
EXP032878	anti-AR	Homo sapiens	10 nM R1881	EXP032874	725	unspecified	P10275	PC3(bone mets prostate adenocarcinoma)	NULL
EXP032879	none	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032880	anti-cJun	Mus musculus		EXP032879	2479	unspecified	P05627	CD8+ T-cells	NULL
EXP032881	anti-JunB	Mus musculus		NULL	2479	unspecified	P09450	CD8+ T-cells	NULL
EXP032882	anti-JunD	Mus musculus		NULL	2479	unspecified	P15066	CD8+ T-cells	NULL
EXP032883	IgG	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP032884	anti-BATF	Mus musculus		EXP032879	2479	unspecified	O35284	CD8+ T-cells	NULL
EXP032885	anti-IRF4	Mus musculus		EXP032879	2479	unspecified	Q64287	CD8+ T-cells	NULL
EXP032886	None	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP032887	None	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP032888	None	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP032889	anti-Meis1/2	Mus musculus		EXP032886	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	NULL
EXP032890	anti-Meis1/2	Mus musculus		EXP032887	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	NULL
EXP032891	anti-Meis1/2	Mus musculus		EXP032888	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	NULL
EXP032892	anti-Prep1	Mus musculus		EXP032888	12	unspecified	O70477	MEF (mouse embryonic fibroblasts)	NULL
EXP032893	anti-HIF1a	Homo sapiens		NULL	771	unspecified	Q16665	Caki-2 (renal carcinoma)	NULL
EXP032894	sox2	Mus musculus		NULL	204	unspecified	P48432	D3 (embryonic stem cells)	NULL
EXP032895	PU.1 (sc-352)	Mus musculus		NULL	123	unspecified	P17433	BV-2 (brain microglial cells)	NULL
EXP032896	PU.1 (sc-352)	Mus musculus	wt human Htt overexpression	NULL	123	unspecified	P17433	BV-2 (brain microglial cells)	NULL
EXP032897	PU.1 (sc-352)	Mus musculus	mutant human Htt overexpression	NULL	123	unspecified	P17433	BV-2 (brain microglial cells)	NULL
EXP032898	CEBPa (sc-61)	Mus musculus		NULL	123	unspecified	P53566	BV-2 (brain microglial cells)	NULL
EXP032899	CEBPa (sc-61)	Mus musculus	wt human Htt overexpression	NULL	123	unspecified	P53566	BV-2 (brain microglial cells)	NULL
EXP032900	CEBPa (sc-61)	Mus musculus	mutant human Htt overexpression	NULL	123	unspecified	P53566	BV-2 (brain microglial cells)	NULL
EXP032901	CEBPb (sc-150)	Mus musculus		NULL	123	unspecified	P28033	BV-2 (brain microglial cells)	NULL
EXP032902	CEBPb (sc-150)	Mus musculus	wt human Htt overexpression	NULL	123	unspecified	P28033	BV-2 (brain microglial cells)	NULL
EXP032903	CEBPb (sc-150)	Mus musculus	mutant human Htt overexpression	NULL	123	unspecified	P28033	BV-2 (brain microglial cells)	NULL
EXP032904	None	Mus musculus		NULL	632	chip_control	NULL	prostate	NULL
EXP032905	SRC-2 (A300-346A, Bethyl Lab., Inc.)	Mus musculus		EXP032904	632	unspecified	Q61026	prostate	NULL
EXP032906	None	Mus musculus		NULL	477	chip_control	NULL	IDG-SW3 (bone cells)	NULL
EXP032907	sc-1008	Mus musculus		EXP032906	477	unspecified	P48281	IDG-SW3 (bone cells)	NULL
EXP032908	sc-1008	Mus musculus	100nM 1,25(OH)2D3 for 3 hours	EXP032906	477	unspecified	P48281	IDG-SW3 (bone cells)	NULL
EXP032909	sc-774	Mus musculus		EXP032906	477	unspecified	P28700	IDG-SW3 (bone cells)	NULL
EXP032910	sc-774	Mus musculus	100nM 1,25(OH)2D3 for 3 hours	EXP032906	477	unspecified	P28700	IDG-SW3 (bone cells)	NULL
EXP032911	rabbit IgG	Homo sapiens		NULL	51	chip_control	NULL	adipose stromal cell adipocytes	NULL
EXP032912	custom-made EBF1 antibody (rabbit)	Homo sapiens		EXP032911	51	unspecified	Q9UH73	adipose stromal cell adipocytes	NULL
EXP032913	Anti-Brachyury antibody, Custom-made, rabbits were immunized with Brachyury residues 249-436 GST fusion proteins	Mus musculus		NULL	204	unspecified	P20293	D3 (embryonic stem cells)	NULL
EXP032914	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	NULL
EXP032915	anti-p50	Mus musculus		NULL	141	unspecified	P25799	retina	NULL
EXP032916	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	NULL
EXP032917	anti-p50	Mus musculus		NULL	141	unspecified	P25799	retina	NULL
EXP032918	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	NULL
EXP032919	anti-p50	Mus musculus		NULL	141	unspecified	P25799	retina	NULL
EXP032920	anti-p50	Mus musculus	LPS	NULL	141	unspecified	P25799	retina	NULL
EXP032921	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	NULL
EXP032922	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	NULL
EXP032923	anti-ATF3	Mus musculus	LPS	NULL	141	unspecified	Q60765	retina	NULL
EXP032924	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	NULL
EXP032925	anti-p65	Mus musculus	LPS	NULL	141	unspecified	Q04207	retina	NULL
EXP032926	anti-p65	Mus musculus		NULL	141	unspecified	Q04207	retina	NULL
EXP032927	anti-ATF3	Mus musculus	LPS	NULL	141	unspecified	Q60765	retina	NULL
EXP032928	pre-immune IgG	Mus musculus		NULL	204	chip_control	NULL	D3 (embryonic stem cells)	NULL
EXP032929	Anti-Brachyury antibody Rabbit #1, Custom-made, rabbits were immunized with Brachyury residues 249-436 GST fusion protein	Mus musculus		EXP032928	204	unspecified	P20293	D3 (embryonic stem cells)	NULL
EXP032930	Anti-Brachyury antibody Rabbit #2, Custom-made, rabbits were immunized with Brachyury residues 249-436 GST fusion protein	Mus musculus		EXP032928	204	unspecified	P20293	D3 (embryonic stem cells)	NULL
EXP032931	IgG	Homo sapiens		NULL	147	chip_control	NULL	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP032932	Anti-BCL11a	Homo sapiens		EXP032931	147	unspecified	Q9H165	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP032933	No antibody	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP032934	CTCF : 07-729 Millipore Lot. DAM1745366	Homo sapiens		EXP032933	2334	unspecified	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP032935	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: none	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP032936	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: Vehicle	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP032937	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 12 hours of DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP032938	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 12 hours of 500nM JQ1 and then 12 hours of DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP032939	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 6 hours of MDV3100 and then 12 hours of DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP032940	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 6 hours of 25ÂµM Bicalutamide and then 12 hours of 10nM DHT; Time point: 12 hours	EXP032935	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP032941	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: DMSO for 12 hours; Time point: 12 hours	EXP032935	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP032942	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: 12 hours of 500nM JQ1; Time point: 12 hours	EXP032935	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP032943	none	Mus musculus		NULL	760	chip_control	NULL	Py2T (breast cancer)	NULL
EXP032944	anti-Tead2	Mus musculus		EXP032943	760	unspecified	P48301	Py2T (breast cancer)	NULL
EXP032945	None	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032946	Foxp3	Mus musculus		EXP032945	44	unspecified	Q99JB6	T-cells	NULL
EXP032947	none (input)	Mus musculus		NULL	476	chip_control	NULL	neural tube	NULL
EXP032948	none (input)	Mus musculus		NULL	476	chip_control	NULL	neural tube	NULL
EXP032949	anti-Ascl1	Mus musculus		EXP032947	476	unspecified	Q02067	neural tube	NULL
EXP032950	anti-Ptf1a	Mus musculus		NULL	476	unspecified	Q9QX98	neural tube	NULL
EXP032951	anti-Ptf1a	Mus musculus		NULL	476	unspecified	Q9QX98	neural tube	NULL
EXP032952	IgG	Homo sapiens		NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP032953	anti-p53	Homo sapiens	none	EXP032952	93	unspecified	P04637	BJ (fibroblasts)	NULL
EXP032954	anti-p53	Homo sapiens	ionizing radiation	EXP032952	93	unspecified	P04637	BJ (fibroblasts)	NULL
EXP032955		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032956		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032957	ER? HC-20 (sc543 from Santa Cruz, 1 Âµg used)	Homo sapiens	JQ1+E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032958	ER? HC-20 (sc543 from Santa Cruz, 1 Âµg used)	Homo sapiens	E2	EXP032956	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP032959	IgG2a	Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP032960	Anti-Flag	Mus musculus		NULL	243	chip_control	NULL	EL4 (lymphoma)	NULL
EXP032961	anti-Foxp3	Mus musculus		NULL	243	unspecified	Q99JB6	EL4 (lymphoma)	NULL
EXP032962	anti-RORgamma	Mus musculus		EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032963	anti-RORgamma	Mus musculus	Th17 polarizing conditions	EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032964	anti-RORgamma	Mus musculus	DMSO	EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032965	anti-RORgamma	Mus musculus	TMP778 (2.5uM)	EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032966	anti-RORgamma	Mus musculus	Digoxin (10uM)	EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032967	anti-RORgamma	Mus musculus	TMP920 (10uM)	EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032968	anti-RORgamma	Mus musculus	DMSO and Th17 polarizing conditions	EXP032959	498	unspecified	P51450	Th17-cells	NULL
EXP032969	Anti-Flag	Mus musculus		EXP032960	243	unspecified	P51450	EL4 (lymphoma)	NULL
EXP032970	anti-Foxp3	Mus musculus		NULL	498	unspecified	Q99JB6	Th17-cells	NULL
EXP032971	none	Mus musculus	Activin A	NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP032972	none	Mus musculus		NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP032973	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032974	none	Mus musculus	Dox	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032975	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032976	anti-Oct4	Mus musculus	Activin A	EXP032971	206	unspecified	P20263	epiblast-like cells	NULL
EXP032977	anti-Oct4	Mus musculus		EXP032972	206	unspecified	P20263	epiblast-like cells	NULL
EXP032978	anti-Otx2	Mus musculus	Activin A	EXP032971	206	unspecified	P80206	epiblast-like cells	NULL
EXP032979	anti-Otx2	Mus musculus		EXP032972	206	unspecified	P80206	epiblast-like cells	NULL
EXP032980	anti-Oct4	Mus musculus		EXP032973	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP032981	anti-Otx2	Mus musculus		EXP032973	2	unspecified	P80206	mESCs (mouse embryonic stem cells)	NULL
EXP032982	anti-Oct4	Mus musculus	Dox	EXP032974	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP032983	anti-Otx2	Mus musculus	Dox	EXP032974	2	unspecified	P80206	mESCs (mouse embryonic stem cells)	NULL
EXP032984	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP032985	anti-Oct4	Mus musculus		EXP032975	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP032986	anti-Otx2	Mus musculus		EXP032975	2	unspecified	P80206	mESCs (mouse embryonic stem cells)	NULL
EXP032987	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP032988	anti-Runx1	Mus musculus		EXP032987	44	unspecified	Q03347	T-cells	NULL
EXP032989	E47	Mus musculus		NULL	171	unspecified	P15806	CD4+ CD8+ T cells	NULL
EXP032990	anti-Ets1	Mus musculus		EXP032987	44	unspecified	P27577	T-cells	NULL
EXP032992	anti-ERalpha	Mus musculus	saline vehicle	NULL	852	unspecified	P19785	uterine cells	NULL
EXP032993	anti-ERalpha	Mus musculus	estradiol (250 ng/mouse)	NULL	852	unspecified	O08537	uterine cells	NULL
EXP032994	none	Homo sapiens	none	NULL	468	chip_control	NULL	neonatal keratinocytes	NULL
EXP032995	anti-p63	Homo sapiens	none	EXP032994	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP032996	anti-p63	Homo sapiens	350nM Adrimycin	EXP032994	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP032997	anti-p63	Homo sapiens	25uM Cisplatin	EXP032994	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP032998	anti-p53	Homo sapiens	none	EXP032994	468	unspecified	P04637	neonatal keratinocytes	NULL
EXP032999	anti-p53	Homo sapiens	350nM Adrimycin	EXP032994	468	unspecified	P04637	neonatal keratinocytes	NULL
EXP033000	anti-p53	Homo sapiens	25uM Cisplatin	EXP032994	468	unspecified	P04637	neonatal keratinocytes	NULL
EXP033001	none	Mus musculus	none	NULL	20	chip_control	NULL	3T3-L1-derived adipocytes	NULL
EXP033002	anti-C/EBPalpha	Mus musculus	none	EXP033001	20	unspecified	P53566	3T3-L1-derived adipocytes	NULL
EXP033003	anti-C/EBPbeta	Mus musculus		EXP033001	20	unspecified	P28033	3T3-L1-derived adipocytes	NULL
EXP033004	anti-ATF2	Mus musculus		EXP033001	20	unspecified	P16951	3T3-L1-derived adipocytes	NULL
EXP033005	anti-JunD	Mus musculus		EXP033001	20	unspecified	P15066	3T3-L1-derived adipocytes	NULL
EXP033006	None	Homo sapiens		NULL	686	chip_control	NULL	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033007	None	Homo sapiens		NULL	683	chip_control	NULL	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP033008	None	Homo sapiens		NULL	394	chip_control	NULL	H929 (plasma cell myeloma)	NULL
EXP033009	None	Homo sapiens		NULL	686	chip_control	NULL	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033010	None	Homo sapiens		NULL	686	chip_control	NULL	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033011	anti-B-ATF	Homo sapiens		EXP033006	686	unspecified	Q16520	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033012	anti-IRF4	Homo sapiens		EXP033006	686	unspecified	Q15306	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033013	anti-PU.1	Homo sapiens		EXP033006	686	unspecified	P17947	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033014	anti-SPI-B	Homo sapiens		EXP033006	686	unspecified	Q01892	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033015	anti-B-ATF	Homo sapiens		EXP033007	683	unspecified	Q16520	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP033016	anti-IRF4	Homo sapiens		EXP033007	683	unspecified	Q15306	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP033017	anti-PU.1	Homo sapiens		EXP033007	683	unspecified	P17947	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP033018	anti-SPI-B	Homo sapiens		EXP033007	683	unspecified	Q01892	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP033019	anti-IRF4	Homo sapiens		EXP033008	394	unspecified	Q15306	H929 (plasma cell myeloma)	NULL
EXP033020	anti-PU.1	Homo sapiens		EXP033008	394	unspecified	P17947	H929 (plasma cell myeloma)	NULL
EXP033021	anti-SPI-B	Homo sapiens		EXP033008	394	unspecified	Q01892	H929 (plasma cell myeloma)	NULL
EXP033022	anti-IRF4	Homo sapiens		EXP033009	686	unspecified	Q15306	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033023	anti-PU.1	Homo sapiens		EXP033009	686	unspecified	P17947	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033024	anti-SPI-B	Homo sapiens		EXP033009	686	unspecified	Q01892	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033025	anti-IRF4	Homo sapiens		EXP033010	686	unspecified	Q15306	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033026	anti-PU.1	Homo sapiens		EXP033010	686	unspecified	P17947	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033027	anti-SPI-B	Homo sapiens		EXP033010	686	unspecified	Q01892	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP033028	anti-ATF2	Mus musculus		NULL	18	unspecified	P16951	3T3-L1 (embryonic fibroblasts)	NULL
EXP033029	anti-ATF7	Mus musculus		NULL	18	unspecified	Q8R0S1	3T3-L1 (embryonic fibroblasts)	NULL
EXP033030	anti-cJun	Mus musculus		NULL	18	unspecified	P05627	3T3-L1 (embryonic fibroblasts)	NULL
EXP033031	anti-JunB	Mus musculus		NULL	18	unspecified	P09450	3T3-L1 (embryonic fibroblasts)	NULL
EXP033032	anti-KLF4	Mus musculus		NULL	18	unspecified	Q60793	3T3-L1 (embryonic fibroblasts)	NULL
EXP033033	anti-KLF5	Mus musculus		NULL	18	unspecified	Q9Z0Z7	3T3-L1 (embryonic fibroblasts)	NULL
EXP033034	anti-PBX1	Mus musculus		NULL	18	unspecified	P41778	3T3-L1 (embryonic fibroblasts)	NULL
EXP033035	anti-STAT1	Mus musculus		NULL	18	unspecified	P42225	3T3-L1 (embryonic fibroblasts)	NULL
EXP033036	anti-VDR	Mus musculus		NULL	18	unspecified	P48281	3T3-L1 (embryonic fibroblasts)	NULL
EXP033037	anti-RXR	Mus musculus		NULL	18	unspecified	O54915	3T3-L1 (embryonic fibroblasts)	NULL
EXP033038	None (input)	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP033039	anti-CTCF	Homo sapiens		EXP033038	725	unspecified	P49711	PC3(bone mets prostate adenocarcinoma)	NULL
EXP033040	none (input)	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP033041	Anti-AP4	Mus musculus		EXP033040	2479	unspecified	Q9JIZ5	CD8+ T-cells	NULL
EXP033042	Anti-Myc	Mus musculus		EXP033040	2479	unspecified	P01108	CD8+ T-cells	NULL
EXP033043	IgG [Santa Cruz, sc-2027]	Mus musculus		NULL	523	chip_control	NULL	kidney	NULL
EXP033044	anti-WT1 (C-19) [Santa Cruz, sc-192]	Mus musculus		EXP033043	523	unspecified	P22561	kidney	NULL
EXP033045	none	Mus musculus		NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP033046	anti-Ebf1 (Abnova H00001879-M01)	Mus musculus		EXP033045	18	unspecified	Q07802	3T3-L1 (embryonic fibroblasts)	NULL
EXP033047	none	Mus musculus		NULL	400	chip_control	NULL	hematopoietic progenitors	NULL
EXP033048	anti-HA	Mus musculus		EXP033047	400	unspecified	P09631	hematopoietic progenitors	NULL
EXP033049	anti-C/EBPalpha	Mus musculus		EXP033047	400	unspecified	P53566	hematopoietic progenitors	NULL
EXP033050	none	Homo sapiens		NULL	431	chip_control	NULL	embryonic stem cell-derived pancreatic cells	NULL
EXP033051	anti-PDX1	Homo sapiens		EXP033050	431	unspecified	P52945	embryonic stem cell-derived pancreatic cells	NULL
EXP033052	Twist1 (Sigma, T6451, 5 ?g)	Mus musculus	none	NULL	227	unspecified	P26687	E12.5 embryonic endocardial cushion cells	NULL
EXP033053	Twist1 (Sigma, T6451, 5 ?g)	Mus musculus	none	NULL	226	unspecified	P26687	E10.5 embryonic limb bud cells	NULL
EXP033054	Twist1 (Sigma, T6451, 5 ?g)	Mus musculus	none	NULL	731	unspecified	P26687	peripheral nerve sheath tumor	NULL
EXP033055	anti-CTCF	Homo sapiens	none	NULL	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP033056	input	Mus musculus	none	NULL	693	chip_control	NULL	OG2 transgenetic mouse embryonic stem cells	NULL
EXP033057	c-Jun	Mus musculus	KSM; Doxycycline	EXP033056	693	unspecified	P05627	OG2 transgenetic mouse embryonic stem cells	NULL
EXP033058	c-Jun	Mus musculus	KSM; Doxycycline; c-Jun (dominant negative)	EXP033056	694	unspecified	P05627	OG2 transgenetic mouse embryonic fibroblasts	NULL
EXP033060	none	Mus musculus	MycER chimera; EtOH	NULL	22	chip_control	NULL	3T9 fibroblasts	NULL
EXP033061	none	Homo sapiens	none	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP033062	none	Mus musculus	serum starved or stimulated (unclear)	NULL	22	chip_control	NULL	3T9 fibroblasts	NULL
EXP033064	none	Mus musculus	none	NULL	41	chip_control	NULL	B-cells	NULL
EXP033082	anti-AR (N20) from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	Bicalutamide	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP033083	anti-AR (N20) from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	Enzalutamide	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP033084	IgG (Santa Cruz Biotechnology, Inc.: sc-2027)	Homo sapiens	double thymidine block	NULL	553	chip_control	NULL	LoVo (colorectal adenocarcinoma)	NULL
EXP033085	IgG (Santa Cruz Biotechnology, Inc.: sc-2027)	Homo sapiens	double thymidine block + nocodazole	NULL	553	chip_control	NULL	LoVo (colorectal adenocarcinoma)	NULL
EXP033086	anti-HNF4a (Santa Cruz Biotechnology, Inc.: sc-8987)	Homo sapiens	double thymidine block	EXP033084	553	unspecified	P41235	LoVo (colorectal adenocarcinoma)	NULL
EXP033087	anti-KLF5 (Santa Cruz Biotechnology, Inc. : sc-22797)	Homo sapiens	double thymidine block	EXP033084	553	unspecified	Q13887	LoVo (colorectal adenocarcinoma)	NULL
EXP033088	anti-MYC (MILLIPORE: 06-340)	Homo sapiens	double thymidine block	EXP033084	553	unspecified	P01106	LoVo (colorectal adenocarcinoma)	NULL
EXP033089	anti-HNF4a (Santa Cruz Biotechnology, Inc.: sc-8987)	Homo sapiens	double thymidine block + nocodazole	EXP033085	553	unspecified	P41235	LoVo (colorectal adenocarcinoma)	NULL
EXP033090	anti-KLF5 (Santa Cruz Biotechnology, Inc. : sc-22797)	Homo sapiens	double thymidine block + nocodazole	EXP033085	553	unspecified	Q13887	LoVo (colorectal adenocarcinoma)	NULL
EXP033091	anti-MYC (MILLIPORE: 06-340)	Homo sapiens	double thymidine block + nocodazole	EXP033085	553	unspecified	P01106	LoVo (colorectal adenocarcinoma)	NULL
EXP033092	none	Homo sapiens	none	NULL	870	chip_control	NULL	YCC3 (gastric adenocarcinoma)	NULL
EXP033093	none	Homo sapiens	none	NULL	59	chip_control	NULL	AGS (gastric adenocarcinoma)	NULL
EXP033094	none	Homo sapiens	none	NULL	518	chip_control	NULL	KATOIII (signet ring cell gastric adenocarcinoma)	NULL
EXP033095	sc-22797	Homo sapiens	none	EXP033092	870	unspecified	Q13887	YCC3 (gastric adenocarcinoma)	NULL
EXP033096	sc-9053	Homo sapiens	none	EXP033092	870	unspecified	P43694	YCC3 (gastric adenocarcinoma)	NULL
EXP033097	sc-9055	Homo sapiens	none	EXP033092	870	unspecified	Q92908	YCC3 (gastric adenocarcinoma)	NULL
EXP033098	sc-22797	Homo sapiens	none	EXP033093	59	unspecified	Q13887	AGS (gastric adenocarcinoma)	NULL
EXP033099	sc-9053	Homo sapiens	none	EXP033093	59	unspecified	P43694	AGS (gastric adenocarcinoma)	NULL
EXP033100	sc-9055	Homo sapiens	none	EXP033093	59	unspecified	Q92908	AGS (gastric adenocarcinoma)	NULL
EXP033101	sc-22797	Homo sapiens	none	EXP033094	518	unspecified	Q13887	KATOIII (signet ring cell gastric adenocarcinoma)	NULL
EXP033102	sc-9053	Homo sapiens	none	EXP033094	518	unspecified	P43694	KATOIII (signet ring cell gastric adenocarcinoma)	NULL
EXP033103	sc-9055	Homo sapiens	none	EXP033094	518	unspecified	Q92908	KATOIII (signet ring cell gastric adenocarcinoma)	NULL
EXP033104	none (input)	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP033105	none (input)	Mus musculus	none	NULL	53	chip_control	NULL	heart	NULL
EXP033106	sc-1237x, Santa Cruz	Mus musculus	none	EXP033104	53	unspecified	Q08369	heart	NULL
EXP033107	none (streptavidin-coated beads used to pulldown biotinylated Gata4; 11205D, M-280 Streptavidin Invitrogen)	Mus musculus	none	EXP033104	53	unspecified	Q08369	heart	NULL
EXP033108	sc-1237x, Santa Cruz	Mus musculus	none	EXP033105	53	unspecified	Q08369	heart	NULL
EXP033109	none (streptavidin-coated beads used to pulldown biotinylated Gata4; 11205D, M-280 Streptavidin Invitrogen)	Mus musculus	none	EXP033105	53	unspecified	Q08369	heart	NULL
EXP033110	IgG (Cell Signaling, 2729)	Homo sapiens	none	NULL	372	chip_control	NULL	Granta-519 (mantle cell lymphoma)	NULL
EXP033111	Anti-SOX11 (Sigma, HPA000536. Lot: B33103)	Homo sapiens	none	EXP033110	372	unspecified	P35716	Granta-519 (mantle cell lymphoma)	NULL
EXP033112	anti-CTCF	Homo sapiens	none	NULL	376	unspecified	P49711	WA01 (H1, human embryonic stem cells)	NULL
EXP033113	anti-CTCF	Homo sapiens	none	NULL	379	unspecified	P49711	H1-derived mesendodermal cells	NULL
EXP033114	anti-CTCF	Homo sapiens	none	NULL	378	unspecified	P49711	H1-derived mesenchymal stem cells	NULL
EXP033115	anti-CTCF	Homo sapiens	none	NULL	380	unspecified	P49711	H1-derived neuronal progenitors	NULL
EXP033116	anti-CTCF	Homo sapiens	none	NULL	382	unspecified	P49711	H1-derived trophectodermal cells	NULL
EXP033117	IgG	Homo sapiens	none	NULL	895	chip_control	NULL	erythroid progenitors	NULL
EXP033118	IgG	Homo sapiens	none	NULL	895	chip_control	NULL	erythroid progenitors	NULL
EXP033119	anti-CTCF	Homo sapiens	none	EXP033118	895	unspecified	P49711	erythroid progenitors	NULL
EXP033120	Flag (anti-Flag-M2, Sigma)	Homo sapiens	none	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP033121	Mouse-IgG	Homo sapiens	none	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP033122	Flag (anti-Flag-M2, Sigma)	Homo sapiens	none	EXP033121	65	unspecified	Q9H2W2	U937 (adult acute monocytic leukemia)	NULL
EXP033123	Flag (anti-Flag-M2, Sigma)	Homo sapiens	none	EXP033121	65	unspecified	Q9H2W2	U937 (adult acute monocytic leukemia)	NULL
EXP033124	MAF (Santa Cruz, cat.# SC-10022, lot# B1513)_wrong antibody ID (for Maf-B)	Homo sapiens	differentiation induction	NULL	463	unspecified	O75444	epidermal keratinocytes	NULL
EXP033125	MAFB (Santa Cruz, cat.# SC-7866, lot# G0312)_wrong antibody ID (for c-Maf)	Homo sapiens	differentiation induction	NULL	463	unspecified	Q9Y5Q3	epidermal keratinocytes	NULL
EXP033126	none (input)	Mus musculus	none	NULL	5	chip_control	NULL	liver	NULL
EXP033127	SRC-2  antibody (Bethyl Laboratories, catalog number A300-346, lot number A-1)	Mus musculus	none	EXP033126	5	unspecified	Q61026	liver	NULL
EXP033128	SRC-2  antibody (Bethyl Laboratories, catalog number A300-346, lot number A-1)	Mus musculus	none	EXP033126	5	unspecified	Q61026	liver	NULL
EXP033129	SRC-2  antibody (Bethyl Laboratories, catalog number A300-346, lot number A-1)	Mus musculus	none	EXP033126	5	unspecified	Q61026	liver	NULL
EXP033130	none (input)	Homo sapiens		NULL	1521	chip_control	NULL	Namalwa (Burkitt lymphoma)	NULL
EXP033131	anti-NRF1 [in house antibody]	Homo sapiens		EXP033130	1521	unspecified	Q16656	Namalwa (Burkitt lymphoma)	NULL
EXP033132	none	Mus musculus	none	NULL	176	chip_control	NULL	CGR8 (embryonic stem cells)	NULL
EXP033133	none	Mus musculus	10 uM SB431542 inhibitor of TGF-beta pathway	NULL	176	chip_control	NULL	CGR8 (embryonic stem cells)	NULL
EXP033134	none	Mus musculus	none	NULL	177	chip_control	NULL	embryonic stem cell-derived endodermal cells	NULL
EXP033135	none	Mus musculus	10 uM SB431542 inhibitor of TGF-beta pathway	NULL	177	chip_control	NULL	embryonic stem cell-derived endodermal cells	NULL
EXP033136	SMAD2/3 (R&D Systems, AF3797, lot XHY01)	Mus musculus	none	EXP033132	176	unspecified	Q62432	CGR8 (embryonic stem cells)	NULL
EXP033137	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	none	EXP033132	176	unspecified	Q61286	CGR8 (embryonic stem cells)	NULL
EXP033138	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	10 uM SB431542 inhibitor of TGF-beta pathway	EXP033133	176	unspecified	Q61286	CGR8 (embryonic stem cells)	NULL
EXP033139	SMAD2/3 (R&D Systems, AF3797, lot XHY01)	Mus musculus	none	EXP033134	177	unspecified	Q62432	embryonic stem cell-derived endodermal cells	NULL
EXP033140	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	none	EXP033134	177	unspecified	Q61286	embryonic stem cell-derived endodermal cells	NULL
EXP033141	HEB (Santa Cruz, sc-357, lot G0209)	Mus musculus	10 uM SB431542 inhibitor of TGF-beta pathway	EXP033135	177	unspecified	Q61286	embryonic stem cell-derived endodermal cells	NULL
EXP033142	C/EBPa (sc-61, Santa Cruz)	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033143	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033144	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033145	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033146	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033147	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033148	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033149	C/EBPa (sc-61, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P53566	C10 (pre-B-cells)	NULL
EXP033150	C/EBPb (sc-150, Santa Cruz)	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	P28033	C10 (pre-B-cells)	NULL
EXP033151	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	NULL
EXP033152	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	NULL
EXP033153	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	NULL
EXP033154	C/EBPb (sc-150, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P28033	C10 (pre-B-cells)	NULL
EXP033155	PU.1 (sc-352, Santa Cruz)	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	P17433	C10 (pre-B-cells)	NULL
EXP033156	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	NULL
EXP033157	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	NULL
EXP033158	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	NULL
EXP033159	PU.1 (sc-352, Santa Cruz)	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	P17433	C10 (pre-B-cells)	NULL
EXP033160	abnova 1879-mol clone 1c12	Mus musculus	0.1% ethanol as control sample	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	NULL
EXP033161	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	NULL
EXP033162	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	NULL
EXP033163	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	NULL
EXP033164	abnova 1879-mol clone 1c12	Mus musculus	100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1	NULL	401	unspecified	Q07802	C10 (pre-B-cells)	NULL
EXP033165	anti-CTCF (catalog# 07-729, Millipore)	Homo sapiens	unstimulated	NULL	111	unspecified	P49711	T47D (invasive ductal carcinoma)	NULL
EXP033166	anti-CTCF (catalog# 07-729, Millipore)	Homo sapiens	progestin R5020-stimulated	NULL	111	unspecified	P49711	T47D (invasive ductal carcinoma)	NULL
EXP033167	Input	Homo sapiens	DNA damage response	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP033168	Input	Homo sapiens	none (growing)	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP033169	Input	Homo sapiens	Ras-induced senescence	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP033170	Input	Homo sapiens	proapoptotic condition (sustained 53 activation; pAPO)	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP033171	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	none (growing)	EXP033168	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP033172	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	DNA damage response	NULL	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP033173	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	Ras-induced senescence	EXP033169	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP033174	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	DNA damage response	EXP033167	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP033175	anti-p53 mouse monoclonal (DO-1) Sigma	Homo sapiens	proapoptotic condition (sustained 53 activation; pAPO)	EXP033170	489	unspecified	P04637	IMR90 (lung fibroblasts)	NULL
EXP033176	none	Homo sapiens	1 ug/mL Doxycycline	NULL	219	chip_control	NULL	DLD-1 (colon adenocarcinoma)	NULL
EXP033177	none	Homo sapiens	1 ug/mL Doxycycline	NULL	219	chip_control	NULL	DLD-1 (colon adenocarcinoma)	NULL
EXP033178	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	none	EXP033176	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	NULL
EXP033179	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033176	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	NULL
EXP033180	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033176	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	NULL
EXP033181	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	none	EXP033177	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	NULL
EXP033182	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033177	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	NULL
EXP033183	Anti-FLAG Beads Sigma (A2220)	Homo sapiens	1 ug/mL Doxycycline	EXP033177	219	unspecified	P36402	DLD-1 (colon adenocarcinoma)	NULL
EXP033184	p65	Homo sapiens	None	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP033185	p65	Homo sapiens	TNF alpha	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP033186	p65	Homo sapiens	TNF alpha and JQ1	NULL	472	unspecified	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP033187	IgG	Mus musculus	none	NULL	286	chip_control	NULL	pancreatic beta-cells	NULL
EXP033188	Insm1 (Welcker et al , 2013)	Mus musculus	none	EXP033187	286	unspecified	Q63ZV0	pancreatic beta-cells	NULL
EXP033189	Neurod1 (#4373, Cell Signaling Technology, Danvers, MA)	Mus musculus	none	EXP033187	286	unspecified	Q60867	pancreatic beta-cells	NULL
EXP033190	Foxa2 (sc-6554, Santa Cruz Biotechnology)	Mus musculus	none	EXP033187	286	unspecified	P35583	pancreatic beta-cells	NULL
EXP033191	none	Mus musculus	none	NULL	571	chip_control	NULL	DLK1+ hepatoblasts	NULL
EXP033192	HNF4a SantaCruz H191 sc-8987 lot #J1003	Mus musculus	none	EXP033191	571	unspecified	P49698	DLK1+ hepatoblasts	NULL
EXP033193	FOXA2 Santa Cruz sc-6554	Mus musculus	none	EXP033191	571	unspecified	P35583	DLK1+ hepatoblasts	NULL
EXP033194	none	Homo sapiens	none	NULL	894	chip_control	NULL	erythroid cells	NULL
EXP033195	none	Homo sapiens	none	NULL	894	chip_control	NULL	erythroid cells	NULL
EXP033196	none	Homo sapiens	none	NULL	894	chip_control	NULL	erythroid cells	NULL
EXP033197	rabbit anti-TR4 antibody	Homo sapiens	none	EXP033194	894	unspecified	P49116	erythroid cells	NULL
EXP033198	rabbit anti-TR4 antibody	Homo sapiens	none	EXP033196	894	unspecified	P49116	erythroid cells	NULL
EXP033199	rabbit anti-TR4 antibody	Homo sapiens	none	EXP033196	894	unspecified	P49116	erythroid cells	NULL
EXP033200	none	Homo sapiens	none	NULL	202	chip_control	NULL	CyT49-derived endodermal cells	NULL
EXP033201	none	Homo sapiens	none	NULL	202	chip_control	NULL	CyT49-derived endodermal cells	NULL
EXP033202	none	Homo sapiens	none	NULL	202	chip_control	NULL	CyT49-derived endodermal cells	NULL
EXP033203	none	Homo sapiens	none	NULL	202	chip_control	NULL	CyT49-derived endodermal cells	NULL
EXP033204	none	Homo sapiens	none	NULL	202	chip_control	NULL	CyT49-derived endodermal cells	NULL
EXP033205	anti-PDX1, BCBC goat	Homo sapiens	none	EXP033200	202	unspecified	P52945	CyT49-derived endodermal cells	NULL
EXP033206	anti-FOXA1	Homo sapiens	none	EXP033201	202	unspecified	P55317	CyT49-derived endodermal cells	NULL
EXP033207	FOXA1	Homo sapiens	none	EXP033202	202	unspecified	P55317	CyT49-derived endodermal cells	NULL
EXP033208	FOXA1	Homo sapiens	none	EXP033203	202	unspecified	P55317	CyT49-derived endodermal cells	NULL
EXP033209	FOXA1	Homo sapiens	none	EXP033204	202	unspecified	P55317	CyT49-derived endodermal cells	NULL
EXP033210	FOXA2	Homo sapiens	none	EXP033201	202	unspecified	Q9Y261	CyT49-derived endodermal cells	NULL
EXP033211	FOXA2	Homo sapiens	none	EXP033202	202	unspecified	Q9Y261	CyT49-derived endodermal cells	NULL
EXP033212	FOXA2	Homo sapiens	none	EXP033203	202	unspecified	Q9Y261	CyT49-derived endodermal cells	NULL
EXP033213	FOXA2	Homo sapiens	none	EXP033204	202	unspecified	Q9Y261	CyT49-derived endodermal cells	NULL
EXP033214	none	Mus musculus	Dox	NULL	35	chip_control	NULL	A2lox FMsgn1 (embryonic stem cells)	NULL
EXP033215	anti-Flag M2 (Sigma, Cat#F3165)	Mus musculus		EXP033214	35	unspecified	Q9JK54	A2lox FMsgn1 (embryonic stem cells)	NULL
EXP033216	IgG (Sigma, catalog# I8140, lot# 115k7551)	Mus musculus	none	NULL	614	chip_control	NULL	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP033217	anti-TGIF-1 (H-172) (Santa Cruz Biotechnology, catalog# sc-9084, lot# K2608)	Mus musculus	EtOH	EXP033216	614	unspecified	P70284	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP033218	anti-TGIF-1 (H-172) (Santa Cruz Biotechnology, catalog# sc-9084, lot# K2608)	Mus musculus	4-OHT	EXP033216	614	unspecified	P70284	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP033219	anti-Meis-1 (Abcam, catalog# ab19867, lot# GR76623-1)	Mus musculus	EtOH	EXP033216	614	unspecified	Q60954	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP033220	anti-Meis-1 (Abcam, catalog# ab19867, lot# GR76623-1)	Mus musculus	4-OHT	EXP033216	614	unspecified	Q60954	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP033221	anti-TBP rabbit polyclonal, Santa Cruz Technology, catalog # sc-204X (ChIP-grade), lot # C-0513	Homo sapiens	none	NULL	514	unspecified	P20226	K562 (myelogenous leukemia)	NULL
EXP033222	IgG	Homo sapiens	none	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033223	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 0 min	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033224	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 2 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033225	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 5 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033226	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 10 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033227	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol 40 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033228	ER (Santa Cruz, sc-542)	Homo sapiens	100nM estradiol1 60 mins	EXP033222	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033229	none	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033230	none	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033231	Anti-Zfp57, Abcam ab45341	Mus musculus	none	EXP033229	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP033232	Anti-Zfp57, Abcam ab45341	Mus musculus	none	EXP033230	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP033233	none	Homo sapiens	none	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033234	none	Homo sapiens	SNAI2 knockdown	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033235	none	Homo sapiens	LACZ overexpressing	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033236	none	Homo sapiens	SNAI2 overexpressing	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033237	none	Homo sapiens	LACZ overexpressing + Differentiation medium	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033238	none	Homo sapiens	SNAI2 overexpressing + Differentiation medium	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033239	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	none	EXP033233	215	unspecified	O43623	keratinocytes	NULL
EXP033240	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	SNAI2 knockdown	EXP033234	215	unspecified	O43623	keratinocytes	NULL
EXP033241	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	LACZ overexpressing	EXP033235	215	unspecified	O43623	keratinocytes	NULL
EXP033242	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	SNAI2 overexpressing	EXP033236	215	unspecified	O43623	keratinocytes	NULL
EXP033243	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	LACZ overexpressing + Differentiation medium	EXP033237	215	unspecified	O43623	keratinocytes	NULL
EXP033244	anti-SNAI2 (Slug (C19G7)) Rabbit mAb	Homo sapiens	SNAI2 overexpressing + Differentiation medium	EXP033238	215	unspecified	O43623	keratinocytes	NULL
EXP033245	none	Mus musculus	LIF	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033246	anti-Jarid2 IP (Li et al. Gene & development 2010)	Mus musculus	LIF	EXP033245	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP033247	anti-Jarid2 K116me2 IP (this study, Sanulli et al.)	Mus musculus	LIF	EXP033245	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP033248	input	Homo sapiens	0.2 ug/ml Doxorubicin 12 hours	NULL	334	chip_control	NULL	GM06170 (fetal skin fibroblasts)	NULL
EXP033249	input	Homo sapiens	0.2 ug/ml Doxorubicin 12 hours	NULL	333	chip_control	NULL	GM00011 (fetal skin fibroblasts)	NULL
EXP033250	input	Mus musculus	0.2 ug/ml Doxorubicin 12 hours	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP033251	anti-p53	Homo sapiens	0.2 ug/ml Doxorubicin 12 hours	EXP033248	334	unspecified	P04637	GM06170 (fetal skin fibroblasts)	NULL
EXP033252	anti-p53	Homo sapiens	0.2 ug/ml Doxorubicin 12 hours	EXP033249	333	unspecified	P04637	GM00011 (fetal skin fibroblasts)	NULL
EXP033253	anti-p53	Mus musculus	0.2 ug/ml Doxorubicin 12 hours	EXP033250	595	unspecified	P02340	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP033254	none	Rattus norvegicus		NULL	389	chip_control	NULL	H4-II-E (hepatocellular carcinoma)	NULL
EXP033255	anti-TCF7L2 (CST, Cat #2569, lot 2, ref: 07/2010)	Rattus norvegicus		EXP033254	389	unspecified	D4A8X6	H4-II-E (hepatocellular carcinoma)	NULL
EXP033256	none	Homo sapiens	differentiated with TPA for 96 hours	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP033257	2469(non-commercial, unpublished)	Homo sapiens	differentiated with TPA for 96 hours	EXP033256	65	unspecified	P29375	U937 (adult acute monocytic leukemia)	NULL
EXP033258	2471(Klose et al.,Cell 128:889-900)	Homo sapiens	differentiated with TPA for 96 hours	EXP033256	65	unspecified	P29375	U937 (adult acute monocytic leukemia)	NULL
EXP033259		Mus musculus		NULL	246	chip_control	NULL	E12.5 embryonic vertebral column	NULL
EXP033260		Mus musculus		NULL	246	chip_control	NULL	E12.5 embryonic vertebral column	NULL
EXP033261		Mus musculus		NULL	17	chip_control	NULL	3T3 (embryonic fibroblasts)	NULL
EXP033262	S-peptide tagged Bapx1 [S-Pepetide - Bethyl laboratories (A-190-134A)]	Mus musculus		EXP033259	246	unspecified	P97503	E12.5 embryonic vertebral column	NULL
EXP033263	Sox9 [R&D system (AF3075)]	Mus musculus		EXP033260	246	unspecified	Q04887	E12.5 embryonic vertebral column	NULL
EXP033264	V5, ab15828	Mus musculus		EXP033261	17	unspecified	P97503	3T3 (embryonic fibroblasts)	NULL
EXP033265	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP033266	Zic3	Mus musculus		EXP033265	230	unspecified	Q62521	ES-E14 (E14, embryonic stem cells)	NULL
EXP033267	GATA2	Homo sapiens		NULL	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP033268	FLAG	Mus musculus		NULL	757	chip_control	NULL	proximal caput epididymus	NULL
EXP033269	FLAG	Mus musculus		EXP033268	757	unspecified	P19091	proximal caput epididymus	NULL
EXP033270	FLAG	Mus musculus		NULL	679	unspecified	P19091	non-proliferating proximal caput epididymus	NULL
EXP033271		Mus musculus		NULL	579	chip_control	NULL	mature megakaryocytes	NULL
EXP033272	Fli-1, antibody vendor, cat#, lot #: Abcam, ab15289, gr1478-2	Mus musculus		EXP033271	579	unspecified	P26323	mature megakaryocytes	NULL
EXP033273	Runx1, antibody vendor, cat#, lot #: Abcam, ab23980, gr25538-1	Mus musculus		EXP033271	579	unspecified	Q03347	mature megakaryocytes	NULL
EXP033274	input	Mus musculus		NULL	481	chip_control	NULL	immature megakaryocytes	NULL
EXP033275	input	Mus musculus		NULL	579	chip_control	NULL	mature megakaryocytes	NULL
EXP033276	input	Mus musculus		NULL	479	chip_control	NULL	immature erythroid cells	NULL
EXP033277	input	Mus musculus		NULL	480	chip_control	NULL	immature granulocytes	NULL
EXP033278	NF-E2 TB16+TB17, home made	Mus musculus		EXP033274	481	unspecified	Q07279	immature megakaryocytes	NULL
EXP033279	NF-E2 TB16+TB17, home made	Mus musculus		EXP033275	579	unspecified	Q07279	mature megakaryocytes	NULL
EXP033280	NF-E2 TB16+TB17, home made	Mus musculus		EXP033276	479	unspecified	Q07279	immature erythroid cells	NULL
EXP033281	PU.1, antibody vendor, cat #, lot #: Santa Cruz, sc-352, D2011	Mus musculus		EXP033277	480	unspecified	P17433	immature granulocytes	NULL
EXP033282	Scl/TAL1 (gifted by C. Porcher).	Homo sapiens		NULL	894	unspecified	P17542	erythroid cells	NULL
EXP033283	Scl/TAL1 (gifted by C. Porcher).	Homo sapiens		NULL	894	unspecified	P17542	erythroid cells	NULL
EXP033284	HIF1a	Homo sapiens	normoxy	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033285	HIF1a	Homo sapiens	normoxy	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033286	HIF1a	Homo sapiens	hypoxy	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033287	HIF1a	Homo sapiens	hypoxy	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033288	HIF2a	Homo sapiens	normoxy	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033289	HIF2a	Homo sapiens	normoxy	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033290	HIF2a	Homo sapiens	hypoxy	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033291	HIF2a	Homo sapiens	hypoxy	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033292	HIF1a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033293	HIF1a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033294	HIF1a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033295	HIF1a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q16665	macrophages	NULL
EXP033296	HIF2a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033297	HIF2a	Homo sapiens	normoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033298	HIF2a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033299	HIF2a	Homo sapiens	hypoxy, Interleukin-10	NULL	911	unspecified	Q99814	macrophages	NULL
EXP033300	anti-FoxA1 from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	vehicle, control	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP033301	anti-FoxA1 from Santa Cruz Biotechnology (Santa Cruz, CA)	Homo sapiens	10 nm DHT	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP033302	input	Homo sapiens	Treatment: none	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP033303	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	EXP033302	71	normal	P03372	VCaP (prostate carcinoma)	NULL
EXP033304	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	NULL	71	normal	P03372	VCaP (prostate carcinoma)	NULL
EXP033305	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	NULL	71	normal	P03372	VCaP (prostate carcinoma)	NULL
EXP033306	anti-ER-alpha (diagenode, AC-066-100, lot 001)	Homo sapiens	Treatment: 14 hours of 10nM 17 b estradiol (E2); Conditions: cells were hormone starved for 48 hours prior to treatment; Time point: 14 hours	NULL	656	normal	P03372	NCI-H660 (prostate carcinoma)	NULL
EXP033307		Homo sapiens		NULL	735	chip_control	NULL	pre-B acute lymphoblastic leukemia	NULL
EXP033308	Affinity-purified anti-Ikaros antibody	Homo sapiens		EXP033307	735	unspecified	Q13422	pre-B acute lymphoblastic leukemia	NULL
EXP033309	BMAL1	Homo sapiens		NULL	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP033310	CLOCK	Homo sapiens		NULL	848	unspecified	O15516	U2OS (osteosarcoma)	NULL
EXP033311	CRY1	Homo sapiens		NULL	848	unspecified	Q16526	U2OS (osteosarcoma)	NULL
EXP033312		Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP033313	sc-8697	Mus musculus		EXP033312	53	unspecified	P42582	heart	NULL
EXP033314	none	Homo sapiens		NULL	205	chip_control	NULL	DAOY (medulloblastoma)	NULL
EXP033315	ZFX	Homo sapiens		EXP033314	205	unspecified	P17010	DAOY (medulloblastoma)	NULL
EXP033316	none	Homo sapiens		NULL	867	chip_control	NULL	WI-38 (lung fibroblasts)	NULL
EXP033317	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP033318	anti-TRF2 / Rabbit polyclonal IgG (Santa Cruz sc-9143)	Homo sapiens		EXP033316	867	unspecified	P62380	WI-38 (lung fibroblasts)	NULL
EXP033319	anti-NR2F2 / Rabbit polyclonal IgG (Abcam ab50487)	Homo sapiens		EXP033316	867	unspecified	P24468	WI-38 (lung fibroblasts)	NULL
EXP033320	anti-NR2C2 / Mouse monoclonal IgG (PPMX PP-H0107B-00)	Homo sapiens		EXP033316	867	unspecified	P49116	WI-38 (lung fibroblasts)	NULL
EXP033321	anti-HMBOX1 / Rabbit polyclonal IgG (Abcam ab97643)	Homo sapiens		EXP033316	867	unspecified	Q6NT76	WI-38 (lung fibroblasts)	NULL
EXP033322	anti-TRF2 / Rabbit polyclonal IgG (Santa Cruz sc-9143)	Homo sapiens		EXP033317	78	unspecified	P62380	HeLa (cervical adenocarcinoma)	NULL
EXP033323	anti-NR2F2 / Rabbit polyclonal IgG (Abcam ab50487)	Homo sapiens		EXP033317	78	unspecified	P24468	HeLa (cervical adenocarcinoma)	NULL
EXP033324	anti-NR2C2 / Mouse monoclonal IgG (PPMX PP-H0107B-00)	Homo sapiens		EXP033317	78	unspecified	P49116	HeLa (cervical adenocarcinoma)	NULL
EXP033325	anti-HMBOX1 / Rabbit polyclonal IgG (Abcam ab97643)	Homo sapiens		EXP033317	78	unspecified	Q6NT76	HeLa (cervical adenocarcinoma)	NULL
EXP033326	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP033327	FKHR (H-128)X sc-11350X lot# F0310	Mus musculus		EXP033326	1058	unspecified	Q9R1E0	CD4+ T-cells	NULL
EXP033328	none	Mus musculus	none	NULL	668	chip_control	NULL	ES-D3 embryonic stem cell-derived neurons	NULL
EXP033329	ERR? (Dufour et al. Cell Metab 5, 345-356 (2007))	Mus musculus	none	EXP033328	668	unspecified	P62509	ES-D3 embryonic stem cell-derived neurons	NULL
EXP033330	normal goat IgG	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP033331	input	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033332	input	Mus musculus	48h 1ug/ml doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033333	input	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP033334	Scl/Tal1	Mus musculus		NULL	602	unspecified	P22091	erythroleukemic cells	NULL
EXP033335	Scl/Tal1	Mus musculus	EB formation, 48h 1ug/ml doxycycline from day2 of EB formation, enrichment for Flk1+ cells at day 4	NULL	2	unspecified	P22091	mESCs (mouse embryonic stem cells)	NULL
EXP033336	sc-9413X	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	EXP033333	506	unspecified	Q64279	J1 (embryonic stem cells)	NULL
EXP033337	sc-12984X	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	EXP033333	506	unspecified	P22091	J1 (embryonic stem cells)	NULL
EXP033338	sc-12984X	Mus musculus	EB formation, enrichment for Flk1+ cells at day 4	EXP033331	2	unspecified	P22091	mESCs (mouse embryonic stem cells)	NULL
EXP033339	sc-12984X	Mus musculus	48h 1ug/ml doxycycline	EXP033332	2	unspecified	P22091	mESCs (mouse embryonic stem cells)	NULL
EXP033340	rIgG (20009-5, Alpha Diagnostic International)	Homo sapiens		NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP033341	HOXB7 (H0291, Sigma-Aldrich)	Homo sapiens		EXP033340	120	unspecified	P09629	BT-549 (breast invasive ductal carcinoma)	NULL
EXP033342	input	Homo sapiens		NULL	720	chip_control	NULL	PaTu8988S (pancreatic adenocarcinoma)	NULL
EXP033343	anti hGATA6 R&D AF1700	Homo sapiens		EXP033342	720	unspecified	Q92908	PaTu8988S (pancreatic adenocarcinoma)	NULL
EXP033344	anti-Stat3	Mus musculus	PBS	NULL	323	unspecified	P42227	gastric tumors	NULL
EXP033345	anti-Stat3	Mus musculus	IL6	NULL	323	unspecified	P42227	gastric tumors	NULL
EXP033346	anti-Stat3	Mus musculus	IL11	NULL	323	unspecified	P42227	gastric tumors	NULL
EXP033347	input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033348	anti-REST (Nurit Ballas et al. Cell 2005)	Mus musculus		EXP033347	2	unspecified	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP033349		Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP033350	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q9JI44	J1 (embryonic stem cells)	NULL
EXP033351	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q8R0K9	J1 (embryonic stem cells)	NULL
EXP033352	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q9D1P2	J1 (embryonic stem cells)	NULL
EXP033353	antiFLAG	Mus musculus		EXP033349	506	unspecified	P28574	J1 (embryonic stem cells)	NULL
EXP033354	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q80Z64	J1 (embryonic stem cells)	NULL
EXP033355	antiFLAG	Mus musculus		EXP033349	506	unspecified	P01108	J1 (embryonic stem cells)	NULL
EXP033356	antiFLAG	Mus musculus		EXP033349	506	unspecified	Q61066	J1 (embryonic stem cells)	NULL
EXP033357	none	Mus musculus		NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP033358	Meis1 (Abcam, ab19867, lot 676286)	Mus musculus		EXP033357	1493	unspecified	Q60954	acute myeloid leukemia	NULL
EXP033359	FLAG (Sigma, F7425, lot 011M4789)	Mus musculus		EXP033357	1493	unspecified	P09631	acute myeloid leukemia	NULL
EXP033360	FLAG (Sigma, F7425, lot 011M4789)	Mus musculus		NULL	1493	unspecified	P09631	acute myeloid leukemia	NULL
EXP033361	Pbx1/2/3 (Santa Cruz, sc-888, lot J157)	Mus musculus		EXP033357	1493	unspecified	P41778	acute myeloid leukemia	NULL
EXP033362	Pbx1/2/3 (Santa Cruz, sc-888, lot J157)	Mus musculus		NULL	1493	unspecified	P41778	acute myeloid leukemia	NULL
EXP033363	input	Homo sapiens		NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP033364	anti-REST Ab (Millipore 07-579)	Homo sapiens		EXP033363	881	unspecified	Q13127	CD4+ T-cells	NULL
EXP033365	input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033366	input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033367	input	Mus musculus		NULL	214	chip_control	NULL	embryoid body (day 4)	NULL
EXP033368	input	Mus musculus		NULL	214	chip_control	NULL	embryoid body (day 4)	NULL
EXP033369	MLL4	Mus musculus		EXP033365	2	unspecified	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP033370	MLL4	Mus musculus		EXP033366	2	bio_control	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP033371	MLL4	Mus musculus		EXP033367	214	unspecified	O08550	embryoid body (day 4)	NULL
EXP033372	MLL4	Mus musculus		EXP033368	214	bio_control	O08550	embryoid body (day 4)	NULL
EXP033373	input	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP033374	VDR	Homo sapiens		EXP033373	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP033375	VDR	Homo sapiens	1,25D for 1h	EXP033373	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP033376	VDR	Homo sapiens	1,25D for 2h	EXP033373	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP033377	IgG (Millipore, Cat # 12-370)	Mus musculus		NULL	885	chip_control	NULL	astrocytes	NULL
EXP033378	STAT3 antibody (Cell Signaling Technology, Cat# 9132)	Mus musculus		EXP033377	885	unspecified	P42227	astrocytes	NULL
EXP033379	input	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP033380	input	Homo sapiens		NULL	388	chip_control	NULL	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033381	SMAD3 [Abcam, Catalog#: ab4085, Lot#: GR27326-2]	Homo sapiens	siControl	EXP033380	388	unspecified	P84022	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033382	SMAD3 [Abcam, Catalog#: ab4085, Lot#: GR27326-2]	Homo sapiens	siTTF-1	EXP033380	388	unspecified	P84022	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033383	TTF-1 [Thermo Scientific, Catalog#: MS-699-P clone 8G7G3/1]	Homo sapiens		EXP033380	388	unspecified	P43699	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033384	TTF-1 [Thermo Scientific, Catalog#: MS-699-P clone 8G7G3/1]	Homo sapiens	1.5h	EXP033380	388	unspecified	P43699	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033385	SMAD4 [R&D, Catalog#: AF2097]	Homo sapiens	siControl	EXP033380	388	unspecified	Q13485	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033386	SMAD4 [R&D, Catalog#: AF2097]	Homo sapiens	siTTF-1	EXP033380	388	unspecified	Q13485	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP033387	SMAD3 [Abcam, Catalog#: ab4085, Lot#: GR27326-2]	Homo sapiens		EXP033379	38	unspecified	P84022	A549 (lung carcinoma)	NULL
EXP033388	CTCF (Pugacheva et. al. 2005 Hum Mol Genet 14, 953-965; PMID: 15731119)	Mus musculus		NULL	96	unspecified	Q61164	trophoblast stem cells	NULL
EXP033389	anti-Flag (Sigma, Catalog# F3165)	Homo sapiens		NULL	552	chip_control	NULL	LN229 (glioblastoma)	NULL
EXP033390	anti-Flag (Sigma, Catalog# F3165)	Homo sapiens		EXP033389	552	unspecified	Q06945	LN229 (glioblastoma)	NULL
EXP033391	none (chromatin Input control sample)	Homo sapiens		NULL	309	chip_control	NULL	Flp-In-T-REx-293 (embryonic kidney)	NULL
EXP033392	Anti-FOXK1 (ab18196),  Abcam	Homo sapiens		EXP033391	309	unspecified	P85037	Flp-In-T-REx-293 (embryonic kidney)	NULL
EXP033393	VDR	Homo sapiens	unstimulated	NULL	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP033394	VDR	Homo sapiens	1Î±,25(OH)2D3	NULL	2334	unspecified	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP033395	none	Homo sapiens		NULL	824	chip_control	NULL	T3M-1 Cl-10 (oral cavity squamous cell carcinoma)	NULL
EXP033396	none	Homo sapiens	L211M mutation of ELF4	NULL	824	chip_control	NULL	T3M-1 Cl-10 (oral cavity squamous cell carcinoma)	NULL
EXP033397	Monoclonal ANTI-FLAG M2, Clone M2, F1804	Homo sapiens		EXP033395	824	unspecified	Q99607	T3M-1 Cl-10 (oral cavity squamous cell carcinoma)	NULL
EXP033398	Monoclonal ANTI-FLAG M2, Clone M2, F1804	Homo sapiens	L211M mutation of ELF4	EXP033396	824	unspecified	Q99607	T3M-1 Cl-10 (oral cavity squamous cell carcinoma)	NULL
EXP033399		Rattus norvegicus	pooled	NULL	389	chip_control	NULL	H4-II-E (hepatocellular carcinoma)	NULL
EXP033400	HNF4A (Lot A-2, clone H1415, cat # PP-H1415-00, R&D Systems, Minneapolis, MN, USA)	Rattus norvegicus	siRNA - Scrambled	EXP033399	389	unspecified	P22449	H4-II-E (hepatocellular carcinoma)	NULL
EXP033401	HNF4A (Lot A-2, clone H1415, cat # PP-H1415-00, R&D Systems, Minneapolis, MN, USA)	Rattus norvegicus	siRNA - Tcf7l2	EXP033399	389	unspecified	P22449	H4-II-E (hepatocellular carcinoma)	NULL
EXP033402	TCF7L2 (Lot 2, clone C48H11, cat # 2569, Cell Signaling Technology, Danvers, MA, USA)	Rattus norvegicus	siRNA - Scrambled	EXP033399	389	unspecified	D4A8X6	H4-II-E (hepatocellular carcinoma)	NULL
EXP033403	TCF7L2 (Lot 2, clone C48H11, cat # 2569, Cell Signaling Technology, Danvers, MA, USA)	Rattus norvegicus	siRNA -Tcf7l2	EXP033399	389	unspecified	D4A8X6	H4-II-E (hepatocellular carcinoma)	NULL
EXP033404	None	Mus musculus		NULL	819	chip_control	NULL	superior cervical ganglion	NULL
EXP033405	Anti-Meis Millipore 05-779	Mus musculus		EXP033404	819	unspecified	Q60954	superior cervical ganglion	NULL
EXP033406	none	Mus musculus		NULL	682	chip_control	NULL	nucleus accumbens cells	NULL
EXP033407	none	Mus musculus	resilient	NULL	682	chip_control	NULL	nucleus accumbens cells	NULL
EXP033408	none	Mus musculus	susceptible	NULL	682	chip_control	NULL	nucleus accumbens cells	NULL
EXP033409	ab3749	Mus musculus		EXP033406	682	unspecified	Q91ZW3	nucleus accumbens cells	NULL
EXP033410	ab3749	Mus musculus	resilient	EXP033407	682	unspecified	Q91ZW3	nucleus accumbens cells	NULL
EXP033411	ab3749	Mus musculus	susceptible	EXP033408	682	unspecified	Q91ZW3	nucleus accumbens cells	NULL
EXP033412	none	Mus musculus		NULL	428	chip_control	NULL	hepatocellular carcinoma	NULL
EXP033413	V5-KLF6	Mus musculus		EXP033412	428	unspecified	O08584	hepatocellular carcinoma	NULL
EXP033414		Homo sapiens		NULL	130	chip_control	NULL	LNCaP C4-2 (prostate carcinoma)	NULL
EXP033415		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP033416	Santa Cruz, N-20	Homo sapiens	ethanol	EXP033414	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP033417	Santa Cruz, N-20	Homo sapiens	10 nmol/l of mibolerone	EXP033414	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP033418	Santa Cruz, N-20	Homo sapiens	ethanol	EXP033415	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP033419	Santa Cruz, N-20	Homo sapiens	10 nmol/l of mibolerone	EXP033415	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP033420		Homo sapiens		NULL	540	chip_control	NULL	MCF-7aro Let-R (invasive ductal carcinoma)	NULL
EXP033421		Homo sapiens		NULL	563	chip_control	NULL	LY-2 (invasive ductal carcinoma)	NULL
EXP033422	sc-543	Homo sapiens	androstendione for 45min	EXP033420	540	unspecified	P03372	MCF-7aro Let-R (invasive ductal carcinoma)	NULL
EXP033423	sc-543	Homo sapiens		EXP033420	540	unspecified	P03372	MCF-7aro Let-R (invasive ductal carcinoma)	NULL
EXP033424	ER	Homo sapiens		EXP033421	563	unspecified	P03372	LY-2 (invasive ductal carcinoma)	NULL
EXP033425	rabbit polyclonal anti-Atf3 antibody	Mus musculus		NULL	81	unspecified	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP033426	rabbit polyclonal anti-Atf3 antibody	Mus musculus	2mg/ml HDL for 6h	NULL	81	unspecified	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP033427	rabbit polyclonal anti-Atf3 antibody	Mus musculus	2mg/ml HDL for 6h + 100nM CpG for 4h	NULL	81	unspecified	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP033428	None	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033429	Tgif1 (Santa Cruz, SC9084X)	Mus musculus		EXP033428	2	unspecified	P70284	mESCs (mouse embryonic stem cells)	NULL
EXP033430	Smad3 (Abcam, ab28379)	Mus musculus		EXP033428	2	unspecified	Q8BUN5	mESCs (mouse embryonic stem cells)	NULL
EXP033431	streptavidin-conjugated beads	Mus musculus		EXP033428	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP033432	streptavidin-conjugated beads (life technology, 64601).	Mus musculus		EXP033428	2	unspecified	Q8C0Y1	mESCs (mouse embryonic stem cells)	NULL
EXP033433	anti-CEBPA	Mus musculus		NULL	829	unspecified	P53566	leukemic bone marrow	NULL
EXP033434	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus	RbKO	NULL	495	unspecified	O35261	intestinal crypt cells	NULL
EXP033435	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus	RbKO	NULL	495	unspecified	P01108	intestinal crypt cells	NULL
EXP033436	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus	RbKO	NULL	496	unspecified	O35261	intestinal villus	NULL
EXP033437	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus	RbKO	NULL	496	unspecified	P01108	intestinal villus	NULL
EXP033438	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus		NULL	495	unspecified	O35261	intestinal crypt cells	NULL
EXP033439	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus		NULL	495	unspecified	P01108	intestinal crypt cells	NULL
EXP033440	E2f3 (Santa Cruz; sc-878 X, lot# E1712)	Mus musculus		NULL	496	unspecified	O35261	intestinal villus	NULL
EXP033441	Myc (Santa Cruz; sc-764 X, lot# D2314)	Mus musculus		NULL	496	unspecified	P01108	intestinal villus	NULL
EXP033442	c-Jun Antibody (H-79) from Santa Cruz Biotechnology	Homo sapiens		NULL	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033443	c-Jun Antibody (H-79) from Santa Cruz Biotechnology	Homo sapiens	dexametasone	NULL	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033444	c-Jun Antibody (H-79) from Santa Cruz Biotechnology	Homo sapiens	compaund A	NULL	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033445	NF?B p65 Antibody (C-20) from Santa Cruz Biotechnology	Homo sapiens		NULL	2301	unspecified	Q04206	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033446	NF?B p65 Antibody (C-20) from Santa Cruz Biotechnology	Homo sapiens	dexametasone	NULL	2301	unspecified	Q04206	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033447	NF?B p65 Antibody (C-20) from Santa Cruz Biotechnology	Homo sapiens	compaund A	NULL	2301	unspecified	Q04206	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033448	Glucocorticoid Receptor (D8H2) XPÂ® Rabbit mAb #3660 from CST	Homo sapiens		NULL	2301	unspecified	P04150	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033449	Glucocorticoid Receptor (D8H2) XPÂ® Rabbit mAb #3660 from CST	Homo sapiens	dexametasone	NULL	2301	unspecified	P04150	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033450	Glucocorticoid Receptor (D8H2) XPÂ® Rabbit mAb #3660 from CST	Homo sapiens	compaund A	NULL	2301	unspecified	P04150	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP033451	none	Homo sapiens		NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP033452	none	Homo sapiens	NiCl2	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP033453	CTCF (Active Motif, 61311)	Homo sapiens		EXP033451	87	unspecified	P49711	BEAS-2B (bronchial epithelium)	NULL
EXP033454	CTCF (Active Motif, 61311)	Homo sapiens	NiCl2	EXP033452	87	unspecified	P49711	BEAS-2B (bronchial epithelium)	NULL
EXP033455	Rabbit IgG (in house purified)	Mus musculus		NULL	904	chip_control	NULL	myoblasts	NULL
EXP033456	mouse IgG (278-010, Ancell)	Mus musculus		NULL	904	chip_control	NULL	myoblasts	NULL
EXP033457	Rabbit anti c-Jun (sc-1694, Santa Cruz Biotechnology)	Mus musculus		EXP033455	904	unspecified	P05627	myoblasts	NULL
EXP033458	Runx1 (in house)	Mus musculus		EXP033456	904	unspecified	Q03347	myoblasts	NULL
EXP033459	Mouse anti MyoD (sc-32758, Santa Cruz Biotechnology)	Mus musculus		EXP033456	904	unspecified	P10085	myoblasts	NULL
EXP033460	Mouse anti MyoG (sc-12732, Santa Cruz Biotechnology)	Mus musculus		EXP033456	645	unspecified	P12979	myotubes	NULL
EXP033461	anti-IgG (rabbit, Santa Cruz, sc-2027)	Homo sapiens	Treatment: 2 hours of 10nM R1881 and EtOH; Time point: 2 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP033462	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033463	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: 2 hours of EtOH; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP033464	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP033465	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: siPIAS1 transefection and 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033466	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: siNON transefection and 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP033467	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: siPIAS1 transefection and 2 hours of 10nM R1881; Time point: 2 hours	EXP033461	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP033468	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus		NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP033469	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP033470	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP033471	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus		NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP033472	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP033473	IRF8 (in-house rabbit polyclonal anti-mouse IRF8 146-162aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP033474	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP033475	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP033476	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP033477	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus		NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP033478	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP033479	PU.1 (in-house rabbit polyclonal anti-mouse PU.1 1-100aa)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP033480	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033481	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 30 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033482	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 60 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033483	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033484	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 30 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033485	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta for 60 minutes	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033486	STAT1 (santa cruz, sc-592)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033487	STAT2 (santa crus, sc-950)	Mus musculus		NULL	81	unspecified	Q9WVL2	BMDM (bone marrow-derived macrophages)	NULL
EXP033488	STAT2 (santa crus, sc-950)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	Q9WVL2	BMDM (bone marrow-derived macrophages)	NULL
EXP033489	STAT2 (santa crus, sc-950)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	Q9WVL2	BMDM (bone marrow-derived macrophages)	NULL
EXP033490	IRF1 (santa cruz, sc-640)	Mus musculus		NULL	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP033491	IRF1 (santa cruz, sc-640)	Mus musculus	LPS 10ng/ml for 2 hours	NULL	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP033492	IRF1 (santa cruz, sc-640)	Mus musculus	LPS 10ng/ml for 4 hours	NULL	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP033493	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033494	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033495	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033496	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033497	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033498	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033499	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033500	STAT1 (santa cruz, sc-592)	Mus musculus	IFNbeta 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033501	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033502	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033503	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033504	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033505	STAT1 (santa cruz, sc-592)	Mus musculus		NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033506	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 1 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033507	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 2 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033508	STAT1 (santa cruz, sc-592)	Mus musculus	IFNgamma 100U/ml for 4 hour	NULL	81	unspecified	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP033509	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033510	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033511	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033512	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033513	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033514	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033515	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033516	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033517	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033518	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033519	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033520	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033521	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033522	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033523	AR	Homo sapiens		NULL	916	unspecified	P10275	prostate	NULL
EXP033524	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033525	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033526	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033527	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033528	AR	Homo sapiens		NULL	435	unspecified	P10275	prostate tumor	NULL
EXP033529	foxa1	Homo sapiens		NULL	435	unspecified	P55317	prostate tumor	NULL
EXP033530	hoxb13	Homo sapiens		NULL	435	unspecified	Q92826	prostate tumor	NULL
EXP033531	hoxb13	Homo sapiens		NULL	70	unspecified	Q92826	LNCaP (prostate carcinoma)	NULL
EXP033532	AR	Homo sapiens	FOXA1 overexpression	NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	NULL
EXP033533	AR	Homo sapiens	HOXB13 overexpression	NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	NULL
EXP033534	AR	Homo sapiens	HOXB13 and FOXA1 overexpression	NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	NULL
EXP033535	AR	Homo sapiens		NULL	544	unspecified	P10275	LHSAR (prostate epithelial cells)	NULL
EXP033536	anti OCT3 antibody	Homo sapiens		NULL	1143	unspecified	Q01860	iPSC (induced pluripotent stem cells)	NULL
EXP033537	anti SOX2 antibody	Homo sapiens		NULL	1143	unspecified	P48431	iPSC (induced pluripotent stem cells)	NULL
EXP033538	anti KLF4 antibody	Homo sapiens		NULL	1143	unspecified	O43474	iPSC (induced pluripotent stem cells)	NULL
EXP033539	normal goat serum (negative control)	Mus musculus		NULL	803	chip_control	NULL	spermatocytes	NULL
EXP033540	normal goat serum (negative control)	Mus musculus	heatshock_38C	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP033541	normal goat serum (negative control)	Mus musculus	heatshock_43C	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP033542	anti-HSF1 (cat. no SPA-901, Enzo)	Mus musculus		EXP033539	803	unspecified	P38532	spermatocytes	NULL
EXP033543	anti-HSF1 (cat. no SPA-901, Enzo)	Mus musculus	heatshock_38C	EXP033540	803	unspecified	P38532	spermatocytes	NULL
EXP033544	anti-HSF1 (cat. no SPA-901, Enzo)	Mus musculus	heatshock_43C	EXP033541	803	unspecified	P38532	spermatocytes	NULL
EXP033545	anti-HSF2 (cat. no AF5227, R&D Systems)	Mus musculus		EXP033539	803	unspecified	P38533	spermatocytes	NULL
EXP033546	anti-HSF2 (cat. no AF5227, R&D Systems)	Mus musculus	heatshock_38C	EXP033540	803	unspecified	P38533	spermatocytes	NULL
EXP033547	anti-HSF2 (cat. no AF5227, R&D Systems)	Mus musculus	heatshock_43C	EXP033541	803	unspecified	P38533	spermatocytes	NULL
EXP033548	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033549	NFYA: Santa-cruz, NF-YA (G-2)X, sc-17753X, Mouse monoclonal IgG2a	Mus musculus		EXP033548	2	unspecified	P23708	mESCs (mouse embryonic stem cells)	NULL
EXP033550	NFYB: Santa-cruz, NF-YB (FL-207)X, sc-13045X, Rabbit polyclonal	Mus musculus		EXP033548	2	unspecified	P63139	mESCs (mouse embryonic stem cells)	NULL
EXP033551	NFYC: Santa-cruz, NF-YC (N-19)X, sc-7715X, Rabbit polyclonal	Mus musculus		EXP033548	2	unspecified	P70353	mESCs (mouse embryonic stem cells)	NULL
EXP033552	None	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP033553	Arid3a Streptavidin-conjugated beads	Mus musculus	Arid3a overexpression high	EXP033552	506	unspecified	Q62431	J1 (embryonic stem cells)	NULL
EXP033554	Arid3a Streptavidin-conjugated beads	Mus musculus	Arid3a overexpression moderate	EXP033552	506	unspecified	Q62431	J1 (embryonic stem cells)	NULL
EXP033555	none	Mus musculus		NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP033556	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus		EXP033555	292	unspecified	P11416	F9 (embryonal carcinoma)	NULL
EXP033557	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus		EXP033555	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP033558	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus	all-trans retinoic acid 2h	NULL	292	unspecified	P11416	F9 (embryonal carcinoma)	NULL
EXP033559	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus	all-trans retinoic acid 2h	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP033560	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus	all-trans retinoic acid 24h	NULL	292	unspecified	P11416	F9 (embryonal carcinoma)	NULL
EXP033561	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus	all-trans retinoic acid 24h	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP033562	anti-panRAR (Santa Cruz, Sc-773)	Mus musculus	all-trans retinoic acid 48h	NULL	292	unspecified	P11416	F9 (embryonal carcinoma)	NULL
EXP033563	anti-panRXR (Santa Cruz, Sc-553)	Mus musculus	all-trans retinoic acid 48h	NULL	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP033564	none (input)	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP033565	Santa Cruz sc-13450, Lot D1911	Mus musculus		EXP033564	1153	unspecified	P42128	C2C12 (myoblasts)	NULL
EXP033566	none	Mus musculus	Standard Serum	NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP033567	sc-8628 X (Pou5f1)	Mus musculus	Standard Serum	EXP033566	521	unspecified	P20263	KH2 (embryonic stem cells)	NULL
EXP033568	sc-8628 X (Pou5f1)	Mus musculus	2i for 24 hours	EXP033566	521	unspecified	P20263	KH2 (embryonic stem cells)	NULL
EXP033569	REC-RCAB0002P-F (Nanog)	Mus musculus	GFP_high_Serum	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	NULL
EXP033570	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 24 hours_v3	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	NULL
EXP033571	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 24 hours	EXP033566	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP033572	REC-RCAB0002P-F (Nanog)	Mus musculus	Standard Serum	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	NULL
EXP033573	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 3 passages	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	NULL
EXP033574	REC-RCAB0002P-F (Nanog)	Mus musculus	2i for 24 hours_v1	EXP033566	521	unspecified	Q80Z64	KH2 (embryonic stem cells)	NULL
EXP033575	None	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033576	None	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033577	None	Mus musculus		NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP033578	None	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033579	ATRX	Mus musculus		EXP033575	12	unspecified	Q61687	MEF (mouse embryonic fibroblasts)	NULL
EXP033580	ATRX	Mus musculus		EXP033576	2	unspecified	Q61687	mESCs (mouse embryonic stem cells)	NULL
EXP033581	ATRX	Mus musculus		EXP033577	216	unspecified	Q61687	differentiated embryonic stem cells	NULL
EXP033582	ATRX	Mus musculus		EXP033578	12	unspecified	Q61687	MEF (mouse embryonic fibroblasts)	NULL
EXP033583	none	Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP033584	Smad4 R&D Systems, cat.# AF2097, Lot# KUH0311081	Mus musculus		EXP033583	561	unspecified	P97471	lung	NULL
EXP033585	none	Mus musculus		NULL	764	chip_control	NULL	R1 embryonic stem cell-derived neural progenitors	NULL
EXP033586	R&D hSOX3 (AF2569)	Mus musculus		EXP033585	764	unspecified	P53784	R1 embryonic stem cell-derived neural progenitors	NULL
EXP033587	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033588	rabbit polyclonal anti-E4F1	Mus musculus		EXP033587	2	unspecified	Q8CCE9	mESCs (mouse embryonic stem cells)	NULL
EXP033589	normal rabbit IgG (sc-2027, Santa Cruz)	Homo sapiens	0.1% DMSO for 1h	NULL	900	chip_control	NULL	hepatocytes	NULL
EXP033590	normal rabbit IgG (sc-2027, Santa Cruz)	Homo sapiens	0.1% DMSO + 5uM GW4064 for 1h	NULL	900	chip_control	NULL	hepatocytes	NULL
EXP033591	FXR (1:1 mixture of sc-1204x and sc-13063x, ChIP grade, Santa Cruz)	Homo sapiens	0.1% DMSO for 1h	EXP033589	900	unspecified	Q96RI1	hepatocytes	NULL
EXP033592	FXR (1:1 mixture of sc-1204x and sc-13063x, ChIP grade, Santa Cruz)	Homo sapiens	0.1% DMSO + 5uM GW4064 for 1h	EXP033590	900	unspecified	Q96RI1	hepatocytes	NULL
EXP033593	none	Mus musculus	none	NULL	713	chip_control	NULL	pancreas	NULL
EXP033594	GATA6	Mus musculus	none	EXP033593	713	unspecified	Q61169	pancreas	NULL
EXP033595	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033596	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033597	rabbit polyclonal anti-E4F1	Mus musculus		EXP033595	12	unspecified	Q8CCE9	MEF (mouse embryonic fibroblasts)	NULL
EXP033598	rabbit polyclonal anti-E4F1	Mus musculus		EXP033596	12	unspecified	Q8CCE9	MEF (mouse embryonic fibroblasts)	NULL
EXP033599	Upstate 12-370	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP033600	Upstate 07-633	Mus musculus		EXP033599	5	unspecified	P35583	liver	NULL
EXP033601	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	638	unspecified	P17433	multipotent hematopoietic progenitors	NULL
EXP033602	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	189	unspecified	P17433	common dendritic cell progenitors	NULL
EXP033603	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	104	unspecified	P17433	dendritic cells	NULL
EXP033604	PU.1 ( Santa Cruz, sc-352)	Mus musculus		NULL	312	unspecified	P17433	plasmacytoid dendritic cells	NULL
EXP033605		Mus musculus		NULL	711	chip_control	NULL	P6D4 (thymic lymphoma)	NULL
EXP033606		Mus musculus		NULL	28	chip_control	NULL	70Z/3 (leukemia)	NULL
EXP033607	rabbit anti-Miz-1 H-190	Mus musculus		EXP033605	711	unspecified	Q60821	P6D4 (thymic lymphoma)	NULL
EXP033608	rabbit anti-Miz-1 H-190	Mus musculus		EXP033606	28	unspecified	Q60821	70Z/3 (leukemia)	NULL
EXP033609	none (input)	Mus musculus		NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP033610	none (input)	Mus musculus	Sall4 flox/-	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033611	none (input)	Mus musculus	Sall4 KO	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033612	none (input)	Mus musculus	scrambled shRNA	NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP033613	none (input)	Mus musculus	shRNA of Tet1	NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP033614	SALL1 (Abcam, ab41974)	Mus musculus		EXP033609	839	unspecified	Q9ER74	TT2 (embryonic stem cells)	NULL
EXP033615	Polyclonal antibody against TET1 was raised in a rabbit.(PMID:21514197)	Mus musculus		EXP033609	839	unspecified	Q3URK3	TT2 (embryonic stem cells)	NULL
EXP033616	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	Sall4 flox/-	EXP033610	2	unspecified	Q8BX22	mESCs (mouse embryonic stem cells)	NULL
EXP033617	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	Sall4 KO	EXP033611	2	unspecified	Q8BX22	mESCs (mouse embryonic stem cells)	NULL
EXP033618	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	scrambled shRNA	EXP033612	839	unspecified	Q8BX22	TT2 (embryonic stem cells)	NULL
EXP033619	The monoclonal antibody against SALL4A was generated with the immunogenic peptide TSGPNSRDLM in mice at Abmart.	Mus musculus	shRNA of Tet1	EXP033613	839	unspecified	Q8BX22	TT2 (embryonic stem cells)	NULL
EXP033620	R&D AF3640 Lot # XVH0311061	Homo sapiens		NULL	463	unspecified	O43474	epidermal keratinocytes	NULL
EXP033621	Santa Cruz SC-30189 Lot # C2511	Homo sapiens		NULL	463	unspecified	Q9UKL0	epidermal keratinocytes	NULL
EXP033622	none	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP033623	TBP (Abcam ab28175)	Mus musculus		EXP033622	5	unspecified	P29037	liver	NULL
EXP033624	TBP (Abcam ab28175)	Mus musculus	Taf4-/-	EXP033622	5	unspecified	P29037	liver	NULL
EXP033625	HNF4A (Santa Cruz sc-8987 X)	Mus musculus		EXP033622	5	unspecified	P49698	liver	NULL
EXP033626	HNF4A (Santa Cruz sc-8987 X)	Mus musculus	Taf4-/-	EXP033622	5	unspecified	P49698	liver	NULL
EXP033627	CTCF ((Millipore 07-729)	Mus musculus		EXP033622	5	unspecified	Q61164	liver	NULL
EXP033628	CTCF ((Millipore 07-729)	Mus musculus	Taf4-/-	EXP033622	5	unspecified	Q61164	liver	NULL
EXP033629	HNF4A (Santa Cruz sc-8987 X)	Mus musculus		NULL	5	unspecified	P49698	liver	NULL
EXP033630	none	Homo sapiens	heat shock	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033631	none	Homo sapiens	none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033632	none	Homo sapiens	heat shock	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033633	none	Homo sapiens	none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033634	HSF1: Cell Signaling, 4356	Homo sapiens	none	EXP033631	417	unspecified	Q00613	HCT-116 (colon carcinoma)	NULL
EXP033635	HSF1: Cell Signaling, 4356	Homo sapiens	none	EXP033633	417	unspecified	Q00613	HCT-116 (colon carcinoma)	NULL
EXP033636	HSF1: Cell Signaling, 4356	Homo sapiens	heat shock	EXP033632	417	unspecified	Q00613	HCT-116 (colon carcinoma)	NULL
EXP033637	HSF1: Cell Signaling, 4356	Homo sapiens	heat shock	EXP033630	417	unspecified	Q00613	HCT-116 (colon carcinoma)	NULL
EXP033638	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033639	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033640	GATA4 (R&D system, AF2606, lot VAZ0312091)	Mus musculus		EXP033638	12	unspecified	Q08369	MEF (mouse embryonic fibroblasts)	NULL
EXP033641	GATA6 (R&D system, AF1700, lot KWT0112101)	Mus musculus		EXP033639	12	unspecified	Q61169	MEF (mouse embryonic fibroblasts)	NULL
EXP033642	none	Mus musculus		NULL	862	chip_control	NULL	WEHI-279 (lymphoma)	NULL
EXP033643	none	Mus musculus		NULL	862	chip_control	NULL	WEHI-279 (lymphoma)	NULL
EXP033644	Monoclonal ANTI-FLAG M2 (F3165 SIGMA)	Mus musculus		EXP033642	862	unspecified	P17433	WEHI-279 (lymphoma)	NULL
EXP033645	Monoclonal ANTI-FLAG M2 (F3165 SIGMA)	Mus musculus		EXP033643	862	unspecified	O35906	WEHI-279 (lymphoma)	NULL
EXP033646	none	Mus musculus		NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP033647	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033648	CTCF (Cell Signaling 2899)	Mus musculus		EXP033646	216	unspecified	Q61164	differentiated embryonic stem cells	NULL
EXP033649	CTCF (Cell Signaling 2899)	Mus musculus		EXP033647	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP033650	IgG control	Homo sapiens		NULL	45	chip_control	NULL	acute myeloblastic leukemia	NULL
EXP033651	IgG control	Homo sapiens	dexametasone	NULL	45	chip_control	NULL	acute myeloblastic leukemia	NULL
EXP033652	Cell Signaling 3660S	Homo sapiens		EXP033650	45	unspecified	P04150	acute myeloblastic leukemia	NULL
EXP033653	Cell Signaling 3660S	Homo sapiens	dexametasone	EXP033651	45	unspecified	P04150	acute myeloblastic leukemia	NULL
EXP033654	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP033655	none	Mus musculus	blt/blt	NULL	44	chip_control	NULL	T-cells	NULL
EXP033656	Zfp335/NIF1 (A300-797A, Bethyl Laboratories, lot no. A300-797A-1)	Mus musculus		EXP033654	44	unspecified	A2A5K6	T-cells	NULL
EXP033657	Zfp335/NIF1 (A300-797A, Bethyl Laboratories, lot no. A300-797A-1)	Mus musculus	blt/blt	EXP033655	44	unspecified	A2A5K6	T-cells	NULL
EXP033658	Zfp335/NIF1 (A300-798A, Bethyl Laboratories, lot no. A300-798A-1)	Mus musculus		EXP033654	44	unspecified	A2A5K6	T-cells	NULL
EXP033659	Zfp335/NIF1 (A300-798A, Bethyl Laboratories, lot no. A300-798A-1)	Mus musculus	blt/blt	EXP033655	44	unspecified	A2A5K6	T-cells	NULL
EXP033660		Homo sapiens		NULL	652	chip_control	NULL	NCI-H1993 (lung adenocarcinoma)	NULL
EXP033661		Homo sapiens		NULL	654	chip_control	NULL	NCI-H2347 (lung adenocarcinoma)	NULL
EXP033662	Polyclonal (goat) against full length His-EGFP	Homo sapiens		EXP033660	652	unspecified	P37231	NCI-H1993 (lung adenocarcinoma)	NULL
EXP033663	Polyclonal (goat) against full length His-EGFP	Homo sapiens		EXP033661	654	unspecified	P37231	NCI-H2347 (lung adenocarcinoma)	NULL
EXP033664	foxd	Mus musculus	Lif 2i	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033665	IgG (normal rabbit)	Mus musculus	-Lif -2i day 1	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP033666	IgG (normal rabbit)	Mus musculus	-Lif -2i day 3	NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP033667	sc-9081X	Mus musculus	Lif 2i	EXP033664	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP033668	sc-9081X	Mus musculus	-Lif -2i day 1	EXP033665	216	unspecified	P20263	differentiated embryonic stem cells	NULL
EXP033669	sc-9081X	Mus musculus	-Lif -2i day 3	EXP033666	206	unspecified	P20263	epiblast-like cells	NULL
EXP033670	M2 anti-Flag	Mus musculus	Lif 2i	EXP033664	2	unspecified	Q61060	mESCs (mouse embryonic stem cells)	NULL
EXP033671	M2 anti-Flag	Mus musculus	Lif 2i	EXP033666	206	unspecified	Q61060	epiblast-like cells	NULL
EXP033672	anti-SATB1	Rattus norvegicus		NULL	770	unspecified	Q5U2Y2	GC pituitary cells	NULL
EXP033674	anti-HA-tagged-Pit1wild	Rattus norvegicus	none	NULL	770	unspecified	P10037	GC pituitary cells	NULL
EXP033675	anti-HA-tagged-Pit1R27W1 mutant	Rattus norvegicus	none	NULL	770	unspecified	P10037	GC pituitary cells	NULL
EXP033676	anti-Oct4 (Abcam, catalog# ab19857)	Homo sapiens	none	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP033677	anti-Oct4 (Abcam, catalog# ab19857)	Homo sapiens	none	EXP033676	38	unspecified	Q01860	A549 (lung carcinoma)	NULL
EXP033678	none	Homo sapiens	none	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP033679	anti-AR (N20, Santa Cruz)	Homo sapiens	non-target siRNA	EXP033678	7	unspecified	P10275	22RV1 (prostate carcinoma)	NULL
EXP033680	anti-AR (N20, Santa Cruz)	Homo sapiens	siRNA targeting AR exon 7 to knock-down AR-FL	EXP033678	7	unspecified	P10275	22RV1 (prostate carcinoma)	NULL
EXP033681	anti-AR (N20, Santa Cruz)	Homo sapiens	siRNA targeting all AR isoforms	EXP033678	7	unspecified	P10275	22RV1 (prostate carcinoma)	NULL
EXP033682	none (input)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP033683	none (input)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP033684	none (input)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP033685	anti-FOXP1 (home-made)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	Q9H334	VCaP (prostate carcinoma)	NULL
EXP033686	anti-RUNX1 (Abcam, catalog ab23980)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	Q01196	VCaP (prostate carcinoma)	NULL
EXP033687	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against FOXA1; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033688	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against FOXP1; Time point: 24 hours; Genotype: FOXP1 knockdown	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033689	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against RUNX1; Time point: 24 hours; Genotype: RUNX1 knockdown	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033690	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033682	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP033691	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033683	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP033692	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033683	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033693	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033684	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP033694	anti-FOXA1 (Abcam, catalog ab23738)	Homo sapiens	Treatment: 24 hours of ethanol (vehicle); Time point: 24 hours; Genotype: FOXA1 knockdown	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP033695	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM, siRNA against FOXA1; Time point: 24 hours; Genotype: FOXA1 knockdown	EXP033684	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP033696	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours	EXP033682	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP033697	anti-AR (Santa Cruz, catalog H-280)	Homo sapiens	Treatment: 24 hours of DHT 10 nM; Time point: 24 hours	EXP033684	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP033698	anti-p53 (FL636 from SC-6243)	Homo sapiens	5FU for 12h	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033699	anti-p53 (FL636 from SC-6243)	Homo sapiens	5FU for 0h	NULL	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP033700	none	Homo sapiens	5FU for 6 hrs	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033701	p53-specific DO1	Homo sapiens	5FU for 6 hrs	EXP033700	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP033702	HA	Homo sapiens		NULL	753	unspecified	P10275	ovarian granulosa cells	NULL
EXP033703	HA	Homo sapiens	Insertion	NULL	753	unspecified	P10275	ovarian granulosa cells	NULL
EXP033704	androgen	Homo sapiens	Deletion	NULL	753	unspecified	P10275	ovarian granulosa cells	NULL
EXP033705	none	Homo sapiens		NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP033706	PU.1 SC-352 from SantaCruz	Homo sapiens		EXP033705	620	unspecified	P17947	monocyte-derived dendritic cells	NULL
EXP033707	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: 12 hours of 50 ÂµM mutational form of ERG inhibitory peptidomimetics; Time point: 12 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP033708	anti-ERG (Epitomics, 2805-1)	Homo sapiens	Treatment: 12 hours of 50 ÂµM functional form of ERG inhibitory peptidomimetics; Time point: 12 hours	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP033709	none	Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP033710	anti-ER-alpha (HC20)	Homo sapiens		EXP033709	583	unspecified	P03372	MCF10A (breast epithelial cells)	NULL
EXP033711	None	Mus musculus	none	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033712	None	Mus musculus	none	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP033713	anti-Meis1/2 (Santa Cruz Biotechnology, sc-10599X, lot# C2912)	Mus musculus	none	EXP033711	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	NULL
EXP033714	anti-Prep1(N-15X) (Santa Cruz Biotechnology, sc-6245X, lot# F2003)	Mus musculus	none	EXP033711	12	unspecified	O70477	MEF (mouse embryonic fibroblasts)	NULL
EXP033715	anti-Meis1/2 (Santa Cruz Biotechnology, sc-10599X, lot# C2912)	Mus musculus	none	EXP033712	12	unspecified	Q60954	MEF (mouse embryonic fibroblasts)	NULL
EXP033716	Prep1(N-15X) (Santa Cruz Biotechnology, sc-6245X, lot# F2003)	Mus musculus	none	EXP033712	12	unspecified	O70477	MEF (mouse embryonic fibroblasts)	NULL
EXP033717	N/A	Homo sapiens		NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP033718	N/A	Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP033719	ETS1 (Santa Cruz, sc-350, lot #F2811)	Homo sapiens		EXP033717	223	unspecified	P14921	DU145 (prostate carcinoma)	NULL
EXP033720	ELF1 (Santa Cruz, sc-631, lot #L2702)	Homo sapiens		EXP033717	223	unspecified	P32519	DU145 (prostate carcinoma)	NULL
EXP033721	ELK4 (Santa Cruz, sc-1426, lot #G2711)	Homo sapiens		EXP033717	223	unspecified	P28324	DU145 (prostate carcinoma)	NULL
EXP033722	GABPA (Santa Cruz, sc-13442, lot #B2009)	Homo sapiens		EXP033717	223	unspecified	Q06546	DU145 (prostate carcinoma)	NULL
EXP033723	JUND (Santa Cruz, sc-74, lot #K1111)	Homo sapiens		EXP033717	223	unspecified	P17535	DU145 (prostate carcinoma)	NULL
EXP033724	ETS1 (Santa Cruz, sc-350, lot #F1312)	Homo sapiens		EXP033718	712	unspecified	P14921	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP033725	Anti-p53, clone DO-1	Homo sapiens		NULL	113	unspecified	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033726	Anti-p53, clone DO-1	Homo sapiens		NULL	588	unspecified	P04637	MDA-MB-175VII (invasive ductal carcinoma)	NULL
EXP033727	Anti-p53, clone DO-1	Homo sapiens		NULL	591	unspecified	P04637	MDA-MB-468 (breast adenocarcinoma)	NULL
EXP033728	Anti-p53, clone DO-1	Homo sapiens		NULL	412	unspecified	P04637	HCC70 (ductal breast carcinoma)	NULL
EXP033729	Anti-p53, clone DO-1	Homo sapiens		NULL	120	unspecified	P04637	BT-549 (breast invasive ductal carcinoma)	NULL
EXP033730	none	Homo sapiens	BI8622	NULL	188	chip_control	NULL	LS174T (colon adenocarcinoma)	NULL
EXP033731	none	Homo sapiens	DMSO	NULL	188	chip_control	NULL	LS174T (colon adenocarcinoma)	NULL
EXP033732	10E2	Homo sapiens	BI8622	EXP033730	188	unspecified	Q13105	LS174T (colon adenocarcinoma)	NULL
EXP033733	sc764	Homo sapiens	BI8622	EXP033730	188	unspecified	P01106	LS174T (colon adenocarcinoma)	NULL
EXP033734	10E2	Homo sapiens	DMSO	EXP033731	188	unspecified	Q13105	LS174T (colon adenocarcinoma)	NULL
EXP033735	sc764	Homo sapiens	DMSO	EXP033731	188	unspecified	P01106	LS174T (colon adenocarcinoma)	NULL
EXP033736	pAb	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033737	IgG	Mus musculus	doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033738	pAb	Mus musculus	doxycycline	EXP033736	2	unspecified	P41163	mESCs (mouse embryonic stem cells)	NULL
EXP033739	V5	Mus musculus		EXP033737	2	unspecified	P41163	mESCs (mouse embryonic stem cells)	NULL
EXP033740	sc-9550 and sc-9549	Mus musculus		NULL	5	unspecified	O08750	liver	NULL
EXP033741	sc-6062	Mus musculus		NULL	5	unspecified	P51448	liver	NULL
EXP033742	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033743	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033744	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033745	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033746	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033747	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033748	None	Mus musculus	none	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033749	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033742	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	NULL
EXP033750	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033743	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	NULL
EXP033751	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033744	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	NULL
EXP033752	anti-FLAG M2 antibody (Sigma #F3165)	Mus musculus	none	EXP033745	2	unspecified	Q61079	mESCs (mouse embryonic stem cells)	NULL
EXP033753	anti-Oct3/4 (N-19) (Santa Cruz #sc-8628)	Mus musculus	none	EXP033746	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP033754	anti-Nanog (D2A3) XPÂ® (Cell Signaling #8822)	Mus musculus	none	EXP033746	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP033755	anti-Sox2 (Santa Cruz #sc-17320)	Mus musculus	none	EXP033747	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP033756	anti-Med1 (CRSP1/TRAP220) (Bethyl #A300-793A)	Mus musculus	none	EXP033748	2	unspecified	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP033757	anti-Med12 (Bethyl #A300-774A)	Mus musculus	none	EXP033748	2	unspecified	A2AGH6	mESCs (mouse embryonic stem cells)	NULL
EXP033758	NA	Homo sapiens	none	NULL	754	chip_control	NULL	ICN12 (primary pre-B acute lymphomablastic leukemia)	NULL
EXP033759	NA	Homo sapiens	none	NULL	754	chip_control	NULL	ICN12 (primary pre-B acute lymphomablastic leukemia)	NULL
EXP033760	anti-BCL6 (rabbit 4242, Cell Signalling)	Homo sapiens	none	EXP033758	754	unspecified	P41182	ICN12 (primary pre-B acute lymphomablastic leukemia)	NULL
EXP033761	anti-E2A (rabbit sc-888, Santa Cruz)	Homo sapiens	none	EXP033758	754	unspecified	P15923	ICN12 (primary pre-B acute lymphomablastic leukemia)	NULL
EXP033762	anti-PBX1 (rabbit, Roeder Lab)	Homo sapiens	none	EXP033759	754	unspecified	P40424	ICN12 (primary pre-B acute lymphomablastic leukemia)	NULL
EXP033763	None	Homo sapiens	none	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP033764	None	Homo sapiens	none	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP033765	None	Homo sapiens	none	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP033766	None	Homo sapiens	none	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP033767	None	Homo sapiens	none	NULL	621	chip_control	NULL	MOLT3 (adult T acute lymphoblastic leukemia)	NULL
EXP033768	anti-MYB (Millipore 05-175)	Homo sapiens	none	EXP033763	509	unspecified	P10242	Jurkat (T-cells)	NULL
EXP033769	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033763	509	unspecified	P10242	Jurkat (T-cells)	NULL
EXP033770	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033765	509	unspecified	P10242	Jurkat (T-cells)	NULL
EXP033771	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033764	509	unspecified	P10242	Jurkat (T-cells)	NULL
EXP033772	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033766	509	unspecified	P10242	Jurkat (T-cells)	NULL
EXP033773	anti-MYB (ab45150, Abcam)	Homo sapiens	none	EXP033767	621	unspecified	P10242	MOLT3 (adult T acute lymphoblastic leukemia)	NULL
EXP033774	anti-Tal-1 (Santa Cruz SC-12984)	Homo sapiens	none	EXP033767	621	unspecified	P17542	MOLT3 (adult T acute lymphoblastic leukemia)	NULL
EXP033775	anti-Tal-1 (Santa Cruz SC-12984)	Homo sapiens	none	NULL	154	unspecified	P17542	CD133+ umbilical cord blood cells	NULL
EXP033776	None (input)	Homo sapiens	differentiaiton inductors	NULL	439	chip_control	NULL	hMADS-3 (adipose-derived stem cells)	NULL
EXP033777	None (input)	Homo sapiens	differentiaiton inductors	NULL	439	chip_control	NULL	hMADS-3 (adipose-derived stem cells)	NULL
EXP033778	anti-KLF11 (10D8; Novus Biologicals)	Homo sapiens	differentiaiton inductors	EXP033776	439	unspecified	O14901	hMADS-3 (adipose-derived stem cells)	NULL
EXP033779	anti-KLF11 (10D8; Novus Biologicals)	Homo sapiens	differentiaiton inductors	EXP033777	439	unspecified	O14901	hMADS-3 (adipose-derived stem cells)	NULL
EXP033780	anti-PPAR? (H-100, sc-7196; Santa Cruz)	Homo sapiens	differentiaiton inductors	EXP033776	439	unspecified	P37231	hMADS-3 (adipose-derived stem cells)	NULL
EXP033781	anti-PPAR? (H-100, sc-7196; Santa Cruz)	Homo sapiens	differentiaiton inductors	EXP033777	439	unspecified	P37231	hMADS-3 (adipose-derived stem cells)	NULL
EXP033782	None (Input)	Mus musculus	none	NULL	5	chip_control	NULL	liver	NULL
EXP033783	None (Input)	Mus musculus	none	NULL	5	chip_control	NULL	liver	NULL
EXP033784	None (Input)	Mus musculus	none	NULL	5	chip_control	NULL	liver	NULL
EXP033785	None (Input)	Mus musculus	prednisolone	NULL	5	chip_control	NULL	liver	NULL
EXP033786	None (Input)	Mus musculus	none	NULL	5	chip_control	NULL	liver	NULL
EXP033787	None (Input)	Mus musculus	prednisolone	NULL	5	chip_control	NULL	liver	NULL
EXP033788	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033783	5	unspecified	P06537	liver	NULL
EXP033789	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033784	5	unspecified	P06537	liver	NULL
EXP033790	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	prednisolone	EXP033785	5	unspecified	P06537	liver	NULL
EXP033791	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033782	5	unspecified	P06537	liver	NULL
EXP033792	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	none	EXP033786	5	unspecified	P06537	liver	NULL
EXP033793	anti-GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Mus musculus	prednisolone	EXP033787	5	unspecified	P06537	liver	NULL
EXP033794	anti-C/EBPb, sc-150, Santa Cruz	Mus musculus	none	EXP033786	5	unspecified	P28033	liver	NULL
EXP033795	anti-C/EBPb, sc-150, Santa Cruz	Mus musculus	none	EXP033782	5	unspecified	P28033	liver	NULL
EXP033796	anti-C/EBPb, sc-150, Santa Cruz	Mus musculus	prednisolone	EXP033787	5	unspecified	P28033	liver	NULL
EXP033797	anti-GR, sc-1004, Santa Cruz	Mus musculus	dexamethasone and (or) lipopolysaccharide	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP033798	anti-GR, sc-1004, Santa Cruz	Mus musculus	dexamethasone and (or) lipopolysaccharide	EXP033797	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP033799	anti-GR, sc-1004, Santa Cruz	Mus musculus	dexamethasone and (or) lipopolysaccharide	EXP033797	81	unspecified	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP033800	Input control	Homo sapiens	differentiation stimulation	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP033801	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP033802	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP033803	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP033804	anti-p63 (H129, Santa Cruz)	Homo sapiens	differentiation stimulation	EXP033800	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP033805	normal goat IgG	Mus musculus	none	NULL	602	chip_control	NULL	erythroleukemic cells	NULL
EXP033806	anti-Gfi-1B Antibody (D-19)	Mus musculus	none	EXP033805	602	unspecified	O70237	erythroleukemic cells	NULL
EXP033807	none (input)	Homo sapiens	none	NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP033808	anti-BCL6 (Santa Cruz, sc-858)	Homo sapiens	none	EXP033807	881	unspecified	P41182	CD4+ T-cells	NULL
EXP033809	HA antibody, Clone 7	Homo sapiens	hypoxia and DMOG for 16 hrs	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP033810	anti-HIF-1a(Ab-2185, Abcam)	Homo sapiens	hypoxia and DMOG for 16 hrs	EXP033809	111	unspecified	Q16665	T47D (invasive ductal carcinoma)	NULL
EXP033811	anti-HIF-1b(Ab-2, Abcam)	Homo sapiens	hypoxia and DMOG for 16 hrs	EXP033809	111	unspecified	Q9Y2N7	T47D (invasive ductal carcinoma)	NULL
EXP033812	anti-NRF1 (AB55744, Abcam)	Homo sapiens	hypoxia and DMOG for 16 hrs	EXP033809	111	unspecified	Q16656	T47D (invasive ductal carcinoma)	NULL
EXP033813	none	Mus musculus	10 ug/ml curdlan for 30 min (control)	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP033814	anti-V5 antibody	Mus musculus	10 ug/ml curdlan for 30 min	EXP033813	104	unspecified	Q60591	dendritic cells	NULL
EXP033815	anti-FLAG M2 antibody (anti-HES-1; F1804, SIGMA)	Homo sapiens	none	NULL	820	unspecified	Q14469	SW1353 (chondrosarcoma)	NULL
EXP033816	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033817	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033818	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033819	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033820	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033821	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033822	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033823	anti-HNF6, sc-13050	Mus musculus	none	NULL	5	unspecified	O08755	liver	NULL
EXP033824	anti-RUNX1, Ab23980	Homo sapiens		NULL	45	unspecified	Q01196	acute myeloblastic leukemia	NULL
EXP033825	anti-C/EBPA, sc-61X lot C1510	Homo sapiens		NULL	516	unspecified	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP033826	anti-C/EBPA, sc-61X lot C1510	Homo sapiens	RUNX1/ETO knockdown	NULL	516	unspecified	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP033827	anti-PU.1 (Santa Cruz, sc-352x)	Homo sapiens		NULL	516	unspecified	P17947	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP033828	anti-PU.1 (Santa Cruz, sc-352x)	Homo sapiens	RUNX1/ETO knockdown	NULL	516	unspecified	P17947	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP033829	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033830	anti-GFP, RbIgG, Abcam ab290	Mus musculus		EXP033829	734	unspecified	Q60636	primordial germ cell-like cells	NULL
EXP033831	anti-GFP, RbIgG, Abcam ab290	Mus musculus		EXP033829	734	unspecified	Q60636	primordial germ cell-like cells	NULL
EXP033832	none (input)	Homo sapiens	none	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP033833	none (input)	Mus musculus	none	NULL	748	chip_control	NULL	lymphoma	NULL
EXP033834	none (input)	Mus musculus	none	NULL	748	chip_control	NULL	lymphoma	NULL
EXP033835	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Homo sapiens	shControl	EXP033832	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP033836	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Homo sapiens	shTerc	EXP033832	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP033837	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Homo sapiens	shTert	EXP033832	708	unspecified	P01106	P493-6 (B-cell lymphoma)	NULL
EXP033838	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Mus musculus	none	EXP033833	748	unspecified	P01108	lymphoma	NULL
EXP033839	c-Myc Antibody (N-262) (Santa Cruz, catalog# sc-764, lot# D0413)	Mus musculus	none	EXP033834	748	unspecified	P01108	lymphoma	NULL
EXP033840	CTCF, Millipore #07-729	Mus musculus		NULL	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP033841	CTCF, Millipore #07-729	Mus musculus		NULL	2	unspecified	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP033842	CTCF, Millipore #07-729	Mus musculus		NULL	180	unspecified	Q61164	motor neurons	NULL
EXP033843	CTCF, Millipore #07-729	Mus musculus		NULL	180	unspecified	Q61164	motor neurons	NULL
EXP033844	none	Mus musculus	4 hours after the initiation of CIP	NULL	716	chip_control	NULL	pancreatic tissue	NULL
EXP033845	Anti-ATF3 (cat#sc-188 Santa Cruz)	Mus musculus	4 hours after the initiation of CIP	EXP033844	716	unspecified	Q60765	pancreatic tissue	NULL
EXP033846	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP033847	Anti-p53 AB7 (Calbiochem)	Homo sapiens		EXP033846	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP033848	Anti-p53 AB7 (Calbiochem)	Homo sapiens		EXP033846	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP033849	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033850	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)g	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033851	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033852	GATA3, Santa Cruz Biotech, SC-268	Homo sapiens	1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033853	AP2g, Santa Cruz Biotech, SC-8977	Homo sapiens	1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033854	ERa, Santa Cruz Biotech, SC-12915-R	Homo sapiens	shCTL, 1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033855	ERa, Santa Cruz Biotech, SC-12915-R	Homo sapiens	shRARs, 1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033856	FOXA1, Abcam, ab5089	Homo sapiens	1hr treatment with vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033857	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	1hr treatment with 100nM E2	EXP033849	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033858	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	no treatment with doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033859	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033860	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033861	RARa, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P10276	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033862	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033863	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033864	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 1Î¼M RA and 100nM E2	NULL	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033865	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	EXP033850	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033866	RARg, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	EXP033851	113	unspecified	P13631	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033867	GATA3, Santa Cruz Biotech, SC-268	Homo sapiens	1hr treatment with 100nM E2	EXP033852	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033868	Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033869	GATA3, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033870	GATA3, Biotin-ChIP using Streptavidin Magnetic beads (Solulink)	Homo sapiens	24hrs treatment with 2Î¼g/ml doxycycline, 1hr treatment with 100nM E2	NULL	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033871	AP2g, Santa Cruz Biotech, SC-8977	Homo sapiens	1hr treatment with 100nM E2	EXP033853	113	unspecified	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033872	ERa, Santa Cruz Biotech, SC-12915-R	Homo sapiens	shCTL, 1hr treatment with 100nM E2	EXP033854	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033873	ERa, Santa Cruz Biotech, SC-12915-R	Homo sapiens	shRARs, 1hr treatment with 100nM E2	EXP033855	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033874	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	shCTL, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033875	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	shRARs, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033876	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siCTL, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033877	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siGATA3, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033878	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siCTL, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033879	ERa, Santa Cruz Biotech, SC-543	Homo sapiens	siFoxA1, 1hr treatment with 100nM E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033880	FOXA1, Abcam, ab5089	Homo sapiens	1hr treatment with 100nM E2	NULL	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033881	anti-RARa (Diagenode C15310155)	Mus musculus		NULL	76	unspecified	P11416	Th1-cells	NULL
EXP033882	none	Homo sapiens		NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP033883	anti-PROX1 goat antibody (R&D Systems)	Homo sapiens		EXP033882	821	unspecified	Q92786	SW480 (colon adenocarcinoma)	NULL
EXP033884	Foxa2-specific rabbit antiserum, WRAB-1200	Mus musculus		NULL	5	unspecified	P35583	liver	NULL
EXP033885	Foxa2-specific rabbit antiserum, WRAB-1200	Mus musculus		NULL	5	unspecified	P35583	liver	NULL
EXP033886	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033887	Jarid2 (Abcam, ab48137)	Mus musculus		EXP033886	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP033888	Jarid2 (Abcam, ab48137)	Mus musculus		NULL	2	unspecified	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP033889	none	Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP033890	Rabbit polyclonal antibodies to DMRT6(DMRTB1)	Mus musculus		EXP033889	32	unspecified	A2A9I7	testis	NULL
EXP033891	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP033892	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP033893	Foxo1 antibody (Abcam, Ab39670)	Mus musculus		EXP033891	1058	unspecified	Q9R1E0	CD4+ T-cells	NULL
EXP033894	Strepdavidin	Mus musculus		EXP033892	1058	unspecified	Q9R1E0	CD4+ T-cells	NULL
EXP033895	ERG, sc-353x	Homo sapiens	none	NULL	838	unspecified	P11308	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033896	ERG	Homo sapiens	1 um ATRA for 24 hrs	NULL	838	unspecified	P11308	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033897	RARa, A704, Diagenode	Homo sapiens	none	NULL	838	unspecified	P10276	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033898	Fli-1, sc-356	Homo sapiens	none	NULL	838	unspecified	Q01543	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033899	RXR, sc-774x	Homo sapiens	none	NULL	838	unspecified	P19793	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033900	RUNX1, ab23980	Homo sapiens	none	NULL	838	unspecified	Q01196	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033901	GATA2, sc-9008	Homo sapiens	none	NULL	838	unspecified	P23769	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033902	LYL1, sc-374164x	Homo sapiens	none	NULL	838	unspecified	P12980	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033903	TAL1, sc-12984x	Homo sapiens	none	NULL	838	unspecified	P17542	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033904	SPI1/PU.1, sc-352x	Homo sapiens	none	NULL	838	unspecified	P17947	TSU-1621-MT (adult acute myeloid leukemia)	NULL
EXP033905	chip antibody: anti-CTCF	Mus musculus	FACS sorted naive CD4+T cells cultured in vitro for 7 days under Th1 condition	NULL	76	unspecified	Q61164	Th1-cells	NULL
EXP033906	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033907	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033908	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	558	unspecified	P03372	LTED (breast cancer)	NULL
EXP033909	ERa antibody (HC-20) (Santa Cruz, catalog# sc-543)	Homo sapiens	none	NULL	558	unspecified	P03372	LTED (breast cancer)	NULL
EXP033910	none (input)	Homo sapiens	none	NULL	397	chip_control	NULL	H9-derived endodermal progenitors	NULL
EXP033911	none (input)	Homo sapiens	none	NULL	398	chip_control	NULL	H9-derived mesodermal progenitors	NULL
EXP033912	BRACHYURY (R&D systems, AF2085)	Homo sapiens	none	EXP033910	397	unspecified	O15178	H9-derived endodermal progenitors	NULL
EXP033913	BRACHYURY (R&D systems, AF2085)	Homo sapiens	none	EXP033911	398	unspecified	O15178	H9-derived mesodermal progenitors	NULL
EXP033914	BRACHYURY (Santa Cruz, sc-20109)	Homo sapiens	none	EXP033910	397	unspecified	O15178	H9-derived endodermal progenitors	NULL
EXP033915	BRACHYURY (Santa Cruz, sc-20109)	Homo sapiens	none	EXP033911	398	unspecified	O15178	H9-derived mesodermal progenitors	NULL
EXP033916	anti-MITF (ab12039, abcam)	Homo sapiens	none	NULL	601	unspecified	O75030	melanocytes	NULL
EXP033917	anti-MITF (ab12039, abcam)	Homo sapiens	none	NULL	601	unspecified	O75030	melanocytes	NULL
EXP033918	Hey-1	Mus musculus	none	NULL	639	unspecified	Q9WV93	CM7/1 (embryonic stem cells)	NULL
EXP033919	Hey-1	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	639	unspecified	Q9WV93	CM7/1 (embryonic stem cells)	NULL
EXP033920	Hey-2	Mus musculus	none	NULL	639	unspecified	Q9QUS4	CM7/1 (embryonic stem cells)	NULL
EXP033921	Hey-2	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	639	unspecified	Q9QUS4	CM7/1 (embryonic stem cells)	NULL
EXP033922	Hey-1	Mus musculus	none	NULL	497	unspecified	Q9WV93	CM7/1-derived cardiomyocytes	NULL
EXP033923	Hey-1	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	497	unspecified	Q9WV93	CM7/1-derived cardiomyocytes	NULL
EXP033924	Hey-2	Mus musculus	none	NULL	497	unspecified	Q9QUS4	CM7/1-derived cardiomyocytes	NULL
EXP033925	Hey-2	Mus musculus	50 ng/ml doxycycline for 48 hrs	NULL	497	unspecified	Q9QUS4	CM7/1-derived cardiomyocytes	NULL
EXP033926	none (input)	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP033927	none (input)	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP033928	total rabbit IgG, Millipore, Cat. #12-370	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP033929	total rabbit IgG, Millipore, Cat. #12-370	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP033930	anti-Zic 1/2 C-terminus	Mus musculus	none	EXP033926	25	unspecified	P46684	cerebellum	NULL
EXP033931	anti-Zic 1/2 C-terminus	Mus musculus	none	EXP033927	25	unspecified	P46684	cerebellum	NULL
EXP033932	none (control sample composed -Input)	Homo sapiens	none	NULL	269	chip_control	NULL	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP033933	anti-Gata2	Homo sapiens	none (vehicle)	EXP033932	269	unspecified	P23769	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP033934	anti-Gata2, sc-9008	Homo sapiens	ACY-957 (HDAC1/2 selective inhibitor)	EXP033932	269	unspecified	P23769	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP033935	none	Homo sapiens	none	NULL	465	chip_control	NULL	HaCaT (keratinocytes)	NULL
EXP033936	p63, H-129, Santa Cruz	Homo sapiens	Ad-LacZ	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	NULL
EXP033937	p63, H-129, Santa Cruz	Homo sapiens	Ad-LacZ and 3 ng/ml of TGF-beta3 for 1.5 hrs	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	NULL
EXP033938	p63, H-129, Santa Cruz	Homo sapiens	Ad-caRAS and 3 ng/ml of TGF-beta3 for 1.5 hrs	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	NULL
EXP033939	p63, H-129, Santa Cruz	Homo sapiens	Ad-dnRAS and 3 ng/ml of TGF-beta3 for 1.5 hrs	EXP033935	465	unspecified	Q9H3D4	HaCaT (keratinocytes)	NULL
EXP033940	anti-ASH2 (Bethyl Laboratories, A300-489A)	Homo sapiens	Treatment: vehicle; Time point: 12 hours; Conditions: cells were grown in 5% charcoal-stripped serum containing media for 48 hours	NULL	71	normal	Q99929	VCaP (prostate carcinoma)	NULL
EXP033941	anti-ASH2 (Bethyl Laboratories, A300-489A)	Homo sapiens	Treatment: 12 hours of 100nM R1881; Time point: 12 hours; Conditions: cells were grown in 5% charcoal-stripped serum containing media for 48 hours	NULL	71	normal	Q99929	VCaP (prostate carcinoma)	NULL
EXP033942	none	Mus musculus	none	NULL	173	chip_control	NULL	preantral follicles	NULL
EXP033943	anti-FOXL2 C-terminal antibody (from lab)	Mus musculus	none	EXP033942	173	unspecified	O88470	preantral follicles	NULL
EXP033944	input	Homo sapiens	Vehicle	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033945	input	Homo sapiens	E2	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033946	input	Homo sapiens	TNFa	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033947	input	Homo sapiens	E2+TNFa	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033948	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa, siCTRL	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033949	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa, siFOXA1	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033950	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	Vehicle	EXP033944	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033951	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2	EXP033945	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033952	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	TNFa	EXP033946	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033953	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa	EXP033947	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033954	p65  (Abcam ab7970)	Homo sapiens	Vehicle	EXP033944	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033955	p65  (Abcam ab7970)	Homo sapiens	E2	EXP033945	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033956	p65  (Abcam ab7970)	Homo sapiens	TNFa	EXP033946	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033957	p65  (Abcam ab7970)	Homo sapiens	E2+TNFa	EXP033947	113	unspecified	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033958	FoxA1 (Abcam ab23738)	Homo sapiens	Vehicle	EXP033944	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033959	FoxA1 (Abcam ab23738)	Homo sapiens	E2	EXP033945	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033960	FoxA1 (Abcam ab23738)	Homo sapiens	TNFa	EXP033946	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033961	FoxA1 (Abcam ab23738)	Homo sapiens	E2+TNFa	EXP033947	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033962	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa, siCTRL	EXP033948	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033963	ER alpha (rabbit polyclonal generated in the Kraus Lab)	Homo sapiens	E2+TNFa, siFOXA1	EXP033949	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP033964	CTCF Millipore #07-729	Mus musculus	TFII-I KD	NULL	861	unspecified	Q61164	WEHI-231 (lymphoma )	NULL
EXP033965	CTCF Millipore #07-729	Mus musculus		NULL	861	unspecified	Q61164	WEHI-231 (lymphoma )	NULL
EXP033966	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP033967	anti-HSF1	Homo sapiens	heat shock at 43C for 10 minutes	EXP033966	848	unspecified	Q00613	U2OS (osteosarcoma)	NULL
EXP033968	anti-HSF1	Homo sapiens	heat shock at 43C for 20 minutes	EXP033966	848	unspecified	Q00613	U2OS (osteosarcoma)	NULL
EXP033969	none	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP033970	none	Mus musculus		NULL	295	chip_control	NULL	CD4+, CD8+, CD3low thymocytes	NULL
EXP033971	none	Mus musculus		NULL	294	chip_control	NULL	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25+, CD44- thymocytes	NULL
EXP033972	none	Mus musculus		NULL	293	chip_control	NULL	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25-, CD44- thymocytes	NULL
EXP033973	Ikaros	Mus musculus		EXP033969	171	unspecified	Q03267	CD4+ CD8+ T cells	NULL
EXP033974	Ikaros	Mus musculus		EXP033971	294	unspecified	Q03267	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25+, CD44- thymocytes	NULL
EXP033975	Ikaros	Mus musculus		EXP033972	293	unspecified	Q03267	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25-, CD44- thymocytes	NULL
EXP033976	Ikaros	Mus musculus		EXP033970	295	unspecified	Q03267	CD4+, CD8+, CD3low thymocytes	NULL
EXP033977	anti-Mta2 (ab8106, Abcam)	Mus musculus		EXP033971	294	unspecified	Q9R190	CD4-, CD8-, CD3-, B220-, CD11b-, Gr1-, NK1.1-, CD25+, CD44- thymocytes	NULL
EXP033978	no antibody	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP033979	Zic3 (Abcam, ab80966)	Mus musculus		EXP033978	2	unspecified	Q62521	mESCs (mouse embryonic stem cells)	NULL
EXP033980	Zic2 (Abcam, ab150404)	Mus musculus		EXP033978	2	unspecified	Q62520	mESCs (mouse embryonic stem cells)	NULL
EXP033981	anti-HA	Mus musculus		NULL	23	chip_control	NULL	416B (hematopoietic precursor cells)	NULL
EXP033982	anti-HA	Mus musculus		EXP033981	23	unspecified	P17433	416B (hematopoietic precursor cells)	NULL
EXP033983	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	NULL
EXP033984	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	NULL
EXP033985	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	842	unspecified	P50553	non-small cell lung carcinoma	NULL
EXP033986	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	NULL
EXP033987	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	NULL
EXP033988	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	842	unspecified	P50553	non-small cell lung carcinoma	NULL
EXP033989	mouse anti-ASCL1,BD Pharmigen, cat# 556604	Homo sapiens		NULL	841	unspecified	P50553	small cell lung carcinoma	NULL
EXP033990		Mus musculus	high slug expression	NULL	619	chip_control	NULL	MMTV-PyMT breast cancer cells	NULL
EXP033991		Mus musculus	high snail expression	NULL	619	chip_control	NULL	MMTV-PyMT breast cancer cells	NULL
EXP033992	Slug (C19G7) Rabbit mAb	Mus musculus	high slug expression	EXP033990	619	unspecified	P97469	MMTV-PyMT breast cancer cells	NULL
EXP033993	Anti-SNAIL + SLUG antibody	Mus musculus	high snail expression	EXP033991	619	unspecified	Q02085	MMTV-PyMT breast cancer cells	NULL
EXP033994		Mus musculus		NULL	14	chip_control	NULL	3134 (mammary adenocarcinoma)	NULL
EXP033995		Mus musculus	cort for 20min	NULL	14	chip_control	NULL	3134 (mammary adenocarcinoma)	NULL
EXP033996		Mus musculus	cort pulsed 60min	NULL	14	chip_control	NULL	3134 (mammary adenocarcinoma)	NULL
EXP033997		Mus musculus	cort constant 60min	NULL	14	chip_control	NULL	3134 (mammary adenocarcinoma)	NULL
EXP033998	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus		EXP033994	14	unspecified	P06537	3134 (mammary adenocarcinoma)	NULL
EXP033999	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus	cort for 20min	EXP033995	14	unspecified	P06537	3134 (mammary adenocarcinoma)	NULL
EXP034000	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus	cort pulsed 60min	EXP033996	14	unspecified	P06537	3134 (mammary adenocarcinoma)	NULL
EXP034001	GR Antibody; PA-510A; PA-511A; sc-1004	Mus musculus	cort constant 60min	EXP033997	14	unspecified	P06537	3134 (mammary adenocarcinoma)	NULL
EXP034002	Millipore 07-729	Mus musculus		EXP033994	14	unspecified	Q61164	3134 (mammary adenocarcinoma)	NULL
EXP034003	none	Mus musculus		NULL	95	chip_control	NULL	E12.5 embryonic heart	NULL
EXP034004	anti-HIF1a	Mus musculus		EXP034003	95	unspecified	Q61221	E12.5 embryonic heart	NULL
EXP034005	input	Homo sapiens	FBS	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034006	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control Ethl	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034007	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control R1881	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034008	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR Ethl	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034009	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR R1881	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034010	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control knockdown Ethl	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP034011	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	control knockdown R1881	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP034012	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR knockdown Ethl	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP034013	AR (Millipore; catalog: 06-680; lot number: 2328016	Homo sapiens	HOTAIR knockdown R1881	NULL	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP034014	IgG	Homo sapiens		NULL	192	chip_control	NULL	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP034015	Santa Cruz sc-1694	Homo sapiens		EXP034014	192	unspecified	P05412	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP034016	Santa Cruz sc-74	Homo sapiens		EXP034014	192	unspecified	P17535	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP034017	Sigma HPA013189	Homo sapiens		EXP034014	192	unspecified	O43680	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP034018	Abcam #ab49475, Lot No. 153899	Homo sapiens		EXP034014	192	unspecified	O43680	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP034019		Mus musculus	Mef2d KO	NULL	141	chip_control	NULL	retina	NULL
EXP034020		Mus musculus	unstim Ctx1	NULL	141	chip_control	NULL	retina	NULL
EXP034021		Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP034022		Mus musculus	Crx KO	NULL	141	chip_control	NULL	retina	NULL
EXP034023		Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP034024	anti-MEF2D (Flavell et al., 2008)	Mus musculus	Mef2d KO	EXP034019	141	unspecified	Q63943	retina	NULL
EXP034025	anti-MEF2D (Flavell et al., 2008)	Mus musculus	unstim Ctx1	EXP034020	141	unspecified	Q63943	retina	NULL
EXP034026	anti-MEF2D (Flavell et al., 2008)	Mus musculus	stim Ctx1	EXP034021	141	unspecified	Q63943	retina	NULL
EXP034027	anti-MEF2D (Flavell et al., 2008)	Mus musculus	unstim Ctx2	NULL	141	unspecified	Q63943	retina	NULL
EXP034028	anti-MEF2D (Flavell et al., 2008)	Mus musculus	stim Ctx2	NULL	141	unspecified	Q63943	retina	NULL
EXP034029	anti-MEF2D (Flavell et al., 2008)	Mus musculus	Crx KO	EXP034022	141	unspecified	Q63943	retina	NULL
EXP034030	anti-MEF2D (Flavell et al., 2008)	Mus musculus		EXP034023	141	unspecified	Q63943	retina	NULL
EXP034031	Millipore 05-909 TFAP2C	Mus musculus		NULL	574	unspecified	Q61312	mammary tumor	NULL
EXP034032	none	Mus musculus	LPS and IL-4	NULL	41	chip_control	NULL	B-cells	NULL
EXP034033	anti-PU.1	Mus musculus	LPS and IL-4	EXP034032	41	unspecified	P17433	B-cells	NULL
EXP034034	anti-PU.1	Mus musculus	LPS and IL-4	EXP034032	41	unspecified	P17433	B-cells	NULL
EXP034035	anti-PU.1	Mus musculus	LPS and IL-4	EXP034032	41	unspecified	P17433	B-cells	NULL
EXP034036	none	Mus musculus	none	NULL	606	chip_control	NULL	MIN6-4N (insulinoma)	NULL
EXP034037	anti-phospho-HLXB9	Mus musculus	none	EXP034036	606	unspecified	Q9QZW9	MIN6-4N (insulinoma)	NULL
EXP034038	none	Mus musculus		NULL	803	chip_control	NULL	spermatocytes	NULL
EXP034039	Prdm9	Mus musculus		EXP034038	803	unspecified	Q96EQ9	spermatocytes	NULL
EXP034040		Mus musculus		NULL	284	chip_control	NULL	ventral neural progenitors	NULL
EXP034041		Mus musculus		NULL	284	chip_control	NULL	ventral neural progenitors	NULL
EXP034042		Mus musculus		NULL	284	chip_control	NULL	ventral neural progenitors	NULL
EXP034043		Mus musculus		NULL	283	chip_control	NULL	dorsal neural progenitors	NULL
EXP034044	none	Mus musculus		NULL	138	chip_control	NULL	neural progenitors	NULL
EXP034045	none	Mus musculus		NULL	138	chip_control	NULL	neural progenitors	NULL
EXP034046	Anti-NKX2-2	Mus musculus		EXP034040	284	unspecified	P42586	ventral neural progenitors	NULL
EXP034047	anti-NKX6.1	Mus musculus		EXP034041	284	unspecified	Q99MA9	ventral neural progenitors	NULL
EXP034048	Millipore AB9610	Mus musculus		EXP034042	284	unspecified	Q9EQW6	ventral neural progenitors	NULL
EXP034049	anti-FLAG M2 clone	Mus musculus		EXP034043	283	unspecified	Q61602	dorsal neural progenitors	NULL
EXP034050	Cocktail of DSHB (74.5A5), Sigma (HPA003468), and custom (from T. Jessell)	Mus musculus		EXP034044	138	unspecified	P42586	neural progenitors	NULL
EXP034051	Cocktail of DSHB (F55A10, F55A12, F64A6B4, and F65A2), RD Systems  (AF5857) and custom (from T. Jessell)	Mus musculus		EXP034045	138	unspecified	Q99MA9	neural progenitors	NULL
EXP034052	Millipore (AB9610)	Mus musculus		EXP034045	138	unspecified	Q9EQW6	neural progenitors	NULL
EXP034053	anti-PPARalpha	Mus musculus		NULL	5	unspecified	P23204	liver	NULL
EXP034054	anti-PPARalpha	Mus musculus	GW7647	NULL	5	unspecified	P23204	liver	NULL
EXP034055	anti-PPARalpha	Mus musculus	PPARalpha KO	NULL	5	unspecified	P23204	liver	NULL
EXP034056	anti-PPARalpha	Mus musculus	GW7647, PPARalpha KO	NULL	5	unspecified	P23204	liver	NULL
EXP034057	none (input)	Homo sapiens	Ethanol (vehicle control)	NULL	761	chip_control	NULL	R1-AD1 (prostate cancer)	NULL
EXP034058	none (input)	Homo sapiens	Ethanol (vehicle control)	NULL	762	chip_control	NULL	R1-D567 (prostate cancer)	NULL
EXP034059	AR -N20 (Santa Cruz, SC-816 lot B1012)	Homo sapiens	Ethanol (vehicle control)	EXP034057	761	unspecified	P10275	R1-AD1 (prostate cancer)	NULL
EXP034060	AR -N20 (Santa Cruz, SC-816 lot B1012)	Homo sapiens	dihydrotestosterone, 1nM	EXP034057	761	unspecified	P10275	R1-AD1 (prostate cancer)	NULL
EXP034061	AR -N20 (Santa Cruz, SC-816 lot B1012)	Homo sapiens	Ethanol (vehicle control)	EXP034058	762	unspecified	P10275	R1-D567 (prostate cancer)	NULL
EXP034062		Homo sapiens		NULL	788	chip_control	NULL	SF268 (astrocytoma )	NULL
EXP034063	BD Transduction Laboratories 610922	Homo sapiens		EXP034062	788	unspecified	P28347	SF268 (astrocytoma )	NULL
EXP034064	input	Mus musculus	dex	NULL	141	chip_control	NULL	retina	NULL
EXP034065	input	Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP034066	BuGR2, monoclonal (Pierce/ThermoFisher)	Mus musculus	dex	EXP034064	141	unspecified	P06537	retina	NULL
EXP034067	BuGR2, monoclonal (Pierce/ThermoFisher)	Mus musculus		EXP034065	141	unspecified	P06537	retina	NULL
EXP034068	input	Homo sapiens		NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP034069	Sigma Imprint anti-GR, monoclonal	Homo sapiens		EXP034068	466	unspecified	P04150	MDM(monocyte derived macrophages)	NULL
EXP034070	zfhx3	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	NULL
EXP034071	zfhx3	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	NULL
EXP034072	klf6	Homo sapiens		NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	NULL
EXP034073	klf6	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	NULL
EXP034074	klf6	Homo sapiens		NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	NULL
EXP034075	klf6	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q99612	HeLa (cervical adenocarcinoma)	NULL
EXP034076	zbtb16	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q05516	HeLa (cervical adenocarcinoma)	NULL
EXP034077	zbtb16	Homo sapiens		NULL	78	unspecified	Q05516	HeLa (cervical adenocarcinoma)	NULL
EXP034078	zfhx3	Homo sapiens		NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	NULL
EXP034079	zfhx3	Homo sapiens	1Î¼M of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor Î± (T0157, Sigma-Aldrich) for the last 1 hour.	NULL	78	unspecified	Q15911	HeLa (cervical adenocarcinoma)	NULL
EXP034080	none	Mus musculus	HA-tagged full-length GATA1	NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034081	none	Mus musculus	HA-tagged full-length GATA1	NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034082	none	Mus musculus	GATA1s	NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034083	none	Mus musculus	GATA1s	NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034084	anti-HA	Mus musculus	HA-tagged full-length GATA1	EXP034080	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034085	anti-HA	Mus musculus	HA-tagged full-length GATA1	EXP034081	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034086	anti-HA	Mus musculus	GATA1s	EXP034082	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034087	anti-HA	Mus musculus	GATA1s	EXP034083	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034088	WCE	Homo sapiens		NULL	289	chip_control	NULL	SK-N-MC (Askin tumor)	NULL
EXP034089	WCE	Homo sapiens		NULL	288	chip_control	NULL	A673 (Ewing sarcoma)	NULL
EXP034090	FLI1 (Santa Cruz, sc-356)	Homo sapiens		EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	NULL
EXP034091	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shGFP for 48h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	NULL
EXP034092	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shGFP for 96h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	NULL
EXP034093	GABPA (Santa Cruz, sc-22810)	Homo sapiens	shGFP for 96h	EXP034088	289	unspecified	Q06546	SK-N-MC (Askin tumor)	NULL
EXP034094	ELF1 (Santa Cruz, sc-631)	Homo sapiens	shGFP for 96h	EXP034088	289	unspecified	P32519	SK-N-MC (Askin tumor)	NULL
EXP034095	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shFLI1 for 48h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	NULL
EXP034096	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shFLI1 for 96h	EXP034088	289	unspecified	Q01543	SK-N-MC (Askin tumor)	NULL
EXP034097	GABPA (Santa Cruz, sc-22810)	Homo sapiens	shFLI1 for 96h	EXP034088	289	unspecified	Q06546	SK-N-MC (Askin tumor)	NULL
EXP034098	ELF1 (Santa Cruz, sc-631)	Homo sapiens	shFLI1 for 96h	EXP034088	289	unspecified	P32519	SK-N-MC (Askin tumor)	NULL
EXP034099	FLI1 (Santa Cruz, sc-356)	Homo sapiens		EXP034089	288	unspecified	Q01543	A673 (Ewing sarcoma)	NULL
EXP034100	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shGFP for 48h	EXP034089	288	unspecified	Q01543	A673 (Ewing sarcoma)	NULL
EXP034101	FLI1 (Santa Cruz, sc-356)	Homo sapiens	shFLI1 for 48h	EXP034089	288	unspecified	Q01543	A673 (Ewing sarcoma)	NULL
EXP034102		Homo sapiens		NULL	201	chip_control	NULL	CyT49 (embryonic stem cells)	NULL
EXP034103	Millipore AB5535	Homo sapiens		EXP034102	201	unspecified	P48436	CyT49 (embryonic stem cells)	NULL
EXP034104		Homo sapiens		NULL	27	chip_control	NULL	501Mel-Cl8 (melanoma)	NULL
EXP034105		Homo sapiens		NULL	26	chip_control	NULL	501Mel (melanoma)	NULL
EXP034106	HA : IGBMC (12CA5)	Homo sapiens		EXP034104	27	unspecified	O75030	501Mel-Cl8 (melanoma)	NULL
EXP034107	SOX10 : Abcam (ab155270)	Homo sapiens		EXP034105	26	unspecified	P56693	501Mel (melanoma)	NULL
EXP034108	none (Input)	Homo sapiens		NULL	896	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP034109	none (Input)	Homo sapiens		NULL	281	chip_control	NULL	embryonic stem cell- derived mid radial glial neural progenitors	NULL
EXP034110	Abcam,Ab21990,GR139309-4Â 	Homo sapiens		EXP034108	896	unspecified	P32243	embryonic stem cell-derived neural progenitors	NULL
EXP034111	Abcam,Ab21990,GR139309-4Â 	Homo sapiens		EXP034109	281	unspecified	P32243	embryonic stem cell- derived mid radial glial neural progenitors	NULL
EXP034112		Homo sapiens		NULL	324	chip_control	NULL	HSR-GBM1A (glioblastoma)	NULL
EXP034113		Homo sapiens		NULL	325	chip_control	NULL	HSR-GBM1B (glioblastoma)	NULL
EXP034114	klf9	Homo sapiens		EXP034112	324	unspecified	Q13886	HSR-GBM1A (glioblastoma)	NULL
EXP034115	klf9	Homo sapiens		EXP034113	325	unspecified	Q13886	HSR-GBM1B (glioblastoma)	NULL
EXP034116	none	Homo sapiens	1hr with ethanol, double crosslinked	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034117	none	Homo sapiens	1hr with 100nM E2, double crosslinked	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034118	SC-543, Santa Cruz Biotech	Homo sapiens	1hr with ethanol, crosslinked with 1% formaldehyde	EXP034116	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034119	SC-543, Santa Cruz Biotech	Homo sapiens	1hr with 100nM E2, crosslinked with 1% formaldehyde	EXP034117	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034120	SC-543, Santa Cruz Biotech	Homo sapiens	cells transfected with siNCAPG, and 1hr with 100nM E2, double crosslinked	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034121	SC-543, Santa Cruz Biotech	Homo sapiens	cells transfected with siNCAPD3 and H2 together, and 1hr with 100nM E2, double crosslinked	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034122	SC-543, Santa Cruz Biotech	Homo sapiens	cells transfected with siCTL, and 1hr with 100nM E2, double crosslinked	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034123	none (input)	Homo sapiens		NULL	61	chip_control	NULL	ALL-SIL (acute lymphoblastic leukemia)	NULL
EXP034124	anti-TLX1 (C-18 rabbit polyclonal antibody (sc-880), Santa Cruz Biotechnology)	Homo sapiens		EXP034123	61	unspecified	P31314	ALL-SIL (acute lymphoblastic leukemia)	NULL
EXP034125	Prdm5	Mus musculus		NULL	582	chip_control	NULL	MC3T3 (osteogenic cell line)	NULL
EXP034126	Prdm5 ab1	Mus musculus		EXP034125	582	unspecified	Q9CXE0	MC3T3 (osteogenic cell line)	NULL
EXP034127	Prdm5 ab2	Mus musculus		EXP034125	582	unspecified	Q9CXE0	MC3T3 (osteogenic cell line)	NULL
EXP034128	IgG	Homo sapiens		NULL	152	chip_control	NULL	CC-LP-1 (intrahepatic cholangiocarcinoma)	NULL
EXP034129	Input	Homo sapiens		NULL	152	chip_control	NULL	CC-LP-1 (intrahepatic cholangiocarcinoma)	NULL
EXP034130	TEAD	Homo sapiens		EXP034128	152	unspecified	P28347	CC-LP-1 (intrahepatic cholangiocarcinoma)	NULL
EXP034131	none	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP034132	FOXM1	Homo sapiens		EXP034131	440	unspecified	Q08050	HMEC (human mammary epithelial cells)	NULL
EXP034133	MYBL2	Homo sapiens		EXP034131	440	unspecified	P10244	HMEC (human mammary epithelial cells)	NULL
EXP034134	E2F1	Homo sapiens		EXP034131	440	unspecified	Q01094	HMEC (human mammary epithelial cells)	NULL
EXP034135	none (input)	Homo sapiens	Treatment: none; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034136	none (input)	Homo sapiens	Treatment: none; Conditions: cells were grown in regular media; Time point: 1 hour	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP034137	none (input)	Homo sapiens	Treatment: none; Conditions: cells were grown in regular media; Time point: 1 hour	NULL	200	chip_control	NULL	CWR22 (prostate carcinoma)	NULL
EXP034138	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of vehicle; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP034139	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM R1881; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP034140	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM R1881 and 10uM Bicalutamide; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP034141	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM R1881 and 10uM MDV3100; Conditions: cells were grown in charcoal-stripped serum containing phenol-red free media for 72 hours; Time point: 1 hour	EXP034135	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP034142	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of vehicle; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP034143	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP034144	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM Bicalutamide; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP034145	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM MDV3100; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034136	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP034146	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of vehicle; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	NULL
EXP034147	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	NULL
EXP034148	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM Bicalutamide; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	NULL
EXP034149	anti-AR (Millipore, 06-680)	Homo sapiens	Treatment: 1 hour of 1nM DHT and 10uM MDV3100; Conditions: cells were grown in regular media; Time point: 1 hour	EXP034137	200	normal	P10275	CWR22 (prostate carcinoma)	NULL
EXP034150	none (input)	Homo sapiens		NULL	256	chip_control	NULL	endometrial stromal cells	NULL
EXP034151	anti-flag M2 affinity gel (Sigma, A2220)	Homo sapiens	PGR-A isoform	EXP034150	256	unspecified	P06401	endometrial stromal cells	NULL
EXP034152	anti-flag M2 affinity gel (Sigma, A2220)	Homo sapiens	PGR-B isoform	EXP034150	256	unspecified	P06401	endometrial stromal cells	NULL
EXP034153	NA	Homo sapiens	PMA/ionomycin	NULL	886	chip_control	NULL	Th1-cells	NULL
EXP034154	NA	Mus musculus	PMA/ionomycin	NULL	76	chip_control	NULL	Th1-cells	NULL
EXP034155	NA	Mus musculus	PMA/ionomycin, T-bet KO	NULL	76	chip_control	NULL	Th1-cells	NULL
EXP034156	NA	Mus musculus		NULL	243	chip_control	NULL	EL4 (lymphoma)	NULL
EXP034157	NA	Mus musculus		NULL	243	chip_control	NULL	EL4 (lymphoma)	NULL
EXP034158	Abcam 46540	Homo sapiens	PMA/ionomycin	NULL	886	chip_control	NULL	Th1-cells	NULL
EXP034159	SY4530 (custom)	Homo sapiens	PMA/ionomycin	EXP034153	886	unspecified	Q9UL17	Th1-cells	NULL
EXP034160	Sigma M2	Mus musculus	PMA/ionomycin	NULL	243	unspecified	Q9JKD8	EL4 (lymphoma)	NULL
EXP034161	Sigma M2	Mus musculus	PMA/ionomycin	NULL	243	unspecified	Q9JKD8	EL4 (lymphoma)	NULL
EXP034162	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin	EXP034156	243	unspecified	Q04207	EL4 (lymphoma)	NULL
EXP034163	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin	EXP034157	243	unspecified	Q04207	EL4 (lymphoma)	NULL
EXP034164	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin	EXP034154	76	unspecified	Q04207	Th1-cells	NULL
EXP034165	Santa Cruz C-20 (sc-372)	Mus musculus	PMA/ionomycin, T-bet KO	EXP034155	76	unspecified	Q04207	Th1-cells	NULL
EXP034166	Santa Cruz C-20 (sc-372)	Homo sapiens	PMA/ionomycin, DMSO	EXP034158	886	unspecified	Q04206	Th1-cells	NULL
EXP034167	p65	Homo sapiens	PMA/ionomycin, BAY 11-7082	NULL	886	unspecified	Q04206	Th1-cells	NULL
EXP034168	Input	Homo sapiens	DHT 10 nM treatment	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034169	AR	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034170	AR	Homo sapiens	R1881 10 nM	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034171	AR	Homo sapiens	DHT 10 nM treatment, siControl	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034172	AR	Homo sapiens	DHT 10 nM treatment, siFOXP1	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034173	FOXP1	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	unspecified	Q9H334	LNCaP (prostate carcinoma)	NULL
EXP034174	FOXP1	Homo sapiens	DHT 10 nM treatment	EXP034168	70	unspecified	Q9H334	LNCaP (prostate carcinoma)	NULL
EXP034175	RUNX1	Homo sapiens	ethanol (Vehicle) treatment	NULL	70	unspecified	Q01196	LNCaP (prostate carcinoma)	NULL
EXP034176	RUNX1	Homo sapiens	DHT 10 nM treatment	EXP034168	70	unspecified	Q01196	LNCaP (prostate carcinoma)	NULL
EXP034177	AR	Homo sapiens	DHT 10 nM treatment, siControl	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034178	AR	Homo sapiens	DHT 10 nM treatment, siRUNX1	EXP034168	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034179	none	Mus musculus		NULL	487	chip_control	NULL	multipotent otic progenitors	NULL
EXP034180	c-Myc (N-262) Santa Cruz Cat# sc-764	Mus musculus		EXP034179	487	unspecified	P01108	multipotent otic progenitors	NULL
EXP034181	Sox2 clone 6F1.2 EMD Millipore Cat# 17-656	Mus musculus		EXP034179	487	unspecified	P48432	multipotent otic progenitors	NULL
EXP034182	none	Mus musculus		NULL	173	chip_control	NULL	preantral follicles	NULL
EXP034183	anti-FOXL2 C-terminal antibody (from lab)	Mus musculus		EXP034182	173	unspecified	O88470	preantral follicles	NULL
EXP034184	anti-ESR1 C-terminal antibody (Santa Cruz sc543)	Mus musculus		EXP034182	173	unspecified	P19785	preantral follicles	NULL
EXP034185	Rabbit Serum IgG (Sigma I5006)	Mus musculus		NULL	253	chip_control	NULL	EML -C1(EML, clone 1)	NULL
EXP034186	Rabbit polyclonal  anti-RUNX1 (non-commercial antibody)	Mus musculus		EXP034185	253	unspecified	Q03347	EML -C1(EML, clone 1)	NULL
EXP034187	IgG antibody (Abcam, #ab171870)	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP034188	ZNF644	Homo sapiens		EXP034187	10	unspecified	Q9H582	HEK293T (embryonic kidney)	NULL
EXP034189	WIZ	Homo sapiens		EXP034187	10	unspecified	O95785	HEK293T (embryonic kidney)	NULL
EXP034190	Input DNA	Mus musculus		NULL	901	chip_control	NULL	prostate tumor	NULL
EXP034191	AR IP (Epitomics clone ER179(2))	Mus musculus		EXP034190	901	unspecified	P19091	prostate tumor	NULL
EXP034192	AR IP (Epitomics clone ER179(2))	Mus musculus	castrate	EXP034190	901	unspecified	P19091	prostate tumor	NULL
EXP034193	AR IP (Epitomics clone ER179(2))	Mus musculus	bicalutamide	EXP034190	901	unspecified	P19091	prostate tumor	NULL
EXP034194	AR IP (Epitomics clone ER179(2))	Mus musculus	enzalutamide	EXP034190	901	unspecified	P19091	prostate tumor	NULL
EXP034195		Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP034196	aebp2	Mus musculus		EXP034195	139	unspecified	Q9Z248	thymus	NULL
EXP034197	Irf7	Mus musculus	t0	NULL	190	unspecified	P70434	myeloid cells	NULL
EXP034198	Irf7	Mus musculus	t1	NULL	190	unspecified	P70434	myeloid cells	NULL
EXP034199	Irf7	Mus musculus	t2	NULL	190	unspecified	P70434	myeloid cells	NULL
EXP034200	Irf7	Mus musculus	t4	NULL	190	unspecified	P70434	myeloid cells	NULL
EXP034201	Pu.1	Mus musculus		NULL	914	unspecified	P17433	monocyte-derived dendritic cells	NULL
EXP034202	Pu.1	Mus musculus		NULL	312	unspecified	P17433	plasmacytoid dendritic cells	NULL
EXP034203	Irf8	Mus musculus		NULL	914	unspecified	P23611	monocyte-derived dendritic cells	NULL
EXP034204	Irf8	Mus musculus		NULL	312	unspecified	P23611	plasmacytoid dendritic cells	NULL
EXP034205	Cebpb	Mus musculus		NULL	914	unspecified	P28033	monocyte-derived dendritic cells	NULL
EXP034206	Cebpb	Mus musculus		NULL	312	unspecified	P28033	plasmacytoid dendritic cells	NULL
EXP034207		Homo sapiens		NULL	692	chip_control	NULL	OF4155 (neural progenitors)	NULL
EXP034208	mouse monoclonal anti-FLAG M2 Sigma-Aldrich F1804	Homo sapiens		EXP034207	692	unspecified	Q9H334	OF4155 (neural progenitors)	NULL
EXP034209	GATA-1 Antibody (N6) sc-265	Mus musculus		NULL	265	unspecified	P17679	G1E (embryonic stem cells)	NULL
EXP034210	GATA-1 Antibody (N6) sc-265	Mus musculus	250nM JQ1 for 24 hours	NULL	265	unspecified	P17679	G1E (embryonic stem cells)	NULL
EXP034211	Meis1/2 (K830, K844)	Mus musculus		NULL	131	unspecified	Q60954	E10.5 embryonic optic cups	NULL
EXP034212	none (input)	Mus musculus	Dexamethasone and GW7647 4 hrs	NULL	122	chip_control	NULL	burst-forming unit erythroid	NULL
EXP034213	GR (Santa Cruz: H300, sc-8992)	Mus musculus		NULL	122	unspecified	P06537	burst-forming unit erythroid	NULL
EXP034214	PPAR alpha (Santa Cruz: H-98, sc-9000)	Mus musculus		NULL	122	unspecified	P23204	burst-forming unit erythroid	NULL
EXP034215	GR (Santa Cruz: H300, sc-8992)	Mus musculus	Dexamethasone 4 hrs	NULL	122	unspecified	P06537	burst-forming unit erythroid	NULL
EXP034216	PPAR alpha (Santa Cruz: H-98, sc-9000)	Mus musculus	Dexamethasone 4 hrs	NULL	122	unspecified	P23204	burst-forming unit erythroid	NULL
EXP034217	GR (Santa Cruz: H300, sc-8992)	Mus musculus	Dexamethasone and GW7647 4 hrs	EXP034212	122	unspecified	P06537	burst-forming unit erythroid	NULL
EXP034218	PPAR alpha (Santa Cruz: H-98, sc-9000)	Mus musculus	Dexamethasone and GW7647 4 hrs	EXP034212	122	unspecified	P23204	burst-forming unit erythroid	NULL
EXP034219	none	Mus musculus		NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034220	none	Mus musculus		NULL	800	chip_control	NULL	small peritoneal macrophages	NULL
EXP034221	none	Mus musculus		NULL	605	chip_control	NULL	microglia	NULL
EXP034222	none	Mus musculus		NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP034223	none	Mus musculus		NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034224	none	Mus musculus		NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034225	none	Mus musculus		NULL	605	chip_control	NULL	microglia	NULL
EXP034226		Mus musculus	4ng/ml Mcsf 7d, 2um DMSO 7d	NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034227		Mus musculus	4ng/ml Mcsf 7d, 2um ATRA 7d	NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034228		Mus musculus	4ng/ml Mcsf 7d, 1ng/ml TGFB1 7d	NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034229		Mus musculus	4ng/ml Mcsf 7d, 1ng/ml VehTGFB1 7d	NULL	535	chip_control	NULL	large peritoneal macrophages	NULL
EXP034230	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034219	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034231	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034220	800	unspecified	P17433	small peritoneal macrophages	NULL
EXP034232	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034221	605	unspecified	P17433	microglia	NULL
EXP034233	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1808)	Mus musculus		EXP034222	732	unspecified	P17433	peritoneal macrophages	NULL
EXP034234	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034223	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034235	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034224	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034236	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		NULL	605	unspecified	P17433	microglia	NULL
EXP034237	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus		EXP034225	605	unspecified	P17433	microglia	NULL
EXP034238	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 2um DMSO 7d	EXP034226	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034239	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 2um ATRA 7d	EXP034227	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034240	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 1ng/ml TGFB1 7d	EXP034228	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034241	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# B0314)	Mus musculus	4ng/ml Mcsf 7d, 1ng/ml VehTGFB1 7d	EXP034229	535	unspecified	P17433	large peritoneal macrophages	NULL
EXP034242	HA 12CA5	Mus musculus		NULL	16	chip_control	NULL	MIN6-B1 (insulinoma)	NULL
EXP034243	HA 12CA5	Mus musculus		EXP034242	16	unspecified	Q8C7R7	MIN6-B1 (insulinoma)	NULL
EXP034244	input	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034245	AML1	Homo sapiens		EXP034244	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034246	SC-1609	Homo sapiens		EXP034244	516	unspecified	O75376	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034247	none (input)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a2 expression	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP034248	none (input)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a8 expression	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP034249	affinity-purified anti-HNF4? (?445)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a2 expression	EXP034247	417	unspecified	P41235	HCT-116 (colon carcinoma)	NULL
EXP034250	affinity-purified anti-HNF4? (?445)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a8 expression	EXP034248	417	unspecified	P41235	HCT-116 (colon carcinoma)	NULL
EXP034251	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.0 Î¼g/mL DOX, HNF4a2 expression	NULL	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	NULL
EXP034252	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a2 expression	EXP034247	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	NULL
EXP034253	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.0 Î¼g/mL DOX, HNF4a8 expression	NULL	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	NULL
EXP034254	anti-TCF7L2 (TCF4) (Millipore; cat# 6H5-3)	Homo sapiens	0.3 Î¼g/mL DOX, HNF4a8 expression	EXP034248	417	unspecified	Q9NQB0	HCT-116 (colon carcinoma)	NULL
EXP034255		Homo sapiens		NULL	77	chip_control	NULL	CP-A(Barrett esophagus epithelium)	NULL
EXP034256	sox15	Homo sapiens		EXP034255	77	unspecified	O60248	CP-A(Barrett esophagus epithelium)	NULL
EXP034258	IgG	Homo sapiens		NULL	244	chip_control	NULL	NT2-D1 (embryonic carcinoma)	NULL
EXP034262	sox2	Homo sapiens		EXP034258	244	unspecified	P48431	NT2-D1 (embryonic carcinoma)	NULL
EXP034263	nanog	Homo sapiens		EXP034258	244	unspecified	Q9H9S0	NT2-D1 (embryonic carcinoma)	NULL
EXP034264	oct4	Homo sapiens		EXP034258	244	unspecified	Q01860	NT2-D1 (embryonic carcinoma)	NULL
EXP034265	CREB1	Homo sapiens		NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	NULL
EXP034266	FOXA1	Homo sapiens		NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP034267	CREB1	Homo sapiens		NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	NULL
EXP034268	FoxA1 (Abcam ab23738)	Homo sapiens	siControl	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP034269	CREB1 (Abcam ab31387)	Homo sapiens	siControl	NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	NULL
EXP034270	FoxA1 (Abcam ab23738)	Homo sapiens	siCREB1	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP034271	CREB1 (Abcam ab31387)	Homo sapiens	siFOXA1	NULL	70	unspecified	P16220	LNCaP (prostate carcinoma)	NULL
EXP034272	none (input DNA)	Homo sapiens		NULL	468	chip_control	NULL	neonatal keratinocytes	NULL
EXP034273	JunB (Cell signaling 3753S)	Homo sapiens		EXP034272	468	unspecified	P17275	neonatal keratinocytes	NULL
EXP034274		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034275	AR (Santa Cruz; sc-816)	Homo sapiens		EXP034274	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034276	STAT3 (Invitrogen, 13-7000)	Mus musculus		NULL	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034277	STAT3 (Invitrogen, 13-7000)	Mus musculus	IL21	NULL	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034278	STAT3 (Invitrogen, 13-7000)	Mus musculus	Stat1 KO	NULL	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034279	STAT3 (Invitrogen, 13-7000)	Mus musculus	Stat1 KO, IL21	NULL	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034280	STAT1 (Santa Cruz, sc-346)	Mus musculus		NULL	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034281	STAT1 (Santa Cruz, sc-346)	Mus musculus	IL21	NULL	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034282	STAT1 (Santa Cruz, sc-346)	Mus musculus	Stat3 KO	NULL	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034283	STAT1 (Santa Cruz, sc-346)	Mus musculus	Stat3 KO, IL21	NULL	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034284	IgG	Homo sapiens		NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP034285	IgG	Homo sapiens	Dex 1uM	NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP034286	IgG	Homo sapiens		NULL	617	chip_control	NULL	MM1.RL (plasma cell myeloma)	NULL
EXP034287	IgG	Homo sapiens	Dex 1uM	NULL	617	chip_control	NULL	MM1.RL (plasma cell myeloma)	NULL
EXP034288	Input	Homo sapiens		NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP034289	Input	Homo sapiens	Dex 1uM	NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP034290	Input	Homo sapiens		NULL	617	chip_control	NULL	MM1.RL (plasma cell myeloma)	NULL
EXP034291	Input	Homo sapiens	Dex 1uM	NULL	617	chip_control	NULL	MM1.RL (plasma cell myeloma)	NULL
EXP034292	GR	Homo sapiens		EXP034284	618	unspecified	P04150	MM1.S (plasma cell myeloma)	NULL
EXP034293	GR	Homo sapiens	Dex 1uM	EXP034285	618	unspecified	P04150	MM1.S (plasma cell myeloma)	NULL
EXP034294	GR	Homo sapiens		EXP034286	617	unspecified	P04150	MM1.RL (plasma cell myeloma)	NULL
EXP034295	GR	Homo sapiens	Dex 1uM	EXP034287	617	unspecified	P04150	MM1.RL (plasma cell myeloma)	NULL
EXP034296	anti-UBF1/2 rabbit polyclonal	Mus musculus		NULL	675	unspecified	P25976	NIH 3T3 (embryonic fibroblasts)	NULL
EXP034297	anti-UBF1/2 rabbit polyclonal	Homo sapiens		NULL	440	unspecified	P17480	HMEC (human mammary epithelial cells)	NULL
EXP034298	anti-UBF1/2 rabbit polyclonal	Homo sapiens		NULL	442	unspecified	P17480	HMLER (mammary epithelial cells)	NULL
EXP034299		Homo sapiens		NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP034300	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	407	chip_control	NULL	HBL1 (diffuse large B-cell lymphoma)	NULL
EXP034301	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	453	chip_control	NULL	HT (diffuse large B-cell lymphoma)	NULL
EXP034302	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	689	chip_control	NULL	OCI-LY8 (diffuse large B-cell lymphoma)	NULL
EXP034303	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	683	chip_control	NULL	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP034304	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	684	chip_control	NULL	OCI-LY19 (diffuse large B-cell lymphoma)	NULL
EXP034305	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	835	chip_control	NULL	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP034306	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034299	92	unspecified	Q9H334	BJAB (Burkitt lymphoma)	NULL
EXP034307	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034300	407	unspecified	Q9H334	HBL1 (diffuse large B-cell lymphoma)	NULL
EXP034308	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034301	453	unspecified	Q9H334	HT (diffuse large B-cell lymphoma)	NULL
EXP034309	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034302	689	unspecified	Q9H334	OCI-LY8 (diffuse large B-cell lymphoma)	NULL
EXP034310	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034303	683	unspecified	Q9H334	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP034311	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034304	684	unspecified	Q9H334	OCI-LY19 (diffuse large B-cell lymphoma)	NULL
EXP034312	Anti-FOXP1 polyclonal (Gift from Ed Morrisey lab)	Homo sapiens		EXP034305	835	unspecified	Q9H334	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP034313	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034314	PREP-1 N-15 (Santa Cruz Biotechnology, sc-6245)	Mus musculus		EXP034313	2	unspecified	O70477	mESCs (mouse embryonic stem cells)	NULL
EXP034315	Rabbit IgG (Sigma I5006)	Mus musculus	PuER	NULL	869	chip_control	NULL	X18.1.1 (acute myeloid leukemia)	NULL
EXP034316	Rabbit IgG (Sigma I5006)	Mus musculus		NULL	869	chip_control	NULL	X18.1.1 (acute myeloid leukemia)	NULL
EXP034317	Pu.1 (Santa Cruz sc352x)	Mus musculus	PuER	EXP034315	869	unspecified	P17433	X18.1.1 (acute myeloid leukemia)	NULL
EXP034318	Pu.1 (Santa Cruz sc352x)	Mus musculus		EXP034316	869	unspecified	P17433	X18.1.1 (acute myeloid leukemia)	NULL
EXP034319	CEBPA (Santa Cruz sc61x)	Mus musculus	PuER	EXP034315	869	unspecified	P53566	X18.1.1 (acute myeloid leukemia)	NULL
EXP034320	CEBPA (Santa Cruz sc61x)	Mus musculus		EXP034316	869	unspecified	P53566	X18.1.1 (acute myeloid leukemia)	NULL
EXP034321	none (input)	Homo sapiens		NULL	148	chip_control	NULL	Calu-3 (lung adenocarcinoma)	NULL
EXP034322	EHF (Clone 5A.5), Pierce	Homo sapiens		EXP034321	148	unspecified	Q9NZC4	Calu-3 (lung adenocarcinoma)	NULL
EXP034323	none	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034324	none	Homo sapiens		NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP034325	none	Homo sapiens		NULL	648	chip_control	NULL	NB4 (acute promyelocytic leukemia )	NULL
EXP034326	anti-LYL1	Homo sapiens		EXP034323	516	unspecified	P12980	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034327	anti-LYL1	Homo sapiens		EXP034324	438	unspecified	P12980	HL-60 (acute myeloid leukemia)	NULL
EXP034328	anti-LYL1	Homo sapiens		EXP034325	648	unspecified	P12980	NB4 (acute promyelocytic leukemia )	NULL
EXP034329	anti-LYL1	Homo sapiens		NULL	2334	unspecified	P12980	THP-1 (acute monocytic leukemia)	NULL
EXP034330	none	Homo sapiens		NULL	24	chip_control	NULL	451Lu (WM-451Lu, Melanoma)	NULL
EXP034331	HSF1 (Cell Signaling, catalog# 4356, lot# 2)	Homo sapiens		EXP034330	24	unspecified	Q00613	451Lu (WM-451Lu, Melanoma)	NULL
EXP034332	none (input)	Mus musculus		NULL	228	chip_control	NULL	E14.5 embryonic cerebral cortices	NULL
EXP034333	anti-Tbr2, Chemicon cat.no AB9618	Mus musculus		EXP034332	228	unspecified	O54839	E14.5 embryonic cerebral cortices	NULL
EXP034334	anti-Neurog2, non-commercial: a gift of Prof. Yongchao Ma, Chicago	Mus musculus		EXP034332	228	unspecified	P70447	E14.5 embryonic cerebral cortices	NULL
EXP034335	none (input)	Homo sapiens		NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP034336	SOX9  (Millipore, AB5535)	Homo sapiens		EXP034335	452	unspecified	P48436	HT29 (colon adenocarcinoma)	NULL
EXP034337	sc-553, sc-774	Mus musculus		NULL	732	unspecified	P28700	peritoneal macrophages	NULL
EXP034338	sc-7196, sc-1984	Mus musculus		NULL	732	unspecified	P37238	peritoneal macrophages	NULL
EXP034339	sc-13551, sc-8984, sc-367	Mus musculus	GW3965 6h	NULL	732	unspecified	Q9WTN3	peritoneal macrophages	NULL
EXP034340	HEB	Mus musculus		NULL	171	unspecified	Q61286	CD4+ CD8+ T cells	NULL
EXP034341	TCF1	Mus musculus		NULL	171	unspecified	Q00417	CD4+ CD8+ T cells	NULL
EXP034342	none	Homo sapiens		NULL	531	chip_control	NULL	L1236 (Hodgkin lymphoma)	NULL
EXP034343	NFkB p65 (C-20) #sc-372, rabbit pkAb	Homo sapiens		EXP034342	531	unspecified	Q04206	L1236 (Hodgkin lymphoma)	NULL
EXP034344	RelB (C-19) #sc-226, rabbit pkAb	Homo sapiens		EXP034342	531	unspecified	Q01201	L1236 (Hodgkin lymphoma)	NULL
EXP034345	NFkB p50 (C-19) #sc-1190, goat pkAb	Homo sapiens		EXP034342	531	unspecified	P19838	L1236 (Hodgkin lymphoma)	NULL
EXP034346	NFkB p52 Millipore #05-361, mouse mk Ab	Homo sapiens		EXP034342	531	unspecified	Q00653	L1236 (Hodgkin lymphoma)	NULL
EXP034347	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP034348	none	Mus musculus	Hmga2 KO	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP034349	HMGA2 (Santa cruz, cat. sc-30223, lot: F1407 )	Mus musculus		EXP034347	12	unspecified	P52927	MEF (mouse embryonic fibroblasts)	NULL
EXP034350	HMGA2 (Santa cruz, cat. sc-30223, lot: F1407 )	Mus musculus	Hmga2 KO	EXP034348	12	unspecified	P52927	MEF (mouse embryonic fibroblasts)	NULL
EXP034351	smad	Homo sapiens		NULL	786	unspecified	Q15796	NCI-H345 (small cell lung carcinoma)	NULL
EXP034352		Mus musculus		NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP034353	Made in Lab (Harms et al. 2014. Cell Metab.)	Mus musculus		EXP034352	115	unspecified	A2A935	brown adipose tissue	NULL
EXP034354	Made in Lab (Harms et al. 2014. Cell Metab.)	Mus musculus	Prdm16 KO	EXP034352	115	unspecified	A2A935	brown adipose tissue	NULL
EXP034355	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP034356	sc-5279, Santa Cruz	Mus musculus	shCtrl	EXP034355	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP034357	sc-5279, Santa Cruz	Mus musculus	shNup153-2	EXP034355	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP034358	none	Mus musculus	Non-stimulated control	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP034359	Santa Cruz (sc-15408)	Mus musculus	Non-stimulated control	EXP034358	159	unspecified	Q61687	cortical neurons	NULL
EXP034360	Santa Cruz (sc-15408)	Mus musculus	KCl stimulated (Isotonic KCl, 55 mM)	EXP034358	159	unspecified	Q61687	cortical neurons	NULL
EXP034361	none	Mus musculus		NULL	522	chip_control	NULL	kidney cortex	NULL
EXP034362	WT1 (Santa Cruz, sc-192, Lot F1711)	Mus musculus		EXP034361	522	unspecified	P22561	kidney cortex	NULL
EXP034363	HA : IGBMC (12CA5)	Homo sapiens		NULL	26	chip_control	NULL	501Mel (melanoma)	NULL
EXP034364	HA : IGBMC (12CA5)	Homo sapiens		EXP034363	26	unspecified	O75030	501Mel (melanoma)	NULL
EXP034365	IgG	Homo sapiens	Dexamethasone (24h)	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP034366	IgG	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP034367	Anti-Flag antibody	Homo sapiens	Dexamethasone (24h)	NULL	10	unspecified	P04150	HEK293T (embryonic kidney)	NULL
EXP034368	Anti-Flag antibody	Homo sapiens		EXP034366	10	unspecified	O00327	HEK293T (embryonic kidney)	NULL
EXP034369	none	Homo sapiens	IL1	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP034370	none	Homo sapiens		NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP034371	none	Homo sapiens	1ÂµM 5Z-7-oxozeaenol for 1 h	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP034372	none	Homo sapiens	1ÂµM 5Z-7-oxozeaenol for 1 h + IL1	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP034373	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens		EXP034370	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP034374	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	IL1	EXP034369	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP034375	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	5ÂµM PHA-408	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP034376	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	5ÂµM PHA-408 + IL1	NULL	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP034377	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	1ÂµM 5Z-7-oxozeaenol for 1 h	EXP034371	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP034378	anti-p65 (Santa Cruz, catalog# sc-372, Lot #K2210)	Homo sapiens	1ÂµM 5Z-7-oxozeaenol for 1 h + IL1	EXP034372	519	unspecified	Q04206	KB (cervical adenocarcinoma)	NULL
EXP034379		Homo sapiens		NULL	789	chip_control	NULL	SGBS (Simpson Golabi Behmel syndrome type 1 adipocytes)	NULL
EXP034380		Homo sapiens	TNF	NULL	789	chip_control	NULL	SGBS (Simpson Golabi Behmel syndrome type 1 adipocytes)	NULL
EXP034381	RELA (C-20, sc-372, Santa Cruz)	Homo sapiens	TNF	EXP034380	789	unspecified	Q04206	SGBS (Simpson Golabi Behmel syndrome type 1 adipocytes)	NULL
EXP034382	RELA (C-20, sc-372, Santa Cruz)	Homo sapiens		EXP034379	789	unspecified	Q04206	SGBS (Simpson Golabi Behmel syndrome type 1 adipocytes)	NULL
EXP034383	none	Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP034384	sc-8431	Homo sapiens		EXP034383	215	unspecified	Q9H3D4	keratinocytes	NULL
EXP034385		Mus musculus		NULL	320	chip_control	NULL	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034386	anti-HA	Mus musculus		EXP034385	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034387	anti-HA	Mus musculus	GATA1 short isoform	EXP034385	320	unspecified	P17679	G1ME (megakaryocyte progenitor cell line)	NULL
EXP034388	none (input)	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP034389	none (input)	Mus musculus	NFAT1 KO Mock	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP034390	none (input)	Mus musculus	NFAT1 KO CA-RIT-RV	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP034391	none (input)	Mus musculus	P+I 1h	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP034392	none (input)	Mus musculus	NFAT1 KO P+I 1h	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP034393	none (input)	Mus musculus	NFAT1 KO CA-RIT-RV P+I 1h	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP034394	anti-mouse NFAT1 (67.1)	Mus musculus		EXP034388	2479	unspecified	Q60591	CD8+ T-cells	NULL
EXP034395	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO Mock	EXP034389	2479	unspecified	Q60591	CD8+ T-cells	NULL
EXP034396	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO CA-RIT-RV	EXP034390	2479	unspecified	Q60591	CD8+ T-cells	NULL
EXP034397	anti-mouse NFAT1 (67.1)	Mus musculus	P+I 1h	EXP034391	2479	unspecified	Q60591	CD8+ T-cells	NULL
EXP034398	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO P+I 1h	EXP034392	2479	unspecified	Q60591	CD8+ T-cells	NULL
EXP034399	anti-mouse NFAT1 (67.1)	Mus musculus	NFAT1 KO CA-RIT-RV P+I 1h	EXP034393	2479	unspecified	Q60591	CD8+ T-cells	NULL
EXP034400	none (input)	Mus musculus		NULL	321	chip_control	NULL	medulloblastoma, type G3	NULL
EXP034401	none (input)	Mus musculus		NULL	321	chip_control	NULL	medulloblastoma, type G3	NULL
EXP034402	none (input)	Mus musculus		NULL	791	chip_control	NULL	Sonic Hedgehog medulloblastoma	NULL
EXP034403	10E2	Mus musculus		EXP034400	321	unspecified	Q60821	medulloblastoma, type G3	NULL
EXP034404	N262 (sc-764)	Mus musculus		EXP034400	321	unspecified	P01108	medulloblastoma, type G3	NULL
EXP034405	10E2	Mus musculus		EXP034401	321	unspecified	Q60821	medulloblastoma, type G3	NULL
EXP034406	B8.4.B (sc-53993, Lot#D0214)	Mus musculus		EXP034401	321	unspecified	P03966	medulloblastoma, type G3	NULL
EXP034407	10E2	Mus musculus		EXP034402	791	unspecified	Q60821	Sonic Hedgehog medulloblastoma	NULL
EXP034408	B8.4.B (sc-53993, Lot#D0214)	Mus musculus		EXP034402	791	unspecified	P03966	Sonic Hedgehog medulloblastoma	NULL
EXP034409		Mus musculus		NULL	136	chip_control	NULL	white adipose tissue	NULL
EXP034410		Mus musculus		NULL	4	chip_control	NULL	inguinal white adipose tissue	NULL
EXP034411		Mus musculus		NULL	4	chip_control	NULL	inguinal white adipose tissue	NULL
EXP034412	sc-7196	Mus musculus	standard rodent chow diet	EXP034409	136	unspecified	P37238	white adipose tissue	NULL
EXP034413	sc-7196	Mus musculus	standard rodent chow diet	EXP034410	4	unspecified	P37238	inguinal white adipose tissue	NULL
EXP034414	anti-PPAR? antibody	Mus musculus	standard rodent chow diet	EXP034411	4	unspecified	P37238	inguinal white adipose tissue	NULL
EXP034415	sc-7196	Mus musculus		NULL	18	unspecified	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP034416	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus	standard rodent chow diet	EXP034409	136	unspecified	P06537	white adipose tissue	NULL
EXP034417	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus	standard rodent chow diet	EXP034410	4	unspecified	P06537	inguinal white adipose tissue	NULL
EXP034418	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus		NULL	136	unspecified	P06537	white adipose tissue	NULL
EXP034419	Affinity BioReagents, PA1-511A (3 ug)	Mus musculus		NULL	3	unspecified	P06537	epididymal white adipose tissue	NULL
EXP034420	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034421	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034422	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034423	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034424	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034425	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034426	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034427	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034428	sc-7196	Mus musculus	low fat diet	NULL	136	unspecified	P37238	white adipose tissue	NULL
EXP034429	sc-7196	Mus musculus	low fat diet	NULL	3	unspecified	P37238	epididymal white adipose tissue	NULL
EXP034430	sc-7196	Mus musculus	standard rodent chow diet	NULL	136	unspecified	P37238	white adipose tissue	NULL
EXP034431	sc-7196	Mus musculus	standard rodent chow diet	NULL	3	unspecified	P37238	epididymal white adipose tissue	NULL
EXP034432	sc-7196	Mus musculus	standard rodent chow diet	NULL	3	unspecified	P37238	epididymal white adipose tissue	NULL
EXP034433	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034434	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034435	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034436	sc-7196	Homo sapiens		NULL	807	unspecified	P37231	subcutaneous white adipose tissue	NULL
EXP034437	ascl1	Mus musculus		NULL	75	unspecified	Q02067	AtT-20 (pituitary tumor)	NULL
EXP034438	anti-TBX19 (HPA005800, Sigma-Aldrich)	Mus musculus		NULL	75	unspecified	Q99ME7	AtT-20 (pituitary tumor)	NULL
EXP034439	Sigma HPA003479	Homo sapiens		NULL	697	unspecified	P78545	pancreatic ductal adenocarcinoma	NULL
EXP034440	Abcam 23738	Homo sapiens		NULL	697	unspecified	P55317	pancreatic ductal adenocarcinoma	NULL
EXP034441	Sigma HPA002083	Homo sapiens		NULL	697	unspecified	P35680	pancreatic ductal adenocarcinoma	NULL
EXP034442	SC-640	Homo sapiens		NULL	697	unspecified	P10914	pancreatic ductal adenocarcinoma	NULL
EXP034443	Millipore 07-1580	Homo sapiens		NULL	697	unspecified	Q13887	pancreatic ductal adenocarcinoma	NULL
EXP034444	SC-25388	Homo sapiens		NULL	697	unspecified	P37275	pancreatic ductal adenocarcinoma	NULL
EXP034445	RnD AF3640	Homo sapiens		NULL	697	unspecified	O43474	pancreatic ductal adenocarcinoma	NULL
EXP034446	Anti-KLF6 (SCBT # SC-7158)	Homo sapiens		NULL	697	unspecified	Q99612	pancreatic ductal adenocarcinoma	NULL
EXP034447	Anti-ELF3 (Sigma # HPA003479)	Homo sapiens	KLF5 KO	NULL	697	unspecified	P78545	pancreatic ductal adenocarcinoma	NULL
EXP034448	Anti-FOXA1 (Abcam # 23738)	Homo sapiens	KLF5 KO	NULL	697	unspecified	P55317	pancreatic ductal adenocarcinoma	NULL
EXP034449	Anti-ELF3 (Sigma # HPA003479)	Homo sapiens		NULL	697	unspecified	P78545	pancreatic ductal adenocarcinoma	NULL
EXP034450	Anti-FOXA1 (Abcam # 23738)	Homo sapiens		NULL	697	unspecified	P55317	pancreatic ductal adenocarcinoma	NULL
EXP034451	RUNX1	Mus musculus		NULL	278	unspecified	Q03347	embryonic stem cell-derived myeloid progenitors	NULL
EXP034452	RUNX1	Mus musculus	induced	NULL	278	unspecified	Q03347	embryonic stem cell-derived myeloid progenitors	NULL
EXP034453	MyoD antibody 6196	Mus musculus	MyoD transduction	NULL	705	unspecified	P10085	P19 (embryonic carcinoma)	NULL
EXP034454	MyoD antibody 6975	Mus musculus	MyoD transduction	NULL	705	unspecified	P10085	P19 (embryonic carcinoma)	NULL
EXP034455	NeuroD2 antibody 1165	Mus musculus	NeuroD2 transduction	NULL	705	unspecified	Q62414	P19 (embryonic carcinoma)	NULL
EXP034456	NeuroD2 antibody 1240	Mus musculus	NeuroD2 transduction	NULL	705	unspecified	Q62414	P19 (embryonic carcinoma)	NULL
EXP034457	NeuroD2 antibody 1240	Mus musculus		NULL	705	unspecified	Q62414	P19 (embryonic carcinoma)	NULL
EXP034458	MyoD antibody 6975	Mus musculus		NULL	705	unspecified	P10085	P19 (embryonic carcinoma)	NULL
EXP034459	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034460	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034461	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034462	Santa cruz N21	Homo sapiens		EXP034459	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034463	homemade	Homo sapiens		EXP034460	70	unspecified	P11473	LNCaP (prostate carcinoma)	NULL
EXP034464	Abcam, ab5090	Homo sapiens		EXP034461	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP034465		Rattus norvegicus		NULL	921	chip_control	NULL	spinal cord	NULL
EXP034466		Rattus norvegicus		NULL	785	chip_control	NULL	sciatic nerve	NULL
EXP034467	Sox-10; Santa Cruz Biotechnology, sc-17342x	Rattus norvegicus		EXP034465	921	unspecified	O55170	spinal cord	NULL
EXP034468	Sox-10; Santa Cruz Biotechnology, sc-17342x	Rattus norvegicus		EXP034466	785	unspecified	O55170	sciatic nerve	NULL
EXP034469	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens		NULL	890	unspecified	P51692	CD8+ T-cells	NULL
EXP034470	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	IL2	NULL	890	unspecified	P51692	CD8+ T-cells	NULL
EXP034471	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	H9	NULL	890	unspecified	P51692	CD8+ T-cells	NULL
EXP034472	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	H9RET	NULL	890	unspecified	P51692	CD8+ T-cells	NULL
EXP034473	STAT5B (Invitrogen, 135300, LOT-1477602A)	Homo sapiens	H9RETR	NULL	890	unspecified	P51692	CD8+ T-cells	NULL
EXP034474	anti-Ig (Dako, catalog# X0936, lot# 73343)	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034475	none (input)	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034476	anti-Ig (Dako, catalog# X0936, lot# 73343)	Mus musculus	NLRP3KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034477	none (input)	Mus musculus	NLRP3KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034478	anti-STAT6 (Cell Signalling, catalog# sc9362, lot# 4)	Mus musculus		EXP034474	1058	unspecified	P52633	CD4+ T-cells	NULL
EXP034479	anti-IRF4 (Santa Cruz, catalog# sc6059, lot# B2614)	Mus musculus		EXP034474	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP034480	anti-BATF (Cell Signalling, catalog# sc8638, lot# 1)	Mus musculus		EXP034474	1058	unspecified	O35284	CD4+ T-cells	NULL
EXP034481	anti-STAT6 (Cell Signalling, catalog# sc9362, lot# 4)	Mus musculus	NLRP3KO	EXP034476	1058	unspecified	P52633	CD4+ T-cells	NULL
EXP034482	anti-IRF4 (Santa Cruz, catalog# sc6059, lot# B2614)	Mus musculus	NLRP3KO	EXP034476	1058	unspecified	Q64287	CD4+ T-cells	NULL
EXP034483	anti-BATF (Cell Signalling, catalog# sc8638, lot# 1)	Mus musculus	NLRP3KO	EXP034476	1058	unspecified	O35284	CD4+ T-cells	NULL
EXP034484		Homo sapiens		NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP034485	LEF-1 (homemade)	Homo sapiens		EXP034484	878	unspecified	Q9UJU2	embryonic stem cells	NULL
EXP034486	LEF-1 (homemade)	Homo sapiens	Wnt3a 4h	EXP034484	878	unspecified	Q9UJU2	embryonic stem cells	NULL
EXP034487	none	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP034488	CREB (clone: 48H2)	Mus musculus		EXP034487	81	unspecified	Q01147	BMDM (bone marrow-derived macrophages)	NULL
EXP034489	Runx1, ab23980	Homo sapiens		NULL	45	unspecified	Q01196	acute myeloblastic leukemia	NULL
EXP034490	Santa Cruz Biotechnology; sc-253	Homo sapiens	siMM	NULL	641	unspecified	P01100	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP034491	Santa Cruz Biotechnology; sc-253	Homo sapiens	siFLT3	NULL	641	unspecified	P01100	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP034492	Santa Cruz Biotechnology; sc-835	Homo sapiens		NULL	641	unspecified	P42229	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP034493	Abcam; ab23980	Homo sapiens		NULL	45	unspecified	Q01196	acute myeloblastic leukemia	NULL
EXP034494	Abcam; ab23980	Homo sapiens		NULL	724	unspecified	Q01196	stem cells from periferal blood	NULL
EXP034495	sc-6243	Homo sapiens		NULL	430	unspecified	P04637	HepG2 (hepatoblastoma)	NULL
EXP034496	sc-6243	Homo sapiens	HBV HBx protein expressing	NULL	430	unspecified	P04637	HepG2 (hepatoblastoma)	NULL
EXP034498	none (input)	Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP034500	dmrt1 Antibody (PMID: 11040213)	Mus musculus		EXP034498	32	unspecified	Q9QZ59	testis	NULL
EXP034501	sc-816	Homo sapiens	ethanol	NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP034502	sc-816	Homo sapiens	10 nmol/l of mibolerone	NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP034503	sc-816	Homo sapiens	ethanol	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034504	sc-816	Homo sapiens	10 nmol/l of mibolerone	NULL	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034505		Mus musculus		NULL	222	chip_control	NULL	A2lox (embryonic stem cells)	NULL
EXP034506	neurod1	Mus musculus		EXP034505	222	unspecified	Q60867	A2lox (embryonic stem cells)	NULL
EXP034507	Abcam ab19857	Mus musculus		NULL	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP034508	Tcf4 (Santa Cruz, Cat# SC-8631, Lot# J0709)	Rattus norvegicus	proliferation medium	NULL	696	unspecified	D4A8X6	oligodendrocyte progenitors	NULL
EXP034509	Tcf4 (Santa Cruz, Cat# SC-8631, Lot# J0709)	Rattus norvegicus	T3 treated for 1 day	NULL	696	unspecified	D4A8X6	oligodendrocyte progenitors	NULL
EXP034510	Tcf4 (Santa Cruz, Cat# SC-8631, Lot# J0709)	Rattus norvegicus	T3 treated for 3 days	NULL	696	unspecified	D4A8X6	oligodendrocyte progenitors	NULL
EXP034511		Mus musculus		NULL	429	chip_control	NULL	hepatocytes	NULL
EXP034512		Mus musculus	cebpa KO	NULL	429	chip_control	NULL	hepatocytes	NULL
EXP034513	V5 (Abcam ab15828)	Mus musculus		EXP034511	429	unspecified	A2BH40	hepatocytes	NULL
EXP034514	C/ebp? (Santa Cruz, sc-61)	Mus musculus		EXP034511	429	unspecified	P53566	hepatocytes	NULL
EXP034515	C/ebp? (Santa Cruz, sc-61)	Mus musculus	cebpa KO	EXP034512	429	unspecified	P53566	hepatocytes	NULL
EXP034516	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034517	RUNX1	Homo sapiens		EXP034516	113	unspecified	Q01196	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034518	input	Mus musculus		NULL	195	chip_control	NULL	crypt cells	NULL
EXP034519	anti-Tcf4 (Cell signaling, catalog 2569S and lot2)	Mus musculus	Ring KO	EXP034518	195	unspecified	Q924A0	crypt cells	NULL
EXP034520	anti-Tcf4 (Cell signaling, catalog 2569S and lot2)	Mus musculus		EXP034518	195	unspecified	Q924A0	crypt cells	NULL
EXP034521	none (input control)	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034522	none (input control)	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP034523	anti-AML1 (C19) (ab23980; Abcam)	Homo sapiens		EXP034521	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034524	anti-AML1 (N20) (sc-8563 X; Santa Cruz Biotechnology)	Homo sapiens		EXP034521	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP034525	anti-AML1 (C19) (ab23980; Abcam)	Homo sapiens		EXP034522	65	unspecified	Q01196	U937 (adult acute monocytic leukemia)	NULL
EXP034526	none (input)	Homo sapiens	Pool of control and Bptf-silenced cells transduced with MycER, treated with 4-hydroxytamoxifen (4-OHT)	NULL	659	chip_control	NULL	neonatal foreskin fibroblasts	NULL
EXP034527	anti-MYC N262 (Santa Cruz Biotechnology, catalog number sc-764)	Homo sapiens	transduced with MycER and BPTF-targeting shRNA, treated with 4-hydroxytamoxifen (4-OHT)	EXP034526	659	unspecified	P01106	neonatal foreskin fibroblasts	NULL
EXP034528	anti-MYC N262 (Santa Cruz Biotechnology, catalog number sc-764)	Homo sapiens	transduced with MycER and control shRNA, treated with 4-hydroxytamoxifen (4-OHT)	EXP034526	659	unspecified	P01106	neonatal foreskin fibroblasts	NULL
EXP034529	none, input	Mus musculus	3 day in vitro culture for Th0	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034530	none, input_	Mus musculus	3 day in vitro culture for Th0, treatment (IL6)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034531	none, input_	Mus musculus	3 day in vitro culture for Th0, treatment (IL27)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034532	none, input_	Mus musculus	3 day in vitro culture for Th0, STAT1 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034533	none, input	Mus musculus	3 day in vitro culture for Th0, treatment (IL6), STAT1 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034534	none, input	Mus musculus	3 day in vitro culture for Th0, treatment (IL27), STAT1 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034535	none, input	Mus musculus	3 day in vitro culture for Th0, STAT3 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034536	none, input	Mus musculus	3 day in vitro culture for Th0, treatment (IL6), STAT3 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034537	none, input	Mus musculus	3 day in vitro culture for Th0, treatment (IL27), STAT3 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034538	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0	EXP034529	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034539	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0	EXP034529	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034540	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6)	EXP034530	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034541	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6)	EXP034530	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034542	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27)	EXP034531	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034543	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27)	EXP034531	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034544	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, STAT1 KO	EXP034532	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034545	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6), STAT1 KO	EXP034533	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034546	STAT3 (eBioscience, #14-6727-81)(Lot #E034014)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27), STAT1 KO	EXP034534	1058	unspecified	P42227	CD4+ T-cells	NULL
EXP034547	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, STAT3 KO	EXP034535	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034548	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL6), STAT3 KO	EXP034536	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034549	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	Mus musculus	3 day in vitro culture for Th0, treatment (IL27), STAT3 KO	EXP034537	1058	unspecified	P42225	CD4+ T-cells	NULL
EXP034550	None	Homo sapiens		NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP034551	None	Homo sapiens		NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP034552	None	Homo sapiens		NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP034553	None	Homo sapiens		NULL	669	chip_control	NULL	NGP (neuroblastoma)	NULL
EXP034554	None	Homo sapiens		NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP034555	GATA3	Homo sapiens		NULL	520	unspecified	P23771	Kelly (neuroblastoma)	NULL
EXP034556	GATA3	Homo sapiens		EXP034550	664	unspecified	P23771	SH-SY5Y (neuroblastoma)	NULL
EXP034557	GATA3	Homo sapiens		EXP034554	82	unspecified	P23771	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP034558	GATA3	Homo sapiens		EXP034552	82	unspecified	P23771	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP034559	GATA3	Homo sapiens		EXP034553	669	unspecified	P23771	NGP (neuroblastoma)	NULL
EXP034560	RXR (Santa Cruz, SC-774)	Mus musculus		NULL	233	unspecified	P28700	E14TG2A (embryonic stem cells)	NULL
EXP034561	Nur77 (Santa Cruz, SC-5569)	Mus musculus		NULL	233	unspecified	P12813	E14TG2A (embryonic stem cells)	NULL
EXP034562	RXR (Santa Cruz, SC-774)	Mus musculus	1um Retinoic Acid (RA) for 48hrs	NULL	233	unspecified	P28700	E14TG2A (embryonic stem cells)	NULL
EXP034563	Nur77 (Santa Cruz, SC-5569)	Mus musculus	1um Retinoic Acid (RA) for 48hrs	NULL	233	unspecified	P12813	E14TG2A (embryonic stem cells)	NULL
EXP034564		Mus musculus		NULL	151	chip_control	NULL	CCE (embryonic stem cells)	NULL
EXP034565	SC-55351x	Mus musculus		EXP034564	151	unspecified	Q3U0X6	CCE (embryonic stem cells)	NULL
EXP034566	none (Whole cell extract)	Mus musculus	Smchd1 null	NULL	229	chip_control	NULL	E14.5 brain-derived neural progenitor cells	NULL
EXP034567	none (Whole cell extract)	Mus musculus		NULL	229	chip_control	NULL	E14.5 brain-derived neural progenitor cells	NULL
EXP034568	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	Ctcf.6 shRNA	EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	NULL
EXP034569	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	Ctcf.7 shRNA	EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	NULL
EXP034570	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	Smchd1 null	EXP034567	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	NULL
EXP034571	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus	non-silencing shRNA	EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	NULL
EXP034572	Ctcf (Millipore, 07-729, lot 2452497)	Mus musculus		EXP034566	229	unspecified	Q61164	E14.5 brain-derived neural progenitor cells	NULL
EXP034573	GKLF, Santa Cruz Biotechnology, sc-20691, Lot# J1212	Mus musculus		NULL	612	unspecified	Q60793	mixture of cell types	NULL
EXP034574	GKLF, Santa Cruz Biotechnology, sc-20691, Lot# J1212	Mus musculus	KLF4 KO	NULL	612	unspecified	Q60793	mixture of cell types	NULL
EXP034575	none, input	Homo sapiens		NULL	261	chip_control	NULL	epidermal stem cells	NULL
EXP034576	none, input	Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP034577	none, input	Homo sapiens	shDNMT3A	NULL	261	chip_control	NULL	epidermal stem cells	NULL
EXP034578	none, input	Homo sapiens	shDNMT3B	NULL	315	chip_control	NULL	foreskin	NULL
EXP034579	Dnmt3a (SantaCruz H-295	Homo sapiens		EXP034576	215	unspecified	Q9Y6K1	keratinocytes	NULL
EXP034580	Dnmt3b (Novus Biotechnology. Cat: NB100-266)	Homo sapiens		NULL	215	unspecified	Q9UBC3	keratinocytes	NULL
EXP034581	DNMT3A SantaCruz (H-295)	Homo sapiens	shDNMT3A	EXP034577	261	unspecified	Q9Y6K1	epidermal stem cells	NULL
EXP034582	DNMT3B Novus (NB300-516)	Homo sapiens	shDNMT3B	EXP034578	315	unspecified	Q9UBC3	foreskin	NULL
EXP034583	DNMT3A SantaCruz (H-295)	Homo sapiens	shSETD2	EXP034575	261	unspecified	Q9Y6K1	epidermal stem cells	NULL
EXP034584	DNMT3B Novus (NB300-516)	Homo sapiens	shSETD2	EXP034575	261	unspecified	Q9UBC3	epidermal stem cells	NULL
EXP034585	Dnmt3a (SantaCruz H-295	Homo sapiens		EXP034575	261	unspecified	Q9Y6K1	epidermal stem cells	NULL
EXP034586	Dnmt3b (Novus Biotechnology. Cat: NB100-266)	Homo sapiens		EXP034575	261	unspecified	Q9UBC3	epidermal stem cells	NULL
EXP034587	none	Homo sapiens	siNS	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP034588	none	Homo sapiens	siHic5	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP034589	GR (Santa Cruz)	Homo sapiens	siNS	EXP034587	848	unspecified	P04150	U2OS (osteosarcoma)	NULL
EXP034590	GR (Santa Cruz)	Homo sapiens	siHic5	EXP034588	848	unspecified	P04150	U2OS (osteosarcoma)	NULL
EXP034591	none	Mus musculus	rest	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034592	none	Mus musculus	restimulated	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP034593	SantaCruz, catalog# sc-232X	Mus musculus	rest	EXP034591	1058	unspecified	P25425	CD4+ T-cells	NULL
EXP034594	SantaCruz, catalog# sc-232X	Mus musculus	restimulated	EXP034592	1058	unspecified	P25425	CD4+ T-cells	NULL
EXP034595	none (input)	Homo sapiens		NULL	864	chip_control	NULL	WHIM12 (breast cancer)	NULL
EXP034596	Polyclonal V5 Antibody (Abcam, catalog# 9116)	Homo sapiens		EXP034595	864	unspecified	P49910	WHIM12 (breast cancer)	NULL
EXP034597	anti-IgG (Jackson ImmunoResearch, catalog# 011-000-003, lot# 79330)	Mus musculus		NULL	631	chip_control	NULL	placenta	NULL
EXP034598	anti-Grhl2 (Sigma Aldrich, catalog# HPA004820, lot# A35809)	Mus musculus		EXP034597	631	unspecified	Q8K5C0	placenta	NULL
EXP034599	input	Homo sapiens	Bicalutamide 1 Î¼M	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034600	input	Homo sapiens	Bicalutamide 1 Î¼M	NULL	90	chip_control	NULL	BicR (prostate cancer)	NULL
EXP034601	input	Homo sapiens	ethanol	NULL	90	chip_control	NULL	BicR (prostate cancer)	NULL
EXP034602	input	Homo sapiens	DHT 10 nM	NULL	90	chip_control	NULL	BicR (prostate cancer)	NULL
EXP034603	AR (santacruz H-280)	Homo sapiens	Bicalutamide 1 Î¼M	EXP034599	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP034604	AR (santacruz H-280)	Homo sapiens	DHT 10 nM	EXP034602	90	unspecified	P10275	BicR (prostate cancer)	NULL
EXP034605	AR (santacruz H-280)	Homo sapiens	Bicalutamide 1 Î¼M	EXP034600	90	unspecified	P10275	BicR (prostate cancer)	NULL
EXP034606	AR (santacruz H-280)	Homo sapiens	ethanol	EXP034601	90	unspecified	P10275	BicR (prostate cancer)	NULL
EXP034607		Mus musculus	expressing Blimp-1-eGFP fusion protein	NULL	799	chip_control	NULL	small intestine	NULL
EXP034608		Mus musculus		NULL	799	chip_control	NULL	small intestine	NULL
EXP034609		Mus musculus	Prdm1/Blimp-1 mutant	NULL	799	chip_control	NULL	small intestine	NULL
EXP034610	GFP Tag Antibody (3E6)	Mus musculus	expressing Blimp-1-eGFP fusion protein	EXP034607	799	unspecified	Q60636	small intestine	NULL
EXP034611	polyclonal rabbit anti-Irf1 antibody (M-20)	Mus musculus		EXP034608	799	unspecified	P15314	small intestine	NULL
EXP034612	polyclonal rabbit anti-Irf1 antibody (M-20)	Mus musculus	Prdm1/Blimp-1 mutant	EXP034609	799	unspecified	P15314	small intestine	NULL
EXP034613	Rabbit IgG (Sigma, I5006)	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP034614	TEF-3 (N-G2) (SCBT, sc-101184, lot C2812)	Homo sapiens		EXP034613	2301	unspecified	Q15561	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP034615	JUN (BD Bioscience, 610326, lot 3263734)	Homo sapiens		EXP034613	2301	unspecified	P05412	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP034616	none	Mus musculus		NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP034617	Pu.1 (sc-352; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P17433	acute myeloid leukemia	NULL
EXP034618	Fli1 (ab15289; Abcam)	Mus musculus		EXP034616	1493	unspecified	P26323	acute myeloid leukemia	NULL
EXP034619	Erg (sc-354; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P81270	acute myeloid leukemia	NULL
EXP034620	C/EBP? (sc-61; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P53566	acute myeloid leukemia	NULL
EXP034621	C/EBP? (sc-150; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P28033	acute myeloid leukemia	NULL
EXP034622	Myb (sc-7874; Santa Cruz)	Mus musculus		EXP034616	1493	unspecified	P06876	acute myeloid leukemia	NULL
EXP034623	none	Mus musculus		NULL	31	chip_control	NULL	8946 cells - Flag-Zmiz1/ L1601PDP (T lymphoblastic leukemia)	NULL
EXP034624	Rbpj (Cell Signaling Technology, 5313)	Mus musculus		EXP034623	31	unspecified	P31266	8946 cells - Flag-Zmiz1/ L1601PDP (T lymphoblastic leukemia)	NULL
EXP034625	C/EBP beta antibody (Santa Cruz, catalog# sc-150, lot# co513)	Homo sapiens		NULL	911	unspecified	P17676	macrophages	NULL
EXP034626	C/EBP beta antibody (Santa Cruz, catalog# sc-150, lot# co513)	Homo sapiens	oxLDL (50mcg/ml)	NULL	911	unspecified	P17676	macrophages	NULL
EXP034627	none	Homo sapiens		NULL	145	chip_control	NULL	Caco-2 (colon adenocarcinoma)	NULL
EXP034628	FOXA2 (Santa-Cruz sc-6554)	Homo sapiens		EXP034627	145	unspecified	Q9Y261	Caco-2 (colon adenocarcinoma)	NULL
EXP034629	none	Mus musculus		NULL	80	chip_control	NULL	B lymphoblastic leukemia	NULL
EXP034630	Pu.1 (#2266, Cell Signaling)	Mus musculus		EXP034629	80	unspecified	P17433	B lymphoblastic leukemia	NULL
EXP034631	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP034632	Satb1 (AbCam ab109122)	Mus musculus		EXP034631	44	unspecified	Q60611	T-cells	NULL
EXP034633	none	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP034634	HA (Abcam ab 9110)	Homo sapiens		EXP034633	440	unspecified	P01106	HMEC (human mammary epithelial cells)	NULL
EXP034635	NCOR2  (PA1-843) (Thermo Scientific)	Mus musculus		NULL	81	unspecified	Q9WU42	BMDM (bone marrow-derived macrophages)	NULL
EXP034636	IgG	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP034637	Mouse normal IgG	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP034638	sc-126, Santa Cruz	Homo sapiens		EXP034637	2301	unspecified	P04637	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP034639	rabbit polyclonal anti-H3K4me1 antibody (Abcam cat.# 8895)	Homo sapiens	GM-CSF (72h)	NULL	729	chip_control	NULL	macrophages form periferal blood	NULL
EXP034640	rabbit polyclonal anti-H3K4me1 antibody (Abcam cat.# 8895)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + IFN-y	NULL	729	chip_control	NULL	macrophages form periferal blood	NULL
EXP034641	rabbit polyclonal anti-H3K4me1 antibody (Abcam cat.# 8895)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + IL4	NULL	729	chip_control	NULL	macrophages form periferal blood	NULL
EXP034642	rabbit polyclonal anti-H3K4me1 antibody (Abcam cat.# 8895)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + TNF-a + PGE2 + Pam3CSK4	NULL	729	chip_control	NULL	macrophages form periferal blood	NULL
EXP034643	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF (72h)	EXP034639	729	unspecified	P17947	macrophages form periferal blood	NULL
EXP034644	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + IFN-y	EXP034640	729	unspecified	P17947	macrophages form periferal blood	NULL
EXP034645	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + IL4	EXP034641	729	unspecified	P17947	macrophages form periferal blood	NULL
EXP034646	PU.1 polyclonal rabbit antibody (SantaCruz, sc-352)	Homo sapiens	GM-CSF for 72h and additional 72h with GM-CSF + TNF-a + PGE2 + Pam3CSK4	EXP034642	729	unspecified	P17947	macrophages form periferal blood	NULL
EXP034647	BETHYL A302-564A	Homo sapiens		NULL	691	unspecified	Q8IVW6	OECM1 (oral cavity squamous cell carcinoma)	NULL
EXP034648	BETHYL A302-564A	Homo sapiens	ARID3B KD	NULL	691	unspecified	Q8IVW6	OECM1 (oral cavity squamous cell carcinoma)	NULL
EXP034649		Mus musculus		NULL	159	chip_control	NULL	cortical neurons	NULL
EXP034650	Abcam ab79436	Mus musculus	minus	EXP034649	159	unspecified	Q8CFN5	cortical neurons	NULL
EXP034651	Abcam ab79436	Mus musculus	plus	EXP034649	159	unspecified	Q8CFN5	cortical neurons	NULL
EXP034652	Santa Cruz Biotechnologies sc-313	Mus musculus	minus	EXP034649	159	unspecified	Q60929	cortical neurons	NULL
EXP034653	Santa Cruz Biotechnologies sc-313	Mus musculus	plus	EXP034649	159	unspecified	Q60929	cortical neurons	NULL
EXP034654	Rosenfeld Lab	Mus musculus	minus	EXP034649	159	unspecified	Q60974	cortical neurons	NULL
EXP034655	Rosenfeld lab	Mus musculus	plus	EXP034649	159	unspecified	Q60974	cortical neurons	NULL
EXP034656	none	Mus musculus		NULL	104	chip_control	NULL	dendritic cells	NULL
EXP034657	anti-Batf3	Mus musculus		EXP034656	311	unspecified	Q9D275	CD24+ dendritic cells	NULL
EXP034658	anti-Irf8	Mus musculus		EXP034656	311	unspecified	P23611	CD24+ dendritic cells	NULL
EXP034659	anti-Batf3	Mus musculus		EXP034656	310	unspecified	Q9D275	CD172+ dendritic cells	NULL
EXP034660	anti-Irf8	Mus musculus		EXP034656	312	unspecified	P23611	plasmacytoid dendritic cells	NULL
EXP034661	normal rabbit IgG	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP034662	none	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP034663	none	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP034664	anti-Flag	Mus musculus	Flag-Six4	EXP034661	1153	unspecified	Q61321	C2C12 (myoblasts)	NULL
EXP034665	anti-Six4	Mus musculus	shNS	EXP034663	1153	unspecified	Q61321	C2C12 (myoblasts)	NULL
EXP034666	anti-Six4	Mus musculus	shSix4	EXP034662	1153	unspecified	Q61321	C2C12 (myoblasts)	NULL
EXP034667	HIF1? (ab2185, Abcam)	Homo sapiens	hypoxia	NULL	78	unspecified	Q16665	HeLa (cervical adenocarcinoma)	NULL
EXP034668	E2F7 (sc-66870, Santa Cruz Biotechnology)	Homo sapiens	normoxia	NULL	78	unspecified	Q96AV8	HeLa (cervical adenocarcinoma)	NULL
EXP034669	E2F7 (sc-66870, Santa Cruz Biotechnology)	Homo sapiens	hypoxia	NULL	78	unspecified	Q96AV8	HeLa (cervical adenocarcinoma)	NULL
EXP034670	none	Mus musculus		NULL	313	chip_control	NULL	forebrain	NULL
EXP034671	none	Mus musculus		NULL	539	chip_control	NULL	lens	NULL
EXP034672	Pax6 (Millipore, ab2237, lot# NG1731333)	Mus musculus		EXP034671	539	unspecified	P63015	lens	NULL
EXP034673	Pax6 (Millipore, ab2237, lot# NG1731333)	Mus musculus		EXP034670	313	unspecified	P63015	forebrain	NULL
EXP034674	none (input)	Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP034675	Ikaros (Ik-C, rabbit antibody (kind gift of S.Smale))	Mus musculus		EXP034674	105	unspecified	Q03267	pro-B cells	NULL
EXP034676	Ikaros (Ik-C, rabbit antibody (kind gift of S.Smale))	Mus musculus		NULL	198	unspecified	Q03267	pre-pro-B-cells	NULL
EXP034677	input	Homo sapiens		NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP034678	input	Homo sapiens	CASP1	NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP034679	sc-1003	Homo sapiens	CASP1	EXP034678	646	unspecified	P04150	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP034680	sc-1003	Homo sapiens		EXP034677	646	unspecified	P04150	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP034681	VSV (V4888, Sigma)	Homo sapiens	16 hours doxycyclin	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP034682	p53	Homo sapiens	16 hours doxycyclin, p53-VSV	EXP034681	821	unspecified	P04637	SW480 (colon adenocarcinoma)	NULL
EXP034683	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034684	GATA3 (sigma)	Homo sapiens		EXP034683	113	unspecified	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034685	MTA3 (upstate)	Homo sapiens		EXP034683	113	unspecified	Q9BTC8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034686	none	Homo sapiens		NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP034687	none	Homo sapiens	HIF-1a re-expression	NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP034688	none	Homo sapiens	HIF-2a over expression	NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP034689	Novus Biological, NB100-110	Homo sapiens		EXP034686	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	NULL
EXP034690	HIF-2alpha Antibody (PM9)	Homo sapiens		EXP034686	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	NULL
EXP034691	HIF-1alpha Antibody (PM14)	Homo sapiens	HIF-1a re-expression	EXP034687	30	unspecified	Q16665	RCC 7860 (Renal cell carcinoma)	NULL
EXP034692	Novus Biological, NB100-110	Homo sapiens	HIF-1a re-expression	EXP034687	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	NULL
EXP034693	HIF-2alpha Antibody (PM9)	Homo sapiens	HIF-1a re-expression	EXP034687	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	NULL
EXP034694	Novus Biological, NB100-110	Homo sapiens	HIF-2a over expression	EXP034688	30	unspecified	P27540	RCC 7860 (Renal cell carcinoma)	NULL
EXP034695	HIF-2alpha Antibody (PM9)	Homo sapiens	HIF-2a over expression	EXP034688	30	unspecified	Q99814	RCC 7860 (Renal cell carcinoma)	NULL
EXP034696	Input	Mus musculus	-EGS	NULL	247	chip_control	NULL	embryonic heart	NULL
EXP034697	Input	Mus musculus	+EGS	NULL	247	chip_control	NULL	embryonic heart	NULL
EXP034698	Flag, Sigma M2	Mus musculus	-EGS	EXP034696	247	unspecified	Q8R1H0	embryonic heart	NULL
EXP034699	Flag, Sigma M2	Mus musculus	+EGS	EXP034697	247	unspecified	Q8R1H0	embryonic heart	NULL
EXP034700	Anti-Goat IgG (whole molecule) antibody	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP034701	Sigma F1804	Homo sapiens		EXP034700	78	unspecified	Q8N1L9	HeLa (cervical adenocarcinoma)	NULL
EXP034702	Sox2	Homo sapiens		NULL	505	unspecified	P48431	IVF-derived glioma stem cells	NULL
EXP034703	Sox2	Homo sapiens		NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	NULL
EXP034704	Sox2	Homo sapiens	inhibition of the PI3K and MAPK signaling pathways	NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	NULL
EXP034705	Sox2	Homo sapiens	Inhibition of P53	NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	NULL
EXP034706	Sox2	Homo sapiens	Inhibition of P53 and PI3K and MAPK signaling pathways	NULL	502	unspecified	P48431	iPSC-derived neural progenitor cells	NULL
EXP034707	none	Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP034708	KMT2D antibody	Homo sapiens		EXP034707	687	unspecified	Q9UMN6	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP034709	none, input	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP034710		Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP034711		Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP034712	none, input	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP034713	SRF	Mus musculus	Lipid A stimulation for 0 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	NULL
EXP034714	SRF	Mus musculus	Lipid A stimulation for 15 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	NULL
EXP034715	SRF	Mus musculus	Lipid A stimulation for 30 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	NULL
EXP034716	SRF	Mus musculus	Lipid A stimulation for 60 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	NULL
EXP034717	SRF	Mus musculus	Lipid A stimulation for 120 minutes	EXP034709	81	unspecified	Q9JM73	BMDM (bone marrow-derived macrophages)	NULL
EXP034718	IRF3	Mus musculus	Lipid A stimulation for 0 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034719	IRF3	Mus musculus	Lipid A stimulation for 15 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034720	IRF3	Mus musculus	Lipid A stimulation for 30 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034721	IRF3	Mus musculus	Lipid A stimulation for 60 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034722	IRF3	Mus musculus	Lipid A stimulation for 120 minutes	EXP034710	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034723	IRF3	Mus musculus	Lipid A stimulation for 0 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034724	IRF3	Mus musculus	Lipid A stimulation for 15 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034725	IRF3	Mus musculus	Lipid A stimulation for 30 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034726	IRF3	Mus musculus	Lipid A stimulation for 60 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034727	IRF3	Mus musculus	Lipid A stimulation for 120 minutes	EXP034711	81	unspecified	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP034728	RelA	Mus musculus	Lipid A stimulation for 0 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP034729	RelA	Mus musculus	Lipid A stimulation for 15 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP034730	RelA	Mus musculus	Lipid A stimulation for 30 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP034731	RelA	Mus musculus	Lipid A stimulation for 60 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP034732	RelA	Mus musculus	Lipid A stimulation for 120 minutes	EXP034712	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP034733	none (input)	Homo sapiens		NULL	468	chip_control	NULL	neonatal keratinocytes	NULL
EXP034734	H137 (Santa Cruz, cat#sc-8343, lot#A0614)	Homo sapiens	Brg1/Brm	EXP034733	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP034735	H137 (Santa Cruz, cat#sc-8343, lot#A0614)	Homo sapiens		EXP034733	468	unspecified	Q9H3D4	neonatal keratinocytes	NULL
EXP034736	sc-111	Mus musculus		NULL	1058	unspecified	P27577	CD4+ T-cells	NULL
EXP034737	sc-111	Mus musculus		NULL	1058	unspecified	P27577	CD4+ T-cells	NULL
EXP034738	ab23980	Mus musculus		NULL	1058	unspecified	Q03347	CD4+ T-cells	NULL
EXP034739	ab23980	Mus musculus		NULL	1058	unspecified	Q03347	CD4+ T-cells	NULL
EXP034740	ab23980	Mus musculus	PMA 120 min	NULL	1058	unspecified	Q03347	CD4+ T-cells	NULL
EXP034741	sc-46	Mus musculus		NULL	1058	unspecified	P09450	CD4+ T-cells	NULL
EXP034742	sc-46	Mus musculus	120 min PMA	NULL	1058	unspecified	P09450	CD4+ T-cells	NULL
EXP034743	Input control	Mus musculus		NULL	322	chip_control	NULL	gastric epithelial cells	NULL
EXP034744	ICSBP/IRF8 (Santa Cruz, sc-6058, Lot C2713)	Mus musculus		EXP034743	322	unspecified	P23611	gastric epithelial cells	NULL
EXP034745	ICSBP/IRF8 (Santa Cruz, sc-6058, Lot C2713)	Mus musculus	10ng/ml IFNg for 2 days	EXP034743	322	unspecified	P23611	gastric epithelial cells	NULL
EXP034746	none	Homo sapiens		NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP034747	none	Homo sapiens		NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP034748	anti-MLL2 (Sigma, catalog# HPA035977, lot# A69497)	Homo sapiens		EXP034746	327	unspecified	Q9UMN6	germinal center B-cells	NULL
EXP034749	anti-MLL2 (Sigma, catalog# HPA035977, lot# A69497)	Homo sapiens		EXP034747	327	unspecified	Q9UMN6	germinal center B-cells	NULL
EXP034750	none	Mus musculus		NULL	897	chip_control	NULL	fibroblasts	NULL
EXP034751	none	Mus musculus	Xist deletion	NULL	212	chip_control	NULL	dermal fibroblasts	NULL
EXP034752	Millipore 07-729	Mus musculus		EXP034750	897	unspecified	Q61164	fibroblasts	NULL
EXP034753	Millipore 07-729	Mus musculus	Xist deletion	EXP034751	212	unspecified	Q61164	dermal fibroblasts	NULL
EXP034754	none	Mus musculus		NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP034755	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034756	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034757	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034758	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034759	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034760	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034761	none	Mus musculus		NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP034762	none	Mus musculus		NULL	287	chip_control	NULL	induced embryonic stem cells	NULL
EXP034763	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034754	750	unspecified	P20263	E13.5 embryonic fibroblasts	NULL
EXP034764	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034755	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034765	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034756	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034766	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034757	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034767	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034758	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034768	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034759	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034769	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034760	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034770	anti-Flag-M2, Sigma(F1804)	Mus musculus		EXP034761	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034771	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034754	750	unspecified	P20263	E13.5 embryonic fibroblasts	NULL
EXP034772	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034755	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034773	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034756	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034774	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034757	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034775	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034758	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034776	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034759	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034777	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034760	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034778	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034761	906	unspecified	P20263	induced pluripotent stem cells	NULL
EXP034779	anti-Oct4, Santa Cruz(Sc-8628X)	Mus musculus		EXP034762	287	unspecified	P20263	induced embryonic stem cells	NULL
EXP034780	GFP antibody, vendor:Santa Cruz, cat#:sc-8334, lot#:H0612	Mus musculus		NULL	174	chip_control	NULL	cerebral cortex	NULL
EXP034781	NeuroD2 antibody, vendor:Abcam, cat#:ab168932, lot#:GR161014-2	Mus musculus		EXP034780	174	unspecified	Q62414	cerebral cortex	NULL
EXP034782	NeuroD2 antibody, vendor:Abcam, cat#:ab104430, lot#:GR94291-1	Mus musculus		EXP034780	174	unspecified	Q62414	cerebral cortex	NULL
EXP034783	NeuroD2 antibody, Abcam, cat#:ab109406, lot#:YK010204CS	Mus musculus		EXP034780	174	unspecified	Q62414	cerebral cortex	NULL
EXP034784	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP034785	none	Mus musculus	day 2	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP034786	c-Myc antibody (sc-764, Santa Cruz)	Mus musculus		EXP034784	12	unspecified	P01108	MEF (mouse embryonic fibroblasts)	NULL
EXP034787	c-Myc antibody (sc-764, Santa Cruz)	Mus musculus	day 2	EXP034785	12	unspecified	P01108	MEF (mouse embryonic fibroblasts)	NULL
EXP034788	Control IgG (Santa Cruz, sc-2028, sc-3883, sc-3888)	Mus musculus		NULL	904	chip_control	NULL	myoblasts	NULL
EXP034789	Anti-GATA4 (Santa Cruz, C-20; Santa Cruz, H-112; eBioscience, eBioevan)	Mus musculus		EXP034788	904	unspecified	Q08369	myoblasts	NULL
EXP034790	none	Homo sapiens		NULL	145	chip_control	NULL	Caco-2 (colon adenocarcinoma)	NULL
EXP034791	sc-8986x	Homo sapiens		EXP034790	145	unspecified	P20823	Caco-2 (colon adenocarcinoma)	NULL
EXP034792	TI	Homo sapiens		NULL	471	chip_control	NULL	stem and progenitor cells	NULL
EXP034793	TI	Homo sapiens		NULL	894	chip_control	NULL	erythroid cells	NULL
EXP034794	CTCF	Homo sapiens		EXP034792	471	unspecified	P49711	stem and progenitor cells	NULL
EXP034795	CTCF	Homo sapiens		EXP034793	894	unspecified	P49711	erythroid cells	NULL
EXP034796		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP034797	sc-193	Homo sapiens		EXP034796	70	unspecified	Q01094	LNCaP (prostate carcinoma)	NULL
EXP034798	anti-GFP (ab290, Abcam)	Mus musculus		NULL	108	chip_control	NULL	brain caudate putamen	NULL
EXP034799	anti-RARbeta (sc-552, Santa Cruz)	Mus musculus		EXP034798	108	unspecified	P22605	brain caudate putamen	NULL
EXP034800	None	Mus musculus	CT10	NULL	5	chip_control	NULL	liver	NULL
EXP034801	BAF180 (Bethyl A301-591A)	Mus musculus	CT10	EXP034800	5	unspecified	Q8BSQ9	liver	NULL
EXP034802	BAF180 (Bethyl A301-591A)	Mus musculus	CT22	EXP034800	5	unspecified	Q8BSQ9	liver	NULL
EXP034803	BAF180 (Active Motif 61381)	Mus musculus	CT22	EXP034800	5	unspecified	Q8BSQ9	liver	NULL
EXP034804	REV-ERB? (Cell signaling 2124)	Mus musculus		EXP034800	5	unspecified	Q3UV55	liver	NULL
EXP034805	REV-ERB? (Cell signaling 2124)	Mus musculus	src-2 -/-	EXP034800	5	unspecified	Q3UV55	liver	NULL
EXP034806	none	Mus musculus	adaptation to 2i (> 3 weeks)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034807	none	Mus musculus	adaptation from 2i back to serum (3 weeks)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034808	none	Mus musculus	serum, NRF1 overexpression	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034809	none (input)	Mus musculus	serum	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034810	none (input)	Mus musculus	serum, DNMT TKO	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034811	none (input)	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP034812	none (input)	Homo sapiens		NULL	410	chip_control	NULL	HCC1954 (ductal breast carcinoma)	NULL
EXP034813	none (input)	Mus musculus		NULL	138	chip_control	NULL	neural progenitors	NULL
EXP034814	NRF1 (Abcam, ab55744)	Mus musculus	adaptation to 2i (> 3 weeks)	EXP034806	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP034815	NRF1 (Abcam, ab55744)	Mus musculus	adaptation from 2i back to serum (3 weeks)	EXP034807	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP034816	NRF1 (Abcam, ab55744)	Mus musculus	serum, NRF1 overexpression	EXP034808	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP034817	NRF1 (Abcam, ab55744)	Mus musculus	serum	EXP034809	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP034818	NRF1 (Abcam, ab55744)	Mus musculus	serum, DNMT TKO	EXP034810	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP034819	NRF1 (Abcam, ab55744)	Mus musculus		EXP034813	138	unspecified	Q9WU00	neural progenitors	NULL
EXP034820	NRF1 (Abcam, ab55744)	Homo sapiens		EXP034811	440	unspecified	Q16656	HMEC (human mammary epithelial cells)	NULL
EXP034821	NRF1 (Abcam, ab55744)	Homo sapiens		EXP034812	410	unspecified	Q16656	HCC1954 (ductal breast carcinoma)	NULL
EXP034822		Mus musculus		NULL	3	chip_control	NULL	epididymal white adipose tissue	NULL
EXP034823		Mus musculus		NULL	110	chip_control	NULL	brain (ventral tegmental area)	NULL
EXP034824	Rev-erbalpha	Mus musculus		EXP034823	110	unspecified	Q3UV55	brain (ventral tegmental area)	NULL
EXP034825	RORalpha	Mus musculus		NULL	5	unspecified	P51448	liver	NULL
EXP034826	RORgamma	Mus musculus	ZT10	NULL	5	unspecified	P51450	liver	NULL
EXP034827	RORgamma	Mus musculus	ZT22	NULL	5	unspecified	P51450	liver	NULL
EXP034828	Rev-erbalpha	Mus musculus		EXP034822	3	unspecified	Q3UV55	epididymal white adipose tissue	NULL
EXP034829	Rev-erbalpha	Mus musculus		NULL	5	unspecified	Q3UV55	liver	NULL
EXP034830	Rev-erbalpha	Mus musculus		NULL	5	unspecified	Q3UV55	liver	NULL
EXP034831	Rev-erbalpha	Mus musculus	DBD mutant	NULL	5	unspecified	Q3UV55	liver	NULL
EXP034832	none (input)	Homo sapiens	Treatment: none	NULL	435	chip_control	NULL	prostate tumor	NULL
EXP034833	none (input)	Homo sapiens	Treatment: none	NULL	565	chip_control	NULL	prostate cancer metastasis	NULL
EXP034834	none (input)	Homo sapiens	Treatment: none	NULL	2538	chip_control	NULL	primary prostate cancer	NULL
EXP034835	none (input)	Homo sapiens	Treatment: none	NULL	2538	chip_control	NULL	primary prostate cancer	NULL
EXP034836	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 3+4=7; Source: initial PSA 15.65	EXP034834	2538	normal	P10275	primary prostate cancer	NULL
EXP034837	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 3+4=7; Source: initial PSA 16.28	EXP034835	2538	normal	P10275	primary prostate cancer	NULL
EXP034838	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 4+5=9; Source: initial PSA 8.5	EXP034834	2538	normal	P10275	primary prostate cancer	NULL
EXP034839	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 5+5=10; Source: initial PSA 6.5	EXP034832	435	normal	P10275	prostate tumor	NULL
EXP034840	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 5+5=10; Source: initial PSA 511	EXP034832	435	normal	P10275	prostate tumor	NULL
EXP034841	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 5+5=10; Source: initial PSA 35	EXP034832	435	normal	P10275	prostate tumor	NULL
EXP034842	anti-AR (sc-618, Santa Cruz)	Homo sapiens	Treatment: none; Gleason score: 4+5=9; Source: initial PSA 38	EXP034835	2538	normal	P10275	primary prostate cancer	NULL
EXP034843	None	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034844	None	Mus musculus	1uM DMSO under ES culture conditions for 6hr	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034845	None	Mus musculus	1uM DMSO under ES culture conditions for 6hr	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034846	none	Mus musculus	shLuciferase	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034847	none	Mus musculus	shExosc3	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP034848	Bio-yy1	Mus musculus		EXP034843	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034849	Bio-yy1	Mus musculus	100 uM DRB under ES culture conditions for 30min	EXP034843	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034850	Bio-yy1	Mus musculus	1uM DMSO under ES culture conditions for 6hr	EXP034844	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034851	Bio-yy1	Mus musculus	1 uM ACTD treated 6 hrs	EXP034844	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034852	Bio-yy1	Mus musculus	1 uM DMSO for 6 hrs	EXP034845	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034853	Bio-yy1	Mus musculus	CDK7 inhibitor (10 uMTHZ1 for 6 hrs)	EXP034845	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034854	Bio-yy1	Mus musculus	1 uM Triptolide under ES culture condiction	EXP034845	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034855	Bio-YY1	Mus musculus	100 uM DRB under ES culture conditions for 30min	EXP034843	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034856	Bio-YY1	Mus musculus	shLuciferase	EXP034846	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034857	Bio-YY1	Mus musculus	shExosc3	EXP034847	2	unspecified	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP034858	none	Homo sapiens		NULL	794	chip_control	NULL	SK-MEL-147 (melanoma)	NULL
EXP034859	E2F-1 Antibody (C-20)	Homo sapiens		EXP034858	794	unspecified	Q01094	SK-MEL-147 (melanoma)	NULL
EXP034860	Isotype antibody	Mus musculus		NULL	156	chip_control	NULL	CD133(+) tumor inititating stem cells	NULL
EXP034861	Isotype antibody	Mus musculus		NULL	155	chip_control	NULL	CD133(-) tumor inititating stem cells	NULL
EXP034862	Nanog, Abcam ab21624	Mus musculus		EXP034860	156	unspecified	Q80Z64	CD133(+) tumor inititating stem cells	NULL
EXP034863	Nanog, Abcam ab21624	Mus musculus		EXP034861	155	unspecified	Q80Z64	CD133(-) tumor inititating stem cells	NULL
EXP034864	none, input	Mus musculus		NULL	210	chip_control	NULL	decapsulated testis	NULL
EXP034865	none, input	Mus musculus		NULL	210	chip_control	NULL	decapsulated testis	NULL
EXP034866	sc-10657	Mus musculus		EXP034864	210	unspecified	P48379	decapsulated testis	NULL
EXP034867	sc-10657	Mus musculus		EXP034865	210	unspecified	P48379	decapsulated testis	NULL
EXP034868	none (input)	Homo sapiens	BJ fibroblasts 5 days post induced viral expression of OSKM	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP034869	Anti-Smad3 (ab28379)	Homo sapiens	BJ fibroblasts 5 days post induced viral expression of OSKM	EXP034868	93	unspecified	P84022	BJ (fibroblasts)	NULL
EXP034870	Input	Homo sapiens		NULL	454	chip_control	NULL	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP034871	IgG	Homo sapiens		NULL	454	chip_control	NULL	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP034872	TEAD1	Homo sapiens		EXP034871	454	unspecified	P28347	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP034873	TEAD4	Homo sapiens		EXP034871	454	unspecified	Q15561	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP034874	no antibody	Homo sapiens		NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP034875	no antibody	Homo sapiens		NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP034876	anti-FOXO1 (Abcam, ab39670)	Homo sapiens		EXP034874	327	unspecified	Q12778	germinal center B-cells	NULL
EXP034877	anti-FOXO1 (Abcam, ab39670)	Homo sapiens		EXP034875	327	unspecified	Q12778	germinal center B-cells	NULL
EXP034878	anti-BCL6, N3 (Santa Cruz)	Homo sapiens		EXP034874	327	unspecified	P41182	germinal center B-cells	NULL
EXP034879	bcl6	Homo sapiens		EXP034875	327	unspecified	P41182	germinal center B-cells	NULL
EXP034880	sc-543	Homo sapiens	Vehicle	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034881	sc-543	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034882	sc-543	Homo sapiens	PG	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034883	sc-543	Homo sapiens	E2+PG	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034884	sc-543	Homo sapiens	Vehicle	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034885	sc-543	Homo sapiens	E2	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034886	sc-543	Homo sapiens	PG	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034887	sc-543	Homo sapiens	E2+PG	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034888	sc-7208	Homo sapiens	Vehicle	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034889	sc-7208	Homo sapiens	E2	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034890	sc-7208	Homo sapiens	PG	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034891	sc-7208	Homo sapiens	E2+PG	NULL	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034892	sc-7208	Homo sapiens	Vehicle	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034893	sc-7208	Homo sapiens	E2	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034894	sc-7208	Homo sapiens	PG	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034895	sc-7208	Homo sapiens	E2+PG	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034896	none (Input)	Homo sapiens	Vehicle	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034897	none (Input)	Homo sapiens	E2	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034898	none (Input)	Homo sapiens	E2+PG	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034899	sc-543	Homo sapiens	Vehicle	EXP034896	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034900	sc-7208	Homo sapiens	Vehicle	EXP034896	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034901	sc-543	Homo sapiens	E2	EXP034897	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034902	sc-7208	Homo sapiens	E2	EXP034897	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034903	sc-543	Homo sapiens	E2+PG	EXP034898	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034904	progest	Homo sapiens	E2+PG	EXP034898	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034905		Mus musculus	EGFP KD	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP034906	none	Mus musculus	MBD3 KO	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP034907	none	Mus musculus	Smarca4 KD	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP034908	Klf4 (kind gift from Dr. Ng from the Genome Institute of Singapore)	Mus musculus	EGFP KD	EXP034905	230	unspecified	Q60793	ES-E14 (E14, embryonic stem cells)	NULL
EXP034909	Klf4 (kind gift from Dr. Ng from the Genome Institute of Singapore)	Mus musculus	MBD3 KO	EXP034906	230	unspecified	Q60793	ES-E14 (E14, embryonic stem cells)	NULL
EXP034910	Klf4 (kind gift from Dr. Ng from the Genome Institute of Singapore)	Mus musculus	Smarca4 KD	EXP034907	230	unspecified	Q60793	ES-E14 (E14, embryonic stem cells)	NULL
EXP034911	none	Mus musculus	EtOH	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP034912	none	Mus musculus	EtOH	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP034913	In house	Mus musculus	EtOH	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP034914	In house	Mus musculus	ATRA 2h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP034915	In house	Mus musculus	ATRA 6h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP034916	In house	Mus musculus	ATRA 24h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP034917	In house	Mus musculus	ATRA 48h	EXP034912	292	unspecified	P28700	F9 (embryonal carcinoma)	NULL
EXP034918	In house	Mus musculus	EtOH	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	NULL
EXP034919	In house	Mus musculus	ATRA 2h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	NULL
EXP034920	In house	Mus musculus	ATRA 6h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	NULL
EXP034921	In house	Mus musculus	ATRA 24h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	NULL
EXP034922	In house	Mus musculus	ATRA 48h	EXP034911	705	unspecified	P28700	P19 (embryonic carcinoma)	NULL
EXP034923	none (Input DNA)	Mus musculus		NULL	513	chip_control	NULL	K14CreER SmoM2 (basal cell carcinoma)	NULL
EXP034924	Sox9 (Millipore, AB5535)	Mus musculus		EXP034923	513	unspecified	Q04887	K14CreER SmoM2 (basal cell carcinoma)	NULL
EXP034925	none (input)	Homo sapiens	Full_Media	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP034926	none (input)	Homo sapiens	Full_Media	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034927	PR Antibody (H-190)	Homo sapiens	R5020	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034928	ER? Antibody (HC-20)	Homo sapiens	Full_Media	EXP034925	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034929	ER? Antibody (HC-20)	Homo sapiens	Progesterone	EXP034925	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034930	ER? Antibody (HC-20)	Homo sapiens	R5020	EXP034925	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP034931	PR Antibody (H-190)	Homo sapiens	Full_Media	EXP034925	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034932	PR Antibody (H-190)	Homo sapiens	Progesterone	EXP034925	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034933	PR Antibody (H-190)	Homo sapiens	R5020	EXP034925	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP034934	ER? Antibody (HC-20)	Homo sapiens	Full_Media	EXP034926	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034935	ER? Antibody (HC-20)	Homo sapiens	Progesterone	EXP034926	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034936	ER? Antibody (HC-20)	Homo sapiens	R5020	EXP034926	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034937	PR Antibody (H-190)	Homo sapiens	Full_Media	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034938	PR Antibody (H-190)	Homo sapiens	Progesterone	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034939	PR Antibody (H-190)	Homo sapiens	R5020	EXP034926	113	unspecified	P06401	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP034940	none, input	Mus musculus	DMSO	NULL	614	chip_control	NULL	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP034941	none, input	Mus musculus	MM-401	NULL	614	chip_control	NULL	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP034942	MLL (anti-rabbit antibody made by our lab)	Mus musculus	DMSO	EXP034940	614	unspecified	P55200	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP034943	MLL (anti-rabbit antibody made by our lab)	Mus musculus	MM-401	EXP034941	614	unspecified	P55200	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP034944	none	Mus musculus		NULL	163	chip_control	NULL	embryo cerebral cortex (day 15)	NULL
EXP034945	SATB2 antibody	Mus musculus		EXP034944	163	unspecified	Q8VI24	embryo cerebral cortex (day 15)	NULL
EXP034946		Mus musculus		NULL	507	chip_control	NULL	jejunal epithelial cells	NULL
EXP034947	gata4	Mus musculus		EXP034946	507	unspecified	Q08369	jejunal epithelial cells	NULL
EXP034948		Mus musculus		NULL	793	chip_control	NULL	sinoatrial node cells	NULL
EXP034949	ISL1	Mus musculus		EXP034948	793	unspecified	P61372	sinoatrial node cells	NULL
EXP034950	None	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP034951	None	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP034952	Input	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP034953	Input	Homo sapiens	mutated	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP034954	CTCF	Homo sapiens		EXP034950	509	unspecified	P49711	Jurkat (T-cells)	NULL
EXP034955	RUNX1	Homo sapiens		EXP034951	509	unspecified	Q01196	Jurkat (T-cells)	NULL
EXP034956	GATA3	Homo sapiens		EXP034951	509	unspecified	P23771	Jurkat (T-cells)	NULL
EXP034957	CTCF	Homo sapiens	mutated	EXP034953	10	unspecified	P49711	HEK293T (embryonic kidney)	NULL
EXP034958	CTCF	Homo sapiens		EXP034952	10	unspecified	P49711	HEK293T (embryonic kidney)	NULL
EXP034959		Homo sapiens		NULL	683	chip_control	NULL	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP034960	anti-FOXP1	Homo sapiens		NULL	685	unspecified	Q9H334	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP034961	anti-FOXP1	Homo sapiens		NULL	686	unspecified	Q9H334	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP034962	anti-FOXP1	Homo sapiens		NULL	687	unspecified	Q9H334	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP034963	anti-FOXP1	Homo sapiens		EXP034959	683	unspecified	Q9H334	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP034964	anti-FOXP1	Homo sapiens		NULL	747	unspecified	Q9H334	memory B-cells	NULL
EXP034965	none	Homo sapiens	none	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP034966	none	Homo sapiens	none	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP034967	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034966	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034968	C/EBPb, sc-150, Santa Cruz	Homo sapiens	DMI for 6 hrs	EXP034966	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034969	CEBPb, sc-150, Santa Cruz	Homo sapiens	DMI for 6 hrs	EXP034966	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034970	GR, PA1-511A, Pierce; sc-1004, Santa Cruz	Homo sapiens	DMI for 6 hrs	EXP034966	892	unspecified	P04150	MSC (mesenchymal stem cells)	NULL
EXP034971	ATF4, sc-200, Santa Cruz	Homo sapiens	none	EXP034966	892	unspecified	P18848	MSC (mesenchymal stem cells)	NULL
EXP034972	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034973	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034974	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034975	C/EBPb, sc-150, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P17676	MSC (mesenchymal stem cells)	NULL
EXP034976	ATF4, sc-200, Santa Cruz	Homo sapiens	none	EXP034965	892	unspecified	P18848	MSC (mesenchymal stem cells)	NULL
EXP034977	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	273	unspecified	P28033	embryonic stem cell-derived hemangioblasts	NULL
EXP034978	Gata2 Santa Cruz sc267	Mus musculus	none	NULL	273	unspecified	O09100	embryonic stem cell-derived hemangioblasts	NULL
EXP034979	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	273	unspecified	P22091	embryonic stem cell-derived hemangioblasts	NULL
EXP034980	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	275	unspecified	P28033	embryonic stem cell-derived hemogenic endothelium	NULL
EXP034981	Fli1 Santa Cruz sc356	Mus musculus	none	NULL	275	unspecified	P26323	embryonic stem cell-derived hemogenic endothelium	NULL
EXP034982	Meis1 Santa Cruz sc10599	Mus musculus	none	NULL	275	unspecified	Q60954	embryonic stem cell-derived hemogenic endothelium	NULL
EXP034983	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	275	unspecified	P22091	embryonic stem cell-derived hemogenic endothelium	NULL
EXP034984	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	274	unspecified	P28033	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034985	Fli1 Santa Cruz sc356	Mus musculus	none	NULL	274	unspecified	P26323	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034986	Gata1 AbCam ab11963	Mus musculus	none	NULL	274	unspecified	P17679	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034987	Gata2 Santa Cruz sc267	Mus musculus	none	NULL	274	unspecified	O09100	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034988	Gfi1 AbCam ab21061	Mus musculus	none	NULL	274	unspecified	P70338	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034989	Gfi1b Santa Cruz sc8559	Mus musculus	none	NULL	274	unspecified	O70237	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034990	Runx1 AbCam ab23980	Mus musculus	none	NULL	274	unspecified	Q03347	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034991	Spi1 Santa Cruz sc352	Mus musculus	none	NULL	274	unspecified	P17433	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034992	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	274	unspecified	P22091	embryonic stem cell-derived hematopoietic progenitors	NULL
EXP034993	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	276	unspecified	P28033	embryonic stem cell-derived macrophages	NULL
EXP034994	Fli1 Santa Cruz sc356	Mus musculus	none	NULL	276	unspecified	P26323	embryonic stem cell-derived macrophages	NULL
EXP034995	Runx1 AbCam ab23980	Mus musculus	none	NULL	276	unspecified	Q03347	embryonic stem cell-derived macrophages	NULL
EXP034996	Spi1 Santa Cruz sc352	Mus musculus	none	NULL	276	unspecified	P17433	embryonic stem cell-derived macrophages	NULL
EXP034997	Tal1 Santa Cruz sc12984	Mus musculus	none	NULL	276	unspecified	P22091	embryonic stem cell-derived macrophages	NULL
EXP034998	C/ebpb Santa Cruz sc150	Mus musculus	none	NULL	277	unspecified	P28033	embryonic stem cell-derived mesoderm	NULL
EXP034999	Elk4 Santa Cruz sc13030	Mus musculus	none	NULL	277	unspecified	P41158	embryonic stem cell-derived mesoderm	NULL
EXP035000	Pou5F1 Santa Cruz sc8628	Mus musculus	none	NULL	277	unspecified	P20263	embryonic stem cell-derived mesoderm	NULL
EXP035001	Tead-4 (Abcam ab58310)	Mus musculus	none	NULL	273	unspecified	Q62296	embryonic stem cell-derived hemangioblasts	NULL
EXP035002	IgG santa cruz sc-2027 X	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP035003	BMAL1 bethyl A302-616A	Homo sapiens		EXP035002	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP035004	HIF1A active motif (cat # 39665).	Homo sapiens		EXP035002	848	unspecified	Q16665	U2OS (osteosarcoma)	NULL
EXP035005	none	Mus musculus		NULL	707	chip_control	NULL	rib chondrocytes	NULL
EXP035006	none	Mus musculus	none	NULL	235	chip_control	NULL	E17.5 embryonic nasal chondrocytes	NULL
EXP035007	Sox9	Mus musculus	none	EXP035005	707	unspecified	Q04887	rib chondrocytes	NULL
EXP035008	rabbit IgG	Mus musculus	none	NULL	707	chip_control	NULL	rib chondrocytes	NULL
EXP035009	Sox9	Mus musculus	none	EXP035006	235	unspecified	Q04887	E17.5 embryonic nasal chondrocytes	NULL
EXP035010	None	Homo sapiens	untreated	NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP035011	None	Homo sapiens	RA treated	NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP035012	RARa (C-20), Santa Cruz,Cat No. Sc551	Homo sapiens	untreated	EXP035010	665	unspecified	P10276	SK-N-SH (neuroblastoma)	NULL
EXP035013	RARa (C-20), Santa Cruz,Cat No. Sc551	Homo sapiens	RA treated	EXP035011	665	unspecified	P10276	SK-N-SH (neuroblastoma)	NULL
EXP035014	none (input)	Mus musculus	antisense oligonucleotide	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035015	none (input)	Mus musculus	7SK antisense oligonucleotide	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035016	anti-Pou5f1, Santa Cruz, Cat# sc-8629	Mus musculus	antisense oligonucleotide	EXP035014	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP035017	anti-Baf155	Mus musculus	antisense oligonucleotide	EXP035014	2	unspecified	P97496	mESCs (mouse embryonic stem cells)	NULL
EXP035018	anti-Pou5f1, Santa Cruz, Cat# sc-8629	Mus musculus	7SK antisense oligonucleotide	EXP035015	2	unspecified	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP035019	anti-Baf155, Gift from Crabtree Lab	Mus musculus	7SK antisense oligonucleotide	EXP035015	2	unspecified	P97496	mESCs (mouse embryonic stem cells)	NULL
EXP035020	none (input)	Mus musculus	antisense oligonucleotide	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035021	none (input)	Mus musculus	7SK antisense oligonucleotide	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035022	None	Mus musculus	1,25(OH)2D3 (10 ng/g bw)	NULL	225	chip_control	NULL	duodenum and jejunum	NULL
EXP035023	anti-VDR (Santa Cruz Biotechnology; sc-1008)	Mus musculus	vehicle control	EXP035022	225	unspecified	P48281	duodenum and jejunum	NULL
EXP035024	anti-VDR (Santa Cruz Biotechnology; sc-1008)	Mus musculus	1,25(OH)2D3 (10 ng/g bw)	EXP035022	225	unspecified	P48281	duodenum and jejunum	NULL
EXP035025	none	Mus musculus	none	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP035026	none	Mus musculus	none	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP035027	none	Mus musculus	none	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP035028	none	Mus musculus	none	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP035029	anti-Ebf1	Mus musculus	none	EXP035025	105	unspecified	Q07802	pro-B cells	NULL
EXP035030	anti-Ebf1	Mus musculus	none	EXP035026	105	unspecified	Q07802	pro-B cells	NULL
EXP035031	anti-Ebf1	Mus musculus	none	EXP035027	105	unspecified	Q07802	pro-B cells	NULL
EXP035032	anti-Ebf1	Mus musculus	none	EXP035028	105	unspecified	Q07802	pro-B cells	NULL
EXP035033	none	Homo sapiens	2 mM histidinol, 24 hours	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP035034	ATF4 (Santa Cruz Biotechnology sc-200, Lot No. C0513)	Homo sapiens	2 mM histidinol, 24 hours	EXP035033	1507	unspecified	P18848	HAP1 (chronic myelogenous leukemia)	NULL
EXP035035	ATF4 (Cell Signaling Technology, D4B8, Cat. No. 11815, Lot No. 2)	Homo sapiens	2 mM histidinol, 24 hours	EXP035033	1507	unspecified	P18848	HAP1 (chronic myelogenous leukemia)	NULL
EXP035036	ATF4 (Millipore, ABE387)	Homo sapiens	2 mM histidinol, 24 hours	EXP035033	1507	unspecified	P18848	HAP1 (chronic myelogenous leukemia)	NULL
EXP035037	none	Mus musculus	Input control in embryonic stem cell line1 36h following Gata6 induction	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035038	none	Mus musculus	Input control in FLAG-tagged Gata6 in embryonic stem cell line2 36h following Gata6 induction	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035039	none	Mus musculus		NULL	291	chip_control	NULL	endodermal stem cells	NULL
EXP035040	none	Mus musculus		NULL	291	chip_control	NULL	endodermal stem cells	NULL
EXP035041	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	ChIP for FLAG-tagged Gata6 in embryonic stem cell line1 36h following Gata6 induction	EXP035037	2	unspecified	Q61169	mESCs (mouse embryonic stem cells)	NULL
EXP035042	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	ChIP for FLAG-tagged Gata6 in embryonic stem cell line2 36h following Gata6 induction	EXP035038	2	unspecified	Q61169	mESCs (mouse embryonic stem cells)	NULL
EXP035043	anti-Gata-6 (R&D, catalog number AF1700)	Mus musculus		EXP035039	291	unspecified	Q61169	endodermal stem cells	NULL
EXP035044	Gata6 (R&D, catalog number AF1700)	Mus musculus		EXP035040	291	unspecified	Q61169	endodermal stem cells	NULL
EXP035045	none	Homo sapiens		NULL	637	chip_control	NULL	MSTO-211H (pleural mesothelioma)	NULL
EXP035046	TEAD1	Homo sapiens		EXP035045	637	unspecified	P28347	MSTO-211H (pleural mesothelioma)	NULL
EXP035047	Santa Cruz Cat#: H-86x	Homo sapiens		NULL	766	unspecified	P22415	R3/R4 erythroid cells	NULL
EXP035048	Santa Cruz Cat#: C-20x	Homo sapiens		NULL	766	unspecified	Q15853	R3/R4 erythroid cells	NULL
EXP035049	none	Homo sapiens		NULL	390	chip_control	NULL	NCI-H524 (small cell lung carcinoma)	NULL
EXP035050		Homo sapiens		NULL	393	chip_control	NULL	NCI-H889 (small cell lung carcinoma)	NULL
EXP035051	none	Mus musculus		NULL	666	chip_control	NULL	neuroendocrine lung tumor	NULL
EXP035052	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Homo sapiens		NULL	374	unspecified	P50553	NCI-H128 (small cell lung carcinoma)	NULL
EXP035053	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Homo sapiens		NULL	383	unspecified	P50553	NCI-H2107 (small cell lung carcinoma)	NULL
EXP035054	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Homo sapiens		EXP035050	393	unspecified	P50553	NCI-H889 (small cell lung carcinoma)	NULL
EXP035055	goat anti-NEUROD1 (Santa Cruz, N-19)	Homo sapiens		NULL	392	unspecified	Q13562	NCI-H82 (small cell lung carcinoma)	NULL
EXP035056	goat anti-NEUROD1 (Santa Cruz, N-19)	Homo sapiens		EXP035049	390	unspecified	Q13562	NCI-H524 (small cell lung carcinoma)	NULL
EXP035057	mouse anti-ASCL1 antibody (BD Biosciences, cat# 556604)	Mus musculus		EXP035051	666	unspecified	Q02067	neuroendocrine lung tumor	NULL
EXP035058	none	Homo sapiens		NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP035059	none	Homo sapiens		NULL	395	chip_control	NULL	H9-derived neural progenitors	NULL
EXP035060	SOX2 (R&D 2018)	Homo sapiens		EXP035058	878	unspecified	P48431	embryonic stem cells	NULL
EXP035061	SOX2 (R&D 2018)	Homo sapiens		EXP035059	395	unspecified	P48431	H9-derived neural progenitors	NULL
EXP035062	None	Mus musculus		NULL	484	chip_control	NULL	E13.5 stomach mesenchymal cells	NULL
EXP035063	Flag M2 Antibody Sigma	Mus musculus		EXP035062	484	unspecified	Q9ER42	E13.5 stomach mesenchymal cells	NULL
EXP035064	none	Homo sapiens		NULL	256	chip_control	NULL	endometrial stromal cells	NULL
EXP035065	H-190/sc-7208	Homo sapiens		EXP035064	256	unspecified	P06401	endometrial stromal cells	NULL
EXP035066	Q-20/sc-604	Homo sapiens		EXP035064	256	unspecified	P15408	endometrial stromal cells	NULL
EXP035067		Homo sapiens		NULL	256	chip_control	NULL	endometrial stromal cells	NULL
EXP035068	H-128/sc-11350	Homo sapiens		EXP035067	256	unspecified	Q12778	endometrial stromal cells	NULL
EXP035069	none	Mus musculus		NULL	132	chip_control	NULL	uterus	NULL
EXP035070	Millipore, cat # 07-618	Mus musculus		EXP035069	132	unspecified	P33242	uterus	NULL
EXP035071		Homo sapiens		NULL	209	chip_control	NULL	DB (diffuse large B-cell lymphoma)	NULL
EXP035072		Homo sapiens		NULL	221	chip_control	NULL	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP035073		Homo sapiens		NULL	1138	chip_control	NULL	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP035074		Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP035075		Homo sapiens		NULL	815	chip_control	NULL	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP035076	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035071	209	unspecified	Q02080	DB (diffuse large B-cell lymphoma)	NULL
EXP035077	MEF2B_HPA004734 (Atlas, catalog# HPA004734, lot# R57933)	Homo sapiens		EXP035071	209	unspecified	Q02080	DB (diffuse large B-cell lymphoma)	NULL
EXP035078	Bach2 (ARP39513, AVIVA)	Homo sapiens		EXP035072	221	unspecified	Q9BYV9	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP035079	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035072	221	unspecified	Q02080	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP035080	PAX5 (Santa Cruz, catalog# sc-1975x, lot# I1511)	Homo sapiens		EXP035072	221	unspecified	Q02548	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP035081	Pu.1 (Santa Cruz, catalog# sc-22805, lot# D0609)	Homo sapiens		EXP035072	221	unspecified	P17947	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP035082	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035073	1138	unspecified	Q02080	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP035083	Bach2 (ARP39513, AVIVA)	Homo sapiens		EXP035074	687	unspecified	Q9BYV9	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP035084	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035074	687	unspecified	Q02080	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP035085	PAX5 (Santa Cruz, catalog# sc-1975x, lot# I1511)	Homo sapiens		EXP035074	687	unspecified	Q02548	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP035086	Pu.1 (Santa Cruz, catalog# sc-22805, lot# D0609)	Homo sapiens		EXP035074	687	unspecified	P17947	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP035087	MEF2B (Abcam, catalog# ab33540, lot# GR90081-1)	Homo sapiens		EXP035075	815	unspecified	Q02080	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP035088	MEF2B_HPA004734 (Atlas, catalog# HPA004734, lot# R57933)	Homo sapiens		EXP035075	815	unspecified	Q02080	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP035089	none (input)	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP035090	Santa Cruz -  sc-32761X	Homo sapiens		EXP035089	430	unspecified	O14497	HepG2 (hepatoblastoma)	NULL
EXP035091	Santa Cruz - sc-32762X	Homo sapiens		EXP035089	430	unspecified	Q8NFD5	HepG2 (hepatoblastoma)	NULL
EXP035092	Bethyl - A302-230A	Homo sapiens		EXP035089	430	unspecified	Q68CP9	HepG2 (hepatoblastoma)	NULL
EXP035093	none	Mus musculus		NULL	13	chip_control	NULL	2TS22C (embryonic stem cells)	NULL
EXP035094	none	Mus musculus	O-GlcNAc-deficient SOX2	NULL	13	chip_control	NULL	2TS22C (embryonic stem cells)	NULL
EXP035095	FLAG M2 (Sigma F1805)	Mus musculus	O-GlcNAc-deficient SOX2, long fragments	EXP035094	13	unspecified	P48432	2TS22C (embryonic stem cells)	NULL
EXP035096	FLAG M2 (Sigma F1805)	Mus musculus	O-GlcNAc-deficient SOX2, short fragments	EXP035094	13	unspecified	P48432	2TS22C (embryonic stem cells)	NULL
EXP035097	FLAG M2 (Sigma F1805)	Mus musculus	long fragments	EXP035093	13	unspecified	P48432	2TS22C (embryonic stem cells)	NULL
EXP035098	FLAG M2 (Sigma F1805)	Mus musculus	short fragments	EXP035093	13	unspecified	P48432	2TS22C (embryonic stem cells)	NULL
EXP035099	None	Homo sapiens		NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP035100	None	Homo sapiens		NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP035101	Millipore 07-729	Homo sapiens		EXP035099	878	unspecified	P49711	embryonic stem cells	NULL
EXP035102	sc8628	Homo sapiens		EXP035099	878	unspecified	Q01860	embryonic stem cells	NULL
EXP035103	Upstate/Millipore 07-729	Homo sapiens		EXP035100	878	unspecified	P49711	embryonic stem cells	NULL
EXP035104	sc8628	Homo sapiens		EXP035100	878	unspecified	Q01860	embryonic stem cells	NULL
EXP035105	anti-Tip60	Mus musculus		NULL	2	unspecified	Q8CHK4	mESCs (mouse embryonic stem cells)	NULL
EXP035106	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 3	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035107	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 4	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035108	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 11	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035109	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 12	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035110	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 5	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035111	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Female 9	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035112	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Male 1	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035113	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Male 2	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035114	Egr1 (Santa Cruz, catalog# sc-110-X, lot# H1611)	Rattus norvegicus	Male 3	NULL	593	unspecified	P08154	medial prefrontal cortex	NULL
EXP035115	IgG	Mus musculus		NULL	23	chip_control	NULL	416B (hematopoietic precursor cells)	NULL
EXP035116	sc-354x	Mus musculus		EXP035115	23	unspecified	P81270	416B (hematopoietic precursor cells)	NULL
EXP035117	ab15289-500	Mus musculus		EXP035115	23	unspecified	P26323	416B (hematopoietic precursor cells)	NULL
EXP035118	sc-9008x	Mus musculus		EXP035115	23	unspecified	O09100	416B (hematopoietic precursor cells)	NULL
EXP035119	sc-8559x	Mus musculus		EXP035115	23	unspecified	O70237	416B (hematopoietic precursor cells)	NULL
EXP035120	ab30334-200	Mus musculus		EXP035115	23	unspecified	P27792	416B (hematopoietic precursor cells)	NULL
EXP035121	sc-10599x	Mus musculus		EXP035115	23	unspecified	Q60954	416B (hematopoietic precursor cells)	NULL
EXP035122	sc-352x	Mus musculus		EXP035115	23	unspecified	P17433	416B (hematopoietic precursor cells)	NULL
EXP035123	ab23890	Mus musculus		EXP035115	23	unspecified	Q03347	416B (hematopoietic precursor cells)	NULL
EXP035124	sc-12984x	Mus musculus		EXP035115	23	unspecified	P22091	416B (hematopoietic precursor cells)	NULL
EXP035125	none (input)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035126	Pou3f1 antibody (Santa Cruz, sc-11661, Lot# C2012)	Mus musculus		EXP035125	2	unspecified	P21952	mESCs (mouse embryonic stem cells)	NULL
EXP035127	CTCF	Mus musculus		NULL	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP035128	CTCF1	Mus musculus	AKT1 KO	NULL	12	unspecified	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP035129	anti-FLAG (Sigma F3165)	Mus musculus		NULL	528	chip_control	NULL	Lin-Sca-1+ c-Kit+ hematopietic multipotent stem cells	NULL
EXP035130	anti-FLAG (Sigma F3165)	Mus musculus		EXP035129	528	unspecified	Q8BW74	Lin-Sca-1+ c-Kit+ hematopietic multipotent stem cells	NULL
EXP035131	Sox-2 Antibody (Y-17); goat polyclonal	Mus musculus		NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP035132	rabbit polyclonals	Mus musculus		NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP035133	Brn-2 Antibody (C-20); goat polyclonal	Mus musculus		NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP035134	Sox-2 Antibody (Y-17); goat polyclonal	Mus musculus		EXP035131	2775	unspecified	P48432	neural stem cells	NULL
EXP035135	rabbit polyclonals	Mus musculus		EXP035132	2775	unspecified	P21952	neural stem cells	NULL
EXP035136	rabbit polyclonals	Mus musculus		EXP035132	2775	unspecified	P31361	neural stem cells	NULL
EXP035137	Brn-2 Antibody (C-20); goat polyclonal	Mus musculus		EXP035133	2775	unspecified	P31360	neural stem cells	NULL
EXP035138	in-house GR antibody	Mus musculus		NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP035139	in-house GR antibody	Mus musculus	dexametasone	NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP035140	in-house GR antibody	Mus musculus	Klf15 -/-	NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP035141	in-house GR antibody	Mus musculus	dexametasone, Klf15 -/-	NULL	12	unspecified	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP035142	none	Mus musculus		NULL	913	chip_control	NULL	melanocytes	NULL
EXP035143	SOX10 (sc-17342X; Santa Cruz Biotechnology)	Mus musculus		EXP035142	913	unspecified	Q04888	melanocytes	NULL
EXP035144	none	Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP035145	HA	Homo sapiens		EXP035144	440	unspecified	P01106	HMEC (human mammary epithelial cells)	NULL
EXP035146	HA	Homo sapiens		EXP035144	440	unspecified	P01106	HMEC (human mammary epithelial cells)	NULL
EXP035147	none	Rattus norvegicus		NULL	769	chip_control	NULL	chondrosarcoma	NULL
EXP035148	none	Rattus norvegicus		NULL	769	chip_control	NULL	chondrosarcoma	NULL
EXP035149	SOX9 (AB5535, Millipore)	Rattus norvegicus		EXP035147	769	unspecified	F1LYL9	chondrosarcoma	NULL
EXP035150	SOX6 (ab30455, Abcam)	Rattus norvegicus		EXP035148	769	unspecified	Q4V8G3	chondrosarcoma	NULL
EXP035151	IgG (sc-2027)	Homo sapiens	10 nM R1881 for 2hrs	NULL	590	chip_control	NULL	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035152	rabbit antiserum against AR	Homo sapiens	10 nM R1881 for 2hrs, siPIAS1	EXP035151	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035153	rabbit antiserum against AR	Homo sapiens	10 nM R1881 for 2hrs	EXP035151	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035154		Mus musculus		NULL	373	chip_control	NULL	granulocyte macrophage progenitors	NULL
EXP035155	Gfi1 antibody http://www.ncbi.nlm.nih.gov/pubmed/24141388	Mus musculus		EXP035154	373	unspecified	P70338	granulocyte macrophage progenitors	NULL
EXP035156	Irf8 antibody Santa Cruz sc-6058	Mus musculus		EXP035154	373	unspecified	P23611	granulocyte macrophage progenitors	NULL
EXP035157		Mus musculus		NULL	176	chip_control	NULL	CGR8 (embryonic stem cells)	NULL
EXP035158	bcl3	Mus musculus		EXP035157	176	unspecified	Q9Z2F6	CGR8 (embryonic stem cells)	NULL
EXP035159		Mus musculus		NULL	95	chip_control	NULL	E12.5 embryonic heart	NULL
EXP035160	anti-HA	Mus musculus		EXP035159	95	unspecified	P70390	E12.5 embryonic heart	NULL
EXP035161	SC-8697	Mus musculus		EXP035159	95	unspecified	P42582	E12.5 embryonic heart	NULL
EXP035162	none	Mus musculus	Placebo	NULL	5	chip_control	NULL	liver	NULL
EXP035163	none	Mus musculus	E2	NULL	5	chip_control	NULL	liver	NULL
EXP035164	none	Mus musculus	E2, ER KO	NULL	5	chip_control	NULL	liver	NULL
EXP035165	Antibody Mix: MC20 (SantaCruz) + ab10 (TE111-SD1) (Abcam)	Mus musculus	Placebo	EXP035162	5	unspecified	P19785	liver	NULL
EXP035166	Antibody Mix: MC20 (SantaCruz) + ab10 (TE111-SD1) (Abcam)	Mus musculus	E2	EXP035163	5	unspecified	P19785	liver	NULL
EXP035167	Antibody Mix: clone 3C10 (Millipore) + ab23630 (Abcam)	Mus musculus	E2	EXP035163	5	unspecified	P35583	liver	NULL
EXP035168	Antibody Mix: MC20 (SantaCruz) + ab10 (TE111-SD1) (Abcam)	Mus musculus	E2, ER KO	EXP035164	5	unspecified	P19785	liver	NULL
EXP035169	Antibody Mix: clone 3C10 (Millipore) + ab23630 (Abcam)	Mus musculus	E2, ER KO	NULL	5	unspecified	P35583	liver	NULL
EXP035170	anti-NR4A1 antibody, clone H1648 (Perseus Proteomics, catalog# PP-H1648-00, lot# A-1)	Mus musculus		NULL	44	unspecified	P12813	T-cells	NULL
EXP035171	none	Mus musculus		NULL	572	chip_control	NULL	mammary gland	NULL
EXP035172	STAT5A (Santa Cruz, sc-1081)	Mus musculus	Ezh2 KO	EXP035171	572	unspecified	P42230	mammary gland	NULL
EXP035173	STAT5A (Santa Cruz, sc-1081)	Mus musculus		EXP035171	572	unspecified	P42230	mammary gland	NULL
EXP035174		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP035175	ctcf	Homo sapiens		EXP035174	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP035176	gata1	Homo sapiens		EXP035174	514	unspecified	P15976	K562 (myelogenous leukemia)	NULL
EXP035177	pu.1	Homo sapiens		EXP035174	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP035178	rest	Homo sapiens		EXP035174	514	unspecified	Q13127	K562 (myelogenous leukemia)	NULL
EXP035179	input	Mus musculus		NULL	303	chip_control	NULL	FH-Foxd3 (embryonic stem cells)	NULL
EXP035180	anti-HA (H3663, Sigma)	Mus musculus		EXP035179	303	unspecified	Q61060	FH-Foxd3 (embryonic stem cells)	NULL
EXP035181	anti-Flag (F3165, Sigma)	Mus musculus		EXP035179	303	unspecified	Q61060	FH-Foxd3 (embryonic stem cells)	NULL
EXP035182	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP035183	none	Mus musculus		NULL	260	chip_control	NULL	epiblast stem cells	NULL
EXP035184	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus		EXP035182	230	unspecified	P70340	ES-E14 (E14, embryonic stem cells)	NULL
EXP035185	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus	BMP-4	EXP035182	230	unspecified	P70340	ES-E14 (E14, embryonic stem cells)	NULL
EXP035186	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus	BMP4 for 1.5h	EXP035183	260	unspecified	P70340	epiblast stem cells	NULL
EXP035187	anti-Smad1 (clone 913C1b, Bio Matrix Research, Japan)	Mus musculus	BMP4 for 24h	EXP035183	260	unspecified	P70340	epiblast stem cells	NULL
EXP035188		Homo sapiens		NULL	745	chip_control	NULL	fetal CD34+ hematopoietic stem progenitor cells	NULL
EXP035189		Homo sapiens		NULL	741	chip_control	NULL	CD34+ hematopoietic stem progenitor cells	NULL
EXP035190	ab11852	Homo sapiens		EXP035188	745	unspecified	P15976	fetal CD34+ hematopoietic stem progenitor cells	NULL
EXP035191	ab11852	Homo sapiens		EXP035189	741	unspecified	P15976	CD34+ hematopoietic stem progenitor cells	NULL
EXP035192	sc-12984	Homo sapiens		EXP035188	745	unspecified	P17542	fetal CD34+ hematopoietic stem progenitor cells	NULL
EXP035193	sc-12984	Homo sapiens		NULL	746	unspecified	P17542	fetal proerythroblasts	NULL
EXP035194	sc-12984	Homo sapiens		EXP035189	741	unspecified	P17542	CD34+ hematopoietic stem progenitor cells	NULL
EXP035195	sc-291	Homo sapiens		EXP035188	745	unspecified	Q16621	fetal CD34+ hematopoietic stem progenitor cells	NULL
EXP035196	sc-291	Homo sapiens		NULL	746	unspecified	Q16621	fetal proerythroblasts	NULL
EXP035197	sc-291	Homo sapiens		EXP035189	741	unspecified	Q16621	CD34+ hematopoietic stem progenitor cells	NULL
EXP035198	ab55331	Homo sapiens		EXP035189	741	unspecified	P14316	CD34+ hematopoietic stem progenitor cells	NULL
EXP035199	sc-22805	Homo sapiens		EXP035188	745	unspecified	P17947	fetal CD34+ hematopoietic stem progenitor cells	NULL
EXP035200	sc-22805	Homo sapiens		EXP035189	741	unspecified	P17947	CD34+ hematopoietic stem progenitor cells	NULL
EXP035201	ab23980	Homo sapiens		EXP035188	745	unspecified	Q01196	fetal CD34+ hematopoietic stem progenitor cells	NULL
EXP035202	ab23980	Homo sapiens		EXP035189	741	unspecified	Q01196	CD34+ hematopoietic stem progenitor cells	NULL
EXP035203	ab22849	Homo sapiens		NULL	743	unspecified	P23769	proerythroblasts	NULL
EXP035204	TBP (ab28175, Abcam)	Mus musculus		NULL	2	unspecified	P29037	mESCs (mouse embryonic stem cells)	NULL
EXP035205	TBP (ab28175, Abcam)	Mus musculus	TAF4 KO	NULL	2	unspecified	P29037	mESCs (mouse embryonic stem cells)	NULL
EXP035206	TBP (ab28175, Abcam)	Mus musculus		NULL	237	unspecified	P29037	embryoid body	NULL
EXP035207	TBP (ab28175, Abcam)	Mus musculus	TAF4 KO	NULL	237	unspecified	P29037	embryoid body	NULL
EXP035208		Homo sapiens		NULL	224	chip_control	NULL	DUCaP (prostate carcinoma)	NULL
EXP035209		Homo sapiens	androgen	NULL	224	chip_control	NULL	DUCaP (prostate carcinoma)	NULL
EXP035210		Homo sapiens		EXP035208	224	unspecified	P10275	DUCaP (prostate carcinoma)	NULL
EXP035211		Homo sapiens	androgen	EXP035209	224	unspecified	P10275	DUCaP (prostate carcinoma)	NULL
EXP035212	none	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP035213	Rabbit IgG, purified (Millipore, PP64B, lot DAM1852692, 1mg/ml)	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP035214	none	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP035215	Dynabeads MyOne Streptavidin T1 (Invitrogen, cat. no. 65001)	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP035216	Rabbit IgG, purified (Millipore, PP64B, lot DAM1852692, 1mg/ml)	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP035217	Rabbit IgG, purified (Millipore, PP64B, lot DAM1852692, 1mg/ml)	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP035218	none	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP035219	Rabbit IgG, purified (Millipore, PP64B, lot DAM1852692, 1mg/ml)	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP035220	anti-Bmal1 (Abcam, ab93806, lot GR8441-9, 1mg/ml)	Homo sapiens		EXP035219	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	NULL
EXP035221	anti-Bmal1 (Abcam, ab93806, lot GR8441-9, 1mg/ml)	Homo sapiens		EXP035213	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	NULL
EXP035222	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035213	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	NULL
EXP035223	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035213	677	unspecified	O15516	NOMO-1 (acute monocytic leukemia)	NULL
EXP035224	hoxa9	Homo sapiens		EXP035215	677	unspecified	P31269	NOMO-1 (acute monocytic leukemia)	NULL
EXP035225	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035216	2334	unspecified	O00327	THP-1 (acute monocytic leukemia)	NULL
EXP035226	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035216	2334	unspecified	O15516	THP-1 (acute monocytic leukemia)	NULL
EXP035227	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035217	2334	unspecified	O00327	THP-1 (acute monocytic leukemia)	NULL
EXP035228	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035217	2334	unspecified	O15516	THP-1 (acute monocytic leukemia)	NULL
EXP035229	anti-Bmal1 (Abcam, ab3350, lot GR152555-3, 1mg/ml)	Homo sapiens		EXP035219	677	unspecified	O00327	NOMO-1 (acute monocytic leukemia)	NULL
EXP035230	anti-KAT13D/Clock (Abcam, ab3517, lot GR130170-5, 1mg/ml)	Homo sapiens		EXP035219	677	unspecified	O15516	NOMO-1 (acute monocytic leukemia)	NULL
EXP035231	STAT5	Mus musculus	TPO	NULL	445	unspecified	P42230	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP035232	STAT5	Mus musculus		NULL	445	unspecified	P42230	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP035233	anti-IRF4 (Santa Curz, M-17)	Mus musculus	culture time 72h	NULL	41	unspecified	Q64287	B-cells	NULL
EXP035234	anti-IRF4 (Santa Curz, M-17)	Mus musculus	culture time 48h	NULL	41	unspecified	Q64287	B-cells	NULL
EXP035235	anti-IRF8 (Santa Cruz, C-19)	Mus musculus	culture time 72h	NULL	41	unspecified	P23611	B-cells	NULL
EXP035236	anti-IRF8 (Santa Cruz, C-19)	Mus musculus	culture time 48h	NULL	41	unspecified	P23611	B-cells	NULL
EXP035237	anti-IRF8 (Santa Cruz, C-19)	Mus musculus		NULL	41	unspecified	P23611	B-cells	NULL
EXP035238	C/EBPa, sc-61, Santa Cruz	Mus musculus		NULL	5	unspecified	P53566	liver	NULL
EXP035239	C/EBPa, sc-61, Santa Cruz	Mus musculus	Trib1_LSKO	NULL	5	unspecified	P53566	liver	NULL
EXP035240	C/EBPa, sc-61, Santa Cruz	Mus musculus	AAV_Null	NULL	5	unspecified	P53566	liver	NULL
EXP035241	C/EBPa, sc-61, Santa Cruz	Mus musculus	AAV_Cebpa	NULL	5	unspecified	P53566	liver	NULL
EXP035242	none (input)	Homo sapiens		NULL	194	chip_control	NULL	cranial neural crest cells	NULL
EXP035243	anti-NR2F1 (Perseus Proteomics, catalog# PP-H8132-00, lot# A-2)	Homo sapiens		EXP035242	194	unspecified	P10589	cranial neural crest cells	NULL
EXP035244	anti-TFAP2A (Santa Cruz Biotechnology, catalog# sc-184, lot# H0911)	Homo sapiens		EXP035242	194	unspecified	P05549	cranial neural crest cells	NULL
EXP035245	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP035246	none	Homo sapiens		NULL	211	chip_control	NULL	Delta47 (plasma cell myeloma)	NULL
EXP035247	none	Homo sapiens		NULL	701	chip_control	NULL	OVCAR8 (high grade ovarian serous adenocarcinoma)	NULL
EXP035248	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035249	none	Homo sapiens		NULL	672	chip_control	NULL	normal dermal fibroblasts	NULL
EXP035250	none	Mus musculus		NULL	636	chip_control	NULL	round spermatids	NULL
EXP035251	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		EXP035245	514	unspecified	P49711	K562 (myelogenous leukemia)	NULL
EXP035252	boris	Homo sapiens		EXP035245	514	unspecified	Q8NI51	K562 (myelogenous leukemia)	NULL
EXP035253	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		EXP035246	211	unspecified	P49711	Delta47 (plasma cell myeloma)	NULL
EXP035254	custom mouse monoclonal BORIS  (characterized in PMID: 21659515)	Homo sapiens		EXP035246	211	unspecified	Q8NI51	Delta47 (plasma cell myeloma)	NULL
EXP035255	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		EXP035247	701	unspecified	P49711	OVCAR8 (high grade ovarian serous adenocarcinoma)	NULL
EXP035256	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens		EXP035247	701	unspecified	Q8NI51	OVCAR8 (high grade ovarian serous adenocarcinoma)	NULL
EXP035257	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens		NULL	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035258	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens	Clone1, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035259	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Homo sapiens	Clone2, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035260	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens	Clone1, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	Q8NI51	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035261	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens	Clone2, single-cell clone of MCF7 cell, stably expressing BORIS	EXP035248	113	unspecified	Q8NI51	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035262	custom mouse monoclonal BORIS (characterized in PMID: 21659515)	Homo sapiens		EXP035249	672	unspecified	Q8NI51	normal dermal fibroblasts	NULL
EXP035263	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Mus musculus		EXP035250	636	unspecified	Q61164	round spermatids	NULL
EXP035264	custom rabbit polyclonal BORIS (characterized in PMID:20231363)	Mus musculus		EXP035250	636	unspecified	A2APF3	round spermatids	NULL
EXP035265		Mus musculus		NULL	52	chip_control	NULL	intestinal stem cells	NULL
EXP035266	CDX2	Mus musculus		EXP035265	52	unspecified	P43241	intestinal stem cells	NULL
EXP035267	Rabbit IgG	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP035268	Rabbit IgG	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035269	ATRX antibody (SC-15408)	Mus musculus		EXP035267	506	unspecified	Q61687	J1 (embryonic stem cells)	NULL
EXP035270	ATRX antibody (SC-15408)	Mus musculus		EXP035268	2	unspecified	Q61687	mESCs (mouse embryonic stem cells)	NULL
EXP035271	Santa Cruz M19 H1908	Mus musculus		NULL	1058	unspecified	P70338	CD4+ T-cells	NULL
EXP035272	Santa Cruz M19 H1908	Mus musculus	Gfi1 KO	NULL	1058	unspecified	P70338	CD4+ T-cells	NULL
EXP035273	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP035274	none	Homo sapiens		NULL	534	chip_control	NULL	LAN6 (neuroblastoma)	NULL
EXP035275	ATRX (Santa Cruz, sc-15408 H300, 10ug)	Homo sapiens		EXP035273	514	unspecified	P46100	K562 (myelogenous leukemia)	NULL
EXP035276	ATRX (Abcam, ab97508, 10ug)	Homo sapiens		EXP035273	514	unspecified	P46100	K562 (myelogenous leukemia)	NULL
EXP035277	ATRX (Abcam, ab97508, 6ug)	Homo sapiens		EXP035274	534	unspecified	P46100	LAN6 (neuroblastoma)	NULL
EXP035278		Mus musculus	clone 1	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP035279		Mus musculus	clone 2	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP035280		Mus musculus	parental	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP035281	Anti-Lhx1 (Santa Cruz sc-19341,goat IgG)	Mus musculus	clone1	EXP035278	705	unspecified	P63006	P19 (embryonic carcinoma)	NULL
EXP035282	Anti-Lhx1 (Santa Cruz sc-19341,goat IgG)	Mus musculus	clone 2	EXP035279	705	unspecified	P63006	P19 (embryonic carcinoma)	NULL
EXP035283	Anti-Lhx1 (Santa Cruz sc-19341,goat IgG)	Mus musculus	parental	EXP035280	705	unspecified	P63006	P19 (embryonic carcinoma)	NULL
EXP035284		Mus musculus		NULL	88	chip_control	NULL	Beta-TC-6 (insulinoma)	NULL
EXP035285		Mus musculus		NULL	88	chip_control	NULL	Beta-TC-6 (insulinoma)	NULL
EXP035286	bmal1	Mus musculus		EXP035285	88	unspecified	Q9WTL8	Beta-TC-6 (insulinoma)	NULL
EXP035287	clock	Mus musculus		EXP035285	88	unspecified	O08785	Beta-TC-6 (insulinoma)	NULL
EXP035288	pdx1	Mus musculus		EXP035284	88	unspecified	P52946	Beta-TC-6 (insulinoma)	NULL
EXP035289		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP035290		Mus musculus	shTip5	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP035291	Jarid2 (AbCam, ab48137)	Mus musculus		EXP035289	230	unspecified	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP035292	Jarid2 (AbCam, ab48137)	Mus musculus	shTip5	EXP035290	230	unspecified	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP035293	none	Homo sapiens		NULL	699	chip_control	NULL	OVCAR3 (high grade ovarian serous adenocarcinoma)	NULL
EXP035294	none	Homo sapiens		NULL	698	chip_control	NULL	OVCA429 (ovarian cystadenocarcinoma)	NULL
EXP035295	none	Homo sapiens		NULL	700	chip_control	NULL	PEO1 (ovarian cystadenocarcinoma)	NULL
EXP035296	GRHL2	Homo sapiens		EXP035293	699	unspecified	Q6ISB3	OVCAR3 (high grade ovarian serous adenocarcinoma)	NULL
EXP035297	GRHL2	Homo sapiens		EXP035294	698	unspecified	Q6ISB3	OVCA429 (ovarian cystadenocarcinoma)	NULL
EXP035298	GRHL2	Homo sapiens		EXP035295	700	unspecified	Q6ISB3	PEO1 (ovarian cystadenocarcinoma)	NULL
EXP035299	anti-CTCF (Millipore #07-729)	Mus musculus		NULL	230	unspecified	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP035300	anti-CTCF (Millipore #07-729)	Mus musculus		NULL	232	unspecified	Q61164	E14-derived embryonic neural progenitor cells	NULL
EXP035301		Mus musculus	4h 7Gy	NULL	41	chip_control	NULL	B-cells	NULL
EXP035302	p53	Mus musculus	mock	EXP035301	41	unspecified	P02340	B-cells	NULL
EXP035303	p53	Mus musculus	4h 7Gy	EXP035301	41	unspecified	P02340	B-cells	NULL
EXP035304	p53	Mus musculus	mock	NULL	678	unspecified	P02340	spleen non-B-cells	NULL
EXP035305	p53	Mus musculus	4h 7Gy	NULL	678	unspecified	P02340	spleen non-B-cells	NULL
EXP035306	p53	Mus musculus	4h 7Gy	NULL	917	unspecified	P02340	spleen	NULL
EXP035307	anti-mouse IgG	Mus musculus		NULL	846	chip_control	NULL	ILC3 (type 3 Innate lympoid cells)	NULL
EXP035308	anti-GATA3 (L50-823)	Mus musculus		EXP035307	846	unspecified	P23772	ILC3 (type 3 Innate lympoid cells)	NULL
EXP035309	anti-GATA3 (L50-823)	Mus musculus		NULL	845	unspecified	P23772	ILC2 (type 2 Innate lympoid cells)	NULL
EXP035310	anti-GATA3 (L50-823)	Mus musculus		NULL	499	unspecified	P23772	Th2-cells	NULL
EXP035311	n/a	Mus musculus		NULL	546	chip_control	NULL	limb bud	NULL
EXP035312	n/a	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP035313	Gli2 (R&D Systems, AF3635)	Mus musculus		NULL	419	unspecified	Q0VGT2	head	NULL
EXP035314	Gli2 (R&D Systems, AF3635)	Mus musculus		EXP035311	546	unspecified	Q0VGT2	limb bud	NULL
EXP035315	Gli2 (R&D Systems, AF3635)	Mus musculus		NULL	837	unspecified	Q0VGT2	trunk	NULL
EXP035316	Gli2 (R&D Systems, AF3635)	Mus musculus		EXP035312	25	unspecified	Q0VGT2	cerebellum	NULL
EXP035317	none (input)	Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP035318	none (input)	Mus musculus	Cebpa18h	NULL	41	chip_control	NULL	B-cells	NULL
EXP035319	none (input)	Mus musculus	Cebpa18h, OSKM1d	NULL	41	chip_control	NULL	B-cells	NULL
EXP035320	none (input)	Mus musculus	Cebpa18h, OSKM2d	NULL	41	chip_control	NULL	B-cells	NULL
EXP035321	R&D, AF3158	Mus musculus		EXP035317	41	unspecified	Q60793	B-cells	NULL
EXP035322	R&D, AF3158	Mus musculus	Cebpa18h	EXP035318	41	unspecified	Q60793	B-cells	NULL
EXP035323	R&D, AF3158	Mus musculus	Cebpa18h, OSKM1d	EXP035319	41	unspecified	Q60793	B-cells	NULL
EXP035324	R&D, AF3158	Mus musculus	Cebpa18h, OSKM2d	EXP035320	41	unspecified	Q60793	B-cells	NULL
EXP035325	Santa Cruz, SC-61	Mus musculus	Cebpa18h	EXP035318	41	unspecified	P53566	B-cells	NULL
EXP035326	Santa Cruz, SC-61	Mus musculus		EXP035317	41	unspecified	P53566	B-cells	NULL
EXP035327	sc-352, Santa Cruz	Mus musculus		EXP035317	41	unspecified	P17433	B-cells	NULL
EXP035328	sc-352, Santa Cruz	Mus musculus	Cebpa18h	EXP035318	41	unspecified	P17433	B-cells	NULL
EXP035329	rabbit IgG	Mus musculus		NULL	478	chip_control	NULL	IMCD3 inner medullary collecting duct)	NULL
EXP035330	rabbit IgG	Mus musculus		NULL	478	chip_control	NULL	IMCD3 inner medullary collecting duct)	NULL
EXP035331	Sc22840	Mus musculus		EXP035329	478	unspecified	P27889	IMCD3 inner medullary collecting duct)	NULL
EXP035332	Sc22840	Mus musculus		EXP035330	478	unspecified	P27889	IMCD3 inner medullary collecting duct)	NULL
EXP035333	PBX3 (Abcam ab109173, lot/batch number GR-46727-7)	Homo sapiens		NULL	801	unspecified	P40426	SMMC-7721 (hepatocellular carcinoma)	NULL
EXP035334	ER	Homo sapiens	EtOH	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035335	ER	Homo sapiens	EtOH, HOTAIR transgene	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035336	ER	Homo sapiens	E2	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035337	ER	Homo sapiens	E2, HOTAIR transgene	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035338	none	Homo sapiens		NULL	875	chip_control	NULL	ZR-75-30 (invasive ductal carcinoma)	NULL
EXP035339	none	Homo sapiens	RACK7 KO	NULL	875	chip_control	NULL	ZR-75-30 (invasive ductal carcinoma)	NULL
EXP035340	Bethyl, A301-034A	Homo sapiens		EXP035338	875	unspecified	P41229	ZR-75-30 (invasive ductal carcinoma)	NULL
EXP035341	Bethyl, A301-034A	Homo sapiens	RACK7 KO	EXP035339	875	unspecified	P41229	ZR-75-30 (invasive ductal carcinoma)	NULL
EXP035342	anti-E2F1 (Santa Cruz, catalog# sc-193x, lot# B0615)	Mus musculus		NULL	12	unspecified	Q61501	MEF (mouse embryonic fibroblasts)	NULL
EXP035343	anti-E2F3 (Santa Cruz, catalog# sc-878x, lot# E1712)	Mus musculus	E2F3A overexpression	NULL	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	NULL
EXP035344	anti-E2F3 (Santa Cruz, catalog# sc-878x, lot# E1712)	Mus musculus	E2F3B overexpression	NULL	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	NULL
EXP035345	anti-E2F1 (Santa Cruz, catalog# sc-193x, lot# B0615)	Mus musculus	E2F1 KO	NULL	12	unspecified	Q61501	MEF (mouse embryonic fibroblasts)	NULL
EXP035346	anti-E2F3 (Santa Cruz, catalog# sc-878x, lot# E1712)	Mus musculus	E2F3 KO	NULL	12	unspecified	O35261	MEF (mouse embryonic fibroblasts)	NULL
EXP035347	none (input)	Mus musculus		NULL	866	chip_control	NULL	E15.5 embryonic cortex	NULL
EXP035348	Rabbit anti TBR1 (Abcam) antibody	Mus musculus		EXP035347	866	unspecified	Q64336	E15.5 embryonic cortex	NULL
EXP035349	none	Homo sapiens	none (no stimulation control)	NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035350	none	Homo sapiens	none (no stimulation control)	NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035351	none	Homo sapiens	10 nM dexamethasone for 1 hour	NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035352	none	Homo sapiens	10 nM dexamethasone for 1 hour	NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035353	GR (Novus, NB300-731; Cell Signaling, D8H2; Abcam ab3579)	Homo sapiens	none (no stimulation control)	EXP035349	779	unspecified	P04150	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035354	PU.1 (Pierce, E.388.3; Cell Signaling, 2266; Santa Cruz Biotechnology, SC-352X)	Homo sapiens	none (no stimulation control)	EXP035350	779	unspecified	P17947	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035355	GR (Novus, NB300-731; Cell Signaling, D8H2; Abcam ab3579)	Homo sapiens	10 nM dexamethasone for 1 hour	EXP035351	779	unspecified	P04150	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035356	PU.1 (Pierce, E.388.3; Cell Signaling, 2266; Santa Cruz Biotechnology, SC-352X)	Homo sapiens	10 nM dexamethasone for 1 hour	EXP035352	779	unspecified	P17947	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP035357	none	Mus musculus		NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP035358	none	Homo sapiens		NULL	245	chip_control	NULL	NCCIT (testicular embryonic carcinoma)	NULL
EXP035359	POU5F1 (Santa Cruz, catalog# sc-5279)	Mus musculus		EXP035357	521	unspecified	P20263	KH2 (embryonic stem cells)	NULL
EXP035360	PRDM14 (Homemade)	Mus musculus		EXP035357	521	unspecified	E9Q3T6	KH2 (embryonic stem cells)	NULL
EXP035361	PRDM14 (Homemade)	Homo sapiens		EXP035358	245	unspecified	Q9GZV8	NCCIT (testicular embryonic carcinoma)	NULL
EXP035362	Streptavidin	Mus musculus		NULL	723	unspecified	P17433	plasmablasts	NULL
EXP035363	Irf4 Ab, SantaCruz SC6059X, lot: E0608	Mus musculus		NULL	41	unspecified	Q64287	B-cells	NULL
EXP035364	Irf4 Ab, SantaCruz SC6059X, lot: E0608	Mus musculus		NULL	723	unspecified	Q64287	plasmablasts	NULL
EXP035365	Irf4 Ab, SantaCruz SC6059X, lot: E0608	Mus musculus		NULL	740	unspecified	Q64287	preplasmablasts	NULL
EXP035366	Streptavidin	Mus musculus		NULL	723	unspecified	Q60636	plasmablasts	NULL
EXP035367	AR	Homo sapiens	siPSA-eRNA	NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP035368	AR	Homo sapiens		NULL	130	unspecified	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP035369	non-specific IgG	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035370		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035371	non-specific IgG	Mus musculus	after 12 min heat shock	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035372		Mus musculus	after 12 min heat shock	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035373	non-specific IgG	Mus musculus	after 60 min heat shock	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035374		Mus musculus	after 60 min heat shock	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035375	Cell Signaling (CS) #4356	Mus musculus		EXP035369	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035376	gift from Morimoto lab (MM)	Mus musculus		EXP035369	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035377	Cell Signaling (CS) #4356	Mus musculus	after 12 min heat shock	EXP035371	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035378	gift from Morimoto lab (MM)	Mus musculus	after 12 min heat shock	EXP035371	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035379	Cell Signaling (CS) #4356	Mus musculus	after 60 min heat shock	EXP035373	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035380	gift from Morimoto lab (MM)	Mus musculus	after 60 min heat shock	EXP035373	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035381	Cell Signaling (CS) #4356	Mus musculus	HSF1KO	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035382	gift from Morimoto lab (MM)	Mus musculus	HSF1KO	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035383	Cell Signaling (CS) #4356	Mus musculus	HSF1KO, after 12 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035384	gift from Morimoto lab (MM)	Mus musculus	HSF1KO, after 12 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035385	Cell Signaling (CS) #4356	Mus musculus	HSF1KO, after 60 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035386	gift from Morimoto lab (MM)	Mus musculus	HSF1KO, after 60 min heat shock	NULL	12	unspecified	P38532	MEF (mouse embryonic fibroblasts)	NULL
EXP035387	SRF (D71A9) from Cell Signaling (#5147)	Mus musculus		NULL	12	unspecified	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP035388	SRF (D71A9) from Cell Signaling (#5147)	Mus musculus	after 12 min heat shock	NULL	12	unspecified	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP035389	SRF (D71A9) from Cell Signaling (#5147)	Mus musculus	after 60 min heat shock	NULL	12	unspecified	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP035390		Homo sapiens		NULL	888	chip_control	NULL	thymus	NULL
EXP035391	gata3	Homo sapiens		EXP035390	888	unspecified	P23771	thymus	NULL
EXP035392	KMT2D (Sigma, HPA035977)	Homo sapiens		NULL	719	unspecified	Q9UMN6	cutaneous melanoma	NULL
EXP035393	KMT2D (Sigma, HPA035977)	Homo sapiens	shKMT2D	NULL	719	unspecified	Q9UMN6	cutaneous melanoma	NULL
EXP035394	KMT2D (Sigma, HPA035977)	Homo sapiens	shLuc	NULL	719	unspecified	Q9UMN6	cutaneous melanoma	NULL
EXP035395	KMT2D (Sigma, HPA035977)	Homo sapiens	shLuc	NULL	719	unspecified	Q9UMN6	cutaneous melanoma	NULL
EXP035396	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035397	none	Mus musculus		NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP035398	none	Mus musculus		NULL	206	chip_control	NULL	epiblast-like cells	NULL
EXP035399	NANOG (RCAB0001P)	Mus musculus		EXP035396	2	unspecified	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP035400	NANOG (RCAB0001P)	Mus musculus		EXP035397	206	unspecified	Q80Z64	epiblast-like cells	NULL
EXP035401	NANOG (RCAB0001P)	Mus musculus		EXP035398	206	unspecified	Q80Z64	epiblast-like cells	NULL
EXP035402	Tcf4 (C48H11) (Cell signaling, catalog# 2569S, lot# 2)	Mus musculus		NULL	799	chip_control	NULL	small intestine	NULL
EXP035403	Tcf4 (C48H11) (Cell signaling, catalog# 2569S, lot# 2)	Mus musculus		EXP035402	799	unspecified	Q924A0	small intestine	NULL
EXP035404	normal rabbit IgG (sc-2027, Santa Cruz)	Homo sapiens	TNFÎ± for 6 h	NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP035405	none	Homo sapiens	TNFÎ± for 6 h	NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP035406	c-Jun (H-79, Santa Cruz)	Homo sapiens		NULL	120	unspecified	P05412	BT-549 (breast invasive ductal carcinoma)	NULL
EXP035407	c-Jun (H-79, Santa Cruz)	Homo sapiens	TNFÎ± for 6 h	EXP035404	120	unspecified	P05412	BT-549 (breast invasive ductal carcinoma)	NULL
EXP035408	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035409	none	Homo sapiens		NULL	586	chip_control	NULL	MCFDCIS (breast cancer)	NULL
EXP035410	p63 antibody (Santa Cruz, H129)	Homo sapiens		EXP035408	2301	unspecified	Q9H3D4	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035411	p63 antibody (Santa Cruz, H129)	Homo sapiens		EXP035409	586	unspecified	Q9H3D4	MCFDCIS (breast cancer)	NULL
EXP035412	GATA3	Mus musculus		NULL	1058	unspecified	P23772	CD4+ T-cells	NULL
EXP035413	GATA3	Mus musculus	TGF-Î² +IL-4	NULL	1058	unspecified	P23772	CD4+ T-cells	NULL
EXP035414		Mus musculus		NULL	527	chip_control	NULL	KSIC_c806 (pancreatic cancer)	NULL
EXP035415	ab137676	Mus musculus		EXP035414	527	unspecified	Q9Z0Z7	KSIC_c806 (pancreatic cancer)	NULL
EXP035416	Diagenode C1531012A	Mus musculus		EXP035414	527	unspecified	Q06831	KSIC_c806 (pancreatic cancer)	NULL
EXP035417	Cell Signaling #8685	Mus musculus	Smad4	EXP035414	527	unspecified	Q62432	KSIC_c806 (pancreatic cancer)	NULL
EXP035418	Cell Signaling #8685	Mus musculus		EXP035414	527	unspecified	Q62432	KSIC_c806 (pancreatic cancer)	NULL
EXP035419	GABPA, Santa Cruz Biotechnology, sc-28312	Homo sapiens	modified	NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	NULL
EXP035420	CREB1 Santa Cruz Biotechnology, sc-240	Homo sapiens	modified	NULL	430	unspecified	P16220	HepG2 (hepatoblastoma)	NULL
EXP035421	FLAG M2 Sigma F1804	Mus musculus		NULL	252	unspecified	Q00422	V6.5 (embryonic stem cells)	NULL
EXP035422	GABPA, Santa Cruz Biotechnology, sc-28312	Homo sapiens		NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	NULL
EXP035423	FLAG M2 Sigma F1804	Homo sapiens	modified	NULL	430	unspecified	Q06546	HepG2 (hepatoblastoma)	NULL
EXP035424	CREB1	Homo sapiens		NULL	430	unspecified	P16220	HepG2 (hepatoblastoma)	NULL
EXP035425	FLAG M2 Sigma F1804	Homo sapiens		NULL	430	unspecified	P16220	HepG2 (hepatoblastoma)	NULL
EXP035426	FLAG M2 Sigma F1804	Homo sapiens		NULL	430	unspecified	P18846	HepG2 (hepatoblastoma)	NULL
EXP035427	N/A	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035428	N/A	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035429	N/A	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035438	Bcl6	Mus musculus		EXP035437	501	unspecified	P41183	T follicular helpers	NULL
EXP035437	IgG	Mus musculus		NULL	501	chip_control	NULL	T follicular helpers	NULL
EXP035434	GATA3 serum (Adomas et al, 2014)	Homo sapiens		EXP035427	2301	unspecified	P23771	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035435	GATA3 serum (Adomas et al, 2014)	Homo sapiens		EXP035428	2301	unspecified	P23771	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035436	GATA3	Homo sapiens		EXP035429	2301	unspecified	P23771	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP035439	Bcl6	Mus musculus		NULL	500	unspecified	P41183	non-T follicular helpers	NULL
EXP035440	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone and 17Î²-estradiol	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035441	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone and 17Î²-estradiol	NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035442	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone and 17Î²-estradiol	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP035443	GR E-20X sc-1003 Santa Cruz	Homo sapiens		EXP035440	113	unspecified	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035444	GR E-20X sc-1003 Santa Cruz	Homo sapiens	Dexamethasone	EXP035440	113	unspecified	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035445	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens		EXP035440	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035446	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens	17Î²-estradiol	EXP035440	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035447	FoxA1 ab23738 Abcam	Homo sapiens		EXP035440	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035448	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone	EXP035440	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035449	FoxA1 ab23738 Abcam	Homo sapiens	17Î²-estradiol	EXP035440	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035450	GR E-20X sc-1003 Santa Cruz	Homo sapiens		EXP035441	874	unspecified	P04150	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035451	GR E-20X sc-1003 Santa Cruz	Homo sapiens	Dexamethasone	EXP035441	874	unspecified	P04150	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035452	estrogen	Homo sapiens		EXP035441	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035453	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens	17Î²-estradiol	EXP035441	874	unspecified	P03372	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035454	FoxA1 ab23738 Abcam	Homo sapiens		EXP035441	874	unspecified	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035455	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone	EXP035441	874	unspecified	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035456	FoxA1 ab23738 Abcam	Homo sapiens	17Î²-estradiol	EXP035441	874	unspecified	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP035457	GR E-20X sc-1003 Santa Cruz	Homo sapiens		EXP035442	111	unspecified	P04150	T47D (invasive ductal carcinoma)	NULL
EXP035458	GR E-20X sc-1003 Santa Cruz	Homo sapiens	Dexamethasone	EXP035442	111	unspecified	P04150	T47D (invasive ductal carcinoma)	NULL
EXP035459	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens		EXP035442	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP035460	ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	Homo sapiens	17Î²-estradiol	EXP035442	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP035461	FoxA1 ab23738 Abcam	Homo sapiens		EXP035442	111	unspecified	P55317	T47D (invasive ductal carcinoma)	NULL
EXP035462	FoxA1 ab23738 Abcam	Homo sapiens	Dexamethasone	EXP035442	111	unspecified	P55317	T47D (invasive ductal carcinoma)	NULL
EXP035463	FoxA1 ab23738 Abcam	Homo sapiens	17Î²-estradiol	EXP035442	111	unspecified	P55317	T47D (invasive ductal carcinoma)	NULL
EXP035464		Homo sapiens		NULL	907	chip_control	NULL	Th2-cells	NULL
EXP035465		Homo sapiens		NULL	886	chip_control	NULL	Th1-cells	NULL
EXP035466	myb	Homo sapiens		EXP035464	907	unspecified	P10242	Th2-cells	NULL
EXP035467	maf	Homo sapiens		EXP035464	907	unspecified	O75444	Th2-cells	NULL
EXP035468	gata3	Homo sapiens		EXP035465	886	unspecified	P23771	Th1-cells	NULL
EXP035469	gata3	Homo sapiens		EXP035464	907	unspecified	P23771	Th2-cells	NULL
EXP035470	myb	Homo sapiens		EXP035465	886	unspecified	P10242	Th1-cells	NULL
EXP035471	maf	Homo sapiens		EXP035465	886	unspecified	O75444	Th1-cells	NULL
EXP035472	RFX1	Mus musculus		NULL	286	unspecified	P48377	pancreatic beta-cells	NULL
EXP035473	RFX3	Mus musculus		NULL	286	unspecified	P48381	pancreatic beta-cells	NULL
EXP035474	FOXA1	Homo sapiens		NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP035475	anti-STAT5/R & D Systems, #PA-ST5A, lot #RU07	Mus musculus		NULL	2479	unspecified	P42230	CD8+ T-cells	NULL
EXP035476	anti-STAT5/R & D Systems, #PA-ST5A, lot #RU07	Mus musculus	0.5 ug/ml IL-2 for 1 hour	NULL	2479	unspecified	P42230	CD8+ T-cells	NULL
EXP035477	none (input)	Mus musculus		NULL	714	chip_control	NULL	alphaTC1 Clone 9 (pancreatic alpha cells)	NULL
EXP035478	Antibody:  ANTI-FLAGÂ® M2 Affinity Gel A2220 (Sigma-Aldrich)	Mus musculus		EXP035477	714	unspecified	Q6XP49	alphaTC1 Clone 9 (pancreatic alpha cells)	NULL
EXP035479	IgG (Abcam ab18443)	Homo sapiens		NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP035480	MYCN (Abcam ab16898)	Homo sapiens		EXP035479	82	unspecified	P04198	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP035481	none (input)	Homo sapiens		NULL	191	chip_control	NULL	corneal epithelium	NULL
EXP035482	sc-85804	Homo sapiens		EXP035481	191	unspecified	Q9BRP0	corneal epithelium	NULL
EXP035483	sc-85804	Homo sapiens		NULL	191	unspecified	Q9BRP0	corneal epithelium	NULL
EXP035484	SNF2H (Abcam, ab72499)	Homo sapiens		NULL	70	unspecified	O60264	LNCaP (prostate carcinoma)	NULL
EXP035485	SMARCA1 (Abcam, ab37003)	Homo sapiens		NULL	70	unspecified	P28370	LNCaP (prostate carcinoma)	NULL
EXP035486		Homo sapiens	vehicle for 24hrs	NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP035487		Homo sapiens	5 ÂµM SR2211 for 24hrs	NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP035488	AR (Santa Cruz; sc-815)	Homo sapiens	vehicle for 24hrs	EXP035486	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP035489	AR (Santa Cruz; sc-815)	Homo sapiens	5 ÂµM SR2211 for 24hrs	EXP035487	129	unspecified	P10275	LNCaP C4-2B (prostate carcinoma)	NULL
EXP035490	Sox10 (Abcam ab27655)	Rattus norvegicus		NULL	218	unspecified	O55170	oligodendrocytes	NULL
EXP035491	none (input)	Mus musculus	Chaf1a KO	NULL	695	chip_control	NULL	OKSM reprogrammed embryonic fibroblasts	NULL
EXP035492	none (input)	Mus musculus		NULL	695	chip_control	NULL	OKSM reprogrammed embryonic fibroblasts	NULL
EXP035493	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035494	goat polyclonal Anti-Sox2 (R&D, catalog# AF2018, lot# KOY0213101)	Mus musculus	Chaf1a KO	EXP035491	695	unspecified	P48432	OKSM reprogrammed embryonic fibroblasts	NULL
EXP035495	goat polyclonal Anti-Sox2 (R&D, catalog# AF2018, lot# KOY0213101)	Mus musculus		EXP035492	695	unspecified	P48432	OKSM reprogrammed embryonic fibroblasts	NULL
EXP035496	goat polyclonal Anti-Sox2 (AF2018, R&D); lot#: KOY0213101	Mus musculus		EXP035493	12	unspecified	P48432	MEF (mouse embryonic fibroblasts)	NULL
EXP035497	anti-E2A (sc-349; Santa Cruz Technologies)	Homo sapiens		NULL	768	unspecified	P15923	Ramos (Burkitt lymphoma)	NULL
EXP035498		Mus musculus		NULL	787	chip_control	NULL	subcutaneous osteosarcoma	NULL
EXP035499	fli1	Mus musculus		EXP035498	787	unspecified	P26323	subcutaneous osteosarcoma	NULL
EXP035500	LEF1	Homo sapiens	EGF for 0h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	NULL
EXP035501	LEF1	Homo sapiens	EGF for 12h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	NULL
EXP035502	LEF1	Homo sapiens	EGF for 24h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	NULL
EXP035503	LEF1	Homo sapiens	EGF for 48h	NULL	775	unspecified	Q9UJU2	RL95-2 (endometrial adenosquamous carcinoma)	NULL
EXP035504	none	Mus musculus	vehicle 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035505	none	Mus musculus	tissuehomogenate 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035506	none	Mus musculus	vehicle 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035507	none	Mus musculus	tissuehomogenate 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035508	none	Mus musculus	no treatment	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035509	none	Mus musculus	KLA 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035510	none	Mus musculus	vehicle 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035511	none	Mus musculus	tissuehomogenate 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035512	none	Mus musculus	KLA 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035513	none	Mus musculus	TGFb 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035514	none	Mus musculus	no treatment	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035515	none	Mus musculus	no treatment	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035516	none	Mus musculus	TGFb 4h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035517	none	Mus musculus	vehicle 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035518	none	Mus musculus	tissuehomogenate 6h	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035519	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1214)	Mus musculus	vehicle 6h	EXP035504	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP035520	PU.1 (Vendor: Santa Cruz, cat# sc-352, lot# F1214)	Mus musculus	tissuehomogenate 6h	EXP035505	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP035521	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	vehicle 6h	EXP035506	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP035522	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	tissuehomogenate 6h	EXP035507	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP035523	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	no treatment	EXP035508	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP035524	cFos (Vendor: Santa Cruz, cat# Sc-7202, lot# )	Mus musculus	KLA 6h	EXP035509	81	unspecified	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP035525	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	vehicle 6h	EXP035510	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP035526	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	tissuehomogenate 6h	EXP035511	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP035527	Smad3 (Vendor: Abcam, cat# ab28379, lot# GR188908-1)	Mus musculus	vehicle 6h	EXP035510	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	NULL
EXP035528	Smad3 (Vendor: Abcam, cat# ab28379, lot# GR188908-1)	Mus musculus	tissuehomogenate 6h	EXP035511	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	NULL
EXP035529	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	KLA 6h	EXP035512	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP035530	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	TGFb 6h	EXP035513	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP035531	NFkB p65 (Vendor: Santa Cruz, cat# sc-372X, lot# A0314)	Mus musculus	no treatment	EXP035514	81	unspecified	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP035532	Smad3 (Vendor: Abcam, cat# ab28379)	Mus musculus	no treatment	EXP035515	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	NULL
EXP035533	Smad3 (Vendor: Abcam, cat# ab28379)	Mus musculus	TGFb 4h	EXP035516	81	unspecified	Q8BUN5	BMDM (bone marrow-derived macrophages)	NULL
EXP035534	Nrf2  (Vendor: Santa Cruz, cat# sc-13032X, lot# I1311)	Mus musculus	vehicle 6h	EXP035517	81	unspecified	Q60795	BMDM (bone marrow-derived macrophages)	NULL
EXP035535	Nrf2  (Vendor: Santa Cruz, cat# sc-13032X, lot# I1311)	Mus musculus	tissuehomogenate 6h	EXP035518	81	unspecified	Q60795	BMDM (bone marrow-derived macrophages)	NULL
EXP035536		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035537	foxm1	Homo sapiens	Proliferating	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035538	foxm1	Homo sapiens	Confluent	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035539	foxm1	Homo sapiens	mi63	NULL	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035540	foxm1	Homo sapiens		EXP035536	113	unspecified	Q08050	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035541	none	Mus musculus	plus Dox to induce Flag-Sp5 expression	NULL	34	chip_control	NULL	A2Lox.cre (embryonic stem cells)	NULL
EXP035542	M2 (Sigma, catalog# F3165, lot# SLBF1225). Used 4ug of antibody per ChIP	Mus musculus	plus Dox to induce Flag-Sp5 expression	EXP035541	34	unspecified	Q9JHX2	A2Lox.cre (embryonic stem cells)	NULL
EXP035543	none (input)	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP035544	none (input)	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP035545	Helios (Santa Cruz, G-20, sc-9866)	Mus musculus		EXP035544	1058	unspecified	P81183	CD4+ T-cells	NULL
EXP035546	Helios (Santa Cruz, G-20, sc-9866)	Mus musculus		EXP035543	2479	unspecified	P81183	CD8+ T-cells	NULL
EXP035547	none	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP035548	SOX9 (Millipore, catalog# AB5535, lot# LV 1478872)	Mus musculus		EXP035547	858	unspecified	Q04887	valve mesenchyme	NULL
EXP035549	SOX9 (Millipore, catalog# AB5535, lot# LV 1478872)	Mus musculus		EXP035547	548	unspecified	Q04887	limb mesenchyme	NULL
EXP035550	Tcf1	Mus musculus		NULL	44	unspecified	Q00417	T-cells	NULL
EXP035551	Tcf1	Mus musculus	Tcf1-deficient	NULL	44	unspecified	Q00417	T-cells	NULL
EXP035552	none	Homo sapiens		NULL	146	chip_control	NULL	Caki-1 (renal carcinoma)	NULL
EXP035553	ab72152	Homo sapiens		EXP035552	146	unspecified	P41229	Caki-1 (renal carcinoma)	NULL
EXP035554	Bethyl A301-034	Homo sapiens		EXP035552	146	unspecified	P41229	Caki-1 (renal carcinoma)	NULL
EXP035555	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035556	ERalpha (H-20, Santa Cruz)	Homo sapiens		EXP035555	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035557	FOXA1 (Abcam, Cat. # ab23738, Lot # GR44102-1)	Homo sapiens	shCtrl	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP035558	FOXA1 (Abcam, Cat. # ab23738, Lot # GR44102-1)	Homo sapiens	shTET1	NULL	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP035559	none (input)	Mus musculus		NULL	179	chip_control	NULL	chondrocytes	NULL
EXP035560	Jun(Abcam Cat#ab31419)	Mus musculus		EXP035559	179	unspecified	P05627	chondrocytes	NULL
EXP035561	Input	Mus musculus		NULL	833	chip_control	NULL	THY1+ spermatogonia	NULL
EXP035562	Input	Mus musculus		NULL	833	chip_control	NULL	THY1+ spermatogonia	NULL
EXP035563	Input	Mus musculus		NULL	833	chip_control	NULL	THY1+ spermatogonia	NULL
EXP035564	PLZF	Mus musculus		EXP035561	833	unspecified	Q3UQ17	THY1+ spermatogonia	NULL
EXP035565	PLZF	Mus musculus		EXP035562	833	unspecified	Q3UQ17	THY1+ spermatogonia	NULL
EXP035566	PLZF	Mus musculus		EXP035563	833	unspecified	Q3UQ17	THY1+ spermatogonia	NULL
EXP035567	SALL4	Mus musculus		EXP035561	833	unspecified	Q8BX22	THY1+ spermatogonia	NULL
EXP035568	SALL4	Mus musculus		EXP035562	833	unspecified	Q8BX22	THY1+ spermatogonia	NULL
EXP035569	SALL4	Mus musculus		EXP035563	833	unspecified	Q8BX22	THY1+ spermatogonia	NULL
EXP035570	HA-antibody (Abcam, ab9110)	Mus musculus	doxycycline treatment	NULL	2	unspecified	P83870	mESCs (mouse embryonic stem cells)	NULL
EXP035571	HA-antibody (Abcam, ab9110)	Mus musculus		NULL	2	unspecified	P83870	mESCs (mouse embryonic stem cells)	NULL
EXP035572	anti-IgG (Santa Cruz; catalog# sc-2028; lot# J2114)	Mus musculus		NULL	102	chip_control	NULL	BMiFLT3(15-3) (murine acute lymphoblastic leukemia)	NULL
EXP035573	anti-Mef2c (Santa Cruz; catalog# sc-13266X; lot# C2309)	Mus musculus		EXP035572	102	unspecified	Q8CFN5	BMiFLT3(15-3) (murine acute lymphoblastic leukemia)	NULL
EXP035574	none	Homo sapiens		NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP035575	MLLc (Millipore 05-765)	Homo sapiens		EXP035574	641	unspecified	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP035576	MLLn (Bethyl Laboratories A300-086A)	Homo sapiens		EXP035574	641	unspecified	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP035577		Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP035578		Mus musculus		NULL	503	chip_control	NULL	pre-B cells	NULL
EXP035579		Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP035580		Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP035581	YY1	Mus musculus		EXP035577	105	unspecified	Q00899	pro-B cells	NULL
EXP035582	YY1	Mus musculus		EXP035578	503	unspecified	Q00899	pre-B cells	NULL
EXP035583	YY1	Mus musculus		EXP035579	41	unspecified	Q00899	B-cells	NULL
EXP035584	YY1	Mus musculus		EXP035580	41	unspecified	Q00899	B-cells	NULL
EXP035585		Homo sapiens	vehicle (Ham's F-12 media)	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP035586		Homo sapiens	100 nM amyloid-beta1-42 oligomers for 4 h	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP035587	anti-SATB1 (sc-5990)	Homo sapiens	vehicle (Ham's F-12 media)	EXP035585	664	unspecified	Q01826	SH-SY5Y (neuroblastoma)	NULL
EXP035588	anti-SATB1 (sc-5990)	Homo sapiens	100 nM amyloid-beta1-42 oligomers for 4 h	EXP035586	664	unspecified	Q01826	SH-SY5Y (neuroblastoma)	NULL
EXP035589	none	Mus musculus	OCA (10mg/kg/day)	NULL	5	chip_control	NULL	liver	NULL
EXP035590	none	Mus musculus	OCA (10mg/kg/day)	NULL	5	chip_control	NULL	liver	NULL
EXP035591	none	Mus musculus	vehicle (1% methyl cellulose)	NULL	5	chip_control	NULL	liver	NULL
EXP035592	none	Mus musculus	vehicle (1% methyl cellulose)	NULL	5	chip_control	NULL	liver	NULL
EXP035593	FXR (SantaCruz, sc-13063)	Mus musculus	OCA (10mg/kg/day)	EXP035589	5	unspecified	Q60641	liver	NULL
EXP035594	FXR (SantaCruz, sc-13063)	Mus musculus	OCA (10mg/kg/day)	EXP035590	5	unspecified	Q60641	liver	NULL
EXP035595	FXR (SantaCruz, sc-13063)	Mus musculus	vehicle (1% methyl cellulose)	EXP035591	5	unspecified	Q60641	liver	NULL
EXP035596	FXR (SantaCruz, sc-13063)	Mus musculus	vehicle (1% methyl cellulose)	EXP035592	5	unspecified	Q60641	liver	NULL
EXP035597	Gata2 (Santa Cruz, cat# sc9008x, lot# I0109)	Mus musculus	TGFb	NULL	545	unspecified	O09100	Lhx2 (hematopoietic stem cells)	NULL
EXP035598	none	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP035599	Anti-Nanog antibody (R&D AF1997)	Homo sapiens		EXP035598	396	unspecified	Q9H9S0	WA09 (embryonic stem cells)	NULL
EXP035600	none	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP035601	none	Mus musculus	KLF15 knockout	NULL	53	chip_control	NULL	heart	NULL
EXP035602	none	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP035603	REV-ERBa (Cell Signaling, E1Y6D, #13418)	Mus musculus		EXP035600	53	unspecified	Q3UV55	heart	NULL
EXP035604	REV-ERBa (Cell Signaling, E1Y6D, #13418)	Mus musculus	KLF15 knockout	EXP035601	53	unspecified	Q3UV55	heart	NULL
EXP035605	FLAG (Sigma, F3165)	Mus musculus		EXP035602	53	unspecified	Q9EPW2	heart	NULL
EXP035606	NA	Homo sapiens		NULL	462	chip_control	NULL	embryonic kidney cortex	NULL
EXP035607	NA	Mus musculus		NULL	903	chip_control	NULL	embryonic kidney	NULL
EXP035608	SIX2 antibody (MyBiosource, MBS610128)	Homo sapiens		EXP035606	462	unspecified	Q9NPC8	embryonic kidney cortex	NULL
EXP035609	Six2 antibody (Proteintech,11562-1-AP)	Mus musculus		EXP035607	903	unspecified	Q62232	embryonic kidney	NULL
EXP035610	SIX2 antibody (MyBiosource, MBS610128)	Mus musculus		EXP035607	903	unspecified	Q62232	embryonic kidney	NULL
EXP035611	anti-Flag M2	Homo sapiens		NULL	421	unspecified	Q9NZL3	HEK293 (embryonic kidney)	NULL
EXP035612	input	Mus musculus		NULL	260	chip_control	NULL	epiblast stem cells	NULL
EXP035613	input	Mus musculus	MM401	NULL	260	chip_control	NULL	epiblast stem cells	NULL
EXP035614	MLL1	Mus musculus		EXP035612	260	unspecified	P55200	epiblast stem cells	NULL
EXP035615	MLL1	Mus musculus	MM401	EXP035613	260	unspecified	P55200	epiblast stem cells	NULL
EXP035616	none (input)	Mus musculus		NULL	429	chip_control	NULL	hepatocytes	NULL
EXP035617	E2F1 c20 ( santa cruz sc193)	Mus musculus		EXP035616	429	unspecified	Q61501	hepatocytes	NULL
EXP035618		Mus musculus		NULL	616	chip_control	NULL	MLL-ENL leukemia	NULL
EXP035619	M2 Flag	Mus musculus		EXP035618	616	unspecified	P43120	MLL-ENL leukemia	NULL
EXP035620	none	Homo sapiens		NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP035621	ERalpha (H-20, Santa Cruz)	Homo sapiens		EXP035620	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP035622	Santa Cruz (sc-350x)	Mus musculus		NULL	710	unspecified	P27577	P5424 (thymic cells)	NULL
EXP035623	IgG (Santa Cruz)	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP035624	YY1 (Santa Cruz)	Mus musculus		EXP035623	1153	unspecified	Q00899	C2C12 (myoblasts)	NULL
EXP035625	none (input)	Homo sapiens		NULL	590	chip_control	NULL	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035626	AR (Santa Cruz Biotech, N-20, sc-816)	Homo sapiens		EXP035625	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035627	AR (Santa Cruz Biotech, N-20, sc-816)	Homo sapiens	DHT 10nM	NULL	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035628	AR (Santa Cruz Biotech, N-20, sc-816)	Homo sapiens	medroxyprogesterone acetate 10nM	NULL	590	unspecified	P10275	MDA-MB-453 (breast adenocarcinoma)	NULL
EXP035629	Rabbit IgG (Cat. 2729, Cell Signaling)	Mus musculus		NULL	104	chip_control	NULL	dendritic cells	NULL
EXP035630	STAT3 (Cat. 9132, Cell Signaling)	Mus musculus		EXP035629	104	unspecified	P42227	dendritic cells	NULL
EXP035631	STAT3 (Cat. 9132, Cell Signaling)	Mus musculus	SAHA (500nm)	EXP035629	104	unspecified	P42227	dendritic cells	NULL
EXP035632	none (input)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035633	none (input)	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP035634	HA (Covance, MMS-101P)	Mus musculus		EXP035632	2	unspecified	E9QAG8	mESCs (mouse embryonic stem cells)	NULL
EXP035635	HA (Covance, MMS-101P)	Mus musculus		EXP035633	1153	unspecified	E9QAG8	C2C12 (myoblasts)	NULL
EXP035636		Mus musculus		NULL	137	chip_control	NULL	hindbrain	NULL
EXP035637	mycPet-1	Mus musculus		EXP035636	137	unspecified	Q8QZW2	hindbrain	NULL
EXP035638	ATF3	Homo sapiens	camptothecin	NULL	417	unspecified	P18847	HCT-116 (colon carcinoma)	NULL
EXP035639	ATF3	Homo sapiens	ATF3 KO	NULL	417	unspecified	P18847	HCT-116 (colon carcinoma)	NULL
EXP035640	p53	Homo sapiens	camptothecin	NULL	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP035641	p53	Homo sapiens	p53 KO	NULL	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP035642	ATF3	Homo sapiens	DMSO	NULL	417	unspecified	P18847	HCT-116 (colon carcinoma)	NULL
EXP035643	none (input)	Homo sapiens	DMSO	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP035644	none (input)	Homo sapiens	6AN	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP035645	anti-BMAL1 (ab3350; Abcam)	Homo sapiens	DMSO	EXP035643	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP035646	anti-BMAL1 (ab3350; Abcam)	Homo sapiens	6AN	EXP035644	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP035647	anti-CLOCK (NB100-126; Novus Biologicals)	Homo sapiens	DMSO	EXP035643	848	unspecified	O15516	U2OS (osteosarcoma)	NULL
EXP035648	anti-CLOCK (NB100-126; Novus Biologicals)	Homo sapiens	6AN	EXP035644	848	unspecified	O15516	U2OS (osteosarcoma)	NULL
EXP035649	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035650	HA (ab9110)	Mus musculus		EXP035649	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	NULL
EXP035651	HA (ab9110)	Mus musculus		EXP035649	2	unspecified	E9Q3T6	mESCs (mouse embryonic stem cells)	NULL
EXP035652	Mouse IgG	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035653	sc-17320	Mus musculus		EXP035652	2	unspecified	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP035654		Mus musculus		NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP035655	olig2	Mus musculus		EXP035654	2775	unspecified	Q9EQW6	neural stem cells	NULL
EXP035656	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035657	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP035658	ZFP57 (Abcam, ab45341)	Mus musculus		EXP035656	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP035659	ZFP57 (Abcam, ab45341)	Mus musculus		EXP035657	2	unspecified	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP035660	none (input)	Homo sapiens		NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP035661	none (input)	Homo sapiens		NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP035662	MLL (Bethyl, A300-086A)	Homo sapiens		EXP035660	541	unspecified	Q03164	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP035663	CFP1 (Bethyl, A303-161A/1)	Homo sapiens		EXP035661	541	unspecified	Q9P0U4	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP035664	sc-6029	Homo sapiens		NULL	887	unspecified	P20265	neural progenitors	NULL
EXP035665	sc-393324	Homo sapiens		NULL	887	unspecified	P20265	neural progenitors	NULL
EXP035666	sc-6029	Homo sapiens	after 2 weeks of differentiation	NULL	887	unspecified	P20265	neural progenitors	NULL
EXP035667	sc-393324	Homo sapiens	after 2 weeks of differentiation	NULL	887	unspecified	P20265	neural progenitors	NULL
EXP035668	normal rabbit IgG (Santa Cruz, sc-2027)	Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP035669	custom-made antibodies against Ronin G4275	Mus musculus		EXP035668	141	unspecified	Q9JJD0	retina	NULL
EXP035670	ELF5 (Santa Cruz, sc-9645)	Mus musculus	pregnancy day 13	NULL	572	unspecified	Q8VDK3	mammary gland	NULL
EXP035671	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE1a	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035672	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE1b	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035673	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE1c	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035674	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE2	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035675	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1, Wap-delE3	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035676	ELF5 (Santa Cruz, sc-9645)	Mus musculus	lactation day 1, Wap-delE1b	NULL	572	unspecified	Q8VDK3	mammary gland	NULL
EXP035677	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035678	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day 1	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035679	ELF5 (Santa Cruz, sc-9645)	Mus musculus	lactation day 1	NULL	572	unspecified	Q8VDK3	mammary gland	NULL
EXP035680	STAT5A (Santa Cruz, sc-1081)	Mus musculus	pregnancy day 13	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035681	GR (Thermo Scientific, PA1-511A)	Mus musculus	pregnancy day 13	NULL	572	unspecified	P06537	mammary gland	NULL
EXP035682	ELF5 (Santa Cruz, sc-9645)	Mus musculus	pregnancy day 13	NULL	572	unspecified	Q8VDK3	mammary gland	NULL
EXP035683	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE1a	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035684	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE1b	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035685	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE1c	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035686	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE2	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035687	STAT5A (Santa Cruz, sc-1081)	Mus musculus	lactation day 1, Wap-delE3	NULL	572	unspecified	P42230	mammary gland	NULL
EXP035688	ELF5 (Santa Cruz, sc-9645)	Mus musculus	lactation day 1, Wap-delE1c	NULL	572	unspecified	Q8VDK3	mammary gland	NULL
EXP035689	Normal Rabbit IgG [2729] (Cell signaling) Lot #5	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP035690	Normal Rabbit IgG [2729] (Cell signaling) Lot #5	Homo sapiens		NULL	882	chip_control	NULL	T-cells	NULL
EXP035691	anti-CTCF [D31H2] (Cell signaling) Lot #1	Homo sapiens		EXP035689	882	unspecified	P49711	T-cells	NULL
EXP035692	anti-CTCF [D31H2] (Cell signaling) Lot #1	Homo sapiens		EXP035690	882	unspecified	P49711	T-cells	NULL
EXP035693	none	Mus musculus	FGF19	NULL	5	chip_control	NULL	liver	NULL
EXP035694	none	Mus musculus	vehicle	NULL	5	chip_control	NULL	liver	NULL
EXP035695	SHP (sc-30169)	Mus musculus	FGF19	EXP035693	5	unspecified	Q62227	liver	NULL
EXP035696	SHP (sc-30169)	Mus musculus	vehicle	EXP035694	5	unspecified	Q62227	liver	NULL
EXP035697		Homo sapiens	DMSO (0.1%, 6h)	NULL	47	chip_control	NULL	KG1 (acute myeloid leukemia)	NULL
EXP035698		Homo sapiens	XX-650-23 (5 mM, 6hrs)	NULL	47	chip_control	NULL	KG1 (acute myeloid leukemia)	NULL
EXP035699	CREB (Millipore, 17-600)	Homo sapiens	DMSO (0.1%, 6h)	EXP035697	47	unspecified	P16220	KG1 (acute myeloid leukemia)	NULL
EXP035700	CREB (Millipore, 17-600)	Homo sapiens	XX-650-23 (5 mM, 6hrs)	EXP035698	47	unspecified	P16220	KG1 (acute myeloid leukemia)	NULL
EXP035701	anti-CTCF polyclonal antibody (ab070303, Abcam)	Homo sapiens		NULL	878	unspecified	P49711	embryonic stem cells	NULL
EXP035702		Homo sapiens	SFEM doxycycline+ (Day0)	NULL	893	chip_control	NULL	erythroblasts	NULL
EXP035703		Homo sapiens	EDM-II (Day8)	NULL	326	chip_control	NULL	CD34+ stem cells-derived erythroblasts	NULL
EXP035704	zbtb7a	Homo sapiens	SFEM doxycycline+ (Day0)	EXP035702	893	unspecified	O95365	erythroblasts	NULL
EXP035705	zbtb7a	Homo sapiens	EDM-II (Day8)	EXP035703	326	unspecified	O95365	CD34+ stem cells-derived erythroblasts	NULL
EXP035706	none, DNA input control	Mus musculus		NULL	142	chip_control	NULL	intestine	NULL
EXP035707	cJUN Polyclonal Rabbit antibody (Santa Cruz sc-44)	Mus musculus		EXP035706	142	unspecified	P05627	intestine	NULL
EXP035708	rabbit IgG Sigma I5006	Mus musculus		NULL	780	chip_control	NULL	embryonic blood cell progenitors	NULL
EXP035709	rabbit anti-Gata1, Abcam ab11963, lot I0303	Mus musculus		EXP035708	780	unspecified	P17679	embryonic blood cell progenitors	NULL
EXP035710		Homo sapiens	0.5% 1xPBS vehicle	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP035711		Homo sapiens	0.5 mM NaBut	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP035712	sc-22805	Homo sapiens	0.5% 1xPBS vehicle	EXP035710	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP035713	sc-22805	Homo sapiens	0.5 mM NaBut	EXP035711	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP035714	sc-22805	Homo sapiens	0.01% DMSO vehicle	NULL	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP035715	sc-22805	Homo sapiens	1 Î¼M SAHA	NULL	514	unspecified	P17947	K562 (myelogenous leukemia)	NULL
EXP035716	none	Mus musculus		NULL	135	chip_control	NULL	embryonic brain	NULL
EXP035717	Rcor2	Mus musculus		EXP035716	135	unspecified	Q8C796	embryonic brain	NULL
EXP035718	Nr3b2	Mus musculus	DOX, asynchronous	NULL	233	unspecified	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP035719	Nr3b2	Mus musculus	DOX, mitosis	NULL	233	unspecified	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP035720	Nr3b2	Mus musculus	DOX, asynchronous	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	NULL
EXP035721	Nr3b2	Mus musculus	48h DOX withdrawal, asynchronous	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	NULL
EXP035722	Nr3b2	Mus musculus	DOX, mitosis	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	NULL
EXP035723	Nr3b2	Mus musculus	48h DOX withdrawal, mitosis	NULL	242	unspecified	Q61539	EKOiE (embryonic stem cells)	NULL
EXP035724		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035725		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035726	Cell Signaling #4334	Homo sapiens		EXP035724	113	unspecified	Q01196	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035727	Cell Signaling #4334	Homo sapiens		EXP035725	113	unspecified	Q01196	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035728	NONE	Homo sapiens		NULL	432	chip_control	NULL	primary stromal cells	NULL
EXP035729	sc-11146	Homo sapiens		EXP035728	432	unspecified	Q05516	primary stromal cells	NULL
EXP035730	GFP (Santa Cruz; FL)	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035731	CEBPG C-terminal antiserum (our lab)	Mus musculus		EXP035730	12	unspecified	P53568	MEF (mouse embryonic fibroblasts)	NULL
EXP035732	ATF4 (Santa Cruz; C-20)	Mus musculus		EXP035730	12	unspecified	Q06507	MEF (mouse embryonic fibroblasts)	NULL
EXP035733	none	Mus musculus	Nrf2(AY/AY) mutant	NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP035734	none	Mus musculus	Nrf2(AY/AY) mutant	NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP035735	none	Mus musculus		NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP035736	none	Mus musculus		NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP035737	none	Mus musculus		NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP035738	none	Mus musculus	Nrf2(AY/AY) mutant	NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP035739	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus	Nrf2(AY/AY) mutant	EXP035733	732	unspecified	Q60795	peritoneal macrophages	NULL
EXP035740	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus	Nrf2(AY/AY) mutant	EXP035734	732	unspecified	Q60795	peritoneal macrophages	NULL
EXP035741	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus		EXP035735	732	unspecified	Q60795	peritoneal macrophages	NULL
EXP035742	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus		EXP035736	732	unspecified	Q60795	peritoneal macrophages	NULL
EXP035743	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus		EXP035737	732	unspecified	Q60795	peritoneal macrophages	NULL
EXP035744	Nrf2 (Cell Signaling Technology; D1Z9C)	Mus musculus	Nrf2(AY/AY) mutant	EXP035738	732	unspecified	Q60795	peritoneal macrophages	NULL
EXP035745		Mus musculus		NULL	834	chip_control	NULL	thymic epithelial cells	NULL
EXP035746	M2 anti-FLAG antibody (F1804; Sigma)	Mus musculus		EXP035745	834	unspecified	Q61575	thymic epithelial cells	NULL
EXP035747	Stat2 (EMD Millipore, #07-140)	Mus musculus		NULL	41	unspecified	Q9WVL2	B-cells	NULL
EXP035748	Stat2 (EMD Millipore, #07-140)	Mus musculus	10,000U IFNa	NULL	41	unspecified	Q9WVL2	B-cells	NULL
EXP035749	Stat1 (Santa Cruz Biotechnology, sc-592)	Mus musculus		NULL	41	unspecified	P42225	B-cells	NULL
EXP035750	Stat1 (Santa Cruz Biotechnology, sc-592)	Mus musculus	10,000U IFNa	NULL	41	unspecified	P42225	B-cells	NULL
EXP035751		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP035752		Homo sapiens	differentiated at day 0	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP035753		Homo sapiens	differentiated at day 1	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP035754		Homo sapiens	differentiated at 48 hours	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP035755	SMAD3, Abcam, AB28379	Homo sapiens		EXP035751	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	NULL
EXP035756	SMAD3, Abcam, AB28379	Homo sapiens	differentiated at day 0	EXP035752	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	NULL
EXP035757	SMAD3, Abcam, AB28379	Homo sapiens	differentiated at day 1	EXP035753	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	NULL
EXP035758	SMAD3, Abcam, AB28379	Homo sapiens	differentiated at 48 hours	EXP035754	376	unspecified	P84022	WA01 (H1, human embryonic stem cells)	NULL
EXP035759		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035760		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035761	myod	Mus musculus		EXP035759	12	unspecified	P10085	MEF (mouse embryonic fibroblasts)	NULL
EXP035762	myf5	Mus musculus		EXP035760	12	unspecified	P24699	MEF (mouse embryonic fibroblasts)	NULL
EXP035763	IgG	Homo sapiens		NULL	640	chip_control	NULL	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP035764	IgG	Homo sapiens		NULL	537	chip_control	NULL	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP035765	EMD Millipore AB10523	Homo sapiens		EXP035763	640	unspecified	Q9UH73	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP035766	EMD Millipore AB10523	Homo sapiens		EXP035764	537	unspecified	Q9UH73	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP035767	Abcam AB25949	Homo sapiens		EXP035763	640	unspecified	Q06330	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP035768	Abcam AB25949	Homo sapiens		EXP035764	537	unspecified	Q06330	pooled Yoruba and Tuscan lymphoblastoid cell lines	NULL
EXP035769		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP035770	p53 Antibody (FL-393R)	Homo sapiens		EXP035769	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP035771	p53 Antibody (FL-393R)	Homo sapiens	5 Î¼M Camptothecin (Sigma) for 8 hrs	EXP035769	417	unspecified	P04637	HCT-116 (colon carcinoma)	NULL
EXP035772		Mus musculus	Maf-DKO	NULL	570	chip_control	NULL	macrophages	NULL
EXP035773		Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP035774		Mus musculus		NULL	62	chip_control	NULL	alveolar macrophages	NULL
EXP035775	PU.1 (Santa Cruz Biotechnology, sc-352)	Mus musculus	Maf-DKO	EXP035772	570	unspecified	P17433	macrophages	NULL
EXP035776	PU.1 (Santa Cruz Biotechnology, sc-352)	Mus musculus		EXP035773	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP035777	PU.1 (Santa Cruz Biotechnology, sc-352)	Mus musculus		EXP035774	62	unspecified	P17433	alveolar macrophages	NULL
EXP035778	Flag M2 antibody (Sigma)	Mus musculus	Maf-DKO	EXP035772	570	unspecified	P54841	macrophages	NULL
EXP035779	MafB (Bethyl IHC-101)	Mus musculus		EXP035773	81	unspecified	P54841	BMDM (bone marrow-derived macrophages)	NULL
EXP035780	input whole cell lysate	Mus musculus	9 day in vitro culture for Th17 cells, growth protocol1	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP035781	input whole cell lysate	Mus musculus	3 day in vitro culture for Treg, growth protocol 2	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP035782	Blimp1 (Cell Signaling #9115)	Mus musculus	9 day in vitro culture for Th17 cells, growth protocol1	EXP035780	498	unspecified	Q60636	Th17-cells	NULL
EXP035783	Blimp1 (Cell Signaling #9115)	Mus musculus	3 day in vitro culture for Treg, growth protocol 2	EXP035781	1058	unspecified	Q60636	CD4+ T-cells	NULL
EXP035784	Rabbit IgG (Santa Cruz, Catalog# sc-806, Lot# F0908)	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP035785	TFE3 (Sigma, Catalog# HPA023881, Lot# E96562)	Mus musculus		EXP035784	12	unspecified	Q64092	MEF (mouse embryonic fibroblasts)	NULL
EXP035786	TFE3 (Sigma, Catalog# HPA023881, Lot# E96562)	Mus musculus	starvation	EXP035784	12	unspecified	Q64092	MEF (mouse embryonic fibroblasts)	NULL
EXP035787	TFE3 (Sigma, Catalog# HPA023881, Lot# E96562)	Mus musculus	tunicamycin	EXP035784	12	unspecified	Q64092	MEF (mouse embryonic fibroblasts)	NULL
EXP035788	anti-ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035789	anti-ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP035790	anti-ERa (SC-543; Santa Cruz)	Homo sapiens	sgRNA_enh588	NULL	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035791	anti-ERa (SC-543; Santa Cruz)	Homo sapiens	sgRNA_enh588	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP035792	none	Homo sapiens		NULL	467	chip_control	NULL	myoblasts	NULL
EXP035793	V5-tag (Abcam ab15828)	Homo sapiens		EXP035792	467	unspecified	Q9UBX2	myoblasts	NULL
EXP035794	Rabbit IgG (Santa Cruz, Catalog# sc-806, Lot# F0908)	Mus musculus		NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP035795	TFE3: Sigma, Catalog: HPA023881-100ul, Lot: E96562	Mus musculus		EXP035794	91	unspecified	Q64092	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP035796	TFE3: Sigma, Catalog: HPA023881-100ul, Lot: E96562	Mus musculus	starvation	EXP035794	91	unspecified	Q64092	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP035797	TFE3: Sigma, Catalog: HPA023881-100ul, Lot: E96562	Mus musculus	LPS	EXP035794	91	unspecified	Q64092	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP035798		Mus musculus	Pooled Input (WT + SMCX KO)	NULL	625	chip_control	NULL	embryonic cortex	NULL
EXP035799		Mus musculus	Pooled Input (WT + SMCX KO)	NULL	625	chip_control	NULL	embryonic cortex	NULL
EXP035800	KDM5c 333	Mus musculus		EXP035798	625	unspecified	P41230	embryonic cortex	NULL
EXP035801	KDM5c 333	Mus musculus	SMCX KO	EXP035798	625	unspecified	P41230	embryonic cortex	NULL
EXP035802	KDM5c 333	Mus musculus		EXP035799	625	unspecified	P41230	embryonic cortex	NULL
EXP035803	KDM5c 333	Mus musculus	SMCX KO	EXP035799	625	unspecified	P41230	embryonic cortex	NULL
EXP035804	none	Homo sapiens		NULL	119	chip_control	NULL	BT-474 (breast invasive ductal carcinoma)	NULL
EXP035805	ERRa	Homo sapiens		EXP035804	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	NULL
EXP035806	ERRa	Homo sapiens	AICAR	EXP035804	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	NULL
EXP035807		Homo sapiens	16 weeks 2 days	NULL	772	chip_control	NULL	renal cortex	NULL
EXP035808		Homo sapiens	17 weeks 3 days	NULL	772	chip_control	NULL	renal cortex	NULL
EXP035809		Homo sapiens	17 weeks 2 days	NULL	772	chip_control	NULL	renal cortex	NULL
EXP035810	six1	Homo sapiens	16 weeks 2 days	EXP035807	772	unspecified	Q15475	renal cortex	NULL
EXP035811	six1	Homo sapiens	17 weeks 3 days	EXP035808	772	unspecified	Q15475	renal cortex	NULL
EXP035812	six1	Homo sapiens	17 weeks 2 days	EXP035809	772	unspecified	Q15475	renal cortex	NULL
EXP035813	six2	Homo sapiens	16 weeks 2 days	EXP035807	772	unspecified	Q9NPC8	renal cortex	NULL
EXP035814	six2	Homo sapiens	17 weeks 3 days	EXP035808	772	unspecified	Q9NPC8	renal cortex	NULL
EXP035815	six2	Homo sapiens	17 weeks 2 days	EXP035809	772	unspecified	Q9NPC8	renal cortex	NULL
EXP035816	six2	Homo sapiens	17 weeks 2 days	EXP035809	772	unspecified	Q9NPC8	renal cortex	NULL
EXP035817	NA	Mus musculus		NULL	127	chip_control	NULL	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP035818	CS2443 (lot#2)	Mus musculus		EXP035817	127	unspecified	P37238	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP035819	none	Mus musculus	Myoblast	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP035820	none (input)	Mus musculus	Myotubes	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP035821	anti-Pbx1 (Abnova, Cat# H00005087, Lot# E5141-4A2)	Mus musculus	CTLi	EXP035820	1153	unspecified	P41778	C2C12 (myoblasts)	NULL
EXP035822	anti-Pbx1 (Abnova, Cat# H00005087, Lot# E5141-4A2)	Mus musculus	mH2A1i	EXP035820	1153	unspecified	P41778	C2C12 (myoblasts)	NULL
EXP035823	anti-Pbx1 (Abnova, Cat# H00005087,  Lot# E5141-4A2)	Mus musculus	Myoblast	EXP035819	1153	unspecified	P41778	C2C12 (myoblasts)	NULL
EXP035824	anti-Pbx1 (Abnova, Cat# H00005087, Lot# E5141-4A2)	Mus musculus	Myotubes	EXP035820	1153	unspecified	P41778	C2C12 (myoblasts)	NULL
EXP035825	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc (tet-Myc expression off)	NULL	5	unspecified	P01108	liver	NULL
EXP035826	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	LAPtTA	NULL	5	unspecified	P01108	liver	NULL
EXP035827	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus		NULL	5	unspecified	P01108	liver	NULL
EXP035828	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus		NULL	5	unspecified	P01108	liver	NULL
EXP035829	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035830	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035831	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035832	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035833	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035834	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression on)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035835	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression off)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035836	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression off)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035837	c-Myc N262 (Santa Cruz sc764-X)	Mus musculus	tet-Myc/LAPtTA (tet-Myc expression off)	NULL	551	unspecified	P01108	liver tumor	NULL
EXP035838	ab23980	Homo sapiens		NULL	509	unspecified	Q01196	Jurkat (T-cells)	NULL
EXP035839	sc-22206X	Homo sapiens		NULL	509	unspecified	P23771	Jurkat (T-cells)	NULL
EXP035840	none (input)	Mus musculus		NULL	889	chip_control	NULL	osteoblasts	NULL
EXP035841	none (input)	Mus musculus		NULL	581	chip_control	NULL	MC3T3-E1 (preosteoblasts)	NULL
EXP035842	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035840	889	unspecified	Q8VI67	osteoblasts	NULL
EXP035843	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035841	581	unspecified	Q8VI67	MC3T3-E1 (preosteoblasts)	NULL
EXP035844	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035841	581	unspecified	P70396	MC3T3-E1 (preosteoblasts)	NULL
EXP035845	FLAG M2 antibody (Sigma, F1804)	Mus musculus		EXP035841	581	unspecified	O89090	MC3T3-E1 (preosteoblasts)	NULL
EXP035846	none	Homo sapiens		NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP035847	none	Homo sapiens	100 nM of JQ1	NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP035848	c-Myc (Santa Cruz Biotech., sc-764)	Homo sapiens		EXP035846	767	unspecified	P01106	Raji (Burkitt lymphoma)	NULL
EXP035849	E2F-1 (Santa Cruz Biotech., sc-193)	Homo sapiens		EXP035846	767	unspecified	Q01094	Raji (Burkitt lymphoma)	NULL
EXP035850	c-Myc (Santa Cruz Biotech., sc-764)	Homo sapiens	100 nM of JQ1	EXP035847	767	unspecified	P01106	Raji (Burkitt lymphoma)	NULL
EXP035851	E2F-1 (Santa Cruz Biotech., sc-193)	Homo sapiens	100 nM of JQ1	EXP035847	767	unspecified	Q01094	Raji (Burkitt lymphoma)	NULL
EXP035852	ZNF143 (Novus Biologicals H00007702-M01)	Homo sapiens	vehicle	NULL	113	unspecified	P52747	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035853	ZNF143 (Novus Biologicals H00007702-M01)	Homo sapiens	10 uM 17-beta oestradiol (E2)	NULL	113	unspecified	P52747	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035854		Mus musculus		NULL	569	chip_control	NULL	macrophage-derived p3 iPS	NULL
EXP035855		Mus musculus		NULL	568	chip_control	NULL	macrophage-derived p20 iPS	NULL
EXP035856	CTCF	Mus musculus		EXP035855	568	unspecified	Q61164	macrophage-derived p20 iPS	NULL
EXP035857	CTCF	Mus musculus		EXP035854	569	unspecified	Q61164	macrophage-derived p3 iPS	NULL
EXP035858	CTCF	Mus musculus		NULL	596	unspecified	Q61164	embryonic fibroblast-derived p20 iPSC	NULL
EXP035859	CTCF	Mus musculus		NULL	597	unspecified	Q61164	embryonic fibroblast-derived p3 iPSC	NULL
EXP035860	CTCF	Mus musculus		NULL	680	unspecified	Q61164	neural stem cell-derived p20 iPSC	NULL
EXP035861	CTCF	Mus musculus		NULL	681	unspecified	Q61164	neural stem cell-derived p3 iPSC	NULL
EXP035862	CTCF	Mus musculus		NULL	736	unspecified	Q61164	preB-derived p20 induced pluripotent stem cells	NULL
EXP035863	CTCF	Mus musculus		NULL	737	unspecified	Q61164	preB-derived p3 induced pluripotent stem cells	NULL
EXP035864	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	A0PJY2	HEK293 (embryonic kidney)	NULL
EXP035865	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	B2RXF5	HEK293 (embryonic kidney)	NULL
EXP035866	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O14978	HEK293 (embryonic kidney)	NULL
EXP035867	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O43296	HEK293 (embryonic kidney)	NULL
EXP035868	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O43829	HEK293 (embryonic kidney)	NULL
EXP035869	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O60765	HEK293 (embryonic kidney)	NULL
EXP035870	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O75467	HEK293 (embryonic kidney)	NULL
EXP035871	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O75626	HEK293 (embryonic kidney)	NULL
EXP035872	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O75840	HEK293 (embryonic kidney)	NULL
EXP035873	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P08047	HEK293 (embryonic kidney)	NULL
EXP035874	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P10074	HEK293 (embryonic kidney)	NULL
EXP035875	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P10075	HEK293 (embryonic kidney)	NULL
EXP035876	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P13682	HEK293 (embryonic kidney)	NULL
EXP035877	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P15622	HEK293 (embryonic kidney)	NULL
EXP035878	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17019	HEK293 (embryonic kidney)	NULL
EXP035879	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17022	HEK293 (embryonic kidney)	NULL
EXP035880	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17032	HEK293 (embryonic kidney)	NULL
EXP035881	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17098	HEK293 (embryonic kidney)	NULL
EXP035882	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P28698	HEK293 (embryonic kidney)	NULL
EXP035883	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P36508	HEK293 (embryonic kidney)	NULL
EXP035884	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P52737	HEK293 (embryonic kidney)	NULL
EXP035885	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P52738	HEK293 (embryonic kidney)	NULL
EXP035886	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P52741	HEK293 (embryonic kidney)	NULL
EXP035887	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P56270	HEK293 (embryonic kidney)	NULL
EXP035888	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P59817	HEK293 (embryonic kidney)	NULL
EXP035889	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q02086	HEK293 (embryonic kidney)	NULL
EXP035890	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q03923	HEK293 (embryonic kidney)	NULL
EXP035891	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q06730	HEK293 (embryonic kidney)	NULL
EXP035892	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q06889	HEK293 (embryonic kidney)	NULL
EXP035893	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q0VGE8	HEK293 (embryonic kidney)	NULL
EXP035894	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q13351	HEK293 (embryonic kidney)	NULL
EXP035895	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q15072	HEK293 (embryonic kidney)	NULL
EXP035896	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q3ZCT1	HEK293 (embryonic kidney)	NULL
EXP035897	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q53GI3	HEK293 (embryonic kidney)	NULL
EXP035898	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q5HYK9	HEK293 (embryonic kidney)	NULL
EXP035899	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6IQ21	HEK293 (embryonic kidney)	NULL
EXP035900	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6NX45	HEK293 (embryonic kidney)	NULL
EXP035901	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6P9A3	HEK293 (embryonic kidney)	NULL
EXP035902	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6P9G9	HEK293 (embryonic kidney)	NULL
EXP035903	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6U7Q0	HEK293 (embryonic kidney)	NULL
EXP035904	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q6ZN55	HEK293 (embryonic kidney)	NULL
EXP035905	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q7Z7K2	HEK293 (embryonic kidney)	NULL
EXP035906	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q86TJ5	HEK293 (embryonic kidney)	NULL
EXP035907	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q86UD4	HEK293 (embryonic kidney)	NULL
EXP035908	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IVP9	HEK293 (embryonic kidney)	NULL
EXP035909	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IWY8	HEK293 (embryonic kidney)	NULL
EXP035910	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IYB9	HEK293 (embryonic kidney)	NULL
EXP035911	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8IZ26	HEK293 (embryonic kidney)	NULL
EXP035912	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N141	HEK293 (embryonic kidney)	NULL
EXP035913	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N2R0	HEK293 (embryonic kidney)	NULL
EXP035914	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N8E2	HEK293 (embryonic kidney)	NULL
EXP035915	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8N9F8	HEK293 (embryonic kidney)	NULL
EXP035916	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NBF1	HEK293 (embryonic kidney)	NULL
EXP035917	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NCA9	HEK293 (embryonic kidney)	NULL
EXP035918	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TA94	HEK293 (embryonic kidney)	NULL
EXP035919	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TC21	HEK293 (embryonic kidney)	NULL
EXP035920	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TF45	HEK293 (embryonic kidney)	NULL
EXP035921	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TF68	HEK293 (embryonic kidney)	NULL
EXP035922	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q92664	HEK293 (embryonic kidney)	NULL
EXP035923	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96BR6	HEK293 (embryonic kidney)	NULL
EXP035924	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96HQ0	HEK293 (embryonic kidney)	NULL
EXP035925	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96LW9	HEK293 (embryonic kidney)	NULL
EXP035926	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96MU6	HEK293 (embryonic kidney)	NULL
EXP035927	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96PE6	HEK293 (embryonic kidney)	NULL
EXP035928	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q99592	HEK293 (embryonic kidney)	NULL
EXP035929	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q99676	HEK293 (embryonic kidney)	NULL
EXP035930	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9BWW7	HEK293 (embryonic kidney)	NULL
EXP035931	znf341	Homo sapiens		NULL	421	unspecified	Q9BYN7	HEK293 (embryonic kidney)	NULL
EXP035932	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9C0F3	HEK293 (embryonic kidney)	NULL
EXP035933	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9H5H4	HEK293 (embryonic kidney)	NULL
EXP035934	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9HBE1	HEK293 (embryonic kidney)	NULL
EXP035935	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NPC7	HEK293 (embryonic kidney)	NULL
EXP035936	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NQX0	HEK293 (embryonic kidney)	NULL
EXP035937	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NXT0	HEK293 (embryonic kidney)	NULL
EXP035938	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NZL3	HEK293 (embryonic kidney)	NULL
EXP035939	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9UL59	HEK293 (embryonic kidney)	NULL
EXP035940	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9ULM2	HEK293 (embryonic kidney)	NULL
EXP035941	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y2X9	HEK293 (embryonic kidney)	NULL
EXP035942	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y473	HEK293 (embryonic kidney)	NULL
EXP035943	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y4X4	HEK293 (embryonic kidney)	NULL
EXP035944	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	A2RRD8	HEK293 (embryonic kidney)	NULL
EXP035945	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	O95863	HEK293 (embryonic kidney)	NULL
EXP035946	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P10073	HEK293 (embryonic kidney)	NULL
EXP035947	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P11161	HEK293 (embryonic kidney)	NULL
EXP035948	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17026	HEK293 (embryonic kidney)	NULL
EXP035949	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P17039	HEK293 (embryonic kidney)	NULL
EXP035950	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P25490	HEK293 (embryonic kidney)	NULL
EXP035951	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P49711	HEK293 (embryonic kidney)	NULL
EXP035952	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P51814	HEK293 (embryonic kidney)	NULL
EXP035953	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	P58317	HEK293 (embryonic kidney)	NULL
EXP035954	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q02446	HEK293 (embryonic kidney)	NULL
EXP035955	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q15916	HEK293 (embryonic kidney)	NULL
EXP035956	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q3MIS6	HEK293 (embryonic kidney)	NULL
EXP035957	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NEM1	HEK293 (embryonic kidney)	NULL
EXP035958	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8NHY6	HEK293 (embryonic kidney)	NULL
EXP035959	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q8TBZ5	HEK293 (embryonic kidney)	NULL
EXP035960	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96MM3	HEK293 (embryonic kidney)	NULL
EXP035961	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96NG8	HEK293 (embryonic kidney)	NULL
EXP035962	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96PQ6	HEK293 (embryonic kidney)	NULL
EXP035963	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q96SR6	HEK293 (embryonic kidney)	NULL
EXP035964	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9GZX5	HEK293 (embryonic kidney)	NULL
EXP035965	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9H4T2	HEK293 (embryonic kidney)	NULL
EXP035966	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9HCK0	HEK293 (embryonic kidney)	NULL
EXP035967	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NPA5	HEK293 (embryonic kidney)	NULL
EXP035968	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9NQX6	HEK293 (embryonic kidney)	NULL
EXP035969	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9UIH9	HEK293 (embryonic kidney)	NULL
EXP035970	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y2Q1	HEK293 (embryonic kidney)	NULL
EXP035971	anti-GFP antibody (ab290, Abcam)	Homo sapiens		NULL	421	unspecified	Q9Y330	HEK293 (embryonic kidney)	NULL
EXP035972		Mus musculus		NULL	279	chip_control	NULL	embryonic stem cell-drived neuroepithelial cells	NULL
EXP035973		Mus musculus		NULL	279	chip_control	NULL	embryonic stem cell-drived neuroepithelial cells	NULL
EXP035974	smad2	Mus musculus		EXP035972	279	unspecified	Q62432	embryonic stem cell-drived neuroepithelial cells	NULL
EXP035975	smad3	Mus musculus		EXP035973	279	unspecified	Q8BUN5	embryonic stem cell-drived neuroepithelial cells	NULL
EXP035976	Mouse IgG (Millipore #12-371)	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP035977	N/A	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP035978	anti-UBTF (Millipore # MABE195)	Homo sapiens		EXP035976	396	unspecified	P17480	WA09 (embryonic stem cells)	NULL
EXP035979	anti-UBTF (Millipore # MABE195)	Homo sapiens	50 ng/mL Activin A for 6 hours	EXP035976	396	unspecified	P17480	WA09 (embryonic stem cells)	NULL
EXP035980	none	Homo sapiens		NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP035981	HIF-1alpha	Homo sapiens		EXP035980	375	unspecified	Q16665	NCI-H1299 (large cell lung carcinoma)	NULL
EXP035982	CTCF (Millipore, catalog# 07-729)	Homo sapiens		NULL	665	unspecified	P49711	SK-N-SH (neuroblastoma)	NULL
EXP035983	none	Homo sapiens	100nM E2, 120min	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035984	sc543x	Homo sapiens	100nM E2, 120min	EXP035983	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP035985	input	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP035986	Anti-Wiz NBP180586, Novus Biologicals, USA	Mus musculus		EXP035985	25	unspecified	O88286	cerebellum	NULL
EXP035987	NA	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP035988	NA	Mus musculus	Arid1a KO	NULL	5	chip_control	NULL	liver	NULL
EXP035989	E2f4 (Santa Cruz, sc-866x)	Mus musculus		EXP035987	5	unspecified	Q8R0K9	liver	NULL
EXP035990	E2f4 (Santa Cruz, sc-866x)	Mus musculus	Arid1a KO	EXP035988	5	unspecified	Q8R0K9	liver	NULL
EXP035991	none (input)	Homo sapiens	GW3965 2h	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035992	none (input)	Homo sapiens	GW3965 48h	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035993	none (input)	Homo sapiens	GW3965 2h	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035994	none (input)	Homo sapiens	GW3965 48h	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035995	none (input)	Homo sapiens	Rosiglitazone 2h	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035996	none (input)	Homo sapiens	Rosiglitazone 48h	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035997	none (input)	Homo sapiens	DMSO	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP035998	anti-NR1H2 (Active Motif, 61178)	Homo sapiens	GW3965 2h	EXP035991	452	unspecified	P55055	HT29 (colon adenocarcinoma)	NULL
EXP035999	anti-NR1H2 (Active Motif, 61178)	Homo sapiens	GW3965 48h	EXP035992	452	unspecified	P55055	HT29 (colon adenocarcinoma)	NULL
EXP036000	anti-FLAG (Sigma, F1804)	Homo sapiens	GW3965 2h	EXP035993	452	unspecified	Q13133	HT29 (colon adenocarcinoma)	NULL
EXP036001	anti-FLAG (Sigma, F1804)	Homo sapiens	GW3965 48h	EXP035994	452	unspecified	Q13133	HT29 (colon adenocarcinoma)	NULL
EXP036002	anti-PPARG (Santa Cruz, sc-7273)	Homo sapiens	Rosiglitazone 2h	EXP035995	452	unspecified	P37231	HT29 (colon adenocarcinoma)	NULL
EXP036003	anti-PPARG (Santa Cruz, sc-7273)	Homo sapiens	Rosiglitazone 48h	EXP035996	452	unspecified	P37231	HT29 (colon adenocarcinoma)	NULL
EXP036004	anti-JunD (Santa Cruz, sc-74)	Homo sapiens	DMSO	EXP035997	452	unspecified	P17535	HT29 (colon adenocarcinoma)	NULL
EXP036005	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP036006	Bmal1 (Santa Cruz, catalog# sc-8550, lot# J1211 )	Mus musculus		EXP036005	12	unspecified	Q9WTL8	MEF (mouse embryonic fibroblasts)	NULL
EXP036007		Mus musculus		NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036008		Mus musculus	unstimulated	EXP036007	159	unspecified	P48377	cortical neurons	NULL
EXP036009		Mus musculus	KCl Depolarized 1 hour	EXP036007	159	unspecified	P48377	cortical neurons	NULL
EXP036010		Mus musculus		EXP036007	159	unspecified	P48377	cortical neurons	NULL
EXP036011	none	Homo sapiens	DMSO	NULL	891	chip_control	NULL	dermal fibroblasts	NULL
EXP036012	none	Homo sapiens	Nutlin-3a 10 Î¼M	NULL	891	chip_control	NULL	dermal fibroblasts	NULL
EXP036013	p53-DO1 (Santa Cruz, catalog# sc126, lot#K2613)	Homo sapiens	DMSO	EXP036011	891	unspecified	P04637	dermal fibroblasts	NULL
EXP036014	p53-DO1 (Santa Cruz, catalog# sc126, lot#K2613)	Homo sapiens	Nutlin-3a 10 Î¼M	EXP036012	891	unspecified	P04637	dermal fibroblasts	NULL
EXP036015	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP036016	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP036017	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP036018	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP036019	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP036020	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP036021	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036015	892	unspecified	Q01094	MSC (mesenchymal stem cells)	NULL
EXP036022	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036016	892	unspecified	Q01094	MSC (mesenchymal stem cells)	NULL
EXP036023	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036017	892	unspecified	Q01094	MSC (mesenchymal stem cells)	NULL
EXP036024	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036018	892	unspecified	Q01094	MSC (mesenchymal stem cells)	NULL
EXP036025	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036019	892	unspecified	Q01094	MSC (mesenchymal stem cells)	NULL
EXP036026	E2F1 (10ug Santa Cruz, sc-193X)	Homo sapiens		EXP036020	892	unspecified	Q01094	MSC (mesenchymal stem cells)	NULL
EXP036027		Mus musculus		NULL	330	chip_control	NULL	GHFT1 (pituitary cell line)	NULL
EXP036028	prop1	Mus musculus		EXP036027	330	unspecified	P97458	GHFT1 (pituitary cell line)	NULL
EXP036029	IgG (rabbit, Sigma)	Homo sapiens	empty vector	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036030	HA (ab9110 , Abcam)	Homo sapiens	HA-OmoMYCwt, Doxycycline	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036031	c-MYC (N262, Santa Cruz)	Homo sapiens	empty vector	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036032	c-MYC (N262, Santa Cruz)	Homo sapiens	empty vector, Doxycycline	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036033	c-MYC (N262, Santa Cruz)	Homo sapiens	HA-OmoMYCwt	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036034	c-MYC (N262, Santa Cruz)	Homo sapiens	HA-OmoMYCwt, Doxycycline	EXP036029	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036035	HES1 (H-140), Santa CruzÃ¯Â¼? Cat # sc-25392, Lot # : I2413	Mus musculus		NULL	81	unspecified	P35428	BMDM (bone marrow-derived macrophages)	NULL
EXP036036	HES1 (H-140), Santa CruzÃ¯Â¼? Cat # sc-25392, Lot # : I2413	Mus musculus	LPS for 1 hour	NULL	81	unspecified	P35428	BMDM (bone marrow-derived macrophages)	NULL
EXP036037	non	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036038	none	Homo sapiens	siCTR and siMYC	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036039	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens	Dox	EXP036037	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036040	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens		EXP036037	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036041	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens	siCTR	EXP036038	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036042	c-MYC N262 (Santa Cruz, sc764)	Homo sapiens	siMYC	EXP036038	848	unspecified	P01106	U2OS (osteosarcoma)	NULL
EXP036043	none	Mus musculus		NULL	37	chip_control	NULL	A3 (embryonic stem cells)	NULL
EXP036044	none	Mus musculus		NULL	37	chip_control	NULL	A3 (embryonic stem cells)	NULL
EXP036045	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP036046	ZFP57 (Abcam, ab45341)	Mus musculus		EXP036043	37	unspecified	Q8C6P8	A3 (embryonic stem cells)	NULL
EXP036047	ZFP57 (Abcam, ab45341)	Mus musculus	Zfp57 -/-	EXP036044	37	unspecified	Q8C6P8	A3 (embryonic stem cells)	NULL
EXP036048	ZFP57 (Abcam, ab45341)	Mus musculus		EXP036045	230	unspecified	Q8C6P8	ES-E14 (E14, embryonic stem cells)	NULL
EXP036049	Avi-tag (Vendor: Genescript,  cat# A01738)	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP036050	Avi-tag (Vendor: Genescript,  cat# A01738)	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP036051	Avi-tag (Vendor: Genescript,  cat# A01738)	Mus musculus		EXP036049	5	unspecified	O54790	liver	NULL
EXP036052	Avi-tag (Vendor: Genescript,  cat# A01738)	Mus musculus		EXP036050	5	unspecified	O54790	liver	NULL
EXP036053	no IP	Mus musculus		NULL	572	chip_control	NULL	mammary gland	NULL
EXP036054	sc-543X	Mus musculus		EXP036053	572	unspecified	P19785	mammary gland	NULL
EXP036055	sc-7208X	Mus musculus		EXP036053	572	unspecified	Q00175	mammary gland	NULL
EXP036056	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036057	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A DKO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036058	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A+/- STAT5B+/-	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036059	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036060	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5B DKO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036061	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A DKO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036062	input	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A+/- STAT5B+/-	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036063	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1)	EXP036056	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036064	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A DKO	EXP036057	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036065	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5B DKO	NULL	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036066	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A+/- STAT5B+/-	EXP036058	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036067	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1)	EXP036059	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036068	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5B DKO	EXP036060	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036069	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A DKO	EXP036061	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036070	pan-STAT5 (polyclonal rabbit anti-human/mouse antibody purchased from Abcam; ab7969)(Lot #GR93813-4)	Mus musculus	48 hour in vitro culture with IL-2 (growth protocol 1), STAT5A+/- STAT5B+/-	EXP036062	1058	unspecified	P42230	CD4+ T-cells	NULL
EXP036071		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP036072		Mus musculus	FoxA1 and FoxA2 KO	NULL	5	chip_control	NULL	liver	NULL
EXP036073	Santa Cruz, sc-5361	Mus musculus		EXP036071	5	unspecified	P35584	liver	NULL
EXP036074	Santa Cruz, sc-5361	Mus musculus	FoxA1 and FoxA2 KO	EXP036072	5	unspecified	P35584	liver	NULL
EXP036075	Santa Cruz, sc-150	Mus musculus		EXP036071	5	unspecified	P28033	liver	NULL
EXP036076	Santa Cruz, sc-150	Mus musculus	FoxA1 and FoxA2 KO	EXP036072	5	unspecified	P28033	liver	NULL
EXP036077	Abcam, ab42898	Mus musculus		EXP036071	5	unspecified	P49698	liver	NULL
EXP036078	Abcam, ab42898	Mus musculus	FoxA1 and FoxA2 KO	EXP036072	5	unspecified	P49698	liver	NULL
EXP036079	n.a.	Mus musculus		NULL	578	chip_control	NULL	mature B-cells	NULL
EXP036080	Tcf3	Mus musculus	DSG, 2-day LPS stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	NULL
EXP036081	Tcf3	Mus musculus	2-day LPS stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	NULL
EXP036082	Tcf3	Mus musculus	DSG, 2-day anti-CD40 rIL-4 stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	NULL
EXP036083	Tcf3	Mus musculus	2-day anti-CD40 rIL-4 stimulation whole population	EXP036079	41	unspecified	P15806	B-cells	NULL
EXP036084	Tcf3	Mus musculus	DSG, CD138- MACS-sorted	EXP036079	740	unspecified	P15806	preplasmablasts	NULL
EXP036085	Tcf3	Mus musculus	CD138- MACS-sorted	EXP036079	740	unspecified	P15806	preplasmablasts	NULL
EXP036086	Tcf3	Mus musculus	DSG, CD138+ MACS-sorted	EXP036079	723	unspecified	P15806	plasmablasts	NULL
EXP036087	Tcf3	Mus musculus	CD138+ MACS-sorted	EXP036079	723	unspecified	P15806	plasmablasts	NULL
EXP036088	Tcf3	Mus musculus	DSG, CD43â€“ and CD23+ MACS-sorted	EXP036079	41	unspecified	P15806	B-cells	NULL
EXP036089	Tcf3	Mus musculus	CD43â€“ and CD23+ MACS-sorted	EXP036079	41	unspecified	P15806	B-cells	NULL
EXP036090	none (input)	Homo sapiens	Treatment: siRNA control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP036091	none (input)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036092	none (input)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP036093	none (input)	Homo sapiens	Treatment: siRNA control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036094	none (input)	Homo sapiens	Treatment: vehicle control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036095	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036090	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036096	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA against OCT1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036090	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036097	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036091	70	normal	P14859	LNCaP (prostate carcinoma)	NULL
EXP036098	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036091	70	normal	P14859	LNCaP (prostate carcinoma)	NULL
EXP036099	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: siRNA against FOXA1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P14859	LNCaP (prostate carcinoma)	NULL
EXP036100	anti-FOXA1 (Abcam, catalog ab94580)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP036101	anti-FOXA1 (Abcam, catalog ab94580)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP036102	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of vehicle; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P14859	VCaP (prostate carcinoma)	NULL
EXP036103	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036092	71	normal	P14859	VCaP (prostate carcinoma)	NULL
EXP036104	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: siRNA against FOXA1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036090	71	normal	P14859	VCaP (prostate carcinoma)	NULL
EXP051010	anti-FOXA1 (Abcam, catalog ab94580)	Homo sapiens	Treatment: siRNA against OCT1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP036106	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP036107	anti-AR (Santa Cruz, catalog H-280, lot K2912)	Homo sapiens	Treatment: siRNA against OCT1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036093	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP036108	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: vehicle control and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036094	70	normal	P14859	LNCaP (prostate carcinoma)	NULL
EXP036109	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: PI polyamide Oct1-1 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036094	70	normal	P14859	LNCaP (prostate carcinoma)	NULL
EXP036110	anti-Oct1 (Abcam, catalog ab8895, lot GR114621-3)	Homo sapiens	Treatment: PI polyamide Oct1-3 and 24 hours of DHT; Growth: cells were cultured in DMEM or RPMI 1640 containing 10% FBS. Before hormone treatment, cells were incubated in Phenol red-free DMEM or RPMI 1640 containing 2.5% charcoal/dextran treated FBS for three days.; Time point: 24 hours	EXP036094	70	normal	P14859	LNCaP (prostate carcinoma)	NULL
EXP036111	anti Myc-tag antibody (CST, 9B11, mouse mAb)	Mus musculus		NULL	2	unspecified	P13864	mESCs (mouse embryonic stem cells)	NULL
EXP036112	IgG control Ab (SantaCruz, sc-2028)	Mus musculus	no treatment	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP036113	anti-IRF8 (SantaCruz, sc-6058x)	Mus musculus	no treatment	EXP036112	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP036114	anti-IRF8 (SantaCruz, sc-6058x)	Mus musculus	IFNg (400U/ml) 0.5h	EXP036112	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP036115	anti-IRF8 (SantaCruz, sc-6058x)	Mus musculus	IFNg (400U/ml) 3h	EXP036112	81	unspecified	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP036116	anti-IRF1 (SantaCruz, sc-640x)	Mus musculus	no treatment	EXP036112	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP036117	anti-IRF1 (SantaCruz, sc-640x)	Mus musculus	IFNg (400U/ml) 0.5h	EXP036112	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP036118	anti-IRF1 (SantaCruz, sc-640x)	Mus musculus	IFNg (400U/ml) 3h	EXP036112	81	unspecified	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP036119	anti-PU.1 (SantaCruz, sc-352x)	Mus musculus	no treatment	EXP036112	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP036120	anti-PU.1 (SantaCruz, sc-352x)	Mus musculus	IFNg (400U/ml) 0.5h	EXP036112	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP036121	anti-PU.1 (SantaCruz, sc-352x)	Mus musculus	IFNg (400U/ml) 3h	EXP036112	81	unspecified	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP036122	none	Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP036123	FOXF1, R&D Biosystems, AF4798, Lot#B1508	Mus musculus		EXP036122	561	unspecified	Q61080	lung	NULL
EXP036124		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036125		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036126		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036127		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036128		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036129		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036130		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036131		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036132		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036133		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036134		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036135		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036136		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036137		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036138		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP036139	sp1	Homo sapiens		EXP036124	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP036140	sp1	Homo sapiens		EXP036125	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP036141	sp1	Homo sapiens		EXP036126	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP036142	sp1	Homo sapiens		EXP036127	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP036143	sp1	Homo sapiens		EXP036128	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP036144	sp1	Homo sapiens		EXP036129	417	unspecified	P08047	HCT-116 (colon carcinoma)	NULL
EXP036145	myc	Homo sapiens		EXP036130	417	unspecified	P01106	HCT-116 (colon carcinoma)	NULL
EXP036146	myc	Homo sapiens		EXP036131	417	unspecified	P01106	HCT-116 (colon carcinoma)	NULL
EXP036147	myc	Homo sapiens		EXP036132	417	unspecified	P01106	HCT-116 (colon carcinoma)	NULL
EXP036148	myc	Homo sapiens		EXP036133	417	unspecified	P01106	HCT-116 (colon carcinoma)	NULL
EXP036149	myc	Homo sapiens		EXP036134	417	unspecified	P01106	HCT-116 (colon carcinoma)	NULL
EXP036150	myc	Homo sapiens		EXP036135	417	unspecified	P01106	HCT-116 (colon carcinoma)	NULL
EXP036151	tcf7l1	Homo sapiens		EXP036136	417	unspecified	Q9HCS4	HCT-116 (colon carcinoma)	NULL
EXP036152	tcf7l1	Homo sapiens		EXP036137	417	unspecified	Q9HCS4	HCT-116 (colon carcinoma)	NULL
EXP036153	tcf7l1	Homo sapiens		EXP036138	417	unspecified	Q9HCS4	HCT-116 (colon carcinoma)	NULL
EXP036154	mouse IgG (Santa Cruz, sc-2025)	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP036155	Oct4 (Santa Cruz, sc-5279)	Mus musculus	G1	EXP036154	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP036156	Oct4 (Santa Cruz, sc-5279)	Mus musculus	G2/M	EXP036154	230	unspecified	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP036157	INPUT DNA	Homo sapiens	Normoxia	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036158	INPUT DNA	Homo sapiens	Hypoxia	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036159	INPUT DNA	Homo sapiens	Normoxia	NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP036160	CTCF (#07-729, Millipore)	Homo sapiens	Normoxia	EXP036157	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036161	CTCF (#07-729, Millipore)	Homo sapiens	Hypoxia	EXP036158	113	unspecified	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036162	CTCF (#07-729, Millipore)	Homo sapiens	Normoxia	EXP036159	30	unspecified	P49711	RCC 7860 (Renal cell carcinoma)	NULL
EXP036163	none	Homo sapiens	250 ng/ml doxycycline 6hrs	NULL	486	chip_control	NULL	LHCN-M2 (myoblasts)	NULL
EXP036164	Flag (Sigma, F1804)	Homo sapiens	250 ng/ml doxycycline 6hrs	EXP036163	486	unspecified	Q9UBX2	LHCN-M2 (myoblasts)	NULL
EXP036165		Homo sapiens	Vehicle treatment	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036166		Homo sapiens	Vehicle treatment	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036167	HC-20, santacruz	Homo sapiens	Vehicle treatment	EXP036165	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036168	HC-20, santacruz	Homo sapiens	E2 treatment	EXP036165	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036169	HC-20, santacruz	Homo sapiens	Vehicle treatment	EXP036166	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036170	HC-20, santacruz	Homo sapiens	E2 treatment	EXP036166	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036171	none	Mus musculus		NULL	174	chip_control	NULL	cerebral cortex	NULL
EXP036172	Pbx1/2/3 (Santa Cruz, sc-888)	Mus musculus		EXP036171	174	unspecified	P41778	cerebral cortex	NULL
EXP036173	Pbx1/2/3 (Santa Cruz, sc-888)	Mus musculus	PBX blocking peptide (Santa Cruz, sc-888P)	EXP036171	174	unspecified	P41778	cerebral cortex	NULL
EXP036174		Mus musculus	100 nmol/L CDDO-Im for 3 h	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP036175	Cell Signaling Technology D1Z9C	Mus musculus	100 nmol/L CDDO-Im for 3 h	EXP036174	1153	unspecified	Q60795	C2C12 (myoblasts)	NULL
EXP036176	none	Rattus norvegicus	adenovirus encoding Myc	NULL	658	chip_control	NULL	neonatal cardiomyocytes	NULL
EXP036177	none	Rattus norvegicus	adenovirus encoding LacZ control	NULL	658	chip_control	NULL	neonatal cardiomyocytes	NULL
EXP036178	Myc (D84C12) (CST, catalog# 5605, lot# 0004)	Rattus norvegicus	adenovirus encoding Myc	EXP036176	658	unspecified	P09416	neonatal cardiomyocytes	NULL
EXP036179	Myc (D84C12) (CST, catalog# 5605, lot# 0004)	Rattus norvegicus	adenovirus encoding LacZ control	EXP036177	658	unspecified	P09416	neonatal cardiomyocytes	NULL
EXP036180	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	826	unspecified	P41969	differentiated embryonic fibroblasts	NULL
EXP036181	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	826	unspecified	P41969	differentiated embryonic fibroblasts	NULL
EXP036182	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	826	unspecified	P41969	differentiated embryonic fibroblasts	NULL
EXP036183	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	181	unspecified	P41969	induced neural stem cell-like cells	NULL
EXP036184	Elk1 antibody (Epitomics, 1277-1, lot GR106696-8)	Mus musculus		NULL	138	unspecified	P41969	neural progenitors	NULL
EXP036185	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	826	unspecified	Q0VGT2	differentiated embryonic fibroblasts	NULL
EXP036186	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	826	unspecified	Q0VGT2	differentiated embryonic fibroblasts	NULL
EXP036187	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	826	unspecified	Q0VGT2	differentiated embryonic fibroblasts	NULL
EXP036188	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	181	unspecified	Q0VGT2	induced neural stem cell-like cells	NULL
EXP036189	Gli2 antibody (Abcam, 26056, lot GR223520-2)	Mus musculus		NULL	138	unspecified	Q0VGT2	neural progenitors	NULL
EXP036190	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against NTC (non targeting control); Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: none	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036191	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh1; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036192	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh2; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036193	anti-AR	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh3; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036194	anti-AR	Homo sapiens	Treatment: 24 hours of R1881 and shRNA against NTC (non targeting control); Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: none	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036195	anti-AR	Homo sapiens	Treatment: 24 hours of R1881 and shRNA against PRMT5 sh1; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036196	anti-AR	Homo sapiens	Treatment: 24 hours of R1881 and shRNA against PRMT5 sh2; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036197	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against NTC (non targeting control); Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: none	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP036198	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh1; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP036199	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh2; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP036200	anti-ERG	Homo sapiens	Treatment: 24 hours of DHT and shRNA against PRMT5 sh3; Growth: DMEM, Charcol Dextran stripped FBS for hormone depletion(2days), Doxycycline for shRNA construct induction (5days); Time point: 24 hours; Genotype: PRMT5 knockdown	NULL	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP036201		Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP036202	EBF1	Mus musculus		EXP036201	105	unspecified	Q07802	pro-B cells	NULL
EXP036206		Mus musculus		NULL	2392	chip_control	NULL	fetal liver	NULL
EXP036207	EBF1	Mus musculus	ebf1 delta C	EXP036206	2392	unspecified	Q07802	fetal liver	NULL
EXP036208	none	Mus musculus		NULL	174	chip_control	NULL	cerebral cortex	NULL
EXP036209	Pbx1/2/3 (Santa Cruz, sc-888)	Mus musculus		EXP036208	174	unspecified	P41778	cerebral cortex	NULL
EXP036210	Pbx1/2/3 (Santa Cruz, sc-888) mixed with the PBX blocking peptide (Santa Cruz, sc-888P) at 1:400 molar ratio	Mus musculus	PBX blocking peptide (Santa Cruz, sc-888P)	EXP036208	174	unspecified	P41778	cerebral cortex	NULL
EXP036211	Input	Mus musculus		NULL	3	chip_control	NULL	epididymal white adipose tissue	NULL
EXP036212	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus		EXP036211	3	unspecified	Q3UV55	epididymal white adipose tissue	NULL
EXP036213	none	Mus musculus		NULL	919	chip_control	NULL	oligodendrocyte progenitors	NULL
EXP036214	none	Mus musculus		NULL	919	chip_control	NULL	oligodendrocyte progenitors	NULL
EXP036215	none	Mus musculus		NULL	905	chip_control	NULL	immature oligodendrocytes	NULL
EXP036216	none	Mus musculus		NULL	905	chip_control	NULL	immature oligodendrocytes	NULL
EXP036217	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036213	919	unspecified	O08584	oligodendrocyte progenitors	NULL
EXP036218	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036214	919	unspecified	O08584	oligodendrocyte progenitors	NULL
EXP036219	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036215	905	unspecified	O08584	immature oligodendrocytes	NULL
EXP036220	Klf6 (Santa Cruz, SC-7158X, Lot: F1212)	Mus musculus		EXP036216	905	unspecified	O08584	immature oligodendrocytes	NULL
EXP036221	c-Fos (Santa Cruz Biotechnology, catalog# sc-253-X)	Mus musculus	0d	NULL	203	unspecified	P01101	Flk1+ hemangioblasts	NULL
EXP036222	c-Jun (Santa Cruz Biotechnology, catalog# sc-1694-X)	Mus musculus	0d	NULL	203	unspecified	P05627	Flk1+ hemangioblasts	NULL
EXP036223	TEAD4 (Abcam, catalog# ab58310)	Mus musculus	0d	NULL	203	unspecified	Q62296	Flk1+ hemangioblasts	NULL
EXP036224	TEAD4 (Abcam, catalog# ab58310)	Mus musculus	1d	NULL	203	unspecified	Q62296	Flk1+ hemangioblasts	NULL
EXP036225	TEAD4 (Abcam, catalog# ab58310)	Mus musculus	0d	NULL	868	unspecified	Q62296	hemogenic endothelium	NULL
EXP036226	sc-253-X	Mus musculus	0d	NULL	203	unspecified	P05627	Flk1+ hemangioblasts	NULL
EXP036227	jun	Mus musculus	1d	NULL	203	unspecified	P05627	Flk1+ hemangioblasts	NULL
EXP036228	blimp1	Mus musculus		NULL	2479	unspecified	Q60636	CD8+ T-cells	NULL
EXP036229	anti-GR (Santa Cruz Biotechnology, sc-1003)	Homo sapiens	dex	NULL	38	unspecified	P04150	A549 (lung carcinoma)	NULL
EXP036230	anti-GR (Santa Cruz Biotechnology, sc-1003)	Homo sapiens	etoh	NULL	38	unspecified	P04150	A549 (lung carcinoma)	NULL
EXP036231		Homo sapiens		NULL	407	chip_control	NULL	HBL1 (diffuse large B-cell lymphoma)	NULL
EXP036232		Homo sapiens		NULL	407	chip_control	NULL	HBL1 (diffuse large B-cell lymphoma)	NULL
EXP036233		Homo sapiens		NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP036234	oct2	Homo sapiens		EXP036231	407	unspecified	P09086	HBL1 (diffuse large B-cell lymphoma)	NULL
EXP036235	oct2	Homo sapiens		EXP036232	407	unspecified	P09086	HBL1 (diffuse large B-cell lymphoma)	NULL
EXP036236	oct2	Homo sapiens		EXP036233	92	unspecified	P09086	BJAB (Burkitt lymphoma)	NULL
EXP036237	none	Homo sapiens	NR4A1 mRNA electroporation	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP036238	none	Homo sapiens	NR4A1 mRNA electroporation	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP036239	anti-NR4A1 (Santa Cruz, sc-990)	Homo sapiens	NR4A1 mRNA electroporation	EXP036237	516	unspecified	P22736	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP036240	anti-NR4A1 (Santa Cruz, sc-990)	Homo sapiens	NR4A1 mRNA electroporation	EXP036238	516	unspecified	P22736	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP036241	none	Homo sapiens		NULL	342	chip_control	NULL	GM12763 (female B-cells)	NULL
EXP036242	rabbit monoclonal anti-NRF2 (Abcam, Clone ID EP1808Y)	Homo sapiens		EXP036241	342	unspecified	Q16236	GM12763 (female B-cells)	NULL
EXP036243	Flag (M2 affinity gel, Sigma), TRF2 (in house)	Mus musculus		NULL	32	unspecified	P62340	testis	NULL
EXP036244	Flag (M2 affinity gel, Sigma), TRF2 (in house)	Mus musculus	TRF2 -/-	NULL	32	unspecified	P62340	testis	NULL
EXP036245	TBP (ab28175, Abcam), TBP (ab51841, Abcam)	Mus musculus		NULL	32	unspecified	P29037	testis	NULL
EXP036246	TBP (ab28175, Abcam), TBP (ab51841, Abcam)	Mus musculus	TRF2 -/-	NULL	32	unspecified	P29037	testis	NULL
EXP036247	none	Homo sapiens		NULL	857	chip_control	NULL	VAL-3 (embryonic stem cells)	NULL
EXP036248	Santa Cruz FOXM1-C20 (sc-502)	Homo sapiens		EXP036247	857	unspecified	Q08050	VAL-3 (embryonic stem cells)	NULL
EXP036249	Non	Mus musculus		NULL	231	chip_control	NULL	E14-derived embryonic cardiac progenitor cells	NULL
EXP036250	ISL1 Abcam ab109517	Mus musculus		EXP036249	231	unspecified	P61372	E14-derived embryonic cardiac progenitor cells	NULL
EXP036251	input	Homo sapiens		NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP036252	input	Homo sapiens		NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP036253	Abcam ab25949	Homo sapiens		EXP036251	332	unspecified	Q06330	glioblastoma cells	NULL
EXP036254	Abcam ab25949	Homo sapiens		EXP036252	332	unspecified	Q06330	glioblastoma cells	NULL
EXP036255	none	Homo sapiens		NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP036256	p65	Homo sapiens	TNF	EXP036255	87	unspecified	Q04206	BEAS-2B (bronchial epithelium)	NULL
EXP036257	GR	Homo sapiens	dexamethasone	EXP036255	87	unspecified	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP036258	GR	Homo sapiens	dexamethasone + TNF	EXP036255	87	unspecified	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP036259	p65	Homo sapiens	dexamethasone + TNF	EXP036255	87	unspecified	Q04206	BEAS-2B (bronchial epithelium)	NULL
EXP036260	GR	Homo sapiens	vehicle	EXP036255	87	unspecified	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP036261	p65	Homo sapiens	vehicle	EXP036255	87	unspecified	Q04206	BEAS-2B (bronchial epithelium)	NULL
EXP036262	none	Mus musculus		NULL	575	chip_control	NULL	bone marrow-derived mesenchymal stem cells	NULL
EXP036263	none	Mus musculus	osteogenic media day 7	NULL	575	chip_control	NULL	bone marrow-derived mesenchymal stem cells	NULL
EXP036264	none	Mus musculus	osteogenic media day 15	NULL	575	chip_control	NULL	bone marrow-derived mesenchymal stem cells	NULL
EXP036265	none	Mus musculus	adipose media day 7	NULL	575	chip_control	NULL	bone marrow-derived mesenchymal stem cells	NULL
EXP036266	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus		EXP036262	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036267	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3	EXP036262	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036268	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus		EXP036262	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036269	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3	EXP036262	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036270	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus		EXP036262	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	NULL
EXP036271	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus		EXP036262	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	NULL
EXP036272	C/EBP? (14AA, sc-61, lot# J1811)	Mus musculus		EXP036262	575	unspecified	P53566	bone marrow-derived mesenchymal stem cells	NULL
EXP036273	PPAR? (81B8, 2443s, lot# 2)	Mus musculus		EXP036262	575	unspecified	P37238	bone marrow-derived mesenchymal stem cells	NULL
EXP036274	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036275	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3 + osteogenic media day 7	EXP036263	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036276	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036277	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3 + osteogenic media day 7	EXP036263	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036278	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	NULL
EXP036279	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	NULL
EXP036280	C/EBP? (14AA, sc-61, lot# J1811)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P53566	bone marrow-derived mesenchymal stem cells	NULL
EXP036281	PPAR? (81B8, 2443s, lot# 2)	Mus musculus	osteogenic media day 7	EXP036263	575	unspecified	P37238	bone marrow-derived mesenchymal stem cells	NULL
EXP036282	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036283	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3 + osteogenic media day 15	EXP036264	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036284	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036285	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3 + osteogenic media day 15	EXP036264	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036286	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	NULL
EXP036287	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	osteogenic media day 15	EXP036264	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	NULL
EXP036288	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036289	VDR (Santa Cruz, C-20, sc-1008, lot# A0912)	Mus musculus	1,25(OH)2D3 + adipose media day 7	EXP036265	575	unspecified	P48281	bone marrow-derived mesenchymal stem cells	NULL
EXP036290	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036291	RXR (Santa Cruz, ?N-197, sc-774, lot# G2310)	Mus musculus	1,25(OH)2D3 + adipose media day 7	EXP036265	575	unspecified	P28700	bone marrow-derived mesenchymal stem cells	NULL
EXP036292	RUNX2 (Santa Cruz, M-70, sc10758, lot# D1411)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	Q08775	bone marrow-derived mesenchymal stem cells	NULL
EXP036293	C/EBP? (Santa Cruz, C-19, sc-150, lot# F3011)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P28033	bone marrow-derived mesenchymal stem cells	NULL
EXP036294	C/EBP? (14AA, sc-61, lot# J1811)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P53566	bone marrow-derived mesenchymal stem cells	NULL
EXP036295	PPAR? (81B8, 2443s, lot# 2)	Mus musculus	adipose media day 7	EXP036265	575	unspecified	P37238	bone marrow-derived mesenchymal stem cells	NULL
EXP036296	GFP (Abcam, ab290)	Homo sapiens		NULL	422	chip_control	NULL	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP036297	GFP (Abcam, ab290)	Homo sapiens	GFP-GATAD2A	EXP036296	422	unspecified	Q86YP4	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP036298	GFP (Abcam, ab290)	Homo sapiens	GFP-GATAD2B	EXP036296	422	unspecified	Q8WXI9	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP036299	none	Homo sapiens		NULL	318	chip_control	NULL	FT33 (fallopian tube secretory cells)	NULL
EXP036300	none	Homo sapiens		NULL	316	chip_control	NULL	FT194 (fallopian tube secretory cells)	NULL
EXP036301	none	Homo sapiens		NULL	317	chip_control	NULL	FT246 (fallopian tube secretory cells)	NULL
EXP036302	none	Homo sapiens		NULL	529	chip_control	NULL	KURAMOCHI (high grade ovarian serous adenocarcinoma)	NULL
EXP036303	none	Homo sapiens		NULL	702	chip_control	NULL	OVSAHO (high grade ovarian serous adenocarcinoma)	NULL
EXP036304	none	Homo sapiens		NULL	508	chip_control	NULL	JHOS4 (high grade ovarian serous adenocarcinoma)	NULL
EXP036305	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036299	318	unspecified	Q06710	FT33 (fallopian tube secretory cells)	NULL
EXP036306	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036300	316	unspecified	Q06710	FT194 (fallopian tube secretory cells)	NULL
EXP036307	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036301	317	unspecified	Q06710	FT246 (fallopian tube secretory cells)	NULL
EXP036308	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036302	529	unspecified	Q06710	KURAMOCHI (high grade ovarian serous adenocarcinoma)	NULL
EXP036309	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036303	702	unspecified	Q06710	OVSAHO (high grade ovarian serous adenocarcinoma)	NULL
EXP036310	PAX8 antibody (Novus, Product #NBP1-32440, Littleton, CO)	Homo sapiens		EXP036304	508	unspecified	Q06710	JHOS4 (high grade ovarian serous adenocarcinoma)	NULL
EXP036311		Mus musculus		NULL	706	chip_control	NULL	P19CL6 (embryonic carcinoma)	NULL
EXP036312	Tbx1	Mus musculus		EXP036311	706	unspecified	P70323	P19CL6 (embryonic carcinoma)	NULL
EXP036313	none	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP036314	Cxxc1	Mus musculus	Cxxc1 +/-	NULL	171	unspecified	Q9CWW7	CD4+ CD8+ T cells	NULL
EXP036315	Cxxc1	Mus musculus		EXP036313	171	unspecified	Q9CWW7	CD4+ CD8+ T cells	NULL
EXP036316	znf618	Homo sapiens		NULL	10	unspecified	Q5T7W0	HEK293T (embryonic kidney)	NULL
EXP036317	Olig2 (Millipore, cat# AB9610)	Mus musculus		NULL	109	unspecified	Q9EQW6	glioma	NULL
EXP036318	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus		NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP036319	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus	dox	NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP036320	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus	sr3	NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP036321	anti-Nrf1 antibody (ab34682, Abcam)	Mus musculus	sr8	NULL	2	unspecified	Q9WU00	mESCs (mouse embryonic stem cells)	NULL
EXP036322	NA	Homo sapiens	None	NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP036323	NA	Homo sapiens	0.2 ug/mL DOX for 24HR	NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP036324	NA	Homo sapiens	0.2 ug/mL DOX for 2HR	NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP036325	ab16898	Homo sapiens	None	EXP036322	790	unspecified	P04198	Tet21N (neuroblastoma)	NULL
EXP036326	ab16898	Homo sapiens	0.2 ug/mL DOX for 24HR	EXP036323	790	unspecified	P04198	Tet21N (neuroblastoma)	NULL
EXP036327	ab16898	Homo sapiens	0.2 ug/mL DOX for 2HR	EXP036324	790	unspecified	P04198	Tet21N (neuroblastoma)	NULL
EXP036328	NA	Homo sapiens		NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP036329	NA	Homo sapiens		NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP036330	NA	Homo sapiens		NULL	669	chip_control	NULL	NGP (neuroblastoma)	NULL
EXP036331	NA	Homo sapiens		NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP036332	NA	Homo sapiens	0.2 ug/mL DOX for 24HR	NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP036333	NA	Homo sapiens	0.2 ug/mL DOX for 2HR	NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP036334	ab16898	Homo sapiens		EXP036328	82	unspecified	P04198	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP036335	ab50887	Homo sapiens		EXP036328	82	unspecified	Q15672	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP036336	ab16898	Homo sapiens		EXP036329	520	unspecified	P04198	Kelly (neuroblastoma)	NULL
EXP036337	ab16898	Homo sapiens		EXP036330	669	unspecified	P04198	NGP (neuroblastoma)	NULL
EXP036338	ab16898	Homo sapiens		EXP036331	790	unspecified	P04198	Tet21N (neuroblastoma)	NULL
EXP036339	TWIST	Homo sapiens		NULL	790	unspecified	Q15672	Tet21N (neuroblastoma)	NULL
EXP036340	TWIST	Homo sapiens	0.2 ug/mL DOX for 24HR	EXP036332	790	unspecified	Q15672	Tet21N (neuroblastoma)	NULL
EXP036341	ab16898	Homo sapiens	0.2 ug/mL DOX for 24HR	EXP036332	790	unspecified	P04198	Tet21N (neuroblastoma)	NULL
EXP036342	ab16898	Homo sapiens	0.2 ug/mL DOX for 2HR	EXP036333	790	unspecified	P04198	Tet21N (neuroblastoma)	NULL
EXP036343	ab50887	Homo sapiens	0.2 ug/mL DOX for 2HR	EXP036333	790	unspecified	Q15672	Tet21N (neuroblastoma)	NULL
EXP036344	none	Mus musculus		NULL	581	chip_control	NULL	MC3T3-E1 (preosteoblasts)	NULL
EXP036345	none	Mus musculus		NULL	889	chip_control	NULL	osteoblasts	NULL
EXP036346	FLAG M2 antibody (Sigma, catalog# F1804, lot# SLBK1346V)	Mus musculus		EXP036344	581	unspecified	Q8VI67	MC3T3-E1 (preosteoblasts)	NULL
EXP036347	FLAG M2 antibody (Sigma, catalog# F1804, lot# SLBK1346V)	Mus musculus		EXP036344	581	unspecified	Q8VI67	MC3T3-E1 (preosteoblasts)	NULL
EXP036348	Sp7 antibody (Abcam, catalog #ab22552, lot# GR193738-1)	Mus musculus		EXP036345	889	unspecified	Q8VI67	osteoblasts	NULL
EXP036349		Homo sapiens	Vehicle	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036350		Homo sapiens	10 nM Estradiol	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036351		Homo sapiens	10 nM R5020	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036352		Homo sapiens	10nM Estradiol + 10 nM R5020	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036353		Homo sapiens	Vehicle, PR-deficient	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036354		Homo sapiens	10 nM Estradiol, PR-deficient	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036355		Homo sapiens	10 nM R5020, PR-deficient	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036356		Homo sapiens	10nM Estradiol + 10 nM R5020, PR-deficient	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP036357	PR	Homo sapiens	Vehicle	EXP036349	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP036358	ER	Homo sapiens	Vehicle	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036359	PR	Homo sapiens	10 nM Estradiol	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP036360	ER	Homo sapiens	10 nM Estradiol	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036361	PR	Homo sapiens	10 nM R5020	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP036362	ER	Homo sapiens	10 nM R5020	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036363	PR	Homo sapiens	10nM Estradiol + 10 nM R5020	NULL	111	unspecified	P06401	T47D (invasive ductal carcinoma)	NULL
EXP036364	ER	Homo sapiens	10nM Estradiol + 10 nM R5020	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036365	ER	Homo sapiens	Vehicle	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036366	ER	Homo sapiens	10 nM Estradiol	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036367	ER	Homo sapiens	10 nM R5020	NULL	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036368	ER	Homo sapiens	10nM Estradiol + 10 nM R5020	EXP036356	111	unspecified	P03372	T47D (invasive ductal carcinoma)	NULL
EXP036369		Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP036370	ERRa	Mus musculus		EXP036369	126	unspecified	O08580	C2C12 (myotubes)	NULL
EXP036371	KDM5A #1416 (gift Kaelin Lab DFCI)	Homo sapiens	DMSO	NULL	111	unspecified	P29375	T47D (invasive ductal carcinoma)	NULL
EXP036372	KDM5A #1416 (gift Kaelin Lab DFCI)	Homo sapiens	MK2206	NULL	111	unspecified	P29375	T47D (invasive ductal carcinoma)	NULL
EXP036373		Mus musculus		NULL	328	chip_control	NULL	germinal center dark zone cells	NULL
EXP036374		Mus musculus		NULL	329	chip_control	NULL	germinal center light zone cells	NULL
EXP036375		Mus musculus		NULL	41	chip_control	NULL	B-cells	NULL
EXP036376	anti-AP4 (in house)	Mus musculus		EXP036373	328	unspecified	Q9JIZ5	germinal center dark zone cells	NULL
EXP036377	anti-AP4 (in house)	Mus musculus		EXP036374	329	unspecified	Q9JIZ5	germinal center light zone cells	NULL
EXP036378	Anti-c-MYC (Santa cruz sc-764)	Mus musculus		EXP036375	41	unspecified	P01108	B-cells	NULL
EXP036379	none	Mus musculus	DNMT3A overexpression	NULL	542	chip_control	NULL	leukemic cells	NULL
EXP036380	none	Mus musculus		NULL	542	chip_control	NULL	leukemic cells	NULL
EXP036381	Abcam ab15289	Mus musculus	DNMT3A overexpression	EXP036379	542	unspecified	P26323	leukemic cells	NULL
EXP036382	Abcam ab15289	Mus musculus		EXP036380	542	unspecified	P26323	leukemic cells	NULL
EXP036383	None	Homo sapiens	DMSO	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036384	None	Homo sapiens	E2	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036385	None	Homo sapiens	DMSO	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036386	None	Homo sapiens	E2	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036387	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	DMSO	EXP036383	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036388	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	E2	EXP036384	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036389	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	DMSO	EXP036385	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036390	Anti-ER? (Santa Cruz, sc-543, clone HC-20)	Homo sapiens	E2	EXP036386	113	unspecified	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036391		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036392	foxa1	Homo sapiens		EXP036391	113	unspecified	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036393		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP036394	klf5	Mus musculus	day0 of differentiation	EXP036393	1153	unspecified	Q9Z0Z7	C2C12 (myoblasts)	NULL
EXP036395	klf5	Mus musculus	day2 of differentiation	EXP036393	1153	unspecified	Q9Z0Z7	C2C12 (myoblasts)	NULL
EXP036396	klf5	Mus musculus	day5 of differentiation	EXP036393	1153	unspecified	Q9Z0Z7	C2C12 (myoblasts)	NULL
EXP036397	MyoD	Mus musculus	day3 of differentiation	EXP036393	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP036398	MyoD	Mus musculus	day3 of differentiation, KLF5 KO	EXP036393	1153	unspecified	P10085	C2C12 (myoblasts)	NULL
EXP036399	In house aYY2 polyclonal rabbit serum	Mus musculus		NULL	836	unspecified	Q3TTC2	trophoblast precursors	NULL
EXP036400	Described in Garcia-TuÃ±on I et al. Stem Cell Res.(2011)7(1), 1-16. and in PÃ©rez-Palacios et al., 2016.	Mus musculus		NULL	836	unspecified	Q3TTC2	trophoblast precursors	NULL
EXP036401	N/A	Mus musculus		NULL	182	chip_control	NULL	CJ7 (embryonic stem cells)	NULL
EXP036402	Zfp281 (Abcam #ab101318)	Mus musculus		EXP036401	182	unspecified	Q99LI5	CJ7 (embryonic stem cells)	NULL
EXP036403	Rabbit IgG (ab37415, Abcam)	Mus musculus	RUNX-ERt2	NULL	298	chip_control	NULL	FDC-P1 (lymphoblasts)	NULL
EXP036404	Rabbit IgG (ab37415, Abcam)	Mus musculus		NULL	298	chip_control	NULL	FDC-P1 (lymphoblasts)	NULL
EXP036405	Runx1, rabbit (Aziz-Aloya R, 1998)	Mus musculus	RUNX-ERt2	EXP036403	298	unspecified	Q03347	FDC-P1 (lymphoblasts)	NULL
EXP036406	Runx1, rabbit (Aziz-Aloya R, 1998)	Mus musculus		EXP036404	298	unspecified	Q03347	FDC-P1 (lymphoblasts)	NULL
EXP036407	input	Homo sapiens		NULL	257	chip_control	NULL	endometrioid adenocarcinoma	NULL
EXP036408	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor A	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	NULL
EXP036409	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor A	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	NULL
EXP036410	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor C	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	NULL
EXP036411	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor C	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	NULL
EXP036412	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor D	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	NULL
EXP036413	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor E	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	NULL
EXP036414	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor E	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	NULL
EXP036415	ERa (SC-543; Santa Cruz)	Homo sapiens	tumor B	EXP036407	257	unspecified	P03372	endometrioid adenocarcinoma	NULL
EXP036416	FOXA1/2 (SC-6554; Santa cruz)	Homo sapiens	tumor B	EXP036407	257	unspecified	Q9Y261	endometrioid adenocarcinoma	NULL
EXP036417		Mus musculus		NULL	6	chip_control	NULL	16T (small cell lung carcinoma)	NULL
EXP036418		Mus musculus		NULL	524	chip_control	NULL	KP1 (small cell lung carcinoma)	NULL
EXP036419		Mus musculus		NULL	525	chip_control	NULL	KP22 (small cell lung carcinoma)	NULL
EXP036420	Nfib antibody (Sigma, #HPA003956)	Mus musculus		EXP036417	6	unspecified	P97863	16T (small cell lung carcinoma)	NULL
EXP036421	Nfib antibody (Sigma, #HPA003956)	Mus musculus		EXP036418	524	unspecified	P97863	KP1 (small cell lung carcinoma)	NULL
EXP036422	Nfib antibody (Sigma, #HPA003956)	Mus musculus		EXP036419	525	unspecified	P97863	KP22 (small cell lung carcinoma)	NULL
EXP036423	AML1-ETO (Diagenode, Cat. C15310197; Lot A706-001)	Homo sapiens		NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP036424	AML1-ETO (Diagenode, Cat. C15310197; Lot A706-001)	Homo sapiens	MEIS2 KD	NULL	516	unspecified	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP036425		Rattus norvegicus		NULL	493	chip_control	NULL	INS-1E (pancreatic beta-cells)	NULL
EXP036426		Rattus norvegicus		NULL	493	chip_control	NULL	INS-1E (pancreatic beta-cells)	NULL
EXP036427		Rattus norvegicus		NULL	493	chip_control	NULL	INS-1E (pancreatic beta-cells)	NULL
EXP036428	anti-ChREBP (NB400-135, Novus Biologicals)	Rattus norvegicus		EXP036425	493	unspecified	Q8VIP2	INS-1E (pancreatic beta-cells)	NULL
EXP036429	anti-ChREBP (NB400-135, Novus Biologicals)	Rattus norvegicus	2h glucose	EXP036426	493	unspecified	Q8VIP2	INS-1E (pancreatic beta-cells)	NULL
EXP036430	anti-ChREBP (NB400-135, Novus Biologicals)	Rattus norvegicus	12h glucose	EXP036427	493	unspecified	Q8VIP2	INS-1E (pancreatic beta-cells)	NULL
EXP036431	IgG antibody (Millipore, 12-371)	Homo sapiens		NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP036432	HIF-2? (Novus, NB100-122)	Homo sapiens		EXP036431	87	unspecified	Q99814	BEAS-2B (bronchial epithelium)	NULL
EXP036433		Homo sapiens	starved, PBS	NULL	758	chip_control	NULL	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036434		Homo sapiens	starved, 100uM EGF 90min	NULL	758	chip_control	NULL	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036435		Homo sapiens	starved, 100uM HRG 90min	NULL	758	chip_control	NULL	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036436		Homo sapiens	starved, PBS	NULL	119	chip_control	NULL	BT-474 (breast invasive ductal carcinoma)	NULL
EXP036437		Homo sapiens	untreated	NULL	758	chip_control	NULL	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036438		Homo sapiens	lapatinib 2uM	NULL	556	chip_control	NULL	LR-SK-BR-3 (lapatinib-resistant breast adenocarcinoma)	NULL
EXP036439	err1	Homo sapiens	starved, PBS	EXP036436	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	NULL
EXP036440	err1	Homo sapiens	starved, 100uM EGF 90min	NULL	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	NULL
EXP036441	err1	Homo sapiens	starved, 100uM HRG 90min	NULL	119	unspecified	P11474	BT-474 (breast invasive ductal carcinoma)	NULL
EXP036442	err1	Homo sapiens	starved, PBS	EXP036433	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036443	err1	Homo sapiens	starved, 100uM EGF 90min	EXP036434	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036444	err1	Homo sapiens	starved, 100uM HRG 90min	EXP036435	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036445	err1	Homo sapiens	untreated	EXP036437	758	unspecified	P11474	SK-BR-3 (breast adenocarcinoma)	NULL
EXP036446	err1	Homo sapiens	lapatinib 2uM	EXP036438	556	unspecified	P11474	LR-SK-BR-3 (lapatinib-resistant breast adenocarcinoma)	NULL
EXP036447	none	Mus musculus		NULL	485	chip_control	NULL	embryonic spleen mesenchymal cells	NULL
EXP036448	Hox11	Mus musculus		EXP036447	485	unspecified	P43345	embryonic spleen mesenchymal cells	NULL
EXP036449	None	Mus musculus	PLZF tg/BirA tg mice	NULL	44	chip_control	NULL	T-cells	NULL
EXP036450	None	Mus musculus	PLZF tg/BirA tg/Valpha14 tg mice	NULL	44	chip_control	NULL	T-cells	NULL
EXP036451	Streptavidin beads (Invitrogen; 14204)	Mus musculus	PLZF tg/BirA tg mice	EXP036449	44	unspecified	Q3UQ17	T-cells	NULL
EXP036452	plzf	Mus musculus	PLZF tg/BirA tg/Valpha14 tg mice	EXP036450	44	unspecified	Q3UQ17	T-cells	NULL
EXP036453		Mus musculus		NULL	248	chip_control	NULL	E12.5 embryonic limb	NULL
EXP036454	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		EXP036453	248	unspecified	P70390	E12.5 embryonic limb	NULL
EXP036455	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		NULL	249	unspecified	P70390	E13.5 embryonic limb	NULL
EXP036456	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		NULL	251	unspecified	P70390	E12.5 embryonic palate	NULL
EXP036457	anti-HA(Abcam, Cat.Ab9110, Lot.  GR146572-6)	Mus musculus		NULL	250	unspecified	P70390	embryonic limb and palate mix	NULL
EXP036458	pbx	Mus musculus		EXP036453	248	unspecified	P41778	E12.5 embryonic limb	NULL
EXP036459	none (input)	Homo sapiens	72 hour CDT + 3 hour EtOH	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036460	none (input)	Homo sapiens	treated for 24 hours with 0.5Î¼M PD-0332991 +3 hour 10nm DHT	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036461	none (input)	Homo sapiens	treated for 24 hours with 5Î¼g/mL roscovitine + 3 hour DHT	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036462	none (input)	Homo sapiens	treated for 24 hours with 2Î¼g/mL aphidicolin +3 hour 10nm DHT	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036463	none (input)	Homo sapiens	treated for 24 hours with 1mM hydroxyurea +3 hour 10nm DHT	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036464	none (input)	Homo sapiens	2Î¼g/mL aphidicolin for 15 hours, followed by washout and treatment with 50ng/mL nocodozole for 9 hours +3 hour 10nm DHT	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036465	AR N-20 (SC-816)	Homo sapiens	72 hour CDT + 3 hour EtOH	EXP036459	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036466	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 0.5Î¼M PD-0332991 +3 hour 10nm DHT	EXP036460	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036467	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 5Î¼g/mL roscovitine + 3 hour DHT	EXP036461	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036468	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 2Î¼g/mL aphidicolin +3 hour 10nm DHT	EXP036462	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036469	AR N-20 (SC-816)	Homo sapiens	treated for 24 hours with 1mM hydroxyurea +3 hour 10nm DHT	EXP036463	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036470	AR N-20 (SC-816)	Homo sapiens	2Î¼g/mL aphidicolin for 15 hours, followed by washout and treatment with 50ng/mL nocodozole for 9 hours +3 hour 10nm DHT	EXP036464	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036471	None	Homo sapiens	None	NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP036472	None	Homo sapiens	None	NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP036473	JARID1D (Bethyl, A301-750A, A310-624A)	Homo sapiens	None	EXP036471	223	unspecified	Q9BY66	DU145 (prostate carcinoma)	NULL
EXP036474	JARID1D (Bethyl, A301-750A, A310-624A)	Homo sapiens	None	EXP036472	223	unspecified	Q9BY66	DU145 (prostate carcinoma)	NULL
EXP042336	none	Caenorhabditis elegans	Treatment: N2 strain	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP036477	none	Homo sapiens		NULL	464	chip_control	NULL	fetal osteoblasts	NULL
EXP036478	Santa Cruz, sc-150, C-19	Homo sapiens		EXP036477	464	unspecified	P17676	fetal osteoblasts	NULL
EXP036479	fra2	Homo sapiens		EXP036477	464	unspecified	P15408	fetal osteoblasts	NULL
EXP036480	Santa Cruz, sc-74,329	Homo sapiens		EXP036477	464	unspecified	P17535	fetal osteoblasts	NULL
EXP036481	BD Biosciences,  610922, 31/TEF-1	Homo sapiens		EXP036477	464	unspecified	P28347	fetal osteoblasts	NULL
EXP036482	Santa Cruz, sc-482, C-20	Homo sapiens		EXP036477	464	unspecified	P40763	fetal osteoblasts	NULL
EXP036483		Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP036484	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP036485	anti-FS2 (Gift from Prof.Rob Klose; reference: Elife. 2012 Dec 18;1:e00205. doi: 10.7554/eLife.00205)	Mus musculus		EXP036483	2	unspecified	Q9Z248	mESCs (mouse embryonic stem cells)	NULL
EXP036486	anti-AEBP2 (generated in this study)	Mus musculus		EXP036484	2	unspecified	Q9Z248	mESCs (mouse embryonic stem cells)	NULL
EXP036487	none	Homo sapiens	3xFLAG WT ZNF335	NULL	511	chip_control	NULL	T-REx-Jurkat (T-cells)	NULL
EXP036488	anti-FLAG M2 mouse monoclonal (Sigma)	Homo sapiens		NULL	511	chip_control	NULL	T-REx-Jurkat (T-cells)	NULL
EXP036489	anti-FLAG M2 mouse monoclonal (Sigma)	Homo sapiens	3xFLAG WT ZNF335	EXP036487	511	unspecified	Q9H4Z2	T-REx-Jurkat (T-cells)	NULL
EXP036490	anti-FLAG M2 mouse monoclonal (Sigma)	Homo sapiens	3xFLAG bloto (R1092W) ZNF335	EXP036488	511	unspecified	Q9H4Z2	T-REx-Jurkat (T-cells)	NULL
EXP036491		Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP036492		Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP036493	zfat	Mus musculus		EXP036492	139	unspecified	Q7TS63	thymus	NULL
EXP036494	zfat	Mus musculus		EXP036491	139	unspecified	Q7TS63	thymus	NULL
EXP036495		Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP036496	c-Myc	Homo sapiens		EXP036495	509	unspecified	P01106	Jurkat (T-cells)	NULL
EXP036497	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus		NULL	5	unspecified	Q3UV55	liver	NULL
EXP036498	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus		NULL	5	unspecified	Q3UV55	liver	NULL
EXP036499	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus		NULL	5	unspecified	Q3UV55	liver	NULL
EXP036500	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus	HNF6 KO	NULL	5	unspecified	Q3UV55	liver	NULL
EXP036501	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus	HNF6 KO	NULL	5	unspecified	Q3UV55	liver	NULL
EXP036502	Rev-erba, Cell Signaling Technology (CST#2124)	Mus musculus	HNF6 KO	NULL	5	unspecified	Q3UV55	liver	NULL
EXP036503	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036504	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	TNF-alpha (1000 U/ml, 2h) + siFOXA1	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	NULL
EXP036505	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	NULL
EXP036506	anti-AR (Karvonen et al., 1997)	Homo sapiens	DHT (100nM, 2h) + TNF-alpha (1000U/ml, 2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036507	anti-AR (Karvonen et al., 1997)	Homo sapiens	DHT (100nM, 2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036508	anti-AR (Karvonen et al., 1997)	Homo sapiens	DMSO (2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036509	anti-AR (Karvonen et al., 1997)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036510	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	DHT (100nM, 2h) + TNF-alpha (1000U/ml, 2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036511	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	DHT (100nM, 2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036512	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	DMSO (2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036513	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036514	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	DHT (100nM, 2h) + TNF-alpha (1000U/ml, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	NULL
EXP036515	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	DHT (100nM, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	NULL
EXP036516	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	DMSO (2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	NULL
EXP036517	anti-p65 (Santa Cruz Biotechnology, sc-372)	Homo sapiens	TNF-alpha (1000 U/ml, 2h)	EXP036503	70	unspecified	Q04206	LNCaP (prostate carcinoma)	NULL
EXP036518	none	Mus musculus		NULL	180	chip_control	NULL	motor neurons	NULL
EXP036519	rabbit anti-Chx10	Mus musculus		EXP036518	180	unspecified	Q61412	motor neurons	NULL
EXP036520		Mus musculus		NULL	810	chip_control	NULL	stomach	NULL
EXP036521	goat anti-SOX2 (AF2018, R&D).	Mus musculus		EXP036520	810	unspecified	P48432	stomach	NULL
EXP036522	goat anti-SOX2 (AF2018, R&D).	Mus musculus	SOX2 KO	EXP036520	810	unspecified	P48432	stomach	NULL
EXP036523	oligo2	Rattus norvegicus		NULL	218	unspecified	G3V612	oligodendrocytes	NULL
EXP036524	oligo2	Rattus norvegicus	LPC (12.5 mM) for 6h	NULL	218	unspecified	G3V612	oligodendrocytes	NULL
EXP036525	STAT3 (Santa Cruz, sc-482)	Mus musculus	lactation day one	NULL	572	unspecified	P42227	mammary gland	NULL
EXP036526	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	heterozygous for Stat5, lactation day one	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036527	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	one Stat5-null allele and one mutant allele, lactation day one	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036528	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	lactation day one	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036529	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	involution 12 hours	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036530	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	involution 24 hours	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036531	GR (Thermo Scientific, PA1-511A)	Mus musculus	lactation day one	NULL	572	unspecified	P06537	mammary gland	NULL
EXP036532	GR (Thermo Scientific, PA1-511A)	Mus musculus	involution 12 hours	NULL	572	unspecified	P06537	mammary gland	NULL
EXP036533	GR (Thermo Scientific, PA1-511A)	Mus musculus	involution 24 hours	NULL	572	unspecified	P06537	mammary gland	NULL
EXP036534	STAT3 (Santa Cruz, sc-482)	Mus musculus	involution 12 hours	NULL	572	unspecified	P42227	mammary gland	NULL
EXP036535	STAT3 (Santa Cruz, sc-482)	Mus musculus	involution 24 hours	NULL	572	unspecified	P42227	mammary gland	NULL
EXP036536	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	homozygous for the Stat5 enhancer mutation, lactation day one	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036537	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	homozygous for the Stat5 enhancer mutation, involution 12 hours	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036538	STAT5A (Santa Cruz, sc-1081x)	Mus musculus	homozygous for the Stat5 enhancer mutation, involution 24 hours	NULL	572	unspecified	P42230	mammary gland	NULL
EXP036539	input	Homo sapiens		NULL	795	chip_control	NULL	SK-N-BE2 (neuroblastoma)	NULL
EXP036540	anti-TEAD4 (ab58310; abcam)	Homo sapiens		EXP036539	795	unspecified	Q15561	SK-N-BE2 (neuroblastoma)	NULL
EXP036541	anti-IgG (sc-2027)	Homo sapiens	Treatment: 2 hours of Ethanol and 10nM R1881; Time point: 2 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP036542	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 30 min of 10nM R1881; Time point: 30 min; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036543	anti-AR (rabbit antiserum)	Homo sapiens	Treatment: 4 hours of 10nM R1881; Time point: 4 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP036544	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: 2 hours of Ethanol; Time point: 2 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P49711	VCaP (prostate carcinoma)	NULL
EXP036545	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: 2 hours of 10nM R1881; Time point: 2 hours; Growth: cells were grown in DMEM containing 10% (v/v) defined FBS, 25 U/ml penicillin and 25 mg/ml streptomycin in a 5% CO2 atmosphere at 37 C incubator.	EXP036541	71	normal	P49711	VCaP (prostate carcinoma)	NULL
EXP036546		Homo sapiens		NULL	517	chip_control	NULL	Kasumi-3 (adult acute myeloid leukemia with minimal differentiation)	NULL
EXP036547	gata2	Homo sapiens		EXP036546	517	unspecified	P23769	Kasumi-3 (adult acute myeloid leukemia with minimal differentiation)	NULL
EXP036548	anti-FLAG M2 (Sigma-Aldrich, Catalog no. F3165)	Homo sapiens		NULL	166	chip_control	NULL	CD34+ hematopoietic stem cells	NULL
EXP036549	anti-FLAG M2 (Sigma-Aldrich, Catalog no. F3165)	Homo sapiens		EXP036548	166	unspecified	Q9C0K0	CD34+ hematopoietic stem cells	NULL
EXP036550	BCL11B	Homo sapiens	mutant BCL11B	EXP036548	166	unspecified	Q9C0K0	CD34+ hematopoietic stem cells	NULL
EXP036551	Streptavidin (BioChIP using a Streptavidin pulldown; PMID:21552207)	Mus musculus		NULL	44	unspecified	P15806	T-cells	NULL
EXP036552	no	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036553	abcam ab3350	Homo sapiens	peak DMOG	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP036554	abcam ab3350	Homo sapiens	trough DMOG	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP036555	abcam ab3350	Homo sapiens	peak DMSO	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP036556	abcam ab3350	Homo sapiens	through DMSO	EXP036552	848	unspecified	O00327	U2OS (osteosarcoma)	NULL
EXP036557	active motif (cat # 39665).	Homo sapiens	peak DMOG	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	NULL
EXP036558	active motif (cat # 39666).	Homo sapiens	trough DMOG	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	NULL
EXP036559	active motif (cat # 39667).	Homo sapiens	peak DMSO	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	NULL
EXP036560	active motif (cat # 39668).	Homo sapiens	through DMSO	EXP036552	848	unspecified	Q16665	U2OS (osteosarcoma)	NULL
EXP036561	none	Homo sapiens		NULL	798	chip_control	NULL	SK-OV-3 (ovarian serous cystadenocarcinoma)	NULL
EXP036562	Anti-CTCF antibody - ChIP Grade,ab70303	Homo sapiens		EXP036561	798	unspecified	P49711	SK-OV-3 (ovarian serous cystadenocarcinoma)	NULL
EXP036563	none (input)	Homo sapiens		NULL	459	chip_control	NULL	hematopoietic stem cells and progenitors	NULL
EXP036564	sc-53993	Homo sapiens		EXP036563	459	unspecified	P04198	hematopoietic stem cells and progenitors	NULL
EXP036565	NKX2-1 polyclonal (Santa Cruz Biotechnology #sc-13040 RRID:AB_10015210)	Mus musculus		NULL	158	chip_control	NULL	basal ganglia	NULL
EXP036566	NKX2-1 polyclonal (Santa Cruz Biotechnology #sc-13040 RRID:AB_10015210)	Mus musculus		NULL	158	chip_control	NULL	basal ganglia	NULL
EXP036567	LHX6 polyclonal (Genscript)	Mus musculus		NULL	158	chip_control	NULL	basal ganglia	NULL
EXP036568	LHX6 polyclonal (Genscript)	Mus musculus		NULL	158	chip_control	NULL	basal ganglia	NULL
EXP036569	NKX2-1 polyclonal (Santa Cruz Biotechnology #sc-13040 RRID:AB_10015210)	Mus musculus		EXP036566	158	unspecified	P50220	basal ganglia	NULL
EXP036570	LHX6 polyclonal (Genscript)	Mus musculus		EXP036568	158	unspecified	Q9R1R0	basal ganglia	NULL
EXP036571		Mus musculus	DMSO	NULL	214	chip_control	NULL	embryoid body (day 4)	NULL
EXP036572		Mus musculus	IWR1	NULL	214	chip_control	NULL	embryoid body (day 4)	NULL
EXP036573	Cell Signaling Technology #9743	Mus musculus	DMSO	EXP036571	214	unspecified	P70340	embryoid body (day 4)	NULL
EXP036574	Cell Signaling Technology #9743	Mus musculus	IWR1	EXP036572	214	unspecified	P70340	embryoid body (day 4)	NULL
EXP036575	none	Mus musculus		NULL	713	chip_control	NULL	pancreas	NULL
EXP036576	PTF1A antiboby from RJ MacDonald	Mus musculus		EXP036575	713	unspecified	Q9QX98	pancreas	NULL
EXP036577	PTF1A antiboby from JE Johnson	Mus musculus		EXP036575	713	unspecified	Q9QX98	pancreas	NULL
EXP036578		Mus musculus		NULL	713	chip_control	NULL	pancreas	NULL
EXP036579	rabbit antibody against human MIST1 provided by Mills JC. (Am J Pathol. 2010 Sep;177(3):1514-33.)	Mus musculus		EXP036578	713	unspecified	Q9QYC3	pancreas	NULL
EXP036580	rabbit antibody against rat MIST1 provided by Konieczny SF. (Dev Biol. 1997 Feb 1;182(1):101-13.)	Mus musculus		EXP036578	713	unspecified	Q9QYC3	pancreas	NULL
EXP036581	none (input)	Mus musculus	IKDN CD2 Cre	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP036582	none (input)	Mus musculus		NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP036583	EMD Millipore/MABE911	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	O08900	pre-pro-B-cells	NULL
EXP036584	EMD Millipore/MABE911	Mus musculus		EXP036582	198	unspecified	O08900	pre-pro-B-cells	NULL
EXP036585	Santa Cruz Biotech/sc-6059x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	P15806	pre-pro-B-cells	NULL
EXP036586	Santa Cruz Biotech/sc-349x	Mus musculus		EXP036582	198	unspecified	P15806	pre-pro-B-cells	NULL
EXP036587	Abnova/H00001879-M01	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q07802	pre-pro-B-cells	NULL
EXP036588	Abnova/H00001879-M01	Mus musculus		EXP036582	198	unspecified	Q07802	pre-pro-B-cells	NULL
EXP036589	Santa Cruz Biotech/sc-349x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	P27577	pre-pro-B-cells	NULL
EXP036590	Santa Cruz Biotech/sc-350x	Mus musculus		EXP036582	198	unspecified	P27577	pre-pro-B-cells	NULL
EXP036591	EMD Millipore/MABE912 & MABE913	Mus musculus		EXP036582	198	unspecified	Q03267	pre-pro-B-cells	NULL
EXP036592	Santa Cruz Biotech/sc-6059x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q64287	pre-pro-B-cells	NULL
EXP036593	Santa Cruz Biotech/sc-6059x	Mus musculus		EXP036582	198	unspecified	Q64287	pre-pro-B-cells	NULL
EXP036594	Santa Cruz Biotech/sc-349x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q9Z0S2	pre-pro-B-cells	NULL
EXP036595	Santa Cruz Biotech/sc-6059x	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	Q02650	pre-pro-B-cells	NULL
EXP036596	Santa Cruz Biotech/sc-6059x	Mus musculus		EXP036582	198	unspecified	Q02650	pre-pro-B-cells	NULL
EXP036597	BD Transduction Laboratories/610923	Mus musculus	IKDN CD2 Cre	EXP036581	198	unspecified	P30051	pre-pro-B-cells	NULL
EXP036598	BD Transduction Laboratories/610923	Mus musculus		EXP036582	198	unspecified	P30051	pre-pro-B-cells	NULL
EXP036599	anti-rabbit IgG antibody	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP036600	rabbit-anti-Nrf2 monoclonal	Mus musculus		EXP036599	12	unspecified	Q60795	MEF (mouse embryonic fibroblasts)	NULL
EXP036601	rabbit-anti-Nrf2 polyclonal	Mus musculus		EXP036599	12	unspecified	Q60795	MEF (mouse embryonic fibroblasts)	NULL
EXP036602	none	Mus musculus		NULL	162	chip_control	NULL	olfactory bulb	NULL
EXP036603	Sp9 (homemade antibody)	Mus musculus		EXP036602	162	unspecified	Q64HY3	olfactory bulb	NULL
EXP036604	sc-13063	Mus musculus	No treatment (Chow)	NULL	5	unspecified	Q60641	liver	NULL
EXP036605	sc-13063	Mus musculus	TCA	NULL	5	unspecified	Q60641	liver	NULL
EXP036606	sc-13063	Mus musculus	Metformin	NULL	5	unspecified	Q60641	liver	NULL
EXP036607	sc-13063	Mus musculus	TCA+Metformin	NULL	5	unspecified	Q60641	liver	NULL
EXP036608	N/A	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP036609	B2D and AFKJS-9 from eBioscience	Mus musculus		EXP036608	44	unspecified	P51450	T-cells	NULL
EXP036610	B2D and AFKJS-9 from eBioscience	Mus musculus	MRL-871	EXP036608	44	unspecified	P51450	T-cells	NULL
EXP036611	B2D and AFKJS-9 from eBioscience	Mus musculus	MRL-248	EXP036608	44	unspecified	P51450	T-cells	NULL
EXP036612	B2D and AFKJS-9 from eBioscience	Mus musculus	RORC -/-	EXP036608	44	unspecified	P51450	T-cells	NULL
EXP036613		Homo sapiens		NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP036614		Homo sapiens	GIPZ	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP036615	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ RPMI+10%FBS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036616	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shFOXA1 RPMI+10%FBS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036617	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ phenolfree RPMI+5%FCS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036618	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shFOXA1 phenolfree RPMI+5%FCS	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036619	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ phenolfree RPMI+5%FCS	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036620	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ csFCS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036621	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shFOXA1 csFCS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036622	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ FBS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036623	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shFOXA1 FBS	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036624	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ R1881 (10nM,16h)	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036625	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ R1881 (10nM,16h)	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036626	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ R1881 (10nM,16h)	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036627	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shGATA2 R1881 (10nM,16h)	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036628	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	shGATA2 R1881 (10nM,16h)	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036629	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shGATA2 R1881 (10nM,16h)	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036630	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	GIPZ EtOH	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036631	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ EtOH	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036632	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	GIPZ EtOH	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036633	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	shGATA2 EtOH	EXP036614	70	unspecified	P10275	LNCaP (prostate carcinoma)	NULL
EXP036634	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	shGATA2 EtOH	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036635	GATA2 (santa cruz, catalog# sc-9008, lot# H1511)	Homo sapiens	shGATA2 EtOH	EXP036614	70	unspecified	P23769	LNCaP (prostate carcinoma)	NULL
EXP036636	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	Ad LacZ	EXP036613	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP036637	AR (millipore, catalog# 06-680 lot# JBC1860890)	Homo sapiens	Ad GATA2	EXP036613	223	unspecified	P10275	DU145 (prostate carcinoma)	NULL
EXP036638	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	GIPZ Normal	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036639	FoxA1 (abcam, catalog# ab23738, lot# GR44102-1)	Homo sapiens	shFOXA1 Normal	EXP036614	70	unspecified	P55317	LNCaP (prostate carcinoma)	NULL
EXP036640	None	Homo sapiens		NULL	448	chip_control	NULL	retinal pigment epithelial cells	NULL
EXP036641	None	Homo sapiens		NULL	448	chip_control	NULL	retinal pigment epithelial cells	NULL
EXP036642	Input	Homo sapiens		NULL	448	chip_control	NULL	retinal pigment epithelial cells	NULL
EXP036643	Upstate 07-729	Homo sapiens		EXP036642	448	unspecified	P49711	retinal pigment epithelial cells	NULL
EXP036644	Santa Cruz SC-1082	Homo sapiens		EXP036642	448	unspecified	Q16254	retinal pigment epithelial cells	NULL
EXP036645	Abgent AP4646A	Homo sapiens		EXP036642	448	unspecified	Q03936	retinal pigment epithelial cells	NULL
EXP036646	AB21990	Homo sapiens		EXP036640	448	unspecified	P32243	retinal pigment epithelial cells	NULL
EXP036647	Active motif 39789	Homo sapiens		EXP036641	448	unspecified	O75030	retinal pigment epithelial cells	NULL
EXP036648	AB5790	Homo sapiens		EXP036640	448	unspecified	P26367	retinal pigment epithelial cells	NULL
EXP036649	SC-19342X	Homo sapiens		EXP036640	448	unspecified	P50458	retinal pigment epithelial cells	NULL
EXP036650	none	Homo sapiens		NULL	9	chip_control	NULL	Flp-In-293 (embryonic kidney)	NULL
EXP036651	none	Homo sapiens	GFP-foxm1	NULL	9	chip_control	NULL	Flp-In-293 (embryonic kidney)	NULL
EXP036652	anti-FOXM1 (GTX-1000276 and GTX102170)	Homo sapiens		EXP036650	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	NULL
EXP036653	anti-GFP (ab290)	Homo sapiens	GFP-foxm1	EXP036651	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	NULL
EXP036654	anti-GFP (ab290)	Homo sapiens	GFP-foxm1 HA mut	EXP036651	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	NULL
EXP036655	anti-GFP (ab290)	Homo sapiens	GFP-foxm1 RA mut	EXP036651	9	unspecified	Q08050	Flp-In-293 (embryonic kidney)	NULL
EXP036656	N/A	Mus musculus		NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036657	N/A	Mus musculus	KCl stimulated	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036658	N/A	Mus musculus		NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036659	N/A	Mus musculus	KCl stimulated	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036660	N/A	Mus musculus	KCl stimulated, control shRNA	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036661	N/A	Mus musculus	KCl stimulated, c-Fos shRNA	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036662	N/A	Mus musculus	KCl stimulated, FosB shRNA	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036663	N/A	Mus musculus	KCl stimulated, control shRNA	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036664	N/A	Mus musculus	KCl stimulated, c-Fos shRNA	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036665	N/A	Mus musculus	KCl stimulated, FosB shRNA	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP036666	sc52	Mus musculus		EXP036656	159	unspecified	P01101	cortical neurons	NULL
EXP036667	sc7202	Mus musculus		EXP036656	159	unspecified	P01101	cortical neurons	NULL
EXP036668	sc48	Mus musculus		EXP036656	159	unspecified	P13346	cortical neurons	NULL
EXP036669	sc52	Mus musculus	KCl stimulated	EXP036657	159	unspecified	P01101	cortical neurons	NULL
EXP036670	sc7202	Mus musculus	KCl stimulated	EXP036657	159	unspecified	P01101	cortical neurons	NULL
EXP036671	sc48	Mus musculus	KCl stimulated	EXP036657	159	unspecified	P13346	cortical neurons	NULL
EXP036672	sc52	Mus musculus		EXP036658	159	unspecified	P01101	cortical neurons	NULL
EXP036673	sc7202	Mus musculus		EXP036658	159	unspecified	P01101	cortical neurons	NULL
EXP036674	sc48	Mus musculus		EXP036658	159	unspecified	P13346	cortical neurons	NULL
EXP036675	sc46	Mus musculus		EXP036658	159	unspecified	P09450	cortical neurons	NULL
EXP036676	sc52	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P01101	cortical neurons	NULL
EXP036677	sc7202	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P01101	cortical neurons	NULL
EXP036678	sc48	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P13346	cortical neurons	NULL
EXP036679	sc46	Mus musculus	KCl stimulated	EXP036659	159	unspecified	P09450	cortical neurons	NULL
EXP036680	sc52	Mus musculus	KCl stimulated, control shRNA	EXP036660	159	unspecified	P01101	cortical neurons	NULL
EXP036681	sc48	Mus musculus	KCl stimulated, control shRNA	EXP036660	159	unspecified	P13346	cortical neurons	NULL
EXP036682	sc52	Mus musculus	KCl stimulated, c-Fos shRNA	EXP036661	159	unspecified	P01101	cortical neurons	NULL
EXP036683	sc48	Mus musculus	KCl stimulated, FosB shRNA	EXP036662	159	unspecified	P13346	cortical neurons	NULL
EXP036684	sc52	Mus musculus	KCl stimulated, control shRNA	EXP036663	159	unspecified	P01101	cortical neurons	NULL
EXP036685	sc48	Mus musculus	KCl stimulated, control shRNA	EXP036663	159	unspecified	P13346	cortical neurons	NULL
EXP036686	sc52	Mus musculus	KCl stimulated, c-Fos shRNA	EXP036664	159	unspecified	P01101	cortical neurons	NULL
EXP036687	sc48	Mus musculus	KCl stimulated, FosB shRNA	EXP036665	159	unspecified	P13346	cortical neurons	NULL
EXP036688	Purified rabbit IgG (Bethyl P120-101)	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP036689	M2 agarose (Sigma; F1804)	Homo sapiens	no exogenious myc expression	NULL	421	unspecified	P01106	HEK293 (embryonic kidney)	NULL
EXP036690	M2 agarose (Sigma; F1804)	Homo sapiens	WT-MYC expression	EXP036688	421	unspecified	P01106	HEK293 (embryonic kidney)	NULL
EXP036691	M2 agarose (Sigma; F1804)	Homo sapiens	WBM-MYC expressing	EXP036688	421	unspecified	P01106	HEK293 (embryonic kidney)	NULL
EXP036692	NA	Homo sapiens		NULL	455	chip_control	NULL	HUES64 (embryonic stem cells)	NULL
EXP036693	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens		NULL	455	unspecified	O75626	HUES64 (embryonic stem cells)	NULL
EXP036694	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens		NULL	455	unspecified	O75626	HUES64 (embryonic stem cells)	NULL
EXP036695	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens		EXP036692	455	unspecified	O75626	HUES64 (embryonic stem cells)	NULL
EXP036696	PRDM1(Cell Signaling,9115BF,5)	Homo sapiens	HUES64 dEN	NULL	455	unspecified	O75626	HUES64 (embryonic stem cells)	NULL
EXP036697	CDX2(Novus,NB100-2136,A1)	Homo sapiens		NULL	455	unspecified	Q99626	HUES64 (embryonic stem cells)	NULL
EXP036698	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	NULL
EXP036699	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	NULL
EXP036700	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	NULL
EXP036701	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		NULL	455	unspecified	P49711	HUES64 (embryonic stem cells)	NULL
EXP036702	EOMES(Abcam,ab23345,GR50189-1)	Homo sapiens		EXP036692	455	unspecified	O95936	HUES64 (embryonic stem cells)	NULL
EXP036703	FOXA1(Santa Cruz,sc-101058,H1111)	Homo sapiens		EXP036692	455	unspecified	P55317	HUES64 (embryonic stem cells)	NULL
EXP036704	FOXA1(Santa Cruz,sc-101058,H1111)	Homo sapiens		EXP036692	455	unspecified	P55317	HUES64 (embryonic stem cells)	NULL
EXP036705	FOXA2(Santa Cruz,sc-6554 X,C1810)	Homo sapiens		NULL	455	unspecified	Q9Y261	HUES64 (embryonic stem cells)	NULL
EXP036706	FOXA2	Homo sapiens		EXP036692	455	unspecified	Q9Y261	HUES64 (embryonic stem cells)	NULL
EXP036707	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens		EXP036692	455	unspecified	P43694	HUES64 (embryonic stem cells)	NULL
EXP036708	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens		NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	NULL
EXP036709	GATA6	Homo sapiens		EXP036692	455	unspecified	Q92908	HUES64 (embryonic stem cells)	NULL
EXP036710	GATA6	Homo sapiens		NULL	455	unspecified	Q92908	HUES64 (embryonic stem cells)	NULL
EXP036711	HEY1(Santa Cruz,sc-16424 X,F2411)	Homo sapiens		NULL	455	unspecified	Q9Y5J3	HUES64 (embryonic stem cells)	NULL
EXP036712	HNF1B(Santa Cruz,sc-22840 X,E2108)	Homo sapiens		EXP036692	455	unspecified	P35680	HUES64 (embryonic stem cells)	NULL
EXP036713	HNF1B(Santa Cruz,sc-22840 X,E2108)	Homo sapiens		NULL	455	unspecified	P35680	HUES64 (embryonic stem cells)	NULL
EXP036714	HNF4A(Santa Cruz,sc-8987 X,L1709)	Homo sapiens		NULL	455	unspecified	P41235	HUES64 (embryonic stem cells)	NULL
EXP036715	HNF4A(Santa Cruz,sc-8987 X,L1709)	Homo sapiens		EXP036692	455	unspecified	P41235	HUES64 (embryonic stem cells)	NULL
EXP036716	KLF5(Santa Cruz,sc-22797 X,I2804)	Homo sapiens		NULL	455	unspecified	Q13887	HUES64 (embryonic stem cells)	NULL
EXP036717	KLF5(Santa Cruz,sc-22797 X,I2804)	Homo sapiens		NULL	455	unspecified	Q13887	HUES64 (embryonic stem cells)	NULL
EXP036718	KLF5(Santa Cruz,sc-22797 X,I2804)	Homo sapiens		EXP036692	455	unspecified	Q13887	HUES64 (embryonic stem cells)	NULL
EXP036719	LEF1(Santa Cruz,sc-8591 X,J0510)	Homo sapiens		NULL	455	unspecified	Q9UJU2	HUES64 (embryonic stem cells)	NULL
EXP036720	LEF1(Santa Cruz,sc-8591 X,J0510)	Homo sapiens		NULL	455	unspecified	Q9UJU2	HUES64 (embryonic stem cells)	NULL
EXP036721	NR5A2(Abcam,ab18293,GR34910-1)	Homo sapiens		EXP036692	455	unspecified	O00482	HUES64 (embryonic stem cells)	NULL
EXP036722	NR5A2(Abcam,ab18293,GR34910-1)	Homo sapiens		NULL	455	unspecified	O00482	HUES64 (embryonic stem cells)	NULL
EXP036723	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	NULL
EXP036724	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	NULL
EXP036725	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	NULL
EXP036726	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	NULL
EXP036727	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	NULL
EXP036728	PAX6(Abcam,ab5790,GR23677-3)	Homo sapiens		NULL	455	unspecified	P26367	HUES64 (embryonic stem cells)	NULL
EXP036729	PAX6(Abcam,ab5790,GR23677-3)	Homo sapiens		NULL	455	unspecified	P26367	HUES64 (embryonic stem cells)	NULL
EXP036730	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	NULL
EXP036731	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	NULL
EXP036732	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	NULL
EXP036733	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		NULL	455	unspecified	Q01860	HUES64 (embryonic stem cells)	NULL
EXP036734	REX1(Abcam,ab28141,GR43152-1)	Homo sapiens		NULL	455	unspecified	Q96MM3	HUES64 (embryonic stem cells)	NULL
EXP036735	REX1(Abcam,ab28141,GR43152-1)	Homo sapiens		NULL	455	unspecified	Q96MM3	HUES64 (embryonic stem cells)	NULL
EXP036736	REX1(Abcam,ab28141,GR43152-1)	Homo sapiens		EXP036692	455	unspecified	Q96MM3	HUES64 (embryonic stem cells)	NULL
EXP036737	SALL4(Santa Cruz,sc-101147,G1811)	Homo sapiens		EXP036692	455	unspecified	Q9UJQ4	HUES64 (embryonic stem cells)	NULL
EXP036738	SALL4(Santa Cruz,sc-101147,G1811)	Homo sapiens		NULL	455	unspecified	Q9UJQ4	HUES64 (embryonic stem cells)	NULL
EXP036739	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036740	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		EXP036692	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036741	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036742	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	NULL
EXP036743	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	NULL
EXP036744	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	NULL
EXP036745	SNAI2	Homo sapiens		EXP036692	455	unspecified	O43623	HUES64 (embryonic stem cells)	NULL
EXP036746	SNAI2(Santa Cruz,sc-15391 X,I2409)	Homo sapiens		NULL	455	unspecified	O43623	HUES64 (embryonic stem cells)	NULL
EXP036747	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		EXP036692	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	NULL
EXP036748	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		NULL	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	NULL
EXP036749	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		NULL	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	NULL
EXP036750	SOX17(R&D Systems,AF1924,KGA0208101)	Homo sapiens		NULL	455	unspecified	Q9H6I2	HUES64 (embryonic stem cells)	NULL
EXP036751	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	NULL
EXP036752	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	NULL
EXP036753	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		NULL	455	unspecified	P48431	HUES64 (embryonic stem cells)	NULL
EXP036754	SP1(Cell Signaling,9389BF,2)	Homo sapiens		NULL	455	unspecified	P08047	HUES64 (embryonic stem cells)	NULL
EXP036755	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	NULL
EXP036756	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	NULL
EXP036757	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	NULL
EXP036758	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		NULL	455	unspecified	P11831	HUES64 (embryonic stem cells)	NULL
EXP036759	STAT3(Cell Signaling,4904BF,4)	Homo sapiens		NULL	455	unspecified	P40763	HUES64 (embryonic stem cells)	NULL
EXP036760	STAT3(Cell Signaling,4904BF,4)	Homo sapiens		NULL	455	unspecified	P40763	HUES64 (embryonic stem cells)	NULL
EXP036761	STAT3	Homo sapiens		EXP036692	455	unspecified	P40763	HUES64 (embryonic stem cells)	NULL
EXP036762	T(R&D Systems,AF2085,KQP0212061)	Homo sapiens		EXP036692	455	unspecified	O15178	HUES64 (embryonic stem cells)	NULL
EXP036763	TAL1(Abcam,ab75738,GR33312-8)	Homo sapiens		EXP036692	455	unspecified	P17542	HUES64 (embryonic stem cells)	NULL
EXP036764	TAL1(Abcam,ab75738,GR33312-8)	Homo sapiens		NULL	455	unspecified	P17542	HUES64 (embryonic stem cells)	NULL
EXP036765	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	NULL
EXP036766	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	NULL
EXP036767	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	NULL
EXP036768	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		NULL	455	unspecified	Q9NQB0	HUES64 (embryonic stem cells)	NULL
EXP036769	TCF4(Cell Signaling,2569BF,3)	Homo sapiens		EXP036692	455	unspecified	P15884	HUES64 (embryonic stem cells)	NULL
EXP036770	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	NULL
EXP036771	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	NULL
EXP036772	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	NULL
EXP036773	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		NULL	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	NULL
EXP036774	THAP11(Abcam,ab113210,GR94662-2)	Homo sapiens		EXP036692	455	unspecified	Q96EK4	HUES64 (embryonic stem cells)	NULL
EXP036775	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	NULL
EXP036776	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	NULL
EXP036777	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	NULL
EXP036778	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		EXP036692	455	unspecified	P01106	HUES64 (embryonic stem cells)	NULL
EXP036779	CMYC(Santa Cruz,sc-764x,A2111)	Homo sapiens		NULL	455	unspecified	P01106	HUES64 (embryonic stem cells)	NULL
EXP036780	HAND2(Santa Cruz,sc-22818 X,I2804)	Homo sapiens		NULL	455	unspecified	P61296	HUES64 (embryonic stem cells)	NULL
EXP036781	HAND1(Santa Cruz,sc-22817 X,F2304)	Homo sapiens		NULL	455	unspecified	O96004	HUES64 (embryonic stem cells)	NULL
EXP036782	HAND1(Santa Cruz,sc-22817 X,F2304)	Homo sapiens		EXP036692	455	unspecified	O96004	HUES64 (embryonic stem cells)	NULL
EXP036783	HAND1(Santa Cruz,sc-22817 X,F2304)	Homo sapiens		NULL	455	unspecified	O96004	HUES64 (embryonic stem cells)	NULL
EXP036784	CTCF(Millipore,07-729,DAM1472197)	Homo sapiens		EXP036692	455	unspecified	P49711	HUES64 (embryonic stem cells)	NULL
EXP036785	EOMES(Abcam,ab23345,GR50189-1)	Homo sapiens		NULL	455	unspecified	O95936	HUES64 (embryonic stem cells)	NULL
EXP036786	EOMES(Abcam,ab23345,GR50189-1)	Homo sapiens		NULL	455	unspecified	O95936	HUES64 (embryonic stem cells)	NULL
EXP036787	FOXA1(Santa Cruz,sc-101058,H1111)	Homo sapiens		NULL	455	unspecified	P55317	HUES64 (embryonic stem cells)	NULL
EXP036788	FOXA2(Santa Cruz,sc-6554 X,C1810)	Homo sapiens		NULL	455	unspecified	Q9Y261	HUES64 (embryonic stem cells)	NULL
EXP036789	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens		NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	NULL
EXP036790	GATA4	Homo sapiens		NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	NULL
EXP036791	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens	shGATA4	NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	NULL
EXP036792	GATA4(R&D Systems,AF2606,VAZ0312041)	Homo sapiens	shGATA4	NULL	455	unspecified	P43694	HUES64 (embryonic stem cells)	NULL
EXP036793	GATA6(Santa Cruz,sc-7244 X,H0911)	Homo sapiens		NULL	455	unspecified	Q92908	HUES64 (embryonic stem cells)	NULL
EXP036794	GATA6(Santa Cruz,sc-7244 X,H0911)	Homo sapiens		NULL	455	unspecified	Q92908	HUES64 (embryonic stem cells)	NULL
EXP036795	HNF1B(Santa Cruz,sc-22840 X,E2108)	Homo sapiens		NULL	455	unspecified	P35680	HUES64 (embryonic stem cells)	NULL
EXP036796	HNF4A(Santa Cruz,sc-8987 X,L1709)	Homo sapiens		NULL	455	unspecified	P41235	HUES64 (embryonic stem cells)	NULL
EXP036797	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		EXP036692	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	NULL
EXP036798	NANOG(R&D Systems,AF1997,KKJ0512051)	Homo sapiens		NULL	455	unspecified	Q9H9S0	HUES64 (embryonic stem cells)	NULL
EXP036799	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		EXP036692	455	unspecified	P32243	HUES64 (embryonic stem cells)	NULL
EXP036800	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	NULL
EXP036801	OTX2(Abcam,ab21990,GR9703-1)	Homo sapiens		NULL	455	unspecified	P32243	HUES64 (embryonic stem cells)	NULL
EXP036802	POU5F1(Abcam,ab19857,GR21088-1)	Homo sapiens		EXP036692	455	unspecified	Q01860	HUES64 (embryonic stem cells)	NULL
EXP036803	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036804	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens		NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036805	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens	shGATA4	NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036806	SMAD1(Cell Signaling,9743BF,3)	Homo sapiens	shGATA4	NULL	455	unspecified	Q15797	HUES64 (embryonic stem cells)	NULL
EXP036807	SMAD4	Homo sapiens		EXP036692	455	unspecified	Q13485	HUES64 (embryonic stem cells)	NULL
EXP036808	SMAD4(Cell Signaling,9515BF,3)	Homo sapiens		NULL	455	unspecified	Q13485	HUES64 (embryonic stem cells)	NULL
EXP036809	SOX2(Santa Cruz,sc-17320 X,L3011)	Homo sapiens		EXP036692	455	unspecified	P48431	HUES64 (embryonic stem cells)	NULL
EXP036810	SP1(Cell Signaling,9389BF,2)	Homo sapiens		EXP036692	455	unspecified	P08047	HUES64 (embryonic stem cells)	NULL
EXP036811	SRF(Santa Cruz,sc-335 X,H0511)	Homo sapiens		EXP036692	455	unspecified	P11831	HUES64 (embryonic stem cells)	NULL
EXP036812	T(R&D Systems,AF2085,KQP0212061)	Homo sapiens		NULL	455	unspecified	O15178	HUES64 (embryonic stem cells)	NULL
EXP036813	sc-542	Mus musculus	IGF1	NULL	132	normal	P19785	uterus	NULL
EXP036814	sc-542	Mus musculus	ICI 182,780	NULL	132	normal	P19785	uterus	NULL
EXP036815	IGG	Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP036816	MEF2	Mus musculus	WT3	EXP036815	53	normal	Q60929	heart	NULL
EXP036817	MEF2	Mus musculus	WT70	EXP036815	53	normal	Q60929	heart	NULL
EXP036818	MEF2	Mus musculus	Med12 KO58	EXP036815	53	normal	Q60929	heart	NULL
EXP036819	MEF2	Mus musculus	Med12 KO60	EXP036815	53	normal	Q60929	heart	NULL
EXP036820		Homo sapiens	irradiation 0h	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036821		Homo sapiens	irradiation 2.5h	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036822		Homo sapiens	irradiation 5h	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036823		Homo sapiens	irradiation 7.5h	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036824	sc-126 X	Homo sapiens	irradiation 0h	EXP036820	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036825	sc-126 X	Homo sapiens	irradiation 1h	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036826	sc-126 X	Homo sapiens	irradiation 2.5h	EXP036821	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036827	sc-126 X	Homo sapiens	irradiation 4h	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036828	sc-126 X	Homo sapiens	irradiation 5h	EXP036822	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036829	sc-126 X	Homo sapiens	irradiation 7.5h	EXP036823	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036830	sc-126 X	Homo sapiens	irradiation 7.5h + Nutlin	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036831	p65	Homo sapiens		NULL	466	normal	Q04206	MDM(monocyte derived macrophages)	NULL
EXP036832	p65	Homo sapiens	TNF (10ng/ml) for 24 hours	NULL	466	normal	Q04206	MDM(monocyte derived macrophages)	NULL
EXP036833	irf1	Homo sapiens		NULL	466	normal	P10914	MDM(monocyte derived macrophages)	NULL
EXP036834	irf1	Homo sapiens	FNA (25ng/ml) for 24 hours	NULL	466	normal	P10914	MDM(monocyte derived macrophages)	NULL
EXP036835	PU.1 (sc-352) lot#B0513	Homo sapiens	untreated	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP036836	PU.1 (sc-352) lot#B0513	Homo sapiens	IL-4	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP036837	RXR (sc-774) lot#E0213	Homo sapiens	untreated	NULL	466	normal	P19793	MDM(monocyte derived macrophages)	NULL
EXP036838	RXR (sc-774) lot#E0213	Homo sapiens	IL-4	NULL	466	normal	P19793	MDM(monocyte derived macrophages)	NULL
EXP036839	STAT6 (sc-981) lot#I1812	Homo sapiens	untreated	NULL	466	normal	P42226	MDM(monocyte derived macrophages)	NULL
EXP036840	STAT6 (sc-981) lot#I1812	Homo sapiens	IL-4	NULL	466	normal	P42226	MDM(monocyte derived macrophages)	NULL
EXP036841	CTCF	Homo sapiens		NULL	687	normal	P49711	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP036842	CTCF	Homo sapiens		NULL	687	normal	P49711	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP036843	CTCF	Homo sapiens		NULL	926	normal	P49711	IPSC-derived bipolar neuron	NULL
EXP036844	CTCF	Homo sapiens		NULL	926	normal	P49711	IPSC-derived bipolar neuron	NULL
EXP036845	CTCF	Homo sapiens		NULL	221	normal	P49711	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP036846	CTCF	Homo sapiens		NULL	221	normal	P49711	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP036847	KDM5B	Homo sapiens		NULL	376	normal	Q9UGL1	WA01 (H1, human embryonic stem cells)	NULL
EXP036848	KDM5B	Homo sapiens		NULL	199	normal	Q9UGL1	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP036849	CTCF	Homo sapiens		NULL	927	normal	P49711	PC9 (lung adenocarcinoma)	NULL
EXP036850	CTCF	Homo sapiens		NULL	927	normal	P49711	PC9 (lung adenocarcinoma)	NULL
EXP036851	Cayman HIF-1a (Cay10006421)	Homo sapiens	1 mM dimethyloxalylglycine	NULL	928	normal	Q16665	renal tubular cells	NULL
EXP036852	Novus HIF-1b (NB100-110)	Homo sapiens	1 mM dimethyloxalylglycine	NULL	928	normal	P27540	renal tubular cells	NULL
EXP036853	CTCF	Homo sapiens		NULL	618	normal	P49711	MM1.S (plasma cell myeloma)	NULL
EXP036854	CTCF	Homo sapiens		NULL	618	normal	P49711	MM1.S (plasma cell myeloma)	NULL
EXP036855	CTCF	Homo sapiens		NULL	900	normal	P49711	hepatocytes	NULL
EXP036856	CTCF	Homo sapiens		NULL	900	normal	P49711	hepatocytes	NULL
EXP036857	CTCF	Homo sapiens		NULL	900	normal	P49711	hepatocytes	NULL
EXP036858	WHSC1	Homo sapiens		NULL	356	normal	O96028	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP036859	WHSC1	Homo sapiens		NULL	356	normal	O96028	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP036860	REST	Homo sapiens		NULL	376	normal	Q13127	WA01 (H1, human embryonic stem cells)	NULL
EXP036861	REST	Homo sapiens		NULL	376	normal	Q13127	WA01 (H1, human embryonic stem cells)	NULL
EXP036862	CTCF	Homo sapiens		NULL	929	normal	P49711	neutrophils	NULL
EXP036863	CTCF	Homo sapiens		NULL	929	normal	P49711	neutrophils	NULL
EXP036864	REST	Homo sapiens		NULL	38	normal	Q13127	A549 (lung carcinoma)	NULL
EXP036865	REST	Homo sapiens		NULL	38	normal	Q13127	A549 (lung carcinoma)	NULL
EXP036866	KDM5A	Homo sapiens		NULL	38	normal	P29375	A549 (lung carcinoma)	NULL
EXP036867	KDM5A	Homo sapiens		NULL	38	normal	P29375	A549 (lung carcinoma)	NULL
EXP036868	KDM5A	Homo sapiens		NULL	356	normal	P29375	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP036869	KDM5A	Homo sapiens		NULL	356	normal	P29375	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP036870	none	Homo sapiens	untreated	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036871	none	Homo sapiens	untreated	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036872	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	400 ng/mL neocarzinostatin for 3 h	EXP036870	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036873	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	untreated	EXP036870	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036874	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	400 ng/mL neocarzinostatin for 3 h	NULL	128	normal	P04637	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP036875	p53 (Santa Cruz Biotechnology, sc-126 X)	Homo sapiens	untreated	EXP036871	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036876	RXR	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP036877	RXR	Mus musculus	GW3965 for 24 h	EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	NULL
EXP036878	RXR	Mus musculus	LG268 for 24 h	EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	NULL
EXP036879	RXR	Mus musculus	RA for 24 h	EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	NULL
EXP036880	RXR	Mus musculus		EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	NULL
EXP036881	RXR	Mus musculus		EXP036876	2	normal	P28700	mESCs (mouse embryonic stem cells)	NULL
EXP036882	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036883	anti-GABPalpha (sc-22810X, Santa Cruz).	Mus musculus		EXP036882	1058	normal	Q00422	CD4+ T-cells	NULL
EXP036884		Homo sapiens	radiation	NULL	762	chip_control	NULL	R1-D567 (prostate cancer)	NULL
EXP036885		Homo sapiens		NULL	762	chip_control	NULL	R1-D567 (prostate cancer)	NULL
EXP036886	Androgen Receptor (SCBT, sc-816)	Homo sapiens	radiation	EXP036884	762	normal	P10275	R1-D567 (prostate cancer)	NULL
EXP036887	Androgen Receptor (SCBT, sc-816)	Homo sapiens		EXP036885	762	normal	P10275	R1-D567 (prostate cancer)	NULL
EXP036888		Homo sapiens	untreated	NULL	930	chip_control	NULL	226LDM (normal breast luminal cells)	NULL
EXP036889		Homo sapiens	hydroxyurea and nocodazole	NULL	930	chip_control	NULL	226LDM (normal breast luminal cells)	NULL
EXP036890	anti-CTCF antibody (Millipore, 07-729)	Homo sapiens	untreated	EXP036888	930	normal	P49711	226LDM (normal breast luminal cells)	NULL
EXP036891	anti-CTCF antibody (Millipore, 07-729)	Homo sapiens	hydroxyurea and nocodazole	EXP036889	930	normal	P49711	226LDM (normal breast luminal cells)	NULL
EXP036892		Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036893	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	wild type FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	NULL
EXP036894	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus		NULL	1058	bio_control	Q99JB6	CD4+ T-cells	NULL
EXP036895	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	mutated FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	NULL
EXP036896	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	mutated FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	NULL
EXP036897	anti-V5 (Invitrogen, #R960) and anti-6XHIS (Abcam, #ab9108)	Mus musculus	mutated FoxP3	EXP036892	1058	normal	Q99JB6	CD4+ T-cells	NULL
EXP036898		Homo sapiens	TNF-alpha 0 h	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP036899		Homo sapiens	TNF-alpha 16 h	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP036900	anti-p53 (FL393, sc6243)	Homo sapiens	TNF-alpha 0 h	EXP036898	821	normal	P04637	SW480 (colon adenocarcinoma)	NULL
EXP036901	anti-p53 (FL393, sc6243)	Homo sapiens	TNF-alpha 16 h	EXP036899	821	normal	P04637	SW480 (colon adenocarcinoma)	NULL
EXP036902	anti-p65 (sc372x)	Homo sapiens	TNF-alpha 0 h	EXP036898	821	normal	Q04206	SW480 (colon adenocarcinoma)	NULL
EXP036903	anti-p65 (sc372x)	Homo sapiens	TNF-alpha 16 h	EXP036899	821	normal	Q04206	SW480 (colon adenocarcinoma)	NULL
EXP036904	anti-ERalpha HC20	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036905	normal rabbit IgG	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036906	anti-SRC1 M341	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP036907	anti-ERalpha HC20	Homo sapiens	E2	EXP036904	848	normal	P03372	U2OS (osteosarcoma)	NULL
EXP036908	anti-SRC1 M341	Homo sapiens	E2	EXP036906	848	normal	Q15788	U2OS (osteosarcoma)	NULL
EXP036909	goat IgG	Mus musculus		NULL	932	chip_control	NULL	E13.5 limbs and tails	NULL
EXP036910	rabbit IgG	Mus musculus		NULL	932	chip_control	NULL	E13.5 limbs and tails	NULL
EXP036911	rabbit IgG	Mus musculus		NULL	932	chip_control	NULL	E13.5 limbs and tails	NULL
EXP036912	anti-Sox9	Mus musculus		EXP036909	932	normal	Q04887	E13.5 limbs and tails	NULL
EXP036913	anti-HA	Mus musculus		EXP036910	932	normal	P35710	E13.5 limbs and tails	NULL
EXP036914	anti-Sox6	Mus musculus		EXP036911	932	normal	P40645	E13.5 limbs and tails	NULL
EXP036915	IgG	Mus musculus	calorie restricted diet	NULL	5	chip_control	NULL	liver	NULL
EXP036916	IgG	Mus musculus	calorie restricted diet	NULL	5	chip_control	NULL	liver	NULL
EXP036917	IgG	Mus musculus	high-fat diet	NULL	5	chip_control	NULL	liver	NULL
EXP036918	IgG	Mus musculus	high-fat diet	NULL	5	chip_control	NULL	liver	NULL
EXP036919	RXR?	Mus musculus	calorie restricted diet	EXP036915	5	normal	P28700	liver	NULL
EXP036920	PPAR?	Mus musculus	calorie restricted diet	EXP036916	5	normal	P23204	liver	NULL
EXP036921	RXR?	Mus musculus	high-fat diet	EXP036917	5	normal	P28700	liver	NULL
EXP036922	PPAR?	Mus musculus	high-fat diet	EXP036918	5	normal	P23204	liver	NULL
EXP036923	RXR?	Mus musculus	calorie restricted diet	EXP036915	5	normal	P28700	liver	NULL
EXP036924	PPAR?	Mus musculus	calorie restricted diet	EXP036916	5	normal	P23204	liver	NULL
EXP036925	RXR?	Mus musculus	high-fat diet	EXP036917	5	normal	P28700	liver	NULL
EXP036926	PPAR?	Mus musculus	high-fat diet	EXP036918	5	normal	P23204	liver	NULL
EXP036927	None	Homo sapiens		NULL	933	chip_control	NULL	T778 (well differentiated liposarcoma)	NULL
EXP036928	MAZ	Homo sapiens		EXP036927	933	normal	P56270	T778 (well differentiated liposarcoma)	NULL
EXP036929		Homo sapiens		NULL	934	chip_control	NULL	HOT1 tumor derived from a human glioblastoma	NULL
EXP036930	Monoclonal (rabbit) against SOX2	Homo sapiens		EXP036929	934	normal	P48431	HOT1 tumor derived from a human glioblastoma	NULL
EXP036931		Homo sapiens		NULL	735	chip_control	NULL	pre-B acute lymphoblastic leukemia	NULL
EXP036932		Homo sapiens		NULL	735	chip_control	NULL	pre-B acute lymphoblastic leukemia	NULL
EXP036933	Ik-C, Smale lab	Homo sapiens		EXP036931	735	normal	Q13422	pre-B acute lymphoblastic leukemia	NULL
EXP036934	Ik-C, Smale lab	Homo sapiens		EXP036932	735	normal	Q13422	pre-B acute lymphoblastic leukemia	NULL
EXP036935	H-100, Santa Cruz, sc-13039 X	Homo sapiens		EXP036931	735	normal	Q13422	pre-B acute lymphoblastic leukemia	NULL
EXP036936	H-100, Santa Cruz, sc-13039 X	Homo sapiens		EXP036932	735	normal	Q13422	pre-B acute lymphoblastic leukemia	NULL
EXP036937	none	Mus musculus	dexamethasone synchronized	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036938	none	Mus musculus	dexamethasone synchronized	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036939	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036937	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036940	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036937	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036941	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036942	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036943	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036944	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036945	anti-BMAL1	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	Q9WTL8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036946	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036947	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036948	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036949	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036950	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036951	anti-CLOCK	Mus musculus	dexamethasone synchronized	EXP036938	675	normal	O08785	NIH 3T3 (embryonic fibroblasts)	NULL
EXP036952	anti-CLOCK	Mus musculus		NULL	5	normal	O08785	liver	NULL
EXP036953	none	Homo sapiens		NULL	935	chip_control	NULL	HEK293-FT (human embryonic kidney, female transformed)	NULL
EXP036954	Monoclonal ANTI-FLAGÂ®Â M2 (SIGMA ALDRICH, F3165, lot-SLBG5311 )	Homo sapiens	NUP98-HOXA9-FLAG expression	EXP036953	935	normal	P31269	HEK293-FT (human embryonic kidney, female transformed)	NULL
EXP036955	Monoclonal ANTI-FLAGÂ®Â M2 (SIGMA ALDRICH, F3165, lot-SLBG5311 )	Homo sapiens	HOXA9-FLAG expression	EXP036953	935	normal	P31269	HEK293-FT (human embryonic kidney, female transformed)	NULL
EXP036956		Mus musculus	GATA6 overexpression	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP036957	Gata6 (AF1700, R&D Systems)	Mus musculus	GATA6 overexpression	EXP036956	936	normal	Q61169	primary keratinocytes	NULL
EXP036958	Gata6 (D61E4, Cell Signaling)	Mus musculus	GATA6 overexpression	EXP036956	936	normal	Q61169	primary keratinocytes	NULL
EXP036959	Flag	Mus musculus		NULL	936	bio_control	Q61169	primary keratinocytes	NULL
EXP036960	Bach2 (SIGMA, cat#: SAB2001201, lot#: QC10599	Mus musculus		NULL	1058	normal	P97303	CD4+ T-cells	NULL
EXP036961	Bach2 (SIGMA, cat#: SAB2001201, lot#: QC10599	Mus musculus	Bach2 knockout	NULL	1058	bio_control	P97303	CD4+ T-cells	NULL
EXP036962	none (input)	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP036963	none (input)	Mus musculus	differentiated	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP036964	MyoD (Santa Cruz, sc-760)	Mus musculus		NULL	1153	normal	P10085	C2C12 (myoblasts)	NULL
EXP036965	MyoD (Santa Cruz, sc-760)	Mus musculus	differentiated	EXP036963	1153	normal	P10085	C2C12 (myoblasts)	NULL
EXP036966	Flag-HES5	Mus musculus		NULL	277	bio_control	P70120	embryonic stem cell-derived mesoderm	NULL
EXP036967	Flag-HES5	Mus musculus	doxycycline for 48 h	NULL	277	normal	P70120	embryonic stem cell-derived mesoderm	NULL
EXP036968		Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP036969	ZNF143 antibodies	Homo sapiens		EXP036968	65	normal	P52747	U937 (adult acute monocytic leukemia)	NULL
EXP036970	anti-FOXO3	Mus musculus		NULL	2775	normal	Q9WVH4	neural stem cells	NULL
EXP036971	anti-FOXO3	Mus musculus	Tet2 knockout	NULL	2775	normal	Q9WVH4	neural stem cells	NULL
EXP036972	none	Homo sapiens		NULL	938	chip_control	NULL	Th17-cells	NULL
EXP036973	anti-STAT3	Homo sapiens		EXP036972	938	normal	P40763	Th17-cells	NULL
EXP036974	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IKK7	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036975	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IL1b+IKK7	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036976	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	E2+ICI	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036977	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IL1b+ICI	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036978	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	E2+ICI	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036979	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	IL1b+ICI	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036980	ER (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens		NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036981	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	E2 for 45m	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036982	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	IL1b for 45m	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036983	ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)	Homo sapiens	TNFa for 45m	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036984	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	vehicle	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036985	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	E2 for 45m	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036986	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	IL1b for 45m	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036987	p65 (Vendor: Santa Cruz, cat# sc-372, lot# D0604)	Homo sapiens	TNFa for 45m	NULL	113	normal	Q04206	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP036988	Mouse IgG (Millipore, Billerica, MA)	Homo sapiens		NULL	939	chip_control	NULL	neonatal primary melanocytes	NULL
EXP036989	anti-TFAP2A (3B5, Santa Cruz Biotechnology, Inc.	Homo sapiens		EXP036988	939	normal	P05549	neonatal primary melanocytes	NULL
EXP036990		Homo sapiens	DMSO	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP036991		Homo sapiens	25 Î¼M A771726	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP036992	SP1 (Abcam) antibody	Homo sapiens	DMSO	EXP036990	36	normal	P08047	A375 (malignant melanoma)	NULL
EXP036993	SP1 (Abcam) antibody	Homo sapiens	25 Î¼M A771726	EXP036991	36	normal	P08047	A375 (malignant melanoma)	NULL
EXP036994	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP036995	MLL4 (PMCID: PMC3869375)	Mus musculus		EXP036994	1058	normal	O08550	CD4+ T-cells	NULL
EXP036996	YY1 antibody sc-7341(Santa Cruz Biotechnology)	Homo sapiens		NULL	78	normal	P25490	HeLa (cervical adenocarcinoma)	NULL
EXP036997	IgG	Homo sapiens		NULL	940	chip_control	NULL	GEN2.2 (blastic plasmacytoid dendritic cell neoplasm)	NULL
EXP036998	anti-MYC antibody (Santacruz Biotechnology, N262X)	Homo sapiens		NULL	940	normal	P01106	GEN2.2 (blastic plasmacytoid dendritic cell neoplasm)	NULL
EXP036999	none	Rattus norvegicus	quiescence	NULL	941	chip_control	NULL	hippocampal neural stem cells	NULL
EXP037000	none	Rattus norvegicus	proliferation	NULL	941	chip_control	NULL	hippocampal neural stem cells	NULL
EXP037001	anti-REST (Millipore, 17-641)	Rattus norvegicus	quiescence	EXP036999	941	normal	O54963	hippocampal neural stem cells	NULL
EXP037002	anti-REST (Hsieh lab homemade antibody)	Rattus norvegicus	quiescence	EXP036999	941	normal	O54963	hippocampal neural stem cells	NULL
EXP037003	anti-REST (Millipore, 17-641)	Rattus norvegicus	proliferation	EXP037000	941	normal	O54963	hippocampal neural stem cells	NULL
EXP037004	anti-REST (Hsieh lab homemade antibody)	Rattus norvegicus	proliferation	EXP037000	941	normal	O54963	hippocampal neural stem cells	NULL
EXP037005	Rabbit IgG  (Santa Cruz: sc2027)	Mus musculus		NULL	942	chip_control	NULL	NS5 (neural stem cells)	NULL
EXP037006	Rabbit IgG  (Santa Cruz: sc2027)	Mus musculus		NULL	942	chip_control	NULL	NS5 (neural stem cells)	NULL
EXP037007	Goat IgG (Santa Cruz: sc2028)	Mus musculus		NULL	942	chip_control	NULL	NS5 (neural stem cells)	NULL
EXP037008	Rabbit Anti-Npas3 (Sigma: HPA002892)	Mus musculus		EXP037005	942	normal	Q9QZQ0	NS5 (neural stem cells)	NULL
EXP037009	Rabbit Anti-Olig2 (Milipore: AB9610)	Mus musculus		EXP037006	942	normal	Q9EQW6	NS5 (neural stem cells)	NULL
EXP037010	Smad4 antibody (R&D Systems: AF2097)	Mus musculus		EXP037007	942	normal	P97471	NS5 (neural stem cells)	NULL
EXP037011	none	Homo sapiens	none	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037012	none	Homo sapiens	none	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037013	none	Homo sapiens	none	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037014	none	Homo sapiens	none	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037015	none	Homo sapiens	none	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037016	none	Homo sapiens	none	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037017	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037011	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037018	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037012	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037019	rabbit anti-Prox1 (ProteinTech)	Homo sapiens	none	EXP037013	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037020	rabbit anti-Prox1 (ProteinTech)	Homo sapiens	none	EXP037014	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037021	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037015	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037022	rabbit anti-FLAG (Pierce)	Homo sapiens	none	EXP037016	472	normal	Q92786	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP037023	none	Mus musculus	(Z)-4-Hydroxytamoxifen at a final concentration of 200 nM for 3 h; K1-ER construct	NULL	943	chip_control	NULL	KLF1 erythroblasts	NULL
EXP037024	none	Mus musculus	(Z)-4-Hydroxytamoxifen at a final concentration of 200 nM for 3 h; K1-NanER construct	NULL	943	chip_control	NULL	KLF1 erythroblasts	NULL
EXP037025	KLF1 Antibody	Mus musculus	(Z)-4-Hydroxytamoxifen at a final concentration of 200 nM for 3 h; K1-ER construct	EXP037023	943	normal	P46099	KLF1 erythroblasts	NULL
EXP037026	KLF1 Antibody	Mus musculus	(Z)-4-Hydroxytamoxifen at a final concentration of 200 nM for 3 h; K1-NanER construct	EXP037024	943	normal	P46099	KLF1 erythroblasts	NULL
EXP037027	None	Mus musculus		NULL	944	chip_control	NULL	E11.5 maxillary arch	NULL
EXP037028	Anti-Lhx6	Mus musculus		EXP037027	944	normal	Q9R1R0	E11.5 maxillary arch	NULL
EXP037029	CREB (48H2) Rabbit mAb #9197	Mus musculus		NULL	429	normal	Q01147	hepatocytes	NULL
EXP037030	C/EBP ?  (C-19), sc-150	Mus musculus	fed 10 h	NULL	429	normal	P28033	hepatocytes	NULL
EXP037031	C/EBP ?  (C-19), sc-150	Mus musculus	fasted 24 h	NULL	429	normal	P28033	hepatocytes	NULL
EXP037032	Phospho-CREB (Ser133) (87G3) Rabbit mAb #9198	Mus musculus	fed 24 h	NULL	429	normal	Q01147	hepatocytes	NULL
EXP037033	Phospho-CREB (Ser133) (87G3) Rabbit mAb #9198	Mus musculus	fasted 24 h	NULL	429	normal	Q01147	hepatocytes	NULL
EXP037034	cocktail of GR Abs (3.3ul of each Ab): PA1-511A (ThermoScientific),  MA1-510 (ThermoScientific), M-20 (sc-1004, Santa Cruz)	Mus musculus	fed 10 h	NULL	429	normal	P06537	hepatocytes	NULL
EXP037035	cocktail of GR Abs (3.3ul of each Ab): PA1-511A (ThermoScientific),  MA1-510 (ThermoScientific), M-20 (sc-1004, Santa Cruz)	Mus musculus	fasted 24 h	NULL	429	normal	P06537	hepatocytes	NULL
EXP037036	CREB (48H2) Rabbit mAb #9197	Mus musculus	glucagon (10nM) for 1hr	NULL	429	normal	Q01147	hepatocytes	NULL
EXP037037	CREB (48H2) Rabbit mAb #9197	Mus musculus	glucagon (10nM) + corticosterone (1.7uM) for 1 hr	NULL	429	normal	Q01147	hepatocytes	NULL
EXP037038	cocktail of GR Abs (3.3ul of each Ab): PA1-511A (ThermoScientific),  MA1-510 (ThermoScientific), M-20 (sc-1004, Santa Cruz)	Mus musculus	glucagon (10nM) + corticosterone (1.7uM) for 1hr	NULL	429	normal	P06537	hepatocytes	NULL
EXP037200		Homo sapiens	vitamin D treated	NULL	955	chip_control	NULL	primary foreskin fibroblasts	NULL
EXP037199		Homo sapiens	vehicle treated control	NULL	955	chip_control	NULL	primary foreskin fibroblasts	NULL
EXP037041	none	Mus musculus		NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP037042	anti-AhR HA (abcam, ab9110)	Mus musculus		EXP037041	936	normal	P30561	primary keratinocytes	NULL
EXP037043	none (input)	Mus musculus	6 days of wash 	NULL	401	chip_control	NULL	C10 (pre-B-cells)	NULL
EXP037044	none (input)	Mus musculus	induction Cebpa for 6 h	NULL	401	chip_control	NULL	C10 (pre-B-cells)	NULL
EXP037045	none (input)	Mus musculus		NULL	401	chip_control	NULL	C10 (pre-B-cells)	NULL
EXP037046	anti-Pu.1 (SantaCruz Sc-352X, lot B0314)	Mus musculus	6 days of wash 	EXP037043	401	normal	P17433	C10 (pre-B-cells)	NULL
EXP037047	anti-Pu.1 (SantaCruz Sc-352X, lot B0314)	Mus musculus		EXP037045	401	normal	P17433	C10 (pre-B-cells)	NULL
EXP037048	anti-Pu.1 (SantaCruz Sc-352X, lot B0314)	Mus musculus	induction Cebpa for 6 h	EXP037044	401	normal	P17433	C10 (pre-B-cells)	NULL
EXP037049	none	Mus musculus		NULL	945	chip_control	NULL	Melan-a (immortalized melanocytes)	NULL
EXP037050	AP-2alpha (3B5):sc12726	Mus musculus		EXP037049	945	normal	P34056	Melan-a (immortalized melanocytes)	NULL
EXP037051	none	Mus musculus		NULL	946	chip_control	NULL	E10.5 embryonic heart	NULL
EXP037052	mouse monoclonal anti-FLAG , M2 (Sigma, Cat.-No.: F1804)	Mus musculus		EXP037051	946	normal	Q61039	E10.5 embryonic heart	NULL
EXP037053	none	Homo sapiens	Treatment: None; Growth: cells were grown in Keratinocyte SFM media supplemented with bovine pitutiary extract, human recombinant epidermal growth factor, penicillin/streptomycin, and selection agents (puromycin/hygromycin)	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP037054	none	Homo sapiens	Treatment: None; Growth: cells were grown in DMEM media (Mediatech-cellgro) with 10%FBS and 1% penicillin/streptomycin	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP037055	anti-ERG (Clone 9FY Biocare CM421 C)	Homo sapiens	Treatment: None; Growth: cells were grown in DMEM media (Mediatech-cellgro) with 10%FBS and 1% penicillin/streptomycin	EXP037054	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP037056	anti-ERG (Clone 9FY Biocare CM421 C)	Homo sapiens	Treatment: mutated ERG; Growth: cells were grown in Keratinocyte SFM media supplemented with bovine pitutiary extract, human recombinant epidermal growth factor, penicillin/streptomycin, and selection agents (puromycin/hygromycin)	EXP037053	781	normal	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP037057	anti-ERG (Clone 9FY Biocare CM421 C)	Homo sapiens	Treatment: none; Growth: cells were grown in Keratinocyte SFM media supplemented with bovine pitutiary extract, human recombinant epidermal growth factor, penicillin/streptomycin, and selection agents (puromycin/hygromycin)	EXP037053	781	normal	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP037058	Input Control	Mus musculus		NULL	947	chip_control	NULL	primary whole bone marrow cells	NULL
EXP037059	Input Control	Mus musculus	CEBPE knockout	NULL	947	chip_control	NULL	primary whole bone marrow cells	NULL
EXP037060	CEBPe GTX109155 (GeneTex)	Mus musculus		EXP037058	947	normal	Q6PZD9	primary whole bone marrow cells	NULL
EXP037061	CEBPe GTX109155 (GeneTex)	Mus musculus	CEBPE knockout	EXP037059	947	bio_control	Q6PZD9	primary whole bone marrow cells	NULL
EXP037062	CEBPe SC-158 (Santa Cruz Biotechnology)	Mus musculus		EXP037058	947	normal	Q6PZD9	primary whole bone marrow cells	NULL
EXP037063	CEBPe SC-158 (Santa Cruz Biotechnology)	Mus musculus	CEBPE knockout	EXP037059	947	bio_control	Q6PZD9	primary whole bone marrow cells	NULL
EXP037064	none	Homo sapiens	R1881	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP037065	none	Homo sapiens	R1881+Doxycycline	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP037066	anti-AR, santa cruz (scbt-816X)	Homo sapiens	R1881	EXP037064	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP037067	anti-AR, santa cruz (scbt-816X)	Homo sapiens	R1881+Doxycycline	EXP037065	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP037068	anti-MYC, RnD (AF3696)	Homo sapiens	R1881	EXP037064	70	normal	P01106	LNCaP (prostate carcinoma)	NULL
EXP037069	anti-MYC, RnD (AF3696)	Homo sapiens	R1881+Doxycycline	EXP037064	70	normal	P01106	LNCaP (prostate carcinoma)	NULL
EXP037070	none	Mus musculus	PARP-1 KO	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP037071	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP037072	Oct4 (Santa Cruz; sc-8628)	Mus musculus	PARP-1 KO	EXP037070	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP037073	Sox2 (Santa Cruz; sc-17320)	Mus musculus	PARP-1 KO	EXP037070	2	normal	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP037074	Sox2 (Santa Cruz; sc-17320)	Mus musculus		EXP037071	2	normal	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP037075	Oct4 (Santa Cruz; sc-8628)	Mus musculus		EXP037071	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP037076		Mus musculus	Pparg-flox/flox	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037077		Mus musculus	Pparg-flox/flox	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037078		Mus musculus	Pparg-flox/flox	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037079		Mus musculus	Pparg-flox/flox	NULL	116	chip_control	NULL	brown adipocytes	NULL
EXP037080		Mus musculus	MLL3 -/-; MLL4 flox/flox	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037081		Mus musculus	MLL3 -/-; MLL4 -/-	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037082	none	Mus musculus		NULL	20	chip_control	NULL	3T3-L1-derived adipocytes	NULL
EXP037083	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	P53566	brown preadipocytes	NULL
EXP037084	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	P53566	brown preadipocytes	NULL
EXP037085	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	P53566	brown preadipocytes	NULL
EXP037086	C/EBP ? Antibody (14AA)	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	P53566	brown adipocytes	NULL
EXP037087	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	P28033	brown preadipocytes	NULL
EXP037088	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	NULL	483	normal	P28033	brown preadipocytes	NULL
EXP037089	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	P28033	brown preadipocytes	NULL
EXP037090	C/EBP ? Antibody (C-19)	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	P28033	brown adipocytes	NULL
EXP037091	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	O08792	brown preadipocytes	NULL
EXP037092	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	O08792	brown preadipocytes	NULL
EXP037093	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	O08792	brown preadipocytes	NULL
EXP037094	Human/Mouse EBF-2 Antibody	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	O08792	brown adipocytes	NULL
EXP037095	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	P37238	brown preadipocytes	NULL
EXP037096	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	P37238	brown preadipocytes	NULL
EXP037097	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	P37238	brown preadipocytes	NULL
EXP037098	PPAR? Antibody (H-100)	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	P37238	brown adipocytes	NULL
EXP037099	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037076	483	normal	Q61164	brown preadipocytes	NULL
EXP037100	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037077	483	normal	Q61164	brown preadipocytes	NULL
EXP037101	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037078	483	normal	Q61164	brown preadipocytes	NULL
EXP037102	Anti-CTCF Antibody	Mus musculus	Pparg-flox/flox	EXP037079	116	normal	Q61164	brown adipocytes	NULL
EXP037103	Anti-MLL4 #3	Mus musculus	MLL3 -/-; MLL4 flox/flox	EXP037080	483	normal	O08550	brown preadipocytes	NULL
EXP037104	Anti-MLL4 #3	Mus musculus	MLL3 -/-; MLL4 -/-	EXP037081	483	normal	O08550	brown preadipocytes	NULL
EXP037105	Anti-MLL4 #3 (Home-made)	Mus musculus		EXP037082	20	normal	O08550	3T3-L1-derived adipocytes	NULL
EXP037106		Mus musculus		NULL	260	chip_control	NULL	epiblast stem cells	NULL
EXP037107	anti-ZIC2	Mus musculus		EXP037106	260	normal	Q62520	epiblast stem cells	NULL
EXP037108	anti-OTX2	Mus musculus		EXP037106	260	normal	P80206	epiblast stem cells	NULL
EXP037109	anti-SOX2	Mus musculus		EXP037106	260	normal	P48432	epiblast stem cells	NULL
EXP037110	anti-POU5F1	Mus musculus		EXP037106	260	normal	P20263	epiblast stem cells	NULL
EXP037111	anti-POU3F1	Mus musculus		EXP037106	260	normal	P21952	epiblast stem cells	NULL
EXP037112	anti-ZIC2	Mus musculus	feeder free	EXP037106	260	normal	Q62520	epiblast stem cells	NULL
EXP037113	anti-OTX2	Mus musculus	feeder free	EXP037106	260	normal	P80206	epiblast stem cells	NULL
EXP037114	anti-SOX2	Mus musculus	feeder free	EXP037106	260	normal	P48432	epiblast stem cells	NULL
EXP037115	anti-POU5F1	Mus musculus	feeder free	EXP037106	260	normal	P20263	epiblast stem cells	NULL
EXP037116	anti-POU3F1	Mus musculus	feeder free	EXP037106	260	normal	P21952	epiblast stem cells	NULL
EXP037117	IgG	Homo sapiens	doxycycline for 4 days; empty vector	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP037118	NANOG IgG	Homo sapiens	doxycycline for 4 days; empty vector	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP037119	NANOG IgG	Homo sapiens		EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	NULL
EXP037120	NANOG IgG	Homo sapiens	doxycycline for 4 days	EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	NULL
EXP037121	NANOGP8 IgG	Homo sapiens		EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	NULL
EXP037122	NANOGP8 IgG	Homo sapiens	doxycycline for 4 days	EXP037117	70	normal	Q9H9S0	LNCaP (prostate carcinoma)	NULL
EXP037123	none	Homo sapiens	tamoxifen	NULL	948	chip_control	NULL	MCF-7L (invasive ductal carcinoma)	NULL
EXP037124	none	Homo sapiens		NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP037125	FOXA1	Homo sapiens	tamoxifen	EXP037123	948	normal	P55317	MCF-7L (invasive ductal carcinoma)	NULL
EXP037126	FOXA1	Homo sapiens	tamoxifen	EXP037124	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP037127	ELK-1 in house antibody	Mus musculus	TKO recon pMY Empty; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037128	ELK-1 in house antibody	Mus musculus	TKO recon pMY Empty; 12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037129	ELK1 in house antibody	Mus musculus	TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037130	ELK1 in house antibody	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037131	ELK1 in house antibody	Mus musculus	TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037132	ELK1 in house antibody	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037133	ELK1 in house antibody	Mus musculus	TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037134	ELK1 in house antibody	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes; TCFs KO	NULL	12	normal	P41969	MEF (mouse embryonic fibroblasts)	NULL
EXP037135	SRF (sc-335) (Lot: D3013)	Mus musculus		NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP037136	SRF (sc-335) (Lot: D3013)	Mus musculus	12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes	NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP037137	SRF (sc-335) (Lot: D3013)	Mus musculus	TCF KO	NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP037138	SRF (sc-335) (Lot: D3013)	Mus musculus	TCF KO; 12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes	NULL	12	normal	Q9JM73	MEF (mouse embryonic fibroblasts)	NULL
EXP037139	None	Homo sapiens	0.5 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037140	None	Homo sapiens	1 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037141	None	Homo sapiens	2 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037142	None	Homo sapiens	0.5 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037143	None	Homo sapiens	1 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037144	None	Homo sapiens	2 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037145	None	Homo sapiens	1 DPT	NULL	950	chip_control	NULL	MRC-5 (fetal lung fibroblasts)	NULL
EXP037146	NEUROG2 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037139	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037147	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037139	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037148	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037140	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037149	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037140	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037150	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037141	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037151	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037141	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037152	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037142	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037153	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	0.5 DPT	EXP037142	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037154	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037143	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037155	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037143	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037156	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037144	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037157	Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	2 DPT	EXP037144	950	normal	Q9H2A3	MRC-5 (fetal lung fibroblasts)	NULL
EXP037158	Sox4 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037145	950	normal	Q06945	MRC-5 (fetal lung fibroblasts)	NULL
EXP037159	Sox4 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037145	950	normal	Q06945	MRC-5 (fetal lung fibroblasts)	NULL
EXP037160	Sox4 Rabbit anti-HA polyclonal antibody (Abcam, AB9110)	Homo sapiens	1 DPT	EXP037145	950	normal	Q06945	MRC-5 (fetal lung fibroblasts)	NULL
EXP037161	none	Mus musculus		NULL	528	chip_control	NULL	Lin-Sca-1+ c-Kit+ hematopietic multipotent stem cells	NULL
EXP037162	anti-MLL1 (BETHYL, A300-086A, lot 4)	Mus musculus		EXP037161	528	normal	P55200	Lin-Sca-1+ c-Kit+ hematopietic multipotent stem cells	NULL
EXP037163		Mus musculus		NULL	951	chip_control	NULL	bone marrow-derived mesenchymal stromal cells	NULL
EXP037164		Mus musculus		NULL	951	chip_control	NULL	bone marrow-derived mesenchymal stromal cells	NULL
EXP037165		Mus musculus		NULL	951	chip_control	NULL	bone marrow-derived mesenchymal stromal cells	NULL
EXP037166		Mus musculus		NULL	951	chip_control	NULL	bone marrow-derived mesenchymal stromal cells	NULL
EXP037167	CTCF	Mus musculus		EXP037163	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	NULL
EXP037168	Runx2	Mus musculus		EXP037163	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	NULL
EXP037169	CTCF	Mus musculus		EXP037164	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	NULL
EXP037170	Runx2	Mus musculus		EXP037164	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	NULL
EXP037171	CTCF	Mus musculus		EXP037165	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	NULL
EXP037172	Runx2	Mus musculus		EXP037165	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	NULL
EXP037173	CTCF	Mus musculus		EXP037166	951	normal	Q61164	bone marrow-derived mesenchymal stromal cells	NULL
EXP037174	Runx2	Mus musculus		EXP037166	951	normal	Q08775	bone marrow-derived mesenchymal stromal cells	NULL
EXP037175	Sox2	Homo sapiens		NULL	396	normal	P48431	WA09 (embryonic stem cells)	NULL
EXP037176	Sox2	Homo sapiens		NULL	953	normal	P48431	H9-derived neuroectoderm cells	NULL
EXP037177	anti-ASH1 (made in-house)	Homo sapiens		NULL	514	normal	P50553	K562 (myelogenous leukemia)	NULL
EXP037178		Homo sapiens		NULL	147	chip_control	NULL	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP037179		Homo sapiens		NULL	940	chip_control	NULL	GEN2.2 (blastic plasmacytoid dendritic cell neoplasm)	NULL
EXP037180	TCF4	Homo sapiens		EXP037178	147	normal	P15884	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP037181	TCF4	Homo sapiens		EXP037179	940	normal	P15884	GEN2.2 (blastic plasmacytoid dendritic cell neoplasm)	NULL
EXP037182	CTCF (Upstate 07-729)	Mus musculus	WT; 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037183	CTCF (Upstate 07-729)	Mus musculus	WT; 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037184	CTCF (Upstate 07-729)	Mus musculus	Ctcf(fl/fl); 4h Adeno-Cre and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037185	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Smc3(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037186	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Smc3(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037187	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Wapl(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037188	CTCF (Upstate 07-729)	Mus musculus	Rosa26(CreER/+) Wapl(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting	NULL	750	normal	Q61164	E13.5 embryonic fibroblasts	NULL
EXP037189	none (input)	Homo sapiens	Treatment: None	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP037190	anti-SOX9 (Millipore AB5535)	Homo sapiens	Treatment: None	EXP037189	71	normal	P48436	VCaP (prostate carcinoma)	NULL
EXP037191	FLI1	Homo sapiens		NULL	516	normal	Q01543	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP037192	ERG	Homo sapiens		NULL	516	normal	P11308	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP037193	GATA2	Homo sapiens		NULL	516	normal	P23769	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP037194	TAL1	Homo sapiens		NULL	516	normal	P17542	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP037195	LYL	Homo sapiens		NULL	516	normal	P12980	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP037196	RUNX1	Homo sapiens		NULL	516	normal	Q01196	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP037197	None	Mus musculus		NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP037198	KLF4	Mus musculus		EXP037197	171	normal	Q60793	CD4+ CD8+ T cells	NULL
EXP037201	anti-VDR	Homo sapiens	vehicle treated control	EXP037199	955	normal	P11473	primary foreskin fibroblasts	NULL
EXP037202	anti-VDR	Homo sapiens	vitamin D treated	EXP037200	955	normal	P11473	primary foreskin fibroblasts	NULL
EXP037203	No antibody	Homo sapiens		NULL	783	chip_control	NULL	SaOS2 (osteosarcoma)	NULL
EXP037204	Custom made RUNX2 antibody	Homo sapiens		EXP037203	783	normal	Q13950	SaOS2 (osteosarcoma)	NULL
EXP037205	none	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP037206	Satb1 (AbCam ab109122)	Mus musculus		EXP037205	44	normal	Q60611	T-cells	NULL
EXP037207	none	Mus musculus	transduced with AAV8-hSyn-Satb2-V5 at DIV4	NULL	956	chip_control	NULL	primary hippocampal neuron	NULL
EXP037208	Anti-V5 (Abcam, catalog# 15828, lot# GR195596-1)	Mus musculus	transduced with AAV8-hSyn-Satb2-V5 at DIV4	EXP037207	956	normal	Q8VI24	primary hippocampal neuron	NULL
EXP037209	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037210	Znf281	Mus musculus		EXP037209	252	normal	Q99LI5	V6.5 (embryonic stem cells)	NULL
EXP037211	input	Mus musculus		NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP037212	Zic1	Mus musculus		EXP037211	280	normal	P46684	embryonic stem cell-derived neural progenitors	NULL
EXP037213		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP037214	Avi-tagged hGATA6	Homo sapiens		EXP037213	376	normal	Q92908	WA01 (H1, human embryonic stem cells)	NULL
EXP037215	none	Mus musculus		NULL	957	chip_control	NULL	mpkDCT4a (immortalized murine DCT cell line)	NULL
EXP037216	rabbit anti-Hnf1?  (Santa Cruz, H-85, SC-22840)	Mus musculus		EXP037215	957	normal	P27889	mpkDCT4a (immortalized murine DCT cell line)	NULL
EXP037217		Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP037218	Santa Cruz, C-20, lot SC-193	Homo sapiens		EXP037217	725	normal	Q01094	PC3(bone mets prostate adenocarcinoma)	NULL
EXP037219	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP037220	Flag (Sigma, Cat. F1804)	Mus musculus	tet1e isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037221	Flag (Sigma, Cat. F1804)	Mus musculus	tet1s isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037222	Flag (Sigma, Cat. F1804)	Mus musculus	tet1e delta cxxc isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037223	Flag (Sigma, Cat. F1804)	Mus musculus	Tet1n isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037224	Flag (Sigma, Cat. F1804)	Mus musculus	tet1delta delta cxxc isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037225	Tet1 (home-made; same as the one used for ChIP-seq in PMID 21514197)	Mus musculus		EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037226	Tet1 (home-made; same as the one used for ChIP-seq in PMID 21514197)	Mus musculus	tet1cs isoform	EXP037219	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP037227	none	Mus musculus	mCXXC/mCXXC genotype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037228	none	Mus musculus	mCXXC/mCXXC genotype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037229	none	Mus musculus	Y2602A/Y2602A genotype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037230	none	Mus musculus	Y2602A/Y2602A genotype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037231	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037232	none	Mus musculus	shMenin	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037233	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037234	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037235	none	Mus musculus	shGFP	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037236	none	Mus musculus	shMll2	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037237	Mll2 (Homemade, #9173)	Mus musculus	mCXXC/mCXXC genotype	EXP037227	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037238	Mll2 (Homemade, #9173)	Mus musculus	mCXXC/mCXXC genotype	EXP037228	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037239	Mll2 (Homemade, #9173)	Mus musculus	Y2602A/Y2602A genotype	EXP037229	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037240	Mll2 (Homemade, #9173)	Mus musculus	Y2602A/Y2602A genotype	EXP037230	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037241	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo-MLL2(deltaCXXC)	EXP037231	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037242	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo-MLL2(Y2604A)	EXP037231	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037243	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo-MLL2(WT)	EXP037231	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037244	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO + Halo	EXP037231	252	bio_control	O08550	V6.5 (embryonic stem cells)	NULL
EXP037245	Mll2 (Homemade, #9173)	Mus musculus	Mll2KO	EXP037231	252	bio_control	O08550	V6.5 (embryonic stem cells)	NULL
EXP037246	Mll2 (Homemade, #9173)	Mus musculus	Halo	EXP037233	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037247	Mll2 (Homemade, #9173)	Mus musculus		EXP037233	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037248	Mll2 (Homemade, #9173)	Mus musculus	shMenin	EXP037232	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037249	Mll2 (Homemade, #9173)	Mus musculus	shMll2	EXP037236	252	bio_control	O08550	V6.5 (embryonic stem cells)	NULL
EXP037250	Mll2 (Homemade, #9175)	Mus musculus		EXP037234	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037251	Mll2 (Homemade, #9173)	Mus musculus	shGFP	EXP037235	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP037252	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus	4Â°C	NULL	80	normal	Q3UV55	B lymphoblastic leukemia	NULL
EXP037253	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus	30Â°C	NULL	80	normal	Q3UV55	B lymphoblastic leukemia	NULL
EXP037254	Rev-erb alpha (Cell Signaling, catalog number CS2124, rabbit antibody)	Mus musculus	30Â°C, Rev-erb alpha KO	NULL	80	bio_control	Q3UV55	B lymphoblastic leukemia	NULL
EXP037255	none	Mus musculus	1000 ng/ml doxycycline	NULL	958	chip_control	NULL	BN cells (granulocyte-macrophage progenitor)	NULL
EXP037256	none	Mus musculus		NULL	958	chip_control	NULL	BN cells (granulocyte-macrophage progenitor)	NULL
EXP037257	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus		EXP037256	958	normal	P17433	BN cells (granulocyte-macrophage progenitor)	NULL
EXP037258	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus	1000 ng/ml doxycycline	EXP037255	958	normal	P17433	BN cells (granulocyte-macrophage progenitor)	NULL
EXP037259	none	Mus musculus		NULL	803	chip_control	NULL	spermatocytes	NULL
EXP037260	07-729, Millipore	Mus musculus		EXP037259	803	normal	Q61164	spermatocytes	NULL
EXP037261	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP037262	AR (santa cruz, sc-815X, lot K0713)	Homo sapiens		NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP037263	AR (santa cruz, sc-815X, lot K0713)	Homo sapiens	NOV induced	EXP037261	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP037264		Mus musculus	KLA for 24 hours	NULL	959	chip_control	NULL	peritoneal thioglycolate-elicited macrophages	NULL
EXP037265		Mus musculus	none (control)	NULL	959	chip_control	NULL	peritoneal thioglycolate-elicited macrophages	NULL
EXP037266		Mus musculus	none (control)	NULL	959	chip_control	NULL	peritoneal thioglycolate-elicited macrophages	NULL
EXP037267		Mus musculus	KLA for 24 hours	NULL	959	chip_control	NULL	peritoneal thioglycolate-elicited macrophages	NULL
EXP037268		Mus musculus	Srebp1 -/-	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037269		Mus musculus	none (control)	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037270		Mus musculus	KLA for 1 hours, Srebp1 -/-	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037271		Mus musculus	KLA for 1 hours	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037272		Mus musculus	KLA for 6 hours, Srebp1 -/-	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037273		Mus musculus	KLA for 6 hours	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037274		Mus musculus	KLA for 24 hours, Srebp1 -/-	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037275		Mus musculus	KLA for 24 hours	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037276	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	none (control)	EXP037266	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	NULL
EXP037277	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	Desmosterol (20uM) for 18 hours	EXP037266	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	NULL
EXP037278	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	GW3965 (1uM) for 18 hours	EXP037266	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	NULL
EXP037279	Srebp1 (Santa Cruz sc-8984X, lot:G1811, sc-13551X, lot:E1613, sc367X, lot:G1212)	Mus musculus	KLA for 24 hours	EXP037267	959	normal	Q9WTN3	peritoneal thioglycolate-elicited macrophages	NULL
EXP037280	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	none (control)	EXP037265	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	NULL
EXP037281	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	none (control)	EXP037264	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	NULL
EXP037282	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	none (control)	EXP037265	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	NULL
EXP037283	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	KLA for 6 hours	EXP037265	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	NULL
EXP037284	LXR (Santa Cruz sc-1000X, Lot:I0310, Abcam ab-41902, lot:GR9889-3, Active Motif 61177, lot:29111001)	Mus musculus	KLA for 24 hours	EXP037264	959	normal	Q9Z0Y9	peritoneal thioglycolate-elicited macrophages	NULL
EXP037285	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	none (control)	EXP037269	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037286	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 1 hours	EXP037271	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037287	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 6 hours	EXP037273	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037288	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 24 hours	EXP037275	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037289	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	Srebp1 -/-	EXP037268	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037290	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 1 hours, Srebp1 -/-	EXP037270	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037291	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 6 hours, Srebp1 -/-	EXP037272	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037292	p65 (Vendor: Santa Cruz, cat# sc-372, lot# A0314)	Mus musculus	KLA for 24 hours, Srebp1 -/-	EXP037274	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP037293	none	Mus musculus	IL3 maintenance	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP037294	STAT5a (Santa Cruz, sc1081X)	Mus musculus	IL3 deprivation for 6h	EXP037293	105	normal	P42230	pro-B cells	NULL
EXP037295	STAT5a (Santa Cruz, sc1081X)	Mus musculus	IL3 deprivation for 6h and IL3 stimulation for 30min	EXP037293	105	normal	P42230	pro-B cells	NULL
EXP037296	abcam 46540 (Lot GR172884-2)	Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP037297	anti JARID2 rabbit Novus NB100-2214	Mus musculus		EXP037296	233	normal	Q62315	E14TG2A (embryonic stem cells)	NULL
EXP037298	anti JARID2 rabbit Novus NB100-2214	Mus musculus	c17orf96 knock-down	EXP037296	233	normal	Q62315	E14TG2A (embryonic stem cells)	NULL
EXP037299	Nkx2.2 (Sigma-Hpa003468)	Mus musculus		NULL	16	chip_control	NULL	MIN6-B1 (insulinoma)	NULL
EXP037300	Nkx2.2 (Sigma-Hpa003468)	Mus musculus		EXP037299	16	normal	P42586	MIN6-B1 (insulinoma)	NULL
EXP037301	MLL	Homo sapiens		NULL	641	normal	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037302	RUNX1	Homo sapiens		NULL	641	normal	Q01196	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037303	MLL	Homo sapiens		NULL	2334	normal	Q03164	THP-1 (acute monocytic leukemia)	NULL
EXP037304	RUNX1	Homo sapiens		NULL	2334	normal	Q01196	THP-1 (acute monocytic leukemia)	NULL
EXP037305	none	Mus musculus		NULL	103	chip_control	NULL	bone marrow	NULL
EXP037306	3ug Santa Cruz sc-352x/IP	Mus musculus		EXP037305	960	normal	P17433	Ly6Chi monocytes	NULL
EXP037307	3ug Santa Cruz sc-352x/IP	Mus musculus		EXP037305	961	normal	P17433	Ly6Clo monocytes	NULL
EXP037308	3ug Santa Cruz sc-150x/IP	Mus musculus		EXP037305	961	normal	P28033	Ly6Clo monocytes	NULL
EXP037309		Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037310		Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037311		Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037312		Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037313		Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037314		Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037315		Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	NULL	41	chip_control	NULL	B-cells	NULL
EXP037316	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037309	41	normal	P02340	B-cells	NULL
EXP037317	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037310	41	normal	P02340	B-cells	NULL
EXP037318	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037311	41	normal	P02340	B-cells	NULL
EXP037319	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 1/1000 vol. EtOH	EXP037312	41	normal	P02340	B-cells	NULL
EXP037320	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037309	41	normal	P02340	B-cells	NULL
EXP037321	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037310	41	normal	P02340	B-cells	NULL
EXP037322	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037311	41	normal	P02340	B-cells	NULL
EXP037323	p53	Mus musculus	lymph nodes from EÎ¼-myc Trp53KI/âˆ† lymphomas, 2hrs 100nM OHT	EXP037312	41	normal	P02340	B-cells	NULL
EXP037324	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	EXP037313	41	normal	P02340	B-cells	NULL
EXP037325	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	EXP037314	41	normal	P02340	B-cells	NULL
EXP037326	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas	EXP037315	41	normal	P02340	B-cells	NULL
EXP037327	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O	EXP037313	41	normal	P02340	B-cells	NULL
EXP037328	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O	EXP037314	41	normal	P02340	B-cells	NULL
EXP037329	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O	EXP037315	41	normal	P02340	B-cells	NULL
EXP037330	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO	EXP037313	41	normal	P02340	B-cells	NULL
EXP037331	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO	EXP037314	41	normal	P02340	B-cells	NULL
EXP037332	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO	EXP037315	41	normal	P02340	B-cells	NULL
EXP037333	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (+)-Nutlin	EXP037313	41	normal	P02340	B-cells	NULL
EXP037334	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (+)-Nutlin	EXP037314	41	normal	P02340	B-cells	NULL
EXP037335	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (+)-Nutlin	EXP037315	41	normal	P02340	B-cells	NULL
EXP037336	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1ÂµM doxorubicin	EXP037313	41	normal	P02340	B-cells	NULL
EXP037337	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1ÂµM doxorubicin	EXP037314	41	normal	P02340	B-cells	NULL
EXP037338	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1ÂµM doxorubicin	EXP037315	41	normal	P02340	B-cells	NULL
EXP037339	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (-)-Nutlin	EXP037313	41	normal	P02340	B-cells	NULL
EXP037340	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (-)-Nutlin	EXP037314	41	normal	P02340	B-cells	NULL
EXP037341	p53	Mus musculus	lymph nodes from EÎ¼-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5ÂµM (-)-Nutlin	EXP037315	41	normal	P02340	B-cells	NULL
EXP037342	Sigma HPA004820	Homo sapiens		NULL	70	normal	Q6ISB3	LNCaP (prostate carcinoma)	NULL
EXP037343	Santa Cruz sc-816 X	Homo sapiens		NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP037344	none	Mus musculus		NULL	962	chip_control	NULL	haploid mESCs derived from strain 129/Ola	NULL
EXP037345	none	Mus musculus		NULL	963	chip_control	NULL	embryonic stem cells from stran 129	NULL
EXP037346	antibody: millipore (07-729)	Mus musculus		EXP037344	962	normal	Q61164	haploid mESCs derived from strain 129/Ola	NULL
EXP037347	antidoby: calbiochem (SC1000)	Mus musculus		EXP037344	962	normal	Q80Z64	haploid mESCs derived from strain 129/Ola	NULL
EXP037348	antibody: calbiochem (SC1000)	Mus musculus		EXP037345	963	normal	Q80Z64	embryonic stem cells from stran 129	NULL
EXP037349	none	Mus musculus	+12hrDox(iFlag.Ngn2)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037350	none	Mus musculus	+12hrDox(iIsl1.Lhx3.V5)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037351	none	Mus musculus	+48hrDox(iIsl1.Lhx3.V5)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037352	none	Mus musculus	(iNgn2.Isl1.Lhx3.V5)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037353	none	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037354	none	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037355	none	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037356	none	Mus musculus	+12hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037357	none	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037358	none	Mus musculus	+24hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037359	none	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037360	none	Mus musculus	+36hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	chip_control	NULL	embryoid body	NULL
EXP037361	anti-Oct4 (Santa Cruz sc-5279)	Mus musculus	+12hrDox(iFlag.Ngn2)	EXP037349	237	normal	P20263	embryoid body	NULL
EXP037362	anti-Oct4 (Santa Cruz sc-5279)	Mus musculus	(iNgn2.Isl1.Lhx3.V5)	EXP037352	237	normal	P20263	embryoid body	NULL
EXP037363	anti-Oct4 (Santa Cruz sc-5279)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P20263	embryoid body	NULL
EXP037364	anti-V5 (Abcam ab15828)	Mus musculus	+36hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	EXP037360	237	normal	P50481	embryoid body	NULL
EXP037365	anti-V5 (Abcam ab15828)	Mus musculus	+48hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	NULL	237	normal	P50481	embryoid body	NULL
EXP037366	anti-Ngn2 (Santa Cruz sc-19233)	Mus musculus	+12hrDox(iFlag.Ngn2)	EXP037349	237	normal	P70447	embryoid body	NULL
EXP037367	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iIsl1.Lhx3.V5)	EXP037350	237	normal	P50481	embryoid body	NULL
EXP037368	anti-V5 (Abcam ab15828)	Mus musculus	+48hrDox(iIsl1.Lhx3.V5)	EXP037351	237	normal	P50481	embryoid body	NULL
EXP037369	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+8hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	normal	P61372	embryoid body	NULL
EXP037370	anti-V5 (Abcam ab15828)	Mus musculus	+8hrDox(iNgn2.Isl1.Lhx3.V5)	NULL	237	normal	P50481	embryoid body	NULL
EXP037371	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P61372	embryoid body	NULL
EXP037372	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P50481	embryoid body	NULL
EXP037373	anti-Ngn2 (Santa Cruz sc-19233)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037353	237	normal	P70447	embryoid body	NULL
EXP037374	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037354	237	normal	P61372	embryoid body	NULL
EXP037375	anti-V5 (Abcam ab15828)	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037354	237	normal	P50481	embryoid body	NULL
EXP037376	anti-Ebf2 (Abcam ab156999)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	O08792	embryoid body	NULL
EXP037377	anti-Isl1 combination (DSHB 40.3A4, 39.3F7, 40.206)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	P61372	embryoid body	NULL
EXP037378	anti-V5 (Abcam ab15828)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	P50481	embryoid body	NULL
EXP037379	anti-Onecut2 (R&D Systems AF294)	Mus musculus	+48hrDox(iNgn2.Isl1.Lhx3.V5)	EXP037355	237	normal	Q6XBJ3	embryoid body	NULL
EXP037380	anti-V5 (Abcam ab15828)	Mus musculus	+24hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	EXP037358	237	normal	P50481	embryoid body	NULL
EXP037381	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iNgn2.Isl1.Lhx3.V5.Ebf2.Onecut2)	EXP037357	237	normal	P50481	embryoid body	NULL
EXP037382	anti-V5 (Abcam ab15828)	Mus musculus	+24hrDox(iNgn2.Isl1.Lhx3.V5.Ebf2.Onecut2)	EXP037359	237	normal	P50481	embryoid body	NULL
EXP037383	anti-V5 (Abcam ab15828)	Mus musculus	+12hrDox(iIsl1.Lhx3.V5.Ebf2.Onecut2)	EXP037356	237	normal	P50481	embryoid body	NULL
EXP037384		Mus musculus		NULL	73	chip_control	NULL	G1E-derived erythroid cells	NULL
EXP037385		Mus musculus	D_Brd2KO	NULL	73	chip_control	NULL	G1E-derived erythroid cells	NULL
EXP037386		Mus musculus	C8_Brd2KO	NULL	73	chip_control	NULL	G1E-derived erythroid cells	NULL
EXP037387	CTCF (Millipore, 07-729, lot 2517762)	Mus musculus		EXP037384	73	normal	Q61164	G1E-derived erythroid cells	NULL
EXP037388	CTCF (Millipore, 07-729, lot 2517762)	Mus musculus	D_Brd2KO	EXP037385	73	normal	Q61164	G1E-derived erythroid cells	NULL
EXP037389	CTCF (Millipore, 07-729, lot 2517762)	Mus musculus	C8_Brd2KO	EXP037386	73	normal	Q61164	G1E-derived erythroid cells	NULL
EXP037390	N/A	Homo sapiens	none	NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP037391	N/A	Homo sapiens	none	NULL	964	chip_control	NULL	U266 (plasma cell myeloma)	NULL
EXP037392	anti DP1	Homo sapiens	none	EXP037390	618	normal	Q14186	MM1.S (plasma cell myeloma)	NULL
EXP037393	anti E2F1	Homo sapiens	none	EXP037390	618	normal	Q01094	MM1.S (plasma cell myeloma)	NULL
EXP037394	anti DP1	Homo sapiens	none	EXP037391	964	normal	Q14186	U266 (plasma cell myeloma)	NULL
EXP037395	anti E2F1	Homo sapiens	none	EXP037391	964	normal	Q01094	U266 (plasma cell myeloma)	NULL
EXP037396		Homo sapiens	WT1 minusKTS splice isoform	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP037397		Homo sapiens	WT1 plusKTS splice isoform	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP037398	WT1	Homo sapiens		EXP037396	514	normal	P19544	K562 (myelogenous leukemia)	NULL
EXP037399	WT1	Homo sapiens	WT1 plusKTS splice isoform	EXP037397	514	normal	P19544	K562 (myelogenous leukemia)	NULL
EXP037400	none	Mus musculus		NULL	965	chip_control	NULL	frontal cortex	NULL
EXP037401	SC-66882, Santa Cruz Biotechnology	Mus musculus		EXP037400	965	normal	O08580	frontal cortex	NULL
EXP037402	-	Mus musculus		NULL	314	chip_control	NULL	forelimb bud	NULL
EXP037403	-	Mus musculus		NULL	314	chip_control	NULL	forelimb bud	NULL
EXP037404	anti-HoxA13 (in-house, affinity purified)	Mus musculus		EXP037402	314	normal	Q62424	forelimb bud	NULL
EXP037405	anti-HoxD13 (in-house, affinity purified)	Mus musculus		EXP037403	314	normal	P70217	forelimb bud	NULL
EXP037406		Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037407		Mus musculus	GR KO	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037408		Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037409		Mus musculus		NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037410		Mus musculus	GR KO	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP037411	GR Antibody	Mus musculus		EXP037406	483	normal	P06537	brown preadipocytes	NULL
EXP037412	GR Antibody	Mus musculus	GR KO	EXP037407	483	normal	P06537	brown preadipocytes	NULL
EXP037413	GR Antibody	Mus musculus		EXP037408	483	normal	P06537	brown preadipocytes	NULL
EXP037414	GR Antibody	Mus musculus		EXP037409	483	normal	P06537	brown preadipocytes	NULL
EXP037415	C/EBP ? Antibody (C-19)	Mus musculus		EXP037408	483	normal	P53566	brown preadipocytes	NULL
EXP037416	C/EBP ? Antibody (C-19)	Mus musculus		EXP037409	483	normal	P53566	brown preadipocytes	NULL
EXP037417	C/EBP ? Antibody (C-19)	Mus musculus	GR KO	EXP037410	483	normal	P53566	brown preadipocytes	NULL
EXP037418	p-CREB Antibody	Mus musculus		EXP037408	483	normal	Q01147	brown preadipocytes	NULL
EXP037419	p-CREB Antibody	Mus musculus		EXP037409	483	normal	Q01147	brown preadipocytes	NULL
EXP037420	p-CREB Antibody	Mus musculus	GR KO	EXP037410	483	normal	Q01147	brown preadipocytes	NULL
EXP037421	anti-FOXR2 (Rabbit polyclonal antibody against human FOXR2 (residues 1311) was generated and affinity purified in house)	Homo sapiens		NULL	591	normal	Q6PJQ5	MDA-MB-468 (breast adenocarcinoma)	NULL
EXP037422	anti-MAX(S20) (Cell signaling, catalog# 4739)	Homo sapiens		NULL	591	normal	P61244	MDA-MB-468 (breast adenocarcinoma)	NULL
EXP037423	anti-MYC(D84C12) (Cell signaling, catalog# 5605S, lot# 6)	Homo sapiens		NULL	591	normal	P01106	MDA-MB-468 (breast adenocarcinoma)	NULL
EXP037424	none (Input DNA)	Homo sapiens		NULL	891	chip_control	NULL	dermal fibroblasts	NULL
EXP037425	ATF3 (Santa Cruz Cat.No. 188 C-19)	Homo sapiens		EXP037424	891	normal	P18847	dermal fibroblasts	NULL
EXP037426	ATF3 (SantaCruz Cat.No.188 C-19)	Homo sapiens	overexpressed ATF3	EXP037424	891	normal	P18847	dermal fibroblasts	NULL
EXP037427	none	Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP037428	Rabbit anti-A-MYB (Sigma-Aldrich, HPA008791)	Mus musculus		EXP037427	32	normal	P51960	testis	NULL
EXP037429		Mus musculus		NULL	966	chip_control	NULL	E13.5 fetal testis	NULL
EXP037430	rabbit anti SOX9 homemade (ref Gasca et al, PNAS 2002, vol 99, 11199-11204)	Mus musculus		EXP037429	966	normal	Q04887	E13.5 fetal testis	NULL
EXP037431	Input	Homo sapiens	No treatment	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037432	Input siCt	Homo sapiens	Nonspecific siRNA	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037433	anti-FOXA1 (ab5089) Abcam	Homo sapiens	No treatment	EXP037431	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037434	anti-FOXA1 (ab5089) Abcam	Homo sapiens	Nonspecific siRNA	EXP037432	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037435	anti-GRHL2 (HPA004820)  Sigma Aldrich	Homo sapiens	No treatment	EXP037431	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037436	IgG control	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037437	Stat1a p91 sc-345	Homo sapiens		EXP037436	113	normal	P42224	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037438	input	Homo sapiens	anti-CD3/CD28	NULL	886	chip_control	NULL	Th1-cells	NULL
EXP037439	input	Homo sapiens	anti-CD3/CD28	NULL	886	chip_control	NULL	Th1-cells	NULL
EXP037440	anti-T-bet SY4530FB	Homo sapiens	anti-CD3/CD28	EXP037438	886	normal	Q9UL17	Th1-cells	NULL
EXP037441	anti-T-bet SY4530FB	Homo sapiens	anti-CD3/CD28	EXP037439	886	normal	Q9UL17	Th1-cells	NULL
EXP037442	streptavidin beads	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037443	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	ICI	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037444	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	ICI, DEX	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037445	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	E2	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037446	Santa Cruz Biotechnologies ER? (HC-20) sc-543	Homo sapiens	E2, DEX	EXP037442	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037447	streptavidin beads	Homo sapiens	ICI	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037448	streptavidin beads	Homo sapiens	ICI, DEX	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037449	streptavidin beads	Homo sapiens	E2	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037450	streptavidin beads	Homo sapiens	E2, DEX	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037451	streptavidin beads	Homo sapiens	ICI, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037452	streptavidin beads	Homo sapiens	ICI, DEX, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037453	streptavidin beads	Homo sapiens	E2, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037454	streptavidin beads	Homo sapiens	E2, DEX, pBox mutant	EXP037442	113	normal	P04150	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037455	streptavidin beads	Homo sapiens	ICI	EXP037442	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037456	streptavidin beads	Homo sapiens	E2	EXP037442	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037457	streptavidin beads	Homo sapiens	E2, DEX	EXP037442	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037458	rabbit IgG (Sigma I5006)	Homo sapiens		NULL	1549	chip_control	NULL	COLO-829 (melanoma)	NULL
EXP037459	CTCF (Millipore 07-729)	Homo sapiens		EXP037458	1549	normal	P49711	COLO-829 (melanoma)	NULL
EXP037460	antibody RUNX1 (Abcam ab23980)	Homo sapiens		NULL	648	normal	Q01196	NB4 (acute promyelocytic leukemia )	NULL
EXP037461	None	Mus musculus		NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP037462	None	Mus musculus	Runx3 KO	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP037463	CBF?	Mus musculus		EXP037461	967	normal	P23708	naive CD8+ T-cells	NULL
EXP037464	CBF?	Mus musculus	CBF-B KO	EXP037461	967	bio_control	P23708	naive CD8+ T-cells	NULL
EXP037465	CBF?	Mus musculus		EXP037461	2479	normal	P23708	CD8+ T-cells	NULL
EXP037466	input	Mus musculus		NULL	968	chip_control	NULL	colon	NULL
EXP037467	input	Mus musculus		NULL	969	chip_control	NULL	distal small intestine	NULL
EXP037468	GFP	Mus musculus		EXP037466	968	normal	P48985	colon	NULL
EXP037469	GFP	Mus musculus		EXP037467	969	normal	P48985	distal small intestine	NULL
EXP037470	Bethy Laboratories, A300-086A	Mus musculus	activated	NULL	970	normal	P55200	spleen B-cells	NULL
EXP037471	Bethy Laboratories, A300-086A	Mus musculus	resting	NULL	970	normal	P55200	spleen B-cells	NULL
EXP037472	abcam, ab70303	Mus musculus	activated	NULL	970	normal	Q61164	spleen B-cells	NULL
EXP037473	abcam, ab70303	Mus musculus	resting	NULL	970	normal	Q61164	spleen B-cells	NULL
EXP037474		Mus musculus		NULL	971	normal	P01108	blastocyst B-cells	NULL
EXP037475	anti-STAT5A (Santa Cruz, sc-1081)	Mus musculus	Socs2 mut, lactation day1	NULL	572	normal	P42230	mammary gland	NULL
EXP037476	anti-STAT5A (Santa Cruz, sc-1081)	Mus musculus	Socs2 mut, pregnancy day13	NULL	572	normal	P42230	mammary gland	NULL
EXP037477	anti-GR (ThermoFisher, PA1-511A)	Mus musculus	Socs2 mut, pregnancy day13	NULL	572	normal	P06537	mammary gland	NULL
EXP037478		Mus musculus		NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP037479		Mus musculus	treated 6 hrs with RA	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP037480		Mus musculus	treated 12 hrs with RA	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP037481		Mus musculus	treated 18 hrs with RA	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP037482		Mus musculus	treated 24 hrs with RA	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP037483		Mus musculus	treated 48 hrs with RA	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP037484	anti-FoxA1, Abcam, ab5089	Mus musculus		EXP037478	292	normal	P35582	F9 (embryonal carcinoma)	NULL
EXP037485	anti-FoxA1, Abcam, ab5089	Mus musculus	treated 48 hrs with RA	EXP037483	292	normal	P35582	F9 (embryonal carcinoma)	NULL
EXP037486	anti-Meis1, Abcam, ab19867	Mus musculus		EXP037478	292	normal	Q60954	F9 (embryonal carcinoma)	NULL
EXP037487	anti-Meis1, Abcam, ab19867	Mus musculus	treated 6 hrs with RA	EXP037479	292	normal	Q60954	F9 (embryonal carcinoma)	NULL
EXP037488	anti-Meis1, Abcam, ab19867	Mus musculus	treated 12 hrs with RA	EXP037480	292	normal	Q60954	F9 (embryonal carcinoma)	NULL
EXP037489	anti-Meis1, Abcam, ab19867	Mus musculus	treated 18 hrs with RA	EXP037481	292	normal	Q60954	F9 (embryonal carcinoma)	NULL
EXP037490	anti-Meis1, Abcam, ab19867	Mus musculus	treated 24 hrs with RA	EXP037482	292	normal	Q60954	F9 (embryonal carcinoma)	NULL
EXP037491	anti-Meis1, Abcam, ab19867	Mus musculus	treated 48 hrs with RA	EXP037483	292	normal	Q60954	F9 (embryonal carcinoma)	NULL
EXP037492	anti-Pbx1, Abnova, H00005087-M01	Mus musculus	treated 48 hrs with RA	EXP037483	292	normal	P41778	F9 (embryonal carcinoma)	NULL
EXP037493	none	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP037494	none	Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP037495	No antibody	Mus musculus		NULL	972	chip_control	NULL	hindlimb muscles	NULL
EXP037496		Mus musculus		NULL	972	chip_control	NULL	hindlimb muscles	NULL
EXP037497		Mus musculus	Tead4 KO	NULL	972	chip_control	NULL	hindlimb muscles	NULL
EXP037498	TEAD4 Aviva	Mus musculus		EXP037493	1153	normal	Q62296	C2C12 (myoblasts)	NULL
EXP037499	TEAD4 Aviva	Mus musculus		EXP037494	126	normal	Q62296	C2C12 (myotubes)	NULL
EXP037500	TEAD1 BD Biosciences	Mus musculus		EXP037493	1153	normal	P30051	C2C12 (myoblasts)	NULL
EXP037501	TEAD1 BD Biosciences	Mus musculus		EXP037494	126	normal	P30051	C2C12 (myotubes)	NULL
EXP037502	TEAD4 Aviva	Mus musculus		EXP037495	972	normal	Q62296	hindlimb muscles	NULL
EXP037503	TEAD4	Mus musculus	Tead4 KO	EXP037497	972	bio_control	Q62296	hindlimb muscles	NULL
EXP037504	none	Mus musculus		NULL	973	chip_control	NULL	bone marrow derived immortalised LSK cells	NULL
EXP037505	anti-MLL1 (MO453, provide by James Hsieh lab)	Mus musculus		EXP037504	973	normal	P55200	bone marrow derived immortalised LSK cells	NULL
EXP037506		Homo sapiens		NULL	974	chip_control	NULL	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP037507		Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP037508		Homo sapiens		NULL	975	chip_control	NULL	KOPN8 (childhood B acute lymphoblastic leukemia)	NULL
EXP037509		Homo sapiens		NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037510		Homo sapiens		NULL	153	chip_control	NULL	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP037511		Homo sapiens		NULL	976	chip_control	NULL	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP037512		Homo sapiens		NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP037513		Homo sapiens	control siRNA	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP037514		Homo sapiens		NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP037515		Homo sapiens		NULL	978	chip_control	NULL	cord blood-derived mononuclear cells	NULL
EXP037516		Homo sapiens		NULL	979	chip_control	NULL	fetal bone marrow-derived mononuclear cells	NULL
EXP037517	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037506	974	normal	Q03164	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP037518	MLL1	Homo sapiens		EXP037507	2334	normal	Q03164	THP-1 (acute monocytic leukemia)	NULL
EXP037519	MLL1	Homo sapiens		EXP037508	975	normal	Q03164	KOPN8 (childhood B acute lymphoblastic leukemia)	NULL
EXP037520	MLL1	Homo sapiens		EXP037509	641	normal	Q03164	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037521	MLL1	Homo sapiens		EXP037510	153	normal	Q03164	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP037522	MLL1	Homo sapiens		EXP037511	976	normal	Q03164	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP037523	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037512	541	normal	Q03164	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP037524	MLL1 (Bethyl, A300-086A)	Homo sapiens	control siRNA	EXP037513	541	normal	Q03164	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP037525	MLL1 (Bethyl, A300-086A)	Homo sapiens	fused MLL1-AF4	EXP037514	541	normal	Q03164	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP037526	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037515	978	normal	Q03164	cord blood-derived mononuclear cells	NULL
EXP037527	MLL1 (Bethyl, A300-086A)	Homo sapiens		EXP037516	979	normal	Q03164	fetal bone marrow-derived mononuclear cells	NULL
EXP037528	.	Homo sapiens		NULL	980	chip_control	NULL	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP037529	MYCN, Santa Cruz (catsc-53993 lot mAb)	Homo sapiens		EXP037528	980	normal	P04198	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP037530	MYOD1 (Santa Cruz, sc-706)	Homo sapiens		EXP037528	980	normal	P15172	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP037531	Myogenin (Santa Cruz, cat. #sc-576)	Homo sapiens		EXP037528	980	normal	P15173	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP037532	CTCF, EMD Millipore (cat07-729 lot2628833 pAb)	Homo sapiens		EXP037528	980	normal	P49711	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP037533	None	Mus musculus		NULL	981	chip_control	NULL	primary splenic B-cells	NULL
EXP037534	Ets1 (Santa Cruz, Sc-350X)	Mus musculus		EXP037533	981	normal	P27577	primary splenic B-cells	NULL
EXP037535	NFI	Mus musculus	day0	NULL	116	normal	Q02780	brown adipocytes	NULL
EXP037536	NFI	Mus musculus	day6	NULL	116	normal	Q02780	brown adipocytes	NULL
EXP037537	FLAG M2	Mus musculus	day0	NULL	1153	normal	Q02780	C2C12 (myoblasts)	NULL
EXP037538	FLAG M2	Mus musculus	day7	NULL	1153	normal	Q02780	C2C12 (myoblasts)	NULL
EXP037539	CEBPalpha	Mus musculus	day0	NULL	116	normal	P53566	brown adipocytes	NULL
EXP037540	CEBPbeta	Mus musculus	day0	NULL	116	normal	P28033	brown adipocytes	NULL
EXP037541	CEBPalpha	Mus musculus	day6	NULL	116	normal	P53566	brown adipocytes	NULL
EXP037542	CEBPbeta	Mus musculus	day6	NULL	116	normal	P28033	brown adipocytes	NULL
EXP037543	NFI	Mus musculus	day7	NULL	982	normal	Q02780	3T3F442A (white adipocytes)	NULL
EXP037544	PPARg	Mus musculus	day7	NULL	982	normal	P37238	3T3F442A (white adipocytes)	NULL
EXP037545	EBF2	Mus musculus	day0	NULL	116	normal	O08792	brown adipocytes	NULL
EXP037546	EBF2	Mus musculus	day6	NULL	116	normal	O08792	brown adipocytes	NULL
EXP037547	PPARg	Mus musculus	day0	NULL	116	normal	P37238	brown adipocytes	NULL
EXP037548	PPARg	Mus musculus	day6	NULL	116	normal	P37238	brown adipocytes	NULL
EXP037549	Anti-NCoR [Custom rabbit antibody, GST fusion of NCoR C-term (a.a.1944-2453), Affinity purified]	Mus musculus	29C	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP037550	Anti-ERRalpha [ABCAM, Cat# 16363, Lot# GR263385-1]	Mus musculus	29C, HDAC3 floxed	EXP037549	115	normal	O08580	brown adipose tissue	NULL
EXP037551	Anti-ERRalpha [ABCAM, Cat# 16363, Lot# GR263385-1]	Mus musculus	29C, Adiponectin-Cre, HDAC3 floxed	EXP037549	115	normal	O08580	brown adipose tissue	NULL
EXP037552	anti-TFAP4 (Santa Cruz Biotechnology, sc-18593X)	Homo sapiens		NULL	983	normal	Q01664	SNU175 (adenocarcinoma)	NULL
EXP037553	anti-TFAP4 (Santa Cruz Biotechnology, sc-18593X)	Homo sapiens		NULL	185	normal	Q01664	COLO-320 (colon adenocarcinoma)	NULL
EXP037554	anti-ELF1 (Santa Cruz Biotechnology, sc-631X)	Homo sapiens		NULL	983	normal	P32519	SNU175 (adenocarcinoma)	NULL
EXP037555	anti-ELF1 (Santa Cruz Biotechnology, sc-631X)	Homo sapiens		NULL	185	normal	P32519	COLO-320 (colon adenocarcinoma)	NULL
EXP037556	none	Mus musculus		NULL	546	chip_control	NULL	limb bud	NULL
EXP037557	Lmx1b polyclonal (BM08), Suleiman et al., 2007	Mus musculus		EXP037556	546	normal	O88609	limb bud	NULL
EXP037558		Mus musculus		NULL	984	chip_control	NULL	T-cell lymphoma	NULL
EXP037559	DLX-5	Mus musculus		EXP037558	984	normal	P70396	T-cell lymphoma	NULL
EXP037560	none	Homo sapiens	Untreated	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP037561	none	Homo sapiens	3 h IL-2	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP037562	none	Homo sapiens	3 h IL-2 + 100 micromolar HODHBt	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP037563	STAT5A (sc-1081)	Homo sapiens	Untreated	EXP037560	985	normal	P42229	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP037564	STAT5A (sc-1081)	Homo sapiens	3 h IL-2	EXP037561	985	normal	P42229	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP037565	STAT5A (sc-1081)	Homo sapiens	3 h IL-2 + 100 micromolar HODHBt	EXP037562	985	normal	P42229	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP037566	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037567	FOXK2	Homo sapiens		EXP037566	113	normal	Q01167	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037568	IgG Rabbit	Mus musculus		NULL	986	chip_control	NULL	Hoxb8-FL	NULL
EXP037569	Cebpa (Santa Cruz, cat no. sc-61x, lot F2811)	Mus musculus		EXP037568	986	normal	P53566	Hoxb8-FL	NULL
EXP037570	Cebpb (Santa Cruz, cat no. sc-150x, lot F0711)	Mus musculus		EXP037568	986	normal	P28033	Hoxb8-FL	NULL
EXP037571	Erg (Santa Cruz, cat no. sc-354x, lot A2510)	Mus musculus		EXP037568	986	normal	P81270	Hoxb8-FL	NULL
EXP037572	Fli1 (Abcam, cat no. ab15289-500, lot 775077)	Mus musculus		EXP037568	986	normal	P26323	Hoxb8-FL	NULL
EXP037573	Gata2 (Santa Cruz, cat no. sc-9008x, lot I0109)	Mus musculus		EXP037568	986	normal	O09100	Hoxb8-FL	NULL
EXP037574	Gfi1 (Abcam, cat no. ab21061, lot 151880)	Mus musculus		EXP037568	986	normal	P70338	Hoxb8-FL	NULL
EXP037575	Gfi1b (Santa Cruz, cat no. sc8559x, lot E1409)	Mus musculus		EXP037568	986	normal	O70237	Hoxb8-FL	NULL
EXP037576	Lyl1 (Abcam, cat no. ab30334-200, lot 383134)	Mus musculus		EXP037568	986	normal	P27792	Hoxb8-FL	NULL
EXP037577	Meis1 (Santa Cruz, cat no. sc-10599x, lot D2310)	Mus musculus		EXP037568	986	normal	Q60954	Hoxb8-FL	NULL
EXP037578	Runx1 (Abcam, cat no. ab23980, lot GR37372-1)	Mus musculus		EXP037568	986	normal	Q03347	Hoxb8-FL	NULL
EXP037579	Spi1 (Santa Cruz, cat no. sc-352x, lot B0314)	Mus musculus		EXP037568	986	normal	P17433	Hoxb8-FL	NULL
EXP037580	Tal1 (Santa Cruz, cat no. sc-12984x, lot B2511)	Mus musculus		EXP037568	986	normal	P22091	Hoxb8-FL	NULL
EXP037581		Mus musculus		NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP037582	KDM5A antibody (ab70892; Abcam)	Mus musculus	day0	EXP037581	18	normal	Q3UXZ9	3T3-L1 (embryonic fibroblasts)	NULL
EXP037583	KDM5A antibody (ab70892; Abcam)	Mus musculus	4hour	EXP037581	18	normal	Q3UXZ9	3T3-L1 (embryonic fibroblasts)	NULL
EXP037584	KDM5A antibody (ab70892; Abcam)	Mus musculus	day2	EXP037581	18	normal	Q3UXZ9	3T3-L1 (embryonic fibroblasts)	NULL
EXP037585	JARID1C/Kdm5C Antibody (A301-034A; Bethyl lab)	Mus musculus	day2	EXP037581	18	normal	P41230	3T3-L1 (embryonic fibroblasts)	NULL
EXP037586		Mus musculus		NULL	987	chip_control	NULL	hippocampus	NULL
EXP037587	CTCF millipore antibody (07-729)	Mus musculus		EXP037586	987	normal	Q61164	hippocampus	NULL
EXP037588		Homo sapiens	BYL719	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP037589		Homo sapiens	DMSO	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP037590	ER alpha (sc543) Santa Cruz	Homo sapiens	DMSO	EXP037589	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP037591	FOXA1 (ab5089) Abcam	Homo sapiens	DMSO	EXP037589	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP037592	ER alpha (sc543) Santa Cruz	Homo sapiens	BYL719	EXP037588	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP037593	FOXA1 (ab5089) Abcam	Homo sapiens	BYL719	EXP037588	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP037594	NA	Homo sapiens		NULL	988	chip_control	NULL	RH18 (alveolar rhabdomyosarcoma)	NULL
EXP037595	Myf-5, Santa Cruz (C-20) cat# sc-302	Homo sapiens		EXP037594	988	normal	P13349	RH18 (alveolar rhabdomyosarcoma)	NULL
EXP037596	CTCF (Millipore, catalog#  07-729, lot# JBC1881349)	Homo sapiens	undifferentiated	NULL	463	normal	P49711	epidermal keratinocytes	NULL
EXP037597	CTCF (Millipore, catalog#  07-729, lot# JBC1881349)	Homo sapiens	day3 of differentiation	NULL	463	normal	P49711	epidermal keratinocytes	NULL
EXP037598	CTCF (Millipore, catalog#  07-729, lot# JBC1881349)	Homo sapiens	day6 of differentiation	NULL	463	normal	P49711	epidermal keratinocytes	NULL
EXP037599	EHF (Santa Cruz, catalog#  sc-166653, lot# C0910)	Homo sapiens	day3 of differentiation	NULL	463	normal	Q9NZC4	epidermal keratinocytes	NULL
EXP037600	BCL11B	Homo sapiens		NULL	989	normal	Q9C0K0	thymus-derived CD34+ cells	NULL
EXP037601	BCL11B	Homo sapiens		NULL	990	normal	Q9C0K0	thymus-derived CD34- cells	NULL
EXP037602	none	Mus musculus		NULL	286	chip_control	NULL	pancreatic beta-cells	NULL
EXP037603	Anti-Islet 1 antibody [EP4182] (Abcam, ab109517)	Mus musculus		EXP037602	286	normal	P61372	pancreatic beta-cells	NULL
EXP037604	Input	Mus musculus		NULL	161	chip_control	NULL	neurosphere cells	NULL
EXP037605	Gfi1 Abcam cat #: ab21061	Mus musculus	p53-/-; p18-/-	EXP037604	161	normal	P70338	neurosphere cells	NULL
EXP037606	Gfi1 Abcam cat #: ab21061	Mus musculus	p53-/-; p18-/-	EXP037604	161	normal	P70338	neurosphere cells	NULL
EXP037607	CTCF (Active motif: 613111)	Mus musculus		NULL	991	normal	Q61164	E10.5 forelimb	NULL
EXP037608	CTCF (Active motif: 613111)	Mus musculus		NULL	992	normal	Q61164	E11.5 forelimb	NULL
EXP037609	CTCF (Active motif: 613111)	Mus musculus		NULL	993	normal	Q61164	E13.5 forelimb	NULL
EXP037610	CTCF (Active motif: 613111)	Mus musculus		NULL	994	normal	Q61164	E10.5 hindlimb	NULL
EXP037611	CTCF (Active motif: 613111)	Mus musculus		NULL	995	normal	Q61164	E11.5 hindlimb	NULL
EXP037612	CTCF (Active motif: 613111)	Mus musculus		NULL	996	normal	Q61164	E13.5 hindlimb	NULL
EXP037613	CTCF (Active motif: 613111)	Mus musculus		NULL	997	normal	Q61164	E10.5 midbrain	NULL
EXP037614	none	Mus musculus		NULL	32	chip_control	NULL	testis	NULL
EXP037615	anti-ARID4B antibody (CAT#: A302-233A, LOT#: A302-233A-1,Bethyl Laboratories)	Mus musculus		EXP037614	32	normal	A2CG63	testis	NULL
EXP037616		Mus musculus		NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP037617		Mus musculus		NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP037618	PPARG (Cell Signaling Technologies SC-7196X)	Mus musculus		EXP037616	18	normal	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP037619	PPARG (Cell Signaling Technologies SC-7196X)	Mus musculus		EXP037617	18	normal	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP037620	NeuroD2 antibody (Abcam, ab168932, GR161014-2)	Mus musculus		NULL	998	normal	Q62414	cortex of postnatal dorsal telencephalon	NULL
EXP037621	NeuroD2 antibody (Abcam, ab104430, GR94291-1)	Mus musculus		NULL	998	normal	Q62414	cortex of postnatal dorsal telencephalon	NULL
EXP037622	NeuroD2 antibody (Abcam, ab109406, YK010204CS)	Mus musculus		NULL	998	normal	Q62414	cortex of postnatal dorsal telencephalon	NULL
EXP037623	none (input)	Mus musculus		NULL	998	chip_control	NULL	cortex of postnatal dorsal telencephalon	NULL
EXP037624	Biogenex, MU392A-UC (CDX2-88)	Mus musculus	24h CHIR99021 + Fgf8	NULL	260	normal	P43241	epiblast stem cells	NULL
EXP037625	brachyury	Mus musculus	24h CHIR99021 + Fgf8	NULL	260	normal	P20293	epiblast stem cells	NULL
EXP037626	none	Homo sapiens	control	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP037627	none	Homo sapiens	control	NULL	999	chip_control	NULL	BeWo (gestational choriocarcinoma)	NULL
EXP037628	ZSCAN5B (Santa Cruz)	Homo sapiens	treatment	EXP037626	421	normal	A6NJL1	HEK293 (embryonic kidney)	NULL
EXP037629	ZSCAN5A	Homo sapiens	treatment	EXP037627	999	normal	Q9BUG6	BeWo (gestational choriocarcinoma)	NULL
EXP037630	ZSCAN5D	Homo sapiens	treatment	EXP037627	999	normal	P0CG00	BeWo (gestational choriocarcinoma)	NULL
EXP037631	ZSCAN5B (Santa Cruz)	Homo sapiens	treatment	EXP037627	999	normal	A6NJL1	BeWo (gestational choriocarcinoma)	NULL
EXP037632		Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP037633	Oct1	Mus musculus		EXP037632	2	normal	P25425	mESCs (mouse embryonic stem cells)	NULL
EXP037634	Oct4	Mus musculus		EXP037632	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP037635		Mus musculus	Vehicle	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP037636		Mus musculus	CEBPB mutated; Vehicle	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP037637		Mus musculus	Doxycycline	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP037638		Mus musculus	CEBPB mutated; Doxycycline	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP037639		Mus musculus	Doxycycline + BYK204165	NULL	19	chip_control	NULL	3T3-L1-derived preadipocytes	NULL
EXP037640	CEBPB	Mus musculus	Vehicle	EXP037635	19	normal	P28033	3T3-L1-derived preadipocytes	NULL
EXP037641		Mus musculus	CEBPB mutated; Vehicle	EXP037636	19	normal	P28033	3T3-L1-derived preadipocytes	NULL
EXP037642		Mus musculus	Doxycycline	EXP037637	19	normal	P28033	3T3-L1-derived preadipocytes	NULL
EXP037643		Mus musculus	CEBPB mutated;Doxycycline	EXP037638	19	normal	P28033	3T3-L1-derived preadipocytes	NULL
EXP037644		Mus musculus	Doxycycline + BYK204165	EXP037639	19	normal	P28033	3T3-L1-derived preadipocytes	NULL
EXP037645	none (input)	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037646	CTCF: Millipore 07-729 (lot #2453497)	Homo sapiens	control; 100 nM 17-beta-estradiol for 0h	EXP037645	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037647	CTCF: Millipore 07-729 (lot #2453497)	Homo sapiens	100 nM 17-beta-estradiol for 45 min	EXP037645	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037648	CTCF: Millipore 07-729 (lot #2453497)	Homo sapiens	100 nM 17-beta-estradiol for 3h	EXP037645	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037649	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	control; 100 nM 17-beta-estradiol for 0h	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037650	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	100 nM 17-beta-estradiol for 45 min	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037651	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	100 nM 17-beta-estradiol for 3h	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037652	FOXA1 AbCam ab5089 (lot #GK122110-17) and ab23738 (lot #GK176970-1)	Homo sapiens	control; 100 nM 17-beta-estradiol for 0h	EXP037645	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037653	FOXA1 AbCam ab5089 (lot #GK122110-17) and ab23738 (lot #GK176970-1)	Homo sapiens	100 nM 17-beta-estradiol for 45 min	EXP037645	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037654	FOXA1 AbCam ab5089 (lot #GK122110-17) and ab23738 (lot #GK176970-1)	Homo sapiens	100 nM 17-beta-estradiol for 3h	EXP037645	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037655	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	siCTCF	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037656	ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	Homo sapiens	siNT	EXP037645	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037657		Mus musculus		NULL	499	chip_control	NULL	Th2-cells	NULL
EXP037658	no antibody	Mus musculus	Batf1/3 DKO	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP037659	anti-BATF	Mus musculus		EXP037657	499	normal	O35284	Th2-cells	NULL
EXP037660	anti-IRF4	Mus musculus		EXP037657	499	normal	Q64287	Th2-cells	NULL
EXP037661	anti-IRF4	Mus musculus	BATF1/3 DKO; overexpressing Batf-HKE	EXP037658	499	normal	Q64287	Th2-cells	NULL
EXP037662	anti-IRF4	Mus musculus	Batf1/3 DKO	EXP037658	499	normal	Q64287	Th2-cells	NULL
EXP037663	anti-IRF4	Mus musculus	day 4, 10 ng	EXP037657	499	normal	Q64287	Th2-cells	NULL
EXP037664	anti-IRF4	Mus musculus	day 4, 2.2 ng	EXP037657	499	normal	Q64287	Th2-cells	NULL
EXP037665	anti-IRF4	Mus musculus	day 2, 10 ng	EXP037657	499	normal	Q64287	Th2-cells	NULL
EXP037666	anti-IRF4	Mus musculus		EXP037657	499	normal	Q64287	Th2-cells	NULL
EXP037667	anti-IRF4	Mus musculus	B-ATF KO	NULL	499	normal	Q64287	Th2-cells	NULL
EXP037668	anti-BATF3	Mus musculus	B-ATF KO	NULL	499	normal	Q9D275	Th2-cells	NULL
EXP037669	input	Mus musculus	2i/LIF conditions	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037670	input	Mus musculus	standard serum/LIF conditions	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP037671	input	Mus musculus		NULL	1000	chip_control	NULL	P1 (neural progenitor cells)	NULL
EXP037672	anti-CTCF (Millipore #07-729)	Mus musculus	2i/LIF conditions	EXP037669	252	normal	Q61164	V6.5 (embryonic stem cells)	NULL
EXP037673	anti-CTCF (Millipore #07-729)	Mus musculus	standard serum/LIF conditions	EXP037670	252	normal	Q61164	V6.5 (embryonic stem cells)	NULL
EXP037674	anti-CTCF (Millipore #07-729)	Mus musculus		EXP037671	1000	normal	Q61164	P1 (neural progenitor cells)	NULL
EXP037675	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037676	anti-MLL1 (A300-086A, Bethyl)	Homo sapiens	vehicle	EXP037675	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037677	anti-MLL2/TRX2 (A300-113A, Bethyl)	Homo sapiens	vehicle	EXP037675	113	normal	Q9UMN6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037678	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP037679	anti-GR antibody (Santa Cruz, sc-8992; lot #H1314)	Homo sapiens		NULL	430	normal	P04150	HepG2 (hepatoblastoma)	NULL
EXP037680	none	Homo sapiens		NULL	114	chip_control	NULL	bronchial epithelial cells	NULL
EXP037681	none	Homo sapiens		NULL	148	chip_control	NULL	Calu-3 (lung adenocarcinoma)	NULL
EXP037682	EHF	Homo sapiens		EXP037680	114	normal	Q9NZC4	bronchial epithelial cells	NULL
EXP037683	c-Jun (sc-1694)	Homo sapiens		EXP037681	148	normal	P05412	Calu-3 (lung adenocarcinoma)	NULL
EXP037684	JunD (sc-74)	Homo sapiens		EXP037681	148	normal	P17535	Calu-3 (lung adenocarcinoma)	NULL
EXP037685	none (input)	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP037686		Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP037687	none (input)	Homo sapiens		NULL	730	chip_control	NULL	mononuclear cells from periferal blood	NULL
EXP037688	RUNX1 antibody (Abcam, cat.no ab23980)	Homo sapiens		EXP037685	509	normal	Q01196	Jurkat (T-cells)	NULL
EXP037689	RUNX1 antibody (Abcam, cat.no ab23980)	Homo sapiens		EXP037686	10	normal	Q01196	HEK293T (embryonic kidney)	NULL
EXP037690	RUNX1 antibody (Abcam, cat.no ab23980)	Homo sapiens		EXP037687	730	normal	Q01196	mononuclear cells from periferal blood	NULL
EXP037691	none (input)	Homo sapiens	N/A	NULL	1003	chip_control	NULL	A139 ER-, PR-, HER2- breast cancer cells	NULL
EXP037692	none (input)	Homo sapiens	N/A	NULL	1004	chip_control	NULL	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP037693	none (input)	Homo sapiens	ethanol	NULL	1001	chip_control	NULL	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP037694	none (input)	Homo sapiens	ethanol	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP037695	none (input)	Homo sapiens	ethanol	NULL	1002	chip_control	NULL	HCC1143 (ductal breast carcinoma)	NULL
EXP037696	none (input)	Homo sapiens	ethanol	NULL	412	chip_control	NULL	HCC70 (ductal breast carcinoma)	NULL
EXP037697	none (input)	Homo sapiens	ethanol	NULL	591	chip_control	NULL	MDA-MB-468 (breast adenocarcinoma)	NULL
EXP037698	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	N/A	EXP037691	1003	normal	P40763	A139 ER-, PR-, HER2- breast cancer cells	NULL
EXP037699	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	N/A	EXP037692	1004	normal	P40763	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP037700	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037693	1001	normal	P40763	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP037701	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037694	2301	normal	P40763	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP037702	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037695	1002	normal	P40763	HCC1143 (ductal breast carcinoma)	NULL
EXP037703	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037696	412	normal	P40763	HCC70 (ductal breast carcinoma)	NULL
EXP037704	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	Homo sapiens	ethanol	EXP037697	591	normal	P40763	MDA-MB-468 (breast adenocarcinoma)	NULL
EXP037705	Input	Homo sapiens		NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037706	Input	Homo sapiens		NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037707	Input	Homo sapiens		NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037708	Input	Homo sapiens		NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037709	Input	Homo sapiens	G296S mutant	NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037710	Input	Homo sapiens	G296S mutant	NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037711	Input	Homo sapiens	G296S mutant	NULL	1005	chip_control	NULL	iPSC-derived cardiomyocytes	NULL
EXP037712	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037705	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037713	TBX5 (sc17866)	Homo sapiens		EXP037705	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037714	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037706	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037715	TBX5 (sc17866)	Homo sapiens		EXP037706	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037716	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037707	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037717	TBX5 (sc17866)	Homo sapiens		EXP037707	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037718	GATA4 (sc1237, lot:E0912)	Homo sapiens		EXP037708	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037719	TBX5 (sc17866)	Homo sapiens		EXP037708	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037720	GATA4 (sc1237, lot:E0912)	Homo sapiens	G296S mutant	EXP037709	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037721	TBX5 (sc17866)	Homo sapiens	G296S mutant	EXP037709	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037722	GATA4 (sc1237, lot:E0912)	Homo sapiens	G296S mutant	EXP037710	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037723	TBX5 (sc17866)	Homo sapiens	G296S mutant	EXP037710	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037724	GATA4 (sc1237, lot:E0912)	Homo sapiens	G296S mutant	EXP037711	1005	normal	P43694	iPSC-derived cardiomyocytes	NULL
EXP037725	TBX5 (sc17866)	Homo sapiens	G296S mutant	EXP037711	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP037726	none (input)	Mus musculus	pioglitazone at a concentration of 200 parts per million in irradiated Purina rodent diet 5001	NULL	1006	chip_control	NULL	thyroid gland	NULL
EXP037727	anti-Myc tag antibody 9B11 (Cell Signaling Technology #2276, lot #24)	Mus musculus	pioglitazone at a concentration of 200 parts per million in irradiated Purina rodent diet 5001	EXP037726	1006	normal	P01108	thyroid gland	NULL
EXP037728		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP037729	SREBP1c Anti-HA, A2095, Sigma-Aldrich	Mus musculus		EXP037728	5	normal	Q9WTN3	liver	NULL
EXP037730		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP037731	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus		EXP037730	5	normal	O35426	liver	NULL
EXP037732	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	shXBP1 (7 days)	EXP037730	5	bio_control	O35426	liver	NULL
EXP037733	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	6h after partial hepatectomy	EXP037730	5	normal	O35426	liver	NULL
EXP037734	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	7d after XBP1 silencing and 6h after partial hepatectomy	EXP037730	5	bio_control	O35426	liver	NULL
EXP037735	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	48h after partial hepatectomy	EXP037730	5	normal	O35426	liver	NULL
EXP037736	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	7d after XBP1 silencing and 48h after partial hepatectomy	EXP037730	5	bio_control	O35426	liver	NULL
EXP037737	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	6h after sham operation	EXP037730	5	normal	O35426	liver	NULL
EXP037738	anti-XBP1 M-186 (sc-7160-X, Santa Cruz, Heidelberg, Germany)	Mus musculus	48h after sham operation	EXP037730	5	normal	O35426	liver	NULL
EXP037739	none	Homo sapiens		NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP037740	ETS1 (sc-350)	Homo sapiens		EXP037739	30	normal	P14921	RCC 7860 (Renal cell carcinoma)	NULL
EXP037741	p65 (sc-372, Santa Cruz)	Homo sapiens		EXP037739	30	normal	Q04206	RCC 7860 (Renal cell carcinoma)	NULL
EXP037742	c-Jun (sc-1694, Santa Cruz)	Homo sapiens		EXP037739	30	normal	P05412	RCC 7860 (Renal cell carcinoma)	NULL
EXP037743	none	Homo sapiens	Input	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP037744	none	Homo sapiens	Input	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037745	none	Homo sapiens	Input	NULL	1518	chip_control	NULL	SJSA-1(osteosarcoma)	NULL
EXP037746	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	DMSO	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP037747	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	Nutlin	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP037748	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	DMSO	EXP037744	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037749	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	Nutlin	EXP037744	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037750	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	DMSO	EXP037745	1518	normal	P04637	SJSA-1(osteosarcoma)	NULL
EXP037751	p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181)	Homo sapiens	Nutlin	EXP037745	1518	normal	P04637	SJSA-1(osteosarcoma)	NULL
EXP037752	STAT3 (Cell Signaling 12640)	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037753	STAT3 (Cell Signaling 12640)	Mus musculus		EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	NULL
EXP037754	STAT3 (Cell Signaling 12640)	Mus musculus	30min IL-10	EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	NULL
EXP037755	STAT3 (Cell Signaling 12640)	Mus musculus	195min LPS	EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	NULL
EXP037756	STAT3 (Cell Signaling 12640)	Mus musculus	195min LPS + 30min IL-10	EXP037752	81	normal	P42227	BMDM (bone marrow-derived macrophages)	NULL
EXP037757	ETS2	Homo sapiens	ETS1 KO	NULL	223	normal	P15036	DU145 (prostate carcinoma)	NULL
EXP037758	none (input)	Homo sapiens		NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP037759	Myc antibody (Cell Signaling Technology, 9402S)	Homo sapiens		EXP037758	1008	normal	P01106	HT1080 (fibrosarcoma)	NULL
EXP037760	none	Homo sapiens	Untreated with Dox	NULL	1009	chip_control	NULL	U87MG(glioblastoma)	NULL
EXP037761	none	Homo sapiens	Dox treated	NULL	1009	chip_control	NULL	U87MG(glioblastoma)	NULL
EXP037762	none	Homo sapiens	Untreated with Dox	NULL	1010	chip_control	NULL	BT168 (glioblastoma stem cells)	NULL
EXP037763	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Untreated with Dox	EXP037760	1009	normal	P01106	U87MG(glioblastoma)	NULL
EXP037764	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Dox treated	EXP037761	1009	normal	P01106	U87MG(glioblastoma)	NULL
EXP037765	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Untreated with Dox	EXP037762	1010	normal	P01106	BT168 (glioblastoma stem cells)	NULL
EXP037766	c-Myc N-262 rabbit polyclonal antibody (sc-764X, Santa Cruz Biotech)	Homo sapiens	Dox treated	EXP037762	1010	normal	P01106	BT168 (glioblastoma stem cells)	NULL
EXP037767	IgG	Mus musculus		NULL	1011	chip_control	NULL	Th17(beta)-cells	NULL
EXP037768	IgG	Mus musculus		NULL	1012	chip_control	NULL	Th17(23)-cells	NULL
EXP037769	JUNB	Mus musculus		EXP037767	1011	normal	P09450	Th17(beta)-cells	NULL
EXP037770	JUNB	Mus musculus		EXP037768	1012	normal	P09450	Th17(23)-cells	NULL
EXP037771	IRF4	Mus musculus		EXP037767	1011	normal	Q64287	Th17(beta)-cells	NULL
EXP037772	IRF4	Mus musculus		EXP037768	1012	normal	Q64287	Th17(23)-cells	NULL
EXP037773	BATF	Mus musculus		EXP037767	1011	normal	O35284	Th17(beta)-cells	NULL
EXP037774	BATF	Mus musculus		EXP037768	1012	normal	O35284	Th17(23)-cells	NULL
EXP037775	er	Homo sapiens	White Medium + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037776	er	Homo sapiens	White Medium	NULL	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP037777	er	Homo sapiens	White Medium + E2	NULL	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP037778	er	Homo sapiens	White Medium	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037779	er	Homo sapiens	White Medium + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037780	er	Homo sapiens	N/A	NULL	1013	normal	P03372	patient-derived pleaural effusion	NULL
EXP037781	Runx2	Homo sapiens	Full Medium + Doxycycline	NULL	113	normal	Q13950	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP037782	none (input)	Mus musculus		NULL	1015	chip_control	NULL	melan-Ink4a-Arf- melanocytes	NULL
EXP037783	HIF1A (#AF1935)	Mus musculus		EXP037782	1015	normal	Q61221	melan-Ink4a-Arf- melanocytes	NULL
EXP037784	none	Homo sapiens	na	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP037785	MYC N262 (sc-764, Santa Cruz)	Homo sapiens	na	NULL	417	normal	P01106	HCT-116 (colon carcinoma)	NULL
EXP037786	none (input)	Mus musculus		NULL	80	chip_control	NULL	B lymphoblastic leukemia	NULL
EXP037787	anti-STAT5 antibody (Santa Cruz, sc-835 (C-17))	Mus musculus		EXP037786	80	normal	P42230	B lymphoblastic leukemia	NULL
EXP037788	THAP1	Mus musculus		NULL	2	normal	Q8CHW1	mESCs (mouse embryonic stem cells)	NULL
EXP037789		Mus musculus		NULL	2	normal	Q8CHW1	mESCs (mouse embryonic stem cells)	NULL
EXP037790	none (input)	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP037791	none (input)	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP037792	NKX2-1 (TTF-1) antibody	Homo sapiens		EXP037790	38	normal	P43699	A549 (lung carcinoma)	NULL
EXP037793	SPDEF antibody	Homo sapiens		EXP037791	38	normal	O95238	A549 (lung carcinoma)	NULL
EXP037794	none	Homo sapiens		NULL	1017	chip_control	NULL	E14 retina	NULL
EXP037795	none	Homo sapiens		NULL	1018	chip_control	NULL	E16 retina	NULL
EXP037796	none	Homo sapiens		NULL	1019	chip_control	NULL	E18 retina	NULL
EXP037797	none	Homo sapiens		NULL	1020	chip_control	NULL	E23 retina	NULL
EXP037798	none	Homo sapiens		NULL	1016	chip_control	NULL	retinoblastoma xenograft	NULL
EXP037799	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037794	1017	normal	P49711	E14 retina	NULL
EXP037800	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037795	1018	normal	P49711	E16 retina	NULL
EXP037801	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037796	1019	normal	P49711	E18 retina	NULL
EXP037802	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037797	1020	normal	P49711	E23 retina	NULL
EXP037803	CTCF (ActiveMotif,61311)	Homo sapiens		EXP037798	1016	normal	P49711	retinoblastoma xenograft	NULL
EXP037804	none	Mus musculus		NULL	1021	chip_control	NULL	PB115 (lung cancer)	NULL
EXP037805	none	Mus musculus		NULL	1022	chip_control	NULL	PB119 (lung cancer)	NULL
EXP037806	none	Mus musculus		NULL	1023	chip_control	NULL	PB120 (lung cancer)	NULL
EXP037807	c-MYC (D3N8F, Cell Signaling Technology)	Mus musculus		EXP037804	1021	normal	P01108	PB115 (lung cancer)	NULL
EXP037808	c-MYC (D3N8F, Cell Signaling Technology)	Mus musculus		EXP037805	1022	normal	P01108	PB119 (lung cancer)	NULL
EXP037809	c-MYC (D3N8F, Cell Signaling Technology)	Mus musculus		EXP037806	1023	normal	P01108	PB120 (lung cancer)	NULL
EXP037810		Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037811		Mus musculus	IFNg 2h	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP037812		Mus musculus	IFNg IL4 2h	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP037813		Mus musculus	IL4 2h	EXP037810	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP037814		Mus musculus	IFNg IL4 2h	EXP037810	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP037815	Anti-STAT1 (Santa Cruz sc-592)	Mus musculus		EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP037816	Anti-STAT1 (Santa Cruz sc-592)	Mus musculus	IFNg (100 ng/ml) for 2hrs	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP037817	Anti-STAT1 (Santa Cruz sc-592)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P42225	BMDM (bone marrow-derived macrophages)	NULL
EXP037818	Anti-IRF1 (Santa Cruz sc-640)	Mus musculus		EXP037810	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP037819	Anti-IRF1 (Santa Cruz sc-640)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP037820	Anti-IRF1 (Santa Cruz sc-640)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP037821	Anti-JunB (Santa Cruz sc-46x)	Mus musculus		EXP037810	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP037822	Anti-JunB (Santa Cruz sc-46x)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP037823	Anti-JunB (Santa Cruz sc-46x)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP037824	Anti-CEBPb (Santa Cruz sc-150X)	Mus musculus		EXP037810	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP037825	Anti-CEBPb (Santa Cruz sc-150X)	Mus musculus	IFNg (100 ng/ml) for 4hrs	EXP037810	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP037826	Anti-CEBPb (Santa Cruz sc-150X)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP037827	Anti-Myc (Santa-Cruz sc-764)	Mus musculus		EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	NULL
EXP037828	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IL4 (10ng/ml) for 2hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	NULL
EXP037829	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	NULL
EXP037830	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 2hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	NULL
EXP037831	Anti-Myc (Santa-Cruz sc-764)	Mus musculus	IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs	EXP037810	81	normal	P01108	BMDM (bone marrow-derived macrophages)	NULL
EXP037832		Homo sapiens		NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037833		Homo sapiens		NULL	1024	normal	Q01196	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037834		Homo sapiens		NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037835		Homo sapiens	RUNX1-EVI1 KD after 10 days	NULL	1024	bio_control	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037836		Homo sapiens		NULL	1024	normal	Q01196	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037837		Homo sapiens	RUNX1-EVI1 KD after 10 days	NULL	1024	bio_control	Q01196	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037838		Homo sapiens		NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037839		Homo sapiens	RUNX1-EVI1 KD after 10 days	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037840	AF2046	Homo sapiens		NULL	1024	normal	P23769	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037841	AF2046	Homo sapiens	RUNX1-EVI1 KD	NULL	1024	normal	P23769	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP037842	none	Mus musculus		NULL	1026	chip_control	NULL	E17.5 retina	NULL
EXP037843	none	Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP037844	none	Mus musculus		NULL	1033	chip_control	NULL	fibroblast-derived iPSCs fG140.03	NULL
EXP037845	none	Mus musculus		NULL	1034	chip_control	NULL	fibroblast-derived iPSCs fG140.04	NULL
EXP037846	none	Mus musculus		NULL	1036	chip_control	NULL	fibroblast-derived iPSCs fMG02	NULL
EXP037847	none	Mus musculus		NULL	1037	chip_control	NULL	fibroblast-derived iPSCs fMG03	NULL
EXP037848	none	Mus musculus		NULL	1038	chip_control	NULL	Eb5 embryonic stem cells	NULL
EXP037849	none	Mus musculus		NULL	1039	chip_control	NULL	immature retinal-derived iPSCs 8601	NULL
EXP037850	none	Mus musculus		NULL	1040	chip_control	NULL	mature retinal-derived iPSCs 3302	NULL
EXP037851	none	Mus musculus		NULL	1041	chip_control	NULL	mature retinal-derived iPSCs 7602	NULL
EXP037852	none	Mus musculus		NULL	1025	chip_control	NULL	E14.5 retina	NULL
EXP037853	none	Mus musculus		NULL	1027	chip_control	NULL	P0 retina	NULL
EXP037854	none	Mus musculus		NULL	1028	chip_control	NULL	P3 retina	NULL
EXP037855	none	Mus musculus		NULL	1029	chip_control	NULL	P7 retina	NULL
EXP037856	none	Mus musculus		NULL	1030	chip_control	NULL	P10 retina	NULL
EXP037857	none	Mus musculus		NULL	1031	chip_control	NULL	P14 retina	NULL
EXP037858	none	Mus musculus		NULL	1032	chip_control	NULL	P21 retina	NULL
EXP037859	none	Mus musculus		NULL	141	chip_control	NULL	retina	NULL
EXP037860	CTCF(ActiveMotif,61311)	Mus musculus	p107 minus minus MDMXTg	EXP037843	141	normal	Q61164	retina	NULL
EXP037861	CTCF(ActiveMotif,61311)	Mus musculus		EXP037844	1033	normal	Q61164	fibroblast-derived iPSCs fG140.03	NULL
EXP037862	CTCF(ActiveMotif,61311)	Mus musculus		EXP037845	1034	normal	Q61164	fibroblast-derived iPSCs fG140.04	NULL
EXP037863	CTCF(ActiveMotif,61311)	Mus musculus		EXP037846	1036	normal	Q61164	fibroblast-derived iPSCs fMG02	NULL
EXP037864	CTCF(ActiveMotif,61311)	Mus musculus		EXP037847	1037	normal	Q61164	fibroblast-derived iPSCs fMG03	NULL
EXP037865	CTCF(ActiveMotif,61311)	Mus musculus		EXP037848	1038	normal	Q61164	Eb5 embryonic stem cells	NULL
EXP037866	CTCF(ActiveMotif,61311)	Mus musculus		EXP037849	1039	normal	Q61164	immature retinal-derived iPSCs 8601	NULL
EXP037867	CTCF(ActiveMotif,61311)	Mus musculus		EXP037850	1040	normal	Q61164	mature retinal-derived iPSCs 3302	NULL
EXP037868	CTCF(ActiveMotif,61311)	Mus musculus		NULL	1041	normal	Q61164	mature retinal-derived iPSCs 7602	NULL
EXP037869	CTCF(ActiveMotif,61311)	Mus musculus		EXP037852	1025	normal	Q61164	E14.5 retina	NULL
EXP037870	CTCF(ActiveMotif,61311)	Mus musculus		EXP037842	1026	normal	Q61164	E17.5 retina	NULL
EXP037871	CTCF(ActiveMotif,61311)	Mus musculus		EXP037853	1027	normal	Q61164	P0 retina	NULL
EXP037872	CTCF(ActiveMotif,61311)	Mus musculus		EXP037854	1028	normal	Q61164	P3 retina	NULL
EXP037873	CTCF(ActiveMotif,61311)	Mus musculus		EXP037855	1029	normal	Q61164	P7 retina	NULL
EXP037874	CTCF(ActiveMotif,61311)	Mus musculus		EXP037856	1030	normal	Q61164	P10 retina	NULL
EXP037875	CTCF(ActiveMotif,61311)	Mus musculus		EXP037857	1031	normal	Q61164	P14 retina	NULL
EXP037876	CTCF(ActiveMotif,61311)	Mus musculus		EXP037858	1032	normal	Q61164	P21 retina	NULL
EXP037877	CTCF(ActiveMotif,61311)	Mus musculus		EXP037859	141	normal	Q61164	retina	NULL
EXP037878		Homo sapiens	DMSO	NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP037879	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	DMSO	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	NULL
EXP037880	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	100nM trametinib	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	NULL
EXP037881	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	300nM JQ1	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	NULL
EXP037882	CEBP? Santa Cruz Biotechnology sc-150X	Homo sapiens	100nM trametinib, 300nM JQ1	EXP037878	817	normal	P17676	SUM159PT (Triple negative breast cancer)	NULL
EXP037883	none	Mus musculus		NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP037884	none	Mus musculus		NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP037885	Bach1 (A1-6)	Mus musculus		EXP037884	198	normal	P97302	pre-pro-B-cells	NULL
EXP037886	MafK	Mus musculus		EXP037884	198	normal	Q61827	pre-pro-B-cells	NULL
EXP037887	Bach2 (Bach2N2)	Mus musculus		EXP037883	198	normal	P97303	pre-pro-B-cells	NULL
EXP037888	none	Mus musculus	none	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP037889	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus	induced	EXP037888	105	normal	P17433	pro-B cells	NULL
EXP037890	Rabbit polyclonal anti-mouse PU.1 (T-21) (Santa Cruz Biotechnology)	Mus musculus	induced	EXP037888	105	normal	P17433	pro-B cells	NULL
EXP037891	none	Mus musculus		NULL	52	chip_control	NULL	intestinal stem cells	NULL
EXP037892	rabbit polyclonal anti-mouse Sox9 antibody (Abcam, UK)	Mus musculus	db/+	EXP037891	52	normal	Q04887	intestinal stem cells	NULL
EXP037893	rabbit polyclonal anti-mouse Sox9 antibody (Abcam, UK)	Mus musculus	db/db	EXP037891	52	normal	Q04887	intestinal stem cells	NULL
EXP037894	none	Homo sapiens		NULL	1042	chip_control	NULL	EndoC-betaH2 (immortalized pancreatic beta cells)	NULL
EXP037895	none	Mus musculus		NULL	1043	chip_control	NULL	MIN6 (insulinoma)	NULL
EXP037896	Rabbit anti-Pax6 (Biolegend,  901301)	Homo sapiens		EXP037894	1042	normal	P26367	EndoC-betaH2 (immortalized pancreatic beta cells)	NULL
EXP037897	Rabbit anti-Pax6 (Biolegend,  901301)	Mus musculus		EXP037895	1043	normal	P63015	MIN6 (insulinoma)	NULL
EXP037898		Homo sapiens	knockout ASCL1	NULL	1044	chip_control	NULL	G523NS (glioblastoma)	NULL
EXP037899		Homo sapiens		NULL	1044	chip_control	NULL	G523NS (glioblastoma)	NULL
EXP037900		Homo sapiens	knockout ASCL1	EXP037898	1044	bio_control	P50553	G523NS (glioblastoma)	NULL
EXP037901		Homo sapiens		EXP037899	1044	normal	P50553	G523NS (glioblastoma)	NULL
EXP037902		Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP037903		Mus musculus	EBF1-H240	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP037904		Mus musculus		EXP037902	105	normal	Q07802	pro-B cells	NULL
EXP037905		Mus musculus	EBF1-H240	EXP037903	105	normal	Q07802	pro-B cells	NULL
EXP037906	NRSF (Santa Cruz, sc25398x)	Rattus norvegicus		NULL	1045	chip_control	NULL	paraventricular nucleus	NULL
EXP037907	NRSF (Santa Cruz, sc25398x)	Rattus norvegicus	CNQX/MK-801 (50 uM) for 52 h	NULL	1045	chip_control	NULL	paraventricular nucleus	NULL
EXP037908	NRSF (Santa Cruz, sc25398x)	Rattus norvegicus		EXP037906	1045	normal	O54963	paraventricular nucleus	NULL
EXP037909	NRSF (Santa Cruz, sc25398x)	Rattus norvegicus	CNQX/MK-801 (50 uM) for 52 h	EXP037907	1045	normal	O54963	paraventricular nucleus	NULL
EXP037910	N/A	Rattus norvegicus		NULL	1046	chip_control	NULL	liver	NULL
EXP037911	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	P17325	liver	NULL
EXP037912	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	P17325	liver	NULL
EXP037913	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	P17325	liver	NULL
EXP037914	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	P17325	liver	NULL
EXP037915	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	P17325	liver	NULL
EXP037916	cJun (Santa Cruz Biotechnology #sc-1694)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	P17325	liver	NULL
EXP037917	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	Q01714	liver	NULL
EXP037918	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	Q01714	liver	NULL
EXP037919	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	Q01714	liver	NULL
EXP037920	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	Q01714	liver	NULL
EXP037921	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	Q01714	liver	NULL
EXP037922	Sp1 (EMD Millipore # 07-645)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	Q01714	liver	NULL
EXP037923	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	P22449	liver	NULL
EXP037924	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	P22449	liver	NULL
EXP037925	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	P22449	liver	NULL
EXP037926	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	P22449	liver	NULL
EXP037927	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	P22449	liver	NULL
EXP037928	HNF (Santa Cruz Biotechnology sc-8986)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	P22449	liver	NULL
EXP037929	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	sham surgery, 14 days after surgery	EXP037910	1046	normal	Q62735	liver	NULL
EXP037930	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	ligated bile duct, 14 days after surgery	EXP037910	1046	normal	Q62735	liver	NULL
EXP037931	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	sham surgery, 5 days after surgery	EXP037910	1046	normal	Q62735	liver	NULL
EXP037932	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	ligated bile duct, 5 days after surgery	EXP037910	1046	normal	Q62735	liver	NULL
EXP037933	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	sham surgery, 1 day after surgery	EXP037910	1046	normal	Q62735	liver	NULL
EXP037934	FXR (Santa Cruz Biotechnology sc-13063)	Rattus norvegicus	ligated bile duct, 1 day after surgery	EXP037910	1046	normal	Q62735	liver	NULL
EXP037935	Goat IgG (Jackson Immuno 005-000-003)	Mus musculus		NULL	523	chip_control	NULL	kidney	NULL
EXP037936	Tfcp2l1 (RnD, AF5726)	Mus musculus		EXP037935	523	normal	Q3UNW5	kidney	NULL
EXP037937	none	Mus musculus	untreated control	NULL	873	chip_control	NULL	ZHBTc4 (embryonic stem cells)	NULL
EXP037938	none	Mus musculus	untreated control, sonicated control	NULL	1047	chip_control	NULL	Brg1fl/fl (embryonic stem cells)	NULL
EXP037939	Cell Signalling (#5677)	Mus musculus	untreated control	EXP037937	873	normal	P20263	ZHBTc4 (embryonic stem cells)	NULL
EXP037940	Cell Signalling (#5677)	Mus musculus	doxycycline-treated	EXP037937	873	bio_control	P20263	ZHBTc4 (embryonic stem cells)	NULL
EXP037941	Cell Signalling (#23064)	Mus musculus	untreated control	EXP037937	873	normal	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP037942	Cell Signalling (#23064)	Mus musculus	doxycycline-treated	EXP037937	873	normal	P48432	ZHBTc4 (embryonic stem cells)	NULL
EXP037943	Cell Signalling (#8822)	Mus musculus	untreated control	EXP037937	873	normal	Q80Z64	ZHBTc4 (embryonic stem cells)	NULL
EXP037944	Cell Signalling (#8822)	Mus musculus	doxycycline-treated	EXP037937	873	normal	Q80Z64	ZHBTc4 (embryonic stem cells)	NULL
EXP037945	Cell Signalling (#5677)	Mus musculus	untreated control	EXP037938	1047	normal	P20263	Brg1fl/fl (embryonic stem cells)	NULL
EXP037946	Cell Signalling (#5677)	Mus musculus	tamoxifen-treated	EXP037938	1047	normal	P20263	Brg1fl/fl (embryonic stem cells)	NULL
EXP037947	Cell Signalling (#23064)	Mus musculus	untreated control	EXP037938	1047	normal	P48432	Brg1fl/fl (embryonic stem cells)	NULL
EXP037948	Cell Signalling (#23064)	Mus musculus	tamoxifen-treated	EXP037938	1047	normal	P48432	Brg1fl/fl (embryonic stem cells)	NULL
EXP037949	Cell Signalling (#8822)	Mus musculus		EXP037938	1047	normal	Q80Z64	Brg1fl/fl (embryonic stem cells)	NULL
EXP037950	Cell Signalling (#8822)	Mus musculus	tamoxifen-treated	EXP037938	1047	normal	Q80Z64	Brg1fl/fl (embryonic stem cells)	NULL
EXP037951	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP037952	CTCF (ActiveMotif: #61311, lot# 16712001)	Homo sapiens		EXP037951	848	normal	P49711	U2OS (osteosarcoma)	NULL
EXP037953		Mus musculus	No treatment	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP037954	Fli1 antibody from Santa Cruz (sc-356X)	Mus musculus	No treatment	EXP037953	81	normal	P26323	BMDM (bone marrow-derived macrophages)	NULL
EXP037955	Elf1 antibody from Santa Cruz (sc-631X)	Mus musculus	No treatment	EXP037953	81	normal	Q60775	BMDM (bone marrow-derived macrophages)	NULL
EXP037956	Elf4 home made antibody	Mus musculus	No treatment	EXP037953	81	normal	Q9Z2U4	BMDM (bone marrow-derived macrophages)	NULL
EXP037957	Elf4 home made antibody	Mus musculus	alpha amanitin 10Î¼g/ml for 5 hours (SIGMA)	EXP037953	81	normal	Q9Z2U4	BMDM (bone marrow-derived macrophages)	NULL
EXP037958	Elf4 home made antibody	Mus musculus	4h LPS treatment (10ng/ml)	EXP037953	81	normal	Q9Z2U4	BMDM (bone marrow-derived macrophages)	NULL
EXP037959	GABP-? antibody from Santa Cruz (sc-22810)	Mus musculus	No treatment	EXP037953	81	normal	Q00422	BMDM (bone marrow-derived macrophages)	NULL
EXP037960	GABP-? antibody from Santa Cruz (sc-22810)	Mus musculus	No treatment	EXP037953	81	normal	Q00422	BMDM (bone marrow-derived macrophages)	NULL
EXP037961	GABP-? antibody from Santa Cruz (sc-22810)	Mus musculus	alpha amanitin 10Î¼g/ml for 5 hours (SIGMA)	EXP037953	81	normal	Q00422	BMDM (bone marrow-derived macrophages)	NULL
EXP037962	PU.1 home made antibody	Mus musculus	No treatment	EXP037953	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP037963	PU.1 home made antibody	Mus musculus	alpha amanitin 10Î¼g/ml for 5 hours (SIGMA)	EXP037953	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP037964		Homo sapiens		NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037965	anti-C/EBP? (EP709Y, Abcam)	Homo sapiens		EXP037964	641	normal	P49715	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037966	anti-C/EBP? (E299, Abcam)	Homo sapiens		EXP037964	641	normal	P17676	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP037967		Mus musculus	high IL-2	NULL	1048	chip_control	NULL	CD4+ Th1	NULL
EXP037968		Mus musculus	low IL-2	NULL	1048	chip_control	NULL	CD4+ Th1	NULL
EXP037969		Mus musculus	low IL-2 + aKG	NULL	1048	chip_control	NULL	CD4+ Th1	NULL
EXP037970	CTCF	Mus musculus	high IL-2	EXP037967	1048	normal	Q61164	CD4+ Th1	NULL
EXP037971	CTCF	Mus musculus	low IL-2	EXP037968	1048	normal	Q61164	CD4+ Th1	NULL
EXP037972	CTCF	Mus musculus	low IL-2 + aKG	EXP037969	1048	normal	Q61164	CD4+ Th1	NULL
EXP037973	none	Homo sapiens		NULL	1049	chip_control	NULL	JHU-029 (laryngeal squamous cell carcinoma)	NULL
EXP037974	p63 (H129, Santacruz)	Homo sapiens		EXP037973	1049	normal	Q9H3D4	JHU-029 (laryngeal squamous cell carcinoma)	NULL
EXP037975	none (input)	Mus musculus		NULL	213	chip_control	NULL	mesenchymal stem cells	NULL
EXP037976	anti-cFos antibody (Santa Cruz, Cat:sc-253)	Mus musculus		EXP037975	213	normal	P01101	mesenchymal stem cells	NULL
EXP037977	none	Mus musculus	mixture of EF, EF_Z, ZF and ZF_E	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP037978	none	Mus musculus	mixture of EF, EF_Z, ZF and ZF_E	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP037979	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Esrrb-FLAG	EXP037977	12	normal	Q61539	MEF (mouse embryonic fibroblasts)	NULL
EXP037980	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Zic3-FLAG	EXP037977	12	normal	Q62521	MEF (mouse embryonic fibroblasts)	NULL
EXP037981	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Esrrb-FLAG	EXP037978	12	normal	Q61539	MEF (mouse embryonic fibroblasts)	NULL
EXP037982	anti-FLAG M2 (Sigma F7425)	Mus musculus	retroviral OSK and Zic3-FLAG	EXP037978	12	normal	Q62521	MEF (mouse embryonic fibroblasts)	NULL
EXP037983	zeb1	Homo sapiens	1 ng/ml of TGF-beta3 for 1.5 h	NULL	1051	normal	P37275	MDA-231-D (breast adenocarcinoma)	NULL
EXP037984	zeb1	Homo sapiens	1 ng/ml of TGF-beta3 for 1.5 h	NULL	449	normal	P37275	HS578T (invasive ductal breast carcinoma)	NULL
EXP037985	none	Homo sapiens	none	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP037986	none	Homo sapiens	10ng/ml IL-1alpha for 1 h	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP037987	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	none	EXP037985	1474	normal	Q04206	HuH7 (hepatocellular carcinoma)	NULL
EXP037988	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	DMEM containing CoV-229E at MOI = 1	EXP037985	1474	normal	Q04206	HuH7 (hepatocellular carcinoma)	NULL
EXP037989	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	10ng/ml IL-1alpha for 1 h	EXP037986	1474	normal	Q04206	HuH7 (hepatocellular carcinoma)	NULL
EXP037990		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP037991	Cell Signaling Technology, anti-TCF11 (D5B10)	Mus musculus		EXP037990	12	normal	Q61985	MEF (mouse embryonic fibroblasts)	NULL
EXP037992	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	EtOH for 2h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP037993	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	100 nM 1,25(OH)2D3 for 2h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP037994	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	EtOH for 24h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP037995	VDR (Cell Signaling Technologies CST 12550)	Homo sapiens	100 nM 1,25(OH)2D3 for 24h	NULL	2334	normal	P11473	THP-1 (acute monocytic leukemia)	NULL
EXP037996	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP037997	none	Mus musculus	MLL knockout	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP037998	none	Homo sapiens	DMSO	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP037999	none	Homo sapiens	IRAK1/4 inhibitor	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP038000	MLL NT86	Mus musculus		EXP037996	12	normal	P55200	MEF (mouse embryonic fibroblasts)	NULL
EXP038001	MLL D2M7U	Mus musculus		EXP037996	12	normal	P55200	MEF (mouse embryonic fibroblasts)	NULL
EXP038002	MLL D2M7U	Mus musculus	MLL knockout	EXP037997	12	bio_control	P55200	MEF (mouse embryonic fibroblasts)	NULL
EXP038003	MLL D2N1D	Mus musculus		EXP037996	12	normal	P55200	MEF (mouse embryonic fibroblasts)	NULL
EXP038004	MLL D2N1D	Mus musculus	MLL knockout	EXP037997	12	bio_control	P55200	MEF (mouse embryonic fibroblasts)	NULL
EXP038005	MLL NT86	Homo sapiens	DMSO	EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	NULL
EXP038006	MLL NT86	Homo sapiens	IRAK1/4 inhibitor	EXP037999	421	normal	Q03164	HEK293 (embryonic kidney)	NULL
EXP038007	MLL D2M7U	Homo sapiens	DMSO	EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	NULL
EXP038008	MLL D2M7U	Homo sapiens	IRAK1/4 inhibitor	EXP037999	421	normal	Q03164	HEK293 (embryonic kidney)	NULL
EXP038009	MLL D2M7U	Homo sapiens		EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	NULL
EXP038010	MLL D2N1D	Homo sapiens		EXP037998	421	normal	Q03164	HEK293 (embryonic kidney)	NULL
EXP038011		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP038012		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP038013		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP038014		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP038015		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP038016		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP038017	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038011	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP038018	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038012	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP038019	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038013	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP038020	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038014	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP038021	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038015	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP038022	Sox2 Y-17 (sc-17320, Santa Cruz)	Mus musculus		EXP038016	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP038023	etv4	Mus musculus		NULL	1052	normal	P28322	EpRas (mammary gland epithelial cells)	NULL
EXP038024	etv5	Mus musculus		NULL	1052	normal	Q9CXC9	EpRas (mammary gland epithelial cells)	NULL
EXP038025	none	Mus musculus		NULL	1053	chip_control	NULL	Treg cells from lymph nodes and spleen	NULL
EXP038026	none	Mus musculus	FoxP3 A384T mutant	NULL	1053	chip_control	NULL	Treg cells from lymph nodes and spleen	NULL
EXP038027	FoxP3 (affinity purified rabbit polyclonal antibody, generated in house)	Mus musculus		EXP038025	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	NULL
EXP038028	FoxP3 (affinity purified rabbit polyclonal antibody, generated in house)	Mus musculus	FoxP3 A384T mutant	EXP038026	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	NULL
EXP038029	IgG	Mus musculus		NULL	1054	chip_control	NULL	suprabasal keratinocytes	NULL
EXP038030	abcam ab178428	Mus musculus		EXP038029	1054	normal	Q64205	suprabasal keratinocytes	NULL
EXP038038	IRF1, Santa Cruz #sc-497x	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	P10914	HAEC (human aortic endothelial cells)	NULL
EXP038037	CEBPD, Santa Cruz #sc-636X	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	P49716	HAEC (human aortic endothelial cells)	NULL
EXP038036	none	Homo sapiens	TNFa, 4h, formaldehyde	NULL	1055	chip_control	NULL	HAEC (human aortic endothelial cells)	NULL
EXP038035	none	Homo sapiens	oxpapc, 4h, formaldehyde	NULL	1055	chip_control	NULL	HAEC (human aortic endothelial cells)	NULL
EXP038034	none	Homo sapiens	IL1b, 4h, formaldehyde	NULL	1055	chip_control	NULL	HAEC (human aortic endothelial cells)	NULL
EXP038033	none	Homo sapiens	control, 4h, formaldehyde	NULL	1055	chip_control	NULL	HAEC (human aortic endothelial cells)	NULL
EXP038032	pu.1	Mus musculus		EXP038031	605	normal	P17433	microglia	NULL
EXP038031		Mus musculus		NULL	605	chip_control	NULL	microglia	NULL
EXP038039	IRF1, Santa Cruz #sc-497x	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	P10914	HAEC (human aortic endothelial cells)	NULL
EXP038040	JUNB, Santa Cruz #sc-73	Homo sapiens	control, 4h	EXP038033	1055	normal	P17275	HAEC (human aortic endothelial cells)	NULL
EXP038041	Santa Cruz #sc354	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	P11308	HAEC (human aortic endothelial cells)	NULL
EXP038042	Santa Cruz #sc-13032X	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	P05412	HAEC (human aortic endothelial cells)	NULL
EXP038043	Santa Cruz #sc-13032X	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	P05412	HAEC (human aortic endothelial cells)	NULL
EXP038044	Santa Cruz #sc-13032X	Homo sapiens	oxpapc, 4h	EXP038035	1055	normal	P05412	HAEC (human aortic endothelial cells)	NULL
EXP038045	ERG, Santa Cruz #sc354	Homo sapiens	control, 4h	EXP038033	1055	normal	P11308	HAEC (human aortic endothelial cells)	NULL
EXP038046	JUN, Santa Cruz #sc-13032X	Homo sapiens	control, 4h	EXP038033	1055	normal	P05412	HAEC (human aortic endothelial cells)	NULL
EXP038047	NRF2, Santa Cruz #sc-1694X	Homo sapiens	oxpapc, 4h	EXP038035	1055	normal	Q16236	HAEC (human aortic endothelial cells)	NULL
EXP038048	p65, Santa Cruz #sc-372X	Homo sapiens	control, 4h	EXP038033	1055	normal	Q04206	HAEC (human aortic endothelial cells)	NULL
EXP038049	p65, Santa Cruz #sc-372X	Homo sapiens	IL1b, 4h	EXP038034	1055	normal	Q04206	HAEC (human aortic endothelial cells)	NULL
EXP038050	p65, Santa Cruz #sc-372X	Homo sapiens	TNFa, 4h	EXP038036	1055	normal	Q04206	HAEC (human aortic endothelial cells)	NULL
EXP038051	none	Mus musculus	0.75ug/ml dox in iPax7 media	NULL	1056	chip_control	NULL	myogenic progenitors	NULL
EXP038052	none	Mus musculus	minusdox 3d iPax7 media	NULL	1056	chip_control	NULL	myogenic progenitors	NULL
EXP038053	Pax7 (DSHB, 3 ug for ChIP)	Mus musculus	0.75ug/ml dox in iPax7 media	EXP038051	1056	normal	P47239	myogenic progenitors	NULL
EXP038054	Pax7 (DSHB, 3 ug for ChIP)	Mus musculus	minusdox 3d iPax7 media	EXP038052	1056	normal	P47239	myogenic progenitors	NULL
EXP038055	Irf8 (Bethyl A303-BL12058)	Mus musculus	mature	NULL	1057	normal	P23611	medullary thymic epithelial cells	NULL
EXP038056	Irf8 (Bethyl A303-BL12058)	Mus musculus	immature	NULL	1057	normal	P23611	medullary thymic epithelial cells	NULL
EXP038057	none	Homo sapiens	no LPS treatment	NULL	911	chip_control	NULL	macrophages	NULL
EXP038058	none	Homo sapiens	LPS treated, 100ng/mL, 4h	NULL	911	chip_control	NULL	macrophages	NULL
EXP038059	SP140	Homo sapiens	no LPS treatment	EXP038057	911	normal	Q13342	macrophages	NULL
EXP038060	SP140	Homo sapiens	LPS treated, 100ng/mL, 4h	EXP038058	911	normal	Q13342	macrophages	NULL
EXP038061	none	Mus musculus	GF	NULL	196	chip_control	NULL	jejunal crypt intestinal epithelial cells	NULL
EXP038062	none	Mus musculus	CV	NULL	196	chip_control	NULL	jejunal crypt intestinal epithelial cells	NULL
EXP038063	Hnf4a (Abcam ab41898)	Mus musculus	GF	EXP038061	196	normal	P49698	jejunal crypt intestinal epithelial cells	NULL
EXP038064	Hnf4a (Abcam ab41898)	Mus musculus	CV	EXP038062	196	normal	P49698	jejunal crypt intestinal epithelial cells	NULL
EXP038065	Hnf4g (Santa Cruz sc-6558X)	Mus musculus	GF	EXP038061	196	normal	Q9WUU6	jejunal crypt intestinal epithelial cells	NULL
EXP038066	Hnf4g (Santa Cruz sc-6558X)	Mus musculus	CV	EXP038062	196	normal	Q9WUU6	jejunal crypt intestinal epithelial cells	NULL
EXP038067	None	Mus musculus	Untreated	NULL	103	chip_control	NULL	bone marrow	NULL
EXP038068	None	Mus musculus	Vitamin C	NULL	103	chip_control	NULL	bone marrow	NULL
EXP038069	Anti-PU.1; SCBT; sc-22805	Mus musculus	Untreated	EXP038067	103	normal	P17433	bone marrow	NULL
EXP038070	Anti-PU.1; SCBT; sc-22805	Mus musculus	Vitamin C	EXP038068	103	normal	P17433	bone marrow	NULL
EXP038071	Anti-Runx1; Abcam; ab23980	Mus musculus	Untreated	EXP038067	103	normal	Q03347	bone marrow	NULL
EXP038072	Anti-Runx1; Abcam; ab23980	Mus musculus	Vitamin C	EXP038068	103	normal	Q03347	bone marrow	NULL
EXP038073	anti-AHR (Santa Cruz, H-211)	Homo sapiens	DMSO for 24h	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038074	anti-AHR (Santa Cruz, H-211)	Homo sapiens	2,3,7,8-tetrachlorodibenzo-Ï-dioxin (TCDD) for 24 h	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038075	anti-AHRR (Sigma, HPA019614)	Homo sapiens	DMSO for 24h	NULL	113	normal	A9YTQ3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038076	anti-AHRR (Sigma, HPA019614)	Homo sapiens	2,3,7,8-tetrachlorodibenzo-Ï-dioxin (TCDD) for 24 h	NULL	113	normal	A9YTQ3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038077	anti-AHR (Santa Cruz, H-211)	Homo sapiens	DMSO for 45 min	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038078	anti-AHR (Santa Cruz, H-211)	Homo sapiens	2,3,7,8-tetrachlorodibenzo-Ï-dioxin (TCDD) for 45 min	NULL	113	normal	P35869	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038079		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP038080		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP038081		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP038082	KLF10 Abcam, ab184182	Homo sapiens		EXP038079	38	normal	Q13118	A549 (lung carcinoma)	NULL
EXP038083	KLF10 Abcam, ab184182	Homo sapiens		EXP038080	38	normal	Q13118	A549 (lung carcinoma)	NULL
EXP038084	KLF10 Abcam, ab184182	Homo sapiens		EXP038081	38	normal	Q13118	A549 (lung carcinoma)	NULL
EXP038085	input	Mus musculus		NULL	44	chip_control	NULL	T-cells	NULL
EXP038086	SATB1	Mus musculus		EXP038085	171	normal	Q60611	CD4+ CD8+ T cells	NULL
EXP038087	SATB1	Mus musculus		EXP038085	1058	normal	Q60611	CD4+ T-cells	NULL
EXP038088	SATB1	Mus musculus		EXP038085	1058	normal	Q60611	CD4+ T-cells	NULL
EXP038089	SATB1	Mus musculus		EXP038085	44	normal	Q60611	T-cells	NULL
EXP038090	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens		NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	NULL
EXP038091	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens		NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	NULL
EXP038092	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens		NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	NULL
EXP038093	anti-FLAG(M2) (Sigma-1804, Lot# SLBK1346V)	Homo sapiens	mutant EBF3	NULL	665	normal	Q9H4W6	SK-N-SH (neuroblastoma)	NULL
EXP038094	none	Mus musculus		NULL	967	chip_control	NULL	naive CD8+ T-cells	NULL
EXP038095	none	Mus musculus		NULL	967	chip_control	NULL	naive CD8+ T-cells	NULL
EXP038096	none	Mus musculus	Restimulation with PMA/Ionomycin in the presence of CsA (Calcineurin inhibitor) 	NULL	967	chip_control	NULL	naive CD8+ T-cells	NULL
EXP038097	none	Mus musculus	Restimulation with PMA/Ionomycin in the presence of DRB (pTEFb inhibitor)	NULL	967	chip_control	NULL	naive CD8+ T-cells	NULL
EXP038098	NFATc2	Mus musculus		EXP038094	967	normal	Q60591	naive CD8+ T-cells	NULL
EXP038099	NFATc2	Mus musculus		EXP038095	967	normal	Q60591	naive CD8+ T-cells	NULL
EXP038100	NFATc2	Mus musculus	Restimulation with PMA/Ionomycin in the presence of CsA (Calcineurin inhibitor) 	EXP038096	967	normal	Q60591	naive CD8+ T-cells	NULL
EXP038101	NFATc2	Mus musculus	Restimulation with PMA/Ionomycin in the presence of DRB (pTEFb inhibitor)	EXP038097	967	normal	Q60591	naive CD8+ T-cells	NULL
EXP038102	Arid3a	Mus musculus		NULL	506	normal	Q62431	J1 (embryonic stem cells)	NULL
EXP038103	Arid3a	Mus musculus		NULL	1059	normal	Q62431	trophoblast stem-like cells	NULL
EXP038104	none	Homo sapiens	Treatment: none	NULL	1061	chip_control	NULL	fetal prostate fibroblasts	NULL
EXP038105	none	Homo sapiens	Treatment: none	NULL	1060	chip_control	NULL	prostate cancer-associated fibroblasts	NULL
EXP038106	anti-AR (Santa Cruz, H280, sc-13062, Lot D0414)	Homo sapiens	Treatment: none	EXP038104	1061	normal	P10275	fetal prostate fibroblasts	NULL
EXP038107	anti-AR (Santa Cruz, H280, sc-13062, Lot D0414)	Homo sapiens	Treatment: none	EXP038105	1060	normal	P10275	prostate cancer-associated fibroblasts	NULL
EXP038108	anti-AR (Santa Cruz, H280, sc-13062, Lot D0414)	Homo sapiens	Treatment: none	NULL	1062	normal	P10275	myofibroblasts	NULL
EXP038109	IgG	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP038110	PROX1	Mus musculus		EXP038109	5	normal	P48437	liver	NULL
EXP038111	PROX1	Mus musculus	HNF4A floxed	EXP038109	5	normal	P48437	liver	NULL
EXP038112	PROX1	Mus musculus	HNF4A floxed, liver KO	EXP038109	5	normal	P48437	liver	NULL
EXP038113	HNF4A	Mus musculus	HNF4A floxed	EXP038109	5	normal	P49698	liver	NULL
EXP038114	HNF4A	Mus musculus	HNF4A floxed, liver KO	EXP038109	5	normal	P49698	liver	NULL
EXP038115	none (input)	Mus musculus		NULL	476	chip_control	NULL	neural tube	NULL
EXP038116	none (input)	Mus musculus	GFP-PRDM13 fusion	NULL	476	chip_control	NULL	neural tube	NULL
EXP038117	Johnson lab generated rabbit polyclonal antibodies (PRDM13-Ab1 (ZF) PA6659, rabbit anti-mouse PRDM13)	Mus musculus		EXP038115	476	normal	E9PZZ1	neural tube	NULL
EXP038118	Johnson lab generated rabbit polyclonal antibodies (PRDM13-Ab2 (FL) TX970, rabbit anti-mouse PRDM13)	Mus musculus		EXP038115	476	normal	E9PZZ1	neural tube	NULL
EXP038119	Johnson lab generated rabbit polyclonal antibodies (PRDM13-Ab2 (FL) TX970, rabbit anti-mouse PRDM13)	Mus musculus		NULL	827	normal	E9PZZ1	telencephalon	NULL
EXP038120	Life Technologies (A6455, rabbit anti-GFP)	Mus musculus	GFP-PRDM13 fusion	EXP038116	476	normal	E9PZZ1	neural tube	NULL
EXP038121	anti-Bcl11b antibody (Bethyl Laboratories, A300383A)	Mus musculus	Thpok gfp genotype	NULL	44	normal	Q99PV8	T-cells	NULL
EXP038122	anti-Bcl11b antibody (Bethyl Laboratories, A300383A)	Mus musculus	Thpok gfp:dTESPE genotype	NULL	44	normal	Q99PV8	T-cells	NULL
EXP038123	none	Mus musculus		NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP038124	Rabbit gamma globulin (Jackson ImmunoResearch 011-000-002)	Mus musculus		NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP038125	none	Mus musculus	Rad21-SNAPf-V5	NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP038126	Rabbit normal IgG (Jackson ImmunoResearch 011-000-002)	Mus musculus	Rad21-SNAPf-V5	NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP038127	CTCF (Abcam ab128873)	Mus musculus		EXP038124	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	NULL
EXP038128	CTCF (Abcam ab128873)	Mus musculus	Rad21-SNAPf-V5	EXP038126	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	NULL
EXP038129	N/A	Mus musculus		NULL	1065	chip_control	NULL	neural stem cell (NSC)-derived pre-iPSCs	NULL
EXP038130	N/A	Mus musculus		NULL	1065	chip_control	NULL	neural stem cell (NSC)-derived pre-iPSCs	NULL
EXP038131	FLAG (Sigma F1804)	Mus musculus		EXP038130	1065	normal	Q80Z64	neural stem cell (NSC)-derived pre-iPSCs	NULL
EXP038132		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038133		Mus musculus		NULL	1067	chip_control	NULL	pre-induced pluripotent stem cells	NULL
EXP038134		Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP038135	KLF4	Mus musculus		EXP038132	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	NULL
EXP038136	cMyc	Mus musculus		EXP038132	12	normal	P01108	MEF (mouse embryonic fibroblasts)	NULL
EXP038137	Oct4	Mus musculus		EXP038132	1066	normal	P20263	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038138	Sox2	Mus musculus		EXP038132	1066	normal	P48432	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038139	KLF4	Mus musculus		EXP038132	1066	normal	Q60793	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038140	cMyc	Mus musculus		EXP038132	1066	normal	P01108	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038141	Oct4	Mus musculus		EXP038134	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP038142	Sox2	Mus musculus		EXP038134	2	normal	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP038143	KLF4	Mus musculus		EXP038134	2	normal	Q60793	mESCs (mouse embryonic stem cells)	NULL
EXP038144	cMyc	Mus musculus		EXP038134	2	normal	P01108	mESCs (mouse embryonic stem cells)	NULL
EXP038145	KLF4	Mus musculus		EXP038132	1070	normal	Q60793	embryonic fibroblasts expressing Klf4 from pMX vector for 48h	NULL
EXP038146	KLF4	Mus musculus		EXP038132	1071	normal	Q60793	embryonic fibroblasts expressing Klf4 from inducible system for 48h	NULL
EXP038147	Oct4	Mus musculus		NULL	1072	normal	P20263	embryonic fibroblasts expressing Oct4 from pMX vector for 48h	NULL
EXP038148	Oct4	Mus musculus		EXP038132	1073	normal	P20263	embryonic fibroblasts expressing Oct4 from inducible system for 48h	NULL
EXP038149	Sox2	Mus musculus		EXP038132	1074	normal	P48432	embryonic fibroblasts expressing Sox2 from pMX vector for 48h	NULL
EXP038150	Sox2	Mus musculus		EXP038132	1075	normal	P48432	embryonic fibroblasts expressing Sox2 from inducible system for 48h	NULL
EXP038151	Oct4	Mus musculus		EXP038132	1076	normal	P20263	embryonic fibroblasts expressing Oct4,Klf4 from pMX vector for 48h	NULL
EXP038152	KLF4	Mus musculus		EXP038132	1076	normal	Q60793	embryonic fibroblasts expressing Oct4,Klf4 from pMX vector for 48h	NULL
EXP038153	Sox2	Mus musculus		EXP038132	1078	normal	P48432	embryonic fibroblasts expressing Sox2,Klf4 from pMX vector for 48h	NULL
EXP038154	KLF4	Mus musculus		EXP038132	1078	normal	Q60793	embryonic fibroblasts expressing Sox2,Klf4 from pMX vector for 48h	NULL
EXP038155	Oct4	Mus musculus		EXP038132	1080	normal	P20263	embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h	NULL
EXP038156	Sox2	Mus musculus		EXP038132	1080	normal	P48432	embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h	NULL
EXP038157	KLF4	Mus musculus		EXP038132	1080	normal	Q60793	embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h	NULL
EXP038158	Oct4	Mus musculus		EXP038132	1082	normal	P20263	embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h	NULL
EXP038159	Sox2	Mus musculus		EXP038132	1082	normal	P48432	embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h	NULL
EXP038160	KLF4	Mus musculus		EXP038132	1082	normal	Q60793	embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h	NULL
EXP038161	Fra1	Mus musculus		EXP038132	12	normal	P48755	MEF (mouse embryonic fibroblasts)	NULL
EXP038162	Fra1	Mus musculus		EXP038132	1066	normal	P48755	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038163	Runx1	Mus musculus		EXP038132	12	normal	Q03347	MEF (mouse embryonic fibroblasts)	NULL
EXP038164	Runx1	Mus musculus		EXP038132	1066	normal	Q03347	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038165	CEBPA	Mus musculus		EXP038132	12	normal	P53566	MEF (mouse embryonic fibroblasts)	NULL
EXP038166	CEBPA	Mus musculus		EXP038132	1066	normal	P53566	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038167	CEBPB	Mus musculus		EXP038132	12	normal	P28033	MEF (mouse embryonic fibroblasts)	NULL
EXP038168	CEBPB	Mus musculus		EXP038132	1066	normal	P28033	embryonic fibroblasts expressing OSKM for 48h	NULL
EXP038169	CEBPB	Mus musculus		EXP038133	1067	normal	P28033	pre-induced pluripotent stem cells	NULL
EXP038170	Nanog	Mus musculus		EXP038134	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP038171	ERR2	Mus musculus		EXP038134	2	normal	Q61539	mESCs (mouse embryonic stem cells)	NULL
EXP038172	Fra1	Mus musculus		EXP038132	1069	normal	P48755	embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h	NULL
EXP038173	Oct4	Mus musculus		EXP038132	1069	normal	P20263	embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h	NULL
EXP038174	KLF4	Mus musculus		EXP038132	1069	normal	Q60793	embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h	NULL
EXP038175	ERR2	Mus musculus		EXP038132	1068	normal	Q61539	embryonic fibroblasts expressing OSKM and Esrrb for 48h	NULL
EXP038176	Oct4	Mus musculus		EXP038132	1068	normal	P20263	embryonic fibroblasts expressing OSKM and Esrrb for 48h	NULL
EXP038177	KLF4	Mus musculus		EXP038132	1068	normal	Q60793	embryonic fibroblasts expressing OSKM and Esrrb for 48h	NULL
EXP038178	Oct4	Mus musculus		EXP038133	1067	normal	P20263	pre-induced pluripotent stem cells	NULL
EXP038179	Sox2	Mus musculus		EXP038133	1067	normal	P48432	pre-induced pluripotent stem cells	NULL
EXP038180	Klf4	Mus musculus		EXP038133	1067	normal	Q60793	pre-induced pluripotent stem cells	NULL
EXP038181	cMyc	Mus musculus		EXP038133	1067	normal	P01108	pre-induced pluripotent stem cells	NULL
EXP038182	IgG	Mus musculus		NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP038183	anti-GATA2	Mus musculus		EXP038182	96	normal	O09100	trophoblast stem cells	NULL
EXP038184	anti-GATA3	Mus musculus		EXP038182	96	normal	P23772	trophoblast stem cells	NULL
EXP038185	anti-IgG	Homo sapiens	Treatment: Input; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP038186	anti-IgG	Homo sapiens	Treatment: Input; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: Expression of Src-527F	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP038187	anti-IgG	Homo sapiens	Treatment: Input; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP038188	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of 10nM DHT; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038185	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP038189	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of vehicle; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038185	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP038190	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of 10nM DHT; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: Expression of Src-527F	EXP038186	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP038191	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of vehicle; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: Expression of Src-527F	EXP038186	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP038192	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of 10nM DHT; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038187	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP038193	anti-AR (N-20 , Cat. SC-816X, Santa Cruz)	Homo sapiens	Treatment: 16 hours of vehicle; Time point: 16 hours; Growth: 10 million cells were grown to 70â€“80% confluence in a 150 mm culture dish containing ADM for 48 h; Genotype: none	EXP038187	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP038194	INPUT	Homo sapiens		NULL	1083	chip_control	NULL	D283 Med (medulloblastoma)	NULL
EXP038195	INPUT	Homo sapiens		NULL	1084	chip_control	NULL	D341 Med (medulloblastoma)	NULL
EXP038196	OTX2	Homo sapiens		EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	NULL
EXP038197	OTX2.abcam	Homo sapiens		EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	NULL
EXP038198	NEUROD1	Homo sapiens		EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	NULL
EXP038199	OTX2	Homo sapiens		EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038200	OTX2.abcam	Homo sapiens		EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038201	NEUROD1	Homo sapiens		EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	NULL
EXP038202	OTX2	Homo sapiens	CRISPR.GFP1	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038203	OTX2	Homo sapiens	CRISPR.GFP2	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038204	OTX2	Homo sapiens	CRISPR.OTX2.2	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038205	OTX2	Homo sapiens	CRISPR.OTX2.4	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038206	NEUROD1	Homo sapiens	shGFP	EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	NULL
EXP038207	NEUROD1	Homo sapiens	shNEUROD1.1154	EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	NULL
EXP038208	NEUROD1	Homo sapiens	shNEUROD1.1579	EXP038195	1084	normal	Q13562	D341 Med (medulloblastoma)	NULL
EXP038209	OTX2	Homo sapiens	shGFP	EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	NULL
EXP038210	OTX2	Homo sapiens	shOTX2.1393	EXP038194	1083	normal	P32243	D283 Med (medulloblastoma)	NULL
EXP038211	NEUROD1	Homo sapiens	shGFP	EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	NULL
EXP038212	NEUROD1	Homo sapiens	shNEUROD1.1154	EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	NULL
EXP038213	NEUROD1	Homo sapiens	shNEUROD1.1579	EXP038194	1083	normal	Q13562	D283 Med (medulloblastoma)	NULL
EXP038214	OTX2	Homo sapiens	shGFP	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038215	OTX2	Homo sapiens	shOTX2.1393	EXP038195	1084	normal	P32243	D341 Med (medulloblastoma)	NULL
EXP038216	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delAB mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038217	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delC mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038218	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delE mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038219	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus		NULL	572	normal	Q61164	mammary gland	NULL
EXP038220	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delCDE mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038221	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delD mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038222		Mus musculus		NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP038223	PPARG (Santa Cruz, sc-7196X)	Mus musculus		EXP038222	115	normal	P37238	brown adipose tissue	NULL
EXP038224	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delA mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038225	GR (Thermo Scientific, PA1-511A)	Mus musculus	delA mutant	NULL	572	normal	P06537	mammary gland	NULL
EXP038226	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	delA mutant	NULL	572	normal	P42230	mammary gland	NULL
EXP038227	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delC mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038228	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delB mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038229	GR (Thermo Scientific, PA1-511A)	Mus musculus	delC mutant	NULL	572	normal	P06537	mammary gland	NULL
EXP038230	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	delC mutant	NULL	572	normal	P42230	mammary gland	NULL
EXP038231	CTCF (Abcam ab70303 / Millipore 07-729)	Mus musculus	delD mutant	NULL	572	normal	Q61164	mammary gland	NULL
EXP038232	IgG	Mus musculus		NULL	1057	chip_control	NULL	medullary thymic epithelial cells	NULL
EXP038233	Aire	Mus musculus		EXP038232	1057	normal	Q9Z0E3	medullary thymic epithelial cells	NULL
EXP038234		Mus musculus	high fat diet, 12 weeks	NULL	4	chip_control	NULL	inguinal white adipose tissue	NULL
EXP038235	PPARG	Mus musculus		NULL	18	normal	P37238	3T3-L1 (embryonic fibroblasts)	NULL
EXP038236	PPARG	Mus musculus		NULL	732	normal	P37238	peritoneal macrophages	NULL
EXP038237	PPARG	Mus musculus	high fat diet, 12 weeks	EXP038234	4	normal	P37238	inguinal white adipose tissue	NULL
EXP038238	PPARG	Mus musculus	low fat diet, 12 weeks	NULL	4	normal	P37238	inguinal white adipose tissue	NULL
EXP038239	PPARG	Mus musculus	low fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038240	PPARG	Mus musculus	high fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038241	PPARG	Mus musculus	low fat diet, 4 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038242	PPARG	Mus musculus	high fat diet, 4 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038243	PPARG	Mus musculus	high fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038244	PPARG	Mus musculus	low fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038245	PPARG	Mus musculus	rosiglitazone, high fat diet, 12 weeks	NULL	3	normal	P37238	epididymal white adipose tissue	NULL
EXP038246		Mus musculus	induced with tamoxifen	NULL	1085	chip_control	NULL	J2E (erythroid cells)	NULL
EXP038247	KLF1 Antibody	Mus musculus	induced with tamoxifen, tamoxifen-inducible KLF1-ER	EXP038246	1085	normal	P46099	J2E (erythroid cells)	NULL
EXP038248	Fli	Homo sapiens	no doxycycline, serum-induction	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP038249	SRF	Homo sapiens	no doxycycline, serum-induction	NULL	1086	normal	P11831	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP038250	none	Mus musculus	asynchronous cell cycle	NULL	1088	chip_control	NULL	E3.5 embryonic stem cells	NULL
EXP038251	none	Mus musculus	asynchronous cell cycle	NULL	1088	chip_control	NULL	E3.5 embryonic stem cells	NULL
EXP038252	none	Mus musculus		NULL	1088	chip_control	NULL	E3.5 embryonic stem cells	NULL
EXP038253	none	Mus musculus	asynchronous cell cycle	NULL	1088	chip_control	NULL	E3.5 embryonic stem cells	NULL
EXP038254	none	Mus musculus		NULL	1088	chip_control	NULL	E3.5 embryonic stem cells	NULL
EXP038255	none	Mus musculus	asynchronous cell cycle	NULL	1087	chip_control	NULL	embryonic stem and neural progenitor cells	NULL
EXP038256	Klf4 (R&D AF3158)	Mus musculus	asynchronous cell cycle	EXP038251	1088	normal	Q60793	E3.5 embryonic stem cells	NULL
EXP038257	Klf4 (R&D AF3158)	Mus musculus	asynchronous cell cycle	EXP038250	1088	normal	Q60793	E3.5 embryonic stem cells	NULL
EXP038258	Klf4 (R&D AF3158)	Mus musculus	asynchronous cell cycle	EXP038253	1088	normal	Q60793	E3.5 embryonic stem cells	NULL
EXP038259	Klf4 (R&D AF3158)	Mus musculus		EXP038254	1088	normal	Q60793	E3.5 embryonic stem cells	NULL
EXP038260	Klf4 (R&D AF3158)	Mus musculus		EXP038255	1087	normal	Q60793	embryonic stem and neural progenitor cells	NULL
EXP038261	Oct4 (Santa Cruz SC-8628)	Mus musculus	asynchronous cell cycle	EXP038253	1088	normal	P20263	E3.5 embryonic stem cells	NULL
EXP038262	Sox2  (R&D AF2018)	Mus musculus	asynchronous cell cycle	EXP038253	1088	normal	P48432	E3.5 embryonic stem cells	NULL
EXP038263	Klf4 (R&D AF3158)	Mus musculus		EXP038252	1088	normal	Q60793	E3.5 embryonic stem cells	NULL
EXP038264	Oct4 (Santa Cruz SC-8628)	Mus musculus		EXP038254	1088	normal	P20263	E3.5 embryonic stem cells	NULL
EXP038265	Sox2 (R&D AF2018)	Mus musculus		EXP038254	1088	normal	P48432	E3.5 embryonic stem cells	NULL
EXP038266	None	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP038267	CTCF	Homo sapiens		EXP038266	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP038268	CTCF	Homo sapiens	+DOX 3 days, mutant CTCF	EXP038266	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP038269	CTCF	Homo sapiens		NULL	417	normal	P49711	HCT-116 (colon carcinoma)	NULL
EXP038270	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP038271	CUX1 sc-6327 Santa Cruz	Homo sapiens		EXP038270	514	normal	P39880	K562 (myelogenous leukemia)	NULL
EXP038272	CUX1 sc-6327 Santa Cruz	Homo sapiens		EXP038270	514	normal	P39880	K562 (myelogenous leukemia)	NULL
EXP038273	CUX1 sc-6327 Santa Cruz	Homo sapiens		EXP038270	514	normal	P39880	K562 (myelogenous leukemia)	NULL
EXP038274	ETS1, Santa-Cruz sc-111X	Homo sapiens		NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038275	ETS1, Santa-Cruz sc-111X	Homo sapiens	VEGF stimulation for 1hour	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038276	ETS1, Santa-Cruz sc-111X	Homo sapiens	VEGF stimulation for 4hours	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038277	ETS1, Santa-Cruz sc-111X	Homo sapiens	VEGF stimulation for 12hours	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038278	ETS1, Santa-Cruz sc-111X	Homo sapiens		NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038279	ETS1, Santa-Cruz sc-111X	Homo sapiens		NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038280	myc, Santa Cruz sc-764 X	Homo sapiens		NULL	472	normal	P01106	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP038281	input	Homo sapiens	estrogen	NULL	1089	chip_control	NULL	breast tumor xenograft	NULL
EXP038282	input	Homo sapiens	estrogen plus progesterone	NULL	1089	chip_control	NULL	breast tumor xenograft	NULL
EXP038283	IgG (sc-2027, Santa Cruz Biotechnology), lot # H2615	Homo sapiens	estrogen	EXP038281	1089	chip_control	NULL	breast tumor xenograft	NULL
EXP038284	ER (sc-543X, Santa Cruz Biotechnology), lot# F1215	Homo sapiens	estrogen	EXP038281	1089	normal	P03372	breast tumor xenograft	NULL
EXP038285	PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415	Homo sapiens	estrogen	EXP038281	1089	normal	P06401	breast tumor xenograft	NULL
EXP038286	ER (sc-543X, Santa Cruz Biotechnology), lot# F1215	Homo sapiens	estrogen plus progesterone	EXP038282	1089	normal	P03372	breast tumor xenograft	NULL
EXP038287	PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415	Homo sapiens	estrogen plus progesterone	EXP038282	1089	normal	P06401	breast tumor xenograft	NULL
EXP038288	IgG (sc-2027, Santa Cruz Biotechnology), lot # H2615	Homo sapiens	estrogen plus progesterone	EXP038282	1089	chip_control	NULL	breast tumor xenograft	NULL
EXP038289	None	Mus musculus		NULL	1091	chip_control	NULL	ECOMG-derived differentiated neutrophils	NULL
EXP038290	None	Mus musculus		NULL	1092	chip_control	NULL	ECOMG (myeloid progenitor cell line)	NULL
EXP038291	CTCF 07-729 Millipore	Mus musculus		EXP038289	1091	normal	Q61164	ECOMG-derived differentiated neutrophils	NULL
EXP038292	CTCF 07-729 Millipore	Mus musculus		EXP038290	1092	normal	Q61164	ECOMG (myeloid progenitor cell line)	NULL
EXP038293	anti-HA	Mus musculus	DOXYCYCLINE	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP038294	MO488, MO489 (anti-hDUX4)	Mus musculus	DOXYCYCLINE	EXP038293	1153	normal	A1JVI8	C2C12 (myoblasts)	NULL
EXP038295		Homo sapiens		NULL	891	chip_control	NULL	dermal fibroblasts	NULL
EXP038296	MyoD	Homo sapiens		EXP038295	891	normal	P15172	dermal fibroblasts	NULL
EXP038297	IgG Sigma I5381	Homo sapiens		NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP038298	Pitx	Homo sapiens		EXP038297	664	normal	O75364	SH-SY5Y (neuroblastoma)	NULL
EXP038299	none	Mus musculus	EtOH	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038300	none	Mus musculus	4-OHT	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038301	BMAL1 (Bethyl, A302-616A)	Mus musculus	EtOH	EXP038299	12	normal	Q9WTL8	MEF (mouse embryonic fibroblasts)	NULL
EXP038302	BMAL1 (Bethyl, A302-616A)	Mus musculus	4-OHT	EXP038300	12	normal	Q9WTL8	MEF (mouse embryonic fibroblasts)	NULL
EXP038303	IgG	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP038304	FOXD3	Homo sapiens		EXP038303	38	normal	Q9UJU5	A549 (lung carcinoma)	NULL
EXP038305	none (input)	Homo sapiens		NULL	269	chip_control	NULL	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP038306	GATA1 (Abcam, ab11852)	Homo sapiens		EXP038305	269	normal	P15976	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP038307	TAL1 (Santa Cruz, sc-12984)	Homo sapiens		EXP038305	269	normal	P17542	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP038308	none	Mus musculus	tamoxifen	NULL	5	chip_control	NULL	liver	NULL
EXP038309	none	Mus musculus	tamoxifen	NULL	5	chip_control	NULL	liver	NULL
EXP038310	CTCF (Millipore 07-729)	Mus musculus	tamoxifen	EXP038308	5	normal	Q61164	liver	NULL
EXP038311	CTCF (Millipore 07-729)	Mus musculus	tamoxifen	EXP038309	5	normal	Q61164	liver	NULL
EXP038312		Mus musculus		NULL	1093	chip_control	NULL	Lin- bone marrow-derived CD44- CD25+ thymocytes	NULL
EXP038313	Bcl11b  Abs, a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST)	Mus musculus		EXP038312	1093	normal	Q99PV8	Lin- bone marrow-derived CD44- CD25+ thymocytes	NULL
EXP038314	none	Mus musculus	Untreated	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP038315	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	0h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038316	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	3h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038317	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	8h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038318	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex 3h pre, 0h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038319	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex 3h pre, 3h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038320	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex 3h pre, 8h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038321	RelA (Ab7970, Abcam) and Dynabeads Protein A	Mus musculus	Dex late, 8h LPS RelA	EXP038314	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038322	GR (MA1-510, Thermo Fisher Scientific) and anti-IgG paramagnetic beads	Mus musculus	Dex/DSG+FA	NULL	81	normal	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP038323	GR (MA1-510, Thermo Fisher Scientific) and anti-IgG paramagnetic beads	Mus musculus	LPS+Dex/DSG+FA	NULL	81	normal	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP038324		Mus musculus		NULL	105	chip_control	NULL	pro-B cells	NULL
EXP038325	anti-V5 antibody (clone V5-10)	Mus musculus		EXP038324	1094	normal	Q99PV5	splenic B-1a-cells	NULL
EXP038326	anti-V5 antibody (clone V5-10)	Mus musculus		EXP038324	1094	normal	Q99PV5	splenic B-1a-cells	NULL
EXP038327		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038328	FOXN3	Homo sapiens		EXP038327	113	normal	O00409	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038329		Homo sapiens		NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP038330	MYB	Homo sapiens		EXP038329	1095	normal	P10242	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP038331	MYB	Homo sapiens		NULL	1097	normal	P10242	PF-382 (childhood T acute lymphoblastic leukemia)	NULL
EXP038332	MYB	Homo sapiens		NULL	1096	normal	P10242	DU-528 (childhood T acute lymphoblastic leukemia)	NULL
EXP038333	FOXA1 antibodies mixed ab5089, ab23738	Homo sapiens		NULL	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038334	FOXA1 antibodies mixed ab5089, ab23738	Homo sapiens	ShMEN1	NULL	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038335	 F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	NoTreat	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038336	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	5min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038337	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	10min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038338	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	20min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038339	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	40min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038340	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	80min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038341	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	160min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038342	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	320min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038343	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	640min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038344	F3A6 (to ERalpha, Gronemeyer)	Homo sapiens	1280min E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038345	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038346	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038347	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038348	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038349	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038350	ERa (SC-543; Santa Cruz)	Homo sapiens	Tamoxifen-associated	NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038351	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038352	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038353	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038354	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038355	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038356	ERa (SC-543; Santa Cruz)	Homo sapiens		NULL	257	normal	P03372	endometrioid adenocarcinoma	NULL
EXP038357	N/A	Mus musculus	DMSO vehicle	NULL	1099	chip_control	NULL	E??-Myc lymphoma	NULL
EXP038358	N/A	Mus musculus	DMSO vehicle	NULL	1100	chip_control	NULL	AT-3 (mammary tumor)	NULL
EXP038359	anti-MYC (ab32072, Abcam)	Mus musculus	DMSO vehicle	EXP038357	1099	normal	P01108	E??-Myc lymphoma	NULL
EXP038360	anti-MYC (ab32072, Abcam)	Mus musculus	1000nM JQ1	EXP038357	1099	normal	P01108	E??-Myc lymphoma	NULL
EXP038361	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	DMSO vehicle	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	NULL
EXP038362	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	1000nM JQ1	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	NULL
EXP038363	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	1ng/mL IFN-Î³	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	NULL
EXP038364	IRF1 (sc-497, Santa Cruz Biotechnology, Inc)	Mus musculus	1000nM JQ1+ 1ng/mL IFN-Î³	EXP038358	1100	normal	P15314	AT-3 (mammary tumor)	NULL
EXP038365	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	DMSO vehicle	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	NULL
EXP038366	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	1000nM JQ1	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	NULL
EXP038367	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	1ng/mL IFN-Î³	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	NULL
EXP038368	anti-STAT1? (sc-345, Santa Cruz Biotechnology)	Mus musculus	1000nM JQ1+ 1ng/mL IFN-Î³	EXP038358	1100	normal	P42225	AT-3 (mammary tumor)	NULL
EXP038369	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038370	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038371	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038372	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038373	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038374	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038375	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038376	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038377	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038378	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038379	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038380	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038381	ER	Homo sapiens	E2	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP038382	ER	Homo sapiens	Doxycycline	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP038383	ER	Homo sapiens	Doxycycline + E2	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP038384	ER	Homo sapiens	none	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038385	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038386	ER	Homo sapiens	none	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038387	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038388	ER	Homo sapiens	E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038389	ER	Homo sapiens	Doxycycline	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038390	ER	Homo sapiens	Doxycycline + E2	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038391	none	Mus musculus		NULL	132	chip_control	NULL	uterus	NULL
EXP038392	Eralpha, Santa Cruz sc-542	Mus musculus	saline (Vehicle, V); mutant ERa	EXP038391	132	normal	P19785	uterus	NULL
EXP038393	Eralpha, Santa Cruz sc-542	Mus musculus	250 ng of estradiol (E2); mutant ERa	EXP038391	132	normal	P19785	uterus	NULL
EXP038394	none	Homo sapiens		NULL	669	chip_control	NULL	NGP (neuroblastoma)	NULL
EXP038395	none	Homo sapiens		NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP038396	none	Homo sapiens		NULL	1101	chip_control	NULL	NB-1643 (neuroblastoma)	NULL
EXP038397	N-MYC B8.4b (Santa Cruz, Catalog# sc-53993, Lot# K1315)	Homo sapiens		EXP038394	669	normal	P04198	NGP (neuroblastoma)	NULL
EXP038398	N-MYC B8.4b (Santa Cruz, Catalog# sc-53993, Lot# K1315)	Homo sapiens		EXP038395	520	normal	P04198	Kelly (neuroblastoma)	NULL
EXP038399	N-MYC B8.4b (Santa Cruz, Catalog# sc-53993, Lot# K1315)	Homo sapiens		EXP038396	1101	normal	P04198	NB-1643 (neuroblastoma)	NULL
EXP038400	IgG	Rattus norvegicus		NULL	784	chip_control	NULL	Schwann cells	NULL
EXP038401	Taz	Rattus norvegicus		EXP038400	784	normal	Q9JKY3	Schwann cells	NULL
EXP038402	Grhl3	Homo sapiens		NULL	468	normal	Q8TE85	neonatal keratinocytes	NULL
EXP038403	none (input)	Homo sapiens		NULL	1102	chip_control	NULL	MDA231-LM2-4175 (breast adenocarcinoma)	NULL
EXP038404	Fra-1 (or FOSL1) (Santa Cruz; sc-183)	Homo sapiens		EXP038403	1102	normal	P15407	MDA231-LM2-4175 (breast adenocarcinoma)	NULL
EXP038405	c-Myc (Santa Cruz; sc-764)	Homo sapiens		EXP038403	1102	normal	P01106	MDA231-LM2-4175 (breast adenocarcinoma)	NULL
EXP038406	E2F1 (Millipore; 05-379)	Homo sapiens		EXP038403	1102	normal	Q01094	MDA231-LM2-4175 (breast adenocarcinoma)	NULL
EXP038407	p53 (BD-Pharmingen; 554294)	Homo sapiens		EXP038403	1102	normal	P04637	MDA231-LM2-4175 (breast adenocarcinoma)	NULL
EXP038408	DUX4	Homo sapiens	18hr dox-induction	NULL	1143	normal	Q9UBX2	iPSC (induced pluripotent stem cells)	NULL
EXP038409		Mus musculus	18hr dox-induction	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP038410	DUX	Mus musculus	12hr dox-induction	EXP038409	2	normal	A1JVI8	mESCs (mouse embryonic stem cells)	NULL
EXP038411	DUX	Mus musculus	18hr dox-induction	EXP038409	2	normal	A1JVI8	mESCs (mouse embryonic stem cells)	NULL
EXP038412	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038413	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038414	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038415	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038416	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038417	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038418	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038419	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038420	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038421	CTCF antibody, Cat#07-729; RRID:AB_441965	Mus musculus		NULL	19	normal	Q61164	3T3-L1-derived preadipocytes	NULL
EXP038422	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	NULL
EXP038423	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	NULL
EXP038424	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	NULL
EXP038425	NCoR antibody, Cat#A301-145A; RRID:AB_873085	Mus musculus		NULL	19	normal	Q60974	3T3-L1-derived preadipocytes	NULL
EXP038426	Mouse IgG	Homo sapiens		NULL	1103	chip_control	NULL	HCC827 (lung adenocarcinoma)	NULL
EXP038427	Mouse IgG	Homo sapiens		NULL	1104	chip_control	NULL	HCC827 ZDR3 (lung adenocarcinoma)	NULL
EXP038428	C-Jun Santa Cruz catalog# SC-1694X	Homo sapiens		EXP038426	1103	normal	P05412	HCC827 (lung adenocarcinoma)	NULL
EXP038429	C-Jun Santa Cruz catalog# SC-1694X	Homo sapiens		EXP038427	1104	normal	P05412	HCC827 ZDR3 (lung adenocarcinoma)	NULL
EXP038430	CTCF (Active motif REF# 61311)	Mus musculus		NULL	1105	normal	Q61164	E12.5 embryonic distal forelimb	NULL
EXP038431	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP038432	anti-AR (Santa Cruz Biotechnology cat. sc-816)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP038433	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	7	normal	Q92826	22RV1 (prostate carcinoma)	NULL
EXP038434	anti-FOXA1 (EMD Millipore cat. 17-10267)	Homo sapiens	Treatment: none; Growth: cells were cultured in RPMI supplemented with 10% FBS and 1% Pen/Strep	NULL	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP038435	anti-FOXA1 (EMD Millipore cat. 17-10267)	Homo sapiens	Treatment: siRNA against control; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep	NULL	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP038436	anti-FOXA1 (EMD Millipore cat. 17-10267)	Homo sapiens	Treatment: siRNA against ERG; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep; Genotype: ERG knockdown	NULL	71	normal	P55317	VCaP (prostate carcinoma)	NULL
EXP038437	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: siRNA against control; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep	NULL	71	normal	Q92826	VCaP (prostate carcinoma)	NULL
EXP038438	anti-HOXB13 (Santa Cruz Biotechnology cat. sc-66923)	Homo sapiens	Treatment: siRNA against ERG; Growth: cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep; Genotype: ERG knockdown	NULL	71	normal	Q92826	VCaP (prostate carcinoma)	NULL
EXP038439	none	Mus musculus		NULL	831	chip_control	NULL	Th9-cells	NULL
EXP038440	IRF1 abcam, ab186384	Mus musculus	IFN-g	EXP038439	831	normal	P15314	Th9-cells	NULL
EXP038441	IRF1	Mus musculus	IFN-g	NULL	831	normal	P15314	Th9-cells	NULL
EXP038442	IRF4 abcam,  ab101168	Mus musculus		EXP038439	831	normal	Q64287	Th9-cells	NULL
EXP038443	IRF4 abcam,  ab101168	Mus musculus	IFN-g	EXP038439	831	normal	Q64287	Th9-cells	NULL
EXP038444	N/A	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038445	N/A	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038446	N/A	Mus musculus	ChIP-seq in vitro culture protocol (nc)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038447	N/A	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038448	N/A	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038449	N/A	Mus musculus	ChIP-seq in vitro culture protocol (nc)	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038450	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038444	1058	normal	P42225	CD4+ T-cells	NULL
EXP038451	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038445	1058	normal	P42225	CD4+ T-cells	NULL
EXP038452	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038446	1058	normal	P42225	CD4+ T-cells	NULL
EXP038453	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038444	1058	normal	Q9WVL2	CD4+ T-cells	NULL
EXP038454	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038445	1058	normal	Q9WVL2	CD4+ T-cells	NULL
EXP038455	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038446	1058	normal	Q9WVL2	CD4+ T-cells	NULL
EXP038456	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038447	1058	normal	P42225	CD4+ T-cells	NULL
EXP038457	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038448	1058	normal	P42225	CD4+ T-cells	NULL
EXP038458	STAT1, sc-592, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038449	1058	normal	P42225	CD4+ T-cells	NULL
EXP038459	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038447	1058	normal	Q9WVL2	CD4+ T-cells	NULL
EXP038460	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038448	1058	normal	Q9WVL2	CD4+ T-cells	NULL
EXP038461	anti-STAT2, ab124283, AbCam	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038449	1058	normal	Q9WVL2	CD4+ T-cells	NULL
EXP038462	anti-T-bet, sc-21003, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î²)	EXP038447	1058	normal	Q9JKD8	CD4+ T-cells	NULL
EXP038463	anti-T-bet, sc-21003, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (IFN-Î³)	EXP038448	1058	normal	Q9JKD8	CD4+ T-cells	NULL
EXP038464	anti-T-bet, sc-21003, Santa Cruz Biotechnology	Mus musculus	ChIP-seq in vitro culture protocol (nc)	EXP038449	1058	normal	Q9JKD8	CD4+ T-cells	NULL
EXP038465	none	Homo sapiens	none	NULL	1106	chip_control	NULL	ZNF532-NUT 24335 (NUT-midline carcinoma)	NULL
EXP038466	ZNF532 (anti-ZNF532, 10ul  Bethyl Laboratories, cat. no. A305-442A	Homo sapiens	none	EXP038465	1106	normal	Q9HCE3	ZNF532-NUT 24335 (NUT-midline carcinoma)	NULL
EXP038467	none	Homo sapiens		NULL	1108	chip_control	NULL	HMLE-Twist-ER (breast cancer)	NULL
EXP038468	none	Homo sapiens	125 nM 4-OHT for 14 days	NULL	1108	chip_control	NULL	HMLE-Twist-ER (breast cancer)	NULL
EXP038469	SMARCC1 (Santa Cruz, sc-9746)	Homo sapiens		EXP038467	1108	normal	Q92922	HMLE-Twist-ER (breast cancer)	NULL
EXP038470	SMARCE1 (Abcam, ab70540)	Homo sapiens		EXP038467	1108	normal	Q969G3	HMLE-Twist-ER (breast cancer)	NULL
EXP038471	SMARCC1 (Santa Cruz, sc-9746)	Homo sapiens	125 nM 4-OHT for 14 days	EXP038468	1108	normal	Q92922	HMLE-Twist-ER (breast cancer)	NULL
EXP038472	SMARCE1 (Abcam, ab70540)	Homo sapiens	125 nM 4-OHT for 14 days	EXP038468	1108	normal	Q969G3	HMLE-Twist-ER (breast cancer)	NULL
EXP038473	PPARy H100 (sc-7196X)	Mus musculus		NULL	115	normal	P37238	brown adipose tissue	NULL
EXP038474	PPARy H100 (sc-7196X)	Mus musculus	EBF2 KO	NULL	115	normal	P37238	brown adipose tissue	NULL
EXP038475	EBF2 (R+D AF 7006)	Mus musculus		NULL	115	normal	O08792	brown adipose tissue	NULL
EXP038476	CDX-2, Clone CDX2-88; cat.no. AM392-10M; Biogenex	Homo sapiens		NULL	188	normal	Q99626	LS174T (colon adenocarcinoma)	NULL
EXP038477	HA-probe Antibody (Y-11); cat.no. sc-805; Santa Cruz Biotechnology	Homo sapiens		NULL	188	chip_control	NULL	LS174T (colon adenocarcinoma)	NULL
EXP038478		Homo sapiens		NULL	849	chip_control	NULL	U87 (glioblastoma)	NULL
EXP038479	KLF4	Homo sapiens	R458A mutation	EXP038478	849	normal	O43474	U87 (glioblastoma)	NULL
EXP038480	KLF4	Homo sapiens		EXP038478	849	normal	O43474	U87 (glioblastoma)	NULL
EXP038481	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038482	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038483	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038484	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038485	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038486	AhR SA-210	Mus musculus	TCDD	EXP038481	5	normal	P30561	liver	NULL
EXP038487	AhR SA-210	Mus musculus	TCDD	EXP038482	5	normal	P30561	liver	NULL
EXP038488	AhR SA-210	Mus musculus	TCDD	EXP038483	5	normal	P30561	liver	NULL
EXP038489	AhR SA-210	Mus musculus	TCDD	EXP038484	5	normal	P30561	liver	NULL
EXP038490	AhR SA-210	Mus musculus	TCDD	EXP038485	5	normal	P30561	liver	NULL
EXP038491	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038492	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038493	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038494	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038495	None	Mus musculus	TCDD	NULL	5	chip_control	NULL	liver	NULL
EXP038496	AhR SA-210	Mus musculus	TCDD	EXP038491	5	normal	P30561	liver	NULL
EXP038497	AhR SA-210	Mus musculus	TCDD	EXP038492	5	normal	P30561	liver	NULL
EXP038498	AhR SA-210	Mus musculus	TCDD	EXP038493	5	normal	P30561	liver	NULL
EXP038499	AhR SA-210	Mus musculus	TCDD	EXP038494	5	normal	P30561	liver	NULL
EXP038500	AhR SA-210	Mus musculus	TCDD	EXP038495	5	normal	P30561	liver	NULL
EXP038501	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038502	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038503	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038504	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038505	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP038506	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038507	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038508	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038509	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038510	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038511	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP038512	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038513	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038514	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038515	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038516	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038517	none	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038518	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP038519	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP038520	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP051011	KLF10 R846.1.1D3	Homo sapiens		EXP038501	430	normal	Q13118	HepG2 (hepatoblastoma)	NULL
EXP038522	NFIL3 R1053.1.2B5	Homo sapiens		EXP038510	430	normal	Q16649	HepG2 (hepatoblastoma)	NULL
EXP038523	ZBTB2	Homo sapiens		EXP038514	356	normal	Q8N680	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP051012	FOXO3 R5.2.1B7	Homo sapiens		EXP038501	430	normal	O43524	HepG2 (hepatoblastoma)	NULL
EXP038525	SMAD4 13.2.1A5	Homo sapiens		EXP038506	430	normal	Q13485	HepG2 (hepatoblastoma)	NULL
EXP038526	FOXO3  R5.2.1B7	Homo sapiens		EXP038505	514	normal	O43524	K562 (myelogenous leukemia)	NULL
EXP038527	TSC22D4 R154.1.3E10	Homo sapiens		EXP038513	356	normal	Q9Y3Q8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038528	STAT2 R16.1.2H10	Homo sapiens		EXP038513	356	normal	P52630	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038529	L3MBTL4	Homo sapiens		EXP038509	430	normal	Q8NA19	HepG2 (hepatoblastoma)	NULL
EXP038530	SMAD4 R516.1.1G12	Homo sapiens		EXP038512	430	normal	Q13485	HepG2 (hepatoblastoma)	NULL
EXP038531	SMAD4 R516.2.1D12	Homo sapiens		EXP038512	430	normal	Q13485	HepG2 (hepatoblastoma)	NULL
EXP038532	ZNF639 R270.2.1E7	Homo sapiens		EXP038519	514	normal	Q9UID6	K562 (myelogenous leukemia)	NULL
EXP038533	ZNF639	Homo sapiens		EXP038519	514	normal	Q9UID6	K562 (myelogenous leukemia)	NULL
EXP038534	BATF R451.2.1E10	Homo sapiens		EXP038503	356	normal	Q16520	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038535	ZNF410 R585.2.2C9	Homo sapiens		EXP038518	514	normal	Q86VK4	K562 (myelogenous leukemia)	NULL
EXP038536	NRF1	Homo sapiens		EXP038511	514	normal	Q16656	K562 (myelogenous leukemia)	NULL
EXP038537	NRF1 R157.1.3H1	Homo sapiens		EXP038511	514	normal	Q16656	K562 (myelogenous leukemia)	NULL
EXP038538	NRF1 R157.1.3H3	Homo sapiens		EXP038511	514	normal	Q16656	K562 (myelogenous leukemia)	NULL
EXP038539	ZNF18	Homo sapiens		EXP038511	514	normal	P17022	K562 (myelogenous leukemia)	NULL
EXP038540	ZNF410 R585.2.2C9	Homo sapiens		EXP038511	514	normal	Q86VK4	K562 (myelogenous leukemia)	NULL
EXP038541	HMG20A R1617.1.2H9	Homo sapiens		EXP038516	356	normal	Q9NP66	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP051013	ZBTB2 R6.1.3.46F2	Homo sapiens		EXP038501	430	normal	Q8N680	HepG2 (hepatoblastoma)	NULL
EXP038543	NF-1A R1356.1.2C6	Homo sapiens		EXP038515	430	normal	Q12857	HepG2 (hepatoblastoma)	NULL
EXP038544	NRF1  R157.1.3H3	Homo sapiens		EXP038515	430	normal	Q16656	HepG2 (hepatoblastoma)	NULL
EXP038545	ARID3A R21.1.1E9	Homo sapiens		EXP038501	430	normal	Q99856	HepG2 (hepatoblastoma)	NULL
EXP038546	ZSCAN2 R767.1.1F8	Homo sapiens		EXP038501	430	normal	Q7Z7L9	HepG2 (hepatoblastoma)	NULL
EXP038547	USF2 R1156.1.1A7	Homo sapiens		EXP038501	430	normal	Q15853	HepG2 (hepatoblastoma)	NULL
EXP038548	ZNF75A R1014.1.1B6	Homo sapiens		EXP038520	514	normal	Q96N20	K562 (myelogenous leukemia)	NULL
EXP038549	NF-1A R1356.1.2C6	Homo sapiens		EXP038520	514	normal	Q12857	K562 (myelogenous leukemia)	NULL
EXP038550	ZNF18 R177.1.2D2	Homo sapiens		EXP038517	356	normal	P17022	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038551	BATF3 R1066.1.1H3	Homo sapiens		EXP038517	356	normal	Q9NR55	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038552	HMG20A R1617.1.2H9	Homo sapiens		EXP038517	356	normal	Q9NP66	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038553	P73 YP322.1.1A8	Homo sapiens		EXP038517	356	normal	O15350	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038554	ETV6 R1092.1.1A7	Homo sapiens		EXP038504	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038555	ETV6 R1092.1.1A9	Homo sapiens		EXP038504	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038556	ZNF597 R917.1.1C12	Homo sapiens		EXP038504	356	normal	Q96LX8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038557	TSC22D4 R154.1.3E10	Homo sapiens		EXP038504	356	normal	Q9Y3Q8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038558	USF2 R1156.1.1A7	Homo sapiens		EXP038504	356	normal	Q15853	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP038559	HES1	Homo sapiens		EXP038507	430	normal	Q14469	HepG2 (hepatoblastoma)	NULL
EXP038560	NFATC3 R1106.1.2A12	Homo sapiens		EXP038507	430	normal	Q12968	HepG2 (hepatoblastoma)	NULL
EXP038561	TSC22D4 R160.2.2A2	Homo sapiens		EXP038507	430	normal	Q9Y3Q8	HepG2 (hepatoblastoma)	NULL
EXP038562	SMAD4 R516.2.1D12	Homo sapiens		EXP038507	430	normal	Q13485	HepG2 (hepatoblastoma)	NULL
EXP038563	ATF2 YP185.1.1B4	Homo sapiens		EXP038507	430	normal	P15336	HepG2 (hepatoblastoma)	NULL
EXP038564	KLF10  R846.1.1D3	Homo sapiens		EXP038508	113	normal	Q13118	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038565	ZNF701 R1015.1.1C5	Homo sapiens		EXP038508	113	normal	Q9NV72	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038566	ZNF75A R1014.1.1B6	Homo sapiens		EXP038508	113	normal	Q96N20	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038567	ZXDC JH98.1.2B5	Homo sapiens		EXP038508	113	normal	Q2QGD7	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038568	NRF1 R157.1.3D4	Homo sapiens		EXP038508	113	normal	Q16656	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038569	NRF1 R157.1.3H1	Homo sapiens		EXP038508	113	normal	Q16656	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038570	ZSCAN2	Homo sapiens		EXP038508	113	normal	Q7Z7L9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038571	anti-CTCF, Millipore 07-729	Mus musculus	Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	NULL
EXP038572	anti-CTCF, Millipore 07-729	Mus musculus	D29 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	NULL
EXP038573	anti-CTCF, Millipore 07-729	Mus musculus	D38_D39 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	NULL
EXP038574	anti-CTCF, Millipore 07-729	Mus musculus	D38 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	NULL
EXP038575	anti-CTCF, Millipore 07-729	Mus musculus	D39 mutant of CTCF; Phenylhydrazine	NULL	1109	normal	Q61164	spleen-derived Ter119+ erythroid cells	NULL
EXP038576	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038577	ZNF516	Homo sapiens		EXP038576	113	normal	Q92618	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038578		Mus musculus	DMSO	NULL	1110	chip_control	NULL	Eph4 (mammary epithelial cells)	NULL
EXP038579		Mus musculus	AU-1 (5uM)	NULL	1110	chip_control	NULL	Eph4 (mammary epithelial cells)	NULL
EXP038580	Myc	Mus musculus	DMSO	EXP038578	1110	normal	P01108	Eph4 (mammary epithelial cells)	NULL
EXP038581	Myc	Mus musculus	AU-1 (5uM)	EXP038579	1110	normal	P01108	Eph4 (mammary epithelial cells)	NULL
EXP038582	ZEB1	Homo sapiens		NULL	113	normal	P37275	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038583	anti-HA antibody (ab9110, abcam)	Mus musculus	Spinal metastatic tumor	NULL	791	normal	P48985	Sonic Hedgehog medulloblastoma	NULL
EXP038584	anti-HA antibody (ab9110, abcam)	Mus musculus	Primary tumor	NULL	791	normal	P48985	Sonic Hedgehog medulloblastoma	NULL
EXP038585	Control IgG	Mus musculus	Primary tumor	NULL	791	chip_control	NULL	Sonic Hedgehog medulloblastoma	NULL
EXP038586	anti-MAF (Santa Cruz sc-7866)	Homo sapiens	IFN-gamma	NULL	466	normal	O75444	MDM(monocyte derived macrophages)	NULL
EXP038587	anti-MAF (Santa Cruz sc-7866)	Homo sapiens	none	NULL	466	normal	O75444	MDM(monocyte derived macrophages)	NULL
EXP038588	anti-C/EBPB (Santa Cruz sc-150)	Homo sapiens	IFN-gamma	NULL	466	normal	P17676	MDM(monocyte derived macrophages)	NULL
EXP038589	anti-C/EBPB (Santa Cruz sc-150)	Homo sapiens	none	NULL	466	normal	P17676	MDM(monocyte derived macrophages)	NULL
EXP038590	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	IFN-gamma	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP038591	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	none	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP038592	none	Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038593	none	Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038594	none	Mus musculus		NULL	1111	chip_control	NULL	Junb+/+ CD4cre Th17-cells	NULL
EXP038595	none	Mus musculus		NULL	1112	chip_control	NULL	Junb fl/fl CD4cre Th17-cells	NULL
EXP038596	JunB (N-17; sc-46x)	Mus musculus		EXP038592	498	normal	P09450	Th17-cells	NULL
EXP038597	JunB (C-11; sc-8051x)	Mus musculus		EXP038593	498	normal	P09450	Th17-cells	NULL
EXP038598	JunD (329; sc-74x)	Mus musculus		EXP038594	1111	normal	P15066	Junb+/+ CD4cre Th17-cells	NULL
EXP038599	JunD (329; sc-74x)	Mus musculus		EXP038595	1112	normal	P15066	Junb fl/fl CD4cre Th17-cells	NULL
EXP038600	none	Homo sapiens	pooled controls	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP038601	none	Homo sapiens	pooled mutafed samples	NULL	566	chip_control	NULL	lymphoblastoid cells	NULL
EXP038602	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038603	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038604	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038605	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038606	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038607	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Asp380Tyr)	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038608	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Lys179*)	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038609	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1 hemizygous deletion	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038610	YY1, (c-20)X sc-281X lot#F1614 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Leu366Pro)	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038611	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038612	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038613	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038614	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038615	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens		EXP038600	566	normal	P25490	lymphoblastoid cells	NULL
EXP038616	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Asp380Tyr)	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038617	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Lys179*)	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038618	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1 hemizygous deletion	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038619	YY1, (H-414)X sc-1703X lot#A1414 rabbit polyclonal	Homo sapiens	YY1-mutated (p.Leu366Pro)	EXP038601	566	normal	P25490	lymphoblastoid cells	NULL
EXP038620		Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP038621		Homo sapiens		NULL	1113	chip_control	NULL	MCF10AT1 (breast premetastatic epithelial cells)	NULL
EXP038622		Homo sapiens		NULL	1114	chip_control	NULL	MCF10CA1a (breast metastatic epithelial cells)	NULL
EXP038623	CTCF	Homo sapiens		EXP038620	583	normal	P49711	MCF10A (breast epithelial cells)	NULL
EXP038624	CTCF	Homo sapiens		EXP038621	1113	normal	P49711	MCF10AT1 (breast premetastatic epithelial cells)	NULL
EXP038625	CTCF	Homo sapiens		EXP038622	1114	normal	P49711	MCF10CA1a (breast metastatic epithelial cells)	NULL
EXP038626		Mus musculus		NULL	647	chip_control	NULL	natural killer T cells	NULL
EXP038627	Runx1 Abcam; ab23980	Mus musculus		EXP038626	647	normal	Q03347	natural killer T cells	NULL
EXP038628	Spike in antibody only (Active Motif 61686)	Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP038629	Input for CTCF ChIP-seq	Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP038630	CTCF (Active Motif 61311) + Spike in antibody (Active Motif 61686)	Mus musculus		EXP038628	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP038631	CTCF (Active Motif 61311) + Spike in antibody (Active Motif 61686)	Mus musculus		EXP038629	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP038632	CTCF (Active Motif 61311) + Spike in antibody (Active Motif 61686)	Mus musculus	washoff2days	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP038633	none (input)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP038634	none (input)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP038635	none (input)	Homo sapiens	Treatment: shRNA against ERG and then 100ng/mL doxycycline	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP038636	anti-AR (ab108341)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	EXP038633	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP038637	anti-ERG (ab92513)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	EXP038633	71	normal	P11308	VCaP (prostate carcinoma)	NULL
EXP038638	anti-ERF (PA5-30237)	Homo sapiens	Treatment: shRNA against ERG and then vehicle	EXP038634	71	normal	P50548	VCaP (prostate carcinoma)	NULL
EXP038639	anti-ERF (PA5-30237)	Homo sapiens	Treatment: shRNA against ERG and then 100ng/mL doxycycline	EXP038635	71	normal	P50548	VCaP (prostate carcinoma)	NULL
EXP038640	none (input)	Homo sapiens	dox-treated from (day 10 to 23)	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP038641	PAX7 (Developmental Studies Hybridoma Bank)	Homo sapiens	dox-treated from (day 10 to 23)	EXP038640	396	normal	P23759	WA09 (embryonic stem cells)	NULL
EXP038642	normal rabbit IgG (Santa Cruz, sc-2027)	Homo sapiens	10 ng/mL of TNFÎ±	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038643	normal rabbit IgG (Santa Cruz, sc-2027)	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP038644	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens	10 ng/mL of TNFÎ±	NULL	430	normal	Q04206	HepG2 (hepatoblastoma)	NULL
EXP038645	p65 (Santa Cruz, C-20, sc-372)	Homo sapiens		NULL	430	normal	Q04206	HepG2 (hepatoblastoma)	NULL
EXP038646	CTCF	Mus musculus		NULL	1115	normal	Q61164	activated primary B-cells	NULL
EXP038647	CTCF	Mus musculus		NULL	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP038648	CTCF	Mus musculus		NULL	1116	normal	Q61164	resting primary B-cells	NULL
EXP038649	CTCF	Mus musculus		NULL	1117	normal	Q61164	primary T-cells	NULL
EXP038650	Ipt genomic DNA	Mus musculus		NULL	1118	chip_control	NULL	pancreatic ductal adenocarcinoma	NULL
EXP038651	Ipt genomic DNA	Mus musculus		NULL	1118	chip_control	NULL	pancreatic ductal adenocarcinoma	NULL
EXP038652	Ipt genomic DNA	Mus musculus		NULL	1118	chip_control	NULL	pancreatic ductal adenocarcinoma	NULL
EXP038653	Ipt genomic DNA	Mus musculus		NULL	1119	chip_control	NULL	pancreatic ductal adenocarcinoma, liver metastasis	NULL
EXP038654	Ipt genomic DNA	Mus musculus		NULL	1120	chip_control	NULL	pancreatic ductal adenocarcinoma, peritoneum metastasis	NULL
EXP038655	Ipt genomic DNA	Mus musculus		NULL	1120	chip_control	NULL	pancreatic ductal adenocarcinoma, peritoneum metastasis	NULL
EXP038656	Ipt genomic DNA	Mus musculus	Transduced with MSCV/emp retrovirus	NULL	1121	chip_control	NULL	cultured pancreatic ductal adenocarcinoma cells	NULL
EXP038657	Ipt genomic DNA	Mus musculus	transduced with MSCV/FOXA1 retrovirus	NULL	1121	chip_control	NULL	cultured pancreatic ductal adenocarcinoma cells	NULL
EXP038658	Ipt genomic DNA	Mus musculus	Transduced with miR-E/shRen retrovirus	NULL	1119	chip_control	NULL	pancreatic ductal adenocarcinoma, liver metastasis	NULL
EXP038659	Ipt genomic DNA	Mus musculus	Transduced with miR-E/shFoxa1.2959 retrovirus	NULL	1119	chip_control	NULL	pancreatic ductal adenocarcinoma, liver metastasis	NULL
EXP038660	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038650	1118	normal	P35582	pancreatic ductal adenocarcinoma	NULL
EXP038661	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038651	1118	normal	P35582	pancreatic ductal adenocarcinoma	NULL
EXP038662	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038652	1118	normal	P35582	pancreatic ductal adenocarcinoma	NULL
EXP038663	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038653	1119	normal	P35582	pancreatic ductal adenocarcinoma, liver metastasis	NULL
EXP038664	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038654	1120	normal	P35582	pancreatic ductal adenocarcinoma, peritoneum metastasis	NULL
EXP038665	FOXA1 (ab23738; Abcam)	Mus musculus		EXP038655	1120	normal	P35582	pancreatic ductal adenocarcinoma, peritoneum metastasis	NULL
EXP038666	FOXA1 (ab23738; Abcam)	Mus musculus	Transduced with miR-E/shRen retrovirus	EXP038658	1119	normal	P35582	pancreatic ductal adenocarcinoma, liver metastasis	NULL
EXP038667	FOXA1 (ab23738; Abcam)	Mus musculus	Transduced with miR-E/shFoxa1.2959 retrovirus	EXP038659	1119	normal	P35582	pancreatic ductal adenocarcinoma, liver metastasis	NULL
EXP038668	FOXA1 (ab23738; Abcam)	Mus musculus	Transduced with MSCV/emp retrovirus	EXP038656	1121	normal	P35582	cultured pancreatic ductal adenocarcinoma cells	NULL
EXP038669	FOXA1 (ab23738; Abcam)	Mus musculus	transduced with MSCV/FOXA1 retrovirus	EXP038657	1121	normal	P35582	cultured pancreatic ductal adenocarcinoma cells	NULL
EXP038670		Mus musculus		NULL	174	chip_control	NULL	cerebral cortex	NULL
EXP038671		Mus musculus		NULL	174	chip_control	NULL	cerebral cortex	NULL
EXP038672	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	NULL
EXP038673	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	NULL
EXP038674	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	NULL
EXP038675	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	NULL
EXP038676	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	NULL
EXP038677	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	NULL
EXP038678	CTCF	Mus musculus	CK-KO	EXP038671	174	normal	Q61164	cerebral cortex	NULL
EXP038679	CTCF	Mus musculus		EXP038670	174	normal	Q61164	cerebral cortex	NULL
EXP038680	None	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP038681	None	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP038682	None	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP038683	None	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP038684	HA (ab9110)	Homo sapiens	ChimpPRDM9(W11a)_HA	EXP038683	10	normal	Q9NQV7	HEK293T (embryonic kidney)	NULL
EXP038685	V5 (ab9116)	Homo sapiens	ChimpPRDM9(W11a)_V5	NULL	10	normal	Q9NQV7	HEK293T (embryonic kidney)	NULL
EXP038686	HA (ab9110)	Homo sapiens	HumanPRDM9(B)_HA	EXP038683	10	normal	Q9NQV7	HEK293T (embryonic kidney)	NULL
EXP038687	V5 (ab9116)	Homo sapiens	HumanPRDM9(B)_V5	EXP038683	10	normal	Q9NQV7	HEK293T (embryonic kidney)	NULL
EXP038688	GFP (Abcam ab290)	Homo sapiens	YFP_HumanPRDM9(B)	EXP038681	10	normal	Q9NQV7	HEK293T (embryonic kidney)	NULL
EXP038689	Input	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP038690	Input	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP038691	NANOG	Homo sapiens		EXP038689	396	normal	Q9H9S0	WA09 (embryonic stem cells)	NULL
EXP038692	NANOG	Homo sapiens		EXP038690	396	normal	Q9H9S0	WA09 (embryonic stem cells)	NULL
EXP038693	OCT4	Homo sapiens		EXP038689	396	normal	Q01860	WA09 (embryonic stem cells)	NULL
EXP038694	OCT4	Homo sapiens		EXP038690	396	normal	Q01860	WA09 (embryonic stem cells)	NULL
EXP038695	None	Mus musculus	100ng/ml of CNTF (Peprotech) for 15 m	NULL	1122	chip_control	NULL	primary cortical oligodendrocyte progenitors	NULL
EXP038696	p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	Mus musculus	100ng/ml of CNTF (Peprotech) for 15 m	EXP038695	1122	normal	P42227	primary cortical oligodendrocyte progenitors	NULL
EXP038697	none (input)	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP038698	none (input)	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP038699	none (input)	Mus musculus	lipid A	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP038700	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP038701	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP038702	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP038703	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP038704	CEBPb (in-house rabbit polyclonal antisera for mouse CEBP? aa 22-195)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP038705	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 0 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	NULL
EXP038706	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 15 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	NULL
EXP038707	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 30 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	NULL
EXP038708	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 60 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	NULL
EXP038709	CEBPd (Santa Cruz, catalog# sc-151, lot# K1711)	Mus musculus	lipid A 120 min	EXP038699	81	normal	Q00322	BMDM (bone marrow-derived macrophages)	NULL
EXP038710	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP038711	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP038712	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP038713	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP038714	Fos (Santa Cruz, catalog# sc-253, lot# I0808)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP038715	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP038716	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP038717	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP038718	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP038719	JunB (Santa Cruz, catalog# sc-46, lot# F1814)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP038720	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 0 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP038721	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 15 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP038722	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 30 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP038723	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 60 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP038724	JunD (Santa Cruz, catalog# sc-74, lot3 A3015)	Mus musculus	lipid A 120 min	EXP038699	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP038725	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 0 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP038726	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 15 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP038727	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 30 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP038728	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 60 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP038729	ATF3 (Santa Cruz, catalog# sc-188, lot# L2214)	Mus musculus	lipid A 120 min	EXP038699	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP038730	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 0 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038731	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 15 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038732	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 30 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038733	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 60 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038734	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 120 min	EXP038697	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038735	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 0 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038736	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 15 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038737	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 30 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038738	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 60 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038739	RelA (Santa Cruz, catalgo# sc-372, lot# H1114)	Mus musculus	lipid A 120 min; IRF3 KO	EXP038698	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP038740	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 0 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	NULL
EXP038741	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 15 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	NULL
EXP038742	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 30 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	NULL
EXP038743	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 60 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	NULL
EXP038744	CREB (Santa Cruz, catalog# sc-186 lot# C0614)	Mus musculus	lipid A 120 min	EXP038699	81	normal	Q01147	BMDM (bone marrow-derived macrophages)	NULL
EXP038745	IgG	Mus musculus	post IL21	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP038746	IRF4	Mus musculus	IRF4 KO; pre IL21	NULL	1058	normal	Q64287	CD4+ T-cells	NULL
EXP038747	IRF4	Mus musculus	IRF4 KO; post IL21	NULL	1058	normal	Q64287	CD4+ T-cells	NULL
EXP038748	IRF4	Mus musculus	pre IL21	NULL	1058	normal	Q64287	CD4+ T-cells	NULL
EXP038749	IRF4	Mus musculus	post IL21	EXP038745	1058	normal	Q64287	CD4+ T-cells	NULL
EXP038750	STAT3	Mus musculus		NULL	1058	normal	P42227	CD4+ T-cells	NULL
EXP038751	STAT3	Mus musculus		NULL	1058	normal	P42227	CD4+ T-cells	NULL
EXP038752	STAT3	Mus musculus	IRF4 KO; pre IL21	NULL	1058	normal	P42227	CD4+ T-cells	NULL
EXP038753	STAT3	Mus musculus	IRF4 KO; post IL21	NULL	1058	normal	P42227	CD4+ T-cells	NULL
EXP038754	none, input DNA	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP038755	CEBPA sc9314	Mus musculus		EXP038754	5	normal	P53566	liver	NULL
EXP038756	input_DNA	Homo sapiens		NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP038757	input_DNA	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038758	input_DNA	Homo sapiens	doxycycline	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP038759	input_DNA	Homo sapiens		NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP038760	ER	Homo sapiens		EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038761	ER	Homo sapiens	vehicle	EXP038756	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP038762	ER	Homo sapiens	Tam	EXP038756	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP038763	FoxA1	Homo sapiens		EXP038757	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038764	FoxA1	Homo sapiens		EXP038759	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP038765	FoxA1	Homo sapiens		EXP038758	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP038766	FoxA1	Homo sapiens		EXP038756	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP038767	CTCF	Homo sapiens		EXP038757	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038768	ER	Homo sapiens	E2	EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038769	ER	Homo sapiens		EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038770	ER	Homo sapiens	siNT	EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038771	ER	Homo sapiens	siFOXA1	EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038772	FoxA1	Homo sapiens		EXP038757	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038773	CTCF	Homo sapiens		EXP038757	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038774	CTCF	Homo sapiens		EXP038757	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038775	ER	Homo sapiens		EXP038757	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038776	ER	Homo sapiens		EXP038759	874	normal	P03372	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP038777	ER	Homo sapiens		EXP038758	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP038778		Homo sapiens	Tam-Responsive	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038779		Homo sapiens	Tam-Responsive	NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP038780		Homo sapiens	Tam-Responsive	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP038781		Homo sapiens	Tam-Resist	NULL	119	chip_control	NULL	BT-474 (breast invasive ductal carcinoma)	NULL
EXP038782		Homo sapiens	Tam-Resist	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP038783	none (input)	Homo sapiens	ER-	NULL	1123	chip_control	NULL	breast tumor	NULL
EXP038784	none (input)	Homo sapiens	Metastasis	NULL	1124	chip_control	NULL	breast tumour metastasis	NULL
EXP038785	none (input)	Homo sapiens	Non-responder	NULL	1123	chip_control	NULL	breast tumor	NULL
EXP038786	none (input)	Homo sapiens	Responder	NULL	1123	chip_control	NULL	breast tumor	NULL
EXP038787	anti-FOXA1 (AB5089, Abcam)	Homo sapiens	Veh_90	EXP038778	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038788	anti-FOXA1 (AB5089, Abcam)	Homo sapiens	Cocktail_90	EXP038778	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038789	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Cocktail_90	EXP038778	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038790	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Resist	EXP038782	949	normal	P03372	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP038791	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Resist	EXP038781	119	normal	P03372	BT-474 (breast invasive ductal carcinoma)	NULL
EXP038792	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Responsive	EXP038780	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP038793	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Responsive	EXP038779	874	normal	P03372	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP038794	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Tam-Responsive	EXP038778	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP038795	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	ER-	EXP038783	1123	normal	P03372	breast tumor	NULL
EXP038796	ER	Homo sapiens	Metastasis	EXP038784	1124	normal	P03372	breast tumour metastasis	NULL
EXP038797	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Non-responder	NULL	1123	normal	P03372	breast tumor	NULL
EXP038798	anti-ER (SC-543, Santa Cruz Biotechnologies)	Homo sapiens	Responder	EXP038786	1123	normal	P03372	breast tumor	NULL
EXP038799		Mus musculus	IRF4 wt	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038800		Mus musculus	IRF4 ko	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038801		Mus musculus	IRF4 wt; 48h	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038802		Mus musculus	IRF4 ko; 48h	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038803		Mus musculus	Batf +/+; 48h	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038804		Mus musculus	Batf -/-; 48h	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038805		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038806		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038807		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038808		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038809		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038810		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038811		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038812		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038813		Mus musculus		NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038814		Mus musculus	Batf wt	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038815		Mus musculus	Batf ko	NULL	830	chip_control	NULL	Th0-cells	NULL
EXP038816		Mus musculus	16h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038817		Mus musculus	16h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038818		Mus musculus	16h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038819		Mus musculus	3h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038820		Mus musculus	3h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038821		Mus musculus	Batf +/+; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038822		Mus musculus	Batf -/-; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038823		Mus musculus	IRF4 wt; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038824		Mus musculus	IRF4 wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038825		Mus musculus	IRF4 ko; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038826		Mus musculus	48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038827		Mus musculus	48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038828		Mus musculus	48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038829		Mus musculus	48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038830		Mus musculus	48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038831		Mus musculus	Stat3 +/+ CD4-Cre; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038832		Mus musculus	Stat3 fl/fl CD4-Cre; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038833		Mus musculus	Batf +/+; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038834		Mus musculus	Batf -/-; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038835		Mus musculus	IRF4 +/+; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038836		Mus musculus	IRF4 -/-; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038837		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038838		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038839		Mus musculus	IRF4 ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038840		Mus musculus	RORg ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038841		Mus musculus	STAT3 ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038842		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038843		Mus musculus	RORg wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038844		Mus musculus	RORg ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038845		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038846		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038847		Mus musculus	RORg wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038848		Mus musculus	RORg ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038849		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038850		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038851		Mus musculus	RORg wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038852		Mus musculus	RORg ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038853		Mus musculus	c-Maf ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038854		Mus musculus	B-ATF ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038855		Mus musculus	RORg wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038856		Mus musculus	RORg ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038857		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038858		Mus musculus	RORg wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038859		Mus musculus	RORg ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038860		Mus musculus		NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038861		Mus musculus	Batf wt	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038862		Mus musculus	Batf ko	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038863	B-ATF	Mus musculus		EXP038811	830	normal	O35284	Th0-cells	NULL
EXP038864	B-ATF	Mus musculus		EXP038812	830	normal	O35284	Th0-cells	NULL
EXP038865	B-ATF	Mus musculus		EXP038850	498	normal	O35284	Th17-cells	NULL
EXP038866	B-ATF	Mus musculus		EXP038850	498	normal	O35284	Th17-cells	NULL
EXP038867	B-ATF	Mus musculus	B-ATF ko	EXP038854	498	bio_control	O35284	Th17-cells	NULL
EXP038868	Batf	Mus musculus	IRF4 wt	EXP038799	830	normal	O35284	Th0-cells	NULL
EXP038869	Batf	Mus musculus	IRF4 ko	EXP038800	830	normal	O35284	Th0-cells	NULL
EXP038870	Batf	Mus musculus	IRF4 wt	EXP038801	830	normal	O35284	Th0-cells	NULL
EXP038871	Batf	Mus musculus	IRF4 ko	EXP038802	830	normal	O35284	Th0-cells	NULL
EXP038872	BATF	Mus musculus	16h	EXP038818	498	normal	O35284	Th17-cells	NULL
EXP038873	Batf	Mus musculus	IRF4 wt	EXP038823	498	normal	O35284	Th17-cells	NULL
EXP038874	Batf	Mus musculus	IRF4 ko	NULL	498	normal	O35284	Th17-cells	NULL
EXP038875	Batf	Mus musculus	IRF4 wt	EXP038824	498	normal	O35284	Th17-cells	NULL
EXP038876	Batf	Mus musculus	IRF4 ko	EXP038825	498	normal	O35284	Th17-cells	NULL
EXP038877	c-Maf	Mus musculus		EXP038808	830	normal	P54843	Th0-cells	NULL
EXP038878	c-Maf	Mus musculus		EXP038846	498	normal	P54843	Th17-cells	NULL
EXP038879	c-Maf	Mus musculus		EXP038846	498	normal	P54843	Th17-cells	NULL
EXP038880	c-Maf	Mus musculus	c-Maf ko	EXP038853	498	bio_control	P54843	Th17-cells	NULL
EXP038881	CTCF	Mus musculus		EXP038812	830	normal	Q61164	Th0-cells	NULL
EXP038882	CTCF	Mus musculus		EXP038813	830	normal	Q61164	Th0-cells	NULL
EXP038883	CTCF	Mus musculus		EXP038849	498	normal	Q61164	Th17-cells	NULL
EXP038884	CTCF	Mus musculus		EXP038857	498	normal	Q61164	Th17-cells	NULL
EXP038885	Etv6	Mus musculus		EXP038827	498	normal	P97360	Th17-cells	NULL
EXP038886	Etv6	Mus musculus	48h	EXP038830	498	normal	P97360	Th17-cells	NULL
EXP038887	Fra	Mus musculus		EXP038809	830	normal	P47930	Th0-cells	NULL
EXP038888	Fra2	Mus musculus		EXP038845	498	normal	P47930	Th17-cells	NULL
EXP038889	Fra2	Mus musculus		EXP038860	498	normal	P47930	Th17-cells	NULL
EXP038890	Hif1a	Mus musculus	48h	EXP038826	498	normal	Q61221	Th17-cells	NULL
EXP038891	Hif1a	Mus musculus	48h	EXP038828	498	normal	Q61221	Th17-cells	NULL
EXP038892	IRF4	Mus musculus	Batf +/+; 48h	EXP038803	830	normal	Q64287	Th0-cells	NULL
EXP038893	IRF4	Mus musculus	Batf -/-; 48h	EXP038804	830	normal	Q64287	Th0-cells	NULL
EXP038894	IRF4	Mus musculus		EXP038805	830	normal	Q64287	Th0-cells	NULL
EXP038895	IRF4	Mus musculus		EXP038807	830	normal	Q64287	Th0-cells	NULL
EXP038896	IRF4	Mus musculus	Batf wt	EXP038814	830	normal	Q64287	Th0-cells	NULL
EXP038897	IRF4	Mus musculus	Batf ko	EXP038815	830	normal	Q64287	Th0-cells	NULL
EXP038898	IRF4	Mus musculus	16h	EXP038817	498	normal	Q64287	Th17-cells	NULL
EXP038899	IRF4	Mus musculus	3h	EXP038820	498	normal	Q64287	Th17-cells	NULL
EXP038900	IRF4	Mus musculus	Batf +/+; 48h	EXP038821	498	normal	Q64287	Th17-cells	NULL
EXP038901	IRF4	Mus musculus	Batf -/-; 48h	EXP038822	498	normal	Q64287	Th17-cells	NULL
EXP038902	IRF4	Mus musculus		EXP038837	498	normal	Q64287	Th17-cells	NULL
EXP038903	IRF4	Mus musculus	IRF4 ko	EXP038839	498	bio_control	Q64287	Th17-cells	NULL
EXP038904	IRF4	Mus musculus	RORg wt	EXP038847	498	normal	Q64287	Th17-cells	NULL
EXP038905	IRF4	Mus musculus	RORg ko	EXP038848	498	normal	Q64287	Th17-cells	NULL
EXP038906	IRF4	Mus musculus	RORg wt	EXP038855	498	normal	Q64287	Th17-cells	NULL
EXP038907	IRF4	Mus musculus	RORg ko	EXP038856	498	normal	Q64287	Th17-cells	NULL
EXP038908	IRF4	Mus musculus	Batf wt	EXP038861	498	normal	Q64287	Th17-cells	NULL
EXP038909	IRF4	Mus musculus	Batf ko	EXP038862	498	normal	Q64287	Th17-cells	NULL
EXP038910	RORg	Mus musculus		EXP038813	830	normal	P51450	Th0-cells	NULL
EXP038911	RORg	Mus musculus	RORg ko	EXP038840	498	bio_control	P51450	Th17-cells	NULL
EXP038912	RORg	Mus musculus		EXP038842	498	normal	P51450	Th17-cells	NULL
EXP038913	RORg	Mus musculus		EXP038846	498	normal	P51450	Th17-cells	NULL
EXP038914	STAT3	Mus musculus		EXP038813	830	normal	P42227	Th0-cells	NULL
EXP038915	Stat3	Mus musculus	16h	EXP038816	498	normal	P42227	Th17-cells	NULL
EXP038916	Stat3	Mus musculus	3h	EXP038819	498	normal	P42227	Th17-cells	NULL
EXP038917	STAT3	Mus musculus		EXP038838	498	normal	P42227	Th17-cells	NULL
EXP038918	STAT3	Mus musculus		EXP038838	498	normal	P42227	Th17-cells	NULL
EXP038919	STAT3	Mus musculus	STAT3 ko	EXP038841	498	bio_control	P42227	Th17-cells	NULL
EXP038920	STAT3	Mus musculus	RORg wt	EXP038847	498	normal	P42227	Th17-cells	NULL
EXP038921	STAT3	Mus musculus	RORg ko	EXP038848	498	normal	P42227	Th17-cells	NULL
EXP038922	STAT3	Mus musculus	RORg wt	EXP038855	498	normal	P42227	Th17-cells	NULL
EXP038923	STAT3	Mus musculus	RORg ko	EXP038856	498	normal	P42227	Th17-cells	NULL
EXP038924		Mus musculus	IRF4 ko; 48h	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP038925	none	Mus musculus		NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP038926	Pou5f1/Oct4 SC8628	Mus musculus		NULL	292	normal	P20263	F9 (embryonal carcinoma)	NULL
EXP038927	Pou5f1/Oct4 SC8628	Mus musculus	Treated with retinoic acid; Differentiated into primitive endoderm-like cells	NULL	292	normal	P20263	F9 (embryonal carcinoma)	NULL
EXP038928	Sox17 AF1924	Mus musculus	Treated with retinoic acid; Differentiated into primitive endoderm-like cells	NULL	292	normal	Q61473	F9 (embryonal carcinoma)	NULL
EXP038929	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox17-V5 tagged	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	NULL
EXP038930	V5 R96025	Mus musculus	Overexpress Sox2-V5 tagged	EXP038925	521	normal	P48432	KH2 (embryonic stem cells)	NULL
EXP038931	Sox17 AF1924, V5 R96025	Mus musculus	Overexpress Sox17-V5 tagged	EXP038925	521	normal	Q61473	KH2 (embryonic stem cells)	NULL
EXP038932	V5 R96025	Mus musculus	Overexpress Sox2KE-V5 tagged; Sox2KE variant	EXP038925	521	normal	P48432	KH2 (embryonic stem cells)	NULL
EXP038933	V5 R96025	Mus musculus	Overexpress Sox17EK-V5 tagged; Sox17EK variant	EXP038925	521	normal	Q61473	KH2 (embryonic stem cells)	NULL
EXP038934	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox2-V5 tagged	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	NULL
EXP038935	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox2KE-V5 tagged; Sox2KE	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	NULL
EXP038936	Pou5f1/Oct4 SC8628, V5 R96025	Mus musculus	Overexpress Sox17EK-V5 tagged; Sox17EK	EXP038925	521	normal	P20263	KH2 (embryonic stem cells)	NULL
EXP038937	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP038938	ZC3H8	Homo sapiens		EXP038937	417	normal	Q8N5P1	HCT-116 (colon carcinoma)	NULL
EXP038939	none	Mus musculus		NULL	970	chip_control	NULL	spleen B-cells	NULL
EXP054552	none (input)	Homo sapiens	Genotype: pCI1-EGFP; 	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP038943	none	Mus musculus		NULL	970	chip_control	NULL	spleen B-cells	NULL
EXP054551	none (input)	Homo sapiens	Genotype: HSP70K71E-EGFP; 	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP038945	c-Myc N262 (Santa Cruz, catalog# sc764, lot#G0111)	Mus musculus		EXP038943	970	normal	P01108	spleen B-cells	NULL
EXP038946	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Homo sapiens	0.2 Âµg/mL Tetracycline (Myc transgene repressed)	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP038947	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Homo sapiens	200 nM OHT (endogenous Myc activated) and 0.2 Âµg/mL Tetracyclin (Myc transgene repressed)	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP038948	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Homo sapiens	none (Myc transgene expressed)	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP038949	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Mus musculus	c-mycflox/flox; in vitro infected with MycER; EtOH	EXP038940	22	normal	P01108	3T9 fibroblasts	NULL
EXP038950	c-Myc N262 (Santa Cruz , catalog# sc764, lot#G0111)	Mus musculus	c-mycflox/flox; in vitro infected with MycER; 400 nM 4-hydroxytamoxifen	EXP038940	22	normal	P01108	3T9 fibroblasts	NULL
EXP038951	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Homo sapiens	0.2 Âµg/mL Tetracycline (Myc transgene repressed) for 72h and then released in fresh medium without Tetracycline for 1h	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP038952	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Homo sapiens	0.2 Âµg/mL Tetracycline (Myc transgene repressed) for 72h and then released in fresh medium without Tetracycline for 24h	EXP038941	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP038953	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Mus musculus		EXP038942	22	normal	P01108	3T9 fibroblasts	NULL
EXP038954	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Mus musculus	serum starved (0% FBS for 48h), then serum stimulated (10% FBS for 1h)	EXP038940	22	normal	P01108	3T9 fibroblasts	NULL
EXP038955	c-Myc N262 (Santa Cruz, catalog# sc764, lot# G0111)	Mus musculus	serum starved (0% FBS for 48h), then serum stimulated (10% FBS for 2h)	EXP038942	22	normal	P01108	3T9 fibroblasts	NULL
EXP038956	c-Myc N262 (Santa Cruz, catalog# sc764, lot#G0111)	Mus musculus		NULL	970	normal	P01108	spleen B-cells	NULL
EXP038957	c-Myc N262 (Santa Cruz, catalog# sc764, lot#G0111)	Mus musculus		NULL	1125	normal	P01108	B-cells, lymphnode-derived	NULL
EXP038958	ERa HC20 sc-543	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with 100nM 4-OHT for 24h.	NULL	583	normal	P03372	MCF10A (breast epithelial cells)	NULL
EXP038959	ERa HC20 sc-543	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with solvent control for 24h.	NULL	583	normal	P03372	MCF10A (breast epithelial cells)	NULL
EXP038960	ERa HC20 sc-543	Homo sapiens	Cells were lentivirally transduced with MYC-ER and stable pools were treated with solvent control for 24h.	NULL	583	normal	P03372	MCF10A (breast epithelial cells)	NULL
EXP038961	10E2 (anti-MIZ1)	Homo sapiens		NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	NULL
EXP038962	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with 100nM 4-OHT for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	NULL
EXP038963	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with solvent control for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	NULL
EXP038964	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ER and stable pools were treated with 100nM 4-OHT for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	NULL
EXP038965	10E2 (anti-MIZ1)	Homo sapiens	Cells were lentivirally transduced with MYC-ER and stable pools were treated with solvent control for 24h.	NULL	583	normal	Q13105	MCF10A (breast epithelial cells)	NULL
EXP038966	none	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	NULL	1126	chip_control	NULL	E14TG2a.4 (embryonic stem cells)	NULL
EXP038967	none	Mus musculus		NULL	1126	chip_control	NULL	E14TG2a.4 (embryonic stem cells)	NULL
EXP038968	none	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	NULL	1126	chip_control	NULL	E14TG2a.4 (embryonic stem cells)	NULL
EXP038969	none	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. 	NULL	237	chip_control	NULL	embryoid body	NULL
EXP038970	none	Mus musculus	Trp53-/-, p73shRNA; Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	NULL	237	chip_control	NULL	embryoid body	NULL
EXP038971	anti-Smad2/3	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	EXP038966	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	NULL
EXP038972	anti-Smad2/3	Mus musculus	SB431542 (Tocris, #1614) were used at 10Î¼M	NULL	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	NULL
EXP038973	anti-Tcf3	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	EXP038966	1126	normal	P15806	E14TG2a.4 (embryonic stem cells)	NULL
EXP038974	anti-Smad2/3	Mus musculus		EXP038967	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	NULL
EXP038975	anti-Tcf3	Mus musculus		EXP038967	1126	normal	P15806	E14TG2a.4 (embryonic stem cells)	NULL
EXP038976	anti-p53(FL-393) and anti-p53(M19)	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. 	EXP038968	1126	normal	P02340	E14TG2a.4 (embryonic stem cells)	NULL
EXP038977	anti-p53(FL-393) and anti-p53(M19)	Mus musculus	SB431542 (Tocris, #1614) were used at 10Î¼M	NULL	1126	normal	P02340	E14TG2a.4 (embryonic stem cells)	NULL
EXP038978	anti-Smad2/3	Mus musculus	Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml.	EXP038969	237	normal	Q62432	embryoid body	NULL
EXP038979	anti-Smad2/3	Mus musculus	SB431542 (Tocris, #1614) were used at 10Î¼M	NULL	237	normal	Q62432	embryoid body	NULL
EXP038980	anti-Smad2/3	Mus musculus	Trp53-/-, p73shRNA; Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. 	EXP038970	237	normal	Q62432	embryoid body	NULL
EXP038981	anti-Smad2/3	Mus musculus	Trp53-/-, p73shRNA; SB431542 (Tocris, #1614) were used at 10Î¼M	EXP038970	237	normal	Q62432	embryoid body	NULL
EXP038982		Mus musculus		NULL	1127	chip_control	NULL	E13.5 brain	NULL
EXP038983		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038984		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038985		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038986		Mus musculus	truncated Myt1l(200-623)	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP038987	Myt1la (rabbit)	Mus musculus		EXP038983	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038988	Myt1la (rabbit)	Mus musculus		EXP038984	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038989	Myt1lab	Mus musculus		EXP038982	1127	normal	P97500	E13.5 brain	NULL
EXP038990	Myt1lb (rabbit)	Mus musculus		EXP038983	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038991	Myt1lb (rabbit)	Mus musculus		EXP038984	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038992	Myt1lb (rabbit)	Mus musculus		EXP038985	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038993	Myt1lb (rabbit)	Mus musculus	truncated Myt1l(200-623)	EXP038986	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038994	Myt1lb (rabbit)	Mus musculus		NULL	12	normal	P97500	MEF (mouse embryonic fibroblasts)	NULL
EXP038995	None	Mus musculus	ESCs medium (+Lif)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP038996	None	Mus musculus	ESCs medium (+Lif) and 2i	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP038997	None	Mus musculus	ESCs medium (+Lif) and 2i; Prdm15KO	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP038998	None	Mus musculus	ESCs medium (+Lif) and 2i; Differentiation by culture in KOSR medium without Lif for 3 or 6 days; PRDM15KO 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP038999	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif)	EXP038995	2	normal	E9Q8T2	mESCs (mouse embryonic stem cells)	NULL
EXP039000	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif) and 2i; Prdm15KO	EXP038997	2	bio_control	E9Q8T2	mESCs (mouse embryonic stem cells)	NULL
EXP039001	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif) and 2i; Differentiation by culture in KOSR medium without Lif for 3 or 6 days; Prdm15KO	EXP038998	2	bio_control	E9Q8T2	mESCs (mouse embryonic stem cells)	NULL
EXP039002	PRDM15 antibody (in house)	Mus musculus	ESCs medium (+Lif) and 2i; Differentiation by culture in KOSR medium without Lif for 3 or 6 days	EXP038996	2	normal	E9Q8T2	mESCs (mouse embryonic stem cells)	NULL
EXP039003	none	Homo sapiens	none	NULL	1128	chip_control	NULL	CLB-Ga (neuroblastoma)	NULL
EXP039004	phox2b sc-376997X (mouse monoclonal)	Homo sapiens	none	EXP039003	1128	normal	Q99453	CLB-Ga (neuroblastoma)	NULL
EXP039005	GATA3 sc-22206X (goat polyclonal)	Homo sapiens	none	EXP039003	1128	normal	P23771	CLB-Ga (neuroblastoma)	NULL
EXP039006	hand2 sc-9409 (goat polyclonal)	Homo sapiens	none	EXP039003	1128	normal	P61296	CLB-Ga (neuroblastoma)	NULL
EXP039007	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP039008	none	Homo sapiens	ZBTB48 KO	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP039009	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP039010	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP039011	ZBTB48 (ab1)	Homo sapiens	ZBTB48 KO	EXP039010	78	bio_control	P10074	HeLa (cervical adenocarcinoma)	NULL
EXP039012	ZBTB48 (ab2)	Homo sapiens	ZBTB48 KO	EXP039010	78	bio_control	P10074	HeLa (cervical adenocarcinoma)	NULL
EXP039013	ZBTB48 (ab1)	Homo sapiens		EXP039007	78	normal	P10074	HeLa (cervical adenocarcinoma)	NULL
EXP039014	ZBTB48 (ab2)	Homo sapiens		EXP039007	78	normal	P10074	HeLa (cervical adenocarcinoma)	NULL
EXP039015	ZBTB48 (ab1)	Homo sapiens	ZBTB48 KO	EXP039008	848	bio_control	P10074	U2OS (osteosarcoma)	NULL
EXP039016	ZBTB48 (ab2)	Homo sapiens	ZBTB48 KO	EXP039008	848	bio_control	P10074	U2OS (osteosarcoma)	NULL
EXP039017	ZBTB48 (ab1)	Homo sapiens		EXP039009	848	normal	P10074	U2OS (osteosarcoma)	NULL
EXP039018	ZBTB48 (ab2)	Homo sapiens		EXP039009	848	normal	P10074	U2OS (osteosarcoma)	NULL
EXP039019		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP039020		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039021		Homo sapiens		NULL	1179	chip_control	NULL	tibial nerve	NULL
EXP039022		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039023		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP039024		Homo sapiens		NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP039025		Homo sapiens		NULL	1179	chip_control	NULL	tibial nerve	NULL
EXP039026		Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039027		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039028		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039029		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039030		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP039031		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP039032		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039033		Homo sapiens	1 h with 0.02% Ethanol (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039034		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039035		Homo sapiens		NULL	1148	chip_control	NULL	esophagus squamous epithelium	NULL
EXP039036		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039037		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP039038		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039039		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039040		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039041		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039042		Homo sapiens		NULL	1172	chip_control	NULL	adrenal gland	NULL
EXP039043		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039044		Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP039045		Homo sapiens		NULL	1142	chip_control	NULL	Peyer's patch	NULL
EXP039046	sc-2027	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039047		Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP039048		Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP039049		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039050		Homo sapiens		NULL	1132	chip_control	NULL	heart left ventricle	NULL
EXP039051		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP039052		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039053		Homo sapiens		NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP039054		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039055		Homo sapiens		NULL	1158	chip_control	NULL	vagina	NULL
EXP039056		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039057		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039058		Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039059		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039060		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039061		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039062		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039063		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039064		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039065		Homo sapiens		NULL	633	chip_control	NULL	spleen	NULL
EXP039066		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039067		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039068		Homo sapiens		NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP039069		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039070		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP039071		Homo sapiens		NULL	1178	chip_control	NULL	coronary artery	NULL
EXP039072		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039073		Homo sapiens		NULL	633	chip_control	NULL	spleen	NULL
EXP039074		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039075		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039076		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039077		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039078		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039079		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039080		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039081		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039082		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039083		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039084		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP039085		Mus musculus		NULL	142	chip_control	NULL	intestine	NULL
EXP039086		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039087		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039088		Homo sapiens		NULL	1136	chip_control	NULL	gastrocnemius medialis	NULL
EXP039089		Homo sapiens		NULL	1164	chip_control	NULL	uterus	NULL
EXP039090		Homo sapiens		NULL	1168	chip_control	NULL	thyroid gland	NULL
EXP039091		Homo sapiens		NULL	686	chip_control	NULL	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP039092		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP039093		Mus musculus		NULL	810	chip_control	NULL	stomach	NULL
EXP039094		Homo sapiens		NULL	1150	chip_control	NULL	ovary	NULL
EXP039095		Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039096		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039097		Homo sapiens		NULL	633	chip_control	NULL	spleen	NULL
EXP039098		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039099		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP039100		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039101		Homo sapiens		NULL	1149	chip_control	NULL	testis	NULL
EXP039102		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP039103		Homo sapiens		NULL	1175	chip_control	NULL	prostate gland	NULL
EXP039104		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039105		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039106		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039107		Homo sapiens		NULL	221	chip_control	NULL	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP039108		Homo sapiens		NULL	1180	chip_control	NULL	neural cell	NULL
EXP039109		Homo sapiens		NULL	1176	chip_control	NULL	ascending aorta	NULL
EXP039110		Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP039111		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039112		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039113		Homo sapiens		NULL	1138	chip_control	NULL	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP039114	sc-2027	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039115		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP039116		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP054147	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: control non-targeting siRNA pool, none (uninfected);	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039118		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039119		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039120		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039121		Homo sapiens		NULL	1162	chip_control	NULL	thoracic aorta	NULL
EXP039122		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039123		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039124		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039125		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP039126		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP039127		Homo sapiens		NULL	1149	chip_control	NULL	testis	NULL
EXP039128		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039129		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP039130		Homo sapiens		NULL	633	chip_control	NULL	spleen	NULL
EXP039131		Homo sapiens		NULL	1184	chip_control	NULL	GM23338	NULL
EXP039132		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039133		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP039134		Homo sapiens		NULL	1184	chip_control	NULL	GM23338	NULL
EXP039135		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039136		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039137		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039138		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039139		Homo sapiens		NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP039140		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039141		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP039142		Homo sapiens		NULL	1148	chip_control	NULL	esophagus squamous epithelium	NULL
EXP039143		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039144		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039145		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039146		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039147		Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP039148		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039149		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039150		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039151		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039152		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039153		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039154		Homo sapiens		NULL	1140	chip_control	NULL	subcutaneous adipose tissue	NULL
EXP039155		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039156		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039157		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039158		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039159		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039160		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039161		Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP039162		Homo sapiens		NULL	1179	chip_control	NULL	tibial nerve	NULL
EXP039163		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039164		Mus musculus		NULL	313	chip_control	NULL	forebrain	NULL
EXP039165		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039166		Mus musculus		NULL	1147	chip_control	NULL	midbrain	NULL
EXP039167		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP039168		Homo sapiens		NULL	1135	chip_control	NULL	right atrium auricular region	NULL
EXP039169		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039170		Homo sapiens		NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP039171		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039172		Homo sapiens		NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP039173		Homo sapiens		NULL	1140	chip_control	NULL	subcutaneous adipose tissue	NULL
EXP039174		Homo sapiens		NULL	920	chip_control	NULL	pancreas	NULL
EXP039175		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039176		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039177		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039178		Homo sapiens		NULL	1150	chip_control	NULL	ovary	NULL
EXP039179		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039180		Homo sapiens		NULL	1136	chip_control	NULL	gastrocnemius medialis	NULL
EXP039181		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039182		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039183		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039184		Homo sapiens		NULL	1142	chip_control	NULL	Peyer's patch	NULL
EXP039185		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039186		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP039187		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039188		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039189		Homo sapiens		NULL	1166	chip_control	NULL	epithelial cell of prostate	NULL
EXP039190		Homo sapiens		NULL	1170	chip_control	NULL	lower leg skin	NULL
EXP039191		Homo sapiens		NULL	920	chip_control	NULL	pancreas	NULL
EXP039192		Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP039193		Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039194		Homo sapiens		NULL	1170	chip_control	NULL	lower leg skin	NULL
EXP039195		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039196		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039197		Homo sapiens		NULL	1142	chip_control	NULL	Peyer's patch	NULL
EXP039198		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039199		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP039200		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039201		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039202		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP039203		Homo sapiens		NULL	1168	chip_control	NULL	thyroid gland	NULL
EXP039204		Homo sapiens		NULL	920	chip_control	NULL	pancreas	NULL
EXP039205		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039206		Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP039207		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP039208		Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039209		Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	NULL	1145	chip_control	NULL	bipolar neuron	NULL
EXP039210		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP039211		Homo sapiens		NULL	1148	chip_control	NULL	esophagus squamous epithelium	NULL
EXP039212	sc-2027	Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039213		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP039214		Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039215		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039216		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039217		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039218		Homo sapiens		NULL	1170	chip_control	NULL	lower leg skin	NULL
EXP039219		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP039220		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039221		Homo sapiens		NULL	929	chip_control	NULL	neutrophils	NULL
EXP039222		Homo sapiens		NULL	1172	chip_control	NULL	adrenal gland	NULL
EXP039223		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039224		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039225		Homo sapiens		NULL	920	chip_control	NULL	pancreas	NULL
EXP039226		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP039227		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039228		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039229		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039230		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039231		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039232		Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP039233		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039234		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039235		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039236		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039237		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039238		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039239		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039240		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039241		Homo sapiens		NULL	1132	chip_control	NULL	heart left ventricle	NULL
EXP039242		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039243		Homo sapiens		NULL	1151	chip_control	NULL	right lobe of liver	NULL
EXP039244		Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP039245		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP039246		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039247		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039248		Homo sapiens		NULL	900	chip_control	NULL	hepatocytes	NULL
EXP039249		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039250		Homo sapiens		NULL	1131	chip_control	NULL	tibial artery	NULL
EXP039251	eGFP	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039252		Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	NULL	1145	chip_control	NULL	bipolar neuron	NULL
EXP039253		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP039254		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP039255		Homo sapiens		NULL	1168	chip_control	NULL	thyroid gland	NULL
EXP039256		Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039257		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039258		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039259		Homo sapiens		NULL	1136	chip_control	NULL	gastrocnemius medialis	NULL
EXP039260		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039261		Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP039262		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP039263		Homo sapiens		NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP039264		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039265		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039266		Homo sapiens		NULL	1158	chip_control	NULL	vagina	NULL
EXP039267		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039268		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039269		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039270		Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP039271		Homo sapiens		NULL	920	chip_control	NULL	pancreas	NULL
EXP039272		Homo sapiens		NULL	1148	chip_control	NULL	esophagus squamous epithelium	NULL
EXP039273		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039274		Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039275		Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039276		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP039277		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039278		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039279		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039280		Homo sapiens		NULL	1148	chip_control	NULL	esophagus squamous epithelium	NULL
EXP039281		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP039282		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP039283		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP039284		Homo sapiens		NULL	1172	chip_control	NULL	adrenal gland	NULL
EXP039285		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039286		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039287		Homo sapiens		NULL	1164	chip_control	NULL	uterus	NULL
EXP039288		Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP039289		Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	NULL	1145	chip_control	NULL	bipolar neuron	NULL
EXP039290		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP039291		Homo sapiens		NULL	1182	chip_control	NULL	RWPE2	NULL
EXP039292		Homo sapiens		NULL	1172	chip_control	NULL	adrenal gland	NULL
EXP039293		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039294		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP039295		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039296		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP039297		Homo sapiens		NULL	1170	chip_control	NULL	lower leg skin	NULL
EXP039298		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP039299		Homo sapiens		NULL	1142	chip_control	NULL	Peyer's patch	NULL
EXP039300		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP039301		Homo sapiens		NULL	1175	chip_control	NULL	prostate gland	NULL
EXP039302		Homo sapiens		NULL	879	chip_control	NULL	liver	NULL
EXP039303		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039304		Mus musculus		NULL	137	chip_control	NULL	hindbrain	NULL
EXP039305		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039306		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039307		Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP039308		Mus musculus		NULL	523	chip_control	NULL	kidney	NULL
EXP039309		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP039310	07-729	Homo sapiens		EXP039296	1169	normal	P49711	sigmoid colon	NULL
EXP039311	ab290	Homo sapiens		EXP039092	421	normal	Q13398	HEK293 (embryonic kidney)	NULL
EXP039312	sc-9144	Homo sapiens		EXP039220	356	normal	Q00613	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039313	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039257	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039314	A300-754A	Homo sapiens		EXP039188	356	normal	Q99081	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039315	F1804	Homo sapiens		EXP039140	430	normal	P10828	HepG2 (hepatoblastoma)	NULL
EXP039316	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q3SY52	HEK293 (embryonic kidney)	NULL
EXP039317	A300-348A	Homo sapiens		EXP039074	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039318	ab290	Homo sapiens		EXP039092	421	normal	Q02447	HEK293 (embryonic kidney)	NULL
EXP039319	goat-anti-GFP-UC	Homo sapiens		EXP039145	514	normal	Q9Y473	K562 (myelogenous leukemia)	NULL
EXP039320	A302-473A	Homo sapiens		EXP039034	514	normal	O60315	K562 (myelogenous leukemia)	NULL
EXP039321	07-729	Homo sapiens		EXP039097	633	normal	P49711	spleen	NULL
EXP039322	ab290	Homo sapiens		EXP039092	421	normal	Q9BU19	HEK293 (embryonic kidney)	NULL
EXP039323	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q96K83	HEK293 (embryonic kidney)	NULL
EXP039324	sc-1003	Homo sapiens	1 h with 5 nM Dexamethasone (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039325	sc-1003	Homo sapiens	1 h with 500 pM Dexamethasone (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039326	sc-1003	Homo sapiens	1 h with 50 nM Dexamethasone (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039327	A302-765A	Homo sapiens		EXP039020	430	normal	P27540	HepG2 (hepatoblastoma)	NULL
EXP039328	07-729	Homo sapiens		EXP039194	1170	normal	P49711	lower leg skin	NULL
EXP039329	GTX114991	Homo sapiens		EXP039076	356	normal	P55347	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039330	ab290	Homo sapiens		EXP039092	421	normal	Q96MX3	HEK293 (embryonic kidney)	NULL
EXP039331	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039332	ab55744	Homo sapiens		EXP039046	113	normal	Q16656	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039333	sc-8984	Homo sapiens		EXP039046	113	normal	P36956	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039334	07-729	Homo sapiens		EXP039207	1167	normal	P49711	esophagus muscularis mucosa	NULL
EXP039335	HPA030062	Homo sapiens		EXP039240	113	normal	Q06710	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039336	F1804	Homo sapiens		EXP039140	430	normal	Q9NP66	HepG2 (hepatoblastoma)	NULL
EXP039337	61311	Mus musculus		EXP039093	810	normal	Q61164	stomach	NULL
EXP039338	ab290	Homo sapiens		EXP039092	421	normal	Q9BWM5	HEK293 (embryonic kidney)	NULL
EXP039339	goat-anti-GFP-UC	Homo sapiens		EXP039228	514	normal	Q15329	K562 (myelogenous leukemia)	NULL
EXP039340	ab290	Homo sapiens		EXP039092	421	normal	Q8NBF1	HEK293 (embryonic kidney)	NULL
EXP039341	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039342	GTX114991	Homo sapiens		EXP039232	10	normal	P55347	HEK293T (embryonic kidney)	NULL
EXP039343	ab290	Homo sapiens		EXP039092	421	normal	Q2M1K9	HEK293 (embryonic kidney)	NULL
EXP039344	sc-543	Homo sapiens	1 h with 10 nM Estradiol (Myers)	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP039345	sc-74	Homo sapiens		EXP039193	879	normal	P17535	liver	NULL
EXP039346	sc-543	Homo sapiens	1 h with 100 nM Genistein (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP039347	WH0002120M1	Homo sapiens		EXP039105	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039348	sc-1003	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010555	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	NULL
EXP039349	sc-543	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP039350	goat-anti-GFP-UC	Homo sapiens		EXP039165	514	normal	O43889	K562 (myelogenous leukemia)	NULL
EXP039351	sc-1003	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039352	ab290	Homo sapiens		EXP039092	421	normal	A8K8V0	HEK293 (embryonic kidney)	NULL
EXP039353	sc-543	Homo sapiens	1 h with 10 nM Estradiol (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP039354	sc-543	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP039355	sc-1003	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039026	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039356	sc-543	Homo sapiens	1 h with 100 nM Genistein (Myers)	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP039357	sc-1003	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP039026	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039358	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q6ZS27	HEK293 (embryonic kidney)	NULL
EXP039359	F1804	Homo sapiens		EXP039140	430	normal	P48380	HepG2 (hepatoblastoma)	NULL
EXP039360	sc-1003	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010555	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	NULL
EXP039361	goat-anti-GFP-UC	Homo sapiens		EXP039111	514	normal	P18847	K562 (myelogenous leukemia)	NULL
EXP039362	F1804	Homo sapiens		EXP039140	430	normal	Q8IX15	HepG2 (hepatoblastoma)	NULL
EXP039363	A301-729A	Homo sapiens		EXP039114	430	normal	Q01167	HepG2 (hepatoblastoma)	NULL
EXP039364	sc-101058	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039033	38	normal	P55317	A549 (lung carcinoma)	NULL
EXP039365	F1804	Homo sapiens		EXP039140	430	normal	P28702	HepG2 (hepatoblastoma)	NULL
EXP039366	A303-047A	Homo sapiens		EXP039216	514	normal	P13056	K562 (myelogenous leukemia)	NULL
EXP039367	sc-543	Homo sapiens	100nM bisphenol A (CHEBI:33216) for 30 minute	EXP010676	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP039368	R157.1.3D4	Homo sapiens		EXP039034	514	normal	Q16656	K562 (myelogenous leukemia)	NULL
EXP039369	HPA005732	Homo sapiens		EXP039074	113	normal	Q86T24	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039370	07-729	Homo sapiens		EXP039241	1132	normal	P49711	heart left ventricle	NULL
EXP039371	ab290	Homo sapiens		EXP039092	421	normal	Q9UID6	HEK293 (embryonic kidney)	NULL
EXP039372	ab60931	Homo sapiens		EXP039199	665	normal	Q15853	SK-N-SH (neuroblastoma)	NULL
EXP039373	600-401-A59	Homo sapiens		EXP039106	514	normal	Q15796	K562 (myelogenous leukemia)	NULL
EXP039374	GTX116020	Homo sapiens		EXP039034	514	normal	P17542	K562 (myelogenous leukemia)	NULL
EXP039375	ab290	Homo sapiens		EXP039092	421	normal	Q9H4T2	HEK293 (embryonic kidney)	NULL
EXP039376	A301-531A	Homo sapiens		EXP039046	113	normal	Q92610	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039377	ab85725	Homo sapiens		EXP039081	38	normal	P56270	A549 (lung carcinoma)	NULL
EXP039378	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039379	07-729	Homo sapiens		EXP039300	1167	normal	P49711	esophagus muscularis mucosa	NULL
EXP039380	S9809	Homo sapiens		EXP039034	514	normal	P08047	K562 (myelogenous leukemia)	NULL
EXP039381	ab290	Homo sapiens		EXP039092	421	normal	P17023	HEK293 (embryonic kidney)	NULL
EXP039382	61311	Mus musculus		EXP039308	523	normal	Q61164	kidney	NULL
EXP039383	sc-1003	Homo sapiens		EXP039246	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039384	S9809	Homo sapiens		EXP039020	430	normal	P08047	HepG2 (hepatoblastoma)	NULL
EXP039385	A301-145A	Homo sapiens		EXP039034	514	normal	O75376	K562 (myelogenous leukemia)	NULL
EXP039386	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039387	A302-659A	Homo sapiens		EXP039232	10	normal	Q99607	HEK293T (embryonic kidney)	NULL
EXP039388	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039389	F1804	Homo sapiens		EXP039185	430	normal	Q08945	HepG2 (hepatoblastoma)	NULL
EXP039390	goat-anti-GFP-UC	Homo sapiens		EXP039119	514	normal	Q15853	K562 (myelogenous leukemia)	NULL
EXP039391	sc-769	Homo sapiens		EXP039034	514	normal	Q99583	K562 (myelogenous leukemia)	NULL
EXP039392	HPA003256	Homo sapiens		EXP039034	514	normal	O14770	K562 (myelogenous leukemia)	NULL
EXP039393	ab290	Homo sapiens		EXP039092	421	normal	Q3KP31	HEK293 (embryonic kidney)	NULL
EXP039394	sc-166835	Homo sapiens		EXP039076	356	normal	P41212	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039395	F1804	Homo sapiens		EXP039140	430	normal	Q8IZ40	HepG2 (hepatoblastoma)	NULL
EXP039396	sc-240	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	normal	P16220	A549 (lung carcinoma)	NULL
EXP039397	sc-240	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP010017	38	normal	P16220	A549 (lung carcinoma)	NULL
EXP039398	07-729	Homo sapiens		EXP039292	1172	normal	P49711	adrenal gland	NULL
EXP039399	sc-240	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010017	38	normal	P16220	A549 (lung carcinoma)	NULL
EXP039400	A303-230A	Homo sapiens		EXP039034	514	normal	P67809	K562 (myelogenous leukemia)	NULL
EXP039401	sc-101058	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP039033	38	normal	P55317	A549 (lung carcinoma)	NULL
EXP039402	07-729	Homo sapiens		EXP039222	1172	normal	P49711	adrenal gland	NULL
EXP039403	sc-543	Homo sapiens	1 h with 100 nM Bisphenol A (Myers)	EXP010555	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP039404	F1804	Homo sapiens		EXP039140	430	normal	Q9H582	HepG2 (hepatoblastoma)	NULL
EXP039405	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P10070	HEK293 (embryonic kidney)	NULL
EXP039406	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039407	61311	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039408	goat-anti-GFP-UC	Homo sapiens		EXP039279	514	normal	Q13351	K562 (myelogenous leukemia)	NULL
EXP039409	ab290	Homo sapiens		EXP039092	421	normal	Q52M93	HEK293 (embryonic kidney)	NULL
EXP039410	F1804	Homo sapiens		EXP039140	430	normal	P17097	HepG2 (hepatoblastoma)	NULL
EXP039411	ab290	Homo sapiens		EXP039092	421	normal	Q494X3	HEK293 (embryonic kidney)	NULL
EXP039412	goat-anti-GFP-UC	Homo sapiens		EXP039229	113	normal	P53567	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039413	07-729	Homo sapiens		EXP039053	1095	normal	P49711	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP039414	NRSF	Homo sapiens		EXP039274	879	normal	Q13127	liver	NULL
EXP039415	ab290	Homo sapiens		EXP039092	421	normal	Q9UKN5	HEK293 (embryonic kidney)	NULL
EXP039416	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039417	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q8TD17	HEK293 (embryonic kidney)	NULL
EXP039418	ab290	Homo sapiens		EXP039092	421	normal	Q6ZNG1	HEK293 (embryonic kidney)	NULL
EXP039419	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039420	A301-932A	Homo sapiens		EXP039114	430	normal	Q9NUA8	HepG2 (hepatoblastoma)	NULL
EXP039421	ab290	Homo sapiens		EXP039092	421	normal	O95365	HEK293 (embryonic kidney)	NULL
EXP039422	NRSF	Homo sapiens		EXP039193	879	normal	Q13127	liver	NULL
EXP039423	17-641	Homo sapiens		EXP010775	376	normal	Q13127	WA01 (H1, human embryonic stem cells)	NULL
EXP039424	A301-932A	Homo sapiens		EXP039188	356	normal	Q9NUA8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039425	ab290	Homo sapiens		EXP039092	421	normal	Q96T92	HEK293 (embryonic kidney)	NULL
EXP039426	F1804	Homo sapiens		EXP039140	430	normal	P35711	HepG2 (hepatoblastoma)	NULL
EXP039427	F1804	Homo sapiens		EXP039140	430	normal	P53567	HepG2 (hepatoblastoma)	NULL
EXP039428	A303-279A	Homo sapiens		EXP039074	113	normal	Q8N1G0	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039429	goat-anti-GFP-UC	Homo sapiens		EXP039235	514	normal	Q8NDX6	K562 (myelogenous leukemia)	NULL
EXP039430	A301-669A	Homo sapiens		EXP039074	113	normal	P16220	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039431	ab290	Homo sapiens		EXP039092	421	normal	Q8IZC7	HEK293 (embryonic kidney)	NULL
EXP039432	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039433	A303-266A	Homo sapiens		EXP039240	113	normal	O75362	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039434	61311	Homo sapiens		EXP039112	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039435	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q9Y467	HEK293 (embryonic kidney)	NULL
EXP039436	A303-285A	Homo sapiens		EXP039034	514	normal	Q8IWY8	K562 (myelogenous leukemia)	NULL
EXP039437	goat-anti-GFP-UC	Homo sapiens		EXP039149	514	normal	P40425	K562 (myelogenous leukemia)	NULL
EXP039438	07-729	Homo sapiens		EXP039280	1148	normal	P49711	esophagus squamous epithelium	NULL
EXP039439	39550	Homo sapiens		EXP039177	356	normal	P17275	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039440	goat-anti-GFP-UC	Homo sapiens		EXP039122	514	normal	Q9H582	K562 (myelogenous leukemia)	NULL
EXP039441	ab290	Homo sapiens		EXP039092	421	normal	P52744	HEK293 (embryonic kidney)	NULL
EXP039442	HPA003384	Homo sapiens		EXP039076	356	normal	P17544	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039443	A303-390A	Homo sapiens		EXP039034	514	normal	P18146	K562 (myelogenous leukemia)	NULL
EXP039444	sc-1694	Homo sapiens		EXP039046	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039445	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q9UJU3	HEK293 (embryonic kidney)	NULL
EXP039446	sc-357	Mus musculus		EXP010613	1144	normal	Q61286	CH12.LX (Mouse lymphoma)	NULL
EXP039447	A300-754A	Homo sapiens		EXP039034	514	normal	Q99081	K562 (myelogenous leukemia)	NULL
EXP039448	A303-230A	Homo sapiens		EXP039020	430	normal	P67809	HepG2 (hepatoblastoma)	NULL
EXP039449	F1804	Homo sapiens		EXP039140	430	normal	Q96EK4	HepG2 (hepatoblastoma)	NULL
EXP039450	ab290	Homo sapiens		EXP039092	421	normal	Q9UEG4	HEK293 (embryonic kidney)	NULL
EXP039451	ab290	Homo sapiens		EXP039092	421	normal	Q5TYW1	HEK293 (embryonic kidney)	NULL
EXP039452	goat-anti-GFP-UC	Homo sapiens		EXP039128	514	normal	Q96ME7	K562 (myelogenous leukemia)	NULL
EXP039453	07-729	Homo sapiens		EXP039035	1148	normal	P49711	esophagus squamous epithelium	NULL
EXP039454	07-729	Homo sapiens		EXP039272	1148	normal	P49711	esophagus squamous epithelium	NULL
EXP039455	A301-729A	Homo sapiens		EXP039034	514	normal	Q01167	K562 (myelogenous leukemia)	NULL
EXP039456	07-729	Homo sapiens		EXP039154	1140	normal	P49711	subcutaneous adipose tissue	NULL
EXP039457	07-729	Homo sapiens		EXP039283	440	normal	P49711	HMEC (human mammary epithelial cells)	NULL
EXP039458	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P21506	HEK293 (embryonic kidney)	NULL
EXP039459	GTX104189	Homo sapiens		EXP039120	514	normal	Q6NT76	K562 (myelogenous leukemia)	NULL
EXP039460	sc-7874	Homo sapiens		EXP039220	356	normal	P10242	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039461	GTX114835	Homo sapiens		EXP039034	514	normal	P10589	K562 (myelogenous leukemia)	NULL
EXP039462	A300-343A	Homo sapiens		EXP039034	514	normal	Q15788	K562 (myelogenous leukemia)	NULL
EXP039463	07-729	Homo sapiens		EXP039162	1179	normal	P49711	tibial nerve	NULL
EXP039464	A303-486A	Homo sapiens		EXP039161	10	normal	Q9UJU2	HEK293T (embryonic kidney)	NULL
EXP039465	ab290	Homo sapiens		EXP039092	421	normal	A0PJY2	HEK293 (embryonic kidney)	NULL
EXP039466	HPA039433	Homo sapiens		EXP039034	514	normal	Q9BTC8	K562 (myelogenous leukemia)	NULL
EXP039467	200-401-194	Homo sapiens		EXP039118	38	normal	P48382	A549 (lung carcinoma)	NULL
EXP039468	3418	Homo sapiens	10 nM 17Î²-hydroxy-5Î±-androstan-3-one (CHEBI:16330) for 4 hour	EXP039244	70	normal	P49711	LNCaP (prostate carcinoma)	NULL
EXP039469	07-729	Homo sapiens		EXP039065	633	normal	P49711	spleen	NULL
EXP039470	ab290	Homo sapiens		EXP039092	421	normal	P17028	HEK293 (embryonic kidney)	NULL
EXP039471	A303-626A	Homo sapiens		EXP039216	514	normal	Q99583	K562 (myelogenous leukemia)	NULL
EXP039472	07-729	Homo sapiens		EXP039187	1163	normal	P49711	transverse colon	NULL
EXP039473	ab290	Homo sapiens		EXP039092	421	normal	Q96NG5	HEK293 (embryonic kidney)	NULL
EXP039474	07-729	Homo sapiens		EXP039102	1156	normal	P49711	gastroesophageal sphincter	NULL
EXP039475	07-729	Homo sapiens		EXP039299	1142	normal	P49711	Peyer's patch	NULL
EXP039476	ab290	Homo sapiens		EXP039092	421	normal	Q6ZR52	HEK293 (embryonic kidney)	NULL
EXP039477	WH0055892M1	Homo sapiens		EXP039049	514	normal	Q9NPC7	K562 (myelogenous leukemia)	NULL
EXP039478	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039479	F1804	Homo sapiens		EXP039140	430	normal	P10276	HepG2 (hepatoblastoma)	NULL
EXP039480	WH0006932M1	Homo sapiens		EXP039049	514	normal	P36402	K562 (myelogenous leukemia)	NULL
EXP039481	sc-8984	Homo sapiens		EXP039118	38	normal	P36956	A549 (lung carcinoma)	NULL
EXP039482	sc-13125	Homo sapiens		EXP039030	423	normal	P17480	HeLa S3 (cervical adenocarcinoma)	NULL
EXP039483	A303-091A	Homo sapiens		EXP039188	356	normal	P17028	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039484	ab290	Homo sapiens		EXP039092	421	normal	Q13351	HEK293 (embryonic kidney)	NULL
EXP039485	R157.1.3H3	Homo sapiens		EXP039034	514	normal	Q16656	K562 (myelogenous leukemia)	NULL
EXP039486	A301-017A	Homo sapiens		EXP039240	113	normal	O60264	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039487	3418	Homo sapiens		EXP039189	1166	normal	P49711	epithelial cell of prostate	NULL
EXP039488	sc-1694	Homo sapiens		EXP039081	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039489	A301-649A	Homo sapiens		EXP039188	356	normal	P15336	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039490	F1804	Homo sapiens		EXP039185	430	normal	Q9GZN2	HepG2 (hepatoblastoma)	NULL
EXP039491	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039492	goat-anti-GFP-UC	Homo sapiens		EXP039223	514	normal	Q15776	K562 (myelogenous leukemia)	NULL
EXP039493	A301-146A	Homo sapiens		EXP039216	514	normal	O75376	K562 (myelogenous leukemia)	NULL
EXP039494	16618-1-AP	Homo sapiens		EXP039076	356	normal	P52747	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039495	sc-166705	Homo sapiens		EXP039181	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039496	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039497	A303-391A	Homo sapiens		EXP039077	514	normal	P18146	K562 (myelogenous leukemia)	NULL
EXP039498	3418	Homo sapiens		EXP039291	1182	normal	P49711	RWPE2	NULL
EXP039499	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039500	ab290	Homo sapiens		EXP039084	421	normal	Q9BUY5	HEK293 (embryonic kidney)	NULL
EXP039501	A303-275A	Homo sapiens		EXP039240	113	normal	Q8NAF0	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039502	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039503	ab290	Homo sapiens		EXP039092	421	normal	P10074	HEK293 (embryonic kidney)	NULL
EXP039504	sc-166702	Homo sapiens		EXP039290	430	normal	Q15233	HepG2 (hepatoblastoma)	NULL
EXP039505	SAB2102741	Homo sapiens		EXP039151	113	normal	O95625	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039506	A302-474A	Homo sapiens		EXP039034	514	normal	O60315	K562 (myelogenous leukemia)	NULL
EXP039507	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039508	sc-229	Mus musculus		EXP010644	1174	normal	Q61069	MEL cell line	NULL
EXP039509	CST_5419S	Homo sapiens		EXP039068	129	normal	P17010	LNCaP C4-2B (prostate carcinoma)	NULL
EXP039510	F1804	Homo sapiens		EXP039140	430	normal	Q86YP4	HepG2 (hepatoblastoma)	NULL
EXP039511	ab290	Homo sapiens		EXP039092	421	normal	P11161	HEK293 (embryonic kidney)	NULL
EXP039512	goat-anti-GFP-UC	Homo sapiens		EXP039137	514	normal	P49116	K562 (myelogenous leukemia)	NULL
EXP039513	HPA001923	Homo sapiens		EXP039034	514	normal	P35712	K562 (myelogenous leukemia)	NULL
EXP039514	R157.1.3H3	Homo sapiens		EXP039123	430	normal	Q16656	HepG2 (hepatoblastoma)	NULL
EXP039515	ab290	Homo sapiens		EXP039092	421	normal	O95409	HEK293 (embryonic kidney)	NULL
EXP039516	F1804	Homo sapiens		EXP039140	430	normal	Q9UK33	HepG2 (hepatoblastoma)	NULL
EXP039517	ab290	Homo sapiens		EXP039092	421	normal	Q6ZSB9	HEK293 (embryonic kidney)	NULL
EXP039518	61311	Mus musculus		EXP039048	561	normal	Q61164	lung	NULL
EXP039519	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039520	A301-730A	Homo sapiens		EXP039161	10	normal	Q01167	HEK293T (embryonic kidney)	NULL
EXP039521	M8194	Homo sapiens		EXP039167	423	normal	Q9ULX9	HeLa S3 (cervical adenocarcinoma)	NULL
EXP039522	A303-570A	Homo sapiens		EXP039034	514	normal	Q12968	K562 (myelogenous leukemia)	NULL
EXP039523	3418	Homo sapiens		EXP039139	71	normal	P49711	VCaP (prostate carcinoma)	NULL
EXP039524	CST_5419S	Homo sapiens		EXP039019	417	normal	P17010	HCT-116 (colon carcinoma)	NULL
EXP039525	07-729	Homo sapiens		EXP039213	1156	normal	P49711	gastroesophageal sphincter	NULL
EXP039526	ab290	Homo sapiens		EXP039092	421	normal	Q8TDD2	HEK293 (embryonic kidney)	NULL
EXP039527	A302-357A	Homo sapiens		EXP039077	514	normal	Q86YP4	K562 (myelogenous leukemia)	NULL
EXP039528	61311	Mus musculus		EXP039085	142	normal	Q61164	intestine	NULL
EXP039529	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q9P2J8	HEK293 (embryonic kidney)	NULL
EXP039530	ab34682	Mus musculus		EXP010613	1144	normal	Q9WU00	CH12.LX (Mouse lymphoma)	NULL
EXP039531	ab290	Homo sapiens		EXP039031	421	normal	Q9HCK0	HEK293 (embryonic kidney)	NULL
EXP039532	HPA006672	Homo sapiens		EXP039036	430	normal	P17029	HepG2 (hepatoblastoma)	NULL
EXP039533	ab290	Homo sapiens		EXP039092	421	normal	Q9C0K0	HEK293 (embryonic kidney)	NULL
EXP039534	07-729	Homo sapiens		EXP039219	1157	normal	P49711	stomach	NULL
EXP039535	goat-anti-GFP-UC	Homo sapiens		EXP039069	514	normal	P17676	K562 (myelogenous leukemia)	NULL
EXP039536	07-729	Homo sapiens		EXP039127	1149	normal	P49711	testis	NULL
EXP039537	07-729	Homo sapiens		EXP039190	1170	normal	P49711	lower leg skin	NULL
EXP039538	goat-anti-GFP-UC	Homo sapiens		EXP039143	113	normal	P32519	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039539	sc-66882	Homo sapiens		EXP039046	113	normal	P11474	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039540	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039541	A300-810A	Homo sapiens		EXP039034	514	normal	Q969G3	K562 (myelogenous leukemia)	NULL
EXP039542	3742S	Homo sapiens		EXP039034	514	normal	Q01094	K562 (myelogenous leukemia)	NULL
EXP039543	ab290	Homo sapiens		EXP039092	421	normal	Q9NV72	HEK293 (embryonic kidney)	NULL
EXP039544	07-729	Homo sapiens		EXP039221	929	normal	P49711	neutrophils	NULL
EXP039545	558036	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039546	GTX108356	Homo sapiens		EXP039074	113	normal	Q14469	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039547	07-729	Homo sapiens		EXP039184	1142	normal	P49711	Peyer's patch	NULL
EXP039548	07-729	Homo sapiens		EXP039298	1163	normal	P49711	transverse colon	NULL
EXP039549	sc-30189	Homo sapiens		EXP039081	38	normal	Q9UKL0	A549 (lung carcinoma)	NULL
EXP039550	07-729	Homo sapiens		EXP039129	1181	normal	P49711	upper lobe of left lung	NULL
EXP039551	ab26049,ab70892	Homo sapiens		EXP010775	376	normal	P29375	WA01 (H1, human embryonic stem cells)	NULL
EXP039552	goat-anti-GFP-UC	Homo sapiens		EXP039075	514	normal	O95625	K562 (myelogenous leukemia)	NULL
EXP039553	goat-anti-GFP-UC	Homo sapiens		EXP039079	514	normal	Q9H2P0	K562 (myelogenous leukemia)	NULL
EXP039554	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039555	ab290	Homo sapiens		EXP039092	421	normal	Q5JT82	HEK293 (embryonic kidney)	NULL
EXP039556	ab70892	Homo sapiens		EXP039242	356	normal	P29375	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039557	sc-13032	Homo sapiens		EXP039036	430	normal	Q16236	HepG2 (hepatoblastoma)	NULL
EXP039558	ab290	Homo sapiens		EXP039092	421	normal	O15391	HEK293 (embryonic kidney)	NULL
EXP039559	ab290	Homo sapiens		EXP039092	421	normal	Q9NQV6	HEK293 (embryonic kidney)	NULL
EXP039560	goat-anti-GFP-UC	Homo sapiens		EXP039237	514	normal	P10914	K562 (myelogenous leukemia)	NULL
EXP039561	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039562	NB100-1800	Homo sapiens		EXP039188	356	normal	O14503	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039563	1277-1	Homo sapiens		EXP039046	113	normal	P19419	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039564	ab290	Homo sapiens		EXP039092	421	normal	Q9BS34	HEK293 (embryonic kidney)	NULL
EXP039565	ab290	Homo sapiens		EXP039092	421	normal	Q8ND82	HEK293 (embryonic kidney)	NULL
EXP039566	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q9UQR1	HEK293 (embryonic kidney)	NULL
EXP039567	CST_5419S	Homo sapiens		EXP039192	10	normal	P17010	HEK293T (embryonic kidney)	NULL
EXP039568	goat-anti-GFP-UC	Homo sapiens		EXP039148	514	normal	Q96LW1	K562 (myelogenous leukemia)	NULL
EXP039569	07-729	Homo sapiens		EXP039101	1149	normal	P49711	testis	NULL
EXP039570	ab290	Homo sapiens		EXP039092	421	normal	Q96C55	HEK293 (embryonic kidney)	NULL
EXP039571	F1804	Homo sapiens		EXP039140	430	normal	Q8WUU5	HepG2 (hepatoblastoma)	NULL
EXP039572	07-729	Homo sapiens		EXP039141	1157	normal	P49711	stomach	NULL
EXP039573	B0933	Homo sapiens		EXP039240	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039574	07-729	Homo sapiens		EXP039297	1170	normal	P49711	lower leg skin	NULL
EXP039575	A301-281A	Homo sapiens		EXP039240	113	normal	Q8WXI9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039576	07-729	Homo sapiens		EXP039109	1176	normal	P49711	ascending aorta	NULL
EXP039577	ab50322	Homo sapiens		EXP039046	113	normal	O60675	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039578	F1804	Homo sapiens		EXP039140	430	normal	Q13886	HepG2 (hepatoblastoma)	NULL
EXP039579	07-729	Homo sapiens		EXP039301	1175	normal	P49711	prostate gland	NULL
EXP039580	ab19857	Mus musculus		EXP039261	233	normal	P20263	E14TG2A (embryonic stem cells)	NULL
EXP039581	07-729	Homo sapiens		EXP039130	633	normal	P49711	spleen	NULL
EXP039582	A303-242A	Homo sapiens		EXP039074	113	normal	Q9Y2K1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039583	goat-anti-GFP-UC	Homo sapiens		EXP039273	113	normal	Q13886	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039584	sc-166705	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039585	HPA006672	Homo sapiens		EXP039046	113	normal	P17029	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039586	07-729	Homo sapiens		EXP039204	920	normal	P49711	pancreas	NULL
EXP039587	F1804	Homo sapiens		EXP039140	430	normal	Q9P2R6	HepG2 (hepatoblastoma)	NULL
EXP039588	goat-anti-GFP-UC	Homo sapiens		EXP039067	514	normal	Q04206	K562 (myelogenous leukemia)	NULL
EXP039589	1277-1	Homo sapiens		EXP039081	38	normal	P19419	A549 (lung carcinoma)	NULL
EXP039590	sc-150	Homo sapiens		EXP039181	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039591	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039592	F1804	Homo sapiens		EXP039140	430	normal	Q7Z3K6	HepG2 (hepatoblastoma)	NULL
EXP039593	13232S	Homo sapiens		EXP039076	356	normal	Q9UL17	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039594	sc-9081	Homo sapiens		EXP039131	1184	normal	Q01860	GM23338	NULL
EXP039595	GTX108356	Homo sapiens		EXP039034	514	normal	Q14469	K562 (myelogenous leukemia)	NULL
EXP039596	ab290	Homo sapiens		EXP039092	421	normal	Q9BYN7	HEK293 (embryonic kidney)	NULL
EXP039597	61311	Mus musculus		EXP039304	137	normal	Q61164	hindbrain	NULL
EXP039598	goat-anti-GFP-UC	Homo sapiens		EXP039038	514	normal	P50549	K562 (myelogenous leukemia)	NULL
EXP039599	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039600	A301-017A	Homo sapiens		EXP039034	514	normal	O60264	K562 (myelogenous leukemia)	NULL
EXP039601	HPA006672	Homo sapiens		EXP039106	514	normal	P17029	K562 (myelogenous leukemia)	NULL
EXP039602	goat-anti-GFP-UC	Homo sapiens		EXP039155	514	normal	Q9P0K8	K562 (myelogenous leukemia)	NULL
EXP039603	F1804	Homo sapiens		EXP039140	430	normal	Q8N344	HepG2 (hepatoblastoma)	NULL
EXP039604	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039176	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039605	GTX129438	Homo sapiens		EXP039188	356	normal	Q13422	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039606	1277-1	Homo sapiens		EXP039044	489	normal	P19419	IMR90 (lung fibroblasts)	NULL
EXP039607	A303-047A	Homo sapiens		EXP039188	356	normal	P13056	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039608	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039303	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039609	07-729	Homo sapiens		EXP039107	221	normal	P49711	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP039610	07-729	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039252	1145	normal	P49711	bipolar neuron	NULL
EXP039611	ab290	Homo sapiens		EXP039092	421	normal	P17020	HEK293 (embryonic kidney)	NULL
EXP039612	07-729	Homo sapiens		EXP039045	1142	normal	P49711	Peyer's patch	NULL
EXP039613	ab290	Homo sapiens		EXP039092	421	normal	Q96MR9	HEK293 (embryonic kidney)	NULL
EXP039614	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039615	F1804	Homo sapiens		EXP039140	430	normal	P37231	HepG2 (hepatoblastoma)	NULL
EXP039616	A303-197A	Homo sapiens		EXP039034	514	normal	Q6ZNB6	K562 (myelogenous leukemia)	NULL
EXP039617	sc-6327	Homo sapiens		EXP039074	113	normal	P39880	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039618	07-729	Homo sapiens		EXP039186	1169	normal	P49711	sigmoid colon	NULL
EXP039619	F1804	Homo sapiens		EXP039198	514	normal	P40425	K562 (myelogenous leukemia)	NULL
EXP039620	07-729	Homo sapiens		EXP039142	1148	normal	P49711	esophagus squamous epithelium	NULL
EXP039621	ab290	Homo sapiens		EXP039092	421	normal	Q9BWW7	HEK293 (embryonic kidney)	NULL
EXP039622	sc-281	Homo sapiens		EXP039302	879	normal	P25490	liver	NULL
EXP039623	goat-anti-GFP-UC	Homo sapiens		EXP039264	514	normal	P15407	K562 (myelogenous leukemia)	NULL
EXP039624	ab290	Homo sapiens		EXP039031	421	normal	P58317	HEK293 (embryonic kidney)	NULL
EXP039625	ab290	Homo sapiens		EXP039031	421	normal	Q96CX3	HEK293 (embryonic kidney)	NULL
EXP039626	ab290	Homo sapiens		EXP039092	421	normal	Q9C0A1	HEK293 (embryonic kidney)	NULL
EXP039627	goat-anti-GFP-UC	Homo sapiens		EXP039200	514	normal	Q14494	K562 (myelogenous leukemia)	NULL
EXP039628	A301-039A	Homo sapiens		EXP039061	430	normal	Q8TAQ2	HepG2 (hepatoblastoma)	NULL
EXP039629	07-729	Mus musculus		EXP039261	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP039630	goat-anti-GFP-UC	Homo sapiens		EXP039150	514	normal	P51522	K562 (myelogenous leukemia)	NULL
EXP039631	A301-729A	Homo sapiens		EXP039074	113	normal	Q01167	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039632	WH0001390M2	Homo sapiens		EXP039105	356	normal	Q03060	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039633	A300-396A	Homo sapiens		EXP039074	113	normal	O94776	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039634	sc-6059	Mus musculus		EXP010613	1144	normal	Q64287	CH12.LX (Mouse lymphoma)	NULL
EXP039635	39550	Homo sapiens		EXP039086	514	normal	P17275	K562 (myelogenous leukemia)	NULL
EXP039636	GTX80982	Homo sapiens		EXP039086	514	normal	Q9BXK1	K562 (myelogenous leukemia)	NULL
EXP039637	558036	Homo sapiens		EXP039112	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039638	07-729	Homo sapiens		EXP039248	900	normal	P49711	hepatocytes	NULL
EXP039639	07-729	Homo sapiens		EXP039125	440	normal	P49711	HMEC (human mammary epithelial cells)	NULL
EXP039640	sc-185	Homo sapiens		EXP039181	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039641	CST_5419S	Homo sapiens		EXP039056	113	normal	P17010	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039642	A301-932A	Homo sapiens		EXP039240	113	normal	Q9NUA8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039643	A300-810A	Homo sapiens		EXP039240	113	normal	Q969G3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039644	HPA005732	Homo sapiens		EXP039034	514	normal	Q86T24	K562 (myelogenous leukemia)	NULL
EXP039645	07-729	Homo sapiens		EXP039090	1168	normal	P49711	thyroid gland	NULL
EXP039646	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q16670	HEK293 (embryonic kidney)	NULL
EXP039647	sc-345	Homo sapiens		EXP039134	1184	normal	P42224	GM23338	NULL
EXP039648	goat-anti-GFP-UC	Homo sapiens		EXP039153	514	normal	P19419	K562 (myelogenous leukemia)	NULL
EXP039649	F1804	Homo sapiens		EXP039185	430	normal	Q03014	HepG2 (hepatoblastoma)	NULL
EXP039650	sc-160	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039651	ab290	Homo sapiens		EXP039092	421	normal	O00110	HEK293 (embryonic kidney)	NULL
EXP039652	goat-anti-GFP-UC	Homo sapiens		EXP039160	514	normal	Q86UQ0	K562 (myelogenous leukemia)	NULL
EXP039653	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q9ULD5	HEK293 (embryonic kidney)	NULL
EXP039654	ab85725	Homo sapiens		EXP039046	113	normal	P56270	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039655	GTX113275	Homo sapiens		EXP039049	514	normal	Q14186	K562 (myelogenous leukemia)	NULL
EXP039656	A300-993A	Homo sapiens		EXP039034	514	normal	Q9H7Z6	K562 (myelogenous leukemia)	NULL
EXP039657	sc-8987	Homo sapiens		EXP039302	879	normal	P41235	liver	NULL
EXP039658	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039659	A303-516A	Homo sapiens		EXP039188	356	normal	Q13422	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039660	sc-9081	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039289	1145	normal	Q01860	bipolar neuron	NULL
EXP039661	SAB1404509	Homo sapiens		EXP039220	356	normal	P17480	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039662	2569S	Homo sapiens		EXP039106	514	normal	Q9NQB0	K562 (myelogenous leukemia)	NULL
EXP039663	07-729	Homo sapiens		EXP039126	1129	normal	P49711	suprapubic skin	NULL
EXP039664	ab290	Homo sapiens		EXP039031	421	normal	Q5T0B9	HEK293 (embryonic kidney)	NULL
EXP039665	A303-619A	Homo sapiens		EXP039188	356	normal	Q9UKS7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039666	goat-anti-GFP-UC	Homo sapiens		EXP039039	113	normal	Q06546	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039667	07-729	Homo sapiens		EXP039121	1162	normal	P49711	thoracic aorta	NULL
EXP039668	sc-10813	Homo sapiens		EXP039046	113	normal	Q13330	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039669	sc-197	Homo sapiens		EXP039302	879	normal	P61244	liver	NULL
EXP039670	sc-350	Homo sapiens		EXP039131	1184	normal	P14921	GM23338	NULL
EXP039671	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	A6NGD5	HEK293 (embryonic kidney)	NULL
EXP039672	N8664	Homo sapiens		EXP039216	514	normal	Q15233	K562 (myelogenous leukemia)	NULL
EXP039673	ab290	Homo sapiens		EXP039092	421	normal	Q13127	HEK293 (embryonic kidney)	NULL
EXP039674	4373S	Homo sapiens		EXP039106	514	normal	Q13562	K562 (myelogenous leukemia)	NULL
EXP039675	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q7Z3V5	HEK293 (embryonic kidney)	NULL
EXP039676	GTX100308	Homo sapiens		EXP039077	514	normal	P55317	K562 (myelogenous leukemia)	NULL
EXP039677	07-729	Homo sapiens		EXP039041	1163	normal	P49711	transverse colon	NULL
EXP039678	07-729	Homo sapiens		EXP039226	1157	normal	P49711	stomach	NULL
EXP039679	ab290	Homo sapiens		EXP039092	421	normal	Q6ZSZ6	HEK293 (embryonic kidney)	NULL
EXP039680	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039681	ab290	Homo sapiens		EXP039092	421	normal	Q13886	HEK293 (embryonic kidney)	NULL
EXP039682	sc-14700	Homo sapiens		EXP039188	356	normal	O14867	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039683	07-729	Homo sapiens		EXP039024	927	normal	P49711	PC9 (lung adenocarcinoma)	NULL
EXP039684	F1804	Homo sapiens		EXP039140	430	normal	P28347	HepG2 (hepatoblastoma)	NULL
EXP039685	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039179	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039686	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039687	39204	Homo sapiens		EXP039034	514	normal	P26358	K562 (myelogenous leukemia)	NULL
EXP039688	ab290	Homo sapiens		EXP039092	421	normal	Q9Y5A6	HEK293 (embryonic kidney)	NULL
EXP039689	61311	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039209	1145	normal	P49711	bipolar neuron	NULL
EXP039690	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9NQX0	HEK293 (embryonic kidney)	NULL
EXP039691	HPA024069	Homo sapiens		EXP039034	514	normal	Q96BA8	K562 (myelogenous leukemia)	NULL
EXP039692	2750S	Homo sapiens		EXP039106	514	normal	Q01860	K562 (myelogenous leukemia)	NULL
EXP039693	sc-9144	Homo sapiens		EXP039046	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039694	ab290	Homo sapiens		EXP039092	421	normal	Q96EG3	HEK293 (embryonic kidney)	NULL
EXP039695	07-729	Homo sapiens		EXP039210	1154	normal	P49711	omental fat pad	NULL
EXP039696	07-729	Homo sapiens		EXP039175	1163	normal	P49711	transverse colon	NULL
EXP039697	ab290	Homo sapiens		EXP039092	421	normal	O95125	HEK293 (embryonic kidney)	NULL
EXP039698	sc-188	Homo sapiens		EXP039214	879	normal	P18847	liver	NULL
EXP039699	07-729	Homo sapiens		EXP039082	1163	normal	P49711	transverse colon	NULL
EXP039700	07-729	Homo sapiens		EXP039051	1181	normal	P49711	upper lobe of left lung	NULL
EXP039701	A301-530A	Homo sapiens		EXP039216	514	normal	Q92610	K562 (myelogenous leukemia)	NULL
EXP039702	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039064	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039703	A303-626A	Homo sapiens		EXP039240	113	normal	Q99583	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039704	07-729	Homo sapiens		EXP039088	1136	normal	P49711	gastrocnemius medialis	NULL
EXP039705	61311,3418	Homo sapiens		EXP039147	712	normal	P49711	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP039706	WH0009580M1	Homo sapiens		EXP039234	430	normal	Q9UN79	HepG2 (hepatoblastoma)	NULL
EXP039707	07-729	Homo sapiens		EXP039218	1170	normal	P49711	lower leg skin	NULL
EXP039708	NB600-244	Homo sapiens		EXP039167	423	normal	Q9UKY1	HeLa S3 (cervical adenocarcinoma)	NULL
EXP039709	A303-627A	Homo sapiens		EXP039216	514	normal	Q99583	K562 (myelogenous leukemia)	NULL
EXP039710	N8664	Homo sapiens		EXP039020	430	normal	Q15233	HepG2 (hepatoblastoma)	NULL
EXP039711	ab34682	Mus musculus		EXP010644	1174	normal	Q9WU00	MEL cell line	NULL
EXP039712	GTX100255	Homo sapiens		EXP039123	430	normal	P10588	HepG2 (hepatoblastoma)	NULL
EXP039713	61311	Mus musculus		EXP039164	313	normal	Q61164	forebrain	NULL
EXP039714	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q6NX49	HEK293 (embryonic kidney)	NULL
EXP039715	ab290	Homo sapiens		EXP039092	421	normal	O75626	HEK293 (embryonic kidney)	NULL
EXP039716	61311	Mus musculus		EXP039294	5	normal	Q61164	liver	NULL
EXP039717	ab290	Homo sapiens		EXP039092	421	normal	Q9NSC2	HEK293 (embryonic kidney)	NULL
EXP039718	goat-anti-GFP-UC	Homo sapiens		EXP039215	514	normal	Q8IVC4	K562 (myelogenous leukemia)	NULL
EXP039719	ab290	Homo sapiens		EXP039092	421	normal	P52738	HEK293 (embryonic kidney)	NULL
EXP039720	HPA024062	Homo sapiens		EXP039034	514	normal	P17028	K562 (myelogenous leukemia)	NULL
EXP039721	sc-23871	Homo sapiens		EXP039095	879	normal	Q86T24	liver	NULL
EXP039722	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039057	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039723	07-729	Homo sapiens		EXP039250	1131	normal	P49711	tibial artery	NULL
EXP039724	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039059	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039725	goat-anti-GFP-UC	Homo sapiens		EXP039087	514	normal	P13056	K562 (myelogenous leukemia)	NULL
EXP039726	GTX102170	Homo sapiens		EXP039034	514	normal	Q08050	K562 (myelogenous leukemia)	NULL
EXP039727	A302-765A	Homo sapiens		EXP039161	10	normal	P27540	HEK293T (embryonic kidney)	NULL
EXP039728	A303-091A	Homo sapiens		EXP039240	113	normal	P17028	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039729	ab290	Homo sapiens		EXP039092	421	normal	Q8IVP9	HEK293 (embryonic kidney)	NULL
EXP039730	ab290	Homo sapiens		EXP039092	421	normal	P19544	HEK293 (embryonic kidney)	NULL
EXP039731	F1804	Homo sapiens		EXP039140	430	normal	Q9H2W2	HepG2 (hepatoblastoma)	NULL
EXP039732	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039733	ab290	Homo sapiens		EXP039092	421	normal	Q9Y473	HEK293 (embryonic kidney)	NULL
EXP039734	sc-9082	Homo sapiens		EXP039076	356	normal	Q14653	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039735	sc-313	Mus musculus		EXP010613	1144	normal	Q60929	CH12.LX (Mouse lymphoma)	NULL
EXP039736	ab290	Homo sapiens		EXP039092	421	normal	Q9UJL9	HEK293 (embryonic kidney)	NULL
EXP039737	sc-10650	Homo sapiens		EXP039074	113	normal	P22670	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039738	F1804	Homo sapiens		EXP039185	430	normal	Q9UIS9	HepG2 (hepatoblastoma)	NULL
EXP039739	ab290	Homo sapiens		EXP039092	421	normal	P56270	HEK293 (embryonic kidney)	NULL
EXP039740	07-729	Homo sapiens		EXP039172	618	normal	P49711	MM1.S (plasma cell myeloma)	NULL
EXP039741	F1804	Homo sapiens		EXP039140	430	normal	Q9HCK0	HepG2 (hepatoblastoma)	NULL
EXP039742	sc-66882	Homo sapiens		EXP039081	38	normal	P11474	A549 (lung carcinoma)	NULL
EXP039743	sc-8984	Homo sapiens		EXP039106	514	normal	P36956	K562 (myelogenous leukemia)	NULL
EXP039744	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039745	07-729	Homo sapiens		EXP039094	1150	normal	P49711	ovary	NULL
EXP039746	sc-6558	Homo sapiens		EXP039274	879	normal	Q14541	liver	NULL
EXP039747	ab290	Homo sapiens		EXP039092	421	normal	Q8N9Z0	HEK293 (embryonic kidney)	NULL
EXP039748	A301-017A	Homo sapiens		EXP039188	356	normal	O60264	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039749	ab290	Homo sapiens		EXP039092	421	normal	P98169	HEK293 (embryonic kidney)	NULL
EXP039750	goat-anti-GFP-UC	Homo sapiens		EXP039043	514	normal	P15036	K562 (myelogenous leukemia)	NULL
EXP039751	A301-530A	Homo sapiens		EXP039074	113	normal	Q92610	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039752	A301-146A	Homo sapiens		EXP039034	514	normal	O75376	K562 (myelogenous leukemia)	NULL
EXP039753	HPA006079	Homo sapiens		EXP039034	514	normal	Q13127	K562 (myelogenous leukemia)	NULL
EXP039754	ab290	Homo sapiens		EXP039092	421	normal	Q16600	HEK293 (embryonic kidney)	NULL
EXP039755	A301-654A	Homo sapiens		EXP039216	514	normal	P10244	K562 (myelogenous leukemia)	NULL
EXP039756	A303-701A	Homo sapiens		EXP039046	113	normal	O15156	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039757	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039758	sc-166702	Homo sapiens		EXP039309	514	normal	Q15233	K562 (myelogenous leukemia)	NULL
EXP039759	07-729	Homo sapiens		EXP039070	1129	normal	P49711	suprapubic skin	NULL
EXP039760	A301-813A	Homo sapiens		EXP010775	376	normal	Q9UGL1	WA01 (H1, human embryonic stem cells)	NULL
EXP039761	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039762	61311	Homo sapiens		EXP039263	7	normal	P49711	22RV1 (prostate carcinoma)	NULL
EXP039763	sc-188	Homo sapiens		EXP039095	879	normal	P18847	liver	NULL
EXP039764	ab290	Homo sapiens		EXP039092	421	normal	Q8NEK5	HEK293 (embryonic kidney)	NULL
EXP039765	ab290	Homo sapiens		EXP039092	421	normal	Q96NJ6	HEK293 (embryonic kidney)	NULL
EXP039766	ab290	Homo sapiens		EXP039092	421	normal	Q9BUG6	HEK293 (embryonic kidney)	NULL
EXP039767	07-729	Homo sapiens		EXP039113	1138	normal	P49711	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP039768	A303-220A	Homo sapiens		EXP039240	113	normal	Q9UIU6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039769	61311	Mus musculus		EXP039166	1147	normal	Q61164	midbrain	NULL
EXP039770	ab290	Homo sapiens		EXP039084	421	normal	Q8IZ26	HEK293 (embryonic kidney)	NULL
EXP039771	sc-13032	Homo sapiens		EXP039044	489	normal	Q16236	IMR90 (lung fibroblasts)	NULL
EXP039772	07-729	Homo sapiens		EXP039286	1163	normal	P49711	transverse colon	NULL
EXP039773	ab290	Homo sapiens		EXP039092	421	normal	Q6P9A1	HEK293 (embryonic kidney)	NULL
EXP039774	sc-345	Homo sapiens		EXP039076	356	normal	P42224	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039775	sc-10652	Homo sapiens		EXP039074	113	normal	P22670	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039776	F1804	Homo sapiens		EXP039185	430	normal	Q16534	HepG2 (hepatoblastoma)	NULL
EXP039777	sc-6553	Homo sapiens		EXP039274	879	normal	P55317	liver	NULL
EXP039778	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	O14628	HEK293 (embryonic kidney)	NULL
EXP039779	sc-8051x	Homo sapiens		EXP039112	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039780	HPA003876	Homo sapiens		EXP039020	430	normal	Q9H334	HepG2 (hepatoblastoma)	NULL
EXP039781	07-729	Homo sapiens		EXP039089	1164	normal	P49711	uterus	NULL
EXP039782	07-729	Homo sapiens		EXP039243	1151	normal	P49711	right lobe of liver	NULL
EXP039783	sc-271940	Homo sapiens		EXP039302	879	normal	P24468	liver	NULL
EXP039784	ab290	Homo sapiens		EXP039092	421	normal	Q9H165	HEK293 (embryonic kidney)	NULL
EXP039785	sc-23871	Homo sapiens		EXP039302	879	normal	Q86T24	liver	NULL
EXP039786	ab290	Homo sapiens		EXP039092	421	normal	Q9BSG1	HEK293 (embryonic kidney)	NULL
EXP039787	F1804	Homo sapiens		EXP039140	430	normal	Q99612	HepG2 (hepatoblastoma)	NULL
EXP039788	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039789	GTX113850	Homo sapiens		EXP039138	430	normal	P20823	HepG2 (hepatoblastoma)	NULL
EXP039790	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039078	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039791	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039281	421	normal	Q9GZX5	HEK293 (embryonic kidney)	NULL
EXP039792	ab290	Homo sapiens		EXP039092	421	normal	Q14584	HEK293 (embryonic kidney)	NULL
EXP039793	sc-769	Homo sapiens		EXP039046	113	normal	Q99583	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039794	CST_5419S	Homo sapiens		EXP039263	7	normal	P17010	22RV1 (prostate carcinoma)	NULL
EXP039795	ab290	Homo sapiens		EXP039092	421	normal	Q9NPC7	HEK293 (embryonic kidney)	NULL
EXP039796	sc-229	Mus musculus		EXP010613	1144	normal	Q61069	CH12.LX (Mouse lymphoma)	NULL
EXP039797	sc-1003	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039208	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039798	ab60931	Homo sapiens		EXP039044	489	normal	Q15853	IMR90 (lung fibroblasts)	NULL
EXP039799	A300-396A	Homo sapiens		EXP039034	514	normal	O94776	K562 (myelogenous leukemia)	NULL
EXP039800	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039801	GTX100308	Homo sapiens		EXP039020	430	normal	P55317	HepG2 (hepatoblastoma)	NULL
EXP039802	07-729	Homo sapiens		EXP039071	1178	normal	P49711	coronary artery	NULL
EXP039803	ab290	Homo sapiens		EXP039084	421	normal	Q8NEP9	HEK293 (embryonic kidney)	NULL
EXP039804	sc-10652	Homo sapiens		EXP039216	514	normal	P22670	K562 (myelogenous leukemia)	NULL
EXP039805	07-729	Homo sapiens		EXP039225	920	normal	P49711	pancreas	NULL
EXP039806	07-729	Homo sapiens		EXP039055	1158	normal	P49711	vagina	NULL
EXP039807	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039808	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039809	HPA039433	Homo sapiens		EXP039046	113	normal	Q9BTC8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039810	ab290	Homo sapiens		EXP039031	421	normal	Q13029	HEK293 (embryonic kidney)	NULL
EXP039811	ab290	Homo sapiens		EXP039092	421	normal	Q9BXK1	HEK293 (embryonic kidney)	NULL
EXP039812	F1804	Homo sapiens		EXP039140	430	normal	P10588	HepG2 (hepatoblastoma)	NULL
EXP039813	600-401-B29	Homo sapiens		EXP039106	514	normal	Q15797	K562 (myelogenous leukemia)	NULL
EXP039814	F1804	Homo sapiens		EXP039140	430	normal	Q9UKD1	HepG2 (hepatoblastoma)	NULL
EXP039815	ab290	Homo sapiens		EXP039092	421	normal	Q9UK33	HEK293 (embryonic kidney)	NULL
EXP039816	HPA001923	Homo sapiens		EXP039020	430	normal	P35712	HepG2 (hepatoblastoma)	NULL
EXP039817	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039281	421	normal	Q15697	HEK293 (embryonic kidney)	NULL
EXP039818	A301-932A	Homo sapiens		EXP039034	514	normal	Q9NUA8	K562 (myelogenous leukemia)	NULL
EXP039819	sc-10652	Homo sapiens		EXP039034	514	normal	P22670	K562 (myelogenous leukemia)	NULL
EXP039820	F1804	Homo sapiens		EXP039140	430	normal	Q6P2D0	HepG2 (hepatoblastoma)	NULL
EXP039821	ab290	Homo sapiens		EXP039092	421	normal	Q9NR11	HEK293 (embryonic kidney)	NULL
EXP039822	goat-anti-GFP-UC	Homo sapiens		EXP039285	514	normal	P22736	K562 (myelogenous leukemia)	NULL
EXP039823	F1804	Homo sapiens		EXP039140	430	normal	Q14582	HepG2 (hepatoblastoma)	NULL
EXP039824	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q96RE9	HEK293 (embryonic kidney)	NULL
EXP039825	sc-197	Homo sapiens		EXP039095	879	normal	P61244	liver	NULL
EXP039826	F1804	Homo sapiens		EXP039140	430	normal	Q9UMN6	HepG2 (hepatoblastoma)	NULL
EXP039827	ab290	Homo sapiens		EXP039092	421	normal	Q8N3J9	HEK293 (embryonic kidney)	NULL
EXP039828	ab290	Homo sapiens		EXP039092	421	normal	P52736	HEK293 (embryonic kidney)	NULL
EXP039829	ab290	Homo sapiens		EXP039092	421	normal	Q9UJN7	HEK293 (embryonic kidney)	NULL
EXP039830	F1804	Homo sapiens		EXP039100	430	normal	P18846	HepG2 (hepatoblastoma)	NULL
EXP039831	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039832	07-729	Homo sapiens		EXP039037	1181	normal	P49711	upper lobe of left lung	NULL
EXP039833	goat-anti-GFP-UC	Homo sapiens		EXP039201	514	normal	Q14814	K562 (myelogenous leukemia)	NULL
EXP039834	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039835	A301-649A	Homo sapiens		EXP039114	430	normal	P15336	HepG2 (hepatoblastoma)	NULL
EXP039836	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039157	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP039837	sc-313	Mus musculus		EXP010644	1174	normal	Q60929	MEL cell line	NULL
EXP039838	ab290	Homo sapiens		EXP039092	421	normal	Q13105	HEK293 (embryonic kidney)	NULL
EXP039839	NB100-279	Homo sapiens		EXP039188	356	normal	Q99856	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039840	3418	Homo sapiens		EXP039244	70	normal	P49711	LNCaP (prostate carcinoma)	NULL
EXP039841	A303-284A	Homo sapiens		EXP039188	356	normal	Q8IWY8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039842	A301-046A	Homo sapiens		EXP039034	514	normal	Q8NFD5	K562 (myelogenous leukemia)	NULL
EXP039843	WH0000861M6	Homo sapiens		EXP039049	514	normal	Q01196	K562 (myelogenous leukemia)	NULL
EXP039844	ab290	Homo sapiens		EXP039092	421	normal	Q12901	HEK293 (embryonic kidney)	NULL
EXP039845	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039846	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039847	sc-6554	Homo sapiens		EXP039274	879	normal	Q9Y261	liver	NULL
EXP039848	WH0004090M1	Homo sapiens		EXP039052	514	normal	Q99717	K562 (myelogenous leukemia)	NULL
EXP039849	A303-037A	Homo sapiens		EXP039077	514	normal	Q96AV8	K562 (myelogenous leukemia)	NULL
EXP039850	WH0002120M1	Homo sapiens		EXP039022	514	normal	P41212	K562 (myelogenous leukemia)	NULL
EXP039851	H00010782-A01	Homo sapiens		EXP010651	421	normal	Q96GC6	HEK293 (embryonic kidney)	NULL
EXP039852	A303-279A	Homo sapiens		EXP039188	356	normal	Q8N1G0	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039853	ab290	Homo sapiens		EXP039092	421	normal	Q15072	HEK293 (embryonic kidney)	NULL
EXP039854	07-729	Homo sapiens		EXP039108	1180	normal	P49711	neural cell	NULL
EXP039855	F1804	Homo sapiens		EXP039140	430	normal	Q9Y2D9	HepG2 (hepatoblastoma)	NULL
EXP039856	39789	Homo sapiens		EXP039096	514	normal	O75030	K562 (myelogenous leukemia)	NULL
EXP039857	GTX102698	Homo sapiens		EXP039096	514	normal	Q16621	K562 (myelogenous leukemia)	NULL
EXP039858	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q8NDW4	HEK293 (embryonic kidney)	NULL
EXP039859	sc-631	Mus musculus		EXP010613	1144	normal	Q60775	CH12.LX (Mouse lymphoma)	NULL
EXP039860	F1804	Homo sapiens		EXP039140	430	normal	Q9UH92	HepG2 (hepatoblastoma)	NULL
EXP039861	07-729	Homo sapiens		EXP039255	1168	normal	P49711	thyroid gland	NULL
EXP039862	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP039863	61311	Mus musculus		EXP039288	53	normal	Q61164	heart	NULL
EXP039864	07-729	Homo sapiens		EXP039271	920	normal	P49711	pancreas	NULL
EXP039865	sc-6553	Homo sapiens		EXP039193	879	normal	P55317	liver	NULL
EXP039866	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP039867	ab290	Homo sapiens		EXP039092	421	normal	Q9HC78	HEK293 (embryonic kidney)	NULL
EXP039868	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039869	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039870	WH0006932M1	Homo sapiens		EXP039183	356	normal	P36402	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039871	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039872	A300-395A	Homo sapiens		EXP039034	514	normal	O94776	K562 (myelogenous leukemia)	NULL
EXP039873	WH0009189M1	Homo sapiens		EXP039163	356	normal	O96006	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039874	A303-098A	Homo sapiens		EXP039061	430	normal	O15119	HepG2 (hepatoblastoma)	NULL
EXP039875	WH0006932M1	Homo sapiens		EXP039234	430	normal	P36402	HepG2 (hepatoblastoma)	NULL
EXP039876	ab290	Homo sapiens		EXP039092	421	normal	Q02086	HEK293 (embryonic kidney)	NULL
EXP039877	ab290	Homo sapiens		EXP039092	421	normal	Q86Y25	HEK293 (embryonic kidney)	NULL
EXP039878	F1804	Homo sapiens		EXP039140	430	normal	O15535	HepG2 (hepatoblastoma)	NULL
EXP039879	ab290	Homo sapiens		EXP039092	421	normal	Q8IZM8	HEK293 (embryonic kidney)	NULL
EXP039880	07-729	Homo sapiens		EXP039284	1172	normal	P49711	adrenal gland	NULL
EXP039881	A303-386A	Homo sapiens		EXP039076	356	normal	Q13568	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039882	ab290	Homo sapiens		EXP039092	421	normal	P10075	HEK293 (embryonic kidney)	NULL
EXP039883	F1804	Homo sapiens		EXP039140	430	normal	Q12857	HepG2 (hepatoblastoma)	NULL
EXP039884	F1804	Homo sapiens		EXP039146	430	normal	P18848	HepG2 (hepatoblastoma)	NULL
EXP039885	goat-anti-GFP-UC	Homo sapiens		EXP039260	113	normal	O43474	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039886	goat-anti-GFP-UC	Homo sapiens		EXP039072	514	normal	Q8NDX6	K562 (myelogenous leukemia)	NULL
EXP039887	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039888	sc-7202	Homo sapiens		EXP039044	489	normal	P01100	IMR90 (lung fibroblasts)	NULL
EXP039889	F1804	Homo sapiens		EXP039185	430	normal	Q9UIS9	HepG2 (hepatoblastoma)	NULL
EXP039890	A303-248A	Homo sapiens		EXP039034	514	normal	A6NFI3	K562 (myelogenous leukemia)	NULL
EXP039891	F1804	Homo sapiens		EXP039140	430	normal	P55318	HepG2 (hepatoblastoma)	NULL
EXP039892	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039893	200-401-194	Homo sapiens		EXP039046	113	normal	P48382	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039894	ab290	Homo sapiens		EXP039092	421	normal	P15336	HEK293 (embryonic kidney)	NULL
EXP039895	goat-anti-GFP-UC	Homo sapiens		EXP039239	514	normal	Q06546	K562 (myelogenous leukemia)	NULL
EXP039896	F1804	Homo sapiens		EXP039140	430	normal	Q8N5A5	HepG2 (hepatoblastoma)	NULL
EXP039897	F1804	Homo sapiens		EXP039185	430	normal	P40425	HepG2 (hepatoblastoma)	NULL
EXP039898	07-729	Homo sapiens		EXP039212	879	normal	P49711	liver	NULL
EXP039899	F1804	Homo sapiens		EXP039185	430	normal	Q9UBC3	HepG2 (hepatoblastoma)	NULL
EXP039900	NB600-244	Homo sapiens		EXP039106	514	normal	Q9UKY1	K562 (myelogenous leukemia)	NULL
EXP039901	ab290	Homo sapiens		EXP039092	421	normal	Q8N2R0	HEK293 (embryonic kidney)	NULL
EXP039902	A301-730A	Homo sapiens		EXP039034	514	normal	Q01167	K562 (myelogenous leukemia)	NULL
EXP039903	F1804	Homo sapiens		EXP039140	430	normal	Q13952	HepG2 (hepatoblastoma)	NULL
EXP039904	sc-28312	Homo sapiens		EXP039302	879	normal	Q06546	liver	NULL
EXP039905	ab290	Homo sapiens		EXP039092	421	normal	Q9NYW8	HEK293 (embryonic kidney)	NULL
EXP039906	HPA040398	Homo sapiens		EXP039076	356	normal	Q13887	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039907	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP039908	F1804	Homo sapiens		EXP039140	430	normal	Q4LE39	HepG2 (hepatoblastoma)	NULL
EXP039909	A303-486A	Homo sapiens		EXP039034	514	normal	Q9UJU2	K562 (myelogenous leukemia)	NULL
EXP039910	GTX100308	Homo sapiens		EXP039232	10	normal	P55317	HEK293T (embryonic kidney)	NULL
EXP039911	HPA003384	Homo sapiens		EXP039034	514	normal	P17544	K562 (myelogenous leukemia)	NULL
EXP039912	ab290	Homo sapiens		EXP039092	421	normal	Q5TEC3	HEK293 (embryonic kidney)	NULL
EXP039913	goat-anti-GFP-UC	Homo sapiens		EXP039080	514	normal	O14867	K562 (myelogenous leukemia)	NULL
EXP039914	AF4185	Homo sapiens		EXP039108	1180	normal	P50539	neural cell	NULL
EXP039915	ab50322	Homo sapiens		EXP039118	38	normal	O60675	A549 (lung carcinoma)	NULL
EXP039916	ab290	Homo sapiens		EXP039092	421	normal	O75123	HEK293 (embryonic kidney)	NULL
EXP039917	S9809	Homo sapiens		EXP039074	113	normal	P08047	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039918	ab290	Homo sapiens		EXP039031	421	normal	Q9Y6Q3	HEK293 (embryonic kidney)	NULL
EXP039919	F1804	Homo sapiens		EXP039140	430	normal	P10589	HepG2 (hepatoblastoma)	NULL
EXP039920	ab290	Homo sapiens		EXP039092	421	normal	Q9Y2K1	HEK293 (embryonic kidney)	NULL
EXP039921	ab290	Homo sapiens		EXP039092	421	normal	P36508	HEK293 (embryonic kidney)	NULL
EXP039922	ab50322	Mus musculus		EXP010793	230	normal	Q61827	ES-E14 (E14, embryonic stem cells)	NULL
EXP039923	07-729	Homo sapiens		EXP039110	687	normal	P49711	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP039924	goat-anti-GFP-UC	Homo sapiens		EXP039158	514	normal	P17028	K562 (myelogenous leukemia)	NULL
EXP039925	goat-anti-GFP-UC	Homo sapiens		EXP039293	514	normal	P39880	K562 (myelogenous leukemia)	NULL
EXP039926	ab290	Homo sapiens		EXP039092	421	normal	Q5VTD9	HEK293 (embryonic kidney)	NULL
EXP039927	HPA004051	Homo sapiens		EXP039232	10	normal	Q8TF68	HEK293T (embryonic kidney)	NULL
EXP039928	sc-6554	Homo sapiens		EXP039193	879	normal	Q9Y261	liver	NULL
EXP039929	07-729	Homo sapiens		EXP039103	1175	normal	P49711	prostate gland	NULL
EXP039930	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP039931	sc-30189	Homo sapiens		EXP039046	113	normal	Q9UKL0	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039932	F1804	Homo sapiens		EXP039140	430	normal	P41182	HepG2 (hepatoblastoma)	NULL
EXP039933	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q5JNZ3	HEK293 (embryonic kidney)	NULL
EXP039934	A302-765A	Homo sapiens		EXP039034	514	normal	P27540	K562 (myelogenous leukemia)	NULL
EXP039935	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039936	A301-281A	Homo sapiens		EXP039188	356	normal	Q8WXI9	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039937	A303-262A	Homo sapiens		EXP039034	514	normal	Q8N680	K562 (myelogenous leukemia)	NULL
EXP039938	A300-810A	Homo sapiens		EXP039061	430	normal	Q969G3	HepG2 (hepatoblastoma)	NULL
EXP039939	NB100-1800	Homo sapiens		EXP039044	489	normal	O14503	IMR90 (lung fibroblasts)	NULL
EXP039940	WH0004090M1	Homo sapiens		EXP039105	356	normal	Q99717	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039941	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039942	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP039943	61311	Homo sapiens	10 nM 17Î²-hydroxy-5Î±-androstan-3-one (CHEBI:16330) for 4 hour	EXP039263	7	normal	P49711	22RV1 (prostate carcinoma)	NULL
EXP039944	A301-443A	Homo sapiens		EXP039188	356	normal	P32519	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039945	goat-anti-GFP-UC	Homo sapiens		EXP039227	514	normal	P53567	K562 (myelogenous leukemia)	NULL
EXP039946	A303-249A	Homo sapiens		EXP039034	514	normal	A6NFI3	K562 (myelogenous leukemia)	NULL
EXP039947	A303-626A	Homo sapiens		EXP039061	430	normal	Q99583	HepG2 (hepatoblastoma)	NULL
EXP039948	A303-565A	Homo sapiens		EXP039074	113	normal	O00712	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039949	07-729	Homo sapiens		EXP039091	686	normal	P49711	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP039950	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039951	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8N8L2	HEK293 (embryonic kidney)	NULL
EXP039952	07-729	Homo sapiens		EXP039099	440	normal	P49711	HMEC (human mammary epithelial cells)	NULL
EXP039953	sc-13032	Homo sapiens		EXP039081	38	normal	Q16236	A549 (lung carcinoma)	NULL
EXP039954	07-729	Homo sapiens		EXP039259	1136	normal	P49711	gastrocnemius medialis	NULL
EXP039955	A303-123A	Homo sapiens		EXP039034	514	normal	P08651	K562 (myelogenous leukemia)	NULL
EXP039956	ab290	Homo sapiens		EXP039031	421	normal	Q14526	HEK293 (embryonic kidney)	NULL
EXP039957	8186S	Homo sapiens		EXP039114	430	normal	Q9Y261	HepG2 (hepatoblastoma)	NULL
EXP039958	F1804	Homo sapiens		EXP039140	430	normal	O14901	HepG2 (hepatoblastoma)	NULL
EXP039959	sc-735	Homo sapiens		EXP039274	879	normal	P21675	liver	NULL
EXP039960	10007663	Homo sapiens		EXP039118	38	normal	Q12772	A549 (lung carcinoma)	NULL
EXP039961	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP039962	9197S	Homo sapiens		EXP039074	113	normal	P16220	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039963	A303-091A	Homo sapiens		EXP039034	514	normal	P17028	K562 (myelogenous leukemia)	NULL
EXP039964	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q68DI1	HEK293 (embryonic kidney)	NULL
EXP039965	ab290	Homo sapiens		EXP039092	421	normal	Q8NAM6	HEK293 (embryonic kidney)	NULL
EXP039966	F1804	Homo sapiens		EXP039140	430	normal	Q15776	HepG2 (hepatoblastoma)	NULL
EXP039967	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039968	07-729	Homo sapiens		EXP039173	1140	normal	P49711	subcutaneous adipose tissue	NULL
EXP039969	R1283.1.2C6	Homo sapiens		EXP039034	514	normal	Q99459	K562 (myelogenous leukemia)	NULL
EXP039970	A300-113A	Homo sapiens		EXP010582	514	normal	Q9UMN6	K562 (myelogenous leukemia)	NULL
EXP039971	07-729	Homo sapiens		EXP039115	1169	normal	P49711	sigmoid colon	NULL
EXP039972	sc-1237	Mus musculus		EXP039253	5	normal	Q08369	liver	NULL
EXP039973	ab290	Homo sapiens		EXP039092	421	normal	Q8N8C0	HEK293 (embryonic kidney)	NULL
EXP039974	F1804	Homo sapiens		EXP039140	430	normal	Q96MX3	HepG2 (hepatoblastoma)	NULL
EXP039975	ab290	Homo sapiens		EXP039092	421	normal	Q96K75	HEK293 (embryonic kidney)	NULL
EXP039976	A303-091A	Homo sapiens		EXP039061	430	normal	P17028	HepG2 (hepatoblastoma)	NULL
EXP039977	A302-182A	Homo sapiens		EXP039076	356	normal	Q01201	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039978	A300-755A	Homo sapiens		EXP039034	514	normal	Q99081	K562 (myelogenous leukemia)	NULL
EXP039979	A303-197A	Homo sapiens		EXP039188	356	normal	Q6ZNB6	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039980	07-729	Homo sapiens		EXP039073	633	normal	P49711	spleen	NULL
EXP039981	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP039982	A303-487A	Homo sapiens		EXP039077	514	normal	Q9UJU2	K562 (myelogenous leukemia)	NULL
EXP039983	07-729	Homo sapiens		EXP039116	1156	normal	P49711	gastroesophageal sphincter	NULL
EXP039984	sc-13032	Homo sapiens		EXP039167	423	normal	Q16236	HeLa S3 (cervical adenocarcinoma)	NULL
EXP039985	F1804	Homo sapiens		EXP039140	430	normal	Q13485	HepG2 (hepatoblastoma)	NULL
EXP039986	A303-618A	Homo sapiens		EXP039188	356	normal	Q9UKS7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP039987	sc-8987	Homo sapiens		EXP039275	879	normal	P41235	liver	NULL
EXP039988	ab290	Homo sapiens		EXP039092	421	normal	Q9NPA5	HEK293 (embryonic kidney)	NULL
EXP039989	ab290	Homo sapiens		EXP039092	421	normal	O95625	HEK293 (embryonic kidney)	NULL
EXP039990	HPA003384	Homo sapiens		EXP039046	113	normal	P17544	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039991	goat-anti-GFP-UC	Homo sapiens		EXP039306	514	normal	Q02535	K562 (myelogenous leukemia)	NULL
EXP039992	61311	Mus musculus		EXP039282	5	normal	Q61164	liver	NULL
EXP039993	61311	Mus musculus		EXP039270	561	normal	Q61164	lung	NULL
EXP039994	07-729	Homo sapiens		EXP039021	1179	normal	P49711	tibial nerve	NULL
EXP039995	A301-649A	Homo sapiens		EXP039034	514	normal	P15336	K562 (myelogenous leukemia)	NULL
EXP039996	A303-566A	Homo sapiens		EXP039074	113	normal	O00712	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP039997	ab290	Homo sapiens		EXP039092	421	normal	O75840	HEK293 (embryonic kidney)	NULL
EXP039998	NB100-1800	Homo sapiens		EXP039161	10	normal	O14503	HEK293T (embryonic kidney)	NULL
EXP039999	A301-729A	Homo sapiens		EXP039188	356	normal	Q01167	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040000	07-729	Homo sapiens		EXP039266	1158	normal	P49711	vagina	NULL
EXP040001	A303-230A	Homo sapiens		EXP039240	113	normal	P67809	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040002	ab290	Homo sapiens		EXP039092	421	normal	Q9H4Z2	HEK293 (embryonic kidney)	NULL
EXP040003	sc-271940	Homo sapiens		EXP039275	879	normal	P24468	liver	NULL
EXP040004	goat-anti-GFP-UC	Homo sapiens		EXP039032	514	normal	O14709	K562 (myelogenous leukemia)	NULL
EXP040005	A304-063A	Homo sapiens		EXP039034	514	normal	O15062	K562 (myelogenous leukemia)	NULL
EXP040006	A303-235A	Homo sapiens		EXP039074	113	normal	Q96KM6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040007	sc-357	Mus musculus		EXP010644	1174	normal	Q61286	MEL cell line	NULL
EXP040008	HPA005799	Homo sapiens		EXP039020	430	normal	O15119	HepG2 (hepatoblastoma)	NULL
EXP040009	ab290	Homo sapiens		EXP039092	421	normal	O75467	HEK293 (embryonic kidney)	NULL
EXP040010	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP040011	GTX114991	Homo sapiens		EXP039074	113	normal	P55347	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040012	07-729	Homo sapiens		EXP039191	920	normal	P49711	pancreas	NULL
EXP040013	ab290	Homo sapiens		EXP039092	421	normal	Q96GC6	HEK293 (embryonic kidney)	NULL
EXP040014	goat-anti-GFP-UC	Homo sapiens		EXP039182	514	normal	Q14186	K562 (myelogenous leukemia)	NULL
EXP040015	ab290	Homo sapiens		EXP039092	421	normal	P17022	HEK293 (embryonic kidney)	NULL
EXP040016	F1804	Homo sapiens		EXP039140	430	normal	Q9H7Z6	HepG2 (hepatoblastoma)	NULL
EXP040017	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040018	goat-anti-GFP-UC	Homo sapiens		EXP039268	514	normal	Q16621	K562 (myelogenous leukemia)	NULL
EXP040019	ab290	Homo sapiens		EXP039092	421	normal	Q14929	HEK293 (embryonic kidney)	NULL
EXP040020	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP040021	GTX100255	Homo sapiens		EXP039086	514	normal	P10588	K562 (myelogenous leukemia)	NULL
EXP040022	HPA003384	Homo sapiens		EXP039020	430	normal	P17544	HepG2 (hepatoblastoma)	NULL
EXP040023	WH0001390M2	Homo sapiens		EXP039123	430	normal	Q03060	HepG2 (hepatoblastoma)	NULL
EXP040024	GTX114835	Homo sapiens		EXP039188	356	normal	P10589	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040025	ab290	Homo sapiens		EXP039092	421	normal	P17027	HEK293 (embryonic kidney)	NULL
EXP040026	07-729	Homo sapiens		EXP039133	1129	normal	P49711	suprapubic skin	NULL
EXP040027	07-729	Homo sapiens		EXP039025	1179	normal	P49711	tibial nerve	NULL
EXP040028	07-729	Homo sapiens		EXP039168	1135	normal	P49711	right atrium auricular region	NULL
EXP040029	ab290	Homo sapiens		EXP039092	421	normal	Q8N8Y5	HEK293 (embryonic kidney)	NULL
EXP040030	sc-150	Homo sapiens		EXP039220	356	normal	P17676	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040031	07-729	Homo sapiens		EXP039197	1142	normal	P49711	Peyer's patch	NULL
EXP040032	goat-anti-GFP-UC	Homo sapiens		EXP039144	514	normal	P32519	K562 (myelogenous leukemia)	NULL
EXP040033	ab290	Homo sapiens		EXP039092	421	normal	Q8NEM1	HEK293 (embryonic kidney)	NULL
EXP040034	goat-anti-GFP-UC	Homo sapiens		EXP039063	514	normal	Q9Y3Q8	K562 (myelogenous leukemia)	NULL
EXP040035	ab290	Homo sapiens		EXP039092	421	normal	Q96C28	HEK293 (embryonic kidney)	NULL
EXP040036	sc-8051x	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP040037	R157.1.3H3	Homo sapiens		EXP039049	514	normal	Q16656	K562 (myelogenous leukemia)	NULL
EXP040038	sc-769	Homo sapiens		EXP039114	430	normal	Q99583	HepG2 (hepatoblastoma)	NULL
EXP040039	GTX129438	Homo sapiens		EXP039034	514	normal	Q13422	K562 (myelogenous leukemia)	NULL
EXP040040	sc-10813	Homo sapiens		EXP039034	514	normal	Q13330	K562 (myelogenous leukemia)	NULL
EXP040041	GTX112232	Homo sapiens		EXP039234	430	normal	Q9Y6X8	HepG2 (hepatoblastoma)	NULL
EXP040042	A303-516A	Homo sapiens		EXP039034	514	normal	Q13422	K562 (myelogenous leukemia)	NULL
EXP040043	F1804	Homo sapiens		EXP039140	430	normal	P19532	HepG2 (hepatoblastoma)	NULL
EXP040044	F1804	Homo sapiens		EXP039224	430	normal	Q06546	HepG2 (hepatoblastoma)	NULL
EXP040045	ab290	Homo sapiens		EXP039092	421	normal	Q9BZE0	HEK293 (embryonic kidney)	NULL
EXP040046	goat-anti-GFP-UC	Homo sapiens		EXP039156	514	normal	Q15562	K562 (myelogenous leukemia)	NULL
EXP040047	goat-anti-GFP-UC	Homo sapiens		EXP039258	514	normal	O15525	K562 (myelogenous leukemia)	NULL
EXP040048	F1804	Homo sapiens		EXP039140	430	normal	Q99594	HepG2 (hepatoblastoma)	NULL
EXP040049	goat-anti-GFP-UC	Homo sapiens		EXP039152	514	normal	Q9UID6	K562 (myelogenous leukemia)	NULL
EXP040050	07-729	Homo sapiens		EXP039203	1168	normal	P49711	thyroid gland	NULL
EXP040051	sc-365644	Homo sapiens		EXP039034	514	normal	Q01196	K562 (myelogenous leukemia)	NULL
EXP040052	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP040053	16618-1-AP	Homo sapiens		EXP039036	430	normal	P52747	HepG2 (hepatoblastoma)	NULL
EXP040054	07-729	Homo sapiens		EXP039276	1167	normal	P49711	esophagus muscularis mucosa	NULL
EXP040055	ab290	Homo sapiens		EXP039031	421	normal	Q9NQ03	HEK293 (embryonic kidney)	NULL
EXP040056	H00010782-A01	Homo sapiens		EXP010476	417	normal	Q96GC6	HCT-116 (colon carcinoma)	NULL
EXP040057	HPA004051	Homo sapiens		EXP039036	430	normal	Q8TF68	HepG2 (hepatoblastoma)	NULL
EXP040058	07-729	Homo sapiens		EXP039287	1164	normal	P49711	uterus	NULL
EXP040059	sc-631	Mus musculus		EXP010644	1174	normal	Q60775	MEL cell line	NULL
EXP040060	F1804	Homo sapiens		EXP039185	430	normal	O60381	HepG2 (hepatoblastoma)	NULL
EXP040061	ab290	Homo sapiens		EXP039092	421	normal	P49711	HEK293 (embryonic kidney)	NULL
EXP040062	A300-347A	Homo sapiens		EXP039074	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040063	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP040064	A303-738A	Homo sapiens		EXP039034	514	normal	Q99676	K562 (myelogenous leukemia)	NULL
EXP040065	A301-281A	Homo sapiens		EXP039216	514	normal	Q8WXI9	K562 (myelogenous leukemia)	NULL
EXP040066	goat-anti-GFP-UC	Homo sapiens		EXP039124	514	normal	Q9BQA5	K562 (myelogenous leukemia)	NULL
EXP040067	A302-659A	Homo sapiens		EXP039034	514	normal	Q99607	K562 (myelogenous leukemia)	NULL
EXP040068	07-729	Homo sapiens		EXP039178	1150	normal	P49711	ovary	NULL
EXP040069	A303-092A	Homo sapiens		EXP039034	514	normal	P17028	K562 (myelogenous leukemia)	NULL
EXP040070	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP040071	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP040072	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP040073	39879	Homo sapiens		EXP039242	356	normal	O96028	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040074	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q8N143	HEK293 (embryonic kidney)	NULL
EXP040075	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	P52740	HEK293 (embryonic kidney)	NULL
EXP040076	ab290	Homo sapiens		EXP039031	421	normal	Q8N895	HEK293 (embryonic kidney)	NULL
EXP040077	07-729	Homo sapiens		EXP039050	1132	normal	P49711	heart left ventricle	NULL
EXP040078	sc-74	Homo sapiens		EXP039302	879	normal	P17535	liver	NULL
EXP040079	A302-865A	Homo sapiens		EXP039216	514	normal	Q8IWI9	K562 (myelogenous leukemia)	NULL
EXP040080	goat-anti-GFP-UC	Homo sapiens		EXP039278	113	normal	Q16254	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040081	F1804	Homo sapiens		EXP039140	430	normal	Q9BW11	HepG2 (hepatoblastoma)	NULL
EXP040082	61311	Homo sapiens		EXP039131	1184	normal	P49711	GM23338	NULL
EXP040083	A303-197A	Homo sapiens		EXP039240	113	normal	Q6ZNB6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040084	WH0009189M1	Homo sapiens		EXP039096	514	normal	O96006	K562 (myelogenous leukemia)	NULL
EXP040085	A303-230A	Homo sapiens		EXP039076	356	normal	P67809	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040086	sc-185	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP040087	07-729	Homo sapiens		EXP039262	1181	normal	P49711	upper lobe of left lung	NULL
EXP040088	A301-531A	Homo sapiens		EXP039188	356	normal	Q92610	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040089	07-729	Homo sapiens		EXP039245	1154	normal	P49711	omental fat pad	NULL
EXP040090	07-729	Homo sapiens		EXP039023	1154	normal	P49711	omental fat pad	NULL
EXP040091	goat-anti-GFP-UC	Homo sapiens		EXP039265	514	normal	P18846	K562 (myelogenous leukemia)	NULL
EXP040092	17-641	Homo sapiens		EXP039132	38	normal	Q13127	A549 (lung carcinoma)	NULL
EXP040093	ab290	Homo sapiens		EXP039031	421	normal	Q53GI3	HEK293 (embryonic kidney)	NULL
EXP040094	F1804	Homo sapiens		EXP039198	514	normal	P18846	K562 (myelogenous leukemia)	NULL
EXP040095	N8664	Homo sapiens		EXP039046	113	normal	Q15233	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040096	GTX129438	Homo sapiens		EXP039020	430	normal	Q13422	HepG2 (hepatoblastoma)	NULL
EXP040097	A301-443A	Homo sapiens		EXP039034	514	normal	P32519	K562 (myelogenous leukemia)	NULL
EXP040098	HPA001759	Homo sapiens		EXP039034	514	normal	P27540	K562 (myelogenous leukemia)	NULL
EXP040099	ab290	Homo sapiens		EXP039092	421	normal	Q3MJ62	HEK293 (embryonic kidney)	NULL
EXP040100	F1804	Homo sapiens		EXP039140	430	normal	Q9UN79	HepG2 (hepatoblastoma)	NULL
EXP040101	3418	Homo sapiens		EXP039170	781	normal	P49711	RWPE1 (prostate epithelial cells)	NULL
EXP040102	goat-anti-GFP-UC	Homo sapiens		EXP039066	514	normal	Q8TCN5	K562 (myelogenous leukemia)	NULL
EXP040103	sc-66882	Homo sapiens		EXP039034	514	normal	P11474	K562 (myelogenous leukemia)	NULL
EXP040104	sc-9082	Homo sapiens		EXP039199	665	normal	Q14653	SK-N-SH (neuroblastoma)	NULL
EXP040105	ab290	Homo sapiens		EXP039092	421	normal	O95600	HEK293 (embryonic kidney)	NULL
EXP040106	sc-281	Homo sapiens		EXP039095	879	normal	P25490	liver	NULL
EXP040107	07-729	Homo sapiens		EXP039174	920	normal	P49711	pancreas	NULL
EXP040108	GTX114991	Homo sapiens		EXP039034	514	normal	P55347	K562 (myelogenous leukemia)	NULL
EXP040109	ab290	Homo sapiens		EXP039092	421	normal	Q6ZN18	HEK293 (embryonic kidney)	NULL
EXP040110	goat-anti-GFP-UC	Homo sapiens		EXP039171	514	normal	P53567	K562 (myelogenous leukemia)	NULL
EXP040111	ab290	Homo sapiens		EXP039092	421	normal	Q9HBE1	HEK293 (embryonic kidney)	NULL
EXP040112	F1804	Homo sapiens		EXP039140	430	normal	Q6BEB4	HepG2 (hepatoblastoma)	NULL
EXP040113	ab70892	Homo sapiens		EXP039132	38	normal	P29375	A549 (lung carcinoma)	NULL
EXP040114	F1804	Homo sapiens		EXP039140	430	normal	Q3KQV3	HepG2 (hepatoblastoma)	NULL
EXP040115	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP040116	goat-anti-GFP-UC	Homo sapiens		EXP039060	514	normal	Q00978	K562 (myelogenous leukemia)	NULL
EXP040117	goat-anti-GFP-UC	Homo sapiens		EXP039238	514	normal	P17010	K562 (myelogenous leukemia)	NULL
EXP040118	07-729	Homo sapiens		EXP039254	1157	normal	P49711	stomach	NULL
EXP040119	F1804	Homo sapiens		EXP039140	430	normal	P17036	HepG2 (hepatoblastoma)	NULL
EXP040120	GTX102170	Homo sapiens		EXP039161	10	normal	Q08050	HEK293T (embryonic kidney)	NULL
EXP040121	F1804	Homo sapiens		EXP039140	430	normal	Q9P0W2	HepG2 (hepatoblastoma)	NULL
EXP040122	sc-28312	Homo sapiens		EXP039275	879	normal	Q06546	liver	NULL
EXP040123	ab290	Homo sapiens		EXP039092	421	normal	Q6N043	HEK293 (embryonic kidney)	NULL
EXP040124	ab290	Homo sapiens		EXP039092	421	normal	Q9ULJ3	HEK293 (embryonic kidney)	NULL
EXP040125	goat-anti-GFP-UC	Homo sapiens		EXP039267	514	normal	Q9Y2Y9	K562 (myelogenous leukemia)	NULL
EXP040126	F1804	Homo sapiens		EXP039140	430	normal	Q9NPA5	HepG2 (hepatoblastoma)	NULL
EXP040127	A303-265A	Homo sapiens		EXP039188	356	normal	O75362	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040128	07-729	Homo sapiens		EXP039042	1172	normal	P49711	adrenal gland	NULL
EXP040129	sc-166705	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	Q9Y543	A549 (lung carcinoma)	NULL
EXP040130	goat-anti-GFP-UC	Homo sapiens		EXP039305	113	normal	P15408	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040131	A303-070A	Homo sapiens		EXP039034	514	normal	P16989	K562 (myelogenous leukemia)	NULL
EXP040132	A300-396A	Homo sapiens		EXP039188	356	normal	O94776	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040133	ab290	Homo sapiens		EXP039092	421	normal	P17031	HEK293 (embryonic kidney)	NULL
EXP040134	07-729	Homo sapiens		EXP039180	1136	normal	P49711	gastrocnemius medialis	NULL
EXP040135	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP040136	sc-8051x	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	P17275	A549 (lung carcinoma)	NULL
EXP040137	sc-7202	Homo sapiens		EXP039046	113	normal	P01100	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040138	TA805187	Homo sapiens		EXP039216	514	normal	P10827	K562 (myelogenous leukemia)	NULL
EXP040139	GTX114393	Homo sapiens		EXP039138	430	normal	P43268	HepG2 (hepatoblastoma)	NULL
EXP040140	A301-282A	Homo sapiens		EXP039074	113	normal	Q8WXI9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040141	GTX100308	Homo sapiens		EXP039046	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040142	goat-anti-GFP-UC	Homo sapiens		EXP039135	514	normal	Q5HY98	K562 (myelogenous leukemia)	NULL
EXP040143	ab290	Homo sapiens		EXP039092	421	normal	Q6AHZ1	HEK293 (embryonic kidney)	NULL
EXP040144	A304-181A	Homo sapiens		EXP039034	514	normal	Q9C0G0	K562 (myelogenous leukemia)	NULL
EXP040145	3418	Homo sapiens		EXP039068	129	normal	P49711	LNCaP C4-2B (prostate carcinoma)	NULL
EXP040146	WH0007023M3	Homo sapiens		EXP039231	430	normal	Q01664	HepG2 (hepatoblastoma)	NULL
EXP040147	RCAB0002P-F	Mus musculus		EXP039261	233	normal	Q80Z64	E14TG2A (embryonic stem cells)	NULL
EXP040148	HPA019589	Homo sapiens		EXP039034	514	normal	Q8N108	K562 (myelogenous leukemia)	NULL
EXP040149	F1804	Homo sapiens		EXP039140	430	normal	Q9BXK1	HepG2 (hepatoblastoma)	NULL
EXP040150	A300-755A	Homo sapiens		EXP039061	430	normal	Q99081	HepG2 (hepatoblastoma)	NULL
EXP040151	ab290	Homo sapiens		EXP039092	421	normal	Q8N7K0	HEK293 (embryonic kidney)	NULL
EXP040152	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q6ZSS3	HEK293 (embryonic kidney)	NULL
EXP040153	F1804	Homo sapiens		EXP039140	430	normal	Q8NB15	HepG2 (hepatoblastoma)	NULL
EXP040154	A301-443A	Homo sapiens		EXP039240	113	normal	P32519	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040155	sc-13042	Homo sapiens		EXP039106	514	normal	P14316	K562 (myelogenous leukemia)	NULL
EXP040156	F1804	Homo sapiens		EXP039249	430	normal	P16220	HepG2 (hepatoblastoma)	NULL
EXP040157	07-729	Homo sapiens		EXP039211	1148	normal	P49711	esophagus squamous epithelium	NULL
EXP040158	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP040159	sc-160	Homo sapiens		EXP039181	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP040160	F1804	Homo sapiens		EXP039140	430	normal	P78545	HepG2 (hepatoblastoma)	NULL
EXP040161	A302-229A	Homo sapiens		EXP039034	514	normal	Q68CP9	K562 (myelogenous leukemia)	NULL
EXP040162	ab60931	Homo sapiens		EXP039118	38	normal	Q15853	A549 (lung carcinoma)	NULL
EXP040163	ab290	Homo sapiens		EXP039092	421	normal	O60315	HEK293 (embryonic kidney)	NULL
EXP040164	39894	Homo sapiens		EXP039159	430	normal	P43694	HepG2 (hepatoblastoma)	NULL
EXP040165	SAB2102741	Homo sapiens		EXP039029	514	normal	O95625	K562 (myelogenous leukemia)	NULL
EXP040166	F1804	Homo sapiens		EXP039140	430	normal	Q9NPF5	HepG2 (hepatoblastoma)	NULL
EXP040167	F1804	Homo sapiens		EXP039140	430	normal	Q16649	HepG2 (hepatoblastoma)	NULL
EXP040168	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039205	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040169	07-729	Homo sapiens		EXP039202	1156	normal	P49711	gastroesophageal sphincter	NULL
EXP040170	GTX115430	Homo sapiens		EXP039086	514	normal	O75398	K562 (myelogenous leukemia)	NULL
EXP040171	39550	Homo sapiens		EXP039134	1184	normal	P17275	GM23338	NULL
EXP040172	ab290	Homo sapiens		EXP039092	421	normal	P37275	HEK293 (embryonic kidney)	NULL
EXP040173	ab290	Homo sapiens		EXP039092	421	normal	P51786	HEK293 (embryonic kidney)	NULL
EXP040174	F1804	Homo sapiens		EXP039140	430	normal	O14593	HepG2 (hepatoblastoma)	NULL
EXP040175	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q8NC26	HEK293 (embryonic kidney)	NULL
EXP040176	NB100-279	Homo sapiens		EXP039074	113	normal	Q99856	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040177	sc-150	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP040178	sc-185	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	P20749	A549 (lung carcinoma)	NULL
EXP040179	ab290	Homo sapiens		EXP039092	421	normal	Q9UK11	HEK293 (embryonic kidney)	NULL
EXP040180	10007663	Homo sapiens		EXP039030	423	normal	Q12772	HeLa S3 (cervical adenocarcinoma)	NULL
EXP040181	sc-160	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	P15408	A549 (lung carcinoma)	NULL
EXP040182	ab290	Homo sapiens		EXP039092	421	normal	Q3KQV3	HEK293 (embryonic kidney)	NULL
EXP040183	F1804	Homo sapiens		EXP039140	430	normal	P49715	HepG2 (hepatoblastoma)	NULL
EXP040184	ab290	Homo sapiens		EXP039092	421	normal	O60281	HEK293 (embryonic kidney)	NULL
EXP040185	WH0001390M2	Homo sapiens		EXP039049	514	normal	Q03060	K562 (myelogenous leukemia)	NULL
EXP040186	A301-145A	Homo sapiens		EXP010781	430	normal	O75376	HepG2 (hepatoblastoma)	NULL
EXP040187	GTX112232	Homo sapiens		EXP039151	113	normal	Q9Y6X8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040188	S9809	Homo sapiens		EXP039232	10	normal	P08047	HEK293T (embryonic kidney)	NULL
EXP040189	sc-30189	Homo sapiens		EXP039199	665	normal	Q9UKL0	SK-N-SH (neuroblastoma)	NULL
EXP040190	sc-150	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	P17676	A549 (lung carcinoma)	NULL
EXP040191	sc-166835	Homo sapiens		EXP039106	514	normal	P41212	K562 (myelogenous leukemia)	NULL
EXP040192	07-729	Homo sapiens		EXP039230	1163	normal	P49711	transverse colon	NULL
EXP040193	61311	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	P49711	A549 (lung carcinoma)	NULL
EXP040194		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP040195		Homo sapiens		NULL	394	chip_control	NULL	H929 (plasma cell myeloma)	NULL
EXP040196		Homo sapiens		NULL	1184	chip_control	NULL	GM23338	NULL
EXP040197		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP040198		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040199		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP040200		Homo sapiens		NULL	1187	chip_control	NULL	Parathyroid adenoma	NULL
EXP040201		Homo sapiens		NULL	816	chip_control	NULL	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP040202		Homo sapiens	1mM calcium (CHEBI:86158) for 2 day	NULL	1185	chip_control	NULL	foreskin keratinocyte	NULL
EXP040203		Homo sapiens		NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP040204		Homo sapiens		NULL	288	chip_control	NULL	A673 (Ewing sarcoma)	NULL
EXP040205		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040206		Homo sapiens	1mM calcium (CHEBI:86158) for 5 day	NULL	1185	chip_control	NULL	foreskin keratinocyte	NULL
EXP040207		Homo sapiens		NULL	1185	chip_control	NULL	foreskin keratinocyte	NULL
EXP040208		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040209		Homo sapiens		NULL	1186	chip_control	NULL	smooth muscle cell	NULL
EXP040210		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP040211		Homo sapiens		NULL	415	chip_control	NULL	HCM (cardiac myocytes)	NULL
EXP040212		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP040213		Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040214		Homo sapiens		NULL	887	chip_control	NULL	neural progenitors	NULL
EXP040215		Homo sapiens		NULL	1187	chip_control	NULL	Parathyroid adenoma	NULL
EXP040216		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP040217		Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP040218		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040219		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP040220		Homo sapiens		NULL	1183	chip_control	NULL	KMS-11 (Plasma cell myeloma)	NULL
EXP040221	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 20 minute	EXP040219	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040222	A300-346A	Homo sapiens		EXP039216	514	normal	Q15596	K562 (myelogenous leukemia)	NULL
EXP040223	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 minute	EXP040216	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040224	goat-anti-GFP-UC	Homo sapiens		EXP040208	514	normal	Q14119	K562 (myelogenous leukemia)	NULL
EXP040225	A300-832A	Homo sapiens		EXP039034	514	normal	Q66K89	K562 (myelogenous leukemia)	NULL
EXP040226	A300-832A	Homo sapiens		EXP039074	113	normal	Q66K89	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040227	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P28698	HEK293 (embryonic kidney)	NULL
EXP040228	07-729	Homo sapiens		EXP040197	417	normal	P49711	HCT-116 (colon carcinoma)	NULL
EXP040229	A303-284A	Homo sapiens		EXP039034	514	normal	Q8IWY8	K562 (myelogenous leukemia)	NULL
EXP040230	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9Y2Y9	HEK293 (embryonic kidney)	NULL
EXP040231	sc-553	Homo sapiens		EXP039302	879	normal	P19793	liver	NULL
EXP040232	A301-817A	Homo sapiens		EXP039240	113	normal	Q6ZN55	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040233	A302-618A	Homo sapiens		EXP039240	113	normal	O15516	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040234	07-729	Homo sapiens		EXP040200	1187	normal	P49711	Parathyroid adenoma	NULL
EXP040235	A303-571A	Homo sapiens		EXP039188	356	normal	Q12968	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040236	A302-766A	Homo sapiens		EXP039216	514	normal	Q9Y692	K562 (myelogenous leukemia)	NULL
EXP040237	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9UL59	HEK293 (embryonic kidney)	NULL
EXP040238	goat-anti-GFP-UC	Homo sapiens		EXP040198	514	normal	Q9UQR1	K562 (myelogenous leukemia)	NULL
EXP040239	A303-207A	Homo sapiens		EXP039077	514	normal	Q13129	K562 (myelogenous leukemia)	NULL
EXP040240	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039031	421	normal	O75820	HEK293 (embryonic kidney)	NULL
EXP040241	07-729	Homo sapiens		EXP040205	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040242	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	O14771	HEK293 (embryonic kidney)	NULL
EXP040243	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 25 minute	EXP040199	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040244	07-729	Homo sapiens	1mM calcium (CHEBI:86158) for 5 day	EXP040206	1185	normal	P49711	foreskin keratinocyte	NULL
EXP040245	11815S	Homo sapiens		EXP039034	514	normal	P18848	K562 (myelogenous leukemia)	NULL
EXP040246	07-729	Homo sapiens		EXP040203	665	normal	P49711	SK-N-SH (neuroblastoma)	NULL
EXP040247	R303.2.1B10	Homo sapiens		EXP039074	113	normal	P11474	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040248	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 minute	EXP040216	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040249	F1804	Homo sapiens		EXP039140	430	normal	Q49AG3	HepG2 (hepatoblastoma)	NULL
EXP040250	sc-33759	Homo sapiens		EXP039131	1184	normal	Q9H9S0	GM23338	NULL
EXP040251	A303-039A	Homo sapiens		EXP039034	514	normal	A0AVK6	K562 (myelogenous leukemia)	NULL
EXP040252	A303-172A	Homo sapiens		EXP039188	356	normal	P11831	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040253	07-729	Homo sapiens		EXP040211	415	normal	P49711	HCM (cardiac myocytes)	NULL
EXP040254	07-729	Homo sapiens		EXP040220	1183	normal	P49711	KMS-11 (Plasma cell myeloma)	NULL
EXP040255	A302-764A	Homo sapiens		EXP039034	514	normal	P27540	K562 (myelogenous leukemia)	NULL
EXP040256	07-729	Homo sapiens	1mM calcium (CHEBI:86158) for 2 day	EXP040202	1185	normal	P49711	foreskin keratinocyte	NULL
EXP040257	07-729	Homo sapiens		EXP040204	288	normal	P49711	A673 (Ewing sarcoma)	NULL
EXP040258	A303-274A	Homo sapiens		EXP039240	113	normal	Q8TCN5	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040259	07-729	Homo sapiens		EXP040196	1184	normal	P49711	GM23338	NULL
EXP040260	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q68DY1	HEK293 (embryonic kidney)	NULL
EXP040261	TA805006	Homo sapiens		EXP039216	514	normal	P51843	K562 (myelogenous leukemia)	NULL
EXP040262	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9Y2H8	HEK293 (embryonic kidney)	NULL
EXP040263	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 15 minute	EXP040194	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040264	4373S	Homo sapiens		EXP039046	113	normal	Q13562	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040265	558036	Homo sapiens		EXP040210	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040266	A303-265A	Homo sapiens		EXP039074	113	normal	O75362	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040267	GTX101120	Homo sapiens		EXP039034	514	normal	P04150	K562 (myelogenous leukemia)	NULL
EXP040268	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9Y330	HEK293 (embryonic kidney)	NULL
EXP040269	A303-204A	Homo sapiens		EXP039077	514	normal	Q9NQV6	K562 (myelogenous leukemia)	NULL
EXP040270	A301-039A	Homo sapiens		EXP039034	514	normal	Q8TAQ2	K562 (myelogenous leukemia)	NULL
EXP040271	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 25 minute	EXP040199	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040272	A300-344A	Homo sapiens		EXP039034	514	normal	Q15788	K562 (myelogenous leukemia)	NULL
EXP040273	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 15 minute	EXP040194	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040274	A304-064A	Homo sapiens		EXP039034	514	normal	O15062	K562 (myelogenous leukemia)	NULL
EXP040275	07-729	Homo sapiens		EXP040195	394	normal	P49711	H929 (plasma cell myeloma)	NULL
EXP040276	600-401-B29	Homo sapiens		EXP039076	356	normal	Q15797	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040277	sc-1003	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 minute	EXP040212	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040278	07-729	Homo sapiens		EXP040215	1187	normal	P49711	Parathyroid adenoma	NULL
EXP040279	07-729	Homo sapiens		EXP040201	816	normal	P49711	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP040280	A303-234A	Homo sapiens		EXP039074	113	normal	Q96KM6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040281	GTX70250	Homo sapiens		EXP039034	514	normal	Q15788	K562 (myelogenous leukemia)	NULL
EXP040282	07-729	Homo sapiens		EXP040207	1185	normal	P49711	foreskin keratinocyte	NULL
EXP040283	A302-400A	Homo sapiens		EXP039034	514	normal	Q9UID6	K562 (myelogenous leukemia)	NULL
EXP040284	A303-039A	Homo sapiens		EXP039074	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040285	goat-anti-GFP-UC	Homo sapiens		EXP040218	514	normal	Q9NUA8	K562 (myelogenous leukemia)	NULL
EXP040286	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q6P9G9	HEK293 (embryonic kidney)	NULL
EXP040287	HPA024374	Homo sapiens		EXP039020	430	normal	Q9UDV7	HepG2 (hepatoblastoma)	NULL
EXP040288	HPA024374	Homo sapiens		EXP039034	514	normal	Q9UDV7	K562 (myelogenous leukemia)	NULL
EXP040289	HPA030062	Homo sapiens		EXP039188	356	normal	Q06710	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040290	07-729	Homo sapiens		EXP040214	887	normal	P49711	neural progenitors	NULL
EXP040291	07-729	Homo sapiens		EXP040217	725	normal	P49711	PC3(bone mets prostate adenocarcinoma)	NULL
EXP040292	NB100-92169	Homo sapiens		EXP039036	430	normal	P14921	HepG2 (hepatoblastoma)	NULL
EXP040293	A302-401A	Homo sapiens		EXP039034	514	normal	Q9UID6	K562 (myelogenous leukemia)	NULL
EXP040294	HPA005732	Homo sapiens		EXP039076	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040295	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9BSK1	HEK293 (embryonic kidney)	NULL
EXP040296	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q6P280	HEK293 (embryonic kidney)	NULL
EXP040297	sc-1003	Homo sapiens		EXP040210	38	normal	P04150	A549 (lung carcinoma)	NULL
EXP040298	07-729	Homo sapiens		EXP040209	1186	normal	P49711	smooth muscle cell	NULL
EXP040299	A303-039A	Homo sapiens		EXP039076	356	normal	A0AVK6	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040300	2/61715	Homo sapiens		EXP039216	514	normal	P18847	K562 (myelogenous leukemia)	NULL
EXP040301	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q8TD94	HEK293 (embryonic kidney)	NULL
EXP040302	A302-765A	Homo sapiens		EXP039188	356	normal	P27540	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040303	A302-390A	Homo sapiens		EXP039074	113	normal	P17098	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040304	A300-832A	Homo sapiens		EXP039076	356	normal	Q66K89	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP040305	A302-617A	Homo sapiens		EXP039240	113	normal	O15516	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040306	TA800173	Homo sapiens		EXP039034	514	normal	P59817	K562 (myelogenous leukemia)	NULL
EXP040307	GTX70165	Homo sapiens		EXP039216	514	normal	Q01094	K562 (myelogenous leukemia)	NULL
EXP040308	A303-739A	Homo sapiens		EXP039034	514	normal	Q99676	K562 (myelogenous leukemia)	NULL
EXP040309	A304-180A	Homo sapiens		EXP039034	514	normal	Q9C0G0	K562 (myelogenous leukemia)	NULL
EXP040310	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9UK13	HEK293 (embryonic kidney)	NULL
EXP040311	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q15916	HEK293 (embryonic kidney)	NULL
EXP040312	TA806187	Homo sapiens		EXP039034	514	normal	P04150	K562 (myelogenous leukemia)	NULL
EXP040313	A303-269A	Homo sapiens		EXP039074	113	normal	Q8N0Y2	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040314	9197S	Homo sapiens		EXP039020	430	normal	P16220	HepG2 (hepatoblastoma)	NULL
EXP040315	HPA024062	Homo sapiens		EXP039061	430	normal	P17028	HepG2 (hepatoblastoma)	NULL
EXP040316	A303-571A	Homo sapiens		EXP039034	514	normal	Q12968	K562 (myelogenous leukemia)	NULL
EXP040317	39789	Homo sapiens		EXP039034	514	normal	O75030	K562 (myelogenous leukemia)	NULL
EXP040318	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9NQX6	HEK293 (embryonic kidney)	NULL
EXP040319	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q9H5H4	HEK293 (embryonic kidney)	NULL
EXP040320	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 20 minute	EXP040219	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040321	07-729	Homo sapiens		EXP040213	685	normal	P49711	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040322	558036	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 minute	EXP040212	38	normal	P05412	A549 (lung carcinoma)	NULL
EXP040323	sc-10652	Homo sapiens		EXP039020	430	normal	P22670	HepG2 (hepatoblastoma)	NULL
EXP040324	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	P25490	HEK293 (embryonic kidney)	NULL
EXP040325	ab-290 (Lot GR194813-1),ab290	Homo sapiens		EXP039092	421	normal	Q6IQ21	HEK293 (embryonic kidney)	NULL
EXP040326	A300-345A	Homo sapiens		EXP039216	514	normal	Q15596	K562 (myelogenous leukemia)	NULL
EXP040327	Pre-immune serum	Arabidopsis thaliana		NULL	1188	chip_control	NULL	floral tissue	NULL
EXP040328	Pre-immune serum	Arabidopsis thaliana	genotype nrpd1-4	NULL	1188	chip_control	NULL	floral tissue	NULL
EXP044373	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 34Â°C to desired stage	EXP044370	1202	normal	G5EFT5	whole worms (developmental stage: L2)	NULL
EXP040331	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP040332	RBPSUH(D10A4) (Cell Signaling, Catalog# 5313s, lot# 3)	Homo sapiens		EXP040331	2301	normal	Q06330	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP040333	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP040334	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP040335	IRF2	Mus musculus	Hcfc2 KO	EXP040334	12	normal	P23906	MEF (mouse embryonic fibroblasts)	NULL
EXP040336	IRF2	Mus musculus		EXP040333	12	normal	P23906	MEF (mouse embryonic fibroblasts)	NULL
EXP040337		Mus musculus	ATRX -/-	NULL	1189	chip_control	NULL	neuroepithelial progenitor cells	NULL
EXP040338		Mus musculus		NULL	1189	chip_control	NULL	neuroepithelial progenitor cells	NULL
EXP040339		Mus musculus	p53 -/-	NULL	1189	chip_control	NULL	neuroepithelial progenitor cells	NULL
EXP040340	ATRX H300 antibody (Santa Cruz)	Mus musculus	ATRX -/-	EXP040337	1189	bio_control	Q61687	neuroepithelial progenitor cells	NULL
EXP040341	ATRX H300 antibody (Santa Cruz)	Mus musculus		EXP040338	1189	normal	Q61687	neuroepithelial progenitor cells	NULL
EXP040342	ATRX H300 antibody (Santa Cruz)	Mus musculus	p53 -/-	EXP040339	1189	normal	Q61687	neuroepithelial progenitor cells	NULL
EXP040343		Mus musculus	None	NULL	1190	chip_control	NULL	neuroblastoma (Th-MYCN)	NULL
EXP040344	NA	Mus musculus	None	NULL	1190	chip_control	NULL	neuroblastoma (Th-MYCN)	NULL
EXP040345	NA	Mus musculus	None	NULL	1190	chip_control	NULL	neuroblastoma (Th-MYCN)	NULL
EXP040346	MYCN	Mus musculus	None	EXP040343	1190	normal	P03966	neuroblastoma (Th-MYCN)	NULL
EXP040347	MYCN	Mus musculus	None	EXP040344	1190	normal	P03966	neuroblastoma (Th-MYCN)	NULL
EXP040348	MYCN	Mus musculus	None	EXP040345	1190	normal	P03966	neuroblastoma (Th-MYCN)	NULL
EXP040349		Homo sapiens	BSA (control)	NULL	1191	chip_control	NULL	tracheobronchial epithelial cells	NULL
EXP040350		Homo sapiens	GDF15	NULL	1191	chip_control	NULL	tracheobronchial epithelial cells	NULL
EXP040351	anti-pSMAD1	Homo sapiens	BSA (control)	EXP040349	1191	normal	Q15797	tracheobronchial epithelial cells	NULL
EXP040352	anti-pSMAD1	Homo sapiens	GDF15	EXP040350	1191	normal	Q15797	tracheobronchial epithelial cells	NULL
EXP040353	rabbit IgG (Invitrogen, 9172)	Mus musculus	serum-starved	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP040354	rabbit IgG (Invitrogen, 9172)	Mus musculus	thrombopoietin 30 minutes	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP040355	STAT1 (Cell Signaling, 9172)	Mus musculus	serum-starved	EXP040353	445	normal	P42225	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP040356	STAT1 (Cell Signaling, 9172)	Mus musculus	thrombopoietin 30 minutes	EXP040354	445	normal	P42225	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP040357	CTCF (Millipore, 07-729)	Mus musculus	thrombopoietin 30 minutes	EXP040354	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP040358	CTCF (Millipore, 07-729)	Mus musculus	serum-starved	EXP040353	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP040359	None	Mus musculus		NULL	1193	chip_control	NULL	suprabasal transient amplifying cells	NULL
EXP040360	LEF1	Mus musculus		EXP040359	1193	normal	P27782	suprabasal transient amplifying cells	NULL
EXP040361	INPUT (none)	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP040362	INPUT (none)	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP040363	IRF1	Mus musculus	irradiated with 6Gy IR for 0h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP040364	IRF1	Mus musculus	irradiated with 6Gy IR for 1h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP040365	IRF1	Mus musculus	irradiated with 6Gy IR for 2h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP040366	IRF1	Mus musculus	irradiated with 6Gy IR for 6h	EXP040361	81	normal	P15314	BMDM (bone marrow-derived macrophages)	NULL
EXP040367	IRF3	Mus musculus	irradiated with 6Gy IR for 0h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP040368	IRF3	Mus musculus	irradiated with 6Gy IR for 1h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP040369	IRF3	Mus musculus	irradiated with 6Gy IR for 2h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP040370	IRF3	Mus musculus	irradiated with 6Gy IR for 6h	EXP040361	81	normal	P70671	BMDM (bone marrow-derived macrophages)	NULL
EXP040371	p-p53	Mus musculus	irradiated with 6Gy IR for 0h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	NULL
EXP040372	p-p53	Mus musculus	irradiated with 6Gy IR for 0.5h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	NULL
EXP040373	p-p53	Mus musculus	irradiated with 6Gy IR for 1h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	NULL
EXP040374	p-p53	Mus musculus	irradiated with 6Gy IR for 2h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	NULL
EXP040375	p-p53	Mus musculus	irradiated with 6Gy IR for 6h	EXP040362	81	normal	P02340	BMDM (bone marrow-derived macrophages)	NULL
EXP040376	RORa	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP040377	RORg	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP040378	RORa	Mus musculus	ROR LDKO	EXP040376	5	normal	P51448	liver	NULL
EXP040379	RORg	Mus musculus	ROR LDKO	EXP040377	5	normal	P51450	liver	NULL
EXP040380	None	Homo sapiens	Treatment: none	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP040381	None	Homo sapiens	Treatment: none	NULL	1194	chip_control	NULL	SK-N-AS (neuroblastoma)	NULL
EXP040382	None	Homo sapiens	Treatment: none	NULL	1195	chip_control	NULL	NB69 (neuroblastoma)	NULL
EXP040383	CTCF	Homo sapiens	Treatment: none	EXP040380	664	normal	P49711	SH-SY5Y (neuroblastoma)	NULL
EXP040384	CTCF	Homo sapiens	Treatment: none	EXP040381	1194	normal	P49711	SK-N-AS (neuroblastoma)	NULL
EXP040385	CTCF	Homo sapiens	Treatment: none	EXP040382	1195	normal	P49711	NB69 (neuroblastoma)	NULL
EXP040386	rabbit IgG (Santa Cruz)	Mus musculus		NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040387	anti-STAT5B (R&D systems)	Mus musculus		EXP040386	1192	normal	P42232	primary splenic NK cells	NULL
EXP040388	anti-STAT5B (R&D systems)	Mus musculus	40 ng/ml of IL-15 for 1 hr	EXP040386	1192	normal	P42232	primary splenic NK cells	NULL
EXP040389	anti-STAT5B (R&D systems)	Mus musculus	double knockin (DKI) mice	EXP040386	1192	normal	P42232	primary splenic NK cells	NULL
EXP040390	anti-STAT5B (R&D systems)	Mus musculus	double knockin (DKI) mice; 40 ng/ml of IL-15 for 1 hr	EXP040386	1192	bio_control	P42232	primary splenic NK cells	NULL
EXP040391	none	Homo sapiens		NULL	1196	chip_control	NULL	HuES6-derived cardiomyocyte progenitors	NULL
EXP040392	isl1 Cell Signaling Technology # 3724	Homo sapiens	DOX added to induce ISL1 expression	EXP040391	1196	normal	P61371	HuES6-derived cardiomyocyte progenitors	NULL
EXP040393	isl1 Cell Signaling Technology # 3724	Homo sapiens	no DOX	NULL	1196	bio_control	P61371	HuES6-derived cardiomyocyte progenitors	NULL
EXP040394		Drosophila melanogaster	10 microMolar Cu2SO4	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP040395	HA (AbCam ab9110)	Drosophila melanogaster	10 microMolar Cu2SO4; HA-Ubx transfection	EXP040394	1197	normal	P83949	S2-DRSC (embryonic stem cells)	NULL
EXP040396	none	Mus musculus	IL6+TGFbR inhibitor	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP040397	none	Mus musculus	IL6+TGFbR inhibitor; SMAD4 KO	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP040398	Smad4	Mus musculus	IL6+TGFbR inhibitor	EXP040396	1058	normal	P97471	CD4+ T-cells	NULL
EXP040399	Smad4	Mus musculus	IL6+TGFbR inhibitor; SMAD4 KO	EXP040397	1058	normal	P97471	CD4+ T-cells	NULL
EXP040400	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	CD1 strain	NULL	1105	normal	Q61164	E12.5 embryonic distal forelimb	NULL
EXP040401	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	CD1 strain	NULL	1198	normal	Q61164	E12.5 embryonic proximal forelimbs	NULL
EXP040402	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	NULL
EXP040403	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(8-13)d11lac	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	NULL
EXP040404	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(8-13)rXII	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	NULL
EXP040405	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(1-13)d9lac	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	NULL
EXP040406	anti-CTCF (Active motif, 61311, 61312)	Mus musculus	B6CBAF1 strain; delHoxd(attP-rel5)d9lac	NULL	1199	normal	Q61164	E12.5 embryonic forelimbs and hindlimbs	NULL
EXP040407	None	Mus musculus	Serum/LIF; ZBTB2-GFP BAC	NULL	1	chip_control	NULL	IB10 (embryonic stem cells)	NULL
EXP040408	None	Mus musculus	Serum/LIF + 2i; ZBTB2-GFP BAC	NULL	1	chip_control	NULL	IB10 (embryonic stem cells)	NULL
EXP040409	None	Mus musculus	NPC medium; ZBTB2-GFP BAC	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP040410	GFP (Abcam, ab290)	Mus musculus	Serum/LIF; ZBTB2-GFP BAC	EXP040407	1	normal	Q3V3W4	IB10 (embryonic stem cells)	NULL
EXP040411	GFP (Abcam, ab290)	Mus musculus	Serum/LIF	NULL	1	bio_control	P47856	IB10 (embryonic stem cells)	NULL
EXP040412	GFP (Abcam, ab290)	Mus musculus	Serum/LIF + 2i; ZBTB2-GFP BAC	EXP040408	1	normal	Q3V3W4	IB10 (embryonic stem cells)	NULL
EXP040413	GFP (Abcam, ab290)	Mus musculus	NPC medium; ZBTB2-GFP BAC	EXP040409	765	normal	Q3V3W4	R1 (embryonic stem cells)	NULL
EXP040414	GFP (Abcam, ab290)	Mus musculus	NPC medium	NULL	764	bio_control	P47856	R1 embryonic stem cell-derived neural progenitors	NULL
EXP040415	none	Drosophila melanogaster	Control drug (C37)	NULL	1200	chip_control	NULL	S2-DGRC (embryonic stem cells)	NULL
EXP040416	none	Drosophila melanogaster	Control drug (C37)	NULL	1200	chip_control	NULL	S2-DGRC (embryonic stem cells)	NULL
EXP040417	none	Drosophila melanogaster	CBP inhibitor (C646)	NULL	1200	chip_control	NULL	S2-DGRC (embryonic stem cells)	NULL
EXP040418	none	Drosophila melanogaster	CBP inhibitor (C646)	NULL	1200	chip_control	NULL	S2-DGRC (embryonic stem cells)	NULL
EXP040419	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	Control drug (C37)	EXP040415	1200	normal	P29052	S2-DGRC (embryonic stem cells)	NULL
EXP040420	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	Control drug (C37)	EXP040416	1200	normal	P29052	S2-DGRC (embryonic stem cells)	NULL
EXP040421	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	CBP inhibitor (C646)	EXP040417	1200	normal	P29052	S2-DGRC (embryonic stem cells)	NULL
EXP040422	Drosophila TFIIB antibody from Jim Kadonaga (UCSD).	Drosophila melanogaster	CBP inhibitor (C646)	EXP040418	1200	normal	P29052	S2-DGRC (embryonic stem cells)	NULL
EXP040423	none	Homo sapiens	Fetal	NULL	326	chip_control	NULL	CD34+ stem cells-derived erythroblasts	NULL
EXP040424	none	Homo sapiens	Adult	NULL	326	chip_control	NULL	CD34+ stem cells-derived erythroblasts	NULL
EXP040425	CTCF (Millipore, 07-729, lot 2757161)	Homo sapiens	Fetal	EXP040423	326	normal	P49711	CD34+ stem cells-derived erythroblasts	NULL
EXP040426	CTCF (Millipore, 07-729, lot 2757161)	Homo sapiens	Adult	EXP040424	326	normal	P49711	CD34+ stem cells-derived erythroblasts	NULL
EXP040427	none	Caenorhabditis elegans		NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP040428	none	Caenorhabditis elegans		NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP040429	GFP beads(ChromoTek, Gat-20)	Caenorhabditis elegans		EXP040427	1202	normal	P52906	whole worms (developmental stage: L2)	NULL
EXP040430	GFP beads(ChromoTek, Gat-20)	Caenorhabditis elegans		EXP040428	1202	normal	G5ECR9	whole worms (developmental stage: L2)	NULL
EXP040431	rabbit IgG (Santa Cruz)	Mus musculus	CD4	NULL	1203	chip_control	NULL	spleen T cells	NULL
EXP040432	anti-STAT5B (R&D systems)	Mus musculus	CD4	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP040433	anti-STAT3 (Invitrogen)	Mus musculus	CD4	EXP040431	1203	normal	P42227	spleen T cells	NULL
EXP040434	anti-STAT3 (Invitrogen)	Mus musculus	IL-21 (100 ng/ml) for 1h, CD4	EXP040431	1203	normal	P42227	spleen T cells	NULL
EXP040435	anti-STAT5B (R&D systems)	Mus musculus	CD8	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP040436	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, CD8	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP040437	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, UP deletion, CD4	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP040438	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, IN1 deletion, CD4	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP040439	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, IN2 deletion, CD4	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP040440	anti-STAT5B (R&D systems)	Mus musculus	IL-2 (100 U/ml, 2 nM) for 1hr, CD4	EXP040431	1203	normal	P42232	spleen T cells	NULL
EXP044372	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 20Â°C to desired stage	EXP044370	1202	normal	G5EFT5	whole worms (developmental stage: L2)	NULL
EXP044371	Input	Caenorhabditis elegans	AM1061 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP044370	Input	Caenorhabditis elegans	AM1061 strain	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP044369	anti-LEM-2 (Novus Biologicals, catalog #48540002, lot# T01872A01)	Caenorhabditis elegans	GW828 strain	EXP044366	1405	normal	Q9XTB5	whole organism (development stage: early embryonic)	NULL
EXP040446	none	Homo sapiens		NULL	964	chip_control	NULL	U266 (plasma cell myeloma)	NULL
EXP040447	PRDM1 (C14A4) rabbit mAb (Cell Signaling Tecnology)	Homo sapiens		EXP040446	964	normal	O75626	U266 (plasma cell myeloma)	NULL
EXP040448	none	Homo sapiens		NULL	880	chip_control	NULL	B-cells	NULL
EXP040449	BACH2 (D3T3G)	Homo sapiens		EXP040448	880	normal	Q9BYV9	B-cells	NULL
EXP040450	BACH2 (D3T3G)	Homo sapiens	siBACH2	EXP040448	880	bio_control	Q9BYV9	B-cells	NULL
EXP040451	none	Homo sapiens	TREx-F3H3-K-Rta; latent cells	NULL	79	chip_control	NULL	BCBL-1 (B-cell lymphoma)	NULL
EXP040452	none	Homo sapiens	TREx-F3H3-K-Rta; lytic cells	NULL	79	chip_control	NULL	BCBL-1 (B-cell lymphoma)	NULL
EXP040453	ZIC2 (Abcam, ab150404)	Homo sapiens	TREx-F3H3-K-Rta; latent cells	EXP040451	79	normal	O95409	BCBL-1 (B-cell lymphoma)	NULL
EXP040454	ZIC2 (Abcam, ab150404)	Homo sapiens	TREx-F3H3-K-Rta; lytic cells	EXP040452	79	normal	O95409	BCBL-1 (B-cell lymphoma)	NULL
EXP040455	rabbit IgG	Drosophila melanogaster		NULL	1204	chip_control	NULL	13-16 h embryo	NULL
EXP040456	rabbit anti-Grh antibody	Drosophila melanogaster		EXP040455	1204	normal	P13002	13-16 h embryo	NULL
EXP040457	rabbit polyclonal Naa10p (made in-house)	Mus musculus	The mES cells were cultured without feeders for 5 passages for depleting feeder cells; Naa10+/Y	NULL	204	normal	Q9QY36	D3 (embryonic stem cells)	NULL
EXP040458	rabbit polyclonal Naa10p (made in-house)	Mus musculus	The mES cells were cultured without feeders for 5 passages for depleting feeder cells; Naa10-/Y	NULL	204	bio_control	Q9QY36	D3 (embryonic stem cells)	NULL
EXP040459	none	Homo sapiens	Treatment: none	NULL	326	chip_control	NULL	CD34+ stem cells-derived erythroblasts	NULL
EXP040460	Santa Cruz, sc-373739	Homo sapiens	Treatment: untreated	NULL	326	normal	Q13772	CD34+ stem cells-derived erythroblasts	NULL
EXP040461	Santa Cruz, sc-373739	Homo sapiens	Treatment: GC1	EXP040459	326	normal	Q13772	CD34+ stem cells-derived erythroblasts	NULL
EXP040463		Mus musculus	LAP-tta-Arid1afl/fl;Alb-cre;TRE-MYC	NULL	551	chip_control	NULL	liver tumor	NULL
EXP040464		Mus musculus	LAP-tta-Arid1afl/+;Alb-cre;TRE-MYC	NULL	551	chip_control	NULL	liver tumor	NULL
EXP040465		Mus musculus	LAP-tta-Arid1afl/fl;TRE-MYC (WT)	NULL	551	chip_control	NULL	liver tumor	NULL
EXP040466	MYC (Santa Cruz, sc-764x)	Mus musculus	LAP-tta-Arid1afl/fl;Alb-cre;TRE-MYC	EXP040463	551	normal	P01108	liver tumor	NULL
EXP040467	MYC (Santa Cruz, sc-764x)	Mus musculus	LAP-tta-Arid1afl/+;Alb-cre;TRE-MYC	EXP040464	551	normal	P01108	liver tumor	NULL
EXP040468	MYC (Santa Cruz, sc-764x)	Mus musculus	LAP-tta-Arid1aflfl;TRE-MYC (WT)	EXP040465	551	normal	P01108	liver tumor	NULL
EXP040469	none	Homo sapiens	Treatment: none	NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040470	none	Homo sapiens	Treatment: none	NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040471	none	Homo sapiens	Treatment: none	NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP040472	none	Homo sapiens	Treatment: none	NULL	129	chip_control	NULL	LNCaP C4-2B (prostate carcinoma)	NULL
EXP040473	none	Homo sapiens	Treatment: none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP040474	none	Homo sapiens	Treatment: none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP040475	none	Homo sapiens	Treatment: none	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP040476	none	Homo sapiens	Treatment: none	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP040477	ZFX	Homo sapiens	Treatment: none	EXP040469	128	normal	P17010	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040478	ZFX	Homo sapiens	Treatment: none	EXP040470	128	normal	P17010	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040479	ZNF711	Homo sapiens	Treatment: none	EXP040469	128	normal	Q9Y462	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040480	ZNF711	Homo sapiens	Treatment: none	EXP040470	128	normal	Q9Y462	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040481	ZFX	Homo sapiens	Treatment: none	EXP040471	129	normal	P17010	LNCaP C4-2B (prostate carcinoma)	NULL
EXP040482	ZFX	Homo sapiens	Treatment: none	EXP040472	129	normal	P17010	LNCaP C4-2B (prostate carcinoma)	NULL
EXP040483	ZFX	Homo sapiens	Treatment: none	EXP040473	417	normal	P17010	HCT-116 (colon carcinoma)	NULL
EXP040484	ZFX	Homo sapiens	Treatment: none	EXP040474	417	normal	P17010	HCT-116 (colon carcinoma)	NULL
EXP040485	ZFX	Homo sapiens	Treatment: none	EXP040475	10	normal	P17010	HEK293T (embryonic kidney)	NULL
EXP040486	ZFX	Homo sapiens	Treatment: none	EXP040476	10	normal	P17010	HEK293T (embryonic kidney)	NULL
EXP040487	ZFX	Homo sapiens	Treatment: none	NULL	738	normal	P17010	PrEC (prostate cells)	NULL
EXP040489	non-immune IgG control	Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP040490	CSL antibody	Homo sapiens		EXP040489	215	normal	Q14406	keratinocytes	NULL
EXP040491	anti-Smad4	Mus musculus	Abcam (Ab40759)	NULL	1126	normal	P97471	E14TG2a.4 (embryonic stem cells)	NULL
EXP040492	anti-Smad4	Mus musculus	Santa Cruz (SC-7966X)	NULL	1126	normal	P97471	E14TG2a.4 (embryonic stem cells)	NULL
EXP040493	Anti-HA magnetic beads (Thermo Fisher Scientific)	Homo sapiens	Positive IP/test condition	NULL	1205	normal	P41212	Reh (ATCC CRL-8286)	NULL
EXP040494	Anti-HA magnetic beads (Thermo Fisher Scientific)	Homo sapiens	Negative IP/background	NULL	1205	bio_control	P41212	Reh (ATCC CRL-8286)	NULL
EXP040495	SMC3	Homo sapiens	Wild type	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040496	SMC3	Homo sapiens	Wild type	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040497	SMC3	Homo sapiens	WAPL-depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040498	SMC3	Homo sapiens	WAPL-depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040499	SMC3	Homo sapiens	Pds5SA/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040500	SMC3	Homo sapiens	Pds5SA/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040501	SMC3	Homo sapiens	Wapl/Pds5A/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040502	SMC3	Homo sapiens	Wapl/Pds5A/B depletion	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040503	CTCF	Homo sapiens	Wild type	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040504	CTCF	Homo sapiens	Wapl-depletion	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040505	CTCF	Homo sapiens	Pds5SA/B depletion	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040506	CTCF	Homo sapiens	Wapl/Pds5A/B depletion	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP040507	none	Mus musculus		NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP040508	BRD4	Mus musculus	Control	EXP040507	1058	normal	Q9ESU6	CD4+ T-cells	NULL
EXP040509	BRD4	Mus musculus	OX40L treated	EXP040507	1058	normal	Q9ESU6	CD4+ T-cells	NULL
EXP040510	EED(Active Motif,61203 )	Mus musculus	Wild type	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP040511	EED (Active Motif, Cat.61203 )	Mus musculus	Dnmt 3a-/- Dnmt 3b-/-	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP040512	SP5	Homo sapiens	0 h; Wnt3a, 1nM concentration	NULL	376	normal	Q6BEB4	WA01 (H1, human embryonic stem cells)	NULL
EXP040513	SP5	Homo sapiens	24 h; Wnt3a, 1nM concentration	NULL	376	normal	Q6BEB4	WA01 (H1, human embryonic stem cells)	NULL
EXP040514	none	Homo sapiens	Normoxia	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP040515	none	Homo sapiens	Hypoxia	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP040516	SIN3A (Abcam, catalog# ab3479, lot# 2497679 GR220251-4)	Homo sapiens	Normoxia	EXP040514	472	normal	Q96ST3	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP040517	SIN3A (Abcam, catalog# ab3479, lot# 2497679 GR220251-4)	Homo sapiens	Hypoxia	EXP040515	472	normal	Q96ST3	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP040518	olig2	Mus musculus		NULL	804	chip_control	NULL	spinal cord	NULL
EXP040519	Olig2 (Millipore #A9610)	Mus musculus		EXP040518	804	normal	Q9EQW6	spinal cord	NULL
EXP040520	none	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 days (acute exposure)	NULL	1210	chip_control	NULL	HBEC3-KT	NULL
EXP040521	none	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 days (acute exposure)	NULL	1210	chip_control	NULL	HBEC3-KT	NULL
EXP040522	none	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 months (chronic exposure)	NULL	1210	chip_control	NULL	HBEC3-KT	NULL
EXP040523	none	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 months (chronic exposure)	NULL	1210	chip_control	NULL	HBEC3-KT	NULL
EXP040524	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 days (acute exposure)	EXP040520	1210	normal	P26358	HBEC3-KT	NULL
EXP040525	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 days (acute exposure)	EXP040520	1210	normal	Q15910	HBEC3-KT	NULL
EXP040526	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 days (acute exposure)	EXP040521	1210	normal	P26358	HBEC3-KT	NULL
EXP040527	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 days (acute exposure)	EXP040521	1210	normal	Q15910	HBEC3-KT	NULL
EXP040528	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 months (chronic exposure)	EXP040522	1210	normal	P26358	HBEC3-KT	NULL
EXP040529	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Control (DMSO; 10 ug/ml); 10 months (chronic exposure)	EXP040522	1210	normal	Q15910	HBEC3-KT	NULL
EXP040530	DNMT1 (Sigma-Aldrich, D4692)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 months (chronic exposure)	EXP040523	1210	normal	P26358	HBEC3-KT	NULL
EXP040531	EZH2 (Cell signaling, 5246)	Homo sapiens	Treatment: Cigarette smoke condensate (CSC; 10 ug/ml); 10 months (chronic exposure)	EXP040523	1210	normal	Q15910	HBEC3-KT	NULL
EXP040532	none	Homo sapiens		NULL	1211	chip_control	NULL	TREx-(F3H3)-K-Rta BCBL-1 cells	NULL
EXP040533	anti-BRD4 antibody (Bethyl Laboratories)	Homo sapiens		EXP040532	1211	normal	O60885	TREx-(F3H3)-K-Rta BCBL-1 cells	NULL
EXP040534	none	Drosophila melanogaster		NULL	1212	chip_control	NULL	early embryos (0-2 hours after fertilization)	NULL
EXP040535	anti-dBigH1 (Perez-Montero et al., 2013)	Drosophila melanogaster		EXP040534	1212	normal	Q8MSC4	early embryos (0-2 hours after fertilization)	NULL
EXP040536	none	Mus musculus	Control	NULL	1214	chip_control	NULL	mouse embryonic striatal neuron (day 15-160)	NULL
EXP040537	normal rabbit IgG (Invitrogen, cat#10500C, lot#503140C)	Mus musculus	Control	NULL	1214	chip_control	NULL	mouse embryonic striatal neuron (day 15-160)	NULL
EXP040538	none	Mus musculus	10uM forskilin for 3 hours	NULL	1214	chip_control	NULL	mouse embryonic striatal neuron (day 15-160)	NULL
EXP040539	normal rabbit IgG (Invitrogen, cat#10500C, lot#503140C)	Mus musculus	10uM forskilin for 3 hours	NULL	1214	chip_control	NULL	mouse embryonic striatal neuron (day 15-160)	NULL
EXP040540	HDAC5 (Cell Signaling Technology, cat#2082, lot#2)	Mus musculus	Control	EXP040536	1214	normal	Q9Z2V6	mouse embryonic striatal neuron (day 15-160)	NULL
EXP040541	HDAC5 (Cell Signaling Technology, cat#2082, lot#2)	Mus musculus	10uM forskilin for 3 hours	EXP040538	1214	normal	Q9Z2V6	mouse embryonic striatal neuron (day 15-160)	NULL
EXP040542		Mus musculus	Wild type; low-iodine diet (LID) for 2 weeks	NULL	1006	chip_control	NULL	thyroid gland	NULL
EXP040543		Mus musculus	GLIS3-EGFP-fusion; low-iodine diet (LID) for 2 weeks	NULL	1006	chip_control	NULL	thyroid gland	NULL
EXP040544	agarose crosslinked with a GFP-binding peptide	Mus musculus	Wild type; low-iodine diet (LID) for 2 weeks	EXP040542	1006	bio_control	Q03288	thyroid gland	NULL
EXP040545	agarose crosslinked with a GFP-binding peptide	Mus musculus	GLIS3-EGFP-fusion; low-iodine diet (LID) for 2 weeks	EXP040543	1006	normal	Q6XP49	thyroid gland	NULL
EXP040546	IgG (sc-2028)	Homo sapiens	Induction of the BCL11A-ER-V5 system was achieved with the addition of 4-hydroxytamoxifen (dissolved in 100% ethanol) at a final concentration of 10-7 M (0.1 nmol). Cells were harvested after 24 hours of induction for downstream experimentation.	NULL	1215	chip_control	NULL	HUDEP-2 (Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells-2)	NULL
EXP040547	IgG (sc-2028)	Homo sapiens	Induction of the BCL11A-ER-V5 system was achieved with the addition of 4-hydroxytamoxifen (dissolved in 100% ethanol) at a final concentration of 10-7 M (0.1 nmol). Cells were harvested after 24 hours of induction for downstream experimentation.	NULL	1215	chip_control	NULL	HUDEP-2 (Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells-2)	NULL
EXP040548	IgG (sc-2028)	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040549	IgG (sc-2028)	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040550	IgG (sc-2028)	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040551	IgG (sc-2028)	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040552	IgG (sc-2028)	Homo sapiens	Wild type (Î”GÎ³)	NULL	930	chip_control	NULL	226LDM (normal breast luminal cells)	NULL
EXP040553	IgG (sc-2028)	Homo sapiens	195C>G (Î”GÎ³)	NULL	930	chip_control	NULL	226LDM (normal breast luminal cells)	NULL
EXP040554	V5-tag (R960CUS, Life Technologies)	Homo sapiens		EXP040546	1215	normal	Q9H165	HUDEP-2 (Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells-2)	NULL
EXP040555	V5-tag (R960CUS, Life Technologies)	Homo sapiens	Induction of the BCL11A-ER-V5 system was achieved with the addition of 4-hydroxytamoxifen (dissolved in 100% ethanol) at a final concentration of 10-7 M (0.1 nmol). Cells were harvested after 24 hours of induction for downstream experimentation.	EXP040547	1215	normal	Q9H165	HUDEP-2 (Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells-2)	NULL
EXP040556	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040548	514	normal	O95365	K562 (myelogenous leukemia)	NULL
EXP040557	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040549	514	normal	O95365	K562 (myelogenous leukemia)	NULL
EXP040558	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040550	514	normal	O95365	K562 (myelogenous leukemia)	NULL
EXP040559	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens		EXP040551	514	normal	O95365	K562 (myelogenous leukemia)	NULL
EXP040560	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens	Wild type (Î”GÎ³)	EXP040552	930	normal	O95365	226LDM (normal breast luminal cells)	NULL
EXP040561	ZBTB7A (Santa Cruz Biotechnology Inc, sc-33683 x and eBioscience, 14-3309-82)	Homo sapiens	195C>G (Î”GÎ³)	EXP040553	930	normal	O95365	226LDM (normal breast luminal cells)	NULL
EXP040562	Sigma HPA015055	Homo sapiens	Treatment: Untreated	NULL	1216	normal	O60885	AR-dependent LNCaP/AR (LNAR)	NULL
EXP040563	Sigma HPA015055	Homo sapiens	Treatment: Enzalutamide (Enz)	NULL	1216	normal	O60885	AR-dependent LNCaP/AR (LNAR)	NULL
EXP040564	Sigma HPA015055	Homo sapiens	Treatment: Untreated	NULL	555	normal	O60885	LREX' (prostate cancer)	NULL
EXP040565	Sigma HPA015055	Homo sapiens	Treatment: Enzalutamide (Enz)	NULL	555	normal	O60885	LREX' (prostate cancer)	NULL
EXP040566	rabbit anti-BMAL1 	Mus musculus		NULL	1217	normal	Q9WTL8	P20 retina	NULL
EXP040567	rabbit anti-BMAL1 	Mus musculus		NULL	1217	bio_control	Q9WTL8	P20 retina	NULL
EXP040568	none	Mus musculus	Ezh1/Ezh2 dKO (strain: C57BL/6)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP040569	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Wild type (strain: C57BL/6)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040570	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Ezh1/Ezh2 dKO (strain: C57BL/6)	EXP040568	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040571	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Eed KO (strain: C57BL/6)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040572	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Suz12 KO (strain: C57BL/6)	NULL	2	bio_control	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040573	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Wild type (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040574	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Suz12 KO (strain: 129B6F1)	NULL	2	bio_control	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040575	Ezh2 (Cell Signaling, Rabbit mAb, D2C9)	Mus musculus	Wild type (strain: 129B6F1)	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP040576	Ezh2 (Cell Signaling, Rabbit mAb, D2C9)	Mus musculus	Suz12 KO (strain: 129B6F1)	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP040577	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	SUZ12 rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040578	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	SUZ12-VEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040579	Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	SUZ12-DeltaVEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040580	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	SUZ12-VEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040581	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	SUZ12-DeltaVEFS rescue (strain: 129B6F1)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP040582		Drosophila melanogaster		NULL	1218	chip_control	NULL	Stage 5 embryos	NULL
EXP040583	House-made Bicoid antibody (Paris et al 2013)	Drosophila melanogaster		EXP040582	1218	normal	P09081	Stage 5 embryos	NULL
EXP040584	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		NULL	1219	chip_control	NULL	SK1 meiotic cells (4 hours)	NULL
EXP040585	c-Myc monoclonal antibody (9E10, Santa Cruz)	Saccharomyces cerevisiae		NULL	1219	chip_control	NULL	SK1 meiotic cells (4 hours)	NULL
EXP040586	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		EXP040584	1219	normal	P53061	SK1 meiotic cells (4 hours)	NULL
EXP040587	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		EXP040584	1219	normal	Q06032	SK1 meiotic cells (4 hours)	NULL
EXP040588	FLAG monoclonal antibody M2 (Sigma)	Saccharomyces cerevisiae		EXP040584	1219	normal	P40511	SK1 meiotic cells (4 hours)	NULL
EXP040589	c-Myc monoclonal antibody (9E10, Santa Cruz)	Saccharomyces cerevisiae		EXP040585	1219	normal	P17122	SK1 meiotic cells (4 hours)	NULL
EXP040590	na	Homo sapiens	UV	NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040591	sc-2027, Lot# D1513	Homo sapiens	UV	NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040592	na	Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040593	sc-2027, Lot# D1513	Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040594	Bcl-6 (N-3), sc-858, Lot# A3013	Homo sapiens	none	NULL	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040595	Bcl-6 (N-3), sc-858, Lot# A3013	Homo sapiens		EXP040592	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040596	Bcl-6 (N-3), sc-858, Lot# A3013	Homo sapiens	UV	EXP040590	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP040597	anti-FLAG antibody (Wako)	Saccharomyces cerevisiae	3h after meiotic induction	NULL	1220	normal	P14291	SK1	NULL
EXP040598	Biotin	Mus musculus		NULL	845	chip_control	NULL	ILC2 (type 2 Innate lympoid cells)	NULL
EXP040599	Biotin	Mus musculus		NULL	845	chip_control	NULL	ILC2 (type 2 Innate lympoid cells)	NULL
EXP040600	Input	Mus musculus		NULL	1221	chip_control	NULL	AML12	NULL
EXP040601	Input	Mus musculus		NULL	1221	chip_control	NULL	AML12	NULL
EXP040602	Biotin	Mus musculus		EXP040600	1221	normal	Q8VEK3	AML12	NULL
EXP040603	Biotin	Mus musculus		EXP040601	1221	normal	Q8VEK3	AML12	NULL
EXP040604	Millipore (07-729)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q61164	liver	NULL
EXP040605	Millipore (07-729)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q61164	liver	NULL
EXP040606	Bethyl (A300-793A)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q925J9	liver	NULL
EXP040607	Bethyl (A300-793A)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q925J9	liver	NULL
EXP040608	Bethyl (A300-793A)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	normal	Q925J9	liver	NULL
EXP040609	Abcam (ab992)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q61550	liver	NULL
EXP040610	Abcam (ab992)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q61550	liver	NULL
EXP040611	Abcam (ab992)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q61550	liver	NULL
EXP040612	Abcam (ab992)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q61550	liver	NULL
EXP040613	Bethyl (A301-985A100)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q9ESU6	liver	NULL
EXP040614	Bethyl (A301-985A100)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q9ESU6	liver	NULL
EXP040615	Bethyl (A301-985A100)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	normal	Q9ESU6	liver	NULL
EXP040616	Cell Signaling (2124)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q3UV55	liver	NULL
EXP040617	Cell Signaling (2124)	Mus musculus	ZT22 (5AM); Wild type	NULL	5	normal	Q3UV55	liver	NULL
EXP040618	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q3UV55	liver	NULL
EXP040619	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); Wild type	NULL	5	normal	Q3UV55	liver	NULL
EXP040620	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	bio_control	Q3UV55	liver	NULL
EXP040621	Cell Signaling (2124)	Mus musculus	ZT10 (5PM); NR1D1 knockout	NULL	5	bio_control	Q3UV55	liver	NULL
EXP040622	none	Mus musculus	mice without tumor cell inoculation, treated with vehicle	NULL	1223	chip_control	NULL	adult skeletal muscle	NULL
EXP040623	none	Mus musculus	C26-bearing mice, 20 mg/kg body weight of the inactive JQ1 enantiomer	NULL	1223	chip_control	NULL	adult skeletal muscle	NULL
EXP040624	none	Mus musculus	C26-bearing mice, 20 mg/kg body weight of the active JQ1 enantiomer	NULL	1223	chip_control	NULL	adult skeletal muscle	NULL
EXP040625	BRD4	Mus musculus	mice without tumor cell inoculation, treated with vehicle	EXP040622	1223	normal	Q9ESU6	adult skeletal muscle	NULL
EXP040626	BRD4	Mus musculus	C26-bearing mice, 20 mg/kg body weight of the inactive JQ1 enantiomer	EXP040623	1223	normal	Q9ESU6	adult skeletal muscle	NULL
EXP040627	BRD4	Mus musculus	C26-bearing mice, 20 mg/kg body weight of the active JQ1 enantiomer	EXP040624	1223	normal	Q9ESU6	adult skeletal muscle	NULL
EXP040628	anti-NOTCH3 antibody (Cell Signaling, #2889)	Homo sapiens	Treatment: vehicle (DMSO) for 1 day	NULL	1224	normal	Q9UM47	TALL1 (T-Acute Lymphoblastic Leukemia)	NULL
EXP040629	anti-NOTCH3 antibody (Cell Signaling, #2889)	Homo sapiens	Treatment: GSI (compound E 1?M) for 1 day	NULL	1224	normal	Q9UM47	TALL1 (T-Acute Lymphoblastic Leukemia)	NULL
EXP040630	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP040631	anti-APC (a polyclonal antibody recognizing the C-terminal 50 amino acids of APC, catalog #A300-981A, Bethyl Laboratories, Inc.)	Homo sapiens		EXP040630	417	normal	P25054	HCT-116 (colon carcinoma)	NULL
EXP040632		Mus musculus	wild type cells	NULL	1225	chip_control	NULL	MLL-AF9/NrasG12D AML	NULL
EXP040633		Mus musculus	wild type cells	NULL	1225	chip_control	NULL	MLL-AF9/NrasG12D AML	NULL
EXP040634		Mus musculus	dox regulated shREN	NULL	1225	chip_control	NULL	MLL-AF9/NrasG12D AML	NULL
EXP040635		Mus musculus	dox regulated shMYB.2652	NULL	1225	chip_control	NULL	MLL-AF9/NrasG12D AML	NULL
EXP040636	F1804, Sigma/Aldrich	Mus musculus	wild type cells	EXP040632	1225	normal	Q8VE65	MLL-AF9/NrasG12D AML	NULL
EXP040637	ab138774, Abcam	Mus musculus	wild type cells	EXP040633	1225	normal	Q8K0H5	MLL-AF9/NrasG12D AML	NULL
EXP040638	A302-131, Behtyl	Mus musculus	wild type cells	EXP040633	1225	normal	Q8C176	MLL-AF9/NrasG12D AML	NULL
EXP040639	F1804, Sigma/Aldrich	Mus musculus	dox regulated shREN	EXP040634	1225	normal	Q8VE65	MLL-AF9/NrasG12D AML	NULL
EXP040640	F1804, Sigma/Aldrich	Mus musculus	dox regulated shMYB.2652	EXP040635	1225	normal	Q8VE65	MLL-AF9/NrasG12D AML	NULL
EXP040641	none	Mus musculus	none	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP040642	anti-LXR anti-FLAG M2 (SIGMA #F3165)	Mus musculus	GW3965 1uM agonist 24 hours	NULL	81	bio_control	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	NULL
EXP040643	lxra anti-FLAG M2 (SIGMA #F3165)	Mus musculus	GW3965 1uM agonist 24 hours	EXP040641	81	normal	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	NULL
EXP040644	LXRb anti-FLAG M2 (SIGMA #F3165)	Mus musculus	GW3965 1uM agonist 24 hours	EXP040641	81	normal	Q60644	BMDM (bone marrow-derived macrophages)	NULL
EXP040645	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP040646	none	Mus musculus	Firre KO	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP040647	none	Mus musculus	Firre transgene	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP040648	CTCF (Millipore Sigma #07-729)	Mus musculus		EXP040645	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP040649	CTCF (Millipore Sigma #07-729)	Mus musculus	Firre KO	EXP040646	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP040650	CTCF (Millipore Sigma #07-729)	Mus musculus	Firre transgene	EXP040647	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP040651	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	LPS	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP040652	anti-C/EBPB (Santa Cruz sc-150)	Homo sapiens		NULL	466	normal	P17676	MDM(monocyte derived macrophages)	NULL
EXP040653	None	Homo sapiens	Control No Treatment	NULL	1226	chip_control	NULL	OCI-AML3	NULL
EXP040654	None	Homo sapiens	JQ1, 500 nM for 24 h	NULL	1226	chip_control	NULL	OCI-AML3	NULL
EXP040655	CEBPB (sc-7962, H-7, Lot#: E1916, Santa Cruz Biotechnology)	Homo sapiens	Control No Treatment	EXP040653	1226	normal	P17676	OCI-AML3	NULL
EXP040656	CEBPB (sc-7962, H-7, Lot #: E1916, Santa Cruz Biotechnology)	Homo sapiens	JQ1, 500 nM for 24 h	EXP040654	1226	normal	P17676	OCI-AML3	NULL
EXP040657	INPUT	Homo sapiens	Treatment: Treatment: none	NULL	1123	chip_control	NULL	breast tumor	NULL
EXP040658	INPUT	Homo sapiens	Treatment: Treatment: none	NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040659	INPUT	Homo sapiens	Treatment: Treatment: none	NULL	1123	chip_control	NULL	breast tumor	NULL
EXP040660	AR	Homo sapiens	Treatment: Treatment: Female	EXP040657	1123	normal	P10275	breast tumor	NULL
EXP040661	AR	Homo sapiens	Treatment: Treatment: Female	EXP040658	128	normal	P10275	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040662	GR	Homo sapiens	Treatment: Treatment: Female	EXP040658	128	normal	P04150	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP040663	ER	Homo sapiens	Treatment: Treatment: Female	EXP040657	1123	normal	P03372	breast tumor	NULL
EXP040664	FOXA1	Homo sapiens	Treatment: Treatment: Female	EXP040657	1123	normal	P55317	breast tumor	NULL
EXP040665	AR	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P10275	breast tumor	NULL
EXP040666	FOXA1	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P55317	breast tumor	NULL
EXP040667	GATA3	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P23771	breast tumor	NULL
EXP040668	PR	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P06401	breast tumor	NULL
EXP040669	GR	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P04150	breast tumor	NULL
EXP040670	ER	Homo sapiens	Treatment: Treatment: Male	EXP040659	1123	normal	P03372	breast tumor	NULL
EXP040671	RAD21	Homo sapiens	Treatment: N/A	NULL	1228	normal	O60216	HCT-116-RAD21-mAC	NULL
EXP040672	RAD21	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	O60216	HCT-116-RAD21-mAC	NULL
EXP040673	smc1	Homo sapiens	Treatment: N/A	NULL	1228	normal	Q14683	HCT-116-RAD21-mAC	NULL
EXP040674	smc1	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	Q14683	HCT-116-RAD21-mAC	NULL
EXP040675	h2az	Homo sapiens	Treatment: N/A	NULL	1228	normal	P0C0S5	HCT-116-RAD21-mAC	NULL
EXP040676	h2az	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	P0C0S5	HCT-116-RAD21-mAC	NULL
EXP040677	NIPBL	Homo sapiens	Treatment: N/A	NULL	1228	normal	Q6KC79	HCT-116-RAD21-mAC	NULL
EXP040678	NIPBL	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	Q6KC79	HCT-116-RAD21-mAC	NULL
EXP040679	CTCF	Homo sapiens	Treatment: N/A	NULL	1228	normal	P49711	HCT-116-RAD21-mAC	NULL
EXP040680	CTCF	Homo sapiens	Treatment: 500uM auxin (360 min)	NULL	1228	normal	P49711	HCT-116-RAD21-mAC	NULL
EXP040681	N/A	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP040682	SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2 WT; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040683	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2 WT; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040684	SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2 WT; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040685	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2 WT; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040686	Anti-SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2-deltaPBMA; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040687	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2-deltaPBMA; control siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040688	Anti-SMC3 (A845; JM Peters lab; Sumara et al., 2002)	Homo sapiens	ESCO2-deltaPBMA; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040689	Anti-SMC3(ac) (K. Shirahige; Nishiyama et al., 2010)	Homo sapiens	ESCO2-deltaPBMA; ESCO1 siRNA	EXP040681	78	normal	Q9UQE7	HeLa (cervical adenocarcinoma)	NULL
EXP040690	--	Drosophila melanogaster	Treatment: none	NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP040691	--	Drosophila melanogaster	Treatment: none	NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP040692	rabbit-anti-ada2b	Drosophila melanogaster	Treatment: none	EXP040690	1229	normal	Q8I8V0	1-3 h embryo	NULL
EXP040693	rabbit-anti-ada2b	Drosophila melanogaster	Treatment: none	EXP040691	1229	normal	Q8I8V0	1-3 h embryo	NULL
EXP040694		Homo sapiens		NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP040695	HN1L	Homo sapiens		EXP040694	817	normal	Q96RY5	SUM159PT (Triple negative breast cancer)	NULL
EXP040696	none	Homo sapiens	BMP4 for 3 day	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP040697	none	Homo sapiens	BMP4 for 3 day	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP040698	none	Homo sapiens	BMP4 for 3 day	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP040699	none	Homo sapiens	BMP4 for 3 day	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP040700	none	Homo sapiens	BMP4 for 3 day	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP040701	none	Homo sapiens	BMP4 for 3 day	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP040702	anti-GATA3 (#CM405A, Biocare Medical)	Homo sapiens	BMP4 for 3 day	EXP040701	396	normal	P23771	WA09 (embryonic stem cells)	NULL
EXP040703	anti-GATA3 (#CM405A, Biocare Medical)	Homo sapiens	BMP4 for 3 day	EXP040698	396	normal	P23771	WA09 (embryonic stem cells)	NULL
EXP040704	anti-GATA3 (#CM405A, Biocare Medical)	Homo sapiens	BMP4 for 3 day	EXP040698	396	normal	P23771	WA09 (embryonic stem cells)	NULL
EXP040705	anti-GATA2 (H116, sc-9008, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040701	396	normal	P23769	WA09 (embryonic stem cells)	NULL
EXP040706	anti-GATA2 (H116, sc-9008, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040698	396	normal	P23769	WA09 (embryonic stem cells)	NULL
EXP040707	anti-GATA2 (H116, sc-9008, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040700	396	normal	P23769	WA09 (embryonic stem cells)	NULL
EXP040708	anti-TFAP2A (#sc-184, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040696	396	normal	P05549	WA09 (embryonic stem cells)	NULL
EXP040709	anti-TFAP2A (#sc-184, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040697	396	normal	P05549	WA09 (embryonic stem cells)	NULL
EXP040710	anti-TFAP2A (#sc-184, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040701	396	normal	P05549	WA09 (embryonic stem cells)	NULL
EXP040711	anti-TFAP2C (#sc-12762, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040696	396	normal	Q92754	WA09 (embryonic stem cells)	NULL
EXP040712	anti-TFAP2C (#sc-12762, Santa Cruz)	Homo sapiens	BMP4 for 3 day	EXP040699	396	normal	Q92754	WA09 (embryonic stem cells)	NULL
EXP040713	anti-TFAP2C (#sc-12762, Santa Cruz)	Homo sapiens	BMP4 for 3 day	NULL	396	normal	Q92754	WA09 (embryonic stem cells)	NULL
EXP040714	none	Mus musculus	IL12, IL18	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040715	none	Mus musculus	IL12, IL18	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040716	none	Mus musculus	IL12, IL18	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040717	none	Mus musculus	unstim	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040718	none	Mus musculus	IL12, IL18; Stat4KO	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040719	none	Mus musculus	IFNa	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040720	none	Mus musculus	IFNa, IL2	NULL	1192	chip_control	NULL	primary splenic NK cells	NULL
EXP040721	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18	EXP040714	1192	normal	P42228	primary splenic NK cells	NULL
EXP040722	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18	EXP040715	1192	normal	P42228	primary splenic NK cells	NULL
EXP040723	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18	EXP040716	1192	normal	P42228	primary splenic NK cells	NULL
EXP040724	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	unstim	EXP040717	1192	normal	P42228	primary splenic NK cells	NULL
EXP040725	anti-STAT4 (Santa Cruz, sc-468, clone C-20, lot# c2114)	Mus musculus	IL12, IL18; Stat4KO	EXP040718	1192	normal	P42228	primary splenic NK cells	NULL
EXP040726	anti-STAT1 (Santa Cruz, sc-592, clone M-22, lot# F1312)	Mus musculus	IFNa	EXP040719	1192	normal	P42225	primary splenic NK cells	NULL
EXP040727	anti-STAT1 (Santa Cruz, sc-592, clone M-22, lot# F1312)	Mus musculus	IFNa, IL2	EXP040720	1192	normal	P42225	primary splenic NK cells	NULL
EXP040728	Anti-Myc Tag, clone 4A6 (Millipore, Cat. #05-724, Lot #2324563)	Arabidopsis thaliana	mock	NULL	1231	normal	Q6NQK2	whole plants	NULL
EXP040729	Anti-Myc Tag, clone 4A6 (Millipore, Cat. #05-724, Lot #2324563)	Arabidopsis thaliana	15 ÂµM zeocin	NULL	1231	normal	Q6NQK2	whole plants	NULL
EXP040730		Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP040731		Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP040732	SMC4	Saccharomyces cerevisiae		EXP040730	1232	normal	Q12267	S. cerevisiae cells	NULL
EXP040733	SMC4	Saccharomyces cerevisiae		EXP040731	1232	normal	Q12267	S. cerevisiae cells	NULL
EXP040734	CEBPa (sc-61X)	Mus musculus	cells differentiated in the presence of MCSF	NULL	81	normal	P53566	BMDM (bone marrow-derived macrophages)	NULL
EXP040735	IRF8 (sc-32528x)	Mus musculus	cells differentiated in the presence of MCSF	NULL	81	normal	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP040736	JUNB (sc-46x)	Mus musculus	cells differentiated in the presence of MCSF	NULL	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP040737	CEBPa (sc-61X)	Mus musculus	cells differentiated in the presence of MCSF (1h IL4)	NULL	81	normal	P53566	BMDM (bone marrow-derived macrophages)	NULL
EXP040738	IRF8 (sc-32528x)	Mus musculus	cells differentiated in the presence of MCSF (1h IL4)	NULL	81	normal	P23611	BMDM (bone marrow-derived macrophages)	NULL
EXP040739	JUNB (sc-46x)	Mus musculus	cells differentiated in the presence of MCSF (1h IL4)	NULL	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP040740	STAT3	Homo sapiens	DMSO	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP040741	STAT3	Homo sapiens	AZD1480(JAK inhibitor) for 4hrs	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP040742	STAT3	Homo sapiens	DMSO	NULL	683	normal	P40763	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP040743	STAT3	Homo sapiens	AZD1480(JAK inhibitor) for 4hrs	NULL	683	normal	P40763	OCI-LY10 (diffuse large B-cell lymphoma)	NULL
EXP040744	HDAC1 (ab7028)	Mus musculus	control	NULL	81	normal	O09106	BMDM (bone marrow-derived macrophages)	NULL
EXP040745	HDAC1 (ab7028)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	O09106	BMDM (bone marrow-derived macrophages)	NULL
EXP040746	HDAC2 (ab7029)	Mus musculus	control	NULL	81	normal	P70288	BMDM (bone marrow-derived macrophages)	NULL
EXP040747	HDAC2 (ab7029)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	P70288	BMDM (bone marrow-derived macrophages)	NULL
EXP040748	HDAC3 (ab4729)	Mus musculus	control	NULL	81	normal	O88895	BMDM (bone marrow-derived macrophages)	NULL
EXP040749	HDAC3 (ab4729)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	O88895	BMDM (bone marrow-derived macrophages)	NULL
EXP040750	PU1 (sc-352)	Mus musculus	control	NULL	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP040751	PU.1 (sc-352)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP040752	p300 (sc-585)	Mus musculus	control	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP040753	p300 (sc-585)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour).	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP040754	p65 (sc-372)	Mus musculus	control	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP040755	p65 (sc-372)	Mus musculus	Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 24 hours).	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP040756	p65 (sc-372)	Mus musculus	cells differentiated in the presence of MCSF (ctrl_1hLPS)	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP040757	p65 (sc-372)	Mus musculus	cells differentiated in the presence of MCSF (24h IL4_1h LPS)	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP040758	STAT6 (sc-981)	Mus musculus	control	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040759	STAT6 (sc-981)	Mus musculus	cells differentiated in the presence of MCSF (1hIL4)	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040760	STAT6 (sc-981)	Mus musculus	cells differentiated in the presence of MCSF (6hIL4)	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040761	STAT6 (sc-981)	Mus musculus	cells differentiated in the presence of MCSF (24hIL4)	NULL	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040762	anti-ZEB1	Homo sapiens	H1975 R2 (ZEB1 resistant)	NULL	1233	normal	P37275	Lung adenocarcinoma (H1975)	NULL
EXP040763	anti-ZEB1	Homo sapiens	H1975	NULL	1233	normal	P37275	Lung adenocarcinoma (H1975)	NULL
EXP040764		Mus musculus		NULL	1234	chip_control	NULL	Leydig cells	NULL
EXP040765	STF1	Mus musculus	vehicle	EXP040764	1234	normal	P35175	Leydig cells	NULL
EXP040766	STF1	Mus musculus	cAMP	EXP040764	1234	normal	P35175	Leydig cells	NULL
EXP040767		Homo sapiens	Treatment: none	NULL	166	chip_control	NULL	CD34+ hematopoietic stem cells	NULL
EXP040768	CTCF	Homo sapiens	Treatment: none	EXP040767	166	normal	P49711	CD34+ hematopoietic stem cells	NULL
EXP040769		Caenorhabditis elegans		NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP040770	oef-1	Caenorhabditis elegans		EXP040769	1235	normal	G4SGI5	whole worms (developmental stage: young adults)	NULL
EXP040771	CTCF (Millipore, 07-729)	Mus musculus	C57BL/6; 3 months; male	NULL	81	normal	Q61164	BMDM (bone marrow-derived macrophages)	NULL
EXP040772	RAD21 (ab992)	Mus musculus	C57BL/6; 3 months; male	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP040773	IgG (Millipore, 12-370)	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP040774	P300 (sc-585)	Mus musculus		EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP040775	P300 (sc-585)	Mus musculus	1h IL4	EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP040776	P300 (sc-585)	Mus musculus	6h IL4	EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP040777	P300 (sc-585)	Mus musculus	24h IL4	EXP040773	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP040778	PU.1 (sc-352)	Mus musculus		EXP040773	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP040779	PU.1 (sc-352)	Mus musculus	1h IL4	EXP040773	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP040780	RAD21 (ab992)	Mus musculus		EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP040781	RAD21 (ab992)	Mus musculus	1h IL4	EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP040782	RAD21 (ab992)	Mus musculus	6h IL4	EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP040783	RAD21 (ab992)	Mus musculus	24h IL4	EXP040773	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP040784	RXR (sc-774)	Mus musculus		EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040785	RXR (sc-774)	Mus musculus	1h IL4	EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040786	RXR (sc-774)	Mus musculus	6h IL4	EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040787	STAT6 (sc-981)	Mus musculus	1h IL4	EXP040773	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040788	STAT6 (sc-981)	Mus musculus	6h IL4	EXP040773	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040789	STAT6 (sc-981)	Mus musculus	24h IL4	EXP040773	81	normal	P52633	BMDM (bone marrow-derived macrophages)	NULL
EXP040790	PPARg (Perseus #PP-A3409A)	Mus musculus		EXP040773	81	normal	P37238	BMDM (bone marrow-derived macrophages)	NULL
EXP040791	PPARg (Perseus #PP-A3409A)	Mus musculus		EXP040773	81	normal	P37238	BMDM (bone marrow-derived macrophages)	NULL
EXP040792	RXR (sc-774)	Mus musculus	STAT6_KO	NULL	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040793	RXR (sc-774)	Mus musculus	PPARG_KO	NULL	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040794	RXR (sc-774)	Mus musculus		EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040795	RXR (sc-774)	Mus musculus		EXP040773	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP040796	rabbit IgG (I5006, Sigma)	Homo sapiens	Treatment: none	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP040797	rabbit IgG (I5006, Sigma)	Homo sapiens	Treatment: none	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP040798	rabbit IgG (I5006, Sigma)	Homo sapiens	Treatment: none	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP040799	anti-SKI (sc-9140, Santa Cruz)	Homo sapiens	Treatment: none	EXP040797	438	normal	P12755	HL-60 (acute myeloid leukemia)	NULL
EXP040800	anti-RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: none	EXP040796	438	normal	Q01196	HL-60 (acute myeloid leukemia)	NULL
EXP040801	anti-CEBPbeta (sc-150, Santa Cruz)	Homo sapiens	Treatment: none	EXP040796	438	normal	P17676	HL-60 (acute myeloid leukemia)	NULL
EXP040802	anti-SKI (sc-9140, Santa Cruz)	Homo sapiens	Treatment: none	EXP040796	438	normal	P12755	HL-60 (acute myeloid leukemia)	NULL
EXP040803	anti-SKI (sc-9140, Santa Cruz)	Homo sapiens	Treatment: none	EXP040798	438	bio_control	P12755	HL-60 (acute myeloid leukemia)	NULL
EXP040804	none (input)	Homo sapiens	Treatment: none	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040805	none (input)	Homo sapiens	Treatment: MYO1D Non-hub KO	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040806	none (input)	Homo sapiens	Treatment: MYO1D Hub KO	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP040807	GATA1 Abcam, ab11852, 772403	Homo sapiens	Treatment: none	EXP040804	514	normal	P15976	K562 (myelogenous leukemia)	NULL
EXP040808	TAL1 Santa Cruz Biotechnology,sc-12984,C1315	Homo sapiens	Treatment: none	EXP040804	514	normal	P17542	K562 (myelogenous leukemia)	NULL
EXP040809	GATA1 Abcam, ab11852, 772403	Homo sapiens	Treatment: MYO1D Non-hub KO	EXP040805	514	normal	P15976	K562 (myelogenous leukemia)	NULL
EXP040810	TAL1 Santa Cruz Biotechnology,sc-12984,C1315	Homo sapiens	Treatment: MYO1D Non-hub KO	EXP040805	514	normal	P17542	K562 (myelogenous leukemia)	NULL
EXP040811	GATA1 Abcam, ab11852, 772403	Homo sapiens	Treatment: MYO1D Hub KO	EXP040806	514	normal	P15976	K562 (myelogenous leukemia)	NULL
EXP040812	TAL1 Santa Cruz Biotechnology,sc-12984,C1315	Homo sapiens	Treatment: MYO1D Hub KO	EXP040806	514	normal	P17542	K562 (myelogenous leukemia)	NULL
EXP040813	none	Homo sapiens	Treatment: genotype: RXRA WT	NULL	1236	chip_control	NULL	JMSU-1 (Bladder carcinoma)	NULL
EXP040814	none	Homo sapiens	Treatment: genotype: RXRA S427F	NULL	1236	chip_control	NULL	JMSU-1 (Bladder carcinoma)	NULL
EXP040815	RXRA (Perseus Proteomics, K8508, lot A2)	Homo sapiens	Treatment: genotype: RXRA WT	EXP040813	1236	normal	P19793	JMSU-1 (Bladder carcinoma)	NULL
EXP040816	RXRA (Perseus Proteomics, K8508, lot A2)	Homo sapiens	Treatment: genotype: RXRA S427F	EXP040814	1236	normal	P19793	JMSU-1 (Bladder carcinoma)	NULL
EXP040817	NA	Homo sapiens	None	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP040818	INO80 ab105451	Homo sapiens	None	EXP040817	430	normal	Q9ULG1	HepG2 (hepatoblastoma)	NULL
EXP040819	MCRS1	Homo sapiens	None	EXP040817	430	normal	Q96EZ8	HepG2 (hepatoblastoma)	NULL
EXP040820	RUVBL1	Homo sapiens	None	EXP040817	430	normal	Q9Y265	HepG2 (hepatoblastoma)	NULL
EXP040821	RUVBL2	Homo sapiens	None	EXP040817	430	normal	Q9Y230	HepG2 (hepatoblastoma)	NULL
EXP040822	input	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP040823	input	Mus musculus		NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP040824	input	Mus musculus	LPS 1hr	EXP040822	81	normal	A1A546	BMDM (bone marrow-derived macrophages)	NULL
EXP040825	input	Mus musculus	LPS 1hr	EXP040823	81	normal	A1A546	BMDM (bone marrow-derived macrophages)	NULL
EXP040826	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	control	EXP040822	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	NULL
EXP040827	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	control	EXP040823	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	NULL
EXP040828	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	LPS 1hr	EXP040822	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	NULL
EXP040829	LSD1 - abcam, ab17721, GR307810-1	Mus musculus	LPS 1hr	EXP040823	81	normal	Q6ZQ88	BMDM (bone marrow-derived macrophages)	NULL
EXP040830	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	control	EXP040822	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP040831	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	control	EXP040823	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP040832	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	LPS 1hr	EXP040822	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP040833	p65 - Santa Cruz, SC-372 (C-20), A2298	Mus musculus	LPS 1hr	EXP040823	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP040834	None	Homo sapiens		NULL	256	chip_control	NULL	endometrial stromal cells	NULL
EXP040835	GATA2 (Santa Cruz Biotechnologies, sc-9008)	Homo sapiens		EXP040834	256	normal	P23769	endometrial stromal cells	NULL
EXP040840		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP040841	SMRC1	Homo sapiens		EXP040840	430	normal	Q92922	HepG2 (hepatoblastoma)	NULL
EXP040842	SATB1	Homo sapiens		EXP040840	430	normal	Q01826	HepG2 (hepatoblastoma)	NULL
EXP040843	NFIC	Homo sapiens		EXP040840	430	normal	P08651	HepG2 (hepatoblastoma)	NULL
EXP040844	anti-hsf1	Saccharomyces cerevisiae	control	NULL	1232	normal	P10961	S. cerevisiae cells	NULL
EXP040845	anti-hsf1	Saccharomyces cerevisiae	heat shock	NULL	1232	normal	P10961	S. cerevisiae cells	NULL
EXP040846		Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP040847	Suz12	Mus musculus		EXP040846	233	normal	Q80U70	E14TG2A (embryonic stem cells)	NULL
EXP040848	KDM6A	Mus musculus		EXP040846	233	normal	O70546	E14TG2A (embryonic stem cells)	NULL
EXP040849	Ezh2	Mus musculus		EXP040846	233	normal	Q61188	E14TG2A (embryonic stem cells)	NULL
EXP040850	Spt6	Mus musculus		EXP040846	233	normal	Q62383	E14TG2A (embryonic stem cells)	NULL
EXP040851	none	Homo sapiens	untreated	NULL	449	chip_control	NULL	HS578T (invasive ductal breast carcinoma)	NULL
EXP040852	none	Homo sapiens	untreated	NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP040853	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 1.5h	EXP040851	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	NULL
EXP040854	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 16h	EXP040851	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	NULL
EXP040855	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 1.5h	EXP040852	120	normal	Q15796	BT-549 (breast invasive ductal carcinoma)	NULL
EXP040856	anti-SMAD2/3 antibody (BD Transduction Laboratories, catalog# 610843, lot# 2104740)	Homo sapiens	TGFÎ²3 16h	EXP040852	120	normal	Q15796	BT-549 (breast invasive ductal carcinoma)	NULL
EXP040857	none	Mus musculus		NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP040858	Hoxb5	Mus musculus		EXP040857	198	normal	P09079	pre-pro-B-cells	NULL
EXP040859	none	Homo sapiens	mock-infected cells	NULL	1240	chip_control	NULL	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040860	none	Homo sapiens	ela wild type	NULL	1240	chip_control	NULL	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040861	none	Homo sapiens	FOXKb-	NULL	1240	chip_control	NULL	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040862	none	Homo sapiens	DCAF7b-	NULL	1240	chip_control	NULL	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040863	none	Homo sapiens	CtBPb-	NULL	1240	chip_control	NULL	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040864	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	mock-infected cells	EXP040859	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040865	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	ela wild type	EXP040860	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040866	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	FOXKb-	EXP040861	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040867	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	DCAF7b-	EXP040862	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040868	Rabbit polyclonal anti-IRF3 (FL-425) Santa Cruz Cat#sc-9082 Lot#31515	Homo sapiens	CtBPb-	EXP040863	1240	normal	Q14653	HBTEC (Primary Human Bronchial/Tracheal Epithelial Cells)	NULL
EXP040869	none	Drosophila melanogaster		NULL	1239	chip_control	NULL	0-24 h embryo	NULL
EXP040870		Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP040871		Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP040872		Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP040873		Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP040874		Drosophila melanogaster	OregonR	NULL	1239	chip_control	NULL	0-24 h embryo	NULL
EXP040875	CID-GFP	Drosophila melanogaster		EXP040869	1239	normal	Q9V6Q2	0-24 h embryo	NULL
EXP040876	anti-CidH epitope	Drosophila melanogaster		EXP040870	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	NULL
EXP040877	anti-CidM epitope	Drosophila melanogaster		EXP040871	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	NULL
EXP040878	anti-CidM	Drosophila melanogaster		EXP040872	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	NULL
EXP040879	anti-CidM	Drosophila melanogaster		EXP040873	1197	normal	Q9V6Q2	S2-DRSC (embryonic stem cells)	NULL
EXP040880	anti-GFP	Drosophila melanogaster	OregonR	EXP040874	1239	normal	Q9V6Q2	0-24 h embryo	NULL
EXP040881	JMJD1A	Mus musculus		NULL	1241	normal	Q6PCM1	inguinal subcutaneous white adipose tissue-derived preadipocytes	NULL
EXP040882	PPAR?	Mus musculus		NULL	1241	normal	P37238	inguinal subcutaneous white adipose tissue-derived preadipocytes	NULL
EXP040883	none	Arabidopsis thaliana		NULL	1237	chip_control	NULL	inflorescence meristems	NULL
EXP040884		Arabidopsis thaliana		NULL	1238	chip_control	NULL	pistils	NULL
EXP040885	FUL	Arabidopsis thaliana		EXP040883	1237	normal	Q38876	inflorescence meristems	NULL
EXP040886	FUL	Arabidopsis thaliana		EXP040884	1238	normal	Q38876	pistils	NULL
EXP040887	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040888	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040889	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	100 nM ICI for 30 min	EXP040887	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040890	SUMO2/3 (Cedarlane M114-3)	Homo sapiens		EXP040887	113	normal	P61956	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040891	ESR? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	vehicle for 30 min	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040892	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	5 nM E2 for 30 min	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040893	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	vehicle for 3h	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040894	ESR? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	ICI for 3h	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040895	ER? HC-20 (Santa Cruz Biotechnology sc-543)	Homo sapiens	E2 for 3h	EXP040888	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040896	SUMO2/3 (Cedarlane M114-3)	Homo sapiens	vehicle for 30 min	EXP040888	113	normal	P61956	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040897	SUMO2/3 (Cedarlane M114-3)	Homo sapiens	ICI for 3h	EXP040888	113	normal	P61956	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040898	Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #D2215	Mus musculus		NULL	32	normal	Q61880	testis	NULL
EXP040899	DMC1 Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #D2215	Mus musculus		NULL	32	normal	Q61880	testis	NULL
EXP040900	Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #J1215	Mus musculus		NULL	32	normal	Q61880	testis	NULL
EXP040901	Santa Cruz, goat polyclonal anti-DMC1, C-20, lot #D2215	Mus musculus		NULL	32	normal	Q61880	testis	NULL
EXP040902	None	Homo sapiens	Treatment: none	NULL	730	chip_control	NULL	mononuclear cells from periferal blood	NULL
EXP040903	None	Homo sapiens	Treatment: AML patient	NULL	1243	chip_control	NULL	bone marrow-derived nuclear cells (adult)	NULL
EXP040904	BAF155 (R-18) (Santa Cruz Biotechnology, Cat. sc-9746, Lot B1513)	Homo sapiens	Treatment: none	EXP040902	730	normal	Q92922	mononuclear cells from periferal blood	NULL
EXP040905	BAF155 (R-18) (Santa Cruz Biotechnology, Cat. sc-9746, Lot B1513)	Homo sapiens	Treatment: AML patient	EXP040903	1243	normal	Q92922	bone marrow-derived nuclear cells (adult)	NULL
EXP040906	none	Drosophila melanogaster	CLAMP RNAi	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP040907	none	Drosophila melanogaster	GFP RNAi	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP040908	none	Drosophila melanogaster	GAF RNAi	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP040909	rabbit anti-CLAMP	Drosophila melanogaster	CLAMP RNAi	NULL	1242	bio_control	Q961A1	S2 cells	NULL
EXP040910	rabbit anti-GAF	Drosophila melanogaster	CLAMP RNAi	EXP040906	1242	normal	Q08605	S2 cells	NULL
EXP040911	goat anti-MSL3	Drosophila melanogaster	CLAMP RNAi	EXP040906	1242	normal	P50536	S2 cells	NULL
EXP040912	rabbit anti-CLAMP	Drosophila melanogaster	GFP RNAi	EXP040907	1242	normal	Q961A1	S2 cells	NULL
EXP040913	rabbit anti-GAF	Drosophila melanogaster	GFP RNAi	EXP040907	1242	normal	Q08605	S2 cells	NULL
EXP040914	goat anti-MSL3	Drosophila melanogaster	GFP RNAi	EXP040907	1242	normal	P50536	S2 cells	NULL
EXP040915	rabbit anti-CLAMP	Drosophila melanogaster	GAF RNAi	EXP040908	1242	normal	Q961A1	S2 cells	NULL
EXP040916	rabbit anti-GAF	Drosophila melanogaster	GAF RNAi	EXP040908	1242	normal	Q08605	S2 cells	NULL
EXP040917	goat anti-MSL3	Drosophila melanogaster	GAF RNAi	EXP040908	1242	normal	P50536	S2 cells	NULL
EXP040918	none	Homo sapiens	Treatment: none	NULL	47	chip_control	NULL	KG1 (acute myeloid leukemia)	NULL
EXP040919	none	Homo sapiens	Treatment: none	NULL	47	chip_control	NULL	KG1 (acute myeloid leukemia)	NULL
EXP040920	EZH2	Homo sapiens	Treatment: none	EXP040918	47	normal	Q15910	KG1 (acute myeloid leukemia)	NULL
EXP040921	EZH2	Homo sapiens	Treatment: none	EXP040919	47	normal	Q15910	KG1 (acute myeloid leukemia)	NULL
EXP040922	PLZF	Homo sapiens	Treatment: none	EXP040918	47	normal	Q05516	KG1 (acute myeloid leukemia)	NULL
EXP040923	PLZF	Homo sapiens	Treatment: none	NULL	47	normal	Q05516	KG1 (acute myeloid leukemia)	NULL
EXP040924	Suz12	Homo sapiens	Treatment: none	NULL	47	normal	Q15022	KG1 (acute myeloid leukemia)	NULL
EXP040925	none	Mus musculus	Treatment: T-ALL- JAK3 active	NULL	917	chip_control	NULL	spleen	NULL
EXP040926	none	Mus musculus	Treatment: T-ALL-JAK3+HOXA9 active	NULL	917	chip_control	NULL	spleen	NULL
EXP040927	STAT5 Cell Signaling Cat#8363 Lot9	Mus musculus	Treatment: T-ALL- JAK3 active	EXP040925	917	normal	P42230	spleen	NULL
EXP040928	Cell Signaling Cat#8363 Lot9	Mus musculus	Treatment: T-ALL-JAK3+HOXA9 active	EXP040926	917	normal	P24270	spleen	NULL
EXP040929	HOXA9 Sigma Atlas Antibodies Cat#HPA061982 Lot#86503	Mus musculus	Treatment: T-ALL-JAK3+HOXA9 active	EXP040926	917	normal	P09631	spleen	NULL
EXP040930	p53 antibody (Santa Cruz, sc-126)	Homo sapiens		NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040931	p53 antibody (Santa Cruz, sc-126)	Homo sapiens	MDMX C463A mutation	NULL	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040932	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040933	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040934	Input	Homo sapiens	100nm E2 (90 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040935	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040936	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040937	Input	Homo sapiens	100nm E2 (90 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040938	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040939	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040940	Input	Homo sapiens	100nm E2 (90 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040941	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040942	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040943	Input	Homo sapiens	100nm E2 (90 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040944	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040945	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040946	Input	Homo sapiens	control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040947	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040948	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040949	Input	Homo sapiens	100nm E2 (45 min)	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040950	SC-543	Homo sapiens	control	EXP040932	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040951	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040933	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040952	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040934	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040953	SC-543	Homo sapiens	control	EXP040935	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040954	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040936	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040955	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040937	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040956	SC-543	Homo sapiens	control	EXP040938	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040957	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040939	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040958	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040940	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040959	SC-543	Homo sapiens	control	EXP040941	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040960	SC-543	Homo sapiens	100nm E2 (45 min)	EXP040942	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040961	SC-543	Homo sapiens	100nm E2 (90 min)	EXP040943	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040962	HPA004820	Homo sapiens	control	EXP040944	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040963	HPA004820	Homo sapiens	control	EXP040945	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040964	HPA004820	Homo sapiens	control	EXP040946	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040965	HPA004820	Homo sapiens	100nm E2 (45 min)	EXP040947	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040966	HPA004820	Homo sapiens	100nm E2 (45 min)	EXP040948	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040967	HPA004820	Homo sapiens	100nm E2 (45 min)	EXP040949	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP040968	None	Mus musculus		NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP040969	None	Mus musculus		NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP040970	anti-KAP1 (ab10483, Abcam)	Mus musculus		EXP040968	1245	normal	Q62318	Neuro-2A cells	NULL
EXP040971	anti-KAP1 (ab10483, Abcam)	Mus musculus		EXP040969	1245	normal	Q62318	Neuro-2A cells	NULL
EXP040972	IgG (Santa Cruz Biotechnology, sc-2027 x)	Rattus norvegicus	Treatment: none	NULL	784	chip_control	NULL	Schwann cells	NULL
EXP040973	Hdac3 (Santa Cruz Biotechnology, sc-13914)	Rattus norvegicus	Treatment: none	EXP040972	784	normal	Q6P6W3	Schwann cells	NULL
EXP040974	Hdac3 (Santa Cruz Biotechnology, sc-13914)	Rattus norvegicus	Treatment: none	EXP040972	784	normal	Q6P6W3	Schwann cells	NULL
EXP040975	p300	Rattus norvegicus	Treatment: none	EXP040972	784	normal	Q91XT0	Schwann cells	NULL
EXP040976	WCE (none)	Danio rerio		NULL	1248	chip_control	NULL	3.5 hpf embryo	NULL
EXP040977	WCE (none)	Danio rerio		NULL	1247	chip_control	NULL	4.5 hpf embryo	NULL
EXP040978	WCE (none)	Danio rerio		NULL	1247	chip_control	NULL	4.5 hpf embryo	NULL
EXP040979	Myc	Danio rerio		EXP040976	1248	normal	A5JNG8	3.5 hpf embryo	NULL
EXP040980	Myc	Danio rerio		EXP040977	1247	normal	A5JNG8	4.5 hpf embryo	NULL
EXP040981	Myc	Danio rerio		EXP040978	1247	normal	Q9I944	4.5 hpf embryo	NULL
EXP040982	None	Danio rerio	Treatment: none	NULL	1249	chip_control	NULL	red blood cells, adult	NULL
EXP040983	gata1	Danio rerio	Treatment: none	EXP040982	1249	normal	Q05AJ3	red blood cells, adult	NULL
EXP040984	none	Danio rerio		NULL	1251	chip_control	NULL	embryos, late blastula	NULL
EXP040985	Sox2	Danio rerio		EXP040984	1251	normal	Q6P0E1	embryos, late blastula	NULL
EXP040986	anti-FLAGÂ® M2	Danio rerio		EXP040984	1251	normal	Q90270	embryos, late blastula	NULL
EXP040987	anti-FLAGÂ® M2	Danio rerio		EXP040984	1252	normal	Q90270	embryos, 512 cell stage	NULL
EXP040988	Input-control	Danio rerio	wild type	NULL	1253	chip_control	NULL	8 hpf embryo	NULL
EXP040989	Input-control	Danio rerio	sqet33 transgenic	NULL	1254	chip_control	NULL	24 hpf embryo	NULL
EXP040990	Zic3	Danio rerio	wild type	EXP040988	1253	normal	Q6PV84	8 hpf embryo	NULL
EXP040991	Zic3	Danio rerio	sqet33 transgenic	EXP040989	1254	normal	Q6PV84	24 hpf embryo	NULL
EXP040992	input	Danio rerio		NULL	1255	chip_control	NULL	embryos, high sphere stage	NULL
EXP040993	Smad2	Danio rerio		EXP040992	1255	normal	Q9I9P9	embryos, high sphere stage	NULL
EXP040994	Eomesa	Danio rerio		EXP040992	1255	normal	Q98TU2	embryos, high sphere stage	NULL
EXP041016	no antibody input control	Danio rerio		NULL	1257	chip_control	NULL	10 hpf embryo (bud stage)	NULL
EXP041015	no antibody input control	Danio rerio		NULL	1247	chip_control	NULL	4.5 hpf embryo	NULL
EXP041014	no antibody input control	Danio rerio		NULL	1260	chip_control	NULL	2.5 hpf embryo	NULL
EXP040998	none	Danio rerio		NULL	1256	chip_control	NULL	10S embryo	NULL
EXP040999	none	Danio rerio		NULL	1256	chip_control	NULL	10S embryo	NULL
EXP041000	Tbx6	Danio rerio		EXP040998	1256	normal	Q8JIS6	10S embryo	NULL
EXP041001	myc	Danio rerio		EXP040999	1256	normal	P52160	10S embryo	NULL
EXP041002	Smad2	Danio rerio	none	NULL	1247	normal	Q9I9P9	4.5 hpf embryo	NULL
EXP041003	Smad2	Danio rerio	Squint injection	NULL	1247	normal	Q9I9P9	4.5 hpf embryo	NULL
EXP041004	Smad2	Danio rerio	SB505124	NULL	1247	normal	Q9I9P9	4.5 hpf embryo	NULL
EXP041005	FoxH1	Danio rerio	none	NULL	1247	normal	Q9I9E1	4.5 hpf embryo	NULL
EXP041006	FoxH1	Danio rerio	Squint injection	NULL	1247	normal	Q9I9E1	4.5 hpf embryo	NULL
EXP041007	FoxH1	Danio rerio	SB505124	NULL	1247	normal	Q9I9E1	4.5 hpf embryo	NULL
EXP041012	Hif-1a custom antibody	Danio rerio	Wild type	EXP041010	1259	normal	Q6EHI4	4 dpf embryo	NULL
EXP041011	none	Danio rerio	von Hippel Lindau mutant (VHL)	NULL	1259	chip_control	NULL	4 dpf embryo	NULL
EXP041010	none	Danio rerio	Wild type 	NULL	1259	chip_control	NULL	4 dpf embryo	NULL
EXP041008	none	Danio rerio	Treatment: Treatment: none	NULL	1258	chip_control	NULL	melanoma tumor cell line	NULL
EXP041009	SOX10	Danio rerio	Treatment: Treatment: none	EXP041008	1258	normal	Q90XD1	melanoma tumor cell line	NULL
EXP041013	Hif-1a custom antibody	Danio rerio	von Hippel Lindau mutant (VHL)	EXP041011	1259	normal	Q6EHI4	4 dpf embryo	NULL
EXP041017	Rad21	Danio rerio		EXP041014	1260	normal	Q6TEL1	2.5 hpf embryo	NULL
EXP041018	Rad21 (custom made by GenScript Corporation, USA)	Danio rerio		EXP041015	1247	normal	Q6TEL1	4.5 hpf embryo	NULL
EXP041019	Rad21 (custom made by GenScript Corporation, USA)	Danio rerio		EXP041016	1257	normal	Q6TEL1	10 hpf embryo (bud stage)	NULL
EXP041020	CTCF (custom made by GenScript Corporation, USA)	Danio rerio		EXP041016	1257	normal	Q6JAA4	10 hpf embryo (bud stage)	NULL
EXP041021		Danio rerio		NULL	1261	chip_control	NULL	epiboly, 75-85%	NULL
EXP041022		Danio rerio		NULL	1262	chip_control	NULL	epiboly, 30-50%	NULL
EXP041023		Danio rerio		NULL	1261	chip_control	NULL	epiboly, 75-85%	NULL
EXP041024	Mixl1	Danio rerio		EXP041022	1262	normal	Q9PTQ9	epiboly, 30-50%	NULL
EXP041025	Ta	Danio rerio		EXP041021	1261	normal	Q07998	epiboly, 75-85%	NULL
EXP041026	Tbx16	Danio rerio		EXP041023	1261	normal	Q504I8	epiboly, 75-85%	NULL
EXP041027	none	Schizosaccharomyces pombe		NULL	1263	chip_control	NULL	whole cells	NULL
EXP041028	Mediator subunit Med7 antibody [conjugated with beads (IgG Sepharose 6 Fast Flow from GE healthcare, 17-0969-01, Lot# 10026538)]	Schizosaccharomyces pombe		EXP041027	1263	normal	O60104	whole cells	NULL
EXP041029	none	Schizosaccharomyces pombe	Treatment: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041030	none	Schizosaccharomyces pombe	Treatment: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041031	none	Schizosaccharomyces pombe	Treatment: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041032	none	Schizosaccharomyces pombe	Treatment: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041033	none	Schizosaccharomyces pombe	Treatment: none	NULL	1264	chip_control	NULL	spt6-1 strain	NULL
EXP041034	none	Schizosaccharomyces pombe	Treatment: none	NULL	1264	chip_control	NULL	spt6-1 strain	NULL
EXP041035	none	Schizosaccharomyces pombe	Treatment: none	NULL	1264	chip_control	NULL	spt6-1 strain	NULL
EXP041036	none	Schizosaccharomyces pombe	Treatment: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041037	none	Schizosaccharomyces pombe	Treatment: none	NULL	1264	chip_control	NULL	spt6-1 strain	NULL
EXP041038	Ctr9-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041030	1263	normal	O42668	whole cells	NULL
EXP041039	Swd1-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041031	1263	normal	O42858	whole cells	NULL
EXP041040	Set2-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041032	1263	normal	O14026	whole cells	NULL
EXP041041	Spt6	Schizosaccharomyces pombe	Treatment: none	EXP041029	1263	normal	Q09915	whole cells	NULL
EXP041042	Ctr9-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041033	1264	normal	O42668	spt6-1 strain	NULL
EXP041043	Set2-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041034	1264	normal	O14026	spt6-1 strain	NULL
EXP041044	Swd1-myc (anti-Myc)	Schizosaccharomyces pombe	Treatment: none	EXP041035	1264	normal	O42858	spt6-1 strain	NULL
EXP041045	none	Schizosaccharomyces pombe	Treatment: asynchronous population	NULL	1265	chip_control	NULL	KLP694 strain	NULL
EXP041046	Rabbit Polyclonal anti-TBP (Huang et al (2000) JBC 275:31480)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	P17871	KLP694 strain	NULL
EXP041047	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: G2/M	EXP041045	1265	normal	Q9HGP4	KLP694 strain	NULL
EXP041048	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: metaphase	EXP041045	1265	normal	Q9HGP4	KLP694 strain	NULL
EXP041049	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: anaphase	EXP041045	1265	normal	Q9HGP4	KLP694 strain	NULL
EXP041050	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: G1/S	EXP041045	1265	normal	Q9HGP4	KLP694 strain	NULL
EXP041051	Mouse Monoclonal anti-FLAG M2	Schizosaccharomyces pombe	Treatment: G2/M	EXP041045	1265	normal	P41004	KLP694 strain	NULL
EXP041052	Cut3	Schizosaccharomyces pombe	Treatment: metaphase	EXP041045	1265	normal	P41004	KLP694 strain	NULL
EXP041053	Cut3	Schizosaccharomyces pombe	Treatment: anaphase	EXP041045	1265	normal	P41004	KLP694 strain	NULL
EXP041054	Cut3	Schizosaccharomyces pombe	Treatment: G1/S	EXP041045	1265	normal	P41004	KLP694 strain	NULL
EXP041055	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	Q9HGP4	KLP694 strain	NULL
EXP041056	Mouse Monoclonal anti-HA (12CA5)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	P40231	KLP694 strain	NULL
EXP041057	Rabbit Polyclonal anti-ptr6 (RTK7-8) (Mitsuzawa et al (2001) JBC 276:17117)	Schizosaccharomyces pombe	Treatment: asynchronous population	EXP041045	1265	normal	O13701	KLP694 strain	NULL
EXP041058	None	Schizosaccharomyces pombe		NULL	1266	chip_control	NULL	A7988 strain	NULL
EXP041059	None	Schizosaccharomyces pombe		NULL	1267	chip_control	NULL	A7984 strain	NULL
EXP041060	None	Schizosaccharomyces pombe		NULL	1268	chip_control	NULL	A94 strain	NULL
EXP041061	None	Schizosaccharomyces pombe		NULL	1269	chip_control	NULL	5929 strain	NULL
EXP041062	GFP	Schizosaccharomyces pombe		EXP041058	1266	normal	O42995	A7988 strain	NULL
EXP041063	GFP	Schizosaccharomyces pombe		EXP041059	1267	normal	O94682	A7984 strain	NULL
EXP041064	GFP	Schizosaccharomyces pombe		EXP041060	1268	normal	Q9P802	A94 strain	NULL
EXP041065	GFP	Schizosaccharomyces pombe		EXP041061	1269	normal	Q9HDY7	5929 strain	NULL
EXP041066	none	Schizosaccharomyces pombe	Treatment: Treatment: none	NULL	1270	chip_control	NULL	NS29 strain	NULL
EXP041067	none	Schizosaccharomyces pombe	Treatment: Treatment: none	NULL	1271	chip_control	NULL	NS119 strain	NULL
EXP041068	anti-Myc; Clontech Cat. nr 631206	Schizosaccharomyces pombe	Treatment: Treatment: none	EXP041066	1270	normal	Q9UUA2	NS29 strain	NULL
EXP041069	anti-HA; Santa Cruz Cat nr. sc.7392x	Schizosaccharomyces pombe	Treatment: Treatment: none	EXP041067	1271	normal	P87154	NS119 strain	NULL
EXP041070	anti-HA; Santa Cruz Cat nr. sc.7392x	Schizosaccharomyces pombe	Treatment: Treatment: Pfh1-depleted	EXP041067	1271	normal	P87154	NS119 strain	NULL
EXP041071	Input	Danio rerio	Treatment: none	NULL	1257	chip_control	NULL	10 hpf embryo (bud stage)	NULL
EXP041072	Anti-Myc (Abcam ab9132)	Danio rerio	Treatment: none	EXP041071	1257	normal	F1QWA0	10 hpf embryo (bud stage)	NULL
EXP041073	Anti-Myc (Abcam ab9132)	Danio rerio	Treatment: none	EXP041071	1257	normal	F1QDF2	10 hpf embryo (bud stage)	NULL
EXP041074	IgG Sepharose 6 Fast Flow (GE, catalog #17-0969-01, lot #10035322, 10160338)	Schizosaccharomyces pombe	untagged	NULL	1277	normal	O43047	F108 Strain	NULL
EXP041075	IgG Sepharose 6 Fast Flow (GE, catalog #17-0969-01, lot #10035322, 10160338)	Schizosaccharomyces pombe		NULL	1276	normal	O60129	JLP1586 Strain	NULL
EXP041076	IgG Sepharose 6 Fast Flow (GE, catalog #17-0969-01, lot #10035322, 10160338)	Schizosaccharomyces pombe		NULL	1275	normal	P48383	JLP1792 Strain	NULL
EXP041077	sep1	Schizosaccharomyces pombe	1mM bortezomib (45 min.)	NULL	1274	normal	O43058	JLP1670 Strain	NULL
EXP041078	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	NULL	1281	chip_control	NULL	SPK425 Strain	NULL
EXP041079	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	NULL	1281	chip_control	NULL	SPK425 Strain	NULL
EXP041080	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	NULL	1281	chip_control	NULL	SPK425 Strain	NULL
EXP041081	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures	NULL	1288	chip_control	NULL	SPO573 Strain	NULL
EXP041082	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041078	1282	normal	O14126	SPO195 Strain	NULL
EXP044368	anti-LEM-2 (Novus Biologicals, catalog #48540002, lot# T01872A01)	Caenorhabditis elegans	GW638 strain	EXP044365	1405	normal	Q9XTB5	whole organism (development stage: early embryonic)	NULL
EXP041084	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041079	1284	normal	Q9P6R0	SPK971 Strain	NULL
EXP041085	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041080	1285	normal	P41003	SPO16 Strain	NULL
EXP041086	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041080	1286	normal	O60174	SPK886 Strain	NULL
EXP041087	rabbit polyclonal anti-Myc (Novus Biologicals, Cat. NB600-336, Lot. A5)	Schizosaccharomyces pombe	asynchronous cultures	EXP041080	1287	normal	Q9UTL5	SPK1072 Strain	NULL
EXP041088	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures	EXP041081	1289	normal	Q9Y7R3	SPO572 Strain	NULL
EXP041089	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures; Cnd2 F701R	EXP041081	1290	normal	Q9Y7R3	SPO568 Strain	NULL
EXP041090	mouse monoclonal anti-Flag M2 (Sigma, Cat. F3165, Lot. SLBH1191V)	Schizosaccharomyces pombe	asynchronous cultures; Cnd2 C703R	EXP041081	1291	normal	Q9Y7R3	SPO569 Strain	NULL
EXP041091	none	Schizosaccharomyces pombe		NULL	1295	chip_control	NULL	KYP123 Strain	NULL
EXP041092	none	Schizosaccharomyces pombe		NULL	1292	chip_control	NULL	KYP1265 Strain	NULL
EXP041093	none	Schizosaccharomyces pombe	rap1delta	NULL	1293	chip_control	NULL	KYP1308 Strain	NULL
EXP041094	none	Schizosaccharomyces pombe	taz1delta	NULL	1294	chip_control	NULL	KYP1306 Strain	NULL
EXP041095	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe		EXP041091	1295	bio_control	G2TRJ8	KYP123 Strain	NULL
EXP041096	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe		EXP041092	1292	normal	Q96UP3	KYP1265 Strain	NULL
EXP041097	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe	rap1delta	EXP041093	1293	normal	Q96UP3	KYP1308 Strain	NULL
EXP041098	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe	taz1delta	EXP041094	1294	normal	Q96UP3	KYP1306 Strain	NULL
EXP041099	none	Schizosaccharomyces pombe		NULL	1269	normal	A0ZWU1	5929 strain	NULL
EXP041100	ANTI-FLAG M2 Monoclonal Antibody(Sigma), Subclass; IgG1, Clone; M2, Cat No.; F1804	Schizosaccharomyces pombe		NULL	1269	normal	G2TRJ8	5929 strain	NULL
EXP041101		Schizosaccharomyces pombe	mitiotically arrested	NULL	1296	chip_control	NULL	nda3-KM311 Cut14-3FLAG	NULL
EXP041102		Schizosaccharomyces pombe	mitiotically arrested	NULL	1297	chip_control	NULL	nda3-KM311 Rad21-3FLAG	NULL
EXP041103		Schizosaccharomyces pombe	mitiotically arrested	NULL	1298	chip_control	NULL	nda3-KM311 Top2-3FLAG	NULL
EXP041104		Schizosaccharomyces pombe	Asynchronous cells	NULL	1299	chip_control	NULL	Cut14-3FLAG	NULL
EXP041105		Schizosaccharomyces pombe	Asynchronous cells	NULL	1300	chip_control	NULL	Rad21-3FLAG	NULL
EXP041106		Schizosaccharomyces pombe	Asynchronous cells	NULL	1301	chip_control	NULL	Top2-3FLAG	NULL
EXP041107		Schizosaccharomyces pombe	heat shock	NULL	1299	chip_control	NULL	Cut14-3FLAG	NULL
EXP041108		Schizosaccharomyces pombe	heat shock	NULL	1300	chip_control	NULL	Rad21-3FLAG	NULL
EXP041109		Schizosaccharomyces pombe	heat shock	NULL	1301	chip_control	NULL	Top2-3FLAG	NULL
EXP041110	anti-Flag M2 antibody	Schizosaccharomyces pombe	mitiotically arrested	EXP041101	1296	normal	P41003	nda3-KM311 Cut14-3FLAG	NULL
EXP041111	anti-Flag M2 antibody	Schizosaccharomyces pombe	mitiotically arrested	EXP041102	1297	normal	P30776	nda3-KM311 Rad21-3FLAG	NULL
EXP041112	anti-Flag M2 antibody	Schizosaccharomyces pombe	mitiotically arrested	EXP041103	1298	normal	P08096	nda3-KM311 Top2-3FLAG	NULL
EXP041113	anti-Flag M2 antibody	Schizosaccharomyces pombe	Asynchronous cells	EXP041104	1299	normal	P41003	Cut14-3FLAG	NULL
EXP041114	Rad21	Schizosaccharomyces pombe	Asynchronous cells	EXP041105	1300	normal	P30776	Rad21-3FLAG	NULL
EXP041115	anti-Flag M2 antibody	Schizosaccharomyces pombe	Asynchronous cells	EXP041106	1301	normal	P08096	Top2-3FLAG	NULL
EXP041116	Cut14	Schizosaccharomyces pombe	heat shock	EXP041107	1299	normal	P41003	Cut14-3FLAG	NULL
EXP041117	anti-Flag M2 antibody	Schizosaccharomyces pombe	heat shock	EXP041108	1300	normal	P30776	Rad21-3FLAG	NULL
EXP041118	anti-Flag M2 antibody	Schizosaccharomyces pombe	heat shock	EXP041109	1301	normal	P08096	Top2-3FLAG	NULL
EXP041119		Schizosaccharomyces pombe	High Phosphate	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041120		Schizosaccharomyces pombe	Low Phosphate	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041121	GFP-Trap beads	Schizosaccharomyces pombe	High Phosphate	EXP041119	1304	normal	Q9Y7Z8	Myo1-GFP	NULL
EXP041122	GFP-Trap beads	Schizosaccharomyces pombe	Low Phosphate	EXP041120	1304	normal	Q9Y7Z8	Myo1-GFP	NULL
EXP041123	none	Schizosaccharomyces pombe		NULL	1307	chip_control	NULL	SP1173 Strain	NULL
EXP041124	mouse monoclonal anti-V5/Pk1	Schizosaccharomyces pombe		EXP041123	1305	normal	O13861	Y4250 Strain	NULL
EXP041125	mouse monoclonal anti-V5/Pk1	Schizosaccharomyces pombe	SWI1 deletion	EXP041123	1306	normal	O13861	Y4256 Strain	NULL
EXP041126	none	Schizosaccharomyces pombe		NULL	1303	chip_control	NULL	wild-type	NULL
EXP041127	HA tag antibody [12CA5] (abcam16918)	Schizosaccharomyces pombe		EXP041126	1303	normal	P49777	wild-type	NULL
EXP041128	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: untagged	NULL	1308	chip_control	NULL	SPY137 Strain	NULL
EXP041129	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	NULL	1308	normal	Q10103	SPY137 Strain	NULL
EXP041130	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	NULL	1309	normal	Q10103	SPY815 Strain	NULL
EXP041131	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	NULL	1310	normal	Q10103	SPY4642 Strain	NULL
EXP041132	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4I418P	NULL	1311	normal	Q10103	SPY6537 Strain	NULL
EXP041133	Chp1 (Ab18191)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: chp1_delta	NULL	1312	normal	Q10103	SPY2421 Strain	NULL
EXP041134	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	NULL	1308	normal	P40381	SPY137 Strain	NULL
EXP041135	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	NULL	1309	normal	P40381	SPY815 Strain	NULL
EXP041136	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	NULL	1310	normal	P40381	SPY4642 Strain	NULL
EXP041137	Swi6 (Rabbit polyclonal)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: swi6_delta	NULL	1313	normal	P40381	SPY1098 Strain	NULL
EXP041138	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	EXP041128	1314	normal	O42934	SPY5378 Strain	NULL
EXP041139	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	EXP041128	1315	normal	O42934	SPY5380 Strain	NULL
EXP041140	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	EXP041128	1316	normal	O42934	SPY5382 Strain	NULL
EXP041141	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: WT	EXP041128	1317	normal	P56523	SPY5593 Strain	NULL
EXP041142	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4_delta	EXP041128	1318	normal	P56523	SPY5595 Strain	NULL
EXP041143	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: clr4F449Y	EXP041128	1319	normal	P56523	SPY5597 Strain	NULL
EXP041144	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: flag-clr4	EXP041128	1320	normal	O60016	SPY4636 Strain	NULL
EXP041145	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: flag-clr4F449Y	EXP041128	1310	normal	O60016	SPY4642 Strain	NULL
EXP041146	Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Treatment: flag-clr4W31G	EXP041128	1321	normal	O60016	SPY5562 Strain	NULL
EXP041147	IgG	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: IgG_mouse_mock	NULL	1269	chip_control	NULL	5929 strain	NULL
EXP041148	none	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: wt	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041149	none	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: wt	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041150	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: mock_WT	NULL	1303	normal	G2TRJ8	wild-type	NULL
EXP041151	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: mock_WT	EXP041149	1303	normal	G2TRJ8	wild-type	NULL
EXP041152	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1322	normal	O74842	Fft2-5xFLAG	NULL
EXP041153	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1322	normal	O74842	Fft2-5xFLAG	NULL
EXP041154	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1323	normal	O42861	Fft3-5xFLAG	NULL
EXP041155	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1323	normal	O42861	Fft3-5xFLAG	NULL
EXP041156	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1324	normal	O14148	Ino80-5xFLAG	NULL
EXP041157	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1269	normal	O14148	5929 strain	NULL
EXP041158	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1269	normal	Q9UTN6	5929 strain	NULL
EXP041159	Monoclonal ANTI-FLAG M2	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1269	normal	Q9UTN6	5929 strain	NULL
EXP041160	sc-9996; Santa Cruz Biotech.	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041148	1325	normal	O94267	GFP_Spt16	NULL
EXP041161	sc-9996; Santa Cruz Biotech.	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: none	EXP041149	1325	normal	O94267	GFP_Spt16	NULL
EXP041162	ccp1	Schizosaccharomyces pombe	wt (h- ade6+::cnp1-GFP leu1-32 ura4-D18)	NULL	1326	normal	Q9Y812	FL571 Strain	NULL
EXP041163	GFP (Abcam, ab290)	Schizosaccharomyces pombe	ccp1 mutant (h? ccp1{delta}::ura4+ ade6+::cnp1-GFP leu1-32 ura4-D18)	NULL	1327	normal	A0ZWU1	FL656 Strain	NULL
EXP041164	GFP (Abcam, ab290)	Schizosaccharomyces pombe	ccp1 mutant (h? ccp1{delta}::kanMX6 ade6+::cnp1-GFP leu1-32 ura4-D18)	NULL	1328	normal	A0ZWU1	FL657 Strain	NULL
EXP041165		Schizosaccharomyces pombe	h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1, pcf11::pcf11-TAP::KanMX	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041166		Schizosaccharomyces pombe	h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1, pcf11::pcf11-TAP::KanMX	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041167		Schizosaccharomyces pombe	untagged; h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041168		Schizosaccharomyces pombe	untagged; h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041169		Schizosaccharomyces pombe	h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1, pcf11::pcf11-TAP::KanMX	NULL	1263	normal	Q10237	whole cells	NULL
EXP041170		Schizosaccharomyces pombe	h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1, pcf11::pcf11-TAP::KanMX	NULL	1263	normal	Q10237	whole cells	NULL
EXP041171		Schizosaccharomyces pombe	untagged; h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1	NULL	1263	bio_control	A0A075WJH4	whole cells	NULL
EXP041172		Schizosaccharomyces pombe	untagged; h+, ura4-<delta>18, leu1-32, ade6-M210, his3-<delta>1	NULL	1263	bio_control	A0A075WJH4	whole cells	NULL
EXP041173		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041174		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+	NULL	1303	chip_control	NULL	wild-type	NULL
EXP041175		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+, seb1-3HA-TAP::kan MX	NULL	1329	chip_control	NULL	seb1-3HA-TAP	NULL
EXP041176		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+, seb1-3HA-TAP::kan MX	NULL	1329	chip_control	NULL	seb1-3HA-TAP	NULL
EXP041177		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+	EXP041173	1303	normal	A0A075WJH4	wild-type	NULL
EXP041178		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+	EXP041174	1303	normal	A0A075WJH4	wild-type	NULL
EXP041179		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+, seb1-3HA-TAP::kan MX	EXP041175	1329	normal	Q9UTE3	seb1-3HA-TAP	NULL
EXP041180		Schizosaccharomyces pombe	h+, ura4-delta18, leu1-32, ade6-M216, imr1R(NcoI)::ura4+, seb1-3HA-TAP::kan MX	EXP041176	1329	normal	Q9UTE3	seb1-3HA-TAP	NULL
EXP041181	anti-FLAG M2-Magnetic Beads (Sigma-Aldrich)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: wild type	NULL	1330	normal	O74856	773 Strain	NULL
EXP041182	anti-FLAG M2-Magnetic Beads (Sigma-Aldrich)	Schizosaccharomyces pombe	Treatment: Treatment: Treatment: Clr4?	NULL	1331	normal	O74856	848 Strain	NULL
EXP041183	none	Schizosaccharomyces pombe	5 Âµg/mL thiamine	NULL	1332	chip_control	NULL	YUK421 Cnd2-HA	NULL
EXP041184	Cnd2	Schizosaccharomyces pombe	5 Âµg/mL thiamine	EXP041183	1332	normal	Q9Y7R3	YUK421 Cnd2-HA	NULL
EXP041185		Schizosaccharomyces pombe	Treatment: ura4-D18 leu1-32	NULL	1263	chip_control	NULL	whole cells	NULL
EXP041186	anti-FLAG	Schizosaccharomyces pombe	Treatment: ura4-D18 leu1-32	EXP041185	1263	normal	P87048	whole cells	NULL
EXP041187	anti-FLAG	Schizosaccharomyces pombe	Treatment: ura4-D18 leu1-32	EXP041185	1263	normal	Q09720	whole cells	NULL
EXP041188	INPUT	Schizosaccharomyces pombe	DMSO	NULL	1333	chip_control	NULL	FWP486 (Spt5-degron) Strain	NULL
EXP041189	INPUT	Schizosaccharomyces pombe	thiamine + 1-Napthaleneacetic acid (NAA)	NULL	1333	chip_control	NULL	FWP486 (Spt5-degron) Strain	NULL
EXP041190	INPUT	Schizosaccharomyces pombe		NULL	1335	chip_control	NULL	FWP484 (no Tag) Strain	NULL
EXP041191	INPUT	Schizosaccharomyces pombe	no treatment	NULL	1334	chip_control	NULL	FWP485 (Spt5-V5-IAA17) Strain	NULL
EXP041192	INPUT	Schizosaccharomyces pombe	DMSO	NULL	1333	chip_control	NULL	FWP486 (Spt5-degron) Strain	NULL
EXP041193	INPUT	Schizosaccharomyces pombe	thiamine + 1-Napthaleneacetic acid (NAA)	NULL	1334	chip_control	NULL	FWP485 (Spt5-V5-IAA17) Strain	NULL
EXP041194	INPUT	Schizosaccharomyces pombe		NULL	1335	chip_control	NULL	FWP484 (no Tag) Strain	NULL
EXP041195	INPUT	Schizosaccharomyces pombe	no treatment	NULL	1334	chip_control	NULL	FWP485 (Spt5-V5-IAA17) Strain	NULL
EXP041196	anti-V5	Schizosaccharomyces pombe	DMSO	EXP041188	1333	normal	O13936	FWP486 (Spt5-degron) Strain	NULL
EXP041197	anti-V5	Schizosaccharomyces pombe	thiamine + 1-Napthaleneacetic acid (NAA)	EXP041189	1333	normal	O13936	FWP486 (Spt5-degron) Strain	NULL
EXP041198	anti-V5	Schizosaccharomyces pombe	no treatment	EXP041191	1334	normal	O13936	FWP485 (Spt5-V5-IAA17) Strain	NULL
EXP041199	anti-V5	Schizosaccharomyces pombe	DMSO	EXP041192	1333	normal	O13936	FWP486 (Spt5-degron) Strain	NULL
EXP041200	anti-V5	Schizosaccharomyces pombe	thiamine + 1-Napthaleneacetic acid (NAA)	EXP041193	1333	normal	O13936	FWP486 (Spt5-degron) Strain	NULL
EXP041201	anti-V5	Schizosaccharomyces pombe	no treatment	EXP041195	1334	normal	O13936	FWP485 (Spt5-V5-IAA17) Strain	NULL
EXP041202	anti-SEP3	Arabidopsis thaliana	wild type	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP041203	anti-SEP3	Arabidopsis thaliana	wild type	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP041204	anti-SEP3	Arabidopsis thaliana	sep3 mutant (sep3-1)	NULL	1336	bio_control	O22456	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP041205	anti-SEP3	Arabidopsis thaliana	wild type	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP041206	anti-SEP3	Arabidopsis thaliana	agamous mutant (ag-1)	NULL	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP041207	AMS	Arabidopsis thaliana		NULL	1337	normal	Q9ZVX2	buds	NULL
EXP041208	AP2 custom antibody	Arabidopsis thaliana		NULL	1337	chip_control	NULL	buds	NULL
EXP041209	AP2 custom antibody 	Arabidopsis thaliana		EXP041208	1337	normal	P47927	buds	NULL
EXP041210	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	single treatment of 1 uM DEX to the shoot apex (2 hours)	NULL	1338	normal	P35631	apical meristems	NULL
EXP041211	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	single treatment of 1 uM DEX to the shoot apex (2 hours)	NULL	1338	normal	P35631	apical meristems	NULL
EXP041212	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	control	NULL	1338	normal	P35631	apical meristems	NULL
EXP041213	AP1 antibody, affinity-purified against IKC-domains	Arabidopsis thaliana	control	NULL	1338	normal	P35631	apical meristems	NULL
EXP041214	none	Arabidopsis thaliana	Col-0 transgene	NULL	1340	chip_control	NULL	complete seedlings	NULL
EXP041215	none	Arabidopsis thaliana	35S::FLAG-GR-REVd	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041216	F3165 Sigma Monoclonal ANTI-FLAG M2	Arabidopsis thaliana	Col-0 transgene	EXP041214	1340	normal	Q9SE43	complete seedlings	NULL
EXP041217	F3165 Sigma Monoclonal ANTI-FLAG M2	Arabidopsis thaliana	35S::FLAG-GR-REVd	EXP041215	1341	normal	Q9SE43	10 day old seedlings	NULL
EXP041218	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	wild type (Col-0)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041219	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	wild type (Col-0)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041220	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	plants that overexpressed LFY (35S:LFY)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041221	rabbit (#4028) against the LFY C-terminal amino acids 223-424 (BioGenes, Berlin, Germany)	Arabidopsis thaliana	plants that overexpressed LFY (35S:LFY)	NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041222	FLAG (Sigma-Aldrich)	Arabidopsis thaliana	Dark (35S:3FLAG-FHY3-3HA fhy3-4 transgenic line)	NULL	1343	normal	Q9LIE5	4 day old seedlings	NULL
EXP041223	FLAG (Sigma-Aldrich)	Arabidopsis thaliana	Far-Red (35S:3FLAG-FHY3-3HA fhy3-4 transgenic line)	NULL	1343	normal	Q9LIE5	4 day old seedlings	NULL
EXP041224	anti-FlagM2	Arabidopsis thaliana	low R/FR light (PIF5-HA overexpressor Flag tagged)	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041225	anti-FlagM2	Arabidopsis thaliana	low R/FR light (PIF5-HA overexpressor Flag tagged)	EXP041224	1344	normal	Q84LH8	14 day old seedling	NULL
EXP041226	anti-myc antibody	Arabidopsis thaliana	genotype: pPIF4::PIF4-myc (grown in the dark for 5 days)	EXP041227	1340	normal	Q8W2F3	complete seedlings	NULL
EXP041227	anti-myc antibody	Arabidopsis thaliana	wild type (Col-0)	NULL	1340	chip_control	NULL	complete seedlings	NULL
EXP041228	GFP:Living Colors_ full-length A.v. polyclonal antibody Clontech	Arabidopsis thaliana	wild type Col	NULL	1346	normal	Q9FVC1	inflorescence meristem and flower from stages 1 to 11	NULL
EXP041229	GFP:Living Colors_ full-length A.v. polyclonal antibody Clontech	Arabidopsis thaliana	pSVP::SVP-GFP svp-41	NULL	1346	normal	Q9FVC1	inflorescence meristem and flower from stages 1 to 11	NULL
EXP041230	GFP:Living Colors_ full-length A.v. polyclonal antibody Clontech	Arabidopsis thaliana	pSVP::SVP-GFP svp-41	NULL	1348	normal	Q9FVC1	seedlings 2 weeks old	NULL
EXP041231		Arabidopsis thaliana	Wild type (Col-0)	NULL	1347	chip_control	NULL	2-3 week old seedling	NULL
EXP041232		Arabidopsis thaliana	ago4 mutant (ago4-1)	NULL	1347	chip_control	NULL	2-3 week old seedling	NULL
EXP041233		Arabidopsis thaliana	nrpe1 mutant (nrpd1b-11)	NULL	1347	chip_control	NULL	2-3 week old seedling	NULL
EXP041234	AGO4 antibody	Arabidopsis thaliana	Wild type (Col-0)	EXP041231	1347	normal	Q9ZVD5	2-3 week old seedling	NULL
EXP041235	AGO4 antibody	Arabidopsis thaliana	ago4 mutant (ago4-1)	EXP041232	1347	normal	Q9ZVD5	2-3 week old seedling	NULL
EXP041236	AGO4 antibody	Arabidopsis thaliana	nrpe1 mutant (nrpd1b-11)	EXP041233	1347	normal	Q9ZVD5	2-3 week old seedling	NULL
EXP041237	none	Arabidopsis thaliana	TMG-YFP/toc1-2	NULL	1340	chip_control	NULL	complete seedlings	NULL
EXP041238	anti-GFP	Arabidopsis thaliana	TMG-YFP/toc1-2	EXP041237	1340	normal	Q9LKL2	complete seedlings	NULL
EXP041239	Anti-GFP	Arabidopsis thaliana	PI-GFP AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1188	normal	P48007	floral tissue	NULL
EXP041240	ap3	Arabidopsis thaliana	AP3-GFP AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1188	normal	P35632	floral tissue	NULL
EXP041241	Anti-GFP AB290	Arabidopsis thaliana	AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1188	bio_control	F4IIH6	floral tissue	NULL
EXP041242	anti-FLAG catalog #: M8823-5ml, Lot #: 041M6135	Arabidopsis thaliana	Transgenic plants expressing CMT3-FLAG	NULL	1188	normal	Q94F88	floral tissue	NULL
EXP041243	anti-FLAG catalog #: M8823-5ml, Lot #: 041M6135	Arabidopsis thaliana	Wild-type plants not expressing CMT3-FLAG	NULL	1188	bio_control	Q4V3D6	floral tissue	NULL
EXP041244	input	Arabidopsis thaliana	PRR5pro:FLAG-PRR5-GFP/prr5 (12 h light/12 h dark conditions for 18 d; 10 hr after light on)	NULL	1231	chip_control	NULL	whole plants	NULL
EXP041245	anti-GFP	Arabidopsis thaliana	PRR5pro:FLAG-PRR5-GFP/prr5 (12 h light/12 h dark conditions for 18 d; 10 hr after light on)	EXP041244	1231	normal	Q6LA42	whole plants	NULL
EXP041246	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	true dark; WT genotype	NULL	1349	normal	O80536	2 day old seedlings	NULL
EXP041247	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	true dark; pif3-3 genotype	NULL	1349	normal	O80536	2 day old seedlings	NULL
EXP041248	none	Arabidopsis thaliana	eds1 wt; 35S:RPS4-HS	NULL	1350	chip_control	NULL	leaves	NULL
EXP041249	none	Arabidopsis thaliana	eds 1-2 mutant; 35S:RPS4-HS eds1-2	NULL	1350	chip_control	NULL	leaves	NULL
EXP041250	none	Arabidopsis thaliana	WT	NULL	1350	chip_control	NULL	leaves	NULL
EXP041251	anti-HA (Abcam ab9110)	Arabidopsis thaliana	eds1 wt; 35S:RPS4-HS	EXP041248	1350	normal	Q9XGM3	leaves	NULL
EXP041252	anti-HA (Abcam ab9110)	Arabidopsis thaliana	eds 1-2 mutant; 35S:RPS4-HS eds1-2	EXP041249	1350	normal	Q9XGM3	leaves	NULL
EXP041253	anti-HA (Abcam ab9110)	Arabidopsis thaliana		EXP041250	1350	normal	Q9XGM3	leaves	NULL
EXP044367	anti-LEM-2 (Novus Biologicals, catalog #48540002, lot# T01872A01)	Caenorhabditis elegans	GW1 strain	EXP044364	1405	normal	Q9XTB5	whole organism (development stage: early embryonic)	NULL
EXP044366	none	Caenorhabditis elegans	GW828 strain	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP044365	none	Caenorhabditis elegans	GW638 strain	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP044364	none	Caenorhabditis elegans	GW1 strain	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP041259	pif1	Arabidopsis thaliana	Wild type	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041260	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Wild type	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041261	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Wild type	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041262	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF1 (P1M)	EXP041259	1351	normal	Q8GZM7	3 day old seedlings	NULL
EXP041263	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF1 (P1M)	EXP041260	1351	normal	Q8GZM7	3 day old seedlings	NULL
EXP041264	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF1 (P1M)	EXP041261	1351	normal	Q8GZM7	3 day old seedlings	NULL
EXP041265	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Wild type	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041266	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Wild type	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041267	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Wild type	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041268	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF4 (P1M)	EXP041265	1351	normal	Q8W2F3	3 day old seedlings	NULL
EXP041269	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF4 (P1M)	EXP041266	1351	normal	Q8W2F3	3 day old seedlings	NULL
EXP041270	anti-Myc (Abcam, ab9132)	Arabidopsis thaliana	Myc-epitope-tagged-PIF4 (P1M)	EXP041267	1351	normal	Q8W2F3	3 day old seedlings	NULL
EXP041271	FLAG antibody	Arabidopsis thaliana	35S:FLAG-SPL7 transgene	NULL	1352	normal	Q8S9G8	7 days old seedlings	NULL
EXP041272		Arabidopsis thaliana	spl7 mutant	NULL	1352	bio_control	A0A023T4L8	7 days old seedlings	NULL
EXP041273	anti-HA antibodies (H6908, Sigma-Aldrich)	Arabidopsis thaliana	Wild type (Col-0)	NULL	1353	chip_control	NULL	rosette stage (5 weeks, short day)	NULL
EXP041274	anti-HA antibodies (H6908, Sigma-Aldrich)	Arabidopsis thaliana	genotype: 35S:ATAF1-HA	EXP041273	1353	normal	Q39013	rosette stage (5 weeks, short day)	NULL
EXP041275	Anti-GFP AB290 (Abcam)	Arabidopsis thaliana	AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1345	bio_control	P17839	inflorescence	NULL
EXP041276	Anti-GFP AB290 (Abcam)	Arabidopsis thaliana	AG-GFP AP1-GR ap1 cal; 4 days after Dexamethasone treatment (early-intermediate floral stage ~ stage 4-5 flowers)	NULL	1345	normal	P17839	inflorescence	NULL
EXP041277	pre-immune serum	Arabidopsis thaliana	2 days after DEX	NULL	1345	chip_control	NULL	inflorescence	NULL
EXP041278	pre-immune serum	Arabidopsis thaliana	4 days after DEX	NULL	1345	chip_control	NULL	inflorescence	NULL
EXP041279	pre-immune serum	Arabidopsis thaliana	8 days after DEX	NULL	1345	chip_control	NULL	inflorescence	NULL
EXP041280	anti-SEP3 antibody (Eurogentec, custom-made, peptide antibody)	Arabidopsis thaliana	4 days after DEX	EXP041278	1345	normal	O22456	inflorescence	NULL
EXP041281	anti-SEP3 antibody (Eurogentec, custom-made, peptide antibody)	Arabidopsis thaliana	8 days after DEX	EXP041279	1345	normal	O22456	inflorescence	NULL
EXP041282	anti-GR antibody (Glucocorticoid Receptor alpha Polyclonal antibody (Thermo Scientific, cat# PA1-516, lot# MD153967; to precipitate AP1-GR)	Arabidopsis thaliana	4 days after DEX	EXP041278	1345	normal	P35631	inflorescence	NULL
EXP041283	anti-GR antibody (Glucocorticoid Receptor alpha Polyclonal antibody (Thermo Scientific, cat# PA1-516, lot# MD153967; to precipitate AP1-GR)	Arabidopsis thaliana	8 days after DEX	EXP041279	1345	normal	P35631	inflorescence	NULL
EXP041284	anti-GR antibody (Glucocorticoid Receptor alpha Polyclonal antibody (Thermo Scientific, cat# PA1-516, lot# MD153967; to precipitate AP1-GR)	Arabidopsis thaliana	2 days after DEX	EXP041277	1345	normal	P35631	inflorescence	NULL
EXP041285	SEP3 antibody	Arabidopsis thaliana	2 days after DEX	EXP041277	1345	normal	O22456	inflorescence	NULL
EXP041286	input	Arabidopsis thaliana	45 minutes DEX treatment	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041287	Sigma anti-FLAG magnetic beads (Product No. A2220)	Arabidopsis thaliana	45 minutes DEX treatment	EXP041286	1341	normal	Q93WJ9	10 day old seedlings	NULL
EXP041288	IP with untagged FLM protein	Arabidopsis thaliana		NULL	1339	chip_control	NULL	seedling	NULL
EXP041289	IP with untagged FLM protein	Arabidopsis thaliana		NULL	1339	chip_control	NULL	seedling	NULL
EXP041290	IP with untagged FLM protein	Arabidopsis thaliana		NULL	1339	chip_control	NULL	seedling	NULL
EXP041291	anti-GFP	Arabidopsis thaliana		EXP041288	1339	normal	Q9AT76	seedling	NULL
EXP041292	anti-GFP Ab (Abcam #ab290)	Arabidopsis thaliana	iFLM-beta splicing variant	EXP041289	1339	normal	Q9AT76	seedling	NULL
EXP041293	anti-GFP Ab (Abcam #ab290)	Arabidopsis thaliana	iFLM-delta splicing variant	EXP041290	1339	normal	Q9AT76	seedling	NULL
EXP041294	none	Arabidopsis thaliana		NULL	1343	chip_control	NULL	4 day old seedlings	NULL
EXP041295	anti-GFP 632592	Arabidopsis thaliana		EXP041294	1343	normal	P14712	4 day old seedlings	NULL
EXP041296		Arabidopsis thaliana	wild type; mock	NULL	1354	chip_control	NULL	PSB-d dark growing suspension cells	NULL
EXP041297	ERF115	Arabidopsis thaliana	35S::ERF115-HBH genotype	EXP041296	1354	normal	Q9LY29	PSB-d dark growing suspension cells	NULL
EXP041298	input	Arabidopsis thaliana	prr7-3 genotype	NULL	1342	chip_control	NULL	complete 15 day-old seedlings	NULL
EXP041299	input	Arabidopsis thaliana	prr7-3 PRR7::HA-PRR7 genotype	NULL	1342	chip_control	NULL	complete 15 day-old seedlings	NULL
EXP041300	anti-HA	Arabidopsis thaliana	prr7-3 genotype	EXP041298	1342	normal	Q93WK5	complete 15 day-old seedlings	NULL
EXP041301	anti-HA	Arabidopsis thaliana	prr7-3 PRR7::HA-PRR7 genotype	EXP041299	1342	normal	Q93WK5	complete 15 day-old seedlings	NULL
EXP041302	GFP ab290	Arabidopsis thaliana	p35S::GFP (GFP OE) genotype	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041303	GFP ab290	Arabidopsis thaliana	p35S::IBH1-GFP (IBH1OE) genotype	EXP041302	1341	normal	Q9M0B9	10 day old seedlings	NULL
EXP041304		Arabidopsis thaliana	wt genotype	NULL	1355	chip_control	NULL	unopened buds	NULL
EXP041305	anti-GFP	Arabidopsis thaliana	 JAG:JAG-GFP genotype	EXP041304	1355	normal	Q6S591	unopened buds	NULL
EXP041306	anti-myc antibody	Arabidopsis thaliana	35S::GFP-Myc seedlings	NULL	1339	chip_control	NULL	seedling	NULL
EXP041307	anti-myc antibody	Arabidopsis thaliana	ARF6p::ARF6-Myc in arf6;arf8 seedlings	EXP041306	1339	normal	Q9ZTX8	seedling	NULL
EXP041308	antiserum against the full-length LHY protein	Arabidopsis thaliana	lhy-21 (LHY KO)	NULL	1348	chip_control	NULL	seedlings 2 weeks old	NULL
EXP041309	antiserum against the full-length LHY protein	Arabidopsis thaliana		EXP041308	1348	normal	Q6R0H1	seedlings 2 weeks old	NULL
EXP041310	anti-GFP microbeads (Miltenyi ÂµMACS GFP Isolation Kit)	Arabidopsis thaliana		NULL	1356	chip_control	NULL	somatic embryos	NULL
EXP041311	anti-GFP microbeads (Miltenyi ÂµMACS GFP Isolation Kit)	Arabidopsis thaliana		NULL	1358	chip_control	NULL	whole embryogenic seedlings	NULL
EXP041312	anti-GFP microbeads (Miltenyi ÂµMACS GFP Isolation Kit)	Arabidopsis thaliana		EXP041310	1356	normal	Q6PQQ4	somatic embryos	NULL
EXP041313	anti-GFP microbeads (Miltenyi ÂµMACS GFP Isolation Kit)	Arabidopsis thaliana		EXP041311	1358	normal	Q6PQQ4	whole embryogenic seedlings	NULL
EXP041314	YFP antibody (Homemade)	Arabidopsis thaliana		NULL	1359	chip_control	NULL	4 week old seedlings	NULL
EXP041315	YFP antibody (Homemade)	Arabidopsis thaliana		EXP041314	1359	normal	Q9ZPW3	4 week old seedlings	NULL
EXP041316		Arabidopsis thaliana		NULL	1354	chip_control	NULL	PSB-d dark growing suspension cells	NULL
EXP041317	E2Fa	Arabidopsis thaliana		EXP041316	1354	normal	Q9FNY0	PSB-d dark growing suspension cells	NULL
EXP041318	input	Arabidopsis thaliana	OE3-1	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041319	input	Arabidopsis thaliana	OE9-1	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041320	input	Arabidopsis thaliana	OE17-4	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041321	DEK3	Arabidopsis thaliana	OE3-1	EXP041318	1344	normal	Q9SUA1	14 day old seedling	NULL
EXP041322	GFP antibdoy (abcam #290)	Arabidopsis thaliana	OE9-1	EXP041319	1344	normal	Q9SUA1	14 day old seedling	NULL
EXP041323	GFP antibdoy (abcam #290)	Arabidopsis thaliana	OE17-4	EXP041320	1344	normal	Q9SUA1	14 day old seedling	NULL
EXP041324	Polyclonal antibody of AL5 protein	Arabidopsis thaliana	AL5 KO	NULL	1359	chip_control	NULL	4 week old seedlings	NULL
EXP041325	Polyclonal antibody of AL5 protein	Arabidopsis thaliana	AL5 overexpression	EXP041324	1359	normal	Q5XEM9	4 week old seedlings	NULL
EXP041326	Anti-Myc (Cell Signaling Technology, catalog# 71D10, lot# 5)	Arabidopsis thaliana	wt	NULL	1343	chip_control	NULL	4 day old seedlings	NULL
EXP041327	Anti-Myc (Cell Signaling Technology, catalog# 71D10, lot# 5)	Arabidopsis thaliana	SPCHp:SPCH2-4A-MYC in spch3	EXP041326	1343	normal	Q700C7	4 day old seedlings	NULL
EXP041328	none (input)	Arabidopsis thaliana		NULL	1343	chip_control	NULL	4 day old seedlings	NULL
EXP041329	FHY1	Arabidopsis thaliana	35S: GFP-FHY1, fhy1-1	EXP041328	1343	normal	Q8S4Q6	4 day old seedlings	NULL
EXP041330		Arabidopsis thaliana	proMBD7::gMBD7:4xMYC transgenic	NULL	1340	chip_control	NULL	complete seedlings	NULL
EXP041331		Arabidopsis thaliana	wt; 35S-SUC2-Myc-ChIP	NULL	1340	chip_control	NULL	complete seedlings	NULL
EXP041332	c-Myc Mouse Monoclonal Antibody	Arabidopsis thaliana	proMBD7::gMBD7:4xMYC transgenic	EXP041330	1340	normal	Q9FJF4	complete seedlings	NULL
EXP041333	c-Myc Mouse Monoclonal Antibody	Arabidopsis thaliana	wt; 35S-SUC2-Myc-ChIP	EXP041331	1340	normal	Q39231	complete seedlings	NULL
EXP041334	GFP-Trap_A (ChromoTek)	Arabidopsis thaliana	18 h 10 ÂµM PAC, 6 h 5 ÂµM BA	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041335	GFP-Trap_A (ChromoTek)	Arabidopsis thaliana	18 h 10 ÂµM PAC, 6 h 5 ÂµM BA; RGA::RGA-GFP	EXP041334	1341	normal	Q9SLH3	10 day old seedlings	NULL
EXP041336	AbCam290	Arabidopsis thaliana		NULL	1362	chip_control	NULL	roots	NULL
EXP041337	AbCam290	Arabidopsis thaliana		EXP041336	1360	normal	Q700D2	ground tissue and stem cell organizer (QC)	NULL
EXP041338	AT1G14580.1	Arabidopsis thaliana		EXP041336	1361	normal	Q8RWX7	Ground tissue	NULL
EXP041339	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041340	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	EXP041339	1363	normal	Q9SQX9	12 day old seedlings	NULL
EXP041341	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	EXP041339	1363	normal	Q9SQY0	12 day old seedlings	NULL
EXP041342	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: jmj14-1 mutant	EXP041339	1363	bio_control	A0A1I9LN22	12 day old seedlings	NULL
EXP041343	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: none	EXP041339	1363	normal	Q8GUI6	12 day old seedlings	NULL
EXP041344	anti-HA (Sigma, catalog# H6908, lot# 013M4771)	Arabidopsis thaliana	Treatment: JMJ14-FYR-HA genotype	EXP041339	1363	normal	Q8GUI6	12 day old seedlings	NULL
EXP041345	input	Arabidopsis thaliana		NULL	1364	chip_control	NULL	9 day old seedlings	NULL
EXP041346	anti-GFP	Arabidopsis thaliana		EXP041345	1364	normal	Q8H1P9	9 day old seedlings	NULL
EXP044363	a-ELT-2 (455-2A4)	Caenorhabditis elegans	Treatment: N2 strain	EXP044361	1390	normal	Q10655	whole worms (developmental stage: L3)	NULL
EXP044362	IgG	Caenorhabditis elegans	Treatment: N2 strain	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044361	input	Caenorhabditis elegans	Treatment: N2 strain	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044360	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: N2 strain	EXP044353	1235	normal	P48996	whole worms (developmental stage: young adults)	NULL
EXP041353	rabbit (#4028) against the LFY C-terminal amino acids 223-424	Arabidopsis thaliana		NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041354	rabbit (#4028) against the LFY C-terminal amino acids 223-424	Arabidopsis thaliana	p35S:LFY; CA26-15 strain	NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041355	rabbit (#4028) against the LFY C-terminal amino acids 223-424	Arabidopsis thaliana	p35S:LFYTERE; CA29-17 strain	NULL	1342	normal	Q00958	complete 15 day-old seedlings	NULL
EXP041356	HA (Sigma, Catalog: H6908)	Arabidopsis thaliana	Treatment: none	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041357	HA (Sigma, Catalog: H6908)	Arabidopsis thaliana	Treatment: REF6p::REF6-HA ref6-1	EXP041356	1363	normal	Q9STM3	12 day old seedlings	NULL
EXP041358	HA (Sigma, Catalog: H6908)	Arabidopsis thaliana	Treatment: REF6p::REF6-ZnF-HA ref6-1	EXP041356	1363	normal	Q9STM3	12 day old seedlings	NULL
EXP041359	none (input)	Arabidopsis thaliana		NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041360	anti-FLAG M2 magnetic beads (Sigma, catalog# A2220)	Arabidopsis thaliana		EXP041359	1341	normal	P46602	10 day old seedlings	NULL
EXP041361	-	Arabidopsis thaliana	14 hour mock treated; WRKY33-HA	NULL	1365	chip_control	NULL	4 week old mature leaves	NULL
EXP041362	-	Arabidopsis thaliana	14 hour post inoculation with spores of Botrytis cinerea 2100	NULL	1365	chip_control	NULL	4 week old mature leaves	NULL
EXP041363	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour mock treated; wt	NULL	1365	bio_control	A0A178V8T3	4 week old mature leaves	NULL
EXP041364	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour post inoculation with spores of Botrytis cinerea 2100; wt	NULL	1365	bio_control	A0A178V8T3	4 week old mature leaves	NULL
EXP041365	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour mock treated; WRKY33-HA	EXP041361	1365	normal	Q8S8P5	4 week old mature leaves	NULL
EXP041366	rabbit polyclonal antibodies to HA (Sigma)	Arabidopsis thaliana	14 hour post inoculation with spores of Botrytis cinerea 2100	EXP041362	1365	normal	Q8S8P5	4 week old mature leaves	NULL
EXP041367	anti-FLAG antibody	Arabidopsis thaliana	CCA1pro:CCA1-FLAG cca1 lhy	NULL	1344	normal	P92973	14 day old seedling	NULL
EXP041368	anti-FLAG antibody	Arabidopsis thaliana	CCA1pro:CCA1-FLAG cca1 lhy	NULL	1344	normal	P92973	14 day old seedling	NULL
EXP041369	IgG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP041370	IgG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP041371	IgG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP041372	anti-FLAG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	EXP041369	1366	normal	Q96524	5 day old seedlings	NULL
EXP041373	anti-FLAG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	EXP041370	1366	normal	Q8W2F3	5 day old seedlings	NULL
EXP041374	anti-FLAG	Arabidopsis thaliana	5 day white light, low blue for 16 hours	EXP041371	1366	normal	Q84LH8	5 day old seedlings	NULL
EXP041375	none	Arabidopsis thaliana		NULL	1367	chip_control	NULL	Inflorescence containing stage 8 and younger flowers	NULL
EXP041376	Sigma-Aldrich, A2220	Arabidopsis thaliana		EXP041375	1367	normal	Q9LIE5	Inflorescence containing stage 8 and younger flowers	NULL
EXP041377	GFP-Trap A matrix	Arabidopsis thaliana		NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041378	-	Arabidopsis thaliana		NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041379	GFP-Trap A matrix	Arabidopsis thaliana	TRB1pro:TRB1-GFP/TRB1pro:TRB1-GFP	EXP041377	1344	normal	Q8VWK4	14 day old seedling	NULL
EXP041380	anti-TRB1 (5.2)	Arabidopsis thaliana		EXP041378	1344	normal	Q8VWK4	14 day old seedling	NULL
EXP041381		Arabidopsis thaliana	d2c2,; SUVH9-VENUS	NULL	1345	chip_control	NULL	inflorescence	NULL
EXP041382	Chromotek, GFP-Trap	Arabidopsis thaliana		EXP041381	1345	normal	Q9T0G7	inflorescence	NULL
EXP041383	Chromotek, GFP-Trap	Arabidopsis thaliana	WT; SUVH9-VENUS	EXP041381	1345	normal	Q9T0G7	inflorescence	NULL
EXP041384		Arabidopsis thaliana	Constant Light after entrainment in 12h:12h Light: Dark; ZT2	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041385	anti-GFP	Arabidopsis thaliana	Constant Light after entrainment in 12h:12h Light: Dark; ZT14	EXP041384	1344	normal	P92973	14 day old seedling	NULL
EXP041386	anti-GFP	Arabidopsis thaliana	Constant Light after entrainment in 12h:12h Light: Dark; ZT2	EXP041384	1344	normal	P92973	14 day old seedling	NULL
EXP041387	anti-GFP	Arabidopsis thaliana	Diel 12h:12h Light:Dark; ZT2	EXP041384	1344	normal	P92973	14 day old seedling	NULL
EXP041388	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1;soc1-2; 15 days SD + 3 days LD	NULL	1368	chip_control	NULL	transition apices	NULL
EXP041389	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1;soc1-2; 15 days SD + 3 days LD	NULL	1368	chip_control	NULL	transition apices	NULL
EXP041390	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1;soc1-2; 15 days SD + 3 days LD	NULL	1368	chip_control	NULL	transition apices	NULL
EXP041391	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1-GFP;soc1-2; 15 days SD + 3 days LD	EXP041388	1368	normal	O64645	transition apices	NULL
EXP041392	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1-GFP;soc1-2; 15 days SD + 3 days LD	EXP041389	1368	normal	O64645	transition apices	NULL
EXP041393	anti-GFP Abcam ab290	Arabidopsis thaliana	SOC1p:gSOC1-GFP;soc1-2; 15 days SD + 3 days LD	EXP041390	1368	normal	O64645	transition apices	NULL
EXP041394	input	Arabidopsis thaliana	Cycling 12 h light/12 h dark; ZT4	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041395	input	Arabidopsis thaliana	Cycling 12 h light/12 h dark; ZT4	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041396	APRR9	Arabidopsis thaliana	Cycling 12 h light/12 h dark; ZT4	EXP041394	1344	normal	Q8L500	14 day old seedling	NULL
EXP041397	APRR9	Arabidopsis thaliana	Cycling 12 h light/12 h dark; ZT4	EXP041395	1344	normal	Q8L500	14 day old seedling	NULL
EXP041398	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana	rpl-1 mutant transformed with genomic contruct expressing a fusion between RPL and GFP (pRPL:RPL-GFP)	NULL	1369	normal	Q9LZM8	inflorescence apices	NULL
EXP041399	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana	wild-type	NULL	1369	normal	Q9LZM8	inflorescence apices	NULL
EXP041400	none	Arabidopsis thaliana	Treatment: Temp 17C	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041401	Anti-FLAGÂ® M2 Magnetic Beads (M8823 SIGMA)	Arabidopsis thaliana	Treatment: Temp 17C	EXP041400	1363	normal	P41151	12 day old seedlings	NULL
EXP041402	Anti-FLAGÂ® M2 Magnetic Beads (M8823 SIGMA)	Arabidopsis thaliana	Treatment: Temp 27C	EXP041400	1363	normal	P41151	12 day old seedlings	NULL
EXP041403	Anti-FLAGÂ® M2 Magnetic Beads (M8823 SIGMA)	Arabidopsis thaliana	Treatment: Temp 37C	EXP041400	1363	normal	P41151	12 day old seedlings	NULL
EXP041404	anti-GFP	Arabidopsis thaliana	none (untreated; NHS); 35S::FRG1-YFP	NULL	1370	normal	Q9LHE4	6 day old seedlings	NULL
EXP041405	anti-GFP	Arabidopsis thaliana	acclimatizing (ACC) heat stress; 35S::FRG1-YFP	NULL	1370	normal	Q9LHE4	6 day old seedlings	NULL
EXP041406	anti-GFP	Arabidopsis thaliana	acclimatizing (ACC) heat stress; WT	NULL	1370	normal	Q9LHE4	6 day old seedlings	NULL
EXP041407	anti-GFP	Arabidopsis thaliana	none (untreated; NHS); WT	NULL	1370	normal	Q9LHE4	6 day old seedlings	NULL
EXP041408	none, input control	Arabidopsis thaliana	pFUL:FUL-GFP ful-1	NULL	1371	chip_control	NULL	pistil/silique stage 12-16	NULL
EXP041409	anti-GFP	Arabidopsis thaliana		EXP041408	1371	normal	Q38876	pistil/silique stage 12-16	NULL
EXP041410	none	Arabidopsis thaliana	plt1, plt2 double mutant	NULL	1362	chip_control	NULL	roots	NULL
EXP041411	anti-GFP	Arabidopsis thaliana		EXP041410	1362	normal	Q5YGP7	roots	NULL
EXP041412	input	Arabidopsis thaliana	Treatment: none	NULL	1350	chip_control	NULL	leaves	NULL
EXP041413	anti-FLAG	Arabidopsis thaliana	Treatment: none	EXP041412	1350	normal	Q8H0W2	leaves	NULL
EXP041414	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	NULL	1351	chip_control	NULL	3 day old seedlings	NULL
EXP041415	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9M7Q3	3 day old seedlings	NULL
EXP041416	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9M7Q3	3 day old seedlings	NULL
EXP041417	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9M7Q2	3 day old seedlings	NULL
EXP041418	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9M7Q2	3 day old seedlings	NULL
EXP041419	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46897	3 day old seedlings	NULL
EXP041420	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46897	3 day old seedlings	NULL
EXP041421	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	A0A178US99	3 day old seedlings	NULL
EXP041422	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	A0A178US99	3 day old seedlings	NULL
EXP041423	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	O22533	3 day old seedlings	NULL
EXP041424	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	O22533	3 day old seedlings	NULL
EXP041425	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46668	3 day old seedlings	NULL
EXP041426	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46668	3 day old seedlings	NULL
EXP041427	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46667	3 day old seedlings	NULL
EXP041428	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46667	3 day old seedlings	NULL
EXP041429	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9FDW1	3 day old seedlings	NULL
EXP041430	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9FDW1	3 day old seedlings	NULL
EXP041431	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q1PDN3	3 day old seedlings	NULL
EXP041432	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q1PDN3	3 day old seedlings	NULL
EXP041433	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q93VY3	3 day old seedlings	NULL
EXP041434	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q93VY3	3 day old seedlings	NULL
EXP041435	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours	EXP041414	1351	normal	O82132	3 day old seedlings	NULL
EXP041436	GFP (ThermoFisher #A11122)AT5G05410	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	O82132	3 day old seedlings	NULL
EXP041437	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9S9K9	3 day old seedlings	NULL
EXP041438	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9S9K9	3 day old seedlings	NULL
EXP041439	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9C690	3 day old seedlings	NULL
EXP041440	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9C690	3 day old seedlings	NULL
EXP041441	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P46604	3 day old seedlings	NULL
EXP041442	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P46604	3 day old seedlings	NULL
EXP041443	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P42775	3 day old seedlings	NULL
EXP041444	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P42775	3 day old seedlings	NULL
EXP041445	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q8LCG7	3 day old seedlings	NULL
EXP041446	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q8LCG7	3 day old seedlings	NULL
EXP041447	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9CAR0	3 day old seedlings	NULL
EXP041448	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9CAR0	3 day old seedlings	NULL
EXP041449	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q8H115	3 day old seedlings	NULL
EXP041450	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q8H115	3 day old seedlings	NULL
EXP041451	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	P42776	3 day old seedlings	NULL
EXP041452	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	P42776	3 day old seedlings	NULL
EXP041453	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9M7Q5	3 day old seedlings	NULL
EXP041454	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9M7Q5	3 day old seedlings	NULL
EXP041455	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	EtOH mock treatment, 4 hours; dark	EXP041414	1351	normal	Q9FGJ3	3 day old seedlings	NULL
EXP041456	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM abscisic acid, 4 hours; dark	EXP041414	1351	normal	Q9FGJ3	3 day old seedlings	NULL
EXP041457	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM dexamethasone, 6 hours; dark	NULL	1343	chip_control	NULL	4 day old seedlings	NULL
EXP041458	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM dexamethasone, 6 hours; dark	EXP041457	1343	normal	Q9LZU9	4 day old seedlings	NULL
EXP041459	GFP (ThermoFisher #A11122)	Arabidopsis thaliana	10 uM dexamethasone, 6 hours; dark	EXP041457	1343	normal	Q9FK36	4 day old seedlings	NULL
EXP041460	input	Arabidopsis thaliana	Treatment: none	NULL	1372	chip_control	NULL	30 hrs old seedlings	NULL
EXP041461	N/A	Arabidopsis thaliana	Treatment: none	NULL	1372	chip_control	NULL	30 hrs old seedlings	NULL
EXP041462	anti-HA	Arabidopsis thaliana	Treatment: none	EXP041460	1372	normal	Q9LT47	30 hrs old seedlings	NULL
EXP041463	anti-Myc	Arabidopsis thaliana	Treatment: none	EXP041461	1372	normal	Q9SSW1	30 hrs old seedlings	NULL
EXP041464	anti-Myc	Arabidopsis thaliana	Treatment: none	EXP041461	1372	normal	Q9SKD0	30 hrs old seedlings	NULL
EXP041465		Arabidopsis thaliana	untreated	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041466		Arabidopsis thaliana	flg22-treated	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041467		Arabidopsis thaliana	untreated	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041468		Arabidopsis thaliana	flg22-treated	NULL	1363	chip_control	NULL	12 day old seedlings	NULL
EXP041469	anti-HA	Arabidopsis thaliana	untreated	EXP041465	1363	normal	Q8S8P5	12 day old seedlings	NULL
EXP041470	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041466	1363	normal	Q8S8P5	12 day old seedlings	NULL
EXP041471	anti-HA	Arabidopsis thaliana	untreated	EXP041465	1363	normal	Q9C5T4	12 day old seedlings	NULL
EXP041472	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041466	1363	normal	Q9C5T4	12 day old seedlings	NULL
EXP041473	anti-HA	Arabidopsis thaliana	untreated	EXP041465	1363	normal	Q9SAH7	12 day old seedlings	NULL
EXP041474	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041466	1363	normal	Q9SAH7	12 day old seedlings	NULL
EXP041475	anti-HA	Arabidopsis thaliana	untreated	EXP041467	1363	normal	Q8S8P5	12 day old seedlings	NULL
EXP041476	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041468	1363	normal	Q8S8P5	12 day old seedlings	NULL
EXP041477	anti-HA	Arabidopsis thaliana	untreated	EXP041467	1363	normal	Q9C5T4	12 day old seedlings	NULL
EXP041478	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041468	1363	normal	Q9C5T4	12 day old seedlings	NULL
EXP041479	anti-HA	Arabidopsis thaliana	untreated	EXP041467	1363	normal	Q9SAH7	12 day old seedlings	NULL
EXP041480	anti-HA	Arabidopsis thaliana	flg22-treated	EXP041468	1363	normal	Q9SAH7	12 day old seedlings	NULL
EXP041481	none (Input for BAF60 ChIP-seq)	Arabidopsis thaliana	Treatment: none	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041482	anti-GFP (Clontech 632592)	Arabidopsis thaliana	Treatment: none	EXP041481	1344	normal	Q9FMT4	14 day old seedling	NULL
EXP041483	anti-FLC	Arabidopsis thaliana	flc-3 FRI genotype	NULL	1373	chip_control	NULL	above-ground tissue	NULL
EXP041484	anti-FLC	Arabidopsis thaliana	Col FRI genotype	EXP041483	1373	normal	Q9S7Q7	above-ground tissue	NULL
EXP041485		Arabidopsis thaliana	treated at 42C for 1h	NULL	1374	chip_control	NULL	13 day old seedlings	NULL
EXP041486	anti-Myc	Arabidopsis thaliana	control	EXP041485	1374	normal	Q9SG86	13 day old seedlings	NULL
EXP041487	anti-Myc	Arabidopsis thaliana	treated at 42C for 1h	EXP041485	1374	normal	Q9SG86	13 day old seedlings	NULL
EXP041488	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana		NULL	1369	chip_control	NULL	inflorescence apices	NULL
EXP041489	anti-GFP ÂµMACS Microbeads (Milteyi Biotec)	Arabidopsis thaliana		EXP041488	1369	normal	Q9SLH3	inflorescence apices	NULL
EXP041490	IgG	Arabidopsis thaliana	none	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041491	IgG	Arabidopsis thaliana	none	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041492	none	Arabidopsis thaliana	ago1-36; untreated	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041493	none	Arabidopsis thaliana	BTH control; wt	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041494	none	Arabidopsis thaliana	BTH; wt	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041495	none	Arabidopsis thaliana	Cold control	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041496	none	Arabidopsis thaliana	Cold	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041497	none	Arabidopsis thaliana	Flg22 control	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041498	none	Arabidopsis thaliana	Flg22	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041499	none	Arabidopsis thaliana	IAA control	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041500	none	Arabidopsis thaliana	IAA	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041501	none	Arabidopsis thaliana	MeJA control	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041502	none	Arabidopsis thaliana	MeJA	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041503	none	Arabidopsis thaliana	none	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP041504	AGO1	Arabidopsis thaliana	none	EXP041490	1341	normal	O04379	10 day old seedlings	NULL
EXP041505	AGO1	Arabidopsis thaliana	Swi3b genotype	EXP041490	1341	normal	O04379	10 day old seedlings	NULL
EXP041506	AGO1	Arabidopsis thaliana	brm-4 genotype	EXP041490	1341	normal	O04379	10 day old seedlings	NULL
EXP041507	AGO1	Arabidopsis thaliana	ago1-36; untreated	EXP041492	1341	normal	O04379	10 day old seedlings	NULL
EXP041508	AGO1	Arabidopsis thaliana	BTH control; wt	EXP041493	1341	normal	O04379	10 day old seedlings	NULL
EXP041509	AGO1	Arabidopsis thaliana	BTH; wt	EXP041494	1341	normal	O04379	10 day old seedlings	NULL
EXP041510	AGO1	Arabidopsis thaliana	Cold control	EXP041495	1341	normal	O04379	10 day old seedlings	NULL
EXP041511	AGO1	Arabidopsis thaliana	Cold	EXP041496	1341	normal	O04379	10 day old seedlings	NULL
EXP041512	AGO1	Arabidopsis thaliana	Flg22 control	EXP041497	1341	normal	O04379	10 day old seedlings	NULL
EXP041513	AGO1	Arabidopsis thaliana	Flg22	EXP041498	1341	normal	O04379	10 day old seedlings	NULL
EXP041514	AGO1	Arabidopsis thaliana	IAA control	EXP041499	1341	normal	O04379	10 day old seedlings	NULL
EXP041515	AGO1	Arabidopsis thaliana	IAA	EXP041500	1341	normal	O04379	10 day old seedlings	NULL
EXP041516	AGO1	Arabidopsis thaliana	MeJA control	EXP041501	1341	normal	O04379	10 day old seedlings	NULL
EXP041517	AGO1	Arabidopsis thaliana	MeJA	EXP041502	1341	normal	O04379	10 day old seedlings	NULL
EXP041518	AGO1	Arabidopsis thaliana	none	EXP041503	1341	normal	O04379	10 day old seedlings	NULL
EXP041519	N/A	Arabidopsis thaliana		NULL	1372	chip_control	NULL	30 hrs old seedlings	NULL
EXP041520	anti-FIE	Arabidopsis thaliana		EXP041519	1372	normal	Q9LT47	30 hrs old seedlings	NULL
EXP041521	anti-FIE	Arabidopsis thaliana	pRNAi-BPC; pRNAi-ZnF	EXP041519	1372	normal	Q9LT47	30 hrs old seedlings	NULL
EXP041522	NA â€“ Input sample	Arabidopsis thaliana	treatment with a solution containing 10 Î¼M dexamethasone (Sigma-Aldrich), 0.01% (v/v) ethanol, and 0.015% (v/v) Silwet L-77 (De Sangosse).	NULL	1345	chip_control	NULL	inflorescence	NULL
EXP041523	Rabbit polyclonal whole serum raised against LFY	Arabidopsis thaliana	treatment with a solution containing 10 Î¼M dexamethasone (Sigma-Aldrich), 0.01% (v/v) ethanol, and 0.015% (v/v) Silwet L-77 (De Sangosse).	EXP041522	1345	normal	Q00958	inflorescence	NULL
EXP041524	input	Arabidopsis thaliana		NULL	1375	chip_control	NULL	3 week old seedlings	NULL
EXP041525	input	Arabidopsis thaliana		NULL	1375	chip_control	NULL	3 week old seedlings	NULL
EXP041526	Anti-myc antibody	Arabidopsis thaliana		EXP041524	1375	normal	Q5HZ36	3 week old seedlings	NULL
EXP041527	At4g26150	Arabidopsis thaliana		EXP041525	1375	normal	Q9SZI6	3 week old seedlings	NULL
EXP041528	none	Arabidopsis thaliana		NULL	1376	chip_control	NULL	bent cotyledon stage seeds	NULL
EXP041529	anti-GFP (Neuromab, catalog# 75-131, lot# 455-1JD-56)	Arabidopsis thaliana		EXP041528	1376	normal	Q9SFD8	bent cotyledon stage seeds	NULL
EXP041530	none	Arabidopsis thaliana	Treatment: none	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041531	none	Arabidopsis thaliana	Treatment: 30min of flg22	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041532	anti-GFP (abcam ab290)	Arabidopsis thaliana	Treatment: none	EXP041530	1344	normal	Q56WH4	14 day old seedling	NULL
EXP041533	HD2B	Arabidopsis thaliana	Treatment: 30min of flg22	EXP041531	1344	normal	Q56WH4	14 day old seedling	NULL
EXP041534	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041535	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041536	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041537	GFP (ab290, abcam)	Arabidopsis thaliana	brm-1; Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041538	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041539	GFP (ab290, abcam)	Arabidopsis thaliana	ref6-1; Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP041540	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041534	1344	normal	Q6EVK6	14 day old seedling	NULL
EXP041541	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041535	1344	normal	Q9STM3	14 day old seedling	NULL
EXP041542	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041538	1344	normal	Q6EVK6	14 day old seedling	NULL
EXP041543	GFP (ab290, abcam)	Arabidopsis thaliana	ref6-1; Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041539	1344	normal	Q6EVK6	14 day old seedling	NULL
EXP041544	GFP (ab290, abcam)	Arabidopsis thaliana	brm-1; Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041537	1344	normal	Q9STM3	14 day old seedling	NULL
EXP041545	GFP (ab290, abcam)	Arabidopsis thaliana	Plants were grown in 1/2MS media with 22 degree in 16h light/8h dark	EXP041536	1344	normal	Q9STM3	14 day old seedling	NULL
EXP041546	monoclonal anti-Myc antibody 9E10	Saccharomyces cerevisiae	W303-1A	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041547	monoclonal anti-Myc antibody 9E10	Saccharomyces cerevisiae	W303-1A TBF1-13xMyc::HIS3	EXP041546	1232	normal	Q02457	S. cerevisiae cells	NULL
EXP041548	none	Saccharomyces cerevisiae	Treatment: YMC OX phase cells; CEN.PK a SPT7-FLAG::Nat	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041549	none	Saccharomyces cerevisiae	Treatment: YMC RC phase cells; CEN.PK a SPT7-FLAG::Nat	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041550	Flag M2 [200472-21 (Agilent)]	Saccharomyces cerevisiae	Treatment: YMC OX phase cells; CEN.PK a SPT7-FLAG::Nat	EXP041548	1232	normal	P35177	S. cerevisiae cells	NULL
EXP041551	Flag M2 [200472-21 (Agilent)]	Saccharomyces cerevisiae	Treatment: YMC RC phase cells; CEN.PK a SPT7-FLAG::Nat	EXP041549	1232	normal	P35177	S. cerevisiae cells	NULL
EXP041552		Saccharomyces cerevisiae	NoPi, W303 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041553		Saccharomyces cerevisiae	HighPi; W303 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041554		Saccharomyces cerevisiae	NoPi, W303 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041555		Saccharomyces cerevisiae	HighPi; W303 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041556		Saccharomyces cerevisiae	NoPi, W303 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041557	Pho4	Saccharomyces cerevisiae	NoPi; W303 strain	EXP041552	1232	normal	P07270	S. cerevisiae cells	NULL
EXP041558	Pho4	Saccharomyces cerevisiae	HighPi; W303 strain	EXP041553	1232	normal	P07270	S. cerevisiae cells	NULL
EXP041559	Pho2	Saccharomyces cerevisiae	NoPi; W303 strain	EXP041554	1232	normal	P07269	S. cerevisiae cells	NULL
EXP041560	Pho2	Saccharomyces cerevisiae	HighPi; W303 strain	EXP041555	1232	normal	P07269	S. cerevisiae cells	NULL
EXP041561	Cbf1	Saccharomyces cerevisiae	NoPi; W303 strain	EXP041556	1232	normal	P17106	S. cerevisiae cells	NULL
EXP041562	Cbf1	Saccharomyces cerevisiae	HighPi; W303 strain	EXP041556	1232	normal	P17106	S. cerevisiae cells	NULL
EXP041563		Saccharomyces cerevisiae	dPHO80; W303 strain	NULL	1232	normal	A0A023IRJ6	S. cerevisiae cells	NULL
EXP041564		Saccharomyces cerevisiae	dPHO80; dCBF1; W303 strain	NULL	1232	normal	A0A023IRJ6	S. cerevisiae cells	NULL
EXP041565		Saccharomyces cerevisiae	dPHO2; W303 strain	EXP041552	1232	normal	A0A023IRJ6	S. cerevisiae cells	NULL
EXP041566	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041567	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Pgal1-Cse4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041568	anti-HA EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Pgal1-Cse4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041569	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Mif2-9xMyc-KanMX4	EXP041566	1232	normal	P35201	S. cerevisiae cells	NULL
EXP041570	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc10-9xMyc-KanMX4	EXP041566	1232	normal	P32504	S. cerevisiae cells	NULL
EXP041571	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc80-9xMyc-KanMX4	EXP041566	1232	normal	P40460	S. cerevisiae cells	NULL
EXP041572	anti-HA EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Pgal1-Cse4-3xHA-KanMX4 (internal tag)	EXP041568	1232	normal	P36012	S. cerevisiae cells	NULL
EXP041573	Mif2	Saccharomyces cerevisiae	W303 strain; Mif2-9xMyc-KanMX4 Pgal1-Cse4	EXP041567	1232	normal	P35201	S. cerevisiae cells	NULL
EXP041574	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc10-9xMyc-KanMX4 Pgal1-Cse4	EXP041567	1232	normal	P32504	S. cerevisiae cells	NULL
EXP041575	anti-Myc EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; Ndc80-9xMyc-KanMX4 Pgal1-Cse4	EXP041567	1232	normal	P40460	S. cerevisiae cells	NULL
EXP041576	anti-HA EZview affinity gel (Sigma)	Saccharomyces cerevisiae	W303 strain; scm3 deletion; Pgal1-Cse4-3xHA-KanMX4 (internal tag) scm3::HphMX4	EXP041568	1232	normal	P36012	S. cerevisiae cells	NULL
EXP041577	none	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041578	none	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041579	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	(mock-treated by addition of YEPD)	EXP041577	1232	normal	P32485	S. cerevisiae cells	NULL
EXP041580	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	YEPD + 0.4 M KCl for 5 minutes	EXP041578	1232	normal	P32485	S. cerevisiae cells	NULL
EXP041581	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	Dsko1Dhot1 (mock-treated by addition of YEPD)	EXP041577	1232	normal	P32485	S. cerevisiae cells	NULL
EXP041582	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	Dsko1Dhot1 (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	normal	P32485	S. cerevisiae cells	NULL
EXP041583	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	EXP041577	1232	normal	Q02100	S. cerevisiae cells	NULL
EXP041584	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	normal	Q02100	S. cerevisiae cells	NULL
EXP041585	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	EXP041577	1232	normal	Q03213	S. cerevisiae cells	NULL
EXP041586	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	normal	Q03213	S. cerevisiae cells	NULL
EXP041587	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (mock-treated by addition of YEPD)	EXP041577	1232	bio_control	A0A023PXA5	S. cerevisiae cells	NULL
EXP041588	12CA5 anti-HA (not from a commercial source)	Saccharomyces cerevisiae	wild type (YEPD + 0.4 M KCl for 5 minutes)	EXP041578	1232	bio_control	A0A023PXA5	S. cerevisiae cells	NULL
EXP041589	None	Saccharomyces cerevisiae	strain: CEN.PK a IFH1-FLAG::Nat	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041590	None	Saccharomyces cerevisiae	strain: CEN.PK a IFH1-FLAG::Nat	NULL	1380	chip_control	NULL	YMC RC phase S. cerevisiae cells	NULL
EXP041591	FLAG	Saccharomyces cerevisiae	strain: CEN.PK a IFH1-FLAG::Nat	EXP041589	1379	normal	P39520	YMC OX phase S. cerevisiae cells	NULL
EXP041592	FLAG	Saccharomyces cerevisiae	strain: CEN.PK a IFH1-FLAG::Nat	EXP041590	1380	normal	P39520	YMC RC phase S. cerevisiae cells	NULL
EXP041593	normal rabbit IgG	Saccharomyces cerevisiae	Cells were fixed with formaldehyde (final conc. 1%) for six hours and quenched with glycine (final conc. 0.125M) for 10 minutes; mid-log phase (OD 600=0.7) ASF1-18myc cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041594	anti-Myc tag antibody, clone A46	Saccharomyces cerevisiae	Cells were fixed with formaldehyde (final conc. 1%) for six hours and quenched with glycine (final conc. 0.125M) for 10 minutes; mid-log phase (OD 600=0.7) ASF1-18myc cells	EXP041593	1232	normal	P32447	S. cerevisiae cells	NULL
EXP041595	anti-HA 12CA5	Saccharomyces cerevisiae	background strain: BY4741; Hog1-6HA::HIS3;exposed to osmostress (0.4M NaCl) 	NULL	1232	normal	P32485	S. cerevisiae cells	NULL
EXP041596	anti-HA 12CA5	Saccharomyces cerevisiae	background strain: BY4741; Hog1-6HA::HIS3; not exposed to osmostress 	NULL	1232	normal	P32485	S. cerevisiae cells	NULL
EXP041597		Saccharomyces cerevisiae	strain: ML1; none	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041598	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Sir2	EXP041597	1232	normal	P06700	S. cerevisiae cells	NULL
EXP041599	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Sum1	EXP041597	1232	normal	P46676	S. cerevisiae cells	NULL
EXP041600	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst1	EXP041597	1232	normal	P53685	S. cerevisiae cells	NULL
EXP041601	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst2	EXP041597	1232	normal	P53686	S. cerevisiae cells	NULL
EXP041602	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst3	EXP041597	1232	normal	P53687	S. cerevisiae cells	NULL
EXP041603	Anti-myc (9E10)	Saccharomyces cerevisiae	strain: ML1; Myc tagged Hst4	EXP041597	1232	normal	P53688	S. cerevisiae cells	NULL
EXP041604	input DNA	Saccharomyces cerevisiae	GAL-Scc1-HA, + broken cells (beadbeater and sonication), WT; c. cycle: G2 (benomyl)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041605	input DNA	Saccharomyces cerevisiae	GAL-Scc1-HA, - broken cells (beadbeater and sonication), WT; c. cycle: G2 (benomyl) 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041606	input DNA	Saccharomyces cerevisiae	GAL-Scc1-HA, + broken cells (beadbeater and sonication), Rad30 deletion; c. cycle: G2 (benomyl) 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041607	input DNA	Saccharomyces cerevisiae	GAL-Scc1-HA, - broken cells (beadbeater and sonication), Rad30 deletion; c. cycle: G2 (benomyl) 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041608	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, + broken cells (beadbeater and sonication), WT; c. cycle: G2 (benomyl) 	EXP041604	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041609	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, - broken cells (beadbeater and sonication), WT; c. cycle: G2 (benomyl) 	EXP041605	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041610	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, + broken cells (beadbeater and sonication), Rad30 deletion; c. cycle: G2 (benomyl) 	EXP041606	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041611	HA11	Saccharomyces cerevisiae	GAL-Scc1-HA, - broken cells (beadbeater and sonication), Rad30 deletion; c. cycle: G2 (benomyl) 	EXP041607	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041612	no antibody	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; Snt2-13Myc strain;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041613	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; Snt2-13Myc strain;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041614	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; Snt2-13Myc strain;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041615	no antibody	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; Ecm5-13Myc strain;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041616	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; Ecm5-13Myc strain;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041617	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; Ecm5-13Myc strain;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041618	no antibody	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041619	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041620	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041621	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; Snt2-13Myc strain;	EXP041612	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041622	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; Snt2-13Myc strain;	EXP041613	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041623	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; Snt2-13Myc strain;	EXP041614	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041624	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; Ecm5-13Myc strain;	EXP041615	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041625	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; Ecm5-13Myc strain;	EXP041616	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041626	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; Ecm5-13Myc strain;	EXP041617	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041627	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	EXP041618	1232	bio_control	P53127	S. cerevisiae cells	NULL
EXP041628	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	EXP041619	1232	bio_control	P53127	S. cerevisiae cells	NULL
EXP041629	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with H2O2; untagged strain BY4741 (negative control for SNT2 and ECM5)	EXP041620	1232	bio_control	P53127	S. cerevisiae cells	NULL
EXP041630	no antibody	Saccharomyces cerevisiae	untreated (0 hour time-point); Snt2-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041631	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Snt2-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041632	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; Snt2-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041633	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Snt2-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041634	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; Snt2-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041635	no antibody	Saccharomyces cerevisiae	untreated (0 hour time-point); Ecm5-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041636	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Ecm5-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041637	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; Ecm5-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041638	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Ecm5-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041639	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; Ecm5-13Myc strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041640	no antibody	Saccharomyces cerevisiae	untreated (0 hour time-point); untagged strain (BY4741)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041641	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; untagged strain (BY4741)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041642	no antibody	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; untagged strain (BY4741)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041643	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with DMSO; untagged strain (BY4741)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041644	no antibody	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; untagged strain (BY4741)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041645	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	untreated (0 hour time-point); Snt2-13Myc strain	EXP041630	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041646	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Snt2-13Myc strain	EXP041631	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041647	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; Snt2-13Myc strain	EXP041632	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041648	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Snt2-13Myc strain	EXP041633	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041649	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; Snt2-13Myc strain	EXP041634	1232	normal	P53127	S. cerevisiae cells	NULL
EXP041650	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	untreated (0 hour time-point); Ecm5-13Myc strain	EXP041635	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041651	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Ecm5-13Myc strain	EXP041636	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041652	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; Ecm5-13Myc strain	EXP041637	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041653	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; Ecm5-13Myc strain	EXP041638	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041654	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; Ecm5-13Myc strain	EXP041639	1232	normal	Q03214	S. cerevisiae cells	NULL
EXP041655	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	untreated (0 hour time-point); untagged strain (BY4741)	EXP041640	1232	bio_control	Q03214	S. cerevisiae cells	NULL
EXP041656	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with DMSO; untagged strain (BY4741)	EXP041641	1232	bio_control	Q03214	S. cerevisiae cells	NULL
EXP041657	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	0.5 hrs after treatment with Rapamycin; untagged strain (BY4741)	EXP041642	1232	bio_control	Q03214	S. cerevisiae cells	NULL
EXP041658	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with DMSO; untagged strain (BY4741)	EXP041643	1232	bio_control	Q03214	S. cerevisiae cells	NULL
EXP041659	anti-Myc (9E10 monoclonal)	Saccharomyces cerevisiae	4 hrs after treatment with Rapamycin; untagged strain (BY4741)	EXP041644	1232	bio_control	Q03214	S. cerevisiae cells	NULL
EXP041660		Saccharomyces cerevisiae	Treatment: CY1838 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041661	Arp5 antibody from Abcam (ab12099).	Saccharomyces cerevisiae	Treatment: CY1838 strain	EXP041660	1232	normal	P53946	S. cerevisiae cells	NULL
EXP041662	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t1	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041663	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t2	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041664	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t3	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041665	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t4	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041666	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t5	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041667	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t6	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041668	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t7	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041669	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t8	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041670	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t9	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041671	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t10	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041672	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t11	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041673	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t12	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041674	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t13	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041675	FLAG M2 [F1804 (Sigma)]	Saccharomyces cerevisiae	t14	NULL	1381	normal	Q03330	YMC cycling cells	NULL
EXP041676	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t1	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041677	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t2	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041678	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t3	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041679	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t4	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041680	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t5	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041681	Set1	Saccharomyces cerevisiae	t6	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041682	Set1	Saccharomyces cerevisiae	t7	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041683	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t8	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041684	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t9	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041685	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t10	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041686	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t11	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041687	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t12	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041688	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t13	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041689	HA 12CA5 [11583816001 (Roche)]	Saccharomyces cerevisiae	t14	NULL	1381	normal	P38827	YMC cycling cells	NULL
EXP041690	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t1	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041691	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t2	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041692	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t3	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041693	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t4	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041694	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t5	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041695	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t6	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041696	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t7	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041697	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t8	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041698	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t9	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041699	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t10	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041700	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t11	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041701	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t12	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041702	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t13	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041703	Esa1 [ab4466 (Abcam)]	Saccharomyces cerevisiae	t14	NULL	1381	normal	Q08649	YMC cycling cells	NULL
EXP041704	none	Saccharomyces cerevisiae	G1 phase	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041705	none	Saccharomyces cerevisiae	G1 phase	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041706	none	Saccharomyces cerevisiae	S phase	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041707	none	Saccharomyces cerevisiae	S phase	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041708	none	Saccharomyces cerevisiae	S phase	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041709	none	Saccharomyces cerevisiae	S phase	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041710	none	Saccharomyces cerevisiae	S phase	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041711	none	Saccharomyces cerevisiae	S phase	NULL	1379	chip_control	NULL	YMC OX phase S. cerevisiae cells	NULL
EXP041712	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	G1 phase	EXP041704	1232	normal	P30665	S. cerevisiae cells	NULL
EXP041713	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	G1 phase	EXP041705	1232	normal	P53091	S. cerevisiae cells	NULL
EXP041714	Anti-HA (abcam,ab16918)	Saccharomyces cerevisiae	S phase	EXP041706	1379	normal	Q08032	YMC OX phase S. cerevisiae cells	NULL
EXP041715	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase	NULL	1379	normal	P30665	YMC OX phase S. cerevisiae cells	NULL
EXP041716	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase	EXP041708	1379	normal	P53091	YMC OX phase S. cerevisiae cells	NULL
EXP041717	Anti-HA (abcam,ab16918)	Saccharomyces cerevisiae	S phase	EXP041709	1379	normal	P32354	YMC OX phase S. cerevisiae cells	NULL
EXP041718	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase; 72 min	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	NULL
EXP041719	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase; 84 min	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	NULL
EXP041720	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase; 96 min	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	NULL
EXP041721	PCNA (804)	Saccharomyces cerevisiae	S phase	EXP041711	1379	normal	P15873	YMC OX phase S. cerevisiae cells	NULL
EXP041722	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	S phase	EXP041710	1379	normal	P38630	YMC OX phase S. cerevisiae cells	NULL
EXP041723		Saccharomyces cerevisiae	3h after transfer to sporulation medium (SPM)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041724		Saccharomyces cerevisiae	4h after transfer to sporulation medium (SPM)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041725		Saccharomyces cerevisiae	5h after transfer to sporulation medium (SPM)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041726		Saccharomyces cerevisiae	0h after transfer to sporulation medium (SPM)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041727	anti-FLAG	Saccharomyces cerevisiae	YSD3 strain; 4h after transfer to sporulation medium (SPM)	EXP041724	1232	normal	Q12188	S. cerevisiae cells	NULL
EXP041728	anti-Rec8	Saccharomyces cerevisiae	GAL4BD-SPO11; YSD7 strain; 4h after transfer to sporulation medium (SPM)	EXP041724	1232	normal	Q12188	S. cerevisiae cells	NULL
EXP041729	anti-FLAG	Saccharomyces cerevisiae	RKD1311 strain; 3h after transfer to sporulation medium (SPM)	EXP041723	1232	normal	P23179	S. cerevisiae cells	NULL
EXP041730	anti-FLAG	Saccharomyces cerevisiae	RKD1311 strain; 4h after transfer to sporulation medium (SPM)	EXP041724	1232	normal	P23179	S. cerevisiae cells	NULL
EXP041731	anti-FLAG	Saccharomyces cerevisiae	RKD1311 strain; 5h after transfer to sporulation medium (SPM)	EXP041725	1232	normal	P23179	S. cerevisiae cells	NULL
EXP041732		Saccharomyces cerevisiae	GAL4BD-SPO11; YMD97 strain; 0h after transfer to sporulation medium (SPM)	EXP041726	1232	normal	A0A023IRJ6	S. cerevisiae cells	NULL
EXP041733	input DNA	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; DMSO; temperature: 30 C	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041734	IgG	Saccharomyces cerevisiae	BY4741; DMSO; temperature: 30 C	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041735	IgG	Saccharomyces cerevisiae	BY4741; none; temperature: 30 C	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041736	IgG	Saccharomyces cerevisiae	BY4741; none; temperature: 39 C	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041737	IgG	Saccharomyces cerevisiae	BY4741; DMSO; temperature: 30 C	EXP041733	1232	bio_control	A0A023PXA5	S. cerevisiae cells	NULL
EXP041738	IgG	Saccharomyces cerevisiae	MNN10 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041734	1232	normal	P50108	S. cerevisiae cells	NULL
EXP041739	IgG	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041733	1232	normal	P09959	S. cerevisiae cells	NULL
EXP041740	IgG	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; none; temperature: 30 C	EXP041735	1232	normal	P09959	S. cerevisiae cells	NULL
EXP041741	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041734	1232	normal	P16649	S. cerevisiae cells	NULL
EXP041742	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041733	1232	normal	P16649	S. cerevisiae cells	NULL
EXP041743	IgG	Saccharomyces cerevisiae	SWI6 TAP-tagged yeast cells; none; temperature: 39 C	EXP041736	1232	normal	P09959	S. cerevisiae cells	NULL
EXP041744	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; rapamycin; temperature: 30 C	EXP041734	1232	normal	P16649	S. cerevisiae cells	NULL
EXP041745	IgG	Saccharomyces cerevisiae	TUP1 TAP-tagged yeast cells; rapamycin; temperature: 30 C	EXP041733	1232	normal	P16649	S. cerevisiae cells	NULL
EXP041746	IgG	Saccharomyces cerevisiae	HSF1 TAP-tagged yeast cells; none; temperature: 30 C	EXP041735	1232	normal	P10961	S. cerevisiae cells	NULL
EXP041747	IgG	Saccharomyces cerevisiae	HSF1 TAP-tagged yeast cells; none; temperature: 39 C	EXP041736	1232	normal	P10961	S. cerevisiae cells	NULL
EXP041748	IgG	Saccharomyces cerevisiae	RSC2 TAP-tagged yeast cells; DMSO; temperature: 30 C	EXP041733	1232	normal	Q06488	S. cerevisiae cells	NULL
EXP041749	IgG	Saccharomyces cerevisiae	RSC2 TAP-tagged yeast cells; rapamycin; temperature: 30 C	EXP041733	1232	normal	Q06488	S. cerevisiae cells	NULL
EXP041750	none	Saccharomyces cerevisiae	strain: W303	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041751	Monoclonal ANTI-Flag M2 antibody (Sigma, catalog# F3165, lot# 103K6043)	Saccharomyces cerevisiae	strain: W303	EXP041750	1232	normal	P47156	S. cerevisiae cells	NULL
EXP041752	none	Saccharomyces cerevisiae	Strain: W303 (C3632); Wild type; Brn1-PK6	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041753	none	Saccharomyces cerevisiae	Strain: W303 (C3857); Condensin mutant; Brn1 M1 M2 M4-PK6 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041754	anti-V5 tag antibody (AbD Serotec, mouse IgG2a, MCA 1360, batch 1009A)	Saccharomyces cerevisiae	Strain: W303 (C3857); Condensin mutant; Brn1 (M1 M2 M4)-PK6 mutant	EXP041753	1232	normal	P38170	S. cerevisiae cells	NULL
EXP041755	anti-V5 tag antibody (AbD Serotec, mouse IgG2a, MCA 1360, batch 1009A)	Saccharomyces cerevisiae	Strain: W303 (C3632); Wild type; Brn1-PK6	EXP041752	1232	normal	P38170	S. cerevisiae cells	NULL
EXP041756	scc2	Saccharomyces cerevisiae	strain: Y2422; MATa, Scc2-Pk9::TRP1	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041757	PK, clone SV5-Pk1 Serotec MCA1360 #0407	Saccharomyces cerevisiae	strain: Y2422; MATa, Scc2-Pk9::TRP1	NULL	1232	normal	Q04002	S. cerevisiae cells	NULL
EXP041758	PK, clone SV5-Pk1 Serotec MCA1360 #0407	Saccharomyces cerevisiae	strain: Y4373; MATa, Scc4-Pk9::TRP1	NULL	1232	normal	P40090	S. cerevisiae cells	NULL
EXP041759	PK, clone SV5-Pk1 Serotec MCA1360 #0407	Saccharomyces cerevisiae	strain: Y4262; MATa, Sth1-Pk9::TRP1	NULL	1232	normal	P32597	S. cerevisiae cells	NULL
EXP041760	Santa Cruz Biotechnology (sc-33626)	Saccharomyces cerevisiae	4hrs sporulation yeast; wild type	NULL	1220	chip_control	NULL	SK1	NULL
EXP041761	Santa Cruz Biotechnology (sc-33626)	Saccharomyces cerevisiae	4hrs sporulation yeast; H4K44->R mutant yeast	NULL	1220	chip_control	NULL	SK1	NULL
EXP041762	Santa Cruz Biotechnology (sc-33626)	Saccharomyces cerevisiae	4hrs sporulation yeast; H4K44->R mutant yeast	EXP041761	1220	normal	P25454	SK1	NULL
EXP041763	Santa Cruz Biotechnology (sc-33626)	Saccharomyces cerevisiae	4hrs sporulation yeast; wild type	EXP041760	1220	normal	P25454	SK1	NULL
EXP041764		Saccharomyces cerevisiae	W303 (wt); MATalpha ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ HTZ1-2L-3FLAG:KanMX	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041765		Saccharomyces cerevisiae	W303 (wt); MATalpha ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ HTZ1-2L-3FLAG:KanMX	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041766		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ INO80-3FLAG-kanMX4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041767		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ STH1-3FLAG-kanMX4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041768		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ SWR1-3FLAG-kanMX4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041769		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ INO80-3FLAG-kanMX4	EXP041766	1232	normal	P53115	S. cerevisiae cells	NULL
EXP041770		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ STH1-3FLAG-kanMX4	EXP041767	1232	normal	P32597	S. cerevisiae cells	NULL
EXP041771		Saccharomyces cerevisiae	W303 (wt); MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ SWR1-3FLAG-kanMX4	EXP041768	1232	normal	Q05471	S. cerevisiae cells	NULL
EXP041772		Saccharomyces cerevisiae	W303 (wt); MATalpha ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ HTZ1-2L-3FLAG:KanMX	EXP041764	1232	normal	Q12692	S. cerevisiae cells	NULL
EXP041773		Saccharomyces cerevisiae	W303 (wt); MATalpha ade2-1 can1-100 his3-11, 15 leu2-3, 112 trp1-1 ura3-1 RAD5+ HTZ1-2L-3FLAG:KanMX	EXP041765	1232	normal	Q12692	S. cerevisiae cells	NULL
EXP041774	none	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041775	none	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041776	none	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041777	none	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041778	none	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041779	none	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041780	none	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041781	none	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041782	none	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041783	none	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041784	none	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041785	none	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041786	none	Saccharomyces cerevisiae	W303 (Z1256); NRG1-myc; SUT1-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041787	none	Saccharomyces cerevisiae	W303 (Z1256); NRG1-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041788	none	Saccharomyces cerevisiae	W303 (Z1256); SUT1-myc; NRG1-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041789	sut1	Saccharomyces cerevisiae	W303 (Z1256); SUT1-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041790	none	Saccharomyces cerevisiae	W303 (Z1256); SWI4-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041791	none	Saccharomyces cerevisiae	W303 (Z1256); SWI4-myc; SWI6-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041792	none	Saccharomyces cerevisiae	W303 (Z1256); SWI6-myc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041793	none	Saccharomyces cerevisiae	W303 (Z1256); SWI6-myc; SWI4-knockout (co-factor)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041794	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	EXP041774	1232	normal	P03069	S. cerevisiae cells	NULL
EXP041795	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	EXP041775	1232	normal	P03069	S. cerevisiae cells	NULL
EXP041796	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc	EXP041776	1232	normal	P03069	S. cerevisiae cells	NULL
EXP041797	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	EXP041777	1232	normal	P38165	S. cerevisiae cells	NULL
EXP041798	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	EXP041778	1232	normal	P38165	S. cerevisiae cells	NULL
EXP041799	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc	EXP041779	1232	normal	P38165	S. cerevisiae cells	NULL
EXP041800	gcn4	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	EXP041780	1232	normal	P03069	S. cerevisiae cells	NULL
EXP041801	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	EXP041781	1232	normal	P03069	S. cerevisiae cells	NULL
EXP041802	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); GCN4-myc; RTG3-knockout (co-factor)	EXP041782	1232	normal	P03069	S. cerevisiae cells	NULL
EXP041803	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	EXP041783	1232	normal	P38165	S. cerevisiae cells	NULL
EXP041804	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	EXP041784	1232	normal	P38165	S. cerevisiae cells	NULL
EXP041805	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); RTG3-myc; GCN4-knockout (co-factor)	EXP041785	1232	normal	P38165	S. cerevisiae cells	NULL
EXP041806	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI4-myc	EXP041790	1232	normal	P25302	S. cerevisiae cells	NULL
EXP041807	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI4-myc; SWI6-knockout (co-factor)	EXP041791	1232	normal	P25302	S. cerevisiae cells	NULL
EXP041808	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); NRG1-myc; SUT1-knockout (co-factor)	EXP041786	1232	normal	Q03125	S. cerevisiae cells	NULL
EXP041809	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); NRG1-myc	EXP041787	1232	normal	Q03125	S. cerevisiae cells	NULL
EXP041810	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SUT1-myc; NRG1-knockout (co-factor)	EXP041788	1232	normal	P53032	S. cerevisiae cells	NULL
EXP041811	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SUT1-myc	EXP041789	1232	normal	P53032	S. cerevisiae cells	NULL
EXP041812	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI6-myc	EXP041792	1232	normal	P09959	S. cerevisiae cells	NULL
EXP041813	anti-Myc EZiew affinity gel; Sigma E6779	Saccharomyces cerevisiae	W303 (Z1256); SWI6-myc; SWI4-knockout (co-factor)	EXP041793	1232	normal	P09959	S. cerevisiae cells	NULL
EXP041814	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041815	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041816	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041817	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041818	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041819	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041820	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041821	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041822	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041823	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041824	INPUT	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041825	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041826	INPUT	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041827	INPUT	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041828	INPUT	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041829	INPUT	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041830	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041831	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; unstressed	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041832	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041833	INPUT	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041834	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	EXP041814	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041835	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	EXP041815	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041836	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041816	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041837	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041817	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041838	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	EXP041818	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041839	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	EXP041819	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041840	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041820	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041841	Snf2 C' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041821	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041842	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Wild Type; unstressed	EXP041822	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041843	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Wild Type; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041823	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041844	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; unstressed	EXP041824	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041845	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041825	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041846	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; unstressed	EXP041826	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041847	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; unstressed	EXP041827	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041848	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041828	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041849	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041829	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041850	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; unstressed	EXP041830	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041851	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; unstressed	EXP041831	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041852	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041832	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041853	Snf2 N' Ab	Saccharomyces cerevisiae	genotype: Snf2 K1493R K1497R delta bromo; stressed (cells grown in YPD were shifted to YNB + 0.5% dextrose)	EXP041833	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041854	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041855	Custom rabbit polyclonal anti-Rap1	Saccharomyces cerevisiae		EXP041854	1232	normal	P11938	S. cerevisiae cells	NULL
EXP041856	Custom mouse monoclonal anti-myc	Saccharomyces cerevisiae	myc-tagged Fhl1	EXP041854	1232	normal	P39521	S. cerevisiae cells	NULL
EXP041857	Anti-Flag from Sigma (#F1804)	Saccharomyces cerevisiae	Flag-tagged Fhl1	EXP041854	1232	normal	P39521	S. cerevisiae cells	NULL
EXP041858	Custom mouse monoclonal anti-myc	Saccharomyces cerevisiae	myc-tagged Fhl1 with deletion of forkhead domain (Fhl1-?FH-Myc)	EXP041854	1232	normal	P39521	S. cerevisiae cells	NULL
EXP041859	Anti-Flag from Sigma (#F1804)	Saccharomyces cerevisiae	Flag-tagged Fhl1 with deletion of forkhead domain (Fhl1-?FH-Flag)	EXP041854	1232	normal	P39521	S. cerevisiae cells	NULL
EXP041860	Anti-Flag from Sigma (#F1804)	Saccharomyces cerevisiae		EXP041854	1232	normal	Q03973	S. cerevisiae cells	NULL
EXP041861	Custom mouse monoclonal anti-myc	Saccharomyces cerevisiae		EXP041854	1232	normal	P39520	S. cerevisiae cells	NULL
EXP041862	none	Saccharomyces cerevisiae		NULL	1232	bio_control	A0A023PXA5	S. cerevisiae cells	NULL
EXP041863		Saccharomyces cerevisiae	wild type (W303; LS142); no break Chr. VI	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041864		Saccharomyces cerevisiae	wild type (W303; LS143); break Chr. VI	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041865		Saccharomyces cerevisiae	Scc2-4 mutant (W303; LS147); no break Chr. VI	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041866		Saccharomyces cerevisiae	Scc2-4 mutant (W303; LS147); break Chr. VI	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041867	anti-flag Sigma F3165	Saccharomyces cerevisiae	wild type (W303; LS142); no break Chr. VI	EXP041863	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041868	anti-flag Sigma F3165	Saccharomyces cerevisiae	wild type (W303; LS143); break Chr. VI	EXP041864	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041869	anti-flag Sigma F3165	Saccharomyces cerevisiae	Scc2-4 mutant (W303; LS147); no break Chr. VI	EXP041865	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041870	anti-flag Sigma F3165	Saccharomyces cerevisiae	Scc2-4 mutant (W303; LS147); break Chr. VI	EXP041866	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041871		Saccharomyces cerevisiae	strain: YBC2882; genotype: Rsc8-9xMyc	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041872		Saccharomyces cerevisiae	strain: YBC601 p3018; genotype: Sth1-2xFlag	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041873		Saccharomyces cerevisiae	strain: YBC2883 YBC3010	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041874	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC2882; genotype: Rsc8-9xMyc	EXP041871	1232	normal	P43609	S. cerevisiae cells	NULL
EXP041875	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC601 p3018; genotype: Sth1-2xFlag	EXP041872	1232	normal	P32597	S. cerevisiae cells	NULL
EXP041876	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC2883; genotype: Ioc3-13xMyc	EXP041873	1232	normal	P43596	S. cerevisiae cells	NULL
EXP041877	Anti-c-Myc antibody [9E11] Abcam ab56	Saccharomyces cerevisiae	strain: YBC3010; genotype: Snf2-13xMyc	EXP041873	1232	normal	P22082	S. cerevisiae cells	NULL
EXP041888	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); quiescent cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041887	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041886	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); diauxic shift cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041885	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); thiolutin-treated log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041884	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); rapamycin-treated log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041883	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); quiescent cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041882	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041881	TAP	Saccharomyces cerevisiae	strain: w3031a; YPD G1 phase	EXP041879	1232	bio_control	P32558	S. cerevisiae cells	NULL
EXP041880	TAP	Saccharomyces cerevisiae	YPD G1 phase; Spt16 TAP tagged	EXP041878	1232	normal	P32558	S. cerevisiae cells	NULL
EXP041879	none	Saccharomyces cerevisiae	strain: w3031a; YPD G1 phase	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041878	none	Saccharomyces cerevisiae	YPD G1 phase; Spt16 TAP tagged	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041889	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); rapamycin-treated log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041890	none	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); thiolutin-treated log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041891	none	Saccharomyces cerevisiae	Treatment: strain: W303; log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041892	none	Saccharomyces cerevisiae	Treatment: strain: W303; diauxic shift cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041893	none	Saccharomyces cerevisiae	Treatment: strain: W303; quiescent cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041894	none	Saccharomyces cerevisiae	Treatment: strain: W303; log cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041895	none	Saccharomyces cerevisiae	Treatment: strain: W303; diauxic shift cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041896	none	Saccharomyces cerevisiae	Treatment: strain: W303; quiescent cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041897	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); log cells	EXP041882	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041898	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); quiescent cells	EXP041883	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041899	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); rapamycin-treated log cells	EXP041884	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041900	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); thiolutin-treated log cells	EXP041885	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041901	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); diauxic shift cells	EXP041886	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041902	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); log cells	EXP041887	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041903	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); quiescent cells	EXP041888	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041904	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); rapamycin-treated log cells	EXP041889	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041905	c-Myc Covance AFC-150P 9E10 Ascites	Saccharomyces cerevisiae	Treatment: strain: W303 (Rpd3-Myc); thiolutin-treated log cells	EXP041890	1232	normal	P32561	S. cerevisiae cells	NULL
EXP041906	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; log cells	EXP041891	1232	normal	P29055	S. cerevisiae cells	NULL
EXP041907	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; diauxic shift cells	EXP041892	1232	normal	P29055	S. cerevisiae cells	NULL
EXP041908	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; quiescent cells	EXP041893	1232	normal	P29055	S. cerevisiae cells	NULL
EXP041909	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; log cells	EXP041894	1232	normal	P29055	S. cerevisiae cells	NULL
EXP041910	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; diauxic shift cells	EXP041895	1232	normal	P29055	S. cerevisiae cells	NULL
EXP041911	TFIIB Steve Hahn Lab 3655-G	Saccharomyces cerevisiae	Treatment: strain: W303; quiescent cells	EXP041896	1232	normal	P29055	S. cerevisiae cells	NULL
EXP041912	anti-Myc antibody (9E10) [made in-house at MSKCC]	Saccharomyces cerevisiae	Bas1-Myc	NULL	1219	chip_control	NULL	SK1 meiotic cells (4 hours)	NULL
EXP041913	anti-Myc antibody (9E10) [made in-house at MSKCC]	Saccharomyces cerevisiae	Ino4-Myc	NULL	1219	chip_control	NULL	SK1 meiotic cells (4 hours)	NULL
EXP041914	anti-Myc antibody (9E10) [made in-house at MSKCC]	Saccharomyces cerevisiae	Bas1-Myc	EXP041912	1219	normal	P22035	SK1 meiotic cells (4 hours)	NULL
EXP041915	anti-Myc antibody (9E10) [made in-house at MSKCC]	Saccharomyces cerevisiae	Ino4-Myc	EXP041913	1219	normal	P13902	SK1 meiotic cells (4 hours)	NULL
EXP041916	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	wild type; strain: AM1145 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041917	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	ssc4-m35::HIS3 mutant; strain: AM15537 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041918	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	wild type (scc4::HIS3); strain: AM15540 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041919	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	wild type; strain: AM1145 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	EXP041916	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041920	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	ssc4-m35::HIS3 mutant; strain: AM15537 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	EXP041917	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041921	Anti-HA (12CA5) (Roche)	Saccharomyces cerevisiae	wild type (scc4::HIS3); strain: AM15540 (Scc1-6xHA); 2hrs with nocodazole (15 Î¼g/ml) and benomyl (30 Î¼g/ml)	EXP041918	1232	normal	P13586	S. cerevisiae cells	NULL
EXP041922	None	Saccharomyces cerevisiae	wild type	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041923	None	Saccharomyces cerevisiae	wild type	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041924	None	Saccharomyces cerevisiae	wild type	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041925	None	Saccharomyces cerevisiae	genotype: Rec8::3HA	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041926	None	Saccharomyces cerevisiae	genotype: Rec8::3HA	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041927	None	Saccharomyces cerevisiae	genotype: Smc3::3HA	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041928	None	Saccharomyces cerevisiae	genotype: rec8 delta (mutant)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041929	None	Saccharomyces cerevisiae	genotype: rec8 delta (mutant)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041930	None	Saccharomyces cerevisiae	genotype: pREC8-SCC1::3HA, rec8 delta (mutant)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041931	None	Saccharomyces cerevisiae	genotype: pREC8-SCC1::3HA, rec8 delta (mutant)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP041932	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	wild type	EXP041922	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP041933	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	wild type	EXP041923	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP041934	Anti-Hop1 (N. Hollingsworth)	Saccharomyces cerevisiae	wild type	EXP041924	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP041935	Anti-3HA (Cat#: 11867431001, Roche Applied Science)	Saccharomyces cerevisiae	genotype: Rec8::3HA	EXP041925	1382	normal	Q12188	SK1 meiotic cells (3 hours)	NULL
EXP041936	Anti-3HA (Cat#: 11867431001, Roche Applied Science)	Saccharomyces cerevisiae	genotype: Rec8::3HA	EXP041926	1382	normal	Q12188	SK1 meiotic cells (3 hours)	NULL
EXP041937	Anti-3HA (Cat#: 11867431001, Roche Applied Science)	Saccharomyces cerevisiae	genotype: Smc3::3HA	EXP041927	1382	normal	P47037	SK1 meiotic cells (3 hours)	NULL
EXP041938	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: rec8 delta (mutant)	EXP041928	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP041939	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: rec8 delta (mutant)	EXP041929	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP041940	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: pREC8-SCC1::3HA, rec8 delta (mutant)	EXP041930	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP041941	Anti-Red1 (S. Roeder)	Saccharomyces cerevisiae	genotype: pREC8-SCC1::3HA, rec8 delta (mutant)	EXP041931	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP041942	none, input	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP041943	none, input	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP041944	none, input	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP041945	Anti-Zip1	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	EXP041942	1383	normal	P31111	SK1 diploid cells	NULL
EXP041946	Anti-Zip1	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	EXP041943	1383	normal	P31111	SK1 diploid cells	NULL
EXP041947	Anti-Zip1	Saccharomyces cerevisiae	genotype: ndt80-delta to arrest cells in prophase (Cells harvested after 5 hours in SPO)	EXP041944	1383	normal	P31111	SK1 diploid cells	NULL
EXP041948	none, input	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP041949	none, input	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP041950	none, input	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP041951	Anti-HA	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	EXP041948	1383	normal	Q12188	SK1 diploid cells	NULL
EXP041952	Anti-HA	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	EXP041949	1383	normal	Q12188	SK1 diploid cells	NULL
EXP041953	Anti-HA	Saccharomyces cerevisiae	genotype: ndt80-delta (Cells harvested after 5 hours in SPO)	EXP041950	1383	normal	Q12188	SK1 diploid cells	NULL
EXP041954	Anti-FLAG M2  (F1804,Sigma)	Saccharomyces cerevisiae	genotype: wild type (scc4::HIS3); S-phase cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041955	Anti-FLAG M2  (F1804,Sigma)	Saccharomyces cerevisiae	genotype: ssc4-m35::HIS3; S-phase cells	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041956	Anti-FLAG M2  (F1804,Sigma)	Saccharomyces cerevisiae	genotype: wild type (scc4::HIS3); S-phase cells	EXP041954	1232	normal	Q04002	S. cerevisiae cells	NULL
EXP041957	Anti-FLAG M2  (F1804,Sigma)	Saccharomyces cerevisiae	genotype: ssc4-m35::HIS3; S-phase cells	EXP041955	1232	normal	Q04002	S. cerevisiae cells	NULL
EXP041958	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	Fresh SC medium for 5 minutes; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	NULL
EXP041959	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	Fresh SC medium with 1M Sorbitol for 5 minutes; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	NULL
EXP041960	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	none; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	NULL
EXP041961	anti-HA 12CA5 (Roche) 	Saccharomyces cerevisiae	10nM alphaF for 30 minutes; strain: yAS420; genotype: SUB1-3HAtag::kanMX bar1::pFUS1-GFP-LEU2	NULL	1232	normal	P54000	S. cerevisiae cells	NULL
EXP041962	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 1; strain: BY5764: CEN.PK MATa	NULL	1379	normal	P33748	YMC OX phase S. cerevisiae cells	NULL
EXP041963	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 2; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33748	YMC RB phase S. cerevisiae cells	NULL
EXP041964	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 3; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33748	YMC RB phase S. cerevisiae cells	NULL
EXP041965	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 4; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33748	YMC RC phase S. cerevisiae cells	NULL
EXP041966	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 5; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33748	YMC RC phase S. cerevisiae cells	NULL
EXP041967	Msn2(y-300) [Santa Cruz, sc-33631]	Saccharomyces cerevisiae	time point 6; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33748	YMC RC phase S. cerevisiae cells	NULL
EXP041968	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 1; strain: BY5764: CEN.PK MATa	NULL	1379	normal	P33749	YMC OX phase S. cerevisiae cells	NULL
EXP041969	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 2; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33749	YMC RB phase S. cerevisiae cells	NULL
EXP041970	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 3; strain: BY5764: CEN.PK MATa	NULL	1384	normal	P33749	YMC RB phase S. cerevisiae cells	NULL
EXP041971	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 4; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33749	YMC RC phase S. cerevisiae cells	NULL
EXP041972	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 5; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33749	YMC RC phase S. cerevisiae cells	NULL
EXP041973	Msn4(yE-19) [Santa Cruz, sc-15550]	Saccharomyces cerevisiae	time point 6; strain: BY5764: CEN.PK MATa	NULL	1380	normal	P33749	YMC RC phase S. cerevisiae cells	NULL
EXP041974	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041975	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041976	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041977	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041978	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041979	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041980	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041981	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041982	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041974	1232	bio_control	A0A023PXA5	S. cerevisiae cells	NULL
EXP041983	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041975	1232	normal	P10659	S. cerevisiae cells	NULL
EXP041984	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041976	1232	normal	P10659	S. cerevisiae cells	NULL
EXP041985	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041977	1232	normal	P40510	S. cerevisiae cells	NULL
EXP041986	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041978	1232	normal	P40510	S. cerevisiae cells	NULL
EXP041987	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041979	1232	normal	P00549	S. cerevisiae cells	NULL
EXP041988	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041980	1232	normal	P00549	S. cerevisiae cells	NULL
EXP041989	anti-FLAG (Sigma-Aldrich, F1804-1MG)	Saccharomyces cerevisiae		EXP041981	1232	normal	P38827	S. cerevisiae cells	NULL
EXP041990	none	Saccharomyces cerevisiae	strain: S96 yrr1Î”; allele: YRR1_YJM789 ; grown in YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041991	none	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_YJM789; grown in YPD + 4NQO	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041992	none	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96; grown in YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041993	none	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96; grown in YPD + 4NQO	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041994	none	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96-I775E; grown in YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041995	none	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96-I775E; grown in YPD + 4NQO	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP041996	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_YJM789; grown in YPD	EXP041990	1232	normal	Q12172	S. cerevisiae cells	NULL
EXP041997	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_YJM789; grown in YPD + 4NQO	EXP041991	1232	normal	Q12172	S. cerevisiae cells	NULL
EXP041998	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96; grown in YPD	EXP041992	1232	normal	Q12172	S. cerevisiae cells	NULL
EXP041999	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96; grown in YPD + 4NQO	EXP041993	1232	normal	Q12172	S. cerevisiae cells	NULL
EXP042000	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96-I775E; grown in YPD	EXP041994	1232	normal	Q12172	S. cerevisiae cells	NULL
EXP042001	anti-Myc	Saccharomyces cerevisiae	strain: S96 yrr1Î” (YRR1-knockout); allele: YRR1_S96-I775E; grown in YPD + 4NQO	EXP041995	1232	normal	Q12172	S. cerevisiae cells	NULL
EXP042002	anti-c-Myc EZview resin (Sigma E6654)	Saccharomyces cerevisiae	wild type	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042003	anti-c-Myc EZview resin (Sigma E6654)	Saccharomyces cerevisiae	Ubp8-Myc	EXP042002	1232	normal	P50102	S. cerevisiae cells	NULL
EXP042004	anti-c-Myc EZview resin (Sigma E6654)	Saccharomyces cerevisiae	Sgf73-Myc	EXP042002	1232	normal	P53165	S. cerevisiae cells	NULL
EXP042005	none (input)	Saccharomyces cerevisiae	Smc3 E1155Q mutation	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042006	none (input)	Saccharomyces cerevisiae	Smc3 E1155Q K112Q K113Q mutation	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042007	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Smc3 E1155Q mutation	EXP042005	1232	normal	P47037	S. cerevisiae cells	NULL
EXP042008	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Smc3 E1155Q K112Q K113Q mutation	EXP042006	1232	normal	P47037	S. cerevisiae cells	NULL
EXP042009	none (input)	Saccharomyces cerevisiae	strain: BR627; Smc1 D1164E	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042010	none (input)	Saccharomyces cerevisiae	strain: BR625; Smc1 L1129V	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042011	none (input)	Saccharomyces cerevisiae	strain: BR645; Smc1 wild type	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042012	none (input)	Saccharomyces cerevisiae	strain: BR777; Smc3 L1126	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042013	none (input)	Saccharomyces cerevisiae	strain: BR776; Smc3 wild type	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042014	none (input)	Saccharomyces cerevisiae	strain: BR736; Smc3 D1161E	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042015	none (input)	Saccharomyces cerevisiae	strain: BR733; Smc3 wild type	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042016	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR627; Smc1 D1164E	EXP042009	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042017	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR625; Smc1 L1129V	EXP042010	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042018	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR645; Smc1 wild type	EXP042011	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042019	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR777; Smc3 L1126	EXP042012	1232	normal	P47037	S. cerevisiae cells	NULL
EXP042020	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR776; Smc3 wild type	EXP042013	1232	normal	P47037	S. cerevisiae cells	NULL
EXP042021	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR736; Smc3 D1161E	EXP042014	1232	normal	P47037	S. cerevisiae cells	NULL
EXP042022	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	strain: BR733; Smc3 wild type	EXP042015	1232	normal	P47037	S. cerevisiae cells	NULL
EXP042023	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 0 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042024	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 2 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042025	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 2.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042026	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 3 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042027	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 3.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042028	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 4 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042029	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 4.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042030	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042031	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 5.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042032	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 6 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042033	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 7 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042034	none	Saccharomyces cerevisiae	REC114-Myc ARS+; 8 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042035	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 0 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042036	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 2 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042037	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 2.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042038	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 3 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042039	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 3.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042040	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 4 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042041	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 4.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042042	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042043	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 5.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042044	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 6 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042045	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 7 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042046	none	Saccharomyces cerevisiae	REC114-Myc ars-delta; 8 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042047	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 0 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042048	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 1 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042049	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 1.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042050	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 2 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042051	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 2.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042052	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 3 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042053	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 3.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042054	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 4 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042055	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 4.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042056	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042057	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 6 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042058	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 7 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042059	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 0 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042060	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 1 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042061	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 1.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042062	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 2 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042063	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 2.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042064	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 3 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042065	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 3.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042066	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 4 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042067	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 4.5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042068	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 5 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042069	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 6 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042070	none	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 7 hr in meiosis	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042071	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 0 hr in meiosis	EXP042023	1385	normal	P32841	meiotic culture	NULL
EXP042072	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 2 hr in meiosis	EXP042024	1385	normal	P32841	meiotic culture	NULL
EXP042073	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 2.5 hr in meiosis	EXP042025	1385	normal	P32841	meiotic culture	NULL
EXP042074	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 3 hr in meiosis	EXP042026	1385	normal	P32841	meiotic culture	NULL
EXP042075	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 3.5 hr in meiosis	EXP042027	1385	normal	P32841	meiotic culture	NULL
EXP042076	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 4 hr in meiosis	EXP042028	1385	normal	P32841	meiotic culture	NULL
EXP042077	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 4.5 hr in meiosis	EXP042029	1385	normal	P32841	meiotic culture	NULL
EXP042078	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 5 hr in meiosis	EXP042030	1385	normal	P32841	meiotic culture	NULL
EXP042079	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 5.5 hr in meiosis	EXP042031	1385	normal	P32841	meiotic culture	NULL
EXP042080	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 6 hr in meiosis	EXP042032	1385	normal	P32841	meiotic culture	NULL
EXP042081	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 7 hr in meiosis	EXP042033	1385	normal	P32841	meiotic culture	NULL
EXP042082	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ARS+; 8 hr in meiosis	EXP042034	1385	normal	P32841	meiotic culture	NULL
EXP042083	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 0 hr in meiosis	EXP042035	1385	normal	P32841	meiotic culture	NULL
EXP042084	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 2 hr in meiosis	EXP042036	1385	normal	P32841	meiotic culture	NULL
EXP042085	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 2.5 hr in meiosis	EXP042037	1385	normal	P32841	meiotic culture	NULL
EXP042086	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 3 hr in meiosis	EXP042038	1385	normal	P32841	meiotic culture	NULL
EXP042087	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 3.5 hr in meiosis	EXP042039	1385	normal	P32841	meiotic culture	NULL
EXP042088	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 4 hr in meiosis	EXP042040	1385	normal	P32841	meiotic culture	NULL
EXP042089	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 4.5 hr in meiosis	EXP042041	1385	normal	P32841	meiotic culture	NULL
EXP042090	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 5 hr in meiosis	EXP042042	1385	normal	P32841	meiotic culture	NULL
EXP042091	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 5.5 hr in meiosis	EXP042043	1385	normal	P32841	meiotic culture	NULL
EXP042092	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 6 hr in meiosis	EXP042044	1385	normal	P32841	meiotic culture	NULL
EXP042093	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 7 hr in meiosis	EXP042033	1385	normal	P32841	meiotic culture	NULL
EXP042094	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc ars-delta; 8 hr in meiosis	EXP042046	1385	normal	P32841	meiotic culture	NULL
EXP042095	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 0 hr in meiosis	EXP042047	1385	normal	P32841	meiotic culture	NULL
EXP042096	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 1 hr in meiosis	EXP042048	1385	normal	P32841	meiotic culture	NULL
EXP042097	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 1.5 hr in meiosis	EXP042049	1385	normal	P32841	meiotic culture	NULL
EXP042098	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 2 hr in meiosis	EXP042050	1385	normal	P32841	meiotic culture	NULL
EXP042099	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 2.5 hr in meiosis	EXP042051	1385	normal	P32841	meiotic culture	NULL
EXP042100	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 3 hr in meiosis	EXP042052	1385	normal	P32841	meiotic culture	NULL
EXP042101	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 3.5 hr in meiosis	EXP042053	1385	normal	P32841	meiotic culture	NULL
EXP042102	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 4 hr in meiosis	EXP042054	1385	normal	P32841	meiotic culture	NULL
EXP042103	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 4.5 hr in meiosis	EXP042055	1385	normal	P32841	meiotic culture	NULL
EXP042104	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 5 hr in meiosis	EXP042056	1385	normal	P32841	meiotic culture	NULL
EXP042105	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 6 hr in meiosis	EXP042057	1385	normal	P32841	meiotic culture	NULL
EXP042106	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta RS+; 7 hr in meiosis	EXP042058	1385	normal	P32841	meiotic culture	NULL
EXP042107	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 0 hr in meiosis	EXP042059	1385	normal	P32841	meiotic culture	NULL
EXP042108	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 1 hr in meiosis	EXP042060	1385	normal	P32841	meiotic culture	NULL
EXP042109	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 1.5 hr in meiosis	EXP042061	1385	normal	P32841	meiotic culture	NULL
EXP042110	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 2 hr in meiosis	EXP042062	1385	normal	P32841	meiotic culture	NULL
EXP042111	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 2.5 hr in meiosis	EXP042063	1385	normal	P32841	meiotic culture	NULL
EXP042112	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 3 hr in meiosis	EXP042064	1385	normal	P32841	meiotic culture	NULL
EXP042113	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 3.5 hr in meiosis	EXP042065	1385	normal	P32841	meiotic culture	NULL
EXP042114	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 4 hr in meiosis	EXP042066	1385	normal	P32841	meiotic culture	NULL
EXP042115	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 4.5 hr in meiosis	EXP042067	1385	normal	P32841	meiotic culture	NULL
EXP042116	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 5 hr in meiosis	EXP042068	1385	normal	P32841	meiotic culture	NULL
EXP042117	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 6 hr in meiosis	EXP042069	1385	normal	P32841	meiotic culture	NULL
EXP042118	anti-Myc antibody (9E10)	Saccharomyces cerevisiae	REC114-Myc tof1-delta ars-delta; 7 hr in meiosis	EXP042070	1385	normal	P32841	meiotic culture	NULL
EXP042119	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: wild type with no MYC tag	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042120	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1	EXP042119	1232	normal	P43572	S. cerevisiae cells	NULL
EXP042121	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1 Yng2-W247A	EXP042119	1232	normal	P43572	S. cerevisiae cells	NULL
EXP042122	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1 delta-eaf7	EXP042119	1232	normal	P43572	S. cerevisiae cells	NULL
EXP042123	MYC (Babco, 9E10, #10329IF)	Saccharomyces cerevisiae	Treatment: strain: MYC-Epl1 Yng2-W247A delta_eaf7	EXP042119	1232	normal	P43572	S. cerevisiae cells	NULL
EXP042124	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 0 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042125	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 1 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042126	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	2 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042127	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 5 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042128	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 20 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042129	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 0 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042130	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 1 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042131	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 2 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042132	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 5 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042133	anti-HA ChIP-grade (Abcam, #ab9110)	Saccharomyces cerevisiae	strain: SP020 (CRZ1:3xHA); 20 min after pH was raised to 8.0 by adding 1 M KOH and growth resumed	NULL	1232	normal	P53968	S. cerevisiae cells	NULL
EXP042134	none (input)	Saccharomyces cerevisiae	strain: FY56 (SPT16-myc)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042135	none (input)	Saccharomyces cerevisiae	strain: FY56 (MOT1-myc)	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042136	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (SPT16-myc); wild type cells	EXP042134	1232	normal	P32558	S. cerevisiae cells	NULL
EXP042137	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (SPT16-myc); mot1-42 cells 	EXP042134	1232	normal	P32558	S. cerevisiae cells	NULL
EXP042138	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (MOT1-myc); wild type cells 	EXP042135	1232	normal	P32333	S. cerevisiae cells	NULL
EXP042139	myc (9E10, Abcam ab32, lot GR206680-4)	Saccharomyces cerevisiae	strain: FY56 (MOT1-myc); spt16-197 cells	EXP042135	1232	normal	P32333	S. cerevisiae cells	NULL
EXP042140		Saccharomyces cerevisiae	 Abf1 TAP-tagged strain	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042141		Saccharomyces cerevisiae	Reb1 TAP-tagged strain	NULL	1385	chip_control	NULL	meiotic culture	NULL
EXP042142		Saccharomyces cerevisiae	 Abf1 TAP-tagged strain	EXP042140	1385	normal	P14164	meiotic culture	NULL
EXP042143		Saccharomyces cerevisiae	Reb1 TAP-tagged strain	EXP042141	1385	normal	P21538	meiotic culture	NULL
EXP042144		Saccharomyces cerevisiae	treatment: none; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042145		Saccharomyces cerevisiae	treatment: none; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042146		Saccharomyces cerevisiae	0 min after MNase 0.046875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042147		Saccharomyces cerevisiae	30 min after MNase 0.046875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042148		Saccharomyces cerevisiae	0 min after MNase 0.1875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042149		Saccharomyces cerevisiae	30 min after MNase 0.1875 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042150		Saccharomyces cerevisiae	0 min after MNase 0.75 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042151		Saccharomyces cerevisiae	30 min after MNase 0.75 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042152		Saccharomyces cerevisiae	0 min after MNase 3.0 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042153		Saccharomyces cerevisiae	30 min after MNase 3.0 U; genotype: BY4742 tor1-1; fpr1del; RPL13A-FKBP12-NAT; HSF1-FRB-yEGFP-hphMX4	EXP042144	1232	normal	P10961	S. cerevisiae cells	NULL
EXP042154		Saccharomyces cerevisiae	Treatment: strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042155		Saccharomyces cerevisiae	Treatment: strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042156		Saccharomyces cerevisiae	Treatment: strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042157		Saccharomyces cerevisiae	Treatment: strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042158		Saccharomyces cerevisiae	Treatment: strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042159		Saccharomyces cerevisiae	Treatment: strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042160	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042154	1232	normal	P23293	S. cerevisiae cells	NULL
EXP042161	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042155	1232	normal	Q03957	S. cerevisiae cells	NULL
EXP042162	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042156	1232	normal	Q04089	S. cerevisiae cells	NULL
EXP042163	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042157	1232	normal	P53064	S. cerevisiae cells	NULL
EXP042164	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042158	1232	normal	P38827	S. cerevisiae cells	NULL
EXP042165	IgG Sigma, I5006	Saccharomyces cerevisiae	Treatment: strain: BY4741	EXP042159	1232	normal	P46995	S. cerevisiae cells	NULL
EXP042166	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW330 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, RGR1-13xMyc::HPHr)	NULL	1232	normal	P19263	S. cerevisiae cells	NULL
EXP042167	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW330 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, RGR1-13xMyc::HPHr)	NULL	1232	normal	P19263	S. cerevisiae cells	NULL
EXP042168	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW328 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, GAL11-13xMyc::HPHr)	NULL	1232	normal	P04385	S. cerevisiae cells	NULL
EXP042169	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW328 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, GAL11-13xMyc::HPHr)	NULL	1232	normal	P04385	S. cerevisiae cells	NULL
EXP042170	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: YJ146 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB2-13xMyc::HPHr)	NULL	1232	normal	P34162	S. cerevisiae cells	NULL
EXP042171	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: YJ146 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB2-13xMyc::HPHr)	NULL	1232	normal	P34162	S. cerevisiae cells	NULL
EXP042172	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: YJ141 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED8-13xMyc::HPHr)	NULL	1232	normal	P38304	S. cerevisiae cells	NULL
EXP042173	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: YJ141 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED8-13xMyc::HPHr)	NULL	1232	normal	P38304	S. cerevisiae cells	NULL
EXP042174	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: YJ147 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB7-13xMyc::HPHr)	NULL	1232	normal	P47822	S. cerevisiae cells	NULL
EXP042175	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: YJ147 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB7-13xMyc::HPHr)	NULL	1232	normal	P47822	S. cerevisiae cells	NULL
EXP042176	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW332 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB6-13xMyc::HPHr)	NULL	1232	normal	P32570	S. cerevisiae cells	NULL
EXP042177	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW332 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB6-13xMyc::HPHr)	NULL	1232	normal	P32570	S. cerevisiae cells	NULL
EXP042178	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW329 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED7-13xMyc::HPHr)	NULL	1232	normal	Q08278	S. cerevisiae cells	NULL
EXP042179	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW329 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, MED7-13xMyc::HPHr)	NULL	1232	normal	Q08278	S. cerevisiae cells	NULL
EXP042180	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: none; strain: KHW333 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB10-13xMyc::HPHr)	NULL	1232	normal	P39073	S. cerevisiae cells	NULL
EXP042181	c-Myc (9E10, Santa Cruz)	Saccharomyces cerevisiae	treatment: rapamycin; strain: KHW333 with tor1-1 mutation after Kin28-AA (anchor-away) (MATalpha, tor1-1, fpr1::NAT, RPL13A-2xFKB12::TRP1, KIN28-FRB::HIS3, SRB10-13xMyc::HPHr)	NULL	1232	normal	P39073	S. cerevisiae cells	NULL
EXP042182	none (input)	Saccharomyces cerevisiae	Snf11 deletion	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042183	none (input)	Saccharomyces cerevisiae	Swp73 deletion	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042184	none (input)	Saccharomyces cerevisiae	Swp82 deletion	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042185	none (input)	Saccharomyces cerevisiae	Swi3 deletion	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042186	none (input)	Saccharomyces cerevisiae	Snf6 deletion	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042187	none (input)	Saccharomyces cerevisiae	Snf5 deletion	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042188	none (input)	Saccharomyces cerevisiae	none	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042189	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Snf11 deletion	EXP042182	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042190	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Swp73 deletion	EXP042183	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042191	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Swp82 deletion	EXP042184	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042192	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Swi3 deletion	EXP042185	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042193	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Snf6 deletion	EXP042186	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042194	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	Snf5 deletion	EXP042187	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042195	Snf2 C' Ab (antibody raised in Reese lab)	Saccharomyces cerevisiae	none	EXP042188	1232	normal	P22082	S. cerevisiae cells	NULL
EXP042196	none (input)	Saccharomyces cerevisiae	strain: BY4741 MATa his3{delta}1 leu2{delta}0 met15{delta}0 ura3{delta}0 pEGH 2{mu} URA3 promGAL1-10-GST-GCN4	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042197	anti-GST (GE Healthcare Life Sciences, cat# 27-4577-01, lot# 316319)	Saccharomyces cerevisiae	strain: BY4741 MATa his3{delta}1 leu2{delta}0 met15{delta}0 ura3{delta}0 pEGH 2{mu} URA3 promGAL1-10-GST-GCN4	EXP042196	1232	normal	P03069	S. cerevisiae cells	NULL
EXP042198		Saccharomyces cerevisiae	strain: H119 (wild type)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042199		Saccharomyces cerevisiae	strain: H119 (wild type)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042200		Saccharomyces cerevisiae	strain: H119 (wild type)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042201		Saccharomyces cerevisiae	strain: H6408 (wild type)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042202		Saccharomyces cerevisiae	strain: H7660 (rec8-delta)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042203		Saccharomyces cerevisiae	strain: H7772 (rec8-delta)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042204		Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042205		Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042206		Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042207		Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042208		Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP042209	anti-Red1	Saccharomyces cerevisiae	strain: H119 (wild type)	EXP042198	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042210	anti-Red1	Saccharomyces cerevisiae	strain: H119 (wild type)	EXP042199	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042211	anti-Hop1	Saccharomyces cerevisiae	strain: H119 (wild type)	EXP042200	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042212	anti-Hop1	Saccharomyces cerevisiae	strain: H6408 (wild type)	EXP042201	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042213	anti-Red1	Saccharomyces cerevisiae	strain: H7660 (rec8-delta)	EXP042202	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042214	anti-Red1	Saccharomyces cerevisiae	strain: H7772 (rec8-delta)	EXP042203	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042215	anti-Hop1	Saccharomyces cerevisiae	strain: H7660 (rec8-delta)	EXP042202	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042216	anti-Hop1	Saccharomyces cerevisiae	strain: H7772 (rec8-delta)	EXP042203	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042217	anti-Red1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042204	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042218	anti-Red1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042205	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042219	anti-Hop1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042204	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042220	anti-Hop1	Saccharomyces cerevisiae	strain: H7011 (putative condensin allele ycs4S)	EXP042205	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042221	anti-Red1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042206	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042222	anti-Red1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042207	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP042223	anti-Hop1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042206	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042224	anti-Hop1	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042207	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP042225	Mock	Saccharomyces cerevisiae	strain: H7661 (putative condensin allele ycs4S; rec8-delta)	EXP042208	1382	bio_control	A0A023PXA5	SK1 meiotic cells (3 hours)	NULL
EXP042226	normal rabbit serum	Saccharomyces cerevisiae	strain: BY4741	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042227	Sba1 (Freeman et al., 2000)	Saccharomyces cerevisiae	strain: BY4741	EXP042226	1232	normal	P28707	S. cerevisiae cells	NULL
EXP042228		Saccharomyces cerevisiae	YP + 2% galactose media	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042229		Saccharomyces cerevisiae	YPD media	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042230	anti-TAP antibody (Thermo Fisher Scientific, Waltham, MA; #CAB1001, Lot #RL240352) 	Saccharomyces cerevisiae	YP + 2% galactose media	EXP042228	1232	normal	P39705	S. cerevisiae cells	NULL
EXP042231	anti-TAP antibody (Thermo Fisher Scientific, Waltham, MA; #CAB1001, Lot #RL240352) 	Saccharomyces cerevisiae	YPD media	EXP042229	1232	normal	P39705	S. cerevisiae cells	NULL
EXP042232	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: W303-1a (SF1); genotype: MATa ade2-1 can1-100 his3-11 leu2-3,112 trp1 ura3-1 GAL	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042233	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: SF4; genotype: sir3-delta::TRP1 in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042234	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL1 (DMY4350); genotype: sir3{delta}wH::TRP1 in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042235	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: ADR2973; genotype: sir4-I1311N in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042236	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL2 (DMY4351); genotype: sir4-I1311N sir3{delta}wH::TRP1 in SF1	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042237	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: SF1 + pJR104 (pDM602); plasmid genotype: SIR3 under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042238	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL1 + pCL4 (pDM1798); plasmid genotype: sir3{delta}wH under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042239	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: ADR2973 + pJR104; plasmid genotype: SIR3 under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042240	Sir3 antibody (Rudner et al., 2005)	Saccharomyces cerevisiae	strain: CL2 + pCL4; plasmid genotype: sir3{delta}wH under endogenous promoter in YEp24	NULL	1232	normal	P06701	S. cerevisiae cells	NULL
EXP042241	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042242	none	Saccharomyces cerevisiae		NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042243	none	Saccharomyces cerevisiae	hydroxyurea	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042244	none	Saccharomyces cerevisiae	nocodazole	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042245	none	Saccharomyces cerevisiae	37oC	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042246	none	Saccharomyces cerevisiae	cdc15-2::LEU2, âˆ†ctf3::URA3	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042247	none	Saccharomyces cerevisiae	cdc15-2::LEU2, âˆ†ctf3::URA3; nocodazole	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042248	anti-Myc	Saccharomyces cerevisiae		EXP042241	1232	normal	P36012	S. cerevisiae cells	NULL
EXP042249	anti-Myc	Saccharomyces cerevisiae	cdc15-2::LEU2	EXP042242	1232	normal	P43618	S. cerevisiae cells	NULL
EXP042250	anti-Myc	Saccharomyces cerevisiae	hydroxyurea	EXP042243	1232	normal	P43618	S. cerevisiae cells	NULL
EXP042251	anti-Myc	Saccharomyces cerevisiae	nocodazole	EXP042244	1232	normal	P43618	S. cerevisiae cells	NULL
EXP042252	anti-Myc	Saccharomyces cerevisiae	37oC	EXP042245	1232	normal	P43618	S. cerevisiae cells	NULL
EXP042253	anti-Myc	Saccharomyces cerevisiae	cdc15-2::LEU2, âˆ†ctf3::URA3	EXP042246	1232	normal	P43618	S. cerevisiae cells	NULL
EXP042254	anti-Myc	Saccharomyces cerevisiae	cdc15-2::LEU2, âˆ†ctf3::URA3; nocodazole	EXP042247	1232	normal	P43618	S. cerevisiae cells	NULL
EXP042255	human c-myc	Saccharomyces cerevisiae	Ndt80 untagged control SRaff; YTS89 strain	NULL	1386	chip_control	NULL	W303a Strain	NULL
EXP042256	human c-myc	Saccharomyces cerevisiae	yIN219 strain	EXP042255	1386	normal	P38830	W303a Strain	NULL
EXP042257	human c-myc	Saccharomyces cerevisiae	yIN218 strain; Pichia pastoris Ndt80	EXP042255	1386	normal	P38830	W303a Strain	NULL
EXP042258	human c-myc	Saccharomyces cerevisiae	yIN198 strain; Ndt80 untagged control	NULL	1383	chip_control	NULL	SK1 diploid cells	NULL
EXP042259	human c-myc	Saccharomyces cerevisiae	yIN209 strain	EXP042258	1383	normal	A0A023PXA5	SK1 diploid cells	NULL
EXP042260	none	Saccharomyces cerevisiae	Treatment: WT; mock; BY4741 background	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042261	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; PAF1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042262	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; CTR9 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042263	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; LEO1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042264	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; CDC73 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042265	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; HTZ1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042266	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; RTF1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042267	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; SET1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042268	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; RCO1 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042269	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; SET2 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042270	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; SPT4 deletion	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042271	anti-Myc conjugated agarose bead (Sigma Aldrich, cat.# E6654)	Saccharomyces cerevisiae	Treatment: BY4741 background; WT	EXP042260	1232	normal	P32657	S. cerevisiae cells	NULL
EXP042272		Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa prototroph	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042273		Saccharomyces cerevisiae	strain: S288c; genotype: MATa his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042274	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED3-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P40356	S. cerevisiae cells	NULL
EXP042275	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED7-8xGLY-13xMYC-KANMX 	EXP042272	1232	normal	Q08278	S. cerevisiae cells	NULL
EXP042276	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED14-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P19263	S. cerevisiae cells	NULL
EXP042277	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED15-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P19659	S. cerevisiae cells	NULL
EXP042278	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED17-8xGLY-13xMYC-KANMX 	EXP042272	1232	normal	P32569	S. cerevisiae cells	NULL
EXP042279	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa MED19-8xGLY-13xMYC-KANMX	EXP042272	1232	normal	P25046	S. cerevisiae cells	NULL
EXP042280	anti-Myc  (monoclonal 9E10, Clontech)	Saccharomyces cerevisiae	strain: S288c prototroph; genotype: MATa SSN8-8xGLY13xMYC-KANMX	EXP042272	1232	normal	P47821	S. cerevisiae cells	NULL
EXP042281	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED3- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P40356	S. cerevisiae cells	NULL
EXP042282	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED14- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P19263	S. cerevisiae cells	NULL
EXP042283	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED15- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P19659	S. cerevisiae cells	NULL
EXP042284	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED17- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P32569	S. cerevisiae cells	NULL
EXP042285	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa MED19- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P25046	S. cerevisiae cells	NULL
EXP042286	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa SSN8- TAP-HIS3MX his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	EXP042273	1232	normal	P47821	S. cerevisiae cells	NULL
EXP042287	anti-TAP antibody CAB1001	Saccharomyces cerevisiae	strain: S288c; genotype: MATa his3<delta>1 leu2<delta>0 met15<delta>0 ura3<delta>0	NULL	1232	bio_control	A0A023IRJ6	S. cerevisiae cells	NULL
EXP042288	none	Saccharomyces cerevisiae	Treatment: MATa, ura3delta0, leu2delta0, his3delta1, met15delta0; BY4741 strain	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042289	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATa, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100; YF2229 strain	EXP042288	1232	normal	P13393	S. cerevisiae cells	NULL
EXP042290	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_0min	EXP042288	1232	normal	P46677	S. cerevisiae cells	NULL
EXP042291	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_60min	EXP042288	1232	normal	P46677	S. cerevisiae cells	NULL
EXP042292	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_0min	EXP042288	1232	normal	P13393	S. cerevisiae cells	NULL
EXP042293	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, RPB1-FRB::HIS3MX; YSB3202 strain; Rpb1-AA_60min	EXP042288	1232	normal	P13393	S. cerevisiae cells	NULL
EXP042294	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_0min	EXP042288	1232	normal	P46677	S. cerevisiae cells	NULL
EXP042295	anti-taf1 rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_60min	EXP042288	1232	normal	P46677	S. cerevisiae cells	NULL
EXP042296	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_0min	EXP042288	1232	normal	P13393	S. cerevisiae cells	NULL
EXP042297	anti-TBP rabbit polyclonal (custom made)	Saccharomyces cerevisiae	Treatment: MATalpha, ura3-, leu2-3,112, trp1-1, his3-11,15, fpr1::NAT, RPL13A-2xFKBP12::TRP1, tor1-1, ade2-1, can1-100, BDF1-FRB::HIS3MX; YSB3323 strain; Bdf1-AA_60min	EXP042288	1232	normal	P13393	S. cerevisiae cells	NULL
EXP042298	anti-HA	Saccharomyces cerevisiae	0 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042299	anti-HA	Saccharomyces cerevisiae	Hos1 depletion; 0 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042300	anti-HA	Saccharomyces cerevisiae	10 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042301	anti-HA	Saccharomyces cerevisiae	Hos1 depletion; 10 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042302	anti-HA	Saccharomyces cerevisiae	15 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042303	anti-HA	Saccharomyces cerevisiae	Hos1 depletion; 15 min after release to anaphase	NULL	1232	normal	P32908	S. cerevisiae cells	NULL
EXP042304	none	Saccharomyces cerevisiae		NULL	1386	chip_control	NULL	W303a Strain	NULL
EXP042305	Anti-Myc (Clontech, catalog# 631206, lot# 1602362A)	Saccharomyces cerevisiae		EXP042304	1386	normal	Q06211	W303a Strain	NULL
EXP042306	none	Saccharomyces cerevisiae	rad53-1; media: YPD+HU; S phase	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP042307	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	rad53-1; media: YPD+HU; S phase	EXP042306	1232	normal	P22336	S. cerevisiae cells	NULL
EXP042308	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	wild type; media: YPD+HU; S phase	NULL	1232	normal	P53091	S. cerevisiae cells	NULL
EXP042309	Anti-FLAG (SIGMA,F1804)	Saccharomyces cerevisiae	rad53-1; media: YPD+HU; S phase	EXP042306	1232	normal	P53091	S. cerevisiae cells	NULL
EXP042310	none	Caenorhabditis elegans	pha-4 transgenic (GFP:3xFLAG tag) worm; strain: OP37	NULL	1388	chip_control	NULL	whole worms (developmental stage: embryo)	NULL
EXP042311	none	Caenorhabditis elegans	starved L1; pha-4 transgenic (GFP:3xFLAG tag) worm; strain: OP37	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042312	anti-GFP	Caenorhabditis elegans	pha-4 transgenic (GFP:3xFLAG tag) worm; strain: OP37	EXP042310	1388	normal	Q17381	whole worms (developmental stage: embryo)	NULL
EXP042313	anti-GFP	Caenorhabditis elegans	starved L1;pha-4 transgenic (GFP:3xFLAG tag) worm; strain: OP37	EXP042311	1387	normal	Q17381	whole worms (developmental stage: L1)	NULL
EXP042314	none	Caenorhabditis elegans	strain: OP32; DPY27 transgenic worms (GFP-tagged)	NULL	1388	chip_control	NULL	whole worms (developmental stage: embryo)	NULL
EXP042315	none	Caenorhabditis elegans	strain: OP32; DPY27 transgenic worms (GFP-tagged)	NULL	1388	chip_control	NULL	whole worms (developmental stage: embryo)	NULL
EXP042316	anti-GFP	Caenorhabditis elegans	strain: OP32; DPY27 transgenic worms (GFP-tagged)	EXP042314	1388	normal	P48996	whole worms (developmental stage: embryo)	NULL
EXP042317	anti-GFP	Caenorhabditis elegans	strain: OP32; DPY27 transgenic worms (GFP-tagged)	EXP042315	1388	normal	P48996	whole worms (developmental stage: embryo)	NULL
EXP042318	none	Caenorhabditis elegans	daf-16 transgenic (GFP-tagged) worm; strain: TJ356	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042319	none	Caenorhabditis elegans	daf-16 transgenic (GFP-tagged) worm; strain: TJ356	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042320	anti-GFP	Caenorhabditis elegans	daf-16 transgenic (GFP-tagged) worm; strain: TJ356	EXP042318	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	NULL
EXP042321	anti-GFP	Caenorhabditis elegans	daf-16 transgenic (GFP-tagged) worm; strain: TJ356	EXP042319	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	NULL
EXP042322	none	Caenorhabditis elegans	mab-5 transgenic (GFP-tagged) worm; strain: OP26	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042323	none	Caenorhabditis elegans	mab-5 transgenic (GFP-tagged) worm; strain: OP26	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042324	anti-GFP	Caenorhabditis elegans	mab-5 transgenic (GFP-tagged) worm; strain: OP26	EXP042322	1390	normal	P10038	whole worms (developmental stage: L3)	NULL
EXP042325	anti-GFP	Caenorhabditis elegans	mab-5 transgenic (GFP-tagged) worm; strain: OP26	EXP042323	1390	normal	P10038	whole worms (developmental stage: L3)	NULL
EXP042326	none	Caenorhabditis elegans	genotype: CEH-14:GFP:3xFLAG; strain: OP73 	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042327	anti-GFP	Caenorhabditis elegans	genotype: CEH-14:GFP:3xFLAG; strain: OP73 	EXP042326	1202	normal	P20271	whole worms (developmental stage: L2)	NULL
EXP042328	none	Caenorhabditis elegans	genotype: EOR-1:GFP:3xFLAG; strain: OP81	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042329	none	Caenorhabditis elegans	genotype: EOR-1:GFP:3xFLAG; strain: OP81	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042330	anti-GFP	Caenorhabditis elegans	genotype: EOR-1:GFP:3xFLAG; strain: OP81	EXP042328	1390	normal	G5EDU4	whole worms (developmental stage: L3)	NULL
EXP042331	anti-GFP	Caenorhabditis elegans	genotype: EOR-1:GFP:3xFLAG; strain: OP81	EXP042329	1390	normal	G5EDU4	whole worms (developmental stage: L3)	NULL
EXP042332	none	Caenorhabditis elegans	genotype: HLH-8:GFP:3xFLAG; strain: OP74	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042333	none	Caenorhabditis elegans	genotype: HLH-8:GFP:3xFLAG; strain: OP74	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042334	anti-GFP	Caenorhabditis elegans	genotype: HLH-8:GFP:3xFLAG; strain: OP74	EXP042332	1390	normal	Q11094	whole worms (developmental stage: L3)	NULL
EXP042335	anti-GFP	Caenorhabditis elegans	genotype: HLH-8:GFP:3xFLAG; strain: OP74	EXP042333	1390	normal	Q11094	whole worms (developmental stage: L3)	NULL
EXP042337	DPY-27	Caenorhabditis elegans	Treatment: N2 strain	EXP042336	1390	normal	P48996	whole worms (developmental stage: L3)	NULL
EXP042338		Caenorhabditis elegans	strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042339		Caenorhabditis elegans	strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042340	SDQ0820 EPC1	Caenorhabditis elegans	strain: N2	EXP042338	1390	normal	G5EC14	whole worms (developmental stage: L3)	NULL
EXP042341	SDQ0820 EPC1	Caenorhabditis elegans	strain: N2	EXP042339	1390	normal	G5EC14	whole worms (developmental stage: L3)	NULL
EXP042450	None	Caenorhabditis elegans	pGES-1 EFL-1:GFP:FLAG whole animal; YL418 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042451	None	Caenorhabditis elegans	pGES-1 DPL-1:GFP:FLAG whole animal; YL448 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042452	None	Caenorhabditis elegans	pGES-1 LIN-35:GFP:FLAG whole animal; YL398 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042453	None	Caenorhabditis elegans	pGES-1 HPL-2:GFP:FLAG whole animal; YL416 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042454	None	Caenorhabditis elegans	Plin-35_LIN-35:GFP:FLAG whole animal; YL409 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042455	None	Caenorhabditis elegans	Pdpl-1_DPL-1:GFP:FLAG whole animal; YL425 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042456	None	Caenorhabditis elegans	Pefl-1 EFL-1:GFP:FLAG whole animal; YL424 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042457	None	Caenorhabditis elegans	Pmex-5 LIN-35:GFP:FLAG whole animal; YL468 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042458	None	Caenorhabditis elegans	Ppie-1 LIN-35:GFP:FLAG whole animal; YL402 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042459	None	Caenorhabditis elegans	Ppie-1_DPL-1:GFP:FLAG whole animal; YL390 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042460	None	Caenorhabditis elegans	Ppie-1 EFL-1:GFP:FLAG whole animal; YL445 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042461	GFP	Caenorhabditis elegans	pGES-1 EFL-1:GFP:FLAG whole animal; YL418 strain	EXP042450	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP042462	GFP	Caenorhabditis elegans	pGES-1 DPL-1:GFP:FLAG whole animal; YL448 strain	EXP042451	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP042463	GFP	Caenorhabditis elegans	pGES-1 LIN-35:GFP:FLAG whole animal; YL398 strain	EXP042452	1387	normal	G5EDT1	whole worms (developmental stage: L1)	NULL
EXP042464	HPL2	Caenorhabditis elegans	pGES-1 HPL-2:GFP:FLAG whole animal; YL416 strain	EXP042453	1387	normal	G5EDE2	whole worms (developmental stage: L1)	NULL
EXP042465	GFPd	Caenorhabditis elegans	Plin-35_LIN-35:GFP:FLAG whole animal; YL409 strain	EXP042454	1387	normal	G5EDT1	whole worms (developmental stage: L1)	NULL
EXP042466	GFP	Caenorhabditis elegans	Pdpl-1_DPL-1:GFP:FLAG whole animal; YL425 strain	EXP042455	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP042467	GFP	Caenorhabditis elegans	Pefl-1 EFL-1:GFP:FLAG whole animal; YL424 strain	EXP042456	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP042468	GFP	Caenorhabditis elegans	Pmex-5 LIN-35:GFP:FLAG whole animal; YL468 strain	EXP042457	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	NULL
EXP042469	GFP	Caenorhabditis elegans	Ppie-1 LIN-35:GFP:FLAG whole animal; YL402 strain	EXP042458	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	NULL
EXP042470	GFP	Caenorhabditis elegans	Ppie-1_DPL-1:GFP:FLAG whole animal; YL390 strain	EXP042459	1235	normal	Q22703	whole worms (developmental stage: young adults)	NULL
EXP042471	GFP	Caenorhabditis elegans	Ppie-1 EFL-1:GFP:FLAG whole animal; YL445 strain	EXP042460	1235	normal	G5EF11	whole worms (developmental stage: young adults)	NULL
EXP042472	Rabbit IgG from Santa Cruz Biotechnology (sc-2027, Lot # A2609)	Caenorhabditis elegans	strain: N2; wild type	NULL	1388	chip_control	NULL	whole worms (developmental stage: embryo)	NULL
EXP042473	DPY-27 polyclonal rabbit antibody (#699) was generated in: "CHUANG, P. T., D. G. ALBERTSON and B. J. MEYER, 1994 DPY-27:a chromosome condensation protein homolog that regulates C. elegans dosage compensation through association with the X chromosome. Cell 79: 459-474."	Caenorhabditis elegans	strain: N2; wild type	EXP042472	1388	normal	P48996	whole worms (developmental stage: embryo)	NULL
EXP042474		Caenorhabditis elegans	strain: N2; NHR-25::GFP	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042475		Caenorhabditis elegans	strain: N2; NHR-25::GFP	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042476		Caenorhabditis elegans	strain: N2; PHA-4::GFP	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042477	anti-GFP (polyclonal goat IgG; produced in Hyman lab)	Caenorhabditis elegans	strain: N2; NHR-25::GFP	EXP042474	1387	normal	Q19345	whole worms (developmental stage: L1)	NULL
EXP042478	anti-GFP (polyclonal goat IgG; produced in Hyman lab)	Caenorhabditis elegans	strain: N2; NHR-25::GFP	EXP042475	1387	normal	Q19345	whole worms (developmental stage: L1)	NULL
EXP042479	anti-GFP (polyclonal goat IgG; produced in Hyman lab)	Caenorhabditis elegans	strain: N2; PHA-4::GFP	EXP042476	1387	normal	Q17381	whole worms (developmental stage: L1)	NULL
EXP042480	na (input)	Caenorhabditis elegans	N2 strain; no treatment	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042481	SDQ3897_NPP13 [Novus Biologicals, catalog# 48580002, lot# G3048-202, Animal SDQ3897]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	Q9BKT9	whole worms (mixed-stage embryos)	NULL
EXP042482	SDQ0839_TBP1 [Novus Biologicals, catalog# 29610002, lot# G3048-022, Animal SDQ0839]	Caenorhabditis elegans	N2 strain; Empty vector RNAi	EXP042480	1392	normal	P32085	whole worms (mixed-stage embryos)	NULL
EXP042483	SDQ0839_TBP1 [Novus Biologicals, catalog# 29610002, lot# G3048-022, Animal SDQ0839]	Caenorhabditis elegans	N2 strain; NPP-13 RNAi	EXP042480	1392	normal	P32085	whole worms (mixed-stage embryos)	NULL
EXP044359	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: N2 strain	EXP044356	1390	normal	P48996	whole worms (developmental stage: L3)	NULL
EXP042485	SDQ4154_IMB1 [not commercial]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	Q9BIB8	whole worms (mixed-stage embryos)	NULL
EXP042486	SY1539_NPP3 [not commercial]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	Q21436	whole worms (mixed-stage embryos)	NULL
EXP042487	SDQ0839_TBP1 [Novus Biologicals, catalog# 29610002, lot# G3048-022, Animal SDQ0839]	Caenorhabditis elegans	N2 strain; no treatment	EXP042480	1392	normal	P32085	whole worms (mixed-stage embryos)	NULL
EXP042488		Caenorhabditis elegans	N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042489	Rabbit IgG, Abcam antibody catalog number ab46540	Caenorhabditis elegans	N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042490	input	Caenorhabditis elegans	TY1072 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042491	None (input)	Caenorhabditis elegans	N2 strain	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044358	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: MT14911 strain	EXP044355	1388	normal	P48996	whole worms (developmental stage: embryo)	NULL
EXP042493	CAPG-1 SDQ3967 Rabbit polyclonal is against the antigen MPPKKRIRGPKLPALREEKSTGTDVASDESFNESADFLNNEELNNDQNDAENTVLSEGVSTLRINENMTKEDRACISAALFIKKRVVESIRTVFQSRDDI May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	G5EFJ4	whole worms (mixed-stage embryos)	NULL
EXP042494	CAPG-2 SDQ4484 Rabbit polyclonal to 808-907 aa is against the antigen IPKWMNKQCDLMEDDEENIFKNHREIVESLRQFHKRVSETDYWDEDSAKRMMHHFMLFSIVSASSKNDDEAYDDPRDEDYKPPHFISLALIKFILKEKSL May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q20818	whole worms (mixed-stage embryos)	NULL
EXP042495	DPY-26 JL00003 Rabbit polyclonal to 40-1262 aa.  (PMID:19853451) is against the antigen 40-1262 aa	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	G5EGE9	whole worms (mixed-stage embryos)	NULL
EXP042496	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP042497	DPY-28 SDQ4564 Rabbit polyclonal is against the antigen QQQPTRNNDGLSGFKSITEIIAEADNNIPSEQIDKDIDSFSSYSDISDWRGIPKFFPSLSSLSRRASTYENWENRFKVVDYLVSCSGALKDSVSDYVADY May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q9U2M1	whole worms (mixed-stage embryos)	NULL
EXP042498	HCP-6 KH-HCP6 Rabbit Polyclonal to 1708-1722 aa sequence CKSAQAYHLHNIFEEDEES  (PMID:19119011)	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q95Y84	whole worms (mixed-stage embryos)	NULL
EXP042499	HTZ1 BK00001 mouse ascites polyclonal against HTZ-1 specific C-terminal peptide N-PGKPGAPGQGPQ-C (PMID:18787694)	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q27511	whole worms (mixed-stage embryos)	NULL
EXP042500	KLE-2 SDQ3898 Rabbit polyclonal is against the antigen MTRNAPPGQESTDLAWLVTPAKDLVENFSIDVLKALAGYLEVIRQESEDTDNQVDAATTYRLFDFQRACRIIQGSCAVYGRKVDHVYELTISVVDLVENK May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	P34341	whole worms (mixed-stage embryos)	NULL
EXP042501	MIX-1 JL0004 Rabbit polyclonal to 837-1244 aa. (PMID:19853451) is against the antigen 837-1244 aa	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q09591	whole worms (mixed-stage embryos)	NULL
EXP042502	PQN-85 SDQ4481 Rabbit polyclonal is against the antigen QQQPVQQIQRQQPIAQPIPQHTIPPSTSNQFQQQIQSAASSIFDSSVISSHQKLYEEQCRQIEKERKEQEERKRKQELEEQRKRNEELKRLRIAEEKRLL May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q95XZ5	whole worms (mixed-stage embryos)	NULL
EXP042503	SMC-4 OD0039 Rabbit polyclonal from Arshad Desai Lab	Caenorhabditis elegans	N2 strain	EXP042488	1392	normal	Q20060	whole worms (mixed-stage embryos)	NULL
EXP042504	DPY-26 JL00003 Rabbit polyclonal to 40-1262 aa.  (PMID:19853451) is against the antigen 40-1262 aa	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	G5EGE9	whole worms (mixed-stage embryos)	NULL
EXP042505	HCP-6 KH-HCP6 Rabbit Polyclonal to 1708-1722 aa sequence CKSAQAYHLHNIFEEDEES  (PMID:19119011)	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	Q95Y84	whole worms (mixed-stage embryos)	NULL
EXP042506	PQN-85 SDQ4481 Rabbit polyclonal is against the antigen QQQPVQQIQRQQPIAQPIPQHTIPPSTSNQFQQQIQSAASSIFDSSVISSHQKLYEEQCRQIEKERKEQEERKRKQELEEQRKRNEELKRLRIAEEKRLL May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	Q95XZ5	whole worms (mixed-stage embryos)	NULL
EXP042507	KLE-2 SDQ3942 Rabbit polyclonal is against the antigen MTRNAPPGQESTDLAWLVTPAKDLVENFSIDVLKALAGYLEVIRQESEDTDNQVDAATTYRLFDFQRACRIIQGSCAVYGRKVDHVYELTISVVDLVENK May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	TY1072 strain	EXP042490	1392	normal	P34341	whole worms (mixed-stage embryos)	NULL
EXP042508	KLE-2 SDQ3942 Rabbit polyclonal is against the antigen MTRNAPPGQESTDLAWLVTPAKDLVENFSIDVLKALAGYLEVIRQESEDTDNQVDAATTYRLFDFQRACRIIQGSCAVYGRKVDHVYELTISVVDLVENK May be available as part of modENCODE antibodies from Novus Biologicals "http://www.novusbio.com/"	Caenorhabditis elegans	N2 strain	EXP042491	1390	normal	P34341	whole worms (developmental stage: L3)	NULL
EXP042513	input	Caenorhabditis elegans	no treatment	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042514	input	Caenorhabditis elegans	no treatment	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042515	input	Caenorhabditis elegans	no treatment; glp-4 (bn2)	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042516	input	Caenorhabditis elegans	no treatment; spe-11(hc77)	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042517	input	Caenorhabditis elegans	no treatment; tra-1(e1834) heterozygote	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042518	NA	Caenorhabditis elegans	no treatment; tra-1(e1834) homozygote	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042519	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; tra-1(e1834) heterozygote	EXP042517	1390	normal	P34708	whole worms (developmental stage: L3)	NULL
EXP042520	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; tra-1(e1834) homozygote	EXP042518	1390	normal	P34708	whole worms (developmental stage: L3)	NULL
EXP042521	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment	EXP042513	1202	normal	P34708	whole worms (developmental stage: L2)	NULL
EXP042522	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment	NULL	1390	normal	P34708	whole worms (developmental stage: L3)	NULL
EXP042523	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; glp-4 (bn2)	EXP042515	1235	normal	P34708	whole worms (developmental stage: young adults)	NULL
EXP042524	anti-TRA-1 antibody UMN163	Caenorhabditis elegans	no treatment; spe-11(hc77)	EXP042516	1235	normal	P34708	whole worms (developmental stage: young adults)	NULL
EXP042525	anti-GFP Abcam ab290	Caenorhabditis elegans	Treatment: JA1597 strain	NULL	1391	normal	D3YT77	whole worms (developmental stage: late embryo)	NULL
EXP042526	input	Caenorhabditis elegans	5% Triton X-100; OP179 strain	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042527	input	Caenorhabditis elegans	5% Triton X-100; OP179 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042528	input	Caenorhabditis elegans	1% Triton X-100; OP179 strain	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042529	input	Caenorhabditis elegans	1% Triton X-100; YL457 strain	NULL	1393	chip_control	NULL	young adults, germline tissue	NULL
EXP042530	input	Caenorhabditis elegans	Triton X-100; YL524 strain	NULL	1394	chip_control	NULL	young adults, somatic cells	NULL
EXP042531	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	5% Triton X-100; OP179 strain	EXP042526	1389	normal	P91868	whole worms (developmental stage: L4/young adults)	NULL
EXP042532	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	5% Triton X-100; OP179 strain	EXP042527	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP042533	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	1% Triton X-100; OP179 strain	EXP042528	1387	normal	P91868	whole worms (developmental stage: L1)	NULL
EXP042534	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	1% Triton X-100; YL457 strain	EXP042529	1393	normal	P91868	young adults, germline tissue	NULL
EXP042535	anti-GFP antibody (gift from Anthony Hyman)	Caenorhabditis elegans	Triton X-100; YL524 strain	EXP042530	1394	normal	P91868	young adults, somatic cells	NULL
EXP042536	input	Caenorhabditis elegans	genotype: wild type	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042537	input	Caenorhabditis elegans	genotype: wild type	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042538	input	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G10	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042539	input	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G20	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042540	input	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G20	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042541	input	Caenorhabditis elegans	genotype: eap1-null mutant (strain: ok3432)	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042542	EAP-1 antibody	Caenorhabditis elegans	genotype: wild type	EXP042536	1235	normal	P45968	whole worms (developmental stage: young adults)	NULL
EXP042543	EAP-1 antibody	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G10	EXP042538	1235	normal	P45968	whole worms (developmental stage: young adults)	NULL
EXP042544	EAP-1 antibody	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G20	EXP042539	1235	normal	P45968	whole worms (developmental stage: young adults)	NULL
EXP042545	EAP-1 antibody	Caenorhabditis elegans	genotype: eap1-null mutant (strain: ok3432)	EXP042541	1235	bio_control	P45968	whole worms (developmental stage: young adults)	NULL
EXP042546	EAP-1 antibody	Caenorhabditis elegans	genotype: wild type	EXP042537	1235	normal	P45968	whole worms (developmental stage: young adults)	NULL
EXP042547	EAP-1 antibody	Caenorhabditis elegans	genotype: spr-5 mutant; generation: G20	EXP042540	1235	normal	P45968	whole worms (developmental stage: young adults)	NULL
EXP042548	n/a	Caenorhabditis elegans	strain: HML214	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042549	n/a	Caenorhabditis elegans	strain: HML214	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042550	anti GFP (abcam 290)	Caenorhabditis elegans	strain: HML214; genotype: LIN42 GFP-tagged	NULL	1389	normal	Q65ZG8	whole worms (developmental stage: L4/young adults)	NULL
EXP042551	anti GFP (abcam 290)	Caenorhabditis elegans	strain: HML214; genotype: LIN42 GFP-tagged	NULL	1389	normal	Q65ZG8	whole worms (developmental stage: L4/young adults)	NULL
EXP042552	anti LIN-42(KEA/11 Rabbit 2, PrimmBiotech)	Caenorhabditis elegans	strain: HML214; genotype: LIN42 GFP-tagged	EXP042548	1389	normal	Q65ZG8	whole worms (developmental stage: L4/young adults)	NULL
EXP042553		Drosophila melanogaster	strain: gro-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=gro-GFP.FLAG}attP16, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042554		Caenorhabditis elegans	strain: NC1639, genotype: [wdIs49 (pttr39::UNC-55a::GFP; dpy-20+) III, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042555		Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042556		Drosophila melanogaster	strain: Oregon-R, genotype: wild type	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP042557		Drosophila melanogaster	strain: corto-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=corto-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042558		Drosophila melanogaster	strain: scrt-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=scrt-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042559		Caenorhabditis elegans	strain: OP102, genotype: unc-119(tm4063) III; wgIs102., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042560		Drosophila melanogaster	strain: CG6765-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6765-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042561		Drosophila melanogaster	strain: cwo-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=cwo-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042562		Drosophila melanogaster	strain: odd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=odd-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042563		Caenorhabditis elegans	strain: OP81, genotype: unc-119(ed3) III; wgIs81., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042564		Drosophila melanogaster	strain: NK7.1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NK7.1-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042565		Drosophila melanogaster	strain: Dad-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Dad-GFP.FLAG}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042566		Drosophila melanogaster	strain: CG10669-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG10669-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042567		Drosophila melanogaster	strain: mirr-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=mirr-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042568		Caenorhabditis elegans	strain: OP524, genotype: unc-119(tm4063) III; wgIs524., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042569		Drosophila melanogaster	strain: 5T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=eve-EGFP.S}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042570		Drosophila melanogaster	strain: insv-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=insv-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042571		Drosophila melanogaster	strain: OdsH-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=OdsH-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042572		Drosophila melanogaster	strain: CG4424-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG4424-GFP.FPTB}TBD, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042573		Caenorhabditis elegans	strain: OP92, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042574		Caenorhabditis elegans	strain: OP673, genotype: unc-119 (tm4063) III; wgIs673, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042575		Drosophila melanogaster	strain: CG4820-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG4820-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042576		Caenorhabditis elegans	strain: OP638, genotype: unc-119(tm4063) III; wgIs638., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042577		Drosophila melanogaster	strain: Xbp1-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Xbp1-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042578		Caenorhabditis elegans	strain: OP558, genotype: unc-119(tm4063) III; wgIs558., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042579		Drosophila melanogaster	strain: CG12942-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG12942-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042580		Caenorhabditis elegans	strain: OP167, genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042581		Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042582		Drosophila melanogaster	strain: CG9609-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG9609-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042583		Drosophila melanogaster	strain: HmgD-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HmgD-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042584		Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042585		Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042586		Caenorhabditis elegans	strain: OP429, genotype: unc-119(tm4063) III; wgIs429., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042587		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1403	chip_control	NULL	whole organism	NULL
EXP042588		Drosophila melanogaster	strain: Kr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Kr-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042589		Caenorhabditis elegans	strain: OP533, genotype: unc-119(tm4063) III; wgIs533, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042590		Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042591		Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042592		Drosophila melanogaster	strain: net-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=net-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042593		Caenorhabditis elegans	strain: OP252, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042594		Drosophila melanogaster	strain: Sox14-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox14-GFP.FTBP}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042595		Drosophila melanogaster	strain: Su(var)3-7-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Su(var)3-7-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042596		Drosophila melanogaster	strain: ftz-f1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ftz-f1-GFP.FLAG}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042597		Drosophila melanogaster	strain: Pdp1-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Pdp1[MI01532]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042598		Drosophila melanogaster	strain: chn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=chn-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042599		Drosophila melanogaster	strain: Atf-2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Atf-2-GFP.FLAG}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042600		Caenorhabditis elegans	strain: OP81, genotype: unc-119(ed3) III; wgIs81., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042601		Caenorhabditis elegans	strain: MT10430, genotype: lin-35(n745) I., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042602		Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042603		Drosophila melanogaster	strain: 10T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dfd-EGFP.S}VK00037	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042604		Caenorhabditis elegans	strain: OP106, genotype: unc-119(ed3) III; wgIs106., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042605		Drosophila melanogaster	strain: sage-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=sage-GFP.FTBP}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042606		Caenorhabditis elegans	strain: OP312, genotype: unc-119(ed3) III; wgIs312, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042607		Drosophila melanogaster	strain: CG7056-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=HHEX-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042608		Caenorhabditis elegans	strain: OP484, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042609		Drosophila melanogaster	strain: CG9876-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9876-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042610		Caenorhabditis elegans	strain: OP508, genotype: unc-119(tm4063) III; wgIs508., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042611		Drosophila melanogaster	strain: B-H2-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=B-H2-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042612		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042613		Caenorhabditis elegans	strain: OP563, genotype: unc-119(tm4063) III; wgIs563., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042614		Drosophila melanogaster	strain: CG6792-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG6792-GFP.FPTB}VK00033 / tm6C, sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042615		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042616		Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042617		Caenorhabditis elegans	strain: OP124, genotype: unc-119(ed3) III; wgIs124., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042618		Caenorhabditis elegans	strain: OP569, genotype: unc-119(tm4063); wgIs569 [nhr-111::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042619		Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042620		Drosophila melanogaster	strain: CG6683-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CG6683-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042621		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1403	chip_control	NULL	whole organism	NULL
EXP042622		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042623		Drosophila melanogaster	strain: gfzf-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=gfzf-GFP-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042624		Drosophila melanogaster	strain: E(spl)m-beta-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=E(spl)mbeta-HLH-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042625		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042626		Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	NULL	1403	chip_control	NULL	whole organism	NULL
EXP042627		Caenorhabditis elegans	strain: YL485, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042628		Caenorhabditis elegans	strain: xtl1186, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042629		Caenorhabditis elegans	strain: OP427, genotype: unc-119(ed3) III; wgIs427., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042630		Caenorhabditis elegans	strain: YL507, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042631		Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042632		Caenorhabditis elegans	strain: OP429, genotype: unc-119(tm4063) III; wgIs429., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042633		Drosophila melanogaster	strain: Pum-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}pum[MI04825]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042634		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042635		Caenorhabditis elegans	strain: OP594, genotype: unc-119(tm4063) III; wgIs594, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042636		Caenorhabditis elegans	strain: OP432, genotype: unc-119(tm4063) III; wgIs432., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042637		Caenorhabditis elegans	strain: OP471, genotype: unc-119(tm4063) III; wgIs471., sex:hermaphrodite	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042638		Caenorhabditis elegans	strain: OP478, genotype: unc-119(tm4063) III; wgIs478., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042639		Caenorhabditis elegans	strain: OP327, genotype: unc-119(ed3) III; wgIs327., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042640		Drosophila melanogaster	strain: Delg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets97D-GFP.FLAG}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042641		Caenorhabditis elegans	strain: OP470, genotype: unc-119(tm4063) III; wgIs470., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042642		Drosophila melanogaster	strain: CG3995-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG3995-GFP.FPTB}TBD, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042643		Caenorhabditis elegans	strain: OP614, genotype: unc-119(tm4063); wgIs614 [ztf-3::TY1::EGFP::3xFLAG +;unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042644		Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042645		Drosophila melanogaster	strain: Lpt-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Lpt-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042646		Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042647		Caenorhabditis elegans	strain: OP460, genotype: unc-119(tm4063) III; wgIs460., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042648		Drosophila melanogaster	strain: BEAF-32-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=BEAF-32-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042649		Drosophila melanogaster	strain: CG7987-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG7987-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042650		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042651		Drosophila melanogaster	strain: da-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=da-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042652		Caenorhabditis elegans	strain: OP579, genotype: unc-119(tm4063) III; wgIs579., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042653		Caenorhabditis elegans	strain: OP539, genotype: unc-119(tm4063) III; wgIs539, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042654		Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042655		Caenorhabditis elegans	strain: OP54, genotype: unc-119(ed3) III; wgIs54., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042656		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042657		Drosophila melanogaster	strain: Vsx1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Vsx1-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042658		Caenorhabditis elegans	strain: GOU883, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042659		Drosophila melanogaster	strain: CG33213-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG33213-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042660		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042661		Drosophila melanogaster	strain: Mes4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mes4-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042662		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042663		Caenorhabditis elegans	strain: OP418, genotype: unc-119(tm4063) III; wgIs418., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042664		Caenorhabditis elegans	strain: OP521, genotype: unc-119(tm4063) III; wgIs521, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042665		Caenorhabditis elegans	strain: YL402, genotype: unc119(ed3)III; vrIs56[pPIE-1::LIN-35::GFP FLAG: LIN-35 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042666		Caenorhabditis elegans	strain: OP525, genotype: unc-119(tm4063) III; wgIs525, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042667		Caenorhabditis elegans	strain: OP342, genotype: unc-119(ed3) III; wgIs342., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042668		Drosophila melanogaster	strain: esn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=esn-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042669		Drosophila melanogaster	strain: tj-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tj-GFP.FPTB}VK00033, sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042670		Drosophila melanogaster	strain: CG31388-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG31388-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042671		Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042672		Drosophila melanogaster	strain: CG4318-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG4318-GFP.FTBP}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042673		Caenorhabditis elegans	strain: OP124, genotype: unc-119(ed3) III; wgIs124., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042674		Drosophila melanogaster	strain: dac-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dac-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042675		Caenorhabditis elegans	strain: YL529, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042676		Drosophila melanogaster	strain: ss-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ss-GFP.CD.FPTB}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042677		Caenorhabditis elegans	strain: OP642, genotype: unc-119 (tm4063) III; wgIs642, sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP042678		Drosophila melanogaster	strain: Med-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Med-GFP.FLAG}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042679		Drosophila melanogaster	strain: Sox102F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox102F-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042680		Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042681		Caenorhabditis elegans	strain: OP518, genotype: unc-119(tm4063) III; wgIs518., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042682		Caenorhabditis elegans	strain: OP62, genotype: unc-119(ed3) III; wgIs62, sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042683		Drosophila melanogaster	strain: CG34376-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ADD1-GFP.FPTB}attP40 / CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042684		Drosophila melanogaster	strain: CG4617-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG4617-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042685		Drosophila melanogaster	strain: CG18619-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG18619-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042686		Caenorhabditis elegans	strain: OP615, genotype: unc-119(tm4063) III; wgIs615, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042687		Drosophila melanogaster	strain: pho-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pho-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042688		Caenorhabditis elegans	strain: OP373, genotype: unc-119(tm4063) III; wgIs373., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042689		Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042690		Caenorhabditis elegans	strain: YL581, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042691		Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042692		Drosophila melanogaster	strain: bigmax-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=bigmax-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042693		Drosophila melanogaster	strain: dpn-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}dpn[MI00051]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042694		Drosophila melanogaster	strain: Eip78C-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Eip78C-GFP.FLAG}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042695		Drosophila melanogaster	strain: ss-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ss-GFP.A.FPTB}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042696		Caenorhabditis elegans	strain: OP465, genotype: unc-119(tm4063) III; wgIs465., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042697		Caenorhabditis elegans	strain: OP724, genotype: unc-119(tm4063); wgIs724 [attf-5::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042698		Caenorhabditis elegans	strain: OP727, genotype: unc-119(tm4063); wgIs727 [ceh-83::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042699		Drosophila melanogaster	strain: Rel-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Rel-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042700		Drosophila melanogaster	strain: NfI-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=NfI-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042701		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042702		Drosophila melanogaster	strain: chif-RB-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=chif-RB-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042703		Drosophila melanogaster	strain: topi-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=topi-GFP.FTBP}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042704		Drosophila melanogaster	strain: CG14962-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Asciz-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042705		Drosophila melanogaster	strain: Dip3-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dip3-GFP.FPTB}VK00031, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042706		Drosophila melanogaster	strain: br-re-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=br.Z1-GFP.FPTB}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042707		Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP064981	None	Drosophila melanogaster	Treatment: Treatment: Treatment: none; Strain: Iso1; Strain: Iso1; Strain: Iso1	NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP042709		Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042710		Caenorhabditis elegans	strain: OP370, genotype: unc-119(tm4063) III; wgIs370., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042711		Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042712		Drosophila melanogaster	strain: HLH54F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HLH54F-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042713		Caenorhabditis elegans	strain: OP590, genotype: unc-119(tm4063); wgIs590 [zip-4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042714		Drosophila melanogaster	strain: tx-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tx-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042715		Drosophila melanogaster	strain: CG18764-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG18764-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042716		Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042717		Drosophila melanogaster	strain: Hmr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hmr-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042718		Caenorhabditis elegans	strain: OP82, genotype: unc-119(tm4063) III; wgIs82., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042719		Drosophila melanogaster	strain: brk-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=brk-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042720		Drosophila melanogaster	strain: CG1529-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG1529-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042721		Drosophila melanogaster	strain: ab-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ab-GFP.FLAG}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042722		Caenorhabditis elegans	strain: OP240, genotype: unc-119(ed3) III; wgIs240., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042723		Caenorhabditis elegans	strain: OP185, genotype: unc-119(ed3) III; wgIs185., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042724		Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042725		Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042726		Caenorhabditis elegans	strain: QP0661, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042727		Caenorhabditis elegans	strain: OP636, genotype: unc-119(tm4063) III; wgIs636, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042728		Caenorhabditis elegans	strain: OP656, genotype: unc-119 (tm4063) III; wgIs656, sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP042729		Caenorhabditis elegans	strain: OP496, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042730		Drosophila melanogaster	strain: mam-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}mam[MI03814]/SM6a, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042731		Drosophila melanogaster	strain: GATAd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=GATAd-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042732		Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042733		Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042734		Caenorhabditis elegans	strain: N2, genotype: C. elegans wild isolate., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042735		Drosophila melanogaster	strain: org-1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=org-1-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042736		Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042737		Caenorhabditis elegans	strain: OP523, genotype: unc-119(tm4063) III; wgIs523., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042738		Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042739		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042740		Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042741		Drosophila melanogaster	strain: salr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=salr-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042742		Drosophila melanogaster	strain: CG9437-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG9437-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042743		Caenorhabditis elegans	strain: OP487, sex:hermaphrodite	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP042744		Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:hermaphrodite	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042745		Caenorhabditis elegans	strain: OP70, genotype: unc-119(ed3) III; wgIs70., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042746		Drosophila melanogaster	strain: woc-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=woc-GFP.FTBP}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042747		Caenorhabditis elegans	strain: OP443, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042748		Caenorhabditis elegans	strain: OP707, genotype: unc-119(tm4063) III; wgIs707., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042749		Caenorhabditis elegans	strain: OP102, genotype: unc-119(tm4063) III; wgIs102., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042750		Drosophila melanogaster	strain: cnc-GFP, genotype: W[*]; PBac{eGFP w[+mC]=cnc-GFP.FTBP}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042751		Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042752		Caenorhabditis elegans	strain: OP462, genotype: unc-119(tm4063) III; wgIs462., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042753		Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042754		Drosophila melanogaster	strain: Hr4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr4-GFP.FSTF}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042755		Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042756		Drosophila melanogaster	strain: Usf-GFP, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042757		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042758		Caenorhabditis elegans	strain: OP321, genotype: unc-119(tm4063) III; wgIs321., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042759		Drosophila melanogaster	strain: ind-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ind-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042760		Drosophila melanogaster	strain: foxo-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=foxo-GFP.FLAG}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042761		Drosophila melanogaster	strain: CG1233-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG1233-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042762		Caenorhabditis elegans	strain: OP198, genotype: unc-119(ed3) III; wgIs198., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042763		Drosophila melanogaster	strain: fd85E-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=fd85E-GFP.FPTB}attP-40 / CyO, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042764		Drosophila melanogaster	strain: EcR-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=EcR-EGFP.S}VK00033	NULL	1403	chip_control	NULL	whole organism	NULL
EXP042765		Caenorhabditis elegans	strain: YL651, genotype: let-607(tm1423); unc-119(ed3) III; vrIs121[LET-607 fosmid, unc-119 (+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042766		Caenorhabditis elegans	strain: OP474, genotype: unc-119(tm4063) III; wgIs474., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042767		Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042768		Caenorhabditis elegans	strain: OP662, genotype: unc-119(tm4063) III; wgIs662, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042769		Drosophila melanogaster	strain: Oregon-R, genotype: wild type	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP042770		Drosophila melanogaster	strain: CG5180-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG5180-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042771		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1403	chip_control	NULL	whole organism	NULL
EXP042772		Drosophila melanogaster	strain: cato-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=cato-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042773		Drosophila melanogaster	strain: Sry-beta-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=sry-Beta-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042774		Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042775		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042776		Caenorhabditis elegans	strain: OP241, genotype: unc-119(ed3) III; wgIs241., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042777		Drosophila melanogaster	strain: rgr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=rgr-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042778		Caenorhabditis elegans	strain: OP488, genotype: unc-119(tm4063) III; wgIs488., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042779		Drosophila melanogaster	strain: tio-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tio-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042780		Drosophila melanogaster	strain: jing-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=jing-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042781		Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042782		Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042783		Drosophila melanogaster	strain: 10T-Dfd-GFP, genotype: y[1] M{vas-int.Dm}ZH-2A w[*]; PBac{y[+]-attP-3B}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042784		Drosophila melanogaster	strain: maf-S-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=maf-S-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042785		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042786		Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042787		Drosophila melanogaster	genotype: e/se	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP042788		Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042789		Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042790		Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042791		Caenorhabditis elegans	strain: OP117, genotype: unc-119(ed3) III; wgIs117., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042792		Drosophila melanogaster	strain: Pif1A-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pif1A-GFP.FPTB}VK00037, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP042793		Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042794		Caenorhabditis elegans	strain: OP640, genotype: unc-119(tm4063) III; wgIs640., sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP042795		Drosophila melanogaster	strain: CG7556-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7556-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042796		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042797		Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042798		Caenorhabditis elegans	strain: YL563, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042799		Drosophila melanogaster	strain: CG15812-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG15812-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042800		Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042801		Caenorhabditis elegans	strain: OP609, genotype: unc-119(tm4063) III; wgIs609, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042802		Drosophila melanogaster	strain: Fer1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer1-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042803		Caenorhabditis elegans	strain: OP214, genotype: unc-119(ed3) III; wgIs214., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042804		Caenorhabditis elegans	strain: OP51, genotype: unc-119(ed3) III; wgIs51., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042805		Caenorhabditis elegans	strain: OP208, genotype: unc-119(ed3) III; wgIs208., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042806		Drosophila melanogaster	strain: ATbp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ATbp-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042807		Caenorhabditis elegans	strain: OP676, genotype: unc-119(tm4063); wgIs676 [ztf-22::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042808		Caenorhabditis elegans	strain: OP517, genotype: unc-119(tm4063) III; wgIs517., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042809		Caenorhabditis elegans	strain: OP562, genotype: unc-119(tm4063) III; wgIs562, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042810		Caenorhabditis elegans	strain: YL424, genotype: unc-119(ed3)III; vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042811		Caenorhabditis elegans	strain: OP512, genotype: unc-119(tm4063) III; wgIs512., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042812		Caenorhabditis elegans	strain: OP522, genotype: unc-119(tm4063) III; wgIs522., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042813		Drosophila melanogaster	strain: disco-r-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=disco-r-EGFP.S}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042814		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042815		Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042816		Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042817		Drosophila melanogaster	strain: CG6276-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6276-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042818		Drosophila melanogaster	strain: fkh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=fkh-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042819		Drosophila melanogaster	strain: MTF-1-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=MTF-1-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042820		Drosophila melanogaster	strain: CG3919-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG3919-GFP.FTBP}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042821		Caenorhabditis elegans	strain: OP537, genotype: unc-119(tm4063) III; wgIs537, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042822		Drosophila melanogaster	strain: dsf-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dsf-GFP.FLAG}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042823		Drosophila melanogaster	strain: ERR-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ERR-GFP.FSTF}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042824		Drosophila melanogaster	strain: Neu2-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=Neu2-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042825		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042826		Drosophila melanogaster	strain: E(bx)-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=E(bx)-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042827		Drosophila melanogaster	strain: CG13624-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG13624-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042828		Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042829		Caenorhabditis elegans	strain: OP202, genotype: unc-119(ed3) III; wgIs202., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042830		Caenorhabditis elegans	strain: YL472, genotype: unc-119(ed3) III; vrEx66 [pMEX-5::HPL-2:GFP:FLAG::HPL-2 3-UTR, unc-119 (+)]), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042831		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042832		Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042833		Drosophila melanogaster	strain: kni-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=kni-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042834		Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042835		Drosophila melanogaster	strain: CG9139-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Rabex-5-GFP.FTBP}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042836		Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042837		Drosophila melanogaster	strain: OdsH-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=OdsH-GFP.FPTB}VK00033	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042838		Caenorhabditis elegans	strain: OP178, genotype: unc-119(ed3) III; wgIs178., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042839		Caenorhabditis elegans	strain: OP86, genotype: unc-119(ed3) III; wgIs86., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042840		Drosophila melanogaster	strain: fd64A-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=FoxL1-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042841		Caenorhabditis elegans	strain: OP342, genotype: unc-119(ed3) III; wgIs342., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042842		Drosophila melanogaster	strain: AntP-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Antp[MI02272]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042843		Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042844		Drosophila melanogaster	strain: CTCF-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CTCF-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042845		Caenorhabditis elegans	strain: XIL99, sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042846		Drosophila melanogaster	strain: CG1792-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG1792-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042847		Drosophila melanogaster	strain: Notch-GFP, genotype: PBac{y[+]-attP-3B}VK00033	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042848		Caenorhabditis elegans	strain: OP528, genotype: wgIs528(snu-23::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0094_4B11);unc-119(+));unc-119 (tm4063), sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042849		Drosophila melanogaster	strain: CG30431-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG30431-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042850		Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042851		Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042852		Drosophila melanogaster	strain: Bteb2-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Bteb2-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042853		Drosophila melanogaster	strain: Esplmgamma-HLH-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)mgamma-HLH-GFP.FPTB}attP-40 / CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042854		Drosophila melanogaster	strain: Met-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Met-GFP.FTBP}VK00031, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042855		Drosophila melanogaster	strain: Blimp-1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Blimp-1-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042856		Caenorhabditis elegans	strain: OP358, genotype: unc-119(tm4063) III; wgIs358., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042857		Drosophila melanogaster	strain: Mio-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mio-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042858		Caenorhabditis elegans	strain: OP82, genotype: unc-119(tm4063) III; wgIs82., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042859		Caenorhabditis elegans	strain: OP385, genotype: unc-119(tm4063) III; wgIs385., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042860		Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042861		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042862		Caenorhabditis elegans	strain: OP463, genotype: unc-119(tm4063) III; wgIs463., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042863		Caenorhabditis elegans	strain: OP73, genotype: unc-119(ed3) III; wgIs73, sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042864		Caenorhabditis elegans	strain: OP651, genotype: unc-119(tm4063); wgIs651 [bed-3::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042865		Drosophila melanogaster	strain: pb-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pb-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042866		Caenorhabditis elegans	strain: OP541, genotype: unc-119(tm4063) III; wgIs541, sex:hermaphrodite	NULL	1396	chip_control	NULL	whole organism (development stage: midembryonic)	NULL
EXP042867		Drosophila melanogaster	strain: CG17186-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17186-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042868		Caenorhabditis elegans	strain: ZM7247, genotype: daf-16(mu86);daf-2(e1370) III; hpSi4II (Pmyo-3 GFP::daf-16a), sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042869		Drosophila melanogaster	strain: Hr38-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr38-GFP.FLAG}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042870		Caenorhabditis elegans	strain: OP515, genotype: unc-119(tm4063) III; wgIs515., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042871		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042872		Drosophila melanogaster	strain: BtbVII-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=BtbVII-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042873		Caenorhabditis elegans	strain: OP489, genotype: unc-119(tm4063) III; wgIs489., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042874		Drosophila melanogaster	strain: Mnt-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mnt-GFP.FPTB}VK00033/TM3, Sb[1], sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042875		Drosophila melanogaster	strain: CHES-1-like-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CHES-1-like-EGFP.S}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042876		Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042877		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042878		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042879		Drosophila melanogaster	strain: Eip93F-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Eip93F[MI05200]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042880		Caenorhabditis elegans	strain: OP500, genotype: unc-119(tm4063) III; wgIs500., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042881		Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042882		Caenorhabditis elegans	strain: YL478, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042883		Drosophila melanogaster	strain: p53-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}p53[MI01307]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042884		Drosophila melanogaster	strain: sima-RB-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sima-GFP.B.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042885		Drosophila melanogaster	strain: CG12768-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG12768-GFP.FPTB}attP40, sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042886		Drosophila melanogaster	strain: CG10274-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CG10274-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042887		Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042888		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042889		Caenorhabditis elegans	strain: OP529, genotype: unc-119(tm4063) III; wgIs529., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042890		Drosophila melanogaster	strain: Sox15-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Sox15-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042891		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042892		Drosophila melanogaster	strain: ADD1-MiMIC-GFP, genotype: y[1] w[*]; Mi{y[+mDint2]=MIC}ADD1[MI09552], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042893		Caenorhabditis elegans	strain: YL577, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042894		Drosophila melanogaster	strain: CG13775-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG13775-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042895		Caenorhabditis elegans	strain: OP391, genotype: unc-119(ed3) III; wgIs391(med-1::TY1 EGFP FLAG C; unc-119(+)), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042896		Drosophila melanogaster	strain: snoo-MiMIC, genotype: y[1] w[*]; Mi{eGFP=MIC}snoo[MI07577]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP042897		Drosophila melanogaster	strain: grn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=grn-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042898		Drosophila melanogaster	strain: trh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=trh-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042899		Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042900		Drosophila melanogaster	strain: CG15011-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG15011-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042901		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042902		Drosophila melanogaster	strain: cic-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=cic-GFP.FPTB}VK00037, sex:mixed	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042903		Drosophila melanogaster	strain: side-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}side[MI00149]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042904		Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042905		Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042906		Drosophila melanogaster	strain: SuHw-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=su(Hw)-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042907		Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042908		Caenorhabditis elegans	strain: OP739, genotype: unc-119(tm4063); wgIs739 [ceh-19::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042909		Drosophila melanogaster	strain: CG5204-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG5204-GFP.FPTB}VK00033, sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042910		Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042911		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042912		Drosophila melanogaster	strain: sv-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sv-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042913		Drosophila melanogaster	strain: toe-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=toe-GFP.FPTB}VK00037, sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042914		Caenorhabditis elegans	strain: OP646, genotype: unc-119(tm4063) III; wgIs646, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042915		Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042916		Caenorhabditis elegans	strain: OP698, genotype: unc-119(tm4063) III; wgIs698., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042917		Caenorhabditis elegans	strain: OP154, genotype: unc-119(ed3) III; wgIs154, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042918		Drosophila melanogaster	strain: caup-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=caup-GFP.FTBP}VK00037/CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042919		Caenorhabditis elegans	strain: RW10470, genotype: stIs10470 [tbx-8::TY1::EGFP::3xFLAG; unc-119(+)]; unc-119(ed3), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042920		Caenorhabditis elegans	strain: OP534, genotype: unc-119(tm4063) III; wgIs534, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042921		Drosophila melanogaster	strain: MESR4-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=MESR4-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042922		Drosophila melanogaster	strain: Cad-GFP-7T, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=cad-EGFP.S}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042923		Drosophila melanogaster	strain: Chrac-16-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Chrac-16-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042924		Caenorhabditis elegans	strain: OP190, genotype: unc-119(ed3) III; wgIs190., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042925		Drosophila melanogaster	strain: CG2116-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2116-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042926		Caenorhabditis elegans	strain: OP708, genotype: unc-119(tm4063); wgIs708 [C38D4.7::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042927		Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042928		Drosophila melanogaster	strain: CG17385-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=nerfin-1-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042929		Drosophila melanogaster	strain: CG12744-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG12744-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042930		Caenorhabditis elegans	strain: OP703, genotype: unc-119(tm4063); wgIs703 [spr-3::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042931		Drosophila melanogaster	strain: CG17568-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG17568-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042932		Drosophila melanogaster	strain: CG3407-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG3407-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042933		Caenorhabditis elegans	strain: OP43, genotype: unc-119(ed3) III; wgIs43., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042934		Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042935		Caenorhabditis elegans	strain: OP388, genotype: unc-119(ed3) III; wgIs388, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042936		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042937		Caenorhabditis elegans	strain: OR3349, sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042938		Drosophila melanogaster	strain: CG17912-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=BuGZ-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042939		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042940		Drosophila melanogaster	strain: CG3281-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG3281-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042941		Caenorhabditis elegans	strain: OP536, genotype: unc-119(tm4063) III; wgIs536, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042942		Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042943		Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042944		Drosophila melanogaster	strain: CG10631-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10631-GFP.FTBP}VK00033	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042945		Drosophila melanogaster	strain: CG6854-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG45071-GFP.FPTB}attP40/CyO, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP042946		Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042947		Caenorhabditis elegans	strain: YL448, genotype: unc-119(ed3)III; vrIs83 [pGES-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042948		Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042949		Drosophila melanogaster	strain: E(spl)m3-HLH-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)m3-HLH-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042950		Drosophila melanogaster	strain: A3-3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Atf3-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042951		Caenorhabditis elegans	strain: OP709, genotype: unc-119(tm4063); wgIs709 [T23F11.4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042952		Caenorhabditis elegans	strain: OP611, genotype: unc-119(tm4063); wgIs611 [sup-37::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042953		Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042954		Drosophila melanogaster	strain: Clk-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Clk-GFP.FPTB}attP40, sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP042955		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1403	chip_control	NULL	whole organism	NULL
EXP042956		Drosophila melanogaster	strain: CG4328-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG4328-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042957		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042958		Drosophila melanogaster	strain: CG2120-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2120-GFP.FTBP}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042959		Drosophila melanogaster	strain: Meics-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=Meics-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042960		Caenorhabditis elegans	strain: OP688, genotype: unc-119(tm4063) III; wgIs688., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042961		Drosophila melanogaster	strain: CG9727-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG9727-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042962		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042963		Caenorhabditis elegans	strain: OP26, genotype: unc-119(ed3) III; wgIs26 [unc-119(+) mab-5::TY1::EGFP::3xFLAG], sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042964		Drosophila melanogaster	strain: Su(H)-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Su(H)-GFP.FLAG}attP2, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042965		Caenorhabditis elegans	strain: OP196, genotype: unc-119(ed3) III; wgIs196., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042966		Drosophila melanogaster	strain: CG6254-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6254-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042967		Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042968		Caenorhabditis elegans	strain: LW1254, genotype: jjIs1254[Im486.2: pJKL723.2(sma-9C2::gfp+unc-119(+) ]; unc-119(ed4), sex:hermaphrodite	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042969		Drosophila melanogaster	strain: dmrt93B-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=dmrt93B-GFP.FPTB}attP-40, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042970		Drosophila melanogaster	strain: E(var)3-9-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=E(var)3-9-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042971		Caenorhabditis elegans	strain: OP63, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042972		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042973		Caenorhabditis elegans	strain: OP178, genotype: unc-119(ed3) III; wgIs178., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042974		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042975		Drosophila melanogaster	strain: mod(mdg4)-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=mod(mdg4)-GFP.FTBP}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042976		Caenorhabditis elegans	strain: OP332, genotype: unc-119(tm4063) III; wgIs332., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042977		Caenorhabditis elegans	strain: OP568, genotype: unc-119(tm4063) III; wgIs568, sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP042978		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042979		Drosophila melanogaster	strain: Hr46-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr46-GFP.FLAG}VK00033/TM3, Sb[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042980		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042981		Drosophila melanogaster	strain: Hsf-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Hsf-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042982		Caenorhabditis elegans	strain: OP389, genotype: unc-119(tm4063) III; wgIs389., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042983		Caenorhabditis elegans	strain: OP361, genotype: unc-119(tm4063) III; wgIs361., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042984		Caenorhabditis elegans	strain: OP560, genotype: unc-119(tm4063) III; wgIs560, sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP042985		Drosophila melanogaster	strain: shn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=shn-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042986		Drosophila melanogaster	strain: crp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=crp-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042987		Caenorhabditis elegans	strain: OP100, genotype: unc-119(tm4063) III; wgIs100., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042988		Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP042989		Caenorhabditis elegans	strain: OP68, genotype: unc-119(ed3) III; wgIs68., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042990		Caenorhabditis elegans	strain: OP493, genotype: unc-119(tm4063) III; wgIs493., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP042991		Caenorhabditis elegans	strain: YL479, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP042992		Drosophila melanogaster	strain: CG32264-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG32264-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP042993		Drosophila melanogaster	strain: CG16863-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG16863-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042994		Drosophila melanogaster	strain: kay-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=kay-GFP.FLAG}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP042995		Caenorhabditis elegans	strain: OP502, genotype: unc-119(tm4063) III; wgIs502., sex:hermaphrodite	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP042996		Caenorhabditis elegans	strain: OP532, genotype: unc-119(tm4063) III; wgIs532, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP042997		Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP042998		Caenorhabditis elegans	strain: OP696, genotype: unc-119(tm4063) III; wgIs696., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP042999		Drosophila melanogaster	strain: chif-RA-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=chif-RA-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043000		Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043001		Caenorhabditis elegans	strain: CS152, genotype: sma-3(wk30);qcIs[gfp::sma-3+rol-6], sex:hermaphrodite	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043002		Drosophila melanogaster	strain: foxo-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}foxo[MI00493]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043003		Drosophila melanogaster	strain: CG14655-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG14655-GFP.FPTB}attP40, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP043004		Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:hermaphrodite	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043005		Caenorhabditis elegans	strain: OP509, genotype: unc-119(tm4063) III; wgIs509., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043006		Caenorhabditis elegans	strain: OP606, genotype: unc-119(tm4063) III; wgIs606, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043007		Caenorhabditis elegans	strain: OP345, genotype: unc-119(ed3) III; wgIs345., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043008		Caenorhabditis elegans	strain: OP78, genotype: unc-119(ed3) III; wgIs78, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043009		Drosophila melanogaster	strain: jim-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=jim-GFP.FPTB}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043010		Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043011		Drosophila melanogaster	strain: CG4854-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG4854-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043012		Drosophila melanogaster	strain: Pif1B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pif1B-GFP.FPTB}VK00037, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP043013		Drosophila melanogaster	strain: slou-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=slou-EGFP.S}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043014		Caenorhabditis elegans	strain: OP682, genotype: unc-119(tm4063); wgIs682 [Y5F2A.4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043015		Caenorhabditis elegans	strain: RW10325, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043016		Caenorhabditis elegans	strain: NC1639, genotype: [wdIs49 (pttr39::UNC-55a::GFP; dpy-20+) III, sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043017		Drosophila melanogaster	strain: CG8319-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG8319-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043018		Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043019		Caenorhabditis elegans	strain: OP602, sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043020		Drosophila melanogaster	strain: CG16779-MiMIC, genotype: y[1] w[*]; Mi{eGFP=MIC}CG16779[MI06036]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043021		Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043022		Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043023		Drosophila melanogaster	strain: CG12071-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG12071-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043024		Drosophila melanogaster	strain: Dhr51-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr51-GFP.FLAG}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043025		Caenorhabditis elegans	strain: OP565, genotype: unc-119(tm4063) III; wgIs565., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043026		Caenorhabditis elegans	strain: OP311, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043027		Drosophila melanogaster	strain: tai-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tai-GFP.FLAG}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043028		Drosophila melanogaster	strain: CG12236-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG12236-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043029		Drosophila melanogaster	strain: dm-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dm-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043030		Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043031		Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043032		Caenorhabditis elegans	strain: YL409, genotype: unc-119(ed3)III; vrIs60 [pLIN-35::LIN-35:GFP:FLAG::LIN-35 3â€™UTR, unc-119 (+)]), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043033		Caenorhabditis elegans	strain: OP620, genotype: unc-119(tm4063) III; wgIs620, sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP043034		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043035		Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043036		Caenorhabditis elegans	strain: OP27, genotype: unc-119(ed3) III; wgIs27., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043037		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043038		Drosophila melanogaster	strain: CG15514-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG15514-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043039		Drosophila melanogaster	strain: crc-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}crc[MI02300]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043040		Caenorhabditis elegans	strain: OP395, genotype: unc-119(tm4063) III; wgIs395., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043041		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043042		Caenorhabditis elegans	strain: YL474, genotype: lin-35(n745) I; unc-119(ed3) III; vrIs64[pGES-1::HPL-2::GFP FLAG: HPL-2 3-UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043043		Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043044		Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043045		Drosophila melanogaster	strain: Eip74EF-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Eip74EF-GFP.FLAG}VK00037	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043046		Drosophila melanogaster	strain: CG2875-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2875-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043047		Drosophila melanogaster	strain: Hr83-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr83-GFP.FPTB}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043048		Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043049		Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043050		Drosophila melanogaster	strain: lz-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lz-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043051		Drosophila melanogaster	strain: Hr39-RC-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr39-GFP.C.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043052		Caenorhabditis elegans	strain: OP418, genotype: unc-119(tm4063) III; wgIs418., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043053		Caenorhabditis elegans	strain: YL482, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043054		Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043055		Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043056		Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043057		Drosophila melanogaster	strain: wek-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=wek-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043058		Caenorhabditis elegans	strain: OP339, genotype: unc-119(ed3) III; wgIs339., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043059		Drosophila melanogaster	strain: CG10209-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10209-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043060		Drosophila melanogaster	strain: 15T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=h-EGFP.S}VK00037, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043061		Drosophila melanogaster	strain: lbe-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=lbe-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043062		Drosophila melanogaster	strain: Myb-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=Myb-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043063		Drosophila melanogaster	strain: svp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=svp-GFP.FLAG}VK00037/SM5, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043064		Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043065		Drosophila melanogaster	strain: d.ets6-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets21C-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043066		Drosophila melanogaster	strain: HLHm7-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HLHm7-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043067		Caenorhabditis elegans	strain: OP399, genotype: unc-119(tm4063) III; wgIs399., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043068		Drosophila melanogaster	strain: Pita-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pita-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043069		Caenorhabditis elegans	strain: OP587, genotype: unc-119(tm4063) III; wgIs587., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043070		Drosophila melanogaster	strain: repo-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=repo-GFP.FTBP}VK00037/CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043071		Drosophila melanogaster	strain: luna-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}luna[MI05859]/SM6a, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043072		Drosophila melanogaster	strain: CG8359-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=hng2-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043073		Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043074		Caenorhabditis elegans	strain: YL557, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043075		Caenorhabditis elegans	strain: TH184, genotype:  unc-119(ed3) III; ddIs101, sex:hermaphrodite	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043076		Drosophila melanogaster	genotype: e/se	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP043077		Caenorhabditis elegans	strain: OP572, genotype: unc-119(tm4063); wgIs572 [gei-17::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043078		Caenorhabditis elegans	strain: OP324, genotype: unc-119(ed3) III; wgIs324., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043079		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1410	chip_control	NULL	whole organism (development stage: dauer)	NULL
EXP043080		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043081		Caenorhabditis elegans	strain: OP517, genotype: unc-119(tm4063) III; wgIs517., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043082		Caenorhabditis elegans	strain: OP510, genotype: unc-119(tm4063) III; wgIs510., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043083		Caenorhabditis elegans	strain: RW10316, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043084		Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043085		Caenorhabditis elegans	strain: OP608, genotype: unc-119(tm4063); wgIs608 [Y55F3AM.14::TY::EGFP::3xFLAG(p_wTRG5_insertion_c_0075_1C04) + unc-119(+)], sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043086		Caenorhabditis elegans	strain: OP566, genotype: unc-119(tm4063) III; wgIs566, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043087		Drosophila melanogaster	strain: bab2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bab2-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043088		Drosophila melanogaster	strain: CG7045-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7045-GFP.FTBP}VK00037, sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043089		Drosophila melanogaster	strain: CG3065-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG3065-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043090		Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043091		Drosophila melanogaster	strain: CG3163-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG3163-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043092		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043093		Caenorhabditis elegans	strain: OP193, genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119), sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043094		Drosophila melanogaster	strain: ewg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ewg-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043095		Drosophila melanogaster	strain: CG11762-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG11762-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043096		Drosophila melanogaster	strain: vri-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=vri-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043097		Drosophila melanogaster	strain: NC2beta-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NC2Beta-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043098		Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043099		Caenorhabditis elegans	strain: OP240, genotype: unc-119(ed3) III; wgIs240., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043100		Caenorhabditis elegans	strain: OP55, genotype: unc-119(ed3) III; wgIs55., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043101		Drosophila melanogaster	strain: CG6654-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6654-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043102		Drosophila melanogaster	strain: CG9705-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG9705-GFP.FPTB}attP40, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043103		Caenorhabditis elegans	strain: AGK541, genotype: (armSi1[Pmex5::UNC-130::GFP::tbb-2 3'UTR; cb-unc-119(+)II]; unc-119(ed3)III; niDf199IV), sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043104		Caenorhabditis elegans	strain: OP645, genotype: unc-119(tm4063) III; wgIs645, sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043105		Caenorhabditis elegans	strain: OP219, genotype: unc-119(ed3) III; wgIs219., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043106		Caenorhabditis elegans	strain: OP210, genotype: unc-119(ed3) III; wgIs210., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043107		Caenorhabditis elegans	strain: OP659, genotype: unc-119(tm4063) III; wgIs659, sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043108		Caenorhabditis elegans	strain: OP631, genotype: unc-119(tm4063) III; wgIs631, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043109		Drosophila melanogaster	strain: ovo-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ovo-GFP.FPTB}VK00033/TM3, Sb[1], sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043110		Drosophila melanogaster	strain: CG6813-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6813-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043111		Caenorhabditis elegans	strain: OP605, genotype: unc-119(tm4063) III; wgIs605., sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP043112		Drosophila melanogaster	strain: 8T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=tll-EGFP.S}VK00037	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043113		Drosophila melanogaster	strain: Crg-1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Crg-1-GFP.FTBP}VK00033, sex:mixed	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043114		Drosophila melanogaster	strain: jumu-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}jumu[MI00438]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043115		Caenorhabditis elegans	strain: OP200, genotype: unc-119(ed3) III; wgIs200., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043116		Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043117		Drosophila melanogaster	strain: Stat92E-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Stat92E-GFP.FLAG}VK00037	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043118		Drosophila melanogaster	strain: CG32006-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG32006-GFP.FTBP}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043119		Caenorhabditis elegans	strain: OP323, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043120		Caenorhabditis elegans	strain: OP538, genotype: unc-119(tm4063) III; wgIs538, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043121		Drosophila melanogaster	strain: TFAM-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=TFAM-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043122		Caenorhabditis elegans	strain: OP173, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043123		Caenorhabditis elegans	strain: YL390, genotype: unc119(ed3)III; vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043124		Drosophila melanogaster	strain: CG11723-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG11723-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043125		Drosophila melanogaster	strain: Oregon-R, genotype: wild type	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP043126		Drosophila melanogaster	strain: CG18599-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG18599-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043127		Drosophila melanogaster	strain: CG1602-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG1602-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043128		Drosophila melanogaster	strain: sens-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=FTSF.GFP-sens}VK00022, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043129		Drosophila melanogaster	strain: lab-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=lab-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043130		Drosophila melanogaster	strain: NC2alpha-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NC2alpha-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043131		Caenorhabditis elegans	strain: OP471, genotype: unc-119(tm4063) III; wgIs471., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043132		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043133		Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043134		Caenorhabditis elegans	strain: RW12085, genotype: pat-9(mNG^SEC^3xFlag::pat-9]) X, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043135		Caenorhabditis elegans	strain: OP425, genotype: unc-119(tm4063) III; wgIs425., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043136		Drosophila melanogaster	strain: CG7928-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=ZIPIC-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043137		Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043138		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043139		Drosophila melanogaster	strain: Oregon-R, genotype: wild type	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP043140		Drosophila melanogaster	strain: CG31627-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG31627-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043141		Caenorhabditis elegans	strain: OP164, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043142		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043143		Drosophila melanogaster	strain: bsh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bsh-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043144		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043145		Caenorhabditis elegans	strain: RW10702, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043146		Caenorhabditis elegans	strain: OP401, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043147		Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043148		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043149		Drosophila melanogaster	strain: crp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=crp-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043150		Drosophila melanogaster	strain: CG11902-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG11902-GFP.FPTB}VK00037 / CyO, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043151		Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043152		Caenorhabditis elegans	strain: OP62, genotype: unc-119(ed3) III; wgIs62, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043153		Drosophila melanogaster	strain: CG3838-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG3838-GFP.FTBP}VK00033/TM3, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043154		Caenorhabditis elegans	strain: OP485, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043155		Drosophila melanogaster	strain: CG7368-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG7368-GFP.FPTB}attP-40 / tm6C, sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043156		Caenorhabditis elegans	strain: YL521, genotype: unc-119(ed3) III; vrIs117 [pPIE-1::LIN-35:GFP:FLAG::PUF-5 3'UTR, unc-119 (+)]), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043157		Caenorhabditis elegans	strain: OP573, genotype: unc-119(tm4063) III; wgIs573, sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP043158		Caenorhabditis elegans	strain: OP553, genotype: unc-119(tm4063) III; wgIs553., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043159		Drosophila melanogaster	strain: Abd-B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Abd-B-EGFP.S}VK00037/SM57	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043160		Caenorhabditis elegans	strain: YL576, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043161		Caenorhabditis elegans	strain: OP239, genotype: unc-119(ed3) III; wgIs239., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043162		Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043163		Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043164		Caenorhabditis elegans	strain: OP477, genotype: unc-119(tm4063) III; wgIs477., sex:hermaphrodite	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043165		Drosophila melanogaster	strain: Smox-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Smox-GFP.FLAG}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043166		Caenorhabditis elegans	strain: OP222, genotype: unc-119(ed3) III; wgIs222., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043167		Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043168		Drosophila melanogaster	strain: fu2-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=fu2-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043169		Drosophila melanogaster	strain: lilli-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lilli-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043170		Drosophila melanogaster	strain: CG13296-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG13296-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043171		Caenorhabditis elegans	strain: OP27, genotype: unc-119(ed3) III; wgIs27., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043172		Drosophila melanogaster	strain: sc-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sc-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043173		Drosophila melanogaster	strain: D-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=D-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043174		Caenorhabditis elegans	strain: OP622, genotype: unc-119(tm4063) III; wgIs622, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043175		Drosophila melanogaster	strain: Dp-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dp-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043176		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043177		Drosophila melanogaster	strain: Hr46-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr46-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043178		Drosophila melanogaster	strain: Hr96-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=FTSF.GFP-Hr96}VK00037, sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043179		Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043180		Drosophila melanogaster	strain: eyg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=eyg-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043181		Caenorhabditis elegans	strain: OP658, genotype: unc-119(tm4063) III; wgIs658., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043182		Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043183		Drosophila melanogaster	strain: CG1647-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG1647-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043184		Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043185		Caenorhabditis elegans	strain: OP670, genotype: unc-119(tm4063); wgIs670 [sdz-12::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043186		Drosophila melanogaster	strain: CG34406-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG44002-GFP.FTBP}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043187		Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043188		Drosophila melanogaster	strain: Camta-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Camta[MI04570]/SM6a, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043189		Drosophila melanogaster	strain: ets3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets65A-GFP.FLAG}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043190		Caenorhabditis elegans	strain: OP57, genotype: unc-119(ed3) III; wgIs57., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043191		Drosophila melanogaster	strain: CG10565-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10565-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043192		Caenorhabditis elegans	strain: XE1464, genotype: unc-119(ed3) III;, sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043193		Drosophila melanogaster	strain: CG6808-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6808-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043194		Drosophila melanogaster	strain: Mad-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mad-GFP.FLAG}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043195		Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043196		Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043197		Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043198		Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043199		Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043200		Caenorhabditis elegans	strain: OP120, genotype: unc-119(ed3) III; wgIs120., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043201		Caenorhabditis elegans	strain: OP241, genotype: unc-119(ed3) III; wgIs241., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043202		Drosophila melanogaster	strain: CG14965-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG14965-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043203		Drosophila melanogaster	strain: dpn-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=dpn-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043204		Drosophila melanogaster	strain: gcm2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=gcm2-GFP.FLAG}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043205		Drosophila melanogaster	strain: CG1620-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG1620-GFP-GFP.FPTB}VK00033, sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043206		Caenorhabditis elegans	strain: OP480, genotype: unc-119(tm4063) III; wgIs480., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043207		Drosophila melanogaster	strain: Six4-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=Six4-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043208		Drosophila melanogaster	strain: Hnf4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hnf4-GFP.FLAG}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043209		Drosophila melanogaster	strain: 1T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=bcd-EGFP.S}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043210		Drosophila melanogaster	strain: fd59A-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=fd59A-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043211		Drosophila melanogaster	strain: CG12219-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12219-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043212		Caenorhabditis elegans	strain: OP90, genotype: unc-119(ed3) III; wgIs90., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043213		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043214		Drosophila melanogaster	strain: Jra-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Jra-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043215		Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043216		Caenorhabditis elegans	strain: OP315, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043217		Drosophila melanogaster	strain: CG13123-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG13123-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043218		Drosophila melanogaster	strain: CG11617-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG11617-GFP.FPTB}VK00033, sex:mixed	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043219		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043220		Caenorhabditis elegans	strain: OP215, genotype: unc-119(ed3) III; wgIs215., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043221		Drosophila melanogaster	strain: CG9883-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9883-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043222		Caenorhabditis elegans	strain: OP239, genotype: unc-119(ed3) III; wgIs239., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043223		Drosophila melanogaster	strain: CG12104-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12104-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043224		Drosophila melanogaster	strain: Hr78-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr78-GFP.FLAG}VK00037	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043225		Caenorhabditis elegans	strain: YL418, genotype: unc-119(ed3)III; vrIs65[pGES-1::EFL-1::GFP FLAG:EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043226		Drosophila melanogaster	strain: vfl-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=vfl-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043227		Drosophila melanogaster	strain: CG12155-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG12155-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043228		Drosophila melanogaster	strain: CG4282-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG4282-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043229		Drosophila melanogaster	strain: Lhr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Lhr-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043230		Caenorhabditis elegans	strain: OP43, genotype: unc-119(ed3) III; wgIs43., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043231		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043232		Caenorhabditis elegans	strain: OP746, genotype: unc-119(tm4063); wgIs746 [tbp-1::TY1 EGFP 3xFLAG(GlyStock16H06_GlyStock16H06) + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043233		Caenorhabditis elegans	strain: OP677, genotype: unc-119(tm4063) III; wgIs677, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043234		Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043235		Drosophila melanogaster	strain: CG10462-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10462-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043236		Caenorhabditis elegans	strain: OP462, genotype: unc-119(tm4063) III; wgIs462., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043237		Drosophila melanogaster	strain: CG12659-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG12659-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043238		Caenorhabditis elegans	strain: OP372, genotype: unc-119(tm4063) III; wgIs372., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043239		Drosophila melanogaster	strain: achi-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=achi-GFP.FTBP}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043240		Caenorhabditis elegans	strain: OP154, genotype: unc-119(ed3) III; wgIs154, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043241		Caenorhabditis elegans	strain: OP578, genotype: unc-119(tm4063) III; wgIs578, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043242		Caenorhabditis elegans	strain: OP343, genotype: unc-119(ed3) III; wgIs343., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043243		Caenorhabditis elegans	strain: YL468, genotype: unc-119(ed3)III; vrIs93 [pMEX-5::LIN-35:GFP:FLAG::LIN-35 3â€™UTR, unc-119 (+)]), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043244		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043245		Drosophila melanogaster	strain: ey-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ey-GFP.FPTB}VK00033, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043246		Drosophila melanogaster	strain: CG18011-GFP, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043247		Caenorhabditis elegans	strain: OP581, genotype: unc-119(tm4063) III; wgIs581., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043248		Drosophila melanogaster	strain: Ash1-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ash1-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043249		Caenorhabditis elegans	strain: YL487, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043250		Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043251		Caenorhabditis elegans	strain: OP111, genotype: unc-119(ed3) III; wgIs111, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043252		Drosophila melanogaster	strain: l(3)neo38-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=l(3)neo38-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043253		Caenorhabditis elegans	strain: OP202, genotype: unc-119(ed3) III; wgIs202., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043254		Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043255		Caenorhabditis elegans	strain: OP391, genotype: unc-119(ed3) III; wgIs391(med-1::TY1 EGFP FLAG C; unc-119(+)), sex:hermaphrodite	NULL	1396	chip_control	NULL	whole organism (development stage: midembryonic)	NULL
EXP043256		Drosophila melanogaster	strain: CrebA-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}CrebA[MI06441]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043257		Caenorhabditis elegans	strain: OP701, genotype: unc-119(tm4063); wgIs701 [sem-2::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043258		Caenorhabditis elegans	strain: OP383, genotype: unc-119(tm4063) III; wgIs383., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043259		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043260		Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043261		Drosophila melanogaster	strain: CG4707-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG4707-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043262		Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043263		Drosophila melanogaster	strain: Hmx-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Hmx[MI02025]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043264		Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043265		Drosophila melanogaster	strain: sqz-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=zen-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043266		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043267		Drosophila melanogaster	strain: EcR-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=EcR-EGFP.S}VK00033	NULL	1403	chip_control	NULL	whole organism	NULL
EXP043268		Caenorhabditis elegans	strain: OP105, genotype: unc119(ed3);wgIs105(dpl-1::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043269		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043270		Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043271		Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043272		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043273		Drosophila melanogaster	strain: E(spl)m-delta-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)mdelta-HLH-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043274		Caenorhabditis elegans	strain: OP416, genotype: unc-119(tm4063) III; wgIs416., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043275		Caenorhabditis elegans	strain: YL416, genotype: unc119(ed3)III; vrIs64[pGES-1::HPL-2::GFP FLAG: HPL-2 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043276		Drosophila melanogaster	strain: fru-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}fru[MI06350]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043277		Drosophila melanogaster	strain: 9T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=slp2-EGFP.S}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043278		Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043279		Drosophila melanogaster	strain: pnt-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}pnt[MI02427]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043280		Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043281		Caenorhabditis elegans	strain: OP481, genotype: unc-119(tm4063) III; wgIs481., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043282		Caenorhabditis elegans	strain: OP699, genotype: unc-119(tm4063); wgIs699 [ceh-43::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043283		Caenorhabditis elegans	strain: OP77, genotype: unc-119(ed3) III; wgIs77, sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043284		Drosophila melanogaster	strain: acj6-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=acj6-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043285		Caenorhabditis elegans	strain: YL445, genotype: unc119(ed3)III; vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043286		Drosophila melanogaster	strain: CG10654-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG10654-GFP.FPTB}attP-40 / CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043287		Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043288		Drosophila melanogaster	strain: Trl-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Trl[MI02741]/TM6B, sb, Tb, Hu, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043289		Caenorhabditis elegans	strain: OP685, genotype: unc-119(tm4063) III; wgIs685., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043290		Drosophila melanogaster	strain: zf30C-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=dmrt11E-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043291		Caenorhabditis elegans	strain: OP64, genotype: unc-119(ed3) III; wgIs64, sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043292		Drosophila melanogaster	strain: YL-1-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=YL-1-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043293		Drosophila melanogaster	strain: 13T-exd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=exd-EGFP.S}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043294		Drosophila melanogaster	strain: fd102C-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=-GFP.FPTB}VK00033 / Tm6c, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043295		Drosophila melanogaster	genotype: e/se	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP043296		Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043297		Caenorhabditis elegans	strain: OP383, genotype: unc-119(tm4063) III; wgIs383., sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043298		Caenorhabditis elegans	strain: OP550, genotype: unc-119(tm4063) III; wgIs550., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043299		Drosophila melanogaster	strain: CG6854-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG45071-GFP.FPTB}attP40/CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043300		Drosophila melanogaster	strain: D19B-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=D19B-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043301		Drosophila melanogaster	strain: emc-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=emc-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043302		Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043303		Caenorhabditis elegans	strain: OP552, genotype: unc-119(tm4063) III; wgIs552., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043304		Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043305		Drosophila melanogaster	strain: Eip75B-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Eip75B[MI03665], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043306		Drosophila melanogaster	strain: Tup-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=tup-GFP.FPTB}VK00031, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043307		Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043308		Drosophila melanogaster	strain: Hr78-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr78-GFP.FLAG}VK00037	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043309		Drosophila melanogaster	strain: nau-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=nau-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043310		Drosophila melanogaster	strain: pzg-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=pzg-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043311		Drosophila melanogaster	strain: her-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=her-GFP.FTBP}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043312		Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043313		Caenorhabditis elegans	strain: YL398, genotype: unc119(ed3)III; vrIs55[pGES-1::LIN-35::GFP FLAG: LIN-35 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043314		Caenorhabditis elegans	strain: OP248, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043315		Caenorhabditis elegans	strain: OP312, genotype: unc-119(ed3) III; wgIs312, sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043316		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043317		Caenorhabditis elegans	strain: ZM8745, genotype: daf-16(mu86);daf-2(e1370) III; hpSi15 (Pges-1 GFP::daf-16a), sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043318		Drosophila melanogaster	strain: btn-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=btn-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043319		Caenorhabditis elegans	strain: OP130, genotype: unc-119(ed3) III; wgIs130., sex:mixed	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP043320		Drosophila melanogaster	strain: 3T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=en-EGFP.S}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043321		Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043322		Drosophila melanogaster	strain: pdm3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pdm3-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043323		Drosophila melanogaster	strain: CG8145-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=nom-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043324		Caenorhabditis elegans	strain: YL497, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043325		Drosophila melanogaster	strain: cyc-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=cyc-GFP.FTBP}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043326		Drosophila melanogaster	strain: E(z)-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=E(z)-GFP.FTBP}VK00037, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043327		Drosophila melanogaster	strain: Sry-delta-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Sry-delta-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043328		Caenorhabditis elegans	strain: OP357, genotype: unc-119(tm4063) III; wgIs357., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043329		Drosophila melanogaster	strain: tin-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=tin-GFP.FPTB}VK00037 / CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043330		Drosophila melanogaster	strain: CG8089-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG8089-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043331		Drosophila melanogaster	strain: CG11398-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG11398-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043332		Drosophila melanogaster	strain: CG8632-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ZnT49B-GFP.FTBP}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043333		Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043334		Drosophila melanogaster	strain: Suvar2-10-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Su(var)2-10-GFP.FPTB}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043335		Caenorhabditis elegans	strain: OP32, genotype: unc-119(ed3) III; wgIs32, sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043336		Drosophila melanogaster	strain: br-rj-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=br.Z2-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043337		Caenorhabditis elegans	strain: OP483, genotype: unc-119(tm4063) III; wgIs483., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043338		Drosophila melanogaster	strain: CG15073-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG15073-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043339		Caenorhabditis elegans	strain: OP598, genotype: unc-119(tm4063) III; wgIs598, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043340		Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043341		Drosophila melanogaster	strain: CG17181-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Kah-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043342		Caenorhabditis elegans	strain: OP476, genotype: unc-119(tm4063) III; wgIs476., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043343		Caenorhabditis elegans	strain: YL457, genotype: unc-119(ed3)III;vrIs87[pPIE-1::GEI-11::GFP::GEI-11 3'UTR,unc-119(+), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043344		Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043345		Caenorhabditis elegans	strain: OP114, genotype: unc-119(tm4063) III; wgIs114., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043346		Caenorhabditis elegans	strain: YL425, genotype: unc-119(ed3)III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043347		Caenorhabditis elegans	strain: OP652, genotype: unc-119(tm4063) III; wgIs652, sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043348		Drosophila melanogaster	strain: CG9797-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG7987-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043349		Drosophila melanogaster	strain: CG7786-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG7786-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043350		Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043351		Drosophila melanogaster	strain: Jarid2-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=Jarid2-GFP.FPTB}attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043352		Caenorhabditis elegans	strain: OP195, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043353		Drosophila melanogaster	strain: CG5245-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG5245-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043354		Caenorhabditis elegans	strain: OP513, genotype: unc-119(tm4063) III; wgIs513., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043355		Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043356		Caenorhabditis elegans	strain: OP506, genotype: unc-119(tm4063) III; wgIs506., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043357		Drosophila melanogaster	strain: CG18476-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG18476-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043358		Drosophila melanogaster	strain: CG10543-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10543-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043359		Drosophila melanogaster	strain: ac-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ac-GFP.FPTB}VK00033/TM2, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043360		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043361		Drosophila melanogaster	strain: CG13204-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=zf30C-GFP.FPTB}VK00033, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP043362		Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043363		Drosophila melanogaster	strain: kay-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=kay-GFP.FLAG}VK00037, sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043364		Caenorhabditis elegans	strain: OP105, genotype: unc119(ed3);wgIs105(dpl-1::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043365		Caenorhabditis elegans	strain: OP544, genotype: unc-119(tm4063) III; wgIs544, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043366		Caenorhabditis elegans	strain: YL551, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043367		Drosophila melanogaster	strain: CG8216-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=spab-GFP.FPTB}attP40, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP043368		Drosophila melanogaster	strain: zfh2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=zfh2-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043369		Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043370		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1403	chip_control	NULL	whole organism	NULL
EXP043371		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043372		Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043373		Caenorhabditis elegans	strain: OP169, genotype: unc-119(ed3) III; wgIs169., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043374		Drosophila melanogaster	strain: Pdp1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pdp1-GFP.FPTB}VK00037/SM5, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043375		Caenorhabditis elegans	strain: OP589, genotype: unc-119(tm4063); wgIs589 [gei-8::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043376		Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043377		Drosophila melanogaster	strain: CG30403-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG30403-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043378		Caenorhabditis elegans	strain: OP687, genotype: unc-119(tm4063) III; wgIs687., sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043379		Drosophila melanogaster	strain: 16T-GFP, genotype: y[1] w[*]; PBac{eGFP w[+mC]=ems-EGFP.S}VK00037/Tm3, sb, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043380		Drosophila melanogaster	strain: Sox100B-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Sox100B-GFP.FPTB}attP40 / CyO, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043381		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043382		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043383		Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	NULL	1403	chip_control	NULL	whole organism	NULL
EXP043384		Drosophila melanogaster	strain: CG16815-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG16815-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043385		Caenorhabditis elegans	strain: OP301, genotype: unc-119(tm4063) III; wgIs301., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043386		Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043387		Caenorhabditis elegans	strain: OP520, genotype: unc-119(tm4063) III; wgIs520., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043388		Caenorhabditis elegans	strain: OP511, genotype: unc-119(tm4063) III; wgIs511., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043389		Drosophila melanogaster	strain: az2-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=az2-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043390		Caenorhabditis elegans	strain: AGK541, genotype: (armSi1[Pmex5::UNC-130::GFP::tbb-2 3'UTR; cb-unc-119(+)II]; unc-119(ed3)III; niDf199IV), sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043391		Drosophila melanogaster	strain: CG1832-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG1832-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043392		Caenorhabditis elegans	strain: OP222, genotype: unc-119(ed3) III; wgIs222., sex:mixed	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP043393		Drosophila melanogaster	strain: E(spl)m5-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)m5-HLH-GFP.FPTB}attP-40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043394		Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043395		Caenorhabditis elegans	strain: OP702, genotype: unc-119(tm4063); wgIs702 [flh-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043396		Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043397		Caenorhabditis elegans	strain: OP516, genotype: unc-119(tm4063) III; wgIs516., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043398		Drosophila melanogaster	strain: Hand-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hand-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043399		Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043400		Caenorhabditis elegans	strain: OP90, genotype: unc-119(ed3) III; wgIs90., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043401		Drosophila melanogaster	strain: 10T-Dfd-GFP, genotype: y[1] M{vas-int.Dm}ZH-2A w[*]; PBac{y[+]-attP-3B}VK00033	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP043402		Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043403		Drosophila melanogaster	strain: Max-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Max-GFP.FTBP}VK00037, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043404		Caenorhabditis elegans	strain: OP476, genotype: unc-119(tm4063) III; wgIs476., sex:hermaphrodite	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043405		Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043406		Caenorhabditis elegans	strain: OP99, genotype: unc-119(ed3) III; wgIs99., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043407		Caenorhabditis elegans	strain: OP720, genotype: unc-119(tm4063); wgIs720 [lsl-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043408		Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP043409		Caenorhabditis elegans	strain: OP543, sex:hermaphrodite	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043410		Drosophila melanogaster	strain: CG8944-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG8944-RB-GFP-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043411		Caenorhabditis elegans	strain: OR3350, sex:hermaphrodite	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP043412		Caenorhabditis elegans	strain: OP743, genotype: unc-119(tm4063); wgIs743 [lin-54::TY1::EGFP::3xFLAG(Fosmid: lin-54) + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP043413		Drosophila melanogaster	strain: 5T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=eve-EGFP.S}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043414		Drosophila melanogaster	strain: CG9305-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9305-GFP.FTBP}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP043415		Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP043416		Drosophila melanogaster	strain: pad-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=pad-GFP.FPTB}attP40, sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP043417	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP301, genotype: unc-119(tm4063) III; wgIs301., sex:mixed	EXP043385	1387	normal	Q9U325	whole worms (developmental stage: L1)	NULL
EXP043418	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP703, genotype: unc-119(tm4063); wgIs703 [spr-3::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042930	1389	normal	Q17768	whole worms (developmental stage: L4/young adults)	NULL
EXP043419	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:mixed	EXP042946	1389	normal	Q86MJ3	whole worms (developmental stage: L4/young adults)	NULL
EXP043420	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP523, genotype: unc-119(tm4063) III; wgIs523., sex:hermaphrodite	EXP042737	1387	normal	P34555	whole worms (developmental stage: L1)	NULL
EXP043421	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP198, genotype: unc-119(ed3) III; wgIs198., sex:mixed	EXP042762	1390	normal	P41846	whole worms (developmental stage: L3)	NULL
EXP043422	goat-anti-GFP-UC	Drosophila melanogaster	strain: corto-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=corto-GFP.FPTB}VK00037, sex:mixed	EXP042557	1407	normal	P41046	whole organism (development stage: embryonic)	NULL
EXP043423	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP043151	1387	normal	Q09228	whole worms (developmental stage: L1)	NULL
EXP043424	ab290	Drosophila melanogaster	strain: Eip74EF-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Eip74EF-GFP.FLAG}VK00037	EXP043045	1407	normal	P20105	whole organism (development stage: embryonic)	NULL
EXP043425	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042789	1392	normal	Q966B8	whole worms (mixed-stage embryos)	NULL
EXP043426	goat-anti-GFP-UC	Drosophila melanogaster	strain: tai-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tai-GFP.FLAG}VK00033, sex:mixed	EXP043027	1400	normal	M9ND53	whole organism (development stage: wandering third instar larva)	NULL
EXP043427	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8145-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=nom-GFP.FPTB}attP40, sex:mixed	EXP043323	1407	normal	Q9VHM7	whole organism (development stage: embryonic)	NULL
EXP043428	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043041	1389	normal	Q17381	whole worms (developmental stage: L4/young adults)	NULL
EXP043429	non-commercial Lpt modENCODE antibody 1	Drosophila melanogaster	strain: 13T-exd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=exd-EGFP.S}VK00033	EXP043293	1407	normal	Q9W1H0	whole organism (development stage: embryonic)	NULL
EXP043430	goat-anti-GFP-UC	Drosophila melanogaster	strain: 9T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=slp2-EGFP.S}VK00033/TM3, Sb[1], sex:mixed	EXP043277	1407	normal	H5V8D4	whole organism (development stage: embryonic)	NULL
EXP043431	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP042915	1390	normal	G5EBU4	whole worms (developmental stage: L3)	NULL
EXP043432	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m5-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)m5-HLH-GFP.FPTB}attP-40, sex:mixed	EXP043393	1407	normal	P13096	whole organism (development stage: embryonic)	NULL
EXP043433	goat-anti-GFP-UC	Drosophila melanogaster	strain: D-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=D-GFP.FPTB}attP40, sex:mixed	EXP043173	1407	normal	M9PFL2	whole organism (development stage: embryonic)	NULL
EXP043434	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pdp1-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Pdp1[MI01532]/TM6B, sb, Tb, Hu, sex:mixed	EXP042597	1407	normal	Q24217	whole organism (development stage: embryonic)	NULL
EXP043435	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP311, sex:hermaphrodite	EXP043026	1391	normal	Q95PX3	whole worms (developmental stage: late embryo)	NULL
EXP043436	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG14655-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG14655-GFP.FPTB}attP40, sex:mixed	EXP043003	1404	normal	Q9VN56	whole organism (development stage: pupa)	NULL
EXP043437	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP239, genotype: unc-119(ed3) III; wgIs239., sex:mixed	EXP043222	1389	normal	P41999	whole worms (developmental stage: L4/young adults)	NULL
EXP043438	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP512, genotype: unc-119(tm4063) III; wgIs512., sex:hermaphrodite	EXP042811	1387	normal	Q09441	whole worms (developmental stage: L1)	NULL
EXP043439	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(var)3-9-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=E(var)3-9-GFP.FTBP}VK00037, sex:mixed	EXP042970	1407	normal	Q9VHJ3	whole organism (development stage: embryonic)	NULL
EXP043440	goat-anti-GFP-UC	Drosophila melanogaster	strain: AntP-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Antp[MI02272]/TM6B, sb, Tb, Hu, sex:mixed	EXP042842	1407	normal	P02833	whole organism (development stage: embryonic)	NULL
EXP043441	goat-anti-GFP-UC	Drosophila melanogaster	strain: Su(H)-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Su(H)-GFP.FLAG}attP2, sex:mixed	EXP042964	1407	normal	P28159	whole organism (development stage: embryonic)	NULL
EXP043442	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17181-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Kah-GFP.FPTB}attP-40, sex:mixed	EXP043341	1407	normal	Q9W0P9	whole organism (development stage: embryonic)	NULL
EXP043443	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr4-GFP.FSTF}VK00033, sex:mixed	EXP042754	1408	normal	Q9W539	whole organism (development stage: prepupa)	NULL
EXP043444	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042825	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP043445	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043269	1390	normal	G5ECF7	whole worms (developmental stage: L3)	NULL
EXP043446	goat-anti-GFP-UC	Drosophila melanogaster	strain: pho-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pho-GFP.FPTB}VK00033, sex:mixed	EXP042687	1407	normal	Q8ST83	whole organism (development stage: embryonic)	NULL
EXP043447	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP373, genotype: unc-119(tm4063) III; wgIs373., sex:mixed	EXP042688	1390	normal	Q9XVV3	whole worms (developmental stage: L3)	NULL
EXP043448	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP342, genotype: unc-119(ed3) III; wgIs342., sex:mixed	EXP042841	1389	normal	P34707	whole worms (developmental stage: L4/young adults)	NULL
EXP043449	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8216-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=spab-GFP.FPTB}attP40, sex:mixed	EXP043367	1408	normal	A1Z7M0	whole organism (development stage: prepupa)	NULL
EXP043450	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP656, genotype: unc-119 (tm4063) III; wgIs656, sex:mixed	EXP042728	1405	normal	Q9TYT0	whole organism (development stage: early embryonic)	NULL
EXP043451	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL472, genotype: unc-119(ed3) III; vrEx66 [pMEX-5::HPL-2:GFP:FLAG::HPL-2 3-UTR, unc-119 (+)]), sex:mixed	EXP042830	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	NULL
EXP043452	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP178, genotype: unc-119(ed3) III; wgIs178., sex:mixed	EXP042973	1387	normal	P34707	whole worms (developmental stage: L1)	NULL
EXP043453	goat-anti-GFP-UC	Drosophila melanogaster	strain: crp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=crp-GFP.FPTB}VK00033, sex:mixed	EXP043149	1407	normal	Q9V406	whole organism (development stage: embryonic)	NULL
EXP043454	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox100B-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Sox100B-GFP.FPTB}attP40 / CyO, sex:mixed	EXP043380	1407	normal	Q9VA17	whole organism (development stage: embryonic)	NULL
EXP043455	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP500, genotype: unc-119(tm4063) III; wgIs500., sex:mixed	EXP042880	1391	normal	P34522	whole worms (developmental stage: late embryo)	NULL
EXP043456	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042615	1387	normal	G5ECF7	whole worms (developmental stage: L1)	NULL
EXP043457	goat-anti-GFP-UC	Drosophila melanogaster	strain: 3T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=en-EGFP.S}VK00033, sex:mixed	EXP043320	1407	normal	P02836	whole organism (development stage: embryonic)	NULL
EXP044356	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: N2 strain	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044357	DPY-27 JL00001 Rabbit polyclonal to 1-409 aa. (Ercan et al. Nat Genet. 2007) is against the antigen 1-409 aa	Caenorhabditis elegans	Treatment: Treatment: Treatment: CB428 strain	EXP044354	1388	normal	P48996	whole worms (developmental stage: embryo)	NULL
EXP043459	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10209-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10209-GFP.FPTB}VK00033, sex:mixed	EXP043059	1407	normal	Q7K3Q3	whole organism (development stage: embryonic)	NULL
EXP043460	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8944-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG8944-RB-GFP-GFP.FPTB}VK00033, sex:mixed	EXP043410	1407	normal	Q9VXQ6	whole organism (development stage: embryonic)	NULL
EXP043461	goat-anti-GFP-UC	Drosophila melanogaster	strain: tx-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tx-GFP.FTBP}VK00037, sex:mixed	EXP042714	1407	normal	P41894	whole organism (development stage: embryonic)	NULL
EXP043462	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP105, genotype: unc119(ed3);wgIs105(dpl-1::TY1 EGFP FLAG;unc119), sex:mixed	EXP043268	1389	normal	Q22703	whole worms (developmental stage: L4/young adults)	NULL
EXP043463	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12942-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG12942-GFP.FPTB}VK00033, sex:mixed	EXP042579	1407	normal	Q7JW60	whole organism (development stage: embryonic)	NULL
EXP043464	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP484, sex:hermaphrodite	EXP042608	1235	normal	O17025	whole worms (developmental stage: young adults)	NULL
EXP043465	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP57, genotype: unc-119(ed3) III; wgIs57., sex:mixed	EXP043190	1202	normal	G5EFF4	whole worms (developmental stage: L2)	NULL
EXP043466	goat-anti-GFP-UC	Drosophila melanogaster	strain: Trl-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Trl[MI02741]/TM6B, sb, Tb, Hu, sex:mixed	EXP043288	1407	normal	A4V1Y6	whole organism (development stage: embryonic)	NULL
EXP043467	goat-anti-GFP-UC	Caenorhabditis elegans	strain: GOU883, sex:hermaphrodite	EXP042658	1387	normal	Q23045	whole worms (developmental stage: L1)	NULL
EXP043468	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7928-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=ZIPIC-GFP.FPTB}attP40, sex:mixed	EXP043136	1407	normal	Q9VAB8	whole organism (development stage: embryonic)	NULL
EXP043469	goat-anti-GFP-UC	Caenorhabditis elegans	strain: ZM7247, genotype: daf-16(mu86);daf-2(e1370) III; hpSi4II (Pmyo-3 GFP::daf-16a), sex:hermaphrodite	EXP042868	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	NULL
EXP043470	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP709, genotype: unc-119(tm4063); wgIs709 [T23F11.4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042951	1391	normal	Q22696	whole worms (developmental stage: late embryo)	NULL
EXP043471	KW1-dm-D1	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	Q9W4S7	Kc167 (development stage: embryonic)	NULL
EXP043472	non-commercial Sin3A modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043272	1407	normal	A1Z927	whole organism (development stage: embryonic)	NULL
EXP043473	goat-anti-GFP-UC	Drosophila melanogaster	strain: HLH54F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HLH54F-GFP.FTBP}VK00033, sex:mixed	EXP042712	1407	normal	Q0IGU7	whole organism (development stage: embryonic)	NULL
EXP043474	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1792-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG1792-GFP.FPTB}VK00037, sex:mixed	EXP042846	1407	normal	Q9V9V8	whole organism (development stage: embryonic)	NULL
EXP043475	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:mixed	EXP042584	1202	normal	P28515	whole worms (developmental stage: L2)	NULL
EXP043476	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18619-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG18619-GFP.FTBP}VK00033, sex:mixed	EXP042685	1407	normal	Q8IPC7	whole organism (development stage: embryonic)	NULL
EXP043477	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP598, genotype: unc-119(tm4063) III; wgIs598, sex:mixed	EXP043339	1235	normal	Q22798	whole worms (developmental stage: young adults)	NULL
EXP043478	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17186-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17186-GFP.FPTB}attP40, sex:mixed	EXP042867	1407	normal	Q9VDT2	whole organism (development stage: embryonic)	NULL
EXP043479	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hand-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hand-GFP.FPTB}VK00033, sex:mixed	EXP043398	1407	normal	Q9VL05	whole organism (development stage: embryonic)	NULL
EXP043480	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mes4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mes4-GFP.FPTB}VK00033, sex:mixed	EXP042661	1407	normal	Q9W256	whole organism (development stage: embryonic)	NULL
EXP043481	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP563, genotype: unc-119(tm4063) III; wgIs563., sex:mixed	EXP042613	1235	normal	Q18909	whole worms (developmental stage: young adults)	NULL
EXP043482	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP321, genotype: unc-119(tm4063) III; wgIs321., sex:mixed	EXP042758	1387	normal	G5EGF8	whole worms (developmental stage: L1)	NULL
EXP043483	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP640, genotype: unc-119(tm4063) III; wgIs640., sex:mixed	EXP042794	1405	normal	Q20709	whole organism (development stage: early embryonic)	NULL
EXP043484	ab24726	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042962	1407	normal	P05205	whole organism (development stage: embryonic)	NULL
EXP043485	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG14962-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Asciz-GFP.FPTB}attP40, sex:mixed	EXP042704	1407	normal	Q9VZU1	whole organism (development stage: embryonic)	NULL
EXP043486	goat-anti-GFP-UC	Drosophila melanogaster	strain: Suvar2-10-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Su(var)2-10-GFP.FPTB}VK00037, sex:mixed	EXP043334	1407	normal	Q7KNF5	whole organism (development stage: embryonic)	NULL
EXP043487	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	EXP042797	1391	normal	Q10655	whole worms (developmental stage: late embryo)	NULL
EXP043488	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP476, genotype: unc-119(tm4063) III; wgIs476., sex:hermaphrodite	EXP043404	1387	normal	P13528	whole worms (developmental stage: L1)	NULL
EXP043489	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hmr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hmr-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042717	1407	normal	Q86CW5	whole organism (development stage: embryonic)	NULL
EXP043490	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18476-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG18476-GFP.FTBP}VK00037, sex:mixed	EXP043357	1407	normal	Q9VGK1	whole organism (development stage: embryonic)	NULL
EXP043491	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP043278	1389	normal	G5EFY7	whole worms (developmental stage: L4/young adults)	NULL
EXP043492	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox15-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Sox15-GFP.FPTB}VK00033, sex:mixed	EXP042890	1408	normal	P40657	whole organism (development stage: prepupa)	NULL
EXP043493	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9883-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9883-GFP.FTBP}VK00033, sex:mixed	EXP043221	1407	normal	Q9VQD6	whole organism (development stage: embryonic)	NULL
EXP043494	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP043408	1387	normal	Q966B8	whole worms (developmental stage: L1)	NULL
EXP043495	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG30403-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG30403-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP043377	1407	normal	Q8MLV3	whole organism (development stage: embryonic)	NULL
EXP043496	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042785	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP043497	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043266	1392	normal	G5ECF7	whole worms (mixed-stage embryos)	NULL
EXP043498	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: Hr46-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr46-GFP.FLAG}VK00033/TM3, Sb[1]	EXP042979	1407	normal	P91943	whole organism (development stage: embryonic)	NULL
EXP043499	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:hermaphrodite	EXP043004	1202	normal	Q93560	whole worms (developmental stage: L2)	NULL
EXP043500	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP631, genotype: unc-119(tm4063) III; wgIs631, sex:mixed	EXP043108	1391	normal	O45080	whole worms (developmental stage: late embryo)	NULL
EXP043501	goat-anti-GFP-UC	Drosophila melanogaster	strain: vri-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=vri-GFP.FPTB}VK00033, sex:mixed	EXP043096	1408	normal	Q7KTN9	whole organism (development stage: prepupa)	NULL
EXP043502	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP517, genotype: unc-119(tm4063) III; wgIs517., sex:mixed	EXP042808	1391	normal	Q17922	whole worms (developmental stage: late embryo)	NULL
EXP043503	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP043244	1387	normal	P91868	whole worms (developmental stage: L1)	NULL
EXP043504	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP043184	1390	normal	O02274	whole worms (developmental stage: L3)	NULL
EXP043505	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3995-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG3995-GFP.FPTB}TBD, sex:mixed	EXP042642	1407	normal	Q9VEP0	whole organism (development stage: embryonic)	NULL
EXP043506	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP043215	1202	normal	P34684	whole worms (developmental stage: L2)	NULL
EXP043507	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP043079	1410	normal	Q9N5D6	whole organism (development stage: dauer)	NULL
EXP043508	goat-anti-GFP-UC	Drosophila melanogaster	strain: Met-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Met-GFP.FTBP}VK00031, sex:mixed	EXP042854	1408	normal	Q9VYW2	whole organism (development stage: prepupa)	NULL
EXP043509	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042887	1387	normal	O02316	whole worms (developmental stage: L1)	NULL
EXP043510	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP345, genotype: unc-119(ed3) III; wgIs345., sex:mixed	EXP043007	1387	normal	Q18037	whole worms (developmental stage: L1)	NULL
EXP043511	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP609, genotype: unc-119(tm4063) III; wgIs609, sex:mixed	EXP042801	1235	normal	O61845	whole worms (developmental stage: young adults)	NULL
EXP043512	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP522, genotype: unc-119(tm4063) III; wgIs522., sex:hermaphrodite	EXP042812	1387	normal	Q93246	whole worms (developmental stage: L1)	NULL
EXP043513	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP70, genotype: unc-119(ed3) III; wgIs70., sex:mixed	EXP042745	1392	normal	Q21502	whole worms (mixed-stage embryos)	NULL
EXP043514	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13204-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=zf30C-GFP.FPTB}VK00033, sex:mixed	EXP043361	1404	normal	A1Z8K2	whole organism (development stage: pupa)	NULL
EXP043515	goat-anti-GFP-UC	Drosophila melanogaster	strain: l(3)neo38-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=l(3)neo38-GFP.FPTB}attP40, sex:mixed	EXP043252	1407	normal	Q8SZN9	whole organism (development stage: embryonic)	NULL
EXP043516	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP659, genotype: unc-119(tm4063) III; wgIs659, sex:mixed	EXP043107	1392	normal	Q18955	whole worms (mixed-stage embryos)	NULL
EXP043517	goat-anti-GFP-UC	Drosophila melanogaster	strain: HmgD-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HmgD-GFP.FTBP}VK00033, sex:mixed	EXP042583	1407	normal	C0MJA0	whole organism (development stage: embryonic)	NULL
EXP043518	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP389, genotype: unc-119(tm4063) III; wgIs389., sex:mixed	EXP042982	1391	normal	P41936	whole worms (developmental stage: late embryo)	NULL
EXP043519	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP520, genotype: unc-119(tm4063) III; wgIs520., sex:hermaphrodite	EXP043387	1391	normal	Q94178	whole worms (developmental stage: late embryo)	NULL
EXP043520	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:mixed	EXP043073	1202	normal	Q19345	whole worms (developmental stage: L2)	NULL
EXP043521	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3065-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG3065-GFP.FTBP}VK00033, sex:mixed	EXP043089	1407	normal	Q2MGN0	whole organism (development stage: embryonic)	NULL
EXP043522	ab290	Drosophila melanogaster	strain: Hr78-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr78-GFP.FLAG}VK00037	EXP043308	1400	normal	Q24142	whole organism (development stage: wandering third instar larva)	NULL
EXP043523	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13624-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG13624-GFP.FPTB}VK00037, sex:mixed	EXP042827	1407	normal	Q9VC61	whole organism (development stage: embryonic)	NULL
EXP043524	goat-anti-GFP-UC	Drosophila melanogaster	strain: tin-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=tin-GFP.FPTB}VK00037 / CyO, sex:mixed	EXP043329	1407	normal	B6IDS0	whole organism (development stage: embryonic)	NULL
EXP043525	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP602, sex:mixed	EXP043019	1389	normal	Q9N5D6	whole worms (developmental stage: L4/young adults)	NULL
EXP043526	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP528, genotype: wgIs528(snu-23::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0094_4B11);unc-119(+));unc-119 (tm4063), sex:hermaphrodite	EXP042848	1387	normal	P34670	whole worms (developmental stage: L1)	NULL
EXP043527	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP342, genotype: unc-119(ed3) III; wgIs342., sex:mixed	EXP042667	1390	normal	P34707	whole worms (developmental stage: L3)	NULL
EXP043528	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	EXP042755	1387	normal	Q19691	whole worms (developmental stage: L1)	NULL
EXP043529	goat-anti-GFP-UC	Drosophila melanogaster	strain: gfzf-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=gfzf-GFP-GFP.FPTB}VK00037, sex:mixed	EXP042623	1407	normal	Q6NP69	whole organism (development stage: embryonic)	NULL
EXP043530	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP565, genotype: unc-119(tm4063) III; wgIs565., sex:mixed	EXP043025	1235	normal	A5JYU2	whole worms (developmental stage: young adults)	NULL
EXP043531	goat-anti-GFP-UC	Drosophila melanogaster	strain: dmrt93B-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=dmrt93B-GFP.FPTB}attP-40, sex:mixed	EXP042969	1400	normal	Q9VDF1	whole organism (development stage: wandering third instar larva)	NULL
EXP043532	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP99, genotype: unc-119(ed3) III; wgIs99., sex:mixed	EXP043406	1392	normal	Q10902	whole worms (mixed-stage embryos)	NULL
EXP043533	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	EXP042899	1389	normal	Q27395	whole worms (developmental stage: L4/young adults)	NULL
EXP043534	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP77, genotype: unc-119(ed3) III; wgIs77, sex:mixed	EXP043283	1387	normal	Q18694	whole worms (developmental stage: L1)	NULL
EXP043535	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG14965-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG14965-GFP.FTBP}VK00037, sex:mixed	EXP043202	1407	normal	Q960J7	whole organism (development stage: embryonic)	NULL
EXP043536	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP743, genotype: unc-119(tm4063); wgIs743 [lin-54::TY1::EGFP::3xFLAG(Fosmid: lin-54) + unc-119(+)], sex:mixed	EXP043412	1235	normal	Q95QD7	whole worms (developmental stage: young adults)	NULL
EXP043537	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP463, genotype: unc-119(tm4063) III; wgIs463., sex:hermaphrodite	EXP042862	1389	normal	Q9XVJ1	whole worms (developmental stage: L4/young adults)	NULL
EXP043538	goat-anti-GFP-UC	Drosophila melanogaster	strain: ab-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ab-GFP.FLAG}VK00033, sex:mixed	EXP042721	1407	normal	Q9W1P8	whole organism (development stage: embryonic)	NULL
EXP043539	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP043176	1235	normal	Q9N5D6	whole worms (developmental stage: young adults)	NULL
EXP043540	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043037	1407	normal	P91943	whole organism (development stage: embryonic)	NULL
EXP043541	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP043307	1391	normal	O17593	whole worms (developmental stage: late embryo)	NULL
EXP043542	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP042876	1387	normal	G5ECN8	whole worms (developmental stage: L1)	NULL
EXP043543	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sry-delta-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Sry-delta-GFP.FPTB}VK00037, sex:mixed	EXP043327	1407	normal	P07664	whole organism (development stage: embryonic)	NULL
EXP043544	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9876-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9876-GFP.FPTB}VK00033, sex:mixed	EXP042609	1407	normal	Q9W1U7	whole organism (development stage: embryonic)	NULL
EXP043545	Aviva-KW3-D-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042796	1407	normal	M9PFL2	whole organism (development stage: embryonic)	NULL
EXP043546	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP043296	1202	normal	Q09228	whole worms (developmental stage: L2)	NULL
EXP043547	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mad-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mad-GFP.FLAG}VK00033, sex:mixed	EXP043194	1407	normal	P42003	whole organism (development stage: embryonic)	NULL
EXP043548	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP82, genotype: unc-119(tm4063) III; wgIs82., sex:mixed	EXP042858	1390	normal	P34326	whole worms (developmental stage: L3)	NULL
EXP043549	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP529, genotype: unc-119(tm4063) III; wgIs529., sex:hermaphrodite	EXP042889	1389	normal	Q09534	whole worms (developmental stage: L4/young adults)	NULL
EXP043550	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4617-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG4617-GFP.FPTB}VK00033, sex:mixed	EXP042684	1407	normal	Q9W3S4	whole organism (development stage: embryonic)	NULL
EXP043551	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042711	1390	normal	G5ECG2	whole worms (developmental stage: L3)	NULL
EXP043552	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP042997	1389	normal	O02274	whole worms (developmental stage: L4/young adults)	NULL
EXP043553	goat-anti-GFP-UC	Drosophila melanogaster	strain: OdsH-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=OdsH-GFP.FPTB}VK00033, sex:mixed	EXP042571	1408	normal	Q9VX20	whole organism (development stage: prepupa)	NULL
EXP043554	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP241, genotype: unc-119(ed3) III; wgIs241., sex:mixed	EXP042776	1389	normal	G5EE18	whole worms (developmental stage: L4/young adults)	NULL
EXP043555	goat-anti-GFP-UC	Drosophila melanogaster	strain: jing-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=jing-GFP.FPTB}VK00033, sex:mixed	EXP042780	1407	normal	A8DY48	whole organism (development stage: embryonic)	NULL
EXP043556	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP506, genotype: unc-119(tm4063) III; wgIs506., sex:hermaphrodite	EXP043356	1387	normal	G5EE07	whole worms (developmental stage: L1)	NULL
EXP043557	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11723-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG11723-GFP.FTBP}VK00033, sex:mixed	EXP043124	1407	normal	Q9VQ77	whole organism (development stage: embryonic)	NULL
EXP043558	goat-anti-GFP-UC	Drosophila melanogaster	strain: p53-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}p53[MI01307]/TM6B, sb, Tb, Hu, sex:mixed	EXP042883	1407	normal	Q9N6D8	whole organism (development stage: embryonic)	NULL
EXP043559	goat-anti-GFP-UC	Drosophila melanogaster	strain: Smox-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Smox-GFP.FLAG}VK00033, sex:mixed	EXP043165	1408	normal	O96660	whole organism (development stage: prepupa)	NULL
EXP043560	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	EXP043010	1235	normal	G5EEG1	whole worms (developmental stage: young adults)	NULL
EXP043561	sc-25761	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	P28159	Kc167 (development stage: embryonic)	NULL
EXP043562	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr83-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr83-GFP.FPTB}VK00037, sex:mixed	EXP043047	1400	normal	Q9VI12	whole organism (development stage: wandering third instar larva)	NULL
EXP064983	anti-Trl (anti-GAF)	Drosophila melanogaster	Treatment: Treatment: Treatment: none; Strain: Iso1; Strain: Iso1; Strain: Iso1	EXP064981	1417	normal	Q08605	8-16 h embryo	NULL
EXP043564	goat-anti-GFP-UC	Drosophila melanogaster	strain: lbe-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=lbe-GFP.FTBP}VK00037, sex:mixed	EXP043061	1407	normal	Q7KS77	whole organism (development stage: embryonic)	NULL
EXP043565	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9797-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG7987-GFP.FPTB}attP-40, sex:mixed	EXP043348	1407	normal	Q9VHM3	whole organism (development stage: embryonic)	NULL
EXP043566	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP533, genotype: unc-119(tm4063) III; wgIs533, sex:hermaphrodite	EXP042589	1391	normal	P41934	whole worms (developmental stage: late embryo)	NULL
EXP043567	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1233-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG1233-GFP.FPTB}attP-40, sex:mixed	EXP042761	1407	normal	Q9I7U7	whole organism (development stage: embryonic)	NULL
EXP043568	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP383, genotype: unc-119(tm4063) III; wgIs383., sex:hermaphrodite	EXP043297	1235	normal	G4SGI5	whole worms (developmental stage: young adults)	NULL
EXP043569	goat-anti-GFP-UC	Drosophila melanogaster	strain: pdm3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pdm3-GFP.FPTB}VK00033, sex:mixed	EXP043322	1408	normal	B7YZU0	whole organism (development stage: prepupa)	NULL
EXP043570	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18599-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG18599-GFP.FPTB}attP40, sex:mixed	EXP043126	1407	normal	Q9VEA3	whole organism (development stage: embryonic)	NULL
EXP043571	goat-anti-GFP-UC	Drosophila melanogaster	strain: nau-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=nau-GFP.FPTB}attP40, sex:mixed	EXP043309	1407	normal	P22816	whole organism (development stage: embryonic)	NULL
EXP043572	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP240, genotype: unc-119(ed3) III; wgIs240., sex:mixed	EXP043099	1389	normal	Q9N5S3	whole worms (developmental stage: L4/young adults)	NULL
EXP043573	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP636, genotype: unc-119(tm4063) III; wgIs636, sex:mixed	EXP042727	1235	normal	Q22289	whole worms (developmental stage: young adults)	NULL
EXP043574	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL402, genotype: unc119(ed3)III; vrIs56[pPIE-1::LIN-35::GFP FLAG: LIN-35 3â€™UTR, unc-119 (+)], sex:mixed	EXP042665	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	NULL
EXP043575	goat-anti-GFP-UC	Drosophila melanogaster	strain: 1T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=bcd-EGFP.S}VK00037, sex:mixed	EXP043209	1407	normal	P09081	whole organism (development stage: embryonic)	NULL
EXP043576	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP543, sex:hermaphrodite	EXP043409	1235	normal	Q09620	whole worms (developmental stage: young adults)	NULL
EXP043577	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6808-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6808-GFP.FPTB}attP40, sex:mixed	EXP043193	1408	normal	Q7YZ91	whole organism (development stage: prepupa)	NULL
EXP043578	goat-anti-GFP-UC	Drosophila melanogaster	strain: 16T-GFP, genotype: y[1] w[*]; PBac{eGFP w[+mC]=ems-EGFP.S}VK00037/Tm3, sb, sex:mixed	EXP043379	1407	normal	P18488	whole organism (development stage: embryonic)	NULL
EXP043579	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1529-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG1529-GFP.FPTB}VK00033, sex:mixed	EXP042720	1407	normal	B7Z152	whole organism (development stage: embryonic)	NULL
EXP043580	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13123-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG13123-GFP.FPTB}VK00033, sex:mixed	EXP043217	1407	normal	Q9VL80	whole organism (development stage: embryonic)	NULL
EXP043581	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL577, sex:hermaphrodite	EXP042893	1235	normal	O01789	whole worms (developmental stage: young adults)	NULL
EXP043582	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL487, sex:hermaphrodite	EXP043249	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP043583	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042850	1390	normal	O02316	whole worms (developmental stage: L3)	NULL
EXP043584	ab290	Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	EXP042716	1407	normal	P42283	whole organism (development stage: embryonic)	NULL
EXP043585	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043030	1387	normal	Q9N5S3	whole worms (developmental stage: L1)	NULL
EXP043586	goat-anti-GFP-UC	Drosophila melanogaster	strain: foxo-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=foxo-GFP.FLAG}VK00037, sex:mixed	EXP042760	1400	normal	Q95V55	whole organism (development stage: wandering third instar larva)	NULL
EXP043587	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP64, genotype: unc-119(ed3) III; wgIs64, sex:mixed	EXP043291	1392	normal	P22980	whole worms (mixed-stage embryos)	NULL
EXP043588	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP043031	1202	normal	G5EBU4	whole worms (developmental stage: L2)	NULL
EXP043589	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10565-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10565-GFP.FPTB}VK00037, sex:mixed	EXP043191	1407	normal	Q9VP77	whole organism (development stage: embryonic)	NULL
EXP043590	goat-anti-GFP-UC	Drosophila melanogaster	strain: CHES-1-like-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CHES-1-like-EGFP.S}VK00033, sex:mixed	EXP042875	1407	normal	Q9W3Q5	whole organism (development stage: embryonic)	NULL
EXP043591	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP724, genotype: unc-119(tm4063); wgIs724 [attf-5::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042697	1235	normal	Q22173	whole worms (developmental stage: young adults)	NULL
EXP043592	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP042644	1389	normal	Q17905	whole worms (developmental stage: L4/young adults)	NULL
EXP043593	goat-anti-GFP-UC	Drosophila melanogaster	strain: brk-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=brk-GFP.FPTB}VK00033, sex:mixed	EXP042719	1400	normal	Q9XTN4	whole organism (development stage: wandering third instar larva)	NULL
EXP043594	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP043196	1387	normal	G5EBU4	whole worms (developmental stage: L1)	NULL
EXP043595	goat-anti-GFP-UC	Drosophila melanogaster	strain: sage-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=sage-GFP.FTBP}VK00037, sex:mixed	EXP042605	1400	normal	Q9VHG3	whole organism (development stage: wandering third instar larva)	NULL
EXP043596	goat-anti-GFP-UC	Drosophila melanogaster	strain: lab-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=lab-GFP.FPTB}attP40, sex:mixed	EXP043129	1407	normal	P10105	whole organism (development stage: embryonic)	NULL
EXP043597	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP487, sex:hermaphrodite	EXP042743	1405	normal	O01519	whole organism (development stage: early embryonic)	NULL
EXP043598	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP670, genotype: unc-119(tm4063); wgIs670 [sdz-12::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043185	1389	normal	Q9BLC4	whole worms (developmental stage: L4/young adults)	NULL
EXP043599	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042953	1389	normal	G5EG44	whole worms (developmental stage: L4/young adults)	NULL
EXP043600	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP568, genotype: unc-119(tm4063) III; wgIs568, sex:mixed	EXP042977	1390	normal	Q21789	whole worms (developmental stage: L3)	NULL
EXP043601	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP043044	1389	normal	O17894	whole worms (developmental stage: L4/young adults)	NULL
EXP043602	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 10T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dfd-EGFP.S}VK00037	EXP042603	1407	normal	Q7KS72	whole organism (development stage: embryonic)	NULL
EXP043603	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP81, genotype: unc-119(ed3) III; wgIs81., sex:mixed	EXP042563	1390	normal	G5EDU4	whole worms (developmental stage: L3)	NULL
EXP043604	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP120, genotype: unc-119(ed3) III; wgIs120., sex:mixed	EXP043200	1391	normal	Q22909	whole worms (developmental stage: late embryo)	NULL
EXP043605	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP82, genotype: unc-119(tm4063) III; wgIs82., sex:mixed	EXP042718	1202	normal	P34326	whole worms (developmental stage: L2)	NULL
EXP043606	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP358, genotype: unc-119(tm4063) III; wgIs358., sex:hermaphrodite	EXP042856	1389	normal	P91306	whole worms (developmental stage: L4/young adults)	NULL
EXP043607	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL507, sex:hermaphrodite	EXP042630	1235	normal	Q22703	whole worms (developmental stage: young adults)	NULL
EXP043608	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043182	1389	normal	Q23521	whole worms (developmental stage: L4/young adults)	NULL
EXP043609	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP483, genotype: unc-119(tm4063) III; wgIs483., sex:hermaphrodite	EXP043337	1387	normal	O17025	whole worms (developmental stage: L1)	NULL
EXP043610	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043167	1387	normal	Q23294	whole worms (developmental stage: L1)	NULL
EXP043611	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4424-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG4424-GFP.FPTB}TBD, sex:mixed	EXP042572	1407	normal	Q9VDQ6	whole organism (development stage: embryonic)	NULL
EXP043612	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043386	1389	normal	Q17381	whole worms (developmental stage: L4/young adults)	NULL
EXP044353	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: N2 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP044354	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: CB428 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044355	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: MT14911 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP043614	goat-anti-GFP-UC	Drosophila melanogaster	strain: Camta-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Camta[MI04570]/SM6a, sex:mixed	EXP043188	1407	normal	B7YZU5	whole organism (development stage: embryonic)	NULL
EXP043615	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042757	1407	normal	P20482	whole organism (development stage: embryonic)	NULL
EXP043616	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP553, genotype: unc-119(tm4063) III; wgIs553., sex:mixed	EXP043158	1235	normal	O02224	whole worms (developmental stage: young adults)	NULL
EXP043617	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL651, genotype: let-607(tm1423); unc-119(ed3) III; vrIs121[LET-607 fosmid, unc-119 (+)], sex:mixed	EXP042765	1235	normal	O44743	whole worms (developmental stage: young adults)	NULL
EXP043618	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP474, genotype: unc-119(tm4063) III; wgIs474., sex:hermaphrodite	EXP042766	1235	normal	U4PEA1	whole worms (developmental stage: young adults)	NULL
EXP043619	goat-anti-GFP-UC	Drosophila melanogaster	strain: jumu-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}jumu[MI00438]/TM6B, sb, Tb, Hu, sex:mixed	EXP043114	1407	normal	Q9XTP7	whole organism (development stage: embryonic)	NULL
EXP043620	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP696, genotype: unc-119(tm4063) III; wgIs696., sex:mixed	EXP042998	1392	normal	Q21494	whole worms (mixed-stage embryos)	NULL
EXP043621	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL479, sex:hermaphrodite	EXP042991	1235	normal	G5EF11	whole worms (developmental stage: young adults)	NULL
EXP043622	goat-anti-GFP-UC	Drosophila melanogaster	strain: pb-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pb-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042865	1407	normal	P31264	whole organism (development stage: embryonic)	NULL
EXP043623	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP32, genotype: unc-119(ed3) III; wgIs32, sex:mixed	EXP043335	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP043624	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:hermaphrodite	EXP043394	1391	normal	Q86MH8	whole worms (developmental stage: late embryo)	NULL
EXP043625	goat-anti-GFP-UC	Drosophila melanogaster	strain: BtbVII-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=BtbVII-GFP.FPTB}attP40, sex:mixed	EXP042872	1407	normal	Q9VZU5	whole organism (development stage: embryonic)	NULL
EXP043626	goat-anti-GFP-UC	Drosophila melanogaster	strain: Atf-2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Atf-2-GFP.FLAG}VK00033, sex:mixed	EXP042599	1407	normal	Q2PE13	whole organism (development stage: embryonic)	NULL
EXP043627	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pdp1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pdp1-GFP.FPTB}VK00037/SM5, sex:mixed	EXP043374	1407	normal	Q24217	whole organism (development stage: embryonic)	NULL
EXP043628	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP513, genotype: unc-119(tm4063) III; wgIs513., sex:hermaphrodite	EXP043354	1391	normal	O44131	whole worms (developmental stage: late embryo)	NULL
EXP043629	goat-anti-GFP-UC	Drosophila melanogaster	strain: crc-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}crc[MI02300]/TM6B, sb, Tb, Hu, sex:mixed	EXP043039	1407	normal	Q9VID3	whole organism (development stage: embryonic)	NULL
EXP043630	goat-anti-GFP-UC	Drosophila melanogaster	strain: Med-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Med-GFP.FLAG}VK00037, sex:mixed	EXP042678	1407	normal	O62609	whole organism (development stage: embryonic)	NULL
EXP043631	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL409, genotype: unc-119(ed3)III; vrIs60 [pLIN-35::LIN-35:GFP:FLAG::LIN-35 3â€™UTR, unc-119 (+)]), sex:mixed	EXP043032	1387	normal	G5EDT1	whole worms (developmental stage: L1)	NULL
EXP043632	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1647-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG1647-GFP.FPTB}VK00037, sex:mixed	EXP043183	1407	normal	Q9VAT1	whole organism (development stage: embryonic)	NULL
EXP043633	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP401, sex:hermaphrodite	EXP043146	1235	normal	H9G332	whole worms (developmental stage: young adults)	NULL
EXP043634	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP043000	1387	normal	Q17905	whole worms (developmental stage: L1)	NULL
EXP043635	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP43, genotype: unc-119(ed3) III; wgIs43., sex:mixed	EXP042933	1390	normal	P41828	whole worms (developmental stage: L3)	NULL
EXP043636	goat-anti-GFP-UC	Drosophila melanogaster	strain: mirr-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=mirr-GFP.FPTB}attP40, sex:mixed	EXP042567	1407	normal	Q9VU01	whole organism (development stage: embryonic)	NULL
EXP043637	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP698, genotype: unc-119(tm4063) III; wgIs698., sex:mixed	EXP042916	1391	normal	O45103	whole worms (developmental stage: late embryo)	NULL
EXP043638	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042619	1390	normal	G5EG44	whole worms (developmental stage: L3)	NULL
EXP043639	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP323, sex:hermaphrodite	EXP043119	1391	normal	G5ECT8	whole worms (developmental stage: late embryo)	NULL
EXP043640	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW12085, genotype: pat-9(mNG^SEC^3xFlag::pat-9]) X, sex:mixed	EXP043134	1391	normal	Q22829	whole worms (developmental stage: late embryo)	NULL
EXP043641	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042936	1392	normal	P91868	whole worms (mixed-stage embryos)	NULL
EXP043642	goat-anti-GFP-UC	Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	EXP043280	1400	normal	M9PGS2	whole organism (development stage: wandering third instar larva)	NULL
EXP043643	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3163-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG3163-GFP.FPTB}VK00033, sex:mixed	EXP043091	1407	normal	Q9W1C8	whole organism (development stage: embryonic)	NULL
EXP043644	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6792-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG6792-GFP.FPTB}VK00033 / tm6C, sb[1], sex:mixed	EXP042614	1408	normal	Q9VKC4	whole organism (development stage: prepupa)	NULL
EXP043645	ab290	Drosophila melanogaster	strain: Abd-B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Abd-B-EGFP.S}VK00037/SM57	EXP043159	1400	normal	P09087	whole organism (development stage: wandering third instar larva)	NULL
EXP043646	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP68, genotype: unc-119(ed3) III; wgIs68., sex:hermaphrodite	EXP042989	1391	normal	G5EE86	whole worms (developmental stage: late embryo)	NULL
EXP043647	goat-anti-GFP-UC	Drosophila melanogaster	strain: foxo-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}foxo[MI00493]/TM6B, sb, Tb, Hu, sex:mixed	EXP043002	1400	normal	Q95V55	whole organism (development stage: wandering third instar larva)	NULL
EXP043648	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043381	1390	normal	Q17381	whole worms (developmental stage: L3)	NULL
EXP043649	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12071-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG12071-GFP.FPTB}attP40, sex:mixed	EXP043023	1407	normal	Q9VA29	whole organism (development stage: embryonic)	NULL
EXP043650	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP477, genotype: unc-119(tm4063) III; wgIs477., sex:hermaphrodite	EXP043164	1390	normal	Q18299	whole worms (developmental stage: L3)	NULL
EXP043651	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP042815	1390	normal	G5ECN8	whole worms (developmental stage: L3)	NULL
EXP043652	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	EXP043262	1390	normal	Q27395	whole worms (developmental stage: L3)	NULL
EXP043653	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	EXP042881	1389	normal	O44505	whole worms (developmental stage: L4/young adults)	NULL
EXP043654	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043144	1392	normal	Q17381	whole worms (mixed-stage embryos)	NULL
EXP043655	goat-anti-GFP-UC	Drosophila melanogaster	strain: MESR4-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=MESR4-GFP.FPTB}VK00033, sex:mixed	EXP042921	1407	normal	A1ZAV3	whole organism (development stage: embryonic)	NULL
EXP043656	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10702, sex:hermaphrodite	EXP043145	1391	normal	Q10007	whole worms (developmental stage: late embryo)	NULL
EXP043657	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP219, genotype: unc-119(ed3) III; wgIs219., sex:mixed	EXP043105	1389	normal	Q11178	whole worms (developmental stage: L4/young adults)	NULL
EXP043658	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11762-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG11762-GFP.FPTB}attP40, sex:mixed	EXP043095	1408	normal	Q9VHM6	whole organism (development stage: prepupa)	NULL
EXP043659	Aviva-KW3-h-D1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042656	1407	normal	P14003	whole organism (development stage: embryonic)	NULL
EXP043660	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP042934	1387	normal	O62183	whole worms (developmental stage: L1)	NULL
EXP043661	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	EXP043270	1390	normal	Q10655	whole worms (developmental stage: L3)	NULL
EXP043662	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	EXP043098	1391	normal	G5EEG1	whole worms (developmental stage: late embryo)	NULL
EXP043663	goat-anti-GFP-UC	Drosophila melanogaster	strain: dpn-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}dpn[MI00051]/TM6B, sb, Tb, Hu, sex:mixed	EXP042693	1407	normal	Q26263	whole organism (development stage: embryonic)	NULL
EXP043664	goat-anti-GFP-UC	Drosophila melanogaster	strain: fu2-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=fu2-GFP-GFP.FPTB}VK00033, sex:mixed	EXP043168	1407	normal	Q9VLK8	whole organism (development stage: embryonic)	NULL
EXP043665	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG5245-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG5245-GFP.FTBP}VK00037, sex:mixed	EXP043353	1407	normal	Q9VG72	whole organism (development stage: embryonic)	NULL
EXP043666	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL551, sex:hermaphrodite	EXP043366	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP043667	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox14-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox14-GFP.FTBP}VK00033, sex:mixed	EXP042594	1408	normal	P40656	whole organism (development stage: prepupa)	NULL
EXP043668	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:hermaphrodite	EXP042948	1389	normal	Q86MJ3	whole worms (developmental stage: L4/young adults)	NULL
EXP043669	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP581, genotype: unc-119(tm4063) III; wgIs581., sex:mixed	EXP043247	1235	normal	O18065	whole worms (developmental stage: young adults)	NULL
EXP043670	goat-anti-GFP-UC	Drosophila melanogaster	strain: acj6-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=acj6-GFP.FPTB}VK00033, sex:mixed	EXP043284	1408	normal	P24350	whole organism (development stage: prepupa)	NULL
EXP043671	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL581, sex:hermaphrodite	EXP042690	1235	normal	Q9XUB3	whole worms (developmental stage: young adults)	NULL
EXP043672	goat-anti-GFP-UC	Drosophila melanogaster	strain: br-rj-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=br.Z2-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043336	1400	normal	Q01295	whole organism (development stage: wandering third instar larva)	NULL
EXP043673	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15514-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG15514-GFP.FPTB}attP40, sex:mixed	EXP043038	1407	normal	Q9VAF2	whole organism (development stage: embryonic)	NULL
EXP043674	goat-anti-GFP-UC	Drosophila melanogaster	strain: gcm2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=gcm2-GFP.FLAG}VK00033, sex:mixed	EXP043204	1407	normal	Q9VLA2	whole organism (development stage: embryonic)	NULL
EXP043675	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP55, genotype: unc-119(ed3) III; wgIs55., sex:hermaphrodite	EXP043100	1391	normal	P09088	whole worms (developmental stage: late embryo)	NULL
EXP043676	ab24726	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042861	1407	normal	P05205	whole organism (development stage: embryonic)	NULL
EXP043677	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042590	1202	normal	Q966B8	whole worms (developmental stage: L2)	NULL
EXP043678	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP240, genotype: unc-119(ed3) III; wgIs240., sex:mixed	EXP042722	1202	normal	Q9N5S3	whole worms (developmental stage: L2)	NULL
EXP043679	goat-anti-GFP-UC	Drosophila melanogaster	strain: Lpt-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Lpt-GFP.FPTB}VK00033, sex:mixed	EXP042645	1408	normal	Q9W1H0	whole organism (development stage: prepupa)	NULL
EXP043680	goat-anti-GFP-UC	Drosophila melanogaster	strain: Jarid2-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=Jarid2-GFP.FPTB}attP40, sex:mixed	EXP043351	1407	normal	Q9VT00	whole organism (development stage: embryonic)	NULL
EXP043681	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4854-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG4854-GFP.FTBP}VK00037, sex:mixed	EXP043011	1407	normal	Q9VDQ5	whole organism (development stage: embryonic)	NULL
EXP043682	goat-anti-GFP-UC	Drosophila melanogaster	strain: trh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=trh-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042898	1407	normal	Q24119	whole organism (development stage: embryonic)	NULL
EXP043683	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4318-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG4318-GFP.FTBP}VK00033, sex:mixed	EXP042672	1408	normal	Q9VYG4	whole organism (development stage: prepupa)	NULL
EXP043684	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP462, genotype: unc-119(tm4063) III; wgIs462., sex:hermaphrodite	EXP043236	1387	normal	G5EFQ5	whole worms (developmental stage: L1)	NULL
EXP043685	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP685, genotype: unc-119(tm4063) III; wgIs685., sex:mixed	EXP043289	1235	normal	Q18605	whole worms (developmental stage: young adults)	NULL
EXP043686	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042724	1390	normal	G5EFY7	whole worms (developmental stage: L3)	NULL
EXP043687	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	EXP043369	1387	normal	Q11107	whole worms (developmental stage: L1)	NULL
EXP043688	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr46-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr46-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP043177	1407	normal	A8DY91	whole organism (development stage: embryonic)	NULL
EXP043689	goat-anti-GFP-UC	Drosophila melanogaster	strain: btn-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=btn-GFP.FTBP}VK00037, sex:mixed	EXP043318	1407	normal	Q9VCY0	whole organism (development stage: embryonic)	NULL
EXP043690	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9437-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG9437-GFP.FPTB}VK00033, sex:mixed	EXP042742	1407	normal	Q9W2K3	whole organism (development stage: embryonic)	NULL
EXP043691	ab290	Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	EXP042626	1403	normal	M9PGS2	whole organism	NULL
EXP043692	non-commercial CG8478 modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042891	1407	normal	E1JIH4	whole organism (development stage: embryonic)	NULL
EXP043693	non-commercial hth modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042978	1407	normal	O46339	whole organism (development stage: embryonic)	NULL
EXP043694	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	EXP043287	1390	normal	O44505	whole worms (developmental stage: L3)	NULL
EXP043695	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP042911	1202	normal	Q17381	whole worms (developmental stage: L2)	NULL
EXP043696	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP105, genotype: unc119(ed3);wgIs105(dpl-1::TY1 EGFP FLAG;unc119), sex:mixed	EXP043364	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP043697	goat-anti-GFP-UC	Caenorhabditis elegans	strain: LW1254, genotype: jjIs1254[Im486.2: pJKL723.2(sma-9C2::gfp+unc-119(+) ]; unc-119(ed4), sex:hermaphrodite	EXP042968	1202	normal	Q22190	whole worms (developmental stage: L2)	NULL
EXP043698	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL418, genotype: unc-119(ed3)III; vrIs65[pGES-1::EFL-1::GFP FLAG:EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043225	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP043699	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP509, genotype: unc-119(tm4063) III; wgIs509., sex:hermaphrodite	EXP043005	1391	normal	A8WFJ9	whole worms (developmental stage: late embryo)	NULL
EXP043700	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	EXP042654	1202	normal	Q11107	whole worms (developmental stage: L2)	NULL
EXP043701	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1602-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG1602-GFP.FTBP}VK00033, sex:mixed	EXP043127	1407	normal	Q8MSB3	whole organism (development stage: embryonic)	NULL
EXP043702	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7556-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7556-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042795	1407	normal	Q9VWL4	whole organism (development stage: embryonic)	NULL
EXP043703	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4707-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG4707-GFP.FPTB}VK00033, sex:mixed	EXP043261	1407	normal	Q9W137	whole organism (development stage: embryonic)	NULL
EXP043704	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:mixed	EXP042591	1391	normal	Q86MH8	whole worms (developmental stage: late embryo)	NULL
EXP043705	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP524, genotype: unc-119(tm4063) III; wgIs524., sex:hermaphrodite	EXP042568	1391	normal	Q94165	whole worms (developmental stage: late embryo)	NULL
EXP043706	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7786-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG7786-GFP.FPTB}VK00033, sex:mixed	EXP043349	1407	normal	A1ZAC2	whole organism (development stage: embryonic)	NULL
EXP043707	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP682, genotype: unc-119(tm4063); wgIs682 [Y5F2A.4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043014	1389	normal	Q9XWL0	whole worms (developmental stage: L4/young adults)	NULL
EXP043708	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL482, sex:hermaphrodite	EXP043053	1235	normal	Q17694	whole worms (developmental stage: young adults)	NULL
EXP043709	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP339, genotype: unc-119(ed3) III; wgIs339., sex:mixed	EXP043058	1202	normal	A5JYV4	whole worms (developmental stage: L2)	NULL
EXP043710	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP676, genotype: unc-119(tm4063); wgIs676 [ztf-22::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042807	1235	normal	Q9NAG7	whole worms (developmental stage: young adults)	NULL
EXP043711	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL468, genotype: unc-119(ed3)III; vrIs93 [pMEX-5::LIN-35:GFP:FLAG::LIN-35 3â€™UTR, unc-119 (+)]), sex:mixed	EXP043243	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	NULL
EXP043712	goat-anti-GFP-UC	Drosophila melanogaster	strain: snoo-MiMIC, genotype: y[1] w[*]; Mi{eGFP=MIC}snoo[MI07577]/TM6B, sb, Tb, Hu, sex:mixed	EXP042896	1404	normal	Q00G30	whole organism (development stage: pupa)	NULL
EXP043713	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hmx-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Hmx[MI02025]/TM6B, sb, Tb, Hu, sex:mixed	EXP043263	1407	normal	B4F5U4	whole organism (development stage: embryonic)	NULL
EXP043714	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	EXP042707	1387	normal	Q9TZI2	whole worms (developmental stage: L1)	NULL
EXP043715	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10470, genotype: stIs10470 [tbx-8::TY1::EGFP::3xFLAG; unc-119(+)]; unc-119(ed3), sex:mixed	EXP042919	1392	normal	Q22292	whole worms (mixed-stage embryos)	NULL
EXP043716	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP465, genotype: unc-119(tm4063) III; wgIs465., sex:hermaphrodite	EXP042696	1235	normal	O44637	whole worms (developmental stage: young adults)	NULL
EXP043717	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP383, genotype: unc-119(tm4063) III; wgIs383., sex:hermaphrodite	EXP043258	1389	normal	G4SGI5	whole worms (developmental stage: L4/young adults)	NULL
EXP043718	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	EXP042800	1390	normal	Q19691	whole worms (developmental stage: L3)	NULL
EXP043719	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6254-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6254-GFP.FPTB}attP40, sex:mixed	EXP042966	1407	normal	Q9VH18	whole organism (development stage: embryonic)	NULL
EXP043720	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG30431-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG30431-GFP.FTBP}VK00033, sex:mixed	EXP042849	1407	normal	Q4V6Y7	whole organism (development stage: embryonic)	NULL
EXP043721	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL474, genotype: lin-35(n745) I; unc-119(ed3) III; vrIs64[pGES-1::HPL-2::GFP FLAG: HPL-2 3-UTR, unc-119 (+)], sex:mixed	EXP043042	1387	normal	G5EDE2	whole worms (developmental stage: L1)	NULL
EXP043722	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13775-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG13775-GFP.FTBP}VK00033, sex:mixed	EXP042894	1407	normal	Q9VM61	whole organism (development stage: embryonic)	NULL
EXP043723	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8319-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG8319-GFP.FPTB}attP40, sex:mixed	EXP043017	1408	normal	Q9VHA4	whole organism (development stage: prepupa)	NULL
EXP043724	non-commercial CG8478 modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042771	1403	normal	E1JIH4	whole organism	NULL
EXP043725	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1620-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG1620-GFP-GFP.FPTB}VK00033, sex:female	EXP043205	1399	normal	E1JGZ3	whole organism (development stage: adult)	NULL
EXP043726	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL424, genotype: unc-119(ed3)III; vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP042810	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP043727	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP614, genotype: unc-119(tm4063); wgIs614 [ztf-3::TY1::EGFP::3xFLAG +;unc-119(+)], sex:mixed	EXP042643	1235	normal	Q9N5V6	whole worms (developmental stage: young adults)	NULL
EXP043728	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6276-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6276-GFP.FPTB}attP40, sex:mixed	EXP042817	1408	normal	Q9VF93	whole organism (development stage: prepupa)	NULL
EXP043729	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG16779-MiMIC, genotype: y[1] w[*]; Mi{eGFP=MIC}CG16779[MI06036]/TM6B, sb, Tb, Hu, sex:mixed	EXP043020	1408	normal	Q9VHD1	whole organism (development stage: prepupa)	NULL
EXP043730	ab290	Drosophila melanogaster	strain: usp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=usp-GFP.FLAG}VK00033	EXP042662	1407	normal	M9PGS2	whole organism (development stage: embryonic)	NULL
EXP043731	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pum-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}pum[MI04825]/TM6B, sb, Tb, Hu, sex:mixed	EXP042633	1407	normal	P25822	whole organism (development stage: embryonic)	NULL
EXP043732	goat-anti-GFP-UC	Drosophila melanogaster	strain: Clk-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Clk-GFP.FPTB}attP40, sex:male	EXP042954	1399	normal	O61735	whole organism (development stage: adult)	NULL
EXP043733	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP184, genotype: unc-119(tm4063) III; wgIs184., sex:mixed	EXP043264	1387	normal	Q27395	whole worms (developmental stage: L1)	NULL
EXP043734	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: NC1639, genotype: [wdIs49 (pttr39::UNC-55a::GFP; dpy-20+) III, sex:mixed	EXP042554	1391	normal	G5ECR9	whole worms (developmental stage: late embryo)	NULL
EXP043735	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 10T-Dfd-GFP, genotype: y[1] M{vas-int.Dm}ZH-2A w[*]; PBac{y[+]-attP-3B}VK00033	EXP042783	1407	normal	Q7KS72	whole organism (development stage: embryonic)	NULL
EXP043736	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP042736	1389	normal	G5ECN8	whole worms (developmental stage: L4/young adults)	NULL
EXP043737	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: NC1639, genotype: [wdIs49 (pttr39::UNC-55a::GFP; dpy-20+) III, sex:mixed	EXP043016	1202	normal	G5ECR9	whole worms (developmental stage: L2)	NULL
EXP043738	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd102C-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=-GFP.FPTB}VK00033 / Tm6c, sex:mixed	EXP043294	1407	normal	Q9V481	whole organism (development stage: embryonic)	NULL
EXP043739	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: XE1464, genotype: unc-119(ed3) III;, sex:mixed	EXP043192	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	NULL
EXP043740	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP043250	1387	normal	O02274	whole worms (developmental stage: L1)	NULL
EXP043741	goat-anti-GFP-UC	Drosophila melanogaster	strain: ets3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets65A-GFP.FLAG}VK00037, sex:mixed	EXP043189	1407	normal	P29774	whole organism (development stage: embryonic)	NULL
EXP043742	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042907	1202	normal	G5ECG2	whole worms (developmental stage: L2)	NULL
EXP043743	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG34376-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ADD1-GFP.FPTB}attP40 / CyO, sex:mixed	EXP042683	1407	normal	Q9VD04	whole organism (development stage: embryonic)	NULL
EXP043744	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP427, genotype: unc-119(ed3) III; wgIs427., sex:mixed	EXP042629	1202	normal	Q9XTV4	whole worms (developmental stage: L2)	NULL
EXP043745	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP042691	1389	normal	P34684	whole worms (developmental stage: L4/young adults)	NULL
EXP043746	goat-anti-GFP-UC	Drosophila melanogaster	strain: TFAM-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=TFAM-GFP.FPTB}attP40, sex:mixed	EXP043121	1407	normal	Q86BR8	whole organism (development stage: embryonic)	NULL
EXP043747	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP043372	1390	normal	O17593	whole worms (developmental stage: L3)	NULL
EXP043748	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP432, genotype: unc-119(tm4063) III; wgIs432., sex:mixed	EXP042636	1389	normal	Q21148	whole worms (developmental stage: L4/young adults)	NULL
EXP043749	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP042860	1389	normal	O62183	whole worms (developmental stage: L4/young adults)	NULL
EXP043750	non-commercial CG8478 modENCODE antibody 1	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP042769	1197	normal	E1JIH4	S2-DRSC (embryonic stem cells)	NULL
EXP043751	goat-anti-GFP-UC	Drosophila melanogaster	strain: cwo-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=cwo-GFP.FPTB}attP40, sex:mixed	EXP042561	1407	normal	Q9VGZ5	whole organism (development stage: embryonic)	NULL
EXP043752	Aviva-KW3-h-D1	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	P14003	Kc167 (development stage: embryonic)	NULL
EXP043753	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP611, genotype: unc-119(tm4063); wgIs611 [sup-37::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042952	1387	normal	Q8MNV9	whole worms (developmental stage: L1)	NULL
EXP043754	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP652, genotype: unc-119(tm4063) III; wgIs652, sex:mixed	EXP043347	1387	normal	Q9TZK1	whole worms (developmental stage: L1)	NULL
EXP043755	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042814	1387	normal	G5ECF7	whole worms (developmental stage: L1)	NULL
EXP043756	sc-28208	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP042769	1197	normal	Q9W4S7	S2-DRSC (embryonic stem cells)	NULL
EXP043757	goat-anti-GFP-UC	Drosophila melanogaster	strain: eyg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=eyg-GFP.FPTB}VK00037/SM5, sex:mixed	EXP043180	1407	normal	Q9VTX7	whole organism (development stage: embryonic)	NULL
EXP043758	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP536, genotype: unc-119(tm4063) III; wgIs536, sex:hermaphrodite	EXP042941	1387	normal	Q93348	whole worms (developmental stage: L1)	NULL
EXP043759	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3407-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG3407-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042932	1407	normal	Q9VQV3	whole organism (development stage: embryonic)	NULL
EXP043760	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP167, genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119), sex:mixed	EXP042580	1390	normal	G5EFF5	whole worms (developmental stage: L3)	NULL
EXP043761	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9609-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG9609-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042582	1407	normal	Q9VXB4	whole organism (development stage: embryonic)	NULL
EXP043762	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP63, sex:hermaphrodite	EXP042971	1391	normal	Q11094	whole worms (developmental stage: late embryo)	NULL
EXP043763	ab4811	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043259	1407	normal	A1Z768	whole organism (development stage: embryonic)	NULL
EXP043764	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042836	1202	normal	O02316	whole worms (developmental stage: L2)	NULL
EXP043765	goat-anti-GFP-UC	Drosophila melanogaster	strain: maf-S-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=maf-S-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042784	1407	normal	Q4QPP9	whole organism (development stage: embryonic)	NULL
EXP043766	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dhr51-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr51-GFP.FLAG}VK00033, sex:mixed	EXP043024	1407	normal	A1ZA01	whole organism (development stage: embryonic)	NULL
EXP043767	goat-anti-GFP-UC	Drosophila melanogaster	strain: chif-RA-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=chif-RA-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042999	1407	normal	Q9NK54	whole organism (development stage: embryonic)	NULL
EXP043768	goat-anti-GFP-UC	Drosophila melanogaster	strain: zfh2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=zfh2-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043368	1407	normal	P28167	whole organism (development stage: embryonic)	NULL
EXP043769	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP043302	1390	normal	Q09228	whole worms (developmental stage: L3)	NULL
EXP043770	goat-anti-GFP-UC	Drosophila melanogaster	strain: dm-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dm-GFP.FPTB}VK00033, sex:mixed	EXP043029	1407	normal	Q9VP06	whole organism (development stage: embryonic)	NULL
EXP043771	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7368-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG7368-GFP.FPTB}attP-40 / tm6C, sb[1], sex:mixed	EXP043155	1408	normal	Q9VTK6	whole organism (development stage: prepupa)	NULL
EXP043772	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10669-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG10669-GFP.FPTB}attP40, sex:mixed	EXP042566	1408	normal	Q9VBR9	whole organism (development stage: prepupa)	NULL
EXP043773	goat-anti-GFP-UC	Drosophila melanogaster	strain: side-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}side[MI00149]/TM6B, sb, Tb, Hu, sex:mixed	EXP042903	1407	normal	Q9VJ16	whole organism (development stage: embryonic)	NULL
EXP043774	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12768-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG12768-GFP.FPTB}attP40, sex:male	EXP042885	1399	normal	Q9VNP4	whole organism (development stage: adult)	NULL
EXP043775	goat-anti-GFP-UC	Drosophila melanogaster	strain: NfI-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=NfI-GFP.FPTB}VK00033, sex:mixed	EXP042700	1407	normal	Q86P06	whole organism (development stage: embryonic)	NULL
EXP043776	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG5204-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG5204-GFP.FPTB}VK00033, sex:male	EXP042909	1399	normal	Q9VK36	whole organism (development stage: adult)	NULL
EXP043777	goat-anti-GFP-UC	Caenorhabditis elegans	strain: AGK541, genotype: (armSi1[Pmex5::UNC-130::GFP::tbb-2 3'UTR; cb-unc-119(+)II]; unc-119(ed3)III; niDf199IV), sex:hermaphrodite	EXP043390	1235	normal	Q18694	whole worms (developmental stage: young adults)	NULL
EXP043778	Aviva-KW3-psq-D2	Drosophila melanogaster	genotype: e/se	EXP042787	1397	normal	A1Z8A6	Kc167 (development stage: embryonic)	NULL
EXP043779	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043137	1389	normal	Q23521	whole worms (developmental stage: L4/young adults)	NULL
EXP043780	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP658, genotype: unc-119(tm4063) III; wgIs658., sex:mixed	EXP043181	1235	normal	Q19306	whole worms (developmental stage: young adults)	NULL
EXP043781	goat-anti-GFP-UC	Drosophila melanogaster	strain: chif-RB-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=chif-RB-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042702	1407	normal	Q9NK54	whole organism (development stage: embryonic)	NULL
EXP043782	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mio-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mio-GFP.FPTB}VK00033, sex:mixed	EXP042857	1400	normal	Q9VID4	whole organism (development stage: wandering third instar larva)	NULL
EXP043783	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP537, genotype: unc-119(tm4063) III; wgIs537, sex:hermaphrodite	EXP042821	1235	normal	G5EEH5	whole worms (developmental stage: young adults)	NULL
EXP043784	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042709	1389	normal	G5EG44	whole worms (developmental stage: L4/young adults)	NULL
EXP043785	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP042671	1202	normal	O17894	whole worms (developmental stage: L2)	NULL
EXP043786	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042871	1202	normal	Q9N5D6	whole worms (developmental stage: L2)	NULL
EXP043787	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP478, genotype: unc-119(tm4063) III; wgIs478., sex:hermaphrodite	EXP042638	1235	normal	P91437	whole worms (developmental stage: young adults)	NULL
EXP043788	44960002	Caenorhabditis elegans	strain: MT10430, genotype: lin-35(n745) I., sex:mixed	EXP042601	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP043789	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP154, genotype: unc-119(ed3) III; wgIs154, sex:hermaphrodite	EXP043240	1387	normal	G5EDE1	whole worms (developmental stage: L1)	NULL
EXP043790	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP544, genotype: unc-119(tm4063) III; wgIs544, sex:hermaphrodite	EXP043365	1391	normal	G5EG34	whole worms (developmental stage: late embryo)	NULL
EXP043791	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP361, genotype: unc-119(tm4063) III; wgIs361., sex:mixed	EXP042983	1202	normal	G5EBL9	whole worms (developmental stage: L2)	NULL
EXP043792	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pif1B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pif1B-GFP.FPTB}VK00037, sex:mixed	EXP043012	1404	normal	Q9VHL6	whole organism (development stage: pupa)	NULL
EXP043793	goat-anti-GFP-UC	Drosophila melanogaster	strain: Mnt-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Mnt-GFP.FPTB}VK00033/TM3, Sb[1], sex:female	EXP042874	1399	normal	E1JJD1	whole organism (development stage: adult)	NULL
EXP043794	goat-anti-GFP-UC	Drosophila melanogaster	strain: lilli-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lilli-GFP.FPTB}VK00033, sex:mixed	EXP043169	1407	normal	Q9VQI9	whole organism (development stage: embryonic)	NULL
EXP043795	goat-anti-GFP-UC	Drosophila melanogaster	strain: sv-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sv-GFP.FPTB}VK00033, sex:mixed	EXP042912	1400	normal	Q8IM96	whole organism (development stage: wandering third instar larva)	NULL
EXP043796	KW0:TTK-7691	Drosophila melanogaster	genotype: e/se	EXP043295	1397	normal	P17789	Kc167 (development stage: embryonic)	NULL
EXP043797	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP727, genotype: unc-119(tm4063); wgIs727 [ceh-83::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042698	1392	normal	O16749	whole worms (mixed-stage embryos)	NULL
EXP043798	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP460, genotype: unc-119(tm4063) III; wgIs460., sex:hermaphrodite	EXP042647	1235	normal	O76668	whole worms (developmental stage: young adults)	NULL
EXP043799	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP208, genotype: unc-119(ed3) III; wgIs208., sex:mixed	EXP042805	1235	normal	G5EGN8	whole worms (developmental stage: young adults)	NULL
EXP043800	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043147	1390	normal	O16748	whole worms (developmental stage: L3)	NULL
EXP043801	goat-anti-GFP-UC	Drosophila melanogaster	strain: Kr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Kr-GFP.FTBP}VK00033, sex:mixed	EXP042588	1407	normal	P07247	whole organism (development stage: embryonic)	NULL
EXP043802	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	EXP042782	1202	normal	Q9TZI2	whole worms (developmental stage: L2)	NULL
EXP043803	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP391, genotype: unc-119(ed3) III; wgIs391(med-1::TY1 EGFP FLAG C; unc-119(+)), sex:hermaphrodite	EXP043255	1396	normal	G5EF71	whole organism (development stage: midembryonic)	NULL
EXP043804	goat-anti-GFP-UC	Drosophila melanogaster	strain: chn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=chn-GFP.FPTB}VK00033, sex:mixed	EXP042598	1407	normal	Q7YU81	whole organism (development stage: embryonic)	NULL
EXP043805	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042957	1202	normal	G5ECF7	whole worms (developmental stage: L2)	NULL
EXP043806	goat-anti-GFP-UC	Drosophila melanogaster	strain: emc-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=emc-GFP.FTBP}VK00037, sex:mixed	EXP043301	1407	normal	P18491	whole organism (development stage: embryonic)	NULL
EXP043807	goat-anti-GFP-UC	Drosophila melanogaster	strain: br-re-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=br.Z1-GFP.FPTB}VK00037, sex:mixed	EXP042706	1400	normal	Q01295	whole organism (development stage: wandering third instar larva)	NULL
EXP043808	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP688, genotype: unc-119(tm4063) III; wgIs688., sex:mixed	EXP042960	1235	normal	Q19335	whole worms (developmental stage: young adults)	NULL
EXP043809	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043383	1403	normal	P91943	whole organism	NULL
EXP043810	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9727-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG9727-GFP.FTBP}VK00037, sex:mixed	EXP042961	1407	normal	Q9VI23	whole organism (development stage: embryonic)	NULL
EXP043811	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP488, genotype: unc-119(tm4063) III; wgIs488., sex:hermaphrodite	EXP042778	1391	normal	Q95PV3	whole worms (developmental stage: late embryo)	NULL
EXP043812	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043148	1387	normal	G5ECF7	whole worms (developmental stage: L1)	NULL
EXP043813	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP174, genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119), sex:mixed	EXP043064	1392	normal	G5ECN8	whole worms (mixed-stage embryos)	NULL
EXP043814	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042942	1389	normal	Q65CM0	whole worms (developmental stage: L4/young adults)	NULL
EXP043815	non-commercial br modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043360	1407	normal	Q01295	whole organism (development stage: embryonic)	NULL
EXP043816	goat-anti-GFP-UC	Caenorhabditis elegans	strain: xtl1186, sex:hermaphrodite	EXP042628	1235	normal	Q93156	whole worms (developmental stage: young adults)	NULL
EXP043817	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042753	1390	normal	Q65CM0	whole worms (developmental stage: L3)	NULL
EXP043818	goat-anti-GFP-UC	Drosophila melanogaster	strain: scrt-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=scrt-GFP.FPTB}attP40, sex:mixed	EXP042558	1407	normal	Q9VZK2	whole organism (development stage: embryonic)	NULL
EXP043819	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2116-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2116-GFP.FPTB}VK00033, sex:mixed	EXP042925	1407	normal	Q9W3J9	whole organism (development stage: embryonic)	NULL
EXP043820	goat-anti-GFP-UC	Drosophila melanogaster	strain: Meics-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=Meics-GFP.FPTB}attP40, sex:mixed	EXP042959	1407	normal	O96395	whole organism (development stage: embryonic)	NULL
EXP043821	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8632-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ZnT49B-GFP.FTBP}VK00033, sex:mixed	EXP043332	1408	normal	A1Z936	whole organism (development stage: prepupa)	NULL
EXP043822	goat-anti-GFP-UC	Drosophila melanogaster	strain: NK7.1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NK7.1-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042564	1407	normal	Q9VFK4	whole organism (development stage: embryonic)	NULL
EXP043823	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sry-beta-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=sry-Beta-GFP.FPTB}attP-40, sex:mixed	EXP042773	1407	normal	P07665	whole organism (development stage: embryonic)	NULL
EXP043824	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP327, genotype: unc-119(ed3) III; wgIs327., sex:mixed	EXP042639	1392	normal	P46505	whole worms (mixed-stage embryos)	NULL
EXP043825	goat-anti-GFP-UC	Drosophila melanogaster	strain: MTF-1-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=MTF-1-GFP.FPTB}attP-40, sex:mixed	EXP042819	1407	normal	Q8IQC5	whole organism (development stage: embryonic)	NULL
EXP043826	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL485, sex:hermaphrodite	EXP042627	1235	normal	Q7JNN6	whole worms (developmental stage: young adults)	NULL
EXP043827	non-commercial insv modENCODE antibody 1	Drosophila melanogaster	genotype: e/se	EXP043076	1397	normal	Q8SYK5	Kc167 (development stage: embryonic)	NULL
EXP043828	goat-anti-GFP-UC	Drosophila melanogaster	strain: vfl-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=vfl-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043226	1407	normal	Q9VWC6	whole organism (development stage: embryonic)	NULL
EXP043829	goat-anti-GFP-UC	Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	EXP043197	1400	normal	A1Z8A6	whole organism (development stage: wandering third instar larva)	NULL
EXP043830	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9305-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG9305-GFP.FTBP}VK00033, sex:mixed	EXP043414	1407	normal	Q9VJZ3	whole organism (development stage: embryonic)	NULL
EXP043831	goat-anti-GFP-UC	Drosophila melanogaster	strain: svp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=svp-GFP.FLAG}VK00037/SM5, sex:mixed	EXP043063	1408	normal	P16375	whole organism (development stage: prepupa)	NULL
EXP043832	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG32264-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG32264-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042992	1400	normal	D4G7A5	whole organism (development stage: wandering third instar larva)	NULL
EXP043833	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP202, genotype: unc-119(ed3) III; wgIs202., sex:mixed	EXP042829	1391	normal	P56407	whole worms (developmental stage: late embryo)	NULL
EXP043834	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP443, sex:hermaphrodite	EXP042747	1391	normal	O01996	whole worms (developmental stage: late embryo)	NULL
EXP043835	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10631-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10631-GFP.FTBP}VK00033	EXP042944	1408	normal	Q9VIS5	whole organism (development stage: prepupa)	NULL
EXP043836	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dp-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dp-GFP.FPTB}VK00033, sex:mixed	EXP043175	1407	normal	Q24318	whole organism (development stage: embryonic)	NULL
EXP043837	goat-anti-GFP-UC	Drosophila melanogaster	strain: dsf-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dsf-GFP.FLAG}VK00033, sex:mixed	EXP042822	1400	normal	Q9VML1	whole organism (development stage: wandering third instar larva)	NULL
EXP043838	goat-anti-GFP-UC	Drosophila melanogaster	strain: dac-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dac-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042674	1408	normal	Q8IP20	whole organism (development stage: prepupa)	NULL
EXP043839	goat-anti-GFP-UC	Drosophila melanogaster	strain: odd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=odd-GFP.FPTB}VK00033, sex:mixed	EXP042562	1407	normal	P23803	whole organism (development stage: embryonic)	NULL
EXP043840	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP552, genotype: unc-119(tm4063) III; wgIs552., sex:mixed	EXP043303	1387	normal	Q18419	whole worms (developmental stage: L1)	NULL
EXP043841	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP418, genotype: unc-119(tm4063) III; wgIs418., sex:hermaphrodite	EXP042663	1391	normal	Q18248	whole worms (developmental stage: late embryo)	NULL
EXP043842	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 10T-Dfd-GFP, genotype: y[1] M{vas-int.Dm}ZH-2A w[*]; PBac{y[+]-attP-3B}VK00033	EXP043401	1400	normal	Q7KS72	whole organism (development stage: wandering third instar larva)	NULL
EXP043843	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP385, genotype: unc-119(tm4063) III; wgIs385., sex:hermaphrodite	EXP042859	1235	normal	O17890	whole worms (developmental stage: young adults)	NULL
EXP064982	anti-Yki	Drosophila melanogaster	Treatment: Treatment: Treatment: none; Strain: Iso1; Strain: Iso1; Strain: Iso1	EXP064981	1417	normal	Q45VV3	8-16 h embryo	NULL
EXP043845	goat-anti-GFP-UC	Drosophila melanogaster	strain: Eip93F-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Eip93F[MI05200]/TM6B, sb, Tb, Hu, sex:mixed	EXP042879	1408	normal	Q9VD60	whole organism (development stage: prepupa)	NULL
EXP043846	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL497, sex:hermaphrodite	EXP043324	1235	normal	Q22092	whole worms (developmental stage: young adults)	NULL
EXP043847	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP26, genotype: unc-119(ed3) III; wgIs26 [unc-119(+) mab-5::TY1::EGFP::3xFLAG], sex:mixed	EXP042963	1390	normal	P10038	whole worms (developmental stage: L3)	NULL
EXP043848	goat-anti-GFP-UC	Drosophila melanogaster	strain: YL-1-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=YL-1-GFP.FPTB}VK00033, sex:mixed	EXP043292	1407	normal	Q9VKM6	whole organism (development stage: embryonic)	NULL
EXP043849	goat-anti-GFP-UC	Drosophila melanogaster	strain: HLHm7-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=HLHm7-GFP.FTBP}VK00037, sex:mixed	EXP043066	1407	normal	P13097	whole organism (development stage: embryonic)	NULL
EXP043850	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18764-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG18764-GFP.FPTB}attP-40, sex:mixed	EXP042715	1407	normal	Q9I7J8	whole organism (development stage: embryonic)	NULL
EXP043851	goat-anti-GFP-UC	Drosophila melanogaster	strain: cnc-GFP, genotype: W[*]; PBac{eGFP w[+mC]=cnc-GFP.FTBP}VK00037, sex:mixed	EXP042750	1400	normal	P20482	whole organism (development stage: wandering third instar larva)	NULL
EXP043852	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP51, genotype: unc-119(ed3) III; wgIs51., sex:mixed	EXP042804	1392	normal	Q11107	whole worms (mixed-stage embryos)	NULL
EXP043853	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP042631	1390	normal	O62183	whole worms (developmental stage: L3)	NULL
EXP043854	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP042988	1202	normal	Q21701	whole worms (developmental stage: L2)	NULL
EXP043855	goat-anti-GFP-UC	Drosophila melanogaster	strain: jim-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=jim-GFP.FPTB}VK00037, sex:mixed	EXP043009	1400	normal	Q7KAH0	whole organism (development stage: wandering third instar larva)	NULL
EXP043856	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP193, genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119), sex:mixed	EXP043093	1390	normal	S6EZL2	whole worms (developmental stage: L3)	NULL
EXP043857	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP042602	1389	normal	Q09228	whole worms (developmental stage: L4/young adults)	NULL
EXP043858	goat-anti-GFP-UC	Caenorhabditis elegans	strain: AGK541, genotype: (armSi1[Pmex5::UNC-130::GFP::tbb-2 3'UTR; cb-unc-119(+)II]; unc-119(ed3)III; niDf199IV), sex:hermaphrodite	EXP043103	1389	normal	Q18694	whole worms (developmental stage: L4/young adults)	NULL
EXP043859	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP332, genotype: unc-119(tm4063) III; wgIs332., sex:mixed	EXP042976	1389	normal	Q20448	whole worms (developmental stage: L4/young adults)	NULL
EXP043860	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG32006-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG32006-GFP.FTBP}VK00033, sex:mixed	EXP043118	1408	normal	Q8IMA2	whole organism (development stage: prepupa)	NULL
EXP043861	goat-anti-GFP-UC	Drosophila melanogaster	strain: slou-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=slou-EGFP.S}VK00037/SM5, sex:mixed	EXP043013	1407	normal	P22807	whole organism (development stage: embryonic)	NULL
EXP043862	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pif1A-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Pif1A-GFP.FPTB}VK00037, sex:mixed	EXP042792	1404	normal	B7Z0G1	whole organism (development stage: pupa)	NULL
EXP043863	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP485, sex:hermaphrodite	EXP043154	1235	normal	Q86S28	whole worms (developmental stage: young adults)	NULL
EXP043864	44960002	Caenorhabditis elegans	strain: N2, genotype: C. elegans wild isolate., sex:hermaphrodite	EXP042734	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP043865	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP27, genotype: unc-119(ed3) III; wgIs27., sex:mixed	EXP043171	1392	normal	P10038	whole worms (mixed-stage embryos)	NULL
EXP043866	ab290	Drosophila melanogaster	strain: Notch-GFP, genotype: PBac{y[+]-attP-3B}VK00033	EXP042847	1400	normal	M9NE67	whole organism (development stage: wandering third instar larva)	NULL
EXP043867	goat-anti-GFP-UC	Caenorhabditis elegans	strain: ZM8745, genotype: daf-16(mu86);daf-2(e1370) III; hpSi15 (Pges-1 GFP::daf-16a), sex:hermaphrodite	EXP043317	1389	normal	O16850	whole worms (developmental stage: L4/young adults)	NULL
EXP043868	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043162	1389	normal	O16748	whole worms (developmental stage: L4/young adults)	NULL
EXP043869	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12155-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG12155-GFP.FPTB}VK00033, sex:mixed	EXP043227	1407	normal	Q9W3Q2	whole organism (development stage: embryonic)	NULL
EXP043870	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP496, sex:hermaphrodite	EXP042729	1235	normal	B9ZSG9	whole worms (developmental stage: young adults)	NULL
EXP043871	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP508, genotype: unc-119(tm4063) III; wgIs508., sex:hermaphrodite	EXP042610	1235	normal	Q9XWS3	whole worms (developmental stage: young adults)	NULL
EXP043872	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dip3-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Dip3-GFP.FPTB}VK00031, sex:mixed	EXP042705	1407	normal	Q7JZD5	whole organism (development stage: embryonic)	NULL
EXP043873	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP343, genotype: unc-119(ed3) III; wgIs343., sex:mixed	EXP043242	1202	normal	O17208	whole worms (developmental stage: L2)	NULL
EXP043874	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042739	1390	normal	Q9N5D6	whole worms (developmental stage: L3)	NULL
EXP043875	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043234	1387	normal	O16748	whole worms (developmental stage: L1)	NULL
EXP043876	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG18011-GFP, sex:mixed	EXP043246	1407	normal	Q7K1V0	whole organism (development stage: embryonic)	NULL
EXP043877	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6654-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6654-GFP.FPTB}attP40, sex:mixed	EXP043101	1407	normal	Q9VFB9	whole organism (development stage: embryonic)	NULL
EXP043878	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3838-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG3838-GFP.FTBP}VK00033/TM3, sex:mixed	EXP043153	1407	normal	Q9VLA6	whole organism (development stage: embryonic)	NULL
EXP043879	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP471, genotype: unc-119(tm4063) III; wgIs471., sex:hermaphrodite	EXP043131	1391	normal	H2KZR6	whole worms (developmental stage: late embryo)	NULL
EXP043880	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP042793	1389	normal	O17593	whole worms (developmental stage: L4/young adults)	NULL
EXP043881	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6765-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6765-GFP.FPTB}attP40, sex:mixed	EXP042560	1407	normal	Q9VSL1	whole organism (development stage: embryonic)	NULL
EXP043882	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043355	1387	normal	G5ECF7	whole worms (developmental stage: L1)	NULL
EXP043883	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP043376	1390	normal	Q17905	whole worms (developmental stage: L3)	NULL
EXP043884	goat-anti-GFP-UC	Drosophila melanogaster	strain: Jra-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Jra-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP043214	1400	normal	P18289	whole organism (development stage: wandering third instar larva)	NULL
EXP043885	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP106, genotype: unc-119(ed3) III; wgIs106., sex:mixed	EXP042604	1387	normal	G5EG44	whole worms (developmental stage: L1)	NULL
EXP043886	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP102, genotype: unc-119(tm4063) III; wgIs102., sex:mixed	EXP042559	1389	normal	Q21502	whole worms (developmental stage: L4/young adults)	NULL
EXP043887	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP357, genotype: unc-119(tm4063) III; wgIs357., sex:mixed	EXP043328	1387	normal	O45756	whole worms (developmental stage: L1)	NULL
EXP043888	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP708, genotype: unc-119(tm4063); wgIs708 [C38D4.7::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042926	1391	normal	Q18512	whole worms (developmental stage: late embryo)	NULL
EXP043889	goat-anti-GFP-UC	Drosophila melanogaster	strain: repo-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=repo-GFP.FTBP}VK00037/CyO, sex:mixed	EXP043070	1407	normal	Q7KSE4	whole organism (development stage: embryonic)	NULL
EXP043890	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP164, sex:hermaphrodite	EXP043141	1391	normal	J7S155	whole worms (developmental stage: late embryo)	NULL
EXP043891	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:male	EXP042831	1399	normal	P20482	whole organism (development stage: adult)	NULL
EXP043892	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17568-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG17568-GFP.FPTB}VK00033, sex:mixed	EXP042931	1407	normal	Q9VIY9	whole organism (development stage: embryonic)	NULL
EXP043893	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	EXP043133	1391	normal	G5EEG1	whole worms (developmental stage: late embryo)	NULL
EXP043894	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hnf4-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hnf4-GFP.FLAG}VK00033, sex:mixed	EXP043208	1400	normal	P49866	whole organism (development stage: wandering third instar larva)	NULL
EXP043895	goat-anti-GFP-UC	Drosophila melanogaster	strain: bsh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bsh-GFP.FTBP}VK00033, sex:mixed	EXP043143	1407	normal	Q04787	whole organism (development stage: embryonic)	NULL
EXP043896	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15073-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG15073-GFP.FTBP}VK00033, sex:mixed	EXP043338	1407	normal	A1ZBC5	whole organism (development stage: embryonic)	NULL
EXP043897	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP538, genotype: unc-119(tm4063) III; wgIs538, sex:hermaphrodite	EXP043120	1235	normal	Q18277	whole worms (developmental stage: young adults)	NULL
EXP043898	ab290	Drosophila melanogaster	strain: Stat92E-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Stat92E-GFP.FLAG}VK00037	EXP042877	1407	normal	Q24151	whole organism (development stage: embryonic)	NULL
EXP043899	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP572, genotype: unc-119(tm4063); wgIs572 [gei-17::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043077	1235	normal	Q94361	whole worms (developmental stage: young adults)	NULL
EXP043900	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG33213-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG33213-GFP.FTBP}VK00037, sex:mixed	EXP042659	1407	normal	Q9VAY8	whole organism (development stage: embryonic)	NULL
EXP043901	ab290	Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	EXP043054	1400	normal	P42283	whole organism (development stage: wandering third instar larva)	NULL
EXP043902	goat-anti-GFP-UC	Drosophila melanogaster	strain: kay-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=kay-GFP.FLAG}VK00037, sex:male	EXP043363	1399	normal	A8MPH9	whole organism (development stage: adult)	NULL
EXP043903	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2120-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2120-GFP.FTBP}VK00033	EXP042958	1407	normal	Q0IGR3	whole organism (development stage: embryonic)	NULL
EXP043904	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1832-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG1832-GFP.FPTB}VK00033, sex:mixed	EXP043391	1407	normal	Q9V9N4	whole organism (development stage: embryonic)	NULL
EXP043905	goat-anti-GFP-UC	Drosophila melanogaster	strain: Neu2-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=Neu2-GFP.FPTB}VK00037, sex:mixed	EXP042824	1407	normal	B6VQ99	whole organism (development stage: embryonic)	NULL
EXP043906	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hsf-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Hsf-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042981	1407	normal	P22813	whole organism (development stage: embryonic)	NULL
EXP043907	goat-anti-GFP-UC	Drosophila melanogaster	strain: Fer1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer1-GFP.FPTB}attP40, sex:mixed	EXP042802	1407	normal	Q9VI67	whole organism (development stage: embryonic)	NULL
EXP043908	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 5T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=eve-EGFP.S}VK00033	EXP042569	1407	normal	F9W320	whole organism (development stage: embryonic)	NULL
EXP043909	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP370, genotype: unc-119(tm4063) III; wgIs370., sex:hermaphrodite	EXP042710	1391	normal	Q22910	whole worms (developmental stage: late embryo)	NULL
EXP043910	goat-anti-GFP-UC	Drosophila melanogaster	strain: Rel-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Rel-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042699	1400	normal	Q94527	whole organism (development stage: wandering third instar larva)	NULL
EXP043911	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP534, genotype: unc-119(tm4063) III; wgIs534, sex:hermaphrodite	EXP042920	1389	normal	Q20082	whole worms (developmental stage: L4/young adults)	NULL
EXP043912	goat-anti-GFP-UC	Drosophila melanogaster	strain: sqz-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=zen-GFP.FPTB}attP40, sex:mixed	EXP043265	1407	normal	U3PU53	whole organism (development stage: embryonic)	NULL
EXP043913	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP515, genotype: unc-119(tm4063) III; wgIs515., sex:hermaphrodite	EXP042870	1387	normal	Q09565	whole worms (developmental stage: L1)	NULL
EXP043914	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043116	1390	normal	Q23521	whole worms (developmental stage: L3)	NULL
EXP043915	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:mixed	EXP043271	1391	normal	Q86MJ3	whole worms (developmental stage: late embryo)	NULL
EXP043916	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13296-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG13296-GFP.FPTB}attP40, sex:mixed	EXP043170	1407	normal	Q9VRV0	whole organism (development stage: embryonic)	NULL
EXP043917	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP218, genotype: unc-119(ed3) III; wgIs218., sex:mixed	EXP042832	1202	normal	O44505	whole worms (developmental stage: L2)	NULL
EXP043918	goat-anti-GFP-UC	Drosophila melanogaster	strain: da-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=da-GFP.FTBP}VK00033, sex:mixed	EXP042651	1407	normal	P11420	whole organism (development stage: embryonic)	NULL
EXP043919	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP587, genotype: unc-119(tm4063) III; wgIs587., sex:mixed	EXP043069	1391	normal	Q9XV35	whole worms (developmental stage: late embryo)	NULL
EXP043920	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP043254	1202	normal	G5EG44	whole worms (developmental stage: L2)	NULL
EXP043921	goat-anti-GFP-UC	Drosophila melanogaster	strain: Crg-1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Crg-1-GFP.FTBP}VK00033, sex:mixed	EXP043113	1399	normal	Q8IRT6	whole organism (development stage: adult)	NULL
EXP043922	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP701, genotype: unc-119(tm4063); wgIs701 [sem-2::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043257	1392	normal	Q8T3B9	whole worms (mixed-stage embryos)	NULL
EXP043923	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP566, genotype: unc-119(tm4063) III; wgIs566, sex:hermaphrodite	EXP043086	1391	normal	Q18590	whole worms (developmental stage: late embryo)	NULL
EXP043924	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP605, genotype: unc-119(tm4063) III; wgIs605., sex:mixed	EXP043111	1405	normal	O76561	whole organism (development stage: early embryonic)	NULL
EXP043925	goat-anti-GFP-UC	Drosophila melanogaster	strain: insv-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=insv-GFP.FTBP}VK00033, sex:mixed	EXP042570	1407	normal	Q8SYK5	whole organism (development stage: embryonic)	NULL
EXP043926	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9705-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG9705-GFP.FPTB}attP40, sex:mixed	EXP043102	1400	normal	Q9VVA0	whole organism (development stage: wandering third instar larva)	NULL
EXP043927	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042878	1392	normal	Q9N5D6	whole worms (mixed-stage embryos)	NULL
EXP043928	goat-anti-GFP-UC	Drosophila melanogaster	strain: A3-3-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Atf3-GFP.FPTB}VK00033, sex:mixed	EXP042950	1407	normal	Q9XZS8	whole organism (development stage: embryonic)	NULL
EXP043929	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP541, genotype: unc-119(tm4063) III; wgIs541, sex:hermaphrodite	EXP042866	1396	normal	G5EGE2	whole organism (development stage: midembryonic)	NULL
EXP043930	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m-delta-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)mdelta-HLH-GFP.FPTB}attP-40, sex:mixed	EXP043273	1407	normal	Q01071	whole organism (development stage: embryonic)	NULL
EXP043931	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042775	1389	normal	Q9N5D6	whole worms (developmental stage: L4/young adults)	NULL
EXP043932	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12236-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=CG12236-GFP-GFP.FPTB}VK00033, sex:mixed	EXP043028	1407	normal	Q9W458	whole organism (development stage: embryonic)	NULL
EXP043933	goat-anti-GFP-UC	Drosophila melanogaster	strain: Blimp-1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Blimp-1-GFP.FPTB}attP40, sex:mixed	EXP042855	1408	normal	Q9VRN4	whole organism (development stage: prepupa)	NULL
EXP043934	sc-25761	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042656	1407	normal	P28159	whole organism (development stage: embryonic)	NULL
EXP043935	goat-anti-GFP-UC	Drosophila melanogaster	strain: Bteb2-GFP, genotype: y[1] w[*] PBac{y[+mDint2] w[+mC]=Bteb2-GFP-GFP.FPTB}VK00033, sex:mixed	EXP042852	1407	normal	Q0IGQ2	whole organism (development stage: embryonic)	NULL
EXP043936	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP042816	1387	normal	O16748	whole worms (developmental stage: L1)	NULL
EXP043937	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP042767	1390	normal	Q21701	whole worms (developmental stage: L3)	NULL
EXP043938	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP518, genotype: unc-119(tm4063) III; wgIs518., sex:hermaphrodite	EXP042681	1389	normal	Q94407	whole worms (developmental stage: L4/young adults)	NULL
EXP043939	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6813-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG6813-GFP.FPTB}attP40, sex:mixed	EXP043110	1407	normal	Q9VGL1	whole organism (development stage: embryonic)	NULL
EXP043940	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP590, genotype: unc-119(tm4063); wgIs590 [zip-4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042713	1387	normal	H2L0N3	whole worms (developmental stage: L1)	NULL
EXP043941	goat-anti-GFP-UC	Drosophila melanogaster	strain: Six4-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=Six4-GFP.FPTB}attP-40, sex:mixed	EXP043207	1407	normal	Q9Y1P6	whole organism (development stage: embryonic)	NULL
EXP043942	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL425, genotype: unc-119(ed3)III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043346	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP043943	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6683-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CG6683-GFP.FPTB}attP40, sex:mixed	EXP042620	1407	normal	Q9VSL0	whole organism (development stage: embryonic)	NULL
EXP043944	goat-anti-GFP-UC	Drosophila melanogaster	strain: rgr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=rgr-GFP.FPTB}VK00033, sex:mixed	EXP042777	1400	normal	E1JH10	whole organism (development stage: wandering third instar larva)	NULL
EXP043945	goat-anti-GFP-UC	Drosophila melanogaster	strain: sens-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=FTSF.GFP-sens}VK00022, sex:mixed	EXP043128	1407	normal	Q9N658	whole organism (development stage: embryonic)	NULL
EXP043946	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP606, genotype: unc-119(tm4063) III; wgIs606, sex:mixed	EXP043006	1235	normal	Q7YWZ7	whole worms (developmental stage: young adults)	NULL
EXP043947	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042888	1390	normal	G5ECF7	whole worms (developmental stage: L3)	NULL
EXP043948	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP569, genotype: unc-119(tm4063); wgIs569 [nhr-111::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042618	1389	normal	O45521	whole worms (developmental stage: L4/young adults)	NULL
EXP043949	goat-anti-GFP-UC	Drosophila melanogaster	strain: Dad-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Dad-GFP.FLAG}VK00037, sex:mixed	EXP042565	1407	normal	Q5U110	whole organism (development stage: embryonic)	NULL
EXP043950	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP462, genotype: unc-119(tm4063) III; wgIs462., sex:hermaphrodite	EXP042752	1391	normal	G5EFQ5	whole worms (developmental stage: late embryo)	NULL
EXP043951	goat-anti-GFP-UC	Drosophila melanogaster	strain: pzg-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=pzg-GFP.FPTB}attP40, sex:mixed	EXP043310	1407	normal	Q9VP57	whole organism (development stage: embryonic)	NULL
EXP043952	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP646, genotype: unc-119(tm4063) III; wgIs646, sex:mixed	EXP042914	1235	normal	Q18508	whole worms (developmental stage: young adults)	NULL
EXP043953	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15812-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG15812-GFP.FPTB}attP40, sex:mixed	EXP042799	1407	normal	Q9VZU3	whole organism (development stage: embryonic)	NULL
EXP043954	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP353, genotype: unc-119(tm4063) III; wgIs353., sex:mixed	EXP042732	1389	normal	O02316	whole worms (developmental stage: L4/young adults)	NULL
EXP043955	goat-anti-GFP-UC	Drosophila melanogaster	strain: salr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=salr-GFP.FPTB}VK00033, sex:mixed	EXP042741	1408	normal	Q9VKH3	whole organism (development stage: prepupa)	NULL
EXP043956	goat-anti-GFP-UC	Drosophila melanogaster	strain: shn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=shn-GFP.FPTB}VK00033, sex:mixed	EXP042985	1407	normal	Q0E9C5	whole organism (development stage: embryonic)	NULL
EXP043957	goat-anti-GFP-UC	Drosophila melanogaster	strain: tio-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tio-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042779	1407	normal	M9PDE2	whole organism (development stage: embryonic)	NULL
EXP043958	goat-anti-GFP-UC	Drosophila melanogaster	strain: esn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=esn-GFP.FPTB}VK00033, sex:mixed	EXP042668	1408	normal	Q7K579	whole organism (development stage: prepupa)	NULL
EXP043959	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP525, genotype: unc-119(tm4063) III; wgIs525, sex:hermaphrodite	EXP042666	1387	normal	Q9GZC9	whole worms (developmental stage: L1)	NULL
EXP043960	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7987-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG7987-GFP.FPTB}attP-40, sex:mixed	EXP042649	1407	normal	Q29R10	whole organism (development stage: embryonic)	NULL
EXP043961	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m-beta-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=E(spl)mbeta-HLH-GFP.FPTB}attP40, sex:mixed	EXP042624	1407	normal	Q01069	whole organism (development stage: embryonic)	NULL
EXP043962	goat-anti-GFP-UC	Drosophila melanogaster	strain: cato-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=cato-GFP.FTBP}VK00033, sex:mixed	EXP042772	1407	normal	Q0IGT4	whole organism (development stage: embryonic)	NULL
EXP043963	sc-28208	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043316	1400	normal	Q9W4S7	whole organism (development stage: wandering third instar larva)	NULL
EXP043964	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP517, genotype: unc-119(tm4063) III; wgIs517., sex:hermaphrodite	EXP043081	1387	normal	Q17922	whole worms (developmental stage: L1)	NULL
EXP043965	KW0:GRO	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042955	1403	normal	P16371	whole organism	NULL
EXP043966	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:mixed	EXP042725	1389	normal	Q86MH8	whole worms (developmental stage: L4/young adults)	NULL
EXP043967	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP707, genotype: unc-119(tm4063) III; wgIs707., sex:mixed	EXP042748	1392	normal	Q93727	whole worms (mixed-stage embryos)	NULL
EXP043968	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3281-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG3281-GFP.FPTB}attP40, sex:mixed	EXP042940	1407	normal	Q9VGG0	whole organism (development stage: embryonic)	NULL
EXP043969	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL457, genotype: unc-119(ed3)III;vrIs87[pPIE-1::GEI-11::GFP::GEI-11 3'UTR,unc-119(+), sex:mixed	EXP043343	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP043970	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4282-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG4282-GFP.FTBP}VK00033, sex:mixed	EXP043228	1407	normal	Q8T092	whole organism (development stage: embryonic)	NULL
EXP043971	goat-anti-GFP-UC	Drosophila melanogaster	strain: net-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=net-GFP.FPTB}VK00033, sex:mixed	EXP042592	1408	normal	Q9VPI8	whole organism (development stage: prepupa)	NULL
EXP043972	goat-anti-GFP-UC	Drosophila melanogaster	strain: cic-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=cic-GFP.FPTB}VK00037, sex:mixed	EXP042902	1399	normal	Q9U1H0	whole organism (development stage: adult)	NULL
EXP043973	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042774	1392	normal	Q65CM0	whole worms (mixed-stage embryos)	NULL
EXP043974	goat-anti-GFP-UC	Caenorhabditis elegans	strain: XIL99, sex:mixed	EXP042845	1387	normal	Q09604	whole worms (developmental stage: L1)	NULL
EXP043975	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7045-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7045-GFP.FTBP}VK00037, sex:male	EXP043088	1399	normal	Q9VCZ5	whole organism (development stage: adult)	NULL
EXP043976	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	EXP043055	1235	normal	G5EEG1	whole worms (developmental stage: young adults)	NULL
EXP043977	goat-anti-GFP-UC	Caenorhabditis elegans	strain: TH184, genotype:  unc-119(ed3) III; ddIs101, sex:hermaphrodite	EXP043075	1390	normal	G5EEL9	whole worms (developmental stage: L3)	NULL
EXP043978	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP042790	1387	normal	P34684	whole worms (developmental stage: L1)	NULL
EXP043979	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	EXP043396	1387	normal	G5ECU7	whole worms (developmental stage: L1)	NULL
EXP043980	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP315, sex:hermaphrodite	EXP043216	1391	normal	P20271	whole worms (developmental stage: late embryo)	NULL
EXP043981	goat-anti-GFP-UC	Drosophila melanogaster	strain: dpn-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=dpn-GFP.FPTB}VK00033, sex:mixed	EXP043203	1407	normal	Q26263	whole organism (development stage: embryonic)	NULL
EXP043982	non-commercial Orc2 modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043231	1407	normal	Q24168	whole organism (development stage: embryonic)	NULL
EXP043983	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd85E-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=fd85E-GFP.FPTB}attP-40 / CyO, sex:mixed	EXP042763	1408	normal	Q9VH87	whole organism (development stage: prepupa)	NULL
EXP043984	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10274-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CG10274-GFP.FPTB}attP40, sex:mixed	EXP042886	1407	normal	A8JNL9	whole organism (development stage: embryonic)	NULL
EXP043985	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP043362	1389	normal	Q9N5D6	whole worms (developmental stage: L4/young adults)	NULL
EXP043986	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP130, genotype: unc-119(ed3) III; wgIs130., sex:mixed	EXP043319	1202	normal	Q22190	whole worms (developmental stage: L2)	NULL
EXP043987	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP100, genotype: unc-119(tm4063) III; wgIs100., sex:hermaphrodite	EXP042987	1387	normal	O17617	whole worms (developmental stage: L1)	NULL
EXP043988	goat-anti-GFP-UC	Drosophila melanogaster	strain: gro-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=gro-GFP.FLAG}attP16, sex:mixed	EXP042553	1407	normal	P16371	whole organism (development stage: embryonic)	NULL
EXP043989	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP429, genotype: unc-119(tm4063) III; wgIs429., sex:hermaphrodite	EXP042632	1235	normal	Q19753	whole worms (developmental stage: young adults)	NULL
EXP043990	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043340	1392	normal	Q9N5S3	whole worms (mixed-stage embryos)	NULL
EXP043991	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:mixed	EXP043350	1392	normal	Q93560	whole worms (mixed-stage embryos)	NULL
EXP043992	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP27, genotype: unc-119(ed3) III; wgIs27., sex:mixed	EXP043036	1202	normal	P10038	whole worms (developmental stage: L2)	NULL
EXP043993	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL576, sex:hermaphrodite	EXP043160	1389	normal	O01789	whole worms (developmental stage: L4/young adults)	NULL
EXP043994	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10654-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=CG10654-GFP.FPTB}attP-40 / CyO, sex:mixed	EXP043286	1407	normal	Q9VTY7	whole organism (development stage: embryonic)	NULL
EXP043995	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP042660	1389	normal	P91868	whole worms (developmental stage: L4/young adults)	NULL
EXP043996	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2875-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2875-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP043046	1407	normal	Q9W4R1	whole organism (development stage: embryonic)	NULL
EXP043997	goat-anti-GFP-UC	Drosophila melanogaster	strain: fru-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}fru[MI06350]/TM6B, sb, Tb, Hu, sex:mixed	EXP043276	1400	normal	Q8IN81	whole organism (development stage: wandering third instar larva)	NULL
EXP043998	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP043260	1392	normal	O02274	whole worms (mixed-stage embryos)	NULL
EXP043999	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP18, genotype: unc-119(ed3) III; wgIs18., sex:mixed	EXP043195	1390	normal	P34684	whole worms (developmental stage: L3)	NULL
EXP044000	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(z)-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=E(z)-GFP.FTBP}VK00037, sex:mixed	EXP043326	1408	normal	P42124	whole organism (development stage: prepupa)	NULL
EXP044001	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP042786	1202	normal	G5EG44	whole worms (developmental stage: L2)	NULL
EXP044002	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP355, genotype: unc-119(tm4063) III; wgIs355., sex:mixed	EXP043021	1387	normal	G5EG44	whole worms (developmental stage: L1)	NULL
EXP044003	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP043312	1390	normal	P91868	whole worms (developmental stage: L3)	NULL
EXP044004	goat-anti-GFP-UC	Drosophila melanogaster	strain: Max-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Max-GFP.FTBP}VK00037, sex:mixed	EXP043403	1407	normal	M9NDC9	whole organism (development stage: embryonic)	NULL
EXP044005	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP312, genotype: unc-119(ed3) III; wgIs312, sex:hermaphrodite	EXP043315	1387	normal	O17862	whole worms (developmental stage: L1)	NULL
EXP044006	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP177, genotype: unc-119(ed3) III; wgIs177., sex:mixed	EXP042581	1387	normal	Q09228	whole worms (developmental stage: L1)	NULL
EXP044007	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043198	1202	normal	Q9N5S3	whole worms (developmental stage: L2)	NULL
EXP044008	ab290	Drosophila melanogaster	strain: Stat92E-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Stat92E-GFP.FLAG}VK00037	EXP043117	1407	normal	Q24151	whole organism (development stage: embryonic)	NULL
EXP044009	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP608, genotype: unc-119(tm4063); wgIs608 [Y55F3AM.14::TY::EGFP::3xFLAG(p_wTRG5_insertion_c_0075_1C04) + unc-119(+)], sex:mixed	EXP043085	1202	normal	Q9N360	whole worms (developmental stage: L2)	NULL
EXP044010	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10316, sex:hermaphrodite	EXP043083	1235	normal	A0A131MCL4	whole worms (developmental stage: young adults)	NULL
EXP044011	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP042680	1387	normal	O16748	whole worms (developmental stage: L1)	NULL
EXP044012	goat-anti-GFP-UC	Drosophila melanogaster	strain: wek-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=wek-GFP.FPTB}VK00033, sex:mixed	EXP043057	1407	normal	M9PFY1	whole organism (development stage: embryonic)	NULL
EXP044013	non-commercial Tbp modENCODE antibody 1	Drosophila melanogaster	strain: 13T-exd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=exd-EGFP.S}VK00033	EXP043293	1407	normal	P20227	whole organism (development stage: embryonic)	NULL
EXP044014	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP600, genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119), sex:mixed	EXP042622	1387	normal	Q9N5D6	whole worms (developmental stage: L1)	NULL
EXP044015	goat-anti-GFP-UC	Drosophila melanogaster	strain: NC2beta-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NC2Beta-GFP.FTBP}VK00033, sex:mixed	EXP043097	1407	normal	Q9VJQ5	whole organism (development stage: embryonic)	NULL
EXP044016	goat-anti-GFP-UC	Drosophila melanogaster	strain: topi-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=topi-GFP.FTBP}VK00037, sex:mixed	EXP042703	1408	normal	T2FFH5	whole organism (development stage: prepupa)	NULL
EXP044017	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP578, genotype: unc-119(tm4063) III; wgIs578, sex:hermaphrodite	EXP043241	1391	normal	Q93705	whole worms (developmental stage: late embryo)	NULL
EXP044018	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP558, genotype: unc-119(tm4063) III; wgIs558., sex:mixed	EXP042578	1391	normal	H2L008	whole worms (developmental stage: late embryo)	NULL
EXP044019	goat-anti-GFP-UC	Drosophila melanogaster	strain: woc-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=woc-GFP.FTBP}VK00037, sex:mixed	EXP042746	1400	normal	A8JRE3	whole organism (development stage: wandering third instar larva)	NULL
EXP044020	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP511, genotype: unc-119(tm4063) III; wgIs511., sex:hermaphrodite	EXP043388	1387	normal	O02274	whole worms (developmental stage: L1)	NULL
EXP044021	goat-anti-GFP-UC	Drosophila melanogaster	strain: ss-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ss-GFP.A.FPTB}VK00037, sex:mixed	EXP042695	1408	normal	Q9VEV9	whole organism (development stage: prepupa)	NULL
EXP044022	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9139-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Rabex-5-GFP.FTBP}VK00037, sex:mixed	EXP042835	1408	normal	Q9W0H9	whole organism (development stage: prepupa)	NULL
EXP044023	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd59A-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=fd59A-GFP.FPTB}attP40, sex:mixed	EXP043210	1408	normal	Q02361	whole organism (development stage: prepupa)	NULL
EXP044024	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP481, genotype: unc-119(tm4063) III; wgIs481., sex:hermaphrodite	EXP043281	1387	normal	Q17370	whole worms (developmental stage: L1)	NULL
EXP044025	non-commercial prd modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042877	1407	normal	P06601	whole organism (development stage: embryonic)	NULL
EXP044026	ab290	Drosophila melanogaster	strain: lola-RI-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lola.I-GFP.FLAG}VK00033	EXP043402	1407	normal	P42283	whole organism (development stage: embryonic)	NULL
EXP044027	non-commercial scute modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043092	1407	normal	P10084	whole organism (development stage: embryonic)	NULL
EXP044028	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP532, genotype: unc-119(tm4063) III; wgIs532, sex:hermaphrodite	EXP042996	1387	normal	Q9U2V2	whole worms (developmental stage: L1)	NULL
EXP044029	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP416, genotype: unc-119(tm4063) III; wgIs416., sex:mixed	EXP043274	1389	normal	Q09602	whole worms (developmental stage: L4/young adults)	NULL
EXP044030	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP114, genotype: unc-119(tm4063) III; wgIs114., sex:mixed	EXP043345	1387	normal	Q93520	whole worms (developmental stage: L1)	NULL
EXP044031	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL390, genotype: unc119(ed3)III; vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043123	1235	normal	Q22703	whole worms (developmental stage: young adults)	NULL
EXP044032	goat-anti-GFP-UC	Drosophila melanogaster	strain: Esplmgamma-HLH-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)mgamma-HLH-GFP.FPTB}attP-40 / CyO, sex:mixed	EXP042853	1407	normal	Q01070	whole organism (development stage: embryonic)	NULL
EXP044033	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP429, genotype: unc-119(tm4063) III; wgIs429., sex:mixed	EXP042586	1235	normal	Q19753	whole worms (developmental stage: young adults)	NULL
EXP044034	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL478, sex:hermaphrodite	EXP042882	1235	normal	G5EF11	whole worms (developmental stage: young adults)	NULL
EXP044035	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP687, genotype: unc-119(tm4063) III; wgIs687., sex:mixed	EXP043378	1391	normal	Q21578	whole worms (developmental stage: late embryo)	NULL
EXP044036	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP638, genotype: unc-119(tm4063) III; wgIs638., sex:mixed	EXP042576	1235	normal	B3GWA6	whole worms (developmental stage: young adults)	NULL
EXP044037	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP231, genotype: unc-119(ed3) III; wgIs231., sex:mixed	EXP043035	1202	normal	Q23521	whole worms (developmental stage: L2)	NULL
EXP044038	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP645, genotype: unc-119(tm4063) III; wgIs645, sex:mixed	EXP043104	1392	normal	Q18533	whole worms (mixed-stage embryos)	NULL
EXP044039	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP622, genotype: unc-119(tm4063) III; wgIs622, sex:mixed	EXP043174	1391	normal	Q93779	whole worms (developmental stage: late embryo)	NULL
EXP044040	goat-anti-GFP-UC	Drosophila melanogaster	strain: ac-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ac-GFP.FPTB}VK00033/TM2, sex:mixed	EXP043359	1407	normal	P10083	whole organism (development stage: embryonic)	NULL
EXP044041	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP699, genotype: unc-119(tm4063); wgIs699 [ceh-43::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043282	1392	normal	Q18273	whole worms (mixed-stage embryos)	NULL
EXP044042	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP746, genotype: unc-119(tm4063); wgIs746 [tbp-1::TY1 EGFP 3xFLAG(GlyStock16H06_GlyStock16H06) + unc-119(+)], sex:mixed	EXP043232	1235	normal	P32085	whole worms (developmental stage: young adults)	NULL
EXP044043	goat-anti-GFP-UC	Drosophila melanogaster	strain: ftz-f1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ftz-f1-GFP.FLAG}VK00037, sex:mixed	EXP042596	1407	normal	P33244	whole organism (development stage: embryonic)	NULL
EXP044044	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10462-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG10462-GFP.FTBP}VK00033, sex:mixed	EXP043235	1407	normal	M9NEU8	whole organism (development stage: embryonic)	NULL
EXP044045	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL557, sex:hermaphrodite	EXP043074	1235	normal	Q09249	whole worms (developmental stage: young adults)	NULL
EXP044046	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP388, genotype: unc-119(ed3) III; wgIs388, sex:hermaphrodite	EXP042935	1391	normal	Q21192	whole worms (developmental stage: late embryo)	NULL
EXP044047	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG31388-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG31388-GFP.FTBP}VK00037, sex:mixed	EXP042670	1407	normal	Q9VGQ5	whole organism (development stage: embryonic)	NULL
EXP044048	goat-anti-GFP-UC	Drosophila melanogaster	strain: crp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=crp-GFP.FPTB}VK00033, sex:mixed	EXP042986	1407	normal	Q9V406	whole organism (development stage: embryonic)	NULL
EXP044049	non-commercial lov modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042634	1407	normal	P14083	whole organism (development stage: embryonic)	NULL
EXP044050	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP90, genotype: unc-119(ed3) III; wgIs90., sex:mixed	EXP043400	1389	normal	P41829	whole worms (developmental stage: L4/young adults)	NULL
EXP044051	goat-anti-GFP-UC	Drosophila melanogaster	strain: az2-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=az2-GFP.FPTB}VK00033, sex:mixed	EXP043389	1407	normal	Q5BIC3	whole organism (development stage: embryonic)	NULL
EXP044052	goat-anti-GFP-UC	Drosophila melanogaster	strain: cyc-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=cyc-GFP.FTBP}VK00037, sex:mixed	EXP043325	1408	normal	O61734	whole organism (development stage: prepupa)	NULL
EXP044053	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:mixed	EXP043022	1390	normal	Q19345	whole worms (developmental stage: L3)	NULL
EXP044054	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP154, genotype: unc-119(ed3) III; wgIs154, sex:hermaphrodite	EXP042917	1391	normal	G5EDE1	whole worms (developmental stage: late embryo)	NULL
EXP044055	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: EcR-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=EcR-EGFP.S}VK00033	EXP043267	1403	normal	P34021	whole organism	NULL
EXP044056	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP78, genotype: unc-119(ed3) III; wgIs78, sex:hermaphrodite	EXP043008	1391	normal	Q10924	whole worms (developmental stage: late embryo)	NULL
EXP044057	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP212, genotype: unc-119(ed3) III; ddEx58., sex:mixed	EXP043084	1202	normal	O16748	whole worms (developmental stage: L2)	NULL
EXP044058	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP173, sex:hermaphrodite	EXP043122	1391	normal	N1NSG8	whole worms (developmental stage: late embryo)	NULL
EXP044059	goat-anti-GFP-UC	Drosophila melanogaster	strain: ewg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ewg-GFP.FPTB}VK00033, sex:mixed	EXP043094	1407	normal	Q24312	whole organism (development stage: embryonic)	NULL
EXP044060	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP043219	1390	normal	G5ECF7	whole worms (developmental stage: L3)	NULL
EXP044061	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6854-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG45071-GFP.FPTB}attP40/CyO, sex:mixed	EXP043299	1407	normal	Q9VUL1	whole organism (development stage: embryonic)	NULL
EXP044062	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP471, genotype: unc-119(tm4063) III; wgIs471., sex:hermaphrodite	EXP042637	1202	normal	H2KZR6	whole worms (developmental stage: L2)	NULL
EXP044063	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP043399	1392	normal	O17894	whole worms (mixed-stage embryos)	NULL
EXP044064	goat-anti-GFP-UC	Drosophila melanogaster	strain: Xbp1-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=Xbp1-GFP.FPTB}VK00033, sex:mixed	EXP042577	1407	normal	Q9VUG3	whole organism (development stage: embryonic)	NULL
EXP044065	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17912-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=BuGZ-GFP.FPTB}VK00033, sex:mixed	EXP042938	1407	normal	Q9VJI6	whole organism (development stage: embryonic)	NULL
EXP044066	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043132	1400	normal	P91943	whole organism (development stage: wandering third instar larva)	NULL
EXP044067	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12744-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG12744-GFP.FTBP}VK00033, sex:mixed	EXP042929	1407	normal	E2QC93	whole organism (development stage: embryonic)	NULL
EXP044068	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:female	EXP042701	1399	normal	P20482	whole organism (development stage: adult)	NULL
EXP044069	goat-anti-GFP-UC	Drosophila melanogaster	strain: GATAd-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=GATAd-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP042731	1400	normal	Q9VKZ0	whole organism (development stage: wandering third instar larva)	NULL
EXP044070	goat-anti-GFP-UC	Drosophila melanogaster	strain: pnt-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}pnt[MI02427]/TM6B, sb, Tb, Hu, sex:mixed	EXP043279	1407	normal	P51023	whole organism (development stage: embryonic)	NULL
EXP044071	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7056-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=HHEX-GFP.FPTB}attP40, sex:mixed	EXP042607	1407	normal	Q9VDF0	whole organism (development stage: embryonic)	NULL
EXP044072	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP620, genotype: unc-119(tm4063) III; wgIs620, sex:mixed	EXP043033	1405	normal	Q93352	whole organism (development stage: early embryonic)	NULL
EXP044073	goat-anti-GFP-UC	Drosophila melanogaster	strain: ADD1-MiMIC-GFP, genotype: y[1] w[*]; Mi{y[+mDint2]=MIC}ADD1[MI09552], sex:mixed	EXP042892	1407	normal	A1Z8R2	whole organism (development stage: embryonic)	NULL
EXP044074	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:hermaphrodite	EXP042744	1392	normal	P28515	whole worms (mixed-stage embryos)	NULL
EXP044075	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL448, genotype: unc-119(ed3)III; vrIs83 [pGES-1::DPL-1::GFP FLAG: DPL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP042947	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP044076	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP398, genotype: unc-119(tm4063) III; wgIs398., sex:hermaphrodite	EXP043405	1389	normal	Q86MH8	whole worms (developmental stage: L4/young adults)	NULL
EXP044077	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: EcR-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=EcR-EGFP.S}VK00033	EXP042764	1403	normal	P34021	whole organism	NULL
EXP044078	goat-anti-GFP-UC	Drosophila melanogaster	strain: CTCF-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CTCF-GFP.FPTB}attP40, sex:mixed	EXP042844	1407	normal	Q9VS55	whole organism (development stage: embryonic)	NULL
EXP044079	non-commercial su(Hw) modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043034	1407	normal	P08970	whole organism (development stage: embryonic)	NULL
EXP044080	goat-anti-GFP-UC	Drosophila melanogaster	strain: Usf-GFP, sex:mixed	EXP042756	1407	normal	Q9W4J8	whole organism (development stage: embryonic)	NULL
EXP044081	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP124, genotype: unc-119(ed3) III; wgIs124., sex:mixed	EXP042673	1387	normal	O02219	whole worms (developmental stage: L1)	NULL
EXP044082	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP372, genotype: unc-119(tm4063) III; wgIs372., sex:hermaphrodite	EXP043238	1391	normal	Q21374	whole worms (developmental stage: late embryo)	NULL
EXP044083	Aviva-KW4-mod(mdg4)-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042972	1400	normal	Q86B87	whole organism (development stage: wandering third instar larva)	NULL
EXP044084	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11398-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG11398-GFP.FPTB}VK00033, sex:mixed	EXP043331	1407	normal	Q9V3X8	whole organism (development stage: embryonic)	NULL
EXP044085	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP662, genotype: unc-119(tm4063) III; wgIs662, sex:mixed	EXP042768	1235	normal	O01441	whole worms (developmental stage: young adults)	NULL
EXP044086	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP33, genotype: unc-119(ed3) III; wgIs33., sex:hermaphrodite	EXP043187	1389	normal	Q19345	whole worms (developmental stage: L4/young adults)	NULL
EXP044087	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP239, genotype: unc-119(ed3) III; wgIs239., sex:mixed	EXP043161	1202	normal	P41999	whole worms (developmental stage: L2)	NULL
EXP044088	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP49, genotype: unc119(ed3);wgIs49(lin-13::TY1 EGFP FLAG;unc119), sex:mixed	EXP042904	1389	normal	Q11107	whole worms (developmental stage: L4/young adults)	NULL
EXP044089	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(spl)m3-HLH-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=E(spl)m3-HLH-GFP.FPTB}attP-40, sex:mixed	EXP042949	1407	normal	Q01068	whole organism (development stage: embryonic)	NULL
EXP044090	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OR3350, sex:hermaphrodite	EXP043411	1389	normal	G5EGD2	whole worms (developmental stage: L4/young adults)	NULL
EXP044091	goat-anti-GFP-UC	Drosophila melanogaster	strain: CrebA-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}CrebA[MI06441]/TM6B, sb, Tb, Hu, sex:mixed	EXP043256	1400	normal	Q1LZ07	whole organism (development stage: wandering third instar larva)	NULL
EXP044092	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:hermaphrodite	EXP043163	1391	normal	G5EFY7	whole worms (developmental stage: late embryo)	NULL
EXP044093	goat-anti-GFP-UC	Drosophila melanogaster	strain: NC2alpha-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=NC2alpha-GFP.FPTB}VK00033, sex:mixed	EXP043130	1407	normal	Q8MLV5	whole organism (development stage: embryonic)	NULL
EXP044094	goat-anti-GFP-UC	Drosophila melanogaster	strain: bab2-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bab2-GFP.FPTB}VK00037/SM5, sex:mixed	EXP043087	1407	normal	Q9W0K4	whole organism (development stage: embryonic)	NULL
EXP044095	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG31627-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG31627-GFP.FPTB}VK00033, sex:mixed	EXP043140	1408	normal	Q8INU1	whole organism (development stage: prepupa)	NULL
EXP044096	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP720, genotype: unc-119(tm4063); wgIs720 [lsl-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043407	1235	normal	O02273	whole worms (developmental stage: young adults)	NULL
EXP044097	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL529, sex:hermaphrodite	EXP042675	1235	normal	O44743	whole worms (developmental stage: young adults)	NULL
EXP044098	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12104-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12104-GFP.FTBP}VK00037, sex:mixed	EXP043223	1407	normal	Q9W0D2	whole organism (development stage: embryonic)	NULL
EXP044099	non-commercial Orc2 modENCODE antibody 1	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP042556	1197	normal	Q24168	S2-DRSC (embryonic stem cells)	NULL
EXP044100	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP673, genotype: unc-119 (tm4063) III; wgIs673, sex:mixed	EXP042574	1391	normal	Q9NLC2	whole worms (developmental stage: late embryo)	NULL
EXP044101	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP391, genotype: unc-119(ed3) III; wgIs391(med-1::TY1 EGFP FLAG C; unc-119(+)), sex:mixed	EXP042895	1392	normal	G5EF71	whole worms (mixed-stage embryos)	NULL
EXP044102	non-commercial fru modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043142	1407	normal	Q8IN81	whole organism (development stage: embryonic)	NULL
EXP044103	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OR3349, sex:mixed	EXP042937	1389	normal	G5EGD2	whole worms (developmental stage: L4/young adults)	NULL
EXP044104	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP196, genotype: unc-119(ed3) III; wgIs196., sex:mixed	EXP042965	1387	normal	Q93727	whole worms (developmental stage: L1)	NULL
EXP044105	non-commercial Sin3A modENCODE antibody 1	Drosophila melanogaster	genotype: e/se	EXP043295	1397	normal	A1Z927	Kc167 (development stage: embryonic)	NULL
EXP044106	goat-anti-GFP-UC	Drosophila melanogaster	strain: ovo-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ovo-GFP.FPTB}VK00033/TM3, Sb[1], sex:female	EXP043109	1399	normal	P51521	whole organism (development stage: adult)	NULL
EXP044107	goat-anti-GFP-UC	Drosophila melanogaster	strain: kni-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=kni-GFP.FPTB}attP40, sex:mixed	EXP042833	1407	normal	P10734	whole organism (development stage: embryonic)	NULL
EXP044108	goat-anti-GFP-UC	Drosophila melanogaster	strain: D19B-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=D19B-GFP.FPTB}attP40, sex:mixed	EXP043300	1407	normal	Q9VRV4	whole organism (development stage: embryonic)	NULL
EXP044109	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP043344	1387	normal	Q21701	whole worms (developmental stage: L1)	NULL
EXP044110	goat-anti-GFP-UC	Drosophila melanogaster	strain: Eip78C-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Eip78C-GFP.FLAG}VK00037, sex:mixed	EXP042694	1408	normal	P45447	whole organism (development stage: prepupa)	NULL
EXP044111	non-commercial Stat92E modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042771	1403	normal	Q24151	whole organism	NULL
EXP044112	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8089-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG8089-GFP.FPTB}VK00033, sex:mixed	EXP043330	1407	normal	Q4V3F5	whole organism (development stage: embryonic)	NULL
EXP044113	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG3919-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG3919-GFP.FTBP}VK00037, sex:mixed	EXP042820	1408	normal	Q7KUK4	whole organism (development stage: prepupa)	NULL
EXP044114	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP470, genotype: unc-119(tm4063) III; wgIs470., sex:hermaphrodite	EXP042641	1389	normal	P91547	whole worms (developmental stage: L4/young adults)	NULL
EXP044115	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10543-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10543-GFP.FTBP}VK00037, sex:mixed	EXP043358	1407	normal	Q86BG2	whole organism (development stage: embryonic)	NULL
EXP044116	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP186, genotype: unc-119(ed3) III; wgIs186., sex:mixed	EXP042905	1390	normal	O17894	whole worms (developmental stage: L3)	NULL
EXP044117	goat-anti-GFP-UC	Drosophila melanogaster	strain: mod(mdg4)-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=mod(mdg4)-GFP.FTBP}VK00037, sex:mixed	EXP042975	1400	normal	Q86B87	whole organism (development stage: wandering third instar larva)	NULL
EXP044118	non-commercial pan modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043213	1407	normal	P91943	whole organism (development stage: embryonic)	NULL
EXP044119	goat-anti-GFP-UC	Drosophila melanogaster	strain: mam-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}mam[MI03814]/SM6a, sex:mixed	EXP042730	1407	normal	P21519	whole organism (development stage: embryonic)	NULL
EXP044120	goat-anti-GFP-UC	Drosophila melanogaster	strain: pad-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=pad-GFP.FPTB}attP40, sex:female	EXP043416	1399	normal	Q9VEW6	whole organism (development stage: adult)	NULL
EXP044121	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP739, genotype: unc-119(tm4063); wgIs739 [ceh-19::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042908	1391	normal	P26797	whole worms (developmental stage: late embryo)	NULL
EXP044122	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP550, genotype: unc-119(tm4063) III; wgIs550., sex:mixed	EXP043298	1235	normal	H2KYD3	whole worms (developmental stage: young adults)	NULL
EXP044123	goat-anti-GFP-UC	Drosophila melanogaster	strain: toe-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=toe-GFP.FPTB}VK00037, sex:male	EXP042913	1399	normal	Q8T0M4	whole organism (development stage: adult)	NULL
EXP044124	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP579, genotype: unc-119(tm4063) III; wgIs579., sex:mixed	EXP042652	1235	normal	Q09477	whole worms (developmental stage: young adults)	NULL
EXP044125	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG16863-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=CG16863-GFP.FPTB}VK00033, sex:mixed	EXP042993	1407	normal	Q0E8Q6	whole organism (development stage: embryonic)	NULL
EXP044126	goat-anti-GFP-UC	Drosophila melanogaster	strain: 15T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=h-EGFP.S}VK00037, sex:mixed	EXP043060	1400	normal	P14003	whole organism (development stage: wandering third instar larva)	NULL
EXP044127	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP318, genotype: unc-119(ed3) III; wgIs318., sex:mixed	EXP042834	1392	normal	Q21701	whole worms (mixed-stage embryos)	NULL
EXP044128	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042733	1387	normal	G5ECG2	whole worms (developmental stage: L1)	NULL
EXP044129	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP248, sex:hermaphrodite	EXP043314	1389	normal	O17514	whole worms (developmental stage: L4/young adults)	NULL
EXP044130	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042625	1387	normal	G5ECF7	whole worms (developmental stage: L1)	NULL
EXP044131	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP425, genotype: unc-119(tm4063) III; wgIs425., sex:mixed	EXP043135	1202	normal	Q09636	whole worms (developmental stage: L2)	NULL
EXP044132	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP042650	1391	normal	Q17381	whole worms (developmental stage: late embryo)	NULL
EXP044133	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11902-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG11902-GFP.FPTB}VK00037 / CyO, sex:mixed	EXP043150	1408	normal	Q9VBR8	whole organism (development stage: prepupa)	NULL
EXP044134	goat-anti-GFP-UC	Drosophila melanogaster	strain: ss-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ss-GFP.CD.FPTB}VK00037, sex:mixed	EXP042676	1408	normal	Q9VEV9	whole organism (development stage: prepupa)	NULL
EXP044135	goat-anti-GFP-UC	Caenorhabditis elegans	strain: YL563, sex:hermaphrodite	EXP042798	1235	normal	Q9XUB3	whole worms (developmental stage: young adults)	NULL
EXP044136	Aviva-KW3-Trl-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042980	1407	normal	A4V1Y6	whole organism (development stage: embryonic)	NULL
EXP044137	Aviva-KW3-hkb-D1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042939	1407	normal	Q9VN10	whole organism (development stage: embryonic)	NULL
EXP044138	goat-anti-GFP-UC	Drosophila melanogaster	strain: lz-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=lz-GFP.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043050	1408	normal	Q9W349	whole organism (development stage: prepupa)	NULL
EXP044139	non-commercial CTCF modENCODE antibody 2	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP043125	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	NULL
EXP044140	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 8T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=tll-EGFP.S}VK00037	EXP043112	1407	normal	P18102	whole organism (development stage: embryonic)	NULL
EXP044141	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP179, genotype: unc-119(ed3) III; wgIs179., sex:mixed	EXP043080	1202	normal	P91868	whole worms (developmental stage: L2)	NULL
EXP044142	non-commercial hth modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:mixed	EXP043092	1407	normal	O46339	whole organism (development stage: embryonic)	NULL
EXP044143	Aviva-KW4-Hr39-D1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042901	1407	normal	Q05192	whole organism (development stage: embryonic)	NULL
EXP044144	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP493, genotype: unc-119(tm4063) III; wgIs493., sex:hermaphrodite	EXP042990	1391	normal	H9G2Q0	whole worms (developmental stage: late embryo)	NULL
EXP044145	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP178, genotype: unc-119(ed3) III; wgIs178., sex:mixed	EXP042838	1202	normal	P34707	whole worms (developmental stage: L2)	NULL
EXP044146	goat-anti-GFP-UC	Drosophila melanogaster	strain: Ash1-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ash1-GFP.FPTB}attP-40, sex:mixed	EXP043248	1407	normal	Q9VW15	whole organism (development stage: embryonic)	NULL
EXP044147	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP615, genotype: unc-119(tm4063) III; wgIs615, sex:mixed	EXP042686	1391	normal	Q965P0	whole worms (developmental stage: late embryo)	NULL
EXP044148	KW0-CNC	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042621	1403	normal	P20482	whole organism	NULL
EXP044149	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP92, sex:hermaphrodite	EXP042573	1391	normal	G5EBL3	whole worms (developmental stage: late embryo)	NULL
EXP044150	goat-anti-GFP-UC	Drosophila melanogaster	strain: Pita-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=pita-GFP.FPTB}VK00033, sex:mixed	EXP043068	1407	normal	Q9W1N1	whole organism (development stage: embryonic)	NULL
EXP044151	non-commercial scute modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042974	1407	normal	P10084	whole organism (development stage: embryonic)	NULL
EXP044152	Aviva-KW3-psq-D2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043370	1403	normal	A1Z8A6	whole organism	NULL
EXP044153	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP62, genotype: unc-119(ed3) III; wgIs62, sex:mixed	EXP042682	1202	normal	P20154	whole worms (developmental stage: L2)	NULL
EXP044154	sc-25761	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP043382	1407	normal	P28159	whole organism (development stage: embryonic)	NULL
EXP044155	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:mixed	EXP042828	1390	normal	G5EEG1	whole worms (developmental stage: L3)	NULL
EXP044156	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP117, genotype: unc-119(ed3) III; wgIs117., sex:mixed	EXP042791	1391	normal	Q21272	whole worms (developmental stage: late embryo)	NULL
EXP044157	goat-anti-GFP-UC	Drosophila melanogaster	strain: SuHw-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=su(Hw)-GFP.FPTB}attP40, sex:mixed	EXP042906	1407	normal	P08970	whole organism (development stage: embryonic)	NULL
EXP044158	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP418, genotype: unc-119(tm4063) III; wgIs418., sex:mixed	EXP043052	1202	normal	Q18248	whole worms (developmental stage: L2)	NULL
EXP044159	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP241, genotype: unc-119(ed3) III; wgIs241., sex:mixed	EXP043201	1390	normal	G5EE18	whole worms (developmental stage: L3)	NULL
EXP044160	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP489, genotype: unc-119(tm4063) III; wgIs489., sex:hermaphrodite	EXP042873	1391	normal	O62412	whole worms (developmental stage: late embryo)	NULL
EXP044161	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: Cad-GFP-7T, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=cad-EGFP.S}VK00033	EXP042922	1407	normal	P09085	whole organism (development stage: embryonic)	NULL
EXP044162	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG6854-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG45071-GFP.FPTB}attP40/CyO, sex:mixed	EXP042945	1408	normal	Q9VUL1	whole organism (development stage: prepupa)	NULL
EXP044163	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP480, genotype: unc-119(tm4063) III; wgIs480., sex:hermaphrodite	EXP043206	1387	normal	Q9GTD4	whole worms (developmental stage: L1)	NULL
EXP044164	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG11617-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG11617-GFP.FPTB}VK00033, sex:mixed	EXP043218	1399	normal	Q9VPL4	whole organism (development stage: adult)	NULL
EXP044165	goat-anti-GFP-UC	Drosophila melanogaster	strain: ATbp-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ATbp-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042806	1407	normal	Q86P48	whole organism (development stage: embryonic)	NULL
EXP044166	goat-anti-GFP-UC	Drosophila melanogaster	strain: tj-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=tj-GFP.FPTB}VK00033, sex:female	EXP042669	1399	normal	Q9VIW0	whole organism (development stage: adult)	NULL
EXP044167	PRB-291C	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042861	1407	normal	P05205	whole organism (development stage: embryonic)	NULL
EXP044168	goat-anti-GFP-UC	Drosophila melanogaster	strain: Eip75B-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}Eip75B[MI03665], sex:mixed	EXP043305	1408	normal	P13055	whole organism (development stage: prepupa)	NULL
EXP044169	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP594, genotype: unc-119(tm4063) III; wgIs594, sex:mixed	EXP042635	1235	normal	A0A078BQN7	whole worms (developmental stage: young adults)	NULL
EXP044170	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042843	1390	normal	G5EFY7	whole worms (developmental stage: L3)	NULL
EXP044171	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP677, genotype: unc-119(tm4063) III; wgIs677, sex:mixed	EXP043233	1391	normal	Q966L8	whole worms (developmental stage: late embryo)	NULL
EXP044172	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17385-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=nerfin-1-GFP.FPTB}VK00033, sex:mixed	EXP042928	1407	normal	Q4V6X9	whole organism (development stage: embryonic)	NULL
EXP044173	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP75, genotype: unc-119(ed3) III; wgIs75., sex:mixed	EXP042612	1387	normal	G5ECF7	whole worms (developmental stage: L1)	NULL
EXP044174	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP217, genotype: unc-119(ed3) III; ddIs172., sex:mixed	EXP043043	1202	normal	O62183	whole worms (developmental stage: L2)	NULL
EXP044175	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP190, genotype: unc-119(ed3) III; wgIs190., sex:mixed	EXP042924	1387	normal	G5ED66	whole worms (developmental stage: L1)	NULL
EXP044176	goat-anti-GFP-UC	Drosophila melanogaster	strain: B-H2-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=B-H2-GFP.FPTB}VK00033, sex:mixed	EXP042611	1407	normal	Q24256	whole organism (development stage: embryonic)	NULL
EXP044177	goat-anti-GFP-UC	Drosophila melanogaster	strain: BEAF-32-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=BEAF-32-GFP.FPTB}VK00033, sex:mixed	EXP042648	1407	normal	Q94513	whole organism (development stage: embryonic)	NULL
EXP044178	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP510, genotype: unc-119(tm4063) III; wgIs510., sex:hermaphrodite	EXP043082	1389	normal	Q8WQF4	whole worms (developmental stage: L4/young adults)	NULL
EXP044179	goat-anti-GFP-UC	Drosophila melanogaster	strain: E(bx)-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=E(bx)-GFP.FPTB}attP-40, sex:mixed	EXP042826	1407	normal	Q9W0T1	whole organism (development stage: embryonic)	NULL
EXP044180	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP702, genotype: unc-119(tm4063); wgIs702 [flh-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043395	1392	normal	A7DTF1	whole worms (mixed-stage embryos)	NULL
EXP044181	goat-anti-GFP-UC	Drosophila melanogaster	strain: Su(var)3-7-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Su(var)3-7-GFP.FTBP}VK00037, sex:mixed	EXP042595	1407	normal	P20193	whole organism (development stage: embryonic)	NULL
EXP044182	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP56, genotype: unc-119(ed3) III; wgIs56., sex:hermaphrodite	EXP042616	1387	normal	Q10655	whole worms (developmental stage: L1)	NULL
EXP044183	goat-anti-GFP-UC	Drosophila melanogaster	strain: Lhr-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Lhr-GFP.FPTB}VK00033, sex:mixed	EXP043229	1407	normal	Q95RV3	whole organism (development stage: embryonic)	NULL
EXP044184	goat-anti-GFP-UC	Drosophila melanogaster	strain: org-1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=org-1-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042735	1407	normal	Q9W3F4	whole organism (development stage: embryonic)	NULL
EXP044185	goat-anti-GFP-UC	Drosophila melanogaster	strain: Vsx1-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Vsx1-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP042657	1407	normal	Q9W4B2	whole organism (development stage: embryonic)	NULL
EXP044186	non-commercial prd modENCODE antibody 2	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042877	1407	normal	P06601	whole organism (development stage: embryonic)	NULL
EXP044187	goat-anti-GFP-UC	Drosophila melanogaster	strain: grn-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=grn-GFP.FPTB}VK00037, sex:mixed	EXP042897	1407	normal	P91623	whole organism (development stage: embryonic)	NULL
EXP044188	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr39-RC-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr39-GFP.C.FPTB}VK00033/TM3, Sb[1], sex:mixed	EXP043051	1408	normal	Q05192	whole organism (development stage: prepupa)	NULL
EXP044189	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP215, genotype: unc-119(ed3) III; wgIs215., sex:mixed	EXP043220	1389	normal	H2L0N7	whole worms (developmental stage: L4/young adults)	NULL
EXP044190	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP042927	1389	normal	Q9N5S3	whole worms (developmental stage: L4/young adults)	NULL
EXP044191	goat-anti-GFP-UC	Drosophila melanogaster	strain: d.ets6-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets21C-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP043065	1408	normal	A8DYS7	whole organism (development stage: prepupa)	NULL
EXP044192	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP322, genotype: unc-119(ed3) III; wgIs322., sex:mixed	EXP043304	1390	normal	Q9TZI2	whole worms (developmental stage: L3)	NULL
EXP044193	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12219-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12219-GFP.FPTB}VK00033, sex:mixed	EXP043211	1407	normal	Q9W409	whole organism (development stage: embryonic)	NULL
EXP044194	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP62, genotype: unc-119(ed3) III; wgIs62, sex:mixed	EXP043152	1391	normal	P20154	whole worms (developmental stage: late embryo)	NULL
EXP044195	goat-anti-GFP-UC	Drosophila melanogaster	strain: caup-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=caup-GFP.FTBP}VK00037/CyO, sex:mixed	EXP042918	1407	normal	P54269	whole organism (development stage: embryonic)	NULL
EXP044196	goat-anti-GFP-UC	Drosophila melanogaster	strain: sima-RB-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sima-GFP.B.FPTB}VK00037, sex:mixed	EXP042884	1407	normal	Q24167	whole organism (development stage: embryonic)	NULL
EXP044197	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP395, genotype: unc-119(tm4063) III; wgIs395., sex:mixed	EXP043040	1387	normal	P52906	whole worms (developmental stage: L1)	NULL
EXP044198	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP54, genotype: unc-119(ed3) III; wgIs54., sex:mixed	EXP042655	1390	normal	P17486	whole worms (developmental stage: L3)	NULL
EXP044199	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP317, genotype: unc-119(ed3) III; wgIs317., sex:mixed	EXP043333	1392	normal	Q17905	whole worms (mixed-stage embryos)	NULL
EXP044200	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	EXP042689	1390	normal	G5ECU7	whole worms (developmental stage: L3)	NULL
EXP044201	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL445, genotype: unc119(ed3)III; vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3â€™UTR, unc-119 (+)], sex:mixed	EXP043285	1235	normal	G5EF11	whole worms (developmental stage: young adults)	NULL
EXP044202	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr38-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr38-GFP.FLAG}VK00033, sex:mixed	EXP042869	1408	normal	P49869	whole organism (development stage: prepupa)	NULL
EXP044203	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP202, genotype: unc-119(ed3) III; wgIs202., sex:mixed	EXP043253	1390	normal	P56407	whole worms (developmental stage: L3)	NULL
EXP044204	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL398, genotype: unc119(ed3)III; vrIs55[pGES-1::LIN-35::GFP FLAG: LIN-35 3â€™UTR, unc-119 (+)], sex:mixed	EXP043313	1387	normal	G5EDT1	whole worms (developmental stage: L1)	NULL
EXP044205	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP404, genotype: unc-119(tm4063) III; wgIs404., sex:hermaphrodite	EXP042851	1390	normal	G5EEG1	whole worms (developmental stage: L3)	NULL
EXP044206	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP83, genotype: unc-119(ed3) III; wgIs83., sex:mixed	EXP042910	1389	normal	G5EBU4	whole worms (developmental stage: L4/young adults)	NULL
EXP044207	goat-anti-GFP-UC	Drosophila melanogaster	strain: zf30C-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=dmrt11E-GFP.FPTB}VK00033, sex:mixed	EXP043290	1407	normal	Q9VL91	whole organism (development stage: embryonic)	NULL
EXP044208	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox102F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox102F-GFP.FPTB}VK00033, sex:mixed	EXP042679	1408	normal	Q9V480	whole organism (development stage: prepupa)	NULL
EXP044209	goat-anti-GFP-UC	Drosophila melanogaster	strain: Chrac-16-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Chrac-16-GFP.FTBP}VK00033, sex:mixed	EXP042923	1407	normal	Q9V452	whole organism (development stage: embryonic)	NULL
EXP044210	goat-anti-GFP-UC	Drosophila melanogaster	strain: Delg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Ets97D-GFP.FLAG}VK00037, sex:mixed	EXP042640	1407	normal	Q04688	whole organism (development stage: embryonic)	NULL
EXP044211	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd64A-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=FoxL1-GFP.FPTB}attP-40, sex:mixed	EXP042840	1407	normal	D3PFH7	whole organism (development stage: embryonic)	NULL
EXP044212	goat-anti-GFP-UC	Drosophila melanogaster	strain: Myb-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=Myb-GFP.FPTB}VK00033/TM6C, Sb[1], sex:mixed	EXP043062	1407	normal	Q53YG3	whole organism (development stage: embryonic)	NULL
EXP044213	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP521, genotype: unc-119(tm4063) III; wgIs521, sex:hermaphrodite	EXP042664	1389	normal	Q18919	whole worms (developmental stage: L4/young adults)	NULL
EXP044214	goat-anti-GFP-UC	Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	EXP043018	1407	normal	A1Z8A6	whole organism (development stage: embryonic)	NULL
EXP044215	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP185, genotype: unc-119(ed3) III; wgIs185., sex:mixed	EXP042723	1390	normal	Q95QA9	whole worms (developmental stage: L3)	NULL
EXP044216	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP81, genotype: unc-119(ed3) III; wgIs81., sex:mixed	EXP042600	1390	normal	G5EDU4	whole worms (developmental stage: L3)	NULL
EXP044217	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042738	1389	normal	Q966B8	whole worms (developmental stage: L4/young adults)	NULL
EXP044218	non-commercial CTCF modENCODE antibody 2	Drosophila melanogaster	strain: Oregon-R, genotype: wild type	EXP043139	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	NULL
EXP044219	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP37, genotype: unc-119(ed3) III; wgIs37., sex:mixed	EXP043371	1235	normal	Q17381	whole worms (developmental stage: young adults)	NULL
EXP044220	goat-anti-GFP-UC	Drosophila melanogaster	strain: Tup-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=tup-GFP.FPTB}VK00031, sex:mixed	EXP043306	1407	normal	Q9VJ37	whole organism (development stage: embryonic)	NULL
EXP044221	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043179	1389	normal	Q23294	whole worms (developmental stage: L4/young adults)	NULL
EXP044222	goat-anti-GFP-UC	Drosophila melanogaster	strain: kay-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=kay-GFP.FLAG}VK00037, sex:mixed	EXP042994	1407	normal	A8MPH9	whole organism (development stage: embryonic)	NULL
EXP044223	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12659-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG12659-GFP.FPTB}VK00033, sex:mixed	EXP043237	1407	normal	Q9W3D4	whole organism (development stage: embryonic)	NULL
EXP044224	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP109, genotype: unc-119(ed3) III; wgIs109., sex:mixed	EXP042555	1387	normal	Q93560	whole worms (developmental stage: L1)	NULL
EXP044225	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP222, genotype: unc-119(ed3) III; wgIs222., sex:mixed	EXP043166	1389	normal	G5EFF5	whole worms (developmental stage: L4/young adults)	NULL
EXP044226	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP337, genotype: unc119(ed3);wgIs377(fkh-10::TY1 EGFP FLAG;unc119), sex:mixed	EXP043090	1387	normal	O17593	whole worms (developmental stage: L1)	NULL
EXP044227	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP304, genotype: unc-119(ed3) III; wgIs304., sex:mixed	EXP042740	1389	normal	G5ECG2	whole worms (developmental stage: L4/young adults)	NULL
EXP044228	goat-anti-GFP-UC	Drosophila melanogaster	strain: ey-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ey-GFP.FPTB}VK00033, sex:mixed	EXP043245	1400	normal	O18381	whole organism (development stage: wandering third instar larva)	NULL
EXP044229	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RW10325, sex:hermaphrodite	EXP043015	1235	normal	Q9NH52	whole worms (developmental stage: young adults)	NULL
EXP044230	goat-anti-GFP-UC	Drosophila melanogaster	strain: bigmax-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=bigmax-GFP.FPTB}attP40, sex:mixed	EXP042692	1407	normal	Q9VB47	whole organism (development stage: embryonic)	NULL
EXP044231	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042724	1390	normal	G5EFY7	whole worms (developmental stage: L3)	NULL
EXP044232	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP210, genotype: unc-119(ed3) III; wgIs210., sex:hermaphrodite	EXP043106	1387	normal	Q69YW8	whole worms (developmental stage: L1)	NULL
EXP044233	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG5180-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG5180-GFP.FPTB}attP40, sex:mixed	EXP042770	1407	normal	B7Z0N0	whole organism (development stage: embryonic)	NULL
EXP044234	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP159, genotype: unc-119(ed3) III; wgIs159, sex:hermaphrodite	EXP043415	1391	normal	Q19691	whole worms (developmental stage: late embryo)	NULL
EXP044235	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP214, genotype: unc-119(ed3) III; wgIs214., sex:mixed	EXP042803	1235	normal	Q9N5H8	whole worms (developmental stage: young adults)	NULL
EXP044236	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP90, genotype: unc-119(ed3) III; wgIs90., sex:mixed	EXP043212	1202	normal	P41829	whole worms (developmental stage: L2)	NULL
EXP044237	non-commercial Dll modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042587	1403	normal	P20009	whole organism	NULL
EXP044238	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4328-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG4328-GFP.FPTB}attP40, sex:mixed	EXP042956	1407	normal	Q9VTW3	whole organism (development stage: embryonic)	NULL
EXP044239	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hr96-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=FTSF.GFP-Hr96}VK00037, sex:female	EXP043178	1399	normal	Q24143	whole organism (development stage: adult)	NULL
EXP044240	non-commercial su(Hw) modENCODE antibody 1	Drosophila melanogaster	strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1]	EXP042771	1403	normal	P08970	whole organism	NULL
EXP044241	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP642, genotype: unc-119 (tm4063) III; wgIs642, sex:mixed	EXP042677	1405	normal	Q10938	whole organism (development stage: early embryonic)	NULL
EXP044242	ab290	Drosophila melanogaster	strain: Hr78-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Hr78-GFP.FLAG}VK00037	EXP043224	1407	normal	Q24142	whole organism (development stage: embryonic)	NULL
EXP044243	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP539, genotype: unc-119(tm4063) III; wgIs539, sex:hermaphrodite	EXP042653	1387	normal	Q9XUK7	whole worms (developmental stage: L1)	NULL
EXP044244	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG4820-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG4820-GFP.FTBP}VK00037, sex:mixed	EXP042575	1407	normal	A8JQX6	whole organism (development stage: embryonic)	NULL
EXP044245	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP560, genotype: unc-119(tm4063) III; wgIs560, sex:mixed	EXP042984	1405	normal	Q10666	whole organism (development stage: early embryonic)	NULL
EXP044246	goat-anti-GFP-UC	Caenorhabditis elegans	strain: CS152, genotype: sma-3(wk30);qcIs[gfp::sma-3+rol-6], sex:hermaphrodite	EXP043001	1202	normal	P45896	whole worms (developmental stage: L2)	NULL
EXP044247	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP201, genotype: unc-119(tm4063) III; wgIs201., sex:mixed	EXP042943	1387	normal	G5EFY7	whole worms (developmental stage: L1)	NULL
EXP044248	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP86, genotype: unc-119(ed3) III; wgIs86., sex:mixed	EXP042839	1202	normal	H2KZM4	whole worms (developmental stage: L2)	NULL
EXP044249	goat-anti-GFP-UC	Drosophila melanogaster	strain: psq-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=psq-GFP.FPTB}VK00033, sex:mixed	EXP043199	1400	normal	A1Z8A6	whole organism (development stage: wandering third instar larva)	NULL
EXP044250	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8359-GFP, genotype: w[1118]; P{y[+t7.7] w[+mC]=hng2-GFP.FPTB}attP40, sex:mixed	EXP043072	1407	normal	Q9VHL0	whole organism (development stage: embryonic)	NULL
EXP044251	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP354, genotype: unc-119(tm4063) III; wgIs354., sex:mixed	EXP042781	1390	normal	P28515	whole worms (developmental stage: L3)	NULL
EXP044252	goat-anti-GFP-UC	Drosophila melanogaster	strain: ind-GFP, genotype: y[1] w[*]; Pbac{y[+mDint2] w[+mC]=ind-GFP.FPTB}attP-40, sex:mixed	EXP042759	1407	normal	E1JH47	whole organism (development stage: embryonic)	NULL
EXP044253	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP124, genotype: unc-119(ed3) III; wgIs124., sex:mixed	EXP042617	1389	normal	O02219	whole worms (developmental stage: L4/young adults)	NULL
EXP044254	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP222, genotype: unc-119(ed3) III; wgIs222., sex:mixed	EXP043392	1390	normal	G5EFF5	whole worms (developmental stage: L3)	NULL
EXP044255	goat-anti-GFP-UC	Drosophila melanogaster	strain: fkh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=fkh-GFP.FPTB}VK00037/SM5, sex:mixed	EXP042818	1408	normal	P14734	whole organism (development stage: prepupa)	NULL
EXP044256	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP200, genotype: unc-119(ed3) III; wgIs200., sex:mixed	EXP043115	1202	normal	Q21836	whole worms (developmental stage: L2)	NULL
EXP044257	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP042751	1391	normal	Q23294	whole worms (developmental stage: late embryo)	NULL
EXP044258	goat-anti-GFP-UC	Drosophila melanogaster	strain: her-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=her-GFP.FTBP}VK00033/TM3, Sb[1], sex:mixed	EXP043311	1407	normal	Q9VJJ6	whole organism (development stage: embryonic)	NULL
EXP044259	goat-anti-GFP-UC	Drosophila melanogaster	strain: disco-r-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=disco-r-EGFP.S}VK00033/TM3, Sb[1], sex:mixed	EXP042813	1407	normal	Q9VXJ5	whole organism (development stage: embryonic)	NULL
EXP044260	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP651, genotype: unc-119(tm4063); wgIs651 [bed-3::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP042864	1392	normal	Q19787	whole worms (mixed-stage embryos)	NULL
EXP044261	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP169, genotype: unc-119(ed3) III; wgIs169., sex:mixed	EXP043373	1392	normal	Q22812	whole worms (mixed-stage embryos)	NULL
EXP044262	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL521, genotype: unc-119(ed3) III; vrIs117 [pPIE-1::LIN-35:GFP:FLAG::PUF-5 3'UTR, unc-119 (+)]), sex:mixed	EXP043156	1235	normal	G5EDT1	whole worms (developmental stage: young adults)	NULL
EXP044263	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP367, genotype: unc-119(tm4063) III; wgIs367., sex:mixed	EXP043321	1387	normal	Q9N5S3	whole worms (developmental stage: L1)	NULL
EXP044264	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP111, genotype: unc-119(ed3) III; wgIs111, sex:hermaphrodite	EXP043251	1391	normal	D0VWN0	whole worms (developmental stage: late embryo)	NULL
EXP044265	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP102, genotype: unc-119(tm4063) III; wgIs102., sex:mixed	EXP042749	1387	normal	Q21502	whole worms (developmental stage: L1)	NULL
EXP044266	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP43, genotype: unc-119(ed3) III; wgIs43., sex:mixed	EXP043230	1202	normal	P41828	whole worms (developmental stage: L2)	NULL
EXP044267	non-commercial eGFP modENCODE antibody 1	Drosophila melanogaster	strain: 5T-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=eve-EGFP.S}VK00033	EXP043413	1407	normal	F9W320	whole organism (development stage: embryonic)	NULL
EXP044268	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP516, genotype: unc-119(tm4063) III; wgIs516., sex:hermaphrodite	EXP043397	1389	normal	Q23175	whole worms (developmental stage: L4/young adults)	NULL
EXP044269	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP589, genotype: unc-119(tm4063); wgIs589 [gei-8::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP043375	1389	normal	P34333	whole worms (developmental stage: L4/young adults)	NULL
EXP044270	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP312, genotype: unc-119(ed3) III; wgIs312, sex:hermaphrodite	EXP042606	1389	normal	O17862	whole worms (developmental stage: L4/young adults)	NULL
EXP044271	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043048	1202	normal	Q23294	whole worms (developmental stage: L2)	NULL
EXP044272	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP305, genotype: unc-119(ed3) III; wgIs305., sex:mixed	EXP043049	1390	normal	Q23294	whole worms (developmental stage: L3)	NULL
EXP044273	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP562, genotype: unc-119(tm4063) III; wgIs562, sex:hermaphrodite	EXP042809	1391	normal	O44712	whole worms (developmental stage: late embryo)	NULL
EXP044274	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG15011-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=CG15011-GFP.FPTB}VK00033, sex:mixed	EXP042900	1407	normal	Q9VZF2	whole organism (development stage: embryonic)	NULL
EXP044275	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP252, sex:hermaphrodite	EXP042593	1389	normal	Q9XVS4	whole worms (developmental stage: L4/young adults)	NULL
EXP044276	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP203, genotype: unc-119(ed3) III; wgIs203., sex:mixed	EXP042967	1387	normal	Q65CM0	whole worms (developmental stage: L1)	NULL
EXP044277	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG16815-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG16815-GFP.FPTB}VK00033, sex:mixed	EXP043384	1407	normal	Q9VK15	whole organism (development stage: embryonic)	NULL
EXP044278	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP502, genotype: unc-119(tm4063) III; wgIs502., sex:hermaphrodite	EXP042995	1405	normal	Q17561	whole organism (development stage: early embryonic)	NULL
EXP044279	goat-anti-GFP-UC	Drosophila melanogaster	strain: achi-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=achi-GFP.FTBP}VK00033, sex:mixed	EXP043239	1408	normal	Q7JR08	whole organism (development stage: prepupa)	NULL
EXP044280	goat-anti-GFP-UC	Drosophila melanogaster	strain: luna-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}luna[MI05859]/SM6a, sex:mixed	EXP043071	1407	normal	Q8MR37	whole organism (development stage: embryonic)	NULL
EXP044281	goat-anti-GFP-UC	Caenorhabditis elegans	strain: QP0661, sex:hermaphrodite	EXP042726	1235	normal	O45134	whole worms (developmental stage: young adults)	NULL
EXP044282	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP228, genotype: unc-119(ed3) III; wgIs228., sex:mixed	EXP042585	1390	normal	Q966B8	whole worms (developmental stage: L3)	NULL
EXP044283	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP433, genotype: unc-119(tm4063) III; wgIs433., sex:hermaphrodite	EXP042646	1391	normal	Q86MJ3	whole worms (developmental stage: late embryo)	NULL
EXP044284	goat-anti-GFP-UC	Drosophila melanogaster	strain: ERR-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=ERR-GFP.FSTF}VK00037, sex:mixed	EXP042823	1407	normal	Q9VSE9	whole organism (development stage: embryonic)	NULL
EXP044285	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP324, genotype: unc-119(ed3) III; wgIs324., sex:mixed	EXP043078	1202	normal	O17646	whole worms (developmental stage: L2)	NULL
EXP044286	goat-anti-GFP-UC	Drosophila melanogaster	strain: OdsH-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=OdsH-GFP.FPTB}VK00033	EXP042837	1400	normal	Q9VX20	whole organism (development stage: wandering third instar larva)	NULL
EXP044287	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG34406-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG44002-GFP.FTBP}VK00033, sex:mixed	EXP043186	1408	normal	Q9VRC5	whole organism (development stage: prepupa)	NULL
EXP044288	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP195, sex:hermaphrodite	EXP043352	1389	normal	Q23541	whole worms (developmental stage: L4/young adults)	NULL
EXP044289	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP234, genotype: unc-119(ed3) III; wgIs234., sex:mixed	EXP043056	1389	normal	G5ECU7	whole worms (developmental stage: L4/young adults)	NULL
EXP044290	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP573, genotype: unc-119(tm4063) III; wgIs573, sex:mixed	EXP043157	1405	normal	Q18612	whole organism (development stage: early embryonic)	NULL
EXP044291	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP236, genotype: unc-119(ed3) III; wgIs236., sex:mixed	EXP042788	1202	normal	O02274	whole worms (developmental stage: L2)	NULL
EXP044292	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP476, genotype: unc-119(tm4063) III; wgIs476., sex:hermaphrodite	EXP043342	1391	normal	P13528	whole worms (developmental stage: late embryo)	NULL
EXP044293	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP399, genotype: unc-119(tm4063) III; wgIs399., sex:hermaphrodite	EXP043067	1235	normal	Q19723	whole worms (developmental stage: young adults)	NULL
EXP044294	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: OP73, genotype: unc-119(ed3) III; wgIs73, sex:mixed	EXP042863	1202	normal	P20271	whole worms (developmental stage: L2)	NULL
EXP044295	goat-anti-GFP-UC	Drosophila melanogaster	strain: sc-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=sc-GFP.FPTB}VK00033, sex:mixed	EXP043172	1407	normal	P10084	whole organism (development stage: embryonic)	NULL
EXP044296	non-commercial eGFP modENCODE antibody 1	Caenorhabditis elegans	strain: YL416, genotype: unc119(ed3)III; vrIs64[pGES-1::HPL-2::GFP FLAG: HPL-2 3â€™UTR, unc-119 (+)], sex:mixed	EXP043275	1387	normal	G5EDE2	whole worms (developmental stage: L1)	NULL
EXP044297		Caenorhabditis elegans	strain: N2	NULL	1388	chip_control	NULL	whole worms (developmental stage: embryo)	NULL
EXP044298		Caenorhabditis elegans	strain: sdc-2(y93) with RNAi against sdc-2	NULL	1388	chip_control	NULL	whole worms (developmental stage: embryo)	NULL
EXP044299	anti-SDC-3	Caenorhabditis elegans	strain: N2	EXP044297	1388	normal	P34706	whole worms (developmental stage: embryo)	NULL
EXP044300	anti-SDC-3	Caenorhabditis elegans	strain: sdc-2(y93) with RNAi against sdc-2	EXP044298	1388	normal	P34706	whole worms (developmental stage: embryo)	NULL
EXP044301		Caenorhabditis elegans	strain: tdp-1(ok803); temperature: 20C	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP044302	anti-TDP-1	Caenorhabditis elegans	strain: tdp-1(ok803); temperature: 20C	EXP044301	1235	normal	D0VWM8	whole worms (developmental stage: young adults)	NULL
EXP044303	anti-TDP-1	Caenorhabditis elegans	strain: tdp-1(ok803); temperature: 20C	EXP044301	1235	normal	D0VWM8	whole worms (developmental stage: young adults)	NULL
EXP044304	No Antibody	Caenorhabditis elegans	treated with spg-7(RNAi); wildtype	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP044305	ATFS-1 antibody	Caenorhabditis elegans	treated with spg-7(RNAi); wildtype	EXP044304	1389	normal	Q23272	whole worms (developmental stage: L4/young adults)	NULL
EXP044306	input	Caenorhabditis elegans	strain: daf-2 (e1370); temperature:20 Â°C	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044307		Caenorhabditis elegans	strain: Wild-type (N2); temperature:20 Â°C	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044308		Caenorhabditis elegans	strain: daf-16(mgDf50) knocked down by RNAi;daf-2 (e1370); temperature:20 Â°C	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044309		Caenorhabditis elegans	strain: daf-16(mgDf50) knocked down by RNAi; temperature:20 Â°C	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044310	anti-DAF-16	Caenorhabditis elegans	strain: daf-2 (e1370); temperature:20 Â°C	EXP044306	1411	normal	O16850	whole worms (mix stage culture)	NULL
EXP044311	anti-DAF-16	Caenorhabditis elegans	strain: Wild-type (N2); temperature:20 Â°C	EXP044307	1411	normal	O16850	whole worms (mix stage culture)	NULL
EXP044312	anti-DAF-16	Caenorhabditis elegans	strain: daf-16(mgDf50) knocked down by RNAi;daf-2 (e1370); temperature:20 Â°C	EXP044308	1411	bio_control	O16850	whole worms (mix stage culture)	NULL
EXP044313	anti-DAF-16	Caenorhabditis elegans	strain: daf-16(mgDf50) knocked down by RNAi; temperature:20 Â°C	EXP044309	1411	bio_control	O16850	whole worms (mix stage culture)	NULL
EXP044314	NIgG	Caenorhabditis elegans	strain: N2	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044315	none	Caenorhabditis elegans	strain: N2	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044316	anti-LEM2 SDQ3891	Caenorhabditis elegans	strain: N2	EXP044315	1392	normal	Q9XTB5	whole worms (mixed-stage embryos)	NULL
EXP044317		Caenorhabditis elegans	strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044318		Caenorhabditis elegans	strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044319	BH00001 LIN52	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	Q10120	whole worms (developmental stage: L3)	NULL
EXP044320	BH00001 LIN52	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	Q10120	whole worms (developmental stage: L3)	NULL
EXP044323	BH00003 LIN37	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	Q23482	whole worms (developmental stage: L3)	NULL
EXP044324	BH00003 LIN37	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	Q23482	whole worms (developmental stage: L3)	NULL
EXP044327	BH00004_LIN54	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	Q95QD7	whole worms (developmental stage: L3)	NULL
EXP044328	BH00004_LIN54	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	Q95QD7	whole worms (developmental stage: L3)	NULL
EXP044331	BH00005 LIN9	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	P30630	whole worms (developmental stage: L3)	NULL
EXP044332	BH00005 LIN9	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	P30630	whole worms (developmental stage: L3)	NULL
EXP044335	JA00011 LIN35	Caenorhabditis elegans	strain: N2	EXP044317	1390	normal	G5EDT1	whole worms (developmental stage: L3)	NULL
EXP044336	JA00011 LIN35	Caenorhabditis elegans	strain: N2	EXP044318	1390	normal	G5EDT1	whole worms (developmental stage: L3)	NULL
EXP044337		Caenorhabditis elegans	strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044338		Caenorhabditis elegans	strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044339	JL00002 SDC3	Caenorhabditis elegans	strain: N2	EXP044337	1390	normal	P34706	whole worms (developmental stage: L3)	NULL
EXP044340	JL00002 SDC3	Caenorhabditis elegans	strain: N2	EXP044338	1390	normal	P34706	whole worms (developmental stage: L3)	NULL
EXP044342	SDQ2370 LIN53	Caenorhabditis elegans	N2 strain	EXP044318	1390	normal	P90916	whole worms (developmental stage: L3)	NULL
EXP044344	SDQ3590 EFL1	Caenorhabditis elegans	N2 strain	EXP044318	1390	normal	G5EF11	whole worms (developmental stage: L3)	NULL
EXP044346	SDQ3599 DPL1	Caenorhabditis elegans	N2 strain	EXP044318	1390	normal	Q22703	whole worms (developmental stage: L3)	NULL
EXP044347		Caenorhabditis elegans	N2 strain	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044348	SDQ4470 TAG315	Caenorhabditis elegans	N2 strain	EXP044347	1390	normal	Q95PV7	whole worms (developmental stage: L3)	NULL
EXP044350	SDQ4526 SFC1	Caenorhabditis elegans	N2 strain	EXP044347	1390	normal	Q22093	whole worms (developmental stage: L3)	NULL
EXP044351		Caenorhabditis elegans	N2 strain	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044352	JL00001 DPY27	Caenorhabditis elegans	N2 strain	EXP044351	1390	normal	P48996	whole worms (developmental stage: L3)	NULL
EXP044374	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 20Â°C to desired stage	EXP044371	1235	normal	G5EFT5	whole worms (developmental stage: young adults)	NULL
EXP044375	anti-GFP (clontech, #632592)	Caenorhabditis elegans	AM1061 strain; 34Â°C to desired stage	EXP044371	1235	normal	G5EFT5	whole worms (developmental stage: young adults)	NULL
EXP044376	input	Caenorhabditis elegans		NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044377	anti-CEBP1	Caenorhabditis elegans		EXP044376	1411	normal	Q18909	whole worms (mix stage culture)	NULL
EXP044378	none	Caenorhabditis elegans	YL529 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP044379	anti-GFP (gift from Kevin White)	Caenorhabditis elegans	YL529 strain	EXP044378	1235	normal	O44743	whole worms (developmental stage: young adults)	NULL
EXP044380	none	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP044381	HPL-2 (Strategic Diagnostics Inc., Q2324)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	NULL
EXP044382	LET-418 (Strategic Diagnostics Inc., Q3861)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	G5EBZ4	whole worms (developmental stage: young adults)	NULL
EXP044383	LIN-13 (Strategic Diagnostics Inc., Q0838)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	Q11107	whole worms (developmental stage: young adults)	NULL
EXP044384	LIN-61 (Strategic Diagnostics Inc., Q3520)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	B2D6M2	whole worms (developmental stage: young adults)	NULL
EXP044385	MET-2 (Strategic Diagnostics Inc., Q2943)	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044380	1235	normal	P17512	whole worms (developmental stage: young adults)	NULL
EXP044386		Caenorhabditis elegans	genotype: wild type	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044387		Caenorhabditis elegans	genotype: wild type	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044388		Caenorhabditis elegans	genotype: wild type	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044389		Caenorhabditis elegans	genotype: wild type	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044390		Caenorhabditis elegans	genotype: wild type	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044391		Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044392		Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044393		Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP044394	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: wild type	EXP044387	1391	normal	Q22703	whole worms (developmental stage: late embryo)	NULL
EXP044395	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	Q22703	whole worms (developmental stage: late embryo)	NULL
EXP044396	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q22703	whole worms (developmental stage: late embryo)	NULL
EXP044397	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q22703	whole worms (developmental stage: late embryo)	NULL
EXP044398	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q22703	whole worms (developmental stage: late embryo)	NULL
EXP044399	SDIX/Novus Biologicals Q3599	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q22703	whole worms (developmental stage: late embryo)	NULL
EXP044400	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: wild type	EXP044387	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	NULL
EXP044401	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: wild type	EXP044389	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	NULL
EXP044402	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	NULL
EXP044403	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	NULL
EXP044404	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	NULL
EXP044405	SDIX/Novus Biologicals Q3590	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	G5EF11	whole worms (developmental stage: late embryo)	NULL
EXP044406	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: wild type	EXP044386	1391	normal	G5EDT1	whole worms (developmental stage: late embryo)	NULL
EXP044407	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	G5EDT1	whole worms (developmental stage: late embryo)	NULL
EXP044408	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	bio_control	G5EDT1	whole worms (developmental stage: late embryo)	NULL
EXP044409	SDIX/Novus Biologicals Q2003	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	bio_control	G5EDT1	whole worms (developmental stage: late embryo)	NULL
EXP044410	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044386	1391	normal	P30630	whole worms (developmental stage: late embryo)	NULL
EXP044411	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	P30630	whole worms (developmental stage: late embryo)	NULL
EXP044412	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	P30630	whole worms (developmental stage: late embryo)	NULL
EXP044413	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	P30630	whole worms (developmental stage: late embryo)	NULL
EXP044414	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	P30630	whole worms (developmental stage: late embryo)	NULL
EXP044415	Horvitz lab BH0005 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	P30630	whole worms (developmental stage: late embryo)	NULL
EXP044416	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q23482	whole worms (developmental stage: late embryo)	NULL
EXP044417	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q23482	whole worms (developmental stage: late embryo)	NULL
EXP044418	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q23482	whole worms (developmental stage: late embryo)	NULL
EXP044419	SDIX/Novus Biologicals Q3166	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q23482	whole worms (developmental stage: late embryo)	NULL
EXP044420	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044387	1391	normal	Q10120	whole worms (developmental stage: late embryo)	NULL
EXP044421	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044389	1391	normal	Q10120	whole worms (developmental stage: late embryo)	NULL
EXP044422	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q10120	whole worms (developmental stage: late embryo)	NULL
EXP044423	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q10120	whole worms (developmental stage: late embryo)	NULL
EXP044424	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q10120	whole worms (developmental stage: late embryo)	NULL
EXP044425	Horvitz lab BH0001 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q10120	whole worms (developmental stage: late embryo)	NULL
EXP044426	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044386	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	NULL
EXP044427	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044388	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	NULL
EXP044428	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: wild type	EXP044390	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	NULL
EXP044429	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044391	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	NULL
EXP044430	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044392	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	NULL
EXP044431	Horvitz lab BH0004 (Harrison et al. 2006)	Caenorhabditis elegans	genotype: lin-35(n745) (LIN-35-null)	EXP044393	1391	normal	Q95QD7	whole worms (developmental stage: late embryo)	NULL
EXP044432	none	Caenorhabditis elegans	strain: SX2966	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044433	none	Caenorhabditis elegans	strain: SX2966	NULL	1411	chip_control	NULL	whole worms (mix stage culture)	NULL
EXP044434	anti-GFP (Abcam ab290)	Caenorhabditis elegans	strain: SX2966	EXP044432	1411	normal	Q9NAD6	whole worms (mix stage culture)	NULL
EXP044435	anti-GFP (Abcam ab290)	Caenorhabditis elegans	strain: SX2966	EXP044433	1411	normal	Q9NAD6	whole worms (mix stage culture)	NULL
EXP044436	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044437	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044438	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044439	INPUT	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044440	INPUT	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044441	INPUT	Caenorhabditis elegans	Treatment: Treatment: TY2205 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044442	INPUT	Caenorhabditis elegans	Treatment: Treatment: TY2205 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044443	INPUT	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044444	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044445	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044446	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044447	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC54 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044448	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC54 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044449	INPUT	Caenorhabditis elegans	Treatment: Treatment: none	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044450	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044451	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044452	INPUT	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044453	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044454	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044455	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044456	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044457	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044458	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044459	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044460	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044461	INPUT	Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044462		Caenorhabditis elegans	Treatment: Treatment: ERC08 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044463		Caenorhabditis elegans	Treatment: Treatment: ERC08 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044464		Caenorhabditis elegans	Treatment: Treatment: ERC09 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044465		Caenorhabditis elegans	Treatment: Treatment: N2 strain	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP044466	SDC-2	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044453	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044467	SDC-2	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044454	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044468	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044436	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044469	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044455	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044470	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044456	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044471	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044455	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044472	SDC-3	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044437	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044473	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044457	1392	normal	Q10661	whole worms (mixed-stage embryos)	NULL
EXP044474	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044458	1392	normal	Q10661	whole worms (mixed-stage embryos)	NULL
EXP044475	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044453	1392	normal	Q10661	whole worms (mixed-stage embryos)	NULL
EXP044476	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044438	1392	normal	Q10661	whole worms (mixed-stage embryos)	NULL
EXP044477	DPY-30	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044437	1392	normal	Q10661	whole worms (mixed-stage embryos)	NULL
EXP044478	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044453	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044479	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044459	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044480	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044460	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044481	DPY-27	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044456	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044482	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY2205 strain	EXP044441	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044483	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY2205 strain	EXP044442	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044484	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	EXP044439	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044485	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	EXP044439	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044486	SDC-2	Caenorhabditis elegans	Treatment: Treatment: TY1072 strain	EXP044443	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044487	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044444	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044488	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044445	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044489	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044446	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044490	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044444	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044491	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044444	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044492	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044445	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044493	SDC-3	Caenorhabditis elegans	Treatment: Treatment: ERC38 strain	EXP044446	1392	normal	P34706	whole worms (mixed-stage embryos)	NULL
EXP044494	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC54 strain	EXP044447	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044495	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC54 strain	EXP044448	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044496	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC64 strain	EXP044449	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044497	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC64 strain	EXP044449	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044498	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC64 strain	EXP044449	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044499	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	EXP044450	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044500	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	EXP044451	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044501	DPY-27	Caenorhabditis elegans	Treatment: Treatment: ERC51 strain	EXP044452	1392	normal	P48996	whole worms (mixed-stage embryos)	NULL
EXP044502	SDC-2	Caenorhabditis elegans	Treatment: Treatment: N2 strain	EXP044455	1392	normal	G5EBL3	whole worms (mixed-stage embryos)	NULL
EXP044503		Caenorhabditis elegans	strain: sgIs1 (Strain F); genotype: NHR-6::GFP	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP044504		Caenorhabditis elegans	strain: sgIs2 (Strain I); genotype: NHR-6::GFP	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP044505	anti-GFP	Caenorhabditis elegans	strain: sgIs1 (Strain F); genotype: NHR-6::GFP	EXP044503	1390	normal	P41829	whole worms (developmental stage: L3)	NULL
EXP044506	anti-GFP	Caenorhabditis elegans	strain: sgIs2 (Strain I); genotype: NHR-6::GFP	EXP044504	1389	normal	P41829	whole worms (developmental stage: L4/young adults)	NULL
EXP044507		Caenorhabditis elegans	strain: HW1023; genotype: xrn-2::gfp	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP044508		Caenorhabditis elegans	strain: HW1023; genotype: xrn-2::gfp	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP044509		Caenorhabditis elegans	strain: N2; genotype: wild type	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP044510		Caenorhabditis elegans	strain: N2; genotype: wild type	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP044511	anti-GFP	Caenorhabditis elegans	strain: HW1023; genotype: xrn-2::gfp	EXP044507	1389	normal	Q9U299	whole worms (developmental stage: L4/young adults)	NULL
EXP044512	anti-GFP	Caenorhabditis elegans	strain: HW1023; genotype: xrn-2::gfp	EXP044508	1389	normal	Q9U299	whole worms (developmental stage: L4/young adults)	NULL
EXP044513		Caenorhabditis elegans	strain: N2; genotype: wild type	EXP044509	1389	bio_control	A0A023T4K3	whole worms (developmental stage: L4/young adults)	NULL
EXP044514		Caenorhabditis elegans	strain: N2; genotype: wild type	EXP044510	1389	bio_control	A0A023T4K3	whole worms (developmental stage: L4/young adults)	NULL
EXP044515	none	Drosophila melanogaster		NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044516	Wapl	Drosophila melanogaster	mock replicates	NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044517	Rad21	Drosophila melanogaster	mock replicates	NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044518	Pds5	Drosophila melanogaster	mock replicates	NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044519	Brca2	Drosophila melanogaster	mock replicates	NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044520	Wapl	Drosophila melanogaster	iPDS5	EXP044515	1244	normal	Q9W517	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044521	Wapl	Drosophila melanogaster	iBrca2	EXP044515	1244	normal	Q9W517	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044522	SA	Drosophila melanogaster	iWapl	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044523	SA	Drosophila melanogaster	iPds5	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044524	SA	Drosophila melanogaster	iPds5; iWapl	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044525	SA	Drosophila melanogaster	iPds5; iBrca2	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044526	SA	Drosophila melanogaster	iBrca2	EXP044515	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044527	Rad21	Drosophila melanogaster	iPds5	EXP044515	1244	normal	A0A021WW32	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044528	Pds5	Drosophila melanogaster	iWapl	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044529	Pds5	Drosophila melanogaster	iRad21	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044530	Pds5	Drosophila melanogaster	iNipped-B	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044531	Pds5	Drosophila melanogaster	iBrca2	EXP044515	1244	normal	A1Z8S6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044532	Nipped-B	Drosophila melanogaster	iWapl	EXP044515	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044533	Nipped-B	Drosophila melanogaster	iPds5	EXP044515	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044534	Brca2	Drosophila melanogaster	iPds5	EXP044515	1244	normal	Q9W157	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP044535	PSC	Drosophila melanogaster		NULL	1397	normal	P35820	Kc167 (development stage: embryonic)	NULL
EXP044536	input	Drosophila melanogaster		NULL	1412	chip_control	NULL	whole organism (development stage: larvae)	NULL
EXP044537	MSL3-TAP ChIP	Drosophila melanogaster		EXP044536	1412	normal	P50536	whole organism (development stage: larvae)	NULL
EXP044538	mock	Drosophila melanogaster	heat shock	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP044539	HSF	Drosophila melanogaster	heat shock	EXP044538	1197	normal	P22813	S2-DRSC (embryonic stem cells)	NULL
EXP044540	HSF	Drosophila melanogaster	heat shock; HSF knock-down	EXP044538	1197	bio_control	P22813	S2-DRSC (embryonic stem cells)	NULL
EXP044541	HSF	Drosophila melanogaster		EXP044538	1197	normal	P22813	S2-DRSC (embryonic stem cells)	NULL
EXP044542	HSF	Drosophila melanogaster	HSF knock-down	EXP044538	1197	bio_control	P22813	S2-DRSC (embryonic stem cells)	NULL
EXP044543	input	Drosophila melanogaster	21 day female flies	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP044544	input	Drosophila melanogaster		NULL	1413	chip_control	NULL	0-12 h embryo	NULL
EXP044545	input	Drosophila melanogaster		NULL	1415	chip_control	NULL	4-8 h embryo	NULL
EXP044551	input	Drosophila melanogaster		NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP044552	goat anti GFP	Drosophila melanogaster	21 day female flies	EXP044543	1399	normal	P09085	whole organism (development stage: adult)	NULL
EXP044554	goat anti GFP	Drosophila melanogaster		EXP044545	1415	normal	P09085	4-8 h embryo	NULL
EXP044559	caudal	Drosophila melanogaster		EXP044551	1400	normal	P09085	whole organism (development stage: wandering third instar larva)	NULL
EXP044560	HDAC11	Drosophila melanogaster		EXP044544	1413	normal	Q9VC26	0-12 h embryo	NULL
EXP044561	HDAC6	Drosophila melanogaster		EXP044544	1413	normal	C5I798	0-12 h embryo	NULL
EXP044562	HDAC3	Drosophila melanogaster		EXP044544	1413	normal	Q7KTS4	0-12 h embryo	NULL
EXP044563	HDAC1	Drosophila melanogaster		EXP044544	1413	normal	Q94517	0-12 h embryo	NULL
EXP044564	HDAC4a	Drosophila melanogaster		EXP044544	1413	normal	M9NEF2	0-12 h embryo	NULL
EXP044565	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP044566	none	Drosophila melanogaster		NULL	1443	chip_control	NULL	S3 cells (Schneider 3)	NULL
EXP044567	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP044568	anti-AGO2 mAb 9D6	Drosophila melanogaster		EXP044565	1242	normal	Q9VUQ5	S2 cells	NULL
EXP044569	anti-AGO2 mAb 9D6	Drosophila melanogaster		EXP044566	1443	normal	Q9VUQ5	S3 cells (Schneider 3)	NULL
EXP044570	antiAGO2 pAb Mueller [PMID:16934003]	Drosophila melanogaster		EXP044567	1242	normal	Q9VUQ5	S2 cells	NULL
EXP044575	input	Drosophila melanogaster		NULL	1418	chip_control	NULL	0-8 h embryo	NULL
EXP044576	KW4-Pcl-D2	Drosophila melanogaster		EXP044575	1418	normal	Q24459	0-8 h embryo	NULL
EXP044578	KW3-disco-D2	Drosophila melanogaster		EXP042796	1418	normal	P23792	0-8 h embryo	NULL
EXP044579		Drosophila melanogaster	3 day female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP044580	cad-GFP	Drosophila melanogaster	3 day female	EXP044579	1399	normal	P09085	whole organism (development stage: adult)	NULL
EXP044581		Homo sapiens		NULL	1150	chip_control	NULL	ovary	NULL
EXP044582		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044583		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP044584		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044585		Homo sapiens		NULL	1150	chip_control	NULL	ovary	NULL
EXP044586		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP044587		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044588		Homo sapiens		NULL	1140	chip_control	NULL	subcutaneous adipose tissue	NULL
EXP044589		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP044590		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044591		Homo sapiens		NULL	1175	chip_control	NULL	prostate gland	NULL
EXP044592		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP044593		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044594		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044595		Homo sapiens		NULL	1158	chip_control	NULL	vagina	NULL
EXP044596		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP044597		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044598		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP044599		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044600	eGFP	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044601		Mus musculus		NULL	810	chip_control	NULL	stomach	NULL
EXP044602		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP044603		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044604		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044605		Homo sapiens		NULL	1158	chip_control	NULL	vagina	NULL
EXP044606		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP044607		Homo sapiens		NULL	1180	chip_control	NULL	neural cell	NULL
EXP044608		Mus musculus		NULL	53	chip_control	NULL	heart	NULL
EXP044609		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044610		Homo sapiens		NULL	1140	chip_control	NULL	subcutaneous adipose tissue	NULL
EXP044611		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP044612		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044613		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044614		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP044615		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP044616		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044617		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP044618		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP044619		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044620		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP044621		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP044622		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP044623		Homo sapiens		NULL	1156	chip_control	NULL	gastroesophageal sphincter	NULL
EXP044624		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044625		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP044626		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP044627		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044628		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044629		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044630		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044631		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044632		Homo sapiens		NULL	1149	chip_control	NULL	testis	NULL
EXP044633		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044634		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044635		Homo sapiens		NULL	1154	chip_control	NULL	omental fat pad	NULL
EXP044636		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP044637		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP044638		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP044639		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP044640		Homo sapiens		NULL	1419	chip_control	NULL	GM23248	NULL
EXP044641		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044642		Homo sapiens		NULL	289	chip_control	NULL	SK-N-MC (Askin tumor)	NULL
EXP044643		Homo sapiens		NULL	1140	chip_control	NULL	subcutaneous adipose tissue	NULL
EXP044644		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044645		Homo sapiens		NULL	1179	chip_control	NULL	tibial nerve	NULL
EXP044646		Homo sapiens		NULL	1181	chip_control	NULL	upper lobe of left lung	NULL
EXP044647		Homo sapiens		NULL	1169	chip_control	NULL	sigmoid colon	NULL
EXP044648		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044649		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP044650		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP044651		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP044652		Homo sapiens		NULL	1129	chip_control	NULL	suprapubic skin	NULL
EXP044653		Homo sapiens		NULL	1163	chip_control	NULL	transverse colon	NULL
EXP044654		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP044655		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP044656		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044657		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044658		Homo sapiens		NULL	1179	chip_control	NULL	tibial nerve	NULL
EXP044659		Homo sapiens		NULL	1140	chip_control	NULL	subcutaneous adipose tissue	NULL
EXP044660		Homo sapiens		NULL	1157	chip_control	NULL	stomach	NULL
EXP044661		Homo sapiens		NULL	1167	chip_control	NULL	esophagus muscularis mucosa	NULL
EXP044662		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044663		Mus musculus		NULL	561	chip_control	NULL	lung	NULL
EXP044664		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044665		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044666		Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP044667		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP044668		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044669		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044670		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP044671		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP044672	sc-585	Homo sapiens		EXP044592	1181	normal	Q09472	upper lobe of left lung	NULL
EXP044673	sc-994	Homo sapiens		EXP010539	430	normal	Q96ST3	HepG2 (hepatoblastoma)	NULL
EXP044674	61717	Homo sapiens		EXP039034	514	normal	P49736	K562 (myelogenous leukemia)	NULL
EXP044675	sc-585	Homo sapiens		EXP010581	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044676	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044677	A300-868A	Homo sapiens		EXP039034	514	normal	O00267	K562 (myelogenous leukemia)	NULL
EXP044678	ARP40368_P050	Homo sapiens		EXP044665	430	normal	P14866	HepG2 (hepatoblastoma)	NULL
EXP044679	sc-585	Homo sapiens		EXP039181	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044680	ab992	Homo sapiens		EXP010131	514	normal	O60216	K562 (myelogenous leukemia)	NULL
EXP044681	5246S	Homo sapiens		EXP044640	1419	normal	Q15910	GM23248	NULL
EXP044682	sc-585	Homo sapiens		EXP010318	376	normal	Q09472	WA01 (H1, human embryonic stem cells)	NULL
EXP044683	sc-101388	Homo sapiens		EXP010671	514	normal	Q9NYF8	K562 (myelogenous leukemia)	NULL
EXP044684	ab992	Homo sapiens		EXP010228	430	normal	O60216	HepG2 (hepatoblastoma)	NULL
EXP044685	sc-994	Homo sapiens		EXP010671	514	normal	Q96ST3	K562 (myelogenous leukemia)	NULL
EXP044686	sc-585	Homo sapiens		EXP010228	430	normal	Q09472	HepG2 (hepatoblastoma)	NULL
EXP044687	GTX114455	Homo sapiens		EXP044665	430	normal	P35269	HepG2 (hepatoblastoma)	NULL
EXP044688	HPA017013	Homo sapiens		EXP039076	356	normal	O43670	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044689	sc-101167	Homo sapiens		EXP010318	376	normal	Q15545	WA01 (H1, human embryonic stem cells)	NULL
EXP044690	ab992	Homo sapiens	6Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	normal	O60216	SK-N-SH (neuroblastoma)	NULL
EXP044691	sc-585	Homo sapiens	6Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	EXP010512	665	normal	Q09472	SK-N-SH (neuroblastoma)	NULL
EXP044692	ab992	Homo sapiens		EXP010318	376	normal	O60216	WA01 (H1, human embryonic stem cells)	NULL
EXP044693	sc-585	Homo sapiens	1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	EXP010676	111	normal	Q09472	T47D (invasive ductal carcinoma)	NULL
EXP044694	sc-994	Homo sapiens		EXP010318	376	normal	Q96ST3	WA01 (H1, human embryonic stem cells)	NULL
EXP044695	A303-223A	Homo sapiens		EXP044628	430	normal	Q13148	HepG2 (hepatoblastoma)	NULL
EXP044696	sc-101388	Homo sapiens		EXP010137	356	normal	Q9NYF8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044697	GTX100469	Homo sapiens		EXP039020	430	normal	Q06609	HepG2 (hepatoblastoma)	NULL
EXP044698	A303-923A	Homo sapiens		EXP044671	430	normal	Q9NW64	HepG2 (hepatoblastoma)	NULL
EXP044699	sc-994	Homo sapiens		EXP010507	712	normal	Q96ST3	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP044700	A303-595A	Homo sapiens		EXP039034	514	normal	Q92785	K562 (myelogenous leukemia)	NULL
EXP044701	sc-994	Homo sapiens		EXP010101	733	normal	Q96ST3	PFSK1 (primitive neuroectodermal tumor)	NULL
EXP044702	sc-994	Homo sapiens		EXP010505	665	normal	Q96ST3	SK-N-SH (neuroblastoma)	NULL
EXP044703	sc-585	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044704	A300-294A	Homo sapiens		EXP044631	430	normal	P35637	HepG2 (hepatoblastoma)	NULL
EXP044705	A302-524A	Homo sapiens		EXP010781	430	normal	Q14781	HepG2 (hepatoblastoma)	NULL
EXP044706	A301-341A	Homo sapiens		EXP039242	356	normal	Q9UBN7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044707	ab109398	Homo sapiens		EXP040205	113	normal	Q15910	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044708	ab992	Homo sapiens		EXP010137	356	normal	O60216	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044709	sc-6296	Homo sapiens		EXP010228	430	normal	Q92769	HepG2 (hepatoblastoma)	NULL
EXP044710	sc-6296	Homo sapiens		EXP010131	514	normal	Q92769	K562 (myelogenous leukemia)	NULL
EXP044711	A303-670A	Homo sapiens		EXP044613	430	normal	Q08170	HepG2 (hepatoblastoma)	NULL
EXP044712	sc-9571	Homo sapiens		EXP044664	514	normal	P08621	K562 (myelogenous leukemia)	NULL
EXP044713	SAB2100398	Homo sapiens		EXP039220	356	normal	Q03701	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044714	A303-245A	Homo sapiens		EXP039077	514	normal	Q96JP5	K562 (myelogenous leukemia)	NULL
EXP044715	sc-101167	Homo sapiens		EXP010671	514	normal	Q15545	K562 (myelogenous leukemia)	NULL
EXP044716	sc-6298	Homo sapiens		EXP010781	430	normal	Q13547	HepG2 (hepatoblastoma)	NULL
EXP044717	sc-6296	Homo sapiens		EXP010318	376	normal	Q92769	WA01 (H1, human embryonic stem cells)	NULL
EXP044718	A303-241A	Homo sapiens		EXP039216	514	normal	Q96BR9	K562 (myelogenous leukemia)	NULL
EXP044719	A300-608A	Homo sapiens		EXP039034	514	normal	Q9NYF8	K562 (myelogenous leukemia)	NULL
EXP044720	sc-585	Homo sapiens		EXP010832	665	normal	Q09472	SK-N-SH (neuroblastoma)	NULL
EXP044721	A300-608A	Homo sapiens		EXP039061	430	normal	Q9NYF8	HepG2 (hepatoblastoma)	NULL
EXP044722	sc-585	Homo sapiens		EXP010824	504	normal	Q09472	Ishikawa (endometrial adenocarcinoma)	NULL
EXP044723	ab992	Homo sapiens		EXP010917	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044724	sc-101004	Homo sapiens		EXP010900	417	normal	Q13185	HCT-116 (colon carcinoma)	NULL
EXP044725	JH39.2.2F10	Homo sapiens		EXP039120	514	normal	Q14202	K562 (myelogenous leukemia)	NULL
EXP044726	A303-596A	Homo sapiens		EXP039034	514	normal	Q92785	K562 (myelogenous leukemia)	NULL
EXP044727	sc-6296	Homo sapiens		EXP010799	113	normal	Q92769	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044728	A302-869A	Homo sapiens		EXP039034	514	normal	Q99496	K562 (myelogenous leukemia)	NULL
EXP044729	ab992	Homo sapiens		EXP010799	113	normal	O60216	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044730	sc-585	Homo sapiens		EXP010799	113	normal	Q09472	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044731	ab992	Homo sapiens		EXP010824	504	normal	O60216	Ishikawa (endometrial adenocarcinoma)	NULL
EXP044732	sc-71910	Homo sapiens		EXP010546	514	normal	P29590	K562 (myelogenous leukemia)	NULL
EXP044733	sc-271530	Homo sapiens		EXP010780	430	normal	O95243	HepG2 (hepatoblastoma)	NULL
EXP044734	5246BF	Homo sapiens		EXP039172	618	normal	Q15910	MM1.S (plasma cell myeloma)	NULL
EXP044735	sc-71910	Homo sapiens		EXP010918	356	normal	P29590	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044736	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039031	421	normal	Q8WTR7	HEK293 (embryonic kidney)	NULL
EXP044737	sc-81411	Homo sapiens		EXP010546	514	normal	Q13263	K562 (myelogenous leukemia)	NULL
EXP044738	ab992	Homo sapiens		EXP010900	417	normal	O60216	HCT-116 (colon carcinoma)	NULL
EXP044739	sc-994	Homo sapiens		EXP010900	417	normal	Q96ST3	HCT-116 (colon carcinoma)	NULL
EXP044740	sc-994	Homo sapiens	1 h with 0.02% Ethanol (Myers)	EXP010076	38	normal	Q96ST3	A549 (lung carcinoma)	NULL
EXP044741	sc-101004	Homo sapiens		EXP010546	514	normal	Q13185	K562 (myelogenous leukemia)	NULL
EXP054055	HDAC2 (YangShi lab,  A300-705A)	Homo sapiens	Treatment: None;	NULL	376	normal	Q92769	WA01 (H1, human embryonic stem cells)	NULL
EXP054060	JMJD2A (Bethyl Laboratories, A300-861A-1)	Homo sapiens	Treatment: None;	NULL	376	normal	O75164	WA01 (H1, human embryonic stem cells)	NULL
EXP054056	CHD7 (Bethyl Laboratories, A301-223A-1)	Homo sapiens	Treatment: None;	NULL	376	normal	Q9P2D1	WA01 (H1, human embryonic stem cells)	NULL
EXP054059	CHD7 (Bethyl Laboratories, A301-223A-1)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9P2D1	K562 (myelogenous leukemia)	NULL
EXP044746	A303-616A	Homo sapiens		EXP039077	514	normal	O75081	K562 (myelogenous leukemia)	NULL
EXP054067	P300 (Rabbit Polyclonal Antigen Affinity Purified, Unconjugated, Liquid)	Homo sapiens	Treatment: None;	NULL	376	normal	Q09472	WA01 (H1, human embryonic stem cells)	NULL
EXP054051	SIRT6 (abcam,ab48192 )	Homo sapiens	Treatment: None;	NULL	376	normal	Q8N6T7	WA01 (H1, human embryonic stem cells)	NULL
EXP054052	SETDB1 (Proteintech, 11231-1-AP)	Homo sapiens	Treatment: None;	NULL	514	normal	Q15047	K562 (myelogenous leukemia)	NULL
EXP044750	39875	Homo sapiens		EXP010906	880	normal	Q15910	B-cells	NULL
EXP044751	F1804	Homo sapiens		EXP039140	430	normal	Q8N7H5	HepG2 (hepatoblastoma)	NULL
EXP044752	HPA000815	Homo sapiens		EXP039161	10	normal	Q969R5	HEK293T (embryonic kidney)	NULL
EXP044753	39875,39639	Homo sapiens		EXP010775	376	normal	Q15910	WA01 (H1, human embryonic stem cells)	NULL
EXP044754	39875	Homo sapiens		EXP010730	918	normal	Q15910	myotube	NULL
EXP044755	39875	Homo sapiens		EXP010573	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP044756	sc-17824	Homo sapiens		EXP039275	879	normal	P08047	liver	NULL
EXP044757	05-689	Homo sapiens		EXP010775	376	normal	P45973	WA01 (H1, human embryonic stem cells)	NULL
EXP044758	39875	Homo sapiens		EXP010656	423	normal	Q15910	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044759	39875	Homo sapiens		EXP010404	220	normal	Q15910	DND41 (acute lymphoblastic leukemia)	NULL
EXP054073	PCAF (Bethyl Laboratories, A301-666A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q92831	K562 (myelogenous leukemia)	NULL
EXP054071	RNF2 (Bethyl Laboratories, A302-869A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q99496	K562 (myelogenous leukemia)	NULL
EXP044762	A300-135A	Homo sapiens		EXP039020	430	normal	Q13315	HepG2 (hepatoblastoma)	NULL
EXP054070	SIRT6 (abcam, ab48192)	Homo sapiens	Treatment: None;	NULL	514	normal	Q8N6T7	K562 (myelogenous leukemia)	NULL
EXP054069	SUZ12 (Millipore, 05-1317)	Homo sapiens	Treatment: None;	NULL	514	normal	Q15022	K562 (myelogenous leukemia)	NULL
EXP044765	RN025P	Homo sapiens		EXP044604	514	normal	Q15366	K562 (myelogenous leukemia)	NULL
EXP054066	CHD4  (Bethyl Laboratories, A301-081A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q14839	K562 (myelogenous leukemia)	NULL
EXP054062	HDAC6 (Bethyl Laboratories, A301-341A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9UBN7	K562 (myelogenous leukemia)	NULL
EXP054065	PHF8 (Bethyl Laboratories, A301-772A)	Homo sapiens	Treatment: None;	NULL	974	normal	Q9UPP1	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP054078	HDAC6 (Bethyl Laboratories, A301-341A)	Homo sapiens	Treatment: None;	NULL	376	normal	Q9UBN7	WA01 (H1, human embryonic stem cells)	NULL
EXP054081	CBP (Santa Cruz Biotechnology, sc-369)	Homo sapiens	Treatment: None;	NULL	514	normal	Q92793	K562 (myelogenous leukemia)	NULL
EXP054074	CBX2 (Bethyl Laboratories, A302-524A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q14781	K562 (myelogenous leukemia)	NULL
EXP054079	SAP30 (Active Motif, 39731)	Homo sapiens	Treatment: None;	NULL	376	normal	O75446	WA01 (H1, human embryonic stem cells)	NULL
EXP044773	F1804	Homo sapiens		EXP039140	430	normal	Q7RTV0	HepG2 (hepatoblastoma)	NULL
EXP054080	SUZ12 (Millipore, 05-1317)	Homo sapiens	Treatment: None;	NULL	376	normal	Q15022	WA01 (H1, human embryonic stem cells)	NULL
EXP054077	LSD1 (Bethyl Laboratories, A300-215A)	Homo sapiens	Treatment: None;	NULL	514	normal	O60341	K562 (myelogenous leukemia)	NULL
EXP054075	CBX3 (Santa Cruz Biotechnology, SC-101004)	Homo sapiens	Treatment: None;	NULL	514	normal	Q13185	K562 (myelogenous leukemia)	NULL
EXP054076	CBX8 (Bethyl Laboratories, A300-882A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9HC52	K562 (myelogenous leukemia)	NULL
EXP044778	HPA001429	Homo sapiens		EXP039020	430	normal	O60934	HepG2 (hepatoblastoma)	NULL
EXP044779	ab290	Homo sapiens		EXP039092	421	normal	Q8TBC5	HEK293 (embryonic kidney)	NULL
EXP044780	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044781	sc-585	Mus musculus		EXP044608	53	normal	B2RWS6	heart	NULL
EXP044782	3737S	Homo sapiens		EXP039106	514	normal	Q15022	K562 (myelogenous leukemia)	NULL
EXP044783	sc-585	Homo sapiens		EXP044606	1163	normal	Q09472	transverse colon	NULL
EXP044784	RN025P	Homo sapiens		EXP044668	430	normal	Q15366	HepG2 (hepatoblastoma)	NULL
EXP044785	HPA039874	Homo sapiens		EXP039020	430	normal	Q99623	HepG2 (hepatoblastoma)	NULL
EXP044786	T5327	Homo sapiens		EXP039220	356	normal	P26651	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044787	A300-864A	Homo sapiens		EXP044634	430	normal	O43251	HepG2 (hepatoblastoma)	NULL
EXP044788	F1804	Homo sapiens		EXP039140	430	normal	P14316	HepG2 (hepatoblastoma)	NULL
EXP044789	ab290	Homo sapiens		EXP039092	421	normal	Q8N446	HEK293 (embryonic kidney)	NULL
EXP044790	61719	Homo sapiens		EXP039034	514	normal	P25205	K562 (myelogenous leukemia)	NULL
EXP044791	F1804	Homo sapiens		EXP039140	430	normal	Q6PML9	HepG2 (hepatoblastoma)	NULL
EXP044792	5246BF	Homo sapiens		EXP040217	725	normal	Q15910	PC3(bone mets prostate adenocarcinoma)	NULL
EXP044793	ab109398	Homo sapiens		EXP039091	686	normal	Q15910	OCI-LY3 (diffuse large B-cell lymphoma)	NULL
EXP044794	T5327	Homo sapiens		EXP039036	430	normal	P26651	HepG2 (hepatoblastoma)	NULL
EXP044795	A300-027A	Homo sapiens		EXP039240	113	normal	P61201	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044796	A300-705A	Homo sapiens		EXP039132	38	normal	Q92769	A549 (lung carcinoma)	NULL
EXP044797	sc-110	Homo sapiens		EXP039302	879	normal	P18146	liver	NULL
EXP044798	39639	Homo sapiens		EXP040205	113	normal	Q15910	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044799	A300-215A	Homo sapiens		EXP039132	38	normal	O60341	A549 (lung carcinoma)	NULL
EXP044800	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 minute	EXP040216	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044801	39639	Homo sapiens		EXP044607	1180	normal	Q15910	neural cell	NULL
EXP044802	61537	Homo sapiens		EXP039034	514	normal	Q9H8M2	K562 (myelogenous leukemia)	NULL
EXP044803	RN019P	Homo sapiens		EXP044597	514	normal	P61978	K562 (myelogenous leukemia)	NULL
EXP044804	A300-656A	Homo sapiens		EXP039034	514	normal	Q99623	K562 (myelogenous leukemia)	NULL
EXP044805	ab290	Homo sapiens		EXP039092	421	normal	Q9BWE0	HEK293 (embryonic kidney)	NULL
EXP044806	A302-267A	Homo sapiens		EXP039076	356	normal	Q03111	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044807	A303-331A	Homo sapiens		EXP039216	514	normal	Q8IYH5	K562 (myelogenous leukemia)	NULL
EXP044808	GTX103229	Homo sapiens		EXP039240	113	normal	O60934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044809	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044810	ab109398	Homo sapiens		EXP039024	927	normal	Q15910	PC9 (lung adenocarcinoma)	NULL
EXP044811	ab992	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044812	A300-705A	Homo sapiens		EXP039242	356	normal	Q92769	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044813	ab9263	Homo sapiens		EXP039081	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP044814	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039247	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044815	sc-585	Homo sapiens		EXP044650	1157	normal	Q09472	stomach	NULL
EXP044816	5053	Homo sapiens		EXP044590	514	normal	Q9UL18	K562 (myelogenous leukemia)	NULL
EXP044817	sc-585	Homo sapiens		EXP044653	1163	normal	Q09472	transverse colon	NULL
EXP044818	F1804	Homo sapiens		EXP039140	430	normal	Q9H5V7	HepG2 (hepatoblastoma)	NULL
EXP044819	ab109398	Homo sapiens		EXP040196	1184	normal	Q15910	GM23338	NULL
EXP044820	13/61725	Homo sapiens		EXP039034	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP044821	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044822	612155	Homo sapiens		EXP039216	514	normal	Q12906	K562 (myelogenous leukemia)	NULL
EXP044823	A302-079A	Homo sapiens		EXP044665	430	normal	Q01081	HepG2 (hepatoblastoma)	NULL
EXP044824	F1804	Homo sapiens		EXP039140	430	normal	Q14919	HepG2 (hepatoblastoma)	NULL
EXP044825	5246S,5246BF	Homo sapiens		EXP044642	289	normal	Q15910	SK-N-MC (Askin tumor)	NULL
EXP044826	sc-585	Homo sapiens		EXP044589	1169	normal	Q09472	sigmoid colon	NULL
EXP044827	09-868	Homo sapiens		EXP039132	38	normal	Q9UPP1	A549 (lung carcinoma)	NULL
EXP044828	sc-71910	Homo sapiens		EXP010799	113	normal	P29590	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044829	sc-994	Homo sapiens		EXP010799	113	normal	Q96ST3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044830	39533	Homo sapiens		EXP039034	514	normal	Q92769	K562 (myelogenous leukemia)	NULL
EXP044831	ab109398	Homo sapiens		EXP040203	665	normal	Q15910	SK-N-SH (neuroblastoma)	NULL
EXP044832	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039195	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044833	GTX100469	Homo sapiens		EXP039188	356	normal	Q06609	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044834	goat-anti-GFP-UC	Homo sapiens		EXP044594	514	normal	Q9BY41	K562 (myelogenous leukemia)	NULL
EXP044835	5246S	Homo sapiens		EXP039248	900	normal	Q15910	hepatocytes	NULL
EXP044836	RN081PW	Homo sapiens		EXP044613	430	normal	Q13242	HepG2 (hepatoblastoma)	NULL
EXP044837	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP044838	F1804	Homo sapiens		EXP039140	430	normal	O95201	HepG2 (hepatoblastoma)	NULL
EXP044839	sc-585	Homo sapiens		EXP044625	1129	normal	Q09472	suprapubic skin	NULL
EXP044840	ab109398	Homo sapiens		EXP040197	417	normal	Q15910	HCT-116 (colon carcinoma)	NULL
EXP044841	39639	Homo sapiens		EXP039024	927	normal	Q15910	PC9 (lung adenocarcinoma)	NULL
EXP044842	A300-285A	Homo sapiens		EXP039034	514	normal	Q6P1N0	K562 (myelogenous leukemia)	NULL
EXP044843	A300-882A	Homo sapiens		EXP010775	376	normal	Q9HC52	WA01 (H1, human embryonic stem cells)	NULL
EXP044844	sc-585	Homo sapiens		EXP044658	1179	normal	Q09472	tibial nerve	NULL
EXP044845	61222	Homo sapiens		EXP039086	514	normal	O94953	K562 (myelogenous leukemia)	NULL
EXP044846	A301-081A	Homo sapiens		EXP010781	430	normal	Q14839	HepG2 (hepatoblastoma)	NULL
EXP044847	ab290	Homo sapiens		EXP039092	421	normal	Q6ZNC4	HEK293 (embryonic kidney)	NULL
EXP044848	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 hour	EXP039040	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044849	sc-585	Homo sapiens		EXP044636	1129	normal	Q09472	suprapubic skin	NULL
EXP044850	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039277	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044851	A301-068A	Homo sapiens		EXP044619	514	normal	P49756	K562 (myelogenous leukemia)	NULL
EXP044852	A303-810A	Homo sapiens		EXP039216	514	normal	Q9HBM6	K562 (myelogenous leukemia)	NULL
EXP044853	sc-585	Homo sapiens		EXP044581	1150	normal	Q09472	ovary	NULL
EXP044854	A300-109A	Homo sapiens		EXP039242	356	normal	Q15291	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044855	201004	Homo sapiens		EXP044634	430	normal	P13010	HepG2 (hepatoblastoma)	NULL
EXP044856	A302-869A	Homo sapiens		EXP010775	376	normal	Q99496	WA01 (H1, human embryonic stem cells)	NULL
EXP044857	A301-459A	Homo sapiens		EXP039161	10	normal	Q6P4R8	HEK293T (embryonic kidney)	NULL
EXP044858	sc-585	Mus musculus		EXP010910	53	normal	B2RWS6	heart	NULL
EXP044859	sc-585	Mus musculus		EXP010789	117	normal	B2RWS6	Bruce4 (embryonic stem cells)	NULL
EXP044860	40967	Homo sapiens		EXP039034	514	normal	Q13547	K562 (myelogenous leukemia)	NULL
EXP044861	F1804	Homo sapiens		EXP039198	514	normal	P17036	K562 (myelogenous leukemia)	NULL
EXP044862	ARP40368_P050	Homo sapiens		EXP044630	514	normal	P14866	K562 (myelogenous leukemia)	NULL
EXP044863	39980	Homo sapiens		EXP039198	514	normal	P83916	K562 (myelogenous leukemia)	NULL
EXP044864	A301-460A	Homo sapiens		EXP039034	514	normal	Q6P4R8	K562 (myelogenous leukemia)	NULL
EXP044865	F1804	Homo sapiens		EXP039140	430	normal	P41161	HepG2 (hepatoblastoma)	NULL
EXP044866	eGFP	Homo sapiens		EXP044600	514	normal	Q9BY41	K562 (myelogenous leukemia)	NULL
EXP044867	A300-933A	Homo sapiens		EXP039132	38	normal	Q96KQ7	A549 (lung carcinoma)	NULL
EXP044868	A300-650A	Homo sapiens		EXP039034	514	normal	Q9UHI6	K562 (myelogenous leukemia)	NULL
EXP044869	A302-267A	Homo sapiens		EXP039074	113	normal	Q03111	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044870	TFIIIC-110 4286	Homo sapiens		EXP010597	514	normal	Q8WUA4	K562 (myelogenous leukemia)	NULL
EXP044871	sc-225	Homo sapiens		EXP010597	514	normal	Q00403	K562 (myelogenous leukemia)	NULL
EXP044872	C8741	Homo sapiens		EXP039046	113	normal	Q13363	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044873	NB100-61076	Homo sapiens		EXP010597	514	normal	Q15651	K562 (myelogenous leukemia)	NULL
EXP044874	4295	Homo sapiens		EXP010597	514	normal	Q9HAW0	K562 (myelogenous leukemia)	NULL
EXP044875	ab48192	Homo sapiens		EXP010597	514	normal	Q8N6T7	K562 (myelogenous leukemia)	NULL
EXP044876	128	Homo sapiens		EXP010597	514	normal	Q92994	K562 (myelogenous leukemia)	NULL
EXP044877	2663	Homo sapiens		EXP010597	514	normal	A6H8Y1	K562 (myelogenous leukemia)	NULL
EXP044878	sc-585	Homo sapiens		EXP044645	1179	normal	Q09472	tibial nerve	NULL
EXP044879	sc-585	Homo sapiens		EXP044626	1129	normal	Q09472	suprapubic skin	NULL
EXP044880	ZZZ3	Homo sapiens		EXP010027	423	normal	Q8IYH5	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044881	ZZZ3	Homo sapiens		EXP010122	356	normal	Q8IYH5	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044882	128	Homo sapiens		EXP010027	423	normal	Q92994	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044883	2663	Homo sapiens		EXP010027	423	normal	A6H8Y1	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044884	4295	Homo sapiens		EXP010027	423	normal	Q9HAW0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044885	TFIIIC-110 4286	Homo sapiens		EXP010027	423	normal	Q8WUA4	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044886	sc-12419	Homo sapiens		EXP010597	514	normal	O60583	K562 (myelogenous leukemia)	NULL
EXP044887	A301-672A	Homo sapiens		EXP039034	514	normal	Q6W2J9	K562 (myelogenous leukemia)	NULL
EXP044888	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039295	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044889	2676	Homo sapiens		EXP010122	356	normal	Q92830	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044890	SPT20 (3006)	Homo sapiens		EXP010122	356	normal	Q8NEM7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044891	sc-585	Homo sapiens		EXP044588	1140	normal	Q09472	subcutaneous adipose tissue	NULL
EXP044892	A300-650A	Homo sapiens		EXP039240	113	normal	Q9UHI6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044893	NB100-68209	Homo sapiens		EXP039036	430	normal	P51610	HepG2 (hepatoblastoma)	NULL
EXP044894	RN019P	Homo sapiens		EXP044612	430	normal	P61978	HepG2 (hepatoblastoma)	NULL
EXP044895	A303-607A	Homo sapiens		EXP039034	514	normal	Q15645	K562 (myelogenous leukemia)	NULL
EXP044896	ab290	Homo sapiens		EXP039092	421	normal	Q9BV97	HEK293 (embryonic kidney)	NULL
EXP044897	A300-712A	Homo sapiens		EXP039034	514	normal	Q13547	K562 (myelogenous leukemia)	NULL
EXP044898	ab992	Homo sapiens		EXP039108	1180	normal	O60216	neural cell	NULL
EXP044899	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 25 minute	EXP040199	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044900	A300-609A	Homo sapiens		EXP039034	514	normal	Q9NYF8	K562 (myelogenous leukemia)	NULL
EXP044901	A302-531A	Homo sapiens		EXP039077	514	normal	Q9BVI0	K562 (myelogenous leukemia)	NULL
EXP044902	A5016	Homo sapiens		EXP044669	430	normal	Q6UN15	HepG2 (hepatoblastoma)	NULL
EXP044903	ab992	Homo sapiens		EXP010769	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044904	ab9263	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039256	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP044905	C8741	Homo sapiens		EXP039232	10	normal	Q13363	HEK293T (embryonic kidney)	NULL
EXP044906	sc-585	Mus musculus		EXP044663	561	normal	B2RWS6	lung	NULL
EXP044907	A300-195A	Homo sapiens		EXP039034	514	normal	P33992	K562 (myelogenous leukemia)	NULL
EXP044908	A300-713A	Homo sapiens		EXP039034	514	normal	Q13547	K562 (myelogenous leukemia)	NULL
EXP044909	NB100-61057	Homo sapiens		EXP039167	423	normal	P35659	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044910	3737BF	Homo sapiens		EXP039242	356	normal	Q15022	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044911	A300-275A	Homo sapiens		EXP039034	514	normal	Q13263	K562 (myelogenous leukemia)	NULL
EXP044912	ab28179	Homo sapiens		EXP039046	113	normal	P35269	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044913	ab109398	Homo sapiens		EXP039107	221	normal	Q15910	DOHH2 (diffuse large B-cell lymphoma)	NULL
EXP044914	A300-411A	Homo sapiens		EXP039216	514	normal	Q14686	K562 (myelogenous leukemia)	NULL
EXP044915	ab290	Homo sapiens		EXP039092	421	normal	Q96BR9	HEK293 (embryonic kidney)	NULL
EXP044916	A301-459A	Homo sapiens		EXP039240	113	normal	Q6P4R8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044917	goat-anti-GFP-UC	Homo sapiens		EXP044627	514	normal	Q9UHI6	K562 (myelogenous leukemia)	NULL
EXP044918	A301-459A	Homo sapiens		EXP039034	514	normal	Q6P4R8	K562 (myelogenous leukemia)	NULL
EXP044919	ab68480	Homo sapiens		EXP044664	514	normal	Q9BUJ2	K562 (myelogenous leukemia)	NULL
EXP044920	ab290	Homo sapiens		EXP039092	421	normal	Q96DT7	HEK293 (embryonic kidney)	NULL
EXP044921	40968	Homo sapiens		EXP039216	514	normal	O15379	K562 (myelogenous leukemia)	NULL
EXP044922	sc-585	Homo sapiens		EXP044598	1169	normal	Q09472	sigmoid colon	NULL
EXP044923	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039027	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044924	A304-216A	Homo sapiens		EXP039216	514	normal	Q96JM3	K562 (myelogenous leukemia)	NULL
EXP044925	sc-585	Homo sapiens		EXP044591	1175	normal	Q09472	prostate gland	NULL
EXP044926	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 20 minute	EXP040219	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044927	sc-585	Homo sapiens		EXP044595	1158	normal	Q09472	vagina	NULL
EXP044928	ab10483	Homo sapiens		EXP044583	421	normal	Q13263	HEK293 (embryonic kidney)	NULL
EXP044929	39977	Homo sapiens		EXP010918	356	normal	P45973	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044930	A300-815A	Homo sapiens		EXP039034	514	normal	O15164	K562 (myelogenous leukemia)	NULL
EXP044931	A302-268A	Homo sapiens		EXP039034	514	normal	Q03111	K562 (myelogenous leukemia)	NULL
EXP044932	sc-585	Homo sapiens		EXP044651	440	normal	Q09472	HMEC (human mammary epithelial cells)	NULL
EXP044933	F1804	Homo sapiens		EXP039140	430	normal	O95251	HepG2 (hepatoblastoma)	NULL
EXP044934	ab10480	Homo sapiens		EXP039242	356	normal	Q13185	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044935	sc-25388	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039289	1145	normal	P37275	bipolar neuron	NULL
EXP044936	GTX106820	Homo sapiens		EXP039163	356	normal	Q13951	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044937	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP044938	ab68301	Homo sapiens		EXP039199	665	normal	O14647	SK-N-SH (neuroblastoma)	NULL
EXP044939	A300-371A	Homo sapiens		EXP039240	113	normal	Q8TAD8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044940	A300-000A	Homo sapiens		EXP039216	514	normal	P38398	K562 (myelogenous leukemia)	NULL
EXP044941	RN011P	Homo sapiens		EXP044656	430	normal	P26599	HepG2 (hepatoblastoma)	NULL
EXP044942	ab109398	Homo sapiens		EXP039248	900	normal	Q15910	hepatocytes	NULL
EXP044943	sc-585	Homo sapiens		EXP044670	440	normal	Q09472	HMEC (human mammary epithelial cells)	NULL
EXP044944	A300-489A	Homo sapiens		EXP010781	430	normal	Q9UBL3	HepG2 (hepatoblastoma)	NULL
EXP044945	2676	Mus musculus		EXP010613	1144	normal	Q9JHD2	CH12.LX (Mouse lymphoma)	NULL
EXP044946	NB100-60411	Mus musculus		EXP010613	1144	normal	P40201	CH12.LX (Mouse lymphoma)	NULL
EXP044947	NB600-1263	Mus musculus		EXP010613	1144	normal	Q60520	CH12.LX (Mouse lymphoma)	NULL
EXP044948	goat-anti-GFP-UC	Homo sapiens		EXP044633	514	normal	Q9BRQ0	K562 (myelogenous leukemia)	NULL
EXP044949	NB100-74650	Mus musculus		EXP010613	1144	normal	Q6NZF1	CH12.LX (Mouse lymphoma)	NULL
EXP044950	NB100-68209	Mus musculus		EXP010613	1144	normal	Q61191	CH12.LX (Mouse lymphoma)	NULL
EXP044951	ab65767	Mus musculus		EXP010613	1144	normal	Q6P1E1	CH12.LX (Mouse lymphoma)	NULL
EXP044952	NB100-74650	Mus musculus		EXP010793	230	normal	Q6NZF1	ES-E14 (E14, embryonic stem cells)	NULL
EXP044953	NB100-68209	Mus musculus		EXP010793	230	normal	Q61191	ES-E14 (E14, embryonic stem cells)	NULL
EXP044954	sc-585	Homo sapiens		EXP044637	1167	normal	Q09472	esophagus muscularis mucosa	NULL
EXP044955	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039169	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044956	ab68301	Mus musculus		EXP010613	1144	normal	E9PZM4	CH12.LX (Mouse lymphoma)	NULL
EXP044957	ab9263	Mus musculus		EXP010613	1144	normal	Q9CW03	CH12.LX (Mouse lymphoma)	NULL
EXP044958	sc-32912	Mus musculus		EXP010613	1144	normal	P19426	CH12.LX (Mouse lymphoma)	NULL
EXP044959	ab992	Mus musculus		EXP010613	1144	normal	Q61550	CH12.LX (Mouse lymphoma)	NULL
EXP044960	sc-584	Mus musculus		EXP010613	1144	normal	B2RWS6	CH12.LX (Mouse lymphoma)	NULL
EXP044961	sc-585	Homo sapiens		EXP044618	1156	normal	Q09472	gastroesophageal sphincter	NULL
EXP044962	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 5 minute	EXP040212	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP044963	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 2 hour	EXP039028	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP044964	ab10483	Homo sapiens		EXP010651	421	normal	Q13263	HEK293 (embryonic kidney)	NULL
EXP044965	A301-112A	Homo sapiens		EXP044619	514	normal	Q14151	K562 (myelogenous leukemia)	NULL
EXP044966	SUZ12	Homo sapiens		EXP010587	376	normal	Q15022	WA01 (H1, human embryonic stem cells)	NULL
EXP044967	612044	Homo sapiens		EXP010587	376	normal	P56545	WA01 (H1, human embryonic stem cells)	NULL
EXP044968	ab10483	Homo sapiens		EXP010823	514	normal	Q13263	K562 (myelogenous leukemia)	NULL
EXP044969	39548	Homo sapiens		EXP039022	514	normal	Q9UBB5	K562 (myelogenous leukemia)	NULL
EXP044970	200093	Homo sapiens		EXP044664	514	normal	Q8N163	K562 (myelogenous leukemia)	NULL
EXP044971	6964S	Homo sapiens		EXP039106	514	normal	P35226	K562 (myelogenous leukemia)	NULL
EXP044972	11231-1-AP	Homo sapiens		EXP010823	514	normal	Q15047	K562 (myelogenous leukemia)	NULL
EXP044973	3737S	Homo sapiens		EXP039161	10	normal	Q15022	HEK293T (embryonic kidney)	NULL
EXP044974	sc-9571	Homo sapiens		EXP044665	430	normal	P08621	HepG2 (hepatoblastoma)	NULL
EXP044975	NB600-1263	Mus musculus		EXP010644	1174	normal	Q60520	MEL cell line	NULL
EXP044976	NB100-68209	Mus musculus		EXP010644	1174	normal	Q61191	MEL cell line	NULL
EXP044977	ab65767	Mus musculus		EXP010644	1174	normal	Q6P1E1	MEL cell line	NULL
EXP044978	NB100-74650	Mus musculus		EXP010644	1174	normal	Q6NZF1	MEL cell line	NULL
EXP044979	2676	Mus musculus		EXP010644	1174	normal	Q9JHD2	MEL cell line	NULL
EXP044980	NB100-60411	Mus musculus		EXP010644	1174	normal	P40201	MEL cell line	NULL
EXP044981	sc-584	Mus musculus		EXP010644	1174	normal	B2RWS6	MEL cell line	NULL
EXP044982	ab9263	Mus musculus		EXP010644	1174	normal	Q9CW03	MEL cell line	NULL
EXP044983	sc-585	Mus musculus		EXP010644	1174	normal	B2RWS6	MEL cell line	NULL
EXP044984	A301-545A	Homo sapiens		EXP039034	514	normal	Q5VUA4	K562 (myelogenous leukemia)	NULL
EXP044985	ab68301	Mus musculus		EXP010644	1174	normal	E9PZM4	MEL cell line	NULL
EXP044986	ab992	Mus musculus	5 d with 2% Dimethyl sufloxide (DMSO) (Weissman)	EXP010644	1174	normal	Q61550	MEL cell line	NULL
EXP044987	sc-32912	Mus musculus		EXP010644	1174	normal	P19426	MEL cell line	NULL
EXP044988	goat-anti-GFP-UC	Homo sapiens		EXP044629	514	normal	Q15545	K562 (myelogenous leukemia)	NULL
EXP044989	ab992	Mus musculus		EXP010644	1174	normal	Q61550	MEL cell line	NULL
EXP044990	sc-17796	Homo sapiens		EXP010725	423	normal	P51532	HeLa S3 (cervical adenocarcinoma)	NULL
EXP044991	6964S	Homo sapiens		EXP039074	113	normal	P35226	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP044992	SUZ12	Homo sapiens		EXP010048	244	normal	Q15022	NT2-D1 (embryonic carcinoma)	NULL
EXP044993	11231-1-AP	Homo sapiens		EXP010823	514	normal	Q15047	K562 (myelogenous leukemia)	NULL
EXP044994	5246S,39639	Homo sapiens		EXP040214	887	normal	Q15910	neural progenitors	NULL
EXP044995	HPA003575	Homo sapiens		EXP039076	356	normal	Q8IYM9	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP044996	sc-585	Homo sapiens		EXP039108	1180	normal	Q09472	neural cell	NULL
EXP044997	sc-9140	Homo sapiens		EXP039114	430	normal	P12755	HepG2 (hepatoblastoma)	NULL
EXP044998	sc-585	Homo sapiens		EXP044646	1181	normal	Q09472	upper lobe of left lung	NULL
EXP044999	A300-291A	Homo sapiens		EXP039290	430	normal	Q14498	HepG2 (hepatoblastoma)	NULL
EXP045000	A302-344A	Homo sapiens		EXP039034	514	normal	P51825	K562 (myelogenous leukemia)	NULL
EXP045001	sc-585	Homo sapiens		EXP010745	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045002	sc-584	Homo sapiens		EXP010834	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045003	A301-218A	Homo sapiens		EXP010834	356	normal	O14646	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045004	SAB2100398	Homo sapiens		EXP039106	514	normal	Q03701	K562 (myelogenous leukemia)	NULL
EXP045005	ab24550	Homo sapiens		EXP010834	356	normal	Q9BZK7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045006	NB600-1263	Homo sapiens		EXP010834	356	normal	Q96ST3	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045007	ab9263	Homo sapiens		EXP010834	356	normal	Q9UQE7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045008	A300-000A	Homo sapiens		EXP010834	356	normal	P38398	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045009	ab68301	Homo sapiens		EXP010834	356	normal	O14647	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045010	ab992	Homo sapiens		EXP010834	356	normal	O60216	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045011	A300-291A	Homo sapiens		EXP044664	514	normal	Q14498	K562 (myelogenous leukemia)	NULL
EXP045012	ab4731	Homo sapiens		EXP010834	356	normal	Q96S55	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045013	ab992	Homo sapiens		EXP039275	879	normal	O60216	liver	NULL
EXP045014	NB600-1263	Homo sapiens		EXP010714	376	normal	Q96ST3	WA01 (H1, human embryonic stem cells)	NULL
EXP045015	ab28179	Homo sapiens		EXP010714	376	normal	P35269	WA01 (H1, human embryonic stem cells)	NULL
EXP045016	A303-555A	Homo sapiens		EXP039077	514	normal	Q9UI36	K562 (myelogenous leukemia)	NULL
EXP045017	A300-371A	Homo sapiens		EXP039034	514	normal	Q8TAD8	K562 (myelogenous leukemia)	NULL
EXP045018	11231-1-AP	Homo sapiens		EXP044583	421	normal	Q15047	HEK293 (embryonic kidney)	NULL
EXP045019	A300-489A	Homo sapiens		EXP010775	376	normal	Q9UBL3	WA01 (H1, human embryonic stem cells)	NULL
EXP045020	A303-148A	Homo sapiens		EXP039077	514	normal	Q9UHK0	K562 (myelogenous leukemia)	NULL
EXP045021	sc-553	Homo sapiens		EXP039095	879	normal	P19793	liver	NULL
EXP045022	ab992	Homo sapiens		EXP010255	430	normal	O60216	HepG2 (hepatoblastoma)	NULL
EXP045023	sc-13067	Homo sapiens	low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	EXP010368	430	normal	Q9UBK2	HepG2 (hepatoblastoma)	NULL
EXP045024	NB600-1263	Homo sapiens		EXP039118	38	normal	Q96ST3	A549 (lung carcinoma)	NULL
EXP045025	A300-000A	Homo sapiens		EXP010255	430	normal	P38398	HepG2 (hepatoblastoma)	NULL
EXP045026	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP045027	sc-584	Homo sapiens		EXP010255	430	normal	Q09472	HepG2 (hepatoblastoma)	NULL
EXP045028	ab9263	Homo sapiens		EXP010255	430	normal	Q9UQE7	HepG2 (hepatoblastoma)	NULL
EXP045029	ab68301	Homo sapiens		EXP010255	430	normal	O14647	HepG2 (hepatoblastoma)	NULL
EXP045030	ab992	Homo sapiens		EXP010066	489	normal	O60216	IMR90 (lung fibroblasts)	NULL
EXP045031	NB100-68209	Homo sapiens		EXP010530	514	normal	P51610	K562 (myelogenous leukemia)	NULL
EXP045032	NB100-74650	Homo sapiens		EXP010530	514	normal	O75152	K562 (myelogenous leukemia)	NULL
EXP045033	ab65767	Homo sapiens		EXP010530	514	normal	Q9ULJ6	K562 (myelogenous leukemia)	NULL
EXP045034	NB100-60411	Homo sapiens		EXP010066	489	normal	O14646	IMR90 (lung fibroblasts)	NULL
EXP045035	NB100-68209	Homo sapiens		EXP010054	423	normal	P51610	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045036	ab992	Homo sapiens		EXP010714	376	normal	O60216	WA01 (H1, human embryonic stem cells)	NULL
EXP045037	ab68301	Homo sapiens		EXP010054	423	normal	O14647	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045038	ab9263	Homo sapiens		EXP010054	423	normal	Q9UQE7	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045039	SPT20 (3006)	Homo sapiens		EXP010027	423	normal	Q8NEM7	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045040	2676	Homo sapiens		EXP010027	423	normal	Q92830	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045041	ab68301	Homo sapiens		EXP010714	376	normal	O14647	WA01 (H1, human embryonic stem cells)	NULL
EXP045042	HPA008472	Homo sapiens		EXP039188	356	normal	P12757	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045043	A301-218A	Homo sapiens		EXP010714	376	normal	O14646	WA01 (H1, human embryonic stem cells)	NULL
EXP045044	9313S	Homo sapiens		EXP039076	356	normal	P06400	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045045	A300-000A	Homo sapiens		EXP010714	376	normal	P38398	WA01 (H1, human embryonic stem cells)	NULL
EXP045046	F1804	Homo sapiens		EXP039140	430	normal	Q9H334	HepG2 (hepatoblastoma)	NULL
EXP045047	sc-16189	Homo sapiens		EXP010725	423	normal	Q12824	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045048	ab109398	Homo sapiens		EXP039110	687	normal	Q15910	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP045049	SAB2100398	Homo sapiens		EXP010255	430	normal	Q03701	HepG2 (hepatoblastoma)	NULL
EXP045050	sc-585	Homo sapiens		EXP044654	1167	normal	Q09472	esophagus muscularis mucosa	NULL
EXP045051	A303-596A	Homo sapiens		EXP039188	356	normal	Q92785	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045052	sc-584	Homo sapiens		EXP010054	423	normal	Q09472	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045053	ab28179	Homo sapiens		EXP010054	423	normal	P35269	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045054	ab109398	Homo sapiens		EXP039053	1095	normal	Q15910	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP045055	ab992	Homo sapiens		EXP010054	423	normal	O60216	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045056	A300-000A	Homo sapiens		EXP010054	423	normal	P38398	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045057	ab290	Homo sapiens		EXP039092	421	normal	Q96MN9	HEK293 (embryonic kidney)	NULL
EXP045058	11/61721	Homo sapiens		EXP039034	514	normal	P33992	K562 (myelogenous leukemia)	NULL
EXP045059	ab109398	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039252	1145	normal	Q15910	bipolar neuron	NULL
EXP045060	F1804	Homo sapiens		EXP039140	430	normal	Q9H0E3	HepG2 (hepatoblastoma)	NULL
EXP045061	sc-585	Homo sapiens		EXP039167	423	normal	Q09472	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045062	ab9263	Homo sapiens		EXP010530	514	normal	Q9UQE7	K562 (myelogenous leukemia)	NULL
EXP045063	ab24550	Homo sapiens		EXP010530	514	normal	Q9BZK7	K562 (myelogenous leukemia)	NULL
EXP045064	NB600-270	Homo sapiens		EXP010530	514	normal	Q9BZK7	K562 (myelogenous leukemia)	NULL
EXP045065	sc-585	Homo sapiens		EXP010530	514	normal	Q09472	K562 (myelogenous leukemia)	NULL
EXP045066	sc-16189	Homo sapiens		EXP010630	514	normal	Q12824	K562 (myelogenous leukemia)	NULL
EXP045067	sc-17796	Homo sapiens		EXP010630	514	normal	P51532	K562 (myelogenous leukemia)	NULL
EXP045068	ab992	Homo sapiens		EXP010911	665	normal	O60216	SK-N-SH (neuroblastoma)	NULL
EXP045069	sc-584	Homo sapiens		EXP010911	665	normal	Q09472	SK-N-SH (neuroblastoma)	NULL
EXP045070	ab9263	Homo sapiens		EXP010911	665	normal	Q9UQE7	SK-N-SH (neuroblastoma)	NULL
EXP045071	sc-48343	Homo sapiens		EXP010530	514	normal	Q09472	K562 (myelogenous leukemia)	NULL
EXP045072	ab68301	Homo sapiens		EXP010530	514	normal	O14647	K562 (myelogenous leukemia)	NULL
EXP045073	ab28179	Homo sapiens		EXP010530	514	normal	P35269	K562 (myelogenous leukemia)	NULL
EXP045074	F1804	Homo sapiens		EXP039140	430	normal	P24278	HepG2 (hepatoblastoma)	NULL
EXP045075	sc-585	Mus musculus		EXP044666	5	normal	B2RWS6	liver	NULL
EXP045076	HPA028794	Homo sapiens		EXP039020	430	normal	Q8N3X6	HepG2 (hepatoblastoma)	NULL
EXP045077	ab109398	Homo sapiens		EXP044640	1419	normal	Q15910	GM23248	NULL
EXP045078	3737S	Homo sapiens		EXP039074	113	normal	Q15022	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045079	F1804	Homo sapiens		EXP039140	430	normal	Q8N883	HepG2 (hepatoblastoma)	NULL
EXP045080	A303-603A	Homo sapiens		EXP039077	514	normal	Q96BD5	K562 (myelogenous leukemia)	NULL
EXP045081	3378S	Homo sapiens		EXP039036	430	normal	Q92831	HepG2 (hepatoblastoma)	NULL
EXP045082	A303-170A	Homo sapiens		EXP039161	10	normal	P51858	HEK293T (embryonic kidney)	NULL
EXP045083	NB100-68209	Homo sapiens		EXP039046	113	normal	P51610	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045084	JH39.2.2F10	Homo sapiens		EXP039159	430	normal	Q14202	HepG2 (hepatoblastoma)	NULL
EXP045085	RN093PW	Homo sapiens		EXP044668	430	normal	O43172	HepG2 (hepatoblastoma)	NULL
EXP045086	sc-13145	Homo sapiens		EXP039036	430	normal	O75182	HepG2 (hepatoblastoma)	NULL
EXP045087	A304-217A	Homo sapiens		EXP039034	514	normal	Q96JM3	K562 (myelogenous leukemia)	NULL
EXP045088	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039062	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045089	HPA017013	Homo sapiens		EXP039074	113	normal	O43670	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045090	A300-813A	Homo sapiens		EXP039034	514	normal	P51532	K562 (myelogenous leukemia)	NULL
EXP045091	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039217	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045092	5694S	Homo sapiens		EXP039106	514	normal	Q99496	K562 (myelogenous leukemia)	NULL
EXP045093	A300-608A	Homo sapiens		EXP039188	356	normal	Q9NYF8	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045094	A303-877A	Homo sapiens		EXP039034	514	normal	P51532	K562 (myelogenous leukemia)	NULL
EXP045095	6964S	Homo sapiens		EXP039188	356	normal	P35226	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045096	5694S	Homo sapiens		EXP039114	430	normal	Q99496	HepG2 (hepatoblastoma)	NULL
EXP045097	goat-anti-GFP-UC	Homo sapiens		EXP044624	514	normal	Q6NZI2	K562 (myelogenous leukemia)	NULL
EXP045098	sc-585	Homo sapiens		EXP044605	1158	normal	Q09472	vagina	NULL
EXP045099	201004	Homo sapiens		EXP044648	514	normal	P13010	K562 (myelogenous leukemia)	NULL
EXP045100	5246S,39639	Homo sapiens		EXP040204	288	normal	Q15910	A673 (Ewing sarcoma)	NULL
EXP045101	A303-665A	Homo sapiens		EXP044665	430	normal	P26368	HepG2 (hepatoblastoma)	NULL
EXP045102	A301-940A	Homo sapiens		EXP039020	430	normal	O43660	HepG2 (hepatoblastoma)	NULL
EXP045103	RN046PW	Homo sapiens		EXP044656	430	normal	O60506	HepG2 (hepatoblastoma)	NULL
EXP045104	A303-665A	Homo sapiens		EXP044664	514	normal	P26368	K562 (myelogenous leukemia)	NULL
EXP045105	HPA008472	Homo sapiens		EXP039034	514	normal	P12757	K562 (myelogenous leukemia)	NULL
EXP045106	A300-253A	Homo sapiens		EXP039216	514	normal	Q7Z589	K562 (myelogenous leukemia)	NULL
EXP045107	RN024P	Homo sapiens		EXP044665	430	normal	Q15365	HepG2 (hepatoblastoma)	NULL
EXP045108	A5016	Homo sapiens		EXP044616	514	normal	Q6UN15	K562 (myelogenous leukemia)	NULL
EXP045109	T1705	Homo sapiens		EXP039034	514	normal	Q13148	K562 (myelogenous leukemia)	NULL
EXP045110	61203	Homo sapiens		EXP044593	356	normal	O75530	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045111	A301-081A	Homo sapiens		EXP039242	356	normal	Q14839	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045112	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045113	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP045114	T1705	Homo sapiens		EXP039074	113	normal	Q13148	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045115	GTX114210	Homo sapiens		EXP039049	514	normal	Q13148	K562 (myelogenous leukemia)	NULL
EXP045116	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045117	F1804	Homo sapiens		EXP039140	430	normal	Q06330	HepG2 (hepatoblastoma)	NULL
EXP045118	RN011P	Homo sapiens		EXP044590	514	normal	P26599	K562 (myelogenous leukemia)	NULL
EXP045119	F1804	Homo sapiens		EXP039140	430	normal	Q9Y4C1	HepG2 (hepatoblastoma)	NULL
EXP045120	ab992	Homo sapiens		EXP010597	514	normal	O60216	K562 (myelogenous leukemia)	NULL
EXP045121	ab145	Homo sapiens		EXP010597	514	normal	Q13426	K562 (myelogenous leukemia)	NULL
EXP045122	A302-079A	Homo sapiens		EXP044664	514	normal	Q01081	K562 (myelogenous leukemia)	NULL
EXP045123	goat-anti-GFP-UC	Homo sapiens		EXP044641	514	normal	O95997	K562 (myelogenous leukemia)	NULL
EXP045124	A301-477A	Homo sapiens		EXP039216	514	normal	O94953	K562 (myelogenous leukemia)	NULL
EXP045125	RN079PW	Homo sapiens		EXP044644	514	normal	Q16629	K562 (myelogenous leukemia)	NULL
EXP045126	F1804	Homo sapiens		EXP039198	514	normal	Q15072	K562 (myelogenous leukemia)	NULL
EXP045127	sc-585	Homo sapiens		EXP044611	1169	normal	Q09472	sigmoid colon	NULL
EXP045128	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 8 hour	EXP039196	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045129	C8741	Homo sapiens		EXP039034	514	normal	Q13363	K562 (myelogenous leukemia)	NULL
EXP045130	A300-027A	Homo sapiens		EXP039216	514	normal	P61201	K562 (myelogenous leukemia)	NULL
EXP045131	5246S,5246BF	Homo sapiens		EXP040197	417	normal	Q15910	HCT-116 (colon carcinoma)	NULL
EXP045132	A301-748A	Homo sapiens		EXP039034	514	normal	Q9NR48	K562 (myelogenous leukemia)	NULL
EXP045133	5246S,39639	Homo sapiens		EXP040213	685	normal	Q15910	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP045134	ab992	Homo sapiens		EXP039274	879	normal	O60216	liver	NULL
EXP045135	A303-595A	Homo sapiens		EXP039046	113	normal	Q92785	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045136	A300-864A	Homo sapiens		EXP044590	514	normal	O43251	K562 (myelogenous leukemia)	NULL
EXP045137	sc-585	Homo sapiens		EXP044602	1154	normal	Q09472	omental fat pad	NULL
EXP045138	sc-13145	Homo sapiens		EXP039216	514	normal	O75182	K562 (myelogenous leukemia)	NULL
EXP045139	A301-419A	Homo sapiens		EXP039216	514	normal	Q96NB3	K562 (myelogenous leukemia)	NULL
EXP045140	RN024P	Homo sapiens		EXP044604	514	normal	Q15365	K562 (myelogenous leukemia)	NULL
EXP045141	NRSF	Homo sapiens		EXP039134	1184	normal	Q13127	GM23338	NULL
EXP045142	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 4 hour	EXP039307	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP045143	A300-956A	Homo sapiens		EXP039034	514	normal	Q9Y2W1	K562 (myelogenous leukemia)	NULL
EXP045144	sc-585	Homo sapiens		EXP044622	1163	normal	Q09472	transverse colon	NULL
EXP045145	sc-585	Mus musculus		EXP044601	810	normal	B2RWS6	stomach	NULL
EXP045146	9313S	Homo sapiens		EXP039077	514	normal	P06400	K562 (myelogenous leukemia)	NULL
EXP045147	F1804	Homo sapiens		EXP039140	430	normal	P50548	HepG2 (hepatoblastoma)	NULL
EXP045148	sc-17796	Homo sapiens	0.5 Î¼g/mL doxycycline hyclate (CHEBI:34730) for 4 day	EXP039209	1145	normal	P51532	bipolar neuron	NULL
EXP045149	ab28179	Homo sapiens		EXP039036	430	normal	P35269	HepG2 (hepatoblastoma)	NULL
EXP045150	ab109398	Homo sapiens		EXP040217	725	normal	Q15910	PC3(bone mets prostate adenocarcinoma)	NULL
EXP045151	sc-585	Homo sapiens		EXP044617	1154	normal	Q09472	omental fat pad	NULL
EXP045152	3737S	Homo sapiens		EXP039036	430	normal	Q15022	HepG2 (hepatoblastoma)	NULL
EXP045153	A303-923A	Homo sapiens		EXP044619	514	normal	Q9NW64	K562 (myelogenous leukemia)	NULL
EXP045154	GTX100469	Homo sapiens		EXP039034	514	normal	Q06609	K562 (myelogenous leukemia)	NULL
EXP045155	NB600-1263	Homo sapiens		EXP039046	113	normal	Q96ST3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045156	A300-215A	Homo sapiens		EXP010775	376	normal	O60341	WA01 (H1, human embryonic stem cells)	NULL
EXP045157	A302-271A	Homo sapiens		EXP039034	514	normal	Q13772	K562 (myelogenous leukemia)	NULL
EXP045158	HPA003575	Homo sapiens		EXP039240	113	normal	Q8IYM9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045159	T5327	Homo sapiens		EXP039167	423	normal	P26651	HeLa S3 (cervical adenocarcinoma)	NULL
EXP045160	A300-933A	Homo sapiens		EXP039034	514	normal	Q96KQ7	K562 (myelogenous leukemia)	NULL
EXP045161	T1705	Homo sapiens		EXP039076	356	normal	Q13148	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045162	A303-223A	Homo sapiens		EXP044590	514	normal	Q13148	K562 (myelogenous leukemia)	NULL
EXP045163	ab68480	Homo sapiens		EXP044665	430	normal	Q9BUJ2	HepG2 (hepatoblastoma)	NULL
EXP045164	A302-293A	Homo sapiens		EXP044619	514	normal	P42696	K562 (myelogenous leukemia)	NULL
EXP045165	sc-585	Homo sapiens		EXP044615	1154	normal	Q09472	omental fat pad	NULL
EXP045166	A300-541A	Homo sapiens		EXP039216	514	normal	Q96L91	K562 (myelogenous leukemia)	NULL
EXP045167	RN069PW	Homo sapiens		EXP044644	514	normal	Q96PK6	K562 (myelogenous leukemia)	NULL
EXP045168	A301-418A	Homo sapiens		EXP039216	514	normal	Q96NB3	K562 (myelogenous leukemia)	NULL
EXP045169	A303-169A	Homo sapiens		EXP039034	514	normal	P51858	K562 (myelogenous leukemia)	NULL
EXP045170	HPA003575	Homo sapiens		EXP039076	356	normal	Q8IYM9	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045171	39548	Homo sapiens		EXP039151	113	normal	Q9UBB5	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045172	sc-585	Homo sapiens		EXP044635	1154	normal	Q09472	omental fat pad	NULL
EXP045173	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 7 hour	EXP039054	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045174	ab992	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 6 hour	EXP039236	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP045175	A300-216A	Homo sapiens		EXP039216	514	normal	O60341	K562 (myelogenous leukemia)	NULL
EXP045176	A300-215A	Homo sapiens		EXP039216	514	normal	O60341	K562 (myelogenous leukemia)	NULL
EXP045177	ab68301	Homo sapiens		EXP039081	38	normal	O14647	A549 (lung carcinoma)	NULL
EXP045178	A303-170A	Homo sapiens		EXP039076	356	normal	P51858	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045179	ab109398	Homo sapiens		EXP039172	618	normal	Q15910	MM1.S (plasma cell myeloma)	NULL
EXP045180	goat-anti-GFP-UC	Homo sapiens		EXP044603	514	normal	P52657	K562 (myelogenous leukemia)	NULL
EXP045181	sc-585	Homo sapiens		EXP044632	1149	normal	Q09472	testis	NULL
EXP045182	A300-294A	Homo sapiens		EXP044590	514	normal	P35637	K562 (myelogenous leukemia)	NULL
EXP045183	sc-585	Homo sapiens	1 h with 100 nM Dexamethasone (Myers)	EXP039058	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045184	39980	Homo sapiens		EXP039159	430	normal	P83916	HepG2 (hepatoblastoma)	NULL
EXP045185	sc-585	Homo sapiens		EXP044643	1140	normal	Q09472	subcutaneous adipose tissue	NULL
EXP045186	H00027161-M01	Homo sapiens		EXP044634	430	normal	Q9UKV8	HepG2 (hepatoblastoma)	NULL
EXP045187	200093	Homo sapiens		EXP044599	430	normal	Q8N163	HepG2 (hepatoblastoma)	NULL
EXP045188	ab134916	Homo sapiens		EXP044630	514	normal	Q92804	K562 (myelogenous leukemia)	NULL
EXP045189	F1804	Homo sapiens		EXP039140	430	normal	Q9BYH8	HepG2 (hepatoblastoma)	NULL
EXP045190	ab109398	Homo sapiens		EXP039113	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP045191	F1804	Homo sapiens		EXP039140	430	normal	P35869	HepG2 (hepatoblastoma)	NULL
EXP045192	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 15 minute	EXP040194	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045193	goat-anti-GFP-UC	Homo sapiens		EXP044609	514	normal	Q9BTC0	K562 (myelogenous leukemia)	NULL
EXP045194	A300-215A	Homo sapiens		EXP039242	356	normal	O60341	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045195	GTX109642	Homo sapiens		EXP039020	430	normal	Q92769	HepG2 (hepatoblastoma)	NULL
EXP045196	ab134916	Homo sapiens		EXP044631	430	normal	Q92804	HepG2 (hepatoblastoma)	NULL
EXP045197	A301-341A	Homo sapiens		EXP010781	430	normal	Q9UBN7	HepG2 (hepatoblastoma)	NULL
EXP045198	F1804	Homo sapiens		EXP039140	430	normal	Q06547	HepG2 (hepatoblastoma)	NULL
EXP045199	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039083	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045200	ARP58479_P050	Homo sapiens		EXP044634	430	normal	P31943	HepG2 (hepatoblastoma)	NULL
EXP045201	ARP58479_P050	Homo sapiens		EXP044664	514	normal	P31943	K562 (myelogenous leukemia)	NULL
EXP045202	GTX114455	Homo sapiens		EXP044657	514	normal	P35269	K562 (myelogenous leukemia)	NULL
EXP045203	39977	Homo sapiens		EXP039049	514	normal	P45973	K562 (myelogenous leukemia)	NULL
EXP045204	F1804	Homo sapiens		EXP039140	430	normal	Q9Y2G1	HepG2 (hepatoblastoma)	NULL
EXP045205	A300-705A	Homo sapiens		EXP039034	514	normal	Q92769	K562 (myelogenous leukemia)	NULL
EXP045206	3364	Homo sapiens		EXP044657	514	normal	Q9NRR4	K562 (myelogenous leukemia)	NULL
EXP045207	A301-985A50	Homo sapiens		EXP010781	430	normal	O60885	HepG2 (hepatoblastoma)	NULL
EXP045208	A302-584A	Homo sapiens		EXP039034	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP045209	5053	Homo sapiens		EXP044634	430	normal	Q9UL18	HepG2 (hepatoblastoma)	NULL
EXP045210	sc-585	Mus musculus		EXP044638	5	normal	B2RWS6	liver	NULL
EXP045211	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 30 minute	EXP039104	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045212	A300-816A	Homo sapiens		EXP039034	514	normal	O15164	K562 (myelogenous leukemia)	NULL
EXP045213	HPA019653	Homo sapiens		EXP039034	514	normal	Q06547	K562 (myelogenous leukemia)	NULL
EXP045214	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039233	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045215	ab109398	Homo sapiens		EXP040201	816	normal	Q15910	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP045216	sc-585	Homo sapiens		EXP044639	1181	normal	Q09472	upper lobe of left lung	NULL
EXP045217	A301-985A50	Homo sapiens		EXP010582	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP045218	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 10 hour	EXP039098	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045219	sc-585	Homo sapiens		EXP044586	1181	normal	Q09472	upper lobe of left lung	NULL
EXP045220	HPA017013	Homo sapiens		EXP039061	430	normal	O43670	HepG2 (hepatoblastoma)	NULL
EXP045221	A301-081A	Homo sapiens		EXP039132	38	normal	Q14839	A549 (lung carcinoma)	NULL
EXP045222	GTX114210	Homo sapiens		EXP039105	356	normal	Q13148	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045223	sc-585	Homo sapiens		EXP044647	1169	normal	Q09472	sigmoid colon	NULL
EXP045224	A302-267A	Homo sapiens		EXP039034	514	normal	Q03111	K562 (myelogenous leukemia)	NULL
EXP045225	F1804	Homo sapiens		EXP039140	430	normal	O60341	HepG2 (hepatoblastoma)	NULL
EXP045226	ab290	Homo sapiens		EXP039092	421	normal	Q9H4Q4	HEK293 (embryonic kidney)	NULL
EXP045227	A302-870A	Homo sapiens		EXP039034	514	normal	Q99496	K562 (myelogenous leukemia)	NULL
EXP045228	RN080PW	Homo sapiens		EXP044644	514	normal	P84103	K562 (myelogenous leukemia)	NULL
EXP045229	sc-585	Homo sapiens		EXP044623	1156	normal	Q09472	gastroesophageal sphincter	NULL
EXP045230	sc-585	Homo sapiens		EXP044620	1156	normal	Q09472	gastroesophageal sphincter	NULL
EXP045231	NB100-68209	Homo sapiens		EXP039220	356	normal	P51610	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045232	F1804	Homo sapiens		EXP039140	430	normal	O15550	HepG2 (hepatoblastoma)	NULL
EXP045233	39664	Homo sapiens		EXP039086	514	normal	Q99496	K562 (myelogenous leukemia)	NULL
EXP045234	GTX103229	Homo sapiens		EXP039076	356	normal	O60934	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045235	A303-593A	Homo sapiens		EXP039077	514	normal	O43439	K562 (myelogenous leukemia)	NULL
EXP045236	F1804	Homo sapiens		EXP044584	430	normal	O60216	HepG2 (hepatoblastoma)	NULL
EXP045237	A300-191A	Homo sapiens		EXP039034	514	normal	P49736	K562 (myelogenous leukemia)	NULL
EXP045238	HPA007128	Homo sapiens		EXP039020	430	normal	Q6P4R8	HepG2 (hepatoblastoma)	NULL
EXP045239	ab24550	Homo sapiens		EXP039036	430	normal	Q9BZK7	HepG2 (hepatoblastoma)	NULL
EXP045240	T1705	Homo sapiens		EXP039232	10	normal	Q13148	HEK293T (embryonic kidney)	NULL
EXP045241	HPA003575	Homo sapiens		EXP039020	430	normal	Q8IYM9	HepG2 (hepatoblastoma)	NULL
EXP045242	goat-anti-GFP-UC	Homo sapiens		EXP044587	514	normal	P29084	K562 (myelogenous leukemia)	NULL
EXP045243	A302-730A	Homo sapiens		EXP039034	514	normal	Q9BRQ0	K562 (myelogenous leukemia)	NULL
EXP045244	sc-585	Homo sapiens		EXP044660	1157	normal	Q09472	stomach	NULL
EXP045245	sc-585	Homo sapiens		EXP044621	1157	normal	Q09472	stomach	NULL
EXP045246	A300-489A	Homo sapiens		EXP039242	356	normal	Q9UBL3	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045247	sc-585	Homo sapiens		EXP044614	1167	normal	Q09472	esophagus muscularis mucosa	NULL
EXP045248	A301-546A	Homo sapiens		EXP039216	514	normal	Q5VUA4	K562 (myelogenous leukemia)	NULL
EXP045249	ab9263	Homo sapiens		EXP039044	489	normal	Q9UQE7	IMR90 (lung fibroblasts)	NULL
EXP045250	ab68301	Mus musculus		EXP010793	230	normal	E9PZM4	ES-E14 (E14, embryonic stem cells)	NULL
EXP045251	sc-585	Homo sapiens		EXP044652	1129	normal	Q09472	suprapubic skin	NULL
EXP045252	sc-585	Homo sapiens		EXP044585	1150	normal	Q09472	ovary	NULL
EXP045253	A302-585A	Homo sapiens		EXP039034	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP045254	4783	Homo sapiens		EXP044630	514	normal	Q8WVV9	K562 (myelogenous leukemia)	NULL
EXP045255	ab65767	Homo sapiens		EXP039106	514	normal	Q9ULJ6	K562 (myelogenous leukemia)	NULL
EXP045256	ab290	Homo sapiens		EXP039092	421	normal	Q8N7E2	HEK293 (embryonic kidney)	NULL
EXP045257	goat-anti-GFP-UC	Homo sapiens		EXP044667	514	normal	Q9H8N7	K562 (myelogenous leukemia)	NULL
EXP045258	A302-498A	Homo sapiens		EXP044619	514	normal	Q96I25	K562 (myelogenous leukemia)	NULL
EXP045259	sc-585	Homo sapiens		EXP044610	1140	normal	Q09472	subcutaneous adipose tissue	NULL
EXP045260	HPA000815	Homo sapiens		EXP039034	514	normal	Q969R5	K562 (myelogenous leukemia)	NULL
EXP045261	A301-736A	Homo sapiens		EXP039034	514	normal	Q9NRY4	K562 (myelogenous leukemia)	NULL
EXP045262	A300-215A	Homo sapiens		EXP010781	430	normal	O60341	HepG2 (hepatoblastoma)	NULL
EXP045263	RN081PW	Homo sapiens		EXP044644	514	normal	Q13242	K562 (myelogenous leukemia)	NULL
EXP045264	sc-585	Homo sapiens		EXP044655	440	normal	Q09472	HMEC (human mammary epithelial cells)	NULL
EXP045265	F1804	Homo sapiens		EXP039140	430	normal	Q9UID6	HepG2 (hepatoblastoma)	NULL
EXP045266	61731	Homo sapiens		EXP039216	514	normal	O43542	K562 (myelogenous leukemia)	NULL
EXP045267	A303-170A	Homo sapiens		EXP039074	113	normal	P51858	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045268	A300-882A	Homo sapiens		EXP039132	38	normal	Q9HC52	A549 (lung carcinoma)	NULL
EXP045269	HPA004734	Homo sapiens		EXP039188	356	normal	Q02080	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045270	A300-821A	Homo sapiens		EXP044619	514	normal	Q96T37	K562 (myelogenous leukemia)	NULL
EXP045271	A300-933A	Homo sapiens		EXP010781	430	normal	Q96KQ7	HepG2 (hepatoblastoma)	NULL
EXP045272	A303-170A	Homo sapiens		EXP039034	514	normal	P51858	K562 (myelogenous leukemia)	NULL
EXP045273	39875	Homo sapiens		EXP010863	356	normal	Q15910	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045274	39875	Homo sapiens		EXP010845	440	normal	Q15910	HMEC (human mammary epithelial cells)	NULL
EXP054049	RBBP5 (Bethyl Laboratories, A300-109A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q15291	K562 (myelogenous leukemia)	NULL
EXP054045	SAP30 (Active Motif, 39731)	Homo sapiens	Treatment: None;	NULL	514	normal	O75446	K562 (myelogenous leukemia)	NULL
EXP054047	HDAC2 (Bethyl Laboratories, A300-705A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q92769	K562 (myelogenous leukemia)	NULL
EXP054050	PHF8 (Bethyl Laboratories, A301-772A)	Homo sapiens	Treatment: None;	NULL	514	normal	Q9UPP1	K562 (myelogenous leukemia)	NULL
EXP054044	CHD1 (Bethyl Laboratories, A301-218A)	Homo sapiens	Treatment: None;	NULL	376	normal	O14646	WA01 (H1, human embryonic stem cells)	NULL
EXP045280	39875	Homo sapiens		EXP010005	670	normal	Q15910	fibroblast of dermis	NULL
EXP045281	39875	Homo sapiens		EXP010792	215	normal	Q15910	keratinocytes	NULL
EXP045282	39875	Homo sapiens		EXP010367	450	normal	Q15910	skeletal muscles and myoblasts	NULL
EXP045283	39875	Homo sapiens		EXP010781	430	normal	Q15910	HepG2 (hepatoblastoma)	NULL
EXP045284	39875	Homo sapiens		EXP010103	72	normal	Q15910	astrocytes	NULL
EXP045285	ab109398	Homo sapiens		EXP040214	887	normal	Q15910	neural progenitors	NULL
EXP045286	sc-585	Homo sapiens		EXP044649	440	normal	Q09472	HMEC (human mammary epithelial cells)	NULL
EXP045287	39875	Homo sapiens		EXP010582	514	normal	Q15910	K562 (myelogenous leukemia)	NULL
EXP054048	HDAC1 (Santa Cruz Biotechnology, SC-6298)	Homo sapiens	Treatment: None;	NULL	514	normal	Q13547	K562 (myelogenous leukemia)	NULL
EXP045289	sc-585	Homo sapiens		EXP044596	1157	normal	Q09472	stomach	NULL
EXP054086	RBBP5 (Bethyl Laboratories, A300-109A)	Homo sapiens	Treatment: None;	NULL	376	normal	Q15291	WA01 (H1, human embryonic stem cells)	NULL
EXP054082	CHD1 (Bethyl Laboratories, A301-218A)	Homo sapiens	Treatment: None;	NULL	514	normal	O14646	K562 (myelogenous leukemia)	NULL
EXP045292	T5327	Homo sapiens		EXP039106	514	normal	P26651	K562 (myelogenous leukemia)	NULL
EXP045293	sc-585	Homo sapiens		EXP044661	1167	normal	Q09472	esophagus muscularis mucosa	NULL
EXP045294	5246S	Homo sapiens		EXP040196	1184	normal	Q15910	GM23338	NULL
EXP045295	ab174657	Homo sapiens		EXP039188	356	normal	Q969S3	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP045296	A302-524A	Homo sapiens		EXP039132	38	normal	Q14781	A549 (lung carcinoma)	NULL
EXP045297	ab9263	Homo sapiens		EXP039108	1180	normal	Q9UQE7	neural cell	NULL
EXP045298	NB100-74650	Homo sapiens		EXP039118	38	normal	O75152	A549 (lung carcinoma)	NULL
EXP045299	F1804	Homo sapiens		EXP044582	113	normal	O60216	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045300	A300-417A	Homo sapiens		EXP039216	514	normal	Q01844	K562 (myelogenous leukemia)	NULL
EXP045301	sc-585	Homo sapiens		EXP040210	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045302	sc-585	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 3 hour	EXP039136	38	normal	Q09472	A549 (lung carcinoma)	NULL
EXP045303	GTX103229	Homo sapiens		EXP039034	514	normal	O60934	K562 (myelogenous leukemia)	NULL
EXP045304	ab992	Homo sapiens		EXP039112	38	normal	O60216	A549 (lung carcinoma)	NULL
EXP045305	ab70892	Homo sapiens		EXP010781	430	normal	P29375	HepG2 (hepatoblastoma)	NULL
EXP045306	T5327	Homo sapiens		EXP039118	38	normal	P26651	A549 (lung carcinoma)	NULL
EXP045307	5694BF	Homo sapiens		EXP039132	38	normal	Q99496	A549 (lung carcinoma)	NULL
EXP045308	NB600-1263	Homo sapiens		EXP039106	514	normal	Q96ST3	K562 (myelogenous leukemia)	NULL
EXP045309	sc-17824	Homo sapiens		EXP039302	879	normal	P08047	liver	NULL
EXP045310	goat-anti-GFP-UC	Homo sapiens		EXP044662	514	normal	Q13418	K562 (myelogenous leukemia)	NULL
EXP045311	#200580	Homo sapiens		EXP044657	514	normal	Q15424	K562 (myelogenous leukemia)	NULL
EXP045312	A302-756A	Homo sapiens		EXP039077	514	normal	P35269	K562 (myelogenous leukemia)	NULL
EXP045313	RN093PW	Homo sapiens		EXP044604	514	normal	O43172	K562 (myelogenous leukemia)	NULL
EXP045314	ab9263	Homo sapiens	100nM dexamethasone (CHEBI:41879) for 12 hour	EXP039269	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045315	09-868	Homo sapiens		EXP010781	430	normal	Q9UPP1	HepG2 (hepatoblastoma)	NULL
EXP045316	GTX100469	Homo sapiens		EXP039074	113	normal	Q06609	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045317	sc-110	Homo sapiens		EXP039275	879	normal	P18146	liver	NULL
EXP045318	sc-585	Homo sapiens		EXP044659	1140	normal	Q09472	subcutaneous adipose tissue	NULL
EXP045319	4783	Homo sapiens		EXP044634	430	normal	Q8WVV9	HepG2 (hepatoblastoma)	NULL
EXP045320	A302-345A	Homo sapiens		EXP039034	514	normal	P51825	K562 (myelogenous leukemia)	NULL
EXP045321	ab9263	Homo sapiens		EXP039112	38	normal	Q9UQE7	A549 (lung carcinoma)	NULL
EXP045322	NB100-60411	Homo sapiens		EXP039046	113	normal	O14646	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP045323		Drosophila melanogaster		NULL	1426	chip_control	NULL	whole organism (developmental stage: E0-4)	NULL
EXP045324		Drosophila melanogaster		NULL	1423	chip_control	NULL	whole organism (developmental stage: E16-20)	NULL
EXP045325		Drosophila melanogaster		NULL	1425	chip_control	NULL	whole organism (developmental stage: E20-24)	NULL
EXP045326		Drosophila melanogaster		NULL	1421	chip_control	NULL	whole organism (developmental stage: E4-8)	NULL
EXP045327		Drosophila melanogaster	Female	NULL	1409	chip_control	NULL	multi-cellular organism (development stage: adult)	NULL
EXP045328		Drosophila melanogaster	Male	NULL	1409	chip_control	NULL	multi-cellular organism (development stage: adult)	NULL
EXP045329		Drosophila melanogaster		NULL	1422	chip_control	NULL	whole organism (developmental stage: E12-16)	NULL
EXP045330		Drosophila melanogaster		NULL	1421	chip_control	NULL	whole organism (developmental stage: E4-8)	NULL
EXP045331		Drosophila melanogaster		NULL	1427	chip_control	NULL	whole organism (developmental stage: L1)	NULL
EXP045332		Drosophila melanogaster		NULL	1428	chip_control	NULL	whole organism (developmental stage: L3)	NULL
EXP045333		Drosophila melanogaster		NULL	1401	chip_control	NULL	multi-cellular organism (development stage: pupa)	NULL
EXP045334		Drosophila melanogaster		NULL	1422	chip_control	NULL	whole organism (developmental stage: E12-16)	NULL
EXP045335		Drosophila melanogaster		NULL	1424	chip_control	NULL	whole organism (developmental stage: E8-12)	NULL
EXP045336		Drosophila melanogaster		NULL	1424	chip_control	NULL	whole organism (developmental stage: E8-12)	NULL
EXP045337	anti-CBP	Drosophila melanogaster	Female	EXP045327	1409	normal	M9PH39	multi-cellular organism (development stage: adult)	NULL
EXP045338	anti-CBP	Drosophila melanogaster	Male	EXP045328	1409	normal	M9PH39	multi-cellular organism (development stage: adult)	NULL
EXP045339	anti-CBP	Drosophila melanogaster		EXP045329	1422	normal	M9PH39	whole organism (developmental stage: E12-16)	NULL
EXP045340	anti-CBP	Drosophila melanogaster		EXP045330	1421	normal	M9PH39	whole organism (developmental stage: E4-8)	NULL
EXP045341	anti-CBP	Drosophila melanogaster		EXP045331	1427	normal	M9PH39	whole organism (developmental stage: L1)	NULL
EXP045342	anti-CBP	Drosophila melanogaster		EXP045332	1428	normal	M9PH39	whole organism (developmental stage: L3)	NULL
EXP045343	anti-CBP	Drosophila melanogaster		EXP045333	1401	normal	M9PH39	multi-cellular organism (development stage: pupa)	NULL
EXP045344	anti-CBP	Drosophila melanogaster		EXP045324	1423	normal	M9PH39	whole organism (developmental stage: E16-20)	NULL
EXP045345	anti-CBP	Drosophila melanogaster		EXP045325	1425	normal	M9PH39	whole organism (developmental stage: E20-24)	NULL
EXP045346	anti-CBP	Drosophila melanogaster		EXP045323	1426	normal	M9PH39	whole organism (developmental stage: E0-4)	NULL
EXP045347	anti-CBP	Drosophila melanogaster		EXP045336	1424	normal	M9PH39	whole organism (developmental stage: E8-12)	NULL
EXP045350	input	Drosophila melanogaster		NULL	1414	chip_control	NULL	0-4 h embryo	NULL
EXP045351	rbCBP	Drosophila melanogaster		EXP045350	1414	normal	M9MS40	0-4 h embryo	NULL
EXP045352	input	Drosophila melanogaster		NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045353	disco	Drosophila melanogaster		EXP045352	1417	normal	P23792	8-16 h embryo	NULL
EXP045354		Drosophila melanogaster		NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045355	KW3-kni-D2	Drosophila melanogaster		EXP045354	1417	normal	P10734	8-16 h embryo	NULL
EXP045356	none	Drosophila melanogaster	Treatment: none	NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP045357	ASH2	Drosophila melanogaster	Treatment: none	EXP045356	1439	normal	Q94545	wing imaginal disc (developmental stage: L3)	NULL
EXP045358	input	Drosophila melanogaster		NULL	1418	chip_control	NULL	0-8 h embryo	NULL
EXP045359	NW-GFP-Goat[Dfd]	Drosophila melanogaster		EXP045358	1418	normal	P07548	0-8 h embryo	NULL
EXP045364	input	Drosophila melanogaster		NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045365	NW-GFP-Goat[eve]	Drosophila melanogaster		EXP045364	1417	normal	P06602	8-16 h embryo	NULL
EXP045366	input	Drosophila melanogaster	white prepupae stage	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP045367	CTCF-C	Drosophila melanogaster	white prepupae stage	EXP045366	1408	normal	Q9VS55	whole organism (development stage: prepupa)	NULL
EXP045368	none	Drosophila melanogaster	Treatment: none	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP045369	Trx-C	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P20659	S2-DRSC (embryonic stem cells)	NULL
EXP045370	Psc	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P35820	S2-DRSC (embryonic stem cells)	NULL
EXP045371	Ph	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P11346	S2-DRSC (embryonic stem cells)	NULL
EXP045372	Pc	Drosophila melanogaster	Treatment: none	EXP045368	1197	normal	P26017	S2-DRSC (embryonic stem cells)	NULL
EXP045373	input	Drosophila melanogaster		NULL	1418	chip_control	NULL	0-8 h embryo	NULL
EXP045374	Trl	Drosophila melanogaster		EXP045373	1418	normal	Q08605	0-8 h embryo	NULL
EXP045376	CG8478	Drosophila melanogaster		EXP045375	1420	normal	E1JIH4	16-24 h embryo	NULL
EXP045379		Drosophila melanogaster		NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045380	KW3-Trl-D2	Drosophila melanogaster		EXP045379	1417	normal	Q08605	8-16 h embryo	NULL
EXP045385	input	Drosophila melanogaster	Adult Female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP045386	Trem	Drosophila melanogaster	Adult Female	EXP045385	1399	normal	Q8SXZ3	whole organism (development stage: adult)	NULL
EXP045387	input	Drosophila melanogaster		NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045388	KW3-Kr-D2	Drosophila melanogaster		EXP045387	1420	normal	P07247	16-24 h embryo	NULL
EXP045391	input	Drosophila melanogaster		NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045392	anti-Bonus-[GP37]	Drosophila melanogaster		EXP045391	1420	normal	Q9U3Y7	16-24 h embryo	NULL
EXP045393	none	Drosophila melanogaster	Treatment: tissue: wing imaginal discs	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045394	lid	Drosophila melanogaster	Treatment: tissue: wing imaginal discs	EXP045393	1400	normal	Q9VMJ7	whole organism (development stage: wandering third instar larva)	NULL
EXP045395	input	Drosophila melanogaster		NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045396	KW4-Fer3-D1	Drosophila melanogaster		EXP045395	1420	normal	Q9VGJ5	16-24 h embryo	NULL
EXP045397	input	Drosophila melanogaster		NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045398	anti-cbt	Drosophila melanogaster		EXP045397	1420	normal	Q4R0P9	16-24 h embryo	NULL
EXP045399	input	Drosophila melanogaster		NULL	1426	chip_control	NULL	whole organism (developmental stage: E0-4)	NULL
EXP045400	Yki-91	Drosophila melanogaster		EXP045399	1426	normal	Q45VV3	whole organism (developmental stage: E0-4)	NULL
EXP045401	input	Drosophila melanogaster		NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045402	exd-GFP	Drosophila melanogaster		EXP045401	1420	normal	P40427	16-24 h embryo	NULL
EXP045405		Drosophila melanogaster		NULL	1413	chip_control	NULL	0-12 h embryo	NULL
EXP045406	Hr4_GFP	Drosophila melanogaster		EXP045405	1413	normal	Q9W539	0-12 h embryo	NULL
EXP045407	input	Drosophila melanogaster	white pre-pupae	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP045408	KW3-Trl-D2	Drosophila melanogaster	white pre-pupae	EXP045407	1408	normal	Q08605	whole organism (development stage: prepupa)	NULL
EXP045409	input	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045410	input	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045411	anti-SuHw	Drosophila melanogaster		EXP045409	1242	normal	A0A0B4K6W1	S2 cells	NULL
EXP045412	anti-SuHw	Drosophila melanogaster		EXP045410	1242	normal	A0A0B4K6W1	S2 cells	NULL
EXP045413	none	Drosophila melanogaster	temperature: 25C; w1118 strain	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045414	none	Drosophila melanogaster	temperature: 25C; Canton S strain	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045415	guinea pig 1 anti-l(3)mbt 1244-1477aa (glycine elution)	Drosophila melanogaster	temperature: 25C; w1118 strain	EXP045413	1400	normal	Q9VB52	whole organism (development stage: wandering third instar larva)	NULL
EXP045416	guinea pig 1 anti-l(3)mbt 1244-1477aa (glycine elution)	Drosophila melanogaster	temperature: 25C; Canton S strain	EXP045414	1400	normal	Q9VB52	whole organism (development stage: wandering third instar larva)	NULL
EXP045417	FLAG	Drosophila melanogaster	Elav+ cells	NULL	1431	chip_control	NULL	FACS isolated neuronal cells	NULL
EXP045418	none	Drosophila melanogaster	MEF2+ cells	NULL	1430	chip_control	NULL	FACS isolated muscle cells	NULL
EXP045419	none	Drosophila melanogaster	Elav+ cells	NULL	1431	chip_control	NULL	FACS isolated neuronal cells	NULL
EXP045420	none	Drosophila melanogaster	Elav+ cells	NULL	1431	chip_control	NULL	FACS isolated neuronal cells	NULL
EXP045421	FLAG	Drosophila melanogaster	MEF2+ cells	EXP045418	1430	normal	Q8I8V0	FACS isolated muscle cells	NULL
EXP045422	FLAG	Drosophila melanogaster	Elav+ cells	EXP045419	1431	normal	Q8I8V0	FACS isolated neuronal cells	NULL
EXP045423	none	Drosophila melanogaster	20-HE 0 hrs	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045424	anti-CP190	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045425	anti-CP190	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045426	anti-CP190	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045427	anti-Su(Hw)	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	P08970	Kc167 (development stage: embryonic)	NULL
EXP045428	anti-Su(Hw)	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	P08970	Kc167 (development stage: embryonic)	NULL
EXP045429	anti-Su(Hw)	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	P08970	Kc167 (development stage: embryonic)	NULL
EXP045430	anti-dCTCF	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045431	anti-dCTCF	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045432	anti-dCTCF	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045433	anti-BEAF32B	Drosophila melanogaster	20-HE 0 hrs	EXP045423	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045434	anti-BEAF32B	Drosophila melanogaster	20-HE 3 hrs	EXP045423	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045435	anti-BEAF32B	Drosophila melanogaster	20-HE 48 hrs	EXP045423	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045439	anti-ZLD	Drosophila melanogaster	Oregon R strain; mitotic cycles 8-9	NULL	1407	normal	Q7YU17	whole organism (development stage: embryonic)	NULL
EXP045440	anti-ZLD	Drosophila melanogaster	Oregon R strain; mitotic cycles 13-14	NULL	1407	normal	Q7YU17	whole organism (development stage: embryonic)	NULL
EXP045441	anti-ZLD	Drosophila melanogaster	Oregon R strain; late mitotic cycle 14	NULL	1407	normal	Q7YU17	whole organism (development stage: embryonic)	NULL
EXP045442	Ash1C	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	NULL
EXP045443	Ash1N	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	NULL
EXP045444	FSH_ID166 [raised against the N-terminal, common part of FSH-S and FSH-L, protein 1.2]	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	NULL
EXP045445	FSH_ID173 [raised against protein 4.1 (recognizes FSH-L only)]	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	NULL
EXP045446	none (input)	Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP045447	Hsp90	Drosophila melanogaster		EXP045446	1197	normal	M9PBL3	S2-DRSC (embryonic stem cells)	NULL
EXP045448	orc2 (steve bell lab, MIT)	Drosophila melanogaster	salivary gland; OrR genotype	NULL	1400	normal	Q24168	whole organism (development stage: wandering third instar larva)	NULL
EXP045449	orc2 (steve bell lab, MIT)	Drosophila melanogaster	salivary gland; SuUR genotype	NULL	1400	normal	Q24168	whole organism (development stage: wandering third instar larva)	NULL
EXP045450	Anti-FLAG M2	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045451	Anti-FLAG M2	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045452	Anti-FLAG M2	Drosophila melanogaster		EXP045450	1242	normal	P22813	S2 cells	NULL
EXP045453	Anti-FLAG M2	Drosophila melanogaster		EXP045451	1242	normal	P22813	S2 cells	NULL
EXP045454	CP190	Drosophila melanogaster	Interphase	NULL	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045455	CP190	Drosophila melanogaster	Mitosis	NULL	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045456	dCTCF	Drosophila melanogaster	Interphase	NULL	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045457	dCTCF	Drosophila melanogaster	Mitosis	NULL	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045458	BEAF	Drosophila melanogaster	Interphase	NULL	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045459	BEAF	Drosophila melanogaster	Mitosis	NULL	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045460	Su(Hw)	Drosophila melanogaster	Mitosis	NULL	1397	normal	P08970	Kc167 (development stage: embryonic)	NULL
EXP045461	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; wild type; Canton S	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP045462	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; wild type; Canton S	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP045463	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; su(Hw)fv strain; ovary	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP045464	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; su(Hw)fv strain; ovary	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP045465	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; wild type; Canton S strain; ovary	EXP045462	1399	normal	P08970	whole organism (development stage: adult)	NULL
EXP045466	anti-Su(Hw)	Drosophila melanogaster	less than 6 hour old virgin; su(Hw)fv strain; ovary	EXP045464	1399	normal	P08970	whole organism (development stage: adult)	NULL
EXP045469	none	Drosophila melanogaster		NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP045470	gp anti-Yan	Drosophila melanogaster		EXP045469	1434	normal	Q01842	whole organism (developmental stage: embryonic stage 11)	NULL
EXP045473	none	Drosophila melanogaster	Treatment: Jarid2 mutant	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045474	none	Drosophila melanogaster	Treatment: Jarid2 mutant	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045475	none	Drosophila melanogaster	Treatment: eye-antenna imaginal disc	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045476	none	Drosophila melanogaster	Treatment: eye-antenna imaginal disc; Jarid2 mutant	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045477	none	Drosophila melanogaster	Treatment: none	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045478	rb-?-Jarid2 (Masamitsu Yamaguchi)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045473	1400	normal	Q9VT00	whole organism (development stage: wandering third instar larva)	NULL
EXP045479	rb-?-Jarid2 (Masamitsu Yamaguchi)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045474	1400	normal	Q9VT00	whole organism (development stage: wandering third instar larva)	NULL
EXP045480	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045473	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	NULL
EXP045481	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: Jarid2 mutant	EXP045474	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	NULL
EXP045482	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: eye-antenna imaginal disc	EXP045475	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	NULL
EXP045483	rb-?-Su(z)12 full length (JÃ¼rg MÃ¼ller)	Drosophila melanogaster	Treatment: eye-antenna imaginal disc; Jarid2 mutant	EXP045476	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	NULL
EXP045484	rb-?-Jarid2 (Masamitsu Yamaguchi)	Drosophila melanogaster	Treatment: none	EXP045477	1400	normal	Q9VT00	whole organism (development stage: wandering third instar larva)	NULL
EXP045485	Su(z)12	Drosophila melanogaster	Treatment: none	EXP045477	1400	normal	Q9NJG9	whole organism (development stage: wandering third instar larva)	NULL
EXP045488		Drosophila melanogaster	genotype: w1118 (wild type)	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045489		Drosophila melanogaster	genotype: gd7 (lacking intranuclear Dorsal)	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045490	rabbit anti-Drosophila CBP	Drosophila melanogaster	genotype: w1118 (wild type)	EXP045488	1435	normal	M9MS40	2-4 h embryo	NULL
EXP045491	rabbit anti-Drosophila CBP	Drosophila melanogaster	genotype: gd7 (lacking intranuclear Dorsal)	EXP045489	1435	normal	M9MS40	2-4 h embryo	NULL
EXP045500	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045501	CG16778	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045500	1420	normal	P14083	16-24 h embryo	NULL
EXP045504	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045505	Fru	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045504	1420	normal	Q8IN81	16-24 h embryo	NULL
EXP045506	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045507	sr	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045506	1420	normal	Q7JP26	16-24 h embryo	NULL
EXP045514	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045515	jim	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045514	1417	normal	Q7KAH0	8-16 h embryo	NULL
EXP045516	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045517	sr	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045516	1417	normal	Q7JP26	8-16 h embryo	NULL
EXP045522	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045523	Kr	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045522	1397	normal	P07247	Kc167 (development stage: embryonic)	NULL
EXP045528	input	Drosophila melanogaster	iso1 (y; bw cn sp) strain	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045529	en	Drosophila melanogaster	iso1 (y; bw cn sp) strain	EXP045528	1400	normal	P02836	whole organism (development stage: wandering third instar larva)	NULL
EXP045572	none	Drosophila melanogaster		NULL	1418	chip_control	NULL	0-8 h embryo	NULL
EXP045573	BEAF	Drosophila melanogaster		EXP045572	1418	normal	Q94513	0-8 h embryo	NULL
EXP045574	anti-JIL-1	Drosophila melanogaster	Treatment: none; Sex: Female; Development stage: late embryo	NULL	1397	normal	Q9V3I5	Kc167 (development stage: embryonic)	NULL
EXP045575	Mod(mdg4)	Drosophila melanogaster		NULL	1397	normal	Q86B87	Kc167 (development stage: embryonic)	NULL
EXP045576	Mod(mdg4)BTB	Drosophila melanogaster		NULL	1397	normal	Q86B87	Kc167 (development stage: embryonic)	NULL
EXP045577	l(3)mbt	Drosophila melanogaster		NULL	1397	normal	Q9VB52	Kc167 (development stage: embryonic)	NULL
EXP045578		Drosophila melanogaster	strain: iso1 (y; bw cn sp)	NULL	1418	chip_control	NULL	0-8 h embryo	NULL
EXP045579	dm	Drosophila melanogaster	strain: iso1 (y; bw cn sp)	EXP045578	1418	normal	Q9W4S7	0-8 h embryo	NULL
EXP045580	ASH1N	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	NULL
EXP045581	ASH1C	Drosophila melanogaster		NULL	1197	normal	Q9VW15	S2-DRSC (embryonic stem cells)	NULL
EXP045582	FSH-S	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	NULL
EXP045583	FSH-S and FSH-L	Drosophila melanogaster		NULL	1197	normal	P13709	S2-DRSC (embryonic stem cells)	NULL
EXP045584	none (input)	Drosophila melanogaster	Treatment: none	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045585	polyclonal rabbit MSL1, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P50535	S2 cells	NULL
EXP045586	polyclonal rabbit MSL2, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P50534	S2 cells	NULL
EXP045587	polyclonal rabbit MSL3, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P50536	S2 cells	NULL
EXP045588	polyclonal rabbit MOF SA 4897, crude serum	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	O02193	S2 cells	NULL
EXP045589	mle	Drosophila melanogaster	Treatment: none	EXP045584	1242	normal	P24785	S2 cells	NULL
EXP045590	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045591	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045592	none	Drosophila melanogaster	350ng/ml (880nM) colchicine for 15hrs	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045593	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045594	none (streptavidin-coated beads used to pulldown biotinlyated PH)	Drosophila melanogaster	350ng/ml (880nM) colchicine for 15hrs	EXP045590	1242	normal	P11346	S2 cells	NULL
EXP045595	none (streptavidin-coated beads used to pulldown biotinlyated PH)	Drosophila melanogaster		EXP045591	1242	normal	P11346	S2 cells	NULL
EXP045596	PSC custom made rabbit polyclonal antibody that was affinity purified (described in Francis et al., 2009. PMID: 19303136)	Drosophila melanogaster	350ng/ml (880nM) colchicine for 15hrs	EXP045592	1242	normal	P35820	S2 cells	NULL
EXP045597	PSC custom made rabbit polyclonal antibody that was affinity purified (described in Francis et al., 2009. PMID: 19303136)	Drosophila melanogaster		EXP045593	1242	normal	P35820	S2 cells	NULL
EXP045598	none (input)	Drosophila melanogaster		NULL	1436	chip_control	NULL	primary mesodermal cells (developmental stage: E11-12)	NULL
EXP045599	Lmd1 [Cunha et al. 2010 PLoS Genet 6(7): e1001014]	Drosophila melanogaster		EXP045598	1436	normal	Q7K9G4	primary mesodermal cells (developmental stage: E11-12)	NULL
EXP045600	Lmd2 [Cunha et al. 2010 PLoS Genet 6(7): e1001014]	Drosophila melanogaster		EXP045598	1436	normal	Q7K9G4	primary mesodermal cells (developmental stage: E11-12)	NULL
EXP045602	None	Drosophila melanogaster	Treatment: Treatment: Treatment: Iso1 strain; Wing imaginal disc	NULL	1428	chip_control	NULL	whole organism (developmental stage: L3)	NULL
EXP045603	anti-Yki	Drosophila melanogaster	Treatment: Treatment: Treatment: Iso1 strain; Wing imaginal disc	EXP045602	1428	normal	Q45VV3	whole organism (developmental stage: L3)	NULL
EXP045606	anti-Trl (antii-GAF)	Drosophila melanogaster	Treatment: Treatment: Treatment: Iso1 strain; Wing imaginal disc	EXP045602	1428	normal	Q08605	whole organism (developmental stage: L3)	NULL
EXP045607	input	Drosophila melanogaster	control RNAi 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045608	input	Drosophila melanogaster	MSL2 RNAi	NULL	1200	chip_control	NULL	S2-DGRC (embryonic stem cells)	NULL
EXP045609	input	Drosophila melanogaster	control RNAi	NULL	1200	chip_control	NULL	S2-DGRC (embryonic stem cells)	NULL
EXP045610	CLAMP	Drosophila melanogaster	control RNAi 	EXP045607	1397	normal	Q961A1	Kc167 (development stage: embryonic)	NULL
EXP045611	CLAMP	Drosophila melanogaster	MSL2 RNAi	EXP045608	1200	normal	Q961A1	S2-DGRC (embryonic stem cells)	NULL
EXP045612	CLAMP	Drosophila melanogaster	control RNAi	EXP045609	1200	normal	Q961A1	S2-DGRC (embryonic stem cells)	NULL
EXP045616	input	Drosophila melanogaster		NULL	1437	chip_control	NULL	SR2+ (embryonic cells)	NULL
EXP045617	rabbit anti-Dp1	Drosophila melanogaster		EXP045616	1437	normal	Q7KN75	SR2+ (embryonic cells)	NULL
EXP045618	Myc (sc-28208)	Drosophila melanogaster	cells in interphase	NULL	1397	normal	Q9W4S7	Kc167 (development stage: embryonic)	NULL
EXP045619	Myc (sc-28208)	Drosophila melanogaster	cells in mitosis	NULL	1397	normal	Q9W4S7	Kc167 (development stage: embryonic)	NULL
EXP045620	DREF Rabbit polyclonal	Drosophila melanogaster	cells in mitosis	NULL	1397	normal	Q94883	Kc167 (development stage: embryonic)	NULL
EXP045621	DREF Rabbit polyclonal	Drosophila melanogaster	total cells	NULL	1397	normal	Q94883	Kc167 (development stage: embryonic)	NULL
EXP045622		Drosophila melanogaster	strain: Oregon-R	NULL	1438	chip_control	NULL	wing imaginal tissue (developmental stage: L3)	NULL
EXP045623	BEAF-32B (Bushey et. al 2009)	Drosophila melanogaster	strain: Oregon-R	EXP045622	1438	normal	Q94513	wing imaginal tissue (developmental stage: L3)	NULL
EXP045624	anti-GAF	Drosophila melanogaster		NULL	1197	normal	A4V1Y6	S2-DRSC (embryonic stem cells)	NULL
EXP045625	anti-GAF	Drosophila melanogaster	S2 cells depleted of GAF by RNAi	NULL	1197	bio_control	A4V1Y6	S2-DRSC (embryonic stem cells)	NULL
EXP045626	Anti Twist	Drosophila melanogaster	strain: Oregon R	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045627	None	Drosophila melanogaster	strain: Oregon R	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045628	None	Drosophila melanogaster	strain: Oregon R	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045629	None	Drosophila melanogaster	strain: Oregon R	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045630	None	Drosophila melanogaster	strain: Oregon R	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045631	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045626	1435	normal	P10627	2-4 h embryo	NULL
EXP045632	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045627	1435	normal	P10627	2-4 h embryo	NULL
EXP045633	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045628	1435	normal	P10627	2-4 h embryo	NULL
EXP045634	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045629	1435	normal	P10627	2-4 h embryo	NULL
EXP045635	Anti Twist	Drosophila melanogaster	strain: Oregon R	EXP045630	1435	normal	P10627	2-4 h embryo	NULL
EXP045636	none	Drosophila melanogaster		NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045637	Su(Hw)	Drosophila melanogaster		EXP045636	1244	normal	P08970	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045638	Shep, guinea pig	Drosophila melanogaster		EXP045636	1244	normal	Q8MSV2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045639	Shep, rabbit	Drosophila melanogaster		EXP045636	1244	normal	Q8MSV2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045640	Mod(mdg4)2.2, guinea pig	Drosophila melanogaster		EXP045636	1244	normal	A0A0B4K6B8	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045641	Mod(mdg4)2.2, rabbit	Drosophila melanogaster		EXP045636	1244	normal	A0A0B4K6B8	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045642	Brinker	Drosophila melanogaster	strain: Canton S	NULL	1439	normal	Q9XTN4	wing imaginal disc (developmental stage: L3)	NULL
EXP045643	Cabut	Drosophila melanogaster	strain: Canton S	NULL	1439	normal	Q8IPV7	wing imaginal disc (developmental stage: L3)	NULL
EXP045644	none	Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP045645	none	Drosophila melanogaster	3AB treated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP045646	CP190 antibody (rabbit)	Drosophila melanogaster		EXP045644	1197	normal	Q24478	S2-DRSC (embryonic stem cells)	NULL
EXP045647	CP190 antibody (rabbit)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	Q24478	S2-DRSC (embryonic stem cells)	NULL
EXP045648	Su(Hw) antibody 406 (rabbit)	Drosophila melanogaster		EXP045644	1197	normal	P08970	S2-DRSC (embryonic stem cells)	NULL
EXP045649	Su(Hw) antibody 406 (rabbit)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	P08970	S2-DRSC (embryonic stem cells)	NULL
EXP045650	Mod(mdg4)2.2 antibody (rabbit)	Drosophila melanogaster		EXP045644	1197	normal	A0A0B4K6B8	S2-DRSC (embryonic stem cells)	NULL
EXP045651	Mod(mdg4)2.2 antibody (rabbit)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	A0A0B4K6B8	S2-DRSC (embryonic stem cells)	NULL
EXP045652	dCTCF antibody 68 (rat)	Drosophila melanogaster		EXP045644	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	NULL
EXP045653	dCTCF antibody 68 (rat)	Drosophila melanogaster	3AB treated	EXP045645	1197	normal	Q9VS55	S2-DRSC (embryonic stem cells)	NULL
EXP045654		Drosophila melanogaster	Treatment: none; Development stage: MBT embryo, 2-3 hours AEL	NULL	3335	chip_control	NULL	Oregon R (Developmental stage: MBT 2 to 3hrs AEL)	NULL
EXP045655		Drosophila melanogaster	Treatment: none; Development stage: post-MBT embryo, 2-4 hours AEL	NULL	5001	chip_control	NULL	Oregon-R (Developmental stage: post-MBT 2 to 4 hours AEL)	NULL
EXP045656		Drosophila melanogaster	Treatment: none; Development stage: pre-MBT embryo, 1-2 hours AEL	NULL	5002	chip_control	NULL	Oregon-R (Developmental stage: pre-MBT 1 to 2 hours AEL)	NULL
EXP045657	anti-TBP (rabbit poly-antibody)	Drosophila melanogaster	Treatment: none; Development stage: post-MBT embryo, 2-4 hours AEL	EXP045655	5001	normal	P20227	Oregon-R (Developmental stage: post-MBT 2 to 4 hours AEL)	NULL
EXP045658	anti-TBP (rabbit poly-antibody)	Drosophila melanogaster	Treatment: none; Development stage: MBT embryo, 2-3 hours AEL	EXP045654	3335	normal	P20227	Oregon R (Developmental stage: MBT 2 to 3hrs AEL)	NULL
EXP045659	anti-TBP (rabbit poly-antibody)	Drosophila melanogaster	Treatment: none; Development stage: pre-MBT embryo, 1-2 hours AEL	EXP045656	5002	normal	P20227	Oregon-R (Developmental stage: pre-MBT 1 to 2 hours AEL)	NULL
EXP045660	input	Drosophila melanogaster	ZT13	NULL	1445	chip_control	NULL	head, adult	NULL
EXP045661	input	Drosophila melanogaster	ZT13	NULL	1445	chip_control	NULL	head, adult	NULL
EXP045662	input	Drosophila melanogaster	mock; no V5-tag; ZT13	NULL	1445	chip_control	NULL	head, adult	NULL
EXP045663	input	Drosophila melanogaster	ZT13	NULL	1444	chip_control	NULL	body, adult	NULL
EXP045664	input	Drosophila melanogaster	ZT13	NULL	1444	chip_control	NULL	body, adult	NULL
EXP045665	input	Drosophila melanogaster	mock; no V5-tag; ZT13	NULL	1444	chip_control	NULL	body, adult	NULL
EXP045666	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045660	1445	normal	O61735	head, adult	NULL
EXP045667	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045661	1445	normal	O61734	head, adult	NULL
EXP045668	V5 (Sigma)	Drosophila melanogaster	mock; no V5-tag; ZT13	EXP045662	1445	bio_control	Q9VDC3	head, adult	NULL
EXP045669	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045663	1444	normal	O61735	body, adult	NULL
EXP045670	V5 (Sigma)	Drosophila melanogaster	ZT13	EXP045664	1444	normal	O61734	body, adult	NULL
EXP045671	V5 (Sigma)	Drosophila melanogaster	mock; no V5-tag; ZT13	EXP045665	1444	bio_control	Q9VDC3	body, adult	NULL
EXP045672	input	Drosophila melanogaster	male	NULL	1412	chip_control	NULL	whole organism (development stage: larvae)	NULL
EXP045673	input	Drosophila melanogaster	female	NULL	1412	chip_control	NULL	whole organism (development stage: larvae)	NULL
EXP045674	PAP antibody (Sigma P1291)	Drosophila melanogaster	male	EXP045672	1412	normal	Q8T079	whole organism (development stage: larvae)	NULL
EXP045675	PAP antibody (Sigma P1291)	Drosophila melanogaster	female	EXP045673	1412	normal	Q8T079	whole organism (development stage: larvae)	NULL
EXP045676	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045677	none	Drosophila melanogaster		NULL	1443	chip_control	NULL	S3 cells (Schneider 3)	NULL
EXP045678	su(Hw)	Drosophila melanogaster		EXP045676	1242	normal	P08970	S2 cells	NULL
EXP045679	Su(Hw)	Drosophila melanogaster		EXP045677	1443	normal	P08970	S3 cells (Schneider 3)	NULL
EXP045680	Rrp40	Drosophila melanogaster		EXP045677	1443	normal	Q8IPX7	S3 cells (Schneider 3)	NULL
EXP045681	Rrp6	Drosophila melanogaster		EXP045677	1443	normal	Q9VFF3	S3 cells (Schneider 3)	NULL
EXP045682	Rrp40	Drosophila melanogaster		EXP045676	1242	normal	Q8IPX7	S2 cells	NULL
EXP045683	Rrp6	Drosophila melanogaster		EXP045676	1242	normal	Q9VFF3	S2 cells	NULL
EXP045684	none (input)	Drosophila melanogaster	strain: UAS-ab55 (Cook et al. 2004)	NULL	1446	chip_control	NULL	eye/antennal imaginal discs	NULL
EXP045685	none (input)	Drosophila melanogaster	strain: FRT82B, scrib1 (Bilder and Perrimon 2000)	NULL	1446	chip_control	NULL	eye/antennal imaginal discs	NULL
EXP045686	anti-Abrupt (a polyclonal rabbit antibody from Steven Crews)	Drosophila melanogaster	strain: UAS-ab55 (Cook et al. 2004)	EXP045684	1446	normal	Q24174	eye/antennal imaginal discs	NULL
EXP045687	anti-Abrupt (a polyclonal rabbit antibody from Steven Crews)	Drosophila melanogaster	strain: FRT82B, scrib1 (Bilder and Perrimon 2000)	EXP045685	1446	normal	Q24174	eye/antennal imaginal discs	NULL
EXP045688	none	Drosophila melanogaster	strain: chico heterozygous mutants; gender: female	NULL	1447	chip_control	NULL	whole organism (age: 15 day old)	NULL
EXP045689	none	Drosophila melanogaster	strain: chico heterozygous mutants; gender: female	NULL	1447	chip_control	NULL	whole organism (age: 15 day old)	NULL
EXP045690	none	Drosophila melanogaster	strain: IPC ablation mutants; gender: female	NULL	1447	chip_control	NULL	whole organism (age: 15 day old)	NULL
EXP045691	none	Drosophila melanogaster	strain: IPC ablation mutants; gender: female	NULL	1447	chip_control	NULL	whole organism (age: 15 day old)	NULL
EXP045692	dFOXO	Drosophila melanogaster	strain: chico heterozygous mutants; gender: female	EXP045688	1447	normal	Q95V55	whole organism (age: 15 day old)	NULL
EXP045693	dFOXO	Drosophila melanogaster	strain: chico heterozygous mutants; gender: female	EXP045689	1447	normal	Q95V55	whole organism (age: 15 day old)	NULL
EXP045694	dFOXO	Drosophila melanogaster	strain: IPC ablation mutants; gender: female	EXP045690	1447	normal	Q95V55	whole organism (age: 15 day old)	NULL
EXP045695	dFOXO	Drosophila melanogaster	strain: IPC ablation mutants; gender: female	EXP045691	1447	normal	Q95V55	whole organism (age: 15 day old)	NULL
EXP045696		Drosophila melanogaster	Heat shocked	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP045697	BEAF (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	Q94513	KC167 (developmental stage: 6-12h embryo)	NULL
EXP045698	CP190 (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP045699	CTCF (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	Q9VS55	KC167 (developmental stage: 6-12h embryo)	NULL
EXP045700	SuHw (Bushey et al., Genes & Dev. 2009)	Drosophila melanogaster	Heat shocked	EXP045696	1448	normal	A0A0B4K6W1	KC167 (developmental stage: 6-12h embryo)	NULL
EXP045701	no antibody (input control)	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045702	anti-Yki	Drosophila melanogaster		EXP045701	1242	normal	Q45VV3	S2 cells	NULL
EXP045703	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045704	CP190	Drosophila melanogaster		EXP045703	1242	normal	Q24478	S2 cells	NULL
EXP045705	CG8436	Drosophila melanogaster		EXP045703	1242	normal	A0A0B4LGV6	S2 cells	NULL
EXP045706	CG9740	Drosophila melanogaster		EXP045703	1242	normal	Q9VHG6	S2 cells	NULL
EXP045707	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045708	anti-EcR monoclonal antibody (DDA2.7) developed by C. Thummel in D. Hogness laboratory	Drosophila melanogaster		EXP045707	1242	normal	P34021	S2 cells	NULL
EXP045709	anti-EcR monoclonal antibody (DDA2.7) developed by C. Thummel in D. Hogness laboratory	Drosophila melanogaster	cells treated with ecdysone (41 Î¼M; 10 mg of 20-hydroxyecdysone (Sigma; cat. no. H5142) per 500 ml of growth medium)	EXP045707	1242	normal	P34021	S2 cells	NULL
EXP045710	none	Drosophila melanogaster		NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045711	rabbit polyclonal antibody specific to Fs(1)h long isoform	Drosophila melanogaster	long isoform IP	EXP045710	1397	normal	P13709	Kc167 (development stage: embryonic)	NULL
EXP045712	rabbit polyclonal antibody to both isoforms of Fs(1)h	Drosophila melanogaster	long and short isoform IP	EXP045710	1397	normal	P13709	Kc167 (development stage: embryonic)	NULL
EXP045713	input	Drosophila melanogaster		NULL	1449	chip_control	NULL	12-14 h embryo	NULL
EXP045714	anti-GFP	Drosophila melanogaster		EXP045713	1449	normal	P51521	12-14 h embryo	NULL
EXP045715	none	Drosophila melanogaster	no transfection	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045716	anti-V5 (Invitrogen)	Drosophila melanogaster	transfected with pMT5.1- DSXF -V5-His B	EXP045715	1242	normal	P23023	S2 cells	NULL
EXP045717	anti-V5 (Invitrogen)	Drosophila melanogaster	transfected with pMT5.1- DSXM-V5-His B	EXP045715	1242	normal	P23023	S2 cells	NULL
EXP045718	Preimmune sera	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP045719	M1BP antisera generated in a rabbit using recombinant M1BP isolated from E. coli.	Drosophila melanogaster		EXP045718	1450	normal	Q9VHM3	S2R+ (late embryonic stage cells)	NULL
EXP045720	input	Drosophila melanogaster		NULL	1413	chip_control	NULL	0-12 h embryo	NULL
EXP045721	input	Drosophila melanogaster		NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045723	input	Drosophila melanogaster		NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045724	input	Drosophila melanogaster		NULL	1417	chip_control	NULL	8-16 h embryo	NULL
EXP045729	input	Drosophila melanogaster		NULL	1418	chip_control	NULL	0-8 h embryo	NULL
EXP045730	input	Drosophila melanogaster	female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP045732	sc-25761	Drosophila melanogaster		EXP043076	1397	normal	P28159	Kc167 (development stage: embryonic)	NULL
EXP045734	ab290	Drosophila melanogaster		EXP045721	1400	normal	P07207	whole organism (development stage: wandering third instar larva)	NULL
EXP045738	ab290	Drosophila melanogaster		EXP045723	1400	normal	Q24142	whole organism (development stage: wandering third instar larva)	NULL
EXP045739	ab290	Drosophila melanogaster		EXP045724	1417	normal	Q24142	8-16 h embryo	NULL
EXP045744	KW1-br-core	Drosophila melanogaster		EXP045729	1418	normal	Q01295	0-8 h embryo	NULL
EXP045745	KW0-cnc	Drosophila melanogaster	female	EXP045730	1399	normal	P20482	whole organism (development stage: adult)	NULL
EXP045375	input	Drosophila melanogaster		NULL	1420	chip_control	NULL	16-24 h embryo	NULL
EXP045748	none	Drosophila melanogaster	blastoderm; Oregon R strain	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP045749	none	Drosophila melanogaster	blastoderm; MV2-25 strain	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP045750	none	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP045751	Bicoid (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P09081	whole organism (development stage: embryonic)	NULL
EXP045752	Bicoid, counter-purified agians D. virilis protein (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P09081	whole organism (development stage: embryonic)	NULL
EXP045753	GT  (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P39572	whole organism (development stage: embryonic)	NULL
EXP045754	GT  (Li et al. 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P39572	whole organism (development stage: embryonic)	NULL
EXP045755	HB (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P05084	whole organism (development stage: embryonic)	NULL
EXP045756	HB, counter-purified agians D. virilis protein (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P05084	whole organism (development stage: embryonic)	NULL
EXP045757	KR (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R strain	EXP045748	1407	normal	P07247	whole organism (development stage: embryonic)	NULL
EXP045758	KR, counter-purified agians D. virilis protein (Li et al., 2008)	Drosophila melanogaster	blastoderm; Oregon R, MV2-25, V46 strains	EXP045750	1407	normal	P07247	whole organism (development stage: embryonic)	NULL
EXP045759	Bicoid (Li et al. 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P09081	whole organism (development stage: embryonic)	NULL
EXP045760	GT  (Li et al. 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P39572	whole organism (development stage: embryonic)	NULL
EXP045761	HB (Li et al., 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P05084	whole organism (development stage: embryonic)	NULL
EXP045762	KR (Li et al., 2008)	Drosophila melanogaster	blastoderm; MV2-25 strain	EXP045749	1407	normal	P07247	whole organism (development stage: embryonic)	NULL
EXP045763	none	Drosophila melanogaster	Dividing S2 cells	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045764	Mouse monoclonal to Ago2, gift from M. Siomi	Drosophila melanogaster		EXP045763	1242	normal	Q9VUQ5	S2 cells	NULL
EXP045765	input	Drosophila melanogaster		NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045766	CP190 rabbit	Drosophila melanogaster		EXP045765	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045767	Mod(mdg4)2.2 guinea pig	Drosophila melanogaster		EXP045765	1397	normal	A0A0B4K6B8	Kc167 (development stage: embryonic)	NULL
EXP045768	Mod(mdg4)2.2 rabbit	Drosophila melanogaster		EXP045765	1397	normal	A0A0B4K6B8	Kc167 (development stage: embryonic)	NULL
EXP045769	Rump 10c3	Drosophila melanogaster		EXP045765	1397	normal	Q9VHC7	Kc167 (development stage: embryonic)	NULL
EXP045770	Rump 5g4	Drosophila melanogaster		EXP045765	1397	normal	Q9VHC7	Kc167 (development stage: embryonic)	NULL
EXP045771	Shep guinea pig	Drosophila melanogaster		EXP045765	1397	normal	Q8MSV2	Kc167 (development stage: embryonic)	NULL
EXP045772	Shep rabbit	Drosophila melanogaster		EXP045765	1397	normal	Q8MSV2	Kc167 (development stage: embryonic)	NULL
EXP045773	Su(Hw) rabbit	Drosophila melanogaster		EXP045765	1397	normal	P08970	Kc167 (development stage: embryonic)	NULL
EXP045774	anti-TBP 517 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	P20227	Stage 5 embryos	NULL
EXP045775	anti-TBP 518 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	P20227	Stage 5 embryos	NULL
EXP045776	anti-Trf2 274 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	Q07DP5	Stage 5 embryos	NULL
EXP045777	anti-Trf2 275 Antibody (custom polyclonal antibody generated in rabbits)	Drosophila melanogaster		NULL	1218	normal	Q07DP5	Stage 5 embryos	NULL
EXP045778	none	Drosophila melanogaster		NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045779	none	Drosophila melanogaster	Ibf2/cg9740 KO	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045780	CP190	Drosophila melanogaster		EXP045778	1400	normal	Q24478	whole organism (development stage: wandering third instar larva)	NULL
EXP045781	CP190	Drosophila melanogaster	Ibf2/cg9740 KO	EXP045779	1400	normal	Q24478	whole organism (development stage: wandering third instar larva)	NULL
EXP045782	input	Drosophila melanogaster	mutant Beaf	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045783	CP190	Drosophila melanogaster	mutant Beaf	EXP045782	1242	normal	Q24478	S2 cells	NULL
EXP045784	CP190	Drosophila melanogaster	wild type Beaf	EXP045782	1242	normal	Q24478	S2 cells	NULL
EXP045785	none	Drosophila melanogaster	eye-antennal imaginal discs	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045786	guinea pig anti-So (from I. Rebay)	Drosophila melanogaster	eye-antennal imaginal discs	EXP045785	1400	normal	Q27350	whole organism (development stage: wandering third instar larva)	NULL
EXP045787	anti-IgG control antibody	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045788	anti-Beaf32	Drosophila melanogaster		EXP045787	1242	normal	Q94513	S2 cells	NULL
EXP045789	anti-polycomb	Drosophila melanogaster	Treatment: none	NULL	1450	normal	P26017	S2R+ (late embryonic stage cells)	NULL
EXP045790	anti-trl	Drosophila melanogaster	Treatment: none	NULL	1450	normal	Q08605	S2R+ (late embryonic stage cells)	NULL
EXP045791	anti-adf1	Drosophila melanogaster	Treatment: none	NULL	1450	normal	P05552	S2R+ (late embryonic stage cells)	NULL
EXP045792	anti-pho	Drosophila melanogaster	Treatment: none	NULL	1450	normal	Q8ST83	S2R+ (late embryonic stage cells)	NULL
EXP045793	anti-polycomb	Drosophila melanogaster	Treatment: none	NULL	1451	normal	P26017	S2 (Schneider 2)	NULL
EXP045794	anti-polycomb	Drosophila melanogaster	Treatment: none	NULL	1244	normal	P26017	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP045795	anti-pho	Drosophila melanogaster	Treatment: none	NULL	1451	normal	Q8ST83	S2 (Schneider 2)	NULL
EXP045796	anti-trl	Drosophila melanogaster	Treatment: none	NULL	1451	normal	Q08605	S2 (Schneider 2)	NULL
EXP045797	anti-adf1	Drosophila melanogaster	Treatment: none	NULL	1451	normal	P05552	S2 (Schneider 2)	NULL
EXP045798	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP045799	anti-Pita	Drosophila melanogaster		EXP045798	1451	normal	Q9W1N1	S2 (Schneider 2)	NULL
EXP045800	anti-ZIPIC	Drosophila melanogaster		EXP045798	1451	normal	Q9VAB8	S2 (Schneider 2)	NULL
EXP045801	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; 	NULL	1454	chip_control	NULL	ovary (cap cells and terminal filament cells)	NULL
EXP045802	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; 	NULL	1454	chip_control	NULL	ovary (cap cells and terminal filament cells)	NULL
EXP045803	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; 	NULL	1455	chip_control	NULL	ovary (escort cells and early follicle cells)	NULL
EXP045804	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; 	NULL	1455	chip_control	NULL	ovary (escort cells and early follicle cells)	NULL
EXP045805	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: hh-gal4>UASt-HA::Lsd1 (epitope tagged Lsd1)	EXP045801	1454	normal	Q9VCI3	ovary (cap cells and terminal filament cells)	NULL
EXP045806	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: hh-gal4>UASt-HA::Lsd1 (epitope tagged Lsd1)	EXP045802	1454	normal	Q9VCI3	ovary (cap cells and terminal filament cells)	NULL
EXP045807	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: c587-gal4>UASp-HA::Lsd1 (epitope tagged Lsd1)	EXP045803	1455	normal	Q9VCI3	ovary (escort cells and early follicle cells)	NULL
EXP045808	rabbit-HA antibody (Abcam)	Drosophila melanogaster	age: 3-7 day old; gender: females; genotype: c587-gal4>UASp-HA::Lsd1 (epitope tagged Lsd1)	EXP045804	1455	normal	Q9VCI3	ovary (escort cells and early follicle cells)	NULL
EXP045809	input	Drosophila melanogaster	Treatment: Salivary Gland Cells	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045810	JIL-1 monoclonal antibody 5C9	Drosophila melanogaster	Treatment: Salivary Gland Cells	EXP045809	1400	normal	Q9V3I5	whole organism (development stage: wandering third instar larva)	NULL
EXP045811	input	Drosophila melanogaster	eye disks	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045812	Anti-Yki	Drosophila melanogaster	eye disks	EXP045811	1400	normal	Q45VV3	whole organism (development stage: wandering third instar larva)	NULL
EXP045813	Anti-Sd	Drosophila melanogaster	eye disks	EXP045811	1400	normal	P30052	whole organism (development stage: wandering third instar larva)	NULL
EXP045814	None	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP045815	None	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP045816	Bcd	Drosophila melanogaster		EXP045814	1229	normal	P09081	1-3 h embryo	NULL
EXP045817	Bcd	Drosophila melanogaster	zelda mutant	EXP045815	1229	normal	P09081	1-3 h embryo	NULL
EXP045818	input	Drosophila melanogaster	Treatment: whole embryo	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045819	input	Drosophila melanogaster	Treatment: whole embryo	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045820	input	Drosophila melanogaster	Treatment: parasegment 7	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045821	input	Drosophila melanogaster	Treatment: parasegment 7	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045822	input	Drosophila melanogaster	Treatment: parasegment 7	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045823	input	Drosophila melanogaster	Treatment: whole embryo	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045824	input	Drosophila melanogaster	Treatment: parasegment 7	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045825	input	Drosophila melanogaster	Treatment: whole embryo	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045826	input	Drosophila melanogaster	Treatment: parasegment 7	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045827	input	Drosophila melanogaster	Treatment: whole embryo	NULL	1456	chip_control	NULL	5-13 h embryo	NULL
EXP045828	anti-CTCF	Drosophila melanogaster	Treatment: parasegment 7	EXP045820	1456	normal	Q9VS55	5-13 h embryo	NULL
EXP045829	anti-Ph (residues 772-984)	Drosophila melanogaster	Treatment: whole embryo	EXP045818	1456	normal	P11346	5-13 h embryo	NULL
EXP045830	anti-Ph (residues 772-984)	Drosophila melanogaster	Treatment: parasegment 7	EXP045821	1456	normal	P11346	5-13 h embryo	NULL
EXP045831	anti-Pc	Drosophila melanogaster	Treatment: parasegment 7	EXP045822	1456	normal	P26017	5-13 h embryo	NULL
EXP045832	anti-Pc	Drosophila melanogaster	Treatment: whole embryo	EXP045823	1456	normal	P26017	5-13 h embryo	NULL
EXP045833	anti-SU(Z)12	Drosophila melanogaster	Treatment: parasegment 7	EXP045824	1456	normal	Q9NJG9	5-13 h embryo	NULL
EXP045834	anti-SU(Z)12	Drosophila melanogaster	Treatment: whole embryo	EXP045819	1456	normal	Q9NJG9	5-13 h embryo	NULL
EXP045835	anti-CP190	Drosophila melanogaster	Treatment: whole embryo	EXP045825	1456	normal	Q24478	5-13 h embryo	NULL
EXP045836	anti-CP190	Drosophila melanogaster	Treatment: parasegment 7	EXP045826	1456	normal	Q24478	5-13 h embryo	NULL
EXP045837	anti-CTCF	Drosophila melanogaster	Treatment: whole embryo	EXP045827	1456	normal	Q9VS55	5-13 h embryo	NULL
EXP045838	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045839	Polycomb	Drosophila melanogaster		EXP045838	1242	normal	P26017	S2 cells	NULL
EXP045840	Velo	Drosophila melanogaster		EXP045838	1242	normal	Q9VRY4	S2 cells	NULL
EXP045841	SUMO	Drosophila melanogaster		EXP045838	1242	normal	O97102	S2 cells	NULL
EXP045842	input	Drosophila melanogaster	Treatment: 4-6 days old adult	NULL	2203	chip_control	NULL	ovary	NULL
EXP045843	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; rhino knock-down	EXP045842	2203	bio_control	Q7JXA8	ovary	NULL
EXP045844	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; deadlock knock-down	EXP045842	2203	normal	Q7JXA8	ovary	NULL
EXP045845	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; cutoff knock-down	EXP045842	2203	normal	Q7JXA8	ovary	NULL
EXP045846	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult	EXP045842	2203	normal	Q9VIF5	ovary	NULL
EXP045847	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; deadlock knock-down	EXP045842	2203	bio_control	Q9VIF5	ovary	NULL
EXP045848	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult	EXP045842	2203	normal	Q9V629	ovary	NULL
EXP045849	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; cutoff knock-down	EXP045842	2203	bio_control	Q9V629	ovary	NULL
EXP045850	Rhi	Drosophila melanogaster	Treatment: 4-6 days old adult	EXP045842	2203	normal	Q7JXA8	ovary	NULL
EXP045851	custom-made rabbit polyclonal antibody	Drosophila melanogaster	Treatment: 4-6 days old adult; piwi knock-down	EXP045842	2203	normal	Q7JXA8	ovary	NULL
EXP045852	input	Drosophila melanogaster	Treatment: none	NULL	1458	chip_control	NULL	egg chambers, stage 10	NULL
EXP045853	IgG (made in-house)	Drosophila melanogaster	Treatment: none	NULL	1458	chip_control	NULL	egg chambers, stage 10	NULL
EXP045854	input	Drosophila melanogaster	Treatment: none	NULL	1459	chip_control	NULL	egg chambers, pooled stage 12 and 13	NULL
EXP045855	IgG (made in-house)	Drosophila melanogaster	Treatment: none	NULL	1459	chip_control	NULL	egg chambers, pooled stage 12 and 13	NULL
EXP045856	SUUR (made in-house)	Drosophila melanogaster	Treatment: none	EXP045852	1458	normal	Q9VTE2	egg chambers, stage 10	NULL
EXP045857	Cdc45 (made in-house)	Drosophila melanogaster	Treatment: none	EXP045852	1458	normal	O96989	egg chambers, stage 10	NULL
EXP045858	SUUR (made in-house)	Drosophila melanogaster	Treatment: none	EXP045854	1459	normal	Q9VTE2	egg chambers, pooled stage 12 and 13	NULL
EXP045859	Cdc45 (made in-house)	Drosophila melanogaster	Treatment: none	EXP045854	1459	normal	O96989	egg chambers, pooled stage 12 and 13	NULL
EXP045860	PARP-1 (Active motif-39559)	Drosophila melanogaster	late embryonic cells	NULL	1242	normal	P35875	S2 cells	NULL
EXP045861	input	Drosophila melanogaster	Treatment: Treatment: 1-5 day old adults	NULL	2203	chip_control	NULL	ovary	NULL
EXP045862	input	Drosophila melanogaster	Treatment: Treatment: 1-5 day old adults; piwiNt/piwi2 (mutant)	NULL	2203	chip_control	NULL	ovary	NULL
EXP045863	PRB-291C	Drosophila melanogaster	Treatment: Treatment: 1-5 day old adults	EXP045861	2203	normal	P05205	ovary	NULL
EXP045864	PRB-291C	Drosophila melanogaster	Treatment: Treatment: 1-5 day old adults; piwiNt/piwi2 (mutant)	EXP045862	2203	normal	P05205	ovary	NULL
EXP045865	none (input)	Drosophila melanogaster	salivary gland	NULL	1412	chip_control	NULL	whole organism (development stage: larvae)	NULL
EXP045866	none (input)	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	NULL	1412	chip_control	NULL	whole organism (development stage: larvae)	NULL
EXP045867	MSL2	Drosophila melanogaster	salivary gland	EXP045865	1412	normal	P50534	whole organism (development stage: larvae)	NULL
EXP045868	MOF	Drosophila melanogaster	salivary gland	EXP045865	1412	normal	O02193	whole organism (development stage: larvae)	NULL
EXP045869	MSL1	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	EXP045866	1412	normal	P50535	whole organism (development stage: larvae)	NULL
EXP045870	MSL2	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	EXP045866	1412	normal	P50534	whole organism (development stage: larvae)	NULL
EXP045871	MOF	Drosophila melanogaster	salivary gland; rox1 rox2 mutants	EXP045866	1412	normal	O02193	whole organism (development stage: larvae)	NULL
EXP045872	none (input)	Drosophila melanogaster	male salivary glands	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045873	none (input)	Drosophila melanogaster	female salivary glands	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045874	none (input)	Drosophila melanogaster	lacO-roX2+p	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045875	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	male salivary glands	EXP045872	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	NULL
EXP045876	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	female salivary glands	EXP045873	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	NULL
EXP045877	in house MOF antibody raised in rabbit	Drosophila melanogaster	lacO-roX2+p	EXP045874	1400	normal	O02193	whole organism (development stage: wandering third instar larva)	NULL
EXP045879	anti-Zelda antibody (Harrison et al., 2011, PLoS Genet. 7(10):e1002266)	Drosophila melanogaster	Treatment: Treatment: Treatment: Oregon R; mitotic cycle 12-c14d; zelda wt	EXP045878	1407	normal	M9NES1	whole organism (development stage: embryonic)	NULL
EXP045880	anti-Zelda antibody (Harrison et al., 2011, PLoS Genet. 7(10):e1002266)	Drosophila melanogaster	Treatment: Treatment: Treatment: Oregon R; mitotic cycle 12-c14d; zelda mutant	EXP045878	1407	normal	M9NES1	whole organism (development stage: embryonic)	NULL
EXP045881	input	Drosophila melanogaster	Eye-Antennal discs	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045882	CTCF	Drosophila melanogaster	Eye-Antennal discs	EXP045881	1400	normal	Q9VS55	whole organism (development stage: wandering third instar larva)	NULL
EXP045883	input	Drosophila melanogaster		NULL	1460	chip_control	NULL	0-16 h embryo	NULL
EXP045884	input	Drosophila melanogaster		NULL	1460	chip_control	NULL	0-16 h embryo	NULL
EXP045885	anti-E(Z), Carrington & Jones, Development (1996).	Drosophila melanogaster		EXP045883	1460	normal	P42124	0-16 h embryo	NULL
EXP045886	anti-E(Z), Carrington & Jones, Development (1996).	Drosophila melanogaster		EXP045884	1460	normal	P42124	0-16 h embryo	NULL
EXP045887	input	Drosophila melanogaster		NULL	2203	chip_control	NULL	ovary	NULL
EXP045888	input	Drosophila melanogaster		NULL	2203	chip_control	NULL	ovary	NULL
EXP045889	input	Drosophila melanogaster		NULL	2203	chip_control	NULL	ovary	NULL
EXP045890	pan Mouse IgG dynabeads	Drosophila melanogaster		EXP045887	2203	normal	Q7JXA8	ovary	NULL
EXP045891	GFP-4C9	Drosophila melanogaster		EXP045888	2203	normal	Q9V629	ovary	NULL
EXP045892	GFP-4C9	Drosophila melanogaster		EXP045889	2203	normal	Q9V629	ovary	NULL
EXP045893	None	Drosophila melanogaster	yw strain	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP045894	Santa cruz goat polyclonal #sc-15813	Drosophila melanogaster	yw strain	EXP045893	1435	normal	P28159	2-4 h embryo	NULL
EXP045895	Santa cruz rabbit polyclonal #sc-25761	Drosophila melanogaster	yw strain	EXP045893	1435	normal	P28159	2-4 h embryo	NULL
EXP045896	none	Drosophila melanogaster	Treatment: none	NULL	1462	chip_control	NULL	16-18 h embryo	NULL
EXP045897	none (input)	Drosophila melanogaster	Treatment: PH del mutant	NULL	1462	chip_control	NULL	16-18 h embryo	NULL
EXP045898	none (input)	Drosophila melanogaster	Treatment: none	NULL	1462	chip_control	NULL	16-18 h embryo	NULL
EXP045899	none (input)	Drosophila melanogaster	Treatment: none	NULL	1461	chip_control	NULL	4-12 h embryo	NULL
EXP045900	PH	Drosophila melanogaster	Treatment: none	EXP045896	1462	normal	P11346	16-18 h embryo	NULL
EXP045901	PHO	Drosophila melanogaster	Treatment: PH del mutant	EXP045897	1462	normal	Q8ST83	16-18 h embryo	NULL
EXP045902	PC	Drosophila melanogaster	Treatment: PH del mutant	EXP045897	1462	normal	P26017	16-18 h embryo	NULL
EXP045903	PC	Drosophila melanogaster	Treatment: none	EXP045898	1462	normal	P26017	16-18 h embryo	NULL
EXP045904	PHO	Drosophila melanogaster	Treatment: none	EXP045898	1462	normal	Q8ST83	16-18 h embryo	NULL
EXP045905	PHO	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	Q8ST83	4-12 h embryo	NULL
EXP045906	PC	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	P26017	4-12 h embryo	NULL
EXP045907	DSP1	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	Q24537	4-12 h embryo	NULL
EXP045908	PH	Drosophila melanogaster	Treatment: none	EXP045899	1461	normal	P11346	4-12 h embryo	NULL
EXP045909	input	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045910	input	Drosophila melanogaster	mutant (PH-ML)	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045911	Ph	Drosophila melanogaster		EXP045909	1242	normal	P11346	S2 cells	NULL
EXP045912	Ph	Drosophila melanogaster	mutant (PH-ML)	EXP045910	1242	normal	P11346	S2 cells	NULL
EXP045913	Pc (Pirrotta Lab; affinity purified)	Drosophila melanogaster	Treatment: grown at 25C	NULL	1463	normal	P26017	EZ2-2 (E(z) temperature sensitive cells)	NULL
EXP045914	input	Drosophila melanogaster	salivary glands; female	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045915	input	Drosophila melanogaster	salivary glands; male	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045916	input	Drosophila melanogaster	salivary glands; male; mof2 mutant	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045917	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	salivary glands; female	EXP045914	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	NULL
EXP045918	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	salivary glands; male	EXP045915	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	NULL
EXP045919	polyclonal MSL1 antibody raised against the N-terminus (AA1-584)	Drosophila melanogaster	salivary glands; male; mof2 mutant	EXP045916	1400	normal	P50535	whole organism (development stage: wandering third instar larva)	NULL
EXP045920	none (input)	Drosophila melanogaster		NULL	1446	chip_control	NULL	eye/antennal imaginal discs	NULL
EXP045921	anti-GFP	Drosophila melanogaster		EXP045920	1446	normal	P13002	eye/antennal imaginal discs	NULL
EXP045922	IgG	Drosophila melanogaster	Treatment: heat shock	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045923	IgG	Drosophila melanogaster	Treatment: normal temperature	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045924	BEAF	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045925	BEAF	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q94513	Kc167 (development stage: embryonic)	NULL
EXP045926	CapH2	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	NULL
EXP045927	CapH2	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	NULL
EXP045928	CBP	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	M9MS40	Kc167 (development stage: embryonic)	NULL
EXP045929	CBP	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	M9MS40	Kc167 (development stage: embryonic)	NULL
EXP045930	CP190	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045931	CTCF	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045932	DREF	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q94883	Kc167 (development stage: embryonic)	NULL
EXP045933	DREF	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q94883	Kc167 (development stage: embryonic)	NULL
EXP045934	Fs1h-L	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	M9PJC7	Kc167 (development stage: embryonic)	NULL
EXP045935	L3mbt	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VB52	Kc167 (development stage: embryonic)	NULL
EXP045936	L3mbt	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VB52	Kc167 (development stage: embryonic)	NULL
EXP045937	Pc_RJ	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	P26017	Kc167 (development stage: embryonic)	NULL
EXP045938	Pc_RJ	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	P26017	Kc167 (development stage: embryonic)	NULL
EXP045939	Pc_VP	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	P26017	Kc167 (development stage: embryonic)	NULL
EXP045940	Rad21	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	NULL
EXP045941	SuHw	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	A0A0B4K6W1	Kc167 (development stage: embryonic)	NULL
EXP045942	pzg	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VP57	Kc167 (development stage: embryonic)	NULL
EXP045943	pzg	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VP57	Kc167 (development stage: embryonic)	NULL
EXP045944	TFIIIC	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	NULL
EXP045945	TFIIIC	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	NULL
EXP045946	CTCF	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q9VS55	Kc167 (development stage: embryonic)	NULL
EXP045947	CP190	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP045948	CapH2	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q8INL2	Kc167 (development stage: embryonic)	NULL
EXP045949	CBP	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	M9PH39	Kc167 (development stage: embryonic)	NULL
EXP045950	Rad21	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	NULL
EXP045951	Fs1h-L	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	M9PJC7	Kc167 (development stage: embryonic)	NULL
EXP045952	Chromator	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	Q8T9D1	Kc167 (development stage: embryonic)	NULL
EXP045953	Chromator	Drosophila melanogaster	Treatment: normal temperature	EXP045923	1397	normal	Q8T9D1	Kc167 (development stage: embryonic)	NULL
EXP045954	Modmdg4	Drosophila melanogaster	Treatment: heat shock	EXP045922	1397	normal	A0A0B4K6B8	Kc167 (development stage: embryonic)	NULL
EXP045955	none	Drosophila melanogaster	Treatment: none	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045956	none	Drosophila melanogaster	Treatment: CDK12 knockdown	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045957	none	Drosophila melanogaster	Treatment: none	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP045958	HP1a polyclonal (rabbit)	Drosophila melanogaster	Treatment: none	EXP045955	1400	normal	P05205	whole organism (development stage: wandering third instar larva)	NULL
EXP045959	HP1a polyclonal (rabbit)	Drosophila melanogaster	Treatment: CDK12 knockdown	EXP045956	1400	normal	P05205	whole organism (development stage: wandering third instar larva)	NULL
EXP045960	CDK12 polyclonal (rabbit)	Drosophila melanogaster	Treatment: none	EXP045957	1400	normal	Q9VP22	whole organism (development stage: wandering third instar larva)	NULL
EXP045961	none	Drosophila melanogaster		NULL	1464	chip_control	NULL	6-8 h embryo	NULL
EXP045962	none	Drosophila melanogaster		NULL	1465	chip_control	NULL	10-12 h embryo	NULL
EXP045963	ELAV	Drosophila melanogaster		EXP045961	1464	normal	P16914	6-8 h embryo	NULL
EXP045964	ELAV	Drosophila melanogaster		EXP045962	1465	normal	P16914	10-12 h embryo	NULL
EXP045965	none	Drosophila melanogaster		NULL	1460	chip_control	NULL	0-16 h embryo	NULL
EXP045966	none	Drosophila melanogaster	wt	NULL	1460	chip_control	NULL	0-16 h embryo	NULL
EXP045967	anti-V5 agarose affinity gel (Sigma, catalog# A7345, lot# 021M4839)	Drosophila melanogaster		EXP045965	1460	normal	P83949	0-16 h embryo	NULL
EXP045968	Ubx	Drosophila melanogaster	wt, no V5-tag	EXP045966	1460	bio_control	P83949	0-16 h embryo	NULL
EXP045969	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045970	none	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045971	affinity-purified rabbit antibody raised against aa 2540-3190 in Drosophila CBP (nejire)	Drosophila melanogaster		EXP045969	1242	normal	M9MS40	S2 cells	NULL
EXP045972	affinity-purified guinea-pig antibody raised against aa 1-178 in Drosophila CBP (nejire)	Drosophila melanogaster		EXP045970	1242	normal	M9MS40	S2 cells	NULL
EXP045973	none	Drosophila melanogaster		NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP045974	goat anti-Su(H) pAb (Santa Cruz Biotechnology, catalog# sc-15813, lot# I1704)	Drosophila melanogaster		EXP045973	1197	normal	P28159	S2-DRSC (embryonic stem cells)	NULL
EXP045975	none	Drosophila melanogaster	wt	NULL	1466	chip_control	NULL	2-3 h embryo	NULL
EXP045976	none	Drosophila melanogaster	gd7	NULL	1466	chip_control	NULL	2-3 h embryo	NULL
EXP045977	none	Drosophila melanogaster	wt	NULL	1466	chip_control	NULL	2-3 h embryo	NULL
EXP045978	none	Drosophila melanogaster	Zld(-)	NULL	1466	chip_control	NULL	2-3 h embryo	NULL
EXP045979	Zld	Drosophila melanogaster	wt	EXP045975	1466	normal	Q7YU17	2-3 h embryo	NULL
EXP045980	Dl	Drosophila melanogaster	wt	EXP045977	1466	normal	P15330	2-3 h embryo	NULL
EXP045981	Dl	Drosophila melanogaster	Zld(-)	NULL	1466	normal	P15330	2-3 h embryo	NULL
EXP045982	Zld	Drosophila melanogaster	gd7	EXP045976	1466	normal	M9NES1	2-3 h embryo	NULL
EXP045983	none	Drosophila melanogaster		NULL	1467	chip_control	NULL	Psc4-1 (Psc/Su(z)2 ) cell line	NULL
EXP045984	none	Drosophila melanogaster		NULL	1468	chip_control	NULL	Ras3 cell line	NULL
EXP045985	E(Z) from Kahn et al., 2006	Drosophila melanogaster		EXP045983	1467	normal	P42124	Psc4-1 (Psc/Su(z)2 ) cell line	NULL
EXP045986	E(Z) from Kahn et al., 2006	Drosophila melanogaster		EXP045984	1468	normal	P42124	Ras3 cell line	NULL
EXP045987		Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045988	cg1894	Drosophila melanogaster		EXP045987	1242	normal	Q9VAV6	S2 cells	NULL
EXP045989	input	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045990	input	Drosophila melanogaster		NULL	1242	chip_control	NULL	S2 cells	NULL
EXP045991	Anti-V5 antibody (Abcam; ab9116)	Drosophila melanogaster	GFP-KD	EXP045989	1242	normal	Q9VFF3	S2 cells	NULL
EXP045992	Anti-V5 antibody (Abcam; ab9116)	Drosophila melanogaster	Su(var)3-9 KD	EXP045990	1242	normal	Q9VFF3	S2 cells	NULL
EXP045993	none	Drosophila melanogaster		NULL	1469	chip_control	NULL	intestines (developmental stage: adult)	NULL
EXP045994	mouse-raised STAT92E antibody (self-made);	Drosophila melanogaster	strain: W1118; genotype: esgts>Upd STAT92E (intestines ectopically expressing Upd and STAT92E in the progenitor cells)	EXP045993	1469	normal	Q24151	intestines (developmental stage: adult)	NULL
EXP045995	none	Drosophila melanogaster		NULL	1470	chip_control	NULL	whole organism (developmental stage: E13-14)	NULL
EXP045996	Non relevant antibody (HA.11 Clone 16B12 Monoclonal Antibody; Covance #MMS-101P lot 14973401)	Drosophila melanogaster		NULL	1470	chip_control	NULL	whole organism (developmental stage: E13-14)	NULL
EXP045997	Mix of 3 anti-COL home made monoclonal antibodies	Drosophila melanogaster		EXP045995	1470	normal	P56721	whole organism (developmental stage: E13-14)	NULL
EXP045998	IgG control	Drosophila melanogaster		NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP045999	CTCF guinea-pig polyclonal	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	Q8TA44	Kc167 (development stage: embryonic)	NULL
EXP046000	dSmad2 sheep polyclonal (R&D systems cat#AF7948)	Drosophila melanogaster		EXP045998	1397	normal	O96660	Kc167 (development stage: embryonic)	NULL
EXP046001	dSmad2 sheep polyclonal (R&D systems cat#AF7948)	Drosophila melanogaster	RNAi depletion of CTCF	EXP045998	1397	normal	O96660	Kc167 (development stage: embryonic)	NULL
EXP046002	Mad rabbit polyclonal	Drosophila melanogaster		EXP045998	1397	normal	P42003	Kc167 (development stage: embryonic)	NULL
EXP046003	Mad rabbit polyclonal	Drosophila melanogaster	RNAi depletion of CTCF	EXP045998	1397	normal	P42003	Kc167 (development stage: embryonic)	NULL
EXP046004	Mad rabbit polyclonal 	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	P42003	Kc167 (development stage: embryonic)	NULL
EXP046005	Medea rabbit polyclonal 	Drosophila melanogaster		EXP045998	1397	normal	O62609	Kc167 (development stage: embryonic)	NULL
EXP046006	Medea rabbit polyclonal 	Drosophila melanogaster	RNAi depletion of CTCF	EXP045998	1397	normal	O62609	Kc167 (development stage: embryonic)	NULL
EXP046007	Medea rabbit polyclonal 	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	O62609	Kc167 (development stage: embryonic)	NULL
EXP046008	Schnurri rabbit polyclonal	Drosophila melanogaster		EXP045998	1397	normal	Q0E9C5	Kc167 (development stage: embryonic)	NULL
EXP046009	Schnurri rabbit polyclonal	Drosophila melanogaster	treatment with decapentaplegic (DPP)	EXP045998	1397	normal	Q0E9C5	Kc167 (development stage: embryonic)	NULL
EXP046010	none	Drosophila melanogaster	Treatment: wild type	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP046011	none	Drosophila melanogaster	Treatment: gd7 genotype	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP046012	none	Drosophila melanogaster	Treatment: tl10b genotype	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP046013	gaf	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	Q08605	2-4 h embryo	NULL
EXP046014	Pc (d-220) (Santa Cruz, catalog #sc-25762)	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	P26017	2-4 h embryo	NULL
EXP046015	Custom GenScript Sna (Full length) 134626-2	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	P08044	2-4 h embryo	NULL
EXP046016	cbp	Drosophila melanogaster	Treatment: wild type	EXP046010	1435	normal	M9PH39	2-4 h embryo	NULL
EXP046017	Custom GenScript Mad (aa 147-455)	Drosophila melanogaster	Treatment: gd7 genotype	EXP046011	1435	normal	P42003	2-4 h embryo	NULL
EXP046018	Custom GenScript Zen (full length)	Drosophila melanogaster	Treatment: gd7 genotype	EXP046011	1435	normal	P09089	2-4 h embryo	NULL
EXP046019	zld	Drosophila melanogaster	Treatment: gd7 genotype	EXP046011	1435	normal	M9NES1	2-4 h embryo	NULL
EXP046020	Custom GenScript Dl (aa 39-346) 126740-44	Drosophila melanogaster	Treatment: tl10b genotype	EXP046012	1435	normal	P15330	2-4 h embryo	NULL
EXP046021	zld	Drosophila melanogaster	Treatment: tl10b genotype	EXP046012	1435	normal	M9NES1	2-4 h embryo	NULL
EXP046022	Custom Covance Twi (aa 340-490)	Drosophila melanogaster	Treatment: tl10b genotype	EXP046012	1435	normal	P10627	2-4 h embryo	NULL
EXP046023	none	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 5% sucrose for 6 hours (contol conditions); gender: female	NULL	1975	chip_control	NULL	whole organism (age: 1-3 days)	NULL
EXP046024	none	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 6 hours of 20mM paraquat in 5% sucose (oxidative stress); gender: female	NULL	1975	chip_control	NULL	whole organism (age: 1-3 days)	NULL
EXP046025	none	Drosophila melanogaster	Treatment: Treatment: genotype: w1118 (wild type); gender: female	NULL	1975	chip_control	NULL	whole organism (age: 1-3 days)	NULL
EXP046026	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 5% sucrose for 6 hours (contol conditions); gender: female	EXP046023	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	NULL
EXP046027	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 5% sucrose for 6 hours (contol conditions); gender: female	EXP046023	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	NULL
EXP046028	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 6 hours of 20mM paraquat in 5% sucose (oxidative stress); gender: female	EXP046024	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	NULL
EXP046029	anti-HA	Drosophila melanogaster	Treatment: Treatment: genotype: k6801/k6801;gHA-KDM5; treatment: 6 hours of 20mM paraquat in 5% sucose (oxidative stress); gender: female	EXP046024	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	NULL
EXP046030	KDM5	Drosophila melanogaster	Treatment: Treatment: genotype: w1118 (wild type); gender: female	EXP046025	1975	normal	Q9VMJ7	whole organism (age: 1-3 days)	NULL
EXP046031	none (input)	Drosophila melanogaster		NULL	1976	chip_control	NULL	imaginal discs and salivary glands (developmental stage: L3)	NULL
EXP046032	anti-GAF	Drosophila melanogaster		EXP046031	1976	normal	Q08605	imaginal discs and salivary glands (developmental stage: L3)	NULL
EXP046033	none	Drosophila melanogaster	mutation: Su(z)124-null	NULL	1977	chip_control	NULL	S12-26I3	NULL
EXP046034	none	Drosophila melanogaster	mutation: Su(z)124-null	NULL	1977	chip_control	NULL	S12-26I3	NULL
EXP046035	none	Drosophila melanogaster	mutation: none	NULL	1468	chip_control	NULL	Ras3 cell line	NULL
EXP046036	none	Drosophila melanogaster	mutation: none	NULL	1468	chip_control	NULL	Ras3 cell line	NULL
EXP046037	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: Su(z)124-null	EXP046033	1977	normal	P35820	S12-26I3	NULL
EXP046038	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: Su(z)124-null	EXP046034	1977	normal	P35820	S12-26I3	NULL
EXP046039	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: none	EXP046035	1468	normal	P35820	Ras3 cell line	NULL
EXP046040	Psc from Poux et al., 2001	Drosophila melanogaster	mutation: none	EXP046036	1468	normal	P35820	Ras3 cell line	NULL
EXP046041	none	Drosophila melanogaster	HA-tagged SIN3 187 isoform	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046042	none	Drosophila melanogaster	HA-tagged SIN3 187 isoform	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046043	none	Drosophila melanogaster	HA-tagged SIN3 220 isoform	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046044	none	Drosophila melanogaster	HA-tagged SIN3 220 isoform	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046045	sin3	Drosophila melanogaster	HA-tagged SIN3 187 isoform	EXP046041	1451	normal	O77025	S2 (Schneider 2)	NULL
EXP046046	Anti-HA-Agarose antibody (Sigma)	Drosophila melanogaster	HA-tagged SIN3 187 isoform	EXP046042	1451	normal	O77025	S2 (Schneider 2)	NULL
EXP046047	Anti-HA-Agarose antibody (Sigma)	Drosophila melanogaster	HA-tagged SIN3 220 isoform	EXP046043	1451	normal	O77025	S2 (Schneider 2)	NULL
EXP046048	Anti-HA-Agarose antibody (Sigma)	Drosophila melanogaster	HA-tagged SIN3 220 isoform	EXP046044	1451	normal	O77025	S2 (Schneider 2)	NULL
EXP046049	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046050	anti-SMARCAD1 (ASNA), custom-made antibodies	Drosophila melanogaster		EXP046049	1451	normal	Q9VL72	S2 (Schneider 2)	NULL
EXP046051	anti-CBP, custom-made antibodies	Drosophila melanogaster		EXP046049	1451	normal	M9PH39	S2 (Schneider 2)	NULL
EXP046052	none	Drosophila melanogaster	Treatment: 1 day after spaced training; strain: CS10	NULL	1978	chip_control	NULL	mushroom body	NULL
EXP046053	anti-CREB (lab made antibodies)	Drosophila melanogaster	Treatment: 1 day after spaced training; strain: CS10	NULL	1978	normal	Q9VWW0	mushroom body	NULL
EXP046054	anti-CRTC (lab made antibodies)	Drosophila melanogaster	Treatment: 1 day after spaced training; strain: CS10	NULL	1978	normal	Q9VVJ8	mushroom body	NULL
EXP046055	IgG	Drosophila melanogaster	Strain: Oregon R (wild type)	NULL	1979	chip_control	NULL	5-9.5 h embryo	NULL
EXP046056	anti-Deformed	Drosophila melanogaster	Strain: Oregon R (wild type)	EXP046055	1979	normal	P07548	5-9.5 h embryo	NULL
EXP046057		Drosophila melanogaster	strain: w1118; gender: mixed	NULL	1980	chip_control	NULL	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046058		Drosophila melanogaster	strain: w1118; gender: mixed	NULL	1980	chip_control	NULL	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046059		Drosophila melanogaster	strain: w1118; gender: mixed	NULL	1980	chip_control	NULL	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046060		Drosophila melanogaster	strain: w1118; gender: mixed	NULL	1980	chip_control	NULL	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046061	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046057	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046062	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046058	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046063	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046059	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046064	rat anti-dHNF4 3600 (PMID 19254568)	Drosophila melanogaster	strain: w1118; gender: mixed	EXP046060	1980	normal	P49866	whole organism (developmental stage: mature adult, 2 week old)	NULL
EXP046065		Drosophila melanogaster	genotype: fkh-GAL4::UAS-rib-GFP	NULL	1982	chip_control	NULL	whole organism (developmental stage: embryonic stage 11-16))	NULL
EXP046066		Drosophila melanogaster	genotype: sage-GAL4::UAS-rib-GFP	NULL	1982	chip_control	NULL	whole organism (developmental stage: embryonic stage 11-16))	NULL
EXP046067	polyclonal goat anti-GFP antibody	Drosophila melanogaster	genotype: fkh-GAL4::UAS-rib-GFP	EXP046065	1982	normal	P14734	whole organism (developmental stage: embryonic stage 11-16))	NULL
EXP046068	polyclonal goat anti-GFP antibody	Drosophila melanogaster	genotype: sage-GAL4::UAS-rib-GFP	EXP046066	1982	normal	Q9VHG3	whole organism (developmental stage: embryonic stage 11-16))	NULL
EXP046069	none	Drosophila melanogaster	Treatment: none	NULL	1983	chip_control	NULL	eye imaginal disc (developmental stage: L3)	NULL
EXP046070	none	Drosophila melanogaster	Treatment: none	NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP046071	anti-PC	Drosophila melanogaster	Treatment: none	EXP046069	1983	normal	P26017	eye imaginal disc (developmental stage: L3)	NULL
EXP046072	anti-PH	Drosophila melanogaster	Treatment: none	EXP046069	1983	normal	P11346	eye imaginal disc (developmental stage: L3)	NULL
EXP046073	anti-PC	Drosophila melanogaster	Treatment: none	EXP046070	1439	normal	P26017	wing imaginal disc (developmental stage: L3)	NULL
EXP046074	anti-PH	Drosophila melanogaster	Treatment: none	EXP046070	1439	normal	P11346	wing imaginal disc (developmental stage: L3)	NULL
EXP046075	anti-HP1, Covance (#291C)	Drosophila melanogaster	genotype: 291C Antibodies in GFP-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046076	anti-HP1, Covance (#291C)	Drosophila melanogaster	genotype: 291C Antibodies in Piwi-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046077	anti-HP1, DSHB (#C1A9)	Drosophila melanogaster	genotype: C1A9 Antibodies in GFP-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046078	anti-HP1, DSHB (#C1A9)	Drosophila melanogaster	genotype: C1A9 Antibodies in Piwi-Knockdown	NULL	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046079	none	Drosophila melanogaster	strain: Oregon R	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP046080	Normal Rabbit IgG (Millipore 12-370)	Drosophila melanogaster	strain: Oregon R	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP046081	none	Drosophila melanogaster	strain: Oregon R	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP046082	Normal Rabbit IgG (Millipore 12-370)	Drosophila melanogaster	strain: Oregon R	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP046083	CAP-D3 	Drosophila melanogaster	strain: Oregon R	EXP046079	1450	normal	Q9VMQ4	S2R+ (late embryonic stage cells)	NULL
EXP046084	YZ384 (Longworth lab)	Drosophila melanogaster	strain: Oregon R	EXP046081	1450	normal	Q9VMQ4	S2R+ (late embryonic stage cells)	NULL
EXP046085	none (input)	Drosophila melanogaster	days of treatment: 3; RNAi: GFP (control)	NULL	1985	chip_control	NULL	Kc	NULL
EXP046086	none (input)	Drosophila melanogaster	days of treatment: 3; RNAi: GFP (control)	NULL	1985	chip_control	NULL	Kc	NULL
EXP046087	none (input)	Drosophila melanogaster	days of treatment: 3; ; RNAi: SXL construct 1	NULL	1985	chip_control	NULL	Kc	NULL
EXP046088	none (input)	Drosophila melanogaster	days of treatment: 3; ; RNAi: SXL construct 1	NULL	1985	chip_control	NULL	Kc	NULL
EXP046089	none (input)	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 1	NULL	1985	chip_control	NULL	Kc	NULL
EXP046090	none (input)	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 1	NULL	1985	chip_control	NULL	Kc	NULL
EXP046091	none (input)	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 1	NULL	1985	chip_control	NULL	Kc	NULL
EXP046092	none (input)	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 1	NULL	1985	chip_control	NULL	Kc	NULL
EXP046093	none (input)	Drosophila melanogaster	days of treatment: 3;  RNAi: SXL construct 2	NULL	1985	chip_control	NULL	Kc	NULL
EXP046094	none (input)	Drosophila melanogaster	days of treatment: 3;  RNAi: SXL construct 2	NULL	1985	chip_control	NULL	Kc	NULL
EXP046095	none (input)	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 2	NULL	1985	chip_control	NULL	Kc	NULL
EXP046096	none (input)	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 2	NULL	1985	chip_control	NULL	Kc	NULL
EXP046097	none (input)	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 2	NULL	1985	chip_control	NULL	Kc	NULL
EXP046098	none (input)	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 2	NULL	1985	chip_control	NULL	Kc	NULL
EXP046099	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: GFP (control)	EXP046085	1985	normal	P50534	Kc	NULL
EXP046100	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: GFP (control)	EXP046086	1985	normal	P50534	Kc	NULL
EXP046101	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: SXL construct 1	EXP046087	1985	normal	P50534	Kc	NULL
EXP046102	MSL2	Drosophila melanogaster	days of treatment: 3; RNAi: SXL construct 1	EXP046088	1985	normal	P50534	Kc	NULL
EXP046103	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 1	EXP046089	1985	normal	P50534	Kc	NULL
EXP046104	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 1	EXP046090	1985	normal	P50534	Kc	NULL
EXP046105	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 1	EXP046091	1985	normal	P50534	Kc	NULL
EXP046106	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 1	EXP046092	1985	normal	P50534	Kc	NULL
EXP046107	MSL2	Drosophila melanogaster	days of treatment: 3;  RNAi: SXL construct 2	EXP046093	1985	normal	P50534	Kc	NULL
EXP046108	MSL2	Drosophila melanogaster	days of treatment: 3;  RNAi: SXL construct 2	EXP046094	1985	normal	P50534	Kc	NULL
EXP046109	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 2	EXP046095	1985	normal	P50534	Kc	NULL
EXP046110	MSL2	Drosophila melanogaster	days of treatment: 6; RNAi: SXL construct 2	EXP046096	1985	normal	P50534	Kc	NULL
EXP046111	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 2	EXP046097	1985	normal	P50534	Kc	NULL
EXP046112	MSL2	Drosophila melanogaster	days of treatment: 9; RNAi: SXL construct 2	EXP046098	1985	normal	P50534	Kc	NULL
EXP046113	none (input)	Drosophila melanogaster	GST RNAi (control)	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046114	none (input)	Drosophila melanogaster	GST RNAi (control)	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046115	none (input)	Drosophila melanogaster	MLE RNAi	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046116	none (input)	Drosophila melanogaster	MLE RNAi	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046117	none (input)	Drosophila melanogaster	MLE RNAi	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046118	MSL2	Drosophila melanogaster	GST RNAi (control)	EXP046113	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP046119	MSL2	Drosophila melanogaster	GST RNAi (control)	EXP046114	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP046120	MSL2	Drosophila melanogaster	MLE RNAi	EXP046115	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP046121	MSL2	Drosophila melanogaster	MLE RNAi	EXP046116	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP046122	MSL2	Drosophila melanogaster	MLE RNAi	EXP046117	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP046123	none	Drosophila melanogaster	Treatment: genotype: ry	NULL	1986	chip_control	NULL	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046124	none	Drosophila melanogaster	Treatment: genotype: ry	NULL	1986	chip_control	NULL	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046125	anti-Pho	Drosophila melanogaster	Treatment: genotype: ry	EXP046123	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046126	anti-Ph	Drosophila melanogaster	Treatment: genotype: ry	EXP046124	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046127	anti-En	Drosophila melanogaster	Treatment: genotype: ry	NULL	1986	normal	P02836	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046128		Drosophila melanogaster	strain: Oregon-R	NULL	1413	chip_control	NULL	0-12 h embryo	NULL
EXP046129	preimmune rabbit sera	Drosophila melanogaster	strain: Oregon-R	NULL	1413	chip_control	NULL	0-12 h embryo	NULL
EXP046130	Pita (rabbit, aa 550-683)	Drosophila melanogaster	strain: Oregon-R	EXP046128	1413	normal	Q9W1N1	0-12 h embryo	NULL
EXP046131	ZIPIC (rabbit, aa 84-257)	Drosophila melanogaster	strain: Oregon-R	EXP046128	1413	normal	Q9VAB8	0-12 h embryo	NULL
EXP046132	Zw5 (rabbit, aa 98-302)	Drosophila melanogaster	strain: Oregon-R	EXP046128	1413	normal	Q9U9D0	0-12 h embryo	NULL
EXP046133	anti-Ph	Drosophila melanogaster	genotype: ry- enPREs deleted	NULL	1986	chip_control	NULL	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046134	anti-Ph	Drosophila melanogaster	genotype: ry- invPREs deleted	NULL	1986	chip_control	NULL	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046135	anti-Ph	Drosophila melanogaster	genotype: ry- enPREs deleted	EXP046133	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046136	anti-Ph	Drosophila melanogaster	genotype: ry- invPREs deleted	EXP046134	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046137	anti-Ph	Drosophila melanogaster	genotype: ry- invPREs-enPREs deleted	NULL	1986	normal	P11346	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046138	anti-Pho	Drosophila melanogaster	genotype: ry- invPREs-enPREs deleted	NULL	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046139	anti-Pho	Drosophila melanogaster	genotype: ry- invPREs deleted	NULL	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046140	anti-Pho	Drosophila melanogaster	genotype: ry- enPREs deleted	NULL	1986	normal	Q8ST83	CNS and imaginal disks (developmental stage: L3)	NULL
EXP046141	none	Drosophila melanogaster	Treatment: genotype: ry- wild type	NULL	1976	chip_control	NULL	imaginal discs and salivary glands (developmental stage: L3)	NULL
EXP046142	antiCg (custom-made)	Drosophila melanogaster	Treatment: genotype: ry- wild type	EXP046141	1976	normal	Q9NI49	imaginal discs and salivary glands (developmental stage: L3)	NULL
EXP046143	anti-Ph (a kind gift from Donna Arndt-Jovin)	Drosophila melanogaster	Treatment: genotype: cgA22 mutant	NULL	1976	normal	P11346	imaginal discs and salivary glands (developmental stage: L3)	NULL
EXP046144	GAF	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q08605	Kc167 (development stage: embryonic)	NULL
EXP046145	Ibf1	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VHG5	Kc167 (development stage: embryonic)	NULL
EXP046146	Ibf2	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VHG6	Kc167 (development stage: embryonic)	NULL
EXP046147	Pita	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9W1N1	Kc167 (development stage: embryonic)	NULL
EXP046148	ZIPIC	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VAB8	Kc167 (development stage: embryonic)	NULL
EXP046149	Nup98	Drosophila melanogaster	Treatment: none	NULL	1397	normal	Q9VCH5	Kc167 (development stage: embryonic)	NULL
EXP046150		Drosophila melanogaster	Control (RNAi EGFP)	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP046151		Drosophila melanogaster	Piwi-Knockdown (RNAi Piwi)	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP046152		Drosophila melanogaster	H1-Knockdown (RNAi H1)	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP046153	anti-HP1a antibody (C1A9, DSHB)	Drosophila melanogaster	Control (RNAi EGFP)	EXP046150	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046154	anti-HP1a antibody (C1A9, DSHB)	Drosophila melanogaster	Piwi-Knockdown (RNAi Piwi)	EXP046151	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046155	anti-HP1a antibody (C1A9, DSHB)	Drosophila melanogaster	H1-Knockdown (RNAi H1)	EXP046152	1984	normal	P05205	OSC (Ovarian Somatic Cells)	NULL
EXP046156	none	Drosophila melanogaster	strain: CS10	NULL	1978	chip_control	NULL	mushroom body	NULL
EXP046166	creb	Drosophila melanogaster	strain: CS10	EXP046156	1978	normal	Q1LZ07	mushroom body	NULL
EXP046167	anti-CRTC (lab made antibodies)	Drosophila melanogaster	spaced trained 1d; strain: CS10	EXP046156	1978	normal	Q9VVJ8	mushroom body	NULL
EXP046168	crtc	Drosophila melanogaster	strain: CS10	EXP046156	1978	normal	Q9VVJ8	mushroom body	NULL
EXP046169	anti-CREB (lab made antibodies)	Drosophila melanogaster	spaced trained 1d; strain: CS10	EXP046156	1978	normal	Q1LZ07	mushroom body	NULL
EXP046170		Drosophila melanogaster	strain: Bloomington 42269; DAC-GFP	NULL	1987	chip_control	NULL	eye-antennal discs (developmental stage: L3)	NULL
EXP046171	anti-GFP Ab (ab290, Abcam)	Drosophila melanogaster	strain: Bloomington 42269; DAC-GFP	EXP046170	1987	normal	Q9VJK6	eye-antennal discs (developmental stage: L3)	NULL
EXP046172	none	Drosophila melanogaster	genotype: Su(z)124 mutant	NULL	1977	chip_control	NULL	S12-26I3	NULL
EXP046173	none	Drosophila melanogaster	genotype: Su(z)124 mutant	NULL	1977	chip_control	NULL	S12-26I3	NULL
EXP046174	none	Drosophila melanogaster		NULL	1468	chip_control	NULL	Ras3 cell line	NULL
EXP046175	none	Drosophila melanogaster		NULL	1468	chip_control	NULL	Ras3 cell line	NULL
EXP046176	Pc from Poux et al., 2001	Drosophila melanogaster	genotype: Su(z)124 mutant	EXP046172	1977	normal	P26017	S12-26I3	NULL
EXP046177	Pc from Poux et al., 2001	Drosophila melanogaster	genotype: Su(z)124 mutant	EXP046173	1977	normal	P26017	S12-26I3	NULL
EXP046178	Pc from Poux et al., 2001	Drosophila melanogaster		EXP046174	1468	normal	P26017	Ras3 cell line	NULL
EXP046179	Pc from Poux et al., 2001	Drosophila melanogaster		EXP046175	1468	normal	P26017	Ras3 cell line	NULL
EXP046180	none	Drosophila melanogaster		NULL	1988	chip_control	NULL	2-3 hrs AEL embryo	NULL
EXP046181	none	Drosophila melanogaster		NULL	1989	chip_control	NULL	5-6 hrs AEL embryo	NULL
EXP046182	none	Drosophila melanogaster		NULL	1990	chip_control	NULL	11-12 hrs AEL embryo	NULL
EXP046183	none	Drosophila melanogaster		NULL	1991	chip_control	NULL	15-16 hrs AEL embryo	NULL
EXP046184		Drosophila melanogaster		NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP046185	C-terminal anti-GRH	Drosophila melanogaster		EXP046180	1988	normal	P13002	2-3 hrs AEL embryo	NULL
EXP046186	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046180	1988	normal	P13002	2-3 hrs AEL embryo	NULL
EXP046187	C-terminal anti-GRH	Drosophila melanogaster		EXP046181	1989	normal	P13002	5-6 hrs AEL embryo	NULL
EXP046188	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046181	1989	normal	P13002	5-6 hrs AEL embryo	NULL
EXP046189	C-terminal anti-GRH	Drosophila melanogaster		EXP046182	1990	normal	P13002	11-12 hrs AEL embryo	NULL
EXP046190	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046182	1990	normal	P13002	11-12 hrs AEL embryo	NULL
EXP046191	C-terminal anti-GRH	Drosophila melanogaster		EXP046183	1991	normal	P13002	15-16 hrs AEL embryo	NULL
EXP046192	N-terminal antibody 1-441GRH	Drosophila melanogaster		EXP046183	1991	normal	P13002	15-16 hrs AEL embryo	NULL
EXP046193	C-terminal anti-GRH	Drosophila melanogaster		EXP046184	1439	normal	P13002	wing imaginal disc (developmental stage: L3)	NULL
EXP046194	none	Drosophila melanogaster	CP190 RNAi	NULL	1985	chip_control	NULL	Kc	NULL
EXP046195	none	Drosophila melanogaster	GFP RNAi (Control)	NULL	1985	chip_control	NULL	Kc	NULL
EXP046196	none	Drosophila melanogaster	GFP RNAi (Control)	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046197	Gcn5 rabbit polyclonal antibody (5 ug/IP)	Drosophila melanogaster	CP190 RNAi	EXP046194	1985	normal	O76216	Kc	NULL
EXP046198	Gcn5 rabbit polyclonal antibody (5 ug/IP)	Drosophila melanogaster	GFP RNAi (Control)	EXP046195	1985	normal	O76216	Kc	NULL
EXP046199	Gcn5 rabbit polyclonal antibody (5 ug/IP)	Drosophila melanogaster	GFP RNAi (Control)	EXP046196	1451	normal	O76216	S2 (Schneider 2)	NULL
EXP046200	none	Drosophila melanogaster	gender: female	NULL	1428	chip_control	NULL	whole organism (developmental stage: L3)	NULL
EXP046201	none	Drosophila melanogaster	gender: female	NULL	1428	chip_control	NULL	whole organism (developmental stage: L3)	NULL
EXP046202	anti-CLAMP (SDix, Cat# 4988.00.02, Lot# G3131-080A02; PMID 22844249)	Drosophila melanogaster	gender: female	EXP046200	1428	normal	Q9V9N4	whole organism (developmental stage: L3)	NULL
EXP046203	anti-CLAMP (SDix, Cat# 4988.00.02, Lot# G3131-080A02; PMID 22844249)	Drosophila melanogaster	gender: female	EXP046201	1428	normal	Q9V9N4	whole organism (developmental stage: L3)	NULL
EXP046204	none	Drosophila melanogaster		NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046205	Nipped-B	Drosophila melanogaster		EXP046204	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046206	SA	Drosophila melanogaster		EXP046204	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046207	TBPH	Drosophila melanogaster		EXP046204	1244	normal	O97468	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046208	Lark	Drosophila melanogaster		EXP046204	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046209	Nipped-B	Drosophila melanogaster	TBPH RNAi treatment	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046210	SA	Drosophila melanogaster	TBPH RNAi treatment	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046211	Nipped-B	Drosophila melanogaster	Lark RNAi treatment	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046212	SA	Drosophila melanogaster	Lark RNAi treatment	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046213	TBPH	Drosophila melanogaster	Nipped-B RNAi treatment	NULL	1244	normal	O97468	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046214	Lark	Drosophila melanogaster	Nipped-B RNAi treatment	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046215	Nipped-B	Drosophila melanogaster	10 micromolar triptolide treatment (4 hour)	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046216	TBPH	Drosophila melanogaster	10 micromolar triptolide treatment (1 hour)	NULL	1244	normal	O97468	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046217	Lark	Drosophila melanogaster	10 micromolar triptolide treatment (1 hour)	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046218	Lark	Drosophila melanogaster	10 micromolar triptolide treatment (2 hour)	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046219	Lark	Drosophila melanogaster	10 micromolar triptolide treatment (4 hour)	NULL	1244	normal	Q94901	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP046220	Nipped-B	Drosophila melanogaster	gender: yw male	NULL	1439	normal	Q7PLI2	wing imaginal disc (developmental stage: L3)	NULL
EXP046221	TBPH	Drosophila melanogaster	gender: yw male	NULL	1439	normal	O97468	wing imaginal disc (developmental stage: L3)	NULL
EXP046222	Lark	Drosophila melanogaster	gender: yw male	NULL	1439	normal	Q94901	wing imaginal disc (developmental stage: L3)	NULL
EXP046223	none	Drosophila melanogaster	7 days at 29Â°C; genotype: 3HA-scÂ transgene	NULL	1469	chip_control	NULL	intestines (developmental stage: adult)	NULL
EXP046224	none	Drosophila melanogaster	7 days at 29Â°C; genotype: 3HA-esg transgene	NULL	1469	chip_control	NULL	intestines (developmental stage: adult)	NULL
EXP046225	sc	Drosophila melanogaster	7 days at 29Â°C; genotype: 3HA-scÂ transgene	EXP046223	1469	normal	P10084	intestines (developmental stage: adult)	NULL
EXP046226	esg	Drosophila melanogaster	7 days at 29Â°C; genotype: 3HA-esg transgene	EXP046224	1469	normal	P25932	intestines (developmental stage: adult)	NULL
EXP046227	Genomic DNA (input)	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046228		Drosophila melanogaster	GalNAz feeding	EXP046227	1451	normal	Q7KJA9	S2 (Schneider 2)	NULL
EXP046229	Pho antibody	Drosophila melanogaster		EXP046227	1451	normal	Q8ST83	S2 (Schneider 2)	NULL
EXP046360	rabbit ?ROW	Drosophila melanogaster		EXP046358	1451	normal	A0A0B4KER0	S2 (Schneider 2)	NULL
EXP046359	rabbit ?WOC	Drosophila melanogaster		EXP046358	1451	normal	A8JRE3	S2 (Schneider 2)	NULL
EXP046232		Drosophila melanogaster	GalNAz feeding; wild type	NULL	1404	normal	Q7KJA9	whole organism (development stage: pupa)	NULL
EXP046233		Drosophila melanogaster	GalNAz feeding; strain: sxc6/sxc7 null	NULL	1404	bio_control	Q7KJA9	whole organism (development stage: pupa)	NULL
EXP046358	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046234		Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046235	y14	Drosophila melanogaster		EXP046234	1451	normal	Q9V535	S2 (Schneider 2)	NULL
EXP046236	none (input)	Drosophila melanogaster	genotype: K9R	NULL	1428	chip_control	NULL	whole organism (developmental stage: L3)	NULL
EXP046237	none (input)	Drosophila melanogaster	genotype: HWT	NULL	1428	chip_control	NULL	whole organism (developmental stage: L3)	NULL
EXP046238	anti-HP1a (Covance, PRB-291C, Lot #D14JF02175)	Drosophila melanogaster	genotype: HWT	EXP046237	1428	normal	P05205	whole organism (developmental stage: L3)	NULL
EXP046239	anti-HP1a (Covance, PRB-291C, Lot #D14JF02175)	Drosophila melanogaster	genotype: K9R	EXP046236	1428	normal	P05205	whole organism (developmental stage: L3)	NULL
EXP046240		Drosophila melanogaster	Treatment: none	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046241	CTCF (PMID: 15678159)	Drosophila melanogaster	Treatment: none	EXP046240	1407	normal	Q9VS55	whole organism (development stage: embryonic)	NULL
EXP046242	anti-TFIIA rabbit polyclonal, Kadonaga lab	Drosophila melanogaster		NULL	1397	normal	P52654	Kc167 (development stage: embryonic)	NULL
EXP046243	anti-TFIIB rabbit polyclonal, Kadonaga lab	Drosophila melanogaster		NULL	1397	normal	P29052	Kc167 (development stage: embryonic)	NULL
EXP046244	none (input)	Drosophila melanogaster		NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP046245	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	NULL
EXP046246	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	NULL
EXP046247	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P29555	Kc167 (development stage: embryonic)	NULL
EXP046248	anti-GFP	Drosophila melanogaster		EXP046244	1397	normal	P09087	Kc167 (development stage: embryonic)	NULL
EXP046249	anti-GFP	Drosophila melanogaster	mutant Ubx	EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	NULL
EXP046250	anti-GFP	Drosophila melanogaster	Ubx-GFP and Hth expression	EXP046244	1397	normal	P83949	Kc167 (development stage: embryonic)	NULL
EXP046251	IgG	Drosophila melanogaster		NULL	2203	chip_control	NULL	ovary	NULL
EXP046252	anti-Su(Hw) guinea pig antibody (Baxley et al., 2011)	Drosophila melanogaster	su(Hw)M393 allele	EXP046251	2203	normal	P08970	ovary	NULL
EXP046253	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046254	MLF	Drosophila melanogaster		EXP046253	1451	normal	Q9NKV0	S2 (Schneider 2)	NULL
EXP046255	DnaJ1	Drosophila melanogaster		EXP046253	1451	normal	Q24133	S2 (Schneider 2)	NULL
EXP046256	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046257	atro	Drosophila melanogaster		EXP046256	1451	normal	Q8T9N4	S2 (Schneider 2)	NULL
EXP046258	Normal rabbit IgG	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046259	Rabbit anti-Atro sera (SG2524)	Drosophila melanogaster		EXP046258	1451	normal	Q8T9N4	S2 (Schneider 2)	NULL
EXP046260	input	Drosophila melanogaster		NULL	2160	chip_control	NULL	testis	NULL
EXP046261	input	Drosophila melanogaster		NULL	2160	chip_control	NULL	testis	NULL
EXP046262	input	Drosophila melanogaster	UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	NULL	2160	chip_control	NULL	testis	NULL
EXP046263	input	Drosophila melanogaster		NULL	2160	chip_control	NULL	testis	NULL
EXP046264	input	Drosophila melanogaster	UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	NULL	2160	chip_control	NULL	testis	NULL
EXP046265	input	Drosophila melanogaster	alyP-Aly-HA; UAS-RNAi-kmg (VDRC# 107395); TM6b	NULL	2160	chip_control	NULL	testis	NULL
EXP046266	input	Drosophila melanogaster	alyP-Aly-HA; UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	NULL	2160	chip_control	NULL	testis	NULL
EXP046267	Aly	Drosophila melanogaster		EXP046260	2160	bio_control	Q2PNM9	testis	NULL
EXP046268	Kmg	Drosophila melanogaster		EXP046261	2160	normal	Q9VK36	testis	NULL
EXP046269	anti-Kmg	Drosophila melanogaster	UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	EXP046262	2160	normal	Q9VK36	testis	NULL
EXP046270	Dmi2	Drosophila melanogaster		EXP046263	2160	normal	O97159	testis	NULL
EXP046271	Dmi2	Drosophila melanogaster	UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	EXP046264	2160	normal	O97159	testis	NULL
EXP046272	Aly-HA	Drosophila melanogaster	alyP-Aly-HA; UAS-RNAi-kmg (VDRC# 107395); TM6b	EXP046265	2160	normal	Q2PNM9	testis	NULL
EXP046273	Aly-HA	Drosophila melanogaster	alyP-Aly-HA; UAS-RNAi-kmg (VDRC# 107395); bam-gal4, UAS-dicer2	EXP046266	2160	normal	Q2PNM9	testis	NULL
EXP046274	none (input)	Drosophila melanogaster		NULL	1445	chip_control	NULL	head, adult	NULL
EXP046275	anti_Trr (Johnston et al., 2011)	Drosophila melanogaster		EXP046274	1445	normal	Q8IRW8	head, adult	NULL
EXP046276	none	Drosophila melanogaster		NULL	2161	chip_control	NULL	12-24 hrs embryo	NULL
EXP046277	UpSET	Drosophila melanogaster		EXP046276	2161	normal	Q8T0K2	12-24 hrs embryo	NULL
EXP046278	input	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046279	input	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046280	input	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046281	polyclonal antibody against fly Ash1 from rabbit	Drosophila melanogaster	Treatment: siAsh1	EXP046279	1451	bio_control	Q9VW15	S2 (Schneider 2)	NULL
EXP046282	polyclonal antibody against fly Ash1 from rabbit	Drosophila melanogaster	Treatment: siMrg15	EXP046280	1451	normal	Q9VW15	S2 (Schneider 2)	NULL
EXP046283	polyclonal antibody against fly Mrg15 from rabbit	Drosophila melanogaster	Treatment: siAsh1	EXP046279	1451	normal	Q9Y0I1	S2 (Schneider 2)	NULL
EXP046284	polyclonal antibody against fly Mrg15 from rabbit	Drosophila melanogaster	Treatment: siMrg15	EXP046280	1451	bio_control	Q9Y0I1	S2 (Schneider 2)	NULL
EXP046285	Normal Rabbit IgGÂ #2729 from CST Ltd.	Drosophila melanogaster	Treatment: none	NULL	1451	normal	A1Z7S1	S2 (Schneider 2)	NULL
EXP046286	polyclonal antibody against fly Ash1 from rabbit	Drosophila melanogaster	Treatment: none	EXP046278	1451	normal	Q9VW15	S2 (Schneider 2)	NULL
EXP046287	polyclonal antibody against fly Mrg15 from rabbit	Drosophila melanogaster	Treatment: none	EXP046278	1451	normal	Q9Y0I1	S2 (Schneider 2)	NULL
EXP046288	none	Drosophila melanogaster		NULL	2160	chip_control	NULL	testis	NULL
EXP046289	e(pc)	Drosophila melanogaster		EXP046288	2160	normal	P26017	testis	NULL
EXP046290	none	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046291	anti-MSL2 (Becker lab)	Drosophila melanogaster	Treatment: none	EXP046290	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP046292	none	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046293	none	Drosophila melanogaster	Treatment: none	NULL	2163	chip_control	NULL	brain, third instar larva	NULL
EXP046294	IgG (Santa Cruz #2027)	Drosophila melanogaster	Treatment: none	NULL	2163	chip_control	NULL	brain, third instar larva	NULL
EXP046295	Nup98	Drosophila melanogaster	Treatment: wild type	EXP046292	1451	normal	A1YK24	S2 (Schneider 2)	NULL
EXP046296	Nup98	Drosophila melanogaster	Treatment: Nup98 overexpression	EXP046292	1451	normal	A1YK24	S2 (Schneider 2)	NULL
EXP046297	Nup98	Drosophila melanogaster	Treatment: none	EXP046293	2163	normal	A1YK24	brain, third instar larva	NULL
EXP046298	none	Drosophila melanogaster	Treatment: none	NULL	2163	normal	A0A0B4KGX3	brain, third instar larva	NULL
EXP046299	Elys (This study)	Drosophila melanogaster	Treatment: none	EXP046294	2163	normal	Q9VWE6	brain, third instar larva	NULL
EXP046300	Nup93 	Drosophila melanogaster	Treatment: none	EXP046294	2163	normal	Q9XZ06	brain, third instar larva	NULL
EXP046301		Drosophila melanogaster	Treatment: trr[1] ;; trr-WT	NULL	2164	chip_control	NULL	brain, adult	NULL
EXP046302	input	Drosophila melanogaster	Treatment: trr[1] ;; trr-C2398A	NULL	2164	chip_control	NULL	brain, adult	NULL
EXP046303	input	Drosophila melanogaster	Treatment: trr[1] ;; trr-WT	NULL	2164	chip_control	NULL	brain, adult	NULL
EXP046304	input	Drosophila melanogaster	Treatment: trr[1] ;; trr-Y2383F	NULL	2164	chip_control	NULL	brain, adult	NULL
EXP046305	anti-LPT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-C2398A	EXP046302	2164	normal	Q9W1H0	brain, adult	NULL
EXP046306	anti-LPT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-WT	EXP046303	2164	normal	Q9W1H0	brain, adult	NULL
EXP046307	anti-LPT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-Y2383F	EXP046304	2164	normal	Q9W1H0	brain, adult	NULL
EXP046308	anti-TRR-NT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-WT	EXP046301	2164	normal	Q8IRW8	brain, adult	NULL
EXP046309	anti-TRR-NT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-C2398A	EXP046301	2164	normal	Q8IRW8	brain, adult	NULL
EXP046310	anti-TRR-NT (homemade, rabbit polyclonal)	Drosophila melanogaster	Treatment: trr[1] ;; trr-Y2383F	EXP046301	2164	normal	Q8IRW8	brain, adult	NULL
EXP046311	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046312	none	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046313	anti-CP190	Drosophila melanogaster		EXP046311	1451	normal	Q24478	S2 (Schneider 2)	NULL
EXP046314	anti-CP190	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	EXP046312	1451	normal	Q24478	S2 (Schneider 2)	NULL
EXP046315	Anti-dCTCF (N3)	Drosophila melanogaster		EXP046311	1451	normal	Q9VS55	S2 (Schneider 2)	NULL
EXP046316	Anti-dCTCF (N3)	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	EXP046312	1451	normal	Q9VS55	S2 (Schneider 2)	NULL
EXP046317	Anti-FLAG-M2	Drosophila melanogaster		EXP046311	1451	normal	O97102	S2 (Schneider 2)	NULL
EXP046318	Anti-FLAG-M2	Drosophila melanogaster	100mM CuSO4 24 h after seading cells	EXP046312	1451	normal	O97102	S2 (Schneider 2)	NULL
EXP046319	none	Drosophila melanogaster		NULL	2165	chip_control	NULL	testes, adult	NULL
EXP046320	anti-dBigH1 (PÃ©rez-Montero et al., 2013)	Drosophila melanogaster		EXP046319	2165	normal	Q8MSC4	testes, adult	NULL
EXP046321	none	Drosophila melanogaster		NULL	2203	chip_control	NULL	ovary	NULL
EXP046322	none	Drosophila melanogaster	w; rhi[18-5]/ rhi[18-7]; ; rhino KO	NULL	2203	chip_control	NULL	ovary	NULL
EXP046323	none	Drosophila melanogaster	w, moon_FS1{delta}1/moon_FS2{delta}28; ; moonshiner KO	NULL	2203	chip_control	NULL	ovary	NULL
EXP046324	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w1118.tm3; ;	EXP046321	2203	normal	Q7JXA8	ovary	NULL
EXP046325	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w; rhi[18-5]/ rhi[18-7]; ; Rhino KO	EXP046322	2203	bio_control	Q7JXA8	ovary	NULL
EXP046326	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w, moon_FS1{delta}1/moon_FS2{delta}28; ; moonshiner KO	EXP046323	2203	normal	Q7JXA8	ovary	NULL
EXP046327	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	w ; Pld{delta}prom[m1-1] ;	EXP046321	2203	normal	Q7JXA8	ovary	NULL
EXP046328	sera from Preimmune rabbit	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP046329	M1BP	Drosophila melanogaster		EXP046328	1450	normal	Q9VHM3	S2R+ (late embryonic stage cells)	NULL
EXP046330	TAF1 (TAF250)	Drosophila melanogaster		EXP046328	1450	normal	P51123	S2R+ (late embryonic stage cells)	NULL
EXP046331	TRF2	Drosophila melanogaster		EXP046328	1450	normal	Q07DP5	S2R+ (late embryonic stage cells)	NULL
EXP046332	none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP046333	GFP (Abcam, ab290)	Drosophila melanogaster		EXP046332	1451	normal	P26017	S2 (Schneider 2)	NULL
EXP046334		Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046335		Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046336		Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046337	input	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046338	input	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046339	input	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046340	input	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046341	input	Drosophila melanogaster		NULL	1229	chip_control	NULL	1-3 h embryo	NULL
EXP046342	rabbit-anti-sgf11	Drosophila melanogaster		EXP046334	1229	normal	Q9VVR6	1-3 h embryo	NULL
EXP046343	rabbit-anti-sgf11	Drosophila melanogaster		EXP046335	1229	normal	Q9VVR6	1-3 h embryo	NULL
EXP046344	rabbit-anti-sgf11	Drosophila melanogaster		EXP046336	1229	normal	Q9VVR6	1-3 h embryo	NULL
EXP046345	rabbit-anti-nonstop	Drosophila melanogaster		EXP046337	1229	normal	Q9VVR1	1-3 h embryo	NULL
EXP046346	rabbit-anti-nonstop	Drosophila melanogaster		EXP046336	1229	normal	Q9VVR1	1-3 h embryo	NULL
EXP046347	rabbit-anti-ada2b	Drosophila melanogaster		EXP046338	1229	normal	Q8I8V0	1-3 h embryo	NULL
EXP046348	rabbit-anti-ada2b	Drosophila melanogaster		EXP046339	1229	normal	Q8I8V0	1-3 h embryo	NULL
EXP046349	rabbit-anti-ada2b	Drosophila melanogaster		EXP046340	1229	normal	Q8I8V0	1-3 h embryo	NULL
EXP046350	rabbit-anti-ada2b	Drosophila melanogaster		EXP046341	1229	normal	Q8I8V0	1-3 h embryo	NULL
EXP046351	rabbit-anti-spt3	Drosophila melanogaster		EXP046338	1229	normal	Q29R40	1-3 h embryo	NULL
EXP046352	rabbit-anti-spt3	Drosophila melanogaster		EXP046339	1229	normal	Q29R40	1-3 h embryo	NULL
EXP046353	rabbit-anti-spt3	Drosophila melanogaster		EXP046341	1229	normal	Q29R40	1-3 h embryo	NULL
EXP046354		Drosophila melanogaster		NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP046355		Drosophila melanogaster		NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP046356	anti-Myc	Drosophila melanogaster		EXP046354	1439	normal	Q95TJ9	wing imaginal disc (developmental stage: L3)	NULL
EXP046357	anti-Myc	Drosophila melanogaster		EXP046355	1439	normal	Q95TJ9	wing imaginal disc (developmental stage: L3)	NULL
EXP046361	guinea pig ?Z4	Drosophila melanogaster		EXP046358	1451	normal	Q9VP57	S2 (Schneider 2)	NULL
EXP046362	Input	Drosophila melanogaster	dCTCF RNAi	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP046363	rad21	Drosophila melanogaster		EXP046362	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	NULL
EXP046364	barren	Drosophila melanogaster	Interphase	EXP046362	1397	normal	Q9VIP9	Kc167 (development stage: embryonic)	NULL
EXP046365	barren	Drosophila melanogaster	Asynchronous	EXP046362	1397	normal	Q9VIP9	Kc167 (development stage: embryonic)	NULL
EXP046366	CAPH2	Drosophila melanogaster	Interphase	EXP046362	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	NULL
EXP046367	CAPH2	Drosophila melanogaster	Asynchronous	EXP046362	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	NULL
EXP046368	chromator	Drosophila melanogaster		EXP046362	1397	normal	Q86BS3	Kc167 (development stage: embryonic)	NULL
EXP046369	GAF	Drosophila melanogaster		EXP046362	1397	normal	A4V1Y6	Kc167 (development stage: embryonic)	NULL
EXP046370	CP190	Drosophila melanogaster		EXP046362	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP046371	dTFIIIC220	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	NULL
EXP046372	Cohesin (Rad21)	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	A0A021WW32	Kc167 (development stage: embryonic)	NULL
EXP046373	CAPH2	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	A0A0C4DHE3	Kc167 (development stage: embryonic)	NULL
EXP046374	CP190	Drosophila melanogaster	dCTCF RNAi	EXP046362	1397	normal	Q24478	Kc167 (development stage: embryonic)	NULL
EXP046375	dTFIIIC220	Drosophila melanogaster		EXP046362	1397	normal	Q9VJY7	Kc167 (development stage: embryonic)	NULL
EXP046376	mouse anti-FLAG (Sigma-Aldrich Cat# F1804 RRID:AB262044)	Drosophila melanogaster	Treatment: untreated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046377	none	Drosophila melanogaster	Treatment: untreated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046378	mouse anti-FLAG (Sigma-Aldrich Cat# F1804 RRID:AB262044)	Drosophila melanogaster	Treatment: untreated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046379	none	Drosophila melanogaster	Treatment: untreated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046380	none	Drosophila melanogaster	Treatment: untreated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046381	none	Drosophila melanogaster	Treatment: untreated	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046382	none	Drosophila melanogaster	Treatment: Ctrl RNAi	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046383	none	Drosophila melanogaster	Treatment: HMR RNAi	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046384	none	Drosophila melanogaster	Treatment: CP190 RNAi	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046385	none	Drosophila melanogaster	Treatment: Ctrl RNAi	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046386	none	Drosophila melanogaster	Treatment: HMR RNAi	NULL	1197	chip_control	NULL	S2-DRSC (embryonic stem cells)	NULL
EXP046387	HMR	Drosophila melanogaster	Treatment: untreated	EXP046377	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046388	HP1a	Drosophila melanogaster	Treatment: untreated	EXP046377	1197	normal	P05205	S2-DRSC (embryonic stem cells)	NULL
EXP046389	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: untreated	EXP046379	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046390	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: untreated	EXP046379	1197	normal	P05205	S2-DRSC (embryonic stem cells)	NULL
EXP046391	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: untreated	EXP046380	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046392	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: untreated	EXP046381	1197	normal	P05205	S2-DRSC (embryonic stem cells)	NULL
EXP046393	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: Ctrl RNAi	EXP046382	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046394	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: HMR RNAi	EXP046383	1197	bio_control	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046395	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: CP190 RNAi	EXP046384	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046396	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: Ctrl RNAi	EXP046385	1197	normal	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046397	rat anti-HMR 2C10 (RRID: AB2569849)	Drosophila melanogaster	Treatment: HMR RNAi	EXP046386	1197	bio_control	Q86CW5	S2-DRSC (embryonic stem cells)	NULL
EXP046398	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: Ctrl RNAi	EXP046382	1197	normal	P05205	S2-DRSC (embryonic stem cells)	NULL
EXP046399	mouse anti-HP1a C1A9 (RRID: AB528276)	Drosophila melanogaster	Treatment: HMR RNAi	EXP046383	1197	normal	P05205	S2-DRSC (embryonic stem cells)	NULL
EXP046400		Caenorhabditis elegans	strain: OP757, genotype: unc-119(tm4063); wgls757 [F57A8.1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046401		Drosophila melanogaster	strain: Hey, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=Hey-GFP.FPTB} VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046402		Drosophila melanogaster	strain: HmgZ, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=HmgZ-GFP.FPTB} VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046403		Drosophila melanogaster	strain: CG1621, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=Coop-GFP.FPTB} VK00033/TM6C, Sb[1], sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP046404		Drosophila melanogaster	strain: exex, genotype: w[1118]; P{y[+t7.7] w[+mC]=exex-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046405		Drosophila melanogaster	strain: salm, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=salm-GFP.FPTB}VK00033/TM6C, Sb[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046406		Caenorhabditis elegans	strain: OP396, genotype: unc-119(tm4063) III; wgIs396., sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP046407		Drosophila melanogaster	strain: CG17802, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG17802-GFP.FPTB} attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046408		Caenorhabditis elegans	strain: OP700, genotype: wgIs700(drap-1::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0086_1E01);unc-119(+));unc-119 (tm4063), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP046409		Drosophila melanogaster	strain: CG33017, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG33017-GFP.FPTB}VK00033/TM6C, Sb[1], sex:male	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP046410		Drosophila melanogaster	strain: Abd-B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Abd-B-EGFP.S}VK00037/SM57	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046411		Caenorhabditis elegans	strain: OP740, genotype: wgIs740Â [lin-32::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP046412		Drosophila melanogaster	strain: CG7271, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG7271-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046413		Caenorhabditis elegans	strain: OP752, genotype: unc-119(tm4063); wgIs752 [somi-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046414		Caenorhabditis elegans	strain: OP756, genotype: unc-119(tm4063); wgIs756 [ceh-13::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP046415		Drosophila melanogaster	strain: D1, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=D1-GFP.FPTB}attP40	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP046416		Caenorhabditis elegans	strain: OP139, genotype: wgIs139(ceh-27::TY1 EGFP 3xFLAG(P000007_F10); unc-119(+));unc-119(ed3), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046417		Drosophila melanogaster	strain: CG13894, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG13894-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046418		Drosophila melanogaster	strain: CG31365, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG31365-GFP.FPTB} attP40, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046419		Drosophila melanogaster	strain: CG8290, genotype: y[1] w[*]; PBac {y[+mDint2] w[+mC]=ADD1-GFP.FPTB} VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046420		Drosophila melanogaster	strain: CG8301, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG8301-GFP.FPTB} attP40, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP046421		Drosophila melanogaster	strain: Fer3, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer3-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046422		Drosophila melanogaster	strain: Sox102F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox102F-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046423		Drosophila melanogaster	strain: CG8281, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG8281-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046424		Drosophila melanogaster	strain: bsh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bsh-GFP.FTBP}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046425		Drosophila melanogaster	strain: dl-large-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=dl-GFP.FTBP}VK00033	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP046426		Drosophila melanogaster	strain: oc, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=oc-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046427		Caenorhabditis elegans	strain: OP754, genotype: wgIs754Â [T20F7.1::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP046428		Caenorhabditis elegans	strain: OP748, genotype: wgIs748(ceh-6::TY1 EGFP 3xFLAG(P000007_A02_9H01);unc-119(+));unc-119 (ed3); VC2010, sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP046429		Drosophila melanogaster	strain: gsb-n, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=gsb-n-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046430		Drosophila melanogaster	strain: CG34367, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG34367-GFP.FPTB}VK00033	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP046431		Caenorhabditis elegans	strain: OP349, genotype: unc-119(ed3) III; wgIs349., sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP046432		Caenorhabditis elegans	strain: OP660, genotype: unc-119(tm4063); wgIs660 [hmg-4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1405	chip_control	NULL	whole organism (development stage: early embryonic)	NULL
EXP046433		Drosophila melanogaster	strain: CG9817, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG43347-GFP.FPTB}VK00033/TM6C, Sb[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046434		Drosophila melanogaster	strain: CG17806, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17806-GFP.FPTB}attP40	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP046435		Drosophila melanogaster	strain: Fer2, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer2-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046436		Drosophila melanogaster	strain: CG10431-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10431-GFP.FPTB}VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046437		Caenorhabditis elegans	strain: OP768, genotype: unc-119(tm4063); wgls768 [lin-14::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP046438		Drosophila melanogaster	strain: run, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=run-GFP.FPTB}VK00033/TM6C, Sb[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046439		Drosophila melanogaster	strain: stwl, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=stwl-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046440		Drosophila melanogaster	strain: Blimp-1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Blimp-1-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046441		Caenorhabditis elegans	strain: OP745, genotype: wgIs745Â [mxl-3::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1389	chip_control	NULL	whole worms (developmental stage: L4/young adults)	NULL
EXP046442		Drosophila melanogaster	strain: CG12299, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12299-GFP.FPTB}VK00033/TM6C, Sb[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046443		Drosophila melanogaster	strain: dl-small-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dl-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	NULL	1400	chip_control	NULL	whole organism (development stage: wandering third instar larva)	NULL
EXP046444		Drosophila melanogaster	strain: CG17359, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17359-GFP.FPTB}attP40	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046445		Drosophila melanogaster	strain: gl, genotype: w[1118]; P {y[+t7.7] w[+mC]=gl-GFP.FPTB} attP40, sex:mixed	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP046446		Drosophila melanogaster	strain: CrebB, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=CrebB-GFP.FPTB} VK00033, sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046447		Drosophila melanogaster	strain: CG7745, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG7745-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046448		Caenorhabditis elegans	strain: OP344, genotype: unc-119(tm4063); wgIs344 [F49E12.6::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP046449		Drosophila melanogaster	strain: salr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=salr-GFP.FPTB}VK00033, sex:mixed	NULL	1408	chip_control	NULL	whole organism (development stage: prepupa)	NULL
EXP046450		Caenorhabditis elegans	strain: OP362, genotype: unc-119(tm4063) III; wgIs362., sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP046451		Drosophila melanogaster	strain: fd96Cb, genotype: y[1] w[*]; P{y[+mDint2] w[+mC]=fd96Cb-GFP.FPTB}attP40/CyO	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046452		Caenorhabditis elegans	strain: RAF1713, genotype: rrrSi400[Pets-4::ets-4-GFP::ets-4 3'UTR, unc-119(+)]Â II; unc-119(ed3) III, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046453		Caenorhabditis elegans	strain: OP742, genotype: wgIs742Â [C02F12.10::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP046454		Caenorhabditis elegans	strain: OP749, genotype: wgIs749Â [tlf-1::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046455		Drosophila melanogaster	strain: CG2202, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2202-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046456		Caenorhabditis elegans	strain: OP628, genotype: wgIs628(ccch-3::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0161_4E04);unc-119(+));unc-119 (tm4063), sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046457		Caenorhabditis elegans	strain: OP639, genotype: wgIs639Â [ham-2::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1392	chip_control	NULL	whole worms (mixed-stage embryos)	NULL
EXP046458		Drosophila melanogaster	strain: schlank, genotype: y[1] w[*]; PBac {y[+mDint2] w[+mC]=schlank-GFP.FPTB} VK00033/TM6C, Sb[1], sex:mixed	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046459		Drosophila melanogaster	strain: CG7101, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7101-GFP.FPTB}VK00033/TM6C, Sb[1], sex:female	NULL	1399	chip_control	NULL	whole organism (development stage: adult)	NULL
EXP046460		Drosophila melanogaster	strain: PHDP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=PHDP-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046461		Caenorhabditis elegans	strain: OP769, genotype: unc-119(tm4063); wgls769 [sptf-2::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046462		Caenorhabditis elegans	strain: OP760, genotype: unc-119(tm4063); wgIs760 [ceh-8::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP046463		Caenorhabditis elegans	strain: OP744, genotype: wgIs744Â [hlh-13::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP046464		Drosophila melanogaster	strain: Su(var)2-HP2, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Su(var)2-HP2-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046465		Drosophila melanogaster	strain: CG9948, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG9948-GFP.FPTB}attP40	NULL	1404	chip_control	NULL	whole organism (development stage: pupa)	NULL
EXP046466		Caenorhabditis elegans	strain: OP643, genotype: wgIs643Â [hlh-17::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP046467		Caenorhabditis elegans	strain: IG1654, genotype: frSi12[pNP157(akir-1p::AKIR-1::GFP)]II, sex:mixed	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP046468		Drosophila melanogaster	strain: fd3F-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=fd3F-GFP.FPTB}VK00033	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046469		Drosophila melanogaster	strain: unpg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=unpg-GFP.FTBP}VK00033/TM6C, Sb[1]	NULL	1407	chip_control	NULL	whole organism (development stage: embryonic)	NULL
EXP046470	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG2202, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG2202-GFP.FPTB}VK00033	EXP046455	1407	normal	Q9VZ63	whole organism (development stage: embryonic)	NULL
EXP046471	ab290	Drosophila melanogaster	strain: dl-large-GFP, genotype: W[*]; PBac{y[+mDint2] w[+mC]=dl-GFP.FTBP}VK00033	EXP046425	1400	normal	P15330	whole organism (development stage: wandering third instar larva)	NULL
EXP046472	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP745, genotype: wgIs745Â [mxl-3::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046441	1389	normal	Q18711	whole worms (developmental stage: L4/young adults)	NULL
EXP046473	goat-anti-GFP-UC	Drosophila melanogaster	strain: Fer3, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer3-GFP.FPTB}attP40	EXP046421	1407	normal	C0MK09	whole organism (development stage: embryonic)	NULL
EXP046474	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8NCP5	HEK293 (embryonic kidney)	NULL
EXP046475	F1804	Homo sapiens		EXP039140	430	normal	Q9UGU5	HepG2 (hepatoblastoma)	NULL
EXP046476	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG31365, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG31365-GFP.FPTB} attP40, sex:mixed	EXP046418	1407	normal	Q8T051	whole organism (development stage: embryonic)	NULL
EXP046477	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP769, genotype: unc-119(tm4063); wgls769 [sptf-2::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046461	1235	normal	Q22678	whole worms (developmental stage: young adults)	NULL
EXP046478	goat-anti-GFP-UC	Drosophila melanogaster	strain: D1, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=D1-GFP.FPTB}attP40	EXP046415	1404	normal	A4V2K7	whole organism (development stage: pupa)	NULL
EXP046479	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG33017, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG33017-GFP.FPTB}VK00033/TM6C, Sb[1], sex:male	EXP046409	1399	normal	A1ZAC8	whole organism (development stage: adult)	NULL
EXP046480	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7101, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG7101-GFP.FPTB}VK00033/TM6C, Sb[1], sex:female	EXP046459	1399	normal	Q9VWP7	whole organism (development stage: adult)	NULL
EXP046481	goat-anti-GFP-UC	Drosophila melanogaster	strain: HmgZ, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=HmgZ-GFP.FPTB} VK00033, sex:mixed	EXP046402	1407	normal	Q06943	whole organism (development stage: embryonic)	NULL
EXP046482	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP344, genotype: unc-119(tm4063); wgIs344 [F49E12.6::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046448	1387	normal	Q20619	whole worms (developmental stage: L1)	NULL
EXP046483	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP752, genotype: unc-119(tm4063); wgIs752 [somi-1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046413	1235	normal	Q8I4H1	whole worms (developmental stage: young adults)	NULL
EXP046484	goat-anti-GFP-UC	Drosophila melanogaster	strain: salr-GFP, genotype: w[1118]; Pbac{y[+mDint2] w[+mC]=salr-GFP.FPTB}VK00033, sex:mixed	EXP046449	1408	normal	Q9VKH3	whole organism (development stage: prepupa)	NULL
EXP046485	goat-anti-GFP-UC	Drosophila melanogaster	strain: Hey, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=Hey-GFP.FPTB} VK00033, sex:mixed	EXP046401	1407	normal	Q7KM13	whole organism (development stage: embryonic)	NULL
EXP046486	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q86W11	HEK293 (embryonic kidney)	NULL
EXP046487	goat-anti-GFP-UC	Drosophila melanogaster	strain: Fer2, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Fer2-GFP.FPTB}attP40	EXP046435	1407	normal	Q9VEY3	whole organism (development stage: embryonic)	NULL
EXP046488	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP749, genotype: wgIs749Â [tlf-1::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046454	1235	normal	B2D6P4	whole worms (developmental stage: young adults)	NULL
EXP046489	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP639, genotype: wgIs639Â [ham-2::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046457	1392	normal	A3RMS3	whole worms (mixed-stage embryos)	NULL
EXP046490	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG34367, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG34367-GFP.FPTB}VK00033	EXP046430	1404	normal	A2RVG7	whole organism (development stage: pupa)	NULL
EXP046491	goat-anti-GFP-UC	Drosophila melanogaster	strain: run, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=run-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046438	1407	normal	P22814	whole organism (development stage: embryonic)	NULL
EXP046492	goat-anti-GFP-UC	Drosophila melanogaster	strain: Abd-B-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Abd-B-EGFP.S}VK00037/SM57	EXP046410	1407	normal	P09087	whole organism (development stage: embryonic)	NULL
EXP046493	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP756, genotype: unc-119(tm4063); wgIs756 [ceh-13::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046414	1405	normal	P17488	whole organism (development stage: early embryonic)	NULL
EXP046494	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7271, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG7271-GFP.FPTB}attP40	EXP046412	1407	normal	Q9VVQ2	whole organism (development stage: embryonic)	NULL
EXP046495	goat-anti-GFP-UC	Drosophila melanogaster	strain: CrebB, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=CrebB-GFP.FPTB} VK00033, sex:mixed	EXP046446	1407	normal	C6SUU1	whole organism (development stage: embryonic)	NULL
EXP046496	goat-anti-GFP-UC	Drosophila melanogaster	strain: stwl, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=stwl-GFP.FPTB}attP40	EXP046439	1407	normal	Q9VUE5	whole organism (development stage: embryonic)	NULL
EXP046497	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP349, genotype: unc-119(ed3) III; wgIs349., sex:mixed	EXP046431	1392	normal	P46581	whole worms (mixed-stage embryos)	NULL
EXP046498	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9817, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG43347-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046433	1407	normal	Q9W2T1	whole organism (development stage: embryonic)	NULL
EXP046499	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8281, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG8281-GFP.FPTB}attP40	EXP046423	1407	normal	Q9VSB8	whole organism (development stage: embryonic)	NULL
EXP046500	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP660, genotype: unc-119(tm4063); wgIs660 [hmg-4::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046432	1405	normal	P41848	whole organism (development stage: early embryonic)	NULL
EXP046501	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8290, genotype: y[1] w[*]; PBac {y[+mDint2] w[+mC]=ADD1-GFP.FPTB} VK00033, sex:mixed	EXP046419	1407	normal	A1Z8R2	whole organism (development stage: embryonic)	NULL
EXP046502	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17359, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17359-GFP.FPTB}attP40	EXP046444	1407	normal	Q9VUB3	whole organism (development stage: embryonic)	NULL
EXP046503	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8N8E2	HEK293 (embryonic kidney)	NULL
EXP046504	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd96Cb, genotype: y[1] w[*]; P{y[+mDint2] w[+mC]=fd96Cb-GFP.FPTB}attP40/CyO	EXP046451	1407	normal	P32029	whole organism (development stage: embryonic)	NULL
EXP046505	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	P17032	HEK293 (embryonic kidney)	NULL
EXP046506	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP744, genotype: wgIs744Â [hlh-13::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046463	1391	normal	Q20561	whole worms (developmental stage: late embryo)	NULL
EXP046507	goat-anti-GFP-UC	Caenorhabditis elegans	strain: IG1654, genotype: frSi12[pNP157(akir-1p::AKIR-1::GFP)]II, sex:mixed	EXP046467	1235	normal	Q966L3	whole worms (developmental stage: young adults)	NULL
EXP046508	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q13118	HEK293 (embryonic kidney)	NULL
EXP046509	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP740, genotype: wgIs740Â [lin-32::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046411	1392	normal	Q10574	whole worms (mixed-stage embryos)	NULL
EXP046510	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP628, genotype: wgIs628(ccch-3::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0161_4E04);unc-119(+));unc-119 (tm4063), sex:mixed	EXP046456	1235	normal	Q23170	whole worms (developmental stage: young adults)	NULL
EXP046511	goat-anti-GFP-UC	Drosophila melanogaster	strain: Sox102F-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=Sox102F-GFP.FPTB}VK00033	EXP046422	1407	normal	Q9V480	whole organism (development stage: embryonic)	NULL
EXP046512	goat-anti-GFP-UC	Drosophila melanogaster	strain: Su(var)2-HP2, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=Su(var)2-HP2-GFP.FPTB}VK00033	EXP046464	1407	normal	A1Z9S6	whole organism (development stage: embryonic)	NULL
EXP046513	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG9948, genotype: w[1118]; P{y[+t7.7] w[+mC]=CG9948-GFP.FPTB}attP40	EXP046465	1404	normal	Q9VRZ6	whole organism (development stage: pupa)	NULL
EXP046514	goat-anti-GFP-UC	Drosophila melanogaster	strain: gsb-n, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=gsb-n-GFP.FPTB}attP40	EXP046429	1407	normal	P09083	whole organism (development stage: embryonic)	NULL
EXP046515	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q6P9A3	HEK293 (embryonic kidney)	NULL
EXP046516	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG7745, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=CG7745-GFP.FPTB}VK00033	EXP046447	1407	normal	Q7K3E9	whole organism (development stage: embryonic)	NULL
EXP046517	goat-anti-GFP-UC	Drosophila melanogaster	strain: salm, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=salm-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046405	1407	normal	P39770	whole organism (development stage: embryonic)	NULL
EXP046518	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG8301, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG8301-GFP.FPTB} attP40, sex:mixed	EXP046420	1404	normal	Q9VHA9	whole organism (development stage: pupa)	NULL
EXP046519	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q6AZW8	HEK293 (embryonic kidney)	NULL
EXP046520	goat-anti-GFP-UC	Drosophila melanogaster	strain: gl, genotype: w[1118]; P {y[+t7.7] w[+mC]=gl-GFP.FPTB} attP40, sex:mixed	EXP046445	1404	normal	P13360	whole organism (development stage: pupa)	NULL
EXP046521	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP742, genotype: wgIs742Â [C02F12.10::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046453	1387	normal	A3FPJ2	whole worms (developmental stage: L1)	NULL
EXP046522	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP757, genotype: unc-119(tm4063); wgls757 [F57A8.1::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046400	1235	normal	G5EDE0	whole worms (developmental stage: young adults)	NULL
EXP046523	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q8N587	HEK293 (embryonic kidney)	NULL
EXP046524	goat-anti-GFP-UC	Drosophila melanogaster	strain: schlank, genotype: y[1] w[*]; PBac {y[+mDint2] w[+mC]=schlank-GFP.FPTB} VK00033/TM6C, Sb[1], sex:mixed	EXP046458	1407	normal	Q9W423	whole organism (development stage: embryonic)	NULL
EXP046525	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP362, genotype: unc-119(tm4063) III; wgIs362., sex:mixed	EXP046450	1387	normal	Q21836	whole worms (developmental stage: L1)	NULL
EXP046526	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP643, genotype: wgIs643Â [hlh-17::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046466	1387	normal	O45489	whole worms (developmental stage: L1)	NULL
EXP046527	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP396, genotype: unc-119(tm4063) III; wgIs396., sex:mixed	EXP046406	1389	normal	P34474	whole worms (developmental stage: L4/young adults)	NULL
EXP046528	goat-anti-GFP-UC	Drosophila melanogaster	strain: oc, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=oc-GFP.FPTB}VK00033	EXP046426	1407	normal	M9PGN9	whole organism (development stage: embryonic)	NULL
EXP046529	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17802, genotype: y[1] w[*]; P {y[+t7.7] w[+mC]=CG17802-GFP.FPTB} attP40, sex:mixed	EXP046407	1407	normal	Q8SX40	whole organism (development stage: embryonic)	NULL
EXP046530	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP760, genotype: unc-119(tm4063); wgIs760 [ceh-8::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046462	1387	normal	Q94398	whole worms (developmental stage: L1)	NULL
EXP046531	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q86XU0	HEK293 (embryonic kidney)	NULL
EXP046532	goat-anti-GFP-UC	Caenorhabditis elegans	strain: RAF1713, genotype: rrrSi400[Pets-4::ets-4-GFP::ets-4 3'UTR, unc-119(+)]Â II; unc-119(ed3) III, sex:mixed	EXP046452	1235	normal	A8WFJ9	whole worms (developmental stage: young adults)	NULL
EXP046533	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP748, genotype: wgIs748(ceh-6::TY1 EGFP 3xFLAG(P000007_A02_9H01);unc-119(+));unc-119 (ed3); VC2010, sex:mixed	EXP046428	1391	normal	P20268	whole worms (developmental stage: late embryo)	NULL
EXP046534	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP754, genotype: wgIs754Â [T20F7.1::TY1::EGFP::3xFLAG + unc-119(+)];unc-119 (tm4063), sex:mixed	EXP046427	1389	normal	O02169	whole worms (developmental stage: L4/young adults)	NULL
EXP046535	goat-anti-GFP-UC	Drosophila melanogaster	strain: bsh-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=bsh-GFP.FTBP}VK00033	EXP046424	1407	normal	Q04787	whole organism (development stage: embryonic)	NULL
EXP046536	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG12299, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG12299-GFP.FPTB}VK00033/TM6C, Sb[1]	EXP046442	1407	normal	Q9VKQ7	whole organism (development stage: embryonic)	NULL
EXP046537	goat-anti-GFP-UC	Drosophila melanogaster	strain: fd3F-GFP, genotype: w[1118] PBac{y[+mDint2] w[+mC]=fd3F-GFP.FPTB}VK00033	EXP046468	1407	normal	Q7JXV9	whole organism (development stage: embryonic)	NULL
EXP046538	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG10431-GFP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=CG10431-GFP.FPTB}VK00033, sex:mixed	EXP046436	1407	normal	Q9VJ27	whole organism (development stage: embryonic)	NULL
EXP046539	ab290	Drosophila melanogaster	strain: dl-small-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=dl-GFP.FLAG}VK00033/TM3, Sb[1], sex:mixed	EXP046443	1400	normal	P15330	whole organism (development stage: wandering third instar larva)	NULL
EXP046540	goat-anti-GFP-UC	Drosophila melanogaster	strain: exex, genotype: w[1118]; P{y[+t7.7] w[+mC]=exex-GFP.FPTB}attP40	EXP046404	1407	normal	Q9VSC2	whole organism (development stage: embryonic)	NULL
EXP046541	goat-anti-GFP-UC	Drosophila melanogaster	strain: PHDP, genotype: y[1] w[*]; PBac{y[+mDint2] w[+mC]=PHDP-GFP.FPTB}VK00033	EXP046460	1407	normal	Q9W1H7	whole organism (development stage: embryonic)	NULL
EXP046542	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP768, genotype: unc-119(tm4063); wgls768 [lin-14::TY1::EGFP::3xFLAG + unc-119(+)], sex:mixed	EXP046437	1387	normal	Q21446	whole worms (developmental stage: L1)	NULL
EXP046543	goat-anti-GFP-UC	Drosophila melanogaster	strain: Blimp-1-GFP, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=Blimp-1-GFP.FPTB}attP40	EXP046440	1407	normal	Q9VRN4	whole organism (development stage: embryonic)	NULL
EXP046544	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP139, genotype: wgIs139(ceh-27::TY1 EGFP 3xFLAG(P000007_F10); unc-119(+));unc-119(ed3), sex:mixed	EXP046416	1235	normal	Q9XVN4	whole worms (developmental stage: young adults)	NULL
EXP046545	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039092	421	normal	Q99676	HEK293 (embryonic kidney)	NULL
EXP046546	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG17806, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG17806-GFP.FPTB}attP40	EXP046434	1404	normal	Q9VEF3	whole organism (development stage: pupa)	NULL
EXP046547	goat-anti-GFP-UC	Drosophila melanogaster	strain: unpg-GFP, genotype: w[1118]; PBac{y[+mDint2] w[+mC]=unpg-GFP.FTBP}VK00033/TM6C, Sb[1]	EXP046469	1407	normal	Q4V5A3	whole organism (development stage: embryonic)	NULL
EXP046548	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q8TC21	HEK293 (embryonic kidney)	NULL
EXP046549	ab-290 (Lot GR194813-1)	Homo sapiens		EXP039084	421	normal	Q9UKT9	HEK293 (embryonic kidney)	NULL
EXP046550	goat-anti-GFP-UC	Caenorhabditis elegans	strain: OP700, genotype: wgIs700(drap-1::TY1 EGFP 3xFLAG(p_wTRG5_insertion_c_0086_1E01);unc-119(+));unc-119 (tm4063), sex:mixed	EXP046408	1392	normal	Q86G95	whole worms (mixed-stage embryos)	NULL
EXP046551	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG1621, genotype: w[1118]; PBac {y[+mDint2] w[+mC]=Coop-GFP.FPTB} VK00033/TM6C, Sb[1], sex:mixed	EXP046403	1408	normal	Q7JUZ9	whole organism (development stage: prepupa)	NULL
EXP046552	goat-anti-GFP-UC	Drosophila melanogaster	strain: CG13894, genotype: y[1] w[*]; P{y[+t7.7] w[+mC]=CG13894-GFP.FPTB}attP40	EXP046417	1407	normal	Q9W0N5	whole organism (development stage: embryonic)	NULL
EXP046553	CHD8	Rattus norvegicus	Treatment: none	NULL	696	normal	Q9JIX5	oligodendrocyte progenitors	NULL
EXP046554	CHD8	Rattus norvegicus	Treatment: none	NULL	218	normal	Q9JIX5	oligodendrocytes	NULL
EXP046555	Rabbit anti-Chd7:Â Cell signaling Technology; #6505; 1	Rattus norvegicus	Treatment: none	NULL	696	normal	D3ZAP7	oligodendrocyte progenitors	NULL
EXP046556	none	Rattus norvegicus	treatment: 45 Gy radiation; sex: male; age: 4 weeks	NULL	2166	chip_control	NULL	skin tissue	NULL
EXP046557	none	Rattus norvegicus	sex: male; age: 4 weeks	NULL	2166	chip_control	NULL	skin tissue	NULL
EXP046558	yy1	Rattus norvegicus	treatment: 45 Gy radiation; sex: male; age: 4 weeks	EXP046556	2166	normal	Q8CHJ4	skin tissue	NULL
EXP046559		Rattus norvegicus	sex: male; age: 4 weeks	EXP046557	2166	normal	Q8CHJ4	skin tissue	NULL
EXP046560	IgG	Rattus norvegicus		NULL	482	chip_control	NULL	immature oligodendrocytes	NULL
EXP046561	Seh1l	Rattus norvegicus		EXP046560	696	normal	Q7TP06	oligodendrocyte progenitors	NULL
EXP046562	Seh1l	Rattus norvegicus		EXP046560	482	normal	Q7TP06	immature oligodendrocytes	NULL
EXP046563	input	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	NULL	1263	chip_control	NULL	whole cells	NULL
EXP046564	input	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	NULL	1263	chip_control	NULL	whole cells	NULL
EXP046565	Rabbit-IgG antibody (Santa Cruz Biotechnology, sc-2027)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	NULL	1263	chip_control	NULL	whole cells	NULL
EXP046566	input	Schizosaccharomyces pombe	spt5-13myc::kanMX6 dis2-11 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	NULL	1263	chip_control	NULL	whole cells	NULL
EXP046567	Rabbit-IgG antibody (Santa Cruz Biotechnology, sc-2027)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 dis2-11 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	NULL	1263	chip_control	NULL	whole cells	NULL
EXP046568	Anti-pSpt5 antibody (custom made from 21st Century Biochemicals, Marlboro, MA; Sanso et al. 2012)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046563	1263	normal	O13936	whole cells	NULL
EXP046569	Anti-Myc epitope (EMD Millipore, 05-724)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046563	1263	normal	O13936	whole cells	NULL
EXP046570	Anti-pSpt5 antibody (custom made from 21st Century Biochemicals, Marlboro, MA; Sanso et al. 2012)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046564	1263	normal	O13936	whole cells	NULL
EXP046571	Anti-Myc epitope (EMD Millipore, 05-724)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046564	1263	normal	O13936	whole cells	NULL
EXP046572	Anti-pSpt5 antibody (custom made from 21st Century Biochemicals, Marlboro, MA; Sanso et al. 2012)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 dis2-11 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046566	1263	normal	O13936	whole cells	NULL
EXP046573	Anti-Myc epitope (EMD Millipore, 05-724)	Schizosaccharomyces pombe	spt5-13myc::kanMX6 dis2-11 leu1-32 ura4-D18 his3-D1 ade6-M210 h+, temp 30C	EXP046566	1263	normal	O13936	whole cells	NULL
EXP046574	anti-FLAG	Arabidopsis thaliana	Treatment: pCLF::EBS-CLF transformed into clf mutant background; Columbia-0	NULL	1341	normal	P93831	10 day old seedlings	NULL
EXP046575	anti-FLAG	Arabidopsis thaliana	Treatment: ebs mutant; pEBS::EBS-FLAG; Columbia-0	NULL	1341	normal	F4JL28	10 day old seedlings	NULL
EXP046576	anti-FLAG	Arabidopsis thaliana	Treatment: ebs mutant; pEBS::EBS?C-FLAG; Columbia-0	NULL	1341	normal	F4JL28	10 day old seedlings	NULL
EXP046577	none	Arabidopsis thaliana		NULL	1339	chip_control	NULL	seedling	NULL
EXP046578	LHY antiserum	Arabidopsis thaliana		EXP046577	1339	normal	Q6R0H1	seedling	NULL
EXP046579	none	Arabidopsis thaliana		NULL	1339	chip_control	NULL	seedling	NULL
EXP046580	Anti-FLAG (Sigma, F7425)	Arabidopsis thaliana		EXP046579	1339	normal	F4JL28	seedling	NULL
EXP046581	none	Arabidopsis thaliana		NULL	1339	chip_control	NULL	seedling	NULL
EXP046582	Anti-HA (Sigma, H 6908)	Arabidopsis thaliana		EXP046581	1339	normal	Q9FEN9	seedling	NULL
EXP046583	Anti-Cnp1 (from Allshire lab)	Schizosaccharomyces pombe		NULL	1263	normal	Q9Y812	whole cells	NULL
EXP046584	Anti-Cnp1 (from Allshire lab)	Schizosaccharomyces pombe	ccp1 deletion	NULL	1263	normal	Q9Y812	whole cells	NULL
EXP046585	Anti-Cnp1 (from Allshire lab)	Schizosaccharomyces pombe	gar2 deletion	NULL	1263	normal	Q9Y812	whole cells	NULL
EXP051422	NA	Mus musculus	Decription: control Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP046588	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: wild type	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046589	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: wild type	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046590	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: wild type	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046591	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: wild type	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046592	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: det1-1	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046593	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: det1-1	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046594	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: det1-1	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046595	none	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: det1-1	NULL	1366	chip_control	NULL	5 day old seedlings	NULL
EXP046596	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: wild type	EXP046588	1366	normal	P48732	5 day old seedlings	NULL
EXP046597	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: wild type	EXP046589	1366	normal	P48732	5 day old seedlings	NULL
EXP046598	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: wild type	EXP046590	1366	normal	P48732	5 day old seedlings	NULL
EXP046599	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: wild type	EXP046591	1366	normal	P48732	5 day old seedlings	NULL
EXP046600	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: det1-1	EXP046592	1366	normal	P48732	5 day old seedlings	NULL
EXP046601	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) light/dark photoperiod; Genotype: det1-1	EXP046593	1366	normal	P48732	5 day old seedlings	NULL
EXP046602	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: det1-1	EXP046594	1366	normal	P48732	5 day old seedlings	NULL
EXP046603	anti-H2Bub (MM-0029-P, Medimabs)	Arabidopsis thaliana	Treatment: grown under a 16h/8h (23/19Â°C) in constant darkness; Genotype: det1-1	EXP046595	1366	normal	P48732	5 day old seedlings	NULL
EXP046604		Arabidopsis thaliana	Ecotype: Ws	NULL	1231	chip_control	NULL	whole plants	NULL
EXP046611		Arabidopsis thaliana	Genotype: LDL1pro::LDL:GFP	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP046614	Antibody against a C-terminal peptide of SEP3	Arabidopsis thaliana	Genotype: wild type 	NULL	1336	chip_control	NULL	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP046615	Antibody against a C-terminal peptide of SEP3	Arabidopsis thaliana	Genotype: wild type; Method: over pcr amplification;	EXP046614	1336	normal	O22456	inflorescence meristems and floral buds (5-7 weeks)	NULL
EXP046616	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: no stress; Ecotype: Columbia; Treament: native peacks;	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046617	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: no stress; Ecotype: Columbia; Treament: native peacks;	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046618	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: native	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046619	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: native	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046620	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046621	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046622	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046623	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	NULL	2167	chip_control	NULL	5 weeks old leaves	NULL
EXP046624	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: native	EXP046616	2167	normal	O81821	5 weeks old leaves	NULL
EXP046625	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: native	EXP046617	2167	normal	O81821	5 weeks old leaves	NULL
EXP046626	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: native	EXP046618	2167	normal	O81821	5 weeks old leaves	NULL
EXP046627	Anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: native	EXP046619	2167	normal	O81821	5 weeks old leaves	NULL
EXP046628	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046620	2167	normal	O81821	5 weeks old leaves	NULL
EXP046629	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: no heat stress; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046621	2167	normal	O81821	5 weeks old leaves	NULL
EXP046630	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046622	2167	normal	O81821	5 weeks old leaves	NULL
EXP046631	Anti-RFP (Abcam, ab62341)	Arabidopsis thaliana	Treatment: heat stress at 37C for 30 min; Ecotype: Columbia; Genotype: 35S:HSFA1b-RFP-B/Col-0	EXP046623	2167	normal	O81821	5 weeks old leaves	NULL
EXP046632	anti-GFP antibody (ab290; ABCAM)	Arabidopsis thaliana	Genotype: LDL1pro::LDL:GFP	EXP046611	1344	normal	Q8VXV7	14 day old seedling	NULL
EXP046633	anti-GTP	Arabidopsis thaliana	Treatment: blue light treated; Ecotype: Ws; Genotype: HY5 mutant;	EXP046604	1231	normal	A0A1P8BB55	whole plants	NULL
EXP046634	anti-GTP	Arabidopsis thaliana	Treatment: red light treated; Ecotype: Ws; Genotype: HY5 mutant;	EXP046604	1231	normal	A0A1P8BB55	whole plants	NULL
EXP046635		Arabidopsis thaliana	Treatment: 10uM 6BA, 4 hours (Light long day);Tagline:ypet; Accession: ARR1.2ypet;	NULL	2168	chip_control	NULL	whole 3 days seedings	NULL
EXP046636		Arabidopsis thaliana	Treatment: 10uM 6BA, 4 hours (Light long day);Tagline:ypet; Accession: ARR1.2ypet;	NULL	2168	chip_control	NULL	whole 3 days seedings	NULL
EXP046637	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Teratmen: 10 uM DMSO, 4hours (Light etiolated); Tagline: ypet; Acctssion: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	NULL
EXP046638	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Teratmen:10 uM DMSO, 4hours (Light long day); Tagline: ypet; Acctssion: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	NULL
EXP046639	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 4hours (Light long day);Tagline:ypet; Accession: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	NULL
EXP046640	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 72 hours on LS plates (Light long day);Tagline:ypet; Accession: ARR1.2ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	NULL
EXP046641	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM Dex, 4hour (Light long day); Tagline:ypet; Accession: ARR1.2ypet; Genotype: ARR1DDK; 	EXP046635	2168	normal	Q940D0	whole 3 days seedings	NULL
EXP046642	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM DMSO, 4 hours (Light long day);Tagline:ypet; Accession: ARR102ypet;	EXP046635	2168	normal	Q940D0	whole 3 days seedings	NULL
EXP046643	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 72 hours (Light long day);Tagline:ypet; Accession: ARR10ypet16;	EXP046635	2168	normal	O49397	whole 3 days seedings	NULL
EXP046644	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM DMSO, 4 hours (Light long day);Tagline:ypet; Accession: ARR12ypet;	EXP046635	2168	normal	P62598	whole 3 days seedings	NULL
EXP046645	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 4 hours (Light long day);Tagline:ypet; Accession: ARR12ypet;	EXP046635	2168	normal	P62598	whole 3 days seedings	NULL
EXP046646	GFP antibody (Thermo Fisher Scientific, A11111)	Arabidopsis thaliana	Treatment: 10uM 6BA, 4 hours on LS plates (Lightlong day); Tagline:ypet; Accession: ARR14ypet;	EXP046635	2168	normal	Q8L9Y3	whole 3 days seedings	NULL
EXP046647	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046648	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046649	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media containing 0.2 M Hydroxyurea, 45 min, 25 degree;  Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046650	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046651	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046652	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046653	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046654	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype with rtt105-del;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046655	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046656	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046657	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046658	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046659	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046660	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046661	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	NULL	2169	chip_control	NULL	YMC G1 phase S.cerevisiae cells	NULL
EXP046662	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046663	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046647	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	NULL
EXP046664	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype;	EXP046648	2170	normal	Q08032	YMC S phase S cerevisiae cells	NULL
EXP046665	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046649	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	NULL
EXP046666	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: Wildtype with rtt105-del;	EXP046650	2170	normal	Q08032	YMC S phase S cerevisiae cells	NULL
EXP046667	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046651	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	NULL
EXP046668	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046652	2170	normal	P53091	YMC S phase S cerevisiae cells	NULL
EXP046669	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046653	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	NULL
EXP046670	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046654	2170	normal	P53091	YMC S phase S cerevisiae cells	NULL
EXP046671	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046655	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	NULL
EXP046672	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT;	EXP046656	2170	normal	Q08032	YMC S phase S cerevisiae cells	NULL
EXP046673	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046657	2169	normal	Q08032	YMC G1 phase S.cerevisiae cells	NULL
EXP046674	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046658	2170	normal	Q08032	YMC S phase S cerevisiae cells	NULL
EXP046675	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype;	EXP046659	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	NULL
EXP046676	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: G1 phase; Genotype: WT;	EXP046660	2170	normal	P53091	YMC S phase S cerevisiae cells	NULL
EXP046677	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; Release conditions: YPD media containing 0.2 M Hydroxyurea for 45min at 25 degree; Cellcycle: G1 phase; Genotype: Wildtype with rtt105-del;	EXP046661	2169	normal	P53091	YMC G1 phase S.cerevisiae cells	NULL
EXP046678	anti-HA antibody (12CA5, Roche, Cat. No. 11 583 816 001)	Saccharomyces cerevisiae	Treatment: Cells were crosslinked with PFA at 25Â°C 180rpm for 20min, and PFA was quenched by Glycin; realease conditions: YPD media, 72 min, 16 degree;  Cellcycle: S phase; Genotype: WT with rtt105-del;	EXP046662	2170	normal	P53091	YMC S phase S cerevisiae cells	NULL
EXP046679	none (input)	Saccharomyces cerevisiae	Genotype: WT strain(K23889);	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046680	none (input)	Saccharomyces cerevisiae	Genotype: Smc3-Scc1 fusion strain (K24838);	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046681	none (input)	Saccharomyces cerevisiae	Genotype: Strain K26797 (containing 3XminiAID-tagged smc3 in the endogenous locus and Smc3 wild type expressed from an ectopic locus);	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046682	none (input)	Saccharomyces cerevisiae	Genotype: Strain K26611 (containing 3XminiAID tagged-smc3 and smc1DD in their respective endogenous locus, and smc3AAA mutant expressed from an ectopic locus); released conditions: arrested in G1, synthetic auxin (indole-3-acetic acid) was added to 1 mM 30 min before release. The culture was released into YPD containing 1mM auxin and nocodazole to arrest the cultures in G2;	NULL	2172	chip_control	NULL	YMC G2 phase S.cerevisiae cells	NULL
EXP046683	none (input)	Saccharomyces cerevisiae	Genotype: strain K699 (untagged control);	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046684	none (input)	Saccharomyces cerevisiae	Genotype: K24327 (ectopic Smc1)	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046685	none (input)	Saccharomyces cerevisiae	Genotype: K24327 (ectopic Smc1);	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046686	none (input)	Saccharomyces cerevisiae	Genotype: strain K26839 (ectopic Smc1) containing Scc2-PK6;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046687	none (input)	Saccharomyces cerevisiae	Genotype: strain K25646 (ectopic smc1 E1158Q) containing Scc2-PK6;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046688	none (input)	Saccharomyces cerevisiae	Genotype: strain K26840 (ectopic smc1DDD E1158Q) containing Scc2-PK6;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046689	none (input)	Saccharomyces cerevisiae	Genotype: strain K14324 containing a deletion of the endogenous SMC1 gene and expressing the wild type Smc1 from an ectopic locus;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046690	none (input)	Saccharomyces cerevisiae	Genotype: strain K15226 containing a deletion of the endogenous SMC1 gene and expressing the smc1 K650D,K661D mutant from an ectopic locus;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046691	none (input)	Saccharomyces cerevisiae	Genotype: strain K15322 containing a deletion of the endogenous SMC1 gene and expressing the smc1 K554D,K661D mutant from an ectopic locus;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046692	none (input)	Saccharomyces cerevisiae	Genotype: strain K26982, expressing smc1 K554D K661D and Smc3AAA-HA mutant from ectopic loci and containing the deletion of the SMC1 gene;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046693	none (input)	Saccharomyces cerevisiae	Genotype: strain K26983, expressing wild type Smc3-HA and wild type Smc1 from ectopic loci and containing the deletion of the SMC1 gene;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046694	none (input)	Saccharomyces cerevisiae	Genotype: strain K26756 (expressing the wild type Smc3 from the endogenous locus and the smc1DDD mutant from an ectopic locus);	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046695	none (input)	Saccharomyces cerevisiae	Genotype: strain K26757 (expressing smc1 DDD mutant from an ectopic locus and smc3AAA mutant from the endogenous locus;	NULL	2171	chip_control	NULL	Exponentially growing S.cerevisiae cells	NULL
EXP046696	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: WT strain(K23889);	EXP046679	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046697	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: Smc3-Scc1 fusion strain (K24838);	EXP046680	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046698	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: Strain K26797 (containing 3XminiAID-tagged smc3 in the endogenous locus and Smc3 wild type expressed from an ectopic locus);	EXP046681	2171	normal	A6ZQG7	Exponentially growing S.cerevisiae cells	NULL
EXP046699	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: Strain K26611 (containing 3XminiAID tagged-smc3 and smc1DD in their respective endogenous locus, and smc3AAA mutant expressed from an ectopic locus); released conditions: arrested in G1, synthetic auxin (indole-3-acetic acid) was added to 1 mM 30 min before release. The culture was released into YPD containing 1mM auxin and nocodazole to arrest the cultures in G2;	EXP046682	2172	normal	A6ZQG7	YMC G2 phase S.cerevisiae cells	NULL
EXP046700	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype:strain K699 (untagged control);	EXP046683	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046701	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: K24327 (ectopic Smc1);	EXP046684	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046702	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: K24327 (ectopic Smc1);	NULL	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046703	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26839 (ectopic Smc1) containing Scc2-PK6;	EXP046686	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046704	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K25646 (ectopic smc1 E1158Q) containing Scc2-PK6;	EXP046687	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046705	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26840 (ectopic smc1DDD E1158Q) containing Scc2-PK6;	EXP046688	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046706	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K14324 containing a deletion of the endogenous SMC1 gene and expressing the wild type Smc1 from an ectopic locus;	EXP046689	2171	bio_control	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046707	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K15226 containing a deletion of the endogenous SMC1 gene and expressing the smc1 K650D,K661D mutant from an ectopic locus;	EXP046690	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046708	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K15322 containing a deletion of the endogenous SMC1 gene and expressing the smc1 K554D,K661D mutant from an ectopic locus;	EXP046691	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046709	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: strain K26982, expressing smc1 K554D K661D and Smc3AAA-HA mutant from ectopic loci and containing the deletion of the SMC1 gene;	EXP046692	2171	normal	A6ZQG7	Exponentially growing S.cerevisiae cells	NULL
EXP046710	anti-HA atibody (3F10, Roche)	Saccharomyces cerevisiae	Genotype: strain K26983, expressing wild type Smc3-HA and wild type Smc1 from ectopic loci and containing the deletion of the SMC1 gene;	EXP046693	2171	normal	A6ZQG7	Exponentially growing S.cerevisiae cells	NULL
EXP046711	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26756 (expressing the wild type Smc3 from the endogenous locus and the smc1DDD mutant from an ectopic locus);	EXP046694	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046712	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Genotype: strain K26757 (expressing smc1 DDD mutant from an ectopic locus and smc3AAA mutant from the endogenous locus;	EXP046695	2171	normal	N1P3Y5	Exponentially growing S.cerevisiae cells	NULL
EXP046728	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none	NULL	1220	chip_control	NULL	SK1	NULL
EXP046729	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none	NULL	2170	chip_control	NULL	YMC S phase S cerevisiae cells	NULL
EXP046730	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1220	bio_control	A0A023PXA5	SK1	NULL
EXP046731	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2173	normal	A0A023PXA5	SK1 miotic cells(0 hours)	NULL
EXP046732	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2174	normal	A0A023PXA5	SK1 miotic cells(2 hour)	NULL
EXP046733	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	NULL
EXP046734	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Mata/alpha, BRE2-13xmyc-NatMX4/BRE2-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2175	normal	A0A023PXA5	SK1 miotic cells(6 hours)	NULL
EXP046735	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Wildtype;	EXP046728	1220	normal	A0A023PXA5	SK1	NULL
EXP046736	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Wildtype;	EXP046728	2177	normal	A0A023PXA5	SK1 meiotic cells (0 hours)	NULL
EXP046737	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Wildtype;	EXP046728	2176	normal	A0A023PXA5	Sk1 meiotic (2 hours)	NULL
EXP046738	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Wildtype;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	NULL
EXP046739	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Wildtype;	EXP046728	2178	normal	A0A023PXA5	SK1 meiotic cells (6 hours)	NULL
EXP046740	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1220	normal	A0A023PXA5	SK1	NULL
EXP046741	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2177	normal	A0A023PXA5	SK1 meiotic cells (0 hours)	NULL
EXP046742	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2176	normal	A0A023PXA5	Sk1 meiotic (2 hours)	NULL
EXP046743	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	NULL
EXP046744	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Mata/alpha, spp1PHD{delta}-13xmyc-KanMX4/spp1PHD{delta}-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2178	normal	A0A023PXA5	SK1 meiotic cells (6 hours)	NULL
EXP046745	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: pre sporulation medium(0 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1220	normal	A0A023PXA5	SK1	NULL
EXP046746	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(0 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2177	normal	A0A023PXA5	SK1 meiotic cells (0 hours)	NULL
EXP046747	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(2 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2176	normal	A0A023PXA5	Sk1 meiotic (2 hours)	NULL
EXP046748	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(4 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	1219	normal	A0A023PXA5	SK1 meiotic cells (4 hours)	NULL
EXP046749	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: Treatment: sporulation medium(6 hour); Genotype: Mata/alpha, spp1CXXC{delta}-13xmyc-NatMX4/spp1CXXC{delta}-13xmyc-NatMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3;	EXP046728	2178	normal	A0A023PXA5	SK1 meiotic cells (6 hours)	NULL
EXP046758	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added Top1-AID (Topoisomerases);	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP046763	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with dextrose; Genotype: Gal - HO;	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP046764	BRR6	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: flag-targged Brr6N;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP046765		Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: flag-targged Brr6N delta C4N;	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP046766		Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: Genotype: Wiltype(empty vector);	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP046773	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged cft2; 	NULL	2179	chip_control	NULL	S. cerevisiae cell extract	NULL
EXP046774	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Ref2; 	NULL	2179	chip_control	NULL	S. cerevisiae cell extract	NULL
EXP046775	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Syc1; 	NULL	2179	chip_control	NULL	S. cerevisiae cell extract	NULL
EXP046776	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Yth1;	NULL	2179	chip_control	NULL	S. cerevisiae cell extract	NULL
EXP046777	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged cft2; 	EXP046773	2179	normal	Q12102	S. cerevisiae cell extract	NULL
EXP046778	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Ref2; 	NULL	2179	normal	P42073	S. cerevisiae cell extract	NULL
EXP046779	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Syc1; 	NULL	2179	normal	Q08553	S. cerevisiae cell extract	NULL
EXP046780	IgG from rabbit serum (Sigma) directed against the Protein A content of the C-terminal TAP tag	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: TAP tagged Yth1;	NULL	2179	normal	Q06102	S. cerevisiae cell extract	NULL
EXP046781	anti - Hsf1 (Erkine et al., 1996) 	Saccharomyces cerevisiae	Treatment: non heat shock, 30 degrees; Genotype: Wildtype; 	NULL	1219	normal	P10961	SK1 meiotic cells (4 hours)	NULL
EXP046782	anti - Hsf1 (Erkine et al., 1996) 	Saccharomyces cerevisiae	Treatment: 5 min heat shock, 39 degree; Genotype: Wildtype;	NULL	1219	normal	P10961	SK1 meiotic cells (4 hours)	NULL
EXP046783	anti - Hsf1 (Erkine et al., 1996) 	Saccharomyces cerevisiae	Treatment: 120 min heat shock, 39 degree; Genotype: Wildtype;	NULL	1219	normal	P10961	SK1 meiotic cells (4 hours)	NULL
EXP046784	none	Saccharomyces cerevisiae	Treatment: 0 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046785	none	Saccharomyces cerevisiae	Treatment: 0 .5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046786	none	Saccharomyces cerevisiae	Treatment: 1 hr in meiosis; Genotype: Wildtype with MER2-Mec ars{delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046787	none	Saccharomyces cerevisiae	Treatment: 1.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046788	none	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046789	none	Saccharomyces cerevisiae	Treatment: 2.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046790	none	Saccharomyces cerevisiae	Treatment: 3 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046791	none	Saccharomyces cerevisiae	Treatment: 3.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046792	none	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046793	none	Saccharomyces cerevisiae	Treatment: 4.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046794	none	Saccharomyces cerevisiae	Treatment: 5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046795	none	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046796	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 0 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046784	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046797	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 0.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046785	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046798	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 1 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046786	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046799	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 1.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046788	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046800	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046788	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046801	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046789	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046802	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 3 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046790	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046803	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 3.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046791	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046804	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046792	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046805	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4.5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046793	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046806	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 5 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046794	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046807	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: Wildtype with MER2-Mec ars {delta};	EXP046795	2180	normal	P21651	meiotic culture in prophase	NULL
EXP046808		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: Wildtype REC114Myc;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046809		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: Wildtype REC114Myc;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046810		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: Wildtype REC114Myc;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046811		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114 -Myc-zip3;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046812		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114 -Myc-zip3;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046813		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114 -Myc-zip3;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046814		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046815		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046816		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046817		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046818		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046819		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046820		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046821		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046822		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046823		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046824		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046825		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046826		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046827		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with rec8;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046828		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with rec8;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046829		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with ho1 and red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046830		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with ho1 and red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046831		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with ho1 and red1;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046832		Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046833		Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046834		Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	NULL	2180	chip_control	NULL	meiotic culture in prophase	NULL
EXP046835	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: Wildtype REC114Myc;	EXP046808	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046836	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: Wildtype REC114Myc;	EXP046809	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046837	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: Wildtype REC114Myc;	EXP046810	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046838	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114 -Myc-zip3;	EXP046811	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046839	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114 -Myc-zip3;	EXP046812	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046840	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114 -Myc-zip3;	EXP046813	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046841	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	EXP046814	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046842	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	EXP046815	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046843	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr1 and chr 4;	EXP046816	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046844	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	EXP046817	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046845	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	EXP046818	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046846	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with reciprocal translocation between chr8 and chr 9;	EXP046819	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046847	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1;	EXP046820	2180	bio_control	P32841	meiotic culture in prophase	NULL
EXP046848	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1;	EXP046821	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046849	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1;	EXP046822	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046850	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with red1;	EXP046823	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046851	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with red1;	EXP046824	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046852	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with red1;	EXP046825	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046853	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with rec8;	EXP046826	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046854	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with rec8;	EXP046827	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046855	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with rec8;	EXP046828	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046856	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1 and red1;	EXP046829	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046857	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1 and red1;	EXP046833	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046858	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1 and red1;	EXP046831	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046859	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 2 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	EXP046832	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046860	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 4 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	EXP046833	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046861	anti-Myc antibody (9E10); BioXcell (catalog number: BE0238)	Saccharomyces cerevisiae	Treatment: 6 hr in meiosis; Genotype: REC114Myc with hop1, red1,rec8;	EXP046834	2180	normal	P32841	meiotic culture in prophase	NULL
EXP046862	none (input)	Saccharomyces cerevisiae	Treatment: OD 600; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: wild type strain K21388;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046863	none (input)	Saccharomyces cerevisiae	Treatment: OD 600; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: wild type strain K21388;	NULL	2182	chip_control	NULL	10 S.cerevisiae and glabrata at G1 phase	NULL
EXP046864	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: untargged wildtype strain K699;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046865	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	NULL	2183	chip_control	NULL	S.cervisiae, C. glabrata after30 min after G1	NULL
EXP046866	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	NULL	2184	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 45 min in G1	NULL
EXP046867	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: untargged wildtype strain K699;	NULL	2185	chip_control	NULL	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046868	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1 strain K25222;	NULL	2183	chip_control	NULL	S.cervisiae, C. glabrata after30 min after G1	NULL
EXP046869	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1 strain K25222;	NULL	2184	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 45 min in G1	NULL
EXP046870	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K25222; Genotype: MET- Scc1 strain K25222;	NULL	2185	chip_control	NULL	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046871	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET - Scc1 strain K25222;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046872	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET - Scc1 strain K25222;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046873	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046874	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25467 and Candida glabrata strain K23308; Genotype: smc3E1155Q  strain K25467;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046875	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046876	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25370 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25370;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046877	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25373 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25373;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046878	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17438 and Candida glabrata strain K23308; Genotype: Wildtype strain K17438;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046879	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25376 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25376;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046880	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K19012; Genotype: Wildtype strain K19012;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046881	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22390 and Candida glabrata strain K23308; Genotype: no ts scc2 with no ectopic strain K22390;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046882	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24188 and Candida glabrata strain K23308; Genotype: contains ts scc2 with ectopic copy containing mutations K788E H789E strain K24188;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046883	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24185 and Candida glabrata strain K23308; Genotype: strain containing ts scc2 with a WT ectopic copy strain K24185;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046884	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25186 and Candida glabrata strain K23308; Genotype: with an ectopic copy of scc2K788E H789E strain K25186;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046885	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25185 and Candida glabrata strain K23308; Genotype: with a WT ectopic copy of Scc2 strain K25185;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046886	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24687 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain  K24687;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046887	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24744 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc4ts strain K24744;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046888	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22001 and Candida glabrata strain K23308; Genotype: scc4ts strain K22001;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046889	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046890	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25053 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K25053;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046891	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25418 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc4del strain K25418;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046892	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: Wildtype untargged strain K699;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046893	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25054 and Candida glabrata strain K23308; Genotype: Wildtype strain K25054;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046894	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD, arrested in GAL- SIC1; Source: S.cerevisiae strain K25988 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K25988;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046895	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD, arrested in GAl - SIC1; Source: S.cerevisiae strain K25999 and Candida glabrata strain K23308; Genotype: Wildtype strain K25999;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046896	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD arrested in GAL-SIC1; Source: S.cerevisiae strain K26244 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K26244;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046897	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD arrested in GAL-SIC1; Source:S.cerevisiae strain K26292 and Candida glabrata strain K23308; Genotype: Wildtype strain K26292;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046898	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26270 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26270;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046899	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26277 and Candida glabrata strain K23308; Genotype: Wildtype Pds5 strain K26277;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046900	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26273 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26273;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046901	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26274 and Candida glabrata strain K23308; Genotype: Wiltype pds5 strain K26274;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046902	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26362 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-206 and 244-251 deleted K26362;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046903	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25995 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-206 deleted K25995;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046904	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25896 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-256 deleted K25896	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046905	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25997 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 207-256 deleted K25997;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046906	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17184 and Candida glabrata strain K23308; Genotype: expressing WT Scc1 K17184;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046907	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: expressing untagged WT Scc1 K699;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046908	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26251 and Candida glabrata strain K23308; Genotype: MET-Scc1V137K strain K26251;	NULL	2185	chip_control	NULL	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046909	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K216248 and Candida glabrata strain K23308; Genotype: MET-Scc1 wild type strain K26248;	NULL	2185	chip_control	NULL	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046910	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1Untagged strain K25222;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046911	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD addition of 5mM auxin 30 min prior to release from pheromone to deplete Pds5; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26270;	NULL	2187	chip_control	NULL	10 units S. cervisiae and 5 units C.glabrata G2 fase	NULL
EXP046912	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD addition of 5mM auxin 30 min prior to release from pheromone to deplete Pds5; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype Pds5 strain K26277;	NULL	2187	chip_control	NULL	10 units S. cervisiae and 5 units C.glabrata G2 fase	NULL
EXP046913	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K20891 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of wapl deletion K20891;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046914	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K20891 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of wildtype strain K22388;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046915	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25644 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25644;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046916	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25640 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25640;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046917	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25637 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25637;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046918	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17438 and Candida glabrata strain K23308; Genotype: Wildtype strain K17438;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046919	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25652 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25652;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046920	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest Pds5 - PK strain K25448;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046921	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest Scc1 - PK strain K25625;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046922	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: Wildtype strain K25448;	NULL	2188	chip_control	NULL	G2 arrested cells	NULL
EXP046923	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25625 and Candida glabrata strain K23308; Genotype: strain K25625;	NULL	2188	chip_control	NULL	G2 arrested cells	NULL
EXP046924	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24687 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K24687;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046925	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc1 deletion K24745;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046926	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046927	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046928	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 and chl4 deletion strain K24745;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046929	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	NULL	2186	chip_control	NULL	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046930	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: cc2E822K L937F, scc4 deletion  strain K24745;	NULL	2182	chip_control	NULL	10 S.cerevisiae and glabrata at G1 phase	NULL
EXP046931	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: scc4m35 strain K25049;	NULL	2185	chip_control	NULL	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046932	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	NULL	2185	chip_control	NULL	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046933	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype:  scc4m35 strain (K24745);	NULL	2182	chip_control	NULL	10 S.cerevisiae and glabrata at G1 phase	NULL
EXP046934	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD, nokodazole; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc4m35 strain K24745;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046935	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of scc3K404E strain K26286;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046936	none (input)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26281 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of scc3K404E wapl deletion  strain K26281;	NULL	2181	chip_control	NULL	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046937	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatment: OD 600; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: wild type strain K21388;	EXP046862	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046938	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatment: OD 600; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: wild type strain K21388;	EXP046863	2182	normal	Q04002	10 S.cerevisiae and glabrata at G1 phase	NULL
EXP046939	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: untargged wildtype strain K699;	EXP046864	2181	normal	N1P3Y5	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046940	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, release in the presence of methionine; Source: 10 units S.cerevisiae strain K699 and 5 units Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046865	2183	normal	Q04002	S.cervisiae, C. glabrata after30 min after G1	NULL
EXP046941	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046866	2184	normal	Q04002	10 units S. cervisiae 5 units C.glabrata after 45 min in G1	NULL
EXP046942	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046867	2185	normal	Q04002	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046943	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1 strain K25222;	EXP046868	2183	normal	Q04002	S.cervisiae, C. glabrata after30 min after G1	NULL
EXP046944	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1 strain K25222;	EXP046869	2184	normal	Q04002	10 units S. cervisiae 5 units C.glabrata after 45 min in G1	NULL
EXP046945	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K25222; Genotype: MET- Scc1 strain K25222;	EXP046870	2185	normal	Q04002	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046946	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K21388;	EXP046873	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046947	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25467 and Candida glabrata strain K23308; Genotype: smc3E1155Q  strain K25467;	EXP046874	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046948	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046875	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046949	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25370 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25370;	EXP046876	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046950	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25373 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25373;	EXP046877	2181	normal	P40541	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046951	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17438 and Candida glabrata strain K23308; Genotype: Wildtype strain K17438;	EXP046878	2181	normal	P40541	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046952	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25376 and Candida glabrata strain K23308; Genotype: smc3E1155Q strain K25376;	EXP046879	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046953	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K19012; Genotype: Wildtype strain K19012;	EXP046880	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046954	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22390 and Candida glabrata strain K23308; Genotype: no ts scc2 with no ectopic strain K22390;	EXP046881	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046955	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24188 and Candida glabrata strain K23308; Genotype: contains ts scc2 with ectopic copy containing mutations K788E H789E strain K24188;	EXP046882	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046956	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24185 and Candida glabrata strain K23308; Genotype: strain containing ts scc2 with a WT ectopic copy strain K24185;	EXP046883	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046957	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25186 and Candida glabrata strain K23308; Genotype: with an ectopic copy of scc2K788E H789E strain K25186;	EXP046884	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046958	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25185 and Candida glabrata strain K23308; Genotype: with a WT ectopic copy of Scc2 strain K25185;	EXP046885	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046959	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24687 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain  K24687;	EXP046886	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046960	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24744 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc4ts strain K24744;	EXP046887	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046961	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22001 and Candida glabrata strain K23308; Genotype: scc4ts strain K22001;	EXP046888	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046962	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046889	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046963	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25053 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K25053;	EXP046890	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046964	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25418 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc4del strain K25418;	EXP046891	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046965	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K699 and Candida glabrata strain K23308; Genotype: Wildtype untargged strain K699;	EXP046892	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046966	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25054 and Candida glabrata strain K23308; Genotype: Wildtype strain K25054;	EXP046893	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046967	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, arrested in GAL- SIC1; Source: S.cerevisiae strain K25988 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K25988;	EXP046894	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046968	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, arrested in GAl - SIC1; Source: S.cerevisiae strain K25999 and Candida glabrata strain K23308; Genotype: Wildtype strain K25999;	EXP046895	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046969	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD arrested in GAL-SIC1; Source: S.cerevisiae strain K26244 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K26244;	EXP046896	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046970	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD arrested in GAL-SIC1; Source:S.cerevisiae strain K26292 and Candida glabrata strain K23308; Genotype: Wildtype strain K26292;	EXP046897	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046971	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26270 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26270;	EXP046898	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046972	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26277 and Candida glabrata strain K23308; Genotype: Wildtype Pds5 strain K26277;	EXP046899	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046973	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26273 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26273;	EXP046900	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046974	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD GAL-SIC1 arrest after addition of 5mM auxin 30 min prior to release from pheromone; Source: S.cerevisiae strain K26274 and Candida glabrata strain K23308; Genotype: Wiltype pds5 strain K26274;	EXP046901	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046975	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26362 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-206 and 244-251 deleted K26362;	EXP046902	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046976	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25995 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-206 deleted K25995;	EXP046903	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046977	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25896 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 152-256 deleted K25896	EXP046904	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046978	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25997 and Candida glabrata strain K23308; Genotype: expressing Scc1 with residues 207-256 deleted K25997;	EXP046905	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046979	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17184 and Candida glabrata strain K23308; Genotype: expressing WT Scc1 K17184;	EXP046906	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046980	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: expressing untagged WT Scc1 K699;	EXP046907	2181	normal	A6ZQG7	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046981	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26251 and Candida glabrata strain K23308; Genotype: MET-Scc1V137K strain K26251;	EXP046908	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046982	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K216248 and Candida glabrata strain K23308; Genotype: MET-Scc1 wild type strain K26248;	EXP046909	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046983	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25222 and Candida glabrata strain K23308; Genotype: MET-Scc1Untagged strain K25222;	EXP046910	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP046984	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD addition of 5mM auxin 30 min prior to release from pheromone to deplete Pds5; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: deplete Pds5 strain K26270;	EXP046911	2187	bio_control	Q12158	10 units S. cervisiae and 5 units C.glabrata G2 fase	NULL
EXP046985	anti-HA antibody (Roche)	Saccharomyces cerevisiae	Treatmen: 600 OD addition of 5mM auxin 30 min prior to release from pheromone to deplete Pds5; Source: S.cerevisiae strain K26277 and Candida glabrata strain K23308; Genotype: Wildtype Pds5 strain K26277;	EXP046912	2187	normal	Q12158	10 units S. cervisiae and 5 units C.glabrata G2 fase	NULL
EXP046986	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K20891 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of wapl deletion K20891;	EXP046913	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046987	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K20891 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of wildtype strain K22388;	EXP046914	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046988	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25644 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25644;	EXP046915	2181	normal	Q04002	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046989	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25640 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25640;	EXP046916	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046990	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25637 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25637;	EXP046917	2181	normal	N1P3Y5	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046991	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K17438 and Candida glabrata strain K23308; Genotype: Wildtype strain K17438;	EXP046918	2181	normal	N1P3Y5	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046992	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25652 and Candida glabrata strain K23308; Genotype: smc1E1158Q strain K25652;	EXP046919	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046993	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest Pds5 - PK strain K25448;	EXP046920	2181	normal	Q04264	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046994	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25625 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest Scc1 - PK strain K25625;	EXP046921	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP046995	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25448 and Candida glabrata strain K23308; Genotype: Wildtype strain K25448;	EXP046922	2188	normal	Q04264	G2 arrested cells	NULL
EXP046996	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K25625 and Candida glabrata strain K23308; Genotype: strain K25625;	EXP046923	2188	normal	Q12158	G2 arrested cells	NULL
EXP046997	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24687 and Candida glabrata strain K23308; Genotype: scc2E822K L937F strain K24687;	EXP046924	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046998	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F scc1 deletion K24745;	EXP046925	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP046999	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046926	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP047000	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 deletion strain K24745;	EXP046927	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP047001	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 and chl4 deletion strain K24745;	EXP046928	2186	normal	Q12158	10 units S. cervisiae 5 units C.glabrata after 75 min in G1	NULL
EXP047002	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc2E822K L937F, scc4 and chl4 deletion strain K24745;	EXP046930	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP047003	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: cc2E822K L937F, scc4 deletion  strain K24745;	EXP046930	2182	normal	Q12158	10 S.cerevisiae and glabrata at G1 phase	NULL
EXP047004	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: scc4m35 strain K25049;	EXP046931	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP047005	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K22005 and Candida glabrata strain K23308; Genotype: Wildtype strain K22005;	EXP046932	2185	normal	Q12158	10 units S.cervisiae 5 units C. glabrata after 60 min in G1	NULL
EXP047006	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype:  scc4m35 strain (K24745);	EXP046933	2182	normal	Q12158	10 S.cerevisiae and glabrata at G1 phase	NULL
EXP047007	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD, nokodazole; Source: S.cerevisiae strain K24745 and Candida glabrata strain K23308; Genotype: scc4m35 strain K24745;	EXP046934	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP047008	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K21388 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of scc3K404E strain K26286;	EXP046935	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP047009	anti-PK antibody (Bio-Rad)	Saccharomyces cerevisiae	Treatmen: 600 OD; Source: S.cerevisiae strain K26281 and Candida glabrata strain K23308; Genotype: GAL-SIC1 arrest of scc3K404E wapl deletion  strain K26281;	EXP046936	2181	normal	Q12158	10 units S.cervisiae with 5 units of Candida glabrata	NULL
EXP047010	anti-Mcm2 (catalog number SC-6680; Santa Cruz)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: wildtype; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047011	anti-Mcm2 (catalog number SC-6680; Santa Cruz)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: mutation mcm2DENQ; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047012	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: wildtype; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047013	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in alfa-factor for 3 hr; Genotype: mutation mcm2DENQ; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047020	none	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP047021	none	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP047022	none	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	NULL	2190	chip_control	NULL	Early S phase S. cerevisiae cells	NULL
EXP047023	none	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	NULL	2190	chip_control	NULL	Early S phase S. cerevisiae cells	NULL
EXP047024	none	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: delation rtt105; 	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP047025	none	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: delation rtt105; 	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP047026	anti Rfa2	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: delation rtt105; 	NULL	2190	chip_control	NULL	Early S phase S. cerevisiae cells	NULL
EXP047027	none	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: delation rtt105; 	NULL	2190	chip_control	NULL	Early S phase S. cerevisiae cells	NULL
EXP047028	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: delation rtt105; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047029	none	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047030	none	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047031	none	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 72 min, 16 degree; Genotype: delation rtt105; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047032	none	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 96 min, 16 degree; Genotype: delation rtt105; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047033		Saccharomyces cerevisiae	Treatment: arrested at HU for 72 min, 16 degree; Genotype: wildtype; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047034	none	Saccharomyces cerevisiae	Treatment: arrested at HU for 72 min, 16 degree; Genotype: delation trr105; 	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP047035	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	EXP047020	2189	normal	P22336	G1 S.cerevisiae cells	NULL
EXP047036	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: wildtype; 	EXP047021	2189	normal	P22336	G1 S.cerevisiae cells	NULL
EXP047037	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	EXP047022	2190	normal	P22336	Early S phase S. cerevisiae cells	NULL
EXP047038	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: wildtype; 	EXP047023	2190	normal	P22336	Early S phase S. cerevisiae cells	NULL
EXP047039	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: delation rtt105; 	EXP047024	2189	normal	P22336	G1 S.cerevisiae cells	NULL
EXP047040	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with alfa-factor; Genotype: delation rtt105; 	EXP047025	2189	normal	P22336	G1 S.cerevisiae cells	NULL
EXP047041	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 45 min, 25 degree; Genotype: delation rtt105;	EXP047027	2190	normal	P22336	Early S phase S. cerevisiae cells	NULL
EXP047042	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 72 min , 16 degree; Genotype: wildtype; 	EXP047029	2191	normal	P22336	S phase S. cerevisiae cells	NULL
EXP047043	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 96 min, 16 degree; Genotype: wildtype; 	EXP047030	2191	normal	P22336	S phase S. cerevisiae cells	NULL
EXP047044	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 72 min, 16 degree; Genotype: delation rtt105; 	EXP047031	2191	normal	P22336	S phase S. cerevisiae cells	NULL
EXP047045	anti Rfa1	Saccharomyces cerevisiae	Treatment: arrested with 0.2 HU for 96 min, 16 degree; Genotype: delation rtt105; 	EXP047032	2191	normal	P22336	S phase S. cerevisiae cells	NULL
EXP047046	anti Rfa2	Saccharomyces cerevisiae	Treatment: arrested at HU for 72 min, 16 degree; Genotype: wildtype; 	EXP047033	2191	normal	P26754	S phase S. cerevisiae cells	NULL
EXP047047	anti Rfa2	Saccharomyces cerevisiae	Treatment: arrested at HU for 72 min, 16 degree; Genotype:delation rtt105; 	EXP047034	2191	normal	P26754	S phase S. cerevisiae cells	NULL
EXP047052	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 control lambda; 	NULL	2192	normal	P29056	Cell pellet	NULL
EXP047053	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 control lambda; 	NULL	2192	normal	P29056	Cell pellet	NULL
EXP047054	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 treat pileup; 	NULL	2192	bio_control	P29056	Cell pellet	NULL
EXP047055	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 treat pileup; 	NULL	2192	normal	P29056	Cell pellet	NULL
EXP047056	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 control lambda; 	NULL	2192	bio_control	P29056	Cell pellet	NULL
EXP047057	FLAG M2 (Sigma-Aldrich, Lot #SLBJ4607V)	Saccharomyces cerevisiae	Genotype: strain BY4741; Description: Brf1 treat pileup; 	NULL	2192	bio_control	P29056	Cell pellet	NULL
EXP047058	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047059	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047060	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047061	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047062	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047063	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype:W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047064	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047065	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047066	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047067	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX ABF1-FRB-KanMX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047068	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047069	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX REB1-FRB-HIS3MX SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047070	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047071	anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 min rapamycin; Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 STH1-FRB-KanMX RAP1-FRB-RAP1-LEU2 SPT15-13xmyc-KanMX;	NULL	1232	normal	P13393	S. cerevisiae cells	NULL
EXP047072	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047073	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047074	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047072	1390	normal	P91868	whole worms (developmental stage: L3)	NULL
EXP047075	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047073	1390	normal	P91868	whole worms (developmental stage: L3)	NULL
EXP047076	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047077	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047078	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047076	1390	normal	G5ECN8	whole worms (developmental stage: L3)	NULL
EXP047079	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047077	1390	normal	G5ECN8	whole worms (developmental stage: L3)	NULL
EXP047080	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047081	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047082	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047080	1387	normal	G5ECG2	whole worms (developmental stage: L1)	NULL
EXP047083	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047081	1387	normal	G5ECG2	whole worms (developmental stage: L1)	NULL
EXP047084	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs500(ceh-26::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP047085	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs500(ceh-26::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	NULL	1391	chip_control	NULL	whole worms (developmental stage: late embryo)	NULL
EXP047086	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs500(ceh-26::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047084	1391	normal	P34522	whole worms (developmental stage: late embryo)	NULL
EXP047087	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs500(ceh-26::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047085	1391	normal	P34522	whole worms (developmental stage: late embryo)	NULL
EXP047088	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex Hermophrodite;	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP047089	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex Hermophrodite;	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP047090	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex Hermophrodite;	EXP047088	1235	normal	G5EF11	whole worms (developmental stage: young adults)	NULL
EXP047091	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs81 [pPIE-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex Hermophrodite;	EXP047089	1235	normal	G5EF11	whole worms (developmental stage: young adults)	NULL
EXP047092	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermophrodite;	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP047093	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermophrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047094	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermophrodite;	EXP047092	1235	normal	Q22703	whole worms (developmental stage: young adults)	NULL
EXP047095	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3); vrIs48 [pPIE-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermophrodite;	EXP047093	1390	normal	Q22703	whole worms (developmental stage: L3)	NULL
EXP047096	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex: Hermaphrodite;	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047097	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex: Hermaphrodite;	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047098	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex: Hermaphrodite;	EXP047096	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP047099	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); vrIs68[pEFL-1::EFL-1::GFP FLAG: EFL-1 3'UTR; Sex: Hermaphrodite;	EXP047097	1387	normal	G5EF11	whole worms (developmental stage: L1)	NULL
EXP047100	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermaphrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047101	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermaphrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047102	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermaphrodite; 	EXP047100	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP047103	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; vrIs69[pDPL-1::DPL-1::GFP FLAG: DPL-1 3'UTR; Sex: Hermaphrodite; 	EXP047101	1387	normal	Q22703	whole worms (developmental stage: L1)	NULL
EXP047104	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047105	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047106	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047104	1387	normal	G5ECN8	whole worms (developmental stage: L1)	NULL
EXP047107	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs174(ces-1::TY1 EGFP FLAG;unc-119); Sex: Hermaphrodite; 	EXP047105	1387	normal	G5ECN8	whole worms (developmental stage: L1)	NULL
EXP047108	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs184(lin-15B::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047109	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs184(lin-15B::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047110	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs184(lin-15B::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047108	2193	normal	Q27395	whole worms(developmental stage L4)	NULL
EXP047111	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs184(lin-15B::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047109	2193	normal	Q27395	whole worms(developmental stage L4)	NULL
EXP047112	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs305(nhr-11::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047113	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs305(nhr-11::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047114	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs305(nhr-11::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1202	normal	Q23294	whole worms (developmental stage: L2)	NULL
EXP047115	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs305(nhr-11::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047113	1202	normal	Q23294	whole worms (developmental stage: L2)	NULL
EXP047116	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047117	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047118	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119); Sex: Hermaphrodite;	EXP047116	1390	normal	S6EZL2	whole worms (developmental stage: L3)	NULL
EXP047119	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3); wgIs193(sea-2::TY1 EGFP FLAG C; unc-119); Sex: Hermaphrodite;	EXP047117	1390	normal	S6EZL2	whole worms (developmental stage: L3)	NULL
EXP047120	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047121	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047122	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047120	1390	normal	G5EFF5	whole worms (developmental stage: L3)	NULL
EXP047123	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs167(daf-12::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047121	1390	normal	G5EFF5	whole worms (developmental stage: L3)	NULL
EXP047124	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc119(ed3);wgIs114(F16B12.6::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047125	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc119(ed3);wgIs114(F16B12.6::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047126	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc119(ed3);wgIs114(F16B12.6::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047124	1387	normal	Q93520	whole worms (developmental stage: L1)	NULL
EXP047127	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc119(ed3);wgIs114(F16B12.6::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047125	1387	normal	Q93520	whole worms (developmental stage: L1)	NULL
EXP047128	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047129	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047130	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047128	1202	bio_control	P91868	whole worms (developmental stage: L2)	NULL
EXP047131	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs179 [unc-119(+) gei-11::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite;	EXP047129	1202	bio_control	P91868	whole worms (developmental stage: L2)	NULL
EXP047132	anti-GFP	Caenorhabditis elegans	Genotype:unc-119(ed3) III; wgIs81 [unc-119(+) eor-1::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite; 	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047133	anti-GFP	Caenorhabditis elegans	Genotype:unc-119(ed3) III; wgIs81 [unc-119(+) eor-1::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite; 	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047134	anti-GFP	Caenorhabditis elegans	Genotype:unc-119(ed3) III; wgIs81 [unc-119(+) eor-1::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite; 	EXP047132	1390	normal	G5EDU4	whole worms (developmental stage: L3)	NULL
EXP047135	anti-GFP	Caenorhabditis elegans	Genotype:unc-119(ed3) III; wgIs81 [unc-119(+) eor-1::TY1::EGFP::3xFLAG]; Sex: Hermaphrodite; 	EXP047133	1390	normal	G5EDU4	whole worms (developmental stage: L3)	NULL
EXP047136	anti-GFP	Caenorhabditis elegans	Treatmen:fed; Genotype: unc119(ed3);wgIs301(mef-2::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047137	anti-GFP	Caenorhabditis elegans	Treatmen:fed; Genotype: unc119(ed3);wgIs301(mef-2::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047138	anti-GFP	Caenorhabditis elegans	Treatmen:fed; Genotype: unc119(ed3);wgIs301(mef-2::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047136	1387	normal	Q9U325	whole worms (developmental stage: L1)	NULL
EXP047139	anti-GFP	Caenorhabditis elegans	Treatmen:fed; Genotype: unc119(ed3);wgIs301(mef-2::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite; 	EXP047137	1387	normal	Q9U325	whole worms (developmental stage: L1)	NULL
EXP047140	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047141	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047142	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047140	1390	normal	G5ECG2	whole worms (developmental stage: L3)	NULL
EXP047143	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047141	1390	normal	G5ECG2	whole worms (developmental stage: L3)	NULL
EXP047144	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047145	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047146	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047144	2193	normal	G5ECG2	whole worms(developmental stage L4)	NULL
EXP047147	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs304(fos-1::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047145	2193	normal	G5ECG2	whole worms(developmental stage L4)	NULL
EXP047148	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs355(ZK377.2::TY1 EGFP FLAG; unc-119(+)); Sex: Hermaphrodite; 	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047149	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs355(ZK377.2::TY1 EGFP FLAG; unc-119(+)); Sex: Hermaphrodite; 	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047150	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs355(ZK377.2::TY1 EGFP FLAG; unc-119(+)); Sex: Hermaphrodite; 	EXP047148	1202	normal	G5EBF1	whole worms (developmental stage: L2)	NULL
EXP047151	anti-GFP	Caenorhabditis elegans	Genotype: unc-119(ed3) III; wgIs355(ZK377.2::TY1 EGFP FLAG; unc-119(+)); Sex: Hermaphrodite; 	EXP047149	1202	normal	G5EBF1	whole worms (developmental stage: L2)	NULL
EXP047152	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: none	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047153	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: none	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047154	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: Genotype: set9 with gfp;	EXP047152	2193	normal	O44498	whole worms(developmental stage L4)	NULL
EXP047155	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: Genotype: set9 with gfp;	EXP047153	2193	normal	O44498	whole worms(developmental stage L4)	NULL
EXP047156	set26	Caenorhabditis elegans	Treatment: Genotype: set26 with gfp;	EXP047152	2193	normal	Q9U263	whole worms(developmental stage L4)	NULL
EXP047157	anti-GFP (abcam, ab290, lot:GR278073-1)	Caenorhabditis elegans	Treatment: Genotype: set26 with gfp;	EXP047153	2193	normal	Q9U263	whole worms(developmental stage L4)	NULL
EXP047158	none	Caenorhabditis elegans	Treatment: 20 degree; Genotype: N2 Bristol;	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP047159	none	Caenorhabditis elegans	Degree: 20C; Genotype: Wildtype tdp-1;	NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP047160	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: mutante hpl-2; Strain: N2 Bristol;	EXP047158	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	NULL
EXP047161	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: mutante hpl-2; Strain: N2 Bristol;	EXP047158	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	NULL
EXP047162	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: tdp-1 mutante; 	NULL	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	NULL
EXP047163	HPL-2 antibody, Research antibody provided by the Palladino lab	Caenorhabditis elegans	Treatment: 20 degree; Genotype: tdp-1 mutante; 	NULL	1235	normal	G5EDE2	whole worms (developmental stage: young adults)	NULL
EXP047164		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119), transgene nhr-77; Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047165		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119), transgene nhr-77; Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047166	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119), transgene nhr-77; Sex: Hermaphrodite;	EXP047164	1202	normal	O02316	whole worms (developmental stage: L2)	NULL
EXP047167	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119), transgene nhr-77; Sex: Hermaphrodite;	EXP047165	1202	normal	O02316	whole worms (developmental stage: L2)	NULL
EXP047168		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047169		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047170	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047168	1390	normal	O02316	whole worms (developmental stage: L3)	NULL
EXP047171	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047169	1390	normal	O02316	whole worms (developmental stage: L3)	NULL
EXP047172	nhr77	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047173		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047174	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047172	2193	normal	O02316	whole worms(developmental stage L4)	NULL
EXP047175	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs353(nhr-77::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047173	2193	normal	O02316	whole worms(developmental stage L4)	NULL
EXP047176	NHR116	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs226(nhr-116::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047177		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs226(nhr-116::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	NULL	1202	chip_control	NULL	whole worms (developmental stage: L2)	NULL
EXP047178	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs226(nhr-116::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047176	1202	normal	G5EE21	whole worms (developmental stage: L2)	NULL
EXP047179	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs226(nhr-116::TY1 EGFP FLAG;unc119); Sex: Hermaphrodite;	EXP047177	1202	normal	G5EE21	whole worms (developmental stage: L2)	NULL
EXP047180		Caenorhabditis elegans	Treatment: fed; Genotype: unc-119(ed3); wgIs212(F45C12.2:TY1 EGFP FLAG; unc-119(+)); Sex: hermophrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047181		Caenorhabditis elegans	Treatment: fed; Genotype: unc-119(ed3); wgIs212(F45C12.2:TY1 EGFP FLAG; unc-119(+)); Sex: hermophrodite; 	NULL	1387	chip_control	NULL	whole worms (developmental stage: L1)	NULL
EXP047182	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc-119(ed3); wgIs212(F45C12.2:TY1 EGFP FLAG; unc-119(+)); Sex: hermophrodite; 	EXP047180	1387	normal	O16748	whole worms (developmental stage: L1)	NULL
EXP047183	anti-GFP	Caenorhabditis elegans	Treatment: fed; Genotype: unc-119(ed3); wgIs212(F45C12.2:TY1 EGFP FLAG; unc-119(+)); Sex: hermophrodite; 	EXP047181	1387	normal	O16748	whole worms (developmental stage: L1)	NULL
EXP047184		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119); Sex: hermophrodite;	NULL	2194	chip_control	NULL	whole worms(develomental stage: day 4 young adult)	NULL
EXP047185		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119); Sex: hermophrodite;	NULL	2194	chip_control	NULL	whole worms(develomental stage: day 4 young adult)	NULL
EXP047186	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047184	2194	normal	Q9N5D6	whole worms(develomental stage: day 4 young adult)	NULL
EXP047187	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs600(unc-62::TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047185	2194	normal	Q9N5D6	whole worms(develomental stage: day 4 young adult)	NULL
EXP047188		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs83(zag-1::TY1 EGFP FLAG;unc119); Sex; hermophrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047189		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs83(zag-1::TY1 EGFP FLAG;unc119); Sex; hermophrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047190	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs83(zag-1::TY1 EGFP FLAG;unc119); Sex; hermophrodite;	EXP047188	2193	normal	G5EBU4	whole worms(developmental stage L4)	NULL
EXP047191	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs83(zag-1::TY1 EGFP FLAG;unc119); Sex; hermophrodite;	EXP047189	2193	normal	G5EBU4	whole worms(developmental stage L4)	NULL
EXP047192		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs234(T24H10.7:TY1 EGFP FLAG;unc119); Sex: hermophrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047193		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs234(T24H10.7:TY1 EGFP FLAG;unc119); Sex: hermophrodite;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP047194	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs234(T24H10.7:TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047192	2193	normal	G5ECU7	whole worms(developmental stage L4)	NULL
EXP047195	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs234(T24H10.7:TY1 EGFP FLAG;unc119); Sex: hermophrodite;	EXP047193	2193	normal	G5ECU7	whole worms(developmental stage L4)	NULL
EXP047196		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs236(elk-2::TY1 EGFP FLAG;unc119); Sex: hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047197		Caenorhabditis elegans	Genotype: unc119(ed3);wgIs236(elk-2::TY1 EGFP FLAG;unc119); Sex: hermaphrodite;	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP047198	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs236(elk-2::TY1 EGFP FLAG;unc119); Sex: hermaphrodite;	EXP047196	1390	normal	H2L2J7	whole worms (developmental stage: L3)	NULL
EXP047199	anti-GFP	Caenorhabditis elegans	Genotype: unc119(ed3);wgIs236(elk-2::TY1 EGFP FLAG;unc119); Sex: hermaphrodite;	EXP047197	1390	normal	H2L2J7	whole worms (developmental stage: L3)	NULL
EXP047200		Homo sapiens	Stage: 13 - 18; 	NULL	2195	chip_control	NULL	human secondary fibroblast	NULL
EXP047201		Homo sapiens	Stage: 13 - 18; 	NULL	2195	chip_control	NULL	human secondary fibroblast	NULL
EXP047204	Go-ChIP-Grade Purified anti-SSRP1 Antibody	Homo sapiens	Stage: 13 - 18; 	EXP047200	2195	normal	Q08945	human secondary fibroblast	NULL
EXP047205	Go-ChIP-Grade Purified anti-SSRP1 Antibody	Homo sapiens	Stage: 13 - 18; 	EXP047201	2195	normal	Q08945	human secondary fibroblast	NULL
EXP047206	SPT16 (D7I2K) Rabbit mAb	Homo sapiens	Stage: 13 - 18; 	EXP047200	2195	normal	Q9Y5B9	human secondary fibroblast	NULL
EXP047207	SPT16 (D7I2K) Rabbit mAb	Homo sapiens	Stage: 13 - 18; 	EXP047201	2195	normal	Q9Y5B9	human secondary fibroblast	NULL
EXP047242	No antibody	Homo sapiens	Treatment: Genotype: wildtype;	NULL	455	chip_control	NULL	HUES64 (embryonic stem cells)	NULL
EXP047243	No antibody	Homo sapiens	Treatment: Genotype: wildtype;	NULL	455	chip_control	NULL	HUES64 (embryonic stem cells)	NULL
EXP047244	No antibody	Homo sapiens	Treatment: Genotype: wildtype;	NULL	455	chip_control	NULL	HUES64 (embryonic stem cells)	NULL
EXP047245	No antibody	Homo sapiens	Treatment: Genotype: wildtype;	NULL	455	chip_control	NULL	HUES64 (embryonic stem cells)	NULL
EXP047246	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2197	chip_control	NULL	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047247	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2197	chip_control	NULL	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047248	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2197	chip_control	NULL	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047249	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2197	chip_control	NULL	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047250	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2197	chip_control	NULL	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047251	none	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	NULL	2198	chip_control	NULL	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	NULL
EXP047252	none	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	NULL	2198	chip_control	NULL	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	NULL
EXP047253	none	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	NULL	2198	chip_control	NULL	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	NULL
EXP047254	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2196	chip_control	NULL	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047255	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2196	chip_control	NULL	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047256	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP047257	none	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1439	chip_control	NULL	wing imaginal disc (developmental stage: L3)	NULL
EXP047258	anti-BRD1 (Abcam, ab71877)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047242	455	normal	O95696	HUES64 (embryonic stem cells)	NULL
EXP047259	anti-BRD1 (Abcam, ab71877)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047243	455	normal	O95696	HUES64 (embryonic stem cells)	NULL
EXP047260	anti-RING1B (Abcam, ab3832)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047244	455	normal	Q99496	HUES64 (embryonic stem cells)	NULL
EXP047261	anti-RING1B (Abcam, ab3832)	Homo sapiens	Treatment: Genotype: wildtype;	EXP047245	455	normal	Q99496	HUES64 (embryonic stem cells)	NULL
EXP047262	BioTAP-N-Br140	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047246	2197	normal	Q7JVP4	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047263	BioTAP-N-Br140	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047247	2197	normal	Q7JVP4	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047264	anti-Fs(1)h (a kind gift from Dr. Igor B. Dawid)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047248	2197	normal	P13709	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047265	anti-Fs(1)h (a kind gift from Dr. Igor B. Dawid)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047249	2197	normal	P13709	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047266	anti-Fs(1)h (a kind gift from Dr. Igor B. Dawid)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047250	2197	normal	P13709	whole organism (developmental stage: embryo 12 - 24)	NULL
EXP047267	BioTAP-N-Br140	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	EXP047251	2198	normal	Q7JVP4	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	NULL
EXP047268	BioTAP-N-Fs(1)h	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	EXP047252	2198	normal	P13709	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	NULL
EXP047269	BioTAP-C-Fs(1)h	Drosophila melanogaster	Treatment: Genotype: wildtype; Stage: S2;	EXP047253	2198	normal	P13709	embryo-derived cell-line of imaginal disc (developmental stage: late embryonic)	NULL
EXP047270	none	Drosophila melanogaster	Treatment: IMAGO line with ato-gfp;	NULL	2163	chip_control	NULL	brain, third instar larva	NULL
EXP047271	none	Drosophila melanogaster	Treatment: IMAGO line with ato-gfp;	NULL	2163	chip_control	NULL	brain, third instar larva	NULL
EXP047272	anti-GFP	Drosophila melanogaster	Treatment: IMAGO line with ato-gfp;	EXP047270	2163	normal	P48987	brain, third instar larva	NULL
EXP047273	anti-GFP	Drosophila melanogaster	Treatment: IMAGO line with ato-gfp;	EXP047271	2163	normal	P48987	brain, third instar larva	NULL
EXP047274		Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	NULL	384	chip_control	NULL	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047275	c-Myc (D3N8F) Rabbit mAb	Homo sapiens		NULL	2199	chip_control	NULL	SW1271 (small cell lung carcinoma)	NULL
EXP047276		Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	NULL	2199	chip_control	NULL	SW1271 (small cell lung carcinoma)	NULL
EXP047277		Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP047278	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	P51825	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047279	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	P51825	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047280	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	P51825	SW1271 (small cell lung carcinoma)	NULL
EXP047281	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	P51825	SW1271 (small cell lung carcinoma)	NULL
EXP047282	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	Q9UHB7	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047283	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	Q9UHB7	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047284	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	Q9UHB7	SW1271 (small cell lung carcinoma)	NULL
EXP047285	AFF4 antibody	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	Q9UHB7	SW1271 (small cell lung carcinoma)	NULL
EXP047286	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	O00472	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047287	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	O00472	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047288	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	O00472	SW1271 (small cell lung carcinoma)	NULL
EXP047289	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: no mutation of MYC;	EXP047276	2199	normal	O00472	SW1271 (small cell lung carcinoma)	NULL
EXP047290	c-Myc (D3N8F) Rabbit mAb	Homo sapiens	Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC;	EXP047274	384	normal	P01106	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047291	c-Myc (D3N8F) Rabbit mAb	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	P01106	HEK293T (embryonic kidney)	NULL
EXP047292	c-Myc (D3N8F) Rabbit mAb	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	P01106	HEK293T (embryonic kidney)	NULL
EXP047293	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	P51825	HEK293T (embryonic kidney)	NULL
EXP047294	Rabbit anti-AFF1 Antibody, Affinity Purified Bethyl Laboratories	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	P51825	HEK293T (embryonic kidney)	NULL
EXP047295	AFF4 antibody	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	Q9UHB7	HEK293T (embryonic kidney)	NULL
EXP047296	AFF4 antibody	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	Q9UHB7	HEK293T (embryonic kidney)	NULL
EXP047297	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; 	EXP047277	10	normal	O00472	HEK293T (embryonic kidney)	NULL
EXP047298	Rabbit anti-ELL2 Antibody, Affinity Purified	Homo sapiens	Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; 	EXP047277	10	normal	O00472	HEK293T (embryonic kidney)	NULL
EXP047299	input	Drosophila melanogaster	Genotype: yw; 	NULL	2200	chip_control	NULL	leg imaginal discs (developmental stage: L3)	NULL
EXP047300	input	Drosophila melanogaster	Genotype: Sp1-GFP (BAC); 	NULL	2200	chip_control	NULL	leg imaginal discs (developmental stage: L3)	NULL
EXP047307	none	Drosophila melanogaster	Genotype: w1118; 	NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047308	none	Drosophila melanogaster	Genotype: pnt -/- (pnt Delta88);	NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047309	none	Drosophila melanogaster	Genotype: w1118;	NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047310	none	Drosophila melanogaster	Genotype: pnt -/- (pnt AF397);	NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047311	none	Drosophila melanogaster	Genotype: PBac{pnt-GFP.FPTB}VK00037;  	NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047312	none	Drosophila melanogaster	Genotype: yan-/-(yanE833), Pbac{pnt-GFP.FPTB}VK00037;	NULL	1434	chip_control	NULL	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047313	Guinea pig anti-Yan antibody (1:500), Webber et al. (2013) Genetics, 193:633-649	Drosophila melanogaster	Genotype: w1118; 	EXP047307	1434	normal	Q01842	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047314	Guinea pig anti-Yan antibody (1:500), Webber et al. (2013) Genetics, 193:633-649	Drosophila melanogaster	Genotype: pnt -/- (pnt Delta88);	EXP047308	1434	normal	Q01842	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047315	anti-Groucho antibody (1:200), Negre et al. (2011) Nature, 471:527-531	Drosophila melanogaster	Genotype: w1118;	EXP047310	1434	normal	P16371	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047316	anti-Groucho antibody (1:200), Negre et al. (2011) Nature, 471:527-531	Drosophila melanogaster	Genotype: pnt -/- (pnt AF397);	EXP047310	1434	normal	P16371	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047317	rabbit anti-GFP antibody (1:100), Invitrogen A6455, Lot# 1603336	Drosophila melanogaster	Genotype: PBac{pnt-GFP.FPTB}VK00037;  	EXP047311	1434	normal	P51022	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047318	rabbit anti-GFP antibody (1:100), Invitrogen A6455, Lot# 1603336	Drosophila melanogaster	Genotype: yan-/-(yanE833), Pbac{pnt-GFP.FPTB}VK00037;	EXP047312	1434	normal	P51022	whole organism (developmental stage: embryonic stage 11)	NULL
EXP047319	input	Drosophila melanogaster	Treatment: mock; Sex: female; 	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047320	input	Drosophila melanogaster	Treatment: mock; Sex: female; 	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047321	input	Drosophila melanogaster	Treatment: dslamind; Sex: female; 	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047322	input	Drosophila melanogaster	Treatment: dslamind; Sex: female; 	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047323	input	Drosophila melanogaster	Treatment: mock; Sex: female; 	NULL	1448	normal	A0A0B4K692	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047324	input	Drosophila melanogaster	Treatment: mock; Sex: female; 	NULL	1448	normal	A0A0B4K692	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047325	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: mock; Sex: female; 	EXP047319	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047326	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: mock; Sex: female; 	EXP047320	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047327	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: dslaminb; Sex: female; 	EXP047321	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047328	AGO2 (A. Mueller)	Drosophila melanogaster	Treatment: dslamind; Sex: female; 	EXP047322	1448	normal	Q9VUQ5	KC167 (developmental stage: 6-12h embryo)	NULL
EXP047329	none	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047330	none	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047331	none	Drosophila melanogaster	Treatment: siAGO2; Genotype: Ago2 knockdown; Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047332	none	Drosophila melanogaster	Treatment: siAGO2; Genotype: Ago2 knockdown; Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047333	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047329	1397	normal	P92204	Kc167 (development stage: embryonic)	NULL
EXP047334	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047330	1397	normal	P92204	Kc167 (development stage: embryonic)	NULL
EXP047335	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: siAGO2; Genotype: Ago2 knockdown; Sex: female; 	EXP047331	1397	normal	P92204	Kc167 (development stage: embryonic)	NULL
EXP047336	anti-NELF-E (Gilmour Lab)	Drosophila melanogaster	Treatment: siAGO2; Genotype: Ago2 knockdown; Sex: female; 	EXP047332	1397	normal	P92204	Kc167 (development stage: embryonic)	NULL
EXP047337	none	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047338	none	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047339	none	Drosophila melanogaster	Treatment: triptolide (transcription inhibitor); Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047340	none	Drosophila melanogaster	Treatment: triptolide (transcription inhibitor); Sex: female; 	NULL	1397	chip_control	NULL	Kc167 (development stage: embryonic)	NULL
EXP047341	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047337	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	NULL
EXP047342	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: mock; Genotype: control; Sex: female; 	EXP047338	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	NULL
EXP047343	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: triptolide (transcription inhibitor); Sex: female; 	EXP047339	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	NULL
EXP047344	anti-AGO2 (Mueller Lab)	Drosophila melanogaster	Treatment: triptolide (transcription inhibitor); Sex: female; 	EXP047340	1397	normal	Q9VUQ5	Kc167 (development stage: embryonic)	NULL
EXP047345	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is near 10; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	NULL
EXP047346	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is 11; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	NULL
EXP047353	FLAG	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047354	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047355	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047356	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047357	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047358	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047359	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047360	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047361	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047362	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  Top3b 26;AGO2 1-1-7 double mutant;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047363	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  Top3b 26;AGO2 1-1-7 double mutant;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047364	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047365	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047366	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047367	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047368	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047369	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047370	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26 mutant;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047371	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bWT complementation;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047372	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bY332F mutant complementation;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047373	n/a (input chromatin)	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bDRGG mutant complementation;	NULL	1445	chip_control	NULL	head, adult	NULL
EXP047374	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	EXP047354	1445	normal	P05205	head, adult	NULL
EXP047375	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	EXP047355	1445	normal	P05205	head, adult	NULL
EXP047376	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	EXP047356	1445	normal	P05205	head, adult	NULL
EXP047377	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  AGO2 1-1-7 mutant;	EXP047357	1445	normal	P05205	head, adult	NULL
EXP047378	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  AGO2 1-1-7 mutant;	EXP047358	1445	normal	P05205	head, adult	NULL
EXP047379	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	EXP047359	1445	normal	P05205	head, adult	NULL
EXP047380	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	EXP047360	1445	normal	P05205	head, adult	NULL
EXP047381	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b 26 mutant;	EXP047361	1445	normal	P05205	head, adult	NULL
EXP047382	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  Top3b 26;AGO2 1-1-7 double mutant;	EXP047362	1445	normal	P05205	head, adult	NULL
EXP047383	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype:  Top3b 26;AGO2 1-1-7 double mutant;	EXP047363	1445	normal	P05205	head, adult	NULL
EXP047384	FLAG 	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	Q9VUQ5	head, adult	NULL
EXP047385	FLAG	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	Q9VUQ5	head, adult	NULL
EXP047386	anti-Top3b	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	O96651	head, adult	NULL
EXP047387	anti-Top3b	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	O96651	head, adult	NULL
EXP047388	anti-Top3b	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	O96651	head, adult	NULL
EXP047389	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: w1118;	NULL	1445	normal	P05205	head, adult	NULL
EXP047390	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26 mutant;	NULL	1445	normal	P05205	head, adult	NULL
EXP047391	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bWT complementation;	NULL	1445	normal	P05205	head, adult	NULL
EXP047392	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bY332F mutant complementation;	NULL	1445	normal	P05205	head, adult	NULL
EXP047393	HP1	Drosophila melanogaster	Treatment: Treatment: 12h light and 12h gark; Genotype: Top3b26;Act>Top3bDRGG mutant complementation;	NULL	1445	normal	P05205	head, adult	NULL
EXP047394	none	Drosophila melanogaster	Treatment: none	NULL	2203	chip_control	NULL	ovary	NULL
EXP047395	sc-2025, Santa Cruz Biotechnology	Drosophila melanogaster	Treatment: Genotype: mal-d[delta]7; Treatment: control;	NULL	2203	chip_control	NULL	ovary	NULL
EXP047396	none	Drosophila melanogaster	Treatment: Genotype: tub mal-d3xGFP;	NULL	2203	chip_control	NULL	ovary	NULL
EXP047397	sc-2025, Santa Cruz Biotechnology	Drosophila melanogaster	Treatment: Genotype: tub mal-d3xGFP; Control;	NULL	2203	chip_control	NULL	ovary	NULL
EXP047401	none	Drosophila melanogaster	Treatment: Genotype: w1118;	NULL	2203	chip_control	NULL	ovary	NULL
EXP047402	GFP-Trap ChromoTek	Drosophila melanogaster	Treatment: Genotype: mal-d[delta]7;	EXP047394	2203	normal	Q6B4I4	ovary	NULL
EXP047403	AC-74 (A2228)	Drosophila melanogaster	Treatment: Genotype: mal-d[delta]7;	EXP047394	2203	normal	P10987	ovary	NULL
EXP047404	AC-74 (A2228)	Drosophila melanogaster	Treatment: Genotype: tub mal-d3xGFP;	EXP047394	2203	normal	P10987	ovary	NULL
EXP047405	GFP-Trap ChromoTek	Drosophila melanogaster	Treatment: Genotype: tub mal-d3xGFP;	EXP047394	2203	normal	Q6B4I4	ovary	NULL
EXP047406	AC-15 (A1978)	Drosophila melanogaster	Treatment: Genotype: w1118;	EXP047401	2203	normal	P10987	ovary	NULL
EXP047417	Anti-Wds antibody (Cat# 40630002) Novus Biologicals	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1244	normal	Q9V3J8	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP047418	Anti-Wds antibody (Cat# 40630002) Novus Biologicals	Drosophila melanogaster	Treatment: Genotype: DMAD-siRNA knockdown;	NULL	1244	normal	Q9V3J8	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP047419	--	Drosophila melanogaster	Genotype: atf3 mutatnt; Sex: male; Input control;	NULL	1444	chip_control	NULL	body, adult	NULL
EXP047423	--	Drosophila melanogaster	Genotype: atf3 mutatnt; Sex: male; 	NULL	1444	chip_control	NULL	body, adult	NULL
EXP047427	none	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	NULL	2204	chip_control	NULL	Oregon R (developmental stage: 68h AEL)	NULL
EXP047428	none	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	NULL	2204	chip_control	NULL	Oregon R (developmental stage: 68h AEL)	NULL
EXP047429	none	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	NULL	2205	chip_control	NULL	Oregon R (developmental stage: 92h AEL)	NULL
EXP047430	none	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	NULL	2205	chip_control	NULL	Oregon R (developmental stage: 92h AEL)	NULL
EXP047431	none	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	NULL	2206	chip_control	NULL	Oregon R (developmental stage: late 3 WL)	NULL
EXP047432	none	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	NULL	2206	chip_control	NULL	Oregon R (developmental stage: late 3 WL)	NULL
EXP047433	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047427	2204	bio_control	Q24168	Oregon R (developmental stage: 68h AEL)	NULL
EXP047434	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047428	2204	normal	Q24168	Oregon R (developmental stage: 68h AEL)	NULL
EXP047435	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047429	2205	normal	Q24168	Oregon R (developmental stage: 92h AEL)	NULL
EXP047436	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047430	2205	normal	Q24168	Oregon R (developmental stage: 92h AEL)	NULL
EXP047437	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047431	2206	normal	Q24168	Oregon R (developmental stage: late 3 WL)	NULL
EXP047438	anti-ORC2 (Steve Bell lab, MIT)	Drosophila melanogaster	Treatment: fat; Sex: male; Genotype: wildtype; 	EXP047432	2206	normal	Q24168	Oregon R (developmental stage: late 3 WL)	NULL
EXP047439	Monoclonal against Drosophila BRM (non-commercial)	Drosophila melanogaster	Source: endogenus BRM IP; 	NULL	1242	chip_control	NULL	S2 cells	NULL
EXP047440	Monoclonal against Drosophila BRM (non-commercial)	Drosophila melanogaster	Source: endogenus BRM IP; 	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP047441	Monoclonal against Drosophila BRM (non-commercial)	Drosophila melanogaster	Source: endogenus BRM IP; 	EXP047439	1242	normal	P25439	S2 cells	NULL
EXP047442	Monoclonal against Drosophila BRM (non-commercial)	Drosophila melanogaster	Source: endogenus BRM IP; 	EXP047440	1451	normal	P25439	S2 (Schneider 2)	NULL
EXP047443	None	Homo sapiens	Treatment: Genotype: wildtype;	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047446	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + F821A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047447	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + D824A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047448	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047449	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + WT ATAC1 rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047450	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: shNT control vector;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047451	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + D824A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047452	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + F821A rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047453	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: shNT control vector;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047454	Sigma, Flag-M2 F1804	Homo sapiens	Treatment: Genotype: ATAC1 Knock Down + WT ATAC1 rescue;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047455		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047456	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP051014	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2207	normal	P04637	LOXIMVI	NULL
EXP051015	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2208	normal	P04637	UO31	NULL
EXP051016	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2209	normal	P04637	A498	NULL
EXP051017	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	848	normal	P04637	U2OS (osteosarcoma)	NULL
EXP051018	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	1573	normal	P04637	SK-MEL-5 (Cutaneous melanoma)	NULL
EXP051019	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2210	normal	P04637	MALME3	NULL
EXP051020	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	1490	normal	P04637	NCI-H460 (Large cell lung carcinoma)	NULL
EXP051021	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	38	normal	P04637	A549 (lung carcinoma)	NULL
EXP051022	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP051023	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2211	normal	P04637	UACC62	NULL
EXP051024	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2212	normal	P04637	UACC257	NULL
EXP047468	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP051025	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2212	normal	P04637	UACC257	NULL
EXP051026	anti-p53  antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 4GY for 2hrs;	NULL	2213	normal	P04637	RPE	NULL
EXP047471	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens		EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047472	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens		EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047473	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: Decitabine; 	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047474	anti-p53 antibody (DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: Decitabine;	EXP047455	113	normal	P04637	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047475	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047476	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047477	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047478	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047479	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047480	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047481	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047482	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047483	Input	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047484	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	EXP047475	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047485	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	EXP047476	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047486	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shSCR;	EXP047477	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047487	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	EXP047478	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047488	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	EXP047479	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047489	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 1;	EXP047480	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047490	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	EXP047481	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047491	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	EXP047482	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047492	MYC (N262, homemade)	Homo sapiens	Characteristic: pBABE-hygro-MYC, pMN-IRES-GFP-PI3KH1047R, pLKO-tetON-puro-shG9a 4;	EXP047483	583	normal	P01106	MCF10A (breast epithelial cells)	NULL
EXP047493	NLS-HBx-RFP	Mus musculus	Treatment: Source: liver; TumourStage: non-transformed;	NULL	2214	normal	A1A546	murine hepatocytes (MMH-D3)	NULL
EXP047494	HBx	Homo sapiens	Treatment: Source: liver; TumourStage: transformed;	NULL	2215	normal	O43504	HepG2.2.15	NULL
EXP047495	HBx	Homo sapiens	Treatment: Source: liver; TumourStage: transformed;	NULL	2216	normal	O43504	HepG2 H1.3 (human hepatocytes)	NULL
EXP047496	HBx	Homo sapiens	Treatment: Source: liver; TumourStage: primary cell-like;	NULL	2217	normal	O43504	HepaRG	NULL
EXP047497	none	Homo sapiens		NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP047498	C/EBP? (Santa Cruz, sc-150x)	Homo sapiens	Treatment: C/EBPÎ²-overexpressed;	EXP047497	438	normal	Q15125	HL-60 (acute myeloid leukemia)	NULL
EXP047499	input	Homo sapiens	Treatment: DMSO 0.1%; Cell type: essential thrombocythemia;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047500	input	Homo sapiens	Treatment: DMSO 0.1%; Cell type: essential thrombocythemia;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047501	input	Homo sapiens	Treatment: CA 25 nM; Cell type: essential thrombocythemia;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047502	input	Homo sapiens	Treatment: CA 25 nM; Cell type: essential thrombocythemia;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047503	input	Homo sapiens	Treatment: untreated; Cell type: essential thrombocythemia;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047504	input	Homo sapiens	Treatment: untreated; Cell type: essential thrombocythemia;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047505	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: DMSO 0.1%; Cell type: essential thrombocythemia;	EXP047499	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047506	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: DMSO 0.1%; Cell type: essential thrombocythemia;	EXP047500	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047507	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: CA 25 nM; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047508	STAT1?/? (Santa Cruz sc-346)	Homo sapiens	Treatment: CA 25 nM; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047509	STAT1 pS727 (Life Tech #44-382G) 	Homo sapiens	Treatment: untreated; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047510	STAT1 pS727 (Life Tech #44-382G) 	Homo sapiens	Treatment: untreated; Cell type: essential thrombocythemia;	NULL	2218	normal	P42224	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP047511	none (input)	Homo sapiens	Treatment: 24h DMSO;	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047512	none (input)	Homo sapiens	Treatment: 24h 2.5 ÂµM IACS-9571;	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047513	none (input)	Homo sapiens	Treatment: dTRIM24 24h;	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047514	TRIM24 (Bethyl A300-851A)	Homo sapiens	Treatment: 24h DMSO;	EXP047511	2219	normal	O15164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047515	TRIM24 (Bethyl A300-851A)	Homo sapiens	Treatment: 24h 2.5 ÂµM IACS-9571;	EXP047512	2219	normal	O15164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047516	TRIM24 (Bethyl A300-851A)	Homo sapiens	Treatment: dTRIM24 24h;	NULL	2219	normal	O15164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047517		Homo sapiens		NULL	2221	chip_control	NULL	2nd trimester human fetal testis	NULL
EXP047520	anti-OCT4 (sc-8628, Santa Cruz Biotechnology);	Homo sapiens		NULL	376	normal	Q01860	WA01 (H1, human embryonic stem cells)	NULL
EXP047521	anti-OCT4 (sc-8628, Santa Cruz Biotechnology);	Homo sapiens		NULL	2222	normal	Q01860	1% H1 ESCs with 99% fibroblsat	NULL
EXP047522	anti-PAX5 (sc-1974, Santa Cruz Biotechnology);	Homo sapiens		EXP047517	2221	normal	Q02548	2nd trimester human fetal testis	NULL
EXP047523	anti-PRDM1 (C14A4, Cell Signaling Technology);	Homo sapiens		EXP047517	2221	normal	O75626	2nd trimester human fetal testis	NULL
EXP047524		Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047525		Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047526		Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047527	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p33; Treatment: 5 days in 5iLAF;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047528	None	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047529	None	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047530	None	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047531	None	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: No Induc;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047532	None	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047533	None	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C;	NULL	2224	chip_control	NULL	UCLA1 hESCs	NULL
EXP047534	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	EXP047524	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047535	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	EXP047525	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047536	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions;	EXP047526	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047537	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p33; Treatment: 5 days in 5iLAF;	EXP047527	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047538	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	EXP047528	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047539	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	EXP047529	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047540	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p28; CellType: Prime UCLA1 hESSCs;	EXP047530	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047541	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: No Induc;	EXP047531	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047542	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C;	EXP047532	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047543	anti-TFAP2C antibody (sc-8977) 	Homo sapiens	PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C;	EXP047533	2224	normal	Q92754	UCLA1 hESCs	NULL
EXP047544	anti-NIPBL	Mus musculus	Treatment: Source: pancreatic beta cell line;	NULL	1043	normal	Q6KCD5	MIN6 (insulinoma)	NULL
EXP047545	anti-MAU2	Mus musculus	Treatment: Source: pancreatic beta cell line;	NULL	1043	normal	Q9D2X5	MIN6 (insulinoma)	NULL
EXP047546		Homo sapiens	Treatment: none	NULL	938	chip_control	NULL	Th17-cells	NULL
EXP047547		Homo sapiens	Treatment: none	NULL	938	chip_control	NULL	Th17-cells	NULL
EXP047548		Homo sapiens	Treatment: none	NULL	938	chip_control	NULL	Th17-cells	NULL
EXP047549		Homo sapiens	Treatment: none	NULL	938	chip_control	NULL	Th17-cells	NULL
EXP047550		Homo sapiens	Treatment: none	NULL	938	chip_control	NULL	Th17-cells	NULL
EXP047551		Homo sapiens	Treatment: none	NULL	938	chip_control	NULL	Th17-cells	NULL
EXP047552	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: resting;Day:0;	EXP047546	938	normal	O75444	Th17-cells	NULL
EXP047553	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047547	938	normal	O75444	Th17-cells	NULL
EXP047554	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10- lymphocytes; ActivationState: resting;Day:0;	EXP047546	938	normal	O75444	Th17-cells	NULL
EXP047555	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047547	938	normal	O75444	Th17-cells	NULL
EXP047556	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: resting;Day:0;	EXP047548	938	normal	O75444	Th17-cells	NULL
EXP047557	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047549	938	normal	O75444	Th17-cells	NULL
EXP047558	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10- lymphocytes; ActivationState: resting;Day:0;	EXP047548	938	normal	O75444	Th17-cells	NULL
EXP047559	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10-  lymphocytes; ActivationState: resting; Day: 5;	EXP047549	938	normal	O75444	Th17-cells	NULL
EXP047560	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: resting;Day:0;	EXP047550	938	normal	O75444	Th17-cells	NULL
EXP047561	anti c-MAF	Homo sapiens	Treatment: CellType:pool of expanded Th17 clones; Tissue: primary Th17-IL-10+ lymphocytes; ActivationState: recently activeted;Day:5;	EXP047551	938	normal	O75444	Th17-cells	NULL
EXP047562	anti-JMJD6 ab10526(Abcam)	Homo sapiens	Treatment: without estrogen (E2) for 1 h;	NULL	113	normal	Q6NYC1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047563	anti-JMJD6 ab10526(Abcam)	Homo sapiens	Treatment: with estrogen (E2) for 1 h;	NULL	113	normal	Q6NYC1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047564	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: without estrogen (E2) for 1 h; CellType: with siCTL;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047565	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: with estrogen (E2) for 1 h; CellType: with siCTL;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047566	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: without estrogen (E2) for 1 h; CellType: with siJMJD6;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047567	anti-Med12 A300-774A(Bethyl Laboratory)	Homo sapiens	Treatment: with estrogen (E2) for 1 h; CellType: with siJMJD6;	NULL	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047568	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP047569	Prep1 Santa-Cruz N15 (sc-6245)	Homo sapiens		EXP047568	78	normal	P55347	HeLa (cervical adenocarcinoma)	NULL
EXP047570		Homo sapiens	Treatment: Treatment: DMSO for 6 hr; CellType: human inv(16) leukemia cell line;	NULL	592	chip_control	NULL	ME-1 (acute myeloid leukemia )	NULL
EXP047571		Homo sapiens	Treatment: Treatment: Al-10-49 (1uM) for 6 hr; CellType: human inv(16) leukemia cell line;	NULL	592	chip_control	NULL	ME-1 (acute myeloid leukemia )	NULL
EXP047572	Anti-RUNX1/AML1 antibody (ab23980,Abcam,GR309729-1)	Homo sapiens	Treatment: Treatment: DMSO for 6 hr; CellType: human inv(16) leukemia cell line;	EXP047570	592	normal	Q01196	ME-1 (acute myeloid leukemia )	NULL
EXP047573	Anti-RUNX1/AML1 antibody (ab23980,Abcam,GR309729-1)	Homo sapiens	Treatment: Treatment: Al-10-49 (1uM) for 6 hr; CellType: human inv(16) leukemia cell line;	EXP047571	592	normal	Q01196	ME-1 (acute myeloid leukemia )	NULL
EXP047574	None	Homo sapiens	Treatment: None	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP047575	None	Homo sapiens	Treatment: None	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047576	None	Homo sapiens	Treatment: None	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047577	None	Homo sapiens	Treatment: Treatment: without treatment; InternalID: j2386;	NULL	384	chip_control	NULL	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047578	None	Homo sapiens	Treatment: None	NULL	1226	chip_control	NULL	OCI-AML3	NULL
EXP047579	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 1000nM, 4h; Internalid: J3756;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047580	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 100nM, 4h; Internalid: J3758;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047581	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 1nM, 4h; Internalid: J2600, J2609;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047582	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J3764;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047583	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: BI00894999, 35nM, 4h; Internalid: J2601, J2610;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047584	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J3764;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047585	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J2608, J2778;	EXP047575	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047586	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: DMSO, 4h; Internalid: J3764;	EXP047576	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP047587	BRD4 (Bethyl, #A301-985A50)	Homo sapiens	Treatment: Treatment: without treatment; InternalID: j2386;	NULL	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	NULL
EXP047588	none, input	Homo sapiens		NULL	2227	chip_control	NULL	HEYA8 Ovarian cancer cell	NULL
EXP047589	none, input	Homo sapiens		NULL	701	chip_control	NULL	OVCAR8 (high grade ovarian serous adenocarcinoma)	NULL
EXP047590	anti-ETS1 antibody (Aviva Systems Biology Catalog #: P100604_T100)	Homo sapiens		EXP047588	2227	normal	P14921	HEYA8 Ovarian cancer cell	NULL
EXP047591	anti-ETS1 antibody (Aviva Systems Biology Catalog #: P100604_T100)	Homo sapiens		EXP047589	701	normal	P14921	OVCAR8 (high grade ovarian serous adenocarcinoma)	NULL
EXP047592		Homo sapiens	Treatment: Genotype: scramble shRNA;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP047593		Homo sapiens	Treatment: Genotype: Dpy30 shRNA;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP047594	anti-MYC	Homo sapiens	Treatment: Genotype: scramble shRNA;	EXP047592	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP047595	anti-MYC	Homo sapiens	Treatment: Genotype: Dpy30 shRNA;	NULL	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP047596	Lonza CC-2551	Homo sapiens	Passage: less than 10;	NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP047597		Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047598	Lonza CC-2585	Homo sapiens	Passage: less then 10; CellType: primary cells; 	NULL	2229	chip_control	NULL	HCAEC (human coronary artery endothelial cells)	NULL
EXP047599	none	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG2 siRNAs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047600	none	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG1 siRNAs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047601	none	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047602	custom made antibody for SA1 (STAG1)	Homo sapiens	Passage: less than 10;	EXP047596	440	normal	Q8WVM7	HMEC (human mammary epithelial cells)	NULL
EXP047603	custom made antibody for SA2 (STAG2)	Homo sapiens	Passage: less than 10;	EXP047596	440	normal	Q8N3U4	HMEC (human mammary epithelial cells)	NULL
EXP047604	custom made antibody for SMC1	Homo sapiens	Passage: less than 10;	EXP047596	440	normal	Q14683	HMEC (human mammary epithelial cells)	NULL
EXP047605	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	NULL
EXP047606	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	NULL
EXP047607	custom made antibody for SMC1	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q14683	MCF10A (breast epithelial cells)	NULL
EXP047608	Zmym2 antibody was a generous gift from H. Yu (UT Southwestern, US)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047597	583	normal	Q9UBW7	MCF10A (breast epithelial cells)	NULL
EXP047609	custom made antibody for SA1 (STAG1)	Homo sapiens	Passage: less then 10; CellType: primary cells; 	EXP047598	2229	normal	Q8WVM7	HCAEC (human coronary artery endothelial cells)	NULL
EXP047610	custom made antibody for SA2 (STAG2)	Homo sapiens	Passage: less then 10; CellType: primary cells; 	EXP047598	2229	normal	Q8N3U4	HCAEC (human coronary artery endothelial cells)	NULL
EXP047611	custom made antibody for SMC1	Homo sapiens	Passage: less then 10; CellType: primary cells; 	EXP047598	2229	normal	Q14683	HCAEC (human coronary artery endothelial cells)	NULL
EXP047624	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: untreated; 	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047625	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: untreated; 	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047626	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047627	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047628	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047629	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: dexamethasone (DEX) 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047630	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047631	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 20 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047632	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047633	rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific)	Homo sapiens	Treatment: EGF + DEX 60 min;	NULL	583	normal	P04150	MCF10A (breast epithelial cells)	NULL
EXP047634	Rabbit IgG (Sigma, I5006)	Homo sapiens	Treatment: DMSO 6hr; 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047635	Rabbit IgG (Sigma, I5006)	Homo sapiens	Treatment: DMSO 6hr; 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047636	Rabbit IgG (Sigma, I5006)	Homo sapiens	Treatment: JQ1 6hr;	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047637	Rabbit IgG (Sigma, I5006)	Homo sapiens	Treatment: JQ1 6hr;	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047638	Rabbit IgG (Sigma, I5006)	Homo sapiens	Treatment: siYAPTAZ; Genotype: YAP/TAZ depletion;	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047639	Rabbit IgG (Sigma, I5006)	Homo sapiens	Treatment: siYAPTAZ; Genotype: YAP/TAZ depletion;	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047640	input	Homo sapiens	Treatment: DMSO 6hr; 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047641	input	Homo sapiens	Treatment: DMSO 6hr; 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047642	input	Homo sapiens	JQ1	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047643	input	Homo sapiens	JQ1	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047644	input	Homo sapiens	siYAPTAZ	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047645	input	Homo sapiens	siYAPTAZ	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047646	input	Homo sapiens	DMSO	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047647	input	Homo sapiens	DMSO	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047648	input	Homo sapiens	JQ1	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047649	input	Homo sapiens	JQ1	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047650	input	Homo sapiens	siYAPTAZ	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047651	input	Homo sapiens	siYAPTAZ	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047652	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: DMSO 6hr; 	EXP047640	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047653	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: DMSO 6hr; 	EXP047641	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047654	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: JQ1 6hr;	EXP047642	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047655	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: JQ1 6hr;	EXP047643	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047656	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: siYAPTAZ; Genotype: YAP/TAZ depletion;	EXP047644	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047657	BRD4 (Bethyl Laboratories, A301-985A, lot A301-985A100-5)	Homo sapiens	Treatment: siYAPTAZ; Genotype: YAP/TAZ depletion;	EXP047639	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047658	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047659	c-Jun (H-79, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr;  	EXP047658	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047660	c-Jun (H-79, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr;  	EXP047658	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047661	c-Jun (H-79, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1Î¼M for 1hr; 	EXP047658	113	normal	P05412	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047662	ERalpha (H-20, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr;  	EXP047658	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047663	ERalpha (H-20, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr;  	EXP047658	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047664	ERalpha (H-20, Santa Cruz)	Homo sapiens	Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1Î¼M for 1hr; 	EXP047658	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047665	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047666	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047667	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: ethanol; Genotype: SKH1;	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047668	EVI-1 (Cell Signalling, serial no.:2593)	Homo sapiens	Treatment: estradiol; Genotype: SKH1;	NULL	1024	normal	Q03112	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047669	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047670	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047671	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: SKH1;	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047672	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: SKH1;	NULL	1024	normal	P49715	SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP047673	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047674	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047675	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: ethanol; Genotype: Kkasumi1;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047676	ETO (Santa Cruz, serial no.:SC9737)	Homo sapiens	Treatment: estradiol; Genotype: Kkasumi1;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047677	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047678	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER);	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047679	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: ethanol; Genotype: Kkasumi1;	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047680	C/EBPalpha (Santa Cruz, serial no.:A2814)	Homo sapiens	Treatment: estradiol; Genotype: Kkasumi1;	NULL	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047681	none	Homo sapiens		NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP047682	none	Homo sapiens	Treatment: PBRM1 knockdown shRNA;	NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP047683	none	Homo sapiens	Treatment: PBRM1 knockdown shRNA;	NULL	30	chip_control	NULL	RCC 7860 (Renal cell carcinoma)	NULL
EXP047684	Santa Cruz ARID2 (E-3) sc-1666117 mouse monoclonal ab - 5 ug (lot# G2712)	Homo sapiens	Treatment: without shRNA;	EXP047681	30	normal	Q68CP9	RCC 7860 (Renal cell carcinoma)	NULL
EXP047685	Santa Cruz ARID2 (E-3) sc-1666117 mouse monoclonal ab - 5 ug (lot# G2712)	Homo sapiens	Treatment: PBRM1 knockdown shRNA;	EXP047682	30	normal	Q68CP9	RCC 7860 (Renal cell carcinoma)	NULL
EXP047686	Santa Cruz ARID2 (E-3) sc-1666117 mouse monoclonal ab - 5 ug (lot# G2712)	Homo sapiens	Treatment: PBRM1 knockdown shRNA;	EXP047683	30	normal	Q68CP9	RCC 7860 (Renal cell carcinoma)	NULL
EXP047687	Input	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p19; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047688	Input	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p19; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047689	Input	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p19; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047690	Input	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p20; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047691	Input	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p20; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047692	Input	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p20; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047693	Input	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p21; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047694	Input	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p21; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047695	Input	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p21; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047696	Input	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p22; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047697	Input	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p22; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047698	Input	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p22; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047699	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p19; 	EXP047687	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047700	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p19; 	EXP047688	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047701	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p19; 	EXP047689	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047702	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p20; 	EXP047690	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047703	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p20; 	EXP047691	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047704	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p20; 	EXP047692	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047705	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p21; 	EXP047693	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047706	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p21; 	EXP047694	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047707	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p21; 	EXP047695	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047708	ERa sc-543	Homo sapiens	Treatment: vehicle(DMSO 2 hr); Passage: p22; 	EXP047696	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047709	ERa sc-543	Homo sapiens	Treatment: 500nM RAD001 2hr; Passage: p22; 	EXP047697	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047710	ERa sc-543	Homo sapiens	Treatment: 500 nM AZD201 2 hr; Passage: p22; 	EXP047698	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP047711	Affinity purified Gcn4 antibody (HL2871)	Saccharomyces cerevisiae	Treatment: sulfometuron added; Growth: for mid - long fase(OD600 about 0.6 to 0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0; Strain: BY4741 	NULL	1232	normal	P03069	S. cerevisiae cells	NULL
EXP047712	Affinity purified Gcn4 antibody (HL2871)	Saccharomyces cerevisiae	Treatment: without adding sulfometuron; Growth: for mid - long fase(OD600 about 0.6 -0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0; Strain: BY4741	NULL	1232	normal	P03069	S. cerevisiae cells	NULL
EXP047713	Affinity purified Gcn4 antibody (HL2871)	Saccharomyces cerevisiae	Treatment: sulfometuron added; Growth: to mid-long fase (OD600 about 0.6 -0.8);Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0 gcn4Î”::kanMX4; Strain: F731 	NULL	1232	normal	P03069	S. cerevisiae cells	NULL
EXP047714	anti-Myc antibody (11-667-149-001)	Saccharomyces cerevisiae	Treatment: without adding sulfometuron; Growth: for mid - long fase(OD600 0.6 -0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0 SPT15-myc13::HIS3MX6; Strain: HQY366 	NULL	1232	normal	A0A023PXA5	S. cerevisiae cells	NULL
EXP047715	anti-Myc antibody (11-667-149-001)	Saccharomyces cerevisiae	Treatment: sulfometuron added; Growth: for mid - long fase(OD600 0.6 -0.8); Genotype: MATa his3Î”1 leu2Î”0 met15Î”0 ura3Î”0 SPT15-myc13::HIS3MX6; Strain: HQY366	NULL	1232	normal	A0A023PXA5	S. cerevisiae cells	NULL
EXP047716	none	Homo sapiens	TumorType: hepatocellular carcinoma; Tissue: pooled cells; Source: liver;	NULL	2230	chip_control	NULL	SNU398	NULL
EXP047717	clone 6E5 (homemade antibody; also available at Active Motif Inc. catalog#61095)	Homo sapiens	TumorType: hepatocellular carcinoma; Tissue: pooled cells; Source: liver;	EXP047716	2230	bio_control	O60315	SNU398	NULL
EXP047718		Mus musculus		NULL	2231	chip_control	NULL	small pre-B cells	NULL
EXP047719		Mus musculus		NULL	2231	chip_control	NULL	small pre-B cells	NULL
EXP047720	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: brd1 ko; 	EXP047718	2231	normal	Q64287	small pre-B cells	NULL
EXP047723	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: PreB;	EXP047718	2231	normal	Q64287	small pre-B cells	NULL
EXP047726	NF90 (mAb DRBP76; BD)	Homo sapiens	Source: erythroleikemia cells; 	NULL	514	normal	Q12906	K562 (myelogenous leukemia)	NULL
EXP047727	antibody GFI1 (Santa Cruz, N-20, polyclonal, Lot H3012 )	Homo sapiens		NULL	516	normal	Q99684	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP047728	antibody AML1-ETO (Diagenode, A706, polyclonal)	Mus musculus	Genotype: gfil1 KO;	NULL	2232	normal	Q03347	KP66(mouse sleen cells)	NULL
EXP047729	antibody AML1-ETO (Diagenode, A706, polyclonal)	Mus musculus	Genotype: wildtype gfi1;	NULL	2233	normal	Q03347	WT132(mouse spleen)	NULL
EXP047730	none	Homo sapiens	Treatment: Treatment: mock infected 6hr	NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP047731	none	Homo sapiens	Treatment: IFNb treated (06h)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047732	none	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr + Flavopiridol 3hr, eGFP(EP mRNA), siCtrl(siRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047733	none	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047734	none	Homo sapiens	Treatment: Pam3csk4 treated 4hr, IAV NS1(Ep mRNA), siWAPL(siRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047735	none	Homo sapiens	Treatment: untreated	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047736	none	Homo sapiens	Treatment: Pam3csk4 treated (020m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047737	none	Homo sapiens	Treatment: Pam3csk4 treated (025m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047738	none	Homo sapiens	Treatment: Pam3csk4 treated (030m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047739	none	Homo sapiens	Treatment: Pam3csk4 treated (045m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047740	none	Homo sapiens	Treatment: Pam3csk4 treated (060m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047741	none	Homo sapiens	Treatment: Pam3csk4 treated (120m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047742	none	Homo sapiens	Treatment: Pam3csk4 treated (150m) + Flavopiridol (30m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047743	none	Homo sapiens	Treatment: Pam3csk4 treated (180m) + Flavopiridol (60m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047744	none	Homo sapiens	Treatment: Pam3csk4 treated (360m) + Flavopiridol (240m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047745	none	Homo sapiens	Treatment: Flavopiridol (240m)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047746	none	Homo sapiens	Treatment: Treatment: untreated	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047747	none	Homo sapiens	Treatment: Treatment: untreated	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047748	none	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047749	none	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047750	none	Homo sapiens	Treatment: Treatment: untreated, IAV NS1(EP mRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047751	none	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA)	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP047752	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: mock infected 6hr	NULL	466	normal	O60216	MDM(monocyte derived macrophages)	NULL
EXP047753	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: H5N1 IAV infected 6hr	EXP047730	466	normal	O60216	MDM(monocyte derived macrophages)	NULL
EXP047754	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: H5N1-dNS1 IAV infected 6hr	EXP047730	466	normal	O60216	MDM(monocyte derived macrophages)	NULL
EXP047755	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	EXP047730	466	normal	O60216	MDM(monocyte derived macrophages)	NULL
EXP047756	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: mock infected 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP047757	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: H5N1 IAV infected 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP047758	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: H5N1-dNS1 IAV infected 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP047759	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	EXP047730	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP047760	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr + Flavopiridol 3h, IAV NS1(EP mRNA)	EXP047731	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047761	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: IFNb treated 6hr, eGFP(EP mRNA)	EXP047731	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047762	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: IFNb treated 6hr, IAV NS1(EP mRNA)	EXP047731	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047763	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated,eGFP (EP mRNA), siCtrl (siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047764	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP (EP mRNA), siCtrl (siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047765	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated, IAV NS1 (EP mRNA), siCtrl (siRNA)	EXP047732	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047766	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr,  IAV NS1 (EP mRNA), siCtrl (siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047767	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr + Flavopiridol 3hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047768	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047769	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	EXP047733	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047770	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr + Flavopiridol 3hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047771	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047772	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siWAPL(siRNA)	EXP047734	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047773	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047774	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA), siCtrl(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047775	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siCtrl(siRNA)	EXP047737	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047776	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 0hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047777	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047778	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siCtrl(siRNA)	EXP047732	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047779	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047780	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	EXP047733	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047781	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siNIPBL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047782	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047783	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siWAPL(siRNA)	EXP047734	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047784	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siWAPL(siRNA)	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047785	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated	EXP047735	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047786	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 20min	EXP047736	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047787	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 25min	EXP047737	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047788	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 30min	EXP047738	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047789	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 45min	EXP047739	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047790	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 60min	EXP047740	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047791	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 120min	EXP047741	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047792	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 150min + Flavopiridol 30min	EXP047742	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047793	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 180min + Flavopiridol 60min	EXP047743	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047794	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 360min + Flavopiridol 240min	EXP047744	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047795	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment:  Flavopiridol 240min	EXP047745	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047796	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: untreated	EXP047735	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047797	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 20min	EXP047736	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047798	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Pam3csk4 treated (025m)	EXP047737	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047799	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 30min	EXP047738	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047800	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 45min	EXP047739	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047801	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 60min	EXP047740	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047802	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 120min	EXP047741	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047803	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 150min + Flavopiridol 30min	EXP047742	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047804	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 180min + Flavopiridol 60min	EXP047743	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047805	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 360min + Flavopiridol 240min	EXP047744	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047806	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment:  Flavopiridol 240min	EXP047745	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047807	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated	EXP047746	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047808	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: dexamethasone 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047809	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: untreated	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047810	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047811	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: untreated	EXP047746	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047812	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: dexamethasone 6hr	NULL	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP047813	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	P17676	THP-1 (acute monocytic leukemia)	NULL
EXP047814	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	P17676	THP-1 (acute monocytic leukemia)	NULL
EXP047815	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: untreated, IAV NS1(EP mRNA)	EXP047750	2334	normal	P17676	THP-1 (acute monocytic leukemia)	NULL
EXP047816	CEBPb, Santa Cruz: sc-150	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA)	NULL	2334	normal	P17676	THP-1 (acute monocytic leukemia)	NULL
EXP047817	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP047818	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP047819	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: untreated, IAV NS1(EP mRNA)	EXP047750	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP047820	PU.1, Santa Cruz: sc-352	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA)	EXP047751	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP047821	p65, Santa Cruz: sc-372	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	O43245	THP-1 (acute monocytic leukemia)	NULL
EXP047822	p65, Santa Cruz: sc-372	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	Q04206	THP-1 (acute monocytic leukemia)	NULL
EXP047823	FOS, Santa Cruz: sc-7202	Homo sapiens	Treatment: Treatment: untreated, eGFP(EP mRNA)	EXP047748	2334	normal	P01100	THP-1 (acute monocytic leukemia)	NULL
EXP047824	FOS, Santa Cruz: sc-7202	Homo sapiens	Treatment: Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA)	EXP047749	2334	normal	P01100	THP-1 (acute monocytic leukemia)	NULL
EXP047825	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: mock infected 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP047826	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: H5N1 IAV infected 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP047827	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: H5N1-dNS1 IAV infected 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP047828	CTCF, Active Motif: #61311	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	EXP047730	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP047829	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047830	RAD21, Genetex: GTX106012	Homo sapiens	Treatment: Treatment: IFNb treated 6hr	NULL	2334	normal	O60216	THP-1 (acute monocytic leukemia)	NULL
EXP047831	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: Wildtype; Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP047832	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: Sen1-AID adeed (DNA - RNA helicases); 288C	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP047833	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added h1D-h2D(RNase); Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP047834	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added h1D-h2D (RNase), Sen1-AID (RNA-DNA helicase); Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP047835	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 0.5uM Auxin for  4 hours; Genotype: added h1D-h2D( RNase),Top1-AID (Topoisomerases); Strain: 288C	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP047836	RAD52 (D. Bishop Lab)	Saccharomyces cerevisiae	Treatment: treated with 2% galactose; Genotype: Gal - HO; Strain: JKM	NULL	1232	normal	P06778	S. cerevisiae cells	NULL
EXP047837	M2 anti-FLAGAffinity purified DNA	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: flag-targged Brr6N;	EXP046764	1232	normal	P53062	S. cerevisiae cells	NULL
EXP047838	M2 anti-FLAGAffinity purified DNA	Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: flag-targged Brr6N delta C4N;	EXP046765	1232	normal	P53062	S. cerevisiae cells	NULL
EXP047839		Saccharomyces cerevisiae	Treatment: grown for mid-long fase; Genotype: Wiltype(empty vector);	EXP046766	1232	normal	A0A023IRJ6	S. cerevisiae cells	NULL
EXP047840	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in HU for 90 min; Genotype: wildtype; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047841	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in HU for 90 min; Genotype:mutation mcm2DENQ; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047842	 pan-Mcm2-7 polyclonal antibody (UM174; S. P. Bell, MIT)	Saccharomyces cerevisiae	Treatment: arrested in HU for 90 min; Genotype: mutation {delta} mrc1; 	NULL	2189	normal	P29469	G1 S.cerevisiae cells	NULL
EXP047843	anti-myc antibody (abcam ab9132)	Saccharomyces cerevisiae	Genotype: MATa his3{delta}_1, leu2{delta}_0, met15{delta}_0, ura3{delta}_0CBP80-myc13::NAT; Source: Cbp20 tagged strain; 	NULL	1232	normal	Q08920	S. cerevisiae cells	NULL
EXP047844	anti-myc antibody (abcam ab9132)	Saccharomyces cerevisiae	Genotype: MATa his3{delta}_1, leu2{delta}_0, met15{delta}_0, ura3{delta}_0RNT1-myc13::NAT; Source: Rnt1 tagged strain; 	NULL	1232	normal	Q02555	S. cerevisiae cells	NULL
EXP047845	Anti-HA tag antibody 	Caenorhabditis elegans	Genotype: BAT1753 [hmg-3(bar24[hmg-3::3xHA]) I];	NULL	2193	normal	O01683	whole worms(developmental stage L4)	NULL
EXP047846		Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	2196	chip_control	NULL	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047847		Drosophila melanogaster	Treatment: Genotype: spps knockout;	NULL	2196	chip_control	NULL	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047848		Drosophila melanogaster	Treatment: Genotype: Pho knockout;	NULL	2196	chip_control	NULL	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047849	anti-E(z) (rabbit polyclonal raised against bacterially expressed full length E(z))	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	M9PHZ5	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047850	anti-Pc (Santa Cruz Biotech Inc, sc25762)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	P26017	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047851	anti-Ph (Donna-Arndt-Jovin)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	P39769	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047852	anti-Pho (Brown et al., 2003)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	Q8ST83	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047853	anti-Psc (Nicole Francis)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	P35820	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047854	anti-Spps (Brown and Kassis 2010)	Drosophila melanogaster	Treatment: Genotype: wildtype;	EXP047846	2196	normal	A0A0B4KHC8	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047855	anti-E(z) (rabbit polyclonal raised against bacterially expressed full length E(z))	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	A0A021WW32	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047856	anti-Ph (Donna-Arndt-Jovin)	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	P39769	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047857	anti-Pho (Brown et al., 2003)	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	Q8ST83	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047858	anti-Psc (Nicole Francis)	Drosophila melanogaster	Treatment: Genotype: spps knockout;	EXP047847	2196	normal	P35820	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047859	anti-Ph (Donna-Arndt-Jovin)	Drosophila melanogaster	Treatment: Genotype: Pho knockout;	EXP047848	2196	normal	P39769	imaginal discs and brains (developmental stage: third instar larval)	NULL
EXP047860	anti-Dll antibody (sc-15858, Santa Cruz Biotechnology)	Drosophila melanogaster	Genotype: yw; 	EXP047299	2200	normal	P20009	leg imaginal discs (developmental stage: L3)	NULL
EXP047861	anti-GFP antibody (ab290, Abcam)	Drosophila melanogaster	Genotype: Sp1-GFP (BAC); 	EXP047300	2200	normal	Q9U1K4	leg imaginal discs (developmental stage: L3)	NULL
EXP047862	CLAMP (3 nL of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is late 14; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	NULL
EXP047863	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is 13; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	NULL
EXP047864	CLAMP (3 ?L of Novus/SDIX rabbit anti-CLAMP)	Drosophila melanogaster	Source: nuclear cycle is 12; Sex: female; 	NULL	2202	normal	Q9V9N4	sorted female-enriched embryos	NULL
EXP047865	sc-2025, Santa Cruz Biotechnology	Drosophila melanogaster	Treatment: Genotype: w1118;	NULL	2203	chip_control	NULL	ovary	NULL
EXP047866	AC-74 (A2228)	Drosophila melanogaster	Treatment: Genotype: w1118;	EXP047401	2203	normal	P10987	ovary	NULL
EXP047867	anti-DMAD	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1244	normal	M9NEY8	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP047868	Pc, Santa Cruz #sc-25762	Drosophila melanogaster	Treatment: Genotype: wildtype;	NULL	1244	normal	P26017	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP047869	Pc, Santa Cruz #sc-25762	Drosophila melanogaster	Treatment: Genotype: DMAD-siRNA knockdown;	NULL	1244	normal	P26017	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP047870	GFP-Trap_A (gta-20, Chromotek, Germany)	Drosophila melanogaster	Genotype: atf3 mutatnt; Sex: male; Title: Contol;	EXP047419	1444	bio_control	Q9XZS8	body, adult	NULL
EXP047871	GFP-Trap_A (gta-20, Chromotek, Germany)	Drosophila melanogaster	Genotype: atf3 mutatnt; Sex: male; 	EXP047423	1444	normal	Q9XZS8	body, adult	NULL
EXP047872	Rabbit 2616, Laszlo Tora lab	Homo sapiens	Treatment: Genotype: shNT control vector;	EXP047443	375	normal	Q9NZK5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP047873	anti-OCT4 (sc-8628, Santa Cruz Biotechnology);	Homo sapiens		EXP047517	2221	normal	Q01860	2nd trimester human fetal testis	NULL
EXP047874	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047601	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	NULL
EXP047875	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic;	EXP047601	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	NULL
EXP047876	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG1 siRNAs;	EXP047600	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	NULL
EXP047877	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG1 siRNAs;	EXP047600	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	NULL
EXP047878	custom made antibody for SA1 (STAG1)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG2 siRNAs;	EXP047599	583	normal	Q8WVM7	MCF10A (breast epithelial cells)	NULL
EXP047879	custom made antibody for SA2 (STAG2)	Homo sapiens	Source: human mammary epithelial cells; CellType: transformed nontumorigenic; Treatment: STAG2 siRNAs;	EXP047599	583	normal	Q8N3U4	MCF10A (breast epithelial cells)	NULL
EXP047880	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: brd1 ko low DNA; 	EXP047718	2231	normal	Q64287	small pre-B cells	NULL
EXP047881	anti-IRF4 (M-17, Santa Cruz Biotechnogy, sc-6059?Ã—?, lot#J2015)	Mus musculus	Source: PreB low DNA;	EXP047718	2231	normal	Q64287	small pre-B cells	NULL
EXP047882	Antibody against Flag (Sigma, M2)	Homo sapiens	Genotype: control untreated	NULL	741	normal	Q03164	CD34+ hematopoietic stem progenitor cells	NULL
EXP047883		Homo sapiens	Treatment: Source: input, prepared using 5% of original sample	NULL	2235	chip_control	NULL	RMG-1	NULL
EXP047884	Abcam ab182560	Homo sapiens	Treatment: Source: ADR1A was profield in parental RMG-1	EXP047883	2235	normal	O14497	RMG-1	NULL
EXP047885		Homo sapiens	Treatment: input 	NULL	1108	chip_control	NULL	HMLE-Twist-ER (breast cancer)	NULL
EXP047886		Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047887		Homo sapiens		NULL	410	chip_control	NULL	HCC1954 (ductal breast carcinoma)	NULL
EXP047888	CS-129-100, Diagenode	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	NULL
EXP047889	ab28379, abcam	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	NULL
EXP047890	CS-129-100, Diagenode	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	NULL
EXP047891	ab28379, abcam	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	NULL
EXP047892	CS-129-100, Diagenode	Homo sapiens	Treatment:min doxycicline TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	NULL
EXP047893	CS-129-100, Diagenode	Homo sapiens	Treatment:doxycicline and TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047885	1108	normal	Q06945	HMLE-Twist-ER (breast cancer)	NULL
EXP047894	CS-129-100, Diagenode	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	Q06945	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047895	CS-129-100, Diagenode	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	Q06945	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047896	CS-129-100, Diagenode	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	Q06945	HCC1954 (ductal breast carcinoma)	NULL
EXP047897	CS-129-100, Diagenode	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	Q06945	HCC1954 (ductal breast carcinoma)	NULL
EXP047898	CS-129-100, Diagenode	Homo sapiens	CellType: Immortalized human mammary epithelial cells Treatment: Doxycicline	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	NULL
EXP047899	ab28379, abcam	Homo sapiens	CellType: immortalized human mammary epithelial cells Treatment:TGF--beta	EXP047885	1108	normal	P84022	HMLE-Twist-ER (breast cancer)	NULL
EXP047900	ab28379, abcam	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047901	ab28379, abcam	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047886	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047902	ab28379, abcam	Homo sapiens	Treatment: no CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	P84022	HCC1954 (ductal breast carcinoma)	NULL
EXP047903	ab28379, abcam	Homo sapiens	Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells	EXP047887	410	normal	P84022	HCC1954 (ductal breast carcinoma)	NULL
EXP047904	IgG	Homo sapiens	Treatment: under normal conditions	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP047905	IgG	Homo sapiens	Treatment: Treatment: under heat shock conditions	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP047906	CTCF	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P49711	WA09 (embryonic stem cells)	NULL
EXP047907	CTCF	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P49711	WA09 (embryonic stem cells)	NULL
EXP047908	ZNF143	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P52747	WA09 (embryonic stem cells)	NULL
EXP047909	ZNF143	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P52747	WA09 (embryonic stem cells)	NULL
EXP047910	NANOG	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q9H9S0	WA09 (embryonic stem cells)	NULL
EXP047911	NANOG	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q9H9S0	WA09 (embryonic stem cells)	NULL
EXP047912	KLF4	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	O43474	WA09 (embryonic stem cells)	NULL
EXP047913	KLF4	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	O43474	WA09 (embryonic stem cells)	NULL
EXP047914	OCT4	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q01860	WA09 (embryonic stem cells)	NULL
EXP047915	OCT4	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q01860	WA09 (embryonic stem cells)	NULL
EXP047916	RING1B	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q99496	WA09 (embryonic stem cells)	NULL
EXP047917	RING1B	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q99496	WA09 (embryonic stem cells)	NULL
EXP047918	cFos	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P01100	WA09 (embryonic stem cells)	NULL
EXP047919	cFos	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P01100	WA09 (embryonic stem cells)	NULL
EXP047920	Brg1	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P51532	WA09 (embryonic stem cells)	NULL
EXP047921	Brg1	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P51532	WA09 (embryonic stem cells)	NULL
EXP047922	HSF1	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q00613	WA09 (embryonic stem cells)	NULL
EXP047923	HSF1	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q00613	WA09 (embryonic stem cells)	NULL
EXP047924	HSF1	Homo sapiens	Treatment: Treatment: under heat shock conditions and kinase inhibitors	EXP047905	396	normal	Q00613	WA09 (embryonic stem cells)	NULL
EXP047925	WAPL	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q7Z5K2	WA09 (embryonic stem cells)	NULL
EXP047926	WAPL	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q7Z5K2	WA09 (embryonic stem cells)	NULL
EXP047927	NIPBL	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	Q6KC79	WA09 (embryonic stem cells)	NULL
EXP047928	NIPBL	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	Q6KC79	WA09 (embryonic stem cells)	NULL
EXP047929	CTCF	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	P49711	WA09 (embryonic stem cells)	NULL
EXP047930	CTCF	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	P49711	WA09 (embryonic stem cells)	NULL
EXP047931	Rad21	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	O60216	WA09 (embryonic stem cells)	NULL
EXP047932	Rad21	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	O60216	WA09 (embryonic stem cells)	NULL
EXP047933	Rad21	Homo sapiens	Treatment: Treatment: under normal conditions	EXP047904	396	normal	O60216	WA09 (embryonic stem cells)	NULL
EXP047934	Rad21	Homo sapiens	Treatment: Treatment: under heat shock conditions	EXP047905	396	normal	O60216	WA09 (embryonic stem cells)	NULL
EXP047935	none	Homo sapiens	Treatment: Treatment: untreated	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP047936	none	Homo sapiens	Treatment: Treatment: PMA treated (16h)	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP047937	EGR1 bethyl A303-390A	Homo sapiens	Treatment: Treatment: untreated	EXP047935	438	normal	P18146	HL-60 (acute myeloid leukemia)	NULL
EXP047938	EGR1 bethyl A303-390A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	P18146	HL-60 (acute myeloid leukemia)	NULL
EXP047939	INTS13  vendor/catalog#: Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), infected with shRNA against EGR1 (EGR1-KD)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	NULL
EXP047940	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), intected with control shRNA (against LUCIFERASE)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	NULL
EXP047941	NAB2 ThermoFisher PA5-2792	Homo sapiens	Treatment: Treatment: untreated	EXP047935	438	normal	Q15742	HL-60 (acute myeloid leukemia)	NULL
EXP047942	NAB2 ThermoFisher PA5-2792	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	Q15742	HL-60 (acute myeloid leukemia)	NULL
EXP047943	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: none	NULL	2237	normal	Q9NVM9	CD34+(diferentiated monocytes, cord blood)	NULL
EXP047944	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), infected with shRNA against shLUC	NULL	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	NULL
EXP047945	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: untreated	NULL	509	normal	Q9NVM9	Jurkat (T-cells)	NULL
EXP051027	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	NULL	509	normal	Q9NVM9	Jurkat (T-cells)	NULL
EXP047947	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: none	NULL	157	normal	Q9NVM9	CD14+ monocytes	NULL
EXP047948	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: none	NULL	466	normal	Q9NVM9	MDM(monocyte derived macrophages)	NULL
EXP047949	NAB2, ThermoFisher PA5-27925	Homo sapiens	Treatment: none	NULL	157	normal	Q15742	CD14+ monocytes	NULL
EXP047950	NAB2, ThermoFisher PA5-27925	Homo sapiens	Treatment: none	NULL	466	normal	Q15742	MDM(monocyte derived macrophages)	NULL
EXP047951	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: infected with shRNA against EGR1 (EGR1 KD)	NULL	269	normal	Q9NVM9	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP047952	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: infected with shRNA against NAB2 (NAB2 KD)	NULL	269	normal	Q9NVM9	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP047953	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: infected with shRNA against shLUC	NULL	269	normal	Q9NVM9	CD34+ bone marrow cell-derived erythroid progenitors	NULL
EXP047954	INTS11 Bethyl A301-274A	Homo sapiens	Treatment: Treatment: untreated	NULL	438	normal	Q5TA45	HL-60 (acute myeloid leukemia)	NULL
EXP047955	INTS11 Bethyl A301-274A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	Q5TA45	HL-60 (acute myeloid leukemia)	NULL
EXP047956	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: Treatment: untreated	NULL	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	NULL
EXP047957	INTS13 Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	NULL
EXP047958	INTS13, Bethyl A303-575A	Homo sapiens	Treatment: Treatment: PMA treated (16h), infected with shRNA against shNAB2 (NAB2 KD)	EXP047936	438	normal	Q9NVM9	HL-60 (acute myeloid leukemia)	NULL
EXP047959	INPUT	Homo sapiens	Treatment: none	NULL	245	chip_control	NULL	NCCIT (testicular embryonic carcinoma)	NULL
EXP047960	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP047961	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP047962	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP047963	FLI1	Homo sapiens	Treatment: none	NULL	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP047964	none	Homo sapiens	Treatment: none	NULL	2238	chip_control	NULL	iPS (derived pancreatic precursor cells)	NULL
EXP047965	Goat anti PDX1 (Christopher V. E., Wright)	Homo sapiens	Treatment: none	EXP047964	2238	normal	P52945	iPS (derived pancreatic precursor cells)	NULL
EXP047966	None	Homo sapiens	Treatment: none	NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047967	None	Homo sapiens	Treatment: none	NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047968	None	Homo sapiens	Treatment: none	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP047969	TEAD1 (BD Bioscience, Cat# 610923)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	P28347	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047970	TRPS1 (self-made affinity-purified antibody raised against aa 920-1281)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	Q9UHF7	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047971	YAP	Homo sapiens	Treatment: Genotype: wildtype Treatment: yap 5sa induced by doxycycline for 18hr	EXP047966	128	normal	P46937	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047972	CtBP2 (BD Bioscience, Cat# 612044)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	P56545	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047973	HDAC3 (Cell Signaling, Cat# 85057)	Homo sapiens	Treatment: Genotype: wildtype	EXP047966	128	normal	O15379	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047974	CtBP2 (BD Bioscience, Cat# 612044)	Homo sapiens	Treatment: Genotype: TRPS1 KO	EXP047967	128	normal	P56545	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047975	HDAC3 (Cell Signaling, Cat# 85057)	Homo sapiens	Treatment: Genotype: TRPS1 KO	EXP047967	128	normal	O15379	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP047976	TEAD1 (BD Bioscience, Cat# 610923)	Homo sapiens	Treatment: none	EXP047968	111	normal	P28347	T47D (invasive ductal carcinoma)	NULL
EXP047977	TRPS1 (self-made affinity-purified antibody raised against aa 920-1281)	Homo sapiens	Treatment: none	EXP047968	111	normal	Q9UHF7	T47D (invasive ductal carcinoma)	NULL
EXP047978		Homo sapiens	Treatment: none	NULL	2239	chip_control	NULL	heart-derived sendai virus reprogrammed induced pluripotent stem cell)	NULL
EXP047979		Homo sapiens	Treatment: none	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP047980		Homo sapiens	Treatment: none	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047981		Homo sapiens	Treatment: none	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP047982	Homemade (ref. Morey et al., Cell Stem Cell, 2015)	Homo sapiens	Treatment: Modifications: parentall cells	EXP047978	2239	normal	Q99496	heart-derived sendai virus reprogrammed induced pluripotent stem cell)	NULL
EXP047983	Homemade (ref. Morey et al., Cell Stem Cell, 2015)	Homo sapiens	Treatment: CellType: mammary gland fibrocystic disease epithelial cells Modifications: Parental cells	EXP047979	583	normal	Q99496	MCF10A (breast epithelial cells)	NULL
EXP047984	Active Motif # 39663	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047980	2301	normal	Q99496	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047985	Santa Cruz # sc-10744 X	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047980	2301	normal	P35227	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047986	Bethyl Laboratories # A301-985A100	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047980	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP047987	Active Motif # 39663	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047981	111	normal	Q99496	T47D (invasive ductal carcinoma)	NULL
EXP047988	PCGF2	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047981	111	normal	P35227	T47D (invasive ductal carcinoma)	NULL
EXP047989	Diagenode # C15100066	Homo sapiens	Treatment: CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells	EXP047981	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP047990	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP047991	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP047992	MCM7 (Fujita et al., PMID 8626784; Fujita et al., PMID 9099751)	Homo sapiens		NULL	78	normal	P33993	HeLa (cervical adenocarcinoma)	NULL
EXP047993	MCM7 (Fujita et al., PMID 8626784; Fujita et al., PMID 9099751)	Homo sapiens		NULL	78	normal	P33993	HeLa (cervical adenocarcinoma)	NULL
EXP047994	Non-immune IgGs	Homo sapiens		NULL	2240	chip_control	NULL	HDF(human dermal fibroblasts)	NULL
EXP047995	endogenous AR antibody (Santa Cruz Biotechnology)	Homo sapiens		EXP047994	2240	normal	P10275	HDF(human dermal fibroblasts)	NULL
EXP047996	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	Treatment: 0.3 uM CBL0100 , 1.5 hr	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP047997	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	Treatment: no treatment, control	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP047998	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	Treatment: 3 uM CBL0137 ,1.5 hr	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP047999	SSRP1 antibody (BioLegend 10D1 609702)	Homo sapiens	treatment: 3 uM Aclacinomycin A , 1.5 hr	NULL	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048000		Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-SHB_1-gRNA-GFP	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP048001		Homo sapiens		NULL	934	chip_control	NULL	HOT1 tumor derived from a human glioblastoma	NULL
EXP048002	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-SHB_1-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	NULL
EXP048003	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: GK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152_3-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	NULL
EXP048004	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-CCDC85C_3-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	NULL
EXP048005	CTCF (Cell Signaling, 2899B)	Homo sapiens	Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152-gRNA-GFP	EXP048000	78	normal	P49711	HeLa (cervical adenocarcinoma)	NULL
EXP048006	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP048007	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP048008	G4 	Homo sapiens		EXP048006	514	normal	E2RYF6	K562 (myelogenous leukemia)	NULL
EXP048009	G4	Homo sapiens		EXP048007	514	normal	E2RYF6	K562 (myelogenous leukemia)	NULL
EXP048010	None	Homo sapiens		NULL	976	chip_control	NULL	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP048011	ZNF341 (Atlas Antibodies,HPA024607, Lot:R12522)	Homo sapiens		EXP048010	976	normal	Q9BYN7	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP048012	ZNF341 (monoclonal customized antibody)	Homo sapiens		EXP048010	976	normal	Q9BYN7	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP048013	NA	Homo sapiens	Treatment: none	NULL	1593	chip_control	NULL	WA07 (H7, human embryonic stem cells)	NULL
EXP048014	NA	Homo sapiens	Treatment: none	NULL	2241	chip_control	NULL	mesoderm stage cells differentiated from H7	NULL
EXP048015	NA	Homo sapiens	Treatment: none	NULL	2242	chip_control	NULL	cardiac progenitor stage cells differentiated from H7	NULL
EXP048016	NA	Homo sapiens	Treatment: none	NULL	2243	chip_control	NULL	cardiomyocytes stage differentiated from H7	NULL
EXP048017	Abcam ab14820	Homo sapiens	Treatment: none	EXP048013	1593	normal	Q8WTS6	WA07 (H7, human embryonic stem cells)	NULL
EXP048018	Abcam ab14820	Homo sapiens	Treatment: none	EXP048014	2241	normal	Q8WTS6	mesoderm stage cells differentiated from H7	NULL
EXP048019	Abcam ab14820	Homo sapiens	Treatment: none	EXP048015	2242	normal	Q8WTS6	cardiac progenitor stage cells differentiated from H7	NULL
EXP048020	Abcam ab14820	Homo sapiens	Treatment: none	EXP048016	2243	normal	Q8WTS6	cardiomyocytes stage differentiated from H7	NULL
EXP048021	None	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048022	None	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048023	None	Homo sapiens	Source: mammart gland, breast	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048024	None	Homo sapiens	Source: mammart gland, breast	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048025	None	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048026	None	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048027	None	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048028	None	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048029	TUBG1	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest	EXP048021	583	bio_control	P23258	MCF10A (breast epithelial cells)	NULL
EXP048030	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest	EXP048022	583	bio_control	P23258	MCF10A (breast epithelial cells)	NULL
EXP048031	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest	EXP048023	583	normal	P23258	MCF10A (breast epithelial cells)	NULL
EXP048032	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest	EXP048024	583	normal	P23258	MCF10A (breast epithelial cells)	NULL
EXP048033	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048025	583	normal	P23258	MCF10A (breast epithelial cells)	NULL
EXP048034	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 1 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048026	583	normal	P23258	MCF10A (breast epithelial cells)	NULL
EXP048035	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048027	583	normal	P23258	MCF10A (breast epithelial cells)	NULL
EXP048036	gamma-tubulin (Sigma aldrich T3320 and T5196)	Homo sapiens	Source: mammart gland, breast Treatment: 2 hr after rom release to harvest, selection 100 ug/ml Zeocini, transfection with gamma-tubulin shRNA  	EXP048028	583	normal	P23258	MCF10A (breast epithelial cells)	NULL
EXP048037	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt	NULL	2531	chip_control	NULL	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048038	none, input	Homo sapiens	Treatment: Treatment: shRNA shSSX	NULL	2531	chip_control	NULL	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048039	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt Genotype: BAF47 KO	NULL	2531	chip_control	NULL	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048040	none, input	Homo sapiens	Treatment: Treatment: shRNA shSSX Genotype: BAF47 KO	NULL	2531	chip_control	NULL	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048041	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt	NULL	2530	chip_control	NULL	SYO-1(Biphasic synovial sarcoma)	NULL
EXP048042	none, input	Homo sapiens	Treatment: Treatment: shRNA shSSX	NULL	2530	chip_control	NULL	SYO-1(Biphasic synovial sarcoma)	NULL
EXP048043	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048044	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt	NULL	2247	chip_control	NULL	CRL7250(fibroblast)	NULL
EXP048045	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt	NULL	670	chip_control	NULL	fibroblast of dermis	NULL
EXP048046	none, input	Homo sapiens	Treatment: Treatment: shRNA shCt	NULL	670	chip_control	NULL	fibroblast of dermis	NULL
EXP048047	anti-SS18 Cell Signaling D6I4Z	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048048	anti-SS18	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048038	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048049	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q92922	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048050	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	Q92922	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048051	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	P51532	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048052	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	P51532	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048053	anti-BAF200	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q68CP9	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048054	anti-BAF200	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	Q68CP9	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048055	anti-SUZ12	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048037	2531	normal	Q15022	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048056	anti-SUZ12	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048038	2531	normal	Q15022	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048057	anti-SS18	Homo sapiens	Treatment: Treatment: shRNA shCt Genotype: BAF47 KO	EXP048039	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048058	anti-SS18	Homo sapiens	Treatment: Treatment: shRNA shSSX Genotype: BAF47 KO	EXP048040	2531	normal	Q15532	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP048059	anti-SS18 Cell Signaling D6I4Z	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048041	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	NULL
EXP048060	anti-SS18 Cell Signaling D6I4Z	Homo sapiens	Treatment: Treatment: shRNA shSSX	EXP048042	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	NULL
EXP048061	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048041	2530	normal	Q92922	SYO-1(Biphasic synovial sarcoma)	NULL
EXP048062	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048041	2530	normal	P51532	SYO-1(Biphasic synovial sarcoma)	NULL
EXP048063	anti-BAF155	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048043	2253	normal	Q92922	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048064	anti-BRG1	Homo sapiens	Treatment: Treatment: shRNA shCt	EXP048043	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048065	anti-SS18	Homo sapiens	Treatment: Treatment: naive	EXP048044	2247	normal	Q15532	CRL7250(fibroblast)	NULL
EXP048066	anti-V5 Cell Signaling D3H8Q	Homo sapiens	Treatment: Treatment: shRNA SS18	EXP048045	670	normal	P41161	fibroblast of dermis	NULL
EXP048067	anti-V5 Cell Signaling D3H8Q	Homo sapiens	Treatment: Treatment: shRNA sSS18-SSX	EXP048046	670	normal	A0A075B6J1	fibroblast of dermis	NULL
EXP048068	anti-SUZ12 Cell Signaling D39F6	Homo sapiens	Treatment: Treatment: shRNA SS18	EXP048045	670	normal	Q15022	fibroblast of dermis	NULL
EXP048069	anti-SUZ12 Cell Signaling D39F6	Homo sapiens	Treatment: Treatment: shRNA SS18-SSX	EXP048046	670	normal	Q15022	fibroblast of dermis	NULL
EXP048070	anti-HA ( Abcam #ab9110 #GR261166-6)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , ethanol Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	O15164	LNCaP (prostate carcinoma)	NULL
EXP048071	anti HA ( Abcam #ab9110 #GR261166-6)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , 10nM R1881 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	O15164	LNCaP (prostate carcinoma)	NULL
EXP048072	anti-TRIM28 (Abcam #ab10483 #GR17300-19)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , ethanol Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	NULL
EXP048073	anti-TRIM28 (Abcam #ab10483 #GR17300-19)	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , 10nM R1881 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	NULL
EXP048074	anti-AR (Santa Cruz #sc-816x #J216) 	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation ,  ethanol,  knockout control Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP048075	anti-AR (Santa Cruz #sc-816x #J216) 	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation, ethanol, shTRIM24 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP048076	anti-AR (Santa Cruz #sc-816x #J216) 	Homo sapiens	Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation, ethanol , shTRIM28 Genotype: wildtype Source: prostate cancer cells 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP048077	none	Homo sapiens		NULL	2248	chip_control	NULL	NY8 (pancreatic cancer-derived cells)	NULL
EXP048078	none	Homo sapiens		NULL	2248	chip_control	NULL	NY8 (pancreatic cancer-derived cells)	NULL
EXP048079	none	Homo sapiens		NULL	2249	chip_control	NULL	NY15 (pancreatic cancer-derived cells)	NULL
EXP048080	none	Homo sapiens		NULL	2249	chip_control	NULL	NY15 (pancreatic cancer-derived cells)	NULL
EXP048081	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048077	2248	normal	P20823	NY8 (pancreatic cancer-derived cells)	NULL
EXP048082	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048078	2248	normal	P20823	NY8 (pancreatic cancer-derived cells)	NULL
EXP048083	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048079	2249	normal	P20823	NY15 (pancreatic cancer-derived cells)	NULL
EXP048084	HNF1A (goat polyclonal C-19 from Santa Cruz Biotechnology)	Homo sapiens		EXP048080	2249	normal	P20823	NY15 (pancreatic cancer-derived cells)	NULL
EXP048085	none	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:synchronized	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048086	none	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:synchronized	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048087	none	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:unsynchronized	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048088	none	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:unsynchronized	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048089	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:synchronized	EXP048085	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048090	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:synchronized	EXP048086	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048091	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:unsynchronized	EXP048087	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048092	anti CTCF G.758.4 (MA5-11187, Invitrogen)	Homo sapiens	Treatment: treatment: no block with TSA CellPopulation:unsynchronized	EXP048088	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048093	MBL D221-3 (Abcam)	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP048094	MBL D221-3 (Abcam)	Homo sapiens	Treatment: G1/S synchronized with 40ng/ml Nocodazole for 16hr	EXP048093	78	normal	P11226	HeLa (cervical adenocarcinoma)	NULL
EXP048095	MBL D221-3 (Abcam)	Homo sapiens	Treatment: G2/M synchronized with 40ng/ml Nocodazole for 20hr	EXP048093	78	normal	P11226	HeLa (cervical adenocarcinoma)	NULL
EXP048096	none	Homo sapiens	Treatment: Genotype: wildtype  CellLine: AF22	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048097	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048098	none	Homo sapiens	Treatment: Genotype: HA-tag knockin cell	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048099	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048100	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048096	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048101	CHD7 (Bethyl, A301-223A)	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048097	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048102	HA (Roche, clone 3F10)	Homo sapiens	Treatment: Genotype: HA-tag F10 knockin CellLine:	EXP048098	2250	normal	P00742	hiPSC derived It-NES	NULL
EXP048103	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048104	P300 (Santa Cruz,  sc-48343)	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048103	2250	normal	Q09472	hiPSC derived It-NES	NULL
EXP048105	none	Homo sapiens	Treatment: none	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP048106	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype	EXP048105	1143	normal	Q9P2D1	iPSC (induced pluripotent stem cells)	NULL
EXP048107	none	Homo sapiens	Treatment: none	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048108	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype	EXP048107	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048109	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: NE	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048110	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NE	EXP048109	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048111	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: NE	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048112	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NE	EXP048111	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048113	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: NCC (neural crest cell)	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048114	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NCC (neural crest cell)	EXP048113	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048115	none	Homo sapiens	Treatment: Genotype: wildtype CellLine: NCC (neural crest cell)	NULL	2250	chip_control	NULL	hiPSC derived It-NES	NULL
EXP048116	CHD7 (CST, #6505,  clone D3F5)	Homo sapiens	Treatment: Genotype: wildtype CellLine: NCC (neural crest cell)	EXP048115	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048117	CHD7	Homo sapiens	Treatment: Genotype: wildtype CellLine: AF22	EXP048099	2250	normal	Q9P2D1	hiPSC derived It-NES	NULL
EXP048118	none	Homo sapiens	Treatment: 1 uM MG132 for 4 hr	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048119	none	Homo sapiens	Treatment: 1 uM MG132 for 4 hr	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048120	anti-NRF1 antibody (Cell Signaling, D5B10)	Homo sapiens	Treatment: 1 uM MG132 for 4 hr	EXP048118	423	normal	Q14494	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048121	anti-NRF1 antibody (Cell Signaling, D5B10)	Homo sapiens	Treatment: 1 uM MG132 for 4 hr	EXP048119	423	normal	Q14494	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048122	INPUT for BRG1 ChIP	Homo sapiens	Treatment: Gemotype: HA agged HS-SY-II parental line Treatment: shRNA REN.713	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048123	INPUT for KDM2B ChIP	Homo sapiens	Treatment: Gemotype: HA tagged HS-SY-II parental line Treatment: shRNA REN.713	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048124	INPUT for BRG1 and KDM2B ChIP	Homo sapiens	Treatment: none	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048125	INPUT for BRG1 and KDM2B ChIP	Homo sapiens	Treatment: none	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048126	INPUT for BRG1 and KDM2B ChIP	Homo sapiens	Treatment: none	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048127	INPUT for HA ChIP	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: no shRNA	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048128	INPUT for HA ChIP	Homo sapiens	Treatment: none	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048129	INPUT for HA ChIP	Homo sapiens	Treatment: none	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048130	INPUT for HA ChIP	Homo sapiens	Treatment: none	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048131	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: no shRNA	EXP048127	2253	normal	A0AVK6	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048132	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HA tagged HS-SY-II parental line Treatment: shRNA REN.713	EXP048123	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048133	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shRNA REN.713	EXP048122	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048134	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HA tagged HS-SY-II parental line, knockdown of SS18-SSX1 Treatment: shRNA REN.713	EXP048128	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048135	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna SSX.1274 against SS18-SSX1	EXP048125	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048136	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna KDM2B.4395 against KDM2B	EXP048126	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048137	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna REN.713 against KDM2B	EXP048124	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048138	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna SSX.1274 against SS18-SSX1	EXP048125	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048139	KDM2B (Millipore_09-864)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line untagged Treatment: shrna KDM2B.4395 against KDM2B	EXP048126	2253	normal	Q8NHM5	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048140	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line HA tagged Treatment: shrna SSX. 1274 against SS18-SSX1	EXP048129	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048141	HA-tag (Abcam, ab9110)	Homo sapiens	Treatment: Gemotype: HS-SY-II parental line HA tagged Treatment: shrna KDM2B.4395 against KDM2B	EXP048130	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048142	BRG1 (Abcam, Ab110641)	Homo sapiens	Treatment: none	EXP048128	2253	normal	P51532	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP048146	None	Homo sapiens	Treatment: ethanol vehicle for 3 hr Passages: 20-25	NULL	2254	chip_control	NULL	MDA-MB-231ERb(triple negative breast cancer)	NULL
EXP048147	None	Homo sapiens	Treatment: 1 nM estradiol for 3 hr Passage: 20-25	NULL	2254	chip_control	NULL	MDA-MB-231ERb(triple negative breast cancer)	NULL
EXP048148	Flag (Sigma, M2)	Homo sapiens	Treatment: ethanol vehicle for 3 hr Passages: 20-25	EXP048146	2254	normal	Q92731	MDA-MB-231ERb(triple negative breast cancer)	NULL
EXP048149	Flag (Sigma, M2)	Homo sapiens	Treatment: 1 nM estradiol for 3 hr Passage: 20-25	EXP048147	2254	normal	Q92731	MDA-MB-231ERb(triple negative breast cancer)	NULL
EXP048150	Flag (Sigma, M2)	Homo sapiens	Treatment: 10 nM LY500307 for 3 hr Passage: 20-25	EXP048151	2254	normal	Q92731	MDA-MB-231ERb(triple negative breast cancer)	NULL
EXP048151	None	Homo sapiens	Treatment: 10 nM LY500307 for 3 hr Passage: 20-25	NULL	2254	chip_control	NULL	MDA-MB-231ERb(triple negative breast cancer)	NULL
EXP048152	Input	Homo sapiens	Treatment: SMARCA4 induced using +doxycycline(0.5 microg/ml) for 5 days, treated with IACS-10759 (1000nM) for 24 hr pior to extraction Genotype: pINDUCER20-SMARCA4 viral vector stably transduced in H1299 cell lines	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP048153	Input	Homo sapiens	Treatment: SMARCA4 induced using -doxycycline(0.5 microg/ml) for 5 days, treated with IACS-10759 (1000nM) for 24 hr pior to extraction Genotype: pINDUCER20-SMARCA4 viral vector stably transduced in H1299 cell lines	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP048154	Brg1 antibody Abcam ab110641	Homo sapiens	Treatment: SMARCA4 induced using +doxycycline(0.5 microg/ml) for 5 days, treated with IACS-10759 (1000nM) for 24 hr pior to extraction Genotype: pINDUCER20-SMARCA4 viral vector stably transduced in H1299 cell lines	EXP048152	375	normal	P51532	NCI-H1299 (large cell lung carcinoma)	NULL
EXP048155	Brg1 antibody Abcam ab110641	Homo sapiens	Treatment: SMARCA4 induced using -doxycycline(0.5 microg/ml) for 5 days, treated with IACS-10759 (1000nM) for 24 hr pior to extraction Genotype: pINDUCER20-SMARCA4 viral vector stably transduced in H1299 cell lines	EXP048153	375	normal	P51532	NCI-H1299 (large cell lung carcinoma)	NULL
EXP048156	none	Homo sapiens		NULL	2255	chip_control	NULL	HEE (human epididymis epithelial cells)	NULL
EXP048157	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	NULL
EXP048158	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	NULL
EXP048159	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	NULL
EXP048160	AR (Santa Cruz Biotechnology sc-815x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P10275	HEE (human epididymis epithelial cells)	NULL
EXP048161	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	NULL
EXP048162	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	NULL
EXP048163	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	NULL
EXP048164	RUNX1 (Abcam  ab23980)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	Q01196	HEE (human epididymis epithelial cells)	NULL
EXP048165	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	NULL
EXP048166	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	NULL
EXP048167	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: without treatment of R1881 (methyltrienolone)	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	NULL
EXP048168	CEBPB (Santa Cruz Biotechnology sc-150x)	Homo sapiens	Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr	EXP048156	2255	normal	P17676	HEE (human epididymis epithelial cells)	NULL
EXP048169	None	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Long	NULL	741	chip_control	NULL	CD34+ hematopoietic stem progenitor cells	NULL
EXP048170	None	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Long	NULL	741	chip_control	NULL	CD34+ hematopoietic stem progenitor cells	NULL
EXP048171	None	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Short	NULL	2222	chip_control	NULL	1% H1 ESCs with 99% fibroblsat	NULL
EXP048172	None	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Short	NULL	741	chip_control	NULL	CD34+ hematopoietic stem progenitor cells	NULL
EXP048173	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Long	EXP048169	741	normal	P52926	CD34+ hematopoietic stem progenitor cells	NULL
EXP048174	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Long	EXP048170	741	normal	P52926	CD34+ hematopoietic stem progenitor cells	NULL
EXP048175	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Short	EXP048171	2222	normal	P52926	1% H1 ESCs with 99% fibroblsat	NULL
EXP048176	anti-V5-tag (Vendor: MBL intl. Catalog number: M167-3. Lot: #5)	Homo sapiens	Treatment: Treatment: Treatment: Genotype: over-expression by ORF lentiviral TF: HMGA2 - Short	EXP048172	741	normal	P52926	CD34+ hematopoietic stem progenitor cells	NULL
EXP048177	anti-ER? (Bethyl Laboratories, A300-498A )	Homo sapiens	Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP048178	anti-ER? (Bethyl Laboratories, A300-498A )	Homo sapiens	Treatment: 100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP048179	anti-ER? (Bethyl Laboratories, A300-498A )	Homo sapiens	Treatment: a cocktail of 10 ÂµM forskolin plus 100 ÂµM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P03372	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP048180	pCREB1 (Cell Signalling Technology, 87G3, lot 14)	Homo sapiens	Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line   	NULL	587	normal	P16220	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP048181	pCREB1 (Cell Signalling Technology, 87G3, lot 14)	Homo sapiens	Treatment:100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P16220	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP048182	pCREB1 (Cell Signalling Technology, 87G3, lot 14)	Homo sapiens	Treatment:a cocktail of 10 ÂµM forskolin plus 100 ÂµM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line	NULL	587	normal	P16220	MDA-MB-134 (invasive lobular breast carcinoma)	NULL
EXP048183	none	Homo sapiens	Treatment: Tissue: Peripheral blood	NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP048184	none	Homo sapiens	Treatment: Tissue: Peripheral blood	NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP048185	none	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	NULL	2257	chip_control	NULL	pre-B-lymphoblast cells with BCP-ALL	NULL
EXP048186	none	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	NULL	2257	chip_control	NULL	pre-B-lymphoblast cells with BCP-ALL	NULL
EXP048187	none	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	NULL	2257	chip_control	NULL	pre-B-lymphoblast cells with BCP-ALL	NULL
EXP048188	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: Tissue: Peripheral blood	EXP048183	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP048189	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: Tissue: Peripheral blood	EXP048184	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP048190	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	EXP048185	2257	normal	Q01196	pre-B-lymphoblast cells with BCP-ALL	NULL
EXP048191	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	EXP048186	2257	normal	Q01196	pre-B-lymphoblast cells with BCP-ALL	NULL
EXP048192	RUNX1 (ab23980, Abcam)	Homo sapiens	Treatment: DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow	EXP048187	2257	normal	Q01196	pre-B-lymphoblast cells with BCP-ALL	NULL
EXP048193		Homo sapiens	Treatment: none	NULL	2259	chip_control	NULL	primary B-CLL cells	NULL
EXP048194	BRD4 (Active Motif #A301-985A1)	Homo sapiens	Treatment: Treatment: baseline Source: B-Chronic Lymphocytic Leukemia (CLL) cels	EXP048193	2259	normal	O60885	primary B-CLL cells	NULL
EXP048195	BRD4 (Active Motif #A301-985A1)	Homo sapiens	Treatment: Treatment: 4 hours stimulation with 3.2uM of CpG oligonucleotide Source: B-Chronic Lymphocytic Leukemia (CLL) cels	EXP048193	2259	normal	O60885	primary B-CLL cells	NULL
EXP048196	BRD4 (Active Motif #A301-985A1)	Homo sapiens	Treatment: Treatment: 4 hours stimulation with 3.2uM of CpG oligonucleotide + 1 uM of BET inhibitor (PLX51107) Source: B-Chronic Lymphocytic Leukemia (CLL) cels	EXP048193	2259	normal	O60885	primary B-CLL cells	NULL
EXP048197	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048198	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048199	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048200	ETS1, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	P14921	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048201	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048202	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048203	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048204	ERG, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048205	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048206	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048207	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048208	FLI, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048209	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048210	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048211	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048212	JUN, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 012Passage: P3-6	NULL	472	normal	P05412	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048213	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048214	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048215	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048216	RBPJ, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048217	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048218	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048219	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048220	GATA2, Gift from Emery H.Bresnick	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	P23769	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048221	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048222	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048223	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048224	EP300, Santa Cruz	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q09472	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048225	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 0 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048226	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 1 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048227	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 4 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048228	EZH2, Cell Signaling	Homo sapiens	Treatment: Treatment: Treatment: agent VEGF, timepoint 12 Passage: P3-6	NULL	472	normal	Q15910	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP048229	CTCF (D31H2) XP (Cell Signaling Technology, cat # 3418) 	Homo sapiens	Treatment: Sex: female Passages: 3-10 Stage: neural progenitor cells, undifferentiated Treatment: Prior to differentiation, cells were seeded at 3.5 x 10^6 per T75 flask containing complete growth medium and incubated at 37 Â°C for 24 hr	NULL	2260	normal	P49711	LUHMES (lund human mesencephalic cells)	NULL
EXP048230	CTCF (D31H2) XP (Cell Signaling Technology, cat # 3418) 	Homo sapiens	Treatment: Sex: female Passages: 3-10 Stage: dopaminergic neurons, differentiated Treatment: For induction of differentiation, culture medium was changed to freshly prepare DMEM:F12 with 2 mM L-glutamine, 1X N-2, 1 mM cAMP (Carbosynth, Cat # ND07996), 1 mg/mL tetracycline (Sigma, Cat # T7660), and 2 ng/mL glial cell line-derived neurotrophic factor (GDNF) (Sigma, Cat # G1777)	NULL	2260	normal	P49711	LUHMES (lund human mesencephalic cells)	NULL
EXP048231	ER HC-20 (Santa Cruz sc-543)	Homo sapiens	Treatment: Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP048232	GR E-20 (Santa Cruz sc-1003)	Homo sapiens	Treatment: Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour	NULL	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	NULL
EXP048233	ER HC-20 (Santa Cruz sc-543)	Homo sapiens	Treatment: Treatment: 10 nM Estradiol for 1 hour	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP048234	GR E-20 (Santa Cruz sc-1003)	Homo sapiens	Treatment: Treatment: 100 nM Dexamethasone for 1 hour	NULL	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	NULL
EXP048235	ER HC-20 (Santa Cruz sc-543)	Homo sapiens	Treatment: Treatment: DMSO (vehicle) for 1 hour	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP048236	GR E-20 (Santa Cruz sc-1003)	Homo sapiens	Treatment: Treatment: DMSO (vehicle) for 1 hour	NULL	504	normal	P04150	Ishikawa (endometrial adenocarcinoma)	NULL
EXP048237	none (input)	Homo sapiens	CellType: clear cell renall cell carcinoma	NULL	2261	chip_control	NULL	NRCC	NULL
EXP048238	none (input)	Homo sapiens	CellType: clear cell renall cell carcinoma	NULL	2261	chip_control	NULL	NRCC	NULL
EXP048239	none (input)	Homo sapiens	CellType: clear cell renall cell carcinoma	NULL	2261	chip_control	NULL	NRCC	NULL
EXP048240	p65 (Santa Cruz Biotechnology, sc-372-x)	Homo sapiens	CellType: clear cell renall cell carcinoma	EXP048237	2261	normal	Q04206	NRCC	NULL
EXP048241	ZHX2 (Genetex, 112232)	Homo sapiens	CellType: clear cell renall cell carcinoma	EXP048238	2261	normal	Q9Y6X8	NRCC	NULL
EXP048242	ZHX2 (Genetex, 112232)	Homo sapiens	CellType: clear cell renall cell carcinoma	EXP048239	2261	normal	Q9Y6X8	NRCC	NULL
EXP048243	HA (Abcam Ab9110)	Homo sapiens	Treatment: pBABE retroviral vector, control	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	NULL
EXP048244	HA (cell signaling C29F4)	Homo sapiens	Treatment: pBABE retroviral vector, control	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	NULL
EXP048245	HA (Abcam Ab9110)	Homo sapiens	Treatment: pBABE retroviral vector, D4476 60 uM for 48 hr befort crosslinking	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	NULL
EXP048246	HA (cell signaling C29F4)	Homo sapiens	Treatment: pBABE retroviral vector, D4476 60 uM for 48 hr befort crosslinking	NULL	2262	normal	Q99873	primary human neonatal keratinocytes	NULL
EXP048247		Homo sapiens	Treatment: mock Source: cervix	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP048248	STAT2 (Santa Cruz, sc-476)	Homo sapiens	Treatment: mock Source: cervix	EXP048247	78	normal	P52630	HeLa (cervical adenocarcinoma)	NULL
EXP048249	STAT2 (Santa Cruz, sc-476)	Homo sapiens	Treatment: 1000 units/ml  interferon alpha for 2 hr Source: cervix	EXP048247	78	normal	P52630	HeLa (cervical adenocarcinoma)	NULL
EXP048250	IRF9 (Santa Cruz, sc-496)	Homo sapiens	Treatment: mock Source: cervix	EXP048247	78	normal	Q00978	HeLa (cervical adenocarcinoma)	NULL
EXP048251	IRF9 (Santa Cruz, sc-496)	Homo sapiens	Treatment: 1000 units/ml  interferon alpha 2 hr Source: cervix	EXP048247	78	normal	Q00978	HeLa (cervical adenocarcinoma)	NULL
EXP048252	STAT1 (Santa Cruz, sc-345)	Homo sapiens	Treatment: mock Source: cervix	EXP048247	78	normal	P42224	HeLa (cervical adenocarcinoma)	NULL
EXP048253	STAT1 (Santa Cruz, sc-345)	Homo sapiens	Treatmnet: 1000 units/ml interferon alpha for 2hr Source: cervix	EXP048247	78	normal	P42224	HeLa (cervical adenocarcinoma)	NULL
EXP048254	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#45	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048255		Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #45	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048256		Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #45	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048257		Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#90	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048258		Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #90	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048259		Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #90	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048260		Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#104	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048261		Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #104	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048262		Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #104	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048263		Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#116	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048264		Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #116	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048265		Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #116	NULL	2263	chip_control	NULL	PHA-simulated human T-lynphocytes	NULL
EXP048266	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#45	EXP048254	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048267	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #45	EXP048255	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048268	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #45	EXP048256	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048269	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#90	EXP048257	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048270	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #90	EXP048258	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048271	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #90	EXP048259	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048272	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#104	EXP048260	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048273	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #104	EXP048261	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048274	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #104	EXP048262	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048275	p53 DO-1 ab	Homo sapiens	Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#116	EXP048263	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048276	p53 DO-1 ab	Homo sapiens	Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #116	EXP048264	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048277	p53 DO-1 ab	Homo sapiens	Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #116	EXP048265	2263	normal	P04637	PHA-simulated human T-lynphocytes	NULL
EXP048278	none	Homo sapiens	Treatment: none	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP048279	none	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP048280	none	Homo sapiens	Treatment: Genotype: shRNA shKMT2D Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP048281	none	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	NULL	215	chip_control	NULL	keratinocytes	NULL
EXP048282	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shKMT2D Treatment: Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80 degree	EXP048278	215	bio_control	O14686	keratinocytes	NULL
EXP048283	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	EXP048279	215	normal	O14686	keratinocytes	NULL
EXP048284	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shKMT2D Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	EXP048280	215	normal	O14686	keratinocytes	NULL
EXP048285	anti-KMT2D (HPA035977) (Sigma-Aldrich)	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	EXP048281	215	normal	O14686	keratinocytes	NULL
EXP048286	anti-p63 (4A4) (Santa Cruz Biotechnology, sc-8431)	Homo sapiens	Treatment: Genotype: shRNA shSC Cells were harvested by scraping from plates and washed twice in 1Ã— PBS before storage at -80Â°C.	NULL	215	normal	Q9H3D4	keratinocytes	NULL
EXP048287	Anti-BRD4: Bethyl laboratories; cat# A301-985A100; lot# A301-985A100-6	Homo sapiens	Treatment: 2.5 ng ml-1 TNFalfa for 0hr CellType: human colon cancer 	NULL	821	normal	O60885	SW480 (colon adenocarcinoma)	NULL
EXP048288	Anti-BRD4: Bethyl laboratories; cat# A301-985A100; lot# A301-985A100-6	Homo sapiens	Treatment: 2.5 ng ml-1 TNFalfa for 16hr CellType: human colon cancer 	NULL	821	normal	O60885	SW480 (colon adenocarcinoma)	NULL
EXP048289	Rabbit IgG (Millipore [12-370])	Homo sapiens	Treatment: Treatment: 32nM DMSO Passage: 80-85	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP048290	Rabbit IgG (Millipore [12-370])	Homo sapiens	Treatment: Treatment: 32 nM TPA Passage: 80-85	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP048291	HDAC2 (Abcam [ab12169])	Homo sapiens	Treatment: Treatment: 32nM DMSO Passage: 80-85	EXP048289	438	normal	Q92769	HL-60 (acute myeloid leukemia)	NULL
EXP048292	HDAC2 (Abcam [ab12169])	Homo sapiens	Treatment: Treatment: 32 nM TPA Passage: 80-85	EXP048290	438	normal	Q92769	HL-60 (acute myeloid leukemia)	NULL
EXP048293	none	Homo sapiens	Treatment: tonsil 	NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP048294	none	Homo sapiens	Treatment: tonsil 	NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP048295	none	Homo sapiens	Genotype: wiltype MEF2B	NULL	812	chip_control	NULL	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP048296	none	Homo sapiens	Genotype: MEF2B- D83V mutant	NULL	812	chip_control	NULL	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP048297	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Treatment: tonsil 	EXP048293	327	normal	Q02080	germinal center B-cells	NULL
EXP048298	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Treatment: tonsil 	EXP048294	327	normal	Q02080	germinal center B-cells	NULL
EXP048299	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Genotype: wiltype MEF2B	EXP048295	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP048300	anti-Flag (M2, F3165, Sigma) and anti-HA (ab9110, Abcam)	Homo sapiens	Genotype: wiltype MEF2B with Flag and HA	EXP048295	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP048301	anti-MEF2B (epitope aa102-121; Bethyl custom)	Homo sapiens	Genotype: MEF2B- D83V mutant	NULL	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP048302	anti-Flag (M2, F3165, Sigma) and anti-HA (ab9110, Abcam)	Homo sapiens	Genotype: MEF2B- D83V mutant with flag and HA	EXP048296	812	normal	Q02080	SU-DHL-10 (diffuse large B-cell lymphoma)	NULL
EXP048303	p53 polyclonal Ab (Diagenode, C15410083)	Homo sapiens	Treatment: untreated control Sex: female Age:15 years Tissue: bone	NULL	848	normal	P04637	U2OS (osteosarcoma)	NULL
EXP048304	p53 polyclonal Ab (Diagenode, C15410083)	Homo sapiens	Treatment:2hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone	NULL	848	normal	P04637	U2OS (osteosarcoma)	NULL
EXP048305	p53 polyclonal Ab (Diagenode, C15410083)	Homo sapiens	Treatment:4hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone	NULL	848	normal	P04637	U2OS (osteosarcoma)	NULL
EXP048306	Anti-Myc Tag Antibody, clone 4A6 (Millipore,#05-724MG)	Homo sapiens	Treatment: transfected with pcDNA3..1-vector CellType: Papillary thyroid carcinoma Passages: 6-9	NULL	2264	normal	O43435	BCPAP (Poorly differentiated thyroid gland carcinoma)	NULL
EXP048307	Anti-Myc Tag Antibody, clone 4A6 (Millipore,#05-724MG)	Homo sapiens	Treatment: transfected with pcDNA3.1-TBX1 CellType: Papillary thyroid carcinoma Passages: 6-9	NULL	2264	normal	O43435	BCPAP (Poorly differentiated thyroid gland carcinoma)	NULL
EXP048308	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP048309	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP048310	anti-Flag (Sigma, F1804, lot# SLBT7654)	Homo sapiens	Treatment: no 	EXP048308	514	normal	Q6DJT9	K562 (myelogenous leukemia)	NULL
EXP048311	anti-Flag (Sigma, F1804, lot# SLBT7654)	Homo sapiens	Treatment: no 	EXP048309	514	normal	Q6DJT9	K562 (myelogenous leukemia)	NULL
EXP048312	anti-USF2 (SantaCruz, #sc-293443, lot# C2217)	Homo sapiens	Treatment: no 	EXP048308	514	normal	Q15853	K562 (myelogenous leukemia)	NULL
EXP048313	anti-USF2 (SantaCruz, #sc-293443, lot# C2217)	Homo sapiens	Treatment: no 	EXP048309	514	normal	Q15853	K562 (myelogenous leukemia)	NULL
EXP048314	FLAGM2	Homo sapiens	Treatment: only FLAG antibodie	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048315	FLAGM2	Homo sapiens	Treatment: only FLAG antibodie	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048316	Input	Homo sapiens	Treatment: only FLAG antibodie	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048317	Input	Homo sapiens	Treatment: only FLAG antibodie	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048318	Input	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048319	Input	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048320	Input	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048321	Input	Homo sapiens	Treatment: stale expression FLAG-DNMT3B	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048322	Input	Homo sapiens	Treatment: stale expression FLAG-DNMT3B	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048323	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	EXP048318	417	normal	O43167	HCT-116 (colon carcinoma)	NULL
EXP048324	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	EXP048319	417	normal	O43167	HCT-116 (colon carcinoma)	NULL
EXP048325	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-ZBTB24	EXP048320	417	normal	O43167	HCT-116 (colon carcinoma)	NULL
EXP048326	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-DNMT3B	EXP048321	417	normal	Q9UBC3	HCT-116 (colon carcinoma)	NULL
EXP048327	FLAGM2	Homo sapiens	Treatment: stale expression FLAG-DNMT3B	EXP048322	417	normal	Q9UBC3	HCT-116 (colon carcinoma)	NULL
EXP048328	none	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	NULL	2265	chip_control	NULL	HeLa-Tet-On	NULL
EXP048329	none	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	NULL	2265	chip_control	NULL	HeLa-Tet-On	NULL
EXP048330	anti-RAD21 ChIP-grade (Abcam, ab992)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048328	2265	normal	O60216	HeLa-Tet-On	NULL
EXP048331	anti-NIPBL (Bethyl Laboratories, A301-779A)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048328	2265	normal	Q6KC79	HeLa-Tet-On	NULL
EXP048332	anti-RAD21 ChIP-grade (Abcam, ab992)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048329	2265	normal	O60216	HeLa-Tet-On	NULL
EXP048333	anti-NIPBL (Bethyl Laboratories, A301-779A)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048329	2265	normal	Q6KC79	HeLa-Tet-On	NULL
EXP048334	anti-MCM2 (Bethyl Laboratories, A300-191A)	Homo sapiens	Treatment: synchronized with 2 mM thymidine for 16-18 hr	EXP048328	2265	normal	P49736	HeLa-Tet-On	NULL
EXP048335	RCOR1 (07-455 from Merck Millipore)	Homo sapiens	Treatment: Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UKL0	THP-1 (acute monocytic leukemia)	NULL
EXP048336	RCOR1 (07-455 from Merck Millipore)	Homo sapiens	Treatment: Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UKL0	THP-1 (acute monocytic leukemia)	NULL
EXP048337	SPI1 (2258 from Cell Signaling)	Homo sapiens	Treatment: Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP048338	SPI1 (2258 from Cell Signaling)	Homo sapiens	Treatment: Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP048339	MLL4 (kindly provided by Dr Kai Ge; Wang et al., 2016)	Homo sapiens	Treatment: Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UMN6	THP-1 (acute monocytic leukemia)	NULL
EXP048340	MLL4 (kindly provided by Dr Kai Ge; Wang et al., 2016)	Homo sapiens	Treatment: Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum	NULL	2334	normal	Q9UMN6	THP-1 (acute monocytic leukemia)	NULL
EXP048341	n/a	Homo sapiens	Treatment: none	NULL	1004	chip_control	NULL	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP048342	n/a	Homo sapiens	Treatment: none	NULL	1004	chip_control	NULL	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP048343	n/a	Mus musculus	Treatment: Treatment: control Tissue: B16 tumor transplanted in C56BL/6 mice Source: ex vivo scramble	NULL	2266	chip_control	NULL	B16 tumor	NULL
EXP048344	n/a	Mus musculus	Treatment: Treatment: control Tissue: B16 tumor transplanted in C56BL/6 mice Source: LSD1 knockout	NULL	2266	chip_control	NULL	B16 tumor	NULL
EXP048345	LSD1 (Abcam, cat#17721)	Homo sapiens	Treatment: Treatment: control	EXP048341	1004	normal	O60341	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP048346	LSD1 (Abcam, cat#17721)	Homo sapiens	Treatment: Treatment: control	EXP048342	1004	normal	O60341	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP048347	LSD1 (Abcam, cat#17721)	Mus musculus	Treatment: Treatment: control Tissue: B16 tumor transplanted in C56BL/6 mice Source: ex vivo scramble	EXP048343	2266	normal	Q6ZQ88	B16 tumor	NULL
EXP048348	LSD1 (Abcam, cat#17721)	Mus musculus	Treatment: Treatment: control Tissue: B16 tumor transplanted in C56BL/6 mice Source: LCD1 knockout	EXP048344	2266	normal	Q6ZQ88	B16 tumor	NULL
EXP048353	none	Homo sapiens	None	NULL	2267	chip_control	NULL	aortic smooth muscle	NULL
EXP048354	SMAD2	Homo sapiens	Treatment: PBS 	EXP048353	2267	normal	Q15796	aortic smooth muscle	NULL
EXP048356	none	Homo sapiens	Treatment: TGF beta at 0.5 ng/ml daily for 10 days	NULL	2267	chip_control	NULL	aortic smooth muscle	NULL
EXP048357	SMAD2	Homo sapiens	Treatment: TGF beta at 0.5 ng/ml daily for 10 days	EXP048356	2267	normal	Q15796	aortic smooth muscle	NULL
EXP048358	input	Homo sapiens	Treatment: no treatment	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048359	input	Homo sapiens	Treatment: no treatment	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048360	Pygo2 (S3I4; Tzenov et al., J Clin Path.69, pp. 518-26, 2015 )	Homo sapiens	Treatment: no treatment	EXP048358	423	normal	Q9BRQ0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048361	Pygo2 (S3I4; Tzenov et al., J Clin Path.69, pp. 518-26, 2015 )	Homo sapiens	Treatment: no treatment	EXP048359	423	normal	Q9BRQ0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP048362		Mus musculus	Treatment: Passage: p1	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048363		Mus musculus	Treatment: Passage: p10	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048364		Mus musculus	Treatment: Treatment: infected with shNT for 3 days	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048365		Mus musculus	Treatment: Treatment: infected with shNT for 3 days	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048366		Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048367		Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048368	NA	Mus musculus	Treatment: none	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048369	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: none	EXP048368	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048370	MED1(Bethyl; Cat#A300-793A;)	Mus musculus	Treatment: none	EXP048368	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048371	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Passage: p1	EXP048362	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048372	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Passage: p10	EXP048363	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048373	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048364	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048374	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048365	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048375	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048364	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048376	MED1 (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048364	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048377	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048365	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048378	MED1 (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with shNT for 3 days	EXP048365	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048379	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048366	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048380	SRF (SantaCruz; Cat#sc-335; lot#I1014)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048367	2268	normal	Q9JM73	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048381	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048366	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048382	MED1	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048366	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048383	SMAD3 (Abcam; Cat#ab28379; lot#GR240296-12)	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048367	2268	normal	Q8BUN5	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048384	MED1	Mus musculus	Treatment: Treatment: infected with sh2AZ for 3 days	EXP048367	2268	normal	Q925J9	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP048385		Homo sapiens	Treatment: Treatment: 1hr EtOH	NULL	2269	chip_control	NULL	A1-2 (breast cancer cells)	NULL
EXP048386		Homo sapiens	Treatment: Treatment: 1hr Dex	NULL	2269	chip_control	NULL	A1-2 (breast cancer cells)	NULL
EXP048387		Homo sapiens	Treatment: Treatment: 1hr EtOH	NULL	2269	chip_control	NULL	A1-2 (breast cancer cells)	NULL
EXP048388		Homo sapiens	Treatment: Treatment: 1hr Dex	NULL	2269	chip_control	NULL	A1-2 (breast cancer cells)	NULL
EXP048389		Homo sapiens	Treatment: Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line	NULL	2272	chip_control	NULL	A1A3(breast cancer cells)	NULL
EXP048390		Homo sapiens	Treatment: Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line	NULL	2272	chip_control	NULL	A1A3(breast cancer cells)	NULL
EXP048391		Homo sapiens	Treatment: Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	NULL	2272	chip_control	NULL	A1A3(breast cancer cells)	NULL
EXP048392		Homo sapiens	Treatment: Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	NULL	2272	chip_control	NULL	A1A3(breast cancer cells)	NULL
EXP048393	anti-GR (Santa Cruz M-20)	Homo sapiens	Treatment: Treatment: 1hr EtOH	EXP048385	2269	normal	P04150	A1-2 (breast cancer cells)	NULL
EXP048394	anti-GR (Santa Cruz M-20)	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P04150	A1-2 (breast cancer cells)	NULL
EXP048395	lab-made rabbit anti-Brg1	Homo sapiens	Treatment: Treatment: 1hr EtOH	EXP048385	2269	normal	P51532	A1-2 (breast cancer cells)	NULL
EXP048396	lab-made rabbit anti-Brg1	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P51532	A1-2 (breast cancer cells)	NULL
EXP048397	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr EtOH	EXP048387	2269	normal	P55317	A1-2 (breast cancer cells)	NULL
EXP048398	Cell Signaling D13C9	Homo sapiens	Treatment: 1hr EtOH	EXP048387	2269	normal	P23771	A1-2 (breast cancer cells)	NULL
EXP048399	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P55317	A1-2 (breast cancer cells)	NULL
EXP048400	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr Dex	EXP048386	2269	normal	P23771	A1-2 (breast cancer cells)	NULL
EXP048401	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048389	2272	normal	P55317	A1A3(breast cancer cells)	NULL
EXP048402	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048389	2272	normal	P23771	A1A3(breast cancer cells)	NULL
EXP048403	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048390	2272	normal	P55317	A1A3(breast cancer cells)	NULL
EXP048404	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line	EXP048390	2272	normal	P23771	A1A3(breast cancer cells)	NULL
EXP048405	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048391	2272	normal	P55317	A1A3(breast cancer cells)	NULL
EXP048406	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048391	2272	normal	P23771	A1A3(breast cancer cells)	NULL
EXP048407	Abcam ab23738	Homo sapiens	Treatment: Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048392	2272	normal	P55317	A1A3(breast cancer cells)	NULL
EXP048408	Cell Signaling D13C9	Homo sapiens	Treatment: Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown	EXP048392	2272	normal	P23771	A1A3(breast cancer cells)	NULL
EXP048409	anti-goat IgG control antibody (Santa Cruz)	Homo sapiens	CellType: Sh-SY5Y ATCC (validated)  	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP048410	anti-TCF4 antibody K-12, sc-48947 (Santa Cruz, lot# A2507)	Homo sapiens	CellType: Sh-SY5Y ATCC (validated)  	EXP048409	664	normal	P15884	SH-SY5Y (neuroblastoma)	NULL
EXP048411	anti-TCF4 antibody N-16, sc-48949 (Santa Cruz, lot# A2507)	Homo sapiens	CellType: Sh-SY5Y ATCC (validated)  	EXP048409	664	normal	P15884	SH-SY5Y (neuroblastoma)	NULL
EXP048412	none (input)	Homo sapiens	Treatment: CellType: hepatocarcinoma	NULL	2230	chip_control	NULL	SNU398	NULL
EXP048413	SALL4 (Cell Signaling Technolog, cat# 8459BF, Lot 2)	Homo sapiens	Treatment: CellType: hepatocarcinoma	EXP048412	2230	normal	Q9UJQ4	SNU398	NULL
EXP048414	none	Homo sapiens	Treatment: 45 min 10^-7 4OHT	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048415	none	Homo sapiens	Treatment: 45 min 10^-7 4OHT	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048416	none	Homo sapiens	Treatment: 45 min 10^-7 4OHT	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048417	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048418	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048419	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048420	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048421	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048422	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048423	none	Homo sapiens	Treatment: 45 min 10^-7 4OHT	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048424	none	Homo sapiens	Treatment: 45 min 10^-7 4OHT	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048425	none	Homo sapiens	Treatment: 45 min 10^-7 4OHT	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048426	none	Homo sapiens	Treatment: 45 min 10^-8 E2	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048427	none	Homo sapiens	Treatment: 45 min 10^-8 E2	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048428	none	Homo sapiens	Treatment: 45 min 10^-8 E2	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048429	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048430	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048431	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048432	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048433	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048434	none	Homo sapiens	Treatment: 45 min ethanol 	NULL	2273	chip_control	NULL	MCF7 WS8 cells	NULL
EXP048435	none	Homo sapiens	Treatment: 45 min 10^-8 E2	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048436	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048414	949	bio_control	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048437	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048415	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048438	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048416	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048439	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048417	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048440	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048418	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048441	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048419	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048442	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048420	949	normal	Q6ISB3	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048443	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048421	949	normal	Q6ISB3	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048444	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048422	949	normal	Q6ISB3	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048445	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048423	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048446	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048424	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048447	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-7 4OHT	EXP048425	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048448	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048426	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048449	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048427	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048450	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048428	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048451	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048429	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048452	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048430	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048453	Abcam, ab23738	Homo sapiens	Treatment: 45 min ethanol 	EXP048431	2273	normal	P55317	MCF7 WS8 cells	NULL
EXP048454	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048432	2273	normal	Q6ISB3	MCF7 WS8 cells	NULL
EXP048455	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048433	2273	normal	Q6ISB3	MCF7 WS8 cells	NULL
EXP048456	Sigma, HPA004820	Homo sapiens	Treatment: 45 min ethanol 	EXP048434	2273	normal	Q6ISB3	MCF7 WS8 cells	NULL
EXP048457	Abcam, ab23738	Homo sapiens	Treatment: 45 min 10^-8 E2	EXP048435	949	normal	P55317	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP048458	IgG2b	Homo sapiens	Genotype: ZNF341 isoform-2  Patient: hyper-IgE syndrome(HIES) 	NULL	2274	chip_control	NULL	EBV-B cells	NULL
EXP048459	Anti-ZNF341 (8B3.1)	Homo sapiens	Genotype: empty vector Patient: hyper-IgE syndrome(HIES) 	NULL	2274	normal	Q9BYN7	EBV-B cells	NULL
EXP048460	Anti-ZNF341 (8B3.1)	Homo sapiens	Genotype: ZNF341 isoform-1 Patient: hyper-IgE syndrome(HIES) 	NULL	2274	normal	Q9BYN7	EBV-B cells	NULL
EXP048461	Anti-ZNF341 (8B3.1)	Homo sapiens	Genotype: ZNF341 isoform-2  Patient: hyper-IgE syndrome(HIES) 	EXP048458	2274	normal	Q9BYN7	EBV-B cells	NULL
EXP048462	Anti-ZNF341 (8B3.1)	Homo sapiens	Treatment: T cells were activated by incubation for 24-48 hr with antibodies against CD3 and CD28 Patient: hyper-IgE syndrome(HIES) 	NULL	2275	normal	Q9BYN7	HIES (T-cells)	NULL
EXP048463	none	Homo sapiens	bone mets prostate adenocarcinoma	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP048464	ELF1 (sc-631, Santa Cruz Biotechnology)	Homo sapiens	Source: immortalized normal prostate cells	NULL	781	normal	P32519	RWPE1 (prostate epithelial cells)	NULL
EXP048465	ELF1 (sc-631, Santa Cruz Biotechnology)	Homo sapiens	Source: bone mets prostate adenocarcinoma	EXP048463	725	normal	P32519	PC3(bone mets prostate adenocarcinoma)	NULL
EXP048466	none	Homo sapiens	CellType: human lung adenocarcinoma epithelial A549 cells Genotype: wildtype 	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP048467	anti-NRF2 (Santa Cruz, sc-13032, lot C1416)	Homo sapiens	CellType: human lung adenocarcinoma epithelial A549 cells Genotype: wildtype 	EXP048466	38	normal	Q16236	A549 (lung carcinoma)	NULL
EXP048468	BRD2 (rabbit polyclonal)	Homo sapiens	Treatment: Treatment: 500 nM JQ1 24h	NULL	2277	normal	P25440	NCI-H23 (non-small lung adenocarcinoma)	NULL
EXP048469	BRD2	Homo sapiens	Treatment: Treatment:500nM DMSO 24hr	NULL	2277	normal	P25440	NCI-H23 (non-small lung adenocarcinoma)	NULL
EXP048470	no antibody	Homo sapiens	Treatment: NumberofSonications: 1	NULL	2279	chip_control	NULL	adult erythroblasts	NULL
EXP048471	no antibody	Homo sapiens	Treatment: NumberofSonications: 2	NULL	2279	chip_control	NULL	adult erythroblasts	NULL
EXP048472	no antibody	Homo sapiens	Treatment: NumberofSonications: 1	NULL	2279	chip_control	NULL	adult erythroblasts	NULL
EXP048473	no antibody	Homo sapiens	Treatment: NumberofSonications: 1	NULL	2278	chip_control	NULL	EBV-transformed-B-lymphoblasts	NULL
EXP048474	CFP1, non-commercial Ab from Bob Roeder	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	Q9P0U4	adult erythroblasts	NULL
EXP048475	CFP1 (ab56035), from Abcam	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	Q9P0U4	adult erythroblasts	NULL
EXP048476	HCF1 (A301-400A)	Homo sapiens	Treatment: NumberofSonications: 1	EXP048472	2279	normal	P51610	adult erythroblasts	NULL
EXP048477	Menin (A300-105A)	Homo sapiens	Treatment: NumberofSonications: 2	EXP048471	2279	normal	O00255	adult erythroblasts	NULL
EXP048478	RbBP5 (A300-109A)	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	Q15291	adult erythroblasts	NULL
EXP048479	SET1 (A300-289A)	Homo sapiens	Treatment: NumberofSonications: 1	EXP048472	2279	normal	O15047	adult erythroblasts	NULL
EXP048480	UTX (A302-374A) from Bethyl Labs	Homo sapiens	Treatment: NumberofSonications: 1	EXP048470	2279	normal	O15550	adult erythroblasts	NULL
EXP048481	CFP1, non-commercial Ab from Bob Roeder	Homo sapiens	Treatment: NumberofSonications: 1	EXP048473	2278	normal	Q9P0U4	EBV-transformed-B-lymphoblasts	NULL
EXP048482	CFP1 (ab56035), from Abcam	Homo sapiens	Treatment: NumberofSonications: 1	EXP048473	2278	normal	Q9P0U4	EBV-transformed-B-lymphoblasts	NULL
EXP048483	none	Homo sapiens	Treatment: nearly confluent 150 mm dishes were treated with 1% formaldehyde, and harvested in Farnham lysis buffer and a crude nuclear pellet collected after centrifugation.	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048484	anti-FLAG antibody	Homo sapiens	Infection: retrovirus expressing FLAG-ERG Treatment: nearly confluent 150 mm dishes were treated with 1% formaldehyde, and harvested in Farnham lysis buffer and a crude nuclear pellet collected after centrifugation	EXP048483	781	normal	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP048485	anti-FLAG antibody	Homo sapiens	Infection: retrovirus expressing FLAG-EHF Treatment: nearly confluent 150 mm dishes were treated with 1% formaldehyde, and harvested in Farnham lysis buffer and a crude nuclear pellet collected after centrifugation	EXP048483	781	normal	Q9NZC4	RWPE1 (prostate epithelial cells)	NULL
EXP048486	none	Homo sapiens	CellType: ES-derived RPE cells	NULL	2280	chip_control	NULL	hES-PRE	NULL
EXP048487	none	Homo sapiens	CellType: ES-derived RPE cells	NULL	2280	chip_control	NULL	hES-PRE	NULL
EXP048488	rabbit anti-Sox9 (Millipore, AB5535)	Homo sapiens	CellType: ES-derived RPE cells	EXP048486	2280	normal	P48436	hES-PRE	NULL
EXP048489	rabbit anti-Sox9 (Millipore, AB5535)	Homo sapiens	CellType: ES-derived RPE cells	EXP048487	2280	normal	P48436	hES-PRE	NULL
EXP048490	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #1	NULL	435	normal	Q92826	prostate tumor	NULL
EXP048491	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #2	NULL	435	normal	Q92826	prostate tumor	NULL
EXP048492	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #3	NULL	435	normal	Q92826	prostate tumor	NULL
EXP048493	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #4	NULL	435	normal	Q92826	prostate tumor	NULL
EXP048494	anti-FOXA1 (Abcam, ab23738, #GR 176970-2)	Homo sapiens	Treatment: Patient: #1	NULL	435	normal	P55317	prostate tumor	NULL
EXP048495	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #2	NULL	435	normal	P55317	prostate tumor	NULL
EXP048496	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #3	NULL	435	normal	P55317	prostate tumor	NULL
EXP048497	anti-HOXB13 (Santa Cruz Biotechnology, #sc-66923, #E3116)	Homo sapiens	Treatment: Patient: #4	NULL	435	normal	P55317	prostate tumor	NULL
EXP048498	none	Arabidopsis thaliana	Treatment: no DSG	NULL	2281	chip_control	NULL	flowers, 5-week-old plants	NULL
EXP048499	none	Arabidopsis thaliana	Treatment: DSG	NULL	2281	chip_control	NULL	flowers, 5-week-old plants	NULL
EXP048500	GFP	Arabidopsis thaliana	Treatment: no DSG	EXP048498	2281	normal	Q9STM3	flowers, 5-week-old plants	NULL
EXP048501	GFP	Arabidopsis thaliana	Treatment: DSG	EXP048499	2281	normal	Q9STM3	flowers, 5-week-old plants	NULL
EXP048502	GFP	Arabidopsis thaliana	Treatment: DSG	EXP048499	2281	normal	Q9STM3	flowers, 5-week-old plants	NULL
EXP048503	GFP	Arabidopsis thaliana	Treatment: DSG; triple mutant	EXP048499	2281	bio_control	Q9STM3	flowers, 5-week-old plants	NULL
EXP048504	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048505	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048506	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048507	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048508	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048509	TRPS1	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048510	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048511	TRPS1	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q9UHF7	1% H1 ESCs with 99% fibroblsat	NULL
EXP048512	TRPS1	Homo sapiens	Treatment: none	NULL	817	normal	Q9UHF7	SUM159PT (Triple negative breast cancer)	NULL
EXP048513	TRPS1	Homo sapiens	Treatment: none	NULL	817	normal	Q9UHF7	SUM159PT (Triple negative breast cancer)	NULL
EXP048514	TRPS1	Homo sapiens	Treatment: none	NULL	817	normal	Q9UHF7	SUM159PT (Triple negative breast cancer)	NULL
EXP048515	TRPS1	Homo sapiens	Treatment: none	NULL	934	normal	Q9UHF7	HOT1 tumor derived from a human glioblastoma	NULL
EXP048516	TRPS1	Homo sapiens	Treatment: none	NULL	934	normal	Q9UHF7	HOT1 tumor derived from a human glioblastoma	NULL
EXP048517	TRPS1	Homo sapiens	Treatment: none	NULL	934	normal	Q9UHF7	HOT1 tumor derived from a human glioblastoma	NULL
EXP048518	HDAC2	Homo sapiens	Treatment: none	NULL	2222	normal	Q92769	1% H1 ESCs with 99% fibroblsat	NULL
EXP048519	HDAC2	Homo sapiens	Treatment: none	NULL	2222	normal	Q92769	1% H1 ESCs with 99% fibroblsat	NULL
EXP048520	MTA2	Homo sapiens	Treatment: none	NULL	2222	normal	O94776	1% H1 ESCs with 99% fibroblsat	NULL
EXP048521	MTA2	Homo sapiens	Treatment: none	NULL	2222	normal	O94776	1% H1 ESCs with 99% fibroblsat	NULL
EXP048522	GATAD2A	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	NULL
EXP048523	GATAD2A	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	NULL
EXP048524	GATAD2A	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	NULL
EXP048525	GATAD2A	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q86YP4	1% H1 ESCs with 99% fibroblsat	NULL
EXP048526	GATAD2B	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	NULL
EXP048527	GATAD2B	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	NULL
EXP048528	GATAD2B	Homo sapiens	Treatment: No Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	NULL
EXP048529	GATAD2B	Homo sapiens	Treatment: Dox	NULL	2222	normal	Q8WXI9	1% H1 ESCs with 99% fibroblsat	NULL
EXP048530	none	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048531	none	Homo sapiens	Treatment: none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048532	none	Homo sapiens	Treatment: none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048533	SKP2 antibody (ab68455, Abcam)	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	EXP048530	417	normal	Q13309	HCT-116 (colon carcinoma)	NULL
EXP048534	SKP2 antibody (ab68455, Abcam)	Homo sapiens	Treatment: Genotype: RepID knockout CellType: cultured cancer cell line	EXP048531	417	normal	Q13309	HCT-116 (colon carcinoma)	NULL
EXP048535	CDT2 antibody (ab72264, Abcam)	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	NULL	848	normal	Q9NZJ0	U2OS (osteosarcoma)	NULL
EXP048536	CUL4A antibody (ab92554, Abcam)	Homo sapiens	Treatment: Genotype: wildtype CellType: cultured cancer cell line	NULL	848	normal	Q13619	U2OS (osteosarcoma)	NULL
EXP048537	none	Homo sapiens		NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048538	none	Homo sapiens		NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048539	none	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048540	none	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048541	none	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP048542	none	Homo sapiens		NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP048543	none	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP048544	none	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP048545	none	Mus musculus	Source: acute myeloid leukemia	NULL	614	chip_control	NULL	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP048546	none	Mus musculus	Source: acute myeloid leukemia	NULL	614	chip_control	NULL	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP048547	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048537	2219	normal	Q9NPA5	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048548	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048538	2219	normal	Q9NPA5	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048549	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048550	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	NULL	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP048551	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048541	677	normal	Q9NPA5	NOMO-1 (acute monocytic leukemia)	NULL
EXP048552	ZFP64(Proteintech Group,17187-1-AP)	Homo sapiens		EXP048542	677	normal	Q9NPA5	NOMO-1 (acute monocytic leukemia)	NULL
EXP048553	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	EXP048543	677	normal	A0AVK6	NOMO-1 (acute monocytic leukemia)	NULL
EXP048554	FLAG(Sigma-Aldrich,F1804, )	Homo sapiens	Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus	EXP048542	677	normal	A0AVK6	NOMO-1 (acute monocytic leukemia)	NULL
EXP048555	ZFP64(Proteintech Group,17187-1-AP)	Mus musculus	Source: acute myeloid leukemia	EXP048546	614	normal	Q99KE8	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP048556	ZFP64(Proteintech Group,17187-1-AP)	Mus musculus	Source: acute myeloid leukemia	EXP048546	614	normal	Q99KE8	MAF-9 (MLL-AF9 transduced mouse bone marrow cells)	NULL
EXP048557	IgG	Homo sapiens	CellLine: A549	NULL	192	chip_control	NULL	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP048558	SMAD3	Homo sapiens	CellLine: A549	EXP048557	192	normal	P84022	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP048559	None	Homo sapiens		NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP048560	JDP2 (Santa Cruz sc-23456X)	Homo sapiens		EXP048559	1095	normal	Q8WYK2	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP048561	N/A	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048562	N/A	Homo sapiens	Treatment: SCHLAP1 construct, sonicated	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048563	N/A	Homo sapiens	Treatment: LacZ construct, sonicated	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048564	Abcam ab110641	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	EXP048561	781	normal	P51532	RWPE1 (prostate epithelial cells)	NULL
EXP048565	Cell Signaling 11966	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	EXP048561	781	normal	P51531	RWPE1 (prostate epithelial cells)	NULL
EXP048566	Snf5	Homo sapiens	Treatment: SCHLAP1 construct, Mnase digestion	EXP048561	781	normal	Q12824	RWPE1 (prostate epithelial cells)	NULL
EXP048567	FOS	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P01100	MCF10A-ER-Src	NULL
EXP048568	FOS	Homo sapiens	Genotype: transformed	NULL	2284	normal	P01100	MCF10A-ER-Src	NULL
EXP048569	JUNB	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P17275	MCF10A-ER-Src	NULL
EXP048570	JUNB	Homo sapiens	Genotype: transformed	NULL	2284	normal	P17275	MCF10A-ER-Src	NULL
EXP048571	JUN	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P05412	MCF10A-ER-Src	NULL
EXP048572	JUN	Homo sapiens	Genotype: transformed	NULL	2284	normal	P05412	MCF10A-ER-Src	NULL
EXP048573	NFKB1	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P19838	MCF10A-ER-Src	NULL
EXP048574	NFKB1	Homo sapiens	Genotype: transformed	NULL	2284	normal	P19838	MCF10A-ER-Src	NULL
EXP048575	STAT3	Homo sapiens	Genotype: non-transformed	NULL	2284	normal	P40763	MCF10A-ER-Src	NULL
EXP048576	STAT3	Homo sapiens	Genotype: transformed	NULL	2284	normal	P40763	MCF10A-ER-Src	NULL
EXP048577	none	Homo sapiens	none	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048578	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	DMSO	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048579	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	H3B-6545	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048580	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Saturated H3B-6545	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048581	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	800	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048582	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Rad1901	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048583	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	H3B-5942	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048584	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Saturated H3B-5942	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048585	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Tamoxifen	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048586	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	Fulvestrant	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048587	Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	Homo sapiens	E2	EXP048577	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048588		Homo sapiens	Treatment: DMSO for 9hrs CellType: Human epithelial breast cancer cells; passage-immortalized	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP048589		Homo sapiens	Treatment: 0.5 uM VE-822 + 0.2 uM aphidicolin for 9hrs CellType: Human epithelial breast cancer cells; passage-immortalized 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP048590	Mouse monoclonal anti-RPA32 (RPA ChIP on MEF 4-3 cells, Millipore NA19L-100UG; RRID:AB_565123)	Homo sapiens	Treatment: DMSO for 9hrs CellType: Human epithelial breast cancer cells; passage-immortalized	EXP048588	2301	normal	P15927	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP048591	Mouse monoclonal anti-RPA32 (RPA ChIP on MEF 4-3 cells, Millipore NA19L-100UG; RRID:AB_565123)	Homo sapiens	Treatment: 0.5 uM VE-822 + 0.2 uM aphidicolin for 9hrs CellType: Human epithelial breast cancer cells; passage-immortalized 	EXP048589	2301	normal	P15927	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP048592	Input	Homo sapiens	Treatment: Treatment: etoposide (100uM, 6hrs) Source: IMR90 fetal lung fibroblasts Passage: #30-35	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP048593	anti-p53	Homo sapiens	Treatment: Treatment: etoposide (100uM, 6hrs) Source: IMR90 fetal lung fibroblasts Passage: #30-35	EXP048592	489	normal	P04637	IMR90 (lung fibroblasts)	NULL
EXP048594	anti-MLL4 provided by Kai Ge (NIH)	Homo sapiens	Treatment: Treatment: TNF for 16 hr CellType: colon cancer cells	NULL	821	normal	Q9UMN6	SW480 (colon adenocarcinoma)	NULL
EXP048595	anti-p53 (FL393, sc6243)	Homo sapiens	Treatment: treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable control (LacZ) knockdown	NULL	821	normal	P04637	SW480 (colon adenocarcinoma)	NULL
EXP048596	anti-p53 (FL393, sc6243)	Homo sapiens	Treatment: treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable p53 knockdown	NULL	821	normal	P04637	SW480 (colon adenocarcinoma)	NULL
EXP048597	HA (Santa Cruz, sc-7392)	Homo sapiens	Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP048598	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype:Stable ESR1-YAP1 fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP048599	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype: stable ESR1-PCDH11X fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP048600	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype: stable ESR1-NOP2 fusion expressing model Treatment: hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP048601	HA (Santa Cruz, sc-7392)	Homo sapiens	CellSubtype: stable YFP-HA expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP048602	none (input)	Homo sapiens		NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP048603	anti-AR (Santa Cruz H-280)	Homo sapiens	Genotype: empty vector Tissue: skin Treatment: Cells were transfected with pcDNA3.1(-) empty vector control for 24 hr, post-seeding using Lipofectamine 2000	EXP048602	36	normal	P10275	A375 (malignant melanoma)	NULL
EXP048604	anti-AR (Santa Cruz H-280)	Homo sapiens	Genotype: empty vector Tissue: skin Treatment: Cells were transfected with pcDNA3.1(-) vector expressing SLNCR1 for 24 hr, post-seeding using Lipofectamine 2000	EXP048602	36	normal	P10275	A375 (malignant melanoma)	NULL
EXP048605	none (input)	Homo sapiens	Tissue: skin TumorStage: malignant melanoma Treatment: 	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP048606	anti-EGR1 (Cell Signaling, 44D5)	Homo sapiens	Tissue: skin TumorStage: malignant melanoma Treatment: 	EXP048605	36	normal	P18146	A375 (malignant melanoma)	NULL
EXP048607	CTCF antibody 61311 Active Motif	Homo sapiens	Treatment: none	NULL	417	normal	P49711	HCT-116 (colon carcinoma)	NULL
EXP048608		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048609	Santa Cruz HC-20 and the monoclonal ER Ab10 antibodies	Homo sapiens		EXP048608	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048610	none	Homo sapiens	Treatment: 1uM 3-MC for 24 hr 	NULL	2285	chip_control	NULL	GM01310 ( Transformed lymphovlasoid cell line )	NULL
EXP048611	none	Homo sapiens	Treatment: 0.1 % DMSO for 24 hr	NULL	2285	chip_control	NULL	GM01310 ( Transformed lymphovlasoid cell line )	NULL
EXP048612	D5S6H-lot 1 (Cell Signaling Technology)	Homo sapiens	Treatment: 1uM 3-MC for 24 hr 	EXP048610	2285	normal	P35869	GM01310 ( Transformed lymphovlasoid cell line )	NULL
EXP048613	D5S6H-lot 1 (Cell Signaling Technology)	Homo sapiens	Treatment: 0.1 % DMSO for 24 hr	EXP048611	2285	normal	P35869	GM01310 ( Transformed lymphovlasoid cell line )	NULL
EXP048614	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment:control, no triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	NULL
EXP048615	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 2 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	NULL
EXP048616	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 5 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	NULL
EXP048617	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 10 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	NULL
EXP048618	rabbit anti Spt5 (Glover-Cutter et al NSMB 15:71-78, 2008)	Homo sapiens	Treatment: SpikeIn: mouse M12 treatment: after 20 min after triptolide added	NULL	417	normal	O00267	HCT-116 (colon carcinoma)	NULL
EXP048619		Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048620		Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048621	IgG	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048622	IgG	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048623		Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048624		Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048625	IgG	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048626	IgG	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048627		Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048628		Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048629	IgG	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048630	IgG	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048631	anti-GFPE	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048619	781	normal	P13631	RWPE1 (prostate epithelial cells)	NULL
EXP048632	anti-GFPE	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048620	781	normal	P13631	RWPE1 (prostate epithelial cells)	NULL
EXP048633	anti-GFPE	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048623	781	normal	P13631	RWPE1 (prostate epithelial cells)	NULL
EXP048634	anti-GFPE	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048624	781	normal	P13631	RWPE1 (prostate epithelial cells)	NULL
EXP048635	anti-GFPE	Homo sapiens	Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048627	781	normal	P13631	RWPE1 (prostate epithelial cells)	NULL
EXP048636	anti-GFPE	Homo sapiens	Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP	EXP048628	781	normal	P13631	RWPE1 (prostate epithelial cells)	NULL
EXP048637	none	Homo sapiens		NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP048638	none	Homo sapiens		NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP048639	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 0 hr (control) Passage: 2-5 	EXP048637	92	normal	Q04206	BJAB (Burkitt lymphoma)	NULL
EXP048640	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 0 hr (control) Passage: 2-5 	EXP048638	92	normal	Q04206	BJAB (Burkitt lymphoma)	NULL
EXP048641	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 1 hr Passage: 2-5 	EXP048637	92	normal	Q04206	BJAB (Burkitt lymphoma)	NULL
EXP048642	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 1 hr Passage: 2-5 	EXP048638	92	normal	Q04206	BJAB (Burkitt lymphoma)	NULL
EXP048643	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 4 hr Passage: 2-5 	EXP048637	92	normal	Q04206	BJAB (Burkitt lymphoma)	NULL
EXP048644	RelA (sc-372, Santa Cruz)	Homo sapiens	Treatment: 50 ng/ml PMA and 2 uM ionomycin 4 hr Passage: 2-5 	EXP048638	92	normal	Q04206	BJAB (Burkitt lymphoma)	NULL
EXP048645		Homo sapiens	Treatment: untreated	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP048646	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: ActA, 50 ng/ml, 1.5hr	EXP048645	111	normal	Q15796	T47D (invasive ductal carcinoma)	NULL
EXP048647	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: Palbo, 1microM, 24hr, ActA, 50 ng/ml, 1.5hr	EXP048645	111	normal	Q15796	T47D (invasive ductal carcinoma)	NULL
EXP048648	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: ActA, 50 ng/ml, 1.5hr	NULL	449	chip_control	NULL	HS578T (invasive ductal breast carcinoma)	NULL
EXP048649	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: Palbo, 1microM, 24hr, ActA, 50 ng/ml, 1.5hr	NULL	449	chip_control	NULL	HS578T (invasive ductal breast carcinoma)	NULL
EXP048650	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: ActA, 50 ng/ml, 1.5hr	EXP048648	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	NULL
EXP048651	anti-SMAD2 antibody (EP567Y, ab207451, Abcam)	Homo sapiens	Treatment: Palbo, 1microM, 24hr, ActA, 50 ng/ml, 1.5hr	EXP048649	449	normal	Q15796	HS578T (invasive ductal breast carcinoma)	NULL
EXP048652	input	Homo sapiens	Treatment: Treatment: mock infected, time post infection 24 hr	NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP048653	input	Homo sapiens	Treatment: Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025	NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP048654	input	Homo sapiens	Treatment: Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025	NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP048655	CTCF, Active Motif #61311	Homo sapiens	Treatment: Treatment: mock infected, time post infection 24 hr	EXP048652	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP048656	CTCF, Active Motif #61311	Homo sapiens	Treatment: Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025	EXP048653	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP048657	CTCF, Active Motif #61311	Homo sapiens	Treatment: Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025	EXP048654	466	normal	P49711	MDM(monocyte derived macrophages)	NULL
EXP048658	anti-ZNF207 (Santa Cruz Biotechnology, Inc.,  sc-271942)	Homo sapiens		NULL	396	normal	O43670	WA09 (embryonic stem cells)	NULL
EXP048659	NCAPH2 (Bethyl: A302-275A)	Homo sapiens	Passage:10-13	NULL	421	normal	Q6IBW4	HEK293 (embryonic kidney)	NULL
EXP048660	none	Homo sapiens		NULL	2287	chip_control	NULL	LCL (lymphoblastoid cell line)	NULL
EXP048661	none	Homo sapiens		NULL	2287	chip_control	NULL	LCL (lymphoblastoid cell line)	NULL
EXP048662	anti-BMI1; Bethyl Laboratories; A301-694A	Homo sapiens		EXP048660	2287	normal	P35226	LCL (lymphoblastoid cell line)	NULL
EXP048663	anti-SUZ12; Abcam; ab12073	Homo sapiens		EXP048661	2287	normal	Q15022	LCL (lymphoblastoid cell line)	NULL
EXP048664	IgG	Homo sapiens	Treatment: DMSO	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP048665	IgG	Homo sapiens	Treatment: 1uM for 6 hr of OTX015	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP048666	none	Homo sapiens	Treatment: DMSO	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP048667	none	Homo sapiens	Treatment: 1uM for 6 hr of OTX015	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP048668	BCL6	Homo sapiens	Treatment: DMSO	EXP048666	38	normal	P41182	A549 (lung carcinoma)	NULL
EXP048669	BCL6	Homo sapiens	Treatment: 1uM for 6 hr of OTX015	EXP048667	38	normal	P41182	A549 (lung carcinoma)	NULL
EXP048670	BRD3	Homo sapiens	Treatment: DMSO	EXP048666	38	normal	Q15059	A549 (lung carcinoma)	NULL
EXP048671	IgG	Homo sapiens		NULL	2288	chip_control	NULL	AML (monocytes and acute myeloid leukemia)	NULL
EXP048672	LDB1	Homo sapiens		EXP048671	2288	normal	Q86U70	AML (monocytes and acute myeloid leukemia)	NULL
EXP048673	none	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048674	none	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048675	none	Homo sapiens	Treatment: DMSO for 45 min  Genotype: TET2 knockout Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048676	none	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: TET2 knockout Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048677	none	Homo sapiens	Treatment: DMSO for 45 min Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048678	none	Homo sapiens	Treatment: E2 (estrogen) for 45 min Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048679	none	Homo sapiens	Treatment: no targeting shRNA  Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048680	none	Homo sapiens	Treatment: shRNA target MLL3  Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048681	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048682	none	Homo sapiens	Treatment: shRNA target TET2  Passage: 6-10 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048683	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048684	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048685	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048686	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 	EXP048674	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048687	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: DMSO for 45 min  Genotype: TET2 knockout Passage: 6-10 	EXP048675	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048688	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: TET2 knockout Passage: 6-10 	EXP048676	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048689	TET2_NTD (homemade)	Homo sapiens	Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048690	TET2_NTD (homemade)	Homo sapiens	Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048691	TET2_NTD (homemade)	Homo sapiens	Genotype: TET2 knockout Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048692	ESR1	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048693	anti-ERa (Santa Cruz Biotechnology, sc-543)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048694	anti-TET2_NTD (homemade)	Homo sapiens	Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048695	anti-TET2_NTD (homemade)	Homo sapiens	Treatment: Tamoxifen for 45 min  Genotype: wildtype TET2 Passage: 6-10 	NULL	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048696	anti-MLL3 (homemade)	Homo sapiens	Treatment: DMSO for 45 min Passage: 6-10 	EXP048677	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048697	anti-MLL3 (homemade)	Homo sapiens	Treatment: E2 (estrogen) for 45 min  Passage: 6-10 	EXP048678	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048698	anti-MLL3 (homemade)	Homo sapiens	Treatment: no targeting shRNA  Passage: 6-10 	EXP048679	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048699	anti-MLL3 (homemade)	Homo sapiens	Treatment: shRNA target MLL3  Passage: 6-10 	EXP048680	113	normal	Q8NEZ4	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048700	anti-TET2_NTD (homemade)	Homo sapiens	Treatment: shRNA target TET2  Passage: 6-10 	EXP048682	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048701	anti-TET2 (Cell Signaling Technology)	Homo sapiens	Genotype: wildtype TET2 Passage: 6-10 	EXP048683	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048702	anti-TET2 (Cell Signaling Technology)	Homo sapiens	Genotype: TET2 knockout Passage: 6-10 	EXP048684	113	normal	Q6N021	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048703	anti-UTX (homemade)	Homo sapiens	Genotype: parental cells Passage: 6-10 	NULL	113	normal	O15550	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048704	input chromatin	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048705	input chromatin	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048706	input chromatin	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048707	input chromatin	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048709	input chromatin	Homo sapiens		NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048710	input chromatin	Homo sapiens		NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048712	input chromatin	Homo sapiens		NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048713	input chromatin	Homo sapiens	Treatment: degree of hypoxia - normoxia	NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048714	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048709	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048715	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048709	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048716	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048710	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048717	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048710	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048718	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048712	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048719	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout	EXP048712	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048720	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048713	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048721	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout	EXP048713	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048722	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048726	2291	bio_control	Q16665	RCC4 (kidney cancer cell line)	NULL
EXP048723	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048727	2291	normal	Q16665	RCC4 (kidney cancer cell line)	NULL
EXP048724	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048726	2291	normal	Q99814	RCC4 (kidney cancer cell line)	NULL
EXP048725	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048727	2291	normal	Q99814	RCC4 (kidney cancer cell line)	NULL
EXP048726	input chromatin	Homo sapiens	Treatment: degree of hypoxia - normoxia	NULL	2291	chip_control	NULL	RCC4 (kidney cancer cell line)	NULL
EXP048727	input chromatin	Homo sapiens	Treatment: degree of hypoxia - normoxia	NULL	2291	chip_control	NULL	RCC4 (kidney cancer cell line)	NULL
EXP048728	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048730	2291	normal	A0AVK6	RCC4 (kidney cancer cell line)	NULL
EXP048729	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia - normoxia	EXP048731	2291	normal	A0AVK6	RCC4 (kidney cancer cell line)	NULL
EXP048730	input chromatin	Homo sapiens	Treatment: degree of hypoxia - normoxia	NULL	2291	chip_control	NULL	RCC4 (kidney cancer cell line)	NULL
EXP048731	input chromatin	Homo sapiens	Treatment: degree of hypoxia - normoxia	NULL	2291	chip_control	NULL	RCC4 (kidney cancer cell line)	NULL
EXP048732	input chromatin	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP048733	input chromatin	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP048734	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048732	430	normal	A0AVK6	HepG2 (hepatoblastoma)	NULL
EXP048735	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048733	430	normal	A0AVK6	HepG2 (hepatoblastoma)	NULL
EXP048736	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048732	430	normal	Q16665	HepG2 (hepatoblastoma)	NULL
EXP048737	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048733	430	normal	Q16665	HepG2 (hepatoblastoma)	NULL
EXP048738	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048732	430	normal	Q99814	HepG2 (hepatoblastoma)	NULL
EXP048739	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048733	430	normal	Q99814	HepG2 (hepatoblastoma)	NULL
EXP048740	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	EXP048704	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048741	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	EXP048704	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048742	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours	EXP048704	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048743	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048705	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048744	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048705	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048745	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048705	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048746	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	EXP048706	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048747	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	EXP048706	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048748	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours	EXP048706	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048749	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	EXP048707	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048750	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	EXP048707	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048751	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours	EXP048707	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048752	HIF1b (Novus NB100-110)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048755	2289	normal	A0AVK6	HKC8 (kidney proximal tubule cell line)	NULL
EXP048753	HIF1a (PM14)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048755	2289	normal	Q16665	HKC8 (kidney proximal tubule cell line)	NULL
EXP048754	HIF2a (PM9)	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	EXP048755	2289	normal	Q99814	HKC8 (kidney proximal tubule cell line)	NULL
EXP048755	input chromatin	Homo sapiens	Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours	NULL	2289	chip_control	NULL	HKC8 (kidney proximal tubule cell line)	NULL
EXP048756	FOXA2	Homo sapiens	Phase: P (proliferative)	NULL	2292	normal	Q9Y261	endometrium	NULL
EXP048757	FOXA2	Homo sapiens	Phase: MS (mid-secretory)	NULL	2292	normal	Q9Y261	endometrium	NULL
EXP048758	none	Homo sapiens	Cells were hormone-deprived for at least 3 days and then treated with 100 nM 17ÃŽÂ²-estradiol (Sigma) for 45 minutes.	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048759	4439 (Anti-JARID1B antibody, ABE239, EMD Millipore)	Homo sapiens	Treatment: hormone-deprived for at least 3 days and then treated with vehicle for 45 minutes	EXP048758	113	normal	Q9UGL1	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048760	2469 (non-commercial, unpublished)	Homo sapiens	Treatment: hormone-deprived for at least 3 days and then treated with vehicle for 45 minutes	EXP048758	113	normal	P29375	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048761	2469 (non-commercial, unpublished)	Homo sapiens	Treatment: hormone-deprived for at least 3 days and then treated with 100 nM 17|2-estradiol (Sigma) for 45 minutes	EXP048758	113	normal	P29375	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048762	IgG  (Santa Cruz, sc-2027)	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP048763	MTA2 (Santa Cruz, sc-28731)	Homo sapiens		EXP048762	417	normal	O94776	HCT-116 (colon carcinoma)	NULL
EXP048764	EZH2 (Abcam, ab3748)	Homo sapiens		EXP048762	417	normal	Q15910	HCT-116 (colon carcinoma)	NULL
EXP048765	EZH2 (Abcam, ab3748)	Homo sapiens		EXP048762	417	normal	Q15910	HCT-116 (colon carcinoma)	NULL
EXP048766	none, input	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP048767	none, input	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP048768	none, input	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP048769	none, input	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP048770	none, input	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP048771	none, input	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP048772	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048766	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048773	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048767	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048774	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: none Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048768	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048775	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048769	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048776	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048770	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048777	SSRP1 (Biolegend, cat#609702, clone:10D1)	Homo sapiens	Treatment: curaxin Tissue: derived from biopsy of fibrosarcoma of Human male	EXP048771	1008	normal	Q08945	HT1080 (fibrosarcoma)	NULL
EXP048778	YAP (H125)X  (Santa Cruz Biotechnologies,#sc1540, #c-1904)	Homo sapiens	Treatment: no treatment	NULL	2293	normal	P46937	OVCAR5 (ovarian cancer cell line)	NULL
EXP048779	IgG	Homo sapiens		NULL	2294	chip_control	NULL	H69	NULL
EXP048780	YAP Santa Cruz	Homo sapiens		EXP048779	2294	normal	P18509	H69	NULL
EXP048781	YAP	Homo sapiens		EXP048779	2294	normal	P46937	H69	NULL
EXP048782	TEAD	Homo sapiens		EXP048779	2294	normal	P28347	H69	NULL
EXP048783	Monoclonal ANTI-FLAGÂ® M2 antibody (Sigma Aldrich, Cat# F1804)	Homo sapiens	Grnotype: cells transformed with adenovirus 5 DNA for BRD7 overexpression 	NULL	421	normal	Q9NPI1	HEK293 (embryonic kidney)	NULL
EXP048784	Monoclonal ANTI-FLAGÂ® M2 antibody (Sigma Aldrich, Cat# F1804)	Homo sapiens	Grnotype: wildtype  	NULL	421	normal	Q9NPI1	HEK293 (embryonic kidney)	NULL
EXP048785	BPTF; Kindly obtained from Ramin Shiekhattar	Homo sapiens	unstimulated cells	NULL	2295	normal	Q12830	T47D-MTVL	NULL
EXP048786	BPTF; Kindly obtained from Ramin Shiekhattar	Homo sapiens	stimulated cells with 30 minutes	NULL	2295	normal	Q12830	T47D-MTVL	NULL
EXP048787	anti-HP1? (Mab 3450)	Homo sapiens	unstimulated cells	NULL	2295	normal	Q13185	T47D-MTVL	NULL
EXP048788	anti-HP1? (Mab 3450)	Homo sapiens	stimulated cells with 30 minutes	NULL	2295	normal	Q13185	T47D-MTVL	NULL
EXP048789	abcam anti-LSD1	Homo sapiens	unstimulated cells	NULL	2295	normal	O60341	T47D-MTVL	NULL
EXP048790	abcam anti-LSD1	Homo sapiens	stimulated cells with 30 minutes	NULL	2295	normal	O60341	T47D-MTVL	NULL
EXP048791	anti-CTCF	Homo sapiens		NULL	712	normal	P49711	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP048792	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Minicircle	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048793	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Minicircle	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048794	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Episomal vector	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048795	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Episomal vector	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048796	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	2296	normal	Q92769	HES-2 (embryonic stem cells)	NULL
EXP048797	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	1593	normal	Q92769	WA07 (H7, human embryonic stem cells)	NULL
EXP048798	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	396	normal	Q92769	WA09 (embryonic stem cells)	NULL
EXP048799	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	878	normal	Q92769	embryonic stem cells	NULL
EXP048800	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	LentiVirus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048801	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	LentiVirus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048802	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	2298	normal	Q92769	LSJ-1	NULL
EXP048803	HDAC2 (Cell Signaling, 2545S)	Homo sapiens		NULL	2299	normal	Q92769	LSJ-2	NULL
EXP048804	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	mRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048805	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	mRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048806	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Sendai Virus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048807	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	Sendai Virus	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048808	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	microRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048809	HDAC2 (Cell Signaling, 2545S)	Homo sapiens	microRNA	NULL	1143	normal	Q92769	iPSC (induced pluripotent stem cells)	NULL
EXP048810	none	Homo sapiens	Treatment: no treatment Markel Cell: positive	NULL	2297	chip_control	NULL	MKL-1 (Merkel cell carcinoma)	NULL
EXP048811	none	Homo sapiens	Treatment: no treatment Markel Cell: positive	NULL	2297	chip_control	NULL	MKL-1 (Merkel cell carcinoma)	NULL
EXP048812	EP400 (Bethyl, A300-541A)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048810	2297	normal	Q96L91	MKL-1 (Merkel cell carcinoma)	NULL
EXP048813	Max (Santa Cruz, SC-197)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048810	2297	normal	P61244	MKL-1 (Merkel cell carcinoma)	NULL
EXP048814	EP400 (Bethyl, A300-541A)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048811	2297	normal	Q96L91	MKL-1 (Merkel cell carcinoma)	NULL
EXP048815	Max (Santa Cruz, SC-197)	Homo sapiens	Treatment: no treatment Markel Cell: positive	EXP048811	2297	normal	P61244	MKL-1 (Merkel cell carcinoma)	NULL
EXP048816	none	Homo sapiens		NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP048817	CTCF (Millipore 07-729)	Homo sapiens	EtOH	EXP048816	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP048818	CTCF (Millipore 07-729)	Homo sapiens	100 nM 1,25(OH)2D3	EXP048816	2334	normal	P49711	THP-1 (acute monocytic leukemia)	NULL
EXP048819	input	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048820	CARM1 (Epicypher, 13-0006)	Homo sapiens		EXP048819	113	normal	Q86X55	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048821	MED12 (Bethyl, A300-774A)	Homo sapiens		EXP048819	113	normal	Q93074	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP048822	input	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP048823		Homo sapiens	2000U/ml recombinant human IFN-Î² (PBL-11410-2)	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP048824	Cocktail of mouse mAbs to HIRA 	Homo sapiens		EXP048822	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP048825	Cocktail of mouse mAbs to HIRA 	Homo sapiens	2000U/ml recombinant human IFN-Î² (PBL-11410-2)	NULL	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP048826	input	Homo sapiens	Treatment: untreated	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048827	input	Homo sapiens	Treatment: 100 nM Doxorubicin	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048828	input	Homo sapiens	Treatment:1 uMCDK4 inhibitor PD0332991	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048829	input	Homo sapiens	Treatment: coultured in DME-HG media containing only 0.5 % serum-starved	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048830	input	Homo sapiens	Treatment: untreated	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048831	input	Homo sapiens	Treatment: 100 nM Doxorubicin	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048832	input	Homo sapiens	Treatment:1 uMCDK4 inhibitor PD0332991	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048833	input	Homo sapiens	Treatment: coultured in DME-HG media containing only 0.5 % serum-starved	NULL	2300	chip_control	NULL	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048834	input	Homo sapiens	Treatment: untreated	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP048835	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: untreated	EXP048826	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048836	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: 100 nM Doxorubicin	EXP048827	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048837	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment:1 uMCDK4 inhibitor PD0332991	EXP048828	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048838	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: coultured in DME-HG media containing only 0.5 % serum-starved	EXP048829	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048839	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: untreated	EXP048830	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048840	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: 100 nM Doxorubicin	EXP048831	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048841	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment:1 uMCDK4 inhibitor PD0332991	EXP048832	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048842	ATRX (H-300, 1:1000 and D-5, 1:500)	Homo sapiens	Treatment: coultured in DME-HG media containing only 0.5 % serum-starved	EXP048833	2300	normal	P46100	LS8817 (dedifferentiated liposarcoma cells)	NULL
EXP048843	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP048844	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens	Cell line: cervical adenocarcinoma epithelial cell line Genotype: wildtype with GFP-EMSY	EXP048843	78	normal	Q7Z589	HeLa (cervical adenocarcinoma)	NULL
EXP048845	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens	Cell line: cervical adenocarcinoma epithelial cell line Genotype: GFP-EMSY, Znf131 knockdown	EXP048843	78	normal	Q7Z589	HeLa (cervical adenocarcinoma)	NULL
EXP048846	GFP custom antibody (Michiel Vermeulen's lab)	Homo sapiens	Cell line: cervical adenocarcinoma epithelial cell line Genotype: wildtype with GFP-GATAD1	EXP048843	78	normal	Q8WUU5	HeLa (cervical adenocarcinoma)	NULL
EXP048847	none (input)	Homo sapiens	Treatment: no treatment	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP048848	PRMT5 (Bethyl Labs A300-849A)	Homo sapiens	Treatment: no treatment	EXP048847	2301	normal	O14744	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP048849	rabbit IgG antibody (Invitrogen)	Homo sapiens	vehicle	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP048850	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens	Treatment: D,L-sulforaphane (SFN) for 5 hr	EXP048849	87	normal	Q16236	BEAS-2B (bronchial epithelium)	NULL
EXP048851	rabbit monoclonal anti-NRF2 (Epitomics, Clone ID EP1808Y)	Homo sapiens	Treatment: 0.1% (v/v) DMSO as vehicle for 5 hr	NULL	87	normal	Q16236	BEAS-2B (bronchial epithelium)	NULL
EXP048852	None	Homo sapiens	Treatmnet: untreated	NULL	1573	chip_control	NULL	SK-MEL-5 (Cutaneous melanoma)	NULL
EXP048853	Brd4 (Bethyl, #A301-985A)	Homo sapiens	Treatmnet: untreated	EXP048852	1573	normal	O60885	SK-MEL-5 (Cutaneous melanoma)	NULL
EXP048854	none	Homo sapiens	Treatment: untreated 	NULL	2255	chip_control	NULL	HEE (human epididymis epithelial cells)	NULL
EXP048855	none	Homo sapiens	Treatment: untreated 	NULL	2255	chip_control	NULL	HEE (human epididymis epithelial cells)	NULL
EXP048856	HNF1 (sc-8986x, Santa Cruz, #E1603)	Homo sapiens	Treatment: untreated 	EXP048854	2255	normal	P20823	HEE (human epididymis epithelial cells)	NULL
EXP048857	HNF1, sc-8986x	Homo sapiens	Treatment: untreated 	EXP048855	2255	normal	P20823	HEE (human epididymis epithelial cells)	NULL
EXP048858	none	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP048859	none	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP048860	anti-FLAG	Homo sapiens	TNF (20 ng/ml) for 15 min	EXP048858	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP048861	anti-FLAG	Homo sapiens	TNF (20 ng/ml) for 60 min	EXP048858	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP048862	anti-RelA/p65	Homo sapiens	TNF (20 ng/ml) for 15 min	EXP048859	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP048863	anti-RelA/p65	Homo sapiens	TNF (20 ng/ml) for 60 min	EXP048859	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP048864	anti-FLAG	Homo sapiens	TNF (20 ng/ml) for 30 min	EXP048858	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP048865	anti-RelA/p65	Homo sapiens	TNF (20 ng/ml) for 30 min	EXP048859	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP048866		Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell Age: no	NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP048867		Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell Age: 6	NULL	2303	chip_control	NULL	GM17942 (lymphoblastoid cell)	NULL
EXP048868		Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell Age: 41	NULL	335	chip_control	NULL	GM06990 (female B-cells)	NULL
EXP048869		Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 34 	NULL	2306	chip_control	NULL	ID00014 (lymphoblastoid cell, DiGeorge syndrome)	NULL
EXP051037		Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	NULL	2410	chip_control	NULL	lin-bone marrow	NULL
EXP048872		Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 11	NULL	2306	chip_control	NULL	ID00014 (lymphoblastoid cell, DiGeorge syndrome)	NULL
EXP051036		Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	NULL	2410	chip_control	NULL	lin-bone marrow	NULL
EXP051035		Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	NULL	2410	chip_control	NULL	lin-bone marrow	NULL
EXP048875	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 34 	EXP048869	2306	normal	P49711	ID00014 (lymphoblastoid cell, DiGeorge syndrome)	NULL
EXP048876	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell 	EXP048880	2305	normal	P49711	ID00015 (lymphoblastoid cell)	NULL
EXP048877	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 11	EXP048872	2306	normal	P49711	ID00014 (lymphoblastoid cell, DiGeorge syndrome)	NULL
EXP051028	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 6	EXP048867	2303	normal	P49711	GM17942 (lymphoblastoid cell)	NULL
EXP048879	anti-HA antibody (ab9110)	Homo sapiens		NULL	78	normal	O15391	HeLa (cervical adenocarcinoma)	NULL
EXP048880		Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell Age: 57	NULL	2305	chip_control	NULL	ID00015 (lymphoblastoid cell)	NULL
EXP051029	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: wildtype Cell type: lymphoblastoid cell Age: no	EXP048866	356	normal	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP048882	none	Homo sapiens		NULL	2307	chip_control	NULL	IMR-5 (Neuroblastoma)	NULL
EXP048883	none	Homo sapiens		NULL	2307	chip_control	NULL	IMR-5 (Neuroblastoma)	NULL
EXP048884	N-MYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: DMSO for 4 hr	EXP048882	2307	normal	P04198	IMR-5 (Neuroblastoma)	NULL
EXP048885	N-MYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 1uM CD532 for 4 hr	EXP048882	2307	normal	P04198	IMR-5 (Neuroblastoma)	NULL
EXP048886	GTF3C5 (Bethyl, A301-242A)	Homo sapiens	Treatment: DMSO for 4 hr	EXP048882	2307	normal	Q9Y5Q8	IMR-5 (Neuroblastoma)	NULL
EXP048887	GTF3C5 (Bethyl, A301-242A)	Homo sapiens	Treatment: 1uM CD532 for 4 hr	EXP048882	2307	normal	Q9Y5Q8	IMR-5 (Neuroblastoma)	NULL
EXP048888	CTCF (abcam, ab70303)	Homo sapiens		EXP048883	2307	normal	P49711	IMR-5 (Neuroblastoma)	NULL
EXP048889	RAD21 (Bethyl, A300-080A)	Homo sapiens		EXP048883	2307	normal	O60216	IMR-5 (Neuroblastoma)	NULL
EXP048890	none (Input)	Homo sapiens		NULL	2308	chip_control	NULL	NCI-H358 (human nnon small cell lung cancer cell line)	NULL
EXP048891	none (input)	Homo sapiens		NULL	2308	chip_control	NULL	NCI-H358 (human nnon small cell lung cancer cell line)	NULL
EXP048892	none (input)	Homo sapiens		NULL	59	chip_control	NULL	AGS (gastric adenocarcinoma)	NULL
EXP048893	anti-FXR1 (Sigma, HPA018246)	Homo sapiens		EXP048890	2308	normal	P51114	NCI-H358 (human nnon small cell lung cancer cell line)	NULL
EXP048894	anti-STAT1 (Santa Cruz, sc-345; CST, 14994S)	Homo sapiens		EXP048891	2308	normal	P42224	NCI-H358 (human nnon small cell lung cancer cell line)	NULL
EXP048895	anti-STAT3 (Santa Cruz, sc-482; CST, 12640S)	Homo sapiens		EXP048891	2308	normal	P40763	NCI-H358 (human nnon small cell lung cancer cell line)	NULL
EXP048896	anti-FXR1 (Sigma, HPA018246)	Homo sapiens		EXP048892	59	normal	P51114	AGS (gastric adenocarcinoma)	NULL
EXP048897	anti-FXR2 (Invitrogen, PA5-28979)	Homo sapiens		EXP048892	59	normal	P51116	AGS (gastric adenocarcinoma)	NULL
EXP048898	anti-STAT1 (Santa Cruz, sc-345; CST, 14994S)	Homo sapiens		EXP048892	59	normal	P42224	AGS (gastric adenocarcinoma)	NULL
EXP048899	anti-STAT3 (Santa Cruz, sc-482; CST, 12640S)	Homo sapiens		EXP048892	59	normal	P40763	AGS (gastric adenocarcinoma)	NULL
EXP048900	AR Antibody (H-280) (Santa Cruz, sc-13062)	Homo sapiens	Treatment: vehicle (DMSO) of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive	NULL	2310	normal	P10275	LNCaP-abl (Prostate carcinoma)	NULL
EXP048901	AR Antibody (H-280) (Santa Cruz, sc-13062)	Homo sapiens	Treatment: EPZ-6438 of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive	NULL	2310	normal	P10275	LNCaP-abl (Prostate carcinoma)	NULL
EXP048902	AR Antibody (H-280) (Santa Cruz, sc-13062)	Homo sapiens	Treatment: GSK126 of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive	NULL	2310	normal	P10275	LNCaP-abl (Prostate carcinoma)	NULL
EXP048903	TCF7L1 (Santa Cruz, sc-8635)	Homo sapiens	Treatment: none Passage: 44	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP048904	TCF7L1 (Santa Cruz, sc-8635)	Homo sapiens	Treatment: none Passage: 44	EXP048903	396	normal	Q9HCS4	WA09 (embryonic stem cells)	NULL
EXP048905	none	Homo sapiens	Treatment: cells were harvested in log phase growth	NULL	2311	chip_control	NULL	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP048906	none	Homo sapiens	Treatment: cells were harvested in log phase growth	NULL	2312	chip_control	NULL	GIST882 (Gastrointestinal stromal tumor)	NULL
EXP048907	none	Homo sapiens	Treatment: cells were harvested in log phase growth	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP048908	none	Homo sapiens	Treatment: cells were harvested in log phase growth	NULL	2313	chip_control	NULL	COLO800 (human melanoma cells)	NULL
EXP048909	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048905	2311	normal	P50549	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP048910	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048906	2312	normal	P50549	GIST882 (Gastrointestinal stromal tumor)	NULL
EXP048911	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048907	36	normal	P50549	A375 (malignant melanoma)	NULL
EXP048912	ETV1	Homo sapiens	Treatment: cells were harvested in log phase growth	EXP048908	2313	normal	P50549	COLO800 (human melanoma cells)	NULL
EXP048913	none	Homo sapiens	treatment: none	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP048914	FOXA1(ab5089,abcam)	Homo sapiens	Treatment: ethanol 	EXP048913	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP048915	FOXA1(ab5089,abcam)	Homo sapiens	Treatment: R1881	NULL	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP048920	AR(N-20, Santa Cruz)	Homo sapiens	Treatment: non-target siNT+R1881	EXP048913	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP048921	AR(N-20, Santa Cruz)	Homo sapiens	treatment: targeting ARV1/3/4/7 siARVs+R1881	EXP048913	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP048922	AR(N-20, Santa Cruz)	Homo sapiens	Treatment: targeting AR exon 7 siARFL+ ethanol	EXP048913	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP048923	HA (Sigma, H6908)	Homo sapiens	Treatment: untreated 	NULL	2315	normal	X5C3Z9	pre- leukemia stem cells (CD34+ human cord blood cells)	NULL
EXP048924	anti-FOXO1 (Abcam ab39670)	Homo sapiens	Treatment: untreated 	NULL	2315	normal	Q12778	pre- leukemia stem cells (CD34+ human cord blood cells)	NULL
EXP048925	anti-p53	Homo sapiens	Treatment: no treatment, control	NULL	985	normal	P04637	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP048926	MYCN	Homo sapiens	mTreatment: mycn-low lvl induced by 16 hr doxycycline	NULL	985	normal	P04198	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP048927	MYCN	Homo sapiens	Treatment: mycn-high lvl induced by 16 hr doxycycline	NULL	2316	normal	P04198	MYCN3 (neuroblastoma cell line with inducible MYCN expression)	NULL
EXP048944	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	NULL
EXP048945	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	NULL
EXP048946	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	NULL
EXP048947	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	NULL
EXP048948	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	NULL
EXP048949	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	NULL
EXP048950	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	NULL
EXP048951	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	NULL
EXP048952	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	Q01860	MRC-5 (fetal lung fibroblasts)	NULL
EXP048953	Oct4 (Abcam ab19857 Lot: GR187600-1)	Homo sapiens	Treatment: iPS protocol 3s2 Passage: 20	NULL	1143	normal	Q01860	iPSC (induced pluripotent stem cells)	NULL
EXP048954	Sox2 (R&D Systems AF2018)	Homo sapiens	Genotype: wildtype Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	NULL
EXP048955	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	NULL
EXP048956	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P48431	MRC-5 (fetal lung fibroblasts)	NULL
EXP048957	Sox2 (R&D Systems AF2018)	Homo sapiens	Treatment: iPS protocol 3s2 Passage: 20	NULL	2238	normal	P48431	iPS (derived pancreatic precursor cells)	NULL
EXP048958	Klf4 (R&D Systems AF3640)	Homo sapiens	Genotype: wildtype Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	NULL
EXP048959	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	NULL
EXP048960	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	O43474	MRC-5 (fetal lung fibroblasts)	NULL
EXP048961	Klf4 (R&D Systems AF3640)	Homo sapiens	Treatment: iPS protocol 3s2 Passage: 20	NULL	2238	normal	O43474	iPS (derived pancreatic precursor cells)	NULL
EXP048962	Myc (R&D Systems AF3696)	Homo sapiens	Genotype: wildtype Passage: 8 	NULL	950	normal	P01106	MRC-5 (fetal lung fibroblasts)	NULL
EXP048963	Myc (R&D Systems AF3696)	Homo sapiens	Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P01106	MRC-5 (fetal lung fibroblasts)	NULL
EXP048964	Myc (R&D Systems AF3696)	Homo sapiens	Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 	NULL	950	normal	P01106	MRC-5 (fetal lung fibroblasts)	NULL
EXP048965		Homo sapiens	Treatment: untreated	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP048966	anti-SMAD2/3 antibody (#610843, BD Transduction Laboratories) 	Homo sapiens	Treatment: TGF-beta3, 5 ng/ml, 1.5hr	EXP048965	583	normal	Q15796	MCF10A (breast epithelial cells)	NULL
EXP048967	anti-SMAD2/3 antibody (#610843, BD Transduction Laboratories) 	Homo sapiens	Treatment: TGF-beta3, 5 ng/ml, 16hr	EXP048965	583	normal	Q15796	MCF10A (breast epithelial cells)	NULL
EXP048968	IgG(Santa Cruz,sc-2025)	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP048969	GATA4(Thermo fisher,MA5-15532)	Homo sapiens		EXP048968	38	normal	P43694	A549 (lung carcinoma)	NULL
EXP048970	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: DMSO for 3 hours	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	NULL
EXP048971	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: DMSO for 3 hours, EGF simulation 20 min, 100ng/ml	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	NULL
EXP048972	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: 1 uM ERK inhibitor for 3 hours	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	NULL
EXP048973	antibody against phosphothreonine (Cell Signaling, no. 9381)	Homo sapiens	Treatment: 1 uM ERK inhibitor for 3 hours, EGF simulation 20 min, 100ng/ml	NULL	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	NULL
EXP048974	anti-TET2	Homo sapiens	Treatment: DMSO for 24 hr	NULL	2319	normal	Q6N021	MCF12A (human mammary epithelial cells)	NULL
EXP048975	anti-RARb	Homo sapiens	Treatment: DMSO for 24 hr	NULL	2319	normal	P10826	MCF12A (human mammary epithelial cells)	NULL
EXP048976	5hmc	Homo sapiens	Treatment: DMSO for 24 hr	NULL	2319	normal	Q96FZ2	MCF12A (human mammary epithelial cells)	NULL
EXP048977	TET3	Homo sapiens	Treatment: ATRA for 24 hr	NULL	2319	normal	O43151	MCF12A (human mammary epithelial cells)	NULL
EXP048978	RARb	Homo sapiens	Treatment: ATRA for 24 hr	NULL	2319	normal	P10826	MCF12A (human mammary epithelial cells)	NULL
EXP048979	5hmc	Homo sapiens	Treatment: ATRA for 24 hr	NULL	2319	normal	Q96FZ2	MCF12A (human mammary epithelial cells)	NULL
EXP048980	None	Homo sapiens	Treatment: 10 million cells were crosslinked with formaldehyde and used in the experiment Tissue: neonatal foreskin 	NULL	2320	chip_control	NULL	primary human epidermal keratinocytes	NULL
EXP048981	Bethyl rabbit anti-SMC1 (A300-055A)	Homo sapiens	Treatment: 10 million cells were crosslinked with formaldehyde and used in the experiment Tissue: neonatal foreskin 	EXP048980	2320	normal	Q14683	primary human epidermal keratinocytes	NULL
EXP048982		Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP048983		Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP048984		Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP048985		Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP048986	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048982	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP048987	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	EXP048983	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP048988	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048982	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP048989	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	EXP048983	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP048990	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048982	70	normal	Q14541	LNCaP (prostate carcinoma)	NULL
EXP048991	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression	EXP048983	70	normal	Q14541	LNCaP (prostate carcinoma)	NULL
EXP048992	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048984	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP048993	AR (Abcam, ab108341)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	EXP048985	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP048994	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048984	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP048995	FOXA1 (Abcam; ab5089)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	EXP048985	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP048996	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: wildtype	EXP048984	7	normal	Q14541	22RV1 (prostate carcinoma)	NULL
EXP048997	HNF4G (Sigma; HPA005438 or Proteintech; 25801-1-AP)	Homo sapiens	Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G	EXP048985	7	normal	Q14541	22RV1 (prostate carcinoma)	NULL
EXP048998		Homo sapiens	Treatment: no	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP048999	none	Homo sapiens		NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP049000	Anti-ERG Clone 9FY (Biocare, Catalog# CM421 C, Lot #021715)	Homo sapiens	Treatment: no Genotype: expressing point-mutant(S96E) of ERF	EXP048998	781	normal	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP049001	Anti-ERG Clone 9FY (Biocare, Catalog# CM421 C, Lot #021715)	Homo sapiens	Treatment: no Genotype: expressing point-mutant(S96E) of ERF	EXP048999	781	normal	P11308	RWPE1 (prostate epithelial cells)	NULL
EXP049002	Anti-V5 Agarose (Affinity Gel antibody, clone V5-10 Sigma, #A7345)	Homo sapiens	Genotype: empty V5 vector cds	NULL	421	normal	Q9Y6X0	HEK293 (embryonic kidney)	NULL
EXP049003	Anti-V5 Agarose (Affinity Gel antibody, clone V5-10 Sigma, #A7345)	Homo sapiens	Genotype: SETBP1 G870S vector cds	NULL	421	normal	Q9Y6X0	HEK293 (embryonic kidney)	NULL
EXP049004	Anti-V5 Agarose (Affinity Gel antibody, clone V5-10 Sigma, #A7345)	Homo sapiens	Genotype: SETBP1 wildtype	NULL	421	normal	Q9Y6X0	HEK293 (embryonic kidney)	NULL
EXP049005	none, input	Homo sapiens	Treatment: DMSO 4 hours	NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP049006	none, input	Homo sapiens	Treatment: DHT 10nM 4 hours	NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP049007	none, input	Homo sapiens	Treatment: DHT 100nM 4 hours	NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP049008	none, input	Homo sapiens	Treatment: Testosterone 100nM 4 hours	NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP049009	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DMSO 4 hours	EXP049005	915	normal	P10275	hNSC (neural stem cells)	NULL
EXP049010	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DHT 100nM 4 hours	EXP049007	915	normal	P10275	hNSC (neural stem cells)	NULL
EXP049013	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DHT 10nM 4 hours	EXP049006	915	normal	P10275	hNSC (neural stem cells)	NULL
EXP049014	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: Testosterone 100nM 4 hours	EXP049008	915	normal	P10275	hNSC (neural stem cells)	NULL
EXP049015	none, input	Homo sapiens	treatment: DMSO 4 hours	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049016	none, input	Homo sapiens	Treatment: DHT 100nM 4 hours	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049017	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DMSO 4 hours	EXP049015	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049018	AR (3279.4 homemade)	Homo sapiens	Treatment: DMSO 4 hours	EXP049015	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049019	AR (N-20 Santa Cruz sc-816)	Homo sapiens	Treatment: DHT 100nM 4 hours	EXP049016	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049020	AR (3279.4 homemade)	Homo sapiens	Treatment: DHT 100nM 4 hours	EXP049016	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049021	input DNA	Homo sapiens	Treatment: not applicable Stage:adult  Tissue: transitional cell papilloma	NULL	2323	chip_control	NULL	RT4 (Bladder carcinoma cells)	NULL
EXP049022	input DNA	Homo sapiens	Treatment: not applicable Stage:adult  Tissue: transitional cell papilloma	NULL	2323	chip_control	NULL	RT4 (Bladder carcinoma cells)	NULL
EXP049023	FoxA1 (ab5089)	Homo sapiens	Treatment: not applicable Stage:adult  Tissue: transitional cell papilloma	EXP049021	2323	normal	P55317	RT4 (Bladder carcinoma cells)	NULL
EXP049024	FoxA1 (ab5089)	Homo sapiens	Treatment: not applicable Stage:adult  Tissue: transitional cell papilloma	EXP049022	2323	normal	P55317	RT4 (Bladder carcinoma cells)	NULL
EXP049025	none	Homo sapiens	Treatment: resting CD4+ T cells were activated using anti-CD3/CD28 beads (Invitrogen Dynabeads Human T-Activator CD3/CD28, Cat# 11131D)  Tissue: blood	NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP049026	none	Homo sapiens	Treatment: stimulated  Tissue: blood	NULL	881	chip_control	NULL	CD4+ T-cells	NULL
EXP049027	anti-FOSL1 antibody (Santa Cruz Biotechnoloy, catalog# sc-183, lot# 12314)	Homo sapiens	Treatment: resting CD4+ T cells were activated using anti-CD3/CD28 beads (Invitrogen Dynabeads Human T-Activator CD3/CD28, Cat# 11131D)  Tissue: blood	EXP049025	881	normal	P15407	CD4+ T-cells	NULL
EXP049028	anti-FOSL1 antibody (Santa Cruz Biotechnoloy, catalog# sc-183, lot# 12314)	Homo sapiens	Treatment: stimulated  Tissue: blood	EXP049026	881	normal	P15407	CD4+ T-cells	NULL
EXP049029	none	Homo sapiens	Treatment: DMSO 	NULL	2324	chip_control	NULL	TC32 (Ewing's sarcoma)	NULL
EXP049030	IgG (Qiagen, Cat# GAH-111)	Homo sapiens	Treatment: DMSO 	NULL	2324	chip_control	NULL	TC32 (Ewing's sarcoma)	NULL
EXP049031	IgG (Qiagen, Cat# GAH-111)	Homo sapiens	Treatment: DMSO 	NULL	290	chip_control	NULL	EWS502 (Ewing sarcoma)	NULL
EXP049032	none	Homo sapiens	Treatment: DMSO 	NULL	290	chip_control	NULL	EWS502 (Ewing sarcoma)	NULL
EXP049033	IgG (Qiagen, Cat# GAH-111)	Homo sapiens	Treatment: DMSO 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP049034	none	Homo sapiens	Treatment: DMSO 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP049035	IgG (Qiagen, Cat# GAH-111)	Homo sapiens	Treatment: DMSO 	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP049036	none	Homo sapiens	Treatment: DMSO 	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP049037	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049029	2324	normal	P38398	TC32 (Ewing's sarcoma)	NULL
EXP049038	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 0.05 uM Etoposide for 6 hours	EXP049030	2324	normal	P38398	TC32 (Ewing's sarcoma)	NULL
EXP049039	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049031	290	normal	P38398	EWS502 (Ewing sarcoma)	NULL
EXP049040	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 0.25 uM Etoposide for 6 hours	EXP049032	290	normal	P38398	EWS502 (Ewing sarcoma)	NULL
EXP049041	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049033	489	normal	P38398	IMR90 (lung fibroblasts)	NULL
EXP049042	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 6 uM Etoposide for 6 hours	EXP049034	489	normal	P38398	IMR90 (lung fibroblasts)	NULL
EXP049043	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: DMSO 	EXP049035	848	normal	P38398	U2OS (osteosarcoma)	NULL
EXP049044	BRCA1 (Santa Cruz, Cat# sc-646)	Homo sapiens	Treatment: 6 uM Etoposide for 6 hours	EXP049036	848	normal	P38398	U2OS (osteosarcoma)	NULL
EXP049045	None	Homo sapiens	Treatment: confluent, treated with Scr siRNA Passage: 4	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049046	None	Homo sapiens	Treatment: confluent, treated with Scr siRNA and stimulated with IL-1beta Passage: 4	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049047	None	Homo sapiens	Treatment: confluent, treated with Notch1 siRNA and stimulated with IL-1beta Passsage: 4	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049048	None	Homo sapiens	Treatment: confluent, treated with Scr siRNA Passage: 4	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049049	None	Homo sapiens	Treatment: confluent, treated with Scr siRNA and stimulated with IL-1beta Passage: 4	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049050	None	Homo sapiens	Treatment: confluent, treated with Notch1 siRNA and stimulated with IL-1beta Passsage: 4	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049051	None	Homo sapiens	Superconfluent, untreated	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049052	anti-Notch1, Cell Signaling #3608	Homo sapiens	Treatment: Superconfluent, untreated Passage: 4	EXP049051	472	normal	P46531	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049053	anti-RBPJ, Cell Signaling #5313	Homo sapiens	Treatment: Superconfluent, untreated Passage: 4	EXP049051	472	normal	Q06330	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049054	anti-NF-?B/RelA, Santa Cruz Biotechnology sc-372	Homo sapiens	Treatment: confluent, treated with Scr siRNA Passage: 4	EXP049045	472	normal	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049055	anti-NF-?B/RelA, Santa Cruz Biotechnology sc-372	Homo sapiens	Treatment: confluent, treated with Scr siRNA and stimulated with IL-1beta Passage: 4	EXP049046	472	normal	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049056	anti-NF-?B/RelA, Santa Cruz Biotechnology sc-372	Homo sapiens	Treatment: confluent, treated with Notch1 siRNA and stimulated with IL-1beta Passsage: 4	EXP049047	472	normal	Q04206	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049057	no	Homo sapiens	UV-C, 12 J/m2	NULL	2325	chip_control	NULL	CS1AN CVCL_L471 + CSB	NULL
EXP049058	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0hr (untreated) Genotype: wildtype cells	EXP049057	2325	normal	P18847	CS1AN CVCL_L471 + CSB	NULL
EXP049059	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr Genotype: wildtype cells	EXP049057	2325	normal	P18847	CS1AN CVCL_L471 + CSB	NULL
EXP049060	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 24hr Genotype: wildtype cells	EXP049057	2325	normal	P18847	CS1AN CVCL_L471 + CSB	NULL
EXP049061	ATF3 (Santa Cruz, sc-188x)	Homo sapiens	Treatment: UV-C, 12 J/m2 Genotype: mutant cells 	EXP049057	2326	normal	P18847	CS1AN (Cockayne syndrome)	NULL
EXP049062	MDM2 (Santa Cruz, sc-965x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0 hr (untreated) Genotype: wildtype cells	EXP049057	2325	normal	Q00987	CS1AN CVCL_L471 + CSB	NULL
EXP049063	MDM2 (Santa Cruz, sc-965x)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8r Genotype: wildtype cells	EXP049057	2326	normal	Q00987	CS1AN (Cockayne syndrome)	NULL
EXP049064	CSB (rabbit polyclonal, #3222)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0hr Genotype: wildtype cells	EXP049057	2325	normal	Q03468	CS1AN CVCL_L471 + CSB	NULL
EXP049065	CSB (rabbit polyclonal, #3222)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr Genotype: wildtype cells	EXP049057	2325	normal	Q03468	CS1AN CVCL_L471 + CSB	NULL
EXP049066	PSMD-1 (Abcam, ab140682)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr+ lactacystin 3hr Genotype: wildtype cells 	EXP049057	2325	normal	Q99460	CS1AN CVCL_L471 + CSB	NULL
EXP049067	PSMB5 (Santa Cruz, sc-55009)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr+ lactacystin 3hr Genotype: wildtype cells 	EXP049057	2325	normal	P28074	CS1AN CVCL_L471 + CSB	NULL
EXP049068	CSA (Abcam, ab137033)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 0hr Genotype: wildtype cells	EXP049057	2325	normal	Q13216	CS1AN CVCL_L471 + CSB	NULL
EXP049069	CSA (Abcam, ab137033)	Homo sapiens	Treatment: UV-C, 12 J/m2 for 8hr Genotype: wildtype cells	EXP049057	2325	normal	Q13216	CS1AN CVCL_L471 + CSB	NULL
EXP049070	-	Homo sapiens	Treatment: none	NULL	2327	chip_control	NULL	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	NULL
EXP049071	-	Homo sapiens	Treatment: none	NULL	774	chip_control	NULL	RKO (colon carcinoma cell)	NULL
EXP049072	-	Homo sapiens	Treatment: none	NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP049073	-	Homo sapiens	Treatment: none	NULL	2329	chip_control	NULL	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP049074	Anti-ZEB1 (Antibody SC-25388 Lot. H1513)	Homo sapiens	Treatment: none	NULL	2327	normal	P37275	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	NULL
EXP049075	Anti-ZEB1 (Antibody SC-25388 Lot. G2315)	Homo sapiens	Treatment: none	EXP049071	774	normal	P37275	RKO (colon carcinoma cell)	NULL
EXP049076	Anti-ZEB1 (Antibody SC-25388 Lot. K1615)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of MiaPaca2 cells electroporated with plasmids pX330A_D10A-1x2 containing Cas9 nickase	NULL	2327	normal	P37275	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	NULL
EXP049077	Anti-ZEB1 (Antibody SC-25388 Lot. K1615)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of MiaPaca2 cells electroporated with two plasmids pX330A_D10A-1x2 driving the expression of the Cas9-nickase and different pairs of gRNAs designed to target the repeated genomic region upstream MIR200A/B locus 	NULL	2327	normal	P37275	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	NULL
EXP049078	Anti-CTCF (Antibody Millipore Rb Antiserum 07-729 Lot. 2275585)	Homo sapiens	Treatment: none	NULL	2327	normal	P49711	MIA PaCa-2 (pancreatic ductal adenocarcinoma)	NULL
EXP049079	none	Homo sapiens	Treatment: 5 nM TGFb  for 1 hr	NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP049080	SMAD2/3 (R&D, AF3797)	Homo sapiens	Treatment: 5 nM TGFb  for 1 hr	EXP049079	712	normal	Q15796	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP049081	anti HA tag antibody (Sigma,H6908)	Mus musculus	Treatmen: formaldehyde cross-linking Genotype: stable expression of control vector, clone 2D Sex: female Strain: CAST/Ei x 129/Sv/Jae	NULL	2331	chip_control	NULL	undifferentiated embryonic stem cells	NULL
EXP049082		Mus musculus	Treatmen: formaldehyde cross-linking Genotype: stable expression of control vector, clone 2D Sex: female Strain: CAST/Ei x 129/Sv/Jae	NULL	2331	chip_control	NULL	undifferentiated embryonic stem cells	NULL
EXP049083		Mus musculus	Treatmen: formaldehyde cross-linking Genotype: stable expression of HA-tagged Cbx7, clone 12D Sex: female Strain: CAST/Ei x 129/Sv/Jae	NULL	2331	chip_control	NULL	undifferentiated embryonic stem cells	NULL
EXP049084	anti HA tag antibody (Sigma,H6908)	Mus musculus	Treatmen: formaldehyde cross-linking Genotype: stable expression of HA-tagged Cbx7, clone 12D Sex: female Strain: CAST/Ei x 129/Sv/Jae	EXP049083	2331	normal	Q8VDS3	undifferentiated embryonic stem cells	NULL
EXP049085	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing an empty vector	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP049086	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment:Over-expressing Empty vector 	NULL	413	chip_control	NULL	HCC95 (squamous cell lung carcinoma)	NULL
EXP049087	KLF5, Abcam, ab137676	Homo sapiens	Treatment: untreated Tumor: Head and neck squamous cell carcinomas	NULL	2332	normal	Q13887	BICR31 (Tongue squamous cell carcinoma cell)	NULL
EXP049088	p300, Bethyl Lab, A300-358	Homo sapiens	Treatment: untreated 	NULL	2332	normal	Q09472	BICR31 (Tongue squamous cell carcinoma cell)	NULL
EXP049089	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 D418N	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049090	V5, Thermo Scientific, R960-25	Homo sapiens	treatment: Over-expressing KLF5 D418N	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049091	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: over-expressing KLF5 E419K	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049092	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419K	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049093	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419Q	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049094	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419Q	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049095	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049096	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049085	10	normal	Q13887	HEK293T (embryonic kidney)	NULL
EXP049097	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 E419Q	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	NULL
EXP049098	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 D418N	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	NULL
EXP049099	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	NULL
EXP049100	V5, Thermo Scientific, R960-25	Homo sapiens	Treatment: Over-expressing KLF5 WT	EXP049086	413	normal	Q13887	HCC95 (squamous cell lung carcinoma)	NULL
EXP049101	none	Homo sapiens	Treatment: sh Scramble viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	NULL	2333	chip_control	NULL	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049102	none	Homo sapiens	Genotype: underexpressed TRF2 Treatment: sh TRF2 viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	NULL	2333	chip_control	NULL	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049103	none	Homo sapiens	Genotype: overexpressed TRF2 Treatment: pWPIR-TRF2-IRES-GFP viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	NULL	2333	chip_control	NULL	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049104	none	Homo sapiens	Genotype: empty vector Treatment: pWPIR-IRES-GFP viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	NULL	2333	chip_control	NULL	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049105	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Treatment: sh Scramble viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049101	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049106	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Genotype: underexpressed TRF2 Treatment: sh TRF2 viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049102	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049107	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Genotype: overexpressed TRF2 Treatment: pWPIR-TRF2-IRES-GFP viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049103	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049108	TRF2 (IMGENEX, monoclonal mouse IMG-124A, clone 4A794.15)	Homo sapiens	Genotype: empty vector Treatment: pWPIR-IRES-GFP viral transduction performed 5 days after complet differentiation Orgin: mucle biopsy -deltoid Population doublings: 20-25 	EXP049104	2333	normal	P62380	post-mitotic differentiated muscle cells (myotubes)	NULL
EXP049109	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: untreated, control	NULL	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP049110	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 15 min	NULL	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP049111	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 30 min	NULL	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP049112	anti-FLAG (Sigma, Catalog# F1804-50, Lot# SLBQ6349V)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 60 min	NULL	421	normal	O15527	HEK293 (embryonic kidney)	NULL
EXP049113	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: untreated, control	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP049114	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 15 min	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP049115	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 30 min	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP049116	anti-RelA/p65 (Santa Cruz Biotechnology, Catalog# SC-372, Lot# E0416)	Homo sapiens	Treatment: stimulated with 1 uU GOx for 60 min	NULL	421	normal	Q04206	HEK293 (embryonic kidney)	NULL
EXP049120	PU.1 (Santa Cruz sc-22805 X)	Homo sapiens	Treatment: 100nM VDR ligand 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) for 24 hrs Cell type: human monocytic cell line	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP049121	PU.1 (Santa Cruz sc-22805 X)	Homo sapiens	Treatment: EtOH (vehicle) for 24hrs Cell type: human monocytic cell line	NULL	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP049122		Homo sapiens	Treatment: undifferentiated 	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP049123		Homo sapiens	Treatment: adipocyte differentiated (Ad), siRNA treatment was performed 36 hours before differentiation induction. After 2 days of differentiation a second siRNA transfection was performed	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP049124		Homo sapiens	Treatment: osteoblast (Ob), siRNA treatment was performed 36 hours before differentiation induction. After 2 days of differentiation a second siRNA transfection was performed	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP049125		Homo sapiens	Treatment: siCon	NULL	2336	chip_control	NULL	hFOB 1.19 (fetal osteoblast)	NULL
EXP049126		Homo sapiens	Treatment: siCHD1	NULL	2336	chip_control	NULL	hFOB 1.19 (fetal osteoblast)	NULL
EXP049127	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: undifferentiated 	EXP049122	892	normal	O14646	MSC (mesenchymal stem cells)	NULL
EXP049128	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: adipocyte differentiated (Ad), siRNA treatment was performed 36 hours before differentiation induction. After 2 days of differentiation a second siRNA transfection was performed	EXP049123	892	normal	O14646	MSC (mesenchymal stem cells)	NULL
EXP049129	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: osteoblast (Ob), siRNA treatment was performed 36 hours before differentiation induction. After 2 days of differentiation a second siRNA transfection was performed	EXP049124	892	normal	O14646	MSC (mesenchymal stem cells)	NULL
EXP049130	CHD1 (Bethyl ,A301-218A)	Homo sapiens	Treatment: undifferentiated 	NULL	2336	normal	O14646	hFOB 1.19 (fetal osteoblast)	NULL
EXP049131	MLL (AT71-Ab1542, Diagenode)	Homo sapiens	Genotype: translocation MLL-AF9	NULL	2288	normal	Q03164	AML (monocytes and acute myeloid leukemia)	NULL
EXP049132	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: None	NULL	2337	chip_control	NULL	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP049133	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: DMSO (0.1%) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP049134	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: NVP-2 (250 nM) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP049135	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: SNS-032 (250 nM) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP049136	SPT5 (Santa Cruz, #sc-133217)	Homo sapiens	Treatment: THAL-SNS-032 (250 nM) for 2 hours	EXP049132	2337	normal	O00267	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP049137		Homo sapiens	Treatment: untreated	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP049138		Homo sapiens	Treatment: treated with iPol 1 for 1 hr 	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP049139	anti-DDX21 (Novus Biologicals BP100-1781)	Homo sapiens	Treatment: untreated, control	EXP049137	78	normal	Q9NR30	HeLa (cervical adenocarcinoma)	NULL
EXP049140	anti-DDX21 (Novus Biologicals BP100-1781)	Homo sapiens	Treatment: treated with iPol 1 for 1 hr 	EXP049138	78	normal	Q9NR30	HeLa (cervical adenocarcinoma)	NULL
EXP049141	anti-DDX21 (Novus Biologicals BP100-1781)	Homo sapiens	Treatment:  transfected with pools of siRNA targeting FCOF1	EXP049137	78	normal	Q9NR30	HeLa (cervical adenocarcinoma)	NULL
EXP049142	anti-TCOF1 (Novus Biologicals NBP1-86909)	Homo sapiens	Treatment: untreated, control	EXP049137	78	normal	Q13428	HeLa (cervical adenocarcinoma)	NULL
EXP049186	AR (Santa Cruz, catalog# sc-816, mix of 4 lot#s B2114, H2914, A0515, J0614)	Homo sapiens	Treatment: control	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049187	AR (Santa Cruz, catalog# sc-816, mix of 4 lot#s B2114, H2914, A0515, J0614)	Homo sapiens	Treatment: exclude	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049188	None	Homo sapiens	Treatment: 50nM THZ1 for 48 hrs Tissue:skin	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP049189	None	Homo sapiens	Treatment: DMSO	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP049190	None	Homo sapiens	Treatment: Vemurafenib	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP049191	None	Homo sapiens	Treatment: 1uMVemurafenib(PTKi) and 50 nM THZ1 for 48 hrs Tissue: skin	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP049192	None	Homo sapiens	Treatment: GSK1120212	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP049193	None	Homo sapiens	Treatment: THZ1	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP049194	None	Homo sapiens	Treatment: DMSO	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP049195	None	Homo sapiens	Treatment: THZ1 / GSK1120212	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP049196	None	Homo sapiens	Treatment: Crizotinib / THZ1	NULL	655	chip_control	NULL	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049197	None	Homo sapiens	Treatment: DMSO	NULL	655	chip_control	NULL	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049198	None	Homo sapiens	Treatment: THZ1	NULL	655	chip_control	NULL	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049199	None	Homo sapiens	Treatment: crizotinib	NULL	655	chip_control	NULL	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049200	None	Homo sapiens	Treatment: DMSO	NULL	2338	chip_control	NULL	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049201	None	Homo sapiens	Treatment: Lapatinib / THZ1	NULL	2338	chip_control	NULL	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049202	None	Homo sapiens	Treatment: Lapatinib	NULL	2338	chip_control	NULL	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049203	None	Homo sapiens	Treatment: THZ1	NULL	2338	chip_control	NULL	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049204	None	Homo sapiens	Treatment: Erlotinib	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049205	None	Homo sapiens	Treatment: THZ1	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049206	None	Homo sapiens	Treatment: DMSO	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049207	None	Homo sapiens	Treatment: Erlotinib	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049208	None	Homo sapiens	Treatment: Erlotinib / THZ1	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049209	None	Homo sapiens	Treatment: DMSO	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049210	None	Homo sapiens	Treatment: THZ1	NULL	2339	chip_control	NULL	RT-112 (Bladder carcinoma)	NULL
EXP049211	None	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: skin 	NULL	2339	chip_control	NULL	RT-112 (Bladder carcinoma)	NULL
EXP049212	None	Homo sapiens	Treatment: THZ1 / BGJ	NULL	2339	chip_control	NULL	RT-112 (Bladder carcinoma)	NULL
EXP049213	None	Homo sapiens	Treatment: BGJ	NULL	2339	chip_control	NULL	RT-112 (Bladder carcinoma)	NULL
EXP049214	None	Homo sapiens	Treatment: DMSO	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP049215	None	Homo sapiens	Treatment: 1uM Vemurafenib (PTKi) for 48 hrs Tissue: skin 	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP049216	None	Homo sapiens	Treatment: GSK1120212	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP049217	None	Homo sapiens	Treatment: DMSO	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP049218	None	Homo sapiens	Treatment: Crizotinib	NULL	2222	chip_control	NULL	1% H1 ESCs with 99% fibroblsat	NULL
EXP049219	None	Homo sapiens	Treatment: DMSO	NULL	2222	chip_control	NULL	1% H1 ESCs with 99% fibroblsat	NULL
EXP049220	None	Homo sapiens	Treatment: DMSO	NULL	2222	chip_control	NULL	1% H1 ESCs with 99% fibroblsat	NULL
EXP049221	None	Homo sapiens	Treatment: Lapatinib	NULL	2222	chip_control	NULL	1% H1 ESCs with 99% fibroblsat	NULL
EXP049222	None	Homo sapiens	Treatment: DMSO	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049223	None	Homo sapiens	Treatment: erlotinib	NULL	927	chip_control	NULL	PC9 (lung adenocarcinoma)	NULL
EXP049224	None	Homo sapiens	Treatment:DMSO	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP049225	None	Homo sapiens	Treatment:BGJ	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP049226	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: skin 	EXP049189	36	normal	O60885	A375 (malignant melanoma)	NULL
EXP049227	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 50nM THZ1 for 48 hrs Tissue:skin	EXP049188	36	normal	O60885	A375 (malignant melanoma)	NULL
EXP049228	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Vemurafenib (PTKi) for 48 hrs Tissue: skin 	EXP049190	36	normal	O60885	A375 (malignant melanoma)	NULL
EXP049229	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uMVemurafenib(PTKi) and 50 nM THZ1 for 48 hrs Tissue: skin	EXP049191	36	normal	O60885	A375 (malignant melanoma)	NULL
EXP049230	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 200nM GSK1120212 for 48 hrs Tissue: lung	EXP049192	38	normal	O60885	A549 (lung carcinoma)	NULL
EXP049231	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 150nM THZ1 for 48 hrs Tissue: lung	EXP049193	38	normal	O60885	A549 (lung carcinoma)	NULL
EXP049232	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: lung	EXP049194	38	normal	O60885	A549 (lung carcinoma)	NULL
EXP049233	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 150nM THZ1 and 200nM GSK1120212 for 48 hrs Tissue: lung	EXP049195	38	normal	O60885	A549 (lung carcinoma)	NULL
EXP049234	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 50nM THZ1 and 250 nM Crizotinib for 48 hrs Tissue: lung	EXP049196	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049235	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: lung	EXP049197	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049236	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 50 nM THZ1 for 48 hrs Tissue: lung	EXP049198	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049237	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 250 nM Crizotinib for 48 hrs Tissue: lung	EXP049199	655	normal	O60885	NCI-H3122 (lung adenocarcinoma)	NULL
EXP049238	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment:100 nM  Lapatinib and 25 nM THZ1 for 48 hrs Tissue: stomach	EXP049201	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049239	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: stomach	EXP049200	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049240	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100 nM Lapatinib for 48 hrs Tissue: stomach	EXP049202	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049241	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 25 nM THZ1 for 48 hrs Tissue: stomach	EXP049203	2338	normal	O60885	NCI-N87 (Gastric tubular adenocarcinoma )	NULL
EXP049242	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Erlotinib for 48 hrs Tissue: lung	NULL	927	normal	O60885	PC9 (lung adenocarcinoma)	NULL
EXP049243	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Erlotinib and  100nM THZ1 for 48 hrs Tissue: lung 	EXP049208	927	normal	O60885	PC9 (lung adenocarcinoma)	NULL
EXP049244	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs  Tissue: lung	EXP049206	927	normal	O60885	PC9 (lung adenocarcinoma)	NULL
EXP049245	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1 % DMSO for 48 hrs Tissue: lung	EXP049206	927	normal	O60885	PC9 (lung adenocarcinoma)	NULL
EXP049246	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1uM Erlotinib for 48 hrs Tissue: lung	EXP049204	927	normal	O60885	PC9 (lung adenocarcinoma)	NULL
EXP049247	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100nM THZ1 for 48 hrs Tissue: lung	EXP049205	927	normal	O60885	PC9 (lung adenocarcinoma)	NULL
EXP049248	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 1 uM BGJ for 48 hrs Tissue: bladder	EXP049213	2339	normal	O60885	RT-112 (Bladder carcinoma)	NULL
EXP049249	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 0.1% DMSO for 48 hrs Tissue: bladder	EXP049211	2339	normal	O60885	RT-112 (Bladder carcinoma)	NULL
EXP049250	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100nM THZ1 for 48 hrs Tissue: bladder	EXP049210	2339	normal	O60885	RT-112 (Bladder carcinoma)	NULL
EXP049251	Brd4 (Bethyl, A301-985A100, #20160603_4845)	Homo sapiens	Treatment: 100 nM THZ1 and 1 uM BGJ for 48 hrs Tissue: bladdeer	EXP049212	2339	normal	O60885	RT-112 (Bladder carcinoma)	NULL
EXP049252	AR (Santa Cruz, catalog# sc-816, mix of 4 lot#s B2114, H2914, A0515, J0614)	Homo sapiens	Treatment: case	NULL	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049253	IgG	Homo sapiens	Treatment: no	NULL	89	chip_control	NULL	BGO3 (embryonic stem cells)	NULL
EXP049254	IgG	Homo sapiens	Treatment: no	NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP049255	NKX2-5	Homo sapiens	Treatment: no	EXP049254	878	normal	P52952	embryonic stem cells	NULL
EXP049256	NKX2-5	Homo sapiens	Treatment: no	EXP049253	89	normal	P52952	BGO3 (embryonic stem cells)	NULL
EXP049257		Homo sapiens	Treatment: no	NULL	1490	chip_control	NULL	NCI-H460 (Large cell lung carcinoma)	NULL
EXP049258	NR0B1 antibody (Cell Signaling Technology)	Homo sapiens	Treatment: no	EXP049257	1490	normal	P51843	NCI-H460 (Large cell lung carcinoma)	NULL
EXP049259	none	Homo sapiens	Passage: 4-6	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049260	HIF1A (PM14)	Homo sapiens	Passage: 4-6	EXP049259	472	normal	Q16665	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049261	EPAS1 (PM9)	Homo sapiens	Passage: 4-6	EXP049259	472	normal	Q99814	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049262	ARNT (Novus, NB-100-110)	Homo sapiens	Passage: 4-6	EXP049259	472	normal	P27540	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049263	none	Homo sapiens	Treatment: Ethanol for 4 hrs 	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049264	none	Homo sapiens	Treatment: 10 nM DHT for 4 hrs 	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049265	none	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049266	none	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049267	none	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and vector	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049268	none	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and vector	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049269	none	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049270	none	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L  knockout and Bag-1L wildtype	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049271		Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L wildtype	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049272		Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L wildtype	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049273		Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L+CMut 	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049274		Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049275	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs 	EXP049263	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049276	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs 	EXP049264	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049277	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout	EXP049265	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049278	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout	EXP049266	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049279	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and vector	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049280	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and vector	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049281	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype	EXP049269	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049282	AR (N-20) antibody (Santa Cruz, Catalog# sc-816, Lot# I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype	EXP049270	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049283	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs  Genotype: Bag-1L wildtype	EXP049271	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049284	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L wildtype	EXP049272	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049285	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: Ethanol for 4 hrs 	EXP049273	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049286	AR N-20 antibody (Santa Cruz Biotechnology; sc-816;  lot # I0215)	Homo sapiens	Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout	EXP049274	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049287	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	430	normal	Q9Y261	HepG2 (hepatoblastoma)	NULL
EXP049288	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	430	normal	Q9Y261	HepG2 (hepatoblastoma)	NULL
EXP049289	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2343	normal	Q9Y261	KerCT (keratenocytes)	NULL
EXP049290	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2343	normal	Q9Y261	KerCT (keratenocytes)	NULL
EXP049291	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2343	normal	Q9Y261	KerCT (keratenocytes)	NULL
EXP049292	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2344	normal	Q9Y261	definitive endoderm(dEN, ES derived)	NULL
EXP049293	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL	NULL	2344	normal	Q9Y261	definitive endoderm(dEN, ES derived)	NULL
EXP049294	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: cTermCDT1	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049295	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens		NULL	93	normal	A0AVK6	BJ (fibroblasts)	NULL
EXP049296	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens		NULL	38	normal	A0AVK6	A549 (lung carcinoma)	NULL
EXP049297	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: wildtype FOCA2	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049298	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: CDT1 mimo FOXA2	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049299	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049300	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo release	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049301	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: Fochnf1a coexpression FOXA2	NULL	93	normal	P41161	BJ (fibroblasts)	NULL
EXP049302	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 unind	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049303	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL 	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049304	GATA4 (M167-3; Lot 4)	Homo sapiens	Genotype: V5-untarged	NULL	93	normal	P43694	BJ (fibroblasts)	NULL
EXP049305	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL 	NULL	38	normal	Q9Y261	A549 (lung carcinoma)	NULL
EXP049306	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: Mimo FOXA2	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049307	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo released 	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049308	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 {delta}C	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049309	FoxA2 Antibody (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 {delta}N	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049310		Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP049311		Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP049312		Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049313		Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049314		Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2346	chip_control	NULL	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049315		Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	NULL	2346	chip_control	NULL	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049316		Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2347	chip_control	NULL	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049317		Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	NULL	2347	chip_control	NULL	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049318	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049310	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	NULL
EXP049319	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049310	937	normal	Q15022	G401 (rhabdoid tumor of the kidney)	NULL
EXP049320	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049311	937	bio_control	P51532	G401 (rhabdoid tumor of the kidney)	NULL
EXP049321	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47, expresed Tissue: Malignant rhabdoid tumor	EXP049311	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	NULL
EXP049322	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049311	937	normal	Q15022	G401 (rhabdoid tumor of the kidney)	NULL
EXP051030	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049313	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP051031	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049313	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP051032	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049313	2345	normal	Q15022	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049326	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049327	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049328	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q15022	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049329	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049314	2346	normal	P51532	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049330	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2346	normal	Q92922	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049331	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	NULL	2346	normal	Q15022	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049332	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049315	2346	normal	P51532	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049333	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049315	2346	normal	Q92922	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049334	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049315	2346	normal	Q15022	HS-ES-2M (Epithelioid sarcoma)	NULL
EXP049335	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049316	2347	normal	P51532	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049336	anti-BAF155	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049316	2347	normal	Q92922	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049337	anti-SUZ12	Homo sapiens	Treatment: empty vector Tissue: epithelioid sarcoma	EXP049316	2347	normal	Q15022	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049338	anti-BRG1	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049317	2347	normal	P51532	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049339	anti-BAF155	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049317	2347	normal	Q92922	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049340	anti-SUZ12	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: epithelioid sarcoma	EXP049317	2347	normal	Q15022	VA-ES-BJ (Epithelioid sarcoma)	NULL
EXP049341	anti-SS18	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049312	2345	normal	Q15532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049342	anti-SS18	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q15532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049343	anti-BRG1	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049310	937	normal	P51532	G401 (rhabdoid tumor of the kidney)	NULL
EXP049344	BAF200	Homo sapiens	Treatment: empty vector Tissue: Malignant rhabdoid tumor	EXP049312	2345	normal	Q68CP9	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049345	BAF200	Homo sapiens	Treatment: constitutive vector expressing BAF47 Tissue: Malignant rhabdoid tumor	EXP049313	2345	normal	Q68CP9	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP049346	none (input)	Homo sapiens	Treatment: no	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP049347	none (input)	Homo sapiens	Treatment: no	NULL	2348	chip_control	NULL	P12 (P12-Ichikawa, Childhood T acute lymphoblastic leukemia)	NULL
EXP049348	none (input)	Homo sapiens	Treatment: no	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP049349	HSF1 (Cell Signaling 4356)	Homo sapiens	Treatment: no	EXP049346	199	normal	Q00613	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP049350	HSF1 (Cell Signaling 4356)	Homo sapiens	Treatment: no	EXP049347	2348	normal	Q00613	P12 (P12-Ichikawa, Childhood T acute lymphoblastic leukemia)	NULL
EXP049351	MYC (Santa Cruz Biotech, N262)	Homo sapiens	Treatment: no	EXP049348	199	normal	P01106	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP049352	anti-LSD1 (ab17721)	Homo sapiens	Treatment: DMSo vehicle	NULL	2288	normal	O60341	AML (monocytes and acute myeloid leukemia)	NULL
EXP049353	anti-LSD1 (ab17721)	Homo sapiens	Treatment: LSD1 inhibitor OG86	NULL	2288	normal	O60341	AML (monocytes and acute myeloid leukemia)	NULL
EXP049354	anti-GFI1 (ab21061)	Homo sapiens	Treatment: DMSo vehicle	NULL	2288	normal	Q99684	AML (monocytes and acute myeloid leukemia)	NULL
EXP049355	anti-GFI1 (ab21061)	Homo sapiens	Treatment: LSD1 inhibitor OG86	NULL	2288	normal	Q99684	AML (monocytes and acute myeloid leukemia)	NULL
EXP049356	anti-MYB (ab45150) (Abcam)	Homo sapiens	Treatment: DMSo vehicle	NULL	2288	normal	P10242	AML (monocytes and acute myeloid leukemia)	NULL
EXP049357	anti-MYB (ab45150) (Abcam)	Homo sapiens	Treatment: LSD1 inhibitor OG86	NULL	2288	normal	P10242	AML (monocytes and acute myeloid leukemia)	NULL
EXP049358	Ig(Rabbit 2616, Laszlo Tora lab)	Homo sapiens	shNT control vector	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP049359	anti-ZZZ3 (SAB4501106, WB 1:1000)	Homo sapiens	Genotype: shNT control vector	EXP049358	375	normal	Q8IYH5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP049360	anti-ZZZ3 (SAB4501106, WB 1:1000)	Homo sapiens	Genotype: YEATS2 knockdown	EXP049358	375	normal	Q8IYH5	NCI-H1299 (large cell lung carcinoma)	NULL
EXP049361		Homo sapiens	Treatment: no treatment	NULL	2349	chip_control	NULL	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049362	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: no treatment	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049363	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: LPS	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049364	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	treatment: TNFalfa	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049365	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: Pam2CSK4	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049366	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: Poly I:C	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049367	anti-RELA (NFKB p65 (c20):sc-372)	Homo sapiens	Treatment: M tri-DAP	EXP049361	2349	normal	Q04206	Detroit 562 (Pharyngeal squamous cell carcinoma)	NULL
EXP049368	-	Homo sapiens	treatment: Untreated	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049369	-	Homo sapiens	Treatment: 2 ng/mLTGF beta, 1 hr	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049370	-	Homo sapiens	Treatment: 2 ng/mLTGF beta, 1 hr	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049371	SMAD3, Abcam 28379	Homo sapiens	Treatment: Untreated	EXP049368	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049372	pSMAD1/5, Cell Signaling Technologies 11971	Homo sapiens	Treatment: Untreated	EXP049368	2301	normal	Q15797	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049373	SMAD3, Abcam 28379	Homo sapiens	Treatment: 2 ng/mLTGF beta, 1 hr	EXP049369	2301	normal	P84022	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049374	pSMAD1/5, Cell Signaling Technologies 11971	Homo sapiens	Treatment: 2 ng/mLTGF beta, 1 hr	EXP049369	2301	normal	Q15797	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049375	anti-OCT4 (Active Motif: 39811: lot 16210001)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	Q01860	BJ (fibroblasts)	NULL
EXP049376	anti-V5 (M167-3; Lot 4)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	P43694	BJ (fibroblasts)	NULL
EXP049377	anti-V5 (M167-3; Lot 4)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells, FOXA2 and GATA4 coexpressing	NULL	93	normal	P43694	BJ (fibroblasts)	NULL
EXP049378	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: addition of 200 uM mimosine over night Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049379	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Treatment: addition of 200 uM mimosine over night Genotype: Clonal FOXA2 doxycycline inducible cells	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049380	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Genotype: clonal FOXA2 doxycycline inducible cells, OXA2 GATA4 Coexpressing	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049381	anti-FOXA2 (R&D: AF2400: ULB0414041)	Homo sapiens	Genotype: Clonal FOXA2 doxycycline inducible cells, CDT1	NULL	93	normal	Q9Y261	BJ (fibroblasts)	NULL
EXP049382	none (input)	Homo sapiens		NULL	2350	chip_control	NULL	LAL-B (All-B patient-derived cell line)	NULL
EXP049383	none (input)	Homo sapiens		NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP049384	anti-Che-1 (Bethyl, A301-032A)	Homo sapiens		EXP049382	2350	normal	P06276	LAL-B (All-B patient-derived cell line)	NULL
EXP049385	anti-Che-1 (Bethyl, A301-032A)	Homo sapiens		EXP049383	646	normal	P06276	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP049386	none	Homo sapiens	Treatment: vehicle (charcoal stripped) for 6 hrs	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049387	none	Homo sapiens	Treatment: 10 nM DHT for 6 hrs 	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049388	none	Homo sapiens	Treatment: 10 nM DHT+ 500 nM JQ1 for 6 hrs 	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049389	none	Homo sapiens	Treatment: 10 nM DHT+10 uM MDV3100 	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049390	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: vehicle (charcoal stripped) for 6 hrs  TF: full-length AR (AR-FL)	EXP049386	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049391	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: 10 nM DHT for 6 hrs TF: full-length AR (AR-FL)	EXP049387	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049392	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: 10 nM DHT+ 500 nM JQ1 for 6 hrs  TF: full-length AR (AR-FL)	EXP049388	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049393	anti-AR-FL specific (Santa cruz bio#C-19)	Homo sapiens	Treatment: 10 nM DHT+10 uM MDV3100 TF: full-length AR (AR-FL)	EXP049389	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP049394	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: vehicle (charcoal stripped) for 6 hrs	EXP049386	7	normal	O60885	22RV1 (prostate carcinoma)	NULL
EXP049395	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: 10 nM DHT for 6 hrs 	EXP049387	7	normal	O60885	22RV1 (prostate carcinoma)	NULL
EXP049396	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: 10 nM DHT + 500 nM JQ1 for 6 hrs 	EXP049388	7	normal	O60885	22RV1 (prostate carcinoma)	NULL
EXP049397	Anti-BRD4 (Bethyl)	Homo sapiens	Treatment: 10 nM DHT + 10 uM MDV3100 for 6 hrs 	EXP049389	7	normal	O60885	22RV1 (prostate carcinoma)	NULL
EXP049398	anti-ZFX (ThermoFisher)	Homo sapiens	Treatment: charcoal stripped	EXP049386	7	normal	P17010	22RV1 (prostate carcinoma)	NULL
EXP049399	anti-ZFX serum (from Dr Huck-Hui Ng)	Homo sapiens	Treatment: charcoal stripped	EXP049386	7	normal	P17010	22RV1 (prostate carcinoma)	NULL
EXP049400	none	Homo sapiens	Treatment: none	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP049401	Abcam ab45150 Anti-v-Myb and c-Myb	Homo sapiens	Treatment: none	EXP049400	641	normal	P10242	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP049402	Abcam ab45150 Anti-v-Myb and c-Myb	Homo sapiens	Treatment: TG3 control peptide	EXP049400	641	normal	P10242	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP049403	Abcam ab45150 Anti-v-Myb and c-Myb	Homo sapiens	Treatment: MYBMIM peptide	EXP049400	641	normal	P10242	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP049404	input	Homo sapiens	R848 0h	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP049405	input	Homo sapiens	R848 1h	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP049406	input	Homo sapiens	R848 24h	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP049407	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 0h	EXP049404	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049408	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 1h	EXP049405	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049409	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 24h	EXP049406	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049410	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 0h	EXP049404	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049411	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 1h	EXP049405	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049412	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 24h	EXP049406	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049413	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 0h	EXP049404	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049414	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 1h	EXP049405	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049415	DC-SCRIPT/ZNF366 (cat# AF4707, lot# CALX011009A, R&D Systems)	Homo sapiens	R848 24h	EXP049406	620	normal	Q8N895	monocyte-derived dendritic cells	NULL
EXP049416	none	Homo sapiens		NULL	1086	chip_control	NULL	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049417	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Genotype: EWS/FLI knockdown Passage: 15-18	EXP049416	1086	normal	Q01844	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049418	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Treatment: EWS/FLI knockdown + {delta}22 rescue Passage: 15-18	EXP049416	1086	normal	Q01844	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049419	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Treatment: EWS/FLI knockdown + Mut9 rescue Passage: 15-18	EXP049416	1086	normal	Q01844	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049420		Homo sapiens	Treatment: untreated	NULL	794	chip_control	NULL	SK-MEL-147 (melanoma)	NULL
EXP049421		Homo sapiens	Treatment: untreated	NULL	794	chip_control	NULL	SK-MEL-147 (melanoma)	NULL
EXP049422		Homo sapiens	Treatment: untreated	NULL	315	chip_control	NULL	foreskin	NULL
EXP049423		Homo sapiens	Treatment: untreated	NULL	315	chip_control	NULL	foreskin	NULL
EXP049424		Homo sapiens	Treatment: untreated	NULL	26	chip_control	NULL	501Mel (melanoma)	NULL
EXP049425		Homo sapiens	Treatment: untreated	NULL	1630	chip_control	NULL	EL	NULL
EXP049426		Homo sapiens	Treatment: untreated	NULL	1630	chip_control	NULL	EL	NULL
EXP049427	BRD2 (Bethyl Laboratories, A302-583A)	Homo sapiens	Treatment: untreated 	EXP049420	794	normal	P25440	SK-MEL-147 (melanoma)	NULL
EXP049428	BRD2 (Bethyl Laboratories, A302-583A)	Homo sapiens	Treatment: treated with 10nM JQ1 (JQ1(+)) for 6 hours	EXP049420	794	normal	P25440	SK-MEL-147 (melanoma)	NULL
EXP049429	BRD4 (Bethyl Laboratories, A301-985A)	Homo sapiens	Treatment: untreated 	EXP049420	794	normal	O60885	SK-MEL-147 (melanoma)	NULL
EXP049430	BRD4 (Bethyl Laboratories, A301-985A)	Homo sapiens	Treatment: treated with 10nM JQ1 (JQ1(+)) for 6 hours	EXP049420	794	normal	O60885	SK-MEL-147 (melanoma)	NULL
EXP049431	MED1 (Bethyl Laboratories, A300-793A)	Homo sapiens	Treatment: untreated	EXP049420	794	normal	O95243	SK-MEL-147 (melanoma)	NULL
EXP049432	input	Homo sapiens	Treatment:Treatment: 24h ethanol 24h ethanol	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP049433	input	Homo sapiens	Treatment: 24h DHT 1 nM	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP049434	input	Homo sapiens	Treatment: 24h DHT 1 nM	NULL	2351	chip_control	NULL	LTAD (long term androgen deprivation)	NULL
EXP049435	input	Homo sapiens	Treatment: 24h ethanol	NULL	2351	chip_control	NULL	LTAD (long term androgen deprivation)	NULL
EXP049436	input	Homo sapiens	Treatment: 24h DHT 1 nM	NULL	2351	chip_control	NULL	LTAD (long term androgen deprivation)	NULL
EXP049437	input	Homo sapiens	Treatment: 24h DHT 10 nM	NULL	2352	chip_control	NULL	VCaP and LTAD cells	NULL
EXP049438	input	Homo sapiens	Treatment: 24h DHT 10 nM	NULL	2351	chip_control	NULL	LTAD (long term androgen deprivation)	NULL
EXP049439	input	Homo sapiens	Treatment: 24h DHT 10 nM siCOBLL1 treated	NULL	2351	chip_control	NULL	LTAD (long term androgen deprivation)	NULL
EXP049440	AR (santacruz H-280)	Homo sapiens	Treatment: 24h ethanol	EXP049432	985	normal	P10275	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP049441	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049433	70	bio_control	P10275	LNCaP (prostate carcinoma)	NULL
EXP049442	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049434	2351	normal	P10275	LTAD (long term androgen deprivation)	NULL
EXP049443	COBLL1 (Abcam#64465)	Homo sapiens	Treatment: 24h ethanol	EXP049435	2351	normal	Q53SF7	LTAD (long term androgen deprivation)	NULL
EXP049444	PSF	Homo sapiens	Treatment: 24h ethanol	EXP049435	2351	normal	P23246	LTAD (long term androgen deprivation)	NULL
EXP049445	COBLL1 (Abcam#64465)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049436	2351	normal	Q53SF7	LTAD (long term androgen deprivation)	NULL
EXP049446	PSF (sigma#WH0006421M2)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049436	2351	normal	P23246	LTAD (long term androgen deprivation)	NULL
EXP049447	PSF (sigma#WH0006421M2)	Homo sapiens	Treatment: 24h DHT 10 nM siCTBP1-AS treated	EXP049436	2351	normal	P23246	LTAD (long term androgen deprivation)	NULL
EXP049448	PSF (sigma#WH0006421M2)	Homo sapiens	Treatment: 24h ethanol siCTBP1-AS treated	EXP049435	2351	normal	P23246	LTAD (long term androgen deprivation)	NULL
EXP049449	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 10 nM	EXP049437	2352	normal	P10275	VCaP and LTAD cells	NULL
EXP049450	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 1 nM	EXP049437	2352	normal	P10275	VCaP and LTAD cells	NULL
EXP049451	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 10 nM siControl treated	EXP049438	2351	normal	P10275	LTAD (long term androgen deprivation)	NULL
EXP049452	AR (santacruz H-280)	Homo sapiens	Treatment: 24h DHT 10 nM siCOBLL1 treated	EXP049439	2351	normal	P10275	LTAD (long term androgen deprivation)	NULL
EXP049453	none	Homo sapiens	Genotype: wildtype	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP049454	IgG (Abcam, ab171870, #GR260971)	Homo sapiens	Genotype: wildtype	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP049455	METTL3 (Bethyl Laboratories, #A301-568A,#1)	Homo sapiens	Genotype: wildtype	EXP049453	2219	normal	Q86U44	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP049456	METTL14 (Abcam, ab98166, #GR277753-1)	Homo sapiens	Genotype: wildtype	EXP049453	2219	normal	Q9HCE5	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP049457	rabbit IgG (Santa Cruz Biotechnology, sc2027)	Homo sapiens		NULL	2353	chip_control	NULL	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049458	rabbit IgG (Santa Cruz Biotechnology, sc2027)	Homo sapiens		NULL	2354	chip_control	NULL	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049459		Homo sapiens	Treatment: BirA enzyme were transduced with N-terminally tagged BATF3 (pRCMV/TO-flag-BIOTIN-BATF3-puro), empty control 	NULL	2354	chip_control	NULL	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049460	rabbit IgG (Santa Cruz Biotechnology, sc2027)	Homo sapiens	Treatment: untreated 	NULL	2353	chip_control	NULL	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049461	rabbit IgG (Santa Cruz Biotechnology, sc2027)	Homo sapiens	Treatment: untreated 	NULL	2354	chip_control	NULL	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049462		Homo sapiens	Treatment: cells that stably expressed the BirA enzyme were transduced with N-terminally tagged HBZ (pRCMV/TO-flag-BIOTIN-HBZ-puro), empty control	NULL	2353	chip_control	NULL	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049463		Homo sapiens	Treatment: cells that stably expressed the BirA enzyme were transduced with N-terminally tagged HBZ (pRCMV/TO-flag-BIOTIN-HBZ-puro), empty control	NULL	2354	chip_control	NULL	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049464		Homo sapiens	Treatment: BirA enzyme were transduced with N-terminally tagged BATF3 (pRCMV/TO-flag-BIOTIN-BATF3-puro), empty control 	NULL	2353	chip_control	NULL	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049465	IRF4 antibody (Santa Cruz Biotechnology, sc6059 and sc11450 (1:1 mix))	Homo sapiens		EXP049457	2353	normal	Q15306	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049466	IRF4 antibody (Santa Cruz Biotechnology, sc6059 and sc11450 (1:1 mix))	Homo sapiens		EXP049458	2354	normal	Q15306	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049467	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: BirA enzyme were transduced with N-terminally tagged BATF3 (pRCMV/TO-flag-BIOTIN-BATF3-puro)	EXP049459	2354	normal	Q9NR55	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049468	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: untreated 	EXP049460	2353	normal	Q9NR55	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049469	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: untreated 	EXP049461	2354	normal	Q9NR55	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049470	Rabbit-polyclonal-HBZ serum 	Homo sapiens	Treatment: cells that stably expressed the BirA enzyme were transduced with N-terminally tagged HBZ (pRCMV/TO-flag-BIOTIN-HBZ-puro)	EXP049462	2353	normal	P02008	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049471	Rabbit-polyclonal-HBZ serum 	Homo sapiens	Treatment: cells that stably expressed the BirA enzyme were transduced with N-terminally tagged HBZ (pRCMV/TO-flag-BIOTIN-HBZ-puro)	EXP049463	2354	normal	P02008	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049472	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: DMSO for 24 hrs	EXP049457	2353	normal	O60885	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049473	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: 500 nM JQ1 for 24 hrs	EXP049457	2353	normal	O60885	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049474	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: DMSO for 24 hrs	EXP049458	2354	normal	O60885	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049475	BRD4 antibody (Bethyl, Cat No. A301-985A) 	Homo sapiens	Treatment: 250 nM JQ1 for 24 hrs	EXP049458	2354	normal	O60885	ST-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049476	BATF3 antibody (R&D, AF7437)	Homo sapiens	Treatment: BirA enzyme were transduced with N-terminally tagged BATF3 (pRCMV/TO-flag-BIOTIN-BATF3-puro)	EXP049464	2353	normal	Q9NR55	KK1 (Adult T acute lymphoblastic leukemia)	NULL
EXP049477	None	Homo sapiens	Treatment: untreated 	NULL	1141	chip_control	NULL	BE2C	NULL
EXP049478	None	Homo sapiens	Treatment: untreated 	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP049479	PHOX2B (Santa Cruz, sc376997X,#H0712)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	Q99453	BE2C	NULL
EXP049480	HAND2 (Santa Cruz, sc9409X, #c230) 	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P61296	BE2C	NULL
EXP049481	GATA3 (Thermo Fisher, MA1028 , #PE203382)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P23771	Kelly (neuroblastoma)	NULL
EXP049482	n-Myc (Abcam, Ab16898, #GR291423-1)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P04198	BE2C	NULL
EXP049483	ISL1 (DSHB, 40.3A4, #8/22/13)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P61371	BE2C	NULL
EXP049484	TBX2 (Abcam, ab33298, #GR90328-1)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	Q13207	BE2C	NULL
EXP049485	ISL1 (DSHB, 40.3A4, #8/22/13)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P61371	Kelly (neuroblastoma)	NULL
EXP049486	HAND2 (Santa Cruz, sc9409X, #c230) 	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P61296	Kelly (neuroblastoma)	NULL
EXP049487	GATA3 (Thermo Fisher, MA1028 , #PE203382)	Homo sapiens	Treatment: untreated 	EXP049477	1141	normal	P23771	BE2C	NULL
EXP049488	n-Myc (Abcam, Ab16898, #GR291423-1)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	P04198	Kelly (neuroblastoma)	NULL
EXP049489	PHOX2B (Santa Cruz,sc-376997, #A0517)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	Q99453	Kelly (neuroblastoma)	NULL
EXP049490	TBX2 (Abcam, ab33298, #GR90328-1)	Homo sapiens	Treatment: untreated 	EXP049478	520	normal	Q13207	Kelly (neuroblastoma)	NULL
EXP049491	E2F1 (BD-554213 and sc-193)	Homo sapiens	Treatment: CDT for 72 hrs Genotype: knockdown with shRB of RB	NULL	70	normal	Q01094	LNCaP (prostate carcinoma)	NULL
EXP049492	E2F1 (BD-554213 and sc-193)	Homo sapiens	Treatment: CDT for 72 hrs Genotype: knockdown with shCON of CON	NULL	70	normal	Q01094	LNCaP (prostate carcinoma)	NULL
EXP049507	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: wildtype ER-alfa	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049508	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: wildtype ER-alfa	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049509	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: wildtype ER-alfa 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049510	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: wildtype ER-alfa 	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049511	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: transduced with ER-alfa L540Q	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049512	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: transduced with ER-alfa L540Q	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049513	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: transduced with ER-alfa L540Q	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049514	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	E2, 100 nM, 45 min	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049515	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: wildtype ER-alfa	EXP049507	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049516	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: wildtype ER-alfa	EXP049508	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049517	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: wildtype ER-alfa 	EXP049509	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049518	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: wildtype ER-alfa 	EXP049510	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049519	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: transduced with ER-alfa L540Q	EXP049511	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049520	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: transduced with ER-alfa L540Q	EXP049512	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049521	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: transduced with ER-alfa L540Q	EXP049513	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049522	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: transduced with ER-alfa L540Q	EXP049514	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049523		Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: wildtype ER-alfa	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049524		Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: wildtype ER-alfa	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049525	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: wildtype ER-alfa	EXP049523	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049526	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: wildtype ER-alfa	EXP049524	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049527		Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: transduced with ER-alfa L540Q	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049530	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049531	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049532	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049533	ERa, rabbit polyclonal antiserum generated in the Kraus Laboratory against the 1-113 of human ERa	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049534	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049535	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049536	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049537	Med1, Cat. # A300-793A, Lot # A300-793A-2	Homo sapiens	Treatment: E2, 100 nM, 45  min Genotype: ER-alfa L540Q	NULL	2301	normal	O95243	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049538	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049539	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049540	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049541	SRC2 H3K27ac, Cat. # ab4729	Homo sapiens	Treatment: E2, 100 nM, 45 min Genotype: ER-alfa L540Q	NULL	2301	normal	P12931	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049542	p300, Cat. # sc-584x, Lot # I1715	Homo sapiens	Treatment: E2, 100 nM, 20 min Genotype: transduced with ER-alfa L540Q	EXP049527	2301	normal	Q09472	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP049559	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP049560	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP049573	AR (sc-816; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049574	AR (sc-816; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP049575	ARID1a (sc-32761x; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	O14497	LNCaP (prostate carcinoma)	NULL
EXP049576	ARID1a (sc-32761x; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	O14497	LNCaP (prostate carcinoma)	NULL
EXP049577	BRG1 (A300-813A; Bethyl)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	P51532	LNCaP (prostate carcinoma)	NULL
EXP049578	BRG1 (A300-813A; Bethyl)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	P51532	LNCaP (prostate carcinoma)	NULL
EXP049579	FOXA1 (sc-6554; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP049580	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP049581	HOXB13 (sc-66923; Santa Cruz)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP049582	TLE3 (ab94972; Abcam)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q04726	LNCaP (prostate carcinoma)	NULL
EXP049583	TLE3 (ab94972; Abcam)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q04726	LNCaP (prostate carcinoma)	NULL
EXP049584	TRIM28 (ab10483; Abcam)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	NULL
EXP049585	TRIM28 (ab10483; Abcam)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	Q13263	LNCaP (prostate carcinoma)	NULL
EXP049586	WDHD1 (m15-104; CDI labs)	Homo sapiens	Treatment: treated with 10nM  vehicle for 4 hours	NULL	70	normal	O75717	LNCaP (prostate carcinoma)	NULL
EXP049587	WDHD1 (m15-104; CDI labs)	Homo sapiens	Treatment: treated with 10nM  R1881 for 4 hours	NULL	70	normal	O75717	LNCaP (prostate carcinoma)	NULL
EXP049588		Homo sapiens	Genotype: wildtype	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049589		Homo sapiens	Genotype: wildtype	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049590		Homo sapiens	Genotype: MORC2 knockout	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049591		Homo sapiens	Genotype: MORC2 knockout	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049592		Homo sapiens	Genotype: MPP8 knockout	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049593		Homo sapiens	Genotype: MPP8 knockout	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049594		Homo sapiens	Genotype: TASOR knockout	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049595		Homo sapiens	Genotype: TASOR knockout	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049596		Homo sapiens	Genotype: wildtype	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049597		Homo sapiens	Genotype: wildtype	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP049598	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049599	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049600	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049601	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049602		Homo sapiens	Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049603		Homo sapiens	Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049604	MPP8 (16796-1-AP, Protein Technologies Inc)	Mus musculus	Genotype: wildtype	NULL	962	chip_control	NULL	haploid mESCs derived from strain 129/Ola	NULL
EXP049605	MPP8 (16796-1-AP, Protein Technologies Inc)	Mus musculus	Genotype: wildtype	NULL	962	chip_control	NULL	haploid mESCs derived from strain 129/Ola	NULL
EXP049606		Mus musculus	Genotype: wildtype	NULL	962	chip_control	NULL	haploid mESCs derived from strain 129/Ola	NULL
EXP049607		Mus musculus	Genotype: wildtype	NULL	962	chip_control	NULL	haploid mESCs derived from strain 129/Ola	NULL
EXP049608	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: wildtype	EXP049588	514	bio_control	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049609	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: wildtype	EXP049589	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049610	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MORC2 knockout	EXP049590	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049611	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MORC2 knockout	EXP049591	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049612	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MPP8 knockout	EXP049592	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049613	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: MPP8 knockout	EXP049593	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049614	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: TASOR knockout	EXP049594	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049615	MORC2 (A300-149A, Bethyl Laboratories)	Homo sapiens	Genotype: TASOR knockout	EXP049595	514	normal	Q9Y6X9	K562 (myelogenous leukemia)	NULL
EXP049616	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: wildtype	EXP049588	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049617	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: wildtype	EXP049589	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049618	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MORC2 knockout	EXP049590	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049619	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MORC2 knockout	EXP049591	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049620	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MPP8 knockout	EXP049592	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049621	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: MPP8 knockout	EXP049593	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049622	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: TASOR knockout	EXP049594	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049623	MPP8 (16796-1-AP, Protein Technologies Inc)	Homo sapiens	Genotype: TASOR knockout	EXP049595	514	normal	Q99549	K562 (myelogenous leukemia)	NULL
EXP049624	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: wildtype	EXP049588	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049625	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: wildtype	EXP049589	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049626	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: MORC2 knockout	EXP049590	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049627	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: MORC2 knockout	EXP049591	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049628	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens		EXP049592	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049629	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens		EXP049593	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049630	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: TASOR knockout	EXP049594	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP049631	TASOR (HPA006735, Atlas Antibodies)	Homo sapiens	Genotype: TASOR knockout	EXP049595	514	normal	Q9UK61	K562 (myelogenous leukemia)	NULL
EXP056634	RevXlinkChromatin	Homo sapiens	None	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049632	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 400 nM BAY 1238097 (D4) Tissue: skin	EXP049634	2355	normal	O60885	CHL-1 (Melanoma)	NULL
EXP049634	none	Homo sapiens	Treatment: 400 nM BAY 1238097 (D4) Tissue: skin	NULL	2355	chip_control	NULL	CHL-1 (Melanoma)	NULL
EXP049635	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM OTX-015 Tissue: skin	EXP049637	2355	normal	O60885	CHL-1 (Melanoma)	NULL
EXP049637	none	Homo sapiens	Treatment: 500 nM OTX-015 Tissue: skin	NULL	2355	chip_control	NULL	CHL-1 (Melanoma)	NULL
EXP049638	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM DMSO Tissue: skin	EXP049640	2355	normal	O60885	CHL-1 (Melanoma)	NULL
EXP049640	none	Homo sapiens	Treatment: 500 nM DMSO Tissue: skin	NULL	2355	chip_control	NULL	CHL-1 (Melanoma)	NULL
EXP049641	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 400 nM BAY 1238097 (D4) Tissue: skin	EXP049643	2355	normal	O60885	CHL-1 (Melanoma)	NULL
EXP049643	none	Homo sapiens	Treatment: 400 nM BAY 1238097 (D4) Tissue: skin	NULL	2355	chip_control	NULL	CHL-1 (Melanoma)	NULL
EXP049644	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM OTX-015 Tissue: skin	EXP049646	2355	normal	O60885	CHL-1 (Melanoma)	NULL
EXP049646	none	Homo sapiens	Treatment: 500 nM OTX-015 Tissue: skin	NULL	2355	chip_control	NULL	CHL-1 (Melanoma)	NULL
EXP049647	anti-BRD4 (Bethyl Labs, A301-985A100)	Homo sapiens	Treatment: 500 nM DMSO Tissue: skin	EXP049649	2355	normal	O60885	CHL-1 (Melanoma)	NULL
EXP049649	none	Homo sapiens	Treatment: 500 nM DMSO Tissue: skin	NULL	2355	chip_control	NULL	CHL-1 (Melanoma)	NULL
EXP049650	none	Homo sapiens	Treatment: EtOH for 4 hr	NULL	2356	chip_control	NULL	HASM2 (Human airway smooth muscle 2)	NULL
EXP049651	none	Homo sapiens	Treatment: dexamethasone for 4 hr	NULL	2356	chip_control	NULL	HASM2 (Human airway smooth muscle 2)	NULL
EXP049652	GR (gift of Miles Pufall)	Homo sapiens	Treatment: EtOH for 4 hr	EXP049650	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049653	GR (gift of Miles Pufall)	Homo sapiens	Treatment: EtOH for 4 hr	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049654	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr	EXP049651	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049655	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049656	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-GFP transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049657	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-GFP transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049658	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-KLF15 transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049659	GR (gift of Miles Pufall)	Homo sapiens	Treatment: dexamethasone for 4 hr Genotype: Ad-KLF15 transduction	NULL	2356	normal	P04150	HASM2 (Human airway smooth muscle 2)	NULL
EXP049660	none	Homo sapiens	Treatment: untreated	NULL	761	chip_control	NULL	R1-AD1 (prostate cancer)	NULL
EXP049661	none	Homo sapiens	Treatment: untreated	NULL	762	chip_control	NULL	R1-D567 (prostate cancer)	NULL
EXP049662	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 0.1% DMSO + 1 nM ethanol for 4 hrs	EXP049660	761	normal	P10275	R1-AD1 (prostate cancer)	NULL
EXP049663	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 0.1% DMSO + 1 nM DHT for 4 hrs	EXP049660	761	normal	P10275	R1-AD1 (prostate cancer)	NULL
EXP049664	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 50 uM VPC14449 + 1 nM ethanol for 4 hrs	EXP049660	761	normal	P10275	R1-AD1 (prostate cancer)	NULL
EXP049665	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 0.1% DMSO for 4 hrs	EXP049661	762	normal	P10275	R1-D567 (prostate cancer)	NULL
EXP049666	AR-Antibody [Santa Cruz sc-816 (N-20)]	Homo sapiens	Treatment: 50 uM VPC14449 for 4 hrs	EXP049661	762	normal	P10275	R1-D567 (prostate cancer)	NULL
EXP049667	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049668	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049669	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049670	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049671	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049672	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049673	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049674	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049675	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049676	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2357	chip_control	NULL	BA10 (brodmann area 10)	NULL
EXP049677	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049678	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049679	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049680	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049681	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049682	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049683	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049684	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049685	?IgG (#2729, Cell Signaling)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049686	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		NULL	2358	chip_control	NULL	BA40 (brodmann area 40)	NULL
EXP049687	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049668	2357	normal	O15516	BA10 (brodmann area 10)	NULL
EXP049688	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049670	2357	normal	O15516	BA10 (brodmann area 10)	NULL
EXP049689	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049672	2357	normal	O15516	BA10 (brodmann area 10)	NULL
EXP049690	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049674	2357	normal	O15516	BA10 (brodmann area 10)	NULL
EXP049691	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049676	2357	normal	O15516	BA10 (brodmann area 10)	NULL
EXP049692	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049678	2358	normal	O15516	BA40 (brodmann area 40)	NULL
EXP049693	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049680	2358	normal	O15516	BA40 (brodmann area 40)	NULL
EXP049694	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049682	2358	normal	O15516	BA40 (brodmann area 40)	NULL
EXP049695	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049684	2358	normal	O15516	BA40 (brodmann area 40)	NULL
EXP049696	alfa-CLOCK (ab3517, Abcam, lot #GR222742-4)	Homo sapiens		EXP049686	2358	normal	O15516	BA40 (brodmann area 40)	NULL
EXP049697		Homo sapiens	Genotype: B2-1-BirA-CSE1L-Avi Developmental stage:  fetus 	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP049698		Homo sapiens	Genotype: B2-1-BirA Developmental stage:  fetus 	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP049699	CSE1L	Homo sapiens	Genotype: B2-1-BirA-CSE1L-Avi Developmental stage:  fetus 	EXP049697	421	normal	P55060	HEK293 (embryonic kidney)	NULL
EXP049700	CSE1L	Homo sapiens	Genotype: B2-1-BirA Developmental stage:  fetus 	EXP049698	421	normal	P55060	HEK293 (embryonic kidney)	NULL
EXP049701	IgG	Homo sapiens	Treatment: none	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP049702	IgG	Homo sapiens	Treatment: none	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP049703	anti-TCF4	Homo sapiens	Treatment: none	EXP049701	664	normal	P15884	SH-SY5Y (neuroblastoma)	NULL
EXP049704	anti-TCF4	Homo sapiens	Treatment: none	EXP049702	664	normal	P15884	SH-SY5Y (neuroblastoma)	NULL
EXP049705		Homo sapiens	Passage: 23 -27	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP049706		Homo sapiens	Passage: p3 -4	NULL	2359	chip_control	NULL	CPCs (cardiac progenitor cancer cells)	NULL
EXP049707		Homo sapiens	Passage: 3-4	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP049708		Homo sapiens	Passage: 23 -27	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP049709		Homo sapiens	Passage: 3-4 	NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP049710		Homo sapiens	Passage: 23 -27	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP049711		Homo sapiens	Passage: 23 -27	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP049712		Homo sapiens	Passage: p3 -4	NULL	2359	chip_control	NULL	CPCs (cardiac progenitor cancer cells)	NULL
EXP049713		Homo sapiens	Passage: 3-4	NULL	258	chip_control	NULL	endothelial cells	NULL
EXP049714		Homo sapiens	Passage: 23 -27	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP049715		Homo sapiens	Passage: 3-4 	NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP049716		Homo sapiens	Passage: 23 -27	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP049717	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	NULL	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	NULL
EXP049718	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: p3 -4	EXP049706	2359	normal	Q09472	CPCs (cardiac progenitor cancer cells)	NULL
EXP049719	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4	EXP049707	258	normal	Q09472	endothelial cells	NULL
EXP049720	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049710	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	NULL
EXP049721	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4 	EXP049709	2360	normal	Q09472	fibroblasts	NULL
EXP049722	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049710	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	NULL
EXP049723	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049711	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	NULL
EXP049724	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: p3 -4	EXP049712	2359	normal	Q09472	CPCs (cardiac progenitor cancer cells)	NULL
EXP049725	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4	EXP049713	258	normal	Q09472	endothelial cells	NULL
EXP049726	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049714	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	NULL
EXP049727	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 3-4 	EXP049715	2360	normal	Q09472	fibroblasts	NULL
EXP049728	p300 antibody (C-20) (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Passage: 23 -27	EXP049716	1143	normal	Q09472	iPSC (induced pluripotent stem cells)	NULL
EXP049729	none	Homo sapiens	Treatment: none Crosslinking: 1% formaldehyde	NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP049730	none	Homo sapiens	Treatment: none Crosslinking: 1mM DSP and 1% formaldehyde	NULL	223	chip_control	NULL	DU145 (prostate carcinoma)	NULL
EXP049731	none	Homo sapiens	Treatment: none Crosslinking: 1mM DSP and 1% formaldehyde	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP049732	UCHL1 (R&D Systems: MAB6007)	Homo sapiens	Treatment: none Crosslinking: 1% formaldehyde	EXP049729	223	normal	P09936	DU145 (prostate carcinoma)	NULL
EXP049733	UCHL1 (R&D Systems: MAB6007)	Homo sapiens	Treatment: none Crosslinking: 1mM DSP and 1% formaldehyde	EXP049730	223	normal	P09936	DU145 (prostate carcinoma)	NULL
EXP049734	UCHL1 (R&D Systems: MAB6007)	Homo sapiens	Treatment: none Crosslinking: 1mM DSP and 1% formaldehyde	EXP049731	10	normal	P09936	HEK293T (embryonic kidney)	NULL
EXP049735	none	Homo sapiens		NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049736	none	Homo sapiens	Passages: 6 - 10 Genotype: MLL3 Exon8 knockout	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049737	none	Homo sapiens	Passages: 6 - 10 Genotype: MLL3 knockout	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049738	none	Homo sapiens	Passages: 6 - 10 Genotype: MLL3 wildtype	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049739	none	Homo sapiens	Passages: 6 - 10 Genotype: UTX knockout	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049740	none	Homo sapiens	Passages: 6 - 10 Genotype: UTX wildtype	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049741	none	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049742	none	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	NULL	2361	chip_control	NULL	CAL51(Breast carcinoma)	NULL
EXP049743	BAP1_NTD (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q92560	CAL51(Breast carcinoma)	NULL
EXP049744	BAP1_NTD (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q92560	CAL51(Breast carcinoma)	NULL
EXP049745	Suz12(CST)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q86V15	CAL51(Breast carcinoma)	NULL
EXP049746	Suz12(CST)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q86V15	CAL51(Breast carcinoma)	NULL
EXP049747	MLL3_MR (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: MLL3 Exon8 knockout	EXP049736	2361	normal	Q8NEZ4	CAL51(Breast carcinoma)	NULL
EXP049748	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: UTX knockout	EXP049739	2361	normal	O15550	CAL51(Breast carcinoma)	NULL
EXP049749	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: UTX wildtype	EXP049740	2361	normal	O15550	CAL51(Breast carcinoma)	NULL
EXP049750	BAP1_FL (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q92560	CAL51(Breast carcinoma)	NULL
EXP049751	BAP1_FL (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q92560	CAL51(Breast carcinoma)	NULL
EXP049752	MLL3_MR (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	Q8NEZ4	CAL51(Breast carcinoma)	NULL
EXP049753	MLL3_MR (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	Q8NEZ4	CAL51(Breast carcinoma)	NULL
EXP049754	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 deletion	EXP049741	2361	normal	O15550	CAL51(Breast carcinoma)	NULL
EXP049755	UTX (homemade)	Homo sapiens	Passages: 6 - 10 Genotype: BAP1 wildtype	EXP049742	2361	normal	O15550	CAL51(Breast carcinoma)	NULL
EXP049756	CTCF (abcam, ab70303)	Homo sapiens	Genotype: wildtype	NULL	455	normal	P49711	HUES64 (embryonic stem cells)	NULL
EXP049757	CTCF (abcam, ab70303)	Homo sapiens	Genotype: CTCF knockout	NULL	455	normal	P49711	HUES64 (embryonic stem cells)	NULL
EXP049758	RAD21 (abcam, ab992)	Homo sapiens	Genotype: RAD21 wildtype	NULL	455	normal	O60216	HUES64 (embryonic stem cells)	NULL
EXP049759	RAD21 (abcam, ab992)	Homo sapiens	Genotype: RAD21 knockout	NULL	455	normal	O60216	HUES64 (embryonic stem cells)	NULL
EXP049760	none	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP049761	ARID5B antibody (HPA015037, Sigma)	Homo sapiens		EXP049760	509	normal	Q14865	Jurkat (T-cells)	NULL
EXP049762	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP049763	PAF1 (Santa Cruz, catalog# sc-74797)	Homo sapiens		EXP049762	417	normal	P28328	HCT-116 (colon carcinoma)	NULL
EXP049764	PAF1 (Abcam, catalog# ab20662, lot# GR243511-1)	Homo sapiens		EXP049762	417	normal	P28328	HCT-116 (colon carcinoma)	NULL
EXP049765	HA (ROCHE #11867423001)	Homo sapiens	GFP	NULL	288	bio_control	O14503	A673 (Ewing sarcoma)	NULL
EXP049766	HA (ROCHE #11867423001)	Homo sapiens		NULL	288	normal	Q01844	A673 (Ewing sarcoma)	NULL
EXP049767	SMARCA2 (Active Motif #39805)	Homo sapiens	shEWSFLI1	NULL	289	normal	P51531	SK-N-MC (Askin tumor)	NULL
EXP049768	SMARCA2 (Active Motif #39805)	Homo sapiens	shGFP	NULL	289	normal	P51531	SK-N-MC (Askin tumor)	NULL
EXP049769	BAF155 (generated in-house epitope=aa924-1004; C-terminus)	Homo sapiens		NULL	289	normal	Q92922	SK-N-MC (Askin tumor)	NULL
EXP049770	BAF155 (generated in-house epitope=aa924-1004; C-terminus)	Homo sapiens	shEWSFLI1	NULL	289	normal	Q92922	SK-N-MC (Askin tumor)	NULL
EXP049771	BAF155 (generated in-house epitope=aa924-1004; C-terminus)	Homo sapiens	shGFP	NULL	289	normal	Q92922	SK-N-MC (Askin tumor)	NULL
EXP049772	none	Homo sapiens		NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP049773	Anti-ONECUT2 antibody produced in rabbit (Sigma-Aldrich, catalog#)	Homo sapiens		EXP049772	7	normal	O95948	22RV1 (prostate carcinoma)	NULL
EXP049774	input	Homo sapiens	Treatment: untreated 	NULL	2364	chip_control	NULL	SP-49 (Mantle cell lymphoma)	NULL
EXP049775	input	Homo sapiens	Treatment: untreated 	NULL	2365	chip_control	NULL	MEC-1 (Chronic lymphocytic leukemia)	NULL
EXP049776	MAML1 (Cell Signaling, catalog #12166)	Homo sapiens	Treatment: untreated	NULL	2363	normal	Q92585	REC-1 (Mantle cell lymphoma)	NULL
EXP049777	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: untreated 	NULL	2363	normal	Q06330	REC-1 (Mantle cell lymphoma)	NULL
EXP049778	MAML1 (Cell Signaling, catalog #12166)	Homo sapiens	Treatment: untreated 	EXP049774	2364	normal	Q92585	SP-49 (Mantle cell lymphoma)	NULL
EXP049779	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: untreated 	EXP049774	2364	normal	Q06330	SP-49 (Mantle cell lymphoma)	NULL
EXP049780	NICD1 (Cell Signaling, catalog #4147)	Homo sapiens	Treatment: GSI-mock-washout	NULL	2363	normal	P46531	REC-1 (Mantle cell lymphoma)	NULL
EXP049781	NICD1 (Cell Signaling, catalog #4147)	Homo sapiens	Treatment: GSI-washout	NULL	2363	normal	P46531	REC-1 (Mantle cell lymphoma)	NULL
EXP049782	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: GSI-mock-washout	NULL	2363	normal	Q06330	REC-1 (Mantle cell lymphoma)	NULL
EXP049783	RBPJ (Cell Signaling, catalog #5313)	Homo sapiens	Treatment: GSI-washout	NULL	2363	normal	Q06330	REC-1 (Mantle cell lymphoma)	NULL
EXP049784	Input	Homo sapiens		NULL	130	chip_control	NULL	LNCaP C4-2 (prostate carcinoma)	NULL
EXP049785	BMI1 antibody	Homo sapiens		EXP049784	130	normal	P35226	LNCaP C4-2 (prostate carcinoma)	NULL
EXP049786	AR antibody	Homo sapiens		EXP049784	130	normal	P10275	LNCaP C4-2 (prostate carcinoma)	NULL
EXP049787	none	Homo sapiens	Treatment: 3 mg/mL vehicle for 3 days	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP049788	none	Homo sapiens	Treatment: 3 mg/mL ATRA for 3 days	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP049789	none	Homo sapiens	vehicle	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP049790	none	Homo sapiens	Treatment: 3 mg/mL vehicle for 3 days	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP049791	c-myb (Bethyl, catalog# A304-136A, lot# A304-136A-1)	Homo sapiens	Treatment: 3 mg/mL vehicle for 3 days	EXP049787	65	normal	P10242	U937 (adult acute monocytic leukemia)	NULL
EXP049792	c-myb (Bethyl, catalog# A304-136A, lot# A304-136A-1)	Homo sapiens	Treatment: 3 mg/mL ATRA for 3 days	EXP049788	65	normal	P10242	U937 (adult acute monocytic leukemia)	NULL
EXP049793	RAR (Santa Cruz, catalog# sc-773X, lot# B1715)	Homo sapiens	Treatment: 3 mg/mL vehicle for 3 days	EXP049789	65	normal	P10276	U937 (adult acute monocytic leukemia)	NULL
EXP049794	RAR (Santa Cruz, catalog# sc-773X, lot# B1715)	Homo sapiens	Treatment: 3 mg/mL ATRA for 3 days	EXP049790	65	normal	P10276	U937 (adult acute monocytic leukemia)	NULL
EXP049795	GABP-a (Santa Cruz sc-28312 X)	Homo sapiens	Treatment: 100 nM ethanol for 24 hrs	NULL	2334	normal	Q06546	THP-1 (acute monocytic leukemia)	NULL
EXP049796	GABP-a (Santa Cruz sc-28312 X)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 24 hrs	NULL	2334	normal	Q06546	THP-1 (acute monocytic leukemia)	NULL
EXP049797	none	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP049798	none	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP049799	none	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP049800	Hoxc5 (HPA026794, Sigma, lot# R28092)	Homo sapiens	Hoxc5 overexpression	EXP049797	725	normal	Q00444	PC3(bone mets prostate adenocarcinoma)	NULL
EXP049801	PBX4 (HPA049859, Sigma, lot# R59734)	Homo sapiens	Pbx4 overexpression	EXP049798	725	normal	Q9BYU1	PC3(bone mets prostate adenocarcinoma)	NULL
EXP049802	Hoxc5 (HPA026794, Sigma, lot# R28092)	Homo sapiens		EXP049799	725	normal	Q00444	PC3(bone mets prostate adenocarcinoma)	NULL
EXP049803	none	Homo sapiens	proliferating	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049804	none	Homo sapiens	proliferating	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP049805	alpha-HMGB1 (4F10), DSHB	Homo sapiens	proliferating	EXP049803	472	normal	P09429	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049806	hmgb2	Homo sapiens	proliferating	EXP049803	472	normal	P26583	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP049807	alpha-HMGB2, ab67282, Abcam, lot# GR149806	Homo sapiens	proliferating	EXP049804	489	normal	P26583	IMR90 (lung fibroblasts)	NULL
EXP049808	alpha-HMGB2, ab67282, Abcam, lot# GR149806	Homo sapiens	senescent	EXP049804	489	normal	P26583	IMR90 (lung fibroblasts)	NULL
EXP049809	alpha-HMGB1, ab18256, Abcam	Homo sapiens	proliferating	EXP049804	489	normal	P09429	IMR90 (lung fibroblasts)	NULL
EXP049810	none	Mus musculus	Treatment: 24h, Oligomycin Genotype: wildtype Tissue: spleen	NULL	2366	chip_control	NULL	activated B-cells	NULL
EXP049811	none	Mus musculus	Treatment: no Genotype: wildtype Tissue: spleen	NULL	2366	chip_control	NULL	activated B-cells	NULL
EXP049812	none	Mus musculus	Treatment: no Genotype: wildtype	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP049813	none	Mus musculus	Treatment: for activating 24 hr Genotype: wildtype 	NULL	2366	chip_control	NULL	activated B-cells	NULL
EXP049814	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: 24hrs, Oligomycin Genotype: wildtype Tissue: spleen	EXP049810	2366	normal	Q61550	activated B-cells	NULL
EXP049815	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: no	EXP049811	2366	normal	Q61550	activated B-cells	NULL
EXP049816	Nipbl (Bethyl Laboratories; A301-779A)	Mus musculus	Genotype: wildtype Tissue: spleen	NULL	2367	normal	Q6KCD5	ES cells (plasmacytomas)	NULL
EXP049817	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: flavopiridol 2 hrs Genotype: wildtype Tissue: spleen	NULL	2366	normal	Q61550	activated B-cells	NULL
EXP049818	Anti-NIPBL (Bethy Laboratories; catalog# A301-779A, lot# A301-779A-3)	Mus musculus	Treatment: for activating 24 hr treatment Genotype: wildtype Tissue: spleen	NULL	2366	normal	Q6KCD5	activated B-cells	NULL
EXP049819	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment:  for activating 24 hr treatment Genotype: wildtype Tissue: spleen	NULL	2366	normal	Q61550	activated B-cells	NULL
EXP049820	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: no Genotype: wildtype 	EXP049812	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP049821	Anti-Rad21 (abcam; ab992)	Mus musculus	Treatment: no Genotype: CTCFmZF9to11 	EXP049812	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP049822	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: wildtype 	EXP049812	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP049823	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: CTCFmZF9to11 	EXP049812	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP049824	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: wildtype 	NULL	2367	normal	Q61164	ES cells (plasmacytomas)	NULL
EXP049825	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: SA deletion	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP049826	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: no Genotype: half SA deletion	NULL	80	normal	A1A546	B lymphoblastic leukemia	NULL
EXP049827	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: activating 30 hrs and HU treated  Genotype: wildtype	EXP049813	2366	normal	A1A546	activated B-cells	NULL
EXP049828	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: activated, 30hr, UH no treated Genotype: wildtype	EXP049813	2366	normal	Q61164	activated B-cells	NULL
EXP049829	anti-CTCF (EMD Millipore; 07-729)	Mus musculus	Treatment: activated, 24 hrs Genotype: wildtype	EXP049813	2366	normal	A1A546	activated B-cells	NULL
EXP049830	Nipbl (Bethyl Laboratories; A301-779A)	Mus musculus	Treatment: activated, 30 hrs, HU treated Genotype: wildtype	NULL	2366	normal	Q6KCD5	activated B-cells	NULL
EXP049831	Nipbl (Bethyl Laboratories; A301-779A)	Mus musculus	Treatment: activated, 30 hrs, HU untreated Genotype: wildtype	NULL	2366	normal	A1A546	activated B-cells	NULL
EXP049832	abcam; ab992	Mus musculus	Treatment: activated, 30 hrs, HU treated Genotype: wildtype	NULL	2366	normal	A1A546	activated B-cells	NULL
EXP049833	abcam; ab992	Mus musculus	Treatment: activated, 30 hrs, HU untreated Genotype: wildtype	NULL	2366	normal	A1A546	activated B-cells	NULL
EXP049834	anti-lamin A/C (Santa Cruz sc-7292)	Homo sapiens		NULL	1572	normal	P02545	skin fibroblast	NULL
EXP049835	anti-lamin B1 (rabbit polyclonal; Abcam, cat# 16048)	Homo sapiens		NULL	1572	normal	P20700	skin fibroblast	NULL
EXP049836	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP049837	preimmune rabbit IgG (Bethyl Labs P120-101)	Homo sapiens		NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP049838	Anti-BCL11a polyclonal (Bethyl Labs BL1797)	Homo sapiens		EXP049836	646	normal	Q9H165	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP049839	Anti-BCL11a polyclonal (Bethyl Labs BL1797)	Homo sapiens		EXP049837	767	normal	Q9H165	Raji (Burkitt lymphoma)	NULL
EXP049840	none	Homo sapiens	Treatment: Mock	NULL	849	chip_control	NULL	U87 (glioblastoma)	NULL
EXP049841	BRD2 (Proteintech, 22236-1-AP)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	P25440	U87 (glioblastoma)	NULL
EXP049842	BRD2 (Proteintech, 22236-1-AP)	Homo sapiens	Treatment: 500 nM dBET6 for 24 hr	EXP049840	849	normal	P25440	U87 (glioblastoma)	NULL
EXP049843	BRD2 (Proteintech, 22236-1-AP)	Homo sapiens	Treatment: 500 nM dBET6 for 2 hr	EXP049840	849	normal	P25440	U87 (glioblastoma)	NULL
EXP049844	BRD3 (Bethyl, A302-367A)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	Q15059	U87 (glioblastoma)	NULL
EXP049845	BRD3 (Bethyl, A302-367A)	Homo sapiens	Treatment: 500 nM dBET6 for 24 hr	EXP049840	849	normal	Q15059	U87 (glioblastoma)	NULL
EXP049846	BRD3 (Bethyl, A302-367A)	Homo sapiens	Treatment: 500 nM dBET6 for 2 hr	EXP049840	849	normal	Q15059	U87 (glioblastoma)	NULL
EXP049847	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	O60885	U87 (glioblastoma)	NULL
EXP049848	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500 nM dBET6 for 24 hr	EXP049840	849	normal	O60885	U87 (glioblastoma)	NULL
EXP049849	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500 nM dBET6 for 2 hr	EXP049840	849	normal	O60885	U87 (glioblastoma)	NULL
EXP049850	E2F1 (Cell Signalling Technology, 3742S)	Homo sapiens	Treatment: Mock	EXP049840	849	normal	Q01094	U87 (glioblastoma)	NULL
EXP049851	BRD4 (Bethyl, A301-985A, A301-985A-1)	Homo sapiens	Treatment: DMSO	NULL	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP049852	BRD4 (Bethyl, A301-985A, A301-985A-1)	Homo sapiens	Treatment: JQ1 2 hrs 	NULL	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP049853	BRD4 (Bethyl, A301-985A, A301-985A-1)	Homo sapiens	Treatment: JQ1 6 hrs 	NULL	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP049854	NUP98 (Cell Signaling, C39a3, 2598)	Homo sapiens	Treatment: no	NULL	514	normal	P52948	K562 (myelogenous leukemia)	NULL
EXP049855	NUP153 (BioLegend, 906201, B215613)	Homo sapiens	Ntreatment: no	NULL	514	normal	P49790	K562 (myelogenous leukemia)	NULL
EXP049856	Input Control	Homo sapiens	Treatment: Activin A for 15 hr Genotype: wildtype	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049857	Input Control	Homo sapiens	None	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049858	Input Control	Homo sapiens	Treatment: no Genotype: wildtype hESC	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049859	Input Control	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049860	Input Control	Homo sapiens	Treatment: Activin A , Doxycycline for 15 hr Genotype: YAP knockout, Piggy	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049861	Input Control	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout, Piggy	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049862	Input Control	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout in hESC 	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP049863	CTNNB1 	Homo sapiens	Treatment: Activin A for 15 hr Genotype: wildtype	EXP049856	376	normal	P35222	WA01 (H1, human embryonic stem cells)	NULL
EXP049864	beta-Catenin	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	EXP049859	376	normal	P35222	WA01 (H1, human embryonic stem cells)	NULL
EXP049865	Smad2_3	Homo sapiens	Treatment: Activin A for 15 hr Genotype: wildtype	EXP049856	376	normal	Q15796	WA01 (H1, human embryonic stem cells)	NULL
EXP049866	Smad2_3	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	EXP049859	376	normal	Q15796	WA01 (H1, human embryonic stem cells)	NULL
EXP049867	TEAD4	Homo sapiens	Treatment: None Genotype: wildtype hESC	EXP049858	376	normal	Q15561	WA01 (H1, human embryonic stem cells)	NULL
EXP049868	YAP	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP wildtype	EXP049857	376	normal	P46937	WA01 (H1, human embryonic stem cells)	NULL
EXP049869	YAP	Homo sapiens	Treatment: Activin A for 15 hr Genotype: YAP knockout	EXP049862	376	normal	P46937	WA01 (H1, human embryonic stem cells)	NULL
EXP049870	none	Homo sapiens	Genotype: APC wildtype, CTNNB1{delta}Ser45	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP049871	none	Homo sapiens	Genotype: APC wildtype, CTNNB1{delta}Ser45	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP049872	anti-APC (a polyclonal antibody recognizing the C-terminal 50 amino acids of APC, catalog #A300-981A, Bethyl Laboratories, Inc.)	Homo sapiens	Genotype: APC wildtype, CTNNB1{delta}Ser45	EXP049870	417	normal	P25054	HCT-116 (colon carcinoma)	NULL
EXP049873	anti-APC (a polyclonal antibody recognizing the C-terminal 50 amino acids of APC, catalog #A300-981A, Bethyl Laboratories, Inc.)	Homo sapiens	Genotype: APC wildtype, CTNNB1{delta}Ser45	EXP049871	417	normal	P25054	HCT-116 (colon carcinoma)	NULL
EXP049874		Homo sapiens		NULL	2368	chip_control	NULL	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049875		Homo sapiens		NULL	2368	chip_control	NULL	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049876		Homo sapiens		NULL	2368	chip_control	NULL	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049877	anti-TFCP2 (CST #80784)	Homo sapiens		EXP049874	2368	normal	Q12800	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049878	anti-TFCP2 (CST #80784)	Homo sapiens		EXP049875	2368	normal	Q12800	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049879	anti-TFCP2 (CST #80784)	Homo sapiens		EXP049876	2368	normal	Q12800	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049880	anti-YAP (CST #14074)	Homo sapiens		EXP049874	2368	normal	P46937	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049881	anti-YAP (CST #14074)	Homo sapiens		EXP049875	2368	normal	P46937	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049882	anti-YAP (CST #14074)	Homo sapiens		EXP049876	2368	normal	P46937	BEL-7402 (Human papillomavirus-related endocervical adenocarcinoma)	NULL
EXP049883		Homo sapiens	Treatment: no Genotype: wildtype	NULL	2369	chip_control	NULL	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP049884		Homo sapiens	Treatment: no Genotype: Inactivating mutations in TET1, TET2 and TET3	NULL	2369	chip_control	NULL	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP049885	TET1	Homo sapiens	Treatment: no Genotype: wildtype	EXP049883	2369	normal	Q8NFU7	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP049886	DNMT3B	Homo sapiens	Treatment: no Genotype: wildtype	EXP049883	2369	normal	Q9UBC3	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP049887	DNMT3B	Homo sapiens	Treatment: no Genotype: Inactivating mutations in TET1, TET2 and TET3	EXP049884	2369	normal	Q9UBC3	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP049888	N/A	Homo sapiens	Passsage: <10	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP049889	N/A	Homo sapiens	Passsage: <10	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP049890	N/A	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP049891	N/A	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP049892	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP049893	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP049894	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP049895	anti-ERalpha (Santa Cruz, HC-20)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP049896	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049897	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049898	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049899	anti-GATA3 (Cell Signaling, D13C9)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049900	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP049901	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP049902	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP049903	anti-FOXA1 (abcam, ab5089)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P55317	T47D (invasive ductal carcinoma)	NULL
EXP049904	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10	EXP049888	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049905	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10	EXP049889	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049906	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049890	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049907	anti-GATA3 C-terminus (ThermoFisher, PA5-20892)	Homo sapiens	Passsage: <10 Genotype: wt/R330fs mutant with CRISPR	EXP049891	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP049908	None	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP049909	None	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP049910	YY1(Santa Cruz, 281X)	Mus musculus		EXP049908	252	normal	Q00899	V6.5 (embryonic stem cells)	NULL
EXP049911	YY1(Abcam, ab109237)	Homo sapiens		EXP049909	509	normal	P25490	Jurkat (T-cells)	NULL
EXP049912	none (input)	Homo sapiens	Tissue: peripheral blood-derived Sex: male	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP049913	GR	Mus musculus	Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	NULL	570	chip_control	NULL	macrophages	NULL
EXP049914	none (input)	Mus musculus	Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	NULL	373	chip_control	NULL	granulocyte macrophage progenitors	NULL
EXP049915	GR	Mus musculus	Treatment: untreated Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	NULL	373	normal	P06537	granulocyte macrophage progenitors	NULL
EXP049916	GR	Mus musculus	Treatment: Dex, 100nm, 45 min Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	NULL	373	normal	P06537	granulocyte macrophage progenitors	NULL
EXP049917	GR	Homo sapiens	Treatment: untreated Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	P04150	THP-1 (acute monocytic leukemia)	NULL
EXP049918	GR	Homo sapiens	Treatment: Dex, 100 nM, 1hour Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	P04150	THP-1 (acute monocytic leukemia)	NULL
EXP049919	Ncoa2	Homo sapiens	Treatment: untreated Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	NULL
EXP049920	GRIP1	Homo sapiens	Treatment: Dex, 100nm, 1hour Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	NULL
EXP049921	pS469-GRIP1	Homo sapiens	Treatment: untreated Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	NULL
EXP049922	pS469-GRIP1	Homo sapiens	Treatment: Dex, 100nm, 1hour Tissue: peripheral blood-derived Sex: male	EXP049912	2334	normal	Q15596	THP-1 (acute monocytic leukemia)	NULL
EXP049923	GRIP1	Mus musculus	Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	EXP049914	373	normal	Q61026	granulocyte macrophage progenitors	NULL
EXP049924	GRIP1	Mus musculus	Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 	EXP049914	373	normal	Q61026	granulocyte macrophage progenitors	NULL
EXP049925	none (INPUT)	Homo sapiens	Treatmet: Vehicle, 45 min Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049926	none (INPUT)	Homo sapiens	Treatment: 10 nM Estradiol for 45 mins Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049927	none (INPUT)	Homo sapiens	Treatment: 10 nM DHT for 45 mins Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049928	none (INPUT)	Homo sapiens	Treatment: 10nM Estradiol + 10 nM DHT for 45 mins Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049929	none (INPUT)	Homo sapiens	Treatment: Vehicle Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049930	none (INPUT)	Homo sapiens	Treatment: 10 nM Estradiol for 75 mins Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049931	none (INPUT)	Homo sapiens	Treatment: 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049932	none (INPUT)	Homo sapiens	Treatment: 15 mins of 10nM Estradiol and then 10nM Estradiol + 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049933	none (INPUT)	Homo sapiens	10 nM Estradiol	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049934	none (INPUT)	Homo sapiens	10 nM Dexamethasone	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049935	none	Homo sapiens	INPUT	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049936	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM DHT for 45 mins Genotype: ER+/PR+	EXP049927	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049937	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10nM Estradiol + 10 nM DHT for 45 mins Genotype: ER+/PR+	EXP049928	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049938	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: Vehicle for 60 mins Genotype: ER+/PR+	EXP049929	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049939	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM Estradiol for 75 mins Genotype: ER+/PR+	EXP049930	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049940	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+	EXP049931	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049941	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 15 mins of 10nM Estradiol and then 10nM Estradiol + 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+	EXP049932	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049942	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10 nM Aldosterone for 45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049943	anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)	Homo sapiens	Treatment: 10nM Estradiol + 10 nM Aldosterone for 45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049944	none (INPUT)	Homo sapiens	10nM Estradiol + 10 nM Dexamethasone	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049945	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: Vehicle for4 hrs Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049946	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM E2 for4 hrs Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049947	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM R5020 for45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049948	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM E2 + 10 nM R5020 for45 mins Genotype: ER+/PR+	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049949	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatmet: Vehicle, 45 min Genotype: ER+/PR+	EXP049925	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049950	anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)	Homo sapiens	Treatment: 10 nM Estradiol for 45 mins Genotype: ER+/PR+	EXP049926	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP049951	none	Homo sapiens	Treatment: no Tissue: cord blood	NULL	2371	chip_control	NULL	iTreg cells (human induced regulatory T cells )	NULL
EXP049952	none	Homo sapiens	Treatment: no Tissue: cord blood	NULL	2371	chip_control	NULL	iTreg cells (human induced regulatory T cells )	NULL
EXP049953	HIC-1 antibody (Santa Cruz, sc-271499)	Homo sapiens	Treatment: no Tissue: cord blood	EXP049951	2371	normal	Q14526	iTreg cells (human induced regulatory T cells )	NULL
EXP049954	HIC-1 antibody (Santa Cruz, sc-271499)	Homo sapiens	Treatment: no Tissue: cord blood	EXP049952	2371	normal	Q14526	iTreg cells (human induced regulatory T cells )	NULL
EXP049955	none	Homo sapiens	Passage: 15-19 	NULL	1086	chip_control	NULL	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049956	none	Homo sapiens	Passage: 15-19 	NULL	1086	chip_control	NULL	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049957	none	Homo sapiens	Passage: 15-19 	NULL	1086	chip_control	NULL	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049958	none	Homo sapiens	Passage: 15-19 	NULL	1086	chip_control	NULL	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049959	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049955	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049960	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049956	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049961	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049957	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049962	anti-FLI (sc-356X Santa Cruz Biotechnology, Inc)	Homo sapiens	Passage: 15-19 	EXP049958	1086	normal	Q01543	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP049963	C/EBPÃŽÂ² (Santa Cruz, sc-150x)	Mus musculus		NULL	2372	normal	P28033	32D	NULL
EXP049964	JMJD3 (Abcam, ab85392)	Mus musculus		NULL	2372	normal	Q5NCY0	32D	NULL
EXP049965	IgG (Santa Cruz, sc-2027, lot k0507)	Mus musculus	Strain: B6D2F1 Genotype: CD34 positive	NULL	253	chip_control	NULL	EML -C1(EML, clone 1)	NULL
EXP049966	IgG (Santa Cruz, sc-2027, lot k0507)	Mus musculus	Strain: B6D2F1 Genotype: CD34 negative	NULL	253	chip_control	NULL	EML -C1(EML, clone 1)	NULL
EXP049967	STAT3 (Santa Cruz, sc-482x, lot B0615)	Mus musculus	Strain: B6D2F1 Genotype: CD34 positive	EXP049965	253	normal	P42227	EML -C1(EML, clone 1)	NULL
EXP049968	SOX4 (Santa Cruz, sc-17326x, lot D2012)	Mus musculus	Strain: B6D2F1 Genotype: CD34 positive	EXP049965	253	normal	Q06831	EML -C1(EML, clone 1)	NULL
EXP049969	GABPa (Santa Cruz, sc-22810x, lot c2912)	Mus musculus	Strain: B6D2F1 Genotype: CD34 negative	EXP049966	253	normal	Q00422	EML -C1(EML, clone 1)	NULL
EXP049970	none	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	NULL	2373	chip_control	NULL	MA9 transformed mouse leukemia	NULL
EXP049971	anti-Cebpa (Santa Cruz, sc-61)	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	EXP049970	2373	normal	P53566	MA9 transformed mouse leukemia	NULL
EXP049972	anti-Cebpa (Santa Cruz, sc-61)	Mus musculus	Treatment: LSD1 inhibitor GSK-LSD1 Genotype: MLL-AF9 fusion	EXP049970	2373	normal	P53566	MA9 transformed mouse leukemia	NULL
EXP049973	anti-LSD1 (Abcam, ab17721)	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	EXP049970	2373	normal	Q6ZQ88	MA9 transformed mouse leukemia	NULL
EXP049974	anti-PU.1 (Santa Cruz, sc-352)	Mus musculus	Treatment: none Genotype: MLL-AF9 fusion	EXP049970	2373	normal	O35295	MA9 transformed mouse leukemia	NULL
EXP049975	anti-PU.1 (Santa Cruz, sc-352)	Mus musculus	Treatment: LSD1 inhibitor GSK-LSD1 Genotype: MLL-AF9 fusion	EXP049970	2373	normal	O35295	MA9 transformed mouse leukemia	NULL
EXP049976	none	Mus musculus	Treatment: DMSO treatment for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049977	none	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049978	none	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049979	none	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 9hrs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049980	none	Mus musculus	1 uM ATR-45 inhibitor for 18hrs	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049981	none	Mus musculus	Treatment: 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049982	none	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs in TIM KD MEFs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049983	none	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP049984	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00153981)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049978	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049985	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00127062)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049980	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049986	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00153981)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049983	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049987	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00144219)	Mus musculus	Treatment: DMSO treatment for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049976	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049988	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00127062)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049977	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049989	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00144219)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor + 0.2 uM aphidicolin for 9hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049979	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049990	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00127062)	Mus musculus	Treatment: 0.2 uM aphidicolin for 18hrs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049981	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049991	anti-RPA32 (EMD Millipore, NA19L-100UG, lot D00144219)	Mus musculus	Treatment: 1 uM ATR-45 inhibitor for 18hrs in TIM KD MEFs Genotype: ATR+/mouse embrionic fibroblast - 	EXP049982	12	normal	Q62193	MEF (mouse embryonic fibroblasts)	NULL
EXP049992	none	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP049993	none	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1 knockout Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP049994	none	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP049995	none	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1 knockout Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP049996	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049992	2	normal	A2A935	mESCs (mouse embryonic stem cells)	NULL
EXP049997	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1 knockout Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049993	2	normal	A2A935	mESCs (mouse embryonic stem cells)	NULL
EXP049998	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049994	2	normal	A2A935	mESCs (mouse embryonic stem cells)	NULL
EXP049999	M-280 Streptavidin (Thermo Fisher, 11205D)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1 knockout Treatment: Dnmt3a1 expression was induced by adding 2 ug/mL doxycycline in ES medium for 16 hours	EXP049995	2	normal	A2A935	mESCs (mouse embryonic stem cells)	NULL
EXP050000	none	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP050001	none	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a knockout	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP050002	anit-Flag M2 (Sigma, F1804)	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype 	EXP050000	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP050003	anti-Tet1	Mus musculus	Strain: 129S4/SvJae Genotype: wildtype 	EXP050000	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP050004	anit-Flag M2 (Sigma, F1804)	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a knockout	EXP050001	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP050005	anti-Tet1	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a knockout	EXP050001	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP050006	INPUT	Mus musculus	Strain: C57BL/6 Genotype: UTX wildtype	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP050007	INPUT	Mus musculus	Strain: C57BL/6 Genotype: UTX knockout	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP050008	PU.1 (Santa Cruz Biotechnology, #sc-352)	Mus musculus	Strain: C57BL/6 Genotype: UTX wildtype	EXP050006	549	normal	P17433	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP050009	PU.1 (Santa Cruz Biotechnology, #sc-352)	Mus musculus	Strain: C57BL/6 Genotype: UTX knockout	EXP050007	549	normal	P17433	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP050010	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: brain 	NULL	919	normal	Q91VN1	oligodendrocyte progenitors	NULL
EXP050011	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: Zfp191knockout  Tissue: brain 	NULL	919	normal	Q91VN1	oligodendrocyte progenitors	NULL
EXP050012	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: wildtype  Tissue: brain Developmental stage: postnatal day (P) 7 	NULL	2374	normal	Q91VN1	oligodendrocyte	NULL
EXP050013	anti-ZFP191 (sigma) [Cat # HPA024062)]	Mus musculus	Strain: C57BL/6 Genotype: Zfp191 knockout  Tissue: brain Developmental stage: postnatal day (P) 7 	NULL	2374	normal	Q91VN1	oligodendrocyte	NULL
EXP050014	none	Mus musculus	PAssage: 4-6	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP050015	none	Mus musculus	PAssage: 4-6	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP050016	none	Mus musculus	PAssage: 4-6	NULL	127	chip_control	NULL	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP050017	none	Mus musculus	PAssage: 4-6	NULL	127	chip_control	NULL	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP050018	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050014	18	normal	O09100	3T3-L1 (embryonic fibroblasts)	NULL
EXP050019	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050015	18	normal	O09100	3T3-L1 (embryonic fibroblasts)	NULL
EXP050020	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050016	127	normal	O09100	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP050021	GATA2 (sc-9008x, Santa Cruz)	Mus musculus	PAssage: 4-6	EXP050017	127	normal	O09100	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP050022		Mus musculus	Strain: C57BL/6 Passage: 16-19 Treatment: no treatment Cell line:Bry	NULL	275	chip_control	NULL	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050023		Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment  Cell line:Hd1loxlox	NULL	275	chip_control	NULL	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050024		Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment Cell line:Hd2lox 	NULL	275	chip_control	NULL	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050025	Hdac1 antibody, Diagenode (cat# C15410325-50)	Mus musculus	Strain: C57BL/6 Passage: 16-19 Treatment: no treatment Cell line:Bry	EXP050022	275	normal	O09106	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050026	Hdac2 antibody, abcam (cat# ab7029)	Mus musculus	Strain: C57BL/6 Passage: 16-19 Treatment: no treatment Cell line:Bry	EXP050022	275	normal	P70288	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050027	Hdac1 antibody, Diagenode (cat# C15410325-50)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment  Cell line:Hd1loxlox	EXP050023	275	normal	O09106	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050028	Hdac2 antibody, abcam (cat# ab7029)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment  Cell line:Hd1loxlox	EXP050024	275	normal	P70288	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050029	Hdac1 antibody, Diagenode (cat# C15410325-50)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment Cell line:Hd2lox 	EXP050024	275	normal	O09106	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050030	Hdac2 antibody, abcam (cat# ab7029)	Mus musculus	Strain: C57BL/6 Passage: 25-30 Treatment: no treatment Cell line:Hd2lox 	EXP050024	275	normal	P70288	embryonic stem cell-derived hemogenic endothelium	NULL
EXP050031	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050032	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050033	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050034	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050035	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050036	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050037	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050038	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050039	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050040	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050041	Input	Mus musculus		NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050042	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050043	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050044	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050045	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050046	Input	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050047	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050031	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050048	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050032	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050049	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050033	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050050	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050034	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050051	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050035	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050052	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050036	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050053	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050031	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050054	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050032	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050055	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050033	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050056	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050034	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050057	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050035	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050058	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050036	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050059	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050037	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050060	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050037	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050061	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050038	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050062	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050038	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050063	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050039	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050064	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050040	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050065	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050041	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050066	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050042	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050067	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050043	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050068	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050044	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050069	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050045	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050070	anti-OCT4, Santa Cruz Biotechnology Cat#sc-9081, Santa Cruz Biotechnology Cat#sc-8628, Abcam Cat#ab19857	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050046	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050071	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP	EXP050039	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050072	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming.	EXP050040	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050073	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates	EXP050041	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050074	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming.	EXP050042	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050075	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates	EXP050043	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050076	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates	EXP050044	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050077	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates	EXP050045	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050078	anti-SOX2 (Abcam Cat#ab59776)	Mus musculus	Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells	EXP050046	595	normal	P48432	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050079	Mouse anti-HA tag (Diagenode, catalog# C15200190, lot# 001)	Mus musculus	Treatment: 1 ug/mL Dox for 18 hours Genotype: pINDUCER20b-HA-NUR77	NULL	91	normal	P12813	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP050080		Mus musculus		NULL	31	chip_control	NULL	8946 cells - Flag-Zmiz1/ L1601PDP (T lymphoblastic leukemia)	NULL
EXP050081	none	Mus musculus	Genotype: MBD3flox/- Treatment: DOX inducible OSKM reprogramming Title: reanalyzed for GSE49766 	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050082	none	Mus musculus	Genotype: MBD3flox/- Treatment: DOX inducible OSKM reprogramming day4 Title: reanalyzed for GSE49766 	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050083	none	Mus musculus	Genotype: MBD3flox/- Treatment: DOX inducible OSKM reprogramming day8 Title: reanalyzed for GSE49766 	NULL	80	chip_control	NULL	B lymphoblastic leukemia	NULL
EXP050084	none	Mus musculus	Genotype: wildtype (MBD3+/+) TReatment: 8 days after DOX induction Title: reanalyzed for GSE49766 	NULL	595	chip_control	NULL	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050085	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050086	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050087	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050088	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050089	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050090	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050091	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050092	OCT4 (Santa Cruz, SC8628)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line	NULL	2376	normal	P20263	secondary MEF cells	NULL
EXP050093	OCT4 (Santa Cruz, SC8628)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	P20263	V6.5 (embryonic stem cells)	NULL
EXP050094	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050095	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050096	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050097	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050098	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050099	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050100	MYC (Santa Cruz, sc 764)	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	P01108	secondary MEF cells	NULL
EXP050101	MYC (Santa Cruz, sc 764)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	P01108	V6.5 (embryonic stem cells)	NULL
EXP050102	MYC (Santa Cruz, sc 764)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	906	normal	P01108	induced pluripotent stem cells	NULL
EXP050103	MYC (Santa Cruz, sc 764)	Mus musculus	Genotype: Mbd3f/- cell line	NULL	595	normal	P01108	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050104	R&D AF3158	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050105	R&D AF3158	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050106	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050107	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050108	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050109	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050110	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050111	R&D AF3158	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line	NULL	2376	normal	Q60793	secondary MEF cells	NULL
EXP050112	R&D AF3158	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	Q60793	V6.5 (embryonic stem cells)	NULL
EXP050113	R&D AF3158	Mus musculus	Genotype: Mbd3f/- cell line	NULL	906	normal	Q60793	induced pluripotent stem cells	NULL
EXP050114	R&D AF3158	Mus musculus	Genotype: Mbd3f/- cell line	NULL	595	normal	Q60793	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050115	Millipore AB5603	Mus musculus	Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line 	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050116	Millipore AB5603	Mus musculus	Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050117	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050118	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050119	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050120	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050121	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050122	Millipore AB5603	Mus musculus	Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line	NULL	2376	normal	A1A546	secondary MEF cells	NULL
EXP050123	Millipore AB5603	Mus musculus	Genotype: Mbd3f/- cell line	NULL	252	normal	A1A546	V6.5 (embryonic stem cells)	NULL
EXP050124	Millipore AB5603	Mus musculus	Genotype: Mbd3f/- cell line	NULL	906	normal	A1A546	induced pluripotent stem cells	NULL
EXP050125	OCT4 (Santa Cruz, SC8628)	Mus musculus	Genotype: MBD3flox/- Treatment: DOX inducible OSKM reprogramming Title: reanalyzed for GSE49766 	NULL	595	normal	P20263	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050126	Rad21 (cat# Ab992)	Mus musculus	Sex: male Strain: Crl:CD1(ICR) (Charles River, strain code #022)	NULL	5	normal	Q61550	liver	NULL
EXP050127	Millipore anti CTCF (cat# 07-779)	Mus musculus	Sex: male Strain: Crl:CD1(ICR) (Charles River, strain code #022)	NULL	5	normal	Q61164	liver	NULL
EXP050128	NA	Mus musculus	Stable integrate: pBI-EGFP-FLAG-mCtcfl and pTA-N Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP050129	CTCF N2.2	Mus musculus	Stable integrate: N/A Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	NULL
EXP050130	CTCF N2.2	Mus musculus	Stable integrate: pBI-EGFP-FLAG-mCtcfl and pTA-N Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	NULL
EXP050131	CTCFL S6	Mus musculus	Stable integrate: N/A Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	A2APF3	NIH 3T3 (embryonic fibroblasts)	NULL
EXP050132	CTCFL S6	Mus musculus	Stable integrate: pBI-EGFP-FLAG-mCtcfl and pTA-N Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	NULL	675	normal	A2APF3	NIH 3T3 (embryonic fibroblasts)	NULL
EXP050133	CTCF N2.2	Mus musculus	Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	EXP050128	705	normal	Q61164	P19 (embryonic carcinoma)	NULL
EXP050134	CTCFL S6	Mus musculus	Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs	EXP050128	705	normal	A2APF3	P19 (embryonic carcinoma)	NULL
EXP050135	Prdm16 antibody R&D Systems (AF6295)	Mus musculus	Strain: C57BL6/J Developmental stage: 8 - 12 week 	NULL	2377	normal	A2A935	interscapular brown adipose	NULL
EXP050136	None	Mus musculus	Strain: C57BL/6 Treatment: culture conditions Stem cell (10ng/mL IL3, 10ng/mL IL6 100mg/mL SCF) for 7 days	NULL	2379	chip_control	NULL	line-bone marrow untransformed myeloid progenitors	NULL
EXP050137	None	Mus musculus	Genotype: HOXA9/MEIS1-transformed  Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow	NULL	2378	chip_control	NULL	HMM (HOXA9 transormed myeloblasts)	NULL
EXP050138	None	Mus musculus	Genotype: HOXA9 inactivation Treatment: culture conditions Myeloid (10ng/mL IL3) + 4OHT for 25 -31 days wash off Source: Lin- bone marrow 	NULL	2378	chip_control	NULL	HMM (HOXA9 transormed myeloblasts)	NULL
EXP050139	None	Mus musculus	Genotype: viral transduction Hoxa9/Meis1 Treatment: culture conditions B cell (5ng/mL IL7, 5ng/mL Flt3L) for 25 -31 days Source: Lin- bone marrow 	NULL	2380	chip_control	NULL	HMB (HOXA9 transformed proB lymphoblast)	NULL
EXP050140	None	Mus musculus	-	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP050141	None	Mus musculus	-	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP050142	C/EBP ? (Santa Cruz sc-61 X)	Mus musculus	Strain: C57BL/6 Treatment: Stem cell (10ng/mL IL3, 10ng/mL IL6 100mg/mL SCF) for 7 days	EXP050136	2379	normal	P53566	line-bone marrow untransformed myeloid progenitors	NULL
EXP050143	C/EBP ? (Santa Cruz sc-61 X)	Mus musculus	Genotype: HOXA9/MEIS1-transformed  Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow	EXP050137	2378	normal	P53566	HMM (HOXA9 transormed myeloblasts)	NULL
EXP050144	MLL4 #3 (Ge lab)	Mus musculus	Genotype: HOXA9/MEIS1-transformed  Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow	EXP050137	2378	normal	Q6PDK2	HMM (HOXA9 transormed myeloblasts)	NULL
EXP050145	C/EBP ? (Santa Cruz sc-61 X)	Mus musculus	Genotype: HOXA9 inactivation Treatment: culture conditions Myeloid (10ng/mL IL3) + 4OHT for 25 -31 days wash off Source: Lin- bone marrow 	EXP050138	2378	normal	P53566	HMM (HOXA9 transormed myeloblasts)	NULL
EXP050146	HA (Abcam ab9110	Mus musculus	Genotype: viral transduction Hoxa9/Meis1 Treatment: culture conditions B cell (5ng/mL IL7, 5ng/mL Flt3L) for 25 -31 days Source: Lin- bone marrow 	EXP050139	2380	normal	P09631	HMB (HOXA9 transformed proB lymphoblast)	NULL
EXP050147	none (input)	Mus musculus	Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow	NULL	2381	chip_control	NULL	Lin- BM derived DN1 cells	NULL
EXP050148	none (input)	Mus musculus	Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow	NULL	2381	chip_control	NULL	Lin- BM derived DN1 cells	NULL
EXP050149	none (input)	Mus musculus	Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+	NULL	2382	chip_control	NULL	Lin- BM derived DN3 cells	NULL
EXP050150	none (input)	Mus musculus	Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+	NULL	2382	chip_control	NULL	Lin- BM derived DN3 cells	NULL
EXP050151	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow	EXP050147	2381	normal	Q03347	Lin- BM derived DN1 cells	NULL
EXP050152	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow	EXP050148	2381	normal	Q03347	Lin- BM derived DN1 cells	NULL
EXP050153	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+	EXP050149	2382	normal	Q03347	Lin- BM derived DN3 cells	NULL
EXP050154	anti-Runx1 Abs (ab23980,Abcam)	Mus musculus	Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+	EXP050150	2382	normal	Q03347	Lin- BM derived DN3 cells	NULL
EXP050155	BRD4, Bethyl Labs A301-985A-100	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	Q9ESU6	hemogenic endothelium	NULL
EXP050156	BRD4, Bethyl Labs A301-985A-100	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	Q9ESU6	hemogenic endothelium	NULL
EXP050157	CDK9, Santa Cruz sc8338X	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	Q99J95	hemogenic endothelium	NULL
EXP050158	CDK9, Santa Cruz sc8338X	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	Q99J95	hemogenic endothelium	NULL
EXP050159	CDK9, Santa Cruz sc8338X	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX and JQ1	NULL	868	normal	Q99J95	hemogenic endothelium	NULL
EXP050160	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	P26323	hemogenic endothelium	NULL
EXP050161	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: JQ1, no DOX, uniduced 	NULL	868	normal	P26323	hemogenic endothelium	NULL
EXP050162	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	P26323	hemogenic endothelium	NULL
EXP050163	FLI1, Santa Cruz sc356	Mus musculus	Strain: 129P2/OlaHsd Treatment: JQ1, induced by treatment with DOX 	NULL	868	normal	P26323	hemogenic endothelium	NULL
EXP050164	HA (for RUNX1), Sigma H6908	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	Q03347	hemogenic endothelium	NULL
EXP050165	HA (for RUNX1), Sigma H6908	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	Q03347	hemogenic endothelium	NULL
EXP050166	HA (for RUNX1), Sigma H6908	Mus musculus	Strain: 129P2/OlaHsd Treatment: JQ1, induced by treatment with DOX 	NULL	868	normal	Q03347	hemogenic endothelium	NULL
EXP050167	Ldb1, Abcam ab96799	Mus musculus	Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced 	NULL	868	normal	P70662	hemogenic endothelium	NULL
EXP050168	Ldb1, Abcam ab96799	Mus musculus	Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX	NULL	868	normal	P70662	hemogenic endothelium	NULL
EXP050169	none	Mus musculus	Treatment: mock treated Strain: C57BL/6N Genotype: mESHA-Tet1	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP050170	none	Mus musculus	Treatment: treated with RNAse H1 Strain: C57BL/6N Genotype: mESHA-Tet1	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP050171	anti-HA (Abcam ab9111)	Mus musculus	Treatment: mock treated Strain: C57BL/6N Genotype: mESHA-Tet1	EXP050169	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP050172	anti-HA (Abcam ab9111)	Mus musculus	Treatment: treated with RNAse H1 Strain: C57BL/6N Genotype: mESHA-Tet1	EXP050170	2	normal	Q3URK3	mESCs (mouse embryonic stem cells)	NULL
EXP050173	Dlx1 made by Bora Lee	Mus musculus	Tissue: mouse hypothalamus	NULL	2383	chip_control	NULL	E16 mouse emryo brain	NULL
EXP050174	Dlx1 made by Bora Lee	Mus musculus	Tissue: mouse hypothalamus	EXP050173	2383	normal	Q64317	E16 mouse emryo brain	NULL
EXP050175	homemade anti-Tbx4 (1695a)	Mus musculus	Strain: CD1 Tissue: hindlimb Source: e11.5 HL-buds Genotype: wildtype	NULL	995	normal	P70325	E11.5 hindlimb	NULL
EXP050176	Hoxc10 (ab153904, AbCam)	Mus musculus	Strain: CD1 Tissue: hindlimb Source: e11.5 HL-buds Genotype: wildtype	NULL	995	normal	P31257	E11.5 hindlimb	NULL
EXP050177	HoxC10(L-17) (sc-33003, Santa Cruz, Lot L1015)	Mus musculus	Strain: CD1 Tissue: hindlimb Source: e11.5 HL-buds Genotype: wildtype	NULL	995	normal	P31257	E11.5 hindlimb	NULL
EXP050178		Mus musculus	Strain: C57BL/6 Treatment: no Source: Pooled heart Age: 12 week old Sex: male	NULL	53	chip_control	NULL	heart	NULL
EXP050179	anti-ANP32e (Abcam ab5993)	Mus musculus	Strain: C57BL/6 Treatment: Sham Source: normal heart Age: 12 week old Sex: male	EXP050178	53	normal	P97822	heart	NULL
EXP050180	anti-ANP32e (Abcam ab5993)	Mus musculus	Strain: C57BL/6 Treatment: Transaortic coarctation (TAC) for 4days Source: Hypertrophied heart Age: 12 week old Sex: male	EXP050178	53	normal	P97822	heart	NULL
EXP050181	IgG	Mus musculus	Source: pancreas Genotype: KDM6A wildtype Treatment: noneSex: female	NULL	2385	chip_control	NULL	Cell line established from K6A murine pancreatic cancer	NULL
EXP050182	KDM6A	Mus musculus	Source: pancreas Genotype: KDM6A knockout Treatment: noneSex: female	EXP050181	2385	normal	O70546	Cell line established from K6A murine pancreatic cancer	NULL
EXP050183	KDM6A	Mus musculus	Source: pancreas Genotype: KDM6A wildtype Treatment: noneSex: female	EXP050181	2385	normal	O70546	Cell line established from K6A murine pancreatic cancer	NULL
EXP050184	KMT2D	Mus musculus	Source: pancreas Genotype: KDM6A knockout Treatment: noneSex: female	EXP050181	2385	normal	Q6PDK2	Cell line established from K6A murine pancreatic cancer	NULL
EXP050185	KMT2D	Mus musculus	Source: pancreas Genotype: KDM6A wildtype Treatment: noneSex: female	EXP050181	2385	normal	Q6PDK2	Cell line established from K6A murine pancreatic cancer	NULL
EXP050186	anti-L3mbtl1	Mus musculus	Treatment: no Developmental stage: post natal 7-8 days Strain: C57BL6/129 Genotype: wildtype	NULL	987	normal	A2A5N8	hippocampus	NULL
EXP050187	anti-L3mbtl1	Mus musculus	Treatment: no Developmental stage: post natal 7-8 days Strain: C57BL6/129 Genotype: L3mbtl1-/- (L3mbtl1 knockout))	NULL	987	normal	A2A5N8	hippocampus	NULL
EXP050188	none	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	NULL	523	chip_control	NULL	kidney	NULL
EXP050189	none	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	NULL	523	chip_control	NULL	kidney	NULL
EXP050190	none	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	NULL	523	chip_control	NULL	kidney	NULL
EXP050191	ERRg antibody	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	EXP050188	523	normal	P62509	kidney	NULL
EXP050192	ERRg antibody	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	EXP050189	523	normal	P62509	kidney	NULL
EXP050193	HNF1b antibody	Mus musculus	Strain: C57BL/6 Age: 2-3 months 	EXP050190	523	normal	P27889	kidney	NULL
EXP050194	none	Mus musculus	Treatment: sham Age: 6-8 weeks Strain: C57BL/6	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050195	none	Mus musculus	Treatment: sham Age: 6-8 weeks Strain: C57BL/6	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050196	none	Mus musculus	Treatment: sciatic nerve injury Age 6-8 weels Strain: C57BL/6	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050197	none	Mus musculus	Treatment: sciatic nerve injury Age 6-8 weels Strain: C57BL/6	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050198	none	Mus musculus	Treatment: laminectomy Age: 6-8 weeks old Strain: C57BL/6	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050199	none	Mus musculus	Treatment: laminectomy Age: 6-8 weeks old Strain: C57BL/6	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050200	none	Mus musculus	Treatment: spinal cord dorsal column injury Age: 6-8 weeks Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050201	none	Mus musculus	Treatment: spinal cord dorsal column injury Age: 6-8 weeks Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050202	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sham Age: 6-8 weeks Strain: C57BL/6	EXP050194	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050203	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sham Age: 6-8 weeks Strain: C57BL/6	EXP050195	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050204	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sciatic nerve injury Age 6-8 weels Strain: C57BL/6	EXP050196	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050205	HDAC3 Millipore 17-10238	Mus musculus	Treatment: sciatic nerve injury Age 6-8 weels Strain: C57BL/6	EXP050197	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050206	HDAC3 Millipore 17-10238	Mus musculus	Treatment: laminectomy Age: 6-8 weeks old Strain: C57BL/6	EXP050198	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050207	HDAC3 Millipore 17-10238	Mus musculus	Treatment: laminectomy Age: 6-8 weeks old Strain: C57BL/6	EXP050199	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050208	HDAC3 Millipore 17-10238	Mus musculus	Treatment: spinal cord dorsal column injury Age: 6-8 weeks Strain: C57BL/6 	EXP050200	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050209	HDAC3 Millipore 17-10238	Mus musculus	Treatment: spinal cord dorsal column injury Age: 6-8 weeks Strain: C57BL/6 	EXP050201	2387	normal	O88895	DRG (Dorsal Root Ganglia)	NULL
EXP050210	RAR (Santa Cruz sc-773X, Lot. B2414)	Mus musculus	Genotype: wildtype Strain: CD1	NULL	2388	normal	P11416	E11.5 proximal forelimb buds	NULL
EXP050211	RAR (Santa Cruz sc-773X, Lot. B2414)	Mus musculus	Genotype: wildtype Strain: CD1	NULL	2389	normal	P11416	E11.5 distal forelimb buds	NULL
EXP050212	input	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050213	input	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050214	input	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050215	input	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050216	input	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050217	input	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	NULL	2387	chip_control	NULL	DRG (Dorsal Root Ganglia)	NULL
EXP050218	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	EXP050212	2387	normal	P05627	DRG (Dorsal Root Ganglia)	NULL
EXP050219	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	EXP050213	2387	normal	P05627	DRG (Dorsal Root Ganglia)	NULL
EXP050220	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 	EXP050214	2387	normal	P05627	DRG (Dorsal Root Ganglia)	NULL
EXP050221	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	EXP050215	2387	normal	P05627	DRG (Dorsal Root Ganglia)	NULL
EXP050222	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	EXP050216	2387	normal	P05627	DRG (Dorsal Root Ganglia)	NULL
EXP050223	c-Jun (H-79)sc-1694X	Mus musculus	Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 	EXP050217	2387	normal	P05627	DRG (Dorsal Root Ganglia)	NULL
EXP050224	none	Mus musculus	Strain: C57BL/6 Tissue: spleen 	NULL	2390	chip_control	NULL	Treg (regulatory T cells)	NULL
EXP050225	none	Mus musculus	Strain: C57BL/6 Tissue: spleen 	NULL	2390	chip_control	NULL	Treg (regulatory T cells)	NULL
EXP050226	KAP1(active motif, 1Tb-A9)	Mus musculus	Strain: C57BL/6 Tissue: spleen 	EXP050224	2390	normal	Q62318	Treg (regulatory T cells)	NULL
EXP050227	KAP1(active motif, 1Tb-A9)	Mus musculus	Strain: C57BL/6 Tissue: spleen 	EXP050225	2390	normal	Q62318	Treg (regulatory T cells)	NULL
EXP050228	NELF-A	Mus musculus	Treatment: MEFs were treated with 2 uM 4-HT for 72h Tissue: primary mouse embryonic fibroblasts Genotype: wildtype (Rosa26ERT2-cre/+)	NULL	595	normal	Q8BG30	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050229	NELF-A	Mus musculus	Treatment: MEFs were treated with 2 uM 4-HT for 72h Tissue: primary mouse embryonic fibroblasts Genotype: Supt5hFl/- Rosa26ERT2-cre/+	NULL	595	normal	Q8BG30	MEF-1 (mouse embryonic fibroblasts)	NULL
EXP050230	none	Mus musculus	Source: Neural progenitor cells expressing no ectopic gene 	NULL	2391	chip_control	NULL	differentiated neural progenitor cells	NULL
EXP050231	none	Mus musculus	Treatment: transgene of Srf was introduced retrovirally Source: Neural progenitor cells overexpressing Srf	NULL	2391	chip_control	NULL	differentiated neural progenitor cells	NULL
EXP050232	none	Mus musculus	Source: Hepatoblasts (expressing no ectopic gene) 	NULL	2392	chip_control	NULL	fetal liver	NULL
EXP050233	anti-SRF antibody (clone D71A9; Cell Signaling Technology)	Mus musculus	Source: Neural progenitor cells expressing no ectopic gene 	EXP050230	2391	normal	Q9JM73	differentiated neural progenitor cells	NULL
EXP050234	anti-SRF antibody (clone D71A9; Cell Signaling Technology)	Mus musculus	Treatment: transgene of Srf was introduced retrovirally Source: Neural progenitor cells overexpressing Srf	EXP050231	2391	normal	Q9JM73	differentiated neural progenitor cells	NULL
EXP050235	anti-SRF antibody (clone D71A9; Cell Signaling Technology)	Mus musculus	Source: Hepatoblasts (expressing no ectopic gene) 	EXP050232	2392	normal	Q9JM73	fetal liver	NULL
EXP050236	none	Mus musculus	Strain: C57BL/6N Sex: male	NULL	5	chip_control	NULL	liver	NULL
EXP050237	none	Mus musculus	Strain: C57BL/6N Sex: male	NULL	5	chip_control	NULL	liver	NULL
EXP050238	none	Mus musculus	Strain: C57BL/6N Sex: male	NULL	5	chip_control	NULL	liver	NULL
EXP050239	none	Mus musculus	Strain: C3H/HeN Sex: male	NULL	5	chip_control	NULL	liver	NULL
EXP050240	none	Mus musculus	Strain: C3H/HeN Sex: male	NULL	5	chip_control	NULL	liver	NULL
EXP050241	none	Mus musculus	Strain: C3H/HeN Sex: male	NULL	5	chip_control	NULL	liver	NULL
EXP050242	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C57BL/6N Sex: male	EXP050236	5	normal	P35582	liver	NULL
EXP050243	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C57BL/6N Sex: male	EXP050237	5	normal	P35582	liver	NULL
EXP050244	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C57BL/6N Sex: male	EXP050238	5	normal	P35582	liver	NULL
EXP050245	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C3H/HeN Sex: male	EXP050239	5	normal	P35582	liver	NULL
EXP050246	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C3H/HeN Sex: male	EXP050240	5	normal	P35582	liver	NULL
EXP050247	FOXA1 (abcam, ab5089)	Mus musculus	Strain: C3H/HeN Sex: male	EXP050241	5	normal	P35582	liver	NULL
EXP050248	none	Mus musculus	Strain: C57BL6/J Treatment: cultured for 5 days, on Day5, cells were re-stimulated with a-CD3 for 5hours and collected	NULL	2393	chip_control	NULL	CD4+ T helper 9	NULL
EXP050249	none	Mus musculus	Strain: C57BL6/J Treatment: cultured for 5 days, on Day5, cells were re-stimulated with a-CD3 for 5hours and collected	NULL	2393	chip_control	NULL	CD4+ T helper 9	NULL
EXP050250	SC-584X and SC-585X (santa cruz)	Mus musculus	Strain: C57BL6/J Treatment: cultured for 5 days, on Day5, cells were re-stimulated with a-CD3 for 5hours and collected	EXP050248	2393	normal	B2RWS6	CD4+ T helper 9	NULL
EXP050251	SC-584X and SC-585X (santa cruz)	Mus musculus	Strain: C57BL6/J Treatment: cultured for 5 days, on Day5, cells were re-stimulated with a-CD3 for 5hours and collected	EXP050249	2393	normal	B2RWS6	CD4+ T helper 9	NULL
EXP050252	none	Mus musculus	Passage: 30 -32 Strain: C3H Tissue: Skeletal muscle	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP050253	HDAC4 (Santa Cruz, sc-11418)	Mus musculus	Passage: 30 -32 Strain: C3H Tissue: Skeletal muscle	EXP050252	1153	normal	Q6NZM9	C2C12 (myoblasts)	NULL
EXP050254	input	Mus musculus	72 hours after 4-OHT treatment	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP050255	input	Mus musculus	24 hours after 4-OHT treatment	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP050256	input	Mus musculus	CD19+ stage after 4-OHT treatment	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP050257	BioGenes 1C	Mus musculus	72 hours after 4-OHT treatment	EXP050254	198	normal	Q07802	pre-pro-B-cells	NULL
EXP050258	BioGenes 1C	Mus musculus	24 hours after 4-OHT treatment	EXP050255	198	normal	Q07802	pre-pro-B-cells	NULL
EXP050259	BioGenes 1C	Mus musculus	CD19+ stage after 4-OHT treatment	EXP050256	105	normal	Q07802	pro-B cells	NULL
EXP050260	input	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	NULL	2394	chip_control	NULL	CD8-positive dendritic cells	NULL
EXP050261	input	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	NULL	2394	chip_control	NULL	CD8-positive dendritic cells	NULL
EXP050262	input	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	NULL	2394	chip_control	NULL	CD8-positive dendritic cells	NULL
EXP050263	input	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	NULL	2394	chip_control	NULL	CD8-positive dendritic cells	NULL
EXP050264	input	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	NULL	2394	chip_control	NULL	CD8-positive dendritic cells	NULL
EXP050265	input	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	NULL	2394	chip_control	NULL	CD8-positive dendritic cells	NULL
EXP050266	cREL (sc-71x)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	Q91XD7	CD8-positive dendritic cells	NULL
EXP050267	cREL (sc-71x)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	Q91XD7	CD8-positive dendritic cells	NULL
EXP050268	cREL (sc-71x)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	Q91XD7	CD8-positive dendritic cells	NULL
EXP050269	IRF3 (Cell Signalling Technology, D83B9, no. 4302)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P70671	CD8-positive dendritic cells	NULL
EXP050270	IRF3 (Cell Signalling Technology, D83B9, no. 4302)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P70671	CD8-positive dendritic cells	NULL
EXP050271	IRF3 (Cell Signalling Technology, D83B9, no. 4302)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P70671	CD8-positive dendritic cells	NULL
EXP050272	IRF5 (Abcam ab21689)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P56477	CD8-positive dendritic cells	NULL
EXP050273	IRF5 (Abcam ab21689)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P56477	CD8-positive dendritic cells	NULL
EXP050274	IRF5 (Abcam ab21689)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P56477	CD8-positive dendritic cells	NULL
EXP050275	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P23611	CD8-positive dendritic cells	NULL
EXP050276	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050261	2394	normal	P23611	CD8-positive dendritic cells	NULL
EXP050277	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P23611	CD8-positive dendritic cells	NULL
EXP050278	IRF8 (sc-6058)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050263	2394	normal	P23611	CD8-positive dendritic cells	NULL
EXP050279	IRF8 (sc-6058)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P23611	CD8-positive dendritic cells	NULL
EXP050280	IRF8 (sc-6058)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050265	2394	normal	P23611	CD8-positive dendritic cells	NULL
EXP050281	JUNB (sc-46x)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P09450	CD8-positive dendritic cells	NULL
EXP050282	JUNB (sc-46x)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P09450	CD8-positive dendritic cells	NULL
EXP050283	JUNB (sc-46x)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P09450	CD8-positive dendritic cells	NULL
EXP050284	p300 (sc-585)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	B2RWS6	CD8-positive dendritic cells	NULL
EXP050285	p300 (sc-585)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050261	2394	normal	B2RWS6	CD8-positive dendritic cells	NULL
EXP050286	p300 (sc-585)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	B2RWS6	CD8-positive dendritic cells	NULL
EXP050287	p300 (sc-585)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050263	2394	normal	B2RWS6	CD8-positive dendritic cells	NULL
EXP050288	p300 (sc-585)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	B2RWS6	CD8-positive dendritic cells	NULL
EXP050289	p300 (sc-585)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050265	2394	normal	B2RWS6	CD8-positive dendritic cells	NULL
EXP050290	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	O35295	CD8-positive dendritic cells	NULL
EXP050291	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050261	2394	normal	O35295	CD8-positive dendritic cells	NULL
EXP050292	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	O35295	CD8-positive dendritic cells	NULL
EXP050293	PU.1 (sc-352)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050263	2394	normal	O35295	CD8-positive dendritic cells	NULL
EXP050294	PU.1 (sc-352)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	O35295	CD8-positive dendritic cells	NULL
EXP050295	PU.1 (sc-352)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050265	2394	normal	O35295	CD8-positive dendritic cells	NULL
EXP050296	STAT1 (sc-346)	Mus musculus	Treatment: 90 min, 1 mM class B CpG oligonucleotide (1826) Source: dendritic cells from the spleen	EXP050260	2394	normal	P42225	CD8-positive dendritic cells	NULL
EXP050297	STAT1 (sc-346)	Mus musculus	Treatment: 90 min, 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) Source: dendritic cells from the spleen	EXP050262	2394	normal	P42225	CD8-positive dendritic cells	NULL
EXP050298	STAT1 (sc-346)	Mus musculus	Treatment: untreated Source: dendritic cells from the spleen	EXP050262	2394	normal	P42225	CD8-positive dendritic cells	NULL
EXP050299	BioGenes 1C	Mus musculus	6 hrs after doxycycline treatment	NULL	198	normal	Q07802	pre-pro-B-cells	NULL
EXP050300	input	Mus musculus	Genotype:  Ebf1-/- Treatment: B cell progenitors  were transduced with a Tet-on Pax5 inducible expression retroviral construc, the transduced cells were treated with 1ug/ml doxycycline to initate Pax5 expression, cells were harvested 6 hours after treatment 	NULL	2395	chip_control	NULL	Ebf1-deficient B cell progenitors	NULL
EXP050301	input	Mus musculus	Genotype: Ebf1-/-  Treatment: RERTCre B cell progenitors were transduced with a Cre-based inducible EBF1 expression retroviral construct, the transduced cells were treated with 2uM 4-hydroxy-tamoxifen (4-OHT) to initiate EBF1 expression for 5days	NULL	2395	chip_control	NULL	Ebf1-deficient B cell progenitors	NULL
EXP050302	Pax5 (sc-1974X0	Mus musculus	Genotype:  Ebf1-/- Treatment: B cell progenitors  were transduced with a Tet-on Pax5 inducible expression retroviral construc, the transduced cells were treated with 1ug/ml doxycycline to initate Pax5 expression, cells were harvested 6 hours after treatment 	EXP050300	2395	normal	Q02650	Ebf1-deficient B cell progenitors	NULL
EXP050303	Pax5 (sc-1974X0	Mus musculus	Genotype: Ebf1-/-  Treatment: RERTCre B cell progenitors were transduced with a Cre-based inducible EBF1 expression retroviral construct, the transduced cells were treated with 2uM 4-hydroxy-tamoxifen (4-OHT) to initiate EBF1 expression for 5days	EXP050301	2395	normal	Q02650	Ebf1-deficient B cell progenitors	NULL
EXP050304	none	Mus musculus	Strain: 129/FVB Genotype: wildtype	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP050305	none	Mus musculus	Strain: 129/FVB Genotype: wildtype	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP050306	none	Mus musculus	Strain: 129/FVB Genotype: wildtype	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP050307	none	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP050308	none	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP050309	none	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP050310	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: wildtype	EXP050304	965	normal	Q9Z2D6	frontal cortex	NULL
EXP050311	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: wildtype	EXP050305	965	normal	Q9Z2D6	frontal cortex	NULL
EXP050312	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: wildtype	EXP050306	965	normal	Q9Z2D6	frontal cortex	NULL
EXP050313	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	EXP050307	965	normal	Q9Z2D6	frontal cortex	NULL
EXP050314	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	EXP050308	965	normal	Q9Z2D6	frontal cortex	NULL
EXP050315	MeCP2 (Millipore, #17-10491)	Mus musculus	Strain: 129/FVB Genotype: Cam-tTA:Fl-H1.0	EXP050309	965	normal	Q9Z2D6	frontal cortex	NULL
EXP050316	none (Input)	Mus musculus	Developmental stage: round spermatids Genotyp: wildtype Tissue: testis  	NULL	2397	chip_control	NULL	germ cells	NULL
EXP050317	Sox30 (Abclonal, A11715)	Mus musculus	Developmental stage: round spermatids Genotyp: wildtype Tissue: testis  	EXP050316	2397	normal	Q8CGW4	germ cells	NULL
EXP050318	Sox30 (Abclonal, A11715)	Mus musculus	Developmental stage: round spermatids Genotyp: Sox30 knock out by FRT/FRT Tissue: testis  	EXP050316	2397	normal	Q8CGW4	germ cells	NULL
EXP050319	Sox30 (Abclonal, A11715)	Mus musculus	Developmental stage: round spermatids Genotyp: Sox30 global knock out Tissue: testis  	EXP050316	2397	normal	Q8CGW4	germ cells	NULL
EXP050320	none	Mus musculus	Genotype: Tetracycline-inducible YAPS127A Strain: Camargo et al Curr Biol. 2007 Dec 4;17(23):2054-60 	NULL	2392	chip_control	NULL	fetal liver	NULL
EXP050321	anti-YAP (Cell Signaling 14074)	Mus musculus	Genotype: Tetracycline-inducible YAPS127A Strain: Camargo et al Curr Biol. 2007 Dec 4;17(23):2054-60 	EXP050320	2392	normal	P46938	fetal liver	NULL
EXP050322	anti-TEAD4 (Abcam ab58310)	Mus musculus	Genotype: Tetracycline-inducible YAPS127A Strain: Camargo et al Curr Biol. 2007 Dec 4;17(23):2054-60 	EXP050320	2392	normal	Q62296	fetal liver	NULL
EXP050323	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: wildtype Strain: 129/sv	NULL	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	NULL
EXP050324	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: NFAT5 knockout Strain: 129/sv	NULL	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	NULL
EXP050325	Input total chromatin sample without immunoprecipitation	Mus musculus	Genotype: wildtype Strain: 129/sv 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050326	Input total chromatin sample without immunoprecipitation	Mus musculus	Genotype: NFAT5 knockout Strain: 129/sv 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050327	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: wildtype Strain: 129/sv 	EXP050325	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	NULL
EXP050328	anti-NFAT5 antibodies were a mixture of two rabbit polyclonal antibodies to the amino-terminal or DNA binding domain regions of NFAT5	Mus musculus	Genotype: NFAT5 knockout Strain: 129/sv 	EXP050326	81	normal	Q9WV30	BMDM (bone marrow-derived macrophages)	NULL
EXP050329	-	Mus musculus	Genotype: wildtype Treatment: untreated	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050330	-	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 1 hr	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050331	-	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 6 hrs	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050332	-	Mus musculus	Genotype: wildtype Treatment: untreated	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050333	-	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 1 hr	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050334	-	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 6 hrs	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050335	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: untreated	EXP050329	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP050336	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 1 hr	EXP050330	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP050337	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 6 hrs	EXP050331	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP050338	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: untreated	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP050339	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 1 hr	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP050340	Rad21 (Abcam ab992)	Mus musculus	Genotype: wildtype Treatment: LPS treatment (10ng/ml) at 6 hrs	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP050341	none	Mus musculus	Treatment: no Strain: Balb/c	NULL	2399	chip_control	NULL	EWS-FLI1-induced murine Ewing sarcoma cells	NULL
EXP050342	FLAG (Sigma, F7425, lot 085M4774V)	Mus musculus	Treatment: no Strain: Balb/c	EXP050341	2399	normal	P26323	EWS-FLI1-induced murine Ewing sarcoma cells	NULL
EXP050343	input DNA	Mus musculus	Treatment: Zeitgeber Time 4 Strain: C57BL/6J Sex: male Genotype: wildtype	NULL	2400	chip_control	NULL	gastrocnemius	NULL
EXP050344	Bmal1 (ab93806; LOT: GR279846-2)	Mus musculus	Treatment: Zeitgeber Time 4 Strain: C57BL/6J Sex: male Genotype: wildtype	EXP050343	2400	normal	Q9WTL8	gastrocnemius	NULL
EXP050345	Rev-erb? (#23678 and #27401 produced by Ron Evans)	Mus musculus	Treatment: Zeitgeber Time 8 Strain: C57BL/6J Sex: male Genotype: wildtype	EXP050343	2400	normal	Q3UV55	gastrocnemius	NULL
EXP050346	input	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: wildtype	NULL	2401	chip_control	NULL	lung epithelial cells	NULL
EXP050347	input	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression and Nkx2-1 deletion	NULL	2401	chip_control	NULL	lung epithelial cells	NULL
EXP050348	input	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression	NULL	2401	chip_control	NULL	lung epithelial cells	NULL
EXP050349	R&D normal goat IgG control (AB-108-C)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: wildtype	NULL	2401	chip_control	NULL	lung epithelial cells	NULL
EXP050350	R&D normal goat IgG control (AB-108-C)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression and Nkx2-1 deletion	NULL	2401	chip_control	NULL	lung epithelial cells	NULL
EXP050351	R&D normal goat IgG control (AB-108-C)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression	NULL	2401	chip_control	NULL	lung epithelial cells	NULL
EXP050352	R&D goat anti-Sox2 (AF2018)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: wildtype	EXP050346	2401	normal	P48432	lung epithelial cells	NULL
EXP050353	R&D goat anti-Sox2 (AF2018)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression and Nkx2-1 deletion	EXP050347	2401	normal	P48432	lung epithelial cells	NULL
EXP050354	R&D goat anti-Sox2 (AF2018)	Mus musculus	Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression	EXP050348	2401	normal	P48432	lung epithelial cells	NULL
EXP050355	none	Mus musculus	Strain: CD1 Genotype: wildtype	NULL	2402	chip_control	NULL	E10.0 cardiac tissue	NULL
EXP050356	none	Mus musculus	Strain: CD1 Genotype: wildtype	NULL	2402	chip_control	NULL	E10.0 cardiac tissue	NULL
EXP050357	Anti-CHD4 antibody [3F2/4] - ChIP Grade, Abcam, catalog# ab70469, mouse monoclonal	Mus musculus	Strain: CD1 Genotype: wildtype	EXP050355	2402	normal	Q6PDQ2	E10.0 cardiac tissue	NULL
EXP050358	Anti-CHD4 antibody [3F2/4] - ChIP Grade, Abcam, catalog# ab70469, mouse monoclonal	Mus musculus	Strain: CD1 Genotype: wildtype	EXP050356	2402	normal	Q6PDQ2	E10.0 cardiac tissue	NULL
EXP050359	none	Mus musculus	Source: late Th2 Genotype: wildtype 	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP050360	anti-Bcl11b (A300-385A-2) from Bethyl	Mus musculus	Source: late Th2 Genotype: wildtype 	EXP050359	499	normal	Q99PV8	Th2-cells	NULL
EXP050361	anti-GATA3 (L50-823) from BD Biosciences	Mus musculus	Source: late Th2 Genotype: wildtype 	EXP050359	499	normal	P23772	Th2-cells	NULL
EXP050362	none (input)	Mus musculus	Treatment: untrated Age: 8-12 weeks Sex: male Strain: C57BL/6	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050363	none (input)	Mus musculus	Treatment: untreated Age: 8-12 weeks Sex: male Strain: C57BL/6	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP050364	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS for 0hr Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	NULL
EXP050365	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS for 1hr Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	NULL
EXP050366	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS for 3hrs Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	NULL
EXP050367	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/ml LPS+ 100 nM Dex  for 1hr Sex: male Strain: C57BL/6 	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	NULL
EXP050368	BRD4 (Abcam, ab84776)	Mus musculus	Treatment: 10 ng/ml LPS for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6 	NULL	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP050369	BRD4 (Abcam, ab84776)	Mus musculus	Treatment: 10 ng/ml LPS + 100 nM dexfor  45 minutes Age: 8-12 weeks Sex: male  Strain: C57BL/6	NULL	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP050370	BRD4 (Abcam, ab84776)	Mus musculus	Treatment: 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	NULL	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP050371	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP050372	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: 100 nM LPS for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP050373	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: 10 ng/ml LPS + 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP050374	GR (Santa Cruz Biotech, sc-1004X)	Mus musculus	Treatment: untrated Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050362	81	normal	P06537	BMDM (bone marrow-derived macrophages)	NULL
EXP050375	NELF-E (Proteintech, 10705-1-AP)	Mus musculus	Treatment: 10 ng/mL LPS for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	NULL	81	normal	P19426	BMDM (bone marrow-derived macrophages)	NULL
EXP050376	p65 (Santa Cruz Biotech, sc-372X)	Mus musculus	Treatment: 10 ng/mL + 100 nM Dex for  45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050363	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP050377	p65 (Santa Cruz Biotech, sc-372X)	Mus musculus	Treatment: untreated Age: 8-12 weeks Sex: male Strain: C57BL/6	EXP050363	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP050378	Non specific IgG (control) PreImmune Affinity purified.	Mus musculus	CSF1 only	NULL	2396	chip_control	NULL	bone marrow myeloid cells	NULL
EXP050379	PU.1 antibody; In lab described in PMID:17403683	Mus musculus	CSF1 only	EXP050378	2396	normal	P17433	bone marrow myeloid cells	NULL
EXP050380	PU.1 antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 36h	EXP050378	2396	normal	P17433	bone marrow myeloid cells	NULL
EXP050381	PU.1 antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 72h	EXP050378	2396	normal	P17433	bone marrow myeloid cells	NULL
EXP050382	MITF antibody; In lab described in PMID:17403683	Mus musculus	CSF1 only	EXP050378	2396	normal	Q08874	bone marrow myeloid cells	NULL
EXP050383	MITF antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 36h	EXP050378	2396	normal	Q08874	bone marrow myeloid cells	NULL
EXP050384	MITF antibody; In lab described in PMID:17403683	Mus musculus	CSF1 and RANKL for 72h	EXP050378	2396	normal	Q08874	bone marrow myeloid cells	NULL
EXP050385		Mus musculus		NULL	2403	chip_control	NULL	TS-Rs26 (Mouse trophoblast stem cells)	NULL
EXP050386		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	NULL
EXP050387		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	NULL
EXP050388		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	NULL
EXP050389		Mus musculus		EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	NULL
EXP050390		Mus musculus	Tet1 -/-	EXP050385	2403	normal	Q3URK3	TS-Rs26 (Mouse trophoblast stem cells)	NULL
EXP050391	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible WT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP050392	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible WT EED rescue 36hr Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP050393	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible MT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP050394	HA-tag,Abcam,ab9110	Mus musculus	Genotype: inducible MT EED rescue 36hrs Strain: C57BL/6	NULL	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP050395	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050396	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 36hr Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050397	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible MT EED rescue 12hr Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050398	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible MT EED rescue 36hrs Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050399	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, JARID2/MTF2 WT Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050400	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, JARID2 knockout Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050401	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050402	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 12hr, JARID2/MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050403	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, JARID2/MTF2 WT Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050404	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, JARID2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050405	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050406	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 24hr, JARID2/MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050407	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8 days, JARID2/MTF2 WT Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050408	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8 days, MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050409	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8 days, JARID2/MTF2 knockout  Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP050410	none	Mus musculus	Strain: C3H 	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP050411	p300 (Santa Cruz_sc-584)	Mus musculus	Strain: C3H Cell type: proliferating myoblasts	EXP050410	1153	normal	B2RWS6	C2C12 (myoblasts)	NULL
EXP050412	p300 (Santa Cruz_sc-584)	Mus musculus	Strain: C3H Cell type: differentiated myoblast for 24 hrs	EXP050410	1153	normal	B2RWS6	C2C12 (myoblasts)	NULL
EXP050413		Mus musculus	Genotype: B220+CD19+CD43-CD25+IgM- Age: 3 months Tissue: bone marrow Strain: C57BL/6  	NULL	2404	chip_control	NULL	flow sorted pre-B cells	NULL
EXP050414		Mus musculus	Genotype: B220+CD19+CD43-CD25+IgM- Age: 18 -22  months Tissue: bone marrow Strain: C57BL/6  	NULL	2404	chip_control	NULL	flow sorted pre-B cells	NULL
EXP050415	CTCF (Millipore 07-729)	Mus musculus	Genotype: B220+CD19+CD43-CD25+IgM- Age: 3 months Tissue: bone marrow Strain: C57BL/6  	EXP050413	2404	normal	Q61164	flow sorted pre-B cells	NULL
EXP050416	CTCF (Millipore 07-729)	Mus musculus	Genotype: B220+CD19+CD43-CD25+IgM- Age: 18 -22  months Tissue: bone marrow Strain: C57BL/6  	EXP050414	2404	normal	Q61164	flow sorted pre-B cells	NULL
EXP050417	none (input)	Mus musculus	Cell line: Rod_I_Y-8602 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050418	none (input)	Mus musculus	Cell line: Bipo_I_Y-rM0401 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050419	none (input)	Mus musculus	Cell line: Bipo_I_Y-rM0405 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050420	none (input)	Mus musculus	Cell line: Bipo_I_Y-208.03 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050421	none (input)	Mus musculus	Cell line: Bipo_I_Y-208.04 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050422	none (input)	Mus musculus	Cell line: Mull_I_Y-207.11 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050423	none (input)	Mus musculus	Cell line: Mull_M_Y-rCr33.01 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050424	none (input)	Mus musculus	Cell line: Mull_M_Y-rCr33.04 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050425	none (input)	Mus musculus	Cell line: Mull_M_Y-Cr143.01 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050426	none (input)	Mus musculus	Cell line: Mull_M_Y-263.08 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050427	none (input)	Mus musculus	Cell line: Amac_M_Y-30.02 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050428	none (input)	Mus musculus	Cell line: Cone_I_Y-209.11 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050429	none (input)	Mus musculus	Cell line: Cone_I_Y-209.12 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050430	none (input)	Mus musculus	Cell line: Cone_I_Y-209.13 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050431	none (input)	Mus musculus	Cell line: Cone_M_Y-257.03 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050432	none (input)	Mus musculus	Cell line: RodFibr_F_Y-FNR07 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050433	none (input)	Mus musculus	Cell line: Bipo_I_N-rM0408 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050434	none (input)	Mus musculus	Cell line: MullFibr_F_N-FCR01 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050435	none (input)	Mus musculus	Cell line: MullFibr_F_N-FCR02 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050436	none (input)	Mus musculus	Cell line: AmacFibr_F_N-fG140.02 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050437	none (input)	Mus musculus	Cell line: Mull_M_N-rCr33.05 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050438	none (input)	Mus musculus	Cell line: Mull_M_N-rCr263.4 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050439	none (input)	Mus musculus	Cell line: Cone_I_N-rCh209.04 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050440	none (input)	Mus musculus	Cell line: Mull_M_N-rCr143.02 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050441	none (input)	Mus musculus	Cell line: Amac_I_N-rG79.04 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050442	none (input)	Mus musculus	Cell line: Cone_M_N-rCh257.4 Strain: C57BL/6	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP050443	none (input)	Mus musculus	Cell line: CTCF-NRL-Rod_M_N-P21 Strain: C57BL/6	NULL	2405	chip_control	NULL	NRL-GFP sorted Rod cell postnatal day 21	NULL
EXP050444	none (input)	Mus musculus	Cell line: CTCF-NRL-Rod_M_N-P6 Strain: C57BL/6	NULL	2406	chip_control	NULL	NRL-GFP sorted Rod cell postnatal day 6	NULL
EXP050445	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Rod_I_Y-8602 Strain: C57BL/6	EXP050417	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050446	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-rM0401 Strain: C57BL/6	EXP050418	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050447	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-rM0405 Strain: C57BL/6	EXP050419	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050448	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-208.03 Strain: C57BL/6	EXP050420	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050449	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_Y-208.04 Strain: C57BL/6	EXP050421	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050450	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_I_Y-207.11 Strain: C57BL/6	EXP050422	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050451	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-rCr33.01 Strain: C57BL/6	EXP050423	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050452	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-rCr33.04 Strain: C57BL/6	EXP050424	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050453	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-Cr143.01 Strain: C57BL/6	EXP050425	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050454	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_Y-263.08 Strain: C57BL/6	EXP050426	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050455	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Amac_M_Y-30.02 Strain: C57BL/6	EXP050427	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050456	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_Y-209.11 Strain: C57BL/6	EXP050428	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050457	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_Y-209.12 Strain: C57BL/6	EXP050429	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050458	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_Y-209.13 Strain: C57BL/6	EXP050430	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050459	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_M_Y-257.03 Strain: C57BL/6	EXP050431	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050460	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: RodFibr_F_Y-FNR07 Strain: C57BL/6	EXP050432	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050461	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Bipo_I_N-rM0408 Strain: C57BL/6	EXP050433	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050462	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: MullFibr_F_N-FCR01 Strain: C57BL/6	EXP050434	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050463	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: MullFibr_F_N-FCR02 Strain: C57BL/6	EXP050435	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050464	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: AmacFibr_F_N-fG140.02 Strain: C57BL/6	EXP050435	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050465	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_N-rCr33.05 Strain: C57BL/6	EXP050437	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050466	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_N-rCr263.4 Strain: C57BL/6	EXP050438	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050467	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_I_N-rCh209.04 Strain: C57BL/6	EXP050439	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050468	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Mull_M_N-rCr143.02 Strain: C57BL/6	EXP050440	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050469	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Amac_I_N-rG79.04 Strain: C57BL/6	EXP050441	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050470	BRD4 (Bethyl,A301-985A)	Mus musculus	Cell line: Cone_M_N-rCh257.4 Strain: C57BL/6	EXP050442	906	normal	Q9ESU6	induced pluripotent stem cells	NULL
EXP050471	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Rod_I_Y-8602 Strain: C57BL/6	EXP050417	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050472	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-rM0401 Strain: C57BL/6	EXP050418	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050473	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-rM0405 Strain: C57BL/6	EXP050419	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050474	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-208.03 Strain: C57BL/6	EXP050420	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050475	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_Y-208.04 Strain: C57BL/6	EXP050421	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050476	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_I_Y-207.11 Strain: C57BL/6	EXP050422	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050477	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-rCr33.01 Strain: C57BL/6	EXP050423	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050478	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-rCr33.04 Strain: C57BL/6	EXP050424	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050479	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-Cr143.01 Strain: C57BL/6	EXP050425	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050480	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_Y-263.08 Strain: C57BL/6	EXP050426	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050481	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Amac_M_Y-30.02 Strain: C57BL/6	EXP050427	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050482	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_Y-209.11 Strain: C57BL/6	EXP050428	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050483	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_Y-209.12 Strain: C57BL/6	EXP050429	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050484	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_Y-209.13 Strain: C57BL/6	EXP050430	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050485	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_M_Y-257.03 Strain: C57BL/6	EXP050431	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050486	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: RodFibr_F_Y-FNR07 Strain: C57BL/6	EXP050432	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050487	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Bipo_I_N-rM0408 Strain: C57BL/6	EXP050433	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050488	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: MullFibr_F_N-FCR01 Strain: C57BL/6	NULL	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050489	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: MullFibr_F_N-FCR02 Strain: C57BL/6	EXP050435	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050490	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: AmacFibr_F_N-fG140.02 Strain: C57BL/6	EXP050435	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050491	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_N-rCr33.05 Strain: C57BL/6	EXP050437	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050492	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_N-rCr263.4 Strain: C57BL/6	EXP050438	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050493	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_I_N-rCh209.04 Strain: C57BL/6	EXP050439	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050494	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Mull_M_N-rCr143.02 Strain: C57BL/6	EXP050440	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050495	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Amac_I_N-rG79.04 Strain: C57BL/6	EXP050441	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050496	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: Cone_M_N-rCh257.4 Strain: C57BL/6	EXP050442	906	normal	Q61164	induced pluripotent stem cells	NULL
EXP050497	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: CTCF-NRL-Rod_M_N-P21 Strain: C57BL/6	EXP050443	2405	normal	Q61164	NRL-GFP sorted Rod cell postnatal day 21	NULL
EXP050498	CTCF (ActiveMotif,61311)	Mus musculus	Cell line: CTCF-NRL-Rod_M_N-P6 Strain: C57BL/6	EXP050444	2406	normal	Q61164	NRL-GFP sorted Rod cell postnatal day 6	NULL
EXP050499		Mus musculus	Cell ctatus: differentiating Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 48 hours.	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP050500		Mus musculus	Cell ctatus: differentiating Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 120 hours	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP050501	Anti-LSD1 polyclonal antibody (Abcam: ab177721)	Mus musculus	Cell ctatus: differentiating Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 48 hours	EXP050499	1153	normal	Q6ZQ88	C2C12 (myoblasts)	NULL
EXP050502	Anti-LSD1 polyclonal antibody (Abcam: ab177721)	Mus musculus	Cell ctatus: differentiating Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 120 hours	EXP050500	1153	normal	Q6ZQ88	C2C12 (myoblasts)	NULL
EXP050503	Input	Mus musculus	Treatment: untreated Sex: male Strain: C57BL/6 Age: 28 days 	NULL	5	chip_control	NULL	liver	NULL
EXP050504	NRF2 (sc-13032,Santa Cruz)	Mus musculus	Treatment: sesame oil for 2 hr Sex: male Strain: C57BL/6 Age: 28 days 	EXP050503	5	normal	Q60795	liver	NULL
EXP050505	NRF2 (sc-13032,Santa Cruz)	Mus musculus	Treatment: 30 ug/kg TCDD for 2 hr Sex: male Strain: C57BL/6 Age: 28 days 	EXP050503	5	normal	Q60795	liver	NULL
EXP050506	anti-CTCF	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/-  Treatment: cultured with IL7	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP050507		Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- u+ 	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP050508		Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- 	NULL	140	chip_control	NULL	CD4- CD8- T cells	NULL
EXP050509		Mus musculus	Strain: C57BL/6 Genotype: RAG1-/-  	NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP050510	anti-CTCF	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/-  Treatment: cultured with IL7	EXP050506	105	normal	Q61164	pro-B cells	NULL
EXP050511	anti-CTCF	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- u+ 	EXP050507	503	normal	Q61164	pre-B cells	NULL
EXP050512	anti-Rad21	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- u+ 	EXP050507	503	normal	Q61550	pre-B cells	NULL
EXP050513	anti-Rad21	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/- 	EXP050508	140	normal	Q61550	CD4- CD8- T cells	NULL
EXP050514	anti-Rad21	Mus musculus	Strain: C57BL/6 Genotype: RAG1-/-  	EXP050509	171	normal	Q61550	CD4+ CD8+ T cells	NULL
EXP050515	None	Mus musculus	Vehicle	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP050516	None	Mus musculus	Vehicle	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP050517	None	Mus musculus	JQ1	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP050518	Bethyl A301-985A	Mus musculus	Vehicle	EXP050515	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	NULL
EXP050519	Bethyl A301-985A	Mus musculus	Vehicle	EXP050516	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	NULL
EXP050520	Bethyl A301-985A	Mus musculus	JQ1	EXP050517	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	NULL
EXP050521	none	Mus musculus	Treatment: Cold exposure 4 C degree for 6hrs Strain: C57BL/6 Genotype: wildtype	NULL	116	chip_control	NULL	brown adipocytes	NULL
EXP050522	none	Mus musculus	Treatment: Cold exposure 4 C degree for 6hrs Strain: C57BL/6 Genotype: wildtype	NULL	116	chip_control	NULL	brown adipocytes	NULL
EXP050523	PGC-1alfa (Millipore, ST1204)	Mus musculus	Treatment: Cold exposure 4 C degree for 6hrs Strain: C57BL/6 Genotype: wildtype	EXP050521	116	normal	O70343	brown adipocytes	NULL
EXP050524	PGC-1alfa (Millipore, ST1204)	Mus musculus	Treatment: Cold exposure 4 C degree for 6hrs Strain: C57BL/6 Genotype: wildtype	EXP050522	116	normal	O70343	brown adipocytes	NULL
EXP050525	ChromPure Mouse IgG (Jackson 015-000-003	Mus musculus		NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP050526	ChromPure Mouse IgG (Jackson 015-000-003	Mus musculus		NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP050527	TBP (Abcam #51841)	Mus musculus		EXP050525	1064	normal	P29037	JM8.N4 (embryonic stem cells)	NULL
EXP050528	TBP (Abcam #51841)	Mus musculus		EXP050526	1064	normal	P29037	JM8.N4 (embryonic stem cells)	NULL
EXP051038		Mus musculus	Strain: C57BL6/J Gentype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	NULL	2410	chip_control	NULL	lin-bone marrow	NULL
EXP051039		Mus musculus	Genotype: tranduced with shControl-GFP	NULL	2411	chip_control	NULL	Scid.adh.2c2 cells	NULL
EXP051040		Mus musculus	Genotype: tranduced with shBcl11b-GFP	NULL	2411	chip_control	NULL	Scid.adh.2c2 cells	NULL
EXP051041	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q6PDQ2	lin-bone marrow	NULL
EXP051042	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q6PDQ2	lin-bone marrow	NULL
EXP051043	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q6PDQ2	lin-bone marrow	NULL
EXP051044	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q6PDQ2	lin-bone marrow	NULL
EXP051045	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q9R190	lin-bone marrow	NULL
EXP051046	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q9R190	lin-bone marrow	NULL
EXP051047	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q9R190	lin-bone marrow	NULL
EXP051048	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q9R190	lin-bone marrow	NULL
EXP051049	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	P70288	lin-bone marrow	NULL
EXP051050	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	P70288	lin-bone marrow	NULL
EXP051051	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	P70288	lin-bone marrow	NULL
EXP051052	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	P70288	lin-bone marrow	NULL
EXP051053	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q8VIG1	lin-bone marrow	NULL
EXP051054	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q8VIG1	lin-bone marrow	NULL
EXP051055	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q8VIG1	lin-bone marrow	NULL
EXP051056	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q8VIG1	lin-bone marrow	NULL
EXP051057	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q9CQJ4	lin-bone marrow	NULL
EXP051058	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q9CQJ4	lin-bone marrow	NULL
EXP051059	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q9CQJ4	lin-bone marrow	NULL
EXP051060	anti-Ring1b Ab (A302-869A, Bethyl)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q9CQJ4	lin-bone marrow	NULL
EXP051061	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q6ZQ88	lin-bone marrow	NULL
EXP051062	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q6ZQ88	lin-bone marrow	NULL
EXP051063	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q6ZQ88	lin-bone marrow	NULL
EXP051064	anti-LSD1 Ab (ab17721, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q6ZQ88	lin-bone marrow	NULL
EXP051065	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051035	2410	normal	Q03347	lin-bone marrow	NULL
EXP051066	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 	EXP051036	2410	normal	Q03347	lin-bone marrow	NULL
EXP051067	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051037	2410	normal	Q03347	lin-bone marrow	NULL
EXP051068	anti-Runx1 Ab (ab23980, Abcam)	Mus musculus	Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 	EXP051038	2410	normal	Q03347	lin-bone marrow	NULL
EXP051069	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	Q6PDQ2	Scid.adh.2c2 cells	NULL
EXP051070	anti-Chd4 Ab (A301-081A, Bethyl)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	Q6PDQ2	Scid.adh.2c2 cells	NULL
EXP051071	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	P70288	Scid.adh.2c2 cells	NULL
EXP051072	anti-Hdac2 Ab (ab12169, Abcam)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	P70288	Scid.adh.2c2 cells	NULL
EXP051073	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	Q9R190	Scid.adh.2c2 cells	NULL
EXP051074	anti-Mta2 Ab (sc-9447, Santa Cruz)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	Q9R190	Scid.adh.2c2 cells	NULL
EXP051075	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Genotype: tranduced with shControl-GFP	EXP051039	2411	normal	Q8VIG1	Scid.adh.2c2 cells	NULL
EXP051076	anti-Rest Ab (12C11-1B11, Caltech protein center)	Mus musculus	Genotype: tranduced with shBcl11b-GFP	EXP051040	2411	normal	Q8VIG1	Scid.adh.2c2 cells	NULL
EXP051077	NA	Mus musculus	Genotype: wildtype Treatment: no	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051078	none	Mus musculus	Genotype: wildtype Treatment: transduced with GFP-Luciferase/OFP-Luciferase	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051079	none	Mus musculus	Treatment: OFP-H3.3A/GFP-H3.3B Genotype: H3.3 Knockdown	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051080	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q6PDQ2	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051081	HDAC1 (Abcam, ab7028)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	O09106	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051082	HDAC2 (Abcam, ab7029)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	P70288	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051083	Mbd2/3 (Abcam, ab45027)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q8C255	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051084	MTA1 (Santa Cruz, sc-9446)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q8K4B0	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051085	Rbbp4 (Abcam, ab79416)	Mus musculus	Genotype: wildtype Treatment: no	EXP051077	675	normal	Q60972	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051086	MTA1 (Santa Cruz, sc-9446)	Mus musculus	Genotype: wildtype Treatment: transduced with GFP-Luciferase/OFP-Luciferase	EXP051078	675	normal	Q8K4B0	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051087	MTA1 (Santa Cruz, sc-9446)	Mus musculus	Treatment: OFP-H3.3A/GFP-H3.3B Genotype: H3.3 Knockdown	EXP051079	675	normal	Q8K4B0	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051088	Rbbp4 (Abcam, ab79416)	Mus musculus	Genotype: wildtype Treatment: transduced with GFP-Luciferase/OFP-Luciferase	EXP051078	675	normal	Q60972	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051089	Rbbp4 (Abcam, ab79416)	Mus musculus	Treatment: OFP-H3.3A/GFP-H3.3B Genotype: H3.3 Knockdown	EXP051079	675	normal	Q60972	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051090	SRC-3 (5E11) Rabbit mAbÂ #2126 CST	Mus musculus	Strain: C57BL/6 Age: 10 weeks old Sex: male	NULL	5	normal	O09000	liver	NULL
EXP051091	none	Mus musculus	Treatment: DMEM containing 2% donor horse serum (EuroClone) 24 hours (day1)	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051092	Rabbit IgG (#011-000-003; Jackson Immunoresearch)	Mus musculus	Treatment: DMEM containing 2% donor horse serum (EuroClone) 24 hours (day1)	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051093	Rabbit anti-Ash1L (#A301-749A; Bethyl laboratories)	Mus musculus	Treatment: DMEM containing 2% donor horse serum (EuroClone) 24 hours (day1)	EXP051091	1153	normal	Q99MY8	C2C12 (myoblasts)	NULL
EXP051094	none	Mus musculus	Genotype: Asxl1 knock in Source: c-Kit+Bone Marrow cells	NULL	2396	chip_control	NULL	bone marrow myeloid cells	NULL
EXP051095	anti-FLAG	Mus musculus	Genotype: Asxl1 knock in Source: c-Kit+Bone Marrow cells	EXP051094	2396	normal	P59598	bone marrow myeloid cells	NULL
EXP051096	anti-Asxl1	Mus musculus	Genotype: Asxl1 wildtype Source: c-Kit+Bone Marrow cells	NULL	2396	bio_control	P59598	bone marrow myeloid cells	NULL
EXP051097	anti-Asxl1	Mus musculus	Genotype: Asxl1 knock in Source: c-Kit+Bone Marrow cells	EXP051094	2396	normal	P59598	bone marrow myeloid cells	NULL
EXP051098	anti-PPAR? (H100), Santa Cruz, sc7196x, K1010	Mus musculus	Genotype: PPARG knockout Strain: C57BL/6 Age: 8.5 weeks	NULL	2412	normal	P23204	thioglycollate-elicited peritoneal macrophages	NULL
EXP051099	anti-PPAR? (H100), Santa Cruz, sc7196x, K1010	Mus musculus	Genotype: PPARG wildtype Strain: C57BL/6 Age: 8.5 weeks	NULL	2412	normal	P23204	thioglycollate-elicited peritoneal macrophages	NULL
EXP051100	none (input)	Mus musculus	Genotype: IL10Ra-Expressing Strain: C57/Bl6 Source: D5 differentiated cells Treatment: untreated	NULL	2413	chip_control	NULL	iBAd	NULL
EXP051101	anti-CEBPB	Mus musculus	Genotype: IL10Ra-Expressing Strain: C57/Bl6 Source: D5 differentiated cells Treatment: untreated	EXP051100	2413	normal	P28033	iBAd	NULL
EXP051102	anti-CEBPB	Mus musculus	Genotype: IL10Ra-Expressing Strain: C57/Bl6 Source: D5 differentiated cells Treatment: treated with IL10	EXP051100	2413	normal	P28033	iBAd	NULL
EXP051103	input	Mus musculus	KLA 1h; BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051104	input	Mus musculus	KLA 1h; BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051105	input	Mus musculus	KLA 1h; BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051106	input	Mus musculus	KLA 1h; BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051107	input	Mus musculus	KLA 1h; C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051108	input	Mus musculus	KLA 1h; C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051109	input	Mus musculus	C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051110	input	Mus musculus	C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051111	input	Mus musculus	KLA 1h; C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051112	input	Mus musculus	C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051113	input	Mus musculus	KLA 1h; C57BL/6J x PWK/PhJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051114	input	Mus musculus	C57BL/6J x PWK/PhJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051115	input	Mus musculus	KLA 1h; C57BL/6J x SPRET/EiJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051116	input	Mus musculus	C57BL/6J x SPRET/EiJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051117	input	Mus musculus	PWK/PhJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051118	input	Mus musculus	PWK/PhJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051119	input	Mus musculus	KLA 1h; PWK/PhJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051120	input	Mus musculus	PWK/PhJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051121	input	Mus musculus	KLA 1h; SPRET/EiJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051122	input	Mus musculus	SPRET/EiJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051123	input	Mus musculus	KLA 1h; SPRET/EiJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051124	input	Mus musculus	SPRET/EiJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051125	input	Mus musculus	KLA 1h; PWK/PhJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051126	input	Mus musculus	PWK/PhJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051127	input	Mus musculus	KLA 1h; NOD/ShiLtJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051128	input	Mus musculus	KLA 1h; NOD/ShiLtJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051129	input	Mus musculus	NOD/ShiLtJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051130	input	Mus musculus	NOD/ShiLtJ strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051131	input	Mus musculus	KLA 1h; C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051132	input	Mus musculus	C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051133	input	Mus musculus	C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051134	input	Mus musculus	KLA 1h; C57BL/6J strain	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051135	input	Mus musculus	KLA 1h; BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051136	input	Mus musculus	BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051137	input	Mus musculus	BALB/cJ	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP051138	Runx1 (Vendor: Santa Cruz, Cat#sc365644)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051111	81	normal	Q03347	BMDM (bone marrow-derived macrophages)	NULL
EXP051139	Runx1 (Vendor: Santa Cruz, Cat#sc365644)	Mus musculus	C57BL/6J strain	EXP051112	81	normal	Q03347	BMDM (bone marrow-derived macrophages)	NULL
EXP051140	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; C57BL/6J x SPRET/EiJ	EXP051115	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051141	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	C57BL/6J x SPRET/EiJ	EXP051116	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051142	input	Mus musculus	KLA 1h; PWK/PhJ strain	NULL	81	normal	B5DC71	BMDM (bone marrow-derived macrophages)	NULL
EXP051143	input	Mus musculus	PWK/PhJ strain	NULL	81	normal	B5DC71	BMDM (bone marrow-derived macrophages)	NULL
EXP051144	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051121	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051145	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	SPRET/EiJ strain	EXP051122	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051146	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051121	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051147	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	SPRET/EiJ strain	EXP051122	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051148	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051123	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051149	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; SPRET/EiJ strain	EXP051123	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051150	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	SPRET/EiJ strain	EXP051124	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051151	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	SPRET/EiJ strain	EXP051124	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051152	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051125	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051153	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051125	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051154	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	PWK/PhJ strain	EXP051126	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051155	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	PWK/PhJ strain	EXP051126	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051156	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	PWK/PhJ strain	EXP051120	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051157	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051117	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051158	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; PWK/PhJ strain	EXP051119	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051159	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	PWK/PhJ strain	EXP051118	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051160	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051127	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051161	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051127	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051162	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	NOD/ShiLtJ strain	EXP051129	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051163	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	NOD/ShiLtJ strain	EXP051129	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051164	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	NOD/ShiLtJ strain	EXP051130	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051165	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	NOD/ShiLtJ strain	EXP051130	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051166	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051128	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051167	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; NOD/ShiLtJ strain	EXP051128	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051168	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; C57BL/6J x PWK/PhJ	EXP051113	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051169	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	C57BL/6J x PWK/PhJ	EXP051114	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051170	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051131	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051171	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051131	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051172	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	C57BL/6J strain	EXP051132	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051173	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	C57BL/6J strain	EXP051132	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051174	Usf2 (Vendor: Santa Cruz, Cat#sc-862X)	Mus musculus	C57BL/6J strain	EXP051133	81	normal	Q64705	BMDM (bone marrow-derived macrophages)	NULL
EXP051175	Usf2 (Vendor: Santa Cruz, Cat#sc-862X)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051134	81	normal	Q64705	BMDM (bone marrow-derived macrophages)	NULL
EXP051176	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051108	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051177	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	C57BL/6J strain	EXP051110	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051178	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; C57BL/6J strain	EXP051107	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051179	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	C57BL/6J strain	EXP051109	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051180	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	KLA 1h; BALB/cJ	EXP051135	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051181	CEBPb (Vendor: Santa Cruz, Cat#sc-150)	Mus musculus	BALB/cJ	EXP051136	81	normal	P28033	BMDM (bone marrow-derived macrophages)	NULL
EXP051182	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	BALB/cJ	EXP051137	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051183	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	BALB/cJ	EXP051137	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051184	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	KLA 1h; BALB/cJ	EXP051106	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051185	PU1 (Vendor: Santa Cruz, Cat#sc-352X)	Mus musculus	BALB/cJ	EXP051136	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP051186	p65 (Vendor: Santa Cruz, Cat#sc-372X)	Mus musculus	KLA 1h; BALB/cJ	EXP051105	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP051187	cJun (Vendor: Santa Cruz, Cat#sc-1694)	Mus musculus	KLA 1h; BALB/cJ	EXP051104	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP051188	none	Mus musculus	Treatment: DMSO Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051189	none	Mus musculus	Treatment: I-BRD9 for six hours Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051190	none	Mus musculus	Treatment: I-BRD9 for 24 hours Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051191	none	Mus musculus	Cell type: mEsc	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051192	none	Mus musculus	Cell type: mEsc	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051193	none	Mus musculus	Treatment: DMSO for 24 hrs Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051194	none	Mus musculus	Treatment: 3 uM I-BRD9 for 24 hours Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051195	none	Mus musculus	Cell type: mESC 	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051196	none	Mus musculus	Treatment: DMSO for 24 hrs Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051197	none	Mus musculus	Treatment: 3 uM I-BRD9 for 24 hours Cell type: mESC	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051198	none	Mus musculus	Cell type: mESC 	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051199	none	Mus musculus	Cell type: mESC  Treatment: 500 nM JQ1 for 24 hours	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051200	Active Motif 61537	Mus musculus	Treatment: DMSO Cell type: mESC	EXP051188	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	NULL
EXP051201	Active Motif 61537	Mus musculus	Treatment: I-BRD9 for six hours Cell type: mESC	EXP051189	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	NULL
EXP051202	Active Motif 61537	Mus musculus	Treatment: I-BRD9 for 24 hours Cell type: mESC	EXP051190	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	NULL
EXP051203	anti-ARID1A (Santa Cruz sc-32761)	Mus musculus	Cell type: mEsc	EXP051191	252	normal	A2BH40	V6.5 (embryonic stem cells)	NULL
EXP051204	anti-ARID1A (Santa Cruz sc-32761)	Mus musculus	Cell type: mEsc	EXP051192	252	normal	A1A546	V6.5 (embryonic stem cells)	NULL
EXP051205	anti-BRD4 (Bethyl, A301-985A)	Mus musculus	Treatment: DMSO for 24 hrs Cell type: mESC	EXP051193	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP051206	anti-BRD4 (Bethyl, A301-985A)	Mus musculus	Treatment: 3 uM I-BRD9 for 24 hours Cell type: mESC	EXP051194	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP051207	anti-BRD4 (Bethyl, A301-985A)	Mus musculus	Cell type: mESC 	NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP051208	Abcam 110641	Mus musculus	Treatment: DMSO for 24 hrs Cell type: mESC	EXP051196	252	normal	A1A546	V6.5 (embryonic stem cells)	NULL
EXP051209	Abcam 110641	Mus musculus	Treatment: 3 uM I-BRD9 for 24 hours Cell type: mESC	EXP051197	252	normal	A1A546	V6.5 (embryonic stem cells)	NULL
EXP051210	Abcam 110641	Mus musculus	Cell type: mESC 	EXP051198	252	normal	A1A546	V6.5 (embryonic stem cells)	NULL
EXP051211	Active Motif 61537	Mus musculus	Cell type: mESC Treatment: 500 nM JQ1 for 24 hours	EXP051199	252	normal	Q3UQU0	V6.5 (embryonic stem cells)	NULL
EXP051212	none (Input)	Mus musculus	Strain: C57BL/6 Age: 10-12 weeks 	NULL	2414	chip_control	NULL	AT-2 (Alveolar type II cells)	NULL
EXP051213	ETV5 (Proteintech, 13011-1-AP)	Mus musculus	Strain: C57BL/6 Age: 10-12 weeks 	EXP051212	2414	normal	Q9CXC9	AT-2 (Alveolar type II cells)	NULL
EXP051214	EZH2	Mus musculus	EZH2 KO	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051215	EZH2	Mus musculus	EZH2 WT	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP051216	EZH2	Mus musculus	EZH2 KO	EXP051214	230	bio_control	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP051217	EZH2	Mus musculus	EZH2 WT	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP051218	EZH2	Mus musculus	EZH2-P132S rescue 	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP051219	EZH2	Mus musculus	EZH2-F145L rescue 	EXP051214	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP051220	none	Mus musculus	Tissue: Whole cortex lysate Genotype: Prdm16 flox/flox(wildtype)	NULL	866	chip_control	NULL	E15.5 embryonic cortex	NULL
EXP051221	none	Mus musculus	Tissue: Whole cortex lysate Genotype: Prdm16 flox/flox(wildtype)	NULL	866	chip_control	NULL	E15.5 embryonic cortex	NULL
EXP051222	none	Mus musculus	Tissue: Whole cortex lysate Genotype: Emx1Ires-Cre (Prdm16 knockout)	NULL	866	chip_control	NULL	E15.5 embryonic cortex	NULL
EXP051223	none	Mus musculus	Tissue: Whole cortex lysate Genotype: Emx1Ires-Cre (Prdm16 knockout)	NULL	866	chip_control	NULL	E15.5 embryonic cortex	NULL
EXP051224	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Prdm16 flox/flox(wildtype)	EXP051220	866	normal	A2A935	E15.5 embryonic cortex	NULL
EXP051225	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Prdm16 flox/flox(wildtype)	EXP051221	866	normal	A2A935	E15.5 embryonic cortex	NULL
EXP051226	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Emx1Ires-Cre (Prdm16 knockout)	EXP051222	866	normal	A2A935	E15.5 embryonic cortex	NULL
EXP051227	Prdm16 (Donated by Patrick Seale (Upenn, U.S.A.))	Mus musculus	Tissue: Whole cortex lysate Genotype: Emx1Ires-Cre (Prdm16 knockout)	EXP051223	866	normal	A2A935	E15.5 embryonic cortex	NULL
EXP051228	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: Dnmt3a-/- (knockout)	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP051229	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1-/- , Dnmt3a-/- (knockouts)	NULL	13	normal	Q80U70	2TS22C (embryonic stem cells)	NULL
EXP051230	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: Tet1-/- (knockout)	NULL	13	normal	Q80U70	2TS22C (embryonic stem cells)	NULL
EXP051231	anti-SUZ12(Abcam, ab12073)	Mus musculus	Strain: 129S4/SvJae Genotype: wild type	NULL	13	normal	Q80U70	2TS22C (embryonic stem cells)	NULL
EXP051232	none	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Krt14-RFP, Krt10-H2B-GFP	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051233	none	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Krt14-RFP, Krt10-H2B-GFP	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051234	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Krt14-RFP, Krt10-H2B-GFP	EXP051232	2415	normal	Q9CQJ4	epidermal progenitor cells	NULL
EXP051235	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Krt14-RFP, Krt10-H2B-GFP	EXP051233	2415	normal	Q9CQJ4	epidermal progenitor cells	NULL
EXP051236	none	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051237	Auts2 (Sigma, Cat# HPA000390, RRID:AB_1845218)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	A0A087WPF7	epidermal progenitor cells	NULL
EXP051238	Bmi1 (Cell Signaling, Cat# 5856S, RRID:AB_10838137)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	P25916	epidermal progenitor cells	NULL
EXP051239	Bmi1 (Cell Signaling, Cat# 5856S, RRID:AB_10838137)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	P25916	epidermal progenitor cells	NULL
EXP051240	Rybp (Millipore, Cat# ab3637, RRID:AB_2285466)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	Q8CCI5	epidermal progenitor cells	NULL
EXP051241	Rybp (Millipore, Cat# ab3637, RRID:AB_2285466)	Mus musculus	Age:Postnatal day 0 Tissue: Epidermis	EXP051236	2415	normal	Q8CCI5	epidermal progenitor cells	NULL
EXP051242	none	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051243	Auts2 (Sigma, Cat# HPA000390, RRID:AB_1845218)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	A0A087WPF7	epidermal progenitor cells	NULL
EXP051244	Kdm2b (Abcam, Cat# ab137547)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	Q6P1G2	epidermal progenitor cells	NULL
EXP051245	Cbx8 (Bethyl Labs, Cat# A300-882A, RRID:AB_2071525)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	Q9QXV1	epidermal progenitor cells	NULL
EXP051246	L3mbtl2 (Active Motif, Cat# 39570, RRID:AB_2615062)	Mus musculus	Age: Postnatal day 0 Tissue: Epidermis Genotype: Krt14-RFP; Krt10-H2B-GFP	EXP051242	2415	normal	P59178	epidermal progenitor cells	NULL
EXP051247	none	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051248	none	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051249	none	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Ring1a-/- Ring1b-/I53A	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051250	none	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	NULL	2415	chip_control	NULL	epidermal progenitor cells	NULL
EXP051251	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	EXP051247	2415	normal	Q9CQJ4	epidermal progenitor cells	NULL
EXP051252	Suz12 (Active Motif, Cat# 39357, RRID:AB_2614929)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: wildtype 	EXP051247	2415	normal	Q80U70	epidermal progenitor cells	NULL
EXP051253	Ring1b (Cell Signaling, Cat# 5694S)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Ring1a-/- Ring1b-/I53A	EXP051249	2415	normal	Q9CQJ4	epidermal progenitor cells	NULL
EXP051254	Suz12 (Active Motif, Cat# 39357, RRID:AB_2614929)	Mus musculus	Tissue: Epidermis Age: Postnatal day 0 Genotype: Ring1a-/- Ring1b-/I53A	EXP051249	2415	normal	Q80U70	epidermal progenitor cells	NULL
EXP051255	IgG	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051256	IgG	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051257	IgG	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051258	none	Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051259	Foxk1	Mus musculus		EXP051258	12	normal	P42128	MEF (mouse embryonic fibroblasts)	NULL
EXP051260	None	Mus musculus	Treatment: treated with 1.5% 1,6-hexanediol for 30 minutes 	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051261	None	Mus musculus	Treatment: untreated	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051262	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Treatment: treated with 1.5% 1,6-hexanediol for 30 minutes 	EXP051260	252	normal	Q925J9	V6.5 (embryonic stem cells)	NULL
EXP051263	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Treatment: untreated	EXP051261	252	normal	Q925J9	V6.5 (embryonic stem cells)	NULL
EXP051264	Brd4 (Bethyl,A301-985A)	Mus musculus	Treatment: treated with 1.5% 1,6-hexanediol for 30 minutes 	EXP051260	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP051265	Brd4 (Bethyl,A301-985A)	Mus musculus	Treatment: untreated	EXP051261	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP051266	IgG	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: +/- Nup98 knockdown 	NULL	400	chip_control	NULL	hematopoietic progenitors	NULL
EXP051267	IgG	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad)	NULL	400	chip_control	NULL	hematopoietic progenitors	NULL
EXP051268	SET1A (Abcam, ab70378 )	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: +/- Nup98 knockdown 	EXP051266	400	normal	E9PYH6	hematopoietic progenitors	NULL
EXP051269	SET1A (Abcam, ab70378 )	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: +/- Nup98 knockdown, depleted of Nup98 	EXP051266	400	normal	E9PYH6	hematopoietic progenitors	NULL
EXP051270	Nup98 (P671, Cell Signaling Technology, #2292)	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: Nup98 wildtype 	NULL	400	normal	Q6PFD9	hematopoietic progenitors	NULL
EXP051271	Sigma - Flag M2 (affinity gel, #A2220)	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: Flag-Nup98-Nsd1	EXP051266	400	normal	Q6PFD9	hematopoietic progenitors	NULL
EXP051272	Nup98	Mus musculus	Tissue: Hematopoietic System Treatment: siRNA transfection with RNAimax (Biorad) Genotype: Nup98-Nsd1  	EXP051266	400	normal	Q6PFD9	hematopoietic progenitors	NULL
EXP051273	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot A)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: wildtype Strain: C57BL/6	NULL	2417	normal	O35185	GM-CSF-cultured bone marrow	NULL
EXP051274	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot A)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: KO (Bhlhe40-/-) Strain: C57BL/6 	NULL	2417	normal	O35185	GM-CSF-cultured bone marrow	NULL
EXP051275	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot C1)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: wildtype Strain: C57BL/6 Source: TH1-polarizedÂ CD4+Â T cells 	NULL	1058	normal	O35185	CD4+ T-cells	NULL
EXP051276	anti-Bhlhe40 (Novus Biologicals NB100-1800, Lot C1)	Mus musculus	Treatment: 10ug/mL heat-killed Mtb for 4 hours Genotype: KO (Bhlhe40-/-) Strain: C57BL/6  Source: TH1-polarizedÂ CD4+Â T cells	NULL	1058	normal	O35185	CD4+ T-cells	NULL
EXP051277	none	Mus musculus		NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051278	none	Mus musculus		NULL	2418	chip_control	NULL	RAW267.4 (murine monocyte/macrophages-like)	NULL
EXP051279	MafK (Santa Cruz, CAT#sc-22831, Lot#12804)	Mus musculus		EXP051277	675	normal	Q61827	NIH 3T3 (embryonic fibroblasts)	NULL
EXP051280	MafK (Santa Cruz, CAT#sc-22831, Lot#12804)	Mus musculus		EXP051278	2418	normal	Q61827	RAW267.4 (murine monocyte/macrophages-like)	NULL
EXP051281	none	Mus musculus	Treatment: control	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051282	none	Mus musculus	Treatment: control	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP051283	none	Mus musculus	Treatment: transfected SMC3 siDDR with RNAiMAX	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP051284	none	Mus musculus	Treatment: control	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051285	none	Mus musculus	Treatment: control	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP051286	none	Mus musculus	Treatment: transfected SMC3 siDDR with RNAiMAX	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP051287	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051281	1153	normal	Q9CW03	C2C12 (myoblasts)	NULL
EXP051288	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051282	126	normal	Q9CW03	C2C12 (myotubes)	NULL
EXP051289	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: transfected SMC3 siDDR with RNAiMAX	NULL	126	normal	Q9CW03	C2C12 (myotubes)	NULL
EXP051290	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051284	1153	normal	Q9CW03	C2C12 (myoblasts)	NULL
EXP051291	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: control	EXP051285	126	normal	Q9CW03	C2C12 (myotubes)	NULL
EXP051292	SMC3 (Abcam, ab9263, Lot GR290533-10)	Mus musculus	Treatment: transfected SMC3 siDDR with RNAiMAX	EXP051286	126	normal	Q9CW03	C2C12 (myotubes)	NULL
EXP051293		Mus musculus	Strain: C57BL/6 Genotype: RAG-/-Âµ+ Source: Bone marrow and spleen cells	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP051294	Pax5	Mus musculus	Strain: C57BL/6 Genotype: RAG-/-Âµ+ Source: Bone marrow and spleen cells	EXP051293	503	normal	Q02650	pre-B cells	NULL
EXP051295	none	Mus musculus	stably expressing ectopic FS2PWWP2A	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051296	none	Mus musculus	stably expressing FS2 vector	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051297	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051298	none	Mus musculus	double PWWP2A/B knockout	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051299	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051300	FS2 (homemade)	Mus musculus	stably expressing ectopic FS2PWWP2A	EXP051295	230	normal	Q69Z61	ES-E14 (E14, embryonic stem cells)	NULL
EXP051301	FS2 (homemade)	Mus musculus	stably expressing ectopic PWWP-deleted PWWP2A	EXP051295	230	bio_control	Q69Z61	ES-E14 (E14, embryonic stem cells)	NULL
EXP051302	FS2 (homemade)	Mus musculus		NULL	230	normal	Q91WD5	ES-E14 (E14, embryonic stem cells)	NULL
EXP051303	Hdac1 (Abcam #Ab7028)	Mus musculus	stably expressing ectopic FS2PWWP2A	EXP051295	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	NULL
EXP051304	Hdac1 (Abcam #Ab7028)	Mus musculus	stably expressing FS2 vector	EXP051296	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	NULL
EXP051305	Hdac1 (Abcam #Ab7028) + H2Av (Active Motif #61686)	Mus musculus		EXP051297	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	NULL
EXP051306	Mta2 (Abcam #Ab8106) + H2Av (Active Motif #61686)	Mus musculus		EXP051297	230	normal	Q9R190	ES-E14 (E14, embryonic stem cells)	NULL
EXP051307	Hdac1 (Abcam #Ab7028) + H2Av (Active Motif #61686)	Mus musculus	double PWWP2A/B knockout	EXP051298	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	NULL
EXP051308	Mta2 (Abcam #Ab8106) + H2Av (Active Motif #61686)	Mus musculus	double PWWP2A/B knockout	EXP051298	230	normal	Q9R190	ES-E14 (E14, embryonic stem cells)	NULL
EXP051309	Hdac1 (Abcam #Ab7028) + H2Av (Active Motif #61686)	Mus musculus	double PWWP2A/B knockout	EXP051299	230	normal	O09106	ES-E14 (E14, embryonic stem cells)	NULL
EXP051310	Mta2 (Abcam #Ab8106) + H2Av (Active Motif #61686)	Mus musculus		EXP051299	230	normal	Q9R190	ES-E14 (E14, embryonic stem cells)	NULL
EXP051311	FS2 (homemade)	Mus musculus		NULL	230	normal	Q91WD5	ES-E14 (E14, embryonic stem cells)	NULL
EXP051312	FS2 (homemade)	Mus musculus	stably expressing ectopic FS2PWWP2B	EXP051295	230	normal	E9Q9M8	ES-E14 (E14, embryonic stem cells)	NULL
EXP051313	pwwp2a	Mus musculus		EXP051295	230	normal	Q69Z61	ES-E14 (E14, embryonic stem cells)	NULL
EXP051314		Mus musculus	Genotype: wildtype  Strain: C57BL/6N Source: BCR-ABL+ cell lines	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP051315		Mus musculus	Genotype: wildtype  Strain: C57BL/6N Source: BCR-ABL+ cell lines	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP051316		Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP051317		Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP051318		Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	NULL	198	chip_control	NULL	pre-pro-B-cells	NULL
EXP051319	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: wildtype  Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051314	198	normal	Q64261	pre-pro-B-cells	NULL
EXP051320	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: wildtype  Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051315	198	normal	Q64261	pre-pro-B-cells	NULL
EXP051321	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051316	198	normal	Q64261	pre-pro-B-cells	NULL
EXP051322	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051317	198	normal	Q64261	pre-pro-B-cells	NULL
EXP051323	anti-CDK6  rabbit  polyclonal serum (BioGenes)	Mus musculus	Genotype: reconstituted Cdk6   Strain: C57BL/6N Source: BCR-ABL+ cell lines	EXP051318	198	normal	Q64261	pre-pro-B-cells	NULL
EXP051324	none	Mus musculus	Strain: C57BL/6 Age: Embryonic day 12.5&13.5	NULL	2419	chip_control	NULL	forelimb	NULL
EXP051325	Smad4 antibody (04-1033, Millipore)	Mus musculus	Strain: C57BL/6 Age: Embryonic day 12.5&13.5	EXP051324	2419	normal	P97471	forelimb	NULL
EXP051326	NA	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051327	NA	Mus musculus	Uhrf1 KO	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051328	anti-Nanog (#8785, Cell Signaling Technology)	Mus musculus		EXP051326	230	normal	Q80Z64	ES-E14 (E14, embryonic stem cells)	NULL
EXP051329	anti-Sox2 (#23064, Cell Signaling Technology)	Mus musculus		EXP051326	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP051330	anti-Oct4 (#5677, Cell Signaling Technology)	Mus musculus		EXP051326	230	normal	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP051331	anti-Uhrf1 (sc98817, Santa Cruz)	Mus musculus		EXP051326	230	normal	Q8VDF2	ES-E14 (E14, embryonic stem cells)	NULL
EXP051332	anti-Nanog (#8785, Cell Signaling Technology)	Mus musculus	Uhrf1 KO	EXP051327	230	normal	Q80Z64	ES-E14 (E14, embryonic stem cells)	NULL
EXP051333	anti-Sox2 (#23064, Cell Signaling Technology)	Mus musculus	Uhrf1 KO	EXP051327	230	normal	P48432	ES-E14 (E14, embryonic stem cells)	NULL
EXP051334	anti-Oct4 (#5677, Cell Signaling Technology)	Mus musculus	Uhrf1 KO	EXP051327	230	normal	P20263	ES-E14 (E14, embryonic stem cells)	NULL
EXP051335	none	Mus musculus		NULL	2420	chip_control	NULL	E13.5 basal ganglia	NULL
EXP051336	none	Mus musculus		NULL	2422	chip_control	NULL	E16.5 basal ganglia	NULL
EXP051337	Sp9-rabbit(PMID: 27452460)	Mus musculus		EXP051335	2420	normal	Q64HY3	E13.5 basal ganglia	NULL
EXP051338	Sp9-rabbit(PMID: 27452460)	Mus musculus		EXP051336	2422	normal	Q64HY3	E16.5 basal ganglia	NULL
EXP051339	none	Mus musculus		NULL	2423	chip_control	NULL	AxJ (hybrid B-cells)	NULL
EXP051340	ELL2	Mus musculus		EXP051339	2423	normal	Q3UKU1	AxJ (hybrid B-cells)	NULL
EXP051341	none	Mus musculus	Stage: Primary Th17 cells Tissue: spleen and lymph nodes Strain: C57BL/6 	NULL	2421	chip_control	NULL	naive CD4+T cells	NULL
EXP051342	none	Mus musculus	Stage: Primary Th17 cells Tissue: spleen and lymph nodes Strain: C57BL/6 	NULL	2421	chip_control	NULL	naive CD4+T cells	NULL
EXP051343	Trim33 (Bethyl, A301-060A)	Mus musculus	Stage: Primary Th17 cells Tissue: spleen and lymph nodes Strain: C57BL/6 	EXP051341	2421	normal	Q99PP7	naive CD4+T cells	NULL
EXP051344	Trim33 (Bethyl, A301-060A)	Mus musculus	Stage: Primary Th17 cells Tissue: spleen and lymph nodes Strain: C57BL/6 	EXP051342	2421	normal	Q99PP7	naive CD4+T cells	NULL
EXP051345	none	Mus musculus	Strain: C57BL/6 Treatmetn: grown 24h without IL7 supernatant in the presence of 100nM of 4OH-Tamoxifen	NULL	2424	chip_control	NULL	BH1 (Pre-B-cells)	NULL
EXP051346	anti-Ikaros Polyclonal rabbit made in house	Mus musculus	Strain: C57BL/6 Treatmetn: grown 24h without IL7 supernatant in the presence of 100nM of 4OH-Tamoxifen	EXP051345	2424	normal	Q03267	BH1 (Pre-B-cells)	NULL
EXP051347	PPARg (Perseus #PP-A3409A)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6	NULL	81	normal	P37238	BMDM (bone marrow-derived macrophages)	NULL
EXP051348	PPARg (Perseus #PP-A3409A)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 20ng/ul IL-4 /DMSO exposure	NULL	81	normal	P37238	BMDM (bone marrow-derived macrophages)	NULL
EXP051349	PPARg (Perseus #PP-A3409A)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 1uM GW9662 exposure	NULL	81	normal	P37238	BMDM (bone marrow-derived macrophages)	NULL
EXP051350	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051351	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of DMSO exposure	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051352	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 20ng/ul IL-4/ 1uM GW9662 exposure	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051353	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Genotype: wildtype	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051354	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 TGenotype: wildtype Treatment: followed by 24 hours of 20ng/ul IL-4 exposure 	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051355	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Genotype: Pparg knockout	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051356	P300 (sc-585)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of 20ng/ul IL-4 exposure Genotype: Pparg knockout 	NULL	81	normal	B2RWS6	BMDM (bone marrow-derived macrophages)	NULL
EXP051357	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Genotype: wildtype	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP051358	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of IL-4 exposure  Genotype: Pparg knockout	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP051359	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6  Genotype: Pparg knockout	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP051360	RAD21 (ab992)	Mus musculus	Sex: male Age: 3 months Strain:C57BL/6 Treatment: followed by 24 hours of IL-4 exposure  Genotype: Pparg knockout	NULL	81	normal	Q61550	BMDM (bone marrow-derived macrophages)	NULL
EXP051361	none	Mus musculus	9 weeks post tamoxifen	NULL	513	chip_control	NULL	K14CreER SmoM2 (basal cell carcinoma)	NULL
EXP051362	Anti-Tead1 (BD 610922)	Mus musculus	9 weeks post tamoxifen	EXP051361	513	normal	P30051	K14CreER SmoM2 (basal cell carcinoma)	NULL
EXP051363	Anti-Tead4 (ab58310 â€“ Abcam)	Mus musculus	9 weeks post tamoxifen	EXP051361	513	normal	Q62296	K14CreER SmoM2 (basal cell carcinoma)	NULL
EXP051364	input	Mus musculus	WT	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051365	input	Mus musculus	siCtrl	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051366	input	Mus musculus	siEsrrb	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051367	Smc1 (Bethyl, A300-055A)	Mus musculus	WT	EXP051364	230	normal	Q9CU62	ES-E14 (E14, embryonic stem cells)	NULL
EXP051368	Med1 (Santa Cruz, sc-5334)	Mus musculus	siCtrl	EXP051365	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	NULL
EXP051369	Med12 (Abcam, Ab70842)	Mus musculus	siCtrl	EXP051365	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051370	Carey Lab	Mus musculus	siCtrl	EXP051365	230	normal	P62915	ES-E14 (E14, embryonic stem cells)	NULL
EXP051371	Esrrb (Perseus Proteomics,PP-H6705-00)	Mus musculus	siCtrl	EXP051365	230	normal	Q61539	ES-E14 (E14, embryonic stem cells)	NULL
EXP051372	TAF2 (Novus, NBP1-21371)	Mus musculus	siCtrl	EXP051365	230	normal	Q8C176	ES-E14 (E14, embryonic stem cells)	NULL
EXP051373	Med26 (Santa Cruz, sc-1521)	Mus musculus	siCtrl	EXP051365	230	normal	Q7TN02	ES-E14 (E14, embryonic stem cells)	NULL
EXP051374	Med1 (Santa Cruz, sc-5334)	Mus musculus	siEsrrb	EXP051366	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	NULL
EXP051375	Med12 (Abcam, Ab70842)	Mus musculus	siEsrrb	EXP051366	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051376	Carey Lab	Mus musculus	siEsrrb	EXP051366	230	normal	P62915	ES-E14 (E14, embryonic stem cells)	NULL
EXP051377	Esrrb (Perseus Proteomics,PP-H6705-00)	Mus musculus	siEsrrb	EXP051366	230	normal	Q61539	ES-E14 (E14, embryonic stem cells)	NULL
EXP051378	none	Mus musculus	Tissue: a pool of both sham and transverse aortic constriction Phenotype: wildtype Strain: C57BL/6J Sex: male 	NULL	53	chip_control	NULL	heart	NULL
EXP051379	anti-YAP1 (US Biological; Y1200-01D)	Mus musculus	Tissue: sham Phenotype: wildtype Strain: C57BL/6J Sex: male 	EXP051378	53	normal	P46938	heart	NULL
EXP051380	anti-YAP1 (US Biological; Y1200-01D)	Mus musculus	Tissue:transverse aortic constriction Phenotype: wildtype Strain: C57BL/6J Sex: male 	EXP051378	53	normal	P46938	heart	NULL
EXP051381	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1; Lactation day 1	NULL	572	normal	P42230	mammary gland	NULL
EXP051382	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1; Lactation day 1	NULL	572	normal	P06537	mammary gland	NULL
EXP051383	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE2-delE3; Lactation day 1	NULL	572	normal	P42230	mammary gland	NULL
EXP051384	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE2-delE3; Lactation day 1	NULL	572	normal	P06537	mammary gland	NULL
EXP051385	STAT3 (Santa Cruz, sc-482)	Mus musculus	WT; lactation day 10	NULL	523	normal	P42227	kidney	NULL
EXP051386	GR (Thermo Scientific, PA1-511A)	Mus musculus	WT; lactation day 10	NULL	523	normal	P06537	kidney	NULL
EXP051387	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-E12-Ramp3; lactation day 10	NULL	523	normal	P06537	kidney	NULL
EXP051388	STAT3 (Santa Cruz, sc-482)	Mus musculus	Wap-E12-Ramp3; lactation day 10	NULL	523	normal	P42227	kidney	NULL
EXP051389	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-E12-Ramp3; lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051390	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-E2-Ramp3; lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051391	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE3; lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051392	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE2-delE3; lactation day 10	NULL	572	normal	P06537	mammary gland	NULL
EXP051393	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE2-delE3; lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051394	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE3; Lactation day 10	NULL	572	normal	P06537	mammary gland	NULL
EXP051395	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE3; Lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051396	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1-delE3; Lactation day 1	NULL	572	normal	P06537	mammary gland	NULL
EXP051397	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1-delE3; Lactation day 1	NULL	572	normal	P42230	mammary gland	NULL
EXP051398	GR (Thermo Scientific, PA1-511A)	Mus musculus	Wap-delE1; Lactation day 10	NULL	572	normal	P06537	mammary gland	NULL
EXP051399	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	Wap-delE1; Lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051400	MED1 (Bethyl Laboratory, A300-793A)	Mus musculus	WT; Lactation day 10	NULL	572	normal	Q925J9	mammary gland	NULL
EXP051401	GR (Thermo Scientific, PA1-511A)	Mus musculus	WT; Lactation day 10	NULL	572	normal	P06537	mammary gland	NULL
EXP051402	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	WT; Lactation day 10	NULL	572	normal	P42230	mammary gland	NULL
EXP051403	GR (Thermo Scientific, PA1-511A)	Mus musculus	WT; Lactation day 1	NULL	572	normal	P06537	mammary gland	NULL
EXP051404	STAT5A (Santa Cruz Biotechnology, sc-1081)	Mus musculus	WT; Lactation day 1	NULL	572	normal	P42230	mammary gland	NULL
EXP051405	DMC1 (Santa Cruz, sc-8973)	Mus musculus	Age: adult Genotype: Cxxc1 heterozygous with Stra8-iCre	NULL	803	normal	Q61880	spermatocytes	NULL
EXP051406	DMC1 (Santa Cruz, sc-8973)	Mus musculus	Age: adult Genotype: Cxxc1-knockout with Stra8-iCre	NULL	803	normal	Q61880	spermatocytes	NULL
EXP051407	control antibody (anti-IgG Cell Signaling #2729)	Mus musculus	Strain: C57BL/6J	NULL	2426	chip_control	NULL	intestinal tuft cells	NULL
EXP051408		Mus musculus	Strain: C57BL/6J	NULL	2426	chip_control	NULL	intestinal tuft cells	NULL
EXP051409	anti-Pou2f3 antibody (Santa Cruz #SC330)	Mus musculus	Strain: C57BL/6J	EXP051408	2426	normal	P31362	intestinal tuft cells	NULL
EXP051410	Rabbit IgG	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	NULL	2427	chip_control	NULL	cortex and corpus callosum	NULL
EXP051411	none	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	NULL	2427	chip_control	NULL	cortex and corpus callosum	NULL
EXP051412	Rabbit IgG	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	NULL	2427	chip_control	NULL	cortex and corpus callosum	NULL
EXP051413	none	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	NULL	2427	chip_control	NULL	cortex and corpus callosum	NULL
EXP051414	none	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	NULL	2427	chip_control	NULL	cortex and corpus callosum	NULL
EXP051415	Anti-Chd7 (Cell Signaling; 6505)	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	EXP051411	2427	normal	A2AJK6	cortex and corpus callosum	NULL
EXP051416	Anti-Chd7 (Cell Signaling; 6505)	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	EXP051413	2427	normal	A2AJK6	cortex and corpus callosum	NULL
EXP051417	Anti-Chd8 (Bethyl; A301-224A)	Mus musculus	Treatment: none Age: Postnatal day 7 Source: O4+ cells	EXP051414	2427	normal	Q09XV5	cortex and corpus callosum	NULL
EXP051418		Mus musculus	Strain: C57BL/6 Genotype: Ubn23XFlag-HA/3XFlag-HA	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051419	Anti-Flag M2 Affinity Gel(Sigma, A2220)	Mus musculus	Strain: C57BL/6 Genotype: Hira3XFlag-HA/3XFlag-HA	EXP051418	2	normal	Q61666	mESCs (mouse embryonic stem cells)	NULL
EXP051420	Anti-Flag M2 Affinity Gel(Sigma, A2220)	Mus musculus	Strain: C57BL/6 Genotype: Ubn13XFlag-HA/3XFlag-HA	NULL	2	normal	Q4G0F8	mESCs (mouse embryonic stem cells)	NULL
EXP051421	Anti-Flag M2 Affinity Gel(Sigma, A2220)	Mus musculus	Strain: C57BL/6 Genotype: Ubn23XFlag-HA/3XFlag-HA	NULL	2	normal	Q80WC1	mESCs (mouse embryonic stem cells)	NULL
EXP051423	NA	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051424	NA	Mus musculus	Description: DPPA2  and DPPA4 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051425	NA	Mus musculus	Description: DPPA4 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051426	NA	Mus musculus	Treatment: 1ug/ml Doxycyclin for 4 days Genotype: wildtype  Strain: 129S1/SvImJ 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051427	NA	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: wildtype Strain: 129 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051428	NA	Mus musculus	Description:input from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051429	NA	Mus musculus	Description: Dppa2 and Dppa4 overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051430	NA	Mus musculus	Description: Input DNA from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051431	NA	Mus musculus	Description:Input DNA from Dppa2/4 overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051432	DPPA2 (Millipore, MAB4356)	Mus musculus	Decription: control Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051422	12	normal	Q9CWH0	MEF (mouse embryonic fibroblasts)	NULL
EXP051433	DPPA4 (R&D, Systems AF3730)	Mus musculus	Decription: control Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051422	12	normal	Q8CCG4	MEF (mouse embryonic fibroblasts)	NULL
EXP051434	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051423	12	normal	Q9CWH0	MEF (mouse embryonic fibroblasts)	NULL
EXP051435	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: DPPA2 and DPPA4 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051424	12	normal	Q9CWH0	MEF (mouse embryonic fibroblasts)	NULL
EXP051436	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: DPPA2 and DPPA4  overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051424	12	normal	Q8CCG4	MEF (mouse embryonic fibroblasts)	NULL
EXP051437	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: DPPA4 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J] 	EXP051425	12	normal	Q8CCG4	MEF (mouse embryonic fibroblasts)	NULL
EXP051438	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: wildtype Strain: 129 	EXP051427	2	normal	Q9CWH0	mESCs (mouse embryonic stem cells)	NULL
EXP051439	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: DPPA2 overexpression MEF cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: wildtype Strain: 129 	EXP051427	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	NULL
EXP051440	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: Dppa2 ChIP from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	EXP051428	2429	normal	Q9CWH0	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051441	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: Dppa4 ChIP from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	EXP051428	2429	normal	Q8CCG4	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051442	DPPA2 (Millipore, MAB4356)	Mus musculus	Description: Dppa2 and Dppa4 overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	normal	Q9CWH0	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051443	DPPA4 (R&D, Systems AF3730)	Mus musculus	Description: Dppa2 ChIP from Control overexpression OSKM Reprogramming cells Treatment: 1ug/ml Doxycyclin for 4 days Genotype: Rosa26-rtTA+/+, Oct4-GFP+/+ Strain: [B6;129S4-Pou5f1tm2Jae/J]x[B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J]x[B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J ] 	NULL	2429	normal	Q8CCG4	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051444	None	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051445	None	Mus musculus	Genotype: wildtype Treatment: culture conditions NPC medium	NULL	138	chip_control	NULL	neural progenitors	NULL
EXP051446	None	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051447	None	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051448	None	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051449	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: wildtype Treatment: culture conditions NPC medium	EXP051445	138	normal	Q9DA79	neural progenitors	NULL
EXP051450	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: culture conditions NPC medium	EXP051445	138	normal	Q6PDQ2	neural progenitors	NULL
EXP051451	GFP (Abcam, ab290)	Mus musculus	Genotype: ZFP296-BAC Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	E9Q6W4	R1 (embryonic stem cells)	NULL
EXP051452	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051444	765	normal	Q60520	R1 (embryonic stem cells)	NULL
EXP051453	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051446	765	normal	Q9DA79	R1 (embryonic stem cells)	NULL
EXP051454	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051446	765	normal	Q6PDQ2	R1 (embryonic stem cells)	NULL
EXP051455	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051446	765	normal	Q60520	R1 (embryonic stem cells)	NULL
EXP051456	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	Q9DA79	R1 (embryonic stem cells)	NULL
EXP051457	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	Q6PDQ2	R1 (embryonic stem cells)	NULL
EXP051458	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 27 Treatment: culture conditions Serum/LIF +2i	EXP051447	765	normal	Q60520	R1 (embryonic stem cells)	NULL
EXP051459	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	EXP051448	765	normal	Q9DA79	R1 (embryonic stem cells)	NULL
EXP051460	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	EXP051448	765	normal	Q6PDQ2	R1 (embryonic stem cells)	NULL
EXP051461	SIN3A (Abcam, ab3479)	Mus musculus	Genotype: ZFP296 CRISPR KO clone 7 Treatment: culture conditions Serum/LIF +2i	EXP051448	765	normal	Q60520	R1 (embryonic stem cells)	NULL
EXP051462	MBD3 (Bethyl, A302-528A)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051444	765	normal	Q9DA79	R1 (embryonic stem cells)	NULL
EXP051463	CHD4 (Abcam, ab70469)	Mus musculus	Genotype: wildtype Treatment: culture conditions Serum/LIF +2i	EXP051444	765	normal	Q6PDQ2	R1 (embryonic stem cells)	NULL
EXP051464	None	Mus musculus	Ubc9-WT	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP051465	None	Mus musculus	Ubc9-KO	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP051466	SUMO-1 (Abcam, ab32058)	Mus musculus	Ubc9-WT	EXP051464	750	normal	P63166	E13.5 embryonic fibroblasts	NULL
EXP051467	SUMO-1 (Abcam, ab32058)	Mus musculus	Ubc9-KO	EXP051465	750	normal	P63166	E13.5 embryonic fibroblasts	NULL
EXP051468	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Ubc9-WT	EXP051464	750	normal	P61957	E13.5 embryonic fibroblasts	NULL
EXP051469	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Ubc9-KO	EXP051465	750	normal	P61957	E13.5 embryonic fibroblasts	NULL
EXP051470	IgG	Mus musculus	Strain: liver Age: 8 weeks old	NULL	5	chip_control	NULL	liver	NULL
EXP051471	HNF4A	Mus musculus	Strain: liver Age: 8 weeks old Sample: ZT4 	EXP051470	5	normal	P49698	liver	NULL
EXP051472	HNF4A	Mus musculus	Strain: liver Age: 8 weeks old Sample: ZT6 	EXP051470	5	normal	P49698	liver	NULL
EXP051473	none	Mus musculus		NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP051474	IgG	Mus musculus		NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP051475	none	Mus musculus		NULL	846	chip_control	NULL	ILC3 (type 3 Innate lympoid cells)	NULL
EXP051476	IgG	Mus musculus		NULL	846	chip_control	NULL	ILC3 (type 3 Innate lympoid cells)	NULL
EXP051477	Hmgn2	Mus musculus	Source: undifferentiated P19 EC cells	EXP051473	705	normal	P09602	P19 (embryonic carcinoma)	NULL
EXP051478	None	Mus musculus	Tissue: Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors Time: <10 passages 	NULL	2431	chip_control	NULL	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	NULL
EXP051479	None	Mus musculus	Tissue: Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model Time: Flash-frozen 	NULL	2432	chip_control	NULL	Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model; infected with Ad5-CMV-Cre virus; harvested approximately 10 months post-infection.	NULL
EXP051480	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: KPS1 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	EXP051478	2431	normal	P48432	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	NULL
EXP051481	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: KPS2 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	EXP051478	2431	normal	P48432	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	NULL
EXP051482	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: KPS3 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	EXP051478	2431	normal	P48432	Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors	NULL
EXP051483	SOX2 antibody (R&D Systems Cat#AF2018)	Mus musculus	Tissue: Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model	EXP051479	2432	normal	P48432	Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model; infected with Ad5-CMV-Cre virus; harvested approximately 10 months post-infection.	NULL
EXP051484	SOX17 (R&D Systems AF1924)	Mus musculus	Strain: C57BL/6  Genotype: wildtype Sex: female	NULL	132	normal	Q61473	uterus	NULL
EXP051485	input	Mus musculus	Confluence: subconfluent Treatment: Cells were crosslinked for 10 min and sonicated using Covaris sonicator	NULL	18	chip_control	NULL	3T3-L1 (embryonic fibroblasts)	NULL
EXP051486	Sox9	Mus musculus	Confluence: subconfluent Treatment: Cells were crosslinked for 10 min and sonicated using Covaris sonicator	EXP051485	18	normal	Q04887	3T3-L1 (embryonic fibroblasts)	NULL
EXP051487	ZMYND8 (HPA020949, Sigma-Aldrich)	Mus musculus	Genotype: ZMYND8 knockout	NULL	178	normal	A2A479	CH12 (lymphoma)	NULL
EXP051488	ZMYND8 (HPA020949, Sigma-Aldrich)	Mus musculus	Genotype: wildtype	NULL	178	normal	A2A479	CH12 (lymphoma)	NULL
EXP051489	ZMYND8 (HPA020949, Sigma-Aldrich)	Mus musculus	Genotype: Cd19-Cre/+ Tissue: Splenocytes	NULL	2433	normal	A2A479	primary B cells	NULL
EXP051490	anti-Nanog rabbit polyclonal (made in-house)	Mus musculus	Sorted fraction: Esrrb-High	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP051491	anti-Nanog rabbit polyclonal (made in-house)	Mus musculus	Sorted fraction: Esrrb-Medium	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP051492	anti-Nanog rabbit polyclonal (made in-house)	Mus musculus	Sorted fraction: Esrrb-Negative	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP051493	goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, Cat # SC-8628)	Mus musculus	Sorted fraction: Esrrb-High	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP051494	goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, Cat # SC-8628)	Mus musculus	Sorted fraction: Esrrb-Medium	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP051495	goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, Cat # SC-8628)	Mus musculus	Sorted fraction: Esrrb-Negative	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP051496	none	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	NULL	193	chip_control	NULL	cortex	NULL
EXP051497	Rabbit IgG (Santa Cruz Biotech, Cat# sc2027)	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	NULL	193	chip_control	NULL	cortex	NULL
EXP051498	none	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	NULL	193	chip_control	NULL	cortex	NULL
EXP051499	TBR1 blocking peptide (Abcam, Cat# ab25853)	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	NULL	193	chip_control	NULL	cortex	NULL
EXP051500	TBR1 (Santa Cruz Biotech, Cat# sc-48816 X)	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	EXP051496	193	normal	Q64336	cortex	NULL
EXP051501	TBR1 (Santa Cruz Biotech, Cat# sc-48816 X)	Mus musculus	Strain: CD1 Age: P2 Genotype: wildtype	EXP051498	193	normal	Q64336	cortex	NULL
EXP051502	none (input)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing Empty vector	NULL	2435	chip_control	NULL	Ba/F3-Mpl	NULL
EXP051503	none (input)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing WT Calreticuline (CALR)	NULL	2435	chip_control	NULL	Ba/F3-Mpl	NULL
EXP051504	none (input)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing del Calreticuline (CALR)	NULL	2435	chip_control	NULL	Ba/F3-Mpl	NULL
EXP051505	none (input)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing INS Calreticuline (CALR)	NULL	2435	chip_control	NULL	Ba/F3-Mpl	NULL
EXP051506	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing Empty vector	EXP051502	2435	normal	P26323	Ba/F3-Mpl	NULL
EXP051507	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing WT Calreticuline (CALR)	EXP051503	2435	normal	P26323	Ba/F3-Mpl	NULL
EXP051508	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing del Calreticuline (CALR)	EXP051504	2435	normal	P26323	Ba/F3-Mpl	NULL
EXP051509	Fli1 antibody (Abcam, #ab15289, GR3183316-1)	Mus musculus	Cell type: murine pro B cell line Genotype: expressing INS Calreticuline (CALR)	EXP051505	2435	normal	P26323	Ba/F3-Mpl	NULL
EXP051510	None	Mus musculus	Treatment: DMSO for 24 hrs	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051511	None	Mus musculus	Treament: dTAG-47, 100 nM for 24 hrs	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP051512	Oct4 (Santa Cruz, sc-8628X, #A2414)	Mus musculus	Treatment: DMSO for 24 hrs	EXP051510	252	normal	P20263	V6.5 (embryonic stem cells)	NULL
EXP051513	Oct4 (Santa Cruz, sc-8628X, #A2414)	Mus musculus	Treament: dTAG-47, 100 nM for 24 hrs	EXP051511	252	normal	P20263	V6.5 (embryonic stem cells)	NULL
EXP051514	Med1/TRAP220 (Bethyl, A300-793A, #7)	Mus musculus	Treatment: DMSO for 24 hrs	EXP051510	252	normal	Q925J9	V6.5 (embryonic stem cells)	NULL
EXP051515	Med1/TRAP220 (Bethyl, A300-793A, #7)	Mus musculus	Treament: dTAG-47, 100 nM for 24 hrs	EXP051511	252	normal	Q925J9	V6.5 (embryonic stem cells)	NULL
EXP051516	none	Mus musculus		NULL	2430	chip_control	NULL	ESC-derived glial progenitor cells	NULL
EXP051517	NFIA, Sigma, HPA006111	Mus musculus		EXP051516	2430	normal	Q02780	ESC-derived glial progenitor cells	NULL
EXP051518	Sox3, Muhr-lab	Mus musculus		EXP051516	2430	normal	P53784	ESC-derived glial progenitor cells	NULL
EXP051519	Sox9, Millipore, AB5535	Mus musculus		EXP051516	2430	normal	Q04887	ESC-derived glial progenitor cells	NULL
EXP051520	none	Mus musculus	Strain: CD1 Age: E14.5 Treatment: untreated 	NULL	2436	chip_control	NULL	embryonic neural stem cells	NULL
EXP051521	rabbit anti-SOX4 (Diagenode, CS-129-100)	Mus musculus	Strain: CD1 Age: E14.5 Treatment: untreated 	EXP051520	2436	normal	Q06831	embryonic neural stem cells	NULL
EXP051522	none	Mus musculus	Tissue: Testes Strain: C57Bl/6 Age: P21	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP051523	Cfp1 (BETHYL, A303-161A)	Mus musculus	Tissue: Testes Strain: C57Bl/6 Age: P21	EXP051522	803	normal	Q8BGU5	spermatocytes	NULL
EXP051524	anti-PU.1 (Santa Cruz, T-20)	Mus musculus	Strain: C56BL/6 Cell type: Conventional dendritic cells	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP051525	anti-PU.1 (Santa Cruz, T-20)	Mus musculus	Strain: C56BL/6 Cell type: Conventional dendritic cells	EXP051524	104	normal	P17433	dendritic cells	NULL
EXP051526	anti-PU.1 (Santa Cruz, T-20)	Mus musculus	Strain: C56BL/6 Cell type: Plasmacytoid dentritic cells	EXP051524	104	normal	P17433	dendritic cells	NULL
EXP051527	Biotin	Mus musculus	Strain: Balb/c Genotype: Raw-Bap-P2A-BirA	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051528	anti-Flag	Mus musculus	Strain: Balb/c Genotype: Raw-Bap-P2A-BirA	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051529	Biotin	Mus musculus	Strain: Balb/c Genotype: Raw-Bap-Ipr1-P2A-BirA	EXP051527	91	normal	Q8BVK9	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051530	anti-Flag	Mus musculus	Strain: Balb/c Genotype: Raw-Bap-Ipr1-P2A-BirA	EXP051528	91	normal	Q8BVK9	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051531	Arid1a (Cell Signaling Technology, #12354)	Mus musculus	Passage: 10-12 Strain: C57BL/6 Genotype: wildtype 	NULL	2437	normal	A2BH40	intestinal spheroid	NULL
EXP051532	none	Mus musculus	Strain: C57BL/6 	NULL	437	chip_control	NULL	HL-1 (cardiac muscle cells)	NULL
EXP051533	anti-JARID2 BL3844(kindly provided by Eric W. McIntush, Bethyl Laboratories, Inc.)	Mus musculus	Strain: C57BL/6 	NULL	437	normal	Q62315	HL-1 (cardiac muscle cells)	NULL
EXP051534	none	Mus musculus		NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051535	anti-SET (ab85389, Abcam)	Mus musculus		EXP051534	765	normal	Q9EQU5	R1 (embryonic stem cells)	NULL
EXP051536	none	Mus musculus	Passage: 28 -31 Day:9 Strain: C57BL/6 Celltype: matrix-depositing osteoblast	NULL	581	chip_control	NULL	MC3T3-E1 (preosteoblasts)	NULL
EXP051537	Ctcf antibody (Millipore, catalog#07-729, lot#DAM1772428)	Mus musculus	Passage: 28 -31 Day:0 Strain: C57BL/6 Celltype: preosteoblast	NULL	581	normal	Q61164	MC3T3-E1 (preosteoblasts)	NULL
EXP051538	Ctcf antibody (Millipore, catalog#07-729, lot#DAM1772428)	Mus musculus	Passage: 28 -31 Day:9 Strain: C57BL/6 Celltype: matrix-depositing osteoblast	EXP051536	581	normal	Q61164	MC3T3-E1 (preosteoblasts)	NULL
EXP051539	Ctcf antibody (Millipore, catalog#07-729, lot#DAM1772428)	Mus musculus	Passage: 28 -31 Day:28 Strain: C57BL/6 Celltype: mineralizing osteoblast	NULL	581	normal	Q61164	MC3T3-E1 (preosteoblasts)	NULL
EXP051540	Brd4 (Bethyl IHC-00396)	Mus musculus	Treatment: 1uL/1mL DMSO	NULL	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	NULL
EXP051541	Brd4 (Bethyl IHC-00396)	Mus musculus	Treatment: 1 uM MS417 BET-inhibitor	NULL	18	normal	Q9ESU6	3T3-L1 (embryonic fibroblasts)	NULL
EXP051542		Mus musculus	Source: cell Treatment: Cells are treated with 100 ng/ml of lipopolysaccharide (LPS) for 4 hours to induce M1 phenotype Cell type: macrophage-like, Abelson leukemia virus transformed	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051543		Mus musculus	Source: mitochondria Treatment: Cells are treated with 100 ng/ml of lipopolysaccharide (LPS) for 4 hours to induce M1 phenotype Cell type: macrophage-like, Abelson leukemia virus transformed	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051544	Anti-Notch1(Abcam, ab27526 )	Mus musculus	Source: cell Treatment: Cells are treated with 100 ng/ml of lipopolysaccharide (LPS) for 4 hours to induce M1 phenotype Cell type: macrophage-like, Abelson leukemia virus transformed	EXP051542	91	normal	Q01705	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051545	Anti-Notch1(Abcam, ab27526 )	Mus musculus	Source: mitochondria Treatment: Cells are treated with 100 ng/ml of lipopolysaccharide (LPS) for 4 hours to induce M1 phenotype Cell type: macrophage-like, Abelson leukemia virus transformed	EXP051543	91	normal	Q01705	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP051546	Cohesin	Mus musculus	Treatment: C57BL/6	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP051547		Mus musculus	Treatment: C57BL/6 Genotype: wildtype	NULL	243	chip_control	NULL	EL4 (lymphoma)	NULL
EXP051548	anti-CTCF	Mus musculus	Treatment: C57BL/6 Genotype: CTCF-motif knockout Treatment: Genome Editing was carried out by CRISPR/Cas9 system 	NULL	243	chip_control	NULL	EL4 (lymphoma)	NULL
EXP051549	anti-CTCF	Mus musculus	Treatment: C57BL/6	EXP051546	499	normal	Q61164	Th2-cells	NULL
EXP051550	anti-CTCF	Mus musculus	Treatment: C57BL/6 Genotype: wildtype	NULL	243	normal	Q61164	EL4 (lymphoma)	NULL
EXP051551	anti-CTCF	Mus musculus	Treatment: C57BL/6 Genotype: CTCF-motif knockout Treatment: Genome Editing was carried out by CRISPR/Cas9 system 	EXP051548	243	normal	Q61164	EL4 (lymphoma)	NULL
EXP051552	none	Mus musculus	Day: 2 of differentiation Celltype: myoblast	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051553	normal mouse IgG (Millipore, catalog# 12-371B; lot# 2017312)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051554	none	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051555	normal mouse IgG (Millipore, catalog# 12-371B; lot# 2017312)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051556	MyoD (Santa Cruz, catalog# sc-304; lot# C0812)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	EXP051552	1153	normal	P10085	C2C12 (myoblasts)	NULL
EXP051557	Myogenin (Santa Cruz, catalog# sc-12732; lot# J0813)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	EXP051552	1153	normal	P12979	C2C12 (myoblasts)	NULL
EXP051558	MyoD (Santa Cruz, catalog# sc-304; lot# C0812)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	EXP051554	1153	normal	P10085	C2C12 (myoblasts)	NULL
EXP051559	Myogenin (Santa Cruz, catalog# sc-12732; lot# J0813)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	EXP051554	1153	normal	P12979	C2C12 (myoblasts)	NULL
EXP051560	TDP-43 (Abcam, catalog# ab41972; lot# GR200025-1)	Mus musculus	Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturerâ€™s protocol 	EXP051554	1153	normal	Q921F2	C2C12 (myoblasts)	NULL
EXP051561	TDP-43 (Abcam, catalog# ab41972; lot# GR200025-1)	Mus musculus	Day: 2 of differentiation Celltype: myoblast	EXP051552	1153	normal	Q921F2	C2C12 (myoblasts)	NULL
EXP051562		Mus musculus	Genotype: wildtype Developmental stage: Postnatal day 6	NULL	2438	chip_control	NULL	heart ventricels	NULL
EXP051563	anti-Nrf2	Mus musculus	Genotype: wildtype Developmental stage: Postnatal day 6	EXP051562	2438	normal	Q60795	heart ventricels	NULL
EXP051564	anti-Flag BioM2 antibody (Sigma-Aldrich)	Mus musculus	Genotype: wildtype Developmental stage: Postnatal day 6 Treatment: 	EXP051562	2438	normal	P97474	heart ventricels	NULL
EXP051565	No antibody, DNA input control	Mus musculus	Treatment: Strain: C57BL/6J	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051566	anti-SMRT Abcam, ab24551 Lot# GR140820-1	Mus musculus	Treatment: Strain: C57BL/6J	EXP051565	2	normal	Q9WU42	mESCs (mouse embryonic stem cells)	NULL
EXP051567	anti-NCoR Millipore, ABE251, Lot#2153059	Mus musculus	Treatment: Strain: C57BL/6J-OG2 Treatment: OSKM Day:9	NULL	2439	normal	Q60974	Intermediate pluripotent reprogramed cells	NULL
EXP051568	anti-SMRT Abcam, ab24551 Lot# GR140820-1	Mus musculus	Treatment: Strain: C57BL/6J-OG2 Treatment: OSKM Day:9	NULL	2439	normal	Q9WU42	Intermediate pluripotent reprogramed cells	NULL
EXP051569	input DNA	Mus musculus	Treatment: Treatment: genotype: wildtype	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP051570	Reverb-alpha	Mus musculus	Treatment: Treatment: genotype: wildtype	EXP051569	498	normal	Q3UV55	Th17-cells	NULL
EXP051571	none	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051572	none	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days; Kmt2b-/-	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051573	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days	EXP051571	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051574	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days	EXP051571	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051575	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days; Kmt2b-/-	EXP051572	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051576	Abcam ab31902 (rabbit)	Mus musculus	Brn2, Myt1l and Ascl1 for 5 days; Kmt2b-/-	EXP051572	2429	normal	O88559	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP051577	input	Mus musculus	Genotype: wildtype clone1 Strain: C57Bl6/J;129/SvEv Source: Day 2 differentiated trophoblast stem cells	NULL	2440	chip_control	NULL	differentiated trophoblast stem cells	NULL
EXP051578	input	Mus musculus	Genotype: wildtype clone2 Strain: C57Bl6/J;129/SvEv Source: Day 2 trophoblast giant cells	NULL	2440	chip_control	NULL	differentiated trophoblast stem cells	NULL
EXP051579	input	Mus musculus	Genotype: mutant clone Strain: C57Bl6/J;129/SvEv Source: Day 2 trophoblast giant cells	NULL	2440	chip_control	NULL	differentiated trophoblast stem cells	NULL
EXP051580	anti-Blimp1 (Novus, clone 3H2-E8)	Mus musculus	Genotype: wildtype clone1 Strain: C57Bl6/J;129/SvEv Source: Day 2 differentiated trophoblast stem cells	EXP051577	2440	normal	Q60636	differentiated trophoblast stem cells	NULL
EXP051581	anti-Blimp1 (Novus, clone 3H2-E8)	Mus musculus	Genotype: wildtype clone2 Strain: C57Bl6/J;129/SvEv Source: Day 2 trophoblast giant cells	EXP051578	2440	normal	Q60636	differentiated trophoblast stem cells	NULL
EXP051582	anti-Blimp1 (Novus, clone 3H2-E8)	Mus musculus	Genotype: mutant clone Strain: C57Bl6/J;129/SvEv Source: Day 2 trophoblast giant cells	EXP051579	2440	bio_control	Q60636	differentiated trophoblast stem cells	NULL
EXP051583	none	Mus musculus	Passage: 4-5 Strain: C57BL/6	NULL	253	chip_control	NULL	EML -C1(EML, clone 1)	NULL
EXP051584	Ezh2, Cell Signalling, cat no: 5246 , lot: 6	Mus musculus	Passage: 4-5 Strain: C57BL/6	EXP051583	253	normal	P24270	EML -C1(EML, clone 1)	NULL
EXP051585	Runx1, Abcam, cat no: ab23980, lot: GR184947-1	Mus musculus	Passage: 4-5 Strain: C57BL/6	EXP051583	253	normal	Q03347	EML -C1(EML, clone 1)	NULL
EXP051586	input	Mus musculus		NULL	2441	chip_control	NULL	squamous cell carcinoma	NULL
EXP051587	smad2	Mus musculus		EXP051586	2441	normal	Q62432	squamous cell carcinoma	NULL
EXP051588		Mus musculus	Strain: C57BL/6J  Treatment: untreated	NULL	2443	chip_control	NULL	DIV6 (Primary cortical neurons)	NULL
EXP051589		Mus musculus	Strain: C57BL/6J Treatment: 50 mM KCl for 45 min	NULL	2443	chip_control	NULL	DIV6 (Primary cortical neurons)	NULL
EXP051590	anti-Gtf3c1	Mus musculus	Strain: C57BL/6J  Treatment: untreated	EXP051588	2443	normal	Q8K284	DIV6 (Primary cortical neurons)	NULL
EXP051591	anti-Gtf3c1	Mus musculus	Strain: C57BL/6J Treatment: 50 mM KCl for 45 min	EXP051589	2443	normal	Q8K284	DIV6 (Primary cortical neurons)	NULL
EXP051592		Mus musculus	Treatment PBS primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	NULL	53	chip_control	NULL	heart	NULL
EXP051593		Mus musculus	Treatment PBS primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	NULL	53	chip_control	NULL	heart	NULL
EXP051594		Mus musculus	TreatmentTbeta4-primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	NULL	53	chip_control	NULL	heart	NULL
EXP051595		Mus musculus	TreatmentTbeta4-primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	NULL	53	chip_control	NULL	heart	NULL
EXP051596	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	Treatment PBS primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051592	53	normal	Q3TKT4	heart	NULL
EXP051597	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	Treatment PBS primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051593	53	normal	Q3TKT4	heart	NULL
EXP051598	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	TreatmentTbeta4-primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051594	53	normal	Q3TKT4	heart	NULL
EXP051599	Anti-SNF2b/Brg1 (Millipore, 07-478)	Mus musculus	TreatmentTbeta4-primed Tissue: heart 4 days post-injury (MI) Strain: C57BL/6 Age:  Adult (10-12 weeks postnatally)	EXP051595	53	normal	Q3TKT4	heart	NULL
EXP051600	none	Mus musculus	Genotype: Ela1-myc mice Age: 8 weeks-old	NULL	713	chip_control	NULL	pancreas	NULL
EXP051601	none	Mus musculus	Genotype: Ela1-myc mice Age: 8 weeks-old	NULL	713	chip_control	NULL	pancreas	NULL
EXP051602	Ptf1a antibody (kindly supplied by Bernardette BrÃ©ant)	Mus musculus	Genotype: Ela1-myc mice Age: 8 weeks-old	EXP051600	713	normal	Q9QX98	pancreas	NULL
EXP051603	c-Myc antibody (N262, Santa Cruz) 	Mus musculus	Genotype: Ela1-myc mice Age: 8 weeks-old	EXP051601	713	normal	P01108	pancreas	NULL
EXP051604	JunD (sc-74, Santa Cruz)	Mus musculus	Genotype: wildtype Strain: C57BL/6 Tissue: spleen Treament: stimulated ex vivo with plate-bound anti-CD3 and anti-CD28 antibodies	NULL	2444	normal	P15066	pre-activated CD8+ T cells	NULL
EXP051605	JunD (sc-74, Santa Cruz)	Mus musculus	Genotype: Bach2-/- Strain: C57BL/6 Tissue: spleen Treament: stimulated ex vivo with plate-bound anti-CD3 and anti-CD28 antibodies	NULL	2444	normal	P15066	pre-activated CD8+ T cells	NULL
EXP051606	p300 (sc-586, Santa Cruz)	Mus musculus	Genotype: wildtype Strain: C57BL/6 Tissue: spleen 	NULL	2444	normal	B2RWS6	pre-activated CD8+ T cells	NULL
EXP051607		Mus musculus	Strain: C57Bl/6 Genotype: wildtype Age: 5 weeks	NULL	32	chip_control	NULL	testis	NULL
EXP051608		Mus musculus	Strain: C57Bl/6 Genotype: Phf13-/- Age: 5 weeks	NULL	32	chip_control	NULL	testis	NULL
EXP051609		Mus musculus	Strain: C57Bl/6 Genotype: Phf13-/- Age: 5 weeks	NULL	32	chip_control	NULL	testis	NULL
EXP051610	anti-SPOC1	Mus musculus	Strain: C57Bl/6 Genotype: wildtype Age: 5 weeks	EXP051607	32	normal	Q3V230	testis	NULL
EXP051611	anti-SPOC1	Mus musculus	Strain: C57Bl/6 Genotype: Phf13-/- Age: 5 weeks	EXP051608	32	normal	Q3V230	testis	NULL
EXP051612	anti-SPOC1	Mus musculus	Strain: C57Bl/6 Genotype: Phf13-/- Age: 5 weeks	EXP051609	32	normal	Q3V230	testis	NULL
EXP051613	anti-Bcl11b, Bethyl (Cat# A300-385A)	Mus musculus	Tissue: Thymus Strain: C57BL/6	NULL	171	normal	Q99PV8	CD4+ CD8+ T cells	NULL
EXP051614	againt BCL11B, Bethyl (Cat# A300-385A)	Mus musculus	Tissue: Peripheral lymph node Strain: C57BL/6	NULL	2421	normal	Q99PV8	naive CD4+T cells	NULL
EXP051615		Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: wildtype Source: E18.5 derived primary murine keratinocytes	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP051616		Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: TAp63-/-  Source: E18.5 derived primary murine keratinocytes	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP051617		Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: {delta}Np63-/-  Source: E18.5 derived primary murine keratinocytes	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP051618	anti-p63	Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: wildtype Source: E18.5 derived primary murine keratinocytes	EXP051615	936	normal	O88898	primary keratinocytes	NULL
EXP051619	anti-p63	Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: TAp63-/-  Source: E18.5 derived primary murine keratinocytes	EXP051616	936	normal	O88898	primary keratinocytes	NULL
EXP051620	anti-p63	Mus musculus	Passage: p1 Strain: C57BL/6 Genotype: {delta}Np63-/-  Source: E18.5 derived primary murine keratinocytes	EXP051617	936	normal	O88898	primary keratinocytes	NULL
EXP051621	NULL	Mus musculus	Treatment: fixed with EGS Strain: C57BL/6 Tissue: thymocyte Age: adult (11 weeks) Sex: male Genotype: wildtype	NULL	2446	chip_control	NULL	total thymocytes	NULL
EXP051622	NULL	Mus musculus	Treatment: fixed with formaldehyde Strain: C57BL/6 Tissue: thymocyte Age: adult (11 weeks) Sex: male Genotype: wildtype	NULL	2446	chip_control	NULL	total thymocytes	NULL
EXP051623	NULL	Mus musculus	Treatment: fixed with formaldehyde Strain: C57BL/6 Tissue: thymocyte Age: adult (8.1 weeks) Sex: male Genotype: wildtype	NULL	2446	chip_control	NULL	total thymocytes	NULL
EXP051624	anti-Bcl11b Bethyl (Cat# A300-383A)	Mus musculus	Treatment: fixed with EGS Strain: C57BL/6 Tissue: thymocyte Age: adult (11 weeks) Sex: male Genotype: wildtype	EXP051621	2446	normal	Q99PV8	total thymocytes	NULL
EXP051625	anti-Bcl11b Bethyl (Cat# A300-383A)	Mus musculus	Treatment: fixed with formaldehyde Strain: C57BL/6 Tissue: thymocyte Age: adult (11 weeks) Sex: male Genotype: wildtype	EXP051622	2446	normal	Q99PV8	total thymocytes	NULL
EXP051626	anti-Bcl11b Bethyl (Cat# A300-383A)	Mus musculus	Treatment: fixed with formaldehyde Strain: C57BL/6 Tissue: thymocyte Age: adult (8.1 weeks) Sex: male Genotype: wildtype	EXP051623	2446	normal	Q99PV8	total thymocytes	NULL
EXP051627	none	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051628	none	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051629	none	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051630	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051631	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051632	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051633	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051634	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051635	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051636	none	Mus musculus	Strain: 129SV Genotype: wildtype	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051637	none	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051638	none	Mus musculus	Strain: 129SV Genotype: wildtype	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051639	none	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP051640	brg1 (sc10768x ,santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	EXP051627	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	NULL
EXP051641	brg1 (sc10768x ,santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	EXP051628	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	NULL
EXP051642	phf5a (sc82995x, santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	normal	P83870	mESCs (mouse embryonic stem cells)	NULL
EXP051643	phf5a	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 flox flox parental	NULL	2	normal	P83870	mESCs (mouse embryonic stem cells)	NULL
EXP051644	ssrp1 (sc73546, santa cruz)	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	normal	Q08943	mESCs (mouse embryonic stem cells)	NULL
EXP051645	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051636	765	normal	Q3TKT4	R1 (embryonic stem cells)	NULL
EXP051646	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051636	765	normal	Q61103	R1 (embryonic stem cells)	NULL
EXP051647	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051639	765	normal	Q3TKT4	R1 (embryonic stem cells)	NULL
EXP051648	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051639	765	normal	Q61103	R1 (embryonic stem cells)	NULL
EXP051649	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051638	765	normal	Q61103	R1 (embryonic stem cells)	NULL
EXP051650	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051637	765	normal	Q3TKT4	R1 (embryonic stem cells)	NULL
EXP051651	DPF2 (ab134942, Abcam)	Mus musculus	Strain: 129SV Genotype: MLL3/4 double catalytic dead	EXP051637	765	normal	Q61103	R1 (embryonic stem cells)	NULL
EXP051652	brg1 (Abcam ,ab110641)	Mus musculus	Strain: 129SV Genotype: wildtype	EXP051638	765	normal	Q3TKT4	R1 (embryonic stem cells)	NULL
EXP051653	baf155 (sc-365543X, santa cruz)	Mus musculus	Strain : 129/Ola	NULL	2	normal	P97496	mESCs (mouse embryonic stem cells)	NULL
EXP051654	baz1a	Mus musculus	Strain : 129/Ola	NULL	2	normal	O88379	mESCs (mouse embryonic stem cells)	NULL
EXP051655	brg1 (sc10768x, santa cruz)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	NULL
EXP051656	phf5a (sc82995x, santa cruz )	Mus musculus	Strain : 129/Ola	NULL	2	normal	P83870	mESCs (mouse embryonic stem cells)	NULL
EXP051657	ruvbl1 (06-1299,upstate)	Mus musculus	Strain : 129/Ola	NULL	2	normal	P60122	mESCs (mouse embryonic stem cells)	NULL
EXP051658	ruvbl2	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q9WTM5	mESCs (mouse embryonic stem cells)	NULL
EXP051659	sap18 (ab31748, abcam )	Mus musculus	Strain : 129/Ola	NULL	2	normal	O55128	mESCs (mouse embryonic stem cells)	NULL
EXP051660	smc3 (ab9263, abcam )	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q9CW03	mESCs (mouse embryonic stem cells)	NULL
EXP051661	srsf1 (am39544, active motif)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q6PDM2	mESCs (mouse embryonic stem cells)	NULL
EXP051662	srsf2 (sc53518, santa cruz)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q62093	mESCs (mouse embryonic stem cells)	NULL
EXP051663	sur2 (550429, BD pharmingen)	Mus musculus	Strain : 129/Ola	NULL	2	normal	P70170	mESCs (mouse embryonic stem cells)	NULL
EXP051664	wstf (ab51256, abcam)	Mus musculus	Strain : 129/Ola	NULL	2	normal	Q9Z277	mESCs (mouse embryonic stem cells)	NULL
EXP051665	brg1 (sc10768x ,santa cruz)	Mus musculus	Strain : 129/Ola Genotype: MLL3/4 flox flox parental	NULL	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	NULL
EXP051666	med12 (A300-772A, bethyl)	Mus musculus	Strain : 129/Ola	NULL	2	normal	A2AGH6	mESCs (mouse embryonic stem cells)	NULL
EXP051667	med1 (sc8998, santa cruz)	Mus musculus	Strain: 129/Ola  	NULL	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP051668	phrf1 (A302-044A, bethyl )	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 double knockout	NULL	2	normal	A6H619	mESCs (mouse embryonic stem cells)	NULL
EXP051669	phrf1	Mus musculus	Strain: 129/C57 	NULL	2	normal	A6H619	mESCs (mouse embryonic stem cells)	NULL
EXP051670	phrf1	Mus musculus	Strain: 129/C57 Genotype: MLL3/4 flox flox parental	NULL	2	normal	A6H619	mESCs (mouse embryonic stem cells)	NULL
EXP051671	none	Mus musculus	Genotype: wildtype	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051672	none	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051673	none	Mus musculus	Genotype: wildtype	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051674	none	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051675	none	Mus musculus	Genotype: wildtype	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051676	none	Mus musculus	Genotype: wildtype Day: 2.5	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051677	none	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051678	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051679	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051680	none	Mus musculus	Genotype: wildtype Day: 0	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051681	input	Mus musculus	Genotype: wildtype Day: 1	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051682	input	Mus musculus	Genotype: wildtype Day: 1.5	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051683	input	Mus musculus	Genotype: wildtype Day: 2	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051684	input	Mus musculus	Genotype: wildtype Day: 2.5	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051685	input	Mus musculus	Genotype: wildtype Day: 3	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051686	input	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 0	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051687	input	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051688	none	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1.5	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051689	input	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051690	input	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2.5	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051691	input	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051692	Smc3	Mus musculus	Genotype: wildtype	EXP051675	230	normal	Q9CW03	ES-E14 (E14, embryonic stem cells)	NULL
EXP051693	Smc3	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	EXP051677	230	normal	Q9CW03	ES-E14 (E14, embryonic stem cells)	NULL
EXP051694	Med1	Mus musculus	Genotype: wildtype	EXP051675	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	NULL
EXP051695	Med1	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	EXP051676	230	normal	Q925J9	ES-E14 (E14, embryonic stem cells)	NULL
EXP051696	Med12	Mus musculus	Genotype: wildtype	EXP051675	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051697	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	EXP051676	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051698	Med23	Mus musculus	Genotype: wildtype	NULL	230	normal	Q80YQ2	ES-E14 (E14, embryonic stem cells)	NULL
EXP051699	Med23	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout)	NULL	230	normal	Q80YQ2	ES-E14 (E14, embryonic stem cells)	NULL
EXP051700	Med12	Mus musculus	Genotype: wildtype Day: 0	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051701	Rad21	Mus musculus	Genotype: wildtype Day: 0	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051702	Med12	Mus musculus	Genotype: wildtype Day: 1	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051703	Rad21	Mus musculus	Genotype: wildtype Day: 1	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051704	Med12	Mus musculus	Genotype: wildtype Day: 1.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051705	Rad21	Mus musculus	Genotype: wildtype Day: 1.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051706	Med12	Mus musculus	Genotype: wildtype Day: 2	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051707	Rad21	Mus musculus	Genotype: wildtype Day: 2	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051708	Med12	Mus musculus	Genotype: wildtype Day: 2.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051709	Rad21	Mus musculus	Genotype: wildtype Day: 2.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051710	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051711	Rad21	Mus musculus	Genotype: wildtype Day: 3	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051712	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 0	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051713	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 0	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051714	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051715	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051716	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051717	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 1.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051718	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051719	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051720	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2.5	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051721	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 2.5	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051722	Med12	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	normal	A2AGH6	ES-E14 (E14, embryonic stem cells)	NULL
EXP051723	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) Day: 3	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051724	CTCF	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) dead Cas9 protein (dCas9) without  MLL3SET domain 	NULL	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP051725	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout) dead Cas9 protein (dCas9) without  MLL3SET domain 	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051726	CTCF	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout), dCas9-MLL3SET fusion protein	NULL	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP051727	Rad21	Mus musculus	Genotype: Mll3-/- Mll4-/- (double knockout), dCas9-MLL3SET fusion protein	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051728	Rad21	Mus musculus	Genotype: wildtype	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051729	Rad21	Mus musculus	Genotype: MLL3/4 enzymatically dead	NULL	230	normal	Q61550	ES-E14 (E14, embryonic stem cells)	NULL
EXP051730		Mus musculus	Genotype: GPS2 knockout Strain: 129sv/C57BL6J Sex: Female	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP051731		Mus musculus	Genotype: GPS2 wildtype Strain: 129sv/C57BL6J Sex: Female	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP051732		Mus musculus	Genotype: GPS2 knockout Strain: 129sv/C57BL6J Sex: male	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP051733		Mus musculus	Genotype: GPS2 wildtype Strain: 129sv/C57BL6J Sex: male	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP051734	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 knockout Strain: 129sv/C57BL6J Sex: Female	EXP051730	115	normal	Q921N8	brown adipose tissue	NULL
EXP051735	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 wildtype Strain: 129sv/C57BL6J Sex: Female	EXP051731	115	normal	Q921N8	brown adipose tissue	NULL
EXP051736	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 knockout Strain: 129sv/C57BL6J Sex: male	EXP051732	115	normal	Q921N8	brown adipose tissue	NULL
EXP051737	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: GPS2 wildtype Strain: 129sv/C57BL6J Sex: male	EXP051733	115	normal	Q921N8	brown adipose tissue	NULL
EXP051738	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: wildtype Treatment: untreated	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	NULL
EXP051739	GPS2 rabbit polyclonal ct (custom, #aa 307-327)	Mus musculus	Genotype: wildtype Treatment: treated with FCCP	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	NULL
EXP051740	mouse IgG1 (Invitrogen, 10005292, lot V017)	Mus musculus		NULL	2447	chip_control	NULL	cultured embryonic stem cells (ES cells)	NULL
EXP051741	Flag (Sigma M2) + HA tag (F-7), Santa Cruz Biotechnologies, sc-7392	Mus musculus	Genotype: stably expressing FHA-Srap1(wildtype) Passsage: 3-5 Strain: 129SVxC57/BL6 	EXP051740	2447	normal	Q8R1M0	cultured embryonic stem cells (ES cells)	NULL
EXP051742	none	Mus musculus		NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP051743	anti-Zac1	Mus musculus		EXP051742	1245	normal	Q9JLQ4	Neuro-2A cells	NULL
EXP051744	Rad21, abcam ab992	Mus musculus	Treament: treated with KLA for either 1hr or 6hrs	NULL	2448	normal	Q61550	46C (embryonic stem cell)	NULL
EXP051745	Rad21, abcam ab992	Mus musculus	Treatment: treated with KLA for either 1hr or 6hrs	NULL	732	normal	Q61550	peritoneal macrophages	NULL
EXP051746	Rad21, abcam ab992	Mus musculus	Treatment: no	NULL	2448	normal	Q61550	46C (embryonic stem cell)	NULL
EXP051747	IgG (Santa Cruz, sc-2027)	Mus musculus		NULL	5	chip_control	NULL	liver	NULL
EXP051748	Myc N262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA, tet-Myc	EXP051747	5	normal	P01108	liver	NULL
EXP051749	MycN262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA (wildtype)	EXP051747	5	normal	P01108	liver	NULL
EXP051750	TEAD4 (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA, tet-Myc	EXP051747	5	normal	Q62296	liver	NULL
EXP051751	TEAD (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA (wildtype)	EXP051747	5	normal	Q62296	liver	NULL
EXP051752	MycN262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA, tet-YAP	EXP051747	5	normal	P01108	liver	NULL
EXP051753	MycN262 (Santa Cruz, sc 764)	Mus musculus	Genotype: R26-rtTA, tet-YAP, tet-Myc	EXP051747	5	normal	P01108	liver	NULL
EXP051754	TEAD (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA, tet-YAP	EXP051747	5	normal	Q62296	liver	NULL
EXP051755	TEAD (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Genotype: R26-rtTA, tet-YAP, tet-Myc	EXP051747	5	normal	Q62296	liver	NULL
EXP051756	YAP 63.7(Santa Cruz, sc101199)	Mus musculus	Genotype: R26-rtTA, tet-YAP	EXP051747	5	normal	P46938	liver	NULL
EXP051757	YAP 63.7(Santa Cruz, sc101199)	Mus musculus	Genotype: R26-rtTA, tet-YAP, tet-Myc	EXP051747	5	normal	P46938	liver	NULL
EXP051758	IgG (Santa Cruz, sc-2027)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	NULL	22	chip_control	NULL	3T9 fibroblasts	NULL
EXP051759	Myc N262 (Santa Cruz, sc 764)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	EXP051758	22	normal	P01108	3T9 fibroblasts	NULL
EXP051760	TEAD4 (ARP38276_P050, Aviva Systems Biology)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	EXP051758	22	normal	Q62296	3T9 fibroblasts	NULL
EXP051761	YAP 63.7(Santa Cruz, sc101199)	Mus musculus	Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER	EXP051758	22	normal	P46938	3T9 fibroblasts	NULL
EXP051762	none, input	Mus musculus	Cell line: F1-2.1 Genotype: GLI1-3xFLAG Sex: female	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051763	none, input	Mus musculus	Cell line: F1-2.1 Genotype: GLI2-3xFLAG Sex: female	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051764	none, input	Mus musculus	Cell line: F1-2.1 Genotype: GLI1-3xFLAG Sex: female	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051765	none, input	Mus musculus	Cell line: F1-2.1 Genotype: GLI2-3xFLAG Sex: female	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051766	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI1-3xFLAG Sex: female	EXP051762	2	normal	P47806	mESCs (mouse embryonic stem cells)	NULL
EXP051767	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI2-3xFLAG Sex: female	EXP051763	2	normal	Q0VGT2	mESCs (mouse embryonic stem cells)	NULL
EXP051768	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI1-3xFLAG Sex: female	EXP051764	2	normal	P47806	mESCs (mouse embryonic stem cells)	NULL
EXP051769	anti-FLAG M2 agarose (Sigma-Aldrich)	Mus musculus	Cell line: F1-2.1 Genotype: GLI2-3xFLAG Sex: female	EXP051765	2	normal	Q0VGT2	mESCs (mouse embryonic stem cells)	NULL
EXP051770	none	Mus musculus	Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051771	none	Mus musculus	Treatment: no Genotype: Smad3CA expression Source: day 3 of reprogramming 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051772	Oct4	Mus musculus	Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming 	EXP051770	12	normal	P20263	MEF (mouse embryonic fibroblasts)	NULL
EXP051773	Smad3	Mus musculus	Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming 	EXP051770	12	normal	Q8BUN5	MEF (mouse embryonic fibroblasts)	NULL
EXP051774	Smad3	Mus musculus	Treatment: no Genotype: Smad3CA expression Source: day 3 of reprogramming 	EXP051771	12	normal	Q8BUN5	MEF (mouse embryonic fibroblasts)	NULL
EXP051775	None	Mus musculus	Sex: male Age: 1-2 months Strain: C57BL/6 Treatment: transduced with SOX2	NULL	193	chip_control	NULL	cortex	NULL
EXP051776	Rabbit anti-SOX2 polyclonal antibody (Millipore, AB5603)	Mus musculus	Sex: male Age: 1-2 months Strain: C57BL/6 Treatment: transduced with SOX2	EXP051775	193	normal	P48432	cortex	NULL
EXP051777	HNF6 (Santa Cruz, sc-13050)	Mus musculus	Genotype: wildtype Strain: c57bl	NULL	5	normal	O08755	liver	NULL
EXP051778	HNF6 (Santa Cruz, sc-13050)	Mus musculus	Genotype: TET2 and TET3 was deleted after birth in hepatocytes Strain: c57bl	NULL	5	normal	O08755	liver	NULL
EXP051779	none	Mus musculus	Genotype: wildtype 	NULL	204	chip_control	NULL	D3 (embryonic stem cells)	NULL
EXP051780	none	Mus musculus	Genotype: compaction mutant CBX2 (KRA) Treatment: appropriate amounts of doxycycline for 48 hrs	NULL	204	chip_control	NULL	D3 (embryonic stem cells)	NULL
EXP051781	CBX2 (Bethyl Laboratories Inc. A302-524A)	Mus musculus	Genotype: wildtype 	EXP051779	204	normal	P30658	D3 (embryonic stem cells)	NULL
EXP051782	CBX2 (Bethyl Laboratories Inc. A302-524A)	Mus musculus	Genotype: compaction mutant CBX2 (KRA) Treatment: appropriate amounts of doxycycline for 48 hrs	EXP051780	204	normal	P30658	D3 (embryonic stem cells)	NULL
EXP051783		Mus musculus	Genotype: wildtype	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051784	Anti-KAP1 (ab10843)	Mus musculus	Genotype: wildtype	EXP051783	12	normal	Q62318	MEF (mouse embryonic fibroblasts)	NULL
EXP051785	Anti-FOXO1A (abcam , ab39670)	Mus musculus	Treatment: 0.1% ethanol	NULL	401	normal	Q9R1E0	C10 (pre-B-cells)	NULL
EXP051786	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treatment: 0.1% ethanol	NULL	401	normal	Q07802	C10 (pre-B-cells)	NULL
EXP051787	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treamtent: 100 nM of beta-estradiol (Calbiochem) and grown with 10 nM of IL-3 and CSF-1 for 0.3 hr	NULL	401	normal	Q8K5B8	C10 (pre-B-cells)	NULL
EXP051788	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treamtent: 100 nM of beta-estradiol (Calbiochem) and grown with 10 nM of IL-3 and CSF-1 for 12 hrs	NULL	401	normal	Q8K5B8	C10 (pre-B-cells)	NULL
EXP051789	Ebf1 (abnova 1879-mol clone 1c12)	Mus musculus	Treamtent: 100 nM of beta-estradiol (Calbiochem) and grown with 10 nM of IL-3 and CSF-1 for 24 hrs	NULL	401	normal	Q8K5B8	C10 (pre-B-cells)	NULL
EXP051790		Mus musculus	Tissue: pancreas Strain: C57BL/6	NULL	2449	chip_control	NULL	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP051791	anti-HA	Mus musculus	Tissue: pancreas Strain: C57BL/6	EXP051790	2449	normal	P54841	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP051792	none	Mus musculus	Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 48 hours	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP051793	Anti-LSD1 polyclonal antibody (Abcam: ab177721)	Mus musculus	Treatment: For myogenic induction, medium was changed to DMEM containing 25mM glucose and 2% horse serum, then incubated for 48 hours	EXP051792	1153	normal	Q6ZQ88	C2C12 (myoblasts)	NULL
EXP051794	IgG Sigma I5381	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 	NULL	75	chip_control	NULL	AtT-20 (pituitary tumor)	NULL
EXP051795		Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 	NULL	75	chip_control	NULL	AtT-20 (pituitary tumor)	NULL
EXP051796		Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	NULL	75	chip_control	NULL	AtT-20 (pituitary tumor)	NULL
EXP051797	anti- flag (Sigma, F3165)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	P47239	AtT-20 (pituitary tumor)	NULL
EXP051798	Tpit (Pulichino et al. 2003)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	Q99ME7	AtT-20 (pituitary tumor)	NULL
EXP051799	GR (Santa Cruz, Sc1004)	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	P06537	AtT-20 (pituitary tumor)	NULL
EXP051800	GR (Santa Cruz, Sc1004)	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	P06537	AtT-20 (pituitary tumor)	NULL
EXP051801	p300 (Santa Cruz, Sc585)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	B2RWS6	AtT-20 (pituitary tumor)	NULL
EXP051802	p300 (Santa Cruz, Sc585)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	B2RWS6	AtT-20 (pituitary tumor)	NULL
EXP051803	Stat3 Sc482+Sc7993-R	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	P42227	AtT-20 (pituitary tumor)	NULL
EXP051804	Stat3 Sc482+Sc7993-R	Mus musculus	Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	P42227	AtT-20 (pituitary tumor)	NULL
EXP051805	anti- flag (Sigma, F3165)	Mus musculus	Treatment: 3 days of 0.1% ethanol Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing chimera of 3x flag-Pax7 	EXP051795	75	normal	P47239	AtT-20 (pituitary tumor)	NULL
EXP051806	anti- flag (Sigma, F3165)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	P97798	AtT-20 (pituitary tumor)	NULL
EXP051807	Tpit (Pulichino et al. 2003)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20  Genotype: expressing 3x flag-ER-Pax7	EXP051795	75	normal	Q99ME7	AtT-20 (pituitary tumor)	NULL
EXP051808	anti- flag (Sigma, F3165)	Mus musculus	Treatment: >20 days of 4-hydroxy-tamoxifen followed by 18 days of Ethanol Cell type:  Genotype:3x flag-ER-Pax10 Cell type: pituitary corticotroph cell Passage: 10-20   	EXP051795	75	normal	P47239	AtT-20 (pituitary tumor)	NULL
EXP051809	Stat3 (Sc482+Sc7993-R)	Mus musculus	Treatment: 30 minutes of LIF and Dexamethasone, >20 days of 4-hydroxy-tamoxifen Cell type:  Genotype:3x flag-ER-Pax8 Cell type: pituitary corticotroph cell Passage: 10-20   	EXP051795	75	normal	P42227	AtT-20 (pituitary tumor)	NULL
EXP051810	Stat3 (Sc482+Sc7993-R)	Mus musculus	Treatment: 30 minutes of LIF and Dexamethasone, >20 days of 4-hydroxy-tamoxifen followed by 18 days of Ethanol treatment Cell type:  Genotype:3x flag-ER-Pax9 Cell type: pituitary corticotroph cell Passage: 10-20   	EXP051795	75	normal	P42227	AtT-20 (pituitary tumor)	NULL
EXP051811	CTCF (millipore, 07-729)	Mus musculus	Treatment: none Passage: 10-20 Cell type: pituitary corticotroph cell Genotype: expressing 3x flag-Neo	EXP051795	75	normal	Q61164	AtT-20 (pituitary tumor)	NULL
EXP051812	SMC1 (Bethyl, A300-055A)	Mus musculus	Genotype: wildtype Passage: 10-20 Cell type: pituitary corticotroph cell	EXP051795	75	normal	Q9CU62	AtT-20 (pituitary tumor)	NULL
EXP051813	ASH2 (Bethyl A300-489A)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo	EXP051795	75	normal	Q91X20	AtT-20 (pituitary tumor)	NULL
EXP051814	ASH2 (Bethyl A300-489A)	Mus musculus	Treatment: non treated Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 	EXP051796	75	normal	Q91X20	AtT-20 (pituitary tumor)	NULL
EXP051815	none	Mus musculus	Genotype: setd2 f/f  Age: 6 week Strain: C57BL/6 	NULL	142	chip_control	NULL	intestine	NULL
EXP051816	setd2 (Life, LS-C341561)	Mus musculus	Genotype: setd2 f/f  Age: 6 week Strain: C57BL/6 	EXP051815	142	normal	E9Q5F9	intestine	NULL
EXP051817	none	Mus musculus	Treatment: Serum LIF	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051818	none	Mus musculus	Treatment: Serum LIF + 2i(3 uM CHIR99021  and 1 uM PD0325901)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051819	none	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051820	none	Mus musculus	Treatment: Serum LIF	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051821	none	Mus musculus	Treatment: Serum LIF + 2i(3 uM CHIR99021  and 1 uM PD0325901)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051822	none	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051823	none	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 + 2i(3 uM CHIR99021  and 1 uM PD0325901)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051824	anti-Brd4, Bethyl Laboratories A301-985A50	Mus musculus	Treatment: Serum LIF	EXP051817	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	NULL
EXP051825	anti-Brd4, Bethyl Laboratories A301-985A50	Mus musculus	Treatment: Serum LIF + 2i(3 uM CHIR99021  and 1 uM PD0325901)	EXP051818	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	NULL
EXP051826	anti-Brd4, Bethyl Laboratories A301-985A50	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 	EXP051819	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	NULL
EXP051827	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF	EXP051820	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP051828	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF + 2i(3 uM CHIR99021  and 1 uM PD0325901)	EXP051821	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP051829	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 	EXP051822	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP051830	anti-Med1, Bethyl Laboratories A300-793A	Mus musculus	Treatment: Serum LIF + 500 nM JQ1 + 2i(3 uM CHIR99021  and 1 uM PD0325901)	EXP051823	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP051831	none	Mus musculus	Strain: C57BL/6J Age: 4 months Genotype: wildtype Sex: male 	NULL	2450	chip_control	NULL	striatum	NULL
EXP051832	none	Mus musculus	Strain: C57BL/6J Age: 4 months Genotype: Q111/+ Sex: male 	NULL	2450	chip_control	NULL	striatum	NULL
EXP051833	Anti-SMAD3 antibody (Abcam #ab28379 [ChIP grade])	Mus musculus	Strain: C57BL/6J Age: 4 months Genotype: wildtype Sex: male 	EXP051831	2450	normal	Q8BUN5	striatum	NULL
EXP051834	Anti-SMAD3 antibody (Abcam #ab28379 [ChIP grade])	Mus musculus	Strain: C57BL/6J Age: 4 months Genotype: Q111/+ Sex: male 	EXP051832	2450	normal	Q8BUN5	striatum	NULL
EXP051835	none	Mus musculus	Genotype: wildtype Strain: C57BL/6J Age: E12.5 embryo 	NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP051836	E2A (sc-349X, Santa Cruz Biotechnology)	Mus musculus	Genotype: E12 knockout Strain: C57BL/6J Age: E12.5 embryo 	EXP051835	2775	normal	P15806	neural stem cells	NULL
EXP051837	E2A (sc-349X, Santa Cruz Biotechnology)	Mus musculus	Genotype: E47 knockout Strain: C57BL/6J Age: E12.5 embryo 	EXP051835	2775	normal	P15806	neural stem cells	NULL
EXP051838	E2A (sc-349X, Santa Cruz Biotechnology)	Mus musculus	Genotype: wildtype Strain: C57BL/6J Age: E12.5 embryo 	EXP051835	2775	normal	P15806	neural stem cells	NULL
EXP051839	none	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051840	none	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051841	none	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051842	none	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051843	none	Mus musculus	Treatment: 6hrs stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051844	none	Mus musculus	Treatment: 6hrs stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051845	none	Mus musculus	Treatment: 6hrs stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	NULL	2452	chip_control	NULL	primary fibroblasts	NULL
EXP051846	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	P01101	primary fibroblasts	NULL
EXP051847	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	P01101	primary fibroblasts	NULL
EXP051848	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P01101	primary fibroblasts	NULL
EXP051849	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P01101	primary fibroblasts	NULL
EXP051850	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: Fos -/- ( FOS knockout) Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P01101	primary fibroblasts	NULL
EXP051851	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: Fos -/- ( FOS knockout) Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P01101	primary fibroblasts	NULL
EXP051852	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	P47930	primary fibroblasts	NULL
EXP051853	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	P47930	primary fibroblasts	NULL
EXP051854	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P47930	primary fibroblasts	NULL
EXP051855	anti-FOSL2 (Santa Cruz, sc-604X, lot #H2713)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P47930	primary fibroblasts	NULL
EXP051856	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	P15066	primary fibroblasts	NULL
EXP051857	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	P15066	primary fibroblasts	NULL
EXP051858	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	P15066	primary fibroblasts	NULL
EXP051859	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	P15066	primary fibroblasts	NULL
EXP051860	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051843	2452	normal	P01101	primary fibroblasts	NULL
EXP051861	anti-FOS (Santa Cruz, sc-7202X, lot #A2513)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051844	2452	normal	P01101	primary fibroblasts	NULL
EXP051862	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment:starved with 0.5% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051839	2452	normal	P15066	primary fibroblasts	NULL
EXP051863	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051843	2452	normal	P15066	primary fibroblasts	NULL
EXP051864	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment:starved with 0.5% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051840	2452	normal	P15066	primary fibroblasts	NULL
EXP051865	JunD (Santa Cruz, sc-74 lot, #I1014)	Mus musculus	Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 	EXP051844	2452	normal	P15066	primary fibroblasts	NULL
EXP051866	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051867	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051868	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051841	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051869	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051870	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051871	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051845	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051872	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051839	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051873	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051840	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051874	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: starved with 0.5% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051841	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051875	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051843	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051876	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051844	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051877	Smarca4 (Abcam, ab4081, lot #GR152856-1)	Mus musculus	Treatment: 90min stimulation with 15% serum media + anisomycin Passage: 3 Genotype: wildtype Strain:C57BL/6J  Age: E13.5-E14.5	EXP051845	2452	normal	Q3TKT4	primary fibroblasts	NULL
EXP051878	no antibody added	Mus musculus	Tissue: spleen Strain: C57BL/6 Genotype: wildtype	NULL	2453	chip_control	NULL	spleen CD4+ T cells	NULL
EXP051879	no antibody added	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: wildtype	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP051880	no antibody added	Mus musculus	Tissue: spleen Strain: C57BL/6 Genotype: wildtype	NULL	2453	chip_control	NULL	spleen CD4+ T cells	NULL
EXP051881	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: wildtype	EXP051879	1058	normal	P70315	CD4+ T-cells	NULL
EXP051882	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: spleen Strain: C57BL/6 Genotype: wildtype	EXP051880	2453	normal	P70315	spleen CD4+ T cells	NULL
EXP051883	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: wildtype	EXP051879	1058	normal	P70315	CD4+ T-cells	NULL
EXP051884	WASp F-8 (Santa Cruz)	Mus musculus	Tissue: thymus Strain: C57BL/6 Genotype: WASp I296T	EXP051879	1058	normal	P70315	CD4+ T-cells	NULL
EXP051885	CEBPA (14AA, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1- cKit+ CD150- CD41- FcgRII/III(hi) CD115+  Tissue: bone marrow  	NULL	2458	normal	P53566	CFU-M	NULL
EXP051886	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1- cKit+ CD150- CD41- FcgRII/III(hi) CD115+  Tissue: bone marrow  	NULL	2458	normal	P17433	CFU-M	NULL
EXP051887	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1+, ckit  Tissue: bone marrow  	NULL	2454	normal	P17433	LSK	NULL
EXP051888	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105-  Tissue: bone marrow  	NULL	2455	normal	P17433	preGM	NULL
EXP051889	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: CEBPA knockout, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105-  Tissue: bone marrow  	NULL	2455	normal	P17433	preGM	NULL
EXP051890	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, FcgRII/III+  Tissue: bone marrow  	NULL	2456	normal	P17433	GMP	NULL
EXP051891	CEBPA (14AA, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105-  Tissue: bone marrow  	NULL	2455	normal	P53566	preGM	NULL
EXP051892	CEBPA (14AA, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1-cKit+ CD150- CD41- FcgRII/III(hi) CD115-  Tissue: bone marrow  	NULL	2457	normal	P53566	CFU-G	NULL
EXP051893	PU.1 (Sc-352, Santa Cruz)	Mus musculus	Genotype: wildtype, cell markers Lin- Sca1-cKit+ CD150- CD41- FcgRII/III(hi) CD115-  Tissue: bone marrow  	NULL	2457	normal	P17433	CFU-G	NULL
EXP051894		Mus musculus	Tissue: thymus Strain: L-DKO mice (deficient in Id2 and Id3)  Age: 3-5 weeks Sorting: CD1dTet- CD4+ CD8+	NULL	2459	chip_control	NULL	double-positive (DP) CD4+/CD8+ thymocyte	NULL
EXP051895		Mus musculus	Tissue: thymus Strain: L-DKO mice (deficient in Id2 and Id3)  Age: 3-5 weeks Sorting: CD1dTet+ TCR-beta+	NULL	2460	chip_control	NULL	iNKT (Invariant Natural Killer T cells)	NULL
EXP051896	anti-E2A antibody (V-18, Santa Cruz Biotechnology, Lot G0814)	Mus musculus	Tissue: thymus Strain: L-DKO mice (deficient in Id2 and Id3)  Age: 3-5 weeks Sorting: CD1dTet- CD4+ CD8+	EXP051894	2459	normal	P15806	double-positive (DP) CD4+/CD8+ thymocyte	NULL
EXP051897	anti-E2A antibody (V-18, Santa Cruz Biotechnology, Lot G0814)	Mus musculus	Tissue: thymus Strain: L-DKO mice (deficient in Id2 and Id3)  Age: 3-5 weeks Sorting: CD1dTet+ TCR-beta+	EXP051895	2460	normal	P15806	iNKT (Invariant Natural Killer T cells)	NULL
EXP051898	FLAG (Sigma, #F1804)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	NULL	523	chip_control	NULL	kidney	NULL
EXP051899	NA	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	NULL	523	chip_control	NULL	kidney	NULL
EXP051900	rabbit IgG	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	NULL	523	chip_control	NULL	kidney	NULL
EXP051901	NA	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: C57BL/6J	NULL	523	chip_control	NULL	kidney	NULL
EXP051902	NA	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: SJL/J	NULL	523	chip_control	NULL	kidney	NULL
EXP051903	NA	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	NULL	660	chip_control	NULL	nephron progenitors	NULL
EXP051904	NA	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	NULL	660	chip_control	NULL	nephron progenitors	NULL
EXP051905	FLAG (Sigma, #F1804)	Mus musculus	Genotype: Six2DE-Six2BF Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	Q62232	kidney	NULL
EXP051906	FLAG (Sigma, #F1804)	Mus musculus	Genotype: Six2DE-Hoxd11BF Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	P23813	kidney	NULL
EXP051907	Wt1 (ProteinTech, 12609-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051903	660	normal	P22561	nephron progenitors	NULL
EXP051908	Wt1 (ProteinTech, 12609-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051904	660	normal	P22561	nephron progenitors	NULL
EXP051909	CTCF (D31H2) XPÂ® Rabbit mAb	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051903	660	normal	Q61164	nephron progenitors	NULL
EXP051910	CTCF (D31H2) XPÂ® Rabbit mAb	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051904	660	normal	Q61164	nephron progenitors	NULL
EXP051911	Six2 (Proteintech,11562-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: C57BL/6J	EXP051901	523	normal	Q62232	kidney	NULL
EXP051912	Six2 (Proteintech,11562-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: SJL/J	EXP051902	523	normal	Q62232	kidney	NULL
EXP051913	Six2 (Proteintech,11562-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	Q62232	kidney	NULL
EXP051914	FLAG (Sigma, #F1804)	Mus musculus	Genotype: Six2DE-Osr1BF Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	Q9WVG7	kidney	NULL
EXP051915	Wt1 (ProteinTech, 12609-1-AP)	Mus musculus	Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW	EXP051899	523	normal	P22561	kidney	NULL
EXP051916	none	Mus musculus	Genotype: wildtype  Strain: C57BL/6	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP051917	anti-Nrdc (purified monoclonal)	Mus musculus	Genotype: wildtype  Strain: C57BL/6	EXP051916	12	normal	Q8BHG1	MEF (mouse embryonic fibroblasts)	NULL
EXP051918		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP051919	Anti-Ssrp1 (Biolegends)	Mus musculus		EXP051918	230	normal	Q08943	ES-E14 (E14, embryonic stem cells)	NULL
EXP051920	Anti-Supt16 (Cell Signaling)	Mus musculus		EXP051918	230	normal	Q920B9	ES-E14 (E14, embryonic stem cells)	NULL
EXP051921	none	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051922	none	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051923	none	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051924	none	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051925	none	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051926	none	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051927	none	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051928	none	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051929	none	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	NULL	103	chip_control	NULL	bone marrow	NULL
EXP051930	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	EXP051921	103	normal	Q9CW03	bone marrow	NULL
EXP051931	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	EXP051922	103	normal	Q9CW03	bone marrow	NULL
EXP051932	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051923	103	normal	Q9CW03	bone marrow	NULL
EXP051933	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051924	103	normal	Q9CW03	bone marrow	NULL
EXP051934	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	EXP051925	103	normal	Q9CW03	bone marrow	NULL
EXP051935	SMC3 (Abcam, ab9263, GR214360-9)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	EXP051926	103	normal	Q9CW03	bone marrow	NULL
EXP051936	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	EXP051921	103	normal	Q61164	bone marrow	NULL
EXP051937	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051923	103	normal	Q61164	bone marrow	NULL
EXP051938	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult	EXP051924	103	normal	Q61164	bone marrow	NULL
EXP051939	CTCF (Millipore, 07-729, 262833)	Mus musculus	Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult	EXP051925	103	normal	Q61164	bone marrow	NULL
EXP051940	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment:15 min without actinomycin-d,  Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	NULL
EXP051941	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment:30 min without actinomycin-d,  Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	NULL
EXP051942	SMC3 (Abcam, ab9263, GR290533-2)	Mus musculus	Treatment:60 min without actinomycin-d,  Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	NULL
EXP051943	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	EXP051927	103	normal	Q9CW03	bone marrow	NULL
EXP051944	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	EXP051928	103	normal	Q9CW03	bone marrow	NULL
EXP051945	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: cultured in aMEM 20% FBS, IL7, FLT3-L Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: Tumor Age: adult	EXP051929	103	normal	Q9CW03	bone marrow	NULL
EXP051946	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: 15 min with 10 ug/ml actinomycin-d Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	NULL
EXP051947	SMC3 (Abcam, ab9263, GR290533-3)	Mus musculus	Treatment: 30 min with 10 ug/ml actinomycin-d Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	NULL
EXP051948	SMC3 (Abcam, ab9263, GR290533-2)	Mus musculus	Treatment: 60 min with 10 ug/ml actinomycin-d Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult	NULL	103	normal	Q9CW03	bone marrow	NULL
EXP051949		Mus musculus	Characteristic: cell sorting FACS (SSEA1+) Sex: male Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E12.5  Strain: C57BL/6	NULL	2407	chip_control	NULL	primordial germ cell	NULL
EXP051950	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (SSEA1+) Sex: male Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E12.5  Strain: C57BL/6	EXP051949	2407	normal	Q60636	primordial germ cell	NULL
EXP051951	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (SSEA1+) Sex: female Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E12.5  Strain: C57BL/6	NULL	2407	normal	Q60636	primordial germ cell	NULL
EXP051952	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (KIT+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E6.5  Strain: C57BL/6	NULL	2407	normal	Q60636	primordial germ cell	NULL
EXP051953	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (KIT+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1) Age: E9.5  Strain: C57BL/6	NULL	2407	normal	Q60636	primordial germ cell	NULL
EXP051954	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (GFP+, EPCAM+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1)   Strain: C57BL/6	NULL	2462	normal	Q60636	embryonic intestinal epithelium	NULL
EXP051955	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (GFP+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1)   Strain: C57BL/6	NULL	2463	normal	Q60636	photoreceptor precursor	NULL
EXP051956	anti-GFP (Rb polyclonal, ab290)	Mus musculus	Characteristic: cell sorting FACS (GFP+, CD138+)  Genotype: Homozygous EGFP-knocked-in at the N terminus of BLIMP1 (EGFP-BLIMP1)   Strain: C57BL/6	NULL	723	normal	Q60636	plasmablasts	NULL
EXP051957	None	Mus musculus	Strain: C57BL/6J Cell line: NB490 	NULL	2464	chip_control	NULL	pancreatic acinar cells	NULL
EXP051958	PDX1 (Millipore 07-696)	Mus musculus	Strain: C57BL/6J Cell line: NB490 	EXP051957	2464	normal	P52946	pancreatic acinar cells	NULL
EXP051959	PDX1 (Abcam ab47383)	Mus musculus	Strain: C57BL/6J Cell line: NB490 	EXP051957	2464	normal	P52946	pancreatic acinar cells	NULL
EXP051960	None	Mus musculus	Cell line: NB490	NULL	1118	chip_control	NULL	pancreatic ductal adenocarcinoma	NULL
EXP051961	PDX1 (Millipore 07-696)	Mus musculus	Cell line: NB490	EXP051960	1118	normal	P52946	pancreatic ductal adenocarcinoma	NULL
EXP051962	None	Mus musculus	Source: NB490 cell line	NULL	1118	chip_control	NULL	pancreatic ductal adenocarcinoma	NULL
EXP051963	PDX1 (Millipore 07-696)	Mus musculus	Source: NB490 cell line	EXP051962	1118	normal	P52946	pancreatic ductal adenocarcinoma	NULL
EXP051964	none	Mus musculus	Genotype: wildtype Strain: CD1 Age: E14.5	NULL	2465	chip_control	NULL	embryonic genital tubercle	NULL
EXP051965	none	Mus musculus	Genotype: wildtype Strain: CD1 Age: E14.5	NULL	2465	chip_control	NULL	embryonic genital tubercle	NULL
EXP051966	anti-ISL1 rabbit monoclonal (Abcam #EP4182)	Mus musculus	Genotype: wildtype Strain: CD1 Age: E14.5	EXP051964	2465	normal	P61372	embryonic genital tubercle	NULL
EXP051967	anti-ISL1 rabbit monoclonal (Abcam #EP4182)	Mus musculus	Genotype: wildtype Strain: CD1 Age: E14.5	EXP051965	2465	normal	P61372	embryonic genital tubercle	NULL
EXP051968		Mus musculus	Genotype: Etv2 knockout iSCL Treatment: EB formation Tissue: embryoid body Source: Flk1+ mesodermal cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051969		Mus musculus	Genotype: Etv2 knockout iETV2 Treatment: EB formation Tissue: embryoid body Source: Flk1+ mesodermal cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051970	anti-scl	Mus musculus	Genotype: Etv2 knockout iSCL Treatment: EB formation Tissue: embryoid body Source: Flk1+ mesodermal cells	EXP051968	2	normal	P22091	mESCs (mouse embryonic stem cells)	NULL
EXP051971	anti-scl	Mus musculus	Genotype: Etv2 knockout iETV2 Treatment: EB formation Tissue: embryoid body Source: Flk1+ mesodermal cells	EXP051969	2	normal	P22091	mESCs (mouse embryonic stem cells)	NULL
EXP051972	none	Mus musculus	Strain: C57BL/6 Age: 10-day-old mice Source: skeletal muscle	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP051973	anti-SPIN1 antibody (custom SPIN1-5867)	Mus musculus	Strain: C57BL/6 Age: 10-day-old mice Source: skeletal muscle	EXP051972	2466	normal	Q61142	primary myoblasts	NULL
EXP051974		Mus musculus	Age: 6-8 weeks-old mice Strain: C57BL/6 Treatment: untreated	NULL	2467	chip_control	NULL	Sca1+CD45- cardiac cells	NULL
EXP051975	anti-BMI1	Mus musculus	Age: 6-8 weeks-old mice Strain: C57BL/6 Treatment: received a single dose of 20 mg/kg Paraquat (i.p.) dissolved in PBS	EXP051974	2467	normal	P25916	Sca1+CD45- cardiac cells	NULL
EXP051976	anti-BMI1	Mus musculus	Age: 6-8 weeks-old mice Strain: C57BL/6 Treatment: only received PBS	EXP051974	2467	normal	P25916	Sca1+CD45- cardiac cells	NULL
EXP051977		Mus musculus	Genotype: Tcf7+/+ Source: IL-2 activated Splenic NK cells Strain: B6	NULL	2468	chip_control	NULL	spleen natural killer cells	NULL
EXP051978		Mus musculus	Genotype: Tcf7-/- (knockout) Source: IL-2 activated Splenic NK cells Strain: B6.129 Tcf7Tm1Cle	NULL	2468	chip_control	NULL	spleen natural killer cells	NULL
EXP051979	anti-Tcf1	Mus musculus	Genotype: Tcf7+/+ Source: IL-2 activated Splenic NK cells Strain: B6	EXP051977	2468	normal	P22361	spleen natural killer cells	NULL
EXP051980	anti-Tcf1	Mus musculus	Genotype: Tcf7-/- (knockout) Source: IL-2 activated Splenic NK cells Strain: B6.129 Tcf7Tm1Cle	EXP051978	2468	normal	P22361	spleen natural killer cells	NULL
EXP051981	none (input)	Mus musculus	pool1 samples	NULL	2471	chip_control	NULL	enteric precursor cells	NULL
EXP051982	none (input)	Mus musculus	pool2 samples	NULL	2471	chip_control	NULL	enteric precursor cells	NULL
EXP051983	none (input)	Mus musculus	pool3 samples	NULL	2471	chip_control	NULL	enteric precursor cells	NULL
EXP051984	Anti-Dnmt3b antibody-ChIP Grade  (ab2851, Abcam)	Mus musculus	pool1 samples	EXP051981	2471	normal	O88509	enteric precursor cells	NULL
EXP051985	Anti-Dnmt3b antibody-ChIP Grade  (ab2851, Abcam)	Mus musculus	pool2 samples	EXP051982	2471	normal	O88509	enteric precursor cells	NULL
EXP051986	Anti-Dnmt3b antibody-ChIP Grade  (ab2851, Abcam)	Mus musculus	pool3 samples	EXP051983	2471	normal	O88509	enteric precursor cells	NULL
EXP051987	input	Mus musculus		NULL	2472	chip_control	NULL	OEC2 (Epiblast stem cells)	NULL
EXP051988	Zfp281 (Abcam #ab101318)	Mus musculus		EXP051987	2472	normal	Q99LI5	OEC2 (Epiblast stem cells)	NULL
EXP051989	IgG (normal rabbit)	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment:grown in Lif and 2i (GSKi and MEKi), Doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051990	IgG (normal rabbit)	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment:grown in Lif and 2i (GSKi and MEKi), Doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051991	IgG (normal rabbit)	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment: doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	NULL	2470	chip_control	NULL	epiblast cells	NULL
EXP051992	IgG (normal rabbit)	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment: doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	NULL	2470	chip_control	NULL	epiblast cells	NULL
EXP051993	IgG (normal rabbit)	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	NULL	2470	chip_control	NULL	epiblast cells	NULL
EXP051994	IgG (normal rabbit)	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	NULL	2470	chip_control	NULL	epiblast cells	NULL
EXP051995	IgG (normal rabbit)	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	NULL	2470	chip_control	NULL	epiblast cells	NULL
EXP051996	IgG (normal rabbit)	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	NULL	2470	chip_control	NULL	epiblast cells	NULL
EXP051997	IgG (normal rabbit)	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051998	IgG (normal rabbit)	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP051999	HA	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052000	HA	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052001	IgG (normal rabbit)	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052002	IgG (normal rabbit)	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052003	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment:grown in Lif and 2i (GSKi and MEKi), Doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051989	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP052004	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment:grown in Lif and 2i (GSKi and MEKi), Doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051990	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP052005	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment: doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051993	2470	normal	Q9CU62	epiblast cells	NULL
EXP052006	SMC1	Mus musculus	Source: dual miRNA reporter V6.5 ESCs Treatment: doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051992	2470	normal	Q9CU62	epiblast cells	NULL
EXP052007	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051993	2470	normal	Q8K5C0	epiblast cells	NULL
EXP052008	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051994	2470	normal	Q8K5C0	epiblast cells	NULL
EXP052009	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051993	2470	normal	Q9CU62	epiblast cells	NULL
EXP052010	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype	EXP051994	2470	normal	Q9CU62	epiblast cells	NULL
EXP052011	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051995	2470	normal	Q8K5C0	epiblast cells	NULL
EXP052012	GRHL2	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051996	2470	normal	Q8K5C0	epiblast cells	NULL
EXP052013	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051995	2470	normal	Q9CU62	epiblast cells	NULL
EXP052014	SMC1	Mus musculus	Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout	EXP051996	2470	normal	Q9CU62	epiblast cells	NULL
EXP052015	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP051999	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP052016	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA, ColA1-FRT Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP051998	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP052017	HA	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052001	2	normal	P63058	mESCs (mouse embryonic stem cells)	NULL
EXP052018	HA	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052002	2	normal	P63058	mESCs (mouse embryonic stem cells)	NULL
EXP052019	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052001	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP052020	SMC1	Mus musculus	Genotype: Rosa-26 M2rtTA; ColA1-TetO-HA-GRHL2  Treatment: Lif 2i (GSKi and MEKi) and 0.5ug/ml for 24hrs doxycycline	EXP052002	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP052021	input	Mus musculus		NULL	2473	chip_control	NULL	E12.5-14.5 sympathetic neurons	NULL
EXP052022	ab109517	Mus musculus		EXP052021	2473	normal	P61372	E12.5-14.5 sympathetic neurons	NULL
EXP052023	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	NULL	2474	chip_control	NULL	C127	NULL
EXP052024	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	NULL	2474	chip_control	NULL	C127	NULL
EXP052025	none	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	NULL	2474	chip_control	NULL	C127	NULL
EXP052026	none	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	NULL	2474	chip_control	NULL	C127	NULL
EXP052027	alfa-CFP1f (Rabbit polyclonal, This Study)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052025	2474	normal	Q8BGU5	C127	NULL
EXP052028	alfa-CFP1f (Rabbit polyclonal, This Study)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052026	2474	normal	Q8BGU5	C127	NULL
EXP052029	alfa-KDM2B (Rabbit polyclonal, Farcas et al., 2012)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052025	2474	normal	Q6P1G2	C127	NULL
EXP052030	alfa-KDM2B (Rabbit polyclonal, Farcas et al., 2012)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052026	2474	normal	Q6P1G2	C127	NULL
EXP052031	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052025	2474	normal	Q8BGU5	C127	NULL
EXP052032	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: wildtype	EXP052026	2474	normal	Q8BGU5	C127	NULL
EXP052033	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC mutant	EXP052025	2474	normal	Q8BGU5	C127	NULL
EXP052034	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC mutant	EXP052026	2474	normal	Q8BGU5	C127	NULL
EXP052035	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: PHD mutant	EXP052025	2474	normal	Q8BGU5	C127	NULL
EXP052036	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: PHD mutant	EXP052026	2474	normal	Q8BGU5	C127	NULL
EXP052037	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC and PHD mutant 	EXP052025	2474	normal	Q8BGU5	C127	NULL
EXP052038	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: CXXC and PHD mutant 	EXP052026	2474	normal	Q8BGU5	C127	NULL
EXP052039	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: SID mutant	EXP052025	2474	normal	Q8BGU5	C127	NULL
EXP052040	mouse monoclonal antiGFP 3E6, Invitrogen (#A11120)	Mus musculus	Source: mammary epithelial cell Genotype: SID mutant	EXP052026	2474	normal	Q8BGU5	C127	NULL
EXP052041	N/A	Mus musculus	Genotype: OMP-IRES-GFP	NULL	2475	chip_control	NULL	mature olfactory sensory neurons	NULL
EXP052042	N/A	Mus musculus	Genotype: OMP-IRES-GFP	NULL	2475	chip_control	NULL	mature olfactory sensory neurons	NULL
EXP052043	N/A	Mus musculus	Genotype: OMPcre, Lhx2 -/- (Lhx2 knockout)	NULL	2475	chip_control	NULL	mature olfactory sensory neurons	NULL
EXP052044	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052041	2475	normal	Q9Z0S2	mature olfactory sensory neurons	NULL
EXP052045	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052042	2475	normal	Q9Z0S2	mature olfactory sensory neurons	NULL
EXP052046	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052041	2475	normal	Q07802	mature olfactory sensory neurons	NULL
EXP052047	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMP-IRES-GFP	EXP052042	2475	normal	Q07802	mature olfactory sensory neurons	NULL
EXP052048	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMP-IRES-Cre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q07802	mature olfactory sensory neurons	NULL
EXP052049	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMP-IRES-Cre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q9Z0S2	mature olfactory sensory neurons	NULL
EXP052050	anti-Ebf (Aviva, ARP32960_P050)	Mus musculus	Genotype: OMPcre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q07802	mature olfactory sensory neurons	NULL
EXP052051	anti-Lhx2 (Roberson et al., 2001)	Mus musculus	Genotype: OMPcre, Lhx2 -/- (Lhx2 knockout)	EXP052043	2475	normal	Q9Z0S2	mature olfactory sensory neurons	NULL
EXP052052		Mus musculus	Genotype: wildtype Treatment: LPS for 0h (untreated) Strain: C57BL/6J	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP052053		Mus musculus	Genotype: littermate control Treatment: LPS for 0h (untreated) Strain: C57BL/6J	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP052054		Mus musculus	Genotype: Ikzf knockout Treatment: untreated Strain: C57BL/6J	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP052055	RelA (ab7970, Abcam)	Mus musculus	Genotype: wildtype Treatment: LPS for 0h (untreated) Strain: C57BL/6J	EXP052052	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052056	RelA (ab7970, Abcam)	Mus musculus	Genotype: wildtype Treatment: LPS for 3hrs  Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052057	RelA (ab7970, Abcam)	Mus musculus	Genotype: wildtype Treatment: LPS for 8hrs  Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052058	Ikaros (M-20, Santa Cruz)	Mus musculus	Genotype: wildtype Treatment: LPS for 0h (untreated) Strain: C57BL/6J	NULL	81	normal	Q03267	BMDM (bone marrow-derived macrophages)	NULL
EXP052059	Ikaros (M-20, Santa Cruz)	Mus musculus	Genotype: wildtype Treatment: LPS for 3hrs  Strain: C57BL/6J	NULL	81	normal	Q03267	BMDM (bone marrow-derived macrophages)	NULL
EXP052060	Ikaros (M-20, Santa Cruz)	Mus musculus	Genotype: wildtype Treatment: LPS for 8hrs  Strain: C57BL/6J	NULL	81	normal	Q03267	BMDM (bone marrow-derived macrophages)	NULL
EXP052061	RelA (ab7970, Abcam)	Mus musculus	Genotype: littermate control Treatment: LPS for 0hrs (untreated) Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052062	RelA (ab7970, Abcam)	Mus musculus	Genotype: littermate control Treatment: LPS for 3h (untreated) Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052063	RelA (ab7970, Abcam)	Mus musculus	Genotype: littermate control Treatment: LPS for 8hrs (untreated) Strain: C57BL/6J	NULL	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052064	none	Mus musculus	Strain: C57BL/6J Genotype: alphaMHC-MerCreMer +/-	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052065	none	Mus musculus	Strain: C57BL/6J Genotype: G9a flox/flox (G9a knockout), alphaMHC-MerCreMer +/-	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052066	anti-G9a; Sigma (G6919)	Mus musculus	Strain: C57BL/6J Genotype: alphaMHC-MerCreMer +/-	EXP052064	2476	normal	Q9Z148	cardiac myocytes	NULL
EXP052067	anti-Mef2c; Abcam (ab43796)	Mus musculus	Strain: C57BL/6J Genotype: alphaMHC-MerCreMer +/-	EXP052064	2476	normal	Q8CFN5	cardiac myocytes	NULL
EXP052068	anti-G9a; Sigma (G6919)	Mus musculus	Strain: C57BL/6J Genotype: G9a flox/flox (G9a knockout), alphaMHC-MerCreMer +/-	EXP052065	2476	normal	Q9Z148	cardiac myocytes	NULL
EXP052069	anti-Mef2c; Abcam (ab43796)	Mus musculus	Strain: C57BL/6J Genotype: G9a flox/flox (G9a knockout), alphaMHC-MerCreMer +/-	EXP052065	2476	normal	Q8CFN5	cardiac myocytes	NULL
EXP052070	none	Mus musculus	Treatment: No treatment Strain: C57BL/6J	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052071	none	Mus musculus	Treatment: transverse aortic constriction (TAC) for 1 week Strain: C57BL/6J	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052072	anti-G9a; Sigma (G6919)	Mus musculus	Treatment: No treatment Strain: C57BL/6J	EXP052070	2476	normal	Q9Z148	cardiac myocytes	NULL
EXP052073	anti-G9a; Sigma (G6919)	Mus musculus	Treatment: transverse aortic constriction (TAC) for 1 week Strain: C57BL/6J	EXP052071	2476	normal	Q9Z148	cardiac myocytes	NULL
EXP052074	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	chip_control	NULL	Lin- FLP derived CD25+	NULL
EXP052075	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	chip_control	NULL	Lin- FLP derived CD25+	NULL
EXP052076	NA	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	chip_control	NULL	Lin- FLP derived CD25+	NULL
EXP052077	NA	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	chip_control	NULL	Lin- FLP derived CD25+	NULL
EXP052078	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP Strain: CB17-Prkdc<scid> mice 	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052079	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP Strain: CB17-Prkdc<scid> mice 	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052080	NA	Mus musculus	Transduced with Lzr-EVGFP	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052081	NA	Mus musculus	Transduced with Lzr-EVGFP	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052082	NA	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052083	NA	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 24 hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052084	NA	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052085	NA	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 24hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052086		Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052087		Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052088		Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052089		Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052090	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Transduced with Lzr-PU1ENGHA	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052091	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Transduced with Lzr-PU1ETSHA	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052092	NA	Mus musculus	Treatment: Unperturbed (DSG+FA) Strain: CB17-Prkdc<scid> mice	NULL	2478	chip_control	NULL	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052093	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	EXP052076	2477	normal	P17433	Lin- FLP derived CD25+	NULL
EXP052094	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	EXP052077	2477	normal	P17433	Lin- FLP derived CD25+	NULL
EXP052095	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052096	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052097	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052098	Rabbit anti-Satb1 monoclonal IgG (ab109122, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	Q60611	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052099	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052100	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052101	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052102	Rabbit anti-Runx1 polyclonal IgG (ab23980, Abcam)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	Q03347	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052103	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052104	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052105	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052106	Mouse anti-GATA3 monoclonal IgG (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems),	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	P23772	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052107	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052086	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052108	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-Mock-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052087	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052109	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052088	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052110	Goat anti-Fog1 polyclonal IgG (sc-9361, Santa Cruz Biotechnolog)	Mus musculus	Treatment: Transduced with pMxs-PU.1-hNGFR  Strain: CB17-Prkdc<scid> mice	EXP052089	2478	normal	O35615	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052111	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1WTHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	NULL
EXP052112	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1WTHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	NULL
EXP052113	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1ENGHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	NULL
EXP052114	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU1ETSHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5	NULL	2477	normal	P17433	Lin- FLP derived CD25+	NULL
EXP052115	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: transduced with Lzr-PU1WTHA Strain: CB17-Prkdc<scid> mice 	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052116	Rabbit HA-probe polyclonal IgG (sc-805x, Santa Cruz Biotechnology)	Mus musculus	Transduced with Lzr-PU1WTHA	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052117	Rabbit anti-Ets1 polyclonal IgG (sc-350x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Unperturbed (DSG+FA) Strain: CB17-Prkdc<scid> mice	EXP052092	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052118	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052082	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052119	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 24 hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052083	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052120	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 2hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052121	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052084	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052122	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 8hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	NULL	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052123	Rabbit anti-PU.1 polyclonal IgG (sc-352x, Santa Cruz Biotechnology)	Mus musculus	Treatment: Transduced with Lzr-PU.1ert2, treated 24hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice 	EXP052085	2478	normal	P17433	pro-T-tumor derived (Scid.adh.2c2 cells)	NULL
EXP052124	none	Mus musculus	Pathogen: LCMV-OVA Source: adoptively transferred OT-1 Strain: C57BL/6 Genotype: wild type 	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP052125	Rabbit anti-TOX1 antibody (Abcam ab155768, lot GR124281-8)	Mus musculus	Pathogen: LCMV-OVA Source: adoptively transferred OT-1 Strain: C57BL/6 Genotype: wild type 	EXP052124	2479	normal	Q66JW3	CD8+ T-cells	NULL
EXP052126	Rabbit anti-TOX1 antibody (Abcam ab155768, lot GR124281-8)	Mus musculus	Pathogen: LCMV-OVA Source: adoptively transferred OT-1 Strain: C57BL/6 Genotype: Tox-deficient 	NULL	2479	normal	Q66JW3	CD8+ T-cells	NULL
EXP052127	Kdm2b	Mus musculus	Treatment: none Source: reprogramming cells, day 14	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	NULL
EXP052128	Kdm2b	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 14	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	NULL
EXP052129	Ring1b(CST,5694)	Mus musculus	Treatment: none Source: reprogramming cells, day 9	NULL	2480	normal	Q9CQJ4	somatic reprogramming cells	NULL
EXP052130	Ring1b(CST,5694)	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 9	NULL	2480	normal	Q9CQJ4	somatic reprogramming cells	NULL
EXP052131	Kdm2b-Flag: Sigma,F1804	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 6	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	NULL
EXP052132	Kdm2b-Flag: Sigma, F1804	Mus musculus	Treatment: none Source: reprogramming cells, day 6	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	NULL
EXP052133	Kdm2b	Mus musculus	Treatment: none Source: reprogramming cells, day 9	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	NULL
EXP052134	Kdm2b	Mus musculus	Treatment: 10 ng/ml of BMP4 Source: reprogramming cells, day 9	NULL	2480	normal	Q6P1G2	somatic reprogramming cells	NULL
EXP052135	none	Mus musculus	Genotype: wildtype Treatment: no	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052136	Mtf2 (Aviva System Biology ARP34292, lot QC49692-42166)	Mus musculus	Treatment: no Genotype: EED knockout Source: EED -/- cell line 	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP052137	Mtf2 (Aviva System Biology ARP34292, lot QC49692-42166)	Mus musculus	Genotype: wildtype Treatment: no	EXP052135	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP052138	Jarid2 (Novus Biologicals NB100-2214, Lot E2)	Mus musculus	Genotype: wildtype Treatment: no	EXP052135	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP052139	Jarid2 (Novus Biologicals NB100-2214, Lot E2)	Mus musculus	Treatment: no Source: Mtf2 GT/GT cell line Genotype: gene trapping cassette disrupting Mtf CDS 	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP052140	Mtf2 (Aviva System Biology ARP34292, lot QC49692-42166)	Mus musculus	Treatment: no Genotype: Jarid2 knockout	NULL	2481	normal	Q02395	E4 (embryonic stem cells)	NULL
EXP052141	none	Mus musculus	Treatment: treated with 10 u/ml erythropoietin for 30 mins 	NULL	1085	chip_control	NULL	J2E (erythroid cells)	NULL
EXP052142	anti-phospho-STAT5 (Thermofisher Scientific #716900)	Mus musculus	Treatment: treated with 10 u/ml erythropoietin for 30 mins Antibody: antibody against STAT5a and STAT5b	EXP052141	1085	normal	P42230	J2E (erythroid cells)	NULL
EXP052143	-	Mus musculus	Genotype: inducible WT EED rescue 0hr  Strain: C57BL/6	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052144	-	Mus musculus	Genotype: wildtype Source: E14Tga2	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052145	JARID2 (in house)	Mus musculus	Genotype: wildtype Source: E14Tga2	EXP052144	2	normal	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP052146	HA-tag (Abcam,ab9110)	Mus musculus	Genotype: inducible WT EED rescue 0hr  Strain: C57BL/6	EXP052143	2	normal	Q921E6	mESCs (mouse embryonic stem cells)	NULL
EXP052147	SUZ12, Cell Signaling, #3737	Mus musculus	Genotype: inducible WT EED rescue 8days, JARID2 knockout Strain: C57BL/6	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP052148	input	Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP052149	RXR? (Santa Cruz_sc-553)	Mus musculus		EXP052148	1153	normal	P28700	C2C12 (myoblasts)	NULL
EXP052150	RXR? (Santa Cruz_sc-553)	Mus musculus	50 nM bexarotene for 24 hrs	EXP052148	1153	normal	P28700	C2C12 (myoblasts)	NULL
EXP052151	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052152	TET3 (Millipore ABE290, LN: RA1205021)	Mus musculus	Genotype: TET3	EXP052151	230	normal	Q8BG87	ES-E14 (E14, embryonic stem cells)	NULL
EXP052153	TET3 (Millipore ABE290, LN: RA1205021)	Mus musculus	Genotype: TET3-CXXC	EXP052151	230	normal	K9JH93	ES-E14 (E14, embryonic stem cells)	NULL
EXP052154		Mus musculus	Genotype: wildtype 	NULL	2482	chip_control	NULL	total bone marrow	NULL
EXP052155		Mus musculus	Genotype: JMJD1B knockout Treatment: Gene-trap knockout	NULL	2482	chip_control	NULL	total bone marrow	NULL
EXP052156		Mus musculus	Genotype: wildtype Treatment: Gene-trap knockout	NULL	2483	chip_control	NULL	stem/progenitor from bone marrow	NULL
EXP052157		Mus musculus	Genotype: JMJD1B knockout 	NULL	2483	chip_control	NULL	stem/progenitor from bone marrow	NULL
EXP052158	Anti-JMJD1B, Bethyl, Cat# A300-883A	Mus musculus	Genotype: wildtype 	EXP052154	2482	normal	Q6ZPY7	total bone marrow	NULL
EXP052159	Anti-PRMT5, Millipore, Cat# 07-405	Mus musculus	Genotype: wildtype 	EXP052154	2482	normal	Q8CIG8	total bone marrow	NULL
EXP052160	Anti-JMJD1B, Bethyl, Cat# A300-883A	Mus musculus	Genotype: JMJD1B knockout Treatment: Gene-trap knockout	EXP052155	2482	normal	Q6ZPY7	total bone marrow	NULL
EXP052161		Mus musculus	Source: 3T3 cells ectopically expressing Dppa4	NULL	17	chip_control	NULL	3T3 (embryonic fibroblasts)	NULL
EXP052162		Mus musculus	Source: embryonic carcinoma cells	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP052163		Mus musculus	Source: embryonic stem cells	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052164	 DPPA4 antibody (R&D systems AF3730)	Mus musculus	Source: 3T3 cells ectopically expressing Dppa4	EXP052161	17	normal	Q8CCG4	3T3 (embryonic fibroblasts)	NULL
EXP052165	 DPPA4 antibody (R&D systems AF3730)	Mus musculus	Source: embryonic carcinoma cells	EXP052162	705	normal	Q8CCG4	P19 (embryonic carcinoma)	NULL
EXP052166	 DPPA4 antibody (R&D systems AF3730)	Mus musculus	Source: embryonic stem cells	EXP052163	230	normal	Q8CCG4	ES-E14 (E14, embryonic stem cells)	NULL
EXP052167	none (input)	Mus musculus	Treatment: shRNA infected, shControl 	NULL	1221	chip_control	NULL	AML12	NULL
EXP052168	none (input)	Mus musculus	Treatment: shRNA infected, shU Genotype: HNRNPU knockdown	NULL	1221	chip_control	NULL	AML12	NULL
EXP052169	CTCF	Mus musculus	Treatment: shRNA infected, shCtrl Genotype: wildtype	EXP052167	1221	normal	Q61164	AML12	NULL
EXP052170	CTCF	Mus musculus	Treatment: shRNA infected, shU Genotype: HNRNPU knockdown	EXP052168	1221	normal	Q61164	AML12	NULL
EXP052171	RAD21	Mus musculus	Treatment: shRNA infected, shControl 	EXP052167	1221	normal	Q61550	AML12	NULL
EXP052172	RAD21	Mus musculus	Treatment: shRNA infected, shU Genotype: HNRNPU knockdown	EXP052168	1221	normal	Q61550	AML12	NULL
EXP052173		Mus musculus	Treatment: KLA (Kdo2-Lipid A) 0hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP052174		Mus musculus	Treatment: KLA (Kdo2-Lipid A) 0hr Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP052175	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 0hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052176	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 4hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052177	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 8hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052178	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 12hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052179	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 24hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052180	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 48hr Genotype: Bmal knockout Strain: C57BL/6J Source: mouse BMDM	EXP052173	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052181	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 0hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052182	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 4hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052183	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 8hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052184	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 12hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052185	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 24hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052186	anti-NFkB	Mus musculus	Treatment: KLA (Kdo2-Lipid A) 48hr Genotype: wildtype Strain: C57BL/6J Source: mouse BMDM	EXP052174	81	normal	Q04207	BMDM (bone marrow-derived macrophages)	NULL
EXP052187	anti-Bmal1	Mus musculus	Treatment: LPS (bacterial lipopolysaccharide) 0hr Strain: C57BL/6J Source: mouse peritoneal macrophage	NULL	732	normal	Q9WTL8	peritoneal macrophages	NULL
EXP052188	anti-Bmal1	Mus musculus	Treatment: LPS (bacterial lipopolysaccharide) 0hr Strain: C57BL/6J Source: mouse peritoneal macrophage	NULL	732	normal	Q9WTL8	peritoneal macrophages	NULL
EXP052189	anti-Bmal1	Mus musculus	Treatment: LPS (bacterial lipopolysaccharide) 0hr Strain: C57BL/6J Source: mouse peritoneal macrophage	NULL	732	normal	Q9WTL8	peritoneal macrophages	NULL
EXP052190	anti-Lamin-B1 (Abcam, ab16048, #GR228534-1)	Mus musculus	Treatment: TGF- beta at a final concentration of 1-5 ng/ml, 0 hr	NULL	2484	normal	P14733	NMuMG (mammary epithelial cells)	NULL
EXP052191	anti-Lamin-B1 (Abcam, ab16048, #GR228534-1)	Mus musculus	Treatment: TGF- beta for at a final concentration of 1-5 ng/ml, 8 hr	NULL	2484	normal	P14733	NMuMG (mammary epithelial cells)	NULL
EXP052192	anti-Lamin-B1 (Abcam, ab16048, #GR228534-1)	Mus musculus	Treatment: TGF- beta at a final concentration of 1-5 ng/ml, 24 hr	NULL	2484	normal	P14733	NMuMG (mammary epithelial cells)	NULL
EXP052193	none	Mus musculus	Develomental stage: embryonic day 14-15 Strain: CD1	NULL	193	chip_control	NULL	cortex	NULL
EXP052194	none	Mus musculus	Develomental stage: embryonic day 14-15 Strain: CD1	NULL	193	chip_control	NULL	cortex	NULL
EXP052195	Foxg1 antibody	Mus musculus	Develomental stage: embryonic day 14-15 Strain: CD1	EXP052193	193	normal	Q60987	cortex	NULL
EXP052196	Foxg1 antibody	Mus musculus	Develomental stage: embryonic day 14-15 Strain: CD1	EXP052194	193	normal	Q60987	cortex	NULL
EXP052197		Mus musculus	Genotype: Oct4-GFP Protocol: sorting GFP+	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052198		Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	NULL	2485	chip_control	NULL	in-vitro differentiated neural progenitor cells (NPC)	NULL
EXP052199		Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	NULL	2485	chip_control	NULL	in-vitro differentiated neural progenitor cells (NPC)	NULL
EXP052200		Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	NULL	2486	chip_control	NULL	in-vitro differentiated cortical neurons (CN)	NULL
EXP052201		Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	NULL	2486	chip_control	NULL	in-vitro differentiated cortical neurons (CN)	NULL
EXP052202	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052198	2485	normal	Q61164	in-vitro differentiated neural progenitor cells (NPC)	NULL
EXP052203	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052199	2485	normal	Q61164	in-vitro differentiated neural progenitor cells (NPC)	NULL
EXP052204	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052198	2485	normal	Q9CQJ4	in-vitro differentiated neural progenitor cells (NPC)	NULL
EXP052205	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Sox1-GFP Protocol: sorting GFP+	EXP052199	2485	normal	Q9CQJ4	in-vitro differentiated neural progenitor cells (NPC)	NULL
EXP052206	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052200	2486	normal	Q61164	in-vitro differentiated cortical neurons (CN)	NULL
EXP052207	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052201	2486	normal	Q61164	in-vitro differentiated cortical neurons (CN)	NULL
EXP052208	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052200	2486	normal	Q9CQJ4	in-vitro differentiated cortical neurons (CN)	NULL
EXP052209	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Tau-GFP Protocol: sorting GFP+	EXP052201	2486	normal	Q9CQJ4	in-vitro differentiated cortical neurons (CN)	NULL
EXP052210	anti-CTCF, rabbit,  monoclonal (Cell Signaling, Cat# 3418S)	Mus musculus	Genotype: Oct4-GFP Protocol: sorting GFP+	EXP052197	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP052211	anti-Ring1B, rabbit, monoclonal (Cell Signaling, Cat# 5694P)	Mus musculus	Genotype: Oct4-GFP Protocol: sorting GFP+	EXP052197	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP052212	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day2	NULL	2487	normal	Q61164	primary cells (short term)	NULL
EXP052213	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day4	NULL	2487	normal	Q61164	primary cells (short term)	NULL
EXP052214	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day6	NULL	2487	normal	Q61164	primary cells (short term)	NULL
EXP052215	CTCF (Millipore/07-729)	Mus musculus	Treatment: C/EBPa was induced with beta-estradiol, day8	NULL	2487	normal	Q61164	primary cells (short term)	NULL
EXP052216	none	Mus musculus	Treatment: no treatment Genotype: tatsf1 flox/flox CreERT2	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052217	none	Mus musculus	Treatment: no treatment Genotype: tatsf1 flox/flox CreERT2	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052218	anti-HTATSF1 (produced in rabbit against mouse HTATSF1 peptide SGNNLSGNDEFDEQLR-C)	Mus musculus	Treatment: no treatment Genotype: tatsf1 flox/flox CreERT2	EXP052216	2	normal	Q8BGC0	mESCs (mouse embryonic stem cells)	NULL
EXP052219	anti-HTATSF1 (produced in rabbit against mouse HTATSF1 peptide SGNNLSGNDEFDEQLR-C)	Mus musculus	Treatment: no treatment Genotype: tatsf1 flox/flox CreERT2	EXP052217	2	normal	Q8BGC0	mESCs (mouse embryonic stem cells)	NULL
EXP052220	none (input)	Mus musculus	Tissue: Left ventricle Strain :C57BL/6 Genotype: wildtype	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052221	none (input)	Mus musculus	Tissue: Left ventricle Strain :C57BL/6 Genotype: CTCF knockout	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052222	CTCF (Active Motif Cat# 61311)	Mus musculus	Tissue: Left ventricle Strain :C57BL/6 Genotype: wildtype	EXP052220	2476	normal	Q61164	cardiac myocytes	NULL
EXP052223	CTCF (Active Motif Cat# 61311)	Mus musculus	Tissue: Left ventricle Strain :C57BL/6 Genotype: CTCF knockout	EXP052221	2476	normal	Q61164	cardiac myocytes	NULL
EXP052224		Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: no treatment	NULL	2489	chip_control	NULL	primary hepatocytes	NULL
EXP052225	p65 (Santa Cruz, cat# sc-372X, GH2651)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	Q04207	primary hepatocytes	NULL
EXP052226	CEBPB (Santa Cruz, cat# sc-150X, GH2100)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	P28033	primary hepatocytes	NULL
EXP052227	c-Jun (CST, 60A8 #9165 GH2197)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	P05627	primary hepatocytes	NULL
EXP052228	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment:  DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052229	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) + DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052230	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-6 (10ng/ml) + DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052231	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) and IL-6 (10ng/ml) + DN-NFkB for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052232	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: no treatment	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052233	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml)  for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052234	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-6 (10ng/ml) for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052235	STAT3 (Santa Cruz, cat# sc-482X GH2475)	Mus musculus	Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) and IL-6 (10ng/ml) for 2 hr	EXP052224	2489	normal	P42227	primary hepatocytes	NULL
EXP052236		Mus musculus	Strain: C57BL/6 Genotype: wildtype	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052237		Mus musculus	Strain: N/A  	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052238	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: C57BL/6 Genotype: wildtype	EXP052236	12	normal	Q61687	MEF (mouse embryonic fibroblasts)	NULL
EXP052239	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: foetal liver	NULL	267	normal	Q61687	erythroid cells	NULL
EXP052240	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: N/A  	EXP052237	12	normal	Q61687	MEF (mouse embryonic fibroblasts)	NULL
EXP052241	ATRX H300 (Santa Cruz Biotechnology)	Mus musculus	Strain: N/A Genotype: Suv39h1/2 knockouts	NULL	12	normal	Q61687	MEF (mouse embryonic fibroblasts)	NULL
EXP052242	P63 antibody, Cell Signaling, #4892	Mus musculus	Genotype: wildtype Tissue: Skin	NULL	2491	normal	O88898	cultured keratinocytes	NULL
EXP052243	anti-Smyd2 (Santa Cruz, Catalog# sc-79084, Lot# H2014)	Mus musculus	Tissue: kidney Strain: C57BL/6 Genotype: Pkd1 wildtype Developmental stage: Embryo	NULL	2492	normal	Q8R5A0	renal epithelial cells	NULL
EXP052244	anti-Smyd2 (Santa Cruz, Catalog# sc-79084, Lot# H2014)	Mus musculus	Tissue: kidney Strain: C57BL/6 Genotype: Pkd1 knockout Developmental stage: Embryo	NULL	2492	normal	Q8R5A0	renal epithelial cells	NULL
EXP052245	input control	Mus musculus	Treatment: no doxycycline Source: SA-tTA-Ascl1 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052246	input control	Mus musculus	Treatment: no doxycycline Source: SA-tTA-Ascl1 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052247	input control	Mus musculus	Treatment: no doxycycline Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052248	BD Pharmingen 556604 Rat anti-MASH1 (ASCL1)	Mus musculus	Treatment: no doxycycline Source: SA-tTA-Ascl1 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	EXP052245	2	normal	Q02067	mESCs (mouse embryonic stem cells)	NULL
EXP052249	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	treatment: doxycycline Source: SA-tTA-Ascl2 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	normal	O35885	mESCs (mouse embryonic stem cells)	NULL
EXP052250	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	treatment: no doxycycline Source: SA-tTA-Ascl1 Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	EXP052246	2	normal	O35885	mESCs (mouse embryonic stem cells)	NULL
EXP052251	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	Treatment: doxycycline Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	NULL	2	normal	P10085	mESCs (mouse embryonic stem cells)	NULL
EXP052252	anti-FLAG (Sigma, F1804, mouse monoclonal)	Mus musculus	Treatment: no doxycycline no Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac  	EXP052247	2	normal	P10085	mESCs (mouse embryonic stem cells)	NULL
EXP052253	none (input)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic)	NULL	2493	chip_control	NULL	cardiac ventricles	NULL
EXP052254	none (input)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic)	NULL	2493	chip_control	NULL	cardiac ventricles	NULL
EXP052255	none (input)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, Wildtype for beta-catenin (normal)	NULL	2493	chip_control	NULL	cardiac ventricles	NULL
EXP052256	none (input)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, Wildtype for beta-catenin (normal)	NULL	2493	chip_control	NULL	cardiac ventricles	NULL
EXP052257	none (input)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, Wildtype for beta-catenin (normal)	NULL	2493	chip_control	NULL	cardiac ventricles	NULL
EXP052258	anti-TCF7L2 (17-10109, Millipore)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic)	EXP052253	2493	normal	Q924A0	cardiac ventricles	NULL
EXP052259	anti-TCF7L2 (17-10109, Millipore)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic)	EXP052254	2493	normal	Q924A0	cardiac ventricles	NULL
EXP052260	anti-TCF7L2 (17-10109, Millipore)	Mus musculus	Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction  Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, Wildtype for beta-catenin (normal)	EXP052255	2493	normal	Q924A0	cardiac ventricles	NULL
EXP052261	none	Mus musculus	Genotype: control 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052262	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: control 	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP052263	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: MTF2 knockout	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP052264	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: MTF2 wildtype rescue	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP052265	MTF2 (Proteintech, 16208-1-AP)	Mus musculus	Genotype: MTF2 K339A rescue	EXP052261	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP052266	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: control 	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP052267	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: MTF2 knockout	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP052268	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: MTF2 wildtype rescue	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP052269	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Genotype: MTF2 K339A rescue	EXP052261	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP052270	none	Mus musculus	Strain: C57BL/6 Treatment: doxycycline (Dox) (1ug/ml) for 3 days Genotype: transgenic carrying the tetO-OSKM transgene and Oct4-GFP/Rosa26-M2rtTA 	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052271	Flag antibody (Sigma, F1804, SLBB7188)	Mus musculus	Strain: C57BL/6 Treatment: doxycycline (Dox) (1ug/ml) for 3 days Genotype: transgenic carrying the tetO-OSKM transgene and Oct4-GFP/Rosa26-M2rtTA 	EXP052270	2429	normal	G3UX03	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052272	none	Mus musculus	Genotype: wildtype 	NULL	2476	chip_control	NULL	cardiac myocytes	NULL
EXP052273	none	Mus musculus	Genotype: wildtype 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052274	none	Mus musculus	Genotype: CMV-creERT, Hdac3 f/fÂ  (Hdac3 knockout)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052275	none	Mus musculus	Genotype: CMV-creERT, Hdac3 f/fÂ  (Hdac3 knockout) Treatment: tamoxifen 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052276	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: wildtype 	EXP052272	2476	normal	P14733	cardiac myocytes	NULL
EXP052277	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: wildtype 	EXP052273	2	normal	P14733	mESCs (mouse embryonic stem cells)	NULL
EXP052278	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: CMV-creERT, Hdac3 f/fÂ  (Hdac3 knockout)	EXP052274	2	normal	P14733	mESCs (mouse embryonic stem cells)	NULL
EXP052279	Lamin B (sc6217, Santa Cruz)	Mus musculus	Genotype: CMV-creERT, Hdac3 f/fÂ  (Hdac3 knockout) Treatment: tamoxifen 	EXP052275	2	normal	P14733	mESCs (mouse embryonic stem cells)	NULL
EXP052280	none (input)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052281	none (input)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052282	none (input)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052283	none (input)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052284	none (input)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052285	none (input)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052286	none (input)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052287	none (input)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052288	none (input)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052289	none (input)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	NULL	2494	chip_control	NULL	mpkCCD (clone 11)	NULL
EXP052290	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052280	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052291	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052281	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052292	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052282	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052293	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052283	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052294	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052284	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052295	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052285	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052296	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052286	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052297	anti-CREB1 antibody (Millipore, 17-600)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052287	2494	normal	Q01147	mpkCCD (clone 11)	NULL
EXP052298	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052288	2494	normal	P28033	mpkCCD (clone 11)	NULL
EXP052299	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052282	2494	normal	P28033	mpkCCD (clone 11)	NULL
EXP052300	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052289	2494	normal	P28033	mpkCCD (clone 11)	NULL
EXP052301	anti-C/EBPb antibody (Santa Cruz Biotechnology, sc-150X)	Mus musculus	Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12	EXP052286	2494	normal	P28033	mpkCCD (clone 11)	NULL
EXP052302	None	Mus musculus	Genotype: wildtype Passage: 3-5  Characteristic: myogenic differentiation day1	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP052303	None	Mus musculus	Genotype: wildtype Passage: 3-5  Characteristic: adipogenic differentiation day1	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP052304	None	Mus musculus	Genotype: Overexpression of Lsd1 Passage: 3-5  Characteristic: adipogenic differentiation day1	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP052305	LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Genotype: wildtype Passage: 3-5  Characteristic: myogenic differentiation day1	EXP052302	1153	normal	Q6ZQ88	C2C12 (myoblasts)	NULL
EXP052306	LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Genotype: wildtype Passage: 3-5  Characteristic: adipogenic differentiation day1	EXP052303	1153	normal	Q6ZQ88	C2C12 (myoblasts)	NULL
EXP052307	LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Genotype: Overexpression of Lsd1 Passage: 3-5  Characteristic: adipogenic differentiation day1	EXP052304	1153	normal	Q6ZQ88	C2C12 (myoblasts)	NULL
EXP052308	Anti-IRF4 (M-17) (Santa Cruz Biotechnology, sc-6059x)	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: spleen  	NULL	2390	normal	Q64287	Treg (regulatory T cells)	NULL
EXP052309	Anti-IRF4 (M-17) (Santa Cruz Biotechnology, sc-6059x)	Mus musculus	Strain: C57BL/6 Genotype: p65 (RELA) knockout Tissue: spleen  	NULL	2390	normal	Q64287	Treg (regulatory T cells)	NULL
EXP052310	Anti-NFkB/p65 (C-20) (Santa Cruz Biotechnology, sc-372)	Mus musculus	Strain: C57BL/6 Genotype: wildtype Tissue: spleen  	NULL	2390	normal	Q04207	Treg (regulatory T cells)	NULL
EXP052311	Sap30	Mus musculus	Source: reprogramming cells, day7	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052312		Mus musculus	Source: reprogramming cells, day3	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052313		Mus musculus	Source: reprogramming cells, day7	NULL	2429	chip_control	NULL	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052314	anti-Flag ( sigma m1804)	Mus musculus	Source: reprogramming cells, day3	EXP052312	2429	normal	O88574	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052315	anti-Flag ( sigma m1804)	Mus musculus	Source: reprogramming cells, day7	EXP052313	2429	normal	O88574	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052316	anti-SIN3A (AB3479)	Mus musculus	Source: reprogramming cells, day3	NULL	2429	normal	Q60520	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052317	anti-SIN3A (AB3479)	Mus musculus	Source: reprogramming cells, day7	NULL	2429	normal	Q60520	MREF (Mouse Reprogramming Embryonic Fibroblasts)	NULL
EXP052318	none	Mus musculus	Time: 0 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	NULL	22	chip_control	NULL	3T9 fibroblasts	NULL
EXP052319	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 0 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	NULL
EXP052320	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 10 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	NULL
EXP052321	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 20 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	NULL
EXP052322	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 30 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	NULL
EXP052323	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 2hrs Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	NULL
EXP052324	Myc N262 (Santa Cruz, sc-764)	Mus musculus	Time: 4 hrsTreatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 	EXP052318	22	normal	P01108	3T9 fibroblasts	NULL
EXP052325	anti-Miz (10E2) (home-made)	Mus musculus	Genotype: wildtype Source: embryonic fibroblasts, E13.5 	NULL	22	normal	Q8C5D8	3T9 fibroblasts	NULL
EXP052326	anti-Miz (10E2) (home-made)	Mus musculus	Genotype: wildtype Source: embryonic fibroblasts, E13.5 	NULL	2433	normal	Q8C5D8	primary B cells	NULL
EXP052327	None	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: wildtype Strain: C57BL/6	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP052328	None	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: TRIM28 fl/flx CD4cre (Trim28 knockout) Strain: C57BL/6	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP052329	None	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: wildtype Strain: C57BL/6	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP052330	p300 antibody(santa-cruz, sc-585)	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: wildtype Strain: C57BL/6	EXP052327	498	normal	B2RWS6	Th17-cells	NULL
EXP052331	p300 antibody(santa-cruz, sc-585)	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: TRIM28 fl/flx CD4cre (Trim28 knockout) Strain: C57BL/6	EXP052328	498	normal	B2RWS6	Th17-cells	NULL
EXP052332	TRIM28 antibody(Active Motif, 61173)	Mus musculus	Treatment: Naive CD4+ T cells were cultured under Th17 differentiation conditions for 3 days Tissue: Th17 differentiated in vitro for 3 days Genotype: wildtype Strain: C57BL/6	EXP052329	498	normal	Q62318	Th17-cells	NULL
EXP052333	Rabbit pAb BioLegend 902301	Mus musculus	Genotype: HA-NEO Source: ebryonic stem cells 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP052334	Rabbit pAb Abcam ab46540	Mus musculus	Genotype: wildtype Source: ebryonic stem cells 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP052335	Rabbit pAb Abcam ab46540	Mus musculus	Genotype: wildtype Source: ebryonic stem cells 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP052336	anti-cbx7 (Rabbit pAb, Abcam, ab21873)	Mus musculus	Genotype: wildtype Source: ebryonic stem cells 	EXP052334	233	normal	Q8VDS3	E14TG2A (embryonic stem cells)	NULL
EXP052337	anti-Ring1b (Rabbit pAb, In-house)	Mus musculus	Genotype: wildtype Source: ebryonic stem cells 	EXP052335	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP052338	anti-HA (Rabbit pAb, BioLegend, 902301)	Mus musculus	Genotype: Cbx6-3Ã—HA Source: ebryonic stem cells 	EXP052333	233	normal	Q9DBY5	E14TG2A (embryonic stem cells)	NULL
EXP052339	CDX2 antibody (Cell Signaling Technology	Mus musculus	Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	P43241	jejunal epithelial cells	NULL
EXP052340	PBRM1/BAF180 antibody (Bethyl Laboratories, A301-591A)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q8BSQ9	jejunal epithelial cells	NULL
EXP052341	PBRM1/BAF180 antibody (Bethyl Laboratories, A301-591A)	Mus musculus	Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q8BSQ9	jejunal epithelial cells	NULL
EXP052342	MED1 antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q925J9	jejunal epithelial cells	NULL
EXP052343	CTCF antibody (EMD Millipore, 07-729)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	Q61164	jejunal epithelial cells	NULL
EXP052344	CDX2 antibody (Cell Signaling Technology	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	P43241	jejunal epithelial cells	NULL
EXP052345	KDM6A antibody (Cell Signaling Technology, 33510)	Mus musculus	Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	O70546	jejunal epithelial cells	NULL
EXP052346	KDM6A antibody (Cell Signaling Technology, 33510)	Mus musculus	Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine 	NULL	507	normal	O70546	jejunal epithelial cells	NULL
EXP052361	input control	Mus musculus	Cell line: Fbxl19 fl/fl (Fbxl19) Treatment: untreated Passage: 13-20	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052360	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: wildtype, FS2-FBXL19 Passage: 30-36  	EXP052359	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	NULL
EXP052350	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: transgene K49A FS2-FBXL19, CxxC point mutant Passage: 30-36  	EXP052357	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	NULL
EXP052351	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: transgene K49A FS2-FBXL19, CxxC point mutant Passage: 30-36  	EXP052358	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	NULL
EXP052352	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: {delta} CxxC_FBXL19_FS2 transgene, CxxC deletion mutant Passage: 30-36  	EXP052357	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	NULL
EXP052353	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: {delta} CxxC_FBXL19_FS2 transgene, CxxC deletion mutant Passage: 30-36  	EXP052358	230	normal	Q6PB97	ES-E14 (E14, embryonic stem cells)	NULL
EXP052359	rabbit FS2 antibody (Farcas et al. 2012)	Mus musculus	Genotype: wildtype, FS2-emptyvector Passage: 30-36  	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052357	none	Mus musculus	Genotype: wildtype	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052358	none	Mus musculus	Genotype: wildtype	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP052362	input control	Mus musculus	Cell line: Fbxl19 fl/fl (Fbxl19) Treatment: untreated Passage: 13-20	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052363	input control	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen for 96 hrs Genotype: Fbxl19 fl/fl (Fbxl19 knockout) Passage: 13-20	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052364	input control	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen for 96 hrs Genotype: Fbxl19 fl/fl (Fbxl19 knockout) Passage: 13-20	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052365	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Cell line: Fbxl19 fl/fl (Fbxl19) Treatment: untreated Passage: 13-20	EXP052361	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	NULL
EXP052366	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Cell line: Fbxl19 fl/fl (Fbxl19) Treatment: untreated Passage: 13-20	EXP052362	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	NULL
EXP052367	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen for 96 hrs Genotype: Fbxl19 fl/fl (Fbxl19 knockout) Passage: 13-20	EXP052363	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	NULL
EXP052368	CDK8 (Bethyl Laboratories, A302-500A, lot A302-500A-1)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen for 96 hrs Genotype: Fbxl19 fl/fl (Fbxl19 knockout) Passage: 13-20	EXP052364	2	normal	Q8R3L8	mESCs (mouse embryonic stem cells)	NULL
EXP052369	none	Mus musculus	Strain: C57BL6 	NULL	2497	chip_control	NULL	dentate gyrus	NULL
EXP052370	none	Mus musculus	Strain: C57BL6 	NULL	2497	chip_control	NULL	dentate gyrus	NULL
EXP052371	anti-FLAG (Sigma, catalog# F1804)	Mus musculus	Strain: C57BL6  Genotype: FLAG tagged-Mbd1	EXP052369	2497	normal	Q9Z2E2	dentate gyrus	NULL
EXP052372	anti-FLAG (Sigma, catalog# F1804)	Mus musculus	Strain: C57BL6  Genotype: FLAG tagged-Mbd1	EXP052370	2497	normal	Q9Z2E2	dentate gyrus	NULL
EXP052373		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052374		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052375		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052376		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052377		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052378		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052379	SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype	EXP052378	252	normal	E9PYH6	V6.5 (embryonic stem cells)	NULL
EXP052380	SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype	EXP052373	252	normal	E9PYH6	V6.5 (embryonic stem cells)	NULL
EXP052381	SET1A (Homemade, #919)	Mus musculus	Treatment: supplemented with MEK inhibitor, GSK3 inhibitor, and LIF (2i/LIF) Genotype: Set1A SET deletion	NULL	252	normal	E9PYH6	V6.5 (embryonic stem cells)	NULL
EXP052382	None	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052383	None	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052384	None	Mus musculus	Genotype: wildtype Passage: 15-20  	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052385	None	Mus musculus	Genotype: wildtype Passage: 15-20  	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052386	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052387	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052388	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052389	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052390	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052391	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052392	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052393	None	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052394	None	Mus musculus	Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052395	None	Mus musculus	Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052396	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052382	12	normal	P63166	MEF (mouse embryonic fibroblasts)	NULL
EXP052397	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052383	12	normal	P63166	MEF (mouse embryonic fibroblasts)	NULL
EXP052398	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052382	12	normal	P61957	MEF (mouse embryonic fibroblasts)	NULL
EXP052399	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052383	12	normal	P61957	MEF (mouse embryonic fibroblasts)	NULL
EXP052400	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052384	2	normal	P63166	mESCs (mouse embryonic stem cells)	NULL
EXP052401	SUMO-1 (Abcam, ab32058)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052385	2	normal	P63166	mESCs (mouse embryonic stem cells)	NULL
EXP052402	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052384	2	normal	P61957	mESCs (mouse embryonic stem cells)	NULL
EXP052403	SUMO-2 (gift from Dr. M. Dasso)	Mus musculus	Genotype: wildtype Passage: 15-20  	EXP052385	2	normal	P61957	mESCs (mouse embryonic stem cells)	NULL
EXP052404	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052386	12	normal	P20263	MEF (mouse embryonic fibroblasts)	NULL
EXP052405	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052387	12	normal	P20263	MEF (mouse embryonic fibroblasts)	NULL
EXP052406	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052386	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	NULL
EXP052407	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052387	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	NULL
EXP052408	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052386	12	normal	P48432	MEF (mouse embryonic fibroblasts)	NULL
EXP052409	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052387	12	normal	P48432	MEF (mouse embryonic fibroblasts)	NULL
EXP052410	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052388	12	normal	P20263	MEF (mouse embryonic fibroblasts)	NULL
EXP052411	Oct3/4 (Santa Cruz, sc8628)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052389	12	normal	P20263	MEF (mouse embryonic fibroblasts)	NULL
EXP052412	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052388	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	NULL
EXP052413	Klf4 (Santa Cruz, sc20691)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052389	12	normal	Q60793	MEF (mouse embryonic fibroblasts)	NULL
EXP052414	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052388	12	normal	P48432	MEF (mouse embryonic fibroblasts)	NULL
EXP052415	Sox2 (Millipore, AB5603)	Mus musculus	Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1  Source: mouse embryonic fibroblast cells E13.5	EXP052389	12	normal	P48432	MEF (mouse embryonic fibroblasts)	NULL
EXP052416		Mus musculus	Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052417	Mll4 (Homemade, #825)	Mus musculus	Genotype: Mll4 NT deletion	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	NULL
EXP052418	Mll4 (Homemade, #825)	Mus musculus	Genotype: MLL4 SET deletion	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	NULL
EXP052419	Lsd1 (Abcam 17721)	Mus musculus	Genotype: wildtype	EXP052416	252	normal	Q6ZQ88	V6.5 (embryonic stem cells)	NULL
EXP052420	Mll4 (Homemade, #825)	Mus musculus	Genotype: Mll4 knockout Treatment: shRNA knockdown	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	NULL
EXP052421	Mll4 (Homemade, #825)	Mus musculus	Genotype: wildtype Treatment: no	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	NULL
EXP052422	Normal rabbit IgG (Santa Cruz Biotechnology, sc-2027)	Mus musculus	Tissue: primary cultured nerve tumor cells Genotype: Lats1 fl/fl (lats1 knockout), Lats2 fl/+, CcGFP fl/+,Dhh-Cre	NULL	2498	chip_control	NULL	nerve tumor cells	NULL
EXP052423	TEAD1 (Mouse, Santa Cruz Biotechnology sc-393976)	Mus musculus	Tissue: primary cultured nerve tumor cells Genotype: Lats1 fl/fl (lats1 knockout), Lats2 fl/+, CcGFP fl/+,Dhh-Cre	EXP052422	2498	normal	P30051	nerve tumor cells	NULL
EXP052424		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052425		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052426		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052427		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052428		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052429		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052430		Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Brd4-flox/flox (knockout) 	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052431		Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052432		Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: Brd4-flox/flox (knockout) 	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP052433		Mus musculus	Strain: C57BL/6J  Stage: Differentiated myocytes Genotype: wildtype	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP052434	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: wildtype	EXP052424	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052435	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: wildtype	EXP052427	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052436	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	EXP052425	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052437	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: wildtype	EXP052428	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052438	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: wildtype	EXP052426	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052439	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Pparg-flox/flox (knockout) brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: wildtype	EXP052429	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052440	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Brd4-flox/flox (knockout) 	EXP052430	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052441	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: Brd4-flox/flox (knockout) 	EXP052431	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052442	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Brd4-flox/flox brown preadipocytes  Strain: C57BL/6J  Stage: Mature adipocytes (Day 7) Genotype: Brd4-flox/flox (knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052443	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Strain: C57BL/6J  Stage: Differentiated myocytes Genotype: wildtype	NULL	1153	normal	Q9ESU6	C2C12 (myoblasts)	NULL
EXP052444	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Mll3-/- brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Mll3-/- (knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052445	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalizedMll3-/-; Mll4f/f brown preadipocytes  Strain: C57BL/6J  Stage: Confluent preadipocytes (Day 0) Genotype: Mll3-/- and Mll4flox/flox (double knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052446	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalized Mll3-/- brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2)Genotype: Mll3-/- (knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052447	Brd4 (Bethyl, A301-985A100, lot 3)	Mus musculus	Cell type: immortalizedMll3-/-; Mll4f/f brown preadipocytes  Strain: C57BL/6J  Stage: Immature adipocytes (Day 2) Genotype: Mll3-/- and Mll4flox/flox (double knockout) 	NULL	483	normal	Q9ESU6	brown preadipocytes	NULL
EXP052448	none	Mus musculus		NULL	2499	chip_control	NULL	BM-derived MSPCs (bone marrow-derived mesenchymal stem/progenitor cells)	NULL
EXP052449	ASXL1 (Santa Cruz sc-85283)	Mus musculus	Passage: 5 -10 Genotype: wildtype	EXP052448	2499	normal	P59598	BM-derived MSPCs (bone marrow-derived mesenchymal stem/progenitor cells)	NULL
EXP052450		Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP052451		Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP052452		Mus musculus	Source: Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP052453	anti-IRF8	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	P23611	CD4+ T-cells	NULL
EXP052454	anti-PU.1	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	P17433	CD4+ T-cells	NULL
EXP052455	anti-IRF4	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	Q64287	CD4+ T-cells	NULL
EXP052456	anti-BATF	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	O35284	CD4+ T-cells	NULL
EXP052457	anti-ETV6	Mus musculus	Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	EXP052451	1058	normal	P97360	CD4+ T-cells	NULL
EXP052458	anti-IRF8	Mus musculus	Source:Th2 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	normal	P23611	CD4+ T-cells	NULL
EXP052459	anti-ETV6	Mus musculus	Source:Th2 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks  	NULL	1058	normal	P97360	CD4+ T-cells	NULL
EXP052460	None	Mus musculus	Source: Treg + Tconv stim + unstim Tissue: Spleens+Lymph nodes Strain: C57BL/6  	NULL	2500	chip_control	NULL	Tconv and Treg cells	NULL
EXP052461	None	Mus musculus	Source: Treg + Tconv stim + unstim Tissue: Spleens+Lymph nodes Strain: C57BL/6  	NULL	2500	chip_control	NULL	Tconv and Treg cells	NULL
EXP052462	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv + anti-CD3/CD28 stimulation Tissue: Spleens+Lymph nodes	EXP052460	2501	normal	Q04207	Tconv (conventional T cells)	NULL
EXP052463	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv + anti-CD3/CD28 stimulation Tissue: Spleens+Lymph nodes	EXP052461	2501	normal	Q04207	Tconv (conventional T cells)	NULL
EXP052464	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv unstimulated Tissue: Spleens+Lymph nodes	EXP052460	2501	normal	Q04207	Tconv (conventional T cells)	NULL
EXP052465	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Tconv unstimulated Tissue: Spleens+Lymph nodes	EXP052461	2501	normal	Q04207	Tconv (conventional T cells)	NULL
EXP052466	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg + anti-CD3/CD28 stimulationTissue: Spleens+Lymph nodes	EXP052460	1053	normal	Q04207	Treg cells from lymph nodes and spleen	NULL
EXP052467	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg + anti-CD3/CD28 stimulation Tissue: Spleens+Lymph nodes	EXP052461	1053	normal	Q04207	Treg cells from lymph nodes and spleen	NULL
EXP052468	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg unstimulated Tissue: Spleens+Lymph nodes	EXP052460	1053	normal	Q04207	Treg cells from lymph nodes and spleen	NULL
EXP052469	anti-mouse p65 (Santa Cruz, sc-372, #K-0615)	Mus musculus	Source: Treg unstimulated Tissue: Spleens+Lymph nodes	EXP052461	1053	normal	Q04207	Treg cells from lymph nodes and spleen	NULL
EXP052470	none	Mus musculus	Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert)  Background: cell line RAS lox/lox	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052471	none	Mus musculus	Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert)  Background: cell line RAS lox/lox	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052472	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: 4-hydroxy-tamoxifen for at least 7days Background: cell line RAS lox/lox	EXP052470	2	normal	P70459	mESCs (mouse embryonic stem cells)	NULL
EXP052473	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: 4-hydroxy-tamoxifen for at least 7days Background: cell line RAS lox/lox	EXP052471	2	normal	P70459	mESCs (mouse embryonic stem cells)	NULL
EXP052474	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert)  Background: cell line RAS lox/lox	EXP052470	2	normal	P70459	mESCs (mouse embryonic stem cells)	NULL
EXP052475	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert)  Background: cell line RAS lox/lox	EXP052471	2	normal	P70459	mESCs (mouse embryonic stem cells)	NULL
EXP052476	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF knockout, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: no for at least 7days Background: cell line RAS lox/lox	EXP052470	2	normal	P70459	mESCs (mouse embryonic stem cells)	NULL
EXP052477	anti-ERF (Santa Cruz, #sc-15435)	Mus musculus	Genotype: ERF knockout, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: no for at least 7days Background: cell line RAS lox/lox	EXP052471	2	normal	P70459	mESCs (mouse embryonic stem cells)	NULL
EXP052478	IgG (Abcam, 172730)	Mus musculus	Genotype: wildtype Strain: C57bl/6	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052479	IgG (Abcam, 172730)	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP052480	none	Mus musculus	Genotype: wildtype 	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052481	none	Mus musculus	Genotype: catalytic dead Mll2 (Y2602A mutant) 	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP052482	Mll2 (Generated in Shilatifard lab (PubMed id: 23934151))	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP052483	Mll2 (Generated in Shilatifard lab (PubMed id: 23934151))	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	O08550	mESCs (mouse embryonic stem cells)	NULL
EXP052484	CTCF (Millipore, 07-729)	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP052485	CTCF (Millipore, 07-729)	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP052486	Ring1b (Homemade (PubMed id: 22226355))	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP052487	Ring1b (Homemade (PubMed id: 22226355))	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP052488	Suz12 (Abcam, ab12073)	Mus musculus	Genotype: wildtype Strain: C57bl/6	EXP052478	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP052489	Suz12 (Abcam, ab12073)	Mus musculus	Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6	EXP052479	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP052490	anti-Ctip2 (Bcl11b) (abcam ab18465)	Mus musculus	Genotype: Bcl11b fl/fl (knockout) CD4cre+ Strain: C57BL/6	NULL	171	bio_control	Q99PV8	CD4+ CD8+ T cells	NULL
EXP052491	anti-Ctip2 (Bcl11b) (abcam ab18465)	Mus musculus	Genotype: wildtype Strain: C57BL/6 Treatment: infected with Heligmosomoides polygyrus	NULL	1058	normal	Q99PV8	CD4+ T-cells	NULL
EXP052492	rabbit anti-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: Gadd45a wildtype	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052493	rabbit anti-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: HA-GADD45a Strain: C57BL/6N	NULL	12	normal	P48316	MEF (mouse embryonic fibroblasts)	NULL
EXP052494	rabbit a-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: wildtype Strain: C57BL/6N Age: embryonic day E15.5 Passage: 4	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052495	rabbit a-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: wildtype Strain: C57BL/6N Age: embryonic day E15.5 Passage: 4	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP052496	rabbit a-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: HA-ING1 Strain: C57BL/6N Age: embryonic day E15.5 Passage: 4	EXP052494	12	normal	Q9QXV3	MEF (mouse embryonic fibroblasts)	NULL
EXP052497	rabbit a-HA antibody (Abcam, ab9110)	Mus musculus	Genotype: HA-ING1 Strain: C57BL/6N Age: embryonic day E15.5 Passage: 4	EXP052495	12	normal	Q9QXV3	MEF (mouse embryonic fibroblasts)	NULL
EXP052498	none	Mus musculus	Conditions: high fat diet Sex: male Strain: C57BL/6	NULL	187	chip_control	NULL	colon epithelium	NULL
EXP052499	none	Mus musculus	Conditions: high fat diet Sex: male Strain: C57BL/6	NULL	187	chip_control	NULL	colon epithelium	NULL
EXP052500	none	Mus musculus	Conditions: low fat diet Sex: male Strain: C57BL/6	NULL	187	chip_control	NULL	colon epithelium	NULL
EXP052501	none	Mus musculus	Conditions: low fat diet Sex: male Strain: C57BL/6	NULL	187	chip_control	NULL	colon epithelium	NULL
EXP052502	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: high fat diet Sex: male Strain: C57BL/6	EXP052498	187	normal	P49698	colon epithelium	NULL
EXP052503	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: high fat diet Sex: male Strain: C57BL/6	EXP052499	187	normal	P49698	colon epithelium	NULL
EXP052504	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: low fat diet Sex: male Strain: C57BL/6	EXP052500	187	normal	P49698	colon epithelium	NULL
EXP052505	HNF4a (Abcam, ab41898)	Mus musculus	Conditions: low fat diet Sex: male Strain: C57BL/6	EXP052501	187	normal	P49698	colon epithelium	NULL
EXP052506	anti-FLAG	Mus musculus	Passage: 10 Strain: C57BL/6	NULL	138	chip_control	NULL	neural progenitors	NULL
EXP052507	Rabbit IgG	Mus musculus	Passage: 10 Strain: C57BL/6	NULL	138	chip_control	NULL	neural progenitors	NULL
EXP052508	anti-FLAG	Mus musculus	Passage: 10 Strain: C57BL/6	EXP052506	138	normal	A0A286YCP2	neural progenitors	NULL
EXP052509	anti-Nup153	Mus musculus	Passage: 10 Strain: C57BL/6	EXP052507	138	normal	A0A286YCP2	neural progenitors	NULL
EXP052510	E2f1	Mus musculus	Growth: serum conditions	NULL	2	normal	Q61501	mESCs (mouse embryonic stem cells)	NULL
EXP052511	E2f1	Mus musculus	Growth: 2i conditions	NULL	13	normal	Q61501	2TS22C (embryonic stem cells)	NULL
EXP052512	IgG from rabbit serum (Sigma)	Mus musculus	Tissue: testes Treatment: pooled from all treatments Strain: FVB/N Sex: male Age: adult (10-16 weeks)	NULL	32	chip_control	NULL	testis	NULL
EXP052513	none	Mus musculus	Tissue: testes Treatment: equal mixture of all testicular inputs Strain: FVB/N Sex: male Age: adult (10-16 weeks)	NULL	32	chip_control	NULL	testis	NULL
EXP052514	none	Mus musculus	Treatment: equal mixture of all spermatocyte's inputs Strain: FVB/N Sex: male Age: adult (10-16 weeks)	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP052515	N-terminal SPEN ( Abnova, PAB20849)	Mus musculus	Tissue: testes Treatment: untreated control Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052516	N-terminal SPEN ( Abnova, PAB20849)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052517	N-terminal SPEN ( Abnova, PAB20849)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052518	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: untreated control Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052519	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052520	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 30 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052521	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 30 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052522	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 38 degrees Celsius for 15 min and 4hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052523	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 15 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052524	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 30 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052525	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 30 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052526	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes Treatment: heat shocked at 43 degrees Celsius for 30 min and 4hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052513	32	normal	Q62504	testis	NULL
EXP052527	internal SPEN (Abcam, ab72266)	Mus musculus	Tissue: testes/spermatocytes Treatment: untreated control Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	NULL
EXP052528	internal SPEN (Abcam, ab72266)	Mus musculus	testes/spermatocytes Treatment: heat shocked at 43 degrees Celsius for 30 min Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	NULL
EXP052529	internal SPEN (Abcam, ab72266)	Mus musculus	Treatment: heat shocked at 43 degrees Celsius for 30 min and 2hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	NULL
EXP052530	internal SPEN (Abcam, ab72266)	Mus musculus	Treatment: heat shocked at 43 degrees Celsius for 30 min and 4hrs of recovery Strain: FVB/N Sex: male Age: adult (10-16 weeks)	EXP052514	803	normal	Q62504	spermatocytes	NULL
EXP052531		Mus musculus	Genotype: Dnmt3L-/- Strain: C57Bl/6J Age: 30 days post partum	NULL	32	chip_control	NULL	testis	NULL
EXP052532		Mus musculus	Genotype: wildtype Strain: Various Age: adult 	NULL	32	chip_control	NULL	testis	NULL
EXP052533		Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: 15.5 days post coitum	NULL	2505	chip_control	NULL	ovary	NULL
EXP052534	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: Hop2-/- (Psmc3ip-/-) Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	NULL
EXP052535	Anti-DMC1 GP1 custom	Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	NULL
EXP052536	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype:Prdm9-/- Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	NULL
EXP052537	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: Dnmt3L-/- Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	NULL
EXP052538	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: Hop2-/- (Psmc3ip-/-) Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	NULL
EXP052539	Anti-DMC1 Santa Cruz (C-20, sc 8973)	Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: adult 	EXP052532	32	normal	Q61880	testis	NULL
EXP052540	Anti-DMC1 GP1 custom	Mus musculus	Genotype: wildtype Strain: C57Bl/6J Age: 15.5 days post coitum 	EXP052533	2505	normal	Q61880	ovary	NULL
EXP052541	LMO2 (R&D systems AF2726)	Mus musculus	Genotype: wildtype 	NULL	2507	normal	P25801	embryonic stem cells derived Flk-1+ cells	NULL
EXP052542	LMO2 (R&D systems AF2726)	Mus musculus	Genotype: Lmo2-/- (knockout) 	NULL	2507	normal	P25801	embryonic stem cells derived Flk-1+ cells	NULL
EXP052543	TAL1 (Santa Cruz sc-12984X)	Mus musculus	Genotype: wildtype 	NULL	2507	normal	P22091	embryonic stem cells derived Flk-1+ cells	NULL
EXP052544	TAL1 (Santa Cruz sc-12984X)	Mus musculus	Genotype: Lmo2-/- (knockout) 	NULL	2507	normal	P22091	embryonic stem cells derived Flk-1+ cells	NULL
EXP052545	Ldb1 (Abcam ab96799)	Mus musculus	Genotype: wildtype 	NULL	2507	normal	P70662	embryonic stem cells derived Flk-1+ cells	NULL
EXP052546	Ldb1 (Abcam ab96799)	Mus musculus	Genotype: Lmo2-/- (knockout) 	NULL	2507	normal	P70662	embryonic stem cells derived Flk-1+ cells	NULL
EXP052547		Mus musculus	Source: neural progenitor cells Genotype: wildtype	NULL	2508	chip_control	NULL	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052548		Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	NULL	2508	chip_control	NULL	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052549		Mus musculus	Source: neural progenitor cells Genotype: wildtype	NULL	2508	chip_control	NULL	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052550		Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	NULL	2508	chip_control	NULL	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052551	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052547	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052552	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052547	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052553	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052548	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052554	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052548	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052555	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052549	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052556	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: wildtype	EXP052549	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052557	anti-CTCF (Cell Signaling, 2899S, lot:2)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052550	2508	normal	Q61164	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052558	anti-RAD21 (Abcam ab992, lot: GR106791-9)	Mus musculus	Source: neural progenitor cells Genotype: Smchd1-/-	EXP052550	2508	normal	Q61550	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP052559	TAF3 (Millipore 07-1802; Lot#3008423)	Rattus norvegicus	Treatment: Source: Serotonergic tissue culture cells Type: Undifferentiated	NULL	2509	normal	D3ZPB7	RN46A-B14	NULL
EXP052560	TAF3 (Millipore 07-1802; Lot#3008423)	Rattus norvegicus	Treatment: Source: Serotonergic tissue culture cells Type: Differentiated	NULL	2509	normal	D3ZPB7	RN46A-B14	NULL
EXP052561	None	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	NULL	1046	chip_control	NULL	liver	NULL
EXP052562	None	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	NULL	1046	chip_control	NULL	liver	NULL
EXP052563	None	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	NULL	1046	chip_control	NULL	liver	NULL
EXP052564	None	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	NULL	1046	chip_control	NULL	liver	NULL
EXP052565	None	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	NULL	1046	chip_control	NULL	liver	NULL
EXP052566	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052561	1046	normal	P41738	liver	NULL
EXP052567	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052562	1046	normal	P41738	liver	NULL
EXP052568	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052563	1046	normal	P41738	liver	NULL
EXP052569	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052564	1046	normal	P41738	liver	NULL
EXP052570	anti-Ahr SA-210 (Enzo Life Sciences)	Rattus norvegicus	Treatment: 10 ug/kg TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) for 2 hrs Strain: Sprague-Dawley Sex: Female Age: 29 days	EXP052565	1046	normal	P41738	liver	NULL
EXP052571	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052572	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052573	None	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052574	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052575	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052576	None	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052577	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052578	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052579	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052580	None	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052581	None	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	NULL	2510	chip_control	NULL	RASMC	NULL
EXP052582	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours Tissue: Rat aortic smooth muscle cell	EXP052571	2510	normal	A0A0G2JYV0	RASMC	NULL
EXP052583	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 24 hours Tissue: Rat aortic smooth muscle cell	EXP052574	2510	normal	A0A0G2JYV0	RASMC	NULL
EXP052584	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours Tissue: Rat aortic smooth muscle cell	EXP052572	2510	normal	A0A0G2JYV0	RASMC	NULL
EXP052585	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: PDGF (25ng/ml) for 2 hours Tissue: Rat aortic smooth muscle cell	EXP052575	2510	normal	A0A0G2JYV0	RASMC	NULL
EXP052586	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	EXP052573	2510	normal	A0A0G2JYV0	RASMC	NULL
EXP052587	anti-Brd4  (Bethyl, A301-985A)	Rattus norvegicus	Treatment: none Tissue: Rat aortic smooth muscle cell	EXP052576	2510	normal	A0A0G2JYV0	RASMC	NULL
EXP052588		Rattus norvegicus	Strain:Sprague-Dawley  Treatment: none	NULL	2511	chip_control	NULL	differentiated neural stem cell	NULL
EXP052589		Rattus norvegicus	Strain:Sprague-Dawley  Treatment: vitamin C	NULL	2511	chip_control	NULL	differentiated neural stem cell	NULL
EXP052590	NF1 (Santa Cruz, sc-5567, B2613)	Rattus norvegicus	Strain:Sprague-Dawley  Treatment: none	EXP052588	2511	normal	P97526	differentiated neural stem cell	NULL
EXP052591	NF1 (Santa Cruz, sc-5567, B2613)	Rattus norvegicus	Strain:Sprague-Dawley  Treatment: vitamin C	EXP052589	2511	normal	P97526	differentiated neural stem cell	NULL
EXP052592	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 25 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052593	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 50 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052594	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 75 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052595	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 100 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052596	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 125 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052597	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 150 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052598	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 175 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052599	none	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 200 	NULL	2514	chip_control	NULL	Fission Yeast strains	NULL
EXP052600	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 25 	EXP052592	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052601	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 50 	EXP052593	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052602	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 75 	EXP052594	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052603	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 100 	EXP052595	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052604	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 125 	EXP052596	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052605	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 150 	EXP052597	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052606	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 175 	EXP052598	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052607	anti-T7  	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, T7 tag CENP-A  Time after release: 200 	EXP052599	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052608	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 25 	EXP052592	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052609	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 50 	EXP052593	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052610	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 75 	EXP052594	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052611	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 100 	EXP052595	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052612	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 125 	EXP052596	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052613	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 150 	EXP052597	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052614	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 175 	EXP052598	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052615	anti-HA	Schizosaccharomyces pombe	Treatment: treated with 1 mM b-estradiol Genotype: wildtype, HA tag CENP-A  Time after release: 200 	EXP052599	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP052616	none	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	NULL	1263	chip_control	NULL	whole cells	NULL
EXP052617	none	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	NULL	1263	chip_control	NULL	whole cells	NULL
EXP052618	none	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	NULL	1263	chip_control	NULL	whole cells	NULL
EXP052619	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D52_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052616	1263	normal	O14335	whole cells	NULL
EXP052620	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052616	1263	normal	O14335	whole cells	NULL
EXP052621	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D51_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052617	1263	normal	O14335	whole cells	NULL
EXP052622	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glycerol Strain: D52_Scr1-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 scr1::TAP-KanMX6	EXP052618	1263	normal	O14335	whole cells	NULL
EXP052623	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D96_Tup11-TAP Genotype:h+ ura4-d18 leu1-32 ade6-m216 tup11::TAP-KanMX6	EXP052616	1263	normal	Q09715	whole cells	NULL
EXP052624	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D96_Tup11-TAP Genotype:h+ ura4-d18 leu1-32 ade6-m216 tup11::TAP-KanMX6	EXP052617	1263	normal	Q09715	whole cells	NULL
EXP052625	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D96_Tup11-TAP Genotype:h+ ura4-d18 leu1-32 ade6-m216 tup11::TAP-KanMX6	EXP052618	1263	normal	Q09715	whole cells	NULL
EXP052626	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D102_Rst2-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 rst2::TAP-KanMX6	EXP052616	1263	normal	P78871	whole cells	NULL
EXP052627	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% sucrose Strain:  D102_Rst2-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 rst2::TAP-KanMX6	EXP052617	1263	normal	P78871	whole cells	NULL
EXP052628	Protein A (clone SPA-27, Sigma P2921)	Schizosaccharomyces pombe	Growth: YES 3% glucose Strain:  D102_Rst2-TAP Genotype: h+ ura4-d18 leu1-32 ade6-m216 rst2::TAP-KanMX6	EXP052618	1263	normal	P78871	whole cells	NULL
EXP052629	anti-RBR1 (provided by Willhelm Gruissem (ETH, Zurich, Switzerland) and affinity-purified by Hirofumi Harashima in our lab)	Arabidopsis thaliana	days after subculture: 3 Ecotype: Landsberg erecta	NULL	2515	normal	Q9LKZ3	MM2d cell culture	NULL
EXP052630	none	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: pSOG1::SOG1-3xFLAG Time after IR: 20 min	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP052631	none	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: pSOG1::SOG1-3xFLAG Time after IR: 1 hr	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP052632	anti-Flag M2 Magnetic beads (Sigma, Cat# M8823)	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: wildtype Time after IR: 20 min	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP052633	anti-Flag M2 Magnetic beads (Sigma, Cat# M8823)	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: wildtype Time after IR: 1hr 	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP052634	anti-Flag M2 Magnetic beads (Sigma, Cat# M8823)	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: pSOG1::SOG1-3xFLAG Time after IR: 20 min	EXP052630	1341	normal	Q6NQK2	10 day old seedlings	NULL
EXP052635	anti-Flag M2 Magnetic beads (Sigma, Cat# M8823)	Arabidopsis thaliana	Treatment: 75 Gy using a Co60 radioactive source at a dose-rate of 3.75 Gy/min Genotype: pSOG1::SOG1-3xFLAG Time after IR: 1hr 	EXP052631	1341	normal	Q6NQK2	10 day old seedlings	NULL
EXP052636	none	Rattus norvegicus	sham operated	NULL	2516	chip_control	NULL	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052637	none	Rattus norvegicus	amygdala stimulated	NULL	2516	chip_control	NULL	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052638	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	sham operated	EXP052636	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052639	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	sham operated	EXP052636	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052640	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	sham operated	EXP052636	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052641	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052642	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052643	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052644	Anti-MBD3 (A302-528A, Bethyl Laboratories, Montgomery, TX, USA)	Rattus norvegicus	amygdala stimulated	EXP052637	2516	normal	B2RZ64	entorhinal, perirhinal, and piriform cortices and the amygdala	NULL
EXP052645	input	Arabidopsis thaliana	Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::GFP	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP052646	input	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP052647	input	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP052648	input	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	NULL	1344	chip_control	NULL	14 day old seedling	NULL
EXP052649	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::GFP	EXP052645	1344	normal	Q8H159	14 day old seedling	NULL
EXP052650	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	EXP052646	1344	normal	Q8GYC1	14 day old seedling	NULL
EXP052651	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	EXP052647	1344	normal	Q8GYC1	14 day old seedling	NULL
EXP052652	Anti-GFP antibody  (Abcam)	Arabidopsis thaliana	Conditions: long-day conditions  Treatment: 1uM flg22 treatment for 1 hour Genotype: ColO, pUBI10::IDD4:GFP	EXP052648	1344	normal	Q8GYC1	14 day old seedling	NULL
EXP052653	anti-GFP antibody	Arabidopsis thaliana	Genotype: wildtype Conditions: 16 hr light/8 hr dark	NULL	1339	chip_control	NULL	seedling	NULL
EXP052654	anti-GFP antibody	Arabidopsis thaliana	Genotype: SUVH1-GFP in wild type Conditions: 16 hr light/8 hr dark	EXP052653	1339	normal	Q9FF80	seedling	NULL
EXP052655	none (input)	Saccharomyces cerevisiae	Genotype: Flag-lsw2 Source: Asynchronous growth in liquid YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052656	none (input)	Saccharomyces cerevisiae	Genotype: Flag-lsw2 Source: Asynchronous growth in liquid YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052657	none (input)	Saccharomyces cerevisiae	Genotype: Flag-Nhp10 Source: Asynchronous growth in liquid YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052658	none (input)	Saccharomyces cerevisiae	Genotype: Flag-Nhp10 Source: Asynchronous growth in liquid YPD	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052659	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-lsw2 Source: Asynchronous growth in liquid YPD	EXP052655	1232	normal	Q08773	S. cerevisiae cells	NULL
EXP052660	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-lsw2 Source: Asynchronous growth in liquid YPD	EXP052656	1232	normal	Q08773	S. cerevisiae cells	NULL
EXP052661	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-Nhp10 Source: Asynchronous growth in liquid YPD	EXP052657	1232	normal	Q03435	S. cerevisiae cells	NULL
EXP052662	Sigma anti-FLAG monoclonal (F3165)	Saccharomyces cerevisiae	Genotype: Flag-Nhp10 Source: Asynchronous growth in liquid YPD	EXP052658	1232	normal	Q03435	S. cerevisiae cells	NULL
EXP052663	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	NULL	2517	chip_control	NULL	Log cells	NULL
EXP052664	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	NULL	2517	chip_control	NULL	Log cells	NULL
EXP052665	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	NULL	2517	chip_control	NULL	Log cells	NULL
EXP052666	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc Type: All Replicates Merged data	NULL	2517	chip_control	NULL	Log cells	NULL
EXP052667	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052668	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052669	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052670	none, input	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc Type: All Replicates Merged data	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052671	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 7066 and 7068 Genotype: SMC4 knockout, BRN1::myc Treatment: doxycycline Type: All Replicates Merged data	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052672	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6891 and 6892 Genotype: BRN1::myc, msn2 Type: All Replicates Merged data	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052673	M2 anti-FLAG (Sigma, catalog #F1804)	Saccharomyces cerevisiae	Strain: 7072 and 7073 Genotype: MSN2::FLAG BRN1::myc, msn2 Type: All Replicates Merged data	NULL	2518	chip_control	NULL	Quiescent cells	NULL
EXP052674	 9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052663	2517	normal	P38170	Log cells	NULL
EXP052675	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052664	2517	normal	P38170	Log cells	NULL
EXP052676	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052665	2517	normal	P38170	Log cells	NULL
EXP052677	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc Type: All Replicates Merged data	EXP052666	2517	normal	P38170	Log cells	NULL
EXP052678	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052667	2518	normal	P38170	Quiescent cells	NULL
EXP052679	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052668	2518	normal	P38170	Quiescent cells	NULL
EXP052680	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc	EXP052669	2518	normal	P38170	Quiescent cells	NULL
EXP052681	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6619 and 6620 Genotype: BRN1::myc Type: All Replicates Merged data	EXP052670	2518	normal	P38170	Quiescent cells	NULL
EXP052682	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 7066 and 7068 Genotype: SMC4 knockout, BRN1::myc Treatment: doxycycline Type: All Replicates Merged data	EXP052671	2518	normal	P38170	Quiescent cells	NULL
EXP052683	9E10 purified anti-Myc (Covance, catalog #139049002)	Saccharomyces cerevisiae	Strain: 6891 and 6892 Genotype: BRN1::myc, msn2 Type: All Replicates Merged data	EXP052672	2518	normal	P38170	Quiescent cells	NULL
EXP052684	M2 anti-FLAG (Sigma, catalog #F1804)	Saccharomyces cerevisiae	Strain: 7072 and 7073 Genotype: MSN2::FLAG BRN1::myc, msn2 Type: All Replicates Merged data	EXP052673	2518	normal	P33748	Quiescent cells	NULL
EXP052685		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052686		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052687		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052688		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052689		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052690		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8104 Source: meotic time 3 hours Genotype: dot1{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052691		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8104 Source: meotic time 3 hours Genotype: dot1{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052692		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8583 Source: meotic time 3 hours Genotype: dot1{delta},set1{delta} (deletions)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052693		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8583 Source: meotic time 3 hours Genotype: dot1{delta},set1{delta} (deletions)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052694		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8115 Source: meotic time 3 hours Genotype: dot1{delta},rec8{delta} (deletions)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052695		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8115 Source: meotic time 3 hours Genotype: dot1{delta},rec8{delta} (deletions)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052696		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8584 Source: meotic time 3 hours Genotype: set1{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052697		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8584 Source: meotic time 3 hours Genotype: set1{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052698		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8151 Source: meotic time 3 hours Genotype: rec8{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052699		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8151 Source: meotic time 3 hours Genotype: rec8{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052700		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9120 Source: meotic time 3 hours Genotype: hop1{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052701		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9120 Source: meotic time 3 hours Genotype: hop1{delta} (deletion)	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052702		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8218 Source: meotic time 3 hours Genotype: ycs4S/RED1	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052703		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8218 Source: meotic time 3 hours Genotype: ycs4S/RED1	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052704		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8220 Source: meotic time 3 hours Genotype: red1/RED1	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052705		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8220 Source: meotic time 3 hours Genotype: red1/RED1	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052706		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/ycs4S	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052707		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/ycs4S	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052708		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/red1	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052709		Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/red1	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052710		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052711		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 10% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052712		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 15% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052713		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 20% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052714		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 25% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052715		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 30% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052716		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052717		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 10% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052718		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 15% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052719		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 20% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052720		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 25% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052721		Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 30% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	NULL	2519	chip_control	NULL	Cell suspension in synchronous meiosis	NULL
EXP052722	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052685	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052723	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052686	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052724	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052687	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052725	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052688	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052726	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052689	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052727	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8104 Source: meotic time 3 hours Genotype: dot1{delta} (deletion)	EXP052690	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052728	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8104 Source: meotic time 3 hours Genotype: dot1{delta} (deletion)	EXP052691	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052729	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8583 Source: meotic time 3 hours Genotype: dot1{delta},set1{delta} (deletions)	EXP052692	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052730	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8583 Source: meotic time 3 hours Genotype: dot1{delta},set1{delta} (deletions)	EXP052693	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052731	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8115 Source: meotic time 3 hours Genotype: dot1{delta},rec8{delta} (deletions)	EXP052698	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052732	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8115 Source: meotic time 3 hours Genotype: dot1{delta},rec8{delta} (deletions)	EXP052699	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052733	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8584 Source: meotic time 3 hours Genotype: set1{delta} (deletion)	EXP052696	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052734	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8584 Source: meotic time 3 hours Genotype: set1{delta} (deletion)	EXP052697	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052735	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8151 Source: meotic time 3 hours Genotype: rec8{delta} (deletion)	EXP052698	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052736	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8151 Source: meotic time 3 hours Genotype: rec8{delta} (deletion)	EXP052699	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052737	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9120 Source: meotic time 3 hours Genotype: hop1{delta} (deletion)	EXP052700	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052738	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH9120 Source: meotic time 3 hours Genotype: hop1{delta} (deletion)	EXP052701	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052739	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8218 Source: meotic time 3 hours Genotype: ycs4S/RED1	EXP052702	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052740	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8218 Source: meotic time 3 hours Genotype: ycs4S/RED1	EXP052703	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052741	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8220 Source: meotic time 3 hours Genotype: red1/RED1	EXP052704	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052742	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH8220 Source: meotic time 3 hours Genotype: red1/RED1	EXP052705	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052743	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/ycs4S	NULL	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052744	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/ycs4S	NULL	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052745	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/red1	EXP052708	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052746	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Strain: AH7011 Source: meotic time 3 hours Genotype: ycs4S/red1	EXP052709	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052747	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052710	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052748	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 10% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052711	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052749	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 15% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052718	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052750	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 20% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052713	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052751	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 25% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052714	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052752	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 30% spike Strain: AH119 Source: meotic time 3 hours Genotype: wildtype	EXP052715	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052753	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052716	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052754	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 5% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052717	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052755	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 15% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052718	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052756	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 20% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052719	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052757	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 25% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052720	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052758	Anti-Red1 (Lot#16440; kind gift of N. Hollingsworth)	Saccharomyces cerevisiae	Treatment: Treatment: Characteristic: 30% spike Strain: AH9048 Source: meotic time 3 hours Genotype: red1-pG162A	EXP052721	2519	normal	P14291	Cell suspension in synchronous meiosis	NULL
EXP052759	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin Strain: YSK426 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SNF2-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	NULL
EXP052760	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin Strain: YSK426 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SNF2-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	NULL
EXP052761	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin Strain: YSK423 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ISW2-FRB-HIS3MX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	NULL
EXP052762	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin Strain: YSK423 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 ISW2-FRB-HIS3MX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	NULL
EXP052763	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: no auxin Strain: YSK492 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	NULL
EXP052764	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: 30 minutes auxin (3-IAA) Strain: YSK492 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	NULL
EXP052765	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: no auxin Strain: YSK491 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; ISW1-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	NULL
EXP052766	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: 30 minutes auxin (3-IAA) Strain: YSK426 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX; ISW1-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	NULL
EXP052767	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: no rapamycin Strain: YSK474 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 CHD1-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	NULL
EXP052768	Anti-Myc (homemade)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin Strain: YSK474 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 CHD1-FRB-KanMX; SPT15-13xmyc-KanMX	NULL	2520	normal	P13393	whole cells	NULL
EXP052769	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: no rapamycin/auxin Strain: YSK495 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	NULL
EXP052770	ANTI-FLAG M2 (Sigma F3165)	Saccharomyces cerevisiae	Treatment: 60 minutes rapamycin 30 minutes auxin Strain: YSK495 Genotype: W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1W303 tor1-1 fpr1::NAT RPL13A-2XFKB12::TRP1 SPT15-FLAG-HphMX ISW2-FRB-HIS3MX; INO80-aid*-9myc-HphNT Padh1-Os.TIR1	NULL	2520	normal	P13393	whole cells	NULL
EXP052771	input	Saccharomyces cerevisiae	Treatment: Genotype: spt6-S8A	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052772	input	Saccharomyces cerevisiae	Treatment: Genotype: spt6-S8E	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052773	input	Saccharomyces cerevisiae	Treatment: Genotype: wildtype	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP052774	anti-Spt6	Saccharomyces cerevisiae	Treatment: Genotype: spt6-S8A	EXP052771	1232	normal	P23615	S. cerevisiae cells	NULL
EXP052775	anti-Spt6	Saccharomyces cerevisiae	Treatment: Genotype: spt6-S8E	EXP052772	1232	normal	P23615	S. cerevisiae cells	NULL
EXP052776	anti-Spt6	Saccharomyces cerevisiae	Treatment: Genotype: wildtype	EXP052773	1232	normal	P23615	S. cerevisiae cells	NULL
EXP052777		Saccharomyces cerevisiae	Treatment: none Source: input  Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP052778		Saccharomyces cerevisiae	Treatment: none Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP052779		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Source: input Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP052780		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2189	chip_control	NULL	G1 S.cerevisiae cells	NULL
EXP052781		Saccharomyces cerevisiae	Treatment: none Source: input  Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP052782		Saccharomyces cerevisiae	Treatment: none Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP052783		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Source: input Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP052784		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	NULL	2191	chip_control	NULL	S phase S. cerevisiae cells	NULL
EXP052785	anti-Flag	Saccharomyces cerevisiae	Treatment: none Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052777	2189	normal	P46946	G1 S.cerevisiae cells	NULL
EXP052786		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052779	2189	normal	P46946	G1 S.cerevisiae cells	NULL
EXP052787		Saccharomyces cerevisiae	Treatment: none Source: bead control Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052781	2191	normal	P46946	S phase S. cerevisiae cells	NULL
EXP052788		Saccharomyces cerevisiae	Treatment: camptothecin (100 uM) for 50 min Genotype: TP3352 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 sae2::KMX	EXP052783	2191	normal	P46946	S phase S. cerevisiae cells	NULL
EXP052789	anti-GFP antibody (Roche Cat#11814460001, Lot#19958500)	Caenorhabditis elegans	Strain: VL648 Treatment: incubated at 20Â°C overnight with 1%  DMSO Genotype: VL648 unc-119(ed3); wwIs22 [Pnhr-86::nhr-86ORF::GFP unc-119(+)]	NULL	1389	normal	Q965W2	whole worms (developmental stage: L4/young adults)	NULL
EXP052790	anti-GFP antibody (Roche Cat#11814460001, Lot#19958500)	Caenorhabditis elegans	Strain: VL648 Treatment: incubated at 20Â°C overnight with 70 uM R24 Genotype: VL648 unc-119(ed3); wwIs22 [Pnhr-86::nhr-86ORF::GFP unc-119(+)]	NULL	1389	normal	Q965W2	whole worms (developmental stage: L4/young adults)	NULL
EXP052791	IgG	Caenorhabditis elegans	Treatment: Strain: GW638	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052792	IgG	Caenorhabditis elegans	Treatment: Strain: GW638	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052793	IgG	Caenorhabditis elegans	Treatment: Strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP052794	IgG	Caenorhabditis elegans	Treatment: Strain: N2	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP052795	INPUT	Caenorhabditis elegans	Treatment: none	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052796	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052797	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052798	INPUT	Caenorhabditis elegans	Treatment: none	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052799	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052800	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052801	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052802	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052803	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052804	INPUT	Caenorhabditis elegans	Treatment: none	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052805	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052806	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052807	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052808	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052809	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052810	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052811	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052812	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052813	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052814	INPUT	Caenorhabditis elegans	Treatment: none	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052815	INPUT	Caenorhabditis elegans	Treatment: none	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052816	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052817	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052818	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052819	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052820	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052821	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052822	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052823	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052824	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052825	INPUT	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052826	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052827	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052828	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052829	INPUT	Caenorhabditis elegans	Treatment: Strain: 15eh1	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP052830	INPUT	Caenorhabditis elegans	Treatment: Strain: 15eh1	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP052831	INPUT	Caenorhabditis elegans	Treatment: Strain: 15eh1	NULL	1390	chip_control	NULL	whole worms (developmental stage: L3)	NULL
EXP052832	INPUT	Caenorhabditis elegans	Treatment: none	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052833	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052834	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052835	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052836	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052837	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052838	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052839	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052840	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052841	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052842	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052843	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052844	INPUT	Caenorhabditis elegans	Treatment: Strain: N2	NULL	2521	chip_control	NULL	whole worms (mixed embryo)	NULL
EXP052845	CBP-1 (SDIX LLC, SDQ3582 non-commercial cbp-1 modENCODE antibody 1)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052805	2521	normal	P34545	whole worms (mixed embryo)	NULL
EXP052846	CBP-1 (SDIX LLC, SDQ3582 non-commercial cbp-1 modENCODE antibody 1)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052807	2521	normal	P34545	whole worms (mixed embryo)	NULL
EXP052847	MDT-15	Caenorhabditis elegans	Treatment: Strain: N2	EXP052837	2521	normal	Q21955	whole worms (mixed embryo)	NULL
EXP052848	MDT-15	Caenorhabditis elegans	Treatment: Strain: N2	EXP052828	2521	normal	Q21955	whole worms (mixed embryo)	NULL
EXP052849	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052819	2521	normal	Q95XZ5	whole worms (mixed embryo)	NULL
EXP052850	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052825	2521	normal	Q95XZ5	whole worms (mixed embryo)	NULL
EXP052851	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052824	2521	normal	Q95XZ5	whole worms (mixed embryo)	NULL
EXP052852	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052810	2521	normal	Q95XZ5	whole worms (mixed embryo)	NULL
EXP052853	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052811	2521	normal	Q95XZ5	whole worms (mixed embryo)	NULL
EXP052854	PQN-85 (SDIX LLC, SDQ4481 5332.00.02)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052823	2521	normal	Q95XZ5	whole worms (mixed embryo)	NULL
EXP052855	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052799	2521	normal	Q17381	whole worms (mixed embryo)	NULL
EXP052856	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052801	2521	normal	Q17381	whole worms (mixed embryo)	NULL
EXP052857	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: control (RNAi wildtype)	EXP052812	2521	normal	Q17381	whole worms (mixed embryo)	NULL
EXP052858	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052800	2521	normal	Q17381	whole worms (mixed embryo)	NULL
EXP052859	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052802	2521	normal	Q17381	whole worms (mixed embryo)	NULL
EXP052860	anti-GFP (Abcam, ab290)	Caenorhabditis elegans	Treatment: Strain: N2 Genotype: RNAi knockdown	EXP052813	2521	normal	Q17381	whole worms (mixed embryo)	NULL
EXP052861	DPY-27 (Covance Research Products Inc, JL00001_DPY27)	Caenorhabditis elegans	Treatment: Strain: 15eh1	EXP052830	1390	normal	P48996	whole worms (developmental stage: L3)	NULL
EXP052862	DPY-27 (Covance Research Products Inc, JL00001_DPY27)	Caenorhabditis elegans	Treatment: Strain: 15eh1	EXP052831	1390	normal	P48996	whole worms (developmental stage: L3)	NULL
EXP052863	SDC-3 (Covance Research Products Inc, JL00002_SDC3)	Caenorhabditis elegans	Treatment: Strain: GW638	EXP052798	2521	normal	P34706	whole worms (mixed embryo)	NULL
EXP052864	CAPG-1 (Novus, 53230002)	Caenorhabditis elegans	Treatment: Strain: GW638	EXP052798	2521	normal	G5EFJ4	whole worms (mixed embryo)	NULL
EXP052865	CBP-1 (SDIX LLC, SDQ3582 non-commercial cbp-1 modENCODE antibody 1)	Caenorhabditis elegans	Treatment: Strain: N2	EXP052844	2521	normal	P34545	whole worms (mixed embryo)	NULL
EXP052866	none	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	NULL	2523	chip_control	NULL	flight muscles	NULL
EXP052867	none	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	NULL	2523	chip_control	NULL	flight muscles	NULL
EXP052868	anti-Rbf (mouse, DX3/DX5, ratio 1:1, Du W. et al, Genes Dev. 1996;10(10):1206-18)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052866	2523	normal	Q24472	flight muscles	NULL
EXP052869	anti-Rbf (mouse, DX3/DX5, ratio 1:1, Du W. et al, Genes Dev. 1996;10(10):1206-18)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052867	2523	normal	Q24472	flight muscles	NULL
EXP052870	anti-DP (rabbit, #212, Dimova et al., Genes Dev. 2003;17: 2308-2320)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052866	2523	normal	Q24318	flight muscles	NULL
EXP052871	anti-DP (rabbit, #212, Dimova et al., Genes Dev. 2003;17: 2308-2320)	Drosophila melanogaster	Genotype: wildtype, P{UAS-mCherry-RNAi}attP2 ; P{GAL4-Mef2.R}3 Developmental stage: Pharate stage (96h APF at 25 degrees C)  	EXP052867	2523	normal	Q24318	flight muscles	NULL
EXP052872	none	Drosophila melanogaster	Treatment:mock Sex: female Genotype: control Source: embryo	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052873	none	Drosophila melanogaster	Treatment:mock Sex: female Genotype: control Source: embryo	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052874	none	Drosophila melanogaster	Treatment: siAGO2 Sex: female Genotype: Ago2 knockdown Source: embryo	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052875	none	Drosophila melanogaster	Treatment: siAGO2 Sex: female Genotype: Ago2 knockdown Source: embryo	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052876	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment:mock Sex: female Genotype: control Source: embryo	EXP052872	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052877	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment:mock Sex: female Genotype: control Source: embryo	EXP052873	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052878	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment: siAGO2 Sex: female Genotype: Ago2 knockdown Source: embryo	EXP052874	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052879	CDK9 (Nakamura Lab)	Drosophila melanogaster	Treatment: siAGO2 Sex: female Genotype: Ago2 knockdown Source: embryo	EXP052875	1448	normal	O17432	KC167 (developmental stage: 6-12h embryo)	NULL
EXP052880	input	Drosophila melanogaster	Treatment: induced (CuSO4 250 uM) Genotype: pMT - HMR-FLAG-HA 	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052881	input	Drosophila melanogaster	Treatment: uninduced Genotype: pMT - HMR-FLAG-HA 	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052882	input	Drosophila melanogaster	Treatment: induced (CuSO4 250 uM) Genotype: pMT - HMR-FLAG-HA 	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052883	anti-HMR	Drosophila melanogaster	Treatment: induced (CuSO4 250 uM) Genotype: pMT - HMR-FLAG-HA 	EXP052880	1451	normal	Q7YU57	S2 (Schneider 2)	NULL
EXP052884	anti-HMR	Drosophila melanogaster	uninduced	EXP052881	1451	normal	Q7YU57	S2 (Schneider 2)	NULL
EXP052885	anti-HMR	Drosophila melanogaster	Treatment: uninduced Genotype: pMT - HMR-FLAG-HA 	EXP052882	1451	normal	Q7YU57	S2 (Schneider 2)	NULL
EXP052886	none (Input)	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052887	none (Input)	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052888	none (Input)	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052889	none (Input)	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052890	none (Input)	Drosophila melanogaster	Genotype: gst RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052891	none (Input)	Drosophila melanogaster	Genotype: gst RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052892	none (Input)	Drosophila melanogaster	Genotype: gst RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052893	none (Input)	Drosophila melanogaster	Genotype: trl RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052894	none (Input)	Drosophila melanogaster	Genotype: trl RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052895	none (Input)	Drosophila melanogaster	Genotype: trl RNAi Sex: male	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP052896	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052886	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052897	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052887	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052898	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052888	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052899	anti-CLAMP	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052889	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052900	anti-CLAMP	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052890	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052901	anti-CLAMP	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052891	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052902	anti-CLAMP	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052889	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052903	anti-CLAMP	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052893	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052904	anti-CLAMP	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052894	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052905	anti-CLAMP	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052895	1451	normal	Q8IGP5	S2 (Schneider 2)	NULL
EXP052906	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052886	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052907	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052887	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052908	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052888	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052909	MSL2	Drosophila melanogaster	Genotype: clamp RNAi Sex: male	EXP052889	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052910	MSL2	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052890	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052911	MSL2	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052891	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052912	MSL2	Drosophila melanogaster	Genotype: gst RNAi Sex: male	EXP052892	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052913	MSL2	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052893	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052914	MSL2	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052894	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052915	MSL2	Drosophila melanogaster	Genotype: trl RNAi Sex: male	EXP052895	1451	normal	P50534	S2 (Schneider 2)	NULL
EXP052916	PADI2 antibody (z-22, Santa Cruz,sc-133877,#E1214  )	Homo sapiens	Treatment: Untreated Source: T47D PADI2 T0	NULL	111	normal	Q9Y2J8	T47D (invasive ductal carcinoma)	NULL
EXP052917	PADI2 antibody (z-22, Santa Cruz,sc-133877,#H0715 )	Homo sapiens	Treatment: Untreated Source: T47D PADI2 T0	NULL	111	normal	Q9Y2J8	T47D (invasive ductal carcinoma)	NULL
EXP052918	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052919	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shGFP	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052920	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052921	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052922	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052923	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARfl transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052924	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052925	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052926	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052927	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shGFP transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052928	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052929	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARfl transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052930	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052931	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARfl transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052932	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052933	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shGFP	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052934	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052935	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052936	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052937	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052938	INPUT	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) 	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052939	INPUT	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP052940	FOXA1 (Abcam)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	EXP052918	2524	normal	P55317	LNCaP95	NULL
EXP052941	FOXA1 (Abcam)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	EXP052920	2524	normal	P55317	LNCaP95	NULL
EXP052942	FOXA1 (Abcam)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	EXP052922	2524	normal	P55317	LNCaP95	NULL
EXP052943	HOXB13	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	EXP052924	2524	normal	Q92826	LNCaP95	NULL
EXP052944	HOXB13	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	EXP052925	2524	normal	Q92826	LNCaP95	NULL
EXP052945	HOXB13	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	EXP052926	2524	normal	Q92826	LNCaP95	NULL
EXP052946	AR (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection 	EXP052926	2524	normal	P10275	LNCaP95	NULL
EXP052947	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052923	2524	normal	P10275	LNCaP95	NULL
EXP052948	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection 	EXP052932	2524	normal	P10275	LNCaP95	NULL
EXP052949	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shGFP	EXP052933	2524	normal	P10275	LNCaP95	NULL
EXP052950	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection 	EXP052925	2524	normal	P10275	LNCaP95	NULL
EXP052951	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052928	2524	normal	P10275	LNCaP95	NULL
EXP052952	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) 	EXP052936	2524	normal	P10275	LNCaP95	NULL
EXP052953	ARfl (Clone SP242; Spring Bioscience)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052937	2524	normal	P10275	LNCaP95	NULL
EXP052954	AR (N-20, Santa-Cruz Biotechnology)	Homo sapiens	Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) 	EXP052938	2524	normal	P10275	LNCaP95	NULL
EXP052955	AR (N-20, Santa-Cruz Biotechnology)	Homo sapiens	Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection	EXP052939	2524	normal	P10275	LNCaP95	NULL
EXP052956	NA	Homo sapiens	Treatment: 0.1% DMSO for 3 hrs	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP052957	NA	Homo sapiens	Treatment: 1uM CYC065 for 3hrs 	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP052958	CDK9 (H169, santa-cruz, sc-8338)	Homo sapiens	Treatment: 0.1% DMSO for 3 hrs	EXP052956	520	normal	P50750	Kelly (neuroblastoma)	NULL
EXP052959	CDK9 (H169, santa-cruz, sc-8338)	Homo sapiens	Treatment: 1uM CYC065 for 3hrs 	EXP052957	520	normal	P50750	Kelly (neuroblastoma)	NULL
EXP052960		Homo sapiens	Genotype: wildtype 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP052961		Homo sapiens	Genotype: wildtype 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP052962	KDM5A	Homo sapiens	Genotype: wildtype 	EXP052960	417	normal	P29375	HCT-116 (colon carcinoma)	NULL
EXP052963	KDM5A	Homo sapiens	Genotype: wildtype 	EXP052961	417	normal	P29375	HCT-116 (colon carcinoma)	NULL
EXP052964	anti-Glucocorticoid receptor (N499)	Homo sapiens	Treatment: 90min with 0.02% ethanol Genotype: traslocation t(9;22)(q34;11) ? BCR-ABL1 e1-a2 fusion	NULL	2525	normal	P04150	SUP-B15 (Childhood B acute lymphoblastic leukemia)	NULL
EXP052965	Glucocorticoid receptor N499	Homo sapiens	Treatment: 1uM dexamethasone in 0.02% ethanol Genotype: traslocation t(9;22)(q34;11) ? BCR-ABL1 e1-a2 fusion	NULL	2525	normal	P04150	SUP-B15 (Childhood B acute lymphoblastic leukemia)	NULL
EXP052966	Input	Homo sapiens	Treatment: vehicle for 24 hrs Status: naÃ¯ve	NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052967	Input	Homo sapiens	Treatment: vehicle for 24 hrs Status: resistant	NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052968	Input	Homo sapiens	Treatment: JQ1 for 24 hrs Status: naÃ¯ve	NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052969	Input	Homo sapiens	Treatment: JQ1 for 24 hrs Status: resistant	NULL	82	chip_control	NULL	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052970	BRD4	Homo sapiens	Treatment: vehicle for 24 hrs Status: naÃ¯ve	EXP052966	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052971	BRD4	Homo sapiens	Treatment: vehicle for 24 hrs Status: resistant	EXP052967	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052972	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs Status: naÃ¯ve	EXP052968	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052973	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs Status: resistant	EXP052969	82	normal	O60885	SK-N-BE(2)-C (neuroblastoma)	NULL
EXP052974	none	Homo sapiens	Treatment: untreated (control siRNA)	NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP052975	none	Homo sapiens	Treatment: BCL6 targeted siRNA	NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP052976	BCL6 (Santa Cruz N3, sc-858)	Homo sapiens	Treatment: untreated (control siRNA)	EXP052974	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP052977	BCL6 (Santa Cruz N3, sc-858)	Homo sapiens	Treatment: BCL6 targeted siRNA	EXP052975	685	normal	P41182	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP052978	LSD1 (abcam 17721)	Homo sapiens	Treatment: untreated (control siRNA)	EXP052974	685	normal	O60341	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP052979	LSD1 (abcam 17721)	Homo sapiens	Treatment: BCL6 targeted siRNA	EXP052975	685	normal	O60341	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP052980	none	Homo sapiens	Genotype: wildtype Treatment: hiPSC differentiation into hNCC (passage 2)	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP052981	TFAP2A (sc-12726, Santa Cruz)	Homo sapiens	Genotype: wildtype Treatment: hiPSC differentiation into hNCC (passage 2)	EXP052980	1143	normal	P05549	iPSC (induced pluripotent stem cells)	NULL
EXP052982	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siControl every 24 hours, 100nM of DHT for 2 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP052983	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siControl every 24 hours, 100nM of ETOH for 2 hrs, 100nM of ETOH for 2 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP052984	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siLINC00844 every 24 hours, 100nM of DHT for 2 hrs Genotype: transfected with siLINC00844 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP052985	AR Antibody (H-280) (SCBT, cat# sc-13062, lot# B2616)	Homo sapiens	Treatment:  transfected twice with with 5nM of siLINC00844 every 24 hours, 100nM of ETOH for 2 hrs Genotype: transfected with siLINC00844 	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP052986	FLAG-M2 beads(Sigma, M8823)	Homo sapiens	Genotype: stably expressed FLAG tag alone	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP052987	none	Homo sapiens	Genotype: stably expressed FLAG tag alone	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP052988	FLAG-M2 beads(Sigma, M8823)	Homo sapiens	Genotype: stably expressed FLAG tag-CTCF	EXP052987	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP052989	CTCF(Active motif, 61311)	Homo sapiens	Genotype: stably expressed FLAG tag alone	NULL	423	normal	P49711	HeLa S3 (cervical adenocarcinoma)	NULL
EXP052990	RAD21(abcam,ab992)	Homo sapiens	Genotype: stably expressed FLAG tag alone	EXP052987	423	normal	O60216	HeLa S3 (cervical adenocarcinoma)	NULL
EXP052991	None	Homo sapiens		NULL	1086	chip_control	NULL	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP052992	MEIS1 (Abcam, ab19867)	Homo sapiens		EXP052991	1086	normal	O00470	A-673 clone Asp114 (Ewing sarcoma)	NULL
EXP052993	none (input)	Homo sapiens	Genotype: inducible Glis3 expression Treatment:none Doxycycline, 12 hrs Source: G3- human embryonic stem cells 	NULL	2526	chip_control	NULL	H9	NULL
EXP052994	none (input)	Homo sapiens	Genotype: inducible Glis3 expression Treatment: with Doxycycline , 12 hrs Source: G3- human embryonic stem cells 	NULL	2526	chip_control	NULL	H9	NULL
EXP052995	HA antibody (Cell Signaling, Catalog # C29F4)	Homo sapiens	Genotype: inducible Glis3 expression Treatment:none Doxycycline, 12 hrs Source: G3- human embryonic stem cells 	EXP052993	2526	normal	Q8NEA6	H9	NULL
EXP052996	HA antibody (Cell Signaling, Catalog # C29F4)	Homo sapiens	Genotype: inducible Glis3 expression Treatment: with Doxycycline , 12 hrs Source: G3- human embryonic stem cells 	EXP052994	2526	normal	Q8NEA6	H9	NULL
EXP052997	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged control vector	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP052998	None	Homo sapiens	Genotype: wildtype	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP052999	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged N1671A p300-BRPHZT (mutant) 	EXP052998	375	normal	Q99720	NCI-H1299 (large cell lung carcinoma)	NULL
EXP053000	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged N1671A p300-BRPHZT (mutant) 	EXP052998	375	normal	Q09472	NCI-H1299 (large cell lung carcinoma)	NULL
EXP053001	anti-Flag (Sigma F1804)	Homo sapiens	Genotype: FLAG-tagged WT p300-BRPHZT 	EXP052998	375	normal	Q99720	NCI-H1299 (large cell lung carcinoma)	NULL
EXP053002	FLI1 (Santa Cruz, sc-356)	Homo sapiens		NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP053003	FLI1 (Abcam, ab15289)	Homo sapiens		NULL	472	normal	Q01543	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP053004	ERG (Abcam, ab136152)	Homo sapiens		NULL	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP053005		Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053006		Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053007	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053008		Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053009		Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053010		Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053011		Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053012		Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053013		Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053014		Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053015		Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053016		Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	NULL	1474	chip_control	NULL	HuH7 (hepatocellular carcinoma)	NULL
EXP053017	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	EXP053005	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053018	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	EXP053006	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053019	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1  by GFP	EXP053007	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053020	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	EXP053008	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053021	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	EXP053009	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053022	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL interferon beta for 18 hrs Genotype: expression of LEO1  by GFP	EXP053010	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053023	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	EXP053011	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053024	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	EXP053012	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053025	anti-LEO1 antibody	Homo sapiens	Treatment: mock Genotype: expression of LEO1 by  NS5 	EXP053013	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053026	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	EXP053014	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053027	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	EXP053015	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053028	anti-LEO1 antibody	Homo sapiens	Treatment: 31.25 U/mL of interferon-beta for 18 hrs Genotype: expression of LEO1 by  NS5 	EXP053016	1474	normal	Q8WVC0	HuH7 (hepatocellular carcinoma)	NULL
EXP053029	no antibody	Homo sapiens		NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP053030	no antibody	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP053031	ZNF768 (mAb, 7D6)	Homo sapiens		EXP053029	767	normal	Q9H5H4	Raji (Burkitt lymphoma)	NULL
EXP053032	ZNF768 (mAb, 7D6)	Homo sapiens		EXP053030	848	normal	Q9H5H4	U2OS (osteosarcoma)	NULL
EXP053033	none	Homo sapiens	Treatment: no stress  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053034	none	Homo sapiens	Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053035	none	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053036	none	Homo sapiens	Treatment: no stress  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053037	none	Homo sapiens	Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053038	none	Homo sapiens	Treatment: 110 mM NaCl for 30 min  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053039	none	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053040	none	Homo sapiens	untreated	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053041	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	EXP053033	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053042	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell	EXP053034	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053043	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053035	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053044	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	EXP053036	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053045	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell	EXP053037	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053046	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 30 min  Source: T47D whole cell	EXP053038	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053047	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053039	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053048	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053049	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: triploide, no stress  Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053050	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053051	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053052	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053053	CTCF (Millipore 07-729, lot: 2971000)	Homo sapiens	110 mM NaCl	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP053054	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: no stress  Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053055	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: no stess, + triptolide Source: T47D whole cell 	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053056	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053057	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053058	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  + 60 min isotonic Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053059	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + 60 min isotonic Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053060	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053061	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: no stress Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053062	RAD21 (Abcam ab992, lot: GR3194001-2)	Homo sapiens	Treatment: 110 mM NaCl for 60  min +  60 min isotonic Source: T47D whole cell	EXP053040	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP053063		Homo sapiens	Treatment: No treatment, no TPA  Source: HEL-iMKL1 cells	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053064		Homo sapiens	Treatment: No treatment, no TPA  Source: HEL-iMKL1 cells	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053065		Homo sapiens	Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053066		Homo sapiens	Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053067		Homo sapiens	Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053068		Homo sapiens	Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053069		Homo sapiens	Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053070		Homo sapiens	Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed	NULL	2528	chip_control	NULL	HEL (Erythro Leukemia)	NULL
EXP053071	anti-SRF	Homo sapiens	Treatment: No treatment, no TPA  Source: HEL-iMKL1 cells	EXP053063	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053072	anti-SRF	Homo sapiens	Treatment: No treatment, no TPA  Source: HEL-iMKL1 cells	EXP053064	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053073	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells	EXP053065	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053074	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells	EXP053066	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053075	anti-SRF	Homo sapiens	Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells	EXP053067	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053076	anti-SRF	Homo sapiens	Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells	EXP053068	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053077	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed	EXP053069	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053078	anti-SRF	Homo sapiens	Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed	EXP053070	2528	normal	P11831	HEL (Erythro Leukemia)	NULL
EXP053079	none (Input)	Homo sapiens	Treatment: untreated 	NULL	2529	chip_control	NULL	EOL-1 (Acute myeloid leukemia)	NULL
EXP053080	none (Input)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053081	none (Input)	Homo sapiens	Treatment: lentivirally infected with shControl	NULL	2530	chip_control	NULL	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053082	none (Input)	Homo sapiens	Treatment: lentivirally infected with shSSX vector	NULL	2530	chip_control	NULL	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053083	none (Input)	Homo sapiens	Treatment: untreated	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP053084	n/a	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053085	n/a	Homo sapiens	Treatment: DMSO control for 7 days	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053086	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	P51532	EOL-1 (Acute myeloid leukemia)	NULL
EXP053087	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9H8M2	EOL-1 (Acute myeloid leukemia)	NULL
EXP053088	BRD9 (Abcam, 66443 #GR144569-1)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9H8M2	EOL-1 (Acute myeloid leukemia)	NULL
EXP053089	GLTSCR1 (Santa Cruz, SC-240516, #A2313  )	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9NZM4	EOL-1 (Acute myeloid leukemia)	NULL
EXP053090	SMARCC1 (homemade)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q92922	EOL-1 (Acute myeloid leukemia)	NULL
EXP053091	BRD7 (CST, 14910, #1)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q9NPI1	EOL-1 (Acute myeloid leukemia)	NULL
EXP053092	DPF2 (Abcam, ab134942, #YJ031611CS)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	Q92785	EOL-1 (Acute myeloid leukemia)	NULL
EXP053093	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: untreated 	EXP053079	2529	normal	P49711	EOL-1 (Acute myeloid leukemia)	NULL
EXP053094	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	P51532	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053095	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q9H8M2	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053096	BRD7 (CST, 14910, #1)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q9NPI1	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053097	DPF2 (Abcam, ab134942, #YJ031611CS)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q92785	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053098	GLTSCR1 (Santa Cruz, SC-240516, #A2313  )	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	Q9NZM4	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053099	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: treated with 1:10.000 DMSO for 48hr	EXP053080	2219	normal	P49711	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053100	SS18 (CST, 21792s,  Lot 1)	Homo sapiens	Treatment: lentivirally infected with shControl	EXP053081	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053101	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with shControl	EXP053081	2530	normal	Q9H8M2	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053102	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: lentivirally infected with shControl	EXP053081	2530	normal	P49711	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053103	SS18 (CST, 21792s,  Lot 1)	Homo sapiens	Treatment: lentivirally infected with shSSX vector	EXP053082	2530	normal	Q15532	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053104	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with shSSX vector	EXP053082	2530	normal	Q9H8M2	SYO-1(Biphasic synovial sarcoma)	NULL
EXP053105	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: untreated	EXP053083	509	normal	Q9H8M2	Jurkat (T-cells)	NULL
EXP053106	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: untreated	EXP053083	509	normal	P49711	Jurkat (T-cells)	NULL
EXP053107	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with empty vector control 	NULL	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053108	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with vector containing SMARCB1l	NULL	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053109	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	EXP053084	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053110	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: DMSO control for 7 days	EXP053085	2345	normal	Q9H8M2	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053111	CTCF (CST, 3418S, #3)	Homo sapiens	Treatment: lentivirally infected with empty vector control	NULL	2345	normal	P49711	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053112	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with pLKO shScramble	NULL	2531	normal	Q9H8M2	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP053113	BRD9 (Abcam, 137245, #GR257571-3)	Homo sapiens	Treatment: lentivirally infected with shSSX1	NULL	2531	normal	Q9H8M2	Aska-SS (Biphasic synovial sarcoma)	NULL
EXP053114	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	NULL	2219	normal	P51532	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053115	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: 250nM dBRD9 (1:10,000 dilution) for 7 days	EXP053084	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053116	SMARCA4 (Abcam, EPNCIR111A, #GR150844-12 )	Homo sapiens	Treatment: DMSO control for 7 days	EXP053085	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP053117	none	Saccharomyces cerevisiae	ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053118	none	Saccharomyces cerevisiae	ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053119	none	Saccharomyces cerevisiae	ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053120	none	Saccharomyces cerevisiae	ndj1? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053121	none	Saccharomyces cerevisiae	tel1? ndt80? T=6 	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053122	none	Saccharomyces cerevisiae	sir3? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053123	none	Saccharomyces cerevisiae	Ndj1-FRB ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053124	none	Saccharomyces cerevisiae	SK1/ S288c spike-in; ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053125	none	Saccharomyces cerevisiae	SK1/ S288c spike-in; ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053126	none	Saccharomyces cerevisiae	SK1/ S288c spike-in; pch2? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053127	none	Saccharomyces cerevisiae	SK1/ S288c spike-in; pch2? ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053128	none	Saccharomyces cerevisiae	esc1? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053129	none	Saccharomyces cerevisiae	sir2? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053130	none	Saccharomyces cerevisiae	sir2? ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053131	none	Saccharomyces cerevisiae	nup2? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053132	none	Saccharomyces cerevisiae	nup2? ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053133	none	Saccharomyces cerevisiae	ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053134	none	Saccharomyces cerevisiae	ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053135	none	Saccharomyces cerevisiae	ndt80? T=8	NULL	2527	chip_control	NULL	SK1 meiotic cells (8 hours)	NULL
EXP053136	none	Saccharomyces cerevisiae	wild type T=4	NULL	1219	chip_control	NULL	SK1 meiotic cells (4 hours)	NULL
EXP053137	none	Saccharomyces cerevisiae	wild type T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053138	none	Saccharomyces cerevisiae	wild type T=2	NULL	2176	chip_control	NULL	Sk1 meiotic (2 hours)	NULL
EXP053139	none	Saccharomyces cerevisiae	ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053140	none	Saccharomyces cerevisiae	ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053141	none	Saccharomyces cerevisiae	pch2? ndt80? T=3	NULL	1382	chip_control	NULL	SK1 meiotic cells (3 hours)	NULL
EXP053142	none	Saccharomyces cerevisiae	pch2? ndt80? T=6	NULL	2178	chip_control	NULL	SK1 meiotic cells (6 hours)	NULL
EXP053143	anti-Hop1	Saccharomyces cerevisiae	ndj1? ndt80? T=6	EXP053120	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053144	anti-Hop1	Saccharomyces cerevisiae	tel1? ndt80? T=6 	EXP053121	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053145	anti-Hop1	Saccharomyces cerevisiae	sir3? ndt80? T=6	EXP053122	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053146	anti-Hop1	Saccharomyces cerevisiae	Ndj1-FRB ndt80? T=6	EXP053123	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053147	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; ndt80? T=3	EXP053124	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053148	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; ndt80? T=6	EXP053125	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053149	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; pch2? ndt80? T=6	EXP053126	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053150	anti-Hop1	Saccharomyces cerevisiae	SK1/ S288c spike-in; pch2? ndt80? T=3	EXP053127	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053151	anti-Hop1	Saccharomyces cerevisiae	esc1? ndt80? T=6	EXP053128	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053152	anti-Hop1	Saccharomyces cerevisiae	sir2? ndt80? T=6	EXP053129	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053153	anti-Hop1	Saccharomyces cerevisiae	sir2? ndt80? T=3	EXP053130	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053154	anti-Hop1	Saccharomyces cerevisiae	nup2? ndt80? T=6	EXP053131	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053155	anti-Hop1	Saccharomyces cerevisiae	nup2? ndt80? T=3	EXP053132	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053156	anti-Red1	Saccharomyces cerevisiae	ndt80? T=6	EXP053133	2178	normal	P14291	SK1 meiotic cells (6 hours)	NULL
EXP053157	anti-Red1	Saccharomyces cerevisiae	ndt80? T=3	EXP053134	1382	normal	P14291	SK1 meiotic cells (3 hours)	NULL
EXP053158	anti-Rad51	Saccharomyces cerevisiae	ndt80? T=8	EXP053135	2527	normal	P25454	SK1 meiotic cells (8 hours)	NULL
EXP053159	anti-Hop1	Saccharomyces cerevisiae	wild type T=4	EXP053136	1219	normal	P20050	SK1 meiotic cells (4 hours)	NULL
EXP053160	anti-Hop1	Saccharomyces cerevisiae	wild type T=3	EXP053137	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053161	anti-Hop1	Saccharomyces cerevisiae	wild type T=2	EXP053138	2176	normal	P20050	Sk1 meiotic (2 hours)	NULL
EXP053162	anti-Mek1	Saccharomyces cerevisiae	ndt80? T=3	EXP053118	1382	normal	P24719	SK1 meiotic cells (3 hours)	NULL
EXP053163	anti-Hop1	Saccharomyces cerevisiae	ndt80? T=3	EXP053139	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053164	anti-Mek1	Saccharomyces cerevisiae	ndt80? T=6	EXP053119	2178	normal	P24719	SK1 meiotic cells (6 hours)	NULL
EXP053165	anti-Hop1	Saccharomyces cerevisiae	ndt80? T=6	EXP053140	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053166	anti-Hop1	Saccharomyces cerevisiae	pch2? ndt80? T=3	EXP053141	1382	normal	P20050	SK1 meiotic cells (3 hours)	NULL
EXP053167	anti-Hop1	Saccharomyces cerevisiae	pch2? ndt80? T=6	EXP053142	2178	normal	P20050	SK1 meiotic cells (6 hours)	NULL
EXP053168	anti-Zip1 (abcam yC-19)	Saccharomyces cerevisiae		EXP053117	2178	normal	P31111	SK1 meiotic cells (6 hours)	NULL
EXP053169	HA-tag (CST, 3724S)	Homo sapiens	Treatment: 3xHA empty vector Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053170	none	Homo sapiens	Treatment: no Passage: 12  Cell type: SS18-SSX1 fusion protein containing synovial sarcoma cells	NULL	2253	chip_control	NULL	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053171	HA-tag (CST, 3724S)	Homo sapiens	Treatment: exogenous 3xHA tagged BRD9-N216 Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053172	HA-tag (CST, 3724S)	Homo sapiens	Treatment: exogenous 3xHA tagged BRD9-wildtype Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053173	HA-tag (CST, 3724S)	Homo sapiens	Treatment: BI7273 10uM 24h Passage:12 SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053174	HA-tag (CST, 3724S)	Homo sapiens	Treatment: DMSO 24h, BI7273 matched Passage:12 Cell type: SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053175	HA-tag (CST, 3724S)	Homo sapiens	Treatment: DMSO 24h, dBRD9A matched Passage:12 Cell type: SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053176	HA-tag (CST, 3724S)	Homo sapiens	dBRD9-A 100nM 24h	EXP053170	2253	normal	Q9H8M2	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053177	HA-tag (CST, 3724S)	Homo sapiens	Treatment: DMSO 24h Passage: 12 Cell type:  SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053178	HA-tag (CST, 3724S)	Homo sapiens	Treatment: dBRD9-A 100nM 24hrs Passage: 12 Cell type:  SS18-SSX1 fusion protein containing synovial sarcoma cells	EXP053170	2253	normal	Q8IZH1	HS-SY-2(Monophasic synovial sarcoma)	NULL
EXP053179	none	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053180	none	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053181	none	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053182	none	Homo sapiens	Treatment: 10nM R5020 for 30 mins	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053183	none	Homo sapiens	Treatment: 10nM R5020 for 30 mins	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053184	none	Homo sapiens	Treatment: 10nM R5020 for 30 mins	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053185	none	Homo sapiens	Treatment: 1 uM TPA for 30 mins	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053186	none	Homo sapiens	Treatment: 1 uM TPA for 30 mins	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053187	none	Homo sapiens	Treatment: 1 uM TPA for 30 mins	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053188	none	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053189	none	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053190	none	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053191	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	EXP053179	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053192	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	EXP053180	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053193	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: vehicle (ethanol) for 30 mins 	EXP053181	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053194	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 for 30 mins	EXP053182	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053195	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 for 30 mins	EXP053183	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053196	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 for 30 mins	EXP053184	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053197	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 1 uM TPA for 30 mins	EXP053185	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053198	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 1 uM TPA for 30 mins	EXP053186	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053199	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 1 uM TPA for 30 mins	EXP053187	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053200	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	EXP053188	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053201	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	EXP053189	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053202	PR (Santa Cruz SC-7208X)	Homo sapiens	Treatment: 10nM R5020 + 1uM TPA	EXP053190	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP053203	none	Homo sapiens		NULL	840	chip_control	NULL	TT (hereditary thyroid gland medullary carcinoma)	NULL
EXP053204	BRD4 (Bethyl, cat: A301-985A100, lot: A301-985A50-6)	Homo sapiens		EXP053203	840	normal	O60885	TT (hereditary thyroid gland medullary carcinoma)	NULL
EXP053205	None	Homo sapiens	Treatment: none	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053206	None	Homo sapiens	Treatment: none	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP053207	TRPS1 ChIP antibody	Homo sapiens	Treatment: none	EXP053205	111	normal	Q9UHF7	T47D (invasive ductal carcinoma)	NULL
EXP053208	TRPS1 ChIP antibody	Homo sapiens	Treatment: none	EXP053206	111	normal	Q9UHF7	T47D (invasive ductal carcinoma)	NULL
EXP053209	none	Homo sapiens	Genotype: overexpress E2A Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP053210	none	Homo sapiens	Genotype: overexpress HEB Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP053211	none	Homo sapiens	Genotype: overexpress E2-2 Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP053212	HA-Tag (C29F4) Rabbit mAb (CST #3724)	Homo sapiens	Genotype: overexpress E2A Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	NULL	516	normal	P15923	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP053213	HEB	Homo sapiens	Genotype: overexpress HEB Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	EXP053210	516	normal	Q99081	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP053214	HA-Tag (C29F4) Rabbit mAb (CST #3724)	Homo sapiens	Genotype: overexpress E2-2 Source: Myeloblast Cell type: Â leukemic cell line with an 8;21 chromosome translocation Passage: 4-5	EXP053211	516	normal	P15884	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP053215		Homo sapiens	Treatment: none; Donor: LNCAP_Input	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP053216		Homo sapiens	Treatment: none; Donor: MCF7_Input	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053217		Homo sapiens	Treatment: none; Donor: P_Input_DSG	NULL	2538	chip_control	NULL	primary prostate cancer	NULL
EXP053218		Homo sapiens	Treatment: none; Donor: P_Input_FA	NULL	2538	chip_control	NULL	primary prostate cancer	NULL
EXP053219		Homo sapiens	Treatment: none; Donor: B_Input_DSG	NULL	2539	chip_control	NULL	primary breast cancer	NULL
EXP053220		Homo sapiens	Treatment: none; Donor: B_Input_FA	NULL	2539	chip_control	NULL	primary breast cancer	NULL
EXP053221		Homo sapiens	Treatment: none; Donor: E_Input_DSG	NULL	2540	chip_control	NULL	primary endometrium cancer	NULL
EXP053222		Homo sapiens	Treatment: none; Donor: E_Input_FA	NULL	2540	chip_control	NULL	primary endometrium cancer	NULL
EXP053223		Homo sapiens	Treatment: none; Donor: G_Input	NULL	2538	chip_control	NULL	primary prostate cancer	NULL
EXP053224	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: FA (control); Donor: LNCAP_AR_FA	EXP053215	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP053225	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: LNCAP_AR_DSG	EXP053215	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP053226	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: LNCAP_FOXA1_FA	EXP053215	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP053227	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: LNCAP_FOXA1_DSG	EXP053215	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP053228	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: FA (control); Donor: MCF7_ER_FA	EXP053216	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053229	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: MCF7_ER_DSG	EXP053216	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053230	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: MCF7_FOXA1_FA	EXP053216	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053231	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: MCF7_FOXA1_DSG	EXP053216	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053232	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: FA (control); Donor: P2_AR_FA	EXP053218	2538	normal	P10275	primary prostate cancer	NULL
EXP053233	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: P2_AR_DSG	EXP053217	2538	normal	P10275	primary prostate cancer	NULL
EXP053234	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: P2_FOXA1_FA	NULL	2538	normal	P55317	primary prostate cancer	NULL
EXP053235	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: P2_FOXA1_DSG	EXP053217	2538	normal	P55317	primary prostate cancer	NULL
EXP053236	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: FA (control); Donor: B3_ER_FA	EXP053220	2539	normal	P03372	primary breast cancer	NULL
EXP053237	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: B3_ER_DSG	EXP053219	2539	normal	P03372	primary breast cancer	NULL
EXP053238	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: FA (control); Donor: B4_FOXA1_FA	EXP053220	2539	normal	P55317	primary breast cancer	NULL
EXP053239	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: B4_FOXA1_DSG	EXP053219	2539	normal	P55317	primary breast cancer	NULL
EXP053240	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: FA (control); Donor: E3_ER_FA	EXP053222	2540	normal	P03372	primary endometrium cancer	NULL
EXP053241	ER (Santa Cruz; sc-543)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: E2_ER_DSG	EXP053221	2540	normal	P03372	primary endometrium cancer	NULL
EXP053242	AR (Santa Cruz; sc-816)	Homo sapiens	Treatment: FA (control); Donor: G2_AR_DSG	EXP053223	2538	normal	P10275	primary prostate cancer	NULL
EXP053243	FOXA1 (Santa Cruz; sc-6554)	Homo sapiens	Treatment: 25 mins of 2 mM DSG; Donor: G2_FOXA1_DSG	EXP053223	2538	normal	P55317	primary prostate cancer	NULL
EXP053244		Homo sapiens	Source: Surface Ectoderm Cells Genotype: wildtype Treatment: Day 7 of differentiation with RA/BMP4	NULL	2526	normal	A0A023HHK9	H9	NULL
EXP053245		Homo sapiens	Source: Surface Ectoderm Cells Genotype: p63-/- (knockout) Treatment: Day 7 of differentiation with RA/BMP4	NULL	2526	normal	A0A023HHK9	H9	NULL
EXP053246	None	Homo sapiens	Genotype: overexpressing HA-tagged ZNF445 	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP053247	None	Mus musculus	Strain: Castaneous/Black6 Genotype: overexpressing HA-tagged ZFP445	NULL	2447	chip_control	NULL	cultured embryonic stem cells (ES cells)	NULL
EXP053248	None	Mus musculus	Strain: Black6/Castaneous Genotype: overexpressing HA-tagged ZFP445	NULL	2447	chip_control	NULL	cultured embryonic stem cells (ES cells)	NULL
EXP053249	None	Mus musculus	Strain: Black6/Castaneous Genotype: overexpressing HA-tagged ZFP445	NULL	2447	chip_control	NULL	cultured embryonic stem cells (ES cells)	NULL
EXP053250	None	Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP053251	None	Homo sapiens	Sorce: TKD hES Genotype: knockdown for DNA methyltransferases DNMT1, DNMT3A, DNMT3B	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP053252	HA (Covance, MMS-101P)	Homo sapiens	Genotype: overexpressing HA-tagged ZNF445 	EXP053246	376	normal	P59923	WA01 (H1, human embryonic stem cells)	NULL
EXP053253	HA (Covance, MMS-101P)	Mus musculus	Strain: Castaneous/Black6 Genotype: overexpressing HA-tagged ZFP445	EXP053247	2447	normal	Q8R2V3	cultured embryonic stem cells (ES cells)	NULL
EXP053254	HA (Covance, MMS-101P)	Mus musculus	Strain: Black6/Castaneous Genotype: overexpressing HA-tagged ZFP445	EXP053248	2447	normal	Q8R2V3	cultured embryonic stem cells (ES cells)	NULL
EXP053255	HA (Covance, MMS-101P)	Mus musculus	Strain: Black6/Castaneous Genotype: overexpressing HA-tagged ZFP445	EXP053249	2447	normal	Q8R2V3	cultured embryonic stem cells (ES cells)	NULL
EXP053256	HA (Covance, MMS-101P)	Homo sapiens	Genotype: overexpressing HA-tagged ZFP57	EXP053250	376	normal	O14503	WA01 (H1, human embryonic stem cells)	NULL
EXP053257	anti-KAP1 (AbCam, ab10483)	Homo sapiens	Sorce: TKD hES Genotype: knockdown for DNA methyltransferases DNMT1, DNMT3A, DNMT3B	NULL	376	normal	Q13263	WA01 (H1, human embryonic stem cells)	NULL
EXP053258	n/a	Homo sapiens	TERT4	NULL	2532	chip_control	NULL	bone marrow-derived mesenchymal stromal cells	NULL
EXP053259	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2532	normal	O95243	bone marrow-derived mesenchymal stromal cells	NULL
EXP053260	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2534	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation day 7	NULL
EXP053261	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2535	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation day 3	NULL
EXP053262	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2536	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation day 1	NULL
EXP053263	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2537	normal	O95243	bone-marrow-derived mesenchymal stromal cells, osteoblast differentiation 4 hrs	NULL
EXP053264	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2541	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation 4 hrs	NULL
EXP053265	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2542	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 1	NULL
EXP053266	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2543	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 3	NULL
EXP053267	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2544	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 7	NULL
EXP053268	MED1 (M-255, sc-8998, Santa Cruz)	Homo sapiens	TERT4	EXP053258	2545	normal	O95243	bone-marrow-derived mesenchymal stromal cells, adipocyte differentiation day 14	NULL
EXP053269	PPARg(Santa Cruz Biotechnology, Cat# sc-7196)	Homo sapiens	Treatment: treated with rosiglitazone for 48h beginning at day 21 Passage: 3-4 Source: Adipocytes 	NULL	2547	normal	P37231	hASC (derived adipocytes)	NULL
EXP053270	PPARg(Santa Cruz Biotechnology, Cat# sc-7196)	Homo sapiens	Source: Adipose tissue   Passage: 3-4  Source: Adipose tissue   Passage: 3-4 	NULL	2546	normal	P37231	adipose	NULL
EXP053271		Homo sapiens	Treatment: none	NULL	1549	chip_control	NULL	COLO-829 (melanoma)	NULL
EXP053272	anti-MYC	Homo sapiens	Treatment: none	EXP053271	1549	normal	P61244	COLO-829 (melanoma)	NULL
EXP053273	V5 (Invitrogen #46-0705)	Homo sapiens	Genotype: Expressing LHX9-V5 open reading frame Tissue: colon	NULL	417	normal	Q9NQ69	HCT-116 (colon carcinoma)	NULL
EXP053274	V5 (Invitrogen #46-0705)	Homo sapiens	Genotype:Expressing LHX9-V5 open reading frame and shKRAS Tissue: colon	NULL	417	normal	Q9NQ69	HCT-116 (colon carcinoma)	NULL
EXP053275	none	Homo sapiens	Treatment: none	NULL	2548	chip_control	NULL	JB6 (Human anaplastic large cell lymphoma)	NULL
EXP053276	none	Homo sapiens	Treatment: none	NULL	2549	chip_control	NULL	SU-DHL-1 (Anaplastic large cell lymphoma)	NULL
EXP053277	anti-STAT3	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053275	2548	normal	P40763	JB6 (Human anaplastic large cell lymphoma)	NULL
EXP053278	anti-STAT3	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053275	2548	normal	P40763	JB6 (Human anaplastic large cell lymphoma)	NULL
EXP053279	anti-CEBPb	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053275	2548	normal	P17676	JB6 (Human anaplastic large cell lymphoma)	NULL
EXP053280	CEBP beta	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053275	2548	normal	P17676	JB6 (Human anaplastic large cell lymphoma)	NULL
EXP053281	anti-STAT3	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053276	2549	normal	P40763	SU-DHL-1 (Anaplastic large cell lymphoma)	NULL
EXP053282	anti-STAT3	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053276	2549	normal	P40763	SU-DHL-1 (Anaplastic large cell lymphoma)	NULL
EXP053283	anti-CEBPb	Homo sapiens	Treatment: DMSO for 3 hrs	EXP053276	2549	normal	P17676	SU-DHL-1 (Anaplastic large cell lymphoma)	NULL
EXP053284	anti-CEBPb	Homo sapiens	Treatment: 300 nM Crizotinib for 3 hrs	EXP053276	2549	normal	P17676	SU-DHL-1 (Anaplastic large cell lymphoma)	NULL
EXP053285		Homo sapiens	Treatment: edited with CRISPR gRNAs or ssODNs	NULL	2550	chip_control	NULL	angelman Syndrome iPSC	NULL
EXP053286		Homo sapiens	Treatment: edited with CRISPR gRNAs or ssODNs	NULL	2550	chip_control	NULL	angelman Syndrome iPSC	NULL
EXP053287		Homo sapiens	Treament: none	NULL	2551	chip_control	NULL	Prader-Willi Syndrome iPSC	NULL
EXP053288		Homo sapiens	Treament: none	NULL	2551	chip_control	NULL	Prader-Willi Syndrome iPSC	NULL
EXP053289	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treatment: edited with CRISPR gRNAs or ssODNs	EXP053285	2550	normal	P49711	angelman Syndrome iPSC	NULL
EXP053290	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treatment: edited with CRISPR gRNAs or ssODNs	EXP053286	2550	normal	P49711	angelman Syndrome iPSC	NULL
EXP053291	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treament: none	EXP053287	2551	normal	P49711	Prader-Willi Syndrome iPSC	NULL
EXP053292	ChIPAb+ CTCF (17-10044)	Homo sapiens	Treament: none	EXP053288	2551	normal	P49711	Prader-Willi Syndrome iPSC	NULL
EXP053293	rabbit polyclonal anti-MYC antibody (produced in-house)N-262	Homo sapiens	Treatment: 1ug/mL doxycycline for 7 days prior to harvest Genotype: wildtype MYC Passage: 10 -15  Cell type: neuroblastoma cell line	NULL	790	chip_control	NULL	Tet21N (neuroblastoma)	NULL
EXP053294	rabbit polyclonal anti-MYC antibody (produced in-house)N-262	Homo sapiens	Treatment: 1ug/mL doxycycline for 7 days prior to harvest Genotype: wildtype MYC Passage: 10 -15  Cell type: neuroblastoma cell line	EXP053293	790	normal	P01106	Tet21N (neuroblastoma)	NULL
EXP053295	none (Input)	Homo sapiens	Source: Pancreas 	NULL	2552	chip_control	NULL	EndoC-BH1 (human pancreatic beta cell line)	NULL
EXP053296	anti-CTCF	Homo sapiens	Source: Pancreas 	EXP053295	2552	normal	P49711	EndoC-BH1 (human pancreatic beta cell line)	NULL
EXP053297	none	Homo sapiens	Treatment: Overexpressing FLAG-TET2 and HA-SNIP1 after SNIP1 knockdown	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053298	HA beads(FF AGM90054)	Homo sapiens	Treatment: Overexpressing FLAG-TET2 and HA-SNIP1 after SNIP1 knockdown	EXP053297	10	normal	Q8TAD8	HEK293T (embryonic kidney)	NULL
EXP053299	none	Homo sapiens		NULL	815	chip_control	NULL	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP053300	none	Homo sapiens		NULL	815	chip_control	NULL	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP053301	BCL6 (Santa Cruz N3, sc-858)	Homo sapiens		NULL	815	normal	P41182	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP053302	LSD1 (abcam 17721)	Homo sapiens		NULL	815	normal	O60341	SU-DHL-4 (diffuse large B-cell lymphoma)	NULL
EXP053303	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053304	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053305	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs, Fbxo22 depletion (shFbxo)	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053306	ER (CST:D8H8)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs, Fbxo22 depletion	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053307	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053308	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053309	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) for 2 hrs, Fbxo22 depletion (shFbxo)	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053310	SRC-3 (CST:5E11)	Homo sapiens	Treatment: E2 (100nM) and 4OHT (10 nM) for 2 hrs, Fbxo22 depletion	NULL	113	normal	Q9Y6Q9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053311		Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	NULL	2553	chip_control	NULL	MLL-AF9 Leukemic Cells	NULL
EXP053312	none	Homo sapiens		NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053313	none	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP053314	none	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP053315	CHAF1B (Novus: 88235)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	Q9D0N7	MLL-AF9 Leukemic Cells	NULL
EXP053316	CHAF1B (Novus: 88235)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	Q9D0N7	MLL-AF9 Leukemic Cells	NULL
EXP053317	anti-PCNA (Cell Signaling: 13110)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	P17918	MLL-AF9 Leukemic Cells	NULL
EXP053318	anti-Runx2 (Cell Signaling: 12556)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	Q08775	MLL-AF9 Leukemic Cells	NULL
EXP053319	anti-Runx2 (Cell Signaling: 12556)	Mus musculus	Genotype: C1B knockout Strain: C57BL/6  Treatment: treated with 10-7M B-estradiol daily for two days (48 hours)	EXP053311	2553	normal	Q08775	MLL-AF9 Leukemic Cells	NULL
EXP053320	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens		EXP053312	2219	normal	Q13112	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053321	anti-CHAF1A(Novus: 74608)	Homo sapiens		EXP053312	2219	normal	Q13111	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053322	anti-CEBPA (Cell Signaling: 8178)	Homo sapiens		EXP053312	2219	normal	P49715	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP053323	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens		EXP053313	65	normal	Q13112	U937 (adult acute monocytic leukemia)	NULL
EXP053324	anti-CEBPA (Cell Signaling: 8178)	Homo sapiens		EXP053313	65	normal	P49715	U937 (adult acute monocytic leukemia)	NULL
EXP053325	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens	Treatment: shRNA Genotype: shControl 	EXP053313	65	normal	Q13112	U937 (adult acute monocytic leukemia)	NULL
EXP053326	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens		EXP053314	509	normal	Q13112	Jurkat (T-cells)	NULL
EXP053327	anti-GATA3 (Cell Signaling: 5852)	Homo sapiens		EXP053314	509	normal	P23771	Jurkat (T-cells)	NULL
EXP053328	anti-CEBPA (Cell Signaling: 8178)	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	P53566	MLL-AF9 Leukemic Cells	NULL
EXP053329	anti-CEBPA (Cell Signaling: 8178)	Mus musculus	Genotype: C1B knockout Strain: C57BL/6  Treatment: treated with 10-7M B-estradiol daily for two days (48 hours)	EXP053311	2553	normal	P53566	MLL-AF9 Leukemic Cells	NULL
EXP053330	Abcam: ab15289	Mus musculus	Genotype: wildtype Strain: C57BL/6  Treatment: Ethanol	EXP053311	2553	normal	A1A546	MLL-AF9 Leukemic Cells	NULL
EXP053331	Abcam: ab15289	Mus musculus	Genotype: C1B knockout Strain: C57BL/6  Treatment: treated with 10-7M B-estradiol daily for two days (48 hours)	EXP053311	2553	normal	A1A546	MLL-AF9 Leukemic Cells	NULL
EXP053332	anti-CHAF1B (Aviva: OAAF06171)	Homo sapiens	Treatment: shRNA Genotype: shCHAF1B knockout	EXP053313	65	bio_control	A0AVK6	U937 (adult acute monocytic leukemia)	NULL
EXP053333	none	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053334	pS118-ER (Cell Signaling, #2511, lot 16J4)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053335	pS118-ER (Cell Signaling, #2511, lot 16J4)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053336	pS118-ER (Abcam, ab32396, lot GR139357-5)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053337	pS118-ER (Abcam, ab32396, lot GR139357-5)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053338	pS118-ER (Santa Cruz, sc-12915, lot A1614)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053339	pS118-ER (Santa Cruz, sc-12915, lot A1614)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053340	ER (Santa Cruz, sc-543, lot F0316)	Homo sapiens	Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: wildtype ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053341	ER (Santa Cruz, sc-543, lot F0316)	Homo sapiens	Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: wildtype-ER	EXP053333	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053342		Homo sapiens		NULL	650	chip_control	NULL	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP053343	SMARCA4 antibody (abcam, ab110641)	Homo sapiens		EXP053342	650	normal	P51532	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP053344	none	Homo sapiens	Treatment: TCDD (2,3,7,8-Tetrachlorodibenzodioxin) added to a final concentration of 2 nM  Source: embryonic stem cells (ESC)	NULL	2554	chip_control	NULL	MEL1 (Mucosal melanoma)	NULL
EXP053345	none	Homo sapiens	Treatment: TCDD (2,3,7,8-Tetrachlorodibenzodioxin) added to a final concentration of 2 nM  Source: embryonic stem cells (ESC)	NULL	2554	chip_control	NULL	MEL1 (Mucosal melanoma)	NULL
EXP053346	Ah Receptor Antibody (H-211) (Santa Cruz, catalog# sc-5579)	Homo sapiens	Treatment: TCDD (2,3,7,8-Tetrachlorodibenzodioxin) added to a final concentration of 2 nM  Source: embryonic stem cells (ESC)	EXP053344	2554	normal	P35869	MEL1 (Mucosal melanoma)	NULL
EXP053347	Ah Receptor Antibody (H-211) (Santa Cruz, catalog# sc-5579)	Homo sapiens	Treatment: TCDD (2,3,7,8-Tetrachlorodibenzodioxin) added to a final concentration of 2 nM  Source: embryonic stem cells (ESC)	EXP053345	2554	normal	P35869	MEL1 (Mucosal melanoma)	NULL
EXP053348		Homo sapiens	Day 7 of differentiation with RA/BMP4 (surface ectoderm)	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP053349	p63 (Active Motif 39739)	Homo sapiens	Treatment: Doxycycline for 2 days  Geenotype: TetO:Tp63+/-  	EXP053348	2555	normal	Q9H3D4	surface ectoderm cells	NULL
EXP053350	p63 (Active Motif 39739)	Homo sapiens	Treatment: Day 7 of differentiation with RA/BMP4 Genotype: wildtype Source: background cell line WA 09	EXP053348	2555	normal	Q9H3D4	surface ectoderm cells	NULL
EXP053351	p63 (Active Motif 39739)	Homo sapiens	Treatment: Day 0 of epidermal differentiation Genotype: wildtype Source: background cell line WA 09 	EXP053348	2556	normal	Q9H3D4	human keratinocytes	NULL
EXP053352	none (input)	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053353	BRD4 (39909, Lot#24317004, Active Motif)	Homo sapiens	WT	EXP053352	430	normal	O60885	HepG2 (hepatoblastoma)	NULL
EXP053354	C/EBPB (sc-150, Lot#G1814, Santa Cruz Biotechnology)	Homo sapiens	WT	EXP053352	430	normal	P17676	HepG2 (hepatoblastoma)	NULL
EXP053355	BRD4 (39909, Lot#24317004, Active Motif)	Homo sapiens	C/EBP? enh-/-	EXP053352	430	normal	O60885	HepG2 (hepatoblastoma)	NULL
EXP053356	C/EBPB (sc-150, Lot#G1814, Santa Cruz Biotechnology)	Homo sapiens	C/EBP? enh-/-	EXP053352	430	normal	P17676	HepG2 (hepatoblastoma)	NULL
EXP053357	none	Homo sapiens	Treatment: 10nM beta-estradiol, 100nM medroxyprogesterone acetate, and 1mM cAMP	NULL	256	chip_control	NULL	endometrial stromal cells	NULL
EXP053358	anti-NCOA2 (Bethyl A300-346A)	Homo sapiens	Treatment: 10nM beta-estradiol, 100nM medroxyprogesterone acetate, and 1mM cAMP	EXP053357	256	normal	Q15596	endometrial stromal cells	NULL
EXP053359		Homo sapiens	Treatment: 1 ug/ml doxycycline treated cells Genotype: TRExBCBL1-3xFLAG-RTA 	NULL	2557	chip_control	NULL	recombinant KSHV+ PEL cell line	NULL
EXP053360	anti-FLAG	Homo sapiens	Treatment: 1 ug/ml doxycycline treated cells Genotype: TRExBCBL1-3xFLAG-RTA 	EXP053359	2557	normal	O43251	recombinant KSHV+ PEL cell line	NULL
EXP053361	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 0.1 % EtOH for 2 hrs 	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	NULL
EXP053362	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 2 hrs	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	NULL
EXP053363	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 0.1 % EtOH for 8 hrs 	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	NULL
EXP053364	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 8 hrs	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	NULL
EXP053365	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 0.1 % EtOH for 24 hrs 	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	NULL
EXP053366	anti-CEBPA (Diagenode, catalog number: C15410225)	Homo sapiens	Treatment: 100 nM 1,25(OH)2D3 for 24 hrs	NULL	2334	normal	P49715	THP-1 (acute monocytic leukemia)	NULL
EXP053367	CBP (Abcam, ab2832)	Homo sapiens	Tissue: Term placenta Source: Placenta	NULL	2558	normal	Q92793	cytotrophoblast	NULL
EXP053368	HDAC1 (Santa Cruz Biotech, sc-7872)	Homo sapiens	Tissue: Term placenta Source: Placenta	NULL	2558	normal	Q13547	cytotrophoblast	NULL
EXP053369	RelB (Santa Cruz Biotech, sc-226)	Homo sapiens	Tissue: Term placenta Source: Placenta	NULL	2558	normal	Q01201	cytotrophoblast	NULL
EXP053370	none	Homo sapiens	Treatment: under normal conditons	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP053371	anti-human SOD1 primary antibody (Abcam; ab16831)	Homo sapiens	Treatment: under normal conditons	EXP053370	78	normal	P00441	HeLa (cervical adenocarcinoma)	NULL
EXP053372	anti-human SOD1 primary antibody (Abcam; ab16831)	Homo sapiens	Treatment: treated with hydrogen 0.4 mM peroxide	EXP053370	78	normal	P00441	HeLa (cervical adenocarcinoma)	NULL
EXP053373	anti-human SOD1 primary antibody (Abcam; ab16831)	Homo sapiens	Treatment: treated with 50 uM LD100	EXP053370	78	normal	P00441	HeLa (cervical adenocarcinoma)	NULL
EXP053374	SIPA1 (Santa Cruz SC-137043)	Homo sapiens	Source: breast cancer cell	NULL	2301	normal	Q96FS4	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP053375		Homo sapiens	Genotype: empty adenovirus	NULL	152	chip_control	NULL	CC-LP-1 (intrahepatic cholangiocarcinoma)	NULL
EXP053376	anti-myc	Homo sapiens	Genotype: myc-PRH	EXP053375	152	normal	Q03014	CC-LP-1 (intrahepatic cholangiocarcinoma)	NULL
EXP053377	anti-CMYC	Homo sapiens	Source: tumor cell Tissue: breast Genotype: C-MYC overexpression 	NULL	2559	normal	Q16158	UACC-812 (Invasive ductal carcinoma)	NULL
EXP053378	anti-CMYC	Homo sapiens	Source: tumor cell Tissue: breast Genotype: UACC-812 flag cell line	NULL	2559	normal	Q16158	UACC-812 (Invasive ductal carcinoma)	NULL
EXP053379	Proteintech, 10597-1-AP	Homo sapiens	day 30	NULL	1005	normal	Q9UBP5	iPSC-derived cardiomyocytes	NULL
EXP053380	Sigma, SAB1411331	Homo sapiens	day 30	NULL	1005	normal	Q99593	iPSC-derived cardiomyocytes	NULL
EXP053381	Active Motif, 61213	Homo sapiens	day30	NULL	1005	normal	P24468	iPSC-derived cardiomyocytes	NULL
EXP053382	anti-Dicer	Homo sapiens	Treatment: DNA damage	NULL	2560	normal	Q9UPY3	U20S AsiSI	NULL
EXP053383	anti-Dicer	Homo sapiens	Treatment: DNA damage	NULL	2560	normal	Q9UPY3	U20S AsiSI	NULL
EXP053384		Mus musculus	Genotype: non targed flag	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP053385	anti-FLAG antibody	Mus musculus	Genotype: FLAG-Rsf1	NULL	252	normal	A0A0U1RNQ5	V6.5 (embryonic stem cells)	NULL
EXP053386	IgG (12-370, Millipore)	Homo sapiens	Strain: endothelial cells from umbilical cords newborn healthy humans	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP053387	TFEB (#4240, CST)	Homo sapiens	Strain: endothelial cells from umbilical cords newborn healthy humans	EXP053386	472	normal	P19484	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP053388	none	Homo sapiens	untreated	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP053389	none	Homo sapiens	untreated	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP053390	anti-USP7 (Bethyl, catalog# A300-033A, lot# Lot A300-033A-7)	Homo sapiens	untreated	EXP053389	199	normal	Q93009	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP053391	anti-USP7 (Bethyl, catalog# A300-033A, lot# Lot A300-033A-7)	Homo sapiens	untreated	EXP053388	509	normal	Q93009	Jurkat (T-cells)	NULL
EXP053392	none	Homo sapiens		NULL	1083	chip_control	NULL	D283 Med (medulloblastoma)	NULL
EXP053393	ChIP Grade OTX2 - Abcam - ab21990	Homo sapiens		EXP053392	1083	normal	P32243	D283 Med (medulloblastoma)	NULL
EXP053394	none	Homo sapiens	day 0 of differentiation	NULL	2562	chip_control	NULL	Dombi23 (primary keratinocytes)	NULL
EXP053395	abcam #ab23980	Homo sapiens	day 0 of differentiation	EXP053394	2562	normal	Q01196	Dombi23 (primary keratinocytes)	NULL
EXP053396	none	Mus musculus	Q111/+ genotype; 4 months	NULL	2450	chip_control	NULL	striatum	NULL
EXP053397	none	Mus musculus	WT; 4 months	NULL	2450	chip_control	NULL	striatum	NULL
EXP053398	Anti-HTT antibody (Abcam #ab109115,  Lot # GR155234-1)	Mus musculus	Q111/+ genotype; 4 months	EXP053396	2450	normal	P42859	striatum	NULL
EXP053399	Anti-HTT antibody (Abcam #ab109115,  Lot # GR155234-1)	Mus musculus	WT; 4 months	EXP053397	2450	normal	P42859	striatum	NULL
EXP053400	Ezh2	Mus musculus	WT; CD4+, CXCR5+, SLAM-low, CD44-high, and CD62L low	NULL	501	normal	Q61188	T follicular helpers	NULL
EXP053401	Ezh2	Mus musculus	CD4-cre, Ezh2 fl/fl; CD4+, CD62L high, CD44 low to medium	NULL	501	bio_control	Q61188	T follicular helpers	NULL
EXP053402	Tcf1	Mus musculus	WT; CD4+, CXCR5+, SLAM-low, CD44-high, and CD62L low	NULL	501	normal	P22361	T follicular helpers	NULL
EXP053403	Tcf1	Mus musculus	CD4-Cre, Tcf1 fl/fl; CD4+, CD62L high, CD44 low to medium	NULL	501	bio_control	P22361	T follicular helpers	NULL
EXP053404		Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053405		Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	NULL	2563	chip_control	NULL	HEK293T-C49	NULL
EXP053406		Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	NULL	2564	chip_control	NULL	HEK293T-C104	NULL
EXP053407		Homo sapiens	Passage: Low passages (6-10) Genotype: non-targeting dsRNA 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053408		Homo sapiens	Passage: Low passages (6-10) Genotype: human MLL1 dsRNA 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053409		Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with non-targeting dsRNA 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053410		Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with human MLL1 dsRNA	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053411		Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053412		Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053413		Homo sapiens	Passage: Low passages (6-10) Genotype: overexpressed with MLLAF4 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053414		Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and overexpressed with MLLAF4 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053415		Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053416		Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053417		Homo sapiens	Treatment: TTP22 Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053418		Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP053419		Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP053420	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053421	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053422	MLL2 C-terminus (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: wildtype 	NULL	10	normal	Q9UMN6	HEK293T (embryonic kidney)	NULL
EXP053423	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	EXP053405	2563	normal	Q03164	HEK293T-C49	NULL
EXP053424	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	EXP053405	2563	normal	Q03164	HEK293T-C49	NULL
EXP053425	MLL2 C-terminus (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 Cell type: embyronic kidney cells	EXP053405	2563	normal	Q9UMN6	HEK293T-C49	NULL
EXP053426	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9  Cell type: embyronic kidney cells	EXP053406	2564	normal	Q03164	HEK293T-C104	NULL
EXP053427	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053406	2564	normal	Q03164	HEK293T-C104	NULL
EXP053428	MLL2 C-terminus (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053406	2564	normal	Q9UMN6	HEK293T-C104	NULL
EXP053429	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: non-targeting dsRNA 	EXP053407	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053430	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: non-targeting dsRNA 	EXP053407	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053431	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: human MLL1 dsRNA 	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053432	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: human MLL1 dsRNA 	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053433	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with non-targeting dsRNA 	EXP053414	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053434	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with non-targeting dsRNA 	EXP053414	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053435	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with human MLL1 dsRNA	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053436	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and treated with human MLL1 dsRNA	EXP053410	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053437	MLL1 C-terminus (CST)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053411	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053438	MLL1 N-terminus (CST)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053411	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053439	MLL1 C-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053412	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053440	MLL1 N-terminus (CST)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9 	EXP053412	113	normal	Q03164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP053441	ELL2 (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: overexpressed with MLLAF4 	EXP053413	10	normal	O00472	HEK293T (embryonic kidney)	NULL
EXP053442	ELL2 (homemade)	Homo sapiens	Passage: Low passages (6-10) Genotype: knocked out of TASP1 gene by CRISPR/Cas9, and overexpressed with MLLAF4 	EXP053414	10	normal	O00472	HEK293T (embryonic kidney)	NULL
EXP053443	MLL1 C-terminus (CST)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053415	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053444	MLL1 C-terminus (CST)	Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	EXP053416	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053445	MLL1 C-terminus (CST)	Homo sapiens	Treatment: TTP22 Passage: Low passages (6-10) Genotype: wildtype 	EXP053417	10	normal	Q03164	HEK293T (embryonic kidney)	NULL
EXP053446	AFF4 (homemade)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	EXP053418	541	normal	Q9UHB7	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP053447	ELL2 (homemade)	Homo sapiens	Treatment: DMSO vehicle Passage: Low passages (6-10) Genotype: wildtype 	NULL	541	normal	O00472	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP053448	AFF4 (homemade)	Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	EXP053419	541	normal	Q9UHB7	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP053449	ELL2 (homemade)	Homo sapiens	Treatment: CX4945 Passage: Low passages (6-10) Genotype: wildtype 	EXP053419	541	normal	O00472	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP053450	none	Mus musculus	Genotype: wildtype Source: single FLK1+mesoderm  Strain: C57Bl/6 X Sv129 Age: day 3.75	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP053451	none	Mus musculus	Genotype: wildtype Source: single FLK1+mesoderm  Strain: C57Bl/6 X Sv129 Age: day 3.75	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP053452	anti DEDAF (AB3637,) Millipore	Mus musculus	Genotype: wildtype Source: single FLK1+mesoderm  Strain: C57Bl/6 X Sv129 Age: day 3.75	EXP053450	2565	normal	Q8CCI5	embryonic stem cells derived embryonic bodies	NULL
EXP053453	anti DEDAF (AB3637,) Millipore	Mus musculus	Genotype: wildtype Source: single FLK1+mesoderm  Strain: C57Bl/6 X Sv129 Age: day 3.75	EXP053451	2565	normal	Q8CCI5	embryonic stem cells derived embryonic bodies	NULL
EXP053454	none	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 3.5	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP053455	none	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 3.5	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP053456	SCL rabbit anti-serum (in-house)	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 3.5	EXP053454	2565	normal	P22091	embryonic stem cells derived embryonic bodies	NULL
EXP053457	SCL rabbit anti-serum (in-house)	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 3.5	EXP053455	2565	normal	P22091	embryonic stem cells derived embryonic bodies	NULL
EXP053458	none	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 4	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP053459	ETO2 (sc-9741x,santa cruz)	Mus musculus	Source: FLK1+mesoderm Strain: C57Bl/6 X Sv129 Age: day 4	EXP053458	2565	normal	O54972	embryonic stem cells derived embryonic bodies	NULL
EXP053460	anti-HIF1A	Mus musculus	Genotype: wildtype Treament: no	NULL	965	normal	Q61221	frontal cortex	NULL
EXP053461	anti-HIF1A	Mus musculus	Genotype: wildtype Treament: environmental stress	NULL	965	normal	Q61221	frontal cortex	NULL
EXP053462	alfa-FLAG (Sigma, catalog# F3165, lot# 114K6081)	Mus musculus	Genotype: pMX-GFP control Source: Lin-Sca-1+c-Kit+ (LSK) - hematopoietic stem/progenitor cells	NULL	2454	chip_control	NULL	LSK	NULL
EXP053463	alfa-FLAG (Sigma, catalog# F3165, lot# 114K6081)	Mus musculus	Genotype: 3xFLAG-Hlf/Hlf-IRES-GFP Source: Lin-Sca-1+c-Kit+ (LSK) - hematopoietic stem/progenitor cells	EXP053462	2454	normal	Q8BW74	LSK	NULL
EXP053464	c-Myc (N-262) (Santa Cruz, SC-764x, cat# G2916)	Mus musculus	Strain:C57BL/6  Genotype: wildtype	NULL	12	normal	P01108	MEF (mouse embryonic fibroblasts)	NULL
EXP053465	c-Myc (N-262) (Santa Cruz, SC-764x, cat# G2916)	Mus musculus	Strain:C57BL/6  Genotype: PIN1 knockout	NULL	12	normal	P01108	MEF (mouse embryonic fibroblasts)	NULL
EXP053466	Anti-V5 agarose beads (Sigma-Aldrich V5-10)	Mus musculus	Genotype: Prdm1(IhCd2/+) Strain: C57BL/6	NULL	2567	normal	Q60636	In-vitro, Pro-B cell culture	NULL
EXP053467	none	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053468	none	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053469	none	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053470	none	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053471	none	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053472	none	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053473	none	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053474	none	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053475	none	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053476	none	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053477	none	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053478	none	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053479	none	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053480	none	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053481	none	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053482	none	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053483	none	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053484	none	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053485	none	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053486	none	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053487	SmcHD1 (in house)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053467	2568	normal	Q6P5D8	clonal MEF	NULL
EXP053488	SmcHD1 (in house)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053468	2568	normal	Q6P5D8	clonal MEF	NULL
EXP053489	SmcHD1 (in house)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q6P5D8	clonal MEF	NULL
EXP053490	SmcHD1 (in house)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q6P5D8	clonal MEF	NULL
EXP053491	SmcHD1 (in house)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053471	2568	normal	Q6P5D8	clonal MEF	NULL
EXP053492	SmcHD1 (in house)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053472	2568	normal	Q6P5D8	clonal MEF	NULL
EXP053493	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053467	2568	normal	Q61550	clonal MEF	NULL
EXP053494	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053468	2568	normal	Q61550	clonal MEF	NULL
EXP053495	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q61550	clonal MEF	NULL
EXP053496	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053470	2568	normal	Q61550	clonal MEF	NULL
EXP053497	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053473	2568	normal	Q61550	clonal MEF	NULL
EXP053498	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053474	2568	normal	Q61550	clonal MEF	NULL
EXP053499	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053485	2568	normal	Q61550	clonal MEF	NULL
EXP053500	Rad21 (Abcam, ab992, lot GR3194001-1)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053486	2568	normal	Q61550	clonal MEF	NULL
EXP053501	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053467	2568	normal	Q61164	clonal MEF	NULL
EXP053502	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053468	2568	normal	Q61164	clonal MEF	NULL
EXP053503	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053469	2568	normal	Q61164	clonal MEF	NULL
EXP053504	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053470	2568	normal	Q61164	clonal MEF	NULL
EXP053505	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053473	2568	normal	Q61164	clonal MEF	NULL
EXP053506	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053474	2568	normal	Q61164	clonal MEF	NULL
EXP053507	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053483	2568	normal	Q61164	clonal MEF	NULL
EXP053508	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053484	2568	normal	Q61164	clonal MEF	NULL
EXP053509	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053485	2568	normal	Q61164	clonal MEF	NULL
EXP053510	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus	EXP053486	2568	normal	Q61164	clonal MEF	NULL
EXP053511	Input	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	NULL	845	chip_control	NULL	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053512	Input	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	NULL	845	chip_control	NULL	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053513	Rabbit anti-Cbfb polyclonal pAb	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053511	845	normal	Q08024	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053514	Mouse anti-GATA3 mAb (BD L50-823)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053511	845	normal	P23772	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053515	Rabbit anti-Cbfb pAb	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	Q08024	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053516	Mouse anti-GATA3 mAb (BD L50-823)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	P23772	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053517	Rabbit anti-Runx1 pAb (Abcam ab23980)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	Q03347	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053518	Rabbit anti-Runx3 mAb (CST D6E2)	Mus musculus	Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung	EXP053512	845	normal	Q64131	ILC2 (type 2 Innate lympoid cells)	NULL
EXP053519		Mus musculus	Genotype: wildtype Strain: WT-B6 	NULL	1053	chip_control	NULL	Treg cells from lymph nodes and spleen	NULL
EXP053520		Mus musculus	Genotype: mutant M370I Strain: M370I-Tg-B6 	NULL	1053	chip_control	NULL	Treg cells from lymph nodes and spleen	NULL
EXP053521	anti-Foxp3	Mus musculus	Genotype: wildtype Strain: WT-B6 	EXP053519	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	NULL
EXP053522	Foxp3	Mus musculus	Genotype: mutant M370I Strain: M370I-Tg-B6 	EXP053520	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	NULL
EXP053523	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: Lif (leukemia inhibitory factor) for 3 days Genotype: expressing BirA	NULL	506	normal	P46938	J1 (embryonic stem cells)	NULL
EXP053524	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: without Lif (leukemia inhibitory factor) for 3 days Genotype: expressing BirA	NULL	506	normal	P46938	J1 (embryonic stem cells)	NULL
EXP053525	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: Lif (leukemia inhibitory factor) for 3 days Genotype: expressing Yap1 by Flagbio	NULL	506	normal	P46938	J1 (embryonic stem cells)	NULL
EXP053526	anti-Yap1 (Santa Cruz Biotechnology, Cat# sc-101199 )	Mus musculus	Treatment: without Lif (leukemia inhibitory factor) for 3 days Genotype: expressing Yap1 by Flagbio	NULL	506	normal	P46938	J1 (embryonic stem cells)	NULL
EXP053527	none	Mus musculus	Developmental stage: p13 Genotype: SmoM2 overexpression	NULL	2570	chip_control	NULL	medulloblastoma	NULL
EXP053528	none	Mus musculus	Developmental stage: p13 Genotype: SmoM2 overexpression	NULL	2570	chip_control	NULL	medulloblastoma	NULL
EXP053529	none	Mus musculus	Developmental stage: p13 Genotype: Sufu;Spop double knockout	NULL	2570	chip_control	NULL	medulloblastoma	NULL
EXP053530	none	Mus musculus	Developmental stage: p13 Genotype: Sufu;Spop double knockout	NULL	2570	chip_control	NULL	medulloblastoma	NULL
EXP053531	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: SmoM2 overexpression	EXP053527	2570	normal	Q0VGT2	medulloblastoma	NULL
EXP053532	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: SmoM2 overexpression	EXP053528	2570	normal	Q0VGT2	medulloblastoma	NULL
EXP053533	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: Sufu;Spop double knockout	EXP053529	2570	normal	Q0VGT2	medulloblastoma	NULL
EXP053534	Gli2 (homemade)	Mus musculus	Developmental stage: p13 Genotype: Sufu;Spop double knockout	EXP053530	2570	normal	Q0VGT2	medulloblastoma	NULL
EXP053535	none	Mus musculus	Age: 8 weeks Tissue: cortex Strain: C57BL/6	NULL	2571	chip_control	NULL	CamkIIa-positive nuclei	NULL
EXP053536	none	Mus musculus	Age: 8 weeks Tissue: cortex Strain: C57BL/6	NULL	2571	chip_control	NULL	CamkIIa-positive nuclei	NULL
EXP053537	MeCP2 (Chen WG et al. Science 2003)	Mus musculus	Age: 8 weeks Tissue: cortex Strain: C57BL/6	EXP053535	2571	normal	Q9Z2D6	CamkIIa-positive nuclei	NULL
EXP053538	MeCP2 (Chen WG et al. Science 2003)	Mus musculus	Age: 8 weeks Tissue: cortex Strain: C57BL/6	EXP053536	2571	normal	Q9Z2D6	CamkIIa-positive nuclei	NULL
EXP053539	Goat IgG (R&D system, AB-108-C)	Mus musculus	Passage: 11	NULL	2572	chip_control	NULL	Akt (5MOI, mouse prostate stem cell line)	NULL
EXP053540	Anti-KLF4 polyclonal Ab (R&D system, cat#AF3158)	Mus musculus	Passage: 11	EXP053539	2572	normal	Q60793	Akt (5MOI, mouse prostate stem cell line)	NULL
EXP053541		Mus musculus	Mock	NULL	2573	chip_control	NULL	bone marrow dendritic cells	NULL
EXP053542		Mus musculus	 Genotype: wildtype Treatment: Mock for 6 hrs	NULL	2573	chip_control	NULL	bone marrow dendritic cells	NULL
EXP053543		Mus musculus	 Genotype: wildtype Treatment: Mock for 12 hrs	NULL	2573	chip_control	NULL	bone marrow dendritic cells	NULL
EXP053544		Mus musculus	Treatment: infected with WNV for 6 hrs Genotype: wildtype	NULL	2573	chip_control	NULL	bone marrow dendritic cells	NULL
EXP053545		Mus musculus	Treatment: infected with WNV for 12 hrs Genotype: wildtype	NULL	2573	chip_control	NULL	bone marrow dendritic cells	NULL
EXP053546	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	 Genotype: wildtype Treatment: Mock for 6 hrs	EXP053542	2573	normal	P56477	bone marrow dendritic cells	NULL
EXP053547	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	 Genotype: wildtype Treatment: Mock for 12 hrs	EXP053543	2573	normal	P56477	bone marrow dendritic cells	NULL
EXP053548	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	Treatment: infected with WNV for 6 hrs Genotype: wildtype	EXP053544	2573	normal	P56477	bone marrow dendritic cells	NULL
EXP053549	IRF5 antibodies (Bethyl A303-385 and 386)	Mus musculus	Treatment: infected with WNV for 12 hrs Genotype: wildtype	EXP053545	2573	normal	P56477	bone marrow dendritic cells	NULL
EXP053550	none	Mus musculus	Strain: CBA x C57BL/6 F1 Age: 21 days 	NULL	2574	chip_control	NULL	peri-ovulatory granulosa cells	NULL
EXP053551	PGR (sc-7208, Santa Cruz)	Mus musculus	Strain: CBA x C57BL/6 F1 Age: 21 days 	EXP053550	2574	normal	Q00175	peri-ovulatory granulosa cells	NULL
EXP053552	PGR (sc-7208, Santa Cruz)	Mus musculus	Strain: CBA x C57BL/6 F1 Age: 21 days 	EXP053550	2574	normal	Q00175	peri-ovulatory granulosa cells	NULL
EXP053553	none	Mus musculus	Treatment: no	NULL	2449	chip_control	NULL	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053554	none	Mus musculus	Treatment: Simulation by BMP9/10 recombinant protein	NULL	2449	chip_control	NULL	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053555	none	Mus musculus	Treatment: simulation by BMP9/10 recombinant protein	NULL	2449	chip_control	NULL	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053556	none	Mus musculus	Treatment: no	NULL	2449	chip_control	NULL	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053557	SMAD4 (Cell Signaling)	Mus musculus	Treatment: no	EXP053553	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053558	SMAD4 (Cell Signaling)	Mus musculus	Treatment: simulation by BMP9/10 recombinant protein	EXP053556	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053559	SMAD4 (Cell Signaling)	Mus musculus	Treatment: no	EXP053556	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053560	SMAD4 (Cell Signaling)	Mus musculus	Treatment: Simulation by BMP9/10 recombinant protein	EXP053554	2449	normal	P97471	Mile Sven 1 (MS1, mouse endothelial cells)	NULL
EXP053561	CTCF (Active motif: 613111)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1	NULL	2576	normal	Q61164	G4 (embryonic stem cells)	NULL
EXP053562	RAD21 (Abcam: ab992)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1	NULL	2576	normal	Q61550	G4 (embryonic stem cells)	NULL
EXP053563	CTCF (Active motif: 613111)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1DelCTCF	NULL	2576	normal	Q61164	G4 (embryonic stem cells)	NULL
EXP053564	RAD21 (Abcam: ab992)	Mus musculus	Developmental stage: E11.5 Genotype: Inv1DelCTCF	NULL	2576	normal	Q61550	G4 (embryonic stem cells)	NULL
EXP053565	CTCF (Active motif: 613111)	Mus musculus	Genotype: Inv1	NULL	2576	normal	Q61164	G4 (embryonic stem cells)	NULL
EXP053566	RAD21 (Abcam: ab992)	Mus musculus	Genotype: Inv1	NULL	2576	normal	Q61550	G4 (embryonic stem cells)	NULL
EXP053567	none	Mus musculus	Source:VSMC_Thoc5 Strain: C57BL/6 Passage: 4-8	NULL	2268	chip_control	NULL	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP053568	Thoc5 (Bethyl, cat#A302-119A)	Mus musculus	Source:VSMC_Thoc5 Strain: C57BL/6 Passage: 4-8	EXP053567	2268	normal	Q8BKT7	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP053569	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 0 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	NULL
EXP053570	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 4 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	NULL
EXP053571	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 8 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	NULL
EXP053572	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 24 hrs Dox Strain: CAST / C57BL/6 	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	NULL
EXP053573	Anti-FLAG-Sigma-Aldrich-F1804-50UG	Mus musculus	Treatment: 0hrs Dox Genotype: wildtype	NULL	844	normal	O88895	TX1072 (embryonic stem cells)	NULL
EXP053574	input	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	NULL	5	chip_control	NULL	liver	NULL
EXP053575	input	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	NULL	5	chip_control	NULL	liver	NULL
EXP053576	input	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	NULL	5	chip_control	NULL	liver	NULL
EXP053577	input	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	NULL	5	chip_control	NULL	liver	NULL
EXP053578	input	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	NULL	5	chip_control	NULL	liver	NULL
EXP053579	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: diet regular chow Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053580	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: diet regular chow Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053581	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated fat diet Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053582	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated fat diet Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053583	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053584	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053585	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053586	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053587	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053588	input	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053589	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	NULL	5	chip_control	NULL	liver	NULL
EXP053590	input	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr Genotype: wildtype	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP053591	p65 (Abcam, Ab7970)	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053574	5	normal	Q04207	liver	NULL
EXP053592	p65 Abcam  Ab7970	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053575	5	normal	Q04207	liver	NULL
EXP053593	p65 Abcam  Ab7970	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053576	5	normal	Q04207	liver	NULL
EXP053594	p65 Abcam  Ab7970	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053577	5	normal	Q04207	liver	NULL
EXP053595	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053576	5	normal	Q9WTL8	liver	NULL
EXP053596	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	NULL	5	normal	Q9WTL8	liver	NULL
EXP053597	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053577	5	normal	Q9WTL8	liver	NULL
EXP053598	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053578	5	normal	Q9WTL8	liver	NULL
EXP053599	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053574	5	normal	O08785	liver	NULL
EXP053600	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: 100 ng/ml LPS for 1 hr	EXP053575	5	normal	O08785	liver	NULL
EXP053601	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053576	5	normal	O08785	liver	NULL
EXP053602	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr	EXP053577	5	normal	O08785	liver	NULL
EXP053603	p65  (Santa Cruz, sc-372)	Mus musculus	Age: adult Strain: C57BL/6 Conditions: diet regular chow Sex: male 	EXP053579	5	normal	Q04207	liver	NULL
EXP053604	p65, Santa Cruz sc-372	Mus musculus	Age: adult Strain: C57BL/6 Conditions: diet regular chow Sex: male 	EXP053580	5	normal	Q04207	liver	NULL
EXP053605	p65 (Santa Cruz, sc-372)	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated fat diet Sex: male 	EXP053581	5	normal	Q04207	liver	NULL
EXP053606	p65 (Santa Cruz, sc-372)	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated fat diet Sex: male 	EXP053582	5	normal	Q04207	liver	NULL
EXP053607	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053583	5	normal	O08785	liver	NULL
EXP053608	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053583	5	normal	Q9WTL8	liver	NULL
EXP053609	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053584	5	normal	O08785	liver	NULL
EXP053610	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions:  diet, regular show Sex: male 	EXP053585	5	normal	Q9WTL8	liver	NULL
EXP053611	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053586	5	normal	O08785	liver	NULL
EXP053612	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053587	5	normal	Q9WTL8	liver	NULL
EXP053613	CLOCK Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053588	5	normal	O08785	liver	NULL
EXP053614	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Conditions: saturated high-fat diet Sex: male 	EXP053589	5	normal	Q9WTL8	liver	NULL
EXP053615	BMAL1 Perelis et al., 2015	Mus musculus	Age: adult Strain: C57BL/6 Treatment: saline for 1 hr Genotype: wildtype	EXP053590	12	normal	Q9WTL8	MEF (mouse embryonic fibroblasts)	NULL
EXP053616		Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: none	NULL	5	chip_control	NULL	liver	NULL
EXP053617		Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding	NULL	5	chip_control	NULL	liver	NULL
EXP053618	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: pre-prandial injection with vehicle	NULL	5	normal	P06537	liver	NULL
EXP053619	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding, pre-prandial injection with vehicle	NULL	5	normal	P06537	liver	NULL
EXP053620	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding, pre-prandial injection with 1mg/kg dex	NULL	5	normal	P06537	liver	NULL
EXP053621	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: none	EXP053616	5	normal	P06537	liver	NULL
EXP053622	GRL MA1-510 (ThermoFischer), PA1-511a (ThermoFischer), SC-1003 (Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding	EXP053617	5	normal	P06537	liver	NULL
EXP053623	FoxO1 (sc-11350, Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: none	EXP053616	5	normal	Q9R1E0	liver	NULL
EXP053624	FoxO1 (sc-11350, Santa Cruz)	Mus musculus	Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding	EXP053617	5	normal	Q9R1E0	liver	NULL
EXP053625	none	Mus musculus	Strain: Outbred - B6:129Sv Passage: From 8 to 12 Age: day 6 Cell type: Day 6 embryoid bodies from mouse embryonic stem cells	NULL	208	chip_control	NULL	embryoid body (day 6)	NULL
EXP053626	anti-Trim33 (Bethyl A301-060A)	Mus musculus	Strain: Outbred - B6:129Sv Passage: From 8 to 12 Age: day 6 Cell type: Day 6 embryoid bodies from mouse embryonic stem cells	EXP053625	208	normal	Q99PP7	embryoid body (day 6)	NULL
EXP053627	anti-CTCF (Active Motif 61311)	Mus musculus	Strain: Outbred - B6:129Sv Passage: From 8 to 12 Age: day 6 Cell type: Day 6 embryoid bodies from mouse embryonic stem cells	EXP053625	208	normal	Q61164	embryoid body (day 6)	NULL
EXP053628	none	Mus musculus	Genotype: STAT3 wildtype Strain: C57BL/6	NULL	2577	chip_control	NULL	cultured GC B cells	NULL
EXP053629	none	Mus musculus	Genotype: STAT3 knockout Strain: C57BL/6	NULL	2577	chip_control	NULL	cultured GC B cells	NULL
EXP053630	STAT3 Ab (124H6, Cell Signaling Technology)	Mus musculus	Genotype: STAT3 wildtype Strain: C57BL/6	EXP053628	2577	normal	P42227	cultured GC B cells	NULL
EXP053631	STAT3 Ab (124H6, Cell Signaling Technology)	Mus musculus	Genotype: STAT3 knockout Strain: C57BL/6	EXP053629	2577	normal	P42227	cultured GC B cells	NULL
EXP053632	none	Mus musculus	Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: wildtype Tissue: Caput epididymis (containing initial segment)	NULL	150	chip_control	NULL	caput epididymis	NULL
EXP053633	none	Mus musculus	Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: ArKI Tissue: Caput epididymis (containing initial segment)	NULL	150	chip_control	NULL	caput epididymis	NULL
EXP053634	Anti-AR antibody K183	Mus musculus	Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: wildtype Tissue: Caput epididymis (containing initial segment)	EXP053632	150	normal	P19091	caput epididymis	NULL
EXP053635	Anti-AR antibody K183	Mus musculus	Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: ArKI Tissue: Caput epididymis (containing initial segment)	EXP053633	150	normal	P19091	caput epididymis	NULL
EXP053636	anti-JunB	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre JUNB+/+(wildtype) Strain: C57BL/6	NULL	1053	normal	P09450	Treg cells from lymph nodes and spleen	NULL
EXP053637	anti-IRF4	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre JUNB+/+(wildtype) Strain: C57BL/6	NULL	1053	normal	Q64287	Treg cells from lymph nodes and spleen	NULL
EXP053638	anti-BATF	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre JUNB+/+(wildtype) Strain: C57BL/6	NULL	1053	normal	O35284	Treg cells from lymph nodes and spleen	NULL
EXP053639	IRF4	Mus musculus	Source: In vitro-activated Tregs Genotype: Foxp3cre Foxp3cre JUNB -/-(knockout) Strain: C57BL/6	NULL	1053	normal	Q64287	Treg cells from lymph nodes and spleen	NULL
EXP053640	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053641	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053642	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053643	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053644	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053645	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	NULL	2568	chip_control	NULL	clonal MEF	NULL
EXP053646	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053640	2568	normal	Q61164	clonal MEF	NULL
EXP053647	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053641	2568	normal	Q61164	clonal MEF	NULL
EXP053648	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053642	2568	normal	Q61164	clonal MEF	NULL
EXP053649	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053643	2568	normal	Q61164	clonal MEF	NULL
EXP053650	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053644	2568	normal	Q61164	clonal MEF	NULL
EXP053651	CTCF (Milipore, 07-729, lot 297/1000)	Mus musculus	Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female	EXP053645	2568	normal	Q61164	clonal MEF	NULL
EXP053652	MYOD1 antibody 	Mus musculus	Sex: male Strain: C57bl6 Time: collection on 24 hour timecourse	NULL	2578	normal	P10085	Gastrocnemius muscle	NULL
EXP053653	none (input)	Mus musculus	Strain: C57BL/6 Genotype: wildtype	NULL	2579	chip_control	NULL	esophagus	NULL
EXP053654	Nrf2 (Santa Cruz, sc-13032)	Mus musculus	Strain: C57BL/6 Genotype: wildtype	EXP053653	2579	normal	Q60795	esophagus	NULL
EXP053655	Nrf2 (Santa Cruz, sc-13032)	Mus musculus	Strain: C57BL/6 Genotype: Nrf2 knockout	EXP053653	2579	normal	Q60795	esophagus	NULL
EXP053656	Nrf2 (Santa Cruz, sc-13032)	Mus musculus	Strain: C57BL/6 Genotype: Keap1 knockout	EXP053653	2579	normal	Q60795	esophagus	NULL
EXP053657	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053658	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053659	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053660	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053661	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053662	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053663	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053664	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053665	none (Input)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	NULL	2580	chip_control	NULL	Tg2a	NULL
EXP053666	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	Q61539	Tg2a	NULL
EXP053667	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	Q61539	Tg2a	NULL
EXP053668	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	Q61539	Tg2a	NULL
EXP053669	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	Q61539	Tg2a	NULL
EXP053670	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	Q80Z64	Tg2a	NULL
EXP053671	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	Q80Z64	Tg2a	NULL
EXP053672	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	Q80Z64	Tg2a	NULL
EXP053673	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	Q80Z64	Tg2a	NULL
EXP053674	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	Q80Z64	Tg2a	NULL
EXP053675	Nanog (E-bioscience, 14-5761-80, E04352-1631)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	Q80Z64	Tg2a	NULL
EXP053676	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	P20263	Tg2a	NULL
EXP053677	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	P20263	Tg2a	NULL
EXP053678	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053659	2580	normal	P20263	Tg2a	NULL
EXP053679	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053660	2580	normal	P20263	Tg2a	NULL
EXP053680	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	P20263	Tg2a	NULL
EXP053681	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	P20263	Tg2a	NULL
EXP053682	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	P20263	Tg2a	NULL
EXP053683	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053664	2580	normal	P20263	Tg2a	NULL
EXP053684	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	normal	P20263	Tg2a	NULL
EXP053685	Oct4 (Santa Cruz Biotechnology, sc-5279, F1016)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	P20263	Tg2a	NULL
EXP053686	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053657	2580	normal	P48432	Tg2a	NULL
EXP053687	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053658	2580	normal	P48432	Tg2a	NULL
EXP053688	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053659	2580	normal	P48432	Tg2a	NULL
EXP053689	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	EXP053660	2580	normal	P48432	Tg2a	NULL
EXP053690	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l	NULL	2580	normal	P48432	Tg2a	NULL
EXP053691	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	P48432	Tg2a	NULL
EXP053692	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053662	2580	normal	P48432	Tg2a	NULL
EXP053693	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053663	2580	normal	P48432	Tg2a	NULL
EXP053694	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	EXP053664	2580	normal	P48432	Tg2a	NULL
EXP053695	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	P48432	Tg2a	NULL
EXP053696	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cell cecle: l	EXP053661	2580	normal	Q61539	Tg2a	NULL
EXP053697	Esrrb (Perseus Proteomics, PP-H6705-00, A-2)	Mus musculus	Cell type: ebryonic stem cells Treatment: FA Cellcycle: M	EXP053665	2580	normal	Q61539	Tg2a	NULL
EXP053698	Sox2 (Santa Cruz Biotechnology, sc-17320, K0813)	Mus musculus	Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M	NULL	2580	normal	P48432	Tg2a	NULL
EXP053699	none (input)	Mus musculus	Tissue: spleen and lymph nodes Genotype: OT-I transgenic Age: 6-8 weeks Strain: C57BL/6	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP053700	none (input)	Mus musculus	Tissue: spleen and lymph nodes Genotype: OT-I transgenic, Eomes-overexpressing  Age: 6-8 weeks Strain: C57BL/6	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP053701	anti-TBR2/Eomes antibodies (ab23345, abcam)	Mus musculus	Tissue: spleen and lymph nodes Genotype: OT-I transgenic Age: 6-8 weeks Strain: C57BL/6	EXP053699	2479	normal	O54839	CD8+ T-cells	NULL
EXP053702	anti-TBR2/Eomes antibodies (ab23345, abcam)	Mus musculus	Tissue: spleen and lymph nodes Genotype: OT-I transgenic, Eomes-overexpressing  Age: 6-8 weeks Strain: C57BL/6	EXP053700	2479	normal	O54839	CD8+ T-cells	NULL
EXP053703		Mus musculus	Strain: C57BL/6	NULL	2582	chip_control	NULL	murine medulloblastoma tumor	NULL
EXP053704	Rabbit polyclonal, anti-Gfi1 antibody, GNE-CJS-2 (4ug)	Mus musculus	Strain: C57BL/6	EXP053703	2582	normal	P70338	murine medulloblastoma tumor	NULL
EXP053705	Rabbit polyclonal, anti-Lsd1(Abcam, #ab17721 (4ug))	Mus musculus	Strain: C57BL/6	EXP053703	2582	normal	Q6ZQ88	murine medulloblastoma tumor	NULL
EXP053706		Mus musculus	Tissue: bone marrow-derived progenitor cells Genotype: Flag-vector	NULL	23	chip_control	NULL	416B (hematopoietic precursor cells)	NULL
EXP053707		Mus musculus	Tissue: bone marrow-derived progenitor cells Genotype: Flag-vector	NULL	23	chip_control	NULL	416B (hematopoietic precursor cells)	NULL
EXP053708		Mus musculus	Tissue: bone marrow-derived progenitor cells Genotype: PLZF-Flag	NULL	23	chip_control	NULL	416B (hematopoietic precursor cells)	NULL
EXP053709	ZBTB16	Mus musculus	Tissue: bone marrow-derived progenitor cells Genotype: PLZF-Flag	EXP053708	23	normal	A3KMN0	416B (hematopoietic precursor cells)	NULL
EXP053710	normal mouse IgG(Santa Cruz,sc-2025)	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053711	normal mouse IgG(Santa Cruz,sc-2025)	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053712	none	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053713	none	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053714	none	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053715	none	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053716	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053712	2	normal	P70348	mESCs (mouse embryonic stem cells)	NULL
EXP053717	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: no folate supplyment Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053713	2	normal	P70348	mESCs (mouse embryonic stem cells)	NULL
EXP053718	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053714	2	normal	P70348	mESCs (mouse embryonic stem cells)	NULL
EXP053719	GCM1 (Santa Cruz,sc-101173)	Mus musculus	Treatment: folate Passage: 24 Strain: C57BL/6  Cell type:SCRC-1002 embryonic stem cells	EXP053715	2	normal	P70348	mESCs (mouse embryonic stem cells)	NULL
EXP053720	IgG	Mus musculus	Treatment: none Genotype: wildtype	NULL	62	chip_control	NULL	alveolar macrophages	NULL
EXP053721	anti-VDR	Mus musculus	Treatment: none Genotype: wildtype	EXP053720	62	normal	P48281	alveolar macrophages	NULL
EXP053722	anti-VDR	Mus musculus	Treatment: 50 nM Vitamin D3 for 24 hrs Genotype: wildtype	EXP053720	62	normal	P48281	alveolar macrophages	NULL
EXP053723	GFP (Abcam, lot ab290)	Mus musculus	Strain: C57BL/6 Source: Microglia isolated from mPGC-1? mice at 24 h after ischemic stroke	NULL	605	chip_control	NULL	microglia	NULL
EXP053724	GFP (Abcam, lot ab290)	Mus musculus	Strain: C57BL/6 Source: Microglia isolated from mPGC-1? mice at 24 h after ischemic stroke	EXP053723	605	normal	O70343	microglia	NULL
EXP053725	none	Mus musculus	Treatment: saline 	NULL	5	chip_control	NULL	liver	NULL
EXP053726	none	Mus musculus	Treatment: LPS	NULL	5	chip_control	NULL	liver	NULL
EXP053727	p65 antibody (AbCam, Ab7970)	Mus musculus	Treatment: saline 	EXP053725	5	normal	Q04207	liver	NULL
EXP053728	p65 antibody (AbCam Ab7970)	Mus musculus	Treatment: LPS	EXP053726	5	normal	Q04207	liver	NULL
EXP053729	Lamin B1 (Abcam, ab16048, Lot GB95643-1)	Mus musculus	Background strain: CD1 Age: Embryonic day 9.5  Tissue: Whole Heart, pooled 3 litters	NULL	53	chip_control	NULL	heart	NULL
EXP053730	Lamin B1 (Abcam, ab16048, Lot GB95643-1)	Mus musculus	Background strain: CD1 Age: Embryonic day 12.5  Tissue: Whole Heart, pooled 6 embryos	NULL	53	chip_control	NULL	heart	NULL
EXP053731	Lamin B1 (Abcam, ab16048, Lot GB95643-1)	Mus musculus	Background strain: CD1 Age: Embryonic day 9.5  Tissue: Whole Heart, pooled 3 litters	EXP053729	53	normal	P14733	heart	NULL
EXP053732	Lamin B1 (Abcam, ab16048, Lot GB95643-1)	Mus musculus	Background strain: CD1 Age: Embryonic day 12.5  Tissue: Whole Heart, pooled 6 embryos	EXP053730	53	normal	P14733	heart	NULL
EXP053733	none	Mus musculus	Strain: C57BL/6J Age: 8 weeks Developmental stage: day 4.5 of pseudopregnancy	NULL	132	chip_control	NULL	uterus	NULL
EXP053734	anti-FOXO1 (sc-11350 (H-128))	Mus musculus	Strain: C57BL/6J Age: 8 weeks Developmental stage: day 4.5 of pseudopregnancy	EXP053733	132	normal	Q9R1E0	uterus	NULL
EXP053735	None	Mus musculus	Genotype: TCRbeta knockout Sox13 ECFP KI/+ Strain: C57BL/6	NULL	2584	chip_control	NULL	sorted gd T thymocytes	NULL
EXP053736	anti-TCF1 (SantaCruz, sc-13025)	Mus musculus	Genotype: wildtype Strain: C57BL/6	EXP053735	2459	normal	P22361	double-positive (DP) CD4+/CD8+ thymocyte	NULL
EXP053737	anti-TCF1 (SantaCruz, sc-13025)	Mus musculus	Genotype: TCRbeta knockout Sox13 ECFP KI/+ Strain: C57BL/6	EXP053735	2584	normal	P22361	sorted gd T thymocytes	NULL
EXP053738	None	Mus musculus	Genotype: TCRbeta KO.Sox13tg+.Sox13 ECFP KI/+ Strain: C57BL/6	NULL	2584	chip_control	NULL	sorted gd T thymocytes	NULL
EXP053739	anti-TCF1 (SantaCruz, sc-13025)	Mus musculus	Genotype: TCRbeta KO.Sox13tg+.Sox13 ECFP KI/+ Strain: C57BL/6	EXP053738	2584	normal	P22361	sorted gd T thymocytes	NULL
EXP053740	None	Mus musculus	Genotype: TCRbeta knockout Sox13 ECFP KI/+ Strain: C57BL/6	NULL	2584	chip_control	NULL	sorted gd T thymocytes	NULL
EXP053741	anti-Sox13 (Abcam, ab96776)	Mus musculus	Genotype: TCRbeta knockout Sox13 ECFP KI/+ Strain: C57BL/6	EXP053740	2584	normal	Q04891	sorted gd T thymocytes	NULL
EXP053742	none	Mus musculus	Strain: C57BL/6 Passage: 5-10 Genotype: wildtype	NULL	2499	chip_control	NULL	BM-derived MSPCs (bone marrow-derived mesenchymal stem/progenitor cells)	NULL
EXP053743	ASXL1 (Santa Cruz, sc-85283)	Mus musculus	Strain: C57BL/6 Passage: 5-10 Genotype: wildtype	EXP053742	2499	normal	P59598	BM-derived MSPCs (bone marrow-derived mesenchymal stem/progenitor cells)	NULL
EXP053744	none	Mus musculus	Treatment: No stimulation	NULL	2585	chip_control	NULL	M1 (myeloid leukemia)	NULL
EXP053745	Bach1 (A1-6; made in-house)	Mus musculus	Treatment: No stimulation	EXP053744	2585	normal	P97302	M1 (myeloid leukemia)	NULL
EXP053746	Bach2 (Bach2N2; made in-house)	Mus musculus	Treatment: No stimulation	EXP053744	2585	normal	P97303	M1 (myeloid leukemia)	NULL
EXP053747	NF-E2 p18 (c-16) (Santa Cruz, catalog# sc-477, lot# C0606)	Mus musculus	Treatment: No stimulation	EXP053744	2585	normal	Q07279	M1 (myeloid leukemia)	NULL
EXP053748		Mus musculus	Genotype: wildtype Strain: C57BL/6 Age: 3-4 month	NULL	2586	chip_control	NULL	hypothalamus	NULL
EXP053749	HDAC3	Mus musculus	Genotype: wildtype Strain: C57BL/6 Age: 3-4 month	EXP053748	2586	normal	O88895	hypothalamus	NULL
EXP053750	none	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	NULL	1117	chip_control	NULL	primary T-cells	NULL
EXP053751	anti-Hdac1 (Bethyl, A300-713A)	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	EXP053750	1117	normal	O09106	primary T-cells	NULL
EXP053752	anti-Hdac4 (Bethyl, A303-467A)	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	EXP053750	1117	normal	Q6NZM9	primary T-cells	NULL
EXP053753	anti-Hdac7 (Santa Cruz,sc-11421)	Mus musculus	Strain: C57BL/6 Cell type: Th17 cells	EXP053750	1117	normal	A1A546	primary T-cells	NULL
EXP053754	Goat IgG (Jackson Immuno Res)	Mus musculus	Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	NULL	5	chip_control	NULL	liver	NULL
EXP053755	Mouse IgG (Jackson Immuno Res)	Mus musculus	Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	NULL	5	chip_control	NULL	liver	NULL
EXP053756	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt2 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	NULL
EXP053757	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt6 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	NULL
EXP053758	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt10 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	NULL
EXP053759	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt14 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	NULL
EXP053760	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt18 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	NULL
EXP053761	anti-Nelf-A, A-20 (sc-23599, Santa Cruz)	Mus musculus	Time: Zt22 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053754	5	normal	Q8BG30	liver	NULL
EXP053762	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt2 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	NULL
EXP053763	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt6 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	NULL
EXP053764	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt10 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	NULL
EXP053765	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt14 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	NULL
EXP053766	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt18 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	NULL
EXP053767	anti-Tbp (Abcam ab51841)	Mus musculus	Time: Zt22 Strain: C57BL/6  Age: 3-4 month old Genotype: wildtype	EXP053755	5	normal	P29037	liver	NULL
EXP053768	none	Mus musculus		NULL	204	chip_control	NULL	D3 (embryonic stem cells)	NULL
EXP053769	Zeb1 (SantaCruz; clone H-102; #SC25388)	Mus musculus		NULL	204	normal	Q64318	D3 (embryonic stem cells)	NULL
EXP053770	Input	Rattus norvegicus	Treatment: FGF for 6 hrs; Passage: 2; 	NULL	2587	chip_control	NULL	NSC (neural stem cells)	NULL
EXP053771	IgG	Rattus norvegicus	Treatment: FGF for 6 hrs; Passage: 2; 	NULL	2587	chip_control	NULL	NSC (neural stem cells)	NULL
EXP053772	Input	Rattus norvegicus	Treatment: FGF for 24 hrs; Passage: 2; 	NULL	2587	chip_control	NULL	NSC (neural stem cells)	NULL
EXP053773	IgG	Rattus norvegicus	Treatment: FGF for 24 hrs; Passage: 2; 	NULL	2587	chip_control	NULL	NSC (neural stem cells)	NULL
EXP053774	HDAC2 (SC-7899)	Rattus norvegicus	Treatment: FGF for 6 hrs; Passage: 2; 	EXP053770	2587	normal	B1WBY8	NSC (neural stem cells)	NULL
EXP053775	HDAC3 (SC-11417)	Rattus norvegicus	Treatment: FGF for 6 hrs; Passage: 2; 	EXP053770	2587	normal	Q6P6W3	NSC (neural stem cells)	NULL
EXP053776	HDAC2 (SC-7899)	Rattus norvegicus	Treatment: FGF for 24 hrs; Passage: 2; 	EXP053772	2587	normal	B1WBY8	NSC (neural stem cells)	NULL
EXP053777	HDAC3 (SC-11417)	Rattus norvegicus	Treatment: FGF for 24 hrs; Passage: 2; 	EXP053772	2587	normal	Q6P6W3	NSC (neural stem cells)	NULL
EXP053778	none	Rattus norvegicus	Tissue: brain; Developmental stage: embryonic 15.5 days; Strain: Sprague Dawley;	NULL	2588	chip_control	NULL	embryonic cerebral cortex	NULL
EXP053779	LSD1 (CST, 2184s)	Rattus norvegicus	Tissue: brain; Developmental stage: embryonic 15.5 days; Strain: Sprague Dawley;	EXP053778	2588	normal	P97609	embryonic cerebral cortex	NULL
EXP053780	Hdac3 (Abcam ab7030)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	752	normal	Q6P6W3	oligodendrocyte precursors	NULL
EXP053781	Hdac3 (Abcam ab7030)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	218	normal	Q6P6W3	oligodendrocytes	NULL
EXP053782	p300 (Santa Cruz sc-585)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	752	normal	Q91XT0	oligodendrocyte precursors	NULL
EXP053783	p300 (Santa Cruz sc-585)	Rattus norvegicus	Strain: Sprague Dawley; 	NULL	218	normal	Q91XT0	oligodendrocytes	NULL
EXP053784	HMGB2 (abcam, ab67282)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: none; Age: 1 day old;	NULL	2589	normal	P52925	NRVM (Primary neonatal rat ventricular myocytes)	NULL
EXP053785	HMGB2 (abcam, ab67282)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: 10uM phenylephrine (PHE, Sigma, P-6126), 48hrs; Age: 1 day old;	NULL	2589	normal	P52925	NRVM (Primary neonatal rat ventricular myocytes)	NULL
EXP053786	anti-SUZ12 (CST, catalog# 3737, lot# 3))	Rattus norvegicus	Strain: Brown Norway Rat; 	NULL	752	normal	A0A0G2JV08	oligodendrocyte precursors	NULL
EXP053787	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	none	NULL	2590	chip_control	NULL	NRVM (neonatal rat ventricular myocytes)	NULL
EXP053788	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	Treatment: none;	NULL	2590	normal	A0A0G2JYV0	NRVM (neonatal rat ventricular myocytes)	NULL
EXP053789	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	Treatment: phenylepherine;	NULL	2590	normal	A0A0G2JYV0	NRVM (neonatal rat ventricular myocytes)	NULL
EXP053790	anti-BRD4 (Bethyl, A301-985A)	Rattus norvegicus	Treatment: phenylepherine and mir9mimic; 	EXP053787	2590	normal	A0A0G2JYV0	NRVM (neonatal rat ventricular myocytes)	NULL
EXP053791	none	Rattus norvegicus	Treatment: none; Passage: 3-6; Strain: Sprague-Dawley;	NULL	2592	chip_control	NULL	VSMC (Vascular Smooth Muscle Cells )	NULL
EXP053792	none	Rattus norvegicus	Treatment: Angiotensin II for 3 hours; Passage: 3-6; Strain: Sprague-Dawley;	NULL	2592	chip_control	NULL	VSMC (Vascular Smooth Muscle Cells )	NULL
EXP053793	BRD4 (Cat. No. A301-985A100; Bethyl, Montgomery, TX)	Rattus norvegicus	Treatment: none; Passage: 3-6; Strain: Sprague-Dawley;	EXP053791	2592	normal	D3ZGX8	VSMC (Vascular Smooth Muscle Cells )	NULL
EXP053794	BRD4 (Cat. No. A301-985A100; Bethyl, Montgomery, TX)	Rattus norvegicus	Treatment: Angiotensin II for 3 hours; Passage: 3-6; Strain: Sprague-Dawley;	EXP053792	2592	normal	D3ZGX8	VSMC (Vascular Smooth Muscle Cells )	NULL
EXP053795	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053796	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053797	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053798	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc, sir3{del}; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053799	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053800	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053801	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Ino80-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053802	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, MOT1-13Myc, Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053803	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc; Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours,crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053804	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Ino80-13Myc; Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053805		Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053806	none	Mus musculus	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053807	none	Mus musculus	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053808	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053809	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053810	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-13myc; Treatment: crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053811	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc, sir3{del}; Treatment: crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053812	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, bar1{delta}; Treatment: crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053813	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-13myc, bar1{delta}; Treatment: crosslinked with 1% formaldehyde 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053814	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Ino80-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053815	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, MOT1-13Myc, Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053816	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc; Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours,crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053817	none	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Ino80-13Myc, crosslinked with 1% formaldehyde; 	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP053818	none	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP053819	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053795	1232	normal	P53946	S. cerevisiae cells	NULL
EXP053820	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053795	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053821	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde 	EXP053796	1232	normal	P53946	S. cerevisiae cells	NULL
EXP053822	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde 	EXP053796	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053823	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053797	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053824	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc, sir3{del}; Treatment: crosslinked with 1% formaldehyde 	EXP053798	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053825	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	EXP053799	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053826	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc, crosslinked with 1% formaldehyde; 	EXP053800	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053827	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Ino80-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	EXP053801	1232	normal	P53115	S. cerevisiae cells	NULL
EXP053828	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, MOT1-13Myc, Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053802	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053829	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc; Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours,crosslinked with 1% formaldehyde; 	NULL	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053830	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Ino80-13Myc; Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053817	1232	normal	P53115	S. cerevisiae cells	NULL
EXP053831	Anti murine Mot1 antibody (Abcam, ab72285 )	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053805	2	normal	E9QAE3	mESCs (mouse embryonic stem cells)	NULL
EXP053832	Anti INO80 (Proteintech (18810-1-AP)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053805	2	normal	Q6ZPV2	mESCs (mouse embryonic stem cells)	NULL
EXP053833	Anti NC2-beta antibody (Abcam, ab50783)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053805	2	normal	Q91WV0	mESCs (mouse embryonic stem cells)	NULL
EXP053834	Anti Med1 antibody (SC-5334x)	Mus musculus	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053806	1232	normal	Q925J9	S. cerevisiae cells	NULL
EXP053835	Anti Med1 antibody (SC-5334x)	Mus musculus	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde 	EXP053807	1232	normal	Q925J9	S. cerevisiae cells	NULL
EXP053836	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde; 	EXP053808	1232	normal	P53946	S. cerevisiae cells	NULL
EXP053837	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc; Treatment: crosslinked with 1% formaldehyde; 	EXP053808	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053838	Anti-Arp5 antibody (Abcam, ab12099)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde; 	EXP053809	1232	normal	P53946	S. cerevisiae cells	NULL
EXP053839	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, sir3{delta}; Treatment: crosslinked with 1% formaldehyde; 	EXP053809	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053840	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-13myc; Treatment: crosslinked with 1% formaldehyde; 	EXP053810	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053841	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: IINO80-FRB, Nc2-beta-13myc, sir3{del}; Treatment: crosslinked with 1% formaldehyde; 	EXP053811	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053842	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, MOT1-13myc, bar1{delta}; Treatment: crosslinked with 1% formaldehyde; 	EXP053812	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053843	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Nc2-beta-13myc, bar1{delta}; Treatment: crosslinked with 1% formaldehyde 	EXP053813	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053844	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: INO80-FRB, Ino80-13myc, bar1{del}; Treatment: Cells were synchronized in G1 with a-factor in YPD (3hours treatment) and treated with DMSO for 2 hours, crosslinked with 1% formaldehyde;  	EXP053814	1232	normal	P53115	S. cerevisiae cells	NULL
EXP053845	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, MOT1-13Myc, Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053815	1232	normal	P32333	S. cerevisiae cells	NULL
EXP053846	Anti Myc antibody from Abcam (ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc; Treatment: bar1{delta}, TBP-FRB, Nc2-beta-13Myc Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours,crosslinked with 1% formaldehyde; 	EXP053816	1232	normal	Q92317	S. cerevisiae cells	NULL
EXP053847	Anti Myc (Abcam, ab32)	Saccharomyces cerevisiae	Strain: MJE7 Background; Genotype: bar1{delta}, TBP-FRB, MOT1-13Myc Treatment: bar1{delta}, TBP-FRB, Ino80-13Myc; Treatment: Cells were synchronized in G1 with a-factor in YPD (4hours treatment) and treat with rapamycin for 2 hours, crosslinked with 1% formaldehyde; 	EXP053817	1232	normal	P53115	S. cerevisiae cells	NULL
EXP053848	Anti murine Mot1 antibody (Abcam, ab72285 )	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053818	2	normal	E9QAE3	mESCs (mouse embryonic stem cells)	NULL
EXP053849	Anti INO80 (Proteintech (18810-1-AP)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053818	2	normal	Q6ZPV2	mESCs (mouse embryonic stem cells)	NULL
EXP053850	Anti NC2-beta antibody (Abcam, ab50783)	Mus musculus	Age: E14 Treatment: transfected with siRNA,72 hours post transfection, cells were harvested for experiments	EXP053818	2	normal	Q91WV0	mESCs (mouse embryonic stem cells)	NULL
EXP053851	in house none	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053852	input	Mus musculus	Cell type: C57BL/6 (female) x 129/S (male); Passage: 10-18;	NULL	521	chip_control	NULL	KH2 (embryonic stem cells)	NULL
EXP053853	anti-ELL (in house Rabbit, aa 301-584)	Drosophila melanogaster		EXP053851	1451	normal	Q9VW51	S2 (Schneider 2)	NULL
EXP053854	anti-Ice1 (in house Rabbit, CG13550, aa 1-192)	Drosophila melanogaster		EXP053851	1451	normal	Q9W1R4	S2 (Schneider 2)	NULL
EXP053855	anti-Lilli (in house Guinea Pig, aa 1427-1673)	Drosophila melanogaster		EXP053851	1451	normal	Q9VQI9	S2 (Schneider 2)	NULL
EXP053856	anti-ELL(custom, see Lin et al. 2010 (Mol. Cell)	Mus musculus	Cell type: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP053852	521	normal	O08856	KH2 (embryonic stem cells)	NULL
EXP053857	none	Drosophila melanogaster	Genotype: wildtype;	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053858	none	Drosophila melanogaster	Genotype: wildtype;	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053859	none	Drosophila melanogaster	Genotype: Trr knockout;	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053860	alfa-Trr (#570, Ali Shilatifard)	Drosophila melanogaster	Genotype: wildtype;	EXP053858	1451	normal	Q8IRW8	S2 (Schneider 2)	NULL
EXP053861	(rb) alfa-dUTX (#663, Ali Shilatifard)	Drosophila melanogaster	Genotype: wildtype;	EXP053857	1451	normal	M9MRG4	S2 (Schneider 2)	NULL
EXP053862	(rb) alfa-LPT (#470, Ali Shilatifard)	Drosophila melanogaster	Genotype: wildtype;	EXP053857	1451	normal	A0A0B4LGG6	S2 (Schneider 2)	NULL
EXP053863	(rb) ?-dUTX (#663, Ali Shilatifard)	Drosophila melanogaster	Genotype: Trr knockout;	EXP053857	1451	normal	M9MRG4	S2 (Schneider 2)	NULL
EXP053864	(rb) ?-LPT (#470, Ali Shilatifard)	Drosophila melanogaster	Genotype: Trr knockout;	EXP053859	1451	normal	A0A0B4LGG6	S2 (Schneider 2)	NULL
EXP053865	no antibody	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053866	no antibody	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053867	no antibody	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053868	no antibody	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053869	no antibody	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053870	no antibody	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053871	no antibody	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP053872	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	NULL
EXP053873	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053867	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	NULL
EXP053874	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053870	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	NULL
EXP053875	AFF4 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053871	417	normal	Q9UHB7	HCT-116 (colon carcinoma)	NULL
EXP053876	CDK9 (Santa Cruz, sc-484)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	P50750	HCT-116 (colon carcinoma)	NULL
EXP053877	CDK9 (Santa Cruz, sc-484)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	NULL	417	normal	P50750	HCT-116 (colon carcinoma)	NULL
EXP053878	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	O00472	HCT-116 (colon carcinoma)	NULL
EXP053879	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053867	417	normal	O00472	HCT-116 (colon carcinoma)	NULL
EXP053880	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053870	417	normal	O00472	HCT-116 (colon carcinoma)	NULL
EXP053881	ELL2 (homemade)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053871	417	normal	O00472	HCT-116 (colon carcinoma)	NULL
EXP053882	LEO1 (Bethyl, A300-175A)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: PAF1 shRNA #1;	EXP053866	417	normal	Q8WVC0	HCT-116 (colon carcinoma)	NULL
EXP053883	LEO1 (Bethyl, A300-175A)	Homo sapiens	Cell type: colorectalÂ cancer cell line; Treatment: Scramble shRNA;	EXP053870	417	normal	Q8WVC0	HCT-116 (colon carcinoma)	NULL
EXP053884	N/A	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053885	N/A	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053886	N/A	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053887	N/A	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP053888	Trr (homemade)	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	NULL	1451	normal	Q8IRW8	S2 (Schneider 2)	NULL
EXP053889	TrxCT (homemade)	Drosophila melanogaster	Antibody: C - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053884	1451	normal	Q8IRW8	S2 (Schneider 2)	NULL
EXP053890	TrxCT (homemade)	Drosophila melanogaster	Antibody: C - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053885	1451	normal	Q8IRW8	S2 (Schneider 2)	NULL
EXP053891	TrxNT (homemade)	Drosophila melanogaster	Antibody: N - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053884	1451	normal	Q8IRW8	S2 (Schneider 2)	NULL
EXP053892	TrxNT (homemade)	Drosophila melanogaster	Antibody: N - terminal antibody; Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053885	1451	normal	Q8IRW8	S2 (Schneider 2)	NULL
EXP053893	dSet1 (homemade)	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053884	1451	normal	Q5LJZ2	S2 (Schneider 2)	NULL
EXP053894	dSet1 (homemade)	Drosophila melanogaster	Treatment: treated with non-targeting dsRNA; Passage: Low passages (6-10); Cell type: embryo-derived;	EXP053885	1451	normal	Q5LJZ2	S2 (Schneider 2)	NULL
EXP053895	anti-HCE (Glover-Cutter et al NSMB. 15:71, 2008)	Homo sapiens	Genotype: wildtype; Treatment: treated with 10mM NM-PP1 for 24 hr;	NULL	417	normal	O60942	HCT-116 (colon carcinoma)	NULL
EXP053896	rabbit anti-HCE (Glover-Cutter et al NSMB. 15:71, 2008)	Homo sapiens	Genotype: Cdk7as mutant; Treatment: treated with 10mM NM-PP1 for 24 hr;	NULL	417	normal	O60942	HCT-116 (colon carcinoma)	NULL
EXP053897	none	Homo sapiens	Treatment: DMSO;	NULL	2593	chip_control	NULL	J-Lat A72	NULL
EXP053898	none	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	NULL	2593	chip_control	NULL	J-Lat A72	NULL
EXP053899	none	Homo sapiens	Treatment: DMSO;	NULL	2593	chip_control	NULL	J-Lat A72	NULL
EXP053900	none	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	NULL	2593	chip_control	NULL	J-Lat A72	NULL
EXP053901	none	Homo sapiens	Treatment: DMSO;	NULL	2593	chip_control	NULL	J-Lat A72	NULL
EXP053902	none	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	NULL	2593	chip_control	NULL	J-Lat A72	NULL
EXP053903	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: DMSO;	EXP053897	2593	normal	O60885	J-Lat A72	NULL
EXP053904	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: DMSO;	EXP053897	2593	normal	P51532	J-Lat A72	NULL
EXP053905	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053898	2593	normal	O60885	J-Lat A72	NULL
EXP053906	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053898	2593	normal	P51532	J-Lat A72	NULL
EXP053907	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: DMSO;	EXP053899	2593	normal	O60885	J-Lat A72	NULL
EXP053908	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: DMSO;	EXP053899	2593	normal	P51532	J-Lat A72	NULL
EXP053909	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053900	2593	normal	O60885	J-Lat A72	NULL
EXP053910	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053900	2593	normal	P51532	J-Lat A72	NULL
EXP053911	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: DMSO;	EXP053901	2593	normal	O60885	J-Lat A72	NULL
EXP053912	anti-BRD4 (Abcam, ab128874)	Homo sapiens	Treatment: 625nM for ~ 18h JQ1;	EXP053902	2593	normal	O60885	J-Lat A72	NULL
EXP053913	none	Homo sapiens	Source: Cartilage; Passage: Primary; 	NULL	2595	chip_control	NULL	chondrocytes	NULL
EXP053914	none	Homo sapiens	Source: Cartilage; Passage: Primary; 	NULL	2595	chip_control	NULL	chondrocytes	NULL
EXP053915	HPIP antibody (Proteintech, 2102-1-AP)	Homo sapiens	Source: Cartilage; Passage: Primary; 	EXP053913	2595	normal	Q96AQ6	chondrocytes	NULL
EXP053916	HPIP antibody (Proteintech, 2102-1-AP)	Homo sapiens	Source: Cartilage; Passage: Primary; 	EXP053914	2595	normal	Q96AQ6	chondrocytes	NULL
EXP053917	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	O14646	A549 (lung carcinoma)	NULL
EXP053918	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	O14646	A549 (lung carcinoma)	NULL
EXP053919	CTBP1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q13363	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053920	CTBP1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q13363	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053921	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	O14646	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053922	CHD1	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	O14646	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053923	CBX8	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9HC52	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053924	CBX8	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9HC52	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053925	CBX3	Homo sapiens		NULL	376	normal	Q13185	WA01 (H1, human embryonic stem cells)	NULL
EXP053926	CBX3	Homo sapiens		NULL	376	normal	Q13185	WA01 (H1, human embryonic stem cells)	NULL
EXP053927	RING1	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q06587	K562 (myelogenous leukemia)	NULL
EXP053928	RING1	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q06587	K562 (myelogenous leukemia)	NULL
EXP053929	PAF1	Homo sapiens		NULL	376	normal	P28328	WA01 (H1, human embryonic stem cells)	NULL
EXP053930	PAF1	Homo sapiens		NULL	376	normal	P28328	WA01 (H1, human embryonic stem cells)	NULL
EXP053931	CHD7	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9P2D1	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053932	CHD7	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	356	normal	Q9P2D1	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP053933	KMT2B	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q9UMN6	K562 (myelogenous leukemia)	NULL
EXP053934	KMT2B	Homo sapiens	Developmental stage: adult; 	NULL	514	normal	Q9UMN6	K562 (myelogenous leukemia)	NULL
EXP053935	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	P61964	A549 (lung carcinoma)	NULL
EXP053936	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6; 	NULL	38	normal	P61964	A549 (lung carcinoma)	NULL
EXP053937	CBX2	Homo sapiens		NULL	376	normal	Q14781	WA01 (H1, human embryonic stem cells)	NULL
EXP053938	CBX2	Homo sapiens		NULL	376	normal	Q14781	WA01 (H1, human embryonic stem cells)	NULL
EXP053939	CHD7	Homo sapiens	Developmental stage: adult; Passage: 8;	NULL	38	normal	Q9P2D1	A549 (lung carcinoma)	NULL
EXP053940	CHD7	Homo sapiens	Developmental stage: adult; Passage: 8;	NULL	38	normal	Q9P2D1	A549 (lung carcinoma)	NULL
EXP053941	WDR5	Homo sapiens		NULL	376	normal	P61964	WA01 (H1, human embryonic stem cells)	NULL
EXP053942	WDR5	Homo sapiens		NULL	376	normal	P61964	WA01 (H1, human embryonic stem cells)	NULL
EXP053943	RING1	Homo sapiens		NULL	376	normal	Q06587	WA01 (H1, human embryonic stem cells)	NULL
EXP053944	RING1	Homo sapiens		NULL	376	normal	Q06587	WA01 (H1, human embryonic stem cells)	NULL
EXP053945	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP053946	WDR5	Homo sapiens	Developmental stage: adult; Passage: 6;	NULL	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP053947		Homo sapiens	Treatment: tranduced with shBrg1;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053948		Homo sapiens	Treatment: tranduced with shBrg1;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053949		Homo sapiens	Treatment: tranduced with shNS;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053950		Homo sapiens	Treatment: tranduced with shNS;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053951	None	Homo sapiens	Treatment: tranduced with shNS;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053952	None	Homo sapiens	Treatment: tranduced with shNS;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053953	None	Homo sapiens	Treatment: tranduced with shBrg1;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP053954	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053947	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053955	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053948	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053956	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053949	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053957	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053950	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053958	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053947	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053959	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053948	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053960	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shNS;	EXP053949	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053961	BRM (D9E8B), XPÂ® Rabbit mAb)	Homo sapiens	Treatment: tranduced with shNS;	EXP053950	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053962	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053951	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053963	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shNS;	EXP053952	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053964	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shNS;	EXP053951	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053965	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shNS;	EXP053952	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053966	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBRM;	NULL	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053967	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053953	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053968	Anti-BRG1 (Abcam,ab110641, #GR1580844-27)	Homo sapiens	Treatment: tranduced with shBrg1;	EXP053953	430	normal	P51532	HepG2 (hepatoblastoma)	NULL
EXP053969	BRM ( 11966, Cell Signaling, Lot2)	Homo sapiens	Treatment: tranduced with shBRM;	NULL	430	normal	P51531	HepG2 (hepatoblastoma)	NULL
EXP053970	anti-RING1B	Homo sapiens		NULL	396	normal	Q99496	WA09 (embryonic stem cells)	NULL
EXP053971	anti-SUZ12	Mus musculus	Genotype: 129SvJae x C57BL/6; 	NULL	252	normal	Q80U70	V6.5 (embryonic stem cells)	NULL
EXP053972	anti-Ring1b	Mus musculus	Genotype: 129SvJae x C57BL/6; 	NULL	252	normal	Q9CQJ4	V6.5 (embryonic stem cells)	NULL
EXP053973	None	Homo sapiens		NULL	2596	chip_control	NULL	IMR90hTert	NULL
EXP053974	Bdp1 (CS914)	Homo sapiens		EXP053973	2596	normal	A6H8Y1	IMR90hTert	NULL
EXP053975	Brf1 (CS146, #5)	Homo sapiens		EXP053973	2596	normal	Q07352	IMR90hTert	NULL
EXP053976	anti-SNAP45	Homo sapiens		EXP053973	2596	normal	Q13487	IMR90hTert	NULL
EXP053977	None	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr negative;	NULL	2598	chip_control	NULL	RD (Embryonal rhabdomyosarcoma)	NULL
EXP053978	None	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr positive;	NULL	980	chip_control	NULL	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP053979	None	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr positive;	NULL	980	chip_control	NULL	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP053980	pFM2	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr positive;	EXP053978	980	normal	Q9NQX1	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP053981	pFM2	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr positive;	EXP053979	980	normal	Q9NQX1	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP053982	pFM2	Homo sapiens	Treatment: none; Characteristic: pax3-fkhr negative;	EXP053977	2598	normal	Q9NQX1	RD (Embryonal rhabdomyosarcoma)	NULL
EXP053983	Mock	Homo sapiens	Developmental stage: Growing, Quiescent, Senescent; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP053984	anti-pRb	Homo sapiens	Developmental stage: Growing; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP053985	p130	Homo sapiens	Developmental stage: Quiescent; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	NULL
EXP053986	p130	Homo sapiens	Developmental stage: Senescent; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	NULL
EXP053987	pRb	Homo sapiens	Developmental stage: Quiescent; Treatment: expressing shRNA targeting RB; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP053988	p130	Homo sapiens	Developmental stage: Quiescent; Treatment: expressing shRNA targeting p130; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	NULL
EXP053989	pRb	Homo sapiens	Developmental stage: Senescent; Treatment: expressing shRNA targeting RB; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP053990	RBL2	Homo sapiens	Developmental stage: Senescent; Treatment: expressing shRNA targeting 130; 	EXP053983	489	normal	Q08999	IMR90 (lung fibroblasts)	NULL
EXP053991	pRb	Homo sapiens	Developmental stage: Quiescent; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP053992	pRb	Homo sapiens	Developmental stage: Senescent; 	EXP053983	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP053993	none	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP053994	anti-RPB90 (R. Roeder)	Homo sapiens		EXP053993	423	normal	Q07352	HeLa S3 (cervical adenocarcinoma)	NULL
EXP053995	BRF2 (ab17011, abcam)	Homo sapiens		EXP053993	423	normal	Q9HAW0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP053996	rabbit Santa Cruz sc-2027 (normal IgG)	Homo sapiens	Treatment: cultured with serum;	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP053997	rabbit Santa Cruz sc-2027 (normal IgG)	Homo sapiens	Treatment: cultured with serum;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP053998	none (Input DNA )	Homo sapiens	Treatment: 4 days cultured without serum;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP053999	none (Input DNA )	Homo sapiens	Treatment: 4 days without, 4 hours with serum;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP054000	anti-PHF8 (rabbit Abcam ab35471)	Homo sapiens	Treatment: cultured with serum;	EXP053996	423	normal	Q9UPP1	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054001	rabbit Abcam ab35471 (PHF8)	Homo sapiens	Treatment: cultured with serum;	EXP053997	10	normal	Q9UPP1	HEK293T (embryonic kidney)	NULL
EXP054002	rabbit Abcam ab35471 (PHF8)	Homo sapiens	Treatment: 4 days cultured without serum;	EXP053998	2599	normal	Q9UPP1	Hs68 (Canavan disease)	NULL
EXP054003	rabbit Abcam ab35471 (PHF8)	Homo sapiens	Treatment: 4 days without, 4 hours with serum;	EXP053999	2599	normal	Q9UPP1	Hs68 (Canavan disease)	NULL
EXP054004	anti-CBP	Homo sapiens	Characteristic: time after stimulation 0;	NULL	2600	normal	Q92793	T98G (Glioblastoma)	NULL
EXP054005	anti-p300	Homo sapiens	Characteristic: time after stimulation 0;	NULL	2600	normal	Q09472	T98G (Glioblastoma)	NULL
EXP054006	anti-CBP	Homo sapiens	Characteristic: time after stimulation 30 mins;	NULL	2600	normal	Q92793	T98G (Glioblastoma)	NULL
EXP054007	anti-p300	Homo sapiens	Characteristic: time after stimulation 30 mins;	NULL	2600	normal	Q09472	T98G (Glioblastoma)	NULL
EXP054008	Anti-PHF8 antibody( abcam, lot# AP266823, ab36068)	Homo sapiens		NULL	78	normal	Q9UPP1	HeLa (cervical adenocarcinoma)	NULL
EXP054009	Ctrl IgG (preimmun serum)	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054010	TX516 (polyclonal anti TDRD3)	Homo sapiens		EXP054009	113	normal	Q9H7E2	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054011	anti- IGF-I Receptor beta (Cell Signaling Technology, 3027)	Homo sapiens		NULL	2601	normal	P08069	DFB (malignant melanoma cell line)	NULL
EXP054012	none	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054013	anti-DDX5  (Abcam, ab21696, #830301)	Homo sapiens		EXP054012	423	normal	P17844	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054014	input	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP054015	input	Homo sapiens		NULL	2602	chip_control	NULL	H9-derived NEC (neuroectodermal sphere cells)	NULL
EXP054016	p300 (Santa Cruz,  Biotechnologies, sc-585)	Homo sapiens		EXP054014	396	normal	Q09472	WA09 (embryonic stem cells)	NULL
EXP054017	anti-BRG1	Homo sapiens		EXP054014	396	normal	P51532	WA09 (embryonic stem cells)	NULL
EXP054018	p300 (Santa Cruz,  Biotechnologies, sc-585)	Homo sapiens		EXP054015	2602	normal	Q09472	H9-derived NEC (neuroectodermal sphere cells)	NULL
EXP054019	Suz12	Homo sapiens		NULL	89	normal	Q15022	BGO3 (embryonic stem cells)	NULL
EXP054020	hDot1L (Abcam, ab64077, #881913)	Homo sapiens		NULL	245	normal	Q8TEK3	NCCIT (testicular embryonic carcinoma)	NULL
EXP054021	SetDB1 (Santa Cruz, SC-66884, #A2809)	Homo sapiens		NULL	2603	normal	Q15047	WM262 (Melanoma)	NULL
EXP054022	SetDB1 (Santa Cruz, SC-66884, #A2809)	Homo sapiens		NULL	24	normal	Q15047	451Lu (WM-451Lu, Melanoma)	NULL
EXP054023	MCAF1 (Bethyl, A300-169A, #A300-169A-1)	Homo sapiens		NULL	2603	normal	Q6VMQ6	WM262 (Melanoma)	NULL
EXP054068	P300 (Rabbit Polyclonal Antigen Affinity Purified, Unconjugated, Liquid)	Homo sapiens	Treatment: None;	NULL	516	normal	Q09472	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP054085	p300 (Santa Cruz Biotech, sc-585)	Homo sapiens	Treatment: None;	NULL	514	normal	Q09472	K562 (myelogenous leukemia)	NULL
EXP054088	anti-IkappaBalpha	Homo sapiens		NULL	2320	normal	P25963	primary human epidermal keratinocytes	NULL
EXP054089	anti-p300 (Santa Cruz Biotechnology,sc-585, #B2511 )	Homo sapiens	Treatment: none;	NULL	796	normal	Q09472	SKNO-1 (acute myeloid leukemia)	NULL
EXP054099	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: starved by washing cells 2x in PBS; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054092	521	normal	Q9UHB7	KH2 (embryonic stem cells)	NULL
EXP054100	anti-ELL2 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: treated with serum for 30 minutes; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054093	521	normal	O00472	KH2 (embryonic stem cells)	NULL
EXP054101	anti-AFF4 (Lin et al., 2010 Mol. Cell)	Homo sapiens	Treatment: treated with serum for 30 minutes; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054093	521	normal	Q9UHB7	KH2 (embryonic stem cells)	NULL
EXP054102	His tag Cdk9 (amino acids 204-372)	Mus musculus	Treatment: none; Strain: C57BL/6 (female) x 129/S (male); Passage: 10-18;	EXP054090	521	normal	Q99J95	KH2 (embryonic stem cells)	NULL
EXP054103	purified IgG	Homo sapiens		NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP054104	EBNA1 (Advance Biotechnology, 13-210-100 monoclonal antibody)	Homo sapiens		EXP054103	767	normal	Q99848	Raji (Burkitt lymphoma)	NULL
EXP054105	none	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP054106	anti-Tat (Abcam, ab43014)	Homo sapiens	Genotype: expression HIV Tat protein	EXP054105	509	normal	P17735	Jurkat (T-cells)	NULL
EXP054107	SPT20_3006 (Laszlo Tora, Rabbit polyclonal)	Homo sapiens		NULL	78	normal	Q8NEM7	HeLa (cervical adenocarcinoma)	NULL
EXP054108	SPT20_3006 (Laszlo Tora, Rabbit polyclonal)	Homo sapiens		NULL	356	normal	Q8NEM7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054109	anti-V5 (Invitrogen, R960-25, #771149)	Homo sapiens		NULL	219	chip_control	NULL	DLD-1 (colon adenocarcinoma)	NULL
EXP054110	none, input	Homo sapiens		NULL	219	chip_control	NULL	DLD-1 (colon adenocarcinoma)	NULL
EXP054111	anti-V5 (Invitrogen, R960-25, #771149)	Homo sapiens		EXP054110	219	normal	O94907	DLD-1 (colon adenocarcinoma)	NULL
EXP054114	none	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054115	none	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054116	none	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054117	RB1 (Cell signalling 4H1)	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	EXP054112	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054118	p107 (sc-C18)	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	EXP054112	489	normal	P28749	IMR90 (lung fibroblasts)	NULL
EXP054119	RBL2 (sc-C20)	Homo sapiens	Treatment: mock-infected; Passage: 6 to 10; 	EXP054112	489	normal	Q08999	IMR90 (lung fibroblasts)	NULL
EXP054120	anti-acetyl-CBP/p300 (Cell signaling technology, 4771/lot 2, rabbit polyclonal)	Homo sapiens	Developmental stage: adult (45yr); Sex: male; 	NULL	884	normal	Q09472	heart	NULL
EXP054121	anti-acetyl-CBP/p300 (Cell signaling technology, 4771/lot 2, rabbit polyclonal)	Homo sapiens	Developmental stage: fetus (gestational week 16); Sex: male; 	NULL	884	normal	Q09472	heart	NULL
EXP054122	anti-acetyl-CBP/p300 (Cell signaling technology, 4771/lot 2, rabbit polyclonal)	Mus musculus	Developmental stage: adult (45yr); Sex: mixed; Strain: CD-1;	NULL	53	normal	B2RWS6	heart	NULL
EXP054123	anti-MEF2C	Homo sapiens	Treatment: DMSO for 4 hr; Passage: within 6 passage;	NULL	472	normal	Q06413	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP054124	anti-MEF2C	Homo sapiens	Treatment: statin for 4 hr; Passage: within 6 passage;	NULL	472	normal	Q06413	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP054128	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: untreated; Source: cells were pooled from five different donors;	NULL	881	normal	O60885	CD4+ T-cells	NULL
EXP054129	BRD4 (Abcam, Cat no. ab46199, Lot no. 613288)	Homo sapiens	Treatment: 500nM JQ1 treated for 24hr; Source: cells were pooled from five different donors;	NULL	881	normal	O60885	CD4+ T-cells	NULL
EXP054130		Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP054131	AFF4 antibody (Lin et al. 2010)	Homo sapiens		EXP054130	10	normal	Q9UHB7	HEK293T (embryonic kidney)	NULL
EXP054132	f-6 (Santa-Cruz)	Homo sapiens	Treatment: TNFa induction (12 hours); 	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP054133	RELA (f-6, Santa-Cruz)	Homo sapiens	Treatment: TNFa induction (12 hours); 	EXP054132	38	normal	Q04206	A549 (lung carcinoma)	NULL
EXP054134	none	Homo sapiens	Genotype: Flag-HA (empty vector);	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054135	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-RING1B; 	EXP054134	2615	normal	Q99496	293T-Rex	NULL
EXP054136	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-RYBP; 	EXP054134	2615	normal	Q8N488	293T-Rex	NULL
EXP054137	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF1; 	EXP054134	2615	normal	Q9BSM1	293T-Rex	NULL
EXP054138	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF2; 	EXP054134	2615	normal	P35227	293T-Rex	NULL
EXP054139	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF4; 	EXP054134	2615	normal	P35226	293T-Rex	NULL
EXP054140	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF5; 	EXP054134	2615	normal	Q86SE9	293T-Rex	NULL
EXP054141	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-PCGF6; 	EXP054134	2615	normal	Q9BYE7	293T-Rex	NULL
EXP054142	anti-HA (Abcam, ab9110, #GR20600-2)	Homo sapiens	Genotype: Flag-HA-CBX2; 	EXP054134	2615	normal	Q14781	293T-Rex	NULL
EXP054143	anti-RING1B (Bethyl, A302-869A, #1 )	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	Q99496	293T-Rex	NULL
EXP054144	anti-RYBP (Sigma, PRS2227, #22270004)	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	Q8N488	293T-Rex	NULL
EXP054145	anti-PCGF4 (Bethyl, A301-694A, #2)	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	P35226	293T-Rex	NULL
EXP054146	anti-CBX2 (Abcam, ab80044, GR6867-1)	Homo sapiens	Genotype: Flag-HA (empty vector);	EXP054134	2615	normal	Q14781	293T-Rex	NULL
EXP054148	anti-PAF1 (Bethyl laboratories, A301-047A)	Homo sapiens	Treatment: Flag-NS1 virus for 0 hrs (none, uninfected);	NULL	38	normal	P28328	A549 (lung carcinoma)	NULL
EXP054149	anti-PAF1 (Bethyl laboratories, A301-047A)	Homo sapiens	Treatment: Flag-NS1 virus for 12 hrs; 	NULL	38	normal	P28328	A549 (lung carcinoma)	NULL
EXP054150	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: Flag-NS1 virus for 0 hrs (none, uninfected);	NULL	38	normal	Q9Y6Y0	A549 (lung carcinoma)	NULL
EXP054151	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: Flag-NS1 virus for 12 hrs; 	NULL	38	normal	Q9Y6Y0	A549 (lung carcinoma)	NULL
EXP054152	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: control non-targeting siRNA pool, Flag-NS1 virus for 12 hrs;	EXP054147	38	normal	Q9Y6Y0	A549 (lung carcinoma)	NULL
EXP054153	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: siRNA pools targeted to human PAF1, Flag-NS1 virus for 12 hrs;	EXP054147	38	normal	Q9Y6Y0	A549 (lung carcinoma)	NULL
EXP054154	anti-Flag (Sigma, A8592)	Homo sapiens	Treatment: siRNA pools targeted to human CHD1, Flag-NS1 virus for 12 hrs;	EXP054147	38	normal	Q9Y6Y0	A549 (lung carcinoma)	NULL
EXP054155		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054156	p300 Antibody (Santa Cruz, sc-585, #H2610)	Homo sapiens		EXP054155	113	normal	Q09472	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054157	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054158	anti-TTF2 (sheep antibody)	Homo sapiens		EXP054157	78	normal	O00358	HeLa (cervical adenocarcinoma)	NULL
EXP054159	anti-TTF2 (rabbit antibody)	Homo sapiens		EXP054157	78	normal	O00358	HeLa (cervical adenocarcinoma)	NULL
EXP054160	anti-Xrn2 (rabbit  antibody)	Homo sapiens		EXP054157	78	normal	Q9H0D6	HeLa (cervical adenocarcinoma)	NULL
EXP054161	anti-Dcp1a (rabbit  antibody)	Homo sapiens		EXP054157	78	normal	Q9NPI6	HeLa (cervical adenocarcinoma)	NULL
EXP054162	none	Homo sapiens	Passage: 15-18;  	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054163	CtBP (Santa Cruz, #H-440)	Homo sapiens	Passage: 15-18;  	EXP054162	113	normal	Q13363	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054164	None	Homo sapiens		NULL	2617	chip_control	NULL	WM853.2 (Melanoma)	NULL
EXP054165	None	Homo sapiens		NULL	24	chip_control	NULL	451Lu (WM-451Lu, Melanoma)	NULL
EXP054166	None	Homo sapiens		NULL	2603	chip_control	NULL	WM262 (Melanoma)	NULL
EXP054167	SetDB1 (Santa Cruz, SC-66884)	Homo sapiens		EXP054164	2617	normal	Q15047	WM853.2 (Melanoma)	NULL
EXP054168	Lamin B1 (Abcam, ab16048, #953293)	Homo sapiens		NULL	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054169	anti-HCF1	Homo sapiens		NULL	2618	normal	P51610	H293T	NULL
EXP054170	anti-p300 (Santa Cruz antibody, sc-585x, Lot#E2610)	Homo sapiens		NULL	849	normal	Q09472	U87 (glioblastoma)	NULL
EXP054171	none	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054172	none	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054173	anti-Orc1	Homo sapiens		NULL	423	normal	Q13415	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054174	none	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054175	p300 (Santa Cruz, Catalog: SC-585XS, Lot#:  E2209]	Homo sapiens		EXP054174	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP054176	none	Homo sapiens	Genotype: UVSS1 knockout; 	NULL	2619	chip_control	NULL	SV40 (Immortalized Fibroblast)	NULL
EXP054177	anti-CSB (N-Terminus 1B1, Mouse monoclonal)	Homo sapiens	Genotype: UVSS1 knockout; 	EXP054176	2619	normal	Q03468	SV40 (Immortalized Fibroblast)	NULL
EXP054178	none	Homo sapiens	Treatment: none;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054179	anti-CDK8 (Santa Cruz, sc-1521, K1510)	Homo sapiens	Treatment: normoxia for 24 hrs;	EXP054178	417	normal	P49336	HCT-116 (colon carcinoma)	NULL
EXP054180	anti-CDK8 (Santa Cruz, sc-1521, K1510)	Homo sapiens	Treatment: hypoxia (1%O2) for 24hrs;	EXP054178	417	normal	P49336	HCT-116 (colon carcinoma)	NULL
EXP054181	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054182	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054183	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054184	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP054185	none	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054186	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054187	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054188	none	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054189	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054190	none	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP054191	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	EXP054181	2615	normal	O14503	293T-Rex	NULL
EXP054192	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	EXP054181	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054193	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours;  Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal)	EXP054181	2615	normal	P35226	293T-Rex	NULL
EXP054194	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054182	2615	normal	O14503	293T-Rex	NULL
EXP054195	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054182	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054196	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054182	2615	normal	P35226	293T-Rex	NULL
EXP054197	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054183	2615	normal	O14503	293T-Rex	NULL
EXP054198	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054183	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054199	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054183	2615	normal	P35226	293T-Rex	NULL
EXP054200	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: none; 	EXP054184	514	normal	Q9UQR0	K562 (myelogenous leukemia)	NULL
EXP054201	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: none;	EXP054184	514	normal	P35226	K562 (myelogenous leukemia)	NULL
EXP054202	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054185	2615	normal	O14503	293T-Rex	NULL
EXP054203	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054185	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054204	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054185	2615	normal	P35226	293T-Rex	NULL
EXP054205	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054186	2615	normal	O14503	293T-Rex	NULL
EXP054206	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054186	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054207	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054186	2615	normal	P35226	293T-Rex	NULL
EXP054208	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054187	2615	normal	O14503	293T-Rex	NULL
EXP054209	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054187	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054210	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054187	2615	normal	P35226	293T-Rex	NULL
EXP054211	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054188	2615	normal	O14503	293T-Rex	NULL
EXP054212	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054188	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054213	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: no doxycycline; Genotype: N3 (empty vector), Flag-HA-OneSTrEP (N-terminal);	EXP054188	2615	normal	P35226	293T-Rex	NULL
EXP054214	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054189	2615	normal	O14503	293T-Rex	NULL
EXP054215	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054189	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054216	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A, Flag-HA-OneSTrEP (N-terminal)	EXP054189	2615	normal	P35226	293T-Rex	NULL
EXP054217	anti-HA (Abcam, ab9110, Lot#GR52735-1)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054190	2615	normal	O14503	293T-Rex	NULL
EXP054218	SCML2 (in-house, batch# Rb1199-1004)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054190	2615	normal	Q9UQR0	293T-Rex	NULL
EXP054219	BMI1 (Bethyl, A301-694, Lot#A301-694A-2)	Homo sapiens	Treatment: doxycycline treatment for 24 hours; Genotype: N3-SCML2A{delta}RBR (256-330), Flag-HA-OneSTrEP (N-terminal)	EXP054190	2615	normal	P35226	293T-Rex	NULL
EXP054220	None	Homo sapiens	Source: Lymphoblastoid cells; 	NULL	2620	chip_control	NULL	HLS554P	NULL
EXP054221	Smc1 (Bethyl, A300-055A)	Homo sapiens	Source: Lymphoblastoid cells; 	EXP054220	2620	normal	Q14683	HLS554P	NULL
EXP054222	Nipbl (Bethyl, A301-779A)	Homo sapiens	Source: Lymphoblastoid cells; 	EXP054220	2620	normal	Q6KC79	HLS554P	NULL
EXP054223	None (input)	Homo sapiens	Cell status: undifferentiated; 	NULL	245	chip_control	NULL	NCCIT (testicular embryonic carcinoma)	NULL
EXP054224	DNMT1 (Santa Cruz, sc-10219)	Homo sapiens	Cell status: undifferentiated; 	EXP054223	245	normal	P26358	NCCIT (testicular embryonic carcinoma)	NULL
EXP054225	DNMT3A (Santa Cruz, sc-20703))	Homo sapiens	Cell status: undifferentiated; 	EXP054223	245	normal	Q9Y6K1	NCCIT (testicular embryonic carcinoma)	NULL
EXP054226	DNMT3B (Novus, NB300-516)	Homo sapiens	Cell status: undifferentiated; 	EXP054223	245	normal	Q9UBC3	NCCIT (testicular embryonic carcinoma)	NULL
EXP054227	DNMT1 (Santa Cruz, sc-10219)	Homo sapiens	Cell status: differentiated;	EXP054223	245	normal	P26358	NCCIT (testicular embryonic carcinoma)	NULL
EXP054228	DNMT3A (Santa Cruz, sc-20703))	Homo sapiens	Cell status: differentiated;	EXP054223	245	normal	Q9Y6K1	NCCIT (testicular embryonic carcinoma)	NULL
EXP054229	DNMT3B (Novus, NB300-516)	Homo sapiens	Cell status: differentiated;	EXP054223	245	normal	Q9UBC3	NCCIT (testicular embryonic carcinoma)	NULL
EXP054230	n/a	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	880	chip_control	NULL	B-cells	NULL
EXP054231	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	881	normal	P51532	CD4+ T-cells	NULL
EXP054232	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2622	normal	P51532	HSC (hematopoietic stem cells )	NULL
EXP054233	anti-p300 (Santa Cruz, SC-585X, lot D1509)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2622	normal	Q09472	HSC (hematopoietic stem cells )	NULL
EXP054234	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2623	normal	P51532	CD36	NULL
EXP054235	anti-p300 (Santa Cruz, SC-585X, lot D1509)	Homo sapiens	Developmental stage: adult; Tissue: blood;	NULL	2623	normal	Q09472	CD36	NULL
EXP054236	anti-Brg1 (Khavari, P. A., et al., 1993, Nature, 366:170-174)	Homo sapiens	Developmental stage: adult; Tissue: blood;	EXP054230	880	bio_control	P51532	B-cells	NULL
EXP054237	none	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP054238	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	P25440	HEK293 (embryonic kidney)	NULL
EXP054239	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	Q15059	HEK293 (embryonic kidney)	NULL
EXP054240	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	O60885	HEK293 (embryonic kidney)	NULL
EXP054241	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	P45973	HEK293 (embryonic kidney)	NULL
EXP054242	anti-FLAG M2 (Sigma-Aldrich, A2220)	Homo sapiens	Genotype: FLAG-Brd;	EXP054237	421	normal	P83916	HEK293 (embryonic kidney)	NULL
EXP054243		Homo sapiens	Genotype: myc-tagged pcDNA3-NME2, NME2 induced;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP054244		Homo sapiens	Genotype: wildtype;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP054245	anti-c-Myc (Sigma, monoclonal, Clone 9E10)	Homo sapiens	Genotype: myc-tagged pcDNA3-NME2, NME2 induced;	EXP054243	38	normal	P22392	A549 (lung carcinoma)	NULL
EXP054246	anti-nm23-h2 (L-16)	Homo sapiens	Genotype: wildtype;	EXP054244	38	normal	P22392	A549 (lung carcinoma)	NULL
EXP054247	none (input)	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP054248	anti-Ago1 (Wako, 2A7)	Homo sapiens		EXP054247	725	normal	Q9UL18	PC3(bone mets prostate adenocarcinoma)	NULL
EXP054249	anti-Ago2 (Wako, 4G8)	Homo sapiens		EXP054247	725	normal	Q9UKV8	PC3(bone mets prostate adenocarcinoma)	NULL
EXP054250	anti-BRCA1 (rabbit polyclonal I-20, Santa Cruz, sc646)	Homo sapiens		NULL	583	normal	P38398	MCF10A (breast epithelial cells)	NULL
EXP054251	anti-PALB2 (rabbit polyclonal, Bethyl, A301-246A)	Homo sapiens		NULL	583	normal	Q86YC2	MCF10A (breast epithelial cells)	NULL
EXP054252	anti-BRCA1 (mouse monoclonal D-9)	Homo sapiens		NULL	583	normal	P38398	MCF10A (breast epithelial cells)	NULL
EXP054253	rabbit IgG (Santa Cruz, sc-2027)	Homo sapiens	Treatment: none;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054254	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: none;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	NULL
EXP054255	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: EGF 100ng/ml stimulation for 20 mins;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	NULL
EXP054256	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: doxycycline 1microgr/ml 72hrs;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	NULL
EXP054257	anti-AFF4 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Genotype: depletion of INTS11; Treatment: doxycycline 1microgr/ml 72hrs and EGF stimulation for 20 minutes with 100ng/ml;	EXP054253	78	normal	Q9UHB7	HeLa (cervical adenocarcinoma)	NULL
EXP054258	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: none;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	NULL
EXP054259	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: EGF 100ng/ml stimulation for 20 mins;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	NULL
EXP054260	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Treatment: doxycycline 1microgr/ml 72hrs;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	NULL
EXP054261	anti-ELL2 (non-commercial rabbit, PMID 20159561)	Homo sapiens	Genotype: depletion of INTS11; Treatment: doxycycline 1microgr/ml 72hrs and EGF stimulation for 20 minutes with 100ng/ml;	EXP054253	78	normal	O00472	HeLa (cervical adenocarcinoma)	NULL
EXP054262	anti-INTS11 (rabbit polyclonal, Bethyl, A301-274A)	Homo sapiens	Genotype: wildtype; Treatment: none;	EXP054253	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	NULL
EXP054263	anti-INTS11 (rabbit polyclonal, Bethyl, A301-274A)	Homo sapiens	Genotype: wildtype; Treatment: EGF stimulation 100ng/ml for 20 mins;	EXP054253	78	normal	Q5TA45	HeLa (cervical adenocarcinoma)	NULL
EXP054264	none	Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP054265	anti-ARRB1	Homo sapiens	Treatment: serum starvation for 36 hours; Cell type: NSCLC (Non-Small Cell Lung Carcinoma); Passage: 4;	EXP054264	38	normal	P49407	A549 (lung carcinoma)	NULL
EXP054266	anti-ARRB1	Homo sapiens	Treatment: serum starvation for 36 hours and stimulated with 1 uM nicotine for 24 hours; Cell type: NSCLC; Passage: 4;	EXP054264	38	normal	P49407	A549 (lung carcinoma)	NULL
EXP054267	none	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	chip_control	NULL	BF (human fibroblasts)	NULL
EXP054268	none	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	chip_control	NULL	BF (human fibroblasts)	NULL
EXP054269	none	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	chip_control	NULL	BF (human fibroblasts)	NULL
EXP054270	none	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP054271	none	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP054272	none	Homo sapiens	Tissue: normal foreskin; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP054273	anti-CBX6 (MRO19, in house rabbit polyclonal)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	normal	O95503	BF (human fibroblasts)	NULL
EXP054274	anti-CBX7 (AB-21873, ABCAM)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	normal	O95931	BF (human fibroblasts)	NULL
EXP054275	anti-CBX8 (A300-882a, BETHYL)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	NULL	2624	normal	Q9HC52	BF (human fibroblasts)	NULL
EXP054276	anti-RING1 (2820 from Cell Signalling Lab, LRI)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054268	2624	normal	Q06587	BF (human fibroblasts)	NULL
EXP054277	anti-RING2 (Mouse Mab from H. Koseki)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054269	2624	normal	Q92506	BF (human fibroblasts)	NULL
EXP054278	anti-CBX6 (MRO19 - in house rabbit polyclonal)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054270	2599	normal	O95503	Hs68 (Canavan disease)	NULL
EXP054279	anti-CBX7 (AB-21873, ABCAM)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054270	2599	normal	A0AVK6	Hs68 (Canavan disease)	NULL
EXP054280	anti-CBX8 (A300-882a, BETHYL)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054270	2599	normal	Q9HC52	Hs68 (Canavan disease)	NULL
EXP054281	anti-RING1 (2820 from Cell Signalling Lab, LRI)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054271	2599	normal	Q06587	Hs68 (Canavan disease)	NULL
EXP054282	anti-RING2 (Mouse Mab from H. Koseki)	Homo sapiens	Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054271	2599	normal	Q92506	Hs68 (Canavan disease)	NULL
EXP054283	anti-CBX7 (AB-21873, ABCAM)	Homo sapiens	Tissue: normal foreskin; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054272	2599	normal	O95931	Hs68 (Canavan disease)	NULL
EXP054284	anti-CBX8 (A300-882a, BETHYL)	Homo sapiens	Tissue: normal foreskin; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA;	EXP054272	2599	normal	Q9HC52	Hs68 (Canavan disease)	NULL
EXP054285	none (input)	Homo sapiens	Treatment: none;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP054286	control IgG	Homo sapiens	Treatment: none;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP054287	none (input)	Homo sapiens	Treatment: UV- irradiated with 400 J/m2;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP054288	none (input)	Homo sapiens	Genotype: stable SIRT3 knockdown, retroviral expression of shRNAs against SIRT3; Treatment: shRNAs against SIRT3;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP054289	SIRT3 (Santa Cruz, P-19, #L0409)	Homo sapiens	Treatment: none;	EXP054285	848	normal	Q9NTG7	U2OS (osteosarcoma)	NULL
EXP054290	SIRT3 (Santa Cruz, P-19, #L0409)	Homo sapiens	Treatment: UV- irradiated with 400 J/m2;	EXP054285	848	normal	Q9NTG7	U2OS (osteosarcoma)	NULL
EXP054291	SIRT3 (Santa Cruz, P-19, #L0409)	Homo sapiens	Genotype: stable SIRT3 knockdown, retroviral expression of shRNAs against SIRT3; Treatment: shRNAs against SIRT3;	EXP054288	848	normal	Q9NTG7	U2OS (osteosarcoma)	NULL
EXP054292	V5-Agarose	Homo sapiens	Genotype: V5 vector; 	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054293	V5-Agarose (Sigma Aldrich: 021M4839)	Homo sapiens	Treatment: V5-MBD2;	EXP054292	78	normal	Q9UBB5	HeLa (cervical adenocarcinoma)	NULL
EXP054294	V5-Agarose (Sigma Aldrich: 021M4839)	Homo sapiens	Treatment: V5-MBD3;	EXP054292	78	normal	O95983	HeLa (cervical adenocarcinoma)	NULL
EXP054295	none	Homo sapiens	PAssage: 16; Sex: male; 	NULL	2625	chip_control	NULL	HGFDFN168 (forearm skin biopsy, fibroblasts)	NULL
EXP054296	none	Homo sapiens	PAssage: 16; Sex: male; 	NULL	2625	chip_control	NULL	HGFDFN168 (forearm skin biopsy, fibroblasts)	NULL
EXP054297	none	Homo sapiens	PAssage: 16; Sex: male; 	NULL	2626	chip_control	NULL	HGADFN167 (primary fibroblasts with Hutchinson-Gilford progeria syndrome)	NULL
EXP054298	none	Homo sapiens	PAssage: 16; Sex: male; 	NULL	2626	chip_control	NULL	HGADFN167 (primary fibroblasts with Hutchinson-Gilford progeria syndrome)	NULL
EXP054299	anti-lamin A/C (Millipore, MAB3211 )	Homo sapiens	PAssage: 16; Sex: male; 	EXP054295	2625	normal	P02545	HGFDFN168 (forearm skin biopsy, fibroblasts)	NULL
EXP054300	anti-lamin A/C N18 (Santa Cruz, sc-6215)	Homo sapiens	PAssage: 16; Sex: male; 	EXP054296	2625	normal	P02545	HGFDFN168 (forearm skin biopsy, fibroblasts)	NULL
EXP054301	anti-lamin A/C (Millipore, MAB3211 )	Homo sapiens	PAssage: 16; Sex: male; 	EXP054297	2626	normal	P02545	HGADFN167 (primary fibroblasts with Hutchinson-Gilford progeria syndrome)	NULL
EXP054302	anti-lamin A/C N18 (Santa Cruz, sc-6215)	Homo sapiens	PAssage: 16; Sex: male; 	EXP054298	2626	normal	P02545	HGADFN167 (primary fibroblasts with Hutchinson-Gilford progeria syndrome)	NULL
EXP054303		Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	NULL	867	chip_control	NULL	WI-38 (lung fibroblasts)	NULL
EXP054304		Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	NULL	867	chip_control	NULL	WI-38 (lung fibroblasts)	NULL
EXP054305	anti-SUMO2	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	P61956	WI-38 (lung fibroblasts)	NULL
EXP054306	anti-UBC9	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	P63279	WI-38 (lung fibroblasts)	NULL
EXP054307	anti-SUMO2	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	P61956	WI-38 (lung fibroblasts)	NULL
EXP054308	anti-UBC9	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	P63279	WI-38 (lung fibroblasts)	NULL
EXP054309	anti-PIASy	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	Q8N2W9	WI-38 (lung fibroblasts)	NULL
EXP054310	anti-PIASy	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	Q8N2W9	WI-38 (lung fibroblasts)	NULL
EXP054311	anti-SUMO1	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-empty vector; 	EXP054303	867	normal	P63165	WI-38 (lung fibroblasts)	NULL
EXP054312	anti-SUMO1	Homo sapiens	Chatacteristic: Proliferative; Treatment: infected with pBABE-puro-H-RasG12V; 	EXP054304	867	normal	P63165	WI-38 (lung fibroblasts)	NULL
EXP054313	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	NULL
EXP054314	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054315	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 50nM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054316	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 5nM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054317	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 5uM JQ1 treatment for 6hr; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054318	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054319	anti-Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	NULL
EXP054320	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	849	normal	O60885	U87 (glioblastoma)	NULL
EXP054321	anti-Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 500nM JQ1 treatment for 6hr; 	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	NULL
EXP054322	anti-Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 500nM JQ1 treatment for 6hr; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	NULL
EXP054323	anti-Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 0.05% DMSO for 6h;	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	NULL
EXP054324	Anti-EED (Millipore, cat# 05-1320, Lot# NG1841057)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	O75530	DU145 (prostate carcinoma)	NULL
EXP054325	Anti-EED (Millipore, cat# 05-1320, Lot# NG1841057)	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	O75530	DU145 (prostate carcinoma)	NULL
EXP054326	Anti-RING1A (rabbit, Cell Signaling, cat# 2820, lot# 1)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	Q06587	DU145 (prostate carcinoma)	NULL
EXP054327	Anti-RING1A (rabbit, Cell Signaling, cat# 2820, lot# 1)	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	Q06587	DU145 (prostate carcinoma)	NULL
EXP054328	Anti-RING1B (rabbit, Cell Signaling, cat# 5694, lot# 1)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	Q99496	DU145 (prostate carcinoma)	NULL
EXP054329	Anti-RING1B (rabbit, Cell Signaling, cat# 5694, lot# 1)	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	Q99496	DU145 (prostate carcinoma)	NULL
EXP054330	Anti-BMI1 (rabbit, Cell Signaling, cat# 6964, lot# 1)	Homo sapiens	Genotype: control (wildtype);	NULL	223	normal	P35226	DU145 (prostate carcinoma)	NULL
EXP054331	Anti-BMI1 [rabbit, Cell Signaling, cat# 6964, lot# 1]	Homo sapiens	Genotype: EED knockout;	NULL	223	normal	P35226	DU145 (prostate carcinoma)	NULL
EXP054332	p300 (rabbit polyclonal anti?p300 (C?20), Santa Cruz Biotechnology, catalog number = SC-585, Lot number = L2704)	Mus musculus	Developmental stage: E11.5; Strain: 129/C57BL/6; 	NULL	313	normal	B2RWS6	forebrain	NULL
EXP054333	acCBP/p300 (rabbit polyclonal, Cell Signaling Technology, catalog number = 4771,  lot number = 2)	Mus musculus	Developmental stage: P0; Strain: 129/C57BL/6; 	NULL	193	normal	B2RWS6	cortex	NULL
EXP054334	acCBP/p300 (rabbit polyclonal, Cell Signaling Technology, catalog number = 4771,  lot number = 2)	Homo sapiens	Developmental stage: gestational week 20; 	NULL	2627	normal	Q09472	fetal cortex	NULL
EXP054335	CENP-A (Enzo life science, ADI-KAM-CC006-E)	Homo sapiens	Genotype: CenH3 over-expression; 	NULL	423	normal	P49450	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054336	CENP-A (Enzo life science, ADI-KAM-CC006-E)	Homo sapiens	Genotype: wildtype; 	NULL	423	normal	P49450	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054337	anti-Flag M2 Agarose beads (Sigma Aldrich)	Homo sapiens	Genotype: CenH3 over-expression; 	NULL	423	normal	P49450	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054338	Anti-c-Myc (Sigma, Cat#: A7470-1ML, Agarose Affinity Gel)	Homo sapiens	Genotype: empty vector;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP054339	Anti-c-Myc (Sigma, Cat#: A7470-1ML, Agarose Affinity Gel)	Homo sapiens	Genotype: wildtype Myc-Idax;	EXP054338	10	normal	Q9H2H0	HEK293T (embryonic kidney)	NULL
EXP054340	None	Homo sapiens	Passage: 15-18; 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054341	anti-TAF3 (Strategic Diagnostics,SDIX)	Homo sapiens	Passage: 15-18; 	EXP054340	417	normal	Q5VWG9	HCT-116 (colon carcinoma)	NULL
EXP054342	anti-AR (N20) (Santa Cruz Biotechnology, Santa Cruz, CA)	Homo sapiens	Treatment: vehicle, control;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP054343	anti-AR (N20) (Santa Cruz Biotechnology, Santa Cruz, CA)	Homo sapiens	Treatment: 10 nm DHT;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP054344	Mtg16 ( santa cruz biotech, C20)	Homo sapiens		EXP032594	147	normal	O75081	CAL-1 (plasmacytoid dendritic neoplasm)	NULL
EXP054345	IgG (control IP)	Mus musculus	Tissue: bone marrow; Age: 8- to 12-wk-old; Strain: mix strain;	NULL	2628	chip_control	NULL	CD71+Ter119+ cells (facs sorted)	NULL
EXP054346	none (total input control)	Mus musculus	Tissue: bone marrow; Age: 8- to 12-wk-old; Strain: mix strain;	NULL	2628	chip_control	NULL	CD71+Ter119+ cells (facs sorted)	NULL
EXP054347	anti-KAP1 (aa 20â€“418, RBCC, F. R. Santoni de Sio et al.,. Blood 119, 4675, 2012)	Mus musculus	Tissue: bone marrow; Age: 8- to 12-wk-old; Strain: mix strain;	EXP054346	2628	normal	Q62318	CD71+Ter119+ cells (facs sorted)	NULL
EXP054348		Homo sapiens	Genotype: RAD21cv; Treatment: TEV Treated, transfected with a plasmid expressing HRV protease; 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP054349	anti-Smc3	Homo sapiens	Genotype: RAD21cv; Treatment: TEV Treated, transfected with a plasmid expressing HRV protease; 	EXP054348	10	normal	Q9UQE7	HEK293T (embryonic kidney)	NULL
EXP054350	INO80 (Abcam, ab118787, lot GR69872-4)	Homo sapiens	Treatment: incubatedÂ withÂ IL-2 with anti-CD3 and anti-CD28 antibodies;	NULL	881	normal	Q9ULG1	CD4+ T-cells	NULL
EXP054351	SRCAP (Abcam, ab99408, lot GR58857-1)	Homo sapiens	Treatment: incubatedÂ withÂ IL-2 with anti-CD3 and anti-CD28 antibodies;	NULL	985	normal	Q6ZRS2	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP054352	None	Homo sapiens		NULL	2629	chip_control	NULL	PDNC4 (fibroblast)	NULL
EXP054353	None	Homo sapiens		NULL	2630	chip_control	NULL	IMS13q (lymphoblast)	NULL
EXP054354	None	Homo sapiens		NULL	2631	chip_control	NULL	MS4221 (lymphoblast)	NULL
EXP054355	CENP-A (Abcam, ab13939)	Homo sapiens		EXP054352	2629	normal	P49450	PDNC4 (fibroblast)	NULL
EXP054356	CENP-A (Abcam, ab13939)	Homo sapiens		EXP054353	2630	normal	P49450	IMS13q (lymphoblast)	NULL
EXP054357	CENP-A (Abcam, ab13939)	Homo sapiens		EXP054354	2631	normal	P49450	MS4221 (lymphoblast)	NULL
EXP054358	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054359	IgG  (sc-2027, santa cruz, -Lot c2712)	Homo sapiens	Treatment: none; 	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054360	E2F4 (sc-866, santa cruz, Lot-A2804)	Homo sapiens	Treatment:  treated with 100nm Tamoxifen for 48hrs;	EXP054358	113	normal	Q16254	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054361	E2F4 (sc-866, santa cruz, Lot-A2804)	Homo sapiens	Treatment: treated with 100nm ICI 182780 for 48hrs;	EXP054358	113	normal	Q16254	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054362	ER; sc-534 (santa cruz) Lot-(HC-20)	Homo sapiens	MCF7 xenograft tumour in mouse	EXP054358	113	normal	O00321	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054363	GREB1 (ab72999, abcam, Lot-ab12563)	Homo sapiens	Treatment: xenograft tumour in mouse;	EXP054358	113	normal	Q4ZG55	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054364	COT2 (R&D systems ,PP-H7147-00, Lot A2)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	P24468	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054365	KLF4 (R&D systems, AF3640, Lot xvh0310101)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	O43474	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054366	RXRA  (sc-553, santa cruz, Lot E0411)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	P19793	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054367	TLE3 (ab94972, abcam, Lot GR54354-1)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	Q04726	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054368	ER (sc-534, santa cruz, Lot-HC-20)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054369	GREB1 (ab72999, abcam, Lot-ab12563)	Homo sapiens	Treatment: none; 	EXP054358	113	normal	Q4ZG55	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054370	GREB1 (ab72999, abcam, Lot-ab12563)	Homo sapiens	Treatment:  4 hours of 100nM ICI 182780;	EXP054358	113	normal	Q4ZG55	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054371	none, input	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054372	none, input	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP054373	anti-MBD3 antibody (Abcam; ab91458)	Homo sapiens		EXP054371	113	normal	O95983	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054374	anti-MBD3 antibody (Abcam; ab91458)	Homo sapiens		EXP054372	2301	normal	O95983	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP054375	none	Homo sapiens		NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP054376	anti-XPB (Rabbit Polyclonal, Novus Biologicals, NB100-61060)	Homo sapiens		EXP054375	1008	normal	P19447	HT1080 (fibrosarcoma)	NULL
EXP054377	anti-XPD (Rabbit Polyclonal, Santa Cruz Biotechnology, sc-20696)	Homo sapiens		EXP054375	1008	normal	P18074	HT1080 (fibrosarcoma)	NULL
EXP054378		Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054379	ASF1a (equimolar mixture of Ms mAbs MPH7, MPB1, MPD5, Ambagala et al., 2009)	Homo sapiens		EXP054378	78	normal	Q9Y294	HeLa (cervical adenocarcinoma)	NULL
EXP054380	HIRA (equimolar mixture of Ms mAbs WC15, WC19, WC117, WC 119, Hall et al., 2001)	Homo sapiens		EXP054378	78	normal	P54198	HeLa (cervical adenocarcinoma)	NULL
EXP054381	UBN1(Rb pAb, Banumathy et al., 2009)	Homo sapiens		EXP054378	78	normal	Q9NPG3	HeLa (cervical adenocarcinoma)	NULL
EXP054382	none (input)	Homo sapiens	Developmental stage: asynchronous population;	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054383	none (input)	Homo sapiens	Developmental stage: G1 phase;	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054384	IgG control	Homo sapiens	Developmental stage: G1 phase;	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054385	none (input)	Homo sapiens	Developmental stage: S phase;	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054386	IgG control	Homo sapiens	Developmental stage: S phase;	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054387	none (input)	Mus musculus		NULL	2632	chip_control	NULL	pachynema cells	NULL
EXP054388	none (input)	Mus musculus		NULL	2633	chip_control	NULL	spermatids	NULL
EXP054389	SFMBT1 (custom rb4731, LOT#110518)	Homo sapiens	Developmental stage: asynchronous population;	EXP054382	423	normal	Q9UHJ3	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054390	LSD1 (custom protein A purified)	Homo sapiens	Developmental stage: asynchronous population;	EXP054382	423	normal	O60341	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054391	CoREST (Bethyl, A300-130A, LOT#A300-130A-1)	Homo sapiens	Developmental stage: asynchronous population;	EXP054382	423	normal	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054392	SFMBT1 (custom rb4731, LOT#110518)	Homo sapiens	Developmental stage: G1 phase;	EXP054383	423	normal	Q9UHJ3	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054393	LSD1 (custom protein A purified)	Homo sapiens	Developmental stage: G1 phase;	EXP054383	423	normal	O60341	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054394	CoREST (Bethyl, A300-130A, LOT#A300-130A-1)	Homo sapiens	Developmental stage: G1 phase;	EXP054383	423	normal	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054395	SFMBT1 (custom rb4731, LOT#110518)	Homo sapiens	Developmental stage: S phase;	EXP054385	423	normal	Q9UHJ3	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054396	LSD1 (custom protein A purified)	Homo sapiens	Developmental stage: S phase;	EXP054385	423	normal	O60341	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054397	CoREST (Bethyl, A300-130A, LOT#A300-130A-1)	Homo sapiens	Developmental stage: S phase;	EXP054385	423	normal	Q9UKL0	HeLa S3 (cervical adenocarcinoma)	NULL
EXP054398	SFMBT1 (custom rb1219, LOT#110518)	Mus musculus		EXP054387	2632	normal	Q9JMD1	pachynema cells	NULL
EXP054399	LSD1 (custom protein A purified)	Mus musculus		EXP054387	2632	normal	Q6ZQ88	pachynema cells	NULL
EXP054400	SFMBT1 (custom rb1219, LOT#110518)	Mus musculus		EXP054388	2633	normal	Q9JMD1	spermatids	NULL
EXP054401	LSD1 (custom protein A purified)	Mus musculus		EXP054388	2633	normal	Q6ZQ88	spermatids	NULL
EXP054402	Normal Mouse IgG; Upstate (cat#12-371)	Homo sapiens		NULL	2634	chip_control	NULL	HuRef (Lymphoblast)	NULL
EXP054403	CENPA (Stressgen, KAM-CC006)	Homo sapiens		EXP054402	2634	normal	P49450	HuRef (Lymphoblast)	NULL
EXP054404	PHF6 (Bethyl, A301-451A)	Homo sapiens		NULL	509	normal	Q8IWS0	Jurkat (T-cells)	NULL
EXP054405	None	Homo sapiens		NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP054406	None	Homo sapiens	Treatment: Bioruptor 20 cycles-fix12 min; 	NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP054407	none	Homo sapiens	Treatment: none; 	NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP054408	Med1/TRAP220 (Bethyl, A303-876A)	Homo sapiens	Treatment: bioruptor 20 cycles-3x10*6 cells, 12 min fix; 	EXP054406	618	normal	O95243	MM1.S (plasma cell myeloma)	NULL
EXP054409	Brd4 (Bethyl, cgA301-985A-1)	Homo sapiens	Treatment: none; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054410	Brd4 (Bethyl, A301-985A)	Homo sapiens		NULL	1573	normal	O60885	SK-MEL-5 (Cutaneous melanoma)	NULL
EXP054411	Cdk7 (Bethyl A300-405A)	Homo sapiens	Treatment: none; 	EXP054407	618	normal	P50613	MM1.S (plasma cell myeloma)	NULL
EXP054412	None	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054413	Normal rabbit IgG	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054414	Anti-SMCHD1 (Rabbit polyclonal IgG, Sigma-Aldrich, HPA039441, #R36066)	Homo sapiens		EXP054412	417	normal	A6NHR9	HCT-116 (colon carcinoma)	NULL
EXP054415	anti-FANCD2	Homo sapiens	Treatment: none; 	NULL	10	normal	Q9BXW9	HEK293T (embryonic kidney)	NULL
EXP054416	anti-FANCD2	Homo sapiens	Treatment: UV treatment (30J);	NULL	10	normal	Q9BXW9	HEK293T (embryonic kidney)	NULL
EXP054417	none	Homo sapiens	Passage: p8; 	NULL	2635	chip_control	NULL	primary aortic valve endothelial cells	NULL
EXP054418	anti-myc tag (Abcam, ab9132)	Homo sapiens	Passage: p8; 	EXP054417	2635	normal	P46531	primary aortic valve endothelial cells	NULL
EXP054419	homemade	Homo sapiens		NULL	774	chip_control	NULL	RKO (colon carcinoma cell)	NULL
EXP054420	anti-ING2 (epitomics, 3683-1)	Homo sapiens		EXP054419	774	normal	Q9H160	RKO (colon carcinoma cell)	NULL
EXP054421	anti-ING5 (abcam, ab96851)	Homo sapiens		EXP054419	774	normal	Q8WYH8	RKO (colon carcinoma cell)	NULL
EXP054422	anti-brpf2 (abcam, ab71877)	Homo sapiens		EXP054419	774	normal	O95696	RKO (colon carcinoma cell)	NULL
EXP054423	none (input)	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054424	none (input)	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054425	none (input)	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054426	none (input)	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054427	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054424	489	normal	P51608	IMR90 (lung fibroblasts)	NULL
EXP054428	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054425	417	normal	P51608	HCT-116 (colon carcinoma)	NULL
EXP054429	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054426	417	normal	P51608	HCT-116 (colon carcinoma)	NULL
EXP054430	MeCP2 (Abcam; ab2828)	Homo sapiens		EXP054423	489	normal	P51608	IMR90 (lung fibroblasts)	NULL
EXP054431	None	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054432	anti-human BDP1 (CS914, raised against peptide CSDRYRIYKAQK, like CS913, Schramm, 2000 #97)	Homo sapiens		EXP054431	489	normal	A6H8Y1	IMR90 (lung fibroblasts)	NULL
EXP054433	ZMYND110 (home-made)	Homo sapiens	Genotype: wildtype; 	NULL	848	bio_control	Q15326	U2OS (osteosarcoma)	NULL
EXP054434	ZMYND11, home-made	Homo sapiens	Genotype: shRNA control;	NULL	848	bio_control	Q15326	U2OS (osteosarcoma)	NULL
EXP054435	ZMYND11, home-made	Homo sapiens	Genotype: shZMYND11;	NULL	848	normal	Q15326	U2OS (osteosarcoma)	NULL
EXP054436	S2P, Covance MMS-129R	Homo sapiens	Genotype: shCTRL;	NULL	848	bio_control	O43462	U2OS (osteosarcoma)	NULL
EXP054437	S2P, Covance MMS-129R	Homo sapiens	Genotype: shZMYND11;	NULL	848	normal	O43462	U2OS (osteosarcoma)	NULL
EXP054438	Normal Rabbit IgG (Cell Signaling #2729)	Homo sapiens		NULL	455	chip_control	NULL	HUES64 (embryonic stem cells)	NULL
EXP054439	Normal Rabbit IgG (Cell Signaling #2729)	Homo sapiens		NULL	2636	chip_control	NULL	HUES6-derived neural progenitor cells	NULL
EXP054440	Normal Rabbit IgG (Cell Signaling #2729)	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054441	Nup98 (Cell Signaling #2292 )	Homo sapiens		EXP054438	455	normal	P52948	HUES64 (embryonic stem cells)	NULL
EXP054442	Nup98 (Cell Signaling #2292 )	Homo sapiens		EXP054439	2636	normal	P52948	HUES6-derived neural progenitor cells	NULL
EXP054443	Nup98 (Cell Signaling #2292 )	Homo sapiens		NULL	2637	normal	P52948	HUES6-derived neurons	NULL
EXP054444	Nup98 (Cell Signaling #2292 )	Homo sapiens		EXP054440	489	normal	P52948	IMR90 (lung fibroblasts)	NULL
EXP054445	Nup98 (Cell Signaling #2598)	Homo sapiens		EXP054440	489	normal	P52948	IMR90 (lung fibroblasts)	NULL
EXP054446	none	Homo sapiens	Source: Five pooled donors; 	NULL	1531	chip_control	NULL	regulatory T cell	NULL
EXP054447	anti-beta-catenin (Cell Signaling, #9562)	Homo sapiens	Source: Five pooled donors; 	EXP054446	1531	normal	P35222	regulatory T cell	NULL
EXP054448	None	Homo sapiens	Treatment: 0.05% DMSO for 6 hours; 	NULL	384	chip_control	NULL	NCI-H2171 (small cell lung carcinoma)	NULL
EXP054449	None	Homo sapiens	Treatment: 500nM JQ1 for 6 hours; 	NULL	384	chip_control	NULL	NCI-H2171 (small cell lung carcinoma)	NULL
EXP054450	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6 hours; 	NULL	849	normal	O60885	U87 (glioblastoma)	NULL
EXP054451	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 for 6 hours; 	NULL	849	normal	O60885	U87 (glioblastoma)	NULL
EXP054452	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 5nM JQ1 for 6 hours; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	NULL
EXP054453	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 50nM JQ1 for 6 hours; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	NULL
EXP054454	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: 5000nM JQ1 for 6 hours; 	NULL	618	normal	O95243	MM1.S (plasma cell myeloma)	NULL
EXP054455	Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 50nM JQ1 for 6 hours; 	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	NULL
EXP054456	Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: 5000nM JQ1 for 6 hours; 	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	NULL
EXP054457	IRF4 (Santa Cruz, SC-6059)	Homo sapiens		NULL	618	normal	Q15306	MM1.S (plasma cell myeloma)	NULL
EXP054458	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 150nM JQ1 for 6 hours; 	NULL	618	normal	O60885	MM1.S (plasma cell myeloma)	NULL
EXP054459	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6 hours; 	EXP054448	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	NULL
EXP054460	Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 for 6 hours; 	EXP054449	384	normal	O60885	NCI-H2171 (small cell lung carcinoma)	NULL
EXP054461	IgG (SC2027)	Homo sapiens	Treatment: no 4OHT;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054462	IgG (SC2027)	Homo sapiens	Treatment: no 4OHT;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054463	IgG (SC2027)	Homo sapiens	Treatment: no 4OHT;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054464	IgG (SC2027)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054465	IgG (SC2027)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054466	IgG (SC2027)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054467		Homo sapiens	Treatment: no 4OHT;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054468		Homo sapiens	Treatment: no 4OHT;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054469		Homo sapiens	Treatment: no 4OHT;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054470		Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054471		Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054472		Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054473	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: no 4OHT;	EXP054467	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054474	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: no 4OHT;	EXP054468	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054475	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: no 4OHT;	EXP054469	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054476	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	EXP054470	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054477	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	EXP054471	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054478	anti-LMNB1 (abcam, cat# AB16084)	Homo sapiens	Treatment: 100 nM 4OHT for 6 days; 	EXP054472	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054479		Homo sapiens	Genotype: wildtype; 	NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP054480		Homo sapiens	Genotype: CSB{delta}N1;	NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP054481	anti-CSB	Homo sapiens	Genotype: wildtype; 	EXP054479	2360	normal	Q03468	fibroblasts	NULL
EXP054482	anti-CSB	Homo sapiens	Genotype: CSB{delta}N1;	EXP054480	2360	normal	Q03468	fibroblasts	NULL
EXP054483	IgG antibody (Jackson ImmunoResearch, 111-035-144)	Homo sapiens	Treatment: shRNA against BRD4shRNA against BRD4;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP054484	IgG antibody	Homo sapiens	Treatment: shRNA against BRD4shRNA against BRD4;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP054485	antibody against BRD4 (Abcam, ab46199)	Homo sapiens	Treatment: shRNA against BRD4shRNA against BRD4;	EXP054483	10	normal	O60885	HEK293T (embryonic kidney)	NULL
EXP054486	antibody against BRD4 (Abcam, ab75898)	Homo sapiens	Treatment: shRNA against BRD4shRNA against BRD4;	EXP054484	10	normal	O60885	HEK293T (embryonic kidney)	NULL
EXP054487	None	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP054488	None	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP054489	Cdk7 (Abcam, AB9516)	Homo sapiens		EXP054487	509	normal	P50613	Jurkat (T-cells)	NULL
EXP054490	Cdk7 (Bethyl, A300-405A)	Homo sapiens	Treatment: Treated with DMSO for 6 hours;	NULL	618	normal	P50613	MM1.S (plasma cell myeloma)	NULL
EXP054491	Cdk9 (Santa Cruz, SC-484)	Homo sapiens	Treatment: Treated with DMSO for 6 hours;	NULL	618	normal	P50750	MM1.S (plasma cell myeloma)	NULL
EXP054492	Input	Homo sapiens		NULL	339	chip_control	NULL	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054493	Input	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054494	Input	Homo sapiens		NULL	2640	chip_control	NULL	GM12890 (Lymphoblastoid Cell Lines)	NULL
EXP054495	Input	Homo sapiens		NULL	357	chip_control	NULL	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP054496	Input	Homo sapiens		NULL	358	chip_control	NULL	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP054497	Input	Homo sapiens		NULL	2643	chip_control	NULL	GM18486 (Lymphoblastoid Cell Lines)	NULL
EXP054498	Input	Homo sapiens		NULL	362	chip_control	NULL	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054499	Input	Homo sapiens		NULL	363	chip_control	NULL	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP054500	Input	Homo sapiens		NULL	364	chip_control	NULL	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP054501	Input	Homo sapiens		NULL	365	chip_control	NULL	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054502	Input	Homo sapiens		NULL	366	chip_control	NULL	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054503	Input	Homo sapiens		NULL	367	chip_control	NULL	GM19238 (female B-cells lymphoblastoid cell lines)	NULL
EXP054504	Input	Homo sapiens		NULL	368	chip_control	NULL	GM19239 (male B-cells lymphoblastoid cell line)	NULL
EXP054505	Input	Homo sapiens		NULL	369	chip_control	NULL	GM19240 (B cells Lymphoblastoid Cell Lines)	NULL
EXP054506	Input	Homo sapiens		NULL	2652	chip_control	NULL	GM02255 (Lymphoblastoid Cell Lines)	NULL
EXP054507	Input	Homo sapiens		NULL	2653	chip_control	NULL	2588 (Lymphoblastoid Cell Lines)	NULL
EXP054508	Input	Homo sapiens		NULL	2654	chip_control	NULL	GM02610 (Lymphoblastoid Cell Lines)	NULL
EXP054509	Input	Homo sapiens		NULL	2655	chip_control	NULL	GM02630 (Fanconi anemi)	NULL
EXP054510	Input	Homo sapiens		NULL	2656	chip_control	NULL	MS-1 (Small cell lung carcinoma)	NULL
EXP054511	CTCF	Homo sapiens		EXP054492	339	normal	P49711	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054512	SA1	Homo sapiens		EXP054492	339	normal	Q8WVM7	GM10847 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054513	CTCF	Homo sapiens		EXP054493	356	normal	P49711	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054514	SA1	Homo sapiens		EXP054493	356	normal	Q8WVM7	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054515	CTCF	Homo sapiens		EXP054494	2640	normal	P49711	GM12890 (Lymphoblastoid Cell Lines)	NULL
EXP054516	SA1	Homo sapiens		EXP054494	2640	normal	Q8WVM7	GM12890 (Lymphoblastoid Cell Lines)	NULL
EXP054517	CTCF	Homo sapiens		EXP054495	357	normal	P49711	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP054518	SA1	Homo sapiens		EXP054495	357	normal	Q8WVM7	GM12891 (male B- cells lymphoblastoid cell line)	NULL
EXP054519	CTCF	Homo sapiens		EXP054496	358	normal	P49711	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP054520	SA1	Homo sapiens		EXP054496	358	normal	Q8WVM7	GM12892 (female B-cells lymphoblastoid cell line)	NULL
EXP054521	CTCF	Homo sapiens		EXP054497	2643	normal	P49711	GM18486 (Lymphoblastoid Cell Lines)	NULL
EXP054522	SA1	Homo sapiens		EXP054497	2643	normal	Q8WVM7	GM18486 (Lymphoblastoid Cell Lines)	NULL
EXP054523	CTCF	Homo sapiens		EXP054498	362	normal	P49711	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054524	SA1	Homo sapiens		EXP054498	362	normal	Q8WVM7	GM18505 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054525	CTCF	Homo sapiens		EXP054499	363	normal	P49711	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP054526	SA1	Homo sapiens		EXP054499	363	normal	Q8WVM7	GM18526 (B â€“ cells Lymphoblastoid Cell Lines)	NULL
EXP054527	CTCF	Homo sapiens		EXP054500	364	normal	P49711	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP054528	SA1	Homo sapiens		EXP054500	364	normal	Q8WVM7	GM18951 (B-cells Lymphoblastoid Cell Lines)	NULL
EXP054529	CTCF	Homo sapiens		EXP054501	365	normal	P49711	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054530	SA1	Homo sapiens		EXP054501	365	normal	Q8WVM7	GM19099 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054531	CTCF	Homo sapiens		EXP054502	366	normal	P49711	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054532	SA1	Homo sapiens		EXP054502	366	normal	Q8WVM7	GM19193 (female B-cells Lymphoblastoid Cell Lines)	NULL
EXP054533	CTCF	Homo sapiens		EXP054503	367	normal	P49711	GM19238 (female B-cells lymphoblastoid cell lines)	NULL
EXP054534	SA1	Homo sapiens		EXP054503	367	normal	Q8WVM7	GM19238 (female B-cells lymphoblastoid cell lines)	NULL
EXP054535	CTCF	Homo sapiens		EXP054504	368	normal	P49711	GM19239 (male B-cells lymphoblastoid cell line)	NULL
EXP054536	SA1	Homo sapiens		EXP054504	368	normal	Q8WVM7	GM19239 (male B-cells lymphoblastoid cell line)	NULL
EXP054537	CTCF	Homo sapiens		EXP054505	369	normal	P49711	GM19240 (B cells Lymphoblastoid Cell Lines)	NULL
EXP054538	SA1	Homo sapiens		EXP054505	369	normal	Q8WVM7	GM19240 (B cells Lymphoblastoid Cell Lines)	NULL
EXP054539	CTCF	Homo sapiens		EXP054506	2652	normal	P49711	GM02255 (Lymphoblastoid Cell Lines)	NULL
EXP054540	SA1	Homo sapiens		EXP054506	2652	normal	Q8WVM7	GM02255 (Lymphoblastoid Cell Lines)	NULL
EXP054541	CTCF	Homo sapiens		EXP054507	2653	normal	P49711	2588 (Lymphoblastoid Cell Lines)	NULL
EXP054542	SA1	Homo sapiens		EXP054507	2653	normal	Q8WVM7	2588 (Lymphoblastoid Cell Lines)	NULL
EXP054543	CTCF	Homo sapiens		EXP054508	2654	normal	P49711	GM02610 (Lymphoblastoid Cell Lines)	NULL
EXP054544	SA1	Homo sapiens		EXP054508	2654	normal	Q8WVM7	GM02610 (Lymphoblastoid Cell Lines)	NULL
EXP054545	CTCF	Homo sapiens		EXP054509	2655	normal	P49711	GM02630 (Fanconi anemi)	NULL
EXP054546	SA1	Homo sapiens		EXP054509	2655	normal	Q8WVM7	GM02630 (Fanconi anemi)	NULL
EXP054547	CTCF	Homo sapiens		EXP054510	2656	normal	P49711	MS-1 (Small cell lung carcinoma)	NULL
EXP054548	SA1	Homo sapiens		EXP054510	2656	normal	Q8WVM7	MS-1 (Small cell lung carcinoma)	NULL
EXP054549		Homo sapiens	Treatment: menadione; 	NULL	2360	chip_control	NULL	fibroblasts	NULL
EXP054550	Mouse monoclonal anti-CSB N Terminus (1B1)	Homo sapiens	Treatment: menadione; 	EXP054549	2360	normal	Q03468	fibroblasts	NULL
EXP054553	anti-p300 ( our lab,  Byun et al, Nature Comm. 3, 633, 2012)	Homo sapiens	Genotype: HSP70K71E-EGFP; 	EXP054551	421	normal	Q09472	HEK293 (embryonic kidney)	NULL
EXP054554	anti-p300 ( our lab,  Byun et al, Nature Comm. 3, 633, 2012)	Homo sapiens	Genotype: pCI1-EGFP; 	EXP054552	421	normal	Q09472	HEK293 (embryonic kidney)	NULL
EXP054555	anti-CBP  (cat# ab2832 , ABCAM)	Homo sapiens	Genotype: HSP70K71E-EGFP; 	EXP054551	421	normal	Q92793	HEK293 (embryonic kidney)	NULL
EXP054556	anti-CBP  (cat# ab2832 , ABCAM)	Homo sapiens	Genotype: pCI1-EGFP; 	EXP054552	421	normal	Q92793	HEK293 (embryonic kidney)	NULL
EXP054557	CBP (Santa Cruz, SC-369)	Mus musculus	Strain: C57BL/6-129; 	NULL	252	normal	P45481	V6.5 (embryonic stem cells)	NULL
EXP054558	MBD3 (Santa Cruz, SC-9402)	Mus musculus	Strain: C57BL/6-129; 	NULL	252	normal	Q9DA79	V6.5 (embryonic stem cells)	NULL
EXP054559	anti-Ronin (Lab Generated (Zwaka), G4275)	Mus musculus	Strain: C57BL/6-129; 	NULL	252	normal	Q9JJD0	V6.5 (embryonic stem cells)	NULL
EXP054560	anti-P300 (SC-585, Santa Cruz biotechnology)	Homo sapiens		NULL	421	normal	Q09472	HEK293 (embryonic kidney)	NULL
EXP054561	CDK9 (2316S, Cell Signaling Technology)	Homo sapiens	Treatment: siRNA empty vector; 	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP054562	CDK9 (2316S, Cell Signaling Technology)	Homo sapiens	Treatment: siRNA against JMJD6 ; 	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP054563	CDK9 (2316S, Cell Signaling Technology)	Homo sapiens	Treatment: siRNA against BRD4; 	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP054564	Janti-MJD6 (ab10526, Abcam)	Homo sapiens		NULL	78	normal	Q6NYC1	HeLa (cervical adenocarcinoma)	NULL
EXP054565	anti-Brd4 (ab46199, Abcam)	Homo sapiens		NULL	78	normal	O60885	HeLa (cervical adenocarcinoma)	NULL
EXP054566	Janti-MJD6 (ab10526, Abcam)	Homo sapiens		NULL	421	bio_control	Q6NYC1	HEK293 (embryonic kidney)	NULL
EXP054567	anti-Brd4 (ab46199, Abcam)	Homo sapiens		NULL	421	bio_control	O60885	HEK293 (embryonic kidney)	NULL
EXP054568	rabbit IgG	Homo sapiens	Genotype: HMEL-BRAF-RNF2 overexpressing; 	NULL	2657	chip_control	NULL	HMEL-BRAFV600E (human immortalized melanocytes)	NULL
EXP054569	rabbit IgG	Homo sapiens	Genotype: HMEL-BRAF-RNF2 overexpressing; Source: tumor cells;	NULL	2657	chip_control	NULL	HMEL-BRAFV600E (human immortalized melanocytes)	NULL
EXP054570	anti-V5 (Abcam ab9116, lot# 754608)	Homo sapiens	Genotype: HMEL-BRAF-RNF2 overexpressing; 	EXP054568	2657	normal	Q99496	HMEL-BRAFV600E (human immortalized melanocytes)	NULL
EXP054571	anti-V5 (Abcam ab9116, lot# 754608)	Homo sapiens	Genotype: HMEL-BRAF-RNF2 overexpressing; Source: tumor cells;	EXP054569	2657	normal	Q99496	HMEL-BRAFV600E (human immortalized melanocytes)	NULL
EXP054572	anti-LSD1 (Abcam, ab17721, lot GR79477-2)	Homo sapiens	Treatment: none; Conditions: cells were starved in phenol-red-free medium supplemented with 10% charcoal stripped FBS for 3 days	NULL	70	normal	O60341	LNCaP (prostate carcinoma)	NULL
EXP054573	anti-LSD1 (Abcam, ab17721, lot GR79477-2)	Homo sapiens	Treatment: none; Conditions: cells were starved in phenol-red-free medium supplemented with 10% charcoal stripped FBS for 3 days	NULL	71	normal	O60341	VCaP (prostate carcinoma)	NULL
EXP054574	anti-SETX	Homo sapiens	Treatment: non infected; 	NULL	38	normal	Q7Z333	A549 (lung carcinoma)	NULL
EXP054575	anti-SETX	Homo sapiens	Treatment: infected by Influenza PR8{delta}NS1;	NULL	38	normal	Q7Z333	A549 (lung carcinoma)	NULL
EXP054576		Homo sapiens		NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP054577	CIITA (Brown, JA et al. Nucleic acids research, 1998. 26:4128-36)	Homo sapiens		EXP054576	767	normal	P33076	Raji (Burkitt lymphoma)	NULL
EXP054578	CIITA (Rockland Immunochemicals, 100-401-249)	Homo sapiens		EXP054576	767	normal	P33076	Raji (Burkitt lymphoma)	NULL
EXP054579	CIITA (Diagenode, C15410062)	Homo sapiens		EXP054576	767	normal	P33076	Raji (Burkitt lymphoma)	NULL
EXP054580	SPT5 (H-300) (Santa Cruz, sc-28678)	Homo sapiens		NULL	78	normal	O00267	HeLa (cervical adenocarcinoma)	NULL
EXP054581	NELF-A (A-20) (Santa Cruz, sc-23599)	Homo sapiens		NULL	78	normal	Q9H3P2	HeLa (cervical adenocarcinoma)	NULL
EXP054582	none	Homo sapiens	Treatment: 5 days of HCMV infection;  Source: mixed patients;	NULL	166	chip_control	NULL	CD34+ hematopoietic stem cells	NULL
EXP054583	against KAP1 (aa 20â€“418, RBCC, F. R. Santoni de Sio et al.,. Blood 119, 4675, 2012)	Homo sapiens	Treatment: 5 days of HCMV infection;  Source: mixed patients;	EXP054582	166	normal	Q13263	CD34+ hematopoietic stem cells	NULL
EXP054584	Total input	Homo sapiens	Treatment: none;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054585	Total input	Homo sapiens	Treatment: 0.65 ng/ml for 60hrs PMA;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054586	PKCtheta (sc-212, SantaCruz)	Homo sapiens	Treatment: none;	EXP054584	113	normal	Q04759	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054587	PKCtheta (sc-212, SantaCruz)	Homo sapiens	Treatment: 0.65 ng/ml for 60hrs PMA;	EXP054585	113	normal	Q04759	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054588	none (input)	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054589	Lamin B1 (Abcam, catalog #ab16048, lot#953293 )	Homo sapiens		EXP054588	489	normal	P20700	IMR90 (lung fibroblasts)	NULL
EXP054590	n/a, input sample	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054591	n/a, input sample	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054592	n/a, input sample	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054593	n/a, input sample	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054594	n/a, input sample	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054595	n/a, input sample	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054596	mose monoclonal p300 (custom generated; 1A3_F8)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054597	mose monoclonal p300 (custom generated; 1F4_E10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054598	mose monoclonal p300 (custom generated; 1F4_E10)	Homo sapiens		EXP054591	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054599	mose monoclonal p300 (custom generated; 2E10_D10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054600	mose monoclonal p300 (custom generated; 2F4_A8)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054601	mose monoclonal p300 (custom generated; 2F6_F7)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054602	mose monoclonal p300 (custom generated; 3B4_G6)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054603	mose monoclonal p300 (custom generated; 3H6_B6)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054604	mose monoclonal p300 (custom generated; 4C5_A1)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054605	mose monoclonal p300 (custom generated; 5D2_A1)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054606	mose monoclonal p300 (custom generated; 5F7_C9)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054607	mose monoclonal p300 (custom generated; 7H5_F2)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054608	p300 (Santa Cruz, sc-585, E3113)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054609	p300 (Santa Cruz, sc-585, F2711)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054610	mouse monoclonal GABP (Santa Cruz, sc-28312)	Homo sapiens		NULL	356	normal	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054611	NRSF (mouse monoclonal, custom generated, Johnson et al. 2007, PMID: 17540862)	Homo sapiens		NULL	356	normal	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054612	SPI1/PU.1(Santa Cruz, sc-22805)	Homo sapiens		NULL	356	normal	P17947	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054613	Kaiso/ZBTB33 (Santa Cruz, sc-23871)	Homo sapiens		NULL	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054614	mouse monoclonal NRSF	Homo sapiens		EXP054590	356	normal	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054615	mouse monoclonal NRSF	Homo sapiens		NULL	509	normal	Q13127	Jurkat (T-cells)	NULL
EXP054616	mouse monoclonal GABP (Santa Cruz, sc-28312)	Homo sapiens		NULL	356	normal	Q06546	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054617	NRSF (custom generated, Johnson et al. 2007, PMID: 17540862)	Homo sapiens		EXP054590	356	normal	Q13127	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054618	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054619	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens	Characteristic: robotic ChIP-seq; 	EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054620	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens	Characteristic: robotic ChIP-seq; 	EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054621	p300 (mouse monoclonal custom generated, 1F4_E10)	Homo sapiens		EXP054590	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054622	p300 (Santa Cruz sc-585, Lot#E3113)	Homo sapiens	Characteristic: robotic ChIP-seq; 	NULL	356	normal	Q09472	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054623	SPI1/PU.1 (Santa Cruz, sc-22805)	Homo sapiens		NULL	356	normal	P17947	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054624	SPI1/PU.1 (Santa Cruz, sc-22805)	Homo sapiens	Characteristic: robotic ChIP-seq; 	NULL	356	normal	P17947	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054625	Kaiso/ZBTB33 (Santa Cruz, sc-23871)	Homo sapiens		NULL	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054626	Kaiso/ZBTB33 (Santa Cruz, sc-23871)	Homo sapiens	Characteristic: robotic ChIP-seq; 	NULL	356	normal	Q86T24	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054627		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP054628		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP054629		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP054630		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP054631	anti-BAHD1 (C mouse monoclonal antibody, clone HPC4, 11814508001, Roche)	Homo sapiens		EXP054627	421	normal	Q8TBE0	HEK293 (embryonic kidney)	NULL
EXP054632	anti-BAHD1 (C mouse monoclonal antibody, clone HPC4, 11814508001, Roche)	Homo sapiens		EXP054628	421	normal	Q8TBE0	HEK293 (embryonic kidney)	NULL
EXP054633	None	Homo sapiens	Treatment: none;	NULL	2660	chip_control	NULL	LY-1 (Diffuse Large B-Cell Lymphoma)	NULL
EXP054634	None	Homo sapiens	Treatment: 500nM JQ1 for 6 hours;	NULL	2660	chip_control	NULL	LY-1 (Diffuse Large B-Cell Lymphoma)	NULL
EXP054635	None	Homo sapiens	Treatment: 0.05% DMSO for 6 hours;	NULL	2660	chip_control	NULL	LY-1 (Diffuse Large B-Cell Lymphoma)	NULL
EXP054636	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.05% DMSO for 6 hours;	EXP054635	2660	normal	O60885	LY-1 (Diffuse Large B-Cell Lymphoma)	NULL
EXP054637	anti-Brd4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 500nM JQ1 for 6 hours;	EXP054634	2660	normal	O60885	LY-1 (Diffuse Large B-Cell Lymphoma)	NULL
EXP054638	Med1/TRAP220 (Bethyl, A300-793A)	Homo sapiens	Treatment: none;	EXP054633	2660	normal	O95243	LY-1 (Diffuse Large B-Cell Lymphoma)	NULL
EXP054639	None	Homo sapiens		NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP054640	None	Homo sapiens		NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP054641	CDK8 (Santa Cruz, SC-1521)	Homo sapiens		EXP054639	452	normal	P49336	HT29 (colon adenocarcinoma)	NULL
EXP054642	CDK8 (Santa Cruz, SC-1521)	Homo sapiens		EXP054640	821	normal	P49336	SW480 (colon adenocarcinoma)	NULL
EXP054643	anti-PGC7	Homo sapiens		NULL	10	normal	Q6W0C5	HEK293T (embryonic kidney)	NULL
EXP054644	anti-TET3	Homo sapiens		NULL	10	normal	O43151	HEK293T (embryonic kidney)	NULL
EXP054645	CDK2	Homo sapiens	Treatment: none;	NULL	2295	normal	P24941	T47D-MTVL	NULL
EXP054646	CDK2	Homo sapiens	Treatment: progestin for 5min;	NULL	2295	normal	P24941	T47D-MTVL	NULL
EXP054647	CDK2	Homo sapiens	Treatment: progestin for 30min;	NULL	2295	normal	P24941	T47D-MTVL	NULL
EXP054648	PARP1	Homo sapiens	Treatment: none;	NULL	2295	normal	P09874	T47D-MTVL	NULL
EXP054649	PARP1	Homo sapiens	Treatment: progestin for 5min;	NULL	2295	normal	P09874	T47D-MTVL	NULL
EXP054650	PARP1	Homo sapiens	Treatment: progestin for 30min;	NULL	2295	normal	P09874	T47D-MTVL	NULL
EXP054651	Control IgG (Santa Cruz, sc-2027)	Homo sapiens	Passage: 10 to 15;	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP054652	Anti-beta catenin(H102) (Santa Cruz, sc-7199)	Homo sapiens	Passage: 10 to 15;	EXP054651	821	normal	P35222	SW480 (colon adenocarcinoma)	NULL
EXP054653	IgG ctrl	Homo sapiens	Treatment: shCtrl;	NULL	2661	chip_control	NULL	KYSE-150 (Esophageal squamous cell carcinoma)	NULL
EXP054654	anti-JMJD2C	Homo sapiens	Treatment: shCtrl;	EXP054653	2661	normal	Q9H3R0	KYSE-150 (Esophageal squamous cell carcinoma)	NULL
EXP054655	anti-JMJD2C	Homo sapiens	Treatment: shJMJD2C;	EXP054653	2661	normal	Q9H3R0	KYSE-150 (Esophageal squamous cell carcinoma)	NULL
EXP054656	none	Homo sapiens	Passage: 5-7;	NULL	2662	chip_control	NULL	Lonza CC-2511 (normal dermal fibroblasts)	NULL
EXP054657	none	Homo sapiens	Passage: 5-7;	NULL	2663	chip_control	NULL	normal primary dermal fibroblasts	NULL
EXP054658	LMNA (Santa Cruz, sc-7292)	Homo sapiens	Passage: 5-7;	EXP054656	2662	normal	P02545	Lonza CC-2511 (normal dermal fibroblasts)	NULL
EXP054659	anti-LMNA (Santa Cruz, sc-7292)	Homo sapiens	Passage: 5-7;	EXP054657	2663	normal	P02545	normal primary dermal fibroblasts	NULL
EXP054660	none	Homo sapiens	Source: umbilical cord blood; Genotype: HSPC-MA9;	NULL	2664	chip_control	NULL	CD34+ cells	NULL
EXP054661	MLL N-terminus (Bethyl 086A)	Homo sapiens	Source: umbilical cord blood; Genotype: HSPC-MA9;	EXP054660	2664	normal	Q03164	CD34+ cells	NULL
EXP054662	AF9 C-terminus (Bethyl 597A)	Homo sapiens	Source: umbilical cord blood; Genotype: HSPC-MA9;	EXP054660	2664	normal	P42568	CD34+ cells	NULL
EXP054663	None	Homo sapiens	vehicle (naÃ¯ve)	NULL	2665	chip_control	NULL	KOPT-K1 (Childhood T acute lymphoblastic leukemia)	NULL
EXP054664	None	Homo sapiens	Treatment: 1uM gamma Secretase inhibitor over 7weeks;	NULL	2665	chip_control	NULL	KOPT-K1 (Childhood T acute lymphoblastic leukemia)	NULL
EXP054665	None	Homo sapiens	Treatment: vehicle (naÃ¯ve);	NULL	220	chip_control	NULL	DND41 (acute lymphoblastic leukemia)	NULL
EXP054666	None	Homo sapiens	Treatment: 1uM gamma Secretase inhibitor over 7weeks;	NULL	220	chip_control	NULL	DND41 (acute lymphoblastic leukemia)	NULL
EXP054667	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: vehicle (naÃ¯ve);	EXP054663	2665	normal	O60885	KOPT-K1 (Childhood T acute lymphoblastic leukemia)	NULL
EXP054668	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: 1uM gamma Secretase inhibitor over 7weeks;	EXP054664	2665	normal	O60885	KOPT-K1 (Childhood T acute lymphoblastic leukemia)	NULL
EXP054669	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: vehicle (naÃ¯ve);	EXP054665	220	normal	O60885	DND41 (acute lymphoblastic leukemia)	NULL
EXP054670	anti-BRD4 (A301-985A, Lot A301-985A-1)	Homo sapiens	Treatment: 1uM gamma Secretase inhibitor over 7weeks;	EXP054666	220	normal	O60885	DND41 (acute lymphoblastic leukemia)	NULL
EXP054671	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing CBX2-GFP control protein;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP054672	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing MEL18-GFP fusion protein;	EXP054671	514	normal	P35227	K562 (myelogenous leukemia)	NULL
EXP054673	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing RINGA1-GFP fusion protein;	EXP054671	514	normal	Q06587	K562 (myelogenous leukemia)	NULL
EXP054674	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing RINGB1-GFP fusion protein;	EXP054671	514	normal	Q99496	K562 (myelogenous leukemia)	NULL
EXP054675	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing BMI1-GFP fusion protein;	EXP054671	514	normal	P35226	K562 (myelogenous leukemia)	NULL
EXP054676	Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing PCGF1-GFP fusion protein;	EXP054671	514	normal	Q9BSM1	K562 (myelogenous leukemia)	NULL
EXP054677	CBX2 Anti-GFP antibody (Abcam, ab290)	Homo sapiens	Genotype: expressing CBX2-GFP fusion protein;	EXP054671	514	normal	Q14781	K562 (myelogenous leukemia)	NULL
EXP054678	anti-KDM2B (Abcam, ab137547)	Homo sapiens		NULL	2288	normal	Q8NHM5	AML (monocytes and acute myeloid leukemia)	NULL
EXP054679	anti-KDM2B (Abcam, ab137547)	Homo sapiens		NULL	2288	normal	Q8NHM5	AML (monocytes and acute myeloid leukemia)	NULL
EXP054680	input DNA purified from chromatin	Homo sapiens	Genotype: TTE-MBD2;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054681	anti-MBD2 Antibody (Rabbit, Bethyl Laboratories, A301-632)	Homo sapiens	Genotype: TTE-MBD2;	EXP054680	113	normal	Q9UBB5	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054682	IgG	Homo sapiens		NULL	2287	chip_control	NULL	LCL (lymphoblastoid cell line)	NULL
EXP054683	TERF1	Homo sapiens		EXP054682	2287	normal	P54274	LCL (lymphoblastoid cell line)	NULL
EXP054684	TERF2	Homo sapiens		EXP054682	2287	normal	Q15554	LCL (lymphoblastoid cell line)	NULL
EXP054685	anti-RELA (Santa Cruz Biotechnology, #sc-372)	Homo sapiens		NULL	356	normal	Q04206	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054686	anti-RELB (Santa Cruz Biotechnology, #sc-226)	Homo sapiens		NULL	356	normal	Q01201	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054687	c-REL (Santa Cruz Biotechnology, #sc-71)	Homo sapiens		NULL	356	normal	Q04864	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054688	NFKB1 (Santa Cruz Biotechnology, #sc-1190)	Homo sapiens		NULL	356	normal	P19838	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054689	NFKB2 (Bethyl Laboratories, #A300-BL7039)	Homo sapiens		NULL	356	normal	Q00653	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054690	none	Homo sapiens	Treatment: EtOH;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP054691	none	Homo sapiens	Treatment: R1881;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP054692	WDR5 (Bethyl Labs, A302-429A)	Homo sapiens	Treatment: EtOH;	EXP054690	70	normal	P61964	LNCaP (prostate carcinoma)	NULL
EXP054693	WDR5 (Bethyl Labs, A302-429A)	Homo sapiens	Treatment: R1881;	EXP054691	70	normal	P61964	LNCaP (prostate carcinoma)	NULL
EXP054694	none	Homo sapiens	Treatment: 300 nM solvent (methanol) for 4 hrs;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP054695	none	Homo sapiens	Treatment: 300 nM 4-hydroxy tamoxifen (OHT) for 4 hhrs;	NULL	2599	chip_control	NULL	Hs68 (Canavan disease)	NULL
EXP054696	anti-pDNA-PKcs (Abcam, ab18192)	Homo sapiens	Treatment: 300 nM solvent (methanol) for 4 hrs;	EXP054694	2599	normal	P78527	Hs68 (Canavan disease)	NULL
EXP054697	anti-pDNA-PKcs (Abcam, ab18192)	Homo sapiens	Treatment: 300 nM 4-hydroxy tamoxifen (OHT) for 4 hhrs;	EXP054695	2599	normal	P78527	Hs68 (Canavan disease)	NULL
EXP054698	anti-MEL18 (Santa Cruz, sc-10744)	Homo sapiens	Treatment: 300 nM solvent (methanol) for 4 hrs;	EXP054694	2599	normal	P35227	Hs68 (Canavan disease)	NULL
EXP054699	anti-MEL18 (Santa Cruz, sc-10744)	Homo sapiens	Treatment: 300 nM 4-hydroxy tamoxifen (OHT) for 4 hhrs;	EXP054695	2599	normal	P35227	Hs68 (Canavan disease)	NULL
EXP054700	anti-ARRB1 (A1CT , gift from Pr R. Lefkowitz)	Homo sapiens	Genotype: parental, endogenous levels of ARRB1;	NULL	130	normal	P49407	LNCaP C4-2 (prostate carcinoma)	NULL
EXP054701	anti-ARRB1 (A1CT , gift from Pr R. Lefkowitz)	Homo sapiens	Genotype: stably expressing nuclear ARRB1;	NULL	130	normal	P49407	LNCaP C4-2 (prostate carcinoma)	NULL
EXP054702	anti-p300 (C-20, Santa Cruz, sc-585)	Homo sapiens	Genotype: stably expressing nuclear ARRB1;	NULL	130	normal	Q09472	LNCaP C4-2 (prostate carcinoma)	NULL
EXP054703	anti-ARRB1 (A1CT , gift from Pr R. Lefkowitz)	Homo sapiens		NULL	916	normal	P49407	prostate	NULL
EXP054704	anti-p300 (C-20, Santa Cruz, sc-585)	Homo sapiens	Genotype: parental, endogenous levels of ARRB1;	NULL	130	normal	Q09472	LNCaP C4-2 (prostate carcinoma)	NULL
EXP054705	rabbit IgG (Sigma, catalog# I8140, lot# 115K7551)	Homo sapiens		NULL	847	chip_control	NULL	U2932 (diffuse large B-cell lymphoma)	NULL
EXP054706	none	Homo sapiens		NULL	847	chip_control	NULL	U2932 (diffuse large B-cell lymphoma)	NULL
EXP054707	anti-PRDM11 (antibody 1, rabbit polyclonal, non-commercial)	Homo sapiens		EXP054706	847	normal	Q9NQV5	U2932 (diffuse large B-cell lymphoma)	NULL
EXP054708	anti-PRDM11 (antibody 2, rabbit polyclonal, non-commercial)	Homo sapiens		EXP054706	847	normal	Q9NQV5	U2932 (diffuse large B-cell lymphoma)	NULL
EXP054709	none	Homo sapiens	Developmental stage: proliferating; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054710	none	Homo sapiens	Developmental stage: replicative senescent; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054711	none	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054712	none	Homo sapiens	Developmental stage: oncogene induced senescence;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054713	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens	Developmental stage: proliferating; 	EXP054709	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP054714	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens	Developmental stage: replicative senescent; 	EXP054710	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP054715	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens		EXP054711	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP054716	HIRA (approximately equimolar mixture of WC15, WC19, WC117, WC 119)	Homo sapiens	Developmental stage: oncogene induced senescence;	EXP054712	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP054717	Dicer	Homo sapiens		NULL	421	normal	Q9UPY3	HEK293 (embryonic kidney)	NULL
EXP054718		Homo sapiens	Treatment: treated with control GSKJ5 inhibito;	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP054719		Homo sapiens	Treatment: treated with control GSKJ5 inhibito;	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP054720	JMJD3 (abgent, AP1022a)	Homo sapiens	Treatment: treated with control GSKJ5 inhibito;	EXP054718	199	normal	O15054	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP054721	JMJD3 (abgent, AP1022a)	Homo sapiens	Treatment: treated with control GSKJ5 inhibito;	EXP054719	199	normal	O15054	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP054722	none	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP054723	DDX21 (Novus Biologicals,  Cat# BP100-1781)	Homo sapiens		EXP054722	421	normal	Q9NR30	HEK293 (embryonic kidney)	NULL
EXP054724	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054725	none	Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP054726	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054727	none	Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP054728	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054729	AGO1 (Millipore, (clone 6D8.2) cat 04-083)	Homo sapiens		EXP054726	113	normal	Q9UL18	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054730	HP1 alpha (Abcam, Ab9057)	Homo sapiens		EXP054728	113	normal	P45973	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054731	AGO1 (Millipore, (clone 6D8.2) cat 04-083)	Homo sapiens		EXP054727	583	normal	Q9UL18	MCF10A (breast epithelial cells)	NULL
EXP054732	HP1 alpha (Abcam, Ab9057)	Homo sapiens		EXP054727	583	normal	P45973	MCF10A (breast epithelial cells)	NULL
EXP054733	anti-AGO1 (4B8-clone, 4B8 (SAB4200084-200UL)	Homo sapiens		EXP054724	113	normal	Q9UL18	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054734	anti-AGO1 (4B8-clone, 4B8 (SAB4200084-200UL)	Homo sapiens		EXP054725	583	normal	Q9UL18	MCF10A (breast epithelial cells)	NULL
EXP054735		Homo sapiens	Treatment: Ethanol (vehicle);	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054736	anti-APOBEC3B (Rabbit polyclonal, antiserum prepared by immunising with overlapping peptides)	Homo sapiens	Treatment: Ethanol (vehicle);	EXP054735	113	normal	Q9UH17	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054737	APOBEC3B ( Rabbit polyclonal, antiserum prepared by immunising with overlapping peptides)	Homo sapiens	Treatment: Estrogen (100 nM);	NULL	113	normal	Q9UH17	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054738		Homo sapiens	Genotype: 17-20; 	NULL	2667	chip_control	NULL	PC-3M-luc (human prostate carcinoma)	NULL
EXP054739	anti-LSD1 (Abcam, ab17721)	Homo sapiens	Treatment: 17-20;	EXP054738	2667	normal	O60341	PC-3M-luc (human prostate carcinoma)	NULL
EXP054740	none	Homo sapiens	Source: sonicated chromatin;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054741	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054742	anti-LMNA (Santa Cruz, sc-7292)	Homo sapiens	Source: sonicated chromatin;	EXP054740	78	normal	P02545	HeLa (cervical adenocarcinoma)	NULL
EXP054743	anti-LMNA (Santa Cruz, sc-7292)	Homo sapiens	Source: micrococcal nuclease-digested chromatin;	EXP054741	78	normal	A0AVK6	HeLa (cervical adenocarcinoma)	NULL
EXP054744	LMNB1(Abcam, ab16048)	Homo sapiens	Source: micrococcal nuclease-digested chromatin;	NULL	78	normal	Q13751	HeLa (cervical adenocarcinoma)	NULL
EXP054745	CHD8 (N terminus, Abcam, ab114126, #GR62009-12)	Mus musculus	Strain: C57BL6J; Developmental stage: Embryonic Day 17.5; Tissue: frontal cortex;	NULL	625	normal	Q09XV5	embryonic cortex	NULL
EXP054746	CHD8 (N terminus, Abcam, ab114126, #GR62009-12)	Mus musculus	Strain: C57BL6J; Developmental stage: embryonic day 17.5; Tissue: occipital cortex;	NULL	866	normal	Q09XV5	E15.5 embryonic cortex	NULL
EXP054747	CHD8 (N terminus, Abcam, ab114126, #GR62009-12)	Homo sapiens		NULL	915	normal	Q9HCK8	hNSC (neural stem cells)	NULL
EXP054748	none	Homo sapiens	Treatment: treated with DMSO for 48 hrs;	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP054749	none	Homo sapiens	Treatment: 25 uM A771726 for 48 hrs;	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP054750	CDK9 (Santa Cruz)	Homo sapiens	Treatment: treated with DMSO;	EXP054748	36	normal	P50750	A375 (malignant melanoma)	NULL
EXP054751	CDK9 (Santa Cruz)	Homo sapiens	Treatment: 25 uM A771726 for 48 hrs;	EXP054749	36	normal	P50750	A375 (malignant melanoma)	NULL
EXP054752	HEXIM1 (Abcam)	Homo sapiens	Treatment: treated with DMSO;	EXP054748	36	normal	O94992	A375 (malignant melanoma)	NULL
EXP054753	HEXIM1 (Abcam)	Homo sapiens	Treatment: 25 uM A771726 for 48 hrs;	EXP054749	36	normal	O94992	A375 (malignant melanoma)	NULL
EXP054754	IgG (Abcam, #ab37415)	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP054755	ALKBH3 (Millipore, #09-882)	Homo sapiens		EXP054754	725	normal	Q96Q83	PC3(bone mets prostate adenocarcinoma)	NULL
EXP054756	N/A	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054757	N/A	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP054758	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: untreated; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	EXP054756	417	bio_control	P11387	HCT-116 (colon carcinoma)	NULL
EXP054759	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: siTop1; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054760	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: CPT (Camptothecin, a topoisomerase I inhibitor); Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054761	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: CPT (Camptothecin, a topoisomerase I inhibitor); Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054762	anti-BRD4 (A301-985A)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	EXP054756	417	normal	O60885	HCT-116 (colon carcinoma)	NULL
EXP054763	anti-BRD4 (A301-985A)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	O60885	HCT-116 (colon carcinoma)	NULL
EXP054764	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	EXP054756	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054765	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem, -16[1];	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054766	anti-BRD4 (A301-985A)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	EXP054757	417	bio_control	O60885	HCT-116 (colon carcinoma)	NULL
EXP054767	anti-BRD4 (A301-985A)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	NULL	417	normal	O60885	HCT-116 (colon carcinoma)	NULL
EXP054768	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	EXP054757	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054769	Anti-Topoisomerase I antibody (Abcam, catalog# ab109374, lot# YH0901152)	Homo sapiens	Treatment: 250 nM (final con .) JQ1 for 2hrs; Genotype: 46,XY,add(10)(q26),add(16)(p13.3),add(18)(p11.2)[2]; 45,idem,-Y[17] and 45,idem,-16[1]; and TOP1-KI; 	NULL	417	normal	P11387	HCT-116 (colon carcinoma)	NULL
EXP054770	none	Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP054771	none	Homo sapiens		NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP054772	anti-KAP1 (Custom rabbit antibody, 60?l per IP)	Homo sapiens		EXP054770	376	normal	Q13263	WA01 (H1, human embryonic stem cells)	NULL
EXP054773	anti-KAP1 (AbCam, ab10483)	Homo sapiens		EXP054771	376	normal	Q13263	WA01 (H1, human embryonic stem cells)	NULL
EXP054774	none (input)	Homo sapiens		NULL	2668	chip_control	NULL	HES-3 (embryonic stem cell)	NULL
EXP054775	Anti-HA Agarose (Thermo Scientific, 26181)	Homo sapiens		EXP054774	2668	normal	Q99496	HES-3 (embryonic stem cell)	NULL
EXP054776		Homo sapiens		NULL	2326	chip_control	NULL	CS1AN (Cockayne syndrome)	NULL
EXP054777	CSB anti-GFP	Homo sapiens		NULL	2326	chip_control	NULL	CS1AN (Cockayne syndrome)	NULL
EXP054778	CSB1	Homo sapiens		NULL	2326	chip_control	NULL	CS1AN (Cockayne syndrome)	NULL
EXP054779		Homo sapiens		NULL	2326	chip_control	NULL	CS1AN (Cockayne syndrome)	NULL
EXP054780	anti-GFP	Homo sapiens		NULL	2326	chip_control	NULL	CS1AN (Cockayne syndrome)	NULL
EXP054781		Homo sapiens		NULL	2326	chip_control	NULL	CS1AN (Cockayne syndrome)	NULL
EXP054782	anti-GFP (Abcam, ab290)	Homo sapiens		EXP054778	2326	normal	Q03468	CS1AN (Cockayne syndrome)	NULL
EXP054783	anti-GFP	Homo sapiens		EXP054781	2326	normal	Q03468	CS1AN (Cockayne syndrome)	NULL
EXP054784		Homo sapiens	Treatment: SVIL shRNA; Developmental stage: B3; 	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP054785		Homo sapiens	Treatment: control shRNA; Developmental stage: B0; 	NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP054786	LSD1 (ab-17721; Abcam)	Homo sapiens	Treatment: LSD1+8a shRNA; Developmental stage: B0; 	NULL	664	normal	O60341	SH-SY5Y (neuroblastoma)	NULL
EXP054787	LSD1 (ab-17721; Abcam)	Homo sapiens	Treatment: control shRNA; Developmental stage: B0; 	EXP054785	664	normal	O60341	SH-SY5Y (neuroblastoma)	NULL
EXP054788	LSD1 (ab-17721; Abcam)	Homo sapiens	Treatment: control shRNA; Developmental stage: B3; 	EXP054785	664	normal	O60341	SH-SY5Y (neuroblastoma)	NULL
EXP054789	SVIL (S8695; Sigma)	Homo sapiens	Treatment: SVIL shRNA; Developmental stage: B3; 	EXP054784	664	normal	O95425	SH-SY5Y (neuroblastoma)	NULL
EXP054790	SVIL (S8695; Sigma)	Homo sapiens	Treatment: control shRNA; Developmental stage: B3; 	EXP054785	664	normal	O95425	SH-SY5Y (neuroblastoma)	NULL
EXP054791	none (input)	Mus musculus	Strain: C57BL/6; Treatment: 2 days after doxycycline induction of Gm6871-HA expression vector expression; Genotype: overexpressing HA-tagged Gm6871; 	NULL	2669	chip_control	NULL	ES3 (ebryonic stem cells)	NULL
EXP054792	none (input)	Mus musculus	Strain: 129S4/SvJae; Genotype: wildtype; 	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP054793	Mouse anti-HA antibody (Covance, catalog# MMS-101P)	Mus musculus	Strain: C57BL/6; Treatment: 2 days after doxycycline induction of Gm6871-HA expression vector expression; Genotype: overexpressing HA-tagged Gm6871; 	EXP054791	2669	normal	E9PZ63	ES3 (ebryonic stem cells)	NULL
EXP054794	anti-KAP1 antibody (Custom rabbit, 5ug per IP)	Mus musculus	Strain: 129S4/SvJae; Genotype: wildtype; 	EXP054792	506	normal	Q62318	J1 (embryonic stem cells)	NULL
EXP054795	none	Homo sapiens	Treatment: none;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054796	none	Homo sapiens	Treatment: none;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054797	anti-PSF (clone 39-1; Santa Cruz Biotechnology, sc-101137, Lot # L1012)	Homo sapiens	Treatment: none;	EXP054795	113	normal	P23246	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054798	anti-PSF (clone 39-1; Santa Cruz Biotechnology, sc-101137, Lot # L1012)	Homo sapiens	Treatment: none;	EXP054796	113	normal	P23246	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054799	none	Homo sapiens		NULL	422	chip_control	NULL	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP054800	anti-EGFP (polyclonal goat )	Homo sapiens		EXP054799	422	normal	P38432	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP054801	goat IgG (DAKO)	Homo sapiens	Treatment: none; 	NULL	2670	chip_control	NULL	SA121 (embryonic stem cell)	NULL
EXP054802	goat IgG (DAKO)	Homo sapiens	Treatment: 3mM CHIR99021 (CHIR) for 6 hrs; 	NULL	2670	chip_control	NULL	SA121 (embryonic stem cell)	NULL
EXP054803	goat IgG (DAKO)	Homo sapiens	Treatment: 3mM CHIR99021+ 10mM SB431542 (CHIR+SB) for 6 hrs; 	NULL	2670	chip_control	NULL	SA121 (embryonic stem cell)	NULL
EXP054804	anti-Beta-Catenin (R&D systems, AF1329)	Homo sapiens	Treatment: none; 	EXP054801	2670	normal	P35222	SA121 (embryonic stem cell)	NULL
EXP054805	anti-Beta-Catenin (R&D systems, AF1329)	Homo sapiens	Treatment: 3mM CHIR99021 (CHIR) for 6 hrs; 	EXP054802	2670	normal	P35222	SA121 (embryonic stem cell)	NULL
EXP054806	anti-Beta-Catenin (R&D systems, AF1329)	Homo sapiens	Treatment: 3mM CHIR99021+ 10mM SB431542 (CHIR+SB) for 6 hrs; 	EXP054803	2670	normal	P35222	SA121 (embryonic stem cell)	NULL
EXP054807	Anti- CK2a Abcam (Cat. No. Ab70774)	Homo sapiens	Passage: 40-45; Treatment: 100 nM DHT for 2.5 hrs;	NULL	70	normal	P68400	LNCaP (prostate carcinoma)	NULL
EXP054808	none (input)	Homo sapiens		NULL	2671	chip_control	NULL	NTERA-2 (embryonal carcinoma)	NULL
EXP054809	p68 antibody (Bethyl Laboratories, catalog# A300-523A, lot# A300-523A-1)	Homo sapiens		EXP054808	2671	normal	P17844	NTERA-2 (embryonal carcinoma)	NULL
EXP054810	anti-PAR2	Homo sapiens	Passage: 15-18; Treatment: stimulated with peptide SLGKV; 	NULL	421	normal	P55085	HEK293 (embryonic kidney)	NULL
EXP054811	BRD2	Homo sapiens	Treatment: DMSO (0.1%) for 16 hrs; 	NULL	562	normal	P25440	LX-2 (hepatic stellate cells)	NULL
EXP054812	BRD2	Homo sapiens	Treatment:500 nM JQ1 for 16 hrs; 	NULL	562	normal	P25440	LX-2 (hepatic stellate cells)	NULL
EXP054813	BRD3	Homo sapiens	Treatment: DMSO (0.1%) for 16 hrs; 	NULL	562	normal	Q15059	LX-2 (hepatic stellate cells)	NULL
EXP054814	BRD3	Homo sapiens	Treatment:500 nM JQ1 for 16 hrs; 	NULL	562	normal	Q15059	LX-2 (hepatic stellate cells)	NULL
EXP054815	BRD4	Homo sapiens	Treatment: DMSO (0.1%) for 16 hrs; 	NULL	562	normal	O60885	LX-2 (hepatic stellate cells)	NULL
EXP054816	BRD4	Homo sapiens	Treatment:500 nM JQ1 for 16 hrs; 	NULL	562	normal	O60885	LX-2 (hepatic stellate cells)	NULL
EXP054817	none	Homo sapiens	Treatment: DMSO for 6hrs; Passage: 30-35; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054818	none	Homo sapiens	Treatment: nutlin3a (5uM final) for 6hrs; Passage: 30-35; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054819	p53 (EMD Millipore (DO1))	Homo sapiens	Treatment: DMSO for 6hrs; Passage: 30-35; 	EXP054817	489	normal	P04637	IMR90 (lung fibroblasts)	NULL
EXP054820	p53 (EMD Millipore (DO1))	Homo sapiens	Treatment: nutlin3a (5uM final) for 6hrs; Passage: 30-35; 	EXP054818	489	normal	P04637	IMR90 (lung fibroblasts)	NULL
EXP054821	EED (Millipore 17-10034)	Homo sapiens		NULL	167	normal	O75530	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP054822	SUZ12 (Abcam ab12073; Active Motif 39357, lot 29111002)	Homo sapiens		NULL	167	normal	Q15022	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP054823	NFE2 (Santa Cruz Biotechnology sc-291)	Homo sapiens		NULL	167	normal	Q16621	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP054824	TAL1 (Santa Cruz Biotechnology sc-12984)	Homo sapiens		NULL	167	normal	P17542	CD34+ hematopoietic stem cells-derived proerythroblasts	NULL
EXP054825	anti-p300 (N-15) (Santa Cruz, catalog# sc-584)	Homo sapiens	Treatment: mock-infected;	NULL	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP054826	anti-p300 (N-15) (Santa Cruz, catalog# sc-584)	Homo sapiens	Treatment: dl1500 infected;	NULL	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP054827	none	Homo sapiens	Treatment: mock-infected;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054828	none	Homo sapiens	Treatment: dl1500-infected;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054829	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: mock-infected;	EXP054827	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054830	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: dl1500-infected;	EXP054828	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054831	none	Homo sapiens	Treatment: dl312-infected;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054832	none	Homo sapiens	Treatment: e1aWT-infected;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054833	none	Homo sapiens	Treatment: P300 binding mutant-infected;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054834	none	Homo sapiens	Treatment: RB binding mutant-infected; 	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054835	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: dl312-infected;	EXP054831	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054836	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: e1aWT-infected;	EXP054832	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054837	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: P300 binding mutant-infected;	EXP054833	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054838	anti-RB1 (4H1) (Cell Signaling, catalog# 9309L)	Homo sapiens	Treatment: RB binding mutant-infected; 	EXP054834	489	normal	P06400	IMR90 (lung fibroblasts)	NULL
EXP054839	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP054840	anti-LSD2 (polyclonal antibody, raised in rabbits by administering recombinant human LSD2 protein (region 26 â€“ 822))	Homo sapiens		EXP054839	430	normal	Q8NB78	HepG2 (hepatoblastoma)	NULL
EXP054841	none (input)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	NULL	1149	chip_control	NULL	testis	NULL
EXP054842	none (input)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	NULL	1149	chip_control	NULL	testis	NULL
EXP054843	none (input)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	NULL	1149	chip_control	NULL	testis	NULL
EXP054844	none (input)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	NULL	1149	chip_control	NULL	testis	NULL
EXP054845	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054841	1149	normal	Q14565	testis	NULL
EXP054846	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054842	1149	normal	Q14565	testis	NULL
EXP054847	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054844	1149	normal	Q14565	testis	NULL
EXP054848	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Homo sapiens	Genotype: PRDM9A / PRDM9B; 	EXP054843	1149	normal	Q14565	testis	NULL
EXP054849		Homo sapiens	Tissue: abdomen skin; Passage: 4-6;	NULL	2663	chip_control	NULL	normal primary dermal fibroblasts	NULL
EXP054850	CSL (Cell Signaling RBPSUH Cat.No. 5313)	Homo sapiens	Tissue: abdomen skin; Passage: 4-6;	EXP054849	2663	normal	Q14406	normal primary dermal fibroblasts	NULL
EXP054851	CSL (Eurogentech, Seraign, Belgium - Affinity purified rabbit polyclonal -Epitopes: aa 209-224, aa 426-440 )	Homo sapiens	Tissue: abdomen skin; Passage: 4-6;	EXP054849	2663	normal	Q14406	normal primary dermal fibroblasts	NULL
EXP054854	anti-Cdk7 (Bethyl, A300-405A)	Homo sapiens	Treatment: treated with 500nM THZ-2-102 for 12 hours;	NULL	509	normal	P50613	Jurkat (T-cells)	NULL
EXP054855	anti-Cdk7 (Bethyl, A300-405A)	Homo sapiens	Treatment: treated with DMSO/vehicle for 12 hours;	NULL	509	normal	P50613	Jurkat (T-cells)	NULL
EXP054856	anti-Cdk7 (Bethyl, A300-405A)	Mus musculus		NULL	252	normal	Q03147	V6.5 (embryonic stem cells)	NULL
EXP054857	anti-cdk8 (Santa Cruz, SC-1521)	Mus musculus		NULL	252	normal	Q8R3L8	V6.5 (embryonic stem cells)	NULL
EXP054858	none	Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP054859	ELK3 (2005, in house)	Homo sapiens		EXP054858	472	normal	P41970	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP054860	IgG Santa Cruz (2027)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP054861	IgG Santa Cruz (2027)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP054862	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	EXP054860	396	normal	O60885	WA09 (embryonic stem cells)	NULL
EXP054863	BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	EXP054861	396	normal	O60885	WA09 (embryonic stem cells)	NULL
EXP054864	BRD2 (Bethyl, A302-583A)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	EXP054860	396	normal	P25440	WA09 (embryonic stem cells)	NULL
EXP054865	BRD2 (Bethyl, A302-583A)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	EXP054861	396	normal	P25440	WA09 (embryonic stem cells)	NULL
EXP054866	BRD3 (Bethyl, A302-368A)	Homo sapiens	Treatment: vehicle (DMSO) for 6 hrs;	EXP054860	396	normal	Q15059	WA09 (embryonic stem cells)	NULL
EXP054867	BRD3 (Bethyl, A302-368A)	Homo sapiens	Treatment: MS417-treated at 250nM concentration for 6h;	EXP054861	396	normal	Q15059	WA09 (embryonic stem cells)	NULL
EXP054868	none	Homo sapiens		NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP054869	none	Homo sapiens		NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP054870	ZNF486 (abcam ab104878, lot#GR52278-1)	Homo sapiens		EXP054868	878	normal	Q96H40	embryonic stem cells	NULL
EXP054871	ZNF486 (abcam ab104878, lot#GR52278-1)	Homo sapiens		EXP054869	878	normal	Q96H40	embryonic stem cells	NULL
EXP054872	KAP1 ChIP (abcam ab10483, lot#GR17300)	Homo sapiens		EXP054869	878	normal	Q13263	embryonic stem cells	NULL
EXP054873		Homo sapiens	Genotype: wildtype; 	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP054874	anti-AF9 (Sigma, HPA001824)	Homo sapiens	Genotype: 3Flag-AF9 stable;	EXP054873	78	normal	P42568	HeLa (cervical adenocarcinoma)	NULL
EXP054875	anti-FLAG (Sigma M2)	Homo sapiens	Genotype: 3Flag-AF9 stable;	EXP054873	78	normal	P42568	HeLa (cervical adenocarcinoma)	NULL
EXP054876	none	Mus musculus	Strain: CD1; Stage: p1; 	NULL	143	chip_control	NULL	brain	NULL
EXP054877	none	Homo sapiens	Passage: 15-20; 	NULL	11	chip_control	NULL	HEK293-T-Rex (embryonic kidney)	NULL
EXP054878	AUTS2 (house made)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	A0A087WPF7	brain	NULL
EXP054879	RING1B (form Luciano Di Croce)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	Q9CQJ4	brain	NULL
EXP054880	BMI1 (Bethyl, A301-694A, lot# A301-694A-3)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	P25916	brain	NULL
EXP054881	P300 (Santa Cruz, sc585, lot# B0413)	Mus musculus	Strain: CD1; Stage: p1; 	EXP054876	143	normal	B2RWS6	brain	NULL
EXP054882	anti-HA (abcam, ab9110, lot# GR20600-2)	Homo sapiens	Passage: 15-20; 	EXP054877	11	normal	Q8WXX7	HEK293-T-Rex (embryonic kidney)	NULL
EXP054883		Homo sapiens		NULL	2672	chip_control	NULL	HeLa-LTR-Luciferase cells	NULL
EXP054884		Homo sapiens		NULL	2672	chip_control	NULL	HeLa-LTR-Luciferase cells	NULL
EXP054885	Anti-INTS3 (Bethyl Laboratories, A302-051A)	Homo sapiens		EXP054883	2672	normal	Q68E01	HeLa-LTR-Luciferase cells	NULL
EXP054886	Anti-NELF-E (Millipore, ABE48)	Homo sapiens		EXP054883	2672	normal	P18615	HeLa-LTR-Luciferase cells	NULL
EXP054887	Anti-Spt5 (BD Transduction Laboratories, 611106)	Homo sapiens		EXP054883	2672	normal	O00267	HeLa-LTR-Luciferase cells	NULL
EXP054888	Anti-INTS13/Asun (Bethyl Laboratories)	Homo sapiens		EXP054883	2672	normal	Q9NVM9	HeLa-LTR-Luciferase cells	NULL
EXP054889	Anti-INTS11	Homo sapiens		NULL	2672	normal	Q5TA45	HeLa-LTR-Luciferase cells	NULL
EXP054890	None	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP054891	None	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP054892	DEK (Abcam, ab-74975)	Homo sapiens		EXP054890	65	normal	P35659	U937 (adult acute monocytic leukemia)	NULL
EXP054893	DEK (Abcam, ab-74975)	Homo sapiens		EXP054891	65	normal	P35659	U937 (adult acute monocytic leukemia)	NULL
EXP054894	none (input)	Homo sapiens		NULL	2614	chip_control	NULL	primary CD4+ T-cells	NULL
EXP054895	anti-LEDGF/p75 (Bethyl, A300-848)	Homo sapiens	Source: infected chronic HIV-1 subtype C infection cohort; 	EXP054894	2614	normal	O75475	primary CD4+ T-cells	NULL
EXP054896	anti-USP7 (Bethyl, catalog# A300-033A)	Homo sapiens		NULL	11	normal	Q93009	HEK293-T-Rex (embryonic kidney)	NULL
EXP054897	none (total input)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO- CD62L+ CD127hi CD25-; 	NULL	2614	chip_control	NULL	primary CD4+ T-cells	NULL
EXP054898	none (total input)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127lo CD25- (effector memory);	NULL	2614	chip_control	NULL	primary CD4+ T-cells	NULL
EXP054899	none (total input)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127hi CD25- (resting memory);	NULL	2614	chip_control	NULL	primary CD4+ T-cells	NULL
EXP054900	none (total input)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127hi CD25+ (activated memory);	NULL	2614	chip_control	NULL	primary CD4+ T-cells	NULL
EXP054901	none (total input)	Homo sapiens	Treatment: none;	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP054902	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO- CD62L+ CD127hi CD25-; 	EXP054897	2614	normal	Q04759	primary CD4+ T-cells	NULL
EXP054903	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127lo CD25- (effector memory);	EXP054898	2614	normal	Q04759	primary CD4+ T-cells	NULL
EXP054904	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127hi CD25- (resting memory);	EXP054899	2614	normal	Q04759	primary CD4+ T-cells	NULL
EXP054905	PKCtheta (SantaCruz, catalog# sc-212, lot# I2110)	Homo sapiens	Treatment: none; Cell type: CD4+ CD45RO+ CD62L+/- CD127hi CD25+ (activated memory);	EXP054900	2614	normal	Q04759	primary CD4+ T-cells	NULL
EXP054906	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: none;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	NULL
EXP054907	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: PMA and Ionomycin;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	NULL
EXP054908	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: prestimulation;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	NULL
EXP054909	PKCtheta (SantaCruz, catalog# sc-212, lot# K0713)	Homo sapiens	Treatment: prestimulation and PMA and Ionomycin;	EXP054901	509	normal	Q04759	Jurkat (T-cells)	NULL
EXP054910		Homo sapiens	Genotype: TRS wildtype; Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	NULL	2674	chip_control	NULL	dermal transformed fibroblasts	NULL
EXP054911		Homo sapiens	Genotype: TRS wildtype; Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	NULL	2674	chip_control	NULL	dermal transformed fibroblasts	NULL
EXP054912		Homo sapiens	Genotype: TRS-HGPS (Hutchinson Gilford Progeria Syndrome); Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	NULL	2674	chip_control	NULL	dermal transformed fibroblasts	NULL
EXP054913		Homo sapiens	Genotype: TRS-HGPS (Hutchinson Gilford Progeria Syndrome); Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	NULL	2674	chip_control	NULL	dermal transformed fibroblasts	NULL
EXP054914	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS wildtype; Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	NULL	2674	normal	O60885	dermal transformed fibroblasts	NULL
EXP054915	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS wildtype; Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	EXP054911	2674	normal	O60885	dermal transformed fibroblasts	NULL
EXP054916	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS-HGPS (Hutchinson Gilford Progeria Syndrome); Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	EXP054912	2674	normal	O60885	dermal transformed fibroblasts	NULL
EXP054917	BRD4 (Bethyl labs, A301-985A)	Homo sapiens	Genotype: TRS-HGPS (Hutchinson Gilford Progeria Syndrome); Treatment: transformed by retroviral introduction of TERT, HRAS and SV40 T antigens;	EXP054913	2674	normal	O60885	dermal transformed fibroblasts	NULL
EXP054918	anti-SSu72 (Genetex catalog number: GTX116436)	Homo sapiens	Passage: 40-55; Developmental stage: pluripotent; 	NULL	376	normal	Q9NP77	WA01 (H1, human embryonic stem cells)	NULL
EXP054919	none	Homo sapiens	Genotype: shRNA targeting GFP;	NULL	2675	chip_control	NULL	GM8330-8-derived NPC	NULL
EXP054920	anti-CHD8 (Bethyl A301-224A)	Homo sapiens	Genotype: shRNA targeting GFP;	EXP054919	2675	normal	Q9HCK8	GM8330-8-derived NPC	NULL
EXP054921	anti-CHD7 (Bethyl A301-223A)	Homo sapiens	Genotype: shRNA targeting GFP;	EXP054919	2675	normal	Q9P2D1	GM8330-8-derived NPC	NULL
EXP054922	anti-CHD8 (Novus Biological NB100-60418)	Homo sapiens	Genotype: shRNA targeting GFP;	EXP054919	2675	normal	Q9HCK8	GM8330-8-derived NPC	NULL
EXP054923	PARP-1 (Active motif-39559)	Homo sapiens	Passage: 10 -15; 	NULL	113	normal	P09874	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP054924	PARP-1 (Active motif-39559)	Homo sapiens	Passage: 10 -15; 	NULL	2301	normal	P09874	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP054925	anti-NIPBL Antibody (Bethyl, A301-779A)	Homo sapiens	Genotype: wildtype; 	NULL	768	normal	Q6KC79	Ramos (Burkitt lymphoma)	NULL
EXP054926		Homo sapiens	Genotype: wildtype; 	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP054927		Homo sapiens		NULL	153	chip_control	NULL	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP054928	anti-PAF1  (Bethyl, A300-172A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	P28328	THP-1 (acute monocytic leukemia)	NULL
EXP054929	anti-CDC73 (Bethyl, A300-170A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	Q6P1J9	THP-1 (acute monocytic leukemia)	NULL
EXP054930	anti-LEO1 (Bethyl, A300-175A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	Q8WVC0	THP-1 (acute monocytic leukemia)	NULL
EXP054931	anti-CTR9 (Bethyl, A301-395A)	Homo sapiens	Genotype: wildtype; 	EXP054926	2334	normal	Q6PD62	THP-1 (acute monocytic leukemia)	NULL
EXP054932	anti-LEO1 (Bethyl, A300-175A)	Homo sapiens	Treatment: DMSO; Genotype: wild type (control); 	NULL	2334	normal	Q8WVC0	THP-1 (acute monocytic leukemia)	NULL
EXP054933	anti-LEO1 (Bethyl, A300-175A)	Homo sapiens	Treatment: Flavopiridol;	NULL	2334	normal	Q8WVC0	THP-1 (acute monocytic leukemia)	NULL
EXP054934	anti-PAF1 (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY56 (control); Genotype: vector control;	NULL	2334	normal	P28328	THP-1 (acute monocytic leukemia)	NULL
EXP054935	anti-PAF1 (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY136 (PAF1 shRNA #1); Genotype: PAF1 knockdown;	NULL	2334	normal	P28328	THP-1 (acute monocytic leukemia)	NULL
EXP054936	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: pMY56 (control); Genotype: vector control;	NULL	2334	normal	P50750	THP-1 (acute monocytic leukemia)	NULL
EXP054937	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: pMY136 (PAF1 shRNA #1); Genotype: PAF1 knockdown;	NULL	2334	normal	P50750	THP-1 (acute monocytic leukemia)	NULL
EXP054938	anti-PAF1  (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY56 (control); genotype: vector control; 	EXP054927	153	normal	P28328	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP054939	anti-PAF1  (Bethyl, A300-172A)	Homo sapiens	Treatment: pMY137 (PAF1 shRNA #2); Genotype: PAF1 knockdown;	EXP054927	153	normal	P28328	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP054940	anti-CDK12 (LSBio, LS-A7350)	Homo sapiens	Treatment: pMY56 (control); Genotype: vector control; 	EXP054927	153	normal	Q9NYV4	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP054941	anti-CDK12 (LSBio, LS-A7350)	Homo sapiens	Treatment: pMY136 (PAF1 shRNA #1); Genotype: PAF1 knockdown;	EXP054927	153	normal	Q9NYV4	CCRF-CEM (T acute lymphoblastic leukemia)	NULL
EXP054942	none (input)	Homo sapiens	Treatment: two parts with 37 and 42 degree;	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP054943	anti-KDM3A (Millipore Biotech (Billerica, MA, USA), 09-823)	Homo sapiens	Treatment: 37 degree, 1hr;	EXP054942	509	normal	Q9Y4C1	Jurkat (T-cells)	NULL
EXP054944	Rabbit IgG SIGMA	Homo sapiens	Treatment: none; 	NULL	2295	chip_control	NULL	T47D-MTVL	NULL
EXP054945	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: none; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	NULL
EXP054946	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: R5020 for 5 min;	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	NULL
EXP054947	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: EtOH for 5 min; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	NULL
EXP054948	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: R5020 45 min; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	NULL
EXP054949	anti-CHD8 (A301-224A, Bethyl Laboratories)	Homo sapiens	Treatment: EtOH 45 min; 	EXP054944	2295	normal	Q9HCK8	T47D-MTVL	NULL
EXP054950		Homo sapiens	Developmental stage: 5 days expansion;  Source: Hematopoietic progenitor cells; 	NULL	2664	chip_control	NULL	CD34+ cells	NULL
EXP054951	anti-Notch (home-made)	Homo sapiens	Developmental stage: 5 days expansion;  Source: Hematopoietic progenitor cells; 	EXP054950	2664	normal	P46531	CD34+ cells	NULL
EXP054952	none	Homo sapiens	Treatment: DMSO for 24hrs;	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP054953	none	Homo sapiens	Treatment: PD-032901 (2uM) + JQ1 (100nM) for 24hrs;	NULL	985	chip_control	NULL	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP054954	anti-BRD4 (Bethyl, A301-085A)	Homo sapiens	Treatment: DMSO for 24hrs;	EXP054952	985	normal	O60885	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP054955	anti-BRD4 (Bethyl, A301-085A)	Homo sapiens	Treatment: PD-032901 (2uM) + JQ1 (100nM) for 24hrs;	EXP054953	985	normal	O60885	HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells	NULL
EXP054956	Rad21	Homo sapiens		NULL	356	normal	O60216	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054957	anti-BRD4 (Bethyl Labs, A301-985A, lot# A301-985A-1)	Homo sapiens	Treatment: EBV-infected;	NULL	356	normal	O60885	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP054958	none (input)	Homo sapiens		NULL	2678	chip_control	NULL	HMEC-hTERT	NULL
EXP054959	none (input)	Homo sapiens		NULL	442	chip_control	NULL	HMLER (mammary epithelial cells)	NULL
EXP054960	anti-MBD2 (a custom-made rabbit polyclonalcorresponding to the N-terminal part Covalab, Villeurbanne, Lyon, Perriaud et al. Curr. Pharm. Des 2013)	Homo sapiens		EXP054958	2678	normal	Q9UBB5	HMEC-hTERT	NULL
EXP054961	anti-MBD2 (a custom-made rabbit polyclonalcorresponding to the N-terminal part Covalab, Villeurbanne, Lyon, Perriaud et al. Curr. Pharm. Des 2013)	Homo sapiens		EXP054959	442	normal	Q9UBB5	HMLER (mammary epithelial cells)	NULL
EXP054962	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: proliferating, undifferentiated; 	NULL	2679	normal	P02545	pre-adipocytes	NULL
EXP054963	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: non-proliferating (confluent), undifferentiated; 	NULL	2679	normal	P02545	pre-adipocytes	NULL
EXP054964	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: Non-proliferating, differentiated for 1 day; 	NULL	2679	normal	P02545	pre-adipocytes	NULL
EXP054965	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: non-proliferating, differentiated for 3 day; 	NULL	2679	normal	P02545	pre-adipocytes	NULL
EXP054966	anti-Lamina (Santa Cruz, sc7292)	Homo sapiens	Passage: 5-7; Developmental stage: non-proliferating, differentiated for 9 day; 	NULL	2679	normal	P02545	pre-adipocytes	NULL
EXP054967	N/A	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054968	N/A	Homo sapiens		NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP054969	anti-lamin B1 (Abcam, #ab16048)	Homo sapiens		EXP054967	489	normal	Q03252	IMR90 (lung fibroblasts)	NULL
EXP054970	anti-lamin B1 (Abcam, #ab16048)	Homo sapiens		EXP054968	489	normal	Q03252	IMR90 (lung fibroblasts)	NULL
EXP054971	LC3 (Cell Signaling Technology #3868)	Homo sapiens		EXP054967	489	normal	Q9GZQ8	IMR90 (lung fibroblasts)	NULL
EXP054972	LC3 (Cell Signaling Technology #3868)	Homo sapiens		EXP054968	489	normal	Q9GZQ8	IMR90 (lung fibroblasts)	NULL
EXP054973	none	Homo sapiens	Treatment: DMSO 3 hrs;	NULL	2680	chip_control	NULL	SUM159R	NULL
EXP054974	none	Homo sapiens	Treatment: DMSO 3 hrs;	NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP054975	none	Homo sapiens	Treatment: DMSO 12 hrs;	NULL	2681	chip_control	NULL	HCC1395 (Ductal breast carcinoma)	NULL
EXP054976	none	Homo sapiens	Treatment: DMSO 12 hrs;	NULL	2682	chip_control	NULL	MDA-MB-436 (Invasive ductal carcinoma)	NULL
EXP054977	none	Homo sapiens	Treatment: DMSO 12 hrs;	NULL	2683	chip_control	NULL	SUM 1315 (Invasive ductal carcinoma)	NULL
EXP054978	none	Homo sapiens	Treatment: DMSO 3 hrs;	NULL	2684	chip_control	NULL	SUM149R	NULL
EXP054979	none	Homo sapiens	Treatment: DMSO 12 hrs;	NULL	2685	chip_control	NULL	SUM149	NULL
EXP054980	none	Homo sapiens	Treatment: DMSO 12 hrs;	NULL	818	chip_control	NULL	SUM185PE (ductal breast carcinoma)	NULL
EXP054981	none	Homo sapiens	Treatment: DMSO 12 hrs;	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP054982	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: DMSO 3 hrs;	NULL	2680	normal	O60885	SUM159R	NULL
EXP054983	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: JQ1 3 hrs;	NULL	2680	normal	O60885	SUM159R	NULL
EXP054984	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: DMSO 3 hrs;	EXP054974	817	normal	O60885	SUM159PT (Triple negative breast cancer)	NULL
EXP054985	BRD4 (Bethyl, catalog# A301-985A, lot# 2)	Homo sapiens	Treatment: JQ1 3 hrs;	NULL	817	normal	O60885	SUM159PT (Triple negative breast cancer)	NULL
EXP054986	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054975	2681	normal	O60885	HCC1395 (Ductal breast carcinoma)	NULL
EXP054987	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2681	normal	O60885	HCC1395 (Ductal breast carcinoma)	NULL
EXP054988	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054976	2682	normal	O60885	MDA-MB-436 (Invasive ductal carcinoma)	NULL
EXP054989	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2682	normal	O60885	MDA-MB-436 (Invasive ductal carcinoma)	NULL
EXP054990	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054977	2683	normal	O60885	SUM 1315 (Invasive ductal carcinoma)	NULL
EXP054991	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2683	normal	O60885	SUM 1315 (Invasive ductal carcinoma)	NULL
EXP054992	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054978	2684	normal	O60885	SUM149R	NULL
EXP054993	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2684	normal	O60885	SUM149R	NULL
EXP054994	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054979	2685	normal	O60885	SUM149	NULL
EXP054995	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	2685	normal	O60885	SUM149	NULL
EXP054996	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054980	818	normal	O60885	SUM185PE (ductal breast carcinoma)	NULL
EXP054997	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	818	normal	O60885	SUM185PE (ductal breast carcinoma)	NULL
EXP054998	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: DMSO 12 hrs;	EXP054981	111	normal	O60885	T47D (invasive ductal carcinoma)	NULL
EXP054999	BRD4 (Bethyl, catalog# A301-985A, lot# 4)	Homo sapiens	Treatment: JQ1 12 hrs;	NULL	111	normal	O60885	T47D (invasive ductal carcinoma)	NULL
EXP055000	rabbit IgG (sc-2027)	Homo sapiens	Tissue: brain; 	NULL	2600	chip_control	NULL	T98G (Glioblastoma)	NULL
EXP055001	rabbit IgG (sc-2027)	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055002	DYRK1A antibody (ab69811)	Homo sapiens	Tissue: brain; 	EXP055000	2600	normal	Q13627	T98G (Glioblastoma)	NULL
EXP055003	DYRK1A antibody (ab69811)	Homo sapiens	Tissue: brain; Growing condition: serum starvation; 	EXP055000	2600	normal	Q13627	T98G (Glioblastoma)	NULL
EXP055004	DYRK1A antibody (ab69811)	Homo sapiens		EXP055001	78	normal	Q13627	HeLa (cervical adenocarcinoma)	NULL
EXP055005	homemade rabbit IgG	Homo sapiens	Treatment: mimosine 0.5mM for 22h, cells released 3h and HU-3mM treated for 1h30;	NULL	774	chip_control	NULL	RKO (colon carcinoma cell)	NULL
EXP055006	anti-BRPF3 (homemade rabbit, from X-J Yang, McGill univ)	Homo sapiens		NULL	774	normal	Q9ULD4	RKO (colon carcinoma cell)	NULL
EXP055007	anti-BRPF3 (homemade rabbit, from X-J Yang, McGill univ)	Homo sapiens	Treatment: mimosine 0.5mM for 22h;	NULL	774	normal	Q9ULD4	RKO (colon carcinoma cell)	NULL
EXP055008	anti-BRPF3 (homemade rabbit, from X-J Yang, McGill univ)	Homo sapiens	Treatment: mimosine 0.5mM for 22h, cells released 3h and HU-3mM treated for 1h30;	EXP055005	774	normal	Q9ULD4	RKO (colon carcinoma cell)	NULL
EXP055009	IgG	Homo sapiens	Passage: 16-19;Treatment: nonspecific shRNA virus;	NULL	2686	chip_control	NULL	BGC-823 (Gastric adenocarcinoma)	NULL
EXP055010	anti-WDR5 (CST,13105)	Homo sapiens	Passage: 16-19;Treatment: nonspecific shRNA virus;	EXP055009	2686	normal	Q86V15	BGC-823 (Gastric adenocarcinoma)	NULL
EXP055011	anti-WDR5 (CST,13105)	Homo sapiens	Genotype: WDR5 knockout; Passage: 16-19; Treatment: nonspecific shRNA adenovirus against human lncRNA PRLG;	EXP055009	2686	normal	Q86V15	BGC-823 (Gastric adenocarcinoma)	NULL
EXP055012	anti-KAT2A (CST,3305)	Homo sapiens	Passage: 16-19;Treatment: nonspecific shRNA virus;	EXP055009	2686	normal	Q92830	BGC-823 (Gastric adenocarcinoma)	NULL
EXP055013	anti-KAT2A (CST,3305)	Homo sapiens	Genotype: KAT2A knockout; Passage: 16-19; Treatment: nonspecific shRNA adenovirus against human lncRNA PRLG;	EXP055009	2686	normal	Q92830	BGC-823 (Gastric adenocarcinoma)	NULL
EXP055014	none	Homo sapiens	Genotype: overexpressing mdm2; 	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP055015	none	Homo sapiens	Genotype: knockout mdm2; 	NULL	375	chip_control	NULL	NCI-H1299 (large cell lung carcinoma)	NULL
EXP055016	anti-Mdm2 N20 (Santa Cruz, catalog# sc-813, lot# JO412)	Homo sapiens	Genotype: overexpressing mdm2; 	EXP055014	375	normal	Q00987	NCI-H1299 (large cell lung carcinoma)	NULL
EXP055017	anti-Mdm2 N20 (Santa Cruz, catalog# sc-813, lot# JO412)	Homo sapiens	Genotype: knockout mdm2; 	EXP055015	375	normal	Q00987	NCI-H1299 (large cell lung carcinoma)	NULL
EXP055018	None	Homo sapiens	Treatment: none; Passage: 10;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP055019	None	Homo sapiens	Treatment: DHT 10-7M 210 min; Passage: 10; Genotype: CHD1 knockdown;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP055020	anti-CHD1 (Bethyl, catalog# A301-218A, lot# A301-218A-1)	Homo sapiens	Treatment: DHT 10-7M 210 min; Passage: 10;	EXP055018	70	normal	O14646	LNCaP (prostate carcinoma)	NULL
EXP055021	anti-CHD1 (Bethyl, catalog# A301-218A, lot# A301-218A-1)	Homo sapiens	Treatment: none; Passage: 10;	EXP055018	70	normal	O14646	LNCaP (prostate carcinoma)	NULL
EXP055022	anti-CHD1 (Bethyl, catalog# A301-218A, lot# A301-218A-1)	Homo sapiens	Treatment: DHT 10-7M 210 min; Passage: 10; Genotype: CHD1 knockdown;	EXP055019	70	normal	O14646	LNCaP (prostate carcinoma)	NULL
EXP055023	IgG control	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP055024	UTX (home made 9838P mixed with A302-374A)	Homo sapiens		EXP055023	509	normal	O15550	Jurkat (T-cells)	NULL
EXP055025	none	Homo sapiens	Treatment: DMSO(0.1%) for 15 min;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055026	none	Homo sapiens	Treatment: 50 uM MNNG for 15 min;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055027	Goat polyclonal anti-MIF(Abcam ab38146)	Homo sapiens	Treatment: DMSO(0.1%) for 15 min;	EXP055025	78	normal	P03971	HeLa (cervical adenocarcinoma)	NULL
EXP055028	Goat polyclonal anti-MIF(Abcam ab38146)	Homo sapiens	Treatment: 50 uM MNNG for 15 min;	EXP055026	78	normal	P03971	HeLa (cervical adenocarcinoma)	NULL
EXP055029	input	Homo sapiens	Treatment: untreated;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055030	input	Homo sapiens	Treatment: untreated;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055031	input	Homo sapiens	Treatment: untreated;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055032	input	Homo sapiens	Treatment: DMSO;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055033	input	Homo sapiens	Treatment: CA25;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055034	input	Homo sapiens	Treatment: untreated;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP055035	input	Homo sapiens	Treatment: untreated;	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP055036	input	Homo sapiens	Treatment: untreated;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055037	input	Homo sapiens	Treatment: untreated;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055038	input	Homo sapiens	Treatment: DMSO;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055039	input	Homo sapiens	Treatment: DMSO;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055040	input	Homo sapiens	Treament: iBET151_500;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055041	input	Homo sapiens	Treament: iBET151_500;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055042	input	Homo sapiens	Treatment: DMSO;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055043	input	Homo sapiens	Treatment: DMSO;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055044	input	Homo sapiens	Treament: iBET151_500;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055045	input	Homo sapiens	Treament: iBET151_500;	NULL	2687	chip_control	NULL	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055046	CDK8_b1	Homo sapiens	Treatment: untreated;	EXP055029	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055047	CDK8_b1	Homo sapiens	Treatment: untreated;	EXP055030	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055048	MED1	Homo sapiens	Treatment: untreated;	EXP055031	2687	normal	O95243	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055049	BRD4	Homo sapiens	Treatment: DMSO;	EXP055032	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055050	BRD4	Homo sapiens	Treatment: CA25;	EXP055033	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055051	CDK8	Homo sapiens	Treatment: untreated;	EXP055034	2218	normal	P49336	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP055052	CDK8	Homo sapiens	Treatment: untreated;	EXP055035	2218	normal	P49336	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP055053	CDK8	Homo sapiens	Treatment: untreated;	EXP055036	641	normal	P49336	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055054	CDK8	Homo sapiens	Treatment: untreated;	EXP055037	514	normal	P49336	K562 (myelogenous leukemia)	NULL
EXP055055	CDK8	Homo sapiens	Treatment: DMSO;	EXP055038	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055056	CDK8	Homo sapiens	Treatment: DMSO;	EXP055039	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055057	CDK8	Homo sapiens	Treament: iBET151_500;	EXP055040	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055058	CDK8	Homo sapiens	Treament: iBET151_500;	EXP055041	2687	normal	P49336	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055059	BRD4	Homo sapiens	Treatment: DMSO;	EXP055042	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055060	BRD4	Homo sapiens	Treatment: DMSO;	EXP055043	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055061	BRD4	Homo sapiens	Treament: iBET151_500;	EXP055044	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055062	BRD4	Homo sapiens	Treament: iBET151_500;	EXP055045	2687	normal	O60885	MOLM14 (Adult acute myeloid leukemia)	NULL
EXP055063	rabbit IgG	Homo sapiens	Treatment: none (control); Genotype: phosphoEGFR (Tyr845);	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055064	rabbit IgG	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoEGFR (Tyr845);	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055065	none	Homo sapiens	Treatment: none (control); Genotype: phosphoEGFR (Tyr845);	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055066	none	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoEGFR (Tyr845);	NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055067	pEGFR (Cell Signaling, D63B4)	Homo sapiens	Treatment: none (control); Genotype: phosphoEGFR (Tyr845);	EXP055065	423	normal	P00533	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055068	pEGFR (Cell Signaling, D63B4)	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoEGFR (Tyr845);	EXP055066	423	normal	P00533	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055069	pErk1/2 (Cell Signaling, 4370P)	Homo sapiens	Treatment: none (control); Genotype: phosphoErk1/2 (Thr202/Tyr204);	EXP055065	423	normal	P27361	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055070	pErk1/2 (Cell Signaling, 4370P)	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoErk1/2 (Thr202/Tyr204);	EXP055066	423	normal	P27361	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055071	Mek1/2 (Cell Signaling, 9121S)	Homo sapiens	Treatment: none (control); Genotype: phosphoMek1/2 (Ser217/221);	EXP055065	423	normal	Q02750	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055072	Mek1/2 (Cell Signaling, 9121S)	Homo sapiens	Treatment: EGF (100 ng/ml) for 20min; Genotype: phosphoMek1/2 (Ser217/221);	EXP055066	423	normal	Q02750	HeLa S3 (cervical adenocarcinoma)	NULL
EXP055073	none	Homo sapiens		NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP055074	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055075	none	Homo sapiens		NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP055076	CENP-A (Santa Cruz, sc-22787 & sc-11277)	Homo sapiens		EXP055073	821	normal	P49450	SW480 (colon adenocarcinoma)	NULL
EXP055077	CENP-A (Santa Cruz, sc-22787 & sc-11277)	Homo sapiens		NULL	2688	normal	P49450	HcoEpiC (Human normal colon cell line)	NULL
EXP055078	CENP-A (Santa Cruz, sc-22787 & sc-11277)	Homo sapiens		EXP055074	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP055079	HJURP (Bethyl, A302-822A)	Homo sapiens		EXP055073	821	normal	Q8NCD3	SW480 (colon adenocarcinoma)	NULL
EXP055080	HJURP (Bethyl, A302-822A)	Homo sapiens		EXP055074	78	normal	Q8NCD3	HeLa (cervical adenocarcinoma)	NULL
EXP055081	CNOT3 (Novus Biologicals, catalog# H00004849_M01, lot# A1171-4B8)	Homo sapiens		NULL	417	normal	O75175	HCT-116 (colon carcinoma)	NULL
EXP055082	CNOT3 (Novus Biologicals, catalog# H00004849_M01, lot# A1171-4B8)	Homo sapiens		NULL	2689	normal	O75175	primary colorectal carcinoma	NULL
EXP055083		Homo sapiens	Treatment: DMSO;	NULL	2690	chip_control	NULL	NCI-H526 (Small cell lung carcinoma)	NULL
EXP055084		Homo sapiens	Treatment: 1 uM GSK2879552 for 24 hours;	NULL	2690	chip_control	NULL	NCI-H526 (Small cell lung carcinoma)	NULL
EXP055085	LSD1	Homo sapiens	Treatment: DMSO;	EXP055083	2690	normal	O60341	NCI-H526 (Small cell lung carcinoma)	NULL
EXP055086	LSD1	Homo sapiens	Treatment: 1 uM GSK2879552 for 24 hours;	EXP055084	2690	normal	O60341	NCI-H526 (Small cell lung carcinoma)	NULL
EXP055087	none (input)	Homo sapiens	Treatment: control, non heat shock (37 degree C); Time point: 30 min	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055088	none (input)	Homo sapiens	Treatment: heat shock (30min at 43 degree C); Time point: 30 min	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055089	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: control, non heat shock (37 degree C); Time point: 30 min	EXP055087	514	normal	P61956	K562 (myelogenous leukemia)	NULL
EXP055090	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: heat shock (30min at 43 degree C); Time point: 30 min	EXP055088	514	normal	P61956	K562 (myelogenous leukemia)	NULL
EXP055091	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against HSF1, non heat shock (37 degree C); Time point: 30 min; Genotype: HSF1 knockdown	NULL	514	normal	P61956	K562 (myelogenous leukemia)	NULL
EXP055092	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against HSF1, heat shock (30min at 43 degree C); Time point: 30 min; Genotype: HSF1 knockdown	EXP055088	514	normal	P61956	K562 (myelogenous leukemia)	NULL
EXP055093	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against SCR, non heat shock (37 degree C); Time point: 30 min	EXP055087	514	normal	P61956	K562 (myelogenous leukemia)	NULL
EXP055094	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: shRNA against SCR, heat shock (30min at 43 degree C); Time point: 30 min	EXP055088	514	normal	P61956	K562 (myelogenous leukemia)	NULL
EXP055095	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: heat shock (30min at 43 degree C);; Time point: 30 min	NULL	71	normal	P61956	VCaP (prostate carcinoma)	NULL
EXP055096	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: heat shock and recovery (30min at 43 degree C followed by 1h at 37 degree C); Time point: 90 min	NULL	71	normal	P61956	VCaP (prostate carcinoma)	NULL
EXP055097	anti-PIAS1 (Abcam, catalog ab77231, lot YI122105C)	Homo sapiens	Treatment: heat shock (30min at 43 degree C); Time point: 30 min	NULL	71	normal	O75925	VCaP (prostate carcinoma)	NULL
EXP055098	anti-PIAS1 (Abcam, catalog ab77231, lot YI122105C)	Homo sapiens	Treatment: heat shock and recovery (30min at 43 degree C followed by 1h at 37 degree C); Time point: 90 min	NULL	71	normal	O75925	VCaP (prostate carcinoma)	NULL
EXP055099	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: control siRNA, non heat shock (37 degree C); Time point: 30 min	NULL	71	normal	P11226	VCaP (prostate carcinoma)	NULL
EXP055100	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: control siRNA, heat shock (30min at 43 degree C); Time point: 30 min	NULL	71	normal	P11226	VCaP (prostate carcinoma)	NULL
EXP055101	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: siRNA against PIAS1, non heat shock (37 degree C); Time point: 30 min; Genotype: PIAS1 knockdown	NULL	71	normal	P11226	VCaP (prostate carcinoma)	NULL
EXP055102	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: siRNA against PIAS1, heat shock (30min at 43 degree C); Time point: 30 min; Genotype: PIAS1 knockdown	NULL	71	normal	P11226	VCaP (prostate carcinoma)	NULL
EXP055103	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: 3 hours of 1uM Triptolide; Time point: 3 hours	NULL	71	normal	P61956	VCaP (prostate carcinoma)	NULL
EXP055104	anti-SUMO-2/3 (MBL, catalog M114-3, lot 024)	Homo sapiens	Treatment: 3 hours of 100uM DBR (5,6-Dichlorobenzimidazole 1-beta-D-ribofuranoside); Time point: 3 hours	NULL	71	normal	P61956	VCaP (prostate carcinoma)	NULL
EXP055105	None	Homo sapiens	Treatment: untreated control;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055106	None	Homo sapiens	Treatment: untreated control;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055107	Anti-Top2Beta (made in-house)	Homo sapiens	Treatment: untreated control;	EXP055105	113	normal	Q6LC06	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055108	Anti-Top2Beta (made in-house)	Homo sapiens	Treatment: 10 nM Estradiol for 30 mins; 	EXP055106	113	normal	Q6LC06	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055109	none	Homo sapiens	Treatment: DMSO for 48 hrs;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055110	none	Homo sapiens	Treatment: DMSO for 96 hrs;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055111	none	Homo sapiens	Treatment: UNC0638 for 48 hrs;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055112	none	Homo sapiens	Treatment: UNC0638 for 96 hrs;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055113	none	Homo sapiens	Treatment: NS;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055114	none	Homo sapiens	Treatment: siWIZ;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055115	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: DMSO for 48 hrs;	EXP055109	10	normal	Q96KQ7	HEK293T (embryonic kidney)	NULL
EXP055116	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: DMSO for 96 hrs;	NULL	10	normal	Q96KQ7	HEK293T (embryonic kidney)	NULL
EXP055117	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: UNC0638 for 48 hrs;	EXP055111	10	normal	Q96KQ7	HEK293T (embryonic kidney)	NULL
EXP055118	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: UNC0638 for 96 hrs;	EXP055112	10	normal	Q96KQ7	HEK293T (embryonic kidney)	NULL
EXP055119	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: NS;	EXP055113	10	normal	Q96KQ7	HEK293T (embryonic kidney)	NULL
EXP055120	anti-G9a (Abcam, #ab40542)	Homo sapiens	Treatment: siWIZ;	EXP055114	10	normal	Q96KQ7	HEK293T (embryonic kidney)	NULL
EXP055121	none	Homo sapiens	Genotype: wildtype MEF2B-V5;	NULL	2691	chip_control	NULL	HEK293-A	NULL
EXP055122	none	Homo sapiens	Genotype: wildtype MEF2B-V5;	NULL	2691	chip_control	NULL	HEK293-A	NULL
EXP055123	none	Homo sapiens	Genotype: K4E-MEF2B-V5;	NULL	2691	chip_control	NULL	HEK293-A	NULL
EXP055124	none	Homo sapiens	Genotype: K4E-MEF2B-V5;	NULL	2691	chip_control	NULL	HEK293-A	NULL
EXP055125	none	Homo sapiens	Genotype: D83V-MEF2B-V5;	NULL	2691	chip_control	NULL	HEK293-A	NULL
EXP055126	none	Homo sapiens	Genotype: D83V-MEF2B-V5;	NULL	2691	chip_control	NULL	HEK293-A	NULL
EXP055127	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: wildtype MEF2B-V5;	EXP055121	2691	normal	Q02080	HEK293-A	NULL
EXP055128	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: wildtype MEF2B-V5;	EXP055122	2691	normal	Q02080	HEK293-A	NULL
EXP055129	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: K4E-MEF2B-V5;	EXP055123	2691	normal	Q02080	HEK293-A	NULL
EXP055130	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: K4E-MEF2B-V5;	EXP055124	2691	normal	Q02080	HEK293-A	NULL
EXP055131	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: D83V-MEF2B-V5;	EXP055125	2691	normal	Q02080	HEK293-A	NULL
EXP055132	anti-V5 (Invitrogen, R960-25)	Homo sapiens	Genotype: D83V-MEF2B-V5;	EXP055126	2691	normal	Q02080	HEK293-A	NULL
EXP055133		Homo sapiens	Treatment: DMSO;	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP055134		Homo sapiens	Treatment: 25 uM A771726;	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP055135	anti-CDK9 (Santa Cruz)	Homo sapiens	Treatment: DMSO;	EXP055133	36	normal	P50750	A375 (malignant melanoma)	NULL
EXP055136	anti-CDK9 (Santa Cruz)	Homo sapiens	Treatment: 25 uM A771726;	EXP055134	36	normal	P50750	A375 (malignant melanoma)	NULL
EXP055137	anti-HEXIM1 (Abcam)	Homo sapiens	Treatment: DMSO;	EXP055133	36	normal	O94992	A375 (malignant melanoma)	NULL
EXP055138	anti-HEXIM1 (Abcam)	Homo sapiens	Treatment: 25 uM A771726;	EXP055134	36	normal	O94992	A375 (malignant melanoma)	NULL
EXP055139	none	Homo sapiens	Developmental stage: Day 12 ; 	NULL	2692	chip_control	NULL	differentiated NPC cells	NULL
EXP055140	anti-AF9 (NOVUS, NB100-1566)	Homo sapiens	Developmental stage: Day 12 ; 	EXP055139	2692	normal	P42568	differentiated NPC cells	NULL
EXP055141	anti-TET2 (Abiocode, R-1086)	Homo sapiens	Developmental stage: Day 12 ; 	EXP055139	2692	normal	Q6N021	differentiated NPC cells	NULL
EXP055142	IgG	Homo sapiens		NULL	454	chip_control	NULL	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055143	MED1 (Bethyl, catalog# A300-793A, lot# A300-793A)	Homo sapiens	Treatment: siRNA control; 	NULL	454	bio_control	O95243	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055144	MED1 (Bethyl, catalog# A300-793A, lot# A300-793A)	Homo sapiens	Treatment: siYAP/TAZ; 	EXP055142	454	normal	O95243	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055145	SMC1 (Bethyl, catalog# A300-005A, lot# A300-055A-3)	Homo sapiens	Treatment: siRNA control; 	EXP055142	454	bio_control	Q14683	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055146	SMC1 (Bethyl, catalog# A300-005A, lot# A300-055A-3)	Homo sapiens	Treatment: siYAP/TAZ; 	EXP055142	454	normal	Q14683	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055147	CDK9 (Santa Cruz, catalog# sc-484, lot# I0414)	Homo sapiens	Treatment: siRNA control; 	EXP055142	454	bio_control	P50750	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055148	CDK9 (Santa Cruz, catalog# sc-484, lot# I0414)	Homo sapiens	Treatment: siYAP/TAZ; 	EXP055142	454	normal	P50750	HuCCT1 (intrahepatic cholangiocarcinoma)	NULL
EXP055149	none	Homo sapiens	Genotype: wildtype; 	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055150	none	Homo sapiens	Genotype: DAXX knockdown; 	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055151	anti-DAXX (sc-7001)	Homo sapiens	Genotype: wildtype; 	EXP055149	725	normal	Q9UER7	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055152	anti-DAXX (sc-7001)	Homo sapiens	Genotype: DAXX knockdown; 	EXP055150	725	normal	Q9UER7	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055153	anti-DNMT1 (sc-10219)	Homo sapiens	Genotype: wildtype; 	EXP055149	725	normal	P26358	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055154	anti-DNMT1 (sc-10219)	Homo sapiens	Genotype: DAXX knockdown; 	NULL	725	normal	P26358	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055155	IgG non specific antibody	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP055156	anti-WRN antibody	Homo sapiens		EXP055155	421	normal	Q14191	HEK293 (embryonic kidney)	NULL
EXP055157	IgG	Homo sapiens	Treatment: untreated;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055158	none	Homo sapiens	Treatment: untreated;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055159	AGO2 (Millipore 04-642)	Homo sapiens	Treatment: untreated;	EXP055158	514	normal	Q9UKV8	K562 (myelogenous leukemia)	NULL
EXP055160	AGO2 (Abcam, ab57113)	Homo sapiens	Treatment: untreated;	EXP055158	514	normal	Q9UKV8	K562 (myelogenous leukemia)	NULL
EXP055161	normal rabbit IgG (sc-2027, Santa Cruz Biotechnology)	Homo sapiens		NULL	2693	chip_control	NULL	hTERT-RPE1	NULL
EXP055162	normal goat IgG (sc-2028, Santa Cruz Biotechnology)	Homo sapiens		NULL	2693	chip_control	NULL	hTERT-RPE1	NULL
EXP055163	normal rabbit IgG (sc-2027, Santa Cruz Biotechnology)	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055164	normal goat IgG (sc-2028, Santa Cruz Biotechnology)	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055165	E2F1 (sc-193, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q01094	hTERT-RPE1	NULL
EXP055166	CASP8AP2 (sc-9088, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q9UKL3	hTERT-RPE1	NULL
EXP055167	NPAT (sc-67007, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q14207	hTERT-RPE1	NULL
EXP055168	HINFP (sc-49818, Santa Cruz Biotechnology)	Homo sapiens		EXP055161	2693	normal	Q9BQA5	hTERT-RPE1	NULL
EXP055169	E2F1 (sc-193, Santa Cruz Biotechnology)	Homo sapiens		EXP055164	848	normal	Q01094	U2OS (osteosarcoma)	NULL
EXP055170	CASP8AP2 (sc-9088, Santa Cruz Biotechnology)	Homo sapiens		NULL	848	normal	Q9UKL3	U2OS (osteosarcoma)	NULL
EXP055171	NPAT (sc-67007, Santa Cruz Biotechnology)	Homo sapiens		EXP055164	848	normal	Q14207	U2OS (osteosarcoma)	NULL
EXP055172	HINFP (sc-49818, Santa Cruz Biotechnology)	Homo sapiens		EXP055164	848	normal	Q9BQA5	U2OS (osteosarcoma)	NULL
EXP055173	none	Homo sapiens	Treatment: vehicle (ETOH) for 4 hrs;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP055174	none	Homo sapiens	Treatment: 10nM DHT for 4 hrs;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP055175	none	Homo sapiens	Treatment: vehicle (ETOH) for 4 hrs;	NULL	2310	chip_control	NULL	LNCaP-abl (Prostate carcinoma)	NULL
EXP055176	TRIM24 (Bethyl, A300-815A)	Homo sapiens	Treatment: vehicle (ETOH) for 4 hrs;	EXP055173	70	normal	O15164	LNCaP (prostate carcinoma)	NULL
EXP055177	TRIM24 (Bethyl, A300-815A)	Homo sapiens	Treatment: 10nM DHT for 4 hrs;	EXP055174	70	normal	O15164	LNCaP (prostate carcinoma)	NULL
EXP055178	TRIM24 (Bethyl, A300-815A)	Homo sapiens	Treatment: vehicle (ETOH) for 4 hrs;	EXP055175	2310	normal	O15164	LNCaP-abl (Prostate carcinoma)	NULL
EXP055179	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: cR1; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055180	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: cR2; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055181	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: cR2; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055182	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: Db; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055183	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R1b knockout; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055184	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R2b knockout; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055185	RAG1	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: wildtype; Sex: female;	NULL	44	normal	P15919	T-cells	NULL
EXP055186	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: Db; Sex: female;	NULL	44	normal	P21784	T-cells	NULL
EXP055187	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: wildtype; Sex: female;	NULL	44	normal	P21784	T-cells	NULL
EXP055188	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: cR1; Sex: female;	NULL	44	normal	P21784	T-cells	NULL
EXP055189	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: cR2; Sex: female;	NULL	44	normal	P21784	T-cells	NULL
EXP055190	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R1b knockout; Sex: female;	NULL	44	normal	P21784	T-cells	NULL
EXP055191	RAG2	Mus musculus	Age: 5 weeks; Strain: C57BL/6; Genotype: R2b knockout; Sex: female;	NULL	44	normal	P21784	T-cells	NULL
EXP055192	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: Db; Sex: female;	NULL	2695	normal	P15919	CD19+ bone marrow cell	NULL
EXP055193	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: R1b kncokout; Sex: pooled male and female;	NULL	2695	normal	P15919	CD19+ bone marrow cell	NULL
EXP055194	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: R1b kncokout; Sex: pooled male and female;	NULL	2695	normal	P15919	CD19+ bone marrow cell	NULL
EXP055195	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: BD; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	NULL
EXP055196	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: R2b kncokout; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	NULL
EXP055197	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: wildtype; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	NULL
EXP055198	RAG2	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: BD; Sex: pooled male and female;	NULL	2695	normal	P21784	CD19+ bone marrow cell	NULL
EXP055199	RAG1	Mus musculus	Age: 4 weeks; Strain: C57BL/6; Genotype: V-ABL; Sex: pooled male and female;	NULL	2425	normal	P15919	a pool of both sham and transverse aortic constriction	NULL
EXP055200	RAG1	Homo sapiens	Age: Mixture: 4 months or 1.5 years;	NULL	882	normal	P15918	T-cells	NULL
EXP055201	RAG2	Homo sapiens	Age: 4 months;	NULL	882	normal	P55895	T-cells	NULL
EXP055202	RAG1	Homo sapiens	Age: 4 months or 1.5 years; 	NULL	882	normal	P15918	T-cells	NULL
EXP055203	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055204	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q05BQ5	K562 (myelogenous leukemia)	NULL
EXP055205	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q9H2F5	K562 (myelogenous leukemia)	NULL
EXP055206	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q92993	K562 (myelogenous leukemia)	NULL
EXP055207	ANTI-FLAG M2 antibody (Sigma, F1802, SLFB6631)	Homo sapiens		EXP055203	514	normal	Q9H2F5	K562 (myelogenous leukemia)	NULL
EXP055208	anti-V5 antibody (Cat# R960CUS, Life Technologies)	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP055209	anti-V5 antibody (Cat# R960CUS, Life Technologies)	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP055210	anti-V5 antibody (Cat# R960CUS, Life Technologies)	Homo sapiens		EXP055208	421	normal	P57682	HEK293 (embryonic kidney)	NULL
EXP055211	anti-V5 antibody (Cat# R960CUS, Life Technologies)	Homo sapiens		EXP055209	421	normal	P57682	HEK293 (embryonic kidney)	NULL
EXP055212	None	Homo sapiens		NULL	2634	chip_control	NULL	HuRef (Lymphoblast)	NULL
EXP055213	Anti-CENP-A (Abcam anti-CENP-A Ab13939)	Homo sapiens		EXP055212	2634	normal	P49450	HuRef (Lymphoblast)	NULL
EXP055214	Anti-CENP-T (Abcam cat #Ab114120)	Homo sapiens		EXP055212	2634	normal	Q96BT3	HuRef (Lymphoblast)	NULL
EXP055215	Normal Rabbit IgG (Santa Cruz Biotechnology, sc-2027)	Homo sapiens	Genotype: wildtype; 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055216	Normal Rabbit IgG (Santa Cruz Biotechnology, sc-2027)	Homo sapiens	Genotype: p53 knockout; 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055217	SMAR1/BANP (Bethyl Laboratories, A300-279A)	Homo sapiens	Genotype: wildtype; 	EXP055215	417	normal	Q8N9N5	HCT-116 (colon carcinoma)	NULL
EXP055218	SMAR1/BANP (Bethyl Laboratories, A300-279A)	Homo sapiens	Genotype: p53 knockout; 	EXP055216	417	normal	Q8N9N5	HCT-116 (colon carcinoma)	NULL
EXP055219	ORC2 antibody (Santa Cruz, sc-28742)	Homo sapiens		NULL	514	normal	Q13416	K562 (myelogenous leukemia)	NULL
EXP055220	none	Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055221	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055222	LMTK3 (monoclonal antibody (M02), clone 2H6, Abnova, H00114783-M02)	Homo sapiens		EXP055220	113	normal	Q96Q04	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055223	LMTK3 (monoclonal antibody (M02), clone 2H6, Abnova, H00114783-M02)	Homo sapiens		EXP055221	2301	normal	Q96Q04	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055224	input	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055225	input	Homo sapiens		NULL	1205	chip_control	NULL	Reh (ATCC CRL-8286)	NULL
EXP055226	input	Homo sapiens		NULL	2525	chip_control	NULL	SUP-B15 (Childhood B acute lymphoblastic leukemia)	NULL
EXP055227	input	Homo sapiens		NULL	444	chip_control	NULL	HPB-ALL (T acute lymphoblastic leukemia)	NULL
EXP055228	input	Homo sapiens		NULL	61	chip_control	NULL	ALL-SIL (acute lymphoblastic leukemia)	NULL
EXP055229	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055224	514	normal	Q8NHM5	K562 (myelogenous leukemia)	NULL
EXP055230	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055225	1205	normal	Q8NHM5	Reh (ATCC CRL-8286)	NULL
EXP055231	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055226	2525	normal	Q8NHM5	SUP-B15 (Childhood B acute lymphoblastic leukemia)	NULL
EXP055232	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		NULL	220	normal	Q8NHM5	DND41 (acute lymphoblastic leukemia)	NULL
EXP055233	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055227	444	normal	Q8NHM5	HPB-ALL (T acute lymphoblastic leukemia)	NULL
EXP055234	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		NULL	509	normal	Q8NHM5	Jurkat (T-cells)	NULL
EXP055235	anti-KDM2B (Millipore, catalog# 09-864)	Homo sapiens		EXP055228	61	normal	Q8NHM5	ALL-SIL (acute lymphoblastic leukemia)	NULL
EXP055236	none	Homo sapiens	Treatment: none;	NULL	2696	chip_control	NULL	TC-797	NULL
EXP055237	none	Homo sapiens	Treatment: none;	NULL	2696	chip_control	NULL	TC-797	NULL
EXP055238	none	Homo sapiens	Treatment: none;	NULL	2696	chip_control	NULL	TC-797	NULL
EXP055239	none	Homo sapiens	Treatment: none;	NULL	2696	chip_control	NULL	TC-797	NULL
EXP055240	none	Homo sapiens	Treatment: none;	NULL	2696	chip_control	NULL	TC-797	NULL
EXP055241	none	Homo sapiens	Treatment: none;	NULL	2697	chip_control	NULL	1015 (MNC, Grayson et al. 2014)	NULL
EXP055242	none	Homo sapiens	Treatment: none;	NULL	2697	chip_control	NULL	1015 (MNC, Grayson et al. 2014)	NULL
EXP055243	none	Homo sapiens	Treatment: none;	NULL	2698	chip_control	NULL	PER-403 (Kees et al. 1991)	NULL
EXP055244	none	Homo sapiens	Treatment: none;	NULL	2699	chip_control	NULL	10326 (NMC, French et al. 2008)	NULL
EXP055245	none	Homo sapiens	Treatment: 4hr  JQ1 (final concentration of 500 nM);	NULL	2696	chip_control	NULL	TC-797	NULL
EXP055246	none	Homo sapiens	Treatment: No Tetracycline was added to the media;	NULL	11	chip_control	NULL	HEK293-T-Rex (embryonic kidney)	NULL
EXP055247	none	Homo sapiens	Treatment: 2hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	NULL	11	chip_control	NULL	HEK293-T-Rex (embryonic kidney)	NULL
EXP055248	none	Homo sapiens	Treatment: 7hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	NULL	11	chip_control	NULL	HEK293-T-Rex (embryonic kidney)	NULL
EXP055249	none	Homo sapiens	Treatment: 3hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	NULL	11	chip_control	NULL	HEK293-T-Rex (embryonic kidney)	NULL
EXP055250	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: none;	EXP055236	2696	normal	O60885	TC-797	NULL
EXP055251	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: none;	EXP055237	2696	normal	O60885	TC-797	NULL
EXP055252	BRD4 long form (anti-BRD4-L, against long isoforms of BRD4, Active Motif, catalog no. 39909)	Homo sapiens	Treatment: none;	EXP055236	2696	normal	O15534	TC-797	NULL
EXP055253	BRD4 long form (anti-BRD4-L, against long isoforms of BRD4, Active Motif, catalog no. 39909)	Homo sapiens	Treatment: none;	EXP055237	2696	normal	O60885	TC-797	NULL
EXP055254	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055236	2696	normal	O60885	TC-797	NULL
EXP055255	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055237	2696	normal	O60885	TC-797	NULL
EXP055256	anti-P300 (10 ul, Bethyl, catalog no. A300-358A)	Homo sapiens	Treatment: none;	EXP055238	2696	normal	Q09472	TC-797	NULL
EXP055257	anti-P300 (10 ul, Bethyl, catalog no. A300-358A)	Homo sapiens	Treatment: none;	EXP055239	2696	normal	Q09472	TC-797	NULL
EXP055258	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055240	2696	normal	O60885	TC-797	NULL
EXP055259	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055241	2697	normal	O60885	1015 (MNC, Grayson et al. 2014)	NULL
EXP055260	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055242	2697	normal	O60885	1015 (MNC, Grayson et al. 2014)	NULL
EXP055261	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055243	2698	normal	O60885	PER-403 (Kees et al. 1991)	NULL
EXP055262	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: none;	EXP055244	2699	normal	O60885	10326 (NMC, French et al. 2008)	NULL
EXP055263	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: 4hr  JQ1 (final concentration of 500 nM);	EXP055245	2696	normal	O60885	TC-797	NULL
EXP055264	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: 4hr  JQ1 (final concentration of 500 nM);	EXP055245	2696	normal	O60885	TC-797	NULL
EXP055265	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: No Tetracycline was added to the media;	EXP055246	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055266	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: No Tetracycline was added to the media;	EXP055246	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055267	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	2h -incubation time period with Tetracycline (final concentration of 1ug/ml).	EXP055247	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055268	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	2h -incubation time period with Tetracycline (final concentration of 1ug/ml).	EXP055247	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055269	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: 7hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055248	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055270	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: 7hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055248	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055271	anti-BRD4 (against short and long isoforms of BRD4, Bethyl, catalog no. A301-985A)	Homo sapiens	Treatment: 3hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055249	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055272	anti-NUT (Cell Signaling, catalog no. 3625)	Homo sapiens	Treatment: 3hrs -incubation time period with Tetracycline (final concentration of 1ug/ml);	EXP055249	11	normal	O60885	HEK293-T-Rex (embryonic kidney)	NULL
EXP055273		Homo sapiens	Treatment: Doxycycline;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP055274		Homo sapiens	Treatment: untreated;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP055275		Homo sapiens	Treatment: untreated;	NULL	2700	chip_control	NULL	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055276		Homo sapiens	Treatment: Doxycycline;	NULL	2700	chip_control	NULL	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055277		Homo sapiens	Treatment: untreated;	NULL	2700	chip_control	NULL	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055278		Homo sapiens	Treatment: Doxycycline;	NULL	2700	chip_control	NULL	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055279		Homo sapiens	Treatment: untreated;	NULL	2701	chip_control	NULL	TTC-549 (extrarenal rhabdoid tumor)	NULL
EXP055280		Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	NULL	2701	chip_control	NULL	TTC-549 (extrarenal rhabdoid tumor)	NULL
EXP055281	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055273	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	NULL
EXP055282	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: Doxycycline induced SMARCA4 reexpresion;	EXP055273	937	normal	P51532	G401 (rhabdoid tumor of the kidney)	NULL
EXP055283	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: untreated;	EXP055274	937	normal	Q92922	G401 (rhabdoid tumor of the kidney)	NULL
EXP055284	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: untreated;	EXP055274	937	normal	P51532	G401 (rhabdoid tumor of the kidney)	NULL
EXP055285	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: untreated;	EXP055275	2700	normal	Q92922	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055286	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: untreated;	EXP055275	2700	normal	P51532	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055287	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055276	2700	normal	Q92922	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055288	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055276	2700	normal	P51532	BT-16 (atypical teratoid/rhabdoid tumor)	NULL
EXP055289	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: untreated;	EXP055279	2701	normal	Q92922	TTC-549 (extrarenal rhabdoid tumor)	NULL
EXP055290	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: untreated;	EXP055279	2701	normal	P51532	TTC-549 (extrarenal rhabdoid tumor)	NULL
EXP055291	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Treatment: Doxycycline induced SMARCB1 reexpresion;	EXP055280	2701	normal	Q92922	TTC-549 (extrarenal rhabdoid tumor)	NULL
EXP055292	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Treatment: Doxycycline induced SMARCA4 reexpresion;	EXP055280	2701	normal	P51532	TTC-549 (extrarenal rhabdoid tumor)	NULL
EXP055293		Homo sapiens	Genotype: Parental;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055294		Homo sapiens	Genotype: Homozygous ARID1A-knockout;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055295	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Genotype: Parental;	EXP055293	417	normal	P51532	HCT-116 (colon carcinoma)	NULL
EXP055296	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Genotype: Parental;	EXP055293	417	normal	Q92922	HCT-116 (colon carcinoma)	NULL
EXP055297	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Homo sapiens	Genotype: Homozygous ARID1A-knockout;	EXP055294	417	normal	P51532	HCT-116 (colon carcinoma)	NULL
EXP055298	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Homo sapiens	Genotype: Homozygous ARID1A-knockout;	EXP055294	417	normal	Q92922	HCT-116 (colon carcinoma)	NULL
EXP055299	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055300	anti-Flag (Sigma, catalog# F1804, lot# SLBF6631)	Homo sapiens	Genotype: transiently expressing Flag-Za;	EXP055299	78	normal	Q9UM89	HeLa (cervical adenocarcinoma)	NULL
EXP055301	none	Homo sapiens	Treatment: DMSO for 4 days;	NULL	796	chip_control	NULL	SKNO-1 (acute myeloid leukemia)	NULL
EXP055302	none	Homo sapiens	Treatment: 1 uM RN-1 for 4 hrs; 	NULL	796	chip_control	NULL	SKNO-1 (acute myeloid leukemia)	NULL
EXP055303	none	Homo sapiens	Treatment: 1 uM GSK690 for 4 days;	NULL	796	chip_control	NULL	SKNO-1 (acute myeloid leukemia)	NULL
EXP055304	none	Homo sapiens	Treatment: DMSO for 72 hrs;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP055305	none	Homo sapiens	Treatment: 1 uM RN-1 for 72 hrs; 	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP055306	none	Homo sapiens	Treatment: 1 uM GSK690 for 72 hrs;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP055307	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: DMSO for 4 days;	EXP055301	796	normal	O60341	SKNO-1 (acute myeloid leukemia)	NULL
EXP055308	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM RN-1 for 4 days; 	EXP055302	796	normal	O60341	SKNO-1 (acute myeloid leukemia)	NULL
EXP055309	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM GSK690 for 4 days;	EXP055303	796	normal	O60341	SKNO-1 (acute myeloid leukemia)	NULL
EXP055310	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: DMSO for 72 hrs;	EXP055304	516	normal	O60341	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP055311	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM RN-1 for 72 hrs; 	EXP055305	516	normal	O60341	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP055312	anti-KDM1A (Bethyl, A300-215A)	Homo sapiens	Treatment: 1 uM GSK690 for 72 hrs;	EXP055306	516	normal	O60341	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP055313	none	Homo sapiens	Treatment: 0.1% DMSO;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055314	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 0.1% DMSO;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055315	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 500nM I-BET151;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055316	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 5uM SGC0946;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055317	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 500nM I-BET151 and 5uM SGC0946;	EXP055313	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055318	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 0.1% DMSO;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055319	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 5uM SGC0946 for 8hrs;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055320	anti-BRD4 (E2A7X, cell signalling, lot 1)	Homo sapiens	Treatment: 5uM SGC0946 for 8 hrs and washout;	NULL	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055321	none	Homo sapiens	Treatment: siRNA control;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055322	none	Homo sapiens	Treatment: siRNA treatment; Genotype: KDM3B knockout; 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055323	KDM3B (Millipore, 09-816)	Homo sapiens	Treatment: siRNA control;	EXP055321	417	normal	Q7LBC6	HCT-116 (colon carcinoma)	NULL
EXP055324	KDM3B (Millipore, 09-816)	Homo sapiens	Treatment: siRNA treatment; Genotype: KDM3B knockout; 	EXP055322	417	normal	Q7LBC6	HCT-116 (colon carcinoma)	NULL
EXP055325		Homo sapiens	Treatment: 2.5 uM SGC-CBP30;	NULL	2702	chip_control	NULL	LP-1 (plasma cell myeloma)	NULL
EXP055326		Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	2702	chip_control	NULL	LP-1 (plasma cell myeloma)	NULL
EXP055327	none	Homo sapiens	Treatment: 0.25 uM CPI267203;	NULL	2702	chip_control	NULL	LP-1 (plasma cell myeloma)	NULL
EXP055328	anti-P300 (Santa Cruz, sc-585X)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP055326	2702	normal	Q09472	LP-1 (plasma cell myeloma)	NULL
EXP055329	anti-P300 (Santa Cruz, sc-585X)	Homo sapiens	Treatment: 2.5 uM SGC-CBP30;	EXP055325	2702	normal	Q09472	LP-1 (plasma cell myeloma)	NULL
EXP055330	anti-BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP055326	2702	normal	O60885	LP-1 (plasma cell myeloma)	NULL
EXP055331	anti-BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 0.25 uM CPI267203;	EXP055327	2702	normal	O60885	LP-1 (plasma cell myeloma)	NULL
EXP055332	anti-P300 (Santa Cruz, sc-585X)	Homo sapiens	Treatment: 0.25 uM CPI267203;	EXP055327	2702	normal	Q09472	LP-1 (plasma cell myeloma)	NULL
EXP055333	anti-BRD4 (Bethyl, A301-985A)	Homo sapiens	Treatment: 2.5 uM SGC-CBP30;	EXP055325	2702	normal	O60885	LP-1 (plasma cell myeloma)	NULL
EXP055334	CDK12 (Greenleaf Lab)	Homo sapiens	Treatment: 0.1% DMSO for 6 hrs;	NULL	509	normal	Q9NYV4	Jurkat (T-cells)	NULL
EXP055335	none (input)	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055336	KAP1 (Abcam; ab22553)	Homo sapiens		EXP055335	417	normal	Q13263	HCT-116 (colon carcinoma)	NULL
EXP055337	Larp7 (Sigma; av40847)	Homo sapiens		EXP055335	417	normal	Q4G0J3	HCT-116 (colon carcinoma)	NULL
EXP055338	Hexim1 (Abcam; ab25388)	Homo sapiens		EXP055335	417	normal	O94992	HCT-116 (colon carcinoma)	NULL
EXP055339	Cdk9 (C-20) (SCBT; sc-484)	Homo sapiens		EXP055335	417	normal	P50750	HCT-116 (colon carcinoma)	NULL
EXP055340	anti-Xrn2 (aa402-537, affinity pure Brannan et al Mol Cell 46, 311-324, 2012 )	Homo sapiens	Source: HEK293 Flp-in T-REx pcDNA5 HA-Xrn2 WT;	NULL	421	normal	Q9H0D6	HEK293 (embryonic kidney)	NULL
EXP055341	anti-BRD4 (N-terminal antibody kindly provided by Prof. Cheng Ming Chiang)	Homo sapiens	Passage: 5; 	NULL	583	normal	O60885	MCF10A (breast epithelial cells)	NULL
EXP055342		Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	NULL	2703	chip_control	NULL	TF-1 (erythroleukemia)	NULL
EXP055343		Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	NULL	2703	chip_control	NULL	TF-1 (erythroleukemia)	NULL
EXP055344		Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	NULL	2703	chip_control	NULL	TF-1 (erythroleukemia)	NULL
EXP055345		Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	NULL	2703	chip_control	NULL	TF-1 (erythroleukemia)	NULL
EXP055346	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055342	2703	normal	P23769	TF-1 (erythroleukemia)	NULL
EXP055347	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055343	2703	normal	P23769	TF-1 (erythroleukemia)	NULL
EXP055348	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055344	2703	normal	P23769	TF-1 (erythroleukemia)	NULL
EXP055349	GATA2 (Clone: sc-9008, Santa Cruz Biotechnology)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055345	2703	normal	P23769	TF-1 (erythroleukemia)	NULL
EXP055350	RUNX1 (Clone: sc-365644, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055342	2703	normal	Q01196	TF-1 (erythroleukemia)	NULL
EXP055351	RUNX1 (Clone: sc-365644, Santa Cruz Biotechnology)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055343	2703	normal	Q01196	TF-1 (erythroleukemia)	NULL
EXP055352	RUNX1 (Clone: sc-365644, Santa Cruz Biotechnology)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055344	2703	normal	Q01196	TF-1 (erythroleukemia)	NULL
EXP055353	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055342	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	NULL
EXP055354	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: wildtype; Treatment: DOX for 6 days; 	EXP055343	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	NULL
EXP055355	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055344	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	NULL
EXP055356	SMC3 (clone: ab9263, Abcam)	Homo sapiens	Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days;	EXP055345	2703	normal	Q9UQE7	TF-1 (erythroleukemia)	NULL
EXP055357	None	Homo sapiens	Genotype: CIMP (+); 	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055358	None	Homo sapiens	Genotype: CIMP (+); 	NULL	452	chip_control	NULL	HT29 (colon adenocarcinoma)	NULL
EXP055359	None	Homo sapiens	Genotype: CIMP (+); 	NULL	2704	chip_control	NULL	COLO 205 (colon adenocarcinoma)	NULL
EXP055360	None	Homo sapiens	Genotype: CIMP (+); 	NULL	418	chip_control	NULL	HCT-15 (colon carcinoma)	NULL
EXP055361	None	Homo sapiens	Genotype: CIMP (-); 	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP055362	None	Homo sapiens	Genotype: CIMP (-); 	NULL	185	chip_control	NULL	COLO-320 (colon adenocarcinoma)	NULL
EXP055363	None	Homo sapiens	Genotype: CIMP (-); 	NULL	557	chip_control	NULL	LS180 (colon cancer)	NULL
EXP055364	None	Homo sapiens	Genotype: CIMP (-); 	NULL	2705	chip_control	NULL	COLO 741 (melanoma)	NULL
EXP055365	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055357	417	normal	O60885	HCT-116 (colon carcinoma)	NULL
EXP055366	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055358	452	normal	O60885	HT29 (colon adenocarcinoma)	NULL
EXP055367	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055359	2704	normal	O60885	COLO 205 (colon adenocarcinoma)	NULL
EXP055368	Brd4	Homo sapiens	Genotype: CIMP (+); 	EXP055360	418	normal	O60885	HCT-15 (colon carcinoma)	NULL
EXP055369	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055361	821	normal	O60885	SW480 (colon adenocarcinoma)	NULL
EXP055370	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055362	185	normal	O60885	COLO-320 (colon adenocarcinoma)	NULL
EXP055371	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055363	557	normal	O60885	LS180 (colon cancer)	NULL
EXP055372	Brd4	Homo sapiens	Genotype: CIMP (-); 	EXP055364	2705	normal	O60885	COLO 741 (melanoma)	NULL
EXP055373	IgG (Invitrogen Cat # 10500C)	Homo sapiens		NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP055374	SMN (Santa Cruz pAb Cat # H-195)	Homo sapiens		NULL	421	normal	Q16637	HEK293 (embryonic kidney)	NULL
EXP055375	GFP (Abcam pAb Cat# 290)	Homo sapiens		NULL	421	normal	Q16637	HEK293 (embryonic kidney)	NULL
EXP055376	none	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP055377	FUS (sc-47711, Santa Cruz)	Homo sapiens		EXP055376	421	normal	P35637	HEK293 (embryonic kidney)	NULL
EXP055378	EWS (sc-48404, Santa Cruz)	Homo sapiens		EXP055376	421	normal	Q01844	HEK293 (embryonic kidney)	NULL
EXP055379	TAF15	Homo sapiens		EXP055376	421	normal	Q16514	HEK293 (embryonic kidney)	NULL
EXP055380	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055381	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055382	none	Homo sapiens		NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055383	none	Homo sapiens	TReatment: mock siRNA (GFP) for 72 hr;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055384	anti-EP400 (Abcam, ab70301)	Homo sapiens		EXP055380	848	normal	Q96L91	U2OS (osteosarcoma)	NULL
EXP055385	anti-EP400 (Abcam, ab70301)	Homo sapiens		EXP055381	848	normal	Q96L91	U2OS (osteosarcoma)	NULL
EXP055386	anti-EP400 (Abcam, ab70301)	Homo sapiens		EXP055382	848	normal	Q96L91	U2OS (osteosarcoma)	NULL
EXP055387	anti-MED26 (Santa Cruz Biotechnology, sc-48776)	Homo sapiens	TReatment: mock siRNA (GFP) for 72 hr;	EXP055383	848	bio_control	O95402	U2OS (osteosarcoma)	NULL
EXP055388	anti-MED26 (Santa Cruz Biotechnology, sc-48776)	Homo sapiens	Treatment: siEP400 for 72 hrs; Genotype: EP400 knockout;	EXP055383	848	normal	O95402	U2OS (osteosarcoma)	NULL
EXP055389	IgG	Homo sapiens	Cell type: EBV positive;	NULL	767	chip_control	NULL	Raji (Burkitt lymphoma)	NULL
EXP055390	IgG	Homo sapiens	Cell type: EBV positive;	NULL	640	chip_control	NULL	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055391	IgG	Homo sapiens	Cell type: EBV positive;	NULL	2287	chip_control	NULL	LCL (lymphoblastoid cell line)	NULL
EXP055392	IgG	Homo sapiens	Cell type: EBV positive;	NULL	2706	chip_control	NULL	C666-1 (nasopharyngeal carcinoma)	NULL
EXP055393	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055389	767	normal	Q99848	Raji (Burkitt lymphoma)	NULL
EXP055394	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055390	640	normal	Q99848	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055395	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055391	2287	normal	Q99848	LCL (lymphoblastoid cell line)	NULL
EXP055396	anti-EBNA1	Homo sapiens	Cell type: EBV positive;	EXP055392	2706	normal	Q99848	C666-1 (nasopharyngeal carcinoma)	NULL
EXP055397	none (input)	Homo sapiens	Developmental stage: proliferating;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP055398	none (input)	Homo sapiens	Developmental stage: quiescent;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP055399	none (input)	Homo sapiens	Developmental stage: senescent;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP055400	-	Homo sapiens	Developmental stage: proliferating;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP055401	-	Homo sapiens	Developmental stage: quiescent;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP055402	-	Homo sapiens	Developmental stage: senescent;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP055403	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: proliferating;	EXP055397	489	normal	O60885	IMR90 (lung fibroblasts)	NULL
EXP055404	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: quiescent;	EXP055398	489	normal	O60885	IMR90 (lung fibroblasts)	NULL
EXP055405	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: senescent;	EXP055399	489	normal	O60885	IMR90 (lung fibroblasts)	NULL
EXP055406	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: proliferating;	EXP055400	489	normal	O60885	IMR90 (lung fibroblasts)	NULL
EXP055407	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: quiescent;	EXP055401	489	normal	O60885	IMR90 (lung fibroblasts)	NULL
EXP055408	Brd4 (A301-985A; Bethyl)	Homo sapiens	Developmental stage: senescent;	EXP055402	489	normal	O60885	IMR90 (lung fibroblasts)	NULL
EXP055409	none	Homo sapiens	Treatment: none;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055410	none	Homo sapiens	Treatment: none;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055411	none	Homo sapiens	Treatment: 30 um MnTE-2PyP for 24 hours;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055412	anti-p300 antibody (Abcam #54984)	Homo sapiens	Treatment: none;	EXP055409	725	normal	Q09472	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055413	anti-p300 antibody (Abcam #54984)	Homo sapiens	Treatment: none;	EXP055410	725	normal	Q09472	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055414	anti-p300 antibody (Abcam #54984)	Homo sapiens	Treatment: 30 um MnTE-2PyP for 24 hours;	EXP055411	725	normal	Q09472	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055415	none	Homo sapiens	Characteristic: in vivo intrancranial tumor;	NULL	2707	chip_control	NULL	IN528 (Primary Patient Derived Tumor Model)	NULL
EXP055416	none	Homo sapiens	Characteristic: serum free cell culture;	NULL	2707	chip_control	NULL	IN528 (Primary Patient Derived Tumor Model)	NULL
EXP055417	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens	Characteristic: in vivo intrancranial tumor;	EXP055415	2707	normal	Q6NYC1	IN528 (Primary Patient Derived Tumor Model)	NULL
EXP055418	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens	Characteristic: serum free cell culture;	EXP055416	2707	normal	Q6NYC1	IN528 (Primary Patient Derived Tumor Model)	NULL
EXP055419	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens		NULL	2708	normal	Q6NYC1	3565 (Primary Patient Derived Tumor Model)	NULL
EXP055420	JMJD6 (Abcam, ab64575, lot GR54735-1)	Homo sapiens	Characteristic: cells were collected;	NULL	2708	normal	Q6NYC1	3565 (Primary Patient Derived Tumor Model)	NULL
EXP055421	NA	Homo sapiens	Treatment: chronic 1 uM dasatinib;	NULL	2350	chip_control	NULL	LAL-B (All-B patient-derived cell line)	NULL
EXP055422	NA	Homo sapiens	4 day 1 ÂµM dasatinib	NULL	2350	chip_control	NULL	LAL-B (All-B patient-derived cell line)	NULL
EXP055423	NA	Homo sapiens	Treatment: 12 day 1 uM dasatinib;	NULL	2350	chip_control	NULL	LAL-B (All-B patient-derived cell line)	NULL
EXP055424	NA	Homo sapiens	Treatment: none;	NULL	2350	chip_control	NULL	LAL-B (All-B patient-derived cell line)	NULL
EXP055425	NA	Homo sapiens	chronic 2 ÂµM PD0325901	NULL	2350	chip_control	NULL	LAL-B (All-B patient-derived cell line)	NULL
EXP055426	RBPJ (Abcam, ab25949, lot GR169397-1)	Homo sapiens	Treatment: chronic 1 uM dasatinib;	EXP055421	2350	normal	Q06330	LAL-B (All-B patient-derived cell line)	NULL
EXP055427	RBPJ (Abcam, ab25949, lot GR169397-1)	Homo sapiens	Treatment: 12 day 1 uM dasatinib;	EXP055423	2350	normal	Q06330	LAL-B (All-B patient-derived cell line)	NULL
EXP055428	RBPJ (Abcam, ab25949, lot GR169397-1)	Homo sapiens	Treatment: none;	EXP055424	2350	normal	Q06330	LAL-B (All-B patient-derived cell line)	NULL
EXP055429	cleaved Notch1 (Val1744) (CST, 4147, lot 4)	Homo sapiens	Treatment: chronic 1 uM dasatinib;	EXP055421	2350	normal	P46531	LAL-B (All-B patient-derived cell line)	NULL
EXP055430	cleaved Notch1 (Val1744) (CST, 4147, lot 4)	Homo sapiens	Treatment: 12 day 1 uM dasatinib;	EXP055423	2350	normal	P46531	LAL-B (All-B patient-derived cell line)	NULL
EXP055431	cleaved Notch1 (Val1744) (CST, 4147, lot 4)	Homo sapiens	Treatment: none;	EXP055424	2350	normal	P46531	LAL-B (All-B patient-derived cell line)	NULL
EXP055432	none	Homo sapiens		NULL	2709	chip_control	NULL	NAMEC8 (spontaneously immortalized)	NULL
EXP055433	none	Homo sapiens		NULL	2709	chip_control	NULL	NAMEC8 (spontaneously immortalized)	NULL
EXP055434	none	Homo sapiens	Treatment: treating with cholera toxin every 2 days over a period of 14 days;	NULL	2710	chip_control	NULL	N8-CTx cells derived from NAMEC8	NULL
EXP055435	PHF2 Antibody (Cell Signaling Technology, Catalog #3497, Lot#2)	Homo sapiens		EXP055433	2709	normal	O75151	NAMEC8 (spontaneously immortalized)	NULL
EXP055436	PHF2 Antibody (Cell Signaling Technology, Catalog #3497, Lot#2)	Homo sapiens	Treatment: treating with cholera toxin every 2 days over a period of 14 days;	EXP055434	2710	normal	O75151	N8-CTx cells derived from NAMEC8	NULL
EXP055437		Homo sapiens	Genotype: empty vector; 	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055438	anti-HA antibody (Cell Signaling; C29F4)	Homo sapiens	Treatment: HA-Tet2;	EXP055437	10	normal	Q6N021	HEK293T (embryonic kidney)	NULL
EXP055439	anti-HA antibody (Cell Signaling; C29F4)	Homo sapiens	Treatment: HA-MBD3L2;	EXP055437	10	normal	Q8NHZ7	HEK293T (embryonic kidney)	NULL
EXP055440	none (input control)	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP055441	anti-PARP1 antibody (Active Motif; lot# 00909001; catalog# 39561)	Homo sapiens		EXP055440	10	normal	P09874	HEK293T (embryonic kidney)	NULL
EXP055442	None	Homo sapiens		NULL	59	chip_control	NULL	AGS (gastric adenocarcinoma)	NULL
EXP055443	None	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055444	None	Mus musculus	Strain: 129S4/SvJae;	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP055445	anti-H1T (rabbit polyclonal antibody, prepared in-house)	Homo sapiens		EXP055442	59	normal	P22492	AGS (gastric adenocarcinoma)	NULL
EXP055446	anti-H1T (rabbit polyclonal antibody, prepared in-house)	Homo sapiens		EXP055443	2301	normal	P22492	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055447	anti-H1T (rabbit polyclonal antibody, prepared in-house)	Mus musculus	Strain: 129S4/SvJae;	EXP055444	506	normal	Q07133	J1 (embryonic stem cells)	NULL
EXP055448	Med12 (A-300-774A)	Homo sapiens	Developmental stage: 6 days expanded;	NULL	741	chip_control	NULL	CD34+ hematopoietic stem progenitor cells	NULL
EXP055449	Med12 (A-300-774A)	Homo sapiens	Developmental stage: 6 days expanded;	EXP055448	741	normal	Q93074	CD34+ hematopoietic stem progenitor cells	NULL
EXP055450	MBD3	Homo sapiens		NULL	2301	normal	O95983	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055451		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055452		Mus musculus		NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055453	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055454	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055455	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055456	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055457	FLAG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP, FLAG;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055458	FLAG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP, FLAG;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055459	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055460	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055461	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, HDAg-S;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055462	IgG	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, HDAg-S;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055463	IgG	Homo sapiens	Genotype: PARP-1 knockdown; Treatment: vehicle, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055464	IgG	Homo sapiens	Genotype: PARP-1 knockdown; Treatment: vehicle, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055465	IgG	Homo sapiens	Genotype: PARP-1 Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055466	IgG	Homo sapiens	Genotype: PARP-1 Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055467	IgG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055468	IgG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055469	IgG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055470	IgG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055471	IgG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055472	IgG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055473	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP, FLAG;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055474	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP, FLAG;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055475	PARP-1	Mus musculus		EXP055451	12	normal	P11103	MEF (mouse embryonic fibroblasts)	NULL
EXP055476	PARP-1	Mus musculus		EXP055452	12	normal	P11103	MEF (mouse embryonic fibroblasts)	NULL
EXP055477	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP;	EXP055453	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055478	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, GFP;	EXP055454	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055479	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055455	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055480	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055456	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055481	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, GFP;	EXP055459	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055482	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, GFP;	EXP055460	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055483	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, HDAg-S;	EXP055461	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055484	NELFE	Homo sapiens	Genotype: Luciferase Knockdown; Treatment: 100 uM DRB, HDAg-S;	EXP055462	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055485	NELFE	Homo sapiens	Genotype: PARP-1 knockdown; Treatment: vehicle, GFP;	EXP055463	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055486	NELFE	Homo sapiens	Genotype: PARP-1 knockdown; Treatment: vehicle, GFP;	EXP055464	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055487	NELFE	Homo sapiens	Genotype: PARP-1 Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055465	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055488	NELFE	Homo sapiens	Genotype: PARP-1 Knockdown; Treatment: vehicle, viral NELF inhibitor HDAg-S;	EXP055466	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055489	NELFE	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP;	EXP055467	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055490	NELFE	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, GFP;	EXP055468	113	normal	P18615	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055491	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype;	EXP055469	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055492	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype;	EXP055470	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055493	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant;	EXP055471	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055494	FLAG	Homo sapiens	Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant;	EXP055472	113	normal	A0AVK6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055495		Homo sapiens	Treatment: Control (none);	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055496	TRIM28	Homo sapiens	Treatment: Control (none);	EXP055495	113	normal	Q13263	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055497	none (input)	Mus musculus	Developmental stage: E14; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP055498	none (input)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP055499	EPOP (Ab1)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	NULL
EXP055500	EPOP (Ab1)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	NULL
EXP055501	EPOP (Ab2)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	NULL
EXP055502	EPOP (Ab2)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	NULL
EXP055503	EPOP (Ab3, Active Motif #61753)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	NULL
EXP055504	EPOP (Ab3, Active Motif #61753)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q7TNS8	mESCs (mouse embryonic stem cells)	NULL
EXP055505	USP7 (Bethyl, A300-033A)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	Q6A4J8	mESCs (mouse embryonic stem cells)	NULL
EXP055506	USP7 (Bethyl, A300-033A)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	Q6A4J8	mESCs (mouse embryonic stem cells)	NULL
EXP055507	Elongin B (abcam, ab168836)	Mus musculus	Developmental stage: E14; 	EXP055497	2	normal	P62869	mESCs (mouse embryonic stem cells)	NULL
EXP055508	Elongin B (abcam, ab168836)	Mus musculus	Genotype: EPOP knockout; Developmental stage: E14; 	EXP055498	2	normal	P62869	mESCs (mouse embryonic stem cells)	NULL
EXP055509	anti-p300 (Santa Cruz, SC-584)	Homo sapiens	Genotype: parental;	NULL	875	normal	Q09472	ZR-75-30 (invasive ductal carcinoma)	NULL
EXP055510	none	Homo sapiens	Developmental stage: asynchronization;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055511	none	Homo sapiens	Developmental stage: asynchronization;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055512	RPA2 (Abcam, catalog# ab16850, lot# GR88602-1)	Homo sapiens	Developmental stage: asynchronization;	EXP055510	78	normal	P15927	HeLa (cervical adenocarcinoma)	NULL
EXP055513	RPA2 (Abcam, catalog# ab16850, lot# GR88602-1)	Homo sapiens	Developmental stage: asynchronization;	EXP055511	78	normal	P15927	HeLa (cervical adenocarcinoma)	NULL
EXP055514	RPA1 (gifted by Dr. Bruce Stillman)	Homo sapiens	Developmental stage: asynchronization;	NULL	78	normal	P27694	HeLa (cervical adenocarcinoma)	NULL
EXP055515	none	Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP055516	anti-SRPK1 (Abcam, catalog# ab90527)	Homo sapiens		EXP055515	583	normal	Q96SB4	MCF10A (breast epithelial cells)	NULL
EXP055517	anti-SRPK2 (Bethyl Labs, catalog# A302-467A)	Homo sapiens		EXP055515	583	normal	P78362	MCF10A (breast epithelial cells)	NULL
EXP055518	SON antibody (recognizing the N-terminus of SON, amino acids 74-88 of human SON)	Homo sapiens		NULL	514	normal	P18583	K562 (myelogenous leukemia)	NULL
EXP055519	SON antibody (Abcam, ab121759)	Homo sapiens		NULL	514	normal	P18583	K562 (myelogenous leukemia)	NULL
EXP055520		Homo sapiens		NULL	2711	chip_control	NULL	P493 (Lymphoma derived)	NULL
EXP055521		Homo sapiens		NULL	2712	chip_control	NULL	hESC-1 (Embryonic stem cells)	NULL
EXP055522		Homo sapiens		NULL	2713	chip_control	NULL	hESC-3 (Embryonic stem cells)	NULL
EXP055523		Homo sapiens		NULL	2714	chip_control	NULL	BLM (Amelanotic melanoma)	NULL
EXP055524		Homo sapiens		NULL	2207	chip_control	NULL	LOXIMVI	NULL
EXP055525		Homo sapiens		NULL	33	chip_control	NULL	A2780 (ovarian carcinoma)	NULL
EXP055526		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055527	TERT	Homo sapiens		EXP055525	33	normal	O14746	A2780 (ovarian carcinoma)	NULL
EXP055528	TERT	Homo sapiens		EXP055526	417	normal	O14746	HCT-116 (colon carcinoma)	NULL
EXP055529	TERT	Homo sapiens		EXP055520	2711	normal	O14746	P493 (Lymphoma derived)	NULL
EXP055530	TERT	Homo sapiens		EXP055521	2712	normal	O14746	hESC-1 (Embryonic stem cells)	NULL
EXP055531	TERT	Homo sapiens		EXP055522	2713	normal	O14746	hESC-3 (Embryonic stem cells)	NULL
EXP055532	TERT	Homo sapiens		EXP055523	2714	normal	O14746	BLM (Amelanotic melanoma)	NULL
EXP055533	TERT	Homo sapiens		EXP055524	2207	normal	O14746	LOXIMVI	NULL
EXP055534	none (input)	Homo sapiens	Treatment: none;	NULL	699	chip_control	NULL	OVCAR3 (high grade ovarian serous adenocarcinoma)	NULL
EXP055535	anti-BRD4 (Bethyl Laboratories, catalog# A301-985A, lot# A301-985A50-4)	Homo sapiens	Treatment: 125 nM DMSO for 40 min; 	EXP055534	699	normal	O60885	OVCAR3 (high grade ovarian serous adenocarcinoma)	NULL
EXP055536	anti-BRD4 (Bethyl Laboratories, catalog# A301-985A, lot# A301-985A50-4)	Homo sapiens	Treatment: 125 nM JQ1 for 40 min; 	EXP055534	699	normal	O60885	OVCAR3 (high grade ovarian serous adenocarcinoma)	NULL
EXP055537	none	Homo sapiens	Passage: low passages (6-10);	NULL	2715	chip_control	NULL	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055538	none	Homo sapiens	Passage: low passages (6-10);	NULL	2715	chip_control	NULL	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055539	none	Homo sapiens	Passage: low passages (6-10);	NULL	2716	chip_control	NULL	SU-DIPG-IV (diffuse intrinsic pontine glioma)	NULL
EXP055540	SUZ12 (CST, 3737)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	Q15022	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055541	SUZ12 (CST, 3737)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	Q15022	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055542	EZH2 (CST, 5246)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	Q15910	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055543	EZH2 (CST, 5246)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	Q15910	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055544	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	P25440	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055545	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	P25440	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055546	BRD4 (CST, 13440)	Homo sapiens	Passage: low passages (6-10);	EXP055537	2715	normal	O60885	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055547	BRD4 (CST, 13440)	Homo sapiens	Passage: low passages (6-10);	EXP055538	2715	normal	O60885	SF8628 (Diffuse intrinsic pontine glioma)	NULL
EXP055548	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	P25440	SU-DIPG-IV (diffuse intrinsic pontine glioma)	NULL
EXP055549	BRD2 (CST, 5848)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	P25440	SU-DIPG-IV (diffuse intrinsic pontine glioma)	NULL
EXP055550	SUZ12 (CST, 3737)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	Q15022	SU-DIPG-IV (diffuse intrinsic pontine glioma)	NULL
EXP055551	EZH2 (CST, 5246)	Homo sapiens	Passage: low passages (6-10);	EXP055539	2716	normal	Q15910	SU-DIPG-IV (diffuse intrinsic pontine glioma)	NULL
EXP055552	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: None;	NULL	2337	chip_control	NULL	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055553	None	Homo sapiens	Treatment: None;	NULL	2337	chip_control	NULL	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055554	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: DMSO;	EXP055552	2337	normal	O60885	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055555	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: JQ1;	EXP055552	2337	normal	O60885	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055556	anti-BRD4 (Bethyl, A301-985A100)	Homo sapiens	Treatment: dBET6;	EXP055552	2337	normal	O60885	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055557	anti-CDK9 (Santa Cruz, C-20)	Homo sapiens	Treatment: DMSO;	NULL	2337	normal	P50750	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055558	anti-CDK9 (Santa Cruz, C-20)	Homo sapiens	Treatment: JQ1;	EXP055553	2337	normal	P50750	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055559	anti-CDK9 (Santa Cruz, C-20)	Homo sapiens	Treatment: dBET6;	EXP055553	2337	normal	P50750	MOLT-4 (Adult T acute lymphoblastic leukemia)	NULL
EXP055560	none	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP055561	none	Homo sapiens	Treatment: none; Genotype: MLL-AF9/KrasG13D;	NULL	677	chip_control	NULL	NOMO-1 (acute monocytic leukemia)	NULL
EXP055562	none	Mus musculus	Treatment: DMSO; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP055563	none	Mus musculus	Treatment: BI-7273; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP055564	none	Mus musculus	Treatment: DMSO; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP055565	none	Mus musculus	Treatment: BI-7273; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP055566	Brd9 (ab66443; Abcam)	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	EXP055560	2717	normal	Q3UQU0	RN2 (acute myeloid leukemia)	NULL
EXP055567	Brg1 (ab110641; Abcam)	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	EXP055560	2717	normal	Q3TKT4	RN2 (acute myeloid leukemia)	NULL
EXP055568	BRD9 (ab66443; Abcam)	Homo sapiens	Treatment: none; Genotype: MLL-AF9/KrasG13D;	EXP055561	677	normal	Q9H8M2	NOMO-1 (acute monocytic leukemia)	NULL
EXP055569	BRD9 (A303-781A; Bethyl)	Homo sapiens	Treatment: none; Genotype: MLL-AF9/KrasG13D;	EXP055561	677	normal	Q9H8M2	NOMO-1 (acute monocytic leukemia)	NULL
EXP055570	FLAG (F1804; Sigma)	Mus musculus	Treatment: DMSO; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	EXP055562	2717	normal	Q3UQU0	RN2 (acute myeloid leukemia)	NULL
EXP055571	FLAG (F1804; Sigma)	Mus musculus	Treatment: BI-7273; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	EXP055563	2717	normal	Q3UQU0	RN2 (acute myeloid leukemia)	NULL
EXP055572	Brg1 (ab110641; Abcam)	Mus musculus	Treatment: DMSO; Strain: C57BL/6; Genotype: MLL-AF9/NrasG12D;	EXP055564	2717	normal	Q3TKT4	RN2 (acute myeloid leukemia)	NULL
EXP055573	Brg1 (ab110641; Abcam)	Mus musculus	Treatment: BI-7273; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6;	EXP055565	2717	normal	Q3TKT4	RN2 (acute myeloid leukemia)	NULL
EXP055574	none	Homo sapiens		NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP055575	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055576	EFP (BD, 610570, lot 5061873)	Homo sapiens		EXP055574	120	normal	Q14258	BT-549 (breast invasive ductal carcinoma)	NULL
EXP055577	EFP (BD, 610570, lot 5061873)	Homo sapiens		EXP055575	2301	normal	Q14258	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP055578		Homo sapiens	Donor: 195307 + 7F3158; Passage: 3; Source: Lonza;	NULL	2718	chip_control	NULL	HBEC (Human bronchial epithelial cells)	NULL
EXP055579	INTS12 (Sigma cat. num. HPA03577)	Homo sapiens	Donor: 195307; Passage: 3; Source: Lonza;	EXP055578	2718	normal	Q96CB8	HBEC (Human bronchial epithelial cells)	NULL
EXP055580	INTS12 (Sigma cat. num. HPA03577)	Homo sapiens	Donor: 7F3158; Passage: 3; Source: Lonza;	EXP055578	2718	normal	Q96CB8	HBEC (Human bronchial epithelial cells)	NULL
EXP055581	none	Homo sapiens	Treatment: none (Control);	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP055582	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: Control;	EXP055581	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP055583	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Genotype: ENL knockout; Treatment: CRISPR knockout;	EXP055581	2219	normal	A0AVK6	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP055584	anti-Flag M2 (Sigma F3165)	Homo sapiens	genotype: Control (wildtype ENL)	EXP055581	2219	normal	Q03111	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP055585	anti-FLAG (Sigma F1804)	Homo sapiens	control	NULL	641	normal	Q03111	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055586	None	Homo sapiens		NULL	2619	chip_control	NULL	SV40 (Immortalized Fibroblast)	NULL
EXP055587	None	Homo sapiens		NULL	2619	chip_control	NULL	SV40 (Immortalized Fibroblast)	NULL
EXP055588	MCM3 (Bethyl, A300-192A)	Homo sapiens	Developmental stage: arrested in G1/S phase; 	EXP055587	2619	normal	P25205	SV40 (Immortalized Fibroblast)	NULL
EXP055589	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-{delta}A; 	EXP055586	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	NULL
EXP055590	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-{delta}B; 	EXP055586	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	NULL
EXP055591	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-{delta}AB; 	EXP055586	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	NULL
EXP055592	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2-PIP Q374A, I376A, I377A; 	EXP055587	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	NULL
EXP055593	GFP-trap beads (Chromotek, gta-200)	Homo sapiens	Developmental stage: arrested in G1/S phase;  Genotype: GFP-ESCO2 wildtype; 	EXP055587	2619	normal	Q56NI9	SV40 (Immortalized Fibroblast)	NULL
EXP055594	none	Homo sapiens		NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP055595	Mouse anti-GFP, Cell Signaling #2955, lot 4B10	Homo sapiens	Genotype: GFP;	NULL	2719	chip_control	NULL	RPE (retina epithelial cells immortalized with hTERT)	NULL
EXP055596	anti-PGBD5 (orb13159,Biorbyt, Berkeley, CA, USA)	Homo sapiens		EXP055594	937	normal	Q8N414	G401 (rhabdoid tumor of the kidney)	NULL
EXP055597	anti-GFP (Cell Signaling #2955, lot 4B10)	Homo sapiens	Genotype: PGBD5-GFP;	EXP055595	2719	normal	Q8N414	RPE (retina epithelial cells immortalized with hTERT)	NULL
EXP055598	Mouse anti-GFP, Cell Signaling #2955, lot 4B10	Homo sapiens	Genotype: triple mutant PGBD5-GFP;	EXP055595	2719	normal	Q8N414	RPE (retina epithelial cells immortalized with hTERT)	NULL
EXP055599	anti-ORCA 	Homo sapiens	Developmental stage: early-G1;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055600	anti-ORCA 	Homo sapiens	Developmental stage: mid-G1;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055601	anti-ORCA 	Homo sapiens	Developmental stage: late-G1;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055602	anti-ORCA 	Homo sapiens	Developmental stage: early-G1;	EXP055599	848	normal	Q13501	U2OS (osteosarcoma)	NULL
EXP055603	anti-ORCA 	Homo sapiens	Developmental stage: mid-G1;	EXP055600	848	normal	Q13501	U2OS (osteosarcoma)	NULL
EXP055604	anti-ORCA 	Homo sapiens	Developmental stage: late-G1;	EXP055601	848	normal	Q13501	U2OS (osteosarcoma)	NULL
EXP055605		Homo sapiens		NULL	2720	chip_control	NULL	VA13 (transformed lung fibroblasts)	NULL
EXP055606	anti-TERT (abcam, ab32020, Lot YI021602CR)	Homo sapiens		EXP055605	2720	normal	O14746	VA13 (transformed lung fibroblasts)	NULL
EXP055607		Homo sapiens	Genotype: CONCR knockout;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP055608		Homo sapiens	Genotype: none;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP055609	anti-DDX11 antibody (ab66971, Abcam)	Homo sapiens	Genotype: CONCR knockout;	EXP055607	38	normal	Q96FC9	A549 (lung carcinoma)	NULL
EXP055610	anti-DDX11 antibody (ab66971, Abcam)	Homo sapiens	Genotype: none;	EXP055608	38	normal	Q96FC9	A549 (lung carcinoma)	NULL
EXP055611		Homo sapiens		NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP055612	anti-KDM2B (Gearhart, et al. Mol Cell Biol 2006; 26:6880-6889)	Homo sapiens		EXP055611	685	normal	Q8NHM5	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP055613	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055614	N/A	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055615	N/A	Homo sapiens	Passage: 5-7; Genotype: normal;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055616	N/A	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055617	N/A	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055618	N/A	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055619	N/A	Homo sapiens	Passage: 5-7;	NULL	2721	chip_control	NULL	HSF (primary dermal fibroblasts)	NULL
EXP055620	N/A	Homo sapiens	Passage: 5-7;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055621	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055613	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055622	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055614	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055623	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055615	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055624	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055616	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055625	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055617	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055626	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055618	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055627	anti-LMNA (Santa Cruz sc-7292)	Homo sapiens	Passage: 5-7; Genotype: LMNA p.R482W mutation;	EXP055619	2721	normal	P02545	HSF (primary dermal fibroblasts)	NULL
EXP055628	anti-Flag (Sigma F-1804)	Homo sapiens	Passage: 5-7; Genotype: normal;	EXP055620	78	normal	P02545	HeLa (cervical adenocarcinoma)	NULL
EXP055629	anti-Flag (Sigma F-1804)	Homo sapiens	Passage: 5-7; Genotype: L647R LMNA mutant; 	EXP055620	78	normal	P02545	HeLa (cervical adenocarcinoma)	NULL
EXP055630	anti-Flag (Sigma F-1804)	Homo sapiens	Passage: 5-7; Genotype: R388P LMNA mutant; 	EXP055620	78	normal	P02545	HeLa (cervical adenocarcinoma)	NULL
EXP055631	None	Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP055632	None	Homo sapiens	Genotype: Flag-ZMYND8;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP055633	ZMYND8 (Bethyl Laboratory, A302-089A)	Homo sapiens		EXP055631	421	normal	Q9ULU4	HEK293 (embryonic kidney)	NULL
EXP055634	Flag (Sigma, F1804)	Homo sapiens	Genotype: Flag-ZMYND8;	EXP055632	421	normal	Q9ULU4	HEK293 (embryonic kidney)	NULL
EXP055635	none	Homo sapiens	Treatment: none;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055636	none	Homo sapiens	Treatment: none;	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP055637	none	Homo sapiens	Treatment: none; Genotype: ENL-FKBP (ENL knockout);	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055638	anti-ENL (Cell Signalling, 14893)	Homo sapiens	Treatment: none;	EXP055635	641	normal	Q03111	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055639	anti-HA beads (Pierce, 88836)	Homo sapiens	Treatment: none; Genotype: ENL-FKBP (ENL knockout);	EXP055635	641	normal	Q03111	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055640	anti-ENL (Cell Signalling, 14893)	Homo sapiens	Treatment: none;	EXP055636	2219	normal	Q03111	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP055641	anti-AFF4 (Abcam, Ab57077)	Homo sapiens	Treatment: 0.01% DMSO for 6 hr; Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	Q9UHB7	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055642	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: 0.01% DMSO for 6 hr; Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	P50750	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055643	anti-AFF4 (Abcam, Ab57077)	Homo sapiens	Treatment: 0.01% DMSO, 500 nM dTAG-13 for 6 hr; Genotype: Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	Q9UHB7	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055644	anti-CDK9 (Santa Cruz, sc-484)	Homo sapiens	Treatment: 0.01% DMSO, 500 nM dTAG-13 for 6 hr; Genotype: Genotype: ENL-FKBP (ENL knockout);	EXP055637	641	normal	P50750	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055645	n/a	Homo sapiens	Treatment: Hydroxyurea was added to media for 3 hours;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055646	anti-Myc	Homo sapiens	Treatment: Hydroxyurea was added to media for 3 hours;	EXP055645	78	normal	Q9H668	HeLa (cervical adenocarcinoma)	NULL
EXP055647	anti-G9a	Homo sapiens	Characteristic: sorting marker CD133;	NULL	2722	normal	Q96KQ7	T5088 (colon cancer stem cells)	NULL
EXP055648	anti-G9a	Homo sapiens	Characteristic: sorting marker CD133; Genotype: shG9a-DNG9a;	NULL	2722	normal	Q96KQ7	T5088 (colon cancer stem cells)	NULL
EXP055649	anti-G9a	Homo sapiens	Characteristic: sorting marker CD133; Genotype: shGLP-DNG9a;	NULL	2722	normal	Q96KQ7	T5088 (colon cancer stem cells)	NULL
EXP055650		Homo sapiens	Genotype: wildtype;	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP055651	anti-Ino80 (proteintech, 18810-1-AP)	Homo sapiens	Genotype: wildtype;	EXP055650	36	normal	Q9ULG1	A375 (malignant melanoma)	NULL
EXP055652		Homo sapiens		NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP055653		Homo sapiens	Treatment: infected with lenti-viral based shNT; 	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP055654		Homo sapiens	infected with lenti-viral based shIno80; Genotype: shIno80;	NULL	36	chip_control	NULL	A375 (malignant melanoma)	NULL
EXP055655		Homo sapiens		NULL	794	chip_control	NULL	SK-MEL-147 (melanoma)	NULL
EXP055656		Homo sapiens		NULL	601	chip_control	NULL	melanocytes	NULL
EXP055657	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens		EXP055652	36	normal	O95243	A375 (malignant melanoma)	NULL
EXP055658	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens	Treatment: infected with lenti-viral based shNT; 	EXP055653	36	normal	O95243	A375 (malignant melanoma)	NULL
EXP055659	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens	infected with lenti-viral based shIno80; Genotype: shIno80;	EXP055654	36	normal	O95243	A375 (malignant melanoma)	NULL
EXP055660	anti-Ino80 (proteintech, 18810-1-AP)	Homo sapiens		EXP055655	794	normal	Q9ULG1	SK-MEL-147 (melanoma)	NULL
EXP055661	anti-Med1 (Bethyl, A300-793A-2)	Homo sapiens		EXP055655	794	normal	O95243	SK-MEL-147 (melanoma)	NULL
EXP055662	anti-Ino80 (proteintech, 18810-1-AP)	Homo sapiens		EXP055656	601	normal	Q9ULG1	melanocytes	NULL
EXP055663	none	Homo sapiens	Genotype: overexpressing sGC-beta1;	NULL	1009	chip_control	NULL	U87MG(glioblastoma)	NULL
EXP055664	anti-sGC-beta1 (Sigma G4405, lot 021M4843)	Homo sapiens	Genotype: overexpressing sGC-beta1;	EXP055663	1009	normal	Q02153	U87MG(glioblastoma)	NULL
EXP055665	NA	Homo sapiens	Treatment: empty vector added;	NULL	2723	chip_control	NULL	7250 (Fibroblast cell line)	NULL
EXP055666	NA	Homo sapiens	Treatment: PAX3-FOXO vector added;	NULL	2723	chip_control	NULL	7250 (Fibroblast cell line)	NULL
EXP055667	BRD4 (Bethyl, A301-985A50)	Homo sapiens	Treatment: empty vector added;	EXP055665	2723	normal	O60885	7250 (Fibroblast cell line)	NULL
EXP055668	BRD4 (Bethyl, A301-985A50)	Homo sapiens	Treatment: PAX3-FOXO vector added;	EXP055666	2723	normal	O60885	7250 (Fibroblast cell line)	NULL
EXP055669	anti-BRG1  (Abcam, ab110641, EPNCIR111A)	Homo sapiens	Treatment: 0 mins after progestin R5020 treatment; 	NULL	111	normal	P51532	T47D (invasive ductal carcinoma)	NULL
EXP055670	anti-BRG1  (Abcam, ab110641, EPNCIR111A)	Homo sapiens	Treatment: 30 mins after progestin R5020 treatment; 	NULL	111	normal	P51532	T47D (invasive ductal carcinoma)	NULL
EXP055671	anti-RAG1 	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 5 weeks; Sex: male; 	NULL	44	normal	P15919	T-cells	NULL
EXP055672	none (input)	Homo sapiens	Treatment: not treated;	NULL	640	chip_control	NULL	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055673	none (input)	Homo sapiens	Treatment: not treated;	NULL	640	chip_control	NULL	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055674	BRD4	Homo sapiens	Treatment: not treated;	EXP055672	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055675	BRD4	Homo sapiens	Treatment: not treated;	EXP055673	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055676	BRD2	Homo sapiens	Treatment: not treated;	EXP055672	640	normal	P25440	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055677	BRD2	Homo sapiens	Treatment: not treated;	EXP055673	640	normal	P25440	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055678	BRD3	Homo sapiens	Treatment: not treated;	EXP055672	640	normal	Q15059	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055679	BRD3	Homo sapiens	Treatment: not treated;	EXP055673	640	normal	Q15059	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055680	BRD4	Homo sapiens	Treatment: vehicle for 24 hours;	EXP055672	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055681	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs;	EXP055672	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055682	BRD4	Homo sapiens	Treatment: vehicle for 24 hours;	EXP055673	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055683	BRD4	Homo sapiens	Treatment: JQ1 for 24 hrs;	EXP055673	640	normal	O60885	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP055684	none	Homo sapiens		NULL	502	chip_control	NULL	iPSC-derived neural progenitor cells	NULL
EXP055685	Kap1 (AbCam 10483)	Homo sapiens		EXP055684	502	normal	Q13263	iPSC-derived neural progenitor cells	NULL
EXP055686	ASXL2 antibody (Bethyl, A302-037A)	Homo sapiens	Genotype: fusion protein AML-ETO;	NULL	796	normal	Q76L83	SKNO-1 (acute myeloid leukemia)	NULL
EXP055687	none	Homo sapiens	Developmental stage: primed;	NULL	2724	chip_control	NULL	WIBR3 (embryonic stem cell)	NULL
EXP055688	none	Homo sapiens	Developmental stage: naive;	NULL	2724	chip_control	NULL	WIBR3 (embryonic stem cell)	NULL
EXP055689	anti-KAP1 (Abcam, ab10483)	Homo sapiens	Developmental stage: primed;	EXP055687	2724	normal	Q13263	WIBR3 (embryonic stem cell)	NULL
EXP055690	anti-KAP1 (Abcam, ab10483)	Homo sapiens	Developmental stage: naive;	EXP055688	2724	normal	Q13263	WIBR3 (embryonic stem cell)	NULL
EXP055691	anti-HMGB2 (Abcam, ab67282, #GR149806-19)	Homo sapiens	Conditions: RAS-induced senescent cells;	NULL	489	normal	P26583	IMR90 (lung fibroblasts)	NULL
EXP055692	anti-HMGB2 (Abcam, ab67282, #GR149806-19)	Homo sapiens	Conditions: growing cells;	NULL	489	normal	P26583	IMR90 (lung fibroblasts)	NULL
EXP055693	p300 (Bethyl, A300-358A/3)	Homo sapiens		NULL	976	normal	Q09472	RCH-ACV (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP055694	mouse IgG (Santa Cruz, sc-2025, #J2015)	Homo sapiens	Passage: Multiple;	NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP055695	rabbit IgG (Santa Cruz, sc-2027, #J2014 )	Homo sapiens	Passage: Multiple;	NULL	92	chip_control	NULL	BJAB (Burkitt lymphoma)	NULL
EXP055696	anti-SPT5 (Santa Cruz, sc-28878, #L1713)	Homo sapiens	Passage: Multiple;	EXP055694	92	normal	O00267	BJAB (Burkitt lymphoma)	NULL
EXP055697	anti-TRIM28 (Abcam, ab622553, #GR229743-11 )	Homo sapiens	Passage: Multiple;	EXP055694	92	normal	Q13263	BJAB (Burkitt lymphoma)	NULL
EXP055698	Rad21 (AbCam 992)	Homo sapiens	Treatment: vehicle for 8hrs; Developmental stage: exponential growth phase;	NULL	417	normal	O60216	HCT-116 (colon carcinoma)	NULL
EXP055699	Rad21 (AbCam, 992)	Homo sapiens	Treatment: 250 nM daunorubicin for 8hrs; Developmental stage: exponential growth phase;	NULL	417	normal	O60216	HCT-116 (colon carcinoma)	NULL
EXP055700	N/A	Homo sapiens		NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP055701	N/A	Homo sapiens		NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP055702	anti-HDAC1 (Millipore, 17-10199)	Homo sapiens		EXP055700	618	normal	Q13547	MM1.S (plasma cell myeloma)	NULL
EXP055703	anti-HDAC4 (Abcam, AB1437)	Homo sapiens		EXP055700	618	normal	P56524	MM1.S (plasma cell myeloma)	NULL
EXP055704	anti-HDAC3 (Millipore, 17-10238)	Homo sapiens		EXP055700	618	normal	O15379	MM1.S (plasma cell myeloma)	NULL
EXP055705	anti-HDAC2 (Millipore, 17-10237)	Homo sapiens		EXP055700	618	normal	Q92769	MM1.S (plasma cell myeloma)	NULL
EXP055706	anti-CCND2 (Santa Cruz, SC-181)	Homo sapiens		EXP055701	618	normal	P30279	MM1.S (plasma cell myeloma)	NULL
EXP055707	anti-CDKN1B (Santa Cruz, SC-528)	Homo sapiens		EXP055701	618	normal	P46527	MM1.S (plasma cell myeloma)	NULL
EXP055708	anti-CDKN1B (Santa Cruz, SC-1641)	Homo sapiens		EXP055701	618	normal	P46527	MM1.S (plasma cell myeloma)	NULL
EXP055709	anti-CCND2 (Santa Cruz, SC-593)	Homo sapiens		EXP055701	618	normal	P30279	MM1.S (plasma cell myeloma)	NULL
EXP055710	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055711	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055712	none	Homo sapiens		NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055713	none	Homo sapiens		NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055714	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055710	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP055715	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055711	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP055716	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055712	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055717	anti-BRD4 (E2A7X, Cell Signalling)	Homo sapiens		EXP055713	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP055718	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: DMSO;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	NULL
EXP055719	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hrs;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	NULL
EXP055720	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: DMSO;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	NULL
EXP055721	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hrs;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	NULL
EXP055722	BRD4 (BETHYL,A301-985A100)	Homo sapiens	Treatment: DMSO;	NULL	130	normal	O60885	LNCaP C4-2 (prostate carcinoma)	NULL
EXP055723	none	Homo sapiens	Tissue: tonsil;	NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP055724	none	Homo sapiens	Tissue: tonsil;	NULL	327	chip_control	NULL	germinal center B-cells	NULL
EXP055725	CREBBP (Santa Cruz, sc369, Rabbit polyclonal)	Homo sapiens	Tissue: tonsil;	EXP055723	327	normal	Q92793	germinal center B-cells	NULL
EXP055726	CREBBP (Santa Cruz, sc369, Rabbit polyclonal)	Homo sapiens	Tissue: tonsil;	EXP055724	327	normal	Q92793	germinal center B-cells	NULL
EXP055727	Lamin B1 (Abcam ab1648)	Homo sapiens	Genotype: wildtype;	NULL	2725	normal	P20700	BL-2 (Burkitt lymphoma)	NULL
EXP055728	Lamin B1 (Abcam ab1648)	Homo sapiens	Genotype: Somatic hypermutation;	NULL	2725	normal	P20700	BL-2 (Burkitt lymphoma)	NULL
EXP055729	Genotype: TIAM1 knockout;	Homo sapiens		NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP055730		Homo sapiens	Genotype: wildtype;	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP055731	TAZ antibody	Homo sapiens	Genotype: TIAM1 knockout;	EXP055729	821	normal	Q16635	SW480 (colon adenocarcinoma)	NULL
EXP055732	TAZ antibody	Homo sapiens	Genotype: wildtype;	EXP055730	821	normal	Q16635	SW480 (colon adenocarcinoma)	NULL
EXP055733	anti-IgG (Santa Cruz, SC-2027, lot: F2413)	Homo sapiens	Treatment: vehicle (NaH2PO4, 50mM);	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055734	anti-IgG (Santa Cruz, SC-2027, lot: F2413)	Homo sapiens	Treatment: vehicle (NaH2PO4, 50mM);	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055735	anti-IgG (Santa Cruz, SC-2027, lot: F2413)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055736	anti-IgG (Santa Cruz, SC-2027, lot: F2413)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055737	anti-IgG (Santa Cruz, SC-2027, lot: F2413)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP055738	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: vehicle (NaH2PO4, 50mM);	EXP055733	848	normal	Q06609	U2OS (osteosarcoma)	NULL
EXP055739	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: vehicle (NaH2PO4, 50mM);	EXP055734	848	normal	Q06609	U2OS (osteosarcoma)	NULL
EXP055740	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	EXP055735	848	normal	Q06609	U2OS (osteosarcoma)	NULL
EXP055741	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	EXP055736	848	normal	Q06609	U2OS (osteosarcoma)	NULL
EXP055742	anti-RAD51 (Santa Cruz, SC-8349, lot: G2314)	Homo sapiens	Treatment: CX-5461 10-7M for 24 hours;	EXP055737	848	normal	Q06609	U2OS (osteosarcoma)	NULL
EXP055743		Homo sapiens	Treatment: shRNA control; Genotype: wildtype;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055744		Homo sapiens	Treatment: shCHD1; Genotype: CHD1 knockout;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055745	CHD1 antibody (Bethyl, #A301-218A)	Homo sapiens	Treatment: shRNA control; Genotype: wildtype;	EXP055743	725	normal	O14646	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055746	CHD1 antibody (Bethyl, #A301-218A)	Homo sapiens	Treatment: shCHD1; Genotype: CHD1 knockout;	EXP055744	725	normal	O14646	PC3(bone mets prostate adenocarcinoma)	NULL
EXP055747		Homo sapiens	Treatment: neuronal media for 2 days;	NULL	2726	chip_control	NULL	iPSC derived NPC	NULL
EXP055748		Homo sapiens	Treatment: neuronal media for 2 days; Source: patient with Schizophrenia;	NULL	2726	chip_control	NULL	iPSC derived NPC	NULL
EXP055749	FGFR1 (Abcam, ab10646)	Homo sapiens	Treatment: neuronal media for 2 days;	EXP055747	2726	normal	P11362	iPSC derived NPC	NULL
EXP055750	FGFR1 (Abcam, ab10646)	Homo sapiens	Treatment: neuronal media for 2 days; Source: patient with Schizophrenia;	EXP055748	2726	normal	P11362	iPSC derived NPC	NULL
EXP055751	NOTCH (obtained from Dr. Jon C. Aster)	Homo sapiens	Treatment: neuronal media for 2 days; Source: patient with Schizophrenia;	EXP055748	2726	normal	P46531	iPSC derived NPC	NULL
EXP055752	None	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055753	None	Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055754	NIPBL (Bethyl, A301-779A)	Homo sapiens		EXP055752	356	normal	Q6KC79	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055755	NIPBL (Bethyl, A301-779A)	Homo sapiens		EXP055753	356	normal	Q6KC79	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055756	SMC1A (Bethyl, A300-055A)	Homo sapiens		EXP055752	356	normal	Q14683	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055757	SMC1A (Bethyl, A300-055A)	Homo sapiens		EXP055753	356	normal	Q14683	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055758	MED1 (Bethyl, A300-793A)	Homo sapiens		EXP055752	356	normal	O95243	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055759	MED1 (Bethyl, A300-793A)	Homo sapiens		EXP055753	356	normal	O95243	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP055760	anti-p300 (Santa Cruz, #sc-585X)	Homo sapiens	Tissue: Peripheral Blood; Cell markers: CD3+CD8+CD4-CD45RO-CD27+;	NULL	2727	normal	Q09472	naive CD8+ T cells	NULL
EXP055761	anti-p300 (Santa Cruz, #sc-585X)	Homo sapiens	Tissue: Peripheral Blood; Cell markers: CD3+CD8+CD4-CD45RO+;	NULL	2728	normal	Q09472	memory CD8+ T cells	NULL
EXP055762	none	Homo sapiens	Treatment: none;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP055763	anti-mTOR	Homo sapiens	Treatment: treated for 48h with  vehicle (EtOH);	EXP055762	70	normal	P42345	LNCaP (prostate carcinoma)	NULL
EXP055764	anti-mTOR	Homo sapiens	Treatment: treated for 48h with 10 nM R1881; 	EXP055762	70	normal	P42345	LNCaP (prostate carcinoma)	NULL
EXP055765	anti-MED1	Homo sapiens		NULL	2729	normal	O95243	THRS (tyrosine hydroxylase reporter stem cell line) derived to dopaminergic neurons	NULL
EXP055766	anti-p27 (Santa Cruz, catalog# sc-528, lot# I 2115)	Homo sapiens	Developmental stage: G0 synchronized;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055767	anti-p27 (Santa Cruz, catalog# sc-528, lot# I 2115)	Homo sapiens	Developmental stage: asynchronously growing;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055768	anti-p27 (Santa Cruz, catalog# sc-528, lot# I 2115)	Homo sapiens	Developmental stage: G0 synchronized;	EXP055766	417	normal	P46527	HCT-116 (colon carcinoma)	NULL
EXP055769	anti-p27 (Santa Cruz, catalog# sc-528, lot# I 2115)	Homo sapiens	Developmental stage: asynchronously growing;	EXP055767	417	normal	P46527	HCT-116 (colon carcinoma)	NULL
EXP055770	anti-SREBP2 antibody (Cayman, Michigan, USA)	Homo sapiens	Treatment: Control (pH =7.4);	NULL	712	normal	Q12772	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP055771	anti-SREBP2 antibody (Cayman, Michigan, USA)	Homo sapiens	Treatment: low pH (pH=6.8);	NULL	712	normal	Q12772	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP055772	anti-Menin/MEN1 (A300-115A,Bethyl)	Homo sapiens		NULL	111	normal	O00255	T47D (invasive ductal carcinoma)	NULL
EXP055773	anti-Menin/MEN1 (A300-115A,Bethyl)	Homo sapiens		NULL	583	normal	O00255	MCF10A (breast epithelial cells)	NULL
EXP055774	HA.11 (BioLegend, 901502)	Homo sapiens	Time: 24 hours after transfection; Genotype: plasmid encoding for a HA-tagged form of DUX4;	NULL	376	normal	Q9UBX2	WA01 (H1, human embryonic stem cells)	NULL
EXP055775	anti-LMO1	Homo sapiens		NULL	509	normal	P25800	Jurkat (T-cells)	NULL
EXP055776	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP055777	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP055778	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens		EXP055776	417	normal	Q96EB6	HCT-116 (colon carcinoma)	NULL
EXP055779	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens		EXP055776	417	normal	P33993	HCT-116 (colon carcinoma)	NULL
EXP055780	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: G1 phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	NULL
EXP055781	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: early S phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	NULL
EXP055782	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: middle S phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	NULL
EXP055783	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: late S phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	NULL
EXP055784	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens	Developmental stage: G2 phase;	EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	NULL
EXP055785	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: G1 phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP055786	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: early S phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP055787	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: middle phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP055788	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: late S phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP055789	anti-S139 phosphorylated MCM2 antibody (12958S, Cell signaling)	Homo sapiens	Developmental stage: G2 phase;	EXP055777	514	normal	P33993	K562 (myelogenous leukemia)	NULL
EXP055790	anti-T530 phosphorylated SIRT1 antibody (ab156585, Abcam)	Homo sapiens		EXP055777	514	normal	Q96EB6	K562 (myelogenous leukemia)	NULL
EXP055791	IgG	Homo sapiens		NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP055792	IgG	Homo sapiens	Genotype: Wapl knockout;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP055793	IgG	Homo sapiens	Genotype: SCC4 knockout;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP055794	IgG	Homo sapiens	Genotype: Wapl and SCC4 knockout;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP055795	anti-CTCF	Homo sapiens	Genotype: wildtype;	EXP055791	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	NULL
EXP055796	anti-CTCF	Homo sapiens	Genotype: Wapl knockout;	EXP055792	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	NULL
EXP055797	anti-CTCF	Homo sapiens	Genotype: SCC4 knockout;	EXP055793	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	NULL
EXP055798	anti-CTCF	Homo sapiens	Genotype: Wapl and SCC4 knockout;	EXP055794	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	NULL
EXP055799	anti-SMC1	Homo sapiens	Genotype: wildtype;	EXP055791	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	NULL
EXP055800	anti-SMC1	Homo sapiens	Genotype: Wapl knockout;	EXP055792	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	NULL
EXP055801	anti-SMC1	Homo sapiens	Genotype: SCC4 knockout;	EXP055793	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	NULL
EXP055802	anti-SMC1	Homo sapiens	Genotype: Wapl and SCC4 knockout;	EXP055794	1507	normal	Q14683	HAP1 (chronic myelogenous leukemia)	NULL
EXP055803	none	Homo sapiens	Treatment: DMSO for 4 hrs; Passage: 5 to 10;	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP055804	none	Homo sapiens	Treatment: BYL719 1uM for 4hrs; Passage: 5 to 10;	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP055805	Anti-KMT2D, HPA035977, Sigma	Homo sapiens	Treatment: DMSO for 4 hrs; Passage: 5 to 10;	EXP055803	111	normal	O14686	T47D (invasive ductal carcinoma)	NULL
EXP055806	Anti-KMT2D, HPA035977, Sigma	Homo sapiens	Treatment: BYL719 1uM for 4hrs; Passage: 5 to 10;	EXP055804	111	normal	O14686	T47D (invasive ductal carcinoma)	NULL
EXP055807		Homo sapiens	Genotype: MORC2 knockout, V5-tagged MORC2;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055808		Homo sapiens	Genotype: MORC2 knockout, V5-ragged MORC2;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055809		Homo sapiens	Genotype: MORC2 knockout, V5-vector;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055810		Homo sapiens	Genotype: MORC2 knockout, V5-tagged MORC2;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055811		Homo sapiens	Genotype: V5-tagged W505A MORC2 mutant, MORC2 knockout;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055812		Homo sapiens	Genotype: HUSH triple knockout, V5-tagged MORC2	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055813		Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP055814	anti-V5 (Sigma-Aldrich, A7345)	Homo sapiens	Genotype: MORC2 knockout, V5-tagged MORC2;	EXP055810	78	normal	Q9Y6X9	HeLa (cervical adenocarcinoma)	NULL
EXP055815	anti-V5 (Sigma-Aldrich, A7345)	Homo sapiens	Genotype: V5-tagged W505A MORC2 mutant, MORC2 knockout;	EXP055811	78	normal	Q9Y6X9	HeLa (cervical adenocarcinoma)	NULL
EXP055816	anti-V5 (Sigma-Aldrich, A7345)	Homo sapiens	Genotype: HUSH triple knockout, V5-tagged MORC2	EXP055812	78	normal	Q9Y6X9	HeLa (cervical adenocarcinoma)	NULL
EXP055817	anti-TASOR	Homo sapiens		EXP055813	78	normal	Q9UK61	HeLa (cervical adenocarcinoma)	NULL
EXP055818	none	Homo sapiens	Genotype: DNMT3B wildtype;	NULL	2731	chip_control	NULL	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055819	none	Homo sapiens	Genotype: DNMT3BA603T wildtype;	NULL	2731	chip_control	NULL	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055820	none	Homo sapiens		NULL	2731	chip_control	NULL	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055821	none	Homo sapiens		NULL	2731	chip_control	NULL	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055822	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3B wildtype;	EXP055818	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055823	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3BA603T wildtype;	EXP055819	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055824	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3BA603T/STP807ins;	EXP055820	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055825	DNMT3B (Diagenode)	Homo sapiens	Genotype: DNMT3BV699G/R54X;	EXP055821	2731	normal	Q9UBC3	B-LCL (B-lymphoblastoid cell line)	NULL
EXP055826	anti-NELF-A (J Cell Biochem. 107, 131-139)	Homo sapiens		NULL	2732	normal	Q9H3P2	normal breast	NULL
EXP055827		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055828	anti-UTX	Homo sapiens		EXP055827	113	normal	O15550	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP055829	NCAPH2 (Bethyl: A302-275A)	Homo sapiens	Passage: 10-13; Genotype: wildtype;	NULL	421	normal	Q6IBW4	HEK293 (embryonic kidney)	NULL
EXP055830	NCAPH2 (Bethyl: A302-275A)	Homo sapiens	Passage: 10-13; Genotype: SET1 knockout;	NULL	421	normal	Q6IBW4	HEK293 (embryonic kidney)	NULL
EXP055831	anti-IgG	Homo sapiens		NULL	2733	chip_control	NULL	SCC9 (tongue squamous cell carcinoma)	NULL
EXP055832	anti-IgG	Homo sapiens		NULL	2733	chip_control	NULL	SCC9 (tongue squamous cell carcinoma)	NULL
EXP055833	anti-CHD4	Homo sapiens	Genotype: -DOC1;	EXP055831	2733	normal	Q14839	SCC9 (tongue squamous cell carcinoma)	NULL
EXP055834	anti-CHD4	Homo sapiens	Genotype: +DOC1;	EXP055832	2733	normal	Q14839	SCC9 (tongue squamous cell carcinoma)	NULL
EXP055835	anti-BRD4	Homo sapiens	Treatment: vehicle (DMSO) for 1 hr;	NULL	2734	normal	O60885	Akata-Zta (cell line infected by Epstein-Barr virus)	NULL
EXP055836	anti-BRD4	Homo sapiens	Treatment: 1 uM JQ1 for 1 hr;	NULL	2734	normal	O60885	Akata-Zta (cell line infected by Epstein-Barr virus)	NULL
EXP055837	Suz12 (D39F6, Cell Signaling, rabbit monoclonal)	Homo sapiens		NULL	2735	normal	Q15022	Lu130 (Small cell lung carcinoma)	NULL
EXP055838	None	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP055839	ANTI-FLAG(R) M2 antibody	Homo sapiens		EXP055838	65	normal	P18433	U937 (adult acute monocytic leukemia)	NULL
EXP055840	None	Mus musculus	Tissue: Connective tissue; Developmental stage: 10.5 day old embryos; Strain: BALB/c; Genotype: Actb +/+;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055841	None	Mus musculus	Tissue: Connective tissue; Developmental stage: 10.5 day old embryos; Strain: BALB/c; Genotype: Actb knockout;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055842	Brg1 (from anki.ostlund Farrant (Stockholm University))	Mus musculus	Tissue: Connective tissue; Developmental stage: 10.5 day old embryos; Strain: BALB/c; Genotype: Actb +/+;	EXP055840	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	NULL
EXP055843	Brg1 (from anki.ostlund Farrant (Stockholm University))	Mus musculus	Tissue: Connective tissue; Developmental stage: 10.5 day old embryos; Strain: BALB/c; Genotype: Actb knockout;	EXP055841	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	NULL
EXP055844	anti-p300	Mus musculus	Developmental stage: day 11.5 (e11.5); Strain: CD1; Sex: mixed male/female;	NULL	313	normal	B2RWS6	forebrain	NULL
EXP055845	anti-p300	Mus musculus	Developmental stage: day 11.5 (e11.5); Strain: CD1; Sex: mixed male/female;	NULL	1147	normal	B2RWS6	midbrain	NULL
EXP055846	anti-p300	Mus musculus	Developmental stage: day 11.5 (e11.5); Strain: CD1; Sex: mixed male/female;	NULL	547	normal	B2RWS6	limb	NULL
EXP055847		Mus musculus	Source: E14Tg2a murine ES cells; Genotype: Brg knockout;	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP055848	anti-Brg/Brm antibody (Clone J1, Khavari et al., 1993, Nature, PMID: 8232556)	Mus musculus	Source: E14Tg2a murine ES cells; Genotype: Brg knockout;	EXP055847	506	normal	Q6DIC0	J1 (embryonic stem cells)	NULL
EXP055849	PCL2 (MTF2)	Mus musculus		NULL	765	normal	Q02395	R1 (embryonic stem cells)	NULL
EXP055850	jmjd3	Mus musculus	Treatment: LPS (lipopolysaccharide) + IFNgamma (interferon gamma ) treated for 2hrs;	NULL	81	normal	Q5NCY0	BMDM (bone marrow-derived macrophages)	NULL
EXP055851	anti-Eset antibody (rabbit polyclonal )	Mus musculus	Treatment: unperturbed;	NULL	230	normal	O88974	ES-E14 (E14, embryonic stem cells)	NULL
EXP055852	WCE	Mus musculus	Treatment: none; 	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP055853	anti-SetDB1	Mus musculus	Treatment: none; 	EXP055852	252	normal	O88974	V6.5 (embryonic stem cells)	NULL
EXP055854	none	Mus musculus	Strain: 129SV; Passage: 13-18;	NULL	963	chip_control	NULL	embryonic stem cells from stran 129	NULL
EXP055855	IgG	Mus musculus	Strain: 129SV; Passage: 13-18;	NULL	963	chip_control	NULL	embryonic stem cells from stran 129	NULL
EXP055856	anti-LSD1 (Abcam #07-449)	Mus musculus	Strain: 129SV; Passage: 13-18;	EXP055854	963	normal	Q6ZQ88	embryonic stem cells from stran 129	NULL
EXP055857	NelfA (Santa Cruz (A-20), sc-23599)	Mus musculus		NULL	252	normal	Q8BG30	V6.5 (embryonic stem cells)	NULL
EXP055858	Supt5 (gift from Yuki Yamaguchi and Hiroshi Handa (Wada et al., 1998))	Mus musculus		NULL	252	normal	O55201	V6.5 (embryonic stem cells)	NULL
EXP055859	Ctr9 (Bethyl labs, A301-395)	Mus musculus		NULL	252	normal	Q62018	V6.5 (embryonic stem cells)	NULL
EXP055860	none	Mus musculus	Genotype: wildtype RAP1; 	NULL	2737	chip_control	NULL	SV40-large T immortalized mouse embryonic fibroblast	NULL
EXP055861	anti-RAP1	Mus musculus	Genotype: wildtype RAP1; 	EXP055860	2737	normal	Q91VL8	SV40-large T immortalized mouse embryonic fibroblast	NULL
EXP055862	anti-RAP1	Mus musculus	Genotype: RAP1 knockout;	NULL	2737	normal	Q91VL8	SV40-large T immortalized mouse embryonic fibroblast	NULL
EXP055863	RAG2 (rabbit polyclonal antibody raised to RAG2 aa 70-516 (Leu and Schatz, PMID: 7565717))	Mus musculus	Genotype: R2 knockout;	NULL	2446	normal	P21784	total thymocytes	NULL
EXP055864	RAG2 (rabbit polyclonal antibody raised to RAG2 aa 70-516 (Leu and Schatz, PMID: 7565717))	Mus musculus	Genotype: D708A-R1 knockout; 	NULL	2446	normal	P21784	total thymocytes	NULL
EXP055865	RAG2 (rabbit polyclonal antibody raised to RAG2 aa 70-516 (Leu and Schatz, PMID: 7565717))	Mus musculus	Genotype: wildtype;	NULL	2446	normal	P21784	total thymocytes	NULL
EXP055866	no Ab	Mus musculus	Strain: 129P2/OlaHsd; Passage: 25-30;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP055867	LUZP1 (Rabbit sera)	Mus musculus	Strain: 129P2/OlaHsd; Passage: 25-30;	EXP055866	230	normal	Q8R4U7	ES-E14 (E14, embryonic stem cells)	NULL
EXP055868	CHD7 (Abcam, ab31824, batch #215651)	Mus musculus	Strain: R1; 	NULL	2	normal	A2AJK6	mESCs (mouse embryonic stem cells)	NULL
EXP055869	p300 (Santa Cruz, sc-585, batch # unknown)	Mus musculus	Strain: R1; 	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	NULL
EXP055870	anti-p300 antibody (Santa Cruz Biotechnology, SC-585, Lot L2704)	Mus musculus	Developmental stage: embryonic day 11.5 (e11.5); Sex: Mixed male / female; Strain: CD-1;	NULL	247	normal	B2RWS6	embryonic heart	NULL
EXP055871	anti-p300 antibody (Santa Cruz Biotechnology, SC-585, Lot L2704)	Mus musculus	Developmental stage: embryonic day 11.5 (e11.5); Sex: Mixed male / female; Strain: CD-1;	NULL	2739	normal	B2RWS6	embryonic midbrain	NULL
EXP055872	none	Mus musculus	Genotype: C3H;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP055873	none	Mus musculus	Genotype: C3H;	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP055874	none	Mus musculus	Genotype: C3H;	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP055875	anti-Sin3A (Santa Cruz Biotechnology, sc-767, D1505)	Mus musculus	Genotype: C3H;	EXP055873	126	normal	Q60520	C2C12 (myotubes)	NULL
EXP055876	anti-Sin3A (Santa Cruz Biotechnology, sc-767, D1505)	Mus musculus	Genotype: C3H;	EXP055874	126	normal	Q60520	C2C12 (myotubes)	NULL
EXP055877	anti-Sin3B  (Santa Cruz Biotechnology, sc-767, H0904)	Mus musculus	Genotype: C3H;	EXP055873	126	normal	Q62141	C2C12 (myotubes)	NULL
EXP055878	anti-Sin3A (Santa Cruz Biotechnology, sc-767, I2908)	Mus musculus	Genotype: C3H;	EXP055872	1153	normal	Q60520	C2C12 (myoblasts)	NULL
EXP055879	anti-Sin3B  (Santa Cruz Biotechnology, sc-767, H0904)	Mus musculus	Genotype: C3H;	EXP055872	1153	normal	Q62141	C2C12 (myoblasts)	NULL
EXP055880	anti-Sin3B  (Santa Cruz Biotechnology, sc-767, H0904)	Mus musculus	Genotype: C3H;	EXP055874	126	normal	Q62141	C2C12 (myotubes)	NULL
EXP055881	no IP	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP055882	no IP	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP055883	no IP	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP055884	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP055881	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP055885	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055881	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP055886	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055882	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP055887	Ring1B (Hybridoma 20, 43-6, 2001)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055883	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP055888	anti-CBX7 (Abcam, ab21873)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP055881	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP055889	anti-CBX7 (Abcam, ab21873)	Mus musculus	Genotype: Eed knockout; Strain: C57BL/6;	EXP055881	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP055890	None	Mus musculus	Strain: Balb/C; Age: 4-6 week mice; Tissue: spleens and lymph nodes;	NULL	1588	chip_control	NULL	CD4-positive helper T cell	NULL
EXP055891	BRG1 (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Strain: Balb/C; Age: 4-6 week mice; Tissue: spleens and lymph nodes;	EXP055890	2740	normal	Q3TKT4	naive CD4+ T helper	NULL
EXP055892	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2741	normal	Q3TKT4	resting Th1 CD4+ T helper cells	NULL
EXP055893	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2742	normal	Q3TKT4	resting Th2 CD4+ T helper cells	NULL
EXP055894	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2743	normal	Q3TKT4	stimulated Th1 CD4+ T helper cells	NULL
EXP055895	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2744	normal	Q3TKT4	stimulated Th2 CD4+ T helper cells	NULL
EXP055896	BRG (J1 antibody described in Genes Dev. 1996 Sep 1;10(17):2117-30, PubMed ID: 8804307)	Mus musculus	Source: from Naive cells; Strain: Balb/C;	EXP055890	2745	normal	Q3TKT4	stimulated Th17 CD4+ T helper cells	NULL
EXP055897	n/a	Mus musculus	Strain: C57BL/6 x 129; Treatment: 2i serum-free medium;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP055898	anti-Suz12 (Abcam, ab12073-100, 418328)	Mus musculus	Strain: C57BL/6 x 129; Treatment: 2i serum-free medium;	EXP055897	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP055899	anti-Suz12 (Abcam, ab12073-100, 418328)	Mus musculus	Strain: C57BL/6 x 129; Treatment: serum medium;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP055900	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: C57BL/6 x 129; Treatment: 2i serum-free medium;	EXP055897	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP055901	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: C57BL/6 x 129; Treatment: serum medium;	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP055902	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: 129/Ola; Treatment: serum medium;	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP055903	anti-Ezh2 (Active Motif, 39639, #3809001)	Mus musculus	Strain: 129/Ola; Treatment: 2i serum-free medium;	NULL	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP055904	IgG (Jackson Immunoresearch, 76310, 005-000-003)	Mus musculus		NULL	763	chip_control	NULL	R1/E (embryonic stem cells)	NULL
EXP055905	IgG (Jackson Immunoresearch, 76310, 005-000-003)	Mus musculus	Developmental stage: differentiation day 12;	NULL	2746	chip_control	NULL	R1/E-derived ebryoid bodies	NULL
EXP055906	anti-eGFP (raised against His-tagged full-length eGFP and affinity-purified with GST-tagged full-length eGFP)	Mus musculus		EXP055904	763	normal	Q61550	R1/E (embryonic stem cells)	NULL
EXP055907	anti-eGFP (raised against His-tagged full-length eGFP and affinity-purified with GST-tagged full-length eGFP)	Mus musculus	Developmental stage: differentiation day 12;	EXP055905	2746	normal	Q61550	R1/E-derived ebryoid bodies	NULL
EXP055908	none	Mus musculus	Genotype: Nelf-b knockout; Strain: mixed background of 129/SvJ, C57BL/6, and FVB;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055909	anti-Nelf-b (purified polyclonal)	Mus musculus	Genotype: Nelf-b knockout; Strain: mixed background of 129/SvJ, C57BL/6, and FVB;	EXP055908	12	normal	Q8C4Y3	MEF (mouse embryonic fibroblasts)	NULL
EXP055910	Mixture of various non-specific antibodies	Mus musculus	Strain: C57BL/6;	NULL	41	chip_control	NULL	B-cells	NULL
EXP055911	anti-AID (Rabbit polyclonal described in Chaudhuri et al., Nature 2003)	Mus musculus	Genotype: AID knockout; 	EXP055910	2366	normal	Q8BJ51	activated B-cells	NULL
EXP055912	anti-Spt5 (H300) (Santa Cruz Biotechnology)	Mus musculus	Strain: C57BL/6; 	EXP055910	2366	normal	A1A546	activated B-cells	NULL
EXP055913	anti-AID (Rabbit polyclonal described in Chaudhuri et al., Nature 2003)	Mus musculus	Strain: C57BL/6; 	EXP055910	2366	normal	Q8BJ51	activated B-cells	NULL
EXP055914	rabbit IgG	Mus musculus	Strain: C57BL/6-cast; 	NULL	2747	chip_control	NULL	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	NULL
EXP055915	anti-Cbp antibody 	Mus musculus	Strain: C57BL/6-cast; 	EXP055914	2747	normal	P45481	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	NULL
EXP055916	anti-Ezh2 (Active Motif, 39639)	Mus musculus	Strain: C3H; Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	Q61188	C2C12 (myoblasts)	NULL
EXP055917	Ezh1	Mus musculus	Strain: C3H; Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	P70351	C2C12 (myoblasts)	NULL
EXP055918	Ezh1	Mus musculus	Developmental stage: 24-hours differentiated Myotubes; Strain: C3H; 	NULL	126	normal	P70351	C2C12 (myotubes)	NULL
EXP055919	Ezh1	Mus musculus	Developmental stage: 24-hours differentiated Myotubes; Strain: C3H; 	NULL	1153	normal	P70351	C2C12 (myoblasts)	NULL
EXP055920	anti-Suz12 (Millipore, NG1800878, 17-661)	Mus musculus	Strain: C3H; Developmental stage: Proliferating Myoblasts;	NULL	126	normal	Q80U70	C2C12 (myotubes)	NULL
EXP055921	anti-Suz12 (Millipore, NG1800878, 17-661)	Mus musculus	Developmental stage: 24-hours differentiated Myotubes; Strain: C3H; 	NULL	1153	normal	Q80U70	C2C12 (myoblasts)	NULL
EXP055922	input DNA and IgG	Mus musculus	Strain: 13R/9R and 9R/13R crosses; Genotype: Hop2 -/- (knockout);	NULL	2748	chip_control	NULL	adult testis	NULL
EXP055923	input DNA and IgG	Mus musculus	Strain: 9R/13R cross; Genotype: wildtype;	NULL	2748	chip_control	NULL	adult testis	NULL
EXP055924	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 9R/13R cross; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q61880	adult testis	NULL
EXP055925	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 13R/9R and 9R/13R crosses; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q61880	adult testis	NULL
EXP055926	RAD51 (H92) (Santa Cruz, sc 8349, D2209)	Mus musculus	Strain: 13R/9R cross; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q08297	adult testis	NULL
EXP055927	RAD51 (H92) (Santa Cruz, sc 8349, D2209)	Mus musculus	Strain: 9R/13R cross; Genotype: Hop2 -/- (knockout);	EXP055922	2748	normal	Q08297	adult testis	NULL
EXP055928	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: C57BL/6J/129R cross; Genotype: Spo11 -/-  (knockout);	EXP055922	2748	normal	Q61880	adult testis	NULL
EXP055929	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 13R/9R cross; Genotype: Hop2 -/- (knockout);	NULL	2748	normal	Q61880	adult testis	NULL
EXP055930	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Strain: 9R/13R cross; Genotype: wildtype;	EXP055923	2748	normal	Q61880	adult testis	NULL
EXP055931	anti-Dpy-30 (unreleased product from Bethyl Laboratories, developed by Christina Hughes (David Allis lab, Rockefeller University) through Bethyl)	Mus musculus		NULL	230	normal	Q99LT0	ES-E14 (E14, embryonic stem cells)	NULL
EXP055932	none	Mus musculus	Treatment: Pcl3-shRNA7; Genotype: Pcl3-TAP, Pcl3 wildtype knockout;	NULL	2749	chip_control	NULL	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055933	none	Mus musculus	Treatment: Pcl3-shRNA6; Genotype: Pcl3-TAP, Pcl3 wildtype knockout;	NULL	2749	chip_control	NULL	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055934	none	Mus musculus	Treatment: Pcl3-shRNA; Genotype: Suz12^Suz12TAP/+, Pcl3 knockout;	NULL	2749	chip_control	NULL	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055935	none	Mus musculus	Treatment: shRNA control; Genotype: Suz12^Suz12TAP/+;	NULL	2749	chip_control	NULL	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055936	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: Pcl3-shRNA; Genotype: Suz12^Suz12TAP/+, Pcl3 knockout;	EXP055934	2749	normal	Q80U70	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055937	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: shRNA control; Genotype: Suz12^Suz12TAP/+;	EXP055935	2749	normal	Q80U70	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055938	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: Pcl3-shRNA7; Genotype: Pcl3-TAP, Pcl3 wildtype knockout;	EXP055932	2749	normal	Q9CXG9	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055939	anti-FlagM2 (Sigma, 088k6018)	Mus musculus	Treatment: Pcl3-shRNA6; Genotype: Pcl3-TAP, Pcl3 wildtype knockout;	EXP055933	2749	normal	Q9CXG9	BayGenomics ES cell line XG122 (embryonic stem cells)	NULL
EXP055940		Mus musculus		NULL	602	chip_control	NULL	erythroleukemic cells	NULL
EXP055941	anti-FLAG	Mus musculus	Genotype: expressing BirA; 	EXP055940	602	normal	Q9QYE3	erythroleukemic cells	NULL
EXP055942	none	Mus musculus	Source: E12.5 heart apex. 120 hearts; Tissue: heart apex;	NULL	95	chip_control	NULL	E12.5 embryonic heart	NULL
EXP055943	anti-Ezh2	Mus musculus	Source: E12.5 heart apex. 120 hearts; Tissue: heart apex;	EXP055942	95	normal	Q61188	E12.5 embryonic heart	NULL
EXP055944	anti-Smc1 (Bethyl, A301-779A)	Mus musculus	Treatment: DMSO for 1 hr;	NULL	252	normal	Q9CU62	V6.5 (embryonic stem cells)	NULL
EXP055945	anti-Smc1 (Bethyl, A301-779A)	Mus musculus	Treatment: 1 uM flavopiridol for 1 hr;	NULL	252	normal	Q9CU62	V6.5 (embryonic stem cells)	NULL
EXP055946	IgG (isotypic control antibody) [Abcam; Cat. no.: ab46540]	Mus musculus	Starin: C57BL/6; Passage: mixed for eNSCs: 2-3 and p2-pOLs 0;	NULL	2751	chip_control	NULL	neural stem cells and pre-myelinating oligodendrocytes	NULL
EXP055947	Anti Ezh2 [Diagenode (http://www.diagenode.com/en/index.php); Cat. no.: CS-039-100; Lot no.: 001]	Mus musculus	Strain: C57BL/6; Tissue: brain; Passage:  2-3 (cultured as neurospheres);	EXP055946	2775	normal	Q61188	neural stem cells	NULL
EXP055948	Anti Ezh2 [Diagenode (http://www.diagenode.com/en/index.php); Cat. no.: CS-039-100; Lot no.: 001]	Mus musculus	Strain: C57BL/6; Tissue: brain; Passage:  0 (single time monolayer cultures);	EXP055946	2750	normal	Q61188	pOLs (pre-myelinating oligodendrocytes)	NULL
EXP055949	anti-Mbd3 (Abcam, ab3755)	Mus musculus	Genotype: Tet1 knockout;	NULL	2	normal	Q9DA79	mESCs (mouse embryonic stem cells)	NULL
EXP055950	anti-Mbd3 (Abcam, ab3755)	Mus musculus	Genotype: Brg1 knockout;	NULL	2	normal	Q9DA79	mESCs (mouse embryonic stem cells)	NULL
EXP055951	anti-Mbd3 (Abcam, ab3755)	Mus musculus	Genotype: wildtype;	NULL	2	normal	Q9DA79	mESCs (mouse embryonic stem cells)	NULL
EXP055952	NA	Mus musculus	Treatment: Unstimulated; Strain: C57BL6; Developmental stage: E16+7DIV;	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP055953	NA	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP055954	NA	Mus musculus	Treatment: Unstimulated; Strain: C57BL6; Developmental stage: E16+7DIV;	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP055955	NA	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	NULL	159	chip_control	NULL	cortical neurons	NULL
EXP055956	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: Unstimulated; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055952	159	normal	Q9Z2D6	cortical neurons	NULL
EXP055957	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055953	159	normal	Q9Z2D6	cortical neurons	NULL
EXP055958	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: Unstimulated; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055954	159	normal	Q9Z2D6	cortical neurons	NULL
EXP055959	Anti-MeCP2 (Custom  c-terminal antibody)	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055955	159	normal	Q9Z2D6	cortical neurons	NULL
EXP055960	Anti-pS421 MeCP2  (Custom antibody)	Mus musculus	Treatment: 2 hrs KCl depolarized; Strain: C57BL6; Developmental stage: E16+7DIV;	EXP055955	159	normal	Q9Z2D6	cortical neurons	NULL
EXP055961	anti-Tnni2 (Santa Cruz biotechnology, sc-30486)	Mus musculus	Strain: 129sv; Genotype: del175k mutant; 	NULL	2752	normal	P13412	primary osteoblast	NULL
EXP055962	anti-Tnni2 (Santa Cruz biotechnology, sc-30486)	Mus musculus	Strain: 129sv; Genotype: wildtype; 	NULL	2752	normal	P13412	primary osteoblast	NULL
EXP055963	none	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Source: pooled wild type and SA1knockout cells; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055964	none	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Source: pooled wild type and SA1knockout cells; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP055965	anti-SA1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	NULL	12	normal	Q9D3E6	MEF (mouse embryonic fibroblasts)	NULL
EXP055966	anti-SA2	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	NULL	12	normal	O35638	MEF (mouse embryonic fibroblasts)	NULL
EXP055967	anti-SA2	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	NULL	12	normal	O35638	MEF (mouse embryonic fibroblasts)	NULL
EXP055968	anti-SMC1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	EXP055964	12	normal	Q9CU62	MEF (mouse embryonic fibroblasts)	NULL
EXP055969	anti-SMC3	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: wildtype; 	EXP055964	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	NULL
EXP055970	SMC3	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: SA1 knockout;	EXP055964	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	NULL
EXP055971	anti-SA1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: SA1 knockout; 	EXP055964	12	normal	Q9D3E6	MEF (mouse embryonic fibroblasts)	NULL
EXP055972	anti-SMC1	Mus musculus	Developmental stage: E12.5; Strain: C57BL/6 x 129 Sv; Genotype: SA1 knockout; 	EXP055964	12	normal	Q9CU62	MEF (mouse embryonic fibroblasts)	NULL
EXP055973	none	Mus musculus	Treatment: unstimulated;	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP055974	none	Mus musculus	Treatment: stimulated for 2h with 100ng/ml LPS;	NULL	104	chip_control	NULL	dendritic cells	NULL
EXP055975	anti-JmjD2d (clone 1-7)	Mus musculus	Treatment: unstimulated;	EXP055973	104	normal	Q3U2K5	dendritic cells	NULL
EXP055976	anti-JmjD2d (clone 1-7)	Mus musculus	Treatment: stimulated for 2h with 100ng/ml LPS;	EXP055974	104	normal	Q3U2K5	dendritic cells	NULL
EXP055977	None WCE	Mus musculus	Treatment: 200 ng/ml nocodazole;	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP055978	anti-CapD3 (Tatsuya Hirano, AFR319-3L)	Mus musculus	Treatment: none;	NULL	252	normal	Q6ZQK0	V6.5 (embryonic stem cells)	NULL
EXP055979	anti-CapD3 (Tatsuya Hirano, AFR319-3L)	Mus musculus	Treatment: 200 ng/ml nocodazole;	EXP055977	252	normal	Q6ZQK0	V6.5 (embryonic stem cells)	NULL
EXP055980	anti-CapG (Tatsuya Hirano, AFR310-4L)	Mus musculus	Treatment: none;	NULL	252	normal	P24452	V6.5 (embryonic stem cells)	NULL
EXP055981	anti-CapG (Tatsuya Hirano, AFR310-4L)	Mus musculus	Treatment: 200 ng/ml nocodazole;	EXP055977	252	normal	P24452	V6.5 (embryonic stem cells)	NULL
EXP055982	anti-Rad21 (Bethyl, A300-080A)	Mus musculus	Treatment: none;	NULL	252	normal	Q61550	V6.5 (embryonic stem cells)	NULL
EXP055983	input	Mus musculus	Treatment: equal mix of Samples treated with IL4 and BSA; Strain: C57BL/6; 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP055984	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Treatment: BSA; Strain: C57BL/6;	EXP055983	81	normal	O88895	BMDM (bone marrow-derived macrophages)	NULL
EXP055985	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Treatment: IL4; Strain: C57BL/6;	EXP055983	81	normal	O88895	BMDM (bone marrow-derived macrophages)	NULL
EXP055986	none	Mus musculus		NULL	2753	chip_control	NULL	OS25 (embryonic stem cells)	NULL
EXP055987	anti-Ring1B (A-20)	Mus musculus		EXP055986	2753	normal	Q9CQJ4	OS25 (embryonic stem cells)	NULL
EXP055988	IgG	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	NULL	2748	chip_control	NULL	adult testis	NULL
EXP055989	IgG	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	NULL	2748	chip_control	NULL	adult testis	NULL
EXP055990	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	NULL	2748	normal	Q61880	adult testis	NULL
EXP055991	anti-RAD51 (H92) (Santa Cruz,sc 8349,  D2209)	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	EXP055988	2748	normal	Q08297	adult testis	NULL
EXP055992	anti-RAD51 (H92) (Santa Cruz,sc 8349,  D2209)	Mus musculus	Genotype: Hop2 -/- knockout; Background strain: 9R female x 13R male F1;	EXP055989	2748	normal	Q08297	adult testis	NULL
EXP055993	anti-DMC1 (C-20) (Santa Cruz, sc 8973, G0909)	Mus musculus	Genotype: wildtype; Background strain: 9R female x 13R male F1;	NULL	2748	normal	Q61880	adult testis	NULL
EXP055994	none (input)	Mus musculus	Genotype: Notch1-IC over-expressing;	NULL	2754	chip_control	NULL	T-ALL (Acute Lymphoblastic Leukemia)	NULL
EXP055995	anti-Notch1	Mus musculus	Genotype: Notch1-IC over-expressing;	EXP055994	2754	normal	Q01705	T-ALL (Acute Lymphoblastic Leukemia)	NULL
EXP055996		Mus musculus	Strain: B10.F-H2pb1/(13R)J X B11.S-H2t4/(9R)/J; Genotype: wildtype;	NULL	32	chip_control	NULL	testis	NULL
EXP055997	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Srain: B6;129P2-Prdm9tm1Ymat/J; Genotype: Prdm9 knockout;	NULL	32	normal	Q61880	testis	NULL
EXP055998	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: C57Bl/6J; Genotype: wildtype;	NULL	32	normal	Q61880	testis	NULL
EXP055999	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: B10.F-H2pb1/(13R)J; Genotype: wildtype;	NULL	32	normal	Q61880	testis	NULL
EXP056000	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: B11.S-H2t4/(9R)/J; Genotype: wildtype;	NULL	32	normal	Q61880	testis	NULL
EXP056001	Anti-DMC1 (C-20) (Santa Cruz, sc-8973)	Mus musculus	Strain: B10.F-H2pb1/(13R)J X B11.S-H2t4/(9R)/J; Genotype: wildtype;	EXP055996	32	normal	Q61880	testis	NULL
EXP056003	anti-CTCF (Millipore, 07-729)	Mus musculus		EXP010869	624	normal	Q61164	E14.5 limb	NULL
EXP056004	CTCF	Mus musculus		NULL	1053	normal	Q61164	Treg cells from lymph nodes and spleen	NULL
EXP056005	anti-Brg1 (Lab Generated (Crabtree) J1)	Mus musculus		NULL	252	normal	Q3TKT4	V6.5 (embryonic stem cells)	NULL
EXP056006	anti-Brd4 (Bethyl, A301-985A)	Mus musculus		NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP056007	anti-SA2 (Bethyl, A300-158A)	Mus musculus		NULL	252	normal	O35638	V6.5 (embryonic stem cells)	NULL
EXP056008	anti-SA1 (Bethyl, A300-157A)	Mus musculus		NULL	252	normal	Q9D3E6	V6.5 (embryonic stem cells)	NULL
EXP056009	anti-M2 Flag (Sigma, A2220)	Mus musculus	Genotype: Flag-empty vector; Strain: C57BL/6;	NULL	2755	chip_control	NULL	bone marrow hematopoietic stem/progenitor cells	NULL
EXP056010	anti-M2 Flag (Sigma, A2220)	Mus musculus	Genotype: Flag-Cbx7; Strain: C57BL/6;	NULL	2755	normal	Q8VDS3	bone marrow hematopoietic stem/progenitor cells	NULL
EXP056011	anti-M2 Flag (Sigma, A2220)	Mus musculus	Genotype: Flag-Cbx8; Strain: C57BL/6;	NULL	2755	normal	Q9QXV1	bone marrow hematopoietic stem/progenitor cells	NULL
EXP056012	none	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: wildtype;	NULL	2756	chip_control	NULL	B cell enriched splenocytes	NULL
EXP056013	anti-KAP1 (RBCC, Schultz et al. Genes Dev. 2001)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: wildtype;	EXP056012	2756	normal	Q62318	B cell enriched splenocytes	NULL
EXP056014	anti-KAP1 (RBCC, Schultz et al. Genes Dev. 2001)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: KAP1 knockout;	EXP056012	2756	normal	Q62318	B cell enriched splenocytes	NULL
EXP056015	none	Mus musculus	Sex: Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: 27;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056016	none	Mus musculus	Sex: Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: 27;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056017	none	Mus musculus	Developmental stage: day 7; Sex Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: passage 27; 	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056018	none	Mus musculus	Sex: Female; Strain: F1: 129S1 x CastEiJ; Passage: 14;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056019	anti-Ezh2	Mus musculus	Sex: Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: 27;	EXP056015	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056020	anti-Ezh2	Mus musculus	Developmental stage: day 7; Sex Female; Strain: F2: 129S1/CastEiJ x 129S1; Passage: passage 27; 	NULL	216	normal	Q61188	differentiated embryonic stem cells	NULL
EXP056021	anti-Ezh2	Mus musculus	Sex: Female; Strain: F1: 129S1 x CastEiJ; Passage: 14;	EXP056018	12	normal	Q61188	MEF (mouse embryonic fibroblasts)	NULL
EXP056022	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2757	chip_control	NULL	E11.5 embryonic forebrain	NULL
EXP056023	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2758	chip_control	NULL	E11.5 embryonic limb	NULL
EXP056024	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2759	chip_control	NULL	E11.5 embryonic neural tube	NULL
EXP056025	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2760	chip_control	NULL	E11.5 embryonic heart	NULL
EXP056026	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	626	chip_control	NULL	E11.5 embryonic face	NULL
EXP056027		Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2761	chip_control	NULL	E11.5 embryonic midbrain	NULL
EXP056028	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP032583	626	normal	Q3TKT4	E11.5 embryonic face	NULL
EXP056029	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056022	2757	normal	Q3TKT4	E11.5 embryonic forebrain	NULL
EXP056030	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056023	2758	normal	Q3TKT4	E11.5 embryonic limb	NULL
EXP056031	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056024	2759	normal	Q3TKT4	E11.5 embryonic neural tube	NULL
EXP056032	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2	normal	Q3TKT4	mESCs (mouse embryonic stem cells)	NULL
EXP056033	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	627	normal	Q3TKT4	E11.5 embryonic hindbrain	NULL
EXP056034	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056025	2760	normal	Q3TKT4	E11.5 embryonic heart	NULL
EXP056035	p300 anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056026	626	normal	B2RWS6	E11.5 embryonic face	NULL
EXP056036	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	NULL	2756	normal	B2RWS6	B cell enriched splenocytes	NULL
EXP056037	anti-FLAG (Sigma- F1804, Lot #: 088K6018)	Mus musculus	Strain: 129/C57BL/6; Genotype: SMARCA4/FLAG knock-in;	EXP056027	2761	normal	Q3TKT4	E11.5 embryonic midbrain	NULL
EXP056038	none	Mus musculus	Passage: 15-18; Strain: C57BL/6;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056039	anti-Mof (Santa Cruz)	Mus musculus	Passage: 15-18; Strain: C57BL/6;	EXP056038	2	normal	Q9D1P2	mESCs (mouse embryonic stem cells)	NULL
EXP056040	None	Mus musculus	Strain: C57BL/6; Conditions: 0 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	NULL	5	chip_control	NULL	liver	NULL
EXP056041	None	Mus musculus	Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	NULL	5	chip_control	NULL	liver	NULL
EXP056042	None	Mus musculus	Strain: C57BL/6; Conditions: 12 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	NULL	5	chip_control	NULL	liver	NULL
EXP056043	None	Mus musculus	Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	NULL	5	chip_control	NULL	liver	NULL
EXP056044	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 0 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056040	5	normal	Q8BRH4	liver	NULL
EXP056045	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056041	5	normal	Q8BRH4	liver	NULL
EXP056046	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 12 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056042	5	normal	Q8BRH4	liver	NULL
EXP056047	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056043	5	normal	Q8BRH4	liver	NULL
EXP056048	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056041	5	normal	Q8BRH4	liver	NULL
EXP056049	anti-Mll3 (Abcam, ab71200)	Mus musculus	Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056043	5	normal	Q8BRH4	liver	NULL
EXP056050	anti-Mll3 (Abcam, ab71200)	Mus musculus	Genotype: Mll3 knockout; Strain: C57BL/6; Conditions: 6 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056041	5	normal	Q8BRH4	liver	NULL
EXP056051	anti-Mll3 (Abcam, ab71200)	Mus musculus	Genotype: Mll3 knockout; Strain: C57BL/6; Conditions: 18 hrs around the clock in "free-running", continuous conditions (constant darkness, temperature and food available ad libitum);	EXP056043	5	normal	Q8BRH4	liver	NULL
EXP056052	IgG (Thermo scientific, 23212, lot LI150449)	Mus musculus	Treatment: shScr;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056053	IgG (Thermo scientific, 23212, lot LI150449)	Mus musculus	Treatment: HA -empty vector;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056054	FLAG (Sigma, A2220) and HA (Sigma, A2095)	Mus musculus	Genotype: FLAG-HA-Fbxl10;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056055	anti-Fbxl10 (custom-made)	Mus musculus	Treatment: shScr (control);	EXP056052	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	NULL
EXP056056	Fbxl10 (custom-made)	Mus musculus	Treatment: shFbxl10;	EXP056054	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	NULL
EXP056057	anti-Ring1B (custom-made)	Mus musculus	Treatment: shScr (control);	EXP056052	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056058	anti-Ring1B (custom-made)	Mus musculus	Treatment: shFbxl10;	EXP056054	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056059	IgG (Thermo scientific, 23212, lot LI150449)	Mus musculus	Treatment: shFbxl10;	NULL	2	normal	O08917	mESCs (mouse embryonic stem cells)	NULL
EXP056060	Ring1B (custom-made)	Mus musculus	Genotype: Ring1b knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056061	Ring1B (custom-made)	Mus musculus	Genotype: Suz12 knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056062	Ring1B (custom-made)	Mus musculus	Genotype: Ring1b wildtype;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056063	none	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056064	anti-RBP-J (1F1 rat monoclonal, Ascenion)	Mus musculus	Treatment: doxycycline; Genotype: NICDGFP;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056065	anti-RBP-J (1F1 rat monoclonal, Ascenion)	Mus musculus	Treatment: doxycycline;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056066	anti-RBP-J (E. Kieff, rabbit polyclonal)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	EXP056063	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056067	anti-RBP-J (E. Kieff, rabbit polyclonal)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs	NULL	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056068	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	EXP056063	1153	normal	B2RWS6	C2C12 (myoblasts)	NULL
EXP056069	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs	NULL	1153	normal	B2RWS6	C2C12 (myoblasts)	NULL
EXP056070	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs;	NULL	1153	normal	B2RWS6	C2C12 (myoblasts)	NULL
EXP056071	anti-p300 (santa cruz, sc-585, J2909)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs	NULL	1153	normal	B2RWS6	C2C12 (myoblasts)	NULL
EXP056072	anti-RBP-J (1F1 rat monoclonal, Ascenion)	Mus musculus	Treatment: doxycycline; Genotype: NICDGFP;	EXP056064	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056073	anti-RBP-J (1F1 rat monoclonal, Ascenion)	Mus musculus	Treatment: doxycycline;	EXP056065	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056074	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs;	EXP056063	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056075	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs	NULL	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056076	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs;	NULL	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056077	anti-RBP-J (Ascenion, 1F1 rat monoclonal)	Mus musculus	DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs	NULL	1153	normal	P31266	C2C12 (myoblasts)	NULL
EXP056078	none	Mus musculus	Strain: C57BL/6 (female) x 129/S (male); Source: murine embryonic stem cells;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056079	anti-ELL3 (A fragment of human  (aa 1-248) was expressed as His-tag fusion protein in pET-16b, purified on NTA-agarose according to Qiagenâ€™s protocol and sent to Pocono Rabbit Farm and Labs for immunization into rabbits)	Mus musculus	Strain: C57BL/6 (female) x 129/S (male); Source: murine embryonic stem cells;	EXP056078	2	normal	Q80VR2	mESCs (mouse embryonic stem cells)	NULL
EXP056080	none	Mus musculus	Treatment: TGFb (Millipore) was used at a final concentration of 5 ng/ml for 3hrs; Developmental stage: e12.5; Tissue: cerebral cortex; Genotype: wildtype;	NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP056081	anti-JMJD3 (affinity purified antibody against mouse, Dr. K. Helin)	Mus musculus	Treatment: TGFb (Millipore) was used at a final concentration of 5 ng/ml for 3hrs; Developmental stage: e12.5; Tissue: cerebral cortex; Genotype: wildtype;	EXP056080	2775	normal	Q5NCY0	neural stem cells	NULL
EXP056082	9317	Mus musculus	Strain: 129/C57BL6; Genotype: wildtype; Sex: male; 	NULL	2736	chip_control	NULL	whole brain	NULL
EXP056083	anti-MECP2 (Sigma, 9317)	Mus musculus	Strain: 129/C57BL6; Genotype: wildtype; Sex: male; 	EXP056082	2736	normal	Q9Z2D6	whole brain	NULL
EXP056084	none	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: wildtype; Tissue: Total thymocytes;	NULL	2762	chip_control	NULL	T-cells progenitors	NULL
EXP056085	anti-KAP1 (RBCC,amino acids 20â€“418)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: wildtype; Tissue: Total thymocytes;	EXP056084	2762	normal	Q62318	T-cells progenitors	NULL
EXP056086	anti-KAP1 (RBCC,amino acids 20â€“418)	Mus musculus	Strain: C57BL/6 / sv129sv; Genotype: Kap1 knockout; Tissue: Total thymocytes;	EXP056084	2762	normal	Q62318	T-cells progenitors	NULL
EXP056087	Anti-IgG (IgG from rabbit serum, Sigma-Aldrich, catalog# I5006)	Mus musculus	Strain: 129/Ola; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056088	Anti-OGT (O-Linked N-Acetylglucosamine Transferase antibody sold, Abcam, catalog# ab50273)	Mus musculus	Strain: 129/Ola; 	EXP056087	230	normal	Q8CGY8	ES-E14 (E14, embryonic stem cells)	NULL
EXP056089	none	Mus musculus	Strain: C57BL/6; Sex: male; Developmental stage: meiotic; Genotype: wildtype; 	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP056090	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Sex: male; Developmental stage: post-meiotic;	NULL	636	chip_control	NULL	round spermatids	NULL
EXP056091	none	Mus musculus	Strain: C57BL/6; Sex: male; Developmental stage: meiotic; Genotype: Brdt BD1 deletion; 	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP056092	none	Mus musculus	Genotype:  Brdt BD1 deletion; Strain: C57BL/6; Sex: male; Developmental stage: post-meiotic;	NULL	636	chip_control	NULL	round spermatids	NULL
EXP056093	anti-Brdt (Immunopurified rabbit anti-Brdt produced against the recombinant protein.]	Mus musculus	Strain: C57BL/6; Sex: male; Developmental stage: meiotic; Genotype: wildtype; 	EXP056089	803	normal	Q91Y44	spermatocytes	NULL
EXP056094	anti-Brdt [Immunopurified rabbit anti-Brdt produced against the recombinant protein.]	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Sex: male; Developmental stage: post-meiotic;	EXP056090	636	normal	Q91Y44	round spermatids	NULL
EXP056095	anti-Brdt	Mus musculus	Strain: C57BL/6; Sex: male; Developmental stage: meiotic; Genotype: Brdt BD1 deletion; 	EXP056091	803	normal	Q91Y44	spermatocytes	NULL
EXP056096	anti-Brdt	Mus musculus	Genotype:  Brdt BD1 deletion; Strain: C57BL/6; Sex: male; Developmental stage: post-meiotic;	EXP056092	636	normal	Q91Y44	round spermatids	NULL
EXP056097	anti-SRF (Santa Cruz Biotechnology, sc-335)	Mus musculus	Treatment: sictrl; Background cell line: C3H/HeN; 	NULL	2763	normal	Q9JM73	10T1/2	NULL
EXP056098	anti-SRF (Santa Cruz Biotechnology, sc-335)	Mus musculus	Treatment: siMed23; Background cell line: C3H/HeN; Genotype: knockdown Med23;	NULL	845	normal	Q9JM73	ILC2 (type 2 Innate lympoid cells)	NULL
EXP056099	none	Mus musculus	Tissue: bone marrow; 	NULL	2764	chip_control	NULL	32D granuolocytic progenitor cells	NULL
EXP056100	anti-Lsd1 (Abcam, ab17721)	Mus musculus	Tissue: bone marrow; 	EXP056099	2764	normal	Q6ZQ88	32D granuolocytic progenitor cells	NULL
EXP056101	none (input control)	Mus musculus	Strain: C57BL/6; Genotype: BAP1wildtype; Passage: Primary cells;	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP056102	anti-FLAG (Sigma, catalog# A2220)	Mus musculus	Strain: C57BL/6; Genotype: BAP1-3X Flag Tagged KI; Passage: Primary cells;	EXP056101	81	normal	Q6RHR9	BMDM (bone marrow-derived macrophages)	NULL
EXP056103	anti-HCF1 (Bethyl Laboratories, catalog# A301-399A)	Mus musculus	Strain: C57BL/6; Genotype: BAP1wildtype; Passage: Primary cells;	NULL	81	normal	Q61191	BMDM (bone marrow-derived macrophages)	NULL
EXP056104	anti-OGT1 (Sigma, catalog# 06264)	Mus musculus	Strain: C57BL/6; Genotype: BAP1wildtype; Passage: Primary cells;	NULL	81	normal	O55242	BMDM (bone marrow-derived macrophages)	NULL
EXP056105	IgG	Mus musculus	Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056106	IgG	Mus musculus	Genotype: Kdm2b knockout;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056107	anti-Ezh2 (Cell signaling Technology, 5246)	Mus musculus	Genotype: wildtype; 	EXP056105	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP056108	anti-Ezh2 (Cell signaling Technology, 5246)	Mus musculus	Genotype: Kdm2b knockout;	EXP056106	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP056109	anti-Flag (Sigma, F7425)	Mus musculus	Genotype: wildtype; 	EXP056105	230	normal	Q6P1G2	ES-E14 (E14, embryonic stem cells)	NULL
EXP056110	anti-Flag (Sigma, F7425)	Mus musculus	Genotype: Kdm2b knockout;	EXP056106	230	normal	Q6P1G2	ES-E14 (E14, embryonic stem cells)	NULL
EXP056111	anti-Ring1b (Cell signaling Technology, 5694)	Mus musculus	Genotype: wildtype; 	EXP056105	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056112	anti-Ring1b (Cell signaling Technology, 5694)	Mus musculus	Genotype: Kdm2b knockout;	EXP056106	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056113		Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, cecle stage G1;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP056114		Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, S cycle stage;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP056115		Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, cycle stage M;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP056116	anti-CTCF (Abcam, ab70303)	Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, cecle stage G1;	EXP056113	96	normal	Q61164	trophoblast stem cells	NULL
EXP056117	anti-CTCF (Abcam, ab70303)	Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, S cycle stage;	EXP056114	96	normal	Q61164	trophoblast stem cells	NULL
EXP056118	anti-CTCF (Abcam, ab70303)	Mus musculus	Strain: CD1(ICR); Developmental stage: blastocysts, cycle stage M;	EXP056115	96	normal	Q61164	trophoblast stem cells	NULL
EXP056119		Mus musculus	Strain: C57BL/6-ICR; Genotype: Tdg fl/fl; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056120		Mus musculus	Strain: C57BL/6-ICR; Genotype: Tdg -/- knockout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056121	anti-p300 (Santa Cruz, sc-585)	Mus musculus	Strain: C57BL/6-ICR; Genotype: Tdg fl/fl; 	EXP056119	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	NULL
EXP056122	anti-p300 (Santa Cruz, sc-585)	Mus musculus	Strain: C57BL/6-ICR; Genotype: Tdg -/- knockout; 	EXP056120	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	NULL
EXP056123	IgG; Abcam, #46540	Mus musculus	Genotype: wildtype; 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP056124	IgG; Abcam, #46540	Mus musculus	Genotype: wildtype; 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP056125	anti-Suz12 (Abcam, #12073)	Mus musculus	Genotype: wildtype; 	EXP056123	233	normal	Q80U70	E14TG2A (embryonic stem cells)	NULL
EXP056126	anti-Phf19 (OpenBiosystems, costum made)	Mus musculus	Genotype: wildtype; 	EXP056124	233	normal	Q9CXG9	E14TG2A (embryonic stem cells)	NULL
EXP056127	anti-Smc3 (Bethyl, A300-060A)	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl +/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056128	anti-Smc3 (Bethyl, A300-060A)	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl -/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056129	anti-CTCF (Upstate, 07-729)	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl +/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	NULL	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP056130	anti-CTCF (Upstate, 07-729)	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl -/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	NULL	12	normal	Q61164	MEF (mouse embryonic fibroblasts)	NULL
EXP056131	WCE	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl +/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	EXP056127	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	NULL
EXP056132	WCE	Mus musculus	Strain: mixed C57BL/6 and 129 background; Genotype: Wapl -/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM;	EXP056128	12	normal	Q9CW03	MEF (mouse embryonic fibroblasts)	NULL
EXP056133	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056134	anti-PHF19 (custom produced rabbit polyclonal )	Mus musculus		EXP056133	230	normal	Q9CXG9	ES-E14 (E14, embryonic stem cells)	NULL
EXP056135	anti-TET2 antibody (in-house made mouse )	Mus musculus	Strain: C57BL/6; 	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	NULL
EXP056136	anti-OGT antibody (Novus, NBP1-32791)	Mus musculus	Strain: C57BL/6; 	NULL	2	normal	Q8CGY8	mESCs (mouse embryonic stem cells)	NULL
EXP056137	None (Total Input)	Mus musculus	Genotype: wildtype; 	NULL	2669	chip_control	NULL	ES3 (ebryonic stem cells)	NULL
EXP056138	None (Total Input)	Mus musculus	Genotype: KAP1 knockout; Treatment: 4 days post 4-OHT inducible CRE;	NULL	2669	chip_control	NULL	ES3 (ebryonic stem cells)	NULL
EXP056139	anti-KAP1 (Tronolab, rabbit polyclonal SY 3267-68)	Mus musculus	Genotype: KAP1 wildtype; 	EXP056137	2669	normal	Q62318	ES3 (ebryonic stem cells)	NULL
EXP056140	anti-KAP1 (Tronolab, rabbit polyclonal SY 3267-68)	Mus musculus	Genotype: KAP1 knockout; Treatment: 4 days post 4-OHT inducible CRE;	EXP056138	2669	normal	Q62318	ES3 (ebryonic stem cells)	NULL
EXP056141	anti-RAD51(H-92) (Santa Cruz, sc-8349, lot#H1810)	Mus musculus	Genotype: Rif1F/FCd19Cre/+;	NULL	2765	normal	Q08297	splenocyte (B lymphocytes)	NULL
EXP056142	anti-RAD51(H-92) (Santa Cruz, sc-8349, lot#H1810)	Mus musculus	Genotype: Cd19Cre/+;	NULL	2765	normal	Q08297	splenocyte (B lymphocytes)	NULL
EXP056143	anti-Rad51	Mus musculus	Genotype: 53BP1knockout; Strain: C57BL/6; 	NULL	2366	normal	Q08297	activated B-cells	NULL
EXP056144	anti-Rad51	Mus musculus	Genotype: 53BP1knockout; Strain: C57BL/6; Developmental stage: cell cycle SG2M; 	NULL	2366	normal	Q08297	activated B-cells	NULL
EXP056145	anti-Rad51	Mus musculus	Genotype: AIDwt; Strain: C57BL/6; 	NULL	2366	normal	Q08297	activated B-cells	NULL
EXP056146	Rad51 (Santa Cruz, sc-8349, H1810 )	Mus musculus	Strain: C57BL/6; Genotype: AIDtg_53BP1 knockout;	NULL	2366	normal	Q08297	activated B-cells	NULL
EXP056147	Rabbit IgG- ab37415	Mus musculus	Strain: 129/Ola; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056148	Rabbit IgG- ab37415	Mus musculus	Strain: 129/Ola; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056149	anti-Ring1B (Ab generated in Di CroceÂ´s lab)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056150	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	NULL
EXP056151	anti-Suz12 (Abcam, ab12073)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056152	anti-RYBP (Millipore, #3637)	Mus musculus	Strain: 129/Ola; 	EXP056148	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	NULL
EXP056153	None	Mus musculus	Strain: C57BL/6-129; 	NULL	873	chip_control	NULL	ZHBTc4 (embryonic stem cells)	NULL
EXP056154	None	Mus musculus	Treatment: 2 ug/mL dox for 48 hrs; 	NULL	873	chip_control	NULL	ZHBTc4 (embryonic stem cells)	NULL
EXP056155	None	Mus musculus		NULL	2767	chip_control	NULL	38B9 (pro-B-cell)	NULL
EXP056156	None	Mus musculus	Strain: C57BL/6-129;	NULL	2767	chip_control	NULL	38B9 (pro-B-cell)	NULL
EXP056157	Med1/TRAP220 (Bethyl, Catalog No.A300-793A)	Mus musculus	Strain: C57BL/6-129; 	EXP056153	873	normal	Q925J9	ZHBTc4 (embryonic stem cells)	NULL
EXP056158	Med1/TRAP220 (Bethyl, Catalog No.A300-793A)	Mus musculus	Treatment: 2 ug/mL dox for 48 hrs; 	EXP056154	873	normal	Q925J9	ZHBTc4 (embryonic stem cells)	NULL
EXP056159	Med1/TRAP220 (Bethyl, Catalog No.A300-793A)	Mus musculus	Strain: C57BL/6-129;	EXP056155	2767	normal	Q925J9	38B9 (pro-B-cell)	NULL
EXP056160	none (Input)	Mus musculus	Strain: C57Bl/6; Treatment: livers were removed at ZT10, 5pm;	NULL	5	chip_control	NULL	liver	NULL
EXP056161	anti-HDAC3 (Abcam, catalog# 7030)	Mus musculus	Genotype: NS-DADm; Strain: C57Bl/6; Treatment: livers were removed at ZT10, 5pm;	EXP056160	5	normal	O88895	liver	NULL
EXP056162	anti-HDAC3 (Abcam, catalog# 7030)	Mus musculus	Genotype: wildtype; Strain: C57Bl/6; Treatment: livers were removed at ZT10, 5pm;	EXP056160	5	normal	O88895	liver	NULL
EXP056163	anti-Aurora B (ab2254, Abcam)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	O70126	CD43 negative resting B cells	NULL
EXP056164	anti-Ring1B (D139-3, MBL)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q9CQJ4	CD43 negative resting B cells	NULL
EXP056165	anti-Cbx7 (ab31765, Abcam)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q8VDS3	CD43 negative resting B cells	NULL
EXP056166	anti-USP16 (sc-130906, Santa Cruz)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q99LG0	CD43 negative resting B cells	NULL
EXP056167	anti-Ezh2 (39875, Active Motif)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Tissue: spleen; Developmental stage: adult;	NULL	2769	normal	Q61188	CD43 negative resting B cells	NULL
EXP056168	anti-Aurora B (ab2254, Abcam)	Mus musculus	Treatment: 250 nM 4-hydroxytamoxifen for 48hrs; Genotype: Aurora B knockout;	NULL	2769	normal	O70126	CD43 negative resting B cells	NULL
EXP056169	anti-Ring1B (D139-3, MBL)	Mus musculus	Treatment: 250 nM 4-hydroxytamoxifen for 48hrs; Genotype: RING1B knockout;	NULL	2769	normal	Q9CQJ4	CD43 negative resting B cells	NULL
EXP056170	anti-Ring1B	Mus musculus	Strain: C57BL/6; Developmental stage: embryonic day 12.5; Genotype: wildtype; 	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP056171	anti-Ring1B	Mus musculus	Strain: C57BL/6; Developmental stage: embryonic day 12.5; Genotype: Phc2 mutant (L307R); 	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP056172	none	Mus musculus	Genotype: Flk1+ BL-CFCs; Source: hemangioblast equivalent cells; 	NULL	214	chip_control	NULL	embryoid body (day 4)	NULL
EXP056173	anti-Ldb1 (antibody N-18, Santa Cruz)	Mus musculus	Genotype: Flk1+ BL-CFCs; Source: hemangioblast equivalent cells; 	EXP056172	214	normal	P70662	embryoid body (day 4)	NULL
EXP056174		Mus musculus	Strain: C57BL/6; 	NULL	2770	chip_control	NULL	embryonic stem cells-derived neural progenitor cells	NULL
EXP056175		Mus musculus	Strain: C57BL/6; 	NULL	2770	chip_control	NULL	embryonic stem cells-derived neural progenitor cells	NULL
EXP056176	anti-PHF20 antibody (Cell signaling, 3934S, #1)	Mus musculus	Strain: C57BL/6; 	EXP056174	2770	normal	Q8BLG0	embryonic stem cells-derived neural progenitor cells	NULL
EXP056177	anti-Wdr5 antibody (Bethyl, A302-429A-1)	Mus musculus	Strain: C57BL/6; 	EXP056174	2770	normal	P61965	embryonic stem cells-derived neural progenitor cells	NULL
EXP056178	anti-PHF20 antibody (Cell signaling, 3934S, #1)	Mus musculus	Strain: C57BL/6; 	EXP056174	2770	normal	Q8BLG0	embryonic stem cells-derived neural progenitor cells	NULL
EXP056179	anti-Wdr5 antibody (Bethyl, A302-429A-1)	Mus musculus	Strain: C57BL/6; 	EXP056175	2770	normal	P61965	embryonic stem cells-derived neural progenitor cells	NULL
EXP056180	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	P48754	activated B-cells	NULL
EXP056181	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	Q8CG46	activated B-cells	NULL
EXP056182	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	P48754	activated B-cells	NULL
EXP056183	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: 53BP1 knockout; 	NULL	2366	normal	P48754	activated B-cells	NULL
EXP056184	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	Q8CG46	activated B-cells	NULL
EXP056185	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 0 mM hydroxyurea for 6 hrs (none treatment); Strain: 129/Sv x C57BL/6; Genotype: 53BP1 knockout; 	NULL	2366	normal	Q8CG46	activated B-cells	NULL
EXP056186	anti-BRCA1 (160-300, amino acids)	Mus musculus	Treatment: 10 mM hydroxyurea for 6 hrs; Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	P48754	activated B-cells	NULL
EXP056187	anti-Smc5 (Calbiochem, DR1030)	Mus musculus	Treatment: 10 mM hydroxyurea for 6 hrs; Strain: 129/Sv x C57BL/6; Genotype: wildtype; 	NULL	2366	normal	Q8CG46	activated B-cells	NULL
EXP056188	anti-TRIM33 (A301-059A, Bethyl, lot: A301-059A1)	Mus musculus	Strain: BALB/c; Genotype: wildtype;	NULL	91	normal	Q99PP7	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056189	anti-TRIM33 (A301-059A, Bethyl, lot: A301-059A1)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	81	normal	Q99PP7	BMDM (bone marrow-derived macrophages)	NULL
EXP056190	anti-Spt6	Mus musculus	Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	Q62383	C2C12 (myoblasts)	NULL
EXP056191	anti-Spt6	Mus musculus	Developmental stage: 48-hours differentiated Myotubes;	NULL	126	normal	Q62383	C2C12 (myotubes)	NULL
EXP056192	anti-KDM6A	Mus musculus	Developmental stage: Proliferating Myoblasts;	NULL	1153	normal	O70546	C2C12 (myoblasts)	NULL
EXP056193	anti-KDM6A	Mus musculus	Developmental stage: 48-hours differentiated Myotubes;	NULL	1153	normal	O70546	C2C12 (myoblasts)	NULL
EXP056194	anti-KDM6A	Mus musculus	Developmental stage: Proliferating Myoblasts; Genotype: KDM6A knockout;	NULL	1153	normal	O70546	C2C12 (myoblasts)	NULL
EXP056195	none (input)	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056196	none (input)	Mus musculus		NULL	2771	chip_control	NULL	fibroblast derived partially reprogrammed cells	NULL
EXP056197	anti-Cbx3 (Millipore, 05-690; clone 42s2)	Mus musculus		EXP056195	2	normal	P23198	mESCs (mouse embryonic stem cells)	NULL
EXP056198	anti-Cbx3 (Millipore, 05-690; clone 42s2)	Mus musculus		EXP056196	2771	normal	P23198	fibroblast derived partially reprogrammed cells	NULL
EXP056199	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: ES maintianence-feeder free;	NULL	230	normal	Q04692	ES-E14 (E14, embryonic stem cells)	NULL
EXP056200	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: ES maintianence-feeder free; Sex: female; Strain: OCT4-deltaPE-GFP x C57BL/6;	NULL	2	normal	Q04692	mESCs (mouse embryonic stem cells)	NULL
EXP056201	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: CI-Amidine treatment;	NULL	230	normal	Q04692	ES-E14 (E14, embryonic stem cells)	NULL
EXP056202	anti-Smarcad1(ab67548, Abcam)	Mus musculus	Treatment: Smarcad1 RNAi; Genotype: Smarcad1 knockout;	NULL	230	normal	Q04692	ES-E14 (E14, embryonic stem cells)	NULL
EXP056203	none	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056204	none	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056205	none	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056206	none	Mus musculus	Treatment: 200 nM 4-OHT in tetrahydrofuran (THF); Genotype: Brg1f/f; Actin-CreER; Time: day 4;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056207	none	Mus musculus	Treatment: 200 nM 4-OHT in tetrahydrofuran (THF); Genotype: Brg1f/f; Actin-CreER; Time: day 4;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056208	anti-FLAG (Sigma M2 F1804)	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	EXP056203	216	normal	Q3TKT4	differentiated embryonic stem cells	NULL
EXP056209	anti-FLAG (Sigma M2 F1804)	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	EXP056204	216	normal	Q3TKT4	differentiated embryonic stem cells	NULL
EXP056210	anti-FLAG (Sigma M2 F1804)	Mus musculus	Genotype: Brg1f/f; Actin-CreER; Time: day 4; 	EXP056205	216	normal	Q3TKT4	differentiated embryonic stem cells	NULL
EXP056211	anti-SUZ12 (Bethyl A302-407A)	Mus musculus	Treatment: tetrahydrofuran (THF); Genotype: Brg1f/f; Actin-CreER; Time: day 4;	EXP056206	216	normal	Q80U70	differentiated embryonic stem cells	NULL
EXP056212	anti-SUZ12 (Bethyl A302-407A)	Mus musculus	Treatment: 200 nM 4-OHT in tetrahydrofuran (THF); Genotype: Brg1f/f; Actin-CreER; Time: day 4;	EXP056207	216	normal	Q80U70	differentiated embryonic stem cells	NULL
EXP056213	Rabbit normal IgG	Mus musculus	Passage: 2~10; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056214	anti-HA (ab9110)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	NULL
EXP056215	anti-HA (ab9110)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	NULL
EXP056216	Anti-SRSF1 (32-4500)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	NULL
EXP056217	anti-SRSF2(Fu and Maniatis, 1990)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	NULL
EXP056218	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF2 wildtype; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	NULL
EXP056219	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF2 knockout; 	EXP056213	12	normal	Q6PDM2	MEF (mouse embryonic fibroblasts)	NULL
EXP056220	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF1 wildtype; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	NULL
EXP056221	anti-HA (ab9110)	Mus musculus	Passage: 2~10; Genotype: SRSF1 knockout; 	EXP056213	12	normal	Q62093	MEF (mouse embryonic fibroblasts)	NULL
EXP056222	anti-CDK9 (mAb #2316)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q99J95	MEF (mouse embryonic fibroblasts)	NULL
EXP056223	anti-HEXIM1 (Abcam, ab25388)	Mus musculus	Passage: 2~10; 	EXP056213	12	normal	Q8R409	MEF (mouse embryonic fibroblasts)	NULL
EXP056224		Mus musculus	Developmental stage: cycling cells (containing 95% interphase and 5% mitosis cells); 	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP056225		Mus musculus	Developmental stage: mitotic cells; 	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP056226	anti-RBPJ antibody (custom-made)	Mus musculus	Developmental stage: cycling cells (containing 95% interphase and 5% mitosis cells); 	EXP056224	292	normal	P31266	F9 (embryonal carcinoma)	NULL
EXP056227	anti-RBPJ antibody (custom-made)	Mus musculus	Developmental stage: mitotic cells; 	EXP056225	292	normal	P31266	F9 (embryonal carcinoma)	NULL
EXP056228		Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP056229		Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP056230		Mus musculus	Strain: C57BL/6 female and CBA male; Genotype: G9a and GLP knockout;	NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP056231	anti-Ezh2 (BD Transduction Laboratories ref : 612666)	Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	EXP056228	839	normal	Q61188	TT2 (embryonic stem cells)	NULL
EXP056232	anti-G9a (Cell Signalling Technologies ref : 3306S)	Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	EXP056228	839	normal	Q9Z148	TT2 (embryonic stem cells)	NULL
EXP056233	anti-G9a (Cell Signalling Technologies ref : 3306S)	Mus musculus	Strain: C57BL/6 female and CBA male; Genotype: G9a and GLP knockout;	EXP056230	839	normal	Q9Z148	TT2 (embryonic stem cells)	NULL
EXP056234	anti-Ezh2 (BD Transduction Laboratories ref : 612666)	Mus musculus	Strain: C57BL/ 6 female and a CBA male; 	EXP056229	839	normal	Q61188	TT2 (embryonic stem cells)	NULL
EXP056235	anti-Ezh2 (BD Transduction Laboratories ref : 612666)	Mus musculus	Strain: C57BL/6 female and CBA male; Genotype: G9a and GLP knockout;	EXP056230	839	normal	Q61188	TT2 (embryonic stem cells)	NULL
EXP056236	none	Mus musculus	Developmental stage: E13.5;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056237	Anti-SNF2beta/BRG1 Antibody (Upstate, 07-478, DAM1718075)	Mus musculus	Developmental stage: E13.5;	EXP056236	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	NULL
EXP056238	None	Mus musculus	Treatment: sham; Strain: C57Bl/6J;	NULL	53	chip_control	NULL	heart	NULL
EXP056239	Anti-Brd4 (Bethyl, A301-985A)	Mus musculus	Treatment: sham; Strain: C57Bl/6J;	EXP056238	53	normal	Q9ESU6	heart	NULL
EXP056240	anti-IgG	Mus musculus		NULL	2774	chip_control	NULL	MEL-c88(Mouse erythroid leukemia)	NULL
EXP056241	anti-CDK9 (C20 antibody, Santa Cruz Biotechnology, C20, sc-484)	Mus musculus		EXP056240	2774	normal	Q99J95	MEL-c88(Mouse erythroid leukemia)	NULL
EXP056242	anti-Stat3	Mus musculus	Treatment: PBS; Age: 10-12 weeks; Genotype: gp130F/F; 	NULL	323	normal	P42227	gastric tumors	NULL
EXP056243	anti-Stat3	Mus musculus	Treatment: IL6; Age: 10-12 weeks; Genotype: gp130F/F; 	NULL	323	normal	P42227	gastric tumors	NULL
EXP056244	anti-Stat3	Mus musculus	Treatment: IL11; Age: 10-12 weeks; Genotype: gp130F/F; 	NULL	323	normal	P42227	gastric tumors	NULL
EXP056245	anti-RING1B antibody (PMID: 11289226)	Mus musculus	Age: 11 dpc; Strain: C57BL/6; 	NULL	313	normal	Q9CQJ4	forebrain	NULL
EXP056246	anti-RING1B antibody (PMID: 11289226)	Mus musculus	Age: 11 dpc; Strain: C57BL/6; 	NULL	1147	normal	Q9CQJ4	midbrain	NULL
EXP056247	anti-RING1B antibody (PMID: 11289226)	Mus musculus	Age: 11 dpc; Strain: C57BL/6; 	NULL	2419	normal	Q9CQJ4	forelimb	NULL
EXP056248	input DNA	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP056249	input DNA	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	NULL	171	chip_control	NULL	CD4+ CD8+ T cells	NULL
EXP056250	anti-Med1 (Bethyl Laboratories, A300-793A, lot A300-793A-1)	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	EXP056248	171	normal	Q925J9	CD4+ CD8+ T cells	NULL
EXP056251	anti-NIPBL (Bethyl Laboratories, A301-779A, lot A301-779A-2)	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	EXP056248	171	normal	Q6KCD5	CD4+ CD8+ T cells	NULL
EXP056252	anti-Rad21 (Abcam, ab992, Multiple Lots)	Mus musculus	Genotype: wildtype; Strain: C57BL\\6 and 129 mixed; 	EXP056249	171	normal	Q61550	CD4+ CD8+ T cells	NULL
EXP056253	none	Mus musculus		NULL	2775	chip_control	NULL	neural stem cells	NULL
EXP056254	none	Mus musculus		NULL	885	chip_control	NULL	astrocytes	NULL
EXP056255	anti-Rad21 (Abcam, ab992)	Mus musculus		EXP056253	2775	normal	Q61550	neural stem cells	NULL
EXP056256	anti-Rad21 (Abcam, ab992)	Mus musculus		EXP056254	885	normal	Q61550	astrocytes	NULL
EXP056257	anti-Ezh2 (D2C9) (Cell Signaling, #5246)	Mus musculus	Treatment: shGFP; 	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP056258	anti-Ezh2 (D2C9) (Cell Signaling, #5246)	Mus musculus	Treatment: shDnmt3L; 	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP056259	anti-p300 (SC-585)	Mus musculus	Developmental stage: e11.5; Strain: CD1;	NULL	2776	normal	B2RWS6	craniofacial tissue	NULL
EXP056260	input	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056261	anti-EZH2 (in-house)	Mus musculus		EXP056260	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP056262	anti-EZH2 (in-house)	Mus musculus	Treatment: EtOH;	EXP056260	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP056263	anti-SUZ12 (Cell signaling, cat# 3737)	Mus musculus		EXP056260	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056264	anti-SUZ12 (Cell signaling, cat# 3737)	Mus musculus	Treatment: EtOH;	EXP056260	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056265		Mus musculus	Age: 3-month old; Genotype: wildtype;	NULL	32	chip_control	NULL	testis	NULL
EXP056266	anti-TAF7L	Mus musculus	Age: 3-month old; Genotype: wildtype;	EXP056265	32	normal	Q9D3R9	testis	NULL
EXP056267		Mus musculus	Strain: C57BL/6; Tissue: skin; Age: newborn; 	NULL	2777	chip_control	NULL	primary epidermal keratinocytes	NULL
EXP056268	anti-Brg1 (H-88) (Santa Cruz Biotechnologies, SC-10768, F1312)	Mus musculus	Strain: C57BL/6; Tissue: skin; Age: newborn; 	EXP056267	2777	normal	Q3TKT4	primary epidermal keratinocytes	NULL
EXP056269	anti-Flag antibody	Mus musculus	Treatment: without Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	NULL
EXP056270	anti-Flag antibody	Mus musculus	Treatment: Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	NULL
EXP056271	anti-Flag antibody	Mus musculus	Treatment: without Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	NULL
EXP056272	anti-Flag antibody	Mus musculus	Treatment: Doxycycline treatment;	NULL	2778	normal	P42227	inducible motor neuron embryonic stem cells	NULL
EXP056273	Rabbit IgG polyclonal  (Southern Biotech, #0111-01, #K3405-Q506)	Mus musculus	Tissue: spleen; Strain: C57BL/6; 	NULL	2779	chip_control	NULL	naive CD4+ Th1 cells	NULL
EXP056274	Rabbit IgG polyclonal	Mus musculus	Tissue: spleen; Strain: C57BL/6; 	NULL	2780	chip_control	NULL	naive CD4+ Th2 cells	NULL
EXP056275		Mus musculus	Tissue: spleen; Strain: C57BL/6; 	NULL	2779	chip_control	NULL	naive CD4+ Th1 cells	NULL
EXP056276		Mus musculus	Tissue: spleen; Strain: C57BL/6; 	NULL	2780	chip_control	NULL	naive CD4+ Th2 cells	NULL
EXP056277	anti-Ezh2 (polyclonal, Diagenode, pAb-039-050, #002)	Mus musculus	Tissue: spleen; Strain: C57BL/6; 	EXP056275	2779	normal	Q61188	naive CD4+ Th1 cells	NULL
EXP056278	anti-Ezh2 (polyclonal, Diagenode, pAb-039-050, #002)	Mus musculus	Tissue: spleen; Strain: C57BL/6; 	EXP056276	2780	normal	Q61188	naive CD4+ Th2 cells	NULL
EXP056279	none	Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP056280	none	Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP056281	anti-PGC-1 (Monoclonal ANTI-FLAG, M2 Antibody, Sigma)	Mus musculus		EXP056279	126	normal	O70343	C2C12 (myotubes)	NULL
EXP056282	anti-PGC-1 (Monoclonal ANTI-FLAG, M2 Antibody, Sigma)	Mus musculus		EXP056280	126	normal	O70343	C2C12 (myotubes)	NULL
EXP056283	anti-MCRS1 ( Proteintech, 11362-1-AP)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	Q99L90	mESCs (mouse embryonic stem cells)	NULL
EXP056284	MCRS1 (Proteintech, 11362-1-AP)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	Q99L90	mESCs (mouse embryonic stem cells)	NULL
EXP056285	MSL1 (in-house, Rabbit Polyclonal, Final Bleed)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	Q6PDM1	mESCs (mouse embryonic stem cells)	NULL
EXP056286	MSL1 (in-house, Rabbit Polyclonal, Final Bleed)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	Q6PDM1	mESCs (mouse embryonic stem cells)	NULL
EXP056287	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	Q69ZF8	mESCs (mouse embryonic stem cells)	NULL
EXP056288	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	Q69ZF8	mESCs (mouse embryonic stem cells)	NULL
EXP056289	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032805	2	normal	A2RSY1	mESCs (mouse embryonic stem cells)	NULL
EXP056290	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032806	2	normal	A2RSY1	mESCs (mouse embryonic stem cells)	NULL
EXP056291	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032807	138	normal	Q69ZF8	neural progenitors	NULL
EXP056292	MSL2 (SIGMA, HPA003413)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032808	138	normal	Q69ZF8	neural progenitors	NULL
EXP056293	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032807	138	normal	A2RSY1	neural progenitors	NULL
EXP056294	KANSL3 (SIGMA, HPA035018)	Mus musculus	Strain: C57BL/6x129sV; Passage: 8-12;	EXP032808	138	normal	A2RSY1	neural progenitors	NULL
EXP056295	none	Mus musculus	Treatment: DMSO;	NULL	1225	chip_control	NULL	MLL-AF9/NrasG12D AML	NULL
EXP056296	none	Mus musculus	Treatment: none;	NULL	1225	chip_control	NULL	MLL-AF9/NrasG12D AML	NULL
EXP056297	anti-Brd4 (Bethyl, A301-985A, A301-985A-1)	Mus musculus	Treatment: DMSO;	EXP056295	1225	normal	Q9ESU6	MLL-AF9/NrasG12D AML	NULL
EXP056298	anti-Brg1 (Abcam, ab4081)	Mus musculus	Treatment: DMSO;	EXP056295	1225	normal	Q3TKT4	MLL-AF9/NrasG12D AML	NULL
EXP056299	none	Mus musculus		NULL	1105	chip_control	NULL	E12.5 embryonic distal forelimb	NULL
EXP056300	anti-Med12 (Bethyl, A300-774A, lotA300-774A-)1	Mus musculus		EXP056299	1105	normal	A2AGH6	E12.5 embryonic distal forelimb	NULL
EXP056301	anti-FLAG (Sigma anti-FLAG M2 agarose beads catalog #A2220)	Mus musculus	Genotype: K510R-Chd1; 	NULL	12	normal	P40201	MEF (mouse embryonic fibroblasts)	NULL
EXP056302	anti-FLAG (Sigma anti-FLAG M2 agarose beads catalog #A2220)	Mus musculus	Genotype: wildtype Chd1;	NULL	12	normal	P40201	MEF (mouse embryonic fibroblasts)	NULL
EXP056303	none	Mus musculus	Passage: p10-p20; Genotype: KDM2Bfl/fl ES cells;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056304	anti-KDM2B ab (Farcas et al., 2012; PMID 23256043)	Mus musculus	Passage: p10-p20; Treatment: untreated; Genotype: KDM2Bfl/fl ES cells;	NULL	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	NULL
EXP056305	anti-KDM2B ab (Farcas et al., 2012; PMID 23256043)	Mus musculus	Genotype: KDM2Bfl/fl ES cells; Passage: p10-p20; Treatment: 4-hydroxy tamoxifen (800 nM) for 72 hrs;	NULL	2	normal	Q6P1G2	mESCs (mouse embryonic stem cells)	NULL
EXP056306	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Passage: p10-p20; Treatment: untreated; Genotype: KDM2Bfl/fl ES cells;	NULL	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	NULL
EXP056307	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Genotype: KDM2Bfl/fl ES cells; Passage: p10-p20; Treatment: 4-hydroxy tamoxifen (800 nM) for 72 hrs;	NULL	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	NULL
EXP056308	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Passage: p10-p20; Treatment: untreated; Genotype: KDM2Bfl/fl ES cells;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056309	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Genotype: KDM2Bfl/fl ES cells; Passage: p10-p20; Treatment: 4-hydroxy tamoxifen (800 nM) for 72 hrs;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056310	none	Mus musculus		NULL	2781	chip_control	NULL	E16.5 whole embryonic mouse skin	NULL
EXP056311	none	Mus musculus		NULL	2782	chip_control	NULL	adult epidermis	NULL
EXP056312	anti-Grhl3 (custom made)	Mus musculus	Treatment: depilation; 	EXP056311	2782	normal	Q5FWH3	adult epidermis	NULL
EXP056313	anti-Grhl3 (custom made)	Mus musculus	Treatment: imiquimod;	EXP056311	2782	normal	Q5FWH3	adult epidermis	NULL
EXP056314	anti-Grhl3 (custom made)	Mus musculus		EXP056310	2781	normal	Q5FWH3	E16.5 whole embryonic mouse skin	NULL
EXP056315	anti-Msl1 (3208)	Mus musculus	Developmental stage: E14; Passage: P26; Genotype: wildtype; Genotype: 129P2/OlaHsd;	NULL	2	normal	Q6PDM1	mESCs (mouse embryonic stem cells)	NULL
EXP056316	anti-Nsl1 (3130)	Mus musculus	Developmental stage: E14; Passage: P26; Genotype: wildtype; Genotype: 129P2/OlaHsd;	NULL	2	normal	Q80TG1	mESCs (mouse embryonic stem cells)	NULL
EXP056317	IgG	Mus musculus	Treatment: absence for 96 hrs;  Strain: C57BL/6; Genotype: conditional Jmjd2c knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056318	anti-Jmjd2c	Mus musculus	Treatment: absence for 96 hrs;  Strain: C57BL/6; Genotype: conditional Jmjd2c knockout;	EXP056317	2	normal	Q8VCD7	mESCs (mouse embryonic stem cells)	NULL
EXP056319	Jmjd2c	Mus musculus	Treatment: 500 nM OHT for 96 hrs; Strain: C57BL/6; Genotype: conditional Jmjd2c knockout;	EXP056317	2	normal	Q8VCD7	mESCs (mouse embryonic stem cells)	NULL
EXP056320	anti-Jmjd2c	Mus musculus	Strain: C57BL/6; Genotype: conditional Jmjd2c knockout; Treatment:absence for 72 hrs;  	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056321	anti-Jmjd2c	Mus musculus	Strain: C57BL/6; Genotype: conditional Jmjd2c knockout; Treatment:absence for 72 hrs;  	EXP056320	12	normal	Q8VCD7	MEF (mouse embryonic fibroblasts)	NULL
EXP056322	anti-Jmjd2c	Mus musculus	Strain: C57BL/6; Genotype: conditional Jmjd2c knockout; Treatment:500 nM OHT for 72 hrs;  	EXP056320	12	normal	Q8VCD7	MEF (mouse embryonic fibroblasts)	NULL
EXP056323	IgG	Mus musculus	Treatment: untreated; 	NULL	1126	chip_control	NULL	E14TG2a.4 (embryonic stem cells)	NULL
EXP056324	Cbx8	Mus musculus	Treatment: untreated; 	EXP056323	1126	normal	Q9QXV1	E14TG2a.4 (embryonic stem cells)	NULL
EXP056325	Cbx8	Mus musculus	Treatment: 1 uM all trans retinoic acid (RA) for 72hrs;	EXP056323	1126	normal	Q9QXV1	E14TG2a.4 (embryonic stem cells)	NULL
EXP056326	GFP (Abcam, Cambridge, UK)	Mus musculus	Genotype: wildtype; Strain: SV129;	NULL	663	chip_control	NULL	neural retina	NULL
EXP056327	anti-Laminin B (Santa-Cruz, California)	Mus musculus	Genotype: wildtype; Strain: SV129;	NULL	776	normal	P14733	retinal pigmented epithelium	NULL
EXP056328	anti-Laminin B (Santa-Cruz, California)	Mus musculus	Genotype: wildtype; Strain: SV129;	NULL	663	normal	P14733	neural retina	NULL
EXP056329	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs 100uM dipyridyl; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP wildtype;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	NULL
EXP056330	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs ethanol vehicle; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP wildtype;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	NULL
EXP056331	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs ethanol vehicle; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP knockout;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	NULL
EXP056332	anti-CBP/CREBBP (Brindle, 8690)	Mus musculus	Treatment: 2hrs 100uM dipyridyl; Passage: 5; Strain: C57BL/6 x 129Sv (F1); Developmental stage: E14.5; Genotype: CBP knockout;	NULL	12	normal	P45481	MEF (mouse embryonic fibroblasts)	NULL
EXP056333	none	Mus musculus	Genotype: Rb +/+; Passage: Proliferating passage 4;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056334	anti-CAP-D3	Mus musculus	Genotype: Rb +/+; Passage: Proliferating passage 4;	EXP056333	12	normal	Q6ZQK0	MEF (mouse embryonic fibroblasts)	NULL
EXP056335	anti-CAP-D3	Mus musculus	Genotype: Rb deleta L /delta;	EXP056333	12	normal	Q6ZQK0	MEF (mouse embryonic fibroblasts)	NULL
EXP056336	none (input)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	NULL	2783	chip_control	NULL	germline stem cells	NULL
EXP056337	none (input)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	2784	chip_control	NULL	pachytene spermatocytes	NULL
EXP056338	anti-Scml2 (Rabbit, produced in-house; Hasegawa et al.)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	EXP056336	2783	normal	Q8BJ51	germline stem cells	NULL
EXP056339	anti-Rnf2 (Mouse, MBL, catalog#D139-3, lot#014)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	EXP056336	2783	normal	Q9CQJ4	germline stem cells	NULL
EXP056340	anti-Bmi1 (Millipore, catalog#05-637, lot#2019726)	Mus musculus	Strain: CD1 x C57BL/6; Genotype: wildtype;	EXP056336	2783	normal	P25916	germline stem cells	NULL
EXP056341	anti-Scml2 (Rabbit , produced in-house; Hasegawa et al.)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP056337	2784	normal	Q8BJ51	pachytene spermatocytes	NULL
EXP056342	none	Mus musculus	Treatment: untreated; Strain: C57BL/6; 	NULL	682	chip_control	NULL	nucleus accumbens cells	NULL
EXP056343	PARP-1 (rabbit polyclonal anti-PARP, ab6079)	Mus musculus	tREATMENT: Saline for 7 days; Strain: C57BL/6;	EXP056342	682	normal	P11103	nucleus accumbens cells	NULL
EXP056344	PARP-1 (rabbit polyclonal anti-PARP, ab6079)	Mus musculus	Treatment: 20 mg/kg chronic cocaine for 7 days; Strain: C57BL/6;	EXP056342	682	normal	P11103	nucleus accumbens cells	NULL
EXP056345	none	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056346	none	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056347	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	NULL
EXP056348	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	NULL
EXP056349	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	NULL
EXP056350	RING1B ab (Atsuta et al., 2001; PMID 11289226)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q8BJ51	mESCs (mouse embryonic stem cells)	NULL
EXP056351	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056352	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056353	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056354	SUZ12 Ab (Cell Signaling #3737S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056355	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056356	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: untreated; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056357	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056345	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056358	EZH2 Ab (Cell Signaling #5246S)	Mus musculus	Treatment: 4-hydroxy tamoxifen 800 nM for 48hrs; Passage: 15-25; Genotype: Ring1A(-/-);Ring1B(fl/fl);R26::CreERT2;	EXP056346	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056359	anti-FLAG (M2) (Sigma,F1804)	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: wildtype;	NULL	2785	chip_control	NULL	limb bud, hearts, branchial arches	NULL
EXP056360	none	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: Hand2 3xFLAG;	NULL	2785	chip_control	NULL	limb bud, hearts, branchial arches	NULL
EXP056361	none	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: wildtype;	NULL	2785	chip_control	NULL	limb bud, hearts, branchial arches	NULL
EXP056362	mouse monoclonal anti-FLAG , M2 (Sigma, Cat.-No.: F1804)	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: Hand2 3xFLAG;	NULL	546	chip_control	NULL	limb bud	NULL
EXP056363	anti-FLAG (M2) (Sigma,F1804)	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: Hand2 3xFLAG;	EXP056360	2785	normal	Q61039	limb bud, hearts, branchial arches	NULL
EXP056364	anti-FLAG , M2 (Sigma, Cat.-No.: F1804)	Mus musculus	Strain: NMRI; Developmental stage: E10.5; Genotype: Hand2 3xFLAG;	EXP056362	546	normal	Q61039	limb bud	NULL
EXP056365	IgG	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	180	chip_control	NULL	motor neurons	NULL
EXP056366	anti-TAF9B	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	EXP056365	180	normal	Q6NZA9	motor neurons	NULL
EXP056367	none (input)	Mus musculus		NULL	636	chip_control	NULL	round spermatids	NULL
EXP056368	anti-Brd4 (Bethyl, A301-985A50)	Mus musculus		EXP056367	636	normal	Q9ESU6	round spermatids	NULL
EXP056369	none	Mus musculus	Tissue: thymus; Strain: C57BL/6;  Age: post natal day 0-3; Genotype: wildtype; 	NULL	2786	chip_control	NULL	gamma delta T cells	NULL
EXP056370	anti-Notch1 mAb (D1E11, Cell Signaling Technology)	Mus musculus	Tissue: thymus; Strain: C57BL/6;  Age: post natal day 0-3; Genotype: wildtype; 	EXP056369	2786	normal	Q01705	gamma delta T cells	NULL
EXP056371	None	Mus musculus	Age: 12 week; Strain: C57BL/6; 	NULL	53	chip_control	NULL	heart	NULL
EXP056372	anti-GTF2B (sc-225)	Mus musculus	Age: 12 week; Strain: C57BL/6; 	EXP056371	53	normal	P62915	heart	NULL
EXP056373	anti-GTF2B (sc-225)	Mus musculus	Age: 12 week; Strain: C57BL/6; Pathology: Hypertrophied heart subjected to Transaortic coarctation (TAC) for 4days	NULL	53	normal	P62915	heart	NULL
EXP056374	anti-GTF2B (sc-225)	Mus musculus	Age: 1-2 age; Strain: C57BL/6; Patholodgy: Postnatal heart;	NULL	53	normal	P62915	heart	NULL
EXP056375	anti-GSK3b	Mus musculus	Passage: 20-25; Strain: C5;	NULL	12	normal	Q9WV60	MEF (mouse embryonic fibroblasts)	NULL
EXP056376	anti-FLAG (Sigma, F1804)	Mus musculus	Genotype: wildtype Dnmt3a2; Passage: 7 to 10;	NULL	506	normal	O88508	J1 (embryonic stem cells)	NULL
EXP056377	anti-FLAG (Sigma, F1804)	Mus musculus	Genotype: wildtype bulk Dnmt3a2; Passage: 7 to 10;	NULL	506	normal	O88508	J1 (embryonic stem cells)	NULL
EXP056378	none	Mus musculus	Developmental stage: adult;	NULL	53	chip_control	NULL	heart	NULL
EXP056379	anti-YAP	Mus musculus	Developmental stage: adult;	EXP056378	53	normal	P46938	heart	NULL
EXP056380	Anti-GPS2	Mus musculus	Treatment: day 0 of induced adipogenesis;	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	NULL
EXP056381	Anti-GPS2	Mus musculus	Treatment: day 6 of induced adipogenesis;	NULL	18	normal	Q921N8	3T3-L1 (embryonic fibroblasts)	NULL
EXP056382	anti-KMD4A antibody (Abcam, ab47984)	Mus musculus	Treatment: siRNA control;	NULL	18	normal	Q8BW72	3T3-L1 (embryonic fibroblasts)	NULL
EXP056383	anti-KMD4A antibody (Abcam, ab47984)	Mus musculus	Treatment: siRNAs specific for GPS2;	NULL	18	normal	Q8BW72	3T3-L1 (embryonic fibroblasts)	NULL
EXP056384	none	Mus musculus	Strain: C57/L; Genotype: derivative of the BW7756 mouse hepatoma; 	NULL	2787	chip_control	NULL	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP056385	anti- PPARGC1A (Bethyl Laboratory, cat no. IHC-00029)	Mus musculus	Strain: C57/L; Genotype: derivative of the BW7756 mouse hepatoma; 	EXP056384	2787	normal	O70343	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP056386		Mus musculus	Age: 9 weeks; Strain: Black Swiss; Genotype: wild type;	NULL	53	chip_control	NULL	heart	NULL
EXP056387		Mus musculus	Treatment: negative control siRNA; Passage: 6-10;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056388		Mus musculus	RBFox2 siRNA	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056389		Mus musculus	Treatment: 100uM DRB for 3 hours; Passage: 6-10;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056390		Mus musculus	Treatment: SUZ12 siRNA; Genotype: SUZ12 knockout; Passage: 6-10;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056391	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Age: 9 weeks; Strain: Black Swiss; Genotype: wild type;	EXP056386	53	normal	Q8BP71	heart	NULL
EXP056392	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Age: 9 weeks; Strain: Black Swiss; Genotype: wild type;	EXP056386	53	normal	Q80U70	heart	NULL
EXP056393	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: negative control siRNA; Passage: 6-10;	EXP056387	12	bio_control	Q8BP71	MEF (mouse embryonic fibroblasts)	NULL
EXP056394	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: RBFox2 siRNA; Genotye: RBFox2 knockout; Passage: 6-10;	EXP056388	12	normal	Q8BP71	MEF (mouse embryonic fibroblasts)	NULL
EXP056395	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: negative control siRNA; Passage: 6-10;	EXP056387	12	normal	Q80U70	MEF (mouse embryonic fibroblasts)	NULL
EXP056396	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: RBFox2 siRNA; Genotye: RBFox2 knockout; Passage: 6-10;	EXP056388	12	normal	Q80U70	MEF (mouse embryonic fibroblasts)	NULL
EXP056397	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: 100uM DRB for 3 hours; Passage: 6-10;	EXP056389	12	normal	Q8BP71	MEF (mouse embryonic fibroblasts)	NULL
EXP056398	anti-SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 100uM DRB for 3 hours; Passage: 6-10;	EXP056389	12	normal	Q80U70	MEF (mouse embryonic fibroblasts)	NULL
EXP056399	anti-RBFox2 (Bethyl, A300-864A)	Mus musculus	Treatment: SUZ12 siRNA; Genotype: SUZ12 knockout; Passage: 6-10;	EXP056390	12	normal	Q8BP71	MEF (mouse embryonic fibroblasts)	NULL
EXP056400	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 100 uM DRB for 6 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056401	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 10 uM Triptolide for 3 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056402	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 0 hrs of DRB;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056403	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 100 uM DRB for 12 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056404	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment:  Triptolide for 0 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056405	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Treatment: 10 uM Triptolide for 9 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056406	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Culture conditions: serum; Genotype: wildtype; Time of differentiation: 72 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056407	anti-Suz12 (D39F6 XP Cell Signaling)	Mus musculus	Culture conditions: serum; Genotype: SUZ12 knockout; Time of differentiation: 0 hrs;	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056408		Mus musculus	Culture cinditions: serum; Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056409	none	Mus musculus	Strain: C57BL/6; 	NULL	2489	chip_control	NULL	primary hepatocytes	NULL
EXP056410	anti-NUCKS (Rabbit polyclonal antibody is generated by i-DNA Biotechnology Pte Ltd by immunizing rabbits with bacterially expressed full-length NUCKS protein)	Mus musculus	Strain: C57BL/6; 	EXP056409	2489	normal	Q80XU3	primary hepatocytes	NULL
EXP056411	none	Mus musculus	Strain: 129P2/Ola; 	NULL	2770	chip_control	NULL	embryonic stem cells-derived neural progenitor cells	NULL
EXP056412	none	Mus musculus	Strain: 129P2/Ola; 	NULL	2770	chip_control	NULL	embryonic stem cells-derived neural progenitor cells	NULL
EXP056413	anti-HP1b (1MOD-1A9-AS, euromedex)	Mus musculus	Strain: 129P2/Ola; 	EXP056411	2770	normal	P83917	embryonic stem cells-derived neural progenitor cells	NULL
EXP056414	anti-HP1b (1MOD-1A9-AS, euromedex)	Mus musculus	Strain: 129P2/Ola; 	EXP056412	2770	normal	P83917	embryonic stem cells-derived neural progenitor cells	NULL
EXP056415	anti-Suv39h1 (ab12405, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056411	2770	normal	O54864	embryonic stem cells-derived neural progenitor cells	NULL
EXP056416	anti-Suv39h1 (ab12405, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056412	2770	normal	O54864	embryonic stem cells-derived neural progenitor cells	NULL
EXP056417	anti-Suv39h2 (ab71683, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056411	2770	normal	Q9EQQ0	embryonic stem cells-derived neural progenitor cells	NULL
EXP056418	anti-Suv39h2 (ab71683, abcam)	Mus musculus	Strain: 129P2/Ola; 	EXP056412	2770	normal	Q9EQQ0	embryonic stem cells-derived neural progenitor cells	NULL
EXP056419		Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056420		Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved and re-fed;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056421		Mus musculus	Treatment: 500 nM JQ1 for 30 mins; Culture conditions: serum starved and re-fed;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056422		Mus musculus	Treatment: none; Culture conditions: continuous culture;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056423	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved;	EXP056419	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056424	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved and re-fed;	EXP056420	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056425	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: 500 nM JQ1 for 30 mins; Culture conditions: serum starved and re-fed;	EXP056421	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056426	anti-BRD4 (C-terminus, made in house)	Mus musculus	Treatment: none; Culture conditions: continuous culture;	EXP056422	675	normal	Q9ESU6	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056427	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved;	EXP056419	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056428	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: DMSO (vehicle) for 30 mins; Culture conditions: serum starved and re-fed;	EXP056420	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056429	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: 500 nM JQ1 for 30 mins; Culture conditions: serum starved and re-fed;	EXP056421	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056430	anti-CDK9 (Santa Cruz Biotechnology, sc-8338)	Mus musculus	Treatment: none; Culture conditions: continuous culture;	EXP056422	675	normal	Q99J95	NIH 3T3 (embryonic fibroblasts)	NULL
EXP056431	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: Nlrc5 flux/flux; Strain: C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	NULL
EXP056432	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: Nlrc5-/- (knockout); Strain: C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	NULL
EXP056433	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: Rfx5-/- (knockout); Strain: mixed Sv129/C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	NULL
EXP056434	anti-NLRC5 (aa 1â€“139, custom mouse  antibody generated by Adipogen)	Mus musculus	Genotype: wildtype; Strain: C57Bl/6 (H2b) background;	NULL	44	normal	C3VPR6	T-cells	NULL
EXP056435		Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	NULL	713	chip_control	NULL	pancreas	NULL
EXP056436		Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	NULL	2788	chip_control	NULL	pancreas and brain	NULL
EXP056437	anti-CTCF	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	EXP056436	713	normal	Q61164	pancreas	NULL
EXP056438	anti-SA1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	NULL	193	normal	Q9D3E6	cortex	NULL
EXP056439	anti-SMC1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	NULL	193	normal	Q9CU62	cortex	NULL
EXP056440	anti-SA1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	EXP056436	713	normal	Q9D3E6	pancreas	NULL
EXP056441	anti-SMC1	Mus musculus	Strain: C57BL/6; Age: 8-10 week old; 	EXP056436	713	normal	Q9CU62	pancreas	NULL
EXP056442	anti-SA1	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8-10 week old;  Developmental stage: E17.5 embryo;	EXP056436	2736	normal	Q9D3E6	whole brain	NULL
EXP056443	anti-SMC1	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8-10 week old;  Developmental stage: E17.5 embryo;	EXP056436	2736	normal	Q9CU62	whole brain	NULL
EXP056444	anti-SMC1	Mus musculus	Genotype: SMC1 knockout; Strain: C57BL/6; Age: 8-10 week old;  Developmental stage: E17.5 embryo;	EXP056436	2736	normal	Q9CU62	whole brain	NULL
EXP056445		Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	NULL	495	chip_control	NULL	intestinal crypt cells	NULL
EXP056446		Mus musculus	Strain: C57BL/6 Genotype: Apc min/+; 	NULL	2789	chip_control	NULL	small intestinal adenoma	NULL
EXP056447	anti-Rad21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP056445	495	normal	Q61550	intestinal crypt cells	NULL
EXP056448	anti-Rad21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6 Genotype: Apc min/+; 	EXP056446	2789	normal	Q61550	small intestinal adenoma	NULL
EXP056449	none (input)	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056450	anti-Pwp1 (Santa Cruz, sc-107983)	Mus musculus		EXP056449	230	normal	Q99LL5	ES-E14 (E14, embryonic stem cells)	NULL
EXP056451	None	Mus musculus		NULL	2790	chip_control	NULL	partially reprogrammed colony 23	NULL
EXP056452	None	Mus musculus		NULL	2790	chip_control	NULL	partially reprogrammed colony 23	NULL
EXP056453	None	Mus musculus	Cell type: NGFP iPSC;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP056454	None	Mus musculus	Cell type: NGFP2;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056455	None	Mus musculus		NULL	2791	chip_control	NULL	OSKM4 induced iPSC into somatic cells	NULL
EXP056456	None	Mus musculus		NULL	2792	chip_control	NULL	OSKM8 induced iPSC into somatic cells	NULL
EXP056457	None	Mus musculus		NULL	2793	chip_control	NULL	SNEL3 iPSC	NULL
EXP056458	None	Mus musculus		NULL	2794	chip_control	NULL	SNEL4 iPSC	NULL
EXP056459	None	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP056460	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056451	2790	normal	Q925J9	partially reprogrammed colony 23	NULL
EXP056461	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056452	2790	normal	Q925J9	partially reprogrammed colony 23	NULL
EXP056462	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Cell type: NGFP iPSC;	EXP056453	906	normal	Q925J9	induced pluripotent stem cells	NULL
EXP056463	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus	Cell type: NGFP2;	EXP056454	12	normal	Q925J9	MEF (mouse embryonic fibroblasts)	NULL
EXP056464	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056455	2791	normal	Q925J9	OSKM4 induced iPSC into somatic cells	NULL
EXP056465	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056456	2792	normal	Q925J9	OSKM8 induced iPSC into somatic cells	NULL
EXP056466	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056457	2793	normal	Q925J9	SNEL3 iPSC	NULL
EXP056467	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056458	2794	normal	Q925J9	SNEL4 iPSC	NULL
EXP056468	Med1/TRAP220 (Bethyl, A300-793A)	Mus musculus		EXP056459	252	normal	Q925J9	V6.5 (embryonic stem cells)	NULL
EXP056469	Med1/TRAP220 (Santa Cruz, SC-5334)	Mus musculus		EXP056459	252	normal	Q925J9	V6.5 (embryonic stem cells)	NULL
EXP056470	none	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	NULL	313	chip_control	NULL	forebrain	NULL
EXP056471	none	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	NULL	25	chip_control	NULL	cerebellum	NULL
EXP056472	none	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	NULL	25	chip_control	NULL	cerebellum	NULL
EXP056473	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	EXP056470	313	normal	Q9Z2D6	forebrain	NULL
EXP056474	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	EXP056471	25	normal	Q9Z2D6	cerebellum	NULL
EXP056475	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Age: 8 weeks; 	EXP056472	25	normal	Q9Z2D6	cerebellum	NULL
EXP056476	None	Mus musculus	Genotype: Dicer lox/lox; 	NULL	2795	chip_control	NULL	DTCM23 (embryonic stem cells)	NULL
EXP056477	None	Mus musculus	Genotype: Dicer knockout, Dicer deficient;	NULL	2795	chip_control	NULL	DTCM23 (embryonic stem cells)	NULL
EXP056478	anti-Ezh2 antibody (Diagenode)	Mus musculus	Genotype: Dicer lox/lox; 	EXP056476	2795	normal	Q61188	DTCM23 (embryonic stem cells)	NULL
EXP056479	anti-Ezh2 antibody (Diagenode)	Mus musculus	Genotype: Dicer knockout, Dicer deficient;	EXP056477	2795	normal	Q61188	DTCM23 (embryonic stem cells)	NULL
EXP056480		Mus musculus	Age: 12 days post-partum; Strain: B6xCAST F1 Hybrid;	NULL	32	chip_control	NULL	testis	NULL
EXP056481	anti-PRDM9	Mus musculus	Age: 12 days post-partum; Strain: B6xCAST F1 Hybrid;	EXP056480	32	normal	Q96EQ9	testis	NULL
EXP056482	no antibody	Mus musculus	Treatment: none; 	NULL	682	chip_control	NULL	nucleus accumbens cells	NULL
EXP056483	beta Catenin antiboy (Cell Signaling 4176, various lot)	Mus musculus	Treatment: none stress; Strain: C57BL/6;	EXP056482	682	normal	Q02248	nucleus accumbens cells	NULL
EXP056484	beta Catenin antiboy (Cell Signaling 4176, various lot)	Mus musculus	Treatment: 10 day chronic social defeat stress; Strain: C57BL/6;	EXP056482	682	normal	Q02248	nucleus accumbens cells	NULL
EXP056485	beta Catenin antiboy (Cell Signaling 4176, various lot)	Mus musculus	Treatment: 10 day chronic social defeat stress, resilient; Strain: C57BL/6;	EXP056482	682	normal	Q02248	nucleus accumbens cells	NULL
EXP056486	none	Mus musculus	Age: P52-60; Strain: CD-1; Sex: Female; Tissue: back skin; Sorting markers: integrin alfa6, CD34 and Sca1;	NULL	2796	chip_control	NULL	HFSC (Telogen quiescent hair follicle stem cells)	NULL
EXP056487	none	Mus musculus	Age: P28-P30; Strain: K14-H2BGFP (Tumbar et al., 2004); Sex: Female; Tissue: back skin; Sorting markers: GFP, integrin alfa6, CD34 and Sca1;	NULL	2797	chip_control	NULL	TAC (transit-amplifying cells)	NULL
EXP056488	Med1 (Crsp1/Trap220, Bethyl Laboratories, catalog# A300-793A, lot# A300-793A-2)	Mus musculus	Age: P52-60; Strain: CD-1; Sex: Female; Tissue: back skin; Sorting markers: integrin alfa6, CD34 and Sca1;	EXP056486	2796	normal	Q925J9	HFSC (Telogen quiescent hair follicle stem cells)	NULL
EXP056489	Med1 (Crsp1/Trap220, Bethyl Laboratories, catalog# A300-793A, lot# A300-793A-2)	Mus musculus	Age: P28-P30; Strain: K14-H2BGFP (Tumbar et al., 2004); Sex: Female; Tissue: back skin; Sorting markers: GFP, integrin alfa6, CD34 and Sca1;	EXP056487	2797	normal	Q925J9	TAC (transit-amplifying cells)	NULL
EXP056490	none (input)	Mus musculus	Genotype: wildtype; Age: 6 weeks old; Treatment: Conditional deletion of Rad21;	NULL	2459	chip_control	NULL	double-positive (DP) CD4+/CD8+ thymocyte	NULL
EXP056491	Anti-Smc1a (Bethyl Laboratories, catalog number A300-055A)	Mus musculus	Genotype: wildtype; Age: 6 weeks old; Treatment: Conditional deletion of Rad21;	EXP056490	2459	normal	Q9CU62	double-positive (DP) CD4+/CD8+ thymocyte	NULL
EXP056492	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056493	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056494	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056495	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056496	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056497	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056498	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056499	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056500	None (Input DNA)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	NULL	2798	chip_control	NULL	resting mature murine splenic B lymphocytes	NULL
EXP056501	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	EXP056492	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056502	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	EXP056493	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056503	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 0 hrs stimulation; 	EXP056494	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056504	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	EXP056495	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056505	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	EXP056496	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056506	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 48 hrs after stimulation;	EXP056497	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056507	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	EXP056498	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056508	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	EXP056499	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056509	anti-RAD21 (Abcam, ab992)	Mus musculus	Strain: C57BL/6; Treatment: 96 hrs after stimulation;	EXP056500	2798	normal	Q61550	resting mature murine splenic B lymphocytes	NULL
EXP056510		Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	NULL	2799	chip_control	NULL	primary murine T-ALL (acute lymphocytic leukemia) cells	NULL
EXP056511		Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	NULL	2799	chip_control	NULL	primary murine T-ALL (acute lymphocytic leukemia) cells	NULL
EXP056512	anti-Notch1 (antisera made in lab)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056510	2799	normal	Q01705	primary murine T-ALL (acute lymphocytic leukemia) cells	NULL
EXP056513	anti-Notch1 (antisera made in lab)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056511	2799	normal	Q01705	primary murine T-ALL (acute lymphocytic leukemia) cells	NULL
EXP056514	anti-RBPSUH (Cell signaling, 5313)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056510	2799	normal	P31266	primary murine T-ALL (acute lymphocytic leukemia) cells	NULL
EXP056515	anti-RBPSUH (Cell signaling, 5313)	Mus musculus	Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; 	EXP056511	2799	normal	P31266	primary murine T-ALL (acute lymphocytic leukemia) cells	NULL
EXP056516	none	Mus musculus	Treatment: Lhx5-FLAG expression with Doxycycline induced; Strain: C57BL/6;	NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP056517	anti-FLAG antibody (Sigma, F2426)	Mus musculus	Treatment: transfected with FLAG-tag control construct; Strain: C57BL/6;	NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP056518	none	Mus musculus	Treatment: transfected with FLAG-tag control construct; Strain: C57BL/6;	NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP056519	anti-FLAG antibody (Sigma, F2426)	Mus musculus	Treatment: Lhx5-FLAG expression with Doxycycline induced; Strain: C57BL/6;	EXP056516	1245	normal	P61375	Neuro-2A cells	NULL
EXP056520	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: none (untreated); Tissue: Spleen; Strain: C57BL/6;	NULL	2800	normal	P42227	pre-activated CD4+ T cells	NULL
EXP056521	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: IL-21 for 1hr; Tissue: Spleen; Strain: C57BL/6;	NULL	2800	normal	P42227	pre-activated CD4+ T cells	NULL
EXP056522	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: none (untreated); Tissue: Spleen; Strain: C57BL/6;	NULL	2801	normal	P42227	splenic conventional dendritic cells	NULL
EXP056523	anti-STAT3 (Invitrogen, 13-7000)	Mus musculus	Treatment: IL-21 for 1hr; Tissue: Spleen; Strain: C57BL/6;	NULL	2801	normal	P42227	splenic conventional dendritic cells	NULL
EXP056524	none	Mus musculus	Treatment: mock;	NULL	2802	chip_control	NULL	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP056525	none	Mus musculus	Treatment: 3 uM UNC2400 for 4 days;	NULL	2802	chip_control	NULL	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP056526	none	Mus musculus	Treatment: 3 uM UNC1999 for 4 days;	NULL	2802	chip_control	NULL	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP056527	anti-SUZ12 (Abcam, 12073)	Mus musculus	Treatment: mock;	EXP056524	2802	normal	Q80U70	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP056528	anti-SUZ12 (Abcam, 12073)	Mus musculus	Treatment: 3 uM UNC2400 for 4 days;	EXP056525	2802	normal	Q80U70	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP056529	anti-SUZ12 (Abcam, 12073)	Mus musculus	Treatment: 3 uM UNC1999 for 4 days;	EXP056526	2802	normal	Q80U70	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP056530	none	Mus musculus	Developmental stage: proliferating myoblasts; 	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056531	anti-Kap1 (homemade rabbit polylconal antibody)	Mus musculus	Developmental stage: proliferating myoblasts; 	EXP056530	1153	normal	Q62318	C2C12 (myoblasts)	NULL
EXP056532	IgG	Mus musculus		NULL	2747	chip_control	NULL	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	NULL
EXP056533	anti-Usp16	Mus musculus		EXP056532	2747	normal	Q99LG0	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	NULL
EXP056534	pCREB (Millipore, Ser 133, 06-519)	Mus musculus	Treatment: DMSO vehicle for 1 hour;	NULL	581	normal	Q01147	MC3T3-E1 (preosteoblasts)	NULL
EXP056535	pCREB (Millipore, Ser 133, 06-519)	Mus musculus	Treatment: 100nM fsk for 1 hour;	NULL	581	normal	Q01147	MC3T3-E1 (preosteoblasts)	NULL
EXP056536	Anti- LSD1 (Abcam,Cat. No. ab17721)	Mus musculus	Treatment: KCl for 0 hrs; Passage: R26/LSD1n DIV10;	NULL	2803	normal	Q6ZQ88	primary cortical neuron	NULL
EXP056537	Anti- LSD1 (Abcam,Cat. No. ab17721)	Mus musculus	Treatment: 55 nM KCl for 1hr; Passage: R26/LSD1n DIV10;	NULL	2803	normal	P24270	primary cortical neuron	NULL
EXP056538	Anti- LSD1 Abcam (Cat. No. ab17721)	Mus musculus	Genotype: LSD1 knockout; 	NULL	2803	normal	P24270	primary cortical neuron	NULL
EXP056539	Anti- LSD1 Abcam (Cat. No. ab17721)	Mus musculus	Genotype: LSD1 knockout; 	NULL	2803	normal	P24270	primary cortical neuron	NULL
EXP056540	Anti- FLAG (M2 Sigma, Cat. No. A2220)	Mus musculus	Treatment: KCl for 0 hrs; Passage: R26/LSD1n DIV10;	NULL	2803	normal	Q6ZQ88	primary cortical neuron	NULL
EXP056541	Anti- FLAG (M2 Sigma, Cat. No. A2220)	Mus musculus	Treatment: 55 nM KCl for 1hr; Passage: R26/LSD1n DIV10;	NULL	2803	normal	Q6ZQ88	primary cortical neuron	NULL
EXP056542		Mus musculus	Strain: C57BL/6; 	NULL	2231	chip_control	NULL	small pre-B cells	NULL
EXP056543		Mus musculus	Strain: C57BL/6; 	NULL	2231	chip_control	NULL	small pre-B cells	NULL
EXP056544	anti-Brwd1 (E15, sc-83517; Lot J1508)	Mus musculus	Strain: C57BL/6; 	EXP056542	2231	normal	Q921C3	small pre-B cells	NULL
EXP056545	anti-Brwd1 (E15, sc-83517; Lot J1508)	Mus musculus	Strain: C57BL/6; 	EXP056543	2231	normal	Q921C3	small pre-B cells	NULL
EXP056546	none (input)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	400	chip_control	NULL	hematopoietic progenitors	NULL
EXP056547	none (input)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	400	chip_control	NULL	hematopoietic progenitors	NULL
EXP056548	anti-BRD2 (Bethyl Labs, A302-583A-2)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	2804	normal	Q7JJ13	5.3S (haematopoietic progenitors)	NULL
EXP056549	anti-BRD3 (Bethyl Labs, A302-368A-1)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	2804	normal	Q8K2F0	5.3S (haematopoietic progenitors)	NULL
EXP056550	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	NULL	2804	normal	Q9ESU6	5.3S (haematopoietic progenitors)	NULL
EXP056551	anti-BRD2 (Bethyl Labs, A302-583A-2)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	2804	normal	Q7JJ13	5.3S (haematopoietic progenitors)	NULL
EXP056552	anti-BRD3 (Bethyl Labs, A302-368A-1)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	2804	normal	Q8K2F0	5.3S (haematopoietic progenitors)	NULL
EXP056553	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	NULL	2804	normal	Q9ESU6	5.3S (haematopoietic progenitors)	NULL
EXP056554	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	EXP056546	400	normal	Q9ESU6	hematopoietic progenitors	NULL
EXP056555	anti-BRD4 (Bethyl Labs,A301-985A-1)	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	EXP056547	400	normal	Q9ESU6	hematopoietic progenitors	NULL
EXP056556	anti-B-catenin	Mus musculus	Phenotype: BET inhibitor sensitive; Strain: C57BL/6; Treatment: 0.1% DMSO; 	EXP056547	400	normal	Q02248	hematopoietic progenitors	NULL
EXP056557	anti-B-catenin	Mus musculus	Phenotype: BET inhibitor resistant; Strain: C57BL/6; Treatment: 600nM I-BET151; 	EXP056546	400	normal	Q02248	hematopoietic progenitors	NULL
EXP056558	B-catenin	Mus musculus	Phenotype: BET inhibitor resistant + DKK; Strain: C57BL/6; Treatment: 600nM I-BET151; 	EXP056546	400	normal	Q02248	hematopoietic progenitors	NULL
EXP056559	none	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	NULL	1117	chip_control	NULL	primary T-cells	NULL
EXP056560	none	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	NULL	1117	chip_control	NULL	primary T-cells	NULL
EXP056561	none	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	NULL	1117	chip_control	NULL	primary T-cells	NULL
EXP056562	Brd2 (Bethyl; IHC-00612)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056559	1117	normal	Q7JJ13	primary T-cells	NULL
EXP056563	Brd4 (Bethyl; IHC-00396)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056559	1117	normal	Q9ESU6	primary T-cells	NULL
EXP056564	Brd4 (Bethyl; IHC-00396)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q9ESU6	primary T-cells	NULL
EXP056565	Brd4 (Bethyl; IHC-00396)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; Genotype: STat3 knockout;	EXP056560	1117	normal	Q9ESU6	primary T-cells	NULL
EXP056566	Nipbl (Bethyl; A301-779A)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q6KCD5	primary T-cells	NULL
EXP056567	Smc1 (Bethyl; A300-055A)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q9CU62	primary T-cells	NULL
EXP056568	Smc3 (Abcam; ab9263)	Mus musculus	Strain: C57BL/6; Source: Th17 cells; 	EXP056560	1117	normal	Q9CW03	primary T-cells	NULL
EXP056569	IgG	Mus musculus	Genotype: wildtype; 	NULL	204	chip_control	NULL	D3 (embryonic stem cells)	NULL
EXP056570	IgG	Mus musculus	Genotype: wildtype; 	NULL	204	chip_control	NULL	D3 (embryonic stem cells)	NULL
EXP056571	IgG	Mus musculus	Genotype: Xpc-/- (knockout);	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056572	RAD23B	Mus musculus	Genotype: wildtype; 	EXP056569	204	normal	P54728	D3 (embryonic stem cells)	NULL
EXP056573	RAD23B	Mus musculus	Genotype: wildtype; 	EXP056570	204	normal	P54728	D3 (embryonic stem cells)	NULL
EXP056574	RAD23B	Mus musculus	Genotype: Xpc-/- (knockout);	EXP056571	2	normal	P54728	mESCs (mouse embryonic stem cells)	NULL
EXP056575	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Treatment: absence (control); Strain: C57Bl/6; Genotype: Jmjd2a(f/f), Rosa26::CreERT2;	NULL	2	normal	Q8BW72	mESCs (mouse embryonic stem cells)	NULL
EXP056576	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Treatment: 500 nM OHT for up to 12 days; Strain: C57Bl/6; Genotype: Jmjd2a(f/f), Rosa26::CreERT2;	NULL	2	normal	Q8BW72	mESCs (mouse embryonic stem cells)	NULL
EXP056577	anti-V5	Mus musculus	Genotype: V5-tagged Fbxl10;	NULL	18	normal	Q6P1G2	3T3-L1 (embryonic fibroblasts)	NULL
EXP056578	anti-RING1B	Mus musculus	Genotype: V5-tagged Fbxl10;	NULL	18	normal	Q9CQJ4	3T3-L1 (embryonic fibroblasts)	NULL
EXP056579	anti-RING1B	Mus musculus	Genotype: V5-tagged dF-box mutant Fbxl10;	NULL	18	normal	Q9CQJ4	3T3-L1 (embryonic fibroblasts)	NULL
EXP056580	anti-RING1B	Mus musculus	Genotype: empty vector;	NULL	18	normal	Q9CQJ4	3T3-L1 (embryonic fibroblasts)	NULL
EXP056581	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; 	NULL	2806	chip_control	NULL	quiescent satellite cells	NULL
EXP056582	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; 	NULL	2807	chip_control	NULL	proliferating satellite cells	NULL
EXP056583	Anti-Sirt1 (Upstate, 07-131)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; 	EXP056581	2806	normal	Q923E4	quiescent satellite cells	NULL
EXP056584	Anti-Sirt1 (Upstate, 07-131)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; 	EXP056582	2807	normal	Q923E4	proliferating satellite cells	NULL
EXP056585	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP056586	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP056587	none	Mus musculus	Strain: KH2;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056588	none	Mus musculus	Strain: TC1; Genotype: wildtype; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056589	none	Mus musculus	Strain: TC1; Genotype: Zfp57 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056590	none	Mus musculus	Strain: AG MEF; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056591	none	Mus musculus	Strain: PG MEF; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056592	Aff3 (Homemade#182)	Mus musculus		EXP056585	252	normal	P51827	V6.5 (embryonic stem cells)	NULL
EXP056593	Aff3 (Homemade#182)	Mus musculus		EXP056586	252	normal	P51827	V6.5 (embryonic stem cells)	NULL
EXP056594	Aff3 (Homemade#13)	Mus musculus		EXP056585	252	normal	P51827	V6.5 (embryonic stem cells)	NULL
EXP056595	Aff3 (Homemade#182)	Mus musculus	Strain: KH2;	EXP056587	2	normal	P51827	mESCs (mouse embryonic stem cells)	NULL
EXP056596	Aff3 (Homemade#182)	Mus musculus	Strain: AG MEF; 	EXP056590	12	normal	P51827	MEF (mouse embryonic fibroblasts)	NULL
EXP056597	Aff3 (Homemade#182)	Mus musculus	Strain: PG MEF; 	EXP056591	12	normal	P51827	MEF (mouse embryonic fibroblasts)	NULL
EXP056598	Aff3 (Homemade#182)	Mus musculus	Strain: TC1; Genotype: wildtype; 	NULL	2	normal	P51827	mESCs (mouse embryonic stem cells)	NULL
EXP056599	Aff3 (Homemade#182)	Mus musculus	Strain: TC1; Genotype: Zfp57 knockout;	EXP056589	2	normal	P51827	mESCs (mouse embryonic stem cells)	NULL
EXP056600	none	Mus musculus	Strain: 129P2/Ola;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056601	anti-HP1b(Euromedex 1MOD-1A9-AS, lot# 091809)	Mus musculus	Strain: 129P2/Ola;	EXP056600	2	normal	P83917	mESCs (mouse embryonic stem cells)	NULL
EXP056602	input	Mus musculus	Treatment: 0 hr treatment; Strain: C57BL/6;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056603	input	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056604	anti-Oct4	Mus musculus	Treatment: 0 hr treatment; Strain: C57BL/6;	EXP056602	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP056605	anti-Oct4	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	EXP056603	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP056606	anti-Spt16	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	EXP056603	2	normal	A1A546	mESCs (mouse embryonic stem cells)	NULL
EXP056607	anti-Jmjd1c	Mus musculus	Treatment: 10 hrs doxycyline treatment; Strain: C57BL/6;	EXP056603	2	normal	Q69ZK6	mESCs (mouse embryonic stem cells)	NULL
EXP056608		Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: MMTV-Cre, wildtype;	NULL	573	chip_control	NULL	mammary tissue	NULL
EXP056609	EZH1 (gift from Sartorelli, Mousavi et al. Mol. Cell 2012)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: E2 knockout;	EXP056608	573	normal	Q61188	mammary tissue	NULL
EXP056610	EZH1 (gift from Sartorelli, Mousavi et al. Mol. Cell 2012)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: MMTV-Cre, wildtype;	EXP056608	573	normal	Q61188	mammary tissue	NULL
EXP056611	EZH2 (Diagenode, cat# C15410039 and lot# 003)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: E2 knockout;	EXP056608	573	normal	Q61188	mammary tissue	NULL
EXP056612	EZH2 (Diagenode, cat# C15410039 and lot# 003)	Mus musculus	Developmental stage: Day 13 of pregnancy (p13); Genotype: MMTV-Cre, wildtype;	EXP056608	573	normal	Q61188	mammary tissue	NULL
EXP056613	none	Mus musculus	Treatment: none;	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP056614	anti-Setdb1 (Santa Cruz, H-300 sc-66884)	Mus musculus	treatment: none;	EXP056613	126	normal	O88974	C2C12 (myotubes)	NULL
EXP056615	anti-Setdb1 (Santa Cruz, H-300 sc-66884)	Mus musculus	Treatment: DMSO for 24 hrs;	EXP056613	126	normal	O88974	C2C12 (myotubes)	NULL
EXP056616	anti-Setdb1 (Santa Cruz, H-300 sc-66884)	Mus musculus	Treatment: 50 ng/ml Wnt-3a (#1324-WN, R&D systems) for 24 hrs;	EXP056613	126	normal	O88974	C2C12 (myotubes)	NULL
EXP056617	none	Mus musculus	Treatment: No; Genotype: wildtype;	NULL	963	chip_control	NULL	embryonic stem cells from stran 129	NULL
EXP056618	none	Mus musculus	Treatment: No; Genotype: Sirt6 knockout;	NULL	963	chip_control	NULL	embryonic stem cells from stran 129	NULL
EXP056619	Sirt6 (Cell Signaling Technology, 12486 in a ratio of 1ml/2e7 cells)	Mus musculus	Treatment: No; Genotype: wildtype;	EXP056617	963	normal	P59941	embryonic stem cells from stran 129	NULL
EXP056620	Sirt6 (Cell Signaling Technology, 12486 in a ratio of 1ml/2e7 cells)	Mus musculus	Treatment: No; Genotype: Sirt6 knockout;	EXP056618	963	normal	P59941	embryonic stem cells from stran 129	NULL
EXP056621	Sirt6 (Cell Signaling Technology, 12486 in a ratio of 5ml/2e7 cells)	Mus musculus	Treatment: No; Genotype: Sirt6 knockout;	EXP056618	963	normal	P59941	embryonic stem cells from stran 129	NULL
EXP056622	HDAC1 (3 FLAG-HDAC1, Sigma,F7425)	Mus musculus	Strain: 129/Ola; Developmental stage: 2 days;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP056623	anti-FLAG (Sigma,F7425)	Mus musculus	Strain: 129/Ola; Developmental stage: 2 days;	EXP056622	216	normal	O09106	differentiated embryonic stem cells	NULL
EXP056624	none	Mus musculus	Genotype: stable Flag-Set1a; Treatment: treated with 1ug/ml puromycin;	NULL	176	chip_control	NULL	CGR8 (embryonic stem cells)	NULL
EXP056625	anti-FLAG M2 (Sigma, M8823)	Mus musculus	Genotype: stable Flag-Set1a; Treatment: treated with 1ug/ml puromycin;	EXP056624	176	normal	E9PYH6	CGR8 (embryonic stem cells)	NULL
EXP056626	SUMO1 (Y299 monoclonal antibody)	Mus musculus	Genotype: UBC9 wildtype; Treatment: none;	NULL	2808	normal	P63166	bone marrow derived dendritic cells	NULL
EXP056627	SUMO1 (Y299 monoclonal antibody)	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 2 hours;	NULL	2808	normal	P63166	bone marrow derived dendritic cells	NULL
EXP056628	SUMO2	Mus musculus	Genotype: UBC9 wildtype; Treatment: none;	NULL	2808	normal	P61957	bone marrow derived dendritic cells	NULL
EXP056629	SUMO2	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 2 hours;	NULL	2808	normal	P61957	bone marrow derived dendritic cells	NULL
EXP056630	SUMO1 (Y299 monoclonal antibody)	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 1 hours;	NULL	2808	normal	P63166	bone marrow derived dendritic cells	NULL
EXP056631	SUMO2	Mus musculus	Genotype: UBC9 wildtype; Treatment: LPS 10ng/ml 1 hours;	NULL	2808	normal	P61957	bone marrow derived dendritic cells	NULL
EXP056632	RevXlinkChromatin	Homo sapiens	DEX_100nM	NULL	1004	chip_control	NULL	A137 ER-, PR-, HER2- breast cancer cells	NULL
EXP056633	RevXlinkChromatin	Homo sapiens	None	NULL	849	chip_control	NULL	U87 (glioblastoma)	NULL
EXP056635	HEY1	Homo sapiens	None	NULL	514	normal	Q9Y5J3	K562 (myelogenous leukemia)	NULL
EXP056636	HEY1	Homo sapiens	Treatment: None;	NULL	430	normal	Q9Y5J3	HepG2 (hepatoblastoma)	NULL
EXP056637	BCL3	Homo sapiens	Treatment: None;	NULL	514	normal	P20749	K562 (myelogenous leukemia)	NULL
EXP056638	anti-PML (Millipore, catalog# 05-718, lot# 2684855)	Mus musculus	Treatment: untreated; Developmental stage: Proliferating; genotype: wildtype; Strain: C57BL/6; Passage: 10-15;  	NULL	12	normal	Q60953	MEF (mouse embryonic fibroblasts)	NULL
EXP056639	anti-PML (Millipore, catalog# 05-718, lot# 2684855)	Mus musculus	Treatment: untreated; Developmental stage: Proliferating; genotype: PML knockout; Strain: C57BL/6; Passage: 10-15;  	NULL	12	normal	Q60953	MEF (mouse embryonic fibroblasts)	NULL
EXP056640	anti-ESR1 (Santa Cruz Biotechnology, sc-8002X)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Tissue: spleen;	NULL	41	normal	P19785	B-cells	NULL
EXP056641	anti-Nbs1 (Abcam, ab32074)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Tissue: spleen;	NULL	41	normal	Q9R207	B-cells	NULL
EXP056642	anti-Nbs1 (Abcam, ab32074)	Mus musculus	Genotype: Aid knockout; Strain: C57BL/6; Tissue: spleen;	NULL	41	normal	Q9R207	B-cells	NULL
EXP056643	N/A	Mus musculus		NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP056644	N/A	Mus musculus		NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP056645	N/A	Mus musculus	Treatment: shSetdb1; Sex: female; Genotype: Setdb1+/gt Xist-deltaA/+; Strain: 129/C57 dams x CAST sires;	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP056646	Setdb1 (Santa Cruz Biotechnology, sc-66884, lot L1812)	Mus musculus	Sex: female; Genotype: Setdb1+/+ Xist-deltaA/+; Strain: 129/C57 dams x CAST sires;	EXP056643	750	normal	O88974	E13.5 embryonic fibroblasts	NULL
EXP056647	Setdb1 (Santa Cruz Biotechnology, sc-66884, lot L1812)	Mus musculus	Sex: male; Genotype: Setdb1+/+ X/Y; Strain: 129/C57 dams x CAST sires;	EXP056644	750	normal	O88974	E13.5 embryonic fibroblasts	NULL
EXP056648	Setdb1 (Santa Cruz Biotechnology, sc-66884, lot L1812)	Mus musculus	Treatment: shSetdb1; Sex: female; Genotype: Setdb1+/gt Xist-deltaA/+; Strain: 129/C57 dams x CAST sires;	EXP056645	750	normal	O88974	E13.5 embryonic fibroblasts	NULL
EXP056649	Normal Mouse IgG (Millipore 12-371)	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP056650	N/A	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP056651	anti-Flag (Sigma F1804)	Mus musculus		EXP056650	506	normal	Q3URQ0	J1 (embryonic stem cells)	NULL
EXP056652	total input	Mus musculus	Strain: C57BL/6; Genotype: wildtype;  Age: 12-16 weeks;	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP056653	total input	Mus musculus		NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056654	anti-GPS2 (N-terminal home raised)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;  Age: 12-16 weeks;	EXP056652	81	normal	Q921N8	BMDM (bone marrow-derived macrophages)	NULL
EXP056655	anti-GPS2 (N-terminal home raised)	Mus musculus	Strain: C57BL/6; Genotype: GPS2 knockout;  Age: 12-16 weeks;	EXP056652	81	normal	Q921N8	BMDM (bone marrow-derived macrophages)	NULL
EXP056656	anti-GPS2 (C-terminal home raised)	Mus musculus		EXP056653	91	normal	Q921N8	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056657	anti-GPS2 (N-terminal home raised)	Mus musculus		EXP056653	91	normal	Q921N8	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056658	Whole cell extract	Mus musculus	Treatment: No Tamoxifen; Genotype: Ezh2 wildtype; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056659	Whole cell extract	Mus musculus	Genotype: Ezh2 knockout; Treatment: treated with 800 nM 4-hydroxy-tamoxifen for 96 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056660	anti-Suz12 (Abcam, ab12073)	Mus musculus	Treatment: No Tamoxifen; Genotype: Ezh2 wildtype; 	EXP056658	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056661	anti-Ezh2 (Cell Signaling, #3147)	Mus musculus	Treatment: No Tamoxifen; Genotype: Ezh2 wildtype; 	EXP056658	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056662	anti-Suz12 (Abcam, ab12073)	Mus musculus	Genotype: Ezh2 knockout; Treatment: treated with 800 nM 4-hydroxy-tamoxifen for 96 hours;	EXP056659	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056663	anti-Ezh2 (Cell Signaling, #3147)	Mus musculus	Genotype: Ezh2 knockout; Treatment: treated with 800 nM 4-hydroxy-tamoxifen for 96 hours;	EXP056659	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056664	anti-p300(Bethyl, A300-358A)	Mus musculus	Treatment: No Rnase;Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	NULL
EXP056665	anti-p300(Bethyl, A300-358A)	Mus musculus	Treatment: plus RNase; Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	NULL
EXP056666	anti-Suz12 (Abcam, ab12073)	Mus musculus	Treatment: No Rnase;Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056667	anti-Suz12 (Abcam, ab12073)	Mus musculus	Treatment: plus RNase; Genotype: Ezh2 fl/fl wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056668	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 6 weeks;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP056669	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 6 weeks;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP056670	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8 weeks;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP056671	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 6 weeks;	EXP056668	965	normal	Q9Z2D6	frontal cortex	NULL
EXP056672	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 6 weeks;	EXP056669	965	normal	Q9Z2D6	frontal cortex	NULL
EXP056673	Total MeCP2 antibody (Chen et al. 2003)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Age: 8 weeks;	EXP056670	965	normal	Q9Z2D6	frontal cortex	NULL
EXP056674	anti-MYO1C	Mus musculus	Passage: 20-25; Strain: C5;	NULL	12	normal	Q9WTI7	MEF (mouse embryonic fibroblasts)	NULL
EXP056675		Mus musculus	Genotype: Mecp2-/y, MECP2-EGFP; Age: 7 weeks;	NULL	2586	chip_control	NULL	hypothalamus	NULL
EXP056676	anti-GFP	Mus musculus	Genotype: Mecp2-/y, MECP2-EGFP; Age: 7 weeks;	EXP056675	2586	normal	Q9Z2D6	hypothalamus	NULL
EXP056677	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: non tag Flag; Treatment: none;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056678	Rabbit-IgG (ab37415; GR90135-1; Abcam)	Mus musculus	Genotype: Tip60-H3F; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056679	Rabbit-IgG (ab37415; GR90135-1; Abcam)	Mus musculus	Genotype: Tip60-H3F;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056680	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056681	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) for 9 hrs;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056682	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: Triptolide (TRI) for 4 hrs;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056683	anti-Flag-M2 (Sigma, F1804)	Mus musculus	Genotype: Tip60-H3F; Treatment: RNase H1 overexpression;	EXP056678	230	normal	Q8CHK4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056684	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	NULL
EXP056685	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) for 9 hrs;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	NULL
EXP056686	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: Triptolide (TRI) for 4 hrs;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	NULL
EXP056687	anti-p400 (A300-541A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: RNase H1 overexpression;	EXP056678	230	normal	Q8CHI8	ES-E14 (E14, embryonic stem cells)	NULL
EXP056688	Suz12 (A302-407A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056678	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056689	Suz12 (A302-407A; Bethyl)	Mus musculus		EXP056678	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056690	Suz12 (A302-407A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: untreated;	EXP056679	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056691	Suz12 (A302-407A; Bethyl)	Mus musculus	Genotype: Tip60-H3F; Treatment: RNase H1 overexpression;	EXP056679	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP056692	anti-Brg1	Mus musculus	Treatment: vehicle;	NULL	2809	normal	Q3TKT4	iBATs (immortalized brown adipocytes)	NULL
EXP056693	anti-Brg1	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	Q3TKT4	iBATs (immortalized brown adipocytes)	NULL
EXP056694	anti-Arid1a	Mus musculus	Treatment: vehicle;	NULL	2809	normal	A2BH40	iBATs (immortalized brown adipocytes)	NULL
EXP056695	anti-Arid1a	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	A2BH40	iBATs (immortalized brown adipocytes)	NULL
EXP056696	anti-Ppar-g	Mus musculus	Treatment: vehicle;	NULL	2809	normal	P37238	iBATs (immortalized brown adipocytes)	NULL
EXP056697	anti-Ppar-g	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	P37238	iBATs (immortalized brown adipocytes)	NULL
EXP056698	anti-Jmjd1a	Mus musculus	Treatment: vehicle;	NULL	2809	normal	Q6PCM1	iBATs (immortalized brown adipocytes)	NULL
EXP056699	anti-Jmjd1a	Mus musculus	Treatment: 1 uM isoproterenol for 2hrs;	NULL	2809	normal	Q6PCM1	iBATs (immortalized brown adipocytes)	NULL
EXP056700	none (input)	Mus musculus	Genotype: wildtype; Age: 8.5 months; Strain: C57BL6/CBA;	NULL	5	chip_control	NULL	liver	NULL
EXP056701	none (input)	Mus musculus	Genotype: wildtype; Age: 8.5 months; Strain: C57BL6/CBA;	NULL	5	chip_control	NULL	liver	NULL
EXP056702	Smyd3 antiserum (raised in-house in rabbits injected with full length recombinant Smyd3 protein)	Mus musculus	Genotype: wildtype; Age: 8.5 months; Strain: C57BL6/CBA;	EXP056700	5	normal	Q9CWR2	liver	NULL
EXP056703	Smyd3 antiserum (raised in-house in rabbits injected with full length recombinant Smyd3 protein)	Mus musculus	Genotype: wildtype; Age: 8.5 months; Strain: C57BL6/CBA;	EXP056701	5	normal	Q9CWR2	liver	NULL
EXP056704	-	Mus musculus		NULL	2810	chip_control	NULL	E14Tg2A derived mesoderm precursors	NULL
EXP056705	Mel18 (Santa Cruz, catalog: H-115-X, lot: D0903)	Mus musculus		NULL	233	normal	P23798	E14TG2A (embryonic stem cells)	NULL
EXP056706	Mel18 (Santa Cruz, catalog: H-115-X, lot: D0903)	Mus musculus		EXP056704	2810	normal	P23798	E14Tg2A derived mesoderm precursors	NULL
EXP056707	Cbx2 (Bethyl, catalog:A302-524A, lot: A302-524A-1)	Mus musculus		EXP056704	2810	normal	P30658	E14Tg2A derived mesoderm precursors	NULL
EXP056708	Ring1b (Home-made)	Mus musculus		EXP056704	2810	normal	Q9CQJ4	E14Tg2A derived mesoderm precursors	NULL
EXP056709	RYBP (Millipore, catalog: Ab3637, lot: 2066315)	Mus musculus		EXP056704	2810	normal	Q8CCI5	E14Tg2A derived mesoderm precursors	NULL
EXP056710	Brd2 (Bethyl A302-583A, lot 1)	Mus musculus	Genotype: wildtype; Treatment: none;	NULL	252	normal	Q7JJ13	V6.5 (embryonic stem cells)	NULL
EXP056711	Brd2 (Bethyl A302-583A, lot 1)	Mus musculus	Genotype: H2A.Z(WT)-YFP; Treatment: expressing wild type H2A.Z;	NULL	252	normal	Q7JJ13	V6.5 (embryonic stem cells)	NULL
EXP056712	Brd4 (Bethyl A301-985A50, lot 3)	Mus musculus	Genotype: H2A.Z(WT)-YFP; Treatment: expressing wild type H2A.Z;	NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP056713	Brd2 (Bethyl A302-583A, lot 1)	Mus musculus	Treatment: H2A.Z(K3R3)-YFP; Genotype: expressing a ubiquitin mutant version of H2A.Z;	NULL	252	normal	Q7JJ13	V6.5 (embryonic stem cells)	NULL
EXP056714	Brd4 (Bethyl A301-985A50, lot 3)	Mus musculus	Treatment: H2A.Z(K3R3)-YFP; Genotype: expressing a ubiquitin mutant version of H2A.Z;	NULL	252	normal	Q9ESU6	V6.5 (embryonic stem cells)	NULL
EXP056715	input	Mus musculus	Strain:FVB; Age: 84 days post partum; Genotype: Trim33 +/+;	NULL	32	chip_control	NULL	testis	NULL
EXP056716	Anti-Trim33 (Bethyl Laboratories, A301-060A)	Mus musculus	Strain:FVB; Age: 84 days post partum; Genotype: Trim33 +/+;	EXP056715	32	normal	Q99PP7	testis	NULL
EXP056717	none	Mus musculus	Strain: C5; Passage: 20-25;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056718	anti-beta-actin (clone AC74, Sigma Aldrich)	Mus musculus	Strain: C5; Passage: 20-25;	EXP056717	12	normal	P60710	MEF (mouse embryonic fibroblasts)	NULL
EXP056719	anti-WSTF (Abcam, ab50850)	Mus musculus	Strain: C5; Passage: 20-25;	EXP056717	12	normal	Q9Z277	MEF (mouse embryonic fibroblasts)	NULL
EXP056720	anti-SNF2h (Abcam, ab3749)	Mus musculus	Strain: C5; Passage: 20-25;	EXP056717	12	normal	Q91ZW3	MEF (mouse embryonic fibroblasts)	NULL
EXP056721	GATA1 (sc265)	Mus musculus	Strain: 129;	NULL	265	normal	P17679	G1E (embryonic stem cells)	NULL
EXP056722	GATA1 (sc265)	Mus musculus	Strain: 129; Treatment: none;	NULL	319	normal	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP056723	GATA1 (sc265)	Mus musculus	Strain: 129; Treatment: 3 hours with 10 nM beta-estradiol (Hardison);	NULL	319	normal	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP056724	GATA1 (sc265)	Mus musculus	Strain: 129; Treatment: 24 hours with 10 nM beta-estradiol (Hardison);	NULL	319	normal	P17679	G1E-ER4 (embryonic stem cells)	NULL
EXP056725	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: none; 	NULL	265	normal	P22091	G1E (embryonic stem cells)	NULL
EXP056726	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: none; 	NULL	319	normal	P22091	G1E-ER4 (embryonic stem cells)	NULL
EXP056727	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: 3 hours  with 10 nM beta-estradiol (Hardison)	NULL	319	normal	P22091	G1E-ER4 (embryonic stem cells)	NULL
EXP056728	TAL1 (sc12984)	Mus musculus	Strain: 129; Treatment: 24 hours  with 10 nM beta-estradiol (Hardison)	NULL	319	normal	P22091	G1E-ER4 (embryonic stem cells)	NULL
EXP056729	none (input)	Mus musculus	Genotype: CAG-CreER, Rosa26-SmoM2; 	NULL	2570	chip_control	NULL	medulloblastoma	NULL
EXP056730	anti-Brg1/Brm (J1, Khavari et al., 1993).	Mus musculus	Genotype: CAG-CreER, Rosa26-SmoM2; 	EXP056729	2570	normal	Q3TKT4	medulloblastoma	NULL
EXP056731	none	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	NULL	2812	chip_control	NULL	basal ganglia and septum	NULL
EXP056732	Normal Goat IgG (SC, catalog# 2028, lot# F1411)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	NULL	2812	chip_control	NULL	basal ganglia and septum	NULL
EXP056733	none	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	NULL	2812	chip_control	NULL	basal ganglia and septum	NULL
EXP056734	Normal Goat IgG (SC, catalog# 2028, lot# F1411)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	NULL	2812	chip_control	NULL	basal ganglia and septum	NULL
EXP056735	none	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	NULL	2812	chip_control	NULL	basal ganglia and septum	NULL
EXP056736	anti-OTX2 (R&D, catalog# AF1979, lot# KNO0211051)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	EXP056731	2812	normal	P80206	basal ganglia and septum	NULL
EXP056737	anti-OTX2 (R&D, catalog# AF1979, lot# KNO0211051)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	EXP056733	2812	normal	P80206	basal ganglia and septum	NULL
EXP056738	anti-OTX2 (R&D, catalog# AF1979, lot# KNO0211051)	Mus musculus	Developmental stage: E12.5; Genotype: wildtype; Strain: CD-1; 	EXP056735	2812	normal	P80206	basal ganglia and septum	NULL
EXP056739	none	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP056740	none	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; 	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP056741	none	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; Genotype: Ring1B I53A/I53A;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056742	none	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; Genotype: Ring1B I53A/I53A;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056743	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; 	EXP056739	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP056744	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; 	EXP056740	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP056745	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; Genotype: Ring1B I53A/I53A;	EXP056741	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056746	Ring1B (MBL D139-3)	Mus musculus	Strain: 129P2/OlaHsd; Sex: male; Genotype: Ring1B I53A/I53A;	EXP056742	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056747	anti-RING1B (Activ Motif 39664, Lot. 23012002)	Mus musculus	Developmental stage: E11.5; Strain: CD1;	NULL	2813	normal	Q9CQJ4	proximal forelimb bud	NULL
EXP056748	anti-RING1B (Activ Motif 39664, Lot. 23012002)	Mus musculus	Developmental stage: E11.5; Strain: CD1;	NULL	2814	normal	Q9CQJ4	distal forelimb bud	NULL
EXP056749	none	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	NULL	897	chip_control	NULL	fibroblasts	NULL
EXP056750	none	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 12; Tissue: dermis;	NULL	897	chip_control	NULL	fibroblasts	NULL
EXP056751	none	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	NULL	897	chip_control	NULL	fibroblasts	NULL
EXP056752	none	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 30; Tissue: dermis;	NULL	897	chip_control	NULL	fibroblasts	NULL
EXP056753	anti-Lap2a (8C10-1H11, hybridoma supernatant)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	Q61029	fibroblasts	NULL
EXP056754	anti-Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	P48678	fibroblasts	NULL
EXP056755	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	P48678	fibroblasts	NULL
EXP056756	Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056750	897	normal	P48678	fibroblasts	NULL
EXP056757	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056750	897	normal	P48678	fibroblasts	NULL
EXP056758	anti-Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056751	897	normal	P48678	fibroblasts	NULL
EXP056759	anti-Lmna (N18, Santa Cruz sc-6215)	Mus musculus	Genotype: Lap2alpha -/- (knockout); Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056752	897	normal	P48678	fibroblasts	NULL
EXP056760	Lap2alpha 8C10-1H11, hybridoma supernatant	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056751	897	normal	A1A546	fibroblasts	NULL
EXP056761	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus		EXP056751	897	normal	P48678	fibroblasts	NULL
EXP056762	anti-LaminA (3A6-4C11, Active Motif 39287)	Mus musculus		EXP056752	897	normal	P48678	fibroblasts	NULL
EXP056763	anti-LaminB1 (Proteintech, 12987-1-AP)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 12; Tissue: dermis;	EXP056749	897	normal	P14733	fibroblasts	NULL
EXP056764	anti-LaminB1 (Proteintech, 12987-1-AP)	Mus musculus	Genotype: Lap2alpha +/+; Developmental stage: sonication cyclesl 30; Tissue: dermis;	EXP056751	897	normal	P14733	fibroblasts	NULL
EXP056765		Mus musculus	Genotype: wildtype; 	NULL	2448	chip_control	NULL	46C (embryonic stem cell)	NULL
EXP056766	Anti-HA	Mus musculus	Genotype: Atad2 TAP-tag; 	EXP056765	2448	normal	Q8CDM1	46C (embryonic stem cell)	NULL
EXP056767		Mus musculus	Strain: CD1; 	NULL	2815	chip_control	NULL	mK4	NULL
EXP056768	anti-Notch1	Mus musculus	Strain: CD1; 	EXP056767	2815	normal	Q01705	mK4	NULL
EXP056769	anti-HA (sc-7392, Santa Cruz Biotechnology)	Mus musculus	Treatment: CRISPR and donor plasmids were co-transfected ; 	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP056770	anti-HA (sc-7392, Santa Cruz Biotechnology)	Mus musculus	Treatment: transient transfection of pCAG-HA-ZFP809 (isoform 2);	NULL	668	chip_control	NULL	ES-D3 embryonic stem cell-derived neurons	NULL
EXP056771	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056772	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056773	anti-HA (sc-7392, Santa Cruz Biotechnology)	Mus musculus	Treatment: CRISPR and donor plasmids were co-transfected ; 	EXP056769	292	normal	Q9QWF0	F9 (embryonal carcinoma)	NULL
EXP056774	anti-HA (sc-7392, Santa Cruz Biotechnology)	Mus musculus	Treatment: transient transfection of pCAG-HA-ZFP809 (isoform 2);	EXP056770	668	normal	G3X9G7	ES-D3 embryonic stem cell-derived neurons	NULL
EXP056775	Anti-Sumo2/3 (abcam, Cat #:ab3742, Lot:GR54180-2)	Mus musculus		EXP056771	230	normal	P61957	ES-E14 (E14, embryonic stem cells)	NULL
EXP056776	anti-KAP-1 (Affinity Purified,Â  1mg/ml, A300-274A,BETHYL)	Mus musculus		EXP056772	230	normal	Q62318	ES-E14 (E14, embryonic stem cells)	NULL
EXP056777		Mus musculus	Genotype: wild-type; Strain: B6.129P2(C)-Mecp2tm1.1Bird/J X C57BL/6J;	NULL	2929	chip_control	NULL	olfactory epithelium	NULL
EXP056778		Mus musculus	Genotype: wild-type; Strain: B6.129P2(C)-Mecp2tm1.1Bird/J X C57BL/6J;	NULL	2929	chip_control	NULL	olfactory epithelium	NULL
EXP056779	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Genotype: wild-type; Strain: B6.129P2(C)-Mecp2tm1.1Bird/J X C57BL/6J;	EXP056777	2929	normal	Q9Z2D6	olfactory epithelium	NULL
EXP056780	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Genotype: wild-type; Strain: B6.129P2(C)-Mecp2tm1.1Bird/J X C57BL/6J;	EXP056778	2929	normal	Q9Z2D6	olfactory epithelium	NULL
EXP056781	none	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP056782	none	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP056783	none	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP056784	BRD4 (A301-985A; Bethyl)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056781	2717	normal	Q9ESU6	RN2 (acute myeloid leukemia)	NULL
EXP056785	NSD3 (polyclonal antibody made in house raised against the peptide: PTDYYHSEIPNTRPHEC)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056781	2717	normal	Q6P2L6	RN2 (acute myeloid leukemia)	NULL
EXP056786	CHD8 (#A301-224A; Bethyl)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056781	2717	normal	Q09XV5	RN2 (acute myeloid leukemia)	NULL
EXP056787	CHD8 (#A301-224A; Bethyl)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056783	2717	normal	Q09XV5	RN2 (acute myeloid leukemia)	NULL
EXP056788	NSD3 (polyclonal antibody made in house raised against the peptide: PTDYYHSEIPNTRPHEC)	Mus musculus	Strain: C57BL/6; Source: MLL-AF9/NrasG12D murine cell line; Genotype: MLL-AF9/NrasG12D;	EXP056783	2717	normal	Q6P2L6	RN2 (acute myeloid leukemia)	NULL
EXP056789		Mus musculus	Genotype: Smarca4 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056790		Mus musculus	Genotype: Smarca4 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056791		Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056792		Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056793		Mus musculus	Genotype: wildtype; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056794		Mus musculus	Genotype: wildtype; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056795		Mus musculus	Genotype: wildtype; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056796		Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056797		Mus musculus	Genotype: Smarca4 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056798		Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056799	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Mus musculus	Genotype: wildtype; Strain: B6/129;	EXP056793	12	normal	P97496	MEF (mouse embryonic fibroblasts)	NULL
EXP056800	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Mus musculus	Genotype: wildtype; Strain: B6/129;	EXP056793	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	NULL
EXP056801	SMARCC1/BAF155 (Santa Cruz, R-8, sc-9746)	Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	EXP056791	12	normal	P97496	MEF (mouse embryonic fibroblasts)	NULL
EXP056802	SMARCA4/BRG1 (Abcam, EPNCIR111A, ab110641)	Mus musculus	Genotype: Smarcb1 knockout; Strain: B6/129;	EXP056792	12	normal	Q3TKT4	MEF (mouse embryonic fibroblasts)	NULL
EXP056803		Mus musculus	Genotype: wildtype; Strain: B6/129;	NULL	12	normal	A0A023J5X2	MEF (mouse embryonic fibroblasts)	NULL
EXP056804		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP056805	anti-Ring1B (home made)	Mus musculus		EXP056804	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP056806	anti-Dzip3 (home made)	Mus musculus		EXP056804	230	normal	Q7TPV2	ES-E14 (E14, embryonic stem cells)	NULL
EXP056807	none	Mus musculus	Developmental stage: E14; Treatment: Serum medium growth cells;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056808	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: 2i medium growth cells;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056809	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day3;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056810	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day3;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056811	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day 1;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056812	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: Serum growth cells switching to 2i medium day 1;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056813	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: Serum medium growth cells;	EXP056807	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056814	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: Serum medium growth cells;	EXP056807	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056815	Anti-Suz12 (ab1207, Abcam)	Mus musculus	Developmental stage: E14; Treatment: 2i medium growth cells;	EXP056808	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056816	Anti-Ring1B (D22F2, Cell Signaling)	Mus musculus	Developmental stage: E14; Treatment: 2i medium growth cells;	EXP056808	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056817	WCE	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	NULL	987	chip_control	NULL	hippocampus	NULL
EXP056818	WCE	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	NULL	987	chip_control	NULL	hippocampus	NULL
EXP056819	WCE	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	NULL	987	chip_control	NULL	hippocampus	NULL
EXP056820	WCE	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Age: P45;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP056821	WCE	Mus musculus	Strain: C57BL/6J; Genotype: Mecp2 knockout; Age: P45;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP056822	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	EXP056817	987	normal	O88895	hippocampus	NULL
EXP056823	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	EXP056818	987	normal	O88895	hippocampus	NULL
EXP056824	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; 	EXP056819	987	normal	O88895	hippocampus	NULL
EXP056825	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Age: P45;	EXP056820	987	normal	O88895	hippocampus	NULL
EXP056826	anti-HDAC3 (Abcam, ab7030)	Mus musculus	Strain: C57BL/6J; Genotype: Mecp2 knockout; Age: P45;	EXP056821	987	normal	O88895	hippocampus	NULL
EXP056827		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056828		Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP056829		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056830		Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP056831		Mus musculus		NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP056832		Mus musculus		NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP056833	anti-Leo1	Mus musculus		NULL	1153	normal	Q5XJE5	C2C12 (myoblasts)	NULL
EXP056834	anti-Leo1	Mus musculus		EXP056828	126	normal	Q5XJE5	C2C12 (myotubes)	NULL
EXP056835	anti-Paf1	Mus musculus		EXP056829	1153	normal	P55098	C2C12 (myoblasts)	NULL
EXP056836		Mus musculus		EXP056830	126	normal	P55098	C2C12 (myotubes)	NULL
EXP056837	anti-Rtf1	Mus musculus		EXP056831	1153	normal	A2AQ19	C2C12 (myoblasts)	NULL
EXP056838	anti-Rtf1	Mus musculus		EXP056832	126	normal	A2AQ19	C2C12 (myotubes)	NULL
EXP056839	none	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: 1 day of lactation;	NULL	572	chip_control	NULL	mammary gland	NULL
EXP056840	anti-MED1 (Bethyl lab, A300-793A)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: 1 day of lactation;	EXP056839	572	normal	Q925J9	mammary gland	NULL
EXP056841	Control IgG (Millipore 12-370)	Mus musculus	Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056842	Control IgG (Millipore 12-370)	Mus musculus	Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056843	Dnmt3b (ab122932)	Mus musculus	Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	EXP056841	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056844	Dnmt3b (ab122932)	Mus musculus	Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	EXP056842	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056845	Dnmt3b (ab122932)	Mus musculus	Treatment: control shRNA; Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056846	Dnmt3b (ab122932)	Mus musculus	Treatment: empry vector; Genotype: wildtype; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056847	Dnmt3b (ab122932)	Mus musculus	Treatment: Dnmt3b wildtype transfected; Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056848	Dnmt3b (ab122932)	Mus musculus	Treatment: Dnmt3b V725G wildtype transfected; Genotype: Dnmt3b knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056849	Dnmt3b (ab122932)	Mus musculus	Treatment: Setd2 shRNA; Genotype: Setd2 knockout; Developmental stage: E14; Strain: 129/Ola;	NULL	2	normal	O88509	mESCs (mouse embryonic stem cells)	NULL
EXP056850	Dnmt3a (Abcam ab13888, mouse)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/+); 	NULL	12	normal	O88508	MEF (mouse embryonic fibroblasts)	NULL
EXP056851	Dnmt3a (Abcam ab2850, rabbit)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/+); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP056852	Dnmt3a (Abcam ab13888, mouse)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/-); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP056853	Dnmt3a (Abcam ab2850, rabbit)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(+/-); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP056854	Dnmt3a (Abcam ab13888, mouse)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(-/m); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP056855	Dnmt3a (Abcam ab2850, rabbit)	Mus musculus	Strain: C57BL/6; Genotype: Dnmt3a(-/m); 	NULL	2268	normal	O88508	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP056856		Mus musculus		NULL	839	chip_control	NULL	TT2 (embryonic stem cells)	NULL
EXP056857		Mus musculus		NULL	213	chip_control	NULL	mesenchymal stem cells	NULL
EXP056858		Mus musculus		NULL	21	chip_control	NULL	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056859	anti-SETDB1	Mus musculus		EXP056856	839	normal	O88974	TT2 (embryonic stem cells)	NULL
EXP056860	anti-SETDB1	Mus musculus		EXP056857	213	normal	O88974	mesenchymal stem cells	NULL
EXP056861	anti-SETDB1	Mus musculus	Developmental stage: day 6 of differentiation; 	NULL	20	normal	O88974	3T3-L1-derived adipocytes	NULL
EXP056862	anti-SETDB1	Mus musculus	Treatment: control siRNA;	NULL	21	bio_control	O88974	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056863	anti-SETDB1	Mus musculus	Treatment: siRNA targeting Mbd1; Genotype: Mbd1 knockout;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056864	anti-SETDB1	Mus musculus	Treatment: siRNA targeting Mcaf1; Genotype: Mcaf1 knockout;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056865	anti-SETDB1	Mus musculus	Treatment: none;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056866	anti-SETDB1	Mus musculus	Treatment: siRNA targeting Setdb1; Genotype: Setdb1 knockout;	NULL	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056867	anti-SETDB1	Mus musculus		EXP056858	21	normal	O88974	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056868	anti-MBD1	Mus musculus		EXP056858	21	normal	Q9Z2E2	3T3-L1-derived preadipocytes and adipocytes	NULL
EXP056869	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	2930	chip_control	NULL	primary B220 B cells	NULL
EXP056870	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	2930	chip_control	NULL	primary B220 B cells	NULL
EXP056871	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP056872	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP056873	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	76	chip_control	NULL	Th1-cells	NULL
EXP056874	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	76	chip_control	NULL	Th1-cells	NULL
EXP056875	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP056876	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP056877	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	2742	chip_control	NULL	resting Th2 CD4+ T helper cells	NULL
EXP056878	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	2742	chip_control	NULL	resting Th2 CD4+ T helper cells	NULL
EXP056879	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	2930	chip_control	NULL	primary B220 B cells	NULL
EXP056880	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	2930	chip_control	NULL	primary B220 B cells	NULL
EXP056881	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP056882	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP056883	none	Mus musculus	Strain: C57BL/6;	NULL	2931	chip_control	NULL	B6N-22 (embryonic stem cell)	NULL
EXP056884	Mouse IgG1 Isotype Control Ab (Southern Biotech, catalog# 0102-01, lot# JC044-V877)	Mus musculus	Strain: C57BL/6;	NULL	2931	chip_control	NULL	B6N-22 (embryonic stem cell)	NULL
EXP056885	none	Mus musculus	Strain: C57BL/6;	NULL	2931	chip_control	NULL	B6N-22 (embryonic stem cell)	NULL
EXP056886	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	1058	chip_control	NULL	CD4+ T-cells	NULL
EXP056887	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP056888	none	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6; Treatment: 10 nM TSA;	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP056889	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056869	2930	normal	P25916	primary B220 B cells	NULL
EXP056890	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056869	2930	normal	O88559	primary B220 B cells	NULL
EXP056891	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056871	1058	normal	P25916	CD4+ T-cells	NULL
EXP056892	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056871	1058	normal	O88559	CD4+ T-cells	NULL
EXP056893	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056873	76	normal	P25916	Th1-cells	NULL
EXP056894	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056873	76	normal	O88559	Th1-cells	NULL
EXP056895	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056875	499	normal	P25916	Th2-cells	NULL
EXP056896	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056875	499	normal	O88559	Th2-cells	NULL
EXP056897	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056877	2742	normal	P25916	resting Th2 CD4+ T helper cells	NULL
EXP056898	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056877	2742	normal	O88559	resting Th2 CD4+ T helper cells	NULL
EXP056899	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056880	2930	normal	Q61188	primary B220 B cells	NULL
EXP056900	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056881	1058	normal	Q61188	CD4+ T-cells	NULL
EXP056901	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Strain: C57BL/6;	EXP056883	2931	normal	Q61188	B6N-22 (embryonic stem cell)	NULL
EXP056902	Bmi1 (Santa Cruz, catalog# sc-10745, lot#  K1008)	Mus musculus	Strain: C57BL/6;	NULL	2931	normal	P25916	B6N-22 (embryonic stem cell)	NULL
EXP056903	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Strain: C57BL/6;	NULL	2931	normal	O88559	B6N-22 (embryonic stem cell)	NULL
EXP056904	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Strain: C57BL/6;	EXP056885	2931	normal	Q61188	B6N-22 (embryonic stem cell)	NULL
EXP056905	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Strain: C57BL/6;	EXP056885	2931	normal	O88559	B6N-22 (embryonic stem cell)	NULL
EXP056906	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056886	1058	normal	Q61188	CD4+ T-cells	NULL
EXP056907	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056871	1058	normal	O88559	CD4+ T-cells	NULL
EXP056908	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056887	499	normal	Q61188	Th2-cells	NULL
EXP056909	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6;	EXP056887	499	normal	O88559	Th2-cells	NULL
EXP056910	Ezh2 (Diagenode, catalog# pAb-039-050, lot# 001)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6; Treatment: 10 nM TSA;	EXP056888	499	normal	Q61188	Th2-cells	NULL
EXP056911	Menin (Bethyl, catalog# A300-105A, lot#  A300-105A-1)	Mus musculus	Age: 6-8 week old mice; Strain: C57BL/6; Treatment: 10 nM TSA;	EXP056888	499	normal	O88559	Th2-cells	NULL
EXP056912	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: (PWDxB6)F1; Genotype: PWD/Humanized;	NULL	2932	chip_control	NULL	whole adult testis	NULL
EXP056913	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Genotype: B6/Humanized; Strain: C57BL/6J;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056914	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Genotype: Humanized/Humanized; Strain: C57BL/6J;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056915	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Genotype: PWD/PWD; Strain: PWD/PhJ;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056916	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: PWD/B6;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056917	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: PWD/Humanized;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056918	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: B6/PWD;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056919	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: Humanized/PWD;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056920	anti-DMC1 (Santa Cruz C-20, sc-8973)	Mus musculus	Strain: PWDB6F1; Genotype: B6/CAST;	NULL	2932	normal	Q61880	whole adult testis	NULL
EXP056921	anti-DDX5 (Abcam, ab10261, #GR101334-5)	Mus musculus	Genotype: DX5+/+, CD4Cre+; Strain: C57BL/6; Age: 6-8 weeks;	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP056922	N/A	Mus musculus	Genotype: DDX5 knockout, CD4Cre+; Strain: C57BL/6; Age: 6-8 weeks;	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP056923	anti-DDX5 (Abcam, ab10261, #GR101334-5)	Mus musculus	Genotype: DX5+/+, CD4Cre+; Strain: C57BL/6; Age: 6-8 weeks;	EXP056921	498	normal	Q61656	Th17-cells	NULL
EXP056924	anti-DDX5 (Abcam, ab10261, #GR101334-5)	Mus musculus	Genotype: DX5+/+, CD4Cre+; Strain: C57BL/6; Age: 6-8 weeks;	EXP056922	498	normal	Q61656	Th17-cells	NULL
EXP056925	anti-FLAG antibody (Sigma F3165)	Mus musculus		NULL	230	normal	Q8K3Y3	ES-E14 (E14, embryonic stem cells)	NULL
EXP056926	none (INPUT)	Mus musculus	Genotype: BRG-FLAG; 	NULL	1027	chip_control	NULL	P0 retina	NULL
EXP056927	anti-FLAG	Mus musculus	Genotype: BRG-FLAG; 	EXP056926	1027	normal	Q3TKT4	P0 retina	NULL
EXP056928	none	Mus musculus	Strain: R1; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056929	none	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP056930	anti-Suz12 (Abcam, ab12073)	Mus musculus	Strain: R1; 	EXP056928	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056931	anti-Ezh2 (Diagenode, pAB-039-050)	Mus musculus	Strain: R1; 	EXP056928	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056932	anti-Ring1b (D22F2, Cell Signaling)	Mus musculus	Strain: R1; 	EXP056928	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056933	anti-Pcgf2 (sc-10744x, Santa Cruz)	Mus musculus	Strain: R1; 	EXP056928	2	normal	P23798	mESCs (mouse embryonic stem cells)	NULL
EXP056934	anti-Suz12 (Abcam, ab12073)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP056935	anti-Ezh2 (Diagenode, pAB-039-050)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	Q61188	mESCs (mouse embryonic stem cells)	NULL
EXP056936	anti-Ring1b (D22F2, Cell Signaling)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056937	anti-Pcgf2 (sc-10744x, Santa Cruz)	Mus musculus	Strain: R1; Source: ES-derived neural progenitor cells;	EXP056929	2	normal	P23798	mESCs (mouse embryonic stem cells)	NULL
EXP056938	anti-GFP (abcam, ab290)	Mus musculus	Strain: R1; 	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP056939	none	Mus musculus	Treatment: DMSO for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP056940	none	Mus musculus	Treatment: 500nM JQ1 for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	NULL	2717	chip_control	NULL	RN2 (acute myeloid leukemia)	NULL
EXP056941	anti-Brd4 (A301-985A, Bethyl)	Mus musculus	Treatment: DMSO for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056939	2717	normal	Q9ESU6	RN2 (acute myeloid leukemia)	NULL
EXP056942	anti-Brd4 (A301-985A, Bethyl)	Mus musculus	Treatment: 500nM JQ1 for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056940	2717	normal	Q9ESU6	RN2 (acute myeloid leukemia)	NULL
EXP056943	anti-Med1 (A300-793A, Bethyl)	Mus musculus	Treatment: none; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	NULL	2717	normal	Q925J9	RN2 (acute myeloid leukemia)	NULL
EXP056944	anti-Med1 (A300-793A, Bethyl)	Mus musculus	Treatment: DMSO for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056939	2717	normal	Q925J9	RN2 (acute myeloid leukemia)	NULL
EXP056945	anti-Med1 (A300-793A, Bethyl)	Mus musculus	Treatment: 500nM JQ1 for 2 hours; Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; 	EXP056940	2717	normal	Q925J9	RN2 (acute myeloid leukemia)	NULL
EXP056946	None	Mus musculus	Genotype: BCR-ABL1 overexpressed p19 null; Strain: C57BL/6J; 	NULL	2933	chip_control	NULL	pre-B cell leukemia	NULL
EXP056947	anti-PHF6 (A301-451A, Bethyl)	Mus musculus	Genotype: BCR-ABL1 overexpressed p19 null; Strain: C57BL/6J; 	EXP056946	2933	normal	Q9D4J7	pre-B cell leukemia	NULL
EXP056948	n/a	Mus musculus	Maternal strain: B10.F-H2pb1/(13R)J; Paternal strain: C57Bl/6J;	NULL	32	chip_control	NULL	testis	NULL
EXP056949	n/a	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	chip_control	NULL	testis	NULL
EXP056950	n/a	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: CAST/EiJ;	NULL	32	chip_control	NULL	testis	NULL
EXP056951	n/a	Mus musculus	Maternal strain: CAST/EiJ; Paternal strain: C57Bl/6J;	NULL	32	chip_control	NULL	testis	NULL
EXP056952	n/a	Mus musculus	Maternal strain: B10.F-H2pb1/(13R)J; Paternal strain: B10.S-H2t4/(9R)/J;	NULL	32	chip_control	NULL	testis	NULL
EXP056953	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: B10.F-H2pb1/(13R)J; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	NULL
EXP056954	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: B10.F-H2pb1/(13R)J; Paternal strain: C57Bl/6J;	EXP056948	32	normal	Q61880	testis	NULL
EXP056955	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	NULL
EXP056956	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: C3H/HeJ;	NULL	32	normal	Q61880	testis	NULL
EXP056957	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: PWD/PhJ;	NULL	32	normal	Q61880	testis	NULL
EXP056958	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: B10.F-H2pb1/(13R)J;	EXP056949	32	normal	Q61880	testis	NULL
EXP056959	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: CAST/EiJ;	EXP056950	32	normal	Q61880	testis	NULL
EXP056960	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056961	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: C3H/HeJ;	NULL	32	normal	Q61880	testis	NULL
EXP056962	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C57Bl/6J; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	NULL
EXP056963	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	NULL
EXP056964	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: CAST/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056965	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: C3H/HeJ; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056966	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ; Paternal strain: CAST/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056967	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	NULL
EXP056968	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056969	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: CAST/EiJ Paternal strain: C57Bl/6J;	EXP056951	32	normal	Q61880	testis	NULL
EXP056970	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: MOLF/EiJ; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056971	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: MOLF/EiJ; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	NULL
EXP056972	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: MOLF/EiJ; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	NULL
EXP056973	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: PWD/PhJ;	NULL	32	normal	Q61880	testis	NULL
EXP056974	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: B10.F-H2pb1/(13R)J;	NULL	32	normal	Q61880	testis	NULL
EXP056975	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	NULL
EXP056976	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: C3H/HeJ;	NULL	32	normal	Q61880	testis	NULL
EXP056977	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: CAST/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056978	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: PWD/PhJ; Paternal strain: MOLF/EiJ;	NULL	32	normal	Q61880	testis	NULL
EXP056979	Anti-DMC1 (Santa Cruz C-20, sc 8973)	Mus musculus	Maternal strain: B6;129P2-Prdm9<tm1Ymat>/J; Paternal strain: B6;129P2-Prdm9<tm1Ymat>/J;	NULL	32	normal	Q61880	testis	NULL
EXP056980	none (input)	Mus musculus		NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP056981	p300 (santa cruz sc-585 X, lot j2214)	Mus musculus	Treatment: shMed12; Genotype: Med12 knokout;	NULL	445	normal	B2RWS6	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP056982	p300 (santa cruz sc-585 X, lot j2214)	Mus musculus	Treatment: shSCR;	NULL	445	normal	B2RWS6	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP056983	Med12 (bethyl-A300-774A, lot 1)	Mus musculus		EXP056980	445	normal	A2AGH6	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP056984	p300 (santa cruz sc-585 X, lot j2214)	Mus musculus		EXP056980	445	normal	B2RWS6	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP056985		Mus musculus	Genotype: overexpressing HA-tagged Fbxl10; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056986		Mus musculus	Genotype: overexpressing HA-tagged Fbxl10;  Treatment: 1 ug/ml doxycycline for 48hrs;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP056987	anti-HA antibody (ab9110, Abcam)	Mus musculus	Genotype: overexpressing HA-tagged Fbxl10; 	EXP056985	12	normal	Q6P1G2	MEF (mouse embryonic fibroblasts)	NULL
EXP056988	anti-HA antibody (ab9110, Abcam)	Mus musculus	Genotype: overexpressing HA-tagged Fbxl10;  Treatment: 1 ug/ml doxycycline for 48hrs;	EXP056986	12	normal	Q6P1G2	MEF (mouse embryonic fibroblasts)	NULL
EXP056989	none	Mus musculus	Treatment: unstimulated;	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056990	none	Mus musculus	Treatment: 100 ng\\mL LPS for 2 hrs;	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056991	none	Mus musculus	Treatment: unstimulated; Genotype: FLAG-AF9;	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056992	none	Mus musculus	Treatment: 100 ng\\mL LPS for 2 hrs; Genotype: FLAG-AF9;	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056993	none	Mus musculus	Genotype: FLAG-AF9; reatment: Crotonate pre-treatment, 10mM sodium crotonate for 16 hrs prior to 100 ng\\mL LPS for 2 hrs;	NULL	91	chip_control	NULL	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056994	AF9 (Sigma HPA001824)	Mus musculus	Treatment: unstimulated;	EXP056989	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056995	AF9 (Sigma HPA001824)	Mus musculus	Treatment: 100 ng\\mL LPS for 2 hrs;	EXP056990	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056996	anti-FLAG-M2 (Sigma F1804)	Mus musculus	Treatment: unstimulated; Genotype: FLAG-AF9;	EXP056991	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056997	anti-FLAG-M2 (Sigma F1804)	Mus musculus	Treatment: 100 ng\\mL LPS for 2 hrs; Genotype: FLAG-AF9;	EXP056992	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056998	anti-FLAG-M2 (Sigma F1804)	Mus musculus	Genotype: FLAG-AF9; Treatment: Crotonate pre-treatment, 10mM sodium crotonate for 16 hrs prior to 100 ng\\mL LPS for 2 hrs;	EXP056993	91	normal	A2AM29	RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages)	NULL
EXP056999	Input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057000	Input	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057001	Input	Mus musculus		NULL	237	chip_control	NULL	embryoid body	NULL
EXP057002	Input	Mus musculus		NULL	237	chip_control	NULL	embryoid body	NULL
EXP057003	anti-Brd4 (Abcam 128874)	Mus musculus		EXP056999	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	NULL
EXP057004	anti-Brd4 (Abcam 128874)	Mus musculus		EXP057000	2	normal	Q9ESU6	mESCs (mouse embryonic stem cells)	NULL
EXP057005	anti-Brd4 (Abcam 128874)	Mus musculus		EXP057001	237	normal	Q9ESU6	embryoid body	NULL
EXP057006	anti-Brd4 (Abcam 128874)	Mus musculus		EXP057002	237	normal	Q9ESU6	embryoid body	NULL
EXP057007	none	Mus musculus	Genotype: wildtype; Passage: 13-19; 	NULL	2934	chip_control	NULL	MPI-II (embryonic stem cell)	NULL
EXP057008	anti-DEDAF (Millipore, AB3637, lot 2426983)	Mus musculus	Genotype: wildtype; Passage: 13-19; 	EXP057007	2934	normal	Q8CCI5	MPI-II (embryonic stem cell)	NULL
EXP057009	none	Mus musculus	Strain: C57BL/6;	NULL	2935	chip_control	NULL	CAD (undifferentiated neurons)	NULL
EXP057010	none	Mus musculus	Strain: C57BL/6;	NULL	2936	chip_control	NULL	CAD differentiated neurons	NULL
EXP057011	anti-ACSS2 (Cell Signaling 3658, lot# 1)	Mus musculus	Strain: C57BL/6;	NULL	2935	normal	Q9QXG4	CAD (undifferentiated neurons)	NULL
EXP057012	anti-ACSS2 (Thermo MA5-145810, lot# QD2005961)	Mus musculus	Strain: C57BL/6;	NULL	2935	normal	Q9QXG4	CAD (undifferentiated neurons)	NULL
EXP057013	anti-ACSS2 (Cell Signaling 3658, lot# 1)	Mus musculus	Strain: C57BL/6;	EXP057010	2936	normal	Q9QXG4	CAD differentiated neurons	NULL
EXP057014	anti-ACSS2 (Thermo MA5-145810, lot# QD2005961)	Mus musculus	Strain: C57BL/6;	EXP057010	2936	normal	Q9QXG4	CAD differentiated neurons	NULL
EXP057015		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype:  expressing E861K Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057016		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing E882K Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057017		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing G784E Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057018		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing K785R Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057019		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing R885H Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057020		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing wildtype Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057021		Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing Y860H Smarca4V5; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057022		Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Arid1a knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057023		Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Arid1a knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057024		Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057025		Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057026	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Arid1a knockout;	EXP057022	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057027	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Arid1a knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057028	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype:  expressing E861K Smarca4V5; Passage: 15-20;	EXP057015	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057029	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing E882K Smarca4V5; Passage: 15-20;	EXP057016	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057030	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing G784E Smarca4V5; Passage: 15-20;	EXP057017	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057031	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing K785R Smarca4V5; Passage: 15-20;	EXP057018	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057032	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing R885H Smarca4V5; Passage: 15-20;	EXP057019	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057033	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing wildtype Smarca4V5; Passage: 15-20;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057034	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing Y860H Smarca4V5; Passage: 15-20;	EXP057021	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057035	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057036	anti-Ring1b (Cell Signaling, 5694, Lot 1 (Ref: 09/2014))	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057037	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Arid1a knockout;	EXP057022	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057038	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Arid1a knockout;	EXP057023	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057039	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057024	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057040	anti-Suz12 (Active Motif, 39357, Lot 29111002)	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057025	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057041	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: ethanol (EtOH) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057024	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP057042	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: 0.8 uM 4-hydroxytamoxifen (Tam) for 48 hrs; Genotype: Smarca4 knockout; Passage: 15-20;	EXP057025	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP057043	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing wildtype Smarca4V5; Passage: 15-20;	EXP057020	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP057044	anti-Cbx7 (Abcam, ab21873, #GR255463-2)	Mus musculus	Strain: 129SvEv; Treatment: none; Genotype: expressing G784E Smarca4V5; Passage: 15-20;	EXP057017	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP057045		Mus musculus	Treatment: 10 uM SB-431542 overnight, 1 hr Media replacement containing 10 ?M SB-431542; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057046		Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 1 hr 20 ng/ml Activin A; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057047		Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 8 hr 20 ng/ml Activin A; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057048		Mus musculus	Treatment: none; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057049	Invitrogen prot A dynabeads	Mus musculus	Treatment: none;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057050		Mus musculus	Treatment: 10 uM SB-431542 overnight, 1 hr Media replacement containing 10 ?M SB-431542; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057051		Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 1 hr 20 ng/ml Activin A; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057052		Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 8 hr 20 ng/ml Activin A; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057053		Mus musculus	Treatment: none; Passage: p19;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057054	Invitrogen prot A dynabeads	Mus musculus	Treatment: none;	NULL	2937	chip_control	NULL	embryonic teratoma	NULL
EXP057055	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight, 1 hr Media replacement containing 10 ?M SB-431542; Passage: p19;	EXP057045	2937	normal	Q62432	embryonic teratoma	NULL
EXP057056	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 1 hr 20 ng/ml Activin A; Passage: p19;	EXP057046	2937	normal	Q62432	embryonic teratoma	NULL
EXP057057	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 8 hr 20 ng/ml Activin A; Passage: p19;	EXP057047	2937	normal	Q62432	embryonic teratoma	NULL
EXP057058	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: none; Passage: p19;	EXP057048	2937	normal	Q62432	embryonic teratoma	NULL
EXP057059	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight, 1 hr Media replacement containing 10 ?M SB-431542; Passage: p19;	EXP057050	2937	normal	Q62432	embryonic teratoma	NULL
EXP057060	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 1 hr 20 ng/ml Activin A; Passage: p19;	EXP057051	2937	normal	Q62432	embryonic teratoma	NULL
EXP057061	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: 10 uM SB-431542 overnight + washout, replacement of fresh media containing 8 hr 20 ng/ml Activin A; Passage: p19;	EXP057052	2937	normal	Q62432	embryonic teratoma	NULL
EXP057062	SMAD2 (Cell signaling 5339)	Mus musculus	Treatment: none; Passage: p19;	EXP057053	2937	normal	Q62432	embryonic teratoma	NULL
EXP057063	none	Mus musculus	Strain: C57BL/6; Genotype: Rag2 knockout;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP057064	anti-Setdb1 (Santa Cruz, SC-66884X)	Mus musculus	Strain: C57BL/6; Genotype: Rag2 knockout;	NULL	105	normal	O88974	pro-B cells	NULL
EXP057065	anti-Setdb1 (Themo Scientific, PA5-30334)	Mus musculus	Strain: C57BL/6; Genotype: Rag2 knockout;	NULL	105	normal	O88974	pro-B cells	NULL
EXP057066	None	Mus musculus	Stage: E12.5; Strain: C57BL/6;	NULL	247	chip_control	NULL	embryonic heart	NULL
EXP057067	Sap130 (A302-491A: Bethyl laboratories)	Mus musculus	Stage: E12.5; Strain: C57BL/6;	EXP057066	247	normal	Q8BIH0	embryonic heart	NULL
EXP057068		Mus musculus	Growth conditions: quiescence via serum-deprivation; Developmental stage: E13.5; Passage: 4;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP057069		Mus musculus	Genotype: mutant Rb; Growth conditions: quiescence via serum-deprivation; Developmental stage: E13.5; Passage: 4;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP057070	Ezh2 (Cell signalling, 5264)	Mus musculus	Growth conditions: quiescence via serum-deprivation; Developmental stage: E13.5; Passage: 4;	EXP057068	12	normal	Q61188	MEF (mouse embryonic fibroblasts)	NULL
EXP057071	Ezh2 (Cell signalling, 5264)	Mus musculus	Genotype: mutant Rb; Growth conditions: quiescence via serum-deprivation; Developmental stage: E13.5; Passage: 4;	EXP057069	12	normal	Q61188	MEF (mouse embryonic fibroblasts)	NULL
EXP057072	none	Mus musculus	Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; Treatment: none Doxycycline, shRNA against MED12;	NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP057073	none	Mus musculus	Genotype: MLL-AF9/NrasG12D, MED12 knockout; Strain: C57BL/6; Treatment: Doxycycline, shRNA against MED12;	NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP057074	none	Mus musculus	Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; Treatment: none Doxycycline, shRNA against MED23;	NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP057075	none	Mus musculus	Genotype: MLL-AF9/NrasG12D, MED12 knockout; Strain: C57BL/6; Treatment: Doxycycline, shRNA against MED23;	NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP057076	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; Treatment: none Doxycycline, shRNA against MED12;	EXP057072	1493	normal	Q9ESU6	acute myeloid leukemia	NULL
EXP057077	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D, MED12 knockout; Strain: C57BL/6; Treatment: Doxycycline, shRNA against MED12;	EXP057073	1493	normal	Q9ESU6	acute myeloid leukemia	NULL
EXP057078	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D; Strain: C57BL/6; Treatment: none Doxycycline, shRNA against MED23;	EXP057074	1493	normal	Q9ESU6	acute myeloid leukemia	NULL
EXP057079	Brd4 (A301-985A; Bethyl)	Mus musculus	Genotype: MLL-AF9/NrasG12D, MED12 knockout; Strain: C57BL/6; Treatment: Doxycycline, shRNA against MED23;	EXP057075	1493	normal	Q9ESU6	acute myeloid leukemia	NULL
EXP057080	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP057081	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP057082	none	Mus musculus		NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP057083	anti-MORC3 antibody (100-401-N96S, Rockland)	Mus musculus		EXP057080	252	normal	F7BJB9	V6.5 (embryonic stem cells)	NULL
EXP057084	anti-MORC3 antibody (100-401-N96S, Rockland)	Mus musculus		EXP057081	252	normal	F7BJB9	V6.5 (embryonic stem cells)	NULL
EXP057085	anti-MORC3 antibody (100-401-N96S, Rockland)	Mus musculus		EXP057082	252	normal	F7BJB9	V6.5 (embryonic stem cells)	NULL
EXP057086	none (input)	Mus musculus	Developmental stage: E3.5; Passage: 15-20;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP057087	anti-Lsd1 (20752)	Mus musculus	Developmental stage: E3.5; Passage: 15-20;	EXP057086	96	normal	Q6ZQ88	trophoblast stem cells	NULL
EXP057088	input	Mus musculus	Treatment: phenyhydrazine treated ; Tissue: spleen;  Strain: C57Bl6;	NULL	267	chip_control	NULL	erythroid cells	NULL
EXP057089	anti-Med1	Mus musculus	Treatment: phenyhydrazine treated ; Tissue: spleen;  Strain: C57Bl6;	EXP057088	267	normal	Q925J9	erythroid cells	NULL
EXP057090	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057091	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057092	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057093	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057094	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057095	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057096	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057097	None	Mus musculus	Treatment: none;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057098	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057090	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057099	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057091	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057100	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057092	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057101	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #1; Genotype: Wapal depletion;	EXP057093	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057102	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057094	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057103	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057095	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057104	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057096	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057105	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Wapal shRNA #2; Genotype: Wapal depletion;	EXP057097	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057106	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057090	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057107	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057091	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057108	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057092	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057109	anti-Ring1b (Active Motif 39664)	Mus musculus	Treatment: Empty Vector control shRNA; Genotype: control empty vector;	EXP057093	216	normal	Q9CQJ4	differentiated embryonic stem cells	NULL
EXP057110	none	Mus musculus	Age: adult, 10-12 weeks old;	NULL	898	chip_control	NULL	pancreatic islets	NULL
EXP057111	anti-Kat2b (Abcam, ab12188)	Mus musculus	Age: adult, 10-12 weeks old;	EXP057110	898	normal	Q9JHD1	pancreatic islets	NULL
EXP057112	none	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP057113	none	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP057114	none	Mus musculus		NULL	2939	chip_control	NULL	NSC cells derived by differentiation of J1 ESC	NULL
EXP057115	anti-Cbx2 (Santa Cruz, sc-19297)	Mus musculus		EXP057112	506	normal	P30658	J1 (embryonic stem cells)	NULL
EXP057116	anti-Ezh2(D2C9) (Cell Signaling, 5246S)	Mus musculus		EXP057112	506	normal	Q61188	J1 (embryonic stem cells)	NULL
EXP057117	anti-RNF2 (Bethyl, A302-869A)	Mus musculus		EXP057113	506	normal	Q9CQJ4	J1 (embryonic stem cells)	NULL
EXP057118	anti-RNF2 (Bethyl, A302-869A)	Mus musculus		EXP057114	2939	normal	Q9CQJ4	NSC cells derived by differentiation of J1 ESC	NULL
EXP057119	anti-Elongin B (abcam, ab168836)	Mus musculus		NULL	2	normal	P62869	mESCs (mouse embryonic stem cells)	NULL
EXP057120	anti-Elongin B (abcam, ab168836)	Mus musculus	Genotype: Elongin B knockout;	NULL	2	normal	P62869	mESCs (mouse embryonic stem cells)	NULL
EXP057121	none (input)	Mus musculus	Age: 4-months old;  Genotype: HDAC3 wildtype; Strain: C57B/6;	NULL	2940	chip_control	NULL	quadriceps muscle	NULL
EXP057122	none (input)	Mus musculus	Age: 4-months old;  Genotype: HDAC3 wildtype; Strain: C57B/6;	NULL	2940	chip_control	NULL	quadriceps muscle	NULL
EXP057123	none (input)	Mus musculus	Age: 4-months old;  Genotype: HDAC3 Knock-out; Strain: C57B/6;	NULL	2940	chip_control	NULL	quadriceps muscle	NULL
EXP057124	anti-HDAC3	Mus musculus	Age: 4-months old;  Genotype: HDAC3 wildtype; Strain: C57B/6;	EXP057121	2940	normal	O88895	quadriceps muscle	NULL
EXP057125	anti-HDAC3	Mus musculus	Age: 4-months old;  Genotype: HDAC3 wildtype; Strain: C57B/6;	EXP057122	2940	normal	O88895	quadriceps muscle	NULL
EXP057126	anti-HDAC3	Mus musculus	Age: 4-months old;  Genotype: HDAC3 Knock-out; Strain: C57B/6;	EXP057123	2940	normal	O88895	quadriceps muscle	NULL
EXP057127		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057128		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057129		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057130		Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057131		Mus musculus	Genotype: Mbd3abc-FLAG;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057132		Mus musculus	Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057133		Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057134		Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057135		Mus musculus	Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057136	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: EGFP knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057137	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: EGFP knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057138	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Dnmt1 knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057139	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Dnmt1 knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057140	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Tet1 knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057141	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Tet1 knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057142	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Mbd3 knockout;	EXP057127	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057143	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: Mbd3 knockout;	EXP057128	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057144	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: EGFP knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057145	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: EGFP knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057146	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Dnmt1 knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057147	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Dnmt1 knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057148	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Tet1 knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057149	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Tet1 knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057150	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Mbd2 knockout;	EXP057129	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057151	Mbd3 antibody (Bethyl) 	Mus musculus	Genotype: Mbd2 knockout;	EXP057130	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057152	anti-Flag M2 (Sigma F1804)	Mus musculus	Genotype: EGFP knockout,  Mbd3abc-FLAG;	EXP057131	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057153	anti-Flag M2 (Sigma F1804)	Mus musculus	Genotype: Dnmt1 knockout,  6XHIS-3XFLAG tag-Mbd3abc;	EXP057131	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057154		Mus musculus	Genotype: Tet1 knockout,  Genotype: Dnmt1 knockout,  6XHIS-3XFLAG tag-Mbd3abc;;	EXP057131	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057155	Mbd2 antibody (Bethyl)	Mus musculus		EXP057132	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057156	Mbd3 antibody (Bethyl)	Mus musculus		EXP057132	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057157	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057133	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057158	Mbd2 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057134	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057159	Mbd3 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057133	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057160	Mbd3 antibody (Bethyl)	Mus musculus	Genotype: two point mutations in catalytic domain of Tet1;	EXP057134	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057161	Dnmt1 antibody (bethyl)	Mus musculus	Genotype: wildtype; 	EXP057135	230	normal	P13864	ES-E14 (E14, embryonic stem cells)	NULL
EXP057162	Dnmt1 antibody (bethyl)	Mus musculus	Genotype: Dnmt1 knockout; 	EXP057135	230	normal	P13864	ES-E14 (E14, embryonic stem cells)	NULL
EXP057163	Dnmt1 antibody (bethyl)	Mus musculus	Genotype: Mbd3 knockout;	EXP057135	230	normal	P13864	ES-E14 (E14, embryonic stem cells)	NULL
EXP057164	none	Mus musculus	Strain: CD1; Developmental stage: E12.5;  Genotype: wildtype;	NULL	247	chip_control	NULL	embryonic heart	NULL
EXP057165	anti-HIRA (WC15 )	Mus musculus	Strain: CD1; Developmental stage: E12.5;  Genotype: wildtype;	EXP057164	247	normal	Q61666	embryonic heart	NULL
EXP057166	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057167	anti-Flag(Sigma,  F3165)	Mus musculus		EXP057166	230	normal	Q9QZL6	ES-E14 (E14, embryonic stem cells)	NULL
EXP057168	anti-NCAPH2 (Bethyl, A302-275A)	Mus musculus	Treatment: shTFIIIC; Genotype: TFIIIC knockout;	NULL	252	normal	Q8BSP2	V6.5 (embryonic stem cells)	NULL
EXP057169	anti-NCAPH2 (Bethyl, A302-275A)	Mus musculus	Treatment: shGFP;	NULL	252	normal	Q8BSP2	V6.5 (embryonic stem cells)	NULL
EXP057170	none	Mus musculus		NULL	2941	chip_control	NULL	N2A (neuroblastoma)	NULL
EXP057171	Nacc1 antibody (abcam,ab29047)	Mus musculus		EXP057170	2941	normal	Q7TSZ8	N2A (neuroblastoma)	NULL
EXP057172	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA (Luc control);	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057173	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA H2A.Z; Genotype: H2A.Z knockdown;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057174	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA Osr; Genotype: Osr1 knockdown;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057175	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA (Luc control);	EXP057172	675	normal	Q9WVG7	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057176	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA H2A.Z; Genotype: H2A.Z knockdown;	EXP057173	675	normal	Q9WVG7	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057177	anti-Osr1 (Santa Cruz, catalog# sc68392, GA8165)	Mus musculus	Treatment: shRNA Osr; Genotype: Osr1 knockdown;	EXP057174	675	normal	Q9WVG7	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057178	none	Mus musculus	Strain: C57BL/6; Genotype: Lgr5Gfp-CreERT2;	NULL	195	chip_control	NULL	crypt cells	NULL
EXP057179	anti-Suz12	Mus musculus	Strain: C57BL/6; Genotype: Lgr5Gfp-CreERT2;	EXP057178	195	normal	Q80U70	crypt cells	NULL
EXP057180	none (genomic DNA)	Mus musculus	Treatment: grown in 100?units/ml LIF (Millipore, cat. ESG1107);	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057181	none (genomic DNA)	Mus musculus	Treatment: grown in  50nM 4-hydroxytamoxifen (OHT) (Sigma, cat. H6278);	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057182	none (chromatin processed without incubation with the antibody)	Mus musculus	Treatment: grown in 100?units/ml LIF (Millipore, cat. ESG1107);	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057183	none (genomic DNA)	Mus musculus	Treatment: grown in  50nM 4-hydroxytamoxifen (OHT) (Sigma, cat. H6278);	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057184	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in 100?units/ml LIF (Millipore, cat. ESG1107);	EXP057180	765	normal	Q80U70	R1 (embryonic stem cells)	NULL
EXP057185	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in  50nM 4-hydroxytamoxifen (OHT) (Sigma, cat. H6278);	EXP057181	765	normal	Q80U70	R1 (embryonic stem cells)	NULL
EXP057186	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in 100?units/ml LIF (Millipore, cat. ESG1107);	EXP057182	765	normal	Q80U70	R1 (embryonic stem cells)	NULL
EXP057187	anti-Suz12 (D39F6, Cell Signalling)	Mus musculus	Treatment: grown in  50nM 4-hydroxytamoxifen (OHT) (Sigma, cat. H6278);	EXP057183	765	normal	Q80U70	R1 (embryonic stem cells)	NULL
EXP057188	anti-Sin3a	Mus musculus		NULL	230	normal	Q60520	ES-E14 (E14, embryonic stem cells)	NULL
EXP057189	anti-Fam60a	Mus musculus		NULL	230	normal	Q8C8M1	ES-E14 (E14, embryonic stem cells)	NULL
EXP057190	anti-Sin3a	Mus musculus		NULL	675	normal	Q60520	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057191	anti-Fam60a	Mus musculus		NULL	675	normal	Q8C8M1	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057192		Mus musculus	Treatment: non-targeting pLKO.1 shScrambled;	NULL	230	normal	A0A023J5X2	ES-E14 (E14, embryonic stem cells)	NULL
EXP057193		Mus musculus	Treatment: pLKO.1 targeting mouse Fam60a; Genotype: Fam60a knockdown; 	NULL	230	normal	A0A023J5X2	ES-E14 (E14, embryonic stem cells)	NULL
EXP057194	none	Mus musculus	Treatment: IWP2; Genotype: Wnt3 knockout;	NULL	260	chip_control	NULL	epiblast stem cells	NULL
EXP057195	none	Mus musculus	Treatment: IWP2; Genotype: Wnt3 knockout;	NULL	260	chip_control	NULL	epiblast stem cells	NULL
EXP057196	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: IWP2; Genotype: Wnt3 knockout;	EXP057194	260	normal	Q9CQJ4	epiblast stem cells	NULL
EXP057197	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: IWP2; Genotype: Wnt3 knockout;	EXP057195	260	normal	Q9CQJ4	epiblast stem cells	NULL
EXP057198	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: 72hrs rsCHIR99021; Genotype: Wnt3 knockout;	NULL	260	normal	Q9CQJ4	epiblast stem cells	NULL
EXP057199	anti-Ring1b (ActiveMotif, 39663)	Mus musculus	Treatment: 5hrs Wnt3a 125 ng/ml; Genotype: Wnt3 knockout;	NULL	260	normal	Q9CQJ4	epiblast stem cells	NULL
EXP057200	none	Mus musculus	Generation: F1; Strain: B6/129; Age: 8-week-old; 	NULL	193	chip_control	NULL	cortex	NULL
EXP057201	none	Mus musculus	Generation: F1; Strain: B6/129; Age: 8-week-old; 	NULL	193	chip_control	NULL	cortex	NULL
EXP057202	anti-FLAG M2 (Sigma, catalog# F1804)	Mus musculus	Generation: F1; Strain: B6/129; Age: 8-week-old; 	EXP057200	193	normal	Q61818	cortex	NULL
EXP057203	anti-FLAG M2 (Sigma, catalog# F1804)	Mus musculus	Generation: F1; Strain: B6/129; Age: 8-week-old; 	EXP057201	193	normal	Q61818	cortex	NULL
EXP057204	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: control;	NULL	2942	normal	Q8BW72	L-GMP transformed with MLL-AF9	NULL
EXP057205	anti-Jmjd2a (Cell Signaling Technology, #5328)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: 500nM OHT 4-hydroxytamoxifen for 96hrs;	NULL	2942	normal	Q8BW72	L-GMP transformed with MLL-AF9	NULL
EXP057206	anti-Jmjd2c (ktwl)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: control;	NULL	2942	normal	Q8VCD7	L-GMP transformed with MLL-AF9	NULL
EXP057207	anti-Jmjd2c (ktwl)	Mus musculus	Genotype: Jmjd2a/b/cf/f;Rosa26::CreERT2; Strain: C57BL/6; Treatment: 500nM OHT 4-hydroxytamoxifen for 96hrs;	NULL	2942	normal	Q8VCD7	L-GMP transformed with MLL-AF9	NULL
EXP057208	anti-STAT5 (R&D Systems, AF1584)	Mus musculus	Strain: C57Bl.6; Treatment: none;	NULL	2581	normal	P42232	spleen and lymph nodes	NULL
EXP057209	anti-STAT5 (R&D Systems, AF1584)	Mus musculus	Strain: C57Bl.6; Treatment: stimulation with TSLP (40 ng/ml, R&D) for 25 minutes; 	NULL	2581	normal	P42232	spleen and lymph nodes	NULL
EXP057210	None	Mus musculus	Strain: C57BL/6 N; Passage: 2-3; 	NULL	2944	chip_control	NULL	differentiated primary brown adipocytes	NULL
EXP057211	anti-LSD1 (20752, homemade, SchÃ¼le lab)	Mus musculus	Strain: C57BL/6 N; Passage: 2-3; 	EXP057210	2944	normal	Q6ZQ88	differentiated primary brown adipocytes	NULL
EXP057212	none	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057213	none	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057214	none	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057215	none	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057216	none	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057217	none	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057218	none	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057219	none	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057220	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057212	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057221	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057213	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057222	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057214	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057223	anti-Ezh2 (D2C9) (Cell Signaling Technology, catalog# 5246S, lot# 6)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057215	675	normal	Q61188	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057224	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057216	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057225	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: pre heat shock , transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057217	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057226	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057218	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057227	anti-Suz12 (Active motif, catalog# 39357, lot# 28612003)	Mus musculus	Treatment: Post heat shock (45C) 15 minutes, transfection with LNAs against B2 RNA (500nM) and Ezh2(25nM) for 24hrs;	EXP057219	675	normal	Q80U70	NIH 3T3 (embryonic fibroblasts)	NULL
EXP057228	anti-CRTC2	Mus musculus	Treatment: 10 uM Forskolin;	NULL	19	normal	Q3U182	3T3-L1-derived preadipocytes	NULL
EXP057229	anti-CRTC2	Mus musculus	Treatment: 500 nM P6 + 10 uM Forskolin;	NULL	19	normal	Q3U182	3T3-L1-derived preadipocytes	NULL
EXP057230	none	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057231	none	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057232	none	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057233	none	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057234	none	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057235	none	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057236	RYBP (Millipore, AB3637)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057230	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	NULL
EXP057237	RYBP (Millipore, AB3637)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057231	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	NULL
EXP057238	RYBP (Millipore, AB3637)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057232	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	NULL
EXP057239	RYBP (Millipore, AB3637)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057233	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	NULL
EXP057240	RYBP (Millipore, AB3637)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057234	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	NULL
EXP057241	RYBP (Millipore, AB3637)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057235	2	normal	Q8CCI5	mESCs (mouse embryonic stem cells)	NULL
EXP057242	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057230	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057243	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057231	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057244	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057232	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057245	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057233	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057246	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057234	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057247	RING1B (Cell Signaling, D22F2)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057235	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057248	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057230	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057249	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057231	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057250	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: none;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057232	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057251	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057233	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057252	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057234	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057253	SUZ12 (Cell Signaling, D39F6)	Mus musculus	Treatment: 800nM 4-hydroxytamoxifen (OHT) for 96 hrs;  Genotype: RYBPfl/fl, YAF2 kncokout; 	EXP057235	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP057254	--	Mus musculus	Genotype: wildtype; Developmental stage: P22;	NULL	25	chip_control	NULL	cerebellum	NULL
EXP057255	--	Mus musculus	Genotype: Chd4 knockout;  Developmental stage: P22;	NULL	25	chip_control	NULL	cerebellum	NULL
EXP057256	anti-Chd4  (Abcam, ab72418)	Mus musculus	Genotype: wildtype; Developmental stage: P22;	EXP057254	25	normal	Q6PDQ2	cerebellum	NULL
EXP057257	anti-Chd4  (Abcam, ab72418)	Mus musculus	Genotype: Chd4 knockout;  Developmental stage: P22;	EXP057255	25	normal	Q6PDQ2	cerebellum	NULL
EXP057258		Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	2945	chip_control	NULL	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	NULL
EXP057259	anti-ASXL1	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP057258	2945	normal	P59598	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	NULL
EXP057260	anti-SMC1A	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP057258	2945	normal	Q9CU62	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	NULL
EXP057261	anti-SMC1A	Mus musculus	Genotype: SMC1A knockout; Strain: C57BL/6;	NULL	2945	normal	Q9CU62	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	NULL
EXP057262	anti-RAD21	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP057258	2945	normal	Q61550	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	NULL
EXP057263	anti-RAD21	Mus musculus	Genotype: RAD21 knockout; Strain: C57BL/6;	NULL	2945	normal	Q61550	bone marrow derived Lin-Kit+ hematopoietic stem/progenitor cells	NULL
EXP057264	none	Mus musculus	Strain: C57BL/6; 	NULL	2946	chip_control	NULL	primary colon epithelial cell	NULL
EXP057265	anti-EZH2 (Active Motif, cat # 3990)	Mus musculus	Strain: C57BL/6; 	EXP057264	2946	normal	Q61188	primary colon epithelial cell	NULL
EXP057266		Mus musculus		NULL	151	chip_control	NULL	CCE (embryonic stem cells)	NULL
EXP057267	anti-Pcgf6 (Santa Cruz, sc-160649)	Mus musculus		EXP057266	151	normal	Q99NA9	CCE (embryonic stem cells)	NULL
EXP057268	anti-Pcgf6 (Abcam, ab48010)	Mus musculus		EXP057266	151	normal	Q99NA9	CCE (embryonic stem cells)	NULL
EXP057269	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: 20 mg/kg cocaine; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	NULL
EXP057270	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: 0.9% Saline; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	NULL
EXP057271	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: none, normal control; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	NULL
EXP057272	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: Resilient; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	NULL
EXP057273	anti-WSTF (abcam, ab51256)	Mus musculus	Treatment: Susceptible; Strain: C57BL/6J;	NULL	682	normal	Q9Z277	nucleus accumbens cells	NULL
EXP057274		Mus musculus	Genotype: wildtype; Tissue: whole blood; 	NULL	2947	chip_control	NULL	promyelocytes	NULL
EXP057275		Mus musculus	Genotype: wildtype; Tissue: whole blood; 	NULL	2947	chip_control	NULL	promyelocytes	NULL
EXP057276		Mus musculus	Genotype: wildtype; Tissue: whole blood; 	NULL	2948	chip_control	NULL	granulocytes	NULL
EXP057277		Mus musculus	Genotype: wildtype; Tissue: whole blood; 	NULL	2948	chip_control	NULL	granulocytes	NULL
EXP057278	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057274	2947	normal	Q9Z2D6	promyelocytes	NULL
EXP057279	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057275	2947	normal	Q9Z2D6	promyelocytes	NULL
EXP057280	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057276	2948	normal	Q9Z2D6	granulocytes	NULL
EXP057281	anti-MeCP2 antibody	Mus musculus	Genotype: wildtype; Tissue: whole blood; 	EXP057277	2948	normal	Q9Z2D6	granulocytes	NULL
EXP057282	anti-Ezh2 (Cell signaling, 5246S, lot unknown)	Mus musculus	Genotype: Y641F Ezh2; Treatment: modification by TALEN;	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP057283	anti-Ezh2 (Cell signaling, 5246S, lot unknown)	Mus musculus	Genotype: wildtype Ezh2; 	NULL	230	normal	Q61188	ES-E14 (E14, embryonic stem cells)	NULL
EXP057284	NA	Mus musculus	Source: 4 days post SLHR induction;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP057285	anti- Lmo2 (AF2726, R&D Systems)	Mus musculus	Source: 4 days post SLHR induction;	EXP057284	12	normal	P25801	MEF (mouse embryonic fibroblasts)	NULL
EXP057286	Input	Mus musculus	Treatment: shControl; 	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP057287	Input	Mus musculus	Treatment: shControl; 	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP057288	Input	Mus musculus	Treatment: shPhf5a; Genotype: Phf5a knockout; 	NULL	126	chip_control	NULL	C2C12 (myotubes)	NULL
EXP057289	anti-Leo1 antibody (serum purified)	Mus musculus	Treatment: shControl; 	EXP057286	1153	normal	Q5XJE5	C2C12 (myoblasts)	NULL
EXP057290	anti-Leo1 antibody (serum purified)	Mus musculus	Treatment: shControl; 	EXP057287	126	normal	Q5XJE5	C2C12 (myotubes)	NULL
EXP057291	anti-Leo1 antibody (serum purified)	Mus musculus	Treatment: shPhf5a; Genotype: Phf5a knockout; 	EXP057288	126	normal	Q5XJE5	C2C12 (myotubes)	NULL
EXP057292	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057293	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057294	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: EGFP knockdown, 3XFLAG Mbd3;	NULL	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057295	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd3 knockdown, 3XFLAG Mbd3;	NULL	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057296	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd2 knockdown, 3XFLAG Mbd3;	NULL	230	normal	Q9DA79	ES-E14 (E14, embryonic stem cells)	NULL
EXP057297	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: EGFP knockdown, , 3XFLAG Mbd2;	NULL	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057298	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd3 knockdown, 3XFLAG Mbd2;	NULL	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057299	anti-Flag M2 (Sigma, catalog# F1804, lot# 080M6035)	Mus musculus	Genotype: Mbd2 knockdown, 3XFLAG Mbd2;	NULL	230	normal	Q8C255	ES-E14 (E14, embryonic stem cells)	NULL
EXP057300	anti-Flag antibody	Mus musculus	Treatment: none;  Strain: C57BL/6; 	NULL	2	normal	Q99NA9	mESCs (mouse embryonic stem cells)	NULL
EXP057301	anti-Flag antibody	Mus musculus	Treatment: OHT for 4 days;  Strain: C57BL/6; 	NULL	2	normal	Q99NA9	mESCs (mouse embryonic stem cells)	NULL
EXP057302	anti-Flag antibody	Mus musculus	Treatment: OHT for 8 days;  Strain: C57BL/6; 	NULL	2	normal	Q99NA9	mESCs (mouse embryonic stem cells)	NULL
EXP057303	Ring1b antibody (Clone#3)	Mus musculus	Treatment: none;  Strain: C57BL/6; Genotype: Ring1A/B double knockout; 	NULL	2	bio_control	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057304	Ring1b antibody (Clone#3)	Mus musculus	Treatment: none;  Strain: C57BL/6; Genotype: Bmil/Mel18 double knockout; 	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP057305	anti-IgG	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: mDUX codon-altered; 	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP057306	anti-HA 	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: HDUX4 codon-altered; 	NULL	1153	normal	A1JVI8	C2C12 (myoblasts)	NULL
EXP057307	anti-DUX4 (MO488, MO489 )	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: HDUX4 codon-altered; 	NULL	1153	normal	A1JVI8	C2C12 (myoblasts)	NULL
EXP057308	anti-DUX (A-19)	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: mDUX codon-altered; 	EXP057305	1153	normal	A1JVI8	C2C12 (myoblasts)	NULL
EXP057309	anti-mDUX (S-20)	Mus musculus	Treatment: 2ug/ml doxycycline treatment for 18 hours; Genotype: mDUX codon-altered; 	EXP057305	1153	normal	A1JVI8	C2C12 (myoblasts)	NULL
EXP057310		Mus musculus	Genotype: wildtype Kap1 loxP/loxP; Developmental stage: E3; Strain: C57BL/6; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057311		Mus musculus	Genotype: wildtype Kap1 loxP/loxP; Developmental stage: E3; Strain: C57BL/6; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP057312		Mus musculus		NULL	2787	chip_control	NULL	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP057313	anti-KAP1 (Trono laboratory, rabbit polyclonal S23470)	Mus musculus	Genotype: wildtype Kap1 loxP/loxP; Developmental stage: E3; Strain: C57BL/6; 	EXP057310	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP057314	anti-KAP1 (Trono laboratory, rabbit polyclonal S23470)	Mus musculus	Genotype: wildtype Kap1 loxP/loxP; Developmental stage: E3; Strain: C57BL/6; 	EXP057311	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP057315	anti-KAP1 (Trono laboratory, rabbit polyclonal S23470)	Mus musculus		EXP057312	2787	normal	Q62318	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP057316	anti-SETDB1 (Sripathy, Stevens et al. 2006)	Mus musculus		EXP057312	2787	normal	Q8BJ51	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP057317	none	Mus musculus	Genotype: wildtype Smc1b; Strain: C57BL/6;	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP057318	none	Mus musculus	Genotype: N-terminally LAP-tagged Smc1b; Strain: C57BL/6; Tissue: testes; 	NULL	803	chip_control	NULL	spermatocytes	NULL
EXP057319	anti-SMC3 (Abcam, ab9263)	Mus musculus	Genotype: wildtype Smc1b; Strain: C57BL/6; Tissue: testes; 	EXP057317	803	normal	Q9CW03	spermatocytes	NULL
EXP057320	anti-SMC3 (Abcam, ab9263)	Mus musculus	Genotype: N-terminally LAP-tagged Smc1b; Strain: C57BL/6; Tissue: testes; 	EXP057318	803	normal	Q9CW03	spermatocytes	NULL
EXP057321	anti-Tet3 (gift from Dr. Guoliang Xu, PMID: 21892189)	Mus musculus	Strain: C57BL/6; 	NULL	2770	chip_control	NULL	embryonic stem cells-derived neural progenitor cells	NULL
EXP057322	anti-Tet3 (gift from Dr. Guoliang Xu, PMID: 21892189)	Mus musculus	Strain: C57BL/6; 	EXP057321	2770	normal	Q8BG87	embryonic stem cells-derived neural progenitor cells	NULL
EXP057323	none	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP057324	anti-Ezh2 antibody (Santa Cruz H-80,sc-25383,H0213)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; 	EXP057323	2479	normal	Q61188	CD8+ T-cells	NULL
EXP057325	none (input)	Mus musculus	Treatment: none; Background cell line: V6.5;	NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP057326	none (input)	Mus musculus	Treatment: control siRNA transfection; Background cell line: V6.5;	NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP057327	none (input)	Mus musculus	Treatment: Cbx3 siRNA transfection; Background cell line: V6.5; Genotype: Cbx3 knockout; 	NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP057328	none (input)	Mus musculus	Treatment: control siRNA transfection; Background cell line: V6.5;	NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP057329	none (input)	Mus musculus	Treatment: Cbx3 siRNA transfection; Background cell line: V6.5; Genotype: Cbx3 knockout;	NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP057330	none	Mus musculus	Treatment: none; Background cell line: V6.5;	NULL	280	chip_control	NULL	embryonic stem cell-derived neural progenitors	NULL
EXP057331	Anti-Cbx3 antibody (Millipore, 05-690; clone 42s2)	Mus musculus	Treatment: none; Background cell line: V6.5;	EXP057325	280	normal	P23198	embryonic stem cell-derived neural progenitors	NULL
EXP057332	Anti-Med26 (sc-48776)	Mus musculus	Treatment: control siRNA transfection; Background cell line: V6.5;	EXP057326	280	bio_control	Q7TN02	embryonic stem cell-derived neural progenitors	NULL
EXP057333	Anti-Med26 (sc-48776)	Mus musculus	Treatment: Cbx3 siRNA transfection; Background cell line: V6.5; Genotype: Cbx3 knockout; 	EXP057327	280	normal	Q7TN02	embryonic stem cell-derived neural progenitors	NULL
EXP057334	Anti-Cdk8 antibody (sc-1521)	Mus musculus	Treatment: control siRNA transfection; Background cell line: V6.5;	EXP057328	280	bio_control	Q8R3L8	embryonic stem cell-derived neural progenitors	NULL
EXP057335	Anti-Cdk8 antibody (sc-1521)	Mus musculus	Treatment: Cbx3 siRNA transfection; Background cell line: V6.5; Genotype: Cbx3 knockout;	EXP057329	280	normal	Q8R3L8	embryonic stem cell-derived neural progenitors	NULL
EXP057336	Anti-Cbx3 antibody (Millipore, 05-690; clone 42s2)	Mus musculus	Treatment: none; Background cell line: V6.5;	EXP057330	280	normal	P23198	embryonic stem cell-derived neural progenitors	NULL
EXP057337	none	Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP057338	none	Mus musculus		NULL	2949	chip_control	NULL	J1 embryonic stem cells derived neural progenitors cells	NULL
EXP057339	anti-Ring1b	Mus musculus		EXP057337	506	normal	Q9CQJ4	J1 (embryonic stem cells)	NULL
EXP057340	anti-Phc1	Mus musculus		EXP057337	506	normal	Q64028	J1 (embryonic stem cells)	NULL
EXP057341	anti-Cbx7	Mus musculus		EXP057337	506	normal	Q8VDS3	J1 (embryonic stem cells)	NULL
EXP057342	anti-Cbx2	Mus musculus		EXP057337	506	normal	P30658	J1 (embryonic stem cells)	NULL
EXP057343	anti-Ezh2	Mus musculus		EXP057337	506	normal	Q61188	J1 (embryonic stem cells)	NULL
EXP057344	anti-Ring1b	Mus musculus		EXP057338	2949	normal	Q9CQJ4	J1 embryonic stem cells derived neural progenitors cells	NULL
EXP057345	anti-Cbx8	Mus musculus		EXP057338	2949	normal	Q9QXV1	J1 embryonic stem cells derived neural progenitors cells	NULL
EXP057346	anti-Cbx2	Mus musculus		EXP057338	2949	normal	P30658	J1 embryonic stem cells derived neural progenitors cells	NULL
EXP057347	anti-Ezh2	Mus musculus		EXP057338	2949	normal	Q61188	J1 embryonic stem cells derived neural progenitors cells	NULL
EXP057348		Mus musculus	Strain: C57BL/6J; Age: 10 weeks; Treatment: corn oil vehicle daily for 5 days 2 weeks; Genotype: wildtype (HDAC3 f/f); 	NULL	898	chip_control	NULL	pancreatic islets	NULL
EXP057349		Mus musculus	Strain: C57BL/6J; Age: 10 weeks; Treatment: gavaged tamoxifen (2mg/day)e daily for 5 days 2 weeks; Genotype: HDAC3beta knockout; 	NULL	898	chip_control	NULL	pancreatic islets	NULL
EXP057350	anti-HDAC3	Mus musculus	Strain: C57BL/6J; Age: 10 weeks; Treatment: corn oil vehicle daily for 5 days 2 weeks; Genotype: wildtype (HDAC3 f/f); 	EXP057348	898	normal	O88895	pancreatic islets	NULL
EXP057351	anti-HDAC3	Mus musculus	Strain: C57BL/6J; Age: 10 weeks; Treatment: gavaged tamoxifen (2mg/day)e daily for 5 days 2 weeks; Genotype: HDAC3beta knockout; 	EXP057349	898	normal	O88895	pancreatic islets	NULL
EXP057352	Input	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	NULL	193	chip_control	NULL	cortex	NULL
EXP057353	Input	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	NULL	193	chip_control	NULL	cortex	NULL
EXP057354	Input	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	NULL	193	chip_control	NULL	cortex	NULL
EXP057355	Input	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	NULL	193	chip_control	NULL	cortex	NULL
EXP057356	Input	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	NULL	193	chip_control	NULL	cortex	NULL
EXP057357	Input	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	NULL	193	chip_control	NULL	cortex	NULL
EXP057358	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	EXP057352	193	normal	Q9Z2D6	cortex	NULL
EXP057359	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	EXP057353	193	normal	Q9Z2D6	cortex	NULL
EXP057360	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: Dnmt3a knockout;	EXP057354	193	normal	Q9Z2D6	cortex	NULL
EXP057361	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	EXP057355	193	normal	Q9Z2D6	cortex	NULL
EXP057362	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	EXP057356	193	normal	Q9Z2D6	cortex	NULL
EXP057363	anti-MeCP2 antibody (Zhou et al. 2006)	Mus musculus	Strain: C57BL/6; Age: 6 weeks; Genotype: wildtype;	EXP057357	193	normal	Q9Z2D6	cortex	NULL
EXP057364	none	Mus musculus	Treatment: none; Strain: C57BL/6;	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP057365	none	Mus musculus	Treatment: none; Strain: C57BL/6;	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP057366	none	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP057367	none	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	NULL	498	chip_control	NULL	Th17-cells	NULL
EXP057368	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057364	498	normal	Q7JJ13	Th17-cells	NULL
EXP057369	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057365	498	normal	Q7JJ13	Th17-cells	NULL
EXP057370	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057364	498	normal	Q9ESU6	Th17-cells	NULL
EXP057371	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: none; Strain: C57BL/6;	EXP057365	498	normal	Q9ESU6	Th17-cells	NULL
EXP057372	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057366	498	normal	Q9ESU6	Th17-cells	NULL
EXP057373	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057367	498	normal	Q9ESU6	Th17-cells	NULL
EXP057374	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057366	498	normal	Q7JJ13	Th17-cells	NULL
EXP057375	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Treatment: JQ1; Strain: C57BL/6;	EXP057367	498	normal	Q7JJ13	Th17-cells	NULL
EXP057376		Mus musculus	Sex: male; Strain: C57BL/6;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP057377	anti-ACSS2 (Thermo MA5-145810, QD2005961)	Mus musculus	Sex: male; Strain: C57BL/6;	EXP057376	987	normal	Q9QXG4	hippocampus	NULL
EXP057378	Dnmt3a (Santa Cruz, H-295)	Mus musculus	Genotype: wildtype; Sex: female; Age: 14 weeks; Strain: CU Black Six; Treatment: DMBA and TPA;	NULL	2950	normal	O88508	back skin	NULL
EXP057379	Dnmt3a (Santa Cruz, H-295)	Mus musculus	Genotype: Dnmt3a knockout; Sex: female; Age: 14 weeks; Strain: CU Black Six; Treatment: DMBA and TPA;	NULL	2950	normal	O88508	back skin	NULL
EXP057380		Mus musculus	Sex: male; Strain: Balb/c;	NULL	32	chip_control	NULL	testis	NULL
EXP057381		Mus musculus	Sex: male; Strain: Balb/c;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP057382	anti-Lap1	Mus musculus	Sex: male; Strain: Balb/c;	EXP057380	32	normal	P97449	testis	NULL
EXP057383	anti-Lap1	Mus musculus	Sex: male; Strain: Balb/c;	EXP057381	987	normal	P97449	hippocampus	NULL
EXP057384	anti-Lap1	Mus musculus	Sex: male; Strain: Balb/c; Source: technical replicate;	NULL	32	normal	P97449	testis	NULL
EXP057385		Mus musculus	Strain: C57BL/6N;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP057386	anti-Sox2 (R&D Systems, AF2018)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	P48432	differentiated embryonic stem cells	NULL
EXP057387	anti-T (Santa Cruz, sc-17743)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	P20293	differentiated embryonic stem cells	NULL
EXP057388	anti-Tbx6 (this paper)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	P70327	differentiated embryonic stem cells	NULL
EXP057389	anti-beta-catenin (Invitrogen, 71-2700)	Mus musculus	Strain: C57BL/6N;	EXP057385	216	normal	Q02248	differentiated embryonic stem cells	NULL
EXP057390	none	Mus musculus	Developmental stage: P7; Strain: C57BL/6;	NULL	2951	chip_control	NULL	granule neuron progenitor	NULL
EXP057391	none	Mus musculus	Developmental stage: P7; Strain: C57BL/6;	NULL	2952	chip_control	NULL	granule neuron	NULL
EXP057392	anti-Chd7 (Cell Siganling)	Mus musculus	Developmental stage: P7; Strain: C57BL/6;	EXP057390	2951	normal	A2AJK6	granule neuron progenitor	NULL
EXP057393	anti-Chd7 (Cell Siganling)	Mus musculus	Developmental stage: P7; Strain: C57BL/6; Genotype: Chd7 knockout;	NULL	2951	normal	A2AJK6	granule neuron progenitor	NULL
EXP057394	anti-Top2b (Santa Cruz)	Mus musculus	Developmental stage: P7; Strain: C57BL/6;	EXP057391	2952	normal	Q64511	granule neuron	NULL
EXP057395	anti-Top2b (Santa Cruz)	Mus musculus	Developmental stage: P7; Strain: C57BL/6; Genotype: Chd7 knockout;	NULL	2952	normal	Q64511	granule neuron	NULL
EXP057396	input DNA	Mus musculus	Treatment: cultured in 2i/LIF conditions;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057397	input DNA	Mus musculus	Treatment: cultured in serum/LIF conditions;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057398	input DNA	Mus musculus	Treatment: cultured in serum/LIF conditions;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057399	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	Treatment: cultured in serum/LIF conditions;	EXP057397	230	normal	Q8VCD7	ES-E14 (E14, embryonic stem cells)	NULL
EXP057400	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	Treatment: cultured in serum/LIF conditions;	EXP057398	230	normal	Q8VCD7	ES-E14 (E14, embryonic stem cells)	NULL
EXP057401	anti-FLAG (Sigma, catalog number F1804)	Mus musculus	Treatment: cultured in 2i/LIF conditions;	EXP057396	230	normal	Q8VCD7	ES-E14 (E14, embryonic stem cells)	NULL
EXP057402	none	Mus musculus	Treatment: tranfected with siGFP for 48hrs; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP057403	HP1gamma (Millipore, MAB3450, lot 2021184)	Mus musculus	Treatment: tranfected with siGFP for 48hrs; 	EXP057402	230	bio_control	P23198	ES-E14 (E14, embryonic stem cells)	NULL
EXP057404	HP1gamma (Millipore, MAB3450, lot 2021184)	Mus musculus	Treatment: tranfected with siHP1g for 48hrs; Genotype: HP1gamma knockout;	EXP057402	230	normal	P23198	ES-E14 (E14, embryonic stem cells)	NULL
EXP057405	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: C57BL/6JOlaHsd;   Source: B6; 	NULL	32	chip_control	NULL	testis	NULL
EXP057406	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: C57BL/6JOlaHsd;   Source: B6; 	NULL	32	chip_control	NULL	testis	NULL
EXP057407	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm;  Source: RJ2; 	NULL	32	chip_control	NULL	testis	NULL
EXP057408	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm;  Source: RJ2; 	NULL	32	chip_control	NULL	testis	NULL
EXP057409	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: 129P2-Prdm9tm1Ymat/J; Genotype: prdm9 knockout; 	NULL	32	chip_control	NULL	testis	NULL
EXP057410	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: Spo11tm1M; Genotype: Spo11tm1 knockout; 	NULL	32	chip_control	NULL	testis	NULL
EXP057411	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: Spo11tm1M; Genotype: Spo11tm1 knockout; 	NULL	32	chip_control	NULL	testis	NULL
EXP057412	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: C57BL/6JOlaHsd;   Source: B6; 	EXP057405	32	normal	Q96EQ9	testis	NULL
EXP057413	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: C57BL/6JOlaHsd;   Source: B6; 	EXP057406	32	normal	Q96EQ9	testis	NULL
EXP057414	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm;  Source: RJ2; 	EXP057407	32	normal	Q96EQ9	testis	NULL
EXP057415	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm;  Source: RJ2; 	EXP057408	32	normal	Q96EQ9	testis	NULL
EXP057416	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: 129P2-Prdm9tm1Ymat/J; Genotype: prdm9 knockout; 	EXP057409	32	normal	Q96EQ9	testis	NULL
EXP057417	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: Spo11tm1M; Genotype: Spo11tm1 knockout; 	EXP057410	32	normal	Q96EQ9	testis	NULL
EXP057418	anti-PRDM9 (BdM)	Mus musculus	Age: 13 days post-partum; Strain: Spo11tm1M; Genotype: Spo11tm1 knockout; 	EXP057411	32	normal	Q96EQ9	testis	NULL
EXP057419	anti-DMC1 (Santa Cruz, C-20)	Mus musculus	Age: 5 weeks post-partum; Strain: C57BL/6JOlaHsd; Source: B6;	NULL	32	normal	Q61880	testis	NULL
EXP057420	anti-DMC1 (Santa Cruz, C-20)	Mus musculus	Age: 5 weeks post-partum; Strain: B10.MOLSGR(A)-(D17Mit58-D17Jcs11)/Bdm; Source: RJ2;	NULL	32	normal	Q61880	testis	NULL
EXP057421	none	Mus musculus	Treatment: shLuc; 	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057422	none	Mus musculus	Treatment: shSmyd5; Genotype: Smyd5 kncokout;	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057423	none	Mus musculus		NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057424	Anti-HP1 antibody (Millipore)	Mus musculus	Treatment: shLuc; 	EXP057421	765	bio_control	Q61687	R1 (embryonic stem cells)	NULL
EXP057425	Anti-HP1 antibody (Millipore)	Mus musculus	Treatment: shSmyd5; Genotype: Smyd5 kncokout;	EXP057422	765	normal	Q61687	R1 (embryonic stem cells)	NULL
EXP057426	Anti-FLAG antibody (Sigma)	Mus musculus		EXP057423	765	normal	Q3TYX3	R1 (embryonic stem cells)	NULL
EXP057427		Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP057428		Mus musculus		NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP057429	anti-KAP1 (custom rabbit polyclonal)	Mus musculus		EXP057427	506	normal	Q62318	J1 (embryonic stem cells)	NULL
EXP057430	anti-KAP1 (custom rabbit polyclonal)	Mus musculus		EXP057428	506	normal	Q62318	J1 (embryonic stem cells)	NULL
EXP057431	none	Mus musculus	Strain: C57BL/6;	NULL	1117	chip_control	NULL	primary T-cells	NULL
EXP057432	none	Mus musculus	Strain: C57BL/6;	NULL	1117	chip_control	NULL	primary T-cells	NULL
EXP057433	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Strain: C57BL/6;	EXP057431	1117	normal	Q7JJ13	primary T-cells	NULL
EXP057434	anti-Brd2 (Bethyl, IHC-00612)	Mus musculus	Strain: C57BL/6;	EXP057432	1117	normal	Q7JJ13	primary T-cells	NULL
EXP057435	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Strain: C57BL/6;	EXP057431	1117	normal	Q9ESU6	primary T-cells	NULL
EXP057436	anti-Brd4 (Bethyl, IHC-00396)	Mus musculus	Strain: C57BL/6;	EXP057432	1117	normal	Q9ESU6	primary T-cells	NULL
EXP057437	none	Mus musculus	Strain: C57BL6; Genotype: wildtype; Developmental stage: 2.5 dpc; 	NULL	132	chip_control	NULL	uterus	NULL
EXP057438	none	Mus musculus	Strain: C57BL6; Genotype: Kdm4a knockout; Developmental stage: 2.5 dpc; 	NULL	132	chip_control	NULL	uterus	NULL
EXP057439	Anti-Rabbit IgG (Sigma Aldrich; Catalog nr #I5006)	Mus musculus	Strain: C57BL6; Genotype: wildtype; Developmental stage: 2.5 dpc; 	NULL	132	chip_control	NULL	uterus	NULL
EXP057440	Anti-Jmjd2a (Cell Signaling, Catalog Nr #5328)	Mus musculus	Strain: C57BL6; Genotype: Kdm4a knockout; Developmental stage: 2.5 dpc; 	EXP057438	132	normal	Q8BW72	uterus	NULL
EXP057441	Anti-Jmjd2a (Cell Signaling, Catalog Nr #5328)	Mus musculus	Strain: C57BL6; Genotype: wildtype; Developmental stage: 2.5 dpc; 	EXP057437	132	normal	Q8BW72	uterus	NULL
EXP057442		Mus musculus	Strain: C57BL/6; Age: 6-8 weeks;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP057443	anti-CDYL	Mus musculus	Strain: C57BL/6; Age: 6-8 weeks;	EXP057442	987	normal	Q9WTK2	hippocampus	NULL
EXP057444	Anti-p300 (Santa Cruz, sc-585)	Mus musculus	Genotype: UTX Wildtype; 	NULL	2	normal	B2RWS6	mESCs (mouse embryonic stem cells)	NULL
EXP057445	Anti-UTX (Bethyl laboratories, A302-374A)	Mus musculus	Genotype: UTX Wildtype; 	NULL	2	normal	O70546	mESCs (mouse embryonic stem cells)	NULL
EXP057446	input	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-GFP; 	NULL	247	chip_control	NULL	embryonic heart	NULL
EXP057447	input	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-GFP; 	NULL	247	chip_control	NULL	embryonic heart	NULL
EXP057448	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-EZH1; 	EXP057446	247	normal	P70351	embryonic heart	NULL
EXP057449	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-EZH1; 	EXP057447	247	normal	P70351	embryonic heart	NULL
EXP057450	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-GFP; 	EXP057446	247	bio_control	P70351	embryonic heart	NULL
EXP057451	anti-EZH1 (a gitf from Jian Xu)	Mus musculus	Strain: C57BL/6; Passage: P13; Genotype:  wildtype; Treatment: AAV-GFP; 	EXP057447	247	bio_control	P70351	embryonic heart	NULL
EXP057452		Mus musculus	Genotype: wildtype; 	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057453		Mus musculus	Genotype: Mll3/4 double knockout;	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057454		Mus musculus	Genotype: catalytically-deficient Mll3/4; 	NULL	765	chip_control	NULL	R1 (embryonic stem cells)	NULL
EXP057455	anti-Mll3/4 (custom)	Mus musculus	Genotype: catalytically-deficient Mll3/4; 	EXP057454	765	normal	Q8BRH4	R1 (embryonic stem cells)	NULL
EXP057456	anti-Mll3/4 (custom)	Mus musculus	Genotype: wildtype; 	EXP057452	765	normal	Q8BRH4	R1 (embryonic stem cells)	NULL
EXP057457	anti-Mll3/4 (custom)	Mus musculus	Genotype: Mll3/4 double knockout;	EXP057453	765	normal	Q8BRH4	R1 (embryonic stem cells)	NULL
EXP057458		Mus musculus	Genotype: wildtype;	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP057459	anti-MLL2 (Homemade, #9173)	Mus musculus	Genotype: wildtype;	EXP057458	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP057460	anti-MLL4 (Homemade, #825)	Mus musculus	Genotype: wildtype;	EXP057458	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	NULL
EXP057461	anti-SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype;	EXP057458	252	normal	E9PYH6	V6.5 (embryonic stem cells)	NULL
EXP057462	anti-MLL2 (Homemade, #9173)	Mus musculus	Genotype: wildtype; Treatment: RA-induced differentiation;	NULL	252	normal	O08550	V6.5 (embryonic stem cells)	NULL
EXP057463	MLL4 (Homemade, #825)	Mus musculus	Genotype: wildtype; Treatment: RA-induced differentiation;	NULL	252	normal	Q6PDK2	V6.5 (embryonic stem cells)	NULL
EXP057464	anti-SET1A (Homemade, #919)	Mus musculus	Genotype: wildtype; Treatment: RA-induced differentiation;	NULL	252	normal	E9PYH6	V6.5 (embryonic stem cells)	NULL
EXP057465	anti-ERF (PA5-30237)	Mus musculus	Treatment: vehicle;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP057466	anti-ERF (PA5-30237)	Mus musculus	Treatment: vehicle;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP057467	anti-ERF (PA5-30237)	Mus musculus	Treatment: 100ng/mL doxycycline;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP057468	anti-ERF (PA5-30237)	Mus musculus	Treatment: 100ng/mL doxycycline;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP057469	anti-ERF (PA5-30237)	Mus musculus	Treatment: vehicle;	EXP057465	2953	normal	P70459	prostate organoids	NULL
EXP057470	anti-ERF (PA5-30237)	Mus musculus	Treatment: vehicle;	EXP057466	2953	normal	P70459	prostate organoids	NULL
EXP057471	anti-ERF (PA5-30237)	Mus musculus	Treatment: 100ng/mL doxycycline;	EXP057467	2953	normal	P70459	prostate organoids	NULL
EXP057472	anti-ERF (PA5-30237)	Mus musculus	Treatment: 100ng/mL doxycycline;	EXP057468	2953	normal	P70459	prostate organoids	NULL
EXP057473	none	Mus musculus	Strain: C57BL/6;  Age: Five-day cultured Th2 cells;	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP057474	none	Mus musculus	Strain: C57BL/6;  Age: Three-week cultured Th2 cells ;	NULL	499	chip_control	NULL	Th2-cells	NULL
EXP057475	anti-Menin (Bethyl, A300-105A)	Mus musculus	Strain: C57BL/6;  Age: Five-day cultured Th2 cells;	EXP057473	499	normal	O88559	Th2-cells	NULL
EXP057476	anti-Menin (Bethyl, A300-105A)	Mus musculus	Strain: C57BL/6;  Age: Three-week cultured Th2 cells ;	EXP057474	499	normal	O88559	Th2-cells	NULL
EXP057477	None	Mus musculus	Genotype: wildtype; Strain: C57BL/6N; Developmental stage: P56; 	NULL	313	chip_control	NULL	forebrain	NULL
EXP057478	anti-Chd8 (Abcam ab114126)	Mus musculus	Genotype: wildtype; Strain: C57BL/6N; Developmental stage: P56; 	EXP057477	313	normal	Q09XV5	forebrain	NULL
EXP057479	none (input)	Rattus norvegicus	Genotype: Cdkn1b+/+; Age: 9 weeks; Strain:ACI;	NULL	2962	chip_control	NULL	mammary gland	NULL
EXP057480	none (input)	Rattus norvegicus	Genotype: Cdkn1b knockout; Age: 9 weeks; Strain:ACI;	NULL	2962	chip_control	NULL	mammary gland	NULL
EXP057481	Anti-PR antibody (H-190, Santa Cruz, cat# sc-7208)	Rattus norvegicus	Genotype: Cdkn1b+/+; Age: 9 weeks; Strain:ACI;	EXP057479	2962	normal	Q63449	mammary gland	NULL
EXP057482	Anti-PR antibody (H-190, Santa Cruz, cat# sc-7208)	Rattus norvegicus	Genotype: Cdkn1b knockout; Age: 9 weeks; Strain:ACI;	EXP057480	2962	normal	Q63449	mammary gland	NULL
EXP057483	none	Rattus norvegicus	Genotype:stable expression pCDNA3 vector; Passage:18-20;	NULL	2963	chip_control	NULL	PC12(Rat adrenal gland pheochromocytoma)	NULL
EXP057484	none	Rattus norvegicus	Genotype:stable expression human alpha1ACT; Passage:18-20;	NULL	2963	chip_control	NULL	PC12(Rat adrenal gland pheochromocytoma)	NULL
EXP057485	Anti-FLAG(M2)	Rattus norvegicus	Genotype:stable expression pCDNA3 vector; Passage:18-20;	EXP057483	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	NULL
EXP057486	anti-FLAG(1804)	Rattus norvegicus	Genotype:stable expression pCDNA3 vector; Passage:18-20;	EXP057483	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	NULL
EXP057487	Anti-FLAG(M2)	Rattus norvegicus	Genotype:stable expression human alpha1ACT; Passage:18-20;	EXP057484	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	NULL
EXP057488	anti-FLAG(1804)	Rattus norvegicus	Genotype:stable expression human alpha1ACT; Passage:18-20;	EXP057484	2963	normal	P05545	PC12(Rat adrenal gland pheochromocytoma)	NULL
EXP057489	None (Input)	Danio rerio	Genotype: myl7:GFP_rnf2+/+; Developmental stage: 3 dpf; Strain: TU/TLF mixed background; 	NULL	2964	chip_control	NULL	3 dpf embryo	NULL
EXP057490	None (Input)	Danio rerio	Genotype: myl7:GFP_rnf2 knockout; Developmental stage: 3 dpf; Strain: TU/TLF mixed background; 	NULL	2964	chip_control	NULL	3 dpf embryo	NULL
EXP057491	anti-RING1B (Cell Signaling D22F2); H2A? (Active Motif 104597)	Danio rerio	Genotype: myl7:GFP_rnf2 +/+t; Developmental stage: 3 dpf; Strain: TU/TLF mixed background; 	EXP057489	2964	normal	Q803I4	3 dpf embryo	NULL
EXP057492	anti-RING1B (Cell Signaling D22F2); H2A? (Active Motif 104597)	Danio rerio	Genotype: myl7:GFP_rnf2 knockout; Developmental stage: 3 dpf; Strain: TU/TLF mixed background; 	EXP057490	2964	normal	Q803I4	3 dpf embryo	NULL
EXP010929		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010428	RevXlinkChromatin	Homo sapiens	None	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP010053		Homo sapiens		NULL	353	chip_control	NULL	GM12873 (female B-cells)	NULL
EXP010823		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010827		Homo sapiens		NULL	408	chip_control	NULL	HBMEC (human brain microvascular endothelial cells)	NULL
EXP010815		Homo sapiens	6 Î¼M all-trans-retinoic acid (CHEBI:15367) for 48 hour	NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP010744		Homo sapiens		NULL	354	chip_control	NULL	GM12874 (male B-cells)	NULL
EXP010048		Homo sapiens		NULL	244	chip_control	NULL	NT2-D1 (embryonic carcinoma)	NULL
EXP010476		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP010814		Homo sapiens		NULL	1146	chip_control	NULL	epithelial cell of proximal tubule	NULL
EXP010876		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010581		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010786		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010397		Homo sapiens		NULL	863	chip_control	NULL	WERI-Rb-1 (retinoblastoma)	NULL
EXP010094		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010288		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010801		Homo sapiens		NULL	648	chip_control	NULL	NB4 (acute promyelocytic leukemia )	NULL
EXP010802		Homo sapiens		NULL	420	chip_control	NULL	esophageal epithelial cells	NULL
EXP010925		Homo sapiens		NULL	114	chip_control	NULL	bronchial epithelial cells	NULL
EXP010790		Homo sapiens		NULL	441	chip_control	NULL	HMF (human mammary fibroblasts)	NULL
EXP010877		Homo sapiens		NULL	414	chip_control	NULL	HCFaa (cardiac fibroblasts - adult atrial)	NULL
EXP010830		Homo sapiens		NULL	1141	chip_control	NULL	BE2C	NULL
EXP010898		Homo sapiens		NULL	55	chip_control	NULL	AG04450 (fibroblasts)	NULL
EXP010851		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010113		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010686		Homo sapiens		NULL	344	chip_control	NULL	GM12864 (male B-cells)	NULL
EXP010922		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010061		Homo sapiens		NULL	391	chip_control	NULL	D54 (H54, Human glioblastoma)	NULL
EXP010419		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010784		Homo sapiens		NULL	434	chip_control	NULL	HFF-Myc (fetal fibroblasts)	NULL
EXP010819		Homo sapiens		NULL	56	chip_control	NULL	AG09309 (fibroblasts)	NULL
EXP010221		Homo sapiens		NULL	712	chip_control	NULL	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP010778		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP010881		Homo sapiens		NULL	54	chip_control	NULL	AG04449 (fibroblasts)	NULL
EXP010838		Homo sapiens		NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP010783		Homo sapiens		NULL	57	chip_control	NULL	AG09319 (fibroblasts)	NULL
EXP010706		Homo sapiens		NULL	345	chip_control	NULL	GM12865 (female B-cells)	NULL
EXP010913		Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP010798		Homo sapiens		NULL	58	chip_control	NULL	AG10803 (fibroblasts)	NULL
EXP010599		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP010629		Homo sapiens		NULL	352	chip_control	NULL	GM12872 (male B-cells)	NULL
EXP010889		Homo sapiens		NULL	955	chip_control	NULL	primary foreskin fibroblasts	NULL
EXP010867		Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP010829		Homo sapiens		NULL	1160	chip_control	NULL	HRE (Human Renal Epithelial cells)	NULL
EXP010916		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010854		Homo sapiens		NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP010908		Homo sapiens		NULL	473	chip_control	NULL	human villous mesenchymal fibroblast cells	NULL
EXP010812		Homo sapiens		NULL	1152	chip_control	NULL	fibroblast of pulmonary artery	NULL
EXP010921		Homo sapiens		NULL	67	chip_control	NULL	aortic adventitial fibroblasts	NULL
EXP010805		Homo sapiens		NULL	416	chip_control	NULL	HCPEpiC (choroid plexus epithelial cells)	NULL
EXP010875		Mus musculus		NULL	139	chip_control	NULL	thymus	NULL
EXP010779		Homo sapiens		NULL	399	chip_control	NULL	astrocytes of cerebellum	NULL
EXP010741		Homo sapiens		NULL	355	chip_control	NULL	GM12875 (female B-cells)	NULL
EXP010328		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP010811		Homo sapiens		NULL	446	chip_control	NULL	HPF (pulmonary fibroblasts isolated from lung tissue)	NULL
EXP010902		Homo sapiens		NULL	440	chip_control	NULL	HMEC (human mammary epithelial cells)	NULL
EXP010912		Homo sapiens		NULL	415	chip_control	NULL	HCM (cardiac myocytes)	NULL
EXP010794		Homo sapiens		NULL	448	chip_control	NULL	retinal pigment epithelial cells	NULL
EXP010601		Homo sapiens		NULL	343	chip_control	NULL	GM12801 (male B-cells)	NULL
EXP010808		Homo sapiens		NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP010904		Homo sapiens		NULL	405	chip_control	NULL	human astrocytes from spinal cord	NULL
EXP010928		Homo sapiens		NULL	145	chip_control	NULL	Caco-2 (colon adenocarcinoma)	NULL
EXP010924		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010901		Homo sapiens		NULL	335	chip_control	NULL	GM06990 (female B-cells)	NULL
EXP010787		Homo sapiens		NULL	867	chip_control	NULL	WI-38 (lung fibroblasts)	NULL
EXP010813		Homo sapiens		NULL	910	chip_control	NULL	lung	NULL
EXP010914		Homo sapiens		NULL	909	chip_control	NULL	kidney	NULL
EXP010810		Homo sapiens		NULL	360	chip_control	NULL	GM13977 (female B-cells)	NULL
EXP010852		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010873		Homo sapiens		NULL	337	chip_control	NULL	GM10248 (male B-cells)	NULL
EXP010926		Homo sapiens		NULL	955	chip_control	NULL	primary foreskin fibroblasts	NULL
EXP010848		Homo sapiens		NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP010915		Homo sapiens		NULL	1177	chip_control	NULL	LNCaP clone FGC	NULL
EXP010866		Homo sapiens		NULL	356	chip_control	NULL	GM12878 (female B-cells lymphoblastoid cell line)	NULL
EXP010878		Homo sapiens		NULL	370	chip_control	NULL	GM20000 (B-cells)	NULL
EXP010886		Homo sapiens		NULL	338	chip_control	NULL	GM10266 (male B-cells)	NULL
EXP010846		Homo sapiens		NULL	633	chip_control	NULL	spleen	NULL
EXP039117		Homo sapiens		NULL	446	chip_control	NULL	HPF (pulmonary fibroblasts isolated from lung tissue)	NULL
EXP010932		Homo sapiens		NULL	920	chip_control	NULL	pancreas	NULL
EXP010890		Homo sapiens		NULL	1159	chip_control	NULL	medulloblastoma	NULL
EXP010884		Homo sapiens		NULL	359	chip_control	NULL	GM13976 (female B-cells)	NULL
EXP038941	none	Homo sapiens		NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP038940	none	Mus musculus	c-mycflox/flox; in vitro infected with MycER	NULL	22	chip_control	NULL	3T9 fibroblasts	NULL
EXP038942	none	Mus musculus		NULL	22	chip_control	NULL	3T9 fibroblasts	NULL
EXP010781		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP010906		Homo sapiens		NULL	880	chip_control	NULL	B-cells	NULL
EXP010573		Homo sapiens		NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP010005		Homo sapiens		NULL	670	chip_control	NULL	fibroblast of dermis	NULL
EXP010792		Homo sapiens		NULL	215	chip_control	NULL	keratinocytes	NULL
EXP057493	none (input)	Saccharomyces cerevisiae	Strain: ROY4825 W-303; Genotype:MATa SCC2-13xMyc::KanMX ADE2 his3-11,15 leu2-3, 112 lys2D trp1-1 ura3-1;	NULL	2969	chip_control	NULL	ROY4825 W-303 strain	NULL
EXP057494	none (input)	Saccharomyces cerevisiae	Genotype:MATa SCC2-13xMyc::KanMX ade2-1 trp1-1 ura3-1 chrIII (t0D, t1D, t3D, t4D, t5D, t6D, t7D, t8D+t9D::LEU2), T1+T7::HIS3;	NULL	2968	chip_control	NULL	ROY5151 W-303 strain	NULL
EXP057495	anti-Myc (monoclonal 9E10)	Saccharomyces cerevisiae	Genotype:MATa SCC2-13xMyc::KanMX ade2-1 trp1-1 ura3-1 chrIII (t0D, t1D, t3D, t4D, t5D, t6D, t7D, t8D+t9D::LEU2), T1+T7::HIS3;	EXP057494	2968	normal	P23285	ROY5151 W-303 strain	NULL
EXP057496	anti-Myc (monoclonal 9E10)	Saccharomyces cerevisiae	Strain: ROY4825 W-303; Genotype:MATa SCC2-13xMyc::KanMX ADE2 his3-11,15 leu2-3, 112 lys2D trp1-1 ura3-1;	EXP057493	2969	normal	P23285	ROY4825 W-303 strain	NULL
EXP057497	anti-Flag antibody (M2-antiflag, Sigma)	Saccharomyces cerevisiae	Genotype: Hmo1tag, Control plasmid expressed; Treatment: teamperature 37 for 2hr 15mins; Cell cycle: log cells;	NULL	2517	chip_control	NULL	Log cells	NULL
EXP057498	anti-Flag antibody (M2-antiflag, Sigma)	Saccharomyces cerevisiae	Genotype: Hmo1tag;top2-1;top1<delta>, Ecoli TopA expression using plasmid; Treatment: teamperature 37 for 2hr 15mins; Cell cycle: log cells;	NULL	2517	chip_control	NULL	Log cells	NULL
EXP057499	anti-Flag antibody (M2-antiflag, Sigma)	Saccharomyces cerevisiae	Genotype: Hmo1tag, Control plasmid expressed; Treatment: teamperature 37 for 2hr 15mins; Cell cycle: log cells;	EXP057497	2517	normal	Q03973	Log cells	NULL
EXP057500	anti-Flag antibody (M2-antiflag, Sigma)	Saccharomyces cerevisiae	Genotype: Hmo1tag;top2-1;top1<delta>, Ecoli TopA expression using plasmid; Treatment: teamperature 37 for 2hr 15mins; Cell cycle: log cells;	EXP057498	2517	normal	Q03973	Log cells	NULL
EXP057501		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: SET2-H366N ;	NULL	2970	chip_control	NULL	FY3182 strain log phase	NULL
EXP057502		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: SET2-H366N ;	NULL	2970	chip_control	NULL	FY3182 strain log phase	NULL
EXP057503		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 mutant;	NULL	2971	chip_control	NULL	FY3180 strain log phase	NULL
EXP057504		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 mutant;	NULL	2971	chip_control	NULL	FY3180 strain log phase	NULL
EXP057505		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 and SET2-H366N mutant;	NULL	2972	chip_control	NULL	FY3181 log phase	NULL
EXP057506		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 and SET2-H366N mutant;	NULL	2972	chip_control	NULL	FY3181 log phase	NULL
EXP057507		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: wildtype;	NULL	2973	chip_control	NULL	FY3179 log phase	NULL
EXP057508		Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: wildtype;	NULL	2973	chip_control	NULL	FY3179 log phase	NULL
EXP057509	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: SET2-H366N ;	EXP057501	2970	normal	P46995	FY3182 strain log phase	NULL
EXP057510	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: SET2-H366N ;	EXP057502	2970	normal	P46995	FY3182 strain log phase	NULL
EXP057511	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 mutant;	EXP057503	2971	normal	P46995	FY3180 strain log phase	NULL
EXP057512	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 mutant;	EXP057504	2971	normal	P46995	FY3180 strain log phase	NULL
EXP057513	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 and SET2-H366N mutant;	EXP057505	2972	normal	P46995	FY3181 log phase	NULL
EXP057514	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: spt6-1004 and SET2-H366N mutant;	EXP057506	2972	normal	P46995	FY3181 log phase	NULL
EXP057515	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: wildtype;	EXP057507	2973	normal	P46995	FY3179 log phase	NULL
EXP057516	Anti-HA	Saccharomyces cerevisiae	Treatment: teamperature 30C; Genotype: wildtype;	EXP057508	2973	normal	P46995	FY3179 log phase	NULL
EXP057517		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057518		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057519		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057520		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057521		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057522		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057523		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057524		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057525		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057526		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057527		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057528		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057529		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057530		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057531		Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057532		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057533		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057534		Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057535	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057517	2520	normal	P08638	whole cells	NULL
EXP057536	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057518	2520	normal	P08638	whole cells	NULL
EXP057537	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057519	2520	normal	P08638	whole cells	NULL
EXP057538	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057520	2520	normal	P08638	whole cells	NULL
EXP057539	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057521	2520	normal	P08638	whole cells	NULL
EXP057540	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057522	2520	normal	P08638	whole cells	NULL
EXP057541	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057523	2520	normal	A0A250WE75	whole cells	NULL
EXP057542	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057524	2520	normal	A0A250WE75	whole cells	NULL
EXP057543	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057525	2520	normal	A0A250WE75	whole cells	NULL
EXP057544	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057526	2520	normal	A0A250WE75	whole cells	NULL
EXP057545	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057527	2520	normal	A0A250WE75	whole cells	NULL
EXP057546	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057522	2520	normal	A0A250WE75	whole cells	NULL
EXP057547	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057529	2520	normal	P32862	whole cells	NULL
EXP057548	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057530	2520	normal	P32862	whole cells	NULL
EXP057549	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, saturated in YPD;	EXP057531	2520	normal	P32862	whole cells	NULL
EXP057550	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057532	2520	normal	P32862	whole cells	NULL
EXP057551	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057533	2520	normal	P32862	whole cells	NULL
EXP057552	anti-TAP	Saccharomyces cerevisiae	Treatment: tempreture 30C, exponential in YPD;	EXP057534	2520	normal	P32862	whole cells	NULL
EXP057553	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GLUCOSE 2%; Genotype: leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2977	chip_control	NULL	YDS2 strain	NULL
EXP057554	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GALACTOSE 2%, 60 mins after treatment; Genotype: GAL1p-SFP1-TAP::URA3 MATa;	EXP057553	2974	normal	P32432	YHL201 strain	NULL
EXP057555	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: RAFFINOSE2%, 0 mins after treatment; Genotype: GAL1p-SFP1-TAP::URA3 MATa;	EXP057553	2974	normal	P32432	YHL201 strain	NULL
EXP057556	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GLUCOSE 2%; Genotype: SFP1_TAP::URA3leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2975	normal	P32432	YHL38 strain	NULL
EXP057557	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: RAFFINOSE2%; Genotype: SFP1_TAP::URA3leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2975	normal	P32432	YHL38 strain	NULL
EXP057558	Anti-TAP (thermoscientific TAP CAB1001)	Saccharomyces cerevisiae	Treatment: GALACTOSE2%; Genotype: SFP1_TAP::URA3leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 MATa;	NULL	2975	normal	P32432	YHL38 strain	NULL
EXP057559	Anti-MYC	Saccharomyces cerevisiae	Treatment: Rapamycin, 20min after treatment; Genotype: TBP-MYC::G418,tor1-1 fpr1{delta}::Nat RPL13A-2XFKB12::TRP1 SFP1-FRB-KanMX MAT{alpha};	NULL	2976	normal	P13393	YSK420 strain	NULL
EXP057560	Anti-MYC	Saccharomyces cerevisiae	Treatment: no Rapamycin; Genotype: TBP-MYC::G418,tor1-1 fpr1{delta}::Nat RPL13A-2XFKB12::TRP1 SFP1-FRB-KanMX MAT{alpha};	NULL	2976	normal	P13393	YSK420 strain	NULL
EXP057561	None	Saccharomyces cerevisiae	Treatment: none; Genotype: Sko1-WT; 	NULL	1386	chip_control	NULL	W303a Strain	NULL
EXP057562	None	Saccharomyces cerevisiae	Treatment: none; Genotype: Sko1-MT; 	NULL	1386	chip_control	NULL	W303a Strain	NULL
EXP057563	None	Saccharomyces cerevisiae	Treatment: 0.4 M NaCl for 5 min; Genotype: Sko1-WT; 	NULL	1386	chip_control	NULL	W303a Strain	NULL
EXP057564	None	Saccharomyces cerevisiae	Treatment: 0.4 M NaCl for 5 min; Genotype: Sko1-MT; 	NULL	1386	chip_control	NULL	W303a Strain	NULL
EXP057565	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: none; Genotype: Sko1-WT; 	EXP057561	1386	normal	Q02100	W303a Strain	NULL
EXP057566	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: none; Genotype: Sko1-MT; 	EXP057562	1386	normal	Q02100	W303a Strain	NULL
EXP057567	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: 0.4 M NaCl for 5 min; Genotype: Sko1-WT; 	EXP057563	1386	normal	Q02100	W303a Strain	NULL
EXP057568	anti-HA (Novus Rabbit ,NB600-363)	Saccharomyces cerevisiae	Treatment: 0.4 M NaCl for 5 min; Genotype: Sko1-MT; 	EXP057564	1386	normal	Q02100	W303a Strain	NULL
EXP057569	anti-HA	Saccharomyces cerevisiae	Conditions: SL, 0.17% yeast nitrogen base without amino acids; Genotype: CEN.PK; MATa; RPH1-HA-HYG;	NULL	2520	normal	P39956	whole cells	NULL
EXP057570	anti-HA	Saccharomyces cerevisiae	Conditions: SL, containing 0.5% ammonium sulfate (Difco), 2% lactate; Genotype: CEN.PK; MATa; RPH1-HA-HYG;	NULL	2520	normal	P39956	whole cells	NULL
EXP057571	anti-HA	Saccharomyces cerevisiae	Conditions: YPL, 1% yeast extract, 2% peptone and 2% lactate; Genotype: CEN.PK; MATa; RPH1-S412A-HA-HYG;	NULL	2520	normal	P39956	whole cells	NULL
EXP057572	anti-HA	Saccharomyces cerevisiae	Conditions: YPL, 1% yeast extract, 2% peptone and 2% lactate; Genotype: CEN.PK; MATa; RPH1-HA-HYG; ppm1::kanMX;	NULL	2520	normal	P39956	whole cells	NULL
EXP057573	anti-HA	Saccharomyces cerevisiae	Conditions: YPL, 1% yeast extract, 2% peptone and 2% lactate; Genotype: CEN.PK; MATa; RPH1-HA-HYG;	NULL	2520	normal	P39956	whole cells	NULL
EXP057574	anti-HA(Pierce catno:88837)	Saccharomyces cerevisiae	Genotype: Cse4-HA;	NULL	2191	bio_control	P36012	S phase S. cerevisiae cells	NULL
EXP057575	anti-TFIIB 	Saccharomyces cerevisiae	Genotype: Spt16 anchor-away; Treatment: no raptomicyn;	NULL	2978	normal	P29055	YJ127 strain	NULL
EXP057576	anti-TFIIB 	Saccharomyces cerevisiae	Genotype: Spt16 anchor-away; Treatment: raptomicyn;	NULL	2978	normal	P29055	YJ127 strain	NULL
EXP057577	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057578	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057579	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057580	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057581	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057582	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057583	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057584	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057585	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: uls1 delta;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057586	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: uls1 delta;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057587	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine); Genotype: uls1 delta;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057588	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine); Genotype: uls1 delta;	NULL	2979	chip_control	NULL	budding yeast	NULL
EXP057589	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057577	2979	normal	Q08562	budding yeast	NULL
EXP057590	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057578	2979	normal	Q08562	budding yeast	NULL
EXP057591	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057579	2979	normal	Q08562	budding yeast	NULL
EXP057592	anti-FLAG (Sigma, F3165)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057580	2979	normal	Q08562	budding yeast	NULL
EXP057593	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057581	2979	normal	P06786	budding yeast	NULL
EXP057594	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: wildtype;	EXP057582	2979	normal	P06786	budding yeast	NULL
EXP057595	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057583	2979	normal	P06786	budding yeast	NULL
EXP057596	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine);	EXP057584	2979	normal	P06786	budding yeast	NULL
EXP057597	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: uls1 delta;	EXP057585	2979	normal	P06786	budding yeast	NULL
EXP057598	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: YPD; Genotype: uls1 delta;	EXP057586	2979	normal	P06786	budding yeast	NULL
EXP057599	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine); Genotype: uls1 delta;	EXP057587	2979	normal	P06786	budding yeast	NULL
EXP057600	anti-HA (Roche, ROAHAHA)	Saccharomyces cerevisiae	Treatment: ACF(Top2 poison acriflavine); Genotype: uls1 delta;	EXP057584	2979	normal	P06786	budding yeast	NULL
EXP057601		Saccharomyces cerevisiae	Genotype: CSE4-HA cdc4-1; 	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP057602		Saccharomyces cerevisiae	Genotype: CSE4-HA cdc4-1; 	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP057603		Saccharomyces cerevisiae	Genotype: CSE4-HA met30-6;	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP057604		Saccharomyces cerevisiae	Genotype: CSE4-HA met30-6;	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP057605		Saccharomyces cerevisiae	Genotype: CSE4-HA(wildtype);	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP057606		Saccharomyces cerevisiae	Genotype: CSE4-HA(wildtype);	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP057607	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA cdc4-1; 	EXP057601	2980	normal	P36012	S288C strain	NULL
EXP057608	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA cdc4-1; 	EXP057602	2980	normal	P36012	S288C strain	NULL
EXP057609	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA met30-6;	EXP057603	2980	normal	P36012	S288C strain	NULL
EXP057610	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA met30-6;	EXP057604	2980	normal	P36012	S288C strain	NULL
EXP057611	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA(wildtype);	EXP057605	2980	normal	P36012	S288C strain	NULL
EXP057612	anti-HA (A2220, Sigma)	Saccharomyces cerevisiae	Genotype: CSE4-HA(wildtype);	EXP057606	2980	normal	P36012	S288C strain	NULL
EXP057613	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: wildtype; Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057614	Input	Saccharomyces cerevisiae	Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057615	Input	Saccharomyces cerevisiae	Genotype: Gat1-Myc; Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057616	Input	Saccharomyces cerevisiae	Genotype: Dal80-Myc; Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057617	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057618	Input	Saccharomyces cerevisiae	Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057619	Input	Saccharomyces cerevisiae	Genotype: Gat1-Myc; Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057620	Input	Saccharomyces cerevisiae	Genotype: Dal80-Myc; Conditions: grown in proline-containing medium;	NULL	2520	chip_control	NULL	whole cells	NULL
EXP057621	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Gat1-Myc; Conditions: grown in proline-containing medium;	EXP057615	2520	normal	P43574	whole cells	NULL
EXP057622	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Dal80-Myc; Conditions: grown in proline-containing medium;	EXP057616	2520	normal	P26343	whole cells	NULL
EXP057623	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Gat1-Myc; Conditions: grown in proline-containing medium;	EXP057619	2520	normal	A6ZTW2	whole cells	NULL
EXP057624	c-Myc Antibody (9E10, Santa Cruz Biotechnology, catalog# sc-40)	Saccharomyces cerevisiae	Genotype: Dal80-Myc; Conditions: grown in proline-containing medium;	EXP057620	2520	normal	P26343	whole cells	NULL
EXP057625	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP057626	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP057627	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP057628	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		NULL	2981	chip_control	NULL	N2 strain (developmental stage L4)	NULL
EXP057629	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		NULL	2981	chip_control	NULL	N2 strain (developmental stage L4)	NULL
EXP057630	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		NULL	2981	chip_control	NULL	N2 strain (developmental stage L4)	NULL
EXP057631	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057625	2193	normal	A7DTF0	whole worms(developmental stage L4)	NULL
EXP057632	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057626	2193	normal	A7DTF0	whole worms(developmental stage L4)	NULL
EXP057633	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057627	2193	normal	A7DTF0	whole worms(developmental stage L4)	NULL
EXP057634	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057628	2981	normal	A7DTF0	N2 strain (developmental stage L4)	NULL
EXP057635	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057629	2981	normal	A7DTF0	N2 strain (developmental stage L4)	NULL
EXP057636	MRG-1 antibody (Novus bio)	Caenorhabditis elegans		EXP057630	2981	normal	A7DTF0	N2 strain (developmental stage L4)	NULL
EXP057637		Caenorhabditis elegans		NULL	1235	chip_control	NULL	whole worms (developmental stage: young adults)	NULL
EXP057638	anti-PRDE-1	Caenorhabditis elegans		EXP057637	1235	normal	O17828	whole worms (developmental stage: young adults)	NULL
EXP057639	anti-SNPC4	Caenorhabditis elegans		EXP057637	1235	normal	P91868	whole worms (developmental stage: young adults)	NULL
EXP057640	anti-TOFU4	Caenorhabditis elegans		EXP057637	1235	normal	O01819	whole worms (developmental stage: young adults)	NULL
EXP057641	anti-TOFU5	Caenorhabditis elegans		EXP057637	1235	normal	Q23096	whole worms (developmental stage: young adults)	NULL
EXP057642	none	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	NULL	2982	chip_control	NULL	DLS395 strain (day1 adult)	NULL
EXP057643	none	Caenorhabditis elegans	Genotype: unc-119(tm4063); wgIs201;	NULL	2984	chip_control	NULL	OP201 strain(day 1 adult)	NULL
EXP057644	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	EXP057642	2982	normal	Q45EK2	DLS395 strain (day1 adult)	NULL
EXP057645	anti-HA (mIgG1, Pierce, 26181)	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	EXP057642	2982	normal	Q45EK2	DLS395 strain (day1 adult)	NULL
EXP057646	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: ceh-60(rhd116), gaIs285;	NULL	2983	normal	Q45EK2	DLS396 strain(day 1 adult)	NULL
EXP057647	anti-GFP (3E6, Thermo Fisher, A-11120)	Caenorhabditis elegans	Genotype: ceh-60(rhd116); gaIs285; Comment: isoform 7a;	NULL	2983	normal	Q9N5D6	DLS396 strain(day 1 adult)	NULL
EXP057648	anti-FLAG (M2, Sigma-Aldrich, F1804)	Caenorhabditis elegans	Genotype: unc-119(tm4063); wgIs201;	EXP057643	2984	normal	G5EFY7	OP201 strain(day 1 adult)	NULL
EXP057649	anti-FLAG (M2, Sigma-Aldrich, F1804)	Caenorhabditis elegans	Genotype: ceh-60(ok1485), wgIs201;	NULL	2985	normal	G5EFY7	DLS422 strain(day 1 adult)	NULL
EXP057650	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: ceh-60(rhd116);	NULL	2986	normal	Q45EK2	DLS395(day 1 adult)	NULL
EXP057651	anti-HA (3F10, Sigma-Aldrich, 11867423001)	Caenorhabditis elegans	Genotype: pqm-1(ok485), ceh-60(rhd116);	NULL	2987	normal	Q45EK2	DLS435(day 1 adult)	NULL
EXP057652	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial PA14 exposure for 4 hrs; Genotype: wildtype;	NULL	2981	normal	B3GWA6	N2 strain (developmental stage L4)	NULL
EXP057653	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial OP50 exposure for 4 hrs; Genotype: atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	NULL
EXP057654	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial PA14 exposure for 4 hrs; Genotype: atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	NULL
EXP057655	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial OP50 exposure for 4 hrs; Genotype: pmk-1 mutation, pmk-1(km25);atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	NULL
EXP057656	anti-GFP (Abcam,Ab290)	Caenorhabditis elegans	Conditions: bacterial PA14 exposure for 4 hrs; Genotype: pmk-1 mutation, pmk-1(km25);atf-7(qd328[atf-7::2xTY1::GFP]);	NULL	2193	normal	B3GWA6	whole worms(developmental stage L4)	NULL
EXP057657	none	Caenorhabditis elegans	Genotype: wildtype;	NULL	2988	chip_control	NULL	N2 strain	NULL
EXP057658	none	Caenorhabditis elegans	Genotype: wildtype;	NULL	2988	chip_control	NULL	N2 strain	NULL
EXP057659	none	Caenorhabditis elegans	Genotype: wildtype;	NULL	2988	chip_control	NULL	N2 strain	NULL
EXP057660	none	Caenorhabditis elegans		NULL	2989	chip_control	NULL	met-2(n4256) III strain	NULL
EXP057661	none	Caenorhabditis elegans		NULL	2989	chip_control	NULL	met-2(n4256) III strain	NULL
EXP057662	none	Caenorhabditis elegans		NULL	2989	chip_control	NULL	met-2(n4256) III strain	NULL
EXP057663	none	Caenorhabditis elegans		NULL	2990	chip_control	NULL	set-25(n5021) III	NULL
EXP057664	none	Caenorhabditis elegans		NULL	2990	chip_control	NULL	set-25(n5021) III	NULL
EXP057665	none	Caenorhabditis elegans		NULL	2990	chip_control	NULL	set-25(n5021) III	NULL
EXP057666	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans	Genotype: wildtype;	EXP057657	2988	normal	Q9XTB5	N2 strain	NULL
EXP057667	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans	Genotype: wildtype;	EXP057658	2988	normal	Q9XTB5	N2 strain	NULL
EXP057668	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans	Genotype: wildtype;	EXP057659	2988	normal	Q9XTB5	N2 strain	NULL
EXP057669	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057660	2989	normal	Q9XTB5	met-2(n4256) III strain	NULL
EXP057670	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057661	2989	normal	Q9XTB5	met-2(n4256) III strain	NULL
EXP057671	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057662	2989	normal	Q9XTB5	met-2(n4256) III strain	NULL
EXP057672	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057663	2990	normal	Q9XTB5	set-25(n5021) III	NULL
EXP057673	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057664	2990	normal	Q9XTB5	set-25(n5021) III	NULL
EXP057674	Lem-2 antibody (Novus Biologicals 48540002)	Caenorhabditis elegans		EXP057665	2990	normal	Q9XTB5	set-25(n5021) III	NULL
EXP057675	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057676	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057677	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057678	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057679	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057680	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057681	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057682	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057683	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057684	none	Drosophila melanogaster	Treatment: mock;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057685	none	Drosophila melanogaster	Treatment: dsCLAMP;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057686	none	Drosophila melanogaster	Treatment: dsCLAMP;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057687	anti-suhw(Guinea pig serum against Su(Hw), Moshkovich and Lei, 2010 PMID: 21852534)	Drosophila melanogaster	Treatment: mock;	EXP057684	1448	normal	A0A0B4K6W1	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057688	anti-suhw(Guinea pig serum against Su(Hw), Moshkovich and Lei, 2010 PMID: 21852534)	Drosophila melanogaster	Treatment: mock;	EXP057675	1448	normal	A0A0B4K6W1	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057689	anti-mod (Van Bortle et al., 2012, PMID: 22722341)	Drosophila melanogaster	Treatment: mock;	EXP057676	1448	normal	A0A0B4K6B8	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057690	anti-clamp (sdix, Cat no# 4988.00.02)	Drosophila melanogaster	Treatment: mock;	EXP057677	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057691	anti-cp190 (Pai et al. 2004, PMID: 15574329)	Drosophila melanogaster	Treatment: mock;	EXP057678	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057692	anti-mod (Van Bortle et al., 2012, PMID: 22722341)	Drosophila melanogaster	Treatment: mock;	EXP057679	1448	normal	A0A0B4K6B8	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057693	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: mock;	EXP057680	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057694	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: mock;	EXP057681	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057695	anti-clamp (sdix, Cat no# 4988.00.02)	Drosophila melanogaster	Treatment: mock;	EXP057682	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057696	anti-cp190 (Pai et al. 2004, PMID: 15574329)	Drosophila melanogaster	Treatment: mock;	EXP057683	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057697	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: dsCLAMP;	EXP057685	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057698	anti-clamp(abcam,by Erica N. Larschan, Brown University))	Drosophila melanogaster	Treatment: dsCLAMP;	EXP057686	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057699	anti-HA (Santa Cruz,F-7)	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057700	anti-HA (Santa Cruz,F-7)	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057701		Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057702		Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057703		Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057704	anti-HA (Santa Cruz,F-7)	Drosophila melanogaster		EXP057702	1450	normal	Q9VHS8	S2R+ (late embryonic stage cells)	NULL
EXP057705	anti-HA (Santa Cruz,F-7)	Drosophila melanogaster		EXP057703	1450	normal	Q9V535	S2R+ (late embryonic stage cells)	NULL
EXP057706	input	Drosophila melanogaster	Genotype: w1118; 	NULL	2203	chip_control	NULL	ovary	NULL
EXP057707	input	Drosophila melanogaster	Genotype: w1118; 	NULL	2203	chip_control	NULL	ovary	NULL
EXP057708	input	Drosophila melanogaster	Genotype: w1118; 	NULL	2203	chip_control	NULL	ovary	NULL
EXP057709	anti-dLsd1 (Dyson team in Boston [PMID 17462898])	Drosophila melanogaster	Genotype: w1118; 	EXP057706	2203	normal	B7Z0G7	ovary	NULL
EXP057710	anti-dLsd1 (Dyson team in Boston [PMID 17462898])	Drosophila melanogaster	Genotype: w1118; 	EXP057707	2203	normal	B7Z0G7	ovary	NULL
EXP057711	anti-dLsd1 (Dyson team in Boston [PMID 17462898])	Drosophila melanogaster	Genotype: w1118; 	EXP057708	2203	normal	B7Z0G7	ovary	NULL
EXP057712	None	Drosophila melanogaster		NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP057713	UPF1 Antibody (Generated in Lab)	Drosophila melanogaster		EXP057712	1451	normal	Q9VYS3	S2 (Schneider 2)	NULL
EXP057714	none	Drosophila melanogaster	Treatment: mock; Sex: female;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057715	none	Drosophila melanogaster	Treatment: mock; Sex: female;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057716	none	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057717	none	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057718	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057714	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057719	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057714	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057720	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057715	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057721	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: mock; Sex: female;	EXP057715	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057722	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057716	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057723	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057716	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057724	anti-CLAMP (rabbit, Rieder et al., 2017)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057717	1448	normal	Q9V9N4	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057725	anti-CP190 (rabbit, Pai et al., 2004)	Drosophila melanogaster	Treatment: CP190 knockdown; Sex: female;	EXP057717	1448	normal	Q24478	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057726	anti-Cap-H2	Drosophila melanogaster	Treatment: none;	NULL	1448	normal	A0A0C4DHE3	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057727	anti-Cap-H2	Drosophila melanogaster	Treatment: 3 hours Flv treatment;	NULL	1448	normal	A0A0C4DHE3	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057728	anti-Rad21	Drosophila melanogaster	Treatment: none;	NULL	1448	normal	Q9UB09	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057729	anti-Rad21	Drosophila melanogaster	Treatment: 3 hours Flv treatment;	NULL	1448	normal	Q9UB09	KC167 (developmental stage: 6-12h embryo)	NULL
EXP057730		Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057731		Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057732		Drosophila melanogaster	Treatment: none; Genotype: Mago knockdown;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057733	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057734	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057735	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RNAse treatment;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057736	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RNAse treatment;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057737	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RNAse treatment;	EXP057735	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057738	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RNAse treatment;	EXP057736	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057739	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none; 	EXP057731	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057740	HA-probe Antibody (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none; Genotype: Mago knockdown;	EXP057732	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057741		Drosophila melanogaster	Age: adult; Genotype: w[1118]; 	NULL	2203	chip_control	NULL	ovary	NULL
EXP057742		Drosophila melanogaster	Age: adult; Genotype: w[1118], rhi[18-5] / rhi[18-7] (rhino knockout); 	NULL	2203	chip_control	NULL	ovary	NULL
EXP057743		Drosophila melanogaster	Age: adult; Genotype: w[1118], nxf3[FS1_A3-5] / nxf3[FS3_B1-4] (nxf3 knockout);	NULL	2203	chip_control	NULL	ovary	NULL
EXP057744	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	Age: adult; Genotype: w[1118]; 	NULL	2203	normal	Q7JXA8	ovary	NULL
EXP057745	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	Age: adult; Genotype: w[1118], rhi[18-5] / rhi[18-7] (rhino knockout); 	EXP057742	2203	normal	Q7JXA8	ovary	NULL
EXP057746	anti-Rhino rabbit polyclonal antibody (PMID: 24906153)	Drosophila melanogaster	Age: adult; Genotype: w[1118], nxf3[FS1_A3-5] / nxf3[FS3_B1-4] (nxf3 knockout);	EXP057743	2203	normal	Q7JXA8	ovary	NULL
EXP057747	none	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057748	none	Drosophila melanogaster	Treatment: none;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057749	none	Drosophila melanogaster	Treatment: none; Genotype: Mago knockdown;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057750	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057751	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster		NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057752	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: Rnase T1;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057753	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: Rnase T1;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057754	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: Rnase T1;	EXP057752	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057755	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: Rnase T1;	EXP057753	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057756	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none;	EXP057748	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057757	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none; Genotype: Mago knockdown;	EXP057749	1450	normal	P49028	S2R+ (late embryonic stage cells)	NULL
EXP057758	none	Drosophila melanogaster	Treatment: none RnaseT1;	NULL	1450	chip_control	NULL	S2R+ (late embryonic stage cells)	NULL
EXP057759	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: none RnaseT1;	EXP057758	1450	normal	Q9VHC0	S2R+ (late embryonic stage cells)	NULL
EXP057760	anti-HA (F-7) (Santa Cruz, catalog# sc-7392, lot# I0916)	Drosophila melanogaster	Treatment: RnaseT1;	NULL	1450	normal	Q9VHC0	S2R+ (late embryonic stage cells)	NULL
EXP057761	none	Homo sapiens	Source: Head and neck squamous cell carcinoma;	NULL	1552	chip_control	NULL	tongue	NULL
EXP057762	anti-Pitx1 (Santa Cruz, 18922)	Homo sapiens	Source: Head and neck squamous cell carcinoma;	EXP057761	1552	normal	P78337	tongue	NULL
EXP057763	anti-Sox2 (R&D, AF2018)	Homo sapiens	Source: Head and neck squamous cell carcinoma;	EXP057761	1552	normal	P48431	tongue	NULL
EXP057764	anti-TP63 (Cell Signaling, 13109)	Homo sapiens	Source: Head and neck squamous cell carcinoma;	EXP057761	1552	normal	Q9H3D4	tongue	NULL
EXP057765		Homo sapiens	Developmental stage: day 8;	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP057766	anti-HNF4a	Homo sapiens	Developmental stage: day 8;	EXP057765	1143	normal	P41235	iPSC (induced pluripotent stem cells)	NULL
EXP057767	none	Homo sapiens		NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP057768	none (input)	Homo sapiens		NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP057769	anti-DNMT3B	Homo sapiens	Genotype: wildtype(control); 	EXP057767	1143	normal	Q9UBC3	iPSC (induced pluripotent stem cells)	NULL
EXP057770	anti-DNMT3B	Homo sapiens	Genotype: SALL3 knockout;	NULL	1143	normal	Q9UBC3	iPSC (induced pluripotent stem cells)	NULL
EXP057771	anti-SALL3	Homo sapiens		EXP057768	1143	normal	Q9BXA9	iPSC (induced pluripotent stem cells)	NULL
EXP057772	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: dBET6;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057773	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: dBET6;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057774	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Tratment: DMSO;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057775	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Tratment: DMSO;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057776		Homo sapiens	Treatment: dBET6;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057777		Homo sapiens	Treatment: dBET6;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057778		Homo sapiens	Tratment: DMSO;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057779		Homo sapiens	Tratment: DMSO;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057780	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Genotype: MTHFD1, clone C8;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057781		Homo sapiens	Genotype: MTHFD1, clone C8;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057782	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Genotype: MTHFD1, clone F5;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057783		Homo sapiens	Genotype: MTHFD1, clone F5;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057784	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: none; Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057785	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: none; Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057786		Homo sapiens	Treatment: none; Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057787		Homo sapiens	Treatment: none; Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP057788	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Treatment: dBET6;	EXP057776	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057789	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Treatment: dBET6;	EXP057777	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057790	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Tratment: DMSO;	EXP057778	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057791	anti-BRD4 (A301?985A, Bethyl Labs)	Homo sapiens	Tratment: DMSO;	EXP057779	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057792	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: dBET6;	EXP057776	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057793	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: dBET6;	EXP057777	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057794	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Tratment: DMSO;	EXP057778	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057795	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Tratment: DMSO;	EXP057779	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057796	mouse IgG (sc-2025, Santa Cruz)	Homo sapiens	Treatment: mock; 	NULL	1507	normal	A0A023HHK9	HAP1 (chronic myelogenous leukemia)	NULL
EXP057797	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Genotype: MTHFD1, clone C8;	EXP057781	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057798	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Genotype: MTHFD1, clone C8;	EXP057781	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057799	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Genotype: MTHFD1, clone F5;	EXP057783	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057800	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Genotype: MTHFD1, clone F5;	EXP057783	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057801	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057786	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057802	anti-BRD4 ((A301?985A, Bethyl Labs)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057787	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP057803	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057786	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057804	anti-MTHFD1 (C3, Santa Cruz)	Homo sapiens	Treatment: none; Genotype: wildtype;	EXP057787	1507	normal	P11586	HAP1 (chronic myelogenous leukemia)	NULL
EXP057805	anti-IgG (Abcam ab37415, RRID: AB_2631996)	Homo sapiens	Developmental stage: proliferating fibroblasts;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057806	anti-IgG (Abcam ab37415, RRID: AB_2631996)	Homo sapiens	Developmental stage: proliferating fibroblasts;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057807	anti-IgG (Abcam ab37415, RRID: AB_2631996)	Homo sapiens	Developmental stage: replicative senescence;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057808	anti-IgG (Abcam ab37415, RRID: AB_2631996)	Homo sapiens	Developmental stage: replicative senescence;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057809	none	Homo sapiens	Developmental stage: proliferating fibroblasts;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057810	none	Homo sapiens	Developmental stage: proliferating fibroblasts;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057811	none	Homo sapiens	Developmental stage: replicative senescence;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057812	none	Homo sapiens	Developmental stage: replicative senescence;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP057813	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057809	489	normal	Q92793	IMR90 (lung fibroblasts)	NULL
EXP057814	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057810	489	normal	Q92793	IMR90 (lung fibroblasts)	NULL
EXP057815	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: replicative senescence;	EXP057811	489	normal	Q92793	IMR90 (lung fibroblasts)	NULL
EXP057816	anti-CBP(Cell Signaling Technology 7389, RRID: AB_10949313)	Homo sapiens	Developmental stage: replicative senescence;	EXP057812	489	normal	Q92793	IMR90 (lung fibroblasts)	NULL
EXP057817	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057809	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP057818	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: proliferating fibroblasts;	EXP057810	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP057819	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: replicative senescence;	EXP057811	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP057820	anti-p300(Santa Cruz Biotechnology sc-585X, RRID: AB_2616339)	Homo sapiens	Developmental stage: replicative senescence;	EXP057812	489	normal	Q09472	IMR90 (lung fibroblasts)	NULL
EXP057821	anti-HIF1A	Homo sapiens	Treatment: siCtrl;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	NULL
EXP057822	anti-HIF1A	Homo sapiens	Treatment: siOC2; Genotype: OC2 knockout ;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	NULL
EXP057823	anti-Flag	Homo sapiens	Treatment: normoxia;	NULL	70	normal	O95948	LNCaP (prostate carcinoma)	NULL
EXP057824	anti-Flag	Homo sapiens	Treatment: hypoxia(0.2% O2);	NULL	70	normal	O95948	LNCaP (prostate carcinoma)	NULL
EXP057825	anti-HIF2A	Homo sapiens	Treatment: hypoxia(0.2% O2);	NULL	725	normal	Q99814	PC3(bone mets prostate adenocarcinoma)	NULL
EXP057826	anti-HIF1A	Homo sapiens	Treatment: hypoxia(0.2% O2), siCtrl;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	NULL
EXP057827	anti-HIF1A	Homo sapiens	Treatment: hypoxia(0.2% O2), siSMAD3; Genotype: SMAD3 knockout;	NULL	725	normal	Q16665	PC3(bone mets prostate adenocarcinoma)	NULL
EXP057828	anti-SMAD3	Homo sapiens	Treatment: hypoxia (0.2% O2);	NULL	725	normal	P84022	PC3(bone mets prostate adenocarcinoma)	NULL
EXP057829	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP057830	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP057831	none	Homo sapiens		NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP057832	none	Homo sapiens		NULL	664	chip_control	NULL	SH-SY5Y (neuroblastoma)	NULL
EXP057833	none	Homo sapiens	Treatment: serum starvation;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP057834	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057830	430	normal	P06213	HepG2 (hepatoblastoma)	NULL
EXP057835	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057829	430	normal	P06213	HepG2 (hepatoblastoma)	NULL
EXP057836	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057831	664	normal	P06213	SH-SY5Y (neuroblastoma)	NULL
EXP057837	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens		EXP057832	664	normal	P06213	SH-SY5Y (neuroblastoma)	NULL
EXP057838	anti-IR beta (Santa Cruz, sc-711,rabbit)	Homo sapiens	Treatment: serum starvation;	EXP057833	430	normal	P06213	HepG2 (hepatoblastoma)	NULL
EXP057839	none	Homo sapiens	Genotype: wildtype;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP057840	none	Homo sapiens	Genotype: wildtype;	NULL	395	chip_control	NULL	H9-derived neural progenitors	NULL
EXP057841	anti-53BP1(Abcam,ab36823)	Homo sapiens	Genotype: wildtype;	EXP057840	395	normal	Q12888	H9-derived neural progenitors	NULL
EXP057842	anti-53BP1(Novus,NB100-304)	Homo sapiens	Genotype: wildtype;	EXP057840	395	normal	Q12888	H9-derived neural progenitors	NULL
EXP057843	anti-UTX(Abcam,ab84190)	Homo sapiens	Genotype: wildtype;	EXP057840	395	normal	O15550	H9-derived neural progenitors	NULL
EXP057844	anti-UTX(Abcam,ab91231)	Homo sapiens	Genotype: wildtype;	NULL	396	normal	O15550	WA09 (embryonic stem cells)	NULL
EXP057845	anti-UTX (Bethyl,A302-374A)	Homo sapiens	Genotype: wildtype; 	NULL	934	normal	O15550	HOT1 tumor derived from a human glioblastoma	NULL
EXP057846	anti-53BP1(Abcam,ab36823)	Homo sapiens	Genotype: wildtype;	EXP057839	396	normal	Q12888	WA09 (embryonic stem cells)	NULL
EXP057847	anti-53BP1(Novus,NB100-304)	Homo sapiens	Genotype: wildtype;	EXP057839	396	normal	Q12888	WA09 (embryonic stem cells)	NULL
EXP057848	anti-UTX(Abcam,ab84190)	Homo sapiens	Genotype: wildtype;	EXP057839	396	normal	O15550	WA09 (embryonic stem cells)	NULL
EXP057849	anti-UTX (Bethyl,A302-374A)	Homo sapiens	Genotype: 53BP1 KO;	NULL	395	normal	O15550	H9-derived neural progenitors	NULL
EXP057850	anti-53BP1 (Novus,NB100-304)	Homo sapiens	Genotype: UTX knockdown;	NULL	396	normal	Q12888	WA09 (embryonic stem cells)	NULL
EXP057851		Homo sapiens	Treatment: untreated;	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057852		Homo sapiens	Treatment: treated with E2 for 1 hr;	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057853		Homo sapiens	Treatment: treated with E2 for 4 hrs;	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057854		Homo sapiens	Treatment: treated with E2 for 16 hrs;	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057855		Homo sapiens	Treatment: treated with E2 for 24 hrs;	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057856		Homo sapiens		NULL	2992	chip_control	NULL	MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line)	NULL
EXP057857	anti-ERa	Homo sapiens	Treatment: untreated;	EXP057851	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057858	anti-CTCF	Homo sapiens	Treatment: untreated;	EXP057851	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057859	anti-ERa	Homo sapiens	Treatment: treated with E2 for 1 hr;	EXP057852	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057860	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 1 hr;	EXP057852	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057861	anti-ERa	Homo sapiens	Treatment: treated with E2 for 4 hrs;	EXP057853	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057862	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 4 hrs;	EXP057853	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057863	anti-ERa	Homo sapiens	Treatment: treated with E2 for 16 hrs;	EXP057854	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057864	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 16 hrs;	EXP057854	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057865	anti-ERa	Homo sapiens	Treatment: treated with E2 for 24 hrs;	EXP057855	2991	normal	P03372	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057866	anti-CTCF	Homo sapiens	Treatment: treated with E2 for 24 hrs;	EXP057855	2991	normal	P49711	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP057867	anti-ERa	Homo sapiens		EXP057856	2992	normal	P03372	MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line)	NULL
EXP057868	anti-CTCF	Homo sapiens		EXP057856	2992	normal	P49711	MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line)	NULL
EXP057869	anti-HIF-1alpha (Bethyl Laboratories, Cat.# A300-286A)	Homo sapiens	Treatment: 1% O2;	NULL	2301	normal	Q16665	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP057870	anti-ZMYND8 (Bethyl Laboratories, Cat.#A302-089A)	Homo sapiens	Treatment: 1% O2;	NULL	2301	normal	Q9ULU4	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP057871	None	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057872	None	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057873	None	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057874	None	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057875	None	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057876	None	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057877	None	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057878	None	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP057879	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	EXP057873	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057880	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: mock, normal state;	EXP057874	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057881	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	EXP057877	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057882	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Conditions: mock, normal state;	EXP057878	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057883	TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: starvation, no-serum;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057884	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: wildtype; Conditions: SF, addition of FBS into the no-serum culture after cell-starved for for 24 h;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057885	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Treatment: starvation, no-serum;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057886	anti-TEAD1(Cell Signaling Technology.12292S)	Homo sapiens	Genotype: KDM3A knockout; Conditions:SF, addition of FBS into the no-serum culture after cell-starved for for 24 h;	NULL	417	normal	P28347	HCT-116 (colon carcinoma)	NULL
EXP057887	IgG	Homo sapiens	Passage: ten-thirty; Genotype: EGFP transfection;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP057888	IgG	Homo sapiens	Passage: ten-thirty; Genotype: EGFP transfection;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP057889	IgG	Homo sapiens	Passage: ten-thirty; Genotype: OMOMYC transfection;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP057890	IgG	Homo sapiens	Passage: ten-thirty; Genotype: OMOMYC transfection;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP057891	IgG	Homo sapiens	Passage: ten-thirty; Genotype: SNF5 transfection;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP057892	IgG	Homo sapiens	Passage: ten-thirty; Genotype: SNF5 transfection;	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP057893	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: EGFP transfection;	EXP057887	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	NULL
EXP057894	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: EGFP transfection;	EXP057888	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	NULL
EXP057895	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: OMOMYC transfection;	EXP057889	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	NULL
EXP057896	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: OMOMYC transfection;	EXP057890	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	NULL
EXP057897	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: SNF5 transfection;	EXP057891	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	NULL
EXP057898	anti-MYC	Homo sapiens	Passage: ten-thirty; Genotype: SNF5 transfection;	EXP057892	937	normal	P01106	G401 (rhabdoid tumor of the kidney)	NULL
EXP057899	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with DMSO (Veh control) for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 12;	NULL	2993	normal	P04150	monocytes from periferal blood	NULL
EXP057900	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with 1 micromolar (1uM) TA for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 12;	NULL	2993	normal	P04150	monocytes from periferal blood	NULL
EXP057901	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with DMSO (Veh control) for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 11;	NULL	911	normal	P04150	macrophages	NULL
EXP057902	anti-Glucocorticoid receptor	Homo sapiens	Treatment: treated with 1 micromolar (1uM) TA for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 11;	NULL	911	normal	P04150	macrophages	NULL
EXP057903	none (input)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	NULL	2994	chip_control	NULL	definitive endoderm from HUES8	NULL
EXP057904	none (input)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	NULL	2994	chip_control	NULL	definitive endoderm from HUES8	NULL
EXP057905	none (input)	Homo sapiens	Genotype: SOX17-GFP knockout;	NULL	2369	chip_control	NULL	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057906		Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	NULL	2994	chip_control	NULL	definitive endoderm from HUES8	NULL
EXP057907		Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	NULL	2994	chip_control	NULL	definitive endoderm from HUES8	NULL
EXP057908		Homo sapiens	Genotype: SOX17-GFP knockout;	NULL	2369	chip_control	NULL	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057909		Homo sapiens	Genotype: SOX17-GFP knockout;	NULL	2994	chip_control	NULL	definitive endoderm from HUES8	NULL
EXP057910		Homo sapiens	Genotype: SOX17-GFP knockout;	NULL	2994	chip_control	NULL	definitive endoderm from HUES8	NULL
EXP057911	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057903	2994	normal	Q15796	definitive endoderm from HUES8	NULL
EXP057912	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057903	2994	normal	P05412	definitive endoderm from HUES8	NULL
EXP057913	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057903	2994	normal	Q92908	definitive endoderm from HUES8	NULL
EXP057914	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057904	2994	normal	Q15796	definitive endoderm from HUES8	NULL
EXP057915	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057904	2994	normal	Q92908	definitive endoderm from HUES8	NULL
EXP057916	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	Q15796	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057917	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	P05412	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057918	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057906	2994	normal	Q15796	definitive endoderm from HUES8	NULL
EXP057919	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057906	2994	normal	P05412	definitive endoderm from HUES8	NULL
EXP057920	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: DMSO;	EXP057906	2994	normal	Q92908	definitive endoderm from HUES8	NULL
EXP057921	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057907	2994	normal	Q15796	definitive endoderm from HUES8	NULL
EXP057922	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout; Treatment: JNKi;	EXP057907	2994	normal	Q92908	definitive endoderm from HUES8	NULL
EXP057923	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057908	2369	normal	Q15796	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057924	anti-JUN (Cell Signaling Techology 9165S)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057908	2369	normal	P05412	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057925	anti-OCT4	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	Q01860	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057926	anti-NANOG	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057905	2369	normal	Q9H9S0	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057927	anti-OCT4	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057908	2369	normal	Q01860	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057928	anti-NANOG	Homo sapiens	Genotype: SOX17-GFP knockout;	NULL	2369	normal	Q9H9S0	HUES8 (Embryonic stem cell, blastocyst stage)	NULL
EXP057929	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057909	2994	normal	Q15796	definitive endoderm from HUES8	NULL
EXP057930	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057909	2994	normal	Q92908	definitive endoderm from HUES8	NULL
EXP057931	anti-SMAD2/3 (Cell Signaling Techology 8685)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057910	2994	normal	Q15796	definitive endoderm from HUES8	NULL
EXP057932	anti-GATA6 (Cell Signaling Techology 5851)	Homo sapiens	Genotype: SOX17-GFP knockout;	EXP057910	2994	normal	Q92908	definitive endoderm from HUES8	NULL
EXP057933	input	Homo sapiens	Developmental stage: day 1;	NULL	2996	chip_control	NULL	adipose stem cells	NULL
EXP057934	input	Homo sapiens	Developmental stage: day 3;	NULL	2996	chip_control	NULL	adipose stem cells	NULL
EXP057935	input	Homo sapiens	Developmental stage: day 0;	NULL	2996	chip_control	NULL	adipose stem cells	NULL
EXP057936	input	Homo sapiens		NULL	2995	chip_control	NULL	proliferating adipose stem cells (ASC)	NULL
EXP057937	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens		EXP057936	2995	normal	P20700	proliferating adipose stem cells (ASC)	NULL
EXP057938	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens	Developmental stage: day 0;	EXP057935	2996	normal	P20700	adipose stem cells	NULL
EXP057939	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens	Developmental stage: day 1;	EXP057933	2996	normal	P20700	adipose stem cells	NULL
EXP057940	anti-lamin B1 antibody (Abcam, ab16048)	Homo sapiens	Developmental stage: day 3;	EXP057934	2996	normal	P20700	adipose stem cells	NULL
EXP057941	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after HySp5 transfection;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP057942	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after HySp5_dDBD transfection;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP057943	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after zFSp5 transfection;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP057944	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after zFSp5_dDBD transfection;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP057945	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after HySp5 transfection;	EXP057941	421	normal	Q6BEB4	HEK293 (embryonic kidney)	NULL
EXP057946	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after HySp5_dDBD transfection;	EXP057942	421	normal	Q6BEB4	HEK293 (embryonic kidney)	NULL
EXP057947	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after zFSp5 transfection;	EXP057943	421	normal	Q6BEB4	HEK293 (embryonic kidney)	NULL
EXP057948	anti-HA (Novus biologicals NB600-363)	Homo sapiens	Treatment :24 hrs after zFSp5_dDBD transfection;	EXP057944	421	normal	Q6BEB4	HEK293 (embryonic kidney)	NULL
EXP057949	anti-Flag (Sigma, catalog# F1804, lot# SLBT7654) antibody	Homo sapiens	Treatment: treated started from 5 uM,  increased to 10 uM, 15uM and finally 20 uM;	NULL	2997	normal	P51532	TOV-21G (Ovarian clear cell adenocarcinoma)	NULL
EXP057950	anti-Flag (Sigma, catalog# F1804, lot# SLBT7654) antibody	Homo sapiens	Treatment: treated started from 5 uM,  increased to 10 uM, 15uM and finally 20 uM;	NULL	2998	normal	P51532	resistant clone 3 TOV21G (Ovarian clear cell adenocarcinoma)	NULL
EXP057951	Input	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	2999	chip_control	NULL	foreskin fibroblast	NULL
EXP057952	Input	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	NULL	2999	chip_control	NULL	foreskin fibroblast	NULL
EXP057953	Input	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP057954	Input	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP057955	Input	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP057956	Input	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP057957	Input	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	2999	chip_control	NULL	foreskin fibroblast	NULL
EXP057958	Input	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	NULL	2999	chip_control	NULL	foreskin fibroblast	NULL
EXP057959	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057951	2999	normal	P04637	foreskin fibroblast	NULL
EXP057960	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057952	2999	normal	P04637	foreskin fibroblast	NULL
EXP057961	anti-p63	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057953	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	NULL
EXP057962	anti-p63	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057954	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	NULL
EXP057963	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057953	583	normal	P04637	MCF10A (breast epithelial cells)	NULL
EXP057964	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057954	583	normal	P04637	MCF10A (breast epithelial cells)	NULL
EXP057965	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057955	583	normal	P04637	MCF10A (breast epithelial cells)	NULL
EXP057966	anti-p63	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057955	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	NULL
EXP057967	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057956	583	normal	P04637	MCF10A (breast epithelial cells)	NULL
EXP057968	anti-p63	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057956	583	normal	Q9H3D4	MCF10A (breast epithelial cells)	NULL
EXP057969	anti-p53	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP057957	2999	normal	P04637	foreskin fibroblast	NULL
EXP057970	anti-p53	Homo sapiens	Treatment: 5 uM Nutlin3A for 6 hrs;	EXP057958	2999	normal	P04637	foreskin fibroblast	NULL
EXP057971	none	Homo sapiens		NULL	3000	chip_control	NULL	LPS141 (Dedifferentiated liposarcoma)	NULL
EXP057972	none	Homo sapiens		NULL	3001	chip_control	NULL	MLS 402-91 (Myxoid liposarcoma)	NULL
EXP057973	anti-BRD2 (Proteintech, #22236-1-AP)	Homo sapiens		EXP057971	3000	normal	P25440	LPS141 (Dedifferentiated liposarcoma)	NULL
EXP057974	anti-BRD3 (Bethyl, #A302-367A)	Homo sapiens		EXP057971	3000	normal	Q15059	LPS141 (Dedifferentiated liposarcoma)	NULL
EXP057975	anti-BRD4 (Bethyl, #A301-985A, lot4)	Homo sapiens		EXP057971	3000	normal	O60885	LPS141 (Dedifferentiated liposarcoma)	NULL
EXP057976	anti-FOSL2 (Santa Cruz, #sc-604X)	Homo sapiens		EXP057971	3000	normal	P15408	LPS141 (Dedifferentiated liposarcoma)	NULL
EXP057977	anti-pan-RUNX (Abcam, #ab92336)	Homo sapiens		EXP057971	3000	normal	Q01196	LPS141 (Dedifferentiated liposarcoma)	NULL
EXP057978	anti-DIT3 (Cell Signaling Technology, #2895)	Homo sapiens		EXP057972	3001	normal	P35638	MLS 402-91 (Myxoid liposarcoma)	NULL
EXP057979	anti-BRD4 (Bethyl, #A301-985A, lot4)	Homo sapiens		EXP057972	3001	normal	O60885	MLS 402-91 (Myxoid liposarcoma)	NULL
EXP057980	anti-CENP-A	Homo sapiens	Developmental stage: Asynchronous;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP057981	anti-CENP-A	Homo sapiens	Developmental stage: Asynchronous;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP057982	anti-CENP-A	Homo sapiens	Developmental stage: G1;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP057983	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP057984	anti-CENP-A	Homo sapiens	Developmental stage: Asynchronous;	EXP057980	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP057985	anti-CENP-A	Homo sapiens	Developmental stage: G1;	EXP057982	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP057986	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	EXP057983	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP057987	anti-CENP-A	Homo sapiens	Developmental stage: Asynchronous;	EXP057981	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP057988	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	NULL	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP057989	anti-CENP-A	Homo sapiens	Developmental stage: S4;	NULL	78	normal	P49450	HeLa (cervical adenocarcinoma)	NULL
EXP057990	anti-CENP-A	Homo sapiens	Developmental stage: S/G2;	NULL	78	normal	A0AVK6	HeLa (cervical adenocarcinoma)	NULL
EXP057991	anti-MLLT3 (Genetex, GTX102835)	Homo sapiens		NULL	3003	chip_control	NULL	hSPC CD34+CD38-/lowCD90+	NULL
EXP057992	anti-MLLT3 (Genetex, GTX102835)	Homo sapiens		EXP057991	3003	normal	P42568	hSPC CD34+CD38-/lowCD90+	NULL
EXP057993	anti-MLLT3 (Genetex, GTX102835)	Homo sapiens		NULL	3002	normal	P42568	erythroblasts CD34-CD71+CD235a+	NULL
EXP057994	anti-V5(Abcam, ab15828)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: control;  Treatment: lentivirus infection with empty vector;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	NULL
EXP057995	anti-V5(Abcam, ab15828)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: MLLT3 overexpression; Treatment: lentivirus infection with MLLT3 overexpression;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	NULL
EXP057996	anti-MLLT3(Genetex, GTX102835)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: control;  Treatment: lentivirus infection with empty vector;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	NULL
EXP057997	anti-MLLT3(Genetex, GTX102835)	Homo sapiens	Source:fetal liver FL CD34+CD38-/lowCD90+GFP+ cells; Genotype: MLLT3 overexpression; Treatment: lentivirus infection with MLLT3 overexpression;	NULL	3004	normal	P42568	hematopoietic stem-progenitor cells	NULL
EXP057998	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	NULL
EXP057999	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	NULL
EXP058000	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Bone marrow; Age: 55-60; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	NULL
EXP058001	RUNX1 antibody (Abcam: ab23980)	Homo sapiens	Sex: male; Tissue: Venous blood; Age: 65-70; Genotype: RUNX1 mutant;	NULL	3005	normal	Q01196	myeloid cell	NULL
EXP058002	anti-HMGA1 antibody (Abcam, Cat. No. 129153, lot GR211599-2)	Homo sapiens	Treatment: infected with RAS;	NULL	489	normal	P17096	IMR90 (lung fibroblasts)	NULL
EXP058003	anti-HMGA1 antibody (Abcam, Cat. No. 129153, lot GR211599-2)	Homo sapiens	Treatment: infected with vector control;	NULL	489	normal	P17096	IMR90 (lung fibroblasts)	NULL
EXP058004	none	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	NULL	3006	chip_control	NULL	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058005	none	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	NULL	3006	chip_control	NULL	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058006	none	Homo sapiens	Treatment: trasfection pWZL-NMYCwt;	NULL	3006	chip_control	NULL	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058007	none	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058008	none	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058009	none	Homo sapiens	Treatment: 200 nM EtOH,4-OHT for 3hrs, etoposide,flavopiridol for 2 hrs;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058010	none	Homo sapiens	Treatment: 200 nM EtOH,4-OHT for 3hrs, shSCR, shBRCA1#1;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058011	none	Homo sapiens	Treatment: pRRL-NMYC;	NULL	3006	chip_control	NULL	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058012	none	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, shBRCA1#1;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058013	none	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, shBRCA1#1; 	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058014	none	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, shSCR;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058015	none	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, shSCR; 	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058016	none	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058017	none	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058018	none	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058019	none	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	NULL	3007	chip_control	NULL	SH-EP-NMYCER	NULL
EXP058020	anti-BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058004	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058021	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058005	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058022	anti-BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: trasfection pWZL-empty;	EXP058006	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058023	anti-BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: trasfection pWZL-NMYCwt;	EXP058006	3006	normal	P38398	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058024	anti-NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058007	3007	normal	P04198	SH-EP-NMYCER	NULL
EXP058025	anti-NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058008	3007	normal	P04198	SH-EP-NMYCER	NULL
EXP058026	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058009	3007	normal	P38398	SH-EP-NMYCER	NULL
EXP058027	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, 5uM etoposide for 2 hrs;	EXP058009	3007	normal	P38398	SH-EP-NMYCER	NULL
EXP058028	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, 5uM etoposide for 2 hrs; 	EXP058009	3007	normal	P38398	SH-EP-NMYCER	NULL
EXP058029	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, 10nM flavopiridol for 2 hrs;	EXP058009	3007	normal	P38398	SH-EP-NMYCER	NULL
EXP058030	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, 10nM flavopiridol for 2 hrs; 	EXP058009	3007	normal	P38398	SH-EP-NMYCER	NULL
EXP058031	BRCA1 (Bethyl, A300-000A)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058009	3007	normal	P38398	SH-EP-NMYCER	NULL
EXP058032	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, shBRCA1#1;	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	NULL
EXP058033	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs,shBRCA1#1; 	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	NULL
EXP058034	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs, shSCR;	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	NULL
EXP058035	DCP1A (Santa Cruz, sc-100706)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs, shSCR; 	EXP058010	3007	normal	Q9NPI6	SH-EP-NMYCER	NULL
EXP058036	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: pRRL-NMYC;	EXP058011	3006	normal	P04198	SH-EP (Neuroblastoma, Derived from metastatic site: Bone marrow)	NULL
EXP058037	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058012	3007	normal	P04198	SH-EP-NMYCER	NULL
EXP058038	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058013	3007	normal	P04198	SH-EP-NMYCER	NULL
EXP058039	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM EtOH continuously for 3 hrs;	EXP058014	3007	normal	P04198	SH-EP-NMYCER	NULL
EXP058040	NMYC (B8.4.B, Santa Cruz, sc-53993)	Homo sapiens	Treatment: 200 nM 4-OHT continuously for 3 hrs; 	EXP058015	3007	normal	P04198	SH-EP-NMYCER	NULL
EXP058041	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Genotype: control; 	NULL	3008	normal	Q01196	cord blood CD34 cells	NULL
EXP058042	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Genotype: RUNX1mut transduced;	NULL	3008	normal	Q01196	cord blood CD34 cells	NULL
EXP058043	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 31 day;Genotype: control; 	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	NULL
EXP058044	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 31 day; Treatment: dox; Genotype: DOX-induced RUNX1mut;	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	NULL
EXP058045	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 34 day; Genotype: control; 	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	NULL
EXP058046	anti-RUNX1(Abcam, ab23980)	Homo sapiens	Characteristic: harvest time 34 day; Treatment: dox; Genotype: DOX-induced RUNX1mut;	NULL	1143	normal	Q01196	iPSC (induced pluripotent stem cells)	NULL
EXP058047	none	Homo sapiens	Treatment: none; Condition: heat shock;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058048	none	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058049	anti-NELFA (Santa Cruz, sc-23599)	Homo sapiens	Treatment: none; Condition: heat shock;	EXP058047	514	normal	Q9H3P2	K562 (myelogenous leukemia)	NULL
EXP058050	anti-NELFE (Sigma, A81919)	Homo sapiens	Treatment: none; Condition: heat shock;	EXP058047	514	normal	P18615	K562 (myelogenous leukemia)	NULL
EXP058051	anti-NELFA (Santa Cruz, sc-23599)	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	EXP058048	514	normal	Q9H3P2	K562 (myelogenous leukemia)	NULL
EXP058052	anti-NELFE (Sigma, A81919)	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	EXP058048	514	normal	P18615	K562 (myelogenous leukemia)	NULL
EXP058053	anti-p38 (MAPK14,E229, ab170099)	Homo sapiens	Treatment: none; Condition: Non Heat-Shock;	EXP058048	514	normal	Q16539	K562 (myelogenous leukemia)	NULL
EXP058054	anti-p38 (MAPK14,E229, ab170099)	Homo sapiens	Treatment: none; Condition: Heat-Shock;	EXP058047	514	normal	Q16539	K562 (myelogenous leukemia)	NULL
EXP058055	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058056	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058057	none	Homo sapiens		NULL	3009	chip_control	NULL	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	NULL
EXP058058	none	Homo sapiens		NULL	3009	chip_control	NULL	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	NULL
EXP058059	none	Homo sapiens		NULL	3010	chip_control	NULL	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058060	none	Homo sapiens		NULL	3010	chip_control	NULL	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058061	none	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	NULL	3010	chip_control	NULL	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058062	none	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	NULL	3010	chip_control	NULL	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058063	c Jun (Cell Signaling; 9165S)	Homo sapiens		EXP058055	2301	normal	P05412	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058064	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058056	2301	normal	P05412	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058065	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058057	3009	normal	P05412	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	NULL
EXP058066	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058058	3009	normal	P05412	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	NULL
EXP058067	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058059	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058068	cJun (Cell Signaling; 9165S)	Homo sapiens		EXP058060	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058069	cJun (Cell Signaling; 9165S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058061	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058070	cJun (Cell Signaling; 9165S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058062	3010	normal	P05412	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058071	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058055	2301	normal	P46527	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058072	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058056	2301	normal	P46527	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058073	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058057	3009	normal	P46527	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	NULL
EXP058074	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058058	3009	normal	P46527	MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line)	NULL
EXP058075	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058059	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058076	p27 (Cell Signaling; 3686S)	Homo sapiens		EXP058060	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058077	p27 (Cell Signaling; 3686S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058061	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058078	p27 (Cell Signaling; 3686S)	Homo sapiens	Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27;	EXP058062	3010	normal	P46527	MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line)	NULL
EXP058079	None	Homo sapiens	Treatment: shRNA; Genotype: CDH1 knockdown;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP058080	None	Homo sapiens	Source: organoid dissociation;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP058081	None	Homo sapiens	Source: organoid integrity;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP058082	None	Homo sapiens	Source: organoid dissociation;	NULL	3012	chip_control	NULL	CRC121 (colorectal cancer metastatic stem cells)	NULL
EXP058083	None	Homo sapiens	Source: organoid integrity;	NULL	3012	chip_control	NULL	CRC121 (colorectal cancer metastatic stem cells)	NULL
EXP058084	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Treatment: shRNA; Genotype: CDH1 knockdown;	EXP058079	3011	normal	Q13127	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP058085	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid dissociation;	EXP058080	3011	normal	Q13127	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP058086	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid integrity;	EXP058081	3011	normal	Q13127	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP058087	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid dissociation;	EXP058082	3012	normal	Q13127	CRC121 (colorectal cancer metastatic stem cells)	NULL
EXP058088	REST (Millipore Sigma, 07-579, lot 2843200)	Homo sapiens	Source: organoid integrity;	EXP058083	3012	normal	Q13127	CRC121 (colorectal cancer metastatic stem cells)	NULL
EXP058089	None	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058090	None	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058091	anti-FoxN3 (Abgent, AP19255B)	Homo sapiens		EXP058089	430	normal	O00409	HepG2 (hepatoblastoma)	NULL
EXP058092	anti-FoxN3 (Abgent, AP19255B)	Homo sapiens		EXP058090	430	normal	O00409	HepG2 (hepatoblastoma)	NULL
EXP058093	none	Mus musculus		NULL	3013	chip_control	NULL	duodenum epithelium	NULL
EXP058094	Smad4 (Cell signaling ,#46535, lot 2)	Mus musculus		EXP058093	3013	normal	P97471	duodenum epithelium	NULL
EXP058095	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058096	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058097	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP058098	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP058099	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058095	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058100	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058096	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058101	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058095	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058102	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058096	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058103	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058098	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP058104	anti-FOXA1 (ab5089, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058097	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP058105	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with vehicle;	EXP058097	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP058106	anti-FOXA1 (ab23738, Abcam)	Homo sapiens	Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins;	EXP058098	874	normal	P55317	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP058107	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	2311	chip_control	NULL	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP058108	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treament: 500 nM of Imatinib;	NULL	2311	chip_control	NULL	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP058109	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treatment: 500 nM of JQ1;	NULL	2311	chip_control	NULL	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP058110	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treatment: DMSO for 24 hours;	EXP058107	2311	normal	O60885	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP058111	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treament: 500 nM of Imatinib;	EXP058108	2311	normal	O60885	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP058112	anti-BRD4 (Bethyl Laboratories, A301-985A100)	Homo sapiens	Treatment: 500 nM of JQ1;	EXP058109	2311	normal	O60885	GIST-T1 (Gastrointestinal stromal tumor)	NULL
EXP058113	anti-EZH2	Homo sapiens	Genotype: wildtype; Passage: 30-60;	NULL	878	normal	Q15910	embryonic stem cells	NULL
EXP058114	anti-EZH2	Homo sapiens	Genotype: Bach1 knockout; Passage: 30-60;	NULL	878	normal	Q15910	embryonic stem cells	NULL
EXP058115	anti-mettl3	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058116	anti-mettl3	Homo sapiens		EXP058115	78	normal	Q86U44	HeLa (cervical adenocarcinoma)	NULL
EXP058117	none	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP058118	anti-HA (C29F4, Rabbit mAb, CST #3724)	Homo sapiens		EXP058117	516	normal	P49715	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP058119	NA	Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP058120	NA	Homo sapiens	Source: Primary tonsilar B cells;	NULL	3014	chip_control	NULL	naive IgD+ B cells	NULL
EXP058121	NA	Homo sapiens	Source: Primary tonsilar B cells;	NULL	3015	chip_control	NULL	germinal center CD77+ B cells	NULL
EXP058122	none	Homo sapiens		NULL	687	chip_control	NULL	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP058123	anti-CREBBP	Homo sapiens		EXP058119	687	normal	Q92793	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP058124	anti-EP300	Homo sapiens		EXP058119	687	normal	Q09472	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP058125	anti-MED1	Homo sapiens		EXP058119	687	normal	O95243	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP058126	anti-FOXP1 (ab4729, Rabbit, 2 ug)	Homo sapiens	Source: Primary tonsilar B cells;	EXP058120	3014	normal	Q9H334	naive IgD+ B cells	NULL
EXP058127	anti-FOXP1 (ab4729, Rabbit, 2 ug)	Homo sapiens	Source: Primary tonsilar B cells;	EXP058121	3015	normal	Q9H334	germinal center CD77+ B cells	NULL
EXP058128	anti-FOXP1	Homo sapiens		EXP058122	687	normal	Q9H334	OCI-LY7 (diffuse large B-cell lymphoma)	NULL
EXP058129		Mus musculus	Genotype: wildtype; Treatment: none; Strain: C57BL6; Source: midgut;	NULL	3016	chip_control	NULL	epithelial cells	NULL
EXP058130		Homo sapiens	Treatment: none; Genotype: wildtype;	NULL	3019	chip_control	NULL	Wnt+Fgf-specified intestinal culture cells	NULL
EXP058131	anti-Cdx2	Mus musculus	Strain: C57BL6; Developmental stage: E16.5; Genotype: Wild-Type(Cdx2 f/f; vil-Cre-ERT2 X Cdx2 f/f; vil-Cre-ERT2);	EXP058129	3018	normal	P43241	embryonic whole tissue from midgut	NULL
EXP058132	anti-Cdx2	Mus musculus	Strain: CD1; Developmental stage: E17.5;	EXP058129	3018	normal	P43241	embryonic whole tissue from midgut	NULL
EXP058133	anti-Cdx2	Mus musculus	Strain: mixed; Developmental stage: adult;	EXP058129	3017	normal	P43241	villus epithelium	NULL
EXP058134	anti-CDX2	Homo sapiens	Treatment: none; Genotype: wildtype; Donor: patient 1; 	NULL	3021	normal	Q99626	duodenal cells	NULL
EXP058135	anti-CDX2	Homo sapiens	Treatment: none; Genotype: wildtype; Donor: patient 2; 	NULL	3021	normal	Q99626	duodenal cells	NULL
EXP058136	anti-CDX2	Mus musculus	Strain: CD1; Developmental stage: E17.5;	EXP058129	2781	normal	P43241	E16.5 whole embryonic mouse skin	NULL
EXP058137	anti-CDX2	Homo sapiens	Genotype: wildtype; 	EXP058130	3019	normal	Q99626	Wnt+Fgf-specified intestinal culture cells	NULL
EXP058138	anti-CDX2	Homo sapiens	Treatment: Doxycycline; Genotype: wildtype; Source: induced CDX2 culture cells;	EXP058130	3020	normal	Q99626	naive endoderm	NULL
EXP058139	antiSpt5 (D3 X scbt; Lot:B1309)	Homo sapiens	Treatment: none; 	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP058140	antiSpt5 (D3 X scbt; Lot:B1309)	Homo sapiens	Treatment: siCTR;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	NULL
EXP058141	antiSpt5 (D3 X scbt; Lot:B1309)	Homo sapiens	Treatment: siMYC; Genotype: MYC knockout;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	NULL
EXP058142	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: Dox - 12-16 hours (when dox is added)/48 hours, siMYC; Genotype: MYC knockout + MYC activation;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	NULL
EXP058143	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: Dox - 12-16 hours (when dox is added)/48 hours, siCTR; Genotype: MYC activation;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	NULL
EXP058144	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: DMSO - 12-16 hours (when dox is added)/48 hours	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	NULL
EXP058145	antiSpt5 (Santa Cruz Biotechnology D-3 X, #sc-133217 X)	Homo sapiens	Treatment: THZ1;	EXP058139	848	normal	O00267	U2OS (osteosarcoma)	NULL
EXP058146	IgG (Cell Signaling , 2729S)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058147	IgG (Cell Signaling , 2729S)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058148	IgG (Cell Signaling , 2729S)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058149	IgG (Cell Signaling , 2729S)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058150	IgG (Cell Signaling , 2729S)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058151	IgG (Cell Signaling , 2729S)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058152	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058153	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058154	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058155	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058156	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058157	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058158	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058159	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058160	Cell Signaling IgG (2729S)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058161	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058146	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP058162	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058147	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP058163	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058148	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP058164	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058149	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP058165	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058150	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP058166	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058151	514	normal	P61964	K562 (myelogenous leukemia)	NULL
EXP058167	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058152	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058168	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058153	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058169	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058154	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058170	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058155	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058171	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058156	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058172	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6nc for 4 hours;	EXP058157	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058173	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058158	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058174	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058159	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058175	anti-WDR5 (D9E1I,Cell Signaling)	Homo sapiens	Treatment: 2 uM C6 for 4 hours;	EXP058160	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058176	anti-WDR5 (Bethyl , A302-429A)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058152	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058177	anti-WDR5 (Bethyl , A302-429A)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058153	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058178	anti-WDR5 (Bethyl , A302-429A)	Homo sapiens	Treatment: 0.1% DMSO for 4 hours;	EXP058154	641	normal	P61964	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP058179	none	Homo sapiens		NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP058180	anti-BRG1 (abcam, ab110641)	Homo sapiens		EXP058179	7	normal	P51532	22RV1 (prostate carcinoma)	NULL
EXP058181	anti-BRG1 (abcam, ab110641)	Homo sapiens	Genotype: PTEN knockdown;	EXP058179	7	normal	P51532	22RV1 (prostate carcinoma)	NULL
EXP058182	Anti-Flag (F1804, Monoclonal M2 Ab Sigma)	Homo sapiens	Treatment: FLAG-EGFP;	NULL	3022	chip_control	NULL	786-M1A (Renal cell carcinoma)	NULL
EXP058183	Anti-Flag (F1804, Monoclonal M2 Ab Sigma)	Homo sapiens	Genotype: FLAG-KLF6; Treatment: FLAG-KLF6;	EXP058182	3022	normal	Q99612	786-M1A (Renal cell carcinoma)	NULL
EXP058184	none (input)	Mus musculus	Genotype: tetotet3iresgfp, omptta (overexpressing Tet3);	NULL	3023	chip_control	NULL	olfactory neurons	NULL
EXP058185	none (input)	Mus musculus	Genotype: tetogfp, omptta;	NULL	3023	chip_control	NULL	olfactory neurons	NULL
EXP058186	CTCF (Pugacheva et al, 2015)	Homo sapiens		NULL	665	normal	P49711	SK-N-SH (neuroblastoma)	NULL
EXP058187	Rad21 (Abcam ab992)	Homo sapiens		NULL	665	normal	O60216	SK-N-SH (neuroblastoma)	NULL
EXP058188	CTCF (Pugacheva et al, 2015)	Homo sapiens		NULL	10	normal	P49711	HEK293T (embryonic kidney)	NULL
EXP058189	anti-CTCF	Mus musculus	Genotype: tetotet3iresgfp, omptta (overexpressing Tet3);	EXP058184	3023	normal	Q61164	olfactory neurons	NULL
EXP058190	anti-CTCF	Mus musculus	Genotype: tetogfp, omptta;	EXP058185	3023	normal	Q61164	olfactory neurons	NULL
EXP058191	anti-IgG polyclonal antibody (12-370, Millipore Sigma)	Homo sapiens	Treatment: vehicle and vitamin D;	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP058192	anti-IgG polyclonal antibody (12-370, Millipore Sigma)	Homo sapiens	Treatment: vehicle and vitamin D;	NULL	781	chip_control	NULL	RWPE1 (prostate epithelial cells)	NULL
EXP058193	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vehicle;	EXP058191	781	normal	P11473	RWPE1 (prostate epithelial cells)	NULL
EXP058194	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vehicle;	EXP058192	781	normal	P11473	RWPE1 (prostate epithelial cells)	NULL
EXP058195	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vitamin D;	EXP058191	781	normal	P11473	RWPE1 (prostate epithelial cells)	NULL
EXP058196	anti-VDR polyclonal antibody (C-20, sc-1008, Santa Cruz Biotechnology)	Homo sapiens	Treatment: vitamin D;	EXP058192	781	normal	P11473	RWPE1 (prostate epithelial cells)	NULL
EXP058197	input	Homo sapiens	Treatment: untreated;	NULL	1001	chip_control	NULL	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058198	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-washout;	NULL	1001	normal	P46531	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058199	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-mock-washout;	NULL	1001	normal	P46531	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058200	anti-RBPJ (D10A4mCST, cat# 5313)	Homo sapiens	Treatment: GSI-washout;	NULL	1001	normal	Q06330	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058201	anti-RBPJ (D10A4mCST, cat# 5313)	Homo sapiens	Treatment: GSI-mock-washout;	NULL	1001	normal	Q06330	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058202	anti-SMC1a (Bethyl, cat# A300-055A)	Homo sapiens	Treatment: untreated;	EXP058197	1001	normal	Q14683	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058203	anti-CTCF (EMD Millipore cat# 07-729)	Homo sapiens	Treatment: untreated;	EXP058197	1001	normal	P49711	MDA-MB-157 (triple negative breast carcinoma)	NULL
EXP058204	input	Homo sapiens	Treatment: untreated;	NULL	3026	chip_control	NULL	HCC-1599(ductal breast carcinoma)	NULL
EXP058205	input	Homo sapiens	Treatment: GSI-mock-washout;	NULL	3026	chip_control	NULL	HCC-1599(ductal breast carcinoma)	NULL
EXP058206	input	Homo sapiens	Treatment: GSI-washout;	NULL	3026	chip_control	NULL	HCC-1599(ductal breast carcinoma)	NULL
EXP058207	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-washout;	EXP058206	3026	normal	P46531	HCC-1599(ductal breast carcinoma)	NULL
EXP058208	anti-Notch1 (Wang et al., 2014)	Homo sapiens	Treatment: GSI-mock-washout;	EXP058205	3026	normal	P46531	HCC-1599(ductal breast carcinoma)	NULL
EXP058209	anti-RBPJ (D10A4, CST, cat# 5313)	Homo sapiens	Treatment: GSI-washout;	EXP058206	3026	normal	Q06330	HCC-1599(ductal breast carcinoma)	NULL
EXP058210	anti-RBPJ (D10A4, CST, cat# 5313)	Homo sapiens	Treatment: GSI-mock-washouts;	EXP058205	3026	normal	Q06330	HCC-1599(ductal breast carcinoma)	NULL
EXP058211	Jun D Antibody (329, sc-74)	Homo sapiens	Genotype: control (scrambled shRNA);	NULL	516	normal	P05412	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP058212	Jun D Antibody (329, sc-74)	Homo sapiens	Genotype: RUNX1/ETO knockdown;	NULL	516	normal	P05412	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP058213	GATA-2 (H-116, Santa Cruz)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, GATA2 wildtype;	NULL	592	normal	P23769	ME-1 (acute myeloid leukemia )	NULL
EXP058214	GATA-2 (H-116) Santa Cruz	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, GATA2 knockdown;	NULL	592	normal	P23769	ME-1 (acute myeloid leukemia )	NULL
EXP058215	anti-MYH11 ( Novus Biologicals)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, MYH11 wildtype;	NULL	592	normal	P35749	ME-1 (acute myeloid leukemia )	NULL
EXP058216	anti-RUNX1 (ab23980, abcam)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, RUNX1 wildtype;	NULL	592	normal	Q01196	ME-1 (acute myeloid leukemia )	NULL
EXP058217	anti-RUNX1 (ab23980, abcam)	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, RUNX1 knockdown;	NULL	592	normal	Q01196	ME-1 (acute myeloid leukemia )	NULL
EXP058218	anti-CBFB (sc-20693x, Santa Cruz)	Homo sapiens	Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, CBFB wildtype;	NULL	592	normal	Q13951	ME-1 (acute myeloid leukemia )	NULL
EXP058219	anti-CBFB (sc-20693x, Santa Cruz)	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, CBFB knockdown;	NULL	592	normal	Q13951	ME-1 (acute myeloid leukemia )	NULL
EXP058220	anti-MYH11 ( Novus Biologicals)	Homo sapiens	Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, MYH11 knockdown;	NULL	592	normal	P35749	ME-1 (acute myeloid leukemia )	NULL
EXP058221	none	Homo sapiens	Genotype: control;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058222	none	Homo sapiens	Genotype: control;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058223	anti-six2 (Proteintech, cat#11562-1-AP)	Homo sapiens	Genotype: six2 overexpression;	EXP058221	113	normal	Q9NPC8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058224	anti-six2 (Proteintech, cat#11562-1-AP)	Homo sapiens	Genotype: six2 overexpression;	EXP058222	113	normal	Q9NPC8	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058225	anti-ESR1 (Santacruz biotechnology, HC-20)	Homo sapiens	Treatment: with Estrogen; 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058226	anti-ESR1 (Santacruz biotechnology, HC-20)	Homo sapiens	Treatment: with Estrogen +1,6-Hexanediol; 	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058227	anti-GATA3(Santacruz biotechnology, HG3-31)	Homo sapiens	Treatment: with Estrogen; 	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058228	anti-GATA3(Santacruz biotechnology, HG3-31)	Homo sapiens	Treatment: with Estrogen +1,6-Hexanediol; 	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058229	anti-AP-2gamma(Santacruz biotechnology, H-77)	Homo sapiens	Treatment: with Estrogen; 	NULL	113	normal	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058230	anti-AP-2gamma(Santacruz biotechnology, H-77)	Homo sapiens	Treatment: with Estrogen +1,6-Hexanediol; 	NULL	113	normal	Q92754	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP058231	none	Homo sapiens	Treatment: lentivirus conrol;	NULL	3027	chip_control	NULL	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058232	none	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	NULL	3027	chip_control	NULL	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058233	none	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	NULL	3027	chip_control	NULL	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058234	none	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	NULL	3027	chip_control	NULL	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058235	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058236	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058237	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058238	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058239	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: none;	NULL	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058240	45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: none;	NULL	3027	normal	A0A126GW21	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058241	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: none;	NULL	3028	normal	Q92922	SCCOHT-1	NULL
EXP058242	BAF45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: none;	NULL	3028	normal	Q92785	SCCOHT-1	NULL
EXP058243	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058244	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058245	BAF45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058246	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058247	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058248	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058249	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058250	BAF45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058251	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058252	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058253	ARID2 (CST, D8D8U)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q68CP9	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058254	45D (Abcam, ab134942, GR3185597-1)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058255	SS18 (Cell Signaling Technologies, D6I4Z)	Homo sapiens	Treatment: SMARCA4.K785R lentivirus; Genotype: SMARCA4 overexpression;	EXP058233	3027	normal	Q15532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058256	DPF2 (Abcam, ab134942)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q92785	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058257	MLL3 (homemade, PMID: 29404406)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q8NEZ4	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058258	MLL3 (homemade, PMID: 29404406)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q8NEZ4	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058259	MLL3 (homemade, PMID: 29404406)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q8NEZ4	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058260	MLL4 (homemade, PMID: 29404406)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q9UMN6	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058261	MLL4, homemade (PMID: 29404406)	Homo sapiens	Treatment: letivirus SMARCA4; Genotype: SMARCA4 overexpression;	EXP058232	3027	normal	Q9UMN6	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058262	MLL4, homemade (PMID: 29404406)	Homo sapiens	Treatment: lentivirus SMARCA4.T910M; Genotype: SMARCA4 overexpression;	EXP058234	3027	normal	Q9UMN6	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058263	BRG1 (Abcam, ab110641, GR150844-25)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	P51532	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058264	BAF155 (Homemade, Fx3)	Homo sapiens	Treatment: lentivirus conrol;	EXP058231	3027	normal	Q92922	BIN-67 (Ovarian small cell carcinoma, hypercalcemic type)	NULL
EXP058265	none, Input	Homo sapiens	Treatment: none wnt; 	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058266	none, Input	Homo sapiens	Treatment: Wnt3a;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP058267	anti-Gfi1b	Homo sapiens	Treatment: none wnt; 	EXP058265	514	normal	Q5VTD9	K562 (myelogenous leukemia)	NULL
EXP058268	anti-Gfi1b	Homo sapiens	Treatment: Wnt3a;	EXP058266	514	normal	Q5VTD9	K562 (myelogenous leukemia)	NULL
EXP058269	anti-Beta-Catenin	Homo sapiens	Treatment: none wnt; 	EXP058265	514	normal	P35222	K562 (myelogenous leukemia)	NULL
EXP058270	anti-Beta-Catenin	Homo sapiens	Treatment: Wnt3a;	EXP058266	514	normal	P35222	K562 (myelogenous leukemia)	NULL
EXP058271	anti-LSD1	Homo sapiens	Treatment: none wnt; 	EXP058265	514	normal	O60341	K562 (myelogenous leukemia)	NULL
EXP058272	anti-LSD1	Homo sapiens	Treatment: Wnt3a;	EXP058266	514	normal	O60341	K562 (myelogenous leukemia)	NULL
EXP058273	input	Homo sapiens		NULL	3029	chip_control	NULL	RH41(Alveolar rhabdomyosarcoma)	NULL
EXP058274	anti-G9a (abcam, #40452)	Homo sapiens		EXP058273	3029	normal	Q96KQ7	RH41(Alveolar rhabdomyosarcoma)	NULL
EXP058275	none (WCE)	Homo sapiens	Treatment: 60 ng/ml Tetracyclin for 24 hrs; Genotype: inducible TCF4 expression;	NULL	813	chip_control	NULL	SU-DHL-2 (anaplastic large cell lymphoma)	NULL
EXP058276	TCF4 (PMID 27846392)	Homo sapiens	Treatment: 60 ng/ml Tetracyclin for 24 hrs; Genotype: inducible TCF4 expression;	EXP058275	813	normal	P15884	SU-DHL-2 (anaplastic large cell lymphoma)	NULL
EXP058277	none (WCE)	Homo sapiens	Treatment: 60ng/ml  Tetracyclin for 24 hrs; Genotype: inducible TCF4 expression;	NULL	835	chip_control	NULL	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP058278	TCF4 (PMID 27846392)	Homo sapiens	Treatment: 60ng/ml  Tetracyclin for 24 hrs; Genotype: inducible TCF4 expression;	EXP058277	835	normal	P15884	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP058279	anti-LMNA (Santa Cruz mouse monoclonal, sc7292x)	Homo sapiens	Treatment: None;	NULL	430	normal	P02545	HepG2 (hepatoblastoma)	NULL
EXP058280	anti-LMNB1(Abcam rabbit polyclonal, Ab16048)	Homo sapiens	Treatment: None;	NULL	430	normal	P20700	HepG2 (hepatoblastoma)	NULL
EXP058281	anti-LMNA (Santa Cruz mouse monoclonal, sc7292x)	Homo sapiens	Treatment: 10 uM CsA for 72 hrs;	NULL	430	normal	P02545	HepG2 (hepatoblastoma)	NULL
EXP058282	anti-LMNB1(Abcam rabbit polyclonal, Ab16048)	Homo sapiens	Treatment: 10 uM CsA for 72 hrs;	NULL	430	normal	P20700	HepG2 (hepatoblastoma)	NULL
EXP058283	none	Homo sapiens	Genotype: wildtype tumor derived cell line; 	NULL	937	chip_control	NULL	G401 (rhabdoid tumor of the kidney)	NULL
EXP058284	anti-HA-tag (Cell Signaling Technology: 3724)	Homo sapiens	Genotype: wildtype tumor derived cell line; 	EXP058283	937	normal	Q9H8M2	G401 (rhabdoid tumor of the kidney)	NULL
EXP058285		Homo sapiens	Genotype: PTEN wildtype; 	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058286	anti-PTEN (6H2.1, Millipore, 04-035)	Homo sapiens	Genotype: PTEN wildtype; 	EXP058285	78	normal	P60484	HeLa (cervical adenocarcinoma)	NULL
EXP058287	anti-PTEN (138G6, Cell Signaling, 9559)	Homo sapiens	Genotype: PTEN wildtype; 	EXP058285	78	normal	P60484	HeLa (cervical adenocarcinoma)	NULL
EXP058288	SPT5 (Bethyl Laboratories, A300-868A)	Homo sapiens	Genotype: PTEN wildtype; 	EXP058285	78	normal	O00267	HeLa (cervical adenocarcinoma)	NULL
EXP058289	SPT5 (Bethyl Laboratories, A300-868A)	Homo sapiens	Genotype: CRISPR-PTEN KO;	NULL	78	normal	O00267	HeLa (cervical adenocarcinoma)	NULL
EXP058290	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: wildtype;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058291	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: wildtype;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058292	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058293	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058294	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 Y22A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058295	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 Y22A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058296	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18G21Y22A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058297	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18G21Y22A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058298	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KNR-A expressing; 	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058299	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KNR-A expressing; 	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058300	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KYNR-A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058301	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KYNR-A expressing;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058302	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: wildtype;	EXP058290	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058303	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: wildtype;	EXP058291	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058304	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18A expressing;	EXP058292	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058305	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18A expressing;	EXP058293	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058306	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 Y22A expressing;	EXP058294	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058307	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 Y22A expressing;	EXP058295	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058308	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18G21Y22A expressing;	EXP058296	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058309	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 K18G21Y22A expressing;	EXP058297	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058310	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KNR-A expressing; 	EXP058298	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058311	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KNR-A expressing; 	EXP058299	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058312	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KYNR-A expressing;	EXP058300	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058313	anti-GFP (gta-20, ChromoTek)	Homo sapiens	Genotype: HRP3 KYNR-A expressing;	EXP058301	430	normal	Q9Y3E1	HepG2 (hepatoblastoma)	NULL
EXP058314	NA	Homo sapiens	Genotype: Renilla knockout; Treatment: shRenilla; 	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP058315	NA	Homo sapiens	Genotype: GREB1 knockout; Treatment: shGREB1; 	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP058316	AR (Santa Cruz, sc-816)	Homo sapiens	Genotype: Renilla knockout; Treatment: shRenilla; 	EXP058314	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP058317	AR (Santa Cruz, sc-816)	Homo sapiens	Genotype: GREB1 knockout; Treatment: shGREB1; 	EXP058315	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP058318		Homo sapiens	Genotype: PCM1 positive; Sex: female; Age: 59; Group: control;	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058319		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 43; Group: control;	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058320		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 23; Group: control;	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058321		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 19; Group: control;	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058322		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 34; Group: control;	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058323		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 56; Group: DCM (Dilated Cardiomyopathy);	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058324		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 38; Group: DCM (Dilated Cardiomyopathy);	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058325		Homo sapiens	Genotype: PCM1 positive; Sex: female; Age: 66; Group: DCM (Dilated Cardiomyopathy);	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058326		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 49; Group: DCM (Dilated Cardiomyopathy);	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058327		Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 45; Group: DCM (Dilated Cardiomyopathy);	NULL	3030	chip_control	NULL	cardiac myocyte nuclei	NULL
EXP058328	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: female; Age: 59; Group: control;	EXP058318	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058329	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 43; Group: control;	EXP058319	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058330	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 23; Group: control;	EXP058320	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058331	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 19; Group: control;	EXP058321	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058332	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 34; Group: control;	NULL	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058333	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 56; Group: DCM (Dilated Cardiomyopathy);	EXP058323	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058334	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 38; Group: DCM (Dilated Cardiomyopathy);	EXP058324	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058335	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: female; Age: 66; Group: DCM (Dilated Cardiomyopathy);	EXP058325	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058336	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 49; Group: DCM (Dilated Cardiomyopathy);	EXP058326	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058337	anti LMNA A/C	Homo sapiens	Genotype: PCM1 positive; Sex: male; Age: 45; Group: DCM (Dilated Cardiomyopathy);	EXP058327	3030	normal	P02545	cardiac myocyte nuclei	NULL
EXP058338	N/A	Homo sapiens	Treatment: TNF-a for 12hrs;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP058339	N/A	Homo sapiens	Treatment: TNF-a for 0 (control);	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP058340	anti-p65(sc-372, Santa Cruz)	Homo sapiens	Treatment: TNF-a for 12hrs;	EXP058338	421	normal	O43245	HEK293 (embryonic kidney)	NULL
EXP058341	anti-p65(sc-372, Santa Cruz)	Homo sapiens	Treatment: TNF-a for 0 (control);	EXP058339	421	normal	O43245	HEK293 (embryonic kidney)	NULL
EXP058342	N/A	Homo sapiens	Treatment: DMSO; Genotype: wildtype; 	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058343	N/A	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: wildtype; 	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058344	N/A	Homo sapiens	Treatment: DMSO; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058345	N/A	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	NULL	2218	chip_control	NULL	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058346	LSD1 (Bethyl Laboratories A300-215A, LOT# 2)	Homo sapiens	Treatment: DMSO; Genotype: wildtype; 	EXP058342	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058347	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: DMSO; Genotype: wildtype; 	EXP058342	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058348	LSD1 (Bethyl Laboratories A300-215A, LOT# 2	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: wildtype; 	EXP058343	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058349	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: wildtype; 	EXP058343	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058350	LSD1 (Bethyl Laboratories A300-215A, LOT# 2	Homo sapiens	Treatment: DMSO; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058344	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058351	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: DMSO; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058344	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058352	LSD1 (Bethyl Laboratories A300-215A, LOT# 2	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058345	2218	normal	O60341	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058353	GFI1B antibody (Abcam ab26132, LOT# GR318193-8)	Homo sapiens	Treatment: GSK-LSD1 for 48 hrs; Genotype: drug-resistant SET-2 LSD1 (Leu659_Asn660insArg); 	EXP058345	2218	normal	Q5VTD9	SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens)	NULL
EXP058354	N/A	Homo sapiens	Treatment: TNF for 0 mins; 	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058355	N/A	Homo sapiens	Treatment: TNF for 60 mins; 	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058356	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 0 mins; 	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058357	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 60 mins; 	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058358	N/A	Homo sapiens	Treatment: TNF for 0 mins; 	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058359	N/A	Homo sapiens	Treatment: TNF for 60 mins; 	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058360	anti-p65 (abcam)	Homo sapiens	Treatment: TNF for 0 mins; 	EXP058358	472	normal	O43245	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058361	anti-p65 (abcam)	Homo sapiens	Treatment: TNF for 30 mins; 	NULL	472	normal	O43245	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058362	anti-p65 (abcam)	Homo sapiens	Treatment: TNF for 60 mins; 	EXP058359	472	normal	O43245	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058363	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 0 mins; 	EXP058354	472	normal	Q6ZMT4	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058364	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 60 mins; 	EXP058355	472	normal	Q6ZMT4	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058365	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 0 mins; 	EXP058356	472	normal	O15550	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058366	anti-FLAG(Sigma-Aldrich)	Homo sapiens	Treatment: TNF for 60 mins; 	EXP058357	472	normal	O15550	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058367	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058368	none	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058369	none	Homo sapiens	Treatment: 100 uM DRB for 3 hrs;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP058370	anti-HA antibody (11867423001, Roche)	Homo sapiens		EXP058367	430	normal	Q9HCE5	HepG2 (hepatoblastoma)	NULL
EXP058371	anti-HA antibody (11867423001, Roche)	Homo sapiens		EXP058368	430	normal	Q9HCE5	HepG2 (hepatoblastoma)	NULL
EXP058372	anti-HA antibody (11867423001, Roche)	Homo sapiens	Treatment: 100 uM DRB for 3 hrs;	EXP058369	430	normal	Q9HCE5	HepG2 (hepatoblastoma)	NULL
EXP058373	none	Homo sapiens		NULL	3031	chip_control	NULL	SGC-7901(Gastric carcinoma)	NULL
EXP058374	none	Homo sapiens		NULL	3031	chip_control	NULL	SGC-7901(Gastric carcinoma)	NULL
EXP058375	anti-ISL1(abcam)	Homo sapiens		EXP058373	3031	normal	P61371	SGC-7901(Gastric carcinoma)	NULL
EXP058376	anti-ISL1(abcam)	Homo sapiens		EXP058374	3031	normal	P61371	SGC-7901(Gastric carcinoma)	NULL
EXP058377		Homo sapiens	Treatment: none; 	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP058378		Homo sapiens	Treatment: 3 uM final concentration of CBL0137 for 6hrs;	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP058379		Homo sapiens	Treatment: none; 	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP058380		Homo sapiens	Treatment: 3 uM final concentration of CBL0137 for 6hrs;	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP058381	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: none; 	EXP058377	1008	normal	P49711	HT1080 (fibrosarcoma)	NULL
EXP058382	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: 3 uM final concentration of CBL0137 for 6hrs;	EXP058378	1008	normal	P49711	HT1080 (fibrosarcoma)	NULL
EXP058383	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: none; 	EXP058379	1008	normal	P49711	HT1080 (fibrosarcoma)	NULL
EXP058384	anti-CTCF (pAb, ActiveMotif ; Cat. No. 61311, Lot 34614003)	Homo sapiens	Treatment: 3 uM final concentration of CBL0137 for 6hrs;	EXP058380	1008	normal	P49711	HT1080 (fibrosarcoma)	NULL
EXP058385	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP058386	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP058387	none	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP058388	anti-Oct1 (Bethyl, A310-610A)	Homo sapiens		EXP058385	417	normal	P14859	HCT-116 (colon carcinoma)	NULL
EXP058389	anti-Oct1 (Bethyl, A310-610A)	Homo sapiens		EXP058386	417	normal	P14859	HCT-116 (colon carcinoma)	NULL
EXP058390	anti-Oct1 (Bethyl, A310-610A)	Homo sapiens		EXP058387	417	normal	P14859	HCT-116 (colon carcinoma)	NULL
EXP058391	Input	Homo sapiens	Treatment: DHT10 nM for 24 hrs;	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP058392	Input	Homo sapiens	Treatment: DHT10 nM for 24 hrs;	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP058393	anti-FOXA1 (abcam, 23738)	Homo sapiens	Treatment: DHT10 nM for 24 hrs;	EXP058391	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP058394	anti-FOXA1 (abcam, 23738)	Homo sapiens	Treatment: ethanol (Vehicle) treatment for 24 hrs;	NULL	7	normal	P55317	22RV1 (prostate carcinoma)	NULL
EXP058395	anti-OCT1 (Abcam, ab15112)	Homo sapiens	Treatment: DHT10 nM for 24 hrs;	EXP058392	7	normal	P14859	22RV1 (prostate carcinoma)	NULL
EXP058396	anti-OCT1 (Abcam, ab15112)	Homo sapiens	Treatment: ethanol (Vehicle) treatment for 24 hrs;	NULL	7	normal	P14859	22RV1 (prostate carcinoma)	NULL
EXP058397	none	Homo sapiens	Treatment: 50 nM EtOH (vehicle) for 2 hrs;	NULL	3032	chip_control	NULL	primary prostate epithelial cells	NULL
EXP058398	none	Homo sapiens	Treatment: 50 nM 1,25-VitaminD3  for 2 hrs;	NULL	3032	chip_control	NULL	primary prostate epithelial cells	NULL
EXP058399	anti-VDR (C-20x, sc-1008x, rabbit polyclonal, Santa Cruz)	Homo sapiens	Treatment: 50 nM EtOH (vehicle) for 2 hrs;	EXP058397	3032	normal	P11473	primary prostate epithelial cells	NULL
EXP058400	anti-VDR (C-20x, sc-1008x, rabbit polyclonal, Santa Cruz)	Homo sapiens	Treatment: 50 nM 1,25-VitaminD3  for 2 hrs;	EXP058398	3032	normal	P11473	primary prostate epithelial cells	NULL
EXP058401	none	Homo sapiens	Treatment: none;	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058402	anti-ERG (sc-354X, Santa Cruz Biotechnology)	Homo sapiens	Treatment: none;	EXP058401	472	normal	P11308	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058403	none	Homo sapiens	Treatment: control siRNA treated;	NULL	472	chip_control	NULL	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058404	MED1 (A300-793A, Bethyl Laboratories)	Homo sapiens	Treatment: control siRNA treated;	EXP058403	472	normal	O95243	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058405	MED1 (A300-793A, Bethyl Laboratories)	Homo sapiens	Treatment: ERG siRNA treated; Genotype: ERG knockout;	EXP058403	472	normal	O95243	HUVEC-C (HUVEC, umbilical vein endothelial cells)	NULL
EXP058406	none	Homo sapiens		NULL	3033	chip_control	NULL	CD34+ iPSC-differentiated NSC	NULL
EXP058407	anti-SMARCA4 (abcam 110641)	Homo sapiens		EXP058406	3033	normal	P51532	CD34+ iPSC-differentiated NSC	NULL
EXP058408	none	Homo sapiens	Cells were treated with DMEM with normal pH (~pH 7.2; 3.7 g/L sodium bicarbonate)	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058409	none	Homo sapiens	Cells were treated with DMEM with low pH (~pH 6.7; 0.37 g/L sodium bicarbonate).	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058410	anti-MLXIP (Rabbit Polyclonal Antibody, Proteintech; 13614-1-AP)	Homo sapiens	Treatment: treated with DMEM with normal pH (~pH 7.2; 3.7 g/L sodium bicarbonate);	EXP058408	78	normal	Q9HAP2	HeLa (cervical adenocarcinoma)	NULL
EXP058411	anti-MLXIP (Rabbit Polyclonal Antibody, Proteintech; 13614-1-AP)	Homo sapiens	Treatment: treated with DMEM with low pH (~pH 6.7; 0.37 g/L sodium bicarbonate);	EXP058409	78	normal	Q9HAP2	HeLa (cervical adenocarcinoma)	NULL
EXP058412	--	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP058413	--	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP058414	anti-PLZF (SantaCruz, sc-22839)	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	EXP058412	892	normal	Q05516	MSC (mesenchymal stem cells)	NULL
EXP058415	anti-PLZF (SantaCruz, sc-22839)	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	EXP058413	892	normal	Q05516	MSC (mesenchymal stem cells)	NULL
EXP058416	anti-SUZ12 (Cell Signalling, 3737)	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	EXP058412	892	normal	Q15022	MSC (mesenchymal stem cells)	NULL
EXP058417	anti-SUZ12 (Cell Signalling, 3737)	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	EXP058413	892	normal	Q15022	MSC (mesenchymal stem cells)	NULL
EXP058418	anti-RNF2 (NAS, RRID:AB_2755047)	Homo sapiens	Source: Bone marrow; Passage: p4-p10;Conditions: day 0 of osteogenic differentiation;	EXP058412	892	normal	Q99496	MSC (mesenchymal stem cells)	NULL
EXP058419	anti-RNF2 (NAS, RRID:AB_2755047)	Homo sapiens	Source: Bone marrow; Passage: p4-p10; Conditions: day 10 of osteogenic differentiation;	EXP058413	892	normal	Q99496	MSC (mesenchymal stem cells)	NULL
EXP058420	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated; Conditions: day4 of differentiation;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP058421		Mus musculus	Treatment: doxycycline for 1-day; Conditions: day4 of differentiation;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP058422		Mus musculus	Treatment: not treated; Conditions: day4 of differentiation;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP058423		Mus musculus	Treatment: doxycycline for 1-day;	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP058424		Mus musculus	Treatment: doxycycline for 6-day; Conditions: day9 of differentiation; 	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP058425		Mus musculus	Treatment: doxycycline for 6-day; Conditions: day9 of differentiation; 	NULL	216	chip_control	NULL	differentiated embryonic stem cells	NULL
EXP058426		Homo sapiens	Treatment: doxycycline 1-day; Conditions: day 6 of differentiation; 	NULL	2526	chip_control	NULL	H9	NULL
EXP058427	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated; Conditions: day4 of differentiation;	EXP058420	216	normal	P24610	differentiated embryonic stem cells	NULL
EXP058428	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 1-day;	EXP058421	216	normal	P24610	differentiated embryonic stem cells	NULL
EXP058429	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 6-day; Conditions: day9 of differentiation; 	EXP058424	216	normal	P24610	differentiated embryonic stem cells	NULL
EXP058430	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 6-day; Conditions: day9 of differentiation; 	EXP058425	216	normal	P24610	differentiated embryonic stem cells	NULL
EXP058431	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Homo sapiens	Treatment: doxycycline 1-day; Conditions: day 6 of differentiation; 	EXP058426	2526	normal	P23760	H9	NULL
EXP058432	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated;	NULL	675	normal	P24610	NIH 3T3 (embryonic fibroblasts)	NULL
EXP058433	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 1-day;	NULL	675	normal	P24610	NIH 3T3 (embryonic fibroblasts)	NULL
EXP058434	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: not treated; Conditions: day4 of differentiation;	EXP058422	216	normal	P24610	differentiated embryonic stem cells	NULL
EXP058435	anti-Pax3 (Santa Cruz Biotechnology sc-34926)	Mus musculus	Treatment: doxycycline for 1-day;	EXP058423	216	normal	P24610	differentiated embryonic stem cells	NULL
EXP058436	None	Homo sapiens	Treatment: none	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP058437	None	Homo sapiens	Treatment: 1 uM JQ1 for 24 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP058438	None	Homo sapiens	Treatment: Treatment: none;	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP058439	None	Homo sapiens	Treatment: 1 uM JQ1 for 24 hours	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP058440	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: none	EXP058436	71	normal	P23769	VCaP (prostate carcinoma)	NULL
EXP058441	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hours	EXP058437	71	normal	P23769	VCaP (prostate carcinoma)	NULL
EXP058442	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: Treatment: none;	EXP058438	71	normal	P23769	VCaP (prostate carcinoma)	NULL
EXP058443	GATA2 antibody (Sigma, HPA005633)	Homo sapiens	Treatment: 1 uM JQ1 for 24 hours	EXP058439	71	normal	P23769	VCaP (prostate carcinoma)	NULL
EXP058444	2% Input	Homo sapiens	Treatment: shControl;	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP058445	2% Input	Homo sapiens	Treatment: shKDM6A; Genotype: KDM6A knockout;	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP058446	CHD4 (Abcam, Cat. ab70469, Clone: 3F2/4)	Homo sapiens	Treatment: shControl;	EXP058444	65	normal	Q14839	U937 (adult acute monocytic leukemia)	NULL
EXP058447	CHD4 (Abcam, Cat. ab70469, Clone: 3F2/4)	Homo sapiens	Treatment: shKDM6A; Genotype: KDM6A knockout;	EXP058445	65	normal	Q14839	U937 (adult acute monocytic leukemia)	NULL
EXP058448	none	Homo sapiens	Donor: #1; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP058449	none	Homo sapiens	Donor: #2; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP058450	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #2; Genotype: pTRIP-SFFV-EGFP-NLS;	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP058451	none	Homo sapiens	Donor: #3; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP058452	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #3; Genotype: pTRIP-SFFV-EGFP-NLS;	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP058453	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #1; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	EXP058448	620	normal	Q8N884	monocyte-derived dendritic cells	NULL
EXP058454	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #2; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	EXP058449	620	normal	Q8N884	monocyte-derived dendritic cells	NULL
EXP058455	anti-GFP(Chromotek ,Trap, MA, cat#gtma-20)	Homo sapiens	Donor: #3; Genotype: pTRIP-SFFV-EGFP-NLS-FLAG cGAS E225A/D227A;	EXP058451	620	normal	Q8N884	monocyte-derived dendritic cells	NULL
EXP058456	none	Homo sapiens		NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP058457	none	Homo sapiens		NULL	2524	chip_control	NULL	LNCaP95	NULL
EXP058458	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT for 24 hrs;	EXP058456	2524	normal	P10275	LNCaP95	NULL
EXP058459	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT for 24 hrs;	EXP058457	2524	normal	P10275	LNCaP95	NULL
EXP058460	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT and Py-Im polyamide for 24 hrs;	EXP058456	2524	normal	P10275	LNCaP95	NULL
EXP058461	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: 10 nM DHT and Py-Im polyamide for 24 hrs;	EXP058457	2524	normal	P10275	LNCaP95	NULL
EXP058462	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: vehicle (DMSO) for 24 hrs;	EXP058456	2524	normal	P10275	LNCaP95	NULL
EXP058463	AR (06-680, Millipore, lot #3071905)	Homo sapiens	Treatment: vehicle (DMSO) for 24 hrs;	EXP058457	2524	normal	P10275	LNCaP95	NULL
EXP058464	none	Homo sapiens	Conditions: attached;	NULL	650	chip_control	NULL	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP058465	none	Homo sapiens	Conditions: suspended;	NULL	650	chip_control	NULL	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP058466	ANTI-FLAG M2(Sigma, F3165)	Homo sapiens	Conditions: attached;	EXP058464	650	normal	Q01892	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP058467	ANTI-FLAG M2(Sigma, F3165)	Homo sapiens	Conditions: suspended;	EXP058465	650	normal	Q01892	NCI-H1703 (squamous cell lung carcinoma )	NULL
EXP058468	none	Homo sapiens	Genotype: TetO-TFAP2C; Treatment:  with Dox for 7 days; Developmental stage: early differentiaiton;	NULL	3034	chip_control	NULL	embryonic stem cells differentiated to early epidemal cells	NULL
EXP058469	none	Homo sapiens	Genotype: TetO-TFAP2C; Treatment:  with Dox for 7 days; Developmental stage: early differentiaiton;	NULL	3034	chip_control	NULL	embryonic stem cells differentiated to early epidemal cells	NULL
EXP058470	anti-TFAP2C (Santa Cruz, Cat #sc-8977X)	Homo sapiens	Genotype: TetO-TFAP2C; Treatment:  with Dox for 7 days; Developmental stage: early differentiaiton;	EXP058468	3034	normal	Q92754	embryonic stem cells differentiated to early epidemal cells	NULL
EXP058471	anti-TFAP2C (Santa Cruz, Cat #sc-8977X)	Homo sapiens	Genotype: TetO-TFAP2C; Treatment:  with Dox for 7 days; Developmental stage: early differentiaiton;	EXP058469	3034	normal	Q92754	embryonic stem cells differentiated to early epidemal cells	NULL
EXP058472		Homo sapiens	Treatment: 1uM KI-MS2-008 for 0 hrs;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP058473		Homo sapiens	Treatment: 1uM KI-MS2-008 for 0 hrs;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP058474		Homo sapiens	Treatment: 1uM KI-MS2-008 for 24 hrs;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP058475		Homo sapiens	Treatment: 1uM KI-MS2-008 for 4 hrs;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP058476		Homo sapiens	Treatment: 1uM KI-MS2-008 for 4 hrs;	NULL	708	chip_control	NULL	P493-6 (B-cell lymphoma)	NULL
EXP058477	anti- Max (sc-197, C-17, lot #C3016)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 0 hrs;	EXP058473	708	normal	P61244	P493-6 (B-cell lymphoma)	NULL
EXP058478	anti- Max (sc-197, C-17, lot #C3016)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 24 hrs;	EXP058474	708	normal	P61244	P493-6 (B-cell lymphoma)	NULL
EXP058479	anti- Max (sc-197, C-17, lot #C3016)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 4 hrs;	EXP058476	708	normal	P61244	P493-6 (B-cell lymphoma)	NULL
EXP058480	anti-MYC (ab56)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 0 hrs;	EXP058472	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP058481	anti-MYC (ab56)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 24 hrs;	EXP058474	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP058482	anti-MYC (ab56)	Homo sapiens	Treatment: 1uM KI-MS2-008 for 4 hrs;	EXP058475	708	normal	P01106	P493-6 (B-cell lymphoma)	NULL
EXP058483	none	Homo sapiens	Treatment: control (none);	NULL	3035	chip_control	NULL	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP058484	none	Homo sapiens	Treatment: control (none);	NULL	3035	chip_control	NULL	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP058485	anti-CTCF (17-10044, Millipore)	Homo sapiens	Treatment: control (none);	EXP058483	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP058486	anti-CTCF (17-10044, Millipore)	Homo sapiens	Treatment: 0.5 ug/ml TPA for 24 hrs;	EXP058484	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP058487	anti-HA (ab9110, Abcam)	Homo sapiens	Treatment: control (none);	EXP058484	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP058488	anti-HA (ab9110, Abcam)	Homo sapiens	Treatment: 0.5 ug/ml TPA for 24 hrs;	EXP058484	3035	normal	P49711	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP058489	none	Homo sapiens	Genotype: wildtype; 	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP058490	none	Homo sapiens	Genotype: wildtype; 	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP058491	none	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP058492	none	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP058493	none	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP058494	none	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	NULL	93	chip_control	NULL	BJ (fibroblasts)	NULL
EXP058495	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Genotype: wildtype; 	EXP058489	93	normal	O43474	BJ (fibroblasts)	NULL
EXP058496	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Genotype: wildtype; 	EXP058490	93	normal	O43474	BJ (fibroblasts)	NULL
EXP058497	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Genotype: wildtype; 	EXP058489	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058498	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Genotype: wildtype; 	EXP058490	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058499	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058491	93	normal	O43474	BJ (fibroblasts)	NULL
EXP058500	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058492	93	normal	O43474	BJ (fibroblasts)	NULL
EXP058501	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058491	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058502	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: mtp63SAMKLF6 vector; Genotype: mutant p63(I537T), +/- KLF4;	EXP058492	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058503	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058493	93	normal	O43474	BJ (fibroblasts)	NULL
EXP058504	anti-KLF4 (R&D Systems #AF3640)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058494	93	normal	O43474	BJ (fibroblasts)	NULL
EXP058505	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058493	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058506	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: p63KLF4 vector; Genotype: wildtype; 	EXP058494	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058507	anti-Flag(Sigma M2 #F1804)	Homo sapiens	Treatment: p63 vector; Genotype: wildtype;	NULL	93	normal	Q9H3D4	BJ (fibroblasts)	NULL
EXP058508	none	Homo sapiens		NULL	3036	chip_control	NULL	neutrophils from periferal blood	NULL
EXP058509	none	Homo sapiens	Treatment: via co-culture with E. coli strain K1 at an MOI;	NULL	3036	chip_control	NULL	neutrophils from periferal blood	NULL
EXP058510	none	Homo sapiens	Treatment: 25nM PMA (Promega, cat# V1171);	NULL	3036	chip_control	NULL	neutrophils from periferal blood	NULL
EXP058511	anti-SMC3(RRID: AB_307122, Catalog: ab9263; Lot: GR3221084-1)	Homo sapiens	Treatment: unstimmulated;	EXP058508	3036	normal	Q9UQE7	neutrophils from periferal blood	NULL
EXP058512	RRID: AB_441965; Catalog: 07-729; Lots: 2628833; 2575743; 2757161	Homo sapiens	Treatment: via co-culture with E. coli strain K1 at an MOI;	EXP058509	3036	normal	O60682	neutrophils from periferal blood	NULL
EXP058513	anti-SMC3(RRID: AB_307122, Catalog: ab9263; Lot: GR3221084-1)	Homo sapiens	Treatment: via co-culture with E. coli strain K1 at an MOI;	EXP058509	3036	normal	Q9UQE7	neutrophils from periferal blood	NULL
EXP058514	anti-RAD21(RRID: AB_2176601, Catalog: ab992; Lots: GR214359-1; GR235487-1)	Homo sapiens	Treatment: unstimmulated;	EXP058508	3036	normal	O60216	neutrophils from periferal blood	NULL
EXP058515	anti-RAD21(RRID: AB_2176601, Catalog: ab992; Lots: GR214359-1; GR235487-1)	Homo sapiens	Treatment: 25nM PMA (Promega, cat# V1171);	EXP058510	3036	normal	O60216	neutrophils from periferal blood	NULL
EXP058516	anti-CTCF(RRID: AB_441965, Catalog: 07-729; Lots: 2628833; 2575743; 2757161)	Homo sapiens	Treatment: unstimmulated;	EXP058508	3036	normal	P49711	neutrophils from periferal blood	NULL
EXP058517	anti-CTCF(RRID: AB_441965, Catalog: 07-729; Lots: 2628833; 2575743; 2757161)	Homo sapiens	Treatment: 25nM PMA (Promega, cat# V1171);	EXP058510	3036	normal	P49711	neutrophils from periferal blood	NULL
EXP058518	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: 10-7M R1881 (synthetic testosterone) for 4 hrs; Donor: PCDF1; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	NULL
EXP058519	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: DMSO for 4 hrs; Donor: PCDF1; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	NULL
EXP058520	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: DMSO for 4 hrs; Donor: PCDF2; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	NULL
EXP058521	anti-AR (Santa Cruz, sc-816,lot: I0215)	Homo sapiens	Treatment: 10-7M R1881 (synthetic testosterone) for 4 hrs; Donor: PCDF2; Time point: 4 hours	NULL	3037	normal	P10275	prostate cancer-derived fibroblasts	NULL
EXP058522		Homo sapiens	Treatment: infected lentivirus;	NULL	801	chip_control	NULL	SMMC-7721 (hepatocellular carcinoma)	NULL
EXP058523	anti-PTEN-alfa/beta (a gift from Professor Yuxin Yin)	Homo sapiens	Treatment: infected lentivirus;	EXP058522	801	normal	P60484	SMMC-7721 (hepatocellular carcinoma)	NULL
EXP058524	anti-WDR5 (NOVAS, Cat# NBP1-30063)	Homo sapiens	Treatment: infected lentivirus;	EXP058522	801	normal	P04040	SMMC-7721 (hepatocellular carcinoma)	NULL
EXP058525	none	Homo sapiens	Treatment: siControl;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058526	none	Homo sapiens	Treatment: untreated;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058527	none	Homo sapiens	Treament: siControl; Genotype: wildtype;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058528	none	Homo sapiens	Genotype: PCF11 knock-down (5 nM); Treatment: siPCF11;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058529	none	Homo sapiens	Genotype: PCF11 knock-down (5 nM); Treatment: siPCF11;	NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP058530	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Abcam Cat# ab134391)	Homo sapiens	Treatment: siControl;	EXP058525	78	normal	O94913	HeLa (cervical adenocarcinoma)	NULL
EXP058531	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Abcam Cat# ab134391)	Homo sapiens	Treatment: untreated;	EXP058526	78	normal	O94913	HeLa (cervical adenocarcinoma)	NULL
EXP058532	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Bethyl Cat# A303-705A)	Homo sapiens	Treatment: siControl;	EXP058525	78	normal	O94913	HeLa (cervical adenocarcinoma)	NULL
EXP058533	anti-PCF11 (PCF11-Int,Rabbit polyclonal, Bethyl Cat# A303-705A)	Homo sapiens	Treatment: untreated;	EXP058526	78	normal	O94913	HeLa (cervical adenocarcinoma)	NULL
EXP058534	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Treament: siControl; Genotype: wildtype;	EXP058525	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	NULL
EXP058535	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Treament: siControl; Genotype: wildtype;	EXP058527	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	NULL
EXP058536	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Genotype: PCF11 knock-down (5 nM); Treatment: siPCF11;	EXP058528	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	NULL
EXP058537	anti-CPSF73 (Bethyl, Cat# A301-091A, Rabbit polyclonal )	Homo sapiens	Genotype: PCF11 knock-down (5 nM); Treatment: siPCF11;	EXP058529	78	normal	Q9UKF6	HeLa (cervical adenocarcinoma)	NULL
EXP058538	Input	Homo sapiens	Treatment: none;	NULL	618	chip_control	NULL	MM1.S (plasma cell myeloma)	NULL
EXP058539	Input	Homo sapiens	Treatment: none;	NULL	1511	chip_control	NULL	RPMI8226 (Plasma cell myeloma)	NULL
EXP058540	IKZF1 antibody (GeneTex, GTX129438)	Homo sapiens	Treatment: none;	NULL	3038	normal	Q13422	ARP-1(Plasma cell myeloma)	NULL
EXP058541	IKZF1 antibody (GeneTex, GTX129438)	Homo sapiens	Treatment: none;	EXP058538	618	normal	Q13422	MM1.S (plasma cell myeloma)	NULL
EXP058542	IKZF1 antibody (GeneTex, GTX129438)	Homo sapiens	Treatment: none;	EXP058539	1511	normal	Q13422	RPMI8226 (Plasma cell myeloma)	NULL
EXP058543		Homo sapiens	Treatment: vector control;	NULL	3039	chip_control	NULL	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058544		Homo sapiens		NULL	3039	chip_control	NULL	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058545		Homo sapiens		NULL	3039	chip_control	NULL	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058546		Homo sapiens		NULL	3039	chip_control	NULL	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058547	anti-EZH2	Homo sapiens	Treatment: vector control;	EXP058544	3039	normal	Q15910	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058548	anti-EZH2	Homo sapiens	Treatment: vector control; Genotype: FBP1 WT;	EXP058545	3039	normal	Q15910	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058549	anti-EZH2	Homo sapiens	Treatment: vector control; Genotype: FBP1 S169A;	EXP058546	3039	normal	Q15910	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP058550	IgG (Abcam, ab171870)	Homo sapiens		NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058551	none	Homo sapiens		NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058552	IgG (Abcam, ab171870)	Homo sapiens		NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058553	none	Homo sapiens		NULL	128	chip_control	NULL	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058554	IgG (Abcam, ab171870)	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058555	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058556	IgG (Abcam, ab171870)	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058557	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058558	IgG (Abcam, ab171870)	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058559	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058560	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058551	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058561	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058551	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058562	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058551	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058563	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058553	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058564	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058553	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058565	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058553	128	normal	P03372	MCF-7 C4-12 (invasive breast ductal carcinoma)	NULL
EXP058566	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058555	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058567	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058555	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058568	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058555	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058569	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058557	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058570	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058557	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058571	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058557	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058572	anti-ERalpha (Abcam, ab3575)	Homo sapiens		EXP058559	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058573	anti-ERalpha (Santa Cruz, sc-543)	Homo sapiens		EXP058559	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058574	anti-ERalpha (Millipore, 06-935)	Homo sapiens		EXP058559	2301	normal	P03372	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP058575	CTCF antibody (Cell Signaling Technology; #3418)	Homo sapiens		NULL	36	normal	P49711	A375 (malignant melanoma)	NULL
EXP058576	none	Homo sapiens	Genotype: mouse MYOD overexpression;	NULL	3041	chip_control	NULL	IMR90-derived myoblast	NULL
EXP058577	none	Homo sapiens	Genotype: mouse MYOD overexpression;	NULL	3040	chip_control	NULL	IMR90-derived myotube	NULL
EXP058578	anti-MYOD(Santa Cruz, M-318 sc-760)	Homo sapiens	Genotype: mouse MYOD overexpression;	EXP058576	3041	normal	P15172	IMR90-derived myoblast	NULL
EXP058579	anti-MYOD(Santa Cruz, M-318 sc-760)	Homo sapiens	Genotype: mouse MYOD overexpression;	EXP058577	3040	normal	P15172	IMR90-derived myotube	NULL
EXP058580	IgG	Homo sapiens	Genotype: MYOCD overexpression; Treatment: pWPI vector;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP058581	anti-Myocardin	Homo sapiens	Genotype: MYOCD overexpression; Treatment: pWPI vector;	EXP058580	38	normal	Q8IZQ8	A549 (lung carcinoma)	NULL
EXP058582	none	Homo sapiens	Treatment: none;	NULL	2993	chip_control	NULL	monocytes from periferal blood	NULL
EXP058583	none	Homo sapiens	Treatment: none;	NULL	2993	chip_control	NULL	monocytes from periferal blood	NULL
EXP058584	anti-eGFP	Homo sapiens	Treatment: none;	EXP058582	2993	normal	Q12772	monocytes from periferal blood	NULL
EXP058585	eGFP	Homo sapiens	Treatment: none;	EXP058583	2993	normal	Q12772	monocytes from periferal blood	NULL
EXP058586	anti-SREBP2 (Abcam, ab30682)	Homo sapiens	Treatment: none;	EXP058582	2993	normal	Q12772	monocytes from periferal blood	NULL
EXP058587	anti-SREBP2 (Abcam, ab30682)	Homo sapiens	Treatment: none;	EXP058583	2993	normal	Q12772	monocytes from periferal blood	NULL
EXP058588	anti-SREBP2 (Abcam, ab30682)	Homo sapiens	Treatment: TNF (10ng/ml) for 16 hours;	NULL	2993	normal	Q12772	monocytes from periferal blood	NULL
EXP058589	none	Homo sapiens	Treatment: lentiviruses that inducibly express RUNX1, 1 ug/ml doxycycline for 24; Genotype: RUNX1-deleted; 	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP058590	anti-RUNX1	Homo sapiens	Treatment: lentiviruses that inducibly express RUNX1, 1 ug/ml doxycycline for 24; Genotype: RUNX1-deleted; 	EXP058589	583	normal	Q01196	MCF10A (breast epithelial cells)	NULL
EXP058591		Homo sapiens	Treatment: Control (none interferon stimulation), Short-hairpin control(shControl); Genotype: wildtype;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP058592		Homo sapiens	Treatment: Interferon Stimuated, Short-hairpin control(shControl); Genotype: wildtype;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP058593		Homo sapiens	Treatment: Interferon Stimuated,shPML; Genotype: Short-hairpin targeting PML;	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP058594	anti-HIRA(mouse mAbs, gift from Professor Peter Adams )	Homo sapiens	Treatment: Control (none interferon stimulation), Short-hairpin control(shControl); Genotype: wildtype;	EXP058591	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP058595	anti-HIRA(mouse mAbs, gift from Professor Peter Adams )	Homo sapiens	Treatment: Interferon Stimuated, Short-hairpin control(shControl); Genotype: wildtype;	EXP058592	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP058596	anti-HIRA(mouse mAbs, gift from Professor Peter Adams )	Homo sapiens	Treatment: Interferon Stimuated,shPML; Genotype: Short-hairpin targeting PML;	EXP058593	489	normal	P54198	IMR90 (lung fibroblasts)	NULL
EXP058597	anti-ISL1(Abcam, ab20670 )	Homo sapiens	Genotype: overexpression of ISL1; Treatment: transfected by ISL1 Lentivirus;	NULL	1474	normal	P61371	HuH7 (hepatocellular carcinoma)	NULL
EXP058598	none (input)	Homo sapiens	Treatment: 1 uM BB608 snd DMSO for 2 hours;	NULL	3042	chip_control	NULL	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP058599	anti-STAT3 (Santa,Cruz sc-482)	Homo sapiens	Treatment: DMSOfor 2 hrs;	EXP058598	3042	normal	P40763	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP058600	anti-STAT3 (Santa,Cruz sc-482)	Homo sapiens	Treatment: 1 uM BB608 for 2 hours;	EXP058598	3042	normal	P40763	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP058601	anti-STAT1 (Santa Cruz,sc-345)	Homo sapiens	Treatment: DMSOfor 2 hrs;	EXP058598	3042	normal	P42224	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP058602	anti-STAT1 (Santa Cruz,sc-345)	Homo sapiens	Treatment: 1 uM BB608 for 2 hours;	EXP058598	3042	normal	P42224	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP058603	none	Homo sapiens	Treatment: siControl;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058604	none	Homo sapiens	Treatment: siControl;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058605	none	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058606	none	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058607	none	Homo sapiens	Treatment: siControl;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058608	none	Homo sapiens	Treatment: siControl;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058609	none	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058610	none	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP058611	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siControl;	EXP058603	1564	normal	P46531	pulmonary artery endothelial cell	NULL
EXP058612	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siControl;	EXP058604	1564	normal	P46531	pulmonary artery endothelial cell	NULL
EXP058613	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058605	1564	normal	P46531	pulmonary artery endothelial cell	NULL
EXP058614	anti-Notch1 (Cell Signaling Technology, 3608S, lot5)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058606	1564	normal	P46531	pulmonary artery endothelial cell	NULL
EXP058615	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siControl;	EXP058607	1564	normal	Q09472	pulmonary artery endothelial cell	NULL
EXP058616	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siControl;	EXP058608	1564	normal	Q09472	pulmonary artery endothelial cell	NULL
EXP058617	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058609	1564	normal	Q09472	pulmonary artery endothelial cell	NULL
EXP058618	anti-p300 (Santa Cruz Biotechnology, sc-585)	Homo sapiens	Treatment: siPFKFB3 transfection; Genotype: PFKFB3 knockout;	EXP058610	1564	normal	Q09472	pulmonary artery endothelial cell	NULL
EXP058619		Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP058620	anti-RAD51 (Santa Cruz sc8349)	Homo sapiens	Treatment: 4-Hydroxytamoxifen (4OHT) 300 nM for 2hrs; Genotype: MCF10A-AsiSIER;	NULL	583	normal	Q06609	MCF10A (breast epithelial cells)	NULL
EXP058621	anti-NBS1 (Abcam, ab32074)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	O60934	MCF10A (breast epithelial cells)	NULL
EXP058622	anti-RAD51 (Santa Cruz sc8349)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	Q06609	MCF10A (breast epithelial cells)	NULL
EXP058623	anti-TOP2B (Abcam, Ab58442)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	Q02880	MCF10A (breast epithelial cells)	NULL
EXP058624	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Treatment: 4-Hydroxytamoxifen (4OHT) 300 nM for 2hrs; Genotype: MCF10A-AsiSIER;	NULL	583	normal	Q13426	MCF10A (breast epithelial cells)	NULL
EXP058625	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	Q13426	MCF10A (breast epithelial cells)	NULL
EXP058626	anti-TOP1 (Abcam, ab3825)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	P11387	MCF10A (breast epithelial cells)	NULL
EXP058627	anti-PARP1 (Active Motif, #39559)	Homo sapiens	Treatment: none; Genotype: MCF10A-AsiSIER;	EXP058619	583	normal	P09874	MCF10A (breast epithelial cells)	NULL
EXP058628	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Genotype: MCF10A-AsiSIER; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) 20 mM, 30 min;	NULL	583	normal	Q13426	MCF10A (breast epithelial cells)	NULL
EXP058629	anti-XRCC4 (Sigma, HPA006801)	Homo sapiens	Genotype: MCF10A-AsiSIER; Treatment: 5,6-Dichlorobenzimidazole 1-?-D-ribofuranoside (DRB) 20 mM, 30 min+washout 1 hour;	NULL	583	normal	Q13426	MCF10A (breast epithelial cells)	NULL
EXP058630	anti-NBS1 (Abcam, ab32074)	Homo sapiens	Treatment: 4-Hydroxytamoxifen (4OHT) 300 nM for 2hrs; Genotype: MCF10A-AsiSIER;	NULL	583	normal	O60934	MCF10A (breast epithelial cells)	NULL
EXP058631	none	Homo sapiens	Genotype: TRA1-60+; Day of reprogramming: day 2;	NULL	3043	chip_control	NULL	somatic cells reprogrammed into pluripotent stem cells	NULL
EXP058632	none	Homo sapiens	Genotype: TRA1-60+; Day of reprogramming: day 10;	NULL	3043	chip_control	NULL	somatic cells reprogrammed into pluripotent stem cells	NULL
EXP058633	anti-Flag (Sigma)	Homo sapiens	Genotype: TRA1-60+; Day of reprogramming: day 2;	EXP058631	3043	normal	Q01860	somatic cells reprogrammed into pluripotent stem cells	NULL
EXP058634	anti-Flag (Sigma)	Homo sapiens	Genotype: TRA1-60+; Day of reprogramming: day 10;	NULL	3043	normal	Q03052	somatic cells reprogrammed into pluripotent stem cells	NULL
EXP058635		Homo sapiens	Treatment: 1 mM JQ1 was diluted 1:2000 to 500 nM final concentration for 12 hrs;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058636		Homo sapiens	Treatment: 1 mM JQ1 was diluted 1:2000 to 500 nM final concentration for 12 hrs;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058637		Homo sapiens	Treatment: DMSO was diluted 1:2000 to 0.05% for 12 hrs;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058638		Homo sapiens	Treatment: DMSO was diluted 1:2000 to 0.05% for 12 hrs;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058639	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: 1 mM JQ1 was diluted 1:2000 to 500 nM final concentration for 12 hrs;	EXP058635	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058640	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: 1 mM JQ1 was diluted 1:2000 to 500 nM final concentration for 12 hrs;	EXP058636	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058641	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: DMSO was diluted 1:2000 to 0.05% for 12 hrs;	EXP058637	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058642	anti-BRD4 antibody (Bethyl, #A301-985A)	Homo sapiens	Treatment: DMSO was diluted 1:2000 to 0.05% for 12 hrs;	EXP058638	725	normal	O60885	PC3(bone mets prostate adenocarcinoma)	NULL
EXP058643	anti-Lamin A/C (Santa Cruz, #sc7292)	Homo sapiens		NULL	738	normal	P02545	PrEC (prostate cells)	NULL
EXP058644	anti-Lamin B1 (Abcam, #ab16048)	Homo sapiens		NULL	738	normal	P20700	PrEC (prostate cells)	NULL
EXP058645	anti-Lamin A/C (Santa Cruz, #sc7292)	Homo sapiens		NULL	70	normal	P02545	LNCaP (prostate carcinoma)	NULL
EXP058646	anti-Lamin B1 (Abcam, #ab16048)	Homo sapiens		NULL	70	normal	P20700	LNCaP (prostate carcinoma)	NULL
EXP058647	mouse IgG (I5381, Sigma)	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP058648	mouse IgG (I5381, Sigma)	Homo sapiens		NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP058649	anti-Abeta (4G8, SIG-39220, Covance)	Homo sapiens		EXP058647	509	normal	P05067	Jurkat (T-cells)	NULL
EXP058650	anti-Abeta (4G8, SIG-39220, Covance)	Homo sapiens		EXP058648	509	normal	P05067	Jurkat (T-cells)	NULL
EXP058651	none	Mus musculus	Treatment: retrovirally transduced with GFP alone (MIG);	NULL	3044	chip_control	NULL	hepatopoietic stem cells	NULL
EXP058652	none	Mus musculus	Treatment: retrovirally transduced with BCR-ABL and GFP (BCR-ABL);	NULL	3044	chip_control	NULL	hepatopoietic stem cells	NULL
EXP058653	anti-STAT5 (sc-835X, Santa Cruz Biotechnology, lot# A0915)	Mus musculus	Treatment: retrovirally transduced with GFP alone (MIG);	EXP058651	3044	normal	P42230	hepatopoietic stem cells	NULL
EXP058654	anti-STAT5 (sc-835X, Santa Cruz Biotechnology, lot# A0915)	Mus musculus	Treatment: retrovirally transduced with BCR-ABL and GFP (BCR-ABL);	EXP058652	3044	normal	P42230	hepatopoietic stem cells	NULL
EXP058655	N/A	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	chip_control	NULL	squamous cell carcinoma	NULL
EXP058656	N/A	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	NULL	2441	chip_control	NULL	squamous cell carcinoma	NULL
EXP058657	N/A	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	chip_control	NULL	squamous cell carcinoma	NULL
EXP058658	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058655	2441	normal	P70314	squamous cell carcinoma	NULL
EXP058659	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	P70314	squamous cell carcinoma	NULL
EXP058660	anti-Sox2 (R&D, AF2018)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	P48432	squamous cell carcinoma	NULL
EXP058661	anti-TP63 (Cell Signaling, 13109)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	O88898	squamous cell carcinoma	NULL
EXP058662	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	P70314	squamous cell carcinoma	NULL
EXP058663	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Genotype: Pitx1 knockout; Strain: C57BL/6;  Tissue: skin;	EXP058657	2441	normal	P70314	squamous cell carcinoma	NULL
EXP058664	anti-Sox2 (R&D, AF2018)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	P48432	squamous cell carcinoma	NULL
EXP058665	anti-TP63 (Cell Signaling, 13109)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	O88898	squamous cell carcinoma	NULL
EXP058666	anti-Klf4 (R&D, AF3758)	Mus musculus	Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	EXP058657	2441	normal	Q60793	squamous cell carcinoma	NULL
EXP058667	anti-Klf4 (R&D, AF3758)	Mus musculus	Conditions: high calcium (1.5mM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	Q60793	squamous cell carcinoma	NULL
EXP058668	anti-Pitx1 (Santa Cruz, 18922)	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	EXP058656	2441	normal	P70314	squamous cell carcinoma	NULL
EXP058669	anti-Klf4 (R&D, AF3758)	Mus musculus	Treatment: 15,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	NULL	2441	normal	Q60793	squamous cell carcinoma	NULL
EXP058670	anti-Klf4 (R&D, AF3758)	Mus musculus	Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin;	EXP058656	2441	normal	Q60793	squamous cell carcinoma	NULL
EXP058671		Mus musculus	Age: postnatal 5 days; Strain: CD1; Treatment: mice were intraperitoneal injected with one dose EdU (3.3 ug per g body weight) and scarified after 24 hours;	NULL	3045	chip_control	NULL	incisor pulp	NULL
EXP058672	anti-Ring1b	Mus musculus	Age: postnatal 5 days; Strain: CD1; Treatment: mice were intraperitoneal injected with one dose EdU (3.3 ug per g body weight) and scarified after 24 hours;	EXP058671	3045	normal	Q9CQJ4	incisor pulp	NULL
EXP058673	n/a	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058674	n/a	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058675	lnvitrogen Mouse IgG 10005292, lot V017.	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058676	lnvitrogen Mouse IgG 10005292, lot V017.	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058677	anti-Asxl1 (Santa Cruz ASXL1 6E2, Lot J0316)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	P59598	mESCs (mouse embryonic stem cells)	NULL
EXP058678	anti-Asxl1 (Santa Cruz ASXL1 6E2, Lot J0316)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	P59598	mESCs (mouse embryonic stem cells)	NULL
EXP058679	anti-BAP1(Santa Cruz, C-4, Lot B2117)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	NULL
EXP058680	anti-BAP1(Santa Cruz, C-4, Lot B2117)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	NULL
EXP058681	anti-O-GlcNAc (Santa Cruz, CTD110.6, Lot G0715)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	Q8CGY8	mESCs (mouse embryonic stem cells)	NULL
EXP058682	anti-O-GlcNAc (Santa Cruz, CTD110.6, Lot G0715)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	Q8CGY8	mESCs (mouse embryonic stem cells)	NULL
EXP058683	anti-MPND (Invitrogen PA5-68860, Lot T02553192B)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: wildtype;	EXP058673	2	normal	Q3TV65	mESCs (mouse embryonic stem cells)	NULL
EXP058684	anti-MPND (Invitrogen PA5-68860, Lot T02553192B)	Mus musculus	Strain: 129SVxC57/BL6; Passage: 3-5; Genotype: Mettl4 knockout;	EXP058674	2	normal	Q3TV65	mESCs (mouse embryonic stem cells)	NULL
EXP058685	none	Mus musculus	Developmental stage: E13.5;	NULL	827	chip_control	NULL	telencephalon	NULL
EXP058686	none	Mus musculus	Developmental stage: E13.5;	NULL	3046	chip_control	NULL	medial ganglionic eminence	NULL
EXP058687	anti-CTCF(Cell Signaling Technology, rabbit  antibody)	Mus musculus	Developmental stage: E13.5;	EXP058685	827	normal	Q61164	telencephalon	NULL
EXP058688	anti-CTCF(Cell Signaling Technology, rabbit  antibody)	Mus musculus	Developmental stage: E13.5;	EXP058686	3046	normal	Q61164	medial ganglionic eminence	NULL
EXP058689	none	Mus musculus	Source: activated satellite cells; Age: adult;	NULL	3047	chip_control	NULL	muscle satellite cells	NULL
EXP058690	anti-YY1 (rabbit polyclonal antibody, Santa Cruz Biotechnology, SC-1703, Lot#B1115)	Mus musculus	Source: activated satellite cells; Age: adult;	EXP058689	3047	normal	Q00899	muscle satellite cells	NULL
EXP058691	NA	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	NULL	3048	chip_control	NULL	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058692	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058693	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: 100 nM Dexamethasone for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058694	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058695	anti-SMARCA4 (BRG1, Epitomics, EPNCIR11A, made in collaboration with Epitomics, PMID:24317492)	Mus musculus	Treatment: 100 nM Dexamethasone for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	Q3TKT4	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058696	anti-GR-cocktail (Santa Cruz Biotechnology, sc-1004, lot # C1116; ABR, PA1-511A, lot # 019-147; Thermo Fisher Scientific, BuGR2, lot # PI200288)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP058697	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058698	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	EXP058691	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058699	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058700	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	EXP058691	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058701	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058702	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058703	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058704	anti-GR-cocktail (Santa Cruz Biotechnology, sc-1004, lot # C1116; ABR, PA1-511A, lot # 019-147; Thermo Fisher Scientific, BuGR2, lot # PI200288)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058705	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058706	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	3048	normal	P06537	3617-KOGR (mouse adenocarcinoma)	NULL
EXP058707	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP058708	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP058709	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP058710	anti-GFP (Abcam, ab290, lot # GR278073-1)	Mus musculus	Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra;	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP058711	IgG (Normal Rabbit IgG: Santa Cruz #sc-2027)	Mus musculus	Treatment: none;	NULL	942	chip_control	NULL	NS5 (neural stem cells)	NULL
EXP058712	anti-Med1 (Behtyl Labs #A300-793A)	Mus musculus	Treatment: none;	EXP058711	942	normal	Q925J9	NS5 (neural stem cells)	NULL
EXP058713	anti-Jmjd1c (Merck Millipore #17-10262)	Mus musculus	Treatment: none;	EXP058711	942	normal	Q69ZK6	NS5 (neural stem cells)	NULL
EXP058714	anti-Carm1 (Cell Signaling Technology #12495)	Mus musculus	Treatment: none;	EXP058711	942	normal	Q9WVG6	NS5 (neural stem cells)	NULL
EXP058715		Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: wildtype;	NULL	212	chip_control	NULL	dermal fibroblasts	NULL
EXP058716	anti-IgG (Cell signaling, 2729S)	Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: wildtype;	NULL	212	chip_control	NULL	dermal fibroblasts	NULL
EXP058717		Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: Post XCI deletion of Xist on inactive X-chromosome;	NULL	212	chip_control	NULL	dermal fibroblasts	NULL
EXP058718	anti-IgG (Cell signaling, 2729S)	Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: Post XCI deletion of Xist on inactive X-chromosome;	NULL	212	chip_control	NULL	dermal fibroblasts	NULL
EXP058719	anti-BRG1 (ab110641)	Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: wildtype;	EXP058715	212	normal	Q3TKT4	dermal fibroblasts	NULL
EXP058720	anti-BRG1 (ab110641)	Mus musculus	Sex: female; Strain: CAST/Ei x 129/Sv/Jae; Genotype: Post XCI deletion of Xist on inactive X-chromosome;	EXP058717	212	normal	Q3TKT4	dermal fibroblasts	NULL
EXP058721	none	Mus musculus	Strain: CD1; Developmental stage: E14.5; Sex: female;	NULL	3049	chip_control	NULL	fetal ovary	NULL
EXP058722	none	Mus musculus	Strain: CD1; Developmental stage: E14.5; Sex: female;	NULL	3049	chip_control	NULL	fetal ovary	NULL
EXP058723	anti-FOXL2 (Novus, NB100-1277)	Mus musculus	Strain: CD1; Developmental stage: E14.5; Sex: female;	EXP058721	3049	normal	O88470	fetal ovary	NULL
EXP058724	anti-FOXL2 (Novus, NB100-1277)	Mus musculus	Strain: CD1; Developmental stage: E14.5; Sex: female;	EXP058722	3049	normal	O88470	fetal ovary	NULL
EXP058725	none	Mus musculus	Tissue: testis;	NULL	3050	chip_control	NULL	undifferentiated spermatogonia	NULL
EXP058726	none	Mus musculus	Tissue: testis;	NULL	3050	chip_control	NULL	undifferentiated spermatogonia	NULL
EXP058727	anti-DDX5 (Abcam, ab10261, Lot# GR183991-1)	Mus musculus	Tissue: testis;	EXP058725	3050	normal	Q61656	undifferentiated spermatogonia	NULL
EXP058728	anti-DDX5 (Abcam, ab10261, Lot# GR183991-1)	Mus musculus	Tissue: testis;	EXP058726	3050	normal	Q61656	undifferentiated spermatogonia	NULL
EXP058729	FLAG affinity gel, sigma A2220; M-280 Streptavidin, Invitrogen  60210	Mus musculus	Treatment: none; Genotype: Fbio-tagged Safb1;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058730	anti-FLAG(Sigma F1804)	Mus musculus	Treatment: DMSO; Genotype: Fbio-tagged WDR43;	NULL	2	normal	Q6ZQL4	mESCs (mouse embryonic stem cells)	NULL
EXP058731	anti-FLAG(Sigma F1804)	Mus musculus	Treatment: DRB; Genotype: Fbio-tagged WDR43;	NULL	2	normal	Q6ZQL4	mESCs (mouse embryonic stem cells)	NULL
EXP058732	anti-FLAG(Sigma F1804)	Mus musculus	Treatment: ActD; Genotype: Fbio-tagged WDR43;	NULL	2	normal	Q6ZQL4	mESCs (mouse embryonic stem cells)	NULL
EXP058733	anti-FLAG (Sigma F1804)	Mus musculus	Treatment: none; Genotype: Fbio-tagged UTP3;	NULL	2	normal	Q9JI13	mESCs (mouse embryonic stem cells)	NULL
EXP058734	anti-FLAG (Sigma F1804)	Mus musculus	Treatment: none; Genotype: Fbio-tagged UTP6;	NULL	2	normal	Q8VCY6	mESCs (mouse embryonic stem cells)	NULL
EXP058735	anti-FLAG( affinity gel, sigma A2220; M-280 Streptavidin, Invitrogen  60210)	Mus musculus	Treatment: none; Genotype: Fbio-tagged Safb1;	EXP058729	2	normal	O55242	mESCs (mouse embryonic stem cells)	NULL
EXP058736	normal rabbit IgG (abcam, ab171870)	Mus musculus	Strain: MRP8-Cre-ires/GFP (PU.1WT); Genotype: HoxER-PU.1 wildtype;	NULL	3051	chip_control	NULL	neutrophils derived from immortalized progenitors	NULL
EXP058737	normal rabbit IgG (abcam, ab171870)	Mus musculus	Strain: MRP8-Cre-ires/GFP:PU.1f/f (PU.1 KO); Genotype: HoxER-PU.1 knockout;	NULL	3051	chip_control	NULL	neutrophils derived from immortalized progenitors	NULL
EXP058738	anti-JUNB (Cell Signaling, 3753S)	Mus musculus	Strain: MRP8-Cre-ires/GFP (PU.1WT); Genotype: HoxER-PU.1 wildtype;	EXP058736	3051	normal	P09450	neutrophils derived from immortalized progenitors	NULL
EXP058739	anti-JUNB (Cell Signaling, 3753S)	Mus musculus	Strain: MRP8-Cre-ires/GFP:PU.1f/f (PU.1 KO); Genotype: HoxER-PU.1 knockout;	EXP058737	3051	normal	P09450	neutrophils derived from immortalized progenitors	NULL
EXP058740	normal rabbit IgG (Upstate, 12-370)	Mus musculus	Treatment: unstimulated; Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1;	NULL	3051	chip_control	NULL	neutrophils derived from immortalized progenitors	NULL
EXP058741	normal rabbit IgG (Upstate, 12-370)	Mus musculus	Treatment: stimulated for 1 hour with Candida albicans (heat-inactivated); Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1;	NULL	3051	chip_control	NULL	neutrophils derived from immortalized progenitors	NULL
EXP058742	anti-PU.1 (Santa Cruz, sc-352X)	Mus musculus	Treatment: unstimulated; Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1;	EXP058740	3051	normal	P17433	neutrophils derived from immortalized progenitors	NULL
EXP058743	anti-PU.1 (Santa Cruz, sc-352X)	Mus musculus	Treatment: stimulated for 1 hour with Candida albicans (heat-inactivated); Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1;	EXP058741	3051	normal	P17433	neutrophils derived from immortalized progenitors	NULL
EXP058744	input	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	NULL	3052	chip_control	NULL	intestinal villus epithelial cells	NULL
EXP058745	input	Mus musculus	Day: 9; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	NULL	3052	chip_control	NULL	intestinal villus epithelial cells	NULL
EXP058746	anti-Foxg1 (Active Motif 61211)	Mus musculus	Day: 9; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	EXP058745	3052	normal	P35582	intestinal villus epithelial cells	NULL
EXP058747	anti-Foxg1 (Active Motif 61211)	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	NULL	3052	normal	Q60987	intestinal villus epithelial cells	NULL
EXP058755		Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058756		Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058749	anti-Foxg1 (Active Motif 61211)	Mus musculus	Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	NULL	3052	normal	Q60987	intestinal villus epithelial cells	NULL
EXP058754	anti-Foxg1 (Active Motif 61211)	Mus musculus	Day: 9; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	EXP058745	3052	normal	Q60987	intestinal villus epithelial cells	NULL
EXP058751	anti-Suz12  (Cell Signaling D39F6)	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	EXP058744	3052	normal	Q80U70	intestinal villus epithelial cells	NULL
EXP058752	anti-Foxa1(Abcam, ab5089)	Mus musculus	Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background;	EXP058744	3052	normal	P35582	intestinal villus epithelial cells	NULL
EXP058753	anti-Foxa1(Abcam, ab5089)	Mus musculus	Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background;	NULL	3052	normal	P35582	intestinal villus epithelial cells	NULL
EXP058757		Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058758		Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058759	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:C57Bl6;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout;	NULL	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP058760	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:C57Bl6;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout;	NULL	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP058761	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:C57Bl6;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout;	NULL	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP058762	anti-PPARg (sc-7196, C26H12, C15410133)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P37238	BMDM (bone marrow-derived macrophages)	NULL
EXP058763	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP058764	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP058765	anti-Cebpa (sc-61)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P53566	BMDM (bone marrow-derived macrophages)	NULL
EXP058766		Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P53566	BMDM (bone marrow-derived macrophages)	NULL
EXP058767	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP058768	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP058769	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP058770	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP058771	anti-Fra2 (sc-166102)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P47930	BMDM (bone marrow-derived macrophages)	NULL
EXP058772	anti-Fra2 (sc-166102)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P47930	BMDM (bone marrow-derived macrophages)	NULL
EXP058773	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP058774	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP058775	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP058776	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP058777	anti-PU.1 (sc-352)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058755	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP058778	anti-PU.1 (sc-352)	Mus musculus	Sex: male; Strain:C57Bl/6EiJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058756	81	normal	P17433	BMDM (bone marrow-derived macrophages)	NULL
EXP058779	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP058780	anti-Atf3 (PA5-36244)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	Q60765	BMDM (bone marrow-derived macrophages)	NULL
EXP058781	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP058782	anti-Jun (sc-1694)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P05627	BMDM (bone marrow-derived macrophages)	NULL
EXP058783	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP058784	anti-Fos (sc-7202)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P01101	BMDM (bone marrow-derived macrophages)	NULL
EXP058785	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP058786	anti-JunB (sc-73)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P09450	BMDM (bone marrow-derived macrophages)	NULL
EXP058787	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; 	EXP058757	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP058788	anti-JunD (sc-74)	Mus musculus	Sex: male; Strain:Balb/cJ;  Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; 	EXP058758	81	normal	P15066	BMDM (bone marrow-derived macrophages)	NULL
EXP058789	none	Mus musculus	Strain:C57BL/6N; Genotype: Rec8 -/-(knockout);	NULL	32	chip_control	NULL	testis	NULL
EXP058790	none	Mus musculus	Strain:C57BL/6N; Genotype: Rec8 -/-(knockout);	NULL	32	chip_control	NULL	testis	NULL
EXP058791	none	Mus musculus	Strain:C57BL/6N; Genotype: Stag3 -/-, Rec8 -/-(double knockout);	NULL	32	chip_control	NULL	testis	NULL
EXP058792	none	Mus musculus	Strain: C57BL/6N; Genotype: wildtype;	NULL	32	chip_control	NULL	testis	NULL
EXP058793	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Rec8 -/-(knockout);	EXP058789	32	normal	Q61880	testis	NULL
EXP058794	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Rec8 -/-(knockout);	EXP058790	32	normal	Q61880	testis	NULL
EXP058795	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Stag3 -/-, Rec8 -/-(double knockout);	EXP058791	32	normal	Q61880	testis	NULL
EXP058796	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain: C57BL/6N; Genotype: wildtype;	EXP058792	32	normal	Q61880	testis	NULL
EXP058797	Anti-DMC1 (C-20); vendor: Santa Cruz, sc-8973)	Mus musculus	Strain:C57BL/6N; Genotype: Stag3 -/-(knockout);	NULL	32	normal	Q61880	testis	NULL
EXP058798		Mus musculus	Strain: C57BL/6;  Genotype: wildtype;	NULL	187	chip_control	NULL	colon epithelium	NULL
EXP058799	anti-BRG1(Abcam, ab110641, Lot No.GR150844-36)	Mus musculus	Strain: C57BL/6;  Genotype: wildtype;	EXP058798	187	normal	Q3TKT4	colon epithelium	NULL
EXP058800	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058801	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058802	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058803	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058804	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout, Snf2h wiltype add-back;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058805	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h ko, Snf2h mutant add-back;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058806	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058807	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058808	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058809	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058810	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058811	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058812	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058813	none	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058814	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058815	none	Mus musculus		NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058816	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058800	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058817	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout;	EXP058801	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058818	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058806	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058819	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058807	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058820	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058808	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058821	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058809	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058822	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058810	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058823	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058811	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058824	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058812	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058825	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Brg1 knockout;	EXP058813	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058826	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: wildtype;	EXP058802	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058827	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout;	EXP058803	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058828	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout, Snf2h wiltype add-back;	EXP058804	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058829	anti-REST (Santa Cruz, Cat. # H-290)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h ko, Snf2h mutant add-back;	EXP058805	2	normal	Q8VIG1	mESCs (mouse embryonic stem cells)	NULL
EXP058830	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h knockout, Snf2h wiltype add-back;	EXP058814	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058831	anti-CTCF (Santa Cruz, Cat. # C-20X)	Mus musculus	Strain: 129S6/SvEvTac; Genotype: Snf2h ko, Snf2h mutant add-back;	EXP058815	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058832	Input (IgG control)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058833	Input (IgG control)	Mus musculus	Input	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058834	Input (IgG control)	Mus musculus	Strain: C57BL/6; Developmental stage: p1;	NULL	53	chip_control	NULL	heart	NULL
EXP058835	Input (IgG control)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058836	Input (IgG control)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058837	Input (IgG control)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058838	Input (IgG control)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058839	Input (IgG control)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP058840	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	NULL
EXP058841	anti-Hand2 (Diagenode, C15200054)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	Q61039	MEF (mouse embryonic fibroblasts)	NULL
EXP058842	anti-Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	NULL
EXP058843	anti-Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: AGHMT for 2 days; Strain: C57BL/6;	EXP058832	12	normal	P70326	MEF (mouse embryonic fibroblasts)	NULL
EXP058844	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	NULL
EXP058845	anti-Hand2 (Diagenode, C15200054)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q61039	MEF (mouse embryonic fibroblasts)	NULL
EXP058846	Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	NULL
EXP058847	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: GHMT for 2 days; Strain: C57BL/6;	NULL	12	normal	P70326	MEF (mouse embryonic fibroblasts)	NULL
EXP058848	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: GMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	NULL
EXP058849	Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: GMT for 2 days; Strain: C57BL/6;	NULL	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	NULL
EXP058850	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: GMT for 2 days; Strain: C57BL/6;	NULL	12	normal	P70326	MEF (mouse embryonic fibroblasts)	NULL
EXP058851	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Strain: C57BL/6; Developmental stage: p4;	NULL	3053	normal	Q08369	heart ventricle	NULL
EXP058852	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Strain: C57BL/6; Developmental stage: p4;	NULL	3053	normal	P70326	heart ventricle	NULL
EXP058853	anti-Gata4 (Santa Cruz Biothechnology, sc1237)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058836	12	normal	Q08369	MEF (mouse embryonic fibroblasts)	NULL
EXP058854	anti-Hand2 (Diagenode, C15200054)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058837	12	normal	Q61039	MEF (mouse embryonic fibroblasts)	NULL
EXP058855	Mef2C (Diagenode, C15200054)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058838	12	normal	Q8CFN5	MEF (mouse embryonic fibroblasts)	NULL
EXP058856	Tbx5 (Santa Cruz Biotechnology, sc-17866)	Mus musculus	Treatment: Single Factor for 2 days; Strain: C57BL/6; 	EXP058839	12	normal	P70326	MEF (mouse embryonic fibroblasts)	NULL
EXP058857		Mus musculus	Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout;	NULL	3054	chip_control	NULL	prostate cancer	NULL
EXP058858		Mus musculus	Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout;	NULL	3054	chip_control	NULL	prostate cancer	NULL
EXP058859	anti-AR	Mus musculus	Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout;	EXP058857	3054	normal	P19091	prostate cancer	NULL
EXP058860	anti-ERG	Mus musculus	Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout;	EXP058857	3054	normal	P81270	prostate cancer	NULL
EXP058861	anti-AR	Mus musculus	Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout;	EXP058858	3054	normal	P19091	prostate cancer	NULL
EXP058862	anti-ERG	Mus musculus	Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout;	EXP058858	3054	normal	P81270	prostate cancer	NULL
EXP058863	anti-GPS2	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	NULL
EXP058864	anti-GPS2	Mus musculus	Genotype: GPS2 knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	NULL
EXP058865	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	NULL
EXP058866	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: GPS2 knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	NULL
EXP058867	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: PPARa wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	NULL
EXP058868	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: PPARa knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	NULL
EXP058869	anti-GPS2	Mus musculus	Genotype: PPARa wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	NULL
EXP058870	anti-GPS2	Mus musculus	Genotype: PPARa knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	NULL
EXP058871	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	NULL
EXP058872	anti-NCOR (Bethyl laboratories, A301-145A)	Mus musculus	Genotype: PPARa knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q60974	liver	NULL
EXP058873	anti-GPS2	Mus musculus	Genotype: NCOR wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	NULL
EXP058874	anti-GPS2	Mus musculus	Genotype: NCOR knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	Q921N8	liver	NULL
EXP058875	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: NCOR wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	NULL
EXP058876	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: NCOR knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	NULL
EXP058877	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: GPS2 wildtype; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	NULL
EXP058878	anti-PPARa (Millipore, MAB3890)	Mus musculus	Genotype: GPS2 knockout; Age: 8-12 week; Strain: C57BL/6;	NULL	5	normal	P23204	liver	NULL
EXP058879	none (input)	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058880	none (input)	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058881	none (input)	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058882	none (input)	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP058883	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058879	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP058884	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058880	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP058885	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	EXP058881	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP058886	anti-BRD4 (Dey.A et.al. MCB 20 6537 (2000))	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	EXP058882	81	normal	Q9ESU6	BMDM (bone marrow-derived macrophages)	NULL
EXP058887	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058879	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP058888	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058880	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP058889	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: none (untreated); Strain: C57BL6; Genotype: Brd4Fl/Fl;Ert2-cre (knockout);	EXP058881	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP058890	anti-p65 (Santa Cruz, Cat#sc-372)	Mus musculus	Treatment: LPS (100ng/ml) for 4hrs; Strain: C57BL6; Genotype: Brd4Fl/Fl mice (WT);	EXP058882	81	normal	Q5DU09	BMDM (bone marrow-derived macrophages)	NULL
EXP058891	none	Mus musculus		NULL	4	chip_control	NULL	inguinal white adipose tissue	NULL
EXP058892	none	Mus musculus	Genotype: Adipoq-Cre;Sun1-sfGFP-myc; Strain: C57BL/6;	NULL	3055	chip_control	NULL	perigonadal adipose tissue	NULL
EXP058893	anti-Bcl6 (polyconal guinea pig anti mouse ,custom)	Mus musculus	Genotype: Adipoq-Cre;Sun1-sfGFP-myc; Strain: C57BL/6;	EXP058891	4	normal	P41183	inguinal white adipose tissue	NULL
EXP058894	anti-Bcl6 (polyconal guinea pig anti mouse ,custom)	Mus musculus	Genotype: Adipoq-Cre;Sun1-sfGFP-myc; Strain: C57BL/6;	EXP058892	3055	normal	P41183	perigonadal adipose tissue	NULL
EXP058895	none	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP058896	none	Mus musculus	Genotype: Ngn2 overexpression; Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP058897	none	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iAscl1[bHLH:Ngn2].HA);	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP058898	anti-Ascl1 (Abcam ab74065)	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iAscl1.V5);	EXP058895	2565	normal	Q02067	embryonic stem cells derived embryonic bodies	NULL
EXP058899	anti-Neurog2 (Santa Cruz SC-19233)	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	P70447	embryonic stem cells derived embryonic bodies	NULL
EXP058900	anti-HA (Abcam, ab9110)	Mus musculus	Treatment: 3 ug/ml Dox induction for 12 hours; Strain: Ainv15(iAscl1[bHLH:Ngn2].HA);	EXP058897	2565	normal	Q9QX98	embryonic stem cells derived embryonic bodies	NULL
EXP058901	anti-Ascl1 (Abcam ab74065)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	Q02067	embryonic stem cells derived embryonic bodies	NULL
EXP058902	anti-Brn2 (Santa Cruz SC-6029)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	P31360	embryonic stem cells derived embryonic bodies	NULL
EXP058903	anti-Ebf2 (R&D Systems AF7006)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	O08792	embryonic stem cells derived embryonic bodies	NULL
EXP058904	anti-Onecut2 (R&D Systems AF6294)	Mus musculus	Genotype: Ainv15 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iAscl1.V5);	NULL	2565	normal	Q6XBJ3	embryonic stem cells derived embryonic bodies	NULL
EXP058905	anti-Neurog2 (Santa Cruz SC-19233)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	P70447	embryonic stem cells derived embryonic bodies	NULL
EXP058906	anti-Brn2 (Santa Cruz SC-6029)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	P31360	embryonic stem cells derived embryonic bodies	NULL
EXP058907	anti-Ebf2 (R&D Systems AF7006)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	O08792	embryonic stem cells derived embryonic bodies	NULL
EXP058908	anti-Onecut2 (R&D Systems AF6294)	Mus musculus	Genotype: Neurog2 overexpression; Treatment: 3 ug/ml Dox induction for 48 hours; Strain: Ainv15(iFlag.Ngn2);	NULL	2565	normal	Q6XBJ3	embryonic stem cells derived embryonic bodies	NULL
EXP058909	none	Mus musculus	Genotype: TET1/2 double knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058910	none	Mus musculus	Genotype: TET1/2 double knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058911	none	Mus musculus	Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058912	none	Mus musculus	Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058913	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: TET1/2 double knockout;	EXP058909	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058914	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: TET1/2 double knockout;	EXP058910	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058915	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: wildtype;	EXP058911	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058916	CTCF antibody (Active Motif, catalog# 61311)	Mus musculus	Genotype: wildtype;	EXP058912	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP058917	none	Mus musculus	Day: 0; Strain: Hcfc1 hepKO/Y; Sex: male; Age: 12 -14 weeks; Genotype: HCF-1;	NULL	5	chip_control	NULL	liver	NULL
EXP058918	none	Mus musculus	Day: 4; Strain: Hcfc1 hepKO/Y; Sex: male; Age: 12 -14 weeks; Genotype: HCF-1;	NULL	5	chip_control	NULL	liver	NULL
EXP058919	anti-HCFC1  (from: Cell. 1993 Jul 16;74(1):115-25.PMID : 8392914 )	Mus musculus	Day: 0; Strain: Hcfc1 hepKO/Y; Sex: male; Age: 12 -14 weeks; Genotype: HCF-1;	EXP058917	5	normal	Q61191	liver	NULL
EXP058920	anti-HCFC1  (from: Cell. 1993 Jul 16;74(1):115-25.PMID : 8392914 )	Mus musculus	Day: 4; Strain: Hcfc1 hepKO/Y; Sex: male; Age: 12 -14 weeks; Genotype: HCF-1;	EXP058918	5	normal	Q61191	liver	NULL
EXP058921		Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	NULL	3056	chip_control	NULL	postnatal testis	NULL
EXP058922		Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	NULL	3056	chip_control	NULL	postnatal testis	NULL
EXP058923		Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	NULL	3056	chip_control	NULL	postnatal testis	NULL
EXP058924		Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	NULL	3056	chip_control	NULL	postnatal testis	NULL
EXP058925		Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	NULL	3056	chip_control	NULL	postnatal testis	NULL
EXP058926		Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	NULL	3056	chip_control	NULL	postnatal testis	NULL
EXP058927	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058921	3056	normal	P70278	postnatal testis	NULL
EXP058928	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058922	3056	normal	P70278	postnatal testis	NULL
EXP058929	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: wildtype; Sex: male;  Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058923	3056	normal	P70278	postnatal testis	NULL
EXP058930	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058924	3056	normal	P70278	postnatal testis	NULL
EXP058931	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058925	3056	normal	P70278	postnatal testis	NULL
EXP058932	FLAG M2 antibody (F1804, Sigma)	Mus musculus	Strain: C57BL/6 (<4% 129); Genotype: Stra8 FLAG/FLAG; Sex: male; Developmental stage: developmental synchronization to enrich for preleptotenes;	EXP058926	3056	normal	P70278	postnatal testis	NULL
EXP058933	None	Mus musculus	Genotype: Tet2fl/fl (wildtype);Treatment: endogenous epitope tag empty vector; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058934	IgG control	Mus musculus	Genotype: Tet2fl/fl (wildtype);Treatment: endogenous epitope tag empty vector; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP058935	anti-TET2 antibody	Mus musculus	Genotype: Tet2fl/fl (wildtype);Treatment: endogenous epitope tag empty vector; 	EXP058933	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	NULL
EXP058936	anti-TET2 antibody	Mus musculus	Genotype: Tet2-/- (knockout);Treatment: endogenous epitope tag empty vector; 	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	NULL
EXP058937	anti-FLAG M2(Sigma, A2220)	Mus musculus	Genotype: Tet2fl/fl; Treatment: endogenous epitope tag 2x-Flag TET2; 	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	NULL
EXP058938	anti-FLAG M2(Sigma, A2220)	Mus musculus	Genotype: Tet2fl/fl; Treatment: endogenous epitope tag empty vector;  Source: parental cells;	NULL	2	normal	Q4JK59	mESCs (mouse embryonic stem cells)	NULL
EXP058939	None	Mus musculus	Genotype: Tet2fl/fl, AML1-ETO; Treatment: MigR1-AML1-ETO;	NULL	3057	chip_control	NULL	immortalized hematopoietic cells	NULL
EXP058940	IgG control	Mus musculus	Genotype: Tet2fl/fl, AML1-ETO; Treatment: MigR1-AML1-ETO;	NULL	3057	chip_control	NULL	immortalized hematopoietic cells	NULL
EXP058941	None	Mus musculus	Genotype: Npm1+/cA; Fl3+/ITD;	NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP058942	IgG control	Mus musculus	Genotype: Npm1+/cA; Fl3+/ITD;	NULL	1493	chip_control	NULL	acute myeloid leukemia	NULL
EXP058943	anti-TET2 antibody	Mus musculus	Genotype: Tet2fl/fl, AML1-ETO; Treatment: MigR1-AML1-ETO;	EXP058939	3057	normal	Q4JK59	immortalized hematopoietic cells	NULL
EXP058944	anti-TET2 antibody	Mus musculus	Genotype: Tet2-/-(knockout), AML1-ETO; Treatment: MigR1-AML1-ETO;	NULL	3057	normal	Q4JK59	immortalized hematopoietic cells	NULL
EXP058945	anti-TET2 antibody	Mus musculus	Genotype: Npm1+/cA; Fl3+/ITD;	EXP058941	1493	normal	Q4JK59	acute myeloid leukemia	NULL
EXP058946	anti-TET2 antibody	Mus musculus	Genotype: Npm1+/cA; Fl3+/ITD; Tet2-/-; 	NULL	1493	normal	Q4JK59	acute myeloid leukemia	NULL
EXP058947	none	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP058948	anti-SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058949	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058950	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1, Ezh2  knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058951	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: EZh2Y726D;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058952	anti-RING1B(home made)	Mus musculus	Genotype: wildtype; 	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP058953	anti-RING1B(home made)	Mus musculus	Genotype: Ezh2  knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP058954	anti-RING1B(home made)	Mus musculus	Genotype: Ezh1, Ezh2 knockout knockout;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP058955	anti-RING1B(home made)	Mus musculus	Genotype: EZh2Y726D;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP058956	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1  knockout, EZh2Y726D; Treatment: DMSO;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058957	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1  knockout, EZh2Y726D; Treatment: MG132;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058958	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1, Ezh2 knockout, resEZH2;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058959	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1, Ezh2 knockout, resEZH2Y731D;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058960	SUZ12 (D39F6, Cell Signaling #3737)	Mus musculus	Genotype: Ezh1 knockout, Ezh2R685C;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP058961	IgG (Abcam ab172730 (rabbit))	Mus musculus	Genotype: wildtype; 	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP058962	anti-AHCY (MBL RN126PW (rabbit))	Mus musculus	Genotype: wildtype; 	EXP058961	230	normal	P50247	ES-E14 (E14, embryonic stem cells)	NULL
EXP058963	anti-Med12(A300-774A, Bethyl laboratories)	Mus musculus	Strain: CD1;	NULL	3058	normal	A2AGH6	sperm	NULL
EXP058964	anti-ZNF143(16618-1-AP, Proteintech)	Mus musculus	Strain: CD1;	NULL	3058	normal	O70230	sperm	NULL
EXP058965	anti-Foxa1(ab5089, Abcam)	Mus musculus	Strain: CD1;	NULL	3058	normal	P35582	sperm	NULL
EXP058966	anti-ESR1(sc-543, Santa Cruz)	Mus musculus	Strain: CD1;	NULL	3058	normal	P19785	sperm	NULL
EXP058967	anti-AR(sc-816, Santa Cruz)	Mus musculus	Strain: CD1;	NULL	3058	normal	P19091	sperm	NULL
EXP058968	anti-Flag (Sigma)	Mus musculus	Genotype: K14deltaNLef; Strain: C57BL6/CBA;	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP058969		Mus musculus	Genotype: K14deltaNLef; Strain: C57BL6/CBA;	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP058970	Lef1 (Cell Signaling)	Mus musculus	Genotype: K14deltaNLef; Strain: C57BL6/CBA;	EXP058969	936	normal	P27782	primary keratinocytes	NULL
EXP058971	anti-EZH2 (pAb-039-050)	Mus musculus	Treatment: cells were mock transfected for 48 hrs;	NULL	2448	normal	Q61188	46C (embryonic stem cell)	NULL
EXP058972	anti-EZH2 (pAb-039-050)	Mus musculus	Treatment: cells were transfected with RNaseH1-GFP construct for 48 hrs;	NULL	2448	normal	Q61188	46C (embryonic stem cell)	NULL
EXP058973	anti-SUZ12 (A302-407A)	Mus musculus	Treatment: cells were mock transfected for 48 hrs;	NULL	2448	normal	Q80U70	46C (embryonic stem cell)	NULL
EXP058974	anti-SUZ12 (A302-407A)	Mus musculus	Treatment: cells were transfected with RNaseH1-GFP construct for 48 hrs;	NULL	2448	normal	Q80U70	46C (embryonic stem cell)	NULL
EXP058975	none; WCE	Mus musculus	Genotype: vp16 tagged srf; Strain: ICR;	NULL	3059	chip_control	NULL	newborn neurons	NULL
EXP058976	anti-VP16 antibody (Santa Cruz, sc-7545)	Mus musculus	Genotype: vp16 tagged srf; Strain: ICR;	EXP058975	3059	normal	Q9JM73	newborn neurons	NULL
EXP058977	none	Mus musculus	Strain: FBV/N;	NULL	3060	chip_control	NULL	mammary basal epithelial cells	NULL
EXP058978	none	Mus musculus	Strain: FBV/N;	NULL	3061	chip_control	NULL	mammary luminal epithelial cells	NULL
EXP058979	anti-Foxp1	Mus musculus	Strain: FBV/N;	EXP058977	3060	normal	P58462	mammary basal epithelial cells	NULL
EXP058980	anti-Foxp1	Mus musculus	Strain: FBV/N;	EXP058978	3061	normal	P58462	mammary luminal epithelial cells	NULL
EXP058981	Input	Mus musculus	Treatment: 1 ug/mL of Doxycycline;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP058982	anti-Brg1	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	Q3TKT4	E14TG2A (embryonic stem cells)	NULL
EXP058983	anti-Brg1	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	Q3TKT4	E14TG2A (embryonic stem cells)	NULL
EXP058984	anti-Esrrb	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP058985	anti-Esrrb	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP058986	anti-Oct4	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	P20263	E14TG2A (embryonic stem cells)	NULL
EXP058987	anti-Oct4	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	P20263	E14TG2A (embryonic stem cells)	NULL
EXP058988	anti-Sox2	Mus musculus	Treatment: no Dox; Cell type: 44iN; Characteristic: lif +;	NULL	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP058989	anti-Sox2	Mus musculus	Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +;	EXP058981	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP058990	none	Mus musculus	Developmental stage: E11;Genotype: wildtype; Strain: ICR;	NULL	546	chip_control	NULL	limb bud	NULL
EXP058991	none	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	NULL	546	chip_control	NULL	limb bud	NULL
EXP058992	none	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	NULL	546	chip_control	NULL	limb bud	NULL
EXP058993	none	Mus musculus	Developmental stage: E12.5;Genotype: wildtype; Strain: ICR;	NULL	546	chip_control	NULL	limb bud	NULL
EXP058994	anti-Hoxa13 (home-made)	Mus musculus	Developmental stage: E11;Genotype: wildtype; Strain: ICR;	EXP058990	546	normal	Q62424	limb bud	NULL
EXP058995	anti-Hoxa13 (home-made)	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	EXP058991	546	normal	Q62424	limb bud	NULL
EXP058996	anti-Hoxa11 (home-made)	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	EXP058991	546	normal	P31311	limb bud	NULL
EXP058997	anti-Hoxa11 (home-made)	Mus musculus	Developmental stage: E11.5;Genotype: wildtype; Strain: ICR;	EXP058992	546	normal	P31311	limb bud	NULL
EXP058998	anti-Hoxa13 (home-made)	Mus musculus	Developmental stage: E12.5;Genotype: wildtype; Strain: ICR;	EXP058993	546	normal	Q62424	limb bud	NULL
EXP058999		Mus musculus	Genotype: Bcl6 fl/fl (wildtype); Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059000		Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059001		Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted; 	NULL	5	chip_control	NULL	liver	NULL
EXP059002		Mus musculus	Genotype: Ppara-/-(knockout); Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059003		Mus musculus	Genotype: Ppard fl/wildtype; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059004		Mus musculus	Genotype: Ppard fl/fl(knockout), Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059005		Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059006		Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted; 	NULL	5	chip_control	NULL	liver	NULL
EXP059007		Mus musculus	Genotype: Bcl6 fl/fl(wildtype); Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059008		Mus musculus	Genotype: Bcl6 fl/fl(knockout), Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059009		Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	chip_control	NULL	liver	NULL
EXP059010		Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted ; 	NULL	5	chip_control	NULL	liver	NULL
EXP059011	anti-BCL6	Mus musculus	Genotype: Bcl6 fl/fl, Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	NULL	5	normal	P41183	liver	NULL
EXP059012	anti-BCL6	Mus musculus	Genotype: Bcl6 fl/fl (wildtype); Strain:C57BL/6; Conditions: lib fed; 	EXP058999	5	normal	P41183	liver	NULL
EXP059013	anti-BCL6	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059000	5	normal	P41183	liver	NULL
EXP059014	anti-BCL6	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted; 	EXP059001	5	normal	P41183	liver	NULL
EXP059015	anti-BCL6	Mus musculus	Genotype: Ppara-/-(knockout); Strain:C57BL/6; Conditions: lib fed; 	EXP059002	5	normal	P41183	liver	NULL
EXP059016	anti-BCL6	Mus musculus	Genotype: Ppard fl/wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059003	5	normal	P41183	liver	NULL
EXP059017	anti-BCL6	Mus musculus	Genotype: Ppard fl/fl(knockout), Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	EXP059004	5	normal	P41183	liver	NULL
EXP059018	anti-PPARa	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059005	5	normal	P23204	liver	NULL
EXP059019	anti-PPARa	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted; 	EXP059006	5	normal	P23204	liver	NULL
EXP059020	anti-PPARa	Mus musculus	Genotype: Bcl6 fl/fl(wildtype); Strain:C57BL/6; Conditions: lib fed; 	EXP059007	5	normal	P23204	liver	NULL
EXP059021	anti-PPARa	Mus musculus	Genotype: Bcl6 fl/fl(knockout), Albumin-cre; Strain:C57BL/6; Conditions: lib fed; 	EXP059008	5	normal	P23204	liver	NULL
EXP059022	anti-PPARd	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: lib fed; 	EXP059009	5	normal	P35396	liver	NULL
EXP059023	anti-PPARd	Mus musculus	Genotype: wildtype; Strain:C57BL/6; Conditions: overnight fasted ; 	EXP059010	5	normal	P35396	liver	NULL
EXP059024	none	Mus musculus	Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059025	anti-CTCF( clone D31H2 , Rabbit , Cell Signaling Technology, #3418)	Mus musculus	Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant;	NULL	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP059026	anti-Phospho-CTCF (Ser224) (Rabbit, Cell Signaling Technology, this study)	Mus musculus	Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant;	EXP059024	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP059027	anti-Tcf1	Mus musculus	Phenotype: TCRb+, CD4+, CD25-, Foxp3-Cre-GFP-; Genotype: wildtype;	NULL	3063	normal	P22361	conventional CD4+ T cells	NULL
EXP059028	anti-Tcf1	Mus musculus	Phenotype: TCRb+, CD4+, CD25+, Foxp3-Cre-GFP+; Genotype: wildtype;	NULL	1053	normal	P22361	Treg cells from lymph nodes and spleen	NULL
EXP059029	anti-Tcf1	Mus musculus	Phenotype: TCRb+, CD4+; Genotype: Tcf1 deficient;	NULL	3062	normal	P22361	effector CD4+ T cells	NULL
EXP059030		Mus musculus	Genotype: wildtype; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059031	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of BRACHYURY; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P20293	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059032	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of CDX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P43241	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059033	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of DLX1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q64317	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059034	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of DLX6; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P70397	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059035	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of DUXBL; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q7TNE6	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059036	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of EBF1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q07802	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059037	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of FOXA1-RR; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P35582	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059038	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of FOXA1-SW; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P35582	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059039	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of HLF;  Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q8BW74	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059040	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of MAX; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P28574	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059041	 Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of NANOG; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q80Z64	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059042	anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of PRR3; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q811B5	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059043	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of RHOX11; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q810N8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059044	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of SIX6; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q9QZ28	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059045	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of SOX15; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P43267	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059046	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of TEAD1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P30051	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059047	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of THAP4; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q6P3Z3	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059048	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of TOX3; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q80W03	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059049	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of ZFP319; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q9ERR8	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059050	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of BHLHB8; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	Q9QYC3	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059051	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of FOXA1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P35582	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059052	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of OCT4; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P20263	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059053	Anti-HA.11 (IgG, 901501)	Mus musculus	Genotype: Overexpression of SOX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding;	EXP059030	675	normal	P48432	NIH 3T3 (embryonic fibroblasts)	NULL
EXP059054	none	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059055	none	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059056	none	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1-C91A;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059057	none	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059058	none	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: RNF2 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059059	none	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1 knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059060	none	Mus musculus	Genotype: wildtype; Age: E3.5-4.5 days; Strain: C57BL/6;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059061	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: wildtype;	EXP059054	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP059062	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1 knockout;	EXP059055	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP059063	anti-BAP1 (Genentech, PRO424270)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1-C91A;	EXP059056	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	NULL
EXP059064	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: wildtype;	EXP059057	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP059065	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: RNF2 knockout;	EXP059058	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP059066	anti-RNF2 (Abcam, ab3832)	Mus musculus	Strain: C57BL/6; Age: E3.5-4.5 days; Genotype: BAP1 knockout;	EXP059059	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP059067	anti-FLAG (Millipore, M8823)	Mus musculus	Genotype: wildtype; Age: E3.5-4.5 days; Strain: C57BL/6;	EXP059060	2	normal	Q6RHR9	mESCs (mouse embryonic stem cells)	NULL
EXP059068		Mus musculus	Passage: 25 days; Genotype: wildtype; Treatment: pMSCV mediated virus;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP059069		Mus musculus	Passage: 25 days; Genotype: caMKL1 blocked; Treatment: pMSCV mediated virus;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP059070		Mus musculus	Passage: 25 days; Genotype: wildtype; Treatment: pMSCV mediated virus;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP059071		Mus musculus	Passage: 25 days; Genotype: caMKL1 blocked; Treatment: pMSCV mediated virus;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP059072		Mus musculus	Passage: p20-30; Genotype: wildtype; Treatment: none;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP059073		Mus musculus	Passage: p20-30; Genotype: caMKL1 blocked; Treatment: none;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP059074	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: 25 days; Genotype: Overexpression OCT4; Treatment: pMSCV mediated virus;	EXP059068	906	normal	P20263	induced pluripotent stem cells	NULL
EXP059075	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus;	EXP059068	906	normal	Q9JM73	induced pluripotent stem cells	NULL
EXP059076	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: 25 days; Genotype: Overexpression OCT4, caMKL1 blocked; Treatment: pMSCV mediated virus;	EXP059069	906	normal	P20263	induced pluripotent stem cells	NULL
EXP059077	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus;	EXP059069	906	normal	Q9JM73	induced pluripotent stem cells	NULL
EXP059078	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus;	EXP059070	906	normal	Q9JM73	induced pluripotent stem cells	NULL
EXP059079	anti-SRF(Santa Cruz, sc-335)	Mus musculus	Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus;	EXP059071	906	normal	Q9JM73	induced pluripotent stem cells	NULL
EXP059080	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: p20-30; Genotype: wildtype; Treatment: none;	EXP059072	906	normal	P20263	induced pluripotent stem cells	NULL
EXP059081	anti-Oct4(Cell Signaling Technology, 5677S)	Mus musculus	Passage: p20-30; Genotype: caMKL1 blocked; Treatment: none;	EXP059073	906	normal	P20263	induced pluripotent stem cells	NULL
EXP059082	anti-Foxp1(EMD Millipore ABE68)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1f/f(knockout);  Activation status: pooled;	NULL	1053	normal	P58462	Treg cells from lymph nodes and spleen	NULL
EXP059083	anti-Foxp1(EMD Millipore ABE68)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1+/+; Activation status: pooled;	NULL	1053	normal	P58462	Treg cells from lymph nodes and spleen	NULL
EXP059084	anti-Foxp1(EMD Millipore ABE68)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1+/+; Activation status: CD62Lhi;	NULL	2501	normal	P58462	Tconv (conventional T cells)	NULL
EXP059085	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre Foxp1+/+; Activation status: pooled;	NULL	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	NULL
EXP059086	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre, Foxp1f/f(knockout); Activation status: pooled;	NULL	1053	normal	Q99JB6	Treg cells from lymph nodes and spleen	NULL
EXP059087	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre, Foxp1+/+; Activation status: CD62Lhi;	NULL	2501	normal	Q99JB6	Tconv (conventional T cells)	NULL
EXP059088	anti-Foxp3 (Rudensky lab)	Mus musculus	Genotype: Foxp3YFP-Cre, Foxp1f/f(knockout); Activation status: CD62Lhi;	NULL	2501	normal	Q99JB6	Tconv (conventional T cells)	NULL
EXP059089	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: wildtype; Developmental stage: L10;	NULL	572	normal	P42230	mammary gland	NULL
EXP059090	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: Wap super enhancer fused to Tbrg4(seTbrg); Developmental stage: L10; Treatment: CRISPR/Cas9;	NULL	572	normal	P42230	mammary gland	NULL
EXP059091	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: deletion Tbrg4, wap super-enhancer; Developmental stage: L10;Treatment: CRISPR/Cas9;	NULL	572	normal	P42230	mammary gland	NULL
EXP059092	anti-STAT5 (Santa Cruz, sc-835)	Mus musculus	Genotype: wildtype Tbrg4; Developmental stage: L10; 	NULL	572	normal	P42230	mammary gland	NULL
EXP059093		Mus musculus	Genotype: wildtype;	NULL	53	chip_control	NULL	heart	NULL
EXP059094	anti-MEF2C (Santa Cruz, Catalog #sc-313)	Mus musculus	Genotype: wildtype;	EXP059093	53	normal	Q8CFN5	heart	NULL
EXP059095	anti-MEF2C (Santa Cruz, Catalog #sc-313)	Mus musculus	Genotype: JP2NT overexpression;	NULL	53	normal	Q8CFN5	heart	NULL
EXP059096	anti-TBP (Abcam, Catalog #ab51841)	Mus musculus	Genotype: wildtype;	NULL	53	normal	P29037	heart	NULL
EXP059097	anti-TBP (Abcam, Catalog #ab51841)	Mus musculus	Genotype: JP2NT overexpression;	NULL	53	normal	P29037	heart	NULL
EXP059098	anti-HA tag (Abcam, Catalog #ab9110)	Mus musculus	Genotype: wildtype;	EXP059093	53	normal	Q9ET78	heart	NULL
EXP059099	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	NULL	885	chip_control	NULL	astrocytes	NULL
EXP059100	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	NULL	885	chip_control	NULL	astrocytes	NULL
EXP059101	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	NULL	885	chip_control	NULL	astrocytes	NULL
EXP059102	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: none(naive);	NULL	885	chip_control	NULL	astrocytes	NULL
EXP059103	none	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: none(naive);	NULL	885	chip_control	NULL	astrocytes	NULL
EXP059104	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	EXP059099	885	normal	O35426	astrocytes	NULL
EXP059105	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	EXP059100	885	normal	O35426	astrocytes	NULL
EXP059106	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: experimental autoimmune encephalomyelitis;	EXP059101	885	normal	O35426	astrocytes	NULL
EXP059107	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: none(naive);	EXP059102	885	normal	O35426	astrocytes	NULL
EXP059108	XBP1 antibody (sc-8015X)	Mus musculus	Strain: C57Bl/6; Genotype: wildtype; Sex: female; Age: P79; Disease: none(naive);	EXP059103	885	normal	O35426	astrocytes	NULL
EXP059109	anti-Suz12	Mus musculus	Source: thymus;  Strain: C57BL/6; Genotype: wildtype - CD4+/CD8+ (double positive);	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	NULL
EXP059110	anti-Suz12	Mus musculus	Source: thymus;  Strain: C57BL/6; Genotype: Suz12  inactivated, CD4+/CD8+ (double positive); Treatment: Cas9-mediated inactivation of Suz12;	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	NULL
EXP059111	anti-Suz12	Mus musculus	Source: thymus;  Strain: C57BL/6; Genotype: JAK3 mutant, CD8+ (single positive);	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	NULL
EXP059112	anti-Suz12	Mus musculus	Source: thymus; Strain: C57BL/6; Genotype: JAK3 mutant, Suz12 inactivated, CD8+ (single positive); Treatment: Cas9-mediated inactivation of Suz12;	NULL	2754	normal	Q80U70	T-ALL (Acute Lymphoblastic Leukemia)	NULL
EXP059113	input	Mus musculus	Strain: 129/Ola; Genotype: Mta1-FLAG knocked into endogenous Mta1 locus; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059114	input	Mus musculus	Strain: 129/Ola; Genotype: Mta1-FLAG knocked into endogenous Mta1 locus; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059115	input	Mus musculus	Strain: 129/Ola; Genotype: Mta2-GFP knocked in to the endogenous Mta2 locus; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059116	input	Mus musculus	Strain: 129/Ola; Genotype: Mta2-GFP knocked in to the endogenous Mta2 locus; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059117	input	Mus musculus	Strain: 129/Ola; Genotype: Mta3-FLAG knocked in to the endogenous Mta3 locus; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059118	input	Mus musculus	Strain: 129/Ola; Genotype: Mta3-FLAG knocked in to the endogenous Mta3 locus; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059119	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta1-FLAG knocked into endogenous Mta1 locus; 	EXP059113	2	normal	Q8K4B0	mESCs (mouse embryonic stem cells)	NULL
EXP059120	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta1-FLAG knocked into endogenous Mta1 locus; 	EXP059114	2	normal	Q8K4B0	mESCs (mouse embryonic stem cells)	NULL
EXP059121	Anti-GFP	Mus musculus	Strain: 129/Ola; Genotype: Mta2-GFP knocked in to the endogenous Mta2 locus; 	EXP059115	2	normal	Q9R190	mESCs (mouse embryonic stem cells)	NULL
EXP059122	Anti-GFP	Mus musculus	Strain: 129/Ola; Genotype: Mta2-GFP knocked in to the endogenous Mta2 locus; 	EXP059116	2	normal	Q9R190	mESCs (mouse embryonic stem cells)	NULL
EXP059123	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta3-FLAG knocked in to the endogenous Mta3 locus; 	EXP059117	2	normal	Q924K8	mESCs (mouse embryonic stem cells)	NULL
EXP059124	anti-FLAG	Mus musculus	Strain: 129/Ola; Genotype: Mta3-FLAG knocked in to the endogenous Mta3 locus; 	EXP059118	2	normal	Q924K8	mESCs (mouse embryonic stem cells)	NULL
EXP059125	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	3065	chip_control	NULL	bone-marrow derived primary pre B cells	NULL
EXP059126	none	Mus musculus	Genotype: premalignant; Strain: C57BL/6;	NULL	3065	chip_control	NULL	bone-marrow derived primary pre B cells	NULL
EXP059127	none	Mus musculus	Genotype: malignant; Strain: C57BL/6;	NULL	3065	chip_control	NULL	bone-marrow derived primary pre B cells	NULL
EXP059128	anti-UBTF	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP059125	3065	normal	P25976	bone-marrow derived primary pre B cells	NULL
EXP059129	anti-UBTF	Mus musculus	Genotype: premalignant; Strain: C57BL/6;	EXP059126	3065	normal	P25976	bone-marrow derived primary pre B cells	NULL
EXP059130	anti-UBTF	Mus musculus	Genotype: malignant; Strain: C57BL/6;	EXP059127	3065	normal	P25976	bone-marrow derived primary pre B cells	NULL
EXP059131	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: overexprssing H3.3K27M; Treatment: Lentivurses;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	NULL
EXP059132	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: overexprssing H3.3K27R; Treatment: Lentivurses;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	NULL
EXP059133	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: overexprssing EZHIP; Treatment: Lentivurses;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	NULL
EXP059134	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: EED floxed; Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	NULL
EXP059135	anti-CBX2 (Bethyl Lab A302-524A)	Mus musculus	Genotype: EED deletion; Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout;	NULL	12	normal	P30658	MEF (mouse embryonic fibroblasts)	NULL
EXP059136	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: Lentivurses; Genotype: overexprssing H3.3K27M;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP059137	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: Lentivurses;Genotype: overexprssing H3.3K27R;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP059138	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: Lentivurses;Genotype: overexprssing EZHIP;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP059139	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout ; Genotype: overexprssing EED floxed;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP059140	anti-Ring1b (active motif 39663)	Mus musculus	Treatment: treated with cre-recombinanse hit-and-run lentivirus to generate EED knockout ; Genotype: overexprssing EED deletion;	NULL	12	normal	Q9CQJ4	MEF (mouse embryonic fibroblasts)	NULL
EXP059141	anti-Lef1 antibody (C18A7, Cell Signaling Technology)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Phenotype: TCRb+, CD4+, CD25-;	NULL	2501	normal	P27782	Tconv (conventional T cells)	NULL
EXP059142	anti-Lef1 antibody (C18A7, Cell Signaling Technology)	Mus musculus	Genotype: Lef1 deficient; Strain: C57BL/6; Phenotype: TCRb+, CD4+;	NULL	1058	bio_control	P27782	CD4+ T-cells	NULL
EXP059143	anti-DMC1	Mus musculus	Age: adult; Strain: (C57BL/6J x CAST/Eij)F1; Genotype: PRDM9-Humanized/CAST;	NULL	32	normal	Q61880	testis	NULL
EXP059144		Mus musculus	Genotype: expresses HsaCrex-Thra-Tag; Age: Post-natal day 15;	NULL	53	chip_control	NULL	heart	NULL
EXP059145	anti-Tralpha	Mus musculus	Genotype: expresses HsaCrex-Thra-Tag; Age: Post-natal day 15;	EXP059144	53	normal	P63058	heart	NULL
EXP059146	none	Mus musculus	Donor: mouse #1; Age: 6-8 weeks; Strain: C57BL/6N-Mb21d1tm1Ciphe; Genotype: GFP-cGAS knockout;	NULL	2808	chip_control	NULL	bone marrow derived dendritic cells	NULL
EXP059147	none	Mus musculus	Donor: mouse #2 and #3;  Age: 6-8 weeks; Strain: C57BL/6N-Mb21d1tm1Ciphe; Genotype: GFP-cGAS knockout;	NULL	2808	chip_control	NULL	bone marrow derived dendritic cells	NULL
EXP059148	anti-GFP (Trap_MA, Chromotek , cat#gtma-20)	Mus musculus	Donor: mouse #1; Age: 6-8 weeks; Strain: C57BL/6N-Mb21d1tm1Ciphe; Genotype: GFP-cGAS knockout;	EXP059146	2808	normal	Q8C6L5	bone marrow derived dendritic cells	NULL
EXP059149	anti-GFP (Trap_MA, Chromotek , cat#gtma-20)	Mus musculus	Donor: mouse #2 and #3;  Age: 6-8 weeks; Strain: C57BL/6N-Mb21d1tm1Ciphe; Genotype: GFP-cGAS knockout;	EXP059147	2808	normal	Q8C6L5	bone marrow derived dendritic cells	NULL
EXP059150	None	Mus musculus	Age: 8 weeks; Strain: C57BL/6J; Source: Olfactory epithelium;	NULL	2475	chip_control	NULL	mature olfactory sensory neurons	NULL
EXP059151	None	Mus musculus	Age: 8 weeks; Strain: C57BL/6J; Source: Olfactory epithelium;	NULL	2475	chip_control	NULL	mature olfactory sensory neurons	NULL
EXP059152	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Age: 8 weeks; Strain: C57BL/6J; Source: Olfactory epithelium;	EXP059150	2475	normal	Q9Z2D6	mature olfactory sensory neurons	NULL
EXP059153	MeCP2 antibody (Diagenode, pAb-052-050)	Mus musculus	Age: 8 weeks; Strain: C57BL/6J; Source: Olfactory epithelium;	EXP059151	2475	normal	Q9Z2D6	mature olfactory sensory neurons	NULL
EXP059154	-	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059155	-	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP059156	-	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059157	-	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 deletion, overexpression;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059158	-	Mus musculus		NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP059159	-	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 deletion, overexpression;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059160	-	Mus musculus	Treatment: none; Genotype: HA-ZFP708 overexpression;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059161	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708;	NULL	230	normal	F8VPP0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059162	anti-TRIM28 (Abcam ab10484)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	EXP059156	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP059163	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	EXP059156	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	NULL
EXP059164	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 deletion, overexpression;	EXP059157	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	NULL
EXP059165	anti-TRIM28 (Abcam ab10484)	Mus musculus		EXP059158	230	normal	P97469	ES-E14 (E14, embryonic stem cells)	NULL
EXP059166	anti-TRIM28 (Abcam ab10484)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 deletion, overexpression;	EXP059159	2	normal	P97469	mESCs (mouse embryonic stem cells)	NULL
EXP059167	anti-HA (Abcm, ab9110)	Mus musculus	Treatment: none; Genotype: HA-ZFP708 overexpression;	EXP059160	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	NULL
EXP059168	anti-FLAG (Sigma, F3165)	Mus musculus	Treatment: none; Genotype: FLAG-ZFP708 overexpression;	EXP059154	2	normal	F8VPP0	mESCs (mouse embryonic stem cells)	NULL
EXP059169	not applicable	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059170	not applicable	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059171	not applicable	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059172	not applicable	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059173	not applicable	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059174	not applicable	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059175	not applicable	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059176	not applicable	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059177	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059169	2	normal	P70662	mESCs (mouse embryonic stem cells)	NULL
EXP059178	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	P70662	mESCs (mouse embryonic stem cells)	NULL
EXP059179	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059170	2	normal	P70662	mESCs (mouse embryonic stem cells)	NULL
EXP059180	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	P70662	mESCs (mouse embryonic stem cells)	NULL
EXP059181	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059173	2	normal	P70662	mESCs (mouse embryonic stem cells)	NULL
EXP059182	anti-Ldb1(sc-11198, SCBT)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059174	2	normal	P70662	mESCs (mouse embryonic stem cells)	NULL
EXP059183	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059169	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP059184	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059171	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP059185	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059170	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP059186	anti-CTCF(07-729, EMD Millipore)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP059187	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059169	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP059188	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059171	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP059189	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059170	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP059190	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059172	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP059191	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: no doxycycline; Developmental stage: day4 of differentiation;	EXP059173	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP059192	anti-Smc1(A300-055A, Bethyl)	Mus musculus	Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation;	EXP059174	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP059193	none (input)	Mus musculus	Genotype:ectopically expressed DPPA2; Treatment: transfected with appropriate plasmid; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059194	none (input)	Mus musculus	Genotype:ectopically expressed DPPA2; Treatment: transfected with appropriate plasmid; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059195	none (input)	Mus musculus	Genotype:ectopically expressed Dppa4 fl (ENSMUST00000096045 isofor); Treatment: transfected with appropriate plasmid; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059196	none (input)	Mus musculus	Genotype:ectopically expressed Dppa4 fl (ENSMUST00000096045 isofor); Treatment: transfected with appropriate plasmid; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059197	none (input)	Mus musculus	Genotype:ectopically expressed Dppa4 short (ENSMUST00000050705 isoform); Treatment: transfected with appropriate plasmid; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059198	none (input)	Mus musculus	Genotype:ectopically expressed Dppa4 short (ENSMUST00000050705 isoform); Treatment: transfected with appropriate plasmid; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP059199	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed DPPA2; Treatment: transfected with appropriate plasmid; 	EXP059193	2	normal	Q9CWH0	mESCs (mouse embryonic stem cells)	NULL
EXP059200	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed DPPA2; Treatment: transfected with appropriate plasmid; 	EXP059194	2	normal	Q9CWH0	mESCs (mouse embryonic stem cells)	NULL
EXP059201	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 fl (ENSMUST00000096045 isoform); Treatment: transfected with appropriate plasmid; 	EXP059195	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	NULL
EXP059202	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 fl (ENSMUST00000096045 isoform); Treatment: transfected with appropriate plasmid; 	EXP059196	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	NULL
EXP059203	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 short (ENSMUST00000050705 isoform); Treatment: transfected with appropriate plasmid; 	EXP059197	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	NULL
EXP059204	anti-HA.11 (Covance)	Mus musculus	Genotype:ectopically expressed Dppa4 short (ENSMUST00000050705 isoform); Treatment: transfected with appropriate plasmid; 	EXP059198	2	normal	Q8CCG4	mESCs (mouse embryonic stem cells)	NULL
EXP059205		Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP059206		Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP059207		Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP059208		Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP059209	anti-Ty1	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059205	2466	normal	Q9D030	primary myoblasts	NULL
EXP059210	anti-Ty1	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059206	2466	normal	Q9D030	primary myoblasts	NULL
EXP059211	anti-MyoD	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059205	2466	normal	P10085	primary myoblasts	NULL
EXP059212	anti-MyoD	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP;	EXP059206	2466	normal	P10085	primary myoblasts	NULL
EXP059213	anti-Ty1	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059207	2466	normal	Q9D030	primary myoblasts	NULL
EXP059214	anti-MyoD	Mus musculus	Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059207	2466	normal	P10085	primary myoblasts	NULL
EXP059215	anti-Ty1	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059208	2466	normal	Q9D030	primary myoblasts	NULL
EXP059216	anti-MyoD	Mus musculus	Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2;	EXP059208	2466	normal	P10085	primary myoblasts	NULL
EXP059217	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs, 200 ng/ml nocodazole, JQ1; Strain: C57BL/6; Developmental stage: mitosis;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	NULL
EXP059218	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs; Strain: C57BL/6; Developmental stage: interphase;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	NULL
EXP059219	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs, 200 ng/ml nocodazole; Strain: C57BL/6; Developmental stage: mitosis;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	NULL
EXP059220	anti-BRD4(Bethyl A301-985A)	Mus musculus	Treatment: 100 nM estradiol for 13hrs, 10 uM ro3306; Strain: C57BL/6; Developmental stage: mitosis;	NULL	319	normal	Q9ESU6	G1E-ER4 (embryonic stem cells)	NULL
EXP059221	rabbit IgG (Santa Cruz)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell;	NULL	2581	chip_control	NULL	spleen and lymph nodes	NULL
EXP059222	anti-IRF8 (Cell Signaling Technology, clone D20D8)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell;	EXP059221	2581	normal	P23611	spleen and lymph nodes	NULL
EXP059223	Anti-PU.1 (Santa Cruz, sc-390405x)	Mus musculus	Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell;	EXP059221	2581	normal	P17433	spleen and lymph nodes	NULL
EXP059224	None	Mus musculus	Sex: Female; Developmental stage: E14.5; Strain: CD1;	NULL	3049	chip_control	NULL	fetal ovary	NULL
EXP059225	None	Mus musculus	Sex: Female; Developmental stage: E14.5; Strain: CD1;	NULL	3049	chip_control	NULL	fetal ovary	NULL
EXP059226	anti-RUNX1	Mus musculus	Sex: Female; Developmental stage: E14.5; Strain: CD1;	EXP059224	3049	normal	Q03347	fetal ovary	NULL
EXP059227	anti-RUNX1	Mus musculus	Sex: Female; Developmental stage: E14.5; Strain: CD1;	EXP059225	3049	normal	Q03347	fetal ovary	NULL
EXP059228	anti-IgG	Mus musculus	Genotype: wildtype; Developmental stage: E8.5; Strain: Mixed; Source: whole embryo;	NULL	1497	chip_control	NULL	embryo	NULL
EXP059229	anti-Cdx2(Savory et al., 2009b)	Mus musculus	Genotype: wildtype; Developmental stage: E8.5; Strain: Mixed; Source: whole embryo;	EXP059228	1497	normal	P43241	embryo	NULL
EXP059230	none	Mus musculus		NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP059231	anti-hnrnp-k (Abcam, ab70492)	Mus musculus		EXP059230	233	normal	P61979	E14TG2A (embryonic stem cells)	NULL
EXP059232	anti-Etv6 (Santa Cruz, sc-8546x)	Mus musculus		NULL	445	normal	P97360	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059233	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059234	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059235	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 78 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059236	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 79 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059237	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 80 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059238	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 81 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	Q61550	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059239	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Luc knockdown; Treatment: 82 hours knockdown induction with Doxycycline;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059240	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Luc knockdown; Treatment: 83 hours knockdown induction with Doxycycline;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059241	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 84 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059242	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 85 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059243	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 86 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059244	anti-Smc1 (Abcam, ab9262)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 87 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q9CU62	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059245	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Luc knockdown; Treatment: 88 hours knockdown induction with Doxycycline;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059246	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Luc knockdown; Treatment: 89 hours knockdown induction with Doxycycline;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059247	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 90 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059248	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 91 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059249	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 92 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059250	anti-SA2 (Abcam, ab196000)	Mus musculus	Genotype: Smc1a knockdown; Treatment: 93 hours knock-down induction with Doxycycline with shSmc1a;	NULL	445	normal	O35638	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059251	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Luc knockdown; Treatment: 94 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059252	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Luc knockdown; Treatment: 95 hours knockdown induction with Doxycycline;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059253	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 96 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059254	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Stag2 knockdown; Treatment: 97 hours knock-down induction with Doxycycline with shStag2;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059255	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 98 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059256	anti-Ctcf (Abcam, ab70303)	Mus musculus	Genotype: Rad21 knockdown; Treatment: 99 hours knock-down induction with Doxycycline with shRad21;	NULL	445	normal	Q61164	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP059257	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	NULL
EXP059258	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	NULL
EXP059259	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Stag2 knockdown; Treatment: 78 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	NULL
EXP059260	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Stag2 knockdown; Treatment: 79 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q61550	HPC7 derived erythroid cells	NULL
EXP059261	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 80 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61164	HPC7 derived erythroid cells	NULL
EXP059262	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 81 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q61164	HPC7 derived erythroid cells	NULL
EXP059263	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 4 U/l EPO;  Genotype: Stag2 knockdown; Treatment: 82 hours knock-down induction with Doxycycline;	NULL	3067	normal	Q61164	HPC7 derived erythroid cells	NULL
EXP059264	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 83 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	NULL
EXP059265	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 84 hours knockdown induction with Doxycycline;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	NULL
EXP059266	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO;  Genotype: Stag2 knockdown; Treatment: 85 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	NULL
EXP059267	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 4 U/l EPO; Genotype: Stag2 knockdown; Treatment: 86 hours knock-down induction with Doxycycline with shStag2;	NULL	3067	normal	Q9CU62	HPC7 derived erythroid cells	NULL
EXP059268	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 72 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61550	myeloid malignancies	NULL
EXP059269	anti-Rad21 (Abcam, ab992)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 73 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61550	myeloid malignancies	NULL
EXP059270	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 74 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q9CU62	myeloid malignancies	NULL
EXP059271	anti-Smc1 (Abcam, ab9262)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 75 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q9CU62	myeloid malignancies	NULL
EXP059272	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61164	myeloid malignancies	NULL
EXP059273	anti-Ctcf (Abcam, ab70303)	Mus musculus	Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline;	NULL	3068	normal	Q61164	myeloid malignancies	NULL
EXP059274	anti-Sox2 (R&D system, MAB2018)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Source: brain;	NULL	3069	normal	P48432	cerebral endothelial cells	NULL
EXP059275	anti-Sox2 (R&D system, MAB2018)	Mus musculus	Genotype: Mgp knockout; Strain: C57BL/6; Source: brain;	NULL	3069	normal	P48432	cerebral endothelial cells	NULL
EXP059276	none	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), CreER;	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP059277	none	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), CreER, K274R;	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP059278	none	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), wildtype;	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP059279	none	Mus musculus	Treatment: mock; Genotype: Mof(flox/flox),CreER;	NULL	483	chip_control	NULL	brown preadipocytes	NULL
EXP059280	anti-MLL4	Mus musculus	Treatment: mock; Genotype: Mof(flox/flox),CreER;	EXP059279	483	normal	Q6PDK2	brown preadipocytes	NULL
EXP059281	anti-MLL4	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), wildtype;	EXP059278	483	normal	Q6PDK2	brown preadipocytes	NULL
EXP059282	anti-MLL4	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), CreER;	EXP059276	483	normal	Q6PDK2	brown preadipocytes	NULL
EXP059283	anti-MLL4	Mus musculus	Treatment: 4-OHT; Genotype: Mof(flox/flox), CreER, K274R;	EXP059277	483	normal	Q6PDK2	brown preadipocytes	NULL
EXP059284		Mus musculus	Treatment: not treated, not infectred;	NULL	2484	chip_control	NULL	NMuMG (mammary epithelial cells)	NULL
EXP059285		Mus musculus	Treatment: 0.5 uM  Adriamycin for 8hrs, not infectred;	NULL	2484	chip_control	NULL	NMuMG (mammary epithelial cells)	NULL
EXP059286		Mus musculus	Treatment: not treated, infected with L-pWPI empy vector;	NULL	2484	chip_control	NULL	NMuMG (mammary epithelial cells)	NULL
EXP059287		Mus musculus	Treatment: not treated, infected with L-pWPI-MycER;	NULL	2484	chip_control	NULL	NMuMG (mammary epithelial cells)	NULL
EXP059288	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: not treated, not infectred;	EXP059284	2484	normal	P02340	NMuMG (mammary epithelial cells)	NULL
EXP059289	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: 0.5 uM  Adriamycin for 8hrs, not infectred;	EXP059285	2484	normal	P02340	NMuMG (mammary epithelial cells)	NULL
EXP059290	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: not treated, infected with L-pWPI empy vector;	EXP059286	2484	normal	P02340	NMuMG (mammary epithelial cells)	NULL
EXP059291	Anti-p53 (CM5, Novocastra, NCL-L-p53-CM5p,Rabbit Polyclonal )	Mus musculus	Treatment: not treated, infected with L-pWPI-MycER;	EXP059287	2484	normal	P02340	NMuMG (mammary epithelial cells)	NULL
EXP059292	None	Mus musculus	Strain: mixed C57BL/6 x DBA; Source: hippocamus;	NULL	3070	chip_control	NULL	hippocamus-derived neural progenitor cells	NULL
EXP059293	None	Mus musculus	Strain: mixed C57BL/6 x DBA; Source: hippocamus;	NULL	3070	chip_control	NULL	hippocamus-derived neural progenitor cells	NULL
EXP059294	anti-Sox2 (Santa cruz sc-17320)	Mus musculus	Strain: mixed C57BL/6 x DBA; Source: hippocamus;	EXP059292	3070	normal	P48432	hippocamus-derived neural progenitor cells	NULL
EXP059295	anti-Sox2 (Santa cruz sc-17320)	Mus musculus	Strain: mixed C57BL/6 x DBA; Source: hippocamus;	EXP059293	3070	normal	P48432	hippocamus-derived neural progenitor cells	NULL
EXP059296	normalization input	Drosophila melanogaster		NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059325	guinea pig preimmune serum	Drosophila melanogaster		NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059298		Drosophila melanogaster		NULL	1244	chip_control	NULL	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059326	anti-Fs(1)hSL(rabbit,Igor Dawid)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	P13709	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059327	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059328	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059329	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059330	anti-Fs(1)hSL(rabbit,Igor Dawid)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	P13709	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059331	anti-MED1 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q9VP05	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059332	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059333	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059334	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletin;	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059335	anti-MED30 (guinea pig,Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	Q9W0P3	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059336	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059337	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059338	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: MED30 RNAi; Genotype: MED30 depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059339	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: Rad21 RNAi; Genotype: Rad21 depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059340	anti-Nipped-B (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletion;	NULL	1244	normal	Q7PLI2	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059341	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059342	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059343	anti-Rad21 (rabbit,Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletion;	NULL	1244	normal	Q9UB09	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059344	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059345	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059346	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: MED30 RNAi; Genotype: MED30 depletion;	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059347	anti-SA (guinea pig, Dale Dorsett)	Drosophila melanogaster	Treatment: Rad21 RNAi; Genotype: Rad21 depletion;	NULL	1244	normal	O18415	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059348	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: 10 mM JQ1 for  8hrs; 	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059349	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: mock treatment; 	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059350	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: SA RNAi; Genotype: SA depletion;	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059351	anti-Smc1 (rabbit, Dale Dorsett)	Drosophila melanogaster	Treatment: Smc1 RNAi; Genotype: Smc1 depletion;	NULL	1244	normal	B6UXV6	ML-DmBG3-c2 (immortalized CNS cell line)	NULL
EXP059352	none	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059353	none	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059354	none	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059355	none	Mus musculus	Genotype: 0 kcl, ctlshrna; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059356	none	Mus musculus	Treatment: 0 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059357	none	Mus musculus	Treatment: 2 kcl, shCntrl; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059358	none	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 kncokout;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059359	none	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 kncokout;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059360	none	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059361	none	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059362	none	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059363	none	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059364	none	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059365	none	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059366	none	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059367	none	Mus musculus	Treatment: 0 kcl, ncor2shrna; Strain: C57BL/6J; Genotype: ncor2 kncokout;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059368	none	Mus musculus	Treatment: 2 kcl, ncor2shrna; Strain: C57BL/6J; Genotype: ncor2 kncokout;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059369	none	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059370	none	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059371	none	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059372	none	Mus musculus	Treatment: 0 ka (kainic acid), uninfected; Strain: C57BL/6J; Age: adult;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP059373	none	Mus musculus	Treatment: 2 ka (kainic acid), uninfected; Strain: C57BL/6J; Age: adult;	NULL	987	chip_control	NULL	hippocampus	NULL
EXP059374	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 kcl, uninfected Strain: C57BL/6J;	EXP059352	3064	normal	Q61324	embryonic cortices	NULL
EXP059375	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 kcl, uninfected Strain: C57BL/6J;	EXP059353	3064	normal	Q61324	embryonic cortices	NULL
EXP059376	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 kcl, uninfected Strain: C57BL/6J;	EXP059354	3064	normal	Q61324	embryonic cortices	NULL
EXP059377	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, uninfected; Strain: C57BL/6J;	EXP059365	3064	normal	Q61324	embryonic cortices	NULL
EXP059378	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, ctlshrna; Strain: C57BL/6J;	EXP059355	3064	normal	Q61324	embryonic cortices	NULL
EXP059457	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype:Spt6L{delta}YqgF{delta}SH2-GFP;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059380	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q61324	embryonic cortices	NULL
EXP059454	none	Schizosaccharomyces pombe	Genotype: cdc10-V50 mcm2+-9PK;	NULL	3072	chip_control	NULL	KM79 strain at G1phase	NULL
EXP059382	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, ctlshrna; Strain: C57BL/6J;	EXP059369	3064	normal	Q61324	embryonic cortices	NULL
EXP059456	anti-PK (SV5-Pk1)	Schizosaccharomyces pombe	Genotype: cdc10-V50 mcm2+-9PK;	EXP059454	3072	normal	P40377	KM79 strain at G1phase	NULL
EXP059384	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, ctlshrna; Strain: C57BL/6J;	EXP059357	3064	normal	Q61324	embryonic cortices	NULL
EXP059446	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059358	3064	normal	Q61324	embryonic cortices	NULL
EXP059386	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, ctlshrna; Strain: C57BL/6J;	EXP059371	3064	normal	Q61324	embryonic cortices	NULL
EXP059445	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	NULL	3064	normal	Q61324	embryonic cortices	NULL
EXP059388	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2kcl, ctlshrna; Strain: C57BL/6J;	EXP059370	3064	normal	Q61324	embryonic cortices	NULL
EXP059455	anti-PK (SV5-Pk1)	Schizosaccharomyces pombe	Genotype: cdc10-V50 orc4+-9PK;	EXP059453	3071	normal	Q9Y794	KM81 strain at G1 phase	NULL
EXP059447	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 0 ka (kainic acid), uninfected; Strain: C57BL/6J; Age: adult;	EXP059372	987	normal	Q61324	hippocampus	NULL
EXP059448	anti-arnt2(in-house 1048)	Mus musculus	Treatment: 2 ka (kainic acid), uninfected; Strain: C57BL/6J; Age: adult;	EXP059373	987	normal	Q61324	hippocampus	NULL
EXP059394	anti-hdac3(sc11416X)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	O88895	embryonic cortices	NULL
EXP059395	anti-hdac3(sc11416X)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	O88895	embryonic cortices	NULL
EXP059396	anti-hdac3(sc11416X)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	O88895	embryonic cortices	NULL
EXP059397	anti-hdac3(sc11416X)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	O88895	embryonic cortices	NULL
EXP059398	none	Mus musculus	Treatment: 2 kcl, shCntrl; Strain: C57BL/6J; 	NULL	3064	chip_control	NULL	embryonic cortices	NULL
EXP059399	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059400	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059401	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059402	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059403	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059362	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059404	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059354	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059405	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059355	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059406	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059407	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059356	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059408	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059358	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059409	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059355	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059410	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059412	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059358	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059413	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059369	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059414	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059452	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 0 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059356	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059416	anti-NCOR2(Millipore, 06891)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J; Genotype: arnt2 knockout;	EXP059359	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059417	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, ctlshrna; Strain: C57BL/6J;	EXP059371	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059418	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059357	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059419	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, ncor2shrna; Strain: C57BL/6J; Genotype: ncor2 knockout;	EXP059367	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059420	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, ncor2shrna; Strain: C57BL/6J; Genotype: ncor2 knockout;	EXP059368	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059421	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059422	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 0.5 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059423	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 1 kcl, uninfected; Strain: C57BL/6J;	NULL	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059424	anti-NCOR2(Fisher, PA1-843)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059365	3064	normal	Q9WU42	embryonic cortices	NULL
EXP059425	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, n4shrna; Strain: C57BL/6J; Genotype: NPAS4 knockout;	NULL	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059426	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, n4shrna; Strain: C57BL/6J; Genotype: NPAS4 knockout;	NULL	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059427	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059428	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059429	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059362	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059430	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059453	none	Schizosaccharomyces pombe	Genotype: cdc10-V50 orc4+-9PK;	NULL	3071	chip_control	NULL	KM81 strain at G1 phase	NULL
EXP059451	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, ctlshrna; Strain: C57BL/6J;	EXP059398	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059435	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059436	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059354	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059449	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J;Genotype: ARNT2 knockout;	EXP059358	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059450	anti-NPAS4 (custom made protein A purified anti-serum)	Mus musculus	Treatment: 2 kcl, a2shrna; Strain: C57BL/6J;Genotype: ARNT2 knockout;	EXP059359	3064	normal	Q8BGD7	embryonic cortices	NULL
EXP059441	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059360	3064	normal	Q9QXE7	embryonic cortices	NULL
EXP059442	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059352	3064	normal	Q9QXE7	embryonic cortices	NULL
EXP059443	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 0 kcl, uninfected; Strain: C57BL/6J;	EXP059361	3064	normal	Q9QXE7	embryonic cortices	NULL
EXP059444	anti-tbl1(abcam,Ab24528)	Mus musculus	Treatment: 2 kcl, uninfected; Strain: C57BL/6J;	EXP059353	3064	normal	Q9QXE7	embryonic cortices	NULL
EXP059458	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype:Spt6L{delta}HtH{delta}SH2-GFP;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059459	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6LSH{delta}2-GFP;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059460	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L{delta}YqgF-GFP;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059461	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L{delta}HtH-GFP;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059462	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: SPT6L{delta}SH2-GFP;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059463	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L-GFP; Treatment: DMSO 1hr;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059464	NA	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L-GFP; Treatment: 10 uM flavopiridol for 1hr;	NULL	1341	chip_control	NULL	10 day old seedlings	NULL
EXP059465	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: SPT6L{delta}SH2-GFP;	EXP059462	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059466	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype:Spt6L{delta}YqgF{delta}SH2-GFP;	EXP059457	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059467	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype:Spt6L{delta}HtH{delta}SH2-GFP;	EXP059458	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059468	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6LSH{delta}2-GFP;	EXP059459	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059469	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L{delta}YqgF-GFP;	EXP059460	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059470	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L{delta}HtH-GFP;	EXP059461	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059471	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: SPT6L-GFP;	NULL	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059472	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L-GFP; Treatment: DMSO 1hr;	EXP059463	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059473	anti-GFP (ab290, abcam)	Arabidopsis thaliana	Age: 10 days; Ecotype: Col-0; Genotype: Spt6L-GFP; Treatment: 10 uM flavopiridol for 1hr;	EXP059464	1341	normal	A8MS85	10 day old seedlings	NULL
EXP059474	anti-GFP	Arabidopsis thaliana	Ecotype: Col-0;	NULL	1341	normal	F4IIH6	10 day old seedlings	NULL
EXP059475	anti-GFP	Arabidopsis thaliana	Ecotype: Col-0;	NULL	1341	normal	P93831	10 day old seedlings	NULL
EXP059476	anti-GFP	Arabidopsis thaliana	Ecotype: Col-0;	NULL	1341	normal	Q9ZSM8	10 day old seedlings	NULL
EXP059477	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: Col;	NULL	1341	normal	Q9STM3	10 day old seedlings	NULL
EXP059478	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: drm1-2, drm2-2, cmt2-7, cmt3-11 quadruple mutant;	NULL	1341	normal	Q9STM3	10 day old seedlings	NULL
EXP059479	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: met1-1;	NULL	1341	normal	Q9STM3	10 day old seedlings	NULL
EXP059480	anti-REF6 	Arabidopsis thaliana	Ecotype: Columbia; Genotype: ref6-5;	NULL	1341	normal	Q9STM3	10 day old seedlings	NULL
EXP059481	none	Arabidopsis thaliana	Condions: dark grown; Genotype: wildtype;	NULL	1343	chip_control	NULL	4 day old seedlings	NULL
EXP059482	none	Arabidopsis thaliana	Condions: dark grown;Genotype: TCP4 overexpression;	NULL	1343	chip_control	NULL	4 day old seedlings	NULL
EXP059483	anti-Myc (sigma, C3956)	Arabidopsis thaliana	Condions: dark grown; Genotype: wildtype;	EXP059481	1343	normal	Q8LPR5	4 day old seedlings	NULL
EXP059484	anti-Myc (sigma, C3956)	Arabidopsis thaliana	Condions: dark grown;Genotype: TCP4 overexpression;	EXP059482	1343	normal	Q8LPR5	4 day old seedlings	NULL
EXP059485	anti-HA	Arabidopsis thaliana	Genotype: wild type(Col);	NULL	3073	normal	C0SUT9	5 weeks rosette leafs 5 and 6	NULL
EXP059486	anti-HA	Arabidopsis thaliana	Genotype: JMJ16 knockout;	NULL	3073	normal	C0SUT9	5 weeks rosette leafs 5 and 6	NULL
EXP059487	anti-HA (Roche, Mouse monoclonal 12CA5)	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	3074	chip_control	NULL	SK1 meiotic cells (75 mins)	NULL
EXP059488	anti-HA (Roche, Mouse monoclonal 12CA5)	Saccharomyces cerevisiae	Genotype: spo13 deletion;	NULL	3074	chip_control	NULL	SK1 meiotic cells (75 mins)	NULL
EXP059489	anti-HA (Roche, Mouse monoclonal 12CA5)	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059487	3074	normal	Q08490	SK1 meiotic cells (75 mins)	NULL
EXP059490	anti-HA (Roche, Mouse monoclonal 12CA5)	Saccharomyces cerevisiae	Genotype: spo13 deletion;	EXP059488	3074	normal	Q08490	SK1 meiotic cells (75 mins)	NULL
EXP059491	none	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	3074	chip_control	NULL	SK1 meiotic cells (75 mins)	NULL
EXP059492	none	Saccharomyces cerevisiae	Genotype: rec8 deletion;	NULL	3074	chip_control	NULL	SK1 meiotic cells (75 mins)	NULL
EXP059493	anti-FLAG (Sigma,Mouse monoclonal, M2 )	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059491	3074	normal	P23624	SK1 meiotic cells (75 mins)	NULL
EXP059494	anti-FLAG (Sigma,Mouse monoclonal, M2 )	Saccharomyces cerevisiae	Genotype: rec8 deletion;	EXP059492	3074	normal	P23624	SK1 meiotic cells (75 mins)	NULL
EXP059495		Saccharomyces cerevisiae	Genotype: wildtype;	NULL	3075	chip_control	NULL	SC507 strain	NULL
EXP059496	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	P53165	SC507 strain	NULL
EXP059497	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	P53165	SC507 strain	NULL
EXP059498	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	A6ZWK1	SC507 strain	NULL
EXP059499	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	A6ZWK1	SC507 strain	NULL
EXP059500	anti-FLAG	Saccharomyces cerevisiae	Genotype: sgf73 deletion;	NULL	3075	normal	A6ZWK1	SC507 strain	NULL
EXP059501	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	P29055	SC507 strain	NULL
EXP059502	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	P29055	SC507 strain	NULL
EXP059503	anti-FLAG	Saccharomyces cerevisiae	Genotype: sgf73 deletion;	NULL	3075	normal	P29055	SC507 strain	NULL
EXP059504	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059495	3075	normal	Q12159	SC507 strain	NULL
EXP059505	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1;	NULL	3075	normal	Q12159	SC507 strain	NULL
EXP059506	anti-FLAG	Saccharomyces cerevisiae	Genotype: sgf73 deletion;	NULL	3075	normal	Q12159	SC507 strain	NULL
EXP059507	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype; Conditions: before heat shock;	EXP059495	3075	normal	P53165	SC507 strain	NULL
EXP059508	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1; Conditions: before heat shock;	NULL	3075	normal	P53165	SC507 strain	NULL
EXP059509	anti-FLAG	Saccharomyces cerevisiae	Genotype: spt20 deletion; Conditions: before heat shock;	NULL	3075	normal	P53165	SC507 strain	NULL
EXP059510	anti-FLAG	Saccharomyces cerevisiae	Genotype: wildtype; Conditions: 42 degrees  heat shock for 20 mins;	EXP059495	3075	normal	P53165	SC507 strain	NULL
EXP059511	anti-FLAG	Saccharomyces cerevisiae	Genotype: rpt2-1; Conditions: 42 degrees  heat shock for 20 mins;	NULL	3075	normal	P53165	SC507 strain	NULL
EXP059512	anti-FLAG	Saccharomyces cerevisiae	Genotype: spt20 deletion; Conditions: 42 degrees  heat shock for 20 mins;	NULL	3075	normal	P53165	SC507 strain	NULL
EXP059513	none, input	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	3074	chip_control	NULL	SK1 meiotic cells (75 mins)	NULL
EXP059514	anti-HA (Roche,Mouse monoclonal 12CA5 )	Saccharomyces cerevisiae	Genotype: wildtype;	EXP059513	3074	normal	Q12188	SK1 meiotic cells (75 mins)	NULL
EXP059515	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 14 days after eclosion; Sex: female; Genotype:yw +/+; 	NULL	3076	chip_control	NULL	whole body	NULL
EXP059516	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 14 days after eclosion; Sex: female; Genotype:yw +/+; 	NULL	3076	chip_control	NULL	whole body	NULL
EXP059517	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 35 days after eclosion; Sex: female; Genotype:yw +/+; 	NULL	3076	chip_control	NULL	whole body	NULL
EXP059518	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 35 days after eclosion; Sex: female; Genotype:yw +/+; 	NULL	3076	chip_control	NULL	whole body	NULL
EXP059519	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 14 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059515	3076	normal	Q95V55	whole body	NULL
EXP059520	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 14 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059516	3076	normal	Q95V55	whole body	NULL
EXP059521	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 35 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059517	3076	normal	Q95V55	whole body	NULL
EXP059522	anti-dFOXO (Tatar Lab)	Drosophila melanogaster	Age: young; Developmental stage: 35 days after eclosion; Sex: female; Genotype:yw +/+; 	EXP059518	3076	normal	Q95V55	whole body	NULL
EXP059523	none	Drosophila melanogaster	Genotype: pMT-puro-eGFP-Dfd; Treatment: 2 mM CuSO4; Conditions: 24 hour induction;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059524	none	Drosophila melanogaster	Genotype: pMT-puro-eGFP-Ubx; Treatment: 1 mM CuSO4; Conditions: 18 hour induction;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059525	none	Drosophila melanogaster	Genotype: pMT-puro-eGFP-AbdB; Treatment: 0.5 mM CuSO4; Conditions: 24 hour induction;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059526	none	Drosophila melanogaster	Genotype: pMT-puro-eGFP-gcm; Treatment: 2.5 mM CuSO4; Conditions: 24 hour induction;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059527	none	Drosophila melanogaster	Genotype: pMT-puro-Hth-eGFP; Treatment: 1 mM CuSO4; Conditions: 18 hour induction;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059528	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-Dfd; Treatment: 2 mM CuSO4; Conditions: 24 hour induction;	EXP059523	1448	normal	P07548	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059529	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-Ubx; Treatment: 1 mM CuSO4; Conditions: 18 hour induction;	EXP059524	1448	normal	P83949	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059530	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-AbdB; Treatment: 0.5 mM CuSO4; Conditions: 24 hour induction;	EXP059525	1448	normal	P09087	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059531	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-eGFP-gcm; Treatment: 2.5 mM CuSO4; Conditions: 24 hour induction;	EXP059526	1448	normal	Q27403	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059532	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-puro-Hth-eGFP; Treatment: 1 mM CuSO4; Conditions: 18 hour induction;	EXP059527	1448	normal	O46339	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059533	none	Drosophila melanogaster	Genotype: pMT-Lab-eGFP;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059534	none	Drosophila melanogaster	Genotype: pMT-eGFP-pb;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059535	none	Drosophila melanogaster	Genotype: pMT-eGFP-Dfd;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059536	none	Drosophila melanogaster	Genotype: pMT-eGFP-Scr;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059537	none	Drosophila melanogaster	Genotype: pMT-eGFP-Antp;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059538	none	Drosophila melanogaster	Genotype: pMT_eGFP-Ubx;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059539	none	Drosophila melanogaster	Genotype: pMT-eGFP-AbdA;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059540	none	Drosophila melanogaster	Genotype: pMT-eGFP-AbdB;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059541	none	Drosophila melanogaster	Genotype: pMT-Hth-eGFP;	NULL	1448	chip_control	NULL	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059542	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-Lab-eGFP;	EXP059533	1448	normal	P10105	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059543	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-pb;	EXP059534	1448	normal	P31264	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059544	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-Dfd;	EXP059535	1448	normal	P07548	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059545	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-Scr;	EXP059536	1448	normal	P09077	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059546	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-Antp;	EXP059537	1448	normal	P02833	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059547	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT_eGFP-Ubx;	EXP059538	1448	normal	P83949	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059548	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-AbdA;	EXP059539	1448	normal	P29555	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059549	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-eGFP-AbdB;	EXP059540	1448	normal	P09087	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059550	Anti-GFP (Sigma, G1544)	Drosophila melanogaster	Genotype: pMT-Hth-eGFP;	EXP059541	1448	normal	O46339	KC167 (developmental stage: 6-12h embryo)	NULL
EXP059551		Homo sapiens	Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059552		Homo sapiens	Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059553		Homo sapiens	Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059554		Homo sapiens	Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059555		Homo sapiens	Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059556		Homo sapiens	Genotype: wildtype;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059557		Homo sapiens	Genotype: ARID1A knockout;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059558		Homo sapiens	Genotype: ARID1B knockout;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059559		Homo sapiens	Genotype: knockout BCL7B;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059560		Homo sapiens	Genotype: knockout SMARCA2;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059561		Homo sapiens	Genotype: knockout SMARCA4;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059562		Homo sapiens	Genotype: knockout SMARCC1;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059563		Homo sapiens	Genotype: knockout SMARCC2;	NULL	1507	chip_control	NULL	HAP1 (chronic myelogenous leukemia)	NULL
EXP059564	anti-ARID1A	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059565	anti-ARID1A	Homo sapiens	Genotype: wildtype;	EXP059552	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059566	anti-ARID1B	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	Q8NFD5	HAP1 (chronic myelogenous leukemia)	NULL
EXP059567	anti-ARID2	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	Q68CP9	HAP1 (chronic myelogenous leukemia)	NULL
EXP059568	anti-ARID2	Homo sapiens	Genotype: wildtype;	EXP059552	1507	normal	Q68CP9	HAP1 (chronic myelogenous leukemia)	NULL
EXP059569	anti-BRD4	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	O60885	HAP1 (chronic myelogenous leukemia)	NULL
EXP059570	anti-PBRM1	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	Q86U86	HAP1 (chronic myelogenous leukemia)	NULL
EXP059571	anti-SMARCA2	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	P51531	HAP1 (chronic myelogenous leukemia)	NULL
EXP059572	anti-SMARCA4	Homo sapiens	Genotype: wildtype;	EXP059551	1507	normal	P51532	HAP1 (chronic myelogenous leukemia)	NULL
EXP059573	anti-SMARCA4	Homo sapiens	Genotype: wildtype;	EXP059552	1507	normal	P51532	HAP1 (chronic myelogenous leukemia)	NULL
EXP059574	anti-ARID1A	Homo sapiens	Genotype: ARID1A knockout;	EXP059557	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059575	anti-ARID1A	Homo sapiens	Genotype: ARID1B knockout;	EXP059558	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059576	anti-ARID1A	Homo sapiens	Genotype: knockout BCL7B;	EXP059559	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059577	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCA2;	EXP059560	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059578	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCA4;	EXP059561	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059579	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCC1;	EXP059562	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059580	anti-ARID1A(clone C631)	Homo sapiens	Genotype: knockout SMARCC2;	EXP059563	1507	normal	O14497	HAP1 (chronic myelogenous leukemia)	NULL
EXP059581	None	Homo sapiens	Treatment: Lentiviral vector pL-KDM3A; Genotype: KDM3A knockout;	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP059582	None	Homo sapiens	Treatment: shKDM3A(shRNA); Genotype: KDM3A knockout;	NULL	7	chip_control	NULL	22RV1 (prostate carcinoma)	NULL
EXP059583	anti-KDM3A (A301-538A, Bethyl Laboratories, Montgomery, TX)	Homo sapiens	Treatment: Lentiviral vector pL-KDM3A; Genotype: KDM3A knockout;	EXP059581	7	normal	Q9Y4C1	22RV1 (prostate carcinoma)	NULL
EXP059584	anti-AR (PG21, 06-680, Sigma EMD Millipore, Darmstadt, Germany)	Homo sapiens	Treatment: Lentiviral vector pL-KDM3A; Genotype: KDM3A knockout;	EXP059581	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP059585	anti-KDM3A (A301-538A, Bethyl Laboratories, Montgomery, TX)	Homo sapiens	Treatment: shKDM3A(shRNA); Genotype: KDM3A knockout;	EXP059582	7	normal	Q9Y4C1	22RV1 (prostate carcinoma)	NULL
EXP059586	anti-AR (PG21, 06-680, Sigma EMD Millipore, Darmstadt, Germany)	Homo sapiens	Treatment: shKDM3A(shRNA); Genotype: KDM3A knockout;	EXP059582	7	normal	P10275	22RV1 (prostate carcinoma)	NULL
EXP059587	none	Mus musculus	Strain:CD-1;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP059588	none	Mus musculus	Strain:CD-1;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP059589	anti-Zfp281 (abcam, ab101318)	Mus musculus	Strain:CD-1;	EXP059587	96	normal	Q99LI5	trophoblast stem cells	NULL
EXP059590	anti-Zfp281 (abcam, ab101318)	Mus musculus	Strain:CD-1;	EXP059588	96	normal	Q99LI5	trophoblast stem cells	NULL
EXP059591		Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP059592		Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP059593	anti-AR (N20)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP059594	anti-AR (N20)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP059595	anti-AR (N20)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP059596	anti-AR (N20)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP059597	anti-HIF(ab2185)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	Q16665	LNCaP (prostate carcinoma)	NULL
EXP059598	anti-HIF(ab2185)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	Q16665	LNCaP (prostate carcinoma)	NULL
EXP059599	anti-HIF(ab2185)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	Q16665	LNCaP (prostate carcinoma)	NULL
EXP059600	anti-HIF(ab2185)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	Q16665	LNCaP (prostate carcinoma)	NULL
EXP059601	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	P48163	LNCaP (prostate carcinoma)	NULL
EXP059602	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	P48163	LNCaP (prostate carcinoma)	NULL
EXP059603	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	P48163	LNCaP (prostate carcinoma)	NULL
EXP059604	anti-ME1(pAb 194-050)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	P48163	LNCaP (prostate carcinoma)	NULL
EXP059605	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: normal;	EXP059591	70	normal	Q16798	LNCaP (prostate carcinoma)	NULL
EXP059606	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: androgen(R1881); Conditions: hypoxia(1% oxygen for 12 hrs);	EXP059592	70	normal	Q16798	LNCaP (prostate carcinoma)	NULL
EXP059607	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: ethanol; Conditions: normal;	NULL	70	normal	Q16798	LNCaP (prostate carcinoma)	NULL
EXP059608	anti-ME3(pAb 003-050)	Homo sapiens	Treatment: ethanol; Conditions: hypoxia(1% oxygen for 12 hrs);	NULL	70	normal	Q16798	LNCaP (prostate carcinoma)	NULL
EXP059609		Homo sapiens	Genotype: wildtype;	NULL	3078	chip_control	NULL	embryonic stem cells derived definitive endoderm	NULL
EXP059610		Homo sapiens	Genotype: wildtype;	NULL	3078	chip_control	NULL	embryonic stem cells derived definitive endoderm	NULL
EXP059611		Homo sapiens	Genotype: wildtype;	NULL	3079	chip_control	NULL	embryonic stem cells-derived foregut	NULL
EXP059612		Homo sapiens	Genotype: wildtype;	NULL	3079	chip_control	NULL	embryonic stem cells-derived foregut	NULL
EXP059613		Homo sapiens	Genotype: wildtype;	NULL	431	chip_control	NULL	embryonic stem cell-derived pancreatic cells	NULL
EXP059614		Homo sapiens	Genotype: wildtype;	NULL	431	chip_control	NULL	embryonic stem cell-derived pancreatic cells	NULL
EXP059615		Homo sapiens	Genotype: wildtype;	NULL	431	chip_control	NULL	embryonic stem cell-derived pancreatic cells	NULL
EXP059616		Homo sapiens	Genotype: FOXA2 -/-(knockout);	NULL	3078	chip_control	NULL	embryonic stem cells derived definitive endoderm	NULL
EXP059617		Homo sapiens	Genotype: FOXA2 -/-(knockout);	NULL	3079	chip_control	NULL	embryonic stem cells-derived foregut	NULL
EXP059618		Homo sapiens	Genotype: FOXA2 -/-(knockout);	NULL	431	chip_control	NULL	embryonic stem cell-derived pancreatic cells	NULL
EXP059619	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059609	3078	normal	Q92908	embryonic stem cells derived definitive endoderm	NULL
EXP059620	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059610	3078	normal	Q92908	embryonic stem cells derived definitive endoderm	NULL
EXP059621	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	Q92908	embryonic stem cells-derived foregut	NULL
EXP059622	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	Q92908	embryonic stem cells-derived foregut	NULL
EXP059623	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	Q92908	embryonic stem cell-derived pancreatic cells	NULL
EXP059624	anti-GATA6	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	Q92908	embryonic stem cell-derived pancreatic cells	NULL
EXP059625	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059609	3078	normal	P43694	embryonic stem cells derived definitive endoderm	NULL
EXP059626	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059610	3078	normal	P43694	embryonic stem cells derived definitive endoderm	NULL
EXP059627	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	P43694	embryonic stem cells-derived foregut	NULL
EXP059628	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	P43694	embryonic stem cells-derived foregut	NULL
EXP059629	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	P43694	embryonic stem cell-derived pancreatic cells	NULL
EXP059630	anti-GATA4	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	P43694	embryonic stem cell-derived pancreatic cells	NULL
EXP059631	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059609	3078	normal	Q9Y261	embryonic stem cells derived definitive endoderm	NULL
EXP059632	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059610	3078	normal	Q9Y261	embryonic stem cells derived definitive endoderm	NULL
EXP059633	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	Q9Y261	embryonic stem cells-derived foregut	NULL
EXP059634	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	Q9Y261	embryonic stem cells-derived foregut	NULL
EXP059635	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	Q9Y261	embryonic stem cell-derived pancreatic cells	NULL
EXP059636	anti-FOXA2	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	Q9Y261	embryonic stem cell-derived pancreatic cells	NULL
EXP059637	anti-HNF1B	Homo sapiens	Genotype: wildtype;	EXP059611	3079	normal	P35680	embryonic stem cells-derived foregut	NULL
EXP059638	anti-HNF1B	Homo sapiens	Genotype: wildtype;	EXP059612	3079	normal	P35680	embryonic stem cells-derived foregut	NULL
EXP059639	anti-PDX1	Homo sapiens	Genotype: wildtype;	EXP059613	431	normal	P52945	embryonic stem cell-derived pancreatic cells	NULL
EXP059640	anti-PDX1	Homo sapiens	Genotype: wildtype;	EXP059614	431	normal	P52945	embryonic stem cell-derived pancreatic cells	NULL
EXP059641	anti-GATA6	Homo sapiens	Genotype: FOXA2 -/-(knockout);	EXP059616	3078	normal	Q92908	embryonic stem cells derived definitive endoderm	NULL
EXP059642	anti-GATA6	Homo sapiens	Genotype: FOXA2 -/-(knockout);	EXP059617	3079	normal	Q92908	embryonic stem cells-derived foregut	NULL
EXP059643	anti-GATA6	Homo sapiens	Genotype: FOXA2 -/-(knockout);	EXP059618	431	normal	Q92908	embryonic stem cell-derived pancreatic cells	NULL
EXP059644	anti-AR(Santa Cruz Biotechnology,SC816X,F1515)	Homo sapiens	Chromosome: 2;	NULL	916	normal	P10275	prostate	NULL
EXP059645	anti-AR(Santa Cruz Biotechnology,SC816X,F1515)	Homo sapiens	Chromosome: 2;	NULL	435	normal	P10275	prostate tumor	NULL
EXP059646	STAT3	Homo sapiens	Treatment: 10 ug/ml alpha-IgM for 24hrs;	NULL	1625	chip_control	NULL	naive B cell	NULL
EXP059647	anti-pSTAT3(phosphoTyr705, #9145S, Cell signaling)	Homo sapiens	Treatment: DMSO for 4 hrs;	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP059648	anti-pSTAT3(phosphoTyr705, #9145S, Cell signaling)	Homo sapiens	Treatment: AZD1480 for 4 hrs;	NULL	835	normal	P40763	TMD8 (diffuse large B-cell lymphoma)	NULL
EXP059649	anti-STAT3(SC-482X, Santa Cruz)	Homo sapiens	Treatment: 10 ug/ml alpha-IgM for 24hrs;	EXP059646	1625	normal	P40763	naive B cell	NULL
EXP059650	anti-BRD4 (Abcam, 128874)	Homo sapiens	Treatment: 0nM CEM87, sgMYOD; Genotype: MYOD knockout;	NULL	421	normal	O60885	HEK293 (embryonic kidney)	NULL
EXP059651	anti-BRD4 (Abcam, 128874)	Homo sapiens	Treatment: 50nM CEM87, sgMYOD; Genotype: MYOD knockout;	NULL	421	normal	O60885	HEK293 (embryonic kidney)	NULL
EXP059652	anti-BRD4 (Abcam, 128874)	Homo sapiens	Treatment: 50nM CEM87, sgNonTargeting;	NULL	421	normal	O60885	HEK293 (embryonic kidney)	NULL
EXP059653	none	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP059654	none	Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP059655	anti-BRD9, Active Motifs, catalog number: 61538	Homo sapiens		EXP059653	65	normal	Q9H8M2	U937 (adult acute monocytic leukemia)	NULL
EXP059656	anti-BRD9, Active Motifs, catalog number: 61538	Homo sapiens		EXP059654	423	normal	Q9H8M2	HeLa S3 (cervical adenocarcinoma)	NULL
EXP059657	none	Homo sapiens	Sex: female;	NULL	772	chip_control	NULL	renal cortex	NULL
EXP059658	anti-pCREB (EMD Millipore, 06-519, lot# 3108493)	Homo sapiens	Sex: female;	EXP059657	772	normal	P16220	renal cortex	NULL
EXP059659	anti-VDR (Santa Cruz, C-20, sc-1008, lot# H1216)	Homo sapiens	Sex: female;	EXP059657	772	normal	P11473	renal cortex	NULL
EXP059660	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hrs 0.1% DMSO; Genotype: wildtype;	NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP059661	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Genotype: wildtype; Treatment: 1 hr 10nM E2;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP059662	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: wildtype;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP059663	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: ETV4 ectopic expression;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP059664	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: ETV4 ectopic expression;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP059665	anti-FLAG M2(Sigma)	Homo sapiens	Treatment: 1 hr 0.1% DMSO; Genotype: ETV4 ectopic expression;	NULL	111	normal	P43268	T47D (invasive ductal carcinoma)	NULL
EXP059666	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 0.1% DMSO; Genotype: wildtype;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP059667	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Treatment: 1 hr 10nM E2; Genotype: ETV4,knockout and ectopic expression;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP059668	anti-ESR1(Santa Cruz,HC-20)	Homo sapiens	Genotype: ETV4 knockout; Treatment: 1 hr 10nM E2;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP059669	anti-KLF4(R&D Systems RRID:AB_2130224)	Homo sapiens	Conditions: 4iLA media;	NULL	2724	normal	O43474	WIBR3 (embryonic stem cell)	NULL
EXP059670	anti-KLF4(R&D Systems RRID:AB_2130224)	Homo sapiens	Conditions: DMEM+FBS media; Genotype: KLF4 overexpression;	NULL	1507	normal	O43474	HAP1 (chronic myelogenous leukemia)	NULL
EXP059671	none (input)	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP059672	anti-MLLT3(Genetex, GTX102835)	Homo sapiens		EXP059671	514	normal	P42568	K562 (myelogenous leukemia)	NULL
EXP059673	--	Homo sapiens	Genotype: high level of OCT4;	NULL	3081	chip_control	NULL	A2B5+ iOPCs(H)(foreskin fibroblasts)	NULL
EXP059674	--	Homo sapiens	Genotype: high level of OCT4;	NULL	3081	chip_control	NULL	A2B5+ iOPCs(H)(foreskin fibroblasts)	NULL
EXP059675	--	Homo sapiens	Genotype: high level of OCT4;	NULL	3081	chip_control	NULL	A2B5+ iOPCs(H)(foreskin fibroblasts)	NULL
EXP059676	--	Homo sapiens	Genotype: medium level of OCT4;	NULL	3082	chip_control	NULL	A2B5+ iOPCs(M)(foreskin fibroblasts)	NULL
EXP059677	--	Homo sapiens	Genotype: medium level of OCT4;	NULL	3082	chip_control	NULL	A2B5+ iOPCs(M)(foreskin fibroblasts)	NULL
EXP059678	--	Homo sapiens		NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP059679	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: high level of OCT4;	EXP059673	3081	normal	Q01860	A2B5+ iOPCs(H)(foreskin fibroblasts)	NULL
EXP059680	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: high level of OCT4;	EXP059674	3081	normal	Q01860	A2B5+ iOPCs(H)(foreskin fibroblasts)	NULL
EXP059681	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: high level of OCT4;	EXP059675	3081	normal	Q01860	A2B5+ iOPCs(H)(foreskin fibroblasts)	NULL
EXP059682	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: medium level of OCT4;	EXP059676	3082	normal	Q01860	A2B5+ iOPCs(M)(foreskin fibroblasts)	NULL
EXP059683	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens	Genotype: medium level of OCT4;	EXP059677	3082	normal	Q01860	A2B5+ iOPCs(M)(foreskin fibroblasts)	NULL
EXP059684	anti-OCT4(OCT3/4,Santa Cruz Biotechnology, sc-5279 X)	Homo sapiens		EXP059678	396	normal	Q01860	WA09 (embryonic stem cells)	NULL
EXP059685	anti-CTCF(Cell Signaling monoclonal, D31H2, Cat# 3418)	Homo sapiens	Genotype: wildtype; Passage: 7 to 13; Sex: female;	NULL	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP059686	anti-Alyref FLAG(Sigma)	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP059687	anti-Alyref FLAG(Sigma)	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP059688	None	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP059689	None	Homo sapiens		NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP059690	anti-Alyref FLAG(Sigma)	Homo sapiens		EXP059686	10	normal	Q86V81	HEK293T (embryonic kidney)	NULL
EXP059691	anti-Alyref FLAG(Sigma)	Homo sapiens		EXP059687	10	normal	Q86V81	HEK293T (embryonic kidney)	NULL
EXP059692	anti-FLAG(Sigma)	Homo sapiens		EXP059688	10	normal	Q9Y3Y2	HEK293T (embryonic kidney)	NULL
EXP059693	Nxf1 anti-FLAG(Sigma)	Homo sapiens		EXP059689	10	normal	Q9UBU9	HEK293T (embryonic kidney)	NULL
EXP059694	anti-STAT5 (C-17, sc-835 X, rabbit polyclonal )	Homo sapiens	Treatment: transfected with empty vector;	NULL	219	normal	P42229	DLD-1 (colon adenocarcinoma)	NULL
EXP059695	anti-BCL6 (N-3, sc-858 X, rabbit polyclonal )	Homo sapiens	Treatment: transfected with empty vector;	NULL	219	normal	P41182	DLD-1 (colon adenocarcinoma)	NULL
EXP059696	anti-STAT5 (C-17, sc-835 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 activation; Treatment: transfected with pEGFP-C1199Tiam1 and treated with vehicle;	NULL	219	normal	P42229	DLD-1 (colon adenocarcinoma)	NULL
EXP059697	anti-STAT5 (C-17, sc-835 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 inhibition; Treatment: transfected with pEGFP-C1199Tiam1 and treated with 20 microM EHT;	NULL	219	normal	P42229	DLD-1 (colon adenocarcinoma)	NULL
EXP059698	anti-BCL6 (N-3, sc-858 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 inhibition; Treatment: transfected with pEGFP-C1199Tiam1 and treated with 20 microM EHT;	NULL	219	normal	P41182	DLD-1 (colon adenocarcinoma)	NULL
EXP059699	anti-BCL6 (N-3, sc-858 X, rabbit polyclonal )	Homo sapiens	Genotype: RAC1/PAK1 activation; Treatment: transfected with pEGFP-C1199Tiam1 and treated with vehicle;	NULL	219	normal	P41182	DLD-1 (colon adenocarcinoma)	NULL
EXP059700	anti-PU.1	Mus musculus	Treatment: untreated; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	NULL
EXP059701		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 4 days; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	NULL
EXP059702		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 8 days; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	NULL
EXP059703		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 12 days; Genotype: PU.1 restoration;	NULL	3083	normal	P17433	AML246	NULL
EXP059704		Mus musculus	Treatment: 0.1 ug/mL Doxycycline for 12 days; Genotype: PU.1 knockdown;	NULL	3083	normal	P17433	AML246	NULL
EXP059705		Mus musculus	Treatment:4 days doxycycline off; Genotype: PU.1 knockdown;	NULL	3083	normal	P17433	AML246	NULL
EXP059706		Mus musculus	Treatment:8 days doxycycline off; Genotype: PU.1 knockdown;	NULL	3083	normal	P17433	AML246	NULL
EXP059707		Mus musculus	Treatment:12 days doxycycline off;	NULL	3083	normal	P17433	AML246	NULL
EXP059708		Mus musculus	Passage: 18-20; Strain: B6/129; Treatment: 1ug/ml Doxycycline;	NULL	3084	chip_control	NULL	primary iKAP colorectal cancer	NULL
EXP059709	anti-IRF2	Mus musculus	Passage: 18-20; Strain: B6/129; Treatment: 1ug/ml Doxycycline;	EXP059708	3084	normal	P23906	primary iKAP colorectal cancer	NULL
EXP059710	anti-BATF (pab4003, Brookwood Biochemical, rabbit polyclonal)	Mus musculus	Strain: C57BL/6J; Time: 0 hrs; Age:8-12 weeks; Treatment:none ; Genotype:wildtype;	NULL	917	normal	O35284	spleen	NULL
EXP059711	anti-BATF (pab4003, Brookwood Biochemical, rabbit polyclonal)	Mus musculus	Strain: C57BL/6J; Time: 72hrs; Age:8-12 weeks; Treatment: LPS (25ug/mL) and IL-4 (10ng/mL); Genotype: Tet2/3 wildtype (Tet2-flox, Tet3-flox, Rosa26-LSL-YFP);	NULL	917	normal	O35284	spleen	NULL
EXP059712	anti-BATF (pab4003, Brookwood Biochemical, rabbit polyclonal)	Mus musculus	Strain: C57BL/6J; Time: 72hrs; Age:8-12 weeks; Treatment: LPS (25ug/mL) and IL-4 (10ng/mL); Genotype: Tet2/3 duoble knockout (CreERT2, Tet2-flox, Tet3-flox, Rosa26-LSL-YFP);	NULL	917	normal	O35284	spleen	NULL
EXP059713	Ig(AB_737197)	Mus musculus	Genotype: wildtype;  Age: 8-12 weeks; Strain:C57BL/6J;  Treatment: activated with LPS (25ug/mL) and IL-4 (10ng/mL) for 72h;	NULL	917	chip_control	NULL	spleen	NULL
EXP059714	anti-Tet2 (ab124297, Abcam)	Mus musculus	Genotype: wildtype B6;  Age: 8-12 weeks; Strain:C57BL/6J; Treatment: activated with LPS (25ug/mL) and IL-4 (10ng/mL) for 72h;	EXP059713	917	normal	Q4JK59	spleen	NULL
EXP059715	none	Mus musculus	Age: p12; Tissue: testes; Strain: CD1; Genotype: wildtype;	NULL	3085	chip_control	NULL	spermatogenic cells	NULL
EXP059716	none	Mus musculus	Age: p12; Tissue: testes; Strain: CD1; Genotype: wildtype;	NULL	3085	chip_control	NULL	spermatogenic cells	NULL
EXP059717	none	Mus musculus	Age: p18; Tissue: testes; Strain: CD1; Genotype: wildtype;	NULL	3085	chip_control	NULL	spermatogenic cells	NULL
EXP059718	none	Mus musculus	Age: p18; Tissue: testes; Strain: CD1; Genotype: wildtype;	NULL	3085	chip_control	NULL	spermatogenic cells	NULL
EXP059719	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p12; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059715	3085	normal	Q3TKT4	spermatogenic cells	NULL
EXP059720	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p12; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059716	3085	normal	Q3TKT4	spermatogenic cells	NULL
EXP059721	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p18; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059717	3085	normal	Q3TKT4	spermatogenic cells	NULL
EXP059722	anti-BRG1(Abcam, ab110641)	Mus musculus	Age: p18; Tissue: testes; Strain: CD1; Genotype: wildtype;	EXP059718	3085	normal	Q3TKT4	spermatogenic cells	NULL
EXP059723	anti-LRH-1 (R&D PP-H2325-00)	Mus musculus	Strain: C57BL/6; Genotype: LRH-1 +/+; Treatment: none (before ovulatory signal);	NULL	2268	normal	P45448	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP059724	anti-LRH-1 (R&D PP-H2325-00)	Mus musculus	Strain: C57BL/6; Genotype: LRH-1 +/+; Treatment: following ovulatory signal;	NULL	2268	normal	P45448	primary vascular smooth muscle cell (C57BL/6 mice)	NULL
EXP059725	None	Mus musculus	Treatment: None; Strain: RD1;	NULL	3086	chip_control	NULL	brain pericytes	NULL
EXP059726	None	Mus musculus	Treatment: None; Strain: RD1;	NULL	3086	chip_control	NULL	brain pericytes	NULL
EXP059727	Anti-RBPJ (Cell Signaling, #5313)	Mus musculus	Treatment: None; Strain: RD1;	EXP059725	3086	normal	P31266	brain pericytes	NULL
EXP059728	Anti-RBPJ (Cell Signaling, #5313)	Mus musculus	Treatment: None; Strain: RD1;	EXP059726	3086	normal	P31266	brain pericytes	NULL
EXP059729	NA	Mus musculus	Genotype: wildtype; Strain: C57BL/6NCr;	NULL	43	chip_control	NULL	CD4+ Th17+ T-cells	NULL
EXP059730	anti-BCOR (RRID, AB_2750631)	Mus musculus	Genotype: wildtype; Strain: C57BL/6NCr;	EXP059729	43	normal	Q8CGN4	CD4+ Th17+ T-cells	NULL
EXP059731		Mus musculus	Genotype: RGd2 1903.4 parental; Conditions:2i medium;	NULL	3087	chip_control	NULL	RGd2(embryonic stem cells)	NULL
EXP059732	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:20; Conditions: 2i medium;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	NULL
EXP059733	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:32; Conditions: 2i medium;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	NULL
EXP059734	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:20; Conditions: withdrawn from 2i for 16h;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	NULL
EXP059735	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 Etv5-3xFlag knock in; Clonal line:32; Conditions: withdrawn from 2i for 16h;	NULL	3087	normal	Q9CXC9	RGd2(embryonic stem cells)	NULL
EXP059736	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 1903.4 parental; Conditions:2i medium;	EXP059731	3087	bio_control	Q9CXC9	RGd2(embryonic stem cells)	NULL
EXP059737	anti-Flag(M2, Sigma)	Mus musculus	Genotype: RGd2 1903.4 parental; Conditions: withdrawn from 2i for 16h;	NULL	3087	bio_control	Q9CXC9	RGd2(embryonic stem cells)	NULL
EXP059738	input	Mus musculus	Genotype: wildtype;	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP059739	anti-Pcgf1	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059740	anti-Pcgf1	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059741	anti-Pcgf1	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059742	anti-Pcgf1	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059743	anti-Pcgf1	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059744	Pcgf2	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059745	Pcgf2	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059746	Pcgf2	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059747	Pcgf2	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059748	Pcgf2	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059749	Pcgf3	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059750	Pcgf3	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059751	Pcgf3	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059752	Pcgf3	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059753	Pcgf3	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059754	Pcgf6	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059755	Pcgf6	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059756	Pcgf6	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059757	Pcgf6	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059758	Pcgf6	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059759	Ring1b	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059760	Ring1b	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059761	Ring1b	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059762	Ring1b	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059763	Ring1b	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059764	Suz12	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059765	Suz12	Mus musculus	Genotype: Pcgf1-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059766	Suz12	Mus musculus	Genotype: Pcgf2/4-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059767	Suz12	Mus musculus	Genotype: Pcgf3/5-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059768	Suz12	Mus musculus	Genotype: Pcgf6-/-(knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059769	Pcgf1	Mus musculus	Genotype: Ezh1/2-/-(knockout); 	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059770	Pcgf2	Mus musculus	Genotype: Ezh1/2-/-(knockout); 	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059771	Pcgf1	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059772	Pcgf2	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059773	Pcgf3	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059774	Pcgf6	Mus musculus	Genotype: Ring1a-/-(knockout),Ring1b fl/fl; 	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059775	Pcgf1	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	Q8R023	ES-E14 (E14, embryonic stem cells)	NULL
EXP059776	Pcgf2	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP059777	Pcgf3	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059778	Pcgf6	Mus musculus	Genotype: Ring1a-/-(knockout); 	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059779	Ring1b	Mus musculus	Genotype: Pcgf1/2/4-/-(triple knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059780	Suz12	Mus musculus	Genotype: Pcgf1/2/4-/-(triple knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059781	Ring1b	Mus musculus	Genotype: Pcgf1/2/4-/-(triple knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059782	Ring1b	Mus musculus	Genotype: Pcgf3/5/6-/-(triple knockout);	NULL	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP059783	Suz12	Mus musculus	Genotype: Pcgf3/5/6-/-(triple knockout);	NULL	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP059784	Pcgf6	Mus musculus	Treatment: shMGA; Genotype: MGA knockout;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059785	Pcgf6	Mus musculus	Treatment: shMGAdHLH; Genotype: MGAdHLH knockout;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059786	Pcgf6	Mus musculus	Treatment: shE2F6; Genotype: E2F6knockout;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059787	Pcgf6	Mus musculus	Treatment: shE2F6-MGAdHLH; Genotype: E2F6, MGA(double knockout);	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059788	Wdr5	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	P61965	ES-E14 (E14, embryonic stem cells)	NULL
EXP059789	Pcgf3	Mus musculus	Treatment: shCntrl;	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059790	Pcgf3	Mus musculus	Genotype: Usf1 knockout; Treatment: shRNA;	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059791	Pcgf3	Mus musculus	Genotype: Usf2 knockout; Treatment: shRNA;	NULL	230	normal	Q8BTQ0	ES-E14 (E14, embryonic stem cells)	NULL
EXP059792	Usf1	Mus musculus	Genotype: wildtype;	EXP059738	230	normal	Q61069	ES-E14 (E14, embryonic stem cells)	NULL
EXP059793	Pcgf6	Mus musculus	Treatment: shCntrl;	NULL	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP059794		Mus musculus	Genotype: Nf1fl/fl(knockout),DhhCre; Strain: C57BL/6-I129; Treatment: shRNA;	NULL	3088	chip_control	NULL	primary neurofibroma cells	NULL
EXP059795	anti-Runx1 (in-house Antibody)	Mus musculus	Genotype: Nf1fl/fl(knockout),DhhCre; Strain: C57BL/6-I129; Treatment: shRNA;	EXP059794	3088	normal	Q03347	primary neurofibroma cells	NULL
EXP059796	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i4; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059797	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i5; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059798	CTCF (Diagenode:C15410210)	Mus musculus	Genotype: wildtype CTCF; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059799	anti-Rad21 (Abcam,ab992)	Mus musculus	Genotype: deltaCTCF i4i5; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61550	fetal limb bud and midbrain	NULL
EXP059800	anti-Rad21 (Abcam,ab992)	Mus musculus	Genotype: deltaCTCF i4i5ZRS; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61550	fetal limb bud and midbrain	NULL
EXP059801	anti-Rad21 (Abcam,ab992)	Mus musculus	Genotype: wildtype; Developmental stage: E10.5; Strain: Bl.6;	NULL	3089	normal	Q61550	fetal limb bud and midbrain	NULL
EXP059802	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: delta-CTCF i4i5ZRSreg; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059803	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i4i5; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059804	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: deltaCTCF i4i5ZRS; Developmental stage: E10.5; Strain: G4;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059805	anti-CTCF (Diagenode,C15410210)	Mus musculus	Genotype: wildtype; Developmental stage: E10.5; Strain: Bl.6;	NULL	3089	normal	Q61164	fetal limb bud and midbrain	NULL
EXP059806	none: input DNA	Mus musculus	Treatment: none;	NULL	3090	chip_control	NULL	BWTG3(Hepatocellular carcinoma of the mouse)	NULL
EXP059807	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment: none;	EXP059806	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	NULL
EXP059808	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment: 1uM Dex (Sigma, D-2915) for 3 hrs;	NULL	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	NULL
EXP059809	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment: 1uM Dex (Sigma, D-2915) and 1000u/ml recombinant TNF for 3 hrs;	NULL	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	NULL
EXP059810	anti-GR antibody(Santa Cruz Biotechnolgoy, sc-8992,rabbit)	Mus musculus	Treatment:  1000u/ml recombinant TNF for 3 hrs;	NULL	3090	normal	P06537	BWTG3(Hepatocellular carcinoma of the mouse)	NULL
EXP059811	none	Mus musculus	Disease: acute myeloid leukemia; Strain: C57BL/6; Treatment: shRNA; Genotype: Ren knockout; Time: day 7;	NULL	2747	chip_control	NULL	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	NULL
EXP059812	anti-Foxh1(Abcam, 49133)	Mus musculus	Disease: acute myeloid leukemia; Strain: C57BL/6; Treatment: shRNA; Genotype: Ren knockout; Time: day 7;	EXP059811	2747	normal	O88621	BM-HPC (Hematopoietic progenitor/stem cell line derived from Mouse bone marrow)	NULL
EXP059813	none	Mus musculus	Treatment: untreated; Strain: C57BL/6; Sex: male; 	NULL	3091	chip_control	NULL	peritoneal lavage	NULL
EXP059814	none	Mus musculus	Treatment: IL-4c injections; Strain: C57BL/6; Sex: male; 	NULL	3091	chip_control	NULL	peritoneal lavage	NULL
EXP059815	anti-Dec1 (Bhlhe40, NB100-1800, lot C1, Novus Biologicals)	Mus musculus	Treatment: untreated; Strain: C57BL/6; Sex: male; 	EXP059813	3091	normal	O35185	peritoneal lavage	NULL
EXP059816	anti-Dec1 (Bhlhe40, NB100-1800, lot C1, Novus Biologicals)	Mus musculus	Treatment: IL-4c injections; Strain: C57BL/6; Sex: male; 	EXP059814	3091	normal	O35185	peritoneal lavage	NULL
EXP059817	none (input)	Mus musculus		NULL	132	chip_control	NULL	uterus	NULL
EXP059818	none (input)	Mus musculus		NULL	132	chip_control	NULL	uterus	NULL
EXP059819	none (input)	Mus musculus	Treatment: pooled;	NULL	132	chip_control	NULL	uterus	NULL
EXP059820	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 6 hrs; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	NULL
EXP059821	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 8 hrs; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	NULL
EXP059822	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 12 hrs; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	NULL
EXP059823	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: 21 day; Treatment: vehile; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	NULL
EXP059824	anti-ESR1(Santa Cruz SC-542)	Mus musculus	Age: 21 day; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline; Strain: C57BL/6J; 	NULL	132	normal	P19785	uterus	NULL
EXP059825	anti-SMC1(Active Motif #61067)	Mus musculus	Age: 21 day; Treatment: vehile; Strain: C57BL/6J; 	EXP059819	132	normal	Q9CU62	uterus	NULL
EXP059826	anti-SMC1(Active Motif #61067)	Mus musculus	Age: 21 day; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline; Strain: C57BL/6J; 	EXP059819	132	normal	Q9CU62	uterus	NULL
EXP059827	anti-SMC1(Active Motif #61067)	Mus musculus	Age: 21 day; Treatment: 1 mg P4 dissolved in sesame oil; Strain: C57BL/6J; 	EXP059819	132	normal	Q9CU62	uterus	NULL
EXP059828	none; Input sample	Mus musculus	Strain: C57BL/6; Developmental stage: E8.25-E9;	NULL	3092	chip_control	NULL	embryos	NULL
EXP059829	anti-Isl1 (Developmental Studies Hybridoma Bank (DSHB) clone 39.4D5)	Mus musculus	Strain: C57BL/6; Developmental stage: E8.25-E9; Source: anterior part of embryos;	EXP059828	3092	normal	P61372	embryos	NULL
EXP059830	none, input sample	Mus musculus	Developmental stage: day 5 derived cells;	NULL	3093	chip_control	NULL	E14Tg derived cardiac progenitor cells	NULL
EXP059831	anti-Isl1 (Developmental Studies Hybridoma Bank (DSHB) clone 39.4D5)	Mus musculus	Developmental stage: day 5 derived cells;	EXP059830	3093	normal	P61372	E14Tg derived cardiac progenitor cells	NULL
EXP059832		Mus musculus	Genotype: Ai32 fl/fl; Age: 6-8weeks;	NULL	25	chip_control	NULL	cerebellum	NULL
EXP059833		Mus musculus	Genotype: Atoh1-CRE, Ai32 fl/fl; Age: 6-8weeks;	NULL	25	chip_control	NULL	cerebellum	NULL
EXP059834	anti-Rad21	Mus musculus	Genotype: Ai32 fl/fl; Age: 6-8weeks;	EXP059832	25	normal	Q61550	cerebellum	NULL
EXP059835	anti-Rad21	Mus musculus	Genotype: Atoh1-CRE, Ai32 fl/fl; Age: 6-8weeks;	EXP059833	25	normal	Q61550	cerebellum	NULL
EXP059836	anti-CTCF	Mus musculus	Genotype: Ai32 fl/fl; Age: 6-8weeks;	EXP059832	25	normal	Q61164	cerebellum	NULL
EXP059837	anti-CTCF	Mus musculus	Genotype: Atoh1-CRE, Ai32 fl/fl; Age: 6-8weeks;	EXP059833	25	normal	Q61164	cerebellum	NULL
EXP059838	Anti-CTCF (rabbit polyclonal,Millipore,07-729)	Mus musculus	Genotype: Lig4-/-(knockout); Strain: C57BL/6;	NULL	3094	normal	Q61164	Abelson-transformed pre-B cell	NULL
EXP059839	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Lig4-/-(knockout); Strain: C57BL/6;	NULL	3094	normal	Q61550	Abelson-transformed pre-B cell	NULL
EXP059840	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	NULL
EXP059841	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Smc3-/-(knockout); Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	NULL
EXP059842	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Wapl f/f; Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	NULL
EXP059843	Anti-Rad21(rabbit polyclonal,Abcam,ab992)	Mus musculus	Genotype: Wapl f/f + Cre; Strain: C57BL/6;	NULL	12	normal	Q61550	MEF (mouse embryonic fibroblasts)	NULL
EXP059844	anti-Top2b(rabbit polyclonal, Santa Cruz, sc13059, clone H-286)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	12	normal	Q64511	MEF (mouse embryonic fibroblasts)	NULL
EXP059845	anti-Top2b(rabbit polyclonal, Santa Cruz, sc13059, clone H-286)	Mus musculus	Genotype: Smc3-/-(knockout); Strain: C57BL/6;	NULL	12	normal	Q64511	MEF (mouse embryonic fibroblasts)	NULL
EXP059846	anti-Top2b(rabbit polyclonal, Santa Cruz, sc13059, clone H-286)	Mus musculus	Genotype: Wapl f/f + Cre; Strain: C57BL/6;	NULL	12	normal	Q64511	MEF (mouse embryonic fibroblasts)	NULL
EXP059847	anti-Flag (Sigma, F3165)	Mus musculus	Treatment: mock gRNA;	NULL	3095	normal	P30882	2B4(T cell hybridoma)	NULL
EXP059848	anti-Flag (Sigma, F3165)	Mus musculus	Treatment: gRNA specific to the Ccl5 promoter; Genotype: Ccl5 knockout;	NULL	3095	normal	P30882	2B4(T cell hybridoma)	NULL
EXP059849	anti-Mi2b	Mus musculus	Age: adult; Strain: C57BL/6 x 129/Sv; Source: large pre-B; Genotype: wildtype;	NULL	3065	normal	Q6PDQ2	bone-marrow derived primary pre B cells	NULL
EXP059850	anti-CTCF	Mus musculus	Age: adult; Strain: C57BL/6 x 129/Sv; Source: large pre-B; Genotype: wildtype;	NULL	3065	normal	Q61164	bone-marrow derived primary pre B cells	NULL
EXP059851	None	Mus musculus	Strain: C57Bl/6; 	NULL	1588	chip_control	NULL	CD4-positive helper T cell	NULL
EXP059852	None	Mus musculus	Strain: C57Bl/6; 	NULL	2479	chip_control	NULL	CD8+ T-cells	NULL
EXP059853	Anti-CBFb	Mus musculus	Strain: C57Bl/6; 	EXP059851	1588	normal	Q08024	CD4-positive helper T cell	NULL
EXP059854	Anti-CBFb	Mus musculus	Strain: C57Bl/6; 	EXP059852	2479	normal	Q08024	CD8+ T-cells	NULL
EXP059855	input	Mus musculus	Time: day0; Treatment: none;	NULL	3096	chip_control	NULL	MEL(mouse erythroleukemia cells)	NULL
EXP059856	input	Mus musculus	Time: day5; Treatment: 2% DMSO (VWR) added to the medium;	NULL	3096	chip_control	NULL	MEL(mouse erythroleukemia cells)	NULL
EXP059857	anti-PU.1(Santa Cruz Technology, sc-352, Lot#B0513)	Mus musculus	Time: day0; Treatment: none;	NULL	3096	normal	P17433	MEL(mouse erythroleukemia cells)	NULL
EXP059858	anti-PU.1(Santa Cruz Technology, sc-352, Lot#B0513)	Mus musculus	Time: day5; Treatment: 2% DMSO (VWR) added to the medium;	EXP059856	3096	normal	P17433	MEL(mouse erythroleukemia cells)	NULL
EXP059859	anti-PU.1 (T-21, Santa Cruz )	Mus musculus	Source: spleen cells of leukaemic recipient; Treatment: dox for 2 days,GFP-shRNA; Strain: C57BL/6; Immunophenotype: PU.1 High;Genotype: p53 knockout, GFP-shPU.1;	NULL	917	normal	P17433	spleen	NULL
EXP059860	anti-PU.1 (T-21, Santa Cruz )	Mus musculus	Source: spleen cells of leukaemic recipient; Treatment: untreated; Strain: C57BL/6; Immunophenotype: PU.1 Low;	NULL	917	normal	P17433	spleen	NULL
EXP059861	anti-Esrrb	Mus musculus	Strain: F1; Conditions: cultured in 2i medium for 3 days;	NULL	2	normal	Q61539	mESCs (mouse embryonic stem cells)	NULL
EXP059862	anti-Esrrb	Mus musculus	Strain: F1; Conditions: cultured in 2i medium for 3 days; Genotype: Restoration of a polymorphic ESRRB motif; Treatment: CRISPR/Cas9; 	NULL	2	normal	Q61539	mESCs (mouse embryonic stem cells)	NULL
EXP059863	anti-Esrrb	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP059864	anti-Esrrb	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP059865	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP059866	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP059867	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q60793	E14TG2A (embryonic stem cells)	NULL
EXP059868	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q60793	E14TG2A (embryonic stem cells)	NULL
EXP059869	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	P45448	E14TG2A (embryonic stem cells)	NULL
EXP059870	anti-GFP(ab290, Abcam)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	P45448	E14TG2A (embryonic stem cells)	NULL
EXP059871	anti-CTCF (Millipore, 07-729)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP059872	anti-CTCF (Millipore, 07-729)	Mus musculus	Conditions: cultured in EpiLSCs medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP059873	anti-CTCF (Millipore, 07-729)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP059874	anti-SMC1 (Bethyl, A300-055A)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP059875	anti-SMC1 (Bethyl, A300-055A)	Mus musculus	Conditions: cultured in EpiLSCs medium;	NULL	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP059876	anti-SMC1 (Bethyl, A300-055A)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP059877	anti-YY1 (Active Motif, 61779)	Mus musculus	Conditions: cultured in 2i medium for 3 days;	NULL	233	normal	Q00899	E14TG2A (embryonic stem cells)	NULL
EXP059878	anti-YY1 (Active Motif, 61779)	Mus musculus	Conditions: cultured in EpiLSCs medium;	NULL	233	normal	Q00899	E14TG2A (embryonic stem cells)	NULL
EXP059879	anti-YY1 (Active Motif, 61779)	Mus musculus	Conditions: cultured in serum medium;	NULL	233	normal	Q00899	E14TG2A (embryonic stem cells)	NULL
EXP059880		Mus musculus	Treatment: induced with 200 nM tamoxifen at final concentration for 3 hrs; Genotype: transgene CDA-KLF1-ER;	NULL	267	chip_control	NULL	erythroid cells	NULL
EXP059881	anti-ESR1(ThermoScientific cat. #MS-315-P, clone TE111.5D11)	Mus musculus	Treatment: induced with 200 nM tamoxifen at final concentration for 3 hrs; Genotype: transgene CDA-KLF1-ER;	EXP059880	267	normal	P19785	erythroid cells	NULL
EXP059882	anti-Lhx2	Mus musculus	Treatment: transgene Chx10-Cre eGFP; Developmental stage: E14; Strain: CD1; Genotype: Lhx2 knockout;	NULL	3097	normal	Q9Z0S2	retinal progenitor cells	NULL
EXP059883	anti-Lhx2	Mus musculus	Treatment: transgene Chx10-Cre eGFP; Developmental stage: post-natal day 2; Strain: CD1; Genotype: Lhx2 knockout;	NULL	3097	normal	Q9Z0S2	retinal progenitor cells	NULL
EXP059885	anti-CTCF (Millipore 07-729, Lot#2275585)	Homo sapiens		EXP059884	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP059884	-	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP059886	anti-TAP(Sigma i5006-100MG, Lot#SLBM2617V)	Saccharomyces cerevisiae	Genotype: TAP -tag abf1;  Source: GRF88, MATa his4-38, S288C background;	NULL	3099	normal	P14164	BY4741 strain	NULL
EXP059887	anti-TAP(Sigma i5006-100MG, Lot#SLBM2617V)	Saccharomyces cerevisiae	Genotype: TAP -tag Reb1;  Source: GRF88, MATa his4-38, S288C background;	NULL	3099	normal	A6ZZE3	BY4741 strain	NULL
EXP059888	anti-TAP(Sigma i5006-100MG, Lot#SLBM2617V)	Saccharomyces cerevisiae	Genotype: TAP -tag Reb1;  Source: GRF88, MATa his4-38, S288C background;	NULL	3099	normal	P39001	BY4741 strain	NULL
EXP059889	Anti-HA High Affinity; Rat monoclonal antibody (clone 3F10), Roche	Saccharomyces cerevisiae	Genotype: Yfl052w-HA;	NULL	2980	chip_control	NULL	S288C strain	NULL
EXP059890	anti-TAP	Saccharomyces cerevisiae	Treatment: 2% (w/v) glucose;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	NULL
EXP059891	anti-TAP	Saccharomyces cerevisiae	Treatment: 2% (w/v) glucose;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	NULL
EXP059892	anti-TAP	Saccharomyces cerevisiae	Treatment: 1% (v/v) ethanol;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	NULL
EXP059893	anti-TAP	Saccharomyces cerevisiae	Treatment: 1% (v/v) ethanol;	NULL	3101	normal	P40535	CEN.PK 113-5D strain	NULL
EXP059894		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP059895		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP059896		Homo sapiens		NULL	423	chip_control	NULL	HeLa S3 (cervical adenocarcinoma)	NULL
EXP059897	anti-TFIIB	Saccharomyces cerevisiae	Conditions: 37 deegre C; Genotype: wildtype;	NULL	3120	normal	P29055	log phase strain FY3126	NULL
EXP059898	anti-TFIIB	Saccharomyces cerevisiae	Conditions: 37 deegre C; Genotype: spt6-1004;	NULL	3121	normal	P29055	log phase strain FY3127	NULL
EXP059899	anti-TFIIB	Saccharomyces cerevisiae	Conditions: 37 deegre C; Genotype: spt6-1004;	NULL	3121	normal	P29055	log phase strain FY3127	NULL
EXP059900	anti-Spt6	Saccharomyces cerevisiae	Conditions: 30 deegre C; Genotype: wildtype;	NULL	3122	normal	P23615	log phase strain FY3128	NULL
EXP059901	anti-Spt6	Saccharomyces cerevisiae	Conditions: 30 deegre C; Genotype: wildtype;	NULL	3122	normal	P23615	log phase strain FY3128	NULL
EXP059902	p300 (Santa Cruz, catalog# sc-584, lot# I2712)	Mus musculus	Time: day 5; Treatment: iCre, RA, SAG on day 2,DAPT on day 4;	NULL	3134	normal	B2RWS6	Ainv15-derived spinal motor neurons	NULL
EXP059903	p300 (Santa Cruz, catalog# sc-584, lot# I2712)	Mus musculus	Time: day 6; Treatment: iCre, RA, SAG on day 2,DAPT on day 4,5;	NULL	3134	normal	B2RWS6	Ainv15-derived spinal motor neurons	NULL
EXP059904	no antibody	Drosophila melanogaster	Genotype: gd7 mutant;	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP059905	no antibody	Drosophila melanogaster	Genotype: gd7 mutant;	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP059906	anti-dl (rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	P15330	2-4 h embryo	NULL
EXP059907	anti-dl (rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	P15330	2-4 h embryo	NULL
EXP059908	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	Q9U1H0	2-4 h embryo	NULL
EXP059909	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	Q9U1H0	2-4 h embryo	NULL
EXP059910	no antibody	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	A0A0B4KH43	2-4 h embryo	NULL
EXP059911	no antibody	Drosophila melanogaster	Genotype: toll10b mutant;	NULL	1435	normal	A0A0B4KH43	2-4 h embryo	NULL
EXP059912	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: gd7 mutant;	EXP059904	1435	normal	Q9U1H0	2-4 h embryo	NULL
EXP059913	anti-cic(rabbit polyclonal, custom, GenScript)	Drosophila melanogaster	Genotype: gd7 mutant;	EXP059905	1435	normal	Q9U1H0	2-4 h embryo	NULL
EXP059914		Danio rerio	Treatment: Strain: TgBAC(foxd3-Avi-2A-Citrine)ox161 x Tg(ubiq:NLS-BirA-2A-Cherry)ox114; Deveolpmental stage: 75% epiboly;	NULL	2512	chip_control	NULL	Neural crest (foxd3 cells)	NULL
EXP059915		Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 1-2 somites;	NULL	2512	chip_control	NULL	Neural crest (foxd3 cells)	NULL
EXP059916		Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 5-6 somites;	NULL	2512	chip_control	NULL	Neural crest (foxd3 cells)	NULL
EXP059917		Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 14 somites;	NULL	2512	chip_control	NULL	Neural crest (foxd3 cells)	NULL
EXP059918	anti-Avi	Danio rerio	Treatment: Strain: TgBAC(foxd3-Avi-2A-Citrine)ox161 x Tg(ubiq:NLS-BirA-2A-Cherry)ox114; Deveolpmental stage: 75% epiboly;	EXP059914	2512	normal	F1R5S7	Neural crest (foxd3 cells)	NULL
EXP059919	anti-Avi	Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 1-2 somites;	EXP059915	2512	normal	F1R5S7	Neural crest (foxd3 cells)	NULL
EXP059920	anti-Avi	Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 5-6 somites;	NULL	2512	normal	F1R5S7	Neural crest (foxd3 cells)	NULL
EXP059921	anti-Avi	Danio rerio	Treatment: Strain: Gt(foxd3-citrine)ct110; Developmental stage: 14 somites;	NULL	2512	normal	F1R5S7	Neural crest (foxd3 cells)	NULL
EXP059922	anti-ORC()	Saccharomyces cerevisiae	Treatment: 10 ug/ml nocodazole for 2 hrs; Genotype: wildtype; Conditions: temperature 23 degree C; Developmantal stage: G2;	NULL	3208	normal	P32833	w303 strain	NULL
EXP059923	anti myc (Millipore cat no:05-419, 9E10)	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	3255	normal	P32657	TOH1303 strain	NULL
EXP059924		Caenorhabditis elegans		NULL	1387	normal	A0A023T4K3	whole worms (developmental stage: L1)	NULL
EXP059925	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	NULL
EXP059926	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	NULL
EXP059927	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	NULL
EXP059928	anti-HMG-D customized antibody	Drosophila melanogaster		NULL	1451	normal	Q05783	S2 (Schneider 2)	NULL
EXP059929	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059930	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059931	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059932	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059933	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059934	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059935	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059936	anti-bcd	Drosophila melanogaster	Genotype: wildtype (y w p{GFP-Bcd}; bcd[E1]);	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059937	anti-bcd	Drosophila melanogaster	Genotype: w {bcd>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059938	anti-bcd	Drosophila melanogaster	Genotype: w {bcd>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059939	anti-bcd	Drosophila melanogaster	Genotype: w {bcd>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059940	anti-bcd	Drosophila melanogaster	Genotype: w {mtrm>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059941	anti-bcd	Drosophila melanogaster	Genotype: w {mtrm>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059942	anti-bcd	Drosophila melanogaster	Genotype: w {mtrm>GFP-bcd-sqh3'UTR}attP40/+; bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059943	anti-bcd	Drosophila melanogaster	Genotype: w {alphaTub75c>GFP-bcd-sqh3'UTR}attP40/+ bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059944	anti-bcd	Drosophila melanogaster	Genotype: w {alphaTub75c>GFP-bcd-sqh3'UTR}attP40/+ bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059945	anti-bcd	Drosophila melanogaster	Genotype: w {alphaTub75c>GFP-bcd-sqh3'UTR}attP40/+ bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059946	anti-bcd	Drosophila melanogaster	Genotype: w {GFP-bcd[085]}attP40 bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059947	anti-bcd	Drosophila melanogaster	Genotype: w {GFP-bcd[085]}attP40 bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059948	anti-bcd	Drosophila melanogaster	Genotype: w {GFP-bcd[085]}attP40 bcd[E1];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059949	anti-bcd	Drosophila melanogaster	Genotype: y w p{GFP-Bcd} bcd[E1] nos[L7] tsl[4];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059950	anti-bcd	Drosophila melanogaster	Genotype: y w p{GFP-Bcd} bcd[E1] nos[L7] tsl[4];	NULL	3343	normal	P09081	NC14 embryo	NULL
EXP059951	none	Drosophila melanogaster		NULL	3346	chip_control	NULL	OregonR (Developmental stage: adult)	NULL
EXP059952	input	Homo sapiens	Treatment: 5uM nutlin for 2 hrs;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP059953	input	Homo sapiens	Treatment: 5uM  nutlin for 2 hrs and treated with TGFB for 5 days at 2.5ng/ml prior;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP059954	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM nutlin for 2 hrs;	EXP059952	38	normal	P04637	A549 (lung carcinoma)	NULL
EXP059955	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM nutlin for 2 hrs;	EXP059952	38	normal	P04637	A549 (lung carcinoma)	NULL
EXP059956	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM  nutlin for 2 hrs and treated with TGFB for 5 days at 2.5ng/ml prior;	EXP059953	38	normal	P04637	A549 (lung carcinoma)	NULL
EXP059957	anti-p53 ( DO-1, Santa Cruz Biotechnology, SC-126X, Lot:G0115)	Homo sapiens	Treatment: 5uM  nutlin for 2 hrs and treated with TGFB for 5 days at 2.5ng/ml prior;	EXP059953	38	normal	P04637	A549 (lung carcinoma)	NULL
EXP059958	none	Homo sapiens	Treatment: Treatment: untreated;	NULL	3369	chip_control	NULL	SK-MEL-239 (Melanoma)	NULL
EXP059959	anti-SIRT6 (Abcam, ab62739)	Homo sapiens	Treatment: Treatment: untreated; Genotype: wildtype;	EXP059958	3369	normal	Q8N6T7	SK-MEL-239 (Melanoma)	NULL
EXP059960	anti-SIRT6 (Abcam, ab62739)	Homo sapiens	Treatment: Genotype: SIRT6 happloinsufficient cells;	NULL	3369	normal	Q8N6T7	SK-MEL-239 (Melanoma)	NULL
EXP059961	anti-SIRT6 (Abcam, ab62739)	Homo sapiens	Treatment: Genotype: SIRT6 knockout; Treatment: untreated;	NULL	3369	normal	Q8N6T7	SK-MEL-239 (Melanoma)	NULL
EXP059962		Homo sapiens		NULL	3726	chip_control	NULL	NHM1 (foreskin)	NULL
EXP059963	anti-BRD2 (Bethyl Laboratories, A302-583A)	Homo sapiens		EXP059962	3726	normal	P25440	NHM1 (foreskin)	NULL
EXP059964	anti-BRD4 (Bethyl Laboratories, A301-985A)	Homo sapiens		EXP059962	3726	normal	O60885	NHM1 (foreskin)	NULL
EXP059965	anti-CTCF (Millipore 07-729)	Homo sapiens		EXP049420	794	normal	P49711	SK-MEL-147 (melanoma)	NULL
EXP059966	anti-FOSL2 (Santa Cruz SC-604)	Homo sapiens		EXP049420	794	normal	P15408	SK-MEL-147 (melanoma)	NULL
EXP059967	anti-TEAD4 (Santa Cruz SC-101184)	Homo sapiens		EXP049420	794	normal	Q15561	SK-MEL-147 (melanoma)	NULL
EXP059968	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: adult;	NULL	196	normal	P43241	jejunal crypt intestinal epithelial cells	NULL
EXP059969	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: E17;	NULL	3018	normal	P43241	embryonic whole tissue from midgut	NULL
EXP059970	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: E14;	NULL	3863	normal	P43241	E14 embryonic epithelial cells from the small intestine	NULL
EXP059971	anti-CDX2 (#12306, Cell Signaling)	Mus musculus	Genotype:Cdx2f/f (wildtype);  Cell type: villus epithelial cells; Tissue: middle 1/3 of intestine; Developmental stage: E13;	NULL	3018	normal	P43241	embryonic whole tissue from midgut	NULL
EXP059972		Mus musculus	Strain: C57BL/6; Tissue: skin;	NULL	2441	chip_control	NULL	squamous cell carcinoma	NULL
EXP059973	anti-BRG1 (EPNCIR11A, made in collaboration with Epitomics, Burlingame, CA)	Mus musculus	Treatment: Dexamethasone treatment: 100 nM for 1h;	NULL	14	normal	Q3TKT4	3134 (mammary adenocarcinoma)	NULL
EXP059974	anti-BRG1 (EPNCIR11A, made in collaboration with Epitomics, Burlingame, CA)	Mus musculus	Treatment: Dexamethasone treatment: 100 nM for 1h;	NULL	14	normal	Q3TKT4	3134 (mammary adenocarcinoma)	NULL
EXP059975	none	Rattus norvegicus	Strain: Sprague Dawley; Treatment: Strain: Sprague Dawley; Treatment: Ethanol cfor 1 hr;	NULL	4178	chip_control	NULL	neonatal rat ventricular myocytes	NULL
EXP059976	Anti-GR (Santa Cruz, cat# sc8992)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: Strain: Sprague Dawley; Treatment: Ethanol cfor 1 hr;	EXP059975	4178	normal	P06536	neonatal rat ventricular myocytes	NULL
EXP059977	Anti-GR (Santa Cruz, cat# sc8992)	Rattus norvegicus	Strain: Sprague Dawley; Treatment: 100 nM Dexamethasone for 1 hr;	NULL	4178	normal	P06536	neonatal rat ventricular myocytes	NULL
EXP059978		Rattus norvegicus	Strain: Wistar; Sex: female; Age: P0;	NULL	4183	chip_control	NULL	urogenital sinus	NULL
EXP059979		Rattus norvegicus	Strain: Wistar; Sex: male; Age: P0;	NULL	4183	chip_control	NULL	urogenital sinus	NULL
EXP059980	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: female; Age: P0;	EXP059978	4179	normal	P15207	ventral mesenchymal pad of urogenital sinus	NULL
EXP059981	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: female; Age: P0;	EXP059978	4180	normal	P15207	smooth muscle, peri-urethral mesenchyme and urethral epithelium (SU) of urogenital sinus	NULL
EXP059982	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: male; Age: P0;	EXP059979	4181	normal	P15207	ventral prostate of urogenital sinus	NULL
EXP059983	AR (Santa Cruz, H280, sc-13062, Lot D0414)	Rattus norvegicus	Strain: Wistar; Sex: male; Age: P0;	EXP059979	4182	normal	P15207	dorsal/dorsolateral prostate (DP) of urogenital sinus	NULL
EXP059984		Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	NULL	898	chip_control	NULL	pancreatic islets	NULL
EXP059985		Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	898	chip_control	NULL	pancreatic islets	NULL
EXP059986		Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	NULL	2489	chip_control	NULL	primary hepatocytes	NULL
EXP059987		Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	2489	chip_control	NULL	primary hepatocytes	NULL
EXP059988		Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	NULL	493	chip_control	NULL	INS-1E (pancreatic beta-cells)	NULL
EXP059989	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059984	898	normal	Q01147	pancreatic islets	NULL
EXP059990	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059985	898	normal	Q01147	pancreatic islets	NULL
EXP059991	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059984	898	normal	Q3U182	pancreatic islets	NULL
EXP059992	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059985	898	normal	Q3U182	pancreatic islets	NULL
EXP059993	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059986	2489	normal	Q01147	primary hepatocytes	NULL
EXP059994	anti-CREB (rabbit serum, 244)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059987	2489	normal	Q01147	primary hepatocytes	NULL
EXP059995	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059986	2489	normal	Q3U182	primary hepatocytes	NULL
EXP059996	anti-CRTC2 (rabbit serum,6865)	Mus musculus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	EXP059987	2489	normal	Q3U182	primary hepatocytes	NULL
EXP059997	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP059998	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP059999	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060000	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060001	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060002	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060003	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060004	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060005	anti-CRTC2 (rabbit serum, 6865 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	Q3LRZ1	INS-1E (pancreatic beta-cells)	NULL
EXP060006	anti-CRTC2 (rabbit serum, 6865 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	Q3LRZ1	INS-1E (pancreatic beta-cells)	NULL
EXP060007	anti-CBP(rabbit serum, 5613 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	Q6JHU9	INS-1E (pancreatic beta-cells)	NULL
EXP060008	anti-CBP(rabbit serum, 5613 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	Q6JHU9	INS-1E (pancreatic beta-cells)	NULL
EXP060009	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-GFP;	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060010	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-GFP;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060011	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-ACREB;	EXP059988	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060012	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-ACREB;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060013	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-GFP;	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060014	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-GFP;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060015	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-ACREB;	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060016	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-ACREB;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060017	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060018	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060019	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatmet: 3 hours 1 uM JQ1;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060020	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + 3 hours 1 uM JQ1;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060021	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060022	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060023	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 3 hours 10 uM A485;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060024	anti-BRD4 (rabbit , Bethyl A301-985A)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + 3 hours 10 uM A485;	NULL	493	normal	A0A0G2JYV0	INS-1E (pancreatic beta-cells)	NULL
EXP060025	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: none	EXP059988	493	normal	Q64289	INS-1E (pancreatic beta-cells)	NULL
EXP060026	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin;	NULL	493	normal	Q64289	INS-1E (pancreatic beta-cells)	NULL
EXP060027	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA);	NULL	493	normal	Q64289	INS-1E (pancreatic beta-cells)	NULL
EXP060028	anti-NeuroD1 (Goat, Santa Cruz, sc-1086X)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1i; Genotype: NeuroD1i knockout;	NULL	493	normal	Q64289	INS-1E (pancreatic beta-cells)	NULL
EXP060029	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA);	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060030	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: 1 hour 10 uM forskolin + Ad-Usi (non-specific shRNA);	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060031	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1i; Genotype: NeuroD1i knockout;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060032	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1i + 1 hour 10 uM forskolin; Genotype: NeuroD1i knockout;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060033	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA) + 1 hour 10 uM forskolin;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060034	anti-PDX1(serum, 5538 rabbit)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-Usi (non-specific shRNA) + 1 hour 10 uM forskolin;	NULL	493	normal	P52947	INS-1E (pancreatic beta-cells)	NULL
EXP060035	anti-CREB (rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-PDX1i +  1 hour 10 uM forskolin; Genotype: PDX1i knockout;	NULL	493	normal	P15337	INS-1E (pancreatic beta-cells)	NULL
EXP060036	anti-PDX1(serum, 5538 rabbit)	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-PDX1i + 1 hour 10 uM forskolin; Genotype: PDX1i knockout;	NULL	493	normal	P52947	INS-1E (pancreatic beta-cells)	NULL
EXP060037	anti-CREB(rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-GFP;	NULL	4185	normal	P15337	AR42J (rat digestive system neoplasms)	NULL
EXP060038	anti-CREB(rabbit serum, 244 )	Rattus norvegicus	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Ad-NeuroD1; Genotype: NeuroD1 knockout;	NULL	4185	normal	P15337	AR42J (rat digestive system neoplasms)	NULL
EXP060039	none	Danio rerio	Strain: Tubingen;	NULL	4187	chip_control	NULL	256-cells stage	NULL
EXP060040	none	Danio rerio	Strain: Tubingen;	NULL	4188	chip_control	NULL	sphere stage embryos	NULL
EXP060041	none	Danio rerio	Strain: Tubingen;	NULL	4189	chip_control	NULL	epiboly,30% stage	NULL
EXP060042	anti-Brg1(Customized , polyclonal antibody)	Danio rerio	Strain: Tubingen;	EXP060039	4187	normal	Q7ZSY3	256-cells stage	NULL
EXP060043	anti-Brg1(Customized , polyclonal antibody)	Danio rerio	Strain: Tubingen;	EXP060040	4188	normal	Q7ZSY3	sphere stage embryos	NULL
EXP060044	anti-Brg1(Customized , polyclonal antibody)	Danio rerio	Strain: Tubingen;	EXP060041	4189	normal	Q7ZSY3	epiboly,30% stage	NULL
EXP060045	None (Input)	Danio rerio	Genotype: wildtype; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	NULL	4190	chip_control	NULL	whole embryo	NULL
EXP060046	anti-Ezh2 (Cell Signaling 5246S)	Danio rerio	Genotype: MZezh2-/-; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	NULL	4190	normal	Q08BS4	whole embryo	NULL
EXP060047	anti-Ezh2 (Cell Signaling 5246S)	Danio rerio	Genotype: wildtype; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	EXP060045	4190	normal	Q08BS4	whole embryo	NULL
EXP060048	anti-RING1B (Cell Signaling 5694S)	Danio rerio	Genotype: wildtype; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	EXP060045	4190	normal	Q803I4	whole embryo	NULL
EXP060049	anti-RING1B (Cell Signaling 5694S)	Danio rerio	Genotype: MZezh2-/-; Age: 24 hours post-fertilization; Strain:TU/TLF mixed background;	NULL	4190	normal	Q803I4	whole embryo	NULL
EXP060050	anti-Sox3	Danio rerio	Genotype: wildtype;	NULL	1254	normal	Q6EJB7	24 hpf embryo	NULL
EXP060051	anti-Sox3	Danio rerio	Genotype: wildtype;	NULL	3179	normal	Q6EJB7	epiboly, 80%	NULL
EXP060052	anti-p63	Danio rerio	Genotype: wildtype;	NULL	1254	normal	A0A0R4IHL8	24 hpf embryo	NULL
EXP060053	anti-p63	Danio rerio	Genotype: wildtype;	NULL	4191	normal	A0A0R4IHL8	36hpf embryos	NULL
EXP060054	anti-p63	Danio rerio	Genotype: wildtype;	NULL	3179	normal	A0A0R4IHL8	epiboly, 80%	NULL
EXP060055	anti-Sox3	Danio rerio	Genotype: tp63 -/-;	NULL	4191	normal	Q6EJB7	36hpf embryos	NULL
EXP060056	anti-Sox3	Danio rerio	Genotype: wildtype;	NULL	4191	normal	Q6EJB7	36hpf embryos	NULL
EXP060057	none	Danio rerio		NULL	4190	chip_control	NULL	whole embryo	NULL
EXP060058	anti-HA Antibody (ab9110 abcam)	Danio rerio	Genotype: Npas4l-HA;	EXP060057	4190	normal	P0DOC7	whole embryo	NULL
EXP060059	Anti-eGFP (Torrey Pine Biolabs, 0715119, Protein A purified rabbit IgG)	Danio rerio	Genotype: eGFP-tagged FoxH1;	NULL	4192	normal	Q9I9E1	6hpf epiboly-stage	NULL
EXP060060		Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	NULL	1263	chip_control	NULL	whole cells	NULL
EXP060061		Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	NULL	1263	chip_control	NULL	whole cells	NULL
EXP060062	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	NULL	1263	chip_control	NULL	whole cells	NULL
EXP060063		Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	NULL	1263	chip_control	NULL	whole cells	NULL
EXP060064		Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	NULL	1263	chip_control	NULL	whole cells	NULL
EXP060065	FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	NULL	1263	chip_control	NULL	whole cells	NULL
EXP060066	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	EXP060060	1263	normal	O94603	whole cells	NULL
EXP060067	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32;	EXP060061	1263	normal	O94603	whole cells	NULL
EXP060068	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	EXP060063	1263	normal	O94603	whole cells	NULL
EXP060069	anti-FLAG M2 (F1804, Sigma)	Schizosaccharomyces pombe	Genotype: ura4-D18 leu1-32, Rpt4 point-mutation;	EXP060064	1263	normal	O94603	whole cells	NULL
EXP060070	Anti-Myc tag, clone 4A6 (Millipore 05-724, lot 2720363)	Arabidopsis thaliana		NULL	4195	chip_control	NULL	8-day old seedlings	NULL
EXP060071	none	Arabidopsis thaliana		NULL	4195	chip_control	NULL	8-day old seedlings	NULL
EXP060072	none	Arabidopsis thaliana		NULL	4195	chip_control	NULL	8-day old seedlings	NULL
EXP060073	Anti-Myc (tag, clone 4A6 (Millipore 05-724, lot 2720363)	Arabidopsis thaliana	Genotype: bdrs expressing Myc tag-BDR1; Age: 8-day old;	EXP060071	4195	normal	Q8RWG1	8-day old seedlings	NULL
EXP060074	anti-FPA (polyclonal, NEBNext Ultra II DNA library Prep kit (E7645))	Arabidopsis thaliana		NULL	4195	normal	Q8LPQ9	8-day old seedlings	NULL
EXP060075	Flag (Sigma-Aldrich, F1804)	Arabidopsis thaliana	Genotype: wildtype; Ecotype: Col-0;	NULL	4197	chip_control	NULL	13 days shoots	NULL
EXP060076	anti-Flag (Sigma-Aldrich, F1804)	Arabidopsis thaliana	Genotype: mbd9-3 flag; Ecotype: Col-0;	EXP060075	4197	normal	Q9SGH2	13 days shoots	NULL
EXP060077	Anti-Myc tag( clone 4A6 (Millipore 05-724, lot 2824030))	Arabidopsis thaliana	Genotype: wildtype; Ecotype: Col-0;	NULL	4195	chip_control	NULL	8-day old seedlings	NULL
EXP060078	Anti-Myc tag( clone 4A6 (Millipore 05-724, lot 2824030))	Arabidopsis thaliana	Genotype: bdrs expressing Myc tag-BDR1; Ecotype: Col-0;	EXP060077	4195	normal	Q8RWG1	8-day old seedlings	NULL
EXP060079	none	Saccharomyces cerevisiae	Genotype: MATa his3-<delta>200 leu2-3,112 lys2-801 trp1-1 ura3-52 ULP2-6xGly-3xFlag::HIS3MX6;	NULL	4201	chip_control	NULL	MHY7863 strain	NULL
EXP060080	none	Saccharomyces cerevisiae	Genotype: MATa his3-<delta>200 leu2-3,112 lys2-801 trp1-1 ura3-52 ULP2-6xGly-3xFlag::HIS3MX6;	NULL	4201	chip_control	NULL	MHY7863 strain	NULL
EXP060081	anti-Flag (agarose beads, Sigma)	Saccharomyces cerevisiae	Genotype: MATa his3-<delta>200 leu2-3,112 lys2-801 trp1-1 ura3-52 ULP2-6xGly-3xFlag::HIS3MX6;	EXP060079	4201	normal	P40537	MHY7863 strain	NULL
EXP060082	anti-Flag (agarose beads, Sigma)	Saccharomyces cerevisiae	Genotype: MATa his3-<delta>200 leu2-3,112 lys2-801 trp1-1 ura3-52 ULP2-6xGly-3xFlag::HIS3MX6;	EXP060080	4201	normal	P40537	MHY7863 strain	NULL
EXP060083	none	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	4207	chip_control	NULL	ML1 strain	NULL
EXP060084	none	Saccharomyces cerevisiae	Genotype: wildtype;	NULL	4207	chip_control	NULL	ML1 strain	NULL
EXP060085	Anti-myc (9E10)	Saccharomyces cerevisiae	Genotype: wildtype;	EXP060083	4206	normal	Q12267	ML152 strain	NULL
EXP060086	Anti-myc (9E10)	Saccharomyces cerevisiae	Genotype: wildtype;	EXP060084	4206	normal	Q12267	ML152 strain	NULL
EXP060087	Anti-myc (9E10)	Saccharomyces cerevisiae	Genotype: SIR2 deletion;	NULL	4208	normal	Q12267	ML160 strain	NULL
EXP060088		Caenorhabditis elegans	Genotype: wildtype;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060089		Caenorhabditis elegans	Genotype: wildtype;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060090	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: nmad-1 deletion;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060091	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: wildtype;	EXP060088	2193	normal	Q8MNT9	whole worms(developmental stage L4)	NULL
EXP060092	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: wildtype;	EXP060089	2193	normal	Q23670	whole worms(developmental stage L4)	NULL
EXP060093	anti-flag antibody (F3165 Sigma)	Caenorhabditis elegans	Genotype: nmad-1 deletion;	EXP060090	2193	normal	Q23670	whole worms(developmental stage L4)	NULL
EXP060094	IgG	Caenorhabditis elegans	Genotype: wildtype;	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP060095	IgG	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) rex-14(y738) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP060096	IgG	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) yIs197(rex-32) rex-14(y738) yIs201(rex-8) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP060097	IgG	Caenorhabditis elegans	Genotype: yIs196(rex-14) yIs190(rex-47) yIs192(rex-8) I; rex-14(y738) rex-47(y671) rex-8(y737) X;	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP060098	anti-DPY-27	Caenorhabditis elegans	Genotype: wildtype;	EXP060094	3125	normal	P48996	N2 strain (mixed embryos)	NULL
EXP060099	anti-SDC-3	Caenorhabditis elegans	Genotype: wildtype;	EXP060094	3125	normal	P34706	N2 strain (mixed embryos)	NULL
EXP060100	anti-DPY-27	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) rex-14(y738) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060095	3125	normal	P48996	N2 strain (mixed embryos)	NULL
EXP060101	anti-SDC-3	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) rex-14(y738) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060095	3125	normal	P34706	N2 strain (mixed embryos)	NULL
EXP060102	anti-DPY-27	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) yIs197(rex-32) rex-14(y738) yIs201(rex-8) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060096	3125	normal	P48996	N2 strain (mixed embryos)	NULL
EXP060103	anti-SDC-3	Caenorhabditis elegans	Genotype: rex-32(y572) rex-33(y743) yIs197(rex-32) rex-14(y738) yIs201(rex-8) rex-47(y671) rex-8(y737) rex-43(y741) rex-48(y742) rex-35(y740) X;	EXP060096	3125	normal	P34706	N2 strain (mixed embryos)	NULL
EXP060104	anti-SDC-3	Caenorhabditis elegans	Genotype: yIs196(rex-14) yIs190(rex-47) yIs192(rex-8) I; rex-14(y738) rex-47(y671) rex-8(y737) X;	EXP060097	3125	normal	P34706	N2 strain (mixed embryos)	NULL
EXP060105	None	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	NULL	4209	chip_control	NULL	N2 strain whole body (first day of adulthood)	NULL
EXP060106	None	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	NULL	4209	chip_control	NULL	N2 strain whole body (first day of adulthood)	NULL
EXP060107	None	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	NULL	4209	chip_control	NULL	N2 strain whole body (first day of adulthood)	NULL
EXP060108	None	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	NULL	4209	chip_control	NULL	N2 strain whole body (first day of adulthood)	NULL
EXP060109	None	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	NULL	4209	chip_control	NULL	N2 strain whole body (first day of adulthood)	NULL
EXP060110	None	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	NULL	4209	chip_control	NULL	N2 strain whole body (first day of adulthood)	NULL
EXP060111	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	EXP060105	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	NULL
EXP060112	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	EXP060106	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	NULL
EXP060113	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: N2, Is[pvha-6::klf-1-yfp];	EXP060107	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	NULL
EXP060114	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	EXP060108	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	NULL
EXP060115	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	EXP060109	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	NULL
EXP060116	anti-GFP-TRAP (Chromotek; Cat. #gtma-20; Lot. 81025001MA)	Caenorhabditis elegans	Genotype: isp-1(qm150), ctb-1(qm189), Is[pvha-6::klf-1-yfp];	EXP060110	4209	normal	Q9TZ64	N2 strain whole body (first day of adulthood)	NULL
EXP060117	none	Drosophila melanogaster	Genotype: GFP-tagged CG7804; Developmental stage: mixed pupae;	NULL	4210	chip_control	NULL	mixed pupae embryos	NULL
EXP060118	none	Drosophila melanogaster	Genotype: GFP-tagged TBPH; Developmental stage: mixed pupae;	NULL	4210	chip_control	NULL	mixed pupae embryos	NULL
EXP060119	anti- GFP (from Kevin White's lab, University of Chicago)	Drosophila melanogaster	Genotype: GFP-tagged CG7804; Developmental stage: mixed pupae;	EXP060117	4210	normal	Q9VUN2	mixed pupae embryos	NULL
EXP060120	anti-GFP (from Kevin White's lab, University of Chicago)	Drosophila melanogaster	Genotype: GFP-tagged TBPH; Developmental stage: mixed pupae;	EXP060118	4210	normal	O97468	mixed pupae embryos	NULL
EXP060121	anti-Pc	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	P26017	Kc167 (development stage: embryonic)	NULL
EXP060122	anti-EcR	Drosophila melanogaster	Conditions: after 3 hours 20-HE;	NULL	1397	normal	P34021	Kc167 (development stage: embryonic)	NULL
EXP060123	Pc	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	P26017	Kc167 (development stage: embryonic)	NULL
EXP060124	anti-ISWI	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	Q24368	Kc167 (development stage: embryonic)	NULL
EXP060125	anti-EcR	Drosophila melanogaster	Conditions: under normal conditions;	NULL	1397	normal	P34021	Kc167 (development stage: embryonic)	NULL
EXP060126	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060127	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype;	NULL	127	normal	O88509	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060128	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A I310N;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060129	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype, SETD2 knockout; Treatment: sgSETD2;	NULL	127	normal	P63058	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060130	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype, SETD2 knockout; Treatment: sgSETD2;	NULL	127	normal	O88509	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060131	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype, NSD1/2 knockout; Treatment: sgNSD1;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060132	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype, NSD1/2 knockout; Treatment: sgNSD1/2;	NULL	127	normal	O88509	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060133	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype, sgNsd1/Nsd2/Setd2 knockouts; Treatment: sgNsd1/Nsd2/Setd2;	NULL	127	normal	O88508	C3H10T1/2 (embryonic fibroblasts)	NULL
EXP060134	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A wildtype;	NULL	252	normal	O88508	V6.5 (embryonic stem cells)	NULL
EXP060135	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: Dnmt3a knockout; Treatment: sgDnmt3a;	NULL	252	normal	O88508	V6.5 (embryonic stem cells)	NULL
EXP060136	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3A2 wildtype, Nsd1 knockout; Treatment: sgNsd1;	NULL	252	normal	O88508	V6.5 (embryonic stem cells)	NULL
EXP060137	anti-HA (ThermoFisher, #88836)	Mus musculus	Genotype: FLAG-HA tagged DNMT3B wildtype;	NULL	252	normal	O88509	V6.5 (embryonic stem cells)	NULL
EXP060138	anti-Flag	Drosophila melanogaster		NULL	4217	normal	P28159	whole organism (developmenta stage: embryo 9-16)	NULL
EXP060139	anti-Flag	Drosophila melanogaster		NULL	4217	normal	P28159	whole organism (developmenta stage: embryo 9-16)	NULL
EXP060140	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens		NULL	4219	chip_control	NULL	mice breast cancer cells from PDX mice	NULL
EXP060141	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: treated with NaCl only;	NULL	4218	chip_control	NULL	human breast cancer cells from PDX mice	NULL
EXP060142	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment:  treated with ICI;	NULL	4218	chip_control	NULL	human breast cancer cells from PDX mice	NULL
EXP060143	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with NaCl only;	NULL	4218	chip_control	NULL	human breast cancer cells from PDX mice	NULL
EXP060144	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with ICI;	NULL	4218	chip_control	NULL	human breast cancer cells from PDX mice	NULL
EXP060145	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with NaCl only;	EXP060141	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060146	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with ICI;	EXP060142	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060147	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens		EXP060140	4219	normal	P55317	mice breast cancer cells from PDX mice	NULL
EXP060148	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with ICI;	EXP060144	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060149	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with NaCl only;	EXP060143	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060150	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin and ICI;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060151	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin, herceptin and ICI;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060152	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin and ICI;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060153	anti-FoxA1 (rabbit ab23738 (lot GR292351-2))	Homo sapiens	Treatment: Mice treated with heregulin;	NULL	4218	normal	P55317	human breast cancer cells from PDX mice	NULL
EXP060154	IgG	Homo sapiens	Conditions: high glucose;	NULL	4220	chip_control	NULL	HCCLM3 (hepatocellular carcinoma)	NULL
EXP060155	IgG	Homo sapiens	Conditions: low glucose;	NULL	4220	chip_control	NULL	HCCLM3 (hepatocellular carcinoma)	NULL
EXP060156	anti-HNF4A	Homo sapiens	Conditions: high glucose;	EXP060154	4220	normal	P41235	HCCLM3 (hepatocellular carcinoma)	NULL
EXP060157	anti-HNF4A	Homo sapiens	Conditions: low glucose;	EXP060155	4220	normal	P41235	HCCLM3 (hepatocellular carcinoma)	NULL
EXP060158	none	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060159	none	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060160	none	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060161	none	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060162	none	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060163	none	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060164	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060158	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060165	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060159	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060166	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060158	520	normal	O60885	Kelly (neuroblastoma)	NULL
EXP060167	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060159	520	normal	O60885	Kelly (neuroblastoma)	NULL
EXP060168	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060158	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060169	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: TAE sensitive;	EXP060159	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060170	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060160	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060171	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060161	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060172	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060160	520	normal	O60885	Kelly (neuroblastoma)	NULL
EXP060173	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060161	520	normal	O60885	Kelly (neuroblastoma)	NULL
EXP060174	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060160	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060175	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:1uM TAE684 for 48 hrs; Genotype: TAE resistant;	EXP060161	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060176	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060162	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060177	anti-BORIS ( #39851, Active Motif)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060163	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060178	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060162	520	normal	O60885	Kelly (neuroblastoma)	NULL
EXP060179	anti-BRD4 (A301-985A, Bethyl Laboratories)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060163	520	normal	O60885	Kelly (neuroblastoma)	NULL
EXP060180	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060162	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060181	anti-CTCF (#07-729, Millipore)	Homo sapiens	Treatment:2.5 uM JQ1 for 48 hrs; Genotype: TAE resistant;	EXP060163	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060182	none	Mus musculus	Strain: 129s2; Genotype: wildtype;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP060183	none	Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060184	anti-SIRT7 (Cell Signalling, 5360, Lot 1)	Mus musculus	Strain: 129s2; Genotype: wildtype;	EXP060182	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	NULL
EXP060185	anti-SIRT7 (Cell Signalling, 5360, Lot 1)	Homo sapiens		EXP060183	514	normal	Q9NRC8	K562 (myelogenous leukemia)	NULL
EXP060186	none	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	NULL	4222	chip_control	NULL	colonic stem cells	NULL
EXP060187	none	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	NULL	4222	chip_control	NULL	colonic stem cells	NULL
EXP060188	none	Homo sapiens	EtOH	NULL	4222	chip_control	NULL	colonic stem cells	NULL
EXP060189	none	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	NULL	4222	chip_control	NULL	colonic stem cells	NULL
EXP060190	none	Homo sapiens	Treatment: calcitriol + EtOh (pooled);	NULL	4222	chip_control	NULL	colonic stem cells	NULL
EXP060191	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	EXP060186	4222	normal	P11473	colonic stem cells	NULL
EXP060192	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	EXP060187	4222	normal	P11473	colonic stem cells	NULL
EXP060193	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	EXP060188	4222	normal	P11473	colonic stem cells	NULL
EXP060194	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	EXP060189	4222	normal	P11473	colonic stem cells	NULL
EXP060195	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: EtOH for 2 hrs; Cell type: colonic organoids;	EXP060190	4222	normal	P11473	colonic stem cells	NULL
EXP060196	anti- VDR antibody (rabbit-monoclonal, Cell Signalling, custom made 2 mg/mL, MA, USA)	Homo sapiens	Treatment: 10uM 1,25(OH)2D3 (calcitriol) of 2 hrs; Cell type: colonic organoids;	EXP060190	4222	normal	P11473	colonic stem cells	NULL
EXP060197	anti-igG (Ab172730, Abcam)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP060198	anti-igG (Ab172730, Abcam)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	NULL	1143	chip_control	NULL	iPSC (induced pluripotent stem cells)	NULL
EXP060199	anti-GATA2 (H-116: sc-9008, Santa Cruz)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	EXP060197	1143	normal	P23769	iPSC (induced pluripotent stem cells)	NULL
EXP060200	anti-GATA2 (H-116: sc-9008, Santa Cruz)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	EXP060198	1143	normal	P23769	iPSC (induced pluripotent stem cells)	NULL
EXP060201	anti-GATA2 (H-116: sc-9008, Santa Cruz)	Homo sapiens	Treatment: 1 ug/ml Doxycycline;	NULL	4223	normal	P23769	embryoid bodies	NULL
EXP060202	none	Homo sapiens		NULL	3035	chip_control	NULL	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060203	anti-IKZF3 (ab139408, Abcam)	Homo sapiens		EXP060202	3035	normal	Q9UKT9	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060204	anti-IKAROS (ab26083, Abcam)	Homo sapiens		EXP060202	3035	normal	Q13422	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060205	anti-MTA2 (ab8106, Abcam)	Homo sapiens		EXP060202	3035	normal	O94776	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060206	anti-Mi2 (ab72418, Abcam)	Homo sapiens		EXP060202	3035	normal	Q14839	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060207	anti-Bob1 (sc-955, Santa Cruz)	Homo sapiens		EXP060202	3035	normal	Q16633	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060208	anti-OCT2 (sc233, Santa Cruz)	Homo sapiens		EXP060202	3035	normal	P09086	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060209	anti-HDAC2 (Abcam, ab7029)	Homo sapiens		EXP060202	3035	normal	Q92769	697 (B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1))	NULL
EXP060210	None	Homo sapiens	Time point: 0-1 day; Treatment: 2C method; Tissue: Foreskin;	NULL	4224	chip_control	NULL	iPS-derived cells during chondrocyte differentiation	NULL
EXP060211	None	Homo sapiens	Time point: 2 days; Treatment: 2C method; Tissue: Foreskin;	NULL	4225	chip_control	NULL	iPS-derived chondrocytes	NULL
EXP060212	None	Homo sapiens	Time point: 3 day; Treatment: 2C method; Tissue: Foreskin;	NULL	4225	chip_control	NULL	iPS-derived chondrocytes	NULL
EXP060213	None	Homo sapiens	Time point: 4 day; Treatment: 2C method; Tissue: Foreskin;	NULL	4225	chip_control	NULL	iPS-derived chondrocytes	NULL
EXP060214	None	Homo sapiens	Time point: 5 day; Treatment: 2C method; Tissue: Foreskin;	NULL	4225	chip_control	NULL	iPS-derived chondrocytes	NULL
EXP060215	None	Homo sapiens	Time point: 7 day; Treatment: 2C method; Tissue: Foreskin;	NULL	4225	chip_control	NULL	iPS-derived chondrocytes	NULL
EXP060216	None	Homo sapiens	Time point: 9 day; Treatment: 2C method; Tissue: Foreskin;	NULL	4225	chip_control	NULL	iPS-derived chondrocytes	NULL
EXP060217	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 0-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060210	4224	normal	P10276	iPS-derived cells during chondrocyte differentiation	NULL
EXP060218	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 0-2 days; Treatment: 2C method; Tissue: Foreskin;	EXP060210	4224	normal	P10276	iPS-derived cells during chondrocyte differentiation	NULL
EXP060219	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 2-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060211	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060220	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 2-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060211	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060221	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 3-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060212	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060222	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 3-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060212	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060223	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 4-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060213	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060224	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 4-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060213	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060225	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 5-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060214	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060226	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 5-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060214	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060227	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 7-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060215	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060228	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 7-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060215	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060229	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 9-1 day; Treatment: 2C method; Tissue: Foreskin;	EXP060216	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060230	anti-RAR-alfa antibody (Mouse anti-human , Perseus Proteomics, PP-H1920-00)	Homo sapiens	Time point: 9-2 day; Treatment: 2C method; Tissue: Foreskin;	EXP060216	4225	normal	P10276	iPS-derived chondrocytes	NULL
EXP060231	anti-ETS1 (501A, Bethyl Labs)	Homo sapiens		NULL	4226	normal	P14921	SCC25 (Tongue squamous cell carcinoma)	NULL
EXP060232	anti-ETS1(C20, Santa Cruz)	Homo sapiens		NULL	4226	normal	P14921	SCC25 (Tongue squamous cell carcinoma)	NULL
EXP060233	anti-IgG (scbt-816X)	Homo sapiens	Treatment: DMSO for 4 hrs;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060234	no antibody	Homo sapiens	Treatment: DMSO for 4 hrs;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060235	anti-IgG (scbt-816X)	Homo sapiens	Treatment: DMSO for 4 hrs;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060236	anti-MYC (AF3696, R&D systems)	Homo sapiens	Treatment: DMSO for 4 hrs;	EXP060234	70	normal	P01106	LNCaP (prostate carcinoma)	NULL
EXP060237	normal rabbit IgG (sc-2027, Santa Cruz)	Homo sapiens		NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP060238	none	Homo sapiens		NULL	120	chip_control	NULL	BT-549 (breast invasive ductal carcinoma)	NULL
EXP060239	anti-Fra-1 (R-20,sc-605, Santa Cruz)	Homo sapiens		EXP060238	120	normal	P15407	BT-549 (breast invasive ductal carcinoma)	NULL
EXP060240	anti-DDX5 (ab21696, Abcam)	Homo sapiens		EXP060238	120	normal	P17844	BT-549 (breast invasive ductal carcinoma)	NULL
EXP060241	Input	Homo sapiens	Genotype: wildtype;	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP060242	Input	Homo sapiens	Genotype: wildtype;	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP060243	Input	Homo sapiens	Genotype: PWWP domain knockout;	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP060244	Input	Homo sapiens	Genotype: PWWP domain knockout;	NULL	376	chip_control	NULL	WA01 (H1, human embryonic stem cells)	NULL
EXP060245	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: wildtype;	EXP060241	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	NULL
EXP060246	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: wildtype;	EXP060242	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	NULL
EXP060247	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: PWWP domain knockout;	EXP060243	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	NULL
EXP060248	anti-human (DNMT3B rabbit monoclonal antibody (Clone D3C8T, Cell Signaling Technologies, custom-made antibody))	Homo sapiens	Genotype: PWWP domain knockout;	EXP060244	376	normal	Q9UBC3	WA01 (H1, human embryonic stem cells)	NULL
EXP060249	input	Homo sapiens	Genotype: normal;	NULL	4231	chip_control	NULL	breast organoids from normal woman	NULL
EXP060250	input	Homo sapiens	Genotype: BRCA1 mutation;	NULL	4231	chip_control	NULL	breast organoids from normal woman	NULL
EXP060251	input	Homo sapiens	Genotype: BRCA2 mutation;	NULL	4231	chip_control	NULL	breast organoids from normal woman	NULL
EXP060252	input	Homo sapiens	Genotype: BRCA2 mutation;	NULL	4231	chip_control	NULL	breast organoids from normal woman	NULL
EXP060253	input	Homo sapiens	Genotype: normal;	NULL	4231	chip_control	NULL	breast organoids from normal woman	NULL
EXP060254	input	Homo sapiens	Genotype: normal;	NULL	4231	chip_control	NULL	breast organoids from normal woman	NULL
EXP060255	anti-p63	Homo sapiens		NULL	4232	normal	Q9H3D4	MCF10DCIS cells	NULL
EXP060256	anti-TCF7	Homo sapiens	Genotype: BRCA1 mutation;	EXP060249	4231	normal	P36402	breast organoids from normal woman	NULL
EXP060257	anti-TCF7	Homo sapiens	Genotype: BRCA1 mutation;	EXP060250	4231	normal	P36402	breast organoids from normal woman	NULL
EXP060258	anti-TCF7	Homo sapiens	Genotype: BRCA2 mutation;	EXP060251	4231	normal	P36402	breast organoids from normal woman	NULL
EXP060259	anti-TCF7	Homo sapiens	Genotype: BRCA2 mutation;	EXP060252	4231	normal	P36402	breast organoids from normal woman	NULL
EXP060260	anti-TCF7	Homo sapiens	Genotype: normal;	EXP060253	4231	normal	P36402	breast organoids from normal woman	NULL
EXP060261	anti-TCF7	Homo sapiens	Genotype: BRCA1 mutation;	EXP060254	4231	normal	P36402	breast organoids from normal woman	NULL
EXP060262	anti-p63	Homo sapiens		NULL	4231	normal	Q9H3D4	breast organoids from normal woman	NULL
EXP060263	anti-p63	Homo sapiens	Genotype: BRCA1-mut;	NULL	4231	normal	Q9H3D4	breast organoids from normal woman	NULL
EXP060264	anti-p63	Homo sapiens	Genotype: BRCA2-mut;	NULL	4231	normal	Q9H3D4	breast organoids from normal woman	NULL
EXP060265	none	Homo sapiens	Treatment: DMSO for 16 hrs;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060266	anti-AR (Abcam, ab74272)	Homo sapiens	Treatment: DMSO for 16 hrs;	EXP060265	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP060267	anti-AR (Abcam, ab74272)	Homo sapiens	Treatment: 10 uM UPF-1069 for 16 hrs;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP060268	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: DMSO for 16 hrs;	EXP060265	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP060269	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: 10 uM UPF-1069 for 16 hrs;	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP060270	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060271	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060272	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060273	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060274	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060275	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060276	none	Homo sapiens	Genotype: wildtype;	NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060277	anti-ETO (Diagenode, C15310197)	Homo sapiens	Genotype: wildtype;	EXP060270	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060278	anti-TAF1 (Santa Cruz, sc-735)	Homo sapiens	Genotype: wildtype;	EXP060272	516	normal	P21675	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060279	anti-TAF1 (Santa Cruz, sc-735)	Homo sapiens	Genotype: wildtype;	EXP060273	516	normal	P21675	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060280	anti-TAF1 (Santa Cruz, sc-735)	Homo sapiens	Genotype: wildtype;	EXP060274	516	normal	P21675	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060281	anti-ETO (Diagenode, C15310197)	Homo sapiens	Genotype: wildtype;	EXP060275	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060282	anti-P300 (Diagenode, C15200211)	Homo sapiens	Genotype: wildtype;	EXP060271	516	normal	Q09472	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060283	anti-P300 (Santa Cruz sc-585)	Homo sapiens	Genotype: wildtype;	EXP060276	516	normal	Q09472	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060284	anti-ETO (polyclonal antibody (Diagenode, C15310197))	Homo sapiens	Genotype: shControl-AE;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060285	anti-ETO (polyclonal antibody (Diagenode, C15310197))	Homo sapiens	Genotype: shTAF1-AE;	NULL	516	normal	Q06455	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060286	INPUT	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060287	INPUT	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060288	BORIS	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout; Condi	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060289	BORIS	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060290	INPUT	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060291	INPUT	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060292	INPUT	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060293	INPUT	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060294	anti-BORIS	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060286	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060295	anti-BORIS	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060287	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060296	anti-CTCF	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060286	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060297	anti-CTCF	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060287	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060298	anti-SMC1	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060286	520	normal	Q14683	Kelly (neuroblastoma)	NULL
EXP060299	anti-SMC1	Homo sapiens	Treatment: shBORIS; Genotype: BORIS knockout;	EXP060287	520	normal	Q14683	Kelly (neuroblastoma)	NULL
EXP060300	anti-BORIS	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060290	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060301	anti-BORIS	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060291	520	normal	Q8NI51	Kelly (neuroblastoma)	NULL
EXP060302	anti-CTCF	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060290	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060303	anti-CTCF	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060291	520	normal	P49711	Kelly (neuroblastoma)	NULL
EXP060304	anti-SMC1	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060290	520	normal	Q14683	Kelly (neuroblastoma)	NULL
EXP060305	anti-SMC1	Homo sapiens	Treatment: shLUC; Genotype: shLUC;	EXP060291	520	normal	Q14683	Kelly (neuroblastoma)	NULL
EXP060306	input	Homo sapiens	Treatment: DMSO for 48 hrs; Conditions: tae response sensitive;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060307	input	Homo sapiens	Treatment: 1 uM TAE684 for 48 hrs; Conditions: tae response resistant;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060308	input	Homo sapiens	Treatment: 1 uM TAE684 for 48 hrs; Conditions: tae response resistant;	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP060309	anti-MYCN	Homo sapiens	Treatment: 1 uM TAE684 for 48 hrs; Conditions: tae response resistant;	EXP060307	520	normal	P04198	Kelly (neuroblastoma)	NULL
EXP060310	anti-MYCN	Homo sapiens	Treatment: 1 uM TAE684 for 48 hrs; Conditions: tae response resistant;	EXP060308	520	normal	P04198	Kelly (neuroblastoma)	NULL
EXP060311	anti-MYCN	Homo sapiens	Treatment: DMSO for 48 hrs; Conditions: tae response sensitive;	EXP060306	520	normal	P04198	Kelly (neuroblastoma)	NULL
EXP060312	input	Homo sapiens		NULL	2324	chip_control	NULL	TC32 (Ewing's sarcoma)	NULL
EXP060313	input	Homo sapiens		NULL	2324	chip_control	NULL	TC32 (Ewing's sarcoma)	NULL
EXP060314	input	Homo sapiens	Conditions: post-chemotherapy;	NULL	4233	chip_control	NULL	TC-71(Ewing sarcoma cells)	NULL
EXP060315	input	Homo sapiens	Conditions: post-chemotherapy;	NULL	4233	chip_control	NULL	TC-71(Ewing sarcoma cells)	NULL
EXP060316	anti-BORIS	Homo sapiens		EXP060312	2324	normal	Q8NI51	TC32 (Ewing's sarcoma)	NULL
EXP060317	anti-BORIS	Homo sapiens		EXP060313	2324	normal	Q8NI51	TC32 (Ewing's sarcoma)	NULL
EXP060318	anti-SMC1	Homo sapiens		EXP060312	2324	normal	Q14683	TC32 (Ewing's sarcoma)	NULL
EXP060319	anti-SMC1	Homo sapiens		EXP060313	2324	normal	Q14683	TC32 (Ewing's sarcoma)	NULL
EXP060320	anti-BORIS	Homo sapiens	Conditions: post-chemotherapy;	EXP060314	4233	normal	Q8NI51	TC-71(Ewing sarcoma cells)	NULL
EXP060321	anti-BORIS	Homo sapiens	Conditions: post-chemotherapy;	EXP060315	4233	normal	Q8NI51	TC-71(Ewing sarcoma cells)	NULL
EXP060322	anti-SMC1	Homo sapiens	Conditions: post-chemotherapy;	EXP060314	4233	normal	Q14683	TC-71(Ewing sarcoma cells)	NULL
EXP060323	anti-SMC1	Homo sapiens	Conditions: post-chemotherapy;	EXP060315	4233	normal	Q14683	TC-71(Ewing sarcoma cells)	NULL
EXP060324	none	Mus musculus	Treatment: none;	NULL	4234	chip_control	NULL	KPL1 (Invasive ductal carcinoma)	NULL
EXP060325	none	Mus musculus	Treatment: 10 nM 4-OHT for 72 hrs;	NULL	4234	chip_control	NULL	KPL1 (Invasive ductal carcinoma)	NULL
EXP060326	none	Homo sapiens	Treatment: none;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP060327	none	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP060328	anti-LIN9 (Bethyl A300-BL3981)	Mus musculus	Treatment: none;	EXP060324	4234	normal	Q8C735	KPL1 (Invasive ductal carcinoma)	NULL
EXP060329	anti-LIN9 (Bethyl A300-BL3981)	Mus musculus	Treatment: 10 nM 4-OHT for 72 hrs;	EXP060325	4234	normal	Q8C735	KPL1 (Invasive ductal carcinoma)	NULL
EXP060330	anti-YAP (Novus NB110-58358)	Mus musculus	Treatment: none;	EXP060324	4234	normal	P46938	KPL1 (Invasive ductal carcinoma)	NULL
EXP060331	anti-YAP (Novus NB110-58358)	Mus musculus	Treatment: 10 nM 4-OHT for 72 hrs;	EXP060325	4234	normal	P46938	KPL1 (Invasive ductal carcinoma)	NULL
EXP060332	anti-LIN9 (Bethyl A300-BL3981)	Homo sapiens	Treatment: none;	EXP060326	583	normal	Q5TKA1	MCF10A (breast epithelial cells)	NULL
EXP060333	anti-LIN9 (Bethyl A300-BL3981)	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	EXP060327	583	normal	Q5TKA1	MCF10A (breast epithelial cells)	NULL
EXP060334	anti-YAP (Novus NB110-58358)	Homo sapiens	Treatment: none;	EXP060326	583	normal	P46937	MCF10A (breast epithelial cells)	NULL
EXP060335	anti-YAP (Novus NB110-58358)	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	NULL	583	normal	P46937	MCF10A (breast epithelial cells)	NULL
EXP060336	anti-B-MYB (Santa Cruz sc-724)	Homo sapiens	Treatment: none;	EXP060326	583	normal	P10244	MCF10A (breast epithelial cells)	NULL
EXP060337	anti-B-MYB (Santa Cruz sc-724)	Homo sapiens	Treatment: 0.5 ug/ml doxycycline for 12 hrs;	EXP060327	583	normal	P10244	MCF10A (breast epithelial cells)	NULL
EXP060338	none	Homo sapiens	Treament: N/A;	NULL	4235	chip_control	NULL	T cells from peripheral blood	NULL
EXP060339	none	Homo sapiens	Treament: N/A;	NULL	4236	chip_control	NULL	T-ALL cells from peripheral blood	NULL
EXP060340	none	Homo sapiens	Treament: N/A;	NULL	4236	chip_control	NULL	T-ALL cells from peripheral blood	NULL
EXP060341	none	Homo sapiens	Treament: DMSO treatment;	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP060342	none	Homo sapiens	Treament: DMSO treatment;	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP060343	none	Homo sapiens	Treament: 1 uM gSI treatment for 72 hrs;	NULL	199	chip_control	NULL	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP060344	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: N/A;	EXP060338	4235	normal	P49711	T cells from peripheral blood	NULL
EXP060345	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: N/A;	EXP060339	4236	normal	P49711	T-ALL cells from peripheral blood	NULL
EXP060346	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: N/A;	EXP060340	4236	normal	P49711	T-ALL cells from peripheral blood	NULL
EXP060347	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: DMSO treatment;	EXP060341	509	normal	P49711	Jurkat (T-cells)	NULL
EXP060348	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: DMSO treatment;	EXP060342	199	normal	P49711	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP060349	anti-CTCF (D31H2; Catalog no: 3418)	Homo sapiens	Treament: 1 uM gSI treatment for 72 hrs;	EXP060343	199	normal	P49711	CUTLL1 (T-cell lymphoblastic lymphoma 1)	NULL
EXP060350	anti-HDAC2  (Abcam cat7029 lotGR88809-14 pAb)	Homo sapiens	Treatment: untreated;	NULL	980	normal	Q92769	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060351	anti-Sox8 (Abcam, ab104245, rabbit pAb)	Homo sapiens	Treatment: untreated;	NULL	980	normal	P57073	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060352	anti-HDAC2  (Abcam cat7029 lotGR88809-14 pAb)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	Q92769	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060353	anti-HDAC2  (Abcam cat7029 lotGR88809-14 pAb)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	Q92769	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060354	Anti-HDAC1( Abcam, ab7028)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	Q13547	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060355	anti-YY-1 antibody (ab109237)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P25490	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060356	anti-YY-1 antibody (ab109237)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P25490	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060357	anti-HDAC3 (Abcam, ab7030)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	O15379	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060358	anti-HDAC3 (Abcam, ab7030)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	O15379	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060359	MYOD SantaCruz (M-318) sc-760	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P15172	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060360	MYOD SantaCruz (M-318) sc-760	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P15172	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060361	anti-SOX8 (Abcam, ab104245)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P57073	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060362	anti-SOX8 (Abcam, ab104245)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P57073	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060363	anti-MYOG (Thermo, cat # MA1-41042)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	P15173	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060364	anti-MYOG (Thermo, cat # MA1-41042)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	P15173	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060365	anti-Rad21 (Santa Cruz, ChIP Grade ab992)	Homo sapiens	Treatment: DMSO, 6 hours;	NULL	980	normal	O60216	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060366	anti-Rad21 (Santa Cruz, ChIP Grade ab992)	Homo sapiens	Treatment: Entinostat, 1 uM for 6 hours;	NULL	980	normal	O60216	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP060367	anti-ARID4B antibody (CAT#: A302-233A, LOT#: A302-233A-1,Bethyl Laboratories)	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP060368	anti-ARID4B antibody (CAT#: A302-233A, LOT#: A302-233A-1,Bethyl Laboratories)	Homo sapiens		EXP060367	725	normal	Q4LE39	PC3(bone mets prostate adenocarcinoma)	NULL
EXP060369	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP060370	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP060371	anti-CTCF	Homo sapiens	Time point: day 2; Genotype: expressing a H2B-GFP fusion protein;	NULL	4237	chip_control	NULL	WA09 derived mesoderm	NULL
EXP060372	anti-CTCF	Homo sapiens	Time point: day 5; Genotype: expressing a H2B-GFP fusion protein;	NULL	4238	chip_control	NULL	WA09 derived cardiac mesoderm	NULL
EXP060373	anti-CTCF	Homo sapiens	Time point: day 5; Genotype: expressing a H2B-GFP fusion protein;	NULL	4238	chip_control	NULL	WA09 derived cardiac mesoderm	NULL
EXP060374	anti-CTCF	Homo sapiens	Time point: day 7; Genotype: expressing a H2B-GFP fusion protein;	NULL	4239	chip_control	NULL	WA09 derived cardiac progenitor cells	NULL
EXP060375	anti-CTCF	Homo sapiens	Time point: day 7; Genotype: expressing a H2B-GFP fusion protein;	NULL	4239	chip_control	NULL	WA09 derived cardiac progenitor cells	NULL
EXP060376	anti-CTCF	Homo sapiens	Time point: day 15; Genotype: expressing a H2B-GFP fusion protein;	NULL	4240	chip_control	NULL	WA09 derived primitive cardiomyocite	NULL
EXP060377	anti-CTCF	Homo sapiens	Time point: day 15; Genotype: expressing a H2B-GFP fusion protein;	NULL	4240	chip_control	NULL	WA09 derived primitive cardiomyocite	NULL
EXP060378	anti-CTCF	Homo sapiens	Time point: day 80; Genotype: expressing a H2B-GFP fusion protein;	NULL	4241	chip_control	NULL	WA09 derived ventricular cardiomyocyte	NULL
EXP060379	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP060380	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	EXP060369	396	normal	P49711	WA09 (embryonic stem cells)	NULL
EXP060381	anti-CTCF	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	EXP060370	396	normal	P49711	WA09 (embryonic stem cells)	NULL
EXP060382	anti-CTCF	Homo sapiens	Time point: day 5; Genotype: expressing a H2B-GFP fusion protein;	EXP060372	4238	normal	P49711	WA09 derived cardiac mesoderm	NULL
EXP060383	anti-CTCF	Homo sapiens	Time point: day 5; Genotype: expressing a H2B-GFP fusion protein;	EXP060373	4238	normal	P49711	WA09 derived cardiac mesoderm	NULL
EXP060384	anti-CTCF	Homo sapiens	Time point: day 7; Genotype: expressing a H2B-GFP fusion protein;	EXP060374	4239	normal	P49711	WA09 derived cardiac progenitor cells	NULL
EXP060385	anti-CTCF	Homo sapiens	Time point: day 7; Genotype: expressing a H2B-GFP fusion protein;	EXP060375	4239	normal	P49711	WA09 derived cardiac progenitor cells	NULL
EXP060386	anti-CTCF	Homo sapiens	Time point: day 15; Genotype: expressing a H2B-GFP fusion protein;	EXP060376	4240	normal	P49711	WA09 derived primitive cardiomyocite	NULL
EXP060387	anti-CTCF	Homo sapiens	Time point: day 15; Genotype: expressing a H2B-GFP fusion protein;	EXP060377	4240	normal	P49711	WA09 derived primitive cardiomyocite	NULL
EXP060388	anti-CTCF	Homo sapiens	Time point: day 80; Genotype: expressing a H2B-GFP fusion protein;	EXP060378	4241	normal	P49711	WA09 derived ventricular cardiomyocyte	NULL
EXP060389	anti-SMC3	Homo sapiens	Time point: day 0; Genotype: expressing a H2B-GFP fusion protein;	EXP060379	396	normal	Q9UQE7	WA09 (embryonic stem cells)	NULL
EXP060390	anti-CTCF	Homo sapiens	Time point: day 2; Genotype: expressing a H2B-GFP fusion protein;	EXP060371	4237	normal	P49711	WA09 derived mesoderm	NULL
EXP060391	no antibody	Homo sapiens	Treatment: DMSO 48hrs;	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060392	no antibody	Homo sapiens	Treatment: DMSO 48h rDNA;	NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060393	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: DMSO 48hrs;	EXP060391	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060394	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060395	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060396	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060397	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: DMSO 48hrs;	EXP060391	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060398	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060399	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060400	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060401	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: NTsiRNA 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060402	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2AsiRNA 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060403	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2BsiRNA 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060404	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: control siRNA and 100nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060405	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2AsiRNA and 100nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060406	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2BsiRNA and 100nM JQ1 for 48hrs;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060407	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: DMSO 48hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	NULL
EXP060408	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	NULL
EXP060409	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	NULL
EXP060410	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	817	normal	P25440	SUM159PT (Triple negative breast cancer)	NULL
EXP060411	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: control siRNA 48 hrs; 	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	NULL
EXP060412	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2B siRNA 48hrs;	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	NULL
EXP060413	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treament: control siRNA and 500nM JQ1 48hrs;	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	NULL
EXP060414	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: BAZ2B and 500nM JQ1 48hrs;	NULL	3115	normal	P25440	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	NULL
EXP060415	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: DMSO 48hrs rDNA;	EXP060392	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060416	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs rDNA;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060417	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs rDNA;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060418	anti-BRD2 (Bethyl Laboratories A302-583A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs rDNA;	NULL	2301	normal	P25440	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060419	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: DMSO 48hrs rDNA;	EXP060392	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060420	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs rDNA;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060421	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs rDNA;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060422	anti-BRD4 (Bethyl Laboratories A301-985A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs rDNA;	NULL	2301	normal	O60885	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060423	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: DMSO 48hrs;	EXP060391	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060424	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: 10 uM GSK2801 48 hrs;	NULL	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060425	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: 100 nM JQ1 for 48hrs;	NULL	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060426	anti-BRD9 (Bethyl Laboratories A303-781A)	Homo sapiens	Treatment: 100 nM JQ1 and 10 uM GSK2801 for 48hrs;	NULL	2301	normal	Q9H8M2	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP060427	NA	Mus musculus	Genotype: wildtype; Time point: 0 days;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP060428	NA	Mus musculus	Genotype: wildtype; Time point: 5 days;	NULL	4242	chip_control	NULL	E14Tga2 derived embryoid bodies	NULL
EXP060429	NA	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP060430	NA	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	2615	chip_control	NULL	293T-Rex	NULL
EXP060431	NA	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	467	chip_control	NULL	myoblasts	NULL
EXP060432	NA	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	918	chip_control	NULL	myotube	NULL
EXP060433	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060427	233	normal	Q99JF8	E14TG2A (embryonic stem cells)	NULL
EXP060434	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: wildtype; Time point: 5 days;	EXP060428	4242	normal	Q99JF8	E14Tga2 derived embryoid bodies	NULL
EXP060435	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060427	233	normal	Q3UMU9	E14TG2A (embryonic stem cells)	NULL
EXP060436	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: wildtype; Time point: 5 days;	EXP060428	4242	normal	Q3UMU9	E14Tga2 derived embryoid bodies	NULL
EXP060437	anti-SPT16(Cell Signaling, #12191)	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060427	233	normal	Q920B9	E14TG2A (embryonic stem cells)	NULL
EXP060438	SPT16, Cell Signaling, #12191	Mus musculus	Genotype: wildtype; Time point: 0 days;	EXP060428	4242	normal	Q920B9	E14Tga2 derived embryoid bodies	NULL
EXP060439	anti-FLAG (Sigma, #A2220)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	2615	normal	O75475	293T-Rex	NULL
EXP060440	anti-FLAG (Sigma, #A2220)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	2615	normal	Q7Z4V5	293T-Rex	NULL
EXP060441	anti-SPT16 (Cell Signaling, #12191)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	EXP060429	2615	normal	Q9Y5B9	293T-Rex	NULL
EXP060442	anti-HDGF2 (Proteintech, #15134-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	EXP060431	467	normal	Q7Z4V5	myoblasts	NULL
EXP060443	anti-HDGF2 (Proteintech, #15134-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	EXP060432	918	normal	Q7Z4V5	myotube	NULL
EXP060444	anti-LEDGF (Proteintech, #25504-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	467	normal	O75475	myoblasts	NULL
EXP060445	anti-LEDGF (Proteintech, #25504-1-AP)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	918	normal	O75475	myotube	NULL
EXP060446	anti-SPT16 (Cell Signaling, #12191)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	467	normal	Q9Y5B9	myoblasts	NULL
EXP060447	anti-SPT16 (Cell Signaling, #12191)	Homo sapiens	Genotype: wildtype; Time point: 0 days;	NULL	918	normal	Q9Y5B9	myotube	NULL
EXP060448	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	NULL	233	normal	Q3UMU9	E14TG2A (embryonic stem cells)	NULL
EXP060449	anti-HDGF2 (Proteintech, #15134-1-AP)	Mus musculus	Genotype: HDGF2 knockout; Time point: 0 days;	NULL	233	normal	Q3UMU9	E14TG2A (embryonic stem cells)	NULL
EXP060450	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: wildtype; Time point: 0 days;	NULL	233	normal	Q99JF8	E14TG2A (embryonic stem cells)	NULL
EXP060451	anti-LEDGF (Proteintech, #25504-1-AP)	Mus musculus	Genotype: LEDGF knockout; Time point: 0 days;	NULL	233	normal	Q99JF8	E14TG2A (embryonic stem cells)	NULL
EXP060452	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP-N-Myc;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060453	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP-N-Myc;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060454	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP-N-Myc;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060455	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP-N-Myc;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060456	none	Homo sapiens	Treatment: DHT; Genotype: wildtype;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060457	none	Homo sapiens	Treatment: EtOH; Genotype: wildtype;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060458	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: castrated;  Genotype: 22Rv1-xeno N-Myc;	NULL	4243	chip_control	NULL	22Rv1 xenografts	NULL
EXP060459	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: castrated;  Genotype: 22Rv1-xeno N-Myc;	NULL	4243	chip_control	NULL	22Rv1 xenografts	NULL
EXP060460	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: Intact;  Genotype: 22Rv1-xeno N-Myc;	NULL	4243	chip_control	NULL	22Rv1 xenografts	NULL
EXP060461	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: Intact;  Genotype: 22Rv1-xeno N-Myc;	NULL	4243	chip_control	NULL	22Rv1 xenografts	NULL
EXP060462	none	Homo sapiens		NULL	4244	chip_control	NULL	PM154 organoids	NULL
EXP060463	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP-N-Myc;	EXP060452	70	normal	P04198	LNCaP (prostate carcinoma)	NULL
EXP060464	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP-N-Myc;	EXP060453	70	normal	P04198	LNCaP (prostate carcinoma)	NULL
EXP060465	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP-N-Myc;	EXP060454	70	normal	P04198	LNCaP (prostate carcinoma)	NULL
EXP060466	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP-N-Myc;	EXP060455	70	normal	P04198	LNCaP (prostate carcinoma)	NULL
EXP060467	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: wildtype;	EXP060456	70	normal	P04198	LNCaP (prostate carcinoma)	NULL
EXP060468	MYCN (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: wildtype;	EXP060457	70	normal	P04198	LNCaP (prostate carcinoma)	NULL
EXP060469	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: castrated;  Genotype: 22Rv1-xeno N-Myc;	EXP060458	4243	normal	P04198	22Rv1 xenografts	NULL
EXP060470	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: castrated;  Genotype: 22Rv1-xeno N-Myc;	EXP060459	4243	normal	P04198	22Rv1 xenografts	NULL
EXP060471	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: Intact;  Genotype: 22Rv1-xeno N-Myc;	EXP060460	4243	normal	P04198	22Rv1 xenografts	NULL
EXP060472	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens	Conditions: Intact;  Genotype: 22Rv1-xeno N-Myc;	EXP060461	4243	normal	P04198	22Rv1 xenografts	NULL
EXP060473	anti-MYCN (Santa Cruz, sc-53993)	Homo sapiens		EXP060462	4244	normal	P04198	PM154 organoids	NULL
EXP060474	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP NMYC;	EXP060452	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP060475	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP NMYC;	EXP060454	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP060476	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: DHT; Genotype: LNCaP wildtype;	EXP060456	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP060477	anti-HOXB13 (Santa Cruz, sc-53993)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP wildtype;	EXP060457	70	normal	Q92826	LNCaP (prostate carcinoma)	NULL
EXP060478	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: DHT; Genotype: LNCaP NMYC;	EXP060452	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP060479	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: EtOH; Genotype: LNCaP NMYC;	EXP060454	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP060480		Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060481		Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060482	anti-AR	Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP060483	anti-CHD1	Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	normal	O14646	LNCaP (prostate carcinoma)	NULL
EXP060484	anti-cMyc	Homo sapiens	Treatment: 10nM DHT 3 hours;	NULL	70	normal	Q16158	LNCaP (prostate carcinoma)	NULL
EXP060485	anti-AR	Homo sapiens	Treatment: 10nM DHT 3 hours, sgCHD1; Genotype: CHD1 knockout;	EXP060481	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP060486	anti-AR	Homo sapiens	Treatment: 10nM DHT 3 hours, sgControl; Genotype: sgControl;	EXP060480	70	bio_control	P10275	LNCaP (prostate carcinoma)	NULL
EXP060487	none	Homo sapiens		NULL	1205	chip_control	NULL	Reh (ATCC CRL-8286)	NULL
EXP060488	anti-ETV6 (HPA000264, Sigma Aldrich)	Homo sapiens		EXP060487	1205	normal	P41212	Reh (ATCC CRL-8286)	NULL
EXP060489	anti-RUNX1 (ab23980, Abcam)	Homo sapiens		EXP060487	1205	normal	Q01196	Reh (ATCC CRL-8286)	NULL
EXP060490	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060491	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060492	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060493	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060494	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060495	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060496	none	Homo sapiens	Treatment: N/A;	NULL	541	chip_control	NULL	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060497	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: N/A;	EXP060490	541	normal	P49711	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060498	anti-FLI1 (Abcam ab15289)	Homo sapiens	Treatment: N/A;	EXP060491	541	normal	Q01543	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060499	anti-RUNX2 (CST 8486/1)	Homo sapiens	Treatment: N/A;	EXP060492	541	normal	Q13950	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060500	anti-SPI1 (CST 2258/1)	Homo sapiens	Treatment: N/A;	EXP060493	541	normal	P17947	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060501	anti-ELF1 (Bethyl A301-443A)	Homo sapiens	Treatment: N/A;	EXP060494	541	normal	P32519	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060502	anti-ERG (CST 97249)	Homo sapiens	Treatment: N/A;	EXP060495	541	normal	P11308	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060503	anti-MYB (Abcam ab109127)	Homo sapiens	Treatment: N/A;	EXP060496	541	normal	P10242	SEM (childhood B acute lymphoblastic leukemia)	NULL
EXP060504		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060505	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: Vehicle for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060506	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: E2 for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060507	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: Fulvestrant for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060508	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: 4OH Tamoxifen for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060509	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: GDC-0927 for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060510	anti-ESR1 (sc-543, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: GNE-274 for 45 mins;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060511	none	Homo sapiens	Treatment: control;	NULL	4258	chip_control	NULL	T HESCs (Telomerase immortalized cell line)	NULL
EXP060512	none	Homo sapiens	Treatment: control;	NULL	4258	chip_control	NULL	T HESCs (Telomerase immortalized cell line)	NULL
EXP060513	none	Homo sapiens	Treatment: 100 uM L-kynurenine for 1 hr;	NULL	4258	chip_control	NULL	T HESCs (Telomerase immortalized cell line)	NULL
EXP060514	none	Homo sapiens	Treatment: 100 uM L-kynurenine for 1 hr;	NULL	4258	chip_control	NULL	T HESCs (Telomerase immortalized cell line)	NULL
EXP060515	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: control;	EXP060511	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	NULL
EXP060516	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: control;	EXP060512	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	NULL
EXP060517	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: 100 uM L-kynurenine for 1 hr;	EXP060513	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	NULL
EXP060518	anti-AHR (H-211, sc-5579 (Santa Cruz, CA))	Homo sapiens	Treatment: 100 uM L-kynurenine for 1 hr;	EXP060514	4258	normal	P35869	T HESCs (Telomerase immortalized cell line)	NULL
EXP060519	None	Homo sapiens	Genotype:LMNA WT/Corr-WT; Time point: day 40 of differentiation; 	NULL	4259	chip_control	NULL	iPSC derived cardiomyocytes	NULL
EXP060520	None	Homo sapiens	Genotype:LMNA WT/MT; Time point: day 40 of differentiation; 	NULL	4259	chip_control	NULL	iPSC derived cardiomyocytes	NULL
EXP060521	anti-Lamin A/C (Abcam ab8984)	Homo sapiens	Genotype:LMNA WT/Corr-WT; Time point: day 40 of differentiation; 	EXP060519	4259	normal	P02545	iPSC derived cardiomyocytes	NULL
EXP060522	anti-Lamin A/C (Abcam ab8984)	Homo sapiens	Genotype:LMNA WT/MT; Time point: day 40 of differentiation; 	EXP060520	4259	normal	P02545	iPSC derived cardiomyocytes	NULL
EXP060523	anti-Lamin A/C (Santa Cruz Biotechnology sc-376248)	Homo sapiens	Genotype:LMNA WT/Corr-WT; Time point: day 40 of differentiation; 	EXP060519	4259	normal	P02545	iPSC derived cardiomyocytes	NULL
EXP060524	anti-Lamin A/C (Santa Cruz Biotechnology sc-376248)	Homo sapiens	Genotype:LMNA WT/MT; Time point: day 40 of differentiation; 	EXP060520	4259	normal	P02545	iPSC derived cardiomyocytes	NULL
EXP060525	anti-CEBPA (Santa Cruz sc-61, lot#J0407)	Mus musculus	Strain: C57BL/6; Tissue: Whole bone marrow, cKIT enriched, FACs isolated;	NULL	4260	normal	P53566	p30-GMP-blast cells from bone marrow	NULL
EXP060526	anti-CEBPA (Santa Cruz sc-61, lot#J0407)	Mus musculus	Strain: C57BL/6; Tissue: Whole bone marrow, cKIT enriched, FACs isolated;	NULL	103	normal	P53566	bone marrow	NULL
EXP060527	Rabbit IgG (Millipore)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060528	Rabbit IgG (Millipore)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060529	anti-REST (17-641, Millipore)	Homo sapiens		EXP060527	70	normal	Q13127	LNCaP (prostate carcinoma)	NULL
EXP060530	anti-REST (17-641, Millipore)	Homo sapiens		EXP060528	70	normal	Q13127	LNCaP (prostate carcinoma)	NULL
EXP060531	None	Homo sapiens	Conditions: control;	NULL	4261	chip_control	NULL	dermal skin	NULL
EXP060532	None	Homo sapiens	Conditions: mechanic loading;	NULL	4261	chip_control	NULL	dermal skin	NULL
EXP060533	Anti-ELK1 antibody( E277, abcam,ab32106)	Homo sapiens	Conditions: control;	EXP060531	4261	normal	P19419	dermal skin	NULL
EXP060534	Anti-ELK1 antibody( E277, abcam,ab32106)	Homo sapiens	Conditions: mechanic loading;	EXP060532	4261	normal	P19419	dermal skin	NULL
EXP060535	none (input DNA)	Homo sapiens		NULL	288	chip_control	NULL	A673 (Ewing sarcoma)	NULL
EXP060536	anti-MYBL2 antibody (monoclonal rabbit, Abcam, ref: 76009)	Homo sapiens		EXP060535	288	normal	P10244	A673 (Ewing sarcoma)	NULL
EXP060537	none (input)	Homo sapiens	Genotype: wildtype;	NULL	2235	chip_control	NULL	RMG-1	NULL
EXP060538	none (input)	Homo sapiens	Genotype: ARID1A knockout;	NULL	2235	chip_control	NULL	RMG-1	NULL
EXP060539	anti-ARID1A (rabbit, Abcam, cat. no. ab182560)	Homo sapiens	Genotype: wildtype;	EXP060537	2235	normal	O14497	RMG-1	NULL
EXP060540	anti-CAP-H2 (rabbit Bethyl, cat. no. A302-276A)	Homo sapiens	Genotype: wildtype;	EXP060537	2235	normal	Q6IBW4	RMG-1	NULL
EXP060541	anti-CAP-H2 (rabbit Bethyl, cat. no. A302-276A)	Homo sapiens	Genotype: ARID1A knockout;	EXP060538	2235	normal	Q6IBW4	RMG-1	NULL
EXP060542	anti-SNF5 (rabbit , Bethyl, cat. no. A301-087A)	Homo sapiens	Genotype: wildtype;	EXP060537	2235	normal	Q12824	RMG-1	NULL
EXP060543	anti-SNF5 (rabbit , Bethyl, cat. no. A301-087A)	Homo sapiens	Genotype: ARID1A knockout;	EXP060538	2235	normal	Q12824	RMG-1	NULL
EXP060544		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060545		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060546		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060547		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060548		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060549		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060550		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060551		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060552		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060553		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060554		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060555		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060556		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060557		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060558		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060559		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060560		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060561		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060562		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060563		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060564		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060565		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	chip_control	NULL	whole worms(developmental stage L4)	NULL
EXP060566		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	normal	A0A023T4K3	whole worms(developmental stage L4)	NULL
EXP060567		Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	NULL	2193	normal	A0A023T4K3	whole worms(developmental stage L4)	NULL
EXP060568	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060548	2193	normal	G5EDU7	whole worms(developmental stage L4)	NULL
EXP060569	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060549	2193	normal	G5EDU7	whole worms(developmental stage L4)	NULL
EXP060570	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060550	2193	normal	G5EDU7	whole worms(developmental stage L4)	NULL
EXP060571	anti-Myc antibody (9E10 ,Sigma M4439)	Caenorhabditis elegans	Strain: pJK1689; Conditions: 20;	EXP060551	2193	normal	G5EDU7	whole worms(developmental stage L4)	NULL
EXP060572	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced 293Tctrl;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP060573	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced 293Tctrl_Ti;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP060574	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF746;	EXP060572	10	normal	Q6NUN9	HEK293T (embryonic kidney)	NULL
EXP060575	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF213;	EXP060572	10	normal	O14771	HEK293T (embryonic kidney)	NULL
EXP060576	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF256;	EXP060572	10	normal	Q9Y2P7	HEK293T (embryonic kidney)	NULL
EXP060577	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZKSCAN8;	EXP060572	10	normal	Q15776	HEK293T (embryonic kidney)	NULL
EXP060578	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF20;	EXP060572	10	normal	P17024	HEK293T (embryonic kidney)	NULL
EXP060579	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF597;	EXP060572	10	normal	Q96LX8	HEK293T (embryonic kidney)	NULL
EXP060580	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF215;	EXP060572	10	normal	Q9UL58	HEK293T (embryonic kidney)	NULL
EXP060581	Anti-HA (clone 16B12, Covance)	Homo sapiens	Genotype: transduced ZNF746_Ti;	EXP060573	10	normal	Q6NUN9	HEK293T (embryonic kidney)	NULL
EXP060582	none	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060583	none	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060584	none	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060585	none	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060586	none	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060587	none	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060588	none	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060589	none	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP060590	none	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060591	none	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060592	none	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060593	none	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060594	none	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060595	none	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060596	none	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060597	none	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	NULL	641	chip_control	NULL	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060598	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060582	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060599	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060583	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060600	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060584	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060601	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060585	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060602	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060586	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060603	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060587	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060604	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060588	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060605	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060589	514	normal	P25440	K562 (myelogenous leukemia)	NULL
EXP060606	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060590	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060607	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060591	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060608	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060592	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060609	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060593	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060610	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060594	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060611	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060595	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060612	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060596	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060613	anti-BRD2 (Bethyl Labs #A302-583A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060597	641	normal	P25440	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060614	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060582	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060615	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060583	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060616	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060584	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060617	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060585	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060618	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060586	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060619	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060587	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060620	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060588	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060621	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060589	514	normal	Q15059	K562 (myelogenous leukemia)	NULL
EXP060622	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060590	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060623	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060591	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060624	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060592	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060625	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060593	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060626	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060594	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060627	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060595	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060628	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060596	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060629	anti-BRD3 (Bethyl Labs #A302-368A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060597	641	normal	Q15059	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060630	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060582	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060631	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060583	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060632	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060584	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060633	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060585	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060634	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060586	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060635	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060587	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060636	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060588	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060637	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060589	514	normal	O60885	K562 (myelogenous leukemia)	NULL
EXP060638	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060590	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060639	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP060591	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060640	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060592	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060641	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 50 nM I-BET151 for 6 hours;	EXP060593	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060642	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060594	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060643	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 500 nM I-BET151 for 6 hours;	EXP060595	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060644	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060596	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060645	anti-BRD4 (Bethyl labs #A301-985A)	Homo sapiens	Treatment: 5000 nM I-BET151 for 6 hours;	EXP060597	641	normal	O60885	MV-4-11 (Childhood acute monocytic leukemia)	NULL
EXP060646	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	NULL
EXP060647	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	NULL
EXP060648	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment: treated with stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	NULL
EXP060649	anti-CDK8 (Santa Cruz sc-1521)	Homo sapiens	Treatment:Resting;	NULL	4262	normal	P49336	monocyte-derived macrophages from peripheral blood	NULL
EXP060650	anti-SMC1 (Bethyl Laboratories A300-055A)	Homo sapiens	IFNg-LPS	NULL	4262	normal	Q14683	monocyte-derived macrophages from peripheral blood	NULL
EXP060651	anti-SMC1 (Bethyl Laboratories A300-055A)	Homo sapiens	Treatment: treated with stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	Q14683	monocyte-derived macrophages from peripheral blood	NULL
EXP060652	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: IL10;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	NULL
EXP060653	anti-CEBPB (Santa Cruz sc-150)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P17676	monocyte-derived macrophages from peripheral blood	NULL
EXP060654	anti-PU.1 (Santa Cruz sc-352)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P17947	monocyte-derived macrophages from peripheral blood	NULL
EXP060655	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	NULL
EXP060656	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	NULL
EXP060657	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment:Resting;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	NULL
EXP060658	anti-STAT3 (Santa Cruz sc-482)	Homo sapiens	Treatment: treated with stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	P40763	monocyte-derived macrophages from peripheral blood	NULL
EXP060659	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060660	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	4263	chip_control	NULL	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060661	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP060662	anti-V5	Homo sapiens	Genotype: EN1 over expression;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060663	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060664	anti-V5	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, no doxycycline;	NULL	4263	chip_control	NULL	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060665	anti-V5	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, doxycycline for 24 hrs;	NULL	4263	chip_control	NULL	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060666	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060667	anti-V5	Homo sapiens	Genotype: LacZ control;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060668	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	4263	chip_control	NULL	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060669	anti-V5	Homo sapiens	Treatment: no doxycycline;	NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP060670	anti-V5	Homo sapiens	Treatment: doxycycline;	NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP060671	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	EXP060659	113	normal	Q05925	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060672	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	EXP060660	4263	normal	Q05925	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060673	anti-V5	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	EXP060661	817	normal	Q05925	SUM159PT (Triple negative breast cancer)	NULL
EXP060674	anti-CTNNB1	Homo sapiens	Genotype: EN1 overexpression;	EXP060662	113	normal	P35222	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060675	anti-CTNNB1	Homo sapiens	Genotype: LacZ control;	EXP060667	113	normal	P35222	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060676	anti-CTNNB1	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, no doxycycline;	EXP060664	4263	normal	P35222	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060677	anti-CTNNB1	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, doxycycline for 24 hrs;	EXP060665	4263	normal	P35222	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060678	anti-TLE3	Homo sapiens	Genotype: EN1 over-expression;	EXP060662	113	normal	Q04726	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060679	anti-TLE3	Homo sapiens	Genotype: LacZ control;	EXP060663	113	normal	Q04726	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060680	anti-TLE3	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, no doxycycline;	EXP060664	4263	normal	Q04726	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060681	anti-TLE3	Homo sapiens	Genotype: EN1 knockout; Treatment: shEN1, doxycycline for 24 hrs;	EXP060665	4263	normal	Q04726	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060682	anti-TLE3	Homo sapiens	Treatment: no doxycycline;	EXP060669	817	normal	Q04726	SUM159PT (Triple negative breast cancer)	NULL
EXP060683	anti-TLE3	Homo sapiens	Treatment: doxycycline;	EXP060670	817	normal	Q04726	SUM159PT (Triple negative breast cancer)	NULL
EXP060684	anti-FOXA1	Homo sapiens	Genotype: EN1 over-expression;	EXP060662	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060685	anti-FOXA1	Homo sapiens	Genotype: LacZ control;	EXP060663	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060686	anti-EN1	Homo sapiens	Genotype: EN1 overexpression;	NULL	113	normal	Q05925	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060687	anti-EN1	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	4263	normal	Q05925	SUM149PT (Inflammatory breast carcinoma)	NULL
EXP060688	anti-EN1	Homo sapiens	Genotype: exogenously expressed V5-tagged EN1 expression;	NULL	817	normal	Q05925	SUM159PT (Triple negative breast cancer)	NULL
EXP060689	anti-CBX8 (C15410333, Diagenode)	Homo sapiens	Treatment: untreated;	NULL	514	normal	Q9HC52	K562 (myelogenous leukemia)	NULL
EXP060690	anti-CBX8 (C15410333, Diagenode)	Homo sapiens	Conditions: 1hr, 44C (heat shock);	NULL	514	normal	Q9HC52	K562 (myelogenous leukemia)	NULL
EXP060691	anti-GFP (ab290, Abcam)	Homo sapiens	Treatment: untreated;	NULL	514	normal	Q14781	K562 (myelogenous leukemia)	NULL
EXP060692	anti-GFP (ab290, Abcam)	Homo sapiens	Conditions: 1hr, 44C (heat shock);	NULL	514	normal	Q14781	K562 (myelogenous leukemia)	NULL
EXP060693	None	Mus musculus	Treatment: APR 60 hrs; Genotype: Med14Nsmash;	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP060694	None	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP060695	None	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP060696	None	Mus musculus	Genotype: wildtype;	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP060697	None	Mus musculus	Genotype: wildtype;	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP060698	None	Mus musculus	Genotype: wildtype;	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP060699	None	Homo sapiens	Treatment: auxin; Genotype: Rad21Degron;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP060700	None	Homo sapiens	Treatment: untreated; Genotype: Rad21Degron;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP060701	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Treatment: APR 48 hrs; Genotype: Med14Nsmash;	NULL	178	normal	Q7TN02	CH12 (lymphoma)	NULL
EXP060702	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: APR 60 hrs; Genotype: Med14Nsmash;	EXP060693	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP060703	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP060704	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP060705	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q7TN02	CH12 (lymphoma)	NULL
EXP060706	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q7TN02	CH12 (lymphoma)	NULL
EXP060707	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q6KCD5	CH12 (lymphoma)	NULL
EXP060708	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q6KCD5	CH12 (lymphoma)	NULL
EXP060709	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060694	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP060710	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: Med23mm24mm25mm15mm16mm;	EXP060695	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP060711	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP060712	anti-CTCF (Millipore, 07-729)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP060713	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: wildtype; Treatment: APR 48 hrs;	NULL	178	normal	Q7TN02	CH12 (lymphoma)	NULL
EXP060714	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q7TN02	CH12 (lymphoma)	NULL
EXP060715	anti-Med26 (Cell Signaling Technology, 13641S)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q7TN02	CH12 (lymphoma)	NULL
EXP060716	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q6KCD5	CH12 (lymphoma)	NULL
EXP060717	anti-Nipbl (Bethyl, A301-779A)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q6KCD5	CH12 (lymphoma)	NULL
EXP060718	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: wildtype; Treatment: APR 60 hrs;	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP060719	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: wildtype;	EXP060697	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP060720	anti-Rad21 (Abcam, ab992)	Mus musculus	Genotype: wildtype;	EXP060698	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP060721	anti-Med26 (Cell signalling technologies, 13641S)	Homo sapiens	Treatment: auxin; Genotype: Rad21Degron;	EXP060699	417	normal	O95402	HCT-116 (colon carcinoma)	NULL
EXP060722	anti-Med26 (Cell signalling technologies, 13641S)	Homo sapiens	Treatment: untreated; Genotype: Rad21Degron;	EXP060700	417	normal	O95402	HCT-116 (colon carcinoma)	NULL
EXP060723	anti-Rad21 (Abcam, ab992)	Homo sapiens	Treatment: auxin; Genotype: Rad21Degron;	EXP060699	417	normal	O60216	HCT-116 (colon carcinoma)	NULL
EXP060724	anti-Rad21 (Abcam, ab992)	Homo sapiens	Treatment: untreated; Genotype: Rad21Degron;	EXP060700	417	normal	O60216	HCT-116 (colon carcinoma)	NULL
EXP060725		Homo sapiens	Donor: G523;	NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP060726		Homo sapiens	Donor: G523;	NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP060727		Homo sapiens	Donor: G523;	NULL	332	chip_control	NULL	glioblastoma cells	NULL
EXP060728	anti-CTCF (CST #3418; lot 1)	Homo sapiens	Donor: G523;	EXP060725	332	normal	P49711	glioblastoma cells	NULL
EXP060729	anti-CTCF (CST #3418; lot 1)	Homo sapiens	Donor: G567;	EXP060726	332	normal	P49711	glioblastoma cells	NULL
EXP060730	anti-CTCF (CST #3418; lot 1)	Homo sapiens	Donor: G583;	EXP060727	332	normal	P49711	glioblastoma cells	NULL
EXP060731	anti-YY1 (Santa Cruz sc-7341, 1:100)	Mus musculus	Genotype: wildtype;	NULL	2	normal	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP060732	anti-YY1 (Santa Cruz sc-7341, 1:100)	Mus musculus	Genotype: Tet1/2/3 triple knockout;	NULL	2	normal	Q00899	mESCs (mouse embryonic stem cells)	NULL
EXP060733	control input	Homo sapiens	Treatment: iciHHV6 infected;	NULL	1186	chip_control	NULL	smooth muscle cell	NULL
EXP060734	control input	Homo sapiens	Treatment: HHV6 infected;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP060735	anti-TRF1 (GeneTex, cat#32935)	Homo sapiens	Treatment: iciHHV6 infected;	EXP060733	1186	normal	P54274	smooth muscle cell	NULL
EXP060736	anti-TRF1 (GeneTex, cat#32935)	Homo sapiens	Treatment: HHV6 infected;	EXP060734	421	normal	P54274	HEK293 (embryonic kidney)	NULL
EXP060737	anti-TRF2 (GeneTex, cat#13579)	Homo sapiens	Treatment: iciHHV6 infected;	EXP060733	1186	normal	P62380	smooth muscle cell	NULL
EXP060738	anti-TRF2 (GeneTex, cat#13579)	Homo sapiens	Treatment: HHV6 infected;	EXP060734	421	normal	P62380	HEK293 (embryonic kidney)	NULL
EXP060739	anti-CTCF	Homo sapiens	Treatment: pLV dCas9-KRAB;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	NULL
EXP060740	anti-CTCF	Homo sapiens	Treatment: pLV dCas9-KRAB + P1 gRNA;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	NULL
EXP060741	anti-CTCF	Homo sapiens	Treatment: dCas9-Dnmt3a3l + P3 gRNA;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	NULL
EXP060742	anti-CTCF	Homo sapiens	Treatment: dCas9-Dnmt3a3l + KRAB-dCas9 + P1 + P3 gRNA;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	NULL
EXP060743	anti-CTCF	Homo sapiens	Treatment: control;	NULL	421	normal	P49711	HEK293 (embryonic kidney)	NULL
EXP060744	none (input)	Homo sapiens	Genotype: wildtype; Tissue: Neonatal foreskin;	NULL	3363	chip_control	NULL	primary epidermal keratinocytes	NULL
EXP060745	anti-HNRNPK (Bethyl Laboratories A300-674A)	Homo sapiens	Genotype: wildtype; Tissue: Neonatal foreskin;	EXP060744	3363	normal	P61978	primary epidermal keratinocytes	NULL
EXP060746	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060747	none	Homo sapiens	Genotype: K755R/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060748	none	Homo sapiens	Genotype: R1159Q/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060749	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060750	none	Homo sapiens	Genotype: K755R/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060751	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060752	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060753	none	Homo sapiens	Genotype: K755R/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060754	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060755	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060756	none	Homo sapiens	Genotype: K755R/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060757	none	Homo sapiens	Genotype: R1159Q/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060758	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060759	none	Homo sapiens	Genotype: K755R/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060760	none	Homo sapiens	Genotype: R1159Q/+;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060761	none	Homo sapiens	Genotype: wildtype;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060762	none	Homo sapiens	Genotype: Lenriviral expressed R1159Q SMARCA2-AM;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060763	none	Homo sapiens	Genotype: wildtype; Treatment: non-targeting siRNA for 72 hours;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060764	none	Homo sapiens	Genotype: SOX2 and SOX3 knockout; Treatment: SOX2 and SOX3 siRNA for 72 hours;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060765	none	Homo sapiens	Genotype: K755R/+; Treatment: non-targeting siRNA for 72 hours;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060766	none	Homo sapiens	Genotype: K755R/+ and FOSL1, FOSL2 and JUNB knockout; Treatment: FOSL1, FOSL2 and JUNB siRNA for 72 hours;	NULL	887	chip_control	NULL	neural progenitors	NULL
EXP060767	SMARCA2 (Bethyl A301-015A)	Homo sapiens	Genotype: wildtype;	EXP060746	887	normal	P51531	neural progenitors	NULL
EXP060768	SMARCA2 (Bethyl A301-015A)	Homo sapiens	Genotype: K755R/+;	EXP060747	887	normal	P51531	neural progenitors	NULL
EXP060769	SMARCA2 (Bethyl A301-015A)	Homo sapiens	Genotype: R1159Q/+;	EXP060748	887	normal	P51531	neural progenitors	NULL
EXP060770	FOSL2 (Cell signaling Technology 19967)	Homo sapiens	Genotype: wildtype;	EXP060749	887	normal	P15408	neural progenitors	NULL
EXP060771	FOSL2 (Cell signaling Technology 19967)	Homo sapiens	Genotype: K755R/+;	EXP060750	887	normal	P15408	neural progenitors	NULL
EXP060772	FOSL2 (Cell signaling Technology 19967)	Homo sapiens	Genotype: R1159Q/+;	EXP060751	887	normal	P15408	neural progenitors	NULL
EXP060773	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: wildtype;	EXP060752	887	normal	P51532	neural progenitors	NULL
EXP060774	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: K755R/+;	EXP060753	887	normal	P51532	neural progenitors	NULL
EXP060775	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: R1159Q/+;	EXP060754	887	normal	P51532	neural progenitors	NULL
EXP060776	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: wildtype;	EXP060755	887	normal	P51532	neural progenitors	NULL
EXP060777	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: K755R/+;	EXP060756	887	normal	P51532	neural progenitors	NULL
EXP060778	anti-SMARCA4(Abcam ab110641)	Homo sapiens	Genotype: R1159Q/+;	EXP060757	887	normal	P51532	neural progenitors	NULL
EXP060779	anti-SMARCA2 (Abcam ab15597)	Homo sapiens	Genotype: wildtype;	EXP060755	887	normal	P51531	neural progenitors	NULL
EXP060780	anti-SMARCA2 (Abcam ab15597)	Homo sapiens	Genotype: K755R/+;	EXP060756	887	normal	P51531	neural progenitors	NULL
EXP060781	anti-SMARCA2 (Abcam ab15597)	Homo sapiens	Genotype: R1159Q/+;	EXP060757	887	normal	P51531	neural progenitors	NULL
EXP060782	anti-SOX2 (Cell signaling Technology 5024S)	Homo sapiens	Genotype: wildtype;	EXP060758	887	normal	P48431	neural progenitors	NULL
EXP060783	anti-SOX2 (Cell signaling Technology 5024S)	Homo sapiens	Genotype: K755R/+;	EXP060759	887	normal	P48431	neural progenitors	NULL
EXP060784	anti-SOX2 (Cell signaling Technology 5024S)	Homo sapiens	Genotype: R1159Q/+;	EXP060760	887	normal	P48431	neural progenitors	NULL
EXP060785	anti-SOX3 (Novus biology AF2569)	Homo sapiens	Genotype: wildtype;	EXP060758	887	normal	P41225	neural progenitors	NULL
EXP060786	anti-SOX3 (Novus biology AF2569)	Homo sapiens	Genotype: K755R/+;	EXP060759	887	normal	P41225	neural progenitors	NULL
EXP060787	anti-SOX3 (Novus biology AF2569)	Homo sapiens	Genotype: R1159Q/+;	EXP060760	887	normal	P41225	neural progenitors	NULL
EXP060788	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: Lenriviral expressed WT SMARCA2-AM;	EXP060761	887	normal	P51531	neural progenitors	NULL
EXP060789	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: Lenriviral expressed R1159Q SMARCA2-AM;	EXP060762	887	normal	P51531	neural progenitors	NULL
EXP060790	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: wildtype; Treatment: non-targeting siRNA for 72 hours;	EXP060763	887	normal	P51532	neural progenitors	NULL
EXP060791	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: SOX2 and SOX3 knockout; Treatment: SOX2 and SOX3 siRNA for 72 hours;	EXP060764	887	normal	P51532	neural progenitors	NULL
EXP060792	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: K755R/+; Treatment: non-targeting siRNA for 72 hours;	EXP060765	887	normal	P51531	neural progenitors	NULL
EXP060793	anti-SMARCA2 (Active Motif 91111)	Homo sapiens	Genotype: K755R/+ and FOSL1, FOSL2 and JUNB knockout; Treatment: FOSL1, FOSL2 and JUNB siRNA for 72 hours;	EXP060766	887	normal	P51531	neural progenitors	NULL
EXP060794	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: K755R/+; Treatment: non-targeting siRNA for 72 hours;	EXP060765	887	normal	P51532	neural progenitors	NULL
EXP060795	anti-SMARCA4 (Abcam ab110641)	Homo sapiens	Genotype: K755R/+ and FOSL1, FOSL2 and JUNB knockout; Treatment: FOSL1, FOSL2 and JUNB siRNA for 72 hours;	EXP060766	887	normal	P51532	neural progenitors	NULL
EXP060796	IGG	Homo sapiens	Treatmet: reactivated viral infection;	NULL	4264	chip_control	NULL	BC-3 (Primary effusion lymphoma)	NULL
EXP060797	IGG	Homo sapiens	Treatmet: latent viral infection;	NULL	4264	chip_control	NULL	BC-3 (Primary effusion lymphoma)	NULL
EXP060798	anti-Rta	Homo sapiens	Treatmet: reactivated viral infection;	EXP060796	4264	normal	O43251	BC-3 (Primary effusion lymphoma)	NULL
EXP060799	anti-RBP-Jk	Homo sapiens	Treatmet: reactivated viral infection;	EXP060796	4264	normal	Q06330	BC-3 (Primary effusion lymphoma)	NULL
EXP060800	anti-RBP-Jk	Homo sapiens	Treatmet: latent viral infection;	EXP060797	4264	normal	Q06330	BC-3 (Primary effusion lymphoma)	NULL
EXP060801	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060802	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Genotype: wildtype;	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060803	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: control plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060804	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: wildtype plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060805	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: TR1 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060806	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: TR2 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060807	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + control plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060808	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + control plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060809	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + wt plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060810	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + wt plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060811	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + TR1 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060812	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + TR1 plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060813	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siNT + TR2 plasmid; Genotype: wildtype;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060814	anti-HA (05-904, Millipore)	Homo sapiens	Treatment: siFOXA + TR2 plasmid; Genotype: FOXA1 knockout;	NULL	111	normal	P23771	T47D (invasive ductal carcinoma)	NULL
EXP060815	anti-ZBTB7A (R&D Systems, catalog# MAB3496, lot# CDOR0109121, Human, Mouse)	Homo sapiens	Treatment: 10% FBS; Conditions: none	NULL	71	normal	O95365	VCaP (prostate carcinoma)	NULL
EXP060816	anti-ZBTB7A (R&D Systems, catalog# MAB3496, lot# CDOR0109121, Human, Mouse)	Homo sapiens	Treatment: 5% CSS containing phenol red free RPMI 1640; Conditions: none	NULL	71	normal	O95365	VCaP (prostate carcinoma)	NULL
EXP060817	anti-ZBTB7A (R&D Systems, catalog# MAB3496, lot# CDOR0109121, Human, Mouse)	Homo sapiens	Treatment: 10 nM DHT for 4 hours; Conditions: none	NULL	71	normal	O95365	VCaP (prostate carcinoma)	NULL
EXP060818		Homo sapiens		NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP060819	NA	Mus musculus		NULL	4267	chip_control	NULL	Vl3-2m (T cells lymphocytes)	NULL
EXP060820	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing Satb1 full length protein;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	NULL
EXP060821	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing Satb1 without homeodomain (HD);	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	NULL
EXP060822	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing Satb1 N terminal domain and CUT1 domain;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	NULL
EXP060823	Anti-GFP antibody (Abcam, Ab290)	Homo sapiens	Genotype: expressing N-terminal domain of Satb1;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	NULL
EXP060824	GFP antibody	Homo sapiens	Treatment: camptothecin for 2 hrs;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	NULL
EXP060825	GFP antibody	Homo sapiens	Treatment: ICRF-193 for 2 hrs;	NULL	583	normal	Q01826	MCF10A (breast epithelial cells)	NULL
EXP060826	anti-Satb1	Mus musculus	Genotype: expressing Satb1 full length protein;	EXP060819	4267	normal	Q60611	Vl3-2m (T cells lymphocytes)	NULL
EXP060827	anti-CTCF antibody (Millipore #07-729)	Homo sapiens	Time point: day0 (proliferation);	NULL	2562	normal	P49711	Dombi23 (primary keratinocytes)	NULL
EXP060828	anti-CTCF antibody (Millipore #07-729)	Homo sapiens	Time point: day0 (proliferation);	NULL	4268	normal	P49711	R204W (keratinocytes)	NULL
EXP060829	anti-CTCF antibody (Millipore #07-729)	Homo sapiens	Time point: day0 (proliferation);	NULL	4269	normal	P49711	R304W (keratinocytes)	NULL
EXP060830	none (input)	Homo sapiens	Developmental stage: 5 weeks;	NULL	395	chip_control	NULL	H9-derived neural progenitors	NULL
EXP060831	none (input)	Homo sapiens	Developmental stage: 5 weeks;	NULL	395	chip_control	NULL	H9-derived neural progenitors	NULL
EXP060832	none (input)	Homo sapiens	Developmental stage: 10 weeks;	NULL	4272	chip_control	NULL	WA09 (H9) hESC-derived neurons	NULL
EXP060833	none (input)	Homo sapiens	Developmental stage: 10 weeks;	NULL	4272	chip_control	NULL	WA09 (H9) hESC-derived neurons	NULL
EXP060834	none (input)	Homo sapiens	Genotype: UBE3A knockout;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP060835	none (input)	Homo sapiens	Genotype: UBE3A knockout;	NULL	396	chip_control	NULL	WA09 (embryonic stem cells)	NULL
EXP060836	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060830	395	normal	Q05086	H9-derived neural progenitors	NULL
EXP060837	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060831	395	normal	Q05086	H9-derived neural progenitors	NULL
EXP060838	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060830	395	normal	Q05086	H9-derived neural progenitors	NULL
EXP060839	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 5 weeks;	EXP060831	395	normal	Q05086	H9-derived neural progenitors	NULL
EXP060840	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060832	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	NULL
EXP060841	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060833	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	NULL
EXP060842	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060832	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	NULL
EXP060843	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Developmental stage: 10 weeks;	EXP060833	4272	normal	Q05086	WA09 (H9) hESC-derived neurons	NULL
EXP060844	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060834	396	normal	Q05086	WA09 (embryonic stem cells)	NULL
EXP060845	anti-UBE3A (A300-351A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060835	396	normal	Q05086	WA09 (embryonic stem cells)	NULL
EXP060846	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060834	396	normal	Q05086	WA09 (embryonic stem cells)	NULL
EXP060847	anti-UBE3A (A300-352A, Bethyl)	Homo sapiens	Genotype: UBE3A knockout;	EXP060835	396	normal	Q05086	WA09 (embryonic stem cells)	NULL
EXP060848	Anti-IRF2BP2 antibody (A303190A, Bethyl laboratories)	Homo sapiens	Treatment: ethanol for 1hr, steroid-depleted medium, 48 hrs; Genotype: expressing GR;	NULL	421	normal	Q7Z5L9	HEK293 (embryonic kidney)	NULL
EXP060849	Anti-IRF2BP2 antibody (A303190A, Bethyl laboratories)	Homo sapiens	Treatment: dexamethasone, 100 nM for 1hr, steroid-depleted medium, 48 hrs; Genotype: expressing GR;	NULL	421	normal	Q7Z5L9	HEK293 (embryonic kidney)	NULL
EXP060850	none	Homo sapiens		NULL	892	chip_control	NULL	MSC (mesenchymal stem cells)	NULL
EXP060851	anti-PRMT3 (Abcam, Cambridge, UK)	Homo sapiens		EXP060850	892	normal	O60678	MSC (mesenchymal stem cells)	NULL
EXP060852	None	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER eGFP empty;	NULL	4273	chip_control	NULL	Mel270 (Uveal melanoma)	NULL
EXP060853	None	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	NULL	4273	chip_control	NULL	Mel270 (Uveal melanoma)	NULL
EXP060854	None	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER-FLAG-SF3B1_K700E ;	NULL	4273	chip_control	NULL	Mel270 (Uveal melanoma)	NULL
EXP060855	None	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	NULL	4273	chip_control	NULL	Mel270 (Uveal melanoma)	NULL
EXP060856	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER eGFP empty;	EXP060852	4273	normal	P51532	Mel270 (Uveal melanoma)	NULL
EXP060857	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER eGFP empty;	EXP060852	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	NULL
EXP060858	anti-BRD9 (Abcam ab137245)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	EXP060853	4273	normal	Q9H8M2	Mel270 (Uveal melanoma)	NULL
EXP060859	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	EXP060853	4273	normal	P51532	Mel270 (Uveal melanoma)	NULL
EXP060860	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER eGFP empty;	EXP060853	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	NULL
EXP060861	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER-FLAG-SF3B1_K700E ;	EXP060854	4273	normal	P51532	Mel270 (Uveal melanoma)	NULL
EXP060862	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, DMSO, 6 days, pINDUCER-FLAG-SF3B1_K700E ;	EXP060854	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	NULL
EXP060863	anti-BRD9 (Abcam ab137245)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	EXP060855	4273	normal	Q9H8M2	Mel270 (Uveal melanoma)	NULL
EXP060864	anti-BRG1 (Abcam, EPNCIR111A)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	EXP060855	4273	normal	P51532	Mel270 (Uveal melanoma)	NULL
EXP060865	anti-GLTSCR1 (Santa Cruz SC-240516)	Homo sapiens	Treatment: Dox, 500nM dBRD9, 6 days, pINDUCER-FLAG-SF3B1_WT;	EXP060855	4273	normal	Q9NZM4	Mel270 (Uveal melanoma)	NULL
EXP060866	none	Homo sapiens		NULL	2297	chip_control	NULL	MKL-1 (Merkel cell carcinoma)	NULL
EXP060867	none	Homo sapiens		NULL	2297	chip_control	NULL	MKL-1 (Merkel cell carcinoma)	NULL
EXP060868	anti-LSD1 (abcam, rabbit, ab17721)	Homo sapiens		EXP060866	2297	normal	O60341	MKL-1 (Merkel cell carcinoma)	NULL
EXP060869	anti-LSD1 (abcam, rabbit, ab17721)	Homo sapiens		EXP060867	2297	normal	O60341	MKL-1 (Merkel cell carcinoma)	NULL
EXP060870	anti-RCOR2 (Proteintech, rabbit, 23969-1-AP)	Homo sapiens		EXP060866	2297	normal	Q8IZ40	MKL-1 (Merkel cell carcinoma)	NULL
EXP060871	anti-RCOR2 (Proteintech, rabbit, 23969-1-AP)	Homo sapiens		EXP060867	2297	normal	Q8IZ40	MKL-1 (Merkel cell carcinoma)	NULL
EXP060872	anti-ATOH1	Homo sapiens		EXP060866	2297	normal	Q92858	MKL-1 (Merkel cell carcinoma)	NULL
EXP060873	anti-ATOH1	Homo sapiens		EXP060867	2297	normal	Q92858	MKL-1 (Merkel cell carcinoma)	NULL
EXP060874	anti-MED1	Homo sapiens	Treatment: AR stimulation in presence of enzalutamide for 6 hrs; Time point: 6 hours	NULL	71	normal	O95243	VCaP (prostate carcinoma)	NULL
EXP060875	anti-AR	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP060876	anti-AR	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP060877	anti-AR	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP060878	anti-MED1	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	70	normal	O95243	LNCaP (prostate carcinoma)	NULL
EXP060879	anti-MED1	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	70	normal	O95243	LNCaP (prostate carcinoma)	NULL
EXP060880	anti-MED1	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	70	normal	O95243	LNCaP (prostate carcinoma)	NULL
EXP060881	anti-MED1	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	71	normal	O95243	VCaP (prostate carcinoma)	NULL
EXP060882	anti-AR	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP060883	anti-AR	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP060884	anti-AR	Homo sapiens	Treatment: AR stimulation in presence of THZ1 for 6 hrs; Time point: 6 hours	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP060885	anti-MED1	Homo sapiens	Treatment: Vehicle control; Time point: none	NULL	71	normal	O95243	VCaP (prostate carcinoma)	NULL
EXP060886	anti-MED1	Homo sapiens	Treatment: AR stimulation for 6hrs; Time point: 6 hours	NULL	71	normal	O95243	VCaP (prostate carcinoma)	NULL
EXP060887	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060888	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060889	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060890	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060891	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP060892	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	111	normal	P03372	T47D (invasive ductal carcinoma)	NULL
EXP060893	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	111	normal	Q15561	T47D (invasive ductal carcinoma)	NULL
EXP060894	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	111	normal	Q15561	T47D (invasive ductal carcinoma)	NULL
EXP060895	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: ethanol for 1 hrs;	NULL	111	normal	A6NDR6	T47D (invasive ductal carcinoma)	NULL
EXP060896	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr;	NULL	111	normal	A6NDR6	T47D (invasive ductal carcinoma)	NULL
EXP060897	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, Control shRNA;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060898	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr,TEAD4 shRNA; Genotype: TEAD4  knockout;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060899	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, YAP1 shRNA; Genotype: YAP1 knockout;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060900	anti-MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: ethanol for 1 hrs, control shRNA;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060901	MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, control shRNA;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060902	MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: ethanol for 1 hrs, YAP1 shRNA; Genotype: YAP1 knockout;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060903	MED1 (Santa Cruz, sc-74475 and Bethyl laboratories, A300-793A)	Homo sapiens	Treatment: 100 nM 17-beta-estradiol (E2) for 1 hr, YAP1 shRNA; Genotype: YAP1 knockout;	NULL	113	normal	O95243	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060904	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060905	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060906	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: DMSO for 24 hours;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060907	anti-ERalpha (Santa Cruz, sc-7207)	Homo sapiens	Treatment: 100 nM ICI182780  for 24 hours;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060908	anti-TEAD4 (Santa Cruz, sc-101184)	Homo sapiens	Treatment: 100 nM ICI182780  for 24 hours;	NULL	113	normal	Q15561	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060909	anti-YAP (Cell Signaling Technology,14074S)	Homo sapiens	Treatment: 100 nM ICI182780  for 24 hours;	NULL	113	normal	A6NDR6	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP060910	none (Input)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP060911	none (Input)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP060912	none (Input)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP060913	none (Input)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP060914	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060910	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060915	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060911	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060916	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060912	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060917	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060913	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060918	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060910	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060919	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml)  for 1 hr, shCtrl; Genotype: wildtype;	EXP060911	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060920	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060912	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060921	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) for 1 hr, shGR; Genotype: GR knockout;	EXP060913	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060922	anti-GR (IA1)	Homo sapiens	Treatment: ethanol for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060923	anti-GR (IA1)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060924	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) +  100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060925	anti-GR (IA1)	Homo sapiens	Treatment: ethanol for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060926	anti-GR (IA1)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060927	anti-GR (IA1)	Homo sapiens	Treatment: TNF (20 ng/ml) + 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060928	anti-GR (356)	Homo sapiens	Treatment: ethanol for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060929	anti-GR (356)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060930	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) +  100 nM dexamethasone for 1 hr, shCtrl; Genotype: wildtype;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060931	anti-GR (356)	Homo sapiens	Treatment: ethanol for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060932	anti-GR (356)	Homo sapiens	Treatment: 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060933	anti-GR (356)	Homo sapiens	Treatment: TNF (20 ng/ml) + 100 nM dexamethasone for 1 hr, shGR; Genotype: GR knockout;	NULL	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP060934	none	Homo sapiens	Genotype: MeCP2 everexpression 11x;  Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060935	none	Homo sapiens	Genotype: MeCP2 everexpression 4x;  Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060936	none	Homo sapiens	Genotype: MeCP2 knockout; Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060937	none	Homo sapiens	Genotype: wildtype; Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060938	none	Homo sapiens	Genotype: MeCP2 everexpression 11x;  Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060939	none	Homo sapiens	Genotype: MeCP2 everexpression 4x;  Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060940	none	Homo sapiens	Genotype: MeCP2 knockout; Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060941	none	Homo sapiens	Genotype: wildtype; Time point: day 9 of differentiation;	NULL	4274	chip_control	NULL	LUHMES-derived neurons	NULL
EXP060942	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 11x;  Time point: day 9 of differentiation;	EXP060934	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060943	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 4x;  Time point: day 9 of differentiation;	EXP060935	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060944	anti- MeCP2	Homo sapiens	Genotype: MeCP2 knockout; Time point: day 9 of differentiation;	EXP060936	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060945	anti- MeCP2	Homo sapiens	Genotype: wildtype; Time point: day 9 of differentiation;	EXP060937	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060946	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 11x;  Time point: day 9 of differentiation;	EXP060938	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060947	anti- MeCP2	Homo sapiens	Genotype: MeCP2 everexpression 4x;  Time point: day 9 of differentiation;	EXP060939	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060948	anti- MeCP2	Homo sapiens	Genotype: MeCP2 knockout; Time point: day 9 of differentiation;	EXP060940	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060949	anti- MeCP2	Homo sapiens	Genotype: wildtype; Time point: day 9 of differentiation;	EXP060941	4274	normal	P51608	LUHMES-derived neurons	NULL
EXP060950	anit-PDX1 (Christopher V. E., Wright, Goat )	Homo sapiens	Genotype: PDX1P33T/+;	NULL	2238	normal	P52945	iPS (derived pancreatic precursor cells)	NULL
EXP060951	N/A	Homo sapiens		NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060952	N/A	Homo sapiens		NULL	646	chip_control	NULL	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060953	anti-Ebf1 (ABE1294, Millipore, Rabbit polyclonal )	Homo sapiens		EXP060951	646	normal	Q9UH73	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060954	anti-Ebf1 (ABE1294, Millipore, Rabbit polyclonal )	Homo sapiens		EXP060952	646	normal	Q9UH73	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060955	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060951	646	normal	Q02548	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060956	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060952	646	normal	Q02548	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060957	anti-Ikzf1 (ab26083, Abcam, Rabbit polyclonal IgG)	Homo sapiens		EXP060951	646	normal	Q13422	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060958	anti-Ikzf1 (ab26083, Abcam, Rabbit polyclonal IgG)	Homo sapiens		EXP060952	646	normal	Q13422	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060959	anti-RUNX1 (ab23980, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060951	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060960	anti-RUNX1 (ab23980, Abcam, Rabbit polyclonal)	Homo sapiens		EXP060952	646	normal	Q01196	NALM-6 (adult B acute lymphoblastic leukemia)	NULL
EXP060961	none	Homo sapiens	Treatment: vehicle for 24 hrs;	NULL	412	chip_control	NULL	HCC70 (ductal breast carcinoma)	NULL
EXP060962	none	Homo sapiens	Treatment: 5 uM XY018 for 24 hrs;	NULL	412	chip_control	NULL	HCC70 (ductal breast carcinoma)	NULL
EXP060963	none	Homo sapiens	Treatment: vehicle for 24 hrs;	NULL	412	chip_control	NULL	HCC70 (ductal breast carcinoma)	NULL
EXP060964	none	Homo sapiens	Treatment: 5 uM XY018 for 24 hrs;	NULL	412	chip_control	NULL	HCC70 (ductal breast carcinoma)	NULL
EXP060965	anti-SREBP2 (Cayman, #10007663)	Homo sapiens	Treatment: vehicle for 24 hrs;	EXP060961	412	normal	Q12772	HCC70 (ductal breast carcinoma)	NULL
EXP060966	anti-SREBP2 (Cayman, #10007663)	Homo sapiens	Treatment: 5 uM XY018 for 24 hrs;	EXP060962	412	normal	Q12772	HCC70 (ductal breast carcinoma)	NULL
EXP060967	anti-ROR-gamma (rabbit serum was generated by Covance, using purified GST-human RORgamma fragment, amino acids 79-301, expressed in Escherichia coli)	Homo sapiens	Treatment: vehicle for 24 hrs;	EXP060963	412	normal	P51449	HCC70 (ductal breast carcinoma)	NULL
EXP060968	anti-ROR-gamma (rabbit serum was generated by Covance, using purified GST-human RORgamma fragment, amino acids 79-301, expressed in Escherichia coli)	Homo sapiens	Treatment: 5 uM XY018 for 24 hrs;	EXP060964	412	normal	P51449	HCC70 (ductal breast carcinoma)	NULL
EXP060969	none	Homo sapiens	Cell type:neopslatic stage untransformed;	NULL	2240	chip_control	NULL	HDF(human dermal fibroblasts)	NULL
EXP060970	none	Homo sapiens	Cell type: neopslatic stage preneoplastic;	NULL	2240	chip_control	NULL	HDF(human dermal fibroblasts)	NULL
EXP060971	none	Homo sapiens	Cell type: neopslatic stage transformed;	NULL	2240	chip_control	NULL	HDF(human dermal fibroblasts)	NULL
EXP060972	anti-EZH2 (Cell Signalling - 5246S, 1:40)	Homo sapiens	Cell type:neopslatic stage untransformed;	EXP060969	2240	normal	Q15910	HDF(human dermal fibroblasts)	NULL
EXP060973	anti-EZH2 (Cell Signalling - 5246S, 1:40)	Homo sapiens	Cell type: neopslatic stage preneoplastic;	NULL	2240	normal	Q15910	HDF(human dermal fibroblasts)	NULL
EXP060974	anti-EZH2 (Cell Signalling - 5246S, 1:40)	Homo sapiens	Cell type: neopslatic stage transformed;	EXP060971	2240	normal	Q15910	HDF(human dermal fibroblasts)	NULL
EXP060975	none	Homo sapiens	Donor: donor 171;	NULL	4278	chip_control	NULL	CD4+ T cells from blood	NULL
EXP060976	none	Homo sapiens	Donor: donor 206;	NULL	4278	chip_control	NULL	CD4+ T cells from blood	NULL
EXP060977	anti-p50 (#3035, Cell Signaling, Danvers, MA, USA)	Homo sapiens	Donor: donor 171;	EXP060975	4278	normal	P19838	CD4+ T cells from blood	NULL
EXP060978	anti-p50 (#3035, Cell Signaling, Danvers, MA, USA)	Homo sapiens	Donor: donor 206;	EXP060976	4278	normal	P19838	CD4+ T cells from blood	NULL
EXP060979	anti-p65 (ab16502, Abcam, Cambridge, UK)	Homo sapiens	Donor: donor 171;	EXP060975	4278	normal	Q04206	CD4+ T cells from blood	NULL
EXP060980	anti-p65 (ab16502, Abcam, Cambridge, UK)	Homo sapiens	Donor: donor 206;	EXP060976	4278	normal	Q04206	CD4+ T cells from blood	NULL
EXP060981	anti-MondoA (ProteinTech, catalog # 13614-1-AP, lot # 00042515)	Homo sapiens	Genotype: wildtype;	NULL	451	normal	Q9HAP2	skeletal muscle myotubes	NULL
EXP060982	anti-MondoA (ProteinTech, catalog # 13614-1-AP, lot # 00042515)	Homo sapiens	Genotype: MondoA knockout;	NULL	451	normal	Q9HAP2	skeletal muscle myotubes	NULL
EXP060983	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		NULL	516	chip_control	NULL	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060984	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP060985	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		NULL	741	normal	O75081	CD34+ hematopoietic stem progenitor cells	NULL
EXP060986	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		EXP060983	516	normal	O75081	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP060987	anti-ETO2 (Santa Cruz, SC-9741)	Homo sapiens		EXP060984	65	normal	O75081	U937 (adult acute monocytic leukemia)	NULL
EXP060988	anti-HA (abcam, ab9110)	Homo sapiens	Genotype: pN1-LS174T Snail1-HA cells; Treatment: uninduced;	NULL	3383	normal	O95863	primary T-helper 1 CD4+ cells	NULL
EXP060989	anti-HA (abcam, ab9110)	Homo sapiens	Genotype: pN1-LS174T Snail1-HA cells; Treatment: 0.1 mg/ml doxycycline for 6hrs;	NULL	3383	normal	O95863	primary T-helper 1 CD4+ cells	NULL
EXP060990	anti-ZIC5CT289 (homemade)	Homo sapiens		NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060991	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060992	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060993	anti-ZIC5CT289 (homemade)	Homo sapiens		NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060994	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060995	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with non-targeting dsRNA;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060996	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with CTNNB1 dsRNA; Genotype: CTNNB1 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060997		Homo sapiens	Treatment: treated with non-targeting dsRNA;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060998		Homo sapiens	Treatment: treated with non-targeting dsRNA;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP060999		Homo sapiens		NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061000		Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061001		Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061002		Homo sapiens		NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061003		Homo sapiens	Treatment: knocked out of ZIC2 gene by CRISPR/Cas9; Genotype: ZIC2 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061004		Homo sapiens	Treatment: knocked out of ZIC2 gene by CRISPR/Cas9; Genotype: ZIC2 knockout;	NULL	3011	chip_control	NULL	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061005	anti-ZIC5CT289 (homemade)	Homo sapiens		EXP060990	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061006	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP060991	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061007	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP060992	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061008	anti-ZIC5FL290 (homemade)	Homo sapiens		EXP060993	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061009	anti-ZIC5FL290 (homemade)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP060994	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061010	anti-ZIC5CT289 (homemade)	Homo sapiens	Genotype: overexpressed with GFP-Zic5;	NULL	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061011	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with non-targeting dsRNA;	EXP060995	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061012	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with CTNNB1 dsRNA; Genotype: CTNNB1 knockout;	EXP060996	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061013	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with non-targeting dsRNA;	EXP060997	3011	normal	Q96T25	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061014	anti-ZIC5CT289 (homemade)	Homo sapiens	Treatment: treated with TCF7L2 dsRNA; Genotype: TCF7L2 knockout;	EXP060998	3011	normal	A0AVK6	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061015	anti-TCF7L2 (CST)	Homo sapiens		EXP060999	3011	normal	Q9NQB0	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061016	anti-TCF7L2 (CST)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP061000	3011	normal	Q9NQB0	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061017	anti-TCF7L2 (CST)	Homo sapiens	Treatment: knocked out of ZIC5 gene by CRISPR/Cas9; Genotype: Zic5 knockout;	EXP061001	3011	normal	Q9NQB0	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061018	anti-ZIC2 (Abcam)	Homo sapiens		EXP061002	3011	normal	O95409	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061019	anti-ZIC2 (Abcam)	Homo sapiens	Treatment: knocked out of ZIC2 gene by CRISPR/Cas9; Genotype: ZIC2 knockout;	EXP061003	3011	normal	O95409	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061020	anti-ZIC2 (Abcam)	Homo sapiens	Treatment: knocked out of ZIC2 gene by CRISPR/Cas9; Genotype: ZIC2 knockout;	EXP061004	3011	normal	O95409	CRC107 (colorectal cancer metastatic stem cells)	NULL
EXP061021	anti-IRF9 (D2T8M, Cell Signaling Technology Cat# 76684)	Homo sapiens	Treatment: 90min with 250 IU/mL of IFN-beta;	NULL	2334	normal	Q00978	THP-1 (acute monocytic leukemia)	NULL
EXP061022	anti-IRF9 (D2T8M, Cell Signaling Technology Cat# 76684)	Homo sapiens		NULL	2334	normal	Q00978	THP-1 (acute monocytic leukemia)	NULL
EXP061023	anti-Stat1 (D4Y6Z, Cell Signaling Technology Cat# 14995, RRID:AB_2716280)	Homo sapiens	Treatment: 90min with 250 IU/mL of IFN-beta;	NULL	2334	normal	P42224	THP-1 (acute monocytic leukemia)	NULL
EXP061024	anti-Stat1 (D4Y6Z, Cell Signaling Technology Cat# 14995, RRID:AB_2716280)	Homo sapiens		NULL	2334	normal	P42224	THP-1 (acute monocytic leukemia)	NULL
EXP061025	anti-Stat2 (D9J7L, Cell Signaling Technology Cat#72604)	Homo sapiens	Treatment: 90min with 250 IU/mL of IFN-beta;	NULL	2334	normal	P52630	THP-1 (acute monocytic leukemia)	NULL
EXP061026	anti-Stat2 (D9J7L, Cell Signaling Technology Cat#72604)	Homo sapiens		NULL	2334	normal	P52630	THP-1 (acute monocytic leukemia)	NULL
EXP061027	none	Homo sapiens	Treatment: retrovirus mediated trasduction of pBabe vector;	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP061028	none	Homo sapiens	Treatment: retrovirus mediated transduction of pBabe-LKB1; Genotype:LKB1 expression; 	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP061029	anti-CREB (rabbit serum, 244)	Homo sapiens	Treatment: retrovirus mediated trasduction of pBabe vector;	EXP061027	38	normal	P16220	A549 (lung carcinoma)	NULL
EXP061030	anti-CRTC2 (rabbit serum, 6865 )	Homo sapiens	Treatment: retrovirus mediated trasduction of pBabe vector;	EXP061027	38	normal	Q53ET0	A549 (lung carcinoma)	NULL
EXP061031	anti-CREB (rabbit serum, 244)	Homo sapiens	Treatment: retrovirus mediated transduction of pBabe-LKB1; Genotype:LKB1 expression; 	EXP061028	38	normal	P16220	A549 (lung carcinoma)	NULL
EXP061032	anti-CRTC2 (rabbit serum, 6865 )	Homo sapiens	Treatment: retrovirus mediated transduction of pBabe-LKB1; Genotype:LKB1 expression; 	EXP061028	38	normal	Q53ET0	A549 (lung carcinoma)	NULL
EXP061033	anti-NMYC antibody (sc-53993)	Homo sapiens		NULL	4289	normal	P04198	CHP-134 (Neuroblastoma)	NULL
EXP061034	anti-JMJD6 antibody (ab64575)	Homo sapiens		NULL	4289	normal	Q6NYC1	CHP-134 (Neuroblastoma)	NULL
EXP061035	none	Homo sapiens	Genotype: wildtype;	NULL	4290	chip_control	NULL	12Z (endometriotic epithelial cells)	NULL
EXP061036	anti-ARID1A antibody (12354, Cell Signaling)	Homo sapiens	Genotype: wildtype;	EXP061035	4290	normal	O14497	12Z (endometriotic epithelial cells)	NULL
EXP061037	none	Homo sapiens		NULL	4291	chip_control	NULL	GMA24A1F (Keratinocytes cell)	NULL
EXP061038	anti-Deaf1 (PMID: 14507979)	Homo sapiens		EXP061037	4291	normal	O75398	GMA24A1F (Keratinocytes cell)	NULL
EXP061039	none (input)	Homo sapiens	Treatment: siCtrl;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061040	none (input)	Homo sapiens	Treatment: siCtrl;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061041	none (input)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061042	none (input)	Homo sapiens	Treatment: siYAP,siTAZ; Genotype: YAP, TAZ double knockout;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061043	none (input)	Homo sapiens	Treatment: siE1A, siYAP,siTAZ; Genotype: YAP, TAZ, E1A triple knockout;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061044	anti-YAP (D8H1X, Cell Signaling Technology Cat#14074, Rabbit monoclonal )	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	P46937	HEK293 (embryonic kidney)	NULL
EXP061045	anti-YAP (D8H1X, Cell Signaling Technology Cat#14074, Rabbit monoclonal )	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	P46937	HEK293 (embryonic kidney)	NULL
EXP061046	anti-TEF1 (a.k.a. TEAD1 (31/TEF1) BD Transduction Laboratories Cat#610922, Mouse monoclonal)	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	P28347	HEK293 (embryonic kidney)	NULL
EXP061047	anti-TEF1 (a.k.a. TEAD1 (31/TEF1) BD Transduction Laboratories Cat#610922, Mouse monoclonal)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	P28347	HEK293 (embryonic kidney)	NULL
EXP061048	anti-TEF-3 (a.k.a. TEAD4 (N-G2) Santa Cruz Cat#sc-101184, Mouse monoclonal)	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	Q15561	HEK293 (embryonic kidney)	NULL
EXP061049	anti-TEF-3 (a.k.a. TEAD4 (N-G2) Santa Cruz Cat#sc-101184, Mouse monoclonal)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	Q15561	HEK293 (embryonic kidney)	NULL
EXP061050	anti-RAD21 (abcam Cat#ab992,Rabbit polyclonal )	Homo sapiens	Treatment: siCtrl;	EXP061039	421	normal	O60216	HEK293 (embryonic kidney)	NULL
EXP061051	anti-RAD21 (abcam Cat#ab992,Rabbit polyclonal )	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	EXP061043	421	normal	O60216	HEK293 (embryonic kidney)	NULL
EXP061052	anti-RAD21 (abcam Cat#ab992, Rabbit polyclonal )	Homo sapiens	Treatment: siCtrl;	EXP061042	421	normal	O60216	HEK293 (embryonic kidney)	NULL
EXP061053	anti-RAD21 (abcam Cat#ab992, Rabbit polyclonal )	Homo sapiens	Treatment: siE1A, siYAP,siTAZ; Genotype: YAP, TAZ, E1A triple knockout;	EXP061043	421	normal	O60216	HEK293 (embryonic kidney)	NULL
EXP061054	none (input)	Homo sapiens	Treatment: siE1A; Genotype: E1A knockout;	NULL	421	normal	A0AVK6	HEK293 (embryonic kidney)	NULL
EXP061055	none	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP061056	anti-Snail	Homo sapiens		EXP061055	78	normal	O95863	HeLa (cervical adenocarcinoma)	NULL
EXP061057	anti-MTA1	Homo sapiens		EXP061055	78	normal	Q13330	HeLa (cervical adenocarcinoma)	NULL
EXP061058	anti-PRMT5	Homo sapiens		EXP061055	78	normal	O14744	HeLa (cervical adenocarcinoma)	NULL
EXP061059	input	Homo sapiens		NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP061060	input	Homo sapiens		NULL	817	chip_control	NULL	SUM159PT (Triple negative breast cancer)	NULL
EXP061061	input	Homo sapiens		NULL	864	chip_control	NULL	WHIM12 (breast cancer)	NULL
EXP061062	input	Homo sapiens		NULL	864	chip_control	NULL	WHIM12 (breast cancer)	NULL
EXP061063	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061059	817	normal	P84022	SUM159PT (Triple negative breast cancer)	NULL
EXP061064	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061060	817	normal	P84022	SUM159PT (Triple negative breast cancer)	NULL
EXP061065	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061061	864	normal	P84022	WHIM12 (breast cancer)	NULL
EXP061066	anti-SMAD3 (Abcam, ab28379)	Homo sapiens		EXP061062	864	normal	P84022	WHIM12 (breast cancer)	NULL
EXP061067	no antibody	Homo sapiens	Treatment: DMSO for 4.5 hrs;	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP061068	anti-SPT6 (Novus Biologicals, NB100-2582)	Homo sapiens	Treatment: DMSO for 4.5 hrs;	EXP061067	417	normal	Q7KZ85	HCT-116 (colon carcinoma)	NULL
EXP061069	anti-SPT6 (Novus Biologicals, NB100-2582)	Homo sapiens	Treatment: 5 uM 3-MB-PP1 for 4.5 hrs;	NULL	417	normal	Q7KZ85	HCT-116 (colon carcinoma)	NULL
EXP061070		Homo sapiens	Treatment: untreated;	NULL	685	chip_control	NULL	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP061071	anti-FOXO1	Homo sapiens	Treatment: untreated;	EXP061070	685	normal	Q12778	OCI-LY1 (diffuse large B-cell lymphoma)	NULL
EXP061072	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours and then stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	NULL
EXP061073	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: treated with IFN-gamma (100 U/ml) for 48 hours;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	NULL
EXP061074	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: stimulated with LPS (10 ng/ml) for 3 hours;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	NULL
EXP061075	anti-CBP (Santa Cruz sc-369)	Homo sapiens	Treatment: resting;	NULL	4262	normal	Q92793	monocyte-derived macrophages from peripheral blood	NULL
EXP061076	ChIP-input	Homo sapiens	Treatment: CRISPRa-CTCF;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP061077	ChIP-input	Homo sapiens	Treatment: CRISPRk-CTCF;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP061078	ChIP-input	Homo sapiens	Treatment: CRISPRi-CTCF;	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP061079	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRa-CTCF;	EXP061076	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP061080	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRk-CTCF;	EXP061077	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP061081	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRi-CTCF;	EXP061078	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP061082	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRa-CTCF;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP061083	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRk-CTCF;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP061084	anti-CTCF(Millipore, 07-729)	Homo sapiens	Treatment: CRISPRi-CTCF;	NULL	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP061085	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R175H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061086	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: Y220C p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061087	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: M237I p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061088	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R248Q p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061089	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R273H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061090	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: R282W p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061091	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype: p53 knockout;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061092	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 24 hrs; Genotype:  p53 wildtype;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061093	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R175H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061094	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: Y220C p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061095	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: Y220C p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061096	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R248Q p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061097	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R273H p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061098	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: R282W p53 mutant;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061099	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: p53 knockout;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061100	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 24 hrs; Genotype: wildtype;	NULL	514	normal	P04637	K562 (myelogenous leukemia)	NULL
EXP061101	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R175H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061102	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: Y220C p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061103	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: M237I p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061104	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R248Q p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061105	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R273H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061106	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: R282W p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061107	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype: p53 knockout;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061108	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: DMSO for 6 hrs; Genotype:  p53 wildtype;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061109	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R175H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061110	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: Y220C p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061111	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: M237I p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061112	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R248Q p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061113	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R273H p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061114	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: R282W p53 mutant;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061115	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: p53 knockout;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061116	anti-p53 (mAB clone DO-1, abcam, #1101)	Homo sapiens	Treatment: 100 nM daunorubicin for 6 hrs; Genotype: p53 wildtype;	NULL	2219	normal	P04637	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP061117	IgG (Abcam ab37415)	Homo sapiens	Genotype: wild type NSD2 allele inactivated;	NULL	1183	chip_control	NULL	KMS-11 (Plasma cell myeloma)	NULL
EXP061118	IgG (Abcam ab37415)	Homo sapiens	Genotype: overexpressed NSD2 allele inactivated;	NULL	1183	chip_control	NULL	KMS-11 (Plasma cell myeloma)	NULL
EXP061119	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: wild type NSD2 allele inactivated;	EXP061117	1183	normal	P49711	KMS-11 (Plasma cell myeloma)	NULL
EXP061120	anti-CTCF (Millipore 07-729)	Homo sapiens	Genotype: overexpressed NSD2 allele inactivated;	EXP061118	1183	normal	P49711	KMS-11 (Plasma cell myeloma)	NULL
EXP061121	anti-Tcf21 antibody (Sigma #HPA013189)	Homo sapiens		NULL	192	normal	O43680	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP061122	none (input)	Homo sapiens		NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061123	anti-BMI1 (active motif, 39993)	Homo sapiens		EXP061122	725	normal	P35226	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061124	anti-RNF2 (MBL, D139-3)	Homo sapiens		EXP061122	725	normal	Q99496	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061125	anti-PCGF1 (santa cruz, Sc-515371)	Homo sapiens		EXP061122	725	normal	Q9BSM1	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061126	anti-PHC2 (active motif, 39661)	Homo sapiens		EXP061122	725	normal	Q8IXK0	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061127	anti-KDM2B (millipore, 09-864)	Homo sapiens		EXP061122	725	normal	Q8NHM5	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061128	none	Homo sapiens	Genotype: stably expressing Empty Vector (EV);	NULL	4295	chip_control	NULL	FT282 (normal human fallopian tube tissue)	NULL
EXP061129	anti-CTCF (characterized in PMID:15731119, custom mouse monoclonal )	Homo sapiens	Genotype: stably expressing Empty Vector (EV);	EXP061128	4295	normal	P49711	FT282 (normal human fallopian tube tissue)	NULL
EXP061130	anti-CTCF (characterized in PMID:15731119, custom mouse monoclonal )	Homo sapiens	Genotype: stably expressing BORIS;	NULL	4295	normal	P49711	FT282 (normal human fallopian tube tissue)	NULL
EXP061131	anti-BORIS  (characterized in PMID: 21659515, custom mouse monoclonal )	Homo sapiens	Genotype: stably expressing BORIS;	NULL	4295	normal	Q8NI51	FT282 (normal human fallopian tube tissue)	NULL
EXP061132	input for RELA	Homo sapiens	Treatment: None;	NULL	3042	chip_control	NULL	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP061133	anti-RELA antibody (NFKB p65 (c20): sc-372)	Homo sapiens	Treatment: None;	EXP061132	3042	normal	Q04206	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP061134	anti-RELA antibody (NFKB p65 (c20): sc-372)	Homo sapiens	Treatment: LPS at 1ug/mL for 60 minutes;	NULL	3042	normal	Q04206	FaDu(Hypopharyngeal squamous cell carcinoma)	NULL
EXP061135	none	Homo sapiens		NULL	2301	chip_control	NULL	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP061136	anti-Fra-1 (sc-376148X, lot G0814, Santa Cruz Biotechnology)	Homo sapiens		EXP061135	2301	normal	P15407	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP061137	anti-Fra-2 (sc-13017X, lot J2403, Santa Cruz Biotechnology)	Homo sapiens		EXP061135	2301	normal	P15408	MDA-MB-231 (breast adenocarcinoma)	NULL
EXP061138	NA	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	4296	chip_control	NULL	143B (Osteosarcoma)	NULL
EXP061139	NA	Homo sapiens	Treatment: 200 nM E9 for 6 hrs;	NULL	4296	chip_control	NULL	143B (Osteosarcoma)	NULL
EXP061140	NA	Homo sapiens	Treatment: DMSO for 6 hrs;	NULL	1486	chip_control	NULL	MG63 (Osteosarcoma )	NULL
EXP061141	NA	Homo sapiens	Treatment: 200 nM E9 for 6 hrs;	NULL	1486	chip_control	NULL	MG63 (Osteosarcoma )	NULL
EXP061142	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP061138	4296	normal	Q9NYV4	143B (Osteosarcoma)	NULL
EXP061143	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: 200 nM E9 for 6 hrs;	EXP061139	4296	normal	Q9NYV4	143B (Osteosarcoma)	NULL
EXP061144	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: DMSO for 6 hrs;	EXP061140	1486	normal	Q9NYV4	MG63 (Osteosarcoma )	NULL
EXP061145	anti-CDK12 (gift from Arno Greenleaf)	Homo sapiens	Treatment: 200 nM E9 for 6 hrs;	EXP061141	1486	normal	Q9NYV4	MG63 (Osteosarcoma )	NULL
EXP061146	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment: DMSO; Genotype: HA-tagged LSF;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP061147	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment:  5 uM RSL1 ligand for 24 hrs; Genotype: HA-tagged LSF;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP061148	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment: DMSO; Genotype: HA-tagged LSF;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP061149	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment:  5 uM RSL1 ligand for 24 hrs; Genotype: HA-tagged LSF;	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP061150	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment: DMSO; Genotype: HA-tagged LSF;	EXP061146	10	normal	Q12800	HEK293T (embryonic kidney)	NULL
EXP061151	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment:  5 uM RSL1 ligand for 24 hrs; Genotype: HA-tagged LSF;	EXP061147	10	normal	Q12800	HEK293T (embryonic kidney)	NULL
EXP061152	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment: DMSO; Genotype: HA-tagged LSF;	EXP061148	10	normal	Q12800	HEK293T (embryonic kidney)	NULL
EXP061153	Anti-HA (Abcam ab9110)	Homo sapiens	Treatment:  5 uM RSL1 ligand for 24 hrs; Genotype: HA-tagged LSF;	EXP061149	10	normal	Q12800	HEK293T (embryonic kidney)	NULL
EXP061154	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens		NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061155	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens		NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061156	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: D538G ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061157	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: D538G Clone1 ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061158	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: D538G ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061159	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: D538G clone 2 ESR1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061160	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: D538G ESR1 clone 3 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061161	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: D538G ESR1 clone 1 mutant;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061162	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: wildtype clone 1 ESR1;	EXP061154	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061163	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: wildtype clone 1 ESR1;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061164	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 10nM E2 for 1 hr; Genotype: wildtype clone 2 ESR1;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061165	Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256)	Homo sapiens	Treatment: 0.1% DMSO for 1 hr; Genotype: wildtype clone 2 ESR1;	NULL	504	normal	P03372	Ishikawa (endometrial adenocarcinoma)	NULL
EXP061166	None	Homo sapiens	Time point: 2 days of differentiation; Conditions:  altered 2C protocols;	NULL	4297	chip_control	NULL	iPS-derived dermal fibroblasts	NULL
EXP061167	None	Homo sapiens	Time point: 5 days of differentiation; Conditions:  altered 2C protocols;	NULL	4297	chip_control	NULL	iPS-derived dermal fibroblasts	NULL
EXP061168	None	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	NULL	4297	chip_control	NULL	iPS-derived dermal fibroblasts	NULL
EXP061169	None	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	NULL	4297	chip_control	NULL	iPS-derived dermal fibroblasts	NULL
EXP061170	anti-non-phospho beta-catenin antibody (Cell Signaling Technology, 8814)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	EXP061168	4297	normal	P35222	iPS-derived dermal fibroblasts	NULL
EXP061171	anti-non-phospho beta-catenin antibody (Cell Signaling Technology, 8814)	Homo sapiens	Time point: 3 days of differentiation; Conditions:  altered 2C protocols;	NULL	4297	normal	P35222	iPS-derived dermal fibroblasts	NULL
EXP061172	anti-non-phospho beta-catenin antibody (Cell Signaling Technology, 8814)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  altered 2C protocols;	EXP061166	4297	normal	P35222	iPS-derived dermal fibroblasts	NULL
EXP061173	anti-human RARa antibody (Perseus Proteomics, PP-H1920-00, Mouse)	Homo sapiens	Time point: 5 days of differentiation; Conditions:  altered 2C protocols;	EXP061167	4297	normal	P10276	iPS-derived dermal fibroblasts	NULL
EXP061174	anti-human RARa antibody (Perseus Proteomics, PP-H1920-00, Mouse)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	EXP061168	4297	normal	P10276	iPS-derived dermal fibroblasts	NULL
EXP061175	anti-human RARa antibody (Perseus Proteomics, PP-H1920-00, Mouse)	Homo sapiens	Time point: 2 days of differentiation; Conditions:  standard 2C protocol;	EXP061169	4297	normal	P10276	iPS-derived dermal fibroblasts	NULL
EXP061176	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP061177	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  untreated;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	NULL
EXP061178	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  Progesterone;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	NULL
EXP061179	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP061180	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	NULL
EXP061181	anti-C/EBPalpha (Cell Signaling, 8178S)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P49715	T47D (invasive ductal carcinoma)	NULL
EXP061182	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP061183	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone, siControl;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP061184	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP061185	anti-PR (H190 Santa Cruz)	Homo sapiens	Treatment:  Progesterone, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP061186	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP061187	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  Progesterone, siControl;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP061188	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP061189	Anti-Rad21 (ab992)	Homo sapiens	Treatment:  Progesterone, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	O60216	T47D (invasive ductal carcinoma)	NULL
EXP061190	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  no progesterone treatment, siControl;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	NULL
EXP061191	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  Progesterone, siControl;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	NULL
EXP061192	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  no progesterone treatment, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	NULL
EXP061193	anti-IRF1 (Santa Cruz, sc-3659)	Homo sapiens	Treatment:  Progesterone, siCEBPa; Genotype: CEBPa knockout;	NULL	111	normal	P10914	T47D (invasive ductal carcinoma)	NULL
EXP061194	none	Homo sapiens		NULL	4298	chip_control	NULL	ESO-26 (Gastroesophageal junction adenocarcinoma)	NULL
EXP061195	anti-KLF5	Homo sapiens		EXP061194	4298	normal	Q13887	ESO-26 (Gastroesophageal junction adenocarcinoma)	NULL
EXP061196	anti-Flag	Homo sapiens		EXP061194	4298	normal	P78545	ESO-26 (Gastroesophageal junction adenocarcinoma)	NULL
EXP061197	anti-GATA6	Homo sapiens		EXP061194	4298	normal	Q92908	ESO-26 (Gastroesophageal junction adenocarcinoma)	NULL
EXP061198	none (input)	Homo sapiens		NULL	4299	chip_control	NULL	PNT1A (human post pubertal prostate normal)	NULL
EXP061199	none (input)	Homo sapiens		NULL	70	chip_control	NULL	LNCaP (prostate carcinoma)	NULL
EXP061200	none (input)	Homo sapiens		NULL	2667	chip_control	NULL	PC-3M-luc (human prostate carcinoma)	NULL
EXP061201	anti-Menin (Bethyl, INC, rabbit, polyclonal)	Homo sapiens		EXP061198	4299	normal	O00255	PNT1A (human post pubertal prostate normal)	NULL
EXP061202	anti-Menin (Bethyl, INC, rabbit, polyclonal)	Homo sapiens		EXP061199	70	normal	O00255	LNCaP (prostate carcinoma)	NULL
EXP061203	anti-Menin (Bethyl, INC, rabbit, polyclonal)	Homo sapiens		EXP061200	2667	normal	O00255	PC-3M-luc (human prostate carcinoma)	NULL
EXP061204	anti-c-myc antibody	Homo sapiens	Treatment: siRNA control; 	NULL	219	normal	P01106	DLD-1 (colon adenocarcinoma)	NULL
EXP061205	anti-c-myc antibody	Homo sapiens	Treatment: siRNA lncRNA-AF339830;  Genotype: lncRNA-AF339830 knockout;	NULL	219	normal	P01106	DLD-1 (colon adenocarcinoma)	NULL
EXP061206	none	Homo sapiens	Treatment: retrovirally-infected; Genotype: FLAG tagged MED25;	NULL	725	chip_control	NULL	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061207	anti-FLAG (Sigma Life Sciences, F1804)	Homo sapiens	Treatment: retrovirally-infected; Genotype: FLAG tagged MED25;	EXP061206	725	normal	Q71SY5	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061208	anti-ETV4 (Aviva Systems Biology, ARP32262)	Homo sapiens	Treatment: retrovirally-infected; Genotype: FLAG tagged MED25;	EXP061206	725	normal	P43268	PC3(bone mets prostate adenocarcinoma)	NULL
EXP061209	input chromatin	Homo sapiens		NULL	4221	chip_control	NULL	hTERT-HME1(Telomerase immortalized cell line)	NULL
EXP061210	input chromatin	Homo sapiens		NULL	4221	chip_control	NULL	hTERT-HME1(Telomerase immortalized cell line)	NULL
EXP061211	anti-BRCA2	Homo sapiens		EXP061209	4221	normal	P51587	hTERT-HME1(Telomerase immortalized cell line)	NULL
EXP061212	anti-BRCA2	Homo sapiens		EXP061210	4221	normal	P51587	hTERT-HME1(Telomerase immortalized cell line)	NULL
EXP061213	none	Homo sapiens	Treatment: DMSO for 24 hrs;	NULL	3642	chip_control	NULL	NHEK (normal human epidermal keratinocytes)	NULL
EXP061214	none	Homo sapiens	Treatment: DMSO for 24 hrs;	NULL	3642	chip_control	NULL	NHEK (normal human epidermal keratinocytes)	NULL
EXP061215	none	Homo sapiens	Treatment: GSK-LSD1 (2 mM) for 2 days;	NULL	3642	chip_control	NULL	NHEK (normal human epidermal keratinocytes)	NULL
EXP061216	none	Homo sapiens	Treatment: GSK-LSD1 (2 mM) for 2 days;	NULL	3642	chip_control	NULL	NHEK (normal human epidermal keratinocytes)	NULL
EXP061217	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: DMSO for 24 hrs;	EXP061213	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	NULL
EXP061218	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: DMSO for 24 hrs;	EXP061214	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	NULL
EXP061219	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: GSK-LSD1 (2 mM) for 2 days;	EXP061215	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	NULL
EXP061220	anti-Kdm1a (Abcam, Cat# ab17721, Rabbit polyclonal)	Homo sapiens	Treatment: GSK-LSD1 (2 mM) for 2 days;	EXP061216	3642	normal	O60341	NHEK (normal human epidermal keratinocytes)	NULL
EXP061221	HA (F-7)	Homo sapiens	Treatment: EtOH; 	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061222	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 5 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061223	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 10 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061224	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 15 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061225	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 30 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061226	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 60 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061227	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 90 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061228	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 360 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061229	HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 1440 mins;	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP061230	anti-HA (F-7)	Homo sapiens	Treatment: EtOH; 	EXP061221	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061231	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 5 mins;	EXP061222	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061232	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 10 mins;	EXP061223	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061233	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 15 mins;	EXP061224	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061234	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 30 mins;	EXP061225	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061235	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 60 mins;	EXP061226	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061236	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 90 mins;	EXP061227	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061237	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 360 mins;	EXP061228	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061238	anti-HA (F-7)	Homo sapiens	Treatment: 100nM 4OHT; Time point: 1440 mins;	EXP061229	421	normal	P20226	HEK293 (embryonic kidney)	NULL
EXP061239	None	Homo sapiens	Treatment: DMSO 8 days;	NULL	1138	chip_control	NULL	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061240	None	Homo sapiens	Treatment: DMSO 4 days;	NULL	3607	chip_control	NULL	KMS-28BM (Plasma cell myeloma)	NULL
EXP061241	None	Homo sapiens	Treatment: DMSO 4 days;	NULL	4301	chip_control	NULL	KMS-28PE (Plasma cell myeloma)	NULL
EXP061242	None	Homo sapiens	Treatment: DMSO 10 days;	NULL	4302	chip_control	NULL	RL (Diffuse large B-cell lymphoma)	NULL
EXP061243	None	Homo sapiens	Treatment: 5uM CPI169 10 days;	NULL	4302	chip_control	NULL	RL (Diffuse large B-cell lymphoma)	NULL
EXP061244	None	Homo sapiens	Treatment: DMSO 4 days;	NULL	1511	chip_control	NULL	RPMI8226 (Plasma cell myeloma)	NULL
EXP061245	None	Homo sapiens	Treatment: 1.5um CPI360 4 days;	NULL	1511	chip_control	NULL	RPMI8226 (Plasma cell myeloma)	NULL
EXP061246	None	Homo sapiens	Treatment: DMSO 4 days;	NULL	816	chip_control	NULL	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP061247	None	Homo sapiens	Treatment: 1.5uM Compound 1 4 days;	NULL	816	chip_control	NULL	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP061248	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 8 days;	EXP061239	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061249	anti-Suz12 (Active Motif 39357)	Homo sapiens	Treatment: DMSO 8 days;	EXP061239	1138	normal	Q15022	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061250	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatmen: 1.5uM CPI360 8 days;	NULL	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061251	anti-Suz12 (Active Motif 39357)	Homo sapiens	Treatmen: 1.5uM CPI360 8 days;	NULL	1138	normal	Q15022	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061252	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5uM CPI360 4 days;	NULL	1138	normal	Q15910	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061253	anti-Suz12 (Active Motif 39357)	Homo sapiens	Treatment: 1.5uM CPI360 4 days;	NULL	1138	normal	Q15022	KARPAS-422 (diffuse large B-cell lymphoma)	NULL
EXP061254	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061240	3607	normal	Q15910	KMS-28BM (Plasma cell myeloma)	NULL
EXP061255	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5um CPI360 4 days;	NULL	3607	normal	Q15910	KMS-28BM (Plasma cell myeloma)	NULL
EXP061256	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061241	4301	normal	Q15910	KMS-28PE (Plasma cell myeloma)	NULL
EXP061257	Millipore 07-689	Homo sapiens	1.5uM CPI360 4 days	NULL	4301	normal	Q15910	KMS-28PE (Plasma cell myeloma)	NULL
EXP061258	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 10 days;	EXP061242	4302	normal	Q15910	RL (Diffuse large B-cell lymphoma)	NULL
EXP061259	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 5uM CPI169 10 days;	EXP061243	4302	normal	Q15910	RL (Diffuse large B-cell lymphoma)	NULL
EXP061260	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061244	1511	normal	Q15910	RPMI8226 (Plasma cell myeloma)	NULL
EXP061261	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5um CPI360 4 days;	EXP061245	1511	normal	Q15910	RPMI8226 (Plasma cell myeloma)	NULL
EXP061262	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: DMSO 4 days;	EXP061246	816	normal	Q15910	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP061263	anti-EZH2 (Millipore 07-689)	Homo sapiens	Treatment: 1.5uM Compound 1 4 days;	EXP061247	816	normal	Q15910	SU-DHL-6 (diffuse large B-cell lymphoma)	NULL
EXP061264	anti-EGR1 Ab (sc-189X)	Homo sapiens	Treatment: DMSO, ethanol; Genotype: B-RAF-V600E expression;	NULL	2616	normal	P18146	BJ1-hTERT (Human fibroblast telomerase immortalized cell line)	NULL
EXP061265	anti-EGR1 Ab (sc-189X)	Homo sapiens	Treatment: DMSO, doxycycline 1000 ng mL-1; Genotype: B-RAF-V600E expression;	NULL	2616	normal	P18146	BJ1-hTERT (Human fibroblast telomerase immortalized cell line)	NULL
EXP061266	anti-EGR1 Ab (sc-189X)	Homo sapiens	Treatment: clobetasol 2nM, doxycycline 1000 ng mL-1; Genotype: B-RAF-V600E expression;	NULL	2616	normal	P18146	BJ1-hTERT (Human fibroblast telomerase immortalized cell line)	NULL
EXP061267	Anti-Flag	Homo sapiens		NULL	10	normal	P27694	HEK293T (embryonic kidney)	NULL
EXP061268	Anti-Flag	Homo sapiens		NULL	10	normal	P38159	HEK293T (embryonic kidney)	NULL
EXP061269	none (Input)	Homo sapiens	Treatment: vehicle, shCtrl;	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP061270	none (Input)	Homo sapiens	Treatment: dexamethasone (100 nM) for 10 minutes, shCtrl;	NULL	87	chip_control	NULL	BEAS-2B (bronchial epithelium)	NULL
EXP061271	anti-GR(GR-356)	Homo sapiens	Treatment: vehicle, shCtrl;	EXP061269	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP061272	anti-GR(GR-356)	Homo sapiens	Treatment: dexamethasone (100 nM) for 10 minutes, shCtrl;	EXP061270	87	normal	P04150	BEAS-2B (bronchial epithelium)	NULL
EXP061273	none (input)	Homo sapiens		NULL	4303	chip_control	NULL	ME-180 (Human papillomavirus-related cervical squamous cell carcinoma)	NULL
EXP061274	anti-p63 (CST, 13109S)	Homo sapiens		EXP061273	4303	normal	Q9H3D4	ME-180 (Human papillomavirus-related cervical squamous cell carcinoma)	NULL
EXP061275		Homo sapiens		NULL	2320	chip_control	NULL	primary human epidermal keratinocytes	NULL
EXP061276	anti-BRD4	Homo sapiens	Cell type: low stem cell potential;	EXP061275	2320	normal	O60885	primary human epidermal keratinocytes	NULL
EXP061277	anti-BRD4	Homo sapiens	Cell type: high stem cell potential.;	EXP061275	2320	normal	O60885	primary human epidermal keratinocytes	NULL
EXP061278	anti-HA	Homo sapiens	Treatment: no treatment, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	NULL	2320	chip_control	NULL	primary human epidermal keratinocytes	NULL
EXP061279	anti-HA	Homo sapiens	Treatment: no treatment, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	NULL	2320	chip_control	NULL	primary human epidermal keratinocytes	NULL
EXP061280	anti-HA	Homo sapiens	Treatment: treated with 1ug/ml Doxycycline for 3 days plus 2 days with 2ug/ml Doxycycline, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	NULL	2320	chip_control	NULL	primary human epidermal keratinocytes	NULL
EXP061281	anti-HA	Homo sapiens	Treatment: treated with 1ug/ml Doxycycline for 3 days plus 2 days with 2ug/ml Doxycycline, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	NULL	2320	chip_control	NULL	primary human epidermal keratinocytes	NULL
EXP061282	anti-HA	Homo sapiens	Treatment: no treatment, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061278	2320	normal	P14316	primary human epidermal keratinocytes	NULL
EXP061283	anti-HA	Homo sapiens	Treatment: no treatment, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061279	2320	normal	P14316	primary human epidermal keratinocytes	NULL
EXP061284	anti-HA	Homo sapiens	Treatment: treated with 1ug/ml Doxycycline for 3 days plus 2 days with 2ug/ml Doxycycline, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061280	2320	normal	P14316	primary human epidermal keratinocytes	NULL
EXP061285	anti-HA	Homo sapiens	Treatment: treated with 1ug/ml Doxycycline for 3 days plus 2 days with 2ug/ml Doxycycline, shRNA IRF2; Genotype: IRF2  knockdown and a doxycyline inducible IRF2-3xHA allele;	EXP061281	2320	normal	P14316	primary human epidermal keratinocytes	NULL
EXP061286	none	Homo sapiens	Treatment: DOX (1ug/mL) for 48 hour;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP061287	none	Homo sapiens	Treatment: Control;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP061288	none	Homo sapiens	Treatment: DOX (1ug/mL) for 48 hour;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP061289	anti-beta-catenin (CST)	Homo sapiens	Treatment: Control;	EXP061287	430	normal	P35222	HepG2 (hepatoblastoma)	NULL
EXP061290	anti-beta-catenin (CST)	Homo sapiens	Treatment: DOX (1ug/mL) for 48 hour;	EXP061286	430	normal	P35222	HepG2 (hepatoblastoma)	NULL
EXP061291	anti-FLAG(Abcam)	Homo sapiens	Treatment: DOX (1ug/mL) for 48 hour;	EXP061288	430	normal	P43694	HepG2 (hepatoblastoma)	NULL
EXP061292	N/A	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP061293	N/A	Homo sapiens		NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP061294	N/A	Homo sapiens		NULL	4304	chip_control	NULL	DKO-1 (Colon adenocarcinoma)	NULL
EXP061295	N/A	Homo sapiens		NULL	4304	chip_control	NULL	DKO-1 (Colon adenocarcinoma)	NULL
EXP061296	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061292	417	normal	P51608	HCT-116 (colon carcinoma)	NULL
EXP061297	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061293	417	normal	P51608	HCT-116 (colon carcinoma)	NULL
EXP061298	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061294	4304	normal	P51608	DKO-1 (Colon adenocarcinoma)	NULL
EXP061299	anti-MeCP2 (Diagenode, pAb-052-050)	Homo sapiens		EXP061295	4304	normal	P51608	DKO-1 (Colon adenocarcinoma)	NULL
EXP061300	none	Homo sapiens		NULL	4306	chip_control	NULL	ocular melanoma cells	NULL
EXP061301	anti-CTCF antibody(Active Motif, Catalog No: 61311)	Homo sapiens		EXP061300	4306	normal	P49711	ocular melanoma cells	NULL
EXP061302	anti-ZNF274	Homo sapiens	Sex: female;  Donor: ENCDO000ABF;	NULL	421	normal	Q96GC6	HEK293 (embryonic kidney)	NULL
EXP061303	anti-GFP	Homo sapiens	Sex: female; Age: 53 year; Donor: ENCDO000AAD;	NULL	514	normal	Q9UQR1	K562 (myelogenous leukemia)	NULL
EXP061304	anti-XRCC5	Homo sapiens		NULL	430	normal	P13010	HepG2 (hepatoblastoma)	NULL
EXP061305	anti-HNRNPH1	Homo sapiens		NULL	430	normal	P31943	HepG2 (hepatoblastoma)	NULL
EXP061306	anti-SAFB	Homo sapiens		NULL	514	normal	Q15424	K562 (myelogenous leukemia)	NULL
EXP061307	anti-ZNF274	Homo sapiens		NULL	417	normal	Q96GC6	HCT-116 (colon carcinoma)	NULL
EXP061308	anti-TARDBP	Homo sapiens		NULL	430	normal	Q13148	HepG2 (hepatoblastoma)	NULL
EXP061309	anti-AGO2	Homo sapiens		NULL	430	normal	Q9UKV8	HepG2 (hepatoblastoma)	NULL
EXP061310	anti-GFP	Homo sapiens		NULL	514	normal	Q9NUA8	K562 (myelogenous leukemia)	NULL
EXP061311	anti-KDM5A	Homo sapiens		NULL	376	normal	P29375	WA01 (H1, human embryonic stem cells)	NULL
EXP061312	anti-GFP	Homo sapiens		NULL	514	normal	Q14119	K562 (myelogenous leukemia)	NULL
EXP061313	anti-CCAR2	Homo sapiens		NULL	430	normal	Q8N163	HepG2 (hepatoblastoma)	NULL
EXP061314	anti-GFP	Homo sapiens		NULL	514	normal	Q9H8N7	K562 (myelogenous leukemia)	NULL
EXP061315	anti-XRCC5	Homo sapiens		NULL	514	normal	P13010	K562 (myelogenous leukemia)	NULL
EXP061316	anti-CTCF	Homo sapiens	Sex: male; Age: 37 year; Donor: ENCDO845WKR;	NULL	4307	normal	P49711	body of pancreas	NULL
EXP061317	anti-HNRNPH1	Homo sapiens		NULL	514	normal	P31943	K562 (myelogenous leukemia)	NULL
EXP061318	anti-CCAR2	Homo sapiens		NULL	514	normal	Q8N163	K562 (myelogenous leukemia)	NULL
EXP061319	anti-RBM39	Homo sapiens		NULL	514	normal	Q14498	K562 (myelogenous leukemia)	NULL
EXP061320	anti-CTCF	Homo sapiens	Sex: female; Age: 51 years; Donor: ENCDO271OUW;	NULL	1181	normal	P49711	upper lobe of left lung	NULL
EXP061321	anti-SRSF9	Homo sapiens		NULL	514	normal	Q13242	K562 (myelogenous leukemia)	NULL
EXP061322	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061323	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 0.1uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061324	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 0.7uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061325	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061326	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 + 0.1uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061327	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 0.4uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061328	anti-AR (Millipore Cat. # 06-680, PG-21)	Homo sapiens	Treatment: 48 hour CSS + 12 hrs 1nM R1881 0.7uM Doxorubicin;	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP061329	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061330	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 0.1uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061331	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 0.7uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061332	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061333	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 + 0.1uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061334	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12h 1nM R1881 0.4uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061335	anti-TBP (Abcam Cat. #ab63766)	Homo sapiens	Treatment: 48 hour CSS + 12 hrs 1nM R1881 0.7uM Doxorubicin;	NULL	70	normal	P20226	LNCaP (prostate carcinoma)	NULL
EXP061336		Homo sapiens		NULL	672	chip_control	NULL	normal dermal fibroblasts	NULL
EXP061337	anti-PML antibody (PG-M3, sc-966 HRP, Santa Cruz, conjugated with horse-radish peroxidase )	Homo sapiens		EXP061336	672	normal	O95394	normal dermal fibroblasts	NULL
EXP061338	None	Homo sapiens		NULL	78	chip_control	NULL	HeLa (cervical adenocarcinoma)	NULL
EXP061339	anti-BRG1 (Abcam Catalog# B8184)	Homo sapiens		EXP061338	78	normal	P51532	HeLa (cervical adenocarcinoma)	NULL
EXP061340	anti-SMARCAL1 (Custom synthesised polyclonal antibody, Merk, india)	Homo sapiens		EXP061338	78	normal	Q9NZC9	HeLa (cervical adenocarcinoma)	NULL
EXP061341	Input DNA	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siContrl;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061342	Input DNA	Homo sapiens	Treatment: EtOH, shControl;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061343	Input DNA	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siKdm2a; Genotype: Kdm2a knockout;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061344	Input DNA	Homo sapiens	Treatment: EtOH, siKdm2a; Genotype: Kdm2a knockout;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061345	Input DNA	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siNedd4; Genotype: Nedd4 knockout;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061346	Input DNA	Homo sapiens	Treatment: EtOH, siNedd4; Genotype: Nedd4 knockout;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061347	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol;	NULL	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061348	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens		NULL	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061349	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siContrl;	EXP061341	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061350	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: EtOH, shControl;	EXP061342	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061351	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol, siKdm2a; Genotype: Kdm2a knockout;	EXP061343	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061352	anti-NEDD4 (D17, sc-14482, Santa Cruz Biotechnology)	Homo sapiens	Treatment: EtOH, siKdm2a; Genotype: Kdm2a knockout;	EXP061344	113	normal	P46934	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061353	anti-HA-tag (ab9110, abcam)	Homo sapiens	Treatment: 100 nM 17-beta-Estradiol;	NULL	113	normal	Q9Y2K7	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061354	anti-HA-tag (ab9110, abcam)	Homo sapiens	Treatment: EtOH;	NULL	113	normal	Q9Y2K7	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061355		Homo sapiens		NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061356	anti-CTCF	Homo sapiens	Developmental stage: asynchronous cell stage;	EXP061355	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061357	anti-CTCF	Homo sapiens	Developmental stage: mitosis cell stage;	EXP061355	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP061358	Monoclonal mouse IgG2b	Homo sapiens	Conditions: 1% O2 level for 16hrs;	NULL	26	chip_control	NULL	501Mel (melanoma)	NULL
EXP061359	11666606001	Homo sapiens	Conditions: 1% O2 level for 16hrs;	NULL	26	chip_control	NULL	501Mel (melanoma)	NULL
EXP061360	anti-HIF1a (Rabbit Polyclonal in whole antiserum)	Homo sapiens	Conditions: 1% O2 level for 16hrs;	EXP061358	26	normal	Q16665	501Mel (melanoma)	NULL
EXP061361	anti-HIF1b (Novus Biologicals, NB100-110, Rabbit Polyclonal in whole antiserum)	Homo sapiens	Conditions: 1% O2 level for 16hrs;	EXP061358	26	normal	P27540	501Mel (melanoma)	NULL
EXP061362	anti-HIF2a (Rabbit Polyclonal in whole antiserum)	Homo sapiens	Conditions: 1% O2 level for 16hrs;	EXP061358	26	normal	Q99814	501Mel (melanoma)	NULL
EXP061363	anti-SmcHD1 (antiserum)	Homo sapiens	Treatment: none;	NULL	664	normal	A6NHR9	SH-SY5Y (neuroblastoma)	NULL
EXP061364	anti-SmcHD1 (antiserum)	Homo sapiens	Treatment: DNA demethylating agent 5azaC for 72 hrs;	NULL	664	normal	A6NHR9	SH-SY5Y (neuroblastoma)	NULL
EXP061365	none	Mus musculus	Strain: C57BL/6J; Genotype: wildtype;	NULL	5	chip_control	NULL	liver	NULL
EXP061366	none	Mus musculus	Strain: C57BL/6J; Genotype: wildtype;	NULL	5	chip_control	NULL	liver	NULL
EXP061367	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype;	EXP061365	5	normal	O35426	liver	NULL
EXP061368	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype;	EXP061366	5	normal	O35426	liver	NULL
EXP061369	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Conditions: fed;	NULL	5	normal	O35426	liver	NULL
EXP061370	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: wildtype; Conditions: fasted;	NULL	5	normal	O35426	liver	NULL
EXP061371	anti-Xbp-1s (Santa Cruz,sc7610x,lot#D2910)	Mus musculus	Strain: C57BL/6J; Genotype: Ern1 knockout;	NULL	5	normal	O35426	liver	NULL
EXP061372	none	Mus musculus	Genotype: Kdm4b knockout, control retrovirus;	NULL	197	chip_control	NULL	adipocytes	NULL
EXP061373	none	Mus musculus	Genotype: Kdm4b knockout, Flag-KDM4B retrovirus;	NULL	197	chip_control	NULL	adipocytes	NULL
EXP061374	anti-Flag (M2, Sigma)	Mus musculus	Genotype: Kdm4b knockout, control retrovirus;	NULL	197	chip_control	NULL	adipocytes	NULL
EXP061375	anti-Flag (M2, Sigma)	Mus musculus	Genotype: Kdm4b knockout, Flag-KDM4B retrovirus;	EXP061373	197	normal	Q91VY5	adipocytes	NULL
EXP061376	none	Mus musculus	Genotype:Mbd3 Knockout;	NULL	4308	chip_control	NULL	EBRTcH3 (Embryonic stem cell)	NULL
EXP061377	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout, GFP;	NULL	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	NULL
EXP061378	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout (wildtype);	EXP061376	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	NULL
EXP061379	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout, deltaMBD;	NULL	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	NULL
EXP061380	anti-Suz12 (Millipore, 04-046)	Mus musculus	Genotype:Mbd3 Knockout, delta CC;	NULL	4308	normal	Q80U70	EBRTcH3 (Embryonic stem cell)	NULL
EXP061381	none	Mus musculus	Genotype: Sufu, Spop double knockout;	NULL	4310	chip_control	NULL	E17.5 intestine	NULL
EXP061382	none	Mus musculus	Genotype: Sufu, Spop double knockout;	NULL	4310	chip_control	NULL	E17.5 intestine	NULL
EXP061383	anti-Gli2 (homemade)	Mus musculus	Genotype: Sufu, Spop double knockout;	EXP061381	4310	normal	Q0VGT2	E17.5 intestine	NULL
EXP061384	anti-Gli2 (homemade)	Mus musculus	Genotype: Sufu, Spop double knockout;	EXP061382	4310	normal	Q0VGT2	E17.5 intestine	NULL
EXP061385	none	Mus musculus	Time point: day 7 of reprogramming; Genotype: oct4 wildtype;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061386	NA	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4 wildtype;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061387	NA	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4 wildtype;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061388	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4 wildtype;	EXP061386	3787	normal	P20263	MEF reprogramming intermediates to iPSC	NULL
EXP061389	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4 wildtype;	EXP061387	3787	normal	P20263	MEF reprogramming intermediates to iPSC	NULL
EXP061390	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 7 of reprogramming; Genotype: oct4 wildtype;	NULL	3787	normal	P20263	MEF reprogramming intermediates to iPSC	NULL
EXP061391	anti-Oct6 Antibody (Santa Cruz biotech;sc-11661 X; G0606)	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4 wildtype;	EXP061386	3787	normal	P21952	MEF reprogramming intermediates to iPSC	NULL
EXP061392	anti-Oct6 Antibody (Santa Cruz biotech;sc-11661 X; G0606)	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4 wildtype;	EXP061387	3787	normal	P21952	MEF reprogramming intermediates to iPSC	NULL
EXP061393	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 1 of reprogramming; Genotype: oct4YR mutant;	EXP061386	3787	normal	P20263	MEF reprogramming intermediates to iPSC	NULL
EXP061394	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 5 of reprogramming; Genotype: oct4YR mutant;	EXP061387	3787	normal	P20263	MEF reprogramming intermediates to iPSC	NULL
EXP061395	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct4SK mutant;	EXP061386	3787	normal	P48432	MEF reprogramming intermediates to iPSC	NULL
EXP061396	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 5 of reprogramming; Genotype: Oct4SK mutant;	EXP061387	3787	normal	P48432	MEF reprogramming intermediates to iPSC	NULL
EXP061397	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct6SK mutant;	EXP061386	3787	normal	P48432	MEF reprogramming intermediates to iPSC	NULL
EXP061398	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 5 of reprogramming; Genotype: Oct6SK mutant;	EXP061387	3787	normal	P48432	MEF reprogramming intermediates to iPSC	NULL
EXP061399	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 1 of reprogramming; Genotype: YRSK;	EXP061386	3787	normal	P48432	MEF reprogramming intermediates to iPSC	NULL
EXP061400	anti-Sox2 Antibody (Cell Signaling Technology; #2748; 2)	Mus musculus	Time point: day 5 of reprogramming; Genotype: YRSK;	EXP061387	3787	normal	P48432	MEF reprogramming intermediates to iPSC	NULL
EXP061401	anti-Oct4 Antibody (Santa Cruz biotech; sc-8628 X; 12415)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct4SM mutant,SMSK ;	EXP061386	3787	normal	P20263	MEF reprogramming intermediates to iPSC	NULL
EXP061402	anti-Oct6 Antibody (Santa Cruz biotech;sc-11661 X; G0606)	Mus musculus	Time point: day 1 of reprogramming; Genotype: Oct4SM mutant,SMSK ;	EXP061386	3787	normal	P21952	MEF reprogramming intermediates to iPSC	NULL
EXP061403	none (genomic DNA)	Mus musculus		NULL	4311	chip_control	NULL	neural stem cells derived from telencephalic cortex of E14.5 embryos	NULL
EXP061404	anti-V5 Tag (R960-25 Life Technologies)	Mus musculus		EXP061403	4311	normal	Q5XJV7	neural stem cells derived from telencephalic cortex of E14.5 embryos	NULL
EXP061405	N/A	Mus musculus	Strain: PWD/Ph; Genotype: wildtype; Age: adult;	NULL	32	chip_control	NULL	testis	NULL
EXP061406	N/A	Mus musculus	Strain: C57Bl/6J; Genotype: wildtype; Age: adult;	NULL	32	chip_control	NULL	testis	NULL
EXP061407	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Strain: C57Bl/6J; Genotype: wildtype; Age: adult;	EXP061406	32	normal	Q61880	testis	NULL
EXP061408	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Strain: PWD/Ph; Genotype: wildtype; Age: adult;	EXP061405	32	normal	Q61880	testis	NULL
EXP061409	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Genotype: Prdm9-/- (tm1Ymat/tm1Ymat); Strain: C57Bl/6J;	NULL	32	normal	Q61880	testis	NULL
EXP061410	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Genotype: Prdm9-/- (tm1Ymat/tm1Ymat); Strain: C57Bl/6J x C57Bl/6J F7;	NULL	32	normal	Q61880	testis	NULL
EXP061411	Anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Genotype: Prdm9-/- (tm1Ymat/tm1Ymat); Strain: PWD/Ph;	NULL	32	normal	Q61880	testis	NULL
EXP061412		Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	NULL	2802	chip_control	NULL	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061413		Mus musculus	Treatment: IBET; Conditions: I-BET Resistant; 	NULL	2802	chip_control	NULL	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061414	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	EXP061412	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061415	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061416	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061417	anti-Brd4 (A301-985A100, Bethyl Labs)	Mus musculus	Treatment: LSD1i+IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	Q9ESU6	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061418	anti-PU.1/SPI1 (sc325, Santa Cruz Biotechnology)	Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	EXP061412	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061419	anti-PU.1/SPI1 (sc325, Santa Cruz Biotechnology)	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061420	anti-PU.1/SPI1 (sc325, Santa Cruz Biotechnology)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061421	anti-Med1/CRSP1/Trap220 (A300-793A, Bethyl Labs)	Mus musculus	Treatment: DMSO; Conditions: I-BET Sensitive; 	EXP061412	2802	normal	Q925J9	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061422	anti-Med1/CRSP1/Trap220 (A300-793A, Bethyl Labs)	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	Q925J9	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061423	anti-Med1/CRSP1/Trap220 (A300-793A, Bethyl Labs)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q925J9	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061424	anti-KDM1A/LSD1 (ab17721, Abcam)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q6ZQ88	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061425	anti-KDM1A/LSD1 (ab17721, Abcam)	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	Q6ZQ88	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061426	anti-Irf8 (5628S, Cell signaling)Â 	Mus musculus	Treatment: 1000nM IBET; Conditions: I-BET Resistant; 	NULL	2802	normal	P23611	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061427	anti-Irf8 (5628S, Cell signaling)Â 	Mus musculus	Treatment: 500nM LSD1i; Conditions: I-BET Resistant; 	NULL	2802	normal	P23611	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061428	PU.1/SPI1(2258S, Cell Signaling)	Mus musculus	Treatment: IBET, Scrambled; Conditions: I-BET Resistant;	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061429	PU.1/SPI1(2258S, Cell Signaling)	Mus musculus	Treatment: IBET, Irf8 shRNA; Conditions: I-BET Resistant; Genotype: Irf8 knockout; 	NULL	2802	normal	P17433	MLL-AF9 (puro transformed murine leukemia cell line)	NULL
EXP061430	none	Mus musculus	Age: postnatal 10 weeks; Genotype: wildtype; Strain: C57Bl/6, 129Sv; Conditions: DDC diet;	NULL	429	chip_control	NULL	hepatocytes	NULL
EXP061431	anti-Yap (14074 cell signal)	Mus musculus	Age: postnatal 10 weeks; Genotype: wildtype; Strain: C57Bl/6, 129Sv; Conditions: DDC diet;	EXP061430	429	normal	P46938	hepatocytes	NULL
EXP061432	anti-Yap (14074 cell signal)	Mus musculus	Age: postnatal 10 weeks; Genotype: Arid1a liver-specific knockout; Strain: C57Bl/6, 129Sv; Conditions: DDC diet;	NULL	429	normal	P46938	hepatocytes	NULL
EXP061433	anti-Klf4 (R&D cat. numb.#F3158)	Mus musculus	Conditions: cultured in 2i condition;	NULL	252	normal	Q60793	V6.5 (embryonic stem cells)	NULL
EXP061434	anti-Klf4 (R&D cat. numb.#F3158)	Mus musculus	Time point: reprogramming - day 6; Treatment: cultured with dox and ascorbic acid for the number of days indicated;	NULL	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061435	anti-Klf4 (R&D cat. numb.#F3158)	Mus musculus	Time point: reprogramming - day 3; Treatment: cultured with dox and ascorbic acid for the number of days indicated;	NULL	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061436	none	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061437	none	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061438	none	Mus musculus	Time point: reprogrammong day 6; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061439	none	Mus musculus	Time point: reprogrammong day 6; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061440	none	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061441	none	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	NULL	3787	chip_control	NULL	MEF reprogramming intermediates to iPSC	NULL
EXP061442	none	Mus musculus	Conditions: ESC medium;	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP061443	none	Mus musculus	Conditions: ESC medium;	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP061444	none	Mus musculus	Conditions: ESC medium with 2i (1uM MEK inhibitor) and 3uM GSK3 inhibitor;	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP061445	none	Mus musculus	Conditions: ESC medium with 2i (1uM MEK inhibitor) and 3uM GSK3 inhibitor;	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP061446	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061436	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061447	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061437	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061448	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 6; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061438	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061449	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 6; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061439	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061450	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium;	EXP061442	252	normal	Q60793	V6.5 (embryonic stem cells)	NULL
EXP061451	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium;	EXP061443	252	normal	Q60793	V6.5 (embryonic stem cells)	NULL
EXP061452	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium with 2i (1uM MEK inhibitor) and 3uM GSK3 inhibitor;	EXP061444	252	normal	Q60793	V6.5 (embryonic stem cells)	NULL
EXP061453	anti-KLF4 (R&D #3158)	Mus musculus	Conditions: ESC medium with 2i (1uM MEK inhibitor) and 3uM GSK3 inhibitor;	EXP061445	252	normal	Q60793	V6.5 (embryonic stem cells)	NULL
EXP061454	anti-KLF4 (R&D #3158)	Mus musculus	Time point: reprogrammong day 3; Treatment: 1ug/ml doxycycline and 50ug/ml ascorbic acid; Genotype: OKSM Col1a1/M2rtTA ROSA26; Strain: C57BL/6 x 129;	EXP061441	3787	normal	Q60793	MEF reprogramming intermediates to iPSC	NULL
EXP061455	None	Mus musculus	Sex: female; Strain: C57BL/6; Tissue: isolated uteri from wild-type C57BL/6J female (eight weeks old) and then made endometrium fragments by using Miltex Medical Biopsy Punch Dermal 2 mm OR Grade;	NULL	4316	chip_control	NULL	eutopic endometrium	NULL
EXP061456	anti-FLAG (M2 agarose, Sigma, A2220)	Mus musculus	Sex: female; Strain: C57BL/6; Tissue: isolated uteri from wild-type C57BL/6J female (eight weeks old) and then made endometrium fragments by using Miltex Medical Biopsy Punch Dermal 2 mm OR Grade;	NULL	4317	normal	O08537	endometriotic lesions	NULL
EXP061457	anti-FLAG (M2 agarose, Sigma, A2220)	Mus musculus	Sex: female; Strain: C57BL/6; Tissue: isolated uteri from wild-type C57BL/6J female (eight weeks old) and then made endometrium fragments by using Miltex Medical Biopsy Punch Dermal 2 mm OR Grade;	EXP061455	4316	normal	O08537	eutopic endometrium	NULL
EXP061458	none	Mus musculus	Treatment: Sonicated;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP061459	none	Mus musculus	Treatment: Sonicated; Genotype: stably transfected FLAG-SFMBT2;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP061460	none	Mus musculus	Treatment: Micrococcal nuclease-digested;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP061461	none	Mus musculus	Treatment: Micrococcal nuclease-digested; Genotype: stably transfected FLAG-SFMBT2;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP061462	anti-SFMBT2 (generated inhouse, Miri K et al., 2013, protein G Dynabeads (ThermoFisher Scientific #100009D))	Mus musculus	Treatment: Sonicated;	EXP061458	96	normal	Q5DTW2	trophoblast stem cells	NULL
EXP061463	anti-SFMBT2 (generated inhouse, Miri K et al., 2013, protein G Dynabeads (ThermoFisher Scientific #100009D))	Mus musculus	Treatment: Sonicated; Genotype: stably transfected FLAG-SFMBT2;	NULL	96	normal	Q5DTW2	trophoblast stem cells	NULL
EXP061464	anti-SFMBT2 (generated inhouse, Miri K et al., 2013, protein G Dynabeads (ThermoFisher Scientific #100009D))	Mus musculus	Treatment: Micrococcal nuclease-digested;	EXP061460	96	normal	Q5DTW2	trophoblast stem cells	NULL
EXP061465	FLAG-conjugated magnetic beads (Sigma Aldrich #M8823, lot# SLBM0090V)	Mus musculus	Treatment: Micrococcal nuclease-digested; Genotype: stably transfected FLAG-SFMBT2;	EXP061461	96	normal	Q5DTW2	trophoblast stem cells	NULL
EXP061466	n/a (Input)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061467	n/a (Input)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061468	n/a (Input)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061469	n/a (Input)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061470	n/a (Input)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061471	n/a (Input)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061472	n/a (Input)	Mus musculus	Genotype: Chr4-cl wildtype; Strain: B6; Condtions: 20% FCS media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061473	n/a (Input)	Mus musculus	Genotype: Chr4-cl knockout; Strain: B6; Condtions: 20% FCS media;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061474	anti-KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	EXP061466	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061475	anti-KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	EXP061467	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061476	anti-KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl wildtype; Strain: B6; Condtions: 2i media;	EXP061468	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061477	KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	EXP061469	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061478	KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	EXP061470	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061479	KAP1 (Tronolab, rabbit polyclonal S23470)	Mus musculus	Genotype: Chr2-cl knockout; Strain: B6; Condtions: 2i media;	EXP061471	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061480	anti-GFP (#A-11122)	Mus musculus	Genotype: Chr4-cl wildtype; Strain: B6; Condtions: 20% FCS media;	EXP061472	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061481	anti-GFP (#A-11122)	Mus musculus	Genotype: Chr4-cl knockout; Strain: B6; Condtions: 20% FCS media;	EXP061473	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061482	n/a	Mus musculus	Genotype: TI_443 overexpression, SB transposon; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061483	n/a	Mus musculus	Genotype: TI_339 overexpression, SB transposon; 	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061484	HA (ab9110)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP061485	FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP061486	n/a	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	NULL	292	chip_control	NULL	F9 (embryonal carcinoma)	NULL
EXP061487	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	Q8K293	F9 (embryonal carcinoma)	NULL
EXP061488	AW146154	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	E9Q3U2	F9 (embryonal carcinoma)	NULL
EXP061489	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	P63058	F9 (embryonal carcinoma)	NULL
EXP061490	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, SB transposon; 	EXP061486	292	normal	Q32P14	F9 (embryonal carcinoma)	NULL
EXP061491	anti-HA (ab9110)	Mus musculus	Genotype: Gm13139 overexpression, SB transposon; 	EXP061486	292	normal	Q8R1N3	F9 (embryonal carcinoma)	NULL
EXP061492	anti-HA (ab9110)	Mus musculus	Genotype: Gm13150 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	H3BLB0	F9 (embryonal carcinoma)	NULL
EXP061493	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13152 overexpression, SB transposon; 	EXP061486	292	normal	Q6NXV0	F9 (embryonal carcinoma)	NULL
EXP061494	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13154 overexpression, SB transposon; 	EXP061486	292	normal	Q5U4F7	F9 (embryonal carcinoma)	NULL
EXP061495	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13051 overexpression, pCW57.1 (addgene #41393); 	EXP061486	292	normal	A2A7A2	F9 (embryonal carcinoma)	NULL
EXP061496	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13212 overexpression, SB transposon; 	EXP061486	292	normal	B1ASQ6	F9 (embryonal carcinoma)	NULL
EXP061497	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13225cst- overexpression, SB transposon; 	EXP061486	292	normal	B1AVN4	F9 (embryonal carcinoma)	NULL
EXP061498	anti-HA (ab9110)	Mus musculus	Genotype: Gm13235 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	L7MUC9	F9 (embryonal carcinoma)	NULL
EXP061499	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13247 overexpression, SB transposon; 	EXP061486	292	normal	A2A8V6	F9 (embryonal carcinoma)	NULL
EXP061500	anti-FLAG (F1804)	Mus musculus	Genotype: Gm13251 overexpression, SB transposon; 	EXP061486	292	normal	B1ASD8	F9 (embryonal carcinoma)	NULL
EXP061501	anti-HA (ab9110)	Mus musculus	Genotype: Gm13051 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6; 	EXP061482	2	normal	A2BG90	mESCs (mouse embryonic stem cells)	NULL
EXP061502	anti-HA (ab9110)	Mus musculus	Genotype: Gm14326 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2BFG5	F9 (embryonal carcinoma)	NULL
EXP061503	anti-HA (ab9110)	Mus musculus	Genotype: Gm14391 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	Q8C1K5	F9 (embryonal carcinoma)	NULL
EXP061504	anti-FLAG (F1804)	Mus musculus	Genotype: Gm14393 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A2ARW5	F9 (embryonal carcinoma)	NULL
EXP061505	anti-HA (ab9110)	Mus musculus	Genotype: Gm14399 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061483	2	normal	A2ARW7	mESCs (mouse embryonic stem cells)	NULL
EXP061506	anti-HA (ab9110)	Mus musculus	Genotype: Gm14401 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061483	2	normal	A2ARV7	mESCs (mouse embryonic stem cells)	NULL
EXP061507	anti-HA (ab9110)	Mus musculus	Genotype: Gm14406 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A2BFU6	F9 (embryonal carcinoma)	NULL
EXP061508	anti-HA (ab9110)	Mus musculus	Genotype: Gm14410 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2ARW1	F9 (embryonal carcinoma)	NULL
EXP061509	anti-HA (ab9110)	Mus musculus	Genotype: Gm14412 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2ARR7	F9 (embryonal carcinoma)	NULL
EXP061510	anti-HA (ab9110)	Mus musculus	Genotype: Gm14418 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A2ARR5	F9 (embryonal carcinoma)	NULL
EXP061511	anti-HA (ab9110)	Mus musculus	Genotype: Gm14419 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061483	2	normal	A2ARL5	mESCs (mouse embryonic stem cells)	NULL
EXP061512	anti-FLAG (F1804)	Mus musculus	Genotype: Gm14420 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061483	2	normal	B1AYE1	mESCs (mouse embryonic stem cells)	NULL
EXP061513	anti-HA (ab9110)	Mus musculus	Genotype: Gm14436 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2BE20	F9 (embryonal carcinoma)	NULL
EXP061514	anti-HA (ab9110)	Mus musculus	Genotype: Gm14443 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061482	2	normal	A2ARX0	mESCs (mouse embryonic stem cells)	NULL
EXP061515	anti-HA (ab9110)	Mus musculus	Genotype: Gm4631 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061483	2	normal	F7CEW8	mESCs (mouse embryonic stem cells)	NULL
EXP061516	anti-HA (ab9110)	Mus musculus	Genotype: Gm6710 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A2ART0	F9 (embryonal carcinoma)	NULL
EXP061517	anti-HA (ab9110)	Mus musculus	Genotype: Gm8898 overexpression, pLKO.1-puro (addgene #8453); Strain: B6;	EXP061483	2	normal	A2ART1	mESCs (mouse embryonic stem cells)	NULL
EXP061518	anti-HA (ab9110)	Mus musculus	Genotype: Rex2 overexpression, SB transposon; 	EXP061486	292	normal	A2AWF2	F9 (embryonal carcinoma)	NULL
EXP061519	anti-HA (ab9110)	Mus musculus	Genotype: Zfp273 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	F6UQD0	F9 (embryonal carcinoma)	NULL
EXP061520	anti-HA (ab9110)	Mus musculus	Genotype: Zfp429 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	M0QWC3	F9 (embryonal carcinoma)	NULL
EXP061521	anti-HA (ab9110)	Mus musculus	Genotype: Zfp456 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	B2RUK9	F9 (embryonal carcinoma)	NULL
EXP061522	anti-HA (ab9110)	Mus musculus	Genotype: Zfp457 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A286YD11	F9 (embryonal carcinoma)	NULL
EXP061523	anti-HA (ab9110)	Mus musculus	Genotype: Zfp458 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	Q6P5C7	F9 (embryonal carcinoma)	NULL
EXP061524	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp46 overexpression, SB transposon; 	EXP061486	292	normal	D3Z7M1	F9 (embryonal carcinoma)	NULL
EXP061525	anti-HA (ab9110)	Mus musculus	Genotype: Zfp493 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A1Y7VP64	F9 (embryonal carcinoma)	NULL
EXP061526	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp534 overexpression, SB transposon; 	EXP061486	292	normal	A2A7A1	F9 (embryonal carcinoma)	NULL
EXP061527	anti-HA (ab9110)	Mus musculus	Genotype: Zfp58 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	E9PY65	F9 (embryonal carcinoma)	NULL
EXP061528	anti-HA (ab9110)	Mus musculus	Genotype: Zfp595 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	B9EIT6	F9 (embryonal carcinoma)	NULL
EXP061529	anti-HA (ab9110)	Mus musculus	Genotype: Zfp599 overexpression, SB transposon; 	EXP061486	292	normal	E9PWP1	F9 (embryonal carcinoma)	NULL
EXP061530	anti-HA (ab9110)	Mus musculus	Genotype: Zfp600 overexpression, SB transposon; 	EXP061486	292	normal	A2A7U9	F9 (embryonal carcinoma)	NULL
EXP061531	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp617 overexpression, SB transposon; 	EXP061486	292	normal	D3Z0X4	F9 (embryonal carcinoma)	NULL
EXP061532	anti-HA (ab9110)	Mus musculus	Genotype: Zfp661 overexpression, SB transposon; 	EXP061486	292	normal	Q8BIQ3	F9 (embryonal carcinoma)	NULL
EXP061533	anti-HA (ab9110)	Mus musculus	Genotype: Zfp709 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	F6R4Z5	F9 (embryonal carcinoma)	NULL
EXP061534	anti-HA (ab9110)	Mus musculus	Genotype: Zfp712 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	E9PXJ4	F9 (embryonal carcinoma)	NULL
EXP061535	anti-HA (ab9110)	Mus musculus	Genotype: Zfp738 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	B8JJX8	F9 (embryonal carcinoma)	NULL
EXP061536	anti-HA (ab9110)	Mus musculus	Genotype: Zfp759 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A286YDZ7	F9 (embryonal carcinoma)	NULL
EXP061537	anti-HA (ab9110)	Mus musculus	Genotype: Zfp808 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A0A1Y7VJ92	F9 (embryonal carcinoma)	NULL
EXP061538	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp810 overexpression, pCW57.1 (addgene #41393); 	EXP061486	292	normal	A0A1L1SUL0	F9 (embryonal carcinoma)	NULL
EXP061539	anti-HA (ab9110)	Mus musculus	Genotype: Zfp872 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A1L1SRW1	F9 (embryonal carcinoma)	NULL
EXP061540	anti-HA (ab9110)	Mus musculus	Genotype: Zfp874a overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A0A286YD52	F9 (embryonal carcinoma)	NULL
EXP061541	anti-HA (ab9110)	Mus musculus	Genotype: Zfp874b overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	A0A286YDG9	F9 (embryonal carcinoma)	NULL
EXP061542	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp882 overexpression, SB transposon; 	EXP061486	292	normal	D3Z2V3	F9 (embryonal carcinoma)	NULL
EXP061543	anti-HA (ab9110)	Mus musculus	Genotype: Zfp92 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	Q62396	F9 (embryonal carcinoma)	NULL
EXP061544	anti-HA (ab9110)	Mus musculus	Genotype: Zfp931 overexpression, pLKO.1-puro (addgene #8453);  Strain: B6;	EXP061482	2	normal	D3YWJ2	mESCs (mouse embryonic stem cells)	NULL
EXP061545	anti-HA (ab9110)	Mus musculus	Genotype: Zfp933 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	Q3V2G0	F9 (embryonal carcinoma)	NULL
EXP061546	anti-HA (ab9110)	Mus musculus	Genotype: Zfp935 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	A0A1Y7VP04	F9 (embryonal carcinoma)	NULL
EXP061547	anti-HA (ab9110)	Mus musculus	Genotype: Zfp938 overexpression, pLKO.1-puro (addgene #8453); 	EXP061486	292	normal	E9Q9G3	F9 (embryonal carcinoma)	NULL
EXP061548	anti-HA (ab9110)	Mus musculus	Genotype: Zfp953 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	Q3UPV7	F9 (embryonal carcinoma)	NULL
EXP061549	anti-FLAG (F1804)	Mus musculus	Genotype: Zfp961 overexpression, SB transposon; 	EXP061486	292	normal	A0A1D5RMJ2	F9 (embryonal carcinoma)	NULL
EXP061550	anti-HA (ab9110)	Mus musculus	Genotype: Zkscan17 overexpression, SB transposon; 	EXP061486	292	normal	Q5SXI5	F9 (embryonal carcinoma)	NULL
EXP061551	anti-HA (ab9110)	Mus musculus	Genotype: Gm14296 overexpression, pLKO.1-puro (addgene #8453);	EXP061486	292	normal	E9Q3Y3	F9 (embryonal carcinoma)	NULL
EXP061552	none	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	chip_control	NULL	bone marrow derived macrophage	NULL
EXP061553	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	EXP061552	3926	normal	P42225	bone marrow derived macrophage	NULL
EXP061554	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	EXP061552	3926	normal	Q9WVL2	bone marrow derived macrophage	NULL
EXP061555	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q61179	bone marrow derived macrophage	NULL
EXP061556	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	NULL
EXP061557	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	NULL
EXP061558	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q61179	bone marrow derived macrophage	NULL
EXP061559	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	NULL
EXP061560	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	NULL
EXP061561	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: wildtype; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q61179	bone marrow derived macrophage	NULL
EXP061562	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: untreated; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	NULL
EXP061563	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: untreated; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	NULL
EXP061564	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	NULL
EXP061565	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNb for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	NULL
EXP061566	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	P42225	bone marrow derived macrophage	NULL
EXP061567	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: IFNg for 90 mins; Genotype: Irf9 knockout; Age: 8-10 weeks; Strain: C57BL/6; 	NULL	3926	normal	Q9WVL2	bone marrow derived macrophage	NULL
EXP061568	none	Mus musculus	Treatment: siNS for 2d (final concentration of 50 nM);	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP061569	none	Mus musculus	Treatment: siPaf1 for 2d (final concentration of 50 nM); Genotype: Paf1 knockout;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP061570	none	Mus musculus	Treatment: +dox (1 ug/ml Dox) for 4 days; Genotype: conditional Paf1 knockout;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP061571	none	Mus musculus	Treatment: no dox (1 ug/ml Dox) treatment; Genotype: conditional Paf1 knockout;	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP061572	anti-Spt6 (Novus,NB100-2582, Rabbit polyclonal )	Mus musculus	Treatment: siNS for 2d (final concentration of 50 nM);	EXP061568	1153	normal	Q62383	C2C12 (myoblasts)	NULL
EXP061573	Rabbit polyclonal anti-Spt6 (Novus,NB100-2582)	Mus musculus	Treatment: siPaf1 for 2d (final concentration of 50 nM); Genotype: Paf1 knockout;	EXP061569	1153	normal	Q62383	C2C12 (myoblasts)	NULL
EXP061574	anti-SUPT5H (Bethyl,A300-868A, Rabbit polyclonal )	Mus musculus	Treatment: +dox (1 ug/ml Dox) for 4 days; Genotype: conditional Paf1 knockout;	EXP061570	1153	normal	O55201	C2C12 (myoblasts)	NULL
EXP061575	anti-SUPT5H (Bethyl,A300-868A, Rabbit polyclonal )	Mus musculus	Treatment: no dox (1 ug/ml Dox) treatment; Genotype: conditional Paf1 knockout;	EXP061571	1153	normal	O55201	C2C12 (myoblasts)	NULL
EXP061576	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061577	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061578	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-neg; Time point: day 3;	NULL	1556	normal	P35583	mesoderm	NULL
EXP061579	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-neg; Time point: day 3;	NULL	1556	normal	P35583	mesoderm	NULL
EXP061580	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-pos; Time point: day 5;	NULL	254	normal	P35583	endodermal cells	NULL
EXP061581	anti-Foxa2 (Santa Cruz; sc6554x)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-pos; Time point: day 5;	NULL	254	normal	P35583	endodermal cells	NULL
EXP061582	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-neg; Time point: day 3;	NULL	1556	normal	Q08369	mesoderm	NULL
EXP061583	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Genotype: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-pos/Sox17-Cherry-pos; Time point: day 5;	NULL	254	normal	Q08369	endodermal cells	NULL
EXP061584	anti-Nanog (Bethyl lab; A300-397-A)	Mus musculus	Treatment: Foxa2-Venus heterozygous, Sox17-Cherry homozygous; Cell type: Foxa2-Venus-neg/Sox17-Cherry-neg; Time point: day 0;	NULL	2	normal	Q80Z64	mESCs (mouse embryonic stem cells)	NULL
EXP061585	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 1;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061586	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 1;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061587	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 4;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061588	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus; Cell type: Venus-positive; Time point: day 4;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061589	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061590	anti-Foxa2 (SantaCruz; sc6554x)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	P35583	mESCs (mouse embryonic stem cells)	NULL
EXP061591	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	Q08369	mESCs (mouse embryonic stem cells)	NULL
EXP061592	anti-Gata4 (R&D Systems; AF2606)	Mus musculus	Treatment: doxycycline (Dox) inducible ; Genotype: TetON-Foxa2-Venus, TetON-Gata4-tBFP; Cell type: Venus-positive/tBFP-positive; Time point: day 2;	NULL	2	normal	Q08369	mESCs (mouse embryonic stem cells)	NULL
EXP061593	none	Mus musculus		NULL	4337	chip_control	NULL	iWAT-derived primary adipocytes	NULL
EXP061594	anti-TLE3 (Proteintech 11372-1-AP)	Mus musculus		NULL	4338	normal	Q08122	eWAT-derived primary adipocytes	NULL
EXP061595	anti-TLE3 (Proteintech 11372-1-AP)	Mus musculus		EXP061593	4337	normal	Q08122	iWAT-derived primary adipocytes	NULL
EXP061596	anti-TLE3 (Proteintech 11372-1-AP)	Mus musculus		NULL	4339	normal	Q08122	BAT-derived primary adipocytes	NULL
EXP061597	input	Mus musculus	Strain: E mu-Myc transgenic;	NULL	4340	chip_control	NULL	B cells from primary mouse lymphoma	NULL
EXP061598	input	Mus musculus	Strain: E mu-Myc transgenic;	NULL	4340	chip_control	NULL	B cells from primary mouse lymphoma	NULL
EXP061599	input	Mus musculus	Strain: E mu-Myc transgenic;	NULL	4340	chip_control	NULL	B cells from primary mouse lymphoma	NULL
EXP061600	anti-PRDM15 antibody	Mus musculus	Strain: E mu-Myc transgenic;	EXP061597	4340	normal	E9Q8T2	B cells from primary mouse lymphoma	NULL
EXP061601	anti-PRDM15 antibody	Mus musculus	Strain: E mu-Myc transgenic;	EXP061598	4340	normal	E9Q8T2	B cells from primary mouse lymphoma	NULL
EXP061602	anti-PRDM15 antibody	Mus musculus	Strain: E mu-Myc transgenic;	EXP061599	4340	normal	E9Q8T2	B cells from primary mouse lymphoma	NULL
EXP061603	none	Mus musculus	Genotype: wildtype;	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP061604	none	Mus musculus	Genotype: Trim33 knockout;	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP061605	anti-SPT16 (Santa Cruz, sc-28734X)	Mus musculus	Genotype: wildtype;	EXP061603	81	normal	Q920B9	BMDM (bone marrow-derived macrophages)	NULL
EXP061606	anti-SPT16(Santa Cruz, sc-28734X)	Mus musculus	Genotype: Trim33 knockout;	EXP061604	81	normal	Q920B9	BMDM (bone marrow-derived macrophages)	NULL
EXP061607	anti-Ring1b(Chiacchiera, Rossi, Sriganesh Jammula, et al. 2016, home-made lab)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	160	normal	Q9CQJ4	hair follicle stem cells	NULL
EXP061608	anti-Ring1b(Chiacchiera, Rossi, Sriganesh Jammula, et al. 2016, home-made lab)	Mus musculus	Strain: C57BL/6; Genotype: wildtype;	NULL	52	normal	Q9CQJ4	intestinal stem cells	NULL
EXP061609	none	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP061610	none	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP061611	anti-EZH2 (Cell Signaling #5246)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	EXP061610	96	normal	Q61188	trophoblast stem cells	NULL
EXP061612	anti-EZH2 (Cell Signaling #5246)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	NULL	96	normal	Q61188	trophoblast stem cells	NULL
EXP061613	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Airn truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061614	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Airn truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061615	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Kcnq1ot1 truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061616	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Kcnq1ot1 truncation;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061617	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: CRISPR-a no guide RNA;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061618	SMC1 (Bethyl A300-055A)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	EXP061610	96	normal	Q9CU62	trophoblast stem cells	NULL
EXP061619	SMC1 (Bethyl A300-055A)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	NULL	96	normal	Q9CU62	trophoblast stem cells	NULL
EXP061620	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Full length Xist inserted at Rosa26 locus; Time point: 0hrs;	EXP061609	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061621	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Full length Xist inserted at Rosa26 locus; Time point: 12 hrs;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061622	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: CAST/EiJ mother X C57BL/6J father; Genotype: Full length Xist inserted at Rosa26 locus; Time point: 72 hrs;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061623	anti-CTCF	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: wildtype;	EXP061610	96	normal	Q61164	trophoblast stem cells	NULL
EXP061624	anti-RING1B (Cell Signaling #5694)	Mus musculus	Strain: C57BL/6J mother X CAST/EiJ father; Genotype: CRISPR-a Airn-targeting guide RNA;	NULL	96	normal	Q9CQJ4	trophoblast stem cells	NULL
EXP061625		Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: sham;	NULL	53	chip_control	NULL	heart	NULL
EXP061626	anti-ACAA2 (Origene Technologies  TA506126)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: sham;	NULL	53	normal	Q8BWT1	heart	NULL
EXP061627	anti-ACAA2 (Origene Technologies  TA506126)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: Transaortic coarctation for 7 days;	NULL	53	normal	Q8BWT1	heart	NULL
EXP061628	anti-OGDH (Cell Signalling Technologies 26865)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: sham;	NULL	53	normal	Q60597	heart	NULL
EXP061629	anti-OGDH (Cell Signalling Technologies 26865)	Mus musculus	Strain: C57BL/6; Time point: 7 days post; Genotype: wild type;  Age: 12 weeks; Treatment: Transaortic coarctation for 7 days;	NULL	53	normal	Q60597	heart	NULL
EXP061630	IgG	Mus musculus	Genotype: Krt14-Cre, Sox11fl/fl, Sox4fl/fl; Strain: mixed 129SvEx:C57BL/6;	NULL	936	chip_control	NULL	primary keratinocytes	NULL
EXP061631	anti-FLAG antibody (Sigma, mouse )	Mus musculus	Treatment: transduced with Sox4-Flag lentivirus; Genotype: Krt14-Cre, Sox11fl/fl, Sox4fl/fl; Strain: mixed 129SvEx:C57BL/6;	EXP061630	936	normal	Q06831	primary keratinocytes	NULL
EXP061632	anti-FLAG antibody (Sigma, mouse )	Mus musculus	Treatment: transduced with Sox11-Flag lentivirus; Genotype: Krt14-Cre, Sox11fl/fl, Sox4fl/fl; Strain: mixed 129SvEx:C57BL/6;	EXP061630	936	normal	Q7M6Y2	primary keratinocytes	NULL
EXP061633	none	Mus musculus	Genotype: wildtype; Treatment: unstimulated; Strain: C57BL/6;	NULL	4344	chip_control	NULL	vascular smooth muscle cells of aorta	NULL
EXP061634	none	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha; Strain: C57BL/6;	NULL	4344	chip_control	NULL	vascular smooth muscle cells of aorta	NULL
EXP061635	none	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha + 4hrs, 1ug/ml, LPS; Strain: C57BL/6;	NULL	4344	chip_control	NULL	vascular smooth muscle cells of aorta	NULL
EXP061636	none	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10ng/ml, murine IFN gamma; Strain: C57BL/6;	NULL	4344	chip_control	NULL	vascular smooth muscle cells of aorta	NULL
EXP061637	none	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10 ng/ml, murine IFN alpha + 4 hrs 1ug/ml, LPS; Strain: C57BL/6;	NULL	4344	chip_control	NULL	vascular smooth muscle cells of aorta	NULL
EXP061638	none	Mus musculus	Genotype: wildtype; Treatment: stimulated for 4 hrs, 1ug/ml, LPS; Strain: C57BL/6;	NULL	4344	chip_control	NULL	vascular smooth muscle cells of aorta	NULL
EXP061639	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: unstimulated; Strain: C57BL/6;	EXP061633	4344	normal	Q04207	vascular smooth muscle cells of aorta	NULL
EXP061640	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha; Strain: C57BL/6;	EXP061634	4344	normal	Q04207	vascular smooth muscle cells of aorta	NULL
EXP061641	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha + 4hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061635	4344	normal	Q04207	vascular smooth muscle cells of aorta	NULL
EXP061642	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10ng/ml, murine IFN gamma; Strain: C57BL/6;	EXP061636	4344	normal	Q04207	vascular smooth muscle cells of aorta	NULL
EXP061643	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10 ng/ml, murine IFN alpha + 4 hrs 1ug/ml, LPS; Strain: C57BL/6;	EXP061637	4344	normal	Q04207	vascular smooth muscle cells of aorta	NULL
EXP061644	anti-p65 (Cell Signaling Technology, cat# 6956, lot# 7)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 4 hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061638	4344	normal	Q04207	vascular smooth muscle cells of aorta	NULL
EXP061645	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: unstimulated; Strain: C57BL/6;	EXP061633	4344	normal	P42225	vascular smooth muscle cells of aorta	NULL
EXP061646	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha; Strain: C57BL/6;	EXP061634	4344	normal	P42225	vascular smooth muscle cells of aorta	NULL
EXP061647	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 1000U/ml, murine IFN alpha + 4hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061635	4344	normal	P42225	vascular smooth muscle cells of aorta	NULL
EXP061648	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10ng/ml, murine IFN gamma; Strain: C57BL/6;	EXP061636	4344	normal	P42225	vascular smooth muscle cells of aorta	NULL
EXP061649	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 8hrs, 10 ng/ml, murine IFN alpha + 4 hrs 1ug/ml, LPS; Strain: C57BL/6;	EXP061637	4344	normal	P42225	vascular smooth muscle cells of aorta	NULL
EXP061650	anti-STAT1 (Cell Signaling Technology, cat# 14994, lot #4)	Mus musculus	Genotype: wildtype; Treatment: stimulated for 4 hrs, 1ug/ml, LPS; Strain: C57BL/6;	EXP061638	4344	normal	P42225	vascular smooth muscle cells of aorta	NULL
EXP061651	Input DNA	Mus musculus	Genotype: Bcl11b f/f Foxp3-IRES-YFP-Cre (Bcl11b knockout); Strain: C57BL/6;	NULL	4346	chip_control	NULL	sorted CD4+ YFP+ Treg cells	NULL
EXP061652	Input DNA	Mus musculus	Genotype: Bcl11b f/f Foxp3-IRES-YFP-Cre (Bcl11b knockout); Strain: C57BL/6;	NULL	4346	chip_control	NULL	sorted CD4+ YFP+ Treg cells	NULL
EXP061653	Input DNA	Mus musculus	Genotype: Foxp3-GFP knockout; Strain: C57BL/6;	NULL	4347	chip_control	NULL	sorted CD4+ GFP+ Treg cells	NULL
EXP061654	Input DNA	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	NULL	4346	chip_control	NULL	sorted CD4+ YFP+ Treg cells	NULL
EXP061655	Input DNA	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	NULL	4346	chip_control	NULL	sorted CD4+ YFP+ Treg cells	NULL
EXP061656	Input DNA	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	NULL	4346	chip_control	NULL	sorted CD4+ YFP+ Treg cells	NULL
EXP061657	Input DNA	Mus musculus	Genotype:Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	NULL	4348	chip_control	NULL	sorted CD4+YFP+ naive T cells	NULL
EXP061658	anti-Foxp3	Mus musculus	Genotype: Bcl11b f/f Foxp3-IRES-YFP-Cre (Bcl11b knockout); Strain: C57BL/6;	EXP061651	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	NULL
EXP061659	anti-Foxp3	Mus musculus	Genotype: Bcl11b f/f Foxp3-IRES-YFP-Cre (Bcl11b knockout); Strain: C57BL/6;	EXP061652	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	NULL
EXP061660	anti-Bcl11b	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061654	4346	normal	Q99PV8	sorted CD4+ YFP+ Treg cells	NULL
EXP061661	anti-Bcl11b	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061655	4346	normal	Q99PV8	sorted CD4+ YFP+ Treg cells	NULL
EXP061662	anti-Bcl11b	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061656	4346	normal	Q99PV8	sorted CD4+ YFP+ Treg cells	NULL
EXP061663	anti-Foxp3	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061654	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	NULL
EXP061664	anti-Foxp3	Mus musculus	Genotype: Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061655	4346	normal	Q99JB6	sorted CD4+ YFP+ Treg cells	NULL
EXP061665	anti-Bcl11b	Mus musculus	Genotype: Foxp3-GFP knockout; Strain: C57BL/6;	EXP061653	4347	normal	Q99PV8	sorted CD4+ GFP+ Treg cells	NULL
EXP061666	anti-Bcl11b	Mus musculus	Genotype:Foxp3-IRES-YFP-Cre (wildtype); Strain: C57BL/6;	EXP061657	4348	normal	Q99PV8	sorted CD4+YFP+ naive T cells	NULL
EXP061667	none	Mus musculus		NULL	25	chip_control	NULL	cerebellum	NULL
EXP061668	none	Mus musculus		NULL	2570	chip_control	NULL	medulloblastoma	NULL
EXP061669	anti-Olig2 (Millipore, ab9610)	Mus musculus		EXP061667	25	normal	Q9EQW6	cerebellum	NULL
EXP061670	anti-Olig2 (Millipore, ab9610)	Mus musculus		EXP061668	2570	normal	Q9EQW6	medulloblastoma	NULL
EXP061671	None	Mus musculus	Genotype: Zbtb24 knockout;	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP061672	None	Mus musculus	Genotype: Zbtb24 knockout;	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP061673	anti-HA (Cell Signaling Technology (CST), #3724, C29F4)	Mus musculus	Genotype: Zbtb24 knockout;	EXP061671	506	normal	Q80X44	J1 (embryonic stem cells)	NULL
EXP061674	anti-HA (Cell Signaling Technology (CST), #3724, C29F4)	Mus musculus	Genotype: Zbtb24 knockout;	EXP061672	506	normal	Q80X44	J1 (embryonic stem cells)	NULL
EXP061675	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	4349	chip_control	NULL	E14.5 dorsal cortex	NULL
EXP061676	anti-Ash2l (Active Motif, 39099)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061675	4349	normal	Q91X20	E14.5 dorsal cortex	NULL
EXP061677		Mus musculus	Genotype: Zscan4 overexpression; Treatment: transfected with 1000ng pCMV-tag2 vector;	NULL	506	chip_control	NULL	J1 (embryonic stem cells)	NULL
EXP061678	Anti-FLAG antibody	Mus musculus	Genotype: Zscan4 overexpression; Treatment: transfected with 1000ng pCMV-tag2 vector;	EXP061677	506	normal	Q80VJ6	J1 (embryonic stem cells)	NULL
EXP061679	None	Mus musculus	Conditions: 2i; Treatment: shRNA  control, shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP061680	none	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	NULL	906	chip_control	NULL	induced pluripotent stem cells	NULL
EXP061681	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	EXP061679	906	normal	Q80U70	induced pluripotent stem cells	NULL
EXP061682	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	EXP061679	906	normal	Q80U70	induced pluripotent stem cells	NULL
EXP061683	anti-TRF1 (custom)	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	EXP061679	906	normal	P70371	induced pluripotent stem cells	NULL
EXP061684	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA control; Genotype: p53 knockout;	EXP061680	906	normal	Q80U70	induced pluripotent stem cells	NULL
EXP061685	anti-Suz12 (Abcam ab12073, Lot: GR3193535-2)	Mus musculus	Conditions: 2i; Treatment: shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	EXP061680	906	normal	Q80U70	induced pluripotent stem cells	NULL
EXP061686	anti-TRF1 (custom)	Mus musculus	Conditions: 2i; Treatment: shRNA  control, shRNA TRF1; Genotype: p53 knockout, TRF1 knockout;	EXP061680	906	normal	P70371	induced pluripotent stem cells	NULL
EXP061687	Input_Control	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	chip_control	NULL	liver	NULL
EXP061688	Input_Control	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	chip_control	NULL	liver	NULL
EXP061689	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061687	5	normal	P28700	liver	NULL
EXP061690	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061688	5	normal	P28700	liver	NULL
EXP061691	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061687	5	normal	P53566	liver	NULL
EXP061692	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061688	5	normal	P53566	liver	NULL
EXP061693	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061687	5	normal	P28033	liver	NULL
EXP061694	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 3 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	EXP061688	5	normal	P28033	liver	NULL
EXP061695	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28700	liver	NULL
EXP061696	anti-RXRa (Santa-Cruz Biotechnology #SC-553)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28700	liver	NULL
EXP061697	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P53566	liver	NULL
EXP061698	anti-CEBPa (Santa-Cruz Biotechnology #SC-61)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P53566	liver	NULL
EXP061699	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: Vehicle (1% DMSO in corn oil) for 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28033	liver	NULL
EXP061700	anti-CEBPb (Santa-Cruz Biotechnology #SC-150)	Mus musculus	Treatment: 3 mg/kg TCPOBOP 27 hrs; Age: 8 weeks; Sex: male; Strain: CD-1 (Charles River);	NULL	5	normal	P28033	liver	NULL
EXP061701	none	Mus musculus	Strain: C57BL/6J;	NULL	4356	chip_control	NULL	E12.5 neural stem cells	NULL
EXP061702	anti-PHF2 (Cell signaling D45A2)	Mus musculus	Strain: C57BL/6J;	EXP061701	4356	normal	Q9WTU0	E12.5 neural stem cells	NULL
EXP061703	none	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff Cre- BAT; Sex: male;	NULL	2377	chip_control	NULL	interscapular brown adipose	NULL
EXP061704	anti-BCL6 antibody (Cell Signaling Technology #5650)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff Cre- BAT; Sex: male;	EXP061703	2377	normal	P41183	interscapular brown adipose	NULL
EXP061705	anti-BCL6 antibody (Cell Signaling Technology #5650)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff UCP1Cre+ BAT; Sex: male;	NULL	2377	normal	P41183	interscapular brown adipose	NULL
EXP061706	anti-ERRa antibody (Cell Signaling Technology #13826S)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff Cre- BAT; Sex: male;	EXP061703	2377	normal	P19785	interscapular brown adipose	NULL
EXP061707	anti-ERRa antibody (Cell Signaling Technology #13826S)	Mus musculus	Strain: BCL6-floxed (C57BL/6J); Genotype: BCL6ff UCP1Cre+ BAT; Sex: male;	NULL	2377	normal	P19785	interscapular brown adipose	NULL
EXP061708	anti-IgG (DA1E) (CST, #3900)	Mus musculus	Genotype: wildtype; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061709	anti-IgG (CST, #2729)	Mus musculus	Genotype: wildtype; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061710	none	Mus musculus	Genotype: wildtype; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061711	none	Mus musculus	Genotype: wildtype; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061712	anti-IgG (DA1E) (CST, #3900)	Mus musculus	Genotype: TDG knockout; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061713	anti-IgG (CST, #2729)	Mus musculus	Genotype: TDG knockout; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061714	none	Mus musculus	Genotype: TDG knockout; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061715	none	Mus musculus	Genotype: TDG knockout; Strain:129;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061716	anti-CTCF (CST, #3418)	Mus musculus	Genotype: wildtype; Strain:129;	EXP061710	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061717	anti-CTCF (CST, #3418)	Mus musculus	Genotype: wildtype; Strain:129;	EXP061711	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061718	anti-CTCF (CST, #3418)	Mus musculus	Genotype: TDG knockout; Strain:129;	EXP061714	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061719	anti-CTCF (CST, #3418)	Mus musculus	Genotype: TDG knockout; Strain:129;	EXP061715	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061720	None	Mus musculus		NULL	4358	chip_control	NULL	F4 (trophoblast stem cells)	NULL
EXP061721	anti-Esrrb antibody (Perseus Proteomics)	Mus musculus		EXP061720	4358	normal	Q61539	F4 (trophoblast stem cells)	NULL
EXP061722	none (input)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	NULL	4361	chip_control	NULL	E12.5 forelimb bud	NULL
EXP061723	none (input)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	NULL	4361	chip_control	NULL	E12.5 forelimb bud	NULL
EXP061724	none (input)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	NULL	4361	chip_control	NULL	E12.5 forelimb bud	NULL
EXP061725	none (input)	Mus musculus	Genotype: Prrx1Cre, EedDel/Flox; Strain: mixed background C57Bl/6 x 129;	NULL	4361	chip_control	NULL	E12.5 forelimb bud	NULL
EXP061726	anti-SUZ12 (Cell Signaling: D39F6)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061722	4359	normal	Q80U70	E12.5 proximal forelimb bud	NULL
EXP061727	anti-SUZ12 (Cell Signaling: D39F6)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061722	4360	normal	Q80U70	E12.5 distal forelimb bud	NULL
EXP061728	anti-SUZ12 (Cell Signaling: D39F6)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061723	4360	normal	Q80U70	E12.5 distal forelimb bud	NULL
EXP061729	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061724	4359	normal	Q9CQJ4	E12.5 proximal forelimb bud	NULL
EXP061730	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: Prrx1Cre, EedDel/Flox; Strain: mixed background C57Bl/6 x 129;	EXP061725	4359	normal	Q9CQJ4	E12.5 proximal forelimb bud	NULL
EXP061731	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: Prrx1Cre, EedDel/Flox; Strain: mixed background C57Bl/6 x 129;	EXP061725	4360	normal	Q9CQJ4	E12.5 distal forelimb bud	NULL
EXP061732	anti-RING1B (Actif Motif: 39663)	Mus musculus	Genotype: wildtype; Strain: mixed background C57Bl/6 x 129;	EXP061724	4360	normal	Q9CQJ4	E12.5 distal forelimb bud	NULL
EXP061733	none	Mus musculus	Genotype:wildtype;	NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP061734	Rabbit normal IgG (Jackson ImmunoResearch 011-000-002)	Mus musculus	Genotype:wildtype;	NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP061735	none	Mus musculus	Genotype:{delta}RBR (N576_D611del::GDGAGLINS-3xHA);	NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP061736	Rabbit normal IgG (Jackson ImmunoResearch 011-000-002)	Mus musculus	Genotype:{delta}RBR (N576_D611del::GDGAGLINS-3xHA);	NULL	1064	chip_control	NULL	JM8.N4 (embryonic stem cells)	NULL
EXP061737	anti-Scm1a (Bethyl Laboratories Inc. A300-055A)	Mus musculus	Genotype:wildtype;	EXP061733	1064	normal	Q9CU62	JM8.N4 (embryonic stem cells)	NULL
EXP061738	anti-CTCF (Abcam ab128873)	Mus musculus	Genotype:wildtype;	EXP061733	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	NULL
EXP061739	anti-Scm1a (Bethyl Laboratories Inc. A300-055A)	Mus musculus	Genotype:{delta}RBR (N576_D611del::GDGAGLINS-3xHA);	EXP061735	1064	normal	Q9CU62	JM8.N4 (embryonic stem cells)	NULL
EXP061740	anti-CTCF (Abcam ab128873)	Mus musculus	Genotype:{delta}RBR (N576_D611del::GDGAGLINS-3xHA);	EXP061735	1064	normal	Q61164	JM8.N4 (embryonic stem cells)	NULL
EXP061741		Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	4362	chip_control	NULL	diaphragm skeletal muscle	NULL
EXP061742		Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	4363	chip_control	NULL	extensor digitorum longus skeletal muscle	NULL
EXP061743		Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	2940	chip_control	NULL	quadriceps muscle	NULL
EXP061744		Mus musculus	Genotype: wildtype; Strain: C57BL/6;	NULL	4364	chip_control	NULL	soleus skeletal muscle	NULL
EXP061745	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061741	4362	normal	Q925J9	diaphragm skeletal muscle	NULL
EXP061746	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061742	4363	normal	Q925J9	extensor digitorum longus skeletal muscle	NULL
EXP061747	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061743	2940	normal	Q925J9	quadriceps muscle	NULL
EXP061748	anti-Nfat (Millipore MABS409, mouse monoclonal)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061743	2940	normal	O88942	quadriceps muscle	NULL
EXP061749	anti-Med1 (Bethyl Laboratories A300-793A, rabbit)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061744	4364	normal	Q925J9	soleus skeletal muscle	NULL
EXP061750	anti-Nfat (Millipore MABS409, mouse monoclonal)	Mus musculus	Genotype: wildtype; Strain: C57BL/6;	EXP061744	4364	normal	O88942	soleus skeletal muscle	NULL
EXP061751	none (input)	Mus musculus	Genotype: wildtype and ZFP57 knockout pool; Sex: male; Strain: C57BL/6J;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061752	anti-ZFP57 (Abcam, ab45341, lot 754226)	Mus musculus	Genotype: wildtype; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP061753	anti-ZFP57 (Abcam, ab45341, lot 754226)	Mus musculus	Genotype: ZFP57 knockout; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q8C6P8	mESCs (mouse embryonic stem cells)	NULL
EXP061754	anti-KAP1 (Abcam, ab10483, lot J0809)	Mus musculus	Genotype: wildtype; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061755	anti-KAP1 (Abcam, ab10483, lot J0809)	Mus musculus	Genotype: ZFP57 knockout; Sex: male; Strain: C57BL/6J;	EXP061751	2	normal	Q62318	mESCs (mouse embryonic stem cells)	NULL
EXP061756	none	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: wildtype;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP061757	none	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: Egr1 knockout;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP061758	anti-TET1 (Active Motif, 61741)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: wildtype;	EXP061756	965	normal	Q3URK3	frontal cortex	NULL
EXP061759	anti-TET1 (Active Motif, 91171)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: wildtype;	EXP061756	965	normal	Q3URK3	frontal cortex	NULL
EXP061760	anti-TET1 (Active Motif, 61741)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: Egr1 knockout;	EXP061757	965	normal	Q3URK3	frontal cortex	NULL
EXP061761	anti-TET1 (Active Motif, 91171)	Mus musculus	Age: 6 weeks; Sex: male; Strain: C57BL/6; Genotype: Egr1 knockout;	EXP061757	965	normal	Q3URK3	frontal cortex	NULL
EXP061762	none	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	NULL	4367	chip_control	NULL	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061763	none	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	NULL	4368	chip_control	NULL	sarcoma iPSC-derived MEFs	NULL
EXP061764	none	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	NULL	4367	chip_control	NULL	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061765	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 48 hrs HA;	EXP061764	4367	normal	Q07802	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061766	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 4 days HA;	EXP061764	4367	normal	Q07802	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061767	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 48 hrs HA;	EXP061764	4367	normal	Q80Z64	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061768	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Time point: 4 days HA;	EXP061764	4367	normal	Q80Z64	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061769	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	EXP061762	4367	normal	P81269	G1297 (EWS/ATF1 -iduced sarcoma cell line)	NULL
EXP061770	anti-HA (mouse monoclonal antibody, Nacalai cat# 06340-54)	Mus musculus	Treatment: Doxycycline (0.2 ug/ml);	EXP061763	4368	normal	P81269	sarcoma iPSC-derived MEFs	NULL
EXP061771	None	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4372	chip_control	NULL	E11.5 ganglionic eminences	NULL
EXP061772	None	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4373	chip_control	NULL	E13.5 ganglionic eminences	NULL
EXP061773	None	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4374	chip_control	NULL	E16.5 ganglionic eminences	NULL
EXP061774	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4373	chip_control	NULL	E13.5 ganglionic eminences	NULL
EXP061775	None	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4373	chip_control	NULL	E13.5 ganglionic eminences	NULL
EXP061776	anti-Dlx1 (lab-made, described in paper)	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061771	4372	normal	Q64317	E11.5 ganglionic eminences	NULL
EXP061777	anti-Dlx1 (lab-made, described in paper)	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061772	4373	normal	Q61039	E13.5 ganglionic eminences	NULL
EXP061778	anti-Dlx1 (lab-made, described in paper)	Mus musculus	Genotype: wildtype; Strain: CD1;	NULL	4374	normal	Q61039	E16.5 ganglionic eminences	NULL
EXP061779	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061771	4372	normal	P40764	E11.5 ganglionic eminences	NULL
EXP061780	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061774	4373	normal	P40764	E13.5 ganglionic eminences	NULL
EXP061781	anti-Dlx2 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061773	4374	normal	P40764	E16.5 ganglionic eminences	NULL
EXP061782	anti-Dlx5 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061771	4372	normal	P70396	E11.5 ganglionic eminences	NULL
EXP061783	anti-Dlx5 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061775	4373	normal	P70396	E13.5 ganglionic eminences	NULL
EXP061784	anti-Dlx5 (lab-made (described in paper))	Mus musculus	Genotype: wildtype; Strain: CD1;	EXP061773	4374	normal	P70396	E16.5 ganglionic eminences	NULL
EXP061785	anti-CBP (sc583x) 	Mus musculus	Age: 3-6 month; Treatment: Saline; Strain: C57BL/6J;	NULL	4375	normal	P45481	hippocampal excitatory neurons	NULL
EXP061786	anti-CBP (sc583x) 	Mus musculus	Age: 3-6 month; Treatment: induction of SE by Kainic Acid (KA); Strain: C57BL/6J;	NULL	4375	normal	P45481	hippocampal excitatory neurons	NULL
EXP061787		Mus musculus		NULL	1126	chip_control	NULL	E14TG2a.4 (embryonic stem cells)	NULL
EXP061788		Mus musculus	Treatment: Activin for 2 hours;	NULL	4376	chip_control	NULL	E14TG2a.4 derived embryoid body	NULL
EXP061789	anti-Smad2 (Cell Signaling Technology, 5339S)	Mus musculus		EXP061787	1126	normal	Q62432	E14TG2a.4 (embryonic stem cells)	NULL
EXP061790	anti-Smad3 (Cell Signaling Technology, 9523S)	Mus musculus		EXP061787	1126	normal	Q8BUN5	E14TG2a.4 (embryonic stem cells)	NULL
EXP061791	anti-Smad4 (Santa Cruz, 7966X and Abcam, 40759)	Mus musculus		EXP061787	1126	normal	P97471	E14TG2a.4 (embryonic stem cells)	NULL
EXP061792	anti-Foxh1 (Abcam, 49133)	Mus musculus		EXP061787	1126	normal	O88621	E14TG2a.4 (embryonic stem cells)	NULL
EXP061793	anti-Smad2 (Cell Signaling Technology, 5339S)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	Q62432	E14TG2a.4 derived embryoid body	NULL
EXP061794	anti-Smad2 (Cell Signaling Technology, 5339S)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	Q62432	E14TG2a.4 derived embryoid body	NULL
EXP061795	anti-Smad3 (Cell Signaling Technology, 9523S)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	Q8BUN5	E14TG2a.4 derived embryoid body	NULL
EXP061796	anti-Smad3 (Cell Signaling Technology, 9523S)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	Q8BUN5	E14TG2a.4 derived embryoid body	NULL
EXP061797	anti-Smad4 (Santa Cruz, 7966X and Abcam, 40759)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	P97471	E14TG2a.4 derived embryoid body	NULL
EXP061798	anti-Smad4 (Santa Cruz, 7966X and Abcam, 40759)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	P97471	E14TG2a.4 derived embryoid body	NULL
EXP061799	anti-Foxh1 (Abcam, 49133)	Mus musculus	Treatment: SB431542 for 2 hrs;	NULL	4376	normal	O88621	E14TG2a.4 derived embryoid body	NULL
EXP061800	anti-Foxh1 (Abcam, 49133)	Mus musculus	Treatment: Activin for 2 hours;	EXP061788	4376	normal	O88621	E14TG2a.4 derived embryoid body	NULL
EXP061801	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061802	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061803	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061804	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061805	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061806	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061807	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061808	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061809	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061801	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061810	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061802	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061811	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061803	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061812	anti Ctcf (Cell Signaling, #2899)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061804	2	normal	Q61164	mESCs (mouse embryonic stem cells)	NULL
EXP061813	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061805	2	normal	Q61550	mESCs (mouse embryonic stem cells)	NULL
EXP061814	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: wildtype;	EXP061806	2	normal	Q61550	mESCs (mouse embryonic stem cells)	NULL
EXP061815	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061807	2	normal	Q61550	mESCs (mouse embryonic stem cells)	NULL
EXP061816	anti Rad21 (Abcam, ab992)	Mus musculus	Strain: hybrid 129-C57BL/6; Genotype: Adnp knockout;	EXP061808	2	normal	Q61550	mESCs (mouse embryonic stem cells)	NULL
EXP061817	anti-CTCF (Active motif: 613111)	Mus musculus	Genotype: wildtype;	NULL	4377	normal	Q61164	E12.5 limb bud	NULL
EXP061818	anti-IRF3 (D83B9, Cell Signaling)	Mus musculus	Treatment: 5 mg/ml of high molecular weight Polyinosinic-polycytidylic acid (pIC) for 90 mins;	NULL	2394	normal	P70671	CD8-positive dendritic cells	NULL
EXP061819	anti-IRF5 (ab21689, Abcam)	Mus musculus	Treatment:Â 1 mM class B CpG oligonucleotide (1826) for 90 mins;	NULL	2394	normal	P56477	CD8-positive dendritic cells	NULL
EXP061820	anti-IRF9 (AF5629, R&D Systems)	Mus musculus	Treatment: 10U IFN-beta for 90 mins;	NULL	2394	normal	Q61179	CD8-positive dendritic cells	NULL
EXP061821		Mus musculus	Treatment: DMSO;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP061822	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: DMSO;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061823	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: Triptolide for 1 hr;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061824	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: Triptolide for 4 hrs;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061825	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: mock;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061826	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Treatment: Rnase treatment;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061827	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Genotype: wildtype;  Conditions: grown with 500mM of indole-3-acetic acid (IAA, chemical analog of auxin) in the medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061828	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Genotype: ZF1 mutation;  Conditions: grown with 500mM of indole-3-acetic acid (IAA, chemical analog of auxin) in the medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061829	Anti-CTCF antibody (Abcam, ab7030)	Mus musculus	Genotype: ZF10 mutation;  Conditions: grown with 500mM of indole-3-acetic acid (IAA, chemical analog of auxin) in the medium;	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP061830	anti-Flag	Mus musculus	Genotype: expressing Neo;	NULL	4380	chip_control	NULL	AlphaT3-1	NULL
EXP061831		Mus musculus	Genotype: expressing Pax7;	NULL	4380	chip_control	NULL	AlphaT3-1	NULL
EXP061832		Mus musculus	Genotype: expressing Neo;	NULL	4380	chip_control	NULL	AlphaT3-1	NULL
EXP061833	anti-Flag	Mus musculus	Genotype: expressing Pax7;	EXP061831	4380	normal	P47239	AlphaT3-1	NULL
EXP061834	anti-Neurod1 (Poulin et al. Mol. Cell. Biol 20, 4826-4837 (2000))	Mus musculus		NULL	75	normal	Q60867	AtT-20 (pituitary tumor)	NULL
EXP061835	anti-Sox2 (Abcam (Ab59776))	Mus musculus	Genotype: expressing Sox2;	NULL	75	normal	P48432	AtT-20 (pituitary tumor)	NULL
EXP061836	anti-EZH2 (Cell Signaling Technology, 5246S, lot:7)	Mus musculus	Genotype: wildtype;	NULL	2508	normal	Q61188	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP061837	anti-EZH2 (Cell Signaling Technology, 5246S, lot:7)	Mus musculus	Genotype: Smchd1-/-;	NULL	2508	normal	Q61188	embryonic stem cells-derived clonal neural progenitor cells	NULL
EXP061838	none	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	chip_control	NULL	primary naive B-cells from spleen	NULL
EXP061839	c-Myc N262 (Santa Cruz sc764)	Mus musculus	Treatment: untreated; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	EXP061838	4383	normal	P01108	primary naive B-cells from spleen	NULL
EXP061840	anti-c-Myc N262 (Santa Cruz sc764, N262)	Mus musculus	Treatment: LPS (50 ug/ml) for 2 hrs; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	normal	P01108	primary naive B-cells from spleen	NULL
EXP061841	c-Myc N262 (Santa Cruz sc764)	Mus musculus	Treatment: LPS (50 ug/ml) for 4 hrs; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	normal	P01108	primary naive B-cells from spleen	NULL
EXP061842	c-Myc N262 (Santa Cruz sc764)	Mus musculus	Treatment: LPS (50 ug/ml) for 8 hrs; Genotype: wildtype; Age: 7-10 weeks; Strain: C57BL/6;	NULL	4383	normal	P01108	primary naive B-cells from spleen	NULL
EXP061843	NA	Mus musculus		NULL	4384	chip_control	NULL	230-238 (murine PreB cells cell line)	NULL
EXP061844	NA	Mus musculus		NULL	4384	chip_control	NULL	230-238 (murine PreB cells cell line)	NULL
EXP061845	NA	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP061846	NA	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP061847	NA	Mus musculus	Genotype: Pax5 knockout; Strain: C57BL6/J;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP061848	NA	Mus musculus	Genotype: Pax5 knockout; Strain: C57BL6/J;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP061849	NA	Mus musculus	Genotype: Ebf1 knockout; Strain: C57BL6/J;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP061850	NA	Mus musculus	Genotype: Ebf1 knockout; Strain: C57BL6/J;	NULL	105	chip_control	NULL	pro-B cells	NULL
EXP061851	NA	Mus musculus		NULL	4384	chip_control	NULL	230-238 (murine PreB cells cell line)	NULL
EXP061852	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus		EXP061843	4384	normal	Q03267	230-238 (murine PreB cells cell line)	NULL
EXP061853	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus		EXP061844	4384	normal	Q03347	230-238 (murine PreB cells cell line)	NULL
EXP061854	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal )	Mus musculus		EXP061844	4384	normal	Q02650	230-238 (murine PreB cells cell line)	NULL
EXP061855	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	EXP061845	105	normal	Q03267	pro-B cells	NULL
EXP061856	anti-Pax5 (ab183575, Abcam, Rabbit polyclonal )	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	EXP061846	105	normal	Q02650	pro-B cells	NULL
EXP061857	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus	Genotype: wildtype; Strain: C57BL6/J;	EXP061846	105	normal	Q03347	pro-B cells	NULL
EXP061858	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus	Genotype: Pax5 knockout; Strain: C57BL6/J;	EXP061847	105	normal	Q03267	pro-B cells	NULL
EXP061859	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus	Genotype: Pax5 knockout; Strain: C57BL6/J;	EXP061848	105	normal	Q03347	pro-B cells	NULL
EXP061860	anti-Ikzf1 (ab26083, Abcam,Rabbit polyclonal IgG)	Mus musculus	Genotype: Ebf1 knockout; Strain: C57BL6/J;	EXP061849	105	normal	Q03267	pro-B cells	NULL
EXP061861	anti-RUNX1 (ab23980, Abcam,Rabbit polyclonal )	Mus musculus	Genotype: Ebf1 knockout; Strain: C57BL6/J;	EXP061850	105	normal	Q03347	pro-B cells	NULL
EXP061862	anti-FLI1 (ab15289, Abcam, Rabbit polyclonal IgG) 	Mus musculus		EXP061851	4384	normal	P26323	230-238 (murine PreB cells cell line)	NULL
EXP061863	anti-DMC1 (C-20, lot #D2215, Santa Cruz, goat polyclonal)	Mus musculus	Genotype: wildtype; Strain: C57BL/6JCrl;  Age: adult; Sex: male;	NULL	32	normal	Q61880	testis	NULL
EXP061864	anti-DMC1 (C-20, lot #D2215, Santa Cruz, goat polyclonal)	Mus musculus	Genotype: Ankrd31 knockout; Strain: C57BL/6JCrl;  Age: adult; Sex: male;	NULL	32	normal	Q61880	testis	NULL
EXP061865	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: wildtype;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	NULL
EXP061866	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	NULL
EXP061867	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	NULL
EXP061868	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	NULL
EXP061869	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 knockout;	NULL	4386	normal	O89090	A17Lox (embryonic stem cells)	NULL
EXP061870	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: wildtype;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	NULL
EXP061871	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	NULL
EXP061872	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	NULL
EXP061873	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	NULL
EXP061874	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 knockout;	NULL	4386	normal	O70494	A17Lox (embryonic stem cells)	NULL
EXP061875	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: wildtype;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	NULL
EXP061876	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	NULL
EXP061877	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	NULL
EXP061878	anti-Sp1 (Millipore 17-601)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O89090	A17Lox derived Flk1+ cells	NULL
EXP061879	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: wildtype;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	NULL
EXP061880	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 delta DBD;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	NULL
EXP061881	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	NULL
EXP061882	anti-Sp3 (Santa Cruz sc644X)	Mus musculus	Genotype: Sp1 hetrozygous;	NULL	4387	normal	O70494	A17Lox derived Flk1+ cells	NULL
EXP061883		Mus musculus	Strain: 129/Sv;  Conditions: 2i;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061884		Mus musculus	Strain: 129/Sv;  Conditions: serum;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP061885	anti-SA1 antibody (STAG1, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: serum;	EXP061884	2	normal	Q9D3E6	mESCs (mouse embryonic stem cells)	NULL
EXP061886	anti-SA2 antibody (STAG2, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: serum;	EXP061884	2	normal	O35638	mESCs (mouse embryonic stem cells)	NULL
EXP061887	anti-SMC1 (custom made antibody)	Mus musculus	Strain: 129/Sv;  Conditions: serum;	EXP061884	2	normal	Q9CU62	mESCs (mouse embryonic stem cells)	NULL
EXP061888	anti-SA1 antibody (STAG1, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: 2i;	EXP061883	2	normal	Q9D3E6	mESCs (mouse embryonic stem cells)	NULL
EXP061889	anti-SA2 antibody (STAG2, custom made )	Mus musculus	Strain: 129/Sv;  Conditions: 2i;	EXP061883	2	normal	O35638	mESCs (mouse embryonic stem cells)	NULL
EXP061890	anti-cbfb	Mus musculus	Strain: B6/Cast F1;	NULL	4095	normal	Q08024	naive CD8 T cells from spleen	NULL
EXP061891	anti-cbfb	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q08024	activated CD8 T cell from spleen	NULL
EXP061892	anti-eomes	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	O54839	activated CD8 T cell from spleen	NULL
EXP061893	anti-tbet	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q9JKD8	activated CD8 T cell from spleen	NULL
EXP061894	anti-cbfb	Mus musculus	Strain: B6/Cast F1;	NULL	4095	normal	Q08024	naive CD8 T cells from spleen	NULL
EXP061895	anti-cbfb	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q08024	activated CD8 T cell from spleen	NULL
EXP061896	anti-eomes	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	O54839	activated CD8 T cell from spleen	NULL
EXP061897	anti-tbet	Mus musculus	Strain: B6/Cast F1; Treatment: viral infection; Time point: day 7;	NULL	4406	normal	Q9JKD8	activated CD8 T cell from spleen	NULL
EXP061898	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Aebp2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061899	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Epop knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061900	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061901	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl2 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061902	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061903	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	O09102	mESCs (mouse embryonic stem cells)	NULL
EXP061904	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout +Flag-SUZ12 ;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061905	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype:Suz12 knockout Flag-SUZ12-C2;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061906	Flag (Sigma, M2 affinity gel A2220)	Mus musculus	Strain: 129B6F1; Genotype:Suz12 knockout  Flag-SUZ12-DeltaC2;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061907	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP061908	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP061909	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 knockout;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP061910	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout + Flag-SUZ12;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP061911	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout + Flag-SUZ12-C2;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP061912	Mtf2 (Proteintech, Rabbit pAb, #16208-1-AP)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 knockout;	NULL	2	normal	Q02395	mESCs (mouse embryonic stem cells)	NULL
EXP061913	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP061914	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP061915	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 knockout;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP061916	Jarid2 (Cell Signaling, Rabbit mAb, D6M9X)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 knockout;	NULL	2	normal	Q62315	mESCs (mouse embryonic stem cells)	NULL
EXP061917	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 + Aebp2 + Epop triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061918	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Epop + Aebp2 triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061919	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Epop + Jarid2 triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061920	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Jarid2 + Aebp2 triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061921	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: wildtype;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061922	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Suz12 knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061923	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Epop double knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061924	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Jarid2 + Aebp2 double knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061925	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Jarid2 double knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061926	anti-Suz12 (Cell Signaling, Rabbit mAb, D39F6)	Mus musculus	Strain: 129B6F1; Genotype: Pcl1-3 + Jarid2 + Aebp2 + Epop triple knockout;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP061927	none	Mus musculus	Strain: ICR;	NULL	4410	chip_control	NULL	E14.5 dissociated primary cortical cells from forebrain cortex	NULL
EXP061928	anti-ZEB1 (Santa Cruz Biotechnologies, Cat.No.sc25388)	Mus musculus	Strain: ICR;	EXP061927	4410	normal	Q64318	E14.5 dissociated primary cortical cells from forebrain cortex	NULL
EXP061929	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment: stimulated for 90 mins with 250 IU/mL of IFNb (PBL interferon source); Genotype: wildtype;	NULL	12	normal	Q61179	MEF (mouse embryonic fibroblasts)	NULL
EXP061930	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment: stimulated for 90 mins with 250 IU/mL of IFNb (PBL interferon source); Genotype: wildtype;	NULL	12	normal	P42225	MEF (mouse embryonic fibroblasts)	NULL
EXP061931	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment: stimulated for 90 mins with 250 IU/mL of IFNb (PBL interferon source); Genotype: wildtype;	NULL	12	normal	Q9WVL2	MEF (mouse embryonic fibroblasts)	NULL
EXP061932	anti-IRF9 (clone 6F1 homemade)	Mus musculus	Treatment:none; Genotype: wildtype;	NULL	12	normal	Q61179	MEF (mouse embryonic fibroblasts)	NULL
EXP061933	anti-Stat1 (E23, Santa Cruz sc-346, RRID:AB_632435)	Mus musculus	Treatment:none; Genotype: wildtype;	NULL	12	normal	P42225	MEF (mouse embryonic fibroblasts)	NULL
EXP061934	anti-Stat2 (L-20, Santa Cruz sc-950, RRID:AB_2271322)	Mus musculus	Treatment:none; Genotype: wildtype;	NULL	12	normal	Q9WVL2	MEF (mouse embryonic fibroblasts)	NULL
EXP062839	anti-BACH1 (AF577, R&D)	Mus musculus	Treatment: NAC-Treated, sg1BACH1; Genotype: KrasG12D/+, KrasG12D/+, BACH1 knockout; Strain: mixed C57BL/6-129/Sv	NULL	3647	normal	P97302	mixed cell lines(RP23-51O13, RP23-302D24, RP23-67F18)	NULL
EXP062840	anti-BACH1 (AF577, R&D)	Mus musculus	Treatment: Control; Genotype: KrasG12D/+; Strain: mixed C57BL/6-129/Sv	NULL	3647	normal	P97302	mixed cell lines(RP23-51O13, RP23-302D24, RP23-67F18)	NULL
EXP062841	anti-BACH1 (AF577, R&D)	Mus musculus	Treatment: NAC-treated (drinking water of mice); Genotype: KrasG12D/+; Strain: mixed C57BL/6-129/Sv	NULL	3647	normal	P97302	mixed cell lines(RP23-51O13, RP23-302D24, RP23-67F18)	NULL
EXP061941	None	Mus musculus	Treatment: none; Strain: 129s2;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP061942	None	Mus musculus	Treatment: Glucose starvation; Strain: 129s2;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP061943	None	Mus musculus	Treatment: none; Strain: 129s2;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP061944	None	Mus musculus	Treatment: Glucose starvation; Strain: 129s2;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP061945	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: none; Strain: 129s2;	EXP061941	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	NULL
EXP061946	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: Glucose starvation; Strain: 129s2;	EXP061942	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	NULL
EXP061947	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: none; Strain: 129s2;	EXP061943	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	NULL
EXP061948	anti-SIRT7 (Cell signaling, #5360)	Mus musculus	Treatment: Glucose starvation; Strain: 129s2;	EXP061944	12	normal	Q8BKJ9	MEF (mouse embryonic fibroblasts)	NULL
EXP061949	anti-MED1 (Santa Cruz, sc-8998)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	Q925J9	liver	NULL
EXP061950	anti-MED1 (Santa Cruz, sc-8998)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	Q925J9	liver	NULL
EXP061951	anti-NCOR1 (Abcam, ab24552)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	Q60974	liver	NULL
EXP061952	anti-NCOR1 (Abcam, ab24552)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	Q60974	liver	NULL
EXP061953	anti-CBP (Santa Cruz, sc-369)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	P45481	liver	NULL
EXP061954	anti-CBP (Santa Cruz, sc-369)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	P45481	liver	NULL
EXP061955	anti-HDAC3 (Santa Cruz, sc-11417)	Mus musculus	Treatment: PTU; Genotype: wildtype;	NULL	5	normal	O88895	liver	NULL
EXP061956	anti-HDAC3 (Santa Cruz, sc-11417)	Mus musculus	Treatment: PTU, T3; Genotype: wildtype;	NULL	5	normal	O88895	liver	NULL
EXP061957	anti-HDAC3 (Santa Cruz, sc-11417)	Mus musculus	Treatment: PTU; Genotype: L-NCORdeltaID;	NULL	5	normal	O88895	liver	NULL
EXP061958	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: non-synchronized;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061959	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: T0 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061960	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: T6 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061961	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: T12 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061962	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: T18 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061963	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: T24 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061964	anti LMNB1 - Abcam rabbit polyclonal Ab16048	Mus musculus	Developmental stage: T30 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	NULL	5	chip_control	NULL	liver	NULL
EXP061965	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: non-synchronized;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061958	5	normal	P14733	liver	NULL
EXP061966	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T0 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061959	5	normal	P14733	liver	NULL
EXP061967	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T6 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061960	5	normal	P14733	liver	NULL
EXP061968	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T12 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061961	5	normal	P14733	liver	NULL
EXP061969	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T18 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061962	5	normal	P14733	liver	NULL
EXP061970	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T24 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061963	5	normal	P14733	liver	NULL
EXP061971	anti-LMNB1 (Abcam rabbit polyclonal Ab16048)	Mus musculus	Developmental stage: T30 circadian time;  Genotype: wildtype; Strain:C57Bl/6;  Sex: female;	EXP061964	5	normal	P14733	liver	NULL
EXP061972	none	Mus musculus	Genotype: empty vehicle vector;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP061973	none	Mus musculus	Genotype: overexpression of Foxa1 FE255del;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP061974	none	Mus musculus	Genotype: overexpression of Foxa1 R219S;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP061975	none	Mus musculus	Genotype: overexpression of Foxa1 WT;	NULL	2953	chip_control	NULL	prostate organoids	NULL
EXP061976	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: empty vehicle vector;	EXP061972	2953	normal	P19091	prostate organoids	NULL
EXP061977	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: empty vehicle vector;	EXP061972	2953	normal	P35582	prostate organoids	NULL
EXP061978	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: overexpression of Foxa1 FE255del;	EXP061973	2953	normal	P19091	prostate organoids	NULL
EXP061979	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: overexpression of Foxa1 FE255del;	EXP061973	2953	normal	P35582	prostate organoids	NULL
EXP061980	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: overexpression of Foxa1 R219S;	EXP061974	2953	normal	P19091	prostate organoids	NULL
EXP061981	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: overexpression of Foxa1 R219S;	EXP061974	2953	normal	P35582	prostate organoids	NULL
EXP061982	anti-AR Antibody (ER179(2), Abcam)	Mus musculus	Genotype: overexpression of Foxa1 WT;	EXP061975	2953	normal	P19091	prostate organoids	NULL
EXP061983	anti-FoxA1 Antibody (3B3NB, Novus Biologicals)	Mus musculus	Genotype: overexpression of Foxa1 WT;	EXP061975	2953	normal	P35582	prostate organoids	NULL
EXP061984	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: exposed to chronic cold (4C); Genotype: wildtype; Strain: C57BL/6;	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP061985	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: exposed to chronic cold (4C); Genotype: wildtype; Strain: C57BL/6;	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP061986	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: thermoneutrality (29C); Genotype: wildtype; Strain: C57BL/6;	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP061987	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: thermoneutrality (29C); Genotype: wildtype; Strain: C57BL/6;	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP061988	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: exposed to chronic cold (4C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061984	115	normal	Q3UV55	brown adipose tissue	NULL
EXP061989	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: exposed to chronic cold (4C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061985	115	normal	Q3UV55	brown adipose tissue	NULL
EXP061990	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: thermoneutrality (29C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061986	115	normal	Q3UV55	brown adipose tissue	NULL
EXP061991	anti-HA (magnetic beads, Pierce, 88837)	Mus musculus	Conditions: thermoneutrality (29C); Genotype: HA-RevErba; Strain: C57BL/6;	EXP061987	115	normal	Q3UV55	brown adipose tissue	NULL
EXP061992	none	Mus musculus	Genotype: Rag -/- ; Cell type: Abelson cells;	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP061993	none	Mus musculus	Genotype: Art -/-  ; Cell type: Abelson cells;	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP061994	none	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells;	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP061995	none	Mus musculus	Genotype: Art -/- , SPIC-tet; Cell type: Abelson cells;	NULL	503	chip_control	NULL	pre-B cells	NULL
EXP061996	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Rag -/- ; Cell type: Abelson cells;	EXP061992	503	normal	P17433	pre-B cells	NULL
EXP061997	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Art -/-  ; Cell type: Abelson cells;	EXP061993	503	normal	P17433	pre-B cells	NULL
EXP061998	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells; Treatment: none treatment;	EXP061994	503	normal	P17433	pre-B cells	NULL
EXP061999	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Rag -/-, SPIC-tet ; Cell type: Abelson cells; Treatment: DOX  treatment;	EXP061994	503	normal	P17433	pre-B cells	NULL
EXP062000	anti-PU.1 (PA5-17505, Thermo Fisher Scientific)	Mus musculus	Genotype: Art -/- , SPIC-tet; Cell type: Abelson cells; Treatment: none dox;	NULL	503	normal	P17433	pre-B cells	NULL
EXP062001	anti-HA (ab9110, Abcam)	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells; Treatment: DOX  treatment;	NULL	503	normal	Q6P3D7	pre-B cells	NULL
EXP062002	anti-BCLAF1 (A300-608A, Bethyl Laboratories)	Mus musculus	Genotype: Rag -/- , SPIC-tet; Cell type: Abelson cells; Treatment: DOX  treatment;	NULL	503	normal	Q8K019	pre-B cells	NULL
EXP062003	none	Mus musculus	Genotype: Tcf7l2 knockout; Strain: C57BL/6; Passage: 10-13;	NULL	4420	chip_control	NULL	immortalized primary preadipocytes	NULL
EXP062004	none	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Passage: 10-13;	NULL	4420	chip_control	NULL	immortalized primary preadipocytes	NULL
EXP062005	anti-TCF7L2 (Cell signaling #2569 lot#4)	Mus musculus	Genotype: Tcf7l2 knockout; Strain: C57BL/6; Passage: 10-13;	EXP062003	4420	normal	Q924A0	immortalized primary preadipocytes	NULL
EXP062006	anti-TCF7L2 (Cell signaling #2569 lot#4)	Mus musculus	Genotype: wildtype; Strain: C57BL/6; Passage: 10-13;	EXP062004	4420	normal	Q924A0	immortalized primary preadipocytes	NULL
EXP062007	anti-EZH2 (Diagenode, C15410039, 3?g)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1105	normal	Q61188	E12.5 embryonic distal forelimb	NULL
EXP062008	anti-EZH2 (Diagenode, C15410039, 3?g)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1198	normal	Q61188	E12.5 embryonic proximal forelimbs	NULL
EXP062009	anti-RING1B (Active Motif ,39664, 4ug)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1105	normal	Q9CQJ4	E12.5 embryonic distal forelimb	NULL
EXP062010	anti-RING1B (Active Motif ,39664, 4ug)	Mus musculus	Strain: B6CBAF1; Genotype: wildtype;	NULL	1198	normal	Q9CQJ4	E12.5 embryonic proximal forelimbs	NULL
EXP062011		Mus musculus	Strain: BALB/c; Age: 6 weeks; Genotype: wildtype; Treatment: treated with 17beta Estradiol for 2 hours;	NULL	572	chip_control	NULL	mammary gland	NULL
EXP062012	anti-ERa (Santa Cruz, sc-542)	Mus musculus	Strain: BALB/c; Age: 6 weeks; Genotype: wildtype; Treatment: treated with 17beta Estradiol for 2 hours;	EXP062011	572	normal	P19785	mammary gland	NULL
EXP062013	antiRAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	chip_control	NULL	v-Abl transformed pro-B cells	NULL
EXP062014		Mus musculus	Genotype: JH-del, dCas9 expressing, Sg1-sgRNA expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	chip_control	NULL	v-Abl transformed pro-B cells	NULL
EXP062015		Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	chip_control	NULL	v-Abl transformed pro-B cells	NULL
EXP062016		Mus musculus	Genotype: JH-del, dCas9 expressing, Sg1-sgRNA expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	chip_control	NULL	v-Abl transformed pro-B cells	NULL
EXP062017	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Sg1-sgRNA expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062014	4422	normal	Q61550	v-Abl transformed pro-B cells	NULL
EXP062018	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062013	4422	normal	Q61550	v-Abl transformed pro-B cells	NULL
EXP062019	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	normal	Q61550	v-Abl transformed pro-B cells	NULL
EXP062020	anti-RAD21 antibody (Abcam, ab992) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Ig2b-del/del, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	NULL	4422	normal	Q61550	v-Abl transformed pro-B cells	NULL
EXP062021	anti-NIPBL antibody (Bethyl Laboratories, A301-779A) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062015	4422	normal	Q6KCD5	v-Abl transformed pro-B cells	NULL
EXP062022	anti-NIPBL antibody (Bethyl Laboratories, A301-779A) 	Mus musculus	Genotype: JH-del, dCas9 expressing, Sg1-sgRNA expressing, Emu-Bcl2, RAG2 deficient; Treatment: 3 uM STI-571 treated for 4 days;	EXP062016	4422	normal	Q6KCD5	v-Abl transformed pro-B cells	NULL
EXP062023	none	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP062024	none	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP062025	none	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP062026	none	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP062027	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062023	965	normal	D3YY81	frontal cortex	NULL
EXP062028	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062023	965	normal	D3Z7U4	frontal cortex	NULL
EXP062029	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062024	965	normal	D3YY81	frontal cortex	NULL
EXP062030	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 a.m.; Sex: male; Strain: 129/C57BL6;	EXP062024	965	normal	D3Z7U4	frontal cortex	NULL
EXP062031	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062025	965	normal	D3YY81	frontal cortex	NULL
EXP062032	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062025	965	normal	D3Z7U4	frontal cortex	NULL
EXP062033	anti-MeCP2 E1 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062026	965	normal	D3YY81	frontal cortex	NULL
EXP062034	anti-MeCP2 E2 isoform (In-house antibody)	Mus musculus	Time point: 12 p.m.; Sex: male; Strain: 129/C57BL6;	EXP062026	965	normal	D3Z7U4	frontal cortex	NULL
EXP062035		Mus musculus	Strain: Swiss Webster; Genotype: wildtype;	NULL	4428	chip_control	NULL	E10.5 head	NULL
EXP062036	anti-Gli2 antibody (R&D AF3526)	Mus musculus	Strain: Swiss Webster; Genotype: wildtype;	EXP062035	4428	normal	Q0VGT2	E10.5 head	NULL
EXP062037	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062038	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062039	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062040	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062041	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062042	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062043	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062044	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expression of  Mef2c; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062045	none	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expression of Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	NULL	4426	chip_control	NULL	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062046	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062037	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062047	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062038	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062048	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062039	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062049	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062040	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062050	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062041	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062051	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062042	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062052	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062038	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062053	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062039	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062054	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062040	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062055	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062041	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062056	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062038	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062057	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062039	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062058	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062040	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062059	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4, Mef2c, Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062041	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062060	anti-GATA-4 (goat pAb (C-20), Santa Cruz Biotechnology; sc-1237x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expressio of Gata4; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062043	4426	normal	Q08369	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062061	anti-Mef2c ( XP Rabbit mAb (D80C1), Cell Signal Tech #5030)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expression of  Mef2c; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062044	4426	normal	Q8CFN5	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062062	anti-TBX5 (goat pAb (C-20), Santa Cruz Biotechnology, sc-17866x)	Mus musculus	Genotype:alpha-MHC-GFP, exogenous retroviral expression of Tbx5; Treatment: sb431542 and xav939; Time point: day 2 of reprogramming; Strain: CD1;	EXP062045	4426	normal	P70326	neonatal cardiac fibroblast cell line expressing large T antigen	NULL
EXP062063	none	Mus musculus	Treatment: untreated;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062064	none	Mus musculus	Treatment: untreated;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062065	none	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062066	none	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062067	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: untreated;	EXP062063	233	normal	Q925J9	E14TG2A (embryonic stem cells)	NULL
EXP062068	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: untreated;	EXP062064	233	normal	Q925J9	E14TG2A (embryonic stem cells)	NULL
EXP062069	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062065	233	normal	Q925J9	E14TG2A (embryonic stem cells)	NULL
EXP062070	anti-MED1  antibody (Bethyl Laboratories, A300-793A)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062066	233	normal	Q925J9	E14TG2A (embryonic stem cells)	NULL
EXP062071	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: untreated;	EXP062063	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062072	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: untreated;	EXP062064	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062073	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062065	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062074	anti-FLAG (to IP MED24, Sigma, F3165)	Mus musculus	Treatment: 250nM of 4OHT treated for 2hrs;	EXP062066	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062075	anti-GFP (abcam, ab290)	Mus musculus	Age: 3 months; Sex: male; Strain: mixed 129J-C57BL/6; Genotype: wildtype;	NULL	898	normal	Q9R1E0	pancreatic islets	NULL
EXP062076	none	Mus musculus	Genotype: CXXC5 Wild type; Strain: mixed 129/C57BL/6; Passage: 15-18;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062077	none	Mus musculus	Genotype: CXXC5 knockout; Strain: mixed 129/C57BL/6; Passage: 15-18;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062078	Anti-CXXC5 Antibody (CST 84546S)	Mus musculus	Genotype: CXXC5 knockout; Strain: mixed 129/C57BL/6; Passage: 15-18;	EXP062077	2	normal	Q91WA4	mESCs (mouse embryonic stem cells)	NULL
EXP062079	Anti-CXXC5 Antibody (CST 84546S)	Mus musculus	Genotype: CXXC5 Wild type; Strain: mixed 129/C57BL/6; Passage: 15-18;	EXP062076	2	normal	Q91WA4	mESCs (mouse embryonic stem cells)	NULL
EXP062080	anti-FLAG M2 SIGMA (F3165)	Mus musculus	Genotype: expressing 3x flag-Creb3l2;	NULL	75	normal	Q8BH52	AtT-20 (pituitary tumor)	NULL
EXP062081	anti-XBP1 (M-186 Santa Cruz, Sc-7160)	Mus musculus		NULL	75	normal	O35426	AtT-20 (pituitary tumor)	NULL
EXP062082	none	Mus musculus	Genotype: Nr4a1 overexpressed ; Strain: C57BL/6;	NULL	4457	chip_control	NULL	primed CD4+ T cells	NULL
EXP062083	none	Mus musculus	Genotype: HA-Nr4a1; Strain: C57BL/6; Treatment: in vitro activation by TCR/Co-stimulation;	NULL	4458	chip_control	NULL	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062084	IgG	Mus musculus	Genotype: Nr4a1 overexpressed ; Strain: C57BL/6;	NULL	4458	chip_control	NULL	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062085	anti-Nr4a1 (ChIP-antibody, 14-5964-82, clone 357, ebioscience)	Mus musculus	Genotype: Nr4a1 overexpressed ; Strain: C57BL/6;	EXP062082	4457	normal	P12813	primed CD4+ T cells	NULL
EXP062086	HA (Cat3724, clone C29F4, Cell signaling technology)	Mus musculus	Genotype: HA-Nr4a1; Strain: C57BL/6; Treatment: in vitro activation by TCR/Co-stimulation;	EXP062083	4458	normal	P12813	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062087	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype:RV-Nr4a1;  Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062088	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype: RV-vector;Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062089	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype: c-jun knockout; Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062090	anti-C-Jun (sc-45x, Santa Cruz)	Mus musculus	Genotype: wildtype; Treatment: in vitro activation by TCR/Co-stimulation; Strain: C57BL/6;	NULL	4458	normal	P05627	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062091	anti-Batf (PAB4003, Brookwood biomedical)	Mus musculus	Genotype:RV-Nr4a1;  Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	O35284	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062092	anti-Batf (PAB4003, Brookwood biomedical)	Mus musculus	Genotype: RV-vector;Treatment: in vitro activation by TCR/Co-stimulation, retroviral infection; Strain: C57BL/6;	NULL	4458	normal	O35284	activated CD4+ T cells from spleen and peripheral lymoh organs	NULL
EXP062093	input	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062094	input	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062095	input	Mus musculus	Treatment: treated with 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062096	input	Mus musculus	Treatment: treated with 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062097	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062093	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062098	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062094	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062099	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: treated with 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062095	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062100	anti-TBP (Abcam,ab14984)	Mus musculus	Treatment: treated with 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062096	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062101	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062102	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062103	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062104	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062105	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062106	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062107	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062108	input	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062109	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062101	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062110	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062102	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062111	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062103	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062112	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062113	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062101	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062114	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062102	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062115	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062103	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062116	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062104	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062117	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062105	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062118	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062106	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062119	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062107	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062120	anti-ESRRB (R&D, PP-H6705-00)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062108	233	normal	Q61539	E14TG2A (embryonic stem cells)	NULL
EXP062121	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 0 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062105	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062122	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062106	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062123	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 4 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062107	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062124	anti-SOX2 antibody (R&D, AF2018)	Mus musculus	Treatment: 250nM 4OHT; Time point: 8 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062108	233	normal	P48432	E14TG2A (embryonic stem cells)	NULL
EXP062125	input sample	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062126	input sample	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062127	input sample	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062128	anti-FLAG antibody (Sigma, F3165)	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062125	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062129	anti-FLAG antibody (Sigma, F3165)	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062126	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062130	anti-FLAG antibody (Sigma, F3165)	Mus musculus	Treatment: 250nM 4OHT for 2hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062127	233	normal	Q99K74	E14TG2A (embryonic stem cells)	NULL
EXP062131		Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062132		Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062133		Mus musculus	Treatment: 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062134		Mus musculus	Treatment: 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP062135	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062131	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062136	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: untreated; Genotype: cRAF-ErT2 expression cassette;	EXP062132	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062137	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062133	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062138	anti-TBP antibody (abcam, ab28175)	Mus musculus	Treatment: 250nM 4OHT for 2 hrs; Genotype: cRAF-ErT2 expression cassette;	EXP062134	233	normal	P29037	E14TG2A (embryonic stem cells)	NULL
EXP062139	GR coctail: Thermo MA1-510, Santa Cruz #SC-1010	Mus musculus	Treatment: 600 nM Corticosterone for 1 hr; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 1 hr;	NULL	2474	chip_control	NULL	C127	NULL
EXP062140	anti-GR coctail (Thermo MA1-510, Santa Cruz #SC-1008)	Mus musculus	Treatment: untreated; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 0 hrs;	NULL	2474	normal	P06537	C127	NULL
EXP062141	anti-GR coctail (Thermo MA1-510, Santa Cruz #SC-1008)	Mus musculus	Treatment: 600 nM Corticosterone for 1 hr; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 1 hr;	EXP062139	2474	normal	P06537	C127	NULL
EXP062142	anti-GR coctail (Thermo MA1-510, Santa Cruz #SC-1008)	Mus musculus	Treatment: 600 nM Corticosterone for 1 hr; Genotype: stable integrations of a MMTV-pp7 reporter construct and expressing GFP-tagged PP7 coat protein; Time point: 12 hrs;	NULL	2474	normal	P06537	C127	NULL
EXP062143		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	NULL	4459	chip_control	NULL	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062144		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	NULL	4460	chip_control	NULL	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062145		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	NULL	4459	chip_control	NULL	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062146		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	NULL	4460	chip_control	NULL	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062147		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	NULL	4459	chip_control	NULL	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062148		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	NULL	4460	chip_control	NULL	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062149		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	NULL	4459	chip_control	NULL	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062150		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	NULL	4460	chip_control	NULL	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062151		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	NULL	4459	chip_control	NULL	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062152		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	NULL	4460	chip_control	NULL	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062153		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	NULL	4459	chip_control	NULL	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062154		Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	NULL	4460	chip_control	NULL	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062155	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062143	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062156	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062144	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062157	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062145	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062158	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062146	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062159	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062147	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062160	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062148	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062161	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062149	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062162	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: wildtype;	EXP062150	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062163	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062151	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062164	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 knockout;	EXP062152	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062165	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062153	4459	normal	Q61164	activated Th1 cells from splenocytes and lymph nodes	NULL
EXP062166	anti-CTCF antiserum (07-729, Millipore Sigma, 8 Âµl per assay)	Mus musculus	Conditions: 6 days in vitro culture; Strain: C57BL/6; Genotype: Ifng-as1 PolyA KI;	EXP062154	4460	normal	Q61164	activated Th2 cells from splenocytes and lymph nodes	NULL
EXP062167		Mus musculus	Donor: Cell culture #2;	NULL	4461	chip_control	NULL	immortalized mouse skin fibroblasts	NULL
EXP062168		Mus musculus	Donor: Cell culture #2;	NULL	4462	chip_control	NULL	transformed mouse skin fibroblasts	NULL
EXP062169		Mus musculus	Donor: Cell culture #3;	NULL	4462	chip_control	NULL	transformed mouse skin fibroblasts	NULL
EXP062170		Mus musculus	Donor: Cell culture #2;	NULL	4462	chip_control	NULL	transformed mouse skin fibroblasts	NULL
EXP062171		Mus musculus	Donor: Cell culture #2;	NULL	4462	chip_control	NULL	transformed mouse skin fibroblasts	NULL
EXP062172	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #3;	NULL	4461	normal	Q08943	immortalized mouse skin fibroblasts	NULL
EXP062173	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062168	4462	normal	Q08943	transformed mouse skin fibroblasts	NULL
EXP062174	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062170	4462	normal	Q08943	transformed mouse skin fibroblasts	NULL
EXP062175	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062171	4462	normal	Q08943	transformed mouse skin fibroblasts	NULL
EXP062176	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #2;	EXP062167	4461	normal	Q08943	immortalized mouse skin fibroblasts	NULL
EXP062177	anti-SSRP1 (BioLegend, 609702, 10D1)	Mus musculus	Donor: Cell culture #3;	EXP062169	4462	normal	Q08943	transformed mouse skin fibroblasts	NULL
EXP062178	None	Mus musculus	Genotype: BMAL1 KO; Time point: Zeitgeber Time 8;	NULL	5	chip_control	NULL	liver	NULL
EXP062179	None	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 20;	NULL	5	chip_control	NULL	liver	NULL
EXP062180	None	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 20;	NULL	5	chip_control	NULL	liver	NULL
EXP062181	None	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 8;	NULL	5	chip_control	NULL	liver	NULL
EXP062182	None	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 8;	NULL	5	chip_control	NULL	liver	NULL
EXP062183	None	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 20;	NULL	5	chip_control	NULL	liver	NULL
EXP062184	None	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 20;	NULL	5	chip_control	NULL	liver	NULL
EXP062185	None	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 8;	NULL	5	chip_control	NULL	liver	NULL
EXP062186	None	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 8;	NULL	5	chip_control	NULL	liver	NULL
EXP062187	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 KO; Time point: Zeitgeber Time 8;	EXP062178	5	normal	Q9WTL8	liver	NULL
EXP062188	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 20;	EXP062179	5	normal	Q9WTL8	liver	NULL
EXP062189	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 20;	EXP062180	5	normal	Q9WTL8	liver	NULL
EXP062190	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 8;	EXP062181	5	normal	Q9WTL8	liver	NULL
EXP062191	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 Liver-RE; Time point: Zeitgeber Time 8;	EXP062182	5	normal	Q9WTL8	liver	NULL
EXP062192	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 20;	EXP062183	5	normal	Q9WTL8	liver	NULL
EXP062193	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 20;	EXP062184	5	normal	Q9WTL8	liver	NULL
EXP062194	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 8;	EXP062185	5	normal	Q9WTL8	liver	NULL
EXP062195	anti-BMAL1  antibody (Abcam ab93806)	Mus musculus	Genotype: BMAL1 WT; Time point: Zeitgeber Time 8;	EXP062186	5	normal	Q9WTL8	liver	NULL
EXP062196	none	Mus musculus	Time point: day 12 of differentiation;	NULL	4465	chip_control	NULL	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	NULL
EXP062197	none	Mus musculus	Time point: day 12 of differentiation;	NULL	4465	chip_control	NULL	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	NULL
EXP062198	none	Mus musculus	Time point: day 12 of differentiation;	NULL	4465	chip_control	NULL	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	NULL
EXP062199	anti-Bcl6 (Santa Cruz Biotechnology; Cat# sc-858, RRID:AB_2063450)	Mus musculus	Time point: day 12 of differentiation;	EXP062196	4465	normal	P41183	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	NULL
EXP062200	anti-Bcl6 (Santa Cruz Biotechnology; Cat# sc-858, RRID:AB_2063450)	Mus musculus	Time point: day 12 of differentiation;	EXP062197	4465	normal	P41183	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	NULL
EXP062201	anti-Bcl6 (Santa Cruz Biotechnology; Cat# sc-858, RRID:AB_2063450)	Mus musculus	Time point: day 12 of differentiation;	EXP062198	4465	normal	P41183	ES-cell derived A2 lox.Cre Bcl6 cortical progenitor cells	NULL
EXP062202		Mus musculus	Genotype: wildtype Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062203		Mus musculus	Genotype: wildtype Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062204		Mus musculus	Genotype: wildtype Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062205		Mus musculus	Genotype: wildtype Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062206		Mus musculus	Genotype: empty vector;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062207		Mus musculus	Genotype: empty vector;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062208		Mus musculus	Genotype: empty vector;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062209		Mus musculus	Genotype: empty vector;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062210		Mus musculus	Genotype: mutant version of Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062211		Mus musculus	Genotype: mutant version of Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062212		Mus musculus	Genotype: mutant version of Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062213		Mus musculus	Genotype: mutant version of Snai1;	NULL	445	chip_control	NULL	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062214	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062202	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062215	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062203	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062216	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062204	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062217	anti-Snai1	Mus musculus	Genotype: wildtype Snai1;	EXP062205	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062218	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062206	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062219	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062207	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062220	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062208	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062221	anti-Snai1	Mus musculus	Genotype: empty vector;	EXP062209	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062222	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062210	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062223	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062211	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062224	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062212	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062225	anti-Snai1	Mus musculus	Genotype: mutant version of Snai1;	EXP062213	445	normal	Q02085	HPC7 (haematopoietic multipotent progenitors)	NULL
EXP062226	None	Mus musculus	Treatment: Not treated;Time point: day 4 of differentiation;	NULL	4467	chip_control	NULL	E14Tg2a differentiating mES cells	NULL
EXP062227	anti-myc antibody (5ug clone 9E10 â€“ Roche)	Mus musculus	Treatment: Not treated;Time point: day 4 of differentiation;	EXP062226	4467	normal	P40646	E14Tg2a differentiating mES cells	NULL
EXP062228	anti-myc antibody (5ug clone 9E10 â€“ Roche)	Mus musculus	Treatment: doxycycline treated for 24 hrs; Time point: day 4 of differentiation;	NULL	4467	normal	P40646	E14Tg2a differentiating mES cells	NULL
EXP062229	none	Mus musculus	Treatment: Stimulated for 1 hr with IL-4; Genotype: wildtype; Strain: C57BL/6;	NULL	732	chip_control	NULL	peritoneal macrophages	NULL
EXP062230	anti-Stat6 ( Cell Signaling Technology, Cat#5397)	Mus musculus	Treatment: Stimulated for 1 hr with IL-4; Genotype: wildtype; Strain: C57BL/6;	EXP062229	732	normal	P52633	peritoneal macrophages	NULL
EXP062231	anti-Stat6 ( Cell Signaling Technology, Cat#5397)	Mus musculus	Treatment: Stimulated for 1 hr with IL-4; Genotype: Trim24 knockout; Strain: C57BL/6;	NULL	732	normal	P52633	peritoneal macrophages	NULL
EXP062232	none	Mus musculus	Genotype: MafF-/-::MafG-/-::MafK-/-:T-NG2; Treatment: Vehcle for 4 hrs;	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP062233	anti-MafG (PMID: 22965115)	Mus musculus	Genotype: MafF-/-::MafG-/-::MafK-/-:T-NG2; Treatment: Vehcle for 4 hrs;	EXP062232	12	normal	O54790	MEF (mouse embryonic fibroblasts)	NULL
EXP062234	anti-MafG (PMID: 22965115)	Mus musculus	Genotype: MafF-/-::MafG-/-::MafK-/-:T-NG2; Treatment: 100 uM Diethyl Maleate for 4 hrs;	NULL	12	normal	O54790	MEF (mouse embryonic fibroblasts)	NULL
EXP062235	N/A	Mus musculus	Genotype: Bhlhe40+/+Bhlhe41+/+ (wildtype); Strain: C57BL/6;	NULL	62	chip_control	NULL	alveolar macrophages	NULL
EXP062236	anti-Bhlhe40 (Novus Biologicals, NB100-1800, lot C2)	Mus musculus	Genotype: Bhlhe40+/+Bhlhe41+/+ (wildtype); Strain: C57BL/6;	EXP062235	62	normal	O35185	alveolar macrophages	NULL
EXP062237	none	Mus musculus	Time point: zeitgeber time 02; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062238	none	Mus musculus	Time point: zeitgeber time 06; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062239	none	Mus musculus	Time point: zeitgeber time 10; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062240	none	Mus musculus	Time point: zeitgeber time 14; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062241	none	Mus musculus	Time point: zeitgeber time 18; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062242	none	Mus musculus	Time point: zeitgeber time 22; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062243	none	Mus musculus	Time point: zeitgeber time 26; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	chip_control	NULL	liver	NULL
EXP062244	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 02; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062237	5	normal	P28700	liver	NULL
EXP062245	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 06; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062238	5	normal	P28700	liver	NULL
EXP062246	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 10; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062239	5	normal	P28700	liver	NULL
EXP062247	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 14; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062240	5	normal	P28700	liver	NULL
EXP062248	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 18; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062241	5	normal	P28700	liver	NULL
EXP062249	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 22; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	NULL	5	normal	P28700	liver	NULL
EXP062250	anti-RXRa antibody (homemade, generously provided by C Rochette-Egly)	Mus musculus	Time point: zeitgeber time 26; Age: 12-14 week old; Strain: C57BL/6;  Conditions: Normal chow diet;	EXP062243	5	normal	P28700	liver	NULL
EXP062251	none	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062252	none	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062253	none	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062254	none	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062255	none	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062256	none	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062257	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062251	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062258	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062252	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062259	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062253	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062260	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062254	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062261	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062255	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062262	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062256	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062263	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062251	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062264	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062252	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062265	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062253	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062266	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062254	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062267	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062255	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062268	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062256	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062269	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062251	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062270	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	EXP062252	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062271	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062253	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062272	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	EXP062254	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062273	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062255	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062274	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	EXP062256	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062275	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062276	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062277	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062278	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4219 (control compound)  for 4 hours;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062279	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC3866  for 4 hours;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062280	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:20uM of UNC4976 for 4 hours;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062281	anti-Cbx7 (Abcam, ab21873)	Mus musculus	Treatment:Untreated;	NULL	2	normal	Q8VDS3	mESCs (mouse embryonic stem cells)	NULL
EXP062282	anti-Ring1B (Cell Signaling,Â D22F2)	Mus musculus	Treatment:Untreated;	NULL	2	normal	Q9CQJ4	mESCs (mouse embryonic stem cells)	NULL
EXP062283	anti-Suz12 (Cell Signaling, D39F6)	Mus musculus	Treatment:Untreated;	NULL	2	normal	Q80U70	mESCs (mouse embryonic stem cells)	NULL
EXP062284	Normal Rabbit IgG (Cell Signaling Technologies Cat#2729)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: none;	NULL	5	chip_control	NULL	liver	NULL
EXP062285	Normal Rabbit IgG (Cell Signaling Technologies Cat#2729)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: none;	NULL	5	chip_control	NULL	liver	NULL
EXP062286	Normal Rabbit IgG (Cell Signaling Technologies Cat#2729)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: Wy-14,643 (50mg/kg) was intragastrically injected to mice twice a day;	NULL	5	chip_control	NULL	liver	NULL
EXP062287	Normal Rabbit IgG (Cell Signaling Technologies Cat#2729)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: Wy-14,643 (50mg/kg) was intragastrically injected to mice twice a day;	NULL	5	chip_control	NULL	liver	NULL
EXP062288	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: none;	EXP062284	5	normal	P23204	liver	NULL
EXP062289	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: none;	EXP062285	5	normal	P23204	liver	NULL
EXP062290	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: Wy-14,643 (50mg/kg) was intragastrically injected to mice twice a day;	EXP062286	5	normal	P23204	liver	NULL
EXP062291	Anti-PPARalpha antibody (Abcam Cat#ab24509)	Mus musculus	Age: 8 weeks old; Strain: C57BL/6; Treatment: Wy-14,643 (50mg/kg) was intragastrically injected to mice twice a day;	EXP062287	5	normal	P23204	liver	NULL
EXP062292	none	Mus musculus	Treatment: vehicle;	NULL	575	chip_control	NULL	bone marrow-derived mesenchymal stem cells	NULL
EXP062293	anti-TCF4 (Santa Cruz, H-125, sc13027, lot C0707)	Mus musculus	Treatment: vehicle;	EXP062292	575	normal	Q60722	bone marrow-derived mesenchymal stem cells	NULL
EXP062294	anti-TCF4 (Santa Cruz, H-125, sc13027, lot C0707)	Mus musculus	Treatment: LiCl for 3 hrs;	NULL	575	normal	Q60722	bone marrow-derived mesenchymal stem cells	NULL
EXP062295		Mus musculus	Strain: C57BL6N/129SvEv; Age: 6 weeks;	NULL	965	chip_control	NULL	frontal cortex	NULL
EXP062296	anti-Egr1	Mus musculus	Strain: C57BL6N/129SvEv; Age: 6 weeks;	EXP062295	965	normal	P08046	frontal cortex	NULL
EXP062297	IgG (Sigma, I5006)	Mus musculus	Treatment: None; Genotype: Control-ATG;	NULL	23	chip_control	NULL	416B (hematopoietic precursor cells)	NULL
EXP062298	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: None; Genotype: Control-ATG;	EXP062297	23	normal	Q03347	416B (hematopoietic precursor cells)	NULL
EXP062299	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: None; Genotype: Control-ATG;	EXP062297	23	normal	A2AJK6	416B (hematopoietic precursor cells)	NULL
EXP062300	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: Control-ATG;	NULL	23	normal	Q03347	416B (hematopoietic precursor cells)	NULL
EXP062301	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: Control-ATG;	NULL	23	normal	A2AJK6	416B (hematopoietic precursor cells)	NULL
EXP062302	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: None; Genotype: CBFB-MYH11;	NULL	23	normal	Q03347	416B (hematopoietic precursor cells)	NULL
EXP062303	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: None; Genotype: CBFB-MYH11;	NULL	23	normal	A2AJK6	416B (hematopoietic precursor cells)	NULL
EXP062304	anti-Runx1 (Abcam, ab23980)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: CBFB-MYH11;	NULL	23	normal	Q03347	416B (hematopoietic precursor cells)	NULL
EXP062305	anti-Chd7 (Abcam, ab31824)	Mus musculus	Treatment: 1 ug/ml Doxycycline for 24 hours; Genotype: CBFB-MYH11;	NULL	23	normal	A2AJK6	416B (hematopoietic precursor cells)	NULL
EXP062306	none	Mus musculus	Conditions: ovariectomized; Strain: C57BL6/6J, 129 mixed strain; Age: 8-10 weeks;	NULL	132	chip_control	NULL	uterus	NULL
EXP062307	anti-PGR antibody (Santa Cruz #sc-7208)	Mus musculus	Conditions: ovariectomized; Strain: C57BL6/6J, 129 mixed strain; Age: 8-10 weeks;	EXP062306	132	normal	Q00175	uterus	NULL
EXP062308	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: CTD diet; Genotype: wildtype;	NULL	860	normal	Q80TJ7	ventral prostate	NULL
EXP062309	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: CTD diet; Genotype: Hi-MYC;	NULL	860	normal	Q80TJ7	ventral prostate	NULL
EXP062310	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: high-fat diet; Genotype: wildtype;	NULL	860	normal	Q80TJ7	ventral prostate	NULL
EXP062311	anti-PHF8 (Bethyl Laboratories, #A301-772A)	Mus musculus	Conditions: high-fat diet; Genotype: Hi-MYC;	NULL	860	normal	Q80TJ7	ventral prostate	NULL
EXP062312	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4194	normal	Q9Y812	Nott519 strain	NULL
EXP062313	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4389	normal	Q9Y812	Nott520 strain	NULL
EXP062314	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1  deletion;	NULL	4390	normal	Q9Y812	Nott688 strain	NULL
EXP062315	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1  deletion;	NULL	4391	normal	Q9Y812	Nott689 strain	NULL
EXP062316	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4392	normal	Q9Y812	Nott850 strain	NULL
EXP062317	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	4393	normal	Q9Y812	Nott851 strain	NULL
EXP062318	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Empty vector + Cnp1  deletion;	NULL	4394	normal	Q9Y812	Nott631 strain	NULL
EXP062319	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Empty vector + Cnp1  deletion;	NULL	4395	normal	Q9Y812	Nott632 strain	NULL
EXP062320	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 5.9kb Cnp1 before deletion;	NULL	4397	normal	Q9Y812	Nott819 strain	NULL
EXP062321	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 5.9kb Cnp1  deletion;	NULL	4398	normal	Q9Y812	Nott820 strain	NULL
EXP062322	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 5.9kb Cnp1  deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062323	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 Cnp1 before deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062324	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 before deletion;	NULL	4399	normal	Q9Y812	Nott817 strain	NULL
EXP062325	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 before deletion;	NULL	4400	normal	Q9Y812	Nott818 strain	NULL
EXP062326	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062327	anti-CENP-A	Schizosaccharomyces pombe	Genotype: A+T rich C. acetobutylicum DNA Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062328	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 before deletion;	NULL	4401	normal	Q9Y812	Nott493 strain	NULL
EXP062329	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 before deletion;	NULL	4402	normal	Q9Y812	Nott494 strain	NULL
EXP062330	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 deletion;	NULL	4403	normal	Q9Y812	Nott678 strain	NULL
EXP062331	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen5 Cnp1 deletion;	NULL	4404	normal	Q9Y812	Nott679 strain	NULL
EXP062332	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062333	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062334	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062335	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen1 Cnp1 deletion;	NULL	2514	normal	Q9Y812	Fission Yeast strains	NULL
EXP062336	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 before deletion;	NULL	4405	normal	Q9Y812	Nott821 strain	NULL
EXP062337	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 before deletion;	NULL	4464	normal	Q9Y812	Nott822 strain	NULL
EXP062338	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 deletion;	NULL	4466	normal	Q9Y812	Nott833 strain	NULL
EXP062339	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Art cen 6.2kb Cnp1 deletion;	NULL	4480	normal	Q9Y812	Nott834 strain	NULL
EXP062340	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 ade6;	NULL	4481	normal	Q9Y812	Nott376 strain	NULL
EXP062341	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 ade6;	NULL	4482	normal	Q9Y812	Nott377 strain	NULL
EXP062342	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 at neo cen;	NULL	4483	normal	Q9Y812	Nott810 strain	NULL
EXP062343	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Cen8 at neo cen;	NULL	4484	normal	Q9Y812	Nott802 strain	NULL
EXP062344	anti-CENP-A	Schizosaccharomyces pombe	Genotype: 5.3kb Cnp1 before deletion;	NULL	4485	normal	Q9Y812	Nott823 strain	NULL
EXP062345	anti-CENP-A	Schizosaccharomyces pombe	Genotype: 5.3kb Cnp1 before deletion;	NULL	4486	normal	Q9Y812	Nott824 strain	NULL
EXP062346	anti-CENP-A	Schizosaccharomyces pombe	Genotype: GC rich Cnp1 before deletion;	NULL	4487	normal	Q9Y812	Nott860 strain	NULL
EXP062347	anti-CENP-A	Schizosaccharomyces pombe	Genotype: GC rich Cnp1 before deletion;	NULL	4488	normal	Q9Y812	Nott861 strain	NULL
EXP062348	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Alphoid Cnp1 before deletion;	NULL	4489	normal	Q9Y812	Nott496 strain	NULL
EXP062349	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Alphoid Cnp1 before deletion;	NULL	4490	normal	Q9Y812	Nott497 strain	NULL
EXP062350	anti-CENP-A	Schizosaccharomyces pombe	Genotype: Empty vector + Cnp3 deletion;	NULL	4396	normal	Q9Y812	Nott775 strain	NULL
EXP062351		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062352		Homo sapiens	Age: 39;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062353		Homo sapiens	Age: 38;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062354		Homo sapiens	Age: 41;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062355		Homo sapiens	Age: 48;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062356		Homo sapiens	Age: 43;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062357		Homo sapiens	Age: 38;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062358		Homo sapiens	Age: 48;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062359		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062360		Homo sapiens	Age: 55;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062361		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062362		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062363		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062364		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062365		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062366		Homo sapiens	Age: 37;	NULL	4491	chip_control	NULL	ER+ breast tumor	NULL
EXP062367		Homo sapiens	Genotype: ER+;	NULL	4492	chip_control	NULL	normal mature luminal breast cells	NULL
EXP062368		Homo sapiens	Genotype: ER+;	NULL	4492	chip_control	NULL	normal mature luminal breast cells	NULL
EXP062369		Homo sapiens	Genotype: ER+;	NULL	4492	chip_control	NULL	normal mature luminal breast cells	NULL
EXP062370		Homo sapiens	Genotype: ER+;	NULL	4492	chip_control	NULL	normal mature luminal breast cells	NULL
EXP062371	Input sample	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062372	anti-ESR1	Homo sapiens	Age: 37;	EXP062351	4491	normal	P03372	ER+ breast tumor	NULL
EXP062373	anti-ESR1	Homo sapiens	Age: 39;	EXP062352	4491	normal	P03372	ER+ breast tumor	NULL
EXP062374	anti-ESR1	Homo sapiens	Age: 38;	EXP062353	4491	normal	P03372	ER+ breast tumor	NULL
EXP062375	anti-ESR1	Homo sapiens	Age: 41;	EXP062354	4491	normal	P03372	ER+ breast tumor	NULL
EXP062376	anti-ESR1	Homo sapiens	Age: 48;	NULL	4491	normal	P03372	ER+ breast tumor	NULL
EXP062377	anti-ESR1	Homo sapiens	Age: 43;	EXP062356	4491	normal	P03372	ER+ breast tumor	NULL
EXP062378	anti-ESR1	Homo sapiens	Age: 38;	EXP062357	4491	normal	P03372	ER+ breast tumor	NULL
EXP062379	anti-ESR1	Homo sapiens	Age: 48;	EXP062358	4491	normal	P03372	ER+ breast tumor	NULL
EXP062380	anti-ESR1	Homo sapiens	Age: 37;	EXP062359	4491	normal	P03372	ER+ breast tumor	NULL
EXP062381	anti-ESR1	Homo sapiens	Age: 55;	EXP062360	4491	normal	P03372	ER+ breast tumor	NULL
EXP062382	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062367	4492	normal	P03372	normal mature luminal breast cells	NULL
EXP062383	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062368	4492	normal	P03372	normal mature luminal breast cells	NULL
EXP062384	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062369	4492	normal	P03372	normal mature luminal breast cells	NULL
EXP062385	anti-ESR1	Homo sapiens	Genotype: ER+;	EXP062370	4492	normal	P03372	normal mature luminal breast cells	NULL
EXP062386	anti-ESR1	Homo sapiens	Genotype: ER+;	NULL	4492	normal	P03372	normal mature luminal breast cells	NULL
EXP062387	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: 10 nM E2 for 45 minutes; Genotype: wildtype;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062388	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	EXP062371	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062389	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: 10 nM E2 for 45 minutes; Genotype: CRISPR GRHL2;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062390	Anti-ER HC-20 (Santa Cruz)	Homo sapiens	Treatment: 10 nM E2 for 45 minutes; Genotype: CRISPR GRHL2;	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062391	Anti-GRHL2 (HPA004820 , Sigma)	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	NULL	113	normal	Q6ISB3	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062392	Anti-GRHL2 (HPA004820 , Sigma)	Homo sapiens	Treatment: Vehicle for 45 minutes; Genotype: wildtype;	NULL	111	normal	Q6ISB3	T47D (invasive ductal carcinoma)	NULL
EXP062393	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062394	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062395	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens	Genotype: YY1 knockout;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062396	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens	Genotype: YY1 knockout;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062397		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062398		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062399		Homo sapiens	Genotype: RBM25 knockout;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062400		Homo sapiens	Genotype: RBM25 knockout;	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062401		Homo sapiens		NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP062402		Homo sapiens		NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP062403	SRSF1 (Bethyl Cat#A302-052A)	Homo sapiens		EXP062401	430	normal	Q07955	HepG2 (hepatoblastoma)	NULL
EXP062404	SRSF3 (MBL Cat# RN080PW)	Homo sapiens		EXP062401	430	normal	P84103	HepG2 (hepatoblastoma)	NULL
EXP062405	SRSF4 (Bethyl Cat# A303-670A)	Homo sapiens		EXP062401	430	normal	Q08170	HepG2 (hepatoblastoma)	NULL
EXP062406	SRSF7 (MBL Cat# RN079PW)	Homo sapiens		EXP062401	430	normal	Q16629	HepG2 (hepatoblastoma)	NULL
EXP062407	SRSF9 (MBL Cat# RN081PW)	Homo sapiens		EXP062401	430	normal	Q13242	HepG2 (hepatoblastoma)	NULL
EXP062408	U2AF1 (Bethyl Cat# A302-079A)	Homo sapiens		EXP062401	430	normal	Q01081	HepG2 (hepatoblastoma)	NULL
EXP062409	U2AF2 (Bethyl Cat# A303-665A)	Homo sapiens		EXP062401	430	normal	P26368	HepG2 (hepatoblastoma)	NULL
EXP062410	HNRNPC (Santa Cruz Biotechnology Cat# sc-10037)	Homo sapiens		EXP062401	430	normal	P07910	HepG2 (hepatoblastoma)	NULL
EXP062411	HNRNPH1 (Aviva Cat# ARP58479_P050)	Homo sapiens		EXP062401	430	normal	P31943	HepG2 (hepatoblastoma)	NULL
EXP062412	HNRNPK (MBL Cat# RN019P)	Homo sapiens		EXP062401	430	normal	P61978	HepG2 (hepatoblastoma)	NULL
EXP062413	HNRNPL (Aviva Cat# ARP40368_P050)	Homo sapiens		EXP062401	430	normal	P14866	HepG2 (hepatoblastoma)	NULL
EXP062414	HNRNPLL (Cell Signaling Technology Cat# 4783S)	Homo sapiens		EXP062401	430	normal	Q8WVV9	HepG2 (hepatoblastoma)	NULL
EXP062415	HNRNPUL1 (Abcam Cat# ab68480)	Homo sapiens		EXP062401	430	normal	Q9BUJ2	HepG2 (hepatoblastoma)	NULL
EXP062416	PTBP1 (MBL Cat# RN011P)	Homo sapiens		EXP062401	430	normal	P26599	HepG2 (hepatoblastoma)	NULL
EXP062417	PCBP1 (MBL Cat# RN024P)	Homo sapiens		EXP062401	430	normal	Q15365	HepG2 (hepatoblastoma)	NULL
EXP062418	PCBP2 (MBL Cat# RN025P)	Homo sapiens		EXP062401	430	normal	Q15366	HepG2 (hepatoblastoma)	NULL
EXP062419	FUS (Bethyl Cat# A300-294A)	Homo sapiens		EXP062401	430	normal	P35637	HepG2 (hepatoblastoma)	NULL
EXP062420	TAF15 (Abcam Cat# ab134916)	Homo sapiens		EXP062401	430	normal	Q92804	HepG2 (hepatoblastoma)	NULL
EXP062421	SNRNP70 (Santa Cruz Biotechnology Cat# sc-9571)	Homo sapiens		EXP062401	430	normal	P08621	HepG2 (hepatoblastoma)	NULL
EXP062422	PRPF4 (MBL Cat# RN093PW)	Homo sapiens		EXP062401	430	normal	O43172	HepG2 (hepatoblastoma)	NULL
EXP062423	FIP1L1 (Abclonal Cat# #A5016)	Homo sapiens		EXP062401	430	normal	Q6UN15	HepG2 (hepatoblastoma)	NULL
EXP062424	RBFOX2 (Bethyl Cat# A300-864A)	Homo sapiens		EXP062401	430	normal	O43251	HepG2 (hepatoblastoma)	NULL
EXP062425	RBM22 (Bethyl Cat# A303-923A)	Homo sapiens		EXP062401	430	normal	Q9NW64	HepG2 (hepatoblastoma)	NULL
EXP062426	RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062401	430	normal	P49756	HepG2 (hepatoblastoma)	NULL
EXP062427	RBM39 (Bethyl Cat# A300-291A)	Homo sapiens		EXP062401	430	normal	Q14498	HepG2 (hepatoblastoma)	NULL
EXP062428	AGO1 (Cell Signaling Technology Cat# 5053)	Homo sapiens		EXP062401	430	normal	Q9UL18	HepG2 (hepatoblastoma)	NULL
EXP062429	AGO2 (Abnova Cat# H00027161-M01)	Homo sapiens		EXP062401	430	normal	Q9UKV8	HepG2 (hepatoblastoma)	NULL
EXP062430	SAFB2 (Bethyl Cat# A301-112A)	Homo sapiens		EXP062401	430	normal	Q14151	HepG2 (hepatoblastoma)	NULL
EXP062431	NONO (Santa Cruz Biotechnology  Cat# sc-166702)	Homo sapiens		EXP062401	430	normal	Q15233	HepG2 (hepatoblastoma)	NULL
EXP062432	GTF2F1 (GeneTex Cat# GTX114455)	Homo sapiens		EXP062401	430	normal	P35269	HepG2 (hepatoblastoma)	NULL
EXP062433	SFPQ (Bethyl Cat# A301-321A)	Homo sapiens		EXP062401	430	normal	P23246	HepG2 (hepatoblastoma)	NULL
EXP062434	TARDBP (Bethyl Cat# A303-223A)	Homo sapiens		EXP062401	430	normal	Q13148	HepG2 (hepatoblastoma)	NULL
EXP062435	XRCC5 (Zen BioScience Cat# 201004)	Homo sapiens		EXP062401	430	normal	P13010	HepG2 (hepatoblastoma)	NULL
EXP062436	CCAR2 (Zen BioScience Cat# 200093)	Homo sapiens		EXP062401	430	normal	Q8N163	HepG2 (hepatoblastoma)	NULL
EXP062437	SRSF1 (Bethyl Cat#A302-052A)	Homo sapiens		EXP062402	514	normal	Q07955	K562 (myelogenous leukemia)	NULL
EXP062438	SRSF3 (MBL Cat# RN080PW)	Homo sapiens		EXP062402	514	normal	P84103	K562 (myelogenous leukemia)	NULL
EXP062439	SRSF4 (Bethyl Cat# A303-670A)	Homo sapiens		EXP062402	514	normal	Q08170	K562 (myelogenous leukemia)	NULL
EXP062440	SRSF7 (MBL Cat# RN079PW)	Homo sapiens		EXP062402	514	normal	Q16629	K562 (myelogenous leukemia)	NULL
EXP062441	SRSF9 (MBL Cat# RN081PW)	Homo sapiens		EXP062402	514	normal	Q13242	K562 (myelogenous leukemia)	NULL
EXP062442	U2AF1 (Bethyl Cat# A302-079A)	Homo sapiens		EXP062402	514	normal	Q01081	K562 (myelogenous leukemia)	NULL
EXP062443	U2AF2 (Bethyl Cat# A303-665A)	Homo sapiens		EXP062402	514	normal	P26368	K562 (myelogenous leukemia)	NULL
EXP062444	HNRNPC (Santa Cruz Biotechnology Cat# sc-10037)	Homo sapiens		EXP062402	514	normal	P07910	K562 (myelogenous leukemia)	NULL
EXP062445	HNRNPH1 (Aviva Cat# ARP58479_P050)	Homo sapiens		EXP062402	514	normal	P31943	K562 (myelogenous leukemia)	NULL
EXP062446	HNRNPK (MBL Cat# RN019P)	Homo sapiens		EXP062402	514	normal	P61978	K562 (myelogenous leukemia)	NULL
EXP062447	HNRNPL (Aviva Cat# ARP40368_P050)	Homo sapiens		EXP062402	514	normal	P14866	K562 (myelogenous leukemia)	NULL
EXP062448	HNRNPLL (Cell Signaling Technology Cat# 4783S)	Homo sapiens		EXP062402	514	normal	Q8WVV9	K562 (myelogenous leukemia)	NULL
EXP062449	HNRNPUL1 (Abcam Cat# ab68480)	Homo sapiens		EXP062402	514	normal	Q9BUJ2	K562 (myelogenous leukemia)	NULL
EXP062450	PTBP1 (MBL Cat# RN011P)	Homo sapiens		EXP062402	514	normal	P26599	K562 (myelogenous leukemia)	NULL
EXP062451	PCBP1 (MBL Cat# RN024P)	Homo sapiens		EXP062402	514	normal	Q15365	K562 (myelogenous leukemia)	NULL
EXP062452	PCBP2 (MBL Cat# RN025P)	Homo sapiens		EXP062402	514	normal	Q15366	K562 (myelogenous leukemia)	NULL
EXP062453	FUS (Bethyl Cat# A300-294A)	Homo sapiens		EXP062402	514	normal	P35637	K562 (myelogenous leukemia)	NULL
EXP062454	TAF15 (Abcam Cat# ab134916)	Homo sapiens		EXP062402	514	normal	Q92804	K562 (myelogenous leukemia)	NULL
EXP062455	SNRNP70 (Santa Cruz Biotechnology Cat# sc-9571)	Homo sapiens		EXP062402	514	normal	P08621	K562 (myelogenous leukemia)	NULL
EXP062456	PRPF4 (MBL Cat# RN093PW)	Homo sapiens		EXP062402	514	normal	O43172	K562 (myelogenous leukemia)	NULL
EXP062457	FIP1L1 (Abclonal Cat# #A5016)	Homo sapiens		EXP062402	514	normal	Q6UN15	K562 (myelogenous leukemia)	NULL
EXP062458	RBFOX2 (Bethyl Cat# A300-864A)	Homo sapiens		EXP062402	514	normal	O43251	K562 (myelogenous leukemia)	NULL
EXP062459	RBM22 (Bethyl Cat# A303-923A)	Homo sapiens		EXP062402	514	normal	Q9NW64	K562 (myelogenous leukemia)	NULL
EXP062460	RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062402	514	normal	P49756	K562 (myelogenous leukemia)	NULL
EXP062461	RBM39 (Bethyl Cat# A300-291A)	Homo sapiens		EXP062402	514	normal	Q14498	K562 (myelogenous leukemia)	NULL
EXP062462	AGO1 (Cell Signaling Technology Cat# 5053)	Homo sapiens		EXP062402	514	normal	Q9UL18	K562 (myelogenous leukemia)	NULL
EXP062463	SAFB (Zen BioScience Cat# 200580)	Homo sapiens		EXP062402	514	normal	Q15424	K562 (myelogenous leukemia)	NULL
EXP062464	SAFB2 (Bethyl Cat# A301-112A)	Homo sapiens		EXP062402	514	normal	Q14151	K562 (myelogenous leukemia)	NULL
EXP062465	NONO (Santa Cruz Biotechnology  Cat# sc-166702)	Homo sapiens		EXP062402	514	normal	Q15233	K562 (myelogenous leukemia)	NULL
EXP062466	GTF2F1 (GeneTex Cat# GTX114455)	Homo sapiens		EXP062402	514	normal	P35269	K562 (myelogenous leukemia)	NULL
EXP062467	SFPQ (Bethyl Cat# A301-321A)	Homo sapiens		EXP062402	514	normal	P23246	K562 (myelogenous leukemia)	NULL
EXP062468	TARDBP (Bethyl Cat# A303-223A)	Homo sapiens		EXP062402	514	normal	Q13148	K562 (myelogenous leukemia)	NULL
EXP062469	XRCC5 (Zen BioScience Cat# 201004)	Homo sapiens		EXP062402	514	normal	P13010	K562 (myelogenous leukemia)	NULL
EXP062470	CCAR2 (Zen BioScience Cat# 200093)	Homo sapiens		EXP062402	514	normal	Q8N163	K562 (myelogenous leukemia)	NULL
EXP062471	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062393	430	normal	P49756	HepG2 (hepatoblastoma)	NULL
EXP062472	RBM25 (Bethyl Cat# A301-068A)	Homo sapiens		EXP062394	430	normal	P49756	HepG2 (hepatoblastoma)	NULL
EXP062473	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens	Genotype: YY1 knockout;	EXP062395	430	normal	P49756	HepG2 (hepatoblastoma)	NULL
EXP062474	anti-RBM25 (Bethyl Cat# A301-068A)	Homo sapiens	Genotype: YY1 knockout;	EXP062396	430	normal	P49756	HepG2 (hepatoblastoma)	NULL
EXP062475	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens		EXP062397	430	normal	P25490	HepG2 (hepatoblastoma)	NULL
EXP062476	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens		EXP062398	430	normal	P25490	HepG2 (hepatoblastoma)	NULL
EXP062477	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens	Genotype: RBM25 knockout;	EXP062399	430	normal	P25490	HepG2 (hepatoblastoma)	NULL
EXP062478	anti-YY1 (Proteintech Cat# 66281-1-lg)	Homo sapiens	Genotype: RBM25 knockout;	EXP062400	430	normal	P25490	HepG2 (hepatoblastoma)	NULL
EXP062479	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: wip1[delta] (meiotic progeny of wip1[delta]/+, carrying the inactivated Centromere 1); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062480	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf1[delta] (meiotic progeny of mhf1[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062481	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062482	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 1); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062483	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: wip1[delta] (meiotic progeny of wip1[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062484	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062485	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf1[delta] (meiotic progeny of mhf1[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062486	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062487	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 2); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062488	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2[delta] (meiotic progeny of mhf2[delta]/+, carrying the inactivated Centromere 3); Conditions: 29 C; Developmental stage: log phase	NULL	3071	normal	Q9Y812	KM81 strain at G1 phase	NULL
EXP062489	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2[delta] (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062490	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062491	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Genotype: mhf2[delta] (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062492	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062493	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1); Developmental stage: log phase	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062494	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2[delta] (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062495	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062496	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Genotype: mhf2[delta] (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062497	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+clr4+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062498	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2[delta]clr4[delta] (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062499	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2[delta]clr4[delta] (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062500	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+clr4+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062501	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: wip1+ (meiotic progeny of wip1{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062502	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf1+ (meiotic progeny of mhf1{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062503	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (meiotic progeny of mhf2{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062504	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (meiotic progeny of mhf2{delta}/+)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062505	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062506	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062507	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062508	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062509	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062510	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062511	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062512	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062513	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062514	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062515	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062516	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062517	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062518	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062519	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062520	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062521	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062522	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062523	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062524	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062525	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062526	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying Cnp1 spreading)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062527	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062528	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2{delta} (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062529	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Developmental stage: log phase; Conditions: 29 C; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062530	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062531	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Developmental stage: log phase; Genotype: mhf2+ (carrying the inactivated Centromere 2)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062532	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Conditions: 29 C; Developmental stage: log phase; Genotype: mhf2+ (carrying the spreading of Cnp1)	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062533	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: clr4{delta} (carrying no inactivated Centromere 1/2/3); Developmental stage: log phase; Conditions: 29 C	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062534	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2{delta}clr4{delta} (carrying the inactivated Centromere 2); Developmental stage: log phase; Conditions: 29 C	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062535	anti-Cnp1 (gift from Robin Allshire lab)	Schizosaccharomyces pombe	Treatment: none; Genotype: mhf2+clr4{delta} (carrying the inactivated Centromere 1); Developmental stage: log phase; Conditions: 29 C	NULL	4494	normal	Q9Y812	fission yeast haploid cells	NULL
EXP062536	anti-SIN3 (Novus Biologicals, Q5986)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	2988	normal	A5JYW9	N2 strain	NULL
EXP062537	anti-SIN3 (Novus Biologicals, Q5986)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	4495	normal	A5JYW9	cfp-1(tm6369) strain	NULL
EXP062538	anti-HDA1 (Novus Biologicals, Q2354)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	2988	normal	O17695	N2 strain	NULL
EXP062539	anti-HDA1 (Novus Biologicals, Q2354)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	4495	normal	O17695	cfp-1(tm6369) strain	NULL
EXP062540	anti-SIN3 (Novus Biologicals, Q6013)	Caenorhabditis elegans	Treatment: none; Developmental stage: MxE	NULL	2988	normal	A5JYW9	N2 strain	NULL
EXP062541	none (Input)	Drosophila melanogaster	Treatment: none	NULL	1985	chip_control	NULL	Kc	NULL
EXP062542	none (Input)	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062543	none (Input)	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062544	none (Input)	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062545	none (Input)	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062546	none (Input)	Drosophila melanogaster	Treatment: none	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062547	anti-JIL-1 (R69AP)	Drosophila melanogaster	Treatment: none	EXP062542	1451	normal	Q9V3I5	S2 (Schneider 2)	NULL
EXP062548	anti-JIL-1 (R69AP)	Drosophila melanogaster	Treatment: none	EXP062543	1451	normal	Q9V3I5	S2 (Schneider 2)	NULL
EXP062549	anti-JIL-1 (R69AP)	Drosophila melanogaster	Treatment: none	NULL	1451	normal	Q9V3I5	S2 (Schneider 2)	NULL
EXP062550	anti-JIL-1 (R69S)	Drosophila melanogaster	Treatment: none	EXP062544	1451	normal	Q9V3I5	S2 (Schneider 2)	NULL
EXP062551	anti-JIL-1 (Hope)	Drosophila melanogaster	Treatment: none	EXP062544	1451	normal	Q9V3I5	S2 (Schneider 2)	NULL
EXP062552	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062542	1451	normal	P50536	S2 (Schneider 2)	NULL
EXP062553	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062545	1451	normal	P50536	S2 (Schneider 2)	NULL
EXP062554	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062546	1451	normal	P50536	S2 (Schneider 2)	NULL
EXP062555	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: none	EXP062541	1985	normal	P50536	Kc	NULL
EXP062556	none	Drosophila melanogaster	Treatment: gfp RNAi	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062557	none	Drosophila melanogaster	Treatment: jil-1_1 RNAi	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP062558	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: gst RNAi	EXP062556	1451	normal	P50536	S2 (Schneider 2)	NULL
EXP062559	anti-MSL3 (GP)	Drosophila melanogaster	Treatment: jil-1_2 RNAi	EXP062557	1451	normal	P50536	S2 (Schneider 2)	NULL
EXP062560		Homo sapiens	Treatment: EtOH for 45 min	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062561		Homo sapiens	Treatment: EtOH for 45 min	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062562		Homo sapiens	Treatment: 100 nM E2 for 45 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062563		Homo sapiens	Treatment: 100 nM E2 for 45 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062564	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: EtOH for 45 min	EXP062560	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062565	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: EtOH for 45 min	EXP062561	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062566	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: 100 nM E2 for 45 mins	EXP062562	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062567	anti-BRD3 (Bethyl Laboratories,A302-368A)	Homo sapiens	Treatment: 100 nM E2 for 45 mins	EXP062563	113	normal	Q15059	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062568	P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: none	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP062569	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: none	EXP062568	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP062570	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: Nutlin treatment	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP062571	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: Negative control siRNA transfected	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP062572	anti-P53 (FL393, sc-6243, Lot #B1709)	Homo sapiens	Treatment: siRNA against iASSP transfected; Genotype: iASSP knockout	NULL	417	normal	P04637	HCT-116 (colon carcinoma)	NULL
EXP062573	anti-AR	Homo sapiens	Treatment: 10nM DHT for 4 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP062574	anti-AR	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 4 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP062575	anti-AR	Homo sapiens	Treatment: vehicle for 4 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP062576	anti-AR	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 48 hrs	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP062577	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 48 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062578	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated 50 uM GSK2879552  for 4 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062579	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated S2101  for 48 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062580	anti-FOXA1	Homo sapiens	Treatment: 10nM DHT for 4 hrs with pretreated S2101  for 4 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062581	anti-FOXA1	Homo sapiens	Treatment: vehicle for 4 hrs	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062582	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	712	normal	Q9Y261	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP062583	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	4496	normal	Q9Y261	PANC1 clonal cell line	NULL
EXP062584	Anti-Flag (Sigma M2 F3165 lot. SLBN8915V)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	2329	normal	O75603	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062585	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	4497	normal	Q9Y261	CFPAC1 clonal cell line	NULL
EXP062586	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062587	Anti-JUNB (Antibody sc73X Lot K0311)	Homo sapiens	Treatment: none	NULL	2329	normal	P17275	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062588	Anti-FOS (Antibody Sigma HPA018531 - Lot E106326)	Homo sapiens	Treatment: none	NULL	2329	normal	P01100	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062589	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none	NULL	4497	normal	Q9Y261	CFPAC1 clonal cell line	NULL
EXP062590	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: HNF1B knockout	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062591	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: Empty vector overexpressing	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062592	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062593	Anti-Flag (Sigma M2 F3165 lot. SLBN8915V)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	2329	normal	P17481	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062594	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: Empty vector overexpressing	NULL	712	normal	Q9Y261	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP062595	Anti-FOXA2 (Antibody sc-6554 Lot. A0715)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	712	normal	Q9Y261	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP062596	Anti-HNF1B (HPA2083)	Homo sapiens	Treatment: none; Genotype: HOXB8 overexpressing	NULL	712	normal	P35680	PANC1 (pancreatic ductal adenocarcinoma)	NULL
EXP062597	Anti-FOXA1 (Ab23738 Lot GR139681-1)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961); Genotype: wildtype	NULL	2329	normal	P55317	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062598	Anti-FOXA1 (Ab23738 Lot GR139681-1)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961) carring the expression of wt Cas9 and a guide RNA targeting FOXA1 gene; Genotype: FOXA1 knockout	NULL	2329	normal	P55317	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062599	Anti-FOXA1 (Ab23738 Lot GR139681-1)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells electroporated with plasmid pX330A_D10A-1x4 containing Cas9 nickase (Multiplex CRISPR/Cas9 Assembly System Kit; Addgene # 1000000055) and guides targeting FOXA2 gene.; Genotype: FOXA2 knockout	NULL	2329	normal	P55317	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062600	Anti-FOXA2 (Antibody sc-6554 Lot. A1014)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961); Genotype: wildtype	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062601	Anti-FOXA2 (Antibody sc-6554 Lot. A1014)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells electroporated with plasmid pX330A_D10A-1x4 containing Cas9 nickase (Multiplex CRISPR/Cas9 Assembly System Kit; Addgene # 1000000055) and guides targeting FOXA2 gene.; Genotype: FOXA2 knockout	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062602	Anti-FOXA2 (Antibody sc-6554 Lot. A1014)	Homo sapiens	Treatment: Isolation of clonal cell line by dilution of CFPAC1 cells infected with lentiCRIPSv2 plasmid (Addgene #52961) carring the expression of wt Cas9 and a guide RNA targeting FOXA1 gene; Genotype: FOXA1 knockout	NULL	2329	normal	Q9Y261	CFPAC-1(pancreatic ductal adenocarcinoma)	NULL
EXP062603	none	Homo sapiens	Treatment: none; Conditions: Hypoxia	NULL	4498	chip_control	NULL	EA.hy 926 (human umbilical vein endothelial cell line)	NULL
EXP062604	none	Homo sapiens	Treatment: TEPA treated; Conditions: Hypoxia	NULL	4498	chip_control	NULL	EA.hy 926 (human umbilical vein endothelial cell line)	NULL
EXP062605	anti-HIF-1alpha (Novus, NB100-134)	Homo sapiens	Treatment: none; Conditions: Hypoxia	EXP062603	4498	normal	Q16665	EA.hy 926 (human umbilical vein endothelial cell line)	NULL
EXP062606	anti-HIF-1alpha (Novus, NB100-134)	Homo sapiens	Treatment: TEPA treated; Conditions: Hypoxia	EXP062604	4498	normal	Q16665	EA.hy 926 (human umbilical vein endothelial cell line)	NULL
EXP062607	anti-PU.1 (T-21, Santa Cruz)	Homo sapiens	Treatment: no LPS added, collection day 10; Conditions: GM-CSF + IL4	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP062608	anti-PU.1 (T-21, Santa Cruz)	Homo sapiens	Treatment: LPS added at day 7, collection day 10; Conditions: GM-CSF + IL4	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP062609	anti-PU.1 (T-21, Santa Cruz)	Mus musculus	Treatment: no LPS added, collection day 10; Conditions: GM-CSF + IL4	NULL	914	normal	P17433	monocyte-derived dendritic cells	NULL
EXP062610	anti-PU.1 (T-21, Santa Cruz)	Mus musculus	Treatment: LPS added at day 7, collection day 10; Conditions: GM-CSF + IL4	NULL	914	normal	P17433	monocyte-derived dendritic cells	NULL
EXP062611	anti-BRD4 (A301-985A50)	Homo sapiens	Treatment: none	NULL	4500	normal	O60885	HCC1937 (breast cancer)	NULL
EXP062612	anti-BRD4 (A301-985A50)	Homo sapiens	Treatment: none	NULL	3115	normal	O60885	HCC1806(Squamous cell breast carcinoma, acantholytic variant)	NULL
EXP062613	input	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	NULL	1089	chip_control	NULL	breast tumor xenograft	NULL
EXP062614	input	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	NULL	1089	chip_control	NULL	breast tumor xenograft	NULL
EXP062615	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	EXP062613	1089	normal	P10275	breast tumor xenograft	NULL
EXP062616	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P10275	breast tumor xenograft	NULL
EXP062617	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	NULL	1089	normal	P10275	breast tumor xenograft	NULL
EXP062618	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P10275	breast tumor xenograft	NULL
EXP062619	anti-AR (Spring Bioscience, E2724, 160627LVB)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	EXP062614	1089	normal	P10275	breast tumor xenograft	NULL
EXP062620	FOXA1	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	EXP062614	1089	normal	P55317	breast tumor xenograft	NULL
EXP062621	anti-FOXA1 (abcam, ab5089 + ab23738, gr122110-14 gr292351-2)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P55317	breast tumor xenograft	NULL
EXP062622	anti-ER (Santa Cruz Biotechnology, Thermo, sc-543, MS-315-P1ABX, c2114, 315X1510A)	Homo sapiens	Treatment: Enobosarm (10 mg/kg)	NULL	1089	normal	P03372	breast tumor xenograft	NULL
EXP062623	anti-ER (Santa Cruz Biotechnology, Thermo, sc-543, MS-315-P1ABX, c2114, 315X1510A)	Homo sapiens	Treatment: Vehicle (DMSO+PEG-300 15:85)	NULL	1089	normal	P03372	breast tumor xenograft	NULL
EXP062624	Anti-RENT1 (UPF1) (Bethyl Laboratories, A301-902A)	Homo sapiens	Treatment: none; Age: 69 years adult; Phenotype: adenocarcinoma	NULL	4501	normal	Q92900	mammary gland breast cancer cells derived from metastatic site pleural effusion	NULL
EXP062625	none (input)	Homo sapiens	Treatment: shRNA lentiviruses, non-targeting; Genotype: cggbp1  endogenous	NULL	10	chip_control	NULL	HEK293T (embryonic kidney)	NULL
EXP062626	anti-CTCF(SC-28198 and SC-271514, Santa Cruz Biotechnology)	Homo sapiens	Treatment: shRNA lentiviruses, non-targeting; Genotype: cggbp1  endogenous	NULL	10	normal	P49711	HEK293T (embryonic kidney)	NULL
EXP062627	SC-28198 and SC-271514 (Santa Cruz Biotechnology)	Homo sapiens	Treatment: shRNA lentiviruses CGGBP1-silencing; Genotype: cggbp1  knockdown	NULL	10	normal	P49711	HEK293T (embryonic kidney)	NULL
EXP062628	SC-28198 and SC-271514 (Santa Cruz Biotechnology)	Homo sapiens	Treatment: shRNA lentiviruses CGGBP1-overexpressing; Genotype: CGGBP1-overexpressing	NULL	10	normal	P49711	HEK293T (embryonic kidney)	NULL
EXP062629	anti-NCoR Millipore, ABE251, Lot#2153059	Mus musculus	Treatment: None	NULL	2756	normal	Q60974	B cell enriched splenocytes	NULL
EXP062630	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: None	NULL	2756	normal	O08917	B cell enriched splenocytes	NULL
EXP062631	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: None	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062632	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+FLAG control transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062633	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+HDAC3-YF transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062634	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+FLAG control transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062635	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+HDAC3-YF transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062636	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+FLAG control transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062637	ant-H3K27ac Abcam, GR167929-1 Lot# ab4729	Mus musculus	Treatment: OSKM+HDAC3-YF transfection	NULL	3962	normal	O08917	2 cells stage preimplantation embryo	NULL
EXP062638	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 0	NULL	3715	chip_control	NULL	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062639	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 2	NULL	3715	chip_control	NULL	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062640	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 5	NULL	3715	chip_control	NULL	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062641	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 9	NULL	3715	chip_control	NULL	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062642	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 14	NULL	3715	chip_control	NULL	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062643	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 0	EXP062638	3715	normal	P14921	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062644	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 2	EXP062639	3715	normal	P15036	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062645	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 5	EXP062640	3715	normal	A0AVK6	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062646	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 9	EXP062641	3715	normal	A0AVK6	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062647	anti-ETS1	Homo sapiens	Treatment: none; Time point: day 14	EXP062642	3715	normal	A0AVK6	WA01 (H1-hESC) derived cardiomyocyte	NULL
EXP062648	None	Homo sapiens	Treatment: Treatment: none	NULL	4502	chip_control	NULL	2102EP (Embryonal carcinoma)	NULL
EXP062649	None	Homo sapiens	Treatment: Treatment: none	NULL	4502	chip_control	NULL	2102EP (Embryonal carcinoma)	NULL
EXP062650	None	Homo sapiens	Treatment: Treatment: none	NULL	4502	chip_control	NULL	2102EP (Embryonal carcinoma)	NULL
EXP062651	None	Homo sapiens	Treatment: Treatment: none	NULL	4503	chip_control	NULL	TCam-2 (Testicular seminoma)	NULL
EXP062652	None	Homo sapiens	Treatment: Treatment: none	NULL	4503	chip_control	NULL	TCam-2 (Testicular seminoma)	NULL
EXP062653	None	Homo sapiens	Treatment: Treatment: none	NULL	4503	chip_control	NULL	TCam-2 (Testicular seminoma)	NULL
EXP062654	Anti-SOX2	Homo sapiens	Treatment: Treatment: none	EXP062648	4502	normal	P48431	2102EP (Embryonal carcinoma)	NULL
EXP062655	Anti-SOX2	Homo sapiens	Treatment: Treatment: none	EXP062649	4502	normal	P48431	2102EP (Embryonal carcinoma)	NULL
EXP062656	Anti-SOX2	Homo sapiens	Treatment: Treatment: none	EXP062650	4502	normal	P48431	2102EP (Embryonal carcinoma)	NULL
EXP062657	Anti-SOX17	Homo sapiens	Treatment: Treatment: none	EXP062651	4503	normal	Q9H6I2	TCam-2 (Testicular seminoma)	NULL
EXP062658	Anti-SOX17	Homo sapiens	Treatment: Treatment: none	EXP062652	4503	normal	Q9H6I2	TCam-2 (Testicular seminoma)	NULL
EXP062659	Anti-SOX17	Homo sapiens	Treatment: Treatment: none	EXP062653	4503	normal	Q9H6I2	TCam-2 (Testicular seminoma)	NULL
EXP062660	none	Homo sapiens	Treatment: none	NULL	3039	chip_control	NULL	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP062661	anti-TCF12 (CST11825, Danvers, MA, USA)	Homo sapiens	Treatment: none	EXP062660	3039	normal	Q99081	Hep 3B2.1-7 (HEP-3B, Hepatocellular carcinoma)	NULL
EXP062662	Input genomic DNA	Homo sapiens	Treatment: none	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP062663	Input genomic DNA	Homo sapiens	Treatment: 10ng/ml IL-1alpha for 1 hr	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP062664	Input genomic DNA	Homo sapiens	Treatment: 1uM 5Z-7-oxozeaenol for 1 hr	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP062665	Input genomic DNA	Homo sapiens	Treatment: 10ng/ml IL-1alpha + 1uM 5Z-7-oxozeaenol for 1 hr	NULL	519	chip_control	NULL	KB (cervical adenocarcinoma)	NULL
EXP062666	anti-CTCF	Homo sapiens	Treatment: none	EXP062662	519	normal	P49711	KB (cervical adenocarcinoma)	NULL
EXP062667	anti-CTCF	Homo sapiens	Treatment: 10ng/ml IL-1alpha for 1 hr	EXP062663	519	normal	P49711	KB (cervical adenocarcinoma)	NULL
EXP062668	anti-CTCF	Homo sapiens	Treatment: 1uM 5Z-7-oxozeaenol for 1 hr	EXP062664	519	normal	P49711	KB (cervical adenocarcinoma)	NULL
EXP062669	anti-CTCF	Homo sapiens	Treatment: 10ng/ml IL-1alpha + 1uM 5Z-7-oxozeaenol for 1 hr	EXP062665	519	normal	P49711	KB (cervical adenocarcinoma)	NULL
EXP062670		Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	NULL	4513	chip_control	NULL	CAR-T cells	NULL
EXP062671		Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	NULL	4513	chip_control	NULL	CAR-T cells	NULL
EXP062672		Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	NULL	4513	chip_control	NULL	CAR-T cells	NULL
EXP062673		Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	NULL	4513	chip_control	NULL	CAR-T cells	NULL
EXP062674	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	EXP062670	4513	normal	Q15306	CAR-T cells	NULL
EXP062675	anti-JUN (Active Motif, #39309)	Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	EXP062670	4513	normal	P05412	CAR-T cells	NULL
EXP062676	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: none; Genotype: Retroviral transduction with HA construct	EXP062671	4513	normal	Q15306	CAR-T cells	NULL
EXP062677	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062672	4513	normal	Q15306	CAR-T cells	NULL
EXP062678	anti-JUN (Active Motif, #39309)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062672	4513	normal	P05412	CAR-T cells	NULL
EXP062679	anti-IRF4 (Abcam, #ab101168)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062673	4513	normal	Q15306	CAR-T cells	NULL
EXP062680	anti-JUN (Active Motif, #39309)	Homo sapiens	Treatment: Retroviral transduction with JUN-HA construct; Genotype: JUN-HA overexpressing	EXP062673	4513	normal	P05412	CAR-T cells	NULL
EXP062681	N/A	Homo sapiens	Treatment: none	NULL	934	chip_control	NULL	HOT1 tumor derived from a human glioblastoma	NULL
EXP062682	N/A	Homo sapiens	Treatment: none	NULL	4516	chip_control	NULL	KNS62 (Squamous cell lung carcinoma)	NULL
EXP062683	N/A	Homo sapiens	Treatment: none	NULL	4517	chip_control	NULL	HCC2814 (Squamous cell lung carcinoma)	NULL
EXP062684	N/A	Homo sapiens	Treatment: none	NULL	4514	chip_control	NULL	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062685	N/A	Homo sapiens	Treatment: none	NULL	4515	chip_control	NULL	NCI-H520 (Squamous cell lung carcinoma)	NULL
EXP062686	N/A	Homo sapiens	Treatment: none; Genotype: GFP	NULL	4514	chip_control	NULL	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062687	N/A	Homo sapiens	Treatment: none; Genotype: DNp63	NULL	4514	chip_control	NULL	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062688	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	NULL	4514	normal	P48431	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062689	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	EXP062685	4515	normal	P48431	NCI-H520 (Squamous cell lung carcinoma)	NULL
EXP062690	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	NULL	413	normal	P48431	HCC95 (squamous cell lung carcinoma)	NULL
EXP062691	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	EXP062682	4516	normal	P48431	KNS62 (Squamous cell lung carcinoma)	NULL
EXP062692	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none	EXP062683	4517	normal	P48431	HCC2814 (Squamous cell lung carcinoma)	NULL
EXP062693	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none; Genotype: GFP	EXP062686	4514	normal	P48431	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062694	anti-Sox2 (R&D, AF2018)	Homo sapiens	Treatment: none; Genotype: DNp63	EXP062687	4514	normal	P48431	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062695	anti-p63 (Santa Cruz, sc-8431)	Homo sapiens	Treatment: none; Genotype: DNp63	EXP062687	4514	normal	Q9H3D4	LK-2 (Squamous cell lung carcinoma)	NULL
EXP062696	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	NULL
EXP062697	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	NULL
EXP062698	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	NULL
EXP062699	anti-Androgen Receptor ( Santa Cruz , sc-816x, lot J216)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	A2NVP9	LNCaP (prostate carcinoma)	NULL
EXP062700	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	NULL
EXP062701	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	NULL
EXP062702	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	NULL
EXP062703	anti-V5 (Cell signaling, #13202, lot2 )	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	Q02930	LNCaP (prostate carcinoma)	NULL
EXP062704	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062705	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: DMSO for 4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062706	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing Luciferase	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062707	anti-FoxA1 (Abcam, ab23738)	Homo sapiens	Treatment: 2.5 uM enzalutamide for  4 days; Genotype: LNCaP expressing CREB5	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP062708		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	NULL	3668	chip_control	NULL	CD34+ hematopoietic stem/progenitor cell from cord blood	NULL
EXP062709		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062710		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062711		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062712		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062713		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062714		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062715		Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	NULL	4305	chip_control	NULL	CD34+ HSPC derived erythroid precursors	NULL
EXP062716		Homo sapiens	Treatment: none; Time point: day 0	NULL	3668	chip_control	NULL	CD34+ hematopoietic stem/progenitor cell from cord blood	NULL
EXP062717	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	EXP062708	3668	normal	Q15797	CD34+ hematopoietic stem/progenitor cell from cord blood	NULL
EXP062718	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	EXP062708	3668	normal	P15976	CD34+ hematopoietic stem/progenitor cell from cord blood	NULL
EXP062719	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 0	EXP062708	3668	normal	P23769	CD34+ hematopoietic stem/progenitor cell from cord blood	NULL
EXP062720	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	EXP062709	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	NULL
EXP062721	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	EXP062709	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	NULL
EXP062722	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: 6 hrs	EXP062709	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	NULL
EXP062723	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	EXP062710	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	NULL
EXP062724	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	EXP062710	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	NULL
EXP062725	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 3	EXP062711	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	NULL
EXP062726	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	EXP062712	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	NULL
EXP062727	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	EXP062712	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	NULL
EXP062728	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 4	EXP062713	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	NULL
EXP062729	anti-GATA1 (Santa Cruz, sc265)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	EXP062714	4305	normal	P15976	CD34+ HSPC derived erythroid precursors	NULL
EXP062730	anti-GATA2 (Santa Cruz, sc9008)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	EXP062715	4305	normal	P23769	CD34+ HSPC derived erythroid precursors	NULL
EXP062731	anti-SMAD1 (Santa Cruz, sc7965)	Homo sapiens	Treatment: 25ng/ml hrBMP4 for 2hrs before collection; Time point: day 5	EXP062714	4305	normal	Q15797	CD34+ HSPC derived erythroid precursors	NULL
EXP062732	anti-SMAD2 (Cell Signaling Technology, 5339S)	Homo sapiens	Treatment: none; Time point: day 0	EXP062716	3668	normal	Q15796	CD34+ hematopoietic stem/progenitor cell from cord blood	NULL
EXP062733	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: No treatment; Genotype: Stably transfected with empty vector	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062734	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: 10 nM  Docetaxel for 24 hours; Genotype: Stably transfected with empty vector	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062735	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: No treatment; Genotype: Stably transfected with Caspase-3 cDNA	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062736	anti-Caspase-3 (Asp175, 5A1E, Rabbit mAb from Cell Signaling, Ref: #9664, Batch: 0019)	Homo sapiens	Treatment: 10 nM  Docetaxel for 24 hours; Genotype: Stably transfected with Caspase-3 cDNA	NULL	113	normal	P42574	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP062737	anti-HA (GeneTex, GTX29110)	Homo sapiens	Treatment: none; Genotype: vector control	NULL	1490	chip_control	NULL	NCI-H460 (Large cell lung carcinoma)	NULL
EXP062738	anti-HA (GeneTex, GTX29110)	Homo sapiens	Treatment: none; Genotype: vector control	NULL	1490	chip_control	NULL	NCI-H460 (Large cell lung carcinoma)	NULL
EXP062739	anti-HA (GeneTex, GTX29110)	Homo sapiens	Treatment: none; Genotype: HA-tagged ZNF322A overexpressing	EXP062737	1490	normal	Q6U7Q0	NCI-H460 (Large cell lung carcinoma)	NULL
EXP062740	anti-HA (GeneTex, GTX29110)	Homo sapiens	Treatment: none; Genotype: HA-tagged ZNF322A overexpressing	EXP062738	1490	normal	Q6U7Q0	NCI-H460 (Large cell lung carcinoma)	NULL
EXP062741	anti-Phf21b	Mus musculus	Treatment: none; Time point: Day2 differentiated	NULL	1245	chip_control	NULL	Neuro-2A cells	NULL
EXP062742	anti-Phf21b	Mus musculus	Treatment: none; Time point: Day2 differentiated	EXP062741	1245	normal	Q8C966	Neuro-2A cells	NULL
EXP062743	anti-Phf21b	Mus musculus	Treatment: none	NULL	2	normal	Q8C966	mESCs (mouse embryonic stem cells)	NULL
EXP062744	Mock	Mus musculus	Treatment: none; Strain: TS3.5	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP062745	Mock	Mus musculus	Treatment: none; Strain: TS3.5	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP062746	Mock	Mus musculus	Treatment: none; Strain: TS3.5	NULL	2440	chip_control	NULL	differentiated trophoblast stem cells	NULL
EXP062747	anti-p300	Mus musculus	Treatment: none; Strain: TS3.5	NULL	506	normal	B2RWS6	J1 (embryonic stem cells)	NULL
EXP062748	anti-Arid3a	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q62431	trophoblast stem cells	NULL
EXP062749	Bbx	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8VBW5	trophoblast stem cells	NULL
EXP062750	Bbx	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8VBW5	trophoblast stem cells	NULL
EXP062751	Bhlhe40	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O35185	trophoblast stem cells	NULL
EXP062752	Bhlhe40	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O35185	trophoblast stem cells	NULL
EXP062753	Cbfa2t3	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O54972	trophoblast stem cells	NULL
EXP062754	Cbfa2t3	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O54972	trophoblast stem cells	NULL
EXP062755	Creb3l2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8BH52	trophoblast stem cells	NULL
EXP062756	Creb3l2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8BH52	trophoblast stem cells	NULL
EXP062757	Ctcf	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q61164	trophoblast stem cells	NULL
EXP062758	Elf5	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8VDK3	trophoblast stem cells	NULL
EXP062759	Eomes	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O54839	trophoblast stem cells	NULL
EXP062760	Eomes	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O54839	trophoblast stem cells	NULL
EXP062761	Ets2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P15037	trophoblast stem cells	NULL
EXP062762	Ets2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	P15037	trophoblast stem cells	NULL
EXP062763	Fbxo21	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q8VDH1	trophoblast stem cells	NULL
EXP062764	Fbxo21	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8VDH1	trophoblast stem cells	NULL
EXP062765	Foxj2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q9ES18	trophoblast stem cells	NULL
EXP062766	Foxj2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q9ES18	trophoblast stem cells	NULL
EXP062767	Hic2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q9JLZ6	trophoblast stem cells	NULL
EXP062768	Hic2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q9JLZ6	trophoblast stem cells	NULL
EXP062769	Hopx	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q8R1H0	trophoblast stem cells	NULL
EXP062770	Hpox	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	A1A546	trophoblast stem cells	NULL
EXP062771	Id2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P41136	trophoblast stem cells	NULL
EXP062772	Id2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	P41136	trophoblast stem cells	NULL
EXP062773	Irf2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P23906	trophoblast stem cells	NULL
EXP062774	Irf2	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	P23906	trophoblast stem cells	NULL
EXP062775	Lrrfip1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q3UZ39	trophoblast stem cells	NULL
EXP062776	Lrrfip1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q3UZ39	trophoblast stem cells	NULL
EXP062777	Maff	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O54791	trophoblast stem cells	NULL
EXP062778	Maff	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O54791	trophoblast stem cells	NULL
EXP062779	Mafk	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q61827	trophoblast stem cells	NULL
EXP062780	Mafk	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q61827	trophoblast stem cells	NULL
EXP062781	Med12	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	A2AGH6	trophoblast stem cells	NULL
EXP062782	Mef2d	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q63943	trophoblast stem cells	NULL
EXP062783	Mef2d	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q63943	trophoblast stem cells	NULL
EXP062784	Meis1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q60954	trophoblast stem cells	NULL
EXP062785	anti-p300	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	B2RWS6	trophoblast stem cells	NULL
EXP062786	Pcgf5	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q3UK78	trophoblast stem cells	NULL
EXP062787	Pcgf5	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q3UK78	trophoblast stem cells	NULL
EXP062788	Pou3f1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P21952	trophoblast stem cells	NULL
EXP062789	Smad6	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O35182	trophoblast stem cells	NULL
EXP062790	Smad6	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O35182	trophoblast stem cells	NULL
EXP062791	Tbx20	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q9ES03	trophoblast stem cells	NULL
EXP062792	Tbx20	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q9ES03	trophoblast stem cells	NULL
EXP062793	Tead4	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q62296	trophoblast stem cells	NULL
EXP062794	Tead4	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	Q62296	trophoblast stem cells	NULL
EXP062795	Tfap2c	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	Q61312	trophoblast stem cells	NULL
EXP062796	Zfpm1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	O35615	trophoblast stem cells	NULL
EXP062797	Zfpm1	Mus musculus	Treatment: none; Strain: TS3.5	EXP062745	96	normal	O35615	trophoblast stem cells	NULL
EXP062798	cFos	Mus musculus	Treatment: none; Strain: TS3.5	EXP062744	96	normal	P01101	trophoblast stem cells	NULL
EXP062799	Bbx	Mus musculus	Treatment: none; Strain: TS3.5; Time point: 3 days of differentiation; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8VBW5	differentiated trophoblast stem cells	NULL
EXP062800	Creb3l2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8BH52	differentiated trophoblast stem cells	NULL
EXP062801	Elf5	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8VDK3	differentiated trophoblast stem cells	NULL
EXP062802	Ets2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P15037	differentiated trophoblast stem cells	NULL
EXP062803	Foxj2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q9ES18	differentiated trophoblast stem cells	NULL
EXP062804	Hic2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q9JLZ6	differentiated trophoblast stem cells	NULL
EXP062805	Hopx	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q8R1H0	differentiated trophoblast stem cells	NULL
EXP062806	Irf2	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P23906	differentiated trophoblast stem cells	NULL
EXP062807	Maff	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	O54791	differentiated trophoblast stem cells	NULL
EXP062808	Mafk	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q61827	differentiated trophoblast stem cells	NULL
EXP062809	Meis1	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q60954	differentiated trophoblast stem cells	NULL
EXP062810	Pcgf5	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q3UK78	differentiated trophoblast stem cells	NULL
EXP062811	Pou3f1	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P21952	differentiated trophoblast stem cells	NULL
EXP062812	Tfap2c	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	Q61312	differentiated trophoblast stem cells	NULL
EXP062813	Zfpm1	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	O35615	differentiated trophoblast stem cells	NULL
EXP062814	cFos	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	P01101	differentiated trophoblast stem cells	NULL
EXP062815	anti-p300	Mus musculus	Treatment: none; Strain: TS3.5; Conditions: To differentiate TSCs, They were cultivated in TS basal medium without Fgf4 and heparin	EXP062746	2440	normal	B2RWS6	differentiated trophoblast stem cells	NULL
EXP062816	none	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 0 hrs	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP062817	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	4102	normal	P48432	B cells derived iPSC	NULL
EXP062818	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 0 hrs	EXP062816	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP062819	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP062820	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P20263	mESCs (mouse embryonic stem cells)	NULL
EXP062821	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 48 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	NULL
EXP062822	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	NULL
EXP062823	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	NULL
EXP062824	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 96 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	NULL
EXP062825	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	NULL
EXP062826	anti-OCT4 (Santa Cruz, sc-8628x)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P20263	induced pluripotent stem cells	NULL
EXP062827	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP062828	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 0 hrs	NULL	2	normal	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP062829	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 0 hrs	EXP062816	2	normal	P48432	mESCs (mouse embryonic stem cells)	NULL
EXP062830	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 48 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	NULL
EXP062831	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 48 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	NULL
EXP062832	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: 2 ug/ml Doxycycline; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	NULL
EXP062833	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: GFP targeted to the endogenous Nanog locus and constitutive nuclear RFP; Time point: 96 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	NULL
EXP062834	anti-SOX2 (Santa Cruz, sc07-030)	Mus musculus	Treatment: none; Genotype: wildtype; Time point: 96 hrs	NULL	906	normal	P48432	induced pluripotent stem cells	NULL
EXP062835	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: none; Genotype: SBR knockout	NULL	693	normal	P20263	OG2 transgenetic mouse embryonic stem cells	NULL
EXP062836	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: treated with doxycycline; Genotype: OCT4-HALO	NULL	873	normal	P20263	ZHBTc4 (embryonic stem cells)	NULL
EXP062837	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: treated with doxycycline; Genotype: YPet-OCT4	NULL	873	normal	P20263	ZHBTc4 (embryonic stem cells)	NULL
EXP062838	Anti-OCT4 (C30A3C1, 5677S)	Mus musculus	Treatment: treated with doxycycline; Genotype: YPet-SOX2	NULL	13	normal	P48432	2TS22C (embryonic stem cells)	NULL
EXP062842		Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	NULL	561	chip_control	NULL	lung	NULL
EXP062843	anti-NKX2-1 (Abcam #133737 lot#GR154535-1)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	NULL
EXP062844	anti-NKX2-1 (Millipore #07-601 lot#2887266)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	NULL
EXP062845	anti-NKX2-1 (Abcam#76013 lot#GR297063-2)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	NULL
EXP062846	anti-NKX2-1 (Abcam #133737 lot#GR154535-1)	Mus musculus	Treatment: none; Genotype: wildtype; Age: P10	EXP062842	561	normal	P50220	lung	NULL
EXP062847	anti-CTCF (Millipore 07-729)	Mus musculus	Treatment: methylated adaptors and bisulfite converted	NULL	521	normal	Q61164	KH2 (embryonic stem cells)	NULL
EXP062848	anti-CTCF (Millipore 07-729)	Mus musculus	Treatment: methylated adaptors not converted	NULL	521	normal	Q61164	KH2 (embryonic stem cells)	NULL
EXP062849	anti-CTCF (Millipore 07-729)	Mus musculus	Treatment: Nextera adaptors	NULL	521	normal	Q61164	KH2 (embryonic stem cells)	NULL
EXP062850	anti-KLF4 (R&D AF3158)	Mus musculus	Treatment: none; Genotype: KLF4 knockout	NULL	521	normal	Q60793	KH2 (embryonic stem cells)	NULL
EXP062851	anti-KLF4 (R&D AF3158)	Mus musculus	Treatment: none; Genotype: KLF4 knockout  that re-express WT Klf4	NULL	521	normal	Q60793	KH2 (embryonic stem cells)	NULL
EXP062852	anti-KLF4 (R&D AF3158)	Mus musculus	Treatment: none; Genotype: KLF4 knockout that re-express R462A mutant Klf4	NULL	521	normal	Q60793	KH2 (embryonic stem cells)	NULL
EXP062853	none	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	NULL	4519	chip_control	NULL	CH12F3 (Mouse lymphoma)	NULL
EXP062854	none	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	NULL	4519	chip_control	NULL	CH12F3 (Mouse lymphoma)	NULL
EXP062855	none	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient; Strain: C57BL/6	NULL	4520	chip_control	NULL	primary mature splenic B cells	NULL
EXP062856	none	Mus musculus	Treatment: with aCD40/IL4 stimulation; Genotype: AID-deficient; Strain: C57BL/6	NULL	4520	chip_control	NULL	primary mature splenic B cells	NULL
EXP062857	none	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	NULL	4519	chip_control	NULL	CH12F3 (Mouse lymphoma)	NULL
EXP062858	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	EXP062853	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	NULL
EXP062859	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	EXP062854	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	NULL
EXP062860	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	NULL	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	NULL
EXP062861	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	NULL	4519	normal	Q6KCD5	CH12F3 (Mouse lymphoma)	NULL
EXP062862	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: with aCD40/IL4 stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062856	4520	normal	Q6KCD5	primary mature splenic B cells	NULL
EXP062863	anti-NIPBL (Bethyl, A301-779A)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062855	4520	normal	Q6KCD5	primary mature splenic B cells	NULL
EXP062864	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient	EXP062853	4519	normal	Q61550	CH12F3 (Mouse lymphoma)	NULL
EXP062865	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	EXP062854	4519	normal	Q61550	CH12F3 (Mouse lymphoma)	NULL
EXP062866	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: with aCD40/IL4/TGFb stimulation; Genotype: AID-deficient	EXP062857	4519	normal	Q61550	CH12F3 (Mouse lymphoma)	NULL
EXP062867	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: without stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062855	4520	normal	Q61550	primary mature splenic B cells	NULL
EXP062868	anti-Rad21 (Abcam, ab992)	Mus musculus	Treatment: with aCD40/IL4 stimulation; Genotype: AID-deficient; Strain: C57BL/6	EXP062856	4520	normal	Q61550	primary mature splenic B cells	NULL
EXP062869	none	Mus musculus	Treatment: none; Genotype: Stag2 knockout	NULL	103	chip_control	NULL	bone marrow	NULL
EXP062870	none	Mus musculus	Treatment: none; Genotype: Staag2 wildtype	NULL	103	chip_control	NULL	bone marrow	NULL
EXP062871	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062869	103	normal	P17433	bone marrow	NULL
EXP062872	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	NULL	917	normal	P17433	spleen	NULL
EXP062873	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Staag2 wildtype	EXP062870	103	normal	P17433	bone marrow	NULL
EXP062874	anti-PU.1 (Santa Cruz sc-352)	Mus musculus	Treatment: none; Genotype: Staag2 wildtype	NULL	917	normal	P17433	spleen	NULL
EXP062875	none	Mus musculus	Treatment: none; Genotype: Stag2 knockout	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP062876	none	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	NULL	549	chip_control	NULL	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP062877	none	Mus musculus	Treatment: none; Genotype: Stag2 knockout	NULL	4523	chip_control	NULL	Lin- hematopoietic stem and progenitor cells (HSPCs) from spleen	NULL
EXP062878	none	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	NULL	4523	chip_control	NULL	Lin- hematopoietic stem and progenitor cells (HSPCs) from spleen	NULL
EXP062879	none	Mus musculus	Treatment: none; Genotype: Stag2 knockout	NULL	4524	chip_control	NULL	hematopoietic stem and progenitor cells	NULL
EXP062880	none	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	NULL	4524	chip_control	NULL	hematopoietic stem and progenitor cells	NULL
EXP062881	anti-CTCF (Cell Signaling, 3418S)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062875	549	normal	Q61164	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP062882	anti-CTCF (Cell Signaling, 3418S)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062876	549	normal	Q61164	Lin- bone marrow hematopoietic progenitor cells	NULL
EXP062883	Stag1 (Bethyl, A302-579A)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062877	4523	normal	Q9D3E6	Lin- hematopoietic stem and progenitor cells (HSPCs) from spleen	NULL
EXP062884	Stag1 (Bethyl, A302-579A)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062878	4523	normal	Q9D3E6	Lin- hematopoietic stem and progenitor cells (HSPCs) from spleen	NULL
EXP062885	anti-Smc1a (Active Motif, 61067)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062879	4524	normal	Q9CU62	hematopoietic stem and progenitor cells	NULL
EXP062886	anti-Smc3 (Bethyl, A300-060A)	Mus musculus	Treatment: none; Genotype: Stag2 knockout	EXP062879	4524	normal	Q9CW03	hematopoietic stem and progenitor cells	NULL
EXP062887	anti-Smc1a (Active Motif, 61067)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062880	4524	normal	Q9CU62	hematopoietic stem and progenitor cells	NULL
EXP062888	anti-Smc3 (Bethyl, A300-060A)	Mus musculus	Treatment: none; Genotype: Stag2 wildtype	EXP062880	4524	normal	Q9CW03	hematopoietic stem and progenitor cells	NULL
EXP062889	None (Input)	Mus musculus	Treatment: none; Genotype: MEF2A Control; Sex: Female; Strain: C57BL/6	NULL	25	chip_control	NULL	cerebellum	NULL
EXP062890	None (Input)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: Female; Strain: C57BL/6	NULL	25	chip_control	NULL	cerebellum	NULL
EXP062891	None (Input)	Mus musculus	Treatment: none; Genotype: MEF2A Control; Sex: Female; Strain: C57BL/6	NULL	25	chip_control	NULL	cerebellum	NULL
EXP062892	None (Input)	Mus musculus	Treatment: none; Genotype: MEF2D Conditional knockout; Sex: Female; Strain: C57BL/6	NULL	25	chip_control	NULL	cerebellum	NULL
EXP062893	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: Female; Strain: C57BL/6	EXP062890	25	normal	Q60929	cerebellum	NULL
EXP062894	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: male; Strain: C57BL/6	NULL	25	normal	Q60929	cerebellum	NULL
EXP062895	anti-MEF2D (Greenberg Lab)	Mus musculus	Treatment: none; Genotype: MEF2D Conditional knockout; Sex: Female; Strain: C57BL/6	EXP062892	25	normal	Q63943	cerebellum	NULL
EXP062896	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2A Control; Sex: Female; Strain: C57BL/6	EXP062889	25	normal	Q60929	cerebellum	NULL
EXP062897	anti-MEF2A (Santa Cruz, C-21)	Mus musculus	Treatment: none; Genotype: MEF2D Conditional knockout; Sex: Female; Strain: C57BL/6	EXP062892	25	normal	Q60929	cerebellum	NULL
EXP062898	anti-MEF2D (Greenberg Lab)	Mus musculus	Treatment: none; Genotype: MEF2A Control; Sex: Female; Strain: C57BL/6	EXP062891	25	normal	Q63943	cerebellum	NULL
EXP062899	anti-MEF2D (Greenberg Lab)	Mus musculus	Treatment: none; Genotype: MEF2A Conditional Knockout; Sex: Female; Strain: C57BL/6	EXP062890	25	normal	Q63943	cerebellum	NULL
EXP062900	none	Mus musculus	Treatment: none; Genotype: Salv knockout; Age: postnatal day 8; Strain: 129	NULL	3053	chip_control	NULL	heart ventricle	NULL
EXP062901	none	Mus musculus	Treatment: none; Genotype: Salv knockout; Age: postnatal day 12; Strain: 129	NULL	3053	chip_control	NULL	heart ventricle	NULL
EXP062902	anti-YAP1 (Novus #NB110-58358)	Mus musculus	Treatment: none; Genotype: Salv knockout; Age: postnatal day 8; Strain: 129	EXP062900	3053	normal	P46938	heart ventricle	NULL
EXP062903	anti-YAP1 Antibody (Novus #NB110-58358)	Mus musculus	Treatment: none; Genotype: Salv knockout; Age: postnatal day 12; Strain: 129	EXP062901	3053	normal	P46938	heart ventricle	NULL
EXP062904	none	Rattus norvegicus	Treatment: Cocaine	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062905	none	Rattus norvegicus	Treatment: Cocaine	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062906	none	Rattus norvegicus	Treatment: Saline	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062907	none	Rattus norvegicus	Treatment: Saline	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062908	none	Rattus norvegicus	Treatment: Saline	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062909	none	Rattus norvegicus	Treatment: Saline	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062910	none	Rattus norvegicus	Treatment: Saline	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062911	none	Rattus norvegicus	Treatment: Saline	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062912	none	Rattus norvegicus	Treatment: Cocaine	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062913	none	Rattus norvegicus	Treatment: Cocaine	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062914	none	Rattus norvegicus	Treatment: Cocaine	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062915	none	Rattus norvegicus	Treatment: Cocaine	NULL	4573	chip_control	NULL	nucleus accumbens	NULL
EXP062916	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062904	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062917	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062905	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062918	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062906	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062919	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062907	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062920	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062908	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062921	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062909	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062922	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062910	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062923	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Saline	EXP062911	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062924	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062912	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062925	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062913	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062926	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062914	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062927	anti-INO80 Antibody (Bethyl Laboratories, Inc., catalog# A303-371A, lot# A303-371A-1)	Rattus norvegicus	Treatment: Cocaine	EXP062915	4573	normal	D4A6Q6	nucleus accumbens	NULL
EXP062928	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	chip_control	NULL	hippocampal neurons	NULL
EXP062929	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	chip_control	NULL	hippocampal neurons	NULL
EXP062930	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	chip_control	NULL	hippocampal neurons	NULL
EXP062931	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	chip_control	NULL	hippocampal neurons	NULL
EXP062932	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062928	4576	normal	P41739	hippocampal neurons	NULL
EXP062933	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062929	4576	normal	P41739	hippocampal neurons	NULL
EXP062934	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062928	4576	normal	P41739	hippocampal neurons	NULL
EXP062935	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062929	4576	normal	P41739	hippocampal neurons	NULL
EXP062936	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	normal	Q8CJH6	hippocampal neurons	NULL
EXP062937	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: 2 hours stimulation of  50 uM Picrotoxin; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	NULL	4576	normal	Q8CJH6	hippocampal neurons	NULL
EXP062938	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062930	4576	normal	P41739	hippocampal neurons	NULL
EXP062939	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062931	4576	normal	P41739	hippocampal neurons	NULL
EXP062940	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062930	4576	normal	P41739	hippocampal neurons	NULL
EXP062941	anti-ARNT1 (clone D28F3, Cell Signaling Technology, Cat#5537)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062931	4576	normal	P41739	hippocampal neurons	NULL
EXP062942	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062930	4576	normal	Q8CJH6	hippocampal neurons	NULL
EXP062943	anti-NPAS4 (clone 92-3, DART Neuroscience)	Rattus norvegicus	Treatment: Treatment: Treatment: none; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley; Age: postnatal day 1; Strain: Sprague Dawley	EXP062931	4576	normal	Q8CJH6	hippocampal neurons	NULL
EXP062944		Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype	NULL	4582	chip_control	NULL	logarithmic growing cells	NULL
EXP062945		Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype	NULL	4582	chip_control	NULL	logarithmic growing cells	NULL
EXP062946	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype	EXP062945	4582	normal	P40848	logarithmic growing cells	NULL
EXP062947	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: swd22 delta	NULL	4582	normal	P40848	logarithmic growing cells	NULL
EXP062948	Input	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 1	NULL	1263	chip_control	NULL	whole cells	NULL
EXP062949	Input	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 1	NULL	1263	chip_control	NULL	whole cells	NULL
EXP062950	Input	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 1	NULL	1263	chip_control	NULL	whole cells	NULL
EXP062951	Input	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 1	NULL	1263	chip_control	NULL	whole cells	NULL
EXP062952	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 9	HEXP003911	1263	normal	O94529	whole cells	NULL
EXP062953	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 9	HEXP003912	1263	normal	O94529	whole cells	NULL
EXP062954	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 10	EXP062949	1263	normal	O94529	whole cells	NULL
EXP062955	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 10	EXP062949	1263	normal	O94529	whole cells	NULL
EXP062956	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 11	EXP062950	1263	normal	O94529	whole cells	NULL
EXP062957	anti-Pob3  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 11	EXP062951	1263	normal	O94529	whole cells	NULL
EXP062958	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 12	HEXP003911	1263	normal	O94267	whole cells	NULL
EXP062959	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: H2BK119R; GTRD_Rep_Group: 12	HEXP003912	1263	normal	O94267	whole cells	NULL
EXP062960	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 13	EXP062949	1263	normal	O94267	whole cells	NULL
EXP062961	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: pob3; GTRD_Rep_Group: 13	EXP062949	1263	normal	O94267	whole cells	NULL
EXP062962	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 14	EXP062950	1263	normal	O94267	whole cells	NULL
EXP062963	anti-Spt16  (Ladurner lab stock)	Schizosaccharomyces pombe	Treatment: none; Genotype: wildtype; GTRD_Rep_Group: 14	EXP062951	1263	normal	O94267	whole cells	NULL
EXP062964	NA	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	NULL	1263	chip_control	NULL	whole cells	NULL
EXP062965	NA	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	NULL	1263	chip_control	NULL	whole cells	NULL
EXP062966	anti-HA	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062964	1263	normal	Q9Y7X8	whole cells	NULL
EXP062967	anti-HA	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062965	1263	normal	Q9Y7X8	whole cells	NULL
EXP062968	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062964	1263	normal	P24488	whole cells	NULL
EXP062969	anti-GFP	Schizosaccharomyces pombe	Treatment: none; Genotype: Hap2-GFP Arp5-3HA	EXP062965	1263	normal	P24488	whole cells	NULL
EXP062970	Goat IgG whole molecule	Arabidopsis thaliana	Treatment: none; Conditions: Air 2 hrs; Genotype: expressing MYC2 YpET	NULL	1339	chip_control	NULL	seedling	NULL
EXP062971	Goat IgG whole molecule	Arabidopsis thaliana	Treatment: none; Conditions: Air 2 hrs; Genotype: expressing MYC2 YpET	NULL	1339	chip_control	NULL	seedling	NULL
EXP062972	Goat IgG whole molecule	Arabidopsis thaliana	Treatment: none; Conditions: Air 2 hrs; Genotype: expressing MYC2 YpET	NULL	1339	chip_control	NULL	seedling	NULL
EXP062973	Goat IgG whole molecule	Arabidopsis thaliana	Treatment: none; Conditions: Air 2 hrs; Genotype: expressing MYC2 YpET	NULL	1339	chip_control	NULL	seedling	NULL
EXP062974	anti-GFP (Polyclonal)	Arabidopsis thaliana	Treatment: JA 2hrs; Genotype: expressing MYC3 YpET	NULL	1339	normal	Q9FIP9	seedling	NULL
EXP062975	anti-GFP (Polyclonal)	Arabidopsis thaliana	Treatment: JA 2hrs; Genotype: expressing MYC2 YpET	NULL	1339	normal	Q39204	seedling	NULL
EXP062976	anti-GFP (Tag Antibody, A-11120, Thermo Fisher Scientific)	Arabidopsis thaliana	Treatment: none; Genotype: PHE1::PHE1-GFP	NULL	4589	chip_control	NULL	silique	NULL
EXP062977	anti-GFP (Tag Antibody, A-11120, Thermo Fisher Scientific)	Arabidopsis thaliana	Treatment: none; Genotype: PHE1::PHE1-GFP	NULL	4589	chip_control	NULL	silique	NULL
EXP062978	anti-GFP (Tag Antibody, A-11120, Thermo Fisher Scientific)	Arabidopsis thaliana	Treatment: none; Genotype: PHE1::PHE1-GFP	EXP062976	4589	normal	O80805	silique	NULL
EXP062979	anti-GFP (Tag Antibody, A-11120, Thermo Fisher Scientific)	Arabidopsis thaliana	Treatment: none; Genotype: PHE1::PHE1-GFP	EXP062977	4589	normal	O80805	silique	NULL
EXP062980	IgG control	Arabidopsis thaliana	Treatment: none; Conditions: no ferum (Fe)	NULL	1362	chip_control	NULL	roots	NULL
EXP062981	IgG control	Arabidopsis thaliana	Treatment: none; Conditions: ferum (Fe)	NULL	1362	chip_control	NULL	roots	NULL
EXP062982	anti-IRT1	Arabidopsis thaliana	Treatment: none; Conditions: no ferum (Fe)	EXP062980	1362	normal	Q38856	roots	NULL
EXP062983	anti-IRT1	Arabidopsis thaliana	Treatment: none; Conditions: ferum (Fe)	EXP062981	1362	normal	Q38856	roots	NULL
EXP062984	anti-FLAG	Arabidopsis thaliana	Treatment: none; Genotype: wildtype	NULL	1339	chip_control	NULL	seedling	NULL
EXP062985	anti-FLAG	Arabidopsis thaliana	Treatment: none; Genotype: PIE1-Flag + wild type	EXP062984	1339	normal	Q7X9V2	seedling	NULL
EXP062986	anti-FLAG	Arabidopsis thaliana	Treatment: none; Genotype: CHR11-Flag + wild type	EXP062984	1339	normal	Q8RWY3	seedling	NULL
EXP062987	antibody: RFP-trap (rta-100; ChromoTek)	Arabidopsis thaliana	Treatment: 2 hrs 25 microM dexamethasone; Ecotype: Columbia-0	NULL	4587	chip_control	NULL	whole seedlings 5 days after germination	NULL
EXP062988	antibody: RFP-trap (rta-100; ChromoTek)	Arabidopsis thaliana	Treatment: 2 hrs 25 microM dexamethasone; Ecotype: Columbia-0	NULL	4587	chip_control	NULL	whole seedlings 5 days after germination	NULL
EXP062989	anti-RFP-trap (rta-100; ChromoTek)	Arabidopsis thaliana	Treatment: 2 hrs 25 microM dexamethasone; Ecotype: Columbia-0; Genotype: pUBI10 mCherry-GR-linker-WUS	EXP062987	4587	normal	Q9SB92	whole seedlings 5 days after germination	NULL
EXP062990	antibody: RFP-trap (rta-100; ChromoTek)	Arabidopsis thaliana	Treatment: 2 hrs 25 microM dexamethasone; Ecotype: Columbia-0	EXP062988	4587	normal	Q9SB92	whole seedlings 5 days after germination	NULL
EXP062991	none	Saccharomyces cerevisiae	Treatment: none; Genotype: Wildtype Swr1-Myc-Tag	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP062992	none	Saccharomyces cerevisiae	Treatment: none; Genotype: del-Htz1 Swr1-Myc-Tag	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP062993	none	Saccharomyces cerevisiae	Treatment: none; Genotype: Wildtype Ino80-Myc-Tag	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP062994	none	Saccharomyces cerevisiae	Treatment: none; Genotype: del-Htz1 Ino80-Myc-Tag	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP062995	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: Wildtype Swr1-Myc-Tag	EXP062991	3099	normal	Q05471	BY4741 strain	NULL
EXP062996	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: del-Htz1 Swr1-Myc-Tag	EXP062992	3099	normal	Q05471	BY4741 strain	NULL
EXP062997	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: Wildtype Ino80-Myc-Tag	EXP062993	3099	normal	A6ZU34	BY4741 strain	NULL
EXP062998	anti-Myc	Saccharomyces cerevisiae	Treatment: none; Genotype: del-Htz1 Ino80-Myc-Tag	EXP062994	3099	normal	A6ZU34	BY4741 strain	NULL
EXP062999	none (ChIP Input)	Saccharomyces cerevisiae	Treatment: Diamide 0 min; Time point: 0 min; Genotype: HSF1 V5-tagged	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP063000	none (ChIP Input)	Saccharomyces cerevisiae	Treatment: Diamide 30 min; Time point: 30 min; Genotype: HSF1 V5-tagged	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP063001	none (ChIP Input)	Saccharomyces cerevisiae	Treatment: Diamide 60 min; Time point: 60 min; Genotype: HSF1 V5-tagged	NULL	3099	chip_control	NULL	BY4741 strain	NULL
EXP063002	anti-V5 (BioRad, cat# MCA1360G)	Saccharomyces cerevisiae	Treatment: Diamide 0 min; Time point: 0 min; Genotype: HSF1 V5-tagged	EXP062999	3099	normal	P10961	BY4741 strain	NULL
EXP063003	anti-V5 (BioRad, cat# MCA1360G)	Saccharomyces cerevisiae	Treatment: Diamide 30 min; Time point: 30 min; Genotype: HSF1 V5-tagged	EXP063000	3099	normal	P10961	BY4741 strain	NULL
EXP063004	anti-V5 (BioRad, cat# MCA1360G)	Saccharomyces cerevisiae	Treatment: Diamide 60 min; Time point: 60 min; Genotype: HSF1 V5-tagged	EXP063001	3099	normal	P10961	BY4741 strain	NULL
EXP063005	anti-FLAG (monoclonal antibody M2, Sigma)	Saccharomyces cerevisiae	Treatment: none; Genotype: none; Time point: 4 hrs	NULL	4591	chip_control	NULL	meiotic cells of strain VBD1421	NULL
EXP063006	anti-FLAG (monoclonal antibody M2, Sigma)	Saccharomyces cerevisiae	Treatment: none; Genotype: His6-Flag3; Time point: 4 hrs	NULL	4591	normal	P51979	meiotic cells of strain VBD1421	NULL
EXP063007	anti-FLAG (monoclonal antibody M2, Sigma)	Saccharomyces cerevisiae	Treatment: none; Genotype: His6-Flag3; Time point: 4 hrs	NULL	4591	normal	P51979	meiotic cells of strain VBD1421	NULL
EXP063008	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs; Source: pCUP1-IME1-synchronized meiosis	NULL	4592	normal	Q12083	meiotic cells of strain VBD1837	NULL
EXP063009	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4592	normal	Q12083	meiotic cells of strain VBD1837	NULL
EXP063010	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs; Source: pCUP1-IME1-synchronized meiosis	NULL	4593	normal	Q12083	meiotic cells of strain VBD1841	NULL
EXP063011	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4593	normal	Q12083	meiotic cells of strain VBD1841	NULL
EXP063012	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4594	normal	Q12083	meiotic cells of strain VBD2026	NULL
EXP063013	anti-c-Myc (monoclonal antibody, 9E10, Santa Cruz)	Saccharomyces cerevisiae	Treatment: none; Genotype: Myc8; Time point: 5 hrs 30 mins; Source: pCUP1-IME1-synchronized meiosis	NULL	4593	normal	Q12083	meiotic cells of strain VBD1841	NULL
EXP063014	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Full length Set1	HEXP004023	4595	normal	P38827	exponential growing culture of strain BY4741	NULL
EXP063015	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Set1 N-term (1-200) deletion	HEXP004024	4595	normal	P38827	exponential growing culture of strain BY4741	NULL
EXP063016	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Nrd1CID fusion to Set1 N-terminal deletion	HEXP004025	4595	normal	P53617	exponential growing culture of strain BY4741	NULL
EXP063017	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Full length Set1	HEXP004026	4595	normal	P38827	exponential growing culture of strain BY4741	NULL
EXP063018	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Set1 N-term (1-200) deletion	HEXP004027	4595	normal	P38827	exponential growing culture of strain BY4741	NULL
EXP063019	anti-Flag	Saccharomyces cerevisiae	Treatment: none; Genotype: Nrd1CID fusion to Set1 N-terminal deletion	HEXP004028	4595	normal	P53617	exponential growing culture of strain BY4741	NULL
EXP063020	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-3FLAG::KANMX; Developmental stage: ealy S phase time point (45min at 18C)	NULL	4598	chip_control	NULL	strain YMS439-1	NULL
EXP063021	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-3FLAG::KANMX rrm3D::HPHMX4; Developmental stage: ealy S phase time point (45min at 18C)	NULL	4599	chip_control	NULL	strain YMS1295_1-6	NULL
EXP063022	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4; Developmental stage: Asyncrhonous cell culture	NULL	4600	normal	P30665	strain YSM266-4	NULL
EXP063023	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4601	normal	P30665	strain YMS1289-7	NULL
EXP063024	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4 rrm3D::HPHMX4; Developmental stage: Asyncrhonous cell culture	NULL	4602	normal	P30665	strain YMS1294_5-1	NULL
EXP063025	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D Mcm4-13MYC::HIS3MX4 rrm3D::HPHMX4 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4603	normal	P30665	strain YMS1299-13	NULL
EXP063026	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6; Developmental stage: Asyncrhonous cell culture	NULL	4604	normal	Q08032	strain YMS461-2	NULL
EXP063027	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4605	normal	Q08032	strain YMS1288-3	NULL
EXP063028	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6 rrm3D::HPHMX4; Developmental stage: Asyncrhonous cell culture	NULL	4606	normal	Q08032	strain YMS1293_4-1	NULL
EXP063029	Anti-MYC	Saccharomyces cerevisiae	Treatment: none; Genotype: W303 MATa RAD5+ bar1D CDC45-13MYC::HIS3MX6 rrm3D::HPHMX4 tof1D::LEU2; Developmental stage: Asyncrhonous cell culture	NULL	4607	normal	Q08032	strain YMS1298-7	NULL
EXP063030	Anti-MYC	Saccharomyces cerevisiae	Treatment: alpha-Factor for 2.5 hrs and then release with pronase; Genotype: w303 MATa RAD5+ bar1D Mcm4-3FLAG::KANMX TOP1-13MYC::HIS3MX4; Developmental stage: ealy S phase time point (45min at 18C)	NULL	4596	normal	P04786	strain YMS1539-5	NULL
EXP063031	Anti-MYC	Saccharomyces cerevisiae	Treatment: alpha-Factor for 2.5 hrs and then release with pronase; Genotype: W303 MATa RAD5+ bar1D Mcm4-3FLAG::KANMX TOP1-13MYC::HIS3MX4 tof1D::LEU2; Developmental stage: ealy S phase time point (45min at 18C)	NULL	4597	normal	P04786	strain YMS1540-9	NULL
EXP063032	none	Saccharomyces cerevisiae	Treatment: none; Time point: 16 hrs culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063033	none	Saccharomyces cerevisiae	Treatment: none; Time point: 16 hrs culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063034	none	Saccharomyces cerevisiae	Treatment: none; Time point: 14 days culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063035	none	Saccharomyces cerevisiae	Treatment: none; Time point: 14 days culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063036	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 16 hrs culture	EXP063032	4608	normal	P11938	strain JDY86	NULL
EXP063037	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 16 hrs culture	EXP063033	4608	normal	P11938	strain JDY86	NULL
EXP063038	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 14 days culture	EXP063034	4608	normal	P11938	strain JDY86	NULL
EXP063039	anti-Rap1 (Abcam, ab103520)	Saccharomyces cerevisiae	Treatment: none; Time point: 14 days culture	EXP063035	4608	normal	P11938	strain JDY86	NULL
EXP063040	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	NULL	4609	chip_control	NULL	strain JDY86 H3E50A	NULL
EXP063041	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4610	chip_control	NULL	strain JDY86 H4H18A	NULL
EXP063042	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	NULL	4610	chip_control	NULL	strain JDY86 H4H18A	NULL
EXP063043	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4611	chip_control	NULL	strain JDY86 H4K16Q	NULL
EXP063044	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	NULL	4611	chip_control	NULL	strain JDY86 H4K16Q	NULL
EXP063045	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063046	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063047	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4609	chip_control	NULL	strain JDY86 H3E50A	NULL
EXP063048	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	NULL	4609	chip_control	NULL	strain JDY86 H3E50A	NULL
EXP063049	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4610	chip_control	NULL	strain JDY86 H4H18A	NULL
EXP063050	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	NULL	4610	chip_control	NULL	strain JDY86 H4H18A	NULL
EXP063051	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4611	chip_control	NULL	strain JDY86 H4K16Q	NULL
EXP063052	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	NULL	4608	chip_control	NULL	strain JDY86	NULL
EXP063053	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063040	4609	normal	P06701	strain JDY86 H3E50A	NULL
EXP063054	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063041	4610	normal	P06701	strain JDY86 H4H18A	NULL
EXP063055	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063042	4610	normal	P06701	strain JDY86 H4H18A	NULL
EXP063056	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063043	4611	normal	P06701	strain JDY86 H4K16Q	NULL
EXP063057	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063044	4611	normal	P06701	strain JDY86 H4K16Q	NULL
EXP063058	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063045	4608	normal	P06701	strain JDY86	NULL
EXP063059	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063046	4608	normal	P06701	strain JDY86	NULL
EXP063060	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063047	4609	normal	P06701	strain JDY86 H3E50A	NULL
EXP063061	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063048	4609	normal	P06701	strain JDY86 H3E50A	NULL
EXP063062	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063049	4610	normal	P06701	strain JDY86 H4H18A	NULL
EXP063063	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 6 days culture	EXP063050	4610	normal	P06701	strain JDY86 H4H18A	NULL
EXP063064	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063051	4611	normal	P06701	strain JDY86 H4K16Q	NULL
EXP063065	anti-Sir3	Saccharomyces cerevisiae	Treatment: none; Time point: 1 day culture	EXP063052	4608	normal	P06701	strain JDY86	NULL
EXP063066	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta; Conditions: no stimulated; GTRD_Rep_Group: 18	NULL	3099	normal	P13393	BY4741 strain	NULL
EXP063067	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta; Conditions: stimulated; GTRD_Rep_Group: 19	NULL	3099	normal	P13393	BY4741 strain	NULL
EXP063068	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta ino80delta::kanMX4; Conditions: no stimulated; GTRD_Rep_Group: 20	NULL	4612	normal	P13393	strain YR092	NULL
EXP063069	anti-TBP (antibody is a generous gift from Joe Reese)	Saccharomyces cerevisiae	Treatment: Formaldehyde-fixed and sonicated; Genotype: MATa his3delta1 leu2delta met15delta ura3delta ino80delta::kanMX4; Conditions: stimulated; GTRD_Rep_Group: 21	NULL	4612	normal	P13393	strain YR092	NULL
EXP063070	Mouse mAb IgG1 Isotype Control (Cell Signaling Technology, G3A1)	Caenorhabditis elegans	Treatment: none; Sex: hermaphrodite worms; Genotype: LONP1-FLAG	NULL	3129	chip_control	NULL	N2 strain(Developmental stage: L4 larvae)	NULL
EXP063071	anti-FLAG M2 antibody (Sigma, F1804, Monoclonal)	Caenorhabditis elegans	Treatment: none; Sex: hermaphrodite worms; Genotype: LONP1-FLAG	EXP063070	3129	normal	O44952	N2 strain(Developmental stage: L4 larvae)	NULL
EXP063072	none	Drosophila melanogaster	Treatment: untreated	NULL	4622	chip_control	NULL	DL1 cells	NULL
EXP063073	anti-IntS1	Drosophila melanogaster	Treatment: untreated	EXP063072	4622	normal	Q9W1C5	DL1 cells	NULL
EXP063074	anti-IntS12	Drosophila melanogaster	Treatment: untreated	EXP063072	4622	normal	Q9VBB3	DL1 cells	NULL
EXP063075		Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 2-4 hrs old embryo; Developmental stage: 2-4 hrs old embryo	NULL	4623	chip_control	NULL	Oregon R (Developmental stage: 2-4 hrs embryos)	NULL
EXP063076		Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 14-16 hrs old embryo; Developmental stage: 14-16 hrs old embryo	NULL	4624	chip_control	NULL	Oregon R (Developmental stage: 14 - 16 hrs)	NULL
EXP063077		Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 0-6 hrs old embryo; Genotype: wildtype; Developmental stage: 0-6 hrs old embryo; Genotype: wildtype	NULL	4625	chip_control	NULL	Oregon R (Developmental stage: 0 - 6 hrs embryos)	NULL
EXP063078		Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 0-6 hrs old embryo; Genotype: esc mutant; Developmental stage: 0-6 hrs old embryo; Genotype: esc mutant	NULL	4626	chip_control	NULL	0-6 hr old zyg- embryos	NULL
EXP063079	anti-Pho (Papp and MÃ¼ller 2006)	Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 2-4 hrs old embryo; Developmental stage: 2-4 hrs old embryo	EXP063075	4623	normal	Q8ST83	Oregon R (Developmental stage: 2-4 hrs embryos)	NULL
EXP063080	anti-Pho (Papp and MÃ¼ller 2006)	Drosophila melanogaster	Treatment: Treatment: none; Developmental stage: 14-16 hrs old embryo; Developmental stage: 14-16 hrs old embryo	EXP063076	4624	normal	Q8ST83	Oregon R (Developmental stage: 14 - 16 hrs)	NULL
EXP063081	none	Drosophila melanogaster	Treatment: shRNA wildtype; Genotype: wildtype	NULL	4627	chip_control	NULL	adult ovaries	NULL
EXP063082	none	Drosophila melanogaster	Treatment: shRNA against SUMO ligase (Su(var)2-10); Genotype: shSu(var)2-10	NULL	4627	chip_control	NULL	adult ovaries	NULL
EXP063083	none	Drosophila melanogaster	Treatment: shRNA wildtype; Genotype: wildtype	NULL	4627	chip_control	NULL	adult ovaries	NULL
EXP063084	none	Drosophila melanogaster	Treatment: shRNA against SUMO ligase (Su(var)2-10); Genotype: shSu(var)2-10	NULL	4627	chip_control	NULL	adult ovaries	NULL
EXP063085	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA wildtype; Genotype: wildtype	EXP063081	4627	normal	P05205	adult ovaries	NULL
EXP063086	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA against SUMO ligase (Su(var)2-10); Genotype: shSu(var)2-10	NULL	4627	normal	P05205	adult ovaries	NULL
EXP063087	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA wildtype; Genotype: wildtype	EXP063083	4627	normal	P05205	adult ovaries	NULL
EXP063088	anti-Su(var)2-10(C1A9, DSHB)	Drosophila melanogaster	Treatment: shRNA against SUMO ligase (Su(var)2-10); Genotype: shSu(var)2-10	EXP063084	4627	normal	P05205	adult ovaries	NULL
EXP063089		Drosophila melanogaster	Treatment: siRNA against egfp; Genotype: egfp knockout; Time point: 4 days	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP063090		Drosophila melanogaster	Treatment: siRNA against egg; Genotype: egg knockout; Time point: 4 days	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP063091		Drosophila melanogaster	Treatment: siRNA against egfp; Genotype: egfp knockout; Time point: 4 days	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP063092		Drosophila melanogaster	Treatment: siRNA against egg; Genotype: egg knockout; Time point: 4 days	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP063093		Drosophila melanogaster	Treatment: siRNA against piwi; Genotype: piwi knockout; Time point: 4 days	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP063094		Drosophila melanogaster	Treatment: siRNA against wde; Genotype: wde knockout; Time point: 4 days	NULL	1984	chip_control	NULL	OSC (Ovarian Somatic Cells)	NULL
EXP063095	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egfp; Genotype: egfp knockout; Time point: 4 days	EXP063089	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	NULL
EXP063096	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egg; Genotype: egg knockout; Time point: 4 days	EXP063090	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	NULL
EXP063097	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egfp; Genotype: egfp knockout; Time point: 4 days	EXP063091	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	NULL
EXP063098	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against egg; Genotype: egg knockout; Time point: 4 days	EXP063092	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	NULL
EXP063099	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against piwi; Genotype: piwi knockout; Time point: 4 days	EXP063093	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	NULL
EXP063100	anti-Egg antibody	Drosophila melanogaster	Treatment: siRNA against wde; Genotype: wde knockout; Time point: 4 days	EXP063094	1984	normal	Q32KD2	OSC (Ovarian Somatic Cells)	NULL
EXP063101		Drosophila melanogaster	Treatment: treated for 2 days with DMSO; Time point: 2 days; Genotype: mut-Beaf32	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP063102	IgG control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063103	IgG control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063104	IgG control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063105	IgG control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063106	IgG control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: wildtype	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063107	Input control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063108	Input control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063109	Input control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063110	Input control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063111	Input control in ChIP	Drosophila melanogaster	Treatment: none; Genotype: wildtype	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063112	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q9VR17	2-4 h embryo	NULL
EXP063113	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q9VQD6	2-4 h embryo	NULL
EXP063114	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q9VR19	2-4 h embryo	NULL
EXP063115	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba1 mutant	EXP063107	1435	normal	Q8SYK5	2-4 h embryo	NULL
EXP063116	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q9VR17	2-4 h embryo	NULL
EXP063117	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q9VQD6	2-4 h embryo	NULL
EXP063118	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q9VR19	2-4 h embryo	NULL
EXP063119	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba2 mutant	EXP063108	1435	normal	Q8SYK5	2-4 h embryo	NULL
EXP063120	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q9VR17	2-4 h embryo	NULL
EXP063121	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q9VQD6	2-4 h embryo	NULL
EXP063122	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q9VR19	2-4 h embryo	NULL
EXP063123	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: elba3 mutant	EXP063109	1435	normal	Q8SYK5	2-4 h embryo	NULL
EXP063124	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	EXP063110	1435	normal	Q9VR17	2-4 h embryo	NULL
EXP063125	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	normal	Q9VQD6	2-4 h embryo	NULL
EXP063126	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	normal	Q9VR19	2-4 h embryo	NULL
EXP063127	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: insv mutant	NULL	1435	normal	Q8SYK5	2-4 h embryo	NULL
EXP063128	anti-Elba1 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q9VR17	2-4 h embryo	NULL
EXP063129	anti-Elba2 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q9VQD6	2-4 h embryo	NULL
EXP063130	anti-Elba3 (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q9VR19	2-4 h embryo	NULL
EXP063131	anti-Insv (antibody in ChIP)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063111	1435	normal	Q8SYK5	2-4 h embryo	NULL
EXP063132	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4629	chip_control	NULL	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063133	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4629	chip_control	NULL	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063134	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4629	chip_control	NULL	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063135	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4629	chip_control	NULL	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063136	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063137	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063138	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063139	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063140	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063141	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063142	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063143	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4630	chip_control	NULL	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063144	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063145	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063146	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063147	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063148	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063149	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063150	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063151	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4631	chip_control	NULL	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063152	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063153	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063154	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063155	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063156	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063157	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063158	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063159	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	4632	chip_control	NULL	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063160	none (input)	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063161	IgG	Drosophila melanogaster	Treatment: none; Sex: Female	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063162	none (input)	Drosophila melanogaster	Treatment: none; Sex: male	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063163	IgG	Drosophila melanogaster	Treatment: none; Sex: male	NULL	1435	chip_control	NULL	2-4 h embryo	NULL
EXP063164	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063132	4629	normal	Q961A1	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063165	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063134	4629	normal	Q961A1	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063166	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063134	4629	normal	P50536	embryo (Developmental stage: nuclear cycle 11)	NULL
EXP063167	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063136	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063168	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063137	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063169	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063140	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063170	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063141	4630	normal	Q961A1	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063171	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063140	4630	normal	P50536	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063172	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063141	4630	normal	P50536	embryo (Developmental stage: nuclear cycle 12)	NULL
EXP063173	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063144	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063174	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063145	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063175	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063148	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063176	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063149	4631	normal	Q961A1	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063177	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063148	4631	normal	P50536	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063178	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063149	4631	normal	P50536	embryo (Developmental stage: nuclear cycle 13)	NULL
EXP063179	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063152	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063180	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063153	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063181	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063156	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063182	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063157	4632	normal	Q961A1	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063183	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063156	4632	normal	P50536	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063184	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063157	4632	normal	P50536	embryo (Developmental stage: nuclear cycle 14)	NULL
EXP063185	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: Female	EXP063160	1435	normal	Q961A1	2-4 h embryo	NULL
EXP063186	anti-CLAMP	Drosophila melanogaster	Treatment: none; Sex: male	EXP063162	1435	normal	Q961A1	2-4 h embryo	NULL
EXP063187	anti-MSL3	Drosophila melanogaster	Treatment: none; Sex: male	EXP063162	1435	normal	P50536	2-4 h embryo	NULL
EXP063188	IgG (rabbit)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP063189	IgG (rabbit)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	NULL	1451	chip_control	NULL	S2 (Schneider 2)	NULL
EXP063190	anti-Elys (Pascual-Garcia et al., 2017)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063188	1451	normal	Q9VWE6	S2 (Schneider 2)	NULL
EXP063191	anti-Nup107 (this study)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063188	1451	normal	Q9V466	S2 (Schneider 2)	NULL
EXP063192	anti-Nup93 (Pascual-Garcia et al., 2017)	Drosophila melanogaster	Treatment: none; Genotype: wildtype	EXP063188	1451	normal	Q9XZ06	S2 (Schneider 2)	NULL
EXP063193	rat IgG	Drosophila melanogaster	Treatment: Treatment: none; Strain: Oregon-R; Developmental stage: 0-12 hrs  after egg-laying; Strain: Oregon-R; Developmental stage: 0-12 hrs  after egg-laying	NULL	4636	chip_control	NULL	OregonR (Developmental stage: 0-12h after egg-laying embryos)	NULL
EXP063194	anti-dCTCF (aa 612-818, rat )	Drosophila melanogaster	Treatment: Treatment: none; Strain: Oregon-R; Developmental stage: 0-12 hrs  after egg-laying; Strain: Oregon-R; Developmental stage: 0-12 hrs  after egg-laying	EXP063193	4636	normal	Q9VS55	OregonR (Developmental stage: 0-12h after egg-laying embryos)	NULL
EXP063195		Drosophila melanogaster	Treatment: GST RNAi (control); Genotype: wildtype	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063196		Drosophila melanogaster	Treatment: dCenpC RNAi; Genotype: dCenpC knockout	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063197		Drosophila melanogaster	Treatment: control induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063198		Drosophila melanogaster	Treatment: HMR+LHR induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro (HMR+LHR over-expression)	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063199		Drosophila melanogaster	Treatment: GST RNAi; Genotype: wildtype	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063200		Drosophila melanogaster	Treatment: dCenpC RNAi; Genotype: dCenpC knockout	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063201		Drosophila melanogaster	Treatment: control induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063202		Drosophila melanogaster	Treatment: HMR+LHR induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro (HMR+LHR over-expression)	NULL	4637	chip_control	NULL	L2-4	NULL
EXP063203	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: GST RNAi; Genotype: wildtype	EXP063195	4637	normal	Q86CW5	L2-4	NULL
EXP063204	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: dCenpC RNAi; Genotype: dCenpC knockout	EXP063196	4637	normal	Q86CW5	L2-4	NULL
EXP063205	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: control induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro	EXP063197	4637	normal	Q7YU87	L2-4	NULL
EXP063206	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: HMR+LHR induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro (HMR+LHR over-expression)	EXP063198	4637	normal	Q7YU87	L2-4	NULL
EXP063207	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: GST RNAi; Genotype: wildtype	EXP063199	4637	normal	Q86CW5	L2-4	NULL
EXP063208	anti-HMR (Thomae et al, 2013)	Drosophila melanogaster	Treatment: dCenpC RNAi; Genotype: dCenpC knockout	EXP063200	4637	normal	Q86CW5	L2-4	NULL
EXP063209	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: control induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro	EXP063201	4637	normal	Q7YU87	L2-4	NULL
EXP063210	anti-CAPH2 (Hartl et al, 2008)	Drosophila melanogaster	Treatment: HMR+LHR induced; Genotype: Flag-HA-HMR/pMT Hygro+Myc-LHR/pMT Hygro (HMR+LHR over-expression)	EXP063202	4637	normal	Q7YU87	L2-4	NULL
EXP063211	none	Drosophila melanogaster	Treatment: none; Genotype: knock in IMAGO line ato:GFP	NULL	1983	chip_control	NULL	eye imaginal disc (developmental stage: L3)	NULL
EXP063212	none	Drosophila melanogaster	Treatment: none; Genotype: knock in IMAGO line ato:GFP	NULL	1983	chip_control	NULL	eye imaginal disc (developmental stage: L3)	NULL
EXP063213	anti-GFP	Drosophila melanogaster	Treatment: none; Genotype: knock in IMAGO line ato:GFP	EXP063211	1983	normal	P48987	eye imaginal disc (developmental stage: L3)	NULL
EXP063214	anti-GFP	Drosophila melanogaster	Treatment: none; Genotype: knock in IMAGO line ato:GFP	EXP063212	1983	normal	P48987	eye imaginal disc (developmental stage: L3)	NULL
EXP063215	none	Homo sapiens	Treatment: none (untreated); Genotype: ATRX wildtype	NULL	4638	chip_control	NULL	SK-N-FI (Neuroblastoma)	NULL
EXP063216	none	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	NULL	4639	chip_control	NULL	SKNMM (metastatic neuroblastoma)	NULL
EXP063217	none	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	NULL	4640	chip_control	NULL	CHLA-90 (neuroblastoma)	NULL
EXP063218	anti-ATRX (Abcam, ab97508)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX wildtype	EXP063215	4638	normal	P46100	SK-N-FI (Neuroblastoma)	NULL
EXP063219	anti-ATRX (Abcam, ab97508)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063216	4639	normal	P46100	SKNMM (metastatic neuroblastoma)	NULL
EXP063220	anti-REST (Millipore, 07-579)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063216	4639	normal	Q13127	SKNMM (metastatic neuroblastoma)	NULL
EXP063221	anti-ATRX (Abcam, ab97508)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063217	4640	normal	P46100	CHLA-90 (neuroblastoma)	NULL
EXP063222	anti-REST (Millipore, 07-579)	Homo sapiens	Treatment: none (untreated); Genotype: ATRX in-frame	EXP063217	4640	normal	Q13127	CHLA-90 (neuroblastoma)	NULL
EXP063223	none	Homo sapiens	Treatment: none	NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063224	none	Homo sapiens	Treatment: none	NULL	504	chip_control	NULL	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063225	none	Homo sapiens	Treatment: none	NULL	4643	chip_control	NULL	HEC-1-A (Endometrial adenocarcinoma)	NULL
EXP063226	none	Homo sapiens	Treatment: none	NULL	4643	chip_control	NULL	HEC-1-A (Endometrial adenocarcinoma)	NULL
EXP063227	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063228	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063229	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063230	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063231	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063232	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063223	504	normal	P55317	Ishikawa (endometrial adenocarcinoma)	NULL
EXP063233	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063225	4643	normal	P55317	HEC-1-A (Endometrial adenocarcinoma)	NULL
EXP063234	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063225	4643	normal	P55317	HEC-1-A (Endometrial adenocarcinoma)	NULL
EXP063235	anti-FoxA1 (rabbit ab23738, lot GR292351-2)	Homo sapiens	Treatment: none	EXP063225	4643	normal	P55317	HEC-1-A (Endometrial adenocarcinoma)	NULL
EXP063236		Homo sapiens	Treatment: 0.5ug/mL of Shh ligand for 48 hours; Time point: 48 hours; Source: primary cells	NULL	4644	chip_control	NULL	chondrosarcoma	NULL
EXP063237	anti-Gli1 (R&D catalog number AF3324)	Homo sapiens	Treatment: 0.5ug/mL of Shh ligand for 48 hours; Time point: 48 hours; Source: primary cells	EXP063236	4644	normal	P08151	chondrosarcoma	NULL
EXP063238	anti-Gli2 (R&D catalog number AF3526)	Homo sapiens	Treatment: 0.5ug/mL of Shh ligand for 48 hours; Time point: 48 hours; Source: primary cells	EXP063236	4644	normal	P10070	chondrosarcoma	NULL
EXP063239	anti-CTCF (Millipore 07-729, rabbit)	Homo sapiens	Treatment: none; Developmental stage: Mixed (asynchronous); Genotype: wildtype	NULL	4645	normal	P49711	MDA-MB-435 (amelanotic melanoma)	NULL
EXP063240	anti-pT431 CTCF (custom, rabbit )	Homo sapiens	Treatment: none; Developmental stage: Mitosis (nocodazole-arrested); Genotype: pT431 CTCF	NULL	4645	normal	P49711	MDA-MB-435 (amelanotic melanoma)	NULL
EXP063241	none (input)	Homo sapiens	Treatment: none; Genotype: retrovirally transduced ONECUT2	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP063242	none (input)	Homo sapiens	Treatment: none; Genotype: ONECUT2 {delta}DBD) mutant	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP063243	input	Homo sapiens	Treatment: none; Genotype: retrovirally transduced ONECUT2	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP063244	anti-HA (Abcam,ab9110)	Homo sapiens	Treatment: none; Genotype: retrovirally transduced ONECUT2	EXP063241	38	normal	O95948	A549 (lung carcinoma)	NULL
EXP063245	anti-HA (Abcam,ab9110)	Homo sapiens	Treatment: none; Genotype: retrovirally transduced ONECUT2	EXP063243	38	normal	O95948	A549 (lung carcinoma)	NULL
EXP063246		Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Time point: day 0	NULL	4646	chip_control	NULL	mobilised peripheral blood CD34+ erythrocyte precursors cells	NULL
EXP063247		Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Time point: day 0	NULL	4646	chip_control	NULL	mobilised peripheral blood CD34+ erythrocyte precursors cells	NULL
EXP063248		Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: empty control	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063249		Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: overexpressinng PU1	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063250		Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: empty control	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063251		Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: overexpressinng PU1	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063252	anti-PU1 (Santa Cruz, sc352X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Time point: day 0	EXP063246	4646	normal	P17947	mobilised peripheral blood CD34+ erythrocyte precursors cells	NULL
EXP063253	anti-KLF1 (Abcam, ab2483)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Time point: day 5	EXP063247	4646	normal	Q13351	mobilised peripheral blood CD34+ erythrocyte precursors cells	NULL
EXP063254	anti-PU1 (Santa Cruz, sc352X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: empty control	EXP063248	514	normal	P17947	K562 (myelogenous leukemia)	NULL
EXP063255	anti-PU1 (Santa Cruz, sc352X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: overexpressinng PU1	EXP063249	514	normal	P17947	K562 (myelogenous leukemia)	NULL
EXP063256	anti-SMAD1 (Santa Cruz, sc7965X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: empty control	EXP063250	514	normal	Q15797	K562 (myelogenous leukemia)	NULL
EXP063257	anti-SMAD1 (Santa Cruz, sc7965X)	Homo sapiens	Treatment: hrBMP4 25ng/ml 7hrs 25ng/ml hrBMP4 for 2hrs prior to collection; Genotype: overexpressinng PU1	EXP063251	514	normal	Q15797	K562 (myelogenous leukemia)	NULL
EXP063258	none	Homo sapiens	Treatment: none	NULL	1564	chip_control	NULL	pulmonary artery endothelial cell	NULL
EXP063259	anti-FLAG M2 (Sigma-Aldrich, Merck, catalog# F3165)	Homo sapiens	Treatment: lentiviral infection LV-FLAG-ATOH8; Genotype: stably expressing FLAG-ATOH8	EXP063258	1564	normal	Q96SQ7	pulmonary artery endothelial cell	NULL
EXP063260	none	Homo sapiens	Treatment: Ethanol (0.01% final); Genotype: pcDNA6/TR and pcDNA4/TO, Invitrogen	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063261	none	Homo sapiens	Treatment: 10-8M Estradiol (Sigma); Genotype: pcDNA6/TR and pcDNA4/TO, Invitrogen	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063262	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: Ethanol (0.01% final); Genotype: pcDNA6/TR and pcDNA4/TO, Invitrogen	EXP063260	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063263	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10-8M Estradiol (Sigma); Genotype: pcDNA6/TR and pcDNA4/TO, Invitrogen	EXP063261	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063264	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: Ethanol (0.01% final); Genotype: ectopically expressing a dominant form of the MKL1 protein (cDNA6/TR and pcDNA4/TO -MKL1 deltaN200, Invitrogen)	EXP063260	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063265	anti-ESR1 (HC-20, sc-543, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10-8M Estradiol (Sigma); Genotype: ectopically expressing a dominant form of the MKL1 protein (cDNA6/TR and pcDNA4/TO -MKL1 deltaN200, Invitrogen)	EXP063261	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063266	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: GG allels (non-carrier (G) allele); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	NULL
EXP063267	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: CC allels,  ((C) allele of rs10846744 SNP associated with cardiovascular disease (CVD)); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	NULL
EXP063268	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: GG allels (non-carrier (G) allele); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	NULL
EXP063269	anti-NR2F2 (Active Motif #61213)	Homo sapiens	Treatment: none; Genotype: CC allels,  ((C) allele of rs10846744 SNP associated with cardiovascular disease (CVD)); Tissue: peripheral blood mononuclear cells; Sex: female	NULL	4653	normal	P24468	EBV (Epstein Barr Virus)-transformed B lymphocyte cells	NULL
EXP063270	none	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	4232	chip_control	NULL	MCF10DCIS cells	NULL
EXP063271	Anti-WDR5 (Antibody from Diego Pasini Lab)	Homo sapiens	Treatment: Cells were infected with pRSI-U6-shLuc-UbiC-TagRFP-2A-Puro vector and selectioned with 3Âµg/ml of Puromycin; Genotype: wildtype	NULL	4232	normal	P61964	MCF10DCIS cells	NULL
EXP063272	Anti-WDR5 (Antibody from Diego Pasini Lab)	Homo sapiens	Treatment: Cells were infected with pRSI-U6-shWDR5-UbiC-TagRFP-2A-Puro vector and selectioned with 3Âµg/ml of Puromycin; Genotype: WDR5 silenced	NULL	4232	normal	P61964	MCF10DCIS cells	NULL
EXP063273	None	Homo sapiens	Treatment: Ethanol as vehicle control	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063274	anti-TRIM24 (Novus Biologicals)	Homo sapiens	Treatment: Estrogen (10 nM) for 3 hours	EXP063273	113	normal	O15164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063275	anti-TRIM24 (Novus Biologicals)	Homo sapiens	Treatment: Ethanol as vehicle control	EXP063273	113	normal	O15164	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063276	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	NULL	4654	chip_control	NULL	SNU-16 (Gastric adenocarcinoma)	NULL
EXP063277		Homo sapiens	Treatment: Treatment: none	NULL	4655	chip_control	NULL	OCUM-1 (Signet ring cell gastric adenocarcinoma)	NULL
EXP063278		Homo sapiens	Treatment: Treatment: none	NULL	4656	chip_control	NULL	IM95 (Gastric adenocarcinoma)	NULL
EXP063279		Homo sapiens	Treatment: Treatment: none	NULL	4657	chip_control	NULL	ISt-1 (Gastric carcinoma)	NULL
EXP063280		Homo sapiens	Treatment: Treatment: none	NULL	518	chip_control	NULL	KATOIII (signet ring cell gastric adenocarcinoma)	NULL
EXP063281		Homo sapiens	Treatment: Treatment: none	NULL	4658	chip_control	NULL	NUGC4 (Signet ring cell gastric adenocarcinoma)	NULL
EXP063282		Homo sapiens	Treatment: Treatment: none	NULL	870	chip_control	NULL	YCC3 (gastric adenocarcinoma)	NULL
EXP063283		Homo sapiens	Treatment: Treatment: none; Genotype: HNF4a overexpressing; Genotype: HNF4a overexpressing	NULL	4659	chip_control	NULL	HFE-145 (Normal gastric epithelial cells)	NULL
EXP063284	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063276	4654	normal	P41235	SNU-16 (Gastric adenocarcinoma)	NULL
EXP063285	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063277	4655	normal	P41235	OCUM-1 (Signet ring cell gastric adenocarcinoma)	NULL
EXP063286	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063278	4656	normal	P41235	IM95 (Gastric adenocarcinoma)	NULL
EXP063287	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063279	4657	normal	P41235	ISt-1 (Gastric carcinoma)	NULL
EXP063288	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063280	518	normal	P41235	KATOIII (signet ring cell gastric adenocarcinoma)	NULL
EXP063289	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063281	4658	normal	P41235	NUGC4 (Signet ring cell gastric adenocarcinoma)	NULL
EXP063290	anti-HNF4a	Homo sapiens	Treatment: Treatment: none	EXP063282	870	normal	P41235	YCC3 (gastric adenocarcinoma)	NULL
EXP063291	anti-HNF4a	Homo sapiens	Treatment: Treatment: none; Genotype: HNF4a overexpressing; Genotype: HNF4a overexpressing	EXP063283	4659	normal	P41235	HFE-145 (Normal gastric epithelial cells)	NULL
EXP063292	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063293	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: HOTTIP knockout	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063294	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: CBS79 knockout	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063295	Anti-MLL (Millipore, #05-765)	Homo sapiens	Treatment: none; Genotype: CBS79 knockout - VP-HOTTIP	NULL	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063296		Homo sapiens	Treatment: Treatment: none; Time point: 0 hrs; Time point: 0 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063297		Homo sapiens	Treatment: Treatment: none; Time point: 3 hrs; Time point: 3 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063298		Homo sapiens	Treatment: Treatment: none; Time point: 6 hrs; Time point: 6 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063299		Homo sapiens	Treatment: Treatment: none; Time point: 12 hrs; Time point: 12 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063300		Homo sapiens	Treatment: Treatment: none; Time point: 24 hrs; Time point: 24 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063301		Homo sapiens	Treatment: Treatment: none; Time point: 48 hrs; Time point: 48 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063302		Homo sapiens	Treatment: Treatment: none; Time point: 72 hrs; Time point: 72 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063303		Homo sapiens	Treatment: Treatment: none; Time point: 0 hrs; Time point: 0 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063304		Homo sapiens	Treatment: Treatment: none; Time point: 3 hrs; Time point: 3 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063305		Homo sapiens	Treatment: Treatment: none; Time point: 6 hrs; Time point: 6 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063306		Homo sapiens	Treatment: Treatment: none; Time point: 12 hrs; Time point: 12 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063307		Homo sapiens	Treatment: Treatment: none; Time point: 24 hrs; Time point: 24 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063308		Homo sapiens	Treatment: Treatment: none; Time point: 48 hrs; Time point: 48 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063309		Homo sapiens	Treatment: Treatment: none; Time point: 72 hrs; Time point: 72 hrs	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063310	anti-cFOS (Cell Signaling #2250)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	P01100	activated primary CD4+ T cells from blood	NULL
EXP063311	anti-JUNB (Cell Signaling #3753)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	P17275	activated primary CD4+ T cells from blood	NULL
EXP063312	anti-NFAT1 (Cell Signaling #5861)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	Q13469	activated primary CD4+ T cells from blood	NULL
EXP063313	anti-NFAT1 (Cell Signaling #5861)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	Q13469	activated primary CD4+ T cells from blood	NULL
EXP063314	ant-NFAT2 (Cell Signaling #8032)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	O95644	activated primary CD4+ T cells from blood	NULL
EXP063315	anti-NFkB1  (Cell Signaling #12540)	Homo sapiens	Treatment: activation 5 hrs with anti-CD3 and -CD28 antibodies; Tissue: peripheral blood; Donor: healthy donor; Time point: 5 hrs	NULL	4139	normal	P19838	activated primary CD4+ T cells from blood	NULL
EXP063316	Normal rabbit IgG (Thermo Fisher Scientific, 10500C, lot#503104B)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP063317	Normal rabbit IgG (Thermo Fisher Scientific, 10500C, lot#503104B)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	NULL	4670	chip_control	NULL	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063318		Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP063319		Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	NULL	4670	chip_control	NULL	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063320	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063321	anti-FLAG (clone M2, Sigma Aldrich, Mouse monoclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063322	anti-CAP-H2 (Bethyl Laboratories, A302-276A, lot #A1, Rabbit polyclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063323	anti-CAP-H2 (Bethyl Laboratories, A302-276A, lot #A1, Rabbit polyclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	Q6IBW4	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063324	anti-CTCF (Millipore, 07-729, lot# 2475698, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	P49711	IMR90 (lung fibroblasts)	NULL
EXP063325	anti-CTCF (Millipore, 07-729, lot# 2475698, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	P49711	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063326	anti-SMC1 (Bethyl Laboratories, A300-055A, lot# A4, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063318	489	normal	P05067	IMR90 (lung fibroblasts)	NULL
EXP063327	anti-SMC1 (Bethyl Laboratories, A300-055A, lot# A4, Rabbit polyclonal)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	P05067	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063328	anti-SMC2 (Bethyl Laboratories, A300-058A), lot #A3, Rabbit polyclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	O95347	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063329	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: control; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063330	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: Triptolide for 5min; Genotype: wildtype; Karyotype: Normal diploid; Time point: 5min; Genotype: wildtype; Karyotype: Normal diploid; Time point: 5min	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063331	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: Triptolide for 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063332	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: alpha-amanitin for 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 30 mins	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063333	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: alpha-amanitin for 60 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 60 mins; Genotype: wildtype; Karyotype: Normal diploid; Time point: 60 mins	NULL	489	normal	Q6IBW4	IMR90 (lung fibroblasts)	NULL
EXP063334	anti-CAP-H2 (Rabbit polyclonal , Bethyl Laboratories, A302-275A, lot #A2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	Q6IBW4	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063335	anti-FLAG (clone M2, Sigma Aldrich, Mouse monoclonal )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Karyotype: Normal diploid; Genotype: wildtype; Karyotype: Normal diploid	EXP063319	4670	normal	Q6IBW4	IMR90 derived OIS (Oncogene-Induced Senescence) cells	NULL
EXP063336	none	Homo sapiens	Treatment: Treatment: none	NULL	949	chip_control	NULL	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP063337	none	Homo sapiens	Treatment: Treatment: none	NULL	4671	chip_control	NULL	MCF7-FasR (fulvestrant-resistant Invasive ductal carcinoma)	NULL
EXP063338	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: Treatment: none	EXP063336	949	normal	P49711	MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant)	NULL
EXP063339	anti-CTCF (Millipore 07-729)	Homo sapiens	Treatment: Treatment: none	EXP063337	4671	normal	P49711	MCF7-FasR (fulvestrant-resistant Invasive ductal carcinoma)	NULL
EXP063340	anti-AR antibody	Homo sapiens	Treatment: DHT (1xE-08M) for 72hrs; Disease: Polycystic ovary syndrome	NULL	256	normal	P10275	endometrial stromal cells	NULL
EXP063341	None	Homo sapiens	Treatment: none; Donor: 20180324_7010	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP063342	None	Homo sapiens	Treatment: none; Donor: 20180324_7009	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP063343	anti-LMO1 (A300-BL1145,140916 )	Homo sapiens	Treatment: none; Donor: 20180324_7010	EXP063341	520	normal	P25800	Kelly (neuroblastoma)	NULL
EXP063344	anti-LMO1 (A300-BL1145,140916 )	Homo sapiens	Treatment: none; Donor: 20180324_7009	EXP063342	520	normal	P25800	Kelly (neuroblastoma)	NULL
EXP063345	anti-ASCL1 (Santa Cruz, sc-374104X, I0711)	Homo sapiens	Treatment: none; Donor: 20180324_7006	NULL	520	normal	P50553	Kelly (neuroblastoma)	NULL
EXP063346	none	Homo sapiens	Treatment: none; Conditions: serum starved	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP063347	none	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP063348	none	Homo sapiens	Treatment: none; Conditions: serum starved	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP063349	none	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP063350	none	Homo sapiens	Treatment: none; Conditions: serum starved	NULL	2600	chip_control	NULL	T98G (Glioblastoma)	NULL
EXP063351	none	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	2600	chip_control	NULL	T98G (Glioblastoma)	NULL
EXP063352	none	Homo sapiens	Treatment: none; Conditions: serum starved	NULL	489	chip_control	NULL	IMR90 (lung fibroblasts)	NULL
EXP063353	none	Homo sapiens	Treatment: none; Conditions: reserum	NULL	111	chip_control	NULL	T47D (invasive ductal carcinoma)	NULL
EXP063354	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063346	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	NULL
EXP063355	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063346	111	normal	A6H8Y1	T47D (invasive ductal carcinoma)	NULL
EXP063356	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063347	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	NULL
EXP063357	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063347	111	normal	A6H8Y1	T47D (invasive ductal carcinoma)	NULL
EXP063358	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063348	583	normal	Q8WUA4	MCF10A (breast epithelial cells)	NULL
EXP063359	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063348	583	normal	A6H8Y1	MCF10A (breast epithelial cells)	NULL
EXP063360	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063349	583	normal	Q8WUA4	MCF10A (breast epithelial cells)	NULL
EXP063361	anti-BDP1 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063349	583	normal	A6H8Y1	MCF10A (breast epithelial cells)	NULL
EXP063362	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063350	2600	normal	Q8WUA4	T98G (Glioblastoma)	NULL
EXP063363	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	EXP063351	2600	normal	Q8WUA4	T98G (Glioblastoma)	NULL
EXP063364	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: serum starved	EXP063352	489	normal	Q8WUA4	IMR90 (lung fibroblasts)	NULL
EXP063365	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	489	normal	Q8WUA4	IMR90 (lung fibroblasts)	NULL
EXP063366	anti-CTCF (Millipore 07-729, rabbit polyclonal)	Homo sapiens	Treatment: none; Conditions: serum starved	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP063367	anti-H3K18ac (in house rabbit polyclonal antibody )	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	normal	H3K18ac	T47D (invasive ductal carcinoma)	NULL
EXP063368	anti-CTCF (Millipore 07-729, rabbit polyclonal)	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	normal	P49711	T47D (invasive ductal carcinoma)	NULL
EXP063369	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: reserum	EXP063353	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	NULL
EXP063370	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: none; Conditions: reserum	NULL	2600	normal	Q8WUA4	T98G (Glioblastoma)	NULL
EXP063371	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: siCTRL (control); Genotype: wildtype	NULL	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	NULL
EXP063372	anti-GTF3C2 (rabbit polyclonal, in house)	Homo sapiens	Treatment: siRNA against ADNP; Genotype: ADNP knockout	NULL	111	normal	Q8WUA4	T47D (invasive ductal carcinoma)	NULL
EXP063373	anti-GTF3C1 (Novus Biologicals, NB100-606570)	Homo sapiens	Treatment: none; Conditions: non-serum starved	NULL	111	normal	Q12789	T47D (invasive ductal carcinoma)	NULL
EXP063374	none	Homo sapiens	Treatment: none	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063375	anti-HOXB8  (Abcam, cat# ab125727)	Homo sapiens	Treatment: none	EXP063374	514	normal	P17481	K562 (myelogenous leukemia)	NULL
EXP063376	anti-CTCF (ab70303)	Homo sapiens	Treatment: Control mismatch; Genotype: wildtype	NULL	516	normal	P49711	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP063377	anti-CTCF (ab70303)	Homo sapiens	Treatment: siRNA adainst RUNX1/ETO; Genotype: RUNX1/ETO knockout	NULL	516	normal	P49711	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP063378	anti-LDB1 (ab96799)	Homo sapiens	Treatment: Control mismatch; Genotype: wildtype	NULL	516	normal	Q86U70	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP063379	anti-LDB1 (ab96799)	Homo sapiens	Treatment: siRNA adainst RUNX1/ETO; Genotype: RUNX1/ETO knockout	NULL	516	normal	Q86U70	Kasumi-1 (acute myeloblastic leukemia)	NULL
EXP063380		Arabidopsis thaliana	Treatment: none; Ecotype: Col-0	NULL	4674	chip_control	NULL	rosette leaves	NULL
EXP063381	anti-FLAG (Millipore Sigma, F1804)	Arabidopsis thaliana	Treatment: none; Ecotype: Col-0; Genotype: myc2 MYC2::MYC2-FLAG	EXP063380	4674	normal	Q39204	rosette leaves	NULL
EXP063382	anti-FLAG (Millipore Sigma, F1804)	Arabidopsis thaliana	Treatment: 25 min touch treatment; Ecotype: Col-0; Genotype: myc2 MYC2::MYC2-FLAG; Time point: 25 mins	EXP063380	4674	normal	Q39204	rosette leaves	NULL
EXP063383	na	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063384	na	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063385	na	Homo sapiens	Treatment: Treatment: Thaps treated, sh RNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063386	na	Homo sapiens	Treatment: Treatment: shRNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063387	na	Homo sapiens	Treatment: Treatment: Thaps treated, shLuc (control); Genotype: wildtype; Genotype: wildtype	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063388	na	Homo sapiens	Treatment: Treatment: shLuc (control); Genotype: wildtype; Genotype: wildtype	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063389	anti-ATXN7L3(Bethyl Labs cat# A302-800A)	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	EXP063383	417	normal	Q14CW9	HCT-116 (colon carcinoma)	NULL
EXP063390	anti-ATXN7L3(Bethyl Labs cat# A302-800A)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063384	417	normal	Q14CW9	HCT-116 (colon carcinoma)	NULL
EXP063391	anti-GCN5 (Santa Cruz cat# sc-20698)	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	EXP063383	417	normal	Q92830	HCT-116 (colon carcinoma)	NULL
EXP063392	anti-GCN5 (Santa Cruz cat# sc-20698)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063384	417	normal	Q92830	HCT-116 (colon carcinoma)	NULL
EXP063393	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: Thaps treated, sh RNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063385	417	normal	O95243	HCT-116 (colon carcinoma)	NULL
EXP063394	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: shRNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063386	417	normal	O95243	HCT-116 (colon carcinoma)	NULL
EXP063395	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: Thaps treated, shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063387	417	normal	O95243	HCT-116 (colon carcinoma)	NULL
EXP063396	anti-MED1(Bethyl Labs cat# A300-793A)	Homo sapiens	Treatment: Treatment: shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063388	417	normal	O95243	HCT-116 (colon carcinoma)	NULL
EXP063397	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: Thaps treated, sh RNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063385	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	NULL
EXP063398	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: shRNA against USP22; Genotype: USP22 knockout; Genotype: USP22 knockout	EXP063386	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	NULL
EXP063399	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: Thaps treated, shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063387	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	NULL
EXP063400	anti-MED16 (Abcam cat# ab130996)	Homo sapiens	Treatment: Treatment: shLuc (control); Genotype: wildtype; Genotype: wildtype	EXP063388	417	normal	Q9Y2X0	HCT-116 (colon carcinoma)	NULL
EXP063401	anti-USP22 (Novus Biologicals cat# NBP1-49644)	Homo sapiens	Treatment: Treatment: Thaps treated; Genotype: wildtype; Genotype: wildtype	EXP063383	417	normal	Q9UPT9	HCT-116 (colon carcinoma)	NULL
EXP063402	anti-USP22 (Novus Biologicals cat# NBP1-49644)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063384	417	normal	Q9UPT9	HCT-116 (colon carcinoma)	NULL
EXP063403	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: vehicle (DMSO) for 24 hrs; Genotype: wildtype; Time point: 24 hours	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	NULL
EXP063404	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10 nM R1881 for 3 hrs; Genotype: wildtype; Time point: 24 hours	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	NULL
EXP063405	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10nM Thapsigargin for 3 hrs; Genotype: wildtype; Time point: 3 hrs	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	NULL
EXP063406	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10nM Thapsigargin for 3 hrs; Genotype: wildtype; Time point: 3 hrs	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	NULL
EXP063407	anti-XBP1s (Biolegend, 619502)	Homo sapiens	Treatment: 10nM Thapsigargin for 3 hrs; Genotype: ERN1 Knockout; Time point: 3 hrs	NULL	70	normal	P17861	LNCaP (prostate carcinoma)	NULL
EXP063408	no antibody	Homo sapiens	Treatment: none	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP063409	none	Homo sapiens	Treatment: none	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP063410	none	Homo sapiens	Treatment: none	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP063411	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: treated with 500 U/ml IFN-beta for 0 hrs; Time point: 0 hrs	EXP063408	38	normal	P32519	A549 (lung carcinoma)	NULL
EXP063412	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: treated with 500 U/ml IFN-beta for 6 hrs; Time point: 6 hrs	NULL	38	normal	P32519	A549 (lung carcinoma)	NULL
EXP063413	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: none	EXP063409	38	normal	P32519	A549 (lung carcinoma)	NULL
EXP063414	anti-ELF1 (Cat# sc-631; RRID:AB_631428;Clone: C-20)	Homo sapiens	Treatment: none	EXP063410	38	normal	P32519	A549 (lung carcinoma)	NULL
EXP063415	rabbit monoclonal anti-H2AK119ub antibody (Cell Signaling Technology, 8240)	Homo sapiens	Treatment: steroid-depleted medium, 72h, ethanol, 1hr; Time point: 73 hrs; Genotype: wildtype	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP063416	rabbit monoclonal anti-H2AK119ub antibody (Cell Signaling Technology, 8240)	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881, 10nM for 1hr; Time point: 73 hrs; Genotype: wildtype	NULL	71	chip_control	NULL	VCaP (prostate carcinoma)	NULL
EXP063417	anti-BCOR antibody (A310-672A, Bethyl Laboratories, rabbit polyclonal )	Homo sapiens	Treatment: steroid-depleted medium, 72h, ethanol, 1hr; Time point: 73 hrs; Genotype: wildtype	EXP063415	71	normal	Q6W2J9	VCaP (prostate carcinoma)	NULL
EXP063418	anti-BCOR antibody (A310-672A, Bethyl Laboratories, rabbit polyclonal )	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881, 10nM for 1hr; Time point: 73 hrs; Genotype: wildtype	EXP063416	71	normal	Q6W2J9	VCaP (prostate carcinoma)	NULL
EXP063419	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72hrs, ethanol for 1hr, siBCOR transfection for 72h; Time point: 73 hrs; Genotype: BCOR knockout	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP063420	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881 10nM for 1hr, siBCOR transfection for 72hrs; Time point: 73 hrs; Genotype: BCOR knockout	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP063421	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72hrs, ethanol for 1hr, siNON transfection for 72hrs; Time point: 73 hrs; Genotype: wildtype	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP063422	anti-AR (rabbit antiserum )	Homo sapiens	Treatment: steroid-depleted medium for 72 hrs, R1881, 10nM for 1hr, siNON transfection for 72hrs; Time point: 73 hrs; Genotype: wildtype	NULL	71	normal	P10275	VCaP (prostate carcinoma)	NULL
EXP063423	None	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063424	None	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063425	None	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP063426	None	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	NULL	874	chip_control	NULL	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP063427	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063428	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063429	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063430	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063431	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063432	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063433	None	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063434	None	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063435	None	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063436	None	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063437	None	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063438	None	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063439	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063427	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063440	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063428	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063441	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063429	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063442	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063430	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063443	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063431	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063444	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 72 hrs + 6 hrs; Genotype: wildtype; Time point: 72 hrs + 6 hrs; Genotype: wildtype; Time point: 72 hrs + 6 hrs; Genotype: wildtype	EXP063432	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063445	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063427	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063446	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063428	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063447	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063429	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063448	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063430	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063449	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063431	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063450	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063432	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063451	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063427	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063452	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063428	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063453	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: 10 nM Fulvestrant for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063429	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063454	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: 250 nM JQ1 for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063430	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063455	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063431	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063456	anti-SNF5 (Bethyl A301-087A)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, 10 nM B-estradiol for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063432	113	normal	Q12824	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063457	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063458	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063459	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063460	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063461	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063437	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063462	anti-ESR1 (Abcam ab3575 and Millipore 06-935 antibody mix)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063463	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063464	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063465	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063466	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063467	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063437	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063468	anti-HDAC1 (Diagenode Premium C15410325)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	Q13547	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063469	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063470	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063471	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063472	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063473	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	NULL	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063474	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063475	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063476	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063477	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063478	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063479	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063437	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063480	anti-ARID2 (Bethyl A302-229A)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14; Time point: 6 hrs; Genotype: ARID1A knockout clone 14	EXP063438	113	normal	Q68CP9	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063481	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: vehicle (DMSO) treated for 6 hrs; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063433	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063482	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype; Time point: 6 hrs; Genotype: wildtype	EXP063434	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063483	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: Vehicle; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063435	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063484	anti-BRD4 (N-terminal antibody from Cheng Ming Chiang)	Homo sapiens	Treatment: Treatment: Treatment: 100 nM 4-hydroxy tamoxifen for 6 hours; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11; Time point: 6 hrs; Genotype: ARID1A knockout clone 11	EXP063436	113	normal	O60885	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063485	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063423	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063486	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063424	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063487	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063423	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063488	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063424	113	normal	O14497	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063489	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063425	874	normal	P51532	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP063490	anti-BRG1 (ab215998)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063426	874	normal	P51532	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP063491	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours, siControl; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype; Time point: 72 hrs; Genotype: wildtype	EXP063425	874	normal	O14497	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP063492	anti-ARID1A (HPA005456)	Homo sapiens	Treatment: Treatment: Treatment: Charcoal stripped serum for 72 hours - vehicle, siRNA against FOXA1; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout; Time point: 72 hrs; Genotype: FOXA1 knockout	EXP063426	874	normal	O14497	ZR-75-1 (invasive ductal carcinoma)	NULL
EXP063493	none	Homo sapiens	Treatment: hDFs transduced with rtTA and tet-HA-ETV2, without doxycycline; Genotype: rtTA and tet-HA-ETV2; Time point: day 7	NULL	4693	chip_control	NULL	ETV2-induced endothelial cells (iECs) from human fibroblasts	NULL
EXP063494	none	Homo sapiens	Treatment: hDFs transduced with rtTA and tet-HA-ETV2 with doxycycline and DMSO for 7 days; Genotype: rtTA and tet-HA-ETV2; Time point: day 7	NULL	4693	chip_control	NULL	ETV2-induced endothelial cells (iECs) from human fibroblasts	NULL
EXP063495	anti-HA (901501, BioLegend)	Homo sapiens	Treatment: hDFs transduced with rtTA and tet-HA-ETV2, without doxycycline; Genotype: rtTA and tet-HA-ETV2; Time point: day 7	EXP063493	4693	normal	O00321	ETV2-induced endothelial cells (iECs) from human fibroblasts	NULL
EXP063496	anti-HA (901501, BioLegend)	Homo sapiens	Treatment: hDFs transduced with rtTA and tet-HA-ETV2 with doxycycline and DMSO for 7 days; Genotype: rtTA and tet-HA-ETV2; Time point: day 7	EXP063494	4693	normal	O00321	ETV2-induced endothelial cells (iECs) from human fibroblasts	NULL
EXP063497	none (input)	Homo sapiens	Treatment: none	NULL	192	chip_control	NULL	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP063498	anti-SRF (Santa Cruz sc-335)	Homo sapiens	Treatment: none	EXP063497	192	normal	P11831	HCASMC (Human coronary artery smooth muscle cells)	NULL
EXP063499	None	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063500	None	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063501	None	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063502	None	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063503	None	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063504	None	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063505	None	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-2; Genotype: ARID1A knockout; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063506	None	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-2; Genotype: ARID1A knockout; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063507	anti-BAF155	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063499	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063508	anti-BRG1	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063499	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063509	anti-BAF155	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063499	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063510	anti-BRG1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063500	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063511	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063501	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063512	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgNT-1; Genotype: wildtype; Genotype: wildtype	EXP063502	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063513	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063503	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063514	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-1; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063504	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063515	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-2; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063505	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063516	anti-ESR1	Homo sapiens	Treatment: Treatment: DMSO, sgRNA against ARID1A-2; Genotype: ARID1A knockout; Genotype: ARID1A knockout	EXP063506	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063517	none	Homo sapiens	Treatment: none	NULL	4695	chip_control	NULL	AsPC-1 (Pancreatic ductal adenocarcinoma)	NULL
EXP063518	none	Homo sapiens	Treatment: none	NULL	4696	chip_control	NULL	SW1990 (Pancreatic adenocarcinoma)	NULL
EXP063519	anti-Bach1 (House made (A1-6))	Homo sapiens	Treatment: none	EXP063517	4695	normal	O14867	AsPC-1 (Pancreatic ductal adenocarcinoma)	NULL
EXP063520	anti-Bach1 (House made (A1-6))	Homo sapiens	Treatment: none	EXP063518	4696	normal	O14867	SW1990 (Pancreatic adenocarcinoma)	NULL
EXP063521	None	Homo sapiens	Treatment: DMSO for 24 hrs; Time point: 24 hrs	NULL	1177	chip_control	NULL	LNCaP clone FGC	NULL
EXP063522	None	Homo sapiens	Treatment: DMSO for 24 hrs; Time point: 24 hrs	NULL	1177	chip_control	NULL	LNCaP clone FGC	NULL
EXP063523	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP063521	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063524	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063525	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063526	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 and A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063527	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP063522	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063528	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063529	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063530	anti-p300 (Developmental Studies Hybridoma Bank, University of Iowa, ENCITp300-1)	Homo sapiens	Treatment: ICBP112 and A485 for 24 hrs; Time point: 24 hrs	NULL	1177	normal	Q09472	LNCaP clone FGC	NULL
EXP063531	none (input)	Homo sapiens	Treatment: Treatment: Treatment: no Dox; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP063532	none (input)	Homo sapiens	Treatment: Treatment: Treatment: 1 ug/ml Dox for 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days	NULL	2991	chip_control	NULL	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP063533	anti-FOXA1 (abcam, ab23738, lot GR176970-2)	Homo sapiens	Treatment: Treatment: Treatment: no Dox; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days	EXP063531	2991	normal	P55317	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP063534	anti-FOXA1 (abcam, ab23738, lot GR176970-2)	Homo sapiens	Treatment: Treatment: Treatment: 1 ug/ml Dox for 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days; Genotype: Dox-inducible FOXA1 overexpression; Time point: 5 days	EXP063532	2991	normal	P55317	MCF7L-P(immortalized breast epithelial cell line)	NULL
EXP063535	input	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063536	input	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063537	input	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063538	input	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063539	input	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063540	input	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063541	input	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063542	anti-CTCF	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	EXP063535	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063543	anti-ESR1	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	EXP063535	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063544	anti-FoxA1	Homo sapiens	Treatment: sgRNA control; Genotype: wildtype	EXP063535	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063545	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	EXP063536	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063546	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	EXP063536	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063547	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47521695-47621796; Genotype: targeting chr20:47521695-47621796	EXP063536	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063548	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	EXP063539	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063549	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	EXP063537	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063550	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	EXP063537	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063551	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47407744-47407846; Genotype: targeting chr20:47407744-47407846	EXP063537	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063552	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	EXP063538	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063553	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	EXP063538	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063554	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47407727-47407826; Genotype: targeting chr20:47407727-47407826	EXP063538	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063555	anti-CTCF	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	EXP063540	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063556	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	EXP063539	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063557	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47481433-47481536; Genotype: targeting chr20:47481433-47481536	EXP063539	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063558	anti-ESR1	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	EXP063540	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063559	anti-FoxA1	Homo sapiens	Treatment: sgRNA against targeting chr20:47314838-47314940; Genotype: targeting chr20:47314838-47314940	EXP063540	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063560	anti-CTCF	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	EXP063541	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063561	anti-ESR1	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	EXP063541	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063562	anti-FoxA1	Homo sapiens	Treatment: sgRNA against chr20:47314838-47314940; Genotype: Targeting chr20:47407679-47407782	EXP063541	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063563	none	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	NULL	4698	chip_control	NULL	SAH (induced pluripotent stem cell line)	NULL
EXP063564	none	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	NULL	4698	chip_control	NULL	SAH (induced pluripotent stem cell line)	NULL
EXP063565	none	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063566	none	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063567	none	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063568	none	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063569	none	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	NULL	2345	chip_control	NULL	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063570	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	P51532	SAH (induced pluripotent stem cell line)	NULL
EXP063571	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	Q12824	SAH (induced pluripotent stem cell line)	NULL
EXP063572	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	Q92922	SAH (induced pluripotent stem cell line)	NULL
EXP063573	SUZ12 (Cell Signaling Tech., 3737S, lot: 6)	Homo sapiens	Treatment: Treatment: none; Genotype: SMARCB1^K364del/+; Time point: 0 days; Genotype: SMARCB1^K364del/+; Time point: 0 days	EXP063563	4698	normal	Q15022	SAH (induced pluripotent stem cell line)	NULL
EXP063574	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	P51532	SAH (induced pluripotent stem cell line)	NULL
EXP063575	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	Q12824	SAH (induced pluripotent stem cell line)	NULL
EXP063576	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	Q92922	SAH (induced pluripotent stem cell line)	NULL
EXP063577	SUZ12 (Cell Signaling Tech., 3737S, lot: 6)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 days; Genotype: wildtype; Time point: 0 days	EXP063564	4698	normal	Q15022	SAH (induced pluripotent stem cell line)	NULL
EXP063578	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063579	SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063580	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063581	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	EXP063565	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063582	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	NULL	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063583	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	NULL	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063584	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063585	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063586	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063587	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063588	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063589	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063590	anti-BRG1/SMARCA4 (Abcam, ab110641 [EPNCIR111A], lot: GR3208604-7)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	P51532	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063591	anti-SMARCC1/BAF155 (Cell Signaling Tech., 11956S (D7F8S), lot: 2)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	Q92922	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063592	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	Q12824	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063593	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: lentivirus: SMARCB1 Empty; Genotype: wildtype; Genotype: wildtype	EXP063565	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063594	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 lentivirally infected; Genotype: SMARCB1 FL constructs; Genotype: SMARCB1 FL constructs	EXP063566	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063595	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 K364del lentivirally infected; Genotype: SMARCB1 K364del constructs; Genotype: SMARCB1 K364del constructs	EXP063567	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063596	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 R377H lentivirally infected; Genotype: SMARCB1 R377H constucts; Genotype: SMARCB1 R377H constucts	EXP063568	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063597	anti-SMARCB1/BAF47 (Cell Signaling Tech., 91735S (D8M1X), lot: 1)	Homo sapiens	Treatment: Treatment: SMARCB1 delCC (Y326*) lentivirally infected; Genotype: SMARCB1 delCC (Y326*) constructs; Genotype: SMARCB1 delCC (Y326*) constructs	EXP063569	2345	normal	Q92785	TTC-1240 (Rhabdoid tumor of the kidney)	NULL
EXP063598	none (input)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP063599	none (input)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1475	chip_control	NULL	HK-2	NULL
EXP063600	CDK9	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP063601	CDK9	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T2 mutant	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP063602	CDK9	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP063603	CDK9	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged wild type human ENL	NULL	421	normal	P50750	HEK293 (embryonic kidney)	NULL
EXP063604	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged wild type human ENL	EXP063598	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063605	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063606	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1-Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL T1-Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063607	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063608	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2-Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL T2-Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063609	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063610	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3-Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL T3-Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063611	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Expressing empty vector; Genotype: wildtype with  empty vector	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063612	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL Y78A double mutant construction; Genotype: Expressing Flag-tagged human ENL Y78A double mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063613	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged wild type human ENL	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063614	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063615	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063616	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	NULL	421	normal	Q03111	HEK293 (embryonic kidney)	NULL
EXP063617	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged wild type human ENL construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	EXP063599	1475	normal	Q03111	HK-2	NULL
EXP063618	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T1 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	EXP063599	1475	normal	Q03111	HK-2	NULL
EXP063619	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T2 mutant construction; Genotype: Expressing Flag-tagged human ENL T1 mutant	EXP063599	1475	normal	Q03111	HK-2	NULL
EXP063620	anti-Flag (M2, Sigma F1804)	Homo sapiens	Treatment: Flag-tagged human ENL T3 mutant construction; Genotype: Expressing Flag-tagged human ENL T3 mutant	EXP063599	1475	normal	Q03111	HK-2	NULL
EXP063621	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM Non-Target siRNA pool; Genotype: wildtype; Time point: 144 hrs	NULL	70	normal	P49711	LNCaP (prostate carcinoma)	NULL
EXP063622	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM CTCF target siRNA pool; Genotype: CTCF  knockout; Time point: 144 hrs	NULL	70	normal	P49711	LNCaP (prostate carcinoma)	NULL
EXP063623	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM Non-Target siRNA pool; Genotype: wildtype; Time point: 144 hrs	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	NULL
EXP063624	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM CTCF target siRNA pool; Genotype: CTCF  knockout; Time point: 144 hrs	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	NULL
EXP063625	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM Non-Target siRNA pool; Genotype: wildtype; Time point: 144 hrs; Source: Low Cell sample	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	NULL
EXP063626	anti-CTCF  (#07-729, Millipore)	Homo sapiens	Treatment: 20nM CTCF target siRNA pool; Genotype: CTCF  knockout; Time point: 144 hrs; Source: Low Cell sample	NULL	489	normal	P49711	IMR90 (lung fibroblasts)	NULL
EXP063627	none	Homo sapiens	Treatment: none; Genotype: wildtype; Time point: 48 hrs	NULL	2922	chip_control	NULL	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063628	none	Homo sapiens	Treatment: Doxcycline for 48 hrs; Genotype: transfected CASZ1b expression; Time point: 48 hrs	NULL	2922	chip_control	NULL	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063629	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: none; Genotype: wildtype; Time point: 48 hrs	EXP063627	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063630	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: Doxcycline for 48 hrs; Genotype: transfected CASZ1b expression; Time point: 48 hrs	EXP063628	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063631	none	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: wildtype; Time point: 48 hrs	NULL	2922	chip_control	NULL	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063632	none	Homo sapiens	Treatment: 100 nM trametinib for 48 hrs; Genotype: MEK inhibitor trametinib induces; Time point: 48 hrs	NULL	2922	chip_control	NULL	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063633	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: DMSO for 48 hrs; Genotype: wildtype; Time point: 48 hrs	EXP063632	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063634	anti-CASZ1 (in collaboration with Rockland, ab8540)	Homo sapiens	Treatment: 100 nM trametinib for 48 hrs; Genotype: MEK inhibitor trametinib induces; Time point: 48 hrs	EXP063632	2922	normal	Q86V15	SMS-CTR (embryonal rhabdomyosarcoma)	NULL
EXP063635	None	Homo sapiens	Treatment: none; Conditions: control	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063636	anti-HSP90B (Abcam, ab53497)	Homo sapiens	Treatment: none; Conditions: control	EXP063635	514	bio_control	P08238	K562 (myelogenous leukemia)	NULL
EXP063637	anti-SCC1 (Abcam ab992)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1507	normal	O60216	HAP1 (chronic myelogenous leukemia)	NULL
EXP063638	anti-SCC1 (Abcam ab992)	Homo sapiens	Treatment: none; Genotype: CTCF Y226A, F228A mutant	NULL	1507	normal	O60216	HAP1 (chronic myelogenous leukemia)	NULL
EXP063639	anti-CTCF (Cell Signaling 3418S)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	NULL
EXP063640	anti-CTCF (Cell Signaling 3418S)	Homo sapiens	Treatment: none; Genotype: CTCF Y226A, F228A mutant	NULL	1507	normal	P49711	HAP1 (chronic myelogenous leukemia)	NULL
EXP063641	None	Homo sapiens	Treatment: none	NULL	2269	chip_control	NULL	A1-2 (breast cancer cells)	NULL
EXP063642	anti-GR (P-20, sc-1002, Santa Cruz Biotechnology) and anti-GR (PA1-511A, Thermo Fisher Scientific)	Homo sapiens	Treatment: none; Time point: 0 hr	EXP063641	2269	normal	P04150	A1-2 (breast cancer cells)	NULL
EXP063643	Mix: anti-GR, P-20, sc-1002, Santa Cruz Biotechnology and anti-GR, PA1-511A, Thermo Fisher Scientific	Homo sapiens	Treatment: 10 nM Dex for 1 hr; Time point: 1 hr	NULL	2269	normal	P04150	A1-2 (breast cancer cells)	NULL
EXP063644	Mix: anti-GR, P-20, sc-1002, Santa Cruz Biotechnology and anti-GR, PA1-511A, Thermo Fisher Scientific	Homo sapiens	Treatment: 10 nM R5020 for 1 hr; Time point: 1 hr	NULL	2269	normal	P04150	A1-2 (breast cancer cells)	NULL
EXP063645	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: none; Time point: 0 hr	EXP063641	2269	normal	P06401	A1-2 (breast cancer cells)	NULL
EXP063646	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10 nM R5020 for 1 hr; Time point: 1 hr	NULL	2269	normal	P06401	A1-2 (breast cancer cells)	NULL
EXP063647	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: none; Time point: 0 hr; Source: used as control in this work	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP063648	anti-PR (H-190, sc-7208, Santa Cruz Biotechnology)	Homo sapiens	Treatment: 10 nM R5020 for 1 hr; Time point: 1 hr; Source: used as control in this work	NULL	111	normal	P06401	T47D (invasive ductal carcinoma)	NULL
EXP063649	anti-SMC3	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	422	normal	Q9UQE7	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP063650	anti-GFP	Homo sapiens	Treatment: none; Genotype: wildtype, EGFP-STAG1	NULL	422	normal	Q969W9	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP063651	anti-GFP	Homo sapiens	Treatment: none; Genotype: wildtype, STAG2-EGFP	NULL	422	normal	Q8N3U4	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP063652	anti-CTCF	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	422	normal	P49711	HeLa Kyoto (cervical adenocarcinoma)	NULL
EXP063653	none	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	NULL	974	chip_control	NULL	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063654	none	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063655	none	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	2219	chip_control	NULL	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063656	none	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063657	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063653	974	normal	Q8TEK3	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063658	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	974	normal	Q8TEK3	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063659	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063653	974	normal	O00255	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063660	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	974	normal	O00255	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063661	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063653	974	normal	Q03164	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063662	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	974	normal	Q03164	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063663	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063654	2219	normal	Q8TEK3	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063664	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	EXP063655	2219	normal	Q8TEK3	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063665	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: DMSO 0.33% for 4 days; Time point: 4 days	NULL	2219	normal	O00255	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063666	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: 330nM VTP-50469 for 4 hrs; Time point: 4 days	NULL	2219	normal	O00255	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063667	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063654	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063668	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	EXP063655	2219	normal	Q03164	MOLM-13(acute monocytic leukemia(AML), Homo sapiens)	NULL
EXP063669	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063656	779	normal	Q8TEK3	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063670	anti-DOT1L (Cell signaling #77087S clone 1W4Z lot 0)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	779	normal	Q8TEK3	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063671	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063656	779	normal	O00255	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063672	anti-Menin (Bethyl #A300-105A Lot:8)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	779	normal	O00255	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063673	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: DMSO 0.33% for 3 days; Time point: 3 days	EXP063656	779	normal	Q03164	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063674	anti-MLL1n (Bethyl #A300-086A lots: 5 or 6)	Homo sapiens	Treatment: 330nM VTP-50469 for 3 hrs; Time point: 3 days	NULL	779	normal	Q03164	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP063675	anti-HA (Millipore, catalog# 05-904)	Mus musculus	Treatment: AdCre transduction, harvested after 72hrs; Strain: FVB; Genotype: WcrH, P53F/F; Time point: 72 hrs	NULL	902	normal	P19785	mammary epithelial cells	NULL
EXP063676	anti-HA (Millipore, catalog# 05-904)	Mus musculus	Treatment: AdCre transduction, harvested after 72hrs; Strain: FVB; Genotype: WcrH, P53F/F, HA-hERa; Time point: 72 hrs	NULL	902	normal	P19785	mammary epithelial cells	NULL
EXP063677	anti-HA (Millipore, catalog# 05-904)	Mus musculus	Treatment: AdCre transduction, harvested after 72hrs; Strain: FVB; Genotype: WcrH, P53F/F, HA-mERa; Time point: 72 hrs	NULL	902	normal	P19785	mammary epithelial cells	NULL
EXP063678	anti-HA (Millipore, catalog# 05-904)	Homo sapiens	Treatment: Full medium; Genotype: wildtype	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063679	INPUT	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: wildtype	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP063680	INPUT	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: wildtype	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP063681	INPUT	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: FLAG-NPM1 expressing	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP063682	INPUT	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: FLAG-NPM1 expressing	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP063683	anti-FLAG (SIGMA, F1804)	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: wildtype	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP063684	anti-FLAG (SIGMA, F1804)	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: wildtype	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP063685	INPUT	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP063686	INPUT	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	NULL	1226	chip_control	NULL	OCI-AML3	NULL
EXP063687	INPUT	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063688	INPUT	Homo sapiens	Treatment: KPT-330; Strain: 129/Ola	NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063689	INPUT	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	NULL	438	chip_control	NULL	HL-60 (acute myeloid leukemia)	NULL
EXP063690	INPUT	Homo sapiens	Treatment: none; Strain: 129/Ola	NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063691	INPUT	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063692	INPUT	Homo sapiens	Treatment: KPT-330; Strain: 129/Ola	NULL	1095	chip_control	NULL	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063693	INPUT	Homo sapiens	Treatment: none; Strain: 129/Ola	NULL	1226	chip_control	NULL	OCI-AML3	NULL
EXP063694	anti-FLAG (SIGMA, F1804)	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: FLAG-NPM1 expressing	EXP063681	2	normal	Q61937	mESCs (mouse embryonic stem cells)	NULL
EXP063695	anti-FLAG (SIGMA, F1804)	Mus musculus	Treatment: none; Strain: 129/Ola; Genotype: FLAG-NPM1 expressing	EXP063682	2	normal	Q61937	mESCs (mouse embryonic stem cells)	NULL
EXP063696	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063685	514	normal	O14980	K562 (myelogenous leukemia)	NULL
EXP063697	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063686	1226	normal	O14980	OCI-AML3	NULL
EXP063698	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063687	1095	normal	O14980	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063699	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: KPT-330; Strain: 129/Ola	EXP063688	1095	normal	O14980	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063700	anti-Crm1 (CST, 46249)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063689	438	normal	O14980	HL-60 (acute myeloid leukemia)	NULL
EXP063701	anti-Crm1 (Bethyl Laboratories, A300-469A)	Homo sapiens	Treatment: none; Strain: 129/Ola	EXP063690	1095	normal	O14980	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063702	anti-Nup214(Bethyl Laboratories, A300-716A)	Homo sapiens	Treatment: DMSO treated; Strain: 129/Ola	EXP063691	1095	normal	P35658	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063703	anti-Nup214(Bethyl Laboratories, A300-716A)	Homo sapiens	Treatment: KPT-330; Strain: 129/Ola	EXP063692	1095	normal	P35658	Loucy (adult T acute lymphoblastic leukemia)	NULL
EXP063704	anti-NPM1(mutant)(ThermoFischer, PA1-46356)	Homo sapiens	Treatment: none; Strain: 129/Ola	EXP063693	1226	normal	P06748	OCI-AML3	NULL
EXP063705	none	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	NULL	4704	chip_control	NULL	myometrium	NULL
EXP063706	none	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	NULL	4704	chip_control	NULL	myometrium	NULL
EXP063707	none	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	NULL	4704	chip_control	NULL	myometrium	NULL
EXP063708	none	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	NULL	4704	chip_control	NULL	myometrium	NULL
EXP063709	none	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	NULL	4704	chip_control	NULL	myometrium	NULL
EXP063710	none	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	NULL	4705	chip_control	NULL	leiomyoma	NULL
EXP063711	none	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	NULL	4705	chip_control	NULL	leiomyoma	NULL
EXP063712	none	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	NULL	4705	chip_control	NULL	leiomyoma	NULL
EXP063713	none	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	NULL	4705	chip_control	NULL	leiomyoma	NULL
EXP063714	none	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	NULL	4705	chip_control	NULL	leiomyoma	NULL
EXP063715	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	P01100	myometrium	NULL
EXP063716	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	P01100	myometrium	NULL
EXP063717	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	P01100	myometrium	NULL
EXP063718	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	P01100	myometrium	NULL
EXP063719	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	P01100	myometrium	NULL
EXP063720	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	P01100	leiomyoma	NULL
EXP063721	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063711	4705	normal	P01100	leiomyoma	NULL
EXP063722	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	P01100	leiomyoma	NULL
EXP063723	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	P01100	leiomyoma	NULL
EXP063724	anti-FOS (Millipore, cat # 06-341)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	P01100	leiomyoma	NULL
EXP063725	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	P05412	myometrium	NULL
EXP063726	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	P05412	myometrium	NULL
EXP063727	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	P05412	myometrium	NULL
EXP063728	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	P05412	myometrium	NULL
EXP063729	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	P05412	myometrium	NULL
EXP063730	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	P05412	leiomyoma	NULL
EXP063731	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063711	4705	normal	P05412	leiomyoma	NULL
EXP063732	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	P05412	leiomyoma	NULL
EXP063733	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	P05412	leiomyoma	NULL
EXP063734	anti-JUN (abcam, cat # ab31419)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	P05412	leiomyoma	NULL
EXP063735	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	P49336	myometrium	NULL
EXP063736	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	P49336	myometrium	NULL
EXP063737	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	P49336	myometrium	NULL
EXP063738	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	P49336	myometrium	NULL
EXP063739	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	P49336	myometrium	NULL
EXP063740	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	P49336	leiomyoma	NULL
EXP063741	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063711	4705	normal	P49336	leiomyoma	NULL
EXP063742	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	P49336	leiomyoma	NULL
EXP063743	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	P49336	leiomyoma	NULL
EXP063744	anti-CDK8 (Bethyl, cat # A302-500A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	P49336	leiomyoma	NULL
EXP063745	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063705	4704	normal	Q93074	myometrium	NULL
EXP063746	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063706	4704	normal	Q93074	myometrium	NULL
EXP063747	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063707	4704	normal	Q93074	myometrium	NULL
EXP063748	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063708	4704	normal	Q93074	myometrium	NULL
EXP063749	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063709	4704	normal	Q93074	myometrium	NULL
EXP063750	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT848; Donor: PT848	EXP063710	4705	normal	Q93074	leiomyoma	NULL
EXP063751	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT886; Donor: PT886	EXP063711	4705	normal	Q93074	leiomyoma	NULL
EXP063752	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT916; Donor: PT916	EXP063712	4705	normal	Q93074	leiomyoma	NULL
EXP063753	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT967; Donor: PT967	EXP063713	4705	normal	Q93074	leiomyoma	NULL
EXP063754	anti-MED12 (Bethyl, cat # A300-774A)	Homo sapiens	Treatment: Treatment: none; Donor: PT1063; Donor: PT1063	EXP063714	4705	normal	Q93074	leiomyoma	NULL
EXP063755	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: E	NULL	3036	chip_control	NULL	neutrophils from periferal blood	NULL
EXP063756	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: F	NULL	3036	chip_control	NULL	neutrophils from periferal blood	NULL
EXP063757	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: G	NULL	4714	chip_control	NULL	breast-derived primary mast cells	NULL
EXP063758	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: H	NULL	4714	chip_control	NULL	breast-derived primary mast cells	NULL
EXP063759	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 18 hrs	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP063760	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 18 hrs	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP063761	FLAG-epitope (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: L; Time point: 96 hrs	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP063762	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: M; Time point: 96 hrs	NULL	620	chip_control	NULL	monocyte-derived dendritic cells	NULL
EXP063763	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 18 hrs	NULL	2993	chip_control	NULL	monocytes from periferal blood	NULL
EXP063764	none	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: P; Time point: 7 days	NULL	466	chip_control	NULL	MDM(monocyte derived macrophages)	NULL
EXP063765	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	4715	chip_control	NULL	EM-3 (Childhood chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP063766	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	974	chip_control	NULL	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063767	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	47	chip_control	NULL	KG1 (acute myeloid leukemia)	NULL
EXP063768	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	648	chip_control	NULL	NB4 (acute promyelocytic leukemia )	NULL
EXP063769	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	65	chip_control	NULL	U937 (adult acute monocytic leukemia)	NULL
EXP063770	none	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP063771	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP063772	none	Homo sapiens	Treatment: transfected with PMAVD3_PU.1	NULL	2334	chip_control	NULL	THP-1 (acute monocytic leukemia)	NULL
EXP063773	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	NULL	4713	chip_control	NULL	primary B cells from peripheral blood	NULL
EXP063774	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A	NULL	4713	normal	P17947	primary B cells from peripheral blood	NULL
EXP063775	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: C	NULL	4713	normal	P17947	primary B cells from peripheral blood	NULL
EXP063776	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063777	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: D	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063778	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063779	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: D	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063780	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: E	EXP063755	3036	normal	P17947	neutrophils from periferal blood	NULL
EXP063781	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: F	EXP063756	3036	normal	P17947	neutrophils from periferal blood	NULL
EXP063782	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: G	EXP063757	4714	normal	P17947	breast-derived primary mast cells	NULL
EXP063783	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: H	EXP063758	4714	normal	P17947	breast-derived primary mast cells	NULL
EXP063784	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063785	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: K	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063786	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063787	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 18 hrs	EXP063759	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063788	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 18 hrs	EXP063760	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063789	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 27 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063790	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 42 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063791	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 42 hrs	EXP063760	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063792	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 66 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063793	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: L; Time point: 96 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063794	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: M; Time point: 96 hrs	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063795	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: I; Time point: 7 days	NULL	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063796	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: A; Time point: 18 hrs	EXP063760	620	normal	P17947	monocyte-derived dendritic cells	NULL
EXP063797	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 4 hrs	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063798	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 4 hrs	NULL	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063799	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 18 hrs	EXP063763	2993	normal	P17947	monocytes from periferal blood	NULL
EXP063800	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: O; Time point: 7 days	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP063801	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: N; Time point: 7 days	NULL	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP063802	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1; Donor: P; Time point: 7 days	EXP063764	466	normal	P17947	MDM(monocyte derived macrophages)	NULL
EXP063803	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063765	4715	normal	P17947	EM-3 (Childhood chronic myelogenous leukemia, BCR-ABL1 positive)	NULL
EXP063804	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063766	974	normal	P17947	ML-2 (cell line derived from HL60 M4 cell line, adult acute myeloid leukemia)	NULL
EXP063805	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063767	47	normal	P17947	KG1 (acute myeloid leukemia)	NULL
EXP063806	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063768	648	normal	P17947	NB4 (acute promyelocytic leukemia )	NULL
EXP063807	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063769	65	normal	P17947	U937 (adult acute monocytic leukemia)	NULL
EXP063808	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with the transcription PU.1	EXP063770	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP063809	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: transfected with PMAVD3_PU.1	EXP063772	2334	normal	P17947	THP-1 (acute monocytic leukemia)	NULL
EXP063810	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881; Genotype: GFP+pGIPZ	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063811	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063812	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063813	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063814	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063815	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063816	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063817	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063818	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063819	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063820	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: GFP+pGIPZ	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063821	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063822	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063823	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063824	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063825	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063826	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063827	anti-HA (ab9110, GR261166-6)	Homo sapiens	Treatment: Ethanol; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063828	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881; Genotype: GFP+pGIPZ	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063829	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063830	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063831	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063832	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063833	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063834	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063835	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063836	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: 10nM R1881, shRNA against FoxA1; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063837	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol; Genotype: GFP+pGIPZ	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063838	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: GFP+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063839	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: wildtype+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063840	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: G87R transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063841	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: D226N transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063842	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: M253K transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063843	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: FENG transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063844	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: F266S transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063845	anti-AR (Santa Cruz, sc-816x, J216)	Homo sapiens	Treatment: Ethanol,  shRNA against FoxA1; Genotype: L388M transfection+pGIPZ, FoxA1 knockout	NULL	70	normal	P10275	LNCaP (prostate carcinoma)	NULL
EXP063846	none	Homo sapiens	Treatment: none; Donor: ad11; Age: 91; Sex: female; Disease: Alzheimer's disease; Braak stage: none	NULL	4716	chip_control	NULL	brain prefrontal cortex region tissues	NULL
EXP063847	none	Homo sapiens	Treatment: none; Donor: ad16; Age: 95; Sex: female; Disease: Alzheimer's disease; Braak stage: none	NULL	4716	chip_control	NULL	brain prefrontal cortex region tissues	NULL
EXP063848	none	Homo sapiens	Treatment: none; Donor: c13; Age: 69; Sex: male; Disease: normal; Braak stage: none	NULL	4716	chip_control	NULL	brain prefrontal cortex region tissues	NULL
EXP063849	none	Homo sapiens	Treatment: none; Donor: c31; Age: 80; Sex: male; Disease: normal; Braak stage: none	NULL	4716	chip_control	NULL	brain prefrontal cortex region tissues	NULL
EXP063850	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 20134; Age: 80; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063851	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 20138; Age: 92; Sex: male; Disease: Alzheimer's disease; Braak stage: 3	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063852	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2016018; Age: 78; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063853	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2016029; Age: 83; Sex: male; Disease: normal; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063854	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017001; Age: 91; Sex: female; Disease: Alzheimer's disease; Braak stage: 3	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063855	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017011; Age: 83; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063856	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017014; Age: 81; Sex: female; Disease: normal; Braak stage: 1	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063857	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017025; Age: 70; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063858	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2017039; Age: 84; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063859	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 201704; Age: 72; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063860	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2018001; Age: 87; Sex: Alzheimer's disease; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063861	anti-ATF4 (CTS, catalog# 11815S, lot# 4)	Homo sapiens	Treatment: none; Donor: 2018006; Age: 84; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	P18848	brain prefrontal cortex region tissues	NULL
EXP063862	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 20134; Age: 80; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063863	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 20138; Age: 92; Sex: male; Disease: Alzheimer's disease; Braak stage: 3	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063864	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2016018; Age: 78; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063865	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2016029; Age: 83; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063866	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017011; Age: 83; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063867	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017014; Age: 81; Sex: female; Disease: normal; Braak stage: 1	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063868	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017025; Age: 70; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063869	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2017039; Age: 84; Sex: male; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063870	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 201704; Age: 72; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063871	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2018001; Age: 87; Sex: Alzheimer's disease; Disease: Alzheimer's disease; Braak stage: 4	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063872	anti-Olig2 (RnD, catalog# AF2418, lot# UPA0718031)	Homo sapiens	Treatment: none; Donor: 2018006; Age: 84; Sex: female; Disease: normal; Braak stage: 0	NULL	4716	normal	Q13516	brain prefrontal cortex region tissues	NULL
EXP063873	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: 20180807; Age: 72; Sex: male; Disease: normal; Braak stage: 1	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063874	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad11; Age: 91; Sex: female; Disease: Alzheimer's disease; Braak stage: none	EXP063846	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063875	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad16; Age: 95; Sex: female; Disease: Alzheimer's disease; Braak stage: none	EXP063847	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063876	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad1; Age: 69; Sex: male; Disease: Alzheimer's disease; Braak stage: none	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063877	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: ad7; Age: 86; Sex: male; Disease: Alzheimer's disease; Braak stage: none	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063878	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: c13; Age: 69; Sex: male; Disease: normal; Braak stage: none	EXP063849	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063879	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: c23; Age: 86; Sex: female; Disease: normal; Braak stage: none	NULL	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063880	anti-THRA (SantaCruz, catalog# SC-56873, lot# J1614)	Homo sapiens	Treatment: none; Donor: c31; Age: 80; Sex: male; Disease: normal; Braak stage: none	EXP063849	4716	normal	P10827	brain prefrontal cortex region tissues	NULL
EXP063881	none	Homo sapiens	Treatment: none	NULL	4717	chip_control	NULL	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	NULL
EXP063882	anti-TTF-1 (#MS-699-P, Lab Vision Corporation, Fremont, CA, USA)	Homo sapiens	Treatment: none	EXP063881	4717	normal	P43699	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	NULL
EXP063883	anti-ASCL1 (#556604, BD Biosciences, Franklin Lakes, NJ, USA)	Homo sapiens	Treatment: none	EXP063881	4717	normal	P50553	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	NULL
EXP063884	anti-CTCF	Homo sapiens	Treatment: none	NULL	4718	normal	P49711	MutuI-LCL (lymphoblastoid cells)	NULL
EXP063885	anti-CTCF	Homo sapiens	Treatment: none	NULL	640	normal	P49711	Mutu-1 (Epstein-Barr virus-related Burkitt lymphoma)	NULL
EXP063886	Input	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2 not stimulated	NULL	2825	chip_control	NULL	primary human Th1 T cells	NULL
EXP063887	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 A1 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	NULL
EXP063888	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 C7 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	NULL
EXP063889	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 Mut3 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	NULL
EXP063890	anti-STAT3	Homo sapiens	Treatment: after 24 hours starvation in the absence of IL2, stimulated with  IL6 Hyll6 mutant  for 1 hr	EXP063886	2825	normal	P40763	primary human Th1 T cells	NULL
EXP063891	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	38	normal	P27540	A549 (lung carcinoma)	NULL
EXP063892	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	417	normal	P27540	HCT-116 (colon carcinoma)	NULL
EXP063893	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	725	normal	P27540	PC3(bone mets prostate adenocarcinoma)	NULL
EXP063894	anti-HIF1b (Novus NB100-110)	Homo sapiens	Treatment: none; Conditions: hypoxia with o2 concentration 0.50% for 16 hrs	NULL	111	normal	P27540	T47D (invasive ductal carcinoma)	NULL
EXP063895	none	Homo sapiens	Treatment: none	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP063896	anti-HAT1 (Abcam ab194296)	Homo sapiens	Treatment: none	EXP063895	430	normal	O14929	HepG2 (hepatoblastoma)	NULL
EXP063897	anti-SNF5 (ChIP Grade, ab12167)	Homo sapiens	Treatment: None; Genotype: Stably expressing hTERT gene, inducible expression of ER Ras	NULL	4725	normal	Q12824	proliferating fibroblasts	NULL
EXP063898	anti-SNF5 (ChIP Grade, ab12167)	Homo sapiens	Treatment: ASO_CTRL transient transfection, cells collected after 36 hours; Genotype: Stably expressing hTERT gene, inducible expression of ER Ras; Time point: 36 hrs	NULL	4725	normal	Q12824	proliferating fibroblasts	NULL
EXP063899	anti-SNF5 (ChIP Grade, ab12167)	Homo sapiens	Treatment: ASO_LINC#3 transient transfection, cells collected after 36 hours; Genotype: Stably expressing hTERT gene, inducible expression of ER Ras, ASO_LINC#3; Time point: 36 hrs	NULL	4725	normal	Q12824	proliferating fibroblasts	NULL
EXP063900		Homo sapiens	Treatment: none	NULL	4727	chip_control	NULL	GBM39 (Human brain tumor)	NULL
EXP063901		Homo sapiens	Treatment: none	NULL	4727	chip_control	NULL	GBM39 (Human brain tumor)	NULL
EXP063902	anti-CTCF (Abcam ab70303, 5 Âµg)	Homo sapiens	Treatment: none	EXP063900	4727	normal	P49711	GBM39 (Human brain tumor)	NULL
EXP063903	anti-CTCF (Abcam ab70303, 5 Âµg)	Homo sapiens	Treatment: none	EXP063901	4727	normal	P49711	GBM39 (Human brain tumor)	NULL
EXP063904	anti-SMC3 (Abcam ab9263, 5 Âµg)	Homo sapiens	Treatment: none	EXP063900	4727	normal	Q9UQE7	GBM39 (Human brain tumor)	NULL
EXP063905	anti-SMC3 (Abcam ab9263, 5 Âµg)	Homo sapiens	Treatment: none	EXP063901	4727	normal	Q9UQE7	GBM39 (Human brain tumor)	NULL
EXP063906	none	Homo sapiens	Treatment: Treatment: shCTRL; Genotype: wildtype; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063907	none	Homo sapiens	Treatment: Treatment: shRNA against NR2F2; Genotype: NR2F2 knockout; Genotype: NR2F2 knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063908	none	Homo sapiens	Treatment: Treatment: treated with vehicle  for 12 hrs; Genotype: wildtype; Time point: 12 hrs; Genotype: wildtype; Time point: 12 hrs	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063909	none	Homo sapiens	Treatment: Treatment: treated with 10 nM estrogen  for 12 hrs; Genotype: wildtype; Time point: 12 hrs; Genotype: wildtype; Time point: 12 hrs	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063910	anti-ERa (santa cruze, sc-543x,Lot # E3014 )	Homo sapiens	Treatment: Treatment: shCTRL; Genotype: wildtype; Genotype: wildtype	EXP063906	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063911	anti-FOXA1 (Abcam,ab170933, Lot # GR3257262-1)	Homo sapiens	Treatment: Treatment: shCTRL; Genotype: wildtype; Genotype: wildtype	NULL	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063912	anti-ERa (santa cruze, sc-543x,Lot # E3014 )	Homo sapiens	Treatment: Treatment: shRNA against NR2F2; Genotype: NR2F2 knockout; Genotype: NR2F2 knockout	EXP063907	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063913	anti-FOXA1 (Abcam,ab170933, Lot # GR3257262-1)	Homo sapiens	Treatment: Treatment: shRNA against NR2F2; Genotype: NR2F2 knockout; Genotype: NR2F2 knockout	EXP063907	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063914	anti-NR2F2 (active motif, 61213?Lot 10216002)	Homo sapiens	Treatment: Treatment: treated with vehicle  for 12 hrs; Genotype: wildtype; Time point: 12 hrs; Genotype: wildtype; Time point: 12 hrs	EXP063908	113	normal	P24468	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063915	anti-NR2F2 (active motif, 61213?Lot 10216002)	Homo sapiens	Treatment: Treatment: treated with 10 nM estrogen  for 12 hrs; Genotype: wildtype; Time point: 12 hrs; Genotype: wildtype; Time point: 12 hrs	EXP063909	113	normal	P24468	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063916		Homo sapiens	Treatment: none; Conditions: cultured continuously for 14 days in medium containig 10nM 17-beta-estradiol in 0.1% DMSO; Time point: 14 days	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063917	anti-ESR1	Homo sapiens	Treatment: none; Conditions: cultured continuously for 14 days in medium containig 10nM 17-beta-estradiol in 0.1% DMSO; Time point: 14 days	EXP063916	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063918	anti-ESR1	Homo sapiens	Treatment: none; Conditions: cultured continuously for 14 days in medium containig 0.1% DMSO; Time point: 14 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063919	anti-ESR1	Homo sapiens	Treatment: none; Conditions: cultured continuously for 4 days in medium containig 0.1% DMSO,and then cultured continuously for 10 days in medium containig 10nM 17-beta-estradiol in 0.1% DMSO; Time point: 14 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063920	none	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	NULL	4730	chip_control	NULL	SK-UT-1 (Uterine corpus leiomyosarcoma)	NULL
EXP063921	anti-HDAC4 (Paroni et al, 2004 PMID 15075374 )	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063920	4730	normal	P56524	SK-UT-1 (Uterine corpus leiomyosarcoma)	NULL
EXP063922	anti-HDAC9 (Di Giorgio et al, 2019 NAR submitted)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063920	4730	normal	Q9UKV0	SK-UT-1 (Uterine corpus leiomyosarcoma)	NULL
EXP063923	anti-MEF2D (BD Biosciences, clone 9 610775)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP063920	4730	normal	Q14814	SK-UT-1 (Uterine corpus leiomyosarcoma)	NULL
EXP063924	none	Homo sapiens	Treatment: none; Source: menstrual cycle proliferative and mid-secretory phase pool	NULL	2292	chip_control	NULL	endometrium	NULL
EXP063925	none	Homo sapiens	Treatment: none; Source: menstrual cycle proliferative phase	NULL	2292	chip_control	NULL	endometrium	NULL
EXP063926	none	Homo sapiens	Treatment: none; Source: menstrual cycle mid-secretory phase	NULL	2292	chip_control	NULL	endometrium	NULL
EXP063927	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle proliferative phase	EXP063924	2292	normal	P06401	endometrium	NULL
EXP063928	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle mid-secretory phase	EXP063924	2292	normal	P06401	endometrium	NULL
EXP063929	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle proliferative phase	EXP063925	2292	normal	P06401	endometrium	NULL
EXP063930	anti-PGR (Santa Cruz, sc-7208)	Homo sapiens	Treatment: none; Source: menstrual cycle mid-secretory phase	EXP063926	2292	normal	P06401	endometrium	NULL
EXP063931	anti-ER (Santacruz, Cat# sc-543, clone HC-20, Lot # A1F0316)	Homo sapiens	Treatment: DMSO for 7 days; Time point: 7 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063932	anti-ER (Santacruz, Cat# sc-543, clone HC-20, Lot # A1F0316)	Homo sapiens	Treatment: 500 nM Abemaciclib for 7 days; Time point: 7 days	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063933	anti-TRPS1 (sc-26974, Santa Cruz)	Mus musculus	Treatment: none; Genotype: no TRPS1 insertions	NULL	4731	normal	Q925H1	breast cancer cells	NULL
EXP063934	anti-TRPS1 (sc-26974, Santa Cruz)	Mus musculus	Treatment: none; Genotype: TRPS1 insertions	NULL	4731	normal	Q925H1	breast cancer cells	NULL
EXP063935	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Treatment: sgScr (control sgRNA); Genotype: wildtype	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063936	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Treatment: sgRNA aginst TRPS1; Genotype: TRPS1 knockout	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063937	anti-TRPS1 (AF4838, R&D)	Homo sapiens	Treatment: siNT (control siNT); Genotype: wildtype	NULL	113	normal	Q9UHF7	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063938	anti-TRPS1 (AF4838, R&D)	Homo sapiens	Treatment: siRNA against GATA3; Genotype: GATA3 knockout	NULL	113	normal	Q9UHF7	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063939	anti-TRPS1 (AF4838, R&D)	Homo sapiens	Treatment: none	NULL	113	normal	Q9UHF7	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063940	anti-GATA3 (sc-268, Santa Cruz)	Homo sapiens	Treatment: none	NULL	113	normal	P23771	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063941	none (input)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063942	anti-FLAG M2 (Sigma-Aldrich, Catalog number M8823)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063941	4664	normal	O15550	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP063943	anti-FOXA1	Homo sapiens	Treatment: treated with doxycycline for 2 days; Genotype: wildtype	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063944	anti-FOXA1	Homo sapiens	Treatment: treated with doxycycline for 2 days; Genotype: overexpressing D226G FOXA1	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063945	anti-FOXA1	Homo sapiens	Treatment: treated with doxycycline for 2 days; Genotype: overexpressing M253K FOXA1	NULL	70	normal	P55317	LNCaP (prostate carcinoma)	NULL
EXP063946	none (input)	Homo sapiens	Treatment: none; Time point: 1 hr	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063947	anti-ESR1 (Estrogen Receptor alfa (D8H8) Rabbit mAb #8644, from CST)	Homo sapiens	Treatment: DMSO for 1 hour; Time point: 1 hr	EXP063946	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063948	anti-ESR1 (Estrogen Receptor alfa (D8H8) Rabbit mAb #8644, from CST)	Homo sapiens	Treatment: 10 nM estrogen for 1 hour; Time point: 1 hr	EXP063946	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063949	anti-ESR1 (Estrogen Receptor alfa (D8H8) Rabbit mAb #8644, from CST)	Homo sapiens	Treatment: 20 uM OBHS for 1 hour; Time point: 1 hr	EXP063946	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063950		Homo sapiens	Treatment: none	NULL	26	chip_control	NULL	501Mel (melanoma)	NULL
EXP063951	anti-CHD4	Homo sapiens	Treatment: none	EXP063950	26	normal	Q14839	501Mel (melanoma)	NULL
EXP063952		Homo sapiens	Treatment: none; Donor: 387	NULL	3548	chip_control	NULL	glioblastoma stem cells	NULL
EXP063953		Homo sapiens	Treatment: none; Donor: 3565	NULL	3548	chip_control	NULL	glioblastoma stem cells	NULL
EXP063954		Homo sapiens	Treatment: none; Donor: ENSA	NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP063955		Homo sapiens	Treatment: none; Donor: hNP1	NULL	915	chip_control	NULL	hNSC (neural stem cells)	NULL
EXP063956	anti-BMAL1	Homo sapiens	Treatment: none; Donor: 387	EXP063952	3548	normal	O00327	glioblastoma stem cells	NULL
EXP063957	anti-BMAL1	Homo sapiens	Treatment: none; Donor: 3565	EXP063953	3548	normal	O00327	glioblastoma stem cells	NULL
EXP063958	anti-BMAL1	Homo sapiens	Treatment: none; Donor: ENSA	EXP063954	915	normal	O00327	hNSC (neural stem cells)	NULL
EXP063959	anti-BMAL1	Homo sapiens	Treatment: none; Donor: hNP1	EXP063955	915	normal	O00327	hNSC (neural stem cells)	NULL
EXP063960		Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP063961	none	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	1008	chip_control	NULL	HT1080 (fibrosarcoma)	NULL
EXP063962	none	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	417	chip_control	NULL	HCT-116 (colon carcinoma)	NULL
EXP063963	none	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	4304	chip_control	NULL	DKO-1 (Colon adenocarcinoma)	NULL
EXP063964	anti-CTCF (CST:#3418)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063960	1008	normal	P49711	HT1080 (fibrosarcoma)	NULL
EXP063965	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063960	1008	normal	P45973	HT1080 (fibrosarcoma)	NULL
EXP063966	anti-CTCF (CST:#3418)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063961	1008	normal	P49711	HT1080 (fibrosarcoma)	NULL
EXP063967	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063961	1008	normal	P45973	HT1080 (fibrosarcoma)	NULL
EXP063968	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063962	417	normal	P45973	HCT-116 (colon carcinoma)	NULL
EXP063969	anti-HP1beta (CST:8676S)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063962	417	normal	P83916	HCT-116 (colon carcinoma)	NULL
EXP063970	anti-HP1alpha (CST:2616)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063963	4304	normal	P45973	DKO-1 (Colon adenocarcinoma)	NULL
EXP063971	anti-HP1beta (CST:8676S)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP063963	4304	normal	P83916	DKO-1 (Colon adenocarcinoma)	NULL
EXP063972	None	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A1	NULL	1149	chip_control	NULL	testis	NULL
EXP063973	None	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A8	NULL	1149	chip_control	NULL	testis	NULL
EXP063974	None	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A10	NULL	1149	chip_control	NULL	testis	NULL
EXP063975	None	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A16	NULL	1149	chip_control	NULL	testis	NULL
EXP063976	None	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A17	NULL	1149	chip_control	NULL	testis	NULL
EXP063977	None	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: S1	NULL	909	chip_control	NULL	kidney	NULL
EXP063978	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A1	EXP063972	1149	normal	P10243	testis	NULL
EXP063979	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A8	EXP063973	1149	normal	P10243	testis	NULL
EXP063980	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A10	EXP063974	1149	normal	P10243	testis	NULL
EXP063981	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A16	EXP063975	1149	normal	P10243	testis	NULL
EXP063982	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: A17	EXP063976	1149	normal	P10243	testis	NULL
EXP063983	anti-A-MYB	Homo sapiens	Treatment: none; Developmental stage: Adult; Donor: S1	EXP063977	909	normal	P10243	kidney	NULL
EXP063984	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 1 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 1; Time point: day 1	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	NULL
EXP063985	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 2 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 2; Time point: day 2	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	NULL
EXP063986	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 3 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 3; Time point: day 3	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	NULL
EXP063987	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: day 4 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 4; Time point: day 4	NULL	466	normal	P18146	MDM(monocyte derived macrophages)	NULL
EXP063988	anti-EGR1 (BETHYL, RABBIT POLICLONALstA303)	Homo sapiens	Treatment: none	NULL	4752	normal	P18146	primary monocytes	NULL
EXP063989	anti-CDH4 (ABCAM, Rabbit polyclonal, AB72418)	Homo sapiens	Treatment: day 4 of 25 ng/ul GM-CSF treatment; Developmental stage: differentiating macrophages at day 4; Time point: day 4	NULL	466	normal	P55283	MDM(monocyte derived macrophages)	NULL
EXP063990	anti-ESR1 (sc-8002 and ab32063)	Homo sapiens	Treatment: 7 days stripped cells; Time point: 7 days; Genotype: wildtype	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063991	anti-ESR1 (sc-8002 and ab32063)	Homo sapiens	Treatment: Estradiol for 1 hr; Time point: 1 hr; Genotype: wildtype	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063992	anti-ESR1 (sc-8002 and ab32063)	Homo sapiens	Treatment: Estradiol for 1 hr; Time point: 1 hr; Genotype: CRISPR-based deletion of TFF1	NULL	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP063993	none	Homo sapiens	Treatment: Treatment: shRNA control; Genotype: wildtype; Genotype: wildtype	NULL	4753	chip_control	NULL	JR-1 (Embryonal rhabdomyosarcoma. Derived from metastatic site: Lung)	NULL
EXP063994	none	Homo sapiens	Treatment: Treatment: shRNA control; Genotype: wildtype; Genotype: wildtype	NULL	4754	chip_control	NULL	CTR (Rhabdomyosarcoma)	NULL
EXP063995	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA control; Genotype: wildtype; Genotype: wildtype	EXP063993	4753	normal	O43623	JR-1 (Embryonal rhabdomyosarcoma. Derived from metastatic site: Lung)	NULL
EXP063996	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA control; Genotype: wildtype; Genotype: wildtype	EXP063994	4754	normal	O43623	CTR (Rhabdomyosarcoma)	NULL
EXP063997	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	4754	normal	O43623	CTR (Rhabdomyosarcoma)	NULL
EXP063998	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: DMSO; Genotype: wildtype; Genotype: wildtype	NULL	4754	normal	O43623	CTR (Rhabdomyosarcoma)	NULL
EXP063999	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: Trametinib 100 nM; Genotype: wildtype; Genotype: wildtype	NULL	4754	normal	O43623	CTR (Rhabdomyosarcoma)	NULL
EXP064000	anti-MYOD (Santa Cruz, sc-760, M-318)	Homo sapiens	Treatment: Treatment: shCtrl; Genotype: wildtype; Genotype: wildtype	EXP063994	4754	normal	P15172	CTR (Rhabdomyosarcoma)	NULL
EXP064001	anti-MYOD (Santa Cruz, sc-760, M-318)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	4754	normal	P15172	CTR (Rhabdomyosarcoma)	NULL
EXP064002	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shCtrl; Genotype: wildtype; Genotype: wildtype	NULL	2598	normal	O43623	RD (Embryonal rhabdomyosarcoma)	NULL
EXP064003	anti-SNAI2 (Slug, C19G7, Rabbit mAb,  CST 9585)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	2598	normal	O43623	RD (Embryonal rhabdomyosarcoma)	NULL
EXP064004	anti-MyoD (Santa Cruz, cat sc-32758, lot I1113)	Homo sapiens	Treatment: Treatment: shCtrl; Genotype: wildtype; Genotype: wildtype	NULL	2598	normal	P15172	RD (Embryonal rhabdomyosarcoma)	NULL
EXP064005	anti-MyoD (Santa Cruz, cat sc-32758, lot I1113)	Homo sapiens	Treatment: Treatment: shRNA against SNAI2; Genotype: SNAI2 knockout; Genotype: SNAI2 knockout	NULL	2598	normal	P15172	RD (Embryonal rhabdomyosarcoma)	NULL
EXP064006	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 (no tag Flag control) native; GTRD_Rep_Group: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP064007	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 (no tag Flag control); GTRD_Rep_Group: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP064008	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 (no tag Flag control) native; GTRD_Rep_Group: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP064009	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 (no tag Flag control) native; GTRD_Rep_Group: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP064010	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy1964 h- (no tag GFP control); GTRD_Rep_Group: none	NULL	1263	chip_control	NULL	whole cells	NULL
EXP064011	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 wildtype native; GTRD_Rep_Group: none	EXP064006	1263	normal	P40381	whole cells	NULL
EXP064012	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 (no tag Flag control) native; GTRD_Rep_Group: none	NULL	1263	normal	A0ZWU1	whole cells	NULL
EXP064013	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 wildtype native; GTRD_Rep_Group: none	EXP064007	1263	normal	P40381	whole cells	NULL
EXP064014	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064015	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT H3K9R; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064016	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Flag-swi6 WT; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064017	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Rix1-myc; GTRD_Rep_Group: none	NULL	1263	normal	P87243	whole cells	NULL
EXP064018	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Rix1-myc swi6delta; GTRD_Rep_Group: none	NULL	1263	normal	P87243	whole cells	NULL
EXP064019	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Rix1-myc clr4delta; GTRD_Rep_Group: none	NULL	1263	normal	P87243	whole cells	NULL
EXP064020	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Mdn1-myc; GTRD_Rep_Group: none	NULL	1263	normal	O94248	whole cells	NULL
EXP064021	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Mdn1-myc swi6delta; GTRD_Rep_Group: none	NULL	1263	normal	O94248	whole cells	NULL
EXP064022	anti-c-myc (9E10, Covance MMS-150)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Mdn1-myc clr4delta; GTRD_Rep_Group: none	NULL	1263	normal	O94248	whole cells	NULL
EXP064023	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT dcr1delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064024	anti-Flag (Sigma F1804)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 Flag-swi6 WT dcr1delta taz1delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064025	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Npp106-GFP; GTRD_Rep_Group: none	EXP064009	1263	normal	O14310	whole cells	NULL
EXP064026	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy137 Npp106-GFP clr4delta; GTRD_Rep_Group: none	EXP064009	1263	normal	O14310	whole cells	NULL
EXP064027	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy1964 h- Nup211-GFP; GTRD_Rep_Group: none	EXP064010	1263	normal	O74424	whole cells	NULL
EXP064028	anti-GFP (Abcam ab290)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy1964 h- Nup211-GFP clr4delta; GTRD_Rep_Group: none	EXP064010	1263	normal	O74424	whole cells	NULL
EXP064029	anti-Swi6 (home made antibody)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 swi6delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064030	anti-Swi6 (home made antibody)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 WT; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064031	anti-Swi6 (home made antibody)	Schizosaccharomyces pombe	Treatment: none; Conditions: media YEA; Genotype: spy138 npp106delta; GTRD_Rep_Group: none	NULL	1263	normal	P40381	whole cells	NULL
EXP064032	none	Homo sapiens	Treatment: none	NULL	583	chip_control	NULL	MCF10A (breast epithelial cells)	NULL
EXP064033	anti-AIB1 (CST 2126, Lot 4)	Homo sapiens	Treatment: none	EXP064032	583	normal	Q9Y6Q9	MCF10A (breast epithelial cells)	NULL
EXP064034	anti-TEAD4 (sc-101184)	Homo sapiens	Treatment: none	EXP064032	583	normal	Q15561	MCF10A (breast epithelial cells)	NULL
EXP064035	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: Nonpregnant at the proliferative phase; Donor: NP1	NULL	4704	normal	P06401	myometrium	NULL
EXP064036	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: Nonpregnant at the proliferative phase; Donor: NP2	NULL	4704	normal	P06401	myometrium	NULL
EXP064037	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: 38-42 weeks estimated gestational age; Donor: TP1	NULL	4704	normal	P06401	myometrium	NULL
EXP064038	Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)	Homo sapiens	Treatment: none; Developmental stage: 38-42 weeks estimated gestational age; Donor: TP2	NULL	4704	normal	P06401	myometrium	NULL
EXP064039	none	Homo sapiens	Treatment: none	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064040	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: none	EXP064039	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064041	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: estrogen treated for 1hour (10nM); Time point: 1 hrs	NULL	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064042	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: estrogen treated for 2hours (10nM); Time point: 2 hrs	NULL	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064043	anti-HSF1 ( Polyclonal antibody, Enzo, ADI-SPA-901)	Homo sapiens	Treatment: none; Time point: 15 mins; Conditions: subjected to hyperthermia (43 degree celsius) for 15minutes	NULL	113	normal	Q00613	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064044	input	Homo sapiens	Treatment: control siRNA; Genotype: wildtype	NULL	4755	chip_control	NULL	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064045	anti-CTCF	Homo sapiens	Treatment: siRNA against CTCF; Genotype: CTCF knockout	NULL	4755	chip_control	NULL	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064046	input	Homo sapiens	Treatment: siRNA against Rad21; Genotype: Rad21 knockout	NULL	4755	chip_control	NULL	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064047	anti-CTCF	Homo sapiens	Treatment: control siRNA; Genotype: wildtype	NULL	4755	normal	P49711	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064048	anti-Rad21	Homo sapiens	Treatment: control siRNA; Genotype: wildtype	EXP064044	4755	normal	O60216	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064049	anti-CTCF	Homo sapiens	Treatment: siRNA against CTCF; Genotype: CTCF knockout	EXP064045	4755	normal	P49711	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064050	anti-Rad21	Homo sapiens	Treatment: siRNA against CTCF; Genotype: CTCF knockout	EXP064045	4755	normal	O60216	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064051	anti-CTCF	Homo sapiens	Treatment: siRNA against Rad21; Genotype: Rad21 knockout	EXP064046	4755	normal	P49711	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064052	anti-Rad21	Homo sapiens	Treatment: siRNA against Rad21; Genotype: Rad21 knockout	EXP064046	4755	normal	O60216	SLK (Clear cell renal cell carcinoma. Derived from metastatic site: Skin.Clear cell renal cell carcinoma (NCIt: C4033) Derived from metastatic site: Skin)	NULL
EXP064053	anti-THAP11 (sheep, R & D Systems AF5727)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP064054	anti-THAP11 (sheep, R & D Systems AF5727)	Homo sapiens	Treatment: none; Genotype: THAP11-F80L homozygous	NULL	421	chip_control	NULL	HEK293 (embryonic kidney)	NULL
EXP064055	anti-THAP11 (sheep, R & D Systems AF5727)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064053	421	normal	Q96EK4	HEK293 (embryonic kidney)	NULL
EXP064056	anti-THAP11 (sheep, R & D Systems AF5727)	Homo sapiens	Treatment: none; Genotype: THAP11-F80L homozygous	EXP064054	421	normal	Q96EK4	HEK293 (embryonic kidney)	NULL
EXP064057	none	Homo sapiens	Treatment: none	NULL	4756	chip_control	NULL	COG-N-415 (Neuroblastoma)	NULL
EXP064058	none	Homo sapiens	Treatment: none	NULL	520	chip_control	NULL	Kelly (neuroblastoma)	NULL
EXP064059	none	Homo sapiens	Treatment: none	NULL	4759	chip_control	NULL	LA-N-5 (Neuroblastoma. Derived from metastatic site: Bone marrow)	NULL
EXP064060	none	Homo sapiens	Treatment: none	NULL	1101	chip_control	NULL	NB-1643 (neuroblastoma)	NULL
EXP064061	none	Homo sapiens	Treatment: none	NULL	1195	chip_control	NULL	NB69 (neuroblastoma)	NULL
EXP064062	none	Homo sapiens	Treatment: none	NULL	1194	chip_control	NULL	SK-N-AS (neuroblastoma)	NULL
EXP064063	none	Homo sapiens	Treatment: none	NULL	665	chip_control	NULL	SK-N-SH (neuroblastoma)	NULL
EXP064064	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064057	4756	normal	P04198	COG-N-415 (Neuroblastoma)	NULL
EXP064065	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064058	520	normal	P01106	Kelly (neuroblastoma)	NULL
EXP064066	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064059	4759	normal	P04198	LA-N-5 (Neuroblastoma. Derived from metastatic site: Bone marrow)	NULL
EXP064067	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064060	1101	normal	P04198	NB-1643 (neuroblastoma)	NULL
EXP064068	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064061	1195	normal	P01106	NB69 (neuroblastoma)	NULL
EXP064069	anti-N-MYC (Active Motif, #61185)	Homo sapiens	Treatment: none	EXP064061	1195	normal	P04198	NB69 (neuroblastoma)	NULL
EXP064070	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064062	1194	normal	P01106	SK-N-AS (neuroblastoma)	NULL
EXP064071	anti-MYC (Santa Cruz N262, #sc-764)	Homo sapiens	Treatment: none	EXP064063	665	normal	P01106	SK-N-SH (neuroblastoma)	NULL
EXP064072		Homo sapiens	Treatment: none	NULL	4762	chip_control	NULL	NCI-H2009 (Lung adenocarcinoma. Derived from metastatic site: Lymph node)	NULL
EXP064073	anti-ASF1A	Homo sapiens	Treatment: none	EXP064072	4762	normal	Q9Y294	NCI-H2009 (Lung adenocarcinoma. Derived from metastatic site: Lymph node)	NULL
EXP064074	Input	Homo sapiens	Treatment: No auxin; Conditions: 4i medium; Genotype: PGC-competent 4i hESCs (WIS2-NANOS3-T2A-tdTomato)	NULL	878	chip_control	NULL	embryonic stem cells	NULL
EXP064075	Input	Homo sapiens	Treatment: No auxin	NULL	4767	chip_control	NULL	primordial germ cell-like cells	NULL
EXP064076	anti-GFP (abcam ab290)	Homo sapiens	Treatment: With Auxin; Conditions: 4i medium; Genotype: PGC-competent 4i hESCs (WIS2-NANOS3-T2A-tdTomato)	NULL	878	normal	Q9GZV8	embryonic stem cells	NULL
EXP064077	anti-GFP (abcam ab290)	Homo sapiens	Treatment: No auxin; Conditions: 4i medium; Genotype: PGC-competent 4i hESCs (WIS2-NANOS3-T2A-tdTomato)	EXP064074	878	normal	Q9GZV8	embryonic stem cells	NULL
EXP064078	anti-GFP (abcam ab290)	Homo sapiens	Treatment: No auxin	EXP064075	4767	normal	Q9GZV8	primordial germ cell-like cells	NULL
EXP064079	none	Homo sapiens	Treatment: none	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064080	anti-TEAD1 (Abcam: 133533)	Homo sapiens	Treatment: none	EXP064079	2262	normal	P28347	primary human neonatal keratinocytes	NULL
EXP064081	input	Homo sapiens	Treatment: none	NULL	4664	chip_control	NULL	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP064082	anti-FLAG	Homo sapiens	Treatment: none	EXP064081	4664	normal	O15054	WA01 (H1 hESC) -derived neural progenitor cells	NULL
EXP064083	anti-CTCF (Cell Signaling #3418, rabbit)	Homo sapiens	Treatment: none; Donor: GBM3565	NULL	4769	normal	P49711	glioblastoma patient-derived cell model	NULL
EXP064084	anti-CTCF (Cell Signaling #3418, rabbit)	Homo sapiens	Treatment: none	NULL	4707	normal	P49711	GSC23 (Glioblastoma)	NULL
EXP064085		Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064086		Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064087		Homo sapiens	Treatment: Treatment: none; Genotype: Mi2 knockout; Genotype: Mi2 knockout	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064088		Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064089		Homo sapiens	Treatment: Treatment: none; Genotype: Mi2 knockout; Genotype: Mi2 knockout	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064090		Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	NULL	2262	chip_control	NULL	primary human neonatal keratinocytes	NULL
EXP064091	anti-cJUN	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	EXP064085	2262	normal	P05412	primary human neonatal keratinocytes	NULL
EXP064092	anti-cJUN	Homo sapiens	Treatment: Treatment: none; Genotype: Mi2 knockout; Genotype: Mi2 knockout	EXP064087	2262	normal	P05412	primary human neonatal keratinocytes	NULL
EXP064093	anti-JunB	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype control; Genotype: wildtype control	EXP064085	2262	normal	P17275	primary human neonatal keratinocytes	NULL
EXP064094	normal rabbit IgG	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	NULL	768	chip_control	NULL	Ramos (Burkitt lymphoma)	NULL
EXP064095	normal rabbit IgG	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	NULL	768	chip_control	NULL	Ramos (Burkitt lymphoma)	NULL
EXP064096	anti-Aiolos (D1C1E, Rabbit mAb Cell Signaling Technology, Cat#15103)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q9UKT9	Ramos (Burkitt lymphoma)	NULL
EXP064097	anti-BCL6 (Cell Signaling Technology,Cat#5650)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P41182	Ramos (Burkitt lymphoma)	NULL
EXP064098	c-Rel (Cell Signaling Technology, Cat#12659)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q04864	Ramos (Burkitt lymphoma)	NULL
EXP064099	anti-E2A (Cell Signaling Technology, Cat#12258)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	P15923	Ramos (Burkitt lymphoma)	NULL
EXP064100	anti-ELF1 (Bethyl, A301-443A)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P32519	Ramos (Burkitt lymphoma)	NULL
EXP064101	anti-ELF2 (Invitrogen, Cat#52247)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q15723	Ramos (Burkitt lymphoma)	NULL
EXP064102	anti-Helios (D8W4X, Cell Signaling Technology, Cat#4247)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q9UKS7	Ramos (Burkitt lymphoma)	NULL
EXP064103	anti-Ikaros (D10E5 Rabbit mAb, Cell Signaling Technology,Cat#9034)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	Q13422	Ramos (Burkitt lymphoma)	NULL
EXP064104	anti-IRF4 (Cell Signaling Technology, Cat#34964)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q15306	Ramos (Burkitt lymphoma)	NULL
EXP064105	anti-IRF8 (Cell Signaling Technology, Cat#5628)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q02556	Ramos (Burkitt lymphoma)	NULL
EXP064106	anti-MEF2B (Abcam, Cat#33540)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q02080	Ramos (Burkitt lymphoma)	NULL
EXP064107	anti-NFKB1 (Cell Signaling Technology, Cat#12540)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P19838	Ramos (Burkitt lymphoma)	NULL
EXP064108	anti-Nuclear Pore Proteins (Abcam, Cat#24609)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	P57740	Ramos (Burkitt lymphoma)	NULL
EXP064109	anti-p65 (Cell Signaling Technology, Cat#8242)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q04206	Ramos (Burkitt lymphoma)	NULL
EXP064110	anti-Pax5 (Novus, Cat#NBP2-29905)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	Q02548	Ramos (Burkitt lymphoma)	NULL
EXP064111	anti-PU.1 (Cell Signaling Technology, Cat#2258)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P17947	Ramos (Burkitt lymphoma)	NULL
EXP064112	anti-Rad21 (Abcam, Cat#4321)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	O60216	Ramos (Burkitt lymphoma)	NULL
EXP064113	anti-Spt5 (Santa Cruz Biotechnology, H-300x; Cat#sc-28678; RRID: AB_668824)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064095	768	normal	O00267	Ramos (Burkitt lymphoma)	NULL
EXP064114	anti-YY1 (Santa Cruz Biotechnology, Cat#7341X)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P25490	Ramos (Burkitt lymphoma)	NULL
EXP064115	anti-YY2 (Sigma, Cat#HPA030335)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	O15391	Ramos (Burkitt lymphoma)	NULL
EXP064116	anti-ZEB1 (Proteintech, Cat#21544-1-AP)	Homo sapiens	Treatment: Treatment: none; Genotype: wildtype; Genotype: wildtype	EXP064094	768	normal	P37275	Ramos (Burkitt lymphoma)	NULL
EXP064117	none	Homo sapiens	Treatment: untreated	NULL	4717	chip_control	NULL	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	NULL
EXP064118	none	Homo sapiens	Treatment: untreated	NULL	388	chip_control	NULL	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP064119	anti-TTF-1 (#MS-699-P, Lab Vision Corporation, Fremont, CA, USA)	Homo sapiens	Treatment: untreated	EXP064117	4717	normal	P43699	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	NULL
EXP064120	anti-ASCL1 (#556604, BD Biosciences, Franklin Lakes, NJ, USA)	Homo sapiens	Treatment: untreated	EXP064117	4717	normal	P50553	NCI-H209 (Small cell lung carcinoma. Derived from metastatic site: Bone marrow)	NULL
EXP064121	anti-TTF-1 (#MS-699-P, Lab Vision Corporation, Fremont, CA, USA)	Homo sapiens	Treatment: untreated	EXP064118	388	normal	P43699	NCI-H441 (squamous cell lung carcinoma )	NULL
EXP064122	none, input	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	821	chip_control	NULL	SW480 (colon adenocarcinoma)	NULL
EXP064123	anti-LSD1 (abcam, ab17721)	Homo sapiens	Treatment: none; Genotype: LSD1 knockdown	EXP064122	821	normal	O60341	SW480 (colon adenocarcinoma)	NULL
EXP064124	anti-LSD1 (abcam, ab17721)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064122	821	bio_control	O60341	SW480 (colon adenocarcinoma)	NULL
EXP064125	none	Homo sapiens	Treatment: 50ng/m doxycycline for 6 hrs; Time point: 6 hrs; Genotype: PAX2 oeverexpression	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064126	none	Homo sapiens	Treatment: 50ng/ml doxycycline+ 1 uM tamoxifen for 6 hrs; Time point: 6 hrs; Genotype: PAX2 oeverexpression	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064127	anti-HA tag (abcam: ab9110)	Homo sapiens	Treatment: Veh control; Time point: 6 hrs; Genotype: wildtype	NULL	113	bio_control	Q02962	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064128	anti-HA tag (abcam: ab9110)	Homo sapiens	Treatment: 50ng/m doxycycline for 6 hrs; Time point: 6 hrs; Genotype: PAX2 oeverexpression	EXP064125	113	normal	Q02962	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064129	anti-HA tag (abcam: ab9110)	Homo sapiens	Treatment: 50ng/ml doxycycline+ 1 uM tamoxifen for 6 hrs; Time point: 6 hrs; Genotype: PAX2 oeverexpression	EXP064126	113	normal	Q02962	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064130	anti-FLAG, Sigma Aldrich (clone M2, catF1804)	Homo sapiens	Treatment: non tagged Flag; Conditions: IP control; Genotype: wildtype	NULL	980	chip_control	NULL	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP064131	anti-RBBP4 (Epigentek, catA-2703 lotA511004 pAb)	Homo sapiens	Treatment: none; Conditions: NuRD Complex	NULL	980	normal	Q09028	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP064132	anti-FLAG (Sigma Aldrich, clone M2, catF1804)	Homo sapiens	Treatment: CHD4 - nFlag; Conditions: NuRD Complex; Genotype: wildtype, CHD4 flag tagged	EXP064130	980	normal	Q14839	RH4 (alveolar rhabdomyosarcoma)	NULL
EXP064133		Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064134	None	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064135	None	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064136	None	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064137	None	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064138	None	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064139	anti-BAF155 (Santa Cruz, SC-9746)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064133	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064140	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064133	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064141	anti-BAF155 (Santa Cruz, SC-9746)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064138	113	normal	Q92922	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064142	anti-BRG1 (Abcam, ab110641)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064138	113	normal	P51532	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064143	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064134	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064144	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064135	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064145	anti-GRHL1 (Novus Biologicals, NBP1-81321)	Homo sapiens	Treatment: sgRNA control, DMSO treated; Genotype: wildtype	EXP064134	113	normal	Q9NZI5	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064146	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064136	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064147	anti-FOXA1 (Abcam, ab23738)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064137	113	normal	P55317	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064148	anti-GRHL1 (Novus Biologicals, NBP1-81321)	Homo sapiens	Treatment: sgRNA against ARID1A, DMSO treated; Genotype: ARID1A knockout	EXP064136	113	normal	Q9NZI5	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064149	N/A	Homo sapiens	Treatment: none	NULL	4258	chip_control	NULL	T HESCs (Telomerase immortalized cell line)	NULL
EXP064150	anti-EGR1 (Cell Signaling 4154)	Homo sapiens	Treatment: none	EXP064149	4258	normal	P18146	T HESCs (Telomerase immortalized cell line)	NULL
EXP064151	None	Homo sapiens	Treatment: none	NULL	4272	chip_control	NULL	WA09 (H9) hESC-derived neurons	NULL
EXP064152	anti-HA (Rabbit-Sigma-H6908)	Homo sapiens	Treatment: none	EXP064151	4272	normal	Q9HCK8	WA09 (H9) hESC-derived neurons	NULL
EXP064153	anti-CHD8 (Rabbit-Bethyl lab-A301-224A)	Homo sapiens	Treatment: none	EXP064151	4272	normal	Q9HCK8	WA09 (H9) hESC-derived neurons	NULL
EXP064154	IgG antibody	Homo sapiens	Treatment: none	NULL	38	chip_control	NULL	A549 (lung carcinoma)	NULL
EXP064155	anti-Nrf2 (Santa Cruz Biotechnology)	Homo sapiens	Treatment: none	EXP064154	38	normal	Q16236	A549 (lung carcinoma)	NULL
EXP064156	anti-Twist1 (Abcam, ab50887)	Homo sapiens	Treatment: 600 uM metformin for 48hrs	NULL	4779	normal	Q15672	PLC/PRF/5 (Hepatocellular carcinoma)	NULL
EXP064157	anti-YY1 (Abcam, ab109237)	Homo sapiens	Treatment: 600 uM metformin for 48h rs	NULL	4779	normal	P25490	PLC/PRF/5 (Hepatocellular carcinoma)	NULL
EXP064158	anti-Twist1 (Abcam, ab50887)	Homo sapiens	Treatment: control	NULL	4779	normal	Q15672	PLC/PRF/5 (Hepatocellular carcinoma)	NULL
EXP064159	anti-PU.1 (Santa Cruz, catalog# sc-352X)	Homo sapiens	Treatment: none	NULL	4780	normal	P17947	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064160	anti-PU.1 (Santa Cruz, catalog# sc-352X)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	P17947	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064161	anti-CEBPB (Santa Cruz, catalog# sc-150X)	Homo sapiens	Treatment: none	NULL	4780	normal	P17676	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064162	anti-CEBPB (Santa Cruz, catalog# sc-150X)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	P17676	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064163	anti-IRF1 (Santa Cruz, catalog# sc-497)	Homo sapiens	Treatment: none	NULL	4780	normal	P10914	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064164	anti-IRF1 (Santa Cruz, catalog# sc-497)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	P10914	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064165	anti-P300 (Abcam, catalog# ab14984)	Homo sapiens	Treatment: none	NULL	4780	normal	Q09472	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064166	anti-P300 (Abcam, catalog# ab14984)	Homo sapiens	Treatment: 100 uM ZnSO4 treatment for 4 hrs; Time point: 4 hrs	NULL	4780	normal	Q09472	U937-PR9 (acute promyeloid leukemia)	NULL
EXP064167	N/A	Homo sapiens	Treatment: Hormone-deprived media for 48 hrs, veh for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064168	N/A	Homo sapiens	Treatment: Hormone-deprived media for 48 hrs, E2 for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064169	N/A	Homo sapiens	Treatment: Hormone-deprived media with Dox for 48 hrs, veh for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064170	N/A	Homo sapiens	Treatment: Hormone-deprived media with Dox for 48 hrs, E2 for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064171	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media for 48 hrs, veh for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064167	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064172	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media for 48 hrs, E2 for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064168	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064173	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media with Dox for 48 hrs, veh for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064169	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064174	anti-ER (Santa Cruz, sc-8002, clone F-10)	Homo sapiens	Treatment: Hormone-deprived media with Dox for 48 hrs, E2 for 45 min; Genotype: doxycycline inducible NF1 knockdown model; Time point: 45 mins	EXP064170	113	normal	P03372	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064175	NA	Homo sapiens	Treatment: none	NULL	779	chip_control	NULL	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP064176	anti-BCL6 (Rabbit, 2ug, 4242, Cell Signaling)	Homo sapiens	Treatment: none	EXP064175	779	normal	P41182	RS4-11 (adult B acute lymphoblastic leukemia)	NULL
EXP064177	none	Homo sapiens	Treatment: none	NULL	509	chip_control	NULL	Jurkat (T-cells)	NULL
EXP064178	anti-Notch1 (provided by Dr. Jon C. Aster)	Homo sapiens	Treatment: none	EXP064177	509	normal	P46531	Jurkat (T-cells)	NULL
EXP064179	anti-CTNNB1 (BD Bioscience, 610154)	Homo sapiens	Treatment: none	EXP064177	509	normal	P35222	Jurkat (T-cells)	NULL
EXP064180	none	Homo sapiens	Treatment: none	NULL	2711	chip_control	NULL	P493 (Lymphoma derived)	NULL
EXP064181	anti-Myc (Santa Cruz Biotechnology, Catalog#: sc-764, Antibody name: N262, Lot#: D0413)	Homo sapiens	Treatment: none	EXP064180	2711	normal	P01106	P493 (Lymphoma derived)	NULL
EXP064182	anti-Myc (Santa Cruz Biotechnology, Catalog#: sc-764, Antibody name: N262, Lot#: D0413)	Homo sapiens	Treatment: MST-312	NULL	2711	normal	P01106	P493 (Lymphoma derived)	NULL
EXP064183	anti-FLAG (M2 Affinity Gel, Sigma)	Homo sapiens	Treatment: none; Genotype: pNTAP-2Ã—flag expression vectors	NULL	10	normal	Q9H8Y1	HEK293T (embryonic kidney)	NULL
EXP064184		Homo sapiens	Treatment: treated with 5-Azacitidine; Genotype: TET2 knockdown	NULL	4786	chip_control	NULL	acute myeloid leukemia (AML)	NULL
EXP064185	anti-LSD1	Homo sapiens	Treatment: treated with 5-Azacitidine; Genotype: TET2 knockdown	NULL	4786	normal	O60341	acute myeloid leukemia (AML)	NULL
EXP064186		Homo sapiens	Treatment: none	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP064187		Homo sapiens	Treatment: none	NULL	848	chip_control	NULL	U2OS (osteosarcoma)	NULL
EXP064188	anti-NELFE (Milipore, Cat# ABE48)	Homo sapiens	Treatment: none	EXP064186	848	normal	P18615	U2OS (osteosarcoma)	NULL
EXP064189	anti-NELFE (Milipore, Cat# ABE48)	Homo sapiens	Treatment: none	EXP064187	848	normal	P18615	U2OS (osteosarcoma)	NULL
EXP064190	Rabbit IgG	Homo sapiens	Treatment: 50 ng/mL Wnt-3a for 4 hours	NULL	4787	chip_control	NULL	SW1783 (Anaplastic astrocytoma)	NULL
EXP064191	anti-KDM4C antibody (Bethyl Laboratories, A300-885A)	Homo sapiens	Treatment: 50 ng/mL Wnt-3a for 4 hours	EXP064190	4787	normal	Q9H3R0	SW1783 (Anaplastic astrocytoma)	NULL
EXP064192	anti-TCF4 antibody (Cell signaling, #2569)	Homo sapiens	Treatment: 50 ng/mL Wnt-3a for 4 hours	EXP064190	4787	normal	P15884	SW1783 (Anaplastic astrocytoma)	NULL
EXP064193		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Donor: 1; Donor: 1	NULL	4789	chip_control	NULL	alveolar type 2 cells (AT2 cells)	NULL
EXP064194		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Time point: day 4 of differentiation; Donor: 1; Time point: day 4 of differentiation; Donor: 1; Time point: day 4 of differentiation	NULL	4791	chip_control	NULL	in vitro differentiated AT1-like cells	NULL
EXP064195		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Time point: day 6 of differentiation; Donor: 1; Time point: day 6 of differentiation; Donor: 1; Time point: day 6 of differentiation	NULL	4791	chip_control	NULL	in vitro differentiated AT1-like cells	NULL
EXP064196		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Donor: 2; Donor: 2	NULL	4789	chip_control	NULL	alveolar type 2 cells (AT2 cells)	NULL
EXP064197		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Time point: day 4 of differentiation; Donor: 2; Time point: day 4 of differentiation; Donor: 2; Time point: day 4 of differentiation	NULL	4791	chip_control	NULL	in vitro differentiated AT1-like cells	NULL
EXP064198		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Time point: day 6 of differentiation; Donor: 2; Time point: day 6 of differentiation; Donor: 2; Time point: day 6 of differentiation	NULL	4791	chip_control	NULL	in vitro differentiated AT1-like cells	NULL
EXP064199		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 3; Donor: 3; Donor: 3	NULL	4789	chip_control	NULL	alveolar type 2 cells (AT2 cells)	NULL
EXP064200		Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 3; Time point: day 6 of differentiation; Donor: 3; Time point: day 6 of differentiation; Donor: 3; Time point: day 6 of differentiation	NULL	4791	chip_control	NULL	in vitro differentiated AT1-like cells	NULL
EXP064201	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Donor: 1; Donor: 1	EXP064193	4789	normal	P49711	alveolar type 2 cells (AT2 cells)	NULL
EXP064202	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Time point: day 4 of differentiation; Donor: 1; Time point: day 4 of differentiation; Donor: 1; Time point: day 4 of differentiation	EXP064194	4791	normal	P49711	in vitro differentiated AT1-like cells	NULL
EXP064203	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 1; Time point: day 6 of differentiation; Donor: 1; Time point: day 6 of differentiation; Donor: 1; Time point: day 6 of differentiation	EXP064195	4791	normal	P49711	in vitro differentiated AT1-like cells	NULL
EXP064204	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Donor: 2; Donor: 2	EXP064196	4789	normal	P49711	alveolar type 2 cells (AT2 cells)	NULL
EXP064205	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Time point: day 4 of differentiation; Donor: 2; Time point: day 4 of differentiation; Donor: 2; Time point: day 4 of differentiation	EXP064197	4791	normal	P49711	in vitro differentiated AT1-like cells	NULL
EXP064206	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 2; Time point: day 6 of differentiation; Donor: 2; Time point: day 6 of differentiation; Donor: 2; Time point: day 6 of differentiation	EXP064198	4791	normal	P49711	in vitro differentiated AT1-like cells	NULL
EXP064207	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 3; Donor: 3; Donor: 3	EXP064199	4789	normal	P49711	alveolar type 2 cells (AT2 cells)	NULL
EXP064208	anti-CTCF (Cat # 2899S, Cell Signaling Technology)	Homo sapiens	Treatment: Treatment: Treatment: none; Donor: 3; Time point: day 6 of differentiation; Donor: 3; Time point: day 6 of differentiation; Donor: 3; Time point: day 6 of differentiation	EXP064200	4791	normal	P49711	in vitro differentiated AT1-like cells	NULL
EXP064209		Homo sapiens	Treatment: Treatment: no doxycycline	NULL	4792	chip_control	NULL	HMLE-S4	NULL
EXP064210	anti-SOX4 antibody (CS-129-100, Diagenode)	Homo sapiens	Treatment: Treatment: 1 ug/ml of doxycycline for 16 hrs; Time point: 16 hrs; Time point: 16 hrs	NULL	4792	normal	Q06945	HMLE-S4	NULL
EXP064211	anti-SOX4 antibody (CS-129-100, Diagenode)	Homo sapiens	Treatment: Treatment: no doxycycline	EXP064209	4792	normal	Q06945	HMLE-S4	NULL
EXP064212	none	Mus musculus	Treatment: Treatment: Treatment: none; Genotype: Esrrb overexpression; Genotype: Esrrb overexpression; Genotype: Esrrb overexpression	NULL	96	chip_control	NULL	trophoblast stem cells	NULL
EXP064213	anti-Flag M2 (Sigma, F1804?	Mus musculus	Treatment: Treatment: Treatment: none; Genotype: Esrrb overexpression; Genotype: Esrrb overexpression; Genotype: Esrrb overexpression	EXP064212	96	normal	Q61539	trophoblast stem cells	NULL
EXP064214	anti-FLAG (M2) antibody (Sigma)	Mus musculus	Treatment: none; Genotype: wildtype (emrty vector)	NULL	4793	normal	Q9JJP2	Th1 cells from spleen	NULL
EXP064215	anti-FLAG (M2) antibody (Sigma)	Mus musculus	Treatment: none; Genotype: Trp73 overexpressed	NULL	4793	normal	Q9JJP2	Th1 cells from spleen	NULL
EXP064216		Mus musculus	Treatment: Treatment: untreated; Developmental stage: blastocyst derived; Genotype: Mll1fl/fl, Cre-ER TM; Strain: C57BL/6J; Developmental stage: blastocyst derived; Genotype: Mll1fl/fl, Cre-ER TM; Strain: C57BL/6J	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064217	anti-MLL1	Mus musculus	Treatment: Treatment: untreated; Developmental stage: blastocyst derived; Genotype: Mll1fl/fl, Cre-ER TM; Strain: C57BL/6J; Developmental stage: blastocyst derived; Genotype: Mll1fl/fl, Cre-ER TM; Strain: C57BL/6J	EXP064216	2	normal	P55200	mESCs (mouse embryonic stem cells)	NULL
EXP064218		Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 0 hrs	NULL	5	chip_control	NULL	liver	NULL
EXP064219	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 0 hrs; Genotype: GR knockout	NULL	5	normal	P06537	liver	NULL
EXP064220	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 0 hrs	NULL	5	normal	P06537	liver	NULL
EXP064221	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 4 hrs	NULL	5	normal	P06537	liver	NULL
EXP064222	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 8 hrs	NULL	5	normal	P06537	liver	NULL
EXP064223	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 12 hrs	NULL	5	normal	P06537	liver	NULL
EXP064224	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 16 hrs	NULL	5	normal	P06537	liver	NULL
EXP064225	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 20 hrs	NULL	5	normal	P06537	liver	NULL
EXP064226	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 0 hrs	NULL	5	normal	P06537	liver	NULL
EXP064227	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 4 hrs	NULL	5	normal	P06537	liver	NULL
EXP064228	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 8 hrs	NULL	5	normal	P06537	liver	NULL
EXP064229	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 12 hrs	NULL	5	normal	P06537	liver	NULL
EXP064230	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 16 hrs	NULL	5	normal	P06537	liver	NULL
EXP064231	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 20 hrs	NULL	5	normal	P06537	liver	NULL
EXP064232	anti-PPARalpha (Santa Cruz, sc-9000X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 week control Diet (Research Diet, D12329); Time point: 12 hrs	NULL	5	normal	P23204	liver	NULL
EXP064233	anti-PPARalpha (Santa Cruz, sc-9000X)	Mus musculus	Treatment: none; Strain: C57BL/6J; Conditions: 12 weeks High Fat Diet (Research Diet, D12331); Time point: 12 hrs	NULL	5	normal	P23204	liver	NULL
EXP064234	rabbit IgG (CST: 2729P)	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4794	chip_control	NULL	B6ES (Embryonic stem cells cell line)	NULL
EXP064235	mouse IgG (Millipore: 12-371)	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4794	chip_control	NULL	B6ES (Embryonic stem cells cell line)	NULL
EXP064236	rabbit IgG (CST: 2729P)	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4795	chip_control	NULL	B6TS (trophoblast stem cells cell line)	NULL
EXP064237	mouse IgG (Millipore: 12-371)	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4795	chip_control	NULL	B6TS (trophoblast stem cells cell line)	NULL
EXP064238	none	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4795	chip_control	NULL	B6TS (trophoblast stem cells cell line)	NULL
EXP064239	anti-KLF5 antibody (Millipore: 07-1580)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064234	4794	normal	Q9Z0Z7	B6ES (Embryonic stem cells cell line)	NULL
EXP064240	anti-TEAD4 antibody (Abcam: ab58310)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064235	4794	normal	Q62296	B6ES (Embryonic stem cells cell line)	NULL
EXP064241	anti-KLF5 antibody (Millipore: 07-1580)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064236	4795	normal	Q9Z0Z7	B6TS (trophoblast stem cells cell line)	NULL
EXP064242	anti-TEAD4 antibody (Abcam: ab58310)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064237	4795	normal	Q62296	B6TS (trophoblast stem cells cell line)	NULL
EXP064243	anti-TEAD4 antibody (Abcam: ab58310)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064238	4795	normal	Q62296	B6TS (trophoblast stem cells cell line)	NULL
EXP064244	N/A	Mus musculus	Treatment: none; Time point: 0 hrs; Genotype: wildtype; Strain: C57BL/6	NULL	4796	chip_control	NULL	DC1940 (dendritic cells cell line)	NULL
EXP064245	anti-NCoR1	Mus musculus	Treatment: before CpG ligand activation; Time point: 0 hrs; Genotype: wildtype; Strain: C57BL/6	EXP064244	4796	normal	Q60974	DC1940 (dendritic cells cell line)	NULL
EXP064246	anti-NCoR1	Mus musculus	Treatment: 6 hrs after CpG ligand activation; Time point: 6 hrs; Genotype: wildtype; Strain: C57BL/6	NULL	4796	normal	Q60974	DC1940 (dendritic cells cell line)	NULL
EXP064247	anti-Pu1	Mus musculus	Treatment: before CpG ligand activation; Time point: 0 hrs; Genotype: wildtype; Strain: C57BL/6	EXP064244	4796	normal	P17433	DC1940 (dendritic cells cell line)	NULL
EXP064248	anti-Pu1	Mus musculus	Treatment: 6 hrs after CpG ligand activation; Time point: 6 hrs; Genotype: wildtype; Strain: C57BL/6	NULL	4796	normal	P17433	DC1940 (dendritic cells cell line)	NULL
EXP064249	none (input)	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064250	none (input)	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064251	none (input)	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064252	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064249	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	NULL
EXP064253	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064250	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	NULL
EXP064254	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064251	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	NULL
EXP064255	anti-HA antibody	Mus musculus	Treatment: 0.4 ug/mL Dox treated for 16 hrs; Genotype: DMEM knockout; Time point: 16 hrs	EXP064251	230	normal	Q8BG30	ES-E14 (E14, embryonic stem cells)	NULL
EXP064256	anti-Gli2  (homemade)	Mus musculus	Treatment: Treatment: none; Genotype: Sufu, Spop double knockout; Genotype: Sufu, Spop double knockout	HEXP005600	4800	normal	Q0VGT2	E17.5 stomach	NULL
EXP064257		Mus musculus	Treatment: 2% matrigel added at EB day 1, dox added at 12 hrs; Genotype: Wdr5 knockout, hWDR5 rescue; Time point: day 6	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP064258		Mus musculus	Treatment: 2% matrigel added at EB day 1, dox added at 48 hrs; Genotype: Wdr5 knockout, hWDR5 rescue; Time point: day 6	NULL	2565	chip_control	NULL	embryonic stem cells derived embryonic bodies	NULL
EXP064259	anti-HA antibody 	Mus musculus	Treatment: 2% matrigel added at EB day 1, dox added at 12 hrs; Genotype: Wdr5 knockout, hWDR5 rescue; Time point: day 6	EXP064257	2565	normal	P61965	embryonic stem cells derived embryonic bodies	NULL
EXP064260	anti-HA antibody 	Mus musculus	Treatment: 2% matrigel added at EB day 1, dox added at 48 hrs; Genotype: Wdr5 knockout, hWDR5 rescue; Time point: day 6	EXP064258	2565	normal	P61965	embryonic stem cells derived embryonic bodies	NULL
EXP064261	none	Mus musculus	Treatment: no CuSO4, Insulinâ€“Transferrinâ€“Selenium-A supplement; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP064262	none	Mus musculus	Treatment: no CuSO4, Insulinâ€“Transferrinâ€“Selenium-A supplement; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	NULL	2466	chip_control	NULL	primary myoblasts	NULL
EXP064263	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: no CuSO4, Insulinâ€“Transferrinâ€“Selenium-A supplement; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	EXP064261	2466	normal	Q07243	primary myoblasts	NULL
EXP064264	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: no CuSO4, Insulinâ€“Transferrinâ€“Selenium-A supplement; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	EXP064262	2466	normal	Q07243	primary myoblasts	NULL
EXP064265	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: no CuSO4; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	NULL	2466	normal	Q07243	primary myoblasts	NULL
EXP064266	anti-Mtf1 (Santa Cruz, biotechnologies) + Magna ChIP protein A+G Magnetic Beads (Millipore, Sigma)	Mus musculus	Treatment: 100 uM CuSO4Â ; Genotype: wildtype; Age: 3-6 week old; Strain: C57Bl/6	NULL	2466	normal	Q07243	primary myoblasts	NULL
EXP064267	Anti-IgG Abcam (ab46540)	Mus musculus	Treatment: none; Genotype: wildtype; Sex: male; Age: Adult	NULL	2748	chip_control	NULL	adult testis	NULL
EXP064268	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 +/+; Sex: male; Age: 12 days post partum	NULL	3056	normal	Q61880	postnatal testis	NULL
EXP064269	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 +/-; Sex: male; Age: 12 days post partum	NULL	3056	normal	Q61880	postnatal testis	NULL
EXP064270	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 -/- (Ankrd31 knockout); Sex: male; Age: 12 days post partum	NULL	3056	normal	Q61880	postnatal testis	NULL
EXP064271	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Ankrd31 -/- (Ankrd31 knockout); Sex: male; Age: 12 days post partum	NULL	2748	normal	Q61880	adult testis	NULL
EXP064272	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: wildtype; Sex: male; Age: Adult	EXP064267	2748	normal	Q61880	adult testis	NULL
EXP064273	anti-DMC1 (Santa Cruz, C-20, sc 8973)	Mus musculus	Treatment: none; Genotype: Prdm9 -/- (Prdm9 knockout); Sex: male; Age: Adult	NULL	2748	normal	Q61880	adult testis	NULL
EXP064274	none	Mus musculus	Treatment: none	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064275	none	Mus musculus	Treatment: none	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064276	anti-CTCF (Abcam ab70303)	Mus musculus	Treatment: none	EXP064274	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP064277	anti-CTCF (Abcam ab70303)	Mus musculus	Treatment: none	EXP064275	230	normal	Q61164	ES-E14 (E14, embryonic stem cells)	NULL
EXP064278	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	NULL
EXP064279	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 24 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	NULL
EXP064280	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	NULL
EXP064281	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 24 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	NULL
EXP064282	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	NULL
EXP064283	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	NULL
EXP064284	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: Th17 culture conditions (20 ng/ml IL-6; 5 ng/ml human TGFb; 10 ng/ml IL-1b, 10 ug/ml anti-IL-4, and 10 ug/ml anti-IFNg) for 48 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 2 days	NULL	4151	normal	O35284	activated CD4+ T cells from sleen	NULL
EXP064285	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	NULL	4811	normal	O35284	naive CD4+ T cells spleen and lymph nodes	NULL
EXP064286	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	NULL
EXP064287	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	NULL
EXP064288	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	NULL
EXP064289	anti-Med12 (Bethyl, A300-774A, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	A2AGH6	activated CD4+ T cells from sleen	NULL
EXP064290	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	NULL	4811	normal	Q61164	naive CD4+ T cells spleen and lymph nodes	NULL
EXP064291	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6	NULL	4811	normal	Q61164	naive CD4+ T cells spleen and lymph nodes	NULL
EXP064292	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064293	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064294	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064295	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064296	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: Th17 culture conditions (20 ng/ml IL-6; 5 ng/ml human TGFb; 10 ng/ml IL-1b, 10 ug/ml anti-IL-4, and 10 ug/ml anti-IFNg) for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064297	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: Th17 culture conditions (20 ng/ml IL-6; 5 ng/ml human TGFb; 10 ng/ml IL-1b, 10 ug/ml anti-IL-4, and 10 ug/ml anti-IFNg) for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064298	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064299	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: none; Genotype: Ets1c knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064300	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064301	anti-CTCF (Active Motif, 61311, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: Ets1c knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064302	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	NULL
EXP064303	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	NULL
EXP064304	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	NULL
EXP064305	anti-Ets1 (Santa Cruz, sc 350X, raabit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: BATF knockout; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	P27577	activated CD4+ T cells from sleen	NULL
EXP064306	anti-BATF (Schraml et al., 2010, rabbit)	Mus musculus	Treatment: none; Genotype: BATF knockout; Strain: C57BL/6	NULL	4140	normal	O35284	naive CD4 T cells spleen/lymh nodes	NULL
EXP064307	CTCF	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064308	CTCF	Mus musculus	Treatment: 20 ng/ml IL-6 for 24 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 1 day	NULL	4151	normal	Q61164	activated CD4+ T cells from sleen	NULL
EXP064309	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	NULL
EXP064310	anti-IRF4 (Santa Cruz, sc-28696 X, rabbit)	Mus musculus	Treatment: 20 ng/ml IL-6 for 96 hrs; Genotype: wildtype; Strain: C57BL/6; Time point: 4 days	NULL	4151	normal	Q64287	activated CD4+ T cells from sleen	NULL
EXP064311		Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	NULL	4813	chip_control	NULL	prefrontal cortex	NULL
EXP064312		Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	NULL	4813	chip_control	NULL	prefrontal cortex	NULL
EXP064313	anti-Mef2 (sc-313, Santa Cruz Biotechnology)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064311	4813	normal	Q8C854	prefrontal cortex	NULL
EXP064314	anti-Mef2 (sc-313, Santa Cruz Biotechnology)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064312	4813	normal	Q8C854	prefrontal cortex	NULL
EXP064315	anti-LSD1 (ab17721, Abcam)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064311	4813	normal	Q6ZQ88	prefrontal cortex	NULL
EXP064316	anti-LSD1 (ab17721, Abcam)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064312	4813	normal	Q6ZQ88	prefrontal cortex	NULL
EXP064317	anti-Setd1a (A300-289, Bethyl)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064311	4813	normal	E9PYH6	prefrontal cortex	NULL
EXP064318	anti-Setd1a (A300-289, Bethyl)	Mus musculus	Treatment: Treatment: none; Age: 6 weeks old; Sex: male; Age: 6 weeks old; Sex: male	EXP064312	4813	normal	E9PYH6	prefrontal cortex	NULL
EXP064319	none	Mus musculus	Treatment: Tamoxifen induced RBPJ knock-out; Genotype: Rbpj knockout; Time point: day 4	NULL	4814	chip_control	NULL	intestinal crypt epithelial cells	NULL
EXP064320	none	Mus musculus	Treatment: Tamoxifen induced RBPJ knock-out; Genotype: Rbpj knockout; Time point: day 4	NULL	4814	chip_control	NULL	intestinal crypt epithelial cells	NULL
EXP064321	anti-Mtg16 (Abcam, ab33072)	Mus musculus	Treatment: Tamoxifen induced RBPJ knock-out; Genotype: Rbpj knockout; Time point: day 4	EXP064319	4814	normal	O54972	intestinal crypt epithelial cells	NULL
EXP064322	anti-Mtg16 (Abcam, ab33072)	Mus musculus	Treatment: Tamoxifen induced RBPJ knock-out; Genotype: Rbpj knockout; Time point: day 4	EXP064320	4814	normal	O54972	intestinal crypt epithelial cells	NULL
EXP064323		Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064324		Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064325		Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064326		Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064327		Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064328		Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064329		Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064330		Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	NULL	5	chip_control	NULL	liver	NULL
EXP064331	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064323	5	normal	P49698	liver	NULL
EXP064332	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064324	5	normal	P49698	liver	NULL
EXP064333	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064325	5	normal	P49698	liver	NULL
EXP064334	anti-HNF4a (Abcam, ab41898	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064326	5	normal	P49698	liver	NULL
EXP064335	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064327	5	normal	P53566	liver	NULL
EXP064336	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: high fat diet; Sex: male; Strain: C57BL/6	EXP064328	5	normal	P53566	liver	NULL
EXP064337	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064329	5	normal	P53566	liver	NULL
EXP064338	anti-CEBPa (Abcam, ab40764)	Mus musculus	Treatment: none; Conditions: low fat diet; Sex: male; Strain: C57BL/6	EXP064330	5	normal	P53566	liver	NULL
EXP064339	none	Mus musculus	Treatment: none; Genotype: wildtype; Passage: Proliferating passage 4	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP064340	none	Mus musculus	Treatment: none; Genotype: wildtype; Passage: Proliferating passage 4	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP064341	none	Mus musculus	Treatment: none; Genotype: Rb1L/L; Passage: Proliferating passage 4	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP064342	none	Mus musculus	Treatment: none; Genotype: Rb1L/L; Passage: Proliferating passage 4	NULL	750	chip_control	NULL	E13.5 embryonic fibroblasts	NULL
EXP064343	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: wildtype; Passage: Proliferating passage 4	EXP064339	750	normal	Q8K284	E13.5 embryonic fibroblasts	NULL
EXP064344	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: wildtype; Passage: Proliferating passage 4	EXP064340	750	normal	Q8K284	E13.5 embryonic fibroblasts	NULL
EXP064345	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: Rb1L/L; Passage: Proliferating passage 4	EXP064341	750	normal	Q8K284	E13.5 embryonic fibroblasts	NULL
EXP064346	anti-TFIIIC-220 (Bethyl, A301-291A)	Mus musculus	Treatment: none; Genotype: Rb1L/L; Passage: Proliferating passage 4	EXP064342	750	normal	Q8K284	E13.5 embryonic fibroblasts	NULL
EXP064347	none	Mus musculus	Treatment: sh Control; Genotype: wildtype	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP064348	none	Mus musculus	Treatment: shRNA against Zfp281; Genotype: Zfp281 knockout	NULL	252	chip_control	NULL	V6.5 (embryonic stem cells)	NULL
EXP064349	anti-C-Myc(N-262, Santa Cruz, catalog# sc-764, lot# 12613)	Mus musculus	Treatment: sh Control; Genotype: wildtype	EXP064347	252	normal	P01108	V6.5 (embryonic stem cells)	NULL
EXP064350	anti-C-Myc(N-262, Santa Cruz, catalog# sc-764, lot# 12613)	Mus musculus	Treatment: shRNA against Zfp281; Genotype: Zfp281 knockout	EXP064348	252	normal	P01108	V6.5 (embryonic stem cells)	NULL
EXP064351	none	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4825	chip_control	NULL	E6.5 embryos	NULL
EXP064352	anti-PRDM15 Antibody (Guccione lab)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064351	4825	normal	E9Q8T2	E6.5 embryos	NULL
EXP064353	none (input)	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064354	anti-PRDM15 Antibody (Guccione lab)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064353	2	normal	E9Q8T2	mESCs (mouse embryonic stem cells)	NULL
EXP064355	none	Mus musculus	Treatment: none; Genotype: ectopic expression of PPARb; Passage: 7; Strain: FvB/C57BL6 hybrid	NULL	4827	chip_control	NULL	neural stem cell derived oligodendrocyte	NULL
EXP064356	none	Mus musculus	Treatment: none; Strain: C57BL6	NULL	4828	chip_control	NULL	brain oligodendrocyte	NULL
EXP064357	anti-PPARb (Thermo Fisher, Cat# PA1-823A)	Mus musculus	Treatment: none; Genotype: ectopic expression of PPARb; Passage: 7; Strain: FvB/C57BL6 hybrid	EXP064355	4827	normal	P35396	neural stem cell derived oligodendrocyte	NULL
EXP064358	anti-HA (Cell Signaling Technology, #3724S)	Mus musculus	Treatment: none; Genotype: ectopic expression of PPARb; Passage: 7; Strain: FvB/C57BL6 hybrid	EXP064355	4827	normal	P35396	neural stem cell derived oligodendrocyte	NULL
EXP064359	anti-PPARb (Thermo Fisher, Cat# PA1-823A)	Mus musculus	Treatment: none; Strain: C57BL6	EXP064356	4828	normal	P35396	brain oligodendrocyte	NULL
EXP064360	anti-GR ( Proteintech 24050-1-AP)	Mus musculus	Treatment: 16h 1 uM Dex in EtOH + 3 100ng/ul LPS in PBS; Strain: C57BL/6; Sex: male; Genotype: GR wt / wt	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP064361	anti-GR ( Proteintech 24050-1-AP)	Mus musculus	Treatment: 16h 1 uM Dex in EtOH + 3 100ng/ul LPS in PBS; Strain: C57BL/6; Sex: male; Genotype: GR Zn / Zn (GR mutant)	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP064362	anti-GR ( Proteintech 24050-1-AP)	Mus musculus	Treatment: 16h 1 uM Dex in EtOH + 3 100ng/ul LPS in PBS; Strain: C57BL/6; Sex: male; Genotype: GR knockout	NULL	12	normal	P06537	MEF (mouse embryonic fibroblasts)	NULL
EXP064363		Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	NULL	34	chip_control	NULL	A2Lox.cre (embryonic stem cells)	NULL
EXP064364	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	EXP064363	34	normal	O54839	A2Lox.cre (embryonic stem cells)	NULL
EXP064365	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	EXP064363	34	normal	P20293	A2Lox.cre (embryonic stem cells)	NULL
EXP064366	anti-V5 (BioRad, MCA1360, Lot. 0915)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury + Eomes-V5	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	NULL
EXP064367	anti-V5 (BioRad, MCA1360, Lot. 0915)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) + dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury + Eomes-V5	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	NULL
EXP064368	anti-V5 (BioRad, MCA1360, Lot. 0915)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) + dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury + Eomes-VP16	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	NULL
EXP064369	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) +  5 mg/ml dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	NULL	34	normal	O54839	A2Lox.cre (embryonic stem cells)	NULL
EXP064370	anti-GFP (Abcam, ab290, Lot. GR3196305-1)	Mus musculus	Treatment: 30 ng/ml human recombinant ActivinA (ActA) +  5 mg/ml dox from day 2 to day 5; Time point: day 5; Genotype: double knockout of Eomes and Brachyury	NULL	34	normal	P20293	A2Lox.cre (embryonic stem cells)	NULL
EXP064371	input	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	NULL	4830	chip_control	NULL	Kupffer cell	NULL
EXP064372	input	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	NULL	4830	chip_control	NULL	Kupffer cell	NULL
EXP064373	input	Mus musculus	Treatment: in vitro 7 day cultured BMDMs, GW3965 18hrs; Strain: C57BL/6J; Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP064374	input	Mus musculus	Treatment: in vitro 7 day cultured BMDMs, GW3965 18hrs; Strain: C57BL/6J; Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP064375	input	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	NULL	4831	chip_control	NULL	Kupffer cell nuclei	NULL
EXP064376	input	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	NULL	4831	chip_control	NULL	Kupffer cell nuclei	NULL
EXP064377	input	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP064378	input	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP064379	input	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	NULL	4831	chip_control	NULL	Kupffer cell nuclei	NULL
EXP064380	input	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	NULL	4831	chip_control	NULL	Kupffer cell nuclei	NULL
EXP064381	input	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP064382	input	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	NULL	81	chip_control	NULL	BMDM (bone marrow-derived macrophages)	NULL
EXP064383	anti-LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064371	4830	normal	Q9Z0Y9	Kupffer cell	NULL
EXP064384	LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064372	4830	normal	Q9Z0Y9	Kupffer cell	NULL
EXP064385	LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: in vitro 7 day cultured BMDMs, GW3965 18hrs; Strain: C57BL/6J; Genotype: wildtype	EXP064373	81	normal	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	NULL
EXP064386	LXR (2 ug each of  LXR specific antibodies, Santa Cruz Biotechnology: sc-1000X, sc-133221X, sc-271064X)	Mus musculus	Treatment: in vitro 7 day cultured BMDMs, GW3965 18hrs; Strain: C57BL/6J; Genotype: wildtype	EXP064374	81	normal	Q9Z0Y9	BMDM (bone marrow-derived macrophages)	NULL
EXP064387	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064375	4831	normal	P97471	Kupffer cell nuclei	NULL
EXP064388	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064376	4831	normal	P97471	Kupffer cell nuclei	NULL
EXP064389	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064377	81	normal	P97471	BMDM (bone marrow-derived macrophages)	NULL
EXP064390	anti-SMAD4 (1 ug each of Cell Signaling technology 46535 and 38454)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064378	81	normal	P97471	BMDM (bone marrow-derived macrophages)	NULL
EXP064391	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064379	4831	normal	P31266	Kupffer cell nuclei	NULL
EXP064392	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: No treatment; Strain: C57BL/6J; Genotype: Clec4f-cre	EXP064380	4831	normal	P31266	Kupffer cell nuclei	NULL
EXP064393	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064381	81	normal	P31266	BMDM (bone marrow-derived macrophages)	NULL
EXP064394	anti-RBPJ (2 ug, Abcam, ab25949)	Mus musculus	Treatment: in vitro 4 day cultured BMDMs; Strain: C57BL/6J; Genotype: wildtype	EXP064382	81	normal	P31266	BMDM (bone marrow-derived macrophages)	NULL
EXP064395	none	Mus musculus	Treatment: none; Genotype: Esrrb fl/fl  (wildtype)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064396	none	Mus musculus	Treatment: none; Genotype: Esrrb fl/fl  (wildtype)	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064397	none	Mus musculus	Treatment: none; Genotype: Esrrb knockout	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064398	none	Mus musculus	Treatment: none; Genotype: Esrrb knockout	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064399	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb fl/fl  (wildtype)	EXP064395	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP064400	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb fl/fl  (wildtype)	EXP064396	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP064401	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb knockout	EXP064397	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP064402	anti-Med1 (A300-793A Bethyl Laboratories)	Mus musculus	Treatment: none; Genotype: Esrrb knockout	EXP064398	2	normal	Q925J9	mESCs (mouse embryonic stem cells)	NULL
EXP064403	GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 weekd control Diet (Research Diet, D12329); Time point: 6 a.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	NULL
EXP064404	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 wk High Fat Diet (Research Diet, D12331); Time point: 6 a.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	NULL
EXP064405	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 weekd control Diet (Research Diet, D12329); Time point: 6 p.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	NULL
EXP064406	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: none; Conditions: 12 wk High Fat Diet (Research Diet, D12331); Time point: 6 p.m.; Strain: C57BL/6J	NULL	5	normal	P06537	liver	NULL
EXP064407		Mus musculus	Treatment: none; Developmental stage: asynchronized	NULL	4837	chip_control	NULL	G1E-ER4 derived erythroid cells	NULL
EXP064408		Mus musculus	Treatment: synchronized with 200ng/ml nocodazole for 7-8.5 hrs; Developmental stage: synchronized to pro-metaphase	NULL	4837	chip_control	NULL	G1E-ER4 derived erythroid cells	NULL
EXP064409		Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5hrs , released for nocodazole for 25 mins; Developmental stage: ana/telo phase	NULL	4837	chip_control	NULL	G1E-ER4 derived erythroid cells	NULL
EXP064410		Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 60 mins; Developmental stage: early G1	NULL	4837	chip_control	NULL	G1E-ER4 derived erythroid cells	NULL
EXP064411		Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 120 mins; Developmental stage: mid G1	NULL	4837	chip_control	NULL	G1E-ER4 derived erythroid cells	NULL
EXP064412		Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 240 mins; Developmental stage: late G1	NULL	4837	chip_control	NULL	G1E-ER4 derived erythroid cells	NULL
EXP064413	anti-CTCF	Mus musculus	Treatment: none; Developmental stage: asynchronized	EXP064407	4837	normal	Q61164	G1E-ER4 derived erythroid cells	NULL
EXP064414	anti-CTCF	Mus musculus	Treatment: synchronized with 200ng/ml nocodazole for 7-8.5 hrs; Developmental stage: synchronized to pro-metaphase	EXP064408	4837	normal	Q61164	G1E-ER4 derived erythroid cells	NULL
EXP064415	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5hrs , released for nocodazole for 25 mins; Developmental stage: ana/telo phase	EXP064409	4837	normal	Q61164	G1E-ER4 derived erythroid cells	NULL
EXP064416	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 60 mins; Developmental stage: early G1	EXP064410	4837	normal	Q61164	G1E-ER4 derived erythroid cells	NULL
EXP064417	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 120 mins; Developmental stage: mid G1	EXP064411	4837	normal	Q61164	G1E-ER4 derived erythroid cells	NULL
EXP064418	anti-CTCF	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 240 mins; Developmental stage: late G1	EXP064412	4837	normal	Q61164	G1E-ER4 derived erythroid cells	NULL
EXP064419	anti-Rad21	Mus musculus	Treatment: none; Developmental stage: asynchronized	EXP064407	4837	normal	Q61550	G1E-ER4 derived erythroid cells	NULL
EXP064420	anti-Rad21	Mus musculus	Treatment: synchronized with 200ng/ml nocodazole for 7-8.5 hrs; Developmental stage: synchronized to pro-metaphase	EXP064408	4837	normal	Q61550	G1E-ER4 derived erythroid cells	NULL
EXP064421	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5hrs , released for nocodazole for 25 mins; Developmental stage: ana/telo phase	EXP064409	4837	normal	Q61550	G1E-ER4 derived erythroid cells	NULL
EXP064422	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 60 mins; Developmental stage: early G1	EXP064410	4837	normal	Q61550	G1E-ER4 derived erythroid cells	NULL
EXP064423	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 120 mins; Developmental stage: mid G1	EXP064411	4837	normal	Q61550	G1E-ER4 derived erythroid cells	NULL
EXP064424	anti-Rad21	Mus musculus	Treatment: synchronized to pro-metaphase with 200ng/ml nocodazole for 7-8.5h, released for nocodazole for 240 mins; Developmental stage: late G1	EXP064412	4837	normal	Q61550	G1E-ER4 derived erythroid cells	NULL
EXP064425	Normal IgG (Cell Signaling #2729S, Lot7)	Mus musculus	Treatment: Mock; Genotype: HNF-1beta knockout	NULL	478	chip_control	NULL	IMCD3 inner medullary collecting duct)	NULL
EXP064426	None	Mus musculus	Treatment: none; Genotype: HNF-1beta knockout	NULL	478	chip_control	NULL	IMCD3 inner medullary collecting duct)	NULL
EXP064427	Normal IgG (Cell Signaling #2729S, Lot7)	Mus musculus	Treatment: Mock; Genotype: wildtype	NULL	478	chip_control	NULL	IMCD3 inner medullary collecting duct)	NULL
EXP064428	None	Mus musculus	Treatment: none; Genotype: wildtype	NULL	478	chip_control	NULL	IMCD3 inner medullary collecting duct)	NULL
EXP064429	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Mock; Genotype: HNF-1beta knockout	EXP064426	478	normal	Q02248	IMCD3 inner medullary collecting duct)	NULL
EXP064430	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Wnt3a (100ng/ml) for 16hrs; Genotype: HNF-1beta knockout	NULL	478	normal	Q02248	IMCD3 inner medullary collecting duct)	NULL
EXP064431	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Mock; Genotype: wildtype	EXP064428	478	normal	Q02248	IMCD3 inner medullary collecting duct)	NULL
EXP064432	anti-Ctnnb1 (Cell Signaling #8480S, Lot5)	Mus musculus	Treatment: Wnt3a (100ng/ml) for 16hrs; Genotype: wildtype	NULL	478	normal	Q02248	IMCD3 inner medullary collecting duct)	NULL
EXP064433	anti-NELF-E (Abcam, cat# ab28038)	Mus musculus	Treatment: none; Genotype: Wildtype; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	P19426	mESCs (mouse embryonic stem cells)	NULL
EXP064434	anti-NELF-E (Abcam, cat# ab28038)	Mus musculus	Treatment: none; Genotype: SIRT6 knockout; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	P19426	mESCs (mouse embryonic stem cells)	NULL
EXP064435	anti-LEO1 (Bethyl Laboratories. Inc, cat# A300-175A)	Mus musculus	Treatment: none; Genotype: Wildtype; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	Q5XJE5	mESCs (mouse embryonic stem cells)	NULL
EXP064436	anti-LEO1 (Bethyl Laboratories. Inc, cat# A300-175A)	Mus musculus	Treatment: none; Genotype: SIRT6 knockout; Strain: Mouse strain:129 SvJae F1; Passage: 21	NULL	2	normal	Q5XJE5	mESCs (mouse embryonic stem cells)	NULL
EXP064437	anti-Kap1  (Abcam, ab10483)	Mus musculus	Treatment: none; Age: 3 months; Strain: C57BL/6	NULL	5	normal	Q62318	liver	NULL
EXP064438	anti-Kap1  (Abcam, ab10483)	Mus musculus	Treatment: none; Age: 21 months; Strain: C57BL/6	NULL	5	normal	Q62318	liver	NULL
EXP064439	anti-Setdb1 (Proteintech, 11231-1-AP)	Mus musculus	Treatment: none; Age: 3 months; Strain: C57BL/6	NULL	5	normal	O88974	liver	NULL
EXP064440	anti-Setdb1 (Proteintech, 11231-1-AP)	Mus musculus	Treatment: none; Age: 21 months; Strain: C57BL/6	NULL	5	normal	O88974	liver	NULL
EXP064441	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 0 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064442	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 4 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064443	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 8 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064444	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 12 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064445	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 16 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064446	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 20 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064447	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 24 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064448	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 28 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064449	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 32 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064450	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 36 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064451	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 40 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064452	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: wildtype; Time point: 44 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064453	anti-XBP1s (biolegend 6105)	Mus musculus	Treatment: none; Sex: Male; Strain: C57BL/6J; Age: 8-12 weeks of age; Genotype: XBP1 liver-specific knockout; Time point: 0 hrs	NULL	5	bio_control	O35426	liver	NULL
EXP064454	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005918	3087	normal	Q99LI5	RGd2(embryonic stem cells)	NULL
EXP064455	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005919	3087	normal	Q99LI5	RGd2(embryonic stem cells)	NULL
EXP064456	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005920	3087	normal	Q99LI5	RGd2(embryonic stem cells)	NULL
EXP064457	anti-Zfp281 (Bethyl Laboratories, A303-118A)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005921	3087	normal	Q99LI5	RGd2(embryonic stem cells)	NULL
EXP064458	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005918	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064459	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: wildtype	HEXP005919	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064460	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005920	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064461	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: wildtype; Time point: 32 hrs	HEXP005921	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064462	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: Zfp281 knockout	HEXP005922	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064463	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: none; Genotype: Zfp281 knockout	HEXP005923	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064464	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: Zfp281 knockout; Time point: 32 hrs	HEXP005924	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064465	anti-Zic2 (Abcam, ab150404)	Mus musculus	Treatment: 32hrs N2B27; Genotype: Zfp281 knockout; Time point: 32 hrs	HEXP005925	3087	normal	Q62520	RGd2(embryonic stem cells)	NULL
EXP064466	none	Mus musculus	Treatment: none	NULL	2411	chip_control	NULL	Scid.adh.2c2 cells	NULL
EXP064467	none	Mus musculus	Treatment: none	NULL	2411	chip_control	NULL	Scid.adh.2c2 cells	NULL
EXP064468	none	Mus musculus	Treatment: none	NULL	4855	chip_control	NULL	ILC2/b6 cells	NULL
EXP064469	none	Mus musculus	Treatment: none	NULL	4855	chip_control	NULL	ILC2/b6 cells	NULL
EXP064470	none	Mus musculus	Treatment: none	NULL	2411	chip_control	NULL	Scid.adh.2c2 cells	NULL
EXP064471	none	Mus musculus	Treatment: none	NULL	2411	chip_control	NULL	Scid.adh.2c2 cells	NULL
EXP064472	none	Mus musculus	Treatment: none	NULL	4855	chip_control	NULL	ILC2/b6 cells	NULL
EXP064473	none	Mus musculus	Treatment: 1 mg/ml DSG (Thermo Scientific) in PBS for 30 min	NULL	4855	chip_control	NULL	ILC2/b6 cells	NULL
EXP064474	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064470	2411	normal	P23772	Scid.adh.2c2 cells	NULL
EXP064475	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064471	2411	normal	P23772	Scid.adh.2c2 cells	NULL
EXP064476	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064472	4855	normal	P23772	ILC2/b6 cells	NULL
EXP064477	anti-GATA3 (a mixture of sc-268, Santa Cruz Biotechnology and MAB26051, R&D Systems)	Mus musculus	Treatment: none	EXP064473	4855	normal	P23772	ILC2/b6 cells	NULL
EXP064478	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064470	2411	normal	Q99PV8	Scid.adh.2c2 cells	NULL
EXP064479	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064471	2411	normal	Q99PV8	Scid.adh.2c2 cells	NULL
EXP064480	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064472	4855	normal	Q99PV8	ILC2/b6 cells	NULL
EXP064481	anti-Bcl11b (a mixture of A300-383A (Bethyl), A300-385A (Bethyl), ab18465 (Abcam) and 12120 (CST))	Mus musculus	Treatment: none	EXP064473	4855	normal	Q99PV8	ILC2/b6 cells	NULL
EXP064482	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064470	2411	normal	Q03347	Scid.adh.2c2 cells	NULL
EXP064483	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064471	2411	normal	Q03347	Scid.adh.2c2 cells	NULL
EXP064484	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064472	4855	normal	Q03347	ILC2/b6 cells	NULL
EXP064485	anti-Runx1 (ab23980, Abcam)	Mus musculus	Treatment: none	EXP064473	4855	normal	Q03347	ILC2/b6 cells	NULL
EXP064486	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064470	2411	normal	Q64131	Scid.adh.2c2 cells	NULL
EXP064487	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064471	2411	normal	Q64131	Scid.adh.2c2 cells	NULL
EXP064488	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064472	4855	normal	Q64131	ILC2/b6 cells	NULL
EXP064489	anti-Runx3 (kindly provided from Dr. Ditsa Levanon and Dr. Yoram Groner, Weizmann Institute of Science)	Mus musculus	Treatment: none	EXP064473	4855	normal	Q64131	ILC2/b6 cells	NULL
EXP064490	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle I	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064491	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle I	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064492	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle I	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064493	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle M	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064494	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle M	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064495	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle M	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064496	INPUT	Mus musculus	Treatment: no auxin; Developmental stage: cell cycle I	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064497	INPUT	Mus musculus	Treatment: no auxin; Developmental stage: cell cycle M	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064498	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle I	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP064499	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle M	NULL	1153	chip_control	NULL	C2C12 (myoblasts)	NULL
EXP064500	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle I	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP064501	INPUT	Mus musculus	Treatment: none; Developmental stage: cell cycle M	NULL	675	chip_control	NULL	NIH 3T3 (embryonic fibroblasts)	NULL
EXP064502	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Genotype: wildtype; Developmental stage: cell cycle I	EXP064490	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064503	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064491	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064504	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064492	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064505	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064493	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064506	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064494	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064507	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064495	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064508	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064498	1153	normal	Q61164	C2C12 (myoblasts)	NULL
EXP064509	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064499	1153	normal	Q61164	C2C12 (myoblasts)	NULL
EXP064510	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064500	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	NULL
EXP064511	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064501	675	normal	Q61164	NIH 3T3 (embryonic fibroblasts)	NULL
EXP064512	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064490	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP064513	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle I	EXP064491	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP064514	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064493	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP064515	anti-SMC1 (Bethyl Laboratories A300-055A)	Mus musculus	Treatment: none; Developmental stage: cell cycle M	EXP064494	233	normal	Q9CU62	E14TG2A (embryonic stem cells)	NULL
EXP064516	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: no auxin; Developmental stage: cell cycle I; Genotype: CTC FAID	EXP064496	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064517	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: 0.5mM auxin (IAA Sigma, I5148) for 2hrs; Developmental stage: cell cycle I	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064518	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: no auxin; Developmental stage: cell cycle M	EXP064497	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064519	anti-CTCF (Active Motif 61311)	Mus musculus	Treatment: 0.5mM auxin (IAA Sigma, I5148) for 2hrs; Developmental stage: cell cycle M	NULL	233	normal	Q61164	E14TG2A (embryonic stem cells)	NULL
EXP064520	None	Mus musculus	Treatment: none; Genotype: wildtype	NULL	4860	chip_control	NULL	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064521	None	Mus musculus	Treatment: none; Genotype: wildtype	NULL	4860	chip_control	NULL	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064522	None	Mus musculus	Treatment: none; Genotype: Paupar knockout	NULL	4860	chip_control	NULL	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064523	None	Mus musculus	Treatment: none; Genotype: Paupar knockout	NULL	4860	chip_control	NULL	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064524	anti-Pax6	Mus musculus	Treatment: none; Genotype: wildtype	EXP064520	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064525	anti-Pax6	Mus musculus	Treatment: none; Genotype: wildtype	EXP064521	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064526	anti-Pax6	Mus musculus	Treatment: none; Genotype: Paupar knockout	EXP064522	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064527	anti-Pax6	Mus musculus	Treatment: none; Genotype: Paupar knockout	EXP064523	4860	normal	P63015	alphaTC1 (Mouse islet cell adenoma)	NULL
EXP064528	none	Mus musculus	Treatment: normal proliferation	NULL	705	chip_control	NULL	P19 (embryonic carcinoma)	NULL
EXP064529	anti-NIPBL (A301-779A Bethyl)	Mus musculus	Treatment: normal proliferation	EXP064528	705	normal	Q6KCD5	P19 (embryonic carcinoma)	NULL
EXP064530	None	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	NULL	2787	chip_control	NULL	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP064531	anti-Raly (Abcam, Ab170105)	Mus musculus	Treatment: none; Genotype: wildtype; Strain: C57BL/6	EXP064530	2787	normal	Q64012	Hepa1-6 (Hepatocellular carcinoma )	NULL
EXP064532	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, +FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing , BRCA1-/- 53BP1_S25A	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	NULL
EXP064533	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, +FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, BRCA1-/-	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	NULL
EXP064534	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, +FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, wildtype	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	NULL
EXP064535	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, without FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, BRCA1-/-	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	NULL
EXP064536	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, without FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing , BRCA1-/- 53BP1_S25A	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	NULL
EXP064537	anti-RAD51 (Abcam #176458)	Mus musculus	Treatment: treated with 1uM doxocyclin (DOX) for 24 hours and then, for 5 hours with 4-OHT, without FHA-PALB2; Strain: C57BL/6; Genotype: exponentially AsiSI-expressing, wildtype	NULL	12	normal	Q08297	MEF (mouse embryonic fibroblasts)	NULL
EXP064538	IgG (Sigma - I8140)	Mus musculus	Treatment: none; Strain: C57BL/6	NULL	4863	chip_control	NULL	thymocytes isolated from thymus	NULL
EXP064539	anti-TOP2B (SantaCruz â€“ sc13059)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064538	4863	normal	Q64511	thymocytes isolated from thymus	NULL
EXP064540	anti-TOP2B (Novus Biologicals - NB100-40842)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064538	4863	normal	Q64511	thymocytes isolated from thymus	NULL
EXP064541	anti-TOP2A (Abcam - ab52934)	Mus musculus	Treatment: none; Strain: C57BL/6	EXP064538	4863	normal	Q01320	thymocytes isolated from thymus	NULL
EXP064542	none	Mus musculus	Treatment: pyruvate added; Strain: C57BL/6	NULL	4865	chip_control	NULL	myotube differentiated from primary myoblasts	NULL
EXP064543	none	Mus musculus	Treatment: no pyruvate; Strain: C57BL/6	NULL	4865	chip_control	NULL	myotube differentiated from primary myoblasts	NULL
EXP064544	anti-MyoD (SC-760)	Mus musculus	Treatment: pyruvate added; Strain: C57BL/6	EXP064542	4865	normal	P10085	myotube differentiated from primary myoblasts	NULL
EXP064545	anti-MyoD (SC-760)	Mus musculus	Treatment: no pyruvate; Strain: C57BL/6	EXP064543	4865	normal	P10085	myotube differentiated from primary myoblasts	NULL
EXP064546	Anti-OCT4 (CST #5677S)	Mus musculus	Treatment: Untreated for 26 hours; Time point: 26 hrs; Genotype: wildtype	NULL	13	normal	P20263	2TS22C (embryonic stem cells)	NULL
EXP064547	Anti-OCT4 (CST #5677S)	Mus musculus	Treatment: 1 ug/ml doxycycline for 26 hours; Time point: 26 hrs; Genotype: Sox2 knockout	NULL	13	normal	P20263	2TS22C (embryonic stem cells)	NULL
EXP064548	Anti-BRG1 (Abcam #ab110641)	Mus musculus	Treatment: Untreated for 26 hours; Time point: 26 hrs; Genotype: wildtype	NULL	13	normal	Q3TKT4	2TS22C (embryonic stem cells)	NULL
EXP064549	Anti-BRG1 (Abcam #ab110641)	Mus musculus	Treatment: 1 ug/ml doxycycline for 26 hours; Time point: 26 hrs; Genotype: Sox2 knockout	NULL	13	normal	Q3TKT4	2TS22C (embryonic stem cells)	NULL
EXP064550	Input (IgG control)	Mus musculus	Treatment: control; Genotype: wildtype	NULL	4877	chip_control	NULL	fibro-inflammatory progenitors from white adipose tissues	NULL
EXP064551	Input (IgG control)	Mus musculus	Treatment: Mural-Zfp423 transgenic; Genotype: Zfp423 transgene structure	NULL	4877	chip_control	NULL	fibro-inflammatory progenitors from white adipose tissues	NULL
EXP064552	anti-p65 (D14E12, Rabbit mAb (Cell Signaling Technology, #8242))	Mus musculus	Treatment: control; Genotype: wildtype	EXP064550	4877	normal	Q04207	fibro-inflammatory progenitors from white adipose tissues	NULL
EXP064553	anti-p65 (D14E12, Rabbit mAb (Cell Signaling Technology, #8242))	Mus musculus	Treatment: Mural-Zfp423 transgenic; Genotype: Zfp423 transgene structure	EXP064551	4877	normal	Q04207	fibro-inflammatory progenitors from white adipose tissues	NULL
EXP064554	none (input)	Mus musculus	Treatment: chromatin fragmentation by Mnase; Age: 12-14 days post-partum; Genotype: Hells knockout	NULL	4878	chip_control	NULL	male germ cells from testis	NULL
EXP064555	none (input)	Mus musculus	Treatment: none; Age: 6 weeks old; Genotype: Hells het	NULL	2748	chip_control	NULL	adult testis	NULL
EXP064556	none (input)	Mus musculus	Treatment: none; Age: 6 weeks old; Genotype: Hells knockout	NULL	2748	chip_control	NULL	adult testis	NULL
EXP064557	IgG (Millipore/Sigma #12-371, lot: 2880788)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: B6-Prdm9CAST-KI; GTRD_Rep_Group: 1	NULL	32	chip_control	NULL	testis	NULL
EXP064558	none (input)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: B6-Prdm9CAST-KI; GTRD_Rep_Group: 1	NULL	32	chip_control	NULL	testis	NULL
EXP064559	anti-HELLS (Millipore/Sigma, ABD41 lot# 3069868)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: B6-Prdm9CAST-KI	EXP064557	32	normal	Q60848	testis	NULL
EXP064560	anti-HELLS (Millipore/Sigma, ABD41 lot# 3069868)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: B6-Prdm9CAST-KI	EXP064558	32	normal	Q60848	testis	NULL
EXP064561	H3K4me3 (Millipore/Sigma #07-473; lot: 3018770)	Mus musculus	Treatment: none; Age: 12-14 days post-partum; Strain: Hells knockout; GTRD_Rep_Group: 17	NULL	4878	normal	O08917	male germ cells from testis	NULL
EXP064562	anti-DMC1 (Santa Cruz sc-8973, lot: K2614)	Mus musculus	Treatment: none; Age: 6 weeks old; Genotype: Hells het	EXP064555	2748	normal	Q61880	adult testis	NULL
EXP064563	anti-DMC1 (Santa Cruz sc-8973, lot: K2614)	Mus musculus	Treatment: none; Age: 6 weeks old; Genotype: Hells knockout	EXP064556	2748	normal	Q61880	adult testis	NULL
EXP064564		Mus musculus	Treatment: Treatment: none; Genotype: wildtype (Tox2-HA-RV-GFP); Age: 7-8 weeks; Strain: C57BL/6; Genotype: wildtype (Tox2-HA-RV-GFP); Age: 7-8 weeks; Strain: C57BL/6	NULL	4812	chip_control	NULL	follicular T helper cells from spleen and lymph nodes	NULL
EXP064565	anti-HA	Mus musculus	Treatment: Treatment: none; Genotype: wildtype (Tox2-HA-RV-GFP); Age: 7-8 weeks; Strain: C57BL/6; Genotype: wildtype (Tox2-HA-RV-GFP); Age: 7-8 weeks; Strain: C57BL/6	EXP064564	4812	normal	E9Q0B9	follicular T helper cells from spleen and lymph nodes	NULL
EXP064566	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg fulvestrant/ICI182780 (ICI) for 1 hr; Strain: C57BL/6J; Genotype: ERalpha AF-2 mutant; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	NULL
EXP064567	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg tamoxifen for 1 hr; Strain: C57BL/6J; Genotype: ERalpha AF-2 mutant; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	NULL
EXP064568	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 50 ul DMSO for 1 hr; Strain: C57BL/6J; Genotype: ERalpha AF-2 mutant; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	NULL
EXP064569	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg fulvestrant/ICI182780 (ICI); Strain: C57BL/6J; Genotype: wildtype; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	NULL
EXP064570	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 2 mg/kg tamoxifen for 1 hr; Strain: C57BL/6J; Genotype: wildtype; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	NULL
EXP064571	anti-ESR1 (Santa Cruz SC-542)	Mus musculus	Treatment: 50 ul DMSO for 1 hr; Strain: C57BL/6J; Genotype: wildtype; Conditions: Ovariectomized mices, NIH-31 regular diet	NULL	132	normal	P19785	uterus	NULL
EXP064572		Mus musculus	Treatment: Treatment: none; Genotype: Wildtype; Genotype: Wildtype	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064573	anti-SUZ12	Mus musculus	Treatment: Treatment: none; Genotype: Wildtype; Genotype: Wildtype	EXP064572	233	normal	Q80U70	E14TG2A (embryonic stem cells)	NULL
EXP064574	anti-SUZ12	Mus musculus	Treatment: Treatment: none; Genotype: Zfc3h1 knockout; Genotype: Zfc3h1 knockout	NULL	233	normal	Q80U70	E14TG2A (embryonic stem cells)	NULL
EXP064575	anti-GR (ProteinTech, 24050-AP)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week control Diet (Research Diet, D12329); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	NULL
EXP064576	anti-GR (ProteinTech, 24050-AP)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week HFD Diet (Research Diets, D12331); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	NULL
EXP064577	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week control Diet (Research Diet, D12329); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	NULL
EXP064578	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 12 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 12 hrs; Conditions: 12 week HFD Diet (Research Diets, D12331); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	NULL
EXP064579	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 0 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 0 hrs; Conditions: 13 week HFD Diet (Research Diets, D12331); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	NULL
EXP064580	anti-GR (Santa Cruz, sc-1004X)	Mus musculus	Treatment: at 17 weeks of age, Dexamethasone (Sigma, D2915) was administered at 0 hrs, as a single i.p. injection of 10mg/kg, mice; Time point: 0 hrs; Conditions: 16 week control Diet (Research Diet, D12329); Strain: C57BL/6J; Sex: male	NULL	5	normal	P06537	liver	NULL
EXP064581	anti-HA (Abcam, ab9110)	Mus musculus	Treatment: none; Genotype: Shox2HA-DsRed	NULL	4889	normal	P70390	anterior palate	NULL
EXP064582	none	Mus musculus	Treatment: none; Conditions: Mice were maintained on chow diet until 12 weeks of age; Age: 12 weeks; Strain: c57bl/6j	NULL	115	chip_control	NULL	brown adipose tissue	NULL
EXP064583	anti-Zc3h10	Mus musculus	Treatment: none; Conditions: Mice were maintained on chow diet until 12 weeks of age; Age: 12 weeks; Strain: c57bl/6j	EXP064582	115	normal	Q8R205	brown adipose tissue	NULL
EXP064584	Pre-immune serum (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	NULL	313	chip_control	NULL	forebrain	NULL
EXP064585	Pre-immune serum (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	NULL	313	chip_control	NULL	forebrain	NULL
EXP064586	Pre-immune serum (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	NULL	313	chip_control	NULL	forebrain	NULL
EXP064587	Pre-immune serum (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	NULL	313	chip_control	NULL	forebrain	NULL
EXP064588	None	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	NULL	313	chip_control	NULL	forebrain	NULL
EXP064589	None	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	NULL	313	chip_control	NULL	forebrain	NULL
EXP064590	None	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	NULL	313	chip_control	NULL	forebrain	NULL
EXP064591	None	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	NULL	313	chip_control	NULL	forebrain	NULL
EXP064592	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064588	313	normal	Q9Z2D6	forebrain	NULL
EXP064593	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064589	313	normal	Q9Z2D6	forebrain	NULL
EXP064594	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064590	313	normal	Q9Z2D6	forebrain	NULL
EXP064595	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064591	313	normal	Q9Z2D6	forebrain	NULL
EXP064596	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064588	313	normal	Q9Z2D6	forebrain	NULL
EXP064597	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: wildtype	EXP064589	313	normal	Q9Z2D6	forebrain	NULL
EXP064598	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064590	313	normal	Q9Z2D6	forebrain	NULL
EXP064599	anti-MeCP2 (Sigma M6818)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 8 weeks; Sex: Male; Genotype: MeCP2 knockout	EXP064591	313	normal	Q9Z2D6	forebrain	NULL
EXP064600	Rabbit IgG (Millipore, 17-614)	Mus musculus	Treatment: none; Genotype: wildtype; Age: 8 weeks; Disease: none	NULL	2450	chip_control	NULL	striatum	NULL
EXP064601	Rabbit IgG (Millipore, 17-614)	Mus musculus	Treatment: none; Genotype: R6/1 + CHL2; Age: 8 weeks; Disease: Huntingtonâ€™s disease; Source: CHL2 + R6/1	NULL	2450	chip_control	NULL	striatum	NULL
EXP064602	anti-Elk-1 (Santa Cruz, sc-355X)	Mus musculus	Treatment: none; Genotype: wildtype; Age: 8 weeks; Disease: none; Source: R6/1	EXP064600	2450	normal	P41969	striatum	NULL
EXP064603	anti-Elk-1 (Santa Cruz, sc-355X)	Mus musculus	Treatment: none; Genotype: R6/1; Age: 8 weeks; Disease: Huntingtonâ€™s disease; Source: R6/1	EXP064601	2450	normal	P41969	striatum	NULL
EXP064604	none	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype, Zscan4-flag	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP064605	IgG (Sigma-Aldrich, 401590)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP064606	none	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype	NULL	12	chip_control	NULL	MEF (mouse embryonic fibroblasts)	NULL
EXP064607	anti-Flag (Shanghai Genomics Technology, 4110-20)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype, Zscan4-flag	EXP064604	12	normal	Q80VJ6	MEF (mouse embryonic fibroblasts)	NULL
EXP064608	anti-RAG1 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype	NULL	3094	normal	P15919	Abelson-transformed pre-B cell	NULL
EXP064609	anti-RAG1 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK	NULL	3094	normal	P15919	Abelson-transformed pre-B cell	NULL
EXP064610	anti-RAG1 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK-RS	NULL	3094	normal	P15919	Abelson-transformed pre-B cell	NULL
EXP064611	anti-RAG2 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: wildtype	NULL	3094	normal	P21784	Abelson-transformed pre-B cell	NULL
EXP064612	anti-RAG2 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK	NULL	3094	normal	P21784	Abelson-transformed pre-B cell	NULL
EXP064613	anti-RAG2 (rabbit polyclonal)	Mus musculus	Treatment: none; Strain: C57BL/6; Genotype: DJK-RS	NULL	3094	normal	P21784	Abelson-transformed pre-B cell	NULL
EXP064614	none	Mus musculus	Treatment: DMSO for 24 hrs; Time point: 24 hrs	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064615	none	Mus musculus	Treatment: DMSO for 24 hrs; Time point: 24 hrs	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064616	none	Mus musculus	Treatment: 2.5 uM EPZ-6438 for 24 hrs; Time point: 24 hrs	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064617	none	Mus musculus	Treatment: 2.5 uM EPZ-6438 for 24 hrs; Time point: 24 hrs	NULL	233	chip_control	NULL	E14TG2A (embryonic stem cells)	NULL
EXP064618	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP064614	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP064619	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: DMSO for 24 hrs; Time point: 24 hrs	EXP064615	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP064620	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: 2.5 uM EPZ-6438 for 24 hrs; Time point: 24 hrs	EXP064615	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP064621	anti-RING1B (Cell Signalling D22F2)	Mus musculus	Treatment: 2.5 uM EPZ-6438 for 24 hrs; Time point: 24 hrs	EXP064617	233	normal	Q9CQJ4	E14TG2A (embryonic stem cells)	NULL
EXP064622	input	Mus musculus	Treatment: none; Conditions: none; Strain: 129/Ola	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064623	anti-p53 (Novocastra #CM5P)	Mus musculus	Treatment: none; Conditions: serum growth conditions; Strain: 129/Ola	EXP064622	2	normal	P02340	mESCs (mouse embryonic stem cells)	NULL
EXP064624	anti-p53 (Novocastra #CM5P)	Mus musculus	Treatment: none; Conditions: 2i growth conditions; Strain: 129/Ola	EXP064622	2	normal	P02340	mESCs (mouse embryonic stem cells)	NULL
EXP064625	input	Mus musculus	Treatment: Th1 cells were stimulated for 2hrs with 5ug/mL anti-CD3, 3ug/mL anti-CD28, 10ng/mL IL-12, 10ng/ul IL18 and 400U/ml IFNg; Source: Cells were polarized into the Th1 helper cells for 6 days using plate-bound anti-CD3 (5ug/mL), in complete RPMI medium (RPMI-1610, 10% FBS, 1X P/S and 1X non-essential amino acids) containing anti-CD28 (3ug/mL), IL-12 (10ng/mL), IL-2 (10ng/mL) and anti-IL-4 (10ug/mL), with medium replenished after 3 days; Strain: C57BL6/J	NULL	4902	chip_control	NULL	primary naive CD4+ T cells from spleen and lymph nodes polarized to Th1 (T helper 1) cells	NULL
EXP064626	anti-ThPOK (SantaCruz, sc-79127X)	Mus musculus	Treatment: Th1 cells were stimulated for 2hrs with 5ug/mL anti-CD3, 3ug/mL anti-CD28, 10ng/mL IL-12, 10ng/ul IL18 and 400U/ml IFNg; Source: Cells were polarized into the Th1 helper cells for 6 days using plate-bound anti-CD3 (5ug/mL), in complete RPMI medium (RPMI-1610, 10% FBS, 1X P/S and 1X non-essential amino acids) containing anti-CD28 (3ug/mL), IL-12 (10ng/mL), IL-2 (10ng/mL) and anti-IL-4 (10ug/mL), with medium replenished after 3 days; Strain: C57BL6/J	EXP064625	4902	normal	Q64321	primary naive CD4+ T cells from spleen and lymph nodes polarized to Th1 (T helper 1) cells	NULL
EXP064627	anti-RXR (sc-774)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: 3 months; Sex: male	NULL	81	normal	P28700	BMDM (bone marrow-derived macrophages)	NULL
EXP064628	anti-RXR (sc-774)	Mus musculus	Treatment: none; Strain: 129Sv/E14; Developmental stage: adipocyte day 21 of differentiation	NULL	4903	normal	P28700	embryonic stem cell derived adipocytes	NULL
EXP064629	anti-PPARg (Perseus #PP-A3409A)	Mus musculus	Treatment: none; Strain: 129Sv/E14; Developmental stage: adipocyte day 21 of differentiation	NULL	4903	normal	P37238	embryonic stem cell derived adipocytes	NULL
EXP064630	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB500G; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	NULL
EXP064631	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB503; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	NULL
EXP064632	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB502; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	NULL
EXP064633	anti-MYC (CST, 13987)	Mus musculus	Treatment: infected with Ad-Cgrp-Cre; Donor: PB499; Genotype: Rb1fl/fl,p53fl/fl, MycT58ALSL/LSL	NULL	4904	normal	P01108	small cell lung cancer derived from lung	NULL
EXP064634		Mus musculus	Treatment: none; Strain: C57BL6; Age: adult; Cell type: CD4-, CD8-, IL7Ra-, CD11b-, Ly6g-, CD45R-, Ter119-, cKit+, Sca1+	NULL	3973	chip_control	NULL	LSK (Lin(neg)/c-Kit(+)/Sca-1(+)) cells from bone marrow	NULL
EXP064635		Mus musculus	Treatment: none; Strain: C57BL6; Age: adult; Cell type: CD4-, CD8-, IL7Ra-, CD11b-, Ly6g-, CD45R-, Ter119-, cKit+, Sca1-, CD34-, CD16/32-	NULL	4907	chip_control	NULL	bone marrow derived megakaryocyte-erythroid progenitor cell	NULL
EXP064636	anti-CTCF (Millipore, 07-729, lot 2517762)	Mus musculus	Treatment: none; Strain: C57BL6; Age: adult; Cell type: CD4-, CD8-, IL7Ra-, CD11b-, Ly6g-, CD45R-, Ter119-, cKit+, Sca1+	EXP064634	3973	normal	Q61164	LSK (Lin(neg)/c-Kit(+)/Sca-1(+)) cells from bone marrow	NULL
EXP064637		Mus musculus	Treatment: none; Strain: Balb/c; Genotype: wildtype	NULL	4914	chip_control	NULL	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064638		Mus musculus	Treatment: none; Strain: Balb/c; Genotype: wildtype	NULL	4914	chip_control	NULL	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064639		Mus musculus	Treatment: none; Strain: Balb/c; Genotype: T-bet knockout	NULL	4914	chip_control	NULL	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064640	anti-T-bet serum (9856, Custom rabbit )	Mus musculus	Treatment: none; Strain: Balb/c; Genotype: wildtype	EXP064637	4914	normal	Q9JKD8	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064641	anti-T-bet serum (9856, Custom rabbit )	Mus musculus	Treatment: none; Strain: Balb/c; Genotype: wildtype	EXP064638	4914	normal	Q9JKD8	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064642	anti-T-bet serum (9856, Custom rabbit )	Mus musculus	Treatment: none; Strain: Balb/c; Genotype: T-bet knockout	EXP064639	4914	normal	Q9JKD8	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064643		Mus musculus	Treatment: none; Strain: Balb/c	NULL	4914	chip_control	NULL	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064644		Mus musculus	Treatment: none; Strain: Balb/c; Source: were polarized with 20 ng/ml IL-2 (Biolegend) and polarized with 20 ng/ml IL-12 (eBioscience) and 10 ?g/ml anti-IL-4 (BioXCell)	NULL	4902	chip_control	NULL	primary naive CD4+ T cells from spleen and lymph nodes polarized to Th1 (T helper 1) cells	NULL
EXP064645	anti-Foxp3 (Santa Cruz S-31738 and eBioscience FJK-16)	Mus musculus	Treatment: none; Strain: Balb/c	EXP064643	4914	normal	Q99JB6	induced T-regulatory cell (iTreg) from spleen and lymph nodes	NULL
EXP064646	anti-Foxp3 (Santa Cruz S-31738 and eBioscience FJK-16)	Mus musculus	Treatment: none; Strain: Balb/c; Source: were polarized with 20 ng/ml IL-2 (Biolegend) and polarized with 20 ng/ml IL-12 (eBioscience) and 10 ?g/ml anti-IL-4 (BioXCell)	EXP064644	4902	normal	Q99JB6	primary naive CD4+ T cells from spleen and lymph nodes polarized to Th1 (T helper 1) cells	NULL
EXP064647	none	Mus musculus	Treatment: none; Strain: C57BL/6; Age: p7	NULL	4917	chip_control	NULL	pool of oligodendrocytes and oligodendrocyte progenitor cell from cortex	NULL
EXP064648	anti-Nkx2.2 (monoclonal antibody, Protein G affinity purified supernatant from hybridomas (74.5A5-b) developed by Prof. Thomas M Jessell, Columbia University, USA, and obtained from Developmental Studies Hybridoma Bank, University of Iowa, USA)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: p7	EXP064647	4915	normal	P42586	oligodendrocyte progenitor cell from cortex	NULL
EXP064649	anti-Nkx2.2 (monoclonal antibody, Protein G affinity purified supernatant from hybridomas (74.5A5-b) developed by Prof. Thomas M Jessell, Columbia University, USA, and obtained from Developmental Studies Hybridoma Bank, University of Iowa, USA)	Mus musculus	Treatment: none; Strain: C57BL/6; Age: p7	EXP064647	4916	normal	P42586	oligodendrocyte from cortex	NULL
EXP064650	none	Mus musculus	Treatment: none; Strain: BL6/129ola; Genotype: wildtype; Sex: female	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064651	none	Mus musculus	Treatment: none; Strain: BL6/129ola; Genotype: E2f6 knockout; Sex: male	NULL	2	chip_control	NULL	mESCs (mouse embryonic stem cells)	NULL
EXP064652	anti-E2F6 (Abcam: ab53061)	Mus musculus	Treatment: none; Strain: BL6/129ola; Genotype: wildtype; Sex: female	EXP064650	2	normal	O54917	mESCs (mouse embryonic stem cells)	NULL
EXP064653	anti-E2F6 (Abcam: ab53061)	Mus musculus	Treatment: none; Strain: BL6/129ola; Genotype: E2f6 knockout; Sex: male	EXP064651	2	normal	O54917	mESCs (mouse embryonic stem cells)	NULL
EXP064654	Rb IgG (sc-2027, Santa Cruz)	Mus musculus	Treatment: none	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064655	anti-Glyr1 (14833-1-AP, Proteintech Group)	Mus musculus	Treatment: none	EXP064654	230	normal	Q922P9	ES-E14 (E14, embryonic stem cells)	NULL
EXP064656	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: none; Genotype: wildtype; Time point: 0 hrs; Strain: c57bl/6; Genotype: wildtype; Time point: 0 hrs; Strain: c57bl/6	HEXP006173	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	NULL
EXP064657	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: none; Genotype: NSD2 knockout; Time point: 0 hrs; Strain: c57bl/6; Genotype: NSD2 knockout; Time point: 0 hrs; Strain: c57bl/6	HEXP006175	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	NULL
EXP064658	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: IFN-Beta for 16 hrs; Genotype: wildtype; Time point: 16 hrs; Strain: c57bl/6; Genotype: wildtype; Time point: 16 hrs; Strain: c57bl/6	HEXP006174	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	NULL
EXP064659	anti-ZMYND11 (Antibody-ABE1889)	Mus musculus	Treatment: Treatment: IFN-Beta for 16 hrs; Genotype: NSD2 knockout; Time point: 16 hrs; Strain: c57bl/6; Genotype: NSD2 knockout; Time point: 16 hrs; Strain: c57bl/6	HEXP006176	12	normal	Q8R5C8	MEF (mouse embryonic fibroblasts)	NULL
EXP064660		Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	NULL	2376	chip_control	NULL	secondary MEF cells	NULL
EXP064661		Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	NULL	2376	chip_control	NULL	secondary MEF cells	NULL
EXP064662		Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	NULL	2376	chip_control	NULL	secondary MEF cells	NULL
EXP064663	anti-Sox2 (Millipore, AB5603)	Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	EXP064660	2376	normal	P48432	secondary MEF cells	NULL
EXP064664	anti-Sox2 (Millipore, AB5603)	Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	EXP064661	2376	normal	P48432	secondary MEF cells	NULL
EXP064665	anti-Klf4	Mus musculus	Treatment: Day 2 of SKM reprogramming; Time point: day 2	EXP064662	2376	normal	Q60793	secondary MEF cells	NULL
EXP064666	normal rabbit IgG (Bethyl, P120-101)	Mus musculus	Treatment: cells were stimulated with anti-mouse CD40 , IL-21 , and HEL; Genotype: Tg(IghelMD4)4Ccg; Strain: C57BL/6	NULL	4921	chip_control	NULL	B220+ B cells from spleen	NULL
EXP064667	anti-Jmjd2a (abcam, ab70786)	Mus musculus	Treatment: cells were stimulated with anti-mouse CD40 , IL-21 , and HEL; Genotype: Tg(IghelMD4)4Ccg; Strain: C57BL/6	EXP064666	4921	normal	Q8BW72	B220+ B cells from spleen	NULL
EXP064668	anti-Jmjd2c (abcam, ab85454)	Mus musculus	Treatment: cells were stimulated with anti-mouse CD40 , IL-21 , and HEL; Genotype: Tg(IghelMD4)4Ccg; Strain: C57BL/6	EXP064666	4921	normal	Q8VCD7	B220+ B cells from spleen	NULL
EXP064669	none	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing the DMSO; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	chip_control	NULL	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064670	none	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	chip_control	NULL	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064671	none	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	chip_control	NULL	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064672	none	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	chip_control	NULL	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064673	none	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	chip_control	NULL	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064674	none	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	1224	chip_control	NULL	TALL1 (T-Acute Lymphoblastic Leukemia)	NULL
EXP064675	none	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL
EXP064676	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing the DMSO; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	EXP064669	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064677	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing 1 uM PFI-3; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064678	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing 5 uM PFI-3; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064679	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection, inactivated fetal bovine serum containing 10 uM PFI-3; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064680	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064681	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1-BirA-IVT-mRNA transfection; Genotype: PU1-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064682	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1 deletionQ-BirA-IVT-mRNA transfection; Genotype: PU1 deletionQ-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 deletionQ-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064683	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1 deletionA-BirA-IVT-mRNA transfection; Genotype: PU1 deletionA-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 deletionA-Bira transfection; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064684	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064685	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064686	anti-ETS1 (Santa Cruz, #sc-350X)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064670	4712	normal	P14921	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064687	anti-FLI1 (Abcam, #ab15289)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064670	4712	normal	Q01543	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064688	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064670	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064689	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	EXP064671	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064690	anti-PU.1 (Santa Cruz, #sc-352X)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	EXP064671	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064691	anti-ETS1 (Santa Cruz, #sc-350X)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064672	4712	normal	P14921	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064692	anti-FLI1 (Abcam, #ab15289)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064672	4712	normal	Q01543	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064693	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	EXP064672	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064694	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: PU.1 deletion P-mRNA transfection; Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064695	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1 deletion P-mRNA transfection; Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion P; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064696	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1 deletion P-mRNA transfection; Genotype: PU.1 deleltion AQP; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deleltion AQP; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064697	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064698	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064699	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	1224	normal	P17947	TALL1 (T-Acute Lymphoblastic Leukemia)	NULL
EXP064700	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1 mut-IVT-mRNA transfection; Genotype: PU1 mutation; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 mutation; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	1224	normal	P17947	TALL1 (T-Acute Lymphoblastic Leukemia)	NULL
EXP064701	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064702	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1 deletion A-mRNA transfection; Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1 deletion A; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064703	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU1 deletionQ-IVT-mRNA transfection; Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064704	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	430	normal	P17947	HepG2 (hepatoblastoma)	NULL
EXP064705	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	430	normal	P17947	HepG2 (hepatoblastoma)	NULL
EXP064706	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1 deletionQ-IVT-mRNA transfection; Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1 deletionQ; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064707	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064708	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU1-IVT-mRNA transfection; Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU1-IVT-mRNA; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064709	anti-BRG1 (Abcam, #ab110641)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method DSG FA ( 2 mM DSG (Thermo Fisher Scientific) + formaldehyde)	NULL	4712	normal	P51532	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064710	anti-FLAG M2 (Sigma, #F3165)	Homo sapiens	Treatment: Treatment: PU.1mut-IVT-mRNA transfection; Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde); Genotype: PU.1mut; Time point: 8 hrs after transfection; Source: fication method FA (formaldehyde)	NULL	4712	normal	P17947	CTV-1 (Adult T acute lymphoblastic leukemia)	NULL
EXP064711	Mouse IGG, Diagenode (C15400001-15)	Homo sapiens	Treatment: none; Genotype: wildtype	NULL	514	chip_control	NULL	K562 (myelogenous leukemia)	NULL
EXP064712		Homo sapiens	Treatment: none; Genotype: wildtype	NULL	113	chip_control	NULL	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064713	Mouse IGG, Diagenode (C15400001-15)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP064714	None	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP064715	Mouse IGG, Diagenode (C15400001-15)	Mus musculus	Treatment: none; Genotype: homozygous deletion of ZF9-11 in CTCF gene	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP064716	none	Mus musculus	Treatment: none; Genotype: wildtype	NULL	178	chip_control	NULL	CH12 (lymphoma)	NULL
EXP064717	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: expressed BORIS from vector (of pMy-MouseCTCFbiotag-T2A-mOrange)	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064718	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: stably expressed BORIS	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064719	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed BORIS	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064720	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed BORIS	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064721	anti-BORIS  (characterized in PMID: 21659515, custom mouse monoclonal)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed BORIS	NULL	178	normal	A2APF3	CH12 (lymphoma)	NULL
EXP064722	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N1mutant of CTCF(aa1-30) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(aa1-30), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064723	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N1mutant of CTCF(aa1-30) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(aa1-30), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064724	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N2mutant of CTCF(aa1-87) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N2mutant of CTCF(aa1-87), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064725	Anti-NIPBL (Bethy Laboratories; catalog# A301-779A)	Mus musculus	Treatment: none; Genotype: wildtype	NULL	178	normal	Q6KCD5	CH12 (lymphoma)	NULL
EXP064726	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064727	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with 8mM of the PARP-1 inhibitor 3-aminobenzamide (3-ABA); Genotype: wildtype	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064728	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with 8mM of the PARP-1 inhibitor 3-aminobenzamide (3-ABA); Genotype: wildtype	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064729	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with DMSO (8mM); Genotype: wildtype	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064730	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CH12 cells were cultured for 3 days with DMSO (8mM); Genotype: wildtype	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064731	anti-CTCF (mouse monoclonal SantaCruz, SC-271514, B-5)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP064732	anti-CTCF (rabbit polyclonal Millipore, 07-729)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP064733	Mix of CTCF rabbit polyclonal ABs(Novus Biologicals: NB100-56494, NB100-947, NB500-194, Abcam: ab70303; Bethyl Laboratories: A300-543A, A300-544A, A300-542A).	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP064734	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: Chimera2 vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene, stably expressed CTCF and BORIS Chimera2 tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064735	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: Chimera4 vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene, stably expressed CTCF and BORIS Chimera4 tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064736	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: none; Genotype: wildtype	EXP064716	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064737	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: none; Genotype: wildtype	EXP064716	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064738	anti-BORIS  (characterized in PMID: 21659515, custom mouse monoclonal)	Mus musculus	Treatment: pMy-MouseCTCFbiotag-T2A-mOrange; Genotype: expressed BORIS from vector (of pMy-MouseCTCFbiotag-T2A-mOrange)	NULL	178	normal	A2APF3	CH12 (lymphoma)	NULL
EXP064739	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: none; Genotype: homozygous deletion of ZF9-11 in CTCF gene	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064740	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: none; Genotype: homozygous deletion of ZF9-11 in CTCF gene	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064741	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: Fl-CTCF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed Full-Length CTCF, tagged with V5 Tag at the C-terminu	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064742	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: Fl-CTCF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed Full-Length CTCF, tagged with V5 Tag at the C-terminu	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064743	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: Fl-CTCF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF gene with stably expressed Full-Length CTCF, tagged with V5 Tag at the C-terminu	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064744	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: CTCF (N-terminus+11ZFs) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF (N-terminus+11ZFs), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064745	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CTCF (N-terminus+11ZFs) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF (N-terminus+11ZFs), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064746	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: CTCF (N-terminus+11ZFs) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF (N-terminus+11ZFs), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064747	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: (11ZFs+C-terminus) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, expressed truncated CTCF (11ZFs+C-terminus), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064748	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: (11ZFs+C-terminus) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, expressed truncated CTCF (11ZFs+C-terminus), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064749	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: (11ZFs+C-terminus) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, expressed truncated CTCF (11ZFs+C-terminus), tagged with V5 Tag at the C-terminus)	NULL	178	normal	Q9CXC9	CH12 (lymphoma)	NULL
EXP064750	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N1mutant of CTCF(aa1-30) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(aa1-30), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064751	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N2mutant of CTCF(aa1-87) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N2mutant of CTCF(aa1-87), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064752	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N2mutant of CTCF(aa1-87) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N2mutant of CTCF(aa1-87), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064753	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N3mutant of CTCF(aa90-186) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N3mutant of CTCF(aa90-186), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064754	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N3mutant of CTCF(aa90-186) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N3mutant of CTCF(aa90-186), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064755	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N3mutant of CTCF(aa90-186) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N3mutant of CTCF(aa90-186), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064756	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N4mutant of CTCF(aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N4mutant of CTCF(aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064757	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N4mutant of CTCF(aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N4mutant of CTCF(aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064758	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N4mutant of CTCF(aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N4mutant of CTCF(aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064759	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N6mutant of CTCF(The N-terminus truncated to aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N6mutant of CTCF(The N-terminus truncated to aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064760	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N6mutant of CTCF(The N-terminus truncated to aa187-265) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N6mutant of CTCF(The N-terminus truncated to aa187-265), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064761	anti-CTCF (custom mouse monoclonal , characterized in PMID:15731119)	Mus musculus	Treatment: N5mutant of CTCF(11 aa mutations) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(11 aa mutations), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064762	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: N5mutant of CTCF(11 aa mutations) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(11 aa mutations), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064763	anti-V5 (Tag Monoclonal Antibody, ThermoFisher (Catalog # R960-25)	Mus musculus	Treatment: N5mutant of CTCF(11 aa mutations) vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, stably expressed N1mutant of CTCF(11 aa mutations), tagged with V5 Tag at the C-terminus	NULL	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064764	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	EXP064714	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064765	anti-V5 (Tag Monoclonal Antibody, ThermoFisher, Catalog # R960-25)	Mus musculus	Treatment: CTCF mutant with 3 AZF vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed truncated CTCF mutant with 3 AZF, tagged with V5 Tag at the C-terminus)	EXP064714	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064766	anti-RAD21(Abcam, ab992)	Mus musculus	Treatment: CTCF with the first two ZFs deleted vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed mutant CTCF with the first two ZFs deleted, tagged with V5 Tag at the C-terminus)	EXP064715	178	normal	Q61550	CH12 (lymphoma)	NULL
EXP064767	anti-V5 (Tag Monoclonal Antibody, ThermoFisher, Catalog # R960-25)	Mus musculus	Treatment: CTCF with the first two ZFs deleted vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed mutant CTCF with the first two ZFs deleted, tagged with V5 Tag at the C-terminus)	EXP064715	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064768	anti-CTCF (custom mouse monoclonal, characterized in PMID:15731119)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064711	514	normal	P49711	K562 (myelogenous leukemia)	NULL
EXP064769	anti-CTCF (custom mouse monoclonal, characterized in PMID:15731119)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064712	113	normal	P49711	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064770	anti-RAD21(Abcam, ab992)	Homo sapiens	Treatment: none; Genotype: wildtype	EXP064712	113	normal	O60216	MCF7 (Invasive ductal breast carcinoma)	NULL
EXP064771	custom mouse monoclonal CTCF (characterized in PMID:15731119)	Mus musculus	Treatment: CTCF with the first two ZFs deleted vector (of pMy-MouseCTCFbiotag-T2A-mOrange); Genotype: homozygous deletion of ZF9-11 in CTCF, gene stably expressed mutant CTCF with the first two ZFs deleted, tagged with V5 Tag at the C-terminus)	EXP064715	178	normal	Q61164	CH12 (lymphoma)	NULL
EXP064772	None	Mus musculus	Treatment: Treatment: Treatment: 6 hrs KCl; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo	NULL	4922	chip_control	NULL	E16.5 cortical neurons	NULL
EXP064773	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006309	313	normal	Q9Z2D6	forebrain	NULL
EXP064774	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006310	313	normal	Q9Z2D6	forebrain	NULL
EXP064775	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006311	313	normal	Q9Z2D6	forebrain	NULL
EXP064776	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: wildtype; Strain: C57BL/6	HEXP006312	313	normal	Q9Z2D6	forebrain	NULL
EXP064777	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006314	313	normal	Q9Z2D6	forebrain	NULL
EXP064778	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006315	313	normal	Q9Z2D6	forebrain	NULL
EXP064779	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006316	313	normal	Q9Z2D6	forebrain	NULL
EXP064780	anti-MeCP2 (Chen et al., 2003)	Mus musculus	Treatment: Treatment: Treatment: none; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6; Age: 8-12 weeks; Sex: Male; Genotype: MeCP2 R306C; Strain: C57BL/6	HEXP006317	313	normal	Q9Z2D6	forebrain	NULL
EXP064781	anti-YY1 (Abcam ab109237)	Mus musculus	Treatment: Treatment: Treatment: none; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo	NULL	4922	normal	Q00899	E16.5 cortical neurons	NULL
EXP064782	anti-YY1 (Abcam ab109237)	Mus musculus	Treatment: Treatment: Treatment: 6 hrs KCl; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo; Age: E16.5 with 7DIV culture; Sex: Male and female; Genotype: wildtype; Strain: C57BL/6; Developmental stage: embryo	EXP064772	4922	normal	Q00899	E16.5 cortical neurons	NULL
EXP064783	Input	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: wildtype; Time point: 72 hrs	NULL	230	chip_control	NULL	ES-E14 (E14, embryonic stem cells)	NULL
EXP064784	anti-PCGF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP064785	anti-PCGF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP064786	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064787	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064788	anti-PCGF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP064789	anti-RING1B	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP064790	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064791	anti-RING1B	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP064792	anti-SUZ12	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064793	anti-RING1B	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP064794	anti-RING1B	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q9CQJ4	ES-E14 (E14, embryonic stem cells)	NULL
EXP064795	anti-PCGF6	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP064796	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064797	anti-PCGF6	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP064798	anti-PCGF6	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP064799	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064800	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064801	anti-PCGF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	P23798	ES-E14 (E14, embryonic stem cells)	NULL
EXP064802	anti-PCGF6	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q99NA9	ES-E14 (E14, embryonic stem cells)	NULL
EXP064803	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064804	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: RING1B missense mutations I53S; Time point: 48 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064805	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: RING1B missense mutations I53S; Time point: 48 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064806	anti-AEBP2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	NULL
EXP064807	anti-Cbx7	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	NULL
EXP064808	anti-EPOP	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	NULL
EXP064809	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064810	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064811	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S, MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064812	anti-Rybp	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	NULL
EXP064813	anti-JARID2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064814	anti-MTF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: RING1B missense mutations I53S; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064815	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: Parental RING1B; Time point: 48 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064816	MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: Parental RING1B; Time point: 48 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064817	anti-AEBP2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	NULL
EXP064818	anti-Cbx7	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	NULL
EXP064819	anti-EPOP	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	NULL
EXP064820	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064821	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064822	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: Parental RING1B, MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064823	anti-Rybp	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	NULL
EXP064824	anti-AEBP2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	NULL
EXP064825	anti-Cbx7	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	NULL
EXP064826	anti-EPOP	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	NULL
EXP064827	anti-JARID2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064828	anti-MTF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064829	anti-SUZ12	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B, MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064830	anti-Rybp	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: Parental RING1B; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	NULL
EXP064831	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: wildtype; Time point: 48 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064832	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 48 hrs; Genotype: wildtype; Time point: 48 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064833	anti-AEBP2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q9Z248	ES-E14 (E14, embryonic stem cells)	NULL
EXP064834	anti-Cbx7	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q8VDS3	ES-E14 (E14, embryonic stem cells)	NULL
EXP064835	anti-EPOP	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q7TNS8	ES-E14 (E14, embryonic stem cells)	NULL
EXP064836	anti-JARID2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064837	anti-MTF2	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064838	anti-SUZ12	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: MTF2 knockout; Time point: 72 hrs	EXP064783	230	normal	Q80U70	ES-E14 (E14, embryonic stem cells)	NULL
EXP064839	anti-Rybp	Mus musculus	Treatment: 0.5 uM 4-hydroxytamoxifen for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q8CCI5	ES-E14 (E14, embryonic stem cells)	NULL
EXP064840	anti-JARID2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q62315	ES-E14 (E14, embryonic stem cells)	NULL
EXP064841	anti-MTF2	Mus musculus	Treatment: EtOH for 72 hrs; Genotype: wildtype; Time point: 72 hrs	EXP064783	230	normal	Q02395	ES-E14 (E14, embryonic stem cells)	NULL
EXP064842	anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: Treatment: none; Genotype: wild type; Age: 14 day; Ecotype: Col-0; Genotype: wild type; Age: 14 day; Ecotype: Col-0	NULL	4948	chip_control	NULL	14 day old leaves	NULL
EXP064843	none	Arabidopsis thaliana	Treatment: Treatment: none; Genotype: wild type; Age: 14 day; Ecotype: Col-0; Genotype: wild type; Age: 14 day; Ecotype: Col-0	NULL	4948	chip_control	NULL	14 day old leaves	NULL
EXP064844	none	Arabidopsis thaliana	Treatment: Treatment: none; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0	NULL	4948	chip_control	NULL	14 day old leaves	NULL
EXP064845	none	Arabidopsis thaliana	Treatment: Treatment: none; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0	NULL	4948	chip_control	NULL	14 day old leaves	NULL
EXP064846	anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: Treatment: none; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0	EXP064844	4948	normal	Q500V5	14 day old leaves	NULL
EXP064847	anti-GFP (Abcam, ab290)	Arabidopsis thaliana	Treatment: Treatment: none; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0; Age: 14 day; Genotype: GFP-fused ADCP1; Ecotype: Col-0	EXP064845	4948	normal	Q500V5	14 day old leaves	NULL
EXP064848	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	NULL
EXP064849	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	NULL
EXP064850	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	NULL
EXP064851	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	2178	normal	Q03012	SK1 meiotic cells (6 hours)	NULL
EXP064852	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4962	normal	Q03012	SK1 meiotic cells (6.5 hours)	NULL
EXP064853	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	NULL
EXP064854	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	NULL
EXP064855	Anti-GFP (Abcam, ab290)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/NatMX4-pCUP1-1-yGFP-SPP1, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	NULL
EXP064856	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	NULL
EXP064857	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	NULL
EXP064858	myc Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	NULL
EXP064859	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	2178	normal	Q03012	SK1 meiotic cells (6 hours)	NULL
EXP064860	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4962	normal	Q03012	SK1 meiotic cells (6.5 hours)	NULL
EXP064861	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 4.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4959	normal	Q03012	SK1 meiotic cells (4.5 hours)	NULL
EXP064862	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4960	normal	Q03012	SK1 meiotic cells (5 hours)	NULL
EXP064863	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 5.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4961	normal	Q03012	SK1 meiotic cells (5.5 hours)	NULL
EXP064864	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	2178	normal	Q03012	SK1 meiotic cells (6 hours)	NULL
EXP064865	Anti-myc (Abcam, ab56)	Saccharomyces cerevisiae	Treatment: Treatment: none; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3; Cellcycle: meiotic; Time point: 6.5 hour; Genotype: Mata/alpha, SPP1-13xmyc-KanMX4/SPP1-13xmyc-KanMX4, leu2/LEU2, HIS4/his4, trp1/trp1, ura3/ura3	NULL	4962	normal	Q03012	SK1 meiotic cells (6.5 hours)	NULL
EXP064866	none (input)	Saccharomyces cerevisiae	Treatment: none; Genotype: wildtype	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP064867	none (input)	Saccharomyces cerevisiae	Treatment: none; Genotype: wildtype	NULL	1232	chip_control	NULL	S. cerevisiae cells	NULL
EXP064868	anti-IgG (Sigma-Aldrich; I5381-5MG)	Saccharomyces cerevisiae	Treatment: none; Genotype: wildtype	EXP064866	1232	normal	P47156	S. cerevisiae cells	NULL
EXP064869	anti-IgG (Sigma-Aldrich; I5381-5MG)	Saccharomyces cerevisiae	Treatment: none; Genotype: wildtype	EXP064867	1232	normal	P39081	S. cerevisiae cells	NULL
EXP064870	none	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064871	none	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064872	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064873	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064874	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064875	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064876	none	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064877	none	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064878	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064879	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064880	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064881	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064882	none	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064883	none	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064884	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064885	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064886	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064887	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064888	none	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064889	none	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064890	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064891	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064892	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064893	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064894	none	Saccharomyces cerevisiae	Treatment: none; Genotype: HTZ1 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064895	none	Saccharomyces cerevisiae	Treatment: none; Genotype: HTZ1 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064896	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064897	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064898	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064899	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064900	none	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion, HTZ1 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064901	none	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion, HTZ1 deletion; Time point: 0 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064902	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064903	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 1 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064904	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064905	none	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 4 hour	NULL	2520	chip_control	NULL	whole cells	NULL
EXP064906	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	EXP064870	2520	normal	P22336	whole cells	NULL
EXP064907	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	NULL	2520	normal	P22336	whole cells	NULL
EXP064908	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064872	2520	normal	P22336	whole cells	NULL
EXP064909	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064873	2520	normal	P22336	whole cells	NULL
EXP064910	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064874	2520	normal	P22336	whole cells	NULL
EXP064911	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064875	2520	normal	P22336	whole cells	NULL
EXP064912	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064876	2520	normal	P22336	whole cells	NULL
EXP064913	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064877	2520	normal	P22336	whole cells	NULL
EXP064914	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064878	2520	normal	P22336	whole cells	NULL
EXP064915	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064879	2520	normal	P22336	whole cells	NULL
EXP064916	RPA anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064880	2520	normal	P22336	whole cells	NULL
EXP064917	anti-RPA (Agrisera, AS07214)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064881	2520	normal	P22336	whole cells	NULL
EXP064918	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	EXP064882	2520	normal	P25454	whole cells	NULL
EXP064919	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: wild type; Time point: 0 hour	EXP064883	2520	normal	P25454	whole cells	NULL
EXP064920	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064884	2520	normal	P25454	whole cells	NULL
EXP064921	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 1 hour	EXP064885	2520	normal	P25454	whole cells	NULL
EXP064922	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064886	2520	normal	P25454	whole cells	NULL
EXP064923	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: wild type; Time point: 4 hour	EXP064887	2520	normal	P25454	whole cells	NULL
EXP064924	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064888	2520	normal	P25454	whole cells	NULL
EXP064925	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion; Time point: 0 hour	EXP064889	2520	normal	P25454	whole cells	NULL
EXP064926	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064890	2520	normal	P25454	whole cells	NULL
EXP064927	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 1 hour	EXP064891	2520	normal	P25454	whole cells	NULL
EXP064928	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064892	2520	normal	P25454	whole cells	NULL
EXP064929	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion; Time point: 4 hour	EXP064893	2520	normal	P25454	whole cells	NULL
EXP064930	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: HTZ1 deletion; Time point: 0 hour	EXP064894	2520	normal	P25454	whole cells	NULL
EXP064931	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: HTZ1 deletion; Time point: 0 hour	EXP064895	2520	normal	P25454	whole cells	NULL
EXP064932	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 1 hour	EXP064896	2520	normal	P25454	whole cells	NULL
EXP064933	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 1 hour	EXP064897	2520	normal	P25454	whole cells	NULL
EXP064934	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 4 hour	EXP064898	2520	normal	P25454	whole cells	NULL
EXP064935	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: HTZ1 deletion; Time point: 4 hour	EXP064899	2520	normal	P25454	whole cells	NULL
EXP064936	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion, HTZ1 deletion; Time point: 0 hour	EXP064900	2520	normal	P25454	whole cells	NULL
EXP064937	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: none; Genotype: ARP8 deletion, HTZ1 deletion; Time point: 0 hour	EXP064901	2520	normal	P25454	whole cells	NULL
EXP064938	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 1 hour	EXP064902	2520	normal	P25454	whole cells	NULL
EXP064939	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 1 hour	EXP064903	2520	normal	P25454	whole cells	NULL
EXP064940	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 4 hour	EXP064904	2520	normal	P25454	whole cells	NULL
EXP064941	anti-Rad51 (Santa Cruz y-180, lot number: K1209)	Saccharomyces cerevisiae	Treatment: double-strand break (DSB); Genotype: ARP8 deletion, HTZ1 deletion; Time point: 4 hour	EXP064905	2520	normal	P25454	whole cells	NULL
EXP064942	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	2988	chip_control	NULL	N2 strain	NULL
EXP064943	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP064944	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP064945	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4981	chip_control	NULL	CB428 Strain(Developmental stage: L3 Larvae)	NULL
EXP064946	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4981	chip_control	NULL	CB428 Strain(Developmental stage: L3 Larvae)	NULL
EXP064947	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4982	chip_control	NULL	MT14911 Strain(Developmental stage: L3 Larvae)	NULL
EXP064948	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4982	chip_control	NULL	MT14911 Strain(Developmental stage: L3 Larvae)	NULL
EXP064949	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	3125	chip_control	NULL	N2 strain (mixed embryos)	NULL
EXP064950	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4980	chip_control	NULL	MT14911 Strain	NULL
EXP064951	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	3128	chip_control	NULL	N2 strain(Developmental stage: L3 larvae)	NULL
EXP064952	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4982	chip_control	NULL	MT14911 Strain(Developmental stage: L3 Larvae)	NULL
EXP064953	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4982	chip_control	NULL	MT14911 Strain(Developmental stage: L3 Larvae)	NULL
EXP064954	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	4980	chip_control	NULL	MT14911 Strain	NULL
EXP064955	none (input)	Caenorhabditis elegans	Treatment: Treatment: Treatment: none	NULL	3128	chip_control	NULL	N2 strain(Developmental stage: L3 larvae)	NULL
EXP064957	ChIP Input	Caenorhabditis elegans	Treatment: 19?C; Feeding: OP50; Genotype: wild type	NULL	3130	chip_control	NULL	N2 strain(developmental stage: young adults)	NULL
EXP064958	ChIP Input	Caenorhabditis elegans	Treatment: 19?C; Feeding: OP50; Genotype: set-32(ok1457)	NULL	3130	chip_control	NULL	N2 strain(developmental stage: young adults)	NULL
EXP064959	ChIP Input	Caenorhabditis elegans	Treatment: 19?C; Feeding: OP50; Genotype: met-2(n4256);set-25(ok5021)	NULL	3130	chip_control	NULL	N2 strain(developmental stage: young adults)	NULL
EXP064960	ChIP Input	Caenorhabditis elegans	Treatment: 19?C; Feeding: OP50; Genotype: met-2(n4256);set-25(ok5021);set-32(ok1457)	NULL	3130	chip_control	NULL	N2 strain(developmental stage: young adults)	NULL
EXP064961	ChIP Input	Caenorhabditis elegans	Treatment: 19?C; Feeding: OP50; Genotype: hrde-1 (tm-1200)	NULL	3130	chip_control	NULL	N2 strain(developmental stage: young adults)	NULL
EXP064977		Drosophila melanogaster	Treatment: Treatment: none; Strain: Canton S	NULL	1987	chip_control	NULL	eye-antennal discs (developmental stage: L3)	NULL
EXP064978		Drosophila melanogaster	Treatment: Treatment: none; Strain: Canton S	NULL	1987	chip_control	NULL	eye-antennal discs (developmental stage: L3)	NULL
EXP064979	anti-ey (provided by Dr. U. Walldorf)	Drosophila melanogaster	Treatment: Treatment: none; Strain: Canton S	EXP064978	1987	normal	O18381	eye-antennal discs (developmental stage: L3)	NULL
EXP064980	anti-ey (provided by Dr. U. Walldorf)	Drosophila melanogaster	Treatment: Treatment: none; Strain: Canton S	EXP064978	1987	normal	O18381	eye-antennal discs (developmental stage: L3)	NULL
EXP064984	none	Homo sapiens	Treatment: Treatment: none	NULL	430	chip_control	NULL	HepG2 (hepatoblastoma)	NULL